Entries with manually generated images from the JenaLib are marked in bold .
PROTEIN DATA BANK LIST OF IDCODE, RESOLUTION, AND COMPOUND NAMES 1CCM ; -1.00 ; "Ensemble" iterative relaxation matrix approach: a new NMR refinement protocol applied to the solution structure of crambin. 1HFC ; 1.56 ; 1.56 A structure of mature truncated human fibroblast collagenase. 1SSC ; 2.00 ; 1.6-ANGSTROM STRUCTURE OF A SEMISYNTHETIC RIBONUCLEASE CRYSTALLIZED FROM AQUEOUS-ETHANOL - COMPARISON WITH CRYSTALS FROM SALT-SOLUTIONS AND WITH RIBONUCLEASE-A FROM AQUEOUS ALCOHOL-SOLUTIONS. 1PGX ; 1.66 ; 1.67-A X-ray structure of the B2 immunoglobulin-binding domain of streptococcal protein G and comparison to the NMR structure of the B1 domain. 1MYT ; 1.74 ; 1.70 ANGSTROM RESOLUTION STRUCTURE OF MYOGLOBIN FROM YELLOWFIN TUNA - AN EXAMPLE OF A MYOGLOBIN LACKING THE D-HELIX. 1HXN ; 1.80 ; 1.8 A crystal structure of the C-terminal domain of rabbit serum haemopexin. 1THG ; 1.80 ; 1.8 A refined structure of the lipase from Geotrichum candidum. 1FAS ; 1.80 ; 1.9-A resolution structure of fasciculin 1, an anti-acetylcholinesterase toxin from green mamba snake venom. 1CSC ; 1.70 ; 1.9-A structures of ternary complexes of citrate synthase with D- and L- malate: mechanistic implications. 2CSC ; 1.70 ; 1.9-A structures of ternary complexes of citrate synthase with D- and L- malate: mechanistic implications. 3CSC ; 1.90 ; 1.9-A structures of ternary complexes of citrate synthase with D- and L- malate: mechanistic implications. 4CSC ; 1.90 ; 1.9-A structures of ternary complexes of citrate synthase with D- and L- malate: mechanistic implications. 1SRB ; -1.00 ; 1H NMR studies of sarafotoxin SRTb, a nonselective endothelin receptor agonist, and IRL 1620, an ETB receptor-specific agonist. 1DOX ; -1.00 ; 1H and 15N NMR sequential assignment, secondary structure, and tertiary fold of [2Fe-2S] ferredoxin from Synechocystis sp. PCC 6803. 1DOY ; -1.00 ; 1H and 15N NMR sequential assignment, secondary structure, and tertiary fold of [2Fe-2S] ferredoxin from Synechocystis sp. PCC 6803. 1SRL ; -1.00 ; 1H and 15N assignments and secondary structure of the Src SH3 domain. 1SRM ; -1.00 ; 1H and 15N assignments and secondary structure of the Src SH3 domain. 1IFM ; 3.30 ; 2 FORMS OF PF1 INOVIRUS - X-RAY-DIFFRACTION STUDIES ON A STRUCTURAL PHASE-TRANSITION AND A CALCULATED LIBRATION NORMAL MODE OF THE ASYMMETRIC UNIT. 1APM ; 2.00 ; 2.0-ANGSTROM REFINED CRYSTAL-STRUCTURE OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN-KINASE COMPLEXED WITH A PEPTIDE INHIBITOR AND DETERGENT. 1WGC ; 2.20 ; 2.2 A resolution structure analysis of two refined N-acetylneuraminyl- lactose--wheat germ agglutinin isolectin complexes. 1HAR ; 2.20 ; 2.2 A resolution structure of the amino-terminal half of HIV-1 reverse transcriptase (fingers and palm subdomains). 1DCC ; 2.20 ; 2.2 A structure of oxy-peroxidase as a model for the transient enzyme: peroxide complex. 1ATP ; 2.20 ; 2.2-ANGSTROM REFINED CRYSTAL-STRUCTURE OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN-KINASE COMPLEXED WITH MNATP AND A PEPTIDE INHIBITOR. 1RPL ; 2.30 ; 2.3 A crystal structure of the catalytic domain of DEOXYRIBONUCLEIC ACID polymerase beta. 1BAF ; 2.90 ; 2.9 A resolution structure of an anti-dinitrophenyl-spin-label monoclonal antibody Fab fragment with bound hapten. 1VSG ; 2.90 ; 2.9 A resolution structure of the N-terminal domain of a variant surface glycoprotein from Trypanosoma brucei. 1IGI ; 2.70 ; 26-10 Fab-digoxin complex: affinity and specificity due to surface complementarity. 1IGJ ; 2.50 ; 26-10 Fab-digoxin complex: affinity and specificity due to surface complementarity. 1HRS ; 2.60 ; A CRYSTALLOGRAPHIC STUDY OF HEME-BINDING TO FERRITIN. 1D89 ; 2.30 ; A DEOXYRIBONUCLEIC ACID dodecamer containing an adenine tract crystallizes in a unique lattice and exhibits a new bend. 1AYP ; 2.57 ; A PROBE MOLECULE COMPOSED OF 17-PERCENT OF TOTAL DIFFRACTING MATTER GIVES CORRECT SOLUTIONS IN MOLECULAR REPLACEMENT. 1APB ; 1.76 ; A Pro to Gly mutation in the hinge of the arabinose-binding protein enhances binding and alters specificity. Sugar-binding and crystallographic studies. 1BAP ; 1.75 ; A Pro to Gly mutation in the hinge of the arabinose-binding protein enhances binding and alters specificity. Sugar-binding and crystallographic studies. 9ABP ; 1.97 ; A Pro to Gly mutation in the hinge of the arabinose-binding protein enhances binding and alters specificity. Sugar-binding and crystallographic studies. 1GBS ; 1.80 ; A STRATEGY FOR RAPID AND EFFECTIVE REFINEMENT APPLIED TO BLACK SWAN LYSOZYME. 1LPM ; 2.20 ; A STRUCTURAL BASIS FOR THE CHIRAL PREFERENCES OF LIPASES. 1LPS ; 2.20 ; A STRUCTURAL BASIS FOR THE CHIRAL PREFERENCES OF LIPASES. 1GHA ; 2.20 ; A STRUCTURAL EXPLANATION FOR ENZYME MEMORY IN NONAQUEOUS SOLVENTS. 1GHB ; 2.00 ; A STRUCTURAL EXPLANATION FOR ENZYME MEMORY IN NONAQUEOUS SOLVENTS. 2DND ; 2.20 ; A bifurcated hydrogen-bonded conformation in the d(A.T) base pairs of the DEOXYRIBONUCLEIC ACID dodecamer d(CGCAAATTTGCG) and its complex with distamycin. 1MBL ; 2.00 ; A catalytically-impaired class A beta-lactamase: 2 A crystal structure and kinetics of the Bacillus licheniformis E166A mutant. 1CPD ; 2.20 ; A cation binding motif stabilizes the compound I radical of cytochrome c peroxidase. 1CPE ; 2.20 ; A cation binding motif stabilizes the compound I radical of cytochrome c peroxidase. 1CPF ; 2.20 ; A cation binding motif stabilizes the compound I radical of cytochrome c peroxidase. 1CPG ; 2.20 ; A cation binding motif stabilizes the compound I radical of cytochrome c peroxidase. 1L83 ; 1.70 ; A cavity-containing mutant of T4 lysozyme is stabilized by buried benzene. 1L84 ; 1.90 ; A cavity-containing mutant of T4 lysozyme is stabilized by buried benzene. 1HBV ; 2.30 ; A check on rational drug design: crystal structure of a complex of human immunodeficiency virus type 1 protease with a novel gamma-turn mimetic inhibitor. 1CEC ; 2.15 ; A common protein fold and similar active site in two distinct families of beta-glycanases. 1XYZ ; 1.40 ; A common protein fold and similar active site in two distinct families of beta-glycanases. 2HWB ; 3.00 ; A comparison of the anti-rhinoviral drug binding pocket in HRV14 and HRV1A. 2HWC ; 3.00 ; A comparison of the anti-rhinoviral drug binding pocket in HRV14 and HRV1A. 2HWD ; 3.80 ; A comparison of the anti-rhinoviral drug binding pocket in HRV14 and HRV1A. 2HWE ; 3.80 ; A comparison of the anti-rhinoviral drug binding pocket in HRV14 and HRV1A. 2HWF ; 3.80 ; A comparison of the anti-rhinoviral drug binding pocket in HRV14 and HRV1A. 3LDH ; 3.00 ; A comparison of the structures of apo dogfish M4 lactate dehydrogenase and its ternary complexes. 2SBT ; 2.80 ; A comparison of the three-dimensional structures of subtilisin BPN' and subtilisin novo. 1IKF ; 2.50 ; A conformation of cyclosporin A in aqueous environment revealed by the X-ray structure of a cyclosporin-Fab complex. 148L ; 1.90 ; A covalent enzyme-substrate intermediate with saccharide distortion in a mutant T4 lysozyme. 4RUB ; 2.70 ; A crystal form of ribulose-1,5-bisphosphate carboxylase/oxygenase from Nicotiana tabacum in the activated state. 227D ; 2.20 ; A crystallographic and spectroscopic study of the complex between d(CGCGAATTCGCG)2 and 2,5-bis(4-guanylphenyl)furan, an analogue of berenil. Structural origins of enhanced DEOXYRIBONUCLEIC ACID-binding affinity. 1HPG ; 1.50 ; A glutamic acid specific serine protease utilizes a novel histidine triad in substrate binding. 1YTS ; 2.50 ; A ligand-induced conformational change in the Yersinia protein tyrosine phosphatase. 1XIS ; 1.60 ; A metal-mediated hydride shift mechanism for xylose isomerase based on the 1.6 A Streptomyces rubiginosus structures with xylitol and D-xylose. 2XIS ; 1.71 ; A metal-mediated hydride shift mechanism for xylose isomerase based on the 1.6 A Streptomyces rubiginosus structures with xylitol and D-xylose. 3XIS ; 1.60 ; A metal-mediated hydride shift mechanism for xylose isomerase based on the 1.6 A Streptomyces rubiginosus structures with xylitol and D-xylose. 4XIS ; 1.60 ; A metal-mediated hydride shift mechanism for xylose isomerase based on the 1.6 A Streptomyces rubiginosus structures with xylitol and D-xylose. 5TGL ; 3.00 ; A model for interfacial activation in lipases from the structure of a fungal lipase-inhibitor complex. 1HDA ; 2.20 ; A novel allosteric mechanism in haemoglobin. Structure of bovine deoxyhaemoglobin, absence of specific chloride-binding sites and origin of the chloride-linked Bohr effect in bovine and human haemoglobin. 1TNS ; -1.00 ; A novel class of winged helix-turn-helix protein: the DEOXYRIBONUCLEIC ACID-binding domain of Mu transposase. 1TNT ; -1.00 ; A novel class of winged helix-turn-helix protein: the DEOXYRIBONUCLEIC ACID-binding domain of Mu transposase. 1HUL ; 2.40 ; A novel dimer configuration revealed by the crystal structure at 2.4 A resolution of human interleukin-5. 1MOA ; 1.90 ; A novel site-directed mutant of myoglobin with an unusually high O2 affinity and low autooxidation rate. 2SPL ; 1.70 ; A novel site-directed mutant of myoglobin with an unusually high O2 affinity and low autooxidation rate. 2SPM ; 1.70 ; A novel site-directed mutant of myoglobin with an unusually high O2 affinity and low autooxidation rate. 2SPN ; 1.70 ; A novel site-directed mutant of myoglobin with an unusually high O2 affinity and low autooxidation rate. 2SPO ; 1.70 ; A novel site-directed mutant of myoglobin with an unusually high O2 affinity and low autooxidation rate. 1ESC ; 2.10 ; A novel variant of the catalytic triad in the Streptomyces scabies esterase. 1GB1 ; -1.00 ; A novel, highly stable fold of the immunoglobulin binding domain of streptococcal protein G. 2GB1 ; -1.00 ; A novel, highly stable fold of the immunoglobulin binding domain of streptococcal protein G. 1VHH ; 1.70 ; A potential catalytic site revealed by the 1.7-A crystal structure of the amino-terminal signalling domain of Sonic hedgehog. 1ADD ; 2.40 ; A pre-transition-state mimic of an enzyme: X-ray structure of adenosine deaminase with bound 1-deazaadenosine and zinc-activated water. 1TGL ; 1.90 ; A serine protease triad forms the catalytic centre of a triacylglycerol lipase. 1INV ; 2.40 ; A sialic acid-derived phosphonate analog inhibits different strains of influenza virus neuraminidase with different efficiencies. 1INW ; 2.40 ; A sialic acid-derived phosphonate analog inhibits different strains of influenza virus neuraminidase with different efficiencies. 1INX ; 2.40 ; A sialic acid-derived phosphonate analog inhibits different strains of influenza virus neuraminidase with different efficiencies. 1INY ; 2.40 ; A sialic acid-derived phosphonate analog inhibits different strains of influenza virus neuraminidase with different efficiencies. 161D ; 1.90 ; A single 2'-hydroxyl group converts B-DEOXYRIBONUCLEIC ACID to A-DEOXYRIBONUCLEIC ACID. Crystal structure of the DEOXYRIBONUCLEIC ACID-RIBONUCLEIC ACID chimeric decamer duplex d(CCGGC)r(G)d(CCGG) with a novel intermolecular G-C base-paired quadruplet. 1EPL ; 2.00 ; A structural comparison of 21 inhibitor complexes of the aspartic proteinase from Endothia parasitica. 1EPM ; 1.60 ; A structural comparison of 21 inhibitor complexes of the aspartic proteinase from Endothia parasitica. 1EPN ; 1.60 ; A structural comparison of 21 inhibitor complexes of the aspartic proteinase from Endothia parasitica. 1EPR ; 2.30 ; A structural comparison of 21 inhibitor complexes of the aspartic proteinase from Endothia parasitica. 1AGS ; 2.50 ; A surface mutant (G82R) of a human alpha-glutathione S-transferase shows decreased thermal stability and a new mode of molecular association in the crystal. 225D ; -1.00 ; A tetrameric DEOXYRIBONUCLEIC ACID structure with protonated cytosine.cytosine base pairs. 1BBB ; 1.70 ; A third quaternary structure of human hemoglobin A at 1.7-A resolution. 1RMN ; -1.00 ; A three-dimensional model for the hammerhead ribozyme based on fluorescence measurements. 198D ; 1.97 ; A trigonal form of the idarubicin:d(CGATCG) complex; crystal and molecular structure at 2.0 A resolution. 1CSH ; 1.60 ; A very short hydrogen bond provides only moderate stabilization of an enzyme-inhibitor complex of citrate synthase. 1CSI ; 1.70 ; A very short hydrogen bond provides only moderate stabilization of an enzyme-inhibitor complex of citrate synthase. 1AMT ; 1.50 ; A voltage-gated ion channel model inferred from the crystal structure of alamethicin at 1.5-A resolution. 1PNC ; 1.60 ; ACCURACY AND PRECISION IN PROTEIN CRYSTAL-STRUCTURE ANALYSIS - 2 INDEPENDENT REFINEMENTS OF THE STRUCTURE OF POPLAR PLASTOCYANIN AT 173-K. 1PND ; 1.60 ; ACCURACY AND PRECISION IN PROTEIN CRYSTAL-STRUCTURE ANALYSIS - 2 INDEPENDENT REFINEMENTS OF THE STRUCTURE OF POPLAR PLASTOCYANIN AT 173-K. 1ACX ; 2.00 ; ACTINOXANTHIN STRUCTURE AT THE ATOMIC LEVEL. 1FPC ; 2.30 ; ACTIVE-SITE MIMETIC INHIBITION OF THROMBIN. 110D ; 1.90 ; ANTHRACYCLINE DEOXYRIBONUCLEIC ACID INTERACTIONS AT UNFAVORABLE BASE-PAIR TRIPLET-BINDING SITES - STRUCTURES OF D(CGGCCG) DAUNOMYCIN AND D(TGGCCA) ADRIAMYCIN COMPLEXES. 1DA9 ; 1.70 ; ANTHRACYCLINE DEOXYRIBONUCLEIC ACID INTERACTIONS AT UNFAVORABLE BASE-PAIR TRIPLET-BINDING SITES - STRUCTURES OF D(CGGCCG) DAUNOMYCIN AND D(TGGCCA) ADRIAMYCIN COMPLEXES. 1ECM ; 2.20 ; ATOMIC-STRUCTURE OF THE BURIED CATALYTIC POCKET OF ESCHERICHIA-COLI CHORISMATE MUTASE. 1TYN ; 2.00 ; ATOMIC-STRUCTURE OF THE TRYPSIN CYCLOTHEONAMIDE A COMPLEX - LESSONS FOR THE DESIGN OF SERINE-PROTEASE INHIBITORS. 1STA ; 1.70 ; Accommodation of insertion mutations on the surface and in the interior of staphylococcal nuclease. 1STB ; 2.00 ; Accommodation of insertion mutations on the surface and in the interior of staphylococcal nuclease. 1PLC ; 1.33 ; Accuracy and precision in protein structure analysis: restrained least- squares refinement of the structure of poplar plastocyanin at 1.33 A resolution. 1SNM ; 1.74 ; Active site mutant Glu-43----Asp in staphylococcal nuclease displays nonlocal structural changes. 1ORB ; 2.00 ; Active site structural features for chemically modified forms of rhodanese. 1MAE ; 2.80 ; Active site structure of methylamine dehydrogenase: hydrazines identify C6 as the reactive site of the tryptophan-derived quinone cofactor. 1MAF ; 2.60 ; Active site structure of methylamine dehydrogenase: hydrazines identify C6 as the reactive site of the tryptophan-derived quinone cofactor. 1ALD ; 2.00 ; Activity and specificity of human aldolases. 3AAT ; 2.80 ; Activity and structure of the active-site mutants R386Y and R386F of Escherichia coli aspartate aminotransferase. 1NDP ; 2.20 ; Adenosine 5'-diphosphate binding and the active site of nucleoside diphosphate kinase. 1ADL ; 1.60 ; Adipocyte lipid-binding protein complexed with arachidonic acid. Titration calorimetry and X-ray crystallographic studies. 1HML ; 1.70 ; Alpha-lactalbumin possesses a distinct zinc binding site. 1MNI ; 2.07 ; Alteration of axial coordination by protein engineering in myoglobin. Bisimidazole ligation in the His64-->Val/Val68-->His double mutant. 3CCX ; 2.30 ; Altering substrate specificity at the heme edge of cytochrome c peroxidase. 4CCX ; 1.90 ; Altering substrate specificity at the heme edge of cytochrome c peroxidase. 12CA ; 2.40 ; Altering the mouth of a hydrophobic pocket. Structure and kinetics of human carbonic anhydrase II mutants at residue Val-121. 5ZNF ; -1.00 ; Alternating zinc fingers in the human male associated protein ZFY: 2D NMR structure of an even finger and implications for "jumping-linker" DEOXYRIBONUCLEIC ACID recognition. 7ZNF ; -1.00 ; Alternating zinc fingers in the human male associated protein ZFY: 2D NMR structure of an even finger and implications for "jumping-linker" DEOXYRIBONUCLEIC ACID recognition. 4CLA ; 2.00 ; Alternative binding modes for chloramphenicol and 1-substituted chloramphenicol analogues revealed by site-directed mutagenesis and X-ray crystallography of chloramphenicol acetyltransferase. 1SIP ; 2.30 ; Alternative native flap conformation revealed by 2.3 A resolution structure of SIV proteinase. 1D56 ; 1.70 ; Alternative structures for alternating poly(dA-dT) tracts: the structure of the B-DEOXYRIBONUCLEIC ACID decamer C-G-A-T-A-T-A-T-C-G. 1D57 ; 2.00 ; Alternative structures for alternating poly(dA-dT) tracts: the structure of the B-DEOXYRIBONUCLEIC ACID decamer C-G-A-T-A-T-A-T-C-G. 1HLM ; 2.90 ; Amino acid sequence of a globin from the sea cucumber Caudina (Molpadia) arenicola. 1SPD ; 2.40 ; Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. 2LET ; -1.00 ; An 1H NMR determination of the three-dimensional structures of mirror-image forms of a Leu-5 variant of the trypsin inhibitor from Ecballium elaterium (EETI-II). 1NHR ; 2.10 ; An L40C mutation converts the cysteine-sulfenic acid redox center in enterococcal NADH peroxidase to a disulfide. 1NHS ; 2.10 ; An L40C mutation converts the cysteine-sulfenic acid redox center in enterococcal NADH peroxidase to a disulfide. 1BDK ; -1.00 ; An NMR, CD, molecular dynamics, and fluorometric study of the conformation of the bradykinin antagonist B-9340 in water and in aqueous micellar solutions. 1PUT ; -1.00 ; An NMR-derived model for the solution structure of oxidized putidaredoxin, a 2-Fe, 2-S ferredoxin from Pseudomonas. 1DGD ; 2.80 ; An alkali metal ion size-dependent switch in the active site structure of dialkylglycine decarboxylase. 1DGE ; 2.80 ; An alkali metal ion size-dependent switch in the active site structure of dialkylglycine decarboxylase. 2ACQ ; 1.76 ; An anion binding site in human aldose reductase: mechanistic implications for the binding of citrate, cacodylate, and glucose 6-phosphate. 2ACR ; 1.76 ; An anion binding site in human aldose reductase: mechanistic implications for the binding of citrate, cacodylate, and glucose 6-phosphate. 2ACS ; 1.76 ; An anion binding site in human aldose reductase: mechanistic implications for the binding of citrate, cacodylate, and glucose 6-phosphate. 1CBV ; 2.66 ; An autoantibody to single-stranded DEOXYRIBONUCLEIC ACID: comparison of the three-dimensional structures of the unliganded Fab and a deoxynucleotide-Fab complex. 1NBV ; 2.00 ; An autoantibody to single-stranded DEOXYRIBONUCLEIC ACID: comparison of the three-dimensional structures of the unliganded Fab and a deoxynucleotide-Fab complex. 1PIO ; 2.80 ; An engineered Staphylococcus aureus PC1 beta-lactamase that hydrolyses third-generation cephalosporins. 4P2P ; 2.40 ; An independent crystallographic refinement of porcine phospholipase A2 at 2.4 A resolution. 1SBG ; 2.30 ; An orally bioavailable HIV-1 protease inhibitor containing an imidazole-derived peptide bond replacement: crystallographic and pharmacokinetic analysis. 1ADS ; 1.60 ; An unlikely sugar substrate site in the 1.65 A structure of the human aldose reductase holoenzyme implicated in diabetic complications. 1TIA ; 2.00 ; An unusual buried polar cluster in a family of fungal lipases. 1TFG ; 1.95 ; An unusual feature revealed by the crystal structure at 2.2 A resolution of human transforming growth factor-beta 2. 8LYZ ; 2.50 ; An x-ray study of the structure and binding properties of iodine-inactivated lysozyme. 1ELA ; 1.80 ; Analogous inhibitors of elastase do not always bind analogously. 1ELB ; 2.10 ; Analogous inhibitors of elastase do not always bind analogously. 1ELC ; 1.75 ; Analogous inhibitors of elastase do not always bind analogously. 1LPN ; 2.20 ; Analogs of reaction intermediates identify a unique substrate binding site in Candida rugosa lipase. 1LPO ; 2.20 ; Analogs of reaction intermediates identify a unique substrate binding site in Candida rugosa lipase. 1LPP ; 2.05 ; Analogs of reaction intermediates identify a unique substrate binding site in Candida rugosa lipase. 1EPP ; 1.90 ; Analyses of ligand binding in five endothiapepsin crystal complexes and their use in the design and evaluation of novel renin inhibitors. 1EPQ ; 1.90 ; Analyses of ligand binding in five endothiapepsin crystal complexes and their use in the design and evaluation of novel renin inhibitors. 2CRD ; -1.00 ; Analysis of side-chain organization on a refined model of charybdotoxin: structural and functional implications. 1L55 ; 1.90 ; Analysis of the interaction between charged side chains and the alpha-helix dipole using designed thermostable mutants of phage T4 lysozyme. 1L57 ; 1.90 ; Analysis of the interaction between charged side chains and the alpha-helix dipole using designed thermostable mutants of phage T4 lysozyme. 1L59 ; 1.75 ; Analysis of the interaction between charged side chains and the alpha-helix dipole using designed thermostable mutants of phage T4 lysozyme. 1L61 ; 1.80 ; Analysis of the interaction between charged side chains and the alpha-helix dipole using designed thermostable mutants of phage T4 lysozyme. 1L62 ; 1.70 ; Analysis of the interaction between charged side chains and the alpha-helix dipole using designed thermostable mutants of phage T4 lysozyme. 1L63 ; 1.75 ; Analysis of the interaction between charged side chains and the alpha-helix dipole using designed thermostable mutants of phage T4 lysozyme. 1ITM ; -1.00 ; Analysis of the solution structure of human interleukin-4 determined by heteronuclear three-dimensional nuclear magnetic resonance techniques. 1GES ; 1.74 ; Anatomy of an engineered NAD-binding site. 1GET ; 2.00 ; Anatomy of an engineered NAD-binding site. 1GEU ; 2.20 ; Anatomy of an engineered NAD-binding site. 1D54 ; 1.40 ; Anthracycline binding to DEOXYRIBONUCLEIC ACID. High-resolution structure of d(TGTACA) complexed with 4'-epiadriamycin. 1MBA ; 1.60 ; Aplysia limacina myoglobin. Crystallographic analysis at 1.6 A resolution. 3MBA ; 2.00 ; Aplysia limacina myoglobin. Crystallographic analysis at 1.6 A resolution. 4MBA ; 2.00 ; Aplysia limacina myoglobin. Crystallographic analysis at 1.6 A resolution. 1ULA ; 2.75 ; Application of crystallographic and modeling methods in the design of purine nucleoside phosphorylase inhibitors. 1ULB ; 2.75 ; Application of crystallographic and modeling methods in the design of purine nucleoside phosphorylase inhibitors. 1GLN ; 2.50 ; Architectures of class-defining and specific domains of glutamyl-tRNA synthetase. 1MYL ; 2.40 ; Are buried salt bridges important for protein stability and conformational specificity? [see comments] 1ACM ; 2.80 ; Arginine 54 in the active site of Escherichia coli aspartate transcarbamoylase is critical for catalysis: a site-specific mutagenesis, NMR, and X-ray crystallographic study. 1XIM ; 2.20 ; Arginine residues as stabilizing elements in proteins. 2XIM ; 2.30 ; Arginine residues as stabilizing elements in proteins. 3XIM ; 2.30 ; Arginine residues as stabilizing elements in proteins. 1CYL ; -1.00 ; Aspects of receptor binding and signalling of interleukin-4 investigated by site-directed mutagenesis and NMR spectroscopy. 2CYK ; -1.00 ; Aspects of receptor binding and signalling of interleukin-4 investigated by site-directed mutagenesis and NMR spectroscopy. 1CEY ; -1.00 ; Assignments, secondary structure, global fold, and dynamics of chemotaxis Y protein using three- and four-dimensional heteronuclear (13C,15N) NMR spectroscopy. 1CLP ; 2.80 ; At the interface: crystal structures of phospholipases A2. 1SBT ; 2.50 ; Atomic coordinates for subtilisin BPN' (or Novo). 1VAS ; 2.75 ; Atomic model of a pyrimidine dimer excision repair enzyme complexed with a DEOXYRIBONUCLEIC ACID substrate: structural basis for damaged DEOXYRIBONUCLEIC ACID recognition. 1HRB ; 5.50 ; Atomic models for the polypeptide backbones of myohemerythrin and hemerythrin. 1CBN ; 0.83 ; Atomic resolution (0.83 A) crystal structure of the hydrophobic protein crambin at 130 K. 1FKF ; 1.70 ; Atomic structure of FKBP-FK506, an immunophilin-immunosuppressant complex. 1BBH ; 1.80 ; Atomic structure of a cytochrome c' with an unusual ligand-controlled dimer dissociation at 1.8 A resolution. 2ADA ; 2.40 ; Atomic structure of adenosine deaminase complexed with a transition-state analog: understanding catalysis and immunodeficiency mutations. 1HJR ; 2.50 ; Atomic structure of the RuvC resolvase: a holliday junction-specific endonuclease from E. coli. 1ATN ; 2.80 ; Atomic structure of the actin:DNase I complex. 1EAA ; 2.60 ; Atomic structure of the cubic core of the pyruvate dehydrogenase multienzyme complex. 1EAB ; 2.60 ; Atomic structure of the cubic core of the pyruvate dehydrogenase multienzyme complex. 1EAC ; 2.60 ; Atomic structure of the cubic core of the pyruvate dehydrogenase multienzyme complex. 1EAD ; 2.60 ; Atomic structure of the cubic core of the pyruvate dehydrogenase multienzyme complex. 1EAE ; 3.00 ; Atomic structure of the cubic core of the pyruvate dehydrogenase multienzyme complex. 1EAF ; 2.30 ; Atomic structure of the cubic core of the pyruvate dehydrogenase multienzyme complex. 1GFF ; 3.00 ; Atomic structure of the degraded procapsid particle of the bacteriophage G4: induced structural changes in the presence of calcium ions and functional implications. 1TPS ; 1.90 ; Atomic structure of the trypsin-A90720A complex: a unified approach to structure and function. 1SOS ; 2.50 ; Atomic structures of wild-type and thermostable mutant recombinant human Cu,Zn superoxide dismutase. 1RNR ; 2.50 ; Autocatalytic generation of dopa in the engineered protein R2 F208Y from Escherichia coli ribonucleotide reductase and crystal structure of the dopa-208 protein. 1FRH ; 2.30 ; Azotobacter vinelandii ferredoxin I. Alteration of individual surface charges and the [4FE-4S]2+/+ cluster reduction potential. 1FRI ; 2.10 ; Azotobacter vinelandii ferredoxin I. Alteration of individual surface charges and the [4FE-4S]2+/+ cluster reduction potential. 1FRJ ; 2.30 ; Azotobacter vinelandii ferredoxin I. Alteration of individual surface charges and the [4FE-4S]2+/+ cluster reduction potential. 1FRK ; 2.10 ; Azotobacter vinelandii ferredoxin I. Alteration of individual surface charges and the [4FE-4S]2+/+ cluster reduction potential. 1FRL ; 2.30 ; Azotobacter vinelandii ferredoxin I. Alteration of individual surface charges and the [4FE-4S]2+/+ cluster reduction potential. 1FRM ; 2.30 ; Azotobacter vinelandii ferredoxin I. Alteration of individual surface charges and the [4FE-4S]2+/+ cluster reduction potential. 1FDD ; 1.90 ; Azotobacter vinelandii ferredoxin I. Aspartate 15 facilitates proton transfer to the reduced [3Fe-4S] cluster. 1PIV ; 2.90 ; BINDING OF THE ANTIVIRAL DRUG WIN51711 TO THE SABIN STRAIN OF TYPE-3 POLIOVIRUS - STRUCTURAL COMPARISON WITH DRUG-BINDING IN RHINOVIRUS-14. 1BSR ; 1.90 ; BOVINE SEMINAL RIBONUCLEASE - STRUCTURE AT 1.9-ANGSTROM RESOLUTION. 1DNS ; 2.00 ; Base only binding of spermine in the deep groove of the A-DEOXYRIBONUCLEIC ACID octamer d(GTGTACAC). 1D40 ; 1.30 ; Base-specific binding of copper(II) to Z-DEOXYRIBONUCLEIC ACID. The 1.3-A single crystal structure of d(m5CGUAm5CG) in the presence of CuCl2. 2BLM ; 2.00 ; Beta-lactamase of Bacillus licheniformis 749/C at 2 A resolution. 4BLM ; 2.00 ; Beta-lactamase of Bacillus licheniformis 749/C. Refinement at 2 A resolution and analysis of hydration. 5MBA ; 1.90 ; Binding mode of azide to ferric Aplysia limacina myoglobin. Crystallographic analysis at 1.9 A resolution. 8BNA ; 2.20 ; Binding of Hoechst 33258 to the minor groove of B-DEOXYRIBONUCLEIC ACID. 1TMN ; 1.90 ; Binding of N-carboxymethyl dipeptide inhibitors to thermolysin determined by X-ray crystallography: a novel class of transition-state analogues for zinc peptidases. 1SPR ; 2.50 ; Binding of a high affinity phosphotyrosyl peptide to the Src SH2 domain: crystal structures of the complexed and peptide-free forms. 1SPS ; 2.70 ; Binding of a high affinity phosphotyrosyl peptide to the Src SH2 domain: crystal structures of the complexed and peptide-free forms. 3APR ; 1.80 ; Binding of a reduced peptide inhibitor to the aspartic proteinase from Rhizopus chinensis: implications for a mechanism of action. 6BNA ; 2.21 ; Binding of an antitumor drug to DEOXYRIBONUCLEIC ACID, Netropsin and C-G-C-G-A-A-T-T-BrC-G-C-G. 1PAD ; 2.80 ; Binding of chloromethyl ketone substrate analogues to crystalline papain. 2PAD ; 2.80 ; Binding of chloromethyl ketone substrate analogues to crystalline papain. 4PAD ; 2.80 ; Binding of chloromethyl ketone substrate analogues to crystalline papain. 5PAD ; 2.80 ; Binding of chloromethyl ketone substrate analogues to crystalline papain. 6PAD ; 2.80 ; Binding of chloromethyl ketone substrate analogues to crystalline papain. 4TLN ; 2.30 ; Binding of hydroxamic acid inhibitors to crystalline thermolysin suggests a pentacoordinate zinc intermediate in catalysis. 5TLN ; 2.30 ; Binding of hydroxamic acid inhibitors to crystalline thermolysin suggests a pentacoordinate zinc intermediate in catalysis. 1HGD ; 2.70 ; Binding of influenza virus hemagglutinin to analogs of its cell-surface receptor, sialic acid: analysis by proton nuclear magnetic resonance spectroscopy and X-ray crystallography. 1HGE ; 2.60 ; Binding of influenza virus hemagglutinin to analogs of its cell-surface receptor, sialic acid: analysis by proton nuclear magnetic resonance spectroscopy and X-ray crystallography. 1HGF ; 3.00 ; Binding of influenza virus hemagglutinin to analogs of its cell-surface receptor, sialic acid: analysis by proton nuclear magnetic resonance spectroscopy and X-ray crystallography. 1HGG ; 2.90 ; Binding of influenza virus hemagglutinin to analogs of its cell-surface receptor, sialic acid: analysis by proton nuclear magnetic resonance spectroscopy and X-ray crystallography. 1HGH ; 2.70 ; Binding of influenza virus hemagglutinin to analogs of its cell-surface receptor, sialic acid: analysis by proton nuclear magnetic resonance spectroscopy and X-ray crystallography. 1HGI ; 2.70 ; Binding of influenza virus hemagglutinin to analogs of its cell-surface receptor, sialic acid: analysis by proton nuclear magnetic resonance spectroscopy and X-ray crystallography. 1HGJ ; 2.70 ; Binding of influenza virus hemagglutinin to analogs of its cell-surface receptor, sialic acid: analysis by proton nuclear magnetic resonance spectroscopy and X-ray crystallography. 1D21 ; 1.70 ; Binding of the antitumor drug nogalamycin and its derivatives to DEOXYRIBONUCLEIC ACID: structural comparison. 1D22 ; 1.80 ; Binding of the antitumor drug nogalamycin and its derivatives to DEOXYRIBONUCLEIC ACID: structural comparison. 159D ; 1.80 ; Binding of two distamycin A molecules in the minor groove of an alternating B-DEOXYRIBONUCLEIC ACID duplex. 1ANT ; 3.00 ; Biological implications of a 3 A structure of dimeric antithrombin [see comments] 1VFA ; 1.80 ; Bound water molecules and conformational stabilization help mediate an antigen-antibody association. 1VFB ; 1.80 ; Bound water molecules and conformational stabilization help mediate an antigen-antibody association. 2CGA ; 1.80 ; Bovine chymotrypsinogen A X-ray crystal structure analysis and refinement of a new crystal form at 1.8 A resolution. 1GMP ; 1.70 ; COMPLEX OF RIBONUCLEASE FROM STREPTOMYCES-AUREOFACIENS WITH 2'-GMP AT 1.7-ANGSTROM RESOLUTION. 1GMQ ; 1.80 ; COMPLEX OF RIBONUCLEASE FROM STREPTOMYCES-AUREOFACIENS WITH 2'-GMP AT 1.7-ANGSTROM RESOLUTION. 1GMR ; 1.77 ; COMPLEX OF RIBONUCLEASE FROM STREPTOMYCES-AUREOFACIENS WITH 2'-GMP AT 1.7-ANGSTROM RESOLUTION. 1TNV ; 5.00 ; CRYSTAL STRUCTURAL-ANALYSIS OF TOBACCO NECROSIS VIRUS AT 5 ANGSTROM RESOLUTION. 1DIR ; 2.60 ; CRYSTAL-STRUCTURE OF A MONOCLINIC FORM OF DIHYDROPTERIDINE REDUCTASE FROM RAT-LIVER. 1CHR ; 3.00 ; CRYSTAL-STRUCTURE OF CHLOROMUCONATE CYCLOISOMERASE FROM ALCALIGENES-EUTROPHUS JMP134 (PJP4) AT 3 ANGSTROM RESOLUTION. 1GDK ; 1.80 ; CRYSTAL-STRUCTURE OF FERRIC COMPLEX OF THE YELLOW LUPIN LEGHEMOGLOBIN WITH ISOQUINOLINE AT 1.8-A RESOLUTION. 1HPV ; 1.90 ; CRYSTAL-STRUCTURE OF HIV-1 PROTEASE IN COMPLEX WITH VX-478, A POTENT AND ORALLY BIOAVAILABLE INHIBITOR OF THE ENZYME. 1NAR ; 1.80 ; CRYSTAL-STRUCTURE OF NARBONIN AT 1.8-ANGSTROM RESOLUTION. 1LMO ; 1.80 ; CRYSTAL-STRUCTURES OF 3 COMPLEXES BETWEEN CHITO-OLIGOSACCHARIDES AND LYSOZYME FROM THE RAINBOW-TROUT - HOW DISTORTED IS THE NAG SUGAR IN SITE-D. 1LMP ; 2.00 ; CRYSTAL-STRUCTURES OF 3 COMPLEXES BETWEEN CHITO-OLIGOSACCHARIDES AND LYSOZYME FROM THE RAINBOW-TROUT - HOW DISTORTED IS THE NAG SUGAR IN SITE-D. 1LMQ ; 1.60 ; CRYSTAL-STRUCTURES OF 3 COMPLEXES BETWEEN CHITO-OLIGOSACCHARIDES AND LYSOZYME FROM THE RAINBOW-TROUT - HOW DISTORTED IS THE NAG SUGAR IN SITE-D. 1CXA ; 2.20 ; CRYSTALLIZATION AND X-RAY STRUCTURE DETERMINATION OF CYTOCHROME-C(2) FROM RHODOBACTER-SPHAEROIDES IN 3 CRYSTAL FORMS. 1CXC ; 1.60 ; CRYSTALLIZATION AND X-RAY STRUCTURE DETERMINATION OF CYTOCHROME-C(2) FROM RHODOBACTER-SPHAEROIDES IN 3 CRYSTAL FORMS. 2CXB ; 1.95 ; CRYSTALLIZATION AND X-RAY STRUCTURE DETERMINATION OF CYTOCHROME-C(2) FROM RHODOBACTER-SPHAEROIDES IN 3 CRYSTAL FORMS. 1RDH ; 2.80 ; CRYSTALLOGRAPHIC ANALYSES OF AN ACTIVE HIV-1 RIBONUCLEASE H DOMAIN SHOW STRUCTURAL FEATURES THAT DISTINGUISH IT FROM THE INACTIVE FORM. 1SRE ; 1.78 ; CRYSTALLOGRAPHIC AND THERMODYNAMIC COMPARISON OF NATURAL AND SYNTHETIC LIGANDS BOUND TO STREPTAVIDIN. 1PLJ ; 2.80 ; CRYSTALLOGRAPHIC STUDIES ON P21(H-RAS) USING THE SYNCHROTRON LAUE METHOD - IMPROVEMENT OF CRYSTAL QUALITY AND MONITORING OF THE GTPASE REACTION AT DIFFERENT TIME POINTS. 1PLK ; 2.80 ; CRYSTALLOGRAPHIC STUDIES ON P21(H-RAS) USING THE SYNCHROTRON LAUE METHOD - IMPROVEMENT OF CRYSTAL QUALITY AND MONITORING OF THE GTPASE REACTION AT DIFFERENT TIME POINTS. 1PLL ; 2.80 ; CRYSTALLOGRAPHIC STUDIES ON P21(H-RAS) USING THE SYNCHROTRON LAUE METHOD - IMPROVEMENT OF CRYSTAL QUALITY AND MONITORING OF THE GTPASE REACTION AT DIFFERENT TIME POINTS. 2AAA ; 2.10 ; Calcium binding in alpha-amylases: an X-ray diffraction study at 2.1-A resolution of two enzymes from Aspergillus. 3TEC ; 2.00 ; Calcium binding to thermitase. Crystallographic studies of thermitase at 0, 5, and 100 mM calcium. 2C4S ; 3.00 ; Calcium chondroitin 4-sulfate: molecular conformation and organization of polysaccharide chains in a proteoglycan. 1SUB ; 1.75 ; Calcium-independent subtilisin by design. 1SUC ; 1.80 ; Calcium-independent subtilisin by design. 1SUD ; 1.90 ; Calcium-independent subtilisin by design. 1CLL ; 1.70 ; Calmodulin structure refined at 1.7 A resolution. 1CRE ; -1.00 ; Cardiotoxin II from Taiwan cobra venom, Naja naja atra. Structure in solution and comparison among homologous cardiotoxins. 1CRF ; -1.00 ; Cardiotoxin II from Taiwan cobra venom, Naja naja atra. Structure in solution and comparison among homologous cardiotoxins. 1CDT ; 2.50 ; Cardiotoxin VII4 from Naja mossambica mossambica. The refined crystal structure. 4TGL ; 2.60 ; Catalysis at the interface: the anatomy of a conformational change in a triglyceride lipase. 1CGU ; 2.50 ; Catalytic center of cyclodextrin glycosyltransferase derived from X-ray structure analysis combined with site-directed mutagenesis. 1PYD ; 2.40 ; Catalytic centers in the thiamin diphosphate dependent enzyme pyruvate decarboxylase at 2.4-A resolution. 9ICD ; 2.50 ; Catalytic mechanism of NADP(+)-dependent isocitrate dehydrogenase: implications from the structures of magnesium-isocitrate and NADP+ complexes. 1ELS ; 2.40 ; Catalytic metal ion binding in enolase: the crystal structure of an enolase-Mn2+-phosphonoacetohydroxamate complex at 2.4-A resolution. 1GLH ; 2.20 ; Cation binding to a Bacillus (1,3-1,4)-beta-glucanase. Geometry, affinity and effect on protein stability. 1GLC ; 2.65 ; Cation-promoted association of a regulatory and target protein is controlled by protein phosphorylation. 1GLD ; 2.93 ; Cation-promoted association of a regulatory and target protein is controlled by protein phosphorylation. 1GLE ; 2.94 ; Cation-promoted association of a regulatory and target protein is controlled by protein phosphorylation. 3SOD ; 2.10 ; Changes in crystallographic structure and thermostability of a Cu,Zn superoxide dismutase mutant resulting from the removal of a buried cysteine. 1TMT ; 2.20 ; Changes in interactions in complexes of hirudin derivatives and human alpha-thrombin due to different crystal forms. 1TMU ; 2.50 ; Changes in interactions in complexes of hirudin derivatives and human alpha-thrombin due to different crystal forms. 2LDX ; 2.96 ; Characterization of the antigenic sites on the refined 3-A resolution structure of mouse testicular lactate dehydrogenase C4. 1EBG ; 2.10 ; Chelation of serine 39 to Mg2+ latches a gate at the active site of enolase: structure of the bis(Mg2+) complex of yeast enolase and the intermediate analog phosphonoacetohydroxamate at 2.1-A resolution. 1D97 ; 2.17 ; Chiral phosphorothioate analogues of B-DEOXYRIBONUCLEIC ACID. The crystal structure of Rp-d[Gp(S)CpGp(S)CpGp(S)C]. 1C4S ; 3.00 ; Chondroitin 4-sulfate: the structure of a sulfated glycosaminoglycan. 1CHG ; 2.50 ; Chymotrypsinogen: 2.5-angstrom crystal structure, comparison with alpha-chymotrypsin, and implications for zymogen activation. 1ASY ; 3.00 ; Class II aminoacyl transfer RIBONUCLEIC ACID synthetases: crystal structure of yeast aspartyl-tRNA synthetase complexed with tRNA(Asp). 1BLB ; 3.30 ; Close packing of an oligomeric eye lens beta-crystallin induces loss of symmetry and ordering of sequence extensions. 2GD1 ; 2.50 ; Coenzyme-induced conformational changes in glyceraldehyde-3-phosphate dehydrogenase from Bacillus stearothermophilus. 2TBS ; 1.80 ; Cold adaption of enzymes: structural comparison between salmon and bovine trypsins. 1HIH ; 2.20 ; Comparative analysis of the X-ray structures of HIV-1 and HIV-2 proteases in complex with CGP 53820, a novel pseudosymmetric inhibitor. 1HII ; 2.30 ; Comparative analysis of the X-ray structures of HIV-1 and HIV-2 proteases in complex with CGP 53820, a novel pseudosymmetric inhibitor. 1TOR ; -1.00 ; Compared structures of the free nicotinic acetylcholine receptor main immunogenic region (MIR) decapeptide and the antibody-bound [A76]MIR analogue: a molecular dynamics simulation from two-dimensional NMR data. 1KB7 ; -1.00 ; Comparison of NMR solution structures of the receptor binding domains of Pseudomonas aeruginosa pili strains PAO, KB7, and PAK: implications for receptor binding and synthetic vaccine design. 1KB8 ; -1.00 ; Comparison of NMR solution structures of the receptor binding domains of Pseudomonas aeruginosa pili strains PAO, KB7, and PAK: implications for receptor binding and synthetic vaccine design. 1NIL ; -1.00 ; Comparison of NMR solution structures of the receptor binding domains of Pseudomonas aeruginosa pili strains PAO, KB7, and PAK: implications for receptor binding and synthetic vaccine design. 1NIM ; -1.00 ; Comparison of NMR solution structures of the receptor binding domains of Pseudomonas aeruginosa pili strains PAO, KB7, and PAK: implications for receptor binding and synthetic vaccine design. 1PAN ; -1.00 ; Comparison of NMR solution structures of the receptor binding domains of Pseudomonas aeruginosa pili strains PAO, KB7, and PAK: implications for receptor binding and synthetic vaccine design. 1PAO ; -1.00 ; Comparison of NMR solution structures of the receptor binding domains of Pseudomonas aeruginosa pili strains PAO, KB7, and PAK: implications for receptor binding and synthetic vaccine design. 1XIA ; 2.30 ; Comparison of backbone structures of glucose isomerase from Streptomyces and Arthrobacter. 1WTL ; 1.90 ; Comparison of crystal structures of two homologous proteins: structural origin of altered domain interactions in immunoglobulin light-chain dimers. 4MT2 ; 2.00 ; Comparison of the NMR solution structure and the x-ray crystal structure of rat metallothionein-2. 2GPB ; 2.30 ; Comparison of the binding of glucose and glucose 1-phosphate derivatives to T-state glycogen phosphorylase b. 3GPB ; 2.30 ; Comparison of the binding of glucose and glucose 1-phosphate derivatives to T-state glycogen phosphorylase b. 4GPB ; 2.30 ; Comparison of the binding of glucose and glucose 1-phosphate derivatives to T-state glycogen phosphorylase b. 5GPB ; 2.30 ; Comparison of the binding of glucose and glucose 1-phosphate derivatives to T-state glycogen phosphorylase b. 4LZM ; 1.70 ; Comparison of the crystal structure of bacteriophage T4 lysozyme at low, medium, and high ionic strengths. 5LZM ; 1.80 ; Comparison of the crystal structure of bacteriophage T4 lysozyme at low, medium, and high ionic strengths. 6LZM ; 1.80 ; Comparison of the crystal structure of bacteriophage T4 lysozyme at low, medium, and high ionic strengths. 7LZM ; 1.80 ; Comparison of the crystal structure of bacteriophage T4 lysozyme at low, medium, and high ionic strengths. 2FX2 ; 1.90 ; Comparison of the crystal structures of a flavodoxin in its three oxidation states at cryogenic temperatures. 3FX2 ; 1.90 ; Comparison of the crystal structures of a flavodoxin in its three oxidation states at cryogenic temperatures. 4FX2 ; 1.90 ; Comparison of the crystal structures of a flavodoxin in its three oxidation states at cryogenic temperatures. 5FX2 ; 1.90 ; Comparison of the crystal structures of a flavodoxin in its three oxidation states at cryogenic temperatures. 1MSD ; 3.20 ; Comparison of the crystal structures of genetically engineered human manganese superoxide dismutase and manganese superoxide dismutase from Thermus thermophilus: differences in dimer-dimer interaction. 1TPE ; 2.10 ; Comparison of the structures and the crystal contacts of trypanosomal triosephosphate isomerase in four different crystal forms. 1TPF ; 1.80 ; Comparison of the structures and the crystal contacts of trypanosomal triosephosphate isomerase in four different crystal forms. 1LRP ; 3.20 ; Comparison of the structures of cro and lambda repressor proteins from bacteriophage lambda. 7CPA ; 2.00 ; Comparison of the structures of three carboxypeptidase A-phosphonate complexes determined by X-ray crystallography. 8CPA ; 2.00 ; Comparison of the structures of three carboxypeptidase A-phosphonate complexes determined by X-ray crystallography. 1GAD ; 1.80 ; Comparison of the structures of wild-type and a N313T mutant of Escherichia coli glyceraldehyde 3-phosphate dehydrogenases: implication for NAD binding and cooperativity. 1GAE ; 2.17 ; Comparison of the structures of wild-type and a N313T mutant of Escherichia coli glyceraldehyde 3-phosphate dehydrogenases: implication for NAD binding and cooperativity. 1MEE ; 2.00 ; Complex between the subtilisin from a mesophilic bacterium and the leech inhibitor eglin-C. 1ZNA ; 1.60 ; Conformation and dynamics in a Z-DEOXYRIBONUCLEIC ACID tetramer. 1CAP ; 3.00 ; Conformation and molecular organization in fibers of the capsular polysaccharide from Escherichia coli M41 mutant. 127D ; 2.00 ; Conformation of B-DEOXYRIBONUCLEIC ACID containing O6-ethyl-G-C base pairs stabilized by minor groove binding drugs: molecular structure of d(CGC[e6G]AATTCGCG complexed with Hoechst 33258 or Hoechst 33342. 128D ; 2.50 ; Conformation of B-DEOXYRIBONUCLEIC ACID containing O6-ethyl-G-C base pairs stabilized by minor groove binding drugs: molecular structure of d(CGC[e6G]AATTCGCG complexed with Hoechst 33258 or Hoechst 33342. 129D ; 2.25 ; Conformation of B-DEOXYRIBONUCLEIC ACID containing O6-ethyl-G-C base pairs stabilized by minor groove binding drugs: molecular structure of d(CGC[e6G]AATTCGCG complexed with Hoechst 33258 or Hoechst 33342. 130D ; 2.50 ; Conformation of B-DEOXYRIBONUCLEIC ACID containing O6-ethyl-G-C base pairs stabilized by minor groove binding drugs: molecular structure of d(CGC[e6G]AATTCGCG complexed with Hoechst 33258 or Hoechst 33342. 1MRT ; -1.00 ; Conformation of [Cd7]-metallothionein-2 from rat liver in aqueous solution determined by nuclear magnetic resonance spectroscopy. 1D75 ; 2.80 ; Conformation of guanine-8-oxoadenine base pairs in the crystal structure of d(CGCGAATT(O8A)GCG). 1KES ; 3.00 ; Conformation of keratan sulphate. 1ALE ; -1.00 ; Conformation of two peptides corresponding to human apolipoprotein C-I residues 7-24 and 35-53 in the presence of sodium dodecyl sulfate by CD and NMR spectroscopy. 1ALF ; -1.00 ; Conformation of two peptides corresponding to human apolipoprotein C-I residues 7-24 and 35-53 in the presence of sodium dodecyl sulfate by CD and NMR spectroscopy. 1APH ; 2.00 ; Conformational changes in cubic insulin crystals in the pH range 7-11. 1BPH ; 2.00 ; Conformational changes in cubic insulin crystals in the pH range 7-11. 1CPH ; 1.90 ; Conformational changes in cubic insulin crystals in the pH range 7-11. 1DPH ; 1.90 ; Conformational changes in cubic insulin crystals in the pH range 7-11. 1D87 ; 2.25 ; Conformational influence of the ribose 2'-hydroxyl group: crystal structures of DEOXYRIBONUCLEIC ACID-RIBONUCLEIC ACID chimeric duplexes. 1D88 ; 2.00 ; Conformational influence of the ribose 2'-hydroxyl group: crystal structures of DEOXYRIBONUCLEIC ACID-RIBONUCLEIC ACID chimeric duplexes. 1EDP ; -1.00 ; Conformational isomerism of endothelin in acidic aqueous media: a quantitative NOESY analysis. 1TIB ; 1.84 ; Conformational lability of lipases observed in the absence of an oil-water interface: crystallographic studies of enzymes from the fungi Humicola lanuginosa and Rhizopus delemar. 1TIC ; 2.60 ; Conformational lability of lipases observed in the absence of an oil-water interface: crystallographic studies of enzymes from the fungi Humicola lanuginosa and Rhizopus delemar. 5CA2 ; 2.10 ; Conformational mobility of His-64 in the Thr-200----Ser mutant of human carbonic anhydrase II. 4FBP ; 2.50 ; Conformational transition of fructose-1,6-bisphosphatase: structure comparison between the AMP complex (T form) and the fructose 6- phosphate complex (R form). 1OEL ; 2.80 ; Conformational variability in the refined structure of the chaperonin GroEL at 2.8 A resolution. 1MEC ; 3.20 ; Conformational variability of a picornavirus capsid: pH-dependent structural changes of Mengo virus related to its host receptor attachment site and disassembly. 149L ; 2.60 ; Conservation of solvent-binding sites in 10 crystal forms of T4 lysozyme. 150L ; 2.20 ; Conservation of solvent-binding sites in 10 crystal forms of T4 lysozyme. 151L ; 2.20 ; Conservation of solvent-binding sites in 10 crystal forms of T4 lysozyme. 152L ; 2.00 ; Conservation of solvent-binding sites in 10 crystal forms of T4 lysozyme. 3HVP ; 2.80 ; Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease. 1CCE ; 2.30 ; Construction of a bisaquo heme enzyme and binding by exogenous ligands. 1CCG ; 2.10 ; Construction of a bisaquo heme enzyme and binding by exogenous ligands. 1CIS ; -1.00 ; Context dependence of protein secondary structure formation: the three-dimensional structure and stability of a hybrid between chymotrypsin inhibitor 2 and helix E from subtilisin Carlsberg. 1BAN ; 2.20 ; Contribution of buried hydrogen bonds to protein stability. The crystal structures of two barnase mutants. 1BAO ; 2.20 ; Contribution of buried hydrogen bonds to protein stability. The crystal structures of two barnase mutants. 1FFA ; 1.69 ; Contribution of cutinase serine 42 side chain to the stabilization of the oxyanion transition state. 1FFB ; 1.75 ; Contribution of cutinase serine 42 side chain to the stabilization of the oxyanion transition state. 1FFC ; 1.75 ; Contribution of cutinase serine 42 side chain to the stabilization of the oxyanion transition state. 1FFD ; 1.69 ; Contribution of cutinase serine 42 side chain to the stabilization of the oxyanion transition state. 1FFE ; 1.69 ; Contribution of cutinase serine 42 side chain to the stabilization of the oxyanion transition state. 1YAM ; 1.80 ; Contribution of hydrophobic residues to the stability of human lysozyme: calorimetric studies and X-ray structural analysis of the five isoleucine to valine mutants. 1YAN ; 1.80 ; Contribution of hydrophobic residues to the stability of human lysozyme: calorimetric studies and X-ray structural analysis of the five isoleucine to valine mutants. 1YAO ; 1.80 ; Contribution of hydrophobic residues to the stability of human lysozyme: calorimetric studies and X-ray structural analysis of the five isoleucine to valine mutants. 1YAP ; 1.80 ; Contribution of hydrophobic residues to the stability of human lysozyme: calorimetric studies and X-ray structural analysis of the five isoleucine to valine mutants. 1YAQ ; 1.80 ; Contribution of hydrophobic residues to the stability of human lysozyme: calorimetric studies and X-ray structural analysis of the five isoleucine to valine mutants. 1L37 ; 1.85 ; Contributions of engineered surface salt bridges to the stability of T4 lysozyme determined by directed mutagenesis. 1L38 ; 1.80 ; Contributions of engineered surface salt bridges to the stability of T4 lysozyme determined by directed mutagenesis. 1L39 ; 1.85 ; Contributions of engineered surface salt bridges to the stability of T4 lysozyme determined by directed mutagenesis. 1L40 ; 1.85 ; Contributions of engineered surface salt bridges to the stability of T4 lysozyme determined by directed mutagenesis. 1L41 ; 1.75 ; Contributions of engineered surface salt bridges to the stability of T4 lysozyme determined by directed mutagenesis. 1L02 ; 1.70 ; Contributions of hydrogen bonds of Thr 157 to the thermodynamic stability of phage T4 lysozyme. 1L03 ; 1.70 ; Contributions of hydrogen bonds of Thr 157 to the thermodynamic stability of phage T4 lysozyme. 1L04 ; 1.70 ; Contributions of hydrogen bonds of Thr 157 to the thermodynamic stability of phage T4 lysozyme. 1L05 ; 1.70 ; Contributions of hydrogen bonds of Thr 157 to the thermodynamic stability of phage T4 lysozyme. 1L06 ; 1.70 ; Contributions of hydrogen bonds of Thr 157 to the thermodynamic stability of phage T4 lysozyme. 1L07 ; 1.70 ; Contributions of hydrogen bonds of Thr 157 to the thermodynamic stability of phage T4 lysozyme. 1L08 ; 1.70 ; Contributions of hydrogen bonds of Thr 157 to the thermodynamic stability of phage T4 lysozyme. 1L09 ; 1.70 ; Contributions of hydrogen bonds of Thr 157 to the thermodynamic stability of phage T4 lysozyme. 1L11 ; 1.70 ; Contributions of hydrogen bonds of Thr 157 to the thermodynamic stability of phage T4 lysozyme. 1L12 ; 1.70 ; Contributions of hydrogen bonds of Thr 157 to the thermodynamic stability of phage T4 lysozyme. 1L13 ; 1.70 ; Contributions of hydrogen bonds of Thr 157 to the thermodynamic stability of phage T4 lysozyme. 1L14 ; 1.70 ; Contributions of hydrogen bonds of Thr 157 to the thermodynamic stability of phage T4 lysozyme. 1L15 ; 1.70 ; Contributions of hydrogen bonds of Thr 157 to the thermodynamic stability of phage T4 lysozyme. 1L21 ; 1.85 ; Contributions of left-handed helical residues to the structure and stability of bacteriophage T4 lysozyme. 1L22 ; 1.70 ; Contributions of left-handed helical residues to the structure and stability of bacteriophage T4 lysozyme. 1L33 ; 1.70 ; Contributions of left-handed helical residues to the structure and stability of bacteriophage T4 lysozyme. 155L ; 1.85 ; Control of enzyme activity by an engineered disulfide bond. 156L ; 1.80 ; Control of enzyme activity by an engineered disulfide bond. 157L ; 1.85 ; Control of enzyme activity by an engineered disulfide bond. 158L ; 1.80 ; Control of enzyme activity by an engineered disulfide bond. 159L ; 1.80 ; Control of enzyme activity by an engineered disulfide bond. 160L ; 1.80 ; Control of enzyme activity by an engineered disulfide bond. 161L ; 1.70 ; Control of enzyme activity by an engineered disulfide bond. 162L ; 1.80 ; Control of enzyme activity by an engineered disulfide bond. 163L ; 1.80 ; Control of enzyme activity by an engineered disulfide bond. 164L ; 1.80 ; Control of enzyme activity by an engineered disulfide bond. 165L ; 1.75 ; Control of enzyme activity by an engineered disulfide bond. 166L ; 1.75 ; Control of enzyme activity by an engineered disulfide bond. 1ABB ; 2.80 ; Control of phosphorylase b conformation by a modified cofactor: crystallographic studies on R-state glycogen phosphorylase reconstituted with pyridoxal 5'-diphosphate. 1TRB ; 2.00 ; Convergent evolution of similar function in two structurally divergent enzymes. 1GOA ; 1.90 ; Cooperative stabilization of Escherichia coli ribonuclease HI by insertion of Gly-80b and Gly-77-->Ala substitution. 1GOB ; 2.00 ; Cooperative stabilization of Escherichia coli ribonuclease HI by insertion of Gly-80b and Gly-77-->Ala substitution. 1GOC ; 2.00 ; Cooperative stabilization of Escherichia coli ribonuclease HI by insertion of Gly-80b and Gly-77-->Ala substitution. 1CNR ; 1.05 ; Correlated disorder of the pure Pro22/Leu25 form of crambin at 150 K refined to 1.05-A resolution. 2TMD ; 2.40 ; Correlation of x-ray deduced and experimental amino acid sequences of trimethylamine dehydrogenase. 1D39 ; 1.20 ; Covalent modification of guanine bases in double-stranded DEOXYRIBONUCLEIC ACID. The 1.2-A Z-DEOXYRIBONUCLEIC ACID structure of d(CGCGCG) in the presence of CuCl2. 1BPT ; 2.00 ; Crevice-forming mutants in the rigid core of bovine pancreatic trypsin inhibitor: crystal structures of F22A, Y23A, N43G, and F45A. 1BTI ; 2.20 ; Crevice-forming mutants in the rigid core of bovine pancreatic trypsin inhibitor: crystal structures of F22A, Y23A, N43G, and F45A. 1FAN ; 1.95 ; Crevice-forming mutants in the rigid core of bovine pancreatic trypsin inhibitor: crystal structures of F22A, Y23A, N43G, and F45A. 1NAG ; 1.85 ; Crevice-forming mutants in the rigid core of bovine pancreatic trypsin inhibitor: crystal structures of F22A, Y23A, N43G, and F45A. 1SLA ; 2.45 ; Crosslinking of mammalian lectin (galectin-1) by complex biantennary saccharides. 1SLB ; 2.30 ; Crosslinking of mammalian lectin (galectin-1) by complex biantennary saccharides. 1SLC ; 2.15 ; Crosslinking of mammalian lectin (galectin-1) by complex biantennary saccharides. 2AYH ; 1.60 ; Crystal and molecular structure at 0.16-nm resolution of the hybrid Bacillus endo-1,3-1,4-beta-D-glucan 4-glucanohydrolase H(A16-M). 1D24 ; 1.90 ; Crystal and molecular structure of a DEOXYRIBONUCLEIC ACID duplex containing the carcinogenic lesion O6-methylguanine. 1D76 ; 1.30 ; Crystal and molecular structure of a DEOXYRIBONUCLEIC ACID fragment containing a 2-aminoadenine modification: the relationship between conformation, packing, and hydration in Z-DEOXYRIBONUCLEIC ACID hexamers. 1D28 ; 2.70 ; Crystal and molecular structure of a DEOXYRIBONUCLEIC ACID fragment: d(CGTGAATTCACG). 1CAG ; 1.85 ; Crystal and molecular structure of a collagen-like peptide at 1.9 A resolution. 210D ; 1.35 ; Crystal and molecular structure of a new Z-DEOXYRIBONUCLEIC ACID crystal form: d[CGT(2-NH2-A)CG] and its platinated derivative. 211D ; 1.60 ; Crystal and molecular structure of a new Z-DEOXYRIBONUCLEIC ACID crystal form: d[CGT(2-NH2-A)CG] and its platinated derivative. 1AMY ; 2.80 ; Crystal and molecular structure of barley alpha-amylase. 119D ; 2.25 ; Crystal and molecular structure of d(CGTAGATCTACG) at 2.25 A resolution. 118D ; 1.64 ; Crystal and molecular structure of d(GTGCGCAC): investigation of the effects of base sequence on the conformation of octamer duplexes. 1AVH ; 2.30 ; Crystal and molecular structure of human annexin V after refinement. Implications for structure, membrane binding and ion channel formation of the annexin family of proteins. 1AVR ; 2.30 ; Crystal and molecular structure of human annexin V after refinement. Implications for structure, membrane binding and ion channel formation of the annexin family of proteins. 1PK4 ; 1.90 ; Crystal and molecular structure of human plasminogen kringle 4 refined at 1.9-A resolution. 157D ; 1.80 ; Crystal and molecular structure of r(CGCGAAUUAGCG): an RIBONUCLEIC ACID duplex containing two G(anti).A(anti) base pairs. 116D ; 2.50 ; Crystal and molecular structure of the A-DEOXYRIBONUCLEIC ACID dodecamer d(CCGTACGTACGG). Choice of fragment helical axis. 117D ; 2.55 ; Crystal and molecular structure of the alternating dodecamer d(GCGTACGTACGC) in the A-DEOXYRIBONUCLEIC ACID form: comparison with the isomorphous non-alternating dodecamer d(CCGTACGTACGG). 1ACB ; 2.00 ; Crystal and molecular structure of the bovine alpha-chymotrypsin-eglin c complex at 2.0 A resolution. 2CI2 ; 2.00 ; Crystal and molecular structure of the serine proteinase inhibitor CI-2 from barley seeds. 1HTR ; 1.62 ; Crystal and molecular structures of human progastricsin at 1.62 A resolution. 2ATC ; 3.00 ; Crystal and molecular structures of native and CTP-liganded aspartate carbamoyltransferase from Escherichia coli. 1CHO ; 1.80 ; Crystal and molecular structures of the complex of alpha-chymotrypsin with its inhibitor turkey ovomucoid third domain at 1.8 A resolution. 1BDN ; 2.60 ; Crystal lattice packing is important in determining the bend of a DEOXYRIBONUCLEIC ACID dodecamer containing an adenine tract. 1BSA ; 2.00 ; Crystal structural analysis of mutations in the hydrophobic cores of barnase. 1BSB ; 2.00 ; Crystal structural analysis of mutations in the hydrophobic cores of barnase. 1BSC ; 2.00 ; Crystal structural analysis of mutations in the hydrophobic cores of barnase. 1BSD ; 2.30 ; Crystal structural analysis of mutations in the hydrophobic cores of barnase. 1BSE ; 2.00 ; Crystal structural analysis of mutations in the hydrophobic cores of barnase. 4PCY ; 2.15 ; Crystal structure analyses of reduced (CuI) poplar plastocyanin at six pH values. 5PCY ; 1.80 ; Crystal structure analyses of reduced (CuI) poplar plastocyanin at six pH values. 6PCY ; 1.90 ; Crystal structure analyses of reduced (CuI) poplar plastocyanin at six pH values. 4CTS ; 2.90 ; Crystal structure analysis and molecular model of a complex of citrate synthase with oxaloacetate and S-acetonyl-coenzyme A. 2TIR ; 2.00 ; Crystal structure analysis of a mutant Escherichia coli thioredoxin in which lysine 36 is replaced by glutamic acid. 1AAJ ; 1.80 ; Crystal structure analysis of amicyanin and apoamicyanin from Paracoccus denitrificans at 2.0 A and 1.8 A resolution. 1AAN ; 2.00 ; Crystal structure analysis of amicyanin and apoamicyanin from Paracoccus denitrificans at 2.0 A and 1.8 A resolution. 9DNA ; 1.80 ; Crystal structure analysis of an A-DEOXYRIBONUCLEIC ACID fragment at 1.8 A resolution: d(GCCCGGGC). 1XY1 ; 1.04 ; Crystal structure analysis of deamino-oxytocin: conformational flexibility and receptor binding. 1XY2 ; 1.20 ; Crystal structure analysis of deamino-oxytocin: conformational flexibility and receptor binding. 4AZU ; 1.90 ; Crystal structure analysis of oxidized Pseudomonas aeruginosa azurin at pH 5.5 and pH 9.0. A pH-induced conformational transition involves a peptide bond flip. 5AZU ; 1.90 ; Crystal structure analysis of oxidized Pseudomonas aeruginosa azurin at pH 5.5 and pH 9.0. A pH-induced conformational transition involves a peptide bond flip. 1D29 ; 2.50 ; Crystal structure analysis of the B-DEOXYRIBONUCLEIC ACID dodecamer CGTGAATTCACG. 1NBA ; 2.00 ; Crystal structure analysis, refinement and enzymatic reaction mechanism of N-carbamoylsarcosine amidohydrolase from Arthrobacter sp. at 2.0 A resolution. 1ENY ; 2.20 ; Crystal structure and function of the isoniazid target of Mycobacterium tuberculosis. 1ENZ ; 2.70 ; Crystal structure and function of the isoniazid target of Mycobacterium tuberculosis. 1PTS ; 2.00 ; Crystal structure and ligand-binding studies of a screened peptide complexed with streptavidin. 1CPT ; 2.30 ; Crystal structure and refinement of cytochrome P450terp at 2.3 A resolution. 1DNM ; 2.50 ; Crystal structure and sequence-dependent conformation of the A.G mispaired oligonucleotide d(CGCAAGCTGGCG). 1MAC ; 2.30 ; Crystal structure and site-directed mutagenesis of Bacillus macerans endo-1,3-1,4-beta-glucanase. 111D ; 2.25 ; Crystal structure and stability of a DEOXYRIBONUCLEIC ACID duplex containing A(anti).G(syn) base-pairs. 1LYN ; 2.75 ; Crystal structure and subunit dynamics of the abalone sperm lysin dimer: egg envelopes dissociate dimers, the monomer is the active species. 1D53 ; 1.50 ; Crystal structure at 1.5-A resolution of d(CGCICICG), an octanucleotide containing inosine, and its comparison with d(CGCG) and d(CGCGCG) structures. 1HSG ; 2.00 ; Crystal structure at 1.9-A resolution of human immunodeficiency virus (HIV) II protease complexed with L-735,524, an orally bioavailable inhibitor of the HIV proteases. 1HSH ; 1.90 ; Crystal structure at 1.9-A resolution of human immunodeficiency virus (HIV) II protease complexed with L-735,524, an orally bioavailable inhibitor of the HIV proteases. 1HSI ; 2.50 ; Crystal structure at 1.9-A resolution of human immunodeficiency virus (HIV) II protease complexed with L-735,524, an orally bioavailable inhibitor of the HIV proteases. 1DYN ; 2.20 ; Crystal structure at 2.2 A resolution of the pleckstrin homology domain from human dynamin. 1HNG ; 2.80 ; Crystal structure at 2.8 A resolution of a soluble form of the cell adhesion molecule CD2. 1THC ; 2.30 ; Crystal structure determination at 2.3-A resolution of human transthyretin-3',5'-dibromo-2',4,4',6-tetrahydroxyaurone complex. 1HOE ; 2.00 ; Crystal structure determination, refinement and the molecular model of the alpha-amylase inhibitor Hoe-467A. 1RTA ; 2.50 ; Crystal structure disposition of thymidylic acid tetramer in complex with ribonuclease A. 1RTB ; 2.50 ; Crystal structure disposition of thymidylic acid tetramer in complex with ribonuclease A. 1AMP ; 1.80 ; Crystal structure of Aeromonas proteolytica aminopeptidase: a prototypical member of the co-catalytic zinc enzyme family. 1EMY ; 1.78 ; Crystal structure of Asian elephant (Elephas maximus) cyano-metmyoglobin at 1.78-A resolution. Phe29(B10) accounts for its unusual ligand binding properties. 1CC5 ; 2.50 ; Crystal structure of Azotobacter cytochrome c5 at 2.5 A resolution. 196D ; 1.70 ; Crystal structure of C-T-C-T-C-G-A-G-A-G. Implications for the structure of the Holliday junction. 126D ; 2.00 ; Crystal structure of CATGGCCATG and its implications for A-tract bending models. 1RAA ; 2.50 ; Crystal structure of CTP-ligated T state aspartate transcarbamoylase at 2.5 A resolution: implications for ATCase mutants and the mechanism of negative cooperativity. 1RAB ; 2.50 ; Crystal structure of CTP-ligated T state aspartate transcarbamoylase at 2.5 A resolution: implications for ATCase mutants and the mechanism of negative cooperativity. 1RAC ; 2.50 ; Crystal structure of CTP-ligated T state aspartate transcarbamoylase at 2.5 A resolution: implications for ATCase mutants and the mechanism of negative cooperativity. 1RAD ; 2.50 ; Crystal structure of CTP-ligated T state aspartate transcarbamoylase at 2.5 A resolution: implications for ATCase mutants and the mechanism of negative cooperativity. 1RAE ; 2.50 ; Crystal structure of CTP-ligated T state aspartate transcarbamoylase at 2.5 A resolution: implications for ATCase mutants and the mechanism of negative cooperativity. 1RAF ; 2.50 ; Crystal structure of CTP-ligated T state aspartate transcarbamoylase at 2.5 A resolution: implications for ATCase mutants and the mechanism of negative cooperativity. 1RAG ; 2.50 ; Crystal structure of CTP-ligated T state aspartate transcarbamoylase at 2.5 A resolution: implications for ATCase mutants and the mechanism of negative cooperativity. 1RAH ; 2.50 ; Crystal structure of CTP-ligated T state aspartate transcarbamoylase at 2.5 A resolution: implications for ATCase mutants and the mechanism of negative cooperativity. 1RAI ; 2.50 ; Crystal structure of CTP-ligated T state aspartate transcarbamoylase at 2.5 A resolution: implications for ATCase mutants and the mechanism of negative cooperativity. 1MJC ; 2.00 ; Crystal structure of CspA, the major cold shock protein of Escherichia coli. 1DCH ; 3.00 ; Crystal structure of DCoH, a bifunctional, protein-binding transcriptional coactivator. 3CHY ; 1.66 ; Crystal structure of Escherichia coli CheY refined at 1.7-A resolution. 3ECA ; 2.40 ; Crystal structure of Escherichia coli L-asparaginase, an enzyme used in cancer therapy. 1QOR ; 2.20 ; Crystal structure of Escherichia coli QOR quinone oxidoreductase complexed with NADPH. 1RDD ; 2.80 ; Crystal structure of Escherichia coli RNase HI in complex with Mg2+ at 2.8 A resolution: proof for a single Mg(2+)-binding site. 1BTL ; 1.80 ; Crystal structure of Escherichia coli TEM1 beta-lactamase at 1.8 A resolution. 1TDE ; 2.10 ; Crystal structure of Escherichia coli thioredoxin reductase refined at 2 A resolution. Implications for a large conformational change during catalysis. 1HYH ; 2.20 ; Crystal structure of L-2-hydroxyisocaproate dehydrogenase from Lactobacillus confusus at 2.2 A resolution. An example of strong asymmetry between subunits. 1MDY ; 2.80 ; Crystal structure of MyoD bHLH domain-DEOXYRIBONUCLEIC ACID complex: perspectives on DEOXYRIBONUCLEIC ACID recognition and implications for transcriptional activation. 1NHK ; 1.90 ; Crystal structure of Myxococcus xanthus nucleoside diphosphate kinase and its interaction with a nucleotide substrate at 2.0 A resolution. 1NLK ; 2.00 ; Crystal structure of Myxococcus xanthus nucleoside diphosphate kinase and its interaction with a nucleotide substrate at 2.0 A resolution. 2NCK ; 2.00 ; Crystal structure of Myxococcus xanthus nucleoside diphosphate kinase and its interaction with a nucleotide substrate at 2.0 A resolution. 1NDH ; 2.10 ; Crystal structure of NADH-cytochrome b5 reductase from pig liver at 2.4 A resolution. 1TSP ; 2.00 ; Crystal structure of P22 tailspike protein: interdigitated subunits in a thermostable trimer. 1PVU ; 2.40 ; Crystal structure of PvuII endonuclease reveals extensive structural homologies to EcoRV. 1RLS ; 1.90 ; Crystal structure of RNase T1 complexed with the product nucleotide 3'-GMP. Structural evidence for direct interaction of histidine 40 and glutamic acid 58 with the 2'-hydroxyl group of the ribose. 1RGA ; 1.70 ; Crystal structure of RNase T1 with 3'-guanylic acid and guanosine. 1XRA ; 3.00 ; Crystal structure of S-adenosylmethionine synthetase. 1XRC ; 3.00 ; Crystal structure of S-adenosylmethionine synthetase. 1LYD ; 2.00 ; Crystal structure of T4-lysozyme generated from synthetic coding DEOXYRIBONUCLEIC ACID expressed in Escherichia coli. 1YPT ; 2.50 ; Crystal structure of Yersinia protein tyrosine phosphatase at 2.5 A and the complex with tungstate. 1D77 ; 2.40 ; Crystal structure of a B-DEOXYRIBONUCLEIC ACID dodecamer containing inosine, d(CGCIAATTCGCG), at 2.4 A resolution and its comparison with other B-DEOXYRIBONUCLEIC ACID dodecamers. 1CGP ; 3.00 ; Crystal structure of a CAP-DEOXYRIBONUCLEIC ACID complex: the DEOXYRIBONUCLEIC ACID is bent by 90 degrees. 237D ; 2.50 ; Crystal structure of a DEOXYRIBONUCLEIC ACID decamer showing a novel pseudo four-way helix-helix junction. 178D ; 2.50 ; Crystal structure of a DEOXYRIBONUCLEIC ACID duplex containing 8-hydroxydeoxyguanine-adenine base pairs. 1TIE ; 2.50 ; Crystal structure of a Kunitz-type trypsin inhibitor from Erythrina caffra seeds. 1APL ; 2.70 ; Crystal structure of a MAT alpha 2 homeodomain-operator complex suggests a general model for homeodomain-DEOXYRIBONUCLEIC ACID interactions. 1GDH ; 2.40 ; Crystal structure of a NAD-dependent D-glycerate dehydrogenase at 2.4 A resolution. 1PYI ; 3.20 ; Crystal structure of a PPR1-DEOXYRIBONUCLEIC ACID complex: DEOXYRIBONUCLEIC ACID recognition by proteins containing a Zn2Cys6 binuclear cluster. 1SHG ; 1.80 ; Crystal structure of a Src-homology 3 (SH3) domain. 8PTI ; 1.80 ; Crystal structure of a Y35G mutant of bovine pancreatic trypsin inhibitor. 9PTI ; 1.22 ; Crystal structure of a Y35G mutant of bovine pancreatic trypsin inhibitor. 1CTN ; 2.30 ; Crystal structure of a bacterial chitinase at 2.3 A resolution. 1MMO ; 2.20 ; Crystal structure of a bacterial non-haem iron hydroxylase that catalyses the biological oxidation of methane. 1RNB ; 1.90 ; Crystal structure of a barnase-d(GpC) complex at 1.9 A resolution. 1D63 ; 2.00 ; Crystal structure of a berenil-d(CGCAAATTTGCG) complex. An example of drug-DEOXYRIBONUCLEIC ACID recognition based on sequence-dependent structural features. 2DBE ; 2.50 ; Crystal structure of a berenil-dodecanucleotide complex: the role of water in sequence-specific ligand binding. 2GFB ; 3.00 ; Crystal structure of a catalytic antibody Fab with esterase-like activity. 1EAP ; 2.50 ; Crystal structure of a catalytic antibody with a serine protease active site. 1BBJ ; 3.10 ; Crystal structure of a chimeric Fab' fragment of an antibody binding tumour cells. 1SMP ; 2.30 ; Crystal structure of a complex between Serratia marcescens metallo-protease and an inhibitor from Erwinia chrysanthemi. 2PCB ; 2.80 ; Crystal structure of a complex between electron transfer partners, cytochrome c peroxidase and cytochrome c. 2PCC ; 2.30 ; Crystal structure of a complex between electron transfer partners, cytochrome c peroxidase and cytochrome c. 1HIV ; 2.00 ; Crystal structure of a complex of HIV-1 protease with a dihydroxyethylene-containing inhibitor: comparisons with molecular modeling. 274D ; 2.30 ; Crystal structure of a covalent DEOXYRIBONUCLEIC ACID-drug adduct: anthramycin bound to C-C-A-A-C-G-T-T-G-G and a molecular explanation of specificity. 1FBI ; 3.00 ; Crystal structure of a cross-reaction complex between Fab F9.13.7 and guinea fowl lysozyme. 4TS1 ; 2.50 ; Crystal structure of a deletion mutant of a tyrosyl-tRNA synthetase complexed with tyrosine. 1LMK ; 2.60 ; Crystal structure of a diabody, a bivalent antibody fragment. 1FCS ; 1.60 ; Crystal structure of a distal site double mutant of sperm whale myoglobin at 1.6 A resolution. 1POS ; 2.60 ; Crystal structure of a disulfide-linked "trefoil" motif found in a large family of putative growth factors. 1RAR ; 1.90 ; Crystal structure of a fluorescent derivative of RNase A. 1RAS ; 1.70 ; Crystal structure of a fluorescent derivative of RNase A. 190D ; 1.80 ; Crystal structure of a four-stranded intercalated DEOXYRIBONUCLEIC ACID: d(C4). 1GGI ; 2.80 ; Crystal structure of a human immunodeficiency virus type 1 neutralizing antibody, 50.1, in complex with its V3 loop peptide antigen. 153D ; 2.90 ; Crystal structure of a mispaired dodecamer, d(CGAGAATTC(O6Me)GCG)2, containing a carcinogenic O6-methylguanine. 1D64 ; 2.10 ; Crystal structure of a pentamidine-oligonucleotide complex: implications for DEOXYRIBONUCLEIC ACID-binding properties. 1FRG ; 2.80 ; Crystal structure of a peptide complex of anti-influenza peptide antibody Fab 26/9. Comparison of two different antibodies bound to the same peptide antigen. 1ENI ; 2.20 ; Crystal structure of a pyrimidine dimer-specific excision repair enzyme from bacteriophage T4: refinement at 1.45 A and X-ray analysis of the three active site mutants. 1ENJ ; 1.80 ; Crystal structure of a pyrimidine dimer-specific excision repair enzyme from bacteriophage T4: refinement at 1.45 A and X-ray analysis of the three active site mutants. 1ENK ; 2.00 ; Crystal structure of a pyrimidine dimer-specific excision repair enzyme from bacteriophage T4: refinement at 1.45 A and X-ray analysis of the three active site mutants. 2END ; 1.45 ; Crystal structure of a pyrimidine dimer-specific excision repair enzyme from bacteriophage T4: refinement at 1.45 A and X-ray analysis of the three active site mutants. 1OAC ; 2.00 ; Crystal structure of a quinoenzyme: copper amine oxidase of Escherichia coli at 2 A resolution. 1CD8 ; 2.60 ; Crystal structure of a soluble form of the human T cell coreceptor CD8 at 2.6 A resolution. 1COS ; 2.10 ; Crystal structure of a synthetic triple-stranded alpha-helical bundle. 1EMD ; 1.90 ; Crystal structure of a ternary complex of Escherichia coli malate dehydrogenase citrate and NAD at 1.9 A resolution. 1HVC ; 1.80 ; Crystal structure of a tethered dimer of HIV-1 proteinase complexed with an inhibitor. 1RCM ; 1.90 ; Crystal structure of a ubiquitin-dependent degradation substrate: a three-disulfide form of lysozyme. 1ABR ; 2.14 ; Crystal structure of abrin-a at 2.14 A. 9RUB ; 2.60 ; Crystal structure of activated ribulose-1,5-bisphosphate carboxylase complexed with its substrate, ribulose-1,5-bisphosphate. 1AL1 ; 2.70 ; Crystal structure of alpha 1: implications for protein design. 1DTX ; 2.20 ; Crystal structure of alpha-dendrotoxin from the green mamba venom and its comparison with the structure of bovine pancreatic trypsin inhibitor. 1DTS ; 1.65 ; Crystal structure of an ATP-dependent carboxylase, dethiobiotin synthetase, at 1.65 A resolution. 1SDR ; 2.60 ; Crystal structure of an RIBONUCLEIC ACID dodecamer containing the Escherichia coli Shine-Dalgarno sequence. 1AEC ; 1.86 ; Crystal structure of an actinidin-E-64 complex. 1TET ; 2.30 ; Crystal structure of an anticholera toxin peptide complex at 2.3 A. 1MDA ; 2.50 ; Crystal structure of an electron-transfer complex between methylamine dehydrogenase and amicyanin. 2TLD ; 2.60 ; Crystal structure of an engineered subtilisin inhibitor complexed with bovine trypsin. 1HDD ; 2.80 ; Crystal structure of an engrailed homeodomain-DEOXYRIBONUCLEIC ACID complex at 2.8 A resolution: a framework for understanding homeodomain-DEOXYRIBONUCLEIC ACID interactions. 1VCA ; 1.80 ; Crystal structure of an integrin-binding fragment of vascular cell adhesion molecule-1 at 1.8 A resolution. 1D80 ; 2.20 ; Crystal structure of an oligonucleotide duplex containing G.G base pairs: influence of mispairing on DEOXYRIBONUCLEIC ACID backbone conformation. 1AVE ; 2.80 ; Crystal structure of apo-avidin from hen egg-white. 1NOA ; 1.50 ; Crystal structure of apo-neocarzinostatin at 0.15-nm resolution. 1FRS ; 3.50 ; Crystal structure of bacteriophage fr capsids at 3.5 A resolution. 1BFG ; 1.60 ; Crystal structure of basic fibroblast growth factor at 1.6 A resolution. 2BFH ; 2.50 ; Crystal structure of basic fibroblast growth factor at 1.6 A resolution. 1POC ; 2.00 ; Crystal structure of bee-venom phospholipase A2 in a complex with a transition-state analogue. 1AGI ; 1.50 ; Crystal structure of bovine angiogenin at 1.5-A resolution. 1TLD ; 1.50 ; Crystal structure of bovine beta-trypsin at 1.5 A resolution in a crystal form with low molecular packing density. Active site geometry, ion pairs and solvent structure. 1PNT ; 2.20 ; Crystal structure of bovine heart phosphotyrosyl phosphatase at 2.2-A resolution. 1TGB ; 1.80 ; Crystal structure of bovine trypsinogen at 1-8 A resolution. II. Crystallographic refinement, refined crystal structure and comparison with bovine trypsin. 2PKC ; 1.50 ; Crystal structure of calcium-free proteinase K at 1.5-A resolution. 1BGC ; 1.70 ; Crystal structure of canine and bovine granulocyte-colony stimulating factor (G-CSF). 1BGD ; 2.30 ; Crystal structure of canine and bovine granulocyte-colony stimulating factor (G-CSF). 1BGE ; 2.20 ; Crystal structure of canine and bovine granulocyte-colony stimulating factor (G-CSF). 1PYK ; 2.60 ; Crystal structure of cat muscle pyruvate kinase at a resolution of 2.6 A. 1CSB ; 2.10 ; Crystal structure of cathepsin B inhibited with CA030 at 2.0-A resolution: A basis for the design of specific epoxysuccinyl inhibitors. 3DPA ; 2.50 ; Crystal structure of chaperone protein PapD reveals an immunoglobulin fold. 1DR1 ; 2.20 ; Crystal structure of chicken liver dihydrofolate reductase complexed with NADP+ and biopterin. 1CTM ; 2.30 ; Crystal structure of chloroplast cytochrome f reveals a novel cytochrome fold and unexpected heme ligation. 1COY ; 1.80 ; Crystal structure of cholesterol oxidase complexed with a steroid substrate: implications for flavin adenine dinucleotide dependent alcohol oxidases. 3COX ; 1.80 ; Crystal structure of cholesterol oxidase complexed with a steroid substrate: implications for flavin adenine dinucleotide dependent alcohol oxidases. 1ATT ; 3.20 ; Crystal structure of cleaved bovine antithrombin III at 3.2 A resolution. 1HLE ; 1.95 ; Crystal structure of cleaved equine leucocyte elastase inhibitor determined at 1.95 A resolution. 2ACH ; 2.70 ; Crystal structure of cleaved human alpha 1-antichymotrypsin at 2.7 A resolution and its comparison with other serpins. 1POB ; 2.00 ; Crystal structure of cobra-venom phospholipase A2 in a complex with a transition-state analogue. 2CY3 ; 1.70 ; Crystal structure of cytochrome c3 from Desulfovibrio desulfuricans Norway at 1.7 A resolution. 1PRP ; 2.10 ; Crystal structure of d(CGCGAATTCGCG) complexed with propamidine, a short-chain homologue of the drug pentamidine. 1DFN ; 1.90 ; Crystal structure of defensin HNP-3, an amphiphilic dimer: mechanisms of membrane permeabilization. 1CN1 ; 3.20 ; Crystal structure of demetallized concanavalin A: the metal-binding region. 1LLA ; 2.20 ; Crystal structure of deoxygenated Limulus polyphemus subunit II hemocyanin at 2.18 A resolution: clues for a mechanism for allosteric regulation. 1OVT ; 2.40 ; Crystal structure of diferric hen ovotransferrin at 2.4 A resolution. 1CID ; 2.80 ; Crystal structure of domains 3 and 4 of rat CD4: relation to the NH2-terminal domains. 2EBN ; 2.00 ; Crystal structure of endo-beta-N-acetylglucosaminidase F1, an alpha/beta-barrel enzyme adapted for a complex substrate. 1EDT ; 1.90 ; Crystal structure of endo-beta-N-acetylglucosaminidase H at 1.9 A resolution: active-site geometry and substrate recognition. 1D59 ; 2.50 ; Crystal structure of four-stranded Oxytricha telomeric DEOXYRIBONUCLEIC ACID. 1FRP ; 2.00 ; Crystal structure of fructose-1,6-bisphosphatase complexed with fructose 2,6-bisphosphate, AMP, and Zn2+ at 2.0-A resolution: aspects of synergism between inhibitors. 1FBP ; 2.50 ; Crystal structure of fructose-1,6-bisphosphatase complexed with fructose 6-phosphate, AMP, and magnesium. 166D ; 2.20 ; Crystal structure of gamma-oxapentamidine complexed with d(CGCGAATTCGCG)2. The effects of drug structural change on DEOXYRIBONUCLEIC ACID minor-groove recognition. 1HST ; 2.60 ; Crystal structure of globular domain of histone H5 and its implications for nucleosome binding. 1GAL ; 2.30 ; Crystal structure of glucose oxidase from Aspergillus niger refined at 2.3 A resolution. 1GRC ; 3.00 ; Crystal structure of glycinamide ribonucleotide transformylase from Escherichia coli at 3.0 A resolution. A target enzyme for chemotherapy. 1GYP ; 2.80 ; Crystal structure of glycosomal glyceraldehyde-3-phosphate dehydrogenase from Leishmania mexicana: implications for structure-based drug design and a new position for the inorganic phosphate binding site. 3RNT ; 1.80 ; Crystal structure of guanosine-free ribonuclease T1, complexed with vanadate (V), suggests conformational change upon substrate binding. 2HAD ; 1.90 ; Crystal structure of haloalkane dehalogenase: an enzyme to detoxify halogenated alkanes. 2HPD ; 2.00 ; Crystal structure of hemoprotein domain of P450BM-3, a prototype for microsomal P450's. 2LYM ; 2.00 ; Crystal structure of hen egg-white lysozyme at a hydrostatic pressure of 1000 atmospheres. 3LYM ; 2.00 ; Crystal structure of hen egg-white lysozyme at a hydrostatic pressure of 1000 atmospheres. 1HC1 ; 3.20 ; Crystal structure of hexameric haemocyanin from Panulirus interruptus refined at 3.2 A resolution. 1HC2 ; 3.20 ; Crystal structure of hexameric haemocyanin from Panulirus interruptus refined at 3.2 A resolution. 1HC3 ; 3.20 ; Crystal structure of hexameric haemocyanin from Panulirus interruptus refined at 3.2 A resolution. 1HC4 ; 3.20 ; Crystal structure of hexameric haemocyanin from Panulirus interruptus refined at 3.2 A resolution. 1HC5 ; 3.20 ; Crystal structure of hexameric haemocyanin from Panulirus interruptus refined at 3.2 A resolution. 1HC6 ; 3.20 ; Crystal structure of hexameric haemocyanin from Panulirus interruptus refined at 3.2 A resolution. 1HCY ; 3.20 ; Crystal structure of hexameric haemocyanin from Panulirus interruptus refined at 3.2 A resolution. 1AHT ; 1.60 ; Crystal structure of human alpha-thrombin complexed with hirugen and p-amidinophenylpyruvate at 1.6 A resolution. 1ANG ; 2.40 ; Crystal structure of human angiogenin reveals the structural basis for its functional divergence from ribonuclease. 1AIN ; 2.50 ; Crystal structure of human annexin I at 2.5 A resolution. 1HRP ; 3.00 ; Crystal structure of human chorionic gonadotropin. 1HNA ; 1.85 ; Crystal structure of human class mu glutathione transferase GSTM2-2. Effects of lattice packing on conformational heterogeneity. 1HNB ; 3.50 ; Crystal structure of human class mu glutathione transferase GSTM2-2. Effects of lattice packing on conformational heterogeneity. 1HNC ; 3.00 ; Crystal structure of human class mu glutathione transferase GSTM2-2. Effects of lattice packing on conformational heterogeneity. 1DRF ; 2.00 ; Crystal structure of human dihydrofolate reductase complexed with folate. 2MIP ; 2.20 ; Crystal structure of human immunodeficiency virus (HIV) type 2 protease in complex with a reduced amide inhibitor and comparison with HIV-1 protease structures. 7FAB ; 2.00 ; Crystal structure of human immunoglobulin fragment Fab New refined at 2.0 A resolution. 1PSN ; 2.20 ; Crystal structure of human pepsin and its complex with pepstatin. 1PSO ; 2.00 ; Crystal structure of human pepsin and its complex with pepstatin. 1PDG ; 3.00 ; Crystal structure of human platelet-derived growth factor BB. 2HNP ; 2.80 ; Crystal structure of human protein tyrosine phosphatase 1B. 2HNQ ; 2.80 ; Crystal structure of human protein tyrosine phosphatase 1B. 1RCB ; 2.25 ; Crystal structure of human recombinant interleukin-4 at 2.25 A resolution. 1R1A ; 3.20 ; Crystal structure of human rhinovirus serotype 1A (HRV1A). 1TRN ; 2.20 ; Crystal structure of human trypsin 1: unexpected phosphorylation of Tyr151. 1HYP ; 1.80 ; Crystal structure of hydrophobic protein from soybean; a member of a new cysteine-rich family. 2PRD ; 2.00 ; Crystal structure of inorganic pyrophosphatase from Thermus thermophilus. 1INP ; 2.30 ; Crystal structure of inositol polyphosphate 1-phosphatase at 2.3-A resolution. 1DLC ; 2.50 ; Crystal structure of insecticidal delta-endotoxin from Bacillus thuringiensis at 2.5 A resolution. 191D ; 1.40 ; Crystal structure of intercalated four-stranded d(C3T) at 1.4 A resolution. 3IL8 ; 2.00 ; Crystal structure of interleukin 8: symbiosis of NMR and crystallography. 1ILK ; 1.80 ; Crystal structure of interleukin-10 reveals the functional dimer with an unexpected topological similarity to interferon gamma. 1KBA ; 2.30 ; Crystal structure of kappa-bungarotoxin at 2.3-A resolution. 1TLF ; 2.60 ; Crystal structure of lac repressor core tetramer and its implications for DEOXYRIBONUCLEIC ACID looping. 1HBP ; 1.90 ; Crystal structure of liganded and unliganded forms of bovine plasma retinol-binding protein. 1HBQ ; 1.70 ; Crystal structure of liganded and unliganded forms of bovine plasma retinol-binding protein. 4LYM ; 2.10 ; Crystal structure of low humidity tetragonal lysozyme at 2.1-A resolution. Variability in hydration shell and its structural consequences. 1MOM ; 2.16 ; Crystal structure of momordin, a type I ribosome inactivating protein from the seeds of Momordica charantia. 1MLI ; 3.30 ; Crystal structure of muconolactone isomerase at 3.3 A resolution. 2RMC ; 1.64 ; Crystal structure of murine cyclophilin C complexed with immunosuppressive drug cyclosporin A. 1NCO ; 1.80 ; Crystal structure of neocarzinostatin, an antitumor protein-chromophore complex. 1STO ; 2.60 ; Crystal structure of orotate phosphoribosyltransferase. 1HBI ; 1.70 ; Crystal structure of oxygenated Scapharca dimeric hemoglobin at 1.7-A resolution. 1PHH ; 2.30 ; Crystal structure of p-hydroxybenzoate hydroxylase complexed with its reaction product 3,4-dihydroxybenzoate. 1PDH ; 2.10 ; Crystal structure of p-hydroxybenzoate hydroxylase reconstituted with the modified FAD present in alcohol oxidase from methylotrophic yeasts: evidence for an arabinoflavin. 1PPP ; 1.90 ; Crystal structure of papain-E64-c complex. Binding diversity of E64-c to papain S2 and S3 subsites. 1PIP ; 1.70 ; Crystal structure of papain-succinyl-Gln-Val-Val-Ala-Ala-p-nitroanilide complex at 1.7-A resolution: noncovalent binding mode of a common sequence of endogenous thiol protease inhibitors. 1PNG ; 2.20 ; Crystal structure of peptide-N4-(N-acetyl-beta-D-glucosaminyl)asparagine amidase F at 2.2-A resolution. 1SDA ; 2.50 ; Crystal structure of peroxynitrite-modified bovine Cu,Zn superoxide dismutase. 1PSH ; 2.30 ; Crystal structure of phospholipase A2 from Indian cobra reveals a trimeric association. 1BPB ; 2.30 ; Crystal structure of rat DEOXYRIBONUCLEIC ACID polymerase beta: evidence for a common polymerase mechanism. 1BPD ; 3.60 ; Crystal structure of rat DEOXYRIBONUCLEIC ACID polymerase beta: evidence for a common polymerase mechanism. 1BPE ; 3.90 ; Crystal structure of rat DEOXYRIBONUCLEIC ACID polymerase beta: evidence for a common polymerase mechanism. 2BPC ; 2.80 ; Crystal structure of rat DEOXYRIBONUCLEIC ACID polymerase beta: evidence for a common polymerase mechanism. 2IFB ; 2.00 ; Crystal structure of rat intestinal fatty-acid-binding protein. Refinement and analysis of the Escherichia coli-derived protein with bound palmitate. 1DHR ; 2.30 ; Crystal structure of rat liver dihydropteridine reductase. 1TPH ; 1.80 ; Crystal structure of recombinant chicken triosephosphate isomerase- phosphoglycolohydroxamate complex at 1.8-A resolution. 1FPS ; 2.60 ; Crystal structure of recombinant farnesyl diphosphate synthase at 2.6-A resolution. 1I1B ; 2.00 ; Crystal structure of recombinant human interleukin-1 beta at 2.0 A resolution. 2INT ; 2.40 ; Crystal structure of recombinant human interleukin-4. 1RHP ; 2.40 ; Crystal structure of recombinant human platelet factor 4. 1HTI ; 2.80 ; Crystal structure of recombinant human triosephosphate isomerase at 2.8 A resolution. Triosephosphate isomerase-related human genetic disorders and comparison with the trypanosomal enzyme. 1ALB ; 2.50 ; Crystal structure of recombinant murine adipocyte lipid-binding protein. 1SXA ; 1.90 ; Crystal structure of reduced bovine erythrocyte superoxide dismutase at 1.9 A resolution. 1SXB ; 2.00 ; Crystal structure of reduced bovine erythrocyte superoxide dismutase at 1.9 A resolution. 1SXC ; 1.90 ; Crystal structure of reduced bovine erythrocyte superoxide dismutase at 1.9 A resolution. 1RCN ; 2.50 ; Crystal structure of ribonuclease A.d(ApTpApApG) complex. Direct evidence for extended substrate recognition. 1RIL ; 2.80 ; Crystal structure of ribonuclease H from Thermus thermophilus HB8 refined at 2.8 A resolution. 6RNT ; 1.80 ; Crystal structure of ribonuclease T1 complexed with adenosine 2'-monophosphate at 1.8-A resolution. 1STD ; 2.90 ; Crystal structure of scytalone dehydratase--a disease determinant of the rice pathogen, Magnaporthe grisea. 1SEL ; 2.00 ; Crystal structure of selenosubtilisin at 2.0-A resolution. 1SPI ; 2.80 ; Crystal structure of spinach chloroplast fructose-1,6-bisphosphatase at 2.8 A resolution. 1PHC ; 1.60 ; Crystal structure of substrate-free Pseudomonas putida cytochrome P-450. 1CFB ; 2.00 ; Crystal structure of tandem type III fibronectin domains from Drosophila neuroglian at 2.0 A. 1SAT ; 1.75 ; Crystal structure of the 50 kDa metallo protease from Serratia marcescens. 213D ; 1.60 ; Crystal structure of the A-DEOXYRIBONUCLEIC ACID decamer d(CCIGGCCm5CGG) at 1.6 A showing the unexpected wobble I.m5C base pair. 1NDL ; 2.40 ; Crystal structure of the Awd nucleotide diphosphate kinase from Drosophila. 1FCC ; 3.50 ; Crystal structure of the C2 fragment of streptococcal protein G in complex with the Fc domain of human IgG. 2HTS ; 1.83 ; Crystal structure of the DEOXYRIBONUCLEIC ACID binding domain of the heat shock transcription factor. 1BGT ; 2.20 ; Crystal structure of the DEOXYRIBONUCLEIC ACID modifying enzyme beta-glucosyltransferase in the presence and absence of the substrate uridine diphosphoglucose. 1BGU ; 2.20 ; Crystal structure of the DEOXYRIBONUCLEIC ACID modifying enzyme beta-glucosyltransferase in the presence and absence of the substrate uridine diphosphoglucose. 2BGT ; 2.20 ; Crystal structure of the DEOXYRIBONUCLEIC ACID modifying enzyme beta-glucosyltransferase in the presence and absence of the substrate uridine diphosphoglucose. 2BGU ; 2.20 ; Crystal structure of the DEOXYRIBONUCLEIC ACID modifying enzyme beta-glucosyltransferase in the presence and absence of the substrate uridine diphosphoglucose. 1DSB ; 2.00 ; Crystal structure of the DsbA protein required for disulphide bond formation in vivo. 1HMY ; 2.50 ; Crystal structure of the HhaI DEOXYRIBONUCLEIC ACID methyltransferase complexed with S- adenosyl-L-methionine. 1MSC ; 2.00 ; Crystal structure of the MS2 coat protein dimer: implications for RIBONUCLEIC ACID binding and virus assembly. 1OCT ; 3.00 ; Crystal structure of the Oct-1 POU domain bound to an octamer site: DEOXYRIBONUCLEIC ACID recognition with tethered DEOXYRIBONUCLEIC ACID-binding modules. 1SHF ; 1.90 ; Crystal structure of the SH3 domain in human Fyn; comparison of the three-dimensional structures of SH3 domains in tyrosine kinases and spectrin. 1REG ; 1.90 ; Crystal structure of the T4 regA translational regulator protein at 1.9 A resolution. 7RNT ; 1.90 ; Crystal structure of the Tyr45Trp mutant of ribonuclease T1 in a complex with 2'-adenylic acid. 2CLA ; 2.35 ; Crystal structure of the aspartic acid-199----asparagine mutant of chloramphenicol acetyltransferase to 2.35-A resolution: structural consequences of disruption of a buried salt bridge. 1RUS ; 2.90 ; Crystal structure of the binary complex of ribulose-1,5-bisphosphate carboxylase and its product, 3-phospho-D-glycerate. 1HAN ; 1.90 ; Crystal structure of the biphenyl-cleaving extradiol dioxygenase from a PCB-degrading pseudomonad. 3CPP ; 1.90 ; Crystal structure of the carbon monoxide-substrate-cytochrome P-450CAM ternary complex. 1ITG ; 2.30 ; Crystal structure of the catalytic domain of HIV-1 integrase: similarity to other polynucleotidyl transferases. 2EXO ; 1.80 ; Crystal structure of the catalytic domain of the beta-1,4-glycanase cex from Cellulomonas fimi. 2CPK ; 2.70 ; Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. 1SCE ; 2.20 ; Crystal structure of the cell cycle-regulatory protein suc1 reveals a beta-hinge conformational switch. 1BOV ; 2.20 ; Crystal structure of the cell-binding B oligomer of verotoxin-1 from E. coli. 2CST ; 1.90 ; Crystal structure of the closed form of chicken cytosolic aspartate aminotransferase at 1.9 A resolution. 1CBX ; 2.00 ; Crystal structure of the complex between carboxypeptidase A and the biproduct analog inhibitor L-benzylsuccinate at 2.0 A resolution. 1CRA ; 1.90 ; Crystal structure of the complex between human carbonic anhydrase II and the aromatic inhibitor 1,2,4-triazole. 1KNO ; 3.20 ; Crystal structure of the complex of a catalytic antibody Fab fragment with a transition state analog: structural similarities in esterase-like catalytic antibodies. 6CPA ; 2.00 ; Crystal structure of the complex of carboxypeptidase A with a strongly bound phosphonate in a new crystalline form: comparison with structures of other complexes. 1IHS ; 2.00 ; Crystal structure of the complex of human alpha-thrombin and nonhydrolyzable bifunctional inhibitors, hirutonin-2 and hirutonin-6. 1IHT ; 2.10 ; Crystal structure of the complex of human alpha-thrombin and nonhydrolyzable bifunctional inhibitors, hirutonin-2 and hirutonin-6. 1PFK ; 2.40 ; Crystal structure of the complex of phosphofructokinase from Escherichia coli with its reaction products. 1FRT ; 4.50 ; Crystal structure of the complex of rat neonatal Fc receptor with Fc. 2CP4 ; 2.10 ; Crystal structure of the cytochrome P-450CAM active site mutant Thr252Ala. 3CP4 ; 2.30 ; Crystal structure of the cytochrome P-450CAM active site mutant Thr252Ala. 4CP4 ; 2.10 ; Crystal structure of the cytochrome P-450CAM active site mutant Thr252Ala. 1PLQ ; 2.30 ; Crystal structure of the eukaryotic DEOXYRIBONUCLEIC ACID polymerase processivity factor PCNA. 1PLR ; 3.00 ; Crystal structure of the eukaryotic DEOXYRIBONUCLEIC ACID polymerase processivity factor PCNA. 1HNF ; 2.50 ; Crystal structure of the extracellular region of the human cell adhesion molecule CD2 at 2.5 A resolution. 1FIA ; 2.00 ; Crystal structure of the factor for inversion stimulation FIS at 2.0 A resolution. 1FXR ; 2.30 ; Crystal structure of the ferredoxin I from Desulfovibrio africanus at 2.3 A resolution. 1ARP ; 1.90 ; Crystal structure of the fungal peroxidase from Arthromyces ramosus at 1.9 A resolution. Structural comparisons with the lignin and cytochrome c peroxidases. 100D ; 1.90 ; Crystal structure of the highly distorted chimeric decamer r(C)d(CGGCGCCG)r(G).spermine complex--spermine binding to phosphate only and minor groove tertiary base-pairing. 1DLH ; 2.80 ; Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. 1TPK ; 2.40 ; Crystal structure of the kringle 2 domain of tissue plasminogen activator at 2.4-A resolution. 2MHA ; 2.80 ; Crystal structure of the major histocompatibility complex class I H-2Kb molecule containing a single viral peptide: implications for peptide binding and T-cell receptor recognition. 1CMA ; 2.80 ; Crystal structure of the met repressor-operator complex at 2.8 A resolution reveals DEOXYRIBONUCLEIC ACID recognition by beta-strands. 1LSY ; 1.90 ; Crystal structure of the mutant D52S hen egg white lysozyme with an oligosaccharide product. 1LSZ ; 2.00 ; Crystal structure of the mutant D52S hen egg white lysozyme with an oligosaccharide product. 1FPB ; 2.60 ; Crystal structure of the neutral form of fructose 1,6-bisphosphatase complexed with regulatory inhibitor fructose 2,6-bisphosphate at 2.6-A resolution. 5FBP ; 2.10 ; Crystal structure of the neutral form of fructose-1,6-bisphosphatase complexed with the product fructose 6-phosphate at 2.1-A resolution. 1PBE ; 1.90 ; Crystal structure of the p-hydroxybenzoate hydroxylase-substrate complex refined at 1.9 A resolution. Analysis of the enzyme-substrate and enzyme-product complexes. 1SHA ; 1.50 ; Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine-phosphorylated peptides. 1SHB ; 2.00 ; Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine-phosphorylated peptides. 1ACY ; 3.00 ; Crystal structure of the principal neutralization site of HIV-1. 1KNB ; 1.70 ; Crystal structure of the receptor-binding domain of adenovirus type 5 fiber protein at 1.7 A resolution. 2SPC ; 1.80 ; Crystal structure of the repetitive segments of spectrin. 1HRH ; 2.40 ; Crystal structure of the ribonuclease H domain of HIV-1 reverse transcriptase. 1RIS ; 2.00 ; Crystal structure of the ribosomal protein S6 from Thermus thermophilus. 1TNR ; 2.85 ; Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation. 1FNA ; 1.80 ; Crystal structure of the tenth type III cell adhesion module of human fibronectin. 2RUS ; 2.30 ; Crystal structure of the ternary complex of ribulose-1,5-bisphosphate carboxylase, Mg(II), and activator CO2 at 2.3-A resolution. 1PVD ; 2.30 ; Crystal structure of the thiamin diphosphate-dependent enzyme pyruvate decarboxylase from the yeast Saccharomyces cerevisiae at 2.3 A resolution. 1BRP ; 2.50 ; Crystal structure of the trigonal form of human plasma retinol-binding protein at 2.5 A resolution. 1BRQ ; 2.50 ; Crystal structure of the trigonal form of human plasma retinol-binding protein at 2.5 A resolution. 1IRK ; 2.10 ; Crystal structure of the tyrosine kinase domain of the human insulin receptor. 3RUB ; 2.00 ; Crystal structure of the unactivated form of ribulose-1,5-bisphosphate carboxylase/oxygenase from tobacco refined at 2.0-A resolution. 1RLC ; 2.70 ; Crystal structure of the unactivated ribulose 1,5-bisphosphate carboxylase/oxygenase complexed with a transition state analog, 2-carboxy-D-arabinitol 1,5-bisphosphate. 5PAL ; 1.54 ; Crystal structure of the unique parvalbumin component from muscle of the leopard shark (Triakis semifasciata). The first X-ray study of an alpha-parvalbumin. 1THM ; 1.37 ; Crystal structure of thermitase at 1.4 A resolution. 2TRX ; 1.68 ; Crystal structure of thioredoxin from Escherichia coli at 1.68 A resolution. 1TIS ; 3.10 ; Crystal structure of thymidylate synthase from T4 phage: component of a deoxynucleoside triphosphate-synthesizing complex. 1PTX ; 1.30 ; Crystal structure of toxin II from the scorpion Androctonus australis Hector refined at 1.3 A resolution. 2TGI ; 1.80 ; Crystal structure of transforming growth factor-beta 2: an unusual fold for the superfamily. 1TCS ; 1.70 ; Crystal structure of trichosanthin-NADPH complex at 1.7 A resolution reveals active-site architecture. 1TRO ; 1.90 ; Crystal structure of trp repressor/operator complex at atomic resolution. 8RSA ; 1.80 ; Crystal structure of two covalent nucleoside derivatives of ribonuclease A. 9RSA ; 1.80 ; Crystal structure of two covalent nucleoside derivatives of ribonuclease A. 1OVA ; 1.95 ; Crystal structure of uncleaved ovalbumin at 1.95 A resolution. 1DRA ; 1.90 ; Crystal structure of unliganded Escherichia coli dihydrofolate reductase. Ligand-induced conformational changes and cooperativity in binding. 1DRB ; 1.90 ; Crystal structure of unliganded Escherichia coli dihydrofolate reductase. Ligand-induced conformational changes and cooperativity in binding. 5DFR ; 2.30 ; Crystal structure of unliganded Escherichia coli dihydrofolate reductase. Ligand-induced conformational changes and cooperativity in binding. 2PFK ; 2.40 ; Crystal structure of unliganded phosphofructokinase from Escherichia coli. 1VMO ; 2.20 ; Crystal structure of vitelline membrane outer layer protein I (VMO-I): a folding motif with homologous Greek key structures related by an internal three-fold symmetry. 1TBP ; 2.60 ; Crystal structure of yeast TATA-binding protein and model for interaction with DEOXYRIBONUCLEIC ACID. 2CYP ; 1.70 ; Crystal structure of yeast cytochrome c peroxidase refined at 1.7-A resolution. 1COB ; 2.00 ; Crystal structure solution and refinement of the semisynthetic cobalt-substituted bovine erythrocyte superoxide dismutase at 2.0 A resolution. 1MAM ; 2.45 ; Crystal structure to 2.45 A resolution of a monoclonal Fab specific for the Brucella A cell wall polysaccharide antigen. 1XAS ; 2.60 ; Crystal structure, at 2.6-A resolution, of the Streptomyces lividans xylanase A, a member of the F family of beta-1,4-D-glycanases. 1MYK ; 2.40 ; Crystal structure, folding, and operator binding of the hyperstable Arc repressor mutant PL8. 1Q21 ; 2.20 ; Crystal structures at 2.2 A resolution of the catalytic domains of normal ras protein and an oncogenic mutant complexed with GDP. 1SES ; 2.50 ; Crystal structures at 2.5 angstrom resolution of seryl-tRNA synthetase complexed with two analogs of seryl adenylate. 1SET ; 2.50 ; Crystal structures at 2.5 angstrom resolution of seryl-tRNA synthetase complexed with two analogs of seryl adenylate. 1PHO ; 3.00 ; Crystal structures explain functional properties of two E. coli porins. 3DFR ; 1.70 ; Crystal structures of Escherichia coli and Lactobacillus casei dihydrofolate reductase refined at 1.7 A resolution. I. General features and binding of methotrexate. 4DFR ; 1.70 ; Crystal structures of Escherichia coli and Lactobacillus casei dihydrofolate reductase refined at 1.7 A resolution. I. General features and binding of methotrexate. 1ASL ; 2.60 ; Crystal structures of Escherichia coli aspartate aminotransferase in two conformations. Comparison of an unliganded open and two liganded closed forms. 1ASM ; 2.35 ; Crystal structures of Escherichia coli aspartate aminotransferase in two conformations. Comparison of an unliganded open and two liganded closed forms. 1ASN ; 2.50 ; Crystal structures of Escherichia coli aspartate aminotransferase in two conformations. Comparison of an unliganded open and two liganded closed forms. 6DFR ; 2.40 ; Crystal structures of Escherichia coli dihydrofolate reductase: the NADP+ holoenzyme and the folate.NADP+ ternary complex. Substrate binding and a model for the transition state. 7DFR ; 2.50 ; Crystal structures of Escherichia coli dihydrofolate reductase: the NADP+ holoenzyme and the folate.NADP+ ternary complex. Substrate binding and a model for the transition state. 1IDA ; 1.70 ; Crystal structures of HIV-2 protease in complex with inhibitors containing the hydroxyethylamine dipeptide isostere. 1IDB ; 2.20 ; Crystal structures of HIV-2 protease in complex with inhibitors containing the hydroxyethylamine dipeptide isostere. 1BMS ; 2.70 ; Crystal structures of MS2 capsids with mutations in the subunit FG loop. 1MST ; 2.60 ; Crystal structures of MS2 capsids with mutations in the subunit FG loop. 1YHA ; 2.50 ; Crystal structures of Y41H and Y41F mutants of gene V protein from Ff phage suggest possible protein-protein interactions in the GVP-ssDNA complex. 1YHB ; 2.20 ; Crystal structures of Y41H and Y41F mutants of gene V protein from Ff phage suggest possible protein-protein interactions in the GVP-ssDNA complex. 1GTA ; 2.40 ; Crystal structures of a schistosomal drug and vaccine target: glutathione S-transferase from Schistosoma japonica and its complex with the leading antischistosomal drug praziquantel. 1GTB ; 2.60 ; Crystal structures of a schistosomal drug and vaccine target: glutathione S-transferase from Schistosoma japonica and its complex with the leading antischistosomal drug praziquantel. 7ACN ; 2.00 ; Crystal structures of aconitase with isocitrate and nitroisocitrate bound. 8ACN ; 2.00 ; Crystal structures of aconitase with isocitrate and nitroisocitrate bound. 1ACO ; 2.05 ; Crystal structures of aconitase with trans-aconitate and nitrocitrate bound. 1NIS ; 2.05 ; Crystal structures of aconitase with trans-aconitate and nitrocitrate bound. 1P11 ; 1.93 ; Crystal structures of alpha-lytic protease complexes with irreversibly bound phosphonate esters. 1P12 ; 1.90 ; Crystal structures of alpha-lytic protease complexes with irreversibly bound phosphonate esters. 1IGF ; 2.80 ; Crystal structures of an antibody to a peptide and its complex with peptide antigen at 2.8 A. 2IGF ; 2.80 ; Crystal structures of an antibody to a peptide and its complex with peptide antigen at 2.8 A. 7AT1 ; 2.80 ; Crystal structures of aspartate carbamoyltransferase ligated with phosphonoacetamide, malonate, and CTP or ATP at 2.8-A resolution and neutral pH. 8AT1 ; 2.80 ; Crystal structures of aspartate carbamoyltransferase ligated with phosphonoacetamide, malonate, and CTP or ATP at 2.8-A resolution and neutral pH. 1CBQ ; 2.20 ; Crystal structures of cellular retinoic acid binding proteins I and II in complex with all-trans-retinoic acid and a synthetic retinoid. 1CBR ; 2.90 ; Crystal structures of cellular retinoic acid binding proteins I and II in complex with all-trans-retinoic acid and a synthetic retinoid. 1CBS ; 1.80 ; Crystal structures of cellular retinoic acid binding proteins I and II in complex with all-trans-retinoic acid and a synthetic retinoid. 1DR2 ; 2.30 ; Crystal structures of chicken liver dihydrofolate reductase: binary thioNADP+ and ternary thioNADP+.biopterin complexes. 1DR3 ; 2.30 ; Crystal structures of chicken liver dihydrofolate reductase: binary thioNADP+ and ternary thioNADP+.biopterin complexes. 1ARU ; 1.60 ; Crystal structures of cyanide- and triiodide-bound forms of Arthromyces ramosus peroxidase at different pH values. Perturbations of active site residues and their implication in enzyme catalysis. 1ARV ; 1.60 ; Crystal structures of cyanide- and triiodide-bound forms of Arthromyces ramosus peroxidase at different pH values. Perturbations of active site residues and their implication in enzyme catalysis. 1ARW ; 1.60 ; Crystal structures of cyanide- and triiodide-bound forms of Arthromyces ramosus peroxidase at different pH values. Perturbations of active site residues and their implication in enzyme catalysis. 1ARX ; 1.90 ; Crystal structures of cyanide- and triiodide-bound forms of Arthromyces ramosus peroxidase at different pH values. Perturbations of active site residues and their implication in enzyme catalysis. 1ARY ; 1.90 ; Crystal structures of cyanide- and triiodide-bound forms of Arthromyces ramosus peroxidase at different pH values. Perturbations of active site residues and their implication in enzyme catalysis. 2RMA ; 2.10 ; Crystal structures of cyclophilin A complexed with cyclosporin A and N-methyl-4-[(E)-2-butenyl]-4,4-dimethylthreonine cyclosporin A. 2RMB ; 2.10 ; Crystal structures of cyclophilin A complexed with cyclosporin A and N-methyl-4-[(E)-2-butenyl]-4,4-dimethylthreonine cyclosporin A. 4CPP ; 2.11 ; Crystal structures of cytochrome P-450CAM complexed with camphane, thiocamphor, and adamantane: factors controlling P-450 substrate hydroxylation. 6CPP ; 1.90 ; Crystal structures of cytochrome P-450CAM complexed with camphane, thiocamphor, and adamantane: factors controlling P-450 substrate hydroxylation. 8CPP ; 2.10 ; Crystal structures of cytochrome P-450CAM complexed with camphane, thiocamphor, and adamantane: factors controlling P-450 substrate hydroxylation. 1HVQ ; 2.40 ; Crystal structures of hevamine, a plant defence protein with chitinase and lysozyme activity, and its complex with an inhibitor. 1OPA ; 1.90 ; Crystal structures of holo and apo-cellular retinol-binding protein II. 1OPB ; 1.90 ; Crystal structures of holo and apo-cellular retinol-binding protein II. 3MDD ; 2.40 ; Crystal structures of medium-chain acyl-CoA dehydrogenase from pig liver mitochondria with and without substrate. 3MDE ; 2.40 ; Crystal structures of medium-chain acyl-CoA dehydrogenase from pig liver mitochondria with and without substrate. 1PHD ; 1.60 ; Crystal structures of metyrapone- and phenylimidazole-inhibited complexes of cytochrome P-450cam. 1PHE ; 1.60 ; Crystal structures of metyrapone- and phenylimidazole-inhibited complexes of cytochrome P-450cam. 1PHF ; 1.60 ; Crystal structures of metyrapone- and phenylimidazole-inhibited complexes of cytochrome P-450cam. 1PHG ; 1.60 ; Crystal structures of metyrapone- and phenylimidazole-inhibited complexes of cytochrome P-450cam. 1PXA ; 2.30 ; Crystal structures of mutant Pseudomonas aeruginosa p-hydroxybenzoate hydroxylases: the Tyr201Phe, Tyr385Phe, and Asn300Asp variants. 1PXB ; 2.30 ; Crystal structures of mutant Pseudomonas aeruginosa p-hydroxybenzoate hydroxylases: the Tyr201Phe, Tyr385Phe, and Asn300Asp variants. 1PXC ; 2.10 ; Crystal structures of mutant Pseudomonas aeruginosa p-hydroxybenzoate hydroxylases: the Tyr201Phe, Tyr385Phe, and Asn300Asp variants. 1LYA ; 2.50 ; Crystal structures of native and inhibited forms of human cathepsin D: implications for lysosomal targeting and drug design. 1LYB ; 2.50 ; Crystal structures of native and inhibited forms of human cathepsin D: implications for lysosomal targeting and drug design. 1FDA ; 2.10 ; Crystal structures of oxidized and reduced Azotobacter vinelandii ferredoxin at pH 8 and 6. 1FDB ; 2.20 ; Crystal structures of oxidized and reduced Azotobacter vinelandii ferredoxin at pH 8 and 6. 1AYA ; 2.05 ; Crystal structures of peptide complexes of the amino-terminal SH2 domain of the Syp tyrosine phosphatase. 1AYB ; 3.00 ; Crystal structures of peptide complexes of the amino-terminal SH2 domain of the Syp tyrosine phosphatase. 1AYC ; 2.30 ; Crystal structures of peptide complexes of the amino-terminal SH2 domain of the Syp tyrosine phosphatase. 1AYD ; 2.20 ; Crystal structures of peptide complexes of the amino-terminal SH2 domain of the Syp tyrosine phosphatase. 1GHL ; 2.10 ; Crystal structures of pheasant and guinea fowl egg-white lysozymes. 1HHL ; 1.90 ; Crystal structures of pheasant and guinea fowl egg-white lysozymes. 1AT1 ; 2.80 ; Crystal structures of phosphonoacetamide ligated T and phosphonoacetamide and malonate ligated R states of aspartate carbamoyltransferase at 2.8-A resolution and neutral pH. 2AT1 ; 2.80 ; Crystal structures of phosphonoacetamide ligated T and phosphonoacetamide and malonate ligated R states of aspartate carbamoyltransferase at 2.8-A resolution and neutral pH. 3AT1 ; 2.80 ; Crystal structures of phosphonoacetamide ligated T and phosphonoacetamide and malonate ligated R states of aspartate carbamoyltransferase at 2.8-A resolution and neutral pH. 1RPT ; 3.00 ; Crystal structures of rat acid phosphatase complexed with the transition-state analogs vanadate and molybdate. Implications for the reaction mechanism. 1BRB ; 2.10 ; Crystal structures of rat anionic trypsin complexed with the protein inhibitors APPI and BPTI. 1CGE ; 1.90 ; Crystal structures of recombinant 19-kDa human fibroblast collagenase complexed to itself. 1CGF ; 2.10 ; Crystal structures of recombinant 19-kDa human fibroblast collagenase complexed to itself. 1DHF ; 2.30 ; Crystal structures of recombinant human dihydrofolate reductase complexed with folate and 5-deazafolate. 2DHF ; 2.30 ; Crystal structures of recombinant human dihydrofolate reductase complexed with folate and 5-deazafolate. 1CPJ ; 2.20 ; Crystal structures of recombinant rat cathepsin B and a cathepsin B-inhibitor complex. Implications for structure-based inhibitor design. 1CTE ; 2.10 ; Crystal structures of recombinant rat cathepsin B and a cathepsin B-inhibitor complex. Implications for structure-based inhibitor design. 1THE ; 1.90 ; Crystal structures of recombinant rat cathepsin B and a cathepsin B-inhibitor complex. Implications for structure-based inhibitor design. 1FUS ; 1.30 ; Crystal structures of ribonuclease F1 of Fusarium moniliforme in its free form and in complex with 2'GMP. 1FUT ; 2.00 ; Crystal structures of ribonuclease F1 of Fusarium moniliforme in its free form and in complex with 2'GMP. 1RDA ; 2.15 ; Crystal structures of ribonuclease HI active site mutants from Escherichia coli. 1RDB ; 1.90 ; Crystal structures of ribonuclease HI active site mutants from Escherichia coli. 1RDC ; 2.30 ; Crystal structures of ribonuclease HI active site mutants from Escherichia coli. 1BYA ; 2.20 ; Crystal structures of soybean beta-amylase reacted with beta-maltose and maltal: active site components and their apparent roles in catalysis. 1BYB ; 1.90 ; Crystal structures of soybean beta-amylase reacted with beta-maltose and maltal: active site components and their apparent roles in catalysis. 1BYC ; 2.20 ; Crystal structures of soybean beta-amylase reacted with beta-maltose and maltal: active site components and their apparent roles in catalysis. 1BYD ; 2.20 ; Crystal structures of soybean beta-amylase reacted with beta-maltose and maltal: active site components and their apparent roles in catalysis. 1KFD ; 3.90 ; Crystal structures of the Klenow fragment of DEOXYRIBONUCLEIC ACID polymerase I complexed with deoxynucleoside triphosphate and pyrophosphate. 2LHM ; 1.80 ; Crystal structures of the apo- and holomutant human lysozymes with an introduced Ca2+ binding site. 3LHM ; 1.80 ; Crystal structures of the apo- and holomutant human lysozymes with an introduced Ca2+ binding site. 1ENA ; 2.15 ; Crystal structures of the binary Ca2+ and pdTp complexes and the ternary complex of the Asp21-->Glu mutant of staphylococcal nuclease. Implications for catalysis and ligand binding. 1ENC ; 1.95 ; Crystal structures of the binary Ca2+ and pdTp complexes and the ternary complex of the Asp21-->Glu mutant of staphylococcal nuclease. Implications for catalysis and ligand binding. 2ENB ; 2.05 ; Crystal structures of the binary Ca2+ and pdTp complexes and the ternary complex of the Asp21-->Glu mutant of staphylococcal nuclease. Implications for catalysis and ligand binding. 1INC ; 1.94 ; Crystal structures of the complex of porcine pancreatic elastase with two valine-derived benzoxazinone inhibitors. 2CHS ; 1.90 ; Crystal structures of the monofunctional chorismate mutase from Bacillus subtilis and its complex with a transition state analog. 2CHT ; 2.20 ; Crystal structures of the monofunctional chorismate mutase from Bacillus subtilis and its complex with a transition state analog. 1CTP ; 2.90 ; Crystal structures of the myristylated catalytic subunit of cAMP- dependent protein kinase reveal open and closed conformations. 1CMK ; 2.90 ; Crystal structures of the myristylated catalytic subunit of cAMP-dependent protein kinase reveal open and closed conformations. 1MAP ; 2.40 ; Crystal structures of true enzymatic reaction intermediates: aspartate and glutamate ketimines in aspartate aminotransferase. 1MAQ ; 2.30 ; Crystal structures of true enzymatic reaction intermediates: aspartate and glutamate ketimines in aspartate aminotransferase. 1THI ; 3.20 ; Crystal structures of two intensely sweet proteins. 3MON ; 2.80 ; Crystal structures of two intensely sweet proteins. 1NCB ; 2.50 ; Crystal structures of two mutant neuraminidase-antibody complexes with amino acid substitutions in the interface. 1NCC ; 2.50 ; Crystal structures of two mutant neuraminidase-antibody complexes with amino acid substitutions in the interface. 1PBB ; 2.50 ; Crystal structures of wild-type p-hydroxybenzoate hydroxylase complexed with 4-aminobenzoate,2,4-dihydroxybenzoate, and 2-hydroxy-4-aminobenzoate and of the Tyr222Ala mutant complexed with 2-hydroxy-4-aminobenzoate. Evidence for a proton channel and a new binding mode of the flavin ring. 1PBC ; 2.80 ; Crystal structures of wild-type p-hydroxybenzoate hydroxylase complexed with 4-aminobenzoate,2,4-dihydroxybenzoate, and 2-hydroxy-4-aminobenzoate and of the Tyr222Ala mutant complexed with 2-hydroxy-4-aminobenzoate. Evidence for a proton channel and a new binding mode of the flavin ring. 1PBD ; 2.30 ; Crystal structures of wild-type p-hydroxybenzoate hydroxylase complexed with 4-aminobenzoate,2,4-dihydroxybenzoate, and 2-hydroxy-4-aminobenzoate and of the Tyr222Ala mutant complexed with 2-hydroxy-4-aminobenzoate. Evidence for a proton channel and a new binding mode of the flavin ring. 1PBF ; 2.70 ; Crystal structures of wild-type p-hydroxybenzoate hydroxylase complexed with 4-aminobenzoate,2,4-dihydroxybenzoate, and 2-hydroxy-4-aminobenzoate and of the Tyr222Ala mutant complexed with 2-hydroxy-4-aminobenzoate. Evidence for a proton channel and a new binding mode of the flavin ring. 1IAA ; 1.90 ; Crystal structures, spectroscopic features, and catalytic properties of cobalt(II), copper(II), nickel(II), and mercury(II) derivatives of the zinc endopeptidase astacin. A correlation of structure and proteolytic activity. 1IAB ; 1.79 ; Crystal structures, spectroscopic features, and catalytic properties of cobalt(II), copper(II), nickel(II), and mercury(II) derivatives of the zinc endopeptidase astacin. A correlation of structure and proteolytic activity. 1IAE ; 1.83 ; Crystal structures, spectroscopic features, and catalytic properties of cobalt(II), copper(II), nickel(II), and mercury(II) derivatives of the zinc endopeptidase astacin. A correlation of structure and proteolytic activity. 1TAR ; 2.20 ; Crystalline mitochondrial aspartate aminotransferase exists in only two conformations. 1TAS ; 2.80 ; Crystalline mitochondrial aspartate aminotransferase exists in only two conformations. 1TAT ; 3.00 ; Crystalline mitochondrial aspartate aminotransferase exists in only two conformations. 1WBC ; 2.95 ; Crystallization and preliminary X-ray studies of psophocarpin B1, a chymotrypsin inhibitor from winged bean seeds. 1PNE ; 2.00 ; Crystallization and structure determination of bovine profilin at 2.0 A resolution. 1FXA ; 2.50 ; Crystallization and structure determination to 2.5-A resolution of the oxidized [2Fe-2S] ferredoxin isolated from Anabaena 7120. 1MDC ; 1.75 ; Crystallization, structure determination and least-squares refinement to 1.75 A resolution of the fatty-acid-binding protein isolated from Manduca sexta L. 1NHP ; 2.00 ; Crystallographic analyses of NADH peroxidase Cys42Ala and Cys42Ser mutants: active site structures, mechanistic implications, and an unusual environment of Arg 303. 1NHQ ; 2.00 ; Crystallographic analyses of NADH peroxidase Cys42Ala and Cys42Ser mutants: active site structures, mechanistic implications, and an unusual environment of Arg 303. 1PSS ; 3.00 ; Crystallographic analyses of site-directed mutants of the photosynthetic reaction center from Rhodobacter sphaeroides. 1PST ; 3.00 ; Crystallographic analyses of site-directed mutants of the photosynthetic reaction center from Rhodobacter sphaeroides. 1DWB ; 3.16 ; Crystallographic analysis at 3.0-A resolution of the binding to human thrombin of four active site-directed inhibitors. 1DWC ; 3.00 ; Crystallographic analysis at 3.0-A resolution of the binding to human thrombin of four active site-directed inhibitors. 1DWD ; 3.00 ; Crystallographic analysis at 3.0-A resolution of the binding to human thrombin of four active site-directed inhibitors. 1DWE ; 3.00 ; Crystallographic analysis at 3.0-A resolution of the binding to human thrombin of four active site-directed inhibitors. 158D ; 1.90 ; Crystallographic analysis of C-C-A-A-G-C-T-T-G-G and its implications for bending in B-DEOXYRIBONUCLEIC ACID. 1BIC ; 1.90 ; Crystallographic analysis of Thr-200-->His human carbonic anhydrase II and its complex with the substrate, HCO3-. 1OXY ; 2.40 ; Crystallographic analysis of oxygenated and deoxygenated states of arthropod hemocyanin shows unusual differences. 2DHC ; 2.40 ; Crystallographic analysis of the catalytic mechanism of haloalkane dehalogenase. 2DHD ; 2.00 ; Crystallographic analysis of the catalytic mechanism of haloalkane dehalogenase. 2DHE ; 2.10 ; Crystallographic analysis of the catalytic mechanism of haloalkane dehalogenase. 4EST ; 1.78 ; Crystallographic analysis of the inhibition of porcine pancreatic elastase by a peptidyl boronic acid: structure of a reaction intermediate. 5EST ; 2.09 ; Crystallographic analysis of the inhibition of porcine pancreatic elastase by a peptidyl boronic acid: structure of a reaction intermediate. 1GLU ; 2.90 ; Crystallographic analysis of the interaction of the glucocorticoid receptor with DEOXYRIBONUCLEIC ACID. 1PPK ; 1.80 ; Crystallographic analysis of transition-state mimics bound to penicillopepsin: phosphorus-containing peptide analogues. 1PPL ; 1.70 ; Crystallographic analysis of transition-state mimics bound to penicillopepsin: phosphorus-containing peptide analogues. 1PPM ; 1.70 ; Crystallographic analysis of transition-state mimics bound to penicillopepsin: phosphorus-containing peptide analogues. 2FD2 ; 1.90 ; Crystallographic analysis of two site-directed mutants of Azotobacter vinelandii ferredoxin. 1TN1 ; 3.00 ; Crystallographic and biochemical investigation of the lead(II)-catalyzed hydrolysis of yeast phenylalanine tRNA. 1TN2 ; 3.00 ; Crystallographic and biochemical investigation of the lead(II)-catalyzed hydrolysis of yeast phenylalanine tRNA. 1DPB ; 2.50 ; Crystallographic and enzymatic investigations on the role of Ser558, His610, and Asn614 in the catalytic mechanism of Azotobacter vinelandii dihydrolipoamide acetyltransferase (E2p). 1DPC ; 2.60 ; Crystallographic and enzymatic investigations on the role of Ser558, His610, and Asn614 in the catalytic mechanism of Azotobacter vinelandii dihydrolipoamide acetyltransferase (E2p). 1DPD ; 2.70 ; Crystallographic and enzymatic investigations on the role of Ser558, His610, and Asn614 in the catalytic mechanism of Azotobacter vinelandii dihydrolipoamide acetyltransferase (E2p). 1EDB ; 2.01 ; Crystallographic and fluorescence studies of the interaction of haloalkane dehalogenase with halide ions. Studies with halide compounds reveal a halide binding site in the active site. 1EDD ; 2.10 ; Crystallographic and fluorescence studies of the interaction of haloalkane dehalogenase with halide ions. Studies with halide compounds reveal a halide binding site in the active site. 2EDC ; 2.30 ; Crystallographic and fluorescence studies of the interaction of haloalkane dehalogenase with halide ions. Studies with halide compounds reveal a halide binding site in the active site. 4TIM ; 2.40 ; Crystallographic and molecular modeling studies on trypanosomal triosephosphate isomerase: a critical assessment of the predicted and observed structures of the complex with 2-phosphoglycerate. 1GPY ; 2.40 ; Crystallographic binding studies on the allosteric inhibitor glucose-6-phosphate to T state glycogen phosphorylase b. 1NCF ; 2.25 ; Crystallographic evidence for dimerization of unliganded tumor necrosis factor receptor. 1TRZ ; 1.60 ; Crystallographic evidence for dual coordination around zinc in the T3R3 human insulin hexamer. 1OMP ; 1.80 ; Crystallographic evidence of a large ligand-induced hinge-twist motion between the two domains of the maltodextrin binding protein involved in active transport and chemotaxis. 1FC1 ; 2.90 ; Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution. 1FC2 ; 2.80 ; Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution. 1CTS ; 2.70 ; Crystallographic refinement and atomic models of two different forms of citrate synthase at 2.7 and 1.7 A resolution. 2CTS ; 2.00 ; Crystallographic refinement and atomic models of two different forms of citrate synthase at 2.7 and 1.7 A resolution. 3CTS ; 1.70 ; Crystallographic refinement and atomic models of two different forms of citrate synthase at 2.7 and 1.7 A resolution. 2CWG ; 2.00 ; Crystallographic refinement and structure analysis of the complex of wheat germ agglutinin with a bivalent sialoglycopeptide from glycophorin A. 3DNI ; 2.00 ; Crystallographic refinement and structure of DNase I at 2 A resolution. 5RUB ; 1.70 ; Crystallographic refinement and structure of ribulose-1,5-bisphosphate carboxylase from Rhodospirillum rubrum at 1.7 A resolution. 1PRC ; 2.30 ; Crystallographic refinement at 2.3 A resolution and refined model of the photosynthetic reaction centre from Rhodopseudomonas viridis. 1TEC ; 2.20 ; Crystallographic refinement by incorporation of molecular dynamics: thermostable serine protease thermitase complexed with eglin c. 1OVO ; 1.90 ; Crystallographic refinement of Japanese quail ovomucoid, a Kazal-type inhibitor, and model building studies of complexes with serine proteases. 4BP2 ; 1.60 ; Crystallographic refinement of bovine pro-phospholipase A2 at 1.6 A resolution. 1RBP ; 2.00 ; Crystallographic refinement of human serum retinol binding protein at 2A resolution. 2I1B ; 2.00 ; Crystallographic refinement of interleukin 1 beta at 2.0 A resolution. 1LGA ; 2.03 ; Crystallographic refinement of lignin peroxidase at 2 A. 2AAI ; 2.50 ; Crystallographic refinement of ricin to 2.5 A. 4RXN ; 1.20 ; Crystallographic refinement of rubredoxin at 1 x 2 A degrees resolution. 1FDL ; 2.50 ; Crystallographic refinement of the three-dimensional structure of the FabD1.3-lysozyme complex at 2.5-A resolution. 2TMN ; 1.60 ; Crystallographic structural analysis of phosphoramidates as inhibitors and transition-state analogs of thermolysin. 1PGI ; 3.50 ; Crystallographic structure analysis of glucose 6-phosphate isomerase at 3-5 A resolution. 1ORD ; 3.00 ; Crystallographic structure of a PLP-dependent ornithine decarboxylase from Lactobacillus 30a to 3.0 A resolution. 1BLS ; 2.30 ; Crystallographic structure of a phosphonate derivative of the Enterobacter cloacae P99 cephalosporinase: mechanistic interpretation of a beta-lactamase transition-state analog. 1RNA ; 2.25 ; Crystallographic structure of an RIBONUCLEIC ACID helix: [U(UA)6A]2. 2HNT ; 2.50 ; Crystallographic structure of human gamma-thrombin. 1APN ; 2.50 ; Crystallographic structure of metal-free concanavalin A at 2.5 A resolution. 1NIP ; 2.90 ; Crystallographic structure of the nitrogenase iron protein from Azotobacter vinelandii. 1RBC ; 2.00 ; Crystallographic structures of ribonuclease S variants with nonpolar substitution at position 13: packing and cavities. 1RBD ; 1.70 ; Crystallographic structures of ribonuclease S variants with nonpolar substitution at position 13: packing and cavities. 1RBE ; 1.75 ; Crystallographic structures of ribonuclease S variants with nonpolar substitution at position 13: packing and cavities. 1RBF ; 1.80 ; Crystallographic structures of ribonuclease S variants with nonpolar substitution at position 13: packing and cavities. 1RBG ; 1.80 ; Crystallographic structures of ribonuclease S variants with nonpolar substitution at position 13: packing and cavities. 1RBH ; 1.70 ; Crystallographic structures of ribonuclease S variants with nonpolar substitution at position 13: packing and cavities. 1RBI ; 1.80 ; Crystallographic structures of ribonuclease S variants with nonpolar substitution at position 13: packing and cavities. 1NRN ; 3.10 ; Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and novel binding modes. 1NRO ; 3.10 ; Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and novel binding modes. 1NRP ; 3.00 ; Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and novel binding modes. 1NRQ ; 3.50 ; Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and novel binding modes. 1NRR ; 2.40 ; Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and novel binding modes. 1NRS ; 2.40 ; Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and novel binding modes. 2EQL ; 2.50 ; Crystallographic studies of a calcium binding lysozyme from equine milk at 2.5 A resolution. 2CA2 ; 1.90 ; Crystallographic studies of inhibitor binding sites in human carbonic anhydrase II: a pentacoordinated binding of the SCN- ion to the zinc at high pH. 3CA2 ; 2.00 ; Crystallographic studies of inhibitor binding sites in human carbonic anhydrase II: a pentacoordinated binding of the SCN- ion to the zinc at high pH. 1ADB ; 2.40 ; Crystallographic studies of isosteric NAD analogues bound to alcohol dehydrogenase: specificity and substrate binding in two ternary complexes. 1ADC ; 2.70 ; Crystallographic studies of isosteric NAD analogues bound to alcohol dehydrogenase: specificity and substrate binding in two ternary complexes. 1CAN ; 1.90 ; Crystallographic studies of the binding of protonated and unprotonated inhibitors to carbonic anhydrase using hydrogen sulphide and nitrate anions. 1CAO ; 1.90 ; Crystallographic studies of the binding of protonated and unprotonated inhibitors to carbonic anhydrase using hydrogen sulphide and nitrate anions. 1FBC ; 2.60 ; Crystallographic studies of the catalytic mechanism of the neutral form of fructose-1,6-bisphosphatase. 1FBD ; 2.90 ; Crystallographic studies of the catalytic mechanism of the neutral form of fructose-1,6-bisphosphatase. 1FBE ; 3.00 ; Crystallographic studies of the catalytic mechanism of the neutral form of fructose-1,6-bisphosphatase. 1FBF ; 2.70 ; Crystallographic studies of the catalytic mechanism of the neutral form of fructose-1,6-bisphosphatase. 1FBG ; 3.00 ; Crystallographic studies of the catalytic mechanism of the neutral form of fructose-1,6-bisphosphatase. 1FBH ; 2.50 ; Crystallographic studies of the catalytic mechanism of the neutral form of fructose-1,6-bisphosphatase. 1ADF ; 2.90 ; Crystallographic studies of two alcohol dehydrogenase-bound analogues of thiazole-4-carboxamide adenine dinucleotide (TAD), the active anabolite of the antitumor agent tiazofurin. 1ADG ; 2.70 ; Crystallographic studies of two alcohol dehydrogenase-bound analogues of thiazole-4-carboxamide adenine dinucleotide (TAD), the active anabolite of the antitumor agent tiazofurin. 1CRB ; 2.10 ; Crystallographic studies on a family of cellular lipophilic transport proteins. Refinement of P2 myelin protein and the structure determination and refinement of cellular retinol-binding protein in complex with all-trans-retinol. 1PMP ; 2.70 ; Crystallographic studies on a family of cellular lipophilic transport proteins. Refinement of P2 myelin protein and the structure determination and refinement of cellular retinol-binding protein in complex with all-trans-retinol. 1FEL ; 1.80 ; Crystallographic studies on complexes between retinoids and plasma retinol-binding protein. 1FEM ; 1.90 ; Crystallographic studies on complexes between retinoids and plasma retinol-binding protein. 1FEN ; 1.90 ; Crystallographic studies on complexes between retinoids and plasma retinol-binding protein. 1BIL ; 2.40 ; Crystallographic studies on the binding modes of P2-P3 butanediamide renin inhibitors. 1BIM ; 2.80 ; Crystallographic studies on the binding modes of P2-P3 butanediamide renin inhibitors. 1LRA ; 1.90 ; Crystallographic study of Glu58Ala RNase T1 x 2'-guanosine monophosphate at 1.9-A resolution. 1PGN ; 2.30 ; Crystallographic study of coenzyme, coenzyme analogue and substrate binding in 6-phosphogluconate dehydrogenase: implications for NADP specificity and the enzyme mechanism. 1PGO ; 2.50 ; Crystallographic study of coenzyme, coenzyme analogue and substrate binding in 6-phosphogluconate dehydrogenase: implications for NADP specificity and the enzyme mechanism. 1PGP ; 2.50 ; Crystallographic study of coenzyme, coenzyme analogue and substrate binding in 6-phosphogluconate dehydrogenase: implications for NADP specificity and the enzyme mechanism. 1PGQ ; 3.17 ; Crystallographic study of coenzyme, coenzyme analogue and substrate binding in 6-phosphogluconate dehydrogenase: implications for NADP specificity and the enzyme mechanism. 1BD1 ; 1.60 ; Crystallographic study of one turn of G/C-rich B-DEOXYRIBONUCLEIC ACID. 2EST ; 2.50 ; Crystallographic study of the binding of a trifluoroacetyl dipeptide anilide inhibitor with elastase. 1LZ2 ; 2.80 ; Crystallographic study of turkey egg-white lysozyme and its complex with a disaccharide. 1L42 ; 1.80 ; Cumulative site-directed charge-change replacements in bacteriophage T4 lysozyme suggest that long-range electrostatic interactions contribute little to protein stability. 1L43 ; 1.80 ; Cumulative site-directed charge-change replacements in bacteriophage T4 lysozyme suggest that long-range electrostatic interactions contribute little to protein stability. 1L44 ; 1.70 ; Cumulative site-directed charge-change replacements in bacteriophage T4 lysozyme suggest that long-range electrostatic interactions contribute little to protein stability. 1L45 ; 1.70 ; Cumulative site-directed charge-change replacements in bacteriophage T4 lysozyme suggest that long-range electrostatic interactions contribute little to protein stability. 1L46 ; 1.70 ; Cumulative site-directed charge-change replacements in bacteriophage T4 lysozyme suggest that long-range electrostatic interactions contribute little to protein stability. 1L47 ; 1.70 ; Cumulative site-directed charge-change replacements in bacteriophage T4 lysozyme suggest that long-range electrostatic interactions contribute little to protein stability. 122D ; 1.70 ; DEOXYRIBONUCLEIC ACID HELIX STRUCTURE AND REFINEMENT ALGORITHM - COMPARISON OF MODELS FOR D(CCAGGCM(5)CTGG) DERIVED FROM NUCLSQ, TNT AND X-PLOR. 123D ; 1.70 ; DEOXYRIBONUCLEIC ACID HELIX STRUCTURE AND REFINEMENT ALGORITHM - COMPARISON OF MODELS FOR D(CCAGGCM(5)CTGG) DERIVED FROM NUCLSQ, TNT AND X-PLOR. 1HCP ; -1.00 ; DEOXYRIBONUCLEIC ACID RECOGNITION BY THE ESTROGEN-RECEPTOR - FROM SOLUTION TO THE CRYSTAL. 154D ; 2.50 ; DEOXYRIBONUCLEIC ACID distortion in bis-intercalated complexes. 104D ; -1.00 ; DEOXYRIBONUCLEIC ACID duplexes flanked by hybrid duplexes: the solution structure of chimeric junctions in [r(cgcg)d(TATACGCG)]2. 1D66 ; 2.70 ; DEOXYRIBONUCLEIC ACID recognition by GAL4: structure of a protein-DEOXYRIBONUCLEIC ACID complex. 1PAR ; 2.60 ; DEOXYRIBONUCLEIC ACID recognition by beta-sheets in the Arc repressor-operator crystal structure. 175D ; -1.00 ; DEOXYRIBONUCLEIC ACID sequence GCGAATGAGC containing the human centromere core sequence GAAT forms a self-complementary duplex with sheared G.A pairs in solution. 1DA0 ; 1.50 ; DEOXYRIBONUCLEIC ACID-drug interactions. The crystal structure of d(CGATCG) complexed with daunomycin. 182D ; 1.80 ; DEOXYRIBONUCLEIC ACID-nogalamycin interactions: the crystal structure of d(TGATCA) complexed with nogalamycin. 1FKG ; 2.00 ; DESIGN, SYNTHESIS, AND KINETIC EVALUATION OF HIGH-AFFINITY FKBP LIGANDS AND THE X-RAY CRYSTAL-STRUCTURES OF THEIR COMPLEXES WITH FKBP12. 1FKH ; 1.95 ; DESIGN, SYNTHESIS, AND KINETIC EVALUATION OF HIGH-AFFINITY FKBP LIGANDS AND THE X-RAY CRYSTAL-STRUCTURES OF THEIR COMPLEXES WITH FKBP12. 1FKI ; 2.20 ; DESIGN, SYNTHESIS, AND KINETIC EVALUATION OF HIGH-AFFINITY FKBP LIGANDS AND THE X-RAY CRYSTAL-STRUCTURES OF THEIR COMPLEXES WITH FKBP12. 1PPO ; 1.80 ; DETERMINATION OF THE STRUCTURE OF PAPAYA PROTEASE OMEGA. 1HUG ; 2.00 ; DIFFERENCES IN ANIONIC INHIBITION OF HUMAN CARBONIC ANHYDRASE-I REVEALED FROM THE STRUCTURES OF IODIDE AND GOLD CYANIDE INHIBITOR COMPLEXES. 1HUH ; 2.20 ; DIFFERENCES IN ANIONIC INHIBITION OF HUMAN CARBONIC ANHYDRASE-I REVEALED FROM THE STRUCTURES OF IODIDE AND GOLD CYANIDE INHIBITOR COMPLEXES. 2DNJ ; 2.00 ; DNase I-induced DEOXYRIBONUCLEIC ACID conformation. 2 A structure of a DNase I-octamer complex. 1SBP ; 1.70 ; DOMINANT ROLE OF LOCAL DIPOLES IN STABILIZING UNCOMPENSATED CHARGES ON A SULFATE SEQUESTERED IN A PERIPLASMIC ACTIVE-TRANSPORT PROTEIN. 1DTC ; -1.00 ; Delta-toxin and analogues as peptide models for protein ion channels. 2DTB ; -1.00 ; Delta-toxin and analogues as peptide models for protein ion channels. 1L77 ; 2.05 ; Design and structural analysis of alternative hydrophobic core packing arrangements in bacteriophage T4 lysozyme. 1L79 ; 1.90 ; Design and structural analysis of alternative hydrophobic core packing arrangements in bacteriophage T4 lysozyme. 1L80 ; 1.80 ; Design and structural analysis of alternative hydrophobic core packing arrangements in bacteriophage T4 lysozyme. 1L81 ; 2.00 ; Design and structural analysis of alternative hydrophobic core packing arrangements in bacteriophage T4 lysozyme. 1L82 ; 2.10 ; Design and structural analysis of alternative hydrophobic core packing arrangements in bacteriophage T4 lysozyme. 2L78 ; 2.00 ; Design and structural analysis of alternative hydrophobic core packing arrangements in bacteriophage T4 lysozyme. 9LDB ; 2.20 ; Design and synthesis of new enzymes based on the lactate dehydrogenase framework. 9LDT ; 2.00 ; Design and synthesis of new enzymes based on the lactate dehydrogenase framework. 2LTN ; 1.70 ; Design, expression, and crystallization of recombinant lectin from the garden pea (Pisum sativum). 1IFH ; 2.80 ; Detailed analysis of the free and bound conformations of an antibody. X-ray structures of Fab 17/9 and three different Fab-peptide complexes. 1CER ; 2.50 ; Determinants of enzyme thermostability observed in the molecular structure of Thermus aquaticus D-glyceraldehyde-3-phosphate dehydrogenase at 25 Angstroms Resolution. 1BMD ; 1.90 ; Determinants of protein thermostability observed in the 1.9-A crystal structure of malate dehydrogenase from the thermophilic bacterium Thermus flavus. 2SOD ; 2.00 ; Determination and analysis of the 2 A-structure of copper, zinc superoxide dismutase. 1SAR ; 1.80 ; Determination and restrained least-squares refinement of the structures of ribonuclease Sa and its complex with 3'-guanylic acid at 1.8 A resolution. 2SAR ; 1.80 ; Determination and restrained least-squares refinement of the structures of ribonuclease Sa and its complex with 3'-guanylic acid at 1.8 A resolution. 1PIT ; -1.00 ; Determination of a high-quality nuclear magnetic resonance solution structure of the bovine pancreatic trypsin inhibitor and comparison with three crystal structures. 1DYA ; 1.90 ; Determination of alpha-helix propensity within the context of a folded protein. Sites 44 and 131 in bacteriophage T4 lysozyme. 1DYB ; 1.75 ; Determination of alpha-helix propensity within the context of a folded protein. Sites 44 and 131 in bacteriophage T4 lysozyme. 1DYC ; 2.10 ; Determination of alpha-helix propensity within the context of a folded protein. Sites 44 and 131 in bacteriophage T4 lysozyme. 1DYD ; 2.10 ; Determination of alpha-helix propensity within the context of a folded protein. Sites 44 and 131 in bacteriophage T4 lysozyme. 1DYE ; 1.80 ; Determination of alpha-helix propensity within the context of a folded protein. Sites 44 and 131 in bacteriophage T4 lysozyme. 1DYF ; 1.90 ; Determination of alpha-helix propensity within the context of a folded protein. Sites 44 and 131 in bacteriophage T4 lysozyme. 1DYG ; 2.10 ; Determination of alpha-helix propensity within the context of a folded protein. Sites 44 and 131 in bacteriophage T4 lysozyme. 1ATY ; -1.00 ; Determination of local protein structure by spin label difference 2D NMR: the region neighboring Asp61 of subunit c of the F1F0 ATP synthase. 3CYS ; -1.00 ; Determination of the NMR solution structure of the cyclophilin A-cyclosporin A complex. 2AIT ; -1.00 ; Determination of the complete three-dimensional structure of the alpha-amylase inhibitor tendamistat in aqueous solution by nuclear magnetic resonance and distance geometry. 1CTI ; -1.00 ; Determination of the complete three-dimensional structure of the trypsin inhibitor from squash seeds in aqueous solution by nuclear magnetic resonance and a combination of distance geometry and dynamical simulated annealing. 2CTI ; -1.00 ; Determination of the complete three-dimensional structure of the trypsin inhibitor from squash seeds in aqueous solution by nuclear magnetic resonance and a combination of distance geometry and dynamical simulated annealing. 1PMB ; 2.50 ; Determination of the crystal structure of recombinant pig myoglobin by molecular replacement and its refinement. 1AHD ; -1.00 ; Determination of the nuclear magnetic resonance solution structure of an Antennapedia homeodomain-DEOXYRIBONUCLEIC ACID complex. 1PRA ; -1.00 ; Determination of the nuclear magnetic resonance solution structure of the DEOXYRIBONUCLEIC ACID-binding domain (residues 1 to 69) of the 434 repressor and comparison with the X-ray crystal structure. 1ADR ; -1.00 ; Determination of the nuclear magnetic resonance structure of the DEOXYRIBONUCLEIC ACID-binding domain of the P22 c2 repressor (1 to 76) in solution and comparison with the DEOXYRIBONUCLEIC ACID-binding domain of the 434 repressor. 1CLB ; -1.00 ; Determination of the solution structure of Apo calbindin D9k by NMR spectroscopy. 1CTA ; -1.00 ; Determination of the solution structure of a synthetic two-site calcium-binding homodimeric protein domain by NMR spectroscopy. 1CTD ; -1.00 ; Determination of the solution structure of a synthetic two-site calcium-binding homodimeric protein domain by NMR spectroscopy. 1GNA ; -1.00 ; Determination of the solution structure of the peptide hormone guanylin: observation of a novel form of topological stereoisomerism. 1GNB ; -1.00 ; Determination of the solution structure of the peptide hormone guanylin: observation of a novel form of topological stereoisomerism. 2IGG ; -1.00 ; Determination of the solution structures of domains II and III of protein G from Streptococcus by 1H nuclear magnetic resonance. 2IGH ; -1.00 ; Determination of the solution structures of domains II and III of protein G from Streptococcus by 1H nuclear magnetic resonance. 1RES ; -1.00 ; Determination of the structure of the DEOXYRIBONUCLEIC ACID binding domain of gamma delta resolvase in solution. 1RET ; -1.00 ; Determination of the structure of the DEOXYRIBONUCLEIC ACID binding domain of gamma delta resolvase in solution. 1SCY ; -1.00 ; Determination of the three-dimensional solution structure of scyllatoxin by 1H nuclear magnetic resonance. 1CBH ; -1.00 ; Determination of the three-dimensional solution structure of the C- terminal domain of cellobiohydrolase I from Trichoderma reesei. A study using nuclear magnetic resonance and hybrid distance geometry-dynamical simulated annealing. 1BDS ; -1.00 ; Determination of the three-dimensional solution structure of the antihypertensive and antiviral protein BDS-I from the sea anemone Anemonia sulcata: a study using nuclear magnetic resonance and hybrid distance geometry-dynamical simulated annealing. 2BDS ; -1.00 ; Determination of the three-dimensional solution structure of the antihypertensive and antiviral protein BDS-I from the sea anemone Anemonia sulcata: a study using nuclear magnetic resonance and hybrid distance geometry-dynamical simulated annealing. 1MTX ; -1.00 ; Determination of the three-dimensional structure of margatoxin by 1H, 13C, 15N triple-resonance nuclear magnetic resonance spectroscopy. 1HOM ; -1.00 ; Determination of the three-dimensional structure of the Antennapedia homeodomain from Drosophila in solution by 1H nuclear magnetic resonance spectroscopy. 1DKA ; 2.60 ; Dialkylglycine decarboxylase structure: bifunctional active site and alkali metal sites. 2DKB ; 2.10 ; Dialkylglycine decarboxylase structure: bifunctional active site and alkali metal sites. 2SPT ; 2.50 ; Differences in the metal ion structure between Sr- and Ca-prothrombin fragment 1. 1HSB ; 1.90 ; Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle. 1BPM ; 2.90 ; Differentiation and identification of the two catalytic metal binding sites in bovine lens leucine aminopeptidase by x-ray crystallography. 1BPN ; 2.90 ; Differentiation and identification of the two catalytic metal binding sites in bovine lens leucine aminopeptidase by x-ray crystallography. 1EPO ; 2.00 ; Direct observation by X-ray analysis of the tetrahedral "intermediate" of aspartic proteinases. 1YPA ; 2.00 ; Direct observation of better hydration at the N terminus of an alpha-helix with glycine rather than alanine as the N-cap residue. 1YPB ; 2.00 ; Direct observation of better hydration at the N terminus of an alpha-helix with glycine rather than alanine as the N-cap residue. 1YPC ; 1.70 ; Direct observation of better hydration at the N terminus of an alpha-helix with glycine rather than alanine as the N-cap residue. 223D ; 1.70 ; Direct observation of two base-pairing modes of a cytosine-thymine analogue with guanine in a DEOXYRIBONUCLEIC ACID Z-form duplex: significance for base analogue mutagenesis. 1ESA ; 1.65 ; Direct structural observation of an acyl-enzyme intermediate in the hydrolysis of an ester substrate by elastase. 1ESB ; 2.30 ; Direct structural observation of an acyl-enzyme intermediate in the hydrolysis of an ester substrate by elastase. 1LYE ; 1.80 ; Dissection of helix capping in T4 lysozyme by structural and thermodynamic analysis of six amino acid substitutions at Thr 59. 1LYF ; 1.80 ; Dissection of helix capping in T4 lysozyme by structural and thermodynamic analysis of six amino acid substitutions at Thr 59. 1LYG ; 1.80 ; Dissection of helix capping in T4 lysozyme by structural and thermodynamic analysis of six amino acid substitutions at Thr 59. 1LYH ; 1.70 ; Dissection of helix capping in T4 lysozyme by structural and thermodynamic analysis of six amino acid substitutions at Thr 59. 1LYI ; 2.00 ; Dissection of helix capping in T4 lysozyme by structural and thermodynamic analysis of six amino acid substitutions at Thr 59. 1LYJ ; 1.80 ; Dissection of helix capping in T4 lysozyme by structural and thermodynamic analysis of six amino acid substitutions at Thr 59. 1LZA ; 1.60 ; Dissection of protein-carbohydrate interactions in mutant hen egg-white lysozyme complexes and their hydrolytic activity. 1LZB ; 1.50 ; Dissection of protein-carbohydrate interactions in mutant hen egg-white lysozyme complexes and their hydrolytic activity. 1LZC ; 1.80 ; Dissection of protein-carbohydrate interactions in mutant hen egg-white lysozyme complexes and their hydrolytic activity. 1LZD ; 1.80 ; Dissection of protein-carbohydrate interactions in mutant hen egg-white lysozyme complexes and their hydrolytic activity. 1LZE ; 1.80 ; Dissection of protein-carbohydrate interactions in mutant hen egg-white lysozyme complexes and their hydrolytic activity. 1LZG ; 1.80 ; Dissection of protein-carbohydrate interactions in mutant hen egg-white lysozyme complexes and their hydrolytic activity. 1TAY ; 1.70 ; Dissection of the functional role of structural elements of tyrosine-63 in the catalytic action of human lysozyme. 1TBY ; 1.77 ; Dissection of the functional role of structural elements of tyrosine-63 in the catalytic action of human lysozyme. 1TCY ; 1.70 ; Dissection of the functional role of structural elements of tyrosine-63 in the catalytic action of human lysozyme. 1TDY ; 1.70 ; Dissection of the functional role of structural elements of tyrosine-63 in the catalytic action of human lysozyme. 1YCA ; 2.20 ; Distal pocket polarity in ligand binding to myoglobin: deoxy and carbonmonoxy forms of a threonine68(E11) mutant investigated by X-ray crystallography and infrared spectroscopy. 1YCB ; 2.10 ; Distal pocket polarity in ligand binding to myoglobin: deoxy and carbonmonoxy forms of a threonine68(E11) mutant investigated by X-ray crystallography and infrared spectroscopy. 1MYJ ; 1.90 ; Distal pocket polarity in ligand binding to myoglobin: structural and functional characterization of a threonine68(E11) mutant. 1AMA ; 2.30 ; Domain closure in mitochondrial aspartate aminotransferase. 1CGC ; 2.20 ; Double helix conformation, groove dimensions and ligand binding potential of a G/C stretch in B-DEOXYRIBONUCLEIC ACID. 1CTR ; 2.45 ; Drug binding by calmodulin: crystal structure of a calmodulin-trifluoperazine complex. 1D32 ; 1.70 ; Drug-induced DEOXYRIBONUCLEIC ACID repair: X-ray structure of a DEOXYRIBONUCLEIC ACID-ditercalinium complex. 1BTW ; 1.80 ; EPISELECTION - NOVEL K-I-SIMILAR-TO NANOMOLAR INHIBITORS OF SERINE PROTEASES SELECTED BY BINDING OR CHEMISTRY ON AN ENZYME SURFACE. 2ECH ; -1.00 ; Echistatin: the refined structure of a disintegrin in solution by 1H NMR and restrained molecular dynamics. 1D26 ; 2.12 ; Effect of a single 3'-methylene phosphonate linkage on the conformation of an A-DEOXYRIBONUCLEIC ACID octamer double helix. 6CCP ; 2.20 ; Effect of arginine-48 replacement on the reaction between cytochrome c peroxidase and hydrogen peroxide. 7CCP ; 2.20 ; Effect of arginine-48 replacement on the reaction between cytochrome c peroxidase and hydrogen peroxide. 1COA ; 2.20 ; Effect of cavity-creating mutations in the hydrophobic core of chymotrypsin inhibitor 2. 1DNF ; 1.50 ; Effects of 5-fluorouracil/guanine wobble base pairs in Z-DEOXYRIBONUCLEIC ACID: molecular and crystal structure of d(CGCGFG). 2CYM ; 2.00 ; Effects of amino acid substitution on three-dimensional structure: an X-ray analysis of cytochrome c3 from Desulfovibrio vulgaris Hildenborough at 2 A resolution. 1RAT ; 1.50 ; Effects of temperature on protein structure and dynamics: X-ray crystallographic studies of the protein ribonuclease-A at nine different temperatures from 98 to 320 K. 2SGA ; 1.50 ; Electron density calculations as an extension of protein structure refinement. Streptomyces griseus protease A at 1.5 A resolution. 1KAL ; -1.00 ; Elucidation of the primary and three-dimensional structure of the uterotonic polypeptide kalata B1. 118L ; 1.80 ; Energetic cost and structural consequences of burying a hydroxyl group within the core of a protein determined from Ala-->Ser and Val-->Thr substitutions in T4 lysozyme. 119L ; 1.65 ; Energetic cost and structural consequences of burying a hydroxyl group within the core of a protein determined from Ala-->Ser and Val-->Thr substitutions in T4 lysozyme. 120L ; 1.80 ; Energetic cost and structural consequences of burying a hydroxyl group within the core of a protein determined from Ala-->Ser and Val-->Thr substitutions in T4 lysozyme. 122L ; 1.80 ; Energetic cost and structural consequences of burying a hydroxyl group within the core of a protein determined from Ala-->Ser and Val-->Thr substitutions in T4 lysozyme. 123L ; 1.80 ; Energetic cost and structural consequences of burying a hydroxyl group within the core of a protein determined from Ala-->Ser and Val-->Thr substitutions in T4 lysozyme. 125L ; 1.85 ; Energetic cost and structural consequences of burying a hydroxyl group within the core of a protein determined from Ala-->Ser and Val-->Thr substitutions in T4 lysozyme. 126L ; 1.80 ; Energetic cost and structural consequences of burying a hydroxyl group within the core of a protein determined from Ala-->Ser and Val-->Thr substitutions in T4 lysozyme. 127L ; 1.85 ; Energetic cost and structural consequences of burying a hydroxyl group within the core of a protein determined from Ala-->Ser and Val-->Thr substitutions in T4 lysozyme. 128L ; 1.70 ; Energetic cost and structural consequences of burying a hydroxyl group within the core of a protein determined from Ala-->Ser and Val-->Thr substitutions in T4 lysozyme. 21BI ; 2.00 ; Energetic cost and structural consequences of burying a hydroxyl group within the core of a protein determined from Ala-->Ser and Val-->Thr substitutions in T4 lysozyme. 221L ; 1.70 ; Energetic cost and structural consequences of burying a hydroxyl group within the core of a protein determined from Ala-->Ser and Val-->Thr substitutions in T4 lysozyme. 224L ; 1.85 ; Energetic cost and structural consequences of burying a hydroxyl group within the core of a protein determined from Ala-->Ser and Val-->Thr substitutions in T4 lysozyme. 31BI ; 2.00 ; Energetic cost and structural consequences of burying a hydroxyl group within the core of a protein determined from Ala-->Ser and Val-->Thr substitutions in T4 lysozyme. 41BI ; 2.90 ; Energetic cost and structural consequences of burying a hydroxyl group within the core of a protein determined from Ala-->Ser and Val-->Thr substitutions in T4 lysozyme. 1SYC ; 1.80 ; Engineering alternative beta-turn types in staphylococcal nuclease. 1SYD ; 1.70 ; Engineering alternative beta-turn types in staphylococcal nuclease. 1SYE ; 1.80 ; Engineering alternative beta-turn types in staphylococcal nuclease. 1SYF ; 1.80 ; Engineering alternative beta-turn types in staphylococcal nuclease. 1SYG ; 1.90 ; Engineering alternative beta-turn types in staphylococcal nuclease. 4CA2 ; 2.10 ; Engineering the hydrophobic pocket of carbonic anhydrase II. 6CA2 ; 2.50 ; Engineering the hydrophobic pocket of carbonic anhydrase II. 7CA2 ; 2.40 ; Engineering the hydrophobic pocket of carbonic anhydrase II. 8CA2 ; 2.40 ; Engineering the hydrophobic pocket of carbonic anhydrase II. 9CA2 ; 2.80 ; Engineering the hydrophobic pocket of carbonic anhydrase II. 1HVA ; 2.30 ; Engineering the zinc binding site of human carbonic anhydrase II: structure of the His-94-->Cys apoenzyme in a new crystalline form. 3P2P ; 2.10 ; Enhanced activity and altered specificity of phospholipase A2 by deletion of a surface loop. 1L19 ; 1.70 ; Enhanced protein thermostability from designed mutations that interact with alpha-helix dipoles. 1L20 ; 1.85 ; Enhanced protein thermostability from designed mutations that interact with alpha-helix dipoles. 1L23 ; 1.70 ; Enhanced protein thermostability from site-directed mutations that decrease the entropy of unfolding. 1L24 ; 1.70 ; Enhanced protein thermostability from site-directed mutations that decrease the entropy of unfolding. 189L ; 2.50 ; Enhancement of protein stability by the combination of point mutations in T4 lysozyme is additive. 1LZ4 ; 1.80 ; Enthalpic destabilization of a mutant human lysozyme lacking a disulfide bridge between cysteine-77 and cysteine-95. 1CHM ; 1.90 ; Enzymatic mechanism of creatine amidinohydrolase as deduced from crystal structures. 1SCA ; 2.00 ; Enzyme crystal structure in a neat organic solvent. 1SCB ; 2.30 ; Enzyme crystal structure in a neat organic solvent. 1HCB ; 1.60 ; Enzyme-substrate interactions. Structure of human carbonic anhydrase I complexed with bicarbonate. 1BTX ; 1.80 ; Episelection: novel Ki approximately nanomolar inhibitors of serine proteases selected by binding or chemistry on an enzyme surface. 1BTY ; 1.50 ; Episelection: novel Ki approximately nanomolar inhibitors of serine proteases selected by binding or chemistry on an enzyme surface. 1BTZ ; 2.00 ; Episelection: novel Ki approximately nanomolar inhibitors of serine proteases selected by binding or chemistry on an enzyme surface. 1BIA ; 2.30 ; Escherichia coli biotin holoenzyme synthetase/bio repressor crystal structure delineates the biotin- and DEOXYRIBONUCLEIC ACID-binding domains. 1BIB ; 2.80 ; Escherichia coli biotin holoenzyme synthetase/bio repressor crystal structure delineates the biotin- and DEOXYRIBONUCLEIC ACID-binding domains. 1ICM ; 1.50 ; Escherichia coli-derived rat intestinal fatty acid binding protein with bound myristate at 1.5 A resolution and I-FABPArg106-->Gln with bound oleate at 1.74 A resolution. 1ICN ; 1.74 ; Escherichia coli-derived rat intestinal fatty acid binding protein with bound myristate at 1.5 A resolution and I-FABPArg106-->Gln with bound oleate at 1.74 A resolution. 137D ; 1.70 ; Evidence for crystal environment dominating base sequence effects on DEOXYRIBONUCLEIC ACID conformation: crystal structures of the orthorhombic and hexagonal polymorphs of the A-DEOXYRIBONUCLEIC ACID decamer d(GCGGGCCCGC) and comparison with their isomorphous crystal structures. 138D ; 1.80 ; Evidence for crystal environment dominating base sequence effects on DEOXYRIBONUCLEIC ACID conformation: crystal structures of the orthorhombic and hexagonal polymorphs of the A-DEOXYRIBONUCLEIC ACID decamer d(GCGGGCCCGC) and comparison with their isomorphous crystal structures. 1PLG ; 2.80 ; Evidence for the extended helical nature of polysaccharide epitopes. The 2.8 A resolution structure and thermodynamics of ligand binding of an antigen binding fragment specific for alpha-(2-->8)-polysialic acid. 1CLA ; 2.34 ; Evidence for transition-state stabilization by serine-148 in the catalytic mechanism of chloramphenicol acetyltransferase. 241D ; 1.85 ; Extension of the four-stranded intercalated cytosine motif by adenine.adenine base pairing in the crystal structure of d(CCCAAT). 1FKD ; 1.72 ; FK-506-binding protein: three-dimensional structure of the complex with the antagonist L-685,818. 2FKE ; 1.72 ; FK-506-binding protein: three-dimensional structure of the complex with the antagonist L-685,818. 1D35 ; 1.30 ; Facile formation of a crosslinked adduct between DEOXYRIBONUCLEIC ACID and the daunorubicin derivative MAR70 mediated by formaldehyde: molecular structure of the MAR70-d(CGTnACG) covalent adduct. 1D36 ; 1.50 ; Facile formation of a crosslinked adduct between DEOXYRIBONUCLEIC ACID and the daunorubicin derivative MAR70 mediated by formaldehyde: molecular structure of the MAR70-d(CGTnACG) covalent adduct. 2LGS ; 2.80 ; Feedback inhibition of fully unadenylylated glutamine synthetase from Salmonella typhimurium by glycine, alanine, and serine. 1PBP ; 1.90 ; Fine tuning the specificity of the periplasmic phosphate transport receptor. Site-directed mutagenesis, ligand binding, and crystallographic studies. 1IAG ; 2.00 ; First structure of a snake venom metalloproteinase: a prototype for matrix metalloproteinases/collagenases. 1WRP ; 2.20 ; Flexibility of the DEOXYRIBONUCLEIC ACID-binding domains of trp repressor. 3WRP ; 1.80 ; Flexibility of the DEOXYRIBONUCLEIC ACID-binding domains of trp repressor. 1NEL ; 2.60 ; Fluoride inhibition of yeast enolase: crystal structure of the enolase-Mg(2+)-F(-)-Pi complex at 2.6 A resolution. 1L65 ; 1.70 ; Folding and function of a T4 lysozyme containing 10 consecutive alanines illustrate the redundancy of information in an amino acid sequence. 1L66 ; 1.70 ; Folding and function of a T4 lysozyme containing 10 consecutive alanines illustrate the redundancy of information in an amino acid sequence. 1L67 ; 1.90 ; Folding and function of a T4 lysozyme containing 10 consecutive alanines illustrate the redundancy of information in an amino acid sequence. 1L68 ; 1.70 ; Folding and function of a T4 lysozyme containing 10 consecutive alanines illustrate the redundancy of information in an amino acid sequence. 1D33 ; 1.50 ; Formaldehyde cross-links daunorubicin and DEOXYRIBONUCLEIC ACID efficiently: HPLC and X-ray diffraction studies. 2D34 ; 1.40 ; Formaldehyde cross-links daunorubicin and DEOXYRIBONUCLEIC ACID efficiently: HPLC and X-ray diffraction studies. 1CP4 ; 1.90 ; Formation, crystal structure, and rearrangement of a cytochrome P-450cam iron-phenyl complex. 4I1B ; 2.00 ; Functional implications of interleukin-1 beta based on the three-dimensional structure. 4TNA ; 2.50 ; Further refinement of the structure of yeast tRNAPhe. 1CUS ; 1.25 ; Fusarium solani cutinase is a lipolytic enzyme with a catalytic serine accessible to solvent. 1D91 ; 2.10 ; G . T base-pairs in a DEOXYRIBONUCLEIC ACID helix: the crystal structure of d(G-G-G-G-T-C-C-C). 1TAD ; 1.70 ; GTPase mechanism of Gproteins from the 1.7-A crystal structure of transducin alpha-GDP-AIF-4. 1LTA ; 2.20 ; Galactose-binding site in Escherichia coli heat-labile enterotoxin (LT) and cholera toxin (CT). 8GCH ; 1.60 ; Gamma-chymotrypsin is a complex of alpha-chymotrypsin with its own autolysis products. 1PPH ; 1.90 ; Geometry of binding of the N alpha-tosylated piperidides of m-amidino-, p-amidino- and p-guanidino phenylalanine to thrombin and trypsin. X-ray crystal structures of their trypsin complexes and modeling of their thrombin complexes. 1PPC ; 1.80 ; Geometry of binding of the benzamidine- and arginine-based inhibitors N alpha-(2-naphthyl-sulphonyl-glycyl)-DL-p-amidinophenylalanyl-pipe ridine (NAPAP) and (2R,4R)-4-methyl-1-[N alpha-(3-methyl-1,2,3,4-tetrahydro-8- quinolinesulphonyl)-L-arginyl]-2-piperidine carboxylic acid (MQPA) to human alpha-thrombin. X-ray crystallographic determination of the NAPAP-trypsin complex and modeling of NAPAP-thrombin and MQPA-thrombin. 1HBG ; 1.50 ; Glycera dibranchiata hemoglobin. Structure and refinement at 1.5 A resolution. 2HBG ; 1.50 ; Glycera dibranchiata hemoglobin. Structure and refinement at 1.5 A resolution. 150D ; 2.25 ; Guanine-1,N6-ethenoadenine base pairs in the crystal structure of d(CGCGAATT(epsilon dA)GCG). 1D78 ; 1.40 ; HIGH-RESOLUTION REFINEMENT OF THE HEXAGONAL A-DEOXYRIBONUCLEIC ACID OCTAMER D(GTGTACAC) AT 1.4 ANGSTROM. 1D79 ; 1.45 ; HIGH-RESOLUTION REFINEMENT OF THE HEXAGONAL A-DEOXYRIBONUCLEIC ACID OCTAMER D(GTGTACAC) AT 1.4 ANGSTROM. 1SCR ; 2.00 ; HIGH-RESOLUTION STRUCTURES OF SINGLE-METAL-SUBSTITUTED CONCANAVALIN-A - THE CO,CA-PROTEIN AT 1.6-ANGSTROM AND THE NI,CA-PROTEIN AT 2.0-ANGSTROM. 1SCS ; 1.60 ; HIGH-RESOLUTION STRUCTURES OF SINGLE-METAL-SUBSTITUTED CONCANAVALIN-A - THE CO,CA-PROTEIN AT 1.6-ANGSTROM AND THE NI,CA-PROTEIN AT 2.0-ANGSTROM. 1TFD ; 2.30 ; HIGH-RESOLUTION X-RAY STUDIES ON RABBIT SERUM TRANSFERRIN - PRELIMINARY STRUCTURE-ANALYSIS OF THE N-TERMINAL HALF-MOLECULE AT 2.3-A RESOLUTION. 1PBX ; 2.50 ; Haemoglobin of the antarctic fish Pagothenia bernacchii. Amino acid sequence, oxygen equilibria and crystal structure of its carbonmonoxy derivative. 1ANA ; 2.10 ; Helix geometry and hydration in an A-DEOXYRIBONUCLEIC ACID tetramer: IC-C-G-G. 1BAB ; 1.50 ; Hemoglobin Thionville. An alpha-chain variant with a substitution of a glutamate for valine at NA-1 and having an acetylated methionine NH2 terminus. 1HEV ; -1.00 ; Hevein: NMR assignment and assessment of solution-state folding for the agglutinin-toxin motif. 4ER4 ; 2.10 ; High resolution X-ray analyses of renin inhibitor-aspartic proteinase complexes. 160D ; 1.65 ; High resolution crystal structure of the A-DEOXYRIBONUCLEIC ACID decamer d(CCCGGCCGGG). Novel intermolecular base-paired G(G.C) triplets. 1HGA ; 2.10 ; High resolution crystal structures and comparisons of T-state deoxyhaemoglobin and two liganded T-state haemoglobins: T(alpha-oxy)haemoglobin and T(met)haemoglobin. 1HGB ; 2.10 ; High resolution crystal structures and comparisons of T-state deoxyhaemoglobin and two liganded T-state haemoglobins: T(alpha-oxy)haemoglobin and T(met)haemoglobin. 1HGC ; 2.10 ; High resolution crystal structures and comparisons of T-state deoxyhaemoglobin and two liganded T-state haemoglobins: T(alpha-oxy)haemoglobin and T(met)haemoglobin. 1HRN ; 1.80 ; High resolution crystal structures of recombinant human renin in complex with polyhydroxymonoamide inhibitors. 1RTH ; 2.20 ; High resolution structures of HIV-1 RT from four RT-inhibitor complexes. 1RTI ; 3.00 ; High resolution structures of HIV-1 RT from four RT-inhibitor complexes. 1VRT ; 2.20 ; High resolution structures of HIV-1 RT from four RT-inhibitor complexes. 1VRU ; 2.40 ; High resolution structures of HIV-1 RT from four RT-inhibitor complexes. 2NAC ; 1.80 ; High resolution structures of holo and apo formate dehydrogenase. 2NAD ; 2.00 ; High resolution structures of holo and apo formate dehydrogenase. 5ER2 ; 1.80 ; High-resolution X-ray diffraction study of the complex between endothiapepsin and an oligopeptide inhibitor: the analysis of the inhibitor binding and description of the rigid body shift in the enzyme. 1MYG ; 1.75 ; High-resolution X-ray structures of pig metmyoglobin and two CD3 mutants: Mb(Lys45----Arg) and Mb(Lys45----Ser). 1MYH ; 1.90 ; High-resolution X-ray structures of pig metmyoglobin and two CD3 mutants: Mb(Lys45----Arg) and Mb(Lys45----Ser). 1MYI ; 2.00 ; High-resolution X-ray structures of pig metmyoglobin and two CD3 mutants: Mb(Lys45----Arg) and Mb(Lys45----Ser). 1DXT ; 1.80 ; High-resolution X-ray study of deoxy recombinant human hemoglobins synthesized from beta-globins having mutated amino termini. 1DXU ; 1.80 ; High-resolution X-ray study of deoxy recombinant human hemoglobins synthesized from beta-globins having mutated amino termini. 1DXV ; 1.80 ; High-resolution X-ray study of deoxy recombinant human hemoglobins synthesized from beta-globins having mutated amino termini. 1HBA ; 2.10 ; High-resolution X-ray study of deoxyhemoglobin Rothschild 37 beta Trp----Arg: a mutation that creates an intersubunit chloride-binding site. 1HBB ; 1.90 ; High-resolution X-ray study of deoxyhemoglobin Rothschild 37 beta Trp----Arg: a mutation that creates an intersubunit chloride-binding site. 2CPP ; 1.63 ; High-resolution crystal structure of cytochrome P450cam. 1MOB ; 2.20 ; High-resolution crystal structures of distal histidine mutants of sperm whale myoglobin. 1MOC ; 2.00 ; High-resolution crystal structures of distal histidine mutants of sperm whale myoglobin. 1MOD ; 2.00 ; High-resolution crystal structures of distal histidine mutants of sperm whale myoglobin. 2MGA ; 2.20 ; High-resolution crystal structures of distal histidine mutants of sperm whale myoglobin. 2MGB ; 2.00 ; High-resolution crystal structures of distal histidine mutants of sperm whale myoglobin. 2MGC ; 1.90 ; High-resolution crystal structures of distal histidine mutants of sperm whale myoglobin. 2MGD ; 1.80 ; High-resolution crystal structures of distal histidine mutants of sperm whale myoglobin. 2MGE ; 1.70 ; High-resolution crystal structures of distal histidine mutants of sperm whale myoglobin. 2MGF ; 1.80 ; High-resolution crystal structures of distal histidine mutants of sperm whale myoglobin. 2MGG ; 1.80 ; High-resolution crystal structures of distal histidine mutants of sperm whale myoglobin. 2MGH ; 2.00 ; High-resolution crystal structures of distal histidine mutants of sperm whale myoglobin. 2MGI ; 2.00 ; High-resolution crystal structures of distal histidine mutants of sperm whale myoglobin. 2MGJ ; 2.00 ; High-resolution crystal structures of distal histidine mutants of sperm whale myoglobin. 2MGK ; 2.00 ; High-resolution crystal structures of distal histidine mutants of sperm whale myoglobin. 2MGL ; 2.00 ; High-resolution crystal structures of distal histidine mutants of sperm whale myoglobin. 2MGM ; 1.90 ; High-resolution crystal structures of distal histidine mutants of sperm whale myoglobin. 3SDH ; 1.40 ; High-resolution crystallographic analysis of a co-operative dimeric hemoglobin. 4SDH ; 1.60 ; High-resolution crystallographic analysis of a co-operative dimeric hemoglobin. 1YCC ; 1.23 ; High-resolution refinement of yeast iso-1-cytochrome c and comparisons with other eukaryotic cytochromes c. 9PCY ; -1.00 ; High-resolution solution structure of reduced French bean plastocyanin and comparison with the crystal structure of poplar plastocyanin. 1PLA ; -1.00 ; High-resolution solution structure of reduced parsley plastocyanin. 1PLB ; -1.00 ; High-resolution solution structure of reduced parsley plastocyanin. 1HUM ; -1.00 ; High-resolution solution structure of the beta chemokine hMIP-1 beta by multidimensional NMR. 1HUN ; -1.00 ; High-resolution solution structure of the beta chemokine hMIP-1 beta by multidimensional NMR. 1BBO ; -1.00 ; High-resolution solution structure of the double Cys2His2 zinc finger from the human enhancer binding protein MBP-1. 1ATA ; -1.00 ; High-resolution structure of Ascaris trypsin inhibitor in solution: direct evidence for a pH-induced conformational transition in the reactive site. 1ATB ; -1.00 ; High-resolution structure of Ascaris trypsin inhibitor in solution: direct evidence for a pH-induced conformational transition in the reactive site. 1ATD ; -1.00 ; High-resolution structure of Ascaris trypsin inhibitor in solution: direct evidence for a pH-induced conformational transition in the reactive site. 1ATE ; -1.00 ; High-resolution structure of Ascaris trypsin inhibitor in solution: direct evidence for a pH-induced conformational transition in the reactive site. 208D ; 2.05 ; High-resolution structure of a DEOXYRIBONUCLEIC ACID helix forming (C.G)G base triplets. 1D27 ; 2.00 ; High-resolution structure of a mutagenic lesion in DEOXYRIBONUCLEIC ACID. 2ZNF ; -1.00 ; High-resolution structure of an HIV zinc fingerlike domain via a new NMR-based distance geometry approach. 1OLG ; -1.00 ; High-resolution structure of the oligomerization domain of p53 by multi-dimensional NMR. 1OLH ; -1.00 ; High-resolution structure of the oligomerization domain of p53 by multi-dimensional NMR. 1L34 ; 1.90 ; High-resolution structure of the temperature-sensitive mutant of phage lysozyme, Arg 96----His. 1AKY ; 1.63 ; High-resolution structures of adenylate kinase from yeast ligated with inhibitor Ap5A, showing the pathway of phosphoryl transfer. 2AKY ; 1.96 ; High-resolution structures of adenylate kinase from yeast ligated with inhibitor Ap5A, showing the pathway of phosphoryl transfer. 1YMB ; 1.90 ; High-resolution study of the three-dimensional structure of horse heart metmyoglobin. 3ZNF ; -1.00 ; High-resolution three-dimensional structure of a single zinc finger from a human enhancer binding protein in solution. 1HRC ; 1.90 ; High-resolution three-dimensional structure of horse heart cytochrome c. 6I1B ; -1.00 ; High-resolution three-dimensional structure of interleukin 1 beta in solution by three- and four-dimensional nuclear magnetic resonance spectroscopy. 7I1B ; -1.00 ; High-resolution three-dimensional structure of interleukin 1 beta in solution by three- and four-dimensional nuclear magnetic resonance spectroscopy. 3TRX ; -1.00 ; High-resolution three-dimensional structure of reduced recombinant human thioredoxin in solution. 4TRX ; -1.00 ; High-resolution three-dimensional structure of reduced recombinant human thioredoxin in solution. 2AAS ; -1.00 ; High-resolution three-dimensional structure of ribonuclease A in solution by nuclear magnetic resonance spectroscopy. 1HCR ; 1.80 ; Hin recombinase bound to DEOXYRIBONUCLEIC ACID: the origin of specificity in major and minor groove interactions. 1MGN ; 1.90 ; His64(E7)-->Tyr apomyoglobin as a reagent for measuring rates of hemin dissociation. 1RN4 ; 1.80 ; His92Ala mutation in ribonuclease T1 induces segmental flexibility. An X-ray study. 1GHC ; -1.00 ; Homo- and heteronuclear two-dimensional NMR studies of the globular domain of histone H1: full assignment, tertiary structure, and comparison with the globular domain of histone H5. 1HPL ; 2.30 ; Horse pancreatic lipase. The crystal structure refined at 2.3 A resolution. 1BMT ; 3.00 ; How a protein binds B12: A 3.0 A X-ray structure of B12-binding domains of methionine synthase [see comments] 102L ; 1.74 ; How amino-acid insertions are allowed in an alpha-helix of T4 lysozyme. 103L ; 1.90 ; How amino-acid insertions are allowed in an alpha-helix of T4 lysozyme. 104L ; 2.80 ; How amino-acid insertions are allowed in an alpha-helix of T4 lysozyme. 201L ; 2.00 ; How amino-acid insertions are allowed in an alpha-helix of T4 lysozyme. 205L ; 2.10 ; How amino-acid insertions are allowed in an alpha-helix of T4 lysozyme. 1CCF ; -1.00 ; How an epidermal growth factor (EGF)-like domain binds calcium. High resolution NMR structure of the calcium form of the NH2-terminal EGF-like domain in coagulation factor X. 1HPM ; 1.70 ; How potassium affects the activity of the molecular chaperone Hsc70. II. Potassium binds specifically in the ATPase active site. 1IND ; 2.20 ; How the anti-(metal chelate) antibody CHA255 is specific for the metal ion of its antigen: X-ray structures for two Fab'/hapten complexes with different metals in the chelate. 1INE ; 2.80 ; How the anti-(metal chelate) antibody CHA255 is specific for the metal ion of its antigen: X-ray structures for two Fab'/hapten complexes with different metals in the chelate. 1CKS ; 2.10 ; Human CksHs2 atomic structure: a role for its hexameric assembly in cell cycle control. 3HHR ; 2.80 ; Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. 1ITL ; -1.00 ; Human interleukin 4. The solution structure of a four-helix bundle protein. 1HUP ; 2.50 ; Human mannose-binding protein carbohydrate recognition domain trimerizes through a triple alpha-helical coiled-coil. 1R09 ; 2.90 ; Human rhinovirus 14 complexed with antiviral compound R 61837. 2HYA ; 3.00 ; Hyaluronic acid: molecular conformations and interactions in two sodium salts. 3HYA ; 3.00 ; Hyaluronic acid: molecular conformations and interactions in two sodium salts. 1HYA ; 3.00 ; Hyaluronic acid: structure of a fully extended 3-fold helical sodium salt and comparison with the less extended 4-fold helical forms. 187D ; 2.25 ; Hydration patterns and intermolecular interactions in A-DEOXYRIBONUCLEIC ACID crystal structures. Implications for DEOXYRIBONUCLEIC ACID recognition. 188D ; 2.20 ; Hydration patterns and intermolecular interactions in A-DEOXYRIBONUCLEIC ACID crystal structures. Implications for DEOXYRIBONUCLEIC ACID recognition. 189D ; 2.10 ; Hydration patterns and intermolecular interactions in A-DEOXYRIBONUCLEIC ACID crystal structures. Implications for DEOXYRIBONUCLEIC ACID recognition. 1TLA ; 2.00 ; Hydrophobic core repacking and aromatic-aromatic interaction in the thermostable mutant of T4 lysozyme Ser 117-->Phe. 1L17 ; 1.70 ; Hydrophobic stabilization in T4 lysozyme determined directly by multiple substitutions of Ile 3. 1L18 ; 1.70 ; Hydrophobic stabilization in T4 lysozyme determined directly by multiple substitutions of Ile 3. 1AAQ ; 2.50 ; Hydroxyethylene isostere inhibitors of human immunodeficiency virus-1 protease: structure-activity analysis using enzyme kinetics, X-ray crystallography, and infected T-cell assays. 1HVI ; 1.80 ; INFLUENCE OF STEREOCHEMISTRY ON ACTIVITY AND BINDING MODES FOR C(2) SYMMETRY-BASED DIOL INHIBITORS OF HIV-1 PROTEASE. 1HVJ ; 2.00 ; INFLUENCE OF STEREOCHEMISTRY ON ACTIVITY AND BINDING MODES FOR C(2) SYMMETRY-BASED DIOL INHIBITORS OF HIV-1 PROTEASE. 1HVK ; 1.80 ; INFLUENCE OF STEREOCHEMISTRY ON ACTIVITY AND BINDING MODES FOR C(2) SYMMETRY-BASED DIOL INHIBITORS OF HIV-1 PROTEASE. 1HVL ; 1.80 ; INFLUENCE OF STEREOCHEMISTRY ON ACTIVITY AND BINDING MODES FOR C(2) SYMMETRY-BASED DIOL INHIBITORS OF HIV-1 PROTEASE. 1DBP ; 2.20 ; Identical mutations at corresponding positions in two homologous proteins with nonidentical effects. 1SMN ; 2.10 ; Identification of the Serratia endonuclease dimer: structural basis and implications for catalysis. 1CYF ; 2.35 ; Identifying the physiological electron transfer site of cytochrome c peroxidase by structure-based engineering. 1CYG ; 2.50 ; Identifying the physiological electron transfer site of cytochrome c peroxidase by structure-based engineering. 1CWC ; 1.86 ; Improved binding affinity for cyclophilin A by a cyclosporin derivative singly modified at its effector domain. 1YAT ; 2.50 ; Improved calcineurin inhibition by yeast FKBP12-drug complexes. Crystallographic and functional analysis. 2SNM ; 1.97 ; In a staphylococcal nuclease mutant the side-chain of a lysine replacing valine 66 is fully buried in the hydrophobic core. 1SCN ; 1.90 ; Inactivation of subtilisin Carlsberg by N-((tert-butoxycarbonyl)alanylprolylphenylalanyl)-O-benzoylhydroxyl- amine: formation of a covalent enzyme-inhibitor linkage in the form of a carbamate derivative. 1D37 ; 1.80 ; Influence of aglycone modifications on the binding of anthracycline drugs to DEOXYRIBONUCLEIC ACID: the molecular structure of idarubicin and 4-O-demethyl-11-deoxydoxorubicin complexed to d(CGATCG). 1D38 ; 1.70 ; Influence of aglycone modifications on the binding of anthracycline drugs to DEOXYRIBONUCLEIC ACID: the molecular structure of idarubicin and 4-O-demethyl-11-deoxydoxorubicin complexed to d(CGATCG). 212D ; 1.90 ; Influence of counter-ions on the crystal structures of DEOXYRIBONUCLEIC ACID decamers: binding of [Co(NH3)6]3+ and Ba2+ to A-DEOXYRIBONUCLEIC ACID. 220D ; 2.00 ; Influence of counter-ions on the crystal structures of DEOXYRIBONUCLEIC ACID decamers: binding of [Co(NH3)6]3+ and Ba2+ to A-DEOXYRIBONUCLEIC ACID. 221D ; 1.90 ; Influence of counter-ions on the crystal structures of DEOXYRIBONUCLEIC ACID decamers: binding of [Co(NH3)6]3+ and Ba2+ to A-DEOXYRIBONUCLEIC ACID. 222D ; 1.90 ; Influence of counter-ions on the crystal structures of DEOXYRIBONUCLEIC ACID decamers: binding of [Co(NH3)6]3+ and Ba2+ to A-DEOXYRIBONUCLEIC ACID. 1NSC ; 1.70 ; Influenza B virus neuraminidase can synthesize its own inhibitor. 1NSD ; 1.80 ; Influenza B virus neuraminidase can synthesize its own inhibitor. 1BLC ; 2.20 ; Inhibition of beta-lactamase by clavulanate. Trapped intermediates in cryocrystallographic studies. 5ENL ; 2.20 ; Inhibition of enolase: the crystal structures of enolase-Ca2(+)- 2-phosphoglycerate and enolase-Zn2(+)-phosphoglycolate complexes at 2.2-A resolution. 6ENL ; 2.20 ; Inhibition of enolase: the crystal structures of enolase-Ca2(+)- 2-phosphoglycerate and enolase-Zn2(+)-phosphoglycolate complexes at 2.2-A resolution. 1GRH ; 3.00 ; Inhibition of human glutathione reductase by the nitrosourea drugs 1,3-bis(2-chloroethyl)-1-nitrosourea and 1-(2-chloroethyl)-3-(2-hydroxyethyl)-1-nitrosourea. A crystallographic analysis. 1HOS ; 2.30 ; Inhibition of human immunodeficiency virus-1 protease by a C2-symmetric phosphinate. Synthesis and crystallographic analysis. 3PRK ; 2.20 ; Inhibition of proteinase K by methoxysuccinyl-Ala-Ala-Pro-Ala-chloromethyl ketone. An x-ray study at 2.2-A resolution. 1PHA ; 1.63 ; Inhibitor-induced conformational change in cytochrome P-450CAM. 1PHB ; 1.60 ; Inhibitor-induced conformational change in cytochrome P-450CAM. 114D ; 2.50 ; Inosine.adenine base pairs in a B-DEOXYRIBONUCLEIC ACID duplex. 1ESL ; 2.00 ; Insight into E-selectin/ligand interaction from the crystal structure and mutagenesis of the lec/EGF domains. 1CRL ; 2.06 ; Insights into interfacial activation from an open structure of Candida rugosa lipase. 1LOC ; 2.00 ; Interaction of a legume lectin with two components of the bacterial cell wall. A crystallographic study. 1LOD ; 2.05 ; Interaction of a legume lectin with two components of the bacterial cell wall. A crystallographic study. 1MNH ; 2.30 ; Interactions among residues CD3, E7, E10, and E11 in myoglobins: attempts to simulate the ligand-binding properties of Aplysia myoglobin. 1MNJ ; 2.20 ; Interactions among residues CD3, E7, E10, and E11 in myoglobins: attempts to simulate the ligand-binding properties of Aplysia myoglobin. 1MNK ; 2.20 ; Interactions among residues CD3, E7, E10, and E11 in myoglobins: attempts to simulate the ligand-binding properties of Aplysia myoglobin. 1D11 ; 1.20 ; Interactions between an anthracycline antibiotic and DEOXYRIBONUCLEIC ACID: molecular structure of daunomycin complexed to d(CpGpTpApCpG) at 1.2-A resolution. 2DES ; 1.50 ; Interactions between morpholinyl anthracyclines and DEOXYRIBONUCLEIC ACID. The crystal structure of a morpholino doxorubicin bound to d(CGTACG). 1LGR ; 2.80 ; Interactions of nucleotides with fully unadenylylated glutamine synthetase from Salmonella typhimurium. 5ADH ; 2.90 ; Interdomain motion in liver alcohol dehydrogenase. Structural and energetic analysis of the hinge bending mode. 8ADH ; 2.40 ; Interdomain motion in liver alcohol dehydrogenase. Structural and energetic analysis of the hinge bending mode. 1LPA ; 3.04 ; Interfacial activation of the lipase-procolipase complex by mixed micelles revealed by X-ray crystallography. 1POA ; 1.50 ; Interfacial catalysis: the mechanism of phospholipase A2. 1HEY ; 2.24 ; Investigating the structural determinants of the p21-like triphosphate and Mg2+ binding site. 2DRC ; 1.90 ; Investigation of the functional role of tryptophan-22 in Escherichia coli dihydrofolate reductase by site-directed mutagenesis. 3DRC ; 1.90 ; Investigation of the functional role of tryptophan-22 in Escherichia coli dihydrofolate reductase by site-directed mutagenesis. 1CCH ; -1.00 ; Investigation of the solution conformation of cytochrome c-551 from Pseudomonas stutzeri. 1COR ; -1.00 ; Investigation of the solution conformation of cytochrome c-551 from Pseudomonas stutzeri. 1GYL ; 3.00 ; Involvement of Tyr24 and Trp108 in substrate binding and substrate specificity of glycolate oxidase. 1FRN ; 2.00 ; Involvement of serine 96 in the catalytic mechanism of ferredoxin-NADP+ reductase: structure--function relationship as studied by site-directed mutagenesis and X-ray crystallography. 1PAL ; 1.65 ; Ionic interactions with parvalbumins. Crystal structure determination of pike 4.10 parvalbumin in four different ionic environments. 2PAL ; 1.80 ; Ionic interactions with parvalbumins. Crystal structure determination of pike 4.10 parvalbumin in four different ionic environments. 3PAL ; 2.40 ; Ionic interactions with parvalbumins. Crystal structure determination of pike 4.10 parvalbumin in four different ionic environments. 4PAL ; 1.80 ; Ionic interactions with parvalbumins. Crystal structure determination of pike 4.10 parvalbumin in four different ionic environments. 1CAR ; 3.00 ; Iota-carrageenan: molecular structure and packing of polysaccharide double helices in oriented fibres of divalent cation salts. 1GCT ; 1.60 ; Is gamma-chymotrypsin a tetrapeptide acyl-enzyme adduct of alpha-chymotrypsin? 1CPC ; 1.66 ; Isolation, crystallization, crystal structure analysis and refinement of constitutive C-phycocyanin from the chromatically adapting cyanobacterium Fremyella diplosiphon at 1.66 A resolution. 1DRH ; 2.30 ; Isomorphous crystal structures of Escherichia coli dihydrofolate reductase complexed with folate, 5-deazafolate, and 5,10-dideazatetrahydrofolate: mechanistic implications. 1DYH ; 1.90 ; Isomorphous crystal structures of Escherichia coli dihydrofolate reductase complexed with folate, 5-deazafolate, and 5,10-dideazatetrahydrofolate: mechanistic implications. 1DYI ; 1.90 ; Isomorphous crystal structures of Escherichia coli dihydrofolate reductase complexed with folate, 5-deazafolate, and 5,10-dideazatetrahydrofolate: mechanistic implications. 1DYJ ; 1.85 ; Isomorphous crystal structures of Escherichia coli dihydrofolate reductase complexed with folate, 5-deazafolate, and 5,10-dideazatetrahydrofolate: mechanistic implications. 1KTX ; -1.00 ; Kaliotoxin (1-37) shows structural differences with related potassium channel blockers. 1ALH ; 2.50 ; Kinetics and crystal structure of a mutant Escherichia coli alkaline phosphatase (Asp-369-->Asn): a mechanism involving one zinc per active site. 1PMK ; 2.25 ; Kringle-kringle interactions in multimer kringle structures. 1PML ; 2.38 ; Kringle-kringle interactions in multimer kringle structures. 1LTT ; 2.30 ; Lactose binding to heat-labile enterotoxin revealed by X-ray crystallography. 1S01 ; 1.70 ; Large increases in general stability for subtilisin BPN' through incremental changes in the free energy of unfolding. 1CGS ; 2.60 ; Local and transmitted conformational changes on complexation of an anti-sweetener Fab. 2CGR ; 2.20 ; Local and transmitted conformational changes on complexation of an anti-sweetener Fab. 1DHI ; 1.90 ; Long-range structural effects in a second-site revertant of a mutant dihydrofolate reductase. 1DHJ ; 1.80 ; Long-range structural effects in a second-site revertant of a mutant dihydrofolate reductase. 1D43 ; 2.00 ; Low-temperature crystallographic analyses of the binding of Hoechst 33258 to the double-helical DEOXYRIBONUCLEIC ACID dodecamer C-G-C-G-A-A-T-T-C-G-C-G. 1D44 ; 2.00 ; Low-temperature crystallographic analyses of the binding of Hoechst 33258 to the double-helical DEOXYRIBONUCLEIC ACID dodecamer C-G-C-G-A-A-T-T-C-G-C-G. 1D45 ; 1.90 ; Low-temperature crystallographic analyses of the binding of Hoechst 33258 to the double-helical DEOXYRIBONUCLEIC ACID dodecamer C-G-C-G-A-A-T-T-C-G-C-G. 1D46 ; 2.00 ; Low-temperature crystallographic analyses of the binding of Hoechst 33258 to the double-helical DEOXYRIBONUCLEIC ACID dodecamer C-G-C-G-A-A-T-T-C-G-C-G. 2D95 ; 2.00 ; Low-temperature study of the A-DEOXYRIBONUCLEIC ACID fragment d(GGGCGCCC). 1XIB ; 1.60 ; MODES OF BINDING SUBSTRATES AND THEIR ANALOGS TO THE ENZYME D-XYLOSE ISOMERASE. 1XIC ; 1.60 ; MODES OF BINDING SUBSTRATES AND THEIR ANALOGS TO THE ENZYME D-XYLOSE ISOMERASE. 1XID ; 1.70 ; MODES OF BINDING SUBSTRATES AND THEIR ANALOGS TO THE ENZYME D-XYLOSE ISOMERASE. 1XIE ; 1.70 ; MODES OF BINDING SUBSTRATES AND THEIR ANALOGS TO THE ENZYME D-XYLOSE ISOMERASE. 1XIF ; 1.60 ; MODES OF BINDING SUBSTRATES AND THEIR ANALOGS TO THE ENZYME D-XYLOSE ISOMERASE. 1XIG ; 1.70 ; MODES OF BINDING SUBSTRATES AND THEIR ANALOGS TO THE ENZYME D-XYLOSE ISOMERASE. 1XIH ; 1.70 ; MODES OF BINDING SUBSTRATES AND THEIR ANALOGS TO THE ENZYME D-XYLOSE ISOMERASE. 1XII ; 1.70 ; MODES OF BINDING SUBSTRATES AND THEIR ANALOGS TO THE ENZYME D-XYLOSE ISOMERASE. 1XIJ ; 1.70 ; MODES OF BINDING SUBSTRATES AND THEIR ANALOGS TO THE ENZYME D-XYLOSE ISOMERASE. 1PFC ; 3.12 ; MOLECULAR-REPLACEMENT STRUCTURE OF GUINEA-PIG IGG1 PFC' REFINED AT 3.1A RESOLUTION. 172D ; 3.00 ; MULTIPLE BINDING MODES OF ANTICANCER DRUG ACTINOMYCIN-D - X-RAY, MOLECULAR MODELING, AND SPECTROSCOPIC STUDIES OF D(GAAGCTTC)(2)-ACTINOMYCIN-D COMPLEXES AND ITS HOST DEOXYRIBONUCLEIC ACID. 173D ; 3.00 ; MULTIPLE BINDING MODES OF ANTICANCER DRUG ACTINOMYCIN-D - X-RAY, MOLECULAR MODELING, AND SPECTROSCOPIC STUDIES OF D(GAAGCTTC)(2)-ACTINOMYCIN-D COMPLEXES AND ITS HOST DEOXYRIBONUCLEIC ACID. 1CHN ; 1.76 ; Magnesium binding to the bacterial chemotaxis protein CheY results in large conformational changes involving its functional surface. 1GGB ; 2.80 ; Major antigen-induced domain rearrangements in an antibody. 1GGC ; 2.80 ; Major antigen-induced domain rearrangements in an antibody. 1XLA ; 2.30 ; Mechanism for aldose-ketose interconversion by D-xylose isomerase involving ring opening followed by a 1,2-hydride shift. 1XLB ; 2.50 ; Mechanism for aldose-ketose interconversion by D-xylose isomerase involving ring opening followed by a 1,2-hydride shift. 1XLC ; 2.50 ; Mechanism for aldose-ketose interconversion by D-xylose isomerase involving ring opening followed by a 1,2-hydride shift. 1XLD ; 2.50 ; Mechanism for aldose-ketose interconversion by D-xylose isomerase involving ring opening followed by a 1,2-hydride shift. 1XLE ; 2.50 ; Mechanism for aldose-ketose interconversion by D-xylose isomerase involving ring opening followed by a 1,2-hydride shift. 1XLF ; 2.50 ; Mechanism for aldose-ketose interconversion by D-xylose isomerase involving ring opening followed by a 1,2-hydride shift. 1XLG ; 2.50 ; Mechanism for aldose-ketose interconversion by D-xylose isomerase involving ring opening followed by a 1,2-hydride shift. 1XLH ; 2.50 ; Mechanism for aldose-ketose interconversion by D-xylose isomerase involving ring opening followed by a 1,2-hydride shift. 1XLI ; 2.50 ; Mechanism for aldose-ketose interconversion by D-xylose isomerase involving ring opening followed by a 1,2-hydride shift. 1XLJ ; 2.50 ; Mechanism for aldose-ketose interconversion by D-xylose isomerase involving ring opening followed by a 1,2-hydride shift. 1XLK ; 2.50 ; Mechanism for aldose-ketose interconversion by D-xylose isomerase involving ring opening followed by a 1,2-hydride shift. 1XLL ; 2.50 ; Mechanism for aldose-ketose interconversion by D-xylose isomerase involving ring opening followed by a 1,2-hydride shift. 7ENL ; 2.20 ; Mechanism of enolase: the crystal structure of enolase-Mg2(+)-2-phosphoglycerate/phosphoenolpyruvate complex at 2.2-A resolution. 1HDC ; 2.20 ; Mechanism of inhibition of 3 alpha, 20 beta-hydroxysteroid dehydrogenase by a licorice-derived steroidal inhibitor. 1RTJ ; 2.35 ; Mechanism of inhibition of HIV-1 reverse transcriptase by non-nucleoside inhibitors. 1THA ; 2.00 ; Mechanism of molecular recognition. Structural aspects of 3,3'-diiodo-L-thyronine binding to human serum transthyretin. 1NSP ; 2.10 ; Mechanism of phosphate transfer by nucleoside diphosphate kinase: X-ray structures of the phosphohistidine intermediate of the enzymes from Drosophila and Dictyostelium. 2MNR ; 1.90 ; Mechanism of the reaction catalyzed by mandelate racemase. 2. Crystal structure of mandelate racemase at 2.5-A resolution: identification of the active site and possible catalytic residues. 1DBS ; 1.80 ; Mechanistic implications and family relationships from the structure of dethiobiotin synthetase. 1MML ; 1.80 ; Mechanistic implications from the structure of a catalytic fragment of Moloney murine leukemia virus reverse transcriptase. 1CFG ; -1.00 ; Membrane-binding peptide from the C2 domain of factor VIII forms an amphipathic structure as determined by NMR spectroscopy. 1LFI ; 2.10 ; Metal substitution in transferrins: the crystal structure of human copper-lactoferrin at 2.1-A resolution. 1MEA ; -1.00 ; Methionyl-tRNA synthetase zinc binding domain. Three-dimensional structure and homology with rubredoxin and gag retroviral proteins. 1MED ; -1.00 ; Methionyl-tRNA synthetase zinc binding domain. Three-dimensional structure and homology with rubredoxin and gag retroviral proteins. 1BBT ; 2.60 ; Methods used in the structure determination of foot-and-mouth disease virus. 1DLR ; 2.30 ; Methotrexate-resistant variants of human dihydrofolate reductase with substitutions of leucine 22. Kinetics, crystallography, and potential as selectable markers. 1DLS ; 2.30 ; Methotrexate-resistant variants of human dihydrofolate reductase with substitutions of leucine 22. Kinetics, crystallography, and potential as selectable markers. 4DNB ; 2.00 ; Methylation of the EcoRI recognition site does not alter DEOXYRIBONUCLEIC ACID conformation: the crystal structure of d(CGCGAm6ATTCGCG) at 2.0-A resolution. 1RVA ; 2.00 ; Mg2+ binding to the active site of EcoRV endonuclease: a crystallographic study of complexes with substrate and product DEOXYRIBONUCLEIC ACID at 2 A resolution. 1RVB ; 2.10 ; Mg2+ binding to the active site of EcoRV endonuclease: a crystallographic study of complexes with substrate and product DEOXYRIBONUCLEIC ACID at 2 A resolution. 1RVC ; 2.10 ; Mg2+ binding to the active site of EcoRV endonuclease: a crystallographic study of complexes with substrate and product DEOXYRIBONUCLEIC ACID at 2 A resolution. 144D ; 2.25 ; Minor groove binding of SN6999 to an alkylated DEOXYRIBONUCLEIC ACID: molecular structure of d(CGC[e6G]AATTCGCG)-SN6999 complex. 1GDR ; 3.50 ; Model for a DEOXYRIBONUCLEIC ACID-mediated synaptic complex suggested by crystal packing of gamma delta resolvase subunits. 1BRD ; 3.50 ; Model for the structure of bacteriorhodopsin based on high-resolution electron cryo-microscopy. 1IFD ; 4.00 ; Model-building studies of Inovirus: genetic variations on a geometric theme. 2IFO ; -1.00 ; Model-building studies of Inovirus: genetic variations on a geometric theme. 1TMH ; 2.80 ; Modular mutagenesis of a TIM-barrel enzyme: the crystal structure of a chimeric E. coli TIM having the eighth beta alpha-unit replaced by the equivalent unit of chicken TIM. 1CDM ; 2.00 ; Modulation of calmodulin plasticity in molecular recognition on the basis of x-ray structures. 1BYH ; 2.80 ; Molecular and active-site structure of a Bacillus 1,3-1,4-beta-glucanase. 1DA2 ; 1.70 ; Molecular and crystal structure of d(CGCGmo4CG): N4-methoxycytosine.guanine base-pairs in Z-DEOXYRIBONUCLEIC ACID. 4PEP ; 1.80 ; Molecular and crystal structures of monoclinic porcine pepsin refined at 1.8 A resolution. 1TMB ; 2.30 ; Molecular basis for the inhibition of human alpha-thrombin by the macrocyclic peptide cyclotheonamide A. 1LLD ; 2.00 ; Molecular basis of allosteric activation of bacterial L-lactate dehydrogenase. 1DBJ ; 2.70 ; Molecular basis of crossreactivity and the limits of antibody-antigen complementarity. 1DBK ; 3.00 ; Molecular basis of crossreactivity and the limits of antibody-antigen complementarity. 1DBM ; 2.70 ; Molecular basis of crossreactivity and the limits of antibody-antigen complementarity. 2TEC ; 1.98 ; Molecular dynamics refinement of a thermitase-eglin-c complex at 1.98 A resolution and comparison of two crystal forms that differ in calcium content. 1IFI ; 3.30 ; Molecular models and structural comparisons of native and mutant class I filamentous bacteriophages Ff (fd, f1, M13), If1 and IKe. 1IFJ ; 3.30 ; Molecular models and structural comparisons of native and mutant class I filamentous bacteriophages Ff (fd, f1, M13), If1 and IKe. 1IFK ; 5.00 ; Molecular models and structural comparisons of native and mutant class I filamentous bacteriophages Ff (fd, f1, M13), If1 and IKe. 1IFL ; 5.00 ; Molecular models and structural comparisons of native and mutant class I filamentous bacteriophages Ff (fd, f1, M13), If1 and IKe. 3SIC ; 1.80 ; Molecular recognition at the active site of subtilisin BPN': crystallographic studies using genetically engineered proteinaceous inhibitor SSI (Streptomyces subtilisin inhibitor). 5SIC ; 2.20 ; Molecular recognition at the active site of subtilisin BPN': crystallographic studies using genetically engineered proteinaceous inhibitor SSI (Streptomyces subtilisin inhibitor). 1LFG ; 2.20 ; Molecular replacement solution of the structure of apolactoferrin, a protein displaying large-scale conformational change. 1LFH ; 2.80 ; Molecular replacement solution of the structure of apolactoferrin, a protein displaying large-scale conformational change. 1GLP ; 1.90 ; Molecular structure at 1.8 A of mouse liver class pi glutathione S- transferase complexed with S-(p-nitrobenzyl)glutathione and other inhibitors. 1GLQ ; 1.80 ; Molecular structure at 1.8 A of mouse liver class pi glutathione S- transferase complexed with S-(p-nitrobenzyl)glutathione and other inhibitors. 2AT2 ; 3.00 ; Molecular structure of Bacillus subtilis aspartate transcarbamoylase at 3.0 A resolution. 2D47 ; 2.00 ; Molecular structure of a complete turn of A-DEOXYRIBONUCLEIC ACID. 2DCG ; 0.90 ; Molecular structure of a left-handed double helical DEOXYRIBONUCLEIC ACID fragment at atomic resolution. 1D13 ; 2.00 ; Molecular structure of an A-DEOXYRIBONUCLEIC ACID decamer d(ACCGGCCGGT). 1AEP ; 2.70 ; Molecular structure of an apolipoprotein determined at 2.5-A resolution. 1C2R ; 2.50 ; Molecular structure of cytochrome c2 isolated from Rhodobacter capsulatus determined at 2.5 A resolution. 1FCB ; 2.40 ; Molecular structure of flavocytochrome b2 at 2.4 A resolution. 1KAN ; 3.00 ; Molecular structure of kanamycin nucleotidyltransferase determined to 3.0-A resolution. 1LAP ; 2.70 ; Molecular structure of leucine aminopeptidase at 2.7-A resolution. 1NDN ; 3.00 ; Molecular structure of nicked DEOXYRIBONUCLEIC ACID: a substrate for DEOXYRIBONUCLEIC ACID repair enzymes. 1D96 ; 2.00 ; Molecular structure of r(GCG)d(TATACGC): a DEOXYRIBONUCLEIC ACID--RIBONUCLEIC ACID hybrid helix joined to double helical DEOXYRIBONUCLEIC ACID. 121D ; 2.20 ; Molecular structure of the A-tract DEOXYRIBONUCLEIC ACID dodecamer d(CGCAAATTTGCG) complexed with the minor groove binding drug netropsin. 1D65 ; 2.20 ; Molecular structure of the B-DEOXYRIBONUCLEIC ACID dodecamer d(CGCAAATTTGCG)2. An examination of propeller twist and minor-groove water structure at 2.2 A resolution. 112D ; 2.50 ; Molecular structure of the G.A base pair in DEOXYRIBONUCLEIC ACID and its implications for the mechanism of transversion mutations. 1BBP ; 2.00 ; Molecular structure of the bilin binding protein (BBP) from Pieris brassicae after refinement at 2.0 A resolution. 1IMR ; 1.60 ; Molecular structure of the halogenated anti-cancer drug iododoxorubicin complexed with d(TGTACA) and d(CGATCG). 1IMS ; 1.50 ; Molecular structure of the halogenated anti-cancer drug iododoxorubicin complexed with d(TGTACA) and d(CGATCG). 1DNE ; 2.40 ; Molecular structure of the netropsin-d(CGCGATATCGCG) complex: DEOXYRIBONUCLEIC ACID conformation in an alternating AT segment. 1HPI ; 1.80 ; Molecular structure of the oxidized high-potential iron-sulfur protein isolated from Ectothiorhodospira vacuolata. 1FRD ; 1.70 ; Molecular structure of the oxidized, recombinant, heterocyst [2Fe-2S] ferredoxin from Anabaena 7120 determined to 1.7-A resolution. 4Q21 ; 2.00 ; Molecular switch for signal transduction: structural differences between active and inactive forms of protooncogenic ras proteins. 1L69 ; 1.90 ; Multiple alanine replacements within alpha-helix 126-134 of T4 lysozyme have independent, additive effects on both structure and stability. 1L70 ; 1.90 ; Multiple alanine replacements within alpha-helix 126-134 of T4 lysozyme have independent, additive effects on both structure and stability. 1L71 ; 1.85 ; Multiple alanine replacements within alpha-helix 126-134 of T4 lysozyme have independent, additive effects on both structure and stability. 1L72 ; 1.85 ; Multiple alanine replacements within alpha-helix 126-134 of T4 lysozyme have independent, additive effects on both structure and stability. 1L73 ; 1.85 ; Multiple alanine replacements within alpha-helix 126-134 of T4 lysozyme have independent, additive effects on both structure and stability. 1L74 ; 1.70 ; Multiple alanine replacements within alpha-helix 126-134 of T4 lysozyme have independent, additive effects on both structure and stability. 1L75 ; 1.90 ; Multiple alanine replacements within alpha-helix 126-134 of T4 lysozyme have independent, additive effects on both structure and stability. 1HTL ; 2.50 ; Mutation of a buried residue causes loss of activity but no conformational change in the heat-labile enterotoxin of Escherichia coli. 1CTY ; 2.20 ; Mutation of tyrosine-67 to phenylalanine in cytochrome c significantly alters the local heme environment. 1CTZ ; 1.90 ; Mutation of tyrosine-67 to phenylalanine in cytochrome c significantly alters the local heme environment. 1BCX ; 1.80 ; Mutational and crystallographic analyses of the active site residues of the Bacillus circulans xylanase. 1HPN ; -1.00 ; N.m.r. and molecular-modelling studies of the solution conformation of heparin. 1NMA ; 3.00 ; N9 neuraminidase complexes with antibodies NC41 and NC10: empirical free energy calculations capture specificity trends observed with mutant binding data. 1GSB ; 2.50 ; NEW CRYSTAL FORMS OF A MU-CLASS GLUTATHIONE-S-TRANSFERASE FROM RAT-LIVER. 1GSC ; 2.50 ; NEW CRYSTAL FORMS OF A MU-CLASS GLUTATHIONE-S-TRANSFERASE FROM RAT-LIVER. 1ELH ; -1.00 ; NMR analysis of helix I from the 5S RIBONUCLEIC ACID of Escherichia coli. 1TFS ; -1.00 ; NMR and restrained molecular dynamics study of the three-dimensional solution structure of toxin FS2, a specific blocker of the L-type calcium channel, isolated from black mamba venom. 1CHL ; -1.00 ; NMR sequential assignments and solution structure of chlorotoxin, a small scorpion toxin that blocks chloride channels. 1PAJ ; -1.00 ; NMR solution structure and flexibility of a peptide antigen representing the receptor binding domain of Pseudomonas aeruginosa. 1PAK ; -1.00 ; NMR solution structure and flexibility of a peptide antigen representing the receptor binding domain of Pseudomonas aeruginosa. 176D ; -1.00 ; NMR solution structure of a peptide nucleic acid complexed with RIBONUCLEIC ACID. 1ABT ; -1.00 ; NMR solution structure of an alpha-bungarotoxin/nicotinic receptor peptide complex. 1TNW ; -1.00 ; NMR solution structure of calcium-saturated skeletal muscle troponin C. 1TNX ; -1.00 ; NMR solution structure of calcium-saturated skeletal muscle troponin C. 1TRL ; -1.00 ; NMR solution structure of the C-terminal fragment 255-316 of thermolysin: a dimer formed by subunits having the native structure. 1AFP ; -1.00 ; NMR solution structure of the antifungal protein from Aspergillus giganteus: evidence for cysteine pairing isomerism. 1TAP ; -1.00 ; NMR solution structure of the recombinant tick anticoagulant protein (rTAP), a factor Xa inhibitor from the tick Ornithodoros moubata. 1TCP ; -1.00 ; NMR structure determination of tick anticoagulant peptide (TAP). 1EGO ; -1.00 ; NMR structure of oxidized Escherichia coli glutaredoxin: comparison with reduced E. coli glutaredoxin and functionally related proteins. 1FCT ; -1.00 ; NMR structures of ferredoxin chloroplastic transit peptide from Chlamydomonas reinhardtii promoted by trifluoroethanol in aqueous solution. 1CYA ; -1.00 ; NMR studies of [U-13C]cyclosporin A bound to cyclophilin: bound conformation and portions of cyclosporin involved in binding. 1CYB ; -1.00 ; NMR studies of [U-13C]cyclosporin A bound to cyclophilin: bound conformation and portions of cyclosporin involved in binding. 1PRR ; -1.00 ; NMR-derived three-dimensional solution structure of protein S complexed with calcium. 1PRS ; -1.00 ; NMR-derived three-dimensional solution structure of protein S complexed with calcium. 1CPM ; 2.00 ; Native-like in vivo folding of a circularly permuted jellyroll protein shown by crystal structure analysis. 1CPN ; 1.80 ; Native-like in vivo folding of a circularly permuted jellyroll protein shown by crystal structure analysis. 1ELF ; 1.70 ; Nature of the inactivation of elastase by N-peptidyl-O-aroyl hydroxylamine as a function of pH. 1ELG ; 1.65 ; Nature of the inactivation of elastase by N-peptidyl-O-aroyl hydroxylamine as a function of pH. 1MBD ; 1.40 ; Neutron diffraction reveals oxygen-histidine hydrogen bond in oxymyoglobin. 1BET ; 2.30 ; New protein fold revealed by a 2.3-A resolution crystal structure of nerve growth factor. 1RNC ; 1.50 ; Newly observed binding mode in pancreatic ribonuclease. 1RND ; 1.50 ; Newly observed binding mode in pancreatic ribonuclease. 1MLU ; 1.90 ; Nitric oxide recombination to double mutants of myoglobin: role of ligand diffusion in a fluctuating heme pocket. 1EAS ; 1.80 ; Nonpeptidic inhibitors of human leukocyte elastase. 3. Design, synthesis, X-ray crystallographic analysis, and structure-activity relationships for a series of orally active 3-amino-6-phenylpyridin-2-one trifluoromethyl ketones. 1EAT ; 2.00 ; Nonpeptidic inhibitors of human leukocyte elastase. 5. Design, synthesis, and X-ray crystallography of a series of orally active 5-aminopyrimidin-6-one-containing trifluoromethyl ketones. 1EAU ; 2.00 ; Nonpeptidic inhibitors of human leukocyte elastase. 6. Design of a potent, intratracheally active, pyridone-based trifluoromethyl ketone. 1DLA ; 3.00 ; Novel NADPH-binding domain revealed by the crystal structure of aldose reductase. 1ABE ; 1.70 ; Novel stereospecificity of the L-arabinose-binding protein. 1GOF ; 1.70 ; Novel thioether bond revealed by a 1.7 A crystal structure of galactose oxidase. 1GOG ; 1.90 ; Novel thioether bond revealed by a 1.7 A crystal structure of galactose oxidase. 1GOH ; 2.20 ; Novel thioether bond revealed by a 1.7 A crystal structure of galactose oxidase. 1TFI ; -1.00 ; Novel zinc finger motif in the basal transcriptional machinery: three-dimensional NMR studies of the nucleic acid binding domain of transcriptional elongation factor TFIIS. 6RSA ; 2.00 ; Nuclear magnetic resonance and neutron diffraction studies of the complex of ribonuclease A with uridine vanadate, a transition-state analogue. 1DTK ; -1.00 ; Nuclear magnetic resonance solution structure of dendrotoxin K from the venom of Dendroaspis polylepis polylepis. 1HIC ; -1.00 ; Nuclear magnetic resonance solution structure of hirudin(1-51) and comparison with corresponding three-dimensional structures determined using the complete 65-residue hirudin polypeptide chain. 1FTZ ; -1.00 ; Nuclear magnetic resonance solution structure of the fushi tarazu homeodomain from Drosophila and comparison with the Antennapedia homeodomain. 1ERP ; -1.00 ; Nuclear magnetic resonance solution structure of the pheromone Er-10 from the ciliated protozoan Euplotes raikovi. 2PLD ; -1.00 ; Nuclear magnetic resonance structure of an SH2 domain of phospholipase C-gamma 1 complexed with a high affinity binding peptide. 2PLE ; -1.00 ; Nuclear magnetic resonance structure of an SH2 domain of phospholipase C-gamma 1 complexed with a high affinity binding peptide. 1AAF ; -1.00 ; Nucleocapsid zinc fingers detected in retroviruses: EXAFS studies of intact viruses and the solution-state structure of the nucleocapsid protein from HIV-1. 1UDI ; 2.70 ; Nucleotide mimicry in the crystal structure of the uracil-DEOXYRIBONUCLEIC ACID glycosylase-uracil glycosylase inhibitor protein complex. 1CDG ; 2.00 ; Nucleotide sequence and X-ray structure of cyclodextrin glycosyltransferase from Bacillus circulans strain 251 in a maltose-dependent crystal form. 1DID ; 2.50 ; Observations of reaction intermediates and the mechanism of aldose-ketose interconversion by D-xylose isomerase. 1DIE ; 2.50 ; Observations of reaction intermediates and the mechanism of aldose-ketose interconversion by D-xylose isomerase. 1EBH ; 1.90 ; Octahedral coordination at the high-affinity metal site in enolase: crystallographic analysis of the MgII--enzyme complex from yeast at 1.9 A resolution. 1OYA ; 2.00 ; Old yellow enzyme at 2 A resolution: overall structure, ligand binding, and comparison with related flavoproteins. 1OYB ; 2.00 ; Old yellow enzyme at 2 A resolution: overall structure, ligand binding, and comparison with related flavoproteins. 1OYC ; 2.00 ; Old yellow enzyme at 2 A resolution: overall structure, ligand binding, and comparison with related flavoproteins. 115D ; 1.70 ; Ordered water structure in an A-DEOXYRIBONUCLEIC ACID octamer at 1.7 A resolution. 1GBR ; -1.00 ; Orientation of peptide fragments from Sos proteins bound to the N-terminal SH3 domain of Grb2 determined by NMR spectroscopy. 1HSY ; 1.90 ; Origin of the pH-dependent spectroscopic properties of pentacoordinate metmyoglobin variants. 197D ; 2.19 ; Orthorhombic crystal structure of the A-DEOXYRIBONUCLEIC ACID octamer d(GTACGTAC). Comparison with the tetragonal structure. 2YCC ; 1.90 ; Oxidation state-dependent conformational changes in cytochrome c. 1LMA ; 1.75 ; PROTEIN HYDRATION AND WATER-STRUCTURE - X-RAY-ANALYSIS OF A CLOSELY PACKED PROTEIN CRYSTAL WITH VERY LOW SOLVENT CONTENT. 1PSP ; 2.50 ; Pancreatic spasmolytic polypeptide: first three-dimensional structure of a member of the mammalian trefoil family of peptides. 1HIQ ; -1.00 ; Paradoxical structure and function in a mutant human insulin associated with diabetes mellitus. 1PNK ; 1.90 ; Penicillin acylase has a single-amino-acid catalytic centre. 1PNL ; 2.50 ; Penicillin acylase has a single-amino-acid catalytic centre. 1PNM ; 2.50 ; Penicillin acylase has a single-amino-acid catalytic centre. 1SHD ; 2.00 ; Peptide inhibitors of src SH3-SH2-phosphoprotein interactions. 2LIV ; 2.40 ; Periplasmic binding protein structure and function. Refined X-ray structures of the leucine/isoleucine/valine-binding protein and its complex with leucine. 1L00 ; 1.90 ; Perturbation of Trp 138 in T4 lysozyme by mutations at Gln 105 used to correlate changes in structure, stability, solvation, and spectroscopic properties. 1L98 ; 1.80 ; Perturbation of Trp 138 in T4 lysozyme by mutations at Gln 105 used to correlate changes in structure, stability, solvation, and spectroscopic properties. 1L99 ; 1.95 ; Perturbation of Trp 138 in T4 lysozyme by mutations at Gln 105 used to correlate changes in structure, stability, solvation, and spectroscopic properties. 1PFI ; 3.00 ; Pf1 virus structure: helical coat protein and DEOXYRIBONUCLEIC ACID with paraxial phosphates. 1MTI ; 1.90 ; Phe-46(CD4) orients the distal histidine for hydrogen bonding to bound ligands in sperm whale myoglobin. 1MTJ ; 1.70 ; Phe-46(CD4) orients the distal histidine for hydrogen bonding to bound ligands in sperm whale myoglobin. 1MTK ; 1.80 ; Phe-46(CD4) orients the distal histidine for hydrogen bonding to bound ligands in sperm whale myoglobin. 1MUP ; 2.40 ; Pheromone binding to two rodent urinary proteins revealed by X-ray crystallography. 1MCP ; 2.70 ; Phosphocholine binding immunoglobulin Fab McPC603. An X-ray diffraction study at 2.7 A. 3PFK ; 2.40 ; Phosphofructokinase: structure and control. 4PFK ; 2.40 ; Phosphofructokinase: structure and control. 1BPQ ; 1.80 ; Phospholipase A2 engineering. X-ray structural and functional evidence for the interaction of lysine-56 with substrates. 2BPP ; 1.80 ; Phospholipase A2 engineering. X-ray structural and functional evidence for the interaction of lysine-56 with substrates. 2PIA ; 2.00 ; Phthalate dioxygenase reductase: a modular structure for electron transfer from pyridine nucleotides to [2Fe-2S]. 3TMS ; 2.10 ; Plastic adaptation toward mutations in proteins: structural comparison of thymidylate synthases. 4TMS ; 2.35 ; Plastic adaptation toward mutations in proteins: structural comparison of thymidylate synthases. 3POR ; 2.50 ; Porin conformation in the absence of calcium. Refined structure at 2.5 A resolution. 1CIL ; 1.60 ; Positions of His-64 and a bound water in human carbonic anhydrase II upon binding three structurally related inhibitors. 1CIM ; 2.10 ; Positions of His-64 and a bound water in human carbonic anhydrase II upon binding three structurally related inhibitors. 1CIN ; 2.10 ; Positions of His-64 and a bound water in human carbonic anhydrase II upon binding three structurally related inhibitors. 1TNG ; 1.80 ; Prediction of new serine proteinase inhibitors. 1TNH ; 1.80 ; Prediction of new serine proteinase inhibitors. 1TNI ; 1.90 ; Prediction of new serine proteinase inhibitors. 1TNJ ; 1.80 ; Prediction of new serine proteinase inhibitors. 1TNK ; 1.80 ; Prediction of new serine proteinase inhibitors. 1TNL ; 1.90 ; Prediction of new serine proteinase inhibitors. 1MRC ; 2.40 ; Preparation, characterization and crystallization of an antibody Fab fragment that recognizes RIBONUCLEIC ACID. Crystal structures of native Fab and three Fab-mononucleotide complexes. 1MRD ; 2.30 ; Preparation, characterization and crystallization of an antibody Fab fragment that recognizes RIBONUCLEIC ACID. Crystal structures of native Fab and three Fab-mononucleotide complexes. 1MRE ; 2.30 ; Preparation, characterization and crystallization of an antibody Fab fragment that recognizes RIBONUCLEIC ACID. Crystal structures of native Fab and three Fab-mononucleotide complexes. 1MRF ; 2.40 ; Preparation, characterization and crystallization of an antibody Fab fragment that recognizes RIBONUCLEIC ACID. Crystal structures of native Fab and three Fab-mononucleotide complexes. 1SMV ; 3.00 ; Primary structure of sesbania mosaic virus coat protein: its implications to the assembly and architecture of the virus. 1MCB ; 2.70 ; Principles and pitfalls in designing site-directed peptide ligands. 1MCC ; 2.70 ; Principles and pitfalls in designing site-directed peptide ligands. 1MCD ; 2.70 ; Principles and pitfalls in designing site-directed peptide ligands. 1MCE ; 2.70 ; Principles and pitfalls in designing site-directed peptide ligands. 1MCF ; 2.70 ; Principles and pitfalls in designing site-directed peptide ligands. 1MCH ; 2.70 ; Principles and pitfalls in designing site-directed peptide ligands. 1MCI ; 2.70 ; Principles and pitfalls in designing site-directed peptide ligands. 1MCJ ; 2.70 ; Principles and pitfalls in designing site-directed peptide ligands. 1MCK ; 2.70 ; Principles and pitfalls in designing site-directed peptide ligands. 1MCL ; 2.70 ; Principles and pitfalls in designing site-directed peptide ligands. 1MCN ; 2.70 ; Principles and pitfalls in designing site-directed peptide ligands. 1MCQ ; 2.70 ; Principles and pitfalls in designing site-directed peptide ligands. 1MCR ; 2.70 ; Principles and pitfalls in designing site-directed peptide ligands. 1MCS ; 2.70 ; Principles and pitfalls in designing site-directed peptide ligands. 1DRJ ; 2.50 ; Probing protein-protein interactions. The ribose-binding protein in bacterial transport and chemotaxis. 1DRK ; 2.00 ; Probing protein-protein interactions. The ribose-binding protein in bacterial transport and chemotaxis. 2DRI ; 1.60 ; Probing protein-protein interactions. The ribose-binding protein in bacterial transport and chemotaxis. 4ICB ; 1.60 ; Proline cis-trans isomers in calbindin D9k observed by X-ray crystallography. 5CTS ; 1.90 ; Proposed mechanism for the condensation reaction of citrate synthase: 1.9-A structure of the ternary complex with oxaloacetate and carboxymethyl coenzyme A. 6CTS ; 2.50 ; Proposed mechanism for the condensation reaction of citrate synthase: 1.9-A structure of the ternary complex with oxaloacetate and carboxymethyl coenzyme A. 1XIN ; 2.40 ; Protein engineering of xylose (glucose) isomerase from Actinoplanes missouriensis. 1. Crystallography and site-directed mutagenesis of metal binding sites. 2XIN ; 2.30 ; Protein engineering of xylose (glucose) isomerase from Actinoplanes missouriensis. 1. Crystallography and site-directed mutagenesis of metal binding sites. 3XIN ; 2.30 ; Protein engineering of xylose (glucose) isomerase from Actinoplanes missouriensis. 1. Crystallography and site-directed mutagenesis of metal binding sites. 4XIM ; 2.30 ; Protein engineering of xylose (glucose) isomerase from Actinoplanes missouriensis. 1. Crystallography and site-directed mutagenesis of metal binding sites. 5XIM ; 2.60 ; Protein engineering of xylose (glucose) isomerase from Actinoplanes missouriensis. 1. Crystallography and site-directed mutagenesis of metal binding sites. 5XIN ; 2.30 ; Protein engineering of xylose (glucose) isomerase from Actinoplanes missouriensis. 1. Crystallography and site-directed mutagenesis of metal binding sites. 6XIM ; 2.50 ; Protein engineering of xylose (glucose) isomerase from Actinoplanes missouriensis. 1. Crystallography and site-directed mutagenesis of metal binding sites. 7XIM ; 2.40 ; Protein engineering of xylose (glucose) isomerase from Actinoplanes missouriensis. 1. Crystallography and site-directed mutagenesis of metal binding sites. 8XIM ; 2.40 ; Protein engineering of xylose (glucose) isomerase from Actinoplanes missouriensis. 1. Crystallography and site-directed mutagenesis of metal binding sites. 9XIM ; 2.40 ; Protein engineering of xylose (glucose) isomerase from Actinoplanes missouriensis. 1. Crystallography and site-directed mutagenesis of metal binding sites. 167L ; 2.20 ; Protein flexibility and adaptability seen in 25 crystal forms of T4 lysozyme. 168L ; 2.90 ; Protein flexibility and adaptability seen in 25 crystal forms of T4 lysozyme. 169L ; 3.00 ; Protein flexibility and adaptability seen in 25 crystal forms of T4 lysozyme. 170L ; 2.60 ; Protein flexibility and adaptability seen in 25 crystal forms of T4 lysozyme. 171L ; 2.50 ; Protein flexibility and adaptability seen in 25 crystal forms of T4 lysozyme. 172L ; 1.90 ; Protein flexibility and adaptability seen in 25 crystal forms of T4 lysozyme. 173L ; 1.70 ; Protein flexibility and adaptability seen in 25 crystal forms of T4 lysozyme. 174L ; 2.30 ; Protein flexibility and adaptability seen in 25 crystal forms of T4 lysozyme. 175L ; 2.10 ; Protein flexibility and adaptability seen in 25 crystal forms of T4 lysozyme. 176L ; 2.20 ; Protein flexibility and adaptability seen in 25 crystal forms of T4 lysozyme. 177L ; 2.20 ; Protein flexibility and adaptability seen in 25 crystal forms of T4 lysozyme. 178L ; 2.70 ; Protein flexibility and adaptability seen in 25 crystal forms of T4 lysozyme. 179L ; 2.70 ; Protein flexibility and adaptability seen in 25 crystal forms of T4 lysozyme. 180L ; 1.90 ; Protein flexibility and adaptability seen in 25 crystal forms of T4 lysozyme. 4CRO ; 3.90 ; Protein-DEOXYRIBONUCLEIC ACID conformational changes in the crystal structure of a lambda Cro-operator complex. 1BMV ; 3.00 ; Protein-RIBONUCLEIC ACID interactions in an icosahedral virus at 3.0 A resolution. 1BRS ; 2.00 ; Protein-protein recognition: crystal structural analysis of a barnase-barstar complex at 2.0-A resolution. 1DEM ; -1.00 ; Proteinase inhibitor homologues as potassium channel blockers. 1DEN ; -1.00 ; Proteinase inhibitor homologues as potassium channel blockers. 1RTN ; -1.00 ; Proton NMR assignments and solution conformation of RANTES, a chemokine of the C-C type. 1RTO ; -1.00 ; Proton NMR assignments and solution conformation of RANTES, a chemokine of the C-C type. 1VNA ; -1.00 ; Proton nuclear magnetic resonance and distance geometry/simulated annealing studies on the variant-1 neurotoxin from the New World scorpion Centruroides sculpturatus Ewing. 1VNB ; -1.00 ; Proton nuclear magnetic resonance and distance geometry/simulated annealing studies on the variant-1 neurotoxin from the New World scorpion Centruroides sculpturatus Ewing. 1ACJ ; 2.80 ; Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase. 1ACL ; 2.80 ; Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase. 1CVC ; 2.30 ; REDESIGNING THE ZINC-BINDING SITE OF HUMAN CARBONIC ANHYDRASE-II - STRUCTURE OF A HIS2ASP-ZN2+ METAL COORDINATION POLYHEDRON. 1GIG ; 2.30 ; REFINED 3-DIMENSIONAL STRUCTURE OF THE FAB FRAGMENT OF A MURINE IGG1,LAMBDA ANTIBODY. 1AGX ; 2.90 ; REFINED CRYSTAL-STRUCTURE OF ACINETOBACTER GLUTAMINASIFICANS GLUTAMINASE ASPARAGINASE. 1LMN ; 1.80 ; REFINED CRYSTAL-STRUCTURE OF LYSOZYME FROM THE RAINBOW-TROUT (ONCORHYNCHUS-MYKISS). 1PMY ; 1.50 ; REFINED CRYSTAL-STRUCTURE OF PSEUDOAZURIN FROM METHYLOBACTERIUM-EXTORQUENS AM1 AT 1.5-ANGSTROM RESOLUTION. 1CON ; 2.00 ; REFINED STRUCTURE OF CADMIUM-SUBSTITUTED CONCANAVALIN-A AT 2.0 ANGSTROM RESOLUTION. 5CNA ; 2.00 ; REFINED STRUCTURE OF CONCANAVALIN-A COMPLEXED WITH METHYL ALPHA-D-MANNOPYRANOSIDE AT 2.0 ANGSTROM RESOLUTION AND COMPARISON WITH THE SACCHARIDE-FREE STRUCTURE. 1HPC ; 2.60 ; REFINED STRUCTURES AT 2 AND 2.2-ANGSTROM RESOLUTION OF 2 FORMS OF THE H-PROTEIN, A LIPOAMIDE-CONTAINING PROTEIN OF THE GLYCINE DECARBOXYLASE COMPLEX. 1CPI ; 2.05 ; REGIOSELECTIVE STRUCTURAL AND FUNCTIONAL MIMICRY OF PEPTIDES - DESIGN OF HYDROLYTICALLY-STABLE CYCLIC PEPTIDOMIMETIC INHIBITORS OF HIV-1 PROTEASE. 1PPD ; 2.00 ; RESTRAINED LEAST-SQUARES REFINEMENT OF THE SULFHYDRYL PROTEASE PAPAIN TO 2.0 A. 1RGK ; 1.87 ; RNase T1 mutant Glu46Gln binds the inhibitors 2'GMP and 2'AMP at the 3' subsite. 1RGL ; 2.00 ; RNase T1 mutant Glu46Gln binds the inhibitors 2'GMP and 2'AMP at the 3' subsite. 1CRN ; 1.50 ; Raman spectroscopy of homologous plant toxins: crambin and alpha 1- and beta-purothionin secondary structures, disulfide conformation, and tyrosine environment. 138L ; 1.70 ; Rapid crystallization of T4 lysozyme by intermolecular disulfide cross-linking. 139L ; 1.70 ; Rapid crystallization of T4 lysozyme by intermolecular disulfide cross-linking. 2RAN ; 1.90 ; Rat annexin V crystal structure: Ca(2+)-induced conformational changes. 1TON ; 1.80 ; Rat submaxillary gland serine protease, tonin. Structure solution and refinement at 1.8 A resolution. 1HVR ; 1.80 ; Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors. 1HPS ; 2.30 ; Rational design, synthesis, and crystallographic analysis of a hydroxyethylene-based HIV-1 protease inhibitor containing a heterocyclic P1'--P2' amide bond isostere. 9BNA ; 1.90 ; Re-refinement of the B-dodecamer d(CGCGAATTCGCG) with a comparative analysis of the solvent in it and in the Z-hexamer d(5BrCG5BrCG5BrCG). 1ALK ; 2.00 ; Reaction mechanism of alkaline phosphatase based on crystal structures. Two-metal ion catalysis. 8EST ; 1.78 ; Reaction of porcine pancreatic elastase with 7-substituted 3-alkoxy-4-chloroisocoumarins: design of potent inhibitors using the crystal structure of the complex formed with 4-chloro-3-ethoxy-7-guanidinoisocoumarin. 1PI2 ; 2.50 ; Reactive sites of an anticarcinogenic Bowman-Birk proteinase inhibitor are similar to other trypsin inhibitors. 1LYZ ; 2.00 ; Real-space refinement of the structure of hen egg-white lysozyme. 2LYZ ; 2.00 ; Real-space refinement of the structure of hen egg-white lysozyme. 3LYZ ; 2.00 ; Real-space refinement of the structure of hen egg-white lysozyme. 4LYZ ; 2.00 ; Real-space refinement of the structure of hen egg-white lysozyme. 5LYZ ; 2.00 ; Real-space refinement of the structure of hen egg-white lysozyme. 6LYZ ; 2.00 ; Real-space refinement of the structure of hen egg-white lysozyme. 1HIT ; -1.00 ; Receptor binding redefined by a structural switch in a mutant human insulin. 2OR1 ; 2.50 ; Recognition of a DEOXYRIBONUCLEIC ACID operator by the repressor of phage 434: a view at high resolution. 1MFE ; 2.00 ; Recognition of a cell-surface oligosaccharide of pathogenic Salmonella by an antibody Fab fragment. 192D ; 1.92 ; Recombination-like structure of d(CCGCGG). 1HYT ; 1.70 ; Redetermination and refinement of the complex of benzylsuccinic acid with thermolysin and its relation to the complex with carboxypeptidase A. 3CYT ; 1.80 ; Redox conformation changes in refined tuna cytochrome c. 1MCT ; 1.60 ; Refined 1.6 A resolution crystal structure of the complex formed between porcine beta-trypsin and MCTI-A, a trypsin inhibitor of the squash family. Detailed comparison with bovine beta-trypsin and its complex. 1ONC ; 1.70 ; Refined 1.7 A X-ray crystallographic structure of P-30 protein, an amphibian ribonuclease with anti-tumor activity. 1IAC ; 2.10 ; Refined 1.8 A X-ray crystal structure of astacin, a zinc-endopeptidase from the crayfish Astacus astacus L. Structure determination, refinement, molecular structure and comparison with thermolysin. 1IAD ; 2.30 ; Refined 1.8 A X-ray crystal structure of astacin, a zinc-endopeptidase from the crayfish Astacus astacus L. Structure determination, refinement, molecular structure and comparison with thermolysin. 1LMB ; 1.80 ; Refined 1.8 A crystal structure of the lambda repressor-operator complex. 1EPT ; 1.80 ; Refined 1.8 A resolution crystal structure of the porcine epsilon- trypsin. 1MAR ; 1.80 ; Refined 1.8 A structure of human aldose reductase complexed with the potent inhibitor zopolrestat. 1DMB ; 1.80 ; Refined 1.8-A structure reveals the mode of binding of beta- cyclodextrin to the maltodextrin binding protein. 1HSL ; 1.89 ; Refined 1.89-A structure of the histidine-binding protein complexed with histidine and its relationship with many other active transport/chemosensory proteins. 1ETR ; 2.20 ; Refined 2.3 A X-ray crystal structure of bovine thrombin complexes formed with the benzamidine and arginine-based thrombin inhibitors NAPAP, 4-TAPAP and MQPA. A starting point for improving antithrombotics. 1ETS ; 2.30 ; Refined 2.3 A X-ray crystal structure of bovine thrombin complexes formed with the benzamidine and arginine-based thrombin inhibitors NAPAP, 4-TAPAP and MQPA. A starting point for improving antithrombotics. 1ETT ; 2.50 ; Refined 2.3 A X-ray crystal structure of bovine thrombin complexes formed with the benzamidine and arginine-based thrombin inhibitors NAPAP, 4-TAPAP and MQPA. A starting point for improving antithrombotics. 3OVO ; 1.55 ; Refined X-ray crystal structures of the reactive site modified ovomucoid inhibitor third domains from silver pheasant (OMSVP3) and from Japanese quail (OMJPQ3). 4OVO ; 2.50 ; Refined X-ray crystal structures of the reactive site modified ovomucoid inhibitor third domains from silver pheasant (OMSVP3) and from Japanese quail (OMJPQ3). 1NPK ; 1.80 ; Refined X-ray structure of Dictyostelium discoideum nucleoside diphosphate kinase at 1.8 A resolution. 1EDE ; 1.90 ; Refined X-ray structures of haloalkane dehalogenase at pH 6.2 and pH 8.2 and implications for the reaction mechanism. 1IFB ; 1.96 ; Refined apoprotein structure of rat intestinal fatty acid binding protein produced in Escherichia coli. 3SC2 ; 2.20 ; Refined atomic model of wheat serine carboxypeptidase II at 2.2-A resolution. 3NN9 ; 2.30 ; Refined atomic structures of N9 subtype influenza virus neuraminidase and escape mutants. 4NN9 ; 2.30 ; Refined atomic structures of N9 subtype influenza virus neuraminidase and escape mutants. 5NN9 ; 2.30 ; Refined atomic structures of N9 subtype influenza virus neuraminidase and escape mutants. 6NN9 ; 2.30 ; Refined atomic structures of N9 subtype influenza virus neuraminidase and escape mutants. 1SGT ; 1.70 ; Refined crystal structure of Streptomyces griseus trypsin at 1.7 A resolution. 2IMM ; 2.00 ; Refined crystal structure of a recombinant immunoglobulin domain and a complementarity-determining region 1-grafted mutant. 2IMN ; 1.97 ; Refined crystal structure of a recombinant immunoglobulin domain and a complementarity-determining region 1-grafted mutant. 1D92 ; 2.25 ; Refined crystal structure of an octanucleotide duplex with G . T mismatched base-pairs. 1D90 ; 1.70 ; Refined crystal structure of an octanucleotide duplex with I.T. mismatched base pairs. 1AOZ ; 1.90 ; Refined crystal structure of ascorbate oxidase at 1.9 A resolution. 3BLM ; 2.00 ; Refined crystal structure of beta-lactamase from Staphylococcus aureus PC1 at 2.0 A resolution. 4CPV ; 1.50 ; Refined crystal structure of calcium-liganded carp parvalbumin 4.25 at 1.5-A resolution. 5CPA ; 1.54 ; Refined crystal structure of carboxypeptidase A at 1.54 A resolution. 4MDH ; 2.50 ; Refined crystal structure of cytoplasmic malate dehydrogenase at 2.5-A resolution. 1HBS ; 3.00 ; Refined crystal structure of deoxyhemoglobin S. I. Restrained least-squares refinement at 3.0-A resolution. 1LDM ; 2.10 ; Refined crystal structure of dogfish M4 apo-lactate dehydrogenase. 6LDH ; 2.00 ; Refined crystal structure of dogfish M4 apo-lactate dehydrogenase. 8LDH ; 2.80 ; Refined crystal structure of dogfish M4 apo-lactate dehydrogenase. 1FXD ; 1.70 ; Refined crystal structure of ferredoxin II from Desulfovibrio gigas at 1.7 A. 2GCH ; 1.90 ; Refined crystal structure of gamma-chymotrypsin at 1.9 A resolution. Comparison with other pancreatic serine proteases. 3LAD ; 2.20 ; Refined crystal structure of lipoamide dehydrogenase from Azotobacter vinelandii at 2.2 A resolution. A comparison with the structure of glutathione reductase. 2BBK ; 1.75 ; Refined crystal structure of methylamine dehydrogenase from Paracoccus denitrificans at 1.75 A resolution. 1MLD ; 1.90 ; Refined crystal structure of mitochondrial malate dehydrogenase from porcine heart and the consensus structure for dicarboxylic acid oxidoreductases. 1RTP ; 2.00 ; Refined crystal structure of rat parvalbumin, a mammalian alpha-lineage parvalbumin, at 2.0 A resolution. 1FNB ; 1.70 ; Refined crystal structure of spinach ferredoxin reductase at 1.7 A resolution: oxidized, reduced and 2'-phospho-5'-AMP bound states. 1FNC ; 1.70 ; Refined crystal structure of spinach ferredoxin reductase at 1.7 A resolution: oxidized, reduced and 2'-phospho-5'-AMP bound states. 1FND ; 1.70 ; Refined crystal structure of spinach ferredoxin reductase at 1.7 A resolution: oxidized, reduced and 2'-phospho-5'-AMP bound states. 1FDN ; 1.84 ; Refined crystal structure of the 2[4Fe-4S] ferredoxin from Clostridium acidurici at 1.84 A resolution. 2SIC ; 1.80 ; Refined crystal structure of the complex of subtilisin BPN' and Streptomyces subtilisin inhibitor at 1.8 A resolution. 1NCA ; 2.50 ; Refined crystal structure of the influenza virus N9 neuraminidase-NC41 Fab complex. 1NCD ; 2.90 ; Refined crystal structure of the influenza virus N9 neuraminidase-NC41 Fab complex. 1ILR ; 2.10 ; Refined crystal structure of the interleukin-1 receptor antagonist. Presence of a disulfide link and a cis-proline. 6GPB ; 2.86 ; Refined crystal structure of the phosphorylase-heptulose 2-phosphate-oligosaccharide-AMP complex. 4CPA ; 2.50 ; Refined crystal structure of the potato inhibitor complex of carboxypeptidase A at 2.5 A resolution. 1SRY ; 2.50 ; Refined crystal structure of the seryl-tRNA synthetase from Thermus thermophilus at 2.5 A resolution. 5P21 ; 1.35 ; Refined crystal structure of the triphosphate conformation of H-ras p21 at 1.35 A resolution: implications for the mechanism of GTP hydrolysis. 5TNC ; 2.00 ; Refined crystal structure of troponin C from turkey skeletal muscle at 2.0 A resolution. 3CLA ; 1.75 ; Refined crystal structure of type III chloramphenicol acetyltransferase at 1.75 A resolution. 1GCD ; 1.90 ; Refined crystal structures of "aged" and "non-aged" organophosphoryl conjugates of gamma-chymotrypsin. 1GMH ; 2.10 ; Refined crystal structures of "aged" and "non-aged" organophosphoryl conjugates of gamma-chymotrypsin. 3GLY ; 2.20 ; Refined crystal structures of glucoamylase from Aspergillus awamori var. X100. 1SBN ; 2.10 ; Refined crystal structures of subtilisin novo in complex with wild-type and two mutant eglins. Comparison with other serine proteinase inhibitor complexes. 1SIB ; 2.40 ; Refined crystal structures of subtilisin novo in complex with wild-type and two mutant eglins. Comparison with other serine proteinase inhibitor complexes. 1PDC ; -1.00 ; Refined solution structure and ligand-binding properties of PDC-109 domain b. A collagen-binding type II domain. 1PFL ; -1.00 ; Refined solution structure of human profilin I. 2GVA ; -1.00 ; Refined solution structure of the Tyr41-->His mutant of the M13 gene V protein. A comparison with the crystal structure. 2GVB ; -1.00 ; Refined solution structure of the Tyr41-->His mutant of the M13 gene V protein. A comparison with the crystal structure. 156D ; -1.00 ; Refined solution structure of the dimeric quadruplex formed from the Oxytricha telomeric oligonucleotide d(GGGGTTTTGGGG). 1GDC ; -1.00 ; Refined solution structure of the glucocorticoid receptor DEOXYRIBONUCLEIC ACID-binding domain. 2GDA ; -1.00 ; Refined solution structure of the glucocorticoid receptor DEOXYRIBONUCLEIC ACID-binding domain. 1DOG ; 2.40 ; Refined structure for the complex of 1-deoxynojirimycin with glucoamylase from Aspergillus awamori var. X100 to 2.4-A resolution. 1AGM ; 2.40 ; Refined structure for the complex of acarbose with glucoamylase from Aspergillus awamori var. X100 to 2.4-A resolution. 1SHI ; -1.00 ; Refined structure in solution of the sea anemone neurotoxin ShI. 1LTS ; 1.95 ; Refined structure of Escherichia coli heat-labile enterotoxin, a close relative of cholera toxin. 2ALP ; 1.70 ; Refined structure of alpha-lytic protease at 1.7 A resolution. Analysis of hydrogen bonding and solvent structure. 1ALC ; 1.70 ; Refined structure of baboon alpha-lactalbumin at 1.7 A resolution. Comparison with C-type lysozyme. 4TNC ; 2.00 ; Refined structure of chicken skeletal muscle troponin C in the two-calcium state at 2-A resolution. 2CDV ; 1.80 ; Refined structure of cytochrome c3 at 1.8 A resolution. 1DDT ; 2.00 ; Refined structure of dimeric diphtheria toxin at 2.0 A resolution. 3GRS ; 1.54 ; Refined structure of glutathione reductase at 1.54 A resolution. 1CA2 ; 2.00 ; Refined structure of human carbonic anhydrase II at 2.0 A resolution. 4CAC ; 2.20 ; Refined structure of human carbonic anhydrase II at 2.0 A resolution. 5CAC ; 2.20 ; Refined structure of human carbonic anhydrase II at 2.0 A resolution. 1MDT ; 2.30 ; Refined structure of monomeric diphtheria toxin at 2.3 A resolution. 3ADK ; 2.10 ; Refined structure of porcine cytosolic adenylate kinase at 2.1 A resolution. 2PSG ; 1.80 ; Refined structure of porcine pepsinogen at 1.8 A resolution. 1CCD ; 3.00 ; Refined structure of rat Clara cell 17 kDa protein at 3.0 A resolution. 1GOX ; 2.00 ; Refined structure of spinach glycolate oxidase at 2 A resolution. 1GKY ; 2.00 ; Refined structure of the complex between guanylate kinase and its substrate GMP at 2.0 A resolution. 2GN5 ; 2.30 ; Refined structure of the gene 5 DEOXYRIBONUCLEIC ACID binding protein from bacteriophage fd. 1COL ; 2.40 ; Refined structure of the pore-forming domain of colicin A at 2.4 A resolution. 1PRN ; 1.96 ; Refined structure of the porin from Rhodopseudomonas blastica. Comparison with the porin from Rhodobacter capsulatus. 1PYA ; 2.50 ; Refined structure of the pyruvoyl-dependent histidine decarboxylase from Lactobacillus 30a. 1TRK ; 2.00 ; Refined structure of transketolase from Saccharomyces cerevisiae at 2.0 A resolution. 3ENL ; 2.25 ; Refined structure of yeast apo-enolase at 2.25 A resolution. 1THY ; 2.90 ; Refined structures of substrate-bound and phosphate-bound thymidylate synthase from Lactobacillus casei. 1SPH ; 2.00 ; Refined structures of the active Ser83-->Cys and impaired Ser46-->Asp histidine-containing phosphocarrier proteins. 1MDP ; 2.30 ; Refined structures of two insertion/deletion mutants probe function of the maltodextrin binding protein. 1MDQ ; 1.90 ; Refined structures of two insertion/deletion mutants probe function of the maltodextrin binding protein. 1CXN ; -1.00 ; Refined three-dimensional solution structure of a snake cardiotoxin: analysis of the side-chain organization suggests the existence of a possible phospholipid binding site. 1CXO ; -1.00 ; Refined three-dimensional solution structure of a snake cardiotoxin: analysis of the side-chain organization suggests the existence of a possible phospholipid binding site. 1ICA ; -1.00 ; Refined three-dimensional solution structure of insect defensin A. 1PKM ; 2.60 ; Refined three-dimensional structure of cat-muscle (M1) pyruvate kinase at a resolution of 2.6 angstrom. 1PE6 ; 2.10 ; Refined x-ray structure of papain.E-64-c complex at 2.1-A resolution. 2LHB ; 2.00 ; Refinement of a molecular model for lamprey hemoglobin from Petromyzon marinus. 1THB ; 1.50 ; Refinement of a partially oxygenated T state human haemoglobin at 1.5 A resolution. 1HEW ; 1.75 ; Refinement of an enzyme complex with inhibitor bound at partial occupancy. Hen egg-white lysozyme and tri-N-acetylchitotriose at 1.75 A resolution. 2RSL ; 2.30 ; Refinement of gamma delta resolvase reveals a strikingly flexible molecule. 6XIA ; 1.65 ; Refinement of glucose isomerase from Streptomyces albus at 1.65 A with data from an imaging plate. 1LZ1 ; 1.50 ; Refinement of human lysozyme at 1.5 A resolution analysis of non-bonded and hydrogen-bond interactions. 101D ; 2.25 ; Refinement of netropsin bound to DEOXYRIBONUCLEIC ACID: bias and feedback in electron density map interpretation. 1RRO ; 1.30 ; Refinement of recombinant oncomodulin at 1.30 A resolution. 8RXN ; 1.00 ; Refinement of rubredoxin from Desulfovibrio vulgaris at 1.0 A with and without restraints. 1UTG ; 1.34 ; Refinement of the C222(1) crystal form of oxidized uteroglobin at 1.34 A resolution. 1ACP ; -1.00 ; Refinement of the NMR structures for acyl carrier protein with scalar coupling data. 1RNU ; 1.60 ; Refinement of the crystal structure of ribonuclease S. Comparison with and between the various ribonuclease A structures. 1RNV ; 1.60 ; Refinement of the crystal structure of ribonuclease S. Comparison with and between the various ribonuclease A structures. 2RNS ; 1.60 ; Refinement of the crystal structure of ribonuclease S. Comparison with and between the various ribonuclease A structures. 2HMG ; 3.00 ; Refinement of the influenza virus hemagglutinin by simulated annealing. 3HMG ; 2.90 ; Refinement of the influenza virus hemagglutinin by simulated annealing. 4HMG ; 3.00 ; Refinement of the influenza virus hemagglutinin by simulated annealing. 5HMG ; 3.20 ; Refinement of the influenza virus hemagglutinin by simulated annealing. 1FGA ; 2.20 ; Refinement of the structure of human basic fibroblast growth factor at 1.6 A resolution and analysis of presumed heparin binding sites by selenate substitution. 4FGF ; 1.60 ; Refinement of the structure of human basic fibroblast growth factor at 1.6 A resolution and analysis of presumed heparin binding sites by selenate substitution. 1PAZ ; 1.55 ; Refinement of the structure of pseudoazurin from Alcaligenes faecalis S-6 at 1.55 A resolution. 1IFC ; 1.19 ; Refinement of the structure of recombinant rat intestinal fatty acid-binding apoprotein at 1.2-A resolution. 3CI2 ; -1.00 ; Refinement of the three-dimensional solution structure of barley serine proteinase inhibitor 2 and comparison with the structures in crystals. 1LZT ; 1.97 ; Refinement of triclinic lysozyme: I. Fourier and least-squares methods. 2LZT ; 1.97 ; Refinement of triclinic lysozyme: II. The method of stereochemically restrained least squares. 5ICD ; 2.50 ; Regulation of an enzyme by phosphorylation at the active site. 6ICD ; 2.80 ; Regulation of an enzyme by phosphorylation at the active site. 7ICD ; 2.40 ; Regulation of an enzyme by phosphorylation at the active site. 8ICD ; 2.50 ; Regulation of an enzyme by phosphorylation at the active site. 4ICD ; 2.50 ; Regulation of isocitrate dehydrogenase by phosphorylation involves no long-range conformational change in the free enzyme. 3CTI ; -1.00 ; Relaxation matrix refinement of the solution structure of squash trypsin inhibitor. 1BRA ; 2.20 ; Relocating a negative charge in the binding pocket of trypsin. 1BRC ; 2.50 ; Relocating a negative charge in the binding pocket of trypsin. 1CIA ; 2.50 ; Replacement of catalytic histidine-195 of chloramphenicol acetyltransferase: evidence for a general base role for glutamate. 1CSU ; 1.81 ; Replacements in a conserved leucine cluster in the hydrophobic heme pocket of cytochrome c. 1CSV ; 1.90 ; Replacements in a conserved leucine cluster in the hydrophobic heme pocket of cytochrome c. 1CSW ; 1.90 ; Replacements in a conserved leucine cluster in the hydrophobic heme pocket of cytochrome c. 1CSX ; 1.90 ; Replacements in a conserved leucine cluster in the hydrophobic heme pocket of cytochrome c. 1L25 ; 1.80 ; Replacements of Pro86 in phage T4 lysozyme extend an alpha-helix but do not alter protein stability. 1L26 ; 1.70 ; Replacements of Pro86 in phage T4 lysozyme extend an alpha-helix but do not alter protein stability. 1L27 ; 1.80 ; Replacements of Pro86 in phage T4 lysozyme extend an alpha-helix but do not alter protein stability. 1L28 ; 1.90 ; Replacements of Pro86 in phage T4 lysozyme extend an alpha-helix but do not alter protein stability. 1L29 ; 1.70 ; Replacements of Pro86 in phage T4 lysozyme extend an alpha-helix but do not alter protein stability. 1L30 ; 1.70 ; Replacements of Pro86 in phage T4 lysozyme extend an alpha-helix but do not alter protein stability. 1L31 ; 1.80 ; Replacements of Pro86 in phage T4 lysozyme extend an alpha-helix but do not alter protein stability. 1L32 ; 1.70 ; Replacements of Pro86 in phage T4 lysozyme extend an alpha-helix but do not alter protein stability. 1SXL ; -1.00 ; Resonance assignments and solution structure of the second RIBONUCLEIC ACID-binding domain of sex-lethal determined by multidimensional heteronuclear magnetic resonance. 1RPO ; 1.40 ; Restored heptad pattern continuity does not alter the folding of a four-alpha-helix bundle. 1CDP ; 1.60 ; Restrained least squares refinement of native (calcium) and cadmium-substituted carp parvalbumin using X-ray crystallographic data at 1.6-A resolution. 5CPV ; 1.60 ; Restrained least squares refinement of native (calcium) and cadmium-substituted carp parvalbumin using X-ray crystallographic data at 1.6-A resolution. 1TRA ; 3.00 ; Restrained refinement of the monoclinic form of yeast phenylalanine transfer RIBONUCLEIC ACID. Temperature factors and dynamics, coordinated waters, and base-pair propeller twist angles. 2TRA ; 3.00 ; Restrained refinement of two crystalline forms of yeast aspartic acid and phenylalanine transfer RIBONUCLEIC ACID crystals. 3TRA ; 3.00 ; Restrained refinement of two crystalline forms of yeast aspartic acid and phenylalanine transfer RIBONUCLEIC ACID crystals. 4TRA ; 2.70 ; Restrained refinement of two crystalline forms of yeast aspartic acid and phenylalanine transfer RIBONUCLEIC ACID crystals. 3BNA ; 3.00 ; Reversible bending and helix geometry in a B-DEOXYRIBONUCLEIC ACID dodecamer: CGCGAATTBrCGCG. 4BNA ; 2.30 ; Reversible bending and helix geometry in a B-DEOXYRIBONUCLEIC ACID dodecamer: CGCGAATTBrCGCG. 9RNT ; 1.50 ; Ribonuclease T1 with free recognition and catalytic site: crystal structure analysis at 1.5 A resolution. 1RIP ; -1.00 ; Ribosomal protein S17: characterization of the three-dimensional structure by 1H and 15N NMR. 1POV ; 2.88 ; Role and mechanism of the maturation cleavage of VP0 in poliovirus assembly: structure of the empty capsid assembly intermediate at 2.9 A resolution. 133L ; 1.77 ; Role of Arg115 in the catalytic action of human lysozyme. X-ray structure of His115 and Glu115 mutants. 134L ; 1.77 ; Role of Arg115 in the catalytic action of human lysozyme. X-ray structure of His115 and Glu115 mutants. 1SPA ; 2.00 ; Role of Asp222 in the catalytic mechanism of Escherichia coli aspartate aminotransferase: the amino acid residue which enhances the function of the enzyme-bound coenzyme pyridoxal 5'-phosphate. 1IZA ; 2.50 ; Role of B13 Glu in insulin assembly. The hexamer structure of recombinant mutant (B13 Glu-->Gln) insulin. 1IZB ; 2.00 ; Role of B13 Glu in insulin assembly. The hexamer structure of recombinant mutant (B13 Glu-->Gln) insulin. 2AAD ; 2.00 ; Role of histidine-40 in ribonuclease T1 catalysis: three-dimensionalstructures of the partially active His40Lys mutant. 2AAE ; 1.80 ; Role of histidine-40 in ribonuclease T1 catalysis: three-dimensionalstructures of the partially active His40Lys mutant. 1LHH ; 1.80 ; Role of proline residues in human lysozyme stability: a scanning calorimetric study combined with X-ray structure analysis of proline mutants. 1LHI ; 1.80 ; Role of proline residues in human lysozyme stability: a scanning calorimetric study combined with X-ray structure analysis of proline mutants. 1LHJ ; 1.80 ; Role of proline residues in human lysozyme stability: a scanning calorimetric study combined with X-ray structure analysis of proline mutants. 1LHK ; 1.80 ; Role of proline residues in human lysozyme stability: a scanning calorimetric study combined with X-ray structure analysis of proline mutants. 1LHL ; 1.80 ; Role of proline residues in human lysozyme stability: a scanning calorimetric study combined with X-ray structure analysis of proline mutants. 3BP2 ; 2.10 ; Role of the N-terminus in the interaction of pancreatic phospholipase A2 with aggregated substrates. Properties and crystal structure of transaminated phospholipase A2. 1XYL ; 1.80 ; Role of the divalent metal ion in sugar binding, ring opening, and isomerization by D-xylose isomerase: replacement of a catalytic metal by an amino acid. 1XYM ; 1.80 ; Role of the divalent metal ion in sugar binding, ring opening, and isomerization by D-xylose isomerase: replacement of a catalytic metal by an amino acid. 1FIG ; 3.00 ; Routes to catalysis: structure of a catalytic antibody and comparison with its natural counterpart. 1RDG ; 1.40 ; Rubredoxin from Desulfovibrio gigas. A molecular model of the oxidized form at 1.4 A resolution. 1C53 ; 1.80 ; S-class cytochromes c have a variety of folding patterns: structure of cytochrome c-553 from Desulfovibrio vulgaris determined by the multi-wavelength anomalous dispersion method. 1CPY ; 2.60 ; SITE-DIRECTED MUTAGENESIS ON (SERINE) CARBOXYPEPTIDASE-Y FROM YEAST - THE SIGNIFICANCE OF THR60 AND MET398 IN HYDROLYSIS AND AMINOLYSIS REACTIONS. 1PLY ; 3.20 ; SODIUM-IONS AND WATER-MOLECULES IN THE STRUCTURE OF POLY(DA)CENTER-DOT-POLY(DT). 1RLD ; 2.50 ; SOLID-STATE PHASE-TRANSITION IN THE CRYSTAL-STRUCTURE OF RIBULOSE 1,5-BISPHOSPHATE CARBOXYLASE OXYGENASE. 1JIM ; 2.31 ; STEREOSPECIFIC REACTION OF 3-METHOXY-4-CHLORO-7-AMINOISOCOUMARIN WITH CRYSTALLINE PORCINE PANCREATIC ELASTASE. 1HLP ; 3.20 ; STRUCTURAL FEATURES THAT STABILIZE HALOPHILIC MALATE-DEHYDROGENASE FROM AN ARCHAEBACTERIUM. 3TGL ; 1.90 ; STRUCTURE AND MOLECULAR-MODEL REFINEMENT OF RHIZOMUCOR-MIEHEI TRIACYLGLYCERIDE LIPASE - A CASE-STUDY OF THE USE OF SIMULATED ANNEALING IN PARTIAL MODEL REFINEMENT. 1EPS ; 3.00 ; STRUCTURE AND TOPOLOGICAL SYMMETRY OF THE GLYPHOSATE TARGET 5-ENOL-PYRUVYLSHIKIMATE-3-PHOSPHATE SYNTHASE - A DISTINCTIVE PROTEIN FOLD. 1RBL ; 2.20 ; STRUCTURE DETERMINATION AND REFINEMENT OF RIBULOSE 1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE FROM SYNECHOCOCCUS PCC6301. 1DXI ; 2.60 ; STRUCTURE DETERMINATION OF GLUCOSE-ISOMERASE FROM STREPTOMYCES-MURINUS AT 2.6 ANGSTROM RESOLUTION. 1LLC ; 3.00 ; STRUCTURE DETERMINATION OF THE ALLOSTERIC L-LACTATE DEHYDROGENASE FROM LACTOBACILLUS-CASEI AT 3A RESOLUTION. 1HNL ; 1.80 ; STRUCTURE OF A GLUTATHIONYLATED HUMAN LYSOZYME - A FOLDING INTERMEDIATE MIMIC IN THE FORMATION OF A DISULFIDE BOND. 1RMF ; 2.80 ; STRUCTURE OF A MONOCLONAL ANTI-ICAM-1 ANTIBODY R6.5 FAB FRAGMENT AT 2.8 ANGSTROM RESOLUTION. 1AZB ; 2.20 ; STRUCTURE OF APO-AZURIN FROM ALCALIGENES-DENITRIFICANS AT 1.8-ANGSTROM RESOLUTION. 1AZC ; 1.80 ; STRUCTURE OF APO-AZURIN FROM ALCALIGENES-DENITRIFICANS AT 1.8-ANGSTROM RESOLUTION. 1GCS ; 2.00 ; STRUCTURE OF BOVINE GAMMA-B-CRYSTALLIN AT 150-K. 1TOP ; 1.78 ; STRUCTURE OF CHICKEN SKELETAL-MUSCLE TROPONIN-C AT 1.78 ANGSTROM RESOLUTION. 1LCF ; 2.00 ; STRUCTURE OF COPPER-SUBSTITUTED AND OXALATE-SUBSTITUTED HUMAN LACTOFERRIN AT 2.0 ANGSTROM RESOLUTION. 1TEW ; 1.65 ; STRUCTURE OF HEXAGONAL TURKEY EGG-WHITE LYSOZYME AT 1.65-ANGSTROM RESOLUTION. 1TRY ; 1.55 ; STRUCTURE OF INHIBITED TRYPSIN FROM FUSARIUM-OXYSPORUM AT 1.55-ANGSTROM. 1ELT ; 1.61 ; STRUCTURE OF NATIVE PANCREATIC ELASTASE FROM NORTH-ATLANTIC SALMON AT 1.61 ANGSTROM RESOLUTION. 1AZR ; 2.40 ; STRUCTURE OF PSEUDOMONAS-AERUGINOSA ZINC-AZURIN MUTANT ASN47ASP AT 2.4-ANGSTROM RESOLUTION. 1RFB ; 3.00 ; STRUCTURE OF RECOMBINANT BOVINE INTERFERON-GAMMA AT 3.0 ANGSTROM RESOLUTION. 1PHP ; 1.65 ; STRUCTURE OF THE ADP COMPLEX OF THE 3-PHOSPHOGLYCERATE KINASE FROM BACILLUS-STEAROTHERMOPHILUS AT 1.65 ANGSTROM. 1NZR ; 2.20 ; STRUCTURE OF THE AZURIN MUTANT NICKEL-TRP48MET FROM PSEUDOMONAS-AERUGINOSA AT 2.2-ANGSTROM RESOLUTION. 1AZN ; 2.60 ; STRUCTURE OF THE AZURIN MUTANT PHE114ALA FROM PSEUDOMONAS-AERUGINOSA AT 2.6-ANGSTROM RESOLUTION. 4GCR ; 1.47 ; STRUCTURE OF THE BOVINE EYE LENS PROTEIN GAMMA-B(GAMMA-II)-CRYSTALLIN AT 1.47 ANGSTROM. 1ROB ; 1.60 ; STRUCTURE OF THE CRYSTALLINE COMPLEX OF CYTIDYLIC ACID (2'-CMP) WITH RIBONUCLEASE AT 1.6 ANGSTROM RESOLUTION - CONSERVATION OF SOLVENT SITES IN RNASE-A HIGH-RESOLUTION STRUCTURES. 1RCA ; 1.90 ; STRUCTURE OF THE CRYSTALLINE COMPLEX OF DEOXYCYTIDYLYL-3',5'-GUANOSINE (3',5'-DCPDG) COCRYSTALLIZED WITH RIBONUCLEASE AT 1.9-ANGSTROM RESOLUTION. 1FCA ; 1.80 ; STRUCTURE OF THE FERREDOXIN FROM CLOSTRIDIUM-ACIDURICI - MODEL AT 1.8-ANGSTROM RESOLUTION. 1YST ; 3.00 ; STRUCTURE OF THE PHOTOCHEMICAL-REACTION CENTER OF A SPHEROIDENE-CONTAINING PURPLE BACTERIUM, RHODOBACTER-SPHAEROIDES-Y, AT 3 ANGSTROM RESOLUTION. 1OSA ; 1.68 ; STRUCTURE OF THE RECOMBINANT PARAMECIUM-TETRAURELIA CALMODULIN AT 1.68 ANGSTROM RESOLUTION. 1RCF ; 1.40 ; STRUCTURE OF THE TRIGONAL FORM OF RECOMBINANT OXIDIZED FLAVODOXIN FROM ANABAENA-7120 AT 1.40 ANGSTROM RESOLUTION. 1TRE ; 2.60 ; STRUCTURE OF TRIOSEPHOSPHATE ISOMERASE FROM ESCHERICHIA-COLI DETERMINED AT 2.6-ANGSTROM RESOLUTION. 1TYT ; 2.60 ; STRUCTURE OF TRYPANOTHIONE REDUCTASE FROM CRITHIDIA-FASCICULATA AT 2.6 ANGSTROM RESOLUTION - ENZYME-NADP INTERACTIONS AT 2.8 ANGSTROM RESOLUTION. 1FRR ; 1.80 ; STRUCTURE OF [2FE-2S] FERREDOXIN-I FROM EQUISETUM-ARVENSE AT 1.8 ANGSTROM RESOLUTION. 1SRF ; 2.00 ; STRUCTURE-BASED DESIGN OF SYNTHETIC AZOBENZENE LIGANDS FOR STREPTAVIDIN. 1SRG ; 1.80 ; STRUCTURE-BASED DESIGN OF SYNTHETIC AZOBENZENE LIGANDS FOR STREPTAVIDIN. 1SRH ; 2.20 ; STRUCTURE-BASED DESIGN OF SYNTHETIC AZOBENZENE LIGANDS FOR STREPTAVIDIN. 1SRI ; 1.65 ; STRUCTURE-BASED DESIGN OF SYNTHETIC AZOBENZENE LIGANDS FOR STREPTAVIDIN. 1SRJ ; 1.80 ; STRUCTURE-BASED DESIGN OF SYNTHETIC AZOBENZENE LIGANDS FOR STREPTAVIDIN. 1THU ; 2.60 ; STRUCTURES OF 3 CRYSTAL FORMS OF THE SWEET PROTEIN THAUMATIN. 1THV ; 1.75 ; STRUCTURES OF 3 CRYSTAL FORMS OF THE SWEET PROTEIN THAUMATIN. 1THW ; 1.75 ; STRUCTURES OF 3 CRYSTAL FORMS OF THE SWEET PROTEIN THAUMATIN. 1LE2 ; 3.00 ; Salt bridge relay triggers defective LDL receptor binding by a mutant apolipoprotein. 1GRO ; 2.50 ; Second-site suppression of regulatory phosphorylation in Escherichia coli isocitrate dehydrogenase. 1GRP ; 2.50 ; Second-site suppression of regulatory phosphorylation in Escherichia coli isocitrate dehydrogenase. 1CNW ; 2.00 ; Secondary interactions significantly removed from the sulfonamide binding pocket of carbonic anhydrase II influence inhibitor binding constants. 1CNX ; 1.90 ; Secondary interactions significantly removed from the sulfonamide binding pocket of carbonic anhydrase II influence inhibitor binding constants. 1CNY ; 2.30 ; Secondary interactions significantly removed from the sulfonamide binding pocket of carbonic anhydrase II influence inhibitor binding constants. 1NTX ; -1.00 ; Secondary structure determination for alpha-neurotoxin from Dendroaspis polylepis polylepis based on sequence-specific 1H-nuclear-magnetic-resonance assignments. 184D ; 1.80 ; Self-association of a DEOXYRIBONUCLEIC ACID loop creates a quadruplex: crystal structure of d(GCATGCT) at 1.8 A resolution. 3PGK ; 2.50 ; Sequence and structure of yeast phosphoglycerate kinase. 185D ; -1.00 ; Sequence specificity of quinoxaline antibiotics. 1. Solution structure of a 1:1 complex between triostin A and [d(GACGTC)]2 and comparison with the solution structure of the [N-MeCys3,N-MeCys7]TANDEM-[d(GATATC)]2 complex. 102D ; 2.20 ; Sequence-dependent drug binding to the minor groove of DEOXYRIBONUCLEIC ACID: crystal structure of the DEOXYRIBONUCLEIC ACID dodecamer d(CGCAAATTTGCG)2 complexed with propamidine. 180D ; 2.50 ; Sequence-dependent microheterogeneity of Z-DEOXYRIBONUCLEIC ACID: the crystal and molecular structures of d(CACGCG).d(CGCGTG) and d(CGCACG).d(CGTGCG). 181D ; 1.60 ; Sequence-dependent microheterogeneity of Z-DEOXYRIBONUCLEIC ACID: the crystal and molecular structures of d(CACGCG).d(CGCGTG) and d(CGCACG).d(CGTGCG). 1BBA ; -1.00 ; Sequence-specific 1H NMR assignments and solution structure of bovine pancreatic polypeptide. 1EGR ; -1.00 ; Sequence-specific 1H n.m.r. assignments and determination of the three- dimensional structure of reduced Escherichia coli glutaredoxin. 2YHX ; 2.10 ; Sequencing a protein by x-ray crystallography. II. Refinement of yeast hexokinase B co-ordinates and sequence at 2.1 A resolution. 1KDU ; -1.00 ; Sequential 1H NMR assignments and secondary structure of the kringle domain from urokinase. 1AKP ; -1.00 ; Sequential 1H, 13C, and 15N NMR assignments and solution conformation of apokedarcidin. 1OMA ; -1.00 ; Sequential assignment and structure determination of spider toxin omega-Aga-IVB. 1OMB ; -1.00 ; Sequential assignment and structure determination of spider toxin omega-Aga-IVB. 1P01 ; 2.00 ; Serine protease mechanism: structure of an inhibitory complex of alpha-lytic protease and a tightly bound peptide boronic acid. 1L85 ; 2.00 ; Similar hydrophobic replacements of Leu99 and Phe153 within the core of T4 lysozyme have different structural and thermodynamic consequences. 1L86 ; 1.80 ; Similar hydrophobic replacements of Leu99 and Phe153 within the core of T4 lysozyme have different structural and thermodynamic consequences. 1L87 ; 1.80 ; Similar hydrophobic replacements of Leu99 and Phe153 within the core of T4 lysozyme have different structural and thermodynamic consequences. 1L88 ; 1.85 ; Similar hydrophobic replacements of Leu99 and Phe153 within the core of T4 lysozyme have different structural and thermodynamic consequences. 1L89 ; 1.90 ; Similar hydrophobic replacements of Leu99 and Phe153 within the core of T4 lysozyme have different structural and thermodynamic consequences. 1L90 ; 1.75 ; Similar hydrophobic replacements of Leu99 and Phe153 within the core of T4 lysozyme have different structural and thermodynamic consequences. 1L91 ; 1.80 ; Similar hydrophobic replacements of Leu99 and Phe153 within the core of T4 lysozyme have different structural and thermodynamic consequences. 1L92 ; 1.70 ; Similar hydrophobic replacements of Leu99 and Phe153 within the core of T4 lysozyme have different structural and thermodynamic consequences. 1L93 ; 1.80 ; Similar hydrophobic replacements of Leu99 and Phe153 within the core of T4 lysozyme have different structural and thermodynamic consequences. 1L94 ; 1.80 ; Similar hydrophobic replacements of Leu99 and Phe153 within the core of T4 lysozyme have different structural and thermodynamic consequences. 1L95 ; 2.00 ; Similar hydrophobic replacements of Leu99 and Phe153 within the core of T4 lysozyme have different structural and thermodynamic consequences. 2CPL ; 1.63 ; Similarities and differences between human cyclophilin A and other beta-barrel structures. Structural refinement at 1.63 A resolution. 1FD2 ; 1.90 ; Site-directed mutagenesis of Azotobacter vinelandii ferredoxin I: [Fe-S] cluster-driven protein rearrangement. 1FRX ; 2.50 ; Site-directed mutagenesis of Azotobacter vinelandii ferredoxin I: cysteine ligation of the [4Fe-4S] cluster with protein rearrangement is preferred over serine ligation. 1CGV ; 2.50 ; Site-directed mutations in tyrosine 195 of cyclodextrin glycosyltransferase from Bacillus circulans strain 251 affect activity and product specificity. 1CGW ; 2.53 ; Site-directed mutations in tyrosine 195 of cyclodextrin glycosyltransferase from Bacillus circulans strain 251 affect activity and product specificity. 1CGX ; 2.59 ; Site-directed mutations in tyrosine 195 of cyclodextrin glycosyltransferase from Bacillus circulans strain 251 affect activity and product specificity. 1CGY ; 2.50 ; Site-directed mutations in tyrosine 195 of cyclodextrin glycosyltransferase from Bacillus circulans strain 251 affect activity and product specificity. 4TMN ; 1.70 ; Slow- and fast-binding inhibitors of thermolysin display different modes of binding: crystallographic analysis of extended phosphonamidate transition-state analogues. 5TMN ; 1.60 ; Slow- and fast-binding inhibitors of thermolysin display different modes of binding: crystallographic analysis of extended phosphonamidate transition-state analogues. 1CMP ; 1.90 ; Small molecule binding to an artificially created cavity at the active site of cytochrome c peroxidase. 1CMQ ; 2.30 ; Small molecule binding to an artificially created cavity at the active site of cytochrome c peroxidase. 4GST ; 1.90 ; Snapshots along the reaction coordinate of an SNAr reaction catalyzed by glutathione transferase. 5GST ; 2.00 ; Snapshots along the reaction coordinate of an SNAr reaction catalyzed by glutathione transferase. 1ANP ; -1.00 ; Solution conformation of an atrial natriuretic peptide variant selective for the type A receptor. 1COD ; -1.00 ; Solution conformation of cobrotoxin: a nuclear magnetic resonance and hybrid distance geometry-dynamical simulated annealing study. 1COE ; -1.00 ; Solution conformation of cobrotoxin: a nuclear magnetic resonance and hybrid distance geometry-dynamical simulated annealing study. 1BUS ; -1.00 ; Solution conformation of proteinase inhibitor IIA from bull seminal plasma by 1H nuclear magnetic resonance and distance geometry. 2BUS ; -1.00 ; Solution conformation of proteinase inhibitor IIA from bull seminal plasma by 1H nuclear magnetic resonance and distance geometry. 1D18 ; -1.00 ; Solution conformation of purine-pyrimidine DEOXYRIBONUCLEIC ACID octamers using nuclear magnetic resonance, restrained molecular dynamics and NOE-based refinement. 1D19 ; -1.00 ; Solution conformation of purine-pyrimidine DEOXYRIBONUCLEIC ACID octamers using nuclear magnetic resonance, restrained molecular dynamics and NOE-based refinement. 1SSO ; -1.00 ; Solution structure and DEOXYRIBONUCLEIC ACID-binding properties of a thermostable protein from the archaeon Sulfolobus solfataricus. 1PCE ; -1.00 ; Solution structure and dynamics of PEC-60, a protein of the Kazal type inhibitor family, determined by nuclear magnetic resonance spectroscopy. 1CRP ; -1.00 ; Solution structure and dynamics of ras p21.GDP determined by heteronuclear three- and four-dimensional NMR spectroscopy. 1CRQ ; -1.00 ; Solution structure and dynamics of ras p21.GDP determined by heteronuclear three- and four-dimensional NMR spectroscopy. 1CRR ; -1.00 ; Solution structure and dynamics of ras p21.GDP determined by heteronuclear three- and four-dimensional NMR spectroscopy. 177D ; -1.00 ; Solution structure and hydration patterns of a pyrimidine.purine.pyrimidine DEOXYRIBONUCLEIC ACID triplex containing a novel T.CG base-triple. 1PNJ ; -1.00 ; Solution structure and ligand-binding site of the SH3 domain of the p85 alpha subunit of phosphatidylinositol 3-kinase. 2PNI ; -1.00 ; Solution structure and ligand-binding site of the SH3 domain of the p85 alpha subunit of phosphatidylinositol 3-kinase. 1GFC ; -1.00 ; Solution structure and ligand-binding site of the carboxy-terminal SH3 domain of GRB2. 1GFD ; -1.00 ; Solution structure and ligand-binding site of the carboxy-terminal SH3 domain of GRB2. 1CDN ; -1.00 ; Solution structure of (Cd2+)1-calbindin D9k reveals details of the stepwise structural changes along the Apo-->(Ca2+)II1-->(Ca2+)I,II2 binding pathway. 1FKR ; -1.00 ; Solution structure of FKBP, a rotamase enzyme and receptor for FK506 and rapamycin. 1FKS ; -1.00 ; Solution structure of FKBP, a rotamase enzyme and receptor for FK506 and rapamycin. 1FKT ; -1.00 ; Solution structure of FKBP, a rotamase enzyme and receptor for FK506 and rapamycin. 2PAC ; -1.00 ; Solution structure of Fe(II) cytochrome c551 from Pseudomonas aeruginosa as determined by two-dimensional 1H NMR. 1MSG ; -1.00 ; Solution structure of GRO/melanoma growth stimulatory activity determined by 1H NMR spectroscopy. 1MSH ; -1.00 ; Solution structure of GRO/melanoma growth stimulatory activity determined by 1H NMR spectroscopy. 1PNH ; -1.00 ; Solution structure of P05-NH2, a scorpion toxin analog with high affinity for the apamin-sensitive potassium channel. 1RPB ; -1.00 ; Solution structure of RP 71955, a new 21 amino acid tricyclic peptide active against HIV-1 virus. 1RPC ; -1.00 ; Solution structure of RP 71955, a new 21 amino acid tricyclic peptide active against HIV-1 virus. 1D69 ; -1.00 ; Solution structure of [d(ATGAGCGAATA)]2. Adjacent G:A mismatches stabilized by cross-strand base-stacking and BII phosphate groups. 1D68 ; -1.00 ; Solution structure of [d(GCGTATACGC)]2. 1D42 ; -1.00 ; Solution structure of [d(GTATATAC)]2 via restrained molecular dynamics simulations with nuclear magnetic resonance constraints derived from relaxation matrix analysis of two-dimensional nuclear Overhauser effect experiments. 108D ; -1.00 ; Solution structure of a DEOXYRIBONUCLEIC ACID complex with the fluorescent bis- intercalator TOTO determined by NMR spectroscopy. 170D ; -1.00 ; Solution structure of a DEOXYRIBONUCLEIC ACID dodecamer containing the anti-neoplastic agent arabinosylcytosine: combined use of NMR, restrained molecular dynamics, and full relaxation matrix refinement. 171D ; -1.00 ; Solution structure of a DEOXYRIBONUCLEIC ACID dodecamer containing the anti-neoplastic agent arabinosylcytosine: combined use of NMR, restrained molecular dynamics, and full relaxation matrix refinement. 1D70 ; -1.00 ; Solution structure of a DEOXYRIBONUCLEIC ACID octamer containing the Pribnow box via restrained molecular dynamics simulation with distance and torsion angle constraints derived from two-dimensional nuclear magnetic resonance spectral fitting. 1HDP ; -1.00 ; Solution structure of a POU-specific homeodomain: 3D-NMR studies of human B-cell transcription factor Oct-2. 2BBM ; -1.00 ; Solution structure of a calmodulin-target peptide complex by multidimensional NMR. 2BBN ; -1.00 ; Solution structure of a calmodulin-target peptide complex by multidimensional NMR. 1EXG ; -1.00 ; Solution structure of a cellulose-binding domain from Cellulomonas fimi by nuclear magnetic resonance spectroscopy. 1EXH ; -1.00 ; Solution structure of a cellulose-binding domain from Cellulomonas fimi by nuclear magnetic resonance spectroscopy. 2DA8 ; -1.00 ; Solution structure of a complex between [N-MeCys3,N-MeCys7]TANDEM and [d(GATATC)]2. 140D ; -1.00 ; Solution structure of a conserved DEOXYRIBONUCLEIC ACID sequence from the HIV-1 genome: restrained molecular dynamics simulation with distance and torsion angle restraints derived from two-dimensional NMR spectra. 141D ; -1.00 ; Solution structure of a conserved DEOXYRIBONUCLEIC ACID sequence from the HIV-1 genome: restrained molecular dynamics simulation with distance and torsion angle restraints derived from two-dimensional NMR spectra. 142D ; -1.00 ; Solution structure of a conserved DEOXYRIBONUCLEIC ACID sequence from the HIV-1 genome: restrained molecular dynamics simulation with distance and torsion angle restraints derived from two-dimensional NMR spectra. 1BVH ; -1.00 ; Solution structure of a low molecular weight protein tyrosine phosphatase. 1HFH ; -1.00 ; Solution structure of a pair of complement modules by nuclear magnetic resonance. 1HFI ; -1.00 ; Solution structure of a pair of complement modules by nuclear magnetic resonance. 139D ; -1.00 ; Solution structure of a parallel-stranded G-quadruplex DEOXYRIBONUCLEIC ACID. 1PLS ; -1.00 ; Solution structure of a pleckstrin-homology domain. 1PSM ; -1.00 ; Solution structure of a polypeptide containing four heptad repeat units from a merozoite surface antigen of Plasmodium falciparum. 134D ; -1.00 ; Solution structure of a purine.purine.pyrimidine DEOXYRIBONUCLEIC ACID triplex containing G.GC and T.AT triples. 135D ; -1.00 ; Solution structure of a purine.purine.pyrimidine DEOXYRIBONUCLEIC ACID triplex containing G.GC and T.AT triples. 136D ; -1.00 ; Solution structure of a purine.purine.pyrimidine DEOXYRIBONUCLEIC ACID triplex containing G.GC and T.AT triples. 149D ; -1.00 ; Solution structure of a pyrimidine.purine.pyrimidine DEOXYRIBONUCLEIC ACID triplex containing T.AT, C+.GC and G.TA triples. 193D ; -1.00 ; Solution structure of a quinomycin bisintercalator-DEOXYRIBONUCLEIC ACID complex. 1MSE ; -1.00 ; Solution structure of a specific DEOXYRIBONUCLEIC ACID complex of the Myb DEOXYRIBONUCLEIC ACID-binding domain with cooperative recognition helices. 1MSF ; -1.00 ; Solution structure of a specific DEOXYRIBONUCLEIC ACID complex of the Myb DEOXYRIBONUCLEIC ACID-binding domain with cooperative recognition helices. 1PCP ; -1.00 ; Solution structure of a trefoil-motif-containing cell growth factor, porcine spasmolytic protein. 1MFD ; 2.10 ; Solution structure of a trisaccharide-antibody complex: comparison of NMR measurements with a crystal structure. 1NRA ; -1.00 ; Solution structure of an Old World-like neurotoxin from the venom of the New World scorpion Centruroides sculpturatus Ewing. 1NRB ; -1.00 ; Solution structure of an Old World-like neurotoxin from the venom of the New World scorpion Centruroides sculpturatus Ewing. 1MAJ ; -1.00 ; Solution structure of an isolated antibody VL domain. 1MAK ; -1.00 ; Solution structure of an isolated antibody VL domain. 1RAU ; -1.00 ; Solution structure of an unusually stable RIBONUCLEIC ACID tetraplex containing G- and U-quartet structures. 1APC ; -1.00 ; Solution structure of apocytochrome b562. 1BNB ; -1.00 ; Solution structure of bovine neutrophil beta-defensin-12: the peptide fold of the beta-defensins is identical to that of the classical defensins. 1MYF ; -1.00 ; Solution structure of carbonmonoxy myoglobin determined from nuclear magnetic resonance distance and chemical shift constraints. 1CVO ; -1.00 ; Solution structure of cardiotoxin V from Naja naja atra. 1MNT ; -1.00 ; Solution structure of dimeric Mnt repressor (1-76). 1GPS ; -1.00 ; Solution structure of gamma 1-H and gamma 1-P thionins from barley and wheat endosperm determined by 1H-NMR: a structural motif common to toxic arthropod proteins. 1GPT ; -1.00 ; Solution structure of gamma 1-H and gamma 1-P thionins from barley and wheat endosperm determined by 1H-NMR: a structural motif common to toxic arthropod proteins. 2GF1 ; -1.00 ; Solution structure of human insulin-like growth factor 1: a nuclear magnetic resonance and restrained molecular dynamics study. 3GF1 ; -1.00 ; Solution structure of human insulin-like growth factor 1: a nuclear magnetic resonance and restrained molecular dynamics study. 1IGL ; -1.00 ; Solution structure of human insulin-like growth factor II. Relationship to receptor and binding protein interactions. 1IRP ; -1.00 ; Solution structure of human interleukin-1 receptor antagonist protein. 207D ; -1.00 ; Solution structure of mithramycin dimers bound to partially overlapping sites on DEOXYRIBONUCLEIC ACID. 1EGF ; -1.00 ; Solution structure of murine epidermal growth factor determined by NMR spectroscopy and refined by energy minimization with restraints. 3EGF ; -1.00 ; Solution structure of murine epidermal growth factor determined by NMR spectroscopy and refined by energy minimization with restraints. 1SH1 ; -1.00 ; Solution structure of neurotoxin I from the sea anemone Stichodactyla helianthus. A nuclear magnetic resonance, distance geometry, and restrained molecular dynamics study. 2SH1 ; -1.00 ; Solution structure of neurotoxin I from the sea anemone Stichodactyla helianthus. A nuclear magnetic resonance, distance geometry, and restrained molecular dynamics study. 1OMC ; -1.00 ; Solution structure of omega-conotoxin GVIA using 2-D NMR spectroscopy and relaxation matrix analysis. 1OMN ; -1.00 ; Solution structure of omega-conotoxin MVIIC, a high affinity ligand of P-type calcium channels, using 1H NMR spectroscopy and complete relaxation matrix analysis. 1D20 ; -1.00 ; Solution structure of phage lambda half-operator DEOXYRIBONUCLEIC ACID by use of NMR, restrained molecular dynamics, and NOE-based refinement. 1PIR ; -1.00 ; Solution structure of porcine pancreatic phospholipase A2. 1PIS ; -1.00 ; Solution structure of porcine pancreatic phospholipase A2. 1PCN ; -1.00 ; Solution structure of porcine pancreatic procolipase as determined from 1H homonuclear two-dimensional and three-dimensional NMR. 1PCO ; -1.00 ; Solution structure of porcine pancreatic procolipase as determined from 1H homonuclear two-dimensional and three-dimensional NMR. 1TUS ; -1.00 ; Solution structure of reactive-site hydrolyzed turkey ovomucoid third domain by nuclear magnetic resonance and distance geometry methods. 2HIR ; -1.00 ; Solution structure of recombinant hirudin and the Lys-47----Glu mutant: a nuclear magnetic resonance and hybrid distance geometry-dynamical simulated annealing study. 4HIR ; -1.00 ; Solution structure of recombinant hirudin and the Lys-47----Glu mutant: a nuclear magnetic resonance and hybrid distance geometry-dynamical simulated annealing study. 5HIR ; -1.00 ; Solution structure of recombinant hirudin and the Lys-47----Glu mutant: a nuclear magnetic resonance and hybrid distance geometry-dynamical simulated annealing study. 6HIR ; -1.00 ; Solution structure of recombinant hirudin and the Lys-47----Glu mutant: a nuclear magnetic resonance and hybrid distance geometry-dynamical simulated annealing study. 1AMB ; -1.00 ; Solution structure of residues 1-28 of the amyloid beta-peptide. 1AMC ; -1.00 ; Solution structure of residues 1-28 of the amyloid beta-peptide. 1TER ; -1.00 ; Solution structure of tertiapin determined using nuclear magnetic resonance and distance geometry. 1RNG ; -1.00 ; Solution structure of the CUUG hairpin loop: a novel RIBONUCLEIC ACID tetraloop motif. 1ADN ; -1.00 ; Solution structure of the DEOXYRIBONUCLEIC ACID methyl phosphotriester repair domain of Escherichia coli Ada. 1HKS ; -1.00 ; Solution structure of the DEOXYRIBONUCLEIC ACID-binding domain of Drosophila heat shock transcription factor. 1HKT ; -1.00 ; Solution structure of the DEOXYRIBONUCLEIC ACID-binding domain of Drosophila heat shock transcription factor. 1LEA ; -1.00 ; Solution structure of the LexA repressor DEOXYRIBONUCLEIC ACID binding domain determined by 1H NMR spectroscopy. 1LEB ; -1.00 ; Solution structure of the LexA repressor DEOXYRIBONUCLEIC ACID binding domain determined by 1H NMR spectroscopy. 1POG ; -1.00 ; Solution structure of the Oct-1 POU homeodomain determined by NMR and restrained molecular dynamics. 201D ; -1.00 ; Solution structure of the Oxytricha telomeric repeat d[G4(T4G4)3] G-tetraplex. 1HSQ ; -1.00 ; Solution structure of the SH3 domain of phospholipase C-gamma. 1TRF ; -1.00 ; Solution structure of the TR1C fragment of skeletal muscle troponin-C. 186D ; -1.00 ; Solution structure of the Tetrahymena telomeric repeat d(T2G4)4 G-tetraplex. 132D ; -1.00 ; Solution structure of the TnAn DEOXYRIBONUCLEIC ACID duplex GCCGTTAACGCG containing the HpaI restriction site. 1URK ; -1.00 ; Solution structure of the amino-terminal fragment of urokinase-type plasminogen activator. 1KRS ; -1.00 ; Solution structure of the anticodon-binding domain of Escherichia coli lysyl-tRNA synthetase and studies of its interaction with tRNA(Lys). 1KRT ; -1.00 ; Solution structure of the anticodon-binding domain of Escherichia coli lysyl-tRNA synthetase and studies of its interaction with tRNA(Lys). 107D ; -1.00 ; Solution structure of the covalent duocarmycin A-DEOXYRIBONUCLEIC ACID duplex complex. 179D ; -1.00 ; Solution structure of the d(T-C-G-A) duplex at acidic pH. A parallel- stranded helix containing C+ .C, G.G and A.A pairs. 1HRE ; -1.00 ; Solution structure of the epidermal growth factor-like domain of heregulin-alpha, a ligand for p180erbB-4. 1HRF ; -1.00 ; Solution structure of the epidermal growth factor-like domain of heregulin-alpha, a ligand for p180erbB-4. 1TPM ; -1.00 ; Solution structure of the fibrin binding finger domain of tissue-type plasminogen activator determined by 1H nuclear magnetic resonance. 1TPN ; -1.00 ; Solution structure of the fibrin binding finger domain of tissue-type plasminogen activator determined by 1H nuclear magnetic resonance. 143D ; -1.00 ; Solution structure of the human telomeric repeat d[AG3(T2AG3)3] G-tetraplex. 146D ; -1.00 ; Solution structure of the mithramycin dimer-DEOXYRIBONUCLEIC ACID complex. 199D ; -1.00 ; Solution structure of the monoalkylated mitomycin C-DEOXYRIBONUCLEIC ACID complex. 1AGT ; -1.00 ; Solution structure of the potassium channel inhibitor agitoxin 2: caliper for probing channel geometry. 1MHJ ; -1.00 ; Solution structure of the superactive monomeric des-[Phe(B25)] human insulin mutant: elucidation of the structural basis for the monomerization of des-[Phe(B25)] insulin and the dimerization of native insulin. 1PES ; -1.00 ; Solution structure of the tetrameric minimum transforming domain of p53 [published erratum appears in Nat Struct Biol 1995 Jan;2(1):81] 1PET ; -1.00 ; Solution structure of the tetrameric minimum transforming domain of p53 [published erratum appears in Nat Struct Biol 1995 Jan;2(1):81] 1PK2 ; -1.00 ; Solution structure of the tissue-type plasminogen activator kringle 2 domain complexed to 6-aminohexanoic acid an antifibrinolytic drug. 1TUR ; -1.00 ; Solution structure of turkey ovomucoid third domain as determined from nuclear magnetic resonance data. 4TGF ; -1.00 ; Solution structures of human transforming growth factor alpha derived from 1H NMR data. 203D ; -1.00 ; Solution structures of psoralen monoadducted and cross-linked DEOXYRIBONUCLEIC ACID oligomers by NMR spectroscopy and restrained molecular dynamics. 204D ; -1.00 ; Solution structures of psoralen monoadducted and cross-linked DEOXYRIBONUCLEIC ACID oligomers by NMR spectroscopy and restrained molecular dynamics. 105D ; -1.00 ; Solution structures of the i-motif tetramers of d(TCC), d(5methylCCT) and d(T5methylCC): novel NOE connections between amino protons and sugar protons. 106D ; -1.00 ; Solution structures of the i-motif tetramers of d(TCC), d(5methylCCT) and d(T5methylCC): novel NOE connections between amino protons and sugar protons. 230D ; -1.00 ; Solution structures of unimolecular quadruplexes formed by oligonucleotides containing Oxytricha telomere repeats. 1ZRP ; -1.00 ; Solution-state structure by NMR of zinc-substituted rubredoxin from the marine hyperthermophilic archaebacterium Pyrococcus furiosus. 1DN4 ; 1.40 ; Solvation of the left-handed hexamer d(5BrC-G-5BrC-G-5 BrC-G) in crystals grown at two temperatures. 1DN5 ; 1.40 ; Solvation of the left-handed hexamer d(5BrC-G-5BrC-G-5 BrC-G) in crystals grown at two temperatures. 1FHA ; 2.40 ; Solving the structure of human H ferritin by genetically engineering intermolecular crystal contacts. 1TKA ; 2.70 ; Specificity of coenzyme binding in thiamin diphosphate-dependent enzymes. Crystal structures of yeast transketolase in complex with analogs of thiamin diphosphate. 1TKB ; 2.30 ; Specificity of coenzyme binding in thiamin diphosphate-dependent enzymes. Crystal structures of yeast transketolase in complex with analogs of thiamin diphosphate. 1TKC ; 2.70 ; Specificity of coenzyme binding in thiamin diphosphate-dependent enzymes. Crystal structures of yeast transketolase in complex with analogs of thiamin diphosphate. 181L ; 1.80 ; Specificity of ligand binding in a buried nonpolar cavity of T4 lysozyme: linkage of dynamics and structural plasticity. 182L ; 1.80 ; Specificity of ligand binding in a buried nonpolar cavity of T4 lysozyme: linkage of dynamics and structural plasticity. 183L ; 1.80 ; Specificity of ligand binding in a buried nonpolar cavity of T4 lysozyme: linkage of dynamics and structural plasticity. 184L ; 1.80 ; Specificity of ligand binding in a buried nonpolar cavity of T4 lysozyme: linkage of dynamics and structural plasticity. 185L ; 1.80 ; Specificity of ligand binding in a buried nonpolar cavity of T4 lysozyme: linkage of dynamics and structural plasticity. 186L ; 1.80 ; Specificity of ligand binding in a buried nonpolar cavity of T4 lysozyme: linkage of dynamics and structural plasticity. 187L ; 1.80 ; Specificity of ligand binding in a buried nonpolar cavity of T4 lysozyme: linkage of dynamics and structural plasticity. 188L ; 1.80 ; Specificity of ligand binding in a buried nonpolar cavity of T4 lysozyme: linkage of dynamics and structural plasticity. 1NHB ; 1.80 ; Specificity of ligand binding in a buried nonpolar cavity of T4 lysozyme: linkage of dynamics and structural plasticity. 2HLA ; 2.60 ; Specificity pockets for the side chains of peptide antigens in HLA-Aw68. 3AKY ; 2.23 ; Stability, activity and structure of adenylate kinase mutants. 1D41 ; 1.30 ; Stabilization of Z-DEOXYRIBONUCLEIC ACID by demethylation of thymine bases: 1.3-A single-crystal structure of d(m5CGUAm5CG). 1KDA ; 1.90 ; Stabilization of a strained protein loop conformation through protein engineering. 1KDB ; 1.90 ; Stabilization of a strained protein loop conformation through protein engineering. 1KDC ; 2.00 ; Stabilization of a strained protein loop conformation through protein engineering. 168D ; 2.00 ; Stabilizing effects of the RIBONUCLEIC ACID 2'-substituent: crystal structure of an oligodeoxynucleotide duplex containing 2'-O-methylated adenosines. 200D ; 1.85 ; Stable loop in the crystal structure of the intercalated four-stranded cytosine-rich metazoan telomere. 1AMI ; 2.00 ; Steric and conformational features of the aconitase mechanism. 1AMJ ; 2.00 ; Steric and conformational features of the aconitase mechanism. 1KAA ; 1.90 ; Stress and strain in staphylococcal nuclease. 1KAB ; 1.80 ; Stress and strain in staphylococcal nuclease. 1R08 ; 3.00 ; Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses. 2R04 ; 3.00 ; Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses. 2R06 ; 3.00 ; Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses. 2R07 ; 3.00 ; Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses. 2RM2 ; 3.00 ; Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses. 2RR1 ; 3.00 ; Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses. 2RS1 ; 3.00 ; Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses. 2RS3 ; 3.00 ; Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses. 2RS5 ; 3.00 ; Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses. 1IMA ; 2.30 ; Structural analysis of inositol monophosphatase complexes with substrates. 1IMB ; 2.20 ; Structural analysis of inositol monophosphatase complexes with substrates. 1HLB ; 2.50 ; Structural analysis of monomeric hemichrome and dimeric cyanomet hemoglobins from Caudina arenicola. 1P02 ; 2.00 ; Structural analysis of specificity: alpha-lytic protease complexes with analogues of reaction intermediates. 1P03 ; 2.15 ; Structural analysis of specificity: alpha-lytic protease complexes with analogues of reaction intermediates. 1P04 ; 2.55 ; Structural analysis of specificity: alpha-lytic protease complexes with analogues of reaction intermediates. 1P05 ; 2.10 ; Structural analysis of specificity: alpha-lytic protease complexes with analogues of reaction intermediates. 1P06 ; 2.34 ; Structural analysis of specificity: alpha-lytic protease complexes with analogues of reaction intermediates. 1ELD ; 1.80 ; Structural analysis of the active site of porcine pancreatic elastase based on the X-ray crystal structures of complexes with trifluoroacetyl-dipeptide-anilide inhibitors. 1ELE ; 1.80 ; Structural analysis of the active site of porcine pancreatic elastase based on the X-ray crystal structures of complexes with trifluoroacetyl-dipeptide-anilide inhibitors. 7TLN ; 2.30 ; Structural analysis of the inhibition of thermolysin by an active-site-directed irreversible inhibitor. 2CMM ; 1.80 ; Structural analysis of the myoglobin reconstituted with iron porphine. 1L16 ; 1.70 ; Structural analysis of the temperature-sensitive mutant of bacteriophage T4 lysozyme, glycine 156----aspartic acid. 1CAI ; 1.80 ; Structural analysis of the zinc hydroxide-Thr-199-Glu-106 hydrogen-bond network in human carbonic anhydrase II. 1CAJ ; 1.90 ; Structural analysis of the zinc hydroxide-Thr-199-Glu-106 hydrogen-bond network in human carbonic anhydrase II. 1CAK ; 1.90 ; Structural analysis of the zinc hydroxide-Thr-199-Glu-106 hydrogen-bond network in human carbonic anhydrase II. 1CAL ; 2.20 ; Structural analysis of the zinc hydroxide-Thr-199-Glu-106 hydrogen-bond network in human carbonic anhydrase II. 1CAM ; 1.70 ; Structural analysis of the zinc hydroxide-Thr-199-Glu-106 hydrogen-bond network in human carbonic anhydrase II. 2LAL ; 1.80 ; Structural analysis of two crystal forms of lentil lectin at 1.8 A resolution. 1LNA ; 1.90 ; Structural analysis of zinc substitutions in the active site of thermolysin. 1LNB ; 1.80 ; Structural analysis of zinc substitutions in the active site of thermolysin. 1LNC ; 1.80 ; Structural analysis of zinc substitutions in the active site of thermolysin. 1LND ; 1.70 ; Structural analysis of zinc substitutions in the active site of thermolysin. 1LNE ; 1.70 ; Structural analysis of zinc substitutions in the active site of thermolysin. 1LNF ; 1.70 ; Structural analysis of zinc substitutions in the active site of thermolysin. 1HVD ; 2.00 ; Structural and electrophysiological analysis of annexin V mutants. Mutagenesis of human annexin V, an in vitro voltage-gated calcium channel, provides information about the structural features of the ion pathway, the voltage sensor and the ion selectivity filter. 1HVE ; 2.30 ; Structural and electrophysiological analysis of annexin V mutants. Mutagenesis of human annexin V, an in vitro voltage-gated calcium channel, provides information about the structural features of the ion pathway, the voltage sensor and the ion selectivity filter. 1HVF ; 2.00 ; Structural and electrophysiological analysis of annexin V mutants. Mutagenesis of human annexin V, an in vitro voltage-gated calcium channel, provides information about the structural features of the ion pathway, the voltage sensor and the ion selectivity filter. 1HVG ; 3.00 ; Structural and electrophysiological analysis of annexin V mutants. Mutagenesis of human annexin V, an in vitro voltage-gated calcium channel, provides information about the structural features of the ion pathway, the voltage sensor and the ion selectivity filter. 1MPF ; 3.00 ; Structural and functional alterations of a colicin-resistant mutant of OmpF porin from Escherichia coli. 1LZ5 ; 1.80 ; Structural and functional analyses of the Arg-Gly-Asp sequence introduced into human lysozyme. 1LZ6 ; 1.80 ; Structural and functional analyses of the Arg-Gly-Asp sequence introduced into human lysozyme. 1MLF ; 2.00 ; Structural and functional effects of apolar mutations of the distal valine in myoglobin. 1MLG ; 2.00 ; Structural and functional effects of apolar mutations of the distal valine in myoglobin. 1MLH ; 2.00 ; Structural and functional effects of apolar mutations of the distal valine in myoglobin. 1MLJ ; 2.00 ; Structural and functional effects of apolar mutations of the distal valine in myoglobin. 1MLK ; 1.80 ; Structural and functional effects of apolar mutations of the distal valine in myoglobin. 1MLL ; 1.70 ; Structural and functional effects of apolar mutations of the distal valine in myoglobin. 1MLM ; 1.80 ; Structural and functional effects of apolar mutations of the distal valine in myoglobin. 1MLN ; 2.00 ; Structural and functional effects of apolar mutations of the distal valine in myoglobin. 1MLO ; 1.80 ; Structural and functional effects of apolar mutations of the distal valine in myoglobin. 1MLQ ; 2.00 ; Structural and functional effects of apolar mutations of the distal valine in myoglobin. 1MLR ; 2.00 ; Structural and functional effects of apolar mutations of the distal valine in myoglobin. 1MLS ; 1.70 ; Structural and functional effects of apolar mutations of the distal valine in myoglobin. 1CIE ; 1.80 ; Structural and functional effects of multiple mutations at distal sites in cytochrome c. 1CIF ; 1.90 ; Structural and functional effects of multiple mutations at distal sites in cytochrome c. 1CIG ; 1.80 ; Structural and functional effects of multiple mutations at distal sites in cytochrome c. 1CIH ; 1.80 ; Structural and functional effects of multiple mutations at distal sites in cytochrome c. 1CVA ; 2.25 ; Structural and functional importance of a conserved hydrogen bond network in human carbonic anhydrase II. 1CVB ; 2.40 ; Structural and functional importance of a conserved hydrogen bond network in human carbonic anhydrase II. 1HEL ; 1.70 ; Structural and thermodynamic analysis of compensating mutations within the core of chicken egg white lysozyme. 1HEM ; 1.80 ; Structural and thermodynamic analysis of compensating mutations within the core of chicken egg white lysozyme. 1HEN ; 1.80 ; Structural and thermodynamic analysis of compensating mutations within the core of chicken egg white lysozyme. 1HEO ; 1.80 ; Structural and thermodynamic analysis of compensating mutations within the core of chicken egg white lysozyme. 1HEP ; 1.80 ; Structural and thermodynamic analysis of compensating mutations within the core of chicken egg white lysozyme. 1HEQ ; 1.80 ; Structural and thermodynamic analysis of compensating mutations within the core of chicken egg white lysozyme. 1HER ; 1.80 ; Structural and thermodynamic analysis of compensating mutations within the core of chicken egg white lysozyme. 1L48 ; 1.70 ; Structural and thermodynamic analysis of the packing of two alpha-helices in bacteriophage T4 lysozyme. 1L49 ; 1.80 ; Structural and thermodynamic analysis of the packing of two alpha-helices in bacteriophage T4 lysozyme. 1L50 ; 1.85 ; Structural and thermodynamic analysis of the packing of two alpha-helices in bacteriophage T4 lysozyme. 1L51 ; 1.90 ; Structural and thermodynamic analysis of the packing of two alpha-helices in bacteriophage T4 lysozyme. 1L52 ; 1.70 ; Structural and thermodynamic analysis of the packing of two alpha-helices in bacteriophage T4 lysozyme. 1L53 ; 1.85 ; Structural and thermodynamic analysis of the packing of two alpha-helices in bacteriophage T4 lysozyme. 1L54 ; 1.90 ; Structural and thermodynamic consequences of burying a charged residue within the hydrophobic core of T4 lysozyme. 1TLM ; 1.90 ; Structural aspects of inotropic bipyridine binding. Crystal structure determination to 1.9 A of the human serum transthyretin-milrinone complex. 1FPD ; 2.10 ; Structural aspects of the allosteric inhibition of fructose-1,6-bisphosphatase by AMP: the binding of both the substrate analogue 2,5-anhydro-D-glucitol 1,6-bisphosphate and catalytic metal ions monitored by X-ray crystallography. 1FPE ; 2.20 ; Structural aspects of the allosteric inhibition of fructose-1,6-bisphosphatase by AMP: the binding of both the substrate analogue 2,5-anhydro-D-glucitol 1,6-bisphosphate and catalytic metal ions monitored by X-ray crystallography. 1FPF ; 2.10 ; Structural aspects of the allosteric inhibition of fructose-1,6-bisphosphatase by AMP: the binding of both the substrate analogue 2,5-anhydro-D-glucitol 1,6-bisphosphate and catalytic metal ions monitored by X-ray crystallography. 1FPG ; 2.30 ; Structural aspects of the allosteric inhibition of fructose-1,6-bisphosphatase by AMP: the binding of both the substrate analogue 2,5-anhydro-D-glucitol 1,6-bisphosphate and catalytic metal ions monitored by X-ray crystallography. 2LPR ; 2.25 ; Structural basis for broad specificity in alpha-lytic protease mutants. 3LPR ; 2.15 ; Structural basis for broad specificity in alpha-lytic protease mutants. 5LPR ; 2.13 ; Structural basis for broad specificity in alpha-lytic protease mutants. 6LPR ; 2.10 ; Structural basis for broad specificity in alpha-lytic protease mutants. 7LPR ; 2.05 ; Structural basis for broad specificity in alpha-lytic protease mutants. 8LPR ; 2.25 ; Structural basis for broad specificity in alpha-lytic protease mutants. 9LPR ; 2.20 ; Structural basis for broad specificity in alpha-lytic protease mutants. 1LAF ; 2.06 ; Structural basis for multiple ligand specificity of the periplasmic lysine-, arginine-, ornithine-binding protein. 1LAG ; 2.06 ; Structural basis for multiple ligand specificity of the periplasmic lysine-, arginine-, ornithine-binding protein. 1LAH ; 2.06 ; Structural basis for multiple ligand specificity of the periplasmic lysine-, arginine-, ornithine-binding protein. 2BBQ ; 2.30 ; Structural basis for recognition of polyglutamyl folates by thymidylate synthase. 1MAL ; 3.10 ; Structural basis for sugar translocation through maltoporin channels at 3.1 A resolution. 1PYG ; 2.87 ; Structural basis for the activation of glycogen phosphorylase b by adenosine monophosphate. 1BLP ; 2.30 ; Structural basis for the inactivation of the P54 mutant of beta-lactamase from Staphylococcus aureus PC1. 1CKA ; 1.50 ; Structural basis for the specific interaction of lysine-containing proline-rich peptides with the N-terminal SH3 domain of c-Crk. 1CKB ; 1.90 ; Structural basis for the specific interaction of lysine-containing proline-rich peptides with the N-terminal SH3 domain of c-Crk. 1GTS ; 2.80 ; Structural basis for transfer RIBONUCLEIC ACID aminoacylation by Escherichia coli glutaminyl-tRNA synthetase. 107L ; 1.80 ; Structural basis of amino acid alpha helix propensity [see comments] 108L ; 1.80 ; Structural basis of amino acid alpha helix propensity [see comments] 109L ; 1.85 ; Structural basis of amino acid alpha helix propensity [see comments] 110L ; 1.70 ; Structural basis of amino acid alpha helix propensity [see comments] 112L ; 1.80 ; Structural basis of amino acid alpha helix propensity [see comments] 113L ; 1.80 ; Structural basis of amino acid alpha helix propensity [see comments] 114L ; 1.80 ; Structural basis of amino acid alpha helix propensity [see comments] 115L ; 1.80 ; Structural basis of amino acid alpha helix propensity [see comments] 137L ; 1.85 ; Structural basis of amino acid alpha helix propensity. 1GTR ; 2.50 ; Structural basis of anticodon loop recognition by glutaminyl-tRNA synthetase. 1NCG ; 1.90 ; Structural basis of cell-cell adhesion by cadherins. 1NCH ; 2.10 ; Structural basis of cell-cell adhesion by cadherins. 1NCI ; 1.90 ; Structural basis of cell-cell adhesion by cadherins. 1HVS ; 2.25 ; Structural basis of drug resistance for the V82A mutant of HIV-1 proteinase. 1AFA ; 2.00 ; Structural basis of galactose recognition by C-type animal lectins. 1AFB ; 1.90 ; Structural basis of galactose recognition by C-type animal lectins. 1AFD ; 2.00 ; Structural basis of galactose recognition by C-type animal lectins. 1YDA ; 2.10 ; Structural basis of inhibitor affinity to variants of human carbonic anhydrase II. 1YDB ; 1.90 ; Structural basis of inhibitor affinity to variants of human carbonic anhydrase II. 1YDC ; 1.95 ; Structural basis of inhibitor affinity to variants of human carbonic anhydrase II. 1YDD ; 2.10 ; Structural basis of inhibitor affinity to variants of human carbonic anhydrase II. 1NGA ; 2.40 ; Structural basis of the 70-kilodalton heat shock cognate protein ATP hydrolytic activity. II. Structure of the active site with ADP or ATP bound to wild type and mutant ATPase fragment. 1NGB ; 2.38 ; Structural basis of the 70-kilodalton heat shock cognate protein ATP hydrolytic activity. II. Structure of the active site with ADP or ATP bound to wild type and mutant ATPase fragment. 1NGC ; 2.48 ; Structural basis of the 70-kilodalton heat shock cognate protein ATP hydrolytic activity. II. Structure of the active site with ADP or ATP bound to wild type and mutant ATPase fragment. 1NGD ; 2.44 ; Structural basis of the 70-kilodalton heat shock cognate protein ATP hydrolytic activity. II. Structure of the active site with ADP or ATP bound to wild type and mutant ATPase fragment. 1NGE ; 2.43 ; Structural basis of the 70-kilodalton heat shock cognate protein ATP hydrolytic activity. II. Structure of the active site with ADP or ATP bound to wild type and mutant ATPase fragment. 1NGF ; 2.38 ; Structural basis of the 70-kilodalton heat shock cognate protein ATP hydrolytic activity. II. Structure of the active site with ADP or ATP bound to wild type and mutant ATPase fragment. 1NGG ; 2.43 ; Structural basis of the 70-kilodalton heat shock cognate protein ATP hydrolytic activity. II. Structure of the active site with ADP or ATP bound to wild type and mutant ATPase fragment. 1NGH ; 2.50 ; Structural basis of the 70-kilodalton heat shock cognate protein ATP hydrolytic activity. II. Structure of the active site with ADP or ATP bound to wild type and mutant ATPase fragment. 1NGI ; 2.45 ; Structural basis of the 70-kilodalton heat shock cognate protein ATP hydrolytic activity. II. Structure of the active site with ADP or ATP bound to wild type and mutant ATPase fragment. 1NGJ ; 2.35 ; Structural basis of the 70-kilodalton heat shock cognate protein ATP hydrolytic activity. II. Structure of the active site with ADP or ATP bound to wild type and mutant ATPase fragment. 1LZR ; 1.50 ; Structural changes of active site cleft and different saccharide binding modes in human lysozyme co-crystallized with hexa-N-acetyl-chitohexaose at pH 4.0. 1LZS ; 1.60 ; Structural changes of active site cleft and different saccharide binding modes in human lysozyme co-crystallized with hexa-N-acetyl-chitohexaose at pH 4.0. 3SRN ; 2.00 ; Structural changes that accompany the reduced catalytic efficiency of two semisynthetic ribonuclease analogs. 4SRN ; 2.00 ; Structural changes that accompany the reduced catalytic efficiency of two semisynthetic ribonuclease analogs. 1DA1 ; 2.25 ; Structural characterisation of the bromouracil.guanine base pair mismatch in a Z-DEOXYRIBONUCLEIC ACID fragment. 3PGA ; 2.00 ; Structural characterization of Pseudomonas 7A glutaminase-asparaginase. 1NCP ; -1.00 ; Structural characterization of a 39-residue synthetic peptide containing the two zinc binding domains from the HIV-1 p7 nucleocapsid protein by CD and NMR spectroscopy. 1YMA ; 2.00 ; Structural characterization of heme ligation in the His64-->Tyr variant of myoglobin. 1D10 ; 1.50 ; Structural comparison of anticancer drug-DEOXYRIBONUCLEIC ACID complexes: adriamycin and daunomycin. 1D12 ; 1.70 ; Structural comparison of anticancer drug-DEOXYRIBONUCLEIC ACID complexes: adriamycin and daunomycin. 1CPS ; 2.25 ; Structural comparison of sulfodiimine and sulfonamide inhibitors in their complexes with zinc enzymes. 1ENX ; 1.50 ; Structural comparison of two major endo-1,4-xylanases from Trichoderma reesei. 1XYN ; 2.00 ; Structural comparison of two major endo-1,4-xylanases from Trichoderma reesei. 1XYO ; 1.50 ; Structural comparison of two major endo-1,4-xylanases from Trichoderma reesei. 1XYP ; 1.50 ; Structural comparison of two major endo-1,4-xylanases from Trichoderma reesei. 2SEC ; 1.80 ; Structural comparison of two serine proteinase-protein inhibitor complexes: eglin-c-subtilisin Carlsberg and CI-2-subtilisin Novo. 2SNI ; 2.10 ; Structural comparison of two serine proteinase-protein inhibitor complexes: eglin-c-subtilisin Carlsberg and CI-2-subtilisin Novo. 8TLN ; 1.60 ; Structural comparison suggests that thermolysin and related neutral proteases undergo hinge-bending motion during catalysis. 1D85 ; 2.50 ; Structural consequences of a carcinogenic alkylation lesion on DEOXYRIBONUCLEIC ACID: effect of O6-ethylguanine on the molecular structure of the d(CGC[e6G]AATTCGCG)-netropsin complex. 1D86 ; 2.20 ; Structural consequences of a carcinogenic alkylation lesion on DEOXYRIBONUCLEIC ACID: effect of O6-ethylguanine on the molecular structure of the d(CGC[e6G]AATTCGCG)-netropsin complex. 4AT1 ; 2.60 ; Structural consequences of effector binding to the T state of aspartate carbamoyltransferase: crystal structures of the unligated and ATP- and CTP-complexed enzymes at 2.6-A resolution. 5AT1 ; 2.60 ; Structural consequences of effector binding to the T state of aspartate carbamoyltransferase: crystal structures of the unligated and ATP- and CTP-complexed enzymes at 2.6-A resolution. 6AT1 ; 2.60 ; Structural consequences of effector binding to the T state of aspartate carbamoyltransferase: crystal structures of the unligated and ATP- and CTP-complexed enzymes at 2.6-A resolution. 1HEB ; 2.00 ; Structural consequences of hydrophilic amino acid substitutions in the hydrophobic pocket of human carbonic anhydrase II. 1HEC ; 2.00 ; Structural consequences of hydrophilic amino acid substitutions in the hydrophobic pocket of human carbonic anhydrase II. 1HED ; 2.00 ; Structural consequences of hydrophilic amino acid substitutions in the hydrophobic pocket of human carbonic anhydrase II. 1CVD ; 2.20 ; Structural consequences of redesigning a protein-zinc binding site. 1CVE ; 2.25 ; Structural consequences of redesigning a protein-zinc binding site. 1CVF ; 2.25 ; Structural consequences of redesigning a protein-zinc binding site. 1CVH ; 2.30 ; Structural consequences of redesigning a protein-zinc binding site. 132L ; 1.80 ; Structural consequences of reductive methylation of lysine residues in hen egg white lysozyme: an X-ray analysis at 1.8-A resolution. 2RN2 ; 1.48 ; Structural details of ribonuclease H from Escherichia coli as refined to an atomic resolution. 1ETU ; 2.90 ; Structural details of the binding of guanosine diphosphate to elongation factor Tu from E. coli as studied by X-ray crystallography. 1TAG ; 1.80 ; Structural determinants for activation of the alpha-subunit of a heterotrimeric G protein. 1SEM ; 2.00 ; Structural determinants of peptide-binding orientation and of sequence specificity in SH3 domains. 1MYM ; 1.70 ; Structural determinants of the stretching frequency of CO bound to myoglobin. 1HKG ; 3.50 ; Structural dynamics of yeast hexokinase during catalysis. 1AAL ; 1.60 ; Structural effects induced by mutagenesis affected by crystal packing factors: the structure of a 30-51 disulfide mutant of basic pancreatic trypsin inhibitor. 7PTI ; 1.60 ; Structural effects induced by removal of a disulfide-bridge: the X-ray structure of the C30A/C51A mutant of basic pancreatic trypsin inhibitor at 1.6 A. 1NNT ; 2.30 ; Structural evidence for a pH-sensitive dilysine trigger in the hen ovotransferrin N-lobe: implications for transferrin iron release. 1HIL ; 2.00 ; Structural evidence for induced fit as a mechanism for antibody-antigen recognition. 1HIM ; 2.90 ; Structural evidence for induced fit as a mechanism for antibody-antigen recognition. 1HIN ; 3.10 ; Structural evidence for induced fit as a mechanism for antibody-antigen recognition. 1PCH ; 1.80 ; Structural evidence for the evolutionary divergence of mycoplasma from gram-positive bacteria: the histidine-containing phosphocarrier protein. 2PLV ; 2.88 ; Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus. 1D99 ; 2.50 ; Structural features and hydration of a dodecamer duplex containing two C.A mispairs. 1ATL ; 1.80 ; Structural interaction of natural and synthetic inhibitors with the venom metalloproteinase, atrolysin C (form d). 1HTD ; 2.10 ; Structural interaction of natural and synthetic inhibitors with the venom metalloproteinase, atrolysin C (form d). 1SSA ; 2.00 ; Structural investigation of catalytically modified F120L and F120Y semisynthetic ribonucleases. 1SSB ; 2.00 ; Structural investigation of catalytically modified F120L and F120Y semisynthetic ribonucleases. 1GPA ; 2.90 ; Structural mechanism for glycogen phosphorylase control by phosphorylation and AMP. 7GPB ; 2.90 ; Structural mechanism for glycogen phosphorylase control by phosphorylation and AMP. 8GPB ; 2.20 ; Structural mechanism for glycogen phosphorylase control by phosphorylation and AMP. 1STP ; 2.60 ; Structural origins of high-affinity biotin binding to streptavidin. 1P09 ; 2.20 ; Structural plasticity broadens the specificity of an engineered protease. 1P10 ; 2.25 ; Structural plasticity broadens the specificity of an engineered protease. 2MEV ; 3.00 ; Structural refinement and analysis of Mengo virus. 1NFP ; 1.60 ; Structural refinement of the non-fluorescent flavoprotein from Photobacterium leiognathi at 1.60 A resolution. 1TIV ; -1.00 ; Structural studies of HIV-1 Tat protein. 1IMC ; 2.60 ; Structural studies of metal binding by inositol monophosphatase: evidence for two-metal ion catalysis. 1IMD ; 2.60 ; Structural studies of metal binding by inositol monophosphatase: evidence for two-metal ion catalysis. 1IME ; 2.25 ; Structural studies of metal binding by inositol monophosphatase: evidence for two-metal ion catalysis. 1IMF ; 2.50 ; Structural studies of metal binding by inositol monophosphatase: evidence for two-metal ion catalysis. 3LZM ; 1.70 ; Structural studies of mutants of T4 lysozyme that alter hydrophobic stabilization. 1L01 ; 1.70 ; Structural studies of mutants of the lysozyme of bacteriophage T4. The temperature-sensitive mutant protein Thr157----Ile. 1L10 ; 1.70 ; Structural studies of mutants of the lysozyme of bacteriophage T4. The temperature-sensitive mutant protein Thr157----Ile. 1AFC ; 2.70 ; Structural studies of the binding of the anti-ulcer drug sucrose octasulfate to acidic fibroblast growth factor. 1ENH ; 2.10 ; Structural studies of the engrailed homeodomain. 1MVP ; 2.20 ; Structural studies of the retroviral proteinase from avian myeloblastosis associated virus. 1CHH ; 1.97 ; Structural studies of the roles of residues 82 and 85 at the interactive face of cytochrome c. 1CHI ; 2.00 ; Structural studies of the roles of residues 82 and 85 at the interactive face of cytochrome c. 1CHJ ; 1.90 ; Structural studies of the roles of residues 82 and 85 at the interactive face of cytochrome c. 1CNE ; 3.00 ; Structural studies on corn nitrate reductase: refined structure of the cytochrome b reductase fragment at 2.5 A, its ADP complex and an active-site mutant and modeling of the cytochrome b domain. 1CNF ; 2.70 ; Structural studies on corn nitrate reductase: refined structure of the cytochrome b reductase fragment at 2.5 A, its ADP complex and an active-site mutant and modeling of the cytochrome b domain. 2CND ; 2.50 ; Structural studies on corn nitrate reductase: refined structure of the cytochrome b reductase fragment at 2.5 A, its ADP complex and an active-site mutant and modeling of the cytochrome b domain. 1HMR ; 1.40 ; Structural studies on human muscle fatty acid binding protein at 1.4 A resolution: binding interactions with three C18 fatty acids. 1HMS ; 1.40 ; Structural studies on human muscle fatty acid binding protein at 1.4 A resolution: binding interactions with three C18 fatty acids. 1HMT ; 1.40 ; Structural studies on human muscle fatty acid binding protein at 1.4 A resolution: binding interactions with three C18 fatty acids. 1RBR ; 1.80 ; Structural study of mutants of Escherichia coli ribonuclease HI with enhanced thermostability. 1RBS ; 1.80 ; Structural study of mutants of Escherichia coli ribonuclease HI with enhanced thermostability. 1RBT ; 1.80 ; Structural study of mutants of Escherichia coli ribonuclease HI with enhanced thermostability. 1RBU ; 1.80 ; Structural study of mutants of Escherichia coli ribonuclease HI with enhanced thermostability. 1RBV ; 1.80 ; Structural study of mutants of Escherichia coli ribonuclease HI with enhanced thermostability. 9EST ; 1.90 ; Structural study of porcine pancreatic elastase complexed with 7-amino-3-(2-bromoethoxy)-4-chloroisocoumarin as a nonreactivatable doubly covalent enzyme-inhibitor complex. 1D93 ; 2.15 ; Structural variation in d(CTCTAGAG). Implications for protein-DEOXYRIBONUCLEIC ACID interactions. 209D ; 3.00 ; Structural, physical, and biological characteristics of RIBONUCLEIC ACID.DEOXYRIBONUCLEIC ACID binding agent N8-actinomycin D. 2D55 ; 3.00 ; Structural, physical, and biological characteristics of RIBONUCLEIC ACID.DEOXYRIBONUCLEIC ACID binding agent N8-actinomycin D. 3PGM ; 2.80 ; Structure and activity of phosphoglycerate mutase. 4GCH ; 1.90 ; Structure and activity of two photoreversible cinnamates bound to chymotrypsin. 1DEA ; 2.10 ; Structure and catalytic mechanism of glucosamine 6-phosphate deaminase from Escherichia coli at 2.1 A resolution. 1HOR ; 2.40 ; Structure and catalytic mechanism of glucosamine 6-phosphate deaminase from Escherichia coli at 2.1 A resolution. 1HIS ; -1.00 ; Structure and dynamics of des-pentapeptide-insulin in solution: the molten-globule hypothesis. 1DVH ; -1.00 ; Structure and dynamics of ferrocytochrome c553 from Desulfovibrio vulgaris studied by NMR spectroscopy and restrained molecular dynamics. 1GNC ; -1.00 ; Structure and dynamics of the human granulocyte colony-stimulating factor determined by NMR spectroscopy. Loop mobility in a four-helix-bundle protein. 1MUA ; 1.70 ; Structure and energetics of a non-proline cis-peptidyl linkage in a proline-202-->alanine carbonic anhydrase II variant. 1KPT ; 1.75 ; Structure and function of a virally encoded fungal toxin from Ustilago maydis: a fungal and mammalian Ca2+ channel inhibitor. 1NXB ; 1.38 ; Structure and function of snake venom curarimimetic neurotoxins. 1RIB ; 2.20 ; Structure and function of the Escherichia coli ribonucleotide reductase protein R2. 1CEH ; 1.90 ; Structure and function of the catalytic site mutant Asp 99 Asn of phospholipase A2: absence of the conserved structural water. 2GST ; 1.80 ; Structure and function of the xenobiotic substrate binding site of a glutathione S-transferase as revealed by X-ray crystallographic analysis of product complexes with the diastereomers of 9-(S-glutathionyl)-10-hydroxy-9,10-dihydrophenanthrene. 3GST ; 1.90 ; Structure and function of the xenobiotic substrate binding site of a glutathione S-transferase as revealed by X-ray crystallographic analysis of product complexes with the diastereomers of 9-(S-glutathionyl)-10-hydroxy-9,10-dihydrophenanthrene. 1ICE ; 2.60 ; Structure and mechanism of interleukin-1 beta converting enzyme. 6TAA ; 2.10 ; Structure and molecular model refinement of Aspergillus oryzae (TAKA) alpha-amylase: an application of the simulated-annealing method. 2TAA ; 3.00 ; Structure and possible catalytic residues of Taka-amylase A. 1MBO ; 1.60 ; Structure and refinement of oxymyoglobin at 1.6 A resolution. 3APP ; 1.80 ; Structure and refinement of penicillopepsin at 1.8 A resolution. 2UTG ; 1.64 ; Structure and refinement of the oxidized P21 form of uteroglobin at 1.64 A resolution. 1IBG ; 2.70 ; Structure and specificity of the anti-digoxin antibody 40-50. 145D ; 1.30 ; Structure and thermodynamics of nonalternating C.G base pairs in Z-DEOXYRIBONUCLEIC ACID: the 1.3-A crystal structure of the asymmetric hexanucleotide d(m5CGGGm5CG).d(m5CGCCm5CG). 8HVP ; 2.50 ; Structure at 2.5-A resolution of chemically synthesized human immunodeficiency virus type 1 protease complexed with a hydroxyethylene-based inhibitor. 1YEA ; 1.90 ; Structure determination and analysis of yeast iso-2-cytochrome c and a composite mutant protein. 1YEB ; 1.95 ; Structure determination and analysis of yeast iso-2-cytochrome c and a composite mutant protein. 1LDB ; 2.80 ; Structure determination and refinement of Bacillus stearothermophilus lactate dehydrogenase. 2LDB ; 3.00 ; Structure determination and refinement of Bacillus stearothermophilus lactate dehydrogenase. 1ITH ; 2.50 ; Structure determination and refinement of homotetrameric hemoglobin from Urechis caupo at 2.5 A resolution. 1GUH ; 2.60 ; Structure determination and refinement of human alpha class glutathione transferase A1-1, and a comparison with the Mu and Pi class enzymes. 6EBX ; 1.70 ; Structure determination of a dimeric form of erabutoxin-b, crystallized from a thiocyanate solution. 1FOR ; 2.75 ; Structure determination of an Fab fragment that neutralizes human rhinovirus 14 and analysis of the Fab-virus complex. 1HRI ; 3.00 ; Structure determination of antiviral compound SCH 38057 complexed with human rhinovirus 14. 2PGH ; 2.80 ; Structure determination of aquomet porcine hemoglobin at 2.8 A resolution. 1CGM ; 3.40 ; Structure determination of cucumber green mottle mosaic virus by X-ray fiber diffraction. Significance for the evolution of tobamoviruses. 1FPV ; 3.30 ; Structure determination of feline panleukopenia virus empty particles. 2HOA ; -1.00 ; Structure determination of the Antp (C39----S) homeodomain from nuclear magnetic resonance data in solution using a novel strategy for the structure calculation with the programs DIANA, CALIBA, HABAS and GLOMSA. 3LZ2 ; 2.50 ; Structure determination of turkey egg-white lysozyme using Laue diffraction data. 1D14 ; 1.50 ; Structure of 11-deoxydaunomycin bound to DEOXYRIBONUCLEIC ACID containing a phosphorothioate. 1KGA ; 3.50 ; Structure of 2-keto-3-deoxy-6-phosphogluconate aldolase at 2 . 8 A resolution. 1HEX ; 2.50 ; Structure of 3-isopropylmalate dehydrogenase in complex with NAD+: ligand-induced loop closing and mechanism for cofactor specificity. 1KLN ; 3.20 ; Structure of DEOXYRIBONUCLEIC ACID polymerase I Klenow fragment bound to duplex DEOXYRIBONUCLEIC ACID. 231D ; 2.40 ; Structure of DEOXYRIBONUCLEIC ACID-porphyrin complex. 1GSG ; 2.80 ; Structure of E. coli glutaminyl-tRNA synthetase complexed with tRNA(Gln) and ATP at 2.8 A resolution. 1HNV ; 3.00 ; Structure of HIV-1 RT/TIBO R 86183 complex reveals similarity in the binding of diverse nonnucleoside inhibitors. 1HNI ; 2.80 ; Structure of HIV-1 reverse transcriptase in a complex with the non-nucleoside inhibitor alpha-APA R 95845 at 2.8 A resolution. 1NPX ; 2.16 ; Structure of NADH peroxidase from Streptococcus faecalis 10C1 refined at 2.16 A resolution. 1CLM ; 1.80 ; Structure of Paramecium tetraurelia calmodulin at 1.8 A resolution. 1PVI ; 2.80 ; Structure of PvuII endonuclease with cognate DEOXYRIBONUCLEIC ACID. 1SLT ; 1.90 ; Structure of S-lectin, a developmentally regulated vertebrate beta-galactoside-binding protein. 1D49 ; 1.50 ; Structure of a B-DEOXYRIBONUCLEIC ACID decamer with a central T-A step: C-G-A-T-T-A-A-T-C-G. 2BNA ; 2.70 ; Structure of a B-DEOXYRIBONUCLEIC ACID dodecamer at 16 K. 1BNA ; 1.90 ; Structure of a B-DEOXYRIBONUCLEIC ACID dodecamer: conformation and dynamics. 2MSB ; 1.70 ; Structure of a C-type mannose-binding protein complexed with an oligosaccharide. 214D ; -1.00 ; Structure of a DEOXYRIBONUCLEIC ACID duplex containing a single 2'-O-methyl-beta-D-araT: combined use of NMR, restrained molecular dynamics, and full relaxation matrix refinement. 124D ; -1.00 ; Structure of a DEOXYRIBONUCLEIC ACID:RIBONUCLEIC ACID hybrid duplex. Why RNase H does not cleave pure RIBONUCLEIC ACID. 1DN8 ; 1.50 ; Structure of a Z-DEOXYRIBONUCLEIC ACID with two different backbone chain conformations. Stabilization of the decadeoxyoligonucleotide d(CGTACGTACG) by [Co(NH3)6]3+ binding to the guanine. 3ICD ; 2.50 ; Structure of a bacterial enzyme regulated by phosphorylation, isocitrate dehydrogenase. 1LSP ; 2.45 ; Structure of a bulgecin-inhibited g-type lysozyme from the egg white of the Australian black swan. A comparison of the binding of bulgecin to three muramidases. 1LMC ; 2.00 ; Structure of a complex between bulgecin, a bacterial metabolite, and lysozyme from the rainbow trout. 1LMT ; 1.60 ; Structure of a conformationally constrained Arg-Gly-Asp sequence inserted into human lysozyme. 1LEX ; 2.25 ; Structure of a dicationic monoimidazole lexitropsin bound to DEOXYRIBONUCLEIC ACID. 1LEY ; 2.25 ; Structure of a dicationic monoimidazole lexitropsin bound to DEOXYRIBONUCLEIC ACID. 1AAR ; 2.30 ; Structure of a diubiquitin conjugate and a model for interaction with ubiquitin conjugating enzyme (E2). 1TEN ; 1.80 ; Structure of a fibronectin type III domain from tenascin phased by MAD analysis of the selenomethionyl protein. 1L96 ; 2.00 ; Structure of a hinge-bending bacteriophage T4 lysozyme mutant, Ile3-->Pro. 1L97 ; 2.00 ; Structure of a hinge-bending bacteriophage T4 lysozyme mutant, Ile3-->Pro. 1PAA ; -1.00 ; Structure of a histidine-X4-histidine zinc finger domain: insights into ADR1-UAS1 protein-DEOXYRIBONUCLEIC ACID recognition. 1DFB ; 2.70 ; Structure of a human monoclonal antibody Fab fragment against gp41 of human immunodeficiency virus type 1. 1AOR ; 2.30 ; Structure of a hyperthermophilic tungstopterin enzyme, aldehyde ferredoxin oxidoreductase. 1LTE ; 2.00 ; Structure of a legume lectin with an ordered N-linked carbohydrate in complex with lactose. 1FOD ; 2.60 ; Structure of a major immunogenic site on foot-and-mouth disease virus. 165D ; 1.55 ; Structure of a mispaired RIBONUCLEIC ACID double helix at 1.6-A resolution and implications for the prediction of RIBONUCLEIC ACID secondary structure. 1DVR ; 2.36 ; Structure of a mutant adenylate kinase ligated with an ATP-analogue showing domain closure over ATP. 1THT ; 2.10 ; Structure of a myristoyl-ACP-specific thioesterase from Vibrio harveyi. 218D ; 2.25 ; Structure of a new crystal form of a DEOXYRIBONUCLEIC ACID dodecamer containing T.(O6Me)G base pairs. 1HLT ; 3.00 ; Structure of a nonadecapeptide of the fifth EGF domain of thrombomodulin complexed with thrombin. 2RHE ; 1.60 ; Structure of a novel Bence-Jones protein (Rhe) fragment at 1.6 A resolution. 1SRA ; 2.00 ; Structure of a novel extracellular Ca(2+)-binding module in BM-40. 1PSA ; 2.90 ; Structure of a pepsin/renin inhibitor complex reveals a novel crystal packing induced by minor chemical alterations in the inhibitor. 1PTO ; 3.50 ; Structure of a pertussis toxin-sugar complex as a model for receptor binding. 1BLH ; 2.30 ; Structure of a phosphonate-inhibited beta-lactamase. An analog of the tetrahedral transition state/intermediate of beta-lactam hydrolysis. 4CLN ; 2.20 ; Structure of a recombinant calmodulin from Drosophila melanogaster refined at 2.2-A resolution. 1HDT ; 2.60 ; Structure of a retro-binding peptide inhibitor complexed with human alpha-thrombin. 2SCP ; 2.00 ; Structure of a sarcoplasmic calcium-binding protein from Nereis diversicolor refined at 2.0 A resolution. 2SAS ; 2.40 ; Structure of a sarcoplasmic calcium-binding protein from amphioxus refined at 2.4 A resolution. 1MFA ; 1.70 ; Structure of a single-chain antibody variable domain (Fv) fragment complexed with a carbohydrate antigen at 1.7-A resolution. 1CDQ ; -1.00 ; Structure of a soluble, glycosylated form of the human complement regulatory protein CD59. 1CDR ; -1.00 ; Structure of a soluble, glycosylated form of the human complement regulatory protein CD59. 1CDS ; -1.00 ; Structure of a soluble, glycosylated form of the human complement regulatory protein CD59. 1LDN ; 2.50 ; Structure of a ternary complex of an allosteric lactate dehydrogenase from Bacillus stearothermophilus at 2.5 A resolution. 6CHA ; 1.80 ; Structure of a tetrahedral transition state complex of alpha-chymotrypsin dimer at 1.8-A resolution. 1L35 ; 1.80 ; Structure of a thermostable disulfide-bridge mutant of phage T4 lysozyme shows that an engineered cross-link in a flexible region does not increase the rigidity of the folded protein. 6ADH ; 2.90 ; Structure of a triclinic ternary complex of horse liver alcohol dehydrogenase at 2.9 A resolution. 5ACN ; 2.10 ; Structure of activated aconitase: formation of the [4Fe-4S] cluster in the crystal. 6ACN ; 2.50 ; Structure of activated aconitase: formation of the [4Fe-4S] cluster in the crystal. 4CHA ; 1.68 ; Structure of alpha-chymotrypsin refined at 1.68 A resolution. 2PNA ; -1.00 ; Structure of an SH2 domain of the p85 alpha subunit of phosphatidylinositol-3-OH kinase. 2PNB ; -1.00 ; Structure of an SH2 domain of the p85 alpha subunit of phosphatidylinositol-3-OH kinase. 1GBT ; 2.00 ; Structure of an acyl-enzyme intermediate during catalysis: (guanidinobenzoyl)trypsin. 1DN9 ; 2.20 ; Structure of an alternating-B DEOXYRIBONUCLEIC ACID helix and its relationship to A-tract DEOXYRIBONUCLEIC ACID. 3HFM ; 3.00 ; Structure of an antibody-antigen complex: crystal structure of the HyHEL-10 Fab-lysozyme complex. 2IFF ; 2.65 ; Structure of an antibody-lysozyme complex unexpected effect of conservative mutation. 1RSC ; 2.30 ; Structure of an effector-induced inactivated state of ribulose 1,5-bisphosphate carboxylase/oxygenase: the binary complex between enzyme and xylulose 1,5-bisphosphate. 1DCA ; 2.20 ; Structure of an engineered His3Cys zinc binding site in human carbonic anhydrase II. 1DCB ; 2.10 ; Structure of an engineered His3Cys zinc binding site in human carbonic anhydrase II. 1FIV ; 2.00 ; Structure of an inhibitor complex of the proteinase from feline immunodeficiency virus. 1HIB ; 2.40 ; Structure of an interleukin-1 beta mutant with reduced bioactivity shows multiple subtle changes in conformation that affect protein-protein recognition. 1AST ; 1.80 ; Structure of astacin and implications for activation of astacins and zinc-ligation of collagenases. 2AZA ; 1.80 ; Structure of azurin from Alcaligenes denitrificans refinement at 1.8 A resolution and comparison of the two crystallographically independent molecules. 2LZM ; 1.70 ; Structure of bacteriophage T4 lysozyme refined at 1.7 A resolution. 1BUN ; 2.45 ; Structure of beta 2-bungarotoxin: potassium channel binding by Kunitz modules and targeted phospholipase action. 1RHD ; 2.50 ; Structure of bovine liver rhodanese. I. Structure determination at 2.5 A resolution and a comparison of the conformation and sequence of its two domains. 1BP2 ; 1.70 ; Structure of bovine pancreatic phospholipase A2 at 1.7A resolution. 1BPI ; 1.10 ; Structure of bovine pancreatic trypsin inhibitor at 125 K: Definition of carboxyl-terminal residues Gly57 and Ala58. 2PF1 ; 2.20 ; Structure of bovine prothrombin fragment 1 refined at 2.25 A resolution. 1TGN ; 1.65 ; Structure of bovine trypsinogen at 1.9 A resolution. 3CLN ; 2.20 ; Structure of calmodulin refined at 2.2 A resolution. 1CPB ; 2.80 ; Structure of carboxypeptidase B at 2-8 A resolution. 1ALA ; 2.25 ; Structure of chicken annexin V at 2.25-A resolution. 6GCH ; 2.10 ; Structure of chymotrypsin-trifluoromethyl ketone inhibitor complexes: comparison of slowly and rapidly equilibrating inhibitors. 7GCH ; 1.80 ; Structure of chymotrypsin-trifluoromethyl ketone inhibitor complexes: comparison of slowly and rapidly equilibrating inhibitors. 1CAH ; 1.88 ; Structure of cobalt carbonic anhydrase complexed with bicarbonate. 2CDX ; -1.00 ; Structure of cobra cardiotoxin CTX I as derived from nuclear magnetic resonance spectroscopy and distance geometry calculations. 4HVP ; 2.30 ; Structure of complex of synthetic HIV-1 protease with a substrate-based inhibitor at 2.3 A resolution. 3CNA ; 2.40 ; Structure of concanavalin A at 2.4-A resolution. 1CGT ; 2.00 ; Structure of cyclodextrin glycosyltransferase refined at 2.0 A resolution. 351C ; 1.60 ; Structure of cytochrome c551 from Pseudomonas aeruginosa refined at 1.6 A resolution and comparison of the two redox forms. 451C ; 1.60 ; Structure of cytochrome c551 from Pseudomonas aeruginosa refined at 1.6 A resolution and comparison of the two redox forms. 1NIH ; 2.60 ; Structure of deoxy-quaternary haemoglobin with liganded beta subunits. 1HBH ; 2.20 ; Structure of deoxyhaemoglobin of the antarctic fish Pagothenia bernacchii with an analysis of the structural basis of the root effect by comparison of the liganded and unliganded haemoglobin structures. 1DOT ; 2.35 ; Structure of diferric duck ovotransferrin at 2.35 angstrom resolution. 1ECA ; 1.40 ; Structure of erythrocruorin in different ligand states refined at 1.4 A resolution. 1ECD ; 1.40 ; Structure of erythrocruorin in different ligand states refined at 1.4 A resolution. 1ECN ; 1.40 ; Structure of erythrocruorin in different ligand states refined at 1.4 A resolution. 1ECO ; 1.40 ; Structure of erythrocruorin in different ligand states refined at 1.4 A resolution. 1FSC ; 2.00 ; Structure of fasciculin 2 from green mamba snake venom: Evidence for unusual loop flexibility. 1FER ; 2.30 ; Structure of ferredoxin I from Azotobacter vinelandii. 6PTI ; 1.70 ; Structure of form III crystals of bovine pancreatic trypsin inhibitor. 1FBL ; 2.50 ; Structure of full-length porcine synovial collagenase reveals a C-terminal domain containing a calcium-linked, four-bladed beta-propeller. 2GCT ; 1.80 ; Structure of gamma-chymotrypsin in the range pH 2.0 to pH 10.5 suggests that gamma-chymotrypsin is a covalent acyl-enzyme adduct at low pH. 3GCT ; 1.60 ; Structure of gamma-chymotrypsin in the range pH 2.0 to pH 10.5 suggests that gamma-chymotrypsin is a covalent acyl-enzyme adduct at low pH. 1GER ; 1.86 ; Structure of glutathione reductase from Escherichia coli at 1.86 A resolution: comparison with the enzyme from human erythrocytes. 1GGA ; 3.20 ; Structure of glycosomal glyceraldehyde-3-phosphate dehydrogenase from Trypanosoma brucei determined from Laue data. 1COH ; 2.90 ; Structure of haemoglobin in the deoxy quaternary state with ligand bound at the alpha haems. 1HCD ; -1.00 ; Structure of hisactophilin is similar to interleukin-1 beta and fibroblast growth factor. 1HCE ; -1.00 ; Structure of hisactophilin is similar to interleukin-1 beta and fibroblast growth factor. 1GD1 ; 1.80 ; Structure of holo-glyceraldehyde-3-phosphate dehydrogenase from Bacillus stearothermophilus at 1.8 A resolution. 1HCN ; 2.60 ; Structure of human chorionic gonadotropin at 2.6 A resolution from MAD analysis of the selenomethionyl protein. 1HCG ; 2.20 ; Structure of human des(1-45) factor Xa at 2.2 A resolution. 1FDH ; 2.50 ; Structure of human foetal deoxyhaemoglobin. 1MNC ; 2.10 ; Structure of human neutrophil collagenase reveals large S1' specificity pocket. 1HNE ; 1.84 ; Structure of human neutrophil elastase in complex with a peptide chloromethyl ketone inhibitor at 1.84-A resolution. 1HHO ; 2.10 ; Structure of human oxyhaemoglobin at 2.1 A resolution. 1HPH ; -1.00 ; Structure of human parathyroid hormone 1-37 in solution. 1HTM ; 2.50 ; Structure of influenza haemagglutinin at the pH of membrane fusion. 2HHM ; 2.10 ; Structure of inositol monophosphatase, the putative target of lithium therapy. 3INS ; 1.50 ; Structure of insulin: results of joint neutron and X-ray refinement. 1IKA ; 2.70 ; Structure of isocitrate dehydrogenase with alpha-ketoglutarate at 2.7-A resolution: conformational changes induced by decarboxylation of isocitrate. 1DPI ; 2.80 ; Structure of large fragment of Escherichia coli DEOXYRIBONUCLEIC ACID polymerase I complexed with dTMP. 2MHR ; 1.70 ; Structure of myohemerythrin in the azidomet state at 1.7/1.3 A resolution. 2CBA ; 1.54 ; Structure of native and apo carbonic anhydrase II and structure of some of its anion-ligand complexes. 2CBB ; 1.67 ; Structure of native and apo carbonic anhydrase II and structure of some of its anion-ligand complexes. 2CBC ; 1.88 ; Structure of native and apo carbonic anhydrase II and structure of some of its anion-ligand complexes. 2CBD ; 1.67 ; Structure of native and apo carbonic anhydrase II and structure of some of its anion-ligand complexes. 2CBE ; 1.82 ; Structure of native and apo carbonic anhydrase II and structure of some of its anion-ligand complexes. 3EST ; 1.65 ; Structure of native porcine pancreatic elastase at 1.65 A resolutions. 1D17 ; 2.00 ; Structure of nogalamycin bound to a DEOXYRIBONUCLEIC ACID hexamer. 1OMD ; 1.85 ; Structure of oncomodulin refined at 1.85 A resolution. An example of extensive molecular aggregation via Ca2+. 1AAZ ; 2.00 ; Structure of oxidized bacteriophage T4 glutaredoxin (thioredoxin). Refinement of native and mutant proteins. 1ABA ; 1.45 ; Structure of oxidized bacteriophage T4 glutaredoxin (thioredoxin). Refinement of native and mutant proteins. 9PAP ; 1.65 ; Structure of papain refined at 1.65 A resolution. 1LTB ; 2.60 ; Structure of partially-activated E. coli heat-labile enterotoxin (LT) at 2.6 A resolution. 1SAC ; 2.00 ; Structure of pentameric human serum amyloid P component. 2CRO ; 2.35 ; Structure of phage 434 Cro protein at 2.35 A resolution. 7RSA ; 1.26 ; Structure of phosphate-free ribonuclease A refined at 1.26 A. 7INS ; 2.00 ; Structure of porcine insulin cocrystallized with clupeine Z. 1P2P ; 2.60 ; Structure of porcine pancreatic phospholipase A2 at 2.6 A resolution and comparison with bovine phospholipase A2. 2POR ; 1.80 ; Structure of porin refined at 1.8 A resolution. 1PDA ; 1.76 ; Structure of porphobilinogen deaminase reveals a flexible multidomain polymerase with a single catalytic site. 2PAB ; 1.80 ; Structure of prealbumin: secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 A. 2PCD ; 2.15 ; Structure of protocatechuate 3,4-dioxygenase from Pseudomonas aeruginosa at 2.15 A resolution. 3PMG ; 2.40 ; Structure of rabbit muscle phosphoglucomutase refined at 2.4 angstrom resolution. 1PKN ; 2.90 ; Structure of rabbit muscle pyruvate kinase complexed with Mn2+, K+, and pyruvate. 2REN ; 2.50 ; Structure of recombinant human renin, a target for cardiovascular-active drugs, at 2.5 A resolution. 1BBC ; 2.20 ; Structure of recombinant human rheumatoid arthritic synovial fluid phospholipase A2 at 2.2 A resolution. 1RTC ; 2.30 ; Structure of recombinant ricin A chain at 2.3 A. 1BAM ; 1.95 ; Structure of restriction endonuclease bamhi phased at 1.95 A resolution by MAD analysis. 1RBN ; 2.10 ; Structure of ribonuclease A derivative II at 2.1-A resolution. 1RNH ; 2.00 ; Structure of ribonuclease H phased at 2 A resolution by MAD analysis of the selenomethionyl protein. 8RNT ; 1.80 ; Structure of ribonuclease T1 complexed with zinc(II) at 1.8 A resolution: a Zn2+.6H2O.carboxylate clathrate. 1CCR ; 1.50 ; Structure of rice ferricytochrome c at 2.0 A resolution. 7RXN ; 1.50 ; Structure of rubredoxin from Desulfovibrio vulgaris at 1.5 A resolution. 2SN3 ; 1.20 ; Structure of scorpion toxin variant-3 at 1.2 A resolution. 1SVQ ; -1.00 ; Structure of severin domain 2 in solution. 1SVR ; -1.00 ; Structure of severin domain 2 in solution. 1TBE ; 2.40 ; Structure of tetraubiquitin shows how multiubiquitin chains can be formed. 3DNB ; 1.30 ; Structure of the B-DEOXYRIBONUCLEIC ACID decamer C-C-A-A-C-G-T-T-G-G and comparison with isomorphous decamers C-C-A-A-G-A-T-T-G-G and C-C-A-G-G-C-C-T-G-G. 1D60 ; 2.20 ; Structure of the B-DEOXYRIBONUCLEIC ACID decamer C-C-A-A-C-I-T-T-G-G in two different space groups: conformational flexibility of B-DEOXYRIBONUCLEIC ACID. 1CTF ; 1.70 ; Structure of the C-terminal domain of the ribosomal protein L7/L12 from Escherichia coli at 1.7 A. 1CHC ; -1.00 ; Structure of the C3HC4 domain by 1H-nuclear magnetic resonance spectroscopy. A new structural class of zinc-finger. 1ROP ; 1.70 ; Structure of the ColE1 rop protein at 1.7 A resolution. 1PIL ; 2.70 ; Structure of the Escherichia coli signal transducing protein PII. 1EFM ; 2.70 ; Structure of the GDP domain of EF-Tu and location of the amino acids homologous to ras oncogene proteins. 1HME ; -1.00 ; Structure of the HMG box motif in the B-domain of HMG1. 1HMF ; -1.00 ; Structure of the HMG box motif in the B-domain of HMG1. 2LBP ; 2.40 ; Structure of the L-leucine-binding protein refined at 2.4 A resolution and comparison with the Leu/Ile/Val-binding protein structure. 2CHE ; 1.80 ; Structure of the Mg(2+)-bound form of CheY and mechanism of phosphoryl transfer in bacterial chemotaxis. 2CHF ; 1.80 ; Structure of the Mg(2+)-bound form of CheY and mechanism of phosphoryl transfer in bacterial chemotaxis. 1PKS ; -1.00 ; Structure of the PI3K SH3 domain and analysis of the SH3 family. 1PKT ; -1.00 ; Structure of the PI3K SH3 domain and analysis of the SH3 family. 1DEC ; -1.00 ; Structure of the RGD protein decorsin: conserved motif and distinct function in leech proteins that affect blood clotting. 1VTM ; 3.50 ; Structure of the U2 strain of tobacco mosaic virus refined at 3.5 A resolution using X-ray fiber diffraction. 1FXI ; 2.20 ; Structure of the [2Fe-2S] ferredoxin I from the blue-green alga Aphanothece sacrum at 2.2 A resolution. 5LDH ; 2.70 ; Structure of the active ternary complex of pig heart lactate dehydrogenase with S-lac-NAD at 2.7 A resolution. 1GPH ; 3.00 ; Structure of the allosteric regulatory enzyme of purine biosynthesis. 1R69 ; 2.00 ; Structure of the amino-terminal domain of phage 434 repressor at 2.0 A resolution. 2RSP ; 2.00 ; Structure of the aspartic protease from Rous sarcoma retrovirus refined at 2-A resolution. 1BTN ; 2.00 ; Structure of the binding site for inositol phosphates in a PH domain. 1BND ; 2.30 ; Structure of the brain-derived neurotrophic factor/neurotrophin 3 heterodimer. 1MSB ; 2.30 ; Structure of the calcium-dependent lectin domain from a rat mannose-binding protein determined by MAD phasing. 1CTL ; -1.00 ; Structure of the carboxy-terminal LIM domain from the cysteine rich protein CRP. 1CGL ; 2.40 ; Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitor. 2TCL ; 2.20 ; Structure of the catalytic domain of human fibroblast collagenase complexed with an inhibitor. 1MAT ; 2.40 ; Structure of the cobalt-dependent methionine aminopeptidase from Escherichia coli: a new type of proteolytic enzyme. 1AKE ; 1.90 ; Structure of the complex between adenylate kinase from Escherichia coli and the inhibitor Ap5A refined at 1.9 A resolution. A model for a catalytic transition state. 1TSI ; 2.84 ; Structure of the complex between trypanosomal triosephosphate isomerase and N-hydroxy-4-phosphono-butanamide: binding at the active site despite an "open" flexible loop conformation. 1WHS ; 2.30 ; Structure of the complex of L-benzylsuccinate with wheat serine carboxypeptidase II at 2.0-A resolution. 1WHT ; 2.00 ; Structure of the complex of L-benzylsuccinate with wheat serine carboxypeptidase II at 2.0-A resolution. 4SGB ; 2.10 ; Structure of the complex of Streptomyces griseus proteinase B and polypeptide chymotrypsin inhibitor-1 from Russet Burbank potato tubers at 2.1 A resolution. 1LCC ; -1.00 ; Structure of the complex of lac repressor headpiece and an 11 base-pair half-operator determined by nuclear magnetic resonance spectroscopy and restrained molecular dynamics. 1LCD ; -1.00 ; Structure of the complex of lac repressor headpiece and an 11 base-pair half-operator determined by nuclear magnetic resonance spectroscopy and restrained molecular dynamics. 1PEK ; 2.20 ; Structure of the complex of proteinase K with a substrate analogue hexapeptide inhibitor at 2.2-A resolution. 1EPA ; 2.10 ; Structure of the epididymal retinoic acid binding protein at 2.1 A resolution. 1EPB ; 2.20 ; Structure of the epididymal retinoic acid binding protein at 2.1 A resolution. 1TVT ; -1.00 ; Structure of the equine infectious anemia virus Tat protein. 1RSY ; 1.90 ; Structure of the first C2 domain of synaptotagmin I: a novel Ca2+/phospholipid-binding fold. 1CDB ; -1.00 ; Structure of the glycosylated adhesion domain of human T lymphocyte glycoprotein CD2. 1HGT ; 2.20 ; Structure of the hirugen and hirulog 1 complexes of alpha-thrombin. 2HGT ; 2.20 ; Structure of the hirugen and hirulog 1 complexes of alpha-thrombin. 1ABI ; 2.30 ; Structure of the hirulog 3-thrombin complex and nature of the S' subsites of substrates and inhibitors. 1ABJ ; 2.40 ; Structure of the hirulog 3-thrombin complex and nature of the S' subsites of substrates and inhibitors. 1HLA ; 3.50 ; Structure of the human class I histocompatibility antigen, HLA-A2. 1DTP ; 2.50 ; Structure of the isolated catalytic domain of diphtheria toxin. 2RCR ; 3.10 ; Structure of the membrane-bound protein photosynthetic reaction center from Rhodobacter sphaeroides. 1CFH ; -1.00 ; Structure of the metal-free gamma-carboxyglutamic acid-rich membrane binding region of factor IX by two-dimensional NMR spectroscopy. 1FLV ; 2.00 ; Structure of the oxidized long-chain flavodoxin from Anabaena 7120 at 2 A resolution. 3GBP ; 2.40 ; Structure of the periplasmic glucose/galactose receptor of Salmonella typhimurium. 1PCR ; 2.65 ; Structure of the photosynthetic reaction centre from Rhodobacter sphaeroides at 2.65 A resolution: cofactors and protein-cofactor interactions. 1NES ; 1.65 ; Structure of the product complex of acetyl-Ala-Pro-Ala with porcine pancreatic elastase at 1.65 A resolution. 2SAM ; 2.40 ; Structure of the protease from simian immunodeficiency virus: complex with an irreversible nonpeptide inhibitor. 1D48 ; 1.00 ; Structure of the pure-spermine form of Z-DEOXYRIBONUCLEIC ACID (magnesium free) at 1-A resolution. 4RCR ; 2.80 ; Structure of the reaction center from Rhodobacter sphaeroides R-26 and 2.4.1: protein-cofactor (bacteriochlorophyll, bacteriopheophytin, and carotenoid) interactions. 1LCT ; 2.00 ; Structure of the recombinant N-terminal lobe of human lactoferrin at 2.0 A resolution. 1GLA ; 2.60 ; Structure of the regulatory complex of Escherichia coli IIIGlc with glycerol kinase. 1GLB ; 2.60 ; Structure of the regulatory complex of Escherichia coli IIIGlc with glycerol kinase. 1SCM ; 2.80 ; Structure of the regulatory domain of scallop myosin at 2.8 A resolution. 1FLP ; 1.50 ; Structure of the sulfide-reactive hemoglobin from the clam Lucina pectinata. Crystallographic analysis at 1.5 A resolution. 7TIM ; 1.90 ; Structure of the triosephosphate isomerase-phosphoglycolohydroxamate complex: an analogue of the intermediate on the reaction pathway. 1TAB ; 2.30 ; Structure of the trypsin-binding domain of Bowman-Birk type protease inhibitor and its interaction with trypsin. 2TBV ; 2.90 ; Structure of tomato bushy stunt virus. V. Coat protein sequence determination and its structural implications. 1HR3 ; 5.50 ; Structure of trimeric haemerythrin. 1UBQ ; 1.80 ; Structure of ubiquitin refined at 1.8 A resolution. 1CLE ; 2.00 ; Structure of uncomplexed and linoleate-bound Candida cylindracea cholesterol esterase. 1D83 ; -1.00 ; Structure refinement of the chromomycin dimer-DEOXYRIBONUCLEIC ACID oligomer complex in solution. 1RGD ; -1.00 ; Structure refinement of the glucocorticoid receptor-DEOXYRIBONUCLEIC ACID binding domain from NMR data by relaxation matrix calculations. 1SDY ; 2.50 ; Structure solution and molecular dynamics refinement of the yeast Cu,Zn enzyme superoxide dismutase. 2TSC ; 1.97 ; Structure, multiple site binding, and segmental accommodation in thymidylate synthase on binding dUMP and an anti-folate. 2CAB ; 2.00 ; Structure, refinement, and function of carbonic anhydrase isozymes: refinement of human carbonic anhydrase I. 1IVA ; -1.00 ; Structure-activity relationships for P-type calcium channel-selective omega-agatoxins. 1TCG ; -1.00 ; Structure-activity relationships of mu-conotoxin GIIIA: structure determination of active and inactive sodium channel blocker peptides by NMR and simulated annealing calculations. 1TCH ; -1.00 ; Structure-activity relationships of mu-conotoxin GIIIA: structure determination of active and inactive sodium channel blocker peptides by NMR and simulated annealing calculations. 1TCJ ; -1.00 ; Structure-activity relationships of mu-conotoxin GIIIA: structure determination of active and inactive sodium channel blocker peptides by NMR and simulated annealing calculations. 1TCK ; -1.00 ; Structure-activity relationships of mu-conotoxin GIIIA: structure determination of active and inactive sodium channel blocker peptides by NMR and simulated annealing calculations. 1CCS ; 2.35 ; Structure-assisted redesign of a protein-zinc-binding site with femtomolar affinity. 1CCT ; 2.20 ; Structure-assisted redesign of a protein-zinc-binding site with femtomolar affinity. 1CCU ; 2.25 ; Structure-assisted redesign of a protein-zinc-binding site with femtomolar affinity. 1ISA ; 1.80 ; Structure-function in Escherichia coli iron superoxide dismutase: comparisons with the manganese enzyme from Thermus thermophilus. 1ISB ; 1.85 ; Structure-function in Escherichia coli iron superoxide dismutase: comparisons with the manganese enzyme from Thermus thermophilus. 1ISC ; 1.80 ; Structure-function in Escherichia coli iron superoxide dismutase: comparisons with the manganese enzyme from Thermus thermophilus. 1MNG ; 1.80 ; Structure-function in Escherichia coli iron superoxide dismutase: comparisons with the manganese enzyme from Thermus thermophilus. 4XIA ; 2.30 ; Structures of D-xylose isomerase from Arthrobacter strain B3728 containing the inhibitors xylitol and D-sorbitol at 2.5 A and 2.3 A resolution, respectively. 5XIA ; 2.50 ; Structures of D-xylose isomerase from Arthrobacter strain B3728 containing the inhibitors xylitol and D-sorbitol at 2.5 A and 2.3 A resolution, respectively. 1ARD ; -1.00 ; Structures of DEOXYRIBONUCLEIC ACID-binding mutant zinc finger domains: implications for DEOXYRIBONUCLEIC ACID binding. 1ARE ; -1.00 ; Structures of DEOXYRIBONUCLEIC ACID-binding mutant zinc finger domains: implications for DEOXYRIBONUCLEIC ACID binding. 1ARF ; -1.00 ; Structures of DEOXYRIBONUCLEIC ACID-binding mutant zinc finger domains: implications for DEOXYRIBONUCLEIC ACID binding. 1LGB ; 3.30 ; Structures of a legume lectin complexed with the human lactotransferrin N2 fragment, and with an isolated biantennary glycopeptide: role of the fucose moiety. 1LGC ; 2.80 ; Structures of a legume lectin complexed with the human lactotransferrin N2 fragment, and with an isolated biantennary glycopeptide: role of the fucose moiety. 1GFI ; 2.20 ; Structures of active conformations of Gi alpha 1 and the mechanism of GTP hydrolysis. 1GIA ; 2.00 ; Structures of active conformations of Gi alpha 1 and the mechanism of GTP hydrolysis. 1GIL ; 2.30 ; Structures of active conformations of Gi alpha 1 and the mechanism of GTP hydrolysis. 1CDH ; 2.30 ; Structures of an HIV and MHC binding fragment from human CD4 as refined in two crystal lattices. 1CDI ; 2.90 ; Structures of an HIV and MHC binding fragment from human CD4 as refined in two crystal lattices. 1CDD ; 2.80 ; Structures of apo and complexed Escherichia coli glycinamide ribonucleotide transformylase. 1CDE ; 2.50 ; Structures of apo and complexed Escherichia coli glycinamide ribonucleotide transformylase. 1IVB ; 2.40 ; Structures of aromatic inhibitors of influenza virus neuraminidase. 1IVC ; 2.40 ; Structures of aromatic inhibitors of influenza virus neuraminidase. 1IVD ; 1.80 ; Structures of aromatic inhibitors of influenza virus neuraminidase. 1IVE ; 2.40 ; Structures of aromatic inhibitors of influenza virus neuraminidase. 1IVF ; 2.40 ; Structures of aromatic inhibitors of influenza virus neuraminidase. 1IVG ; 2.40 ; Structures of aromatic inhibitors of influenza virus neuraminidase. 4APR ; 2.50 ; Structures of complexes of rhizopuspepsin with pepstatin and other statine-containing inhibitors. 5APR ; 2.10 ; Structures of complexes of rhizopuspepsin with pepstatin and other statine-containing inhibitors. 6APR ; 2.50 ; Structures of complexes of rhizopuspepsin with pepstatin and other statine-containing inhibitors. 1HMD ; 2.00 ; Structures of deoxy and oxy hemerythrin at 2.0 A resolution. 1HMO ; 2.00 ; Structures of deoxy and oxy hemerythrin at 2.0 A resolution. 1POD ; 2.10 ; Structures of free and inhibited human secretory phospholipase A2 from inflammatory exudate. 1POE ; 2.10 ; Structures of free and inhibited human secretory phospholipase A2 from inflammatory exudate. 1HLD ; 2.10 ; Structures of horse liver alcohol dehydrogenase complexed with NAD+ and substituted benzyl alcohols. 3SGA ; 1.80 ; Structures of product and inhibitor complexes of Streptomyces griseus protease A at 1.8 A resolution. A model for serine protease catalysis. 4SGA ; 1.80 ; Structures of product and inhibitor complexes of Streptomyces griseus protease A at 1.8 A resolution. A model for serine protease catalysis. 5SGA ; 1.80 ; Structures of product and inhibitor complexes of Streptomyces griseus protease A at 1.8 A resolution. A model for serine protease catalysis. 129L ; 1.70 ; Structures of randomly generated mutants of T4 lysozyme show that protein stability can be enhanced by relaxation of strain and by improved hydrogen bonding via bound solvent. 130L ; 1.70 ; Structures of randomly generated mutants of T4 lysozyme show that protein stability can be enhanced by relaxation of strain and by improved hydrogen bonding via bound solvent. 131L ; 1.70 ; Structures of randomly generated mutants of T4 lysozyme show that protein stability can be enhanced by relaxation of strain and by improved hydrogen bonding via bound solvent. 2BPF ; 2.90 ; Structures of ternary complexes of rat DEOXYRIBONUCLEIC ACID polymerase beta, a DEOXYRIBONUCLEIC ACID template-primer, and ddCTP. 2BPG ; 3.60 ; Structures of ternary complexes of rat DEOXYRIBONUCLEIC ACID polymerase beta, a DEOXYRIBONUCLEIC ACID template-primer, and ddCTP. 1TPD ; 2.10 ; Structures of the "open" and "closed" state of trypanosomal triosephosphate isomerase, as observed in a new crystal form: implications for the reaction mechanism. 1TRD ; 2.50 ; Structures of the "open" and "closed" state of trypanosomal triosephosphate isomerase, as observed in a new crystal form: implications for the reaction mechanism. 1KRA ; 2.30 ; Structures of the Klebsiella aerogenes urease apoenzyme and two active- site mutants. 1KRB ; 2.50 ; Structures of the Klebsiella aerogenes urease apoenzyme and two active- site mutants. 1KRC ; 2.50 ; Structures of the Klebsiella aerogenes urease apoenzyme and two active- site mutants. 1DPR ; 3.00 ; Structures of the apo- and the metal ion-activated forms of the diphtheria tox repressor from Corynebacterium diphtheriae. 1LEC ; 2.00 ; Structures of the lectin IV of Griffonia simplicifolia and its complex with the Lewis b human blood group determinant at 2.0 A resolution. 1LED ; 2.00 ; Structures of the lectin IV of Griffonia simplicifolia and its complex with the Lewis b human blood group determinant at 2.0 A resolution. 2D94 ; 1.70 ; Structures of the mismatched duplex d(GGGTGCCC) and one of its Watson-Crick analogues d(GGGCGCCC). 1CWP ; 3.20 ; Structures of the native and swollen forms of cowpea chlorotic mottle virus determined by X-ray crystallography and cryo-electron microscopy. 2HPP ; 3.30 ; Structures of the noncovalent complexes of human and bovine prothrombin fragment 2 with human PPACK-thrombin. 2HPQ ; 3.30 ; Structures of the noncovalent complexes of human and bovine prothrombin fragment 2 with human PPACK-thrombin. 1TNP ; -1.00 ; Structures of the troponin C regulatory domains in the apo and calcium- saturated states. 1TNQ ; -1.00 ; Structures of the troponin C regulatory domains in the apo and calcium- saturated states. 1HDX ; 2.50 ; Structures of three human beta alcohol dehydrogenase variants. Correlations with their functional differences. 1HDY ; 2.50 ; Structures of three human beta alcohol dehydrogenase variants. Correlations with their functional differences. 1HDZ ; 2.45 ; Structures of three human beta alcohol dehydrogenase variants. Correlations with their functional differences. 1HEA ; 2.00 ; Structures of three human beta alcohol dehydrogenase variants. Correlations with their functional differences. 1THR ; 2.30 ; Structures of thrombin complexes with a designed and a natural exosite peptide inhibitor. 1THS ; 2.20 ; Structures of thrombin complexes with a designed and a natural exosite peptide inhibitor. 1TDA ; 3.09 ; Structures of thymidylate synthase with a C-terminal deletion: role of the C-terminus in alignment of 2'-deoxyuridine 5'-monophosphate and 5,10-methylenetetrahydrofolate. 1TDB ; 2.65 ; Structures of thymidylate synthase with a C-terminal deletion: role of the C-terminus in alignment of 2'-deoxyuridine 5'-monophosphate and 5,10-methylenetetrahydrofolate. 1TDC ; 2.65 ; Structures of thymidylate synthase with a C-terminal deletion: role of the C-terminus in alignment of 2'-deoxyuridine 5'-monophosphate and 5,10-methylenetetrahydrofolate. 2TDD ; 2.70 ; Structures of thymidylate synthase with a C-terminal deletion: role of the C-terminus in alignment of 2'-deoxyuridine 5'-monophosphate and 5,10-methylenetetrahydrofolate. 6TMN ; 1.60 ; Structures of two thermolysin-inhibitor complexes that differ by a single hydrogen bond. 1GPD ; 2.90 ; Studies of asymmetry in the three-dimensional structure of lobster D-glyceraldehyde-3-phosphate dehydrogenase. 1SMF ; 2.10 ; Studies on an artificial trypsin inhibitor peptide derived from the mung bean trypsin inhibitor: chemical synthesis, refolding, and crystallographic analysis of its complex with trypsin. 1MRG ; 1.80 ; Studies on crystal structures, active-centre geometry and depurinating mechanism of two ribosome-inactivating proteins. 1MRH ; 2.00 ; Studies on crystal structures, active-centre geometry and depurinating mechanism of two ribosome-inactivating proteins. 1MRI ; 2.20 ; Studies on crystal structures, active-centre geometry and depurinating mechanism of two ribosome-inactivating proteins. 1MRJ ; 1.60 ; Studies on crystal structures, active-centre geometry and depurinating mechanism of two ribosome-inactivating proteins. 1MRK ; 1.60 ; Studies on crystal structures, active-centre geometry and depurinating mechanism of two ribosome-inactivating proteins. 1PTK ; 2.40 ; Studies on the inhibitory action of mercury upon proteinase K. 1BRN ; 1.76 ; Subsite binding in an RNase: structure of a barnase-tetranucleotide complex at 1.76-A resolution. 1RBA ; 2.60 ; Substitution of ASP193 to ASN at the active site of ribulose-1,5-bisphosphate carboxylase results in conformational changes. 1MRR ; 2.50 ; Substitution of manganese for iron in ribonucleotide reductase from Escherichia coli. Spectroscopic and crystallographic characterization. 1GRA ; 2.00 ; Substrate binding and catalysis by glutathione reductase as derived from refined enzyme: substrate crystal structures at 2 A resolution. 1GRE ; 2.00 ; Substrate binding and catalysis by glutathione reductase as derived from refined enzyme: substrate crystal structures at 2 A resolution. 1GRF ; 2.00 ; Substrate binding and catalysis by glutathione reductase as derived from refined enzyme: substrate crystal structures at 2 A resolution. 1GRG ; 2.00 ; Substrate binding and catalysis by glutathione reductase as derived from refined enzyme: substrate crystal structures at 2 A resolution. 1TYP ; 2.80 ; Substrate interactions between trypanothione reductase and N1-glutathionylspermidine disulphide at 0.28-nm resolution. 1ABF ; 1.90 ; Substrate specificity and affinity of a protein modulated by bound water molecules. 5ABP ; 1.80 ; Substrate specificity and affinity of a protein modulated by bound water molecules. 1UKY ; 2.13 ; Substrate specificity and assembly of the catalytic center derived from two structures of ligated uridylate kinase. 1UKZ ; 1.90 ; Substrate specificity and assembly of the catalytic center derived from two structures of ligated uridylate kinase. 2GBP ; 1.90 ; Sugar and signal-transducer binding sites of the Escherichia coli galactose chemoreceptor protein. 6ABP ; 1.67 ; Sugar-binding and crystallographic studies of an arabinose-binding protein mutant (Met108Leu) that exhibits enhanced affinity and altered specificity. 7ABP ; 1.67 ; Sugar-binding and crystallographic studies of an arabinose-binding protein mutant (Met108Leu) that exhibits enhanced affinity and altered specificity. 8ABP ; 1.49 ; Sugar-binding and crystallographic studies of an arabinose-binding protein mutant (Met108Leu) that exhibits enhanced affinity and altered specificity. 1CHP ; 2.00 ; Surprising leads for a cholera toxin receptor-binding antagonist: crystallographic studies of CTB mutants. 1CHQ ; 2.10 ; Surprising leads for a cholera toxin receptor-binding antagonist: crystallographic studies of CTB mutants. 2PRK ; 1.50 ; Synchrotron X-ray data collection and restrained least-squares refinement of the crystal structure of proteinase K at 1.5 A resolution. 1LTH ; 2.50 ; T and R states in the crystals of bacterial L-lactate dehydrogenase reveal the mechanism for allosteric control. 1TRI ; 2.40 ; THE CRYSTAL-STRUCTURE OF AN ENGINEERED MONOMERIC TRIOSEPHOSPHATE ISOMERASE, MONOTIM - THE CORRECT MODELING OF AN 8-RESIDUE LOOP. 1TPA ; 1.90 ; THE GEOMETRY OF THE REACTIVE SITE AND OF THE PEPTIDE GROUPS IN TRYPSIN, TRYPSINOGEN AND ITS COMPLEXES WITH INHIBITORS. 1TPO ; 1.70 ; THE GEOMETRY OF THE REACTIVE SITE AND OF THE PEPTIDE GROUPS IN TRYPSIN, TRYPSINOGEN AND ITS COMPLEXES WITH INHIBITORS. 1TPP ; 1.40 ; THE GEOMETRY OF THE REACTIVE SITE AND OF THE PEPTIDE GROUPS IN TRYPSIN, TRYPSINOGEN AND ITS COMPLEXES WITH INHIBITORS. 1LSA ; 1.70 ; THE INFLUENCE OF TEMPERATURE ON LYSOZYME CRYSTALS - STRUCTURE AND DYNAMICS OF PROTEIN AND WATER. 1LSB ; 1.70 ; THE INFLUENCE OF TEMPERATURE ON LYSOZYME CRYSTALS - STRUCTURE AND DYNAMICS OF PROTEIN AND WATER. 1LSC ; 1.70 ; THE INFLUENCE OF TEMPERATURE ON LYSOZYME CRYSTALS - STRUCTURE AND DYNAMICS OF PROTEIN AND WATER. 1LSD ; 1.70 ; THE INFLUENCE OF TEMPERATURE ON LYSOZYME CRYSTALS - STRUCTURE AND DYNAMICS OF PROTEIN AND WATER. 1LSE ; 1.70 ; THE INFLUENCE OF TEMPERATURE ON LYSOZYME CRYSTALS - STRUCTURE AND DYNAMICS OF PROTEIN AND WATER. 1LSF ; 1.70 ; THE INFLUENCE OF TEMPERATURE ON LYSOZYME CRYSTALS - STRUCTURE AND DYNAMICS OF PROTEIN AND WATER. 1OVB ; 2.30 ; THE MECHANISM OF IRON UPTAKE BY TRANSFERRINS - THE STRUCTURE OF AN 18 KDA NII-DOMAIN FRAGMENT FROM DUCK OVOTRANSFERRIN AT 2.3 ANGSTROM RESOLUTION. 1D67 ; 1.60 ; THE STRUCTURE OF AN IDARUBICIN-D(TGATCA) COMPLEX AT HIGH-RESOLUTION. 1TRR ; 2.40 ; Tandem binding in crystals of a trp repressor/operator half-site complex. 1CDL ; 2.20 ; Target enzyme recognition by calmodulin: 2.4 A structure of a calmodulin-peptide complex. 1D15 ; 1.50 ; Ternary interactions of spermine with DEOXYRIBONUCLEIC ACID: 4'-epiadriamycin and other DEOXYRIBONUCLEIC ACID: anthracycline complexes. 1GDD ; 2.20 ; Tertiary and quaternary structural changes in Gi alpha 1 induced by GTP hydrolysis. 4FXC ; 2.50 ; Tertiary structure of [2Fe-2S] ferredoxin from Spirulina platensis refined at 2.5 A resolution: structural comparisons of plant-type ferredoxins and an electrostatic potential analysis. 1TNM ; -1.00 ; Tertiary structure of an immunoglobulin-like domain from the giant muscle protein titin: a new member of the I set. 1TNN ; -1.00 ; Tertiary structure of an immunoglobulin-like domain from the giant muscle protein titin: a new member of the I set. 1ERA ; -1.00 ; Tertiary structure of erabutoxin b in aqueous solution as elucidated by two-dimensional nuclear magnetic resonance. 1FRA ; -1.00 ; Tertiary structure of erabutoxin b in aqueous solution as elucidated by two-dimensional nuclear magnetic resonance. 1KNT ; 1.60 ; The 1.6 A structure of Kunitz-type domain from the alpha 3 chain of human type VI collagen. 1PTF ; 1.60 ; The 1.6 A structure of histidine-containing phosphotransfer protein HPr from Streptococcus faecalis. 1GCA ; 1.70 ; The 1.7 A refined X-ray structure of the periplasmic glucose/galactose receptor from Salmonella typhimurium. 1CBM ; 1.80 ; The 1.8 A structure of carbonmonoxy-beta 4 hemoglobin. Analysis of a homotetramer with the R quaternary structure of liganded alpha 2 beta 2 hemoglobin. 1SGC ; 1.80 ; The 1.8 A structure of the complex between chymostatin and Streptomyces griseus protease A. A model for serine protease catalytic tetrahedral intermediates. 1CBL ; 1.90 ; The 1.9 A structure of deoxy beta 4 hemoglobin. Analysis of the partitioning of quaternary-associated and ligand-induced changes in tertiary structure. 1GCG ; 1.90 ; The 1.9 A x-ray structure of a closed unliganded form of the periplasmic glucose/galactose receptor from Salmonella typhimurium. 1RSM ; 2.00 ; The 2-A resolution structure of a thermostable ribonuclease A chemically cross-linked between lysine residues 7 and 41. 1CEW ; 2.00 ; The 2.0 A X-ray crystal structure of chicken egg white cystatin and its possible mode of interaction with cysteine proteinases. 1POH ; 2.00 ; The 2.0-A resolution structure of Escherichia coli histidine-containing phosphocarrier protein HPr. A redetermination. 1TND ; 2.20 ; The 2.2 A crystal structure of transducin-alpha complexed with GTP gamma S [see comments] 1NSB ; 2.20 ; The 2.2 A resolution crystal structure of influenza B neuraminidase and its complex with sialic acid. 1LPB ; 2.46 ; The 2.46 A resolution structure of the pancreatic lipase-colipase complex inhibited by a C11 alkyl phosphonate. 1PAF ; 2.50 ; The 2.5 A structure of pokeweed antiviral protein. 1PAG ; 2.80 ; The 2.5 A structure of pokeweed antiviral protein. 1LTD ; 2.60 ; The 2.6-A refined structure of the Escherichia coli recombinant Saccharomyces cerevisiae flavocytochrome b2-sulfite complex. 1PXT ; 2.80 ; The 2.8 A crystal structure of peroxisomal 3-ketoacyl-CoA thiolase of Saccharomyces cerevisiae: a five-layered alpha beta alpha beta alpha structure constructed from two core domains of identical topology. 1SER ; 2.90 ; The 2.9 A crystal structure of T. thermophilus seryl-tRNA synthetase complexed with tRNA(Ser). 1LTG ; 2.40 ; The Arg7Lys mutant of heat-labile enterotoxin exhibits great flexibility of active site loop 47-56 of the A subunit. 1CCA ; 1.80 ; The Asp-His-Fe triad of cytochrome c peroxidase controls the reduction potential, electronic structure, and coupling of the tryptophan free radical to the heme. 1CCB ; 2.10 ; The Asp-His-Fe triad of cytochrome c peroxidase controls the reduction potential, electronic structure, and coupling of the tryptophan free radical to the heme. 1CCC ; 2.00 ; The Asp-His-Fe triad of cytochrome c peroxidase controls the reduction potential, electronic structure, and coupling of the tryptophan free radical to the heme. 2PF2 ; 2.20 ; The Ca2+ ion and membrane binding structure of the Gla domain of Ca-prothrombin fragment 1. 1MLA ; 1.50 ; The Escherichia coli malonyl-CoA:acyl carrier protein transacylase at 1.5-A resolution. Crystal structure of a fatty acid synthase component. 1YSA ; 2.90 ; The GCN4 basic region leucine zipper binds DEOXYRIBONUCLEIC ACID as a dimer of uninterrupted alpha helices: crystal structure of the protein-DEOXYRIBONUCLEIC ACID complex. 1AHA ; 2.20 ; The N-glycosidase mechanism of ribosome-inactivating proteins implied by crystal structures of alpha-momorcharin. 1AHB ; 2.20 ; The N-glycosidase mechanism of ribosome-inactivating proteins implied by crystal structures of alpha-momorcharin. 1AHC ; 2.00 ; The N-glycosidase mechanism of ribosome-inactivating proteins implied by crystal structures of alpha-momorcharin. 7CAT ; 2.50 ; The NADPH binding site on beef liver catalase. 8CAT ; 2.50 ; The NADPH binding site on beef liver catalase. 1SHP ; -1.00 ; The NMR solution structure of a Kunitz-type proteinase inhibitor from the sea anemone Stichodactyla helianthus. 1ERC ; -1.00 ; The NMR solution structure of the pheromone Er-1 from the ciliated protozoan Euplotes raikovi. 1ERD ; -1.00 ; The NMR solution structure of the pheromone Er-2 from the ciliated protozoan Euplotes raikovi. 1PBA ; -1.00 ; The NMR structure of the activation domain isolated from porcine procarboxypeptidase B. 1SPF ; -1.00 ; The NMR structure of the pulmonary surfactant-associated polypeptide SP-C in an apolar solvent contains a valyl-rich alpha-helix. 7API ; 3.00 ; The S variant of human alpha 1-antitrypsin, structure and implications for function and metabolism. 8API ; 3.10 ; The S variant of human alpha 1-antitrypsin, structure and implications for function and metabolism. 9API ; 3.00 ; The S variant of human alpha 1-antitrypsin, structure and implications for function and metabolism. 1PRH ; 3.50 ; The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1. 1CWB ; 2.20 ; The X-ray structure of (MeBm2t)1-cyclosporin complexed with cyclophilin A provides an explanation for its anomalously high immunosuppressive activity. 1LFB ; 2.80 ; The X-ray structure of an atypical homeodomain present in the rat liver transcription factor LFB1/HNF1 and implications for DEOXYRIBONUCLEIC ACID binding. 1DGC ; 3.00 ; The X-ray structure of the GCN4-bZIP bound to ATF/CREB site DEOXYRIBONUCLEIC ACID shows the complex depends on DEOXYRIBONUCLEIC ACID flexibility. 1PPI ; 2.20 ; The active center of a mammalian alpha-amylase. Structure of the complex of a pancreatic alpha-amylase with a carbohydrate inhibitor refined to 2.2-A resolution. 1ER8 ; 2.00 ; The active site of aspartic proteinases. 3ER3 ; 2.00 ; The active site of aspartic proteinases. 3ER5 ; 1.80 ; The active site of aspartic proteinases. 4APE ; 2.10 ; The active site of aspartic proteinases. 4ER1 ; 2.00 ; The active site of aspartic proteinases. 4ER2 ; 2.00 ; The active site of aspartic proteinases. 1ASZ ; 3.00 ; The active site of yeast aspartyl-tRNA synthetase: structural and functional aspects of the aminoacylation reaction. 6TIM ; 2.20 ; The adaptability of the active site of trypanosomal triosephosphate isomerase as observed in the crystal structures of three different complexes. 1LIB ; 1.70 ; The adipocyte lipid-binding protein at 1.6-A resolution. Crystal structures of the apoprotein and with bound saturated and unsaturated fatty acids. 1LID ; 1.60 ; The adipocyte lipid-binding protein at 1.6-A resolution. Crystal structures of the apoprotein and with bound saturated and unsaturated fatty acids. 1LIF ; 1.60 ; The adipocyte lipid-binding protein at 1.6-A resolution. Crystal structures of the apoprotein and with bound saturated and unsaturated fatty acids. 1AGA ; 3.00 ; The agarose double helix and its function in agarose gel structure. 1PSD ; 2.75 ; The allosteric ligand site in the Vmax-type cooperative enzyme phosphoglycerate dehydrogenase. 9GPB ; 2.90 ; The allosteric transition of glycogen phosphorylase. 1STY ; 1.67 ; The alpha aneurism: a structural motif revealed in an insertion mutant of staphylococcal nuclease. 1HHG ; 2.60 ; The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2. 1HHH ; 3.00 ; The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2. 1HHI ; 2.50 ; The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2. 1HHJ ; 2.50 ; The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2. 1HHK ; 2.50 ; The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2. 1EST ; 2.50 ; The atomic structure of crystalline porcine pancreatic elastase at 2.5 A resolution: comparisons with the structure of alpha-chymotrypsin. 1HPB ; 2.50 ; The bacterial periplasmic histidine-binding protein. structure/function analysis of the ligand-binding site and comparison with related proteins. 3TMN ; 1.70 ; The binding of L-valyl-L-tryptophan to crystalline thermolysin illustrates the mode of interaction of a product of peptide hydrolysis. 1GDI ; 1.80 ; The binding of carbon monoxide and nitric oxide to leghaemoglobin in comparison with other haemoglobins. 1GDL ; 1.80 ; The binding of carbon monoxide and nitric oxide to leghaemoglobin in comparison with other haemoglobins. 4GR1 ; 2.40 ; The binding of the retro-analogue of glutathione disulfide to glutathione reductase. 2CAS ; 3.00 ; The canine parvovirus empty capsid structure. 1ANK ; 2.00 ; The closed conformation of a highly flexible protein: the structure of E. coli adenylate kinase with bound AMP and AMPPNP. 2PHH ; 2.70 ; The coenzyme analogue adenosine 5-diphosphoribose displaces FAD in the active site of p-hydroxybenzoate hydroxylase. An x-ray crystallographic investigation. 1PER ; 2.50 ; The complex between phage 434 repressor DEOXYRIBONUCLEIC ACID-binding domain and operator site OR3: structural differences between consensus and non-consensus half-sites. 1RGC ; 2.00 ; The complex between ribonuclease T1 and 3'GMP suggests geometry of enzymic reaction path. An X-ray study. 2TCT ; 2.10 ; The complex formed between Tet repressor and tetracycline-Mg2+ reveals mechanism of antibiotic resistance. 1SCL ; -1.00 ; The conformation of the sarcin/ricin loop from 28S ribosomal RIBONUCLEIC ACID. 1D81 ; 2.50 ; The conformational variability of an adenosine.inosine base-pair in a synthetic DEOXYRIBONUCLEIC ACID dodecamer. 2CNA ; 2.00 ; The covalent and three-dimensional structure of concanavalin A. IV. Atomic coordinates, hydrogen bonding, and quaternary structure. 2OVO ; 1.50 ; The crystal and molecular structure of the third domain of silver pheasant ovomucoid (OMSVP3). 1LKI ; 2.00 ; The crystal structure and biological function of leukemia inhibitory factor: implications for receptor binding. 167D ; 2.30 ; The crystal structure of C-C-A-T-T-A-A-T-G-G. Implications for bending of B-DEOXYRIBONUCLEIC ACID at T-A steps. 1RVE ; 2.50 ; The crystal structure of EcoRV endonuclease and of its complexes with cognate and non-cognate DEOXYRIBONUCLEIC ACID fragments. 4RVE ; 3.00 ; The crystal structure of EcoRV endonuclease and of its complexes with cognate and non-cognate DEOXYRIBONUCLEIC ACID fragments. 133D ; 1.80 ; The crystal structure of N4-methylcytosine.guanosine base-pairs in the synthetic hexanucleotide d(CGCGm4CG). 1CBG ; 2.15 ; The crystal structure of a cyanogenic beta-glucosidase from white clover, a family 1 glycosyl hydrolase. 1NSK ; 2.80 ; The crystal structure of a human nucleoside diphosphate kinase, NM23-H2. 1PHR ; 2.10 ; The crystal structure of a low-molecular-weight phosphotyrosine protein phosphatase. 1PPA ; 2.00 ; The crystal structure of a lysine 49 phospholipase A2 from the venom of the cottonmouth snake at 2.0-A resolution. 1LHM ; 1.80 ; The crystal structure of a mutant human lysozyme C77/95A with increased secretion efficiency in yeast. 1LLI ; 2.10 ; The crystal structure of a mutant protein with altered but improved hydrophobic core packing. 1ANX ; 2.50 ; The crystal structure of a new high-calcium form of annexin V. 2DRP ; 2.80 ; The crystal structure of a two zinc-finger peptide reveals an extension to the rules for zinc-finger/DEOXYRIBONUCLEIC ACID recognition. 1HUW ; 2.00 ; The crystal structure of affinity-matured human growth hormone at 2 A resolution. 1CSM ; 2.20 ; The crystal structure of allosteric chorismate mutase at 2.2-A resolution. 2ABX ; 2.50 ; The crystal structure of alpha-bungarotoxin at 2.5 A resolution: relation to solution structure and binding to acetylcholine receptor. 1BVP ; 2.60 ; The crystal structure of bluetongue virus VP7. 1CYC ; 2.30 ; The crystal structure of bonito (katsuo) ferrocytochrome c at 2.3 A resolution. II. Structure and function. 2ANA ; 2.50 ; The crystal structure of d(G-G-G-G-C-C-C-C). A model for poly(dG).poly(dC). 1DN6 ; 3.00 ; The crystal structure of d(GGATGGGAG): an essential part of the binding site for transcription factor IIIA. 1EFT ; 2.50 ; The crystal structure of elongation factor EF-Tu from Thermus aquaticus in the GTP conformation. 1EFG ; 2.70 ; The crystal structure of elongation factor G complexed with GDP, at 2.7 A resolution. 5EBX ; 2.00 ; The crystal structure of erabutoxin a at 2.0-A resolution. 1FBA ; 1.90 ; The crystal structure of fructose-1,6-bisphosphate aldolase from Drosophila melanogaster at 2.5 A resolution. 1CSK ; 2.50 ; The crystal structure of human CskSH3: structural diversity near the RT-Src and n-Src loop. 2HHB ; 1.74 ; The crystal structure of human deoxyhaemoglobin at 1.74 A resolution. 3HHB ; 1.74 ; The crystal structure of human deoxyhaemoglobin at 1.74 A resolution. 4HHB ; 1.74 ; The crystal structure of human deoxyhaemoglobin at 1.74 A resolution. 1HMP ; 2.50 ; The crystal structure of human hypoxanthine-guanine phosphoribosyltransferase with bound GMP. 1LIS ; 1.90 ; The crystal structure of lysin, a fertilization protein. 3PCY ; 1.90 ; The crystal structure of mercury-substituted poplar plastocyanin at 1.9-A resolution. 1PRT ; 2.90 ; The crystal structure of pertussis toxin. 2PCY ; 1.80 ; The crystal structure of poplar apoplastocyanin at 1.8-A resolution. The geometry of the copper-binding site is created by the polypeptide. 1NAP ; 1.90 ; The crystal structure of recombinant human neutrophil-activating peptide-2 (M6L) at 1.9-A resolution. 1RBB ; 2.50 ; The crystal structure of ribonuclease B at 2.5-A resolution. 1STN ; 1.70 ; The crystal structure of staphylococcal nuclease refined at 1.7 A resolution. 1SCU ; 2.50 ; The crystal structure of succinyl-CoA synthetase from Escherichia coli at 2.5-A resolution. 1ST3 ; 1.40 ; The crystal structure of the Bacillus lentus alkaline protease, subtilisin BL, at 1.4 A resolution. 1ABN ; 2.40 ; The crystal structure of the aldose reductase.NADPH binary complex. 1NSN ; 2.90 ; The crystal structure of the antibody N10-staphylococcal nuclease complex at 2.9 A resolution. 1GRL ; 2.80 ; The crystal structure of the bacterial chaperonin GroEL at 2.8 A. 1HCQ ; 2.40 ; The crystal structure of the estrogen receptor DEOXYRIBONUCLEIC ACID-binding domain bound to DEOXYRIBONUCLEIC ACID: how receptors discriminate between their response elements. 2HFT ; 1.69 ; The crystal structure of the extracellular domain of human tissue factor refined to 1.7 A resolution. 1OPR ; 2.30 ; The crystal structure of the orotate phosphoribosyltransferase complexed with orotate and alpha-D-5-phosphoribosyl-1-pyrophosphate. 1SNC ; 1.65 ; The crystal structure of the ternary complex of staphylococcal nuclease, Ca2+, and the inhibitor pdTp, refined at 1.65 A. 1DA3 ; 2.00 ; The crystal structure of the trigonal decamer C-G-A-T-C-G-6meA-T-C-G: a B-DEOXYRIBONUCLEIC ACID helix with 10.6 base-pairs per turn. 1TAH ; 3.00 ; The crystal structure of triacylglycerol lipase from Pseudomonas glumae reveals a partially redundant catalytic aspartate. 2KAU ; 2.00 ; The crystal structure of urease from Klebsiella aerogenes. 1HEF ; 2.20 ; The crystal structures at 2.2-A resolution of hydroxyethylene-based inhibitors bound to human immunodeficiency virus type 1 protease show that the inhibitors are present in two distinct orientations. 1HEG ; 2.20 ; The crystal structures at 2.2-A resolution of hydroxyethylene-based inhibitors bound to human immunodeficiency virus type 1 protease show that the inhibitors are present in two distinct orientations. 1RNE ; 2.40 ; The crystal structures of recombinant glycosylated human renin alone and in complex with a transition state analog inhibitor. 1PZA ; 1.80 ; The crystal structures of reduced pseudoazurin from Alcaligenes faecalis S-6 at two pH values. 1PZB ; 1.80 ; The crystal structures of reduced pseudoazurin from Alcaligenes faecalis S-6 at two pH values. 1HDR ; 2.50 ; The crystallographic structure of a human dihydropteridine reductase NADH binary complex expressed in Escherichia coli by a cDNA constructed from its rat homologue. 1IVP ; 2.50 ; The crystallographic structure of the protease from human immunodeficiency virus type 2 with two synthetic peptidic transition state analog inhibitors. 1IVQ ; 2.60 ; The crystallographic structure of the protease from human immunodeficiency virus type 2 with two synthetic peptidic transition state analog inhibitors. 1IVL ; 2.17 ; The de novo design of an antibody combining site. Crystallographic analysis of the VL domain confirms the structural model. 1SAN ; -1.00 ; The des(1-6)antennapedia homeodomain: comparison of the NMR solution structure and the DEOXYRIBONUCLEIC ACID-binding affinity with the intact Antennapedia homeodomain. 1ANW ; 2.50 ; The effect of metal binding on the structure of annexin V and implications for membrane binding. 232D ; 1.30 ; The high resolution crystal structure of the DEOXYRIBONUCLEIC ACID decamer d(AGGCATGCCT). 1CSE ; 1.20 ; The high-resolution X-ray crystal structure of the complex formed between subtilisin Carlsberg and eglin c, an elastase inhibitor from the leech Hirudo medicinalis. Structural analysis, subtilisin structure and interface geometry. 1AXN ; 1.78 ; The high-resolution crystal structure of human annexin III shows subtle differences with annexin V. 3PSG ; 1.65 ; The high-resolution crystal structure of porcine pepsinogen. 1HDN ; -1.00 ; The high-resolution structure of the histidine-containing phosphocarrier protein HPr from Escherichia coli determined by restrained molecular dynamics from nuclear magnetic resonance nuclear Overhauser effect data. 2PDD ; -1.00 ; The high-resolution structure of the peripheral subunit-binding domain of dihydrolipoamide acetyltransferase from the pyruvate dehydrogenase multienzyme complex of Bacillus stearothermophilus. 2PDE ; -1.00 ; The high-resolution structure of the peripheral subunit-binding domain of dihydrolipoamide acetyltransferase from the pyruvate dehydrogenase multienzyme complex of Bacillus stearothermophilus. 1TRS ; -1.00 ; The high-resolution three-dimensional solution structures of the oxidized and reduced states of human thioredoxin. 1TRU ; -1.00 ; The high-resolution three-dimensional solution structures of the oxidized and reduced states of human thioredoxin. 1TRV ; -1.00 ; The high-resolution three-dimensional solution structures of the oxidized and reduced states of human thioredoxin. 1TRW ; -1.00 ; The high-resolution three-dimensional solution structures of the oxidized and reduced states of human thioredoxin. 1ATH ; 3.20 ; The intact and cleaved human antithrombin III complex as a model for serpin-proteinase interactions. 1ERB ; 1.90 ; The interaction of N-ethyl retinamide with plasma retinol-binding protein (RBP) and the crystal structure of the retinoid-RBP complex at 1.9-A resolution. 1FPH ; 2.50 ; The interaction of thrombin with fibrinogen. A structural basis for its specificity. 1HAG ; 2.00 ; The isomorphous structures of prethrombin2, hirugen-, and PPACK-thrombin: changes accompanying activation and exosite binding to thrombin. 1HAH ; 2.30 ; The isomorphous structures of prethrombin2, hirugen-, and PPACK-thrombin: changes accompanying activation and exosite binding to thrombin. 1HAI ; 2.40 ; The isomorphous structures of prethrombin2, hirugen-, and PPACK-thrombin: changes accompanying activation and exosite binding to thrombin. 1HTP ; 2.20 ; The lipoamide arm in the glycine decarboxylase complex is not freely swinging. 131D ; 1.00 ; The low-temperature crystal structure of the pure-spermine form of Z-DEOXYRIBONUCLEIC ACID reveals binding of a spermine molecule in the minor groove. 1DOB ; 2.00 ; The mobile flavin of 4-OH benzoate hydroxylase. 1DOC ; 2.00 ; The mobile flavin of 4-OH benzoate hydroxylase. 1DOD ; 2.10 ; The mobile flavin of 4-OH benzoate hydroxylase. 1DOE ; 2.30 ; The mobile flavin of 4-OH benzoate hydroxylase. 1D58 ; 1.70 ; The molecular structure of a 4'-epiadriamycin complex with d(TGATCA) at 1.7A resolution: comparison with the structure of 4'-epiadriamycin d(TGTACA) and d(CGATCG) complexes. 1REI ; 2.00 ; The molecular structure of a dimer composed of the variable portions of the Bence-Jones protein REI refined at 2.0-A resolution. 1DNH ; 2.25 ; The molecular structure of the complex of Hoechst 33258 and the DEOXYRIBONUCLEIC ACID dodecamer d(CGCGAATTCGCG). 2HIP ; 2.50 ; The molecular structure of the high potential iron-sulfur protein isolated from Ectothiorhodospira halophila determined at 2.5-A resolution. 1DCG ; 1.00 ; The molecular structure of the left-handed Z-DEOXYRIBONUCLEIC ACID double helix at 1.0-A atomic resolution. Geometry, conformation, and ionic interactions of d(CGCGCG). 3FIS ; 2.30 ; The molecular structure of wild-type and a mutant Fis protein: relationship between mutational changes and recombinational enhancer function or DEOXYRIBONUCLEIC ACID binding. 4FIS ; 2.30 ; The molecular structure of wild-type and a mutant Fis protein: relationship between mutational changes and recombinational enhancer function or DEOXYRIBONUCLEIC ACID binding. 1COM ; 2.20 ; The monofunctional chorismate mutase from Bacillus subtilis. Structure determination of chorismate mutase and its complexes with a transition state analog and prephenate, and implications for the mechanism of the enzymatic reaction. 1LEM ; 3.00 ; The monosaccharide binding site of lentil lectin: an X-ray and molecular modelling study. 1CSA ; -1.00 ; The mutant Escherichia coli F112W cyclophilin binds cyclosporin A in nearly identical conformation as human cyclophilin. 1CMY ; 3.00 ; The mutation beta 99 Asp-Tyr stabilizes Y--a new, composite quaternary state of human hemoglobin. 1FVL ; -1.00 ; The nuclear magnetic resonance solution structure of flavoridin, an antagonist of the platelet GP IIb-IIIa receptor. 3CRO ; 2.50 ; The phage 434 Cro/OR1 complex at 2.5 A resolution. 1RPE ; 2.50 ; The phage 434 OR2/R1-69 complex at 2.5 A resolution. 5BNA ; 2.60 ; The primary mode of binding of cisplatin to a B-DEOXYRIBONUCLEIC ACID dodecamer: C-G-C-G-A-A-T-T-C-G-C-G. 1ARB ; 1.20 ; The primary structure and structural characteristics of Achromobacter lyticus protease I, a lysine-specific serine protease. 1ARC ; 2.00 ; The primary structure and structural characteristics of Achromobacter lyticus protease I, a lysine-specific serine protease. 1HRM ; 1.70 ; The proximal ligand variant His93Tyr of horse heart myoglobin. 1PPB ; 1.92 ; The refined 1.9 A crystal structure of human alpha-thrombin: interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment. 1PPE ; 2.00 ; The refined 2.0 A X-ray crystal structure of the complex formed between bovine beta-trypsin and CMTI-I, a trypsin inhibitor from squash seeds (Cucurbita maxima). Topological similarity of the squash seed inhibitors with the carboxypeptidase A inhibitor from potatoes. 1HUC ; 2.10 ; The refined 2.15 A X-ray crystal structure of human liver cathepsin B: the structural basis for its specificity. 1PPG ; 2.30 ; The refined 2.3 A crystal structure of human leukocyte elastase in a complex with a valine chloromethyl ketone inhibitor. 1STF ; 2.37 ; The refined 2.4 A X-ray crystal structure of recombinant human stefin B in complex with the cysteine proteinase papain: a novel type of proteinase inhibitor interaction. 1LVL ; 2.45 ; The refined crystal structure of Pseudomonas putida lipoamide dehydrogenase complexed with NAD+ at 2.45 A resolution. 1SRN ; 1.80 ; The refined crystal structure of a fully active semisynthetic ribonuclease at 1.8-A resolution. 2CTX ; 2.40 ; The refined crystal structure of alpha-cobratoxin from Naja naja siamensis at 2.4-A resolution. 2BAA ; 1.80 ; The refined crystal structure of an endochitinase from Hordeum vulgare L. seeds at 1.8 A resolution. 1PP2 ; 2.50 ; The refined crystal structure of dimeric phospholipase A2 at 2.5 A. Access to a shielded catalytic center. 1SBC ; 2.50 ; The refined crystal structure of subtilisin Carlsberg at 2.5 A resolution. 2MS2 ; 2.80 ; The refined structure of bacteriophage MS2 at 2.8 A resolution. 2PK4 ; 2.25 ; The refined structure of the epsilon-aminocaproic acid complex of human plasminogen kringle 4. 1GP1 ; 2.00 ; The refined structure of the selenoenzyme glutathione peroxidase at 0.2-nm resolution. 3ICB ; 2.30 ; The refined structure of vitamin D-dependent calcium-binding protein from bovine intestine. Molecular details, ion binding, and implications for the structure of other calcium-binding proteins. 1POW ; 2.50 ; The refined structures of a stabilized mutant and of wild-type pyruvate oxidase from Lactobacillus plantarum. 1POX ; 2.10 ; The refined structures of a stabilized mutant and of wild-type pyruvate oxidase from Lactobacillus plantarum. 153L ; 1.60 ; The refined structures of goose lysozyme and its complex with a bound trisaccharide show that the "goose-type" lysozymes lack a catalytic aspartate residue. 154L ; 1.60 ; The refined structures of goose lysozyme and its complex with a bound trisaccharide show that the "goose-type" lysozymes lack a catalytic aspartate residue. 2HSD ; 2.64 ; The refined three-dimensional structure of 3 alpha,20 beta-hydroxysteroid dehydrogenase and possible roles of the residues conserved in short-chain dehydrogenases. 2BBV ; 2.80 ; The refined three-dimensional structure of an insect virus at 2.8 A resolution. 5CHA ; 1.67 ; The refinement and the structure of the dimer of alpha-chymotrypsin at 1.67-A resolution. 1CRG ; 2.00 ; The role of a conserved internal water molecule and its associated hydrogen bond network in cytochrome c. 1CRH ; 1.90 ; The role of a conserved internal water molecule and its associated hydrogen bond network in cytochrome c. 1CRI ; 2.00 ; The role of a conserved internal water molecule and its associated hydrogen bond network in cytochrome c. 1CRJ ; 2.05 ; The role of a conserved internal water molecule and its associated hydrogen bond network in cytochrome c. 1CMT ; 2.10 ; The role of aspartate-235 in the binding of cations to an artificial cavity at the radical site of cytochrome c peroxidase. 1CMU ; 2.10 ; The role of aspartate-235 in the binding of cations to an artificial cavity at the radical site of cytochrome c peroxidase. 140L ; 2.10 ; The role of backbone flexibility in the accommodation of variants that repack the core of T4 lysozyme. 141L ; 2.00 ; The role of backbone flexibility in the accommodation of variants that repack the core of T4 lysozyme. 142L ; 2.00 ; The role of backbone flexibility in the accommodation of variants that repack the core of T4 lysozyme. 143L ; 2.00 ; The role of backbone flexibility in the accommodation of variants that repack the core of T4 lysozyme. 144L ; 2.10 ; The role of backbone flexibility in the accommodation of variants that repack the core of T4 lysozyme. 145L ; 2.00 ; The role of backbone flexibility in the accommodation of variants that repack the core of T4 lysozyme. 146L ; 1.85 ; The role of backbone flexibility in the accommodation of variants that repack the core of T4 lysozyme. 147L ; 2.00 ; The role of backbone flexibility in the accommodation of variants that repack the core of T4 lysozyme. 1MDR ; 2.10 ; The role of lysine 166 in the mechanism of mandelate racemase from Pseudomonas putida: mechanistic and crystallographic evidence for stereospecific alkylation by (R)-alpha-phenylglycidate. 1MNS ; 2.00 ; The role of lysine 166 in the mechanism of mandelate racemase from Pseudomonas putida: mechanistic and crystallographic evidence for stereospecific alkylation by (R)-alpha-phenylglycidate. 1TCA ; 1.55 ; The sequence, crystal structure determination and refinement of two crystal forms of lipase B from Candida antarctica. 1TCB ; 2.10 ; The sequence, crystal structure determination and refinement of two crystal forms of lipase B from Candida antarctica. 1TCC ; 2.50 ; The sequence, crystal structure determination and refinement of two crystal forms of lipase B from Candida antarctica. 1HUA ; -1.00 ; The solution conformation of hyaluronan: a combined NMR and molecular dynamics study. 1HMA ; -1.00 ; The solution structure and dynamics of the DEOXYRIBONUCLEIC ACID-binding domain of HMG-D from Drosophila melanogaster. 1DA4 ; -1.00 ; The solution structure of a DEOXYRIBONUCLEIC ACID duplex containing the cis-Pt(NH3)2[d(-GTG-)-N7(G),N7(G)] adduct, as determined with high-field NMR and molecular mechanics/dynamics. 1DA5 ; -1.00 ; The solution structure of a DEOXYRIBONUCLEIC ACID duplex containing the cis-Pt(NH3)2[d(-GTG-)-N7(G),N7(G)] adduct, as determined with high-field NMR and molecular mechanics/dynamics. 1ZTA ; -1.00 ; The solution structure of a leucine-zipper motif peptide. 1EGL ; -1.00 ; The solution structure of eglin c based on measurements of many NOEs and coupling constants and its comparison with X-ray structures. 2TGF ; -1.00 ; The solution structure of human transforming growth factor alpha. 3TGF ; -1.00 ; The solution structure of human transforming growth factor alpha. 1MGS ; -1.00 ; The solution structure of melanoma growth stimulating activity. 1AGG ; -1.00 ; The solution structure of omega-Aga-IVB, a P-type calcium channel antagonist from venom of the funnel web spider, Agelenopsis aperta. 1IRL ; -1.00 ; The solution structure of the F42A mutant of human interleukin 2. 1POU ; -1.00 ; The solution structure of the Oct-1 POU-specific domain reveals a striking similarity to the bacteriophage lambda repressor DEOXYRIBONUCLEIC ACID-binding domain. 1LYP ; -1.00 ; The solution structure of the active domain of CAP18--a lipopolysaccharide binding protein from rabbit leukocytes. 1HRA ; -1.00 ; The solution structure of the human retinoic acid receptor-beta DEOXYRIBONUCLEIC ACID- binding domain. 169D ; -1.00 ; The solution structure of the r(gcg)d(TATACCC):d(GGGTATACGC) Okazaki fragment contains two distinct duplex morphologies connected by a junction. 1BOC ; -1.00 ; The solution structures of mutant calbindin D9k's, as determined by NMR, show that the calcium-binding site can adopt different folds. 1BOD ; -1.00 ; The solution structures of mutant calbindin D9k's, as determined by NMR, show that the calcium-binding site can adopt different folds. 1BTQ ; -1.00 ; The solution structures of the first and second transmembrane-spanning segments of band 3. 1BTR ; -1.00 ; The solution structures of the first and second transmembrane-spanning segments of band 3. 1BTS ; -1.00 ; The solution structures of the first and second transmembrane-spanning segments of band 3. 1BTT ; -1.00 ; The solution structures of the first and second transmembrane-spanning segments of band 3. 1TPB ; 1.90 ; The structural basis for pseudoreversion of the E165D lesion by the secondary S96P mutation in triosephosphate isomerase depends on the positions of active site water molecules. 1TPC ; 1.90 ; The structural basis for pseudoreversion of the E165D lesion by the secondary S96P mutation in triosephosphate isomerase depends on the positions of active site water molecules. 1TPU ; 1.90 ; The structural basis for pseudoreversion of the H95N lesion by the secondary S96P mutation in triosephosphate isomerase. 1TPV ; 1.90 ; The structural basis for pseudoreversion of the H95N lesion by the secondary S96P mutation in triosephosphate isomerase. 5CPP ; 2.08 ; The structural basis for substrate-induced changes in redox potential and spin equilibrium in cytochrome P-450CAM. 7CPP ; 2.00 ; The structural basis for substrate-induced changes in redox potential and spin equilibrium in cytochrome P-450CAM. 1AAM ; 2.80 ; The structural basis for the altered substrate specificity of the R292D active site mutant of aspartate aminotransferase from E. coli. 1AAW ; 2.40 ; The structural basis for the altered substrate specificity of the R292D active site mutant of aspartate aminotransferase from E. coli. 1PTH ; 3.40 ; The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase. 1OLA ; 2.10 ; The structural basis of sequence-independent peptide binding by OppA protein. 1UDG ; 1.75 ; The structural basis of specific base-excision repair by uracil-DEOXYRIBONUCLEIC ACID glycosylase. 1UDH ; 1.75 ; The structural basis of specific base-excision repair by uracil-DEOXYRIBONUCLEIC ACID glycosylase. 1FMD ; 3.50 ; The structure and antigenicity of a type C foot-and-mouth disease virus. 1RAP ; 2.25 ; The structure and function of omega loop A replacements in cytochrome c. 1RAQ ; 1.90 ; The structure and function of omega loop A replacements in cytochrome c. 4INS ; 1.50 ; The structure of 2Zn pig insulin crystals at 1.5 A resolution. 2PGD ; 2.00 ; The structure of 6-phosphogluconate dehydrogenase refined at 2.5 A resolution. 1ASH ; 2.15 ; The structure of Ascaris hemoglobin domain I at 2.2 A resolution: molecular features of oxygen avidity. 1D23 ; 1.50 ; The structure of B-helical C-G-A-T-C-G-A-T-C-G and comparison with C-C-A-A-C-G-T-T-G-G. The effect of base pair reversals. 1RPR ; -1.00 ; The structure of ColE1 rop in solution. 1D30 ; 2.40 ; The structure of DAPI bound to DEOXYRIBONUCLEIC ACID. 1EHS ; -1.00 ; The structure of Escherichia coli heat-stable enterotoxin b by nuclear magnetic resonance and circular dichroism. 1FIP ; 1.90 ; The structure of Fis mutant Pro61Ala illustrates that the kink within the long alpha-helix is not due to the presence of the proline residue. 155C ; 2.50 ; The structure of Paracoccus denitrificans cytochrome c550. 1NDA ; 3.30 ; The structure of Trypanosoma cruzi trypanothione reductase in the oxidized and NADPH reduced state. 1TMR ; -1.00 ; The structure of a 19-residue fragment from the C-loop of the fourth epidermal growth factor-like domain of thrombomodulin. 1BCD ; 1.90 ; The structure of a complex between carbonic anhydrase II and a new inhibitor, trifluoromethane sulphonamide. 1NMB ; 2.50 ; The structure of a complex between the NC10 antibody and influenza virus neuraminidase and comparison with the overlapping binding site of the NC41 antibody. 1HRT ; 2.80 ; The structure of a complex of bovine alpha-thrombin and recombinant hirudin at 2.8-A resolution. 1TYL ; 1.90 ; The structure of a complex of hexameric insulin and 4'-hydroxyacetanilide. 1TYM ; 1.90 ; The structure of a complex of hexameric insulin and 4'-hydroxyacetanilide. 1HUT ; 2.90 ; The structure of alpha-thrombin inhibited by a 15-mer single-stranded DEOXYRIBONUCLEIC ACID aptamer. 1RNK ; -1.00 ; The structure of an RIBONUCLEIC ACID pseudoknot that causes efficient frameshifting in mouse mammary tumor virus. 1D98 ; 2.50 ; The structure of an oligo(dA).oligo(dT) tract and its biological implications. 1LBA ; 2.20 ; The structure of bacteriophage T7 lysozyme, a zinc amidase and an inhibitor of T7 RIBONUCLEIC ACID polymerase. 1NIA ; 2.50 ; The structure of copper-nitrite reductase from Achromobacter cycloclastes at five pH values, with NO2- bound and with type II copper depleted. 1NIB ; 2.70 ; The structure of copper-nitrite reductase from Achromobacter cycloclastes at five pH values, with NO2- bound and with type II copper depleted. 1NIC ; 1.90 ; The structure of copper-nitrite reductase from Achromobacter cycloclastes at five pH values, with NO2- bound and with type II copper depleted. 1NID ; 2.20 ; The structure of copper-nitrite reductase from Achromobacter cycloclastes at five pH values, with NO2- bound and with type II copper depleted. 1NIE ; 1.90 ; The structure of copper-nitrite reductase from Achromobacter cycloclastes at five pH values, with NO2- bound and with type II copper depleted. 1NIF ; 1.60 ; The structure of copper-nitrite reductase from Achromobacter cycloclastes at five pH values, with NO2- bound and with type II copper depleted. 2BTF ; 2.55 ; The structure of crystalline profilin-beta-actin. 1FCD ; 2.53 ; The structure of flavocytochrome c sulfide dehydrogenase from a purple phototrophic bacterium. 1RHG ; 2.20 ; The structure of granulocyte-colony-stimulating factor and its relationship to other growth factors. 113D ; 2.50 ; The structure of guanosine-thymidine mismatches in B-DEOXYRIBONUCLEIC ACID at 2.5-A resolution. 2MHB ; 2.00 ; The structure of horse methaemoglobin at 2-0 A resolution. 1RAY ; 1.80 ; The structure of human carbonic anhydrase II in complex with bromide and azide. 1RAZ ; 1.90 ; The structure of human carbonic anhydrase II in complex with bromide and azide. 1HCO ; 2.70 ; The structure of human carbonmonoxy haemoglobin at 2.7 A resolution. 2HCO ; 2.70 ; The structure of human carbonmonoxy haemoglobin at 2.7 A resolution. 1HNY ; 1.80 ; The structure of human pancreatic alpha-amylase at 1.8 A resolution and comparisons with related enzymes. 2MIB ; 2.84 ; The structure of murine interleukin-1 beta at 2.8 A resolution. 1NPC ; 2.00 ; The structure of neutral protease from Bacillus cereus at 0.2-nm resolution. 1OSU ; 1.40 ; The structure of r(UUCGCG) has a 5'-UU-overhang exhibiting Hoogsteen- like trans U.U base pairs. 3RP2 ; 1.90 ; The structure of rat mast cell protease II at 1.9-A resolution. 1PKR ; 2.48 ; The structure of recombinant plasminogen kringle 1 and the fibrin binding site. 1BBR ; 2.30 ; The structure of residues 7-16 of the A alpha-chain of human fibrinogen bound to bovine thrombin at 2.3-A resolution. 1PKP ; 2.80 ; The structure of ribosomal protein S5 reveals sites of interaction with 16S rRNA. 6RXN ; 1.50 ; The structure of rubredoxin from Desulfovibrio desulfuricans strain 27774 at 1.5 A resolution. 2BAT ; 2.00 ; The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor. 1TNF ; 2.60 ; The structure of tumor necrosis factor-alpha at 2.6 A resolution. Implications for receptor binding. 1HMV ; 3.20 ; The structure of unliganded reverse transcriptase from the human immunodeficiency virus type 1. 4ENL ; 1.90 ; The structure of yeast enolase at 2.25-A resolution. An 8-fold beta + alpha-barrel with a novel beta beta alpha alpha (beta alpha)6 topology. 1RPF ; 2.20 ; The structures of RNase A complexed with 3'-CMP and d(CpA): active site conformation and conserved water molecules. 1RPG ; 1.40 ; The structures of RNase A complexed with 3'-CMP and d(CpA): active site conformation and conserved water molecules. 1RPH ; 2.20 ; The structures of RNase A complexed with 3'-CMP and d(CpA): active site conformation and conserved water molecules. 2SIL ; 1.60 ; The structures of Salmonella typhimurium LT2 neuraminidase and its complexes with three inhibitors at high resolution. 2SIM ; 1.60 ; The structures of Salmonella typhimurium LT2 neuraminidase and its complexes with three inhibitors at high resolution. 1IGD ; 1.10 ; The third IgG-binding domain from streptococcal protein G. An analysis by X-ray crystallography of the structure alone and in a complex with Fab. 1CEL ; 1.81 ; The three-dimensional crystal structure of the catalytic core of cellobiohydrolase I from Trichoderma reesei. 1HRQ ; -1.00 ; The three-dimensional solution structure of the reduced high-potential iron-sulfur protein from Chromatium vinosum through NMR. 1HRR ; -1.00 ; The three-dimensional solution structure of the reduced high-potential iron-sulfur protein from Chromatium vinosum through NMR. 1PIH ; -1.00 ; The three-dimensional structure in solution of the paramagnetic high- potential iron-sulfur protein I from Ectothiorhodospira halophila through nuclear magnetic resonance. 1PIJ ; -1.00 ; The three-dimensional structure in solution of the paramagnetic high- potential iron-sulfur protein I from Ectothiorhodospira halophila through nuclear magnetic resonance. 1PBG ; 2.30 ; The three-dimensional structure of 6-phospho-beta-galactosidase from Lactococcus lactis. 1TRM ; 2.30 ; The three-dimensional structure of Asn102 mutant of trypsin: role of Asp102 in serine protease catalysis. 2TRM ; 2.80 ; The three-dimensional structure of Asn102 mutant of trypsin: role of Asp102 in serine protease catalysis. 1ST2 ; 2.00 ; The three-dimensional structure of Bacillus amyloliquefaciens subtilisin at 1.8 A and an analysis of the structural consequences of peroxide inactivation. 2ST1 ; 1.80 ; The three-dimensional structure of Bacillus amyloliquefaciens subtilisin at 1.8 A and an analysis of the structural consequences of peroxide inactivation. 1HOC ; 2.40 ; The three-dimensional structure of H-2Db at 2.4 A resolution: implications for antigen-determinant selection. 1HSA ; 2.10 ; The three-dimensional structure of HLA-B27 at 2.1 A resolution suggests a general mechanism for tight peptide binding to MHC. 1NAL ; 2.20 ; The three-dimensional structure of N-acetylneuraminate lyase from Escherichia coli. 1PGS ; 1.80 ; The three-dimensional structure of PNGase F, a glycosylasparaginase from Flavobacterium meningosepticum. 1TMC ; 2.30 ; The three-dimensional structure of a class I major histocompatibility complex molecule missing the alpha 3 domain of the heavy chain. 2SBL ; 2.60 ; The three-dimensional structure of an arachidonic acid 15-lipoxygenase. 1PLF ; 2.20 ; The three-dimensional structure of bovine platelet factor 4 at 3.0-A resolution. 1CAV ; 2.60 ; The three-dimensional structure of canavalin from jack bean (Canavalia ensiformis). 1RCK ; -1.00 ; The three-dimensional structure of guanine-specific ribonuclease F1 in solution determined by NMR spectroscopy and distance geometry. 1RCL ; -1.00 ; The three-dimensional structure of guanine-specific ribonuclease F1 in solution determined by NMR spectroscopy and distance geometry. 1CMS ; 2.30 ; The three-dimensional structure of recombinant bovine chymosin at 2.3 A resolution. 1HHP ; 2.70 ; The three-dimensional structure of the aspartyl protease from the HIV-1 isolate BRU. 1IXA ; -1.00 ; The three-dimensional structure of the first EGF-like module of human factor IX: comparison with EGF and TGF-alpha. 1WAS ; 2.70 ; The three-dimensional structure of the ligand-binding domain of a wild-type bacterial chemotaxis receptor. Structural comparison to the cross-linked mutant forms and conformational changes upon ligand binding. 1WAT ; 3.00 ; The three-dimensional structure of the ligand-binding domain of a wild-type bacterial chemotaxis receptor. Structural comparison to the cross-linked mutant forms and conformational changes upon ligand binding. 1PHS ; 3.00 ; The three-dimensional structure of the seed storage protein phaseolin at 3 A resolution. 1TTF ; -1.00 ; The three-dimensional structure of the tenth type III module of fibronectin: an insight into RGD-mediated interactions. 1TTG ; -1.00 ; The three-dimensional structure of the tenth type III module of fibronectin: an insight into RGD-mediated interactions. 103D ; -1.00 ; The unusual structure of the human centromere (GGA)2 motif. Unpaired guanosine residues stacked between sheared G.A pairs. 4RHV ; 3.00 ; The use of molecular-replacement phases for the refinement of the human rhinovirus 14 structure. 1TTA ; 1.70 ; The x-ray crystal structure refinements of normal human transthyretin and the amyloidogenic Val-30-->Met variant to 1.7-A resolution. 1TTB ; 1.70 ; The x-ray crystal structure refinements of normal human transthyretin and the amyloidogenic Val-30-->Met variant to 1.7-A resolution. 1TTC ; 1.70 ; The x-ray crystal structure refinements of normal human transthyretin and the amyloidogenic Val-30-->Met variant to 1.7-A resolution. 1LSM ; 1.70 ; Thermal stability determinants of chicken egg-white lysozyme core mutants: hydrophobicity, packing volume, and conserved buried water molecules. 1LSN ; 1.90 ; Thermal stability determinants of chicken egg-white lysozyme core mutants: hydrophobicity, packing volume, and conserved buried water molecules. 195L ; 1.90 ; Thermodynamic and structural compensation in "size-switch" core repacking variants of bacteriophage T4 lysozyme. 196L ; 2.30 ; Thermodynamic and structural compensation in "size-switch" core repacking variants of bacteriophage T4 lysozyme. 197L ; 2.10 ; Thermodynamic and structural compensation in "size-switch" core repacking variants of bacteriophage T4 lysozyme. 198L ; 1.85 ; Thermodynamic and structural compensation in "size-switch" core repacking variants of bacteriophage T4 lysozyme. 199L ; 2.00 ; Thermodynamic and structural compensation in "size-switch" core repacking variants of bacteriophage T4 lysozyme. 200L ; 1.95 ; Thermodynamic and structural compensation in "size-switch" core repacking variants of bacteriophage T4 lysozyme. 2RLN ; 1.85 ; Thermodynamic and structural consequences of changing a sulfur atom to a methylene group in the M13Nle mutation in ribonuclease-S. 1YTC ; 1.80 ; Thermodynamic cycles as probes of structure in unfolded proteins. 1XNC ; 1.60 ; Thermostabilization of the Bacillus circulans xylanase by the introduction of disulfide bonds. 2DHB ; 2.80 ; Three dimensional fourier synthesis of horse deoxyhaemoglobin at 2.8 Angstrom units resolution. 1TTI ; 2.40 ; Three new crystal structures of point mutation variants of monoTIM: conformational flexibility of loop-1, loop-4 and loop-8. 1TTJ ; 2.40 ; Three new crystal structures of point mutation variants of monoTIM: conformational flexibility of loop-1, loop-4 and loop-8. 1IFA ; 2.60 ; Three-dimensional crystal structure of recombinant murine interferon-beta. 264D ; 2.40 ; Three-dimensional crystal structure of the A-tract DEOXYRIBONUCLEIC ACID dodecamer d(CGCAAATTTGCG) complexed with the minor-groove-binding drug Hoechst 33258. 1CMB ; 1.80 ; Three-dimensional crystal structures of Escherichia coli met repressor with and without corepressor. 1CMC ; 1.80 ; Three-dimensional crystal structures of Escherichia coli met repressor with and without corepressor. 1COP ; -1.00 ; Three-dimensional dimer structure of the lambda-Cro repressor in solution as determined by heteronuclear multidimensional NMR. 1EPH ; -1.00 ; Three-dimensional nuclear magnetic resonance structures of mouse epidermal growth factor in acidic and physiological pH solutions. 1EPI ; -1.00 ; Three-dimensional nuclear magnetic resonance structures of mouse epidermal growth factor in acidic and physiological pH solutions. 1EPJ ; -1.00 ; Three-dimensional nuclear magnetic resonance structures of mouse epidermal growth factor in acidic and physiological pH solutions. 1BTA ; -1.00 ; Three-dimensional solution structure and 13C assignments of barstar using nuclear magnetic resonance spectroscopy. 1BTB ; -1.00 ; Three-dimensional solution structure and 13C assignments of barstar using nuclear magnetic resonance spectroscopy. 2PRF ; -1.00 ; Three-dimensional solution structure of Acanthamoeba profilin-I. 1CB1 ; -1.00 ; Three-dimensional solution structure of Ca(2+)-loaded porcine calbindin D9k determined by nuclear magnetic resonance spectroscopy. 1DMC ; -1.00 ; Three-dimensional solution structure of Callinectes sapidus metallothionein-1 determined by homonuclear and heteronuclear magnetic resonance spectroscopy. 1DMD ; -1.00 ; Three-dimensional solution structure of Callinectes sapidus metallothionein-1 determined by homonuclear and heteronuclear magnetic resonance spectroscopy. 1DME ; -1.00 ; Three-dimensional solution structure of Callinectes sapidus metallothionein-1 determined by homonuclear and heteronuclear magnetic resonance spectroscopy. 1DMF ; -1.00 ; Three-dimensional solution structure of Callinectes sapidus metallothionein-1 determined by homonuclear and heteronuclear magnetic resonance spectroscopy. 1TIN ; -1.00 ; Three-dimensional solution structure of Cucurbita maxima trypsin inhibitor-V determined by NMR spectroscopy. 1CLH ; -1.00 ; Three-dimensional solution structure of Escherichia coli periplasmic cyclophilin. 1PSE ; -1.00 ; Three-dimensional solution structure of PsaE from the cyanobacterium Synechococcus sp. strain PCC 7002, a photosystem I protein that shows structural homology with SH3 domains. 1PSF ; -1.00 ; Three-dimensional solution structure of PsaE from the cyanobacterium Synechococcus sp. strain PCC 7002, a photosystem I protein that shows structural homology with SH3 domains. 1NEA ; -1.00 ; Three-dimensional solution structure of a curaremimetic toxin from Naja nigricollis venom: a proton NMR and molecular modeling study. 1ZNF ; -1.00 ; Three-dimensional solution structure of a single zinc finger DEOXYRIBONUCLEIC ACID-binding domain. 1MHI ; -1.00 ; Three-dimensional solution structure of an insulin dimer. A study of the B9(Asp) mutant of human insulin using nuclear magnetic resonance, distance geometry and restrained molecular dynamics. 1BOM ; -1.00 ; Three-dimensional solution structure of bombyxin-II an insulin-like peptide of the silkmoth Bombyx mori: structural comparison with insulin and relaxin. 1BON ; -1.00 ; Three-dimensional solution structure of bombyxin-II an insulin-like peptide of the silkmoth Bombyx mori: structural comparison with insulin and relaxin. 1BBN ; -1.00 ; Three-dimensional solution structure of human interleukin-4 by multidimensional heteronuclear magnetic resonance spectroscopy. 1BCN ; -1.00 ; Three-dimensional solution structure of human interleukin-4 by multidimensional heteronuclear magnetic resonance spectroscopy. 1BAL ; -1.00 ; Three-dimensional solution structure of the E3-binding domain of the dihydrolipoamide succinyltransferase core from the 2-oxoglutarate dehydrogenase multienzyme complex of Escherichia coli. 1BBL ; -1.00 ; Three-dimensional solution structure of the E3-binding domain of the dihydrolipoamide succinyltransferase core from the 2-oxoglutarate dehydrogenase multienzyme complex of Escherichia coli. 1ERG ; -1.00 ; Three-dimensional solution structure of the extracellular region of the complement regulatory protein CD59, a new cell-surface protein domain related to snake venom neurotoxins. 1ERH ; -1.00 ; Three-dimensional solution structure of the extracellular region of the complement regulatory protein CD59, a new cell-surface protein domain related to snake venom neurotoxins. 1AB2 ; -1.00 ; Three-dimensional solution structure of the src homology 2 domain of c-abl. 148D ; -1.00 ; Three-dimensional solution structure of the thrombin-binding DEOXYRIBONUCLEIC ACID aptamer d(GGTTGGTGTGGTTGG). 1BW3 ; -1.00 ; Three-dimensional structure in solution of barwin, a protein from barley seed. 1BW4 ; -1.00 ; Three-dimensional structure in solution of barwin, a protein from barley seed. 1ANS ; -1.00 ; Three-dimensional structure in solution of neurotoxin III from the sea anemone Anemonia sulcata. 1BHA ; -1.00 ; Three-dimensional structure of (1-71)bacterioopsin solubilized in methanol/chloroform and SDS micelles determined by 15N-1H heteronuclear NMR spectroscopy. 1BHB ; -1.00 ; Three-dimensional structure of (1-71)bacterioopsin solubilized in methanol/chloroform and SDS micelles determined by 15N-1H heteronuclear NMR spectroscopy. 2CHY ; 2.70 ; Three-dimensional structure of CheY, the response regulator of bacterial chemotaxis. 1SRD ; 2.00 ; Three-dimensional structure of Cu,Zn-superoxide dismutase from spinach at 2.0 A resolution. 1RN1 ; 1.84 ; Three-dimensional structure of Gln25-ribonuclease T1 at 1.84-A resolution: structural variations at the base recognition and catalytic sites. 1GNE ; 2.50 ; Three-dimensional structure of Schistosoma japonicum glutathione S-transferase fused with a six-amino acid conserved neutralizing epitope of gp41 from HIV. 1TMF ; 3.50 ; Three-dimensional structure of Theiler murine encephalomyelitis virus (BeAn strain). 1TME ; 2.80 ; Three-dimensional structure of Theiler virus. 1XSO ; 1.49 ; Three-dimensional structure of Xenopus laevis Cu,Zn superoxide dismutase b determined by X-ray crystallography at 1.5 angstrom resolution. 1HCC ; -1.00 ; Three-dimensional structure of a complement control protein module in solution. 1LDL ; -1.00 ; Three-dimensional structure of a cysteine-rich repeat from the low-density lipoprotein receptor. 4FAB ; 2.70 ; Three-dimensional structure of a fluorescein-Fab complex crystallized in 2-methyl-2,4-pentanediol. 1JHL ; 2.40 ; Three-dimensional structure of a heteroclitic antigen-antibody cross-reaction complex. 1IPD ; 2.20 ; Three-dimensional structure of a highly thermostable enzyme, 3-isopropylmalate dehydrogenase of Thermus thermophilus at 2.2 A resolution. 1MCO ; 3.20 ; Three-dimensional structure of a human immunoglobulin with a hinge deletion. 1MCW ; 3.50 ; Three-dimensional structure of a hybrid light chain dimer: protein engineering of a binding cavity. 2MCG ; 2.00 ; Three-dimensional structure of a light chain dimer crystallized in water. Conformational flexibility of a molecule in two crystal forms. 3MCG ; 2.00 ; Three-dimensional structure of a light chain dimer crystallized in water. Conformational flexibility of a molecule in two crystal forms. 2CLR ; 2.00 ; Three-dimensional structure of a peptide extending from one end of a class I MHC binding site. 1HPT ; 2.30 ; Three-dimensional structure of a recombinant variant of human pancreatic secretory trypsin inhibitor (Kazal type). 1SIV ; 2.50 ; Three-dimensional structure of a simian immunodeficiency virus protease/inhibitor complex. Implications for the design of human immunodeficiency virus type 1 and 2 protease inhibitors. 1GGT ; 2.65 ; Three-dimensional structure of a transglutaminase: human blood coagulation factor XIII. 1APS ; -1.00 ; Three-dimensional structure of acylphosphatase. Refinement and structure analysis. 1IGM ; 2.30 ; Three-dimensional structure of an Fv from a human IgM immunoglobulin. 1DBA ; 2.80 ; Three-dimensional structure of an anti-steroid Fab' and progesterone-Fab' complex. 1DBB ; 2.70 ; Three-dimensional structure of an anti-steroid Fab' and progesterone-Fab' complex. 2HVP ; 3.00 ; Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1. 1BRL ; 2.40 ; Three-dimensional structure of bacterial luciferase from Vibrio harveyi at 2.4 A resolution. 1BUC ; 2.50 ; Three-dimensional structure of butyryl-CoA dehydrogenase from Megasphaera elsdenii. 4CAT ; 3.00 ; Three-dimensional structure of catalase from Penicillium vitale at 2.0 A resolution. 3CBH ; 2.00 ; Three-dimensional structure of cellobiohydrolase II from Trichoderma reesei. 1CYE ; -1.00 ; Three-dimensional structure of chemotactic Che Y protein in aqueous solution by nuclear magnetic resonance methods. 2GMT ; 1.80 ; Three-dimensional structure of chymotrypsin inactivated with (2S)-N-acetyl-L-alanyl-L-phenylalanyl alpha-chloroethane: implications for the mechanism of inactivation of serine proteases by chloroketones. 1GSS ; 2.80 ; Three-dimensional structure of class pi glutathione S-transferase from human placenta in complex with S-hexylglutathione at 2.8 A resolution. 1YMC ; 2.00 ; Three-dimensional structure of cyanomet-sulfmyoglobin C. 3ANA ; 2.50 ; Three-dimensional structure of d(GGGATCCC) in the crystalline state. 1HMC ; 2.50 ; Three-dimensional structure of dimeric human recombinant macrophage colony-stimulating factor. 2MHU ; -1.00 ; Three-dimensional structure of human [113Cd7]metallothionein-2 in solution determined by nuclear magnetic resonance spectroscopy. 2FGF ; 1.77 ; Three-dimensional structure of human basic fibroblast growth factor, a structural homolog of interleukin 1 beta. 1NNA ; 2.50 ; Three-dimensional structure of influenza A N9 neuraminidase and its complex with the inhibitor 2-deoxy 2,3-dehydro-N-acetyl neuraminic acid. 1NNB ; 2.80 ; Three-dimensional structure of influenza A N9 neuraminidase and its complex with the inhibitor 2-deoxy 2,3-dehydro-N-acetyl neuraminic acid. 1IL8 ; -1.00 ; Three-dimensional structure of interleukin 8 in solution. 2IL8 ; -1.00 ; Three-dimensional structure of interleukin 8 in solution. 7ADH ; 3.20 ; Three-dimensional structure of isonicotinimidylated liver alcohol dehydrogenase. 1LPF ; 2.80 ; Three-dimensional structure of lipoamide dehydrogenase from Pseudomonas fluorescens at 2.8 A resolution. Analysis of redox and thermostability properties. 6FAB ; 1.90 ; Three-dimensional structure of murine anti-p-azophenylarsonate Fab 36- 71. 1. X-ray crystallography, site-directed mutagenesis, and modeling of the complex with hapten. 8FAB ; 1.80 ; Three-dimensional structure of murine anti-p-azophenylarsonate Fab 36- 71. 1. X-ray crystallography, site-directed mutagenesis, and modeling of the complex with hapten. 121P ; 1.54 ; Three-dimensional structure of p21 in the active conformation and analysis of an oncogenic mutant. 1PTA ; 2.10 ; Three-dimensional structure of phosphotriesterase: an enzyme capable of detoxifying organophosphate nerve agents. 1C5A ; -1.00 ; Three-dimensional structure of porcine C5adesArg from 1H nuclear magnetic resonance data. 1PCA ; 2.00 ; Three-dimensional structure of porcine pancreatic procarboxypeptidase A. A comparison of the A and B zymogens and their determinants for inhibition and activation. 1BCT ; -1.00 ; Three-dimensional structure of proteolytic fragment 163-231 of bacterioopsin determined from nuclear magnetic resonance data in solution. 1MRB ; -1.00 ; Three-dimensional structure of rabbit liver [Cd7]metallothionein-2a in aqueous solution determined by nuclear magnetic resonance. 2MRB ; -1.00 ; Three-dimensional structure of rabbit liver [Cd7]metallothionein-2a in aqueous solution determined by nuclear magnetic resonance. 1RPA ; 3.00 ; Three-dimensional structure of rat acid phosphatase in complex with L(+)-tartrate. 1RAL ; 3.00 ; Three-dimensional structure of rat liver 3 alpha- hydroxysteroid/dihydrodiol dehydrogenase: a member of the aldo-keto reductase superfamily. 1CSG ; 2.70 ; Three-dimensional structure of recombinant human granulocyte-macrophage colony-stimulating factor. 1HIG ; 3.50 ; Three-dimensional structure of recombinant human interferon-gamma. 2HMB ; 2.10 ; Three-dimensional structure of recombinant human muscle fatty acid-binding protein. 1REC ; 1.90 ; Three-dimensional structure of recoverin, a calcium sensor in vision. 2RNT ; 1.80 ; Three-dimensional structure of ribonuclease T1 complexed with guanylyl-2',5'-guanosine at 1.8 A resolution. 1BTC ; 2.00 ; Three-dimensional structure of soybean beta-amylase determined at 3.0 A resolution: preliminary chain tracing of the complex with alpha-cyclodextrin. 1BBI ; -1.00 ; Three-dimensional structure of soybean trypsin/chymotrypsin Bowman-Birk inhibitor in solution. 2BBI ; -1.00 ; Three-dimensional structure of soybean trypsin/chymotrypsin Bowman-Birk inhibitor in solution. 1CTX ; 2.80 ; Three-dimensional structure of the "long" neurotoxin from cobra venom. 3HSC ; 1.90 ; Three-dimensional structure of the ATPase fragment of a 70K heat-shock cognate protein. 1F3G ; 2.10 ; Three-dimensional structure of the Escherichia coli phosphocarrier protein IIIglc. 1BBD ; 2.80 ; Three-dimensional structure of the Fab fragment of a neutralizing antibody to human rhinovirus serotype 2. 1LPE ; 2.25 ; Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E. 1DRS ; -1.00 ; Three-dimensional structure of the RGD-containing neurotoxin homologue dendroaspin. 1KAP ; 1.64 ; Three-dimensional structure of the alkaline protease of Pseudomonas aeruginosa: a two-domain protein with a calcium binding parallel beta roll motif. 1APO ; -1.00 ; Three-dimensional structure of the apo form of the N-terminal EGF-like module of blood coagulation factor X as determined by NMR spectroscopy and simulated folding. 2POL ; 2.50 ; Three-dimensional structure of the beta subunit of E. coli DEOXYRIBONUCLEIC ACID polymerase III holoenzyme: a sliding DEOXYRIBONUCLEIC ACID clamp. 1PII ; 2.00 ; Three-dimensional structure of the bifunctional enzyme phosphoribosylanthranilate isomerase: indoleglycerolphosphate synthase from Escherichia coli refined at 2.0 A resolution. 1BNC ; 2.40 ; Three-dimensional structure of the biotin carboxylase subunit of acetyl-CoA carboxylase. 1ACA ; -1.00 ; Three-dimensional structure of the complex between acyl-coenzyme A binding protein and palmitoyl-coenzyme A. 1TGS ; 1.80 ; Three-dimensional structure of the complex between pancreatic secretory trypsin inhibitor (Kazal type) and trypsinogen at 1.8 A resolution. Structure solution, crystallographic refinement and preliminary structural interpretation. 1CGI ; 2.30 ; Three-dimensional structure of the complexes between bovine chymotrypsinogen A and two recombinant variants of human pancreatic secretory trypsin inhibitor (Kazal-type). 1CGJ ; 2.30 ; Three-dimensional structure of the complexes between bovine chymotrypsinogen A and two recombinant variants of human pancreatic secretory trypsin inhibitor (Kazal-type). 1EZM ; 1.50 ; Three-dimensional structure of the elastase of Pseudomonas aeruginosa at 1.5-A resolution. 1GLV ; 2.70 ; Three-dimensional structure of the glutathione synthetase from Escherichia coli B at 2.0 A resolution. 1LAB ; -1.00 ; Three-dimensional structure of the lipoyl domain from Bacillus stearothermophilus pyruvate dehydrogenase multienzyme complex. 1LAC ; -1.00 ; Three-dimensional structure of the lipoyl domain from Bacillus stearothermophilus pyruvate dehydrogenase multienzyme complex. 1FTP ; 2.20 ; Three-dimensional structure of the muscle fatty-acid-binding protein isolated from the desert locust Schistocerca gregaria. 1NN2 ; 2.20 ; Three-dimensional structure of the neuraminidase of influenza virus A/Tokyo/3/67 at 2.2 A resolution. 1ATX ; -1.00 ; Three-dimensional structure of the neurotoxin ATX Ia from Anemonia sulcata in aqueous solution determined by nuclear magnetic resonance spectroscopy. 1LSG ; 2.40 ; Three-dimensional structure of the platelet integrin recognition segment of the fibrinogen gamma chain obtained by carrier protein-driven crystallization. 1AVD ; 2.70 ; Three-dimensional structure of the tetragonal crystal form of egg-white avidin in its functional complex with biotin at 2.7 A resolution. 1TPT ; 2.80 ; Three-dimensional structure of thymidine phosphorylase from Escherichia coli at 2.8 A resolution. 1FAI ; 2.70 ; Three-dimensional structure of two crystal forms of FabR19.9 from a monoclonal anti-arsonate antibody. 1TPL ; 2.30 ; Three-dimensional structure of tyrosine phenol-lyase. 1GSQ ; 2.40 ; Three-dimensional structure, catalytic properties, and evolution of a sigma class glutathione transferase from squid, a progenitor of the lens S-crystallins of cephalopods. 1AGP ; 2.30 ; Three-dimensional structures and properties of a transforming and a nontransforming glycine-12 mutant of p21H-ras. 821P ; 1.50 ; Three-dimensional structures and properties of a transforming and a nontransforming glycine-12 mutant of p21H-ras. 221P ; 2.30 ; Three-dimensional structures of H-ras p21 mutants: molecular basis for their inability to function as signal switch molecules. 421P ; 2.20 ; Three-dimensional structures of H-ras p21 mutants: molecular basis for their inability to function as signal switch molecules. 521P ; 2.60 ; Three-dimensional structures of H-ras p21 mutants: molecular basis for their inability to function as signal switch molecules. 621P ; 2.40 ; Three-dimensional structures of H-ras p21 mutants: molecular basis for their inability to function as signal switch molecules. 721P ; 2.00 ; Three-dimensional structures of H-ras p21 mutants: molecular basis for their inability to function as signal switch molecules. 1BAR ; 2.70 ; Three-dimensional structures of acidic and basic fibroblast growth factors. 1BAS ; 1.90 ; Three-dimensional structures of acidic and basic fibroblast growth factors. 2AVI ; 3.00 ; Three-dimensional structures of avidin and the avidin-biotin complex. 1D31 ; 2.60 ; Three-dimensional structures of bulge-containing DEOXYRIBONUCLEIC ACID fragments. 1LOA ; 2.20 ; Three-dimensional structures of complexes of Lathyrus ochrus isolectin I with glucose and mannose: fine specificity of the monosaccharide-binding site. 1LOB ; 2.00 ; Three-dimensional structures of complexes of Lathyrus ochrus isolectin I with glucose and mannose: fine specificity of the monosaccharide-binding site. 1RMU ; 3.00 ; Three-dimensional structures of drug-resistant mutants of human rhinovirus 14. 2RMU ; 3.00 ; Three-dimensional structures of drug-resistant mutants of human rhinovirus 14. 1LIH ; 2.20 ; Three-dimensional structures of the ligand-binding domain of the bacterial aspartate receptor with and without a ligand. 2LIG ; 2.00 ; Three-dimensional structures of the ligand-binding domain of the bacterial aspartate receptor with and without a ligand. 1LST ; 1.80 ; Three-dimensional structures of the periplasmic lysine/arginine/ornithine-binding protein with and without a ligand. 2LAO ; 1.90 ; Three-dimensional structures of the periplasmic lysine/arginine/ornithine-binding protein with and without a ligand. 1GHR ; 2.20 ; Three-dimensional structures of two plant beta-glucan endohydrolases with distinct substrate specificities. 1GHS ; 2.30 ; Three-dimensional structures of two plant beta-glucan endohydrolases with distinct substrate specificities. 1ATR ; 2.34 ; Threonine 204 of the chaperone protein Hsc70 influences the structure of the active site, but is not essential for ATP hydrolysis. 1ATS ; 2.43 ; Threonine 204 of the chaperone protein Hsc70 influences the structure of the active site, but is not essential for ATP hydrolysis. 1EGT ; -1.00 ; Thrombin-bound structure of an EGF subdomain from human thrombomodulin determined by transferred nuclear Overhauser effects. 1L76 ; 1.90 ; Tolerance of T4 lysozyme to proline substitutions within the long interdomain alpha-helix illustrates the adaptability of proteins to potentially destabilizing lesions. 1L36 ; 1.70 ; Toward a simplification of the protein folding problem: a stabilizing polyalanine alpha-helix engineered in T4 lysozyme. 1GAR ; 1.96 ; Towards structure-based drug design: crystal structure of a multisubstrate adduct complex of glycinamide ribonucleotide transformylase at 1.96 A resolution. 1SYB ; 1.80 ; Transfer of a beta-turn structure to a new protein context. 1CTT ; 2.20 ; Transition-state selectivity for a single hydroxyl group during catalysis by cytidine deaminase. 1CTU ; 2.30 ; Transition-state selectivity for a single hydroxyl group during catalysis by cytidine deaminase. 1TVS ; -1.00 ; Trifluoroethanol stabilizes a helix-turn-helix motif in equine infectious-anemia-virus trans-activator protein. 1RTM ; 1.80 ; Trimeric structure of a C-type mannose-binding protein. 2TMA ; 15.00 ; Tropomyosin crystal structure and muscle regulation. 1PRL ; -1.00 ; Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3-ligand interactions. 1PRM ; -1.00 ; Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3-ligand interactions. 1RLP ; -1.00 ; Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3-ligand interactions. 1RLQ ; -1.00 ; Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3-ligand interactions. 1TRH ; 2.10 ; Two conformational states of Candida rugosa lipase. 1MOL ; 1.70 ; Two crystal structures of a potently sweet protein. Natural monellin at 2.75 A resolution and single-chain monellin at 1.7 A resolution. 1PGA ; 2.07 ; Two crystal structures of the B1 immunoglobulin-binding domain of streptococcal protein G and comparison with NMR. 1PGB ; 1.92 ; Two crystal structures of the B1 immunoglobulin-binding domain of streptococcal protein G and comparison with NMR. 1HIP ; 2.00 ; Two-Angstrom crystal structure of oxidized Chromatium high potential iron protein. 1NOR ; -1.00 ; Two-dimensional 1H-NMR study of the spatial structure of neurotoxin II from Naja naja oxiana. 2ACU ; 1.76 ; Tyrosine-48 is the proton donor and histidine-110 directs substrate stereochemical selectivity in the reduction reaction of human aldose reductase: enzyme kinetics and crystal structure of the Y48H mutant enzyme. 1CA3 ; 2.30 ; UNEXPECTED PH-DEPENDENT CONFORMATION OF HIS-64, THE PROTON SHUTTLE OF CARBONIC ANHYDRASE-II. 1HCA ; 2.30 ; UNEXPECTED PH-DEPENDENT CONFORMATION OF HIS-64, THE PROTON SHUTTLE OF CARBONIC ANHYDRASE-II. 1VLZ ; 2.05 ; Uncoupled phosphorylation and activation in bacterial chemotaxis. The 2.1-A structure of a threonine to isoleucine mutant at position 87 of CheY. 1BTP ; 2.20 ; Unique binding of a novel synthetic inhibitor, N-[3-[4-[4-(amidinophenoxy)carbonyl]phenyl]-2-methyl-2-propenoyl]- N-allylglycine methanesulfonate, to bovine trypsin, revealed by the crystal structure of the complex. 1CSP ; 2.50 ; Universal nucleic acid-binding domain revealed by crystal structure of the B. subtilis major cold-shock protein. 1CSQ ; 2.70 ; Universal nucleic acid-binding domain revealed by crystal structure of the B. subtilis major cold-shock protein. 2ETI ; -1.00 ; Use of restrained molecular dynamics in water to determine three-dimensional protein structure: prediction of the three-dimensional structure of Ecballium elaterium trypsin inhibitor II. 2DLN ; 2.30 ; Vancomycin resistance: structure of D-alanine:D-alanine ligase at 2.3 A resolution. 2TMV ; 2.90 ; Visualization of protein-nucleic acid interactions in a virus. Refined structure of intact tobacco mosaic virus at 2.9 A resolution by X-ray fiber diffraction. 1RHA ; 1.80 ; WATER-DEPENDENT DOMAIN MOTION AND FLEXIBILITY IN RIBONUCLEASE-A AND THE INVARIANT FEATURES IN ITS HYDRATION SHELL - AN X-RAY STUDY OF 2 LOW-HUMIDITY CRYSTAL FORMS OF THE ENZYME. 1RHB ; 1.50 ; WATER-DEPENDENT DOMAIN MOTION AND FLEXIBILITY IN RIBONUCLEASE-A AND THE INVARIANT FEATURES IN ITS HYDRATION SHELL - AN X-RAY STUDY OF 2 LOW-HUMIDITY CRYSTAL FORMS OF THE ENZYME. 1CAY ; 2.10 ; WILD-TYPE AND E106Q MUTANT CARBONIC-ANHYDRASE COMPLEXED WITH ACETATE. 1CAZ ; 1.90 ; WILD-TYPE AND E106Q MUTANT CARBONIC-ANHYDRASE COMPLEXED WITH ACETATE. 152D ; 1.40 ; Water ring structure at DEOXYRIBONUCLEIC ACID interfaces: hydration and dynamics of DEOXYRIBONUCLEIC ACID- anthracycline complexes. 1TYS ; 1.80 ; Water-mediated substrate/product discrimination: the product complex of thymidylate synthase at 1.83 A. 1LYS ; 1.72 ; X-RAY STRUCTURE OF A MONOCLINIC FORM OF HEN EGG-WHITE LYSOZYME CRYSTALLIZED AT 313-K - COMPARISON OF 2 INDEPENDENT MOLECULES. 1LZY ; 1.55 ; X-RAY STRUCTURE OF MONOCLINIC TURKEY EGG LYSOZYME AT 1.3-ANGSTROM RESOLUTION. 1WGT ; 1.90 ; X-RAY STRUCTURE OF WHEAT-GERM-AGGLUTININ ISOLECTIN-3. 194D ; 2.30 ; X-RAY STRUCTURES OF THE B-DEOXYRIBONUCLEIC ACID DODECAMER D(CGCGTTAACGCG) WITH AN INVERTED CENTRAL TETRANUCLEOTIDE AND ITS NETROPSIN COMPLEX. 195D ; 2.30 ; X-RAY STRUCTURES OF THE B-DEOXYRIBONUCLEIC ACID DODECAMER D(CGCGTTAACGCG) WITH AN INVERTED CENTRAL TETRANUCLEOTIDE AND ITS NETROPSIN COMPLEX. 1RZA ; 1.90 ; X-RAY-ANALYSIS OF METAL-SUBSTITUTED HUMAN CARBONIC-ANHYDRASE-II DERIVATIVES. 1RZB ; 1.80 ; X-RAY-ANALYSIS OF METAL-SUBSTITUTED HUMAN CARBONIC-ANHYDRASE-II DERIVATIVES. 1RZC ; 1.90 ; X-RAY-ANALYSIS OF METAL-SUBSTITUTED HUMAN CARBONIC-ANHYDRASE-II DERIVATIVES. 1RZD ; 1.90 ; X-RAY-ANALYSIS OF METAL-SUBSTITUTED HUMAN CARBONIC-ANHYDRASE-II DERIVATIVES. 1RZE ; 1.90 ; X-RAY-ANALYSIS OF METAL-SUBSTITUTED HUMAN CARBONIC-ANHYDRASE-II DERIVATIVES. 1COT ; 1.70 ; X-Ray structure of the cytochrome c2 isolated from Paracoccus denitrificans refined to 1.7-A resolution. 2ER7 ; 1.60 ; X-ray analyses of aspartic proteinases. III Three-dimensional structure of endothiapepsin complexed with a transition-state isostere inhibitor of renin at 1.6 A resolution. 1ENT ; 1.90 ; X-ray analyses of aspartic proteinases. The three-dimensional structure at 2.1 A resolution of endothiapepsin. 1MPP ; 2.00 ; X-ray analyses of aspartic proteinases. V. Structure and refinement at 2.0 A resolution of the aspartic proteinase from Mucor pusillus. 1BBS ; 2.80 ; X-ray analyses of peptide-inhibitor complexes define the structural basis of specificity for human and mouse renins. 1SMR ; 2.00 ; X-ray analysis at 2.0 A resolution of mouse submaxillary renin complexed with a decapeptide inhibitor CH-66, based on the 4-16 fragment of rat angiotensinogen. 8XIA ; 1.90 ; X-ray analysis of D-xylose isomerase at 1.9 A: native enzyme in complex with substrate and with a mechanism-designed inactivator. 9XIA ; 1.90 ; X-ray analysis of D-xylose isomerase at 1.9 A: native enzyme in complex with substrate and with a mechanism-designed inactivator. 3PHV ; 2.70 ; X-ray analysis of HIV-1 proteinase at 2.7 A resolution confirms structural homology among retroviral enzymes. 2BB2 ; 2.10 ; X-ray analysis of beta B2-crystallin and evolution of oligomeric lens proteins. 5RNT ; 3.20 ; X-ray analysis of cubic crystals of the complex formed between ribonuclease T1 and guanosine-3',5'-bisphosphate. 1GCN ; 3.00 ; X-ray analysis of glucagon and its relationship to receptor binding. 1APG ; 3.00 ; X-ray analysis of substrate analogs in the ricin A-chain active site. 1FMP ; 2.80 ; X-ray analysis of substrate analogs in the ricin A-chain active site. 6INS ; 2.00 ; X-ray analysis of the single chain B29-A1 peptide-linked insulin molecule. A completely inactive analogue. 1GNP ; 2.70 ; X-ray crystal structure analysis of the catalytic domain of the oncogene product p21H-ras complexed with caged GTP and mant dGppNHp. 1GNQ ; 2.50 ; X-ray crystal structure analysis of the catalytic domain of the oncogene product p21H-ras complexed with caged GTP and mant dGppNHp. 1GNR ; 1.85 ; X-ray crystal structure analysis of the catalytic domain of the oncogene product p21H-ras complexed with caged GTP and mant dGppNHp. 1LOE ; 1.90 ; X-ray crystal structure determination and refinement at 1.9 A resolution of isolectin I from the seeds of Lathyrus ochrus. 1RIN ; 2.60 ; X-ray crystal structure of a pea lectin-trimannoside complex at 2.6 A resolution. 2MM1 ; 2.80 ; X-ray crystal structure of a recombinant human myoglobin mutant at 2.8 A resolution. 1MYP ; 3.00 ; X-ray crystal structure of canine myeloperoxidase at 3 A resolution. 1SCD ; 2.30 ; X-ray crystal structure of cross-linked subtilisin Carlsberg in water vs. acetonitrile. 2FAL ; 1.80 ; X-ray crystal structure of ferric Aplysia limacina myoglobin in different liganded states. 2FAM ; 2.00 ; X-ray crystal structure of ferric Aplysia limacina myoglobin in different liganded states. 1GMC ; 2.20 ; X-ray crystal structure of gamma-chymotrypsin in hexane. 1GMD ; 2.20 ; X-ray crystal structure of gamma-chymotrypsin in hexane. 1PPF ; 1.80 ; X-ray crystal structure of the complex of human leukocyte elastase (PMN elastase) and the third domain of the turkey ovomucoid inhibitor. 1MBI ; 2.00 ; X-ray crystal structure of the ferric sperm whale myoglobin: imidazole complex at 2.0 A resolution. 1SWM ; 1.80 ; X-ray crystal structure of the ferric sperm whale myoglobin: imidazole complex at 2.0 A resolution. 1HLC ; 2.90 ; X-ray crystal structure of the human dimeric S-Lac lectin, L-14-II, in complex with lactose at 2.9-A resolution. 1MIO ; 3.00 ; X-ray crystal structure of the nitrogenase molybdenum-iron protein from Clostridium pasteurianum at 3.0-A resolution. 1AAP ; 1.50 ; X-ray crystal structure of the protease inhibitor domain of Alzheimer's amyloid beta-protein precursor. 2AZU ; 1.90 ; X-ray crystal structure of the two site-specific mutants His35Gln and His35Leu of azurin from Pseudomonas aeruginosa. 3AZU ; 2.10 ; X-ray crystal structure of the two site-specific mutants His35Gln and His35Leu of azurin from Pseudomonas aeruginosa. 1ILS ; 2.20 ; X-ray crystal structure of the two site-specific mutants Ile7Ser and Phe110Ser of azurin from Pseudomonas aeruginosa. 1ILU ; 2.30 ; X-ray crystal structure of the two site-specific mutants Ile7Ser and Phe110Ser of azurin from Pseudomonas aeruginosa. 1STG ; 1.70 ; X-ray crystal structures of staphylococcal nuclease complexed with the competitive inhibitor cobalt(II) and nucleotide. 1STH ; 1.85 ; X-ray crystal structures of staphylococcal nuclease complexed with the competitive inhibitor cobalt(II) and nucleotide. 1CAA ; 1.80 ; X-ray crystal structures of the oxidized and reduced forms of the rubredoxin from the marine hyperthermophilic archaebacterium Pyrococcus furiosus. 1CAD ; 1.80 ; X-ray crystal structures of the oxidized and reduced forms of the rubredoxin from the marine hyperthermophilic archaebacterium Pyrococcus furiosus. 1EED ; 2.00 ; X-ray crystallographic analysis of inhibition of endothiapepsin by cyclohexyl renin inhibitors. 1TRP ; 2.40 ; X-ray crystallographic and calorimetric studies of the effects of the mutation Trp59-->Tyr in ribonuclease T1. 1TRQ ; 2.30 ; X-ray crystallographic and calorimetric studies of the effects of the mutation Trp59-->Tyr in ribonuclease T1. 1BLL ; 2.40 ; X-ray crystallographic determination of the structure of bovine lens leucine aminopeptidase complexed with amastatin: formulation of a catalytic mechanism featuring a gem-diolate transition state. 3CPA ; 2.00 ; X-ray crystallographic investigation of substrate binding to carboxypeptidase A at subzero temperature. 7HVP ; 2.40 ; X-ray crystallographic structure of a complex between a synthetic protease of human immunodeficiency virus 1 and a substrate-based hydroxyethylamine inhibitor. 1POP ; 2.10 ; X-ray crystallographic structure of a papain-leupeptin complex. 1XYA ; 1.81 ; X-ray crystallographic structures of D-xylose isomerase-substrate complexes position the substrate and provide evidence for metal movement during catalysis. 1XYB ; 1.96 ; X-ray crystallographic structures of D-xylose isomerase-substrate complexes position the substrate and provide evidence for metal movement during catalysis. 1XYC ; 2.19 ; X-ray crystallographic structures of D-xylose isomerase-substrate complexes position the substrate and provide evidence for metal movement during catalysis. 1LIC ; 1.60 ; X-ray crystallographic structures of adipocyte lipid-binding protein complexed with palmitate and hexadecanesulfonic acid. Properties of cavity binding sites. 1LIE ; 1.60 ; X-ray crystallographic structures of adipocyte lipid-binding protein complexed with palmitate and hexadecanesulfonic acid. Properties of cavity binding sites. 1HTE ; 2.80 ; X-ray crystallographic studies of a series of penicillin-derived asymmetric inhibitors of HIV-1 protease. 1HTF ; 2.20 ; X-ray crystallographic studies of a series of penicillin-derived asymmetric inhibitors of HIV-1 protease. 1HTG ; 2.00 ; X-ray crystallographic studies of a series of penicillin-derived asymmetric inhibitors of HIV-1 protease. 1IGP ; 2.20 ; X-ray crystallographic studies of recombinant inorganic pyrophosphatase from Escherichia coli. 1MBS ; 2.50 ; X-ray crystallographic studies of seal myoglobin. The molecule at 2.5 A resolution. 1MPJ ; 2.30 ; X-ray crystallographic studies on hexameric insulins in the presence of helix-stabilizing agents, thiocyanate, methylparaben, and phenol. 2TCI ; 1.80 ; X-ray crystallographic studies on hexameric insulins in the presence of helix-stabilizing agents, thiocyanate, methylparaben, and phenol. 3MTH ; 1.90 ; X-ray crystallographic studies on hexameric insulins in the presence of helix-stabilizing agents, thiocyanate, methylparaben, and phenol. 1ARS ; 1.80 ; X-ray crystallographic study of pyridoxal 5'-phosphate-type aspartate aminotransferases from Escherichia coli in open and closed form. 1ART ; 1.80 ; X-ray crystallographic study of pyridoxal 5'-phosphate-type aspartate aminotransferases from Escherichia coli in open and closed form. 1AMQ ; 2.20 ; X-ray crystallographic study of pyridoxamine 5'-phosphate-type aspartate aminotransferases from Escherichia coli in three forms. 1AMR ; 2.10 ; X-ray crystallographic study of pyridoxamine 5'-phosphate-type aspartate aminotransferases from Escherichia coli in three forms. 1AMS ; 2.70 ; X-ray crystallographic study of pyridoxamine 5'-phosphate-type aspartate aminotransferases from Escherichia coli in three forms. 9LYZ ; 2.50 ; X-ray crystallography of the binding of the bacterial cell wall trisaccharide NAM-NAG-NAM to lysozyme. 1IDS ; 2.00 ; X-ray structure analysis of the iron-dependent superoxide dismutase from Mycobacterium tuberculosis at 2.0 Angstroms resolution reveals novel dimer-dimer interactions. 1PDY ; 2.40 ; X-ray structure and catalytic mechanism of lobster enolase. 1PDZ ; 2.20 ; X-ray structure and catalytic mechanism of lobster enolase. 1MBC ; 1.50 ; X-ray structure and refinement of carbon-monoxy (Fe II)-myoglobin at 1.5 A resolution. 1TGX ; 1.55 ; X-ray structure at 1.55 A of toxin gamma, a cardiotoxin from Naja nigricollis venom. Crystal packing reveals a model for insertion into membranes. 1TLK ; 2.80 ; X-ray structure determination of telokin, the C-terminal domain of myosin light chain kinase, at 2.8 A resolution. 1LAA ; 1.77 ; X-ray structure of Glu 53 human lysozyme. 1LOG ; 2.10 ; X-ray structure of a (alpha-Man(1-3)beta-Man(1-4)GlcNAc)-lectin complex at 2.1-A resolution. The role of water in sugar-lectin interaction. 183D ; 1.60 ; X-ray structure of a DEOXYRIBONUCLEIC ACID decamer containing 7,8-dihydro-8-oxoguanine. 1D16 ; 2.10 ; X-ray structure of a DEOXYRIBONUCLEIC ACID hairpin molecule. 1LOF ; 2.30 ; X-ray structure of a biantennary octasaccharide-lectin complex refined at 2.3-A resolution. 1CWA ; 2.10 ; X-ray structure of a monomeric cyclophilin A-cyclosporin A crystal complex at 2.1 A resolution. 1PVB ; 1.75 ; X-ray structure of a new crystal form of pike 4.10 beta parvalbumin. 1NUE ; 2.00 ; X-ray structure of human nucleoside diphosphate kinase B complexed with GDP at 2 A resolution. 6RLX ; 1.50 ; X-ray structure of human relaxin at 1.5 A. Comparison to insulin and implications for receptor binding determinants. 1ILT ; 2.00 ; X-ray structure of interleukin-1 receptor antagonist at 2.0-A resolution. 1NDC ; 2.00 ; X-ray structure of nucleoside diphosphate kinase complexed with thymidine diphosphate and Mg2+ at 2-A resolution. 1NDK ; 2.20 ; X-ray structure of nucleoside diphosphate kinase. 5P2P ; 2.40 ; X-ray structure of phospholipase A2 complexed with a substrate-derived inhibitor. 1DNK ; 2.30 ; X-ray structure of the DNase I-d(GGTATACC)2 complex at 2.3 A resolution. 2ZTA ; 1.80 ; X-ray structure of the GCN4 leucine zipper, a two-stranded, parallel coiled coil. 2TPR ; 2.40 ; X-ray structure of trypanothione reductase from Crithidia fasciculata at 2.4-A resolution. 1LCO ; 2.90 ; X-ray structure of two complexes of the Y143F flavocytochrome b2 mutant crystallized in the presence of lactate or phenyl lactate. 1LDC ; 2.90 ; X-ray structure of two complexes of the Y143F flavocytochrome b2 mutant crystallized in the presence of lactate or phenyl lactate. 7AAT ; 1.90 ; X-ray structure refinement and comparison of three forms of mitochondrial aspartate aminotransferase. 8AAT ; 2.30 ; X-ray structure refinement and comparison of three forms of mitochondrial aspartate aminotransferase. 9AAT ; 2.20 ; X-ray structure refinement and comparison of three forms of mitochondrial aspartate aminotransferase. 1ASO ; 2.20 ; X-ray structures and mechanistic implications of three functional derivatives of ascorbate oxidase from zucchini. Reduced, peroxide and azide forms. 1ASP ; 2.59 ; X-ray structures and mechanistic implications of three functional derivatives of ascorbate oxidase from zucchini. Reduced, peroxide and azide forms. 1ASQ ; 2.32 ; X-ray structures and mechanistic implications of three functional derivatives of ascorbate oxidase from zucchini. Reduced, peroxide and azide forms. 1FGV ; 1.90 ; X-ray structures of fragments from binding and nonbinding versions of a humanized anti-CD18 antibody: structural indications of the key role of VH residues 59 to 65. 2FGW ; 3.00 ; X-ray structures of fragments from binding and nonbinding versions of a humanized anti-CD18 antibody: structural indications of the key role of VH residues 59 to 65. 1CCP ; 2.20 ; X-ray structures of recombinant yeast cytochrome c peroxidase and three heme-cleft mutants prepared by site-directed mutagenesis. 2CCP ; 2.20 ; X-ray structures of recombinant yeast cytochrome c peroxidase and three heme-cleft mutants prepared by site-directed mutagenesis. 3CCP ; 2.20 ; X-ray structures of recombinant yeast cytochrome c peroxidase and three heme-cleft mutants prepared by site-directed mutagenesis. 4CCP ; 2.20 ; X-ray structures of recombinant yeast cytochrome c peroxidase and three heme-cleft mutants prepared by site-directed mutagenesis. 1FVC ; 2.20 ; X-ray structures of the antigen-binding domains from three variants of humanized anti-p185HER2 antibody 4D5 and comparison with molecular modeling. 1FVD ; 2.50 ; X-ray structures of the antigen-binding domains from three variants of humanized anti-p185HER2 antibody 4D5 and comparison with molecular modeling. 2ER0 ; 3.00 ; X-ray studies of aspartic proteinase-statine inhibitor complexes. 2ER9 ; 2.20 ; X-ray studies of aspartic proteinase-statine inhibitor complexes. 1ZAA ; 2.10 ; Zinc finger-DEOXYRIBONUCLEIC ACID recognition: crystal structure of a Zif268-DEOXYRIBONUCLEIC ACID complex at 2.1 A. 1HVN ; -1.00 ; Zinc- and sequence-dependent binding to nucleic acids by the N-terminal zinc finger of the HIV-1 nucleocapsid protein: NMR structure of the complex with the Psi-site analog, dACGCC. 1HVO ; -1.00 ; Zinc- and sequence-dependent binding to nucleic acids by the N-terminal zinc finger of the HIV-1 nucleocapsid protein: NMR structure of the complex with the Psi-site analog, dACGCC. 1AAT ; 2.80 ; [Conformational changes in cytosol aspartate aminotransferase induced by oxoglutarate] 1SIS ; -1.00 ; [Determination of the spatial structure of insectotoxin 15A from Buthus erpeus by (1)H-NMR spectroscopy data] 1GRM ; -1.00 ; [Refinement of the spatial structure of the gramicidin A ion channel]. [Article in Russian] 1CSR ; 1.70 ; alpha-Fluoro acid and alpha-fluoro amide analogs of acetyl-CoA as inhibitors of citrate synthase: effect of pKa matching on binding affinity and hydrogen bond length. 1CSS ; 1.70 ; alpha-Fluoro acid and alpha-fluoro amide analogs of acetyl-CoA as inhibitors of citrate synthase: effect of pKa matching on binding affinity and hydrogen bond length. 1U98 ; 2.00 ; "CRYSTAL STRUCTURE OF E. COLI RECA IN A COMPRESSED HELICAL FILAMENT FORM3" 1U99 ; 2.60 ; "CRYSTAL STRUCTURES OF E. COLI RECA IN A COMPRESSED HELICAL FILAMENT FORM 4" 1XP8 ; 2.50 ; "DEINOCOCCUS RADIODURANS RECA IN COMPLEX WITH ATP-GAMMA-S" 1XMV ; 1.90 ; "E. COLI RECA IN COMPLEX WITH MGADP" 1XMS ; 2.10 ; "E. COLI RECA IN COMPLEX WITH MNAMP-PNP" 1NM2 ; 2.00 ; "MALONYL-COA:ACP TRANSACYLASE" 1N21 ; 3.10 ; (+)-BORNYL DIPHOSPHATE SYNTHASE: COCRYSTAL WITH MG AND 3- AZA-2,3-DIHYDROGERANYL DIPHOSPHATE 1N20 ; 2.30 ; (+)-BORNYL DIPHOSPHATE SYNTHASE: COMPLEX WITH MG AND 3-AZA- 2,3-DIHYDROGERANYL DIPHOSPHATE 1N24 ; 2.30 ; (+)-BORNYL DIPHOSPHATE SYNTHASE: COMPLEX WITH MG AND PRODUCT 1N1Z ; 2.30 ; (+)-BORNYL DIPHOSPHATE SYNTHASE: COMPLEX WITH MG AND PYROPHOSPHATE 1N23 ; 2.40 ; (+)-BORNYL DIPHOSPHATE SYNTHASE: COMPLEX WITH MG, PYROPHOSPHATE, AND (1R,4S)-2-AZABORNANE 1N22 ; 2.40 ; (+)-BORNYL DIPHOSPHATE SYNTHASE: COMPLEX WITH MG, PYROPHOSPHATE, AND (4R)-7-AZA-7,8-DIHYDROLIMONENE 1DSA ; -1.00 ; (+)-DUOCARMYCIN SA COVALENTLY LINKED TO DUPLEX DEOXYRIBONUCLEIC ACID, NMR, 20 STRUCTURES 1DSM ; -1.00 ; (-)-DUOCARMYCIN SA COVALENTLY LINKED TO DUPLEX DEOXYRIBONUCLEIC ACID 1GZ6 ; 2.38 ; (3R)-HYDROXYACYL-COA DEHYDROGENASE FRAGMENT OF RAT PEROXISOMAL MULTIFUNCTIONAL ENZYME TYPE 2 1H8E ; 2.00 ; (ADP.ALF4)2(ADP.SO4) BOVINE F1-ATPASE (ALL THREE CATALYTIC SITES OCCUPIED) 1GBV ; 2.00 ; (ALPHA-OXY, BETA-(C112G)DEOXY) T-STATE HUMAN HEMOGLOBIN 1NP5 ; -1.00 ; (GAC)3 PARALLEL DUPLEX 1IQ6 ; 1.50 ; (R)-HYDRATASE FROM A. CAVIAE INVOLVED IN PHA BIOSYNTHESIS 1HSS ; 2.06 ; 0.19 ALPHA-AMYLASE INHIBITOR FROM WHEAT 1I0T ; 0.60 ; 0.6 A STRUCTURE OF Z-DEOXYRIBONUCLEIC ACID CGCGCG 1SSX ; 0.83 ; 0.83A RESOLUTION CRYSTAL STRUCTURE OF ALPHA-LYTIC PROTEASE AT PH 8 1N55 ; 0.83 ; 0.83A RESOLUTION STRUCTURE OF THE E65Q MUTANT OF LEISHMANIA MEXICANA TRIOSEPHOSPHATE ISOMERASE COMPLEXED WITH 2- PHOSPHOGLYCOLATE 1X8P ; 0.85 ; 0.85 A CRYSTAL STRUCTURE OF NITROPHORIN 4 FROM RHODNIUS PROLIXUS COMPLEXED WITH AMMONIA AT PH 7.4 1X8Q ; 0.85 ; 0.85 A CRYSTAL STRUCTURE OF NITROPHORIN 4 FROM RHODNIUS PROLIXUS IN COMPLEX WITH WATER AT PH 5.6 1PJX ; 0.85 ; 0.85 ANGSTROM STRUCTURE OF SQUID GANGLION DFPASE 1I1W ; 0.89 ; 0.89 A ULTRA HIGH RESOLUTION STRUCTURE OF A THERMOSTABLE XYLANASE FROM THERMOASCUS AURANTIACUS 1YWA ; 0.89 ; 0.9 A STRUCTURE OF NP4 FROM RHODNIUS PROLIXUS COMPLEXED WITH CO AT PH 5.6 1YWB ; 0.97 ; 0.9 A STRUCTURE OF NP4 FROM RHODNIUS PROLIXUS COMPLEXED WITH NO AT PH 5.6 1C75 ; 0.97 ; 0.97 A "AB INITIO" CRYSTAL STRUCTURE OF CYTOCHROME C-553 FROM BACILLUS PASTEURII 1TG0 ; 0.97 ; 0.97-A STRUCTURE OF THE SH3 DOMAIN OF BBC1 4PRG ; 2.90 ; 0072 PARTIAL AGONIST PPAR GAMMA COCRYSTAL 1EN8 ; 0.98 ; 1 A CRYSTAL STRUCTURES OF B-DEOXYRIBONUCLEIC ACID REVEAL SEQUENCE-SPECIFIC BINDING AND GROOVE-SPECIFIC BENDING OF DEOXYRIBONUCLEIC ACID BY MAGNESIUM AND CALCIUM 1DYP ; 1.54 ; 1,3-ALPHA-1,4-BETA-D-GALACTOSE-4-SULFATE- 3,6-ANHYDRO-D-GALACTOSE 4 GALACTOHYDROLASE 1H80 ; 1.60 ; 1,3-ALPHA-1,4-BETA-D-GALACTOSE-4-SULFATE- 3,6-ANHYDRO-D-GALACTOSE-2-SULFATE 4 GALACTOHYDROLASE 1F2D ; 2.00 ; 1-AMINOCYCLOPROPANE-1-CARBOXYLATE DEAMINASE 1B8G ; 2.37 ; 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE 1CP6 ; 1.90 ; 1-BUTANEBORONIC ACID BINDING TO AEROMONAS PROTEOLYTICA AMINOPEPTIDASE 1XCC ; 2.30 ; 1-CYS PEROXIDOXIN FROM PLASMODIUM YOELLI 1R0L ; 2.70 ; 1-DEOXY-D-XYLULOSE 5-PHOSPHATE REDUCTOISOMERASE FROM ZYMOMONAS MOBILIS IN COMPLEX WITH NADPH 1K5H ; 2.50 ; 1-DEOXY-D-XYLULOSE-5-PHOSPHATE REDUCTOISOMERASE 1QAS ; 2.40 ; 1-PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE PHOSPHODIESTERASE DELTA 1 1QAT ; 3.00 ; 1-PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE PHOSPHODIESTERASE DELTA COMPLEX WITH SAMARIUM (III) CHLORIDE 1UZB ; 1.40 ; 1-PYRROLINE-5-CARBOXYLATE DEHYDROGENASE 1SY2 ; 1.00 ; 1.0 A CRYSTAL STRUCTURE OF D129A/L130A MUTANT OF NITROPHORIN 4 1SXX ; 1.01 ; 1.0 A CRYSTAL STRUCTURE OF D129A/L130A MUTANT OF NITROPHORIN 4 COMPLEXED WITH NITRIC OXIDE 1SY1 ; 1.01 ; 1.0 A CRYSTAL STRUCTURE OF T121V MUTANT OF NITROPHORIN 4 COMPLEXED WITH NITRIC OXIDE 1SY3 ; 1.00 ; 1.00 A CRYSTAL STRUCTURE OF D30N MUTANT OF NITROPHORIN 4 FROM RHODNIUS PROLIXUS COMPLEXED WITH NITRIC OXIDE 1HJ8 ; 1.00 ; 1.00 AA TRYPSIN FROM ATLANTIC SALMON 1X8O ; 1.01 ; 1.01 A CRYSTAL STRUCTURE OF NITROPHORIN 4 FROM RHODNIUS PROLIXUS COMPLEXED WITH NITRIC OXIDE AT PH 5.6 1NH0 ; 1.03 ; 1.03 A STRUCTURE OF HIV-1 PROTEASE: INHIBITOR BINDING INSIDE AND OUTSIDE THE ACTIVE SITE 1SXW ; 1.05 ; 1.05 A CRYSTAL STRUCTURE OF D30A MUTANT OF NITROPHORIN 4 FROM RHODNIUS PROLIXUS COMPLEXED WITH NITRIC OXIDE 1I0M ; 1.05 ; 1.05 A STRUCTURE OF THE A-DECAMER GCGTATACGC WITH A SINGLE 2'-O-FLUOROETHYL THYMINE IN PLACE OF T6, HIGH RB-SALT 1I0K ; 1.05 ; 1.05 A STRUCTURE OF THE A-DECAMER GCGTATACGC WITH A SINGLE 2'-O-METHYL-[TRI(OXYETHYL)] THYMINE IN PLACE OF T6, MEDIUM CS-SALT 1I0J ; 1.06 ; 1.06 A STRUCTURE OF THE A-DECAMER GCGTATACGC WITH A SINGLE 2'-O-METHYL-3'-METHYLENEPHOSPHONATE (MEP) THYMINE IN PLACE OF T6, HIGH CS-SALT 1SFS ; 1.07 ; 1.07 A CRYSTAL STRUCTURE OF AN UNCHARACTERIZED B. STEAROTHERMOPHILUS PROTEIN 1SXY ; 1.07 ; 1.07 A CRYSTAL STRUCTURE OF D30N MUTANT OF NITROPHORIN 4 FROM RHODNIUS PROLIXUS 1X8N ; 1.08 ; 1.08 A CRYSTAL STRUCTURE OF NITROPHORIN 4 FROM RHODNIUS PROLIXUS COMPLEXED WITH NITRIC OXIDE AT PH 7.4 1JBE ; 1.08 ; 1.08 A STRUCTURE OF APO-CHEY REVEALS META-ACTIVE CONFORMATION 1YWD ; 1.08 ; 1.08 A STRUCTURE OF FERROUS NP4 (AQUO COMPLEX) 1A0M ; 1.10 ; 1.1 ANGSTROM CRYSTAL STRUCTURE OF A-CONOTOXIN [TYR15]-EPI 1LU4 ; 1.12 ; 1.1 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF A SECRETED MYCOBACTERIUM TUBERCULOSIS DISULFIDE OXIDOREDUCTASE HOMOLOGOUS TO E. COLI DSBE: IMPLICATIONS FOR FUNCTIONS 1R0R ; 1.10 ; 1.1 ANGSTROM RESOLUTION STRUCTURE OF THE COMPLEX BETWEEN THE PROTEIN INHIBITOR, OMTKY3, AND THE SERINE PROTEASE, SUBTILISIN CARLSBERG 1I1X ; 1.11 ; 1.11 A ATOMIC RESOLUTION STRUCTURE OF A THERMOSTABLE XYLANASE FROM THERMOASCUS AURANTIACUS 1D2U ; 1.15 ; 1.15 A CRYSTAL STRUCTURE OF NITROPHORIN 4 FROM RHODNIUS PROLIXUS 1SY0 ; 1.15 ; 1.15 A CRYSTAL STRUCTURE OF T121V MUTANT OF NITROPHORIN 4 FROM RHODNIUS PROLIXUS 1Z70 ; 1.15 ; 1.15A RESOLUTION STRUCTURE OF THE FORMYLGLYCINE GENERATING ENZYME FGE 1R3G ; 1.16 ; 1.16A X-RAY STRUCTURE OF THE SYNTHETIC DEOXYRIBONUCLEIC ACID FRAGMENT WITH THE INCORPORATED 2'-O-[(2-GUANIDINIUM)ETHYL]-5- METHYLURIDINE RESIDUES 1QU9 ; 1.20 ; 1.2 A CRYSTAL STRUCTURE OF YJGF GENE PRODUCT FROM E. COLI 367D ; 1.20 ; 1.2 A STRUCTURE DETERMINATION OF THE D(CG(5-BRU)ACG)2/5- BROMO-9-AMINO-DACA COMPLEX 1G7A ; 1.20 ; 1.2 A STRUCTURE OF T3R3 HUMAN INSULIN AT 100 K 1KWN ; 1.20 ; 1.2 A STRUCTURE OF THAUMATIN CRYSTALLIZED IN GEL 1AMM ; 1.20 ; 1.2 ANGSTROM STRUCTURE OF GAMMA-B CRYSTALLIN AT 150K 1MJU ; 1.22 ; 1.22 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS6-12 2C9U ; 1.24 ; 1.24 ANGSTROMS RESOLUTION STRUCTURE OF AS-ISOLATED CU-ZN HUMAN SUPEROXIDE DISMUTASE 2C9S ; 1.24 ; 1.24 ANGSTROMS RESOLUTION STRUCTURE OF ZN-ZN HUMAN SUPEROXIDE DISMUTASE 1IKJ ; 1.27 ; 1.27 A CRYSTAL STRUCTURE OF NITROPHORIN 4 FROM RHODNIUS PROLIXUS COMPLEXED WITH IMIDAZOLE 1YR4 ; 1.20 ; 1.2A RESOLUTION STRUCTURE OF A CRAYFISH TRYPSIN COMPLEXED WITH A PEPTIDE INHIBITOR, SGTI 366D ; 1.30 ; 1.3 A STRUCTURE DETERMINATION OF THE D(CG(5-BRU)ACG)2/6-BROMO-9-AMINO-DACA COMPLEX 1G7B ; 1.30 ; 1.3 A STRUCTURE OF T3R3 HUMAN INSULIN AT 100 K 1I0Q ; 1.30 ; 1.3 A STRUCTURE OF THE A-DECAMER GCGTATACGC WITH A SINGLE 2'-O-METHYL-[TRI(OXYETHYL)] THYMINE IN PLACE OF T6, MEDIUM NA-SALT 1I0N ; 1.30 ; 1.3 A STRUCTURE OF THE A-DECAMER GCGTATACGC WITH A SINGLE 2'-O-METHYL-[TRI(OXYETHYL)] THYMINE IN PLACE OF T6, MEDIUM RB-SALT 1I0P ; 1.30 ; 1.3 A STRUCTURE OF THE A-DECAMER GCGTATACGC WITH A SINGLE 2'-O-METHYL-[TRI(OXYETHYL)], MEDIUM K-SALT 1JW8 ; 1.30 ; 1.3 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF P6 FORM OF MYOGLOBIN 1ZGK ; 1.35 ; 1.35 ANGSTROM STRUCTURE OF THE KELCH DOMAIN OF KEAP1 1LK2 ; 1.35 ; 1.35A CRYSTAL STRUCTURE OF H-2KB COMPLEXED WITH THE GNYSFYAL PEPTIDE 1SXV ; 1.30 ; 1.3A CRYSTAL STRUCTURE OF RV3628, MYCOBACTERIUM TUBERCULOSIS INORGANIC PYROPHOSPHATASE (PPASE) AT PH5.0 1SXU ; 1.40 ; 1.4 A CRYSTAL STRUCTURE OF D30N MUTANT OF NITROPHORIN 4 FROM RHODNIUS PROLIXUS COMPLEXED WITH IMIDAZOLE 1D3S ; 1.40 ; 1.4 A CRYSTAL STRUCTURE OF NITROPHORIN 4 FROM RHODNIUS PROLIXIS AT PH5.6. 2TNF ; 1.40 ; 1.4 A RESOLUTION STRUCTURE OF MOUSE TUMOR NECROSIS FACTOR, TOWARDS MODULATION OF ITS SELCTIVITY AND TRIMERISATION 1CXU ; 1.42 ; 1.42A RESOLUTION ASV INTEGRASE CORE DOMAIN FROM CITRATE 1DI6 ; 1.45 ; 1.45 A CRYSTAL STRUCTURE OF THE MOLYBDENUMM COFACTOR BIOSYNTHESIS PROTEIN MOGA FROM ESCHERICHIA COLI 1I0G ; 1.45 ; 1.45 A STRUCTURE OF THE A-DECAMER GCGTATACGC WITH A SINGLE 2'-O-FLUOROETHYL THYMINE IN PLACE OF T6, MEDIUM NA-SALT 1O98 ; 1.40 ; 1.4A CRYSTAL STRUCTURE OF PHOSPHOGLYCERATE MUTASE FROM BACILLUS STEAROTHERMOPHILUS COMPLEXED WITH 2-PHOSPHOGLYCERATE 1QTO ; 1.50 ; 1.5 A CRYSTAL STRUCTURE OF A BLEOMYCIN RESISTANCE DETERMINANT FROM BLEOMYCIN-PRODUCING STREPTOMYCES VERTICILLUS 1PUY ; 1.50 ; 1.5 A RESOLUTION STRUCTURE OF A SYNTHETIC DEOXYRIBONUCLEIC ACID HAIRPIN WITH A STILBENEDIETHER LINKER 1ZEQ ; 1.50 ; 1.5 A STRUCTURE OF APO-CUSF RESIDUES 6-88 FROM ESCHERICHIA COLI 1WPA ; 1.50 ; 1.5 ANGSTROM CRYSTAL STRUCTURE OF HUMAN OCCLUDIN FRAGMENT 413-522 1LMI ; 1.50 ; 1.5 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF A SECRETED PROTEIN FROM MYCOBACTERIUM TUBERCULOSIS-MPT63 1K4V ; 1.53 ; 1.53 A CRYSTAL STRUCTURE OF THE BETA-GALACTOSIDE-ALPHA-1,3- GALACTOSYLTRANSFERASE IN COMPLEX WITH UDP 1MV8 ; 1.55 ; 1.55 A CRYSTAL STRUCTURE OF A TERNARY COMPLEX OF GDP- MANNOSE DEHYDROGENASE FROM PSUEDOMONAS AERUGINOSA 1KQ1 ; 1.55 ; 1.55 A CRYSTAL STRUCTURE OF THE PLEIOTROPIC TRANSLATIONAL REGULATOR, HFQ 1F0L ; 1.55 ; 1.55 ANGSTROM CRYSTAL STRUCTURE OF WILD TYPE DIPHTHERIA TOXIN 1Z6N ; 1.50 ; 1.5A CRYSTAL STRUCTURE OF A HYPOTHETICAL PROTEIN PA1234 FROM PSEUDOMONAS AERUGINOSA 1OZN ; 1.52 ; 1.5A CRYSTAL STRUCTURE OF THE NOGO RECEPTOR LIGAND BINDING DOMAIN REVEALS A CONVERGENT RECOGNITION SCAFFOLD MEDIATING INHIBITION OF MYELINATION 1SQE ; 1.50 ; 1.5A CRYSTAL STRUCTURE OF THE PROTEIN PG130 FROM STAPHYLOCOCCUS AUREUS, STRUCTURAL GENOMICS 1ZKP ; 1.50 ; 1.5A RESOLUTION CRYSTAL STRUCTURE OF A METALLO BETA LACTAMASE FAMILY PROTEIN, THE ELAC HOMOLGUE OF BACILLUS ANTHRACIS, A PUTATIVE RIBONUCLEASE 1JKS ; 1.50 ; 1.5A X-RAY STRUCTURE OF APO FORM OF A CATALYTIC DOMAIN OF DEATH-ASSOCIATED PROTEIN KINASE 1HFE ; 1.60 ; 1.6 A RESOLUTION STRUCTURE OF THE FE-ONLY HYDROGENASE FROM DESULFOVIBRIO DESULFURICANS 1I0F ; 1.60 ; 1.6 A STRUCTURE OF THE A-DECAMER GCGTATACGC WITH A SINGLE 2'-O-AMINOOXYETHYL THYMINE IN PLACE OF T6, BA-FORM 1I0O ; 2.00 ; 1.6 A STRUCTURE OF THE A-DECAMER GCGTATACGC WITH A SINGLE 2'-O-METHYL-3'-METHYLENEPHOSPHONATE THYMINE IN PLACE OF T6, HIGH K-SALT 2BL7 ; 2.20 ; 1.6 ANGSTROM CRYSTAL STRUCTURE OF ENTA-IM: A BACTERIAL IMMUNITY PROTEIN CONFERRING IMMUNITY TO THE ANTIMICROBIAL ACTIVITY OF THE PEDIOCIN-LIKE BACTERIOCIN, ENTEROCIN A 2BL8 ; 1.60 ; 1.6 ANGSTROM CRYSTAL STRUCTURE OF ENTA-IM: A BACTERIAL IMMUNITY PROTEIN CONFERRING IMMUNITY TO THE ANTIMICROBIAL ACTIVITY OF THE PEDIOCIN-LIKE BACTERIOCIN, ENTEROCIN A 1JLJ ; 1.60 ; 1.6 ANGSTROM CRYSTAL STRUCTURE OF THE HUMAN NEURORECEPTOR ANCHORING AND MOLYBDENUM COFACTOR BIOSYNTHESIS PROTEIN GEPHYRIN 2A7M ; 1.60 ; 1.6 ANGSTROM RESOLUTION STRUCTURE OF THE QUORUM-QUENCHING N- ACYL HOMOSERINE LACTONE HYDROLASE OF BACILLUS THURINGIENSIS 1T4B ; 1.60 ; 1.6 ANGSTROM STRUCTURE OF ESHERICHIA COLI ASPARTATE- SEMIALDEHYDE DEHYDROGENASE. 1G4Y ; 1.60 ; 1.60 A CRYSTAL STRUCTURE OF THE GATING DOMAIN FROM SMALL CONDUCTANCE POTASSIUM CHANNEL COMPLEXED WITH CALCIUM- CALMODULIN 1DI7 ; 1.60 ; 1.60 ANGSTROM CRYSTAL STRUCTURE OF THE MOLYBDENUM COFACTOR BIOSYNTHESIS PROTEIN MOGA FROM ESCHERICHIA COLI 1M93 ; 1.65 ; 1.65 A STRUCTURE OF CLEAVED VIRAL SERPIN CRMA 1SDI ; 1.65 ; 1.65 A STRUCTURE OF ESCHERICHIA COLI YCFC GENE PRODUCT 1DHN ; 1.65 ; 1.65 ANGSTROM RESOLUTION STRUCTURE OF 7,8-DIHYDRONEOPTERIN ALDOLASE FROM STAPHYLOCOCCUS AUREUS 1YO3 ; 1.65 ; 1.65 ANGSTROM STRUCTURE OF THE DYNEIN LIGHT CHAIN 1 FROM PLASMODIUM FALCIPARUM 1I2Y ; 1.66 ; 1.66 A STRUCTURE OF A-DUPLEX WITH BULGED ADENOSINE, SPERMINE FORM 1ZKE ; 1.60 ; 1.6A CRYSTAL STRUCTURE OF A HYPOTHETICAL PROTEIN HP1531 FROM HELICOBACTER PYLORI 1LLN ; 1.60 ; 1.6A CRYSTAL STRUCTURE OF POKEWEED ANTIVIRAL PROTEIN-III (PAP-III) WITH METHYLATED LYSINES 1YD9 ; 1.60 ; 1.6A CRYSTAL STRUCTURE OF THE NON-HISTONE DOMAIN OF THE HISTONE VARIANT MACROH2A1.1. 1RZ2 ; 1.60 ; 1.6A CRYSTAL STRUCTURE OF THE PROTEIN BA4783/Q81L49 (SIMILAR TO SORTASE B) FROM BACILLUS ANTHRACIS. 1JUX ; 1.60 ; 1.6A RESOLUTION CRYSTAL STRUCTURES OF THE DEOXYRIBONUCLEIC ACID OCTAMERS D(IUATATAC) AND D(ITITACAC):BINDING OF TWO DISTAMYCIN DRUGS SIDE-BY-SIDE 1JKL ; 1.62 ; 1.6A X-RAY STRUCTURE OF BINARY COMPLEX OF A CATALYTIC DOMAIN OF DEATH-ASSOCIATED PROTEIN KINASE WITH ATP ANALOGUE 1U17 ; 1.70 ; 1.7 A CRYSTAL STRUCTURE OF H60C MUTANT OF NITROPHORIN I. HEME COMPLEXED WITH TWO MOLECULES IMIDAZOLE 1UWF ; 1.69 ; 1.7 A RESOLUTION STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF THE FIMH ADHESIN FROM UROPATHOGENIC E. COLI 1QUS ; 1.70 ; 1.7 A RESOLUTION STRUCTURE OF THE SOLUBLE LYTIC TRANSGLYCOSYLASE SLT35 FROM ESCHERICHIA COLI 1PXZ ; 1.70 ; 1.7 ANGSTROM CRYSTAL STRUCTURE OF JUN A 1, THE MAJOR ALLERGEN FROM CEDAR POLLEN 1Z9L ; 1.70 ; 1.7 ANGSTROM CRYSTAL STRUCTURE OF THE RAT VAP-A MSP HOMOLOGY DOMAIN 1EYE ; 1.70 ; 1.7 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF 6- HYDROXYMETHYL-7,8-DIHYDROPTEROATE SYNTHASE (DHPS) FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH 6- HYDROXYMETHYLPTERIN MONOPHOSPHATE 1I6K ; 1.72 ; 1.7 HIGH RESOLUTION EXPERIMENTAL PHASES FOR TRYPTOPHANYL- TRNA SYNTHETASE COMPLEXED WITH TRYPTOPHANYL-5'AMP 1I6L ; 1.72 ; 1.7 HIGH RESOLUTION EXPERIMENTAL PHASES FOR TRYPTOPHANYL- TRNA SYNTHETASE COMPLEXED WITH TRYPTOPHANYL-5'AMP 1I6M ; 1.72 ; 1.7 HIGH RESOLUTION EXPERIMENTAL PHASES FOR TRYPTOPHANYL- TRNA SYNTHETASE COMPLEXED WITH TRYPTOPHANYL-5'AMP 1RVK ; 1.70 ; 1.70 A CRYSTAL STRUCTURE OF THE HYPOTHETICAL PROTEIN MR.GI- 17937161 FROM AGROBACTERIUM TUMEFACIENS 377D ; 1.76 ; 1.76 A STRUCTURE OF A PYRIMIDINE START ALTERNATING A-RIBONUCLEIC ACID HEXAMER R(CGUAC)DG 1UWL ; 1.76 ; 1.76A STRUCTURE OF UROCANATE HYDRATASE FROM PSEUDOMONAS PUTIDA 1Y7R ; 1.70 ; 1.7A CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN SA2161 FROM METICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS 1P99 ; 1.70 ; 1.7A CRYSTAL STRUCTURE OF PROTEIN PG110 FROM STAPHYLOCOCCUS AUREUS 1T8H ; 1.80 ; 1.8 A CRYSTAL STRUCTURE OF AN UNCHARACTERIZED B. STEAROTHERMOPHILUS PROTEIN 1I6N ; 1.80 ; 1.8 A CRYSTAL STRUCTURE OF IOLI PROTEIN WITH A BINDING ZINC ATOM 1JUE ; 1.80 ; 1.8 A RESOLUTION STRUCTURE OF NATIVE LACTOCOCCUS LACTIS DIHYDROOROTATE DEHYDROGENASE A 406D ; 1.80 ; 1.8 ANGSTROM CRYSTAL STRUCTURE OF A STATICALLY DISORDERED 17 BASE PAIR RIBONUCLEIC ACID DUPLEX: DIRECT CONTACTS BETWEEN CLOSE PACKED RIBONUCLEIC ACID HELICES ARE MEDIATED BY SEQUENCE INDEPENDENT "ZIPPER" INTERACTIONS 1IMX ; 1.82 ; 1.8 ANGSTROM CRYSTAL STRUCTURE OF IGF-1 1MI3 ; 1.80 ; 1.8 ANGSTROM STRUCTURE OF XYLOSE REDUCTASE FROM CANDIDA TENUIS IN COMPLEX WITH NADH 1ODO ; 1.85 ; 1.85 A STRUCTURE OF CYP154A1 FROM STREPTOMYCES COELICOLOR A3(2) 1U6E ; 1.85 ; 1.85 ANGSTROM CRYSTAL STRUCTURE OF THE C112A MUTANT OF MYCOBACTERIUM TUBERCULOSIS BETA-KETOACYL-ACYL CARRIER PROTEIN SYNTHASE III (FABH) 1XFK ; 1.80 ; 1.8A CRSYTAL STRUCUTRE OF FORMIMINOGLUTAMASE FROM VIBRIO CHOLERAE O1 BIOVAR ELTOR STR. N16961 1HUQ ; 1.80 ; 1.8A CRYSTAL STRUCTURE OF THE MONOMERIC GTPASE RAB5C (MOUSE) 1LJ5 ; 1.80 ; 1.8A RESOLUTION STRUCTURE OF LATENT PLASMINOGEN ACTIVATOR INHIBITOR-1(PAI-1) 1IG1 ; 1.80 ; 1.8A X-RAY STRUCTURE OF TERNARY COMPLEX OF A CATALYTIC DOMAIN OF DEATH-ASSOCIATED PROTEIN KINASE WITH ATP ANALOGUE AND MN. 1C4W ; 1.84 ; 1.9 A STRUCTURE OF A-THIOPHOSPHONATE MODIFIED CHEY D57C 1O0E ; 1.90 ; 1.9 ANGSTROM CRYSTAL STRUCTURE OF A PLANT CYSTEINE PROTEASE ERVATAMIN C 1Z9O ; 1.90 ; 1.9 ANGSTROM CRYSTAL STRUCTURE OF THE RAT VAP-A MSP HOMOLOGY DOMAIN IN COMPLEX WITH THE RAT ORP1 FFAT MOTIF 2AFQ ; 1.93 ; 1.9 ANGSTROM CRYTAL STRUCTURE OF WILD-TYPE HUMAN THROMBIN IN THE SODIUM FREE STATE 1EQ6 ; 1.90 ; 1.9 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE SACCHAROMYCES CEREVISIAE RAN-BINDING PROTEIN MOG1P 1XW6 ; 1.90 ; 1.9 ANGSTROM RESOLUTION STRUCTURE OF HUMAN GLUTATHIONE S- TRANSFERASE M1A-1A COMPLEXED WITH GLUTATHIONE 1O6Z ; 1.95 ; 1.95 A RESOLUTION STRUCTURE OF (R207S,R292S) MUTANT OF MALATE DEHYDROGENASE FROM THE HALOPHILIC ARCHAEON HALOARCULA MARISMORTUI (HOLO FORM) 1SUG ; 1.95 ; 1.95 A STRUCTURE OF APO PROTEIN TYROSINE PHOSPHATASE 1B 1U18 ; 1.96 ; 1.96 A CRYSTAL STRUCTURE OF H60C MUTANT OF NITROPHORIN COMPLEXED WITH HISTAMINE 1M5W ; 1.96 ; 1.96 A CRYSTAL STRUCTURE OF PYRIDOXINE 5'-PHOSPHATE SYNTHASE IN COMPLEX WITH 1-DEOXY-D-XYLULOSE PHOSPHATE 1YDP ; 1.90 ; 1.9A CRYSTAL STRUCTURE OF HLA-G 1R4V ; 1.90 ; 1.9A CRYSTAL STRUCTURE OF PROTEIN AQ328 FROM AQUIFEX AEOLICUS 1SFL ; 1.90 ; 1.9A CRYSTAL STRUCTURE OF STAPHYLOCOCCUS AUREUS TYPE I 3- DEHYDROQUINASE, APO FORM 1G6L ; 1.90 ; 1.9A CRYSTAL STRUCTURE OF TETHERED HIV-1 PROTEASE 1XBW ; 1.90 ; 1.9A CRYSTAL STRUCTURE OF THE PROTEIN ISDG FROM STAPHYLOCOCCUS AUREUS AUREUS, STRUCTURAL GENOMICS, MCSG 1CE1 ; 1.90 ; 1.9A STRUCTURE OF THE THERAPEUTIC ANTIBODY CAMPATH-1H FAB IN COMPLEX WITH A SYNTHETIC PEPTIDE ANTIGEN 1K43 ; -1.00 ; 10 STRUCTURE ENSEMBLE OF THE 14-RESIDUE PEPTIDE RG-KWTY-NG- ITYE-GR (MBH12) 2GPN ; 1.99 ; 100 K STRUCTURE OF GLYCOGEN PHOSPHORYLASE AT 2.0 ANGSTROMS RESOLUTION 1FYI ; -1.00 ; 11-MER DEOXYRIBONUCLEIC ACID DUPLEX CONTAINING A 2'-DEOXYARISTEROMYCIN 8-OXO- GUANINE BASE PAIR; 1Q45 ; 2.00 ; 12-0XO-PHYTODIENOATE REDUCTASE ISOFORM 3 1BSO ; 2.23 ; 12-BROMODODECANOIC ACID BINDS INSIDE THE CALYX OF BOVINE BETA-LACTOGLOBULIN 1RSX ; -1.00 ; 12-MER FROM SITE II CALBINDIN D9K (DKNGDGEVSFEE) COORDINATING CD(II) 1RT0 ; -1.00 ; 12-MER FROM SITE II CALBINDIN D9K (DKNGDGEVSFEE) COORDINATING ZN(II) 1RSW ; -1.00 ; 12-MER FROM SITE II CALBINDIN D9K (DKNGDGEVSFEE) COORDINATION PB(II) 1ZJE ; 2.10 ; 12MER-SPD 1ZJF ; 2.20 ; 12MER-SPD-P4N 1ZJG ; 3.00 ; 13MER-CO 2BQ0 ; 2.50 ; 14-3-3 PROTEIN BETA (HUMAN) 2C23 ; 2.65 ; 14-3-3 PROTEIN BETA (HUMAN) IN COMPLEX WITH EXOENZYME S PEPTIDE 2BR9 ; 1.75 ; 14-3-3 PROTEIN EPSILON (HUMAN) COMPLEXED TO PEPTIDE 2C63 ; 2.15 ; 14-3-3 PROTEIN ETA (HUMAN) COMPLEXED TO PEPTIDE 2C74 ; 2.70 ; 14-3-3 PROTEIN ETA (HUMAN) COMPLEXED TO PEPTIDE 2BTP ; 2.80 ; 14-3-3 PROTEIN THETA (HUMAN) COMPLEXED TO PEPTIDE 1A37 ; 3.60 ; 14-3-3 PROTEIN ZETA BOUND TO PS-RAF259 PEPTIDE 1A38 ; 3.35 ; 14-3-3 PROTEIN ZETA BOUND TO R18 PEPTIDE 1A4O ; 2.90 ; 14-3-3 PROTEIN ZETA ISOFORM 1QJB ; 2.00 ; 14-3-3 ZETA/PHOSPHOPEPTIDE COMPLEX (MODE 1) 1QJA ; 2.00 ; 14-3-3 ZETA/PHOSPHOPEPTIDE COMPLEX (MODE 2) 1B4L ; 1.80 ; 15 ATMOSPHERE OXYGEN YEAST CU/ZN SUPEROXIDE DISMUTASE ROOM TEMPERATURE (298K) STRUCTURE 1AT0 ; 1.90 ; 17-KDA FRAGMENT OF HEDGEHOG C-TERMINAL AUTOPROCESSING DOMAIN 1GV8 ; 1.95 ; 18 KDA FRAGMENT OF N-II DOMAIN OF DUCK OVOTRANSFERRIN 1ZNT ; -1.00 ; 18 NMR STRUCTURES OF ACAMP2-LIKE PEPTIDE WITH NON NATURAL FLUOROAROMATIC RESIDUE (ACAMP2F18PFF/Y20PFF) COMPLEX WITH N,N,N-TRIACETYLCHITOTRIOSE 1NP8 ; 2.00 ; 18-K C-TERMINALLY TRUNUCATED SMALL SUBUNIT OF CALPAIN 1GVC ; 1.90 ; 18KDA N-II DOMAIN FRAGMENT OF DUCK OVOTRANSFERRIN + NTA 1RUZ ; 2.90 ; 1918 H1 HEMAGGLUTININ 1RVT ; 2.50 ; 1930 H1 HEMAGGLUTININ IN COMPLEX WITH LSTC 1RUY ; 2.70 ; 1930 SWINE H1 HEMAGGLUTININ 1RV0 ; 2.50 ; 1930 SWINE H1 HEMAGGLUTININ COMPLEXED WITH LSTA 1RVX ; 2.20 ; 1934 H1 HEMAGGLUTININ IN COMPLEX WITH LSTA 1RVZ ; 2.25 ; 1934 H1 HEMAGGLUTININ IN COMPLEX WITH LSTC 1RU7 ; 2.30 ; 1934 HUMAN H1 HEMAGGLUTININ 1FYH ; 2.04 ; 1:1 COMPLEX BETWEEN AN INTERFERON GAMMA SINGLE-CHAIN VARIANT AND ITS RECEPTOR 1HWH ; 2.90 ; 1:1 COMPLEX OF HUMAN GROWTH HORMONE MUTANT G120R WITH ITS SOLUBLE BINDING PROTEIN 1HWG ; 2.50 ; 1:2 COMPLEX OF HUMAN GROWTH HORMONE WITH ITS SOLUBLE BINDING PROTEIN 1EN3 ; 0.98 ; 1A CRYSTAL STRUCTURES OF B-DEOXYRIBONUCLEIC ACID REVEAL SEQUENCE-SPECIFIC BINDING AND GROOVE-SPECIFIC BENDING OF DEOXYRIBONUCLEIC ACID BY MAGNESIUM AND CALCIUM 1EN9 ; 0.98 ; 1A CRYSTAL STRUCTURES OF B-DEOXYRIBONUCLEIC ACID REVEAL SEQUENCE-SPECIFIC BINDING AND GROOVE-SPECIFIC BENDING OF DEOXYRIBONUCLEIC ACID BY MAGNESIUM AND CALCIUM. 1ENE ; 0.98 ; 1A CRYSTAL STRUCTURES OF B-DEOXYRIBONUCLEIC ACID REVEAL SEQUENCE-SPECIFIC BINDING AND GROOVE-SPECIFIC BENDING OF DEOXYRIBONUCLEIC ACID BY MAGNESIUM AND CALCIUM. 1S0W ; 2.30 ; 1B LACTAMSE/ B LACTAMASE INHIBITOR 1BJ6 ; -1.00 ; 1H NMR OF (12-53) NCP7/D(ACGCC) COMPLEX, 10 STRUCTURES 1DF6 ; -1.00 ; 1H NMR SOLUTION STRUCTURE OF CYCLOVIOLACIN O1 1Q3M ; -1.00 ; 1H NMR STRUCTURE BUNDLE OF BOVINE CA2+-OSTEOCALCIN 1ORL ; -1.00 ; 1H NMR STRUCTURE DETERMINATION OF VISCOTOXIN C1 1Y9O ; -1.00 ; 1H NMR STRUCTURE OF ACYLPHOSPHATASE FROM THE HYPERTHERMOPHILE SULFOLOBUS SOLFATARICUS 1MMC ; -1.00 ; 1H NMR STUDY OF THE SOLUTION STRUCTURE OF AC-AMP2 1ESX ; -1.00 ; 1H, 15N AND 13C STRUCTURE OF THE HIV-1 REGULATORY PROTEIN VPR : COMPARISON WITH THE N-AND C-TERMINAL DOMAIN STRUCTURE, (1-51)VPR AND (52-96)VPR 1G47 ; -1.00 ; 1ST LIM DOMAIN OF PINCH PROTEIN 4A3H ; 1.65 ; 2',4' DINITROPHENYL-2-DEOXY-2-FLURO-B-D-CELLOBIOSIDE COMPLEX OF THE ENDOGLUCANASE CEL5A FROM BACILLUS AGARADHAERENS AT 1.6 A RESOLUTION 1BHR ; -1.00 ; 2'-DEOXY-ISOGUANOSINE BASE PAIRED TO THYMIDINE, NMR, MINIMIZED AVERAGE STRUCTURE 1Z7I ; 1.28 ; 2'-ME-SE DERIVITATION OF A-DEOXYRIBONUCLEIC ACID OCTAMER G(UMSE)GTACAC 1EIL ; 2.00 ; 2,3-DIHYDROXYBIPHENYL-1,2-DIOXYGENASE 1EIQ ; 2.00 ; 2,3-DIHYDROXYBIPHENYL-1,2-DIOXYGENASE 1EIR ; 2.00 ; 2,3-DIHYDROXYBIPHENYL-1,2-DIOXYGENASE 1FC4 ; 2.00 ; 2-AMINO-3-KETOBUTYRATE COA LIGASE 1DXE ; 1.80 ; 2-DEHYDRO-3-DEOXY-GALACTARATE ALDOLASE FROM ESCHERICHIA COLI 1DXF ; 2.60 ; 2-DEHYDRO-3-DEOXY-GALACTARATE ALDOLASE FROM ESCHERICHIA COLI IN COMPLEX WITH PYRUVATE 1E4I ; 2.00 ; 2-DEOXY-2-FLUORO-BETA-D-GLUCOSYL/ENZYME INTERMEDIATE COMPLEX OF THE BETA-GLUCOSIDASE FROM BACILLUS POLYMYXA 5A3H ; 1.82 ; 2-DEOXY-2-FLURO-B-D-CELLOBIOSYL/ENZYME INTERMEDIATE COMPLEX OF THE ENDOGLUCANASE CEL5A FROM BACILLUS AGARADHEARANS AT 1.8 ANGSTROMS RESOLUTION 1H11 ; 1.08 ; 2-DEOXY-2-FLURO-B-D-CELLOTRIOSYL/ENZYME INTERMEDIATE COMPLEX OF THE ENDOGLUCANASE CEL5A FROM BACILLUS AGARADHEARANS AT 1.08 ANGSTROM RESOLUTION 6A3H ; 1.68 ; 2-DEOXY-2-FLURO-B-D-CELLOTRIOSYL/ENZYME INTERMEDIATE COMPLEX OF THE ENDOGLUCANASE CEL5A FROM BACILLUS AGARADHEARANS AT 1.6 ANGSTROM RESOLUTION 1DUB ; 2.50 ; 2-ENOYL-COA HYDRATASE, DATA COLLECTED AT 100 K, PH 6.5 1E70 ; 1.65 ; 2-F-GLUCOSYLATED MYROSINASE FROM SINAPIS ALBA 1E73 ; 1.50 ; 2-F-GLUCOSYLATED MYROSINASE FROM SINAPIS ALBA WITH BOUND L-ASCORBATE 1C4X ; 2.40 ; 2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIENOATE HYDROLASE (BPHD) FROM RHODOCOCCUS SP. STRAIN RHA1 1V19 ; 2.30 ; 2-KETO-3-DEOXYGLUCONATE KINASE FROM THERMUS THERMOPHILUS 1V1S ; 3.20 ; 2-KETO-3-DEOXYGLUCONATE KINASE FROM THERMUS THERMOPHILUS (CRYSTAL FORM 2) 1V1A ; 2.10 ; 2-KETO-3-DEOXYGLUCONATE KINASE FROM THERMUS THERMOPHILUS WITH BOUND 2-KETO-3-DEOXYGLUCONATE AND ADP 1V1B ; 2.60 ; 2-KETO-3-DEOXYGLUCONATE KINASE FROM THERMUS THERMOPHILUS WITH BOUND ATP 1W37 ; 2.00 ; 2-KETO-3-DEOXYGLUCONATE(KDG) ALDOLASE OF SULFOLOBUS SOLFATARICUS 1Z01 ; 1.80 ; 2-OXOQUINOLINE 8-MONOOXYGENASE COMPONENT: ACTIVE SITE MODULATION BY RIESKE-[2FE-2S] CENTER OXIDATION/REDUCTION 1Z02 ; 1.80 ; 2-OXOQUINOLINE 8-MONOOXYGENASE COMPONENT: ACTIVE SITE MODULATION BY RIESKE-[2FE-2S] CENTER OXIDATION/REDUCTION 1Z03 ; 1.80 ; 2-OXOQUINOLINE 8-MONOOXYGENASE COMPONENT: ACTIVE SITE MODULATION BY RIESKE-[2FE-2S] CENTER OXIDATION/REDUCTION 1EE0 ; 2.05 ; 2-PYRONE SYNTHASE COMPLEXED WITH ACETOACETYL-COA 1R7L ; 2.00 ; 2.0 A CRYSTAL STRUCTURE OF A PHAGE PROTEIN FROM BACILLUS CEREUS ATCC 14579 1MUU ; 2.00 ; 2.0 A CRYSTAL STRUCTURE OF GDP-MANNOSE DEHYDROGENASE 1NG5 ; 2.00 ; 2.0 A CRYSTAL STRUCTURE OF STAPHYLOCOCCUS AUREUS SORTASE B 2BE6 ; 2.00 ; 2.0 A CRYSTAL STRUCTURE OF THE CAV1.2 IQ DOMAIN-CA/CAM COMPLEX 1DM1 ; 1.99 ; 2.0 A CRYSTAL STRUCTURE OF THE DOUBLE MUTANT H(E7)V, T(E10) R OF MYOGLOBIN FROM APLYSIA LIMACINA 1NI9 ; 2.00 ; 2.0 A STRUCTURE OF GLYCEROL METABOLISM PROTEIN FROM E. COLI 1NIG ; 2.00 ; 2.0 A STRUCTURE OF HYPOTHETICAL PROTEIN FROM THERMOPLASMA ACIDOPHILUM 1MI8 ; 2.00 ; 2.0 ANGSTROM CRYSTAL STRUCTURE OF A DNAB INTEIN FROM SYNECHOCYSTIS SP. PCC 6803 1Q4G ; 2.00 ; 2.0 ANGSTROM CRYSTAL STRUCTURE OF OVINE PROSTAGLANDIN H2 SYNTHASE-1, IN COMPLEX WITH ALPHA-METHYL-4-BIPHENYLACETIC ACID 1N2Z ; 2.00 ; 2.0 ANGSTROM STRUCTURE OF BTUF, THE VITAMIN B12 BINDING PROTEIN OF E. COLI 1QLP ; 2.00 ; 2.0 ANGSTROM STRUCTURE OF INTACT ALPHA-1-ANTITRYPSIN: A CANONICAL TEMPLATE FOR ACTIVE SERPINS 2AFG ; 2.00 ; 2.0 ANGSTROM X-RAY STRUCTURE OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR 2C3C ; 2.15 ; 2.01 ANGSTROM X-RAY CRYSTAL STRUCTURE OF A MIXED DISULFIDE BETWEEN COENZYME M AND NADPH-DEPENDENT OXIDOREDUCTASE 2- KETOPROPYL COENZYME M CARBOXYLASE 1QQH ; 2.10 ; 2.1 A CRYSTAL STRUCTURE OF THE HUMAN PAPILLOMAVIRUS TYPE 18 E2 ACTIVATION DOMAIN 1QDR ; 2.10 ; 2.1 A RESOLUTION STRUCTURE OF ESCHERICHIA COLI LYTIC TRANSGLYCOSYLASE SLT35 1QDT ; 2.10 ; 2.1 A RESOLUTION STRUCTURE OF ESCHERICHIA COLI LYTIC TRANSGLYCOYSLASE SLT35 IN COMPLEX WITH CALCIUM 1QYR ; 2.10 ; 2.1 ANGSTROM CRYSTAL STRUCTURE OF KSGA: A UNIVERSALLY CONSERVED ADENOSINE DIMETHYLTRANSFERASE 1VF6 ; 2.10 ; 2.1 ANGSTROM CRYSTAL STRUCTURE OF THE PALS-1-L27N AND PATJ L27 HETERODIMER COMPLEX 1G6N ; 2.10 ; 2.1 ANGSTROM STRUCTURE OF CAP-CAMP 2A5H ; 2.10 ; 2.1 ANGSTROM X-RAY CRYSTAL STRUCTURE OF LYSINE-2,3- AMINOMUTASE FROM CLOSTRIDIUM SUBTERMINALE SB4, WITH MICHAELIS ANALOG (L-ALPHA-LYSINE EXTERNAL ALDIMINE FORM OF PYRIDOXAL-5'-PHOSPHATE). 4WBC ; 2.14 ; 2.13 A STRUCTURE OF A KUNITZ-TYPE WINGED BEAN CHYMOTRYPSIN INHIBITOR PROTEIN 2C3D ; 2.15 ; 2.15 ANGSTROM CRYSTAL STRUCTURE OF 2-KETOPROPYL COENZYME M OXIDOREDUCTASE CARBOXYLASE WITH A COENZYME M DISULFIDE BOUND AT THE ACTIVE SITE 1H5W ; 2.10 ; 2.1A BACTERIOPHAGE PHI-29 CONNECTOR 1EK9 ; 2.10 ; 2.1A X-RAY STRUCTURE OF TOLC: AN INTEGRAL OUTER MEMBRANE PROTEIN AND EFFLUX PUMP COMPONENT FROM ESCHERICHIA COLI 2WGC ; 2.20 ; 2.2 Angstroms Resolution Structure Analysis of Two Refined N-Acetylneuraminyllactose-Wheat Germ Agglutinin Isolectin Complexes 7WGA ; 2.00 ; 2.2 Angstroms Resolution Structure Analysis of Two Refined N-Acetylneuraminyllactose-Wheat Germ Agglutinin Isolectin Complexes 9WGA ; 1.80 ; 2.2 Angstroms Resolution Structure Analysis of Two Refined N-Acetylneuraminyllactose-Wheat Germ Agglutinin Isolectin Complexes 1Z7H ; 2.30 ; 2.3 ANGSTROM CRYSTAL STRUCTURE OF TETANUS NEUROTOXIN LIGHT CHAIN 1XWK ; 2.30 ; 2.3 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF HUMAN GLUTATHIONE S-TRANSFERASE M1A-1A COMPLEXED WITH GLUTATHIONYL-S-DINITROBENZENE 1S6Y ; 2.31 ; 2.3A CRYSTAL STRUCTURE OF PHOSPHO-BETA-GLUCOSIDASE 1EEP ; 2.40 ; 2.4 A RESOLUTION CRYSTAL STRUCTURE OF BORRELIA BURGDORFERI INOSINE 5'-MONPHOSPHATE DEHYDROGENASE IN COMPLEX WITH A SULFATE ION 1I2X ; 2.40 ; 2.4 A STRUCTURE OF A-DUPLEX WITH BULGED ADENOSINE, SPERMIDINE FORM 1IHH ; 2.40 ; 2.4 ANGSTROM CRYSTAL STRUCTURE OF AN OXALIPLATIN 1,2-D(GPG) INTRASTRAND CROSS-LINK IN A DEOXYRIBONUCLEIC ACID DODECAMER DUPLEX 1LU5 ; 2.40 ; 2.4 ANGSTROM CRYSTAL STRUCTURE OF THE ASYMMETRIC PLATINUM COMPLEX {PT(AMMINE)(CYCLOHEXYLAMINE)}2+ BOUND TO A DODECAMER DEOXYRIBONUCLEIC ACID DUPLEX 1SFJ ; 2.40 ; 2.4A CRYSTAL STRUCTURE OF STAPHYLOCOCCUS AUREUS TYPE I 3- DEHYDROQUINASE, WITH 3-DEHYDROQUINATE BOUND 1JKK ; 2.40 ; 2.4A X-RAY STRUCTURE OF TERNARY COMPLEX OF A CATALYTIC DOMAIN OF DEATH-ASSOCIATED PROTEIN KINASE WITH ATP ANALOGUE AND MG. 1X87 ; 2.40 ; 2.4A X-RAY STRUCTURE OF UROCANASE PROTEIN COMPLEXED WITH NAD 1RC2 ; 2.50 ; 2.5 ANGSTROM RESOLUTION X-RAY STRUCTURE OF AQUAPORIN Z 1TB6 ; 2.50 ; 2.5A CRYSTAL STRUCTURE OF THE ANTITHROMBIN-THROMBIN-HEPARIN TERNARY COMPLEX 1RD3 ; 2.50 ; 2.5A STRUCTURE OF ANTICOAGULANT THROMBIN VARIANT E217K 1F66 ; 2.60 ; 2.6 A CRYSTAL STRUCTURE OF A NUCLEOSOME CORE PARTICLE CONTAINING THE VARIANT HISTONE H2A.Z 1OJU ; 2.79 ; 2.8 A RESOLUTION STRUCTURE OF MALATE DEHYDROGENASE FROM ARCHAEOGLOBUS FULGIDUS IN COMPLEX WITH ETHENO-NAD. 1YSC ; 2.80 ; 2.8 Angstroms Structure of Yeast Serine Carboxypeptidase 2AAT ; 2.80 ; 2.8-Angstroms-Resolution Crystal Structure of an Active-Site Mutant of Aspartate Aminotransferase from Escherichia Coli 1IMV ; 2.85 ; 2.85 A CRYSTAL STRUCTURE OF PEDF 1D2R ; 2.90 ; 2.9 A CRYSTAL STRUCTURE OF LIGAND-FREE TRYPTOPHANYL-TRNA SYNTHETASE: DOMAIN MOVEMENTS FRAGMENT THE ADENINE NUCLEOTIDE BINDING SITE. 1NTA ; 2.90 ; 2.9 A CRYSTAL STRUCTURE OF STREPTOMYCIN RIBONUCLEIC ACID-APTAMER 1NTB ; 2.90 ; 2.9 A CRYSTAL STRUCTURE OF STREPTOMYCIN RIBONUCLEIC ACID-APTAMER COMPLEX 1OJS ; 2.90 ; 2.9 A RESOLUTION STRUCTURE OF MALATE DEHYDROGENASE FROM ARCHAEOGLOBUS FULGIDUS IN COMPLEX WITH NADH. 1C8O ; 2.90 ; 2.9 A STRUCTURE OF CLEAVED VIRAL SERPIN CRMA 1F5O ; 2.90 ; 2.9 ANGSTROM CRYSTAL STRUCTURE OF DEOXYGENATED LAMPREY HEMOGLOBIN V IN THE SPACE GROUP P2(1)2(1)2(1) 1F5P ; 2.90 ; 2.9 ANGSTROM CRYSTAL STRUCTURE OF LAMPREY HEMOGLOBIN THAT HAS BEEN EXPOSED TO CARBON MONOXIDE. 1J2Q ; 2.83 ; 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS 1HCW ; -1.00 ; 23-RESIDUE DESIGNED METAL-FREE PEPTIDE BASED ON THE ZINC FINGER DOMAINS, NMR, 35 STRUCTURES 1GZ0 ; 2.50 ; 23S RIBOSOMAL RIBONUCLEIC ACID G2251 2'O-METHYLTRANSFERASE RLMB 1C2W ; 7.50 ; 23S RRNA STRUCTURE FITTED TO A CRYO-ELECTRON MICROSCOPIC MAP AT 7.5 ANGSTROMS RESOLUTION 1ZUV ; -1.00 ; 24 NMR STRUCTURES OF ACAMP2-LIKE PEPTIDE WITH PHENYLALANINE 18 MUTATED TO TRYPTOPHAN 1RHT ; -1.00 ; 24-MER RIBONUCLEIC ACID HAIRPIN COAT PROTEIN BINDING SITE FOR BACTERIOPHAGE R17 (NMR, MINIMIZED AVERAGE STRUCTURE) 1T0W ; -1.00 ; 25 NMR STRUCTURES OF TRUNCATED HEVEIN OF 32 AA (HEVEIN-32) COMPLEX WITH N,N,N-TRIACETYLGLUCOSAMINA 1OE7 ; 1.80 ; 28KDA GLUTATHIONE S-TRANSFERASE FROM SCHISTOSOMA HAEMATOBIUM 1OE8 ; 1.65 ; 28KDA GLUTATHIONE S-TRANSFERASE FROM SCHISTOSOMA HAEMATOBIUM (GLUTATHIONE SATURATED) 1D4R ; 2.00 ; 29-MER FRAGMENT OF HUMAN SRP RIBONUCLEIC ACID HELIX 6 1A0Q ; 2.30 ; 29G11 COMPLEXED WITH PHENYL [1-(1-N-SUCCINYLAMINO)PENTYL] PHOSPHONATE 1CD9 ; 2.80 ; 2:2 COMPLEX OF G-CSF WITH ITS RECEPTOR 1PGR ; 3.50 ; 2:2 COMPLEX OF G-CSF WITH ITS RECEPTOR 2HRV ; 1.95 ; 2A CYSTEINE PROTEINASE FROM HUMAN RHINOVIRUS 2 1JY8 ; 2.50 ; 2C-METHYL-D-ERYTHRITOL 2,4-CYCLODIPHOSPHATE SYNTHASE (ISPF) 1MWA ; 2.40 ; 2C/H-2KBM3/DEV8 ALLOGENEIC COMPLEX 12E8 ; 1.90 ; 2E8 FAB FRAGMENT 1DOI ; 1.90 ; 2FE-2S FERREDOXIN FROM HALOARCULA MARISMORTUI 1OFF ; 1.80 ; 2FE-2S FERREDOXIN FROM SYNECHOCYSTIS SP. PCC 6803 2BYG ; 1.85 ; 2ND PDZ DOMAIN OF DISCS LARGE HOMOLOGUE 2 2FDN ; 0.94 ; 2[4FE-4S] FERREDOXIN FROM CLOSTRIDIUM ACIDI-URICI 1MFJ ; -1.00 ; 3' STEM-LOOP FROM HUMAN U4 SNRNA 398D ; 1.94 ; 3'-DEOXYRIBONUCLEIC ACID-RIBONUCLEIC ACID-5' JUNCTION FORMED DURING INITIATION OF MINUS-STRAND SYNTHESIS OF HIV REPLICATION 1B99 ; 2.70 ; 3'-FLUORO-URIDINE DIPHOSPHATE BINDING TO NUCLEOSIDE DIPHOSPHATE KINASE 1BUX ; 2.80 ; 3'-PHOSPHORYLATED NUCLEOTIDES BINDING TO NUCLEOSIDE DIPHOSPHATE KINASE 1PVW ; 2.45 ; 3,4-DIHYDROXY-2-BUTANONE 4-PHOSPHATE SYNTHASE FROM M. JANNASCHII 1PVY ; 1.70 ; 3,4-DIHYDROXY-2-BUTANONE 4-PHOSPHATE SYNTHASE FROM M. JANNASCHII IN COMPLEX WITH RIBULOSE 5-PHOSPHATE 1SNN ; 1.55 ; 3,4-DIHYDROXY-2-BUTANONE 4-PHOSPHATE SYNTHASE FROM METHANOCOCCUS JANNASCHII 1B6Y ; -1.00 ; 3,N4-ETHENO-2'-DEOXYCYTIDINE OPPOSITE ADENINE IN AN 11-MER DUPLEX, SOLUTION STRUCTURE FROM NMR AND MOLECULAR DYNAMICS, 2 STRUCTURES 1B60 ; -1.00 ; 3,N4-ETHENO-2'-DEOXYCYTIDINE OPPOSITE CYTIDINE IN AN 11-MER DUPLEX, SOLUTION STRUCTURE FROM NMR AND MOLECULAR DYNAMICS 1B6X ; -1.00 ; 3,N4-ETHENO-2'-DEOXYCYTIDINE OPPOSITE GUANINE IN AN 11-MER DUPLEX, SOLUTION STRUCTURE FROM NMR AND MOLECULAR DYNAMICS, 4 STRUCTURES 1B5K ; -1.00 ; 3,N4-ETHENO-2'-DEOXYCYTIDINE OPPOSITE THYMIDINE IN AN 11- MER DUPLEX, SOLUTION STRUCTURE FROM NMR AND MOLECULAR DYNAMICS 2BYH ; 1.90 ; 3-(5-CHLORO-2,4-DIHYDROXYPHENYL)-PYRAZOLE-4-CARBOXAMIDES AS INHIBITORS OF THE HSP90 MOLECULAR CHAPERONE 2BYI ; 1.60 ; 3-(5-CHLORO-2,4-DIHYDROXYPHENYL)-PYRAZOLE-4-CARBOXAMIDES AS INHIBITORS OF THE HSP90 MOLECULAR CHAPERONE 1LWI ; 2.70 ; 3-ALPHA-HYDROXYSTEROID/DIHYDRODIOL DEHYDROGENASE FROM RATTUS NORVEGICUS 1SYM ; -1.00 ; 3-D SOLUTION STRUCTURE OF REDUCED APO-S100B FROM RAT, NMR, 20 STRUCTURES 1DZA ; 1.65 ; 3-D STRUCTURE OF A HP-RNASE 1GM6 ; 2.13 ; 3-D STRUCTURE OF A SALIVARY LIPOCALIN FROM BOAR 2DHQ ; 2.00 ; 3-DEHYDROQUINATE DEHYDRATASE FROM MYCOBACTERIUM TUBERCULOSIS 1H0S ; 1.70 ; 3-DEHYDROQUINATE DEHYDRATASE FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH 3-HYDROXYIMINO-QUINIC ACID 1H05 ; 1.50 ; 3-DEHYDROQUINATE DEHYDRATASE FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH SULPHATE 1Q9H ; 2.35 ; 3-DIMENSIONAL STRUCTURE OF NATIVE CEL7A FROM TALAROMYCES EMERSONII 1CNZ ; 1.76 ; 3-ISOPROPYLMALATE DEHYDROGENASE (IPMDH) FROM SALMONELLA TYPHIMURIUM 1WAL ; 2.27 ; 3-ISOPROPYLMALATE DEHYDROGENASE (IPMDH) MUTANT (M219A)FROM THERMUS THERMOPHILUS 1CM7 ; 2.06 ; 3-ISOPROPYLMALATE DEHYDROGENASE FROM ESCHERICHIA COLI 2AYQ ; 3.00 ; 3-ISOPROPYLMALATE DEHYDROGENASE FROM THE MODERATE FACULTATIVE THERMOPHILE, BACILLUS COAGULANS 1IDM ; 2.10 ; 3-ISOPROPYLMALATE DEHYDROGENASE, LOOP-DELETED CHIMERA 1XAA ; 2.10 ; 3-ISOPROPYLMALATE DEHYDROGENASE, LOW TEMPERATURE (100K) STRUCTURE 1XAB ; 2.10 ; 3-ISOPROPYLMALATE DEHYDROGENASE, LOW TEMPERATURE (150K) STRUCTURE 1OKG ; 2.10 ; 3-MERCAPTOPYRUVATE SULFURTRANSFERASE FROM LEISHMANIA MAJOR 1MPG ; 1.80 ; 3-METHYLADENINE DEOXYRIBONUCLEIC ACID GLYCOSYLASE II FROM ESCHERICHIA COLI 1PVS ; 2.40 ; 3-METHYLADENINE GLCOSYLASE II(ALKA) HYPOXANTHINE COMPLEX 1ISK ; -1.00 ; 3-OXO-DELTA5-STEROID ISOMERASE, NMR, 20 STRUCTURES 1QPG ; 2.40 ; 3-PHOSPHOGLYCERATE KINASE, MUTATION R65Q 1H6Z ; 3.00 ; 3.0 A RESOLUTION CRYSTAL STRUCTURE OF GLYCOSOMAL PYRUVATE PHOSPHATE DIKINASE FROM TRYPANOSOMA BRUCEI 364D ; 3.00 ; 3.0 A STRUCTURE OF FRAGMENT I FROM E. COLI 5S RRNA 1XQJ ; 3.10 ; 3.10 A CRYSTAL STRUCTURE OF MASPIN, SPACE GROUP I 4 2 2 1XQG ; 3.10 ; 3.10 A CRYSTAL STRUCTURE OF MASPIN, SPACE GROUP P 4 21 2 357D ; 3.50 ; 3.5 A STRUCTURE OF FRAGMENT I FROM E. COLI 5S RRNA 1ZWU ; -1.00 ; 30 NMR STRUCTURES OF ACAMP2-LIKE PEPTIDE WITH NON NATURAL BETA-(2-NAPHTHYL)-ALANINE RESIDUE. 1L5I ; -1.00 ; 30-CONFORMER NMR ENSEMBLE OF THE N-TERMINAL, DEOXYRIBONUCLEIC ACID-BINDING DOMAIN OF THE REPLICATION INITIATION PROTEIN FROM A GEMINIVIRUS (TOMATO YELLOW LEAF CURL VIRUS-SARDINIA) 1U86 ; -1.00 ; 321-TW-322 INSERTION MUTANT OF THE THIRD ZINC FINGER OF BKLF 1FG9 ; 2.90 ; 3:1 COMPLEX OF INTERFERON-GAMMA RECEPTOR WITH INTERFERON- GAMMA DIMER 1N0Q ; 1.26 ; 3ANK: A DESIGNED ANKYRIN REPEAT PROTEIN WITH THREE IDENTICAL CONSENSUS REPEATS 2BHG ; 1.90 ; 3C PROTEASE FROM TYPE A10(61) FOOT-AND-MOUTH DISEASE VIRUS 1TIJ ; 3.03 ; 3D DOMAIN-SWAPPED HUMAN CYSTATIN C WITH AMYLOID-LIKE INTERMOLECULAR BETA-SHEETS 1U34 ; -1.00 ; 3D NMR STRUCTURE OF THE FIRST EXTRACELLULAR DOMAIN OF CRFR- 2BETA, A TYPE B1 G-PROTEIN COUPLED RECEPTOR 1J47 ; -1.00 ; 3D SOLUTION NMR STRUCTURE OF THE M9I MUTANT OF THE HMG-BOX DOMAIN OF THE HUMAN MALE SEX DETERMINING FACTOR SRY COMPLEXED TO DEOXYRIBONUCLEIC ACID 1J46 ; -1.00 ; 3D SOLUTION NMR STRUCTURE OF THE WILD TYPE HMG-BOX DOMAIN OF THE HUMAN MALE SEX DETERMINING FACTOR SRY COMPLEXED TO DEOXYRIBONUCLEIC ACID 1AWZ ; -1.00 ; 3D SOLUTION STRUCTURE OF HUMAN ANGIOGENIN DETERMINED BY 1H, 15N NMR SPECTROSCOPY, 30 STRUCTURES 1XJ1 ; -1.00 ; 3D SOLUTION STRUCTURE OF THE C-TERMINAL CYSTEINE-RICH DOMAIN OF THE VHV1.1 POLYDNAVIRAL GENE PRODUCT 1X3Q ; -1.00 ; 3D SOLUTION STRUCTURE OF THE CHROMO-2 DOMAIN OF CPSRP43 1X3P ; -1.00 ; 3D SOLUTION STRUCTURE OF THE CHROMO-3 DOMAIN OF CPSRP43 1YL8 ; -1.00 ; 3D SOLUTION STRUCTURE OF [TYR3]OCTREOTATE DERIVATIVES IN DMSO 1YL9 ; -1.00 ; 3D SOLUTION STRUCTURE OF [TYR3]OCTREOTATE DERIVATIVES IN DMSO 2BEG ; -1.00 ; 3D STRUCTURE OF ALZHEIMER'S ABETA(1-42) FIBRILS 1W6L ; 2.00 ; 3D STRUCTURE OF COTA INCUBATED WITH CUCL2 1W8E ; 2.20 ; 3D STRUCTURE OF COTA INCUBATED WITH HYDROGEN PEROXIDE 1W6W ; 2.20 ; 3D STRUCTURE OF COTA INCUBATED WITH SODIUM AZIDE 1KCP ; -1.00 ; 3D STRUCTURE OF K-CONOTOXIN PVIIA, A NOVEL POTASSIUM CHANNEL-BLOCKING TOXIN FROM CONE SNAILS, NMR, 22 STRUCTURES 1IK6 ; 2.00 ; 3D STRUCTURE OF THE E1BETA SUBUNIT OF PYRUVATE DEHYDROGENASE FROM THE ARCHEON PYROBACULUM AEROPHILUM 1BXJ ; -1.00 ; 3D STRUCTURE OF THE M8L MUTANT OF SQUASH TRYPSIN INHIBITOR CMTI-I, NMR, 6 STUCTURES 2BHF ; 2.50 ; 3D STRUCTURE OF THE REDUCED FORM OF COTA 1FLR ; 1.85 ; 4-4-20 FAB FRAGMENT 1JXH ; 2.30 ; 4-AMINO-5-HYDROXYMETHYL-2-METHYLPYRIMIDINE PHOSPHATE KINASE FROM SALMONELLA TYPHIMURIUM 1JXI ; 2.64 ; 4-AMINO-5-HYDROXYMETHYL-2-METHYLPYRIMIDINE PHOSPHATE KINASE FROM SALMONELLA TYPHIMURIUM COMPLEXED WITH 4-AMINO-5- HYDROXYMETHYL-2-METHYLPYRIMIDINE 1OHV ; 2.30 ; 4-AMINOBUTYRATE-AMINOTRANSFERASE FROM PIG 1OHY ; 2.80 ; 4-AMINOBUTYRATE-AMINOTRANSFERASE INACTIVATED BY GAMMA-ETHYNYL GABA 1OHW ; 2.30 ; 4-AMINOBUTYRATE-AMINOTRANSFERASE INACTIVATED BY GAMMA-VINYL GABA 1NZY ; 1.80 ; 4-CHLOROBENZOYL COENZYME A DEHALOGENASE FROM PSEUDOMONAS SP. STRAIN CBS-3 1T5D ; 2.21 ; 4-CHLOROBENZOYL-COA LIGASE/SYNTHETASE BOUND TO 4- CHLOROBENZOATE 1T5H ; 2.00 ; 4-CHLOROBENZOYL-COA LIGASE/SYNTHETASE UNLIGANDED, SELENOMETHIONINE 1SP8 ; 2.00 ; 4-HYDROXYPHENYLPYRUVATE DIOXYGENASE 1SP9 ; 3.00 ; 4-HYDROXYPHENYLPYRUVATE DIOXYGENASE 1OTF ; 1.90 ; 4-OXALOCROTONATE TAUTOMERASE - TRICLINIC CRYSTAL FORM 4OTA ; 2.75 ; 4-OXALOCROTONATE TAUTOMERASE OBSERVED AS AN OCTODECAMER, ORTHORHOMBIC CRYSTAL FORM 4OTB ; 2.50 ; 4-OXALOCROTONATE TAUTOMERASE OBSERVED AS AN OCTODECAMER, RHOMBOHEDRAL CRYSTAL FORM 4OTC ; 2.28 ; 4-OXALOCROTONATE TAUTOMERASE OBSERVED AS AN OCTODECAMER, TRIGONAL CRYSTAL FORM 1FSU ; 2.50 ; 4-SULFATASE (HUMAN) 1GAF ; 1.95 ; 48G7 HYBRIDOMA LINE FAB COMPLEXED WITH HAPTEN 5-(PARA-NITROPHENYL PHOSPHONATE)-PENTANOIC ACID 1BP8 ; -1.00 ; 4:2:1 MITHRAMYCIN:MG2+:D(ACCCGGGT)2 COMPLEX 1N0R ; 1.50 ; 4ANK: A DESIGNED ANKYRIN REPEAT PROTEIN WITH FOUR IDENTICAL CONSENSUS REPEATS 1X9Q ; 1.50 ; 4M5.3 ANTI-FLUORESCEIN SINGLE CHAIN ANTIBODY FRAGMENT (SCFV) 1NYP ; -1.00 ; 4TH LIM DOMAIN OF PINCH PROTEIN 1NTS ; -1.00 ; 5'(DCCPUPCPCPUPUP)3':3'(RAGGAGGAAA)5', WHERE PPROPYNYL 1NTQ ; -1.00 ; 5'(DCCUCCUU)3':3'(RAGGAGGAAA)5' 1NTT ; -1.00 ; 5'(DCPCPUPCPCPUPUP)3':(RAGGAGGAAA)5', WHERE PPROPYNYL 423D ; 1.60 ; 5'-D(APCPCPGPAPCPGPTPCPGPGPT)-3' 424D ; 2.70 ; 5'-D(APCPCPGPAPCPGPTPCPGPGPT)-3' 425D ; 2.80 ; 5'-D(APCPCPGPGPTPAPCPCPGPGPT)-3' 427D ; 1.10 ; 5'-D(CPGPCP(CH2-DM1)GPCPG)-3' 403D ; 1.40 ; 5'-D(CPGPCP(HYD)APAPAPTPTPTPGPCPG)-3', 2'-(4- ETHOXYPHENYL)-5-(4-METHYL-1-PIPERAZINYL)-2,5'-BI- BENZIMIDAZOLE 447D ; 2.20 ; 5'-D(CPGPCPGPAPAPTPTPCPGPCPG)-3' 442D ; 1.60 ; 5'-D(CPGPCPGPAPAPTPTPCPGPCPG)-3', BENZIMIDAZOLE DERIVATIVE COMPLEX 444D ; 2.40 ; 5'-D(CPGPCPGPAPAPTPTPCPGPCPG)-3', BENZIMIDAZOLE DERIVATIVE COMPLEX 445D ; 2.60 ; 5'-D(CPGPCPGPAPAPTPTPCPGPCPG)-3', BENZIMIDAZOLE DERIVATIVE COMPLEX 448D ; 2.20 ; 5'-D(CPGPCPGPAPAPTPTPCPGPCPG)-3', BENZIMIDAZOLE DERIVATIVE COMPLEX 449D ; 2.10 ; 5'-D(CPGPCPGPAPAPTPTPCPGPCPG)-3', BENZIMIDAZOLE DERIVATIVE COMPLEX 453D ; 1.80 ; 5'-D(CPGPCPGPAPAPTPTPCPGPCPG)-3'-BENZIMIDAZOLE COMPLEX 1FTD ; 2.00 ; 5'-D(CPGPCPGPAPAPTPTPCPGPCPG)-3'-SYMMETRIC BIS- BENZIMIDAZOLE COMPLEX 443D ; 1.60 ; 5'-D(CPGPCPGPAPAPTPTPCPGPCPG)-3'/ BENZIMIDAZOLE DERIVATIVE COMPLEX 2KBD ; -1.00 ; 5'-D(CPTPGPGPGPGPAPCPTPTPTPCPCPAPGPG)-3', 5'-D(CPCPTPGPGPAPAPAPGPTPCPCPCPCPAPG)-3' 2B1D ; 2.50 ; 5'-D(GPCPAPGPAPCPGPTPCPTPGPC)-3' METHIONINE REPRESSOR BINDING SITE 2B1C ; 2.20 ; 5'-D(GPCPGPTPGPGPGPAPCPC)-3' ZIF268 BINDING SITE 2B1B ; 1.90 ; 5'-D(GPCPGPTPGPGPGPCPAPC)-3' ZIF268 BINDING SITE 431D ; 1.15 ; 5'-D(GPGPCPCPAPAPTPTPGPG)-3' 414D ; 1.90 ; 5'-D(GPGPGPGPCPGPCPCPCPC)-3' 421D ; 1.80 ; 5'-D(TPTPCPTPTP(BRO)CPTPTPC)-3', 5'- R(GPAPAPGPAPAPGPAPA)-3' 1JE1 ; 1.80 ; 5'-DEOXY-5'-METHYLTHIOADENOSINE PHOSPHORYLASE COMPLEX WITH GUANOSINE AND SULFATE 1JDS ; 1.80 ; 5'-DEOXY-5'-METHYLTHIOADENOSINE PHOSPHORYLASE COMPLEX WITH PHOSPHATE (SPACE GROUP P21) 1HPU ; 1.85 ; 5'-NUCLEOTIDASE (CLOSED FORM), COMPLEX WITH AMPCP 1HO5 ; 2.10 ; 5'-NUCLEOTIDASE (E. COLI) IN COMPLEX WITH ADENOSINE AND PHOSPHATE 1OI8 ; 2.10 ; 5'-NUCLEOTIDASE (E. COLI) WITH AN ENGINEERED DISULFIDE BRIDGE (P90C, L424C) 1OID ; 2.10 ; 5'-NUCLEOTIDASE (E. COLI) WITH AN ENGINEERED DISULFIDE BRIDGE (S228C, P513C) 1OIE ; 2.33 ; 5'-NUCLEOTIDASE (E. COLI) WITH AN ENGINEERED DISULFIDE BRIDGE (S228C, P513C) 1HP1 ; 1.70 ; 5'-NUCLEOTIDASE (OPEN FORM) COMPLEX WITH ATP 1USH ; 1.73 ; 5'-NUCLEOTIDASE FROM E. COLI 2USH ; 2.22 ; 5'-NUCLEOTIDASE FROM E. COLI 439D ; 1.60 ; 5'-R(CPUPGPGPGPCPGPG)-3', 5'- R(CPCPGPCPCPUPGPG)-3' 422D ; 2.60 ; 5'-R(GPAPUPCPAPCPUPUPCPGPGPU)-3' 418D ; 2.40 ; 5'-R(GPUPGPCPAPCPA)-D(PC)-3' 435D ; 1.40 ; 5'-R(UPAPGPCPCPCPC)-3', 5'-R(GPGPGPGPCPUPA)-3' 434D ; 1.16 ; 5'-R(UPAPGPCPUPCPC)-3', 5'-R(GPGPGPGPCPUPA)-3' 1B0A ; 2.56 ; 5,10, METHYLENE-TETRAHYDROPHOLATE DEHYDROGENASE/CYCLOHYDROLASE FROM E COLI. 1V93 ; 1.90 ; 5,10-METHYLENETETRAHYDROFOLATE REDUCTASE FROM THERMUS THERMOPHILUS HB8 1AW5 ; 2.30 ; 5-AMINOLEVULINATE DEHYDRATASE FROM SACCHAROMYCES CEREVISIAE 2BWN ; 2.10 ; 5-AMINOLEVULINATE SYNTHASE FROM RHODOBACTER CAPSULATUS 2BWP ; 2.70 ; 5-AMINOLEVULINATE SYNTHASE FROM RHODOBACTER CAPSULATUS IN COMPLEX WITH GLYCINE 2BWO ; 2.80 ; 5-AMINOLEVULINATE SYNTHASE FROM RHODOBACTER CAPSULATUS IN COMPLEX WITH SUCCINYL-COA 1OTG ; 2.10 ; 5-CARBOXYMETHYL-2-HYDROXYMUCONATE ISOMERASE 5EAS ; 2.25 ; 5-EPI-ARISTOLOCHENE SYNTHASE FROM NICOTIANA TABACUM 5EAU ; 2.15 ; 5-EPI-ARISTOLOCHENE SYNTHASE FROM NICOTIANA TABACUM 5EAT ; 2.80 ; 5-EPI-ARISTOLOCHENE SYNTHASE FROM NICOTIANA TABACUM WITH SUBSTRATE ANALOG FARNESYL HYDROXYPHOSPHONATE 1AB4 ; 2.80 ; 59KDA FRAGMENT OF GYRASE A FROM E. COLI 1C2X ; 7.50 ; 5S RRNA STRUCTURE FITTED TO A CRYO-ELECTRON MICROSCOPIC MAP AT 7.5 ANGSTROMS RESOLUTION 1IQ4 ; 1.80 ; 5S-RRNA BINDING RIBOSOMAL PROTEIN L5 FROM BACILLUS STEAROTHERMOPHILUS 1TEM ; 1.95 ; 6 ALPHA HYDROXYMETHYL PENICILLOIC ACID ACYLATED ON THE TEM-1 BETA-LACTAMASE FROM ESCHERICHIA COLI 1HKA ; 1.50 ; 6-HYDROXYMETHYL-7,8-DIHYDROPTERIN PYROPHOSPHOKINASE 2PBG ; 2.50 ; 6-PHOSPHO-BETA-D-GALACTOSIDASE FORM-B 3PBG ; 2.70 ; 6-PHOSPHO-BETA-GALACTOSIDASE FORM-C 4PBG ; 2.50 ; 6-PHOSPHO-BETA-GALACTOSIDASE FORM-CST 1BIF ; 2.00 ; 6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE BIFUNCTIONAL ENZYME COMPLEXED WITH ATP-G-S AND PHOSPHATE 3BIF ; 2.30 ; 6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE EMPTY 6-PF-2K ACTIVE SITE 2BIF ; 2.40 ; 6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE H256A MUTANT WITH F6P IN PHOSPHATASE ACTIVE SITE 1B66 ; 1.90 ; 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASE 1B6Z ; 2.00 ; 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASE 1GTQ ; 2.30 ; 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASE 1EHL ; 2.40 ; 64M-2 ANTIBODY FAB COMPLEXED WITH D(5HT)(6-4)T 1BUL ; 1.89 ; 6ALPHA-(HYDROXYPROPYL)PENICILLANATE ACYLATED ON NMC-A BETA- LACTAMASE FROM ENTEROBACTER CLOACAE 1AHH ; 2.30 ; 7 ALPHA-HYDROXYSTEROID DEHYDROGENASE COMPLEXED WITH NAD+ 1AHI ; 2.30 ; 7 ALPHA-HYDROXYSTEROID DEHYDROGENASE COMPLEXED WITH NADH AND 7-OXO GLYCOCHENODEOXYCHOLIC ACID 1CBK ; 2.02 ; 7,8-DIHYDRO-6-HYDROXYMETHYLPTERIN-PYROPHOSPHOKINASE FROM HAEMOPHILUS INFLUENZAE 1NBU ; 1.60 ; 7,8-DIHYDRONEOPTERIN ALDOLASE COMPLEXED WITH PRODUCT FROM MYCOBACTERIUM TUBERCULOSIS 1B9L ; 2.90 ; 7,8-DIHYDRONEOPTERIN TRIPHOSPHATE EPIMERASE 1FMC ; 1.80 ; 7-ALPHA-HYDROXYSTEROID DEHYDROGENASE COMPLEX WITH NADH AND 7-OXO GLYCOCHENODEOXYCHOLIC ACID 6FDR ; 1.40 ; 7-FE FERREDOXIN FROM AZOTOBACTER VINELANDII AT 100K, NA DITHIONITE REDUCED AT PH 8.5, RESOLUTION 1.4 A 7FD1 ; 1.30 ; 7-FE FERREDOXIN FROM AZOTOBACTER VINELANDII AT PH 8.5, 100 K, 1.35 A 6FD1 ; 1.35 ; 7-FE FERREDOXIN FROM AZOTOBACTER VINELANDII LOW TEMPERATURE, 1.35 A 7FDR ; 1.40 ; 7-FE FERREDOXIN FROM AZOTOBACTER VINELANDII, NA DITHIONITE REDUCED, PH 8.5, 1.4A RESOLUTION, 100 K 1BC6 ; -1.00 ; 7-FE FERREDOXIN FROM BACILLUS SCHLEGELII, NMR, 20 STRUCTURES 1BD6 ; -1.00 ; 7-FE FERREDOXIN FROM BACILLUS SCHLEGELII, NMR, MINIMIZED AVERAGE STRUCTURE 1KAY ; 1.70 ; 70KD HEAT SHOCK COGNATE PROTEIN ATPASE DOMAIN, K71A MUTANT 1KAZ ; 1.70 ; 70KD HEAT SHOCK COGNATE PROTEIN ATPASE DOMAIN, K71E MUTANT 1KAX ; 1.70 ; 70KD HEAT SHOCK COGNATE PROTEIN ATPASE DOMAIN, K71M MUTANT 1U45 ; 2.01 ; 8OXOGUANINE AT THE PRE-INSERTION SITE OF THE POLYMERASE ACTIVE SITE 1DYL ; 9.00 ; 9 ANGSTROM RESOLUTION CRYO-EM RECONSTRUCTION STRUCTURE OF SEMLIKI FOREST VIRUS (SFV) AND FITTING OF THE CAPSID PROTEIN STRUCTURE IN THE EM DENSITY 1FN2 ; 1.60 ; 9-AMINO-(N-(2-DIMETHYLAMINO)BUTYL)ACRIDINE-4-CARBOXAMIDE BOUND TO D(CGTACG)2 1RQY ; 1.55 ; 9-AMINO-[N-(2-DIMETHYLAMINO)PROPLY]-ACRIDINE-4-CARBOXAMIDE BOUND TO D(CGTACG)2 1S6R ; 2.24 ; 908R CLASS C BETA-LACTAMASE BOUND TO IODO-ACETAMIDO-PHENYL BORONIC ACID 460D ; 1.20 ; A "HYDRAT-ION SPINE" IN A B-DEOXYRIBONUCLEIC ACID MINOR GROOVE 461D ; 1.50 ; A "HYDRAT-ION SPINE" IN A B-DEOXYRIBONUCLEIC ACID MINOR GROOVE 397D ; 1.30 ; A 1.3 A RESOLUTION CRYSTAL STRUCTURE OF THE HIV-1 TRANS-ACTIVATION RESPONSE REGION RIBONUCLEIC ACID STEM REVEALS A METAL ION-DEPENDENT BULGE CONFORMATION 1TC1 ; 1.41 ; A 1.4 ANGSTROM CRYSTAL STRUCTURE FOR THE HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE OF TRYPANOSOMA CRUZI 1OQM ; 2.10 ; A 1:1 COMPLEX BETWEEN ALPHA-LACTALBUMIN AND BETA1,4- GALACTOSYLTRANSFERASE IN THE PRESENCE OF UDP-N-ACETYL- GALACTOSAMINE 1HP7 ; 2.10 ; A 2.1 ANGSTROM STRUCTURE OF AN UNCLEAVED ALPHA-1- ANTITRYPSIN SHOWS VARIABILITY OF THE REACTIVE CENTER AND OTHER LOOPS 1Y62 ; 2.45 ; A 2.4 CRYSTAL STRUCTURE OF CONKUNITZIN-S1, A NOVEL KUNITZ- FOLD CONE SNAIL NEUROTOXIN. 1B37 ; 1.90 ; A 30 ANGSTROM U-SHAPED CATALYTIC TUNNEL IN THE CRYSTAL STRUCTURE OF POLYAMINE OXIDASE 1B5Q ; 1.90 ; A 30 ANGSTROM U-SHAPED CATALYTIC TUNNEL IN THE CRYSTAL STRUCTURE OF POLYAMINE OXIDASE 1NKE ; 1.80 ; A BACILLUS DEOXYRIBONUCLEIC ACID POLYMERASE I PRODUCT COMPLEX BOUND TO A CYTOSINE-THYMINE MISMATCH AFTER A SINGLE ROUND OF PRIMER EXTENSION, FOLLOWING INCORPORATION OF DCTP. 1NK8 ; 1.90 ; A BACILLUS DEOXYRIBONUCLEIC ACID POLYMERASE I PRODUCT COMPLEX BOUND TO A GUANINE-THYMINE MISMATCH AFTER A SINGLE ROUND OF PRIMER EXTENSION, FOLLOWING INCORPORATION OF DCTP. 1NKC ; 1.80 ; A BACILLUS DEOXYRIBONUCLEIC ACID POLYMERASE I PRODUCT COMPLEX BOUND TO A GUANINE-THYMINE MISMATCH AFTER FIVE ROUNDS OF PRIMER EXTENSION, FOLLOWING INCORPORATION OF DCTP, DGTP, DTTP, AND DATP. 1NKB ; 2.00 ; A BACILLUS DEOXYRIBONUCLEIC ACID POLYMERASE I PRODUCT COMPLEX BOUND TO A GUANINE-THYMINE MISMATCH AFTER THREE ROUNDS OF PRIMER EXTENSION, FOLLOWING INCORPORATION OF DCTP, DGTP, AND DTTP. 1NK9 ; 1.90 ; A BACILLUS DEOXYRIBONUCLEIC ACID POLYMERASE I PRODUCT COMPLEX BOUND TO A GUANINE-THYMINE MISMATCH AFTER TWO ROUNDS OF PRIMER EXTENSION, FOLLOWING INCORPORATION OF DCTP AND DGTP. 1FNZ ; 2.05 ; A BARK LECTIN FROM ROBINIA PSEUDOACACIA IN COMPLEX WITH N- ACETYLGALACTOSAMINE. 1XBH ; -1.00 ; A BETA-HAIRPIN MIMIC FROM FCERI-ALPHA-CYCLO(L-262) 1C4B ; -1.00 ; A BETA-HAIRPIN MIMIC FROM FCERI-ALPHA-CYCLO(RD-262) 1HAA ; -1.00 ; A BETA-HAIRPIN STRUCTURE IN A 13-MER PEPTIDE THAT BINDS A-BUNGAROTOXIN WITH HIGH AFFINITY AND NEUTRALIZES ITS TOXICITY 1HAJ ; -1.00 ; A BETA-HAIRPIN STRUCTURE IN A 13-MER PEPTIDE THAT BINDS A-BUNGAROTOXIN WITH HIGH AFFINITY AND NEUTRALIZES ITS TOXICITY 1BKX ; 2.60 ; A BINARY COMPLEX OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE AND ADENOSINE FURTHER DEFINES CONFORMATIONAL FLEXIBILITY 1G49 ; 1.90 ; A CARBOXYLIC ACID BASED INHIBITOR IN COMPLEX WITH MMP3 1HY7 ; 1.50 ; A CARBOXYLIC ACID BASED INHIBITOR IN COMPLEX WITH MMP3 1OSH ; 1.80 ; A CHEMICAL, GENETIC, AND STRUCTURAL ANALYSIS OF THE NUCLEAR BILE ACID RECEPTOR FXR 1UZH ; 2.20 ; A CHIMERIC CHLAMYDOMONAS, SYNECHOCOCCUS RUBISCO ENZYME 1QRG ; 1.72 ; A CLOSER LOOK AND THE ACTIVE SITE OF GAMMA-CARBONIC ANHYDRASES: HIGH RESOLUTION CRYSTALLOGRAPHIC STUDIES OF THE CARBONIC ANHYDRASE FROM METHANOSARCINA THERMOPHILA 1QRM ; 1.95 ; A CLOSER LOOK AT THE ACTIVE SITE OF GAMMA-CARBONIC ANHYDRASES: HIGH RESOLUTION CRYSTAL STRUCTURES OF THE CARBONIC ANHYDRASE FROM METHANOSARCINA THERMOPHILA 1QRE ; 1.46 ; A CLOSER LOOK AT THE ACTIVE SITE OF GAMMA-CARBONIC ANHYDRASES: HIGH RESOLUTION CRYSTALLOGRAPHIC STUDIES OF THE CARBONIC ANHYDRASE FROM METHANOSARCINA THERMOPHILA 1QRF ; 1.55 ; A CLOSER LOOK AT THE ACTIVE SITE OF GAMMA-CARBONIC ANHYDRASES: HIGH RESOLUTION CRYSTALLOGRAPHIC STUDIES OF THE CARBONIC ANHYDRASE FROM METHANOSARCINA THERMOPHILA 1QRL ; 1.85 ; A CLOSER LOOK AT THE ACTIVE SITE OF GAMMA-CARBONIC ANHYDRASES: HIGH RESOLUTION CRYSTALLOGRAPHIC STUDIES OF THE CARBONIC ANHYDRASE FROM METHANOSARCINA THERMOPHILA 1YXW ; 2.20 ; A COMMON BINDING SITE FOR DISIALYLLACTOSE AND A TRI-PEPTIDE IN THE C-FRAGMENT OF TETANUS NEUROTOXIN 1YYN ; 2.30 ; A COMMON BINDING SITE FOR DISIALYLLACTOSE AND A TRI-PEPTIDE IN THE C-FRAGMENT OF TETANUS NEUROTOXIN 2C53 ; 1.80 ; A COMPARATIVE STUDY OF URACIL DEOXYRIBONUCLEIC ACID GLYCOSYLASES FROM HUMAN AND HERPES SIMPLEX VIRUS TYPE 1 2C56 ; 2.10 ; A COMPARATIVE STUDY OF URACIL DEOXYRIBONUCLEIC ACID GLYCOSYLASES FROM HUMAN AND HERPES SIMPLEX VIRUS TYPE 1 1HKN ; 2.00 ; A COMPLEX BETWEEN ACIDIC FIBROBLAST GROWTH FACTOR AND 5-AMINO-2-NAPHTHALENESULFONATE 1AHW ; 3.00 ; A COMPLEX OF EXTRACELLULAR DOMAIN OF TISSUE FACTOR WITH AN INHIBITORY FAB (5G9) 1UZX ; 1.85 ; A COMPLEX OF THE VPS23 UEV WITH UBIQUITIN 1Q8C ; 2.00 ; A CONSERVED HYPOTHETICAL PROTEIN FROM MYCOPLASMA GENITALIUM SHOWS STRUCTURAL HOMOLOGY TO NUSB PROTEINS 2AYS ; 1.86 ; A CONSERVED NON-METALLIC BINDING SITE IN THE C-TERMINAL LOBE OF LACTOFERRIN: STRUCTURE OF THE COMPLEX OF C- TERMINAL LOBE OF BOVINE LACTOFERRIN WITH N-ACETYL GALACTOSAMINE AT 1.86 A RESOLUTION 1OK7 ; 1.65 ; A CONSERVED PROTEIN BINDING-SITE ON BACTERIAL SLIDING CLAMPS 282D ; 2.40 ; A CONTINUOUS TRANSITION FROM A-DEOXYRIBONUCLEIC ACID TO B-DEOXYRIBONUCLEIC ACID IN THE 1:1 COMPLEX BETWEEN NOGALAMYCIN AND THE HEXAMER DCCCGGG 1OPZ ; -1.00 ; A CORE MUTATION AFFECTING THE FOLDING PROPERTIES OF A SOLUBLE DOMAIN OF THE ATPASE PROTEIN COPA FROM BACILLUS SUBTILIS 1OQ3 ; -1.00 ; A CORE MUTATION AFFECTING THE FOLDING PROPERTIES OF A SOLUBLE DOMAIN OF THE ATPASE PROTEIN COPA FROM BACILLUS SUBTILIS 1QWH ; 1.36 ; A COVALENT DIMER OF TRANSTHYRETIN THAT AFFECTS THE AMYLOID PATHWAY 1LQT ; 1.05 ; A COVALENT MODIFICATION OF NADP+ REVEALED BY THE ATOMIC RESOLUTION STRUCTURE OF FPRA, A MYCOBACTERIUM TUBERCULOSIS OXIDOREDUCTASE 1SZP ; 3.25 ; A CRYSTAL STRUCTURE OF THE RAD51 FILAMENT 283D ; 2.30 ; A CURVED RIBONUCLEIC ACID HELIX INCORPORATING AN INTERNAL LOOP WITH G-A AND A-A NON-WATSON-CRICK BASE PAIRING 5I1B ; 2.10 ; A Comparison of the High Resolution Structures of Human and Murine Interleukin-1B 8I1B ; 2.40 ; A Comparison of the High Resolution Structures of Human and Murine Interleukin-1B 1FX1 ; 2.00 ; A Crystallographic Structural Study of the Oxidation States of Desulfovibrio Vulgaris Flavodoxin 1N4L ; 2.00 ; A DEOXYRIBONUCLEIC ACID ANALOGUE OF THE POLYPURINE TRACT OF HIV-1 309D ; 2.60 ; A DEOXYRIBONUCLEIC ACID DECAMER WITH A STICKY END: THE CRYSTAL STRUCTURE OF D-CGACGATCGT 1SP6 ; -1.00 ; A DEOXYRIBONUCLEIC ACID DUPLEX CONTAINING A CHOLESTEROL ADDUCT (ALPHA-ANOMER) 1SSJ ; -1.00 ; A DEOXYRIBONUCLEIC ACID DUPLEX CONTAINING A CHOLESTEROL ADDUCT (BETA-ANOMER) 4HB1 ; 2.90 ; A DESIGNED FOUR HELIX BUNDLE PROTEIN. 2SCU ; 2.30 ; A DETAILED DESCRIPTION OF THE STRUCTURE OF SUCCINYL-COA SYNTHETASE FROM ESCHERICHIA COLI 1SZR ; 2.15 ; A DIMER INTERFACE MUTANT OF ORNITHINE DECARBOXYLASE REVEALS STRUCTURE OF GEM DIAMINE INTERMEDIATE 1FS5 ; 1.73 ; A DISCOVERY OF THREE ALTERNATE CONFORMATIONS IN THE ACTIVE SITE OF GLUCOSAMINE-6-PHOSPHATE ISOMERASE 1Q0P ; 1.80 ; A DOMAIN OF FACTOR B 1T31 ; 1.90 ; A DUAL INHIBITOR OF THE LEUKOCYTE PROTEASES CATHEPSIN G AND CHYMASE WITH THERAPEUTIC EFFICACY IN ANIMALS MODELS OF INFLAMMATION 1T32 ; 1.85 ; A DUAL INHIBITOR OF THE LEUKOCYTE PROTEASES CATHEPSIN G AND CHYMASE WITH THERAPEUTIC EFFICACY IN ANIMALS MODELS OF INFLAMMATION 1SJK ; -1.00 ; A DUPLEX DEOXYRIBONUCLEIC ACID WITH AN ABASIC SITE IN A DA TRACT, ALPHA FORM, NMR, MINIMIZED AVERAGE STRUCTURE 1SJL ; -1.00 ; A DUPLEX DEOXYRIBONUCLEIC ACID WITH AN ABASIC SITE IN A DA TRACT, BETA FORM, NMR, MINIMIZED AVERAGE STRUCTURE 1BMW ; -1.00 ; A FIBRONECTIN TYPE III FOLD IN PLANT ALLERGENS: THE SOLUTION STRUCTURE OF PHL PII FROM TIMOTHY GRASS POLLEN, NMR, 38 STRUCTURES 1ORO ; 2.40 ; A FLEXIBLE LOOP AT THE DIMER INTERFACE IS A PART OF THE ACTIVE SITE OF THE ADJACENT MONOMER OF ESCHERICHIA COLI OROTATE PHOSPHORIBOSYLTRANSFERASE 1PX6 ; 2.10 ; A FOLDING MUTANT OF HUMAN CLASS PI GLUTATHIONE TRANSFERASE, CREATED BY MUTATING ASPARTATE 153 OF THE WILD-TYPE PROTEIN TO ASPARAGINE 1PX7 ; 2.03 ; A FOLDING MUTANT OF HUMAN CLASS PI GLUTATHIONE TRANSFERASE, CREATED BY MUTATING ASPARTATE 153 OF THE WILD-TYPE PROTEIN TO GLUTAMATE 1MD3 ; 2.03 ; A FOLDING MUTANT OF HUMAN CLASS PI GLUTATHIONE TRANSFERASE, CREATED BY MUTATING GLYCINE 146 OF THE WILD-TYPE PROTEIN TO ALANINE 1MD4 ; 2.10 ; A FOLDING MUTANT OF HUMAN CLASS PI GLUTATHIONE TRANSFERASE, CREATED BY MUTATING GLYCINE 146 OF THE WILD-TYPE PROTEIN TO VALINE 1GM0 ; -1.00 ; A FORM OF THE PHEROMONE-BINDING PROTEIN FROM BOMBYX MORI 1P8F ; 1.85 ; A FOUR LOCATION MODEL TO EXPLAIN THE STEREOSPECIFICITY OF PROTEINS. 1PB1 ; 1.70 ; A FOUR LOCATION MODEL TO EXPLAIN THE STEREOSPECIFICITY OF PROTEINS. 1MKO ; 2.18 ; A FOURTH QUATERNARY STRUCTURE OF HUMAN HEMOGLOBIN A AT 2.18 A RESOLUTION 1G6R ; 2.80 ; A FUNCTIONAL HOT SPOT FOR ANTIGEN RECOGNITION IN A SUPERAGONIST TCR/MHC COMPLEX 1K51 ; 1.80 ; A G55A MUTATION INDUCES 3D DOMAIN SWAPPING IN THE B1 DOMAIN OF PROTEIN L FROM PEPTOSTREPTOCOCCUS MAGNUS 1G0U ; 2.40 ; A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE 190L ; 2.00 ; A HELIX INITIATION SIGNAL IN T4 LYSOZYME IDENTIFIED BY POLYALANINE MUTAGENESIS 191L ; 1.95 ; A HELIX INITIATION SIGNAL IN T4 LYSOZYME IDENTIFIED BY POLYALANINE MUTAGENESIS 192L ; 1.90 ; A HELIX INITIATION SIGNAL IN T4 LYSOZYME IDENTIFIED BY POLYALANINE MUTAGENESIS 1S2R ; 1.53 ; A HIGH RESOLUTION CRYSTAL STRUCTURE OF [D(CGCAAATTTGCG)]2 1Q1M ; 2.60 ; A HIGHLY EFFICIENT APPROACH TO A SELECTIVE AND CELL ACTIVE PTP1B INHIBITORS 1X0M ; 2.20 ; A HUMAN KYNURENINE AMINOTRANSFERASE II HOMOLOGUE FROM PYROCOCCUS HORIKOSHII OT3 1VDW ; 1.30 ; A HYPOTHETICAL PROTEIN PH1897 FROM PYROCOCCUS HORIKOSHII WITH SIMILARITIES FOR INOSITOL-1 MONOPHOSPHATASE 1A8W ; -1.00 ; A K+ CATION-INDUCED CONFORMATIONAL SWITCH WITHIN A LOOP SPANNING SEGMENT OF A DEOXYRIBONUCLEIC ACID QUADRUPLEX CONTAINING G-G-G-C REPEATS, NMR, 8 STRUCTURES 1LRV ; 2.60 ; A LEUCINE-RICH REPEAT VARIANT WITH A NOVEL REPETITIVE PROTEIN STRUCTURAL MOTIF 1BH7 ; -1.00 ; A LOW ENERGY STRUCTURE FOR THE FINAL CYTOPLASMIC LOOP OF BAND 3, NMR, MINIMIZED AVERAGE STRUCTURE 2PHI ; 2.20 ; A Large Conformational Change is Found in the Crystal Structure of the Porcine Pancreatic Phospholipase A2 Point Mutant F63V 1N09 ; -1.00 ; A MINIMAL BETA-HAIRPIN PEPTIDE SCAFFOLD FOR BETA-TURN DISPLAY 1DS7 ; 2.06 ; A MINOR FMN-DEPENDENT NITROREDUCTASE FROM ESCHERICHIA COLI B 2AEW ; 2.70 ; A MODEL FOR GROWTH HORMONE RECEPTOR ACTIVATION BASED ON SUBUNIT ROTATION WITHIN A RECEPTOR DIMER 1XS9 ; -1.00 ; A MODEL OF THE TERNARY COMPLEX FORMED BETWEEN MARA, THE ALPHA-CTD OF RIBONUCLEIC ACID POLYMERASE AND DEOXYRIBONUCLEIC ACID 1LM3 ; 2.70 ; A MULTI-GENERATION ANALYSIS OF CYTOCHROME B562 REDOX VARIANTS: EVOLUTIONARY STRATEGIES FOR MODULATING REDOX POTENTIAL REVEALED USING A LIBRARY APPROACH 1WCS ; 2.80 ; A MUTANT OF TRYPANOSOMA RANGELI SIALIDASE DISPLAYING TRANS- SIALIDASE ACTIVITY 1KPD ; -1.00 ; A MUTANT RIBONUCLEIC ACID PSEUDOKNOT THAT PROMOTES RIBOSOMAL FRAMESHIFTING IN MOUSE MAMMARY TUMOR VIRUS, NMR, MINIMIZED AVERAGE STRUCTURE 1QOH ; 2.35 ; A MUTANT SHIGA-LIKE TOXIN IIE 2BOS ; 2.00 ; A MUTANT SHIGA-LIKE TOXIN IIE BOUND TO ITS RECEPTOR 2A9N ; 3.00 ; A MUTATION DESIGNED TO ALTER CRYSTAL PACKING PERMITS STRUCTURAL ANALYSIS OF A TIGHT-BINDING FLUORESCEIN-SCFV COMPLEX 1N2R ; 1.70 ; A NATURAL SELECTED DIMORPHISM IN HLA B44 ALTERS SELF, PEPTIDE REPORTOIRE AND T CELL RECOGNITION. 1JJB ; 2.30 ; A NEUTRAL MOLECULE IN CATION-BINDING SITE: SPECIFIC BINDING OF PEG-SH TO ACETYLCHOLINESTERASE FROM TORPEDO CALIFORNICA 3AID ; 2.50 ; A NEW CLASS OF HIV-1 PROTEASE INHIBITOR: THE CRYSTALLOGRAPHIC STRUCTURE, INHIBITION AND CHEMICAL SYNTHESIS OF AN AMINIMIDE PEPTIDE ISOSTERE 1GP9 ; 2.50 ; A NEW CRYSTAL FORM OF THE NK1 SPLICE VARIANT OF HGF/SF DEMONSTRATES EXTENSIVE HINGE MOVEMENT AND SUGGESTS THAT THE NK1 DIMER ORIGINATES BY DOMAIN SWAPPING 1EHV ; 1.80 ; A NEW CRYSTAL STRUCTURE FOR THE DODECAMER C-G-C-G-A-A-T-T-C- G-C-G: SYMMETRY EFFECTS ON SEQUENCE-DEPENDENT DEOXYRIBONUCLEIC ACID STRUCTURE 1Y75 ; 2.30 ; A NEW FORM OF CATALYTICALLY INACTIVE PHOSPHOLIPASE A2 WITH AN UNUSUAL DISULPHIDE BRIDGE CYS 32- CYS 49 REVEALS RECOGNITION FOR N-ACETYLGLUCOSMINE 1O87 ; 2.10 ; A NEW MGGDP COMPLEX OF THE FFH NG DOMAIN 1CHZ ; 1.76 ; A NEW NEUROTOXIN FROM BUTHUS MARTENSII KARSCH 1ENU ; 1.95 ; A NEW TARGET FOR SHIGELLOSIS: RATIONAL DESIGN AND CRYSTALLOGRAPHIC STUDIES OF INHIBITORS OF TRNA-GUANINE TRANSGLYCOSYLASE 1F3E ; 1.85 ; A NEW TARGET FOR SHIGELLOSIS: RATIONAL DESIGN AND CRYSTALLOGRAPHIC STUDIES OF INHIBITORS OF TRNA-GUANINE TRANSGLYCOSYLASE 1U8C ; 3.10 ; A NOVEL ADAPTATION OF THE INTEGRIN PSI DOMAIN REVEALED FROM ITS CRYSTAL STRUCTURE 1UW1 ; 1.94 ; A NOVEL ADP- AND ZINC-BINDING FOLD FROM FUNCTION-DIRECTED IN VITRO EVOLUTION 1EUJ ; 1.80 ; A NOVEL ANTI-TUMOR CYTOKINE CONTAINS A RIBONUCLEIC ACID-BINDING MOTIF PRESENT IN AMINOACYL-TRNA SYNTHETASES 1WCT ; -1.00 ; A NOVEL CONOTOXIN FROM CONUS TEXTILE WITH UNUSUAL POST-TRANSLATIONAL MODIFICATIONS REDUCES PRESYNAPTIC CALCIUM INFLUX, NMR, 1 STRUCTURE, GLYCOSYLATED PROTEIN 1RAM ; 2.70 ; A NOVEL DEOXYRIBONUCLEIC ACID RECOGNITION MODE BY NF-KB P65 HOMODIMER 2RAM ; 2.40 ; A NOVEL DEOXYRIBONUCLEIC ACID RECOGNITION MODE BY NF-KB P65 HOMODIMER 1URR ; 1.50 ; A NOVEL DROSOPHILA MELANOGASTER ACYLPHOSPHATASE (ACPDRO2) 375D ; 2.40 ; A NOVEL END-TO-END BINDING OF TWO NETROPSINS TO THE DEOXYRIBONUCLEIC ACID DECAMER D(CCCCCIIIII)2 474D ; 2.40 ; A NOVEL END-TO-END BINDING OF TWO NETROPSINS TO THE DEOXYRIBONUCLEIC ACID DECAMER D(CCCCCIIIII)2 1H21 ; 2.50 ; A NOVEL IRON CENTRE IN THE SPLIT-SORET CYTOCHROME C FROM DESULFOVIBRIO DESULFURICANS ATCC 27774 2BW7 ; 2.30 ; A NOVEL MECHANISM FOR ADENYLYL CYCLASE INHIBITION FROM THE CRYSTAL STRUCTURE OF ITS COMPLEX WITH CATECHOL ESTROGEN 1N6Z ; -1.00 ; A NOVEL MEMBER OF THE SPLIT BAB FOLD: SOLUTION STRUCTURE OF THE HYPOTHETICAL PROTEIN YML108W FROM SACCHAROMYCES CEREVISIAE 1JAC ; 2.43 ; A NOVEL MODE OF CARBOHYDRATE RECOGNITION IN JACALIN, A MORACEAE PLANT LECTIN WITH A BETA-PRISM 1HL6 ; 2.50 ; A NOVEL MODE OF RBD-PROTEIN RECOGNITION IN THE Y14-MAGO COMPLEX 1S20 ; 2.20 ; A NOVEL NAD BINDING PROTEIN REVEALED BY THE CRYSTAL STRUCTURE OF E. COLI 2,3-DIKETOGULONATE REDUCTASE (YIAK) 1NXE ; 2.30 ; A NOVEL NADH ALLOSTERIC REGULATOR SITE IS FOUND ON THE SURFACE OF THE HEXAMERIC TYPE II PHE383ALA VARIANT OF CITRATE SYNTHASE 1YZI ; 2.07 ; A NOVEL QUATERNARY STRUCTURE OF HUMAN CARBONMONOXY HEMOGLOBIN 1GHV ; 1.85 ; A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI- CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE 1GHW ; 1.75 ; A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI- CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE 1GHX ; 1.65 ; A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI- CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE 1GHY ; 1.85 ; A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI- CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE 1GHZ ; 1.39 ; A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI- CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE 1GI0 ; 1.42 ; A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI- CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE 1GI1 ; 1.42 ; A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI- CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE 1GI2 ; 1.38 ; A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI- CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE 1GI3 ; 1.44 ; A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI- CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE 1GI4 ; 1.37 ; A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI- CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE 1GI5 ; 1.60 ; A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI- CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE 1GI6 ; 1.49 ; A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI- CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE 1GI7 ; 1.79 ; A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI- CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE 1GI8 ; 1.75 ; A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI- CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE 1GI9 ; 1.80 ; A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI- CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE 4SKN ; 2.90 ; A NUCLEOTIDE-FLIPPING MECHANISM FROM THE STRUCTURE OF HUMAN URACIL-DEOXYRIBONUCLEIC ACID GLYCOSYLASE BOUND TO DEOXYRIBONUCLEIC ACID 1R2L ; -1.00 ; A PARALLEL STRANDED DEOXYRIBONUCLEIC ACID DUPLEX WITH AN A-G MISMATCH BASE- PAIR 2GAR ; 1.80 ; A PH-DEPENDENT STABLIZATION OF AN ACTIVE SITE LOOP OBSERVED FROM LOW AND HIGH PH CRYSTAL STRUCTURES OF MUTANT MONOMERIC GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE 3GAR ; 1.90 ; A PH-DEPENDENT STABLIZATION OF AN ACTIVE SITE LOOP OBSERVED FROM LOW AND HIGH PH CRYSTAL STRUCTURES OF MUTANT MONOMERIC GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE 2A23 ; -1.00 ; A PHD FINGER MOTIF IN THE C-TERMINUS OF RAG2 MODULATES RECOMBINATION ACTIVITY 1SOL ; -1.00 ; A PIP2 AND F-ACTIN-BINDING SITE OF GELSOLIN, RESIDUE 150-169 (NMR, AVERAGED STRUCTURE) 1GED ; 2.00 ; A POSITIVE CHARGE ROUTE FOR THE ACCESS OF NADH TO HEME FORMED IN THE DISTAL HEME POCKET OF CYTOCHROME P450NOR 11BG ; 1.90 ; A POTENTIAL ALLOSTERIC SUBSITE GENERATED BY DOMAIN SWAPPING IN BOVINE SEMINAL RIBONUCLEASE 1CL8 ; 1.80 ; A PRE-TRANSITION STATE ECO RI ENDONUCLEASE/COGNATE DEOXYRIBONUCLEIC ACID (TCGCGAPTTCGCG) COMPLEX WITH DEOXYRIBONUCLEIC ACID BASE ANALOG PURINE (P) 1GRZ ; 5.00 ; A PREORGANIZED ACTIVE SITE IN THE CRYSTAL STRUCTURE OF THE TETRAHYMENA RIBOZYME 1OQU ; 2.00 ; A PROTEIN COORDINATED TRI-NUCLEAR FE COMPLEX FORMED DURING SOAKING OF CRYSTALS OF THE RIBONUCLEOTIDE REDUCTASE R2F PROTEIN FROM CORYNEBACTERIUM AMMONIAGENES 1EHJ ; -1.00 ; A PROTON-NMR INVESTIGATION OF THE FULLY REDUCED CYTOCHROME C7 FROM DESULFUROMONAS ACETOXIDANS 1F22 ; -1.00 ; A PROTON-NMR INVESTIGATION OF THE FULLY REDUCED CYTOCHROME C7 FROM DESULFUROMONAS ACETOXIDANS. COMPARISON BETWEEN THE REDUCED AND THE OXIDIZED FORMS. 1VKQ ; 1.60 ; A RE-DETERMINATION OF THE STRUCTURE OF THE TRIPLE MUTANT (K53,56,120M) OF PHOSPHOLIPASE A2 AT 1.6A RESOLUTION USING SULPHUR-SAS AT 1.54A WAVELENGTH 1GSM ; 1.90 ; A REASSESSMENT OF THE MADCAM-1 STRUCTURE AND ITS ROLE IN INTEGRIN RECOGNITION. 1DMZ ; -1.00 ; A REFINED NMR STRUCTURE OF A NEW PHOPHOPEPTIDE-BINDING DOMAIN CONTAINING THE FHA2 OF RAD53 1H6I ; 3.54 ; A REFINED STRUCTURE OF HUMAN AQUAPORIN 1 2D09 ; 1.80 ; A ROLE FOR ACTIVE SITE WATER MOLECULES AND HYDROXYL GROUPS OF SUBSTRATE FOR OXYGEN ACTIVATION IN CYTOCHROME P450 158A2 1MIH ; 2.70 ; A ROLE FOR CHEY GLU 89 IN CHEZ-MEDIATED DEPHOSPHORYLATION OF THE E. COLI CHEMOTAXIS RESPONSE REGULATOR CHEY 5ER1 ; 2.00 ; A Rational Approach to the Design of Antihypertensives. X-Ray Studies of Complexes between Aspartic Proteinases and Aminoalcohol Renin Inhibitors 2CHR ; 3.00 ; A Re-Evaluation of the Crystal Structure of Chloromuconate Cycloisomerase 1HD7 ; 1.95 ; A SECOND DIVALENT METAL ION IN THE ACTIVE SITE OF A NEW CRYSTAL FORM OF HUMAN APURINIC/APYRIDINIMIC ENDONUCLEASE, APE1, AND ITS IMPLICATIONS FOR THE CATALYTIC MECHANISM 1E9N ; 2.20 ; A SECOND DIVALENT METAL ION IN THE ACTIVE SITE OF A NEW CRYSTAL FORM OF HUMAN APURINIC/APYRIMIDINIC ENDONUCLEASE, APE1, AND ITS IMPLICATIONS FOR THE CATALYTIC MECHANISM 2AYR ; 1.90 ; A SERM DESIGNED FOR THE TREATMENT OF UTERINE LEIOMYOMA WITH UNIQUE TISSUE SPECIFICITY FOR UTERUS AND OVARIES IN RATS 1RMX ; -1.00 ; A SHORT LEXITROPSIN THAT RECOGNIZES THE DEOXYRIBONUCLEIC ACID MINOR GROOVE AT 5'-ACTAGT-3': UNDERSTANDING THE ROLE OF ISOPROPYL-THIAZOLE 1RN9 ; -1.00 ; A SHORT LEXITROPSIN THAT RECOGNIZES THE DEOXYRIBONUCLEIC ACID MINOR GROOVE AT 5'-ACTAGT-3': UNDERSTANDING THE ROLE OF ISOPROPYL-THIAZOLE 1ULH ; 2.31 ; A SHORT PEPTIDE INSERTION CRUCIAL FOR ANGIOSTATIC ACTIVITY OF HUMAN TRYPTOPHANYL-TRNA SYNTHETASE 1SMI ; 2.00 ; A SINGLE MUTATION OF P450 BM3 INDUCES THE CONFORMATIONAL REARRANGEMENT SEEN UPON SUBSTRATE-BINDING IN WILD-TYPE ENZYME 1BWM ; -1.00 ; A SINGLE-CHAIN T CELL RECEPTOR 1E3A ; 1.80 ; A SLOW PROCESSING PRECURSOR PENICILLIN ACYLASE FROM ESCHERICHIA COLI 1U3N ; -1.00 ; A SOD-LIKE PROTEIN FROM B. SUBTILIS, UNSTRUCTURED IN SOLUTION, BECOMES ORDERED IN THE CRYSTAL: IMPLICATIONS FOR FUNCTION AND FOR FIBRILLOGENESIS 1OGA ; 1.40 ; A STRUCTURAL BASIS FOR IMMUNODOMINANT HUMAN T-CELL RECEPTOR RECOGNITION. 1J7E ; 2.55 ; A STRUCTURAL BASIS FOR THE UNIQUE BINDING FEATURES OF THE HUMAN VITAMIN D-BINDING PROTEIN 1Z9I ; -1.00 ; A STRUCTURAL MODEL FOR THE MEMBRANE-BOUND FORM OF THE JUXTAMEMBRANE DOMAIN OF THE EPIDERMAL GROWTH FACTOR RECEPTOR 2VSG ; 2.70 ; A STRUCTURAL MOTIF IN THE VARIANT SURFACE GLYCOPROTEINS OF TRYPANOSOMA BRUCEI 485D ; 0.97 ; A SULFATE POCKET FORMED BY THREE GOU PAIRS IN THE STRUCTURE OF A NONAMERIC RIBONUCLEIC ACID 1ZI0 ; 2.60 ; A SUPERHELICAL SPIRAL IN ESCHERICHIA COLI DEOXYRIBONUCLEIC ACID GYRASE A C- TERMINAL DOMAIN IMPARTS UNIDIRECTIONAL SUPERCOILING BIAS 1VZK ; 1.77 ; A THIOPHENE BASED DIAMIDINE FORMS A "SUPER" AT BINDING MINOR GROOVE AGENT 1MP7 ; -1.00 ; A THIRD COMPLEX OF POST-ACTIVATED NEOCARZINOSTATIN CHROMOPHORE WITH DEOXYRIBONUCLEIC ACID. BULGE DEOXYRIBONUCLEIC ACID BINDING FROM THE MINOR GROOVE 417D ; 1.50 ; A THYMINE-LIKE BASE ANALOGUE FORMS WOBBLE PAIRS WITH ADENINE 1F51 ; 3.00 ; A TRANSIENT INTERACTION BETWEEN TWO PHOSPHORELAY PROTEINS TRAPPED IN A CRYSTAL LATTICE REVEALS THE MECHANISM OF MOLECULAR RECOGNITION AND PHOSPHOTRANSFER IN SINGAL TRANSDUCTION 1DQ4 ; 2.90 ; A TRANSIENT UNLOCKED CONCANAVALIN A STRUCTURE WITH MN2+ BOUND IN THE TRANSITION METAL ION BINDING SITE S1 AND AN EMPTY CALCIUM BINDING SITE S2 1GIS ; 1.70 ; A TRICHOSANTHIN(TCS) MUTANT(E85Q) COMPLEX STRUCTURE WITH 2'- DEOXY-ADENOSIN-5'-MONOPHOSPHATE 1GIU ; 1.80 ; A TRICHOSANTHIN(TCS) MUTANT(E85R) COMPLEX STRUCTURE WITH ADENINE 1VLN ; 2.40 ; A TRICLINIC CRYSTAL FORM OF THE LECTIN CONCANAVALIN A 1QIU ; 2.40 ; A TRIPLE BETA-SPIRAL IN THE ADENOVIRUS FIBRE SHAFT REVEALS A NEW STRUCTURAL MOTIF FOR BIOLOGICAL FIBRES 1K71 ; 2.56 ; A TRIPLE HELICAL FRAGMENT CONTAINING A T.AT TRIPLET AT 2.56 ANGSTROM RESOLUTION. 1FV7 ; -1.00 ; A TWO B-Z JUNCTION CONTAINING DEOXYRIBONUCLEIC ACID RESOLVES INTO AN ALL RIGHT HANDED DOUBLE HELIX 1BAH ; -1.00 ; A TWO DISULFIDE DERIVATIVE OF CHARYBDOTOXIN WITH DISULFIDE 13-33 REPLACED BY TWO ALPHA-AMINOBUTYRIC ACIDS, NMR, 30 STRUCTURES 1K50 ; 1.80 ; A V49A MUTATION INDUCES 3D DOMAIN SWAPPING IN THE B1 DOMAIN OF PROTEIN L FROM PEPTOSTREPTOCOCCUS MAGNUS 1SQ8 ; -1.00 ; A VARIANT 434 REPRESSOR DEOXYRIBONUCLEIC ACID BINDING DOMAIN DEVOID OF HYDROXYL GROUPS, NMR, 20 STRUCTURES 1ZNM ; -1.00 ; A ZINC FINGER WITH AN ARTIFICIAL BETA-TURN, ORIGINAL SEQUENCE TAKEN FROM THE THIRD ZINC FINGER DOMAIN OF THE HUMAN TRANSCRIPTIONAL REPRESSOR PROTEIN YY1 (YING AND YANG 1, A DELTA TRANSCRIPTION FACTOR), NMR, 34 STRUCTURES 376D ; 2.10 ; A ZIPPER-LIKE DEOXYRIBONUCLEIC ACID DUPLEX D(GCGAAAGCT) 413D ; 1.80 ; A'-FORM RIBONUCLEIC ACID DOUBLE HELIX IN THE SINGLE CRYSTAL STRUCTURE OF R(UGAGCUUCGGCUC) 1JJP ; -1.00 ; A(GGGG) PENTAD-CONTAINING DIMERIC DEOXYRIBONUCLEIC ACID QUADRUPLEX INVOLVING STACKED G(ANTI)G(ANTI)G(ANTI)G(SYN) TETRADS 1EEG ; -1.00 ; A(GGGG)A HEXAD PAIRING ALIGMENT FOR THE D(G-G-A-G-G-A-G) SEQUENCE 1HC9 ; 1.80 ; A-BUNGAROTOXIN COMPLEXED WITH HIGH AFFINITY PEPTIDE 1DNZ ; 1.60 ; A-DEOXYRIBONUCLEIC ACID DECAMER ACCGGCCGGT WITH MAGNESIUM BINDING SITES 1DPL ; 0.83 ; A-DEOXYRIBONUCLEIC ACID DECAMER GCGTA(T23)TACGC WITH INCORPORATED 2'-METHOXY- 3'-METHYLENEPHOSPHATE-THYMIDINE 1I5W ; 1.40 ; A-DEOXYRIBONUCLEIC ACID DECAMER GCGTA(TLN)ACGC 1MA8 ; 1.30 ; A-DEOXYRIBONUCLEIC ACID DECAMER GCGTA(UMS)ACGC WITH INCORPORATED 2'- METHYLSELENO-URIDINE 1DNO ; 1.40 ; A-DEOXYRIBONUCLEIC ACID/RIBONUCLEIC ACID DODECAMER R(GCG)D(TATACGC) MG BINDING SITES 1Y26 ; 2.10 ; A-RIBOSWITCH-ADENINE COMPLEX 1UUE ; 2.60 ; A-SPECTRIN SH3 DOMAIN (V44T, D48G MUTANT) 1E6H ; 2.01 ; A-SPECTRIN SH3 DOMAIN A11V, M25I, V44I, V58L MUTANTS 1E6G ; 2.30 ; A-SPECTRIN SH3 DOMAIN A11V, V23L, M25I, V53I, V58L MUTANT 1E7O ; 3.20 ; A-SPECTRIN SH3 DOMAIN A11V, V23L, M25V, V44I, V58L MUTATIONS 1H8K ; 2.70 ; A-SPECTRIN SH3 DOMAIN A11V, V23L, M25V, V53I, V58L MUTANT 1BK2 ; 2.00 ; A-SPECTRIN SH3 DOMAIN D48G MUTANT 1HD3 ; 1.98 ; A-SPECTRIN SH3 DOMAIN F52Y MUTANT 1NEV ; -1.00 ; A-TRACT DECAMER 1AL5 ; -1.00 ; A-TRACT RIBONUCLEIC ACID DODECAMER, NMR, 12 STRUCTURES 1ZHA ; 1.74 ; A. AEOLICUS KDO8PS R106G MUTANT IN COMPLEX WITH PEP AND R5P 1U1H ; 2.55 ; A. THALIANA COBALAMINE INDEPENDENT METHIONINE SYNTHASE 1U1J ; 2.40 ; A. THALIANA COBALAMINE INDEPENDENT METHIONINE SYNTHASE 1U1U ; 2.95 ; A. THALIANA COBALAMINE INDEPENDENT METHIONINE SYNTHASE 1U22 ; 2.65 ; A. THALIANA COBALAMINE INDEPENDENT METHIONINE SYNTHASE 1AUQ ; 2.30 ; A1 DOMAIN OF VON WILLEBRAND FACTOR 1SZG ; 2.70 ; A198G:L230A FLAVOCYTOCHROME B2 WITH SULFITE BOUND 1SZF ; 2.70 ; A198G:L230A MUTANT FLAVOCYTOCHROME B2 WITH PYRUVATE BOUND 1C17 ; -1.00 ; A1C12 SUBCOMPLEX OF F1FO ATP SYNTHASE 1AO3 ; 2.20 ; A3 DOMAIN OF VON WILLEBRAND FACTOR 1BH2 ; 2.10 ; A326S MUTANT OF AN INHIBITORY ALPHA SUBUNIT 1YKJ ; 2.00 ; A45G P-HYDROXYBENZOATE HYDROXYLASE WITH P-HYDROXYBENZOATE BOUND 1UXM ; 1.90 ; A4V MUTANT OF HUMAN SOD1 455D ; 1.43 ; A6/A18 INTER-STRAND DITHIOBIS(PROPANE)-CROSSLINKED DODECAMER (CGCGAATTCGCG)2 1FT7 ; 2.20 ; AAP COMPLEXED WITH L-LEUCINEPHOSPHONIC ACID 1CKU ; 1.20 ; AB INITIO SOLUTION AND REFINEMENT OF TWO HIGH POTENTIAL IRON PROTEIN STRUCTURES AT ATOMIC RESOLUTION 1W5I ; 2.30 ; ABA DOES NOT AFFECT TOPOLOGY OF PLI. 1SO8 ; 2.30 ; ABETA-BOUND HUMAN ABAD STRUCTURE [ALSO KNOWN AS 3- HYDROXYACYL-COA DEHYDROGENASE TYPE II (TYPE II HADH), ENDOPLASMIC RETICULUM-ASSOCIATED AMYLOID BETA-PEPTIDE BINDING PROTEIN (ERAB)] 1S22 ; 1.60 ; ABSOLUTE STEREOCHEMISTRY OF ULAPUALIDE A 1PRQ ; 2.50 ; ACANTHAMOEBA CASTELLANII PROFILIN IA 1ACF ; 2.00 ; ACANTHAMOEBA CASTELLANII PROFILIN IB 2ACG ; 2.50 ; ACANTHAMOEBA CASTELLANII PROFILIN II 1E3Z ; 1.93 ; ACARBOSE COMPLEX OF CHIMAERIC AMYLASE FROM B. AMYLOLIQUEFACIENS AND B. LICHENIFORMIS AT 1.93A 1XCW ; 2.00 ; ACARBOSE REARRANGEMENT MECHANISM IMPLIED BY THE KINETIC AND STRUCTURAL ANALYSIS OF HUMAN PANCREATIC ALPHA-AMYLASE IN COMPLEX WITH ANALOGUES AND THEIR ELONGATED COUNTERPARTS 1XCX ; 1.90 ; ACARBOSE REARRANGEMENT MECHANISM IMPLIED BY THE KINETIC AND STRUCTURAL ANALYSIS OF HUMAN PANCREATIC ALPHA-AMYLASE IN COMPLEX WITH ANALOGUES AND THEIR ELONGATED COUNTERPARTS 1XD0 ; 2.00 ; ACARBOSE REARRANGEMENT MECHANISM IMPLIED BY THE KINETIC AND STRUCTURAL ANALYSIS OF HUMAN PANCREATIC ALPHA-AMYLASE IN COMPLEX WITH ANALOGUES AND THEIR ELONGATED COUNTERPARTS 1XD1 ; 2.20 ; ACARBOSE REARRANGEMENT MECHANISM IMPLIED BY THE KINETIC AND STRUCTURAL ANALYSIS OF HUMAN PANCREATIC ALPHA-AMYLASE IN COMPLEX WITH ANALOGUES AND THEIR ELONGATED COUNTERPARTS 1J0D ; 2.20 ; ACC DEAMINASE MUTANT COMPLEXED WITH ACC 1J0E ; 2.45 ; ACC DEAMINASE MUTANT REACTON INTERMEDIATE 1J0C ; 2.75 ; ACC DEAMINASE MUTATED TO CATALYTIC RESIDUE 1ZEZ ; 2.00 ; ACC HOLLIDAY JUNCTION 1LTM ; 1.70 ; ACCELERATED X-RAY STRUCTURE ELUCIDATION OF A 36 KDA MURAMIDASE/TRANSGLYCOSYLASE USING WARP 1IKD ; -1.00 ; ACCEPTOR STEM, NMR, 30 STRUCTURES 1SJS ; 2.42 ; ACCESS TO PHOSPHORYLATION IN ISOCITRATE DEHYDROGENASE MAY OCCUR BY DOMAIN SHIFTING 1S37 ; -1.00 ; ACCOMODATION OF MISPAIR-ALIGNED N3T-ETHYL-N3T DEOXYRIBONUCLEIC ACID INTERSTRAND CROSSLINK 1KH0 ; 1.90 ; ACCURATE COMPUTER BASE DESIGN OF A NEW BACKBONE CONFORMATION IN THE SECOND TURN OF PROTEIN L 1TUY ; 3.00 ; ACETATE KINASE COMPLEXED WITH ADP, ALF3 AND ACETATE 1TUU ; 2.50 ; ACETATE KINASE CRYSTALLIZED WITH ATPGS 2B9V ; 2.00 ; ACETOBACTER TURBIDANS ALPHA-AMINO ACID ESTER HYDROLASE 2B4K ; 3.30 ; ACETOBACTER TURBIDANS ALPHA-AMINO ACID ESTER HYDROLASE COMPLEXED WITH PHENYLGLYCINE 1NX9 ; 2.20 ; ACETOBACTER TURBIDANS ALPHA-AMINO ACID ESTER HYDROLASE S205A MUTANT COMPLEXED WITH AMPICILLIN 1RYY ; 2.80 ; ACETOBACTER TURBIDANS ALPHA-AMINO ACID ESTER HYDROLASE Y206A MUTANT 1YVE ; 1.65 ; ACETOHYDROXY ACID ISOMEROREDUCTASE COMPLEXED WITH NADPH, MAGNESIUM AND INHIBITOR IPOHA (N-HYDROXY-N- ISOPROPYLOXAMATE) 1QMG ; 1.60 ; ACETOHYDROXYACID ISOMEROREDUCTASE COMPLEXED WITH ITS REACTION PRODUCT DIHYDROXY-METHYLVALERATE, MANGANESE AND ADP-RIBOSE. 1PG3 ; 2.30 ; ACETYL COA SYNTHETASE, ACETYLATED ON LYS609 1PG4 ; 1.75 ; ACETYL COA SYNTHETASE, SALMONELLA ENTERICA 1OD2 ; 2.70 ; ACETYL-COA CARBOXYLASE CARBOXYLTRANSFERASE DOMAIN 1OD4 ; 2.70 ; ACETYL-COA CARBOXYLASE CARBOXYLTRANSFERASE DOMAIN 1UYT ; 2.50 ; ACETYL-COA CARBOXYLASE CARBOXYLTRANSFERASE DOMAIN 1UYR ; 2.50 ; ACETYL-COA CARBOXYLASE CARBOXYLTRANSFERASE DOMAIN IN COMPLEX WITH INHIBITOR DICLOFOP 1UYS ; 2.80 ; ACETYL-COA CARBOXYLASE CARBOXYLTRANSFERASE DOMAIN IN COMPLEX WITH INHIBITOR HALOXYFOP 1UYV ; 2.60 ; ACETYL-COA CARBOXYLASE CARBOXYLTRANSFERASE DOMAIN L1705I/ V1967I MUTANT 1DM3 ; 2.00 ; ACETYLATED BIOSYNTHETIC THIOLASE FROM ZOOGLOEA RAMIGERA IN COMPLEX WITH ACETYL-COA 1EEA ; 4.50 ; ACETYLCHOLINESTERASE 1QTI ; 2.50 ; ACETYLCHOLINESTERASE 1AX9 ; 2.80 ; ACETYLCHOLINESTERASE COMPLEXED WITH EDROPHONIUM, LAUE DATA 2ACK ; 2.40 ; ACETYLCHOLINESTERASE COMPLEXED WITH EDROPHONIUM, MONOCHROMATIC DATA 1FSS ; 3.00 ; ACETYLCHOLINESTERASE COMPLEXED WITH FASCICULIN-II 1VOT ; 2.50 ; ACETYLCHOLINESTERASE COMPLEXED WITH HUPERZINE A 1OCE ; 2.70 ; ACETYLCHOLINESTERASE COMPLEXED WITH MF268 1GQS ; 3.00 ; ACETYLCHOLINESTERASE COMPLEXED WITH NAP 1GQR ; 2.20 ; ACETYLCHOLINESTERASE COMPLEXED WITH RIVASTIGMINE 1OHB ; 1.90 ; ACETYLGLUTAMATE KINASE FROM ESCHERICHIA COLI COMPLEXED WITH ADP AND SULPHATE 1OHA ; 1.90 ; ACETYLGLUTAMATE KINASE FROM ESCHERICHIA COLI COMPLEXED WITH MGADP AND N-ACETYL-L-GLUTAMATE 1OH9 ; 1.91 ; ACETYLGLUTAMATE KINASE FROM ESCHERICHIA COLI COMPLEXED WITH MGADP, N-ACETYL-L-GLUTAMATE AND THE TRANSITION-STATE MIMIC ALF4- 2BTY ; 2.75 ; ACETYLGLUTAMATE KINASE FROM THERMOTOGA MARITIMA COMPLEXED WITH ITS INHIBITOR ARGININE 1VEF ; 1.35 ; ACETYLORNITHINE AMINOTRANSFERASE FROM THERMUS THERMOPHILUS HB8 1WKG ; 2.25 ; ACETYLORNITHINE AMINOTRANSFERASE FROM THERMUS THERMOPHILUS HB8 1WKH ; 2.25 ; ACETYLORNITHINE AMINOTRANSFERASE FROM THERMUS THERMOPHILUS HB8 2FBM ; 2.28 ; ACETYLTRANSFERASE DOMAIN OF CDY1 2ATR ; 2.01 ; ACETYLTRANSFERASE, GNAT FAMILY PROTEIN SP0256 FROM STREPTOCOCCUS PNEUMONIAE TIGR4 1G66 ; 0.90 ; ACETYLXYLAN ESTERASE AT 0.90 ANGSTROM RESOLUTION 1BS9 ; 1.10 ; ACETYLXYLAN ESTERASE FROM P. PURPUROGENUM REFINED AT 1.10 ANGSTROMS 1QON ; 2.72 ; ACHE FROM DROSOPHILA MELANOGASTER COMPLEX WITH TACRINE DERIVATIVE 9-(3-IODOBENZYLAMINO)-1,2,3,4-TETRAHYDROACRIDINE 1DX4 ; 2.70 ; ACHE FROM DROSOPHILA MELANOGASTER COMPLEX WITH TACRINE DERIVATIVE 9-(3-PHENYLMETHYLAMINO)-1,2,3,4-TETRAHYDROACRIDINE 1U65 ; 2.61 ; ACHE W. CPT-11 1YPP ; 2.40 ; ACID ANHYDRIDE HYDROLASE 1BXQ ; 1.41 ; ACID PROTEINASE (PENICILLOPEPSIN) COMPLEX WITH PHOSPHONATE INHIBITOR. 1BXO ; 0.95 ; ACID PROTEINASE (PENICILLOPEPSIN) COMPLEX WITH PHOSPHONATE INHIBITOR: METHYL CYCLO[(2S)-2-[[(1R)-1- (N-(L-N-(3-METHYLBUTANOYL)VALYL-L-ASPARTYL)AMINO)-3- METHYLBUT YL] HYDROXYPHOSPHINYLOXY]-3-(3-AMINOMETHYL) PHENYLPROPANOATE 2WEC ; 1.50 ; ACID PROTEINASE (PENICILLOPEPSIN) COMPLEX WITH PHOSPHONATE INHIBITOR: METHYL(2S)-[1-(((N-(1- NAPHTHALENEACETYL))- L-VALYL)AMINOMETHYL)HYDROXY PHOSPHINYLOXY]-3-PHENYLPROPANOATE, SODIUM SALT 2WEB ; 1.50 ; ACID PROTEINASE (PENICILLOPEPSIN) COMPLEX WITH PHOSPHONATE INHIBITOR: METHYL(2S)-[1-(((N-FORMYL)-L- VALYL)AMINO- 2-(2-NAPHTHYL)ETHYL)HYDROXYPHOSPHINYLOXY]-3- PHENYLPROPANOATE, SODIUM SALT 2WEA ; 1.25 ; ACID PROTEINASE (PENICILLOPEPSIN) COMPLEX WITH PHOSPHONATE INHIBITOR: METHYL[CYCLO-7[(2R)- ((N-VALYL) AMINO)-2-(HYDROXYL-(1S)-1-METHYOXYCARBONYL-2-PHENYLETHOXY) PHOSPHINYLOXY-ETHYL]-1-NAPHTHALENEACETAMIDE], SODIUM SALT 2WED ; 1.50 ; ACID PROTEINASE (PENICILLOPEPSIN) COMPLEX WITH PHOSPHONATE MACROCYCLIC INHIBITOR:METHYL[CYCLO-7[(2R)- ((N-VALYL)AMINO)-2-(HYDROXYL-(1S)-1-METHYOXYCARBONYL-2- PHENYLETHOXY)PHOSPHINYLOXY-ETHYL]-1-NAPHTHALENEACETAMIDE], SODIUM SALT 1PSJ ; 2.01 ; ACIDIC PHOSPHOLIPASE A2 FROM AGKISTRODON HALYS PALLAS 1GP7 ; 2.60 ; ACIDIC PHOSPHOLIPASE A2 FROM VENOM OF OPHIOPHAGUS HANNAH 1H1O ; 2.13 ; ACIDITHIOBACILLUS FERROOXIDANS CYTOCHROME C4 STRUCTURE SUPPORTS A COMPLEX-INDUCED TUNING OF ELECTRON TRANSFER 1ECE ; 2.40 ; ACIDOTHERMUS CELLULOLYTICUS ENDOCELLULASE E1 CATALYTIC DOMAIN IN COMPLEX WITH A CELLOTETRAOSE 1B0M ; 2.50 ; ACONITASE R644Q:FLUOROCITRATE COMPLEX 452D ; 1.60 ; ACRIDINE BINDING TO DEOXYRIBONUCLEIC ACID 1C3H ; 2.10 ; ACRP30 CALCIUM COMPLEX 1ZPV ; 1.90 ; ACT DOMAIN PROTEIN FROM STREPTOCOCCUS PNEUMONIAE 1QAG ; 3.00 ; ACTIN BINDING REGION OF THE DYSTROPHIN HOMOLOGUE UTROPHIN 1RDW ; 2.30 ; ACTIN CRYSTAL DYNAMICS: STRUCTURAL IMPLICATIONS FOR F-ACTIN NUCLEATION, POLYMERIZATION AND BRANCHING MEDIATED BY THE ANTI-PARALLEL DIMER 1RFQ ; 3.00 ; ACTIN CRYSTAL DYNAMICS: STRUCTURAL IMPLICATIONS FOR F-ACTIN NUCLEATION, POLYMERIZATION AND BRANCHING MEDIATED BY THE ANTI-PARALLEL DIMER 2A42 ; 1.85 ; ACTIN-DNASE I COMPLEX 1CJA ; 2.90 ; ACTIN-FRAGMIN KINASE, CATALYTIC DOMAIN FROM PHYSARUM POLYCEPHALUM 1MNV ; 2.60 ; ACTINOMYCIN D BINDING TO ATGCTGCAT 1I3W ; 1.70 ; ACTINOMYCIN D BINDING TO CGATCGATCG 1XR3 ; 2.71 ; ACTINORHODIN POLYKETIDE KETOREDUCTASE WITH NADP AND THE INHIBITOR ISONIAZID BOUND 1X7G ; 2.30 ; ACTINORHODIN POLYKETIDE KETOREDUCTASE, ACT KR, WITH NADP BOUND 1X7H ; 2.30 ; ACTINORHODIN POLYKETIDE KETOREDUCTASE, WITH NADPH BOUND 1AF8 ; -1.00 ; ACTINORHODIN POLYKETIDE SYNTHASE ACYL CARRIER PROTEIN FROM STREPTOMYCES COELICOLOR A3(2), NMR, 24 STRUCTURES 2AF8 ; -1.00 ; ACTINORHODIN POLYKETIDE SYNTHASE ACYL CARRIER PROTEIN FROM STREPTOMYCES COELICOLOR A3(2), NMR, MINIMIZED AVERAGE STRUCTURE 1BWV ; 2.40 ; ACTIVATED RIBULOSE 1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE (RUBISCO) COMPLEXED WITH THE REACTION INTERMEDIATE ANALOGUE 2-CARBOXYARABINITOL 1,5-BISPHOSPHATE 1UPM ; 2.30 ; ACTIVATED SPINACH RUBISCO COMPLEXED WITH 2-CARBOXYARABINITOL 2 BISPHOSPHAT AND CA2+. 8RUC ; 1.60 ; ACTIVATED SPINACH RUBISCO COMPLEXED WITH 2-CARBOXYARABINITOL BISPHOSPHATE 1RXO ; 2.20 ; ACTIVATED SPINACH RUBISCO IN COMPLEX WITH ITS SUBSTRATE RIBULOSE-1,5-BISPHOSPHATE AND CALCIUM 1AA1 ; 2.20 ; ACTIVATED SPINACH RUBISCO IN COMPLEX WITH THE PRODUCT 3-PHOSPHOGLYCERATE 1AUS ; 2.20 ; ACTIVATED UNLIGANDED SPINACH RUBISCO 1BJA ; 2.19 ; ACTIVATION DOMAIN OF THE PHAGE T4 TRANSCRIPTION FACTOR MOTA 1AVF ; 2.36 ; ACTIVATION INTERMEDIATE 2 OF HUMAN GASTRICSIN FROM HUMAN STOMACH 1GQT ; 2.34 ; ACTIVATION OF RIBOKINASE BY MONOVALENT CATIONS 1RQI ; 2.42 ; ACTIVE CONFORMATION OF FARNESYL PYROPHOSPHATE SYNTHASE BOUND TO ISOPENTYL PYROPHOSPHATE AND DIMETHYLALLYL S- THIOLODIPHOSPHATE 1RQJ ; 1.95 ; ACTIVE CONFORMATION OF FARNESYL PYROPHOSPHATE SYNTHASE BOUND TO ISOPENTYL PYROPHOSPHATE AND RISEDRONATE 1DVM ; 2.40 ; ACTIVE FORM OF HUMAN PAI-1 1KYA ; 2.40 ; ACTIVE LACCASE FROM TRAMETES VERSICOLOR COMPLEXED WITH 2,5- XYLIDINE 1H9B ; 2.40 ; ACTIVE MUTANT (Q365->C) OF GLUCOSE 6-PHOSPHATE DEHYDROGENASE FROM LEUCONOSTOC MESENTEROIDES 1H93 ; 2.20 ; ACTIVE MUTANT (S215->C) OF GLUCOSE 6-PHOSPHATE DEHYDROGENASE FROM LEUCONOSTOC MESENTEROIDES 1OAJ ; 1.73 ; ACTIVE SITE COPPER AND ZINC IONS MODULATE THE QUATERNARY STRUCTURE OF PROKARYOTIC CU,ZN SUPEROXIDE DISMUTASE 1OAL ; 1.50 ; ACTIVE SITE COPPER AND ZINC IONS MODULATE THE QUATERNARY STRUCTURE OF PROKARYOTIC CU,ZN SUPEROXIDE DISMUTASE 2D26 ; 3.30 ; ACTIVE SITE DISTORTION IS SUFFICIENT FOR PROTEINASE INHIBIT SECOND CRYSTAL STRUCTURE OF COVALENT SERPIN-PROTEINASE COMPLEX 2AUN ; 2.40 ; ACTIVE SITE HIS285ALA MUTANT OF LD-CARBOXYPEPTIDASE 3HAT ; 2.50 ; ACTIVE SITE MIMETIC INHIBITION OF THROMBIN 1E7M ; 2.54 ; ACTIVE SITE MUTANT (D177->N) OF GLUCOSE 6-PHOSPHATE DEHYDROGENASE FROM LEUCONOSTOC MESENTEROIDES 1E7Y ; 2.48 ; ACTIVE SITE MUTANT (D177->N) OF GLUCOSE 6-PHOSPHATE DEHYDROGENASE FROM LEUCONOSTOC MESENTEROIDES COMPLEXED WITH SUBSTRATE AND NADPH 1HM2 ; 2.00 ; ACTIVE SITE OF CHONDROITINASE AC LYASE REVEALED BY THE STRUCTURE OF ENZYME-OLIGOSACCHARIDE COMPLEXES AND MUTAGENESIS 1HM3 ; 2.10 ; ACTIVE SITE OF CHONDROITINASE AC LYASE REVEALED BY THE STRUCTURE OF ENZYME-OLIGOSACCHARIDE COMPLEXES AND MUTAGENESIS 1HMU ; 2.00 ; ACTIVE SITE OF CHONDROITINASE AC LYASE REVEALED BY THE STRUCTURE OF ENZYME-OLIGOSACCHARIDE COMPLEXES AND MUTAGENESIS 1HMW ; 2.30 ; ACTIVE SITE OF CHONDROITINASE AC LYASE REVEALED BY THE STRUCTURE OF ENZYME-OLIGOSACCHARIDE COMPLEXES AND MUTAGENESIS 2BG3 ; 2.40 ; ACTIVE SITE RESTRUCTURING REGULATES LIGAND RECOGNITION IN CLASS A PENICILLIN-BINDING PROTEINS (PBPS) 2BG4 ; 3.00 ; ACTIVE SITE RESTRUCTURING REGULATES LIGAND RECOGNITION IN CLASS A PENICILLIN-BINDING PROTEINS (PBPS) 2BG1 ; 1.90 ; ACTIVE SITE RESTRUCTURING REGULATES LIGAND RECOGNITION IN CLASSA PENICILLIN-BINDING PROTEINS (PBPS) 1C0E ; 2.20 ; ACTIVE SITE S19A MUTANT OF BOVINE HEART PHOSPHOTYROSYL PHOSPHATASE 2AUM ; 2.40 ; ACTIVE SITE SER115ALA MUTANT OF LD-CARBOXYPEPTIDASE 1JNW ; 2.07 ; ACTIVE SITE STRUCTURE OF E. COLI PYRIDOXINE 5'-PHOSPHATE OXIDASE 1WAY ; 2.02 ; ACTIVE SITE THROMBIN INHIBITORS 1WBG ; 2.20 ; ACTIVE SITE THROMBIN INHIBITORS 1AXA ; 2.00 ; ACTIVE-SITE MOBILITY IN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 PROTEASE AS DEMONSTRATED BY CRYSTAL STRUCTURE OF A28S MUTANT 4CEL ; 2.20 ; ACTIVE-SITE MUTANT D214N DETERMINED AT PH 6.0 WITH NO LIGAND BOUND IN THE ACTIVE SITE 3CEL ; 2.00 ; ACTIVE-SITE MUTANT E212Q DETERMINED AT PH 6.0 WITH CELLOBIOSE BOUND IN THE ACTIVE SITE 2CEL ; 2.00 ; ACTIVE-SITE MUTANT E212Q DETERMINED AT PH 6.0 WITH NO LIGAND BOUND IN THE ACTIVE SITE 1TXX ; 2.20 ; ACTIVE-SITE VARIANT OF E.COLI THIOREDOXIN 1BUD ; 1.90 ; ACUTOLYSIN A FROM SNAKE VENOM OF AGKISTRODON ACUTUS AT PH 5.0 1BSW ; 1.95 ; ACUTOLYSIN A FROM SNAKE VENOM OF AGKISTRODON ACUTUS AT PH 7.5 1WUT ; 2.26 ; ACYL UREAS AS HUMAN LIVER GLYCOGEN PHOSPHORYLASE INHIBITORS FOR THE TREATMENT OF TYPE 2 DIABETES 1HBK ; 2.00 ; ACYL-COA BINDING PROTEIN FROM PLASMODIUM FALCIPARUM 1XNV ; 2.30 ; ACYL-COA CARBOXYLASE BETA SUBUNIT FROM S. COELICOLOR (PCCB), APO FORM #1 1XNW ; 2.60 ; ACYL-COA CARBOXYLASE BETA SUBUNIT FROM S. COELICOLOR (PCCB), APO FORM #2, MUTANT D422I 1XO6 ; 2.20 ; ACYL-COA CARBOXYLASE BETA SUBUNIT FROM S. COELICOLOR (PCCB), APO FORM #3 2BU3 ; 1.40 ; ACYL-ENZYME INTERMEDIATE BETWEEN ALR0975 AND GLUTATHIONE AT PH 3.4 2ACY ; 1.80 ; ACYL-PHOSPHATASE (COMMON TYPE) FROM BOVINE TESTIS 2BJE ; 1.90 ; ACYLPHOSPHATASE FROM SULFOLOBUS SOLFATARICUS. MONCLINIC P21 SPACE GROUP 1SFE ; 2.10 ; ADA O6-METHYLGUANINE-DEOXYRIBONUCLEIC ACID METHYLTRANSFERASE FROM ESCHERICHIA COLI 1A4L ; 2.60 ; ADA STRUCTURE COMPLEXED WITH DEOXYCOFORMYCIN AT PH 7.0 1A4M ; 1.95 ; ADA STRUCTURE COMPLEXED WITH PURINE RIBOSIDE AT PH 7.0 2AIG ; 2.60 ; ADAMALYSIN II WITH PEPTIDOMIMETIC INHIBITOR POL647 3AIG ; 2.80 ; ADAMALYSIN II WITH PEPTIDOMIMETIC INHIBITOR POL656 4AIG ; 2.00 ; ADAMALYSIN II WITH PHOSPHONATE INHIBITOR 2BIR ; 2.30 ; ADDITIVITY OF SUBSTRATE BINDING IN RIBONUCLEASE T1 (Y42A MUTANT) 1U49 ; 2.15 ; ADENINE-8OXOGUANINE MISMATCH AT THE POLYMERASE ACTIVE SITE 1NK5 ; 2.10 ; ADENINE-ADENINE MISMATCH AT THE POLYMERASE ACTIVE SITE 1NK0 ; 1.70 ; ADENINE-GUANINE MISMATCH AT THE POLYMERASE ACTIVE SITE 2ADM ; 2.40 ; ADENINE-N6-DEOXYRIBONUCLEIC ACID-METHYLTRANSFERASE TAQI 1G38 ; 2.00 ; ADENINE-SPECIFIC METHYLTRANSFERASE M. TAQ I/DEOXYRIBONUCLEIC ACID COMPLEX 1VFL ; 1.80 ; ADENOSINE DEAMINASE 1UIO ; 2.40 ; ADENOSINE DEAMINASE (HIS 238 ALA MUTANT) 1UIP ; 2.40 ; ADENOSINE DEAMINASE (HIS 238 GLU MUTANT) 1CBU ; 2.30 ; ADENOSYLCOBINAMIDE KINASE/ADENOSYLCOBINAMIDE PHOSPHATE GUANYLYLTRANSFERASE (COBU) FROM SALMONELLA TYPHIMURIUM 1ANV ; 2.70 ; ADENOVIRUS 5 DBP/URANYL FLUORIDE SOAK 1UXB ; 1.75 ; ADENOVIRUS AD19P FIBRE HEAD IN COMPLEX WITH SIALYL-LACTOSE 1H7Z ; 1.60 ; ADENOVIRUS AD3 FIBRE HEAD 1UXE ; 2.00 ; ADENOVIRUS AD37 FIBRE HEAD 1UXA ; 1.50 ; ADENOVIRUS AD37 FIBRE HEAD IN COMPLEX WITH SIALYL-LACTOSE 1V1I ; 1.90 ; ADENOVIRUS FIBRE SHAFT SEQUENCE N-TERMINALLY FUSED TO THE BACTERIOPHAGE T4 FIBRITIN FOLDON TRIMERISATION MOTIF WITH A LONG LINKER 1V1H ; 1.90 ; ADENOVIRUS FIBRE SHAFT SEQUENCE N-TERMINALLY FUSED TO THE BACTERIOPHAGE T4 FIBRITIN FOLDON TRIMERISATION MOTIF WITH A SHORT LINKER 4AKE ; 2.20 ; ADENYLATE KINASE 1P3J ; 1.90 ; ADENYLATE KINASE FROM BACILLUS SUBTILIS 1ZAK ; 3.50 ; ADENYLATE KINASE FROM MAIZE IN COMPLEX WITH THE INHIBITOR P1,P5-BIS(ADENOSINE-5'-)PENTAPHOSPHATE (AP5A) 1KI9 ; 2.76 ; ADENYLATE KINASE FROM METHANOCOCCUS THERMOLITHOTROPHICUS 1KHT ; 2.50 ; ADENYLATE KINASE FROM METHANOCOCCUS VOLTAE 1NKS ; 2.57 ; ADENYLATE KINASE FROM SULFOLOBUS ACIDOCALDARIUS 1AK2 ; 1.92 ; ADENYLATE KINASE ISOENZYME-2 2AK2 ; 2.10 ; ADENYLATE KINASE ISOENZYME-2 1ZIN ; 1.60 ; ADENYLATE KINASE WITH BOUND AP5A 1ZAU ; 3.15 ; ADENYLATION DOMAIN OF NAD+ DEPENDENT DEOXYRIBONUCLEIC ACID LIGASE FROM M.TUBERCULOSIS 1SON ; 2.55 ; ADENYLOSUCCINATE SYNTHETASE IN COMPLEX WITH THE NATURAL FEEDBACK INHIBITOR AMP 1SOO ; 2.60 ; ADENYLOSUCCINATE SYNTHETASE INHIBITED BY HYDANTOCIDIN 5'-MONOPHOSPHATE 2ANS ; 2.50 ; ADIPOCYTE LIPID BINDING PROTEIN COMPLEXED WITH 1-ANILINO-8-NAPHTHALENE SULFONATE 1K98 ; 3.75 ; ADOMET COMPLEX OF METH C-TERMINAL FRAGMENT 1AMW ; 1.85 ; ADP BINDING SITE IN THE HSP90 MOLECULAR CHAPERONE 1XXI ; 4.10 ; ADP BOUND E. COLI CLAMP LOADER COMPLEX 1XJQ ; 2.06 ; ADP COMPLEX OF HUMAN PAPS SYNTHETASE 1 1MOZ ; 3.17 ; ADP-RIBOSYLATION FACTOR-LIKE 1 (ARL1) FROM SACCHAROMYCES CEREVISIAE 1R4B ; 1.85 ; ADP-RIBOSYLTRANSFERASE C3BOT2 FROM CLOSTRIDIUM BOTULINUM, MONOCLINIC FORM 1R45 ; 1.57 ; ADP-RIBOSYLTRANSFERASE C3BOT2 FROM CLOSTRIDIUM BOTULINUM, TRICLINIC FORM 2ADR ; -1.00 ; ADR1 DEOXYRIBONUCLEIC ACID-BINDING DOMAIN FROM SACCHAROMYCES CEREVISIAE, NMR, 25 STRUCTURES 1CJE ; 2.50 ; ADRENODOXIN FROM BOVINE 1E1K ; 1.95 ; ADRENODOXIN REDUCTASE IN COMPLEX WITH NADP+ OBTAINED BY A SOAKING EXPERIMENT 1E1M ; 1.85 ; ADRENODOXIN REDUCTASE IN COMPLEX WITH NADPH OBTAINED BY A SOAKING EXPERIMENT 1E6E ; 2.30 ; ADRENODOXIN REDUCTASE/ADRENODOXIN COMPLEX OF MITOCHONDRIAL P450 SYSTEMS 1YIY ; 1.90 ; AEDES AEGYPTI KYNURENINE AMINOTRANSFERASE 1YIZ ; 1.55 ; AEDES AEGYPTI KYNURENINE AMINOTRASFERASE 1IGB ; 2.30 ; AEROMONAS PROTEOLYTICA AMINOPEPTIDASE COMPLEXED WITH THE INHIBITOR PARA-IODO-D-PHENYLALANINE HYDROXAMATE 1UT2 ; 3.30 ; AFAE-3 ADHESIN FROM ESCHERICHIA COLI 1GVE ; 1.38 ; AFLATOXIN ALDEHYDE REDUCTASE (AKR7A1) FROM RAT LIVER 1AQQ ; -1.00 ; AG-SUBSTITUTED METALLOTHIONEIN FROM SACCHAROMYCES CEREVISIAE, NMR, 10 STRUCTURES 1AOO ; -1.00 ; AG-SUBSTITUTED METALLOTHIONEIN FROM SACCHAROMYCES CEREVISIAE, NMR, MINIMIZED AVERAGE STRUCTURE 2ERB ; 1.50 ; AGAMOBP1, AND ODORANT BINDING PROTEIN FROM ANOPHELES GAMBIAE COMPLEXED WITH PEG 1RJO ; 1.67 ; AGAO + XE 1W5Z ; 1.86 ; AGAO COVALENT COMPLEX WITH BENZYLHYDRAZINE 1W4N ; 1.65 ; AGAO COVALENT COMPLEX WITH TRANYLCYPROMINE 1W6G ; 1.55 ; AGAO HOLOENZYME AT 1.55 ANGSTROMS 1W6C ; 2.20 ; AGAO HOLOENZYME IN A SMALL CELL, AT 2.2 ANGSTROMS 2BT3 ; 1.73 ; AGAO IN COMPLEX WITH RUTHENIUM-C4-WIRE AT 1.73 ANGSTROMS 1SIH ; 1.73 ; AGAO IN COVALENT COMPLEX WITH THE INHIBITOR MOBA ("4-(4- METHYLPHENOXY)-2-BUTYN-1-AMINE") 1SII ; 1.70 ; AGAO IN COVALENT COMPLEX WITH THE INHIBITOR NOBA ("4-(2- NAPHTHYLOXY)-2-BUTYN-1-AMINE") 1ZFM ; 2.20 ; AGC DUPLEX B-DEOXYRIBONUCLEIC ACID 1RZO ; 2.63 ; AGGLUTININ FROM RICINUS COMMUNIS WITH GALACTOAZA 1JLX ; 2.20 ; AGGLUTININ IN COMPLEX WITH T-DISACCHARIDE 1BJJ ; 2.80 ; AGKISTRODOTOXIN, A PHOSPHOLIPASE A2-TYPE PRESYNAPTIC NEUROTOXIN FROM AGKISTRODON HALYS PALLAS 1A2A ; 2.80 ; AGKISTROTOXIN, A PHOSPHOLIPASE A2-TYPE PRESYNAPTIC NEUROTOXIN FROM AGKISTRODON HALYS PALLAS 1HYK ; -1.00 ; AGOUTI-RELATED PROTEIN (87-132) (AC-AGRP(87-132)) 1WW7 ; 1.90 ; AGROCYBE CYLINDRACEA GALECTIN (LIGAND-FREE) 1WW5 ; 2.20 ; AGROCYBE CYLINDRACEA GALECTIN COMPLEXED WITH 3'-SULFONYL LACTOSE 1WW6 ; 2.20 ; AGROCYBE CYLINDRACEA GALECTIN COMPLEXED WITH LACTOSE 1WW4 ; 2.30 ; AGROCYBE CYLINDRACEA GALECTIN COMPLEXED WITH NEUACA2- 3LACTOSE 1SGP ; 1.40 ; ALA 18 VARIANT OF TURKEY OVOMUCOID INHIBITOR THIRD DOMAIN COMPLEXED WITH STREPTOMYCES GRISEUS PROTEINASE B 1B6Q ; 1.80 ; ALANINE 31 PROLINE MUTANT OF ROP PROTEIN 1GMG ; 1.90 ; ALANINE 31 PROLINE MUTANT OF ROP PROTEIN, MONOCLINIC FORM 1XI9 ; 2.33 ; ALANINE AMINOTRANSFERASE FROM PYROCOCCUS FURIOSUS PFU- 1397077-001 1OMO ; 2.32 ; ALANINE DEHYDROGENASE DIMER W/BOUND NAD (ARCHAEAL) 1SFT ; 1.90 ; ALANINE RACEMASE 1L6G ; 2.00 ; ALANINE RACEMASE BOUND WITH N-(5'-PHOSPHOPYRIDOXYL)-D- ALANINE 1L6F ; 2.00 ; ALANINE RACEMASE BOUND WITH N-(5'-PHOSPHOPYRIDOXYL)-L- ALANINE 1BD0 ; 1.60 ; ALANINE RACEMASE COMPLEXED WITH ALANINE PHOSPHONATE 1EPV ; 2.20 ; ALANINE RACEMASE WITH BOUND INHIBITOR DERIVED FROM D- CYCLOSERINE 1NIU ; 2.20 ; ALANINE RACEMASE WITH BOUND INHIBITOR DERIVED FROM L- CYCLOSERINE 2SFP ; 1.90 ; ALANINE RACEMASE WITH BOUND PROPIONATE INHIBITOR 1V7O ; 2.62 ; ALANYL-TRNA SYNTHETASE EDITING DOMAIN HOMOLOGUE PROTEIN FROM PYROCOCCUS HORIKOSHII 1CDO ; 2.05 ; ALCOHOL DEHYDROGENASE (EE ISOZYME) COMPLEXED WITH NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD), AND ZINC 1JQB ; 1.97 ; ALCOHOL DEHYDROGENASE FROM CLOSTRIDIUM BEIJERINCKII: CRYSTAL STRUCTURE OF MUTANT WITH ENHANCED THERMAL STABILITY 1A4U ; 1.92 ; ALCOHOL DEHYDROGENASE FROM DROSOPHILA LEBANONENSIS 1B14 ; 2.40 ; ALCOHOL DEHYDROGENASE FROM DROSOPHILA LEBANONENSIS BINARY COMPLEX WITH NAD+ 1SBY ; 1.10 ; ALCOHOL DEHYDROGENASE FROM DROSOPHILA LEBANONENSIS COMPLEXED WITH NAD+ AND 2,2,2-TRIFLUOROETHANOL AT 1.1 A RESOLUTION 1B16 ; 1.40 ; ALCOHOL DEHYDROGENASE FROM DROSOPHILA LEBANONENSIS TERNARY COMPLEX WITH NAD-3-PENTANONE 1B15 ; 2.20 ; ALCOHOL DEHYDROGENASE FROM DROSOPHILA LEBANONENSIS TERNARY COMPLEX WITH NAD-ACETONE 1B2L ; 1.60 ; ALCOHOL DEHYDROGENASE FROM DROSOPHILA LEBANONENSIS: TERNARY COMPLEX WITH NAD-CYCLOHEXANONE 1R37 ; 2.30 ; ALCOHOL DEHYDROGENASE FROM SULFOLOBUS SOLFATARICUS COMPLEXED WITH NAD(H) AND 2-ETHOXYETHANOL 1JVB ; 1.85 ; ALCOHOL DEHYDROGENASE FROM THE ARCHAEON SULFOLOBUS SOLFATARICUS 1AG8 ; 2.65 ; ALDEHYDE DEHYDROGENASE FROM BOVINE MITOCHONDRIA 1A4Z ; 2.75 ; ALDEHYDE DEHYDROGENASE FROM BOVINE MITOCHONDRIA COMPLEX WITH NAD (REDUCED) AND SAMARIUM (III) 2ALR ; 2.48 ; ALDEHYDE REDUCTASE 1AE4 ; 2.40 ; ALDEHYDE REDUCTASE COMPLEXED WITH COFACTOR AND INHIBITOR, ALPHA CARBON ATOMS ONLY 1YNP ; 1.25 ; ALDO-KETO REDUCTASE AKR11C1 FROM BACILLUS HALODURANS (APO FORM) 1YNQ ; 1.30 ; ALDO-KETO REDUCTASE AKR11C1 FROM BACILLUS HALODURANS (HOLO FORM) 1AH3 ; 2.30 ; ALDOSE REDUCTASE COMPLEXED WITH TOLRESTAT INHIBITOR 2AGT ; 1.00 ; ALDOSE REDUCTASE MUTANT LEU 300 PRO COMPLEXED WITH FIDARESTAT 1SUI ; 2.70 ; ALFALFA CAFFEOYL COENZYME A 3-O-METHYLTRANSFERASE 1J1T ; 2.00 ; ALGINATE LYASE FROM ALTEROMONAS SP.272 1G01 ; 1.90 ; ALKALINE CELLULASE K CATALYTIC DOMAIN 1G0C ; 1.90 ; ALKALINE CELLULASE K CATALYTIC DOMAIN-CELLOBIOSE COMPLEX 1WSD ; 1.50 ; ALKALINE M-PROTEASE FORM I CRYSTAL STRCUTURE 2ANH ; 2.40 ; ALKALINE PHOSPHATASE (D153H) 1ANI ; 2.50 ; ALKALINE PHOSPHATASE (D153H, K328H) 1URA ; 2.30 ; ALKALINE PHOSPHATASE (D51ZN) 1HQA ; 2.25 ; ALKALINE PHOSPHATASE (H412Q) 1ANJ ; 2.30 ; ALKALINE PHOSPHATASE (K328H) 1URB ; 2.10 ; ALKALINE PHOSPHATASE (N51MG) 1EW9 ; 2.00 ; ALKALINE PHOSPHATASE COMPLEX WITH MERCAPTOMETHYL PHOSPHONATE 1EW8 ; 2.20 ; ALKALINE PHOSPHATASE COMPLEX WITH PHOSPHONOACETIC ACID 1B8J ; 1.90 ; ALKALINE PHOSPHATASE COMPLEXED WITH VANADATE 1ZED ; 1.57 ; ALKALINE PHOSPHATASE FROM HUMAN PLACENTA IN COMPLEX WITH P- NITROPHENYL-PHOSPHONATE 1ALI ; 2.20 ; ALKALINE PHOSPHATASE MUTANT (H412N) 1ALJ ; 2.60 ; ALKALINE PHOSPHATASE MUTANT (H412N) 1HJK ; 2.30 ; ALKALINE PHOSPHATASE MUTANT H331Q 1AKL ; 2.00 ; ALKALINE PROTEASE FROM PSEUDOMONAS AERUGINOSA IFO3080 1G1M ; 2.25 ; ALL-FERROUS NITROGENASE IRON PROTEIN FROM AZOTOBACTER VINELANDII 1KFS ; 2.10 ; ALL-OXYGEN DEOXYRIBONUCLEIC ACID COMPLEXED TO THE 3'-5' EXONUCLEASE OF DEOXYRIBONUCLEIC ACID POLYMERASE I FROM E. COLI 1W2Q ; -1.00 ; ALLERGEN ARAH6 FROM PEANUT (ARACHIS HYPOGAEA) 1WHO ; 1.90 ; ALLERGEN PHL P 2 1WHP ; 3.00 ; ALLERGEN PHL P 2 1ALL ; 2.30 ; ALLOPHYCOCYANIN 2GPA ; 2.00 ; ALLOSTERIC INHIBITION OF GLYCOGEN PHOSPHORYLASE A BY A POTENTIAL ANTIDIABETIC DRUG 3AMV ; 2.10 ; ALLOSTERIC INHIBITION OF GLYCOGEN PHOSPHORYLASE A BY A POTENTIAL ANTIDIABETIC DRUG 1T48 ; 2.20 ; ALLOSTERIC INHIBITION OF PROTEIN TYROSINE PHOSPHATASE 1B 1T49 ; 1.90 ; ALLOSTERIC INHIBITION OF PROTEIN TYROSINE PHOSPHATASE 1B 1T4J ; 2.70 ; ALLOSTERIC INHIBITION OF PROTEIN TYROSINE PHOSPHATASE 1B 1XGB ; -1.00 ; ALPHA CONOTOXIN GI: 2-13;3-7 DISULFIDE BOND ISOMER NMR, 24 STRUCTURES 1XGC ; -1.00 ; ALPHA CONOTOXIN GI: 2-3;7-13 DISULFIDE BOND ISOMER, NMR, 25 STRUCTURES 1XGA ; -1.00 ; ALPHA CONOTOXIN GI: 2-7;3-13 (NATIVE) DISULFIDE BOND ISOMER, NMR, 35 STRUCTURES 1EA0 ; 3.00 ; ALPHA SUBUNIT OF A. BRASILENSE GLUTAMATE SYNTHASE 1OLP ; 2.50 ; ALPHA TOXIN FROM CLOSTRIDIUM ABSONUM 1GWW ; 1.80 ; ALPHA-,1,3 GALACTOSYLTRANSFERASE - ALPHA-D-GLUCOSE COMPLEX 1GX0 ; 1.80 ; ALPHA-,1,3 GALACTOSYLTRANSFERASE - BETA-D-GALACTOSE COMPLEX 1GWV ; 2.50 ; ALPHA-,1,3 GALACTOSYLTRANSFERASE - LACTOSE COMPLEX 1GX4 ; 1.46 ; ALPHA-,1,3 GALACTOSYLTRANSFERASE - N-ACETYL LACTOSAMINE COMPLEX 1HCU ; 2.37 ; ALPHA-1,2-MANNOSIDASE FROM TRICHODERMA REESEI 1B9K ; 1.90 ; ALPHA-ADAPTIN APPENDAGE DOMAIN, FROM CLATHRIN ADAPTOR AP2 1MPX ; 1.90 ; ALPHA-AMINO ACID ESTER HYDROLASE LABELED WITH SELENOMETHIONINE 1AQH ; 2.00 ; ALPHA-AMYLASE FROM ALTEROMONAS HALOPLANCTIS 1B0I ; 2.40 ; ALPHA-AMYLASE FROM ALTEROMONAS HALOPLANCTIS 1AQM ; 1.85 ; ALPHA-AMYLASE FROM ALTEROMONAS HALOPLANCTIS COMPLEXED WITH TRIS 1BAG ; 2.50 ; ALPHA-AMYLASE FROM BACILLUS SUBTILIS COMPLEXED WITH MALTOPENTAOSE 1BVZ ; 2.60 ; ALPHA-AMYLASE II (TVAII) FROM THERMOACTINOMYCES VULGARIS R- 47 1L7C ; 2.50 ; ALPHA-CATENIN FRAGMENT, RESIDUES 385-651 1H6G ; 2.20 ; ALPHA-CATENIN M-DOMAIN 1B45 ; -1.00 ; ALPHA-CNIA CONOTOXIN FROM CONUS CONSORS, NMR, 43 STRUCTURES 1CNL ; -1.00 ; ALPHA-CONOTOXIN IMI 1PEN ; 1.10 ; ALPHA-CONOTOXIN PNI1 1AKG ; 1.10 ; ALPHA-CONOTOXIN PNIB FROM CONUS PENNACEUS 1WVC ; 2.50 ; ALPHA-D-GLUCOSE-1-PHOSPHATE CYTIDYLYLTRANSFERASE COMPLEXED WITH CTP 1QZM ; 1.90 ; ALPHA-DOMAIN OF ATPASE 1OBB ; 1.90 ; ALPHA-GLUCOSIDASE A, AGLA, FROM THERMOTOGA MARITIMA IN COMPLEX WITH MALTOSE AND NAD+ 1XV5 ; 1.73 ; ALPHA-GLUCOSYLTRANSFERASE (AGT) IN COMPLEX WITH UDP 1YA6 ; 2.40 ; ALPHA-GLUCOSYLTRANSFERASE IN COMPLEX WITH UDP AND A 13-MER DEOXYRIBONUCLEIC ACID CONTAINING A CENTRAL A:G MISMATCH 1Y8Z ; 1.90 ; ALPHA-GLUCOSYLTRANSFERASE IN COMPLEX WITH UDP AND A 13-MER DEOXYRIBONUCLEIC ACID CONTAINING A HMU BASE AT 1.9 A RESOLUTION 1Y6G ; 2.80 ; ALPHA-GLUCOSYLTRANSFERASE IN COMPLEX WITH UDP AND A 13_MER DEOXYRIBONUCLEIC ACID CONTAINING A HMU BASE AT 2.8 A RESOLUTION 1Y6F ; 2.40 ; ALPHA-GLUCOSYLTRANSFERASE IN COMPLEX WITH UDP-GLUCOSE AND DEOXYRIBONUCLEIC ACID CONTAINING AN ABASIC SITE 7AHL ; 1.90 ; ALPHA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS 1A4V ; 1.80 ; ALPHA-LACTALBUMIN 1HFX ; 1.90 ; ALPHA-LACTALBUMIN 1HFY ; 2.30 ; ALPHA-LACTALBUMIN 1HFZ ; 2.30 ; ALPHA-LACTALBUMIN 1BMR ; -1.00 ; ALPHA-LIKE TOXIN LQH III FROM SCORPION LEIURUS QUINQUESTRIATUS HEBRAEUS, NMR, 25 STRUCTURES 1TAL ; 1.50 ; ALPHA-LYTIC PROTEASE AT 120 K (SINGLE STRUCTURE MODEL) 3PRO ; 1.80 ; ALPHA-LYTIC PROTEASE COMPLEXED WITH C-TERMINAL TRUNCATED PRO REGION 4PRO ; 2.40 ; ALPHA-LYTIC PROTEASE COMPLEXED WITH PRO REGION 1GBJ ; 2.00 ; ALPHA-LYTIC PROTEASE WITH MET 190 REPLACED BY ALA 1GBA ; 2.15 ; ALPHA-LYTIC PROTEASE WITH MET 190 REPLACED BY ALA AND GLY 216 REPLACED BY ALA 1GBB ; 2.15 ; ALPHA-LYTIC PROTEASE WITH MET 190 REPLACED BY ALA AND GLY 216 REPLACED BY ALA COMPLEX WITH METHOXYSUCCINYL-ALA-ALA-PRO-ALANINE BORONIC ACID 1GBC ; 2.20 ; ALPHA-LYTIC PROTEASE WITH MET 190 REPLACED BY ALA AND GLY 216 REPLACED BY ALA COMPLEX WITH METHOXYSUCCINYL-ALA-ALA-PRO-LEUCINE BORONIC ACID 1GBD ; 2.20 ; ALPHA-LYTIC PROTEASE WITH MET 190 REPLACED BY ALA AND GLY 216 REPLACED BY ALA COMPLEX WITH METHOXYSUCCINYL-ALA-ALA-PRO-PHENYLALANINE BORONIC ACID 1GBE ; 2.30 ; ALPHA-LYTIC PROTEASE WITH MET 190 REPLACED BY ALA AND GLY 216 REPLACED BY LEU 1GBF ; 2.15 ; ALPHA-LYTIC PROTEASE WITH MET 190 REPLACED BY ALA AND GLY 216 REPLACED BY LEU COMPLEX WITH METHOXYSUCCINYL-ALA-ALA-PRO-ALANINE BORONIC ACID 1GBH ; 2.20 ; ALPHA-LYTIC PROTEASE WITH MET 190 REPLACED BY ALA AND GLY 216 REPLACED BY LEU COMPLEX WITH METHOXYSUCCINYL-ALA-ALA-PRO-LEUCINE BORONIC ACID 1GBI ; 2.30 ; ALPHA-LYTIC PROTEASE WITH MET 190 REPLACED BY ALA AND GLY 216 REPLACED BY LEU COMPLEX WITH METHOXYSUCCINYL-ALA-ALA-PRO-PHENYLALANINE BORONIC ACID 1GBK ; 2.13 ; ALPHA-LYTIC PROTEASE WITH MET 190 REPLACED BY ALA COMPLEX WITH METHOXYSUCCINYL-ALA-ALA-PRO-ALANINE BORONIC ACID 1GBL ; 2.15 ; ALPHA-LYTIC PROTEASE WITH MET 190 REPLACED BY ALA COMPLEX WITH METHOXYSUCCINYL-ALA-ALA-PRO-LEUCINE BORONIC ACID 1GBM ; 2.28 ; ALPHA-LYTIC PROTEASE WITH MET 190 REPLACED BY ALA COMPLEX WITH METHOXYSUCCINYL-ALA-ALA-PRO-PHENYLALANINE BORONIC ACID 1X74 ; 1.79 ; ALPHA-METHYLACYL-COA RACEMASE FROM MYCOBACTERIUM TUBERCULOSIS- MUTATIONAL AND STRUCTURAL CHARACTERIZATION OF THE FOLD AND ACTIVE SITE 1J2P ; 2.60 ; ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS 1G2B ; 1.12 ; ALPHA-SPECTRIN SRC HOMOLOGY 3 DOMAIN, CIRCULAR PERMUTANT, CUT AT N47-D48 1TUD ; 1.77 ; ALPHA-SPECTRIN SRC HOMOLOGY 3 DOMAIN, CIRCULAR PERMUTANT, CUT AT N47-D48 1TUC ; 1.77 ; ALPHA-SPECTRIN SRC HOMOLOGY 3 DOMAIN, CIRCULAR PERMUTANT, CUT AT S19-P20 1QKX ; 1.80 ; ALPHA-SPECTRIN SRC HOMOLOGY 3 DOMAIN, N47A MUTANT IN THE DISTAL LOOP. 1QKW ; 2.00 ; ALPHA-SPECTRIN SRC HOMOLOGY 3 DOMAIN, N47G MUTANT IN THE DISTAL LOOP. 1AEY ; -1.00 ; ALPHA-SPECTRIN SRC HOMOLOGY 3 DOMAIN, SOLUTION NMR, 15 STRUCTURES 1ABZ ; -1.00 ; ALPHA-T-ALPHA, A DE NOVO DESIGNED PEPTIDE, NMR, 23 STRUCTURES 1UMA ; 2.00 ; ALPHA-THROMBIN (HIRUGEN) COMPLEXED WITH NA-(N,N-DIMETHYLCARBAMOYL)-ALPHA-AZALYSINE 1TOM ; 1.80 ; ALPHA-THROMBIN COMPLEXED WITH HIRUGEN 1BCU ; 2.00 ; ALPHA-THROMBIN COMPLEXED WITH HIRUGEN AND PROFLAVIN 1CA1 ; 1.90 ; ALPHA-TOXIN FROM CLOSTRIDIUM PERFRINGENS 1QMN ; 2.27 ; ALPHA1-ANTICHYMOTRYPSIN SERPIN IN THE DELTA CONFORMATION (PARTIAL LOOP INSERTION) 1KCT ; 3.46 ; ALPHA1-ANTITRYPSIN 1AZ1 ; 1.80 ; ALRESTATIN BOUND TO C298A/W219Y MUTANT HUMAN ALDOSE REDUCTASE 1HJF ; 1.60 ; ALTERATION OF THE CO-SUBSTRATE SELECTIVITY OF DEACETOXYCEPHALOSPORIN C SYNTHASE: THE ROLE OF ARGININE-258 1HJG ; 1.50 ; ALTERATION OF THE CO-SUBSTRATE SELECTIVITY OF DEACETOXYCEPHALOSPORIN C SYNTHASE: THE ROLE OF ARGININE-258 1H2G ; 2.00 ; ALTERED SUBSTRATE SPECIFICITY MUTANT OF PENICILLIN ACYLASE 1JEA ; 2.00 ; ALTERED TOPOLOGY AND FLEXIBILITY IN ENGINEERED SUBTILISIN 1CCK ; 2.10 ; ALTERING SUBSTRATE SPECIFICITY OF CYTOCHROME C PEROXIDASE TOWARDS A SMALL MOLECULAR SUBSTRATE PEROXIDASE BY SUBSTITUTING TYROSINE FOR PHE 202 2RLA ; 3.00 ; ALTERING THE BINUCLEAR MANGANESE CLUSTER OF ARGINASE DIMINISHES THERMOSTABILITY AND CATALYTIC FUNCTION 3RLA ; 2.50 ; ALTERING THE BINUCLEAR MANGANESE CLUSTER OF ARGINASE DIMINISHES THERMOSTABILITY AND CATALYTIC FUNCTION 4RLA ; 2.94 ; ALTERING THE BINUCLEAR MANGANESE CLUSTER OF ARGINASE DIMINISHES THERMOSTABILITY AND CATALYTIC FUNCTION 5RLA ; 2.74 ; ALTERING THE BINUCLEAR MANGANESE CLUSTER OF ARGINASE DIMINISHES THERMOSTABILITY AND CATALYTIC FUNCTION 1C6X ; 2.50 ; ALTERNATE BINDING SITE FOR THE P1-P3 GROUP OF A CLASS OF POTENT HIV-1 PROTEASE INHIBITORS AS A RESULT OF CONCERTED STRUCTURAL CHANGE IN 80'S LOOP. 1C6Y ; 2.50 ; ALTERNATE BINDING SITE FOR THE P1-P3 GROUP OF A CLASS OF POTENT HIV-1 PROTEASE INHIBITORS AS A RESULT OF CONCERTED STRUCTURAL CHANGE IN 80'S LOOP. 1C6Z ; 2.50 ; ALTERNATE BINDING SITE FOR THE P1-P3 GROUP OF A CLASS OF POTENT HIV-1 PROTEASE INHIBITORS AS A RESULT OF CONCERTED STRUCTURAL CHANGE IN 80'S LOOP. 1C70 ; 2.50 ; ALTERNATE BINDING SITE FOR THE P1-P3 GROUP OF A CLASS OF POTENT HIV-1 PROTEASE INHIBITORS AS A RESULT OF CONCERTED STRUCTURAL CHANGE IN 80'S LOOP. 254D ; 1.90 ; ALTERNATING AND NON-ALTERNATING DG-DC HEXANUCLEOTIDES CRYSTALLIZE AS CANONICAL A-DEOXYRIBONUCLEIC ACID 256D ; 2.20 ; ALTERNATING AND NON-ALTERNATING DG-DC HEXANUCLEOTIDES CRYSTALLIZE AS CANONICAL A-DEOXYRIBONUCLEIC ACID 257D ; 2.30 ; ALTERNATING AND NON-ALTERNATING DG-DC HEXANUCLEOTIDES CRYSTALLIZE AS CANONICAL A-DEOXYRIBONUCLEIC ACID 275D ; 2.00 ; ALTERNATING AND NON-ALTERNATING DG-DC HEXANUCLEOTIDES CRYSTALLIZE AS CANONICAL A-DEOXYRIBONUCLEIC ACID 1G00 ; 2.30 ; ALTERNATION OF DEOXYRIBONUCLEIC ACID AND SOLVENT LAYERS IN THE A FORM OF D(GGCGCC) OBTAINED BY ETHANOL CRYSTALLIZATION 1RYF ; 1.75 ; ALTERNATIVE SPLICING OF RAC1 GENERATES RAC1B, A SELF- ACTIVATING GTPASE 1RYH ; 1.75 ; ALTERNATIVE SPLICING OF RAC1 GENERATES RAC1B, A SELF- ACTIVATING GTPASE 1JTM ; 1.90 ; ALTERNATIVE STRUCTURES OF A SEQUENCE EXTENDED T4 LYSOZYME SHOW THAT THE HIGHLY CONSERVED BETA-SHEET HAS WEAK INTRINSIC FOLDING PROPENSITY 1JTN ; 2.30 ; ALTERNATIVE STRUCTURES OF A SEQUENCE EXTENDED T4 LYSOZYME SHOW THAT THE HIGHLY CONSERVED BETA-SHEET REGION HAS WEAK INTRINSIC FOLDING PROPENSITY 1E8S ; 4.00 ; ALU DOMAIN OF THE MAMMALIAN SRP (POTENTIAL ALU RETROPOSITION INTERMEDIATE) 1HZ3 ; -1.00 ; ALZHEIMER'S DISEASE AMYLOID-BETA PEPTIDE (RESIDUES 10-35) 1Z40 ; 1.90 ; AMA1 FROM PLASMODIUM FALCIPARUM 1AAC ; 1.31 ; AMICYANIN OXIDIZED, 1.31 ANGSTROMS 1BXA ; 1.30 ; AMICYANIN REDUCED, PH 4.4, 1.3 ANGSTROMS 2RAC ; 1.30 ; AMICYANIN REDUCED, PH 7.7, 1.3 ANGSTROMS 1QO0 ; 2.25 ; AMIDE RECEPTOR OF THE AMIDASE OPERON OF PSEUDOMONAS AERUGINOSA (AMIC) COMPLEXED WITH THE POSITIVE REGULATOR AMIR. 1PEA ; 2.10 ; AMIDE RECEPTOR/NEGATIVE REGULATOR OF THE AMIDASE OPERON OF PSEUDOMONAS AERUGINOSA (AMIC) COMPLEXED WITH ACETAMIDE 1QNL ; 2.70 ; AMIDE RECEPTOR/NEGATIVE REGULATOR OF THE AMIDASE OPERON OF PSEUDOMONAS AERUGINOSA (AMIC) COMPLEXED WITH BUTYRAMIDE 1B4D ; 2.00 ; AMIDOCARBAMATE INHIBITOR OF GLYCOGEN PHOSPHORYLASE 1ND1 ; 1.93 ; AMINO ACID SEQUENCE AND CRYSTAL STRUCTURE OF BAP1, A METALLOPROTEINASE FROM BOTHROPS ASPER SNAKE VENOM THAT EXERTS MULTIPLE TISSUE-DAMAGING ACTIVITIES. 1R1O ; 2.80 ; AMINO ACID SULFONAMIDES AS TRANSITION-STATE ANALOGUE INHIBITORS OF ARGINASE 1ECL ; 1.90 ; AMINO TERMINAL 67KDA DOMAIN OF ESCHERICHIA COLI DEOXYRIBONUCLEIC ACID TOPOISOMERASE I (RESIDUES 2-590 OF MATURE PROTEIN) CLONING ARTIFACT ADDS TWO RESIDUES TO THE AMINO-TERMINUS WHICH WERE NOT OBSERVED IN THE EXPERIMENTAL ELECTRON DENSITY (GLY-2, SER-1). 1VCC ; 1.60 ; AMINO TERMINAL 9KDA DOMAIN OF VACCINIA VIRUS DEOXYRIBONUCLEIC ACID TOPOISOMERASE I RESIDUES 1-77, EXPERIMENTAL ELECTRON DENSITY FOR RESIDUES 1-77 1ZYM ; 2.50 ; AMINO TERMINAL DOMAIN OF ENZYME I FROM ESCHERICHIA COLI 1EZD ; -1.00 ; AMINO TERMINAL DOMAIN OF ENZYME I FROM ESCHERICHIA COLI NMR, 16 STRUCTURES 1EZA ; -1.00 ; AMINO TERMINAL DOMAIN OF ENZYME I FROM ESCHERICHIA COLI NMR, RESTRAINED REGULARIZED MEAN STRUCTURE 2EZB ; -1.00 ; AMINO TERMINAL DOMAIN OF ENZYME I FROM ESCHERICHIA COLI, NMR, 14 STRUCTURES 2EZC ; -1.00 ; AMINO TERMINAL DOMAIN OF ENZYME I FROM ESCHERICHIA COLI, NMR, 14 STRUCTURES 1EZB ; -1.00 ; AMINO TERMINAL DOMAIN OF ENZYME I FROM ESCHERICHIA COLI, NMR, 17 STRUCTURES 1EZC ; -1.00 ; AMINO TERMINAL DOMAIN OF ENZYME I FROM ESCHERICHIA COLI, NMR, 17 STRUCTURES 2EZA ; -1.00 ; AMINO TERMINAL DOMAIN OF ENZYME I FROM ESCHERICHIA COLI, NMR, RESTRAINED REGULARIZED MEAN STRUCTURE 1QDN ; 2.30 ; AMINO TERMINAL DOMAIN OF THE N-ETHYLMALEIMIDE SENSITIVE FUSION PROTEIN (NSF) 1SUH ; -1.00 ; AMINO-TERMINAL DOMAIN OF EPITHELIAL CADHERIN IN THE CALCIUM BOUND STATE, NMR, 20 STRUCTURES 1A7I ; -1.00 ; AMINO-TERMINAL LIM DOMAIN FROM QUAIL CYSTEINE AND GLYCINE-RICH PROTEIN, NMR, MINIMIZED AVERAGE STRUCTURE 1ZFO ; -1.00 ; AMINO-TERMINAL LIM-DOMAIN PEPTIDE OF LASP-1, NMR 1I2K ; 1.79 ; AMINODEOXYCHORISMATE LYASE FROM ESCHERICHIA COLI 1UA0 ; 2.10 ; AMINOFLUORENE DEOXYRIBONUCLEIC ACID ADDUCT AT THE PRE-INSERTION SITE OF A DEOXYRIBONUCLEIC ACID POLYMERASE 1M44 ; 1.60 ; AMINOGLYCOSIDE 2'-N-ACETYLTRANSFERASE FROM MYCOBACTERIUM TUBERCULOSIS-APO STRUCTURE 1M4I ; 1.50 ; AMINOGLYCOSIDE 2'-N-ACETYLTRANSFERASE FROM MYCOBACTERIUM TUBERCULOSIS-COMPLEX WITH COENZYME A AND KANAMYCIN A 1M4G ; 1.80 ; AMINOGLYCOSIDE 2'-N-ACETYLTRANSFERASE FROM MYCOBACTERIUM TUBERCULOSIS-COMPLEX WITH COENZYME A AND RIBOSTAMYCIN 1M4D ; 1.80 ; AMINOGLYCOSIDE 2'-N-ACETYLTRANSFERASE FROM MYCOBACTERIUM TUBERCULOSIS-COMPLEX WITH COENZYME A AND TOBRAMYCIN 1S5K ; 2.40 ; AMINOGLYCOSIDE N-ACETYLTRANSFERASE AAC(6')-IY IN COMPLEX WITH COA AND N-TERMINAL HIS(6)-TAG (CRYSTAL FORM 1) 1S60 ; 3.00 ; AMINOGLYCOSIDE N-ACETYLTRANSFERASE AAC(6')-IY IN COMPLEX WITH COA AND N-TERMINAL HIS(6)-TAG (CRYSTAL FORM 2) 1S3Z ; 2.00 ; AMINOGLYCOSIDE N-ACETYLTRANSFERASE AAC(6')-IY IN COMPLEX WITH COA AND RIBOSTAMYCIN 1CP7 ; 1.58 ; AMINOPEPTIDASE FROM STREPTOMYCES GRISEUS 1JAW ; 2.70 ; AMINOPEPTIDASE P FROM E. COLI LOW PH FORM 1A16 ; 2.30 ; AMINOPEPTIDASE P FROM E. COLI WITH THE INHIBITOR PRO-LEU 1M35 ; 2.40 ; AMINOPEPTIDASE P FROM ESCHERICHIA COLI 1N51 ; 2.30 ; AMINOPEPTIDASE P IN COMPLEX WITH THE INHIBITOR APSTATIN 1ZJC ; 1.80 ; AMINOPEPTIDASE S FROM S. AUREUS 1E50 ; 2.60 ; AML1/CBF COMPLEX 1H9D ; 2.60 ; AML1/CBF-BETA/DEOXYRIBONUCLEIC ACID COMPLEX 2B2H ; 1.54 ; AMMONIUM TRANSPORTER AMT-1 FROM A. FULGIDUS (AS) 2B2I ; 1.85 ; AMMONIUM TRANSPORTER AMT-1 FROM A. FULGIDUS (MA) 2B2J ; 1.85 ; AMMONIUM TRANSPORTER AMT-1 FROM A. FULGIDUS (XE) 2B2F ; 1.72 ; AMMONIUM TRANSPORTER AMT-1 FROM A.FULGIDUS (NATIVE) 1AM0 ; -1.00 ; AMP RIBONUCLEIC ACID APTAMER COMPLEX, NMR, 8 STRUCTURES 1FSW ; 1.90 ; AMPC BETA-LACTAMASE FROM E. COLI COMPLEXED WITH INHIBITOR CEPHALOTHINBORONIC ACID 1FSY ; 1.75 ; AMPC BETA-LACTAMASE FROM E. COLI COMPLEXED WITH INHIBITOR CLOXACILLINBORONIC ACID 1C3B ; 2.25 ; AMPC BETA-LACTAMASE FROM E. COLI COMPLEXED WITH INHIBITOR, BENZO(B)THIOPHENE-2-BORONIC ACID (BZB) 2BLS ; 2.00 ; AMPC BETA-LACTAMASE FROM ESCHERICHIA COLI 3BLS ; 2.30 ; AMPC BETA-LACTAMASE FROM ESCHERICHIA COLI 1XGI ; 1.96 ; AMPC BETA-LACTAMASE IN COMPLEX WITH 3-(3-NITRO- PHENYLSULFAMOYL)-THIOPHENE-2-CARBOXYLIC ACID 1XGJ ; 1.97 ; AMPC BETA-LACTAMASE IN COMPLEX WITH 3-(4-CARBOXY-2-HYDROXY- PHENYLSULFAMOYL)-THIOPHENE-2-CARBOXYLIC ACID 1MXO ; 1.83 ; AMPC BETA-LACTAMASE IN COMPLEX WITH AN M.CARBOXYPHENYLGLYCYLBORONIC ACID BEARING THE CEPHALOTHIN R1 SIDE CHAIN 1MY8 ; 1.72 ; AMPC BETA-LACTAMASE IN COMPLEX WITH AN M.CARBOXYPHENYLGLYCYLBORONIC ACID BEARING THE CEPHALOTHIN R1 SIDE CHAIN 1URU ; 2.60 ; AMPHIPHYSIN BAR DOMAIN FROM DROSOPHILA 1AVA ; 1.90 ; AMY2/BASI PROTEIN-PROTEIN COMPLEX FROM BARLEY SEED 1QCM ; -1.00 ; AMYLOID BETA PEPTIDE (25-35), NMR, 20 STRUCTURES 1LYY ; 1.75 ; AMYLOIDOGENIC VARIANT (ASP67HIS) OF HUMAN LYSOZYME 1LOZ ; 1.80 ; AMYLOIDOGENIC VARIANT (I56T) VARIANT OF HUMAN LYSOZYME 1G5A ; 1.40 ; AMYLOSUCRASE FROM NEISSERIA POLYSACCHAREA 1MW0 ; 2.01 ; AMYLOSUCRASE MUTANT E328Q CO-CRYSTALLIZED WITH MALTOHEPTAOSE THEN SOAKED WITH MALTOHEPTAOSE. 1MVY ; 2.00 ; AMYLOSUCRASE MUTANT E328Q CO-CRYSTALLIZED WITH MALTOHEPTAOSE. 1MW2 ; 2.10 ; AMYLOSUCRASE SOAKED WITH 100MM SUCROSE 1MW1 ; 2.10 ; AMYLOSUCRASE SOAKED WITH 14MM SUCROSE. 1MW3 ; 2.00 ; AMYLOSUCRASE SOAKED WITH 1M SUCROSE 1EFE ; -1.00 ; AN ACTIVE MINI-PROINSULIN, M2PI 1A72 ; 2.60 ; AN ACTIVE-SITE DOUBLE MUTANT (PHE93->TRP, VAL203->ALA) OF HORSE LIVER ALCOHOL DEHYDROGENASE IN COMPLEX WITH THE ISOSTERIC NAD ANALOG CPAD 257L ; 1.90 ; AN ADAPTABLE METAL-BINDING SITE ENGINEERED INTO T4 LYSOZYME 258L ; 1.80 ; AN ADAPTABLE METAL-BINDING SITE ENGINEERED INTO T4 LYSOZYME 259L ; 1.92 ; AN ADAPTABLE METAL-BINDING SITE ENGINEERED INTO T4 LYSOZYME 260L ; 1.80 ; AN ADAPTABLE METAL-BINDING SITE ENGINEERED INTO T4 LYSOZYME 1H0T ; -1.00 ; AN AFFIBODY IN COMPLEX WITH A TARGET PROTEIN: STRUCTURE AND COUPLED FOLDING 1U0V ; 1.90 ; AN ALDOL SWITCH DISCOVERED IN STILBENE SYNTHASES MEDIATES CYCLIZATION OF SPECIFICITY OF TYPE III POLYKETIDE SYNTHASES: 18XCHS STRUCTURE 1U0W ; 2.00 ; AN ALDOL SWITCH DISCOVERED IN STILBENE SYNTHASES MEDIATES CYCLIZATION SPECIFICITY OF TYPE III POLYKETIDE SYNTHASES: 18XCHS+RESVERATROL STRUCTURE 1U0U ; 2.11 ; AN ALDOL SWITCH DISCOVERED IN STILBENE SYNTHASES MEDIATES CYCLIZATION SPECIFICITY OF TYPE III POLYKETIDE SYNTHASES: PINE STILBENE SYNTHASE STRUCTURE 1X9C ; 2.19 ; AN ALL-RIBONUCLEIC ACID HAIRPIN RIBOZYME WITH MUTATION U39C 1X9K ; 3.17 ; AN ALL-RIBONUCLEIC ACID HAIRPIN RIBOZYME WITH MUTATION U39C 1RD4 ; 2.40 ; AN ALLOSTERIC INHIBITOR OF LFA-1 BOUND TO ITS I-DOMAIN 1NFD ; 2.80 ; AN ALPHA-BETA T CELL RECEPTOR (TCR) HETERODIMER IN COMPLEX WITH AN ANTI-TCR FAB FRAGMENT DERIVED FROM A MITOGENIC ANTIBODY 1MDG ; 1.50 ; AN ALTERNATING ANTIPARALLEL OCTAPLEX IN AN RIBONUCLEIC ACID CRYSTAL STRUCTURE 1G99 ; 2.50 ; AN ANCIENT ENZYME: ACETATE KINASE FROM METHANOSARCINA THERMOPHILA 1W5J ; 2.20 ; AN ANTI-PARALLEL FOUR HELIX BUNDLE 1W5K ; 1.92 ; AN ANTI-PARALLEL FOUR HELIX BUNDLE 1W5G ; 2.16 ; AN ANTI-PARALLEL FOUR HELIX BUNDLE (ACETIMIDE MODIFICATION). 1VZL ; 1.60 ; AN ANTI-PARALLEL FOUR HELIX BUNDLE MUTANT PLI-E20C 1W5H ; 2.50 ; AN ANTI-PARALLEL FOUR HELIX BUNDLE. 1W5L ; 2.17 ; AN ANTI-PARALLEL TO PARALLEL SWITCH. 1SA3 ; 1.95 ; AN ASYMMETRIC COMPLEX OF RESTRICTION ENDONUCLEASE MSPI ON ITS PALINDROMIC DEOXYRIBONUCLEIC ACID RECOGNITION SITE 1PZU ; 3.10 ; AN ASYMMETRIC NFAT1-RHR HOMODIMER ON A PSEUDO-PALINDROMIC, KAPPA-B SITE 1GSU ; 1.94 ; AN AVIAN CLASS-MU GLUTATHIONE S-TRANSFERASE, CGSTM1-1 AT 1.94 ANGSTROM RESOLUTION 1KL4 ; 1.70 ; AN ENGINEERED STREPTAVIDIN WITH IMPROVED AFFINITY FOR THE STREP-TAG II PEPTIDE : APO-SAM2 1KL3 ; 1.70 ; AN ENGINEERED STREPTAVIDIN WITH IMPROVED AFFINITY FOR THE STREP-TAG II PEPTIDE : SAM1-STREPII 1KL5 ; 1.80 ; AN ENGINEERED STREPTAVIDIN WITH IMPROVED AFFINITY FOR THE STREP-TAG II PEPTIDE : SAM2-STREPII 1KFF ; 1.90 ; AN ENGINEERED STREPTAVIDIN WITH IMPROVED AFFINITY FOR THE STREP-TAG II PEPTIDE: APO-SAM1 1GKO ; 2.10 ; AN ENGINEERED TRANSTHYRETIN MONOMER THAT IS NON-AMYLOIDOGENIC - UNLESS PARTIALLY DENATURED 2AEP ; 2.10 ; AN EPIDEMIOLOGICALLY SIGNIFICANT EPITOPE OF A 1998 INFLUENZA VIRUS NEURAMINIDASE FORMS A HIGHLY HYDRATED INTERFACE IN THE NA-ANTIBODY COMPLEX. 2AEQ ; 3.00 ; AN EPIDEMIOLOGICALLY SIGNIFICANT EPITOPE OF A 1998 INFLUENZA VIRUS NEURAMINIDASE FORMS A HIGHLY HYDRATED INTERFACE IN THE NA-ANTIBODY COMPLEX. 1Q1H ; 2.90 ; AN EXTENDED WINGED HELIX DOMAIN IN GENERAL TRANSCRIPTION FACTOR E/IIE ALPHA 1VCR ; 9.50 ; AN ICOSAHEDRAL ASSEMBLY OF LIGHT-HARVESTING CHLOROPHYLL A/B PROTEIN COMPLEX FROM PEA THYLAKOID MEMBRANES 1MYQ ; -1.00 ; AN INTRAMOLECULAR QUADRUPLEX OF (GGA)(4) TRIPLET REPEAT DEOXYRIBONUCLEIC ACID WITH A G:G:G:G TETRAD AND A G(:A):G(:A):G(:A):G HEPTAD, AND ITS DIMERIC INTERACTION 2TPK ; -1.00 ; AN INVESTIGATION OF THE STRUCTURE OF THE PSEUDOKNOT WITHIN THE GENE 32 MESSENGER RIBONUCLEIC ACID OF BACTERIOPHAGE T2 USING HETERONUCLEAR NMR METHODS 1M1U ; 2.30 ; AN ISOLEUCINE-BASED ALLOSTERIC SWITCH CONTROLS AFFINITY AND SHAPE SHIFTING IN INTEGRIN CD11B A-DOMAIN 1SN9 ; 1.20 ; AN OLIGOMERIC DOMAIN-SWAPPED BETA-BETA-ALPHA MINI-PROTEIN 1SNA ; 1.50 ; AN OLIGOMERIC DOMAIN-SWAPPED BETA-BETA-ALPHA MINI-PROTEIN 1SNE ; 1.50 ; AN OLIGOMERIC DOMAIN-SWAPPED BETA-BETA-ALPHA MINI-PROTEIN 1HXI ; 1.60 ; AN UNEXPECTED EXTENDED CONFORMATION FOR THE THIRD TPR MOTIF OF THE PEROXIN PEX5 FROM TRYPANOSOMA BRUCEI 1WQC ; -1.00 ; AN UNUSUAL FOLD FOR POTASSIUM CHANNEL BLOCKERS : NMR STRUCTURE OF THREE TOXINS FROM THE SCORPION OPISTHACANTHUS MADAGASCARIENSIS 1WQD ; -1.00 ; AN UNUSUAL FOLD FOR POTASSIUM CHANNEL BLOCKERS: NMR STRUCTURE OF THREE TOXINS FROM THE SCORPION OPISTHACANTHUS MADAGASCARIENSIS 1WQE ; -1.00 ; AN UNUSUAL FOLD FOR POTASSIUM CHANNEL BLOCKERS: NMR STRUCTURE OF THREE TOXINS FROM THE SCORPION OPISTHACANTHUS MADAGASCARIENSIS 1P78 ; 2.25 ; ANABAENA HU-DEOXYRIBONUCLEIC ACID COCRYSTAL STRUCTURE (AHU2) 1P51 ; 2.50 ; ANABAENA HU-DEOXYRIBONUCLEIC ACID COCRYSTAL STRUCTURE (AHU6) 1P71 ; 1.90 ; ANABAENA HU-DEOXYRIBONUCLEIC ACID CORCRYSTAL STRUCTURE (TR3) 1EWY ; 2.38 ; ANABAENA PCC7119 FERREDOXIN:FERREDOXIN-NADP+-REDUCTASE COMPLEX 1CZP ; 1.17 ; ANABAENA PCC7119 [2FE-2S] FERREDOXIN IN THE REDUCED AND OXIXIZED STATE AT 1.17 A 1XIO ; 2.00 ; ANABAENA SENSORY RHODOPSIN 1QGO ; 2.40 ; ANAEROBIC COBALT CHELATASE IN COBALAMIN BIOSYNTHESIS FROM SALMONELLA TYPHIMURIUM 1QYO ; 1.80 ; ANAEROBIC PRECYLIZATION INTERMEDIATE CRYSTAL STRUCTURE FOR S65G Y66G GFP VARIANT 1F1V ; 1.90 ; ANAEROBIC SUBSTRATE COMPLEX OF HOMOPROTOCATECHUATE 2,3- DIOXYGENASE FROM ARTHROBACTER GLOBIFORMIS. (COMPLEX WITH 3, 4-DIHYDROXYPHENYLACETATE) 1DAU ; -1.00 ; ANALOG OF DICKERSON-DREW DEOXYRIBONUCLEIC ACID DODECAMER WITH 6'-ALPHA-METHYL CARBOCYCLIC THYMIDINES, NMR, MINIMIZED AVERAGE STRUCTURE 1B95 ; 2.05 ; ANALYSIS OF A MUTATIONAL HOT-SPOT IN THE ECORV RESTRICTION ENDONUCLEASE: A CATALYTIC ROLE FOR A MAIN CHAIN CARBONYL GROUP 1B96 ; 2.30 ; ANALYSIS OF A MUTATIONAL HOT-SPOT IN THE ECORV RESTRICTION ENDONUCLEASE: A CATALYTIC ROLE FOR A MAIN CHAIN CARBONYL GROUP 1I13 ; 1.84 ; ANALYSIS OF AN INVARIANT ASPARTIC ACID IN HPRTS-ALANINE MUTANT 1I0L ; 1.72 ; ANALYSIS OF AN INVARIANT ASPARTIC ACID IN HPRTS-ASPARAGINE MUTANT 1I14 ; 1.92 ; ANALYSIS OF AN INVARIANT ASPARTIC ACID IN HPRTS-GLUTAMIC ACID MUTANT 1I0I ; 2.06 ; ANALYSIS OF AN INVARIANT ASPARTIC ACID IN HPRTS-GLUTAMINE MUTANT 1LY3 ; 1.90 ; ANALYSIS OF QUINAZOLINE AND PYRIDOPYRIMIDINE N9-C10 REVERSED BRIDGE ANTIFOLATES IN COMPLEX WITH NADP+ AND PNEUMOCYSTIS CARINII DIHYDROFOLATE REDUCTASE 1LY4 ; 2.10 ; ANALYSIS OF QUINAZOLINE AND PYRIDO[2,3D]PYRIMIDINE N9-C10 REVERSED BRIDGE ANTIFOLATES IN COMPLEX WITH NADP+ AND PNEUMOCYSTIS CARINII DIHYDROFOLATE REDUCTASE 1YO5 ; 2.00 ; ANALYSIS OF THE 2.0A CRYSTAL STRUCTURE OF THE PROTEIN-DEOXYRIBONUCLEIC ACID COMPLEX OF HUMAN PDEF ETS DOMAIN BOUND TO THE PROSTATE SPECIFIC ANTIGEN REGULATORY SITE 1HDB ; 2.20 ; ANALYSIS OF THE CRYSTAL STRUCTURE, MOLECULAR MODELING AND INFRARED SPECTROSCOPY OF THE DISTAL BETA-HEME POCKET VALINE67(E11)-THREONINE MUTATION OF HEMOGLOBIN 1L56 ; 1.80 ; ANALYSIS OF THE INTERACTION BETWEEN CHARGED SIDE CHAINS AND THE ALPHA-HELIX DIPOLE USING DESIGNED THERMOSTABLE MUTANTS OF PHAGE T4 LYSOZYME 1L60 ; 1.70 ; ANALYSIS OF THE INTERACTION BETWEEN CHARGED SIDE CHAINS AND THE ALPHA-HELIX DIPOLE USING DESIGNED THERMOSTABLE MUTANTS OF PHAGE T4 LYSOZYME 1KXW ; 1.96 ; ANALYSIS OF THE STABILIZATION OF HEN LYSOZYME WITH THE HELIX DIPOLE AND CHARGED SIDE CHAINS 1KXX ; 1.71 ; ANALYSIS OF THE STABILIZATION OF HEN LYSOZYME WITH THE HELIX DIPOLE AND CHARGED SIDE CHAINS 1KXY ; 1.79 ; ANALYSIS OF THE STABILIZATION OF HEN LYSOZYME WITH THE HELIX DIPOLE AND CHARGED SIDE CHAINS 1RFP ; 1.75 ; ANALYSIS OF THE STABILIZATION OF HEN LYSOZYME WITH THE HELIX DIPOLE AND CHARGED SIDE CHAINS 1UIA ; 1.76 ; ANALYSIS OF THE STABILIZATION OF HEN LYSOZYME WITH THE HELIX DIPOLE AND CHARGED SIDE CHAINS 1UIB ; 1.76 ; ANALYSIS OF THE STABILIZATION OF HEN LYSOZYME WITH THE HELIX DIPOLE AND CHARGED SIDE CHAINS 1UIC ; 1.95 ; ANALYSIS OF THE STABILIZATION OF HEN LYSOZYME WITH THE HELIX DIPOLE AND CHARGED SIDE CHAINS 1UID ; 1.95 ; ANALYSIS OF THE STABILIZATION OF HEN LYSOZYME WITH THE HELIX DIPOLE AND CHARGED SIDE CHAINS 1UIE ; 1.95 ; ANALYSIS OF THE STABILIZATION OF HEN LYSOZYME WITH THE HELIX DIPOLE AND CHARGED SIDE CHAINS 1UIF ; 1.85 ; ANALYSIS OF THE STABILIZATION OF HEN LYSOZYME WITH THE HELIX DIPOLE AND CHARGED SIDE CHAINS 1UIG ; 1.95 ; ANALYSIS OF THE STABILIZATION OF HEN LYSOZYME WITH THE HELIX DIPOLE AND CHARGED SIDE CHAINS 1UIH ; 1.75 ; ANALYSIS OF THE STABILIZATION OF HEN LYSOZYME WITH THE HELIX DIPOLE AND CHARGED SIDE CHAINS 1PD8 ; 2.10 ; ANALYSIS OF THREE CRYSTAL STRUCTURE DETERMINATIONS OF A 5- METHYL-6-N-METHYLANILINO PYRIDOPYRIMIDINE ANTIFOLATE COMPLEX WITH HUMAN DIHYDROFOLATE REDUCTASE 1PD9 ; 2.20 ; ANALYSIS OF THREE CRYSTAL STRUCTURE DETERMINATIONS OF A 5- METHYL-6-N-METHYLANILINO PYRIDOPYRIMIDINE ANTIFOLATE COMPLEX WITH HUMAN DIHYDROFOLATE REDUCTASE 1PDB ; 2.20 ; ANALYSIS OF THREE CRYSTAL STRUCTURE DETERMINATIONS OF A 5- METHYL-6-N-METHYLANILINO PYRIDOPYRIMIDINE ANTIFOLATE COMPLEX WITH HUMAN DIHYDROFOLATE REDUCTASE 1MVS ; 1.90 ; ANALYSIS OF TWO POLYMORPHIC FORMS OF A PYRIDO[2,3- D]PYRIMIDINE N9-C10 REVERSE-BRIDGE ANTIFOLATE BINARY COMPLEX WITH HUMAN DIHYDROFOLATE REDUCTASE 1MVT ; 1.80 ; ANALYSIS OF TWO POLYMORPHIC FORMS OF A PYRIDO[2,3- D]PYRIMIDINE N9-C10 REVERSE-BRIDGE ANTIFOLATE BINARY COMPLEX WITH HUMAN DIHYDROFOLATE REDUCTASE 1Q38 ; -1.00 ; ANASTELLIN 1OJI ; 2.15 ; ANATOMY OF GLYCOSYNTHESIS: STRUCTURE AND KINETICS OF THE HUMICOLA INSOLENS CEL7BE197A AND E197S GLYCOSYNTHASE MUTANTS 1OJJ ; 1.40 ; ANATOMY OF GLYCOSYNTHESIS: STRUCTURE AND KINETICS OF THE HUMICOLA INSOLENS CEL7BE197A AND E197S GLYCOSYNTHASE MUTANTS 1OJK ; 1.50 ; ANATOMY OF GLYCOSYNTHESIS: STRUCTURE AND KINETICS OF THE HUMICOLA INSOLENS CEL7BE197A AND E197S GLYCOSYNTHASE MUTANTS 1Q0C ; 2.10 ; ANEROBIC SUBSTRATE COMPLEX OF HOMOPROTOCATECHUATE 2,3- DIOXYGENASE FROM BREVIBACTERIUM FUSCUM. (COMPLEX WITH 3,4- DIHYDROXYPHENYLACETATE) 1Z3S ; 2.35 ; ANGIOPOIETIN-2 RECEPTOR BINDING DOMAIN 1S8L ; 2.30 ; ANION-FREE FORM OF THE D85S MUTANT OF BACTERIORHODOPSIN FROM CRYSTALS GROWN IN THE PRESENCE OF HALIDE 1E54 ; 2.10 ; ANION-SELECTIVE PORIN FROM COMAMONAS ACIDOVORANS 2STA ; 1.80 ; ANIONIC SALMON TRYPSIN IN COMPLEX WITH SQUASH SEED INHIBITOR (CUCURBITA MAXIMA TRYPSIN INHIBITOR I) 2STB ; 1.80 ; ANIONIC SALMON TRYPSIN IN COMPLEX WITH SQUASH SEED INHIBITOR (CUCURBITA PEPO TRYPSIN INHIBITOR II) 1MBQ ; 1.80 ; ANIONIC TRYPSIN FROM PACIFIC CHUM SALMON 1AND ; 2.30 ; ANIONIC TRYPSIN MUTANT WITH ARG 96 REPLACED BY HIS 1ANB ; 2.80 ; ANIONIC TRYPSIN MUTANT WITH SER 214 REPLACED BY GLU 1ANC ; 2.20 ; ANIONIC TRYPSIN MUTANT WITH SER 214 REPLACED BY LYS 1ANE ; 2.20 ; ANIONIC TRYPSIN WILD TYPE 2BF9 ; 0.99 ; ANISOTROPIC REFINEMENT OF AVIAN (TURKEY) PANCREATIC POLYPEPTIDE AT 0.99 ANGSTROMS RESOLUTION. 2IGD ; 1.10 ; ANISOTROPIC STRUCTURE OF PROTEIN G IGG-BINDING DOMAIN III AT 1.1 ANGSTROM RESOLUTION 1W7B ; 1.52 ; ANNEXIN A2: DOES IT INDUCE MEMBRANE AGGREGATION BY A NEW MULTIMERIC STATE OF THE PROTEIN. 1N00 ; 2.10 ; ANNEXIN GH1 FROM COTTON 1AII ; 1.95 ; ANNEXIN III CO-CRYSTALLIZED WITH INOSITOL-2-PHOSPHATE 1ANN ; 2.30 ; ANNEXIN IV 1AOW ; 3.00 ; ANNEXIN IV 1G5N ; 1.90 ; ANNEXIN V COMPLEX WITH HEPARIN OLIGOSACCHARIDES 1DM5 ; 1.93 ; ANNEXIN XII E105K HOMOHEXAMER CRYSTAL STRUCTURE 1LZ9 ; 1.70 ; ANOMALOUS SIGNAL OF SOLVENT BROMINES USED FOR PHASING OF LYSOZYME 1JLV ; 1.75 ; ANOPHELES DIRUS SPECIES B GLUTATHIONE S-TRANSFERASES 1-3 1JLW ; 2.45 ; ANOPHELES DIRUS SPECIES B GLUTATHIONE S-TRANSFERASES 1-4 1AGD ; 2.05 ; ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - HIV-1 GAG PEPTIDE (GGKKKYKL - INDEX PEPTIDE) 1AGC ; 2.10 ; ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - HIV-1 GAG PEPTIDE (GGKKKYQL - 7Q MUTATION) 1AGE ; 2.30 ; ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - HIV-1 GAG PEPTIDE (GGKKKYRL - 7R MUTATION) 1AGF ; 2.20 ; ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - HIV-1 GAG PEPTIDE (GGKKRYKL - 5R MUTATION) 1AGB ; 2.20 ; ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - HIV-1 GAG PEPTIDE (GGRKKYKL - 3R MUTATION) 1KX8 ; 2.80 ; ANTENNAL CHEMOSENSORY PROTEIN A6 FROM MAMESTRA BRASSICAE, TETRAGONAL FORM 1KX9 ; 1.65 ; ANTENNAL CHEMOSENSORY PROTEIN A6 FROM THE MOTH MAMESTRA BRASSICAE 9ANT ; 2.40 ; ANTENNAPEDIA HOMEODOMAIN-DEOXYRIBONUCLEIC ACID COMPLEX 1GP4 ; 2.10 ; ANTHOCYANIDIN SYNTHASE FROM ARABIDOPSIS THALIANA (SELENOMETHIONINE SUBSTITUTED) 1GP5 ; 2.20 ; ANTHOCYANIDIN SYNTHASE FROM ARABIDOPSIS THALIANA COMPLEXED WITH TRANS-DIHYDROQUERCETIN 1GP6 ; 1.75 ; ANTHOCYANIDIN SYNTHASE FROM ARABIDOPSIS THALIANA COMPLEXED WITH TRANS-DIHYDROQUERCETIN (WITH 30 MIN EXPOSURE TO O2) 1AHL ; -1.00 ; ANTHOPLEURIN-A,NMR, 20 STRUCTURES 1APF ; -1.00 ; ANTHOPLEURIN-B, NMR, 20 STRUCTURES 1O17 ; 2.05 ; ANTHRANILATE PHOSPHORIBOSYL-TRANSFERASE (TRPD) 1GXB ; 2.70 ; ANTHRANILATE PHOSPHORIBOSYLTRANSFERASE IN COMPLEX WITH PYROPHOSPHATE AND MAGNESIUM 1I7Q ; 1.95 ; ANTHRANILATE SYNTHASE FROM S. MARCESCENS 1I7S ; 2.40 ; ANTHRANILATE SYNTHASE FROM SERRATIA MARCESCENS IN COMPLEX WITH ITS END PRODUCT INHIBITOR L-TRYPTOPHAN 1ACC ; 2.10 ; ANTHRAX PROTECTIVE ANTIGEN 1J7N ; 2.30 ; ANTHRAX TOXIN LETHAL FACTOR 1CL7 ; 3.00 ; ANTI HIV1 PROTEASE FAB 1MF2 ; 2.60 ; ANTI HIV1 PROTEASE FAB COMPLEX 1AY1 ; 2.20 ; ANTI TAQ FAB TP7 1GHF ; 2.70 ; ANTI-ANTI-IDIOTYPE GH1002 FAB FRAGMENT 2CK0 ; 2.20 ; ANTI-ANTI-IDIOTYPIC ANTIBODY AGAINST HUMAN ANGIOTENSIN II, COMPLEX WITH A SYNTHETIC CYCLIC PEPTIDE 3CK0 ; 3.00 ; ANTI-ANTI-IDIOTYPIC ANTIBODY AGAINST HUMAN ANGIOTENSIN II, COMPLEX WITH HUMAN ANGIOTENSIN II 1CK0 ; 2.50 ; ANTI-ANTI-IDIOTYPIC ANTIBODY AGAINST HUMAN ANGIOTENSIN II, UNLIGANDED FORM 1JV5 ; 2.20 ; ANTI-BLOOD GROUP A FV 1CLO ; 2.10 ; ANTI-CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY A5B7 2A1W ; 2.70 ; ANTI-COCAINE ANTIBODY 7.5.21, CRYSTAL FORM I 2A77 ; 1.80 ; ANTI-COCAINE ANTIBODY 7.5.21, CRYSTAL FORM II 2AI0 ; 2.20 ; ANTI-COCAINE ANTIBODY 7.5.21, CRYSTAL FORM III 1RFD ; 2.09 ; ANTI-COCAINE ANTIBODY M82G2 1QYG ; 1.81 ; ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH BENZOYLECGONINE 1Q72 ; 1.70 ; ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH COCAINE 1RIV ; 2.20 ; ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH META- OXYBENZOYLECGONINE 1RIU ; 2.00 ; ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH NORBENZOYLECGONINE 1YMH ; 2.60 ; ANTI-HCV FAB 19D9D6 COMPLEXED WITH PROTEIN L (PPL) MUTANT A66W 1AIF ; 2.90 ; ANTI-IDIOTYPIC FAB 409.5.3 (IGG2A) FAB FROM MOUSE 1UZ8 ; 1.80 ; ANTI-LEWIS X FAB FRAGMENT IN COMPLEX WITH LEWIS X 1UZ6 ; 2.05 ; ANTI-LEWIS X FAB FRAGMENT UNCOMPLEXED 1LQQ ; -1.00 ; ANTI-MAMMAL AND ANTI-INSECT LQQIII SCORPION TOXIN, NMR, 15 STRUCTURES 1Q0Y ; 2.00 ; ANTI-MORPHINE ANTIBODY 9B1 COMPLEXED WITH MORPHINE 1Q0X ; 1.60 ; ANTI-MORPHINE ANTIBODY 9B1 UNLIGANDED FORM 1BLN ; 2.80 ; ANTI-P-GLYCOPROTEIN FAB MRK-16 1CFQ ; 2.80 ; ANTI-P24 (HIV-1) FAB FRAGMENT CB41 1HH6 ; 2.60 ; ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH A PEPTIDE 1HH9 ; 2.70 ; ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH A PEPTIDE 1HI6 ; 2.55 ; ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH A PEPTIDE 1BOG ; 2.60 ; ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH AN EPITOPE-HOMOLOGOUS PEPTIDE 1CFN ; 2.65 ; ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH AN EPITOPE-RELATED PEPTIDE 1CFT ; 2.80 ; ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH AN EPITOPE-UNRELATED D-PEPTIDE 1CFS ; 2.75 ; ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH AN EPITOPE-UNRELATED PEPTIDE 1T51 ; -1.00 ; ANTIBIOTIC ACTIVITY AND STRUCTURAL ANALYSIS OF A SCORPION- DERIVED ANTIMICROBIAL PEPTIDE ISCT AND ITS ANALOGS 1T52 ; -1.00 ; ANTIBIOTIC ACTIVITY AND STRUCTURAL ANALYSIS OF A SCORPION- DERIVED ANTIMICROBIAL PEPTIDE ISCT AND ITS ANALOGS 1T54 ; -1.00 ; ANTIBIOTIC ACTIVITY AND STRUCTURAL ANALYSIS OF A SCORPION- DERIVED ANTIMICROBIAL PEPTIDE ISCT AND ITS ANALOGS 1T55 ; -1.00 ; ANTIBIOTIC ACTIVITY AND STRUCTURAL ANALYSIS OF A SCORPION- DERIVED ANTIMICROBIAL PEPTIDE ISCT AND ITS ANALOGS 1NY9 ; -1.00 ; ANTIBIOTIC BINDING DOMAIN OF A TIPA-CLASS MULTIDRUG RESISTANCE TRANSCRIPTIONAL REGULATOR 1KEG ; 2.40 ; ANTIBODY 64M-2 FAB COMPLEXED WITH DTT(6-4)TT 1MEX ; 1.25 ; ANTIBODY CATALYSIS OF A BIMOLECULAR CYCLOADDITION REACTION 2PCP ; 2.20 ; ANTIBODY FAB COMPLEXED WITH PHENCYCLIDINE 1I7Z ; 2.30 ; ANTIBODY GNC92H2 BOUND TO LIGAND 1OAY ; 2.66 ; ANTIBODY MULTISPECIFICITY MEDIATED BY CONFORMATIONAL DIVERSITY 1BEY ; 3.25 ; ANTIBODY TO CAMPATH-1H HUMANIZED FAB 1HEZ ; 2.70 ; ANTIBODY-ANTIGEN COMPLEX 1MHH ; 2.10 ; ANTIBODY-ANTIGEN COMPLEX 1LNM ; 1.90 ; ANTICALIN DIGA16 IN COMPLEX WITH DIGITOXIGENIN 1VIP ; 2.20 ; ANTICOAGULANT CLASS II PHOSPHOLIPASE A2 FROM THE VENOM OF VIPERA RUSSELLI RUSSELLI 1COU ; -1.00 ; ANTICOAGULANT PROTEIN FROM THE NEMATODE ANCYLOSTOMA CANINUM 1G6E ; -1.00 ; ANTIFUNGAL PROTEIN FROM STREPTOMYCES TENDAE TU901, 30- CONFORMERS ENSEMBLE 1GH5 ; -1.00 ; ANTIFUNGAL PROTEIN FROM STREPTOMYCES TENDAE TU901, NMR AVERAGE STRUCTURE 1VA5 ; 2.02 ; ANTIGEN 85C WITH OCTYLTHIOGLUCOSIDE IN ACTIVE SITE 2HRP ; 2.20 ; ANTIGEN-ANTIBODY COMPLEX 1JFQ ; 1.90 ; ANTIGEN-BINDING FRAGMENT OF THE MURINE ANTI-PHENYLARSONATE ANTIBODY 36-71, "FAB 36-71" 1RB4 ; 1.90 ; ANTIPARALLEL TRIMER OF GCN4-LEUCINE ZIPPER CORE MUTANT AS N16A TETRAGONAL AUTOMATIC SOLUTION 1RB6 ; 1.90 ; ANTIPARALLEL TRIMER OF GCN4-LEUCINE ZIPPER CORE MUTANT AS N16A TETRAGONAL FORM 1RB5 ; 1.90 ; ANTIPARALLEL TRIMER OF GCN4-LEUCINE ZIPPER CORE MUTANT AS N16A TRIGONAL FORM 1CX5 ; -1.00 ; ANTISENSE DEOXYRIBONUCLEIC ACID/RIBONUCLEIC ACID HYBRID CONTAINING MODIFIED BACKBONE 1SR5 ; 3.10 ; ANTITHROMBIN-ANHYDROTHROMBIN-HEPARIN TERNARY COMPLEX STRUCTURE 1AZX ; 2.90 ; ANTITHROMBIN/PENTASACCHARIDE COMPLEX 1KYF ; 1.22 ; AP-2 CLATHRIN ADAPTOR ALPHA-APPENDAGE IN COMPLEX WITH EPS15 DPF PEPTIDE 1KYU ; 1.80 ; AP-2 CLATHRIN ADAPTOR ALPHA-APPENDAGE IN COMPLEX WITH EPS15 DPF PEPTIDE 1KY6 ; 2.00 ; AP-2 CLATHRIN ADAPTOR ALPHA-APPENDAGE IN COMPLEX WITH EPSIN DPW PEPTIDE 1KYD ; 2.00 ; AP-2 CLATHRIN ADAPTOR ALPHA-APPENDAGE IN COMPLEX WITH EPSIN DPW PEPTIDE 1W63 ; 4.00 ; AP1 CLATHRIN ADAPTOR CORE 1GW5 ; 2.59 ; AP2 CLATHRIN ADAPTOR CORE 3YGS ; 2.50 ; APAF-1 CARD IN COMPLEX WITH PRODOMAIN OF PROCASPASE-9 1GQP ; 2.20 ; APC10/DOC1 SUBUNIT OF S. CEREVISIAE 1WCG ; 1.10 ; APHID MYROSINASE 1ASS ; 2.30 ; APICAL DOMAIN OF THE CHAPERONIN FROM THERMOPLASMA ACIDOPHILUM 1ASX ; 2.80 ; APICAL DOMAIN OF THE CHAPERONIN FROM THERMOPLASMA ACIDOPHILUM 1LBE ; 2.40 ; APLYSIA ADP RIBOSYL CYCLASE 1R15 ; 2.40 ; APLYSIA ADP RIBOSYL CYCLASE WITH BOUND NICOTINAMIDE AND R5P 1R16 ; 2.00 ; APLYSIA ADP RIBOSYL CYCLASE WITH BOUND PYRIDYLCARBINOL AND R5P 1WLR ; 2.10 ; APO AMINOPEPTIDASE P FROM E. COLI 1PIW ; 3.00 ; APO AND HOLO STRUCTURES OF AN NADP(H)-DEPENDENT CINNAMYL ALCOHOL DEHYDROGENASE FROM SACCHAROMYCES CEREVISIAE 1Q1N ; 3.15 ; APO AND HOLO STRUCTURES OF AN NADP(H)-DEPENDENT CINNAMYL ALCOHOL DEHYDROGENASE FROM SACCHAROMYCES CEREVISIAE 1ZM8 ; 1.90 ; APO CRYSTAL STRUCTURE OF NUCLEASE A FROM ANABAENA SP. 1EVX ; 2.00 ; APO CRYSTAL STRUCTURE OF THE HOMING ENDONUCLEASE, I-PPOI 1AOV ; 4.00 ; APO DUCK OVOTRANSFERRIN 1ZCV ; 1.98 ; APO FORM OF A MUTANT OF GLYCOGENIN IN WHICH ASP159 IS REPLACED BY ASN 1ZCY ; 1.99 ; APO FORM OF A MUTANT OF GLYCOGENIN IN WHICH ASP159 IS REPLACED BY SER 1EUH ; 1.82 ; APO FORM OF A NADP DEPENDENT ALDEHYDE DEHYDROGENASE FROM STREPTOCOCCUS MUTANS 2ARA ; 2.80 ; APO FORM OF ESCHERICHIA COLI REGULATORY PROTEIN ARAC 1O05 ; 2.25 ; APO FORM OF HUMAN MITOCHONDRIAL ALDEHYDE DEHYDROGENASE 1ZCU ; 2.00 ; APO FORM OF THE 162S MUTANT OF GLYCOGENIN 1XJA ; 2.40 ; APO FORM OF THE Y31V MUTANT DIMERIZATION DOMAIN FRAGMENT OF ESCHERICHIA COLI REGULATORY PROTEIN ARAC 1AIV ; 3.00 ; APO OVOTRANSFERRIN 1XGD ; 2.10 ; APO R268A HUMAN ALDOSE REDUCTASE 1FF9 ; 2.00 ; APO SACCHAROPINE REDUCTASE 1E5L ; 2.40 ; APO SACCHAROPINE REDUCTASE FROM MAGNAPORTHE GRISEA 1SXH ; 2.75 ; APO STRUCTURE OF B. MEGATERIUM TRANSCRIPTION REGULATOR 1W50 ; 1.75 ; APO STRUCTURE OF BACE (BETA SECRETASE) 1PW2 ; 1.95 ; APO STRUCTURE OF HUMAN CYCLIN-DEPENDENT KINASE 2 1CBI ; 2.70 ; APO-CELLULAR RETINOIC ACID BINDING PROTEIN I 1XCA ; 2.30 ; APO-CELLULAR RETINOIC ACID BINDING PROTEIN II 1SWA ; 2.00 ; APO-CORE-STREPTAVIDIN AT PH 4.5 1SWC ; 1.80 ; APO-CORE-STREPTAVIDIN AT PH 4.5 1SWB ; 1.90 ; APO-CORE-STREPTAVIDIN AT PH 7.5 1SWD ; 1.90 ; APO-CORE-STREPTAVIDIN IN COMPLEX WITH BIOTIN (TWO UNOCCUPIED BINDING SITES) AT PH 4.5 1SWE ; 2.10 ; APO-CORE-STREPTAVIDIN IN COMPLEX WITH BIOTIN AT PH 4.5 1BV4 ; 1.85 ; APO-MANNOSE-BINDING PROTEIN-C 1Q5V ; 2.30 ; APO-NIKR 1PZC ; 1.85 ; APO-PSEUDOAZURIN (METAL FREE PROTEIN) 2BLL ; 2.30 ; APO-STRUCTURE OF THE C-TERMINAL DECARBOXYLASE DOMAIN OF ARNA 1OBQ ; 1.85 ; APOCRUSTACYANIN C1 CRYSTALS GROWN IN SPACE AND EARTH USING VAPOUR DIFFUSION GEOMETRY 1OBU ; 2.00 ; APOCRUSTACYANIN C1 CRYSTALS GROWN IN SPACE AND EARTH USING VAPOUR DIFFUSION GEOMETRY 1IEU ; -1.00 ; APOCYTOCHROME B5, PH 6.2, 298 K, NMR, 10 STRUCTURES 1IET ; -1.00 ; APOCYTOCHROME B5, PH 6.2, 298 K, NMR, MINIMIZED AVERAGE STRUCTURE 1B7U ; 3.80 ; APOLACTOFERRIN 1NFO ; 2.00 ; APOLIPOPROTEIN E2 (APOE2, D154A MUTATION) 1BZ4 ; 1.85 ; APOLIPOPROTEIN E3 (APO-E3), TRUNCATION MUTANT 165 1NFN ; 1.80 ; APOLIPOPROTEIN E3 (APOE3) 1OR2 ; 2.50 ; APOLIPOPROTEIN E3 (APOE3) TRUNCATION MUTANT 165 1OR3 ; 1.73 ; APOLIPOPROTEIN E3 (APOE3), TRIGONAL TRUNCATION MUTANT 165 1H7I ; 1.90 ; APOLIPOPROTEIN E3 22KD FRAGMENT LYS146GLN MUTANT 1EA8 ; 1.95 ; APOLIPOPROTEIN E3 22KD FRAGMENT LYS146GLU MUTANT 1B68 ; 2.00 ; APOLIPOPROTEIN E4 (APOE4), 22K FRAGMENT 1GS9 ; 1.70 ; APOLIPOPROTEIN E4, 22K DOMAIN 2IZC ; 1.40 ; APOSTREPTAVIDIN PH 2.0 I222 COMPLEX 2IZA ; 1.46 ; APOSTREPTAVIDIN PH 2.00 I4122 STRUCTURE 2IZD ; 1.60 ; APOSTREPTAVIDIN PH 3.0 I222 COMPLEX 2IZE ; 1.57 ; APOSTREPTAVIDIN PH 3.08 I222 COMPLEX 2IZB ; 1.42 ; APOSTREPTAVIDIN PH 3.12 I4122 STRUCTURE 2RTA ; 1.39 ; APOSTREPTAVIDIN, PH 2.97, SPACE GROUP I4122 2RTB ; 1.50 ; APOSTREPTAVIDIN, PH 3.32, SPACE GROUP I222 2RTC ; 1.50 ; APOSTREPTAVIDIN, PH 3.60, SPACE GROUP I222 1SLF ; 1.73 ; APOSTREPTAVIDIN, PH 5.6, TWO MOLECULES OF (SO4)2 BOUND AT THE BIOTIN BINDING SITE 1R4M ; 3.00 ; APPBP1-UBA3-NEDD8, AN E1-UBIQUITIN-LIKE PROTEIN COMPLEX 1R4N ; 3.60 ; APPBP1-UBA3-NEDD8, AN E1-UBIQUITIN-LIKE PROTEIN COMPLEX WITH ATP 1XNJ ; 1.98 ; APS COMPLEX OF HUMAN PAPS SYNTHETASE 1 1A9G ; -1.00 ; APURINIC DEOXYRIBONUCLEIC ACID WITH BOUND WATER AT THE DAMAGED SITE AND N3 OF CYTOSINE, BETA FORM, NMR, 1 STRUCTURE 1A9H ; -1.00 ; APURINIC DEOXYRIBONUCLEIC ACID WITH BOUND WATER AT THE DAMAGED SITE AND O2 OF CYTOSINE, BETA FORM, NMR, 1 STRUCTURE 1A9I ; -1.00 ; APYRIMIDINIC DEOXYRIBONUCLEIC ACID WITH BOUND WATER AT THE DAMAGED SITE, ALPHA FORM, NMR, 1 STRUCTURE 1A9J ; -1.00 ; APYRIMIDINIC DEOXYRIBONUCLEIC ACID WITH BOUND WATER AT THE DAMAGED SITE, BETA FORM, NMR, 1 STRUCTURE 1SOR ; 3.00 ; AQUAPORIN-0 MEMBRANE JUNCTIONS REVEAL THE STRUCTURE OF A CLOSED WATER PORE 1TZ7 ; 2.15 ; AQUIFEX AEOLICUS AMYLOMALTASE 1FX6 ; 2.06 ; AQUIFEX AEOLICUS KDO8P SYNTHASE 1LRN ; 2.10 ; AQUIFEX AEOLICUS KDO8P SYNTHASE H185G MUTANT IN COMPLEX WITH CADMIUM 1LRO ; 1.80 ; AQUIFEX AEOLICUS KDO8P SYNTHASE H185G MUTANT IN COMPLEX WITH PEP AND CADMIUM 1LRQ ; 1.80 ; AQUIFEX AEOLICUS KDO8P SYNTHASE H185G MUTANT IN COMPLEX WITH PEP, A5P AND CADMIUM 1JCX ; 1.80 ; AQUIFEX AEOLICUS KDO8P SYNTHASE IN COMPLEX WITH API AND CADMIUM 1FXP ; 1.80 ; AQUIFEX AEOLICUS KDO8P SYNTHASE IN COMPLEX WITH CADMIUM 1FY6 ; 1.89 ; AQUIFEX AEOLICUS KDO8P SYNTHASE IN COMPLEX WITH CADMIUM AND A5P 1FWN ; 1.94 ; AQUIFEX AEOLICUS KDO8P SYNTHASE IN COMPLEX WITH PEP 1FXQ ; 1.80 ; AQUIFEX AEOLICUS KDO8P SYNTHASE IN COMPLEX WITH PEP AND A5P 1FWS ; 1.90 ; AQUIFEX AEOLICUS KDO8P SYNTHASE IN COMPLEX WITH PEP AND CADMIUM 1FWW ; 1.85 ; AQUIFEX AEOLICUS KDO8P SYNTHASE IN COMPLEX WITH PEP, A5P AND CADMIUM 1FWT ; 1.90 ; AQUIFEX AEOLICUS KDO8P SYNTHASE IN COMPLEX WITH PEP, E4P AND CADMIUM 1JCY ; 1.90 ; AQUIFEX AEOLICUS KDO8P SYNTHASE IN COMPLEX WITH R5P, PEP AND CADMIUM 1PE1 ; 1.74 ; AQUIFEX AEOLICUS KDO8PS IN COMPLEX WITH CADMIUM AND 2-PGA 1PCW ; 1.85 ; AQUIFEX AEOLICUS KDO8PS IN COMPLEX WITH CADMIUM AND APP, A BISUBSTRATE INHIBITOR 1PCK ; 1.80 ; AQUIFEX AEOLICUS KDO8PS IN COMPLEX WITH Z-METHYL-PEP 1ZJI ; 2.25 ; AQUIFEX AEOLICUS KDO8PS R106G MUTANT IN COMPLEX WITH 2PGA AND R5P 1A6K ; 1.10 ; AQUOMET-MYOGLOBIN, ATOMIC RESOLUTION 1W07 ; 2.00 ; ARABIDOPSIS THALIANA ACYL-COA OXIDASE 1 1W0I ; 2.10 ; ARABIDOPSIS THALIANA MITOCHONDRIAL KAS 1PA2 ; 1.45 ; ARABIDOPSIS THALIANA PEROXIDASE A2 1QO4 ; 3.00 ; ARABIDOPSIS THALIANA PEROXIDASE A2 AT ROOM TEMPERATURE 1QGJ ; 1.90 ; ARABIDOPSIS THALIANA PEROXIDASE N 1VOK ; 2.10 ; ARABIDOPSIS THALIANA TBP (DIMER) 1BDV ; 2.80 ; ARC FV10 COCRYSTAL 1BAZ ; 1.90 ; ARC REPRESSOR MUTANT PHE10VAL 1B28 ; -1.00 ; ARC REPRESSOR MYL MUTANT FROM SALMONELLA BACTERIOPHAGE P22 1AVB ; 1.90 ; ARCELIN-1 FROM PHASEOLUS VULGARIS L 1IOA ; 2.70 ; ARCELIN-5, A LECTIN-LIKE DEFENSE PROTEIN FROM PHASEOLUS VULGARIS 2BA0 ; 2.70 ; ARCHAEAL EXOSOME CORE 2BA1 ; 2.70 ; ARCHAEAL EXOSOME CORE 1OK4 ; 2.10 ; ARCHAEAL FRUCTOSE 1,6-BISPHOSPHATE ALDOLASE COVALENTLY BOUND TO THE SUBSTRATE DIHYDROXYACETONE PHOSPHATE 1JT8 ; -1.00 ; ARCHAEAL INITIATION FACTOR-1A, AIF-1A 1I0S ; 1.65 ; ARCHAEOGLOBUS FULGIDUS FERRIC REDUCTASE COMPLEX WITH NADP+ 1GL9 ; 3.20 ; ARCHAEOGLOBUS FULGIDUS REVERSE GYRASE COMPLEXED WITH ADPNP 1S5L ; 3.50 ; ARCHITECTURE OF THE PHOTOSYNTHETIC OXYGEN EVOLVING CENTER 1JQU ; 2.60 ; ARE CARBOXY TERMINII OF HELICES CODED BY THE LOCAL SEQUENCE OR BY TERTIARY STRUCTURE CONTACTS 1LLH ; 1.80 ; ARE CARBOXY TERMINII OF HELICES CODED BY THE LOCAL SEQUENCE OR BY TERTIARY STRUCTURE CONTACTS 1S9D ; 1.80 ; ARF1[DELTA 1-17]-GDP-MG IN COMPLEX WITH BREFELDIN A AND A SEC7 DOMAIN 1R8S ; 1.46 ; ARF1[DELTA1-17]-GDP IN COMPLEX WITH A SEC7 DOMAIN CARRYING THE MUTATION OF THE CATALYTIC GLUTAMATE TO LYSINE 1ARJ ; -1.00 ; ARG-BOUND TAR RIBONUCLEIC ACID, NMR 1U85 ; -1.00 ; ARG326-TRP MUTANT OF THE THIRD ZINC FINGER OF BKLF 1G3Y ; 2.80 ; ARG80ALA DTXR 3CEV ; 2.40 ; ARGINASE FROM BACILLUS CALDEVELOX, COMPLEXED WITH L-ARGININE 5CEV ; 2.50 ; ARGINASE FROM BACILLUS CALDEVELOX, L-LYSINE COMPLEX 4CEV ; 2.70 ; ARGINASE FROM BACILLUS CALDEVELOX, L-ORNITHINE COMPLEX 2CEV ; 2.15 ; ARGINASE FROM BACILLUS CALDEVELOX, NATIVE STRUCTURE AT PH 8.5 1CEV ; 2.40 ; ARGINASE FROM BACILLUS CALDOVELOX, NATIVE STRUCTURE AT PH 5.6 1ZPE ; 1.70 ; ARGINASE I COVALENTLY MODIFIED WITH BUTYLAMINE AT Q19C 1ZPG ; 1.90 ; ARGINASE I COVALENTLY MODIFIED WITH PROPYLAMINE AT Q19C 1T5F ; 2.20 ; ARGINASE I-AOH COMPLEX 2A0M ; 1.60 ; ARGINASE SUPERFAMILY PROTEIN FROM TRYPANOSOMA CRUZI 1T4P ; 2.60 ; ARGINASE-DEHYDRO-ABH COMPLEX 1T4R ; 2.60 ; ARGINASE-DESCARBOXY-NOR-NOHA COMPLEX 1T4T ; 2.20 ; ARGINASE-DINOR-NOHA COMPLEX 1T5G ; 2.40 ; ARGINASE-F2-L-ARGININE COMPLEX 1T4S ; 2.80 ; ARGINASE-L-VALINE COMPLEX 1NND ; 2.30 ; ARGININE 116 IS ESSENTIAL FOR NUCLEIC ACID RECOGNITION BY THE FINGERS DOMAIN OF MOLONEY MURINE LEUKEMIA VIRUS REVERSE TRANSCRIPTASE 2BUF ; 2.95 ; ARGININE FEED-BACK INHIBITABLE ACETYLGLUTAMATE KINASE 1GV7 ; 2.10 ; ARH-I, AN ANGIOGENIN/RNASE A CHIMERA 1UN5 ; 2.60 ; ARH-II, AN ANGIOGENIN/RNASE A CHIMERA 1DGP ; 2.80 ; ARISTOLOCHENE SYNTHASE FARNESOL COMPLEX 1AY8 ; 2.30 ; AROMATIC AMINO ACID AMINOTRANSFERASE COMPLEX WITH 3-PHENYLPROPIONATE 1AY5 ; 2.50 ; AROMATIC AMINO ACID AMINOTRANSFERASE COMPLEX WITH MALEATE 2AY3 ; 2.40 ; AROMATIC AMINO ACID AMINOTRANSFERASE WITH 3-(3,4-DIMETHOXYPHENYL)PROPIONIC ACID 2AY4 ; 2.20 ; AROMATIC AMINO ACID AMINOTRANSFERASE WITH 3-(P-TOLYL)PROPIONIC ACID 2AY6 ; 2.20 ; AROMATIC AMINO ACID AMINOTRANSFERASE WITH 3-INDOLEBUTYRIC ACID 2AY5 ; 2.40 ; AROMATIC AMINO ACID AMINOTRANSFERASE WITH 3-INDOLEPROPIONIC ACID 2AY8 ; 2.20 ; AROMATIC AMINO ACID AMINOTRANSFERASE WITH 4-(2-THIENYL)BUTYRIC ACID 2AY1 ; 2.20 ; AROMATIC AMINO ACID AMINOTRANSFERASE WITH 4-AMINOHYDROCINNAMIC ACID 2AY7 ; 2.40 ; AROMATIC AMINO ACID AMINOTRANSFERASE WITH 4-PHENYLBUTYRIC ACID 2AY9 ; 2.50 ; AROMATIC AMINO ACID AMINOTRANSFERASE WITH 5-PHENYLVALERIC ACID 2AY2 ; 2.40 ; AROMATIC AMINO ACID AMINOTRANSFERASE WITH CYCLOHEXANE PROPIONIC ACID 1AY4 ; 2.33 ; AROMATIC AMINO ACID AMINOTRANSFERASE WITHOUT SUBSTRATE 1AYR ; 3.30 ; ARRESTIN FROM BOVINE ROD OUTER SEGMENTS 1CF1 ; 2.80 ; ARRESTIN FROM BOVINE ROD OUTER SEGMENTS 1VQX ; -1.00 ; ARRESTIN-BOUND NMR STRUCTURES OF THE PHOSPHORYLATED CARBOXY- TERMINAL DOMAIN OF RHODOPSIN, REFINED 1B3P ; -1.00 ; ARROWHEAD DEOXYRIBONUCLEIC ACID MOTIF: (G-G-A)2 TRIPLET REPEAT SEQUENCE ADOPTS A V-SHAPED INTERLOCKED MISMATCH-ALIGNED MOTIF 1RXE ; 1.70 ; ARSC COMPLEXED WITH MNB 1JZW ; 1.76 ; ARSENATE REDUCTASE + SODIUM ARSENATE FROM E. COLI 1SD9 ; 1.65 ; ARSENATE REDUCTASE C12S MUTANT +0.4M ARSENATE FROM E. COLI 1S3C ; 1.25 ; ARSENATE REDUCTASE C12S MUTANT FROM E. COLI 1I9D ; 1.65 ; ARSENATE REDUCTASE FROM E. COLI 1SK2 ; 1.54 ; ARSENATE REDUCTASE R60A MUTANT +0.4M ARSENATE FROM E. COLI 1SK0 ; 1.80 ; ARSENATE REDUCTASE R60A MUTANT +0.4M ARSENITE FROM E. COLI 1S3D ; 1.54 ; ARSENATE REDUCTASE R60A MUTANT FROM E. COLI 1SK1 ; 1.55 ; ARSENATE REDUCTASE R60K MUTANT +0.4M ARSENATE FROM E. COLI 1SJZ ; 1.80 ; ARSENATE REDUCTASE R60K MUTANT +0.4M ARSENITE FROM E. COLI 1SD8 ; 1.59 ; ARSENATE REDUCTASE R60K MUTANT FROM E. COLI 1J9B ; 1.26 ; ARSENATE REDUCTASE+0.4M ARSENITE FROM E. COLI 1BQX ; -1.00 ; ARTIFICIAL FE8S8 FERREDOXIN: THE D13C VARIANT OF BACILLUS SCHLEGELII FE7S8 FERREDOXIN 1BWE ; -1.00 ; ARTIFICIAL FE8S8 FERREDOXIN: THE D13C VARIANT OF BACILLUS SCHLEGELII FE7S8 FERREDOXIN 1A3O ; 1.80 ; ARTIFICIAL MUTANT (ALPHA Y42H) OF DEOXY HEMOGLOBIN 1N95 ; 2.30 ; ARYL TETRAHYDROPHYRIDINE INHBITORS OF FARNESYLTRANFERASE: GLYCINE, PHENYLALANINE AND HISTIDINE DERIVATIVES 1N94 ; 3.50 ; ARYL TETRAHYDROPYRIDINE INHBITORS OF FARNESYLTRANSFERASE: GLYCINE, PHENYLALANINE AND HISTIDINE DERIVATES 1E2T ; 2.80 ; ARYLAMINE N-ACETYLTRANSFERASE (NAT) FROM SALMONELLA TYPHIMURIUM 1W6F ; 2.10 ; ARYLAMINE N-ACETYLTRANSFERASE FROM MYCOBACTERIUM SMEGMATIS WITH THE ANTI-TUBERCULAR DRUG ISONIAZID BOUND IN THE ACTIVE SITE. 1HDH ; 1.30 ; ARYLSULFATASE FROM PSEUDOMONAS AERUGINOSA 1W9M ; 1.35 ; AS-ISOLATED HYBRID CLUSTER PROTEIN FROM DESULFOVIBRIO VULGARIS X-RAY STRUCTURE AT 1.35A RESOLUTION USING IRON ANOMALOUS SIGNAL 1VPT ; 1.85 ; AS11 VARIANT OF VACCINIA VIRUS PROTEIN VP39 IN COMPLEX WITH S-ADENOSYL-L-METHIONINE 1OAG ; 1.75 ; ASCOBATE PEROXIDASE FROM SOYBEAN CYTOSOL 1OAF ; 1.40 ; ASCOBATE PEROXIDASE FROM SOYBEAN CYTOSOL IN COMPLEX WITH ASCORBATE 1V0H ; 1.46 ; ASCOBATE PEROXIDASE FROM SOYBEAN CYTOSOL IN COMPLEX WITH SALICYLHYDROXAMIC ACID 1XNL ; -1.00 ; ASLV FUSION PEPTIDE 1SGN ; 1.80 ; ASN 18 VARIANT OF TURKEY OVOMUCOID INHIBITOR THIRD DOMAIN COMPLEXED WITH STREPTOMYCES GRISEUS PROTEINASE B 2SGD ; 1.80 ; ASP 18 VARIANT OF TURKEY OVOMUCOID INHIBITOR THIRD DOMAIN COMPLEXED WITH STREPTOMYCES GRISEUS PROTEINASE B AT PH 10.7 1SGD ; 1.80 ; ASP 18 VARIANT OF TURKEY OVOMUCOID INHIBITOR THIRD DOMAIN COMPLEXED WITH STREPTOMYCES GRISEUS PROTEINASE B AT PH 6.5 1EKS ; 2.50 ; ASP128ALA VARIANT OF MOAC PROTEIN FROM E. COLI 1DZN ; 2.80 ; ASP170SER MUTANT OF VANILLYL-ALCOHOL OXIDASE 1C99 ; -1.00 ; ASP61 DEPROTONATED FORM OF SUBUNIT C OF THE F1FO ATP SYNTHASE OF ESCHERICHIA COLI 1YNV ; 1.20 ; ASP79 MAKES A LARGE, UNFAVORABLE CONTRIBUTION TO THE STABILITY OF RNASE SA 2E2A ; 2.10 ; ASP81LEU ENZYME IIA FROM THE LACTOSE SPECIFIC PTS FROM LACTOCOCCUS LACTIS 4ECA ; 2.20 ; ASPARAGINASE FROM E. COLI, MUTANT T89V WITH COVALENTLY BOUND ASPARTATE 1HFJ ; 2.40 ; ASPARAGINASE FROM ERWINIA CHRYSANTHEMI, HEXAGONAL FORM WITH SULFATE 1HFK ; 2.17 ; ASPARAGINASE FROM ERWINIA CHRYSANTHEMI, HEXAGONAL FORM WITH WEAK SULFATE 11AS ; 2.50 ; ASPARAGINE SYNTHETASE MUTANT C51A, C315A COMPLEXED WITH L-ASPARAGINE 12AS ; 2.20 ; ASPARAGINE SYNTHETASE MUTANT C51A, C315A COMPLEXED WITH L-ASPARAGINE AND AMP 1G4X ; 2.20 ; ASPARTATE AMINOTRANSFERASE ACTIVE SITE MUTANT N194A/R292L 1G7X ; 2.20 ; ASPARTATE AMINOTRANSFERASE ACTIVE SITE MUTANT N194A/R292L/R386L 1G7W ; 2.20 ; ASPARTATE AMINOTRANSFERASE ACTIVE SITE MUTANT N194A/R386L 1G4V ; 2.00 ; ASPARTATE AMINOTRANSFERASE ACTIVE SITE MUTANT N194A/Y225F 1IX6 ; 2.20 ; ASPARTATE AMINOTRANSFERASE ACTIVE SITE MUTANT V39F 1IX7 ; 2.20 ; ASPARTATE AMINOTRANSFERASE ACTIVE SITE MUTANT V39F MALEATE COMPLEX 1IX8 ; 2.20 ; ASPARTATE AMINOTRANSFERASE ACTIVE SITE MUTANT V39F/N194A 1CQ6 ; 2.70 ; ASPARTATE AMINOTRANSFERASE COMPLEX WITH C4-PYRIDOXAL-5P- PHOSPHATE 1C9C ; 2.40 ; ASPARTATE AMINOTRANSFERASE COMPLEXED WITH C3-PYRIDOXAL-5'- PHOSPHATE 1CQ7 ; 2.40 ; ASPARTATE AMINOTRANSFERASE COMPLEXED WITH C5- PYRIDOXAL-5P-PHOSPHATE 1CQ8 ; 2.40 ; ASPARTATE AMINOTRANSFERASE COMPLEXED WITH C6- PYRIDOXAL-5P-PHOSPHATE 5EAA ; 2.40 ; ASPARTATE AMINOTRANSFERASE FROM E. COLI, C191S MUTATION 1B4X ; 2.45 ; ASPARTATE AMINOTRANSFERASE FROM E. COLI, C191S MUTATION, WITH BOUND MALEATE 1QIS ; 1.90 ; ASPARTATE AMINOTRANSFERASE FROM ESCHERICHIA COLI, C191F MUTATION, WITH BOUND MALEATE 1QIT ; 1.90 ; ASPARTATE AMINOTRANSFERASE FROM ESCHERICHIA COLI, C191W MUTATION, WITH BOUND MALEATE 1QIR ; 2.20 ; ASPARTATE AMINOTRANSFERASE FROM ESCHERICHIA COLI, C191Y MUTATION, WITH BOUND MALEATE 1J32 ; 2.10 ; ASPARTATE AMINOTRANSFERASE FROM PHORMIDIUM LAPIDEUM 1YAA ; 2.05 ; ASPARTATE AMINOTRANSFERASE FROM SACCHAROMYCES CEREVISIAE CYTOPLASM 1BJW ; 1.80 ; ASPARTATE AMINOTRANSFERASE FROM THERMUS THERMOPHILUS 1BKG ; 2.60 ; ASPARTATE AMINOTRANSFERASE FROM THERMUS THERMOPHILUS WITH MALEATE 1AHE ; 2.30 ; ASPARTATE AMINOTRANSFERASE HEXAMUTANT 1AHF ; 2.30 ; ASPARTATE AMINOTRANSFERASE HEXAMUTANT 1AHG ; 2.50 ; ASPARTATE AMINOTRANSFERASE HEXAMUTANT 1AHX ; 2.00 ; ASPARTATE AMINOTRANSFERASE HEXAMUTANT 1AHY ; 2.30 ; ASPARTATE AMINOTRANSFERASE HEXAMUTANT 1YOO ; 2.40 ; ASPARTATE AMINOTRANSFERASE MUTANT ATB17 WITH ISOVALERIC ACID 1CZC ; 2.50 ; ASPARTATE AMINOTRANSFERASE MUTANT ATB17/139S/142N WITH GLUTARIC ACID 1CZE ; 2.40 ; ASPARTATE AMINOTRANSFERASE MUTANT ATB17/139S/142N WITH SUCCINIC ACID 1BQD ; 2.10 ; ASPARTATE AMINOTRANSFERASE P138A/P195A DOUBLE MUTANT 1BQA ; 2.10 ; ASPARTATE AMINOTRANSFERASE P195A MUTANT 1OXP ; 2.50 ; ASPARTATE AMINOTRANSFERASE, H-ASP COMPLEX, CLOSED CONFORMATION 1OXO ; 2.30 ; ASPARTATE AMINOTRANSFERASE, H-ASP COMPLEX, OPEN CONFORMATION 1ARG ; 2.20 ; ASPARTATE AMINOTRANSFERASE, PHOSPHO-5'-PYRIDOXYL ASPARTATE COMPLEX 1ARI ; 2.30 ; ASPARTATE AMINOTRANSFERASE, W140H MUTANT, MALEATE COMPLEX 1ARH ; 2.30 ; ASPARTATE AMINOTRANSFERASE, Y225R/R386A MUTANT 1BRM ; 2.50 ; ASPARTATE BETA-SEMIALDEHYDE DEHYDROGENASE FROM ESCHERICHIA COLI 1GL3 ; 2.60 ; ASPARTATE BETA-SEMIALDEHYDE DEHYDROGENASE IN COMPLEX WITH NADP AND SUBSTRATE ANALOGUE S-METHYL CYSTEINE SULFOXIDE 1TU0 ; 2.55 ; ASPARTATE TRANSCARBAMOYLASE CATALYTIC CHAIN MUTANT E50A COMPLEX WITH PHOSPHONOACETAMIDE 1TUG ; 2.10 ; ASPARTATE TRANSCARBAMOYLASE CATALYTIC CHAIN MUTANT E50A COMPLEX WITH PHOSPHONOACETAMIDE, MALONATE, AND CYTIDINE-5- PRIME-TRIPHOSPHATE (CTP) 1TTH ; 2.80 ; ASPARTATE TRANSCARBAMOYLASE CATALYTIC CHAIN MUTANT GLU50ALA COMPLEXED WITH N-(PHOSPHONACETYL-L-ASPARTATE) (PALA) 1D09 ; 2.10 ; ASPARTATE TRANSCARBAMOYLASE COMPLEXED WITH N-PHOSPHONACETYL- L-ASPARTATE (PALA) 1Q95 ; 2.46 ; ASPARTATE TRANSCARBAMYLASE (ATCASE) OF ESCHERICHIA COLI: A NEW CRYSTALLINE R STATE BOUND TO PALA, OR TO PRODUCT ANALOGUES PHOSPHATE AND CITRATE 1R0B ; 2.90 ; ASPARTATE TRANSCARBAMYLASE (ATCASE) OF ESCHERICHIA COLI: A NEW CRYSTALLINE R STATE BOUND TO PALA, OR TO PRODUCT ANALOGUES PHOSPHATE AND CITRATE 1NBE ; 2.60 ; ASPARTATE TRANSCARBOMYLASE REGULATORY CHAIN MUTANT (T82A) 2ASI ; 2.15 ; ASPARTIC PROTEINASE 1FY2 ; 1.20 ; ASPARTYL DIPEPTIDASE 1FYE ; 1.20 ; ASPARTYL DIPEPTIDASE (ANISOTROPIC B-FACTOR REFINEMENT) 1G51 ; 2.40 ; ASPARTYL TRNA SYNTHETASE FROM THERMUS THERMOPHILUS AT 2.4 A RESOLUTION 1B8A ; 1.90 ; ASPARTYL-TRNA SYNTHETASE 1L0W ; 2.01 ; ASPARTYL-TRNA SYNTHETASE-1 FROM SPACE-GROWN CRYSTALS 1IBQ ; 2.14 ; ASPERGILLOPEPSIN FROM ASPERGILLUS PHOENICIS 1OXR ; 1.93 ; ASPIRIN INDUCES ITS ANTI-INFLAMMATORY EFFECTS THROUGH ITS SPECIFIC BINDING TO PHOSPHOLIPASE A2: CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN PHOSPHOLIPASE A2 AND ASPIRIN AT 1.9A RESOLUTION 1VDF ; 2.05 ; ASSEMBLY DOMAIN OF CARTILAGE OLIGOMERIC MATRIX PROTEIN 1FBM ; 2.70 ; ASSEMBLY DOMAIN OF CARTILAGE OLIGOMERIC MATRIX PROTEIN IN COMPLEX WITH ALL-TRANS RETINOL 1VSK ; 2.20 ; ASV INTEGRASE CORE DOMAIN D64N MUTATION IN CITRATE BUFFER PH 6.0 1VSL ; 2.20 ; ASV INTEGRASE CORE DOMAIN D64N MUTATION WITH ZINC CATION 1VSM ; 2.15 ; ASV INTEGRASE CORE DOMAIN IN CITRATE BUFFER PH 5.0 1VSI ; 2.20 ; ASV INTEGRASE CORE DOMAIN WITH CA(II) COFACTOR 1VSJ ; 2.10 ; ASV INTEGRASE CORE DOMAIN WITH CD(II) COFACTORS 1A5W ; 2.00 ; ASV INTEGRASE CORE DOMAIN WITH HIV-1 INTEGRASE INHIBITOR Y3 1A5X ; 1.90 ; ASV INTEGRASE CORE DOMAIN WITH HIV-1 INTEGRASE INHIBITOR Y3 1A5V ; 1.90 ; ASV INTEGRASE CORE DOMAIN WITH HIV-1 INTEGRASE INHIBITOR Y3 AND MN CATION 1VSD ; 1.70 ; ASV INTEGRASE CORE DOMAIN WITH MG(II) COFACTOR AND HEPES LIGAND, HIGH MG CONCENTRATION FORM 1VSE ; 2.20 ; ASV INTEGRASE CORE DOMAIN WITH MG(II) COFACTOR AND HEPES LIGAND, LOW MG CONCENTRATION FORM 1VSF ; 2.05 ; ASV INTEGRASE CORE DOMAIN WITH MN(II) COFACTOR AND HEPES LIGAND, HIGH MG CONCENTRATION FORM 1VSH ; 1.95 ; ASV INTEGRASE CORE DOMAIN WITH ZN(II) COFACTORS 1OFH ; 2.50 ; ASYMMETRIC COMPLEX BETWEEN HSLV AND I-DOMAIN DELETED HSLU (H. INFLUENZAE) 1OFI ; 3.20 ; ASYMMETRIC COMPLEX BETWEEN HSLV AND I-DOMAIN DELETED HSLU (H. INFLUENZAE) 1H6S ; 3.00 ; ASYMMETRIC CONDUCTIVITY OF ENGINEERED PROTEINS 4CRX ; 2.20 ; ASYMMETRIC DEOXYRIBONUCLEIC ACID-BENDING IN THE CRE-LOXP SITE-SPECIFIC RECOMBINATION SYNAPSE 5CRX ; 2.70 ; ASYMMETRIC DEOXYRIBONUCLEIC ACID-BENDING IN THE CRE-LOXP SITE-SPECIFIC RECOMBINATION SYNAPSE 1GAC ; -1.00 ; ASYMMETRIC HOMODIMER OF A82846B, A GLYCOPEPTIDE ANTIBIOTIC, COMPLEXED WITH ITS CELL WALL PENTAPEPTIDE FRAGMENT, NMR, 80 MODELS 2ONE ; 2.00 ; ASYMMETRIC YEAST ENOLASE DIMER COMPLEXED WITH RESOLVED 2'-PHOSPHOGLYCERATE AND PHOSPHOENOLPYRUVATE 1ZFC ; 2.00 ; ATC DUPLEX B-DEOXYRIBONUCLEIC ACID 1ZF3 ; 1.84 ; ATC FOUR-STRANDED DEOXYRIBONUCLEIC ACID HOLLIDAY JUNCTION 1ZF4 ; 1.65 ; ATC FOUR-STRANDED DEOXYRIBONUCLEIC ACID HOLLIDAY JUNCTION 9ATC ; 2.40 ; ATCASE Y165F MUTANT 1SAA ; -1.00 ; ATF-2 RECOGNITION SITE, NMR, 10 STRUCTURES 2BTV ; 3.50 ; ATOMIC MODEL FOR BLUETONGUE VIRUS (BTV) CORE 2BGZ ; 12.00 ; ATOMIC MODEL OF THE BACTERIAL FLAGELLAR BASED ON DOCKING AN X-RAY DERIVED HOOK STRUCTURE INTO AN EM MAP. 1VL9 ; 0.97 ; ATOMIC RESOLUTION (0.97A) STRUCTURE OF THE TRIPLE MUTANT (K53,56,121M) OF BOVINE PANCREATIC PHOSPHOLIPASE A2 1GQV ; 0.98 ; ATOMIC RESOLUTION (0.98A) STRUCTURE OF EOSINOPHIL-DERIVED NEUROTOXIN 1NKD ; 1.07 ; ATOMIC RESOLUTION (1.07 ANGSTROMS) STRUCTURE OF THE ROP MUTANT 1Q0E ; 1.15 ; ATOMIC RESOLUTION (1.15 ) CRYSTAL STRUCTURE OF BOVINE COPPER, ZINC SUPEROXIDE DISMUTASE 1CZ9 ; 1.20 ; ATOMIC RESOLUTION ASV INTEGRASE CORE DOMAIN (D64N) FROM CITRATE 1CXQ ; 1.02 ; ATOMIC RESOLUTION ASV INTEGRASE CORE DOMAIN FROM AMMONIUM SULFATE 1CZB ; 1.06 ; ATOMIC RESOLUTION ASV INTEGRASE CORE DOMAIN FROM HEPES 1BZP ; 1.15 ; ATOMIC RESOLUTION CRYSTAL STRUCTURE ANALYSIS OF NATIVE DEOXY AND CO MYOGLOBIN FROM SPERM WHALE AT ROOM TEMPERATURE 1BZR ; 1.15 ; ATOMIC RESOLUTION CRYSTAL STRUCTURE ANALYSIS OF NATIVE DEOXY AND CO MYOGLOBIN FROM SPERM WHALE AT ROOM TEMPERATURE 1BZ6 ; 1.20 ; ATOMIC RESOLUTION CRYSTAL STRUCTURE AQUOMET-MYOGLOBIN FROM SPERM WHALE AT ROOM TEMPERATURE 1L2X ; 1.25 ; ATOMIC RESOLUTION CRYSTAL STRUCTURE OF A VIRAL RIBONUCLEIC ACID PSEUDOKNOT 4LZT ; 0.95 ; ATOMIC RESOLUTION REFINEMENT OF TRICLINIC HEW LYSOZYME AT 295K 1OE3 ; 1.15 ; ATOMIC RESOLUTION STRUCTURE OF 'HALF APO' NIR 1M69 ; 1.10 ; ATOMIC RESOLUTION STRUCTURE OF 5BR-9AMINO-DACA WITH D[CGTACG]2 2BWD ; 1.15 ; ATOMIC RESOLUTION STRUCTURE OF ACHROMOBACTER CYCLOCLASTES CU NITRITE REDUCTASE WITH ENDOGENOUSLY BOUND NITRITE AND NO 1KWF ; 0.94 ; ATOMIC RESOLUTION STRUCTURE OF AN INVERTING GLYCOSIDASE IN COMPLEX WITH SUBSTRATE 1VB0 ; 0.92 ; ATOMIC RESOLUTION STRUCTURE OF ATRATOXIN-B, ONE SHORT-CHAIN NEUROTOXIN FROM NAJA ATRA 1MXT ; 0.95 ; ATOMIC RESOLUTION STRUCTURE OF CHOLESTEROL OXIDASE (STREPTOMYCES SP. SA-COO) 1N4W ; 0.92 ; ATOMIC RESOLUTION STRUCTURE OF CHOLESTEROL OXIDASE @ PH 7.3 (STREPTOMYCES SP. SA-COO) 1N1P ; 0.95 ; ATOMIC RESOLUTION STRUCTURE OF CHOLESTEROL OXIDASE @ PH 7.4 (STREPTOMYCES SP. SA-COO) 1N4V ; 1.00 ; ATOMIC RESOLUTION STRUCTURE OF CHOLESTEROL OXIDASE @PH 5.8 (STREPTOMYCES SP. SA-COO) 1YLT ; 1.10 ; ATOMIC RESOLUTION STRUCTURE OF CTX-M-14 BETA-LACTAMASE 1YLP ; 1.20 ; ATOMIC RESOLUTION STRUCTURE OF CTX-M-27 BETA-LACTAMASE 1YLJ ; 0.98 ; ATOMIC RESOLUTION STRUCTURE OF CTX-M-9 BETA-LACTAMASE 2C9V ; 1.07 ; ATOMIC RESOLUTION STRUCTURE OF CU-ZN HUMAN SUPEROXIDE DISMUTASE 1OE2 ; 1.12 ; ATOMIC RESOLUTION STRUCTURE OF D92E MUTANT OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE 1EUW ; 1.05 ; ATOMIC RESOLUTION STRUCTURE OF E. COLI DUTPASE 1OEX ; 1.10 ; ATOMIC RESOLUTION STRUCTURE OF ENDOTHIAPEPSIN IN COMPLEX WITH A HYDROXYETHYLENE TRANSITION STATE ANALOGUE INHIBITOR H261 1O7J ; 1.00 ; ATOMIC RESOLUTION STRUCTURE OF ERWINIA CHRYSANTHEMI L-ASPARAGINASE 1A7S ; 1.12 ; ATOMIC RESOLUTION STRUCTURE OF HBP 1GWE ; 0.88 ; ATOMIC RESOLUTION STRUCTURE OF MICROCOCCUS LYSODEIKTICUS CATALASE 1GWH ; 1.74 ; ATOMIC RESOLUTION STRUCTURE OF MICROCOCCUS LYSODEIKTICUS CATALASE COMPLEXED WITH NADPH 1OEW ; 0.90 ; ATOMIC RESOLUTION STRUCTURE OF NATIVE ENDOTHIAPEPSIN 2BWI ; 1.10 ; ATOMIC RESOLUTION STRUCTURE OF NITRITE -SOAKED ACHROMOBACTER CYCLOCLASTES CU NITRITE REDUCTASE 2BW5 ; 1.12 ; ATOMIC RESOLUTION STRUCTURE OF NO-BOUND ACHROMOBACTER CYCLOCLASTES CU NITRITE REDUCTASE 1QV0 ; 1.10 ; ATOMIC RESOLUTION STRUCTURE OF OBELIN FROM OBELIA LONGISSIMA 1QV1 ; 1.10 ; ATOMIC RESOLUTION STRUCTURE OF OBELIN FROM OBELIA LONGISSIMA 2BW4 ; 0.90 ; ATOMIC RESOLUTION STRUCTURE OF RESTING STATE OF THE ACHROMOBACTER CYCLOCLASTES CU NITRITE REDUCTASE 1KF2 ; 1.10 ; ATOMIC RESOLUTION STRUCTURE OF RNASE A AT PH 5.2 1KF3 ; 1.05 ; ATOMIC RESOLUTION STRUCTURE OF RNASE A AT PH 5.9 1KF4 ; 1.10 ; ATOMIC RESOLUTION STRUCTURE OF RNASE A AT PH 6.3 1KF5 ; 1.15 ; ATOMIC RESOLUTION STRUCTURE OF RNASE A AT PH 7.1 1KF7 ; 1.15 ; ATOMIC RESOLUTION STRUCTURE OF RNASE A AT PH 8.0 1KF8 ; 1.15 ; ATOMIC RESOLUTION STRUCTURE OF RNASE A AT PH 8.8 1DJT ; 1.20 ; ATOMIC RESOLUTION STRUCTURE OF SCORPION ALPHA-LIKE TOXIN BMK M1 IN A NEW CRYSTAL FORM 1LU0 ; 1.03 ; ATOMIC RESOLUTION STRUCTURE OF SQUASH TRYPSIN INHIBITOR: UNEXPECTED METAL COORDINATION 2BAX ; 1.10 ; ATOMIC RESOLUTION STRUCTURE OF THE DOUBLE MUTANT (K53,56M) OF BOVINE PANCREATIC PHOSPHOLIPASE A2 1R2M ; 1.00 ; ATOMIC RESOLUTION STRUCTURE OF THE HFBII HYDROPHOBIN: A SELF-ASSEMBLING AMPHIPHILE 1H1N ; 1.12 ; ATOMIC RESOLUTION STRUCTURE OF THE MAJOR ENDOGLUCANASE FROM THERMOASCUS AURANTIACUS 1OE1 ; 1.04 ; ATOMIC RESOLUTION STRUCTURE OF THE WILDTYPE NATIVE NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS 1HJ9 ; 0.95 ; ATOMIC RESOLUTION STRUCTURES OF TRYPSIN PROVIDE INSIGHT INTO STRUCTURAL RADIATION DAMAGE 1T8Z ; 1.45 ; ATOMIC STRUCTURE OF A NOVEL TRYPTOPHAN-ZIPPER PENTAMER 1S9U ; 1.38 ; ATOMIC STRUCTURE OF A PUTATIVE ANAEROBIC DEHYDROGENASE COMPONENT 1SZT ; 2.40 ; ATOMIC STRUCTURE OF A THERMOSTABLE SUBDOMAIN OF HIV-1 GP41 1N40 ; 1.06 ; ATOMIC STRUCTURE OF CYP121, A MYCOBACTERIAL P450 1FKK ; 2.20 ; ATOMIC STRUCTURE OF FKBP12, AN IMMUNOPHILIN BINDING PROTEIN 1FKJ ; 1.70 ; ATOMIC STRUCTURE OF FKBP12-FK506, AN IMMUNOPHILIN IMMUNOSUPPRESSANT COMPLEX 1FKL ; 1.70 ; ATOMIC STRUCTURE OF FKBP12-RAPAYMYCIN, AN IMMUNOPHILIN-IMMUNOSUPPRESSANT COMPLEX 1MNZ ; 0.99 ; ATOMIC STRUCTURE OF GLUCOSE ISOMERASE 1ENV ; 2.60 ; ATOMIC STRUCTURE OF THE ECTODOMAIN FROM HIV-1 GP41 1FKB ; 1.70 ; ATOMIC STRUCTURE OF THE RAPAMYCIN HUMAN IMMUNOPHILIN FKBP- 12 COMPLEX 3FAP ; 1.85 ; ATOMIC STRUCTURES OF THE RAPAMYCIN ANALOGS IN COMPLEX WITH BOTH HUMAN FKBP12 AND FRB DOMAIN OF FRAP 4FAP ; 2.80 ; ATOMIC STRUCTURES OF THE RAPAMYCIN ANALOGS IN COMPLEX WITH BOTH HUMAN FKBP12 AND FRB DOMAIN OF FRAP 1HET ; 1.15 ; ATOMIC X-RAY STRUCTURE OF LIVER ALCOHOL DEHYDROGENASE CONTAINING A HYDROXIDE ADDUCT TO NADH 1HEU ; 1.15 ; ATOMIC X-RAY STRUCTURE OF LIVER ALCOHOL DEHYDROGENASE CONTAINING CADMIUM AND A HYDROXIDE ADDUCT TO NADH 1HF3 ; 1.95 ; ATOMIC X-RAY STRUCTURE OF LIVER ALCOHOL DEHYDROGENASE CONTAINING CADMIUM AND A HYDROXIDE ADDUCT TO NADH 1RAW ; -1.00 ; ATP BINDING RIBONUCLEIC ACID APTAMER IN COMPLEX WITH AMP, NMR, 10 STRUCTURES 1AM1 ; 2.00 ; ATP BINDING SITE IN THE HSP90 MOLECULAR CHAPERONE 1W7A ; 2.27 ; ATP BOUND MUTS 1USY ; 2.52 ; ATP PHOSPHORIBOSYL TRANSFERASE (HISG:HISZ) COMPLEX FROM THERMOTOGA MARITIMA 1Z7M ; 2.90 ; ATP PHOSPHORIBOSYL TRANSFERASE (HISZG ATP-PRTASE) FROM LACTOCOCCUS LACTIS 1Z7N ; 3.25 ; ATP PHOSPHORIBOSYL TRANSFERASE (HISZG ATP-PRTASE) FROM LACTOCOCCUS LACTIS WITH BOUND PRPP SUBSTRATE 1NH7 ; 2.70 ; ATP PHOSPHORIBOSYLTRANSFERASE (ATP-PRTASE) FROM MYCOBACTERIUM TUBERCULOSIS 1NH8 ; 1.80 ; ATP PHOSPHORIBOSYLTRANSFERASE (ATP-PRTASE) FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH AMP AND HISTIDINE 1G8F ; 1.95 ; ATP SULFURYLASE FROM S. CEREVISIAE 1G8G ; 2.60 ; ATP SULFURYLASE FROM S. CEREVISIAE: THE BINARY PRODUCT COMPLEX WITH APS 1G8H ; 2.80 ; ATP SULFURYLASE FROM S. CEREVISIAE: THE TERNARY PRODUCT COMPLEX WITH APS AND PPI 1L2P ; 1.55 ; ATP SYNTHASE B SUBUNIT DIMERIZATION DOMAIN 1MT0 ; 2.60 ; ATP-BINDING DOMAIN OF HAEMOLYSIN B FROM ESCHERICHIA COLI 1B0U ; 1.50 ; ATP-BINDING SUBUNIT OF THE HISTIDINE PERMEASE FROM SALMONELLA TYPHIMURIUM 1R6O ; 2.25 ; ATP-DEPENDENT CLP PROTEASE ATP-BINDING SUBUNIT CLPA/ATP- DEPENDENT CLP PROTEASE ADAPTOR PROTEIN CLPS 1A0I ; 2.60 ; ATP-DEPENDENT DEOXYRIBONUCLEIC ACID LIGASE FROM BACTERIOPHAGE T7 COMPLEX WITH ATP 1VE4 ; 1.20 ; ATP-PHOSPHORIBOSYLTRANSFERASE(HISG) FROM THERMUS THERMOPHILUS HB8 1MO7 ; -1.00 ; ATPASE 1MO8 ; -1.00 ; ATPASE 1T4G ; 2.00 ; ATPASE IN COMPLEX WITH AMP-PNP 1XU4 ; 2.40 ; ATPASE IN COMPLEX WITH AMP-PNP, MAGNESIUM AND POTASSIUM CO-F 1XXH ; 3.45 ; ATPGS BOUND E. COLI CLAMP LOADER COMPLEX 1AXH ; -1.00 ; ATRACOTOXIN-HVI FROM HADRONYCHE VERSUTA (AUSTRALIAN FUNNEL-WEB SPIDER, NMR, 20 STRUCTURES 1OV8 ; 1.90 ; AURACYANIN B STRUCTURE IN SPACE GROUP, P65 1QHQ ; 1.55 ; AURACYANIN, A BLUE COPPER PROTEIN FROM THE GREEN THERMOPHILIC PHOTOSYNTHETIC BACTERIUM CHLOROFLEXUS AURANTIACUS 1BQB ; 1.72 ; AUREOLYSIN, STAPHYLOCOCCUS AUREUS METALLOPROTEINASE 1E65 ; 1.85 ; AURIN FROM PSEUDOMONAS AERUGINOSA, APO FORM 1E5Y ; 2.00 ; AURIN FROM PSEUDOMONAS AERUGINOSA, REDUCED FORM, PH 5.5 1E5Z ; 2.00 ; AURIN FROM PSEUDOMONAS AERUGINOSA, REDUCED FORM, PH 9.0 2BMC ; 2.60 ; AURORA-2 T287D T288D COMPLEXED WITH PHA-680632 1U37 ; -1.00 ; AUTO-INHIBITION MECHANISM OF X11S/MINTS FAMILY SCAFFOLD PROTEINS REVEALED BY THE CLOSED CONFORMATION OF THE TANDEM PDZ DOMAINS 1U38 ; -1.00 ; AUTO-INHIBITION MECHANISM OF X11S/MINTS FAMILY SCAFFOLD PROTEINS REVEALED BY THE CLOSED CONFORMATION OF THE TANDEM PDZ DOMAINS 1U39 ; -1.00 ; AUTO-INHIBITION MECHANISM OF X11S/MINTS FAMILY SCAFFOLD PROTEINS REVEALED BY THE CLOSED CONFORMATION OF THE TANDEM PDZ DOMAINS 1U3B ; -1.00 ; AUTO-INHIBITION MECHANISM OF X11S/MINTS FAMILY SCAFFOLD PROTEINS REVEALED BY THE CLOSED CONFORMATION OF THE TANDEM PDZ DOMAINS 1QWT ; 2.10 ; AUTO-INHIBITORY INTERFERON REGULATION FACTOR-3 (IRF3) TRANSACTIVATION DOMAIN 1TKI ; 2.00 ; AUTOINHIBITED SERINE KINASE DOMAIN OF THE GIANT MUSCLE PROTEIN TITIN 1CXR ; -1.00 ; AUTOMATED 2D NOESY ASSIGNMENT AND STRUCTURE CALCULATION OF CRAMBIN(S22/I25) WITH SELF-CORRECTING DISTANCE GEOMETRY BASED NOAH/DIAMOD PROGRAMS 1NH5 ; -1.00 ; AUTOMATIC ASSIGNMENT OF NMR DATA AND DETERMINATION OF THE PROTEIN STRUCTURE OF A NEW WORLD SCORPION NEUROTOXIN USING NOAH/DIAMOD 1ITT ; 1.00 ; AVERAGE CRYSTAL STRUCTURE OF (PRO-PRO-GLY)9 AT 1.0 ANGSTROMS RESOLUTION 1KSM ; -1.00 ; AVERAGE NMR SOLUTION STRUCTURE OF CA LN CALBINDIN D9K 1C9Q ; -1.00 ; AVERAGE NMR SOLUTION STRUCTURE OF THE BIR-2 DOMAIN OF XIAP 1F9X ; -1.00 ; AVERAGE NMR SOLUTION STRUCTURE OF THE BIR-3 DOMAIN OF XIAP 1JAV ; -1.00 ; AVERAGE NMR SOLUTION STRUCTURE OF THE TRP-RICH PEPTIDE OF HIV GP41 BOUND TO DPC MICELLES 1S2F ; -1.00 ; AVERAGE SOLUTION STRUCTURE OF A PSEUDO-5'-SPLICE SITE FROM THE NEGATIVE REGULATOR OF SPLICING OF ROUS SARCOMA VIRUS 1EKI ; -1.00 ; AVERAGE SOLUTION STRUCTURE OF D(TTGGCCAA)2 BOUND TO CHROMOMYCIN-A3 AND COBALT 1N6V ; -1.00 ; AVERAGE STRUCTURE OF THE INTERFERON-BINDING ECTODOMAIN OF THE HUMAN TYPE I INTERFERON RECEPTOR 1QTG ; -1.00 ; AVERAGED NMR MODEL OF SWITCH ARC, A DOUBLE MUTANT OF ARC REPRESSOR 1JOK ; -1.00 ; AVERAGED STRUCTURE FOR STAPHYLOCOCCAL NUCLEASE-H124L IN TERNARY COMPLEX WITH CA2+ AND THYMIDINE-3',5'-BISPHOSPHATE 1JOO ; -1.00 ; AVERAGED STRUCTURE FOR UNLIGATED STAPHYLOCOCCAL NUCLEASE- H124L 1YQ4 ; 2.33 ; AVIAN RESPIRATORY COMPLEX II WITH 3-NITROPROPIONATE AND UBIQUINONE 2FBW ; 2.10 ; AVIAN RESPIRATORY COMPLEX II WITH CARBOXIN BOUND 1YQ3 ; 2.20 ; AVIAN RESPIRATORY COMPLEX II WITH OXALOACETATE AND UBIQUINONE 1ASV ; 2.20 ; AVIAN SARCOMA VIRUS INTEGRASE CATALYTIC CORE DOMAIN 1ASU ; 1.70 ; AVIAN SARCOMA VIRUS INTEGRASE CATALYTIC CORE DOMAIN CRYSTALLIZED FROM 2% PEG 400, 2M AMMONIUM SULFATE, HEPES PH 7.5 1ASW ; 1.80 ; AVIAN SARCOMA VIRUS INTEGRASE CATALYTIC CORE DOMAIN CRYSTALLIZED FROM 20% PEG 4000, 10% ISOPROPANOL, HEPES PH 7.5 USING SELENOMETHIONINE SUBSTITUTED PROTEIN; DATA COLLECTED AT -165 DEGREES C 2CAM ; 2.20 ; AVIDIN MUTANT (K3E,K9E,R26D,R124L) 1LDQ ; 2.70 ; AVIDIN-HOMOBIOTIN COMPLEX 1LDO ; 2.20 ; AVIDIN-NORBIOITN COMPLEX 1WBI ; 1.40 ; AVR2 1OA8 ; 1.70 ; AXH DOMAIN OF HUMAN SPINOCEREBELLAR ATAXIN-1 1V06 ; -1.00 ; AXH DOMAIN OF THE TRANSCRIPTION FACTOR HBP1 FROM M.MUSCULUS 2VHB ; 1.76 ; AZIDE ADDUCT OF THE BACTERIAL HEMOGLOBIN FROM VITREOSCILLA STERCORARIA 1RSV ; 2.20 ; AZIDE COMPLEX OF THE DIFERROUS E238A MUTANT R2 SUBUNIT OF RIBONUCLEOTIDE REDUCTASE 1RSR ; 2.00 ; AZIDE COMPLEX OF THE DIFERROUS F208A MUTANT R2 SUBUNIT OF RIBONUCLEOTIDE REDUCTASE 1YAZ ; 1.70 ; AZIDE-BOUND YEAST CU(II)/ZN SUPEROXIDE DISMUTASE ROOM TEMPERATURE (298K) STRUCTURE 1NNI ; 2.50 ; AZOBENZENE REDUCTASE FROM BACILLUS SUBTILIS 1ATG ; 1.20 ; AZOTOBACTER VINELANDII PERIPLASMIC MOLYBDATE-BINDING PROTEIN 1LWX ; 2.30 ; AZT DIPHOSPHATE BINDING TO NUCLEOSIDE DIPHOSPHATE KINASE 1RT3 ; 3.00 ; AZT DRUG RESISTANT HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH 1051U91 1JVL ; 2.00 ; AZURIN DIMER, COVALENTLY CROSSLINKED THROUGH BIS- MALEIMIDOMETHYLETHER 1JVO ; 2.75 ; AZURIN DIMER, CROSSLINKED VIA DISULFIDE BRIDGE 2TSA ; 2.20 ; AZURIN MUTANT M121A 2TSB ; 2.30 ; AZURIN MUTANT M121A-AZIDE 1URI ; 1.94 ; AZURIN MUTANT WITH MET 121 REPLACED BY GLN 1ETJ ; 2.30 ; AZURIN MUTANT WITH MET 121 REPLACED BY GLU 1A4C ; 2.45 ; AZURIN MUTANT WITH MET 121 REPLACED BY HIS, PH 3.5 CRYSTAL FORM, DATA COLLECTED AT -180 DEGREES CELSIUS 1A4B ; 1.91 ; AZURIN MUTANT WITH MET 121 REPLACED BY HIS, PH 6.5 CRYSTAL FORM, DATA COLLECTED AT -180 DEGREES CELSIUS 1A4A ; 1.89 ; AZURIN MUTANT WITH MET 121 REPLACED BY HIS, PH 6.5 CRYSTAL FORM, DATA COLLECTED AT 16 DEGREES CELSIUS 7BNA ; 1.90 ; Anisotropic Thermal-Parameter Refinement of the DEOXYRIBONUCLEIC ACID Dodecamer Cgcgaattcgcg by the Segmented Rigid-Body Method 1CRY ; 3.00 ; Application of an Automatic Molecular Replacement Procedure to Crystal Structure of Cytochrome C2 from Rhodopseudomonas Viridis 2BPA ; 3.00 ; Atomic Structure of Single-Stranded DEOXYRIBONUCLEIC ACID Bacteriophage PhiX174 and its Functional Implications 1ZEW ; 2.25 ; B-DEOXYRIBONUCLEIC ACID 1ZF0 ; 1.50 ; B-DEOXYRIBONUCLEIC ACID 1DCV ; 2.50 ; B-DEOXYRIBONUCLEIC ACID DECAMER WITH CENTRAL TA DINUCLEOTIDE 1EI4 ; 1.43 ; B-DEOXYRIBONUCLEIC ACID DODECAMER CGCGAAT(TLC)CGCG WITH INCORPORATED [3.3.0]BICYCLO-ARABINO-THYMINE-5'-PHOSPHATE 1QV4 ; 2.50 ; B-DEOXYRIBONUCLEIC ACID DODECAMER CGTGAATTCACG COMPLEXED WITH MINOR GROOVE BINDER METHYLPROAMINE 1QV8 ; 2.50 ; B-DEOXYRIBONUCLEIC ACID DODECAMER D(CGCGAATTCGCG)2 COMPLEXED WITH PROAMINE 1DPN ; 0.95 ; B-DODECAMER CGCGAA(TAF)TCGCG WITH INCORPORATED 2'-DEOXY-2'- FLUORO-ARABINO-FURANOSYL THYMINE 1GNX ; 1.68 ; B-GLUCOSIDASE FROM STREPTOMYCES SP 1GON ; 2.20 ; B-GLUCOSIDASE FROM STREPTOMYCES SP 1A6U ; 2.00 ; B1-8 FV FRAGMENT 1A6V ; 1.80 ; B1-8 FV FRAGMENT COMPLEXED WITH A (4-HYDROXY-3-NITROPHENYL) ACETATE COMPOUND 1A6W ; 1.80 ; B1-8 FV FRAGMENT COMPLEXED WITH A (4-HYDROXY-5-IODO-3-NITROPHENYL) ACETATE COMPOUND 2BLK ; 2.30 ; B116 OF SULFOLOBUS TURRETED ICOSAHEDRAL VIRUS (STIV) 1JY4 ; -1.00 ; B4DIMER: A DE NOVO DESIGNED EIGHT-STRANDED BETA-SHEET ASSEMBLED USING A DISULFIDE BOND 1JY6 ; -1.00 ; B4DIMERA: A DE NOVO DESIGNED FOUR-STRANDED BETA-SHEET ASSEMBLED USING A DISULFIDE BOND 1W51 ; 2.55 ; BACE (BETA SECRETASE) IN COMPLEX WITH A NANOMOLAR NON- PEPTIDIC INHIBITOR 1HZ9 ; 1.80 ; BACILLUS CALDOLYTICUS COLD-SHOCK PROTEIN MUTANTS TO STUDY DETERMINANTS OF PROTEIN STABILITY 1HZA ; 1.80 ; BACILLUS CALDOLYTICUS COLD-SHOCK PROTEIN MUTANTS TO STUDY DETERMINANTS OF PROTEIN STABILITY 1HZB ; 1.28 ; BACILLUS CALDOLYTICUS COLD-SHOCK PROTEIN MUTANTS TO STUDY DETERMINANTS OF PROTEIN STABILITY 1HZC ; 1.32 ; BACILLUS CALDOLYTICUS COLD-SHOCK PROTEIN MUTANTS TO STUDY DETERMINANTS OF PROTEIN STABILITY 1I5F ; 1.40 ; BACILLUS CALDOLYTICUS COLD-SHOCK PROTEIN MUTANTS TO STUDY DETERMINANTS OF PROTEIN STABILITY 1B90 ; 2.50 ; BACILLUS CEREUS BETA-AMYLASE APO FORM 1B9Z ; 2.10 ; BACILLUS CEREUS BETA-AMYLASE COMPLEXED WITH MALTOSE 2BG8 ; 2.50 ; BACILLUS CEREUS METALLO-BETA-LACTAMASE (BCII) ARG (121) CYS MUTANT. SOLVED AT PH4.5 USING 20 MICROMOLAR ZNSO4 IN THE BUFFER. 1MM DTT AND 1MM TCEP-HCL WERE USED AS REDUCING AGENTS. 2BG7 ; 2.10 ; BACILLUS CEREUS METALLO-BETA-LACTAMASE (BCII) ARG (121) CYS MUTANT. SOLVED AT PH4.5 USING 20 MICROMOLAR ZNSO4 IN THE BUFFER. 1MM DTT WAS USED AS A REDUCING AGENT. CYS221 IS OXIDIZED. 2BFZ ; 2.30 ; BACILLUS CEREUS METALLO-BETA-LACTAMASE (BCII) ARG (121) CYS MUTANT. SOLVED AT PH4.5 USING 20MM ZNSO4 IN BUFFER. 1MM DTT WAS USED AS A REDUCING AGENT. CYS221 IS OXIDIZED. 2BG2 ; 2.40 ; BACILLUS CEREUS METALLO-BETA-LACTAMASE (BCII) ARG (121) CYS MUTANT. SOLVED AT PH4.5 USING 20MM ZNSO4 IN THE BUFFER. 1MM DTT AND 1MM TCEP-HCL WERE USED AS REDUCING AGENTS. CYS221 IS REDUCED. 2BG6 ; 2.30 ; BACILLUS CEREUS METALLO-BETA-LACTAMASE (BCII) ARG (121) CYS MUTANT. SOLVED AT PH5 USING 20 MICROMOLAR ZNSO4 IN THE BUFFER. 1MM DTT WAS USED AS A REDUCING AGENT. CYS221 IS OXIDIZED. 2BFL ; 1.80 ; BACILLUS CEREUS METALLO-BETA-LACTAMASE (BCII) ARG (121) CYS MUTANT. SOLVED AT PH5 USING 20MM ZNSO4 IN BUFFER. 1MM DTT WAS USED AS A REDUCING AGENT. 2BGA ; 2.70 ; BACILLUS CEREUS METALLO-BETA-LACTAMASE (BCII) ARG (121) CYS MUTANT. SOLVED AT PH7 USING 20 MICROMOLAR ZNSO4 IN THE BUFFER. 1MM DTT WAS USED AS A REDUCING AGENT. CYS221 IS OXIDIZED. 2BFK ; 2.00 ; BACILLUS CEREUS METALLO-BETA-LACTAMASE (BCII) ARG (121) CYS MUTANT. SOLVED AT PH7 USING 20MM ZNSO4 IN BUFFER. 1MM DTT WAS USED AS A REDUCING AGENT 1OT1 ; 2.00 ; BACILLUS CIRCULANS STRAIN 251 CYCLODEXTRIN GLYCOSYL TRANSFERASE MUTANT D135A 1OT2 ; 2.10 ; BACILLUS CIRCULANS STRAIN 251 CYCLODEXTRIN GLYCOSYL TRANSFERASE MUTANT D135N 1KCK ; 2.43 ; BACILLUS CIRCULANS STRAIN 251 CYCLODEXTRIN GLYCOSYL TRANSFERASE MUTANT N193G 1EO5 ; 2.00 ; BACILLUS CIRCULANS STRAIN 251 CYCLODEXTRIN GLYCOSYLTRANSFERASE IN COMPLEX WITH MALTOHEPTAOSE 1EO7 ; 2.48 ; BACILLUS CIRCULANS STRAIN 251 CYCLODEXTRIN GLYCOSYLTRANSFERASE IN COMPLEX WITH MALTOHEXAOSE 1DTU ; 2.40 ; BACILLUS CIRCULANS STRAIN 251 CYCLODEXTRIN GLYCOSYLTRANSFERASE: A MUTANT Y89D/S146P COMPLEXED TO AN HEXASACCHARIDE INHIBITOR 1PJ9 ; 2.00 ; BACILLUS CIRCULANS STRAIN 251 LOOP MUTANT 183-195 1PEZ ; 2.32 ; BACILLUS CIRCULANS STRAIN 251 MUTANT A230V 1KCL ; 1.94 ; BACILLUS CIRUCLANS STRAIN 251 CYCLODEXTRIN GLYCOSYL TRANSFERASE MUTANT G179L 1W9X ; 2.10 ; BACILLUS HALMAPALUS ALPHA AMYLASE 1ZBI ; 1.85 ; BACILLUS HALODURANS RNASE H CATALYTIC DOMAIN MUTANT D132N IN COMPLEX WITH 12-MER RIBONUCLEIC ACID/DEOXYRIBONUCLEIC ACID HYBRID 1ZBL ; 2.20 ; BACILLUS HALODURANS RNASE H CATALYTIC DOMAIN MUTANT D192N IN COMPLEX WITH 12-MER RIBONUCLEIC ACID/DEOXYRIBONUCLEIC ACID HYBRID 1C9N ; 1.50 ; BACILLUS LENTUS SUBSTILISIN VARIANT (SER 87) K27R/V104Y/N123S/T274A 1NDQ ; 1.80 ; BACILLUS LENTUS SUBTILISIN 1C9J ; 1.80 ; BACILLUS LENTUS SUBTILISIN K27R/N87S/V104Y/N123S/T274A VARIANT 1NDU ; 1.60 ; BACILLUS LENTUS SUBTILISIN VARIANT S101G/V104N 1C9M ; 1.67 ; BACILLUS LENTUS SUBTILSIN (SER 87) N76D/S103A/V104I 1BLI ; 1.90 ; BACILLUS LICHENIFORMIS ALPHA-AMYLASE 1GBG ; 1.80 ; BACILLUS LICHENIFORMIS BETA-GLUCANASE 1XWL ; 1.70 ; BACILLUS STEAROTHERMOPHILUS (NEWLY IDENTIFIED STRAIN AS YET UNNAMED) DEOXYRIBONUCLEIC ACID POLYMERASE FRAGMENT 1ZIP ; 1.85 ; BACILLUS STEAROTHERMOPHILUS ADENYLATE KINASE 1HVX ; 2.00 ; BACILLUS STEAROTHERMOPHILUS ALPHA-AMYLASE 1JQA ; 2.05 ; BACILLUS STEAROTHERMOPHILUS GLYCEROL DEHYDROGENASE COMPLEX WITH GLYCEROL 1JQ5 ; 1.70 ; BACILLUS STEAROTHERMOPHILUS GLYCEROL DEHYDROGENASE COMPLEX WITH NAD+ 1H2E ; 1.69 ; BACILLUS STEAROTHERMOPHILUS PHOE (PREVIOUSLY KNOWN AS YHFR) IN COMPLEX WITH PHOSPHATE 1H2F ; 2.00 ; BACILLUS STEAROTHERMOPHILUS PHOE (PREVIOUSLY KNOWN AS YHFR) IN COMPLEX WITH TRIVANADATE 1EBB ; 2.30 ; BACILLUS STEAROTHERMOPHILUS YHFR 1UVW ; 2.45 ; BACILLUS SUBTILIS COTA LACCASE ADDUCT WITH ABTS 1UX1 ; 2.36 ; BACILLUS SUBTILIS CYTIDINE DEAMINASE WITH A CYS53HIS AND AN ARG56GLN SUBSTITUTION 1UWZ ; 1.99 ; BACILLUS SUBTILIS CYTIDINE DEAMINASE WITH AN ARG56 - ALA SUBSTITUTION 1UX0 ; 1.99 ; BACILLUS SUBTILIS CYTIDINE DEAMINASE WITH AN ARG56 - GLN SUBSTITUTION 1R4Z ; 1.80 ; BACILLUS SUBTILIS LIPASE A WITH COVALENTLY BOUND RC-IPG- PHOSPHONATE-INHIBITOR 1R50 ; 1.45 ; BACILLUS SUBTILIS LIPASE A WITH COVALENTLY BOUND SC-IPG- PHOSPHONATE-INHIBITOR 1ON1 ; 1.75 ; BACILLUS SUBTILIS MANGANESE TRANSPORT REGULATOR (MNTR) BOUND TO MANGANESE 1ON2 ; 1.61 ; BACILLUS SUBTILIS MANGANESE TRANSPORT REGULATOR (MNTR), D8M MUTANT, BOUND TO MANGANESE 1BN8 ; 1.80 ; BACILLUS SUBTILIS PECTATE LYASE 2BSP ; 1.80 ; BACILLUS SUBTILIS PECTATE LYASE R279K MUTANT 1QD9 ; 1.70 ; BACILLUS SUBTILIS YABJ 1WAC ; 3.00 ; BACK-PRIMING MODE OF PHI6 RIBONUCLEIC ACID-DEPENDENT RIBONUCLEIC ACID POLYMERASE 1FH1 ; -1.00 ; BACKBONE FOLD OF NODF 1RWD ; -1.00 ; BACKBONE NMR STRUCTURE OF A MUTANT P. FURIOSUS RUBREDOXIN USING RESIDUAL DIPOLAR COUPLINGS 1RWS ; -1.00 ; BACKBONE SOLUTION STRUCTURE OF MIXED ALPHA/BETA PROTEIN PF1061 1SF0 ; -1.00 ; BACKBONE SOLUTION STRUCTURE OF MIXED ALPHA/BETA PROTEIN PF1061 1XGF ; 2.61 ; BACKBONE STRUCTURE OF COCOSIN, AN 11S STORAGE PROTEIN FROM COCOS NUCIFERA 1L7V ; 3.20 ; BACTERIAL ABC TRANSPORTER INVOLVED IN B12 UPTAKE 1QBB ; 2.00 ; BACTERIAL CHITOBIASE COMPLEXED WITH CHITOBIOSE (DINAG) 1QBA ; 1.85 ; BACTERIAL CHITOBIASE, GLYCOSYL HYDROLASE FAMILY 20 1JU4 ; 1.63 ; BACTERIAL COCAINE ESTERASE COMPLEX WITH PRODUCT 1JU3 ; 1.58 ; BACTERIAL COCAINE ESTERASE COMPLEX WITH TRANSITION STATE ANALOG 1E9R ; 2.40 ; BACTERIAL CONJUGATIVE COUPLING PROTEIN TRWBDELTAN70. TRIGONAL FORM IN COMPLEX WITH SULPHATE. 1E9S ; 2.50 ; BACTERIAL CONJUGATIVE COUPLING PROTEIN TRWBDELTAN70. UNBOUND MONOCLINIC FORM. 1RA5 ; 1.40 ; BACTERIAL CYTOSINE DEAMINASE D314A MUTANT BOUND TO 5-FLUORO- 4-(S)-HYDROXYL-3,4-DIHYDROPYRIMIDINE. 1R9Y ; 1.57 ; BACTERIAL CYTOSINE DEAMINASE D314A MUTANT. 1RA0 ; 1.12 ; BACTERIAL CYTOSINE DEAMINASE D314G MUTANT BOUND TO 5-FLUORO- 4-(S)-HYDROXY-3,4-DIHYDROPYRIMIDINE. 1R9X ; 1.58 ; BACTERIAL CYTOSINE DEAMINASE D314G MUTANT. 1RAK ; 1.32 ; BACTERIAL CYTOSINE DEAMINASE D314S MUTANT BOUND TO 5-FLUORO- 4-(S)-HYDROXYL-3,4-DIHYDROPYRIMIDINE. 1R9Z ; 1.32 ; BACTERIAL CYTOSINE DEAMINASE D314S MUTANT. 1VHB ; 1.83 ; BACTERIAL DIMERIC HEMOGLOBIN FROM VITREOSCILLA STERCORARIA 1LZL ; 1.30 ; BACTERIAL HEROIN ESTERASE 1LZK ; 1.45 ; BACTERIAL HEROIN ESTERASE COMPLEX WITH TRANSITION STATE ANALOG DIMETHYLARSENIC ACID 1LUC ; 1.50 ; BACTERIAL LUCIFERASE 1XKJ ; 2.50 ; BACTERIAL LUCIFERASE BETA2 HOMODIMER 1GYZ ; -1.00 ; BACTERIAL RIBOSOMAL PROTEIN L20 FROM AQUIFEX AEOLICUS 1PED ; 2.15 ; BACTERIAL SECONDARY ALCOHOL DEHYDROGENASE (APO-FORM) 1NBC ; 1.80 ; BACTERIAL TYPE 3A CELLULOSE-BINDING DOMAIN 1MPA ; 2.60 ; BACTERICIDAL ANTIBODY AGAINST NEISSERIA MENINGITIDIS 2MPA ; 2.60 ; BACTERICIDAL ANTIBODY AGAINST NEISSERIA MENINGITIDIS 4BCL ; 1.90 ; BACTERIOCHLOROPHYLL CONTAINING PROTEIN 1GAV ; 3.40 ; BACTERIOPHAGE GA PROTEIN CAPSID 1HJI ; -1.00 ; BACTERIOPHAGE HK022 NUN-PROTEIN-NUTBOXB-RIBONUCLEIC ACID COMPLEX 1RH6 ; 1.70 ; BACTERIOPHAGE LAMBDA EXCISIONASE (XIS)-DEOXYRIBONUCLEIC ACID COMPLEX 1C5E ; 1.10 ; BACTERIOPHAGE LAMBDA HEAD PROTEIN D 1D9U ; 2.60 ; BACTERIOPHAGE LAMBDA LYSOZYME COMPLEXED WITH A CHITOHEXASACHARIDE 1QFQ ; -1.00 ; BACTERIOPHAGE LAMBDA N-PROTEIN-NUTBOXB-RIBONUCLEIC ACID COMPLEX 1G5B ; 2.15 ; BACTERIOPHAGE LAMBDA SER/THR PROTEIN PHOSPHATASE 1BCO ; 2.40 ; BACTERIOPHAGE MU TRANSPOSASE CORE DOMAIN 1BCM ; 2.80 ; BACTERIOPHAGE MU TRANSPOSASE CORE DOMAIN WITH 2 MONOMERS PER ASYMMETRIC UNIT 1QBE ; 3.50 ; BACTERIOPHAGE Q BETA CAPSID 1N80 ; 2.45 ; BACTERIOPHAGE T4 BASEPLATE STRUCTURAL PROTEIN GP8 1N8B ; 2.90 ; BACTERIOPHAGE T4 BASEPLATE STRUCTURAL PROTEIN GP8 1YUE ; 2.90 ; BACTERIOPHAGE T4 CAPSID VERTEX PROTEIN GP24 1C1K ; 1.45 ; BACTERIOPHAGE T4 GENE 59 HELICASE ASSEMBLY PROTEIN 1QEX ; 2.30 ; BACTERIOPHAGE T4 GENE PRODUCT 9 (GP9), THE TRIGGER OF TAIL CONTRACTION AND THE LONG TAIL FIBERS CONNECTOR 1S2E ; 2.30 ; BACTERIOPHAGE T4 GENE PRODUCT 9 (GP9), THE TRIGGER OF TAIL CONTRACTION AND THE LONG TAIL FIBERS CONNECTOR, ALTERNATIVE FIT OF THE FIRST 19 RESIDUES 256L ; 1.80 ; BACTERIOPHAGE T4 LYSOZYME 1D9W ; 1.70 ; BACTERIOPHAGE T4 LYSOZYME MUTANT 4RNP ; 3.00 ; BACTERIOPHAGE T7 RIBONUCLEIC ACID POLYMERASE, HIGH SALT CRYSTAL FORM, LOW TEMPERATURE DATA, ALPHA-CARBONS ONLY 1PY6 ; 1.80 ; BACTERIORHODOPSIN CRYSTALLIZED FROM BICELLS 1XJI ; 2.20 ; BACTERIORHODOPSIN CRYSTALLIZED IN BICELLES AT ROOM TEMPERATURE 1JV6 ; 2.00 ; BACTERIORHODOPSIN D85S/F219L DOUBLE MUTANT AT 2.00 ANGSTROM RESOLUTION 1C8R ; 1.80 ; BACTERIORHODOPSIN D96M BR STATE AT 2.0 A RESOLUTION 1C8S ; 2.00 ; BACTERIORHODOPSIN D96N LATE M STATE INTERMEDIATE 1M0K ; 1.43 ; BACTERIORHODOPSIN K INTERMEDIATE AT 1.43 A RESOLUTION 1O0A ; 1.62 ; BACTERIORHODOPSIN L INTERMEDIATE AT 1.62 A RESOLUTION 1M0M ; 1.43 ; BACTERIORHODOPSIN M1 INTERMEDIATE AT 1.43 A RESOLUTION 1P8H ; 1.52 ; BACTERIORHODOPSIN M1 INTERMEDIATE PRODUCED AT ROOM TEMPERATURE 1P8U ; 1.62 ; BACTERIORHODOPSIN N' INTERMEDIATE AT 1.62 A RESOLUTION 1JV7 ; 2.25 ; BACTERIORHODOPSIN O-LIKE INTERMEDIATE STATE OF THE D85S MUTANT AT 2.25 ANGSTROM RESOLUTION 1F50 ; 1.70 ; BACTERIORHODOPSIN-BR STATE OF THE E204Q MUTANT AT 1.7 ANGSTROM RESOLUTION 1F4Z ; 1.80 ; BACTERIORHODOPSIN-M PHOTOINTERMEDIATE STATE OF THE E204Q MUTANT AT 1.8 ANGSTROM RESOLUTION 1BRX ; 2.30 ; BACTERIORHODOPSIN/LIPID COMPLEX 1M0L ; 1.47 ; BACTERIORHODOPSIN/LIPID COMPLEX AT 1.47 A RESOLUTION 1C3W ; 1.55 ; BACTERIORHODOPSIN/LIPID COMPLEX AT 1.55 A RESOLUTION 1I6Z ; -1.00 ; BAG DOMAIN OF BAG1 COCHAPERONE 1HHU ; 0.89 ; BALHIMYCIN IN COMPLEX WITH D-ALA-D-ALA 1GO6 ; 0.98 ; BALHIMYCIN IN COMPLEX WITH LYS-D-ALA-D-ALA 2BMY ; 2.50 ; BANANA LECTIN 2BN0 ; 2.80 ; BANANA LECTIN BOUND TO LAMINARIBIOSE 2BMZ ; 2.40 ; BANANA LECTIN BOUND TO XYL-B1,3 MAN-A-O-METHYL (XM) 1C40 ; 2.30 ; BAR-HEADED GOOSE HEMOGLOBIN (AQUOMET FORM) 1A4F ; 2.00 ; BAR-HEADED GOOSE HEMOGLOBIN (OXY FORM) 1AQ0 ; 2.00 ; BARLEY 1,3-1,4-BETA-GLUCANASE IN MONOCLINIC SPACE GROUP 1BG9 ; 2.80 ; BARLEY ALPHA-AMYLASE WITH SUBSTRATE ANALOGUE ACARBOSE 1LIP ; -1.00 ; BARLEY LIPID TRANSFER PROTEIN (NMR, 4 STRUCTURES) 1BNR ; -1.00 ; BARNASE 1BNE ; 2.10 ; BARNASE A43C/S80C DISULFIDE MUTANT 1BRI ; 1.90 ; BARNASE MUTANT WITH ILE 76 REPLACED BY ALA 1BRJ ; 2.00 ; BARNASE MUTANT WITH ILE 88 REPLACED BY ALA 1BRK ; 2.00 ; BARNASE MUTANT WITH ILE 96 REPLACED BY ALA 1BRH ; 2.00 ; BARNASE MUTANT WITH LEU 14 REPLACED BY ALA 1BNG ; 2.10 ; BARNASE S85C/H102C DISULFIDE MUTANT 1BNF ; 2.00 ; BARNASE T70C/S92C DISULFIDE MUTANT 1A2P ; 1.50 ; BARNASE WILDTYPE STRUCTURE AT 1.5 ANGSTROMS RESOLUTION 1BNI ; 2.10 ; BARNASE WILDTYPE STRUCTURE AT PH 6.0 1B2X ; 1.80 ; BARNASE WILDTYPE STRUCTURE AT PH 7.5 FROM A CRYO_COOLED CRYSTAL AT 100K 1BNJ ; 2.10 ; BARNASE WILDTYPE STRUCTURE AT PH 9.0 1A19 ; 2.76 ; BARSTAR (FREE), C82A MUTANT 206D ; 2.50 ; BASE-PAIR OPENING AND SPERMINE BINDING - B-DEOXYRIBONUCLEIC ACID FEATURES DISPLAYED IN THE CRYSTAL STRUCTURE OF A GAL OPERON FRAGMENT: IMPLICATIONS FOR PROTEIN-DEOXYRIBONUCLEIC ACID RECOGNITION 1QP5 ; 2.60 ; BASE-PAIRING SHIFT IN A DODECAMER CONTAINING A (CA)N TRACT 330D ; 2.70 ; BASE-PAIRING SHIFT IN THE MAJOR GROOVE OF (CA)N TRACTS BY B-DEOXYRIBONUCLEIC ACID CRYSTAL STRUCTURES 1BLA ; -1.00 ; BASIC FIBROBLAST GROWTH FACTOR (FGF-2) MUTANT WITH CYS 78 REPLACED BY SER AND CYS 96 REPLACED BY SER, NMR 1BLD ; -1.00 ; BASIC FIBROBLAST GROWTH FACTOR (FGF-2) MUTANT WITH CYS 78 REPLACED BY SER AND CYS 96 REPLACED BY SER, NMR 1BFC ; 2.20 ; BASIC FIBROBLAST GROWTH FACTOR COMPLEXED WITH HEPARIN HEXAMER FRAGMENT 1BFB ; 1.90 ; BASIC FIBROBLAST GROWTH FACTOR COMPLEXED WITH HEPARIN TETRAMER FRAGMENT 1B4W ; 2.60 ; BASIC PHOSPHOLIPASE A2 FROM AGKISTRODON HALYS PALLAS- IMPLICATIONS FOR ITS ASSOCIATION AND ANTICOAGULANT ACTIVITIES BY X-RAY CRYSTALLOGRAPHY 1PVP ; 2.35 ; BASIS FOR A SWITCH IN SUBSTRATE SPECIFICITY: CRYSTAL STRUCTURE OF SELECTED VARIANT OF CRE SITE-SPECIFIC RECOMBINASE, ALSHG BOUND TO THE ENGINEERED RECOGNITION SITE LOXM7 1PVQ ; 2.75 ; BASIS FOR A SWITCH IN SUBSTRATE SPECIFICITY: CRYSTAL STRUCTURE OF SELECTED VARIANT OF CRE SITE-SPECIFIC RECOMBINASE, LNSGG BOUND TO THE ENGINEERED RECOGNITION SITE LOXM7 1PVR ; 2.65 ; BASIS FOR A SWITCH IN SUBSTRATE SPECIFICITY: CRYSTAL STRUCTURE OF SELECTED VARIANT OF CRE SITE-SPECIFIC RECOMBINASE, LNSGG BOUND TO THE LOXP (WILDTYPE) RECOGNITION SITE 1W33 ; 2.70 ; BBCRASP-1 FROM BORRELIA BURGDORFERI 1PGL ; 2.80 ; BEAN POD MOTTLE VIRUS (BPMV), MIDDLE COMPONENT 1PGW ; 2.90 ; BEAN POD MOTTLE VIRUS (BPMV), TOP COMPONENT 1ZES ; 1.90 ; BEF3- ACTIVATED PHOB RECEIVER DOMAIN 1LIL ; 2.65 ; BENCE JONES PROTEIN CLE, A LAMBDA III IMMUNOGLOBULIN LIGHT-CHAIN DIMER 1B6D ; 2.74 ; BENCE JONES PROTEIN DEL: AN ENTIRE IMMUNOGLOBULIN KAPPA LIGHT-CHAIN DIMER 1BWW ; 1.70 ; BENCE-JONES IMMUNOGLOBULIN REI VARIABLE PORTION, T39K MUTANT 1V2V ; 1.80 ; BENZAMIDINE IN COMPLEX WITH BOVINE TRYPSIN VARIANT X(SSAI) BT.C1 1V2S ; 1.72 ; BENZAMIDINE IN COMPLEX WITH BOVINE TRYPSIN VARIANT X(SSFI.GLU)BT.D1 1V2J ; 1.90 ; BENZAMIDINE IN COMPLEX WITH BOVINE TRYPSIN VARIANT X(SSRI) BT.C1 1V2M ; 1.65 ; BENZAMIDINE IN COMPLEX WITH BOVINE TRYPSIN VARIANT X(TRIPLE.GLU)BT.A1 1V2L ; 1.60 ; BENZAMIDINE IN COMPLEX WITH BOVINE TRYPSIN VARIANT X(TRIPLE.GLU)BT.D1 1V2U ; 1.80 ; BENZAMIDINE IN COMPLEX WITH BOVINE TRYPSIN VARINAT X(SSAI) BT.D1 1J15 ; 2.00 ; BENZAMIDINE IN COMPLEX WITH RAT TRYPSIN MUTANT X99/175/190RT 1J16 ; 1.60 ; BENZAMIDINE IN COMPLEX WITH RAT TRYPSIN MUTANT X99/175/190RT 1J14 ; 2.40 ; BENZAMIDINE IN COMPLEX WITH RAT TRYPSIN MUTANT X99RT 1BFD ; 1.60 ; BENZOYLFORMATE DECARBOXYLASE FROM PSEUDOMONAS PUTIDA 1MCZ ; 2.80 ; BENZOYLFORMATE DECARBOXYLASE FROM PSEUDOMONAS PUTIDA COMPLEXED WITH AN INHIBITOR, R-MANDELATE 1DXA ; -1.00 ; BENZO[A]PYRENE DIOL EPOXIDE ADDUCT OF DA IN DUPLEX DEOXYRIBONUCLEIC ACID 1BMA ; 1.80 ; BENZYL METHYL AMINIMIDE INHIBITOR COMPLEXED TO PORCINE PANCREATIC ELASTASE 1EH8 ; 2.50 ; BENZYLATED HUMAN O6-ALKYLGUANINE-DEOXYRIBONUCLEIC ACID ALKYLTRANSFERASE 1W0J ; 2.20 ; BERYLLIUM FLUORIDE INHIBITED BOVINE F1-ATPASE 1W0K ; 2.85 ; BERYLLIUM FLUORIDE INHIBITED BOVINE F1-ATPASE 1HO9 ; -1.00 ; BEST 20 NMR CONFORMERS OF D130I MUTANT T3-I2, A 32 RESIDUE PEPTIDE FROM THE ALPHA 2A ADRENERGIC RECEPTOR 1GX7 ; -1.00 ; BEST MODEL OF THE ELECTRON TRANSFER COMPLEX BETWEEN CYTOCHROME C3 AND [FE]-HYDROGENASE 1BEC ; 1.70 ; BETA CHAIN OF A T CELL ANTIGEN RECEPTOR 1C4P ; 2.40 ; BETA DOMAIN OF STREPTOKINASE 1CPX ; 2.00 ; BETA FORM OF CARBOXYPEPTIDASE A (RESIDUES 3-307) FROM BOVINE PANCREAS IN AN ORTHORHOMBIC CRYSTAL FORM WITH TWO ZINC IONS IN THE ACTIVE SITE. 2BV2 ; 1.55 ; BETA GAMMA CRYSTALLIN FROM CIONA INTESTINALIS 1E5M ; 1.54 ; BETA KETOACYL ACYL CARRIER PROTEIN SYNTHASE II (KASII) FROM SYNECHOCYSTIS SP. 2AK5 ; 1.85 ; BETA PIX-SH3 COMPLEXED WITH A CBL-B PEPTIDE 1ZSG ; -1.00 ; BETA PIX-SH3 COMPLEXED WITH AN ATYPICAL PEPTIDE FROM ALPHA- PAK 1NWG ; 2.32 ; BETA-1,4-GALACTOSYLTRANSFERASE COMPLEX WITH ALPHA- LACTALBUMIN AND N-BUTANOYL-GLUCOAMINE 1NMM ; 2.00 ; BETA-1,4-GALACTOSYLTRANSFERASE MUTANT CYS342THR COMPLEX WITH ALPHA-LACTALBUMIN AND GLCNAC 1TW1 ; 2.30 ; BETA-1,4-GALACTOSYLTRANSFERASE MUTANT MET344HIS (M344H-GAL- T1) COMPLEX WITH UDP-GALACTOSE AND MAGNESIUM 1TVY ; 2.30 ; BETA-1,4-GALACTOSYLTRANSFERASE MUTANT MET344HIS (M344H-GAL- T1) COMPLEX WITH UDP-GALACTOSE AND MANGANESE 1EXP ; 1.80 ; BETA-1,4-GLYCANASE CEX-CD 1XNK ; 1.55 ; BETA-1,4-XYLANASE FROM CHAETOMIUM THERMOPHILUM COMPLEXED WITH METHYL THIOXYLOPENTOSIDE 5BCA ; 2.20 ; BETA-AMYLASE FROM BACILLUS CEREUS VAR. MYCOIDES 1ITC ; 2.10 ; BETA-AMYLASE FROM BACILLUS CEREUS VAR. MYCOIDES COMPLEXED WITH MALTOPENTAOSE 1J12 ; 2.10 ; BETA-AMYLASE FROM BACILLUS CEREUS VAR. MYCOIDES IN COMPLEX WITH ALPHA-EBG 1J11 ; 2.00 ; BETA-AMYLASE FROM BACILLUS CEREUS VAR. MYCOIDES IN COMPLEX WITH ALPHA-EPG 1J10 ; 2.10 ; BETA-AMYLASE FROM BACILLUS CEREUS VAR. MYCOIDES IN COMPLEX WITH GGX 1J0Y ; 2.10 ; BETA-AMYLASE FROM BACILLUS CEREUS VAR. MYCOIDES IN COMPLEX WITH GLUCOSE 1J0Z ; 2.20 ; BETA-AMYLASE FROM BACILLUS CEREUS VAR. MYCOIDES IN COMPLEX WITH MALTOSE 1BFN ; 2.07 ; BETA-AMYLASE/BETA-CYCLODEXTRIN COMPLEX 1E0R ; 2.80 ; BETA-APICAL DOMAIN OF THERMOSOME 1M1E ; 2.10 ; BETA-CATENIN ARMADILLO REPEAT DOMAIN BOUND TO ICAT 1QZ7 ; 2.20 ; BETA-CATENIN BINDING DOMAIN OF AXIN IN COMPLEX WITH BETA- CATENIN 1TH1 ; 2.50 ; BETA-CATENIN IN COMPLEX WITH A PHOSPHORYLATED APC 20AA REPEAT FRAGMENT 1I7X ; 3.00 ; BETA-CATENIN/E-CADHERIN COMPLEX 1I7W ; 2.00 ; BETA-CATENIN/PHOSPHORYLATED E-CADHERIN COMPLEX 1BEO ; 2.20 ; BETA-CRYPTOGEIN 1LRI ; 1.45 ; BETA-CRYPTOGEIN-CHOLESTEROL COMPLEX 1EX1 ; 2.20 ; BETA-D-GLUCAN EXOHYDROLASE FROM BARLEY 1YI7 ; 1.90 ; BETA-D-XYLOSIDASE (SELENOMETHIONINE) XYND FROM CLOSTRIDIUM ACETOBUTYLICUM 1Y7B ; 1.60 ; BETA-D-XYLOSIDASE, A FAMILY 43 GLYCOSIDE HYDROLASE 1W2T ; 1.87 ; BETA-FRUCTOSIDASE FROM THERMOTOGA MARITIMA IN COMPLEX WITH RAFFINOSE 1BGL ; 2.50 ; BETA-GALACTOSIDASE (CHAINS A-H) 1BGM ; 2.50 ; BETA-GALACTOSIDASE (CHAINS I-P) 1YQ2 ; 1.90 ; BETA-GALACTOSIDASE FROM ARTHROBACTER SP. C2-2 (ISOENZYME C2- 2-1) 1TBG ; 2.10 ; BETA-GAMMA DIMER OF THE HETEROTRIMERIC G-PROTEIN TRANSDUCIN 1BGA ; 2.40 ; BETA-GLUCOSIDASE A FROM BACILLUS POLYMYXA 1QOX ; 2.70 ; BETA-GLUCOSIDASE FROM BACILLUS CIRCULANS SP. ALKALOPHILUS 1VFF ; 2.50 ; BETA-GLYCOSIDASE FROM PYROCOCCUS HORIKOSHII 1GOW ; 2.60 ; BETA-GLYCOSIDASE FROM SULFOLOBUS SOLFATARICUS 1B3N ; 2.65 ; BETA-KETOACYL CARRIER PROTEIN SYNTHASE AS A DRUG TARGET, IMPLICATIONS FROM THE CRYSTAL STRUCTURE OF A COMPLEX WITH THE INHIBITOR CERULENIN. 1EK4 ; 1.85 ; BETA-KETOACYL [ACYL CARRIER PROTEIN] SYNTHASE I IN COMPLEX WITH DODECANOIC ACID TO 1.85 RESOLUTION 1KAS ; 2.40 ; BETA-KETOACYL-ACP SYNTHASE II FROM ESCHERICHIA COLI 1F91 ; 2.40 ; BETA-KETOACYL-[ACYL-CARRIER-PROTEIN] SYNTHASE I IN COMPLEX WITH C10 FATTY ACID SUBSTRATE 1M1Z ; 1.95 ; BETA-LACTAM SYNTHETASE APO ENZYME 1MB9 ; 2.11 ; BETA-LACTAM SYNTHETASE COMPLEXED WITH ATP 1MC1 ; 2.16 ; BETA-LACTAM SYNTHETASE WITH PRODUCT (DGPC), AMP AND PPI 1MBZ ; 2.47 ; BETA-LACTAM SYNTHETASE WITH TRAPPED INTERMEDIATE 1I2S ; 1.70 ; BETA-LACTAMASE FROM BACILLUS LICHENIFORMIS BS3 1I2W ; 1.70 ; BETA-LACTAMASE FROM BACILLUS LICHENIFORMIS BS3 COMPLEXED WITH CEFOXITIN 1MFO ; 2.40 ; BETA-LACTAMASE FROM MYCOBACTERIUM FORTUITUM 1BSG ; 1.85 ; BETA-LACTAMASE FROM STREPTOMYCES ALBUS G 1BZA ; 1.80 ; BETA-LACTAMASE TOHO-1 FROM ESCHERICHIA COLI TUH12191 1BQC ; 1.50 ; BETA-MANNANASE FROM THERMOMONOSPORA FUSCA 1CF5 ; 2.55 ; BETA-MOMORCHARIN STRUCTURE AT 2.55 A 1C7S ; 1.80 ; BETA-N-ACETYLHEXOSAMINIDASE MUTANT D539A COMPLEXED WITH DI- N-ACETYL-BETA-D-GLUCOSAMINE (CHITOBIASE) 1C7T ; 1.90 ; BETA-N-ACETYLHEXOSAMINIDASE MUTANT E540D COMPLEXED WITH DI- N ACETYL-D-GLUCOSAMINE (CHITOBIASE) 1H6L ; 1.80 ; BETA-PROPELLER PHYTASE IN COMPLEX WITH PHOSPHATE AND CALCIUM IONS 1BJU ; 1.80 ; BETA-TRYPSIN COMPLEXED WITH ACPU 1BJV ; 1.80 ; BETA-TRYPSIN COMPLEXED WITH APPU 1MAX ; 1.80 ; BETA-TRYPSIN PHOSPHONATE INHIBITED 1MAY ; 1.80 ; BETA-TRYPSIN PHOSPHONATE INHIBITED 1TW5 ; 2.30 ; BETA1,4-GALACTOSYLTRANSFERASE MUTANT M344H-GAL-T1 IN COMPLEX WITH CHITOBIOSE 1PY4 ; 2.90 ; BETA2 MICROGLOBULIN MUTANT H31Y DISPLAYS HINTS FOR AMYLOID FORMATIONS 1E42 ; 1.70 ; BETA2-ADAPTIN APPENDAGE DOMAIN, FROM CLATHRIN ADAPTOR AP2 1VYT ; 2.60 ; BETA3 SUBUNIT COMPLEXED WITH AID 1VYU ; 2.30 ; BETA3 SUBUNIT OF VOLTAGE-GATED CA2+-CHANNEL 1VYV ; 3.00 ; BETA4 SUBUNIT OF CA2+ CHANNEL 1A4S ; 2.10 ; BETAINE ALDEHYDE DEHYDROGENASE FROM COD LIVER 1BPW ; 2.80 ; BETAINE ALDEHYDE DEHYDROGENASE FROM COD LIVER 1SXP ; 2.50 ; BGT IN COMPLEX WITH A 13MER DEOXYRIBONUCLEIC ACID CONTAINING A CENTRAL A:G MISMATCH 1SXQ ; 1.80 ; BGT IN COMPLEX WITH A 13MER DEOXYRIBONUCLEIC ACID CONTAINING A CENTRAL C:G BASE PAIR AND UDP 1MQL ; 2.90 ; BHA OF UKR/63 1MQM ; 2.60 ; BHA/LSTA 1MQN ; 3.20 ; BHA/LSTC 1UMY ; 2.50 ; BHMT FROM RAT LIVER 2AB5 ; 2.20 ; BI3 LAGLIDADG MATURASE 1RNI ; 1.85 ; BIFUNCTIONAL DEOXYRIBONUCLEIC ACID PRIMASE/POLYMERASE DOMAIN OF ORF904 FROM THE ARCHAEAL PLASMID PRN1 1RO2 ; 1.60 ; BIFUNCTIONAL DEOXYRIBONUCLEIC ACID PRIMASE/POLYMERASE DOMAIN OF ORF904 FROM THE ARCHAEAL PLASMID PRN1- TRIPLE MUTANT F50M/L107M/L110M MANGANESE SOAK 1RO0 ; 1.80 ; BIFUNCTIONAL DEOXYRIBONUCLEIC ACID PRIMASE/POLYMERASE DOMAIN OF ORF904 FROM THE ARCHAEAL PLASMID PRN1- TRIPLE MUTANT F50M/L107M/L110M SEMET REMOTE 1BEA ; 1.95 ; BIFUNCTIONAL HAGEMAN FACTOR/AMYLASE INHIBITOR FROM MAIZE 1BIP ; -1.00 ; BIFUNCTIONAL PROTEINASE INHIBITOR TRYPSIN/A-AMYLASE FROM SEEDS OF RAGI (ELEUSINE CORACANA GAERTNERI) 1SKS ; 2.30 ; BINARY 3' COMPLEX OF T7 DEOXYRIBONUCLEIC ACID POLYMERASE WITH A DEOXYRIBONUCLEIC ACID PRIMER/TEMPLATE CONTAINING A CIS-SYN THYMINE DIMER ON THE TEMPLATE 1SKW ; 2.30 ; BINARY 3' COMPLEX OF T7 DEOXYRIBONUCLEIC ACID POLYMERASE WITH A DEOXYRIBONUCLEIC ACID PRIMER/TEMPLATE CONTAINING A DISORDERED CIS-SYN THYMINE DIMER ON THE TEMPLATE 1SL1 ; 2.20 ; BINARY 5' COMPLEX OF T7 DEOXYRIBONUCLEIC ACID POLYMERASE WITH A DEOXYRIBONUCLEIC ACID PRIMER/TEMPLATE CONTAINING A CIS-SYN THYMINE DIMER ON THE TEMPLATE 1EH4 ; 2.80 ; BINARY COMPLEX OF CASEIN KINASE-1 FROM S. POMBE WITH AN ATP COMPETITIVE INHIBITOR, IC261 2CSN ; 2.50 ; BINARY COMPLEX OF CASEIN KINASE-1 WITH CKI7 1CSN ; 2.00 ; BINARY COMPLEX OF CASEIN KINASE-1 WITH MGATP 2HMY ; 2.61 ; BINARY COMPLEX OF HHAI METHYLTRANSFERASE WITH ADOMET FORMED IN THE PRESENCE OF A SHORT NONPSECIFIC DEOXYRIBONUCLEIC ACID OLIGONUCLEOTIDE 1M6W ; 2.30 ; BINARY COMPLEX OF HUMAN GLUTATHIONE-DEPENDENT FORMALDEHYDE DEHYDROGENASE AND 12-HYDROXYDODECANOIC ACID 1MP0 ; 2.20 ; BINARY COMPLEX OF HUMAN GLUTATHIONE-DEPENDENT FORMALDEHYDE DEHYDROGENASE WITH NAD(H) 1JCN ; 2.50 ; BINARY COMPLEX OF HUMAN TYPE-I INOSINE MONOPHOSPHATE DEHYDROGENASE WITH 6-CL-IMP 1KDH ; 3.00 ; BINARY COMPLEX OF MURINE TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE WITH A PRIMER SINGLE STRANDED DEOXYRIBONUCLEIC ACID 1BCP ; 2.70 ; BINARY COMPLEX OF PERTUSSIS TOXIN AND ATP 1Q5M ; 1.32 ; BINARY COMPLEX OF RABBIT 20ALPHA-HYDROXYSTEROID DEHYDROGENASE WITH NADPH 4KTQ ; 2.50 ; BINARY COMPLEX OF THE LARGE FRAGMENT OF DEOXYRIBONUCLEIC ACID POLYMERASE I FROM T. AQUATICUS BOUND TO A PRIMER/TEMPLATE DEOXYRIBONUCLEIC ACID 1J8R ; 1.80 ; BINARY COMPLEX OF THE PAPG RECEPTOR-BINDING DOMAIN BOUND TO GBO4 RECEPTOR 1J1C ; 2.10 ; BINARY COMPLEX STRUCTURE OF HUMAN TAU PROTEIN KINASE I WITH ADP 1J1B ; 1.80 ; BINARY COMPLEX STRUCTURE OF HUMAN TAU PROTEIN KINASE I WITH AMPPNP 1OS9 ; 1.85 ; BINARY ENZYME-PRODUCT COMPLEXES OF HUMAN MMP12 1W73 ; 2.10 ; BINARY STRUCTURE OF HUMAN DECR SOLVED BY SEMET SAD. 1W8D ; 2.20 ; BINARY STRUCTURE OF HUMAN DECR. 1Q0S ; 2.30 ; BINARY STRUCTURE OF T4DAM WITH ADOHCY 1C47 ; 2.70 ; BINDING DRIVEN STRUCTURAL CHANGES IN CRYSTALINE PHOSPHOGLUCOMUTASE ASSOCIATED WITH CHEMICAL REACTION 1HSR ; 1.60 ; BINDING MODE OF BENZHYDROXAMIC ACID TO ARTHROMYCES RAMOSUS PEROXIDASE 1C8I ; 2.00 ; BINDING MODE OF HYDROXYLAMINE TO ARTHROMYCES RAMOSUS PEROXIDASE 1CK6 ; 1.90 ; BINDING MODE OF SALICYLHYDROXAMIC ACID TO ARTHROMYCES RAMOSUS PEROXIDASE 1KTI ; 1.97 ; BINDING OF 100 MM N-ACETYL-N'-BETA-D-GLUCOPYRANOSYL UREA TO GLYCOGEN PHOSPHORYLASE B: KINETIC AND CRYSTALLOGRAPHIC STUDIES 2PRI ; 2.30 ; BINDING OF 2-DEOXY-GLUCOSE-6-PHOSPHATE TO GLYCOGEN PHOSPHORYLASE B 1FDG ; 1.60 ; BINDING OF A MACROCYCLIC BISACRIDINE AND AMETANTRONE TO CGTACG INVOLVES SIMILAR UNUSUAL INTERCALATION PLATFORMS (AMETANTRONE COMPLEX) 1FD5 ; 1.10 ; BINDING OF A MACROCYCLIC BISACRIDINE AND AMETANTRONE TO CGTACG INVOLVES SIMILAR UNUSUAL INTERCALATION PLATFORMS (BISACRIDINE COMPLEX) 11BA ; 2.06 ; BINDING OF A SUBSTRATE ANALOGUE TO A DOMAIN SWAPPING PROTEIN IN THE COMPLEX OF BOVINE SEMINAL RIBONUCLEASE WITH URIDYLYL-2',5'-ADENOSINE 2BZS ; 2.00 ; BINDING OF ANTI-CANCER PRODRUG CB1954 TO THE ACTIVATING ENZYME NQO2 REVEALED BY THE CRYSTAL STRUCTURE OF THEIR COMPLEX. 1B0S ; -1.00 ; BINDING OF AR-1-144, A TRI-IMIDAZOLE DEOXYRIBONUCLEIC ACID MINOR GROOVE BINDER, TO CCGG SEQUENCE ANALYZED BY NMR SPECTROSCOPY 1XC7 ; 1.83 ; BINDING OF BETA-D-GLUCOPYRANOSYL BISMETHOXYPHOSPHORAMIDATE TO GLYCOGEN PHOSPHORYLASE B: KINETIC AND CRYSTALLOGRAPHIC STUDIES 2AO8 ; 2.20 ; BINDING OF CHITIN-LIKE POLYSACCHARIDE TO PROTECTIVE SIGNALLING FACTOR: CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN SIGNALLING PROTEIN FROM SHEEP (SPS-40) WITH A TETRASACCHARIDE AT 2.2 A RESOLUTION 2B2P ; 2.80 ; BINDING OF CHITIN-LIKE POLYSACCHARIDES TO PROTECTIVE SIGNALLING FACTOR: CRYSTAL STRUCTURE OF THE COMPLEX OF SIGNALLING PROTEIN FROM SHEEP (SPS-40) WITH A PENTASACCHARIDE AT 2.8 A RESOLUTION 1V5Y ; 1.90 ; BINDING OF COUMARINS TO NAD(P)H:FMN OXIDOREDUCTASE 1V5Z ; 2.00 ; BINDING OF COUMARINS TO NAD(P)H:FMN OXIDOREDUCTASE 308D ; 1.50 ; BINDING OF DAUNOMYCIN TO B-D-GLUCOSYLATED DEOXYRIBONUCLEIC ACID FOUND IN PROTOZOA TRYPANOSOMA BRUCEI STUDIED BY X-RAY CRYSTALLOGRAPHY 1C4A ; 2.40 ; BINDING OF EXOGENOUSLY ADDED CARBON MONOXIDE AT THE ACTIVE SITE OF THE FE-ONLY HYDROGENASE (CPI) FROM CLOSTRIDIUM PASTEURIANUM 1C4C ; 2.40 ; BINDING OF EXOGENOUSLY ADDED CARBON MONOXIDE AT THE ACTIVE SITE OF THE FE-ONLY HYDROGENASE (CPI) FROM CLOSTRIDIUM PASTEURIANUM 1HLF ; 2.26 ; BINDING OF GLUCOPYRANOSYLIDENE-SPIRO-THIOHYDANTOIN TO GLYCOGEN PHOSPHORYLASE B: KINETIC AND CRYSTALLOGRAPHIC STUD 1SFG ; 3.22 ; BINDING OF HEXA-N-ACETYLCHITOHEXAOSE: A POWDER DIFFRACTION STUDY 1SF6 ; 3.22 ; BINDING OF N,N',N"-TRIACETYLCHITOTRIOSE TO HEW LYSOZYME: A POWDER DIFFRACTION STUDY 1SF4 ; 2.98 ; BINDING OF N,N'-DIACETYLCHITOBIOSE TO HEW LYSOZYME: A POWDER DIFFRACTION STUDY 2PRJ ; 2.30 ; BINDING OF N-ACETYL-BETA-D-GLUCOPYRANOSYLAMINE TO GLYCOGEN PHOSPHORYLASE B 1JA2 ; 2.87 ; BINDING OF N-ACETYLGLUCOSAMINE TO CHICKEN EGG LYSOZYME: A POWDER DIFFRACTION STUDY 1JA4 ; 2.94 ; BINDING OF N-ACETYLGLUCOSAMINE TO CHICKEN EGG LYSOZYME: A POWDER DIFFRACTION STUDY 1JA6 ; 2.96 ; BINDING OF N-ACETYLGLUCOSAMINE TO CHICKEN EGG LYSOZYME: A POWDER DIFFRACTION STUDY 1JA7 ; 2.98 ; BINDING OF N-ACETYLGLUCOSAMINE TO CHICKEN EGG LYSOZYME: A POWDER DIFFRACTION STUDY 1TI0 ; 1.40 ; BINDING OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS TO PHOSPHOLIPASE A2: CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN PHOSPHOLIPASE A2 AND INDOMETHACIN AT 1.4A RESOLUTION. 1W4O ; 1.60 ; BINDING OF NONNATURAL 3'-NUCLEOTIDES TO RIBONUCLEASE A 1W4P ; 1.69 ; BINDING OF NONNATURAL 3'-NUCLEOTIDES TO RIBONUCLEASE A 1W4Q ; 1.68 ; BINDING OF NONNATURAL 3'-NUCLEOTIDES TO RIBONUCLEASE A 1HIY ; 2.60 ; BINDING OF NUCLEOTIDES TO NDP KINASE 1SFB ; 3.22 ; BINDING OF PENTA-N-ACETYLCHITOPENTAOSE TO HEW LYSOZYME: A POWDER DIFFRACTION STUDY 1H52 ; 2.00 ; BINDING OF PHOSPHATE AND PYROPHOSPHATE IONS AT THE ACTIVE SITE OF HUMAN ANGIOGENIN AS REVEALED BY X-RAY CRYSTALLOGRAPHY 1H53 ; 2.00 ; BINDING OF PHOSPHATE AND PYROPHOSPHATE IONS AT THE ACTIVE SITE OF HUMAN ANGIOGENIN AS REVEALED BY X-RAY CRYSTALLOGRAPHY 1HBY ; 2.00 ; BINDING OF PHOSPHATE AND PYROPHOSPHATE IONS AT THE ACTIVE SITE OF HUMAN ANGIOGENIN AS REVEALED BY X-RAY CRYSTALLOGRAPHY 1SF7 ; 3.22 ; BINDING OF TETRA-N-ACETYLCHITOTETRAOSE TO HEW LYSOZYME: A POWDER DIFFRACTION STUDY 2KCE ; 2.20 ; BINDING OF THE ANTICANCER DRUG ZD1694 TO E. COLI THYMIDYLATE SYNTHASE: ASSESSING SPECIFICITY AND AFFINITY 380D ; 2.00 ; BINDING OF THE MODIFIED DAUNORUBICIN WP401 ADJACENT TO A T-G BASE PAIR INDUCES THE REVERSE WATSON-CRICK CONFORMATION: CRYSTAL STRUCTURES OF THE WP401-TGGCCG AND WP401-CGG[BR5C]CG COMPLEXES 381D ; 2.10 ; BINDING OF THE MODIFIED DAUNORUBICIN WP401 ADJACENT TO A T-G BASE PAIR INDUCES THE REVERSE WATSON-CRICK CONFORMATION: CRYSTAL STRUCTURES OF THE WP401-TGGCCG AND WP401-CGG[BR5C]CG COMPLEXES 1T1M ; 12.00 ; BINDING POSITION OF RIBOSOME RECYCLING FACTOR (RRF) ON THE E. COLI 70S RIBOSOME 1OKX ; 2.80 ; BINDING STRUCTURE OF ELASTASE INHIBITOR SCYPTOLIN A 1UY1 ; 1.80 ; BINDING SUB-SITE DISSECTION OF A FAMILY 6 CARBOHYDRATE-BINDING MODULE BY X-RAY CRYSTALLOGRAPHY AND ISOTHERMAL TITRATION CALORIMETRY 1UY2 ; 1.70 ; BINDING SUB-SITE DISSECTION OF A FAMILY 6 CARBOHYDRATE-BINDING MODULE BY X-RAY CRYSTALLOGRAPHY AND ISOTHERMAL TITRATION CALORIMETRY 1UY3 ; 1.89 ; BINDING SUB-SITE DISSECTION OF A FAMILY 6 CARBOHYDRATE-BINDING MODULE BY X-RAY CRYSTALLOGRAPHY AND ISOTHERMAL TITRATION CALORIMETRY 1UY4 ; 1.69 ; BINDING SUB-SITE DISSECTION OF A FAMILY 6 CARBOHYDRATE-BINDING MODULE BY X-RAY CRYSTALLOGRAPHY AND ISOTHERMAL TITRATION CALORIMETRY 1H4C ; 1.65 ; BIOCHEMICAL AND STRUCTURAL ANALYSIS OF THE MOLYBDENUM COFACTOR BIOSYNTHESIS PROTEIN MOBA 1H4D ; 1.74 ; BIOCHEMICAL AND STRUCTURAL ANALYSIS OF THE MOLYBDENUM COFACTOR BIOSYNTHESIS PROTEIN MOBA 1H4E ; 1.65 ; BIOCHEMICAL AND STRUCTURAL ANALYSIS OF THE MOLYBDENUM COFACTOR BIOSYNTHESIS PROTEIN MOBA 1HJJ ; 1.65 ; BIOCHEMICAL AND STRUCTURAL ANALYSIS OF THE MOLYBDENUM COFACTOR BIOSYNTHESIS PROTEIN MOBA 1HJL ; 2.00 ; BIOCHEMICAL AND STRUCTURAL ANALYSIS OF THE MOLYBDENUM COFACTOR BIOSYNTHESIS PROTEIN MOBA 1DYW ; 1.80 ; BIOCHEMICAL AND STRUCTURAL CHARACTERIZATION OF A DIVERGENT LOOP CYCLOPHILIN FROM CAENORHABDITIS ELEGANS 2A8N ; 1.60 ; BIOCHEMICAL AND STRUCTURAL STUDIES OF A-TO-I EDITING BY TRNA:A34 DEAMINASES AT THE WOBBLE POSITION OF TRANSFER RIBONUCLEIC ACID 1N8I ; 2.10 ; BIOCHEMICAL AND STRUCTURAL STUDIES OF MALATE SYNTHASE FROM MYCOBACTERIUM TUBERCULOSIS 1N8W ; 2.70 ; BIOCHEMICAL AND STRUCTURAL STUDIES OF MALATE SYNTHASE FROM MYCOBACTERIUM TUBERCULOSIS 2HDH ; 2.20 ; BIOCHEMICAL CHARACTERIZATION AND STRUCTURE DETERMINATION OF HUMAN HEART SHORT CHAIN L-3-HYDROXYACYL COA DEHYDROGENASE PROVIDE INSIGHT INTO CATALYTIC MECHANISM 3HAD ; 2.00 ; BIOCHEMICAL CHARACTERIZATION AND STRUCTURE DETERMINATION OF HUMAN HEART SHORT CHAIN L-3-HYDROXYACYL COA DEHYDROGENASE PROVIDE INSIGHT INTO CATALYTIC MECHANISM 1N3R ; 2.80 ; BIOSYNTHESIS OF PTERIDINS. REACTION MECHANISM OF GTP CYCLOHYDROLASE I 1N3S ; 2.55 ; BIOSYNTHESIS OF PTERIDINS. REACTION MECHANISM OF GTP CYCLOHYDROLASE I 1N3T ; 3.20 ; BIOSYNTHESIS OF PTERIDINS. REACTION MECHANISM OF GTP CYCLOHYDROLASE I 1QFL ; 1.92 ; BIOSYNTHETIC THIOLASE FROM ZOOGLOEA RAMIGERA IN COMPLEX WITH A REACTION INTERMEDIATE. 1OU6 ; 2.07 ; BIOSYNTHETIC THIOLASE FROM ZOOGLOEA RAMIGERA IN COMPLEX WITH ACETYL-O-PANTETHEINE-11-PIVALATE 1DLV ; 2.29 ; BIOSYNTHETIC THIOLASE FROM ZOOGLOEA RAMIGERA IN COMPLEX WITH COA 1M3Z ; 1.87 ; BIOSYNTHETIC THIOLASE, C89A MUTANT, COMPLEXED WITH ACETYL COENZYME A 1M4S ; 1.87 ; BIOSYNTHETIC THIOLASE, CYS89 ACETYLATED, UNLIGANDED FORM 1M4T ; 1.77 ; BIOSYNTHETIC THIOLASE, CYS89 BUTYRYLATED 1M3K ; 1.70 ; BIOSYNTHETIC THIOLASE, INACTIVE C89A MUTANT 1M1T ; 1.94 ; BIOSYNTHETIC THIOLASE, Q64A MUTANT 1XNY ; 2.20 ; BIOTIN AND PROPIONYL-COA BOUND TO ACYL-COA CARBOXYLASE BETA SUBUNIT FROM S. COELICOLOR (PCCB) 1O78 ; -1.00 ; BIOTIN CARBOXYL CARRIER DOMAIN OF TRANSCARBOXYLASE (1.3S) [10-48] DELETION MUTANT 1DCZ ; -1.00 ; BIOTIN CARBOXYL CARRIER DOMAIN OF TRANSCARBOXYLASE (TC 1.3S) 1DD2 ; -1.00 ; BIOTIN CARBOXYL CARRIER DOMAIN OF TRANSCARBOXYLASE (TC 1.3S) 1ULI ; 2.20 ; BIPHENYL DIOXYGENASE (BPHA1A2) DERIVED FROM RHODOCOCCUS SP. STRAIN RHA1 1ULJ ; 2.60 ; BIPHENYL DIOXYGENASE (BPHA1A2) IN COMPLEX WITH THE SUBSTRATE 1B6F ; -1.00 ; BIRCH POLLEN ALLERGEN BET V 1 1BV1 ; 2.00 ; BIRCH POLLEN ALLERGEN BET V 1 1LLT ; 3.10 ; BIRCH POLLEN ALLERGEN BET V 1 MUTANT E45S 1QMR ; 2.15 ; BIRCH POLLEN ALLERGEN BET V 1 MUTANT N28T, K32Q, E45S, P108G 1CQA ; 2.40 ; BIRCH POLLEN PROFILIN 1A49 ; 2.10 ; BIS MG-ATP-K-OXALATE COMPLEX OF PYRUVATE KINASE 1MNB ; -1.00 ; BIV TAT PEPTIDE (RESIDUES 68 - 81), NMR, MINIMIZED AVERAGE STRUCTURE 1XJ3 ; 1.90 ; BJFIXLH IN UNLIGANDED FERROUS FORM 1JXP ; 2.20 ; BK STRAIN HEPATITIS C VIRUS (HCV) NS3-NS4A 1BYL ; 2.30 ; BLEOMYCIN RESISTANCE PROTEIN FROM STREPTOALLOTEICHUS HINDUSTANUS 2BYC ; 1.90 ; BLRB - A BLUF PROTEIN, DARK STATE STRUCTURE 1BFP ; 2.10 ; BLUE VARIANT OF GREEN FLUORESCENT PROTEIN 1BMO ; 3.10 ; BM-40, FS/EC DOMAIN PAIR 1BKT ; -1.00 ; BMKTX TOXIN FROM SCORPION BUTHUS MARTENSII KARSCH, NMR, 25 STRUCTURES 1Y64 ; 3.05 ; BNI1P FORMIN HOMOLOGY 2 DOMAIN COMPLEXED WITH ATP-ACTIN 1DKJ ; 2.00 ; BOBWHITE QUAIL LYSOZYME 1DKK ; 1.90 ; BOBWHITE QUAIL LYSOZYME WITH NITRATE 2BW2 ; -1.00 ; BOFC FROM BACILLUS SUBTILIS 1SI9 ; 2.27 ; BOILING STABLE PROTEIN ISOLATED FROM POPULUS TREMULA 1DQE ; 1.80 ; BOMBYX MORI PHEROMONE BINDING PROTEIN 1BMP ; 2.80 ; BONE MORPHOGENETIC PROTEIN-7 1S3T ; 2.10 ; BORATE INHIBITED BACILLUS PASTEURII UREASE CRYSTAL STRUCTURE 1Y9U ; 1.39 ; BORDETELLA FERRIC BINDING PROTEIN 1LWV ; 2.30 ; BOROHYDRIDE-TRAPPED HOGG1 INTERMEDIATE STRUCTURE CO- CRYSTALLIZED WITH 8-AMINOGUANINE 1LWW ; 2.10 ; BOROHYDRIDE-TRAPPED HOGG1 INTERMEDIATE STRUCTURE CO- CRYSTALLIZED WITH 8-BROMOGUANINE 1F82 ; 2.20 ; BOTULINUM NEUROTOXIN TYPE B CATALYTIC DOMAIN 1F83 ; 2.00 ; BOTULINUM NEUROTOXIN TYPE B CATALYTIC DOMAIN WITH SYNAPTOBREVIN-II BOUND 1BFZ ; -1.00 ; BOUND CONFORMATION OF N-TERMINAL CLEAVAGE PRODUCT PEPTIDE MIMIC (P1-P9 OF RELEASE SITE) WHILE BOUND TO HCMV PROTEASE AS DETERMINED BY TRANSFERRED NOESY EXPERIMENTS (P1-P5 SHOWN ONLY), NMR, 32 STRUCTURES 1AYF ; 1.85 ; BOVINE ADRENODOXIN (OXIDIZED) 1MTN ; 2.80 ; BOVINE ALPHA-CHYMOTRYPSIN:BPTI CRYSTALLIZATION 1AVC ; 2.90 ; BOVINE ANNEXIN VI (CALCIUM-BOUND) 1CJ5 ; -1.00 ; BOVINE BETA-LACTOGLOBULIN A 1B0O ; 2.50 ; BOVINE BETA-LACTOGLOBULIN COMPLEXED WITH PALMITATE, LATTICE Z 1GX9 ; 2.34 ; BOVINE BETA-LACTOGLOBULIN COMPLEXED WITH RETINOIC ACID, TRIGONAL LATTICE Z 1GXA ; 2.35 ; BOVINE BETA-LACTOGLOBULIN COMPLEXED WITH RETINOL AND PALMITIC ACID, TRIGONAL LATTICE Z 1GX8 ; 2.40 ; BOVINE BETA-LACTOGLOBULIN COMPLEXED WITH RETINOL, TRIGONAL LATTICE Z 1BEB ; 1.80 ; BOVINE BETA-LACTOGLOBULIN, LATTICE X 1G3D ; 1.80 ; BOVINE BETA-TRYPSIN BOUND TO META-AMIDINO SCHIFF BASE COPPER (II) CHELATE 1G3B ; 1.80 ; BOVINE BETA-TRYPSIN BOUND TO META-AMIDINO SCHIFF BASE MAGNESIUM(II) CHELATE 1G3C ; 1.80 ; BOVINE BETA-TRYPSIN BOUND TO PARA-AMIDINO SCHIFF BASE IRON(III) CHELATE 1G3E ; 1.80 ; BOVINE BETA-TRYPSIN BOUND TO PARA-AMIDINO SCHIFF-BASE COPPER (II) CHELATE 1IG5 ; 1.50 ; BOVINE CALBINDIN D9K BINDING MG2+ 1IGV ; 1.85 ; BOVINE CALBINDIN D9K BINDING MN2+ 1CA0 ; 2.10 ; BOVINE CHYMOTRYPSIN COMPLEXED TO APPI 1CBW ; 2.60 ; BOVINE CHYMOTRYPSIN COMPLEXED TO BPTI 1VIN ; 2.00 ; BOVINE CYCLIN A3 1IHG ; 1.80 ; BOVINE CYCLOPHILIN 40, MONOCLINIC FORM 1IIP ; 2.00 ; BOVINE CYCLOPHILIN 40, TETRAGONAL FORM 1CYO ; 1.50 ; BOVINE CYTOCHROME B(5) 1PPJ ; 2.10 ; BOVINE CYTOCHROME BC1 COMPLEX WITH STIGMATELLIN AND ANTIMYCIN 1PP9 ; 2.10 ; BOVINE CYTOCHROME BC1 COMPLEX WITH STIGMATELLIN BOUND 2A06 ; 2.10 ; BOVINE CYTOCHROME BC1 COMPLEX WITH STIGMATELLIN BOUND 1PID ; 1.30 ; BOVINE DESPENTAPEPTIDE INSULIN 1EUF ; 2.40 ; BOVINE DUODENASE(NEW SERINE PROTEASE), CRYSTAL STRUCTURE 1NSE ; 1.90 ; BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE 1DM8 ; 2.25 ; BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH 1,2,4-TRIAZOLE-CARBOXAMIDINE (H4B BOUND) 1D1Y ; 2.20 ; BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH 1,3-PBITU (H4B FREE) 1D1X ; 2.00 ; BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH 1,4-PBITU (H4B BOUND) 1FOI ; 1.93 ; BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH 1400W(H4B-FREE) 1D1W ; 2.00 ; BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH 2-AMINOTHIAZOLINE (H4B BOUND) 1D0C ; 1.65 ; BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH 3-BROMO-7-NITROINDAZOLE (H4B FREE) 1D0O ; 1.95 ; BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH 3-BROMO-7-NITROINDAZOLE (H4B PRESENT) 1DMK ; 1.90 ; BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH 4-AMINO-6-PHENYL-TETRAHYDROPTERIDINE 1DMJ ; 2.35 ; BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH 5,6-CYCLIC-TETRAHYDROPTERIDINE 1DMI ; 2.00 ; BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH 6S-H4B 1FOJ ; 2.10 ; BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH 7-NITROINDAZOLE-2-CARBOXAMIDINE (H4B PRESENT) 1DM7 ; 2.10 ; BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH HOMOARGININE (H4B FREE) 1ED4 ; 1.86 ; BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH IPITU (H4B FREE) 1FOP ; 2.30 ; BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH L-ARG AND NO(H4B-BOUND) 1FOO ; 2.00 ; BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH L-ARG AND NO(H4B-FREE) 1ED6 ; 2.05 ; BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH L-NIO (H4B FREE) 1DM6 ; 1.95 ; BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH N-(4-CHLOROPHENYL)-N'-HYDROXYGUANIDINE (H4B FREE) 1I83 ; 2.00 ; BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH N1,N14-BIS((S-METHYL)ISOTHIOUREIDO) TETRADECANE (H4B FREE) 1ED5 ; 1.80 ; BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH NNA(H4B FREE) 1D1V ; 1.93 ; BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH S-ETHYL-N-PHENYL-ISOTHIOUREA (H4B BOUND) 1Q2O ; 1.74 ; BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE N368D MUTANT HEME DOMAIN DIMER WITH L-N(OMEGA)-NITROARGININE-2,4-L- DIAMINOBUTYRAMIDE BOUND 2NSE ; 2.34 ; BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE SUBSTRATE COMPLEX 9NSE ; 2.24 ; BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE, ETHYL- ISOSELENOUREA COMPLEX 7NSE ; 2.35 ; BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE, H4B-FREE, ADMA COMPLEX 6NSE ; 2.35 ; BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE, H4B-FREE, CANAVANINE COMPLEX 5NSE ; 1.90 ; BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE, H4B-FREE, HYDROXY- ARG COMPLEX 4NSE ; 1.95 ; BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE, H4B-FREE, L-ARG COMPLEX 8NSE ; 2.25 ; BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE, NNA COMPLEX 1P6M ; 2.27 ; BOVINE ENDOTHELIAL NOS HEME DOMAIN WITH (4S)-N-(4-AMINO-5- [AMINOETHYL]AMINOPENTYL)-N'-NITROGUANIDINE BOUND 1RS8 ; 2.30 ; BOVINE ENDOTHELIAL NOS HEME DOMAIN WITH D-LYSINE-D- NITROARGININE AMIDE BOUND 1RS9 ; 2.22 ; BOVINE ENDOTHELIAL NOS HEME DOMAIN WITH D-PHENYLALANINE-D- NITROARGININE AMIDE BOUND 1P6N ; 2.50 ; BOVINE ENDOTHELIAL NOS HEME DOMAIN WITH L-N(OMEGA)- NITROARGININE-(4R)-AMINO-L-PROLINE AMIDE BOUND 1P6L ; 2.35 ; BOVINE ENDOTHELIAL NOS HEME DOMAIN WITH L-N(OMEGA)- NITROARGININE-2,4-L-DIAMINOBUTYRIC AMIDE BOUND 1ZZS ; 1.85 ; BOVINE ENOS N368D SINGLE MUTANT WITH L-N(OMEGA)- NITROARGININE-(4R)-AMINO-L-PROLINE AMIDE BOUND 1ZZT ; 2.14 ; BOVINE ENOS N368D/V106M DOUBLE MUTANT WITH L-N(OMEGA)- NITROARGININE-(4R)-AMINO-L-PROLINE AMIDE BOUND 3NSE ; 2.10 ; BOVINE ENOS, H4B-FREE, SEITU COMPLEX 1BEV ; 3.00 ; BOVINE ENTEROVIRUS VG-5-27 1E79 ; 2.40 ; BOVINE F1-ATPASE INHIBITED BY DCCD (DICYCLOHEXYLCARBODIIMIDE) 1KIG ; 3.00 ; BOVINE FACTOR XA 1HWY ; 3.20 ; BOVINE GLUTAMATE DEHYDROGENASE COMPLEXED WITH NAD AND 2- OXOGLUTARATE 1HWZ ; 2.80 ; BOVINE GLUTAMATE DEHYDROGENASE COMPLEXED WITH NADPH, GLUTAMATE, AND GTP 1V54 ; 1.80 ; BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE 2OCC ; 2.30 ; BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE 1V55 ; 1.90 ; BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY REDUCED STATE 1OCZ ; 2.90 ; BOVINE HEART CYTOCHROME C OXIDASE IN AZIDE-BOUND STATE 1OCO ; 2.80 ; BOVINE HEART CYTOCHROME C OXIDASE IN CARBON MONOXIDE-BOUND STATE 1OCR ; 2.35 ; BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE 1BIV ; -1.00 ; BOVINE IMMUNODEFICIENCY VIRUS TAT-TAR COMPLEX, NMR, 5 STRUCTURES 1D9C ; 2.00 ; BOVINE INTERFERON-GAMMA AT 2.0 ANGSTROMS 1D9G ; 2.90 ; BOVINE INTERFERON-GAMMA AT 2.9 ANGSTROMS 1LFC ; -1.00 ; BOVINE LACTOFERRICIN (LFCINB), NMR, 20 STRUCTURES 1LCP ; 1.65 ; BOVINE LENS LEUCINE AMINOPEPTIDASE COMPLEXED WITH L-LEUCINE PHOSPHONIC ACID 1BJ7 ; 1.80 ; BOVINE LIPOCALIN ALLERGEN BOS D 2 1VDV ; 1.98 ; BOVINE MILK XANTHINE DEHYDROGENASE Y-700 BOUND FORM 1BMF ; 2.85 ; BOVINE MITOCHONDRIAL F1-ATPASE 1E1Q ; 2.61 ; BOVINE MITOCHONDRIAL F1-ATPASE AT 100K 1COW ; 3.10 ; BOVINE MITOCHONDRIAL F1-ATPASE COMPLEXED WITH AUROVERTIN B 1OHH ; 2.80 ; BOVINE MITOCHONDRIAL F1-ATPASE COMPLEXED WITH THE INHIBITOR PROTEIN IF1 1EFR ; 3.10 ; BOVINE MITOCHONDRIAL F1-ATPASE COMPLEXED WITH THE PEPTIDE ANTIBIOTIC EFRAPEPTIN 1H8H ; 2.90 ; BOVINE MITOCHONDRIAL F1-ATPASE CRYSTALLISED IN THE PRESENCE OF 5MM AMPPNP 1E1R ; 2.50 ; BOVINE MITOCHONDRIAL F1-ATPASE INHIBITED BY MG2+ADP AND ALUMINIUM FLUORIDE 1NPO ; 2.80 ; BOVINE NEUROPHYSIN II COMPLEX WITH OXYTOCIN 2BO5 ; -1.00 ; BOVINE OLIGOMYCIN SENSITIVITY CONFERRAL PROTEIN N-TERMINAL DOMAIN 1CE5 ; 1.90 ; BOVINE PANCREAS BETA-TRYPSIN IN COMPLEX WITH BENZAMIDINE 2BZA ; 1.90 ; BOVINE PANCREAS BETA-TRYPSIN IN COMPLEX WITH BENZYLAMINE 1LJV ; -1.00 ; BOVINE PANCREATIC POLYPEPTIDE BOUND TO DPC MICELLES 1C0B ; 1.90 ; BOVINE PANCREATIC RIBONUCLEASE A DESICCATED FOR 2.5 DAYS 1C0C ; 2.00 ; BOVINE PANCREATIC RIBONUCLEASE A DESICCATED FOR 4.0 DAYS 1S0R ; 1.02 ; BOVINE PANCREATIC TRYPSIN INHIBITED WITH BENZAMIDINE AT ATOMIC RESOLUTION 1QLQ ; 1.42 ; BOVINE PANCREATIC TRYPSIN INHIBITOR (BPTI) MUTANT WITH ALTERED BINDING LOOP SEQUENCE 1BHC ; 2.70 ; BOVINE PANCREATIC TRYPSIN INHIBITOR CRYSTALLIZED FROM THIOCYANATE 1DWY ; -1.00 ; BOVINE PRION PROTEIN FRAGMENT 121-230 1DWZ ; -1.00 ; BOVINE PRION PROTEIN FRAGMENT 121-230 1DX0 ; -1.00 ; BOVINE PRION PROTEIN RESIDUES 23-230 1DX1 ; -1.00 ; BOVINE PRION PROTEIN RESIDUES 23-230 1NL2 ; 2.30 ; BOVINE PROTHROMBIN FRAGMENT 1 IN COMPLEX WITH CALCIUM AND LYSOPHOSPHOTIDYLSERINE 1NL1 ; 1.90 ; BOVINE PROTHROMBIN FRAGMENT 1 IN COMPLEX WITH CALCIUM ION 1A9P ; 2.40 ; BOVINE PURINE NUCLEOSIDE PHOSPHORYLASE COMPLEXED WITH 9-DEAZAINOSINE AND PHOSPHATE 1A9T ; 2.00 ; BOVINE PURINE NUCLEOSIDE PHOSPHORYLASE COMPLEXED WITH 9-DEAZAINOSINE AND PHOSPHATE 1A9R ; 2.00 ; BOVINE PURINE NUCLEOSIDE PHOSPHORYLASE COMPLEXED WITH HYPOXANTHINE AND SULFATE 1A9Q ; 2.00 ; BOVINE PURINE NUCLEOSIDE PHOSPHORYLASE COMPLEXED WITH INOSINE 1A9S ; 2.00 ; BOVINE PURINE NUCLEOSIDE PHOSPHORYLASE COMPLEXED WITH INOSINE AND SULFATE 1A9O ; 2.00 ; BOVINE PURINE NUCLEOSIDE PHOSPHORYLASE COMPLEXED WITH PHOSPHATE 1XPT ; 1.90 ; BOVINE RIBONUCLEASE A (PHOSPHATE-FREE) 1XPS ; 1.80 ; BOVINE RIBONUCLEASE A (PHOSPHATE-FREE) (93 % HUMIDITY) 1UVU ; 2.80 ; BOVINE THROMBIN--BM12.1700 COMPLEX 1UVT ; 2.50 ; BOVINE THROMBIN--BM14.1248 COMPLEX 1UVS ; 2.80 ; BOVINE THROMBIN--BM51.1011 COMPLEX 1QA0 ; 1.80 ; BOVINE TRYPSIN 2-AMINOBENZIMIDAZOLE COMPLEX 1QBN ; 1.80 ; BOVINE TRYPSIN 2-[AMINO(IMINO)METHYL]-2-HYDROXYPHENOXY]-6- [3-(4,5-DIHYDRO-1H-IMIDAZOL-2-YL)PHENOXY]PYRIDINE-4- CARBOXYLIC ACID (ZK-806688) COMPLEX 1QB6 ; 1.80 ; BOVINE TRYPSIN 3,3'-[3,5-DIFLUORO-4-METHYL-2, 6- PYRIDINEDIYLBIS(OXY)]BIS(BENZENECARBOXIMIDAMIDE) (ZK-805623) COMPLEX 1QB9 ; 1.80 ; BOVINE TRYPSIN 7-[[2-[[1-(1-IMINOETHYL)PIPERIDIN-4-YL]OXY]- 9H-CARBOZOL-9-YL] METHYL]NAPHTHALENE-2-CARBOXIMIDAMIDE (ZK- 806450) COMPLEX 1QBO ; 1.80 ; BOVINE TRYPSIN 7-[[6-[[1-(1-IMINOETHYL)PIPERIDIN-4-YL]OXY]- 2-METHYL-BENZIMIDAZOL-1-YL]METHYL]NAPHTHALENE-2- CARBOXIMIDAMID ZK-806711 INHIBITOR COMPLEX 1TAW ; 1.80 ; BOVINE TRYPSIN COMPLEXED TO APPI 1AZ8 ; 1.80 ; BOVINE TRYPSIN COMPLEXED TO BIS-PHENYLAMIDINE INHIBITOR 1AUJ ; 2.10 ; BOVINE TRYPSIN COMPLEXED TO META-CYANO-BENZYLIC INHIBITOR 1TX8 ; 1.70 ; BOVINE TRYPSIN COMPLEXED WITH AMSO 1TX7 ; 1.75 ; BOVINE TRYPSIN COMPLEXED WITH P- AMIDINOPHENYLMETHYLPHOSPHINIC ACID (AMPA) 1F0U ; 1.90 ; BOVINE TRYPSIN COMPLEXED WITH RPR128515 1F0T ; 1.80 ; BOVINE TRYPSIN COMPLEXED WITH RPR131247 2BTC ; 1.50 ; BOVINE TRYPSIN IN COMPLEX WITH SQUASH SEED INHIBITOR (CUCURBITA PEPO TRYPSIN INHIBITOR II) 1QB1 ; 1.80 ; BOVINE TRYPSIN WITH 1-[2-[5-[AMINO(IMINO)METHYL]-2- HYDROXYPHENOXY]-6-[3-(4,5-DIHYDRO-1-METHYL-1H-IMIDAZOL-2-YL) PHENOXY]PYRIDIN-4-YL]PIPERIDINE-3-CARBOXYLIC ACID (ZK- 806974) 1K1I ; 2.20 ; BOVINE TRYPSIN-INHIBITOR COMPLEX 1K1J ; 2.20 ; BOVINE TRYPSIN-INHIBITOR COMPLEX 1K1L ; 2.50 ; BOVINE TRYPSIN-INHIBITOR COMPLEX 1K1M ; 2.20 ; BOVINE TRYPSIN-INHIBITOR COMPLEX 1K1N ; 2.00 ; BOVINE TRYPSIN-INHIBITOR COMPLEX 1K1O ; 2.00 ; BOVINE TRYPSIN-INHIBITOR COMPLEX 1K1P ; 1.90 ; BOVINE TRYPSIN-INHIBITOR COMPLEX 1B8M ; 2.75 ; BRAIN DERIVED NEUROTROPHIC FACTOR, NEUROTROPHIN-4 1Q7F ; 1.95 ; BRAIN TUMOR NHL DOMAIN 1UM9 ; 2.20 ; BRANCHED-CHAIN 2-OXO ACID DEHYDROGENASE (E1) FROM THERMUS THERMOPHILUS HB8 IN APO-FORM 1UMB ; 2.10 ; BRANCHED-CHAIN 2-OXO ACID DEHYDROGENASE (E1) FROM THERMUS THERMOPHILUS HB8 IN HOLO-FORM 1UMD ; 1.90 ; BRANCHED-CHAIN 2-OXO ACID DEHYDROGENASE (E1) FROM THERMUS THERMOPHILUS HB8 WITH 4-METHYL-2-OXOPENTANOATE AS AN INTERMEDIATE 1UMC ; 2.40 ; BRANCHED-CHAIN 2-OXO ACID DEHYDROGENASE (E1) FROM THERMUS THERMOPHILUS HB8 WITH 4-METHYLPENTANOATE 1GKX ; 2.30 ; BRANCHED-CHAIN ALPHA-KETOACID DEHYDROGENASE KINASE (BCK) 1GKZ ; 2.20 ; BRANCHED-CHAIN ALPHA-KETOACID DEHYDROGENASE KINASE (BCK) COMPLXED WITH ADP 1GJV ; 2.70 ; BRANCHED-CHAIN ALPHA-KETOACID DEHYDROGENASE KINASE (BCK) COMPLXED WITH ATP-GAMMA-S 1A3G ; 2.50 ; BRANCHED-CHAIN AMINO ACID AMINOTRANSFERASE FROM ESCHERICHIA COLI 17RA ; -1.00 ; BRANCHPOINT HELIX FROM YEAST AND BINDING SITE FOR PHAGE GA/MS2 COAT PROTEINS, NMR, 12 STRUCTURES 1CWU ; 2.50 ; BRASSICA NAPUS ENOYL ACP REDUCTASE A138G MUTANT COMPLEXED WITH NAD+ AND THIENODIAZABORINE 1ENO ; 1.90 ; BRASSICA NAPUS ENOYL ACP REDUCTASE/NAD BINARY COMPLEX AT PH 8.0 AND ROOM TEMPERATURE 1ENP ; 1.90 ; BRASSICA NAPUS ENOYL ACP REDUCTASE/NADH BINARY COMPLEX AT PH 8.0 AND ROOM TEMPERATURE 1CDZ ; 3.20 ; BRCT DOMAIN FROM DEOXYRIBONUCLEIC ACID-REPAIR PROTEIN XRCC1 1JKM ; 1.85 ; BREFELDIN A ESTERASE, A BACTERIAL HOMOLOGUE OF HUMAN HORMONE SENSITIVE LIPASE 1JS9 ; 3.40 ; BROME MOSAIC VIRUS 1E6I ; 1.87 ; BROMODOMAIN FROM GCN5 COMPLEXED WITH ACETYLATED H4 PEPTIDE 1A8Q ; 1.75 ; BROMOPEROXIDASE A1 1BRO ; 2.05 ; BROMOPEROXIDASE A2 1BRT ; 1.50 ; BROMOPEROXIDASE A2 MUTANT M99T 1BRY ; 2.10 ; BRYODIN TYPE I RIP 1KNV ; 2.17 ; BSE634I RESTRICTION ENDONUCLEASE 1BUO ; 1.90 ; BTB DOMAIN FROM PLZF 1B77 ; 2.10 ; BUILDING A REPLISOME STRUCTURE FROM INTERACTING PIECES: A SLIDING CLAMP COMPLEXED WITH AN INTERACTION PEPTIDE FROM DEOXYRIBONUCLEIC ACID POLYMERASE 1K8S ; -1.00 ; BULGED ADENOSINE IN AN RIBONUCLEIC ACID DUPLEX 1H8P ; 1.82 ; BULL SEMINAL PLASMA PDC-109 FIBRONECTIN TYPE II MODULE 1RCE ; 2.40 ; BULLFROG RED CELL L FERRITIN SULFATE/MN/PH 6.3 1RCG ; 2.20 ; BULLFROG RED CELL L FERRITIN SULFATE/MN/PH 6.3 1RCC ; 2.40 ; BULLFROG RED CELL L FERRITIN TARTRATE/MG/PH 5.5 1RCD ; 2.00 ; BULLFROG RED CELL L FERRITIN TARTRATE/MG/PH 5.5 1RCI ; 2.00 ; BULLFROG RED CELL L FERRITIN TARTRATE/MG/PH 5.5 1GEV ; 2.10 ; BURIED POLAR MUTANT HUMAN LYSOZYME 1GEZ ; 1.80 ; BURIED POLAR MUTANT HUMAN LYSOZYME 1GF0 ; 1.80 ; BURIED POLAR MUTANT HUMAN LYSOZYME 1GF3 ; 1.80 ; BURIED POLAR MUTANT HUMAN LYSOZYME 1GF4 ; 1.80 ; BURIED POLAR MUTANT HUMAN LYSOZYME 1GF5 ; 1.80 ; BURIED POLAR MUTANT HUMAN LYSOZYME 1GF6 ; 1.80 ; BURIED POLAR MUTANT HUMAN LYSOZYME 1GF7 ; 1.80 ; BURIED POLAR MUTANT HUMAN LYSOZYME 1YS1 ; 1.10 ; BURKHOLDERIA CEPACIA LIPASE COMPLEXED WITH HEXYLPHOSPHONIC ACID (R)-2-METHYL-3-PHENYLPROPYL ESTER 1YS2 ; 1.50 ; BURKHOLDERIA CEPACIA LIPASE COMPLEXED WITH HEXYLPHOSPHONIC ACID (S) 2-METHYL-3-PHENYLPROPYL ESTER 1ZMF ; 1.88 ; C DOMAIN OF HUMAN CYCLOPHILIN-33(HCYP33) 1QVP ; -1.00 ; C TERMINAL SH3-LIKE DOMAIN FROM DIPHTHERIA TOXIN REPRESSOR RESIDUES 144-226. 2D25 ; 1.75 ; C-C-A-G-G-C-M5C-T-G-G; Helical Fine Structure, Hydration, and Comparison with C-C-A-G-G-C-C-T-G-G 1L3W ; 3.08 ; C-CADHERIN ECTODOMAIN 1N2T ; 2.00 ; C-DES MUTANT K223A WITH GLY COVALENTY LINKED TO THE PLP- COFACTOR 1OZS ; -1.00 ; C-DOMAIN OF HUMAN CARDIAC TROPONIN C IN COMPLEX WITH THE INHIBITORY REGION OF HUMAN CARDIAC TROPONIN I 1IAQ ; 2.90 ; C-H-RAS P21 PROTEIN MUTANT WITH THR 35 REPLACED BY SER (T35S) COMPLEXED WITH GUANOSINE-5'-[B,G-IMIDO] TRIPHOSPHATE 1A1A ; 2.20 ; C-SRC (SH2 DOMAIN WITH C188A MUTATION) COMPLEXED WITH ACE-FORMYL PHOSPHOTYR-GLU-(N,N-DIPENTYL AMINE) 1A08 ; 2.20 ; C-SRC (SH2 DOMAIN) COMPLEXED WITH ACE-DIFLUORO PHOSPHOTYR-GLU-(N,N-DIPENTYL AMINE) 1A09 ; 2.00 ; C-SRC (SH2 DOMAIN) COMPLEXED WITH ACE-FORMYL PHOSPHOTYR-GLU-(N,N-DIPENTYL AMINE) 1A07 ; 2.20 ; C-SRC (SH2 DOMAIN) COMPLEXED WITH ACE-MALONYL TYR-GLU- (N,N-DIPENTYL AMINE) 1A1E ; 2.20 ; C-SRC (SH2 DOMAIN) COMPLEXED WITH ACE-PHOSPHOTYR-GLU- (3-BUTYLPIPERIDINE) 1A1B ; 2.20 ; C-SRC (SH2 DOMAIN) COMPLEXED WITH ACE-PHOSPHOTYR-GLU- (N,N-DIPENTYL AMINE) 1A1C ; 2.40 ; C-SRC (SH2 DOMAIN) COMPLEXED WITH ACE-PHOSPHOTYR-GLU- (N-ME(-(CH2)3-CYCLOPENTYL)) 1QWE ; -1.00 ; C-SRC SH3 DOMAIN COMPLEXED WITH LIGAND APP12 1QWF ; -1.00 ; C-SRC SH3 DOMAIN COMPLEXED WITH LIGAND VSL12 1HF9 ; -1.00 ; C-TERMINAL COILED-COIL DOMAIN FROM BOVINE IF1 1SOP ; -1.00 ; C-TERMINAL CYSTINE-RICH DOMAIN OF MINICOLLAGEN-I FROM HYDRA 1QMC ; -1.00 ; C-TERMINAL DEOXYRIBONUCLEIC ACID-BINDING DOMAIN OF HIV-1 INTEGRASE, NMR, 42 STRUCTURES 1VPC ; -1.00 ; C-TERMINAL DOMAIN (52-96) OF THE HIV-1 REGULATORY PROTEIN VPR, NMR, 1 STRUCTURE 1RTG ; 2.60 ; C-TERMINAL DOMAIN (HAEMOPEXIN-LIKE DOMAIN) OF HUMAN MATRIX METALLOPROTEINASE-2 1K4Z ; 2.30 ; C-TERMINAL DOMAIN OF CYCLASE ASSOCIATED PROTEIN 1KQ5 ; 3.00 ; C-TERMINAL DOMAIN OF CYCLASE ASSOCIATED PROTEIN WITH PRO 505 REPLACED BY SER (P505S) 1WSU ; 2.30 ; C-TERMINAL DOMAIN OF ELONGATION FACTOR SELB COMPLEXED WITH SECIS RIBONUCLEIC ACID 1XXC ; 2.80 ; C-TERMINAL DOMAIN OF ESCHERICHIA COLI ARGININE REPRESSOR 1XXB ; 2.60 ; C-TERMINAL DOMAIN OF ESCHERICHIA COLI ARGININE REPRESSOR/ L-ARGININE COMPLEX 1XXA ; 2.20 ; C-TERMINAL DOMAIN OF ESCHERICHIA COLI ARGININE REPRESSOR/ L-ARGININE COMPLEX; PB DERIVATIVE 1YUA ; -1.00 ; C-TERMINAL DOMAIN OF ESCHERICHIA COLI TOPOISOMERASE I 1GEN ; 2.15 ; C-TERMINAL DOMAIN OF GELATINASE A 1RMJ ; -1.00 ; C-TERMINAL DOMAIN OF INSULIN-LIKE GROWTH FACTOR (IGF) BINDING PROTEIN-6: STRUCTURE AND INTERACTION WITH IGF-II 1ZT3 ; 1.80 ; C-TERMINAL DOMAIN OF INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-1 ISOLATED FROM HUMAN AMNIOTIC FLUID 1ZT5 ; 1.82 ; C-TERMINAL DOMAIN OF INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-1 ISOLATED FROM HUMAN AMNIOTIC FLUID COMPLEXED WITH IRON(II) 1MKH ; 2.01 ; C-TERMINAL DOMAIN OF METHIONYL-TRNA SYNTHETASE FROM PYROCOCCUS ABYSSI 1MKC ; -1.00 ; C-TERMINAL DOMAIN OF MIDKINE 1C8Z ; 1.90 ; C-TERMINAL DOMAIN OF MOUSE BRAIN TUBBY PROTEIN 1I7E ; 1.95 ; C-TERMINAL DOMAIN OF MOUSE BRAIN TUBBY PROTEIN BOUND TO PHOSPHATIDYLINOSITOL 4,5-BIS-PHOSPHATE 1Y6Z ; 1.88 ; C-TERMINAL DOMAIN OF PLASMODIUM FALCIPARUM PUTATIVE HEAT SHOCK PROTEIN PF14_0417 1NRF ; 2.50 ; C-TERMINAL DOMAIN OF THE BACILLUS LICHENIFORMIS BLAR PENICILLIN-RECEPTOR 1AA3 ; -1.00 ; C-TERMINAL DOMAIN OF THE E. COLI RECA, NMR, MINIMIZED AVERAGE STRUCTURE 1H8G ; 2.40 ; C-TERMINAL DOMAIN OF THE MAJOR AUTOLYSIN (C-LYTA) FROM STREPTOCOCCUS PNEUMONIAE 1IGU ; 2.20 ; C-TERMINAL DOMAIN OF THE TRANSCRIPTIONAL REPRESSOR PROTEIN KORB 1IGQ ; 1.70 ; C-TERMINAL DOMAIN OF TRANSCRIPTIONAL REPRESSOR PROTEIN KORB 1JAD ; 2.40 ; C-TERMINAL DOMAIN OF TURKEY PLC-BETA 1VVD ; -1.00 ; C-TERMINAL HALF OF VACCINIA VIRUS COMPLEMENT CONTROL PROTEIN, NMR, 21 STRUCTURES 1VVE ; -1.00 ; C-TERMINAL HALF OF VACCINIA VIRUS COMPLEMENT CONTROL PROTEIN, NMR, 21 STRUCTURES 1VVC ; -1.00 ; C-TERMINAL HALF OF VACCINIA VIRUS COMPLEMENT CONTROL PROTEIN, NMR, MINIMIZED AVERAGE STRUCTURE 1KHM ; -1.00 ; C-TERMINAL KH DOMAIN OF HNRNP K (KH3) 1H30 ; 2.20 ; C-TERMINAL LG DOMAIN PAIR OF HUMAN GAS6 1B9W ; 1.80 ; C-TERMINAL MEROZOITE SURFACE PROTEIN 1 FROM PLASMODIUM CYNOMOLGI 1UG3 ; 2.24 ; C-TERMINAL PORTION OF HUMAN EIF4GI 1RXZ ; 2.00 ; C-TERMINAL REGION OF A. FULGIDUS FEN-1 COMPLEXED WITH A. FULGIDUS PCNA 1RXM ; 2.80 ; C-TERMINAL REGION OF FEN-1 BOUND TO A. FULGIDUS PCNA 1HP3 ; -1.00 ; C-TERMINAL TRUNCATION OF OMEGA-ATRACOTOXIN-HV2A (CT-HV2A) 1HEH ; -1.00 ; C-TERMINAL XYLAN BINDING DOMAIN FROM CELLULOMONAS FIMI XYLANASE 11A 1HEJ ; -1.00 ; C-TERMINAL XYLAN BINDING DOMAIN FROM CELLULOMONAS FIMI XYLANASE 11A 1GRW ; 2.60 ; C. ELEGANS MAJOR SPERM PROTEIN 2DAP ; 2.20 ; C. GLUTAMICUM DAP DEHYDROGENASE IN COMPLEX WITH DAP 1DAP ; 2.20 ; C. GLUTAMICUM DAP DEHYDROGENASE IN COMPLEX WITH NADP+ 3DAP ; 2.20 ; C. GLUTAMICUM DAP DEHYDROGENASE IN COMPLEX WITH NADP+ AND THE INHIBITOR 5S-ISOXAZOLINE 1D2K ; 2.20 ; C. IMMITIS CHITINASE 1 AT 2.2 ANGSTROMS RESOLUTION 1RYW ; 2.30 ; C115S MURA LIGANDED WITH REACTION PRODUCTS 1DBZ ; 2.65 ; C153S MUTANT OF PEA FRUCTOSE-1,6-BISPHOSPHATASE 1AB0 ; 1.90 ; C1G/V32D/F57H MUTANT OF MURINE ADIPOCYTE LIPID BINDING PROTEIN AT PH 4.5 1F4N ; 1.90 ; C2 CRYSTAL STRUCTURE OF ALA2ILE2-6, A VERSION OF ROP WITH A REPACKED HYDROPHOBIC CORE AND A NEW FOLD. 1DSY ; 2.60 ; C2 DOMAIN FROM PROTEIN KINASE C (ALPHA) COMPLEXED WITH CA2+ AND PHOSPHATIDYLSERINE 1A25 ; 2.70 ; C2 DOMAIN FROM PROTEIN KINASE C (BETA) 1BDY ; 2.20 ; C2 DOMAIN FROM PROTEIN KINASE C DELTA 1BCI ; -1.00 ; C2 DOMAIN OF CYTOSOLIC PHOSPHOLIPASE A2, NMR, MINIMIZED AVERAGE STRUCTURE 1WFJ ; -1.00 ; C2 DOMAIN-CONTAINING PROTEIN FROM PUTATIVE ELICITOR- RESPONSIVE GENE 1UZI ; 1.89 ; C3 EXOENZYME FROM CLOSTRIDIUM BOTULINUM, TETRAGONAL FORM 1XMC ; 2.00 ; C323M MUTANT STRUCTURE OF MOUSE CARNITINE OCTANOYLTRANSFERASE 1HZF ; 2.30 ; C4ADG FRAGMENT OF HUMAN COMPLEMENT FACTOR C4A 1YOB ; 2.25 ; C69A FLAVODOXIN II FROM AZOTOBACTER VINELANDII 1RWJ ; 1.70 ; C7-TYPE THREE-HEME CYTOCHROME DOMAIN 1GPX ; -1.00 ; C85S GAPDX, NMR, 20 STRUCTURES 1ES3 ; 2.20 ; C98A MUTANT OF STREPTOMYCES K15 DD-TRANSPEPTIDASE 1ES4 ; 1.90 ; C98N MUTANT OF STREPTOMYCES K15 DD-TRANSPEPTIDASE 1W2M ; 2.40 ; CA-SUBSTITUTED FORM OF E. COLI AMINOPEPTIDASE P 1KJU ; 6.00 ; CA2+-ATPASE IN THE E2 STATE 1JHW ; 2.80 ; CA2+-BINDING MIMICRY IN THE CRYSTAL STRUCTURE OF THE EU3+- BOUND MUTANT HUMAN MACROPHAGE CAPPING PROTEIN CAP G 1IJ6 ; 3.10 ; CA2+-BOUND STRUCTURE OF MULTIDOMAIN EF-HAND PROTEIN, CBP40, FROM TRUE SLIME MOLD 1JWD ; -1.00 ; CA2+-INDUCED STRUCTURAL CHANGES IN CALCYCLIN: HIGH- RESOLUTION SOLUTION STRUCTURE OF CA2+-BOUND CALCYCLIN. 1S6I ; -1.00 ; CA2+-REGULATORY REGION (CLD) FROM SOYBEAN CALCIUM-DEPENDENT PROTEIN KINASE-ALPHA (CDPK) IN THE PRESENCE OF CA2+ AND THE JUNCTION DOMAIN (JD) 1MQ1 ; -1.00 ; CA2+-S100B-TRTK-12 COMPLEX 1YC7 ; 1.60 ; CABAN33 VHH FRAGMENT AGAINST VSG 1YC8 ; 2.70 ; CABAN33- Y37V/E44G/R45L TRIPLE MUTANT 1ZMY ; 3.00 ; CABBCII-10 VHH FRAMEWORK WITH CDR LOOPS OF CABLYS3 GRAFTED ON IT AND IN COMPLEX WITH HEN EGG WHITE LYSOZYME 1BHL ; 2.20 ; CACODYLATED CATALYTIC DOMAIN OF HIV-1 INTEGRASE 1CVM ; 2.40 ; CADMIUM INHIBITED CRYSTAL STRUCTURE OF PHYTASE FROM BACILLUS AMYLOLIQUEFACIENS 1ELM ; 2.00 ; CADMIUM-SUBSTITUTED BOVINE PACREATIC CARBOXYPEPTIDASE A (ALFA-FORM) AT PH 5.5 AND 2 MM CHLORIDE IN MONOCLINIC CRYSTAL FORM. 1ELL ; 1.76 ; CADMIUM-SUBSTITUTED BOVINE PANCREATIC CARBOXYPEPTIDASE A (ALFA-FORM) AT PH 7.5 AND 0.25 M CHLORIDE IN MONOCLINIC CRYSTAL FORM. 1EE3 ; 1.70 ; CADMIUM-SUBSTITUTED BOVINE PANCREATIC CARBOXYPEPTIDASE A (ALFA-FORM) AT PH 7.5 AND 2 MM CHLORIDE IN MONOCLINIC CRYSTAL FORM 1R0I ; 1.50 ; CADMIUM-SUBSTITUTED RUBREDOXIN 1BF0 ; -1.00 ; CALCICLUDINE (CAC) FROM GREEN MAMBA DENDROASPIS ANGUSTICEPS, NMR, 15 STRUCTURES 1UOV ; 1.65 ; CALCIUM BINDING DOMAIN C2B 1UOW ; 1.04 ; CALCIUM BINDING DOMAIN C2B 1QMD ; 2.20 ; CALCIUM BOUND CLOSED FORM ALPHA-TOXIN FROM CLOSTRIDIUM PERFRINGENS 1ALV ; 1.90 ; CALCIUM BOUND DOMAIN VI OF PORCINE CALPAIN 1WD9 ; 2.60 ; CALCIUM BOUND FORM OF HUMAN PEPTIDYLARGININE DEIMINASE TYPE4 (PAD4) 476D ; 1.30 ; CALCIUM FORM OF B-DEOXYRIBONUCLEIC ACID UNDECAMER GCGAATTCGCG 463D ; 1.45 ; CALCIUM FORM OF D(CGCGAATTCGCG)2 1UWO ; -1.00 ; CALCIUM FORM OF HUMAN S100B, NMR, 20 STRUCTURES 477D ; 1.70 ; CALCIUM FORM OF THE B-DEOXYRIBONUCLEIC ACID DODECAMER GGCGAATTCGCG 1WD8 ; 2.80 ; CALCIUM FREE FORM OF HUMAN PEPTIDYLARGININE DEIMINASE TYPE4 (PAD4) 1GNV ; 1.90 ; CALCIUM INDEPENDENT SUBTILISIN BPN' MUTANT 1OTM ; 1.93 ; CALCIUM-BINDING MUTANT OF THE INTERNALIN B LRR DOMAIN 1OTN ; 1.97 ; CALCIUM-BINDING MUTANT OF THE INTERNALIN B LRR DOMAIN 1OTO ; 1.96 ; CALCIUM-BINDING MUTANT OF THE INTERNALIN B LRR DOMAIN 1NKF ; -1.00 ; CALCIUM-BINDING PEPTIDE, NMR, 30 STRUCTURES 1B8L ; 1.70 ; CALCIUM-BOUND D51A/E101D/F102W TRIPLE MUTANT OF BETA CARP PARVALBUMIN 1SMG ; -1.00 ; CALCIUM-BOUND E41A MUTANT OF THE N-DOMAIN OF CHICKEN TROPONIN C, NMR, 40 STRUCTURES 1KP4 ; 1.60 ; CALCIUM-BOUND FORM OF PROKARYOTIC PHOSPHOLIPASE A2 1CFC ; -1.00 ; CALCIUM-FREE CALMODULIN 1CFD ; -1.00 ; CALCIUM-FREE CALMODULIN 1SL8 ; 1.70 ; CALCIUM-LOADED APO-AEQUORIN FROM AEQUOREA VICTORIA 1RLW ; 2.40 ; CALCIUM-PHOSPHOLIPID BINDING DOMAIN FROM CYTOSOLIC PHOSPHOLIPASE A2 1DQ1 ; 2.15 ; CALCIUM;CALCIUM CONCANAVALIN A 1V48 ; 2.20 ; CALF SPLEEN PURINE NUCLEOSIDE PHOSPHORYLASE (PNP) BINARY COMPLEX WITH 9-(5,5-DIFLUORO-5-PHOSPHONOPENTHYL)GUANINE 2PIK ; -1.00 ; CALICHEAMICIN GAMMA1I - DEOXYRIBONUCLEIC ACID COMPLEX, NMR, 6 STRUCTURES 1HF8 ; 2.00 ; CALM-N N-TERMINAL DOMAIN OF CLATHRIN ASSEMBLY LYMPHOID MYELOID LEUKAEMIA PROTEIN 1HG5 ; 2.00 ; CALM-N N-TERMINAL DOMAIN OF CLATHRIN ASSEMBLY LYMPHOID MYELOID LEUKAEMIA PROTEIN, INOSITOL(1,2,3,4,5,6)P6 COMPLEX 1HG2 ; 2.00 ; CALM-N N-TERMINAL DOMAIN OF CLATHRIN ASSEMBLY LYMPHOID MYELOID LEUKAEMIA PROTEIN, INOSITOL(4,5)P2 COMPLEX 1HFA ; 2.00 ; CALM-N N-TERMINAL DOMAIN OF CLATHRIN ASSEMBLY LYMPHOID MYELOID LEUKAEMIA PROTEIN, PI(4,5)P2 COMPLEX 1QIW ; 2.30 ; CALMODULIN COMPLEXED WITH N-(3,3,-DIPHENYLPROPYL)-N'-[1-R-( 3,4-BIS-BUTOXYPHENYL)-ETHYL]-PROPYLENEDIAMINE (DPD) 1QIV ; 2.64 ; CALMODULIN COMPLEXED WITH N-(3,3,-DIPHENYLPROPYL)-N'-[1-R-( 3,4-BIS-BUTOXYPHENYL)-ETHYL]-PROPYLENEDIAMINE (DPD), 1:2 COMPLEX 1A29 ; 2.74 ; CALMODULIN COMPLEXED WITH TRIFLUOPERAZINE (1:2 COMPLEX) 1LIN ; 2.00 ; CALMODULIN COMPLEXED WITH TRIFLUOPERAZINE (1:4 COMPLEX) 1AHR ; 1.80 ; CALMODULIN MUTANT WITH A TWO RESIDUE DELETION IN THE CENTRAL HELIX 1DMO ; -1.00 ; CALMODULIN, NMR, 30 STRUCTURES 1A06 ; 2.50 ; CALMODULIN-DEPENDENT PROTEIN KINASE FROM RAT 2F3Y ; 1.45 ; CALMODULIN/IQ DOMAIN COMPLEX 2F3Z ; 1.60 ; CALMODULIN/IQ-AA DOMAIN COMPLEX 1IQ5 ; 1.80 ; CALMODULIN/NEMATODE CA2+/CALMODULIN DEPENDENT KINASE KINASE FRAGMENT 1CKK ; -1.00 ; CALMODULIN/RAT CA2+/CALMODULIN DEPENDENT PROTEIN KINASE FRAGMENT 1NX2 ; 2.20 ; CALPAIN DOMAIN VI 1AJ5 ; 2.30 ; CALPAIN DOMAIN VI APO 1NX1 ; 2.00 ; CALPAIN DOMAIN VI COMPLEXED WITH CALPASTATIN INHIBITORY DOMAIN C (DIC) 1NX3 ; 2.45 ; CALPAIN DOMAIN VI IN COMPLEX WITH THE INHIBITOR PD150606 1DVI ; 2.30 ; CALPAIN DOMAIN VI WITH CALCIUM BOUND 1AA2 ; 2.00 ; CALPONIN HOMOLOGY (CH) DOMAIN FROM HUMAN BETA-SPECTRIN 1BKR ; 1.10 ; CALPONIN HOMOLOGY (CH) DOMAIN FROM HUMAN BETA-SPECTRIN AT 1.1 ANGSTROM RESOLUTION 1HHN ; -1.00 ; CALRETICULIN P-DOMAIN 1QNN ; 1.80 ; CAMBIALISTIC SUPEROXIDE DISMUTASE FROM PORPHYROMONAS GINGIVALIS 1QD0 ; 2.50 ; CAMELID HEAVY CHAIN VARIABLE DOMAINS PROVIDE EFFICIENT COMBINING SITES TO HAPTENS 1KXQ ; 1.60 ; CAMELID VHH DOMAIN IN COMPLEX WITH PORCINE PANCREATIC ALPHA- AMYLASE 1KXT ; 2.00 ; CAMELID VHH DOMAINS IN COMPLEX WITH PORCINE PANCREATIC ALPHA-AMYLASE 1KXV ; 1.60 ; CAMELID VHH DOMAINS IN COMPLEX WITH PORCINE PANCREATIC ALPHA-AMYLASE 1CDK ; 2.00 ; CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT (PROTEIN KINASE A) COMPLEXED WITH PROTEIN KINASE INHIBITOR PEPTIDE FRAGMENT 5-24 (PKI(5-24) ISOELECTRIC VARIANT CA) AND MN2+ ADENYLYL IMIDODIPHOSPHATE (MNAMP-PNP) AT PH 5.6 AND 7C AND 4C 1STC ; 2.30 ; CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC SUBUNIT IN COMPLEX WITH STAUROSPORINE 1BFO ; 2.60 ; CAMPATH-1G IGG2B RAT MONOCLONAL FAB 2CAU ; 2.10 ; CANAVALIN FROM JACK BEAN 2CAV ; 2.00 ; CANAVALIN FROM JACK BEAN 1AI9 ; 1.85 ; CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE 1IA3 ; 1.78 ; CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEX IN WHICH THE DIHYDRONICOTINAMIDE MOIETY OF DIHYDRO-NICOTINAMIDE- ADENINE-DINUCLEOTIDE PHOSPHATE (NADPH) IS DISPLACED BY 5- [(4-TERT-BUTYLPHENYL)SULFANYL]-2,4-QUINAZOLINEDIAMINE (GW995) 1IA4 ; 1.85 ; CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEX IN WHICH THE DIHYDRONICOTINAMIDE MOIETY OF DIHYDRO-NICOTINAMIDE- ADENINE-DINUCLEOTIDE PHOSPHATE (NADPH) IS DISPLACED BY 5- {[4-(4-MORPHOLINYL)PHENYL]SULFANYL}-2,4-QUINAZOLINEDIAMIN (GW2021) 1AOE ; 1.60 ; CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE (NADPH) AND 1,3-DIAMINO-7-(1-ETHYEPROPYE)-7H-PYRRALO- [3,2-F]QUINAZOLINE (GW345) 1M79 ; 1.70 ; CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE (NADPH) AND 5-(4-METHOXYPHENOXY)-2,4-QUINAZOLINEDIAMINE (GW1466) 1IA1 ; 1.70 ; CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE (NADPH) AND 5-(PHENYLSULFANYL)-2,4-QUINAZOLINEDIAMINE (GW997) 1M78 ; 1.71 ; CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE (NADPH) AND 5-CHLORYL-2,4,6-QUINAZOLINETRIAMINE (GW1225) 1IA2 ; 1.82 ; CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE (NADPH) AND 5-[(4-METHYLPHENYL)SULFANYL]-2,4- QUINAZOLINEDIAMINE (GW578) 1M7A ; 1.76 ; CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE (NADPH) AND 7-[2-METHOXY-1-(METHOXYMETHYL)ETHYL]-7H- PYRROLO[3,2-F] QUINAZOLINE-1,3-DIAMINE (GW557) 1BYU ; 2.15 ; CANINE GDP-RAN 1QG4 ; 2.50 ; CANINE GDP-RAN F72Y MUTANT 3RAN ; 2.15 ; CANINE GDP-RAN Q69L MUTANT 1QG2 ; 2.50 ; CANINE GDP-RAN R76E MUTANT 1C8D ; 3.00 ; CANINE PANLEUKOPENIA VIRUS EMPTY CAPSID STRUCTURE 1C8H ; 3.50 ; CANINE PARVOVIRUS STRAIN D EMPTY CAPSID STRUCTURE AT PH 5.5 4DPV ; 2.90 ; CANINE PARVOVIRUS STRAIN D VIRAL PROTEIN 2 1N52 ; 2.11 ; CAP BINDING COMPLEX 1N54 ; 2.72 ; CAP BINDING COMPLEX M7GPPPG FREE 1RUN ; 2.70 ; CAP-DEOXYRIBONUCLEIC ACID RECOGNITION: INTERACTIONS INVOLVING AROMATIC AMINO ACIDS 1RUO ; 2.70 ; CAP-DEOXYRIBONUCLEIC ACID RECOGNITION: INTERACTIONS INVOLVING AROMATIC AMINO ACIDS 1VD0 ; -1.00 ; CAPSID STABILIZING PROTEIN GPD, NMR, 20 STRUCTURES 299D ; 3.00 ; CAPTURING THE STRUCTURE OF A CATALYTIC RIBONUCLEIC ACID INTERMEDIATE 300D ; 3.00 ; CAPTURING THE STRUCTURE OF A CATALYTIC RIBONUCLEIC ACID INTERMEDIATE 301D ; 3.00 ; CAPTURING THE STRUCTURE OF A CATALYTIC RIBONUCLEIC ACID INTERMEDIATE 1B7B ; 2.80 ; CARBAMATE KINASE FROM ENTEROCOCCUS FAECIUM 1JDB ; 2.10 ; CARBAMOYL PHOSPHATE SYNTHETASE FROM ESCHERICHIA COLI 1CE8 ; 2.10 ; CARBAMOYL PHOSPHATE SYNTHETASE FROM ESCHERICHIS COLI WITH COMPLEXED WITH THE ALLOSTERIC LIGAND IMP 1A9X ; 1.80 ; CARBAMOYL PHOSPHATE SYNTHETASE: CAUGHT IN THE ACT OF GLUTAMINE HYDROLYSIS 1Q15 ; 2.30 ; CARBAPENAM SYNTHETASE 1Q19 ; 2.40 ; CARBAPENAM SYNTHETASE 1UXZ ; 1.40 ; CARBOHYDRATE BINDING MODULE (CBM6CM-2) FROM CELLVIBRIO MIXTUS LICHENASE 5A 1UYX ; 1.47 ; CARBOHYDRATE BINDING MODULE (CBM6CM-2) FROM CELLVIBRIO MIXTUS LICHENASE 5A IN COMPLEX WITH CELLOBIOSE 1UYY ; 1.47 ; CARBOHYDRATE BINDING MODULE (CBM6CM-2) FROM CELLVIBRIO MIXTUS LICHENASE 5A IN COMPLEX WITH CELLOTRIOSE 1UY0 ; 1.65 ; CARBOHYDRATE BINDING MODULE (CBM6CM-2) FROM CELLVIBRIO MIXTUS LICHENASE 5A IN COMPLEX WITH GLC-1,3-GLC-1,4-GLC-1,3-GLC 1UZ0 ; 2.00 ; CARBOHYDRATE BINDING MODULE (CBM6CM-2) FROM CELLVIBRIO MIXTUS LICHENASE 5A IN COMPLEX WITH GLC-4GLC-3GLC-4GLC 1UYZ ; 1.60 ; CARBOHYDRATE BINDING MODULE (CBM6CM-2) FROM CELLVIBRIO MIXTUS LICHENASE 5A IN COMPLEX WITH XYLOTETRAOSE 1GMM ; 2.00 ; CARBOHYDRATE BINDING MODULE CBM6 FROM XYLANASE U CLOSTRIDIUM THERMOCELLUM 1GWK ; 2.34 ; CARBOHYDRATE BINDING MODULE FAMILY29 1GWM ; 1.15 ; CARBOHYDRATE BINDING MODULE FAMILY29 COMPLEXED WITH GLUCOHEXAOSE 1GWL ; 1.51 ; CARBOHYDRATE BINDING MODULE FAMILY29 COMPLEXED WITH MANNOHEXAOSE 1R13 ; 2.10 ; CARBOHYDRATE RECOGNITION AND NECK DOMAINS OF SURFACTANT PROTEIN A (SP-A) 1R14 ; 2.50 ; CARBOHYDRATE RECOGNITION AND NECK DOMAINS OF SURFACTANT PROTEIN A (SP-A) CONTAINING SAMARIUM 1UX7 ; 1.50 ; CARBOHYDRATE-BINDING MODULE CBM36 IN COMPLEX WITH CALCIUM AND XYLOTRIOSE 1SU7 ; 1.12 ; CARBON MONOXIDE DEHYDROGENASE FROM CARBOXYDOTHERMUS HYDROGENOFORMANS- DTT REDUCED STATE 1SUF ; 1.15 ; CARBON MONOXIDE DEHYDROGENASE FROM CARBOXYDOTHERMUS HYDROGENOFORMANS-INACTIVE STATE 1SU6 ; 1.64 ; CARBON MONOXIDE DEHYDROGENASE FROM CARBOXYDOTHERMUS HYDROGENOFORMANS: CO REDUCED STATE 1FFV ; 2.25 ; CARBON MONOXIDE DEHYDROGENASE FROM HYDROGENOPHAGA PSEUDOFLAVA 1FFU ; 2.35 ; CARBON MONOXIDE DEHYDROGENASE FROM HYDROGENOPHAGA PSEUDOFLAVA WHICH LACKS THE MO-PYRANOPTERIN MOIETY OF THE MOLYBDENUM COFACTOR 1SU8 ; 1.10 ; CARBON MONOXIDE INDUCED DECOMPOSITION OF THE ACTIVE SITE [NI-4FE-5S] CLUSTER OF CO DEHYDROGENASE 2ABE ; 2.00 ; CARBONIC ANHYDRASE ACTIVATORS: X-RAY CRYSTAL STRUCTURE OF THE ADDUCT OF HUMAN ISOZYME II WITH L-HISTIDINE AS A PLATFORM FOR THE DESIGN OF STRONGER ACTIVATORS 1THJ ; 2.80 ; CARBONIC ANHYDRASE FROM METHANOSARCINA 1G3Z ; 1.86 ; CARBONIC ANHYDRASE II (F131V) 1G4O ; 1.96 ; CARBONIC ANHYDRASE II (F131V) COMPLEXED WITH 4- (AMINOSULFONYL)-N-PHENYLMETHYLBENZAMIDE 1G4J ; 1.84 ; CARBONIC ANHYDRASE II (F131V) COMPLEXED WITH 4- (AMINOSULFONYL)-N-[(2,3,4,5,6-PENTAFLUOROPHENYL)METHYL]- BENZAMIDE 1I9O ; 1.86 ; CARBONIC ANHYDRASE II (F131V) COMPLEXED WITH 4- (AMINOSULFONYL)-N-[(2,3,4-TRIFLUOROPHENYL)METHYL]-BENZAMIDE 1G46 ; 1.84 ; CARBONIC ANHYDRASE II (F131V) COMPLEXED WITH 4- (AMINOSULFONYL)-N-[(2,3-DIFLUOROPHENYL)METHYL]-BENZAMIDE 1I9P ; 1.92 ; CARBONIC ANHYDRASE II (F131V) COMPLEXED WITH 4- (AMINOSULFONYL)-N-[(2,4,6-TRIFLUOROPHENYL)METHYL]-BENZAMIDE 1I9M ; 1.84 ; CARBONIC ANHYDRASE II (F131V) COMPLEXED WITH 4- (AMINOSULFONYL)-N-[(2,4-DIFLUOROPHENYL)METHYL]-BENZAMIDE 1I9N ; 1.86 ; CARBONIC ANHYDRASE II (F131V) COMPLEXED WITH 4- (AMINOSULFONYL)-N-[(2,5-DIFLUOROPHENYL)METHYL]-BENZAMIDE 1G48 ; 1.86 ; CARBONIC ANHYDRASE II (F131V) COMPLEXED WITH 4- (AMINOSULFONYL)-N-[(2,6-DIFLUOROPHENYL)METHYL]-BENZAMIDE 1G45 ; 1.83 ; CARBONIC ANHYDRASE II (F131V) COMPLEXED WITH 4- (AMINOSULFONYL)-N-[(2-FLUOROPHENYL)METHYL]-BENZAMIDE 1I9Q ; 1.80 ; CARBONIC ANHYDRASE II (F131V) COMPLEXED WITH 4- (AMINOSULFONYL)-N-[(3,4,5-TRIFLUOROPHENYL)METHYL]-BENZAMIDE 1I9L ; 1.93 ; CARBONIC ANHYDRASE II (F131V) COMPLEXED WITH 4- (AMINOSULFONYL)-N-[(4-FLUOROPHENYL)METHYL]-BENZAMIDE 1OKL ; 2.10 ; CARBONIC ANHYDRASE II COMPLEX WITH THE 1OKL INHIBITOR 5-DIMETHYLAMINO-NAPHTHALENE-1-SULFONAMIDE 1OKM ; 2.20 ; CARBONIC ANHYDRASE II COMPLEX WITH THE 1OKM INHIBITOR 4-SULFONAMIDE-[1-(4-AMINOBUTANE)]BENZAMIDE 1OKN ; 2.40 ; CARBONIC ANHYDRASE II COMPLEX WITH THE 1OKN INHIBITOR 4-SULFONAMIDE-[1-(4-N-(5-FLUORESCEIN THIOUREA)BUTANE)] 1IF7 ; 1.98 ; CARBONIC ANHYDRASE II COMPLEXED WITH (R)-N-(3-INDOL-1-YL-2- METHYL-PROPYL)-4-SULFAMOYL-BENZAMIDE 1IF8 ; 1.94 ; CARBONIC ANHYDRASE II COMPLEXED WITH (S)-N-(3-INDOL-1-YL-2- METHYL-PROPYL)-4-SULFAMOYL-BENZAMIDE 1IF5 ; 2.00 ; CARBONIC ANHYDRASE II COMPLEXED WITH 2,6- DIFLUOROBENZENESULFONAMIDE 1IF6 ; 2.09 ; CARBONIC ANHYDRASE II COMPLEXED WITH 3,5- DIFLUOROBENZENESULFONAMIDE 1IF4 ; 1.93 ; CARBONIC ANHYDRASE II COMPLEXED WITH 4- FLUOROBENZENESULFONAMIDE 1G54 ; 1.86 ; CARBONIC ANHYDRASE II COMPLEXED WITH 4-(AMINOSULFONYL)-N- [(2,3,4,5,6-PENTAFLUOROPHENYL)METHYL]-BENZAMIDE 1G52 ; 1.80 ; CARBONIC ANHYDRASE II COMPLEXED WITH 4-(AMINOSULFONYL)-N- [(2,3-DIFLUOROPHENYL)METHYL]-BENZAMIDE 1G53 ; 1.94 ; CARBONIC ANHYDRASE II COMPLEXED WITH 4-(AMINOSULFONYL)-N- [(2,6-DIFLUOROPHENYL)METHYL]-BENZAMIDE 1G1D ; 2.04 ; CARBONIC ANHYDRASE II COMPLEXED WITH 4-(AMINOSULFONYL)-N- [(2-FLUOROPHENYL)METHYL]-BENZAMIDE 1I91 ; 2.00 ; CARBONIC ANHYDRASE II COMPLEXED WITH AL-6619 2H-THIENO[3,2- E]-1,2-THIAZINE-6-SULFONAMIDE, 2-(3-HYDROXYPHENYL)-3-(4- MORPHOLINYL)-, 1,1-DIOXIDE 1I8Z ; 1.93 ; CARBONIC ANHYDRASE II COMPLEXED WITH AL-6629 2H-THIENO[3,2- E]-1,2-THIAZINE-6-SULFONAMIDE, 2-(3-METHOXYPHENYL)-3-(4- MORPHOLINYL)-, 1,1-DIOXIDE 1I90 ; 2.00 ; CARBONIC ANHYDRASE II COMPLEXED WITH AL-8520 2H-THIENO[3,2- E]-1,2-THIAZINE-6-SULFONAMIDE, 4-AMINO-3,4-DIHYDRO-2-(3- METHOXYPROPYL)-, 1,1-DIOXIDE, (R) 1IF9 ; 2.00 ; CARBONIC ANHYDRASE II COMPLEXED WITH N-[2-(1H-INDOL-5-YL)- BUTYL]-4-SULFAMOYL-BENZAMIDE 1ZE8 ; 2.00 ; CARBONIC ANHYDRASE II IN COMPLEX WITH A MEMBRANE-IMPERMEANT SULFONAMIDE INHIBITOR 1OQ5 ; 1.50 ; CARBONIC ANHYDRASE II IN COMPLEX WITH NANOMOLAR INHIBITOR 1BN1 ; 2.10 ; CARBONIC ANHYDRASE II INHIBITOR 1BN3 ; 2.20 ; CARBONIC ANHYDRASE II INHIBITOR 1BN4 ; 2.10 ; CARBONIC ANHYDRASE II INHIBITOR 1BNM ; 2.60 ; CARBONIC ANHYDRASE II INHIBITOR 1BNN ; 2.30 ; CARBONIC ANHYDRASE II INHIBITOR 1BNQ ; 2.40 ; CARBONIC ANHYDRASE II INHIBITOR 1BNT ; 2.15 ; CARBONIC ANHYDRASE II INHIBITOR 1BNU ; 2.15 ; CARBONIC ANHYDRASE II INHIBITOR 1BNV ; 2.40 ; CARBONIC ANHYDRASE II INHIBITOR 1BNW ; 2.25 ; CARBONIC ANHYDRASE II INHIBITOR 1AM6 ; 2.10 ; CARBONIC ANHYDRASE II INHIBITOR: ACETOHYDROXAMATE 1ZSA ; 2.50 ; CARBONIC ANHYDRASE II MUTANT E117Q, APO FORM 1ZSC ; 1.80 ; CARBONIC ANHYDRASE II MUTANT E117Q, HOLO FORM 1ZSB ; 2.00 ; CARBONIC ANHYDRASE II MUTANT E117Q, TRANSITION STATE ANALOGUE ACETAZOLAMIDE 1SPG ; 1.95 ; CARBONMONOXY HEMOGLOBIN FROM THE TELEOST FISH LEIOSTOMUS XANTHURUS 1G08 ; 1.90 ; CARBONMONOXY LIGANDED BOVINE HEMOGLOBIN PH 5.0 1G09 ; 2.04 ; CARBONMONOXY LIGANDED BOVINE HEMOGLOBIN PH 7.2 1G0A ; 2.04 ; CARBONMONOXY LIGANDED BOVINE HEMOGLOBIN PH 8.5 1G0B ; 1.90 ; CARBONMONOXY LIGANDED EQUINE HEMOGLOBIN PH 8.5 1AJG ; 1.70 ; CARBONMONOXY MYOGLOBIN AT 40 K 1OUU ; 2.50 ; CARBONMONOXY TROUT HEMOGLOBIN I 1DO4 ; 1.70 ; CARBONMONOXY-MYOGLOBIN (MUTANT L29W) AFTER PHOTOLYSIS AT T<180K 1DO3 ; 1.55 ; CARBONMONOXY-MYOGLOBIN (MUTANT L29W) AFTER PHOTOLYSIS AT T>180K 1DO7 ; 1.85 ; CARBONMONOXY-MYOGLOBIN (MUTANT L29W) REBINDING STRUCTURE AFTER PHOTOLYSIS AT T< 180K 1DO1 ; 1.50 ; CARBONMONOXY-MYOGLOBIN MUTANT L29W AT 105K 1A6G ; 1.15 ; CARBONMONOXY-MYOGLOBIN, ATOMIC RESOLUTION 1CYD ; 1.80 ; CARBONYL REDUCTASE COMPLEXED WITH NADPH AND 2-PROPANOL 1SNY ; 1.75 ; CARBONYL REDUCTASE SNIFFER OF D. MELANOGASTER 1UPB ; 2.35 ; CARBOXYETHYLARGININE SYNTHASE FROM STREPTOMYCES CLAVULIGERUS 1UPC ; 2.45 ; CARBOXYETHYLARGININE SYNTHASE FROM STREPTOMYCES CLAVULIGERUS 1UPA ; 2.35 ; CARBOXYETHYLARGININE SYNTHASE FROM STREPTOMYCES CLAVULIGERUS (SEMET STRUCTURE) 1AUO ; 1.80 ; CARBOXYLESTERASE FROM PSEUDOMONAS FLUORESCENS 1IRB ; 1.70 ; CARBOXYLIC ESTER HYDROLASE 1FDK ; 1.96 ; CARBOXYLIC ESTER HYDROLASE (PLA2 - MJ33 INHIBITOR COMPLEX) 1L8S ; 1.55 ; CARBOXYLIC ESTER HYDROLASE COMPLEX (DIMERIC PLA2 + LPC- ETHER + ACETATE + PHOSPHATE IONS) 1FXF ; 1.85 ; CARBOXYLIC ESTER HYDROLASE COMPLEX (DIMERIC PLA2 + MJ33 INHIBITOR + PHOSPHATE IONS) 1FX9 ; 2.00 ; CARBOXYLIC ESTER HYDROLASE COMPLEX (DIMERIC PLA2 + MJ33 INHIBITOR + SULPHATE IONS) 1MKV ; 1.89 ; CARBOXYLIC ESTER HYDROLASE COMPLEX (PLA2 + TRANSITION STATE ANALOG COMPLEX) 1UNE ; 1.50 ; CARBOXYLIC ESTER HYDROLASE, 1.5 ANGSTROM ORTHORHOMBIC FORM OF THE BOVINE RECOMBINANT PLA2 1MKT ; 1.72 ; CARBOXYLIC ESTER HYDROLASE, 1.72 ANGSTROM TRIGONAL FORM OF THE BOVINE RECOMBINANT PLA2 ENZYME 1LE7 ; 2.09 ; CARBOXYLIC ESTER HYDROLASE, C 2 2 21 SPACE GROUP 1MKU ; 1.80 ; CARBOXYLIC ESTER HYDROLASE, ORTHORHOMBIC FORM OF THE TRIPLE MUTANT 1LE6 ; 1.97 ; CARBOXYLIC ESTER HYDROLASE, P 1 21 1 SPACE GROUP 1KVY ; 1.90 ; CARBOXYLIC ESTER HYDROLASE, SINGLE MUTANT D49E COORDINATED TO CALCIUM 1KVX ; 1.90 ; CARBOXYLIC ESTER HYDROLASE, SINGLE MUTANT D99A OF BOVINE PANCREATIC PLA2, 1.9 A ORTHORHOMBIC FORM 1KVW ; 1.95 ; CARBOXYLIC ESTER HYDROLASE, SINGLE MUTANT H48Q OF BOVINE PANCREATIC PLA2 ENZYME 1MKS ; 1.90 ; CARBOXYLIC ESTER HYDROLASE, TRIGONAL FORM OF THE TRIPLE MUTANT 2A7K ; 2.24 ; CARBOXYMETHYLPROLINE SYNTHASE (CARB) FROM PECTOBACTERIUM CAROTOVORA, APO ENZYME 2A81 ; 3.15 ; CARBOXYMETHYLPROLINE SYNTHASE (CARB) FROM PECTOBACTERIUM CAROTOVORA, COMPLEXED WITH ACETYL COA AND BICINE 1F57 ; 1.75 ; CARBOXYPEPTIDASE A COMPLEX WITH D-CYSTEINE AT 1.75 A 1BAV ; 1.60 ; CARBOXYPEPTIDASE A COMPLEXED WITH 2-BENZYL-3-IODO-PROPANOIC ACID (BIP) 1ARL ; 1.86 ; CARBOXYPEPTIDASE A WITH ZN REMOVED 1ARM ; 1.74 ; CARBOXYPEPTIDASE A WITH ZN REPLACED BY HG 1CG2 ; 2.50 ; CARBOXYPEPTIDASE G2 1OBR ; 2.30 ; CARBOXYPEPTIDASE T 2A1B ; 2.90 ; CARBOXYSOME SHELL PROTEIN CCMK2 2A10 ; 1.80 ; CARBOXYSOME SHELL PROTEIN CCMK4 2A18 ; 2.28 ; CARBOXYSOME SHELL PROTEIN CCMK4, CRYSTAL FORM 2 2YGS ; 1.60 ; CARD DOMAIN FROM APAF-1 1YAL ; 1.70 ; CARICA PAPAYA CHYMOPAPAIN AT 1.7 ANGSTROMS RESOLUTION 1NDF ; 1.90 ; CARNITINE ACETYLTRANSFERASE IN COMPLEX WITH CARNITINE 1NDI ; 2.30 ; CARNITINE ACETYLTRANSFERASE IN COMPLEX WITH COA 1CKJ ; 2.46 ; CASEIN KINASE I DELTA TRUNCATION MUTANT CONTAINING RESIDUES 1 - 317 COMPLEX WITH BOUND TUNGSTATE 1NMS ; 1.70 ; CASPASE-3 TETHERED TO IRREVERSIBLE INHIBITOR 1SHJ ; 2.80 ; CASPASE-7 IN COMPLEX WITH DICA ALLOSTERIC INHIBITOR 1SHL ; 3.00 ; CASPASE-7 IN COMPLEX WITH FICA ALLOSTERIC INHIBITOR 1F9E ; 2.90 ; CASPASE-8 SPECIFICITY PROBED AT SUBSITE S4: CRYSTAL STRUCTURE OF THE CASPASE-8-Z-DEVD-CHO 1DXH ; 2.50 ; CATABOLIC ORNITHINE CARBAMOYLTRANSFERASE FROM PSEUDOMONAS AERUGINOSA 1J59 ; 2.50 ; CATABOLITE GENE ACTIVATOR PROTEIN (CAP)/DEOXYRIBONUCLEIC ACID COMPLEX + ADENOSINE-3',5'-CYCLIC-MONOPHOSPHATE 2CGP ; 2.20 ; CATABOLITE GENE ACTIVATOR PROTEIN/DEOXYRIBONUCLEIC ACID COMPLEX, ADENOSINE-3', 5'-CYCLIC-MONOPHOSPHATE 1A4E ; 2.40 ; CATALASE A FROM SACCHAROMYCES CEREVISIAE 2CAG ; 2.70 ; CATALASE COMPOUND II 1HBZ ; 1.50 ; CATALASE FROM MICROCOCCUS LYSODEIKTICU 1QH6 ; 2.00 ; CATALYSIS AND SPECIFICITY IN ENZYMATIC GLYCOSIDE HYDROLASES: A 2,5B CONFORMATION FOR THE GLYCOSYL-ENZYME INTERMIDIATE REVEALED BY THE STRUCTURE OF THE BACILLUS AGARADHAERENS FAMILY 11 XYLANASE 1QH7 ; 1.78 ; CATALYSIS AND SPECIFICITY IN ENZYMATIC GLYCOSIDE HYDROLASES: A 2,5B CONFORMATION FOR THE GLYCOSYL-ENZYME INTERMIDIATE REVEALED BY THE STRUCTURE OF THE BACILLUS AGARADHAERENS FAMILY 11 XYLANASE 1A3L ; 1.95 ; CATALYSIS OF A DISFAVORED REACTION: AN ANTIBODY EXO DIELS-ALDERASE-TSA-INHIBITOR COMPLEX AT 1.95 A RESOLUTION 1LUV ; 1.85 ; CATALYTIC AND STRUCTURAL EFFECTS OF AMINO-ACID SUBSTITUTION AT HIS 30 IN HUMAN MANGANESE SUPEROXIDE DISMUTASE: INSERTION OF VAL CGAMMA INTO THE SUBSTRATE ACCESS CHANNEL 1LUW ; 2.30 ; CATALYTIC AND STRUCTURAL EFFECTS OF AMINO-ACID SUBSTITUTION AT HIS 30 IN HUMAN MANGANESE SUPEROXIDE DISMUTASE: INSERTION OF VAL CGAMMA INTO THE SUBSTRATE ACCESS CHANNEL 1N0N ; 1.82 ; CATALYTIC AND STRUCTURAL EFFECTS OF AMINO-ACID SUBSTITUTION AT HIS30 IN HUMAN MANGANESE SUPEROXIDE DISMUTASE 1UM6 ; 1.80 ; CATALYTIC ANTIBODY 21H3 1UM5 ; 1.60 ; CATALYTIC ANTIBODY 21H3 WITH ALCOHOL SUBSTRATE 1UM4 ; 1.80 ; CATALYTIC ANTIBODY 21H3 WITH HAPTEN 1KEM ; 2.20 ; CATALYTIC ANTIBODY 28B4 FAB FRAGMENT 1KEL ; 1.90 ; CATALYTIC ANTIBODY 28B4 FAB FRAGMENT COMPLEXED WITH HAPTEN (1-[N-4'-NITROBENZYL-N-4'-CARBOXYBUTYLAMINO] METHYLPHOSPHONIC ACID) 1F3D ; 1.87 ; CATALYTIC ANTIBODY 4B2 IN COMPLEX WITH ITS AMIDINIUM HAPTEN. 25C8 ; 2.00 ; CATALYTIC ANTIBODY 5C8, FAB-HAPTEN COMPLEX 35C8 ; 2.00 ; CATALYTIC ANTIBODY 5C8, FAB-INHIBITOR COMPLEX 15C8 ; 2.50 ; CATALYTIC ANTIBODY 5C8, FREE FAB 1CT8 ; 2.20 ; CATALYTIC ANTIBODY 7C8 COMPLEX 1YEJ ; 1.85 ; CATALYTIC ANTIBODY COMPLEX 1KN2 ; 1.90 ; CATALYTIC ANTIBODY D2.3 COMPLEX 1KN4 ; 1.90 ; CATALYTIC ANTIBODY D2.3 COMPLEX 1YEI ; 1.90 ; CATALYTIC ANTIBODY D2.3 COMPLEX 1YEK ; 2.10 ; CATALYTIC ANTIBODY D2.3 COMPLEX 1FL2 ; 1.90 ; CATALYTIC CORE COMPONENT OF THE ALKYLHYDROPEROXIDE REDUCTASE AHPF FROM E.COLI 1QOZ ; 1.90 ; CATALYTIC CORE DOMAIN OF ACETYL XYLAN ESTERASE FROM TRICHODERMA REESEI 1CLX ; 1.80 ; CATALYTIC CORE OF XYLANASE A 1XYS ; 2.50 ; CATALYTIC CORE OF XYLANASE A E246C MUTANT 1E2O ; 3.00 ; CATALYTIC DOMAIN FROM DIHYDROLIPOAMIDE SUCCINYLTRANSFERASE 1C4T ; 3.00 ; CATALYTIC DOMAIN FROM TRIMERIC DIHYDROLIPOAMIDE SUCCINYLTRANSFERASE 1WEG ; 1.80 ; CATALYTIC DOMAIN OD MUTY FORM ESCHERICHIA COLI K142A MUTANT 1AIH ; 2.50 ; CATALYTIC DOMAIN OF BACTERIOPHAGE HP1 INTEGRASE 1ITX ; 1.10 ; CATALYTIC DOMAIN OF CHITINASE A1 FROM BACILLUS CIRCULANS WL- 12 2BX2 ; 2.85 ; CATALYTIC DOMAIN OF E. COLI RNASE E 2C4R ; 3.60 ; CATALYTIC DOMAIN OF E. COLI RNASE E 2C0B ; 3.18 ; CATALYTIC DOMAIN OF E. COLI RNASE E IN COMPLEX WITH 13-MER RIBONUCLEIC ACID 1RR9 ; 2.10 ; CATALYTIC DOMAIN OF E.COLI LON PROTEASE 2BOD ; 1.50 ; CATALYTIC DOMAIN OF ENDO-1,4-GLUCANASE CEL6A FROM THERMOBIFIDA FUSCA IN COMPLEX WITH METHYL CELLOBIOSYL-4- THIO-BETA-CELLOBIOSIDE 2BOE ; 1.15 ; CATALYTIC DOMAIN OF ENDO-1,4-GLUCANASE CEL6A MUTANT Y73S FROM THERMOBIFIDA FUSCA 2BOF ; 1.64 ; CATALYTIC DOMAIN OF ENDO-1,4-GLUCANASE CEL6A MUTANT Y73S FROM THERMOBIFIDA FUSCA IN COMPLEX WITH CELLOTETROSE 2BOG ; 1.04 ; CATALYTIC DOMAIN OF ENDO-1,4-GLUCANASE CEL6A MUTANT Y73S FROM THERMOBIFIDA FUSCA IN COMPLEX WITH METHYL CELLOBIOSYL- 4-THIO-BETA-CELLOBIOSIDE 1BI4 ; 2.46 ; CATALYTIC DOMAIN OF HIV-1 INTEGRASE 1BL3 ; 2.00 ; CATALYTIC DOMAIN OF HIV-1 INTEGRASE 2ITG ; 2.60 ; CATALYTIC DOMAIN OF HIV-1 INTEGRASE: ORDERED ACTIVE SITE IN THE F185H CONSTRUCT 2ARY ; 2.40 ; CATALYTIC DOMAIN OF HUMAN CALPAIN-1 1ZIV ; 2.31 ; CATALYTIC DOMAIN OF HUMAN CALPAIN-9 1KW0 ; 2.50 ; CATALYTIC DOMAIN OF HUMAN PHENYLALANINE HYDROXYLASE (FE(II) ) IN COMPLEX WITH TETRAHYDROBIOPTERIN AND THIENYLALANINE 1J8T ; 1.70 ; CATALYTIC DOMAIN OF HUMAN PHENYLALANINE HYDROXYLASE FE(II) 1J8U ; 1.50 ; CATALYTIC DOMAIN OF HUMAN PHENYLALANINE HYDROXYLASE FE(II) IN COMPLEX WITH TETRAHYDROBIOPTERIN 1TAZ ; 1.77 ; CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 1B 1SO2 ; 2.40 ; CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 3B IN COMPLEX WITH A DIHYDROPYRIDAZINE INHIBITOR 1SOJ ; 2.90 ; CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 3B IN COMPLEX WITH IBMX 1XM6 ; 1.92 ; CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH (R)-MESOPRAM 1XMY ; 2.40 ; CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH (R)-ROLIPRAM 1XN0 ; 2.31 ; CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH (R,S)-ROLIPRAM 1Y2H ; 2.40 ; CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH 1-(2-CHLORO-PHENYL)-3,5-DIMETHYL-1H-PYRAZOLE-4- CARBOXYLIC ACID ETHYL ESTER 1Y2J ; 2.55 ; CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH 3,5-DIMETHYL-1-(3-NITRO-PHENYL)-1H-PYRAZOLE-4- CARBOXYLIC ACID ETHYL ESTER 1TB5 ; 2.15 ; CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH AMP 1XLX ; 2.19 ; CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH CILOMILAST 1XLZ ; 2.06 ; CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH FILAMINAST 1XM4 ; 2.31 ; CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH PICLAMILAST 1XMU ; 2.30 ; CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH ROFLUMILAST 1XOS ; 2.28 ; CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH SILDENAFIL 1XOT ; 2.34 ; CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH VARDENAFIL 1F0J ; 1.77 ; CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B2B 1Y2E ; 2.10 ; CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH 1-(4-AMINO-PHENYL)-3,5-DIMETHYL-1H-PYRAZOLE-4- CARBOXYLIC ACID ETHYL ESTER 1Y2D ; 1.70 ; CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH 1-(4-METHOXY-PHENYL)-3,5-DIMETHYL-1H-PYRAZOLE-4- CARBOXYLIC ACID ETHYL ESTER 1Y2K ; 1.36 ; CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH 3,5-DIMETHYL-1-(3-NITRO-PHENYL)-1H-PYRAZOLE-4- CARBOXYLIC ACID ETHYL ESTER 1Y2C ; 1.67 ; CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH 3,5-DIMETHYL-1-PHENYL-1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER 1Y2B ; 1.40 ; CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH 3,5-DIMETHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER 1TB7 ; 1.63 ; CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH AMP 1XOM ; 1.55 ; CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH CILOMILAST 1XON ; 1.72 ; CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH PICLAMILAST 1XOQ ; 1.83 ; CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH ROFLUMILAST 1TBB ; 1.60 ; CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH ROLIPRAM 1XOR ; 1.54 ; CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH ZARDAVERINE 1T9R ; 2.10 ; CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 5A 1T9S ; 2.00 ; CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 5A IN COMPLEX WITH GMP 1TBF ; 1.30 ; CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 5A IN COMPLEX WITH SILDENAFIL 1XOZ ; 1.37 ; CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 5A IN COMPLEX WITH TADALAFIL 1XP0 ; 1.79 ; CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 5A IN COMPLEX WITH VARDENAFIL 1BDA ; 3.25 ; CATALYTIC DOMAIN OF HUMAN SINGLE CHAIN TISSUE PLASMINOGEN ACTIVATOR IN COMPLEX WITH DANSYL-EGR-CMK (DANSYL-GLU-GLY-ARG CHLOROMETHYL KETONE) 2SRT ; -1.00 ; CATALYTIC DOMAIN OF HUMAN STROMELYSIN-1 AT PH 5.5 AND 40OC COMPLEXED WITH INHIBITOR 1A5H ; 2.90 ; CATALYTIC DOMAIN OF HUMAN TWO-CHAIN TISSUE PLASMINOGEN ACTIVATOR COMPLEX OF A BIS-BENZAMIDINE 1MK0 ; 1.60 ; CATALYTIC DOMAIN OF INTRON ENDONUCLEASE I-TEVI, E75A MUTANT 1MUY ; 1.40 ; CATALYTIC DOMAIN OF MUTY FROM ESCHERICHIA COLI 1MUN ; 1.20 ; CATALYTIC DOMAIN OF MUTY FROM ESCHERICHIA COLI D138N MUTANT 1WEF ; 1.90 ; CATALYTIC DOMAIN OF MUTY FROM ESCHERICHIA COLI K20A MUTANT 1WEI ; 1.45 ; CATALYTIC DOMAIN OF MUTY FROM ESCHERICHIA COLI K20A MUTANT COMPLEXED TO ADENINE 1MUD ; 1.80 ; CATALYTIC DOMAIN OF MUTY FROM ESCHERICHIA COLI, D138N MUTANT COMPLEXED TO ADENINE 1O6Y ; 2.20 ; CATALYTIC DOMAIN OF PKNB KINASE FROM MYCOBACTERIUM TUBERCULOSIS 1QRZ ; 2.00 ; CATALYTIC DOMAIN OF PLASMINOGEN 1EAK ; 2.66 ; CATALYTIC DOMAIN OF PROMMP-2 E404Q MUTANT 5GCN ; -1.00 ; CATALYTIC DOMAIN OF TETRAHYMENA GCN5 HISTONE ACETYLTRANSFERASE IN COMPLEX WITH COENZYME A 1M55 ; 1.40 ; CATALYTIC DOMAIN OF THE ADENO ASSOCIATED VIRUS TYPE 5 REP PROTEIN 1BKC ; 2.00 ; CATALYTIC DOMAIN OF TNF-ALPHA CONVERTING ENZYME (TACE) 1A5I ; 2.90 ; CATALYTIC DOMAIN OF VAMPIRE BAT (DESMODUS ROTUNDUS) SALIVA PLASMINOGEN ACTIVATOR IN COMPLEX WITH EGR-CMK (GLU-GLY-ARG CHLOROMETHYL KETONE) 1Y0L ; 2.50 ; CATALYTIC ELIMINATION ANTIBODY 34E4 IN COMPLEX WITH HAPTEN 4AYK ; -1.00 ; CATALYTIC FRAGMENT OF HUMAN FIBROBLAST COLLAGENASE COMPLEXED WITH CGS-27023A, NMR, 30 STRUCTURES 3AYK ; -1.00 ; CATALYTIC FRAGMENT OF HUMAN FIBROBLAST COLLAGENASE COMPLEXED WITH CGS-27023A, NMR, MINIMIZED AVERAGE STRUCTURE 1JYK ; 1.50 ; CATALYTIC MECHANISM OF CTP:PHOSPHOCHOLINE CYTIDYLYTRANSFERASE FROM STREPTOCOCCUS PNEUMONIAE (LICC) 1JYL ; 2.40 ; CATALYTIC MECHANISM OF CTP:PHOSPHOCHOLINE CYTIDYLYTRANSFERASE FROM STREPTOCOCCUS PNEUMONIAE (LICC) 1G72 ; 1.90 ; CATALYTIC MECHANISM OF QUINOPROTEIN METHANOL DEHYDROGENASE: A THEORETICAL AND X-RAY CRYSTALLOGRAPHIC INVESTIGATION 1LO0 ; 2.00 ; CATALYTIC RETRO-DIELS-ALDERASE TRANSITION STATE ANALOGUE COMPLEX 488D ; 3.10 ; CATALYTIC RIBONUCLEIC ACID ENZYME-PRODUCT COMPLEX 3CSU ; 1.88 ; CATALYTIC TRIMER OF ESCHERICHIA COLI ASPARTATE TRANSCARBAMOYLASE 1LVM ; 1.80 ; CATALYTICALLY ACTIVE TOBACCO ETCH VIRUS PROTEASE COMPLEXED WITH PRODUCT 1YQL ; 2.60 ; CATALYTICALLY INACTIVE HOGG1 CROSSLINKED WITH 7-DEAZA-8- AZAGUANINE CONTAINING DEOXYRIBONUCLEIC ACID 1YQM ; 2.50 ; CATALYTICALLY INACTIVE HUMAN 8-OXOGUANINE GLYCOSYLASE CROSSLINKED TO 7-DEAZAGUANINE CONTAINING DEOXYRIBONUCLEIC ACID 1YQR ; 2.43 ; CATALYTICALLY INACTIVE HUMAN 8-OXOGUANINE GLYCOSYLASE CROSSLINKED TO OXOG CONTAINING DEOXYRIBONUCLEIC ACID 1LVB ; 2.20 ; CATALYTICALLY INACTIVE TOBACCO ETCH VIRUS PROTEASE COMPLEXED WITH SUBSTRATE 1XEP ; 1.55 ; CATECHOL IN COMPLEX WITH T4 LYSOZYME L99A/M102Q 1H1D ; 2.00 ; CATECHOL O-METHYLTRANSFERASE 1VID ; 2.00 ; CATECHOL O-METHYLTRANSFERASE 1JR4 ; 2.63 ; CATECHOL O-METHYLTRANSFERASE BISUBSTRATE-INHIBITOR COMPLEX 1BT1 ; 2.70 ; CATECHOL OXIDASE FROM IPOMOEA BATATAS (SWEET POTATOES) IN THE NATIVE CU(II)-CU(II) STATE 1BT3 ; 2.50 ; CATECHOL OXIDASE FROM IPOMOEA BATATAS (SWEET POTATOES) IN THE NATIVE CU(II)-CU(II) STATE 1BT2 ; 2.70 ; CATECHOL OXIDASE FROM IPOMOEA BATATAS (SWEET POTATOES) IN THE REDUCED CU(I)-CU(I) STATE 1BUG ; 2.70 ; CATECHOL OXIDASE FROM IPOMOEA BATATAS (SWEET POTATOES)- INHIBITOR COMPLEX WITH PHENYLTHIOUREA (PTU) 1PFP ; 2.30 ; CATHELIN-LIKE MOTIF OF PROTEGRIN-3 1GMY ; 1.90 ; CATHEPSIN B COMPLEXED WITH DIPEPTIDYL NITRILE INHIBITOR 1LYW ; 2.50 ; CATHEPSIN D AT PH 7.5 1YT7 ; 2.30 ; CATHEPSIN K COMPLEXED WITH A CONSTRAINED KETOAMIDE INHIBITOR 1YK8 ; 2.60 ; CATHEPSIN K COMPLEXED WITH A CYANAMIDE-BASED INHIBITOR 1YK7 ; 2.50 ; CATHEPSIN K COMPLEXED WITH A CYANOPYRROLIDINE INHIBITOR 1TU6 ; 1.75 ; CATHEPSIN K COMPLEXED WITH A KETOAMIDE INHIBITOR 1SNK ; 2.40 ; CATHEPSIN K COMPLEXED WITH CARBAMATE DERIVATIZED NORLEUCINE ALDEHYDE 1Q6K ; 2.10 ; CATHEPSIN K COMPLEXED WITH T-BUTYL(1S)-1-CYCLOHEXYL-2- OXOETHYLCARBAMATE 1KYN ; 3.50 ; CATHEPSIN-G 1ND0 ; 2.45 ; CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG 1NCW ; 1.30 ; CATIONIC CYCLIZATION ANTIBODY 4C6 IN COMPLEX WITH BENZOIC ACID 1QSQ ; 1.90 ; CAVITY CREATING MUTATION 6CEL ; 1.70 ; CBH1 (E212Q) CELLOPENTAOSE COMPLEX 5CEL ; 1.90 ; CBH1 (E212Q) CELLOTETRAOSE COMPLEX 7CEL ; 1.90 ; CBH1 (E217Q) IN COMPLEX WITH CELLOHEXAOSE AND CELLOBIOSE 1DY4 ; 1.90 ; CBH1 IN COMPLEX WITH S-PROPRANOLOL 1W90 ; 1.60 ; CBM29-2 MUTANT D114A: PROBING THE MECHANISM OF LIGAND RECOGNITION BY FAMILY 29 CARBOHYDRATE BINDING MODULES 1W8U ; 1.30 ; CBM29-2 MUTANT D83A COMPLEXED WITH MANNOHEXAOSE: PROBING THE MECHANISM OF LIGAND RECOGNITION BY FAMILY 29 CARBOHYDRATE BINDING MODULES 1W8T ; 1.40 ; CBM29-2 MUTANT K74A COMPLEXED WITH CELLULOHEXAOSE: PROBING THE MECHANISM OF LIGAND RECOGNITION BY FAMILY 29 CARBOHYDRATE BINDING MODULES 1W8Z ; 1.85 ; CBM29-2 MUTANT K85A: PROBING THE MECHANISM OF LIGAND RECOGNITION BY FAMILY 29 CARBOHYDRATE BINDING MODULES 1W9F ; 2.25 ; CBM29-2 MUTANT R112A: PROBING THE MECHANISM OF LIGAND RECOGNITION BY FAMILY 29 CARBOHYDRATE BINDING MODULES 1W8W ; 2.10 ; CBM29-2 MUTANT Y46A: PROBING THE MECHANISM OF LIGAND RECOGNITION BY FAMILY 29 CARBOHYDRATE BINDING MODULES 1WCU ; 1.50 ; CBM29_1, A FAMILY 29 CARBOHYDRATE BINDING MODULE FROM PIROMYCES EQUI 1GU3 ; 2.30 ; CBM4 STRUCTURE AND FUNCTION 1GUI ; 1.90 ; CBM4 STRUCTURE AND FUNCTION 1UXX ; 1.60 ; CBM6CT FROM CLOSTRIDIUM THERMOCELLUM IN COMPLEX WITH XYLOPENTAOSE 1PBJ ; 1.40 ; CBS DOMAIN PROTEIN 2BKA ; 1.70 ; CC3(TIP30)CRYSTAL STRUCURE 1YMZ ; -1.00 ; CC45, AN ARTIFICIAL WW DOMAIN DESIGNED USING STATISTICAL COUPLING ANALYSIS 1ZF1 ; 1.35 ; CCC A-DEOXYRIBONUCLEIC ACID 1VUB ; 2.60 ; CCDB, A TOPOISOMERASE POISON FROM E. COLI 2VUB ; 2.45 ; CCDB, A TOPOISOMERASE POISON FROM E. COLI 3VUB ; 1.40 ; CCDB, A TOPOISOMERASE POISON FROM E. COLI 4VUB ; 1.45 ; CCDB, A TOPOISOMERASE POISON FROM ESCHERICHIA COLI 1X75 ; 2.80 ; CCDB:GYRA14 COMPLEX 1ZEX ; 1.65 ; CCG A-DEOXYRIBONUCLEIC ACID 1G3W ; 2.40 ; CD-CYS102SER DTXR 1CD1 ; 2.67 ; CD1(MOUSE) ANTIGEN PRESENTING MOLECULE 1ZOO ; 3.00 ; CD11A I-DOMAIN WITH BOUND MAGNESIUM ION 1ZOP ; 2.00 ; CD11A I-DOMAIN WITH BOUND MAGNESIUM ION 1LFA ; 1.80 ; CD11A I-DOMAIN WITH BOUND MN++ 1ZON ; 2.00 ; CD11A I-DOMAIN WITHOUT BOUND CATION 1GZP ; 2.80 ; CD1B IN COMPLEX WITH GM2 GANGLIOSIDE 1GZQ ; 2.26 ; CD1B IN COMPLEX WITH PHOPHATIDYLINOSITOL 1CDC ; 2.00 ; CD2, N-TERMINAL DOMAIN (1-99), TRUNCATED FORM 1L2Z ; -1.00 ; CD2BP2-GYF DOMAIN IN COMPLEX WITH PROLINE-RICH CD2 TAIL SEGMENT PEPTIDE 1XMW ; -1.00 ; CD3 EPSILON AND DELTA ECTODOMAIN FRAGMENT COMPLEX IN SINGLE- CHAIN CONSTRUCT 1JBJ ; -1.00 ; CD3 EPSILON AND GAMMA ECTODOMAIN FRAGMENT COMPLEX IN SINGLE- CHAIN CONSTRUCT 1E0A ; -1.00 ; CDC42 COMPLEXED WITH THE GTPASE BINDING DOMAIN OF P21 ACTIVATED KINASE 1AJE ; -1.00 ; CDC42 FROM HUMAN, NMR, 20 STRUCTURES 1CF4 ; -1.00 ; CDC42/ACK GTPASE-BINDING DOMAIN COMPLEX 1AN0 ; 2.80 ; CDC42HS-GDP COMPLEX 1GGW ; -1.00 ; CDC4P FROM SCHIZOSACCHAROMYCES POMBE 1R78 ; 2.00 ; CDK2 COMPLEX WITH A 4-ALKYNYL OXINDOLE INHIBITOR 1KE5 ; 2.20 ; CDK2 COMPLEXED WITH N-METHYL-4-{[(2-OXO-1,2-DIHYDRO-3H- INDOL-3-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE 1H01 ; 1.79 ; CDK2 IN COMPLEX WITH A DISUBSTITUTED 2, 4-BIS ANILINO PYRIMIDINE CDK4 INHIBITOR 1H08 ; 1.80 ; CDK2 IN COMPLEX WITH A DISUBSTITUTED 2, 4-BIS ANILINO PYRIMIDINE CDK4 INHIBITOR 1H00 ; 1.60 ; CDK2 IN COMPLEX WITH A DISUBSTITUTED 4, 6-BIS ANILINO PYRIMIDINE CDK4 INHIBITOR 1H07 ; 1.85 ; CDK2 IN COMPLEX WITH A DISUBSTITUTED 4, 6-BIS ANILINO PYRIMIDINE CDK4 INHIBITOR 1V1K ; 2.31 ; CDK2 IN COMPLEX WITH A DISUBSTITUTED 4, 6-BIS ANILINO PYRIMIDINE CDK4 INHIBITOR 1URW ; 1.60 ; CDK2 IN COMPLEX WITH AN IMIDAZO[1,2-B]PYRIDAZINE 1H24 ; 2.50 ; CDK2/CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT PEPTIDE FROM E2F 1H28 ; 2.80 ; CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P107 1H27 ; 2.20 ; CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P27 1H26 ; 2.24 ; CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P53 1H25 ; 2.50 ; CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM RETINOBLASTOMA-ASSOCIATED PROTEIN 1F0H ; -1.00 ; CECROPIN A(1-8)-MAGAININ 2(1-12) A2 IN DODECYLPHOSPHOCHOLINE MICELLES 1F0F ; -1.00 ; CECROPIN A(1-8)-MAGAININ 2(1-12) GIG DELETION MODIFICATION IN DODECYLPHOSPHOCHOLINE MICELLES 1F0D ; -1.00 ; CECROPIN A(1-8)-MAGAININ 2(1-12) IN DODECYLPHOSPHOCHOLINE MICELLES 1F0G ; -1.00 ; CECROPIN A(1-8)-MAGAININ 2(1-12) L2 IN DODECYLPHOSPHOCHOLINE MICELLES 1F0E ; -1.00 ; CECROPIN A(1-8)-MAGAININ 2(1-12) MODIFIED GIG TO P IN DODECYLPHOSPHOCHOLINE MICELLES 1CEF ; 2.04 ; CEFOTAXIME COMPLEXED WITH THE STREPTOMYCES R61 DD-PEPTIDASE 1QJW ; 1.90 ; CEL6A (Y169F) WITH A NON-HYDROLYSABLE CELLOTETRAOSE 1HGW ; 2.10 ; CEL6A D175A MUTANT 1HGY ; 2.20 ; CEL6A D221A MUTANT 1QK0 ; 2.10 ; CEL6A IN COMPLEX WITH M-IODOBENZYL BETA-D-GLUCOPYRANOSYL- BETA(1,4)-D-XYLOPYRANOSIDE 1JZU ; -1.00 ; CELL TRANSFORMATION BY THE MYC ONCOGENE ACTIVATES EXPRESSION OF A LIPOCALIN: ANALYSIS OF THE GENE (Q83) AND SOLUTION STRUCTURE OF ITS PROTEIN PRODUCT 1EGN ; 1.60 ; CELLOBIOHYDROLASE CEL7A (E223S, A224H, L225V, T226A, D262G) MUTANT 1Q2B ; 1.60 ; CELLOBIOHYDROLASE CEL7A WITH DISULPHIDE BRIDGE ADDED ACROSS EXO-LOOP BY MUTATIONS D241C AND D249C 1Q2E ; 1.75 ; CELLOBIOHYDROLASE CEL7A WITH LOOP DELETION 245-252 AND BOUND NON-HYDROLYSABLE CELLOTETRAOSE 1GPI ; 1.32 ; CELLOBIOHYDROLASE CEL7D (CBH 58) FROM PHANEROCHAETE CHRYSOSPORIUM. CATALYTIC MODULE AT 1.32 ANG RESOLUTION 1BVW ; 1.92 ; CELLOBIOHYDROLASE II (CEL6A) FROM HUMICOLA INSOLENS 2BVW ; 1.70 ; CELLOBIOHYDROLASE II (CEL6A) FROM HUMICOLA INSOLENS IN COMPLEX WITH GLUCOSE AND CELLOTETRAOSE 1CB2 ; 2.00 ; CELLOBIOHYDROLASE II, CATALYTIC DOMAIN, MUTANT Y169F 2A3H ; 2.00 ; CELLOBIOSE COMPLEX OF THE ENDOGLUCANASE CEL5A FROM BACILLUS AGARADHERANS AT 2.0 A RESOLUTION 1NAA ; 1.80 ; CELLOBIOSE DEHYDROGENASE FLAVOPROTEIN FRAGMENT IN COMPLEX WITH CELLOBIONOLACTAM 8A3H ; 0.97 ; CELLOBIOSE-DERIVED IMIDAZOLE COMPLEX OF THE ENDOGLUCANASE CEL5A FROM BACILLUS AGARADHAERENS AT 0.97 A RESOLUTION 3A3H ; 1.64 ; CELLOTRIOSE COMPLEX OF THE ENDOGLUCANASE CEL5A FROM BACILLUS AGARADHERANS AT 1.6 A RESOLUTION 2CBR ; 2.80 ; CELLULAR RETINOIC ACID BINDING PROTEIN I IN COMPLEX WITH A RETINOBENZOIC ACID (AM80) 3CBS ; 2.00 ; CELLULAR RETINOIC ACID BINDING PROTEIN II IN COMPLEX WITH A SYNTHETIC RETINOIC ACID (RO-12 7310) 2CBS ; 2.10 ; CELLULAR RETINOIC ACID BINDING PROTEIN II IN COMPLEX WITH A SYNTHETIC RETINOIC ACID (RO-13 6307) 1CEO ; 1.90 ; CELLULASE (CELC) MUTANT WITH GLU 140 REPLACED BY GLN 1CEN ; 2.30 ; CELLULASE (CELC) MUTANT WITH GLU 140 REPLACED BY GLN COMPLEXED WITH CELLOHEXAOSE 1EGZ ; 2.30 ; CELLULASE CEL5 FROM ERWINIA CHRYSANTHEMI, A FAMILY GH 5-2 ENZYME 1TVN ; 1.41 ; CELLULASE CEL5G FROM PSEUDOALTEROMONAS HALOPLANKTIS, A FAMILY GH 5-2 ENZYME 2XYL ; 1.90 ; CELLULOMONAS FIMI XYLANASE/CELLULASE COMPLEXED WITH 2-DEOXY-2-FLUORO-XYLOBIOSE 2HIS ; 1.80 ; CELLULOMONAS FIMI XYLANASE/CELLULASE DOUBLE MUTANT E127A/H205N WITH COVALENT CELLOBIOSE 1QOU ; 1.90 ; CEN (CENTRORADIALIS) PROTEIN FROM ANTIRRHINUM 1GXE ; -1.00 ; CENTRAL DOMAIN OF CARDIAC MYOSIN BINDING PROTEIN C 1OB4 ; 0.95 ; CEPHAIBOL A 1OB6 ; 0.89 ; CEPHAIBOL B 1OB7 ; 0.89 ; CEPHAIBOL C 1ODS ; 1.90 ; CEPHALOSPORIN C DEACETYLASE FROM BACILLUS SUBTILIS 1ODT ; 1.70 ; CEPHALOSPORIN C DEACETYLASE MUTATED, IN COMPLEX WITH ACETATE 1CEG ; 1.76 ; CEPHALOTHIN COMPLEXED WITH DD-PEPTIDASE 1QMJ ; 2.15 ; CG-16, A HOMODIMERIC AGGLUTININ FROM CHICKEN LIVER 1ZEY ; 1.70 ; CGG A-DEOXYRIBONUCLEIC ACID 1ULF ; 2.36 ; CGL2 IN COMPLEX WITH BLOOD GROUP A TETRASACCHARIDE 1ULD ; 2.10 ; CGL2 IN COMPLEX WITH BLOOD GROUP H TYPE II 1ULC ; 2.60 ; CGL2 IN COMPLEX WITH LACTOSE 1ULE ; 2.15 ; CGL2 IN COMPLEX WITH LINEAR B2 TRISACCHARIDE 1ULG ; 2.20 ; CGL2 IN COMPLEX WITH THOMSEN-FRIEDENREICH ANTIGEN 1UL9 ; 2.22 ; CGL2 LIGANDFREE 1VF4 ; 2.45 ; CGSTA1-1 APO FORM 1VF1 ; 1.77 ; CGSTA1-1 IN COMPLEX WITH GLUTATHIONE 1VF3 ; 2.15 ; CGSTA1-1 IN COMPLEX WITH GLUTATHIONE CONJUGATE OF CDNB 1VF2 ; 2.15 ; CGSTA1-1 IN COMPLEX WITH S-HEXYL-GLUTATHIONE 1A47 ; 2.56 ; CGTASE FROM THERMOANAEROBACTERIUM THERMOSULFURIGENES EM1 IN COMPLEX WITH A MALTOHEXAOSE INHIBITOR 1EYP ; 2.50 ; CHALCONE ISOMERASE 1EYQ ; 1.85 ; CHALCONE ISOMERASE AND NARINGENIN 1JEP ; 2.10 ; CHALCONE ISOMERASE COMPLEXED WITH 4'-HYDROXYFLAVANONE 1FM8 ; 2.30 ; CHALCONE ISOMERASE COMPLEXED WITH 5,4'-DIDEOXYFLAVANONE 1FM7 ; 2.30 ; CHALCONE ISOMERASE COMPLEXED WITH 5-DEOXYFLAVANONE 1JX1 ; 2.30 ; CHALCONE ISOMERASE--T48A MUTANT 1JX0 ; 2.85 ; CHALCONE ISOMERASE--Y106F MUTANT 1ZGD ; 1.70 ; CHALCONE REDUCTASE COMPLEXED WITH NADP+ AT 1.7 ANGSTROM RESOLUTION 1I8B ; 1.95 ; CHALCONE SYNTHASE (G256F) 1I89 ; 1.86 ; CHALCONE SYNTHASE (G256L) 1I88 ; 1.45 ; CHALCONE SYNTHASE (G256V) 1D6I ; 2.00 ; CHALCONE SYNTHASE (H303Q MUTANT) 1D6F ; 1.69 ; CHALCONE SYNTHASE C164A MUTANT 1BI5 ; 1.56 ; CHALCONE SYNTHASE FROM ALFALFA 1CHW ; 1.90 ; CHALCONE SYNTHASE FROM ALFALFA COMPLEXED WITH HEXANOYL-COA 1CML ; 1.69 ; CHALCONE SYNTHASE FROM ALFALFA COMPLEXED WITH MALONYL-COA 1CGK ; 1.84 ; CHALCONE SYNTHASE FROM ALFALFA COMPLEXED WITH NARINGENIN 1CGZ ; 1.70 ; CHALCONE SYNTHASE FROM ALFALFA COMPLEXED WITH RESVERATROL 1BQ6 ; 1.56 ; CHALCONE SYNTHASE FROM ALFALFA WITH COENZYME A 1I86 ; 1.50 ; CHALCONE SYNTHASE, G256A MUTANT 1JWX ; 1.63 ; CHALCONE SYNTHASE--F215S MUTANT 1D6H ; 2.15 ; CHALONE SYNTHASE (N336A MUTANT COMPLEXED WITH COA) 1QAC ; 1.80 ; CHANGE IN DIMERIZATION MODE BY REMOVAL OF A SINGLE UNSATISFIED POLAR RESIDUE 2MEA ; 2.20 ; CHANGES IN CONFORMATIONAL STABILITY OF A SERIES OF MUTANT HUMAN LYSOZYMES AT CONSTANT POSITIONS 2MEB ; 1.80 ; CHANGES IN CONFORMATIONAL STABILITY OF A SERIES OF MUTANT HUMAN LYSOZYMES AT CONSTANT POSITIONS 2MEC ; 2.20 ; CHANGES IN CONFORMATIONAL STABILITY OF A SERIES OF MUTANT HUMAN LYSOZYMES AT CONSTANT POSITIONS 2MEG ; 1.80 ; CHANGES IN CONFORMATIONAL STABILITY OF A SERIES OF MUTANT HUMAN LYSOZYMES AT CONSTANT POSITIONS. 1E8P ; -1.00 ; CHARACTERISATION OF THE CELLULOSE DOCKING DOMAIN FROM PIROMYCES EQUI 1E8Q ; -1.00 ; CHARACTERISATION OF THE CELLULOSE DOCKING DOMAIN FROM PIROMYCES EQUI 1N4H ; 2.10 ; CHARACTERIZATION OF LIGANDS FOR THE ORPHAN NUCLEAR RECEPTOR RORBETA 1NQ7 ; 1.50 ; CHARACTERIZATION OF LIGANDS FOR THE ORPHAN NUCLEAR RECEPTOR RORBETA 1R0Q ; 1.61 ; CHARACTERIZATION OF THE CONVERSION OF THE MALFORMED, RECOMBINANT CYTOCHROME RC552 TO A 2-FORMYL-4-VINYL (SPIROGRAPHIS) HEME 1QYZ ; 1.40 ; CHARACTERIZATION OF THE MALFORMED, RECOMBINANT CYTOCHROME RC552 1G9X ; 2.60 ; CHARACTERIZATION OF THE TWINNING STRUCTURE OF MJ1267, AN ATP-BINDING CASSETTE OF AN ABC TRANSPORTER 1LCL ; 1.80 ; CHARCOT-LEYDEN CRYSTAL PROTEIN 1QKQ ; 1.80 ; CHARCOT-LEYDEN CRYSTAL PROTEIN - MANNOSE COMPLEX 1HDK ; 1.80 ; CHARCOT-LEYDEN CRYSTAL PROTEIN - PCMBS COMPLEX 1G86 ; 1.80 ; CHARCOT-LEYDEN CRYSTAL PROTEIN/N-ETHYLMALEIMIDE COMPLEX 1TQG ; 0.98 ; CHEA PHOSPHOTRANSFERASE DOMAIN FROM THERMOTOGA MARITIMA 1CHD ; 1.75 ; CHEB METHYLESTERASE DOMAIN 1M1Y ; 3.20 ; CHEMICAL CROSSLINK OF NITROGENASE MOFE PROTEIN AND FE PROTEIN 1Q2R ; 2.90 ; CHEMICAL TRAPPING AND CRYSTAL STRUCTURE OF A CATALYTIC TRNA GUANINE TRANSGLYCOSYLASE COVALENT INTERMEDIATE 1Q2S ; 3.20 ; CHEMICAL TRAPPING AND CRYSTAL STRUCTURE OF A CATALYTIC TRNA GUANINE TRANSGLYCOSYLASE COVALENT INTERMEDIATE 1N8U ; 1.80 ; CHEMOSENSORY PROTEIN IN COMPLEX WITH BROMO-DODECANOL 1N8V ; 1.39 ; CHEMOSENSORY PROTEIN IN COMPLEX WITH BROMO-DODECANOL 1U0S ; 1.90 ; CHEMOTAXIS KINASE CHEA P2 DOMAIN IN COMPLEX WITH RESPONSE REGULATOR CHEY FROM THE THERMOPHILE THERMOTOGA MARITIMA 1BC5 ; 2.20 ; CHEMOTAXIS RECEPTOR RECOGNITION BY PROTEIN METHYLTRANSFERASE CHER 1AF7 ; 2.00 ; CHER FROM SALMONELLA TYPHIMURIUM 1TMY ; 1.90 ; CHEY FROM THERMOTOGA MARITIMA (APO-I) 2TMY ; 2.30 ; CHEY FROM THERMOTOGA MARITIMA (APO-II) 4TMY ; 2.80 ; CHEY FROM THERMOTOGA MARITIMA (MG-IV) 3TMY ; 2.20 ; CHEY FROM THERMOTOGA MARITIMA (MN-III) 1UDR ; 1.90 ; CHEY MUTANT WITH LYS 91 REPLACED BY ASP, LYS 92 REPLACED BY ALA, ILE 96 REPLACED BY LYS AND ALA 98 REPLACED BY LEU (STABILIZING MUTATIONS IN HELIX 4) 1EAY ; 2.00 ; CHEY-BINDING (P2) DOMAIN OF CHEA IN COMPLEX WITH CHEY FROM ESCHERICHIA COLI 1FWP ; -1.00 ; CHEY-BINDING DOMAIN OF CHEA (RESIDUES 159 - 227), NMR, MINIMIZED AVERAGE STRUCTURE 1A0O ; 2.95 ; CHEY-BINDING DOMAIN OF CHEA IN COMPLEX WITH CHEY 1FFG ; 2.10 ; CHEY-BINDING DOMAIN OF CHEA IN COMPLEX WITH CHEY AT 2.1 A RESOLUTION 1FFS ; 2.40 ; CHEY-BINDING DOMAIN OF CHEA IN COMPLEX WITH CHEY FROM CRYSTALS SOAKED IN ACETYL PHOSPHATE 1FFW ; 2.70 ; CHEY-BINDING DOMAIN OF CHEA IN COMPLEX WITH CHEY WITH A BOUND IMIDO DIPHOSPHATE 1A5J ; -1.00 ; CHICKEN B-MYB DEOXYRIBONUCLEIC ACID BINDING DOMAIN, REPEAT 2 AND REPEAT3, NMR, 32 STRUCTURES 1UP5 ; 1.90 ; CHICKEN CALMODULIN 1AL6 ; 1.85 ; CHICKEN CITRATE SYNTHASE COMPLEX WITH N-HYDROXYAMIDO-COA AND OXALOACETATE 1AMZ ; 1.80 ; CHICKEN CITRATE SYNTHASE COMPLEX WITH NITROMETHYLDE-COA AND MALATE 6CSC ; 2.25 ; CHICKEN CITRATE SYNTHASE COMPLEX WITH TRIFLUOROACETONYL-COA AND CITRATE 1A67 ; -1.00 ; CHICKEN EGG WHITE CYSTATIN WILDTYPE, NMR, 16 STRUCTURES 1AZF ; 1.80 ; CHICKEN EGG WHITE LYSOZYME CRYSTAL GROWN IN BROMIDE SOLUTION 1IIU ; 2.50 ; CHICKEN PLASMA RETINOL-BINDING PROTEIN (RBP) 2PTK ; 2.35 ; CHICKEN SRC TYROSINE KINASE 1WY4 ; 1.55 ; CHICKEN VILLIN SUBDOMAIN HP-35, K65(NLE), N68H, PH5.1 1WY3 ; 0.95 ; CHICKEN VILLIN SUBDOMAIN HP-35, K65(NLE), N68H, PH7.0 1YRI ; 1.00 ; CHICKEN VILLIN SUBDOMAIN HP-35, N68H, PH6.4 1YRF ; 1.07 ; CHICKEN VILLIN SUBDOMAIN HP-35, N68H, PH6.7 1XAC ; 2.10 ; CHIMERA ISOPROPYLMALATE DEHYDROGENASE BETWEEN BACILLUS SUBTILIS (M) AND THERMUS THERMOPHILUS (T) FROM N-TERMINAL: 20% T MIDDLE 20% M RESIDUAL 60% T, MUTATED AT S82R. LOW TEMPERATURE (100K) STRUCTURE. 1XAD ; 2.10 ; CHIMERA ISOPROPYLMALATE DEHYDROGENASE BETWEEN BACILLUS SUBTILIS (M) AND THERMUS THERMOPHILUS (T) FROM N-TERMINAL: 20% T MIDDLE 20% M RESIDUAL 60% T, MUTATED AT S82R. LOW TEMPERATURE (150K) STRUCTURE. 1NGW ; 2.60 ; CHIMERIC AFFINITY MATURED FAB 7G12 COMPLEXED WITH MESOPORPHYRIN 1HO6 ; -1.00 ; CHIMERIC ARABINONUCLEIC ACID (ANA) HAIRPIN WITH ANA/RIBONUCLEIC ACID HYBRID STEM 1NGX ; 1.80 ; CHIMERIC GERMLINE FAB 7G12 WITH JEFFAMINE FRAGMENT BOUND 1NGZ ; 1.60 ; CHIMERIC GERMLINE FAB 7G12-APO 1ME0 ; -1.00 ; CHIMERIC HAIRPIN WITH 2',5'-LINKED RIBONUCLEIC ACID LOOP AND DEOXYRIBONUCLEIC ACID STEM 1ME1 ; -1.00 ; CHIMERIC HAIRPIN WITH 2',5'-LINKED RIBONUCLEIC ACID LOOP AND RIBONUCLEIC ACID STEM 1JEB ; 2.10 ; CHIMERIC HUMAN/MOUSE CARBONMONOXY HEMOGLOBIN (HUMAN ZETA2 / MOUSE BETA2) 1BYX ; -1.00 ; CHIMERIC HYBRID DUPLEX R(GCAGUGGC).R(GCCA)D(CTGC) COMPRISING THE TRNA-DEOXYRIBONUCLEIC ACID JUNCTION FORMED DURING INITIATION OF HIV-1 REVERSE TRANSCRIPTION 1NGY ; 2.20 ; CHIMERIC MATURE FAB 7G12-APO 1ROD ; -1.00 ; CHIMERIC PROTEIN OF INTERLEUKIN 8 AND HUMAN MELANOMA GROWTH STIMULATING ACTIVITY PROTEIN, NMR 1HOQ ; -1.00 ; CHIMERIC RIBONUCLEIC ACID/DEOXYRIBONUCLEIC ACID HAIRPIN 1K9T ; 1.80 ; CHITINASE A COMPLEXED WITH TETRA-N-ACETYLCHITOTRIOSE 1E15 ; 1.90 ; CHITINASE B FROM SERRATIA MARCESCENS 1O6I ; 1.70 ; CHITINASE B FROM SERRATIA MARCESCENS COMPLEXED WITH THE CATALYTIC INTERMEDIATE MIMIC CYCLIC DIPEPTIDE CI4. 1GPF ; 1.85 ; CHITINASE B FROM SERRATIA MARCESCENS IN COMPLEX WITH INHIBITOR PSAMMAPLIN 1E6P ; 1.70 ; CHITINASE B FROM SERRATIA MARCESCENS INACTIVE MUTANT E144Q 1E6N ; 2.25 ; CHITINASE B FROM SERRATIA MARCESCENS INACTIVE MUTANT E144Q IN COMPLEX WITH N-ACETYLGLUCOSAMINE-PENTAMER 1OGB ; 1.85 ; CHITINASE B FROM SERRATIA MARCESCENS MUTANT D142N 1OGG ; 1.97 ; CHITINASE B FROM SERRATIA MARCESCENS MUTANT D142N IN COMPLEX WITH INHIBITOR ALLOSAMIDIN 1E6Z ; 1.99 ; CHITINASE B FROM SERRATIA MARCESCENS WILDTYPE IN COMPLEX WITH CATALYTIC INTERMEDIATE 1E6R ; 2.50 ; CHITINASE B FROM SERRATIA MARCESCENS WILDTYPE IN COMPLEX WITH INHIBITOR ALLOSAMIDIN 1QGI ; 1.60 ; CHITOSANASE FROM BACILLUS CIRCULANS 2D05 ; 2.00 ; CHITOSANASE FROM BACILLUS CIRCULANS MUTANT K218P 1UZD ; 2.40 ; CHLAMYDOMONAS,SPINACH CHIMERIC RUBISCO 1QHN ; 2.70 ; CHLORAMPHENICOL PHOSPHOTRANSFERASE FROM STREPTOMYCES VENEZUELAE 1QHY ; 2.60 ; CHLORAMPHENICOL PHOSPHOTRANSFERASE FROM STREPTOMYCES VENEZUELAE IN COMPLEX WITH ATPGAMMAS AND CHLORAMPHENICOL 1GRR ; 2.90 ; CHLORAMPHENICOL PHOSPHOTRANSFERASE IN COMPLEX WITH 2-NAC-CHLORAMPHENICOL FROM STREPTOMYCES VENEZUELAE 1QHX ; 2.50 ; CHLORAMPHENICOL PHOSPHOTRANSFERASE IN COMPLEX WITH ATP FROM STREPTOMYCES VENEZUELAE 1QHS ; 2.80 ; CHLORAMPHENICOL PHOSPHOTRANSFERASE IN COMPLEX WITH CHLORAMPHENICOL FROM STREPTOMYCES VENEZUELAE 1GRQ ; 2.90 ; CHLORAMPHENICOL PHOSPHOTRANSFERASE IN COMPLEX WITH P-AMINO-CHLORAMPHENICOL FROM STREPTOMYCES VENEZUELAE 1K0N ; 1.80 ; CHLORIDE INTRACELLULAR CHANNEL 1 (CLIC1) COMPLEXED WITH GLUTATHIONE 2BD0 ; 1.70 ; CHLOROBIUM TEPIDUM SEPIAPTERIN REDUCTASE COMPLEXED WITH NADP AND SEPIAPTERIN 1A7D ; 1.80 ; CHLOROMET MYOHEMERYTHRIN FROM THEMISTE ZOSTERICOLA 1CPO ; 1.90 ; CHLOROPEROXIDASE 2CPO ; 2.16 ; CHLOROPEROXIDASE 1A8S ; 1.80 ; CHLOROPEROXIDASE F/PROPIONATE COMPLEX 1VNC ; 2.10 ; CHLOROPEROXIDASE FROM THE FUNGUS CURVULARIA INAEQUALIS 1VNE ; 2.15 ; CHLOROPEROXIDASE FROM THE FUNGUS CURVULARIA INAEQUALIS: MUTANT D292A 1VNG ; 2.20 ; CHLOROPEROXIDASE FROM THE FUNGUS CURVULARIA INAEQUALIS: MUTANT H404A 1VNH ; 2.11 ; CHLOROPEROXIDASE FROM THE FUNGUS CURVULARIA INAEQUALIS: MUTANT H496A 1VNF ; 2.35 ; CHLOROPEROXIDASE FROM THE FUNGUS CURVULARIA INAEQUALIS: MUTANT R360A 1VNI ; 2.15 ; CHLOROPEROXIDASE FROM THE FUNGUS CURVULARIA INAEQUALIS: RECOMBINANT HOLO-CHLOROPEROXIDASE 1A88 ; 1.90 ; CHLOROPEROXIDASE L 1A7U ; 1.75 ; CHLOROPEROXIDASE T 1A8U ; 1.60 ; CHLOROPEROXIDASE T/BENZOATE COMPLEX 1CIV ; 2.80 ; CHLOROPLAST NADP-DEPENDENT MALATE DEHYDROGENASE FROM FLAVERIA BIDENTIS 1CEQ ; 2.00 ; CHLOROQUINE BINDS IN THE COFACTOR BINDING SITE OF PLASMODIUM FALCIPARUM LACTATE DEHYDROGENASE. 1CET ; 2.05 ; CHLOROQUINE BINDS IN THE COFACTOR BINDING SITE OF PLASMODIUM FALCIPARUM LACTATE DEHYDROGENASE. 1C9W ; 2.40 ; CHO REDUCTASE WITH NADP+ 1S5B ; 2.13 ; CHOLERA HOLOTOXIN WITH AN A-SUBUNIT Y30S MUTATION FORM 3 1S5C ; 2.50 ; CHOLERA HOLOTOXIN WITH AN A-SUBUNIT Y30S MUTATION, CRYSTAL FORM 1 1S5D ; 1.75 ; CHOLERA HOLOTOXIN WITH AN A-SUBUNIT Y30S MUTATION, CRYSTAL FORM 2 1S5E ; 1.90 ; CHOLERA HOLOTOXIN, CRYSTAL FORM 1 1S5F ; 2.60 ; CHOLERA HOLOTOXIN, CRYSTAL FORM 2 1XTC ; 2.40 ; CHOLERA TOXIN 2A5G ; 2.66 ; CHOLERA TOXIN A1 SUBUNIT BOUND TO ARF6(Q67L) 2A5F ; 2.02 ; CHOLERA TOXIN A1 SUBUNIT BOUND TO ITS SUBSTRATE, NAD+, AND ITS HUMAN PROTEIN ACTIVATOR, ARF6 1RCV ; 1.60 ; CHOLERA TOXIN B-PENTAMER COMPLEXED WITH BIVALENT NITROPHENOL-GALACTOSIDE LIGAND BV1 1RD9 ; 1.44 ; CHOLERA TOXIN B-PENTAMER COMPLEXED WITH BIVALENT NITROPHENOL-GALACTOSIDE LIGAND BV2 1RDP ; 1.35 ; CHOLERA TOXIN B-PENTAMER COMPLEXED WITH BIVALENT NITROPHENOL-GALACTOSIDE LIGAND BV3 1RF2 ; 1.35 ; CHOLERA TOXIN B-PENTAMER COMPLEXED WITH BIVALENT NITROPHENOL-GALACTOSIDE LIGAND BV4 2CHB ; 2.00 ; CHOLERA TOXIN B-PENTAMER COMPLEXED WITH GM1 PENTASACCHARIDE 3CHB ; 1.25 ; CHOLERA TOXIN B-PENTAMER COMPLEXED WITH GM1 PENTASACCHARIDE 1EEI ; 2.00 ; CHOLERA TOXIN B-PENTAMER COMPLEXED WITH METANITROPHENYL- ALPHA-D-GALACTOSE 1PZK ; 1.35 ; CHOLERA TOXIN B-PENTAMER COMPLEXED WITH N-ACYL PHENYL GALACTOSIDE 9H 1PZJ ; 1.46 ; CHOLERA TOXIN B-PENTAMER COMPLEXED WITH NITROPHENYL GALACTOSIDE 5 1CT1 ; 2.30 ; CHOLERA TOXIN B-PENTAMER MUTANT G33R BOUND TO RECEPTOR PENTASACCHARIDE 1MD2 ; 1.45 ; CHOLERA TOXIN B-PENTAMER WITH DECAVALENT LIGAND BMSC-0013 1JR0 ; 1.30 ; CHOLERA TOXIN B-PENTAMER WITH LIGAND BMSC-0011 1LLR ; 1.46 ; CHOLERA TOXIN B-PENTAMER WITH LIGAND BMSC-0012 1LLF ; 1.40 ; CHOLESTEROL ESTERASE (CANDIDA CYLINDRACEA) CRYSTAL STRUCTURE AT 1.4A RESOLUTION 2BCE ; 1.60 ; CHOLESTEROL ESTERASE FROM BOS TAURUS 1B4V ; 1.50 ; CHOLESTEROL OXIDASE FROM STREPTOMYCES 1N4U ; 0.95 ; CHOLESTEROL OXIDASE FROM STREPTOMYCES @ PH 4.5 (STREPTOMYCES SP. SA-COO) 1IJH ; 1.53 ; CHOLESTEROL OXIDASE FROM STREPTOMYCES ASN485LEU MUTANT 1B8S ; 1.65 ; CHOLESTEROL OXIDASE FROM STREPTOMYCES GLU361GLN MUTANT 1CBO ; 1.80 ; CHOLESTEROL OXIDASE FROM STREPTOMYCES HIS447ASN MUTANT 1CC2 ; 2.20 ; CHOLESTEROL OXIDASE FROM STREPTOMYCES HIS447GLN MUTANT 1GVM ; 2.80 ; CHOLINE BINDING DOMAIN OF THE MAJOR AUTOLYSIN (C-LYTA) FROM STREPTOCOCCUS PNEUMONIAE 1HCX ; 2.60 ; CHOLINE BINDING DOMAIN OF THE MAJOR AUTOLYSIN (C-LYTA) FROM STREPTOCOCCUS PNEUMONIAE 1KNE ; 2.40 ; CHOMO DOMAIN OF HP1 COMPLEXED WITH HISTONE H3 TAIL CONTAINING TRIMETHYLLYSINE 9 1CB8 ; 1.90 ; CHONDROITINASE AC LYASE FROM FLAVOBACTERIUM HEPARINUM 1G1B ; 1.99 ; CHORISMATE LYASE (WILD-TYPE) WITH BOUND PRODUCT 1JD3 ; 2.03 ; CHORISMATE LYASE G90A MUTANT WITH BOUND PRODUCT 1FW9 ; 1.40 ; CHORISMATE LYASE WITH BOUND PRODUCT 1G81 ; 1.71 ; CHORISMATE LYASE WITH BOUND PRODUCT, ORTHORHOMBIC CRYSTAL FORM 1XLR ; 1.94 ; CHORISMATE LYASE WITH INHIBITOR VANILLATE 1TT8 ; 1.00 ; CHORISMATE LYASE WITH PRODUCT, 1.0 A RESOLUTION 1DBF ; 1.30 ; CHORISMATE MUTASE FROM BACILLUS SUBTILIS AT 1.30 ANGSTROM 1XHO ; 2.20 ; CHORISMATE MUTASE FROM CLOSTRIDIUM THERMOCELLUM CTH-682 1L0S ; 2.30 ; CHORISTONEURA FUMIFERANA (SPRUCE BUDWORM) ANTIFREEZE PROTEIN ISOFORM 337 1M8N ; 2.45 ; CHORISTONEURA FUMIFERANA (SPRUCE BUDWORM) ANTIFREEZE PROTEIN ISOFORM 501 1KNA ; 2.10 ; CHROMO DOMAIN OF HP1 COMPLEXED WITH HISTONE H3 TAIL CONTAINING DIMETHYLLYSINE 9. 1E0B ; 1.90 ; CHROMO SHADOW DOMAIN FROM FISSION YEAST SWI6 PROTEIN. 1Q3L ; 1.64 ; CHROMODOMAIN OF HP1 COMPLEXED WITH HISTONE H3 TAIL CONTAINING MONOMETHYLLYSINE 9. 1VZ0 ; 2.30 ; CHROMOSOME SEGREGATION PROTEIN SPO0J FROM THERMUS THERMOPHILUS 1CZI ; 2.30 ; CHYMOSIN COMPLEX WITH THE INHIBITOR CP-113972 1QH2 ; -1.00 ; CHYMOTRYPSIN INHIBITOR (C2) FROM NICOTIANA ALATA 1CQ4 ; 1.80 ; CI2 MUTANT WITH TETRAGLUTAMINE (MGQQQQGM) REPLACING MET59 1D4B ; -1.00 ; CIDE-N DOMAIN OF HUMAN CIDE-B 1CNT ; 2.40 ; CILIARY NEUROTROPHIC FACTOR 1P5C ; 2.50 ; CIRCULAR PERMUTATION OF HELIX A IN T4 LYSOZYME 1SWF ; 2.00 ; CIRCULAR PERMUTED STREPTAVIDIN E51/A46 1SWG ; 1.80 ; CIRCULAR PERMUTED STREPTAVIDIN E51/A46 IN COMPLEX WITH BIOTIN 1AJO ; 2.07 ; CIRCULARLY PERMUTED (1-3,1-4)-BETA-D-GLUCAN 4-GLUCANOHYDROLASE CPA16M-127 1AJK ; 1.80 ; CIRCULARLY PERMUTED (1-3,1-4)-BETA-D-GLUCAN 4-GLUCANOHYDROLASE CPA16M-84 1BD7 ; 2.78 ; CIRCULARLY PERMUTED BB2 - CRYSTALLIN 1ALQ ; 1.80 ; CIRCULARLY PERMUTED BETA-LACTAMASE FROM STAPHYLOCOCCUS AUREUS PC1 1FW8 ; 2.30 ; CIRCULARLY PERMUTED PHOSPHOGLYCERATE KINASE FROM YEAST: PGK P72 1BH4 ; -1.00 ; CIRCULIN A FROM CHASSALIA PARVIFLORA, NMR, 12 STRUCTURES 1ANR ; -1.00 ; CIS-ACTING RIBONUCLEIC ACID REGULATORY ELEMENT (HIV-1 TAR), NMR, 20 STRUCTURES 1BDB ; 2.00 ; CIS-BIPHENYL-2,3-DIHYDRODIOL-2,3-DEHYDROGENASE FROM PSEUDOMONAS SP. LB400 1KV0 ; 1.40 ; CIS/TRANS ISOMERIZATION OF NON-PROLYL PEPTIDE BOND OBSERVED IN CRYSTAL STRUCTURE OF AN SCORPION TOXIN 1AZ2 ; 2.90 ; CITRATE BOUND, C298A/W219Y MUTANT HUMAN ALDOSE REDUCTASE 1Z6K ; 2.30 ; CITRATE LYASE BETA SUBUNIT COMPLEXED WITH OXALOACETATE AND MAGNESIUM FROM M. TUBERCULOSIS 1AJ8 ; 1.90 ; CITRATE SYNTHASE FROM PYROCOCCUS FURIOSUS 1O7X ; 2.70 ; CITRATE SYNTHASE FROM SULFOLOBUS SOLFATARICUS 1RGY ; 1.52 ; CITROBACTER FREUNDII GN346 CLASS C BETA-LACTAMASE COMPLEXED WITH TRANSITION-STATE ANALOG OF CEFOTAXIME 1DKT ; 2.90 ; CKSHS1: HUMAN CYCLIN DEPENDENT KINASE SUBUNIT, TYPE 1 COMPLEX WITH METAVANADATE 1DKS ; 3.20 ; CKSHS1: HUMAN CYCLIN DEPENDENT KINASE SUBUNIT, TYPE 1 IN COMPLEX WITH PHOSPHATE 1AD3 ; 2.60 ; CLASS 3 ALDEHYDE DEHYDROGENASE COMPLEX WITH NICOTINAMIDE-ADENINE-DINUCLEOTIDE 1GYN ; 2.00 ; CLASS II FRUCTOSE 1,6-BISPHOSPHATE ALDOLASE WITH CADMIUM (NOT ZINC) IN THE ACTIVE SITE 1ZEN ; 2.50 ; CLASS II FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE 1RV8 ; 2.30 ; CLASS II FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE FROM THERMUS AQUATICUS IN COMPLEX WITH COBALT 1B57 ; 2.00 ; CLASS II FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE IN COMPLEX WITH PHOSPHOGLYCOLOHYDROXAMATE 2IAD ; 2.40 ; CLASS II MHC I-AD IN COMPLEX WITH AN INFLUENZA HEMAGGLUTININ PEPTIDE 126-138 1IAO ; 2.60 ; CLASS II MHC I-AD IN COMPLEX WITH OVALBUMIN PEPTIDE 323-339 1XI4 ; 7.90 ; CLATHRIN D6 COAT 1XI5 ; 12.00 ; CLATHRIN D6 COAT WITH AUXILIN J-DOMAIN 1B89 ; 2.60 ; CLATHRIN HEAVY CHAIN PROXIMAL LEG SEGMENT (BOVINE) 1BPO ; 2.60 ; CLATHRIN HEAVY-CHAIN TERMINAL DOMAIN AND LINKER 1UTC ; 2.30 ; CLATHRIN TERMINAL DOMAIN COMPLEXED WITH TLPWDLWTT 1QMB ; 2.60 ; CLEAVED ALPHA-1-ANTITRYPSIN POLYMER 3CAA ; 2.40 ; CLEAVED ANTICHYMOTRYPSIN A347R 1AS4 ; 2.10 ; CLEAVED ANTICHYMOTRYPSIN A349R 4CAA ; 2.90 ; CLEAVED ANTICHYMOTRYPSIN T345R 9PAI ; 2.70 ; CLEAVED SUBSTRATE VARIANT OF PLASMINOGEN ACTIVATOR INHIBITOR-1 1ZOX ; 2.10 ; CLM-1 MOUSE MYELOID RECEPTOR EXTRACELLULAR DOMAIN 2B2C ; 2.50 ; CLONING, EXPRESSION, CHARACTERISATION AND THREE- DIMENSIONAL STRUCTURE DETERMINATION OF THE CAENORHABDITIS ELEGANS SPERMIDINE SYNTHASE 1DT0 ; 2.10 ; CLONING, SEQUENCE, AND CRYSTALLOGRAPHIC STRUCTURE OF RECOMBINANT IRON SUPEROXIDE DISMUTASE FROM PSEUDOMONAS OVALIS 2FDX ; 1.65 ; CLOSTRIDIUM BEIJERINCKII FLAVODOXIN MUTANT N137A OXIDIZED 4NUL ; 1.90 ; CLOSTRIDIUM BEIJERINCKII FLAVODOXIN MUTANT: D58P OXIDIZED 1FLN ; 1.90 ; CLOSTRIDIUM BEIJERINCKII FLAVODOXIN MUTANT: D58P REDUCED 3NLL ; 2.40 ; CLOSTRIDIUM BEIJERINCKII FLAVODOXIN MUTANT: G57A OXIDIZED 4NLL ; 1.90 ; CLOSTRIDIUM BEIJERINCKII FLAVODOXIN MUTANT: G57D OXIDIZED 1FLA ; 1.90 ; CLOSTRIDIUM BEIJERINCKII FLAVODOXIN MUTANT: G57D REDUCED 1FVX ; 1.90 ; CLOSTRIDIUM BEIJERINCKII FLAVODOXIN MUTANT: G57N OXIDIZED 1FLD ; 1.80 ; CLOSTRIDIUM BEIJERINCKII FLAVODOXIN MUTANT: G57T OXIDIZED 2FLV ; 1.80 ; CLOSTRIDIUM BEIJERINCKII FLAVODOXIN MUTANT: G57T REDUCED (150K) 2FVX ; 1.80 ; CLOSTRIDIUM BEIJERINCKII FLAVODOXIN MUTANT: G57T REDUCED (277K) 5NUL ; 1.60 ; CLOSTRIDIUM BEIJERINCKII FLAVODOXIN MUTANT: G57T SEMIQUINONE (150K) 2FAX ; 1.80 ; CLOSTRIDIUM BEIJERINCKII FLAVODOXIN MUTANT: N137A OXIDIZED (150K) 6NUL ; 1.80 ; CLOSTRIDIUM BEIJERINCKII FLAVODOXIN MUTANT: N137A REDUCED (150K) 5NLL ; 1.75 ; CLOSTRIDIUM BEIJERINCKII FLAVODOXIN: OXIDIZED 5ULL ; 1.80 ; CLOSTRIDIUM BEIJERINCKII FLAVODOXIN: REDUCED 2FOX ; 1.80 ; CLOSTRIDIUM BEIJERINCKII FLAVODOXIN: SEMIQUINONE 1T3C ; 1.90 ; CLOSTRIDIUM BOTULINUM TYPE E CATALYTIC DOMAIN E212Q MUTANT 2F6E ; 1.85 ; CLOSTRIDIUM DIFFICILE TOXIN A C-TERMINAL FRAGMENT 1 (TCDA- F1) 1CLF ; -1.00 ; CLOSTRIDIUM PASTEURIANUM FERREDOXIN 1BE7 ; 1.65 ; CLOSTRIDIUM PASTEURIANUM RUBREDOXIN C42S MUTANT 1B13 ; 1.50 ; CLOSTRIDIUM PASTEURIANUM RUBREDOXIN G10A MUTANT 1B2O ; 1.90 ; CLOSTRIDIUM PASTEURIANUM RUBREDOXIN G10VG43A MUTANT 1B2J ; 1.60 ; CLOSTRIDIUM PASTEURIANUM RUBREDOXIN G43A MUTANT 1UYJ ; 2.60 ; CLOSTRIDIUM PERFRINGENS EPSILON TOXIN SHOWS STRUCTURAL SIMILARITY WITH THE PORE FORMING TOXIN AEROLYSIN 1R6Q ; 2.35 ; CLPNS WITH FRAGMENTS 1N67 ; 1.90 ; CLUMPING FACTOR A FROM STAPHYLOCOCCUS AUREUS 1YCW ; -1.00 ; CLUSTERED ABASIC LESIONS IN DEOXYRIBONUCLEIC ACID: NMR SOLUTION STRUCTURES OF CLUSTERED BISTRANDED-1 ABASIC LESION 1CKE ; 1.75 ; CMP KINASE FROM ESCHERICHIA COLI FREE ENZYME STRUCTURE 1DXC ; 1.40 ; CO COMPLEX OF MYOGLOBIN MB-YQR AT 100K 1MYZ ; 1.60 ; CO COMPLEX OF MYOGLOBIN MB-YQR AT RT SOLVED FROM LAUE DATA. 1CG8 ; 1.90 ; CO FORM HEMOGLOBIN FROM DASYATIS AKAJEI 1GCW ; 2.00 ; CO FORM HEMOGLOBIN FROM MUSTELUS GRISEUS 1G5L ; -1.00 ; CO(III)-BLEOMYCIN-OOH BOUND TO AN OLIGONUCLEOTIDE CONTAINING A PHOSPHOGLYCOLATE LESION 1GJ2 ; -1.00 ; CO(III)-BLEOMYCIN-OOH BOUND TO AN OLIGONUCLEOTIDE CONTAINING A PHOSPHOGLYCOLATE LESION 2C32 ; 7.01 ; CO-AXIAL ASSOCIATION OF RECOMBINANT EYE LENS AQUAPORIN-0 OBSERVED IN LOOSELY PACKED 3D-CRYSTALS 1XJ2 ; 2.00 ; CO-BOUND STRUCTURE OF BJFIXLH 1XJ4 ; 1.80 ; CO-BOUND STRUCTURE OF BJFIXLH 1G15 ; 1.90 ; CO-CRYSTAL OF E. COLI RNASE HI WITH TWO MN2+ IONS BOUND IN THE THE ACTIVE SITE 1KNJ ; 2.80 ; CO-CRYSTAL STRUCTURE OF 2-C-METHYL-D-ERYTHRITOL 2,4- CYCLODIPHOSPHATE SYNTHASE (ISPF) FROM E. COLI INVOLVED IN MEVALONATE-INDEPENDENT ISOPRENOID BIOSYNTHESIS, COMPLEXED WITH CMP/MECDP/MN2+ 1K73 ; 3.01 ; CO-CRYSTAL STRUCTURE OF ANISOMYCIN BOUND TO THE 50S RIBOSOMAL SUBUNIT 1M1K ; 3.20 ; CO-CRYSTAL STRUCTURE OF AZITHROMYCIN BOUND TO THE 50S RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI 1KC8 ; 3.01 ; CO-CRYSTAL STRUCTURE OF BLASTICIDIN S BOUND TO THE 50S RIBOSOMAL SUBUNIT 1K8A ; 3.00 ; CO-CRYSTAL STRUCTURE OF CARBOMYCIN A BOUND TO THE 50S RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI 1M90 ; 2.80 ; CO-CRYSTAL STRUCTURE OF CCA-PHE-CAPROIC ACID-BIOTIN AND SPARSOMYCIN BOUND TO THE 50S RIBOSOMAL SUBUNIT 1WSF ; 2.30 ; CO-CRYSTAL STRUCTURE OF E.COLI RNASE HI ACTIVE SITE MUTANT (D134A) WITH MN2+ 1WSE ; 2.30 ; CO-CRYSTAL STRUCTURE OF E.COLI RNASE HI ACTIVE SITE MUTANT (E48A) WITH MN2+ 1WSG ; 2.20 ; CO-CRYSTAL STRUCTURE OF E.COLI RNASE HI ACTIVE SITE MUTANT (E48A/D134N) WITH MN2+ 1MZC ; 2.00 ; CO-CRYSTAL STRUCTURE OF HUMAN FARNESYLTRANSFERASE WITH FARNESYLDIPHOSPHATE AND INHIBITOR COMPOUND 33A 1LD8 ; 1.80 ; CO-CRYSTAL STRUCTURE OF HUMAN FARNESYLTRANSFERASE WITH FARNESYLDIPHOSPHATE AND INHIBITOR COMPOUND 49 1LD7 ; 2.00 ; CO-CRYSTAL STRUCTURE OF HUMAN FARNESYLTRANSFERASE WITH FARNESYLDIPHOSPHATE AND INHIBITOR COMPOUND 66 1UBD ; 2.50 ; CO-CRYSTAL STRUCTURE OF HUMAN YY1 ZINC FINGER DOMAIN BOUND TO THE ADENO-ASSOCIATED VIRUS P5 INITIATOR ELEMENT 1ZCW ; 2.25 ; CO-CRYSTAL STRUCTURE OF ORF2 AN AROMATIC PRENYL TRANSFERASE FROM STREPTOMYCES SP. STRAIN CL190 COMPLEXED WITH GPP 1ZB6 ; 1.95 ; CO-CRYSTAL STRUCTURE OF ORF2 AN AROMATIC PRENYL TRANSFERASE FROM STREPTOMYCES SP. STRAIN CL190 COMPLEXED WITH GSPP AND 1,6-DIHYDROXYNAPHTALENE 1ZDW ; 2.02 ; CO-CRYSTAL STRUCTURE OF ORF2 AN AROMATIC PRENYL TRANSFERASE FROM STREPTOMYCES SP. STRAIN CL190 COMPLEXED WITH GSPP AND FLAVIOLIN 1ZDY ; 1.44 ; CO-CRYSTAL STRUCTURE OF ORF2 AN AROMATIC PRENYL TRANSFERASE FROM STREPTOMYCES SP. STRAIN CL190 COMPLEXED WITH TAPS 1FT2 ; 3.40 ; CO-CRYSTAL STRUCTURE OF PROTEIN FARNESYLTRANSFERASE COMPLEXED WITH A FARNESYL DIPHOSPHATE SUBSTRATE 1D8D ; 2.00 ; CO-CRYSTAL STRUCTURE OF RAT PROTEIN FARNESYLTRANSFERASE COMPLEXED WITH A K-RAS4B PEPTIDE SUBSTRATE AND FPP ANALOG AT 2.0A RESOLUTION 1KD1 ; 3.00 ; CO-CRYSTAL STRUCTURE OF SPIRAMYCIN BOUND TO THE 50S RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI 1SVL ; 1.95 ; CO-CRYSTAL STRUCTURE OF SV40 LARGE T ANTIGEN HELICASE DOMAIN AND ADP 1SVM ; 1.94 ; CO-CRYSTAL STRUCTURE OF SV40 LARGE T ANTIGEN HELICASE DOMAIN AND ATP 1K9M ; 3.00 ; CO-CRYSTAL STRUCTURE OF TYLOSIN BOUND TO THE 50S RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI 1TF6 ; 3.10 ; CO-CRYSTAL STRUCTURE OF XENOPUS TFIIIA ZINC FINGER DOMAIN BOUND TO THE 5S RIBOSOMAL RIBONUCLEIC ACID GENE INTERNAL CONTROL REGION 1ONA ; 2.35 ; CO-CRYSTALS OF CONCANAVALIN A WITH METHYL-3,6-DI-O- (ALPHA-D-MANNOPYRANOSYL)-ALPHA-D-MANNOPYRANOSIDE 2ENR ; 2.35 ; CO-CRYSTALS OF DEMETALLIZED CONCANAVALIN A WITH CADMIUM HAVING A CADMIUM ION BOUND IN BOTH THE S1 SITE AND THE S2 SITE 1ENR ; 1.80 ; CO-CRYSTALS OF DEMETALLIZED CONCANAVALIN A WITH ZINC AND CALCIUM HAVING A ZINC ION BOUND IN THE S1 SITE AND A CALCIUM ION BOUND IN THE S2 SITE 1ENQ ; 2.50 ; CO-CRYSTALS OF DEMETALLIZED CONCANAVALIN A WITH ZINC HAVING A ZINC ION BOUND IN THE S1 SITE 1Y39 ; 2.80 ; CO-EVOLUTION OF PROTEIN AND RIBONUCLEIC ACID STRUCTURES WITHIN A HIGHLY CONSERVED RIBOSOMAL DOMAIN 1JBU ; 2.00 ; COAGULATION FACTOR VII ZYMOGEN (EGF2/PROTEASE) IN COMPLEX WITH INHIBITORY EXOSITE PEPTIDE A-183 1FAC ; -1.00 ; COAGULATION FACTOR VIII, NMR, 1 STRUCTURE 1FAX ; 3.00 ; COAGULATION FACTOR XA INHIBITOR COMPLEX 1FXY ; 2.15 ; COAGULATION FACTOR XA-TRYPSIN CHIMERA INHIBITED WITH D-PHE-PRO-ARG-CHLOROMETHYLKETONE 1MGX ; -1.00 ; COAGULATION FACTOR, MG(II), NMR, 7 STRUCTURES (BACKBONE ATOMS ONLY) 1WHF ; -1.00 ; COAGULATION FACTOR, NMR, 15 STRUCTURES 1WHE ; -1.00 ; COAGULATION FACTOR, NMR, 20 STRUCTURES 1MOF ; 1.70 ; COAT PROTEIN 1Q7Q ; 3.10 ; COBALAMIN-DEPENDENT METHIONINE SYNTHASE (1-566) FROM T. MARITIMA (OXIDIZED, ORTHORHOMBIC) 1Q7Z ; 1.70 ; COBALAMIN-DEPENDENT METHIONINE SYNTHASE (1-566) FROM THERMOTOGA MARITIMA (CD2+ COMPLEX) 1Q85 ; 2.00 ; COBALAMIN-DEPENDENT METHIONINE SYNTHASE (1-566) FROM THERMOTOGA MARITIMA (CD2+ COMPLEX, SE-MET) 1Q8J ; 1.90 ; COBALAMIN-DEPENDENT METHIONINE SYNTHASE (1-566) FROM THERMOTOGA MARITIMA (CD2+, HCY, METHYLTETRAHYDROFOLATE COMPLEX) 1Q8A ; 1.70 ; COBALAMIN-DEPENDENT METHIONINE SYNTHASE (1-566) FROM THERMOTOGA MARITIMA (CD2+:L-HCY COMPLEX, SE-MET) 1Q7M ; 2.10 ; COBALAMIN-DEPENDENT METHIONINE SYNTHASE (METH) FROM THERMOTOGA MARITIMA (OXIDIZED, MONOCLINIC) 1BSJ ; 3.00 ; COBALT DEFORMYLASE INHIBITOR COMPLEX FROM E.COLI 1XAM ; 1.86 ; COBALT HEXAMMINE INDUCED TAUTAMERIC SHIFT IN Z-DEOXYRIBONUCLEIC ACID: STRUCTURE OF D(CGCGCA).D(TGCGCG) IN TWO CRYSTAL FORMS. 1XA2 ; 1.71 ; COBALT HEXAMMINE INDUCED TAUTOMERIC SHIFT IN Z-DEOXYRIBONUCLEIC ACID: THE STRUCTURE OF D(CGCGCA).D(TGCGCG) IN TWO CRYSTAL FORMS 1YOG ; 1.65 ; COBALT MYOGLOBIN (DEOXY) 1YOH ; 1.65 ; COBALT MYOGLOBIN (MET) 1YOI ; 1.65 ; COBALT MYOGLOBIN (OXY) 1QQ0 ; 1.76 ; COBALT SUBSTITUTED CARBONIC ANHYDRASE FROM METHANOSARCINA THERMOPHILA 1H0N ; 2.40 ; COBALT SUBSTITUTION OF MOUSE R2 RIBONUCLEOTIDE REDUCTASE TO MODEL THE REACTIVE DIFERROUS STATE 1H0O ; 2.20 ; COBALT SUBSTITUTION OF MOUSE R2 RIBONUCLEOTIDE REDUCTASE TO MODEL THE REACTIVE DIFERROUS STATE 1AO2 ; -1.00 ; COBALT(III)-DEGLYCOPEPLEOMYCIN DETERMINED BY NMR STUDIES 1AO4 ; -1.00 ; COBALT(III)-PEPLOMYCIN COMPLEX DETERMINED BY NMR STUDIES 1R0H ; 1.70 ; COBALT-SUBSTITUTED RUBREDOXIN 1PJV ; -1.00 ; COBATOXIN 1 FROM CENTRUROIDES NOXIUS SCORPION VENOM: CHEMICAL SYNTHESIS, 3-D STRUCTURE IN SOLUTION, PHARMACOLOGY AND DOCKING ON K+ CHANNELS 1HY9 ; -1.00 ; COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT 1NJ9 ; 2.35 ; COCAINE HYDROLYTIC ANTIBODY 15A10 1BKM ; 2.00 ; COCRYSTAL STRUCTURE OF D-AMINO ACID SUBSTITUTED PHOSPHOPEPTIDE COMPLEX 1EJ4 ; 2.25 ; COCRYSTAL STRUCTURE OF EIF4E/4E-BP1 PEPTIDE 1DP7 ; 1.50 ; COCRYSTAL STRUCTURE OF RFX-DBD IN COMPLEX WITH ITS COGNATE X-BOX BINDING SITE 1F2I ; 2.35 ; COCRYSTAL STRUCTURE OF SELECTED ZINC FINGER DIMER BOUND TO DEOXYRIBONUCLEIC ACID 1RP3 ; 2.30 ; COCRYSTAL STRUCTURE OF THE FLAGELLAR SIGMA/ANTI-SIGMA COMPLEX, SIGMA-28/FLGM 1EJ1 ; 2.20 ; COCRYSTAL STRUCTURE OF THE MESSENGER RIBONUCLEIC ACID 5' CAP-BINDING PROTEIN (EIF4E) BOUND TO 7-METHYL-GDP 1L8B ; 1.80 ; COCRYSTAL STRUCTURE OF THE MESSENGER RIBONUCLEIC ACID 5' CAP-BINDING PROTEIN (EIF4E) BOUND TO 7-METHYLGPPPG 1SKJ ; 2.10 ; COCRYSTAL STRUCTURE OF UREA-SUBSTITUTED PHOSPHOPEPTIDE COMPLEX 1QV9 ; 1.54 ; COENZYME F420-DEPENDENT METHYLENETETRAHYDROMETHANOPTERIN DEHYDROGENASE (MTD) FROM METHANOPYRUS KANDLERI: A METHANOGENIC ENZYME WITH AN UNUSUAL QUARTERNARY STRUCTURE 1AL3 ; 1.80 ; COFACTOR BINDING FRAGMENT OF CYSB FROM KLEBSIELLA AEROGENES 1KLI ; 1.69 ; COFACTOR-AND SUBSTRATE-ASSISTED ACTIVATION OF FACTOR VIIA 1HQZ ; 2.10 ; COFILIN HOMOLOGY DOMAIN OF A YEAST ACTIN-BINDING PROTEIN ABP1P 1G1K ; 2.00 ; COHESIN MODULE FROM THE CELLULOSOME OF CLOSTRIDIUM CELLULOLYTICUM 1ANU ; 2.15 ; COHESIN-2 DOMAIN OF THE CELLULOSOME FROM CLOSTRIDIUM THERMOCELLUM 1OHZ ; 2.20 ; COHESIN-DOCKERIN COMPLEX FROM THE CELLULOSOME OF CLOSTRIDIUM THERMOCELLUM 1IJ0 ; 1.86 ; COILED COIL TRIMER GCN4-PVLS SER AT BURIED D POSITION 1D7M ; 2.70 ; COILED-COIL DIMERIZATION DOMAIN FROM CORTEXILLIN I 1WT6 ; 1.60 ; COILED-COIL DOMAIN OF DMPK 1UIX ; 1.80 ; COILED-COIL STRUCTURE OF THE RHOA-BINDING DOMAIN IN RHO- KINASE 1P9I ; 1.17 ; COILED-COIL X-RAY STRUCTURE AT 1.17 A RESOLUTION 1A59 ; 2.09 ; COLD-ACTIVE CITRATE SYNTHASE 1AYI ; 2.00 ; COLICIN E7 IMMUNITY PROTEIN IM7 1GXH ; -1.00 ; COLICIN E8 DNASE IMMUNITY PROTEIN: IM8 1IMP ; -1.00 ; COLICIN E9 IMMUNITY PROTEIN IM9, NMR, 21 STRUCTURES 1IMQ ; -1.00 ; COLICIN E9 IMMUNITY PROTEIN IM9, NMR, MINIMIZED AVERAGE STRUCTURE 1CII ; 3.00 ; COLICIN IA 1A87 ; 3.10 ; COLICIN N 1BKV ; 2.00 ; COLLAGEN 2CUO ; 1.33 ; COLLAGEN MODEL PEPTIDE (PRO-PRO-GLY)9 1AMX ; 2.00 ; COLLAGEN-BINDING DOMAIN FROM A STAPHYLOCOCCUS AUREUS ADHESIN 1PEX ; 2.70 ; COLLAGENASE-3 (MMP-13) C-TERMINAL HEMOPEXIN-LIKE DOMAIN 830C ; 1.60 ; COLLAGENASE-3 (MMP-13) COMPLEXED TO A SULPHONE-BASED HYDROXAMIC ACID 1HXH ; 1.22 ; COMAMONAS TESTOSTERONI 3BETA/17BETA HYDROXYSTEROID DEHYDROGENASE 2BH8 ; 1.90 ; COMBINATORIAL PROTEIN 1B11 1F6H ; 3.31 ; COMBINED RIETVELD AND STEREOCHEMICAL RESTRAINT REFINEMENT OF A PROTEIN 1K1T ; 1.20 ; COMBINING MUTATIONS IN HIV-1 PROTEASE TO UNDERSTAND MECHANISMS OF RESISTANCE 1K1U ; 1.55 ; COMBINING MUTATIONS IN HIV-1 PROTEASE TO UNDERSTAND MECHANISMS OF RESISTANCE 1K2B ; 1.70 ; COMBINING MUTATIONS IN HIV-1 PROTEASE TO UNDERSTAND MECHANISMS OF RESISTANCE 1K2C ; 2.20 ; COMBINING MUTATIONS IN HIV-1 PROTEASE TO UNDERSTAND MECHANISMS OF RESISTANCE 1UZ4 ; 1.71 ; COMMON INHIBITION OF BETA-GLUCOSIDASE AND BETA-MANNOSIDASE BY ISOFAGOMINE LACTAM REFLECTS DIFFERENT CONFORMATIONAL INTINERARIES FOR GLUCOSIDE AND MANNOSIDE HYDROLYSIS 1SJI ; 2.40 ; COMPARING SKELETAL AND CARDIAC CALSEQUESTRIN STRUCTURES AND THEIR CALCIUM BINDING: A PROPOSED MECHANISM FOR COUPLED CALCIUM BINDING AND PROTEIN POLYMERIZATION 1SGU ; 1.90 ; COMPARING THE ACCUMULATION OF ACTIVE SITE AND NON-ACTIVE SITE MUTATIONS IN THE HIV-1 PROTEASE 1SH9 ; 2.50 ; COMPARING THE ACCUMULATION OF ACTIVE SITE AND NON-ACTIVE SITE MUTATIONS IN THE HIV-1 PROTEASE 1NI6 ; 2.10 ; COMPARISIONS OF THE HEME-FREE AND-BOUND CRYSTAL STRUCTURES OF HUMAN HEME OXYGENASE-1 1P1X ; 0.99 ; COMPARISON OF CLASS I ALDOLASE BINDING SITE ARCHITECTURE BASED ON THE CRYSTAL STRUCTURE OF 2-DEOXYRIBOSE-5- PHOSPHATE ALDOLASE DETERMINED AT 0.99 ANGSTROM RESOLUTION 1OA2 ; 1.50 ; COMPARISON OF FAMILY 12 GLYCOSIDE HYDROLASES AND RECRUITED SUBSTITUTIONS IMPORTANT FOR THERMAL STABILITY 1OA3 ; 1.70 ; COMPARISON OF FAMILY 12 GLYCOSIDE HYDROLASES AND RECRUITED SUBSTITUTIONS IMPORTANT FOR THERMAL STABILITY 1OA4 ; 1.50 ; COMPARISON OF FAMILY 12 GLYCOSIDE HYDROLASES AND RECRUITED SUBSTITUTIONS IMPORTANT FOR THERMAL STABILITY 1DAJ ; 2.30 ; COMPARISON OF TERNARY COMPLEXES OF PNEUMOCYSTIS CARINII AND WILD TYPE HUMAN DIHYDROFOLATE REDUCTASE WITH COENZYME NADPH AND A NOVEL CLASSICAL ANTITUMOR FURO[2,3D]PYRIMIDINE ANTIFOLATE 1HFP ; 2.10 ; COMPARISON OF TERNARY CRYSTAL COMPLEXES OF HUMAN DIHYDROFOLATE REDUCTASE WITH NADPH AND A CLASSICAL ANTITUMOR FUROPYRIMDINE 1HFQ ; 2.10 ; COMPARISON OF TERNARY CRYSTAL COMPLEXES OF HUMAN DIHYDROFOLATE REDUCTASE WITH NADPH AND A CLASSICAL ANTITUMOR FUROPYRIMDINE 1HFR ; 2.10 ; COMPARISON OF TERNARY CRYSTAL COMPLEXES OF HUMAN DIHYDROFOLATE REDUCTASE WITH NADPH AND A CLASSICAL ANTITUMOR FUROPYRIMDINE 1R8H ; 1.90 ; COMPARISON OF THE STRUCTURE AND DEOXYRIBONUCLEIC ACID BINDING PROPERTIES OF THE E2 PROTEINS FROM AN ONCOGENIC AND A NON-ONCOGENIC HUMAN PAPILLOMAVIRUS 1B2W ; 2.90 ; COMPARISON OF THE THREE-DIMENSIONAL STRUCTURES OF A HUMANIZED AND A CHIMERIC FAB OF AN ANTI-GAMMA-INTERFERON ANTIBODY 1B4J ; 2.90 ; COMPARISON OF THE THREE-DIMENSIONAL STRUCTURES OF A HUMANIZED AND A CHIMERIC FAB OF AN ANTI-GAMMA-INTERFERON ANTIBODY 1CZH ; 1.86 ; COMPARISONS OF WILD TYPE AND MUTANT FLAVODOXINS FROM ANACYSTIS NIDULANS. STRUCTURAL DETERMINANTS OF THE REDOX POTENTIALS. 1CZK ; 1.90 ; COMPARISONS OF WILD TYPE AND MUTANT FLAVODOXINS FROM ANACYSTIS NIDULANS. STRUCTURAL DETERMINANTS OF THE REDOX POTENTIALS. 1CZL ; 1.80 ; COMPARISONS OF WILD TYPE AND MUTANT FLAVODOXINS FROM ANACYSTIS NIDULANS. STRUCTURAL DETERMINANTS OF THE REDOX POTENTIALS. 1CZO ; 1.85 ; COMPARISONS OF WILD TYPE AND MUTANT FLAVODOXINS FROM ANACYSTIS NIDULANS. STRUCTURAL DETERMINANTS OF THE REDOX POTENTIALS. 1CZR ; 1.90 ; COMPARISONS OF WILD TYPE AND MUTANT FLAVODOXINS FROM ANACYSTIS NIDULANS. STRUCTURAL DETERMINANTS OF THE REDOX POTENTIALS. 1D04 ; 1.85 ; COMPARISONS OF WILD TYPE AND MUTANT FLAVODOXINS FROM ANACYSTIS NIDULANS. STRUCTURAL DETERMINANTS OF THE REDOX POTENTIALS. 1SS7 ; -1.00 ; COMPENSATING BENDS IN A 16 BASE-PAIR DEOXYRIBONUCLEIC ACID OLIGOMER CONTAINING A T3A3 SEGMENT 1SSV ; -1.00 ; COMPENSATING BENDS IN A 16 BASE-PAIR DEOXYRIBONUCLEIC ACID OLIGOMER CONTAINING A T3A3 SEGMENT 1CNC ; 2.20 ; COMPENSATORY PLASTIC EFFECTS IN THE REDESIGN OF PROTEIN- ZINC BINDING SITES 1NT9 ; 4.20 ; COMPLETE 12-SUBUNIT RIBONUCLEIC ACID POLYMERASE II 1WCM ; 3.80 ; COMPLETE 12-SUBUNIT RIBONUCLEIC ACID POLYMERASE II AT 3.8 ANG 2KTX ; -1.00 ; COMPLETE KALIOTOXIN FROM ANDROCTONUS MAURETANICUS MAURETANICUS, NMR, 18 STRUCTURES 1Y1W ; 4.00 ; COMPLETE RIBONUCLEIC ACID POLYMERASE II ELONGATION COMPLEX 1Y77 ; 4.50 ; COMPLETE RIBONUCLEIC ACID POLYMERASE II ELONGATION COMPLEX WITH SUBSTRATE ANALOGUE GMPCPP 2B63 ; 3.80 ; COMPLETE RIBONUCLEIC ACID POLYMERASE II-RIBONUCLEIC ACID INHIBITOR COMPLEX 1JRH ; 2.80 ; COMPLEX (ANTIBODY/ANTIGEN) 1XJ7 ; 2.70 ; COMPLEX ANDROGEN RECEPTOR LBD AND RAC3 PEPTIDE 1CXL ; 1.81 ; COMPLEX BETWEEN A COVALENT INTERMEDIATE AND BACILLUS CIRCULANS STRAIN 251 CGTASE E257Q 1CXK ; 2.09 ; COMPLEX BETWEEN A MALTONONAOSE SUBSTRATE AND BACILLUS CIRCULANS STRAIN 251 CGTASE E257Q/D229N 1OSG ; 3.00 ; COMPLEX BETWEEN BAFF AND A BR3 DERIVED PEPTIDE PRESENTED IN A BETA-HAIRPIN SCAFFOLD 1ES7 ; 2.90 ; COMPLEX BETWEEN BMP-2 AND TWO BMP RECEPTOR IA ECTODOMAINS 1AM4 ; 2.70 ; COMPLEX BETWEEN CDC42HS.GMPPNP AND P50 RHOGAP (H. SAPIENS) 1TEZ ; 1.80 ; COMPLEX BETWEEN DEOXYRIBONUCLEIC ACID AND THE DEOXYRIBONUCLEIC ACID PHOTOLYASE FROM ANACYSTIS NIDULANS 1VOM ; 1.90 ; COMPLEX BETWEEN DICTYOSTELIUM MYOSIN AND MGADP AND VANADATE AT 1.9A RESOLUTION 1F3R ; -1.00 ; COMPLEX BETWEEN FV ANTIBODY FRAGMENT AND AN ANALOGUE OF THE MAIN IMMUNOGENIC REGION OF THE ACETYLCHOLINE RECEPTOR 1OQO ; 2.30 ; COMPLEX BETWEEN G0 VERSION OF AN FC BOUND TO A MINIMIZED VERSION OF PROTEIN A CALLED MINI-Z 2ET3 ; 2.80 ; COMPLEX BETWEEN GENTAMICIN C1A AND THE 16S-RRNA A-SITE 1BD2 ; 2.50 ; COMPLEX BETWEEN HUMAN T-CELL RECEPTOR B7, VIRAL PEPTIDE (TAX) AND MHC CLASS I MOLECULE HLA-A 0201 1AO7 ; 2.60 ; COMPLEX BETWEEN HUMAN T-CELL RECEPTOR, VIRAL PEPTIDE (TAX), AND HLA-A 0201 2ESI ; 3.00 ; COMPLEX BETWEEN KANAMYCIN A AND THE 16S-RRNA A SITE. 1ESV ; 2.00 ; COMPLEX BETWEEN LATRUNCULIN A:RABBIT MUSCLE ALPHA ACTIN:HUMAN GELSOLIN DOMAIN 1 2ESJ ; 2.20 ; COMPLEX BETWEEN LIVIDOMYCIN A AND THE 16S-RRNA A SITE 1DMY ; 2.45 ; COMPLEX BETWEEN MURINE MITOCHONDRIAL CARBONIC ANYHDRASE V AND THE TRANSITION STATE ANALOGUE ACETAZOLAMIDE 1NMC ; 2.50 ; COMPLEX BETWEEN NC10 ANTI-INFLUENZA VIRUS NEURAMINIDASE SINGLE CHAIN ANTIBODY WITH A 15 RESIDUE LINKER AND INFLUENZA VIRUS NEURAMINIDASE 1A14 ; 2.50 ; COMPLEX BETWEEN NC10 ANTI-INFLUENZA VIRUS NEURAMINIDASE SINGLE CHAIN ANTIBODY WITH A 5 RESIDUE LINKER AND INFLUENZA VIRUS NEURAMINIDASE 2ET8 ; 2.50 ; COMPLEX BETWEEN NEAMINE AND THE 16S-RRNA A-SITE 2ET4 ; 2.40 ; COMPLEX BETWEEN NEOMYCIN B AND THE 16S-RRNA A-SITE 1QO3 ; 2.30 ; COMPLEX BETWEEN NK CELL RECEPTOR LY49A AND ITS MHC CLASS I LIGAND H-2DD 1J7T ; 2.50 ; COMPLEX BETWEEN PAROMOMYCIN AND THE 16S-RRNA A-SITE AT 2.5 A RESOLUTION 2BEE ; 2.60 ; COMPLEX BETWEEN PAROMOMYCIN DERIVATIVE JS4 AND THE 16S-RRNA A SITE 2BE0 ; 2.63 ; COMPLEX BETWEEN PAROMOMYCIN DERIVATIVE JS5-39 AND THE 16S- RRNA A-SITE. 1S70 ; 2.70 ; COMPLEX BETWEEN PROTEIN SER/THR PHOSPHATASE-1 (DELTA) AND THE MYOSIN PHOSPHATASE TARGETING SUBUNIT 1 (MYPT1) 1EQY ; 2.30 ; COMPLEX BETWEEN RABBIT MUSCLE ALPHA-ACTIN: HUMAN GELSOLIN DOMAIN 1 1P8Z ; 2.60 ; COMPLEX BETWEEN RABBIT MUSCLE ALPHA-ACTIN: HUMAN GELSOLIN RESIDUES VAL26-GLU156 2ET5 ; 2.20 ; COMPLEX BETWEEN RIBOSTAMYCIN AND THE 16S-RRNA A-SITE 1RSU ; 1.70 ; COMPLEX BETWEEN STREPTAVIDIN AND THE STREP-TAG II PEPTIDE 1RST ; 1.70 ; COMPLEX BETWEEN STREPTAVIDIN AND THE STREP-TAG PEPTIDE 1OAI ; 1.00 ; COMPLEX BETWEEN TAP UBA DOMAIN AND FXFG NUCLEOPORIN PEPTIDE 1ELU ; 1.55 ; COMPLEX BETWEEN THE CYSTINE C-S LYASE C-DES AND ITS REACTION PRODUCT CYSTEINE PERSULFIDE. 1EBP ; 2.80 ; COMPLEX BETWEEN THE EXTRACELLULAR DOMAIN OF ERYTHROPOIETIN (EPO) RECEPTOR [EBP] AND AN AGONIST PEPTIDE [EMP1] 1EBA ; 2.70 ; COMPLEX BETWEEN THE EXTRACELLULAR DOMAIN OF ERYTHROPOIETIN (EPO) RECEPTOR [EBP] AND AN INACTIVE PEPTIDE [EMP33] CONTAINS 3,5-DIBROMOTYROSINE IN POSITION 4 (DENOTED DBY) 1PJJ ; 1.90 ; COMPLEX BETWEEN THE LACTOCOCCUS LACTIS FPG AND AN ABASIC SITE CONTAINING DEOXYRIBONUCLEIC ACID. 1VPP ; 1.90 ; COMPLEX BETWEEN VEGF AND A RECEPTOR BLOCKING PEPTIDE 1OXB ; 2.30 ; COMPLEX BETWEEN YPD1 AND SLN1 RESPONSE REGULATOR DOMAIN IN SPACE GROUP P2(1)2(1)2(1) 1OXK ; 2.10 ; COMPLEX BETWEEN YPD1 AND SLN1 RESPONSE REGULATOR DOMAIN IN SPACE GROUP P3(2) 1TXC ; 2.30 ; COMPLEX CRYSTAL STRUCTURE OF SPE16 WITH ANS 1FSK ; 2.90 ; COMPLEX FORMATION BETWEEN A FAB FRAGMENT OF A MONOCLONAL IGG ANTIBODY AND THE MAJOR ALLERGEN FROM BIRCH POLLEN BET V 1 1BJR ; 2.44 ; COMPLEX FORMED BETWEEN PROTEOLYTICALLY GENERATED LACTOFERRIN FRAGMENT AND PROTEINASE K 1XCT ; 3.05 ; COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55A, L57H, Y64W) IN SPACE GROUP P21212 1XCQ ; 3.50 ; COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55A,L57H, Y64W) IN SPACE GROUP P21 1XF5 ; 2.60 ; COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (H74C, Y64W)IN SPACE GROUP P21212 1NEN ; 2.90 ; COMPLEX II (SUCCINATE DEHYDROGENASE) FROM E. COLI WITH DINITROPHENOL-17 INHIBITOR CO-CRYSTALLIZED AT THE UBIQUINONE BINDING SITE 1NEK ; 2.60 ; COMPLEX II (SUCCINATE DEHYDROGENASE) FROM E. COLI WITH UBIQUINONE BOUND 1JAQ ; 2.25 ; COMPLEX OF 1-HYDROXYLAMINE-2-ISOBUTYLMALONYL-ALA-GLY-NH2 WITH THE CATALYTIC DOMAIN OF MATRIX METALLO PROTEINASE-8 (MET80 FORM) 1I76 ; 1.20 ; COMPLEX OF 2-(BIPHENYL-4-SULFONYL)-1,2,3,4-TETRAHYDRO- ISOQUINOLINE-3-CARBOXYLIC ACID (D-TIC DERIVATIVE) WITH T CATALITIC DOMAIN OF MATRIX METALLO PROTEINASE-8 (MET80 FORM) 2KMB ; 2.00 ; COMPLEX OF 3'-NEUAC-LEWIS-X WITH A SELECTIN-LIKE MUTANT OF MANNOSE-BINDING PROTEIN A 3KMB ; 1.95 ; COMPLEX OF 3'-SULFO-LEWIS-X WITH A SELECTIN-LIKE MUTANT OF MANNOSE-BINDING PROTEIN A 1JAO ; 2.40 ; COMPLEX OF 3-MERCAPTO-2-BENZYLPROPANOYL-ALA-GLY-NH2 WITH THE CATALYTIC DOMAIN OF MATRIX METALLO PROTEINASE-8 (MET80 FORM) 4KMB ; 2.00 ; COMPLEX OF 4'-SULFO-LEWIS-X WITH A SELECTIN-LIKE MUTANT OF MANNOSE-BINDING PROTEIN A 2DHN ; 2.20 ; COMPLEX OF 7,8-DIHYDRONEOPTERIN ALDOLASE FROM STAPHYLOCOCCUS AUREUS WITH 6-HYDROXYMETHYL-7,8-DIHYDROPTERIN AT 2.2 A RESOLUTION 1CXF ; 2.60 ; COMPLEX OF A (D229N/E257Q) DOUBLE MUTANT CGTASE FROM BACILLUS CIRCULANS STRAIN 251 WITH MALTOTETRAOSE AT 120 K AND PH 9.1 OBTAINED AFTER SOAKING THE CRYSTAL WITH ALPHA-CYCLODEXTRIN 1H0G ; 2.00 ; COMPLEX OF A CHITINASE WITH THE NATURAL PRODUCT CYCLOPENTAPEPTIDE ARGADIN FROM CLONOSTACHYS 1H0I ; 2.00 ; COMPLEX OF A CHITINASE WITH THE NATURAL PRODUCT CYCLOPENTAPEPTIDE ARGIFIN FROM GLIOCLADIU 1DIT ; 2.30 ; COMPLEX OF A DIVALENT INHIBITOR WITH THROMBIN 1BZQ ; 2.80 ; COMPLEX OF A DROMEDARY SINGLE-DOMAIN VHH ANTIBODY FRAGMENT WITH RNASE A 1GZG ; 1.66 ; COMPLEX OF A MG2-DEPENDENT PORPHOBILINOGEN SYNTHASE FROM PSEUDOMONAS AERUGINOSA (MUTANT D139N) WITH 5-FLUOROLEVULINIC ACID 2DIJ ; 2.60 ; COMPLEX OF A Y195F MUTANT CGTASE FROM B. CIRCULANS STRAIN 251 COMPLEXED WITH A MALTONONAOSE INHIBITOR AT PH 9.8 OBTAINED AFTER SOAKING THE CRYSTAL WITH ACARBOSE AND MALTOHEXAOSE 1DJ6 ; 1.00 ; COMPLEX OF A Z-DEOXYRIBONUCLEIC ACID HEXAMER, D(CG)3, WITH SYNTHETIC POLYAMINE AT ROOM TEMPERATURE 1H9A ; 2.16 ; COMPLEX OF ACTIVE MUTANT (Q365->C) OF GLUCOSE 6-PHOSPHATE DEHYDROGENASE FROM L. MESENTEROIDES WITH COENZYME NADP 1E77 ; 2.69 ; COMPLEX OF ACTIVE MUTANT (Q365->C) OF GLUCOSE 6-PHOSPHATE DEHYDROGENASE FROM LEUCONOSTOC MESENTEROIDES WITH SUBSTRATE 1H94 ; 2.50 ; COMPLEX OF ACTIVE MUTANT (S215->C) OF GLUCOSE 6-PHOSPHATE DEHYDROGENASE FROM L.MESENTEROIDES WITH COENZYME NAD 1DAN ; 2.00 ; COMPLEX OF ACTIVE SITE INHIBITED HUMAN BLOOD COAGULATION FACTOR VIIA WITH HUMAN RECOMBINANT SOLUBLE TISSUE FACTOR 1AGR ; 2.80 ; COMPLEX OF ALF4-ACTIVATED GI-ALPHA-1 WITH RGS4 1JL8 ; 3.20 ; COMPLEX OF ALPHA-AMYLASE II (TVA II) FROM THERMOACTINOMYCES VULGARIS R-47 WITH BETA-CYCLODEXTRIN BASED ON A CO- CRYSTALLIZATION WITH METHYL BETA-CYCLODEXTRIN 1JIB ; 3.30 ; COMPLEX OF ALPHA-AMYLASE II (TVA II) FROM THERMOACTINOMYCES VULGARIS R-47 WITH MALTOTETRAOSE BASED ON A CRYSTAL SOAKED WITH MALTOHEXAOSE. 1XZ3 ; 1.75 ; COMPLEX OF APOFERRITIN WITH ISOFLURANE 1KSG ; 2.30 ; COMPLEX OF ARL2 AND PDE DELTA, CRYSTAL FORM 1 1KSH ; 1.80 ; COMPLEX OF ARL2 AND PDE DELTA, CRYSTAL FORM 2 (NATIVE) 1KSJ ; 2.60 ; COMPLEX OF ARL2 AND PDE DELTA, CRYSTAL FORM 2 (SEMET) 1EAI ; 2.40 ; COMPLEX OF ASCARIS CHYMOTRPSIN/ELASTASE INHIBITOR WITH PORCINE ELASTASE 2BFY ; 1.80 ; COMPLEX OF AURORA-B WITH INCENP AND HESPERIDIN. 1YAK ; 2.50 ; COMPLEX OF BACILLUS SUBTILIS TENA WITH 4-AMINO-2-METHYL-5- HYDROXYMETHYLPYRIMIDINE 1MMB ; 2.10 ; COMPLEX OF BB94 WITH THE CATALYTIC DOMAIN OF MATRIX METALLOPROTEINASE-8 1G5J ; -1.00 ; COMPLEX OF BCL-XL WITH PEPTIDE FROM BAD 1C9T ; 3.30 ; COMPLEX OF BDELLASTASIN WITH BOVINE TRYPSIN 1C9P ; 2.80 ; COMPLEX OF BDELLASTASIN WITH PORCINE TRYPSIN 1RTF ; 2.30 ; COMPLEX OF BENZAMIDINE WITH THE CATALYTIC DOMAIN OF HUMAN TWO CHAIN TISSUE PLASMINOGEN ACTIVATOR [(TC)-T-PA] 1UNN ; 1.90 ; COMPLEX OF BETA-CLAMP PROCESSIVITY FACTOR AND LITTLE FINGER DOMAIN OF POLIV 1PBO ; 2.20 ; COMPLEX OF BOVINE ODORANT BINDING PROTEIN (OBP) WITH A SELENIUM CONTAINING ODORANT 1GT1 ; 1.71 ; COMPLEX OF BOVINE ODORANT BINDING PROTEIN WITH AMINOANTHRACENE AND PYRAZINE 1GT3 ; 1.80 ; COMPLEX OF BOVINE ODORANT BINDING PROTEIN WITH DIHYDROMYRCENOL 1GT4 ; 2.10 ; COMPLEX OF BOVINE ODORANT BINDING PROTEIN WITH UNDECANAL 1DQ9 ; 2.80 ; COMPLEX OF CATALYTIC PORTION OF HUMAN HMG-COA REDUCTASE WITH HMG-COA 1CXE ; 2.10 ; COMPLEX OF CGTASE WITH MALTOTETRAOSE AT ROOM TEMPERATURE AND PH 9.1 BASED ON DIFFRACTION DATA OF A CRYSTAL SOAKED WITH ALPHA-CYCLODEXTRIN 1CXH ; 2.40 ; COMPLEX OF CGTASE WITH MALTOTETRAOSE AT ROOM TEMPERATURE AND PH 9.6 BASED ON DIFFRACTION DATA OF A CRYSTAL SOAKED WITH MALTOHEPTAOSE 1EM0 ; 0.90 ; COMPLEX OF D(CCTAGG) WITH TETRA-[N-METHYL-PYRIDYL] PORPHYRIN 1IOV ; 2.20 ; COMPLEX OF D-ALA:D-ALA LIGASE WITH ADP AND A PHOSPHORYL PHOSPHONATE 1K9I ; 2.50 ; COMPLEX OF DC-SIGN AND GLCNAC2MAN3 1K9J ; 1.90 ; COMPLEX OF DC-SIGNR AND GLCNAC2MAN3 1XDT ; 2.65 ; COMPLEX OF DIPHTHERIA TOXIN AND HEPARIN-BINDING EPIDERMAL GROWTH FACTOR 1OOH ; 1.25 ; COMPLEX OF DROSOPHILA ODORANT BINDING PROTEIN LUSH WITH BUTANOL 1OOF ; 1.49 ; COMPLEX OF DROSOPHILA ODORANT BINDING PROTEIN LUSH WITH ETHANOL 1OOG ; 1.45 ; COMPLEX OF DROSOPHILA ODORANT BINDING PROTEIN LUSH WITH PROPANOL 1KKF ; 2.60 ; COMPLEX OF E. COLI ADENYLOSUCCINATE SYNTHETASE WITH IMP, HADACIDIN, PYROPHOSPHATE, AND MG 1USQ ; 1.90 ; COMPLEX OF E. COLI DRAE ADHESIN WITH CHLORAMPHENICOL 5TMP ; 1.98 ; COMPLEX OF E. COLI THYMIDYLATE KINASE WITH THE BISUBSTRATE INHIBITOR AZTP5A 4TMK ; 1.98 ; COMPLEX OF E. COLI THYMIDYLATE KINASE WITH THE BISUBSTRATE INHIBITOR TP5A 1CY6 ; 2.50 ; COMPLEX OF E.COLI DEOXYRIBONUCLEIC ACID TOPOISOMERASE I WITH 3' THYMIDINE MONOPHOSPHATE 1CY0 ; 2.45 ; COMPLEX OF E.COLI DEOXYRIBONUCLEIC ACID TOPOISOMERASE I WITH 3'-5'-ADENOSINE DIPHOSPHATE 1CY7 ; 2.40 ; COMPLEX OF E.COLI DEOXYRIBONUCLEIC ACID TOPOISOMERASE I WITH 5'-THYMIDINE MONOPHOSPHATE 1CY8 ; 2.45 ; COMPLEX OF E.COLI DEOXYRIBONUCLEIC ACID TOPOISOMERASE I WITH 5'-THYMIDINE MONOPHOSPHATE AND 3'-THYMIDINE MONOPHOSPHATE 1CY1 ; 2.30 ; COMPLEX OF E.COLI DEOXYRIBONUCLEIC ACID TOPOISOMERASE I WITH 5'PTPTPT 1CY4 ; 2.55 ; COMPLEX OF E.COLI DEOXYRIBONUCLEIC ACID TOPOISOMERASE I WITH 5'PTPTPTP3' 1CY2 ; 2.30 ; COMPLEX OF E.COLI DEOXYRIBONUCLEIC ACID TOPOISOMERASE I WITH TPTPTP3' 1UPN ; 16.00 ; COMPLEX OF ECHOVIRUS TYPE 12 WITH DOMAINS 3 AND 4 OF ITS RECEPTOR DECAY ACCELERATING FACTOR (CD55) BY CRYO ELECTRON MICROSCOPY AT 16 A 1RV5 ; 2.10 ; COMPLEX OF ECORV ENDONUCLEASE WITH D(AAAGAT)/D(ATCTT) 1H9I ; 1.90 ; COMPLEX OF EETI-II MUTANT WITH PORCINE TRYPSIN 1H9H ; 1.50 ; COMPLEX OF EETI-II WITH PORCINE TRYPSIN 1O2F ; -1.00 ; COMPLEX OF ENZYME IIAGLC AND IIBGLC PHOSPHOCARRIER PROTEIN HPR FROM ESCHERICHIA COLI NMR, RESTRAINED REGULARIZED MEAN STRUCTURE 1GGR ; -1.00 ; COMPLEX OF ENZYME IIAGLC AND THE HISTIDINE-CONTAINING PHOSPHOCARRIER PROTEIN HPR FROM ESCHERICHIA COLI NMR, RESTRAINED REGULARIZED MEAN STRUCTURE 1VRC ; -1.00 ; COMPLEX OF ENZYME IIAMANNOSE AND THE HISTIDINE-CONTAINING PHOSPHOCARRIER PROTEIN HPR FROM ESCHERICHIA COLI NMR, RESTRAINED REGULARIZED MEAN STRUCTURE 1J6T ; -1.00 ; COMPLEX OF ENZYME IIAMTL AND THE HISTIDINE-CONTAINING PHOSPHOCARRIER PROTEIN HPR FROM ESCHERICHIA COLI NMR, RESTRAINED REGULARIZED MEAN STRUCTURE 1KKB ; 2.60 ; COMPLEX OF ESCHERICHIA COLI ADENYLOSUCCINATE SYNTHETASE WITH IMP AND HADACIDIN 1FS0 ; 2.10 ; COMPLEX OF GAMMA/EPSILON ATP SYNTHASE FROM E.COLI 1PY1 ; 2.60 ; COMPLEX OF GGA1-VHS DOMAIN AND BETA-SECRETASE C-TERMINAL PHOSPHOPEPTIDE 1LF8 ; 2.30 ; COMPLEX OF GGA3-VHS DOMAIN AND CI-MPR C-TERMINAL PHOSPHOPEPTIDE 1NOI ; 2.50 ; COMPLEX OF GLYCOGEN PHOSPHORYLASE WITH A TRANSITION STATE ANALOGUE NOJIRIMYCIN TETRAZOLE AND PHOSPHATE IN THE T AND R STATES 1NOJ ; 2.40 ; COMPLEX OF GLYCOGEN PHOSPHORYLASE WITH A TRANSITION STATE ANALOGUE NOJIRIMYCIN TETRAZOLE AND PHOSPHATE IN THE T STATE 1NOK ; 2.40 ; COMPLEX OF GLYCOGEN PHOSPHORYLASE WITH A TRANSITION STATE ANALOGUE NOJIRIMYCIN TETRAZOLE AND PHOSPHATE IN THE T STATE 1TL7 ; 2.80 ; COMPLEX OF GS- WITH THE CATALYTIC DOMAINS OF MAMMALIAN ADENYLYL CYCLASE: COMPLEX WITH 2'(3')-O-(N- METHYLANTHRANILOYL)-GUANOSINE 5'-TRIPHOSPHATE AND MN 1AZS ; 2.30 ; COMPLEX OF GS-ALPHA WITH THE CATALYTIC DOMAINS OF MAMMALIAN ADENYLYL CYCLASE 1CUL ; 2.40 ; COMPLEX OF GS-ALPHA WITH THE CATALYTIC DOMAINS OF MAMMALIAN ADENYLYL CYCLASE: COMPLEX WITH 2',5'-DIDEOXY-ADENOSINE 3'- TRIPHOSPHATE AND MG 1CS4 ; 2.50 ; COMPLEX OF GS-ALPHA WITH THE CATALYTIC DOMAINS OF MAMMALIAN ADENYLYL CYCLASE: COMPLEX WITH 2'-DEOXY-ADENOSINE 3'- MONOPHOSPHATE, PYROPHOSPHATE AND MG 1CJK ; 3.00 ; COMPLEX OF GS-ALPHA WITH THE CATALYTIC DOMAINS OF MAMMALIAN ADENYLYL CYCLASE: COMPLEX WITH ADENOSINE 5'-(ALPHA THIO)- TRIPHOSPHATE (RP), MG, AND MN 1CJU ; 2.80 ; COMPLEX OF GS-ALPHA WITH THE CATALYTIC DOMAINS OF MAMMALIAN ADENYLYL CYCLASE: COMPLEX WITH BETA-L-2',3'-DIDEOXYATP AND MG 1CJV ; 3.00 ; COMPLEX OF GS-ALPHA WITH THE CATALYTIC DOMAINS OF MAMMALIAN ADENYLYL CYCLASE: COMPLEX WITH BETA-L-2',3'-DIDEOXYATP, MG, AND ZN 1CJT ; 2.80 ; COMPLEX OF GS-ALPHA WITH THE CATALYTIC DOMAINS OF MAMMALIAN ADENYLYL CYCLASE: COMPLEX WITH BETA-L-2',3'-DIDEOXYATP, MN, AND MG 1XZ1 ; 1.75 ; COMPLEX OF HALOTHANE WITH APOFERRITIN 1HTW ; 1.70 ; COMPLEX OF HI0065 WITH ADP AND MAGNESIUM 1UU1 ; 2.38 ; COMPLEX OF HISTIDINOL-PHOSPHATE AMINOTRANSFERASE (HISC) FROM THERMOTOGA MARITIMA (APO-FORM) 1G70 ; -1.00 ; COMPLEX OF HIV-1 RRE-IIB RIBONUCLEIC ACID WITH RSG-1.2 PEPTIDE 1US7 ; 2.30 ; COMPLEX OF HSP90 AND P50 1HAO ; 2.80 ; COMPLEX OF HUMAN ALPHA-THROMBIN WITH A 15MER OLIGONUCLEOTIDE GGTTGGTGTGGTTGG (BASED ON NMR MODEL OF DEOXYRIBONUCLEIC ACID) 1HAP ; 2.80 ; COMPLEX OF HUMAN ALPHA-THROMBIN WITH A 15MER OLIGONUCLEOTIDE GGTTGGTGTGGTTGG (BASED ON X-RAY MODEL OF DEOXYRIBONUCLEIC ACID) 1A3B ; 1.80 ; COMPLEX OF HUMAN ALPHA-THROMBIN WITH THE BIFUNCTIONAL BORONATE INHIBITOR BOROLOG1 1A3E ; 1.85 ; COMPLEX OF HUMAN ALPHA-THROMBIN WITH THE BIFUNCTIONAL BORONATE INHIBITOR BOROLOG2 1YD8 ; 2.80 ; COMPLEX OF HUMAN GGA3 GAT DOMAIN AND UBIQUITIN 1BKD ; 2.80 ; COMPLEX OF HUMAN H-RAS WITH HUMAN SOS-1 1OP9 ; 1.86 ; COMPLEX OF HUMAN LYSOZYME WITH CAMELID VHH HL6 ANTIBODY FRAGMENT 1B59 ; 1.80 ; COMPLEX OF HUMAN METHIONINE AMINOPEPTIDASE-2 COMPLEXED WITH OVALICIN 1KBQ ; 1.80 ; COMPLEX OF HUMAN NAD(P)H QUINONE OXIDOREDUCTASE WITH 5- METHOXY-1,2-DIMETHYL-3-(4-NITROPHENOXYMETHYL)INDOLE-4,7- DIONE (ES936) 1KBO ; 2.30 ; COMPLEX OF HUMAN RECOMBINANT NAD(P)H:QUINONE OXIDE REDUCTASE TYPE 1 WITH 5-METHOXY-1,2-DIMETHYL-3- (PHENOXYMETHYL)INDOLE-4,7-DIONE (ES1340) 1K6E ; 1.85 ; COMPLEX OF HYDROLYTIC HALOALKANE DEHALOGENASE LINB FROM SPHINGOMONAS PAUCIMOBILIS UT26 WITH 1,2-PROPANEDIOL (PRODUCT OF DEHALOGENATION OF 1,2-DIBROMOPROPANE) AT 1.85A 1K63 ; 1.80 ; COMPLEX OF HYDROLYTIC HALOALKANE DEHALOGENASE LINB FROM SPHINGOMONAS PAUCIMOBILIS WITH UT26 2-BROMO-2-PROPENE-1-OL AT 1.8A RESOLUTION 1H59 ; 2.10 ; COMPLEX OF IGFBP-5 WITH IGF-I 2DPG ; 2.50 ; COMPLEX OF INACTIVE MUTANT (H240->N) OF GLUCOSE 6-PHOSPHATE DEHYDROGENASE FROM LEUCONOSTOC MESENTEROIDES WITH NADP+ 1A53 ; 2.00 ; COMPLEX OF INDOLE-3-GLYCEROLPHOSPHATE SYNTHASE FROM SULFOLOBUS SOLFATARICUS WITH INDOLE-3-GLYCEROLPHOSPHATE AT 2.0 A RESOLUTION 1LDT ; 1.90 ; COMPLEX OF LEECH-DERIVED TRYPTASE INHIBITOR WITH PORCINE TRYPSIN 1RUT ; 1.30 ; COMPLEX OF LMO4 LIM DOMAINS 1 AND 2 WITH THE LDB1 LID DOMAIN 1KZE ; 1.80 ; COMPLEX OF MBP-C AND BIVALENT MAN-TERMINATED GLYCOPEPTIDE 1KZD ; 1.90 ; COMPLEX OF MBP-C AND GLCNAC-TERMINATED CORE 1KZC ; 1.85 ; COMPLEX OF MBP-C AND HIGH-AFFINITY LINEAR TRIMANNOSE 1KZA ; 1.74 ; COMPLEX OF MBP-C AND MAN-A13-MAN 1KZB ; 1.80 ; COMPLEX OF MBP-C AND TRIMANNOSYL CORE 1EL5 ; 1.80 ; COMPLEX OF MONOMERIC SARCOSINE OXIDASE WITH THE INHIBITOR DIMETHYLGLYCINE 1ELI ; 2.00 ; COMPLEX OF MONOMERIC SARCOSINE OXIDASE WITH THE INHIBITOR PYRROLE-2-CARBOXYLATE 1EL8 ; 1.90 ; COMPLEX OF MONOMERIC SARCOSINE OXIDASE WITH THE INHIBITOR [METHYLSELENO]CETATE 1EL9 ; 2.00 ; COMPLEX OF MONOMERIC SARCOSINE OXIDASE WITH THE INHIBITOR [METHYLTHIO]ACETATE 1EL7 ; 1.90 ; COMPLEX OF MONOMERIC SARCOSINE OXIDASE WITH THE INHIBITOR [METHYTELLURO]ACETATE 8ATC ; 2.50 ; COMPLEX OF N-PHOSPHONACETYL-L-ASPARTATE WITH ASPARTATE CARBAMOYLTRANSFERASE. X-RAY REFINEMENT, ANALYSIS OF CONFORMATIONAL CHANGES AND CATALYTIC AND ALLOSTERIC MECHANISMS 1JAP ; 1.82 ; COMPLEX OF PRO-LEU-GLY-HYDROXYLAMINE WITH THE CATALYTIC DOMAIN OF MATRIX METALLO PROTEINASE-8 (MET80 FORM) 1JAN ; 2.50 ; COMPLEX OF PRO-LEU-GLY-HYDROXYLAMINE WITH THE CATALYTIC DOMAIN OF MATRIX METALLO PROTEINASE-8 (PHE79 FORM) 1I73 ; 1.40 ; COMPLEX OF PRO-LEU-L-TRP PHOSPHONATE WITH THE CATALITIC DOMAIN OF MATRIX METALLO PROTEINASE-8 (MET80 FORM) 1IBR ; 2.30 ; COMPLEX OF RAN WITH IMPORTIN BETA 1OYT ; 1.67 ; COMPLEX OF RECOMBINANT HUMAN THROMBIN WITH A DESIGNED FLUORINATED INHIBITOR 1QUQ ; 2.50 ; COMPLEX OF REPLICATION PROTEIN A SUBUNITS RPA14 AND RPA32 1TDG ; 1.80 ; COMPLEX OF S130G SHV-1 BETA-LACTAMASE WITH TAZOBACTAM 1KTK ; 3.00 ; COMPLEX OF STREPTOCOCCAL PYROGENIC ENTEROTOXIN C (SPEC) WITH A HUMAN T CELL RECEPTOR BETA CHAIN (VBETA2.1) 1IKI ; 1.25 ; COMPLEX OF STREPTOMYCES R61 DD-PEPTIDASE WITH THE PRODUCTS OF A SPECIFIC PEPTIDOGLYCAN SUBSTRATE FRAGMENT 1W4L ; 2.16 ; COMPLEX OF TCACHE WITH BIS-ACTING GALANTHAMINE DERIVATIVE 1W6R ; 2.05 ; COMPLEX OF TCACHE WITH GALANTHAMINE DERIVATIVE 2A5R ; -1.00 ; COMPLEX OF TETRA-(4-N-METHYLPYRIDYL) PORPHIN WITH MONOMERIC PARALLEL-STRANDED DEOXYRIBONUCLEIC ACID TETRAPLEX, SNAP-BACK 3+1 3' G-TETRAD, SINGLE-RESIDUE CHAIN REVERSAL LOOPS, GAG TRIAD IN THE CONTEXT OF GAAG DIAGONAL LOOP, C-MYC PROMOTER, NMR, 6 STRUCT. 3TDT ; 2.00 ; COMPLEX OF TETRAHYDRODIPICOLINATE N-SUCCINYLTRANSFERASE WITH 2-AMINO-6-OXOPIMELATE AND COENZYME A 2TDT ; 2.00 ; COMPLEX OF TETRAHYDRODIPICOLINATE N-SUCCINYLTRANSFERASE WITH 2-AMINOPIMELATE AND COENZYME A 1SLY ; 2.80 ; COMPLEX OF THE 70-KDA SOLUBLE LYTIC TRANSGLYCOSYLASE WITH BULGECIN A 3EZB ; -1.00 ; COMPLEX OF THE AMINO TERMINAL DOMAIN OF ENZYME I AND THE HISTIDINE-CONTAINING PHOSPHOCARRIER PROTEIN HPR FROM ESCHERICHIA COLI 3EZA ; -1.00 ; COMPLEX OF THE AMINO TERMINAL DOMAIN OF ENZYME I AND THE HISTIDINE-CONTAINING PHOSPHOCARRIER PROTEIN HPR FROM ESCHERICHIA COLI NMR, RESTRAINED REGULARIZED MEAN STRUCTURE 3EZE ; -1.00 ; COMPLEX OF THE AMINO TERMINAL DOMAIN OF ENZYME I AND THE HISTIDINE-CONTAINING PHOSPHOCARRIER PROTEIN HPR FROM ESCHERICHIA COLI NMR, RESTRAINED REGULARIZED MEAN STRUCTURE 1UZF ; 2.00 ; COMPLEX OF THE ANTI-HYPERTENSIVE DRUG CAPTOPRIL AN THE HUMAN TESTICULAR ANGIOTENSIN I-CONVERTING ENZYME 1UZE ; 1.82 ; COMPLEX OF THE ANTI-HYPERTENSIVE DRUG ENALAPRILAT AND THE HUMAN TESTICULAR ANGIOTENSIN I-CONVERTING ENZYME 1JC2 ; -1.00 ; COMPLEX OF THE C-DOMAIN OF TROPONIN C WITH RESIDUES 1-40 OF TROPONIN I 1G6V ; 3.50 ; COMPLEX OF THE CAMELID HEAVY-CHAIN ANTIBODY FRAGMENT CAB- CA05 WITH BOVINE CARBONIC ANHYDRASE 1BML ; 2.90 ; COMPLEX OF THE CATALYTIC DOMAIN OF HUMAN PLASMIN AND STREPTOKINASE 1HWK ; 2.22 ; COMPLEX OF THE CATALYTIC PORTION OF HUMAN HMG-COA REDUCTASE WITH ATORVASTATIN 1HWJ ; 2.26 ; COMPLEX OF THE CATALYTIC PORTION OF HUMAN HMG-COA REDUCTASE WITH CERIVASTATIN 1HW8 ; 2.10 ; COMPLEX OF THE CATALYTIC PORTION OF HUMAN HMG-COA REDUCTASE WITH COMPACTIN (ALSO KNOWN AS MEVASTATIN) 1HWI ; 2.30 ; COMPLEX OF THE CATALYTIC PORTION OF HUMAN HMG-COA REDUCTASE WITH FLUVASTATIN 1DQ8 ; 2.10 ; COMPLEX OF THE CATALYTIC PORTION OF HUMAN HMG-COA REDUCTASE WITH HMG AND COA 1DQA ; 2.00 ; COMPLEX OF THE CATALYTIC PORTION OF HUMAN HMG-COA REDUCTASE WITH HMG, COA, AND NADP+ 1HWL ; 2.10 ; COMPLEX OF THE CATALYTIC PORTION OF HUMAN HMG-COA REDUCTASE WITH ROSUVASTATIN (FORMALLY KNOWN AS ZD4522) 1HW9 ; 2.33 ; COMPLEX OF THE CATALYTIC PORTION OF HUMAN HMG-COA REDUCTASE WITH SIMVASTATIN 1C7U ; -1.00 ; COMPLEX OF THE DEOXYRIBONUCLEIC ACID BINDING CORE DOMAIN OF THE TRANSCRIPTION FACTOR MEF2A WITH A 20MER OLIGONUCLEOTIDE 1OCQ ; 1.08 ; COMPLEX OF THE ENDOGLUCANASE CEL5A FROM BACILLUS AGARADHEARANS AT 1.08 ANGSTROM RESOLUTION WITH CELLOBIO-DERIVED ISOFAGOMINE 1BVY ; 2.03 ; COMPLEX OF THE HEME AND FMN-BINDING DOMAINS OF THE CYTOCHROME P450(BM-3) 2XAT ; 3.20 ; COMPLEX OF THE HEXAPEPTIDE XENOBIOTIC ACETYLTRANSFERASE WITH CHLORAMPHENICOL AND DESULFO-COENZYME A 1AKJ ; 2.65 ; COMPLEX OF THE HUMAN MHC CLASS I GLYCOPROTEIN HLA-A2 AND THE T CELL CORECEPTOR CD8 1SEB ; 2.70 ; COMPLEX OF THE HUMAN MHC CLASS II GLYCOPROTEIN HLA-DR1 AND THE BACTERIAL SUPERANTIGEN SEB 1IRA ; 2.70 ; COMPLEX OF THE INTERLEUKIN-1 RECEPTOR WITH THE INTERLEUKIN-1 RECEPTOR ANTAGONIST (IL1RA) 1J4W ; -1.00 ; COMPLEX OF THE KH3 AND KH4 DOMAINS OF FBP WITH A SINGLE_STRANDED 29MER DEOXYRIBONUCLEIC ACID OLIGONUCLEOTIDE FROM THE FUSE ELEMENT OF THE C-MYC ONCOGENE 1J5K ; -1.00 ; COMPLEX OF THE KH3 DOMAIN OF HNRNP K WITH A SINGLE_STRANDED 10MER DEOXYRIBONUCLEIC ACID OLIGONUCLEOTIDE 1NWX ; 3.50 ; COMPLEX OF THE LARGE RIBOSOMAL SUBUNIT FROM DEINOCOCCUS RADIODURANS WITH ABT-773 1NWY ; 3.30 ; COMPLEX OF THE LARGE RIBOSOMAL SUBUNIT FROM DEINOCOCCUS RADIODURANS WITH AZITHROMYCIN 1SM1 ; 3.42 ; COMPLEX OF THE LARGE RIBOSOMAL SUBUNIT FROM DEINOCOCCUS RADIODURANS WITH QUINUPRISTIN AND DALFOPRISTIN 2BRR ; 1.95 ; COMPLEX OF THE NEISSERIAL PORA P1.4 EPITOPE PEPTIDE AND TWO FAB-FRAGMENTS (ANTIBODY MN20B9.34) 1ZHI ; 2.70 ; COMPLEX OF THE S. CEREVISIAE ORC1 AND SIR1 INTERACTING DOMAINS 1TFX ; 2.60 ; COMPLEX OF THE SECOND KUNITZ DOMAIN OF TISSUE FACTOR PATHWAY INHIBITOR WITH PORCINE TRYPSIN 1BCR ; 2.50 ; COMPLEX OF THE WHEAT SERINE CARBOXYPEPTIDASE, CPDW-II, WITH THE MICROBIAL PEPTIDE ALDEHYDE INHIBITOR, ANTIPAIN, AND ARGININE AT ROOM TEMPERATURE 1BCS ; 2.10 ; COMPLEX OF THE WHEAT SERINE CARBOXYPEPTIDASE, CPDW-II, WITH THE MICROBIAL PEPTIDE ALDEHYDE INHIBITOR, CHYMOSTATIN, AND ARGININE AT 100 DEGREES KELVIN 1NG3 ; 2.60 ; COMPLEX OF THIO (GLYCINE OXIDASE) WITH ACETYL-GLYCINE 1AD8 ; 2.00 ; COMPLEX OF THROMBIN WITH AND INHIBITOR CONTAINING A NOVEL P1 MOIETY 1VZQ ; 1.54 ; COMPLEX OF THROMBIN WITH DESIGNED INHIBITOR 7165 1GAN ; 2.23 ; COMPLEX OF TOAD OVARY GALECTIN WITH N-ACETYLGALACTOSE 1A78 ; 2.00 ; COMPLEX OF TOAD OVARY GALECTIN WITH THIO-DIGALACTOSE 1UCW ; 2.20 ; COMPLEX OF TRANSALDOLASE WITH THE REDUCED SCHIFF-BASE INTERMEDIATE 1NGS ; 2.40 ; COMPLEX OF TRANSKETOLASE WITH THIAMIN DIPHOSPHATE, CA2+ AND ACCEPTOR SUBSTRATE ERYTHROSE-4-PHOSPHATE 1A2X ; 2.30 ; COMPLEX OF TROPONIN C WITH A 47 RESIDUE (1-47) FRAGMENT OF TROPONIN I 1CIR ; -1.00 ; COMPLEX OF TWO FRAGMENTS OF CI2 [(1-40)(DOT)(41-64)] 1CIQ ; 2.20 ; COMPLEX OF TWO FRAGMENTS OF CI2, RESIDUES 1-40 AND 41-64 1C0Q ; 1.00 ; COMPLEX OF VANCOMYCIN WITH 2-ACETOXY-D-PROPANOIC ACID 1C0R ; 1.00 ; COMPLEX OF VANCOMYCIN WITH D-LACTIC ACID 1FVM ; 1.80 ; COMPLEX OF VANCOMYCIN WITH DI-ACETYL-LYS-D-ALA-D-ALA 1QD8 ; 1.00 ; COMPLEX OF VANCOMYCIN WITH N-ACETYL GLYCINE 1IOW ; 1.90 ; COMPLEX OF Y216F D-ALA:D-ALA LIGASE WITH ADP AND A PHOSPHORYL PHOSPHINATE 1NLI ; 1.93 ; COMPLEX OF [E160A-E189A] TRICHOSANTHIN AND ADENINE 1THD ; 9.50 ; COMPLEX ORGANIZATION OF DENGUE VIRUS E PROTEIN AS REVEALED BY 9.5 ANGSTROM CRYO-EM RECONSTRUCTION 1P58 ; 9.50 ; COMPLEX ORGANIZATION OF DENGUE VIRUS MEMBRANE PROTEINS AS REVEALED BY 9.5 ANGSTROM CRYO-EM RECONSTRUCTION 1AVW ; 1.75 ; COMPLEX PORCINE PANCREATIC TRYPSIN/SOYBEAN TRYPSIN INHIBITOR, ORTHORHOMBIC CRYSTAL FORM 1AVX ; 1.90 ; COMPLEX PORCINE PANCREATIC TRYPSIN/SOYBEAN TRYPSIN INHIBITOR, TETRAGONAL CRYSTAL FORM 1CG9 ; 2.70 ; COMPLEX RECOGNITION OF THE SUPERTYPIC BW6-DETERMINANT ON HLA-B AND-C MOLECULES BY THE MONOCLONAL ANTIBODY SFR8-B6 1NJT ; 2.50 ; COMPLEX STRUCTURE OF HCMV PROTEASE AND A PEPTIDOMIMETIC INHIBITOR 1NJU ; 2.70 ; COMPLEX STRUCTURE OF HCMV PROTEASE AND A PEPTIDOMIMETIC INHIBITOR 1NKK ; 2.60 ; COMPLEX STRUCTURE OF HCMV PROTEASE AND A PEPTIDOMIMETIC INHIBITOR 1NKM ; 2.70 ; COMPLEX STRUCTURE OF HCMV PROTEASE AND A PEPTIDOMIMETIC INHIBITOR 1BDJ ; 2.68 ; COMPLEX STRUCTURE OF HPT DOMAIN AND CHEY 1MEN ; 2.23 ; COMPLEX STRUCTURE OF HUMAN GAR TFASE AND SUBSTRATE BETA-GAR 1EB1 ; 1.80 ; COMPLEX STRUCTURE OF HUMAN THROMBIN WITH N-METHYL-ARGININE INHIBITOR 1WUG ; -1.00 ; COMPLEX STRUCTURE OF PCAF BROMODOMAIN WITH SMALL CHEMICAL LIGAND NP1 1WUM ; -1.00 ; COMPLEX STRUCTURE OF PCAF BROMODOMAIN WITH SMALL CHEMICAL LIGAND NP2 1N5Z ; 2.70 ; COMPLEX STRUCTURE OF PEX13P SH3 DOMAIN WITH A PEPTIDE OF PEX14P 1G9Q ; 2.30 ; COMPLEX STRUCTURE OF THE ADPR-ASE AND ITS SUBSTRATE ADP- RIBOSE 1WTB ; -1.00 ; COMPLEX STRUCTURE OF THE C-TERMINAL RIBONUCLEIC ACID-BINDING DOMAIN OF HNRNP D (AUF1) WITH TELOMERE DEOXYRIBONUCLEIC ACID 1X0F ; -1.00 ; COMPLEX STRUCTURE OF THE C-TERMINAL RIBONUCLEIC ACID-BINDING DOMAIN OF HNRNP D(AUF1) WITH TELOMERIC DEOXYRIBONUCLEIC ACID 1XL3 ; 2.20 ; COMPLEX STRUCTURE OF Y.PESTIS VIRULENCE FACTORS YOPN AND TYEA 1FGH ; 2.05 ; COMPLEX WITH 4-HYDROXY-TRANS-ACONITATE 1GT5 ; 2.08 ; COMPLEXE OF BOVINE ODORANT BINDING PROTEIN WITH BENZOPHENONE 1WQZ ; 3.00 ; COMPLICATED WATER ORIENTATIONS IN THE MINOR GROOVE OF B-DEOXYRIBONUCLEIC ACID DECAMER D(CCATTAATGG)2 OBSERVED BY NEUTRON DIFFRACTION MEASUREMENTS 1HQI ; -1.00 ; COMPONENT P2 FROM THE MULTICOMPONENT PHENOL HYDROXYLASE, NMR, 11 STRUCTURES 1T1O ; 12.00 ; COMPONENTS OF THE CONTROL 70S RIBOSOME TO PROVIDE REFERENCE FOR THE RRF BINDING SITE 1MQF ; 2.50 ; COMPOUND I FROM PROTEUS MIRABILIS CATALASE 1GWF ; 1.96 ; COMPOUND II STRUCTURE OF MICROCOCCUS LYSODEIKTICUS CATALASE 1A1P ; -1.00 ; COMPSTATIN, NMR, 21 STRUCTURES 1PSV ; -1.00 ; COMPUTATIONALLY DESIGNED PEPTIDE WITH A BETA-BETA-ALPHA FOLD SELECTION, NMR, 32 STRUCTURES 1JBC ; 1.20 ; CONCANAVALIN A 1NLS ; 0.94 ; CONCANAVALIN A AND ITS BOUND SOLVENT AT 0.94A RESOLUTION 1CJP ; 2.78 ; CONCANAVALIN A COMPLEX WITH 4'-METHYLUMBELLIFERYL-ALPHA- D-GLUCOPYRANOSIDE 1VAL ; 3.00 ; CONCANAVALIN A COMPLEX WITH 4'-NITROPHENYL-ALPHA-D- GLUCOPYRANOSIDE 1VAM ; 2.75 ; CONCANAVALIN A COMPLEX WITH 4'-NITROPHENYL-ALPHA-D- MANNOPYRANOSIDE 1BXH ; 2.75 ; CONCANAVALIN A COMPLEXED TO METHYL ALPHA1-2 MANNOBIOSIDE 1CVN ; 2.30 ; CONCANAVALIN A COMPLEXED TO TRIMANNOSIDE 1GIC ; 2.00 ; CONCANAVALIN A COMPLEXED WITH METHYL ALPHA-D-GLUCOPYRANOSIDE 1GKB ; 1.56 ; CONCANAVALIN A, NEW CRYSTAL FORM 1JUI ; 2.75 ; CONCANAVALIN A-CARBOHYDRATE MIMICKING 10-MER PEPTIDE COMPLEX 1I3H ; 1.20 ; CONCANAVALIN A-DIMANNOSE STRUCTURE 1JOJ ; 3.00 ; CONCANAVALIN A-HEXAPEPTIDE COMPLEX 1JYI ; 2.75 ; CONCANAVALIN A/12-MER PEPTIDE COMPLEX 1JYC ; 2.75 ; CONCANAVALIN A/15-MER PEPTIDE COMPLEX 1AZD ; 3.00 ; CONCANAVALIN FROM CANAVALIA BRASILIENSIS 1D6V ; 2.00 ; CONFORMATION EFFECTS IN BIOLOGICAL CATALYSIS INTRODUCED BY OXY-COPE ANTIBODY MATURATION 1EFS ; -1.00 ; CONFORMATION OF A DEOXYRIBONUCLEIC ACID-RIBONUCLEIC ACID HYBRID 1KAJ ; -1.00 ; CONFORMATION OF AN RIBONUCLEIC ACID PSEUDOKNOT FROM MOUSE MAMMARY TUMOR VIRUS, NMR, 1 STRUCTURE 1Y4S ; 2.90 ; CONFORMATION REARRANGEMENT OF HEAT SHOCK PROTEIN 90 UPON ADP BINDING 1Y4U ; 2.90 ; CONFORMATION REARRANGEMENT OF HEAT SHOCK PROTEIN 90 UPON ADP BINDING 1ZE1 ; 2.90 ; CONFORMATIONAL CHANGE OF PSEUDOURIDINE 55 SYNTHASE UPON ITS ASSOCIATION WITH RIBONUCLEIC ACID SUBSTRATE 1ZE2 ; 3.00 ; CONFORMATIONAL CHANGE OF PSEUDOURIDINE 55 SYNTHASE UPON ITS ASSOCIATION WITH RIBONUCLEIC ACID SUBSTRATE 1NNO ; 2.65 ; CONFORMATIONAL CHANGES OCCURRING UPON NO BINDING IN NITRITE REDUCTASE FROM PSEUDOMONAS AERUGINOSA 1BL9 ; 2.90 ; CONFORMATIONAL CHANGES OCCURRING UPON REDUCTION IN NITRITE REDUCTASE FROM PSEUDOMONAS AERUGINOSA 1W28 ; 2.30 ; CONFORMATIONAL FLEXIBILITY OF THE C-TERMINUS WITH IMPLICATIONS FOR SUBSTRATE BINDING AND CATALYSIS IN A NEW CRYSTAL FORM OF DEACETOXYCEPHALOSPORIN C SYNTHASE 2BKE ; 3.20 ; CONFORMATIONAL FLEXIBILITY REVEALED BY THE CRYSTAL STRUCTURE OF A CRENARCHAEAL RADA 1ND7 ; 2.10 ; CONFORMATIONAL FLEXIBILITY UNDERLIES UBIQUITIN LIGATION MEDIATED BY THE WWP1 HECT DOMAIN E3 LIGASE 1SSZ ; -1.00 ; CONFORMATIONAL MAPPING OF MINI-B: AN N-TERMINAL/C-TERMINAL CONSTRUCT OF SURFACTANT PROTEIN B USING 13C-ENHANCED FOURIER TRANSFORM INFRARED (FTIR) SPECTROSCOPY 1ERF ; -1.00 ; CONFORMATIONAL MAPPING OF THE N-TERMINAL FUSION PEPTIDE OF HIV-1 GP41 USING 13C-ENHANCED FOURIER TRANSFORM INFRARED SPECTROSCOPY (FTIR) 1P5A ; -1.00 ; CONFORMATIONAL MAPPING OF THE N-TERMINAL PEPTIDE OF HIV-1 GP41 IN LIPID DETERGENT AND AQUEOUS ENVIRONMENTS USING 13C- ENHANCED FOURIER TRANSFORM INFRARED SPECTROSCOPY 1DFW ; -1.00 ; CONFORMATIONAL MAPPING OF THE N-TERMINAL SEGMENT OF SURFACTANT PROTEIN B IN LIPID USING 13C-ENHANCED FOURIER TRANSFORM INFRARED SPECTROSCOPY (FTIR) 1CE4 ; -1.00 ; CONFORMATIONAL MODEL FOR THE CONSENSUS V3 LOOP OF THE ENVELOPE PROTEIN GP120 OF HIV-1 1XH3 ; 1.48 ; CONFORMATIONAL RESTRAINTS AND FLEXIBILITY OF 14-MERIC PEPTIDES IN COMPLEX WITH HLA-B3501 1QX3 ; 1.90 ; CONFORMATIONAL RESTRICTIONS IN THE ACTIVE SITE OF UNLIGANDED HUMAN CASPASE-3 1T0M ; 2.00 ; CONFORMATIONAL SWITCH IN POLYMORPHIC H-2K MOLECULES CONTAINING AN HSV PEPTIDE 1T0N ; 1.80 ; CONFORMATIONAL SWITCH IN POLYMORPHIC H-2K MOLECULES CONTAINING AN HSV PEPTIDE 1CCJ ; 2.10 ; CONFORMER SELECTION BY LIGAND BINDING OBSERVED WITH PROTEIN CRYSTALLOGRAPHY 1WLD ; 1.60 ; CONGERIN II T88I SINGLE MUTANT 1WLW ; 1.80 ; CONGERIN II Y16S SINGLE MUTANT 1WLC ; 2.00 ; CONGERIN II Y16S/T88I DOUBLE MUTANT 1QX0 ; 2.26 ; CONJUGATIVE RELAXASE TRWC IN COMPLEX WITH ORIT DEOXYRIBONUCLEIC ACID. METAL- BOUND STRUCTURE 1S6M ; 2.28 ; CONJUGATIVE RELAXASE TRWC IN COMPLEX WITH ORIT DEOXYRIBONUCLEIC ACID. METAL- BOUND STRUCTURE 1OMH ; 1.95 ; CONJUGATIVE RELAXASE TRWC IN COMPLEX WITH ORIT DEOXYRIBONUCLEIC ACID. METAL- FREE STRUCTURE. 1OSB ; 2.65 ; CONJUGATIVE RELAXASE TRWC IN COMPLEX WITH ORIT DEOXYRIBONUCLEIC ACID. METAL- FREE STRUCTURE. 1YL2 ; -1.00 ; CONKUNITZIN-S1 IS THE FIRST MEMBER OF A NEW KUNITZ-TYPE NEUROTOXIN FAMILY- STRUCTURAL AND FUNCTIONAL CHARACTERIZATION 1FOU ; 3.20 ; CONNECTOR PROTEIN FROM BACTERIOPHAGE PHI29 1JNB ; 3.20 ; CONNECTOR PROTEIN FROM BACTERIOPHAGE PHI29 1R5S ; -1.00 ; CONNEXIN 43 CARBOXYL TERMINAL DOMAIN 1AG7 ; -1.00 ; CONOTOXIN GS, NMR, 20 STRUCTURES 16VP ; 2.10 ; CONSERVED CORE OF THE HERPES SIMPLEX VIRUS TRANSCRIPTIONAL REGULATORY PROTEIN VP16 1EO0 ; -1.00 ; CONSERVED DOMAIN COMMON TO TRANSCRIPTION FACTORS TFIIS, ELONGIN A, CRSP70 1YBX ; 1.80 ; CONSERVED HYPOTHETICAL PROTEIN CTH-383 FROM CLOSTRIDIUM THERMOCELLUM 1YBY ; 1.95 ; CONSERVED HYPOTHETICAL PROTEIN CTH-95 FROM CLOSTRIDIUM THERMOCELLUM 1XRG ; 2.20 ; CONSERVED HYPOTHETICAL PROTEIN FROM CLOSTRIDIUM THERMOCELLUM CTH-2968 1Z6M ; 1.30 ; CONSERVED HYPOTHETICAL PROTEIN FROM ENTEROCOCCUS FAECALIS V583 1YBZ ; 1.82 ; CONSERVED HYPOTHETICAL PROTEIN FROM PYROCOCCUS FURIOSUS PFU- 1581948-001 1VK1 ; 1.20 ; CONSERVED HYPOTHETICAL PROTEIN FROM PYROCOCCUS FURIOSUS PFU- 392566-001 1XX7 ; 2.26 ; CONSERVED HYPOTHETICAL PROTEIN FROM PYROCOCCUS FURIOSUS PFU- 403030-001 1SHE ; 1.85 ; CONSERVED HYPOTHETICAL PROTEIN FROM PYROCOCCUS FURIOSUS PFU- 871755-001 1YD7 ; 2.30 ; CONSERVED HYPOTHETICAL PROTEIN PFU-1647980-001 FROM PYROCOCCUS FURIOSUS 1YB3 ; 1.60 ; CONSERVED HYPOTHETICAL PROTEIN PFU-178653-001 FROM PYROCOCCUS FURIOSUS 1YCY ; 2.80 ; CONSERVED HYPOTHETICAL PROTEIN PFU-1806301-001 FROM PYROCOCCUS FURIOSUS 1Y82 ; 2.30 ; CONSERVED HYPOTHETICAL PROTEIN PFU-367848-001 FROM PYROCOCCUS FURIOSUS 1Y81 ; 1.70 ; CONSERVED HYPOTHETICAL PROTEIN PFU-723267-001 FROM PYROCOCCUS FURIOSUS 1YEM ; 2.30 ; CONSERVED HYPOTHETICAL PROTEIN PFU-838710-001 FROM PYROCOCCUS FURIOSUS 1XG7 ; 1.88 ; CONSERVED HYPOTHETICAL PROTEIN PFU-877259-001 FROM PYROCOCCUS FURIOSUS 1RLK ; 1.95 ; CONSERVED HYPOTHETICAL PROTEIN TA0108 [THERMOPLASMA ACIDOPHILUM] 1UWD ; -1.00 ; CONSERVED HYPOTHETICAL PROTEIN TM0487 FROM THERMOTOGA MARITIMA 1WCJ ; -1.00 ; CONSERVED HYPOTHETICAL PROTEIN TM0487 FROM THERMOTOGA MARITIMA 1VOP ; -1.00 ; CONSERVED RIBONUCLEIC ACID COMPONENT OF THE PEPTIDYL TRANSFERASE CENTER, NMR, 33 STRUCTURES 1KP7 ; -1.00 ; CONSERVED RIBONUCLEIC ACID STRUCTURE WITHIN THE HCV IRES EIF3 BINDING SITE 1Y9B ; 2.20 ; CONSERVERD HYPOTHETICAL PROTEIN FROM VIBRIO CHOLERAE O1 BIOVAR ELTOR STR. N16961 1X18 ; 13.50 ; CONTACT SITES OF ERA GTPASE ON THE THERMUS THERMOPHILUS 30S SUBUNIT 1F23 ; 2.30 ; CONTRIBUTION OF A BURIED HYDROGEN BOND TO HIV-1 ENVELOPE GLYCOPROTEIN STRUCTURE AND FUNCTION 1WQM ; 1.80 ; CONTRIBUTION OF HYDROGEN BONDS TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME 1WQN ; 1.80 ; CONTRIBUTION OF HYDROGEN BONDS TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME 1WQO ; 1.80 ; CONTRIBUTION OF HYDROGEN BONDS TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME 1WQP ; 1.80 ; CONTRIBUTION OF HYDROGEN BONDS TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME 1WQQ ; 1.80 ; CONTRIBUTION OF HYDROGEN BONDS TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME 1WQR ; 1.80 ; CONTRIBUTION OF HYDROGEN BONDS TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME 1B5U ; 1.80 ; CONTRIBUTION OF HYDROGEN BONDS TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME: CALORIMETRY AND X-RAY ANALYSIS OF SIX SER->ALA MUTANT 1B5V ; 2.17 ; CONTRIBUTION OF HYDROGEN BONDS TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME: CALORIMETRY AND X-RAY ANALYSIS OF SIX SER->ALA MUTANTS 1B5W ; 2.17 ; CONTRIBUTION OF HYDROGEN BONDS TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME: CALORIMETRY AND X-RAY ANALYSIS OF SIX SER->ALA MUTANTS 1B5X ; 2.00 ; CONTRIBUTION OF HYDROGEN BONDS TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME: CALORIMETRY AND X-RAY ANALYSIS OF SIX SER->ALA MUTANTS 1B5Y ; 2.20 ; CONTRIBUTION OF HYDROGEN BONDS TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME: CALORIMETRY AND X-RAY ANALYSIS OF SIX SER->ALA MUTANTS 1B5Z ; 2.20 ; CONTRIBUTION OF HYDROGEN BONDS TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME: CALORIMETRY AND X-RAY ANALYSIS OF SIX SER->ALA MUTANTS 2BQA ; 1.80 ; CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME 2BQB ; 1.80 ; CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME 2BQC ; 1.80 ; CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME 2BQD ; 1.80 ; CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME 2BQE ; 1.80 ; CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME 2BQF ; 1.80 ; CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME 2BQG ; 1.80 ; CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME 2BQH ; 1.80 ; CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME 2BQI ; 1.80 ; CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME 2BQJ ; 1.80 ; CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME 2BQK ; 1.80 ; CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME 2BQL ; 1.80 ; CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME 2BQM ; 1.80 ; CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME 2BQN ; 1.80 ; CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME 2BQO ; 1.80 ; CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME 2MED ; 1.80 ; CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME 2MEE ; 1.80 ; CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME 2MEF ; 1.80 ; CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME 2MEH ; 1.80 ; CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME 2MEI ; 1.80 ; CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME 1OUA ; 1.80 ; CONTRIBUTION OF HYDROPHOBIC RESIDUES TO THE STABILITY OF HUMAN LYSOZYME: X-RAY STRUCTURE OF THE I56T MUTANT 1OUB ; 1.80 ; CONTRIBUTION OF HYDROPHOBIC RESIDUES TO THE STABILITY OF HUMAN LYSOZYME: X-RAY STRUCTURE OF THE V100A MUTANT 1OUC ; 1.80 ; CONTRIBUTION OF HYDROPHOBIC RESIDUES TO THE STABILITY OF HUMAN LYSOZYME: X-RAY STRUCTURE OF THE V110A MUTANT 1OUD ; 1.80 ; CONTRIBUTION OF HYDROPHOBIC RESIDUES TO THE STABILITY OF HUMAN LYSOZYME: X-RAY STRUCTURE OF THE V121A MUTANT 1OUE ; 1.80 ; CONTRIBUTION OF HYDROPHOBIC RESIDUES TO THE STABILITY OF HUMAN LYSOZYME: X-RAY STRUCTURE OF THE V125A MUTANT 1OUF ; 1.80 ; CONTRIBUTION OF HYDROPHOBIC RESIDUES TO THE STABILITY OF HUMAN LYSOZYME: X-RAY STRUCTURE OF THE V130A MUTANT 1OUG ; 1.80 ; CONTRIBUTION OF HYDROPHOBIC RESIDUES TO THE STABILITY OF HUMAN LYSOZYME: X-RAY STRUCTURE OF THE V2A MUTANT 1OUH ; 1.80 ; CONTRIBUTION OF HYDROPHOBIC RESIDUES TO THE STABILITY OF HUMAN LYSOZYME: X-RAY STRUCTURE OF THE V74A MUTANT 1OUI ; 1.80 ; CONTRIBUTION OF HYDROPHOBIC RESIDUES TO THE STABILITY OF HUMAN LYSOZYME: X-RAY STRUCTURE OF THE V93A MUTANT 1OUJ ; 1.80 ; CONTRIBUTION OF HYDROPHOBIC RESIDUES TO THE STABILITY OF HUMAN LYSOZYME: X-RAY STRUCTURE OF THE V99A MUTANT 1W8O ; 1.70 ; CONTRIBUTION OF THE ACTIVE SITE ASPARTIC ACID TO CATALYSIS IN THE BACTERIAL NEURAMINIDASE FROM MICROMONOSPORA VIRIDIFACIENS 1W8N ; 2.10 ; CONTRIBUTION OF THE ACTIVE SITE ASPARTIC ACID TO CATALYSIS IN THE BACTERIAL NEURAMINIDASE FROM MICROMONOSPORA VIRIDIFACIENS. 2HEA ; 1.80 ; CONTRIBUTION OF WATER MOLECULES IN THE INTERIOR OF A PROTEIN TO THE CONFORMATIONAL STABILITY 2HEB ; 1.80 ; CONTRIBUTION OF WATER MOLECULES IN THE INTERIOR OF A PROTEIN TO THE CONFORMATIONAL STABILITY 2HEC ; 1.80 ; CONTRIBUTION OF WATER MOLECULES IN THE INTERIOR OF A PROTEIN TO THE CONFORMATIONAL STABILITY 2HED ; 1.80 ; CONTRIBUTION OF WATER MOLECULES IN THE INTERIOR OF A PROTEIN TO THE CONFORMATIONAL STABILITY 2HEE ; 1.80 ; CONTRIBUTION OF WATER MOLECULES IN THE INTERIOR OF A PROTEIN TO THE CONFORMATIONAL STABILITY 2HEF ; 1.80 ; CONTRIBUTION OF WATER MOLECULES IN THE INTERIOR OF A PROTEIN TO THE CONFORMATIONAL STABILITY 1JMF ; 2.50 ; CONTRIBUTIONS OF ORIENTATION AND HYDROGEN BONDING TO CATALYSIS IN ASN-229 MUTANTS OF THYMIDYLATE SYNTHASE 1JMG ; 2.50 ; CONTRIBUTIONS OF ORIENTATION AND HYDROGEN BONDING TO CATALYSIS IN ASN-229 MUTANTS OF THYMIDYLATE SYNTHASE 1JMH ; 2.50 ; CONTRIBUTIONS OF ORIENTATION AND HYDROGEN BONDING TO CATALYSIS IN ASN-229 MUTANTS OF THYMIDYLATE SYNTHASE 1JMI ; 2.50 ; CONTRIBUTIONS OF ORIENTATION AND HYDROGEN BONDING TO CATALYSIS IN ASN-229 MUTANTS OF THYMIDYLATE SYNTHASE 1TVU ; 2.50 ; CONTRIBUTIONS OF ORIENTATION AND HYDROGEN BONDING TO CATALYSIS IN ASN-229 MUTANTS OF THYMIDYLATE SYNTHASE 1TVV ; 2.30 ; CONTRIBUTIONS OF ORIENTATION AND HYDROGEN BONDING TO CATALYSIS IN ASN-229 MUTANTS OF THYMIDYLATE SYNTHASE 1TVW ; 2.50 ; CONTRIBUTIONS OF ORIENTATION AND HYDROGEN BONDING TO CATALYSIS IN ASN-229 MUTANTS OF THYMIDYLATE SYNTHASE 1B4G ; -1.00 ; CONTROL OF K+ CHANNEL GATING BY PROTEIN PHOSPHORYLATION: STRUCTURAL SWITCHES OF THE INACTIVATION GATE, NMR, 22 STRUCTURES 1B4I ; -1.00 ; CONTROL OF K+ CHANNEL GATING BY PROTEIN PHOSPHORYLATION: STRUCTURAL SWITCHES OF THE INACTIVATION GATE, NMR, 22 STRUCTURES 1CF8 ; 2.70 ; CONVERGENCE OF CATALYTIC ANTIBODY AND TERPENE CYCLASE MECHANISMS: POLYENE CYCLIZATION DIRECTED BY CARBOCATION-PI INTERACTIONS 1SHM ; 1.90 ; CONVERGENT SOLUTIONS TO VHH DOMAIN STABILIZATION FROM NATURAL AND IN VITRO EVOLUTION 1JML ; 1.90 ; CONVERSION OF MONOMERIC PROTEIN L TO AN OBLIGATE DIMER BY COMPUTATIONAL PROTEIN DESIGN 1RWB ; 2.00 ; COOPERATIVE EFFECT OF TWO SURFACE AMINO ACID MUTATIONS (Q252L AND E170K) OF GLUCOSE DEHYDROGENASE FROM BACILLUS MEGATERIUM IWG3 FOR THE STABILIZATION OF OLIGOMERIC STATE 1AXR ; 2.30 ; COOPERATIVITY BETWEEN HYDROGEN-BONDING AND CHARGE-DIPOLE INTERACTIONS IN THE INHIBITION OF BETA-GLYCOSIDASES BY AZOLOPYRIDINES: EVIDENCE FROM A STUDY WITH GLYCOGEN PHOSPHORYLASE B 1D1O ; -1.00 ; COOPERATIVITY IN EF-HAND CA2+-BINDING PROTEINS: EVIDENCE OF SITE-SITE COMMUNICATION FROM BINDING-INDUCED CHANGES IN STRUCTURE AND DYNAMICS OF N56A CALBINDIN D9K 1R2X ; 9.00 ; COORDINATES OF L11 WITH 58NTS OF 23S RRNA FITTED INTO THE CRYO-EM MAP OF EF-TU TERNARY COMPLEX (GDP.KIRROMYCIN) BOUND 70S RIBOSOME 1R2W ; 9.00 ; COORDINATES OF L11 WITH 58NTS OF 23S RRNA FITTED INTO THE CRYO-EM MAP OF THE 70S RIBOSOME 1GOL ; 2.80 ; COORDINATES OF RAT MAP KINASE ERK2 WITH AN ARGININE MUTATION AT POSITION 52 1ZN0 ; 15.50 ; COORDINATES OF RRF AND EF-G FITTED INTO CRYO-EM MAP OF THE 50S SUBUNIT BOUND WITH BOTH EF-G (GDPNP) AND RRF 1ZN1 ; 14.10 ; COORDINATES OF RRF FITTED INTO CRYO-EM MAP OF THE 70S POST- TERMINATION COMPLEX 1PN8 ; 10.80 ; COORDINATES OF S12, L11 PROTEINS AND E-SITE TRNA FROM 70S CRYSTAL STRUCTURE SEPARATELY FITTED INTO THE CRYO-EM MAP OF E.COLI 70S.EF-G.GDPNP COMPLEX. THE ATOMIC COORDINATES ORIGINALLY FROM THE E-SITE TRNA WERE FITTED IN THE POSITION OF THE HYBRID P/E-SITE TRNA. 1PN7 ; 10.80 ; COORDINATES OF S12, L11 PROTEINS AND P-TRNA, FROM THE 70S X- RAY STRUCTURE ALIGNED TO THE 70S CRYO-EM MAP OF E.COLI RIBOSOME 1QZC ; 9.00 ; COORDINATES OF S12, SH44, LH69 AND SRL SEPARATELY FITTED INTO THE CRYO-EM MAP OF EF-TU TERNARY COMPLEX (GDP.KIRROMYCIN) BOUND 70S RIBOSOME 1QZB ; 9.00 ; COORDINATES OF THE A-SITE TRNA MODEL FITTED INTO THE CRYO- EM MAP OF 70S RIBOSOME IN THE PRE-TRANSLOCATIONAL STATE 1QZA ; 10.00 ; COORDINATES OF THE A/T SITE TRNA MODEL FITTED INTO THE CRYO- EM MAP OF EF-TU TERNARY COMPLEX (GDP.KIRROMYCIN) BOUND 70S RIBOSOME 2BCW ; 11.20 ; COORDINATES OF THE N-TERMINAL DOMAIN OF RIBOSOMAL PROTEIN L11,C-TERMINAL DOMAIN OF RIBOSOMAL PROTEIN L7/L12 AND A PORTION OF THE G' DOMAIN OF ELONGATION FACTOR G, AS FITTED INTO CRYO-EM MAP OF AN ESCHERICHIA COLI 70SEF- GGDPFUSIDIC ACID COMPLEX 1ZC8 ; 13.00 ; COORDINATES OF TMRNA, SMPB, EF-TU AND H44 FITTED INTO CRYO- EM MAP OF THE 70S RIBOSOME AND TMRNA COMPLEX 1A2V ; 2.40 ; COPPER AMINE OXIDASE FROM HANSENULA POLYMORPHA 1N68 ; 1.70 ; COPPER BOUND TO THE MULTICOPPER OXIDASE CUEO 1CPZ ; -1.00 ; COPPER CHAPERONE OF ENTEROCOCCUS HIRAE (APO-FORM) 1K0V ; -1.00 ; COPPER TRAFFICKING: THE SOLUTION STRUCTURE OF BACILLUS SUBTILIS COPZ 1OLT ; 2.07 ; COPROPORPHYRINOGEN III OXIDASE (HEMN) FROM ESCHERICHIA COLI IS A RADICAL SAM ENZYME. 1SFK ; 3.20 ; CORE (C) PROTEIN FROM WEST NILE VIRUS, SUBTYPE KUNJIN 2JHB ; -1.00 ; CORE BINDING FACTOR BETA 1QS4 ; 2.10 ; CORE DOMAIN OF HIV-1 INTEGRASE COMLEXED WITH MG++ AND 1-(5- CHLOROINDOL-3-YL)-3-HYDROXY-3-(2H-TETRAZOL-5-YL)-PROPENONE 1GPC ; 2.20 ; CORE GP32, DEOXYRIBONUCLEIC ACID-BINDING PROTEIN 1E8O ; 3.20 ; CORE OF THE ALU DOMAIN OF THE MAMMALIAN SRP 1P3N ; 1.55 ; CORE REDESIGN BACK-REVERTANT I103V/CORE10 1KFM ; 2.00 ; CORE SIDE-CHAIN PACKING AND BACKBONE CONFORMATION IN LPP-56 COILED-COIL MUTANTS 1KFN ; 1.65 ; CORE SIDE-CHAIN PACKING AND BACKBONE CONFORMATION IN LPP-56 COILED-COIL MUTANTS 1I9H ; 2.40 ; CORE STREPTAVIDIN-BNA COMPLEX 2EBO ; 1.90 ; CORE STRUCTURE OF GP2 FROM EBOLA VIRUS 1EQ7 ; 1.90 ; CORE STRUCTURE OF THE OUTER MEMBRANE LIPOPROTEIN FROM ESCHERICHIA COLI AT 1.9 ANGSTROM RESOLUTION 1SWS ; 2.00 ; CORE-STREPTAVIDIN MUTANT D128A AT PH 4.5 1SWT ; 2.00 ; CORE-STREPTAVIDIN MUTANT D128A IN COMPLEX WITH BIOTIN AT PH 4.5 1SWL ; 1.80 ; CORE-STREPTAVIDIN MUTANT W108F AT PH 7.0 1SWN ; 2.20 ; CORE-STREPTAVIDIN MUTANT W108F IN COMPLEX WITH BIOTIN AT PH 7.0 1SWQ ; 1.90 ; CORE-STREPTAVIDIN MUTANT W120A AT PH 7.5 1SWR ; 1.90 ; CORE-STREPTAVIDIN MUTANT W120A IN COMPLEX WITH BIOTIN AT PH 7.5 1SWO ; 1.95 ; CORE-STREPTAVIDIN MUTANT W120F AT PH 7.5 1SWP ; 2.00 ; CORE-STREPTAVIDIN MUTANT W120F IN COMPLEX WITH BIOTIN AT PH 7.5 1SWH ; 1.70 ; CORE-STREPTAVIDIN MUTANT W79F AT PH 4.5 1SWJ ; 2.00 ; CORE-STREPTAVIDIN MUTANT W79F AT PH 4.5 1SWK ; 2.00 ; CORE-STREPTAVIDIN MUTANT W79F IN COMPLEX WITH BIOTIN AT PH 4.5 1P9S ; 2.54 ; CORONAVIRUS MAIN PROTEINASE (3CLPRO) STRUCTURE: BASIS FOR DESIGN OF ANTI-SARS DRUGS 1P9U ; 2.37 ; CORONAVIRUS MAIN PROTEINASE (3CLPRO) STRUCTURE: BASIS FOR DESIGN OF ANTI-SARS DRUGS 1YYF ; 4.16 ; CORRECTION OF X-RAY INTENSITIES FROM AN HSLV-HSLU CO- CRYSTAL CONTAINING LATTICE TRANSLOCATION DEFECTS 1M9H ; 2.00 ; CORYNEBACTERIUM 2,5-DKGR A AND PHE 22 REPLACED WITH TYR (F22Y), LYS 232 REPLACED WITH GLY (K232G), ARG 238 REPLACED WITH HIS (R238H)AND ALA 272 REPLACED WITH GLY (A272G)IN PRESENCE OF NADH COFACTOR 1BV7 ; 2.00 ; COUNTERACTING HIV-1 PROTEASE DRUG RESISTANCE: STRUCTURAL ANALYSIS OF MUTANT PROTEASES COMPLEXED WITH XV638 AND SD146, CYCLIC UREA AMIDES WITH BROAD SPECIFICITIES 1ZL3 ; 2.80 ; COUPLING OF ACTIVE SITE MOTIONS AND RIBONUCLEIC ACID BINDING 1FN7 ; 2.60 ; COUPLING OF DAMAGE RECOGNITION AND CATALYSIS BY A HUMAN BASE-EXCISION DEOXYRIBONUCLEIC ACID REPAIR PROTEIN 1N3H ; -1.00 ; COUPLING OF FOLDING AND BINDING IN THE PTB DOMAIN OF THE SIGNALING PROTEIN SHC 1OY2 ; -1.00 ; COUPLING OF FOLDING AND BINDING IN THE PTB DOMAIN OF THE SIGNALING PROTEIN SHC 1PW8 ; 1.30 ; COVALENT ACYL ENZYME COMPLEX OF THE R61 DD-PEPTIDASE WITH A HIGHLY SPECIFIC CEPHALOSPORIN 1PWD ; 1.20 ; COVALENT ACYL ENZYME COMPLEX OF THE STREPTOMYCES R61 DD- PEPTIDASE WITH CEPHALOSPORIN C 1H84 ; 2.00 ; COVALENT ADDUCT BETWEEN POLYAMINE OXIDASE AND N1ETHYLN11 ((CYCLOHEPTYL)METHYL)4,8DIAZAUNDECANE AT PH 4.6 1H86 ; 2.00 ; COVALENT ADDUCT BETWEEN POLYAMINE OXIDASE AND N1ETHYLN11 ((CYCLOHEPTYL)METHYL)4,8DIAZAUNDECANE AT PH 7.0 1DAO ; 3.20 ; COVALENT ADDUCT OF D-AMINO ACID OXIDASE FROM PIG KIDNEY WITH 3-METHYL-2-OXO-VALERIC ACID 1GJM ; 2.20 ; COVALENT ATTACHMENT OF AN ELECTROACTIVE SULPHYDRYL REAGENT IN THE ACTIVE SITE OF CYTOCHROME P450CAM 1H6M ; 1.64 ; COVALENT GLYCOSYL-ENZYME INTERMEDIATE OF HEN EGG WHITE LYSOZYME 1S46 ; 2.20 ; COVALENT INTERMEDIATE OF THE E328Q AMYLOSUCRASE MUTANT 1PWG ; 1.07 ; COVALENT PENICILLOYL ACYL ENZYME COMPLEX OF THE STREPTOMYCES R61 DD-PEPTIDASE WITH A HIGHLY SPECIFIC PENICILLIN 1TQH ; 1.63 ; COVALENT REACTION INTERMEDIATE REVEALED IN CRYSTAL STRUCTURE OF THE GEOBACILLUS STEAROTHERMOPHILUS CARBOXYLESTERASE EST30 1MHT ; 2.80 ; COVALENT TERNARY STRUCTURE OF HHAI METHYLTRANSFERASE, DEOXYRIBONUCLEIC ACID AND S-ADENOSYL-L-HOMOCYSTEINE 1NY7 ; 3.00 ; COWPEA MOSAIC VIRUS (CPMV) 1COV ; 3.50 ; COXSACKIEVIRUS B3 COAT PROTEIN 1K5O ; -1.00 ; CPI-17(35-120) DELETION MUTANT 1IJS ; 3.25 ; CPV(STRAIN D) MUTANT A300D, COMPLEX(VIRAL COAT/DEOXYRIBONUCLEIC ACID), VP2, PH7.5, T4 DEGREES C 1GHQ ; 2.04 ; CR2-C3D COMPLEX STRUCTURE 1EJG ; 0.54 ; CRAMBIN AT ULTRA-HIGH RESOLUTION: VALENCE ELECTRON DENSITY. 1JXT ; 0.89 ; CRAMBIN MIXED SEQUENCE FORM AT 160 K. PROTEIN/WATER SUBSTATES 1JXW ; 0.89 ; CRAMBIN MIXED SEQUENCE FORM AT 180 K. PROTEIN/WATER SUBSTATES 1JXX ; 0.89 ; CRAMBIN MIXED SEQUENCE FORM AT 200 K. PROTEIN/WATER SUBSTATES 1JXY ; 0.89 ; CRAMBIN MIXED SEQUENCE FORM AT 220 K. PROTEIN/WATER SUBSTATES 1JXU ; 0.99 ; CRAMBIN MIXED SEQUENCE FORM AT 240 K. PROTEIN/WATER SUBSTATES 2D3P ; 2.80 ; CRATYLIA FLORIBUNDA SEED LECTIN CRYSTALLIZED AT BASIC PH 2D3R ; 2.90 ; CRATYLIA FOLIBUNDA SEED LECTIN AT ACIDIC PH 1MVQ ; 1.77 ; CRATYLIA MOLLIS LECTIN (ISOFORM 1) IN COMPLEX WITH METHYL- ALPHA-D-MANNOSE 1KBU ; 2.20 ; CRE RECOMBINASE BOUND TO A LOXP HOLLIDAY JUNCTION 3CRX ; 2.50 ; CRE RECOMBINASE/DEOXYRIBONUCLEIC ACID COMPLEX INTERMEDIATE I 1CRX ; 2.40 ; CRE RECOMBINASE/DEOXYRIBONUCLEIC ACID COMPLEX REACTION INTERMEDIATE I 1J2T ; 1.80 ; CREATININASE MN 1J2U ; 1.85 ; CREATININASE ZN 1V7Z ; 1.60 ; CREATININASE-PRODUCT COMPLEX 1B35 ; 2.40 ; CRICKET PARALYSIS VIRUS (CRPV) 1B07 ; 2.50 ; CRK SH3 DOMAIN COMPLEXED WITH PEPTOID INHIBITOR 1ORC ; 1.54 ; CRO REPRESSOR INSERTION MUTANT K56-[DGEVK] 2ORC ; -1.00 ; CRO REPRESSOR INSERTION MUTANT K56-[DGEVK], NMR, 32 STRUCTURES 1ZEI ; 1.90 ; CROSS-LINKED B28 ASP INSULIN 2LYO ; 1.93 ; CROSS-LINKED CHICKEN LYSOZYME CRYSTAL IN 90% ACETONITRILE-WATER 3LYO ; 1.93 ; CROSS-LINKED CHICKEN LYSOZYME CRYSTAL IN 95% ACETONITRILE-WATER 4LYO ; 2.05 ; CROSS-LINKED CHICKEN LYSOZYME CRYSTAL IN NEAT ACETONITRILE, THEN BACK-SOAKED IN WATER 1CLS ; 1.90 ; CROSS-LINKED HUMAN HEMOGLOBIN DEOXY 1LYO ; 1.93 ; CROSS-LINKED LYSOZYME CRYSTAL IN NEAT WATER 1SDK ; 1.80 ; CROSS-LINKED, CARBONMONOXY HEMOGLOBIN A 1SDL ; 1.80 ; CROSS-LINKED, CARBONMONOXY HEMOGLOBIN A 1HAB ; 2.30 ; CROSSLINKED HAEMOGLOBIN 1HAC ; 2.60 ; CROSSLINKED HAEMOGLOBIN 1NYI ; 2.85 ; CROSSLINKED HAMMERHEAD RIBOZYME INITIAL STATE 1BIJ ; 2.30 ; CROSSLINKED, DEOXY HUMAN HEMOGLOBIN A 1E4W ; 1.95 ; CROSSREACTIVE BINDING OF A CIRCULARIZED PEPTIDE TO AN ANTI-TGFALPHA ANTIBODY FAB-FRAGMENT 1E4X ; 1.90 ; CROSSREACTIVE BINDING OF A CIRCULARIZED PEPTIDE TO AN ANTI-TGFALPHA ANTIBODY FAB-FRAGMENT 1V11 ; 1.95 ; CROSSTALK BETWEEN COFACTOR BINDING AND THE PHOSPHORYLATION LOOP CONFORMATION IN THE BCKD MACHINE 1V16 ; 1.90 ; CROSSTALK BETWEEN COFACTOR BINDING AND THE PHOSPHORYLATION LOOP CONFORMATION IN THE BCKD MACHINE 1V1M ; 2.00 ; CROSSTALK BETWEEN COFACTOR BINDING AND THE PHOSPHORYLATION LOOP CONFORMATION IN THE BCKD MACHINE 1V1R ; 1.80 ; CROSSTALK BETWEEN COFACTOR BINDING AND THE PHOSPHORYLATION LOOP CONFORMATION IN THE BCKD MACHINE 1XD7 ; 2.30 ; CRSYTAL STRUCTURE OF A PUTATIVE DEOXYRIBONUCLEIC ACID BINDING PROTEIN 1WVN ; 2.10 ; CRSYTAL STRUCTURE OF DOMAIN 3 OF HUMAN ALPHA POLYC BINDING PROTEIN 1ZNQ ; 2.50 ; CRSYTAL STRUCTURE OF HUMAN LIVER GAPDH 394D ; 1.90 ; CRSYTAL STRUCTURE OF TWO SELF-COMPLEMENTARY CHIMERIC DECAMERS D(CCGG)R(C)D( GCCGG) AND D(CCGG)R(CG)D(CCGG) 393D ; 2.00 ; CRSYTAL STRUCTURE OF TWO SELF-COMPLEMENTARY CHIMERIC DECAMERS, D(CCGG)R(C)D(GCCGG) AND D(CCGG)R(CG)D(CCGG) 1EWP ; 1.75 ; CRUZAIN BOUND TO MOR-LEU-HPQ 1AIM ; 2.00 ; CRUZAIN INHIBITED BY BENZOYL-TYROSINE-ALANINE- FLUOROMETHYLKETONE 2AIM ; 2.20 ; CRUZAIN INHIBITED WITH BENZOYL-ARGININE-ALANINE- FLUOROMETHYLKETONE 1GEG ; 1.70 ; CRYATAL STRUCTURE ANALYSIS OF MESO-2,3-BUTANEDIOL DEHYDROGENASE 1A5B ; 2.00 ; CRYO-CRYSTALLOGRAPHY OF A TRUE SUBSTRATE, INDOLE-3-GLYCEROL PHOSPHATE, BOUND TO A MUTANT (ALPHA D60N) TRYPTOPHAN SYNTHASE ALPHA2BETA2 COMPLEX REVEALS THE CORRECT ORIENTATION OF ACTIVE SITE ALPHA GLU 49 1A5A ; 1.90 ; CRYO-CRYSTALLOGRAPHY OF A TRUE SUBSTRATE, INDOLE-3-GLYCEROL PHOSPHATE, BOUND TO A MUTANT (ALPHAD60N) TRYPTOPHAN SYNTHASE ALPHA2BETA2 COMPLEX REVEALS THE CORRECT ORIENTATION OF ACTIVE SITE ALPHA GLU 49 1SJJ ; 20.00 ; CRYO-EM STRUCTURE OF CHICKEN GIZZARD SMOOTH MUSCLE ALPHA- ACTININ 1JEW ; -1.00 ; CRYO-EM STRUCTURE OF COXSACKIEVIRUS B3(M STRAIN) WITH ITS CELLULAR RECEPTOR, COXSACKIEVIRUS AND ADENOVIRUS RECEPTOR (CAR). 1Z7Z ; 8.00 ; CRYO-EM STRUCTURE OF HUMAN COXSACKIEVIRUS A21 COMPLEXED WITH FIVE DOMAIN ICAM-1KILIFI 1DGI ; 22.00 ; CRYO-EM STRUCTURE OF HUMAN POLIOVIRUS(SEROTYPE 1)COMPLEXED WITH THREE DOMAIN CD155 1D3I ; 26.00 ; CRYO-EM STRUCTURE OF HUMAN RHINOVIRUS 14 (HRV14) COMPLEXED WITH A TWO-DOMAIN FRAGMENT OF ITS CELLULAR RECEPTOR, INTERCELLULAR ADHESION MOLECULE-1 (D1D2-ICAM-1). IMPLICATIONS FOR VIRUS-RECEPTOR INTERACTIONS. ALPHA CARBONS ONLY 1D3E ; 28.00 ; CRYO-EM STRUCTURE OF HUMAN RHINOVIRUS 16 (HRV16) COMPLEXED WITH A TWO-DOMAIN FRAGMENT OF ITS CELLULAR RECEPTOR, INTERCELLULAR ADHESION MOLECULE-1 (D1D2-ICAM-1). IMPLICATIONS FOR VIRUS-RECEPTOR INTERACTIONS. ALPHA CARBONS ONLY 1I84 ; 20.00 ; CRYO-EM STRUCTURE OF THE HEAVY MEROMYOSIN SUBFRAGMENT OF CHICKEN GIZZARD SMOOTH MUSCLE MYOSIN WITH REGULATORY LIGHT CHAIN IN THE DEPHOSPHORYLATED STATE. ONLY C ALPHAS PROVIDED FOR REGULATORY LIGHT CHAIN. ONLY BACKBONE ATOMS PROVIDED FOR S2 FRAGMENT. 1QLE ; 3.00 ; CRYO-STRUCTURE OF THE PARACOCCUS DENITRIFICANS FOUR-SUBUNIT CYTOCHROME C OXIDASE IN THE COMPLETELY OXIDIZED STATE COMPLEXED WITH AN ANTIBODY FV FRAGMENT 1NN8 ; 15.00 ; CRYOEM STRUCTURE OF POLIOVIRUS RECEPTOR BOUND TO POLIOVIRUS 1CXP ; 1.80 ; CRYOGENIC CRYSTAL STRUCTURE OF HUMAN MYELOPEROXIDASE ISOFORM C 1TQO ; 2.00 ; CRYOGENIC CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT TRUNCATED DELTA+PHS I92E 1TT2 ; 1.85 ; CRYOGENIC CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT TRUNCATED DELTA+PHS I92K 1BU7 ; 1.65 ; CRYOGENIC STRUCTURE OF CYTOCHROME P450BM-3 HEME DOMAIN 5CP4 ; 1.75 ; CRYOGENIC STRUCTURE OF P450CAM 1OT6 ; 0.95 ; CRYOTRAPPED CRYSTAL STRUCTURE OF THE E46Q MUTANT OF PHOTOACTIVE YELLOW PROTEIN UNDER CONTINUOUS ILLUMINATION AT 110K 1OT9 ; 1.00 ; CRYOTRAPPED STATE IN WILD TYPE PHOTOACTIVE YELLOW PROTEIN, INDUCED WITH CONTINUOUS ILLUMINATION AT 110K 2AAZ ; 2.08 ; CRYPTOCOCCUS NEOFORMANS THYMIDYLATE SYNTHASE COMPLEXED WITH SUBSTRATE AND AN ANTIFOLATE 1UFY ; 0.96 ; CRYSTAL ANALYSIS OF CHORISMATE MUTASE FROM THERMUS THERMOPHILUS 1UI9 ; 1.65 ; CRYSTAL ANALYSIS OF CHORISMATE MUTASE FROM THERMUS THERMOPHILUS 1ODE ; 1.65 ; CRYSTAL ANALYSIS OF CHORISMATE MUTASE FROM THERMUS THERMOPHILUS. 1V9C ; 2.20 ; CRYSTAL ANALYSIS OF PRECORRIN-8X METHYL MUTASE FROM THERMUS THERMOPHILUS 243D ; 1.90 ; CRYSTAL AND MOLECULAR STRUCTURE OF THE DEOXYRIBONUCLEIC ACID OCTANUCLEOTIDE D(ACGTACGT)2 295D ; 1.50 ; CRYSTAL AND SOLUTION STRUCTURES OF THE OLIGONUCLEOTIDE D(ATGCGCAT)2: A COMBINED X-RAY AND NMR STUDY 1IHO ; 1.70 ; CRYSTAL APO-STRUCTURE OF PANTOTHENATE SYNTHETASE FROM E. COLI 1QA7 ; 1.90 ; CRYSTAL COMPLEX OF THE 3C PROTEINASE FROM HEPATITIS A VIRUS WITH ITS INHIBITOR AND IMPLICATIONS FOR THE POLYPROTEIN PROCESSING IN HAV 1M3J ; 3.00 ; CRYSTAL FORM II OF PERFRINGOLYSIN O 1HYY ; 1.80 ; CRYSTAL FORM II: HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX OF THE HYDROLYTIC ANTIBODY FAB 6D9 AND A TRANSITION-STATE ANALOG 1YS9 ; 2.56 ; CRYSTAL SRUCTURE OF HYPOTHETICAL PROTEIN SPY1043 FROM STREPTOCOCCUS PYOGENES 1RD8 ; 3.00 ; CRYSTAL SRUCTURE OF THE 1918 HUMAN H1 HEMAGGLUTININ PRECURSOR (HA0) 1Y1L ; 2.80 ; CRYSTAL STRACTURE OF ARSENATE REDUCTASE FROM ARCHAEOGLOBUS FULGIDUS DSM 4304, STRUCTURAL GENOMICS 1RVG ; 2.00 ; CRYSTAL STRCUTURE OF CLASS II FRUCTOSE-BISPHOSPHATE ALDOLASE FROM THERMUS AQUATICUS IN COMPLEX WITH Y 1XWO ; 2.80 ; CRYSTAL STRUCTRUE OF GOOSE DELTA CRYSTALLIN 1SL3 ; 1.81 ; CRYSTAL STRUCTUE OF THROMBIN IN COMPLEX WITH A POTENT P1 HETEROCYCLE-ARYL BASED INHIBITOR 1W2I ; 1.50 ; CRYSTAL STRUCTUORE OF ACYLPHOSPHATASE FROM PYROCOCCUS HORIKOSHII COMPLEXED WITH FORMATE 1SS9 ; 2.60 ; CRYSTAL STRUCTURAL ANALYSIS OF ACTIVE SITE MUTANT Q189E OF LGTC 1EJJ ; 1.90 ; CRYSTAL STRUCTURAL ANALYSIS OF PHOSPHOGLYCERATE MUTASE COCRYSTALLIZED WITH 3-PHOSPHOGLYCERATE 1RU9 ; 2.50 ; CRYSTAL STRUCTURE (A) OF U.V.-IRRADIATED CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 4.6 WITH A DATA SET COLLECTED IN-HOUSE. 1RUA ; 1.75 ; CRYSTAL STRUCTURE (B) OF U.V.-IRRADIATED CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 4.6 WITH A DATA SET COLLECTED AT SSRL BEAMLINE 11-1. 1RUK ; 1.40 ; CRYSTAL STRUCTURE (C) OF NATIVE CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 4.6 WITH A DATA SET COLLECTED AT SSRL BEAMLINE 9-1 1RUL ; 1.88 ; CRYSTAL STRUCTURE (D) OF U.V.-IRRADIATED CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 5.6 WITH A DATA SET COLLECTED AT SSRL BEAMLINE 11-1. 1RUM ; 1.48 ; CRYSTAL STRUCTURE (F) OF H2O2-SOAKED CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 8.5 WITH A DATA SET COLLECTED AT SSRL BEAMLINE 9-1. 1RUP ; 1.40 ; CRYSTAL STRUCTURE (G) OF NATIVE CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 8.5 WITH A DATA SET COLLECTED AT APS BEAMLINE 19-ID 1RUQ ; 1.86 ; CRYSTAL STRUCTURE (H) OF U.V.-IRRADIATED DIELS-ALDER ANTIBODY 13G5 FAB AT PH 8.0 WITH A DATA SET COLLECTED IN HOUSE. 1RUR ; 1.50 ; CRYSTAL STRUCTURE (I) OF NATIVE DIELS-ALDER ANTIBODY 13G5 FAB AT PH 8.0 WITH A DATA SET COLLECTED AT SSRL BEAMLINE 9- 1. 1FCQ ; 1.60 ; CRYSTAL STRUCTURE (MONOCLINIC) OF BEE VENOM HYALURONIDASE 1FCU ; 2.10 ; CRYSTAL STRUCTURE (TRIGONAL) OF BEE VENOM HYALURONIDASE 479D ; 1.90 ; CRYSTAL STRUCTURE A DEOXYRIBONUCLEIC ACID:RIBONUCLEIC ACID HYBRID DUPLEX, A DYNAMIC MODEL FOR RNASE H RECOGNITION 1V8S ; 2.20 ; CRYSTAL STRUCTURE ANALUSIS OF THE ADP-RIBOSE PYROPHOSPHATASE COMPLEXED WITH AMP AND MG 1R4X ; 1.90 ; CRYSTAL STRUCTURE ANALYS OF THE GAMMA-COPI APPENDAGE DOMAIN 1MLX ; 1.25 ; CRYSTAL STRUCTURE ANALYSIS OF A 2'-O-[2-(METHYLTHIO)-ETHYL]- MODIFIED OLIGODEOXYNUCLEOTIDE DUPLEX 2AXB ; 1.61 ; CRYSTAL STRUCTURE ANALYSIS OF A 2-O-[2-(METHOXY)ETHYL]-2- THIOTHYMIDINE MODIFIED OLIGODEOXYNUCLEOTIDE DUPLEX 1MHK ; 2.50 ; CRYSTAL STRUCTURE ANALYSIS OF A 26MER RIBONUCLEIC ACID MOLECULE, REPRESENTING A NEW RIBONUCLEIC ACID MOTIF, THE HOOK-TURN 1WIY ; 2.00 ; CRYSTAL STRUCTURE ANALYSIS OF A 6-COORDINATED CYTOCHOROME P450 FROM THERMUS THERMOPHILUS HB8 1JBZ ; 1.50 ; CRYSTAL STRUCTURE ANALYSIS OF A DUAL-WAVELENGTH EMISSION GREEN FLUORESCENT PROTEIN VARIANT AT HIGH PH 1JBY ; 1.80 ; CRYSTAL STRUCTURE ANALYSIS OF A DUAL-WAVELENGTH EMISSION GREEN FLUORESCENT PROTEIN VARIANT AT LOW PH 1JUC ; 2.35 ; CRYSTAL STRUCTURE ANALYSIS OF A HOLLIDAY JUNCTION FORMED BY CCGGTACCGG 1QSW ; 1.85 ; CRYSTAL STRUCTURE ANALYSIS OF A HUMAN LYSOZYME MUTANT W64C C65A 1MCV ; 1.80 ; CRYSTAL STRUCTURE ANALYSIS OF A HYBRID SQUASH INHIBITOR IN COMPLEX WITH PORCINE PANCREATIC ELASTASE 2ALM ; 2.60 ; CRYSTAL STRUCTURE ANALYSIS OF A MUTANT BETA-KETOACYL-[ACYL CARRIER PROTEIN] SYNTHASE II FROM STREPTOCOCCUS PNEUMONIAE 1S5T ; 2.30 ; CRYSTAL STRUCTURE ANALYSIS OF A MUTANT OF DIHYDRODIPICOLINATE SYNTHASE--RESIDUE THR44 TO VAL44 1S5V ; 2.35 ; CRYSTAL STRUCTURE ANALYSIS OF A MUTANT OF DIHYDRODIPICOLINATE SYNTHASE--RESIDUE TYR107 TO PHE107 1S5W ; 2.32 ; CRYSTAL STRUCTURE ANALYSIS OF A MUTANT OF DIHYDRODIPICOLINATE SYNTHASE--RESIDUE TYR133 TO PHE133 1HR2 ; 2.25 ; CRYSTAL STRUCTURE ANALYSIS OF A MUTANT P4-P6 DOMAIN (DELC209) OF TETRAHYMENA THEMOPHILA GROUP I INTRON. 1T4U ; 2.00 ; CRYSTAL STRUCTURE ANALYSIS OF A NOVEL OXYGUANIDINE BOUND TO THROMBIN 1T4V ; 2.00 ; CRYSTAL STRUCTURE ANALYSIS OF A NOVEL OXYGUANIDINE BOUND TO THROMBIN 1JC1 ; 1.90 ; CRYSTAL STRUCTURE ANALYSIS OF A REDOX-SENSITIVE GREEN FLUORESCENT PROTEIN VARIANT IN A OXIDIZED FORM 1JC0 ; 2.00 ; CRYSTAL STRUCTURE ANALYSIS OF A REDOX-SENSITIVE GREEN FLUORESCENT PROTEIN VARIANT IN A REDUCED FORM 1LNI ; 1.00 ; CRYSTAL STRUCTURE ANALYSIS OF A RIBONUCLEASE FROM STREPTOMYCES AUREOFACIENS AT ATOMIC RESOLUTION (1.0 A) 1MFQ ; 3.10 ; CRYSTAL STRUCTURE ANALYSIS OF A TERNARY S-DOMAIN COMPLEX OF HUMAN SIGNAL RECOGNITION PARTICLE 1I9V ; 2.60 ; CRYSTAL STRUCTURE ANALYSIS OF A TRNA-NEOMYCIN COMPLEX 1QZN ; 1.90 ; CRYSTAL STRUCTURE ANALYSIS OF A TYPE II COHESIN DOMAIN FROM THE CELLULOSOME OF ACETIVIBRIO CELLULOLYTICUS 1V8M ; 1.80 ; CRYSTAL STRUCTURE ANALYSIS OF ADP-RIBOSE PYROPHOSPHATASE COMPLEXED WITH ADP-RIBOSE AND GD 1EV5 ; 1.70 ; CRYSTAL STRUCTURE ANALYSIS OF ALA167 MUTANT OF ESCHERICHIA COLI 1EPX ; 1.80 ; CRYSTAL STRUCTURE ANALYSIS OF ALDOLASE FROM L. MEXICANA 1F2J ; 1.90 ; CRYSTAL STRUCTURE ANALYSIS OF ALDOLASE FROM T. BRUCEI 1UA7 ; 2.21 ; CRYSTAL STRUCTURE ANALYSIS OF ALPHA-AMYLASE FROM BACILLUS SUBTILIS COMPLEXED WITH ACARBOSE 1P2C ; 2.00 ; CRYSTAL STRUCTURE ANALYSIS OF AN ANTI-LYSOZYME ANTIBODY 1XQI ; 2.50 ; CRYSTAL STRUCTURE ANALYSIS OF AN NDP KINASE FROM PYROBACULUM AEROPHILUM 1L3Z ; 2.01 ; CRYSTAL STRUCTURE ANALYSIS OF AN RIBONUCLEIC ACID HEPTAMER 1Q1J ; 2.50 ; CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 PEPTIDE 1K3O ; 1.80 ; CRYSTAL STRUCTURE ANALYSIS OF APO GLUTATHIONE S-TRANSFERASE 1I49 ; 2.80 ; CRYSTAL STRUCTURE ANALYSIS OF ARFAPTIN 1G8J ; 2.03 ; CRYSTAL STRUCTURE ANALYSIS OF ARSENITE OXIDASE FROM ALCALIGENES FAECALIS 1G8K ; 1.64 ; CRYSTAL STRUCTURE ANALYSIS OF ARSENITE OXIDASE FROM ALCALIGENES FAECALIS 1VEM ; 1.85 ; CRYSTAL STRUCTURE ANALYSIS OF BACILLUS CEREUS BETA-AMYLASE AT THE OPTIMUM PH (6.5) 1HV4 ; 2.80 ; CRYSTAL STRUCTURE ANALYSIS OF BAR-HEAD GOOSE HEMOGLOBIN (DEOXY FORM) 1SQB ; 2.69 ; CRYSTAL STRUCTURE ANALYSIS OF BOVINE BC1 WITH AZOXYSTROBIN 1SQQ ; 3.00 ; CRYSTAL STRUCTURE ANALYSIS OF BOVINE BC1 WITH METHOXY ACRYLATE STILBENE (MOAS) 1SQP ; 2.70 ; CRYSTAL STRUCTURE ANALYSIS OF BOVINE BC1 WITH MYXOTHIAZOL 1SQX ; 2.60 ; CRYSTAL STRUCTURE ANALYSIS OF BOVINE BC1 WITH STIGMATELLIN A 1SQV ; 2.85 ; CRYSTAL STRUCTURE ANALYSIS OF BOVINE BC1 WITH UHDBT 1V9E ; 1.95 ; CRYSTAL STRUCTURE ANALYSIS OF BOVINE CARBONIC ANHYDRASE II 1ITO ; 2.29 ; CRYSTAL STRUCTURE ANALYSIS OF BOVINE SPLEEN CATHEPSIN B- E64C COMPLEX 1ISF ; 2.50 ; CRYSTAL STRUCTURE ANALYSIS OF BST-1/CD157 1ISI ; 2.10 ; CRYSTAL STRUCTURE ANALYSIS OF BST-1/CD157 COMPLEXED WITH ETHENONAD 1ISH ; 2.40 ; CRYSTAL STRUCTURE ANALYSIS OF BST-1/CD157 COMPLEXED WITH ETHENONADP 1ISM ; 3.00 ; CRYSTAL STRUCTURE ANALYSIS OF BST-1/CD157 COMPLEXED WITH NICOTINAMIDE 1ISJ ; 2.30 ; CRYSTAL STRUCTURE ANALYSIS OF BST-1/CD157 COMPLEXED WITH NMN 1ISG ; 2.60 ; CRYSTAL STRUCTURE ANALYSIS OF BST-1/CD157 WITH ATPGAMMAS 1KYZ ; 2.20 ; CRYSTAL STRUCTURE ANALYSIS OF CAFFEIC ACID/5-HYDROXYFERULIC ACID 3/5-O-METHYLTRANSFERASE FERULIC ACID COMPLEX 1KYW ; 2.40 ; CRYSTAL STRUCTURE ANALYSIS OF CAFFEIC ACID/5-HYDROXYFERULIC ACID 3/5-O-METHYLTRANSFERASE IN COMPLEX WITH 5- HYDROXYCONIFERALDEHYDE 1KRQ ; 2.70 ; CRYSTAL STRUCTURE ANALYSIS OF CAMPYLOBACTER JEJUNI FERRITIN 1M7S ; 1.80 ; CRYSTAL STRUCTURE ANALYSIS OF CATALASE CATF OF PSEUDOMONAS SYRINGAE 1FP1 ; 1.82 ; CRYSTAL STRUCTURE ANALYSIS OF CHALCONE O-METHYLTRANSFERASE 1FNK ; 2.00 ; CRYSTAL STRUCTURE ANALYSIS OF CHORISMATE MUTASE MUTANT C88K/R90S 1FNJ ; 1.90 ; CRYSTAL STRUCTURE ANALYSIS OF CHORISMATE MUTASE MUTANT C88S/R90K 1U9T ; 2.16 ; CRYSTAL STRUCTURE ANALYSIS OF CHUS, AN E. COLI HEME OXYGENASE 1KHO ; 2.40 ; CRYSTAL STRUCTURE ANALYSIS OF CLOSTRIDIUM PERFRINGENS ALPHA- TOXIN ISOLATED FROM AVIAN STRAIN SWCP 1QVR ; 3.00 ; CRYSTAL STRUCTURE ANALYSIS OF CLPB 1MBU ; 2.30 ; CRYSTAL STRUCTURE ANALYSIS OF CLPSN HETERODIMER 1MBV ; 3.30 ; CRYSTAL STRUCTURE ANALYSIS OF CLPSN HETERODIMER TETRAGONAL FORM 1MBX ; 2.25 ; CRYSTAL STRUCTURE ANALYSIS OF CLPSN WITH TRANSITION METAL ION BOUND 1K7U ; 2.20 ; CRYSTAL STRUCTURE ANALYSIS OF CROSSLINKED-WGA3/GLCNACBETA1, 4GLCNAC COMPLEX 1K7T ; 2.40 ; CRYSTAL STRUCTURE ANALYSIS OF CROSSLINKED-WGA3/GLCNACBETA1, 6GAL COMPLEX 1K7V ; 2.20 ; CRYSTAL STRUCTURE ANALYSIS OF CROSSLINKED-WGA3/GLCNACBETA1, 6GALBETA1,4GLC 1F29 ; 2.15 ; CRYSTAL STRUCTURE ANALYSIS OF CRUZAIN BOUND TO A VINYL SULFONE DERIVED INHIBITOR (I) 1F2A ; 1.60 ; CRYSTAL STRUCTURE ANALYSIS OF CRUZAIN BOUND TO A VINYL SULFONE DERIVED INHIBITOR (II) 1F2B ; 1.80 ; CRYSTAL STRUCTURE ANALYSIS OF CRUZAIN BOUND TO VINYL SULFONE DERIVED INHIBITOR (III) 1F2C ; 2.00 ; CRYSTAL STRUCTURE ANALYSIS OF CRYZAIN BOUND TO VINYL SULFONE DERIVED INHIBITOR (IV) 1EV8 ; 2.60 ; CRYSTAL STRUCTURE ANALYSIS OF CYS167 MUTANT OF ESCHERICHIA COLI 1EVF ; 1.70 ; CRYSTAL STRUCTURE ANALYSIS OF CYS167 MUTANT OF ESCHERICHIA COLI 1EVG ; 2.00 ; CRYSTAL STRUCTURE ANALYSIS OF CYS167 MUTANT OF ESCHERICHIA COLI WITH UNMODIFIED CATALYTIC CYSTEINE 1EG6 ; 2.00 ; CRYSTAL STRUCTURE ANALYSIS OF D(CG(5-BRU)ACG) COMPLEXES TO A PHENAZINE 1C0K ; 1.46 ; CRYSTAL STRUCTURE ANALYSIS OF D-AMINO ACID OXIDASE IN COMPLEX WITH L-LACTATE 1GG1 ; 2.00 ; CRYSTAL STRUCTURE ANALYSIS OF DAHP SYNTHASE IN COMPLEX WITH MN2+ AND 2-PHOSPHOGLYCOLATE 1DLK ; 2.14 ; CRYSTAL STRUCTURE ANALYSIS OF DELTA-CHYMOTRYPSIN BOUND TO A PEPTIDYL CHLOROMETHYL KETONE INHIBITOR 1MH9 ; 1.80 ; CRYSTAL STRUCTURE ANALYSIS OF DEOXYRIBONUCLEOTIDASE 1JUV ; 1.70 ; CRYSTAL STRUCTURE ANALYSIS OF DIHYDROFOLATE REDUCTASE FROM BACTERIOPHAGE T4 1HO3 ; 2.50 ; CRYSTAL STRUCTURE ANALYSIS OF E. COLI L-ASPARAGINASE II (Y25F MUTANT) 1T43 ; 3.20 ; CRYSTAL STRUCTURE ANALYSIS OF E.COLI PROTEIN (N5)-GLUTAMINE METHYLTRANSFERASE (HEMK) 1IUE ; 1.70 ; CRYSTAL STRUCTURE ANALYSIS OF FERREDOXIN FROM PLASMODIUM FALCIPARUM 1K9A ; 2.50 ; CRYSTAL STRUCTURE ANALYSIS OF FULL-LENGTH CARBOXYL-TERMINAL SRC KINASE AT 2.5 A RESOLUTION 1XA8 ; 2.40 ; CRYSTAL STRUCTURE ANALYSIS OF GLUTATHIONE-DEPENDENT FORMALDEHYDE-ACTIVATING ENZYME (GFA) 2AF9 ; 2.00 ; CRYSTAL STRUCTURE ANALYSIS OF GM2-ACTIVATOR PROTEIN COMPLEXED WITH PHOSPHATIDYLCHOLINE 2AG2 ; 2.00 ; CRYSTAL STRUCTURE ANALYSIS OF GM2-ACTIVATOR PROTEIN COMPLEXED WITH PHOSPHATIDYLCHOLINE 2AG4 ; 1.80 ; CRYSTAL STRUCTURE ANALYSIS OF GM2-ACTIVATOR PROTEIN COMPLEXED WITH PHOSPHATIDYLCHOLINE 1K34 ; 1.88 ; CRYSTAL STRUCTURE ANALYSIS OF GP41 CORE MUTANT 1NNF ; 1.10 ; CRYSTAL STRUCTURE ANALYSIS OF HAEMOPHLIUS INFLUENZAE FERRIC- ION BINDING PROTEIN H9Q MUTANT FORM 1LGD ; 1.90 ; CRYSTAL STRUCTURE ANALYSIS OF HCA II MUTANT T199P IN COMPLEX WITH BICARBONATE 1LG6 ; 2.20 ; CRYSTAL STRUCTURE ANALYSIS OF HCA II MUTANT T199P IN COMPLEX WITH THIOCYANATE 1Q9B ; 1.50 ; CRYSTAL STRUCTURE ANALYSIS OF HEV B 6.02 (HEVEIN) AT 1.5 ANGSTROMS RESOLUTION 1JOV ; 1.57 ; CRYSTAL STRUCTURE ANALYSIS OF HI1317 1S6S ; 1.53 ; CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE MUTANT I84V WITH A POTENT NON-PEPTIDE INHIBITOR (UIC-94017) 1S65 ; 1.10 ; CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE MUTANT V82A WITH A POTENT NON-PEPTIDE INHIBITOR (UIC-94017) 1S6G ; 1.30 ; CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE WITH A POTENT NON-PEPTIDE INHIBITOR (UIC-94017) 1IXV ; 2.30 ; CRYSTAL STRUCTURE ANALYSIS OF HOMOLOG OF ONCOPROTEIN GANKYRIN, AN INTERACTOR OF RB AND CDK4/6 2B2V ; 2.65 ; CRYSTAL STRUCTURE ANALYSIS OF HUMAN CHD1 CHROMODOMAINS 1 AND 2 BOUND TO HISTONE H3 RESI 1-15 MEK4 1K3Y ; 1.30 ; CRYSTAL STRUCTURE ANALYSIS OF HUMAN GLUTATHIONE S- TRANSFERASE WITH S-HEXYL GLUTATIONE AND GLYCEROL AT 1.3 ANGSTROM 1JQE ; 1.91 ; CRYSTAL STRUCTURE ANALYSIS OF HUMAN HISTAMINE METHYLTRANSFERASE (ILE105 POLYMORPHIC VARIANT) COMPLEXED WITH ADOHCY AND ANTIMALARIAL DRUG QUINACRINE 1JQD ; 2.28 ; CRYSTAL STRUCTURE ANALYSIS OF HUMAN HISTAMINE METHYLTRANSFERASE (THR105 POLYMORPHIC VARIANT) COMPLEXED WITH ADOHCY AND HISTAMINE 1IWT ; 1.40 ; CRYSTAL STRUCTURE ANALYSIS OF HUMAN LYSOZYME AT 113K. 1IWU ; 1.40 ; CRYSTAL STRUCTURE ANALYSIS OF HUMAN LYSOZYME AT 127K. 1IWV ; 1.40 ; CRYSTAL STRUCTURE ANALYSIS OF HUMAN LYSOZYME AT 147K. 1IWW ; 1.40 ; CRYSTAL STRUCTURE ANALYSIS OF HUMAN LYSOZYME AT 152K. 1IWX ; 1.40 ; CRYSTAL STRUCTURE ANALYSIS OF HUMAN LYSOZYME AT 161K. 1IWY ; 1.40 ; CRYSTAL STRUCTURE ANALYSIS OF HUMAN LYSOZYME AT 170K. 1IWZ ; 1.48 ; CRYSTAL STRUCTURE ANALYSIS OF HUMAN LYSOZYME AT 178K. 1JIZ ; 2.60 ; CRYSTAL STRUCTURE ANALYSIS OF HUMAN MACROPHAGE ELASTASE MMP- 12 1P5J ; 2.50 ; CRYSTAL STRUCTURE ANALYSIS OF HUMAN SERINE DEHYDRATASE 1YWR ; 1.95 ; CRYSTAL STRUCTURE ANALYSIS OF INACTIVE P38 KINASE DOMAIN IN COMPLEX WITH A MONOCYCLIC PYRAZOLONE INHIBITOR 1FP2 ; 1.40 ; CRYSTAL STRUCTURE ANALYSIS OF ISOFLAVONE O-METHYLTRANSFERASE 1CUO ; 1.60 ; CRYSTAL STRUCTURE ANALYSIS OF ISOMER-2 AZURIN FROM METHYLOMONAS J 1R5Q ; 2.00 ; CRYSTAL STRUCTURE ANALYSIS OF KAI A FROM PCC7120 1R5P ; 2.20 ; CRYSTAL STRUCTURE ANALYSIS OF KAIB FROM PCC7120 1GG0 ; 3.00 ; CRYSTAL STRUCTURE ANALYSIS OF KDOP SYNTHASE AT 3.0 A 1FPZ ; 2.00 ; CRYSTAL STRUCTURE ANALYSIS OF KINASE ASSOCIATED PHOSPHATASE (KAP) WITH A SUBSTITUTION OF THE CATALYTIC SITE CYSTEINE (CYS140) TO A SERINE 1HQK ; 1.60 ; CRYSTAL STRUCTURE ANALYSIS OF LUMAZINE SYNTHASE FROM AQUIFEX AEOLICUS 1IZC ; 1.70 ; CRYSTAL STRUCTURE ANALYSIS OF MACROPHOMATE SYNTHASE 1P9E ; 2.40 ; CRYSTAL STRUCTURE ANALYSIS OF METHYL PARATHION HYDROLASE FROM PSEUDOMONAS SP WBC-3 1IXK ; 1.90 ; CRYSTAL STRUCTURE ANALYSIS OF METHYLTRANSFERASE HOMOLOG PROTEIN FROM PYROCOCCUS HORIKOSHII 1F5Z ; 1.88 ; CRYSTAL STRUCTURE ANALYSIS OF N-ACETYLNEURAMINATE LYASE FROM HAEMOPHILUS INFLUENZAE: CRYSTAL FORM I 1F6K ; 1.60 ; CRYSTAL STRUCTURE ANALYSIS OF N-ACETYLNEURAMINATE LYASE FROM HAEMOPHILUS INFLUENZAE: CRYSTAL FORM II 1F74 ; 1.60 ; CRYSTAL STRUCTURE ANALYSIS OF N-ACETYLNEURAMINATE LYASE FROM HAEMOPHILUS INFLUENZAE: CRYSTAL FORM II COMPLEXED WITH 4-DEOXY-SIALIC ACID 1F7B ; 1.80 ; CRYSTAL STRUCTURE ANALYSIS OF N-ACETYLNEURAMINATE LYASE FROM HAEMOPHILUS INFLUENZAE: CRYSTAL FORM II IN COMPLEX WITH 4-OXO-SIALIC ACID 1F6P ; 2.25 ; CRYSTAL STRUCTURE ANALYSIS OF N-ACETYLNEURAMINATE LYASE FROM HAEMOPHILUS INFLUENZAE: CRYSTAL FORM III 1F73 ; 1.95 ; CRYSTAL STRUCTURE ANALYSIS OF N-ACETYLNEURAMINATE LYASE FROM HAEMOPHILUS INFLUENZAE: CRYSTAL FORM III IN COMPLEX WITH SIALIC ACID ALDITOL 1NEG ; 2.30 ; CRYSTAL STRUCTURE ANALYSIS OF N-AND C-TERMINAL LABELED SH3- DOMAIN OF ALPHA-CHICKEN SPECTRIN 1FO6 ; 1.95 ; CRYSTAL STRUCTURE ANALYSIS OF N-CARBAMOYL-D-AMINO-ACID AMIDOHYDROLASE 1JSZ ; 1.93 ; CRYSTAL STRUCTURE ANALYSIS OF N7,9-DIMETHYLGUANINE-VP39 COMPLEX 1FVF ; 3.20 ; CRYSTAL STRUCTURE ANALYSIS OF NEURONAL SEC1 FROM THE SQUID L. PEALEI 1FVH ; 2.80 ; CRYSTAL STRUCTURE ANALYSIS OF NEURONAL SEC1 FROM THE SQUID L. PEALEI 1F9A ; 2.00 ; CRYSTAL STRUCTURE ANALYSIS OF NMN ADENYLYLTRANSFERASE FROM METHANOCOCCUS JANNASCHII 1IHM ; 3.40 ; CRYSTAL STRUCTURE ANALYSIS OF NORWALK VIRUS CAPSID 1F8Y ; 2.40 ; CRYSTAL STRUCTURE ANALYSIS OF NUCLEOSIDE 2- DEOXYRIBOSYLTRANSFERASE COMPLEXED WITH 5-METHYL-2'- DEOXYPSEUDOURIDINE 1S9X ; 2.50 ; CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE ANALOGUE, SLLMWITQA, IN COMPLEX WITH HLA-A2 1S9Y ; 2.30 ; CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE ANALOGUE, SLLMWITQS, IN COMPLEX WITH HLA-A2 1S9W ; 2.20 ; CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE, SLLMWITQC, IN COMPLEX WITH HLA-A2 1FHU ; 1.65 ; CRYSTAL STRUCTURE ANALYSIS OF O-SUCCINYLBENZOATE SYNTHASE FROM E. COLI 1FHV ; 1.77 ; CRYSTAL STRUCTURE ANALYSIS OF O-SUCCINYLBENZOATE SYNTHASE FROM E. COLI COMPLEXED WITH MG AND OSB 1SQJ ; 2.20 ; CRYSTAL STRUCTURE ANALYSIS OF OLIGOXYLOGLUCAN REDUCING-END- SPECIFIC CELLOBIOHYDROLASE (OXG-RCBH) 1X7D ; 1.60 ; CRYSTAL STRUCTURE ANALYSIS OF ORNITHINE CYCLODEAMINASE COMPLEXED WITH NAD AND ORNITHINE TO 1.6 ANGSTROMS 1CVZ ; 1.70 ; CRYSTAL STRUCTURE ANALYSIS OF PAPAIN WITH CLIK148(CATHEPSIN L SPECIFIC INHIBITOR) 1Z15 ; 1.70 ; CRYSTAL STRUCTURE ANALYSIS OF PERIPLASMIC LEU/ILE/VAL- BINDING PROTEIN IN SUPEROPEN FORM 1Z16 ; 1.72 ; CRYSTAL STRUCTURE ANALYSIS OF PERIPLASMIC LEU/ILE/VAL- BINDING PROTEIN WITH BOUND LEUCINE 1Z17 ; 1.96 ; CRYSTAL STRUCTURE ANALYSIS OF PERIPLASMIC LEU/ILE/VAL- BINDING PROTEIN WITH BOUND LIGAND ISOLEUCINE 1Z18 ; 2.10 ; CRYSTAL STRUCTURE ANALYSIS OF PERIPLASMIC LEU/ILE/VAL- BINDING PROTEIN WITH BOUND VALINE 1UB0 ; 2.05 ; CRYSTAL STRUCTURE ANALYSIS OF PHOSPHOMETHYLPYRIMIDINE KINASE (THID) FROM THERMUS THERMOPHILUS HB8 1NHW ; 2.35 ; CRYSTAL STRUCTURE ANALYSIS OF PLASMODIUM FALCIPARUM ENOYL- ACYL-CARRIER-PROTEIN REDUCTASE 1VRW ; 2.40 ; CRYSTAL STRUCTURE ANALYSIS OF PLASMODIUM FALCIPARUM ENOYL- ACYL-CARRIER-PROTEIN REDUCTASE WITH NADH 1NHG ; 2.43 ; CRYSTAL STRUCTURE ANALYSIS OF PLASMODIUM FALCIPARUM ENOYL- ACYL-CARRIER-PROTEIN REDUCTASE WITH TRICLOSAN 1NNU ; 2.50 ; CRYSTAL STRUCTURE ANALYSIS OF PLASMODIUM FALCIPARUM ENOYL- ACYL-CARRIER-PROTEIN REDUCTASE WITH TRICLOSAN ANALOG 1I1H ; 2.60 ; CRYSTAL STRUCTURE ANALYSIS OF PRECORRIN-8X METHYLMUTASE COMPLEX WITH HYDROGENOBYRINIC ACID 1F2V ; 2.10 ; CRYSTAL STRUCTURE ANALYSIS OF PRECORRIN-8X METHYLMUTASE OF AEROBIC VITAMIN B12 SYNTHESIS 1YJ3 ; 1.60 ; CRYSTAL STRUCTURE ANALYSIS OF PRODUCT BOUND METHIONINE AMINOPEPTIDASE TYPE 1C FROM MYCOBACTERIUM TUBERCULOSIS 1GA1 ; 1.40 ; CRYSTAL STRUCTURE ANALYSIS OF PSCP (PSEUDOMONAS SERINE- CARBOXYL PROTEINASE) COMPLEXED WITH A FRAGMENT OF IODOTYROSTATIN (THIS ENZYME RENAMED "SEDOLISIN" IN 2003) 1GA6 ; 1.00 ; CRYSTAL STRUCTURE ANALYSIS OF PSCP (PSEUDOMONAS SERINE- CARBOXYL PROTEINASE) COMPLEXED WITH A FRAGMENT OF TYROSTATIN (THIS ENZYME RENAMED "SEDOLISIN" IN 2003) 1GA4 ; 1.40 ; CRYSTAL STRUCTURE ANALYSIS OF PSCP (PSEUDOMONAS SERINE- CARBOXYL PROTEINASE) COMPLEXED WITH INHIBITOR PSEUDOIODOTYROSTATIN (THIS ENZYME RENAMED "SEDOLISIN" IN 2003) 1I2H ; 1.80 ; CRYSTAL STRUCTURE ANALYSIS OF PSD-ZIP45(HOMER1C/VESL-1L) CONSERVED HOMER 1 DOMAIN 1G3Q ; 2.00 ; CRYSTAL STRUCTURE ANALYSIS OF PYROCOCCUS FURIOSUS CELL DIVISION ATPASE MIND 1G3R ; 2.70 ; CRYSTAL STRUCTURE ANALYSIS OF PYROCOCCUS FURIOSUS CELL DIVISION ATPASE MIND 1SG0 ; 1.50 ; CRYSTAL STRUCTURE ANALYSIS OF QR2 IN COMPLEX WITH RESVERATROL 1G98 ; 1.90 ; CRYSTAL STRUCTURE ANALYSIS OF RABBIT PHOSPHOGLUCOSE ISOMERASE COMPLEXED WITH 5-PHOSPHOARABINONATE, A TRANSITION STATE ANALOGUE 1I4D ; 2.50 ; CRYSTAL STRUCTURE ANALYSIS OF RAC1-GDP COMPLEXED WITH ARFAPTIN (P21) 1I4L ; 2.70 ; CRYSTAL STRUCTURE ANALYSIS OF RAC1-GDP IN COMPLEX WITH ARFAPTIN (P41) 1I4T ; 2.60 ; CRYSTAL STRUCTURE ANALYSIS OF RAC1-GMPPNP IN COMPLEX WITH ARFAPTIN 1MJ3 ; 2.10 ; CRYSTAL STRUCTURE ANALYSIS OF RAT ENOYL-COA HYDRATASE IN COMPLEX WITH HEXADIENOYL-COA 1U5I ; 2.86 ; CRYSTAL STRUCTURE ANALYSIS OF RAT M-CALPAIN MUTANT LYS10 THR 1TB3 ; 2.30 ; CRYSTAL STRUCTURE ANALYSIS OF RECOMBINANT RAT KIDNEY LONG- CHAIN HYDROXY ACID OXIDASE 1P2F ; 1.80 ; CRYSTAL STRUCTURE ANALYSIS OF RESPONSE REGULATOR DRRB, A THERMOTOGA MARITIMA OMPR/PHOB HOMOLOG 1K3L ; 1.50 ; CRYSTAL STRUCTURE ANALYSIS OF S-HEXYL-GLUTATHIONE COMPLEX OF GLUTATHIONE TRANSFERASE AT 1.5 ANGSTROMS RESOLUTION 1R17 ; 1.86 ; CRYSTAL STRUCTURE ANALYSIS OF S.EPIDERMIDIS ADHESIN SDRG BINDING TO FIBRINOGEN (ADHESIN-LIGAND COMPLEX) 1R19 ; 3.51 ; CRYSTAL STRUCTURE ANALYSIS OF S.EPIDERMIDIS ADHESIN SDRG BINDING TO FIBRINOGEN (APO STRUCTURE) 1FPQ ; 2.00 ; CRYSTAL STRUCTURE ANALYSIS OF SELENOMETHIONINE SUBSTITUTED CHALCONE O-METHYLTRANSFERASE 1FPX ; 1.65 ; CRYSTAL STRUCTURE ANALYSIS OF SELENOMETHIONINE SUBSTITUTED ISOFLAVONE O-METHYLTRANSFERASE 1QQQ ; 1.50 ; CRYSTAL STRUCTURE ANALYSIS OF SER254 MUTANT OF ESCHERICHIA COLI THYMIDYLATE SYNTHASE 1XUZ ; 2.20 ; CRYSTAL STRUCTURE ANALYSIS OF SIALIC ACID SYNTHASE (NEUB) FROM NEISSERIA MENINGITIDIS, BOUND TO MN2+, PHOSPHOENOLPYRUVATE, AND N-ACETYL MANNOSAMINITOL 1QVC ; 2.20 ; CRYSTAL STRUCTURE ANALYSIS OF SINGLE STRANDED DEOXYRIBONUCLEIC ACID BINDING PROTEIN (SSB) FROM E.COLI 1K30 ; 1.90 ; CRYSTAL STRUCTURE ANALYSIS OF SQUASH (CUCURBITA MOSCHATA) GLYCEROL-3-PHOSPHATE (1)-ACYLTRANSFERASE 1R5B ; 2.35 ; CRYSTAL STRUCTURE ANALYSIS OF SUP35 1R5N ; 2.90 ; CRYSTAL STRUCTURE ANALYSIS OF SUP35 COMPLEXED WITH GDP 1R5O ; 3.20 ; CRYSTAL STRUCTURE ANALYSIS OF SUP35 COMPLEXED WITH GMPPNP 1J9J ; 1.90 ; CRYSTAL STRUCTURE ANALYSIS OF SURE PROTEIN FROM T.MARITIMA 1NP7 ; 1.90 ; CRYSTAL STRUCTURE ANALYSIS OF SYNECHOCYSTIS SP. PCC6803 CRYPTOCHROME 1S9C ; 3.00 ; CRYSTAL STRUCTURE ANALYSIS OF THE 2-ENOYL-COA HYDRATASE 2 DOMAIN OF HUMAN PEROXISOMAL MULTIFUNCTIONAL ENZYME TYPE 2 1SZO ; 1.90 ; CRYSTAL STRUCTURE ANALYSIS OF THE 6-OXO CAMPHOR HYDROLASE HIS122ALA MUTANT BOUND TO ITS NATURAL PRODUCT (2S,4S)- ALPHA-CAMPHOLINIC ACID 1JI0 ; 2.00 ; CRYSTAL STRUCTURE ANALYSIS OF THE ABC TRANSPORTER FROM THERMOTOGA MARITIMA 1J0A ; 2.50 ; CRYSTAL STRUCTURE ANALYSIS OF THE ACC DEAMINASE HOMOLOGUE 1J0B ; 2.70 ; CRYSTAL STRUCTURE ANALYSIS OF THE ACC DEAMINASE HOMOLOGUE COMPLEXED WITH INHIITOR 1YRU ; 2.50 ; CRYSTAL STRUCTURE ANALYSIS OF THE ADENYLYL CYCLAES CATALYTIC DOMAIN OF ADENYLYL CYCLASE TOXIN OF BORDETELLA PERTUSSIS IN PRESENCE OF C-TERMINAL CALMODULIN AND 1MM CALCIUM CHLORIDE 1V8I ; 1.76 ; CRYSTAL STRUCTURE ANALYSIS OF THE ADP-RIBOSE PYROPHOSPHATASE 1V8R ; 1.80 ; CRYSTAL STRUCTURE ANALYSIS OF THE ADP-RIBOSE PYROPHOSPHATASE COMPLEXED WITH ADP-RIBOSE AND ZN 1V8T ; 2.60 ; CRYSTAL STRUCTURE ANALYSIS OF THE ADP-RIBOSE PYROPHOSPHATASE COMPLEXED WITH RIBOSE-5'-PHOSPHATE AND ZN 1V8N ; 1.74 ; CRYSTAL STRUCTURE ANALYSIS OF THE ADP-RIBOSE PYROPHOSPHATASE COMPLEXED WITH ZN 1V8U ; 1.90 ; CRYSTAL STRUCTURE ANALYSIS OF THE ADP-RIBOSE PYROPHOSPHATASE OF E82Q MUTANT WITH SO4 AND MG 1V8W ; 1.66 ; CRYSTAL STRUCTURE ANALYSIS OF THE ADP-RIBOSE PYROPHOSPHATASE OF E82Q MUTANT, COMPLEXED WITH SO4 AND ZN 1V8V ; 1.97 ; CRYSTAL STRUCTURE ANALYSIS OF THE ADP-RIBOSE PYROPHOSPHATASE OF E86Q MUTANT, COMPLEXED WITH ADP-RIBOSE AND MG 1V8Y ; 1.65 ; CRYSTAL STRUCTURE ANALYSIS OF THE ADP-RIBOSE PYROPHOSPHATASE OF E86Q MUTANT, COMPLEXED WITH ADP-RIBOSE AND ZN 1L6B ; 1.50 ; CRYSTAL STRUCTURE ANALYSIS OF THE ALL DEOXYRIBONUCLEIC ACID HOLLIDAY JUNCTION STRUCTURE OF CCGGTACM5CGG 1KGZ ; 2.40 ; CRYSTAL STRUCTURE ANALYSIS OF THE ANTHRANILATE PHOSPHORIBOSYLTRANSFERASE FROM ERWINIA CAROTOVORA (CURRENT NAME, PECTOBACTERIUM CAROTOVORUM) 1KHD ; 1.86 ; CRYSTAL STRUCTURE ANALYSIS OF THE ANTHRANILATE PHOSPHORIBOSYLTRANSFERASE FROM ERWINIA CAROTOVORA AT 1.9 RESOLUTION (CURRENT NAME, PECTOBACTERIUM CAROTOVORUM) 1L7T ; 2.10 ; CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-TESTOSTERONE FAB FRAGMENT 1VPO ; 2.15 ; CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-TESTOSTERONE FAB IN COMPLEX WITH TESTOSTERONE 1IQV ; 2.10 ; CRYSTAL STRUCTURE ANALYSIS OF THE ARCHAEBACTERIAL RIBOSOMAL PROTEIN S7 1ULY ; 2.50 ; CRYSTAL STRUCTURE ANALYSIS OF THE ARSR HOMOLOGUE DEOXYRIBONUCLEIC ACID- BINDING PROTEIN FROM P. HORIKOSHII OT3 1S23 ; 1.60 ; CRYSTAL STRUCTURE ANALYSIS OF THE B-DEOXYRIBONUCLEIC ACID DECAMER CGCAATTGCG 1N5C ; 1.79 ; CRYSTAL STRUCTURE ANALYSIS OF THE B-DEOXYRIBONUCLEIC ACID DODECAMER CGCGAATT(ETHENOC)GCG 1JGR ; 1.20 ; CRYSTAL STRUCTURE ANALYSIS OF THE B-DEOXYRIBONUCLEIC ACID DODECAMER CGCGAATTCGCG WITH THALLIUM IONS. 1S9B ; 2.81 ; CRYSTAL STRUCTURE ANALYSIS OF THE B-DEOXYRIBONUCLEIC ACID GAATTCG 1C9O ; 1.17 ; CRYSTAL STRUCTURE ANALYSIS OF THE BACILLUS CALDOLYTICUS COLD SHOCK PROTEIN BC-CSP 1RRK ; 2.00 ; CRYSTAL STRUCTURE ANALYSIS OF THE BB SEGMENT OF FACTOR B 1RTK ; 2.30 ; CRYSTAL STRUCTURE ANALYSIS OF THE BB SEGMENT OF FACTOR B COMPLEXED WITH 4-GUANIDINOBENZOIC ACID 1RS0 ; 2.60 ; CRYSTAL STRUCTURE ANALYSIS OF THE BB SEGMENT OF FACTOR B COMPLEXED WITH DI-ISOPROPYL-PHOSPHATE (DIP) 1S4U ; 2.10 ; CRYSTAL STRUCTURE ANALYSIS OF THE BETA-PROPELLER PROTEIN SKI8P 1NEP ; 1.70 ; CRYSTAL STRUCTURE ANALYSIS OF THE BOVINE NPC2 (NIEMANN-PICK C2) PROTEIN 1I7N ; 1.90 ; CRYSTAL STRUCTURE ANALYSIS OF THE C DOMAIN OF SYNAPSIN II FROM RAT BRAIN 1U13 ; 2.01 ; CRYSTAL STRUCTURE ANALYSIS OF THE C37L/C151T/C442A-TRIPLE MUTANT OF CYP51 FROM MYCOBACTERIUM TUBERCULOSIS 1Q42 ; 1.75 ; CRYSTAL STRUCTURE ANALYSIS OF THE CANDIDA ALBICANS MTR2 1KWI ; 2.19 ; CRYSTAL STRUCTURE ANALYSIS OF THE CATHELICIDIN MOTIF OF PROTEGRINS 1L0P ; 2.10 ; CRYSTAL STRUCTURE ANALYSIS OF THE COMPLEX BETWEEN PSYCHROPHILIC ALPHA AMYLASE FROM PSEUDOALTEROMONAS HALOPLANCTIS AND NITRATE 1CQP ; 2.60 ; CRYSTAL STRUCTURE ANALYSIS OF THE COMPLEX LFA-1 (CD11A) I- DOMAIN / LOVASTATIN AT 2.6 A RESOLUTION 1I7L ; 2.35 ; CRYSTAL STRUCTURE ANALYSIS OF THE COMPLEX OF THE C DOMAIN OF SYNAPSIN II FROM RAT WITH ATP 1ZOT ; 2.20 ; CRYSTAL STRUCTURE ANALYSIS OF THE CYAA/C-CAM WITH PMEAPP 1MJ4 ; 1.20 ; CRYSTAL STRUCTURE ANALYSIS OF THE CYTOCHROME B5 DOMAIN OF HUMAN SULFITE OXIDASE 1S45 ; 2.20 ; CRYSTAL STRUCTURE ANALYSIS OF THE DEOXYRIBONUCLEIC ACID QUADRUPLEX D(TGGGGT) S1 1S47 ; 2.50 ; CRYSTAL STRUCTURE ANALYSIS OF THE DEOXYRIBONUCLEIC ACID QUADRUPLEX D(TGGGGT)S2 1PTJ ; 2.61 ; CRYSTAL STRUCTURE ANALYSIS OF THE DI AND DIII COMPLEX OF TRANSHYDROGENASE WITH A THIO-NICOTINAMIDE NUCLEOTIDE ANALOGUE 1ZI6 ; 1.70 ; CRYSTAL STRUCTURE ANALYSIS OF THE DIENELACTONE HYDROLASE (C123S) MUTANT- 1.7 A 1ZIC ; 1.70 ; CRYSTAL STRUCTURE ANALYSIS OF THE DIENELACTONE HYDROLASE (C123S, R206A) MUTANT- 1.7 A 1ZI9 ; 1.50 ; CRYSTAL STRUCTURE ANALYSIS OF THE DIENELACTONE HYDROLASE (E36D, C123S) MUTANT- 1.5 A 1ZIY ; 1.90 ; CRYSTAL STRUCTURE ANALYSIS OF THE DIENELACTONE HYDROLASE MUTANT (C123S) BOUND WITH THE PMS MOIETY OF THE PROTEASE INHIBITOR, PHENYLMETHYLSULFONYL FLUORIDE (PMSF)- 1.9 A 1ZJ4 ; 1.70 ; CRYSTAL STRUCTURE ANALYSIS OF THE DIENELACTONE HYDROLASE MUTANT (E36D, C123S) BOUND WITH THE PMS MOIETY OF THE PROTEASE INHIBITOR, PHENYLMETHYLSULFONYL FLUORIDE (PMSF)- 1.7 A 1ZJ5 ; 1.70 ; CRYSTAL STRUCTURE ANALYSIS OF THE DIENELACTONE HYDROLASE MUTANT (E36D, C123S, A134S, S208G, A229V, K234R) BOUND WITH THE PMS MOIETY OF THE PROTEASE INHIBITOR, PHENYLMETHYLSULFONYL FLUORIDE (PMSF)- 1.7 A 1ZIX ; 1.80 ; CRYSTAL STRUCTURE ANALYSIS OF THE DIENELACTONE HYDROLASE MUTANT (E36D, R105H, C123S, G211D, K234N)- 1.8 A 1ZI8 ; 1.40 ; CRYSTAL STRUCTURE ANALYSIS OF THE DIENELACTONE HYDROLASE MUTANT(E36D, C123S, A134S, S208G, A229V, K234R)- 1.4 A 2CZS ; 1.50 ; CRYSTAL STRUCTURE ANALYSIS OF THE DIHEME C-TYPE CYTOCHROME DHC2 1PT9 ; 2.42 ; CRYSTAL STRUCTURE ANALYSIS OF THE DIII COMPONENT OF TRANSHYDROGENASE WITH A THIO-NICOTINAMIDE NUCLEOTIDE ANALOGUE 1J0W ; 2.50 ; CRYSTAL STRUCTURE ANALYSIS OF THE DOK-5 PTB DOMAIN 1EN4 ; 2.00 ; CRYSTAL STRUCTURE ANALYSIS OF THE E. COLI MANGANESE SUPEROXIDE DISMUTASE Q146H MUTANT 1EN6 ; 2.00 ; CRYSTAL STRUCTURE ANALYSIS OF THE E. COLI MANGANESE SUPEROXIDE DISMUTASE Q146L MUTANT 1EN5 ; 2.30 ; CRYSTAL STRUCTURE ANALYSIS OF THE E. COLI MANGANESE SUPEROXIDE DISMUTASE Y34F MUTANT 1JLL ; 2.69 ; CRYSTAL STRUCTURE ANALYSIS OF THE E197BETAA MUTANT OF E. COLI SCS 1GAW ; 2.20 ; CRYSTAL STRUCTURE ANALYSIS OF THE FERREDOXIN-NADP+ REDUCTASE FROM MAIZE LEAF 1SM4 ; 2.50 ; CRYSTAL STRUCTURE ANALYSIS OF THE FERREDOXIN-NADP+ REDUCTASE FROM PAPRIKA 1NUN ; 2.90 ; CRYSTAL STRUCTURE ANALYSIS OF THE FGF10-FGFR2B COMPLEX 1J4H ; 1.80 ; CRYSTAL STRUCTURE ANALYSIS OF THE FKBP12 COMPLEXED WITH 000107 SMALL MOLECULE 1J4I ; 1.80 ; CRYSTAL STRUCTURE ANALYSIS OF THE FKBP12 COMPLEXED WITH 000308 SMALL MOLECULE 1C16 ; 3.10 ; CRYSTAL STRUCTURE ANALYSIS OF THE GAMMA/DELTA T CELL LIGAND T22 1K33 ; 1.75 ; CRYSTAL STRUCTURE ANALYSIS OF THE GP41 CORE MUTANT 1I08 ; 2.20 ; CRYSTAL STRUCTURE ANALYSIS OF THE H30A MUTANT OF MANGANESE SUPEROXIDE DISMUTASE FROM E. COLI 1LG5 ; 1.75 ; CRYSTAL STRUCTURE ANALYSIS OF THE HCA II MUTANT T199P IN COMPLEX WITH BETA-MERCAPTOETHANOL 1FP5 ; 2.30 ; CRYSTAL STRUCTURE ANALYSIS OF THE HUMAN IGE-FC CEPSILON3- CEPSILON4 FRAGMENT. 1S31 ; 2.70 ; CRYSTAL STRUCTURE ANALYSIS OF THE HUMAN TUB PROTEIN (ISOFORM A) SPANNING RESIDUES 289 THROUGH 561 1MWO ; 2.20 ; CRYSTAL STRUCTURE ANALYSIS OF THE HYPERTHERMOSTABLE PYROCOOCUS WOESEI ALPHA-AMYLASE 1N64 ; 2.34 ; CRYSTAL STRUCTURE ANALYSIS OF THE IMMUNODOMINANT ANTIGENIC SITE ON HEPATITIS C VIRUS PROTEIN BOUND TO MAB 19D9D6 1U4N ; 2.10 ; CRYSTAL STRUCTURE ANALYSIS OF THE M211S/R215L EST2 MUTANT 1QWR ; 1.80 ; CRYSTAL STRUCTURE ANALYSIS OF THE MANNOSE 6-PHOSPHATE ISOMERASE FROM BACILLUS SUBTILIS 1IU4 ; 2.40 ; CRYSTAL STRUCTURE ANALYSIS OF THE MICROBIAL TRANSGLUTAMINASE 1ZPI ; 1.60 ; CRYSTAL STRUCTURE ANALYSIS OF THE MINOR GROOVE BINDING QUINOLINIUM QUATERNARY SALT SN 8224 COMPLEXED WITH CGCGAATTCGCG 1ZPH ; 1.80 ; CRYSTAL STRUCTURE ANALYSIS OF THE MINOR GROOVE BINDING QUINOLINIUM QUATERNARY SALT SN 8315 COMPLEXED WITH CGCGAATTCGCG 1N1X ; 1.45 ; CRYSTAL STRUCTURE ANALYSIS OF THE MONOMERIC [S- CARBOXYAMIDOMETHYL-CYS31, S-CARBOXYAMIDOMETHYL-CYS32] BOVINE SEMINAL RIBONUCLEASE 1JD9 ; 2.50 ; CRYSTAL STRUCTURE ANALYSIS OF THE MUTANT K300Q OF PSEUDOALTEROMONAS HALOPLANCTIS ALPHA-AMYLASE 1JD7 ; 2.25 ; CRYSTAL STRUCTURE ANALYSIS OF THE MUTANT K300R OF PSEUDOALTEROMONAS HALOPLANCTIS ALPHA-AMYLASE 1FNQ ; 2.60 ; CRYSTAL STRUCTURE ANALYSIS OF THE MUTANT REACTION CENTER PRO L209-> GLU FROM THE PHOTOSYNTHETIC PURPLE BACTERIUM RHODOBACTER SPHAEROIDES 1FNP ; 2.60 ; CRYSTAL STRUCTURE ANALYSIS OF THE MUTANT REACTION CENTER PRO L209-> PHE FROM THE PHOTOSYNTHETIC PURPLE BACTERIUM RHODOBACTER SPHAEROIDES 1F6N ; 2.80 ; CRYSTAL STRUCTURE ANALYSIS OF THE MUTANT REACTION CENTER PRO L209-> TYR FROM THE PHOTOSYNTHETIC PURPLE BACTERIUM RHODOBACTER SPHAEROIDES 1KDQ ; 2.55 ; CRYSTAL STRUCTURE ANALYSIS OF THE MUTANT S189D RAT CHYMOTRYPSIN 1LV1 ; 2.10 ; CRYSTAL STRUCTURE ANALYSIS OF THE NON-ACTIVE SITE MUTANT OF TETHERED HIV-1 PROTEASE TO 2.1A RESOLUTION 1T6V ; 1.70 ; CRYSTAL STRUCTURE ANALYSIS OF THE NURSE SHARK NEW ANTIGEN RECEPTOR (NAR) VARIABLE DOMAIN IN COMPLEX WITH LYSOZYME 1SQ2 ; 1.45 ; CRYSTAL STRUCTURE ANALYSIS OF THE NURSE SHARK NEW ANTIGEN RECEPTOR (NAR) VARIABLE DOMAIN IN COMPLEX WITH LYXOZYME 1YI9 ; 1.70 ; CRYSTAL STRUCTURE ANALYSIS OF THE OXIDIZED FORM OF THE M314I MUTANT OF PEPTIDYLGLYCINE ALPHA-HYDROXYLATING MONOOXYGENASE 1M21 ; 1.80 ; CRYSTAL STRUCTURE ANALYSIS OF THE PEPTIDE AMIDASE PAM IN COMPLEX WITH THE COMPETITIVE INHIBITOR CHYMOSTATIN 1FU0 ; 1.90 ; CRYSTAL STRUCTURE ANALYSIS OF THE PHOSPHO-SERINE 46 HPR FROM ENTEROCOCCUS FAECALIS 1FQ2 ; 1.20 ; CRYSTAL STRUCTURE ANALYSIS OF THE POTASSIUM FORM OF B-DEOXYRIBONUCLEIC ACID DODECAMER CGCGAATTCGCG 1QTR ; 2.32 ; CRYSTAL STRUCTURE ANALYSIS OF THE PROLYL AMINOPEPTIDASE FROM SERRATIA MARCESCENS 1VB5 ; 2.20 ; CRYSTAL STRUCTURE ANALYSIS OF THE PYROCOCCUS HORIKOSHII OT3 TRANSLATION INITIATION FACTOR EIF-2B 1HM5 ; 1.80 ; CRYSTAL STRUCTURE ANALYSIS OF THE RABBIT D-GLUCOSE 6- PHOSPHATE ISOMERASE (NO LIGAND BOUND) 1KS2 ; 1.50 ; CRYSTAL STRUCTURE ANALYSIS OF THE RPIA, STRUCTURAL GENOMICS, PROTEIN EC1268. 1S4D ; 2.70 ; CRYSTAL STRUCTURE ANALYSIS OF THE S-ADENOSYL-L-METHIONINE DEPENDENT UROPORPHYRINOGEN-III C-METHYLTRANSFERASE SUMT 1NTE ; 1.24 ; CRYSTAL STRUCTURE ANALYSIS OF THE SECOND PDZ DOMAIN OF SYNTENIN 1PN2 ; 1.95 ; CRYSTAL STRUCTURE ANALYSIS OF THE SELENOMETHIONINE LABELLED 2-ENOYL-COA HYDRATASE 2 DOMAIN OF CANDIDA TROPICALIS MULTIFUNCTIONAL ENZYME TYPE 2 1EW0 ; 1.40 ; CRYSTAL STRUCTURE ANALYSIS OF THE SENSOR DOMAIN OF RMFIXL(FERROUS FORM) 1JWO ; 2.50 ; CRYSTAL STRUCTURE ANALYSIS OF THE SH2 DOMAIN OF THE CSK HOMOLOGOUS KINASE CHK 1PL5 ; 2.50 ; CRYSTAL STRUCTURE ANALYSIS OF THE SIR4P C-TERMINAL COILED COIL 1V9I ; 2.95 ; CRYSTAL STRUCTURE ANALYSIS OF THE SITE SPECIFIC MUTANT (Q253C) OF BOVINE CARBONIC ANHYDRASE II 1DD1 ; 2.62 ; CRYSTAL STRUCTURE ANALYSIS OF THE SMAD4 ACTIVE FRAGMENT 1G94 ; 1.74 ; CRYSTAL STRUCTURE ANALYSIS OF THE TERNARY COMPLEX BETWEEN PSYCHROPHILIC ALPHA AMYLASE FROM PSEUDOALTEROMONAS HALOPLANCTIS IN COMPLEX WITH A HEPTA-SACCHARIDE AND A TRIS MOLECULE 1ZZI ; 1.80 ; CRYSTAL STRUCTURE ANALYSIS OF THE THIRD KH DOMAIN OF HNRNP K IN COMPLEX WITH SSDNA 1ILV ; 2.00 ; CRYSTAL STRUCTURE ANALYSIS OF THE TM107 1J4G ; 2.00 ; CRYSTAL STRUCTURE ANALYSIS OF THE TRICHOSANTHIN DELTA C7 1LNS ; 2.20 ; CRYSTAL STRUCTURE ANALYSIS OF THE X-PROLYL DIPEPTIDYL AMINOPEPTIDASE FROM LACTOCOCCUS LACTIS 1Q32 ; 2.03 ; CRYSTAL STRUCTURE ANALYSIS OF THE YEAST TYROSYL-DEOXYRIBONUCLEIC ACID PHOSPHODIESTERASE 1JI1 ; 1.60 ; CRYSTAL STRUCTURE ANALYSIS OF THERMOACTINOMYCES VULGARIS R- 47 ALPHA-AMYLASE 1 1Z9G ; 1.70 ; CRYSTAL STRUCTURE ANALYSIS OF THERMOLYSIN COMPLEXED WITH THE INHIBITOR (R)-RETRO-THIORPHAN 1ZDP ; 1.70 ; CRYSTAL STRUCTURE ANALYSIS OF THERMOLYSIN COMPLEXED WITH THE INHIBITOR (S)-THIORPHAN 1V98 ; 1.82 ; CRYSTAL STRUCTURE ANALYSIS OF THIOREDOXIN FROM THERMUS THERMOPHILUS 1M6Y ; 1.90 ; CRYSTAL STRUCTURE ANALYSIS OF TM0872, A PUTATIVE SAM- DEPENDENT METHYLTRANSFERASE, COMPLEXED WITH SAH 1N2X ; 1.90 ; CRYSTAL STRUCTURE ANALYSIS OF TM0872, A PUTATIVE SAM- DEPENDENT METHYLTRANSFERASE, COMPLEXED WITH SAM 1VEP ; 2.06 ; CRYSTAL STRUCTURE ANALYSIS OF TRIPLE (T47M/Y164E/T328N) /MALTOSE OF BACILLUS CEREUS BETA-AMYLASE AT PH 6.5 1TYJ ; 1.60 ; CRYSTAL STRUCTURE ANALYSIS OF TYPE II COHESIN A11 FROM BACTEROIDES CELLULOSOLVENS 1FX5 ; 2.20 ; CRYSTAL STRUCTURE ANALYSIS OF ULEX EUROPAEUS LECTIN I 1YBD ; 2.60 ; CRYSTAL STRUCTURE ANALYSIS OF URIDYLATE KINASE FROM NEISSERIA MENINGITIDIS 1CW0 ; 2.30 ; CRYSTAL STRUCTURE ANALYSIS OF VERY SHORT PATCH REPAIR (VSR) ENDONUCLEASE IN COMPLEX WITH A DUPLEX DEOXYRIBONUCLEIC ACID 1JTE ; 2.00 ; CRYSTAL STRUCTURE ANALYSIS OF VP39 F180W MUTANT 1JTF ; 2.60 ; CRYSTAL STRUCTURE ANALYSIS OF VP39-F180W MUTANT AND M7GPPPG COMPLEX 1VEN ; 2.02 ; CRYSTAL STRUCTURE ANALYSIS OF Y164E/MALTOSE OF BACILUS CEREUS BETA-AMYLASE AT PH 4.6 1VEO ; 2.12 ; CRYSTAL STRUCTURE ANALYSIS OF Y164F/MALTOSE OF BACILLUS CEREUS BETA-AMYLASE AT PH 4.6 1PV1 ; 2.30 ; CRYSTAL STRUCTURE ANALYSIS OF YEAST HYPOTHETICAL PROTEIN: YJG8_YEAST 1NZJ ; 1.50 ; CRYSTAL STRUCTURE AND ACTIVITY STUDIES OF ESCHERICHIA COLI YADB ORF 1GME ; 2.70 ; CRYSTAL STRUCTURE AND ASSEMBLY OF AN EUKARYOTIC SMALL HEAT SHOCK PROTEIN 2BOL ; 2.50 ; CRYSTAL STRUCTURE AND ASSEMBLY OF TSP36, A METAZOAN SMALL HEAT SHOCK PROTEIN 1JTH ; 2.00 ; CRYSTAL STRUCTURE AND BIOPHYSICAL PROPERTIES OF A COMPLEX BETWEEN THE N-TERMINAL REGION OF SNAP25 AND THE SNARE REGION OF SYNTAXIN 1A 2BTN ; 2.00 ; CRYSTAL STRUCTURE AND CATALYTIC MECHANISM OF THE QUORUM- QUENCHING N-ACYL HOMOSERINE LACTONE HYDROLASE 1OVN ; 1.90 ; CRYSTAL STRUCTURE AND FUNCTIONAL ANALYSIS OF DROSOPHILA WIND-- A PDI-RELATED PROTEIN 468D ; 1.80 ; CRYSTAL STRUCTURE AND IMPROVED ANTISENSE PROPERTIES OF 2'-O- (2-METHOXYETHYL)-RIBONUCLEIC ACID 469D ; 1.70 ; CRYSTAL STRUCTURE AND IMPROVED ANTISENSE PROPERTIES OF 2'-O- (2-METHOXYETHYL)-RIBONUCLEIC ACID 470D ; 1.95 ; CRYSTAL STRUCTURE AND IMPROVED ANTISENSE PROPERTIES OF 2'-O- (2-METHOXYETHYL)-RIBONUCLEIC ACID 471D ; 2.70 ; CRYSTAL STRUCTURE AND IMPROVED ANTISENSE PROPERTIES OF 2'-O- (2-METHOXYETHYL)-RIBONUCLEIC ACID 1RQP ; 1.80 ; CRYSTAL STRUCTURE AND MECHANISM OF A BACTERIAL FLUORINATING ENZYME 1RQR ; 2.67 ; CRYSTAL STRUCTURE AND MECHANISM OF A BACTERIAL FLUORINATING ENZYME, PRODUCT COMPLEX 1JDW ; 1.90 ; CRYSTAL STRUCTURE AND MECHANISM OF L-ARGININE: GLYCINE AMIDINOTRANSFERASE: A MITOCHONDRIAL ENZYME INVOLVED IN CREATINE BIOSYNTHESIS 2JDW ; 2.10 ; CRYSTAL STRUCTURE AND MECHANISM OF L-ARGININE: GLYCINE AMIDINOTRANSFERASE: A MITOCHONDRIAL ENZYME INVOLVED IN CREATINE BIOSYNTHESIS 3JDW ; 2.40 ; CRYSTAL STRUCTURE AND MECHANISM OF L-ARGININE: GLYCINE AMIDINOTRANSFERASE: A MITOCHONDRIAL ENZYME INVOLVED IN CREATINE BIOSYNTHESIS 4JDW ; 2.50 ; CRYSTAL STRUCTURE AND MECHANISM OF L-ARGININE: GLYCINE AMIDINOTRANSFERASE: A MITOCHONDRIAL ENZYME INVOLVED IN CREATINE BIOSYNTHESIS 2ADF ; 1.90 ; CRYSTAL STRUCTURE AND PARATOPE DETERMINATION OF 82D6A3, AN ANTITHROMBOTIC ANTIBODY DIRECTED AGAINST THE VON WILLEBRAND FACTOR A3-DOMAIN 1U08 ; 2.35 ; CRYSTAL STRUCTURE AND REACTIVITY OF YBDL FROM ESCHERICHIA COLI IDENTIFY A METHIONINE AMINOTRANSFERASE FUNCTION. 1J93 ; 2.30 ; CRYSTAL STRUCTURE AND SUBSTRATE BINDING MODELING OF THE UROPORPHYRINOGEN-III DECARBOXYLASE FROM NICOTIANA TABACUM: IMPLICATIONS FOR THE CATALYTIC MECHANISM 2CWS ; 1.00 ; CRYSTAL STRUCTURE AT 1.0 A OF ALGINATE LYASE A1-II', A MEMBER OF POLYSACCHARIDE LYASE FAMILY-7 1M2D ; 1.05 ; CRYSTAL STRUCTURE AT 1.05 ANGSTROMS RESOLUTION OF THE CYS59SER VARIANT OF THE THIOREDOXIN-LIKE [2FE-2S] FERREDOXIN FROM AQUIFEX AEOLICUS 1M2B ; 1.25 ; CRYSTAL STRUCTURE AT 1.25 ANGSTROMS RESOLUTION OF THE CYS55SER VARIANT OF THE THIOREDOXIN-LIKE [2FE-2S] FERREDOXIN FROM AQUIFEX AEOLICUS 2CYG ; 1.45 ; CRYSTAL STRUCTURE AT 1.45- RESOLUTION OF THE MAJOR ALLERGEN ENDO-BETA-1,3-GLUCANASE OF BANANA AS A MOLECULAR BASIS FOR THE LATEX-FRUIT SYNDROME 1M2A ; 1.50 ; CRYSTAL STRUCTURE AT 1.5 ANGSTROMS RESOLUTION OF THE WILD TYPE THIOREDOXIN-LIKE [2FE-2S] FERREDOXIN FROM AQUIFEX AEOLICUS 1KGS ; 1.50 ; CRYSTAL STRUCTURE AT 1.50 A OF AN OMPR/PHOB HOMOLOG FROM THERMOTOGA MARITIMA 1HT6 ; 1.50 ; CRYSTAL STRUCTURE AT 1.5A RESOLUTION OF THE BARLEY ALPHA- AMYLASE ISOZYME 1 1IQ9 ; 1.80 ; CRYSTAL STRUCTURE AT 1.8 A OF TOXIN A FROM NAJA NIGRICOLLIS VENOM 1RKX ; 1.80 ; CRYSTAL STRUCTURE AT 1.8 ANGSTROM OF CDP-D-GLUCOSE 4,6- DEHYDRATASE FROM YERSINIA PSEUDOTUBERCULOSIS 1MO1 ; 1.80 ; CRYSTAL STRUCTURE AT 1.8 ANGSTROMS OF SELENO METHIONYLED CRH, THE BACILLUS SUBTILIS CATABOLITE REPRESSION CONTAINING PROTEIN CRH REVEALS AN UNEXPECTED SWAPPING DOMAIN AS AN UNTERTWINNED DIMER 1MU4 ; 1.80 ; CRYSTAL STRUCTURE AT 1.8 ANGSTROMS OF THE BACILLUS SUBTILIS CATABOLITE REPRESSION HISTIDINE CONTAINING PROTEIN (CRH) 1MZN ; 1.90 ; CRYSTAL STRUCTURE AT 1.9 ANGSTROEMS RESOLUTION OF THE HOMODIMER OF HUMAN RXR ALPHA LIGAND BINDING DOMAIN BOUND TO THE SYNTHETIC AGONIST COMPOUND BMS 649 AND A COACTIVATOR PEPTIDE 1DFO ; 2.40 ; CRYSTAL STRUCTURE AT 2.4 ANGSTROM RESOLUTION OF E. COLI SERINE HYDROXYMETHYLTRANSFERASE IN COMPLEX WITH GLYCINE AND 5-FORMYL TETRAHYDROFOLATE 1EKM ; 2.50 ; CRYSTAL STRUCTURE AT 2.5 A RESOLUTION OF ZINC-SUBSTITUTED COPPER AMINE OXIDASE OF HANSENULA POLYMORPHA EXPRESSED IN ESCHERICHIA COLI 1JVQ ; 2.60 ; CRYSTAL STRUCTURE AT 2.6A OF THE TERNARY COMPLEX BETWEEN ANTITHROMBIN, A P14-P8 REACTIVE LOOP PEPTIDE, AND AN EXOGENOUS TETRAPEPTIDE 1JJC ; 2.60 ; CRYSTAL STRUCTURE AT 2.6A RESOLUTION OF PHENYLALANYL-TRNA SYNTHETASE COMPLEXED WITH PHENYLALANYL-ADENYLATE IN THE PRESENCE OF MANGANESE 1DEE ; 2.70 ; CRYSTAL STRUCTURE AT 2.7A RESOLUTION OF A COMPLEX BETWEEN A STAPHYLOCOCCUS AUREUS DOMAIN AND A FAB FRAGMENT OF A HUMAN IGM ANTIBODY 1TDZ ; 1.80 ; CRYSTAL STRUCTURE COMPLEX BETWEEN THE LACTOCOCCUS LACTIS FPG (MUTM) AND A FAPY-DG CONTAINING DEOXYRIBONUCLEIC ACID 1NNJ ; 1.90 ; CRYSTAL STRUCTURE COMPLEX BETWEEN THE LACTOCOCCUS LACTIS FPG AND AN ABASIC SITE CONTAINING DEOXYRIBONUCLEIC ACID 1XC8 ; 1.95 ; CRYSTAL STRUCTURE COMPLEX BETWEEN THE WILD-TYPE LACTOCOCCUS LACTIS FPG (MUTM) AND A FAPY-DG CONTAINING DEOXYRIBONUCLEIC ACID 1GYC ; 1.90 ; CRYSTAL STRUCTURE DETERMINATION AT ROOM TEMPERATURE OF A LACCASE FROM TRAMETES VERSICOLOR IN ITS OXIDISED FORM CONTAINING A FULL COMPLEMENT OF COPPER IONS 1RTT ; 1.28 ; CRYSTAL STRUCTURE DETERMINATION OF A PUTATIVE NADH- DEPENDENT REDUCTASE USING SULFUR ANOMALOUS SIGNAL 1JFL ; 1.90 ; CRYSTAL STRUCTURE DETERMINATION OF ASPARTATE RACEMASE FROM AN ARCHAEA 1EEY ; 2.25 ; CRYSTAL STRUCTURE DETERMINATION OF HLA A2 COMPLEXED TO PEPTIDE GP2 WITH THE SUBSTITUTION (I2L/V5L/L9V) 1EEZ ; 2.30 ; CRYSTAL STRUCTURE DETERMINATION OF HLA-A2.1 COMPLEXED TO GP2 PEPTIDE VARIANT(I2L/V5L) 1QPW ; 1.80 ; CRYSTAL STRUCTURE DETERMINATION OF PORCINE HEMOGLOBIN AT 1.8A RESOLUTION 1NJJ ; 2.45 ; CRYSTAL STRUCTURE DETERMINATION OF T. BRUCEI ORNITHINE DECARBOXYLASE BOUND TO D-ORNITHINE AND TO G418 1S61 ; 2.10 ; CRYSTAL STRUCTURE OF "TRUNCATED" HEMOGLOBIN N (HBN) FROM MYCOBACTERIUM TUBERCULOSIS, SOAKED WITH BUTYL-ISOCYANIDE 1S56 ; 2.43 ; CRYSTAL STRUCTURE OF "TRUNCATED" HEMOGLOBIN N (HBN) FROM MYCOBACTERIUM TUBERCULOSIS, SOAKED WITH XE ATOMS 1N1B ; 2.00 ; CRYSTAL STRUCTURE OF (+)-BORNYL DIPHOSPHATE SYNTHASE FROM SAGE 2B8M ; 1.70 ; CRYSTAL STRUCTURE OF (1499583) FROM METHANOCOCCUS JANNASCHII AT 1.70 A RESOLUTION 2FEA ; 2.00 ; CRYSTAL STRUCTURE OF (2633731) FROM BACILLUS SUBTILIS AT 2.00 A RESOLUTION 1ZTV ; 3.10 ; CRYSTAL STRUCTURE OF (29342463) FROM ENTEROCOCCUS FAECALIS V583 AT 3.10 A RESOLUTION 2EVR ; 1.60 ; CRYSTAL STRUCTURE OF (53686717) FROM NOSTOC PUNCTIFORME PCC 73102 AT 1.60 A RESOLUTION 1P92 ; 2.10 ; CRYSTAL STRUCTURE OF (H79A)DTXR 1XCV ; 2.10 ; CRYSTAL STRUCTURE OF (H79AC102D)DTXR COMPLEXED WITH NICKEL(II) 2A6B ; 1.70 ; CRYSTAL STRUCTURE OF (NP_358222.1) FROM STREPTOCOCCUS PNEUMONIAE R6 AT 1.70 A RESOLUTION 2A9V ; 2.24 ; CRYSTAL STRUCTURE OF (NP_394403.1) FROM THERMOPLASMA ACIDOPHILUM AT 2.45 A RESOLUTION 2ETS ; 2.25 ; CRYSTAL STRUCTURE OF (NP_646154.1) FROM STAPHYLOCOCCUS AUREUS MW2 AT 2.25 A RESOLUTION 2A2M ; 1.88 ; CRYSTAL STRUCTURE OF (NP_812058.1) FROM BACTERIODES THETAIOTAOMICRON VPI-5482 AT 1.88 A RESOLUTION 2A2O ; 2.16 ; CRYSTAL STRUCTURE OF (NP_812058.1) FROM BACTERIODES THETAIOTAOMICRON VPI-5482 AT 2.16 A RESOLUTION 2A6C ; 1.90 ; CRYSTAL STRUCTURE OF (NP_841403.1) FROM NITROSOMONAS EUROPAEA AT 1.90 A RESOLUTION 1ZG8 ; 2.00 ; CRYSTAL STRUCTURE OF (R)-2-(3-{[AMINO(IMINO) METHYL]AMINO}PHENYL)-3-SULFANYLPROPANOIC ACID BOUND TO ACTIVATED PORCINE PANCREATIC CARBOXYPEPTIDASE B 1JA9 ; 1.50 ; CRYSTAL STRUCTURE OF 1,3,6,8-TETRAHYDROXYNAPHTHALENE REDUCTASE IN COMPLEX WITH NADPH AND PYROQUILON 1U0M ; 2.22 ; CRYSTAL STRUCTURE OF 1,3,6,8-TETRAHYDROXYNAPHTHALENE SYNTHASE (THNS) FROM STREPTOMYCES COELICOLOR A3(2): A BACTERIAL TYPE III POLYKETIDE SYNTHASE (PKS) PROVIDES INSIGHTS INTO ENZYMATIC CONTROL OF REACTIVE POLYKETIDE INTERMEDIATES 1FGG ; 2.30 ; CRYSTAL STRUCTURE OF 1,3-GLUCURONYLTRANSFERASE I (GLCAT-I) COMPLEXED WITH GAL-GAL-XYL, UDP, AND MN2+ 1M2P ; 2.00 ; CRYSTAL STRUCTURE OF 1,8-DI-HYDROXY-4-NITRO- ANTHRAQUINONE/CK2 KINASE COMPLEX 1M2Q ; 1.79 ; CRYSTAL STRUCTURE OF 1,8-DI-HYDROXY-4-NITRO-XANTEN-9- ONE/CK2 KINASE COMPLEX 1TZJ ; 1.99 ; CRYSTAL STRUCTURE OF 1-AMINOCYCLOPROPANE-1-CARBOXYLATE DEAMINASE COMPLEXED WITH D-VINYL GLYCINE 1TZK ; 2.00 ; CRYSTAL STRUCTURE OF 1-AMINOCYCLOPROPANE-1-CARBOXYLATE- DEAMINASE COMPLEXED WITH ALPHA-KETO-BUTYRATE 1TZ2 ; 2.10 ; CRYSTAL STRUCTURE OF 1-AMINOCYCLOPROPANE-1-CARBOYXLATE DEAMINASE COMPLEXED WITH ACC 1TYZ ; 2.00 ; CRYSTAL STRUCTURE OF 1-AMINOCYCLOPROPANE-1-CARBOYXLATE DEAMINASE FROM PSEUDOMONAS 1R0K ; 1.91 ; CRYSTAL STRUCTURE OF 1-DEOXY-D-XYLULOSE 5-PHOSPHATE REDUCTOISOMERASE FROM ZYMOMONAS MOBILIS 1JVS ; 2.20 ; CRYSTAL STRUCTURE OF 1-DEOXY-D-XYLULOSE 5-PHOSPHATE REDUCTOISOMERASE; A TARGET ENZYME FOR ANTIMALARIAL DRUGS 2AMF ; 2.20 ; CRYSTAL STRUCTURE OF 1-PYRROLINE-5-CARBOXYLATE REDUCTASE FROM HUMAN PATHOGEN STREPTOCOCCUS PYOGENES 1ICS ; 2.30 ; CRYSTAL STRUCTURE OF 12-OXOPHYTODIENOATE REDUCTASE 1 FROM TOMATO 1ICQ ; 2.00 ; CRYSTAL STRUCTURE OF 12-OXOPHYTODIENOATE REDUCTASE 1 FROM TOMATO COMPLEXED WITH 9R,13R-OPDA 1ICP ; 1.90 ; CRYSTAL STRUCTURE OF 12-OXOPHYTODIENOATE REDUCTASE 1 FROM TOMATO COMPLEXED WITH PEG400 2B05 ; 2.55 ; CRYSTAL STRUCTURE OF 14-3-3 GAMMA IN COMPLEX WITH A PHOSPHOSERINE PEPTIDE 1Z7F ; 2.10 ; CRYSTAL STRUCTURE OF 16 BASE PAIR RIBONUCLEIC ACID DUPLEX CONTAINING A C- A MISMATCH 1JTV ; 1.54 ; CRYSTAL STRUCTURE OF 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 COMPLEXED WITH TESTOSTERONE 1C0G ; 2.00 ; CRYSTAL STRUCTURE OF 1:1 COMPLEX BETWEEN GELSOLIN SEGMENT 1 AND A DICTYOSTELIUM/TETRAHYMENA CHIMERA ACTIN (MUTANT 228: Q228K/T229A/A230Y/E360H) 1VGJ ; 1.94 ; CRYSTAL STRUCTURE OF 2'-5' RIBONUCLEIC ACID LIGASE FROM PYROCOCCUS HORIKOSHII 1I7J ; 1.19 ; CRYSTAL STRUCTURE OF 2'-O-ME(CGCGCG)2: AN RIBONUCLEIC ACID DUPLEX AT 1.19 A RESOLUTION. 2-METHYL-2,4-PENTANEDIOL AND MAGNESIUM BINDING. 310D ; 1.30 ; CRYSTAL STRUCTURE OF 2'-O-ME(CGCGCG)2: AN RIBONUCLEIC ACID DUPLEX AT 1.3 A RESOLUTION. HYDRATION PATTERN OF 2'-O-METHYLATED RIBONUCLEIC ACID 1KW3 ; 1.45 ; CRYSTAL STRUCTURE OF 2,3-DIHYDROXYBIPHENYAL DIOXYGENASE (BPHC) AT 1.45 A RESOLUTION 1LKD ; 1.70 ; CRYSTAL STRUCTURE OF 2,3-DIHYDROXYBIPHENYL 1,2-DIOXYGENASE (DHBD) COMPLEXED WITH 2',6'-DICL DIHYDROXYBIPHENYL (DHB) 1LGT ; 1.70 ; CRYSTAL STRUCTURE OF 2,3-DIHYDROXYBIPHENYL 1,2-DIOXYGENASE (DHBD) COMPLEXED WITH 2'-CL DIHYDROXYBIPHENYL (DHB) 1KMY ; 2.00 ; CRYSTAL STRUCTURE OF 2,3-DIHYDROXYBIPHENYL 1,2-DIOXYGENASE COMPLEXED WITH 2,3-DIHYDROXYBIPHENYL UNDER ANAEROBIC CONDITION 1KNF ; 1.90 ; CRYSTAL STRUCTURE OF 2,3-DIHYDROXYBIPHENYL 1,2-DIOXYGENASE COMPLEXED WITH 3-METHYL CATECHOL UNDER ANAEROBIC CONDITION 1KND ; 1.90 ; CRYSTAL STRUCTURE OF 2,3-DIHYDROXYBIPHENYL 1,2-DIOXYGENASE COMPLEXED WITH CATECHOL UNDER ANAEROBIC CONDITION 1KW6 ; 1.45 ; CRYSTAL STRUCTURE OF 2,3-DIHYDROXYBIPHENYL DIOXYGENASE (BPHC) IN COMPLEX WITH 2,3-DIHYDROXYBIPHENYL AT 1.45 A RESOLUTION 1KW9 ; 1.95 ; CRYSTAL STRUCTURE OF 2,3-DIHYDROXYBIPHENYL DIOXYGENASE (BPHC) IN COMPLEX WITH 2,3-DIHYDROXYBIPHENYL AT 2.0A RESOLUTION 1VP5 ; 2.40 ; CRYSTAL STRUCTURE OF 2,5-DIKETO-D-GLUCONIC ACID REDUCTASE (TM1009) FROM THERMOTOGA MARITIMA AT 2.40 A RESOLUTION 1ZG7 ; 1.75 ; CRYSTAL STRUCTURE OF 2-(5-{[AMINO(IMINO)METHYL]AMINO}-2- CHLOROPHENYL)-3-SULFANYLPROPANOIC ACID BOUND TO ACTIVATED PORCINE PANCREATIC CARBOXYPEPTIDASE B 1M32 ; 2.20 ; CRYSTAL STRUCTURE OF 2-AMINOETHYLPHOSPHONATE TRANSAMINASE 1T0D ; 2.20 ; CRYSTAL STRUCTURE OF 2-AMINOPURINE LABELLED BACTERIAL DECODING SITE RIBONUCLEIC ACID 1T0E ; 1.70 ; CRYSTAL STRUCTURE OF 2-AMINOPURINE LABELLED BACTERIAL DECODING SITE RIBONUCLEIC ACID 1KNK ; 2.80 ; CRYSTAL STRUCTURE OF 2-C-METHYL-D-ERYTHRITOL 2,4- CYCLODIPHOSPHATE SYNTHASE (ISPF) FROM E. COLI INVOLVED IN MEVALONATE-INDEPENDENT ISOPRENOID BIOSYNTHESIS 1VPA ; 2.67 ; CRYSTAL STRUCTURE OF 2-C-METHYL-D-ERYTHRITOL 4-PHOSPHATE CYTIDYLYLTRANSFERASE (TM1393) FROM THERMOTOGA MARITIMA AT 2.67 A RESOLUTION 1M5A ; 1.20 ; CRYSTAL STRUCTURE OF 2-CO(2+)-INSULIN AT 1.2A RESOLUTION 1VLW ; 2.30 ; CRYSTAL STRUCTURE OF 2-DEHYDRO-3-DEOXYPHOSPHOGLUCONATE ALDOLASE/4-HYDROXY-2-OXOGLUTARATE ALDOLASE (TM0066) FROM THERMOTOGA MARITIMA AT 2.30 A RESOLUTION 1PN4 ; 2.35 ; CRYSTAL STRUCTURE OF 2-ENOYL-COA HYDRATASE 2 DOMAIN OF CANDIDA TROPICALIS MULTIFUNCTIONAL ENZYME TYPE 2 COMPLEXED WITH (3R)-HYDROXYDECANOYL-COA. 1WLY ; 1.30 ; CRYSTAL STRUCTURE OF 2-HALOACRYLATE REDUCTASE 1SV6 ; 2.90 ; CRYSTAL STRUCTURE OF 2-HYDROXYPENTADIENOIC ACID HYDRATASE FROM ESCHERICHIA COLI 1MXS ; 2.20 ; CRYSTAL STRUCTURE OF 2-KETO-3-DEOXY-6-PHOSPHOGLUCONATE (KDPG) ALDOLASE FROM PSEUDOMONAS PUTIDA. 1J5V ; 2.30 ; CRYSTAL STRUCTURE OF 2-KETO-3-DEOXYGLUCONATE KINASE (TM0067) FROM THERMOTOGA MARITIMA AT 2.3 A RESOLUTION 1SZQ ; 2.70 ; CRYSTAL STRUCTURE OF 2-METHYLCITRATE DEHYDRATASE 1UJQ ; 2.10 ; CRYSTAL STRUCTURE OF 2-METHYLISOCITRATE LYASE (PRPB) FROM SALMONELLA ENTERICA SEROVAR TYPHIMURIUM 1VHA ; 2.35 ; CRYSTAL STRUCTURE OF 2C-METHYL-D-ERYTHRITOL 2,4- CYCLODIPHOSPHATE SYNTHASE 1T0A ; 1.60 ; CRYSTAL STRUCTURE OF 2C-METHYL-D-ERYTHRITOL-2,4- CYCLODIPHOSPHATE SYNTHASE FROM SHEWANELLA ONEIDENSIS 1RFK ; 1.25 ; CRYSTAL STRUCTURE OF 2FE2S FERREDOXIN FROM THERMOPHILIC CYANOBACTERIUM MASTIGOCLADUS LAMINOSUS 1J7L ; 2.20 ; CRYSTAL STRUCTURE OF 3',5"-AMINOGLYCOSIDE PHOSPHOTRANSFERASE TYPE IIIA ADP COMPLEX 1L8T ; 2.40 ; CRYSTAL STRUCTURE OF 3',5"-AMINOGLYCOSIDE PHOSPHOTRANSFERASE TYPE IIIA ADP KANAMYCIN A COMPLEX 2B0Q ; 2.70 ; CRYSTAL STRUCTURE OF 3',5"-AMINOGLYCOSIDE PHOSPHOTRANSFERASE TYPE IIIA ADP NEOMYCIN B COMPLEX 1J7U ; 2.40 ; CRYSTAL STRUCTURE OF 3',5"-AMINOGLYCOSIDE PHOSPHOTRANSFERASE TYPE IIIA AMPPNP COMPLEX 1J7I ; 3.20 ; CRYSTAL STRUCTURE OF 3',5"-AMINOGLYCOSIDE PHOSPHOTRANSFERASE TYPE IIIA APOENZYME 1G57 ; 1.40 ; CRYSTAL STRUCTURE OF 3,4-DIHYDROXY-2-BUTANONE 4-PHOSPHATE SYNTHASE 1K49 ; 1.50 ; CRYSTAL STRUCTURE OF 3,4-DIHYDROXY-2-BUTANONE 4-PHOSPHATE SYNTHASE (CATION FREE FORM) 1G58 ; 1.55 ; CRYSTAL STRUCTURE OF 3,4-DIHYDROXY-2-BUTANONE 4-PHOSPHATE SYNTHASE GOLD DERIVATIVE 1K4O ; 1.10 ; CRYSTAL STRUCTURE OF 3,4-DIHYDROXY-2-BUTANONE 4-PHOSPHATE SYNTHASE IN COMPLEX WITH ONE MANGANESE, AND A GLYCEROL 1K4I ; 0.98 ; CRYSTAL STRUCTURE OF 3,4-DIHYDROXY-2-BUTANONE 4-PHOSPHATE SYNTHASE IN COMPLEX WITH TWO MAGNESIUM IONS 1K4L ; 1.60 ; CRYSTAL STRUCTURE OF 3,4-DIHYDROXY-2-BUTANONE 4-PHOSPHATE SYNTHASE IN COMPLEX WITH TWO MANGANESE IONS 1K4P ; 1.00 ; CRYSTAL STRUCTURE OF 3,4-DIHYDROXY-2-BUTANONE 4-PHOSPHATE SYNTHASE IN COMPLEX WITH ZINC IONS 1TKS ; 1.60 ; CRYSTAL STRUCTURE OF 3,4-DIHYDROXY-2-BUTANONE 4-PHOSPHATE SYNTHASE OF CANDIDA ALBICANS 1TKU ; 1.66 ; CRYSTAL STRUCTURE OF 3,4-DIHYDROXY-2-BUTANONE 4-PHOSPHATE SYNTHASE OF CANDIDA ALBICANS IN COMPLEX WITH RIBULOSE-5- PHOSPHATE 1B9H ; 2.00 ; CRYSTAL STRUCTURE OF 3-AMINO-5-HYDROXYBENZOIC ACID (AHBA) SYNTHASE 1B9I ; 2.00 ; CRYSTAL STRUCTURE OF 3-AMINO-5-HYDROXYBENZOIC ACID (AHBA) SYNTHASE 1F8M ; 1.80 ; CRYSTAL STRUCTURE OF 3-BROMOPYRUVATE MODIFIED ISOCITRATE LYASE (ICL) FROM MYCOBACTERIUM TUBERCULOSIS 1RE5 ; 2.60 ; CRYSTAL STRUCTURE OF 3-CARBOXY-CIS,CIS-MUCONATE LACTONIZING ENZYME FROM PSEUDOMONAS PUTIDA 1MQ5 ; 2.10 ; CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO-2-[[(4- CHLOROPHENYL)AMINO]CARBONYL]PHENYL]-4-[(4-METHYL-1- PIPERAZINYL)METHYL]-2-THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA 1MQ6 ; 2.10 ; CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO-2-[[(5-CHLORO-2- PYRIDINYL)AMINO]CARBONYL]-6-METHOXYPHENYL]-4-[[(4,5- DIHYDRO-2-OXAZOLYL)METHYLAMINO]METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA 1L9W ; 2.10 ; CRYSTAL STRUCTURE OF 3-DEHYDROQUINASE FROM SALMONELLA TYPHI COMPLEXED WITH REACTION PRODUCT 1NUA ; 2.85 ; CRYSTAL STRUCTURE OF 3-DEHYDROQUINATE SYNTHASE (DHQS) IN COMPLEX WITH ZN2+ 1NVA ; 2.62 ; CRYSTAL STRUCTURE OF 3-DEHYDROQUINATE SYNTHASE (DHQS) IN COMPLEX WITH ZN2+ AND ADP 1NVB ; 2.70 ; CRYSTAL STRUCTURE OF 3-DEHYDROQUINATE SYNTHASE (DHQS) IN COMPLEX WITH ZN2+ AND CARBAPHOSPHONATE 1NVD ; 2.51 ; CRYSTAL STRUCTURE OF 3-DEHYDROQUINATE SYNTHASE (DHQS) IN COMPLEX WITH ZN2+ AND CARBAPHOSPHONATE 1NRX ; 2.90 ; CRYSTAL STRUCTURE OF 3-DEHYDROQUINATE SYNTHASE (DHQS) IN COMPLEX WITH ZN2+ AND NAD 1NVE ; 2.58 ; CRYSTAL STRUCTURE OF 3-DEHYDROQUINATE SYNTHASE (DHQS) IN COMPLEX WITH ZN2+ AND NAD 1NVF ; 2.80 ; CRYSTAL STRUCTURE OF 3-DEHYDROQUINATE SYNTHASE (DHQS) IN COMPLEX WITH ZN2+, ADP AND CARBAPHOSPHONATE 1NR5 ; 2.10 ; CRYSTAL STRUCTURE OF 3-DEHYDROQUINATE SYNTHASE (DHQS) IN COMPLEX WITH ZN2+, NAD AND CARBAPHOSPHONATE 1RZM ; 2.20 ; CRYSTAL STRUCTURE OF 3-DEOXY-D-ARABINO-HEPTULOSONATE-7- PHOSPHATE SYNTHASE (DAHPS) FROM THERMOTOGA MARITIMA COMPLEXED WITH CD2+, PEP AND E4P 1TVZ ; 2.00 ; CRYSTAL STRUCTURE OF 3-HYDROXY-3-METHYLGLUTARYL-COENZYME A SYNTHASE FROM STAPHYLOCOCCUS AUREUS 1ZEJ ; 2.00 ; CRYSTAL STRUCTURE OF 3-HYDROXYACYL-COA DEHYDROGENASE (HBD- 9) (NP_070841.1) FROM ARCHAEOGLOBUS FULGIDUS AT 2.00 A RESOLUTION 1YFU ; 1.90 ; CRYSTAL STRUCTURE OF 3-HYDROXYANTHRANILATE-3,4-DIOXYGENASE FROM RALSTONIA METALLIDURANS 1YFY ; 3.20 ; CRYSTAL STRUCTURE OF 3-HYDROXYANTHRANILATE-3,4-DIOXYGENASE FROM RALSTONIA METALLIDURANS COMPLEXED WITH 3- HYDROXYANTHRANILIC ACID 1YFX ; 2.00 ; CRYSTAL STRUCTURE OF 3-HYDROXYANTHRANILATE-3,4-DIOXYGENASE FROM RALSTONIA METALLIDURANS COMPLEXED WITH 4-CHLORO-3- HYDROXYANTHRANILIC ACID AND NO 1YFW ; 2.00 ; CRYSTAL STRUCTURE OF 3-HYDROXYANTHRANILATE-3,4-DIOXYGENASE FROM RALSTONIA METALLIDURANS COMPLEXED WITH 4-CHLORO-3- HYDROXYANTHRANILIC ACID AND O2 1VLC ; 1.90 ; CRYSTAL STRUCTURE OF 3-ISOPROPYLMALATE DEHYDROGENASE (TM0556) FROM THERMOTOGA MARITIMA AT 1.90 A RESOLUTION 1KV8 ; 1.62 ; CRYSTAL STRUCTURE OF 3-KETO-L-GULONATE 6-PHOSPHATE DECARBOXYLASE 1XBZ ; 1.80 ; CRYSTAL STRUCTURE OF 3-KETO-L-GULONATE 6-PHOSPHATE DECARBOXYLASE E112D/R139V/T169A MUTANT WITH BOUND L- XYLULOSE 5-PHOSPHATE 1XBV ; 1.66 ; CRYSTAL STRUCTURE OF 3-KETO-L-GULONATE 6-PHOSPHATE DECARBOXYLASE WITH BOUND D-RIBULOSE 5-PHOSPHATE 1KW1 ; 2.20 ; CRYSTAL STRUCTURE OF 3-KETO-L-GULONATE 6-PHOSPHATE DECARBOXYLASE WITH BOUND L-GULONATE 6-PHOSPHATE 1OZ3 ; 1.85 ; CRYSTAL STRUCTURE OF 3-MBT REPEATS OF LETHAL (3) MALIGNANT BRAIN TUMOR (NATIVE-I) AT 1.85 ANGSTROM 1OZ2 ; 1.55 ; CRYSTAL STRUCTURE OF 3-MBT REPEATS OF LETHAL (3) MALIGNANT BRAIN TUMOR (NATIVE-II) AT 1.55 ANGSTROM 1OYX ; 1.85 ; CRYSTAL STRUCTURE OF 3-MBT REPEATS OF LETHAL (3) MALIGNANT BRAIN TUMOR (SELENO-MET) AT 1.85 ANGSTROM 1O66 ; 1.75 ; CRYSTAL STRUCTURE OF 3-METHYL-2-OXOBUTANOATE HYDROXYMETHYLTRANSFERASE 1O68 ; 2.10 ; CRYSTAL STRUCTURE OF 3-METHYL-2-OXOBUTANOATE HYDROXYMETHYLTRANSFERASE 1O5I ; 2.50 ; CRYSTAL STRUCTURE OF 3-OXOACYL-(ACYL CARRIER PROTEIN) REDUCTASE (TM1169) FROM THERMOTOGA MARITIMA AT 2.50 A RESOLUTION 1J3N ; 2.00 ; CRYSTAL STRUCTURE OF 3-OXOACYL-(ACYL-CARRIER PROTEIN) SYNTHASE II FROM THERMUS THERMOPHILUS HB8 1VMB ; 1.70 ; CRYSTAL STRUCTURE OF 30S RIBOSOMAL PROTEIN S6 (TM0603) FROM THERMOTOGA MARITIMA AT 1.70 A RESOLUTION 1VQ0 ; 2.20 ; CRYSTAL STRUCTURE OF 33 KDA CHAPERONIN (HEAT SHOCK PROTEIN 33 HOMOLOG) (HSP33) (TM1394) FROM THERMOTOGA MARITIMA AT 2.20 A RESOLUTION 1ZGL ; 2.80 ; CRYSTAL STRUCTURE OF 3A6 TCR BOUND TO MBP/HLA-DR2A 1JS0 ; 2.20 ; CRYSTAL STRUCTURE OF 3D DOMAIN-SWAPPED RNASE A MINOR TRIMER 1QE1 ; 2.85 ; CRYSTAL STRUCTURE OF 3TC-RESISTANT M184I MUTANT OF HIV-1 REVERSE TRANSCRIPTASE 1UEK ; 1.70 ; CRYSTAL STRUCTURE OF 4-(CYTIDINE 5'-DIPHOSPHO)-2C-METHYL-D- ERYTHRITOL KINASE 1K1W ; 2.80 ; CRYSTAL STRUCTURE OF 4-ALPHA-GLUCANOTRANSFERASE FROM THERMOCOCCUS LITORALIS 1K1X ; 2.40 ; CRYSTAL STRUCTURE OF 4-ALPHA-GLUCANOTRANSFERASE FROM THERMOCOCCUS LITORALIS 1S9A ; 2.47 ; CRYSTAL STRUCTURE OF 4-CHLOROCATECHOL 1,2-DIOXYGENASE FROM RHODOCOCCUS OPACUS 1CP 1YWK ; 2.95 ; CRYSTAL STRUCTURE OF 4-DEOXY-1-THREO-5-HEXOSULOSE-URONATE KETOL-ISOMERASE FROM ENTEROCOCCUS FAECALIS 1I52 ; 1.50 ; CRYSTAL STRUCTURE OF 4-DIPHOSPHOCYTIDYL-2-C- METHYLERYTHRITOL (CDP-ME) SYNTHASE (YGBP) INVOLVED IN MEVALONATE INDEPENDENT ISOPRENOID BIOSYNTHESIS 1INI ; 1.82 ; CRYSTAL STRUCTURE OF 4-DIPHOSPHOCYTIDYL-2-C- METHYLERYTHRITOL (CDP-ME) SYNTHETASE (YGBP) INVOLVED IN MEVALONATE INDEPENDENT ISOPRENOID BIOSYNTHESIS, COMPLEXED WITH CDP-ME AND MG2+ 1VGT ; 1.80 ; CRYSTAL STRUCTURE OF 4-DIPHOSPHOCYTIDYL-2C-METHYL-D- ERYTHRITOL SYNTHASE 1VGU ; 2.80 ; CRYSTAL STRUCTURE OF 4-DIPHOSPHOCYTIDYL-2C-METHYL-D- ERYTHRITOL SYNTHASE 1VGW ; 2.35 ; CRYSTAL STRUCTURE OF 4-DIPHOSPHOCYTIDYL-2C-METHYL-D- ERYTHRITOL SYNTHASE 1VGZ ; 3.00 ; CRYSTAL STRUCTURE OF 4-DIPHOSPHOCYTIDYL-2C-METHYL-D- ERYTHRITOL SYNTHASE 1Q4U ; 1.60 ; CRYSTAL STRUCTURE OF 4-HYDROXYBENZOYL COA THIOESTERASE FROM ARTHROBACTER SP. STRAIN SU COMPLEXED WITH 4-HYDROXYBENZYL COA 1Q4T ; 1.60 ; CRYSTAL STRUCTURE OF 4-HYDROXYBENZOYL COA THIOESTERASE FROM ARTHROBACTER SP. STRAIN SU COMPLEXED WITH 4-HYDROXYPHENYL COA 1U8V ; 1.60 ; CRYSTAL STRUCTURE OF 4-HYDROXYBUTYRYL-COA DEHYDRATASE FROM CLOSTRIDIUM AMINOBUTYRICUM: RADICAL CATALYSIS INVOLVING A [4FE-4S] CLUSTER AND FLAVIN 1VJR ; 2.40 ; CRYSTAL STRUCTURE OF 4-NITROPHENYLPHOSPHATASE (TM1742) FROM THERMOTOGA MARITIMA AT 2.40 A RESOLUTION 1BJP ; 2.40 ; CRYSTAL STRUCTURE OF 4-OXALOCROTONATE TAUTOMERASE INACTIVATED BY 2-OXO-3-PENTYNOATE AT 2.4 ANGSTROMS RESOLUTION 1JDU ; 2.50 ; CRYSTAL STRUCTURE OF 5'-DEOXY-5'-METHYLTHIOADENOSINE PHOSPHORYLASE 1JP7 ; 1.80 ; CRYSTAL STRUCTURE OF 5'-DEOXY-5'-METHYLTHIOADENOSINE PHOSPHORYLASE 1JDV ; 2.00 ; CRYSTAL STRUCTURE OF 5'-DEOXY-5'-METHYLTHIOADENOSINE PHOSPHORYLASE COMPLEXED WITH ADENOSINE AND SULFATE ION 1JDT ; 2.00 ; CRYSTAL STRUCTURE OF 5'-DEOXY-5'-METHYLTHIOADENOSINE PHOSPHORYLASE COMPLEXED WITH MTA AND SULFATE ION 1JE0 ; 1.60 ; CRYSTAL STRUCTURE OF 5'-DEOXY-5'-METHYLTHIOADENOSINE PHOSPHORYLASE COMPLEXED WITH PHOSPHATE AND TRIS MOLECULE 1JPV ; 1.80 ; CRYSTAL STRUCTURE OF 5'-DEOXY-5'-METHYLTHIOADENOSINE PHOSPHORYLASE COMPLEXED WITH SO4 1K27 ; 1.95 ; CRYSTAL STRUCTURE OF 5'-DEOXY-5'-METHYLTHIOADENOSINE PHOSPHORYLASE IN COMPLEX WITH A TRANSITION STATE ANALOGUE 1JDZ ; 2.00 ; CRYSTAL STRUCTURE OF 5'-DEOXY-5'-METHYLTHIOADENOSINE PHOSPHORYLASE WITH FORMYCIN B AND SULFATE ION 1M2R ; 1.70 ; CRYSTAL STRUCTURE OF 5,8-DI-AMINO-1,4-DI-HYDROXY- ANTHRAQUINONE/CK2 KINASE COMPLEX 1OHP ; 1.53 ; CRYSTAL STRUCTURE OF 5-3-KETOSTEROID ISOMERASE MUTANT D38N FROM PSEUDOMONAS TESTOSTERONI COMPLEXED WITH 5ALPHA-ESTRAN-3,17-DIONE 1OHS ; 1.70 ; CRYSTAL STRUCTURE OF 5-3-KETOSTEROID ISOMERASE MUTANT Y14F/ D38N FROM PSEUDOMONAS TESTOSTERONI COMPLEXED WITH ANDROSTANEDIONE 1OGZ ; 2.30 ; CRYSTAL STRUCTURE OF 5-3-KETOSTEROID ISOMERASE MUTANTS P39A COMPLEXED WITH EQUILENIN FROM PSEUDOMONAS TESTOSTERONI 1DL8 ; 1.55 ; CRYSTAL STRUCTURE OF 5-F-9-AMINO-(N-(2-DIMETHYLAMINO)ETHYL) ACRIDINE-4-CARBOXAMIDE BOUND TO D(CGTACG)2 1XRU ; 1.94 ; CRYSTAL STRUCTURE OF 5-KETO-4-DEOXYURONATE ISOMERASE FROM ESCHERICIA COLI 1ZG9 ; 2.00 ; CRYSTAL STRUCTURE OF 5-{[AMINO(IMINO)METHYL]AMINO}-2- (SULFANYLMETHYL)PENTANOIC ACID BOUND TO ACTIVATED PORCINE PANCREATIC CARBOXYPEPTIDASE B 2BVG ; 3.18 ; CRYSTAL STRUCTURE OF 6-HYDOXY-D-NICOTINE OXIDASE FROM ARTHROBACTER NICOTINOVORANS. CRYSTAL FORM 1 (P21) 2BVH ; 2.90 ; CRYSTAL STRUCTURE OF 6-HYDOXY-D-NICOTINE OXIDASE FROM ARTHROBACTER NICOTINOVORANS. CRYSTAL FORM 2 (P21) 2BVF ; 1.92 ; CRYSTAL STRUCTURE OF 6-HYDOXY-D-NICOTINE OXIDASE FROM ARTHROBACTER NICOTINOVORANS. CRYSTAL FORM 3 (P1) 1EX8 ; 1.85 ; CRYSTAL STRUCTURE OF 6-HYDROXYMETHYL-7,8-DIHYDROPTERIN PYROPHOSPHOKINASE COMPLEXED WITH HP4A, THE TWO-SUBSTRATE- MIMICKING INHIBITOR 1VL1 ; 1.55 ; CRYSTAL STRUCTURE OF 6-PHOSPHOGLUCONOLACTONASE (TM1154) FROM THERMOTOGA MARITIMA AT 1.70A RESOLUTION 2A0S ; 2.20 ; CRYSTAL STRUCTURE OF 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASE (PTPS) FROM PLASMODIUM VIVAX AT 2.2 A RESOLUTION 1QJ5 ; 1.80 ; CRYSTAL STRUCTURE OF 7,8-DIAMINOPELARGONIC ACID SYNTHASE 1QJ3 ; 2.70 ; CRYSTAL STRUCTURE OF 7,8-DIAMINOPELARGONIC ACID SYNTHASE IN COMPLEX WITH 7-KETO-8-AMINOPELARGONIC ACID 1MLY ; 1.81 ; CRYSTAL STRUCTURE OF 7,8-DIAMINOPELARGONIC ACID SYNTHASE IN COMPLEX WITH THE CIS ISOMER OF AMICLENOMYCIN 1MLZ ; 2.15 ; CRYSTAL STRUCTURE OF 7,8-DIAMINOPELARGONIC ACID SYNTHASE IN COMPLEX WITH THE TRANS-ISOMER OF AMICLENOMYCIN. 1SQL ; 2.20 ; CRYSTAL STRUCTURE OF 7,8-DIHYDRONEOPTERIN ALDOLASE IN COMPLEX WITH GUANINE 1UNM ; 2.00 ; CRYSTAL STRUCTURE OF 7-AMINOACTINOMYCIN D WITH NON-COMPLEMENTARY DEOXYRIBONUCLEIC ACID 1YL4 ; 5.50 ; CRYSTAL STRUCTURE OF 70S RIBOSOME WITH THRS OPERATOR AND TRNAS. 30S SUBUNIT. THE COORDINATES FOR THE 50S SUBUNIT ARE IN THE PDB ENTRY 1YL3 1YL3 ; 5.50 ; CRYSTAL STRUCTURE OF 70S RIBOSOME WITH THRS OPERATOR AND TRNAS. LARGE SUBUNIT. THE COORDINATES FOR THE SMALL SUBUNIT ARE IN THE PDB ENTRY 1YL4. 1SGF ; 3.15 ; CRYSTAL STRUCTURE OF 7S NGF: A COMPLEX OF NERVE GROWTH FACTOR WITH FOUR BINDING PROTEINS (SERINE PROTEINASES) 1Z43 ; 2.60 ; CRYSTAL STRUCTURE OF 7S.S SRP RIBONUCLEIC ACID OF M. JANNASCHII 1DJ9 ; 2.00 ; CRYSTAL STRUCTURE OF 8-AMINO-7-OXONANOATE SYNTHASE (OR 7- KETO-8AMINIPELARGONATE OR KAPA SYNTHASE) COMPLEXED WITH PLP AND THE PRODUCT 8(S)-AMINO-7-OXONANONOATE (OR KAPA). THE ENZYME OF BIOTIN BIOSYNTHETIC PATHWAY. 1XQP ; 1.69 ; CRYSTAL STRUCTURE OF 8-OXOGUANOSINE COMPLEXED PA-AGOG, 8- OXOGUANINE DEOXYRIBONUCLEIC ACID GLYCOSYLASE FROM PYROBACULUM AEROPHILUM 1FN1 ; 1.60 ; CRYSTAL STRUCTURE OF 9-AMINO-(N-(2-DIMETHYLAMINO)BUTYL) ACRIDINE-4-CARBOXAMIDE BOUND TO D(CG(5BR)UACG)2 1KCI ; 1.80 ; CRYSTAL STRUCTURE OF 9-AMINO-N-[2-(4-MORPHOLINYL)ETHYL]-4- ACRIDINECARBOXAMIDE BOUND TO D(CGTACG)2 433D ; 2.10 ; CRYSTAL STRUCTURE OF A 14 BASE PAIR RIBONUCLEIC ACID DUPLEX WITH NONSYMMETRICAL TANDEM G.U WOBBLE BASE PAIRS 1FUF ; 1.70 ; CRYSTAL STRUCTURE OF A 14BP RIBONUCLEIC ACID OLIGONUCLEOTIDE CONTAINING DOUBLE UU BULGES: A NOVEL INTRAMOLECULAR U(AU) BASE TRIPLE 1IK5 ; 1.80 ; CRYSTAL STRUCTURE OF A 14MER RIBONUCLEIC ACID CONTAINING DOUBLE UU BULGES IN TWO CRYSTAL FORMS: A NOVEL U(AU) INTRAMOLECULAR BASE TRIPLE 420D ; 1.90 ; CRYSTAL STRUCTURE OF A 16-MER RIBONUCLEIC ACID DUPLEX WITH NON-ADJACENT A(ANTI).G(SYN) MISMATCHES 1QC0 ; 1.55 ; CRYSTAL STRUCTURE OF A 19 BASE PAIR COPY CONTROL RELATED RIBONUCLEIC ACID DUPLEX 1VH8 ; 2.35 ; CRYSTAL STRUCTURE OF A 2C-METHYL-D-ERYTHRITOL 2,4- CYCLODIPHOSPHATE SYNTHASE 1A2W ; 2.10 ; CRYSTAL STRUCTURE OF A 3D DOMAIN-SWAPPED DIMER OF BOVINE PANCREATIC RIBONUCLEASE A 2ESC ; 2.10 ; CRYSTAL STRUCTURE OF A 40 KDA PROTECTIVE SIGNALLING PROTEIN FROM BOVINE (SPC-40) AT 2.1 A RESOLUTION 1OWQ ; 2.00 ; CRYSTAL STRUCTURE OF A 40 KDA SIGNALLING PROTEIN (SPC-40) SECRETED DURING INVOLUTION 1XHG ; 2.90 ; CRYSTAL STRUCTURE OF A 40 KDA SIGNALLING PROTEIN FROM PORCINE (SPP-40) AT 2.89A RESOLUTION 1WKC ; 1.70 ; CRYSTAL STRUCTURE OF A 5-FORMYLTETRAHYDROFOLATE CYCLOLIGASE- RELATED PROTEIN FROM THERMUS THERMOPHILUS HB8 1UNJ ; 2.50 ; CRYSTAL STRUCTURE OF A 7-AMINOACTINOMYCIN D COMPLEX WITH NON-COMPLEMENTARY DEOXYRIBONUCLEIC ACID 1VHE ; 1.90 ; CRYSTAL STRUCTURE OF A AMINOPEPTIDASE/GLUCANASE HOMOLOG 1VGX ; 1.90 ; CRYSTAL STRUCTURE OF A AUTOINDUCER-2 SYNTHESIS PROTEIN 1VH2 ; 2.00 ; CRYSTAL STRUCTURE OF A AUTOINDUCER-2 SYNTHESIS PROTEIN 1VJE ; 1.64 ; CRYSTAL STRUCTURE OF A AUTOINDUCER-2 SYNTHESIS PROTEIN WITH BOUND SELENOMETHIONINE 1N1O ; 1.20 ; CRYSTAL STRUCTURE OF A B-FORM DEOXYRIBONUCLEIC ACID DUPLEX CONTAINING (L)- ALPHA-THREOFURANOSYL (3'-2') NUCLEOSIDES: A FOUR-CARBON SUGAR IS EASILY ACCOMMODATED INTO THE BACKBONE OF DEOXYRIBONUCLEIC ACID 1N2A ; 1.90 ; CRYSTAL STRUCTURE OF A BACTERIAL GLUTATHIONE TRANSFERASE FROM ESCHERICHIA COLI WITH GLUTATHIONE SULFONATE IN THE ACTIVE SITE 1QWD ; 1.75 ; CRYSTAL STRUCTURE OF A BACTERIAL LIPOCALIN, THE BLC GENE PRODUCT FROM E. COLI 1XBN ; 2.50 ; CRYSTAL STRUCTURE OF A BACTERIAL NITRIC OXIDE SENSOR: AN ORTHOLOG OF MAMMALIAN SOLUBLE GUANYLATE CYCLASE HEME DOMAIN 1L3L ; 1.66 ; CRYSTAL STRUCTURE OF A BACTERIAL QUORUM-SENSING TRANSCRIPTION FACTOR COMPLEXED WITH PHEROMONE AND DEOXYRIBONUCLEIC ACID 1KN9 ; 2.40 ; CRYSTAL STRUCTURE OF A BACTERIAL SIGNAL PEPTIDASE APO- ENZYME, IMPLICATIONS FOR SIGNAL PEPTIDE BINDING AND THE SER-LYS DYAD MECHANISM. 2CX3 ; 2.64 ; CRYSTAL STRUCTURE OF A BACTERIOFERRITIN COMIGRATORY PROTEIN PEROXIREDOXIN FROM THE AEROPYRUM PERNIX K1 (FORM-1 CRYSTAL) 2CX4 ; 2.30 ; CRYSTAL STRUCTURE OF A BACTERIOFERRITIN COMIGRATORY PROTEIN PEROXIREDOXIN FROM THE AEROPYRUM PERNIX K1 (FORM-2 CRYSTAL) 1HX1 ; 1.90 ; CRYSTAL STRUCTURE OF A BAG DOMAIN IN COMPLEX WITH THE HSC70 ATPASE DOMAIN 1S0M ; 2.70 ; CRYSTAL STRUCTURE OF A BENZO[A]PYRENE DIOL EPOXIDE ADDUCT IN A TERNARY COMPLEX WITH A DEOXYRIBONUCLEIC ACID POLYMERASE 1J18 ; 2.00 ; CRYSTAL STRUCTURE OF A BETA-AMYLASE FROM BACILLUS CEREUS VAR. MYCOIDES COCRYSTALLIZED WITH MALTOSE 1NVM ; 1.70 ; CRYSTAL STRUCTURE OF A BIFUNCTIONAL ALDOLASE-DEHYDROGENASE : SEQUESTERING A REACTIVE AND VOLATILE INTERMEDIATE 2B3Z ; 2.41 ; CRYSTAL STRUCTURE OF A BIFUNCTIONAL DEAMINASE AND REDUCTASE INVOLVED IN RIBOFLAVIN BIOSYNTHESIS 2D5N ; 2.97 ; CRYSTAL STRUCTURE OF A BIFUNCTIONAL DEAMINASE AND REDUCTASE INVOLVED IN RIBOFLAVIN BIOSYNTHESIS 1GD7 ; 2.00 ; CRYSTAL STRUCTURE OF A BIFUNCTIONAL PROTEIN (CSAA) WITH EXPORT-RELATED CHAPERONE AND TRNA-BINDING ACTIVITIES. 1LC3 ; 1.50 ; CRYSTAL STRUCTURE OF A BILIVERDIN REDUCTASE ENZYME-COFACTOR COMPLEX 1AJ2 ; 2.00 ; CRYSTAL STRUCTURE OF A BINARY COMPLEX OF E. COLI DIHYDROPTEROATE SYNTHASE 1RB0 ; 1.35 ; CRYSTAL STRUCTURE OF A BINARY COMPLEX OF E. COLI HPPK WITH 6-HYDROXYMETHYLPTERIN-DIPHOSPHATE AT 1.35 ANGSTROM RESOLUTION 1DAW ; 2.20 ; CRYSTAL STRUCTURE OF A BINARY COMPLEX OF PROTEIN KINASE CK2 (ALPHA-SUBUNIT) AND MG-AMPPNP 1DAY ; 2.20 ; CRYSTAL STRUCTURE OF A BINARY COMPLEX OF PROTEIN KINASE CK2 (ALPHA-SUBUNIT) AND MG-GMPPNP 1LP4 ; 1.86 ; CRYSTAL STRUCTURE OF A BINARY COMPLEX OF THE CATALYTIC SUBUNIT OF PROTEIN KINASE CK2 WITH MG-AMPPNP 1EKU ; 2.90 ; CRYSTAL STRUCTURE OF A BIOLOGICALLY ACTIVE SINGLE CHAIN MUTANT OF HUMAN IFN-GAMMA 1F27 ; 1.30 ; CRYSTAL STRUCTURE OF A BIOTIN-BINDING RIBONUCLEIC ACID PSEUDOKNOT 1TR0 ; 1.80 ; CRYSTAL STRUCTURE OF A BOILING STABLE PROTEIN SP1 1PBI ; 2.70 ; CRYSTAL STRUCTURE OF A BOWMAN-BIRK INHIBITOR FROM PEA SEEDS 1YCO ; 2.40 ; CRYSTAL STRUCTURE OF A BRANCHED-CHAIN PHOSPHOTRANSACYLASE FROM ENTEROCOCCUS FAECALIS V583 1N0X ; 1.80 ; CRYSTAL STRUCTURE OF A BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY IN COMPLEX WITH A PEPTIDE MIMOTOPE 1QBP ; 2.10 ; CRYSTAL STRUCTURE OF A BROMINATED RIBONUCLEIC ACID HELIX WITH FOUR MISMATCHED BASE PAIRS 1TFV ; 2.90 ; CRYSTAL STRUCTURE OF A BUFFALO SIGNALING GLYCOPROTEIN (SPB- 40) SECRETED DURING INVOLUTION 1JZV ; 1.70 ; CRYSTAL STRUCTURE OF A BULGED RIBONUCLEIC ACID FROM THE SL2 STEM-LOOP OF THE HIV-1 PSI-RIBONUCLEIC ACID 1P79 ; 1.10 ; CRYSTAL STRUCTURE OF A BULGED RIBONUCLEIC ACID TETRAPLEX: IMPLICATIONS FOR A NOVEL BINDING SITE IN RIBONUCLEIC ACID TETRAPLEX 1PJK ; 2.50 ; CRYSTAL STRUCTURE OF A C-TERMINAL DELETION MUTANT OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT 1LVA ; 2.12 ; CRYSTAL STRUCTURE OF A C-TERMINAL FRAGMENT OF MOORELLA THERMOACETICA ELONGATION FACTOR SELB 1YZ7 ; 2.26 ; CRYSTAL STRUCTURE OF A C-TERMINAL SEGMENT OF THE ALPHA SUBUNIT OF AIF2 FROM PYROCOCCUS ABYSSI 1Y42 ; 1.95 ; CRYSTAL STRUCTURE OF A C-TERMINALLY TRUNCATED CYT-18 PROTEIN 1KTG ; 1.80 ; CRYSTAL STRUCTURE OF A C. ELEGANS AP4A HYDROLASE BINARY COMPLEX 1OWS ; 2.30 ; CRYSTAL STRUCTURE OF A C49 PHOSPHOLIPASE A2 FROM INDIAN COBRA REVEALS CARBOHYDRATE BINDING IN THE HYDROPHOBIC CHANNEL 1SJ4 ; 2.70 ; CRYSTAL STRUCTURE OF A C75U MUTANT HEPATITIS DELTA VIRUS RIBOZYME PRECURSOR, IN CU2+ SOLUTION 1S36 ; 1.96 ; CRYSTAL STRUCTURE OF A CA2+-DISCHARGED PHOTOPROTEIN: IMPLICATIONS FOR THE MECHANISMS OF THE CALCIUM TRIGGER AND THE BIOLUMINESCENCE 1MH7 ; 2.00 ; CRYSTAL STRUCTURE OF A CALCIUM-FREE ISOFORM OF PHOSPHOLIPASE A2 FROM NAJA NAJA SAGITTIFERA AT 2.0 A RESOLUTION 1MEL ; 2.50 ; CRYSTAL STRUCTURE OF A CAMEL SINGLE-DOMAIN VH ANTIBODY FRAGMENT IN COMPLEX WITH LYSOZYME 1OL0 ; 1.80 ; CRYSTAL STRUCTURE OF A CAMELISED HUMAN VH 1U4J ; 2.18 ; CRYSTAL STRUCTURE OF A CARBOHYDRATE INDUCED DIMER OF GROUP I PHOSPHOLIPASE A2 FROM BUNGARUS CAERULEUS AT 2.1 A RESOLUTION 1MEG ; 2.00 ; CRYSTAL STRUCTURE OF A CARICAIN D158E MUTANT IN COMPLEX WITH E-64 1ZCP ; 2.30 ; CRYSTAL STRUCTURE OF A CATALYTIC SITE MUTANT E. COLI TRXA (CACA) 1P14 ; 1.90 ; CRYSTAL STRUCTURE OF A CATALYTIC-LOOP MUTANT OF THE INSULIN RECEPTOR TYROSINE KINASE 2ATP ; 2.40 ; CRYSTAL STRUCTURE OF A CD8AB HETERODIMER 1TY4 ; 2.20 ; CRYSTAL STRUCTURE OF A CED-9/EGL-1 COMPLEX 1N0E ; 2.70 ; CRYSTAL STRUCTURE OF A CELL DIVISION AND CELL WALL BIOSYNTHESIS PROTEIN UPF0040 FROM MYCOPLASMA PNEUMONIAE: INDICATION OF A NOVEL FOLD WITH A POSSIBLE NEW CONSERVED SEQUENCE MOTIF 1N0F ; 2.80 ; CRYSTAL STRUCTURE OF A CELL DIVISION AND CELL WALL BIOSYNTHESIS PROTEIN UPF0040 FROM MYCOPLASMA PNEUMONIAE: INDICATION OF A NOVEL FOLD WITH A POSSIBLE NEW CONSERVED SEQUENCE MOTIF 1N0G ; 2.80 ; CRYSTAL STRUCTURE OF A CELL DIVISION AND CELL WALL BIOSYNTHESIS PROTEIN UPF0040 FROM MYCOPLASMA PNEUMONIAE: INDICATION OF A NOVEL FOLD WITH A POSSIBLE NEW CONSERVED SEQUENCE MOTIF 1RJ1 ; 1.87 ; CRYSTAL STRUCTURE OF A CELL WALL INVERTASE INHIBITOR FROM TOBACCO 1DOW ; 1.80 ; CRYSTAL STRUCTURE OF A CHIMERA OF BETA-CATENIN AND ALPHA- CATENIN 1MHP ; 2.80 ; CRYSTAL STRUCTURE OF A CHIMERIC ALPHA1 INTEGRIN I-DOMAIN IN COMPLEX WITH THE FAB FRAGMENT OF A HUMANIZED NEUTRALIZING ANTIBODY 1DO8 ; 2.20 ; CRYSTAL STRUCTURE OF A CLOSED FORM OF HUMAN MITOCHONDRIAL NAD(P)+-DEPENDENT MALIC ENZYME 1O0Q ; 2.20 ; CRYSTAL STRUCTURE OF A COLD ADAPTED ALKALINE PROTEASE FROM PSEUDOMONAS TAC II 18, CO-CRYSTALLIZED WITH 1 MM EDTA 1O0T ; 2.50 ; CRYSTAL STRUCTURE OF A COLD ADAPTED ALKALINE PROTEASE FROM PSEUDOMONAS TAC II 18, CO-CRYSTALLIZED WITH 5 MM EDTA (5 DAYS) 1OM6 ; 2.00 ; CRYSTAL STRUCTURE OF A COLD ADAPTED ALKALINE PROTEASE FROM PSEUDOMONAS TAC II 18, CO-CRYSTALLIZED WITH 5MM EDTA (2 MONTHS) 1OM8 ; 2.00 ; CRYSTAL STRUCTURE OF A COLD ADAPTED ALKALINE PROTEASE FROM PSEUDOMONAS TAC II 18, CO-CRYSTALLYZED WITH 10 MM EDTA 1OM7 ; 2.80 ; CRYSTAL STRUCTURE OF A COLD ADAPTED ALKALINE PROTEASE FROM PSEUDOMONAS TAC II 18, SOAKED IN 85 MM EDTA 1SH7 ; 1.84 ; CRYSTAL STRUCTURE OF A COLD ADAPTED SUBTILISIN-LIKE SERINE PROTEINASE 1O91 ; 1.90 ; CRYSTAL STRUCTURE OF A COLLAGEN VIII NC1 DOMAIN TRIMER 1G44 ; 2.60 ; CRYSTAL STRUCTURE OF A COMPLEMENT CONTROL PROTEIN THAT REGULATES BOTH PATHWAYS OF COMPLEMENT ACTIVATION AND BINDS HEPARAN SULFATE PROTEOGLYCANS 1G40 ; 2.20 ; CRYSTAL STRUCTURE OF A COMPLEMENT PROTEIN THAT REGULATES BOTH PATHWAYS OF COMPLEMENT ACTIVATION AND BINDS HEPARAN SULFATE PROTEOGLYCANS 1LBZ ; 2.20 ; CRYSTAL STRUCTURE OF A COMPLEX (P32 CRYSTAL FORM) OF DUAL ACTIVITY FBPASE/IMPASE (AF2372) FROM ARCHAEOGLOBUS FULGIDUS WITH 3 CALCIUM IONS AND FRUCTOSE-1,6 BISPHOSPHATE 1LBY ; 2.25 ; CRYSTAL STRUCTURE OF A COMPLEX (P32 CRYSTAL FORM) OF DUAL ACTIVITY FBPASE/IMPASE (AF2372) FROM ARCHAEOGLOBUS FULGIDUS WITH 3 MANGANESE IONS, FRUCTOSE-6-PHOSPHATE, AND PHOSPHATE ION 1N8O ; 2.00 ; CRYSTAL STRUCTURE OF A COMPLEX BETWEEN BOVINE CHYMOTRYPSIN AND ECOTIN 1G9S ; 2.80 ; CRYSTAL STRUCTURE OF A COMPLEX BETWEEN E.COLI HPRT AND IMP 1MW8 ; 1.90 ; CRYSTAL STRUCTURE OF A COMPLEX BETWEEN H365R MUTANT OF 67 KDA N-TERMINAL FRAGMENT OF E. COLI DEOXYRIBONUCLEIC ACID TOPOISOMERASE I AND 5'-ACTTCGGGATG-3' 1FQ4 ; 2.70 ; CRYSTAL STRUCTURE OF A COMPLEX BETWEEN HYDROXYETHYLENE INHIBITOR CP-108,420 AND YEAST ASPARTIC PROTEINASE A 2B4S ; 2.30 ; CRYSTAL STRUCTURE OF A COMPLEX BETWEEN PTP1B AND THE INSULIN RECEPTOR TYROSINE KINASE 1F93 ; 2.60 ; CRYSTAL STRUCTURE OF A COMPLEX BETWEEN THE DIMERIZATION DOMAIN OF HNF-1 ALPHA AND THE COACTIVATOR DCOH 1F6M ; 2.95 ; CRYSTAL STRUCTURE OF A COMPLEX BETWEEN THIOREDOXIN REDUCTASE, THIOREDOXIN, AND THE NADP+ ANALOG, AADP+ 1Z5S ; 3.01 ; CRYSTAL STRUCTURE OF A COMPLEX BETWEEN UBC9, SUMO-1, RANGAP1 AND NUP358/RANBP2 1T0J ; 2.00 ; CRYSTAL STRUCTURE OF A COMPLEX BETWEEN VOLTAGE-GATED CALCIUM CHANNEL BETA2A SUBUNIT AND A PEPTIDE OF THE ALPHA1C SUBUNIT 1U1Y ; 2.85 ; CRYSTAL STRUCTURE OF A COMPLEX BETWEEN WT BACTERIOPHAGE MS2 COAT PROTEIN AND AN F5 APTAMER RIBONUCLEIC ACID STEMLOOP WITH 2AMINOPURINE SUBSTITUTED AT THE-10 POSITION 1TGM ; 1.86 ; CRYSTAL STRUCTURE OF A COMPLEX FORMED BETWEEN GROUP II PHOSPHOLIPASE A2 AND ASPIRIN AT 1.86 A RESOLUTION 1PO8 ; 2.71 ; CRYSTAL STRUCTURE OF A COMPLEX FORMED BETWEEN KRAIT VENOM PHOSPHOLIPASE A2 AND HEPTANOIC ACID AT 2.7 A RESOLUTION. 1OXG ; 2.20 ; CRYSTAL STRUCTURE OF A COMPLEX FORMED BETWEEN ORGANIC SOLVENT TREATED BOVINE ALPHA-CHYMOTRYPSIN AND ITS AUTOCATALYTICALLY PRODUCED HIGHLY POTENT 14-RESIDUE PEPTIDE AT 2.2 RESOLUTION 1SXK ; 1.21 ; CRYSTAL STRUCTURE OF A COMPLEX FORMED BETWEEN PHOSPHOLIPASE A2 AND A NON-SPECIFIC ANTI-INFLAMMATORY AMINO SALICYLIC ACID AT 1.2 A RESOLUTION 1JQ9 ; 1.80 ; CRYSTAL STRUCTURE OF A COMPLEX FORMED BETWEEN PHOSPHOLIPASE A2 FROM DABOIA RUSSELLI PULCHELLA AND A DESIGNED PENTAPEPTIDE PHE-LEU-SER-TYR-LYS AT 1.8 RESOLUTION 1FYT ; 2.60 ; CRYSTAL STRUCTURE OF A COMPLEX OF A HUMAN ALPHA/BETA-T CELL RECEPTOR, INFLUENZA HA ANTIGEN PEPTIDE, AND MHC CLASS II MOLECULE, HLA-DR1 1J8H ; 2.40 ; CRYSTAL STRUCTURE OF A COMPLEX OF A HUMAN ALPHA/BETA-T CELL RECEPTOR, INFLUENZA HA ANTIGEN PEPTIDE, AND MHC CLASS II MOLECULE, HLA-DR4 1G4C ; 1.65 ; CRYSTAL STRUCTURE OF A COMPLEX OF HPPK(R92A) FROM E.COLI WITH MG2+ AT 1.65 ANGSTROM RESOLUTION 1JOW ; 3.10 ; CRYSTAL STRUCTURE OF A COMPLEX OF HUMAN CDK6 AND A VIRAL CYCLIN 1GG5 ; 2.50 ; CRYSTAL STRUCTURE OF A COMPLEX OF HUMAN NAD[P]H-QUINONE OXIDOREDUCTASE AND A CHEMOTHERAPEUTIC DRUG (E09) AT 2.5 A RESOLUTION 1QJM ; 3.40 ; CRYSTAL STRUCTURE OF A COMPLEX OF LACTOFERRIN WITH A LANTHANIDE ION (SM3+) AT 3.4 ANSTROM RESOLUTION 1JPZ ; 1.65 ; CRYSTAL STRUCTURE OF A COMPLEX OF THE HEME DOMAIN OF P450BM- 3 WITH N-PALMITOYLGLYCINE 1Z58 ; 3.80 ; CRYSTAL STRUCTURE OF A COMPLEX OF THE RIBOSOME LARGE SUBUNIT WITH RAPAMYCIN 1IS0 ; 1.90 ; CRYSTAL STRUCTURE OF A COMPLEX OF THE SRC SH2 DOMAIN WITH CONFORMATIONALLY CONSTRAINED PEPTIDE INHIBITOR 1C9S ; 1.90 ; CRYSTAL STRUCTURE OF A COMPLEX OF TRP RIBONUCLEIC ACID-BINDING ATTENUATION PROTEIN WITH A 53-BASE SINGLE STRANDED RIBONUCLEIC ACID CONTAINING ELEVEN GAG TRIPLETS SEPARATED BY AU DINUCLEOTIDES 1V5V ; 1.50 ; CRYSTAL STRUCTURE OF A COMPONENT OF GLYCINE CLEAVAGE SYSTEM: T-PROTEIN FROM PYROCOCCUS HORIKOSHII OT3 AT 1.5 A RESOLUTION 1ZSZ ; 2.00 ; CRYSTAL STRUCTURE OF A COMPUTATIONALLY DESIGNED SSPB HETERODIMER 1LFP ; 1.72 ; CRYSTAL STRUCTURE OF A CONSERVED HYPOTHETICAL PROTEIN AQ1575 FROM AQUIFEX AEOLICUS 1XFJ ; 1.75 ; CRYSTAL STRUCTURE OF A CONSERVED HYPOTHETICAL PROTEIN FROM CAULOBACTER CRESCENTUS 1T6S ; 1.95 ; CRYSTAL STRUCTURE OF A CONSERVED HYPOTHETICAL PROTEIN FROM CHLOROBIUM TEPIDUM 2CW5 ; 1.94 ; CRYSTAL STRUCTURE OF A CONSERVED HYPOTHETICAL PROTEIN FROM THERMUS THERMOPHILUS HB8 2F4N ; 2.50 ; CRYSTAL STRUCTURE OF A CONSERVED HYPOTHETICAL PROTEIN MJ1651 FROM METHANOCOCCUS JANNASCHII DSM 2661 2CVE ; 1.60 ; CRYSTAL STRUCTURE OF A CONSERVED HYPOTHETICAL PROTEIN TT1547 FROM THERMUS THERMOPHILUS HB8 1HC8 ; 2.80 ; CRYSTAL STRUCTURE OF A CONSERVED RIBOSOMAL PROTEIN-RIBONUCLEIC ACID COMPLEX 1QA6 ; 2.80 ; CRYSTAL STRUCTURE OF A CONSERVED RIBOSOMAL PROTEIN-RIBONUCLEIC ACID COMPLEX 1KMQ ; 1.55 ; CRYSTAL STRUCTURE OF A CONSTITUTIVELY ACTIVATED RHOA MUTANT (Q63L) 1P1Y ; 2.10 ; CRYSTAL STRUCTURE OF A CONTINUOUS THREE-DIMENSIONAL DEOXYRIBONUCLEIC ACID LATTICE FROM D(GGACAGATGGGAG) 1JT0 ; 2.90 ; CRYSTAL STRUCTURE OF A COOPERATIVE QACR-DEOXYRIBONUCLEIC ACID COMPLEX 1NPN ; 1.80 ; CRYSTAL STRUCTURE OF A COPPER RECONSTITUTED H145A MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS 1JES ; 1.50 ; CRYSTAL STRUCTURE OF A COPPER-MEDIATED BASE PAIR IN DEOXYRIBONUCLEIC ACID 1N2K ; 2.75 ; CRYSTAL STRUCTURE OF A COVALENT INTERMEDIATE OF ENDOGENOUS HUMAN ARYLSULFATASE A 1N2L ; 3.20 ; CRYSTAL STRUCTURE OF A COVALENT INTERMEDIATE OF ENDOGENOUS HUMAN ARYLSULFATASE A 1DH3 ; 3.00 ; CRYSTAL STRUCTURE OF A CREB BZIP-CRE COMPLEX REVEALS THE BASIS FOR CREB FAIMLY SELECTIVE DIMERIZATION AND DEOXYRIBONUCLEIC ACID BINDING 1WVR ; 2.40 ; CRYSTAL STRUCTURE OF A CRISP FAMILY CA-CHANNEL BLOCKER DERIVED FROM SNAKE VENOM 1WJ9 ; 1.90 ; CRYSTAL STRUCTURE OF A CRISPR-ASSOCIATED PROTEIN FROM THERMUS THERMOPHILUS 2A5X ; 2.49 ; CRYSTAL STRUCTURE OF A CROSS-LINKED ACTIN DIMER 1KYR ; 1.50 ; CRYSTAL STRUCTURE OF A CU-BOUND GREEN FLUORESCENT PROTEIN ZN BIOSENSOR 1PZS ; 1.63 ; CRYSTAL STRUCTURE OF A CU-ZN SUPEROXIDE DISMUTASE FROM MYCOBACTERIUM TUBERCULOSIS AT 1.63 RESOLUTION 1VH7 ; 1.90 ; CRYSTAL STRUCTURE OF A CYCLASE SUBUNIT OF IMIDAZOLGLYCEROLPHOSPHATE SYNTHASE 1XS7 ; 2.80 ; CRYSTAL STRUCTURE OF A CYCLOAMIDE-URETHANE-DERIVED NOVEL INHIBITOR BOUND TO HUMAN BRAIN MEMAPSIN 2 (BETA-SECRETASE). 1CJL ; 2.20 ; CRYSTAL STRUCTURE OF A CYSTEINE PROTEASE PROFORM 1I1R ; 2.40 ; CRYSTAL STRUCTURE OF A CYTOKINE/RECEPTOR COMPLEX 1ST6 ; 3.10 ; CRYSTAL STRUCTURE OF A CYTOSKELETAL PROTEIN 1UNO ; 1.40 ; CRYSTAL STRUCTURE OF A D,L-ALTERNATING PEPTIDE 1KO0 ; 2.20 ; CRYSTAL STRUCTURE OF A D,L-LYSINE COMPLEX OF DIAMINOPIMELATE DECARBOXYLASE 1EI5 ; 1.90 ; CRYSTAL STRUCTURE OF A D-AMINOPEPTIDASE FROM OCHROBACTRUM ANTHROPI 1HQJ ; 1.20 ; CRYSTAL STRUCTURE OF A DE NOVO DESIGNED TRIMERIC COILED- COIL PEPTIDE 1KYC ; 1.45 ; CRYSTAL STRUCTURE OF A DE NOVO DESIGNED TRIMERIC COILED- COIL PEPTIDE STABLIZED BY IONIC INTERACTIONS 1NJ4 ; 1.90 ; CRYSTAL STRUCTURE OF A DEACYLATION-DEFECTIVE MUTANT OF PENICILLIN-BINDING PROTEIN 5 AT 1.9 A RESOLUTION 1HD8 ; 2.30 ; CRYSTAL STRUCTURE OF A DEACYLATION-DEFECTIVE MUTANT OF PENICILLIN-BINDING PROTEIN 5 AT 2.3 A RESOLUTION 1SDN ; 2.50 ; CRYSTAL STRUCTURE OF A DEACYLATION-DEFECTIVE MUTANT OF PENICILLIN-BINDING PROTEIN 5 MODIFIED BY MERCURY 1HV8 ; 3.00 ; CRYSTAL STRUCTURE OF A DEAD BOX PROTEIN FROM THE HYPERTHERMOPHILE METHANOCOCCUS JANNASCHII 2BJ6 ; 2.60 ; CRYSTAL STRUCTURE OF A DECAMERIC HNA-RIBONUCLEIC ACID HYBRID 1CX4 ; 2.45 ; CRYSTAL STRUCTURE OF A DELETION MUTANT OF THE TYPE II BETA REGULATORY SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE 1NH9 ; 2.00 ; CRYSTAL STRUCTURE OF A DEOXYRIBONUCLEIC ACID BINDING PROTEIN MJA10B FROM THE HYPERTHERMOPHILE METHANOCOCCUS JANNASCHII 1N4E ; 2.50 ; CRYSTAL STRUCTURE OF A DEOXYRIBONUCLEIC ACID DECAMER CONTAINING A THYMINE- DIMER 1SM5 ; 2.00 ; CRYSTAL STRUCTURE OF A DEOXYRIBONUCLEIC ACID DECAMER CONTAINING A THYMINE- DIMER 1T4I ; 2.50 ; CRYSTAL STRUCTURE OF A DEOXYRIBONUCLEIC ACID DECAMER CONTAINING A THYMINE- DIMER 1XRX ; 2.15 ; CRYSTAL STRUCTURE OF A DEOXYRIBONUCLEIC ACID-BINDING PROTEIN 1SVX ; 2.24 ; CRYSTAL STRUCTURE OF A DESIGNED SELECTED ANKYRIN REPEAT PROTEIN IN COMPLEX WITH THE MALTOSE BINDING PROTEIN 1MEY ; 2.20 ; CRYSTAL STRUCTURE OF A DESIGNED ZINC FINGER PROTEIN BOUND TO DEOXYRIBONUCLEIC ACID 1BB1 ; 1.80 ; CRYSTAL STRUCTURE OF A DESIGNED, THERMOSTABLE HETEROTRIMERIC COILED COIL 1Q4Q ; 2.10 ; CRYSTAL STRUCTURE OF A DIAP1-DRONC COMPLEX 1DEJ ; 2.40 ; CRYSTAL STRUCTURE OF A DICTYOSTELIUM/TETRAHYMENA CHIMERA ACTIN (MUTANT 646: Q228K/T229A/A230Y/A231K/S232E/E360H) IN COMPLEX WITH HUMAN GELSOLIN SEGMENT 1 1C1E ; 1.90 ; CRYSTAL STRUCTURE OF A DIELS-ALDERASE CATALYTIC ANTIBODY 1E9 IN COMPLEX WITH ITS HAPTEN 1M2Z ; 2.50 ; CRYSTAL STRUCTURE OF A DIMER COMPLEX OF THE HUMAN GLUCOCORTICOID RECEPTOR LIGAND-BINDING DOMAIN BOUND TO DEXAMETHASONE AND A TIF2 COACTIVATOR MOTIF 1U73 ; 1.90 ; CRYSTAL STRUCTURE OF A DIMERIC ACIDIC PLATELET AGGREGATION INHIBITOR AND HYPOTENSIVE PHOSPHOLIPASE A2 FROM BOTHROPS JARARACUSSU 1RLV ; 3.00 ; CRYSTAL STRUCTURE OF A DIMERIC ARCHAEAL SPLICING ENDONUCLEASE 2AR9 ; 2.80 ; CRYSTAL STRUCTURE OF A DIMERIC CASPASE-9 1CVS ; 2.80 ; CRYSTAL STRUCTURE OF A DIMERIC FGF2-FGFR1 COMPLEX 1UUP ; 2.60 ; CRYSTAL STRUCTURE OF A DIMERIC FORM OF STREPTOCOCCAL PYROGENIC EXOTOXIN A (SPEA1). 1K1Q ; 2.80 ; CRYSTAL STRUCTURE OF A DINB FAMILY ERROR PRONE DEOXYRIBONUCLEIC ACID POLYMERASE FROM SULFOLOBUS SOLFATARICUS 1IM4 ; 2.30 ; CRYSTAL STRUCTURE OF A DINB HOMOLOG (DBH) LESION BYPASS DEOXYRIBONUCLEIC ACID POLYMERASE CATALYTIC FRAGMENT FROM SULFOLOBUS SOLFATARICUS 1TEJ ; 1.90 ; CRYSTAL STRUCTURE OF A DISINTEGRIN HETERODIMER AT 1.9 A RESOLUTION. 1G6U ; 1.48 ; CRYSTAL STRUCTURE OF A DOMAIN SWAPPED DIMER 1L5T ; 3.00 ; CRYSTAL STRUCTURE OF A DOMAIN-OPENED MUTANT (R121D) OF THE HUMAN LACTOFERRIN N-LOBE REFINED FROM A MEROHEDRALLY- TWINNED CRYSTAL FORM. 1JYJ ; 2.00 ; CRYSTAL STRUCTURE OF A DOUBLE VARIANT (W67L/W91H) OF RECOMBINANT HUMAN SERUM RETINOL-BINDING PROTEIN AT 2.0 A RESOLUTION 1AIO ; 2.60 ; CRYSTAL STRUCTURE OF A DOUBLE-STRANDED DEOXYRIBONUCLEIC ACID CONTAINING THE MAJOR ADDUCT OF THE ANTICANCER DRUG CISPLATIN 1A2E ; 1.63 ; CRYSTAL STRUCTURE OF A DOUBLE-STRANDED DEOXYRIBONUCLEIC ACID DECAMER CONTAINING A CISPLATIN INTERSTRAND CROSS-LINK ADDUCT 1N1Q ; 2.20 ; CRYSTAL STRUCTURE OF A DPS PROTEIN FROM BACILLUS BREVIS 1DI2 ; 1.90 ; CRYSTAL STRUCTURE OF A DSRNA-BINDING DOMAIN COMPLEXED WITH DSRNA: MOLECULAR BASIS OF DOUBLE-STRANDED RIBONUCLEIC ACID-PROTEIN INTERACTIONS 1U15 ; 2.50 ; CRYSTAL STRUCTURE OF A DUCK-DELTA-CRYSTALLIN-1 DOUBLE LOOP MUTANT (DLM) 1U16 ; 2.20 ; CRYSTAL STRUCTURE OF A DUCK-DELTA-CRYSTALLIN-1 DOUBLE LOOP MUTANT (DLM) IN COMPLEX WITH SULFATE 1KSI ; 2.20 ; CRYSTAL STRUCTURE OF A EUKARYOTIC (PEA SEEDLING) COPPER-CONTAINING AMINE OXIDASE AT 2.2A RESOLUTION 2BCF ; 2.30 ; CRYSTAL STRUCTURE OF A EVOLVED PUTATIVE PENICILLIN-BINDING PROTEIN HOMOLOG, RV2911, FROM MYCOBACTERIUM TUBERCULOSIS. 1OB1 ; 2.90 ; CRYSTAL STRUCTURE OF A FAB COMPLEX WHITH PLASMODIUM FALCIPARUM MSP1-19 1PZ3 ; 1.75 ; CRYSTAL STRUCTURE OF A FAMILY 51 (GH51) ALPHA-L- ARABINOFURANOSIDASE FROM GEOBACILLUS STEAROTHERMOPHILUS T6 1QW9 ; 1.20 ; CRYSTAL STRUCTURE OF A FAMILY 51 ALPHA-L- ARABINOFURANOSIDASE IN COMPLEX WITH 4-NITROPHENYL-ARA 1QW8 ; 1.80 ; CRYSTAL STRUCTURE OF A FAMILY 51 ALPHA-L- ARABINOFURANOSIDASE IN COMPLEX WITH ARA-ALPHA(1,3)-XYL 1G43 ; 2.20 ; CRYSTAL STRUCTURE OF A FAMILY IIIA CBD FROM CLOSTRIDIUM CELLULOLYTICUM 1VI1 ; 2.95 ; CRYSTAL STRUCTURE OF A FATTY ACID/PHOSPHOLIPID SYNTHESIS PROTEIN 1MIX ; 1.75 ; CRYSTAL STRUCTURE OF A FERM DOMAIN OF TALIN 1FBN ; 1.60 ; CRYSTAL STRUCTURE OF A FIBRILLARIN HOMOLOGUE FROM METHANOCOCCUS JANNASCHII, A HYPERTHERMOPHILE, AT 1.6 A 1QX8 ; 2.02 ; CRYSTAL STRUCTURE OF A FIVE-RESIDUE DELETION MUTANT OF THE ROP PROTEIN 1VH6 ; 2.50 ; CRYSTAL STRUCTURE OF A FLAGELLAR PROTEIN 1MRZ ; 1.90 ; CRYSTAL STRUCTURE OF A FLAVIN BINDING PROTEIN FROM THERMOTOGA MARITIMA, TM379 1SL6 ; 2.25 ; CRYSTAL STRUCTURE OF A FRAGMENT OF DC-SIGNR (CONTAING THE CARBOHYDRATE RECOGNITION DOMAIN AND TWO REPEATS OF THE NECK) COMPLEXED WITH LEWIS-X. 1XAR ; 2.25 ; CRYSTAL STRUCTURE OF A FRAGMENT OF DC-SIGNR (CONTAINING THE CARBOHYDRATE RECOGNITION DOMAIN AND TWO REPEATS OF THE NECK). 1SGS ; 1.60 ; CRYSTAL STRUCTURE OF A FREE KB DEOXYRIBONUCLEIC ACID 1J7X ; 1.80 ; CRYSTAL STRUCTURE OF A FUNCTIONAL UNIT OF INTERPHOTORECEPTOR RETINOID-BINDING PROTEIN (IRBP) 1Y02 ; 1.80 ; CRYSTAL STRUCTURE OF A FYVE-TYPE DOMAIN FROM CASPASE REGULATOR CARP2 1TOQ ; 2.50 ; CRYSTAL STRUCTURE OF A GALACTOSE SPECIFIC LECTIN FROM ARTOCARPUS HIRSUTA IN COMPLEX WITH METHYL-A-D-GALACTOSE 1TP8 ; 3.00 ; CRYSTAL STRUCTURE OF A GALACTOSE SPECIFIC LECTIN FROM ARTOCARPUS HIRSUTA IN COMPLEX WITH METHYL-A-D-GALACTOSE 1JZN ; 2.20 ; CRYSTAL STRUCTURE OF A GALACTOSE-SPECIFIC C-TYPE LECTIN 1BO4 ; 2.30 ; CRYSTAL STRUCTURE OF A GCN5-RELATED N-ACETYLTRANSFERASE: SERRATIA MARESCENS AMINOGLYCOSIDE 3-N-ACETYLTRANSFERASE 1XEA ; 2.65 ; CRYSTAL STRUCTURE OF A GFO/IDH/MOCA FAMILY OXIDOREDUCTASE FROM VIBRIO CHOLERAE 1WIW ; 2.00 ; CRYSTAL STRUCTURE OF A GLUCOSE-6-PHOSPHATE ISOMERASE LIKE PROTEIN FROM THERMUS THERMOPHILUS HB8 2BSW ; 1.63 ; CRYSTAL STRUCTURE OF A GLYPHOSATE-N-ACETYLTRANSFERASE OBTAINED BY DEOXYRIBONUCLEIC ACID SHUFFLING. 1DKD ; 2.10 ; CRYSTAL STRUCTURE OF A GROEL (APICAL DOMAIN) AND A DODECAMERIC PEPTIDE COMPLEX 1ZZN ; 3.37 ; CRYSTAL STRUCTURE OF A GROUP I INTRON/TWO EXON COMPLEX THAT INCLUDES ALL CATALYTIC METAL ION LIGANDS. 1GID ; 2.50 ; CRYSTAL STRUCTURE OF A GROUP I RIBOZYME DOMAIN: PRINCIPLES OF RIBONUCLEIC ACID PACKING 1M5K ; 2.40 ; CRYSTAL STRUCTURE OF A HAIRPIN RIBOZYME IN THE CATALYTICALLY-ACTIVE CONFORMATION 1X42 ; 2.00 ; CRYSTAL STRUCTURE OF A HALOACID DEHALOGENASE FAMILY PROTEIN (PH0459) FROM PYROCOCCUS HORIKOSHII OT3 1Y7W ; 1.86 ; CRYSTAL STRUCTURE OF A HALOTOLERANT CARBONIC ANHYDRASE FROM DUNALIELLA SALINA 1ZZ0 ; 1.60 ; CRYSTAL STRUCTURE OF A HDAC-LIKE PROTEIN WITH ACETATE BOUND 1ZZ3 ; 1.76 ; CRYSTAL STRUCTURE OF A HDAC-LIKE PROTEIN WITH CYPX BOUND 1ZZ1 ; 1.57 ; CRYSTAL STRUCTURE OF A HDAC-LIKE PROTEIN WITH SAHA BOUND 1H6W ; 1.90 ; CRYSTAL STRUCTURE OF A HEAT- AND PROTEASE-STABLE FRAGMENT OF THE BACTERIOPHAGE T4 SHORT FIBRE 1QXM ; 1.70 ; CRYSTAL STRUCTURE OF A HEMAGGLUTININ COMPONENT (HA1) FROM TYPE C CLOSTRIDIUM BOTULINUM 1IW0 ; 1.40 ; CRYSTAL STRUCTURE OF A HEME OXYGENASE (HMUO) FROM CORYNEBACTERIUM DIPHTHERIAE COMPLEXED WITH HEME IN THE FERRIC STATE 1IW1 ; 1.50 ; CRYSTAL STRUCTURE OF A HEME OXYGENASE (HMUO) FROM CORYNEBACTERIUM DIPHTHERIAE COMPLEXED WITH HEME IN THE FERROUS STATE 1X3K ; 1.64 ; CRYSTAL STRUCTURE OF A HEMOGLOBIN COMPONENT (TA-V) FROM TOKUNAGAYUSURIKA AKAMUSI 1X46 ; 1.50 ; CRYSTAL STRUCTURE OF A HEMOGLOBIN COMPONENT (TA-VII) FROM TOKUNAGAYUSURIKA AKAMUSI 1I81 ; 2.00 ; CRYSTAL STRUCTURE OF A HEPTAMERIC LSM PROTEIN FROM METHANOBACTERIUM THERMOAUTOTROPHICUM 1N9R ; 2.80 ; CRYSTAL STRUCTURE OF A HEPTAMERIC RING COMPLEX OF YEAST SMF IN SPACEGROUP P4122 1MGQ ; 1.70 ; CRYSTAL STRUCTURE OF A HEPTAMERIC SM-LIKE PROTEIN FROM METHANOBACTERIUM THERMOAUTOTROPHICUM 1DKF ; 2.50 ; CRYSTAL STRUCTURE OF A HETERODIMERIC COMPLEX OF RAR AND RXR LIGAND-BINDING DOMAINS 1WKX ; 1.70 ; CRYSTAL STRUCTURE OF A HEV B 6.02 ISOALLERGEN 481D ; 1.60 ; CRYSTAL STRUCTURE OF A HEXITOL NUCLEIC ACID (HNA) DUPLEX AT 1.6A RESOLUTION 1D7Z ; 2.21 ; CRYSTAL STRUCTURE OF A HEXITOL NUCLEIC ACID (HNA) DUPLEX AT 2.2 A RESOLUTION 1TJB ; 2.00 ; CRYSTAL STRUCTURE OF A HIGH AFFINITY LANTHANIDE-BINDING PEPTIDE (LBT) 1AQZ ; 1.70 ; CRYSTAL STRUCTURE OF A HIGHLY SPECIFIC ASPERGILLUS RIBOTOXIN, RESTRICTOCIN 1J1I ; 1.86 ; CRYSTAL STRUCTURE OF A HIS-TAGGED SERINE HYDROLASE INVOLVED IN THE CARBAZOLE DEGRADATION (CARC ENZYME) 1U8G ; 2.20 ; CRYSTAL STRUCTURE OF A HIV-1 PROTEASE IN COMPLEX WITH PEPTIDOMIMETIC INHIBITOR KI2-PHE-GLU-GLU-NH2 1N3L ; 1.18 ; CRYSTAL STRUCTURE OF A HUMAN AMINOACYL-TRNA SYNTHETASE CYTOKINE 1XO2 ; 2.90 ; CRYSTAL STRUCTURE OF A HUMAN CYCLIN-DEPENDENT KINASE 6 COMPLEX WITH A FLAVONOL INHIBITOR, FISETIN 1IIX ; 3.50 ; CRYSTAL STRUCTURE OF A HUMAN FCG RECEPTOR IN COMPLEX WITH AN FC FRAGMENT OF IGG1 (HEXAGONAL) 1IIS ; 3.00 ; CRYSTAL STRUCTURE OF A HUMAN FCG RECEPTOR IN COMPLEX WITH AN FC FRAGMENT OF IGG1 (ORTHORHOMBIC) 1SWX ; 1.65 ; CRYSTAL STRUCTURE OF A HUMAN GLYCOLIPID TRANSFER PROTEIN IN APO-FORM 1H3Y ; 4.10 ; CRYSTAL STRUCTURE OF A HUMAN IGG1 FC-FRAGMENT,HIGH SALT CONDITION 1ADQ ; 3.15 ; CRYSTAL STRUCTURE OF A HUMAN IGM RHEUMATOID FACTOR FAB IN COMPLEX WITH ITS AUTOANTIGEN IGG FC 1JK8 ; 2.40 ; CRYSTAL STRUCTURE OF A HUMAN INSULIN PEPTIDE-HLA-DQ8 COMPLEX 5PNT ; 2.20 ; CRYSTAL STRUCTURE OF A HUMAN LOW MOLECULAR WEIGHT PHOSPHOTYROSYL PHOSPHATASE. IMPLICATIONS FOR SUBSTRATE SPECIFICITY 2AW5 ; 2.50 ; CRYSTAL STRUCTURE OF A HUMAN MALIC ENZYME 1R03 ; 1.70 ; CRYSTAL STRUCTURE OF A HUMAN MITOCHONDRIAL FERRITIN 1PI1 ; 2.00 ; CRYSTAL STRUCTURE OF A HUMAN MOB1 PROTEIN; TOWARD UNDERSTANDING MOB-REGULATED CELL CYCLE PATHWAYS. 1ONI ; 1.90 ; CRYSTAL STRUCTURE OF A HUMAN P14.5, A TRANSLATIONAL INHIBITOR REVEALS DIFFERENT MODE OF LIGAND BINDING NEAR THE INVARIANT RESIDUES OF THE YJGF/UK114 PROTEIN FAMILY 1EW2 ; 1.82 ; CRYSTAL STRUCTURE OF A HUMAN PHOSPHATASE 2AJP ; 2.50 ; CRYSTAL STRUCTURE OF A HUMAN PYRIDOXAL KINASE 1K5M ; 2.70 ; CRYSTAL STRUCTURE OF A HUMAN RHINOVIRUS TYPE 14:HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 V3 LOOP CHIMERIC VIRUS MN- III-2 1C9B ; 2.65 ; CRYSTAL STRUCTURE OF A HUMAN TBP CORE DOMAIN-HUMAN TFIIB CORE DOMAIN COMPLEX BOUND TO AN EXTENDED, MODIFIED ADENOVIRAL MAJOR LATE PROMOTER (ADMLP) 1JPW ; 2.50 ; CRYSTAL STRUCTURE OF A HUMAN TCF-4 / BETA-CATENIN COMPLEX 1T89 ; 3.50 ; CRYSTAL STRUCTURE OF A HUMAN TYPE III FC GAMMA RECEPTOR IN COMPLEX WITH AN FC FRAGMENT OF IGG1 (HEXAGONAL) 1T83 ; 3.00 ; CRYSTAL STRUCTURE OF A HUMAN TYPE III FC GAMMA RECEPTOR IN COMPLEX WITH AN FC FRAGMENT OF IGG1 (ORTHORHOMBIC) 1MU7 ; 2.00 ; CRYSTAL STRUCTURE OF A HUMAN TYROSYL-DEOXYRIBONUCLEIC ACID PHOSPHODIESTERASE (TDP1)-TUNGSTATE COMPLEX 1MU9 ; 2.05 ; CRYSTAL STRUCTURE OF A HUMAN TYROSYL-DEOXYRIBONUCLEIC ACID PHOSPHODIESTERASE (TDP1)-VANADATE COMPLEX 1HXM ; 3.12 ; CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR 1T2J ; 1.50 ; CRYSTAL STRUCTURE OF A HUMAN VH DOMAIN 1S3K ; 1.90 ; CRYSTAL STRUCTURE OF A HUMANIZED FAB (HU3S193) IN COMPLEX WITH THE LEWIS Y TETRASACCHARIDE 1UJ3 ; 2.10 ; CRYSTAL STRUCTURE OF A HUMANIZED FAB FRAGMENT OF ANTI- TISSUE-FACTOR ANTIBODY IN COMPLEX WITH TISSUE FACTOR 1B6V ; 2.00 ; CRYSTAL STRUCTURE OF A HYBRID BETWEEN RIBONUCLEASE A AND BOVINE SEMINAL RIBONUCLEASE 1V8B ; 2.40 ; CRYSTAL STRUCTURE OF A HYDROLASE 1LQB ; 2.00 ; CRYSTAL STRUCTURE OF A HYDROXYLATED HIF-1 ALPHA PEPTIDE BOUND TO THE PVHL/ELONGIN-C/ELONGIN-B COMPLEX 1U2X ; 2.00 ; CRYSTAL STRUCTURE OF A HYPOTHETICAL ADP-DEPENDENT PHOSPHOFRUCTOKINASE FROM PYROCOCCUS HORIKOSHII OT3 1O6D ; 1.66 ; CRYSTAL STRUCTURE OF A HYPOTHETICAL PROTEIN 1RXD ; 1.90 ; CRYSTAL STRUCTURE OF A HYPOTHETICAL PROTEIN 1VH0 ; 2.31 ; CRYSTAL STRUCTURE OF A HYPOTHETICAL PROTEIN 1VIV ; 2.60 ; CRYSTAL STRUCTURE OF A HYPOTHETICAL PROTEIN 1X94 ; 2.50 ; CRYSTAL STRUCTURE OF A HYPOTHETICAL PROTEIN 1QW2 ; 1.50 ; CRYSTAL STRUCTURE OF A HYPOTHETICAL PROTEIN "TA1206" FROM THERMOPLASMA ACIDOPHILUM 1YAV ; 2.10 ; CRYSTAL STRUCTURE OF A HYPOTHETICAL PROTEIN (YKUL) CONTAINING CBS DOMAINS FROM BACILLUS SUBTILIS. 2ARH ; 2.46 ; CRYSTAL STRUCTURE OF A HYPOTHETICAL PROTEIN AQ_1966 FROM AQUIFEX AEOLICUS VF5 1SUM ; 2.00 ; CRYSTAL STRUCTURE OF A HYPOTHETICAL PROTEIN AT 2.0 A RESOLUTION 1STZ ; 2.20 ; CRYSTAL STRUCTURE OF A HYPOTHETICAL PROTEIN AT 2.2 A RESOLUTION 1SU0 ; 2.30 ; CRYSTAL STRUCTURE OF A HYPOTHETICAL PROTEIN AT 2.3 A RESOLUTION 2AP6 ; 2.50 ; CRYSTAL STRUCTURE OF A HYPOTHETICAL PROTEIN ATU4242 FROM AGROBACTERIUM TUMEFACIENS (STRAIN C58 / ATCC 33970). NESG TARGET ATR43 1TLQ ; 2.40 ; CRYSTAL STRUCTURE OF A HYPOTHETICAL PROTEIN FROM BACILLUS SUBTILIS 2AZ4 ; 2.00 ; CRYSTAL STRUCTURE OF A HYPOTHETICAL PROTEIN FROM ENTEROCOCCUS FAECALIS V583 1YV9 ; 2.80 ; CRYSTAL STRUCTURE OF A HYPOTHETICAL PROTEIN FROM HYDROLASE HALOACID DEHALOGENASE-LIKE FAMILY 1U6L ; 2.81 ; CRYSTAL STRUCTURE OF A HYPOTHETICAL PROTEIN FROM PSEUDOMONAS AERUGINOSA 1WHZ ; 1.52 ; CRYSTAL STRUCTURE OF A HYPOTHETICAL PROTEIN FROM THERMUS THERMOPHILUS HB8 1WK2 ; 2.50 ; CRYSTAL STRUCTURE OF A HYPOTHETICAL PROTEIN FROM THERMUS THERMOPHILUS HB8 2CV9 ; 2.50 ; CRYSTAL STRUCTURE OF A HYPOTHETICAL PROTEIN FROM THERMUS THERMOPHILUS HB8 1RV9 ; 1.53 ; CRYSTAL STRUCTURE OF A HYPOTHETICAL PROTEIN NMB0706 1TU9 ; 1.20 ; CRYSTAL STRUCTURE OF A HYPOTHETICAL PROTEIN PA3967, A STRUCTURALLY HIGHLY HOMOLOGOUS TO A HUMAN HEMOGLOBIN FROM PSEUDOMONAS AERUGINOSA PAO1 1Z54 ; 2.10 ; CRYSTAL STRUCTURE OF A HYPOTHETICAL PROTEIN TT1821 FROM THERMUS THERMOPHILUS 1ZPW ; 1.64 ; CRYSTAL STRUCTURE OF A HYPOTHETICAL PROTEIN TT1823 FROM THERMUS THERMOPHILUS 1ZVP ; 2.20 ; CRYSTAL STRUCTURE OF A HYPOTHETICAL PROTEIN VC0802 FROM VIBRIO CHOLERAE 1TXL ; 1.70 ; CRYSTAL STRUCTURE OF A HYPOTHETICAL PROTEIN YODA FROM E. COLI (YODA_ECOLI) 1T35 ; 2.72 ; CRYSTAL STRUCTURE OF A HYPOTHETICAL PROTEIN YVDD- A PUTATIVE LYSINE DECARBOXYLASE 1YDF ; 2.60 ; CRYSTAL STRUCTURE OF A HYPOTHETICAL PROTEIN, HYDROLASE HALOACID DEHALOGENASE-LIKE FAMILY 1J27 ; 1.70 ; CRYSTAL STRUCTURE OF A HYPOTHETICAL PROTEIN, TT1725, FROM THERMUS THERMOPHILUS HB8 AT 1.7A RESOLUTION 1Z1B ; 3.80 ; CRYSTAL STRUCTURE OF A LAMBDA INTEGRASE DIMER BOUND TO A COC' CORE SITE 1Z1G ; 4.40 ; CRYSTAL STRUCTURE OF A LAMBDA INTEGRASE TETRAMER BOUND TO A HOLLIDAY JUNCTION 1Z19 ; 2.80 ; CRYSTAL STRUCTURE OF A LAMBDA INTEGRASE(75-356) DIMER BOUND TO A COC' CORE SITE 429D ; 2.70 ; CRYSTAL STRUCTURE OF A LEADZYME; METAL BINDING AND IMPLICATIONS FOR CATALYSIS 1XED ; 1.90 ; CRYSTAL STRUCTURE OF A LIGAND-BINDING DOMAIN OF THE HUMAN POLYMERIC IG RECEPTOR, PIGR 1PV8 ; 2.20 ; CRYSTAL STRUCTURE OF A LOW ACTIVITY F12L MUTANT OF HUMAN PHORPHOBILINOGEN SYNTHASE 1VPR ; 1.80 ; CRYSTAL STRUCTURE OF A LUCIFERASE DOMAIN FROM THE DINOFLAGELLATE LINGULODINIUM POLYEDRUM 2A43 ; 1.34 ; CRYSTAL STRUCTURE OF A LUTEOVIRAL RIBONUCLEIC ACID PSEUDOKNOT AND MODEL FOR A MINIMAL RIBOSOMAL FRAMESHIFTING MOTIF 1UC8 ; 2.00 ; CRYSTAL STRUCTURE OF A LYSINE BIOSYNTHESIS ENZYME, LYSX, FROM THERMUS THERMOPHILUS HB8 1UC9 ; 2.38 ; CRYSTAL STRUCTURE OF A LYSINE BIOSYNTHESIS ENZYME, LYSX, FROM THERMUS THERMOPHILUS HB8 2F08 ; 2.20 ; CRYSTAL STRUCTURE OF A MAJOR HOUSE DUST MITE ALLERGEN, DERF 2 1ZL9 ; 2.01 ; CRYSTAL STRUCTURE OF A MAJOR NEMATODE C.ELEGANS SPECIFIC GST (CE01613) 1SMA ; 2.80 ; CRYSTAL STRUCTURE OF A MALTOGENIC AMYLASE 1QQ2 ; 2.60 ; CRYSTAL STRUCTURE OF A MAMMALIAN 2-CYS PEROXIREDOXIN, HBP23. 1Y23 ; 2.30 ; CRYSTAL STRUCTURE OF A MEMBER OF HIT FAMILY OF PROTEINS FROM BACILLUS SUBTILIS 1XXN ; 1.70 ; CRYSTAL STRUCTURE OF A MESOPHILIC XYLANASE A FROM BACILLUS SUBTILIS 1A1 1UKA ; 1.70 ; CRYSTAL STRUCTURE OF A META-CLEAVAGE PRODUCT HYDROLASE (CUMD) COMPLEXED WITH (S)-2-METHYLBUTYRATE 1UKB ; 1.80 ; CRYSTAL STRUCTURE OF A META-CLEAVAGE PRODUCT HYDROLASE (CUMD) COMPLEXED WITH BENZOATE 1UK9 ; 1.80 ; CRYSTAL STRUCTURE OF A META-CLEAVAGE PRODUCT HYDROLASE (CUMD) COMPLEXED WITH ISOVALERATE 1UK7 ; 1.70 ; CRYSTAL STRUCTURE OF A META-CLEAVAGE PRODUCT HYDROLASE (CUMD) COMPLEXED WITH N-BUTYRATE 1UK8 ; 1.60 ; CRYSTAL STRUCTURE OF A META-CLEAVAGE PRODUCT HYDROLASE (CUMD) COMPLEXED WITH N-VALERATE 1UK6 ; 1.95 ; CRYSTAL STRUCTURE OF A META-CLEAVAGE PRODUCT HYDROLASE (CUMD) COMPLEXED WITH PROPIONATE 1LOJ ; 1.90 ; CRYSTAL STRUCTURE OF A METHANOBACTERIAL SM-LIKE ARCHAEAL PROTEIN (SMAP1) BOUND TO URIDINE-5'-MONOPHOSPHATE (UMP) 1DPF ; 2.00 ; CRYSTAL STRUCTURE OF A MG-FREE FORM OF RHOA COMPLEXED WITH GDP 2D2L ; 2.50 ; CRYSTAL STRUCTURE OF A MINIMAL, ALL-RIBONUCLEIC ACID HAIRPIN RIBOZYME WITH A PROPYL LINKER (C3) AT POSITION U39 2D2K ; 2.65 ; CRYSTAL STRUCTURE OF A MINIMAL, NATIVE (U39) ALL-RIBONUCLEIC ACID HAIRPIN RIBOZYME 1DDX ; 3.00 ; CRYSTAL STRUCTURE OF A MIXTURE OF ARACHIDONIC ACID AND PROSTAGLANDIN BOUND TO THE CYCLOOXYGENASE ACTIVE SITE OF COX-2: PROSTAGLANDIN STRUCTURE 1M3W ; 2.80 ; CRYSTAL STRUCTURE OF A MOLECULAR MAQUETTE SCAFFOLD 1M71 ; 2.80 ; CRYSTAL STRUCTURE OF A MONOCLONAL FAB SPECIFIC FOR SHIGELLA FLEXNERI Y LIPOPOLYSACCHARIDE 1M7I ; 2.50 ; CRYSTAL STRUCTURE OF A MONOCLONAL FAB SPECIFIC FOR SHIGELLA FLEXNERI Y LIPOPOLYSACCHARIDE COMPLEXED WITH A PENTASACCHARIDE 1M7D ; 2.30 ; CRYSTAL STRUCTURE OF A MONOCLONAL FAB SPECIFIC FOR SHIGELLA FLEXNERI Y LIPOPOLYSACCHARIDE COMPLEXED WITH A TRISACCHARIDE 1E1E ; 2.50 ; CRYSTAL STRUCTURE OF A MONOCOT (MAIZE ZMGLU1) BETA-GLUCOSIDASE 1E1F ; 2.60 ; CRYSTAL STRUCTURE OF A MONOCOT (MAIZE ZMGLU1) BETA-GLUCOSIDASE IN COMPLEX WITH P-NITROPHENYL-BETA-D-THIOGLUCOSIDE 1IFG ; 2.00 ; CRYSTAL STRUCTURE OF A MONOMERIC FORM OF GENERAL PROTEASE INHIBITOR, ECOTIN IN ABSENCE OF A PROTEASE 1N5Q ; 1.74 ; CRYSTAL STRUCTURE OF A MONOOXYGENASE FROM THE GENE ACTVA- ORF6 OF STREPTOMYCES COELICOLOR IN COMPLEX WITH DEHYDRATED SANCYCLINE 1N5S ; 1.70 ; CRYSTAL STRUCTURE OF A MONOOXYGENASE FROM THE GENE ACTVA- ORF6 OF STREPTOMYCES COELICOLOR IN COMPLEX WITH THE LIGAND ACETYL DITHRANOL 1N5V ; 2.24 ; CRYSTAL STRUCTURE OF A MONOOXYGENASE FROM THE GENE ACTVA- ORF6 OF STREPTOMYCES COELICOLOR IN COMPLEX WITH THE LIGAND NANAOMYCIN D 1N5T ; 1.90 ; CRYSTAL STRUCTURE OF A MONOOXYGENASE FROM THE GENE ACTVA- ORF6 OF STREPTOMYCES COELICOLOR IN COMPLEX WITH THE LIGAND OXIDIZED ACETYL DITHRANOL 1LQ9 ; 1.30 ; CRYSTAL STRUCTURE OF A MONOOXYGENASE FROM THE GENE ACTVA- ORF6 OF STREPTOMYCES COELICOLOR STRAIN A3(2) 1YN7 ; 2.20 ; CRYSTAL STRUCTURE OF A MOUSE MHC CLASS I PROTEIN, H2-DB, IN COMPLEX WITH A MUTATED PEPTIDE (R7A) OF THE INFLUENZA A ACID POLYMERASE 1YN6 ; 2.20 ; CRYSTAL STRUCTURE OF A MOUSE MHC CLASS I PROTEIN, H2-DB, IN COMPLEX WITH A PEPTIDE FROM THE INFLUENZA A ACID POLYMERASE 1QXP ; 2.80 ; CRYSTAL STRUCTURE OF A MU-LIKE CALPAIN 1MWI ; 2.35 ; CRYSTAL STRUCTURE OF A MUG-DEOXYRIBONUCLEIC ACID PRODUCT COMPLEX 1MWJ ; 2.85 ; CRYSTAL STRUCTURE OF A MUG-DEOXYRIBONUCLEIC ACID PSEUDO SUBSTRATE COMPLEX 1SIF ; 2.18 ; CRYSTAL STRUCTURE OF A MULTIPLE HYDROPHOBIC CORE MUTANT OF UBIQUITIN 1NZK ; 1.95 ; CRYSTAL STRUCTURE OF A MULTIPLE MUTANT (L44F, L73V, V109L, L111I, C117V) OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR 1L8V ; 2.80 ; CRYSTAL STRUCTURE OF A MUTANT (C109G,G212C) P4-P6 DOMAIN OF THE GROUP I INTRON FROM TETRAHYMENA THERMOPHILIA 1XRK ; 1.50 ; CRYSTAL STRUCTURE OF A MUTANT BLEOMYCIN BINDING PROTEIN FROM STREPTOALLOTEICHUS HINDUSTANUS DISPLAYING INCREASED THERMOSTABILITY 1MK8 ; 1.65 ; CRYSTAL STRUCTURE OF A MUTANT CYTOCHROME C PEROXIDASE SHOWING A NOVEL TRP-TYR COVALENT CROSS-LINK 1TI1 ; 2.60 ; CRYSTAL STRUCTURE OF A MUTANT DSBA 2BV3 ; 2.50 ; CRYSTAL STRUCTURE OF A MUTANT ELONGATION FACTOR G TRAPPED WITH A GTP ANALOGUE 1LWF ; 2.80 ; CRYSTAL STRUCTURE OF A MUTANT HIV-1 REVERSE TRANSCRIPTASE (RTMQ+M184V: M41L/D67N/K70R/M184V/T215Y) IN COMPLEX WITH NEVIRAPINE 1I3R ; 2.40 ; CRYSTAL STRUCTURE OF A MUTANT IEK CLASS II MHC MOLECULE 1OUZ ; 2.41 ; CRYSTAL STRUCTURE OF A MUTANT IHF (BETAE44A) COMPLEXED WITH A VARIANT H' SITE (T44A) 1OWF ; 1.95 ; CRYSTAL STRUCTURE OF A MUTANT IHF (BETAE44A) COMPLEXED WITH THE NATIVE H' SITE 1U7X ; 3.00 ; CRYSTAL STRUCTURE OF A MUTANT M. JANNASHII TYROSYL-TRNA SYNTHETASE SPECIFIC FOR O-METHYL-TYROSINE 1IW8 ; 2.50 ; CRYSTAL STRUCTURE OF A MUTANT OF ACID PHOSPHATASE FROM ESCHERICHIA BLATTAE (G74D/I153T) 1YMI ; 1.66 ; CRYSTAL STRUCTURE OF A MUTANT OF HUMAN PROTEIN KINASE CK2ALPHA WITH ALTERED COSUBSTRATE SPECIFICITY 1KQJ ; 1.70 ; CRYSTAL STRUCTURE OF A MUTANT OF MUTY CATALYTIC DOMAIN 1ISE ; 2.20 ; CRYSTAL STRUCTURE OF A MUTANT OF RIBOSOME RECYCLING FACTOR FROM ESCHERICHIA COLI, ARG132GLY 1Q93 ; 2.25 ; CRYSTAL STRUCTURE OF A MUTANT OF THE SARCIN/RICIN DOMAIN FROM RAT 28S RRNA 1Q96 ; 1.75 ; CRYSTAL STRUCTURE OF A MUTANT OF THE SARCIN/RICIN DOMAIN FROM RAT 28S RRNA 1C7H ; 2.50 ; CRYSTAL STRUCTURE OF A MUTANT R75A IN KETOSTEROID ISOMERASE FROM PSEDOMONAS PUTIDA BIOTYPE B 1MKR ; 1.58 ; CRYSTAL STRUCTURE OF A MUTANT VARIANT OF CYTOCHROME C PEROXIDASE (PLATE LIKE CRYSTALS) 1ML2 ; 1.65 ; CRYSTAL STRUCTURE OF A MUTANT VARIANT OF CYTOCHROME C PEROXIDASE WITH ZN(II)-(20-OXO-PROTOPORPHYRIN IX) 1W6Y ; 2.10 ; CRYSTAL STRUCTURE OF A MUTANT W92A IN KETOSTEROID ISOMERASE (KSI) FROM PSEUDOMONAS PUTIDA BIOTYPE B 1FMZ ; 2.05 ; CRYSTAL STRUCTURE OF A MUTANT WINGED BEAN CHYMOTRYPSIN INHIBITOR PROTEIN, N14K. 1K9E ; 1.85 ; CRYSTAL STRUCTURE OF A MUTATED FAMILY-67 ALPHA-D- GLUCURONIDASE (E285N) FROM BACILLUS STEAROTHERMOPHILUS T-6, COMPLEXED WITH 4-O-METHYL-GLUCURONIC ACID 1K9F ; 1.75 ; CRYSTAL STRUCTURE OF A MUTATED FAMILY-67 ALPHA-D- GLUCURONIDASE (E285N) FROM BACILLUS STEAROTHERMOPHILUS T-6, COMPLEXED WITH ALDOTETRAOURONIC ACID 1EP8 ; 2.20 ; CRYSTAL STRUCTURE OF A MUTATED THIOREDOXIN, D30A, FROM CHLAMYDOMONAS REINHARDTII 1N3N ; 3.00 ; CRYSTAL STRUCTURE OF A MYCOBACTERIAL HSP60 EPITOPE WITH THE MURINE CLASS I MHC MOLECULE H-2DB 1U5E ; 2.60 ; CRYSTAL STRUCTURE OF A N-TERMINAL FRAGMENT OF SKAP-HOM CONTAINING BOTH THE HELICAL DIMERIZATION DOMAIN AND THE PH DOMAIN 1Z0U ; 2.00 ; CRYSTAL STRUCTURE OF A NAD KINASE FROM ARCHAEOGLOBUS FULGIDUS BOUND BY NADP 1SUW ; 2.45 ; CRYSTAL STRUCTURE OF A NAD KINASE FROM ARCHAEOGLOBUS FULGIDUS IN COMPLEX WITH ITS SUBSTRATE AND PRODUCT: INSIGHTS INTO THE CATALYSIS OF NAD KINASE 1Z0Z ; 2.85 ; CRYSTAL STRUCTURE OF A NAD KINASE FROM ARCHAEOGLOBUS FULGIDUS IN COMPLEX WITH NAD 1VJY ; 2.00 ; CRYSTAL STRUCTURE OF A NAPHTHYRIDINE INHIBITOR OF HUMAN TGF- BETA TYPE I RECEPTOR 1WNO ; 2.10 ; CRYSTAL STRUCTURE OF A NATIVE CHITINASE FROM ASPERGILLUS FUMIGATUS YJ-407 1MVE ; 1.70 ; CRYSTAL STRUCTURE OF A NATURAL CIRCULARLY-PERMUTATED JELLYROLL PROTEIN: 1,3-1,4-BETA-D-GLUCANASE FROM FIBROBACTER SUCCINOGENES 1FE6 ; 1.80 ; CRYSTAL STRUCTURE OF A NATURALLY OCCURING PARALLEL RIGHT- HANDED COILED-COIL TETRAMER 1MPT ; 2.40 ; CRYSTAL STRUCTURE OF A NEW ALKALINE SERINE PROTEASE (M- PROTEASE) FROM BACILLUS SP. KSM-K16 1LN8 ; 1.65 ; CRYSTAL STRUCTURE OF A NEW ISOFORM OF PHOSPHOLIPASE A2 FROM NAJA NAJA SAGITTIFERA AT 1.6 A RESOLUTION 1RDT ; 2.40 ; CRYSTAL STRUCTURE OF A NEW REXINOID BOUND TO THE RXRALPHA LIGAND BINDING DOAMIN IN THE RXRALPHA/PPARGAMMA HETERODIMER 1RL0 ; 1.40 ; CRYSTAL STRUCTURE OF A NEW RIBOSOME-INACTIVATING PROTEIN (RIP): DIANTHIN 30 1JS1 ; 2.00 ; CRYSTAL STRUCTURE OF A NEW TRANSCARBAMYLASE FROM THE ANAEROBIC BACTERIUM BACTEROIDES FRAGILIS AT 2.0 A RESOLUTION 1LE5 ; 2.75 ; CRYSTAL STRUCTURE OF A NF-KB HETERODIMER BOUND TO AN IFNB-KB 1LE9 ; 3.00 ; CRYSTAL STRUCTURE OF A NF-KB HETERODIMER BOUND TO THE IG/HIV-KB SITI 1YBE ; 2.50 ; CRYSTAL STRUCTURE OF A NICOTINATE PHOSPHORIBOSYLTRANSFERASE 1YIR ; 2.10 ; CRYSTAL STRUCTURE OF A NICOTINATE PHOSPHORIBOSYLTRANSFERASE 1YTK ; 2.65 ; CRYSTAL STRUCTURE OF A NICOTINATE PHOSPHORIBOSYLTRANSFERASE FROM THERMOPLASMA ACIDOPHILUM WITH NICOTINATE MONONUCLEOTIDE 1YTD ; 2.80 ; CRYSTAL STRUCTURE OF A NICOTINATE PHOSPHORIBOSYLTRANSFERASE FROM THERMOPLASMA ACIDOPHILUM, NATIVE STRUCTURE 1YTE ; 2.75 ; CRYSTAL STRUCTURE OF A NICOTINATE PHOSPHORIBOSYLTRANSFERASE FROM THERMOPLASMA ACIDOPHILUM, PHOSPHORIBOSYLPYROPHOSPHATE BOUND STRUCTURE 1YWQ ; 2.30 ; CRYSTAL STRUCTURE OF A NITROREDUCTASE FAMILY PROTEIN FROM BACILLUS CEREUS ATCC 14579 1KCB ; 1.65 ; CRYSTAL STRUCTURE OF A NO-FORMING NITRITE REDUCTASE MUTANT: AN ANALOG OF A TRANSITION STATE IN ENZYMATIC REACTION 1A0J ; 1.70 ; CRYSTAL STRUCTURE OF A NON-PSYCHROPHILIC TRYPSIN FROM A COLD-ADAPTED FISH SPECIES. 1LP7 ; 2.40 ; CRYSTAL STRUCTURE OF A NON-SELF COMPLEMENTARY DEOXYRIBONUCLEIC ACID DODECAMER CONTAINING AN A/T TRACT: ANALYSIS OF THE EFFECT OF CRYSTAL ENVIRONMENT ON LOCAL HELICAL PARAMETERS 1GC5 ; 2.30 ; CRYSTAL STRUCTURE OF A NOVEL ADP-DEPENDENT GLUCOKINASE FROM THERMOCOCCUS LITORALIS 1JCD ; 1.30 ; CRYSTAL STRUCTURE OF A NOVEL ALANINE-ZIPPER TRIMER AT 1.3 A RESOLUTION, I6A,L9A,V13A,L16A,V20A,L23A,V27A,M30A,V34A, L48A,M51A MUTATIONS 1JCC ; 1.70 ; CRYSTAL STRUCTURE OF A NOVEL ALANINE-ZIPPER TRIMER AT 1.7 A RESOLUTION, V13A,L16A,V20A,L23A,V27A,M30A,V34A MUTATIONS 1P9G ; 0.84 ; CRYSTAL STRUCTURE OF A NOVEL ANTIFUNGAL PROTEIN DISTINCT WITH FIVE DISULFIDE BRIDGES FROM ECOMMIA ULMOIDES OLIVER AT ATOMIC RESOLUTION 1M6U ; 2.30 ; CRYSTAL STRUCTURE OF A NOVEL DEOXYRIBONUCLEIC ACID-BINDING DOMAIN FROM NDT80, A TRANSCRIPTIONAL ACTIVATOR REQUIRED FOR MEIOSIS IN YEAST 1M7U ; 2.80 ; CRYSTAL STRUCTURE OF A NOVEL DEOXYRIBONUCLEIC ACID-BINDING DOMAIN FROM NDT80, A TRANSCRIPTIONAL ACTIVATOR REQUIRED FOR MEIOSIS IN YEAST 1Z1X ; 3.20 ; CRYSTAL STRUCTURE OF A NOVEL DISINTEGRIN FROM SAW-SCALED VIPER AT 3.2 A RESOLUTION 1PC8 ; 3.80 ; CRYSTAL STRUCTURE OF A NOVEL FORM OF MISTLETOE LECTIN FROM HIMALAYAN VISCUM ALBUM L. AT 3.8A RESOLUTION 1C8B ; 3.00 ; CRYSTAL STRUCTURE OF A NOVEL GERMINATION PROTEASE FROM SPORES OF BACILLUS MEGATERIUM: STRUCTURAL REARRANGEMENTS AND ZYMOGEN ACTIVATION 1XNP ; 2.80 ; CRYSTAL STRUCTURE OF A NOVEL HEAT SHOCK REGULATOR FROM PYROCOCCUS FURIOSUS 1G2I ; 2.00 ; CRYSTAL STRUCTURE OF A NOVEL INTRACELLULAR PROTEASE FROM PYROCOCCUS HORIKOSHII AT 2 A RESOLUTION 1VJ2 ; 1.65 ; CRYSTAL STRUCTURE OF A NOVEL MANGANESE-CONTAINING CUPIN (TM1459) FROM THERMOTOGA MARITIMA AT 1.65 A RESOLUTION 2A7T ; 2.20 ; CRYSTAL STRUCTURE OF A NOVEL NEUROTOXIN FROM BUTHUS TAMALUS AT 2.2A RESOLUTION. 1T70 ; 2.30 ; CRYSTAL STRUCTURE OF A NOVEL PHOSPHATASE FROM DEINOCOCCUS RADIODURANS 1T71 ; 2.10 ; CRYSTAL STRUCTURE OF A NOVEL PHOSPHATASE MYCOPLASMA PNEUMONIAEFROM 1YXL ; 1.48 ; CRYSTAL STRUCTURE OF A NOVEL PHOSPHOLIPASE A2 FROM NAJA NAJA SAGITTIFERA AT 1.5 A RESOLUTION 1YXH ; 1.86 ; CRYSTAL STRUCTURE OF A NOVEL PHOSPHOLIPASE A2 FROM NAJA NAJA SAGITTIFERA WITH A STRONG ANTICOAGULANT ACTIVITY 1LJY ; 2.90 ; CRYSTAL STRUCTURE OF A NOVEL REGULATORY 40 KDA MAMMARY GLAND PROTEIN (MGP-40) SECRETED DURING INVOLUTION 1YKW ; 2.00 ; CRYSTAL STRUCTURE OF A NOVEL RUBISCO-LIKE PROTEIN FROM THE GREEN SULFUR BACTERIUM CHLOROBIUM TEPIDUM 1M5Q ; 2.00 ; CRYSTAL STRUCTURE OF A NOVEL SM-LIKE ARCHAEAL PROTEIN FROM PYROBACULUM AEROPHILUM 1O5U ; 1.83 ; CRYSTAL STRUCTURE OF A NOVEL THERMOTOGA MARITIMA ENZYME (TM1112) FROM THERMOTOGA MARITIMA AT 1.83 A RESOLUTION 1EGK ; 3.10 ; CRYSTAL STRUCTURE OF A NUCLEIC ACID FOUR-WAY JUNCTION 1GAJ ; 2.50 ; CRYSTAL STRUCTURE OF A NUCLEOTIDE-FREE ATP-BINDING CASSETTE FROM AN ABC TRANSPORTER 1K2E ; 1.80 ; CRYSTAL STRUCTURE OF A NUDIX PROTEIN FROM PYROBACULUM AEROPHILUM 1JRK ; 2.40 ; CRYSTAL STRUCTURE OF A NUDIX PROTEIN FROM PYROBACULUM AEROPHILUM REVEALS A DIMER WITH INTERTWINED BETA SHEETS 1ZBX ; 2.50 ; CRYSTAL STRUCTURE OF A ORC1P-SIR1P COMPLEX 1MOP ; 1.60 ; CRYSTAL STRUCTURE OF A PANTOTHENATE SYNTHETASE FROM M. TUBERCULOSIS 1N2H ; 2.00 ; CRYSTAL STRUCTURE OF A PANTOTHENATE SYNTHETASE FROM M. TUBERCULOSIS IN COMPLEX WITH A REACTION INTERMEDIATE, PANTOYL ADENYLATE 1N2G ; 1.80 ; CRYSTAL STRUCTURE OF A PANTOTHENATE SYNTHETASE FROM M. TUBERCULOSIS IN COMPLEX WITH AMPCPP 1N2E ; 1.60 ; CRYSTAL STRUCTURE OF A PANTOTHENATE SYNTHETASE FROM M. TUBERCULOSIS IN COMPLEX WITH AMPCPP AND PANTOATE 1N2B ; 1.70 ; CRYSTAL STRUCTURE OF A PANTOTHENATE SYNTHETASE FROM M. TUBERCULOSIS IN COMPLEX WITH AMPCPP AND PANTOATE, HIGHER OCCUPANCY OF PANTOATE AND LOWER OCCUPANCY OF AMPCPP IN SUBUNIT A 1N2J ; 1.80 ; CRYSTAL STRUCTURE OF A PANTOTHENATE SYNTHETASE FROM M. TUBERCULOSIS IN COMPLEX WITH PANTOATE 1RZX ; 2.10 ; CRYSTAL STRUCTURE OF A PAR-6 PDZ-PEPTIDE COMPLEX 1KZQ ; 1.70 ; CRYSTAL STRUCTURE OF A PARASITE PROTEIN 1XJ9 ; 2.60 ; CRYSTAL STRUCTURE OF A PARTLY SELF-COMPLEMENTARY PEPTIDE NUCLEIC ACID (PNA) OLIGOMER SHOWING A DUPLEX-TRIPLEX NETWORK 1ZEV ; 1.58 ; CRYSTAL STRUCTURE OF A PATHOGENIC RIBONUCLEIC ACID: CUG REPEATS 1WMH ; 1.50 ; CRYSTAL STRUCTURE OF A PB1 DOMAIN COMPLEX OF PROTEIN KINASE C IOTA AND PAR6 ALPHA 1X8Z ; 2.86 ; CRYSTAL STRUCTURE OF A PECTIN METHYLESTERASE INHIBITOR FROM ARABIDOPSIS THALIANA 1PUP ; 1.70 ; CRYSTAL STRUCTURE OF A PEPTIDE NUCLEIC ACID (PNA) DUPLEX AT 1.7 ANGSTROMS RESOLUTION 1HZS ; 1.82 ; CRYSTAL STRUCTURE OF A PEPTIDE NUCLEIC ACID DUPLEX (BT-PNA) CONTAINING A BICYCLIC ANALOGUE OF THYMINE 1XP4 ; 2.80 ; CRYSTAL STRUCTURE OF A PEPTIDOGLYCAN SYNTHESIS REGULATORY FACTOR (PBP3) FROM STREPTOCOCCUS PNEUMONIAE 1OW4 ; 1.60 ; CRYSTAL STRUCTURE OF A PHEROMONE BINDING PROTEIN FROM THE COCKROACH LEUCOPHAEA MADERAE IN COMPLEX WITH THE FLUORESCENT REPORTER ANS (1-ANILINONAPHTALENE-8-SULFONIC ACID), 1MH8 ; 1.86 ; CRYSTAL STRUCTURE OF A PHOPHOLIPASE A2 MONOMER WITH ISOLEUCINE AT SECOND POSITION 1SRR ; 1.90 ; CRYSTAL STRUCTURE OF A PHOSPHATASE RESISTANT MUTANT OF SPORULATION RESPONSE REGULATOR SPO0F FROM BACILLUS SUBTILIS 1BYR ; 2.00 ; CRYSTAL STRUCTURE OF A PHOSPHOLIPASE D FAMILY MEMBER, NUC FROM SALMONELLA TYPHIMURIUM 1VCH ; 1.94 ; CRYSTAL STRUCTURE OF A PHOSPHORIBOSYLTRANSFERASE-RELATED PROTEIN FROM THERMUS THERMOPHILUS 1QWO ; 1.50 ; CRYSTAL STRUCTURE OF A PHOSPHORYLATED PHYTASE FROM ASPERGILLUS FUMIGATUS, REVEALING THE STRUCTURAL BASIS FOR ITS HEAT RESILIENCE AND CATALYTIC PATHWAY 1KHX ; 1.80 ; CRYSTAL STRUCTURE OF A PHOSPHORYLATED SMAD2 1TD9 ; 2.75 ; CRYSTAL STRUCTURE OF A PHOSPHOTRANSACETYLASE FROM BACILLUS SUBTILIS 1XCO ; 2.85 ; CRYSTAL STRUCTURE OF A PHOSPHOTRANSACETYLASE FROM BACILLUS SUBTILIS IN COMPLEX WITH ACETYLPHOSPHATE 1R5J ; 2.70 ; CRYSTAL STRUCTURE OF A PHOSPHOTRANSACETYLASE FROM STREPTOCOCCUS PYOGENES 1B8D ; 1.90 ; CRYSTAL STRUCTURE OF A PHYCOUROBILIN-CONTAINING PHYCOERYTHRIN 1V4L ; 2.80 ; CRYSTAL STRUCTURE OF A PLATELET AGGLUTINATION FACTOR ISOLATED FROM THE VENOM OF TAIWAN HABU (TRIMERESURUS MUCROSQUAMATUS) 1O69 ; 1.84 ; CRYSTAL STRUCTURE OF A PLP-DEPENDENT ENZYME 1O61 ; 1.90 ; CRYSTAL STRUCTURE OF A PLP-DEPENDENT ENZYME WITH PLP 1FMO ; 2.20 ; CRYSTAL STRUCTURE OF A POLYHISTIDINE-TAGGED RECOMBINANT CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH THE PEPTIDE INHIBITOR PKI(5-24) AND ADENOSINE 1GT0 ; 2.60 ; CRYSTAL STRUCTURE OF A POU/HMG/DEOXYRIBONUCLEIC ACID TERNARY COMPLEX 1WG8 ; 2.00 ; CRYSTAL STRUCTURE OF A PREDICTED S-ADENOSYLMETHIONINE- DEPENDENT METHYLTRANSFERASE TT1512 FROM THERMUS THERMOPHILUS HB8. 2EUI ; 2.80 ; CRYSTAL STRUCTURE OF A PROBABLE ACETYLTRANSFERASE 1WJG ; 2.10 ; CRYSTAL STRUCTURE OF A PROBABLE ATP BINDING PROTEIN FROM THERMUS THEMOPHILUS HB8 1WGB ; 2.00 ; CRYSTAL STRUCTURE OF A PROBABLE FLAVOPROTEIN FROM THERMUS THERMOPHILUS HB8 1YOA ; 1.90 ; CRYSTAL STRUCTURE OF A PROBABLE FLAVOPROTEIN FROM THERMUS THERMOPHILUS HB8 1NNR ; 2.25 ; CRYSTAL STRUCTURE OF A PROBABLE FOSFOMYCIN RESISTANCE PROTEIN (PA1129) FROM PSEUDOMONAS AERUGINOSA WITH SULFATE PRESENT IN THE ACTIVE SITE 1WTY ; 2.20 ; CRYSTAL STRUCTURE OF A PROBABLE NUCLEOTIDYL TRANSFERASE PROTEIN FROM THERMUS THERMOPHILUS HB8 1RI7 ; 2.70 ; CRYSTAL STRUCTURE OF A PROTEIN IN THE LRP/ASNC FAMILY FROM THE HYPERTHERMOPHILIC ARCHAEON PYROCOCCUS SP. OT3 1U32 ; 2.00 ; CRYSTAL STRUCTURE OF A PROTEIN PHOSPHATASE-1: CALCINEURIN HYBRID BOUND TO OKADAIC ACID 1VQW ; 2.40 ; CRYSTAL STRUCTURE OF A PROTEIN WITH SIMILARITY TO FLAVIN- CONTAINING MONOOXYGENASES AND TO MAMMALIAN DIMETHYLALANINE MONOOXYGENASES 1NKX ; 1.90 ; CRYSTAL STRUCTURE OF A PROTEOLYTICALLY GENERATED FUNCTIONAL MONOFERRIC C-LOBE OF BOVINE LACTOFERRIN AT 1.9A RESOLUTION 1JDR ; 1.50 ; CRYSTAL STRUCTURE OF A PROXIMAL DOMAIN POTASSIUM BINDING VARIANT OF CYTOCHROME C PEROXIDASE 1I6J ; 2.00 ; CRYSTAL STRUCTURE OF A PSEUDO-16-MER DEOXYRIBONUCLEIC ACID WITH STACKED GUANINES AND TWO G-A MISPAIRS COMPLEXED WITH THE N- TERMINAL FRAGMENT OF MOLONEY MURINE LEUKEMIA VIRUS REVERSE TRANSCRIPTASE 1G9K ; 1.96 ; CRYSTAL STRUCTURE OF A PSYCHROPHILIC ALKALINE PROTEASE FROM PSEUDOMONAS TAC II 18 1OMJ ; 2.38 ; CRYSTAL STRUCTURE OF A PSYCHROPHILIC ALKALINE PROTEASE FROM PSEUDOMONAS TAC II 18 2CX0 ; 1.80 ; CRYSTAL STRUCTURE OF A PUA DOMAIN (APE0525) FROM THE AEROPYRUM PERNIX K1 (SULFATE COMPLEX) 2CX1 ; 1.80 ; CRYSTAL STRUCTURE OF A PUA DOMAIN (APE0525) FROM THE AEROPYRUM PERNIX K1 (TARTRATE COMPLEX) 1IB2 ; 1.90 ; CRYSTAL STRUCTURE OF A PUMILIO-HOMOLOGY DOMAIN 1M8Z ; 1.90 ; CRYSTAL STRUCTURE OF A PUMILIO-HOMOLOGY DOMAIN 1VHN ; 1.59 ; CRYSTAL STRUCTURE OF A PUTATIVE FLAVIN OXIDOREDUCTASE WITH FLAVIN 1QP8 ; 2.80 ; CRYSTAL STRUCTURE OF A PUTATIVE FORMATE DEHYDROGENASE FROM PYROBACULUM AEROPHILUM 1VHC ; 1.89 ; CRYSTAL STRUCTURE OF A PUTATIVE KHG/KDPG ALDOLASE 2A9F ; 2.50 ; CRYSTAL STRUCTURE OF A PUTATIVE MALIC ENZYME ((S)- MALATE:NAD+ OXIDOREDUCTASE (DECARBOXYLATING)) 1TLT ; 2.70 ; CRYSTAL STRUCTURE OF A PUTATIVE OXIDOREDUCTASE (VIRULENCE FACTOR MVIM HOMOLOG) 1VIX ; 2.50 ; CRYSTAL STRUCTURE OF A PUTATIVE PEPTIDASE T 1VHO ; 1.86 ; CRYSTAL STRUCTURE OF A PUTATIVE PEPTIDASE/ENDOGLUCANASE 1X72 ; 2.50 ; CRYSTAL STRUCTURE OF A PUTATIVE PEPTIDYL-ARGININE DEIMINASE. 2BL1 ; 2.00 ; CRYSTAL STRUCTURE OF A PUTATIVE PHOSPHINOTHRICIN ACETYLTRANSFERASE (PA4866) FROM PSEUDOMONAS AERUGINOSA PAC1 1VHS ; 1.80 ; CRYSTAL STRUCTURE OF A PUTATIVE PHOSPHINOTHRICIN N- ACETYLTRANSFERASE 1VHU ; 1.34 ; CRYSTAL STRUCTURE OF A PUTATIVE PHOSPHOESTERASE 2A2J ; 2.50 ; CRYSTAL STRUCTURE OF A PUTATIVE PYRIDOXINE 5'-PHOSPHATE OXIDASE (RV2607) FROM MYCOBACTERIUM TUBERCULOSIS 1ZE0 ; 3.40 ; CRYSTAL STRUCTURE OF A PUTATIVE REDOX ENZYME MATURATION PROTEIN FROM ARCHAEOGLOBUS FULGIDUS 1WY7 ; 2.20 ; CRYSTAL STRUCTURE OF A PUTATIVE RIBONUCLEIC ACID METHYLTRANSFERASE PH1948 FROM PYROCOCCUS HORIKOSHII 1VH5 ; 1.34 ; CRYSTAL STRUCTURE OF A PUTATIVE THIOESTERASE 1VH9 ; 2.15 ; CRYSTAL STRUCTURE OF A PUTATIVE THIOESTERASE 1VI8 ; 2.20 ; CRYSTAL STRUCTURE OF A PUTATIVE THIOESTERASE 2AYV ; 2.00 ; CRYSTAL STRUCTURE OF A PUTATIVE UBIQUITIN-CONJUGATING ENZYME E2 FROM TOXOPLASMA GONDII 1Z9D ; 2.80 ; CRYSTAL STRUCTURE OF A PUTATIVE URIDYLATE KINASE (UMP- KINASE) FROM STREPTOCOCCUS PYOGENES 1VDX ; 2.40 ; CRYSTAL STRUCTURE OF A PYROCOCCUS HORIKOSHII PROTEIN WITH SIMILARITIES TO 2'5' RIBONUCLEIC ACID-LIGASE 1YQG ; 1.90 ; CRYSTAL STRUCTURE OF A PYRROLINE-5-CARBOXYLATE REDUCTASE FROM NEISSERIA MENINGITIDES MC58 1JMX ; 1.90 ; CRYSTAL STRUCTURE OF A QUINOHEMOPROTEIN AMINE DEHYDROGENASE FROM PSEUDOMONAS PUTIDA 1JMZ ; 2.00 ; CRYSTAL STRUCTURE OF A QUINOHEMOPROTEIN AMINE DEHYDROGENASE FROM PSEUDOMONAS PUTIDA WITH INHIBITOR 1DS6 ; 2.35 ; CRYSTAL STRUCTURE OF A RAC-RHOGDI COMPLEX 1N0W ; 1.70 ; CRYSTAL STRUCTURE OF A RAD51-BRCA2 BRC REPEAT COMPLEX 1WYG ; 2.60 ; CRYSTAL STRUCTURE OF A RAT XANTHINE DEHYDROGENASE TRIPLE MUTANT (C535A, C992R AND C1324S) 1OMY ; 2.00 ; CRYSTAL STRUCTURE OF A RECOMBINANT ALPHA-INSECT TOXIN BMKAIT1 FROM THE SCORPION BUTHUS MARTENSII KARSCH 1I8M ; 2.10 ; CRYSTAL STRUCTURE OF A RECOMBINANT ANTI-SINGLE-STRANDED DEOXYRIBONUCLEIC ACID ANTIBODY FRAGMENT COMPLEXED WITH DT5 1LBK ; 1.86 ; CRYSTAL STRUCTURE OF A RECOMBINANT GLUTATHIONE TRANSFERASE, CREATED BY REPLACING THE LAST SEVEN RESIDUES OF EACH SUBUNIT OF THE HUMAN CLASS PI ISOENZYME WITH THE ADDITIONAL C-TERMINAL HELIX OF HUMAN CLASS ALPHA ISOENZYME 1CC1 ; 2.15 ; CRYSTAL STRUCTURE OF A REDUCED, ACTIVE FORM OF THE NI-FE-SE HYDROGENASE FROM DESULFOMICROBIUM BACULATUM 1CLQ ; 2.70 ; CRYSTAL STRUCTURE OF A REPLICATION FORK DEOXYRIBONUCLEIC ACID POLYMERASE EDITING COMPLEX AT 2.7 A RESOLUTION 1ZLD ; 1.65 ; CRYSTAL STRUCTURE OF A RGD-CONTAINING HOST-SELECTIVE TOXIN: PYRENOPHORA TRITICI-REPENTIS PTR TOXA 1ZLE ; 1.90 ; CRYSTAL STRUCTURE OF A RGD-CONTAINING HOST-SELECTIVE TOXIN: PYRENOPHORA TRITICI-REPENTIS PTR TOXA 1KXK ; 3.00 ; CRYSTAL STRUCTURE OF A RIBONUCLEIC ACID MOLECULE CONTAINING DOMAIN 5 AND 6 OF THE YEAST AI5G GROUP II SELF-SPLICING INTRON 1TFM ; 2.80 ; CRYSTAL STRUCTURE OF A RIBOSOME INACTIVATING PROTEIN IN ITS NATURALLY INHIBITED FORM 1TEL ; 2.70 ; CRYSTAL STRUCTURE OF A RUBISCO-LIKE PROTEIN FROM CHLOROBIUM TEPIDUM 1Y8C ; 2.50 ; CRYSTAL STRUCTURE OF A S-ADENOSYLMETHIONINE-DEPENDENT METHYLTRANSFERASE FROM CLOSTRIDIUM ACETOBUTYLICUM ATCC 824 1R2V ; 2.07 ; CRYSTAL STRUCTURE OF A SECRETORY 40KDA GLYCOPROTEIN FROM SHEEP MAMMARY GLAND AT 2.0A RESOLUTION 1U6B ; 3.10 ; CRYSTAL STRUCTURE OF A SELF-SPLICING GROUP I INTRON WITH BOTH EXONS 1SD4 ; 2.00 ; CRYSTAL STRUCTURE OF A SEMET DERIVATIVE OF BLAI AT 2.0 A 1SD7 ; 2.65 ; CRYSTAL STRUCTURE OF A SEMET DERIVATIVE OF MECI AT 2.65 A 1EZX ; 2.60 ; CRYSTAL STRUCTURE OF A SERPIN:PROTEASE COMPLEX 1OJL ; 3.00 ; CRYSTAL STRUCTURE OF A SIGMA54-ACTIVATOR SUGGESTS THE MECHANISM FOR THE CONFORMATIONAL SWITCH NECESSARY FOR SIGMA54 BINDING 1SIG ; 2.60 ; CRYSTAL STRUCTURE OF A SIGMA70 SUBUNIT FRAGMENT FROM ESCHERICHIA COLI RIBONUCLEIC ACID POLYMERASE 1SV8 ; 2.80 ; CRYSTAL STRUCTURE OF A SIGNALING PROTEIN FROM BUFFALO(SPB- 40)AT 2.8 A RESOLUTION USING CRYSTALS GROWN IN THE PRSENCE OF CARBOHYDRATES 1D2O ; 2.00 ; CRYSTAL STRUCTURE OF A SINGLE B REPEAT UNIT (B1) OF COLLAGEN BINDING SURFACE PROTEIN (CNA) OF STAPHYLOCOCCUS AUREUS. 1O7I ; 1.20 ; CRYSTAL STRUCTURE OF A SINGLE STRANDED DEOXYRIBONUCLEIC ACID BINDING PROTEIN 1ICI ; 2.10 ; CRYSTAL STRUCTURE OF A SIR2 HOMOLOG-NAD COMPLEX 1GDT ; 3.00 ; CRYSTAL STRUCTURE OF A SITE-SPECIFIC RECOMBINASE, GAMMA-DELTA RESOLVASE COMPLEXED WITH A 34 BP CLEAVAGE SITE 1MHD ; 2.80 ; CRYSTAL STRUCTURE OF A SMAD MH1 DOMAIN BOUND TO DEOXYRIBONUCLEIC ACID 1MR1 ; 2.85 ; CRYSTAL STRUCTURE OF A SMAD4-SKI COMPLEX 1S4I ; 1.80 ; CRYSTAL STRUCTURE OF A SOD-LIKE PROTEIN FROM BACILLUS SUBTILIS 1RK4 ; 1.79 ; CRYSTAL STRUCTURE OF A SOLUBLE DIMERIC FORM OF OXIDISED CLIC1 1ST9 ; 1.50 ; CRYSTAL STRUCTURE OF A SOLUBLE DOMAIN OF RESA IN THE OXIDISED FORM 1DR9 ; 3.00 ; CRYSTAL STRUCTURE OF A SOLUBLE FORM OF B7-1 (CD80) 1K0O ; 1.75 ; CRYSTAL STRUCTURE OF A SOLUBLE FORM OF CLIC1. AN INTRACELLULAR CHLORIDE ION CHANNEL 2AHE ; 1.80 ; CRYSTAL STRUCTURE OF A SOLUBLE FORM OF CLIC4. INTERCELLULAR CHLORIDE ION CHANNEL 1K0M ; 1.40 ; CRYSTAL STRUCTURE OF A SOLUBLE MONOMERIC FORM OF CLIC1 AT 1.4 ANGSTROMS 1HUV ; 2.15 ; CRYSTAL STRUCTURE OF A SOLUBLE MUTANT OF THE MEMBRANE- ASSOCIATED (S)-MANDELATE DEHYDROGENASE FROM PSEUDOMONAS PUTIDA AT 2.15A RESOLUTION 1GSZ ; 2.80 ; CRYSTAL STRUCTURE OF A SQUALENE CYCLASE IN COMPLEX WITH THE POTENTIAL ANTICHOLESTEREMIC DRUG RO48-8071 1VH4 ; 1.75 ; CRYSTAL STRUCTURE OF A STABILIZER OF IRON TRANSPORTER 1QWX ; 1.50 ; CRYSTAL STRUCTURE OF A STAPHYLOCOCCAL INHIBITOR/CHAPERONE 1T02 ; 2.60 ; CRYSTAL STRUCTURE OF A STATIN BOUND TO CLASS II HMG-COA REDUCTASE 1PNS ; 8.70 ; CRYSTAL STRUCTURE OF A STREPTOMYCIN DEPENDENT RIBOSOME FROM E. COLI, 30S SUBUNIT OF 70S RIBOSOME. THIS FILE, 1PNS, CONTAINS THE 30S SUBUNIT, TWO TRNAS, AND ONE MRNA MOLECULE. THE 50S RIBOSOMAL SUBUNIT IS IN FILE 1PNU. 1PNU ; 8.70 ; CRYSTAL STRUCTURE OF A STREPTOMYCIN DEPENDENT RIBOSOME FROM ESCHERICHIA COLI, 50S SUBUNIT OF 70S RIBOSOME. THIS FILE, 1PNU, CONTAINS ONLY MOLECULES OF THE 50S RIBOSOMAL SUBUNIT. THE 30S SUBUNIT, MRNA, P-SITE TRNA, AND A-SITE TRNA ARE IN THE PDB FILE 1PNS. 1HQR ; 3.20 ; CRYSTAL STRUCTURE OF A SUPERANTIGEN BOUND TO THE HIGH- AFFINITY, ZINC-DEPENDENT SITE ON MHC CLASS II 2B3P ; 1.40 ; CRYSTAL STRUCTURE OF A SUPERFOLDER GREEN FLUORESCENT PROTEIN 1VC9 ; 2.30 ; CRYSTAL STRUCTURE OF A T.THERMOPHILUS HB8 AP6A HYDROLASE E50Q MUTANT-MG2+-ATP COMPLEX 1VCD ; 1.70 ; CRYSTAL STRUCTURE OF A T.THERMOPHILUS HB8 AP6A HYDROLASE NDX1 1VC8 ; 2.00 ; CRYSTAL STRUCTURE OF A T.THERMOPHILUS HB8 AP6A HYDROLASE NDX1-AP6A COMPLEX 1CEZ ; 2.40 ; CRYSTAL STRUCTURE OF A T7 RIBONUCLEIC ACID POLYMERASE-T7 PROMOTER COMPLEX 1KUG ; 1.37 ; CRYSTAL STRUCTURE OF A TAIWAN HABU VENOM METALLOPROTEINASE COMPLEXED WITH ITS ENDOGENOUS INHIBITOR PENW 1KUK ; 1.45 ; CRYSTAL STRUCTURE OF A TAIWAN HABU VENOM METALLOPROTEINASE COMPLEXED WITH PEKW. 1KUI ; 1.50 ; CRYSTAL STRUCTURE OF A TAIWAN HABU VENOM METALLOPROTEINASE COMPLEXED WITH PEQW. 1QG3 ; 2.15 ; CRYSTAL STRUCTURE OF A TANDEM PAIR OF FIBRONECTIN TYPE III DOMAINS FROM THE CYTOPLASMIC TAIL OF INTEGRIN ALPHA6 BETA4 1FW6 ; 2.70 ; CRYSTAL STRUCTURE OF A TAQ MUTS-DEOXYRIBONUCLEIC ACID-ADP TERNARY COMPLEX 1CQT ; 3.20 ; CRYSTAL STRUCTURE OF A TERNARY COMPLEX CONTAINING AN OCA-B PEPTIDE, THE OCT-1 POU DOMAIN, AND AN OCTAMER ELEMENT 1Q0N ; 1.25 ; CRYSTAL STRUCTURE OF A TERNARY COMPLEX OF 6-HYDROXYMETHYL-7, 8-DIHYDROPTERIN PYROPHOSPHOKINASE FROM E. COLI WITH MGAMPCPP AND 6-HYDROXYMETHYL-7,8-DIHYDROPTERIN AT 1.25 ANGSTROM RESOLUTION 1LBX ; 2.40 ; CRYSTAL STRUCTURE OF A TERNARY COMPLEX OF DUAL ACTIVITY FBPASE/IMPASE (AF2372) FROM ARCHAEOGLOBUS FULGIDUS WITH CALCIUM IONS AND D-MYO-INOSITOL-1-PHOSPHATE 1AJ0 ; 2.00 ; CRYSTAL STRUCTURE OF A TERNARY COMPLEX OF E. COLI DIHYDROPTEROATE SYNTHASE 1RAO ; 1.56 ; CRYSTAL STRUCTURE OF A TERNARY COMPLEX OF E. COLI HPPK WITH AMP AND 6-HYDROXYMETHYLPTERIN-DIPHOSPHATE AT 1.56 ANGSTROM RESOLUTION 1RU1 ; 1.40 ; CRYSTAL STRUCTURE OF A TERNARY COMPLEX OF E. COLI HPPK(V83G/DEL84-89) WITH MGAMPCPP AND 6-HYDROXYMETHYL-7,8- DIHYDROPTERIN AT 1.40 ANGSTROM RESOLUTION (MONOCLINIC FORM) 1NCE ; 2.40 ; CRYSTAL STRUCTURE OF A TERNARY COMPLEX OF E. COLI THYMIDYLATE SYNTHASE D169C WITH DUMP AND THE ANTIFOLATE CB3717 1HQ2 ; 1.25 ; CRYSTAL STRUCTURE OF A TERNARY COMPLEX OF E.COLI HPPK(R82A) WITH MGAMPCPP AND 6-HYDROXYMETHYL-7,8-DIHYDROPTERIN AT 1.25 ANGSTROM RESOLUTION 1RU2 ; 1.48 ; CRYSTAL STRUCTURE OF A TERNARY COMPLEX OF E.COLI HPPK(V83G/DEL84-89) WITH MGAMPCPP AND 6- HYDROXYMETHYLPTERIN AT 1.48 ANGSTROM RESOLUTION (ORTHORHOMBIC FORM) 1Z6J ; 2.00 ; CRYSTAL STRUCTURE OF A TERNARY COMPLEX OF FACTOR VIIA/TISSUE FACTOR/PYRAZINONE INHIBITOR 2BQZ ; 1.50 ; CRYSTAL STRUCTURE OF A TERNARY COMPLEX OF THE HUMAN HISTONE METHYLTRANSFERASE PR-SET7 (ALSO KNOWN AS SET8) 1O9S ; 1.75 ; CRYSTAL STRUCTURE OF A TERNARY COMPLEX OF THE HUMAN HISTONE METHYLTRANSFERASE SET7/9 1XQH ; 1.75 ; CRYSTAL STRUCTURE OF A TERNARY COMPLEX OF THE METHYLTRANSFERASE SET9 (ALSO KNOWN AS SET7/9) WITH A P53 PEPTIDE AND SAH 1E0O ; 2.80 ; CRYSTAL STRUCTURE OF A TERNARY FGF1-FGFR2-HEPARIN COMPLEX 1FQ9 ; 3.00 ; CRYSTAL STRUCTURE OF A TERNARY FGF2-FGFR1-HEPARIN COMPLEX 1XD2 ; 2.70 ; CRYSTAL STRUCTURE OF A TERNARY RAS:SOS:RASGDP COMPLEX 1K6O ; 3.19 ; CRYSTAL STRUCTURE OF A TERNARY SAP-1/SRF/C-FOS SRE DEOXYRIBONUCLEIC ACID COMPLEX 1BXZ ; 2.99 ; CRYSTAL STRUCTURE OF A THERMOPHILIC ALCOHOL DEHYDROGENASE SUBSTRATE COMPLEX FROM THERMOANAEROBACTER BROCKII 1DBI ; 1.80 ; CRYSTAL STRUCTURE OF A THERMOSTABLE SERINE PROTEASE 2CVB ; 1.80 ; CRYSTAL STRUCTURE OF A THIOREDOXIN-LIKE PROTEIN FROM THERMUS THERMOPHILUS HB8 1EXD ; 2.70 ; CRYSTAL STRUCTURE OF A TIGHT-BINDING GLUTAMINE TRNA BOUND TO GLUTAMINE AMINOACYL TRNA SYNTHETASE 2BF5 ; 1.71 ; CRYSTAL STRUCTURE OF A TOLUENE 4-MONOOXYGENASE CATALYTIC EFFECTOR PROTEIN VARIANT MISSING FOUR N-TERMINAL RESIDUES (DELTA-N4 T4MOD) 2BF3 ; 1.96 ; CRYSTAL STRUCTURE OF A TOLUENE 4-MONOOXYGENASE CATALYTIC EFFECTOR PROTEIN VARIANT MISSING TEN N-TERMINAL RESIDUES (DELTA-N10 T4MOD) 1SEG ; 1.30 ; CRYSTAL STRUCTURE OF A TOXIN CHIMERA BETWEEN LQH-ALPHA-IT FROM THE SCORPION LEIURUS QUINQUESTRIATUS HEBRAEUS AND AAH2 FROM ANDROCTONUS AUSTRALIS HECTOR 1VI0 ; 1.65 ; CRYSTAL STRUCTURE OF A TRANSCRIPTIONAL REGULATOR 1PZ2 ; 2.00 ; CRYSTAL STRUCTURE OF A TRANSIENT COVALENT REACTION INTERMEDIATE OF A FAMILY 51 ALPHA-L-ARABINOFURANOSIDASE 1L3R ; 2.00 ; CRYSTAL STRUCTURE OF A TRANSITION STATE MIMIC OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE 1K3X ; 1.25 ; CRYSTAL STRUCTURE OF A TRAPPED REACTION INTERMEDIATE OF THE DEOXYRIBONUCLEIC ACID REPAIR ENZYME ENDONUCLEASE VIII WITH BROMINATED-DEOXYRIBONUCLEIC ACID 1K3W ; 1.42 ; CRYSTAL STRUCTURE OF A TRAPPED REACTION INTERMEDIATE OF THE DEOXYRIBONUCLEIC ACID REPAIR ENZYME ENDONUCLEASE VIII WITH DEOXYRIBONUCLEIC ACID 1Q6H ; 1.97 ; CRYSTAL STRUCTURE OF A TRUNCATED FORM OF FKPA FROM ESCHERICHIA COLI 1Q6I ; 2.25 ; CRYSTAL STRUCTURE OF A TRUNCATED FORM OF FKPA FROM ESCHERICHIA COLI, IN COMPLEX WITH IMMUNOSUPPRESSANT FK506 1HQP ; 2.30 ; CRYSTAL STRUCTURE OF A TRUNCATED FORM OF PORCINE ODORANT- BINDING PROTEIN 1FYF ; 1.65 ; CRYSTAL STRUCTURE OF A TRUNCATED FORM OF THREONYL-TRNA SYNTHETASE COMPLEXED WITH A SERYL ADENYLATE ANALOG 1EVL ; 1.55 ; CRYSTAL STRUCTURE OF A TRUNCATED FORM OF THREONYL-TRNA SYNTHETASE WITH A THREONYL ADENYLATE ANALOG 1EVK ; 2.00 ; CRYSTAL STRUCTURE OF A TRUNCATED FORM OF THREONYL-TRNA SYNTHETASE WITH THE LIGAND THREONINE 1RJU ; 1.44 ; CRYSTAL STRUCTURE OF A TRUNCATED FORM OF YEAST COPPER THIONEIN 2C3Z ; 2.80 ; CRYSTAL STRUCTURE OF A TRUNCATED VARIANT OF INDOLE-3- GLYCEROL PHOSPHATE SYNTHASE FROM SULFOLOBUS SOLFATARICUS 1TCZ ; 1.85 ; CRYSTAL STRUCTURE OF A TRUNCATED VERSION OF THE PHAGE LAMDA PROTEIN GPD 1K6Y ; 2.40 ; CRYSTAL STRUCTURE OF A TWO-DOMAIN FRAGMENT OF HIV-1 INTEGRASE 1TED ; 2.25 ; CRYSTAL STRUCTURE OF A TYPE III POLYKETIDE SYNTHASE PKS18 FROM MYCOBACTERIUM TUBERCULOSIS 1Y9T ; 1.87 ; CRYSTAL STRUCTURE OF A TYPE III SECRETION SYSTEM PROTEIN COMPLEXED WITH THE LIPID, 1-MONOHEXANOYL-2-HYDROXY-SN- GLYCERO-3-PHOSPHATE 1MZW ; 2.00 ; CRYSTAL STRUCTURE OF A U4/U6 SNRNP COMPLEX BETWEEN HUMAN SPLICEOSOMAL CYCLOPHILIN H AND A U4/U6-60K PEPTIDE 1NBF ; 2.30 ; CRYSTAL STRUCTURE OF A UBP-FAMILY DEUBIQUITINATING ENZYME IN ISOLATION AND IN COMPLEX WITH UBIQUITIN ALDEHYDE 1AC6 ; 2.30 ; CRYSTAL STRUCTURE OF A VARIABLE DOMAIN MUTANT OF A T-CELL RECEPTOR ALPHA CHAIN 1ZXT ; 1.70 ; CRYSTAL STRUCTURE OF A VIRAL CHEMOKINE 2F1S ; 1.40 ; CRYSTAL STRUCTURE OF A VIRAL FLIP MC159 1ET4 ; 2.30 ; CRYSTAL STRUCTURE OF A VITAMIN B12 BINDING RIBONUCLEIC ACID APTAMER WITH LIGAND AT 2.3 A 1YOD ; 1.80 ; CRYSTAL STRUCTURE OF A WATER SOLUBLE ANALOG OF PHOSPHOLAMBAN 2B3Q ; 2.30 ; CRYSTAL STRUCTURE OF A WELL-FOLDED VARIANT OF GREEN FLUORESCENT PROTEIN 1EGA ; 2.40 ; CRYSTAL STRUCTURE OF A WIDELY CONSERVED GTPASE ERA 1G50 ; 2.90 ; CRYSTAL STRUCTURE OF A WILD TYPE HER ALPHA LBD AT 2.9 ANGSTROM RESOLUTION 1Q3V ; 2.91 ; CRYSTAL STRUCTURE OF A WILD-TYPE CRE RECOMBINASE-LOXP SYNAPSE: PHOSPHOTYROSINE COVALENT INTERMEDIATE 1Q3U ; 2.90 ; CRYSTAL STRUCTURE OF A WILD-TYPE CRE RECOMBINASE-LOXP SYNAPSE: PRE-CLEAVAGE COMPLEX 1IK9 ; 2.30 ; CRYSTAL STRUCTURE OF A XRCC4-DEOXYRIBONUCLEIC ACID LIGASE IV COMPLEX 1JX4 ; 1.70 ; CRYSTAL STRUCTURE OF A Y-FAMILY DEOXYRIBONUCLEIC ACID POLYMERASE IN A TERNARY COMPLEX WITH DEOXYRIBONUCLEIC ACID SUBSTRATES AND AN INCOMING NUCLEOTIDE 1JXL ; 2.10 ; CRYSTAL STRUCTURE OF A Y-FAMILY DEOXYRIBONUCLEIC ACID POLYMERASE IN A TERNARY COMPLEX WITH DEOXYRIBONUCLEIC ACID SUBSTRATES AND AN INCOMING NUCLEOTIDE 1NGM ; 2.95 ; CRYSTAL STRUCTURE OF A YEAST BRF1-TBP-DEOXYRIBONUCLEIC ACID TERNARY COMPLEX 1B54 ; 2.10 ; CRYSTAL STRUCTURE OF A YEAST HYPOTHETICAL PROTEIN - A STRUCTURE FROM BNL'S HUMAN PROTEOME PROJECT 1D1P ; 2.20 ; CRYSTAL STRUCTURE OF A YEAST LOW MOLECULAR WEIGHT PROTEIN TYROSINE PHOSPHATASE (LTP1) 1D2A ; 1.90 ; CRYSTAL STRUCTURE OF A YEAST LOW MOLECULAR WEIGHT PROTEIN TYROSINE PHOSPHATASE (LTP1) COMPLEXED WITH THE ACTIVATOR ADENINE 1D1Q ; 1.70 ; CRYSTAL STRUCTURE OF A YEAST LOW MOLECULAR WEIGHT PROTEIN TYROSINE PHOSPHATASE (LTP1) COMPLEXED WITH THE SUBSTRATE PNPP 1NH2 ; 1.90 ; CRYSTAL STRUCTURE OF A YEAST TFIIA/TBP/DEOXYRIBONUCLEIC ACID COMPLEX 1MYW ; 2.20 ; CRYSTAL STRUCTURE OF A YELLOW FLUORESCENT PROTEIN WITH IMPROVED MATURATION AND REDUCED ENVIRONMENTAL SENSITIVITY 1E6B ; 1.65 ; CRYSTAL STRUCTURE OF A ZETA CLASS GLUTATHIONE S-TRANSFERASE FROM ARABIDOPSIS THALIANA 1LLM ; 1.50 ; CRYSTAL STRUCTURE OF A ZIF23-GCN4 CHIMERA BOUND TO DEOXYRIBONUCLEIC ACID 1MH2 ; 2.70 ; CRYSTAL STRUCTURE OF A ZINC CONTAINING DIMER OF PHOSPHOLIPASE A2 FROM THE VENOM OF INDIAN COBRA (NAJA NAJA SAGITTIFERA) 1UUF ; 1.76 ; CRYSTAL STRUCTURE OF A ZINC-TYPE ALCOHOL DEHYDROGENASE-LIKE PROTEIN YAHK 1KYS ; 1.44 ; CRYSTAL STRUCTURE OF A ZN-BOUND GREEN FLUORESCENT PROTEIN BIOSENSOR 1NZG ; 1.60 ; CRYSTAL STRUCTURE OF A-DEOXYRIBONUCLEIC ACID DECAMER GCGTA(3ME)ACGC, WITH A MODIFIED 5-METHYLURIDINE 1U2C ; 2.30 ; CRYSTAL STRUCTURE OF A-DYSTROGLYCAN 1VDZ ; 2.55 ; CRYSTAL STRUCTURE OF A-TYPE ATPASE CATALYTIC SUBUNIT A FROM PYROCOCCUS HORIKOSHII OT3 1YVU ; 2.90 ; CRYSTAL STRUCTURE OF A. AEOLICUS ARGONAUTE 1ZJR ; 1.85 ; CRYSTAL STRUCTURE OF A. AEOLICUS TRMH/SPOU TRNA MODIFYING ENZYME 1RXV ; 2.50 ; CRYSTAL STRUCTURE OF A. FULGIDUS FEN-1 BOUND TO DEOXYRIBONUCLEIC ACID 1RXW ; 2.00 ; CRYSTAL STRUCTURE OF A. FULGIDUS FEN-1 BOUND TO DEOXYRIBONUCLEIC ACID 1Z0E ; 2.05 ; CRYSTAL STRUCTURE OF A. FULGIDUS LON PROTEOLYTIC DOMAIN 1Z0G ; 2.27 ; CRYSTAL STRUCTURE OF A. FULGIDUS LON PROTEOLYTIC DOMAIN 1Z0T ; 3.00 ; CRYSTAL STRUCTURE OF A. FULGIDUS LON PROTEOLYTIC DOMAIN 1Z0V ; 3.00 ; CRYSTAL STRUCTURE OF A. FULGIDUS LON PROTEOLYTIC DOMAIN 1Z0W ; 1.20 ; CRYSTAL STRUCTURE OF A. FULGIDUS LON PROTEOLYTIC DOMAIN AT 1.2A RESOLUTION 1Z0C ; 1.55 ; CRYSTAL STRUCTURE OF A. FULGIDUS LON PROTEOLYTIC DOMAIN D508A MUTANT 1Z0B ; 1.55 ; CRYSTAL STRUCTURE OF A. FULGIDUS LON PROTEOLYTIC DOMAIN E506A MUTANT 1TQI ; 2.00 ; CRYSTAL STRUCTURE OF A. FULGIDUS RIO2 SERINE PROTEIN KINASE 1TQM ; 1.99 ; CRYSTAL STRUCTURE OF A. FULGIDUS RIO2 SERINE PROTEIN KINASE BOUND TO AMPPNP 1TQP ; 2.10 ; CRYSTAL STRUCTURE OF A. FULGIDUS RIO2 SERINE PROTEIN KINASE BOUND TO ATP 1ZTF ; 1.99 ; CRYSTAL STRUCTURE OF A.FULGIDUS RIO1 SERINE PROTEIN KINASE 1ZTH ; 1.89 ; CRYSTAL STRUCTURE OF A.FULGIDUS RIO1 SERINE PROTEIN KINASE BOUND TO ADP AND MANGANESE ION 1ZAR ; 1.75 ; CRYSTAL STRUCTURE OF A.FULGIDUS RIO2 KINASE COMPLEXED WITH ADP AND MANGANESE IONS 1ZAO ; 1.84 ; CRYSTAL STRUCTURE OF A.FULGIDUS RIO2 KINASE COMPLEXED WITH ATP AND MANGANESE IONS 2C0N ; 1.86 ; CRYSTAL STRUCTURE OF A197 FROM STIV 1OO8 ; 2.65 ; CRYSTAL STRUCTURE OF A1PI-PITTSBURGH IN THE NATIVE CONFORMATION 1S3S ; 2.90 ; CRYSTAL STRUCTURE OF AAA ATPASE P97/VCP ND1 IN COMPLEX WITH P47 C 1RZ9 ; 3.10 ; CRYSTAL STRUCTURE OF AAV REP COMPLEXED WITH THE REP-BINDING SEQUENCE 1OP0 ; 2.00 ; CRYSTAL STRUCTURE OF AAV-SP-I, A GLYCOSYLATED SNAKE VENOM SERINE PROTEINASE FROM AGKISTRODON ACUTUS 1OP2 ; 2.10 ; CRYSTAL STRUCTURE OF AAV-SP-II, A GLYCOSYLATED SNAKE VENOM SERINE PROTEINASE FROM AGKISTRODON ACUTUS 1U0J ; 2.10 ; CRYSTAL STRUCTURE OF AAV2 REP40-ADP COMPLEX 1U7T ; 2.00 ; CRYSTAL STRUCTURE OF ABAD/HSD10 WITH A BOUND INHIBITOR 1VPL ; 2.10 ; CRYSTAL STRUCTURE OF ABC TRANSPORTER ATP-BINDING PROTEIN (TM0544) FROM THERMOTOGA MARITIMA AT 2.10 A RESOLUTION 1FPU ; 2.40 ; CRYSTAL STRUCTURE OF ABL KINASE DOMAIN IN COMPLEX WITH A SMALL MOLECULE INHIBITOR 1F2K ; 2.30 ; CRYSTAL STRUCTURE OF ACANTHAMOEBA CASTELLANII PROFILIN II, CUBIC CRYSTAL FORM 2B8P ; 2.55 ; CRYSTAL STRUCTURE OF ACANTHAMOEBA POLYPHAGA MIMIVIRUS NDK, THE FIRST VIRAL NUCLEOSIDE DIPHOSPHATE KINASE 1RQX ; 2.50 ; CRYSTAL STRUCTURE OF ACC DEAMINASE COMPLEXED WITH INHIBITOR 1TZM ; 2.08 ; CRYSTAL STRUCTURE OF ACC DEAMINASE COMPLEXED WITH SUBSTRATE ANALOG B-CHLORO-D-ALANINE 1IAY ; 2.70 ; CRYSTAL STRUCTURE OF ACC SYNTHASE COMPLEXED WITH COFACTOR PLP AND INHIBITOR AVG 1IAX ; 2.80 ; CRYSTAL STRUCTURE OF ACC SYNTHASE COMPLEXED WITH PLP 2F4L ; 2.50 ; CRYSTAL STRUCTURE OF ACETAMIDASE, PUTATIVE (TM0119) FROM THERMOTOGA MARITIMA AT 2.50 A RESOLUTION 1K6D ; 1.90 ; CRYSTAL STRUCTURE OF ACETATE COA-TRANSFERASE ALPHA SUBUNIT 1VLQ ; 2.10 ; CRYSTAL STRUCTURE OF ACETYL XYLAN ESTERASE (TM0077) FROM THERMOTOGA MARITIMA AT 2.10 A RESOLUTION 1YTL ; 1.80 ; CRYSTAL STRUCTURE OF ACETYL-COA DECARBONYLASE/SYNTHASE COMPLEX EPSILON SUBUNIT 2 2BR8 ; 2.40 ; CRYSTAL STRUCTURE OF ACETYLCHOLINE-BINDING PROTEIN (ACHBP) FROM APLYSIA CALIFORNICA IN COMPLEX WITH AN ALPHA- CONOTOXIN PNIA VARIANT 2BR7 ; 3.00 ; CRYSTAL STRUCTURE OF ACETYLCHOLINE-BINDING PROTEIN (ACHBP) FROM APLYSIA CALIFORNICA IN COMPLEX WITH HEPES 2AP9 ; 2.80 ; CRYSTAL STRUCTURE OF ACETYLGLUTAMATE KINASE FROM MYCOBACTERIUM TUBERCULOSIS CDC1551 1YH0 ; 2.20 ; CRYSTAL STRUCTURE OF ACETYLORNITHINE TRANSCARBAMYLASE 1YH1 ; 1.90 ; CRYSTAL STRUCTURE OF ACETYLORNITHINE TRANSCARBAMYLASE 2AE6 ; 2.19 ; CRYSTAL STRUCTURE OF ACETYLTRANSFERASE OF GNAT FAMILY FROM ENTEROCOCCUS FAECALIS V583 2BYS ; 2.05 ; CRYSTAL STRUCTURE OF ACHBP FROM APLYSIA CALIFORNICA IN COMPLEX WITH LOBELINE 2BYR ; 2.45 ; CRYSTAL STRUCTURE OF ACHBP FROM APLYSIA CALIFORNICA IN COMPLEX WITH METHYLLYCACONITINE 2BJ0 ; 2.00 ; CRYSTAL STRUCTURE OF ACHBP FROM BULINUS TRUNCATUS REVALS THE CONSERVED STRUCTURAL SCAFFOLD AND SITES OF VARIATION IN NICOTINIC ACETYLCHOLINE RECEPTORS 1D2T ; 1.90 ; CRYSTAL STRUCTURE OF ACID PHOSPHATASE FROM ESCHERICHIA BLATTAE 1EOI ; 2.40 ; CRYSTAL STRUCTURE OF ACID PHOSPHATASE FROM ESCHERICHIA BLATTAE COMPLEXED WITH THE TRANSITION STATE ANALOG MOLYBDATE 1IJL ; 2.60 ; CRYSTAL STRUCTURE OF ACIDIC PHOSPHOLIPASE A2 FROM DEINAGKISTRODON ACUTUS 1SFP ; 1.90 ; CRYSTAL STRUCTURE OF ACIDIC SEMINAL FLUID PROTEIN (ASFP) AT 1.9 A RESOLUTION: A BOVINE POLYPEPTIDE FROM THE SPERMADHESIN FAMILY 1EO2 ; 2.25 ; CRYSTAL STRUCTURE OF ACINETOBACTER SP. ADP1 PROTOCATECHUATE 3,4-DIOXYGENASE 1EO9 ; 2.00 ; CRYSTAL STRUCTURE OF ACINETOBACTER SP. ADP1 PROTOCATECHUATE 3,4-DIOXYGENASE AT PH < 7.0 1EOB ; 2.20 ; CRYSTAL STRUCTURE OF ACINETOBACTER SP. ADP1 PROTOCATECHUATE 3,4-DIOXYGENASE IN COMPLEX WITH 3,4-DIHYDROXYBENZOATE 1EOC ; 2.25 ; CRYSTAL STRUCTURE OF ACINETOBACTER SP. ADP1 PROTOCATECHUATE 3,4-DIOXYGENASE IN COMPLEX WITH 4-NITROCATECHOL 1EOA ; 2.15 ; CRYSTAL STRUCTURE OF ACINETOBACTER SP. ADP1 PROTOCATECHUATE 3,4-DIOXYGENASE IN COMPLEX WITH CYANIDE 1VR3 ; 2.06 ; CRYSTAL STRUCTURE OF ACIREDUCTONE DIOXYGENASE (13543033) FROM MUS MUSCULUS AT 2.06 A RESOLUTION 1Q0Z ; 1.95 ; CRYSTAL STRUCTURE OF ACLACINOMYCIN METHYLESTERASE (RDMC) WITH BOUND PRODUCT ANALOGUE, 10- DECARBOXYMETHYLACLACINOMYCIN A (DCMA) 1Q0R ; 1.45 ; CRYSTAL STRUCTURE OF ACLACINOMYCIN METHYLESTERASE (RDMC) WITH BOUND PRODUCT ANALOGUE, 10- DECARBOXYMETHYLACLACINOMYCIN T (DCMAT) 1XDS ; 2.30 ; CRYSTAL STRUCTURE OF ACLACINOMYCIN-10-HYDROXYLASE (RDMB) IN COMPLEX WITH S-ADENOSYL-L-METHIONINE (SAM) AND 11-DEOXY- BETA-RHODOMYCIN (DBRA) 1R00 ; 2.50 ; CRYSTAL STRUCTURE OF ACLACINOMYCIN-10-HYDROXYLASE (RDMB) IN COMPLEX WITH S-ADENSYL-L-HOMOCYSTEIN (SAH) 1QZZ ; 2.10 ; CRYSTAL STRUCTURE OF ACLACINOMYCIN-10-HYDROXYLASE (RDMB) IN COMPLEX WITH S-ADENSYL-L-METHIONINE (SAM) 1XDU ; 2.70 ; CRYSTAL STRUCTURE OF ACLACINOMYCIN-10-HYDROXYLASE (RDMB) IN COMPLEX WITH SINEFUNGIN (SFG) 1B0J ; 2.50 ; CRYSTAL STRUCTURE OF ACONITASE WITH ISOCITRATE 1IZN ; 2.10 ; CRYSTAL STRUCTURE OF ACTIN FILAMENT CAPPING PROTEIN CAPZ 1YXQ ; 2.01 ; CRYSTAL STRUCTURE OF ACTIN IN COMPLEX WITH SWINHOLIDE A 1SH5 ; 2.00 ; CRYSTAL STRUCTURE OF ACTIN-BINDING DOMAIN OF MOUSE PLECTIN 1SH6 ; 2.00 ; CRYSTAL STRUCTURE OF ACTIN-BINDING DOMAIN OF MOUSE PLECTIN 1A7Y ; 0.94 ; CRYSTAL STRUCTURE OF ACTINOMYCIN D 1A7Z ; 0.95 ; CRYSTAL STRUCTURE OF ACTINOMYCIN Z3 1WPV ; 1.70 ; CRYSTAL STRUCTURE OF ACTIVATED BINARY COMPLEX OF HUTP, AN RIBONUCLEIC ACID BINDING ANTI-TERMINATION PROTEIN 1FQW ; 2.37 ; CRYSTAL STRUCTURE OF ACTIVATED CHEY 1F4V ; 2.22 ; CRYSTAL STRUCTURE OF ACTIVATED CHEY BOUND TO THE N-TERMINUS OF FLIM 1ZDM ; 2.40 ; CRYSTAL STRUCTURE OF ACTIVATED CHEY BOUND TO XE 1Z5R ; 1.40 ; CRYSTAL STRUCTURE OF ACTIVATED PORCINE PANCREATIC CARBOXYPEPTIDASE B 1IR2 ; 1.84 ; CRYSTAL STRUCTURE OF ACTIVATED RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE (RUBISCO) FROM GREEN ALGA, CHLAMYDOMONAS REINHARDTII COMPLEXED WITH 2- CARBOXYARABINITOL-1,5-BISPHOSPHATE (2-CABP) 1WDD ; 1.35 ; CRYSTAL STRUCTURE OF ACTIVATED RICE RUBISCO COMPLEXED WITH 2-CARBOXYARABINITOL-1,5-BISPHOSPHATE 1J6R ; 2.30 ; CRYSTAL STRUCTURE OF ACTIVATION (ADOMET BINDING) DOMAIN OF METHIONINE SYNTHASE (TM0269) FROM THERMOTOGA MARITIMA AT 2.2 A RESOLUTION 1XJT ; 1.75 ; CRYSTAL STRUCTURE OF ACTIVE FORM OF P1 PHAGE ENDOLYSIN LYZ 1XRM ; 2.70 ; CRYSTAL STRUCTURE OF ACTIVE SITE F1-MUTANT E213Q SOAKED WITH PEPTIDE ALA-PHE 1XRN ; 2.80 ; CRYSTAL STRUCTURE OF ACTIVE SITE F1-MUTANT E213Q SOAKED WITH PEPTIDE PHE-ALA 1XRO ; 1.80 ; CRYSTAL STRUCTURE OF ACTIVE SITE F1-MUTANT E213Q SOAKED WITH PEPTIDE PHE-LEU 1XRP ; 2.30 ; CRYSTAL STRUCTURE OF ACTIVE SITE F1-MUTANT E213Q SOAKED WITH PEPTIDE PRO-LEU-GLY-GLY 1XRQ ; 2.80 ; CRYSTAL STRUCTURE OF ACTIVE SITE F1-MUTANT E245Q SOAKED WITH PEPTIDE PHE-LEU 1XRR ; 2.40 ; CRYSTAL STRUCTURE OF ACTIVE SITE F1-MUTANT E245Q SOAKED WITH PEPTIDE PRO-PRO 1XRL ; 1.82 ; CRYSTAL STRUCTURE OF ACTIVE SITE F1-MUTANT Y205F COMPLEX WITH INHIBITOR PCK 1CVW ; 2.28 ; CRYSTAL STRUCTURE OF ACTIVE SITE-INHIBITED HUMAN COAGULATION FACTOR VIIA (DES-GLA) 1NYU ; 3.10 ; CRYSTAL STRUCTURE OF ACTIVIN A BOUND TO THE ECD OF ACTRIIB 1NYS ; 3.05 ; CRYSTAL STRUCTURE OF ACTIVIN A BOUND TO THE ECD OF ACTRIIB P41 1QUA ; 2.20 ; CRYSTAL STRUCTURE OF ACUTOLYSIN-C, A HEMORRHAGIC TOXIN FROM THE SNAKE VENOM OF AGKISTRODON ACUTUS, AT 2.2 A RESOLUTION 1VKU ; 2.00 ; CRYSTAL STRUCTURE OF ACYL CARRIER PROTEIN (TM0175) FROM THERMOTOGA MARITIMA AT 2.00 A RESOLUTION 1TIK ; 2.30 ; CRYSTAL STRUCTURE OF ACYL CARRIER PROTEIN PHOSPHODIESTERASE 1VPM ; 1.66 ; CRYSTAL STRUCTURE OF ACYL-COA HYDROLASE (NP_241664.1) FROM BACILLUS HALODURANS AT 1.66 A RESOLUTION 1Y7U ; 2.80 ; CRYSTAL STRUCTURE OF ACYL-COA HYDROLASE FROM BACILLUS CEREUS 2AHU ; 1.90 ; CRYSTAL STRUCTURE OF ACYL-COA TRANSFERASE (YDIF) APOENZYME FROM ESCHERICHIA COLI O157:H7. 2AHV ; 2.00 ; CRYSTAL STRUCTURE OF ACYL-COA TRANSFERASE FROM E. COLI O157:H7 (YDIF)-THIOESTER COMPLEX WITH COA- 1 2AHW ; 2.15 ; CRYSTAL STRUCTURE OF ACYL-COA TRANSFERASE FROM E. COLI O157:H7 (YDIF)-THIOESTER COMPLEX WITH COA- 2 1V3Z ; 1.72 ; CRYSTAL STRUCTURE OF ACYLPHOSPHATASE FROM PYROCOCCUS HORIKOSHII 1G2P ; 1.75 ; CRYSTAL STRUCTURE OF ADENINE PHOSPHORIBOSYLTRANSFERASE 1G2Q ; 1.50 ; CRYSTAL STRUCTURE OF ADENINE PHOSPHORIBOSYLTRANSFERASE 1MZV ; 2.20 ; CRYSTAL STRUCTURE OF ADENINE PHOSPHORIBOSYLTRANSFERASE (APRT) FROM LEISHMANIA TARENTOLAE 1S9H ; 2.40 ; CRYSTAL STRUCTURE OF ADENO-ASSOCIATED VIRUS TYPE 2 REP40 1D6J ; 2.00 ; CRYSTAL STRUCTURE OF ADENOSINE 5'-PHOSPHOSULFATE (APS) KINASE FROM PENICILLIUM CHRYSOGENUM 1O5R ; 2.35 ; CRYSTAL STRUCTURE OF ADENOSINE DEAMINASE COMPLEXED WITH A POTENT INHIBITOR 1UML ; 2.50 ; CRYSTAL STRUCTURE OF ADENOSINE DEAMINASE COMPLEXED WITH A POTENT INHIBITOR FR233624 1NDV ; 2.30 ; CRYSTAL STRUCTURE OF ADENOSINE DEAMINASE COMPLEXED WITH FR117016 1NDW ; 2.00 ; CRYSTAL STRUCTURE OF ADENOSINE DEAMINASE COMPLEXED WITH FR221647 1NDY ; 2.00 ; CRYSTAL STRUCTURE OF ADENOSINE DEAMINASE COMPLEXED WITH FR230513 1QXL ; 2.25 ; CRYSTAL STRUCTURE OF ADENOSINE DEAMINASE COMPLEXED WITH FR235380 1NDZ ; 2.00 ; CRYSTAL STRUCTURE OF ADENOSINE DEAMINASE COMPLEXED WITH FR235999 1WXY ; 2.50 ; CRYSTAL STRUCTURE OF ADENOSINE DEAMINASE LIGATED WITH A POTENT INHIBITOR 1WXZ ; 2.80 ; CRYSTAL STRUCTURE OF ADENOSINE DEAMINASE LIGATED WITH A POTENT INHIBITOR 1DGM ; 1.80 ; CRYSTAL STRUCTURE OF ADENOSINE KINASE FROM TOXOPLASMA GONDII 1DTY ; 2.14 ; CRYSTAL STRUCTURE OF ADENOSYLMETHIONINE-8-AMINO-7- OXONANOATE AMINOTRANSFERASE WITH PYRIDOXAL PHOSPHATE COFACTOR. 1S3G ; 2.25 ; CRYSTAL STRUCTURE OF ADENYLATE KINASE FROM BACILLUS GLOBISPORUS 1GIM ; 2.50 ; CRYSTAL STRUCTURE OF ADENYLOSUCCINATE SYNTHETASE FROM ESCHERICHIA COLI COMPLEXED WITH GDP, IMP, HADACIDIN, NO3-, AND MG2+. DATA COLLECTED AT 100K (PH6.5) 1GIN ; 2.80 ; CRYSTAL STRUCTURE OF ADENYLOSUCCINATE SYNTHETASE FROM ESCHERICHIA COLI COMPLEXED WITH GDP, IMP, HADACIDIN, NO3-, AND MG2+. DATA COLLECTED AT 298K (PH6.5). 1F7S ; 2.00 ; CRYSTAL STRUCTURE OF ADF1 FROM ARABIDOPSIS THALIANA 1X3M ; 2.20 ; CRYSTAL STRUCTURE OF ADP BOUND PROPIONATE KINASE (TDCD) FROM SALMONELLA TYPHIMURIUM 1T6X ; 2.29 ; CRYSTAL STRUCTURE OF ADP BOUND TM379 1NY3 ; 3.00 ; CRYSTAL STRUCTURE OF ADP BOUND TO MAP KAP KINASE 2 1VHG ; 2.70 ; CRYSTAL STRUCTURE OF ADP COMPOUNDS HYDROLASE 1VHZ ; 2.32 ; CRYSTAL STRUCTURE OF ADP COMPOUNDS HYDROLASE 1T6Y ; 2.80 ; CRYSTAL STRUCTURE OF ADP, AMP, AND FMN BOUND TM379 1L2L ; 2.00 ; CRYSTAL STRUCTURE OF ADP-DEPENDENT GLUCOKINASE FROM A PYROCOCCUS HORIKOSHII 1R0S ; 2.00 ; CRYSTAL STRUCTURE OF ADP-RIBOSYL CYCLASE GLU179ALA MUTANT 1U2R ; 2.60 ; CRYSTAL STRUCTURE OF ADP-RIBOSYLATED RIBOSOMAL TRANSLOCASE FROM SACCHAROMYCES CEREVISIAE 1NA8 ; 2.30 ; CRYSTAL STRUCTURE OF ADP-RIBOSYLATION FACTOR BINDING PROTEIN GGA1 2CWC ; 1.65 ; CRYSTAL STRUCTURE OF ADP-RIBOSYLGLYCOHYDROLASE-RELATED PROTEIN FROM THERMUS THERMOPHILUS HB8 1EJ3 ; 2.30 ; CRYSTAL STRUCTURE OF AEQUORIN 1XRY ; 2.10 ; CRYSTAL STRUCTURE OF AEROMONAS PROTEOLYTICA AMINOPEPTIDASE IN COMPLEX WITH BESTATIN 1HJZ ; 1.70 ; CRYSTAL STRUCTURE OF AF1521 PROTEIN CONTAINING A MACROH2A DOMAIN 1OI0 ; 1.50 ; CRYSTAL STRUCTURE OF AF2198, A JAB1/MPN DOMAIN PROTEIN FROM ARCHAEOGLOBUS FULGIDUS 1WOG ; 1.80 ; CRYSTAL STRUCTURE OF AGMATINASE REVEALS STRUCTURAL CONSERVATION AND INHIBITION MECHANISM OF THE UREOHYDROLASE SUPERFAMILY 1WOH ; 1.75 ; CRYSTAL STRUCTURE OF AGMATINASE REVEALS STRUCTURAL CONSERVATION AND INHIBITION MECHANISM OF THE UREOHYDROLASE SUPERFAMILY 1WOI ; 1.85 ; CRYSTAL STRUCTURE OF AGMATINASE REVEALS STRUCTURAL CONSERVATION AND INHIBITION MECHANISM OF THE UREOHYDROLASE SUPERFAMILY 1Z2I ; 2.20 ; CRYSTAL STRUCTURE OF AGROBACTERIUM TUMEFACIENS MALATE DEHYDROGENASE, NEW YORK STRUCTURAL GENOMICS CONSORTIUM 1N8J ; 2.17 ; CRYSTAL STRUCTURE OF AHPC WITH ACTIVE SITE CYSTEINE MUTATED TO SERINE (C46S) 1XVW ; 1.90 ; CRYSTAL STRUCTURE OF AHPE FROM MYCOBACTERIUM TUBERCULOSIS, A 1-CYS PEROXIREDOXIN 1XXU ; 1.90 ; CRYSTAL STRUCTURE OF AHPE FROM MYCROBACTERIUM TUBERCULOSIS, A 1-CYS PEROXIREDOXIN 1F9N ; 2.70 ; CRYSTAL STRUCTURE OF AHRC, THE ARGININE REPRESSOR/ACTIVATOR PROTEIN FROM BACILLUS SUBTILIS 1Y01 ; 2.80 ; CRYSTAL STRUCTURE OF AHSP BOUND TO FE(II) ALPHA-HEMOGLOBIN 1VLL ; 2.80 ; CRYSTAL STRUCTURE OF ALANINE DEHYDROGENASE (AF1665) FROM ARCHAEOGLOBUS FULGIDUS AT 2.80 A RESOLUTION 1VFH ; 2.00 ; CRYSTAL STRUCTURE OF ALANINE RACEMASE FROM D-CYCLOSERINE PRODUCING STREPTOMYCES LAVENDULAE 1VJO ; 1.70 ; CRYSTAL STRUCTURE OF ALANINE--GLYOXYLATE AMINOTRANSFERASE (ALR1004) FROM NOSTOC SP. AT 1.70 A RESOLUTION 1V4P ; 1.45 ; CRYSTAL STRUCTURE OF ALANYL-TRNA SYNTHETASE FROM PYROCOCCUS HORIKOSHII OT3 1YFR ; 2.15 ; CRYSTAL STRUCTURE OF ALANYL-TRNA SYNTHETASE IN COMPLEX WITH ATP AND MAGNESIUM 1VJ0 ; 2.00 ; CRYSTAL STRUCTURE OF ALCOHOL DEHYDROGENASE (TM0436) FROM THERMOTOGA MARITIMA AT 2.00 A RESOLUTION 1O2D ; 1.30 ; CRYSTAL STRUCTURE OF ALCOHOL DEHYDROGENASE, IRON-CONTAINING (TM0920) FROM THERMOTOGA MARITIMA AT 1.30 A RESOLUTION 1UJM ; 2.00 ; CRYSTAL STRUCTURE OF ALDEHYDE REDUCTASE 2 FROM SPOROBOLOMYCES SALMONICOLOR AKU4429 1X97 ; 1.40 ; CRYSTAL STRUCTURE OF ALDOSE REDUCTASE COMPLEXED WITH 2R4S (STEREOISOMER OF FIDARESTAT, 2S4S) 1X98 ; 1.30 ; CRYSTAL STRUCTURE OF ALDOSE REDUCTASE COMPLEXED WITH 2S4R (STEREOISOMER OF FIDARESTAT, 2S4S) 1X96 ; 1.40 ; CRYSTAL STRUCTURE OF ALDOSE REDUCTASE WITH CITRATES BOUND IN THE ACTIVE SITE 1SUS ; 2.70 ; CRYSTAL STRUCTURE OF ALFALFA FERUOYL COENZYME A 3-O- METHYLTRANSFERASE 1XOK ; 3.00 ; CRYSTAL STRUCTURE OF ALFALFA MOSAIC VIRUS RIBONUCLEIC ACID 3'UTR IN COMPLEX WITH COAT PROTEIN N TERMINAL PEPTIDE 1HV6 ; 2.00 ; CRYSTAL STRUCTURE OF ALGINATE LYASE A1-III COMPLEXED WITH TRISACCHARIDE PRODUCT. 1QAZ ; 1.78 ; CRYSTAL STRUCTURE OF ALGINATE LYASE A1-III FROM SPHINGOMONAS SPECIES A1 AT 1.78A RESOLUTION 1VAV ; 2.00 ; CRYSTAL STRUCTURE OF ALGINATE LYASE PA1167 FROM PSEUDOMONAS AERUGINOSA AT 2.0 A RESOLUTION 1WKY ; 1.65 ; CRYSTAL STRUCTURE OF ALKALINE MANNANASE FROM BACILLUS SP. STRAIN JAMB-602: CATALYTIC DOMAIN AND ITS CARBOHYDRATE BINDING MODULE 1WMD ; 1.30 ; CRYSTAL STRUCTURE OF ALKALINE SERINE PROTEASE KP-43 FROM BACILLUS SP. KSM-KP43 (1.30 ANGSTROM, 100 K) 1WME ; 1.50 ; CRYSTAL STRUCTURE OF ALKALINE SERINE PROTEASE KP-43 FROM BACILLUS SP. KSM-KP43 (1.50 ANGSTROM, 293 K) 1WMF ; 1.73 ; CRYSTAL STRUCTURE OF ALKALINE SERINE PROTEASE KP-43 FROM BACILLUS SP. KSM-KP43 (OXIDIZED FORM, 1.73 ANGSTROM) 1DED ; 2.00 ; CRYSTAL STRUCTURE OF ALKALOPHILIC ASPARAGINE 233-REPLACED CYCLODEXTRIN GLUCANOTRANSFERASE COMPLEXED WITH AN INHIBITOR, ACARBOSE, AT 2.0 A RESOLUTION 1ZOF ; 2.95 ; CRYSTAL STRUCTURE OF ALKYL HYDROPEROXIDE-REDUCTASE (AHPC) FROM HELICOBACTER PYLORI 1N98 ; 1.80 ; CRYSTAL STRUCTURE OF ALL-D MONELLIN AT 1.8 A RESOLUTION 1Z2L ; 2.25 ; CRYSTAL STRUCTURE OF ALLANTOATE-AMIDOHYDROLASE FROM E.COLI K12 IN COMPLEX WITH SUBSTRATE ALLANTOATE 1O59 ; 2.40 ; CRYSTAL STRUCTURE OF ALLANTOICASE (YIR029W) FROM SACCHAROMYCES CEREVISIAE AT 2.40 A RESOLUTION 1Q4V ; 2.00 ; CRYSTAL STRUCTURE OF ALLO-ILEA2-INSULIN, AN INACTIVE CHIRAL ANALOGUE: IMPLICATIONS FOR THE MECHANISM OF RECEPTOR 1KN1 ; 2.20 ; CRYSTAL STRUCTURE OF ALLOPHYCOCYANIN 1WUW ; 1.90 ; CRYSTAL STRUCTURE OF ALPHA HORDOTHIONIN 1G1Y ; 3.00 ; CRYSTAL STRUCTURE OF ALPHA-AMYLASE II (TVAII) FROM THERMOACTINOMYCES VULGARIS R-47 AND BETA-CYCLODEXTRIN COMPLEX 1HJE ; 0.75 ; CRYSTAL STRUCTURE OF ALPHA-CONOTOXIN SI 1ZY9 ; 2.34 ; CRYSTAL STRUCTURE OF ALPHA-GALACTOSIDASE (EC 3.2.1.22) (MELIBIASE) (TM1192) FROM THERMOTOGA MARITIMA AT 2.34 A RESOLUTION 1VJT ; 2.50 ; CRYSTAL STRUCTURE OF ALPHA-GLUCOSIDASE (TM0752) FROM THERMOTOGA MARITIMA AT 2.50 A RESOLUTION 1F8Q ; 2.20 ; CRYSTAL STRUCTURE OF ALPHA-MOMORCHARIN IN ACETONITRILE- WATER MIXTURE 1WE5 ; 2.40 ; CRYSTAL STRUCTURE OF ALPHA-XYLOSIDASE FROM ESCHERICHIA COLI 1MQ8 ; 3.30 ; CRYSTAL STRUCTURE OF ALPHAL I DOMAIN IN COMPLEX WITH ICAM-1 1K8X ; 1.90 ; CRYSTAL STRUCTURE OF ALPHAT183V MUTANT OF TRYPTOPHAN SYNTHASE FROM SALMONELLA TYPHIMURIUM 1KFB ; 1.90 ; CRYSTAL STRUCTURE OF ALPHAT183V MUTANT OF TRYPTOPHAN SYNTHASE FROM SALMONELLA TYPHIMURIUM WITH INDOLE GLYCEROL PHOSPHATE 1KFC ; 1.50 ; CRYSTAL STRUCTURE OF ALPHAT183V MUTANT OF TRYPTOPHAN SYNTHASE FROM SALMONELLA TYPHIMURIUM WITH INDOLE PROPANOL PHOSPHATE 1KFE ; 1.75 ; CRYSTAL STRUCTURE OF ALPHAT183V MUTANT OF TRYPTOPHAN SYNTHASE FROM SALMONELLA TYPHIMURIUM WITH L-SER BOUND TO THE BETA SITE 2BTW ; 2.00 ; CRYSTAL STRUCTURE OF ALR0975 2D3I ; 2.15 ; CRYSTAL STRUCTURE OF ALUMINUM-BOUND OVOTRANSFERRIN AT 2.15 ANGSTROM RESOLUTION 1JLY ; 2.20 ; CRYSTAL STRUCTURE OF AMARANTHUS CAUDATUS AGGLUTININ 2A48 ; 2.00 ; CRYSTAL STRUCTURE OF AMFP486 E150Q 2A47 ; 1.72 ; CRYSTAL STRUCTURE OF AMFP486 H199T 1ID2 ; 2.15 ; CRYSTAL STRUCTURE OF AMICYANIN FROM PARACOCCUS VERSUTUS (THIOBACILLUS VERSUTUS) 1T5K ; 1.40 ; CRYSTAL STRUCTURE OF AMICYANIN SUBSTITUTED WITH COBALT 1WMP ; 2.00 ; CRYSTAL STRUCTURE OF AMINE OXIDASE COMPLEXED WITH COBALT ION 1PA7 ; 1.45 ; CRYSTAL STRUCTURE OF AMINO-TERMINAL MICROTUBULE BINDING DOMAIN OF EB1 1UEG ; 2.40 ; CRYSTAL STRUCTURE OF AMINO-TERMINAL MICROTUBULE BINDING DOMAIN OF EB1 1ET0 ; 2.20 ; CRYSTAL STRUCTURE OF AMINODEOXYCHORISMATE LYASE FROM ESCHERICHIA COLI 1N71 ; 1.80 ; CRYSTAL STRUCTURE OF AMINOGLYCOSIDE 6'-ACETYLTRANSFERASE TYPE II IN COMPLEX WITH COENZYME A 2A4N ; 2.20 ; CRYSTAL STRUCTURE OF AMINOGLYCOSIDE 6'-N-ACETYLTRANSFERASE COMPLEXED WITH COENZYME A 2BKK ; 2.15 ; CRYSTAL STRUCTURE OF AMINOGLYCOSIDE PHOSPHOTRANSFERASE APH (3')-IIIA IN COMPLEX WITH THE INHIBITOR AR_3A 1ND4 ; 2.10 ; CRYSTAL STRUCTURE OF AMINOGLYCOSIDE-3'-PHOSPHOTRANSFERASE- IIA 1TZ3 ; 2.90 ; CRYSTAL STRUCTURE OF AMINOIMIDAZOLE RIBOSIDE KINASE COMPLEXED WITH AMINOIMIDAZOLE RIBOSIDE 1TYY ; 2.60 ; CRYSTAL STRUCTURE OF AMINOIMIDAZOLE RIBOSIDE KINASE FROM SALMONELLA ENTERICA 1TZ6 ; 2.70 ; CRYSTAL STRUCTURE OF AMINOIMIDAZOLE RIBOSIDE KINASE FROM SALMONELLA ENTERICA COMPLEXED WITH AMINOIMIDAZOLE RIBOSIDE AND ATP ANALOG 1VLO ; 1.70 ; CRYSTAL STRUCTURE OF AMINOMETHYLTRANSFERASE (T PROTEIN; TETRAHYDROFOLATE-DEPENDENT) OF GLYCINE CLEAVAGE SYSTEM (NP417381) FROM ESCHERICHIA COLI K12 AT 1.70 A RESOLUTION 1VP4 ; 1.82 ; CRYSTAL STRUCTURE OF AMINOTRANSFERASE, PUTATIVE (TM1131) FROM THERMOTOGA MARITIMA AT 1.82 A RESOLUTION 1U77 ; 2.00 ; CRYSTAL STRUCTURE OF AMMONIA CHANNEL AMTB FROM E. COLI 1U7G ; 1.40 ; CRYSTAL STRUCTURE OF AMMONIA CHANNEL AMTB FROM E. COLI 1YBF ; 2.90 ; CRYSTAL STRUCTURE OF AMP NUCLEOSIDASE FROM BACTEROIDES THETAIOTAOMICRON VPI-5482 1GA9 ; 2.10 ; CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE FROM E. COLI COMPLEXED WITH NON-BETA-LACTAMASE INHIBITOR (2, 3-(4- BENZENESULFONYL-THIOPHENE-2-SULFONYLAMINO)-PHENYLBORONIC ACID) 1IEM ; 2.30 ; CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE FROM E. COLI IN COMPLEX WITH A BORONIC ACID INHIBITOR (1, CEFB4) 1LL9 ; 1.87 ; CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE FROM E. COLI IN COMPLEX WITH AMOXICILLIN 1LLB ; 1.72 ; CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE FROM E. COLI IN COMPLEX WITH ATMO-PENICILLIN 1IEL ; 2.00 ; CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE FROM E. COLI IN COMPLEX WITH CEFTAZIDIME 1X3N ; 2.30 ; CRYSTAL STRUCTURE OF AMPPNP BOUND PROPIONATE KINASE (TDCD) FROM SALMONELLA TYPHIMURIUM 1U7C ; 1.85 ; CRYSTAL STRUCTURE OF AMTB FROM E.COLI WITH METHYL AMMONIUM. 1UD3 ; 2.15 ; CRYSTAL STRUCTURE OF AMYK38 N289H MUTANT 1UD8 ; 2.88 ; CRYSTAL STRUCTURE OF AMYK38 WITH LITHIUM ION 1UD6 ; 2.50 ; CRYSTAL STRUCTURE OF AMYK38 WITH POTASSIUM ION 1UD5 ; 2.70 ; CRYSTAL STRUCTURE OF AMYK38 WITH RUBIDIUM ION 1CWY ; 2.00 ; CRYSTAL STRUCTURE OF AMYLOMALTASE FROM THERMUS AQUATICUS, A GLYCOSYLTRANSFERASE CATALYSING THE PRODUCTION OF LARGE CYCLIC GLUCANS 1JG9 ; 1.66 ; CRYSTAL STRUCTURE OF AMYLOSUCRASE FROM NEISSERIA POLYSACCHAREA IN COMPLEX WITH D-GLUCOSE 1QCU ; 1.20 ; CRYSTAL STRUCTURE OF AN 18 BASE PAIR COPY CONTROL RELATED RIBONUCLEIC ACID DUPLEX 2AVP ; 2.04 ; CRYSTAL STRUCTURE OF AN 8 REPEAT CONSENSUS TPR SUPERHELIX 1BR3 ; 3.00 ; CRYSTAL STRUCTURE OF AN 82-NUCLEOTIDE RIBONUCLEIC ACID-DEOXYRIBONUCLEIC ACID COMPLEX FORMED BY THE 10-23 DEOXYRIBONUCLEIC ACID ENZYME 1DC0 ; 1.30 ; CRYSTAL STRUCTURE OF AN A/B-DEOXYRIBONUCLEIC ACID INTERMEDIATE CATGGGCCCATG 1TIQ ; 1.90 ; CRYSTAL STRUCTURE OF AN ACETYLTRANSFERASE (PAIA) IN COMPLEX WITH COA AND DTT FROM BACILLUS SUBTILIS, NORTHEAST STRUCTURAL GENOMICS TARGET SR64. 1SZ8 ; 1.50 ; CRYSTAL STRUCTURE OF AN ACIDIC PHOSPHOLIPASE A2 FROM NAJA NAJA SAGITTIFERA AT 1.5 A RESOLUTION 1UMV ; 1.79 ; CRYSTAL STRUCTURE OF AN ACIDIC, NON-MYOTOXIC PHOSPHOLIPASE A2 FROM THE VENOM OF BOTHROPS JARARACUSSU 1O6L ; 1.60 ; CRYSTAL STRUCTURE OF AN ACTIVATED AKT/PROTEIN KINASE B (PKB-PIF CHIMERA) TERNARY COMPLEX WITH AMP-PNP AND GSK3 PEPTIDE 1TZS ; 2.35 ; CRYSTAL STRUCTURE OF AN ACTIVATION INTERMEDIATE OF CATHEPSIN E 1R6U ; 2.00 ; CRYSTAL STRUCTURE OF AN ACTIVE FRAGMENT OF HUMAN TRYPTOPHANYL-TRNA SYNTHETASE WITH CYTOKINE ACTIVITY 1Q11 ; 1.60 ; CRYSTAL STRUCTURE OF AN ACTIVE FRAGMENT OF HUMAN TYROSYL- TRNA SYNTHETASE WITH TYROSINOL 1Y0Q ; 3.60 ; CRYSTAL STRUCTURE OF AN ACTIVE GROUP I RIBOZYME-PRODUCT COMPLEX 2APQ ; 1.80 ; CRYSTAL STRUCTURE OF AN ACTIVE SITE MUTANT OF BOVINE PANCREATIC RIBONUCLEASE A (H119A-RNASE A) WITH A 10- GLUTAMINE EXPANSION IN THE C-TERMINAL HINGE-LOOP. 1HYB ; 2.00 ; CRYSTAL STRUCTURE OF AN ACTIVE SITE MUTANT OF METHANOBACTERIUM THERMOAUTOTROPHICUM NICOTINAMIDE MONONUCLEOTIDE ADENYLYLTRANSFERASE 1MKP ; 2.35 ; CRYSTAL STRUCTURE OF AN ACTIVE SITE MUTANT OF THE PYST1 3KTQ ; 2.30 ; CRYSTAL STRUCTURE OF AN ACTIVE TERNARY COMPLEX OF THE LARGE FRAGMENT OF DEOXYRIBONUCLEIC ACID POLYMERASE I FROM THERMUS AQUATICUS 1SC1 ; 2.60 ; CRYSTAL STRUCTURE OF AN ACTIVE-SITE LIGAND-FREE FORM OF THE HUMAN CASPASE-1 C285A MUTANT 1XEB ; 2.35 ; CRYSTAL STRUCTURE OF AN ACYL-COA N-ACYLTRANSFERASE FROM PSEUDOMONAS AERUGINOSA 1VE6 ; 2.10 ; CRYSTAL STRUCTURE OF AN ACYLPEPTIDE HYDROLASE/ESTERASE FROM AEROPYRUM PERNIX K1 1VE7 ; 2.70 ; CRYSTAL STRUCTURE OF AN ACYLPEPTIDE HYDROLASE/ESTERASE FROM AEROPYRUM PERNIX K1 IN COMPLEX WITH P-NITROPHENYL PHOSPHATE 1EFO ; 2.30 ; CRYSTAL STRUCTURE OF AN ADENINE BULGE IN THE RIBONUCLEIC ACID CHAIN OF A DEOXYRIBONUCLEIC ACID/RIBONUCLEIC ACID HYBRID, D(CTCCTCTTC)/R(GAAGAGAGAG) 1I9G ; 1.98 ; CRYSTAL STRUCTURE OF AN ADOMET DEPENDENT METHYLTRANSFERASE 1UA4 ; 1.90 ; CRYSTAL STRUCTURE OF AN ADP-DEPENDENT GLUCOKINASE FROM PYROCOCCUS FURIOSUS 1WCZ ; 2.00 ; CRYSTAL STRUCTURE OF AN ALKALINE FORM OF V8 PROTEASE FROM STAPHYLOCOCCUS AUREUS 1QQ4 ; 1.20 ; CRYSTAL STRUCTURE OF AN ALPHA-LYTIC PROTEASE MUTANT WITH ACCELERATED FOLDING KINETICS, R102H/G134S 1QRW ; 1.20 ; CRYSTAL STRUCTURE OF AN ALPHA-LYTIC PROTEASE MUTANT WITH ACCELERATED FOLDING KINETICS, R102H/G134S, PH 8 1GQU ; 2.50 ; CRYSTAL STRUCTURE OF AN ALTERNATING A-T OLIGONUCLEOTIDE FRAGMENT WITH HOOGSTEEN BASE PAIRING 315D ; 1.38 ; CRYSTAL STRUCTURE OF AN ALTERNATING OCTAMER R(GUAUGUA)D(C) WITH ADJACENT G-U WOBBLE PAIRS 1B87 ; 2.70 ; CRYSTAL STRUCTURE OF AN AMINOGLYCOSIDE 6'-N- ACETYLTRANSFERASE 1I3G ; 2.44 ; CRYSTAL STRUCTURE OF AN AMPICILLIN SINGLE CHAIN FV, FORM 1, FREE 1F4W ; 2.30 ; CRYSTAL STRUCTURE OF AN ANTI-CARBOHYDRATE ANTIBODY DIRECTED AGAINST VIBRIO CHOLERAE O1 IN COMPLEX WITH ANTIGEN 1F4X ; 2.30 ; CRYSTAL STRUCTURE OF AN ANTI-CARBOHYDRATE ANTIBODY DIRECTED AGAINST VIBRIO CHOLERAE O1 IN COMPLEX WITH ANTIGEN 1F4Y ; 2.80 ; CRYSTAL STRUCTURE OF AN ANTI-CARBOHYDRATE ANTIBODY DIRECTED AGAINST VIBRIO CHOLERAE O1 IN COMPLEX WITH ANTIGEN 1SBS ; 2.00 ; CRYSTAL STRUCTURE OF AN ANTI-HCG FAB 1P7K ; 1.75 ; CRYSTAL STRUCTURE OF AN ANTI-SSDNA ANTIGEN-BINDING FRAGMENT (FAB) BOUND TO 4-(2-HYDROXYETHYL)PIPERAZINE-1- ETHANESULFONIC ACID (HEPES) 1IT9 ; 2.80 ; CRYSTAL STRUCTURE OF AN ANTIGEN-BINDING FRAGMENT FROM A HUMANIZED VERSION OF THE ANTI-HUMAN FAS ANTIBODY HFE7A 1KYP ; 1.35 ; CRYSTAL STRUCTURE OF AN APO GREEN FLUORESCENT PROTEIN ZN BIOSENSOR 1Q44 ; 1.90 ; CRYSTAL STRUCTURE OF AN ARABIDOPSIS THALIANA PUTATIVE STEROID SULPHOTRANSFERASE 1XFO ; 1.96 ; CRYSTAL STRUCTURE OF AN ARCHAEAL AMINOPEPTIDASE 1MOJ ; 1.90 ; CRYSTAL STRUCTURE OF AN ARCHAEAL DPS-HOMOLOGUE FROM HALOBACTERIUM SALINARUM 1OJX ; 1.90 ; CRYSTAL STRUCTURE OF AN ARCHAEAL FRUCTOSE 1,6-BISPHOSPHATE ALDOLASE 1DQ3 ; 2.10 ; CRYSTAL STRUCTURE OF AN ARCHAEAL INTEIN-ENCODED HOMING ENDONUCLEASE PI-PFUI 2B98 ; 2.30 ; CRYSTAL STRUCTURE OF AN ARCHAEAL PENTAMERIC RIBOFLAVIN SYNTHASE 2B99 ; 2.22 ; CRYSTAL STRUCTURE OF AN ARCHAEAL PENTAMERIC RIBOFLAVIN SYNTHASE COMPLEX WITH A SUBSTRATE ANALOG INHIBITOR 2CV4 ; 2.30 ; CRYSTAL STRUCTURE OF AN ARCHAEAL PEROXIREDOXIN FROM THE AEROBIC HYPERTHERMOPHILIC CRENARCHAEON AEROPYRUM PERNIX K1 1TH7 ; 1.68 ; CRYSTAL STRUCTURE OF AN ARCHAEAL SM PROTEIN FROM SULFOLOBUS SOLFATARICUS 1QQC ; 2.60 ; CRYSTAL STRUCTURE OF AN ARCHAEBACTERIAL DEOXYRIBONUCLEIC ACID POLYMERASE D.TOK 1D5A ; 2.40 ; CRYSTAL STRUCTURE OF AN ARCHAEBACTERIAL DEOXYRIBONUCLEIC ACID POLYMERASE D.TOK. DEPOSITION OF SECOND NATIVE STRUCTURE AT 2.4 ANGSTROM 1J3F ; 1.45 ; CRYSTAL STRUCTURE OF AN ARTIFICIAL METALLOPROTEIN:CR(III)(3, 3'-ME2-SALOPHEN)/APO-A71G MYOGLOBIN 1UFJ ; 1.60 ; CRYSTAL STRUCTURE OF AN ARTIFICIAL METALLOPROTEIN:FE(III)(3, 3'-ME2-SALOPHEN)/APO-A71G MYOGLOBIN 1UFP ; 2.10 ; CRYSTAL STRUCTURE OF AN ARTIFICIAL METALLOPROTEIN:FE(III)(3, 3'-ME2-SALOPHEN)/APO-WILD TYPE MYOGLOBIN 1V9Q ; 1.45 ; CRYSTAL STRUCTURE OF AN ARTIFICIAL METALLOPROTEIN:MN(III)(3, 3'-ME2-SALOPHEN)/APO-A71G MYOGLOBIN 1W39 ; 3.75 ; CRYSTAL STRUCTURE OF AN ARTIFICIAL TOP COMPONENT OF TURNIP YELLOW MOSAIC VIRUS 1E2S ; 2.35 ; CRYSTAL STRUCTURE OF AN ARYLSULFATASE A MUTANT C69A 1E1Z ; 2.40 ; CRYSTAL STRUCTURE OF AN ARYLSULFATASE A MUTANT C69S 1E3C ; 2.65 ; CRYSTAL STRUCTURE OF AN ARYLSULFATASE A MUTANT C69S SOAKED IN SYNTHETIC SUBSTRATE 1E33 ; 2.50 ; CRYSTAL STRUCTURE OF AN ARYLSULFATASE A MUTANT P426L 1O63 ; 2.00 ; CRYSTAL STRUCTURE OF AN ATP PHOSPHORIBOSYLTRANSFERASE 1O64 ; 2.10 ; CRYSTAL STRUCTURE OF AN ATP PHOSPHORIBOSYLTRANSFERASE 1KMI ; 2.90 ; CRYSTAL STRUCTURE OF AN E.COLI CHEMOTAXIS PROTEIN, CHEZ 1GL2 ; 1.90 ; CRYSTAL STRUCTURE OF AN ENDOSOMAL SNARE CORE COMPLEX 3ORC ; 3.00 ; CRYSTAL STRUCTURE OF AN ENGINEERED CRO MONOMER BOUND NONSPECIFICALLY TO DEOXYRIBONUCLEIC ACID 1SM9 ; 2.20 ; CRYSTAL STRUCTURE OF AN ENGINEERED K274RN276D DOUBLE MUTANT OF XYLOSE REDUCTASE FROM CANDIDA TENUIS OPTIMIZED TO UTILIZE NAD 1CU1 ; 2.50 ; CRYSTAL STRUCTURE OF AN ENZYME COMPLEX FROM HEPATITIS C VIRUS 1JP4 ; 1.69 ; CRYSTAL STRUCTURE OF AN ENZYME DISPLAYING BOTH INOSITOL- POLYPHOSPHATE 1-PHOSPHATASE AND 3'-PHOSPHOADENOSINE-5'- PHOSPHATE PHOSPHATASE ACTIVITIES 1KD7 ; 2.80 ; CRYSTAL STRUCTURE OF AN EXTRACELLULAR DOMAIN FRAGMENT OF HUMAN BAFF 1EJE ; 2.20 ; CRYSTAL STRUCTURE OF AN FMN-BINDING PROTEIN 1C3S ; 2.50 ; CRYSTAL STRUCTURE OF AN HDAC HOMOLOG COMPLEXED WITH SAHA 1C3R ; 2.00 ; CRYSTAL STRUCTURE OF AN HDAC HOMOLOG COMPLEXED WITH TRICHOSTATIN A 1C3P ; 1.80 ; CRYSTAL STRUCTURE OF AN HDAC HOMOLOG FROM AQUIFEX AEOLICUS 1KQ2 ; 2.71 ; CRYSTAL STRUCTURE OF AN HFQ-RIBONUCLEIC ACID COMPLEX 1HU0 ; 2.35 ; CRYSTAL STRUCTURE OF AN HOGG1-DEOXYRIBONUCLEIC ACID BOROHYDRIDE TRAPPED INTERMEDIATE COMPLEX 1O65 ; 2.33 ; CRYSTAL STRUCTURE OF AN HYPOTHETICAL PROTEIN 1O67 ; 2.54 ; CRYSTAL STRUCTURE OF AN HYPOTHETICAL PROTEIN 1VHK ; 2.60 ; CRYSTAL STRUCTURE OF AN HYPOTHETICAL PROTEIN 1VHM ; 2.10 ; CRYSTAL STRUCTURE OF AN HYPOTHETICAL PROTEIN 1VHY ; 1.90 ; CRYSTAL STRUCTURE OF AN HYPOTHETICAL PROTEIN 1VI3 ; 1.76 ; CRYSTAL STRUCTURE OF AN HYPOTHETICAL PROTEIN 1VI7 ; 2.80 ; CRYSTAL STRUCTURE OF AN HYPOTHETICAL PROTEIN 1VIM ; 1.36 ; CRYSTAL STRUCTURE OF AN HYPOTHETICAL PROTEIN 1VIZ ; 1.85 ; CRYSTAL STRUCTURE OF AN HYPOTHETICAL PROTEIN 1U8R ; 2.75 ; CRYSTAL STRUCTURE OF AN IDER-DEOXYRIBONUCLEIC ACID COMPLEX REVEALS A CONFORMATIONAL CHANGE IN ACTIVATED IDER FOR BASE-SPECIFIC INTERACTIONS 1IHF ; 2.50 ; CRYSTAL STRUCTURE OF AN IHF-DEOXYRIBONUCLEIC ACID COMPLEX: A PROTEIN-INDUCED DEOXYRIBONUCLEIC ACID U-TURN 1OY3 ; 2.05 ; CRYSTAL STRUCTURE OF AN IKBBETA/NF-KB P65 HOMODIMER COMPLEX 1FB7 ; 2.60 ; CRYSTAL STRUCTURE OF AN IN VIVO HIV-1 PROTEASE MUTANT IN COMPLEX WITH SAQUINAVIR: INSIGHTS INTO THE MECHANISMS OF DRUG RESISTANCE 1MRV ; 2.80 ; CRYSTAL STRUCTURE OF AN INACTIVE AKT2 KINASE DOMAIN 1MRY ; 2.80 ; CRYSTAL STRUCTURE OF AN INACTIVE AKT2 KINASE DOMAIN 1MD0 ; 2.00 ; CRYSTAL STRUCTURE OF AN INHIBITED FRAGMENT OF ETS-1 1HOZ ; 1.60 ; CRYSTAL STRUCTURE OF AN INOSINE-ADENOSINE-GUANOSINE- PREFERRING NUCLEOSIDE HYDROLASE FROM TRYPANOSOMA VIVAX 1HP0 ; 2.10 ; CRYSTAL STRUCTURE OF AN INOSINE-ADENOSINE-GUANOSINE- PREFERRING NUCLEOSIDE HYDROLASE FROM TRYPANOSOMA VIVAX IN COMPLEX WITH THE SUBSTRATE ANALOGUE 3-DEAZA-ADENOSINE 1XNR ; 3.10 ; CRYSTAL STRUCTURE OF AN INOSINE-CYTOSINE WOBBLE BASE PAIR IN THE CONTEXT OF THE DECODING CENTER 1PN9 ; 2.00 ; CRYSTAL STRUCTURE OF AN INSECT DELTA-CLASS GLUTATHIONE S- TRANSFERASE FROM A DDT-RESISTANT STRAIN OF THE MALARIA VECTOR ANOPHELES GAMBIAE 1MIZ ; 1.90 ; CRYSTAL STRUCTURE OF AN INTEGRIN BETA3-TALIN CHIMERA 1MK7 ; 2.20 ; CRYSTAL STRUCTURE OF AN INTEGRIN BETA3-TALIN CHIMERA 1MK9 ; 2.80 ; CRYSTAL STRUCTURE OF AN INTEGRIN BETA3-TALIN CHIMERA 1P7B ; 3.65 ; CRYSTAL STRUCTURE OF AN INWARD RECTIFIER POTASSIUM CHANNEL 2IRF ; 2.20 ; CRYSTAL STRUCTURE OF AN IRF-2/DEOXYRIBONUCLEIC ACID COMPLEX. 1VHD ; 1.60 ; CRYSTAL STRUCTURE OF AN IRON CONTAINING ALCOHOL DEHYDROGENASE 1DK7 ; 2.02 ; CRYSTAL STRUCTURE OF AN ISOLATED APICAL DOMAIN OF GROEL 1VGM ; 2.00 ; CRYSTAL STRUCTURE OF AN ISOZYME OF CITRATE SYNTHASE FROM SULFOLBUS TOKODAII STRAIN7 1VGP ; 2.70 ; CRYSTAL STRUCTURE OF AN ISOZYME OF CITRATE SYNTHASE FROM SULFOLBUS TOKODAII STRAIN7 1BKN ; 2.90 ; CRYSTAL STRUCTURE OF AN N-TERMINAL 40KD FRAGMENT OF E. COLI DEOXYRIBONUCLEIC ACID MISMATCH REPAIR PROTEIN MUTL 1Z0S ; 1.70 ; CRYSTAL STRUCTURE OF AN NAD KINASE FROM ARCHAEOGLOBUS FULGIDUS IN COMPLEX WITH ATP 1OFX ; 2.00 ; CRYSTAL STRUCTURE OF AN OKAZAKI FRAGMENT AT 2 ANGSTROMS RESOLUTION 2F84 ; 2.10 ; CRYSTAL STRUCTURE OF AN OROTIDINE-5'-MONOPHOSPHATE DECARBOXYLASE HOMOLOG FROM P.FALCIPARUM 1O22 ; 2.00 ; CRYSTAL STRUCTURE OF AN ORPHAN PROTEIN (TM0875) FROM THERMOTOGA MARITIMA AT 2.00 A RESOLUTION 1U4H ; 2.07 ; CRYSTAL STRUCTURE OF AN OXYGEN BINDING H-NOX DOMAIN RELATED TO SOLUBLE GUANYLATE CYCLASES (OXYGEN COMPLEX) 1U55 ; 1.77 ; CRYSTAL STRUCTURE OF AN OXYGEN BINDING H-NOX DOMAIN RELATED TO SOLUBLE GUANYLATE CYCLASES (OXYGEN COMPLEX) 1U56 ; 1.90 ; CRYSTAL STRUCTURE OF AN OXYGEN BINDING H-NOX DOMAIN RELATED TO SOLUBLE GUANYLATE CYCLASES (WATER-LIGATED, FERRIC FORM) 255D ; 2.00 ; CRYSTAL STRUCTURE OF AN RIBONUCLEIC ACID DOUBLE HELIX INCORPORATING A TRACK OF NON-WATSON-CRICK BASE PAIRS 1YY0 ; 3.20 ; CRYSTAL STRUCTURE OF AN RIBONUCLEIC ACID DUPLEX CONTAINING A 2'-AMINE SUBSTITUTION AND A 2'-AMIDE PRODUCT PRODUCED BY IN-CRYSTAL ACYLATION AT A C-A MISMATCH 1YZD ; 2.35 ; CRYSTAL STRUCTURE OF AN RIBONUCLEIC ACID DUPLEX CONTAINING A SITE SPECIFIC 2'-AMINE SUBSTITUTION AT A C-G WATSON-CRICK BASE PAIR 1Z79 ; 2.55 ; CRYSTAL STRUCTURE OF AN RIBONUCLEIC ACID DUPLEX CONTAINING SITE SPECIFIC 2'-AMINE SUBSTITUTION AT A C-A MISMATCH (AT PH 5) 1YRM ; 2.50 ; CRYSTAL STRUCTURE OF AN RIBONUCLEIC ACID DUPLEX CONTAINING SITE SPECIFIC 2'-AMINE SUBSTITUTIONS AT A C-A MISMATCH 1J9H ; 1.40 ; CRYSTAL STRUCTURE OF AN RIBONUCLEIC ACID DUPLEX WITH URIDINE BULGES 1KFO ; 1.60 ; CRYSTAL STRUCTURE OF AN RIBONUCLEIC ACID HELIX RECOGNIZED BY A ZINC- FINGER PROTEIN: AN 18 BASE PAIR DUPLEX AT 1.6 RESOLUTION 437D ; 1.60 ; CRYSTAL STRUCTURE OF AN RIBONUCLEIC ACID PSEUDOKNOT FROM BEET WESTERN YELLOW VIRUS INVOLVED IN RIBOSOMAL FRAMESHIFTING 409D ; 2.50 ; CRYSTAL STRUCTURE OF AN RIBONUCLEIC ACID R(CCCIUGGG) WITH THREE INDEPENDENT DUPLEXES INCORPORATING TANDEM I.U WOBBLES 1KH6 ; 2.90 ; CRYSTAL STRUCTURE OF AN RIBONUCLEIC ACID TERTIARY DOMAIN ESSENTIAL TO HCV IRES-MEDIATED TRANSLATION INITIATION. 1J6S ; 1.40 ; CRYSTAL STRUCTURE OF AN RIBONUCLEIC ACID TETRAPLEX (UGAGGU)4 WITH A- TETRADS, G-TETRADS, U-TETRADS AND G-U OCTADS 1PJO ; 1.10 ; CRYSTAL STRUCTURE OF AN RIBONUCLEIC ACID/DEOXYRIBONUCLEIC ACID HYBRID OF HIV-1 PPT 1F0V ; 1.70 ; CRYSTAL STRUCTURE OF AN RNASE A DIMER DISPLAYING A NEW TYPE OF 3D DOMAIN SWAPPING 1I4K ; 2.50 ; CRYSTAL STRUCTURE OF AN SM-LIKE PROTEIN (AF-SM1) FROM ARCHAEOGLOBUS FULGIDUS AT 2.5A RESOLUTION 1I5L ; 2.75 ; CRYSTAL STRUCTURE OF AN SM-LIKE PROTEIN (AF-SM1) FROM ARCHAEOGLOBUS FULGIDUS COMPLEXED WITH SHORT POLY-U RIBONUCLEIC ACID 1LJO ; 1.95 ; CRYSTAL STRUCTURE OF AN SM-LIKE PROTEIN (AF-SM2) FROM ARCHAEOGLOBUS FULGIDUS AT 1.95A RESOLUTION 1X7F ; 2.30 ; CRYSTAL STRUCTURE OF AN UNCHARACTERIZED B. CEREUS PROTEIN 1DQL ; 2.60 ; CRYSTAL STRUCTURE OF AN UNLIGANDED (NATIVE) FV FROM A HUMAN IGM ANTI-PEPTIDE ANTIBODY 1J73 ; 2.00 ; CRYSTAL STRUCTURE OF AN UNSTABLE INSULIN ANALOG WITH NATIVE ACTIVITY. 1R8O ; 1.83 ; CRYSTAL STRUCTURE OF AN UNUSUAL KUNITZ-TYPE TRYPSIN INHIBITOR FROM COPAIFERA LANGSDORFFII SEEDS 1R4I ; 3.10 ; CRYSTAL STRUCTURE OF ANDROGEN RECEPTOR DEOXYRIBONUCLEIC ACID-BINDING DOMAIN BOUND TO A DIRECT REPEAT RESPONSE ELEMENT 1DK5 ; 2.80 ; CRYSTAL STRUCTURE OF ANNEXIN 24(CA32) FROM CAPSICUM ANNUUM 1N41 ; 2.10 ; CRYSTAL STRUCTURE OF ANNEXIN V K27E MUTANT 1N42 ; 2.10 ; CRYSTAL STRUCTURE OF ANNEXIN V R149E MUTANT 1N44 ; 3.00 ; CRYSTAL STRUCTURE OF ANNEXIN V R23E MUTANT 1V8G ; 2.10 ; CRYSTAL STRUCTURE OF ANTHRANILATE PHOSPHORIBOSYLTRANSFERASE (TRPD) FROM THERMUS THERMOPHILUS HB8 1VQU ; 1.85 ; CRYSTAL STRUCTURE OF ANTHRANILATE PHOSPHORIBOSYLTRANSFERASE 2 (17130499) FROM NOSTOC SP. AT 1.85 A RESOLUTION 1XFY ; 3.30 ; CRYSTAL STRUCTURE OF ANTHRAX EDEMA FACTOR (EF) IN COMPLEX WITH CALMODULIN 1XFV ; 3.35 ; CRYSTAL STRUCTURE OF ANTHRAX EDEMA FACTOR (EF) IN COMPLEX WITH CALMODULIN AND 3' DEOXY-ATP 1XFW ; 3.40 ; CRYSTAL STRUCTURE OF ANTHRAX EDEMA FACTOR (EF) IN COMPLEX WITH CALMODULIN AND 3'5' CYCLIC AMP (CAMP) 1Y0V ; 3.60 ; CRYSTAL STRUCTURE OF ANTHRAX EDEMA FACTOR (EF) IN COMPLEX WITH CALMODULIN AND PYROPHOSPHATE 1XFZ ; 3.25 ; CRYSTAL STRUCTURE OF ANTHRAX EDEMA FACTOR (EF) IN COMPLEX WITH CALMODULIN IN THE PRESENCE OF 1 MILLIMOLAR EXOGENOUSLY ADDED CALCIUM CHLORIDE 1XFX ; 3.20 ; CRYSTAL STRUCTURE OF ANTHRAX EDEMA FACTOR (EF) IN COMPLEX WITH CALMODULIN IN THE PRESENCE OF 10 MILLIMOLAR EXOGENOUSLY ADDED CALCIUM CHLORIDE 1XFU ; 3.35 ; CRYSTAL STRUCTURE OF ANTHRAX EDEMA FACTOR (EF) TRUNCATION MUTANT, EF-DELTA 64 IN COMPLEX WITH CALMODULIN 1PWW ; 2.80 ; CRYSTAL STRUCTURE OF ANTHRAX LETHAL FACTOR ACTIVE SITE MUTANT PROTEIN COMPLEXED WITH AN OPTIMISED PEPTIDE SUBSTRATE IN THE PRESENCE OF ZINC. 1PWU ; 2.70 ; CRYSTAL STRUCTURE OF ANTHRAX LETHAL FACTOR COMPLEXED WITH (3-(N-HYDROXYCARBOXAMIDO)-2-ISOBUTYLPROPANOYL-TRP- METHYLAMIDE), A KNOWN SMALL MOLECULE INHIBITOR OF MATRIX METALLOPROTEASES. 1PWQ ; 3.52 ; CRYSTAL STRUCTURE OF ANTHRAX LETHAL FACTOR COMPLEXED WITH THIOACETYL-TYR-PRO-MET-AMIDE, A METAL-CHELATING PEPTIDYL SMALL MOLECULE INHIBITOR 1PWV ; 2.85 ; CRYSTAL STRUCTURE OF ANTHRAX LETHAL FACTOR WILD-TYPE PROTEIN COMPLEXED WITH AN OPTIMISED PEPTIDE SUBSTRATE. 1NLB ; 1.60 ; CRYSTAL STRUCTURE OF ANTI-HCV MONOCLONAL ANTIBODY 19D9D6 1DQM ; 2.10 ; CRYSTAL STRUCTURE OF ANTI-LYSOZYME ANTIBODY 1DQQ ; 1.80 ; CRYSTAL STRUCTURE OF ANTI-LYSOZYME ANTIBODY HYHEL-63 1XGY ; 2.71 ; CRYSTAL STRUCTURE OF ANTI-META I RHODOPSIN FAB FRAGMENT K42- 41L 1UB5 ; 2.00 ; CRYSTAL STRUCTURE OF ANTIBODY 19G2 WITH HAPTEN AT 100K 1UB6 ; 2.12 ; CRYSTAL STRUCTURE OF ANTIBODY 19G2 WITH SERA LIGAND 1K6Q ; 2.40 ; CRYSTAL STRUCTURE OF ANTIBODY FAB FRAGMENT D3 1KCV ; 1.80 ; CRYSTAL STRUCTURE OF ANTIBODY PC282 1KCS ; 2.50 ; CRYSTAL STRUCTURE OF ANTIBODY PC282 IN COMPLEX WITH PS1 PEPTIDE 1KCR ; 2.90 ; CRYSTAL STRUCTURE OF ANTIBODY PC283 IN COMPLEX WITH PS1 PEPTIDE 1KCU ; 2.20 ; CRYSTAL STRUCTURE OF ANTIBODY PC287 1KC5 ; 2.50 ; CRYSTAL STRUCTURE OF ANTIBODY PC287 IN COMPLEX WITH PS1 PEPTIDE 1EZG ; 1.40 ; CRYSTAL STRUCTURE OF ANTIFREEZE PROTEIN FROM THE BEETLE, TENEBRIO MOLITOR 1DQZ ; 1.50 ; CRYSTAL STRUCTURE OF ANTIGEN 85C FROM MYCOBACTERIUM TUBERCULOSIS 1DQY ; 1.83 ; CRYSTAL STRUCTURE OF ANTIGEN 85C FROM MYCOBACTERIUM TUBERCULOSIS WITH DIETHYL PHOSPHATE INHIBITOR 1NQ9 ; 2.60 ; CRYSTAL STRUCTURE OF ANTITHROMBIN IN THE PENTASACCHARIDE- BOUND INTERMEDIATE STATE 2BEH ; 2.70 ; CRYSTAL STRUCTURE OF ANTITHROMBIN VARIANT S137A/V317C/T401C WITH PLASMA LATENT ANTITHROMBIN 1TSQ ; 2.00 ; CRYSTAL STRUCTURE OF AP2V SUBSTRATE VARIANT OF NC-P1 DECAMER PEPTIDE IN COMPLEX WITH V82A/D25N HIV-1 PROTEASE MUTANT 1XVS ; 2.01 ; CRYSTAL STRUCTURE OF APAG PROTEIN FROM VIBRIO CHOLERAE 1ORU ; 1.80 ; CRYSTAL STRUCTURE OF APC1665, YUAD PROTEIN FROM BACILLUS SUBTILIS 1YLX ; 1.60 ; CRYSTAL STRUCTURE OF APC35702, A HYPOTHETICAL PROTEIN FROM BACILLUS STEAROTHERMOPHILUS 1U84 ; 1.60 ; CRYSTAL STRUCTURE OF APC36109 FROM BACILLUS STEAROTHERMOPHILUS 1WFX ; 2.80 ; CRYSTAL STRUCTURE OF APE0204 FROM AEROPYRUM PERNIX 2CWJ ; 3.60 ; CRYSTAL STRUCTURE OF APE1501, A PUTATIVE ENDONUCLEASE FROM AEROPYRUM PERNIX 1RMT ; 1.40 ; CRYSTAL STRUCTURE OF APHA CLASS B ACID PHOSPHATASE/PHOSPHOTRANSFERASE COMPLEXED WITH ADENOSINE. 2B8J ; 2.03 ; CRYSTAL STRUCTURE OF APHA CLASS B ACID PHOSPHATASE/PHOSPHOTRANSFERASE TERNARY COMPLEX WITH ADENOSINE AND PHOSPHATE AT 2 A RESOLUTION 2B82 ; 1.25 ; CRYSTAL STRUCTURE OF APHA CLASS B ACID PHOSPHATASE/PHOSPHOTRANSFERASE TERNARY COMPLEX WITH ADENOSINE AND PHOSPHATE BOUND TO THE CATALYTIC METAL AT 1.2 A RESOLUTION 1RMY ; 1.75 ; CRYSTAL STRUCTURE OF APHA CLASS B ACID PHOSPHATASE/PHOSPHOTRANSFERASE TERNARY COMPLEX WITH DEOXYCYTOSINE AND PHOSPHATE BOUND TO THE CATALYTIC METAL 1RMQ ; 2.00 ; CRYSTAL STRUCTURE OF APHA CLASS B ACID PHOSPHATASE/PHOSPHOTRANSFERASE WITH OSMIATE MIMICKING THE CATALYTIC INTERMEDIATE 1E5P ; 1.63 ; CRYSTAL STRUCTURE OF APHRODISIN, A SEX PHEROMONE FROM FEMALE HAMSTER 1W81 ; 2.01 ; CRYSTAL STRUCTURE OF APICAL MEMBRANE ANTIGEN 1 FROM PLASMODIUM VIVAX 1W8K ; 1.80 ; CRYSTAL STRUCTURE OF APICAL MEMBRANE ANTIGEN 1 FROM PLASMODIUM VIVAX 2BYP ; 2.07 ; CRYSTAL STRUCTURE OF APLYSIA CALIFORNICA ACHBP IN COMPLEX WITH ALPHA-CONOTOXIN IMI 2BYQ ; 3.40 ; CRYSTAL STRUCTURE OF APLYSIA CALIFORNICA ACHBP IN COMPLEX WITH EPIBATIDINE 1OTJ ; 1.90 ; CRYSTAL STRUCTURE OF APO (IRON-FREE) TAUD 1P1F ; 2.60 ; CRYSTAL STRUCTURE OF APO 1L-MYO-INOSITOL 1-PHOSPHATE SYNTHASE 2BYN ; 2.02 ; CRYSTAL STRUCTURE OF APO ACHBP FROM APLYSIA CALIFORNICA 1T8K ; 1.10 ; CRYSTAL STRUCTURE OF APO ACYL CARRIER PROTEIN FROM E. COLI 1NR7 ; 3.30 ; CRYSTAL STRUCTURE OF APO BOVINE GLUTAMATE DEHYDROGENASE 1TVQ ; 2.00 ; CRYSTAL STRUCTURE OF APO CHICKEN LIVER BASIC FATTY ACID BINDING PROTEIN (OR BILE ACID BINDING PROTEIN) 2BZ1 ; 1.54 ; CRYSTAL STRUCTURE OF APO E. COLI GTP CYCLOHYDROLASE II 1YFE ; 2.19 ; CRYSTAL STRUCTURE OF APO FUMARASE C FROM ESCHERICHIA COLI 1F4Q ; 1.90 ; CRYSTAL STRUCTURE OF APO GRANCALCIN 1XCK ; 2.92 ; CRYSTAL STRUCTURE OF APO GROEL 1IRM ; 2.55 ; CRYSTAL STRUCTURE OF APO HEME OXYGENASE-1 1SNZ ; 2.20 ; CRYSTAL STRUCTURE OF APO HUMAN GALACTOSE MUTAROTASE 1EYB ; 1.90 ; CRYSTAL STRUCTURE OF APO HUMAN HOMOGENTISATE DIOXYGENASE 1ILG ; 2.52 ; CRYSTAL STRUCTURE OF APO HUMAN PREGNANE X RECEPTOR LIGAND BINDING DOMAIN 1I57 ; 2.10 ; CRYSTAL STRUCTURE OF APO HUMAN PTP1B (C215S) MUTANT 1SNX ; 3.20 ; CRYSTAL STRUCTURE OF APO INTERLEUKIN-2 TYROSINE KINASE CATALYTIC DOMAIN 1U7D ; 2.65 ; CRYSTAL STRUCTURE OF APO M. JANNASHII TYROSYL-TRNA SYNTHETASE 1XMG ; 2.10 ; CRYSTAL STRUCTURE OF APO METHANE MONOOXYGENASE HYDROXYLASE FROM M. CAPSULATUS (BATH) 1ZHQ ; 1.90 ; CRYSTAL STRUCTURE OF APO MVL 1S2T ; 2.00 ; CRYSTAL STRUCTURE OF APO PHOSPHOENOLPYRUVATE MUTASE 1QE0 ; 2.70 ; CRYSTAL STRUCTURE OF APO S. AUREUS HISTIDYL-TRNA SYNTHETASE 1KSO ; 1.70 ; CRYSTAL STRUCTURE OF APO S100A3 1XBA ; 2.00 ; CRYSTAL STRUCTURE OF APO SYK TYROSINE KINASE DOMAIN 1HW6 ; 1.90 ; CRYSTAL STRUCTURE OF APO-2,5-DIKETO-D-GLUCONATE REDUCTASE 1F6R ; 2.20 ; CRYSTAL STRUCTURE OF APO-BOVINE ALPHA-LACTALBUMIN 1J48 ; 1.80 ; CRYSTAL STRUCTURE OF APO-C1027 1KQX ; 1.70 ; CRYSTAL STRUCTURE OF APO-CRBP FROM ZEBRAFISH 1KBZ ; 2.20 ; CRYSTAL STRUCTURE OF APO-DTDP-6-DEOXY-L-LYXO-4-HEXULOSE REDUCTASE (RMLD) FROM SALMONELLA ENTERICA SEROVAR TYPHIMURIUM 1LBV ; 1.80 ; CRYSTAL STRUCTURE OF APO-FORM (P21) OF DUAL ACTIVITY FBPASE/IMPASE (AF2372) FROM ARCHAEOGLOBUS FULGIDUS 1LBW ; 2.00 ; CRYSTAL STRUCTURE OF APO-FORM (P32) OF DUAL ACTIVITY FBPASE/IMPASE (AF2372) FROM ARCHAEOGLOBUS FULGIDUS 1JAM ; 2.18 ; CRYSTAL STRUCTURE OF APO-FORM OF Z. MAYS CK2 PROTEIN KINASE ALPHA SUBUNIT 1CRW ; 2.00 ; CRYSTAL STRUCTURE OF APO-GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE FROM PALINURUS VERSICOLOR AT 2.0A RESOLUTION 1BHJ ; 2.50 ; CRYSTAL STRUCTURE OF APO-GLYCINE N-METHYLTRANSFERASE (GNMT) 1OZT ; 2.50 ; CRYSTAL STRUCTURE OF APO-H46R FAMILIAL ALS MUTANT HUMAN CU, ZN SUPEROXIDE DISMUTASE (CUZNSOD) TO 2.5A RESOLUTION 1X2W ; 2.29 ; CRYSTAL STRUCTURE OF APO-HABU IX-BP AT PH 4.6 1ZZ6 ; 2.00 ; CRYSTAL STRUCTURE OF APO-HPPE 1X8F ; 2.40 ; CRYSTAL STRUCTURE OF APO-KDO8P SYNTHASE 1R7O ; 1.85 ; CRYSTAL STRUCTURE OF APO-MANNANASE 26A FROM PSUDOMONAS CELLULOSA 1DG6 ; 1.30 ; CRYSTAL STRUCTURE OF APO2L/TRAIL 1QX5 ; 2.54 ; CRYSTAL STRUCTURE OF APOCALMODULIN 1QX7 ; 3.09 ; CRYSTAL STRUCTURE OF APOCAM BOUND TO THE GATING DOMAIN OF SMALL CONDUCTANCE CA2+-ACTIVATED POTASSIUM CHANNEL 2BIX ; 2.68 ; CRYSTAL STRUCTURE OF APOCAROTENOID CLEAVAGE OXYGENASE FROM SYNECHOCYSTIS, FE-FREE APOENZYME 2BIW ; 2.39 ; CRYSTAL STRUCTURE OF APOCAROTENOID CLEAVAGE OXYGENASE FROM SYNECHOCYSTIS, NATIVE ENZYME 1J3H ; 2.90 ; CRYSTAL STRUCTURE OF APOENZYME CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT 1UGQ ; 2.00 ; CRYSTAL STRUCTURE OF APOENZYME OF CO-TYPE NITRILE HYDRATASE 1M6I ; 1.80 ; CRYSTAL STRUCTURE OF APOPTOSIS INDUCING FACTOR (AIF) 1M7Y ; 1.60 ; CRYSTAL STRUCTURE OF APPLE ACC SYNTHASE IN COMPLEX WITH L- AMINOETHOXYVINYLGLYCINE 1YNU ; 2.25 ; CRYSTAL STRUCTURE OF APPLE ACC SYNTHASE IN COMPLEX WITH L- VINYLGLYCINE 1M4N ; 2.01 ; CRYSTAL STRUCTURE OF APPLE ACC SYNTHASE IN COMPLEX WITH [2- (AMINO-OXY)ETHYL](5'-DEOXYADENOSIN-5'-YL)(METHYL)SULFONIUM 1YRJ ; 2.70 ; CRYSTAL STRUCTURE OF APRAMYCIN BOUND TO A RIBOSOMAL RIBONUCLEIC ACID A SITE OLIGONUCLEOTIDE 1L1Q ; 1.85 ; CRYSTAL STRUCTURE OF APRTASE FROM GIARDIA LAMBLIA COMPLEXED WITH 9-DEAZAADENINE 1L1R ; 1.95 ; CRYSTAL STRUCTURE OF APRTASE FROM GIARDIA LAMBLIA COMPLEXED WITH 9-DEAZAADENINE, MG2+ AND PRPP 1M7H ; 2.00 ; CRYSTAL STRUCTURE OF APS KINASE FROM PENICILLIUM CHRYSOGENUM: STRUCTURE WITH APS SOAKED OUT OF ONE DIMER 1M7G ; 1.43 ; CRYSTAL STRUCTURE OF APS KINASE FROM PENICILLIUM CHRYSOGENUM: TERNARY STRUCTURE WITH ADP AND APS 2EVU ; 2.30 ; CRYSTAL STRUCTURE OF AQUAPORIN AQPM AT 2.3A RESOLUTION 2ABM ; 3.20 ; CRYSTAL STRUCTURE OF AQUAPORIN Z TETRAMER REVEALS BOTH OPEN AND CLOSED WATER-CONDUCTING CHANNELS 1IH5 ; 3.70 ; CRYSTAL STRUCTURE OF AQUAPORIN-1 1P42 ; 2.00 ; CRYSTAL STRUCTURE OF AQUIFEX AEOLICUS LPXC DEACETYLASE (ZINC-INHIBITED FORM) 1YHC ; 2.10 ; CRYSTAL STRUCTURE OF AQUIFEX AEOLICUS LPXC DEACETYLASE COMPLEXED WITH CACODYLATE 1YH8 ; 2.70 ; CRYSTAL STRUCTURE OF AQUIFEX AEOLICUS LPXC DEACETYLASE COMPLEXED WITH PALMITATE 2CSX ; 2.70 ; CRYSTAL STRUCTURE OF AQUIFEX AEOLICUS METHIONYL-TRNA SYNTHETASE COMPLEXED WITH TRNA(MET) 2CT8 ; 2.70 ; CRYSTAL STRUCTURE OF AQUIFEX AEOLICUS METHIONYL-TRNA SYNTHETASE COMPLEXED WITH TRNA(MET) AND METHIONYL- ADENYLATE ANOLOGUE 1M1H ; 1.95 ; CRYSTAL STRUCTURE OF AQUIFEX AEOLICUS N-UTILIZATION SUBSTANCE G (NUSG), SPACE GROUP I222 1M1G ; 2.00 ; CRYSTAL STRUCTURE OF AQUIFEX AEOLICUS N-UTILIZATION SUBSTANCE G (NUSG), SPACE GROUP P2(1) 1NPR ; 2.21 ; CRYSTAL STRUCTURE OF AQUIFEX AEOLICUS NUSG IN C222(1) 1NPP ; 2.00 ; CRYSTAL STRUCTURE OF AQUIFEX AEOLICUS NUSG IN P2(1) 1PYB ; 2.50 ; CRYSTAL STRUCTURE OF AQUIFEX AEOLICUS TRBP111: A STUCTURE- SPECIFIC TRNA BINDING PROTEIN 1FHJ ; 1.80 ; CRYSTAL STRUCTURE OF AQUOMET HEMOGLOBIN-I OF THE MANED WOLF (CHRYSOCYON BRACHYURUS) AT 2.0 RESOLUTION. 1OZ9 ; 1.89 ; CRYSTAL STRUCTURE OF AQ_1354, A HYPOTHETICAL PROTEIN FROM AQUIFEX AEOLICUS 1U8W ; 2.40 ; CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA NUCLEOSIDE DIPHOSPHATE KINASE 1 1WD3 ; 1.75 ; CRYSTAL STRUCTURE OF ARABINOFURANOSIDASE 1WD4 ; 2.07 ; CRYSTAL STRUCTURE OF ARABINOFURANOSIDASE COMPLEXED WITH ARABINOSE 1DIY ; 3.00 ; CRYSTAL STRUCTURE OF ARACHIDONIC ACID BOUND IN THE CYCLOOXYGENASE ACTIVE SITE OF PGHS-1 1U67 ; 3.10 ; CRYSTAL STRUCTURE OF ARACHIDONIC ACID BOUND TO A MUTANT OF PROSTAGLADIN H SYNTHASE-1 THAT FORMS PREDOMINANTLY 11- HPETE. 1CVU ; 2.40 ; CRYSTAL STRUCTURE OF ARACHIDONIC ACID BOUND TO THE CYCLOOXYGENASE ACTIVE SITE OF COX-2 1WN7 ; 2.75 ; CRYSTAL STRUCTURE OF ARCHAEAL FAMILY B DEOXYRIBONUCLEIC ACID POLYMERASE MUTANT 1TR8 ; 2.27 ; CRYSTAL STRUCTURE OF ARCHAEAL NASCENT POLYPEPTIDE- ASSOCIATED COMPLEX (AENAC) 1FXK ; 2.30 ; CRYSTAL STRUCTURE OF ARCHAEAL PREFOLDIN (GIMC). 1WMI ; 2.30 ; CRYSTAL STRUCTURE OF ARCHAEAL RELE-RELB COMPLEX FROM PYROCOCCUS HORIKOSHII OT3 1V76 ; 2.00 ; CRYSTAL STRUCTURE OF ARCHAEAL RIBONUCLEASE P PROTEIN PH1771P FROM PYROCOCCUS HORIKOSHII OT3 1GEH ; 2.80 ; CRYSTAL STRUCTURE OF ARCHAEAL RUBISCO (RIBULOSE 1,5- BISPHOSPHATE CARBOXYLASE/OXYGENASE) 1J1U ; 1.95 ; CRYSTAL STRUCTURE OF ARCHAEAL TYROSYL-TRNA SYNTHETASE COMPLEXED WITH TRNA(TYR) AND L-TYROSINE 1X2I ; 1.45 ; CRYSTAL STRUCTURE OF ARCHAEAL XPF/MUS81 HOMOLOG, HEF FROM PYROCOCCUS FURIOSUS, HELIX-HAIRPIN-HELIX DOMAIN 1J23 ; 1.78 ; CRYSTAL STRUCTURE OF ARCHAEAL XPF/MUS81 HOMOLOG, HEF FROM PYROCOCCUS FURIOSUS, NUCLEASE DOMAIN 1J24 ; 1.78 ; CRYSTAL STRUCTURE OF ARCHAEAL XPF/MUS81 HOMOLOG, HEF FROM PYROCOCCUS FURIOSUS, NUCLEASE DOMAIN, CA COCRYSTAL 1J25 ; 1.78 ; CRYSTAL STRUCTURE OF ARCHAEAL XPF/MUS81 HOMOLOG, HEF FROM PYROCOCCUS FURIOSUS, NUCLEASE DOMAIN, MN COCRYSTAL 1J22 ; 1.80 ; CRYSTAL STRUCTURE OF ARCHAEAL XPF/MUS81 HOMOLOG, HEF FROM PYROCOCCUS FURIOSUS, NUCLEASE DOMAIN, SELENOMET DERIVATIVE 1IT7 ; 2.30 ; CRYSTAL STRUCTURE OF ARCHAEOSINE TRNA-GUANINE TRANSGLYCOSYLASE COMPLEXED WITH GUANINE 1J2B ; 3.30 ; CRYSTAL STRUCTURE OF ARCHAEOSINE TRNA-GUANINE TRANSGLYCOSYLASE COMPLEXED WITH LAMBDA-FORM TRNA(VAL) 1IQ8 ; 2.20 ; CRYSTAL STRUCTURE OF ARCHAEOSINE TRNA-GUANINE TRANSGLYCOSYLASE FROM PYROCOCCUS HORIKOSHII 1IT8 ; 2.50 ; CRYSTAL STRUCTURE OF ARCHAEOSINE TRNA-GUANINE TRANSGLYCOSYLASE FROM PYROCOCCUS HORIKOSHII COMPLEXED WITH ARCHAEOSINE PRECURSOR, PREQ0 1UAZ ; 3.40 ; CRYSTAL STRUCTURE OF ARCHAERHODOPSIN-1 1VGO ; 2.50 ; CRYSTAL STRUCTURE OF ARCHAERHODOPSIN-2 1J5U ; 2.00 ; CRYSTAL STRUCTURE OF ARCHEASE, POSSIBLE CHAPERONE (TM1083) FROM THERMOTOGA MARITIMA AT 2.0 A RESOLUTION 1ZKW ; 2.17 ; CRYSTAL STRUCTURE OF ARG347ALA MUTANT OF BOTULINUM NEUROTOXIN E CATALYTIC DOMAIN 1JRX ; 2.00 ; CRYSTAL STRUCTURE OF ARG402ALA MUTANT FLAVOCYTOCHROME C3 FROM SHEWANELLA FRIGIDIMARINA 1JRY ; 2.00 ; CRYSTAL STRUCTURE OF ARG402LYS MUTANT FLAVOCYTOCHROME C3 FROM SHEWANELLA FRIGIDIMARINA 1JRZ ; 2.00 ; CRYSTAL STRUCTURE OF ARG402TYR MUTANT FLAVOCYTOCHROME C3 FROM SHEWANELLA FRIGIDIMARINA 1VRA ; 2.00 ; CRYSTAL STRUCTURE OF ARGININE BIOSYNTHESIS BIFUNCTIONAL PROTEIN ARGJ (10175521) FROM BACILLUS HALODURANS AT 2.00 A RESOLUTION 1S9R ; 1.60 ; CRYSTAL STRUCTURE OF ARGININE DEIMINASE COVALENTLY LINKED WITH A REACTION INTERMEDIATE 1LXY ; 2.00 ; CRYSTAL STRUCTURE OF ARGININE DEIMINASE COVALENTLY LINKED WITH L-CITRULLINE 1VL2 ; 1.65 ; CRYSTAL STRUCTURE OF ARGININOSUCCINATE SYNTHASE (TM1780) FROM THERMOTOGA MARITIMA AT 1.65 A RESOLUTION 1DI1 ; 2.50 ; CRYSTAL STRUCTURE OF ARISTOLOCHENE SYNTHASE FROM PENICILLIUM ROQUEFORTI 1Z75 ; 2.40 ; CRYSTAL STRUCTURE OF ARNA DEHYDROGENASE (DECARBOXYLASE) DOMAIN, R619M MUTANT 1MDZ ; 2.07 ; CRYSTAL STRUCTURE OF ARNB AMINOTRANSFERASE WITH CYLOSERINE PYRIDOXAL 5' PHOSPHATE 1MDO ; 1.70 ; CRYSTAL STRUCTURE OF ARNB AMINOTRANSFERASE WITH PYRIDOMINE 5' PHOSPHATE 1MDX ; 1.96 ; CRYSTAL STRUCTURE OF ARNB TRANSFERASE WITH PYRIDOXAL 5' PHOSPHATE 1DJU ; 2.10 ; CRYSTAL STRUCTURE OF AROMATIC AMINOTRANSFERASE FROM PYROCOCCUS HORIKOSHII OT3 1K8K ; 2.00 ; CRYSTAL STRUCTURE OF ARP2/3 COMPLEX 1U2V ; 2.55 ; CRYSTAL STRUCTURE OF ARP2/3 COMPLEX WITH BOUND ADP AND CALCIUM 1TYQ ; 2.55 ; CRYSTAL STRUCTURE OF ARP2/3 COMPLEX WITH BOUND ATP AND CALCIUM 1RWA ; 1.30 ; CRYSTAL STRUCTURE OF ARTHROBACTER AURESCENS CHONDROITIN AC LYASE 1RWC ; 1.90 ; CRYSTAL STRUCTURE OF ARTHROBACTER AURESCENS CHONDROITIN AC LYASE 1RWF ; 1.45 ; CRYSTAL STRUCTURE OF ARTHROBACTER AURESCENS CHONDROITIN AC LYASE IN COMPLEX WITH CHONDROITIN TETRASACCHARIDE 1RWG ; 1.50 ; CRYSTAL STRUCTURE OF ARTHROBACTER AURESCENS CHONDROITIN AC LYASE IN COMPLEX WITH CHONDROITIN TETRASACCHARIDE 1RWH ; 1.25 ; CRYSTAL STRUCTURE OF ARTHROBACTER AURESCENS CHONDROITIN AC LYASE IN COMPLEX WITH CHONDROITIN TETRASACCHARIDE 1Q4S ; 1.95 ; CRYSTAL STRUCTURE OF ARTHROBACTER SP. STRAIN SU 4- HYDROXYBENZOYL COA THIOESTERASE COMPLEXED WITH COA AND 4- HYDROXYBENZOIC ACID 1VBP ; 3.50 ; CRYSTAL STRUCTURE OF ARTOCARPIN-MANNOPENTOSE COMPLEX 1VBO ; 2.35 ; CRYSTAL STRUCTURE OF ARTOCARPIN-MANNOTRIOSE COMPLEX 1F32 ; 1.75 ; CRYSTAL STRUCTURE OF ASCARIS PEPSIN INHIBITOR-3 1F34 ; 2.45 ; CRYSTAL STRUCTURE OF ASCARIS PEPSIN INHIBITOR-3 BOUND TO PORCINE PEPSIN 1O0S ; 2.00 ; CRYSTAL STRUCTURE OF ASCARIS SUUM MALIC ENZYME COMPLEXED WITH NADH 1D7F ; 1.90 ; CRYSTAL STRUCTURE OF ASPARAGINE 233-REPLACED CYCLODEXTRIN GLUCANOTRANSFERASE FROM ALKALOPHILIC BACILLUS SP. 1011 DETERMINED AT 1.9 A RESOLUTION 1CT9 ; 2.00 ; CRYSTAL STRUCTURE OF ASPARAGINE SYNTHETASE B FROM ESCHERICHIA COLI 1J3U ; 2.50 ; CRYSTAL STRUCTURE OF ASPARTASE FROM BACILLUS SP. YM55-1 1O4S ; 1.90 ; CRYSTAL STRUCTURE OF ASPARTATE AMINOTRANSFERASE (TM1255) FROM THERMOTOGA MARITIMA AT 1.90 A RESOLUTION 1UHE ; 1.55 ; CRYSTAL STRUCTURE OF ASPARTATE DECARBOXYLASE, ISOASPARGINE COMPLEX 1UHD ; 2.00 ; CRYSTAL STRUCTURE OF ASPARTATE DECARBOXYLASE, PYRUVOLY GROUP BOUND FORM 1J5P ; 1.90 ; CRYSTAL STRUCTURE OF ASPARTATE DEHYDROGENASE (TM1643) FROM THERMOTOGA MARITIMA AT 1.9 A RESOLUTION 1NWH ; 2.00 ; CRYSTAL STRUCTURE OF ASPARTATE SEMIALDEHYDE DEHYDROGENASE FROM HAEMOPHILUS INFLUENZAE AS A TETRAHEDRAL HEMITHIOACETAL REACTION INTERMEDIATE AT 2.0 A 1NX6 ; 2.15 ; CRYSTAL STRUCTURE OF ASPARTATE SEMIALDEHYDE DEHYDROGENASE FROM HAEMOPHILUS INFLUENZAE AS A TETRAHEDRAL HEMITHIOCETAL REACTION INTERMEDIATE WITH PHOSPHATE AT 2.15 A 1MB4 ; 1.84 ; CRYSTAL STRUCTURE OF ASPARTATE SEMIALDEHYDE DEHYDROGENASE FROM VIBRIO CHOLERAE WITH NADP AND S-METHYL-L-CYSTEINE SULFOXIDE 1NWC ; 2.04 ; CRYSTAL STRUCTURE OF ASPARTATE-SEMIALDEHYDE DEHYDROGENASE FROM HAEMOPHILUS INFLUENZAE 1TA4 ; 2.28 ; CRYSTAL STRUCTURE OF ASPARTATE-SEMIALDEHYDE DEHYDROGENASE FROM HAEMOPHILUS INFLUENZAE WITH A BOUND ARSENATE 1TB4 ; 2.15 ; CRYSTAL STRUCTURE OF ASPARTATE-SEMIALDEHYDE DEHYDROGENASE FROM HAEMOPHILUS INFLUENZAE WITH A BOUND PERIODATE 1MC4 ; 2.77 ; CRYSTAL STRUCTURE OF ASPARTATE-SEMIALDEHYDE DEHYDROGENASE FROM VIBRIO CHOLERAE EL TOR 1WKR ; 1.30 ; CRYSTAL STRUCTURE OF ASPARTIC PROTEINASE FROM IRPEX LACTEUS 1EFW ; 3.00 ; CRYSTAL STRUCTURE OF ASPARTYL-TRNA SYNTHETASE FROM THERMUS THERMOPHILUS COMPLEXED TO TRNAASP FROM ESCHERICHIA COLI 1Y43 ; 1.40 ; CRYSTAL STRUCTURE OF ASPERGILLOGLUTAMIC PEPTIDASE FROM ASPERGILLUS NIGER 2A3E ; 1.95 ; CRYSTAL STRUCTURE OF ASPERGILLUS FUMIGATUS CHITINASE B1 IN COMPLEX WITH ALLOSAMIDIN 2A3B ; 1.90 ; CRYSTAL STRUCTURE OF ASPERGILLUS FUMIGATUS CHITINASE B1 IN COMPLEX WITH CAFFEINE 2A3C ; 2.07 ; CRYSTAL STRUCTURE OF ASPERGILLUS FUMIGATUS CHITINASE B1 IN COMPLEX WITH PENTOXIFYLLINE 2A3A ; 2.10 ; CRYSTAL STRUCTURE OF ASPERGILLUS FUMIGATUS CHITINASE B1 IN COMPLEX WITH THEOPHYLLINE 1KKC ; 2.00 ; CRYSTAL STRUCTURE OF ASPERGILLUS FUMIGATUS MNSOD 1SG6 ; 1.70 ; CRYSTAL STRUCTURE OF ASPERGILLUS NIDULANS 3-DEHYDROQUINATE SYNTHASE (ANDHQS) IN COMPLEX WITH ZN2+ AND NAD+, AT 1.7D 1UKC ; 2.10 ; CRYSTAL STRUCTURE OF ASPERGILLUS NIGER ESTA 1IZD ; 1.90 ; CRYSTAL STRUCTURE OF ASPERGILLUS ORYZAE ASPARTIC PROTEINASE 1IZE ; 1.90 ; CRYSTAL STRUCTURE OF ASPERGILLUS ORYZAE ASPARTIC PROTEINASE COMPLEXED WITH PEPSTATIN 1UGR ; 1.80 ; CRYSTAL STRUCTURE OF AT109S MUTANT OF CO-TYPE NITRILE HYDRATASE 1U79 ; 1.85 ; CRYSTAL STRUCTURE OF ATFKBP13 1YSR ; 1.78 ; CRYSTAL STRUCTURE OF ATP BINDING DOMAIN OF PRRB FROM MYCOBACTERIUM TUBERCULOSIS 1I2D ; 2.81 ; CRYSTAL STRUCTURE OF ATP SULFURYLASE FROM PENICILLIUM CHRYSOGENUM 1V47 ; 2.49 ; CRYSTAL STRUCTURE OF ATP SULFURYLASE FROM THERMUS THERMOPHILLUS HB8 IN COMPLEX WITH APS 1JED ; 2.95 ; CRYSTAL STRUCTURE OF ATP SULFURYLASE IN COMPLEX WITH ADP 1JEE ; 2.80 ; CRYSTAL STRUCTURE OF ATP SULFURYLASE IN COMPLEX WITH CHLORATE 1JEC ; 2.50 ; CRYSTAL STRUCTURE OF ATP SULFURYLASE IN COMPLEX WITH THIOSULFATE 1J3B ; 2.00 ; CRYSTAL STRUCTURE OF ATP-DEPENDENT PHOSPHOENOLPYRUVATE CARBOXYKINASE FROM THERMUS THERMOPHILUS HB8 1XKV ; 2.20 ; CRYSTAL STRUCTURE OF ATP-DEPENDENT PHOSPHOENOLPYRUVATE CARBOXYKINASE FROM THERMUS THERMOPHILUS HB8 1F2T ; 1.60 ; CRYSTAL STRUCTURE OF ATP-FREE RAD50 ABC-ATPASE 1V43 ; 2.20 ; CRYSTAL STRUCTURE OF ATPASE SUBUNIT OF ABC SUGAR TRANSPORTER 1ONJ ; 1.55 ; CRYSTAL STRUCTURE OF ATRATOXIN-B FROM CHINESE COBRA VENOM OF NAJA ATRA 1ZP6 ; 3.20 ; CRYSTAL STRUCTURE OF ATU3015, A PUTATIVE CYTIDYLATE KINASE FROM AGROBACTERIUM TUMEFACIENS, NORTHEAST STRUCTURAL GENOMICS TARGET ATR62 2D2E ; 1.70 ; CRYSTAL STRUCTURE OF ATYPICAL CYTOPLASMIC ABC-ATPASE SUFC FROM THERMUS THERMOPHILUS HB8 2D2F ; 1.90 ; CRYSTAL STRUCTURE OF ATYPICAL CYTOPLASMIC ABC-ATPASE SUFC FROM THERMUS THERMOPHILUS HB8 1MUO ; 2.90 ; CRYSTAL STRUCTURE OF AURORA-2, AN ONCOGENIC SERINE- THREONINE KINASE 1MQ4 ; 1.90 ; CRYSTAL STRUCTURE OF AURORA-A PROTEIN KINASE 1JOE ; 2.40 ; CRYSTAL STRUCTURE OF AUTOINDUCER-2 PRODUCTION PROTEIN (LUXS) FROM HEAMOPHILUS INFLUENZAE 1UEC ; 1.82 ; CRYSTAL STRUCTURE OF AUTOINHIBITED FORM OF TANDEM SH3 DOMAIN OF P47PHOX 1NZ6 ; 2.50 ; CRYSTAL STRUCTURE OF AUXILIN J-DOMAIN 1LR5 ; 1.90 ; CRYSTAL STRUCTURE OF AUXIN BINDING PROTEIN 1LRH ; 1.90 ; CRYSTAL STRUCTURE OF AUXIN-BINDING PROTEIN 1 IN COMPLEX WITH 1-NAPHTHALENE ACETIC ACID 1THZ ; 1.80 ; CRYSTAL STRUCTURE OF AVIAN AICAR TRANSFORMYLASE IN COMPLEX WITH A NOVEL INHIBITOR IDENTIFIED BY VIRTUAL LIGAND SCREENING 1G8M ; 1.75 ; CRYSTAL STRUCTURE OF AVIAN ATIC, A BIFUNCTIONAL TRANSFORMYLASE AND CYCLOHYDROLASE ENZYME IN PURINE BIOSYNTHESIS AT 1.75 ANG. RESOLUTION 1VYO ; 1.48 ; CRYSTAL STRUCTURE OF AVIDIN 1S28 ; 3.00 ; CRYSTAL STRUCTURE OF AVRPPHF ORF1, THE CHAPERONE FOR THE TYPE III EFFECTOR AVRPPHF ORF2 FROM P. SYRINGAE 1S21 ; 2.00 ; CRYSTAL STRUCTURE OF AVRPPHF ORF2, A TYPE III EFFECTOR FROM P. SYRINGAE 2FD4 ; 1.80 ; CRYSTAL STRUCTURE OF AVRPTOB (436-553) 1UGS ; 2.00 ; CRYSTAL STRUCTURE OF AY114T MUTANT OF CO-TYPE NITRILE HYDRATASE 1YHQ ; 2.40 ; CRYSTAL STRUCTURE OF AZITHROMYCIN BOUND TO THE G2099A MUTANT 50S RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI 1RKR ; 2.45 ; CRYSTAL STRUCTURE OF AZURIN-I FROM ALCALIGENES XYLOSOXIDANS NCIMB 11015 1L1L ; 1.75 ; CRYSTAL STRUCTURE OF B-12 DEPENDENT (CLASS II) RIBONUCLEOTIDE REDUCTASE 388D ; 1.55 ; CRYSTAL STRUCTURE OF B-DEOXYRIBONUCLEIC ACID WITH INCORPORATED 2'-DEOXY-2'-FLUORO-ARABINO-FURANOSYL THYMINES: IMPLICATIONS OF CONFORMATIONAL PREORGANIZATION FOR DUPLEX STABILITY 389D ; 1.55 ; CRYSTAL STRUCTURE OF B-DEOXYRIBONUCLEIC ACID WITH INCORPORATED 2'-DEOXY-2'-FLUORO-ARABINO-FURANOSYL THYMINES: IMPLICATIONS OF CONFORMATIONAL PREORGANIZATION FOR DUPLEX STABILITY 1T6B ; 2.50 ; CRYSTAL STRUCTURE OF B. ANTHRACIS PROTECTIVE ANTIGEN COMPLEXED WITH HUMAN ANTHRAX TOXIN RECEPTOR 1UOK ; 2.00 ; CRYSTAL STRUCTURE OF B. CEREUS OLIGO-1,6-GLUCOSIDASE 1ZBF ; 1.50 ; CRYSTAL STRUCTURE OF B. HALODURANS RNASE H CATALYTIC DOMAIN MUTANT D132N 1LD3 ; 2.60 ; CRYSTAL STRUCTURE OF B. SUBILIS FERROCHELATASE WITH ZN(2+) BOUND AT THE ACTIVE SITE. 1JL3 ; 1.60 ; CRYSTAL STRUCTURE OF B. SUBTILIS ARSC 1YCL ; 1.80 ; CRYSTAL STRUCTURE OF B. SUBTILIS LUXS IN COMPLEX WITH A CATALYTIC 2-KETONE INTERMEDIATE 1EXC ; 2.70 ; CRYSTAL STRUCTURE OF B. SUBTILIS MAF PROTEIN COMPLEXED WITH D-(UTP) 1NY1 ; 1.80 ; CRYSTAL STRUCTURE OF B. SUBTILIS POLYSACCHARIDE DEACETYLASE NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET SR127. 1TWJ ; 2.50 ; CRYSTAL STRUCTURE OF B. SUBTILIS PURS P21 CRYSTAL FORM 2BX9 ; 2.80 ; CRYSTAL STRUCTURE OF B.SUBTILIS ANTI-TRAP PROTEIN, AN ANTAGONIST OF TRAP-RIBONUCLEIC ACID INTERACTIONS 1ZUW ; 1.75 ; CRYSTAL STRUCTURE OF B.SUBTILIS GLUTAMATE RACEMASE (RACE) WITH D-GLU 1M6T ; 1.81 ; CRYSTAL STRUCTURE OF B562RIL, A REDESIGNED FOUR HELIX BUNDLE 2C5S ; 2.50 ; CRYSTAL STRUCTURE OF BACILLUS ANTHRACIS THII, A TRNA- MODIFYING ENZYME CONTAINING THE PREDICTED RIBONUCLEIC ACID-BINDING THUMP DOMAIN 1I5E ; 3.00 ; CRYSTAL STRUCTURE OF BACILLUS CALDOLYTICUS URACIL PHOSPHORIBOSYLTRANSFERASE WITH BOUND UMP 1ZSW ; 1.65 ; CRYSTAL STRUCTURE OF BACILLUS CEREUS METALLO PROTEIN FROM GLYOXALASE FAMILY 4BDP ; 1.80 ; CRYSTAL STRUCTURE OF BACILLUS DEOXYRIBONUCLEIC ACID POLYMERASE I FRAGMENT COMPLEXED TO 11 BASE PAIRS OF DUPLEX DEOXYRIBONUCLEIC ACID AFTER ADDITION OF TWO DATP RESIDUES 2BDP ; 1.80 ; CRYSTAL STRUCTURE OF BACILLUS DEOXYRIBONUCLEIC ACID POLYMERASE I FRAGMENT COMPLEXED TO 9 BASE PAIRS OF DUPLEX DEOXYRIBONUCLEIC ACID 1L3S ; 1.70 ; CRYSTAL STRUCTURE OF BACILLUS DEOXYRIBONUCLEIC ACID POLYMERASE I FRAGMENT COMPLEXED TO 9 BASE PAIRS OF DUPLEX DEOXYRIBONUCLEIC ACID. 3BDP ; 1.90 ; CRYSTAL STRUCTURE OF BACILLUS DEOXYRIBONUCLEIC ACID POLYMERASE I FRAGMENT COMPLEXED TO DUPLEX DEOXYRIBONUCLEIC ACID AFTER THE INCORPORATION OF +TTP BY THE ENZYME 1L3T ; 1.70 ; CRYSTAL STRUCTURE OF BACILLUS DEOXYRIBONUCLEIC ACID POLYMERASE I FRAGMENT PRODUCT COMPLEX WITH 10 BASE PAIRS OF DUPLEX DEOXYRIBONUCLEIC ACID FOLLOWING ADDITION OF A SINGLE DTTP RESIDUE 1L3U ; 1.80 ; CRYSTAL STRUCTURE OF BACILLUS DEOXYRIBONUCLEIC ACID POLYMERASE I FRAGMENT PRODUCT COMPLEX WITH 11 BASE PAIRS OF DUPLEX DEOXYRIBONUCLEIC ACID FOLLOWING ADDITION OF A DTTP AND A DATP RESIDUE. 1L5U ; 1.95 ; CRYSTAL STRUCTURE OF BACILLUS DEOXYRIBONUCLEIC ACID POLYMERASE I FRAGMENT PRODUCT COMPLEX WITH 12 BASE PAIRS OF DUPLEX DEOXYRIBONUCLEIC ACID FOLLOWING ADDITION OF A DTTP, A DATP, AND A DCTP RESIDUE. 1L3V ; 1.71 ; CRYSTAL STRUCTURE OF BACILLUS DEOXYRIBONUCLEIC ACID POLYMERASE I FRAGMENT PRODUCT COMPLEX WITH 15 BASE PAIRS OF DUPLEX DEOXYRIBONUCLEIC ACID FOLLOWING ADDITION OF DTTP, DATP, DCTP, AND DGTP RESIDUES. 1EAR ; 1.70 ; CRYSTAL STRUCTURE OF BACILLUS PASTEURII UREE AT 1.7 A. TYPE II CRYSTAL FORM. 1EB0 ; 1.85 ; CRYSTAL STRUCTURE OF BACILLUS PASTEURII UREE AT 1.85 A, PHASED BY SIRAS. TYPE I CRYSTAL FORM. 1J0M ; 2.30 ; CRYSTAL STRUCTURE OF BACILLUS SP. GL1 XANTHAN LYASE THAT ACTS ON SIDE CHAINS OF XANTHAN 1J0N ; 2.40 ; CRYSTAL STRUCTURE OF BACILLUS SP. GL1 XANTHAN LYASE THAT ACTS ON SIDE CHAINS OF XANTHAN 1MIV ; 3.50 ; CRYSTAL STRUCTURE OF BACILLUS STEAROTHERMOPHILUS CCA-ADDING ENZYME 1MIW ; 3.00 ; CRYSTAL STRUCTURE OF BACILLUS STEAROTHERMOPHILUS CCA-ADDING ENZYME IN COMPLEX WITH ATP 1MIY ; 3.52 ; CRYSTAL STRUCTURE OF BACILLUS STEAROTHERMOPHILUS CCA-ADDING ENZYME IN COMPLEX WITH CTP 1JPU ; 1.80 ; CRYSTAL STRUCTURE OF BACILLUS STEAROTHERMOPHILUS GLYCEROL DEHYDROGENASE 1J0H ; 1.90 ; CRYSTAL STRUCTURE OF BACILLUS STEAROTHERMOPHILUS NEOPULLULANASE 1LQY ; 1.90 ; CRYSTAL STRUCTURE OF BACILLUS STEAROTHERMOPHILUS PEPTIDE DEFORMYLASE COMPLEXED WITH ANTIBIOTIC ACTINONIN 1OF0 ; 2.45 ; CRYSTAL STRUCTURE OF BACILLUS SUBTILIS COTA AFTER 1H SOAKING WITH EBS 1HKP ; 2.25 ; CRYSTAL STRUCTURE OF BACILLUS SUBTILIS COTA AFTER 1H SOAKING WITH SYRINGALDAZINE (SGZ) 1HL0 ; 2.83 ; CRYSTAL STRUCTURE OF BACILLUS SUBTILIS COTA AFTER 20H SOAKING WITH SYRINGALDAZINE (SGZ) 1OGR ; 2.65 ; CRYSTAL STRUCTURE OF BACILLUS SUBTILIS COTA AFTER 6H SOAKING WITH ABTS 1HKZ ; 2.49 ; CRYSTAL STRUCTURE OF BACILLUS SUBTILIS COTA AFTER 8H SOAKING WITH ABTS 1HL1 ; 2.69 ; CRYSTAL STRUCTURE OF BACILLUS SUBTILIS COTA AFTER20H SOAKING WITH ABTS 1C1H ; 1.90 ; CRYSTAL STRUCTURE OF BACILLUS SUBTILIS FERROCHELATASE IN COMPLEX WITH N-METHYL MESOPORPHYRIN 1WKQ ; 1.17 ; CRYSTAL STRUCTURE OF BACILLUS SUBTILIS GUANINE DEAMINASE. THE FIRST DOMAIN-SWAPPED STRUCTURE IN THE CYTIDINE DEAMINASE SUPERFAMILY 1OYG ; 1.50 ; CRYSTAL STRUCTURE OF BACILLUS SUBTILIS LEVANSUCRASE 1ISP ; 1.30 ; CRYSTAL STRUCTURE OF BACILLUS SUBTILIS LIPASE AT 1.3A RESOLUTION 1EX2 ; 1.85 ; CRYSTAL STRUCTURE OF BACILLUS SUBTILIS MAF PROTEIN 1MKI ; 2.00 ; CRYSTAL STRUCTURE OF BACILLUS SUBTILIS PROBABLE GLUTAMINASE, APC1040 1SF9 ; 1.71 ; CRYSTAL STRUCTURE OF BACILLUS SUBTILIS YFHH HYPOTHETICAL PROTEIN 1NJH ; 1.70 ; CRYSTAL STRUCTURE OF BACILLUS SUBTILIS YOJF PROTEIN 1RTY ; 2.40 ; CRYSTAL STRUCTURE OF BACILLUS SUBTILIS YVQK, A PUTATIVE ATP- BINDING COBALAMIN ADENOSYLTRANSFERASE, THE NORTH EAST STRUCTURAL GENOMICS TARGET SR128 1YSJ ; 2.40 ; CRYSTAL STRUCTURE OF BACILLUS SUBTILIS YXEP PROTEIN (APC1829), A DINUCLEAR METAL BINDING PEPTIDASE FROM M20 FAMILY 1WTF ; 1.60 ; CRYSTAL STRUCTURE OF BACILLUS THERMOPROTEOLYTICUS FERREDOXIN VARIANTS CONTAINING UNEXPECTED [3FE-4S] CLUSTER THAT IS LINKED TO COENZYME A AT 1.6 A RESOLUTION 1QPY ; 2.20 ; CRYSTAL STRUCTURE OF BACKBONE MODIFIED PNA HEXAMER 1JHD ; 1.70 ; CRYSTAL STRUCTURE OF BACTERIAL ATP SULFURYLASE FROM THE RIFTIA PACHYPTILA SYMBIONT 1Y53 ; 1.20 ; CRYSTAL STRUCTURE OF BACTERIAL EXPRESSED AVIDIN RELATED PROTEIN 4 (AVR4) C122S 1LF6 ; 2.10 ; CRYSTAL STRUCTURE OF BACTERIAL GLUCOAMYLASE 1LF9 ; 2.20 ; CRYSTAL STRUCTURE OF BACTERIAL GLUCOAMYLASE COMPLEXED WITH ACARBOSE 1CVL ; 1.60 ; CRYSTAL STRUCTURE OF BACTERIAL LIPASE FROM CHROMOBACTERIUM VISCOSUM ATCC 6918 1IWG ; 3.50 ; CRYSTAL STRUCTURE OF BACTERIAL MULTIDRUG EFFLUX TRANSPORTER ACRB 2A64 ; 3.30 ; CRYSTAL STRUCTURE OF BACTERIAL RIBONUCLEASE P RIBONUCLEIC ACID 1O83 ; 1.64 ; CRYSTAL STRUCTURE OF BACTERIOCIN AS-48 AT PH 7.5, PHOSPHATE BOUND. CRYSTAL FORM I 1O84 ; 2.80 ; CRYSTAL STRUCTURE OF BACTERIOCIN AS-48. N-DECYL-BETA-D- MALTOSIDE BOUND. 1FZR ; 2.10 ; CRYSTAL STRUCTURE OF BACTERIOPHAGE T7 ENDONUCLEASE I 1M0I ; 2.55 ; CRYSTAL STRUCTURE OF BACTERIOPHAGE T7 ENDONUCLEASE I WITH A WILD-TYPE ACTIVE SITE 1M0D ; 1.90 ; CRYSTAL STRUCTURE OF BACTERIOPHAGE T7 ENDONUCLEASE I WITH A WILD-TYPE ACTIVE SITE AND BOUND MANGANESE IONS 1X0K ; 2.60 ; CRYSTAL STRUCTURE OF BACTERIORHODOPSIN AT PH 10 1KME ; 2.00 ; CRYSTAL STRUCTURE OF BACTERIORHODOPSIN CRYSTALLIZED FROM BICELLES 2BRD ; 3.50 ; CRYSTAL STRUCTURE OF BACTERIORHODOPSIN IN PURPLE MEMBRANE 1BM1 ; 3.50 ; CRYSTAL STRUCTURE OF BACTERIORHODOPSIN IN THE LIGHT-ADAPTED STATE 1Q5I ; 2.30 ; CRYSTAL STRUCTURE OF BACTERIORHODOPSIN MUTANT P186A CRYSTALLIZED FROM BICELLES 1Q5J ; 2.10 ; CRYSTAL STRUCTURE OF BACTERIORHODOPSIN MUTANT P91A CRYSTALLIZED FROM BICELLES 1P35 ; 2.20 ; CRYSTAL STRUCTURE OF BACULOVIRUS P35 1YN9 ; 1.50 ; CRYSTAL STRUCTURE OF BACULOVIRUS RIBONUCLEIC ACID 5'-PHOSPHATASE COMPLEXED WITH PHOSPHATE 1RPK ; 2.00 ; CRYSTAL STRUCTURE OF BARLEY ALPHA-AMYLASE ISOZYME 1 (AMY1) IN COMPLEX WITH ACARBOSE 1P6W ; 2.00 ; CRYSTAL STRUCTURE OF BARLEY ALPHA-AMYLASE ISOZYME 1 (AMY1) IN COMPLEX WITH THE SUBSTRATE ANALOGUE, METHYL 4I,4II,4III- TRI-THIOMALTOTETRAOSIDE (THIO-DP4) 1RP9 ; 2.00 ; CRYSTAL STRUCTURE OF BARLEY ALPHA-AMYLASE ISOZYME 1 (AMY1) INACTIVE MUTANT D180A IN COMPLEX WITH ACARBOSE 1RP8 ; 2.00 ; CRYSTAL STRUCTURE OF BARLEY ALPHA-AMYLASE ISOZYME 1 (AMY1) INACTIVE MUTANT D180A IN COMPLEX WITH MALTOHEPTAOSE 1C2A ; 1.90 ; CRYSTAL STRUCTURE OF BARLEY BBI 1IEQ ; 2.70 ; CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 1IEW ; 2.55 ; CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 IN COMPLEX WITH 2-DEOXY-2-FLUORO-ALPHA-D- GLUCOSIDE 1J8V ; 2.40 ; CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 IN COMPLEX WITH 4'-NITROPHENYL 3I- THIOLAMINARITRIOSIDE 1IEX ; 2.20 ; CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 IN COMPLEX WITH 4I,4III,4V-S- TRITHIOCELLOHEXAOSE 1IEV ; 2.80 ; CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 IN COMPLEX WITH CYCLOHEXITOL 1LQ2 ; 2.70 ; CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 IN COMPLEX WITH GLUCO-PHENYLIMIDAZOLE 1X38 ; 1.70 ; CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 IN COMPLEX WITH GLUCO-PHENYLIMIDAZOLE 1X39 ; 1.80 ; CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 IN COMPLEX WITH GLUCO-PHENYLIMIDAZOLE 1BGP ; 1.90 ; CRYSTAL STRUCTURE OF BARLEY GRAIN PEROXIDASE 1 2AUA ; 2.35 ; CRYSTAL STRUCTURE OF BC2332: A HYPOTHETICAL PROTEIN FROM BACILLUS CEREUS 1G8P ; 2.10 ; CRYSTAL STRUCTURE OF BCHI SUBUNIT OF MAGNESIUM CHELATASE 1PQ1 ; 1.65 ; CRYSTAL STRUCTURE OF BCL-XL/BIM 1FCV ; 2.65 ; CRYSTAL STRUCTURE OF BEE VENOM HYALURONIDASE IN COMPLEX WITH HYALURONIC ACID TETRAMER 1J8A ; 1.21 ; CRYSTAL STRUCTURE OF BENZAMIDINE INHIBITED BOVINE PANCREATIC TRYPSIN AT 105K TO 1.21A RESOLUTION FROM LABORATORY SOURCE WITH HIGH NUMBER OF WATERS MODELLED 2AIQ ; 1.54 ; CRYSTAL STRUCTURE OF BENZAMIDINE-INHIBITED PROTEIN C ACTIVATOR FROM THE VENOM OF COPPERHEAD SNAKE AGKISTRODON CONTORTRIX CONTORTRIX 1F8F ; 2.20 ; CRYSTAL STRUCTURE OF BENZYL ALCOHOL DEHYDROGENASE FROM ACINETOBACTER CALCOACETICUS 1VPG ; 2.10 ; CRYSTAL STRUCTURE OF BET3 HOMOLOG (13277653) FROM MUS MUSCULUS AT 2.10 A RESOLUTION 1BTG ; 2.50 ; CRYSTAL STRUCTURE OF BETA NERVE GROWTH FACTOR AT 2.5 A RESOLUTION IN C2 SPACE GROUP WITH ZN IONS BOUND 1FOB ; 1.80 ; CRYSTAL STRUCTURE OF BETA-1,4-GALACTANASE FROM ASPERGILLUS ACULEATUS AT 100K 1FHL ; 2.30 ; CRYSTAL STRUCTURE OF BETA-1,4-GALACTANASE FROM ASPERGILLUS ACULEATUS AT 293K 1YIF ; 1.80 ; CRYSTAL STRUCTURE OF BETA-1,4-XYLOSIDASE FROM BACILLUS SUBTILIS, NEW YORK STRUCTURAL GENOMICS CONSORTIUM 1R3N ; 2.70 ; CRYSTAL STRUCTURE OF BETA-ALANINE SYNTHASE FROM SACCHAROMYCES KLUYVERI 1R43 ; 2.80 ; CRYSTAL STRUCTURE OF BETA-ALANINE SYNTHASE FROM SACCHAROMYCES KLUYVERI (SELENOMETHIONINE SUBSTITUTED PROTEIN) 1FA2 ; 2.30 ; CRYSTAL STRUCTURE OF BETA-AMYLASE FROM SWEET POTATO 1Q5N ; 2.30 ; CRYSTAL STRUCTURE OF BETA-CARBOXY-CIS,CIS-MUCONATE CYCLOISOMERASE (CMLE) FROM ACINETOBACTER CALCOACETICUS SP. ADP1 1JDH ; 1.90 ; CRYSTAL STRUCTURE OF BETA-CATENIN AND HTCF-4 1T08 ; 2.10 ; CRYSTAL STRUCTURE OF BETA-CATENIN/ICAT HELICAL DOMAIN/UNPHOSPHORYLATED APC R3 1LJP ; 1.80 ; CRYSTAL STRUCTURE OF BETA-CINNAMOMIN ELICITIN 1PX8 ; 2.40 ; CRYSTAL STRUCTURE OF BETA-D-XYLOSIDASE FROM THERMOANAEROBACTERIUM SACCHAROLYTICUM, A FAMILY 39 GLYCOSIDE HYDROLASE 1UHV ; 2.10 ; CRYSTAL STRUCTURE OF BETA-D-XYLOSIDASE FROM THERMOANAEROBACTERIUM SACCHAROLYTICUM, A FAMILY 39 GLYCOSIDE HYDROLASE 1Y65 ; 1.85 ; CRYSTAL STRUCTURE OF BETA-HEXOSAMINIDASE FROM VIBRIO CHOLERAE IN COMPLEX WITH N-ACETYL-D-GLUCOSAMINE TO A RESOLUTION OF 1.85 1I01 ; 2.60 ; CRYSTAL STRUCTURE OF BETA-KETOACYL [ACYL CARRIER PROTEIN] REDUCTASE FROM E. COLI. 1HN9 ; 2.00 ; CRYSTAL STRUCTURE OF BETA-KETOACYL-ACP SYNTHASE III 1HNH ; 1.90 ; CRYSTAL STRUCTURE OF BETA-KETOACYL-ACP SYNTHASE III + DEGRADED FORM OF ACETYL-COA 1HNJ ; 1.46 ; CRYSTAL STRUCTURE OF BETA-KETOACYL-ACP SYNTHASE III + MALONYL-COA 1MZS ; 2.10 ; CRYSTAL STRUCTURE OF BETA-KETOACYL-ACP SYNTHASE III WITH BOUND DICHLOROBENZYLOXY-INDOLE-CARBOXYLIC ACID INHIBITOR 1HNK ; 1.90 ; CRYSTAL STRUCTURE OF BETA-KETOACYL-ACP SYNTHASE III, APO TETRAGONAL FORM 1HND ; 1.60 ; CRYSTAL STRUCTURE OF BETA-KETOACYL-ACP SYNTHASE III-COA COMPLEX 1DD8 ; 2.30 ; CRYSTAL STRUCTURE OF BETA-KETOACYL-[ACYL CARRIER PROTEIN] SYNTHASE I FROM ESCHERICHIA COLI 1JGT ; 1.95 ; CRYSTAL STRUCTURE OF BETA-LACTAM SYNTHETASE 1JTD ; 2.30 ; CRYSTAL STRUCTURE OF BETA-LACTAMASE INHIBITOR PROTEIN-II IN COMPLEX WITH TEM-1 BETA-LACTAMASE 1NIO ; 2.00 ; CRYSTAL STRUCTURE OF BETA-LUFFIN, A RIBOSOME INACTIVATING PROTEIN AT 2.0A RESOLUTION 1KD0 ; 1.90 ; CRYSTAL STRUCTURE OF BETA-METHYLASPARTASE FROM CLOSTRIDIUM TETANOMORPHUM. APO-STRUCTURE. 1KCZ ; 1.90 ; CRYSTAL STRUCTURE OF BETA-METHYLASPARTASE FROM CLOSTRIDIUM TETANOMORPHUM. MG-COMPLEX. 1XN3 ; 2.00 ; CRYSTAL STRUCTURE OF BETA-SECRETASE BOUND TO A LONG INHIBITOR WITH ADDITIONAL UPSTREAM RESIDUES. 1M4H ; 2.10 ; CRYSTAL STRUCTURE OF BETA-SECRETASE COMPLEXED WITH INHIBITOR OM00-3 1G9I ; 2.20 ; CRYSTAL STRUCTURE OF BETA-TRYSIN COMPLEX IN CYCLOHEXANE 2BFG ; 2.40 ; CRYSTAL STRUCTURE OF BETA-XYLOSIDASE (FAM GH39) IN COMPLEX WITH DINITROPHENYL-BETA-XYLOSIDE AND COVALENTLY BOUND XYLOSIDE 1KWS ; 2.10 ; CRYSTAL STRUCTURE OF BETA1,3-GLUCURONYLTRANSFERASE I IN COMPLEX WITH THE ACTIVE UDP-GLCUA DONOR 1YRO ; 1.90 ; CRYSTAL STRUCTURE OF BETA14,-GALACTOSYLTRANSFERASE MUTANT ARG228LYS IN COMPLEX WITH ALPHA-LACTALBUMIN IN THE PRESENCE OF UDP-GALACTOSE AND MN 1FUY ; 2.25 ; CRYSTAL STRUCTURE OF BETAA169L/BETAC170W DOUBLE MUTANT OF TRYPTOPHAN SYNTHASE COMPLEXED WITH 5-FLUORO-INDOLE-PROPANOL PHOSPHATE 2B4A ; 2.42 ; CRYSTAL STRUCTURE OF BH3024 PROTEIN (10175646) FROM BACILLUS HALODURANS AT 2.42 A RESOLUTION 2F22 ; 1.42 ; CRYSTAL STRUCTURE OF BH3987 FROM BACILLUS HALODURANS AT 1.42 A RESOLUTION 1MJG ; 2.20 ; CRYSTAL STRUCTURE OF BIFUNCTIONAL CARBON MONOXIDE DEHYDROGENASE/ACETYL-COA SYNTHASE(CODH/ACS) FROM MOORELLA THERMOACETICA (F. CLOSTRIDIUM THERMOACETICUM) 2F6R ; 1.70 ; CRYSTAL STRUCTURE OF BIFUNCTIONAL COENZYME A SYNTHASE (COA SYNTHASE): (18044849) FROM MUS MUSCULUS AT 1.70 A RESOLUTION 1EQM ; 1.50 ; CRYSTAL STRUCTURE OF BINARY COMPLEX OF 6-HYDROXYMETHYL-7,8- DIHYDROPTERIN PYROPHOSPHOKINASE WITH ADENOSINE-5'- DIPHOSPHATE 1LRM ; 2.10 ; CRYSTAL STRUCTURE OF BINARY COMPLEX OF THE CATALYTIC DOMAIN OF HUMAN PHENYLALANINE HYDROXYLASE WITH DIHYDROBIOPTERIN (BH2) 1M33 ; 1.70 ; CRYSTAL STRUCTURE OF BIOH AT 1.7 A 1M1O ; 1.95 ; CRYSTAL STRUCTURE OF BIOSYNTHETIC THIOLASE, C89A MUTANT, COMPLEXED WITH ACETOACETYL-COA 1W93 ; 2.50 ; CRYSTAL STRUCTURE OF BIOTIN CARBOXYLASE DOMAIN OF ACETYL- COENZYME A CARBOXYLASE FROM SACCHAROMYCES CEREVISIAE 1W96 ; 1.80 ; CRYSTAL STRUCTURE OF BIOTIN CARBOXYLASE DOMAIN OF ACETYL- COENZYME A CARBOXYLASE FROM SACCHAROMYCES CEREVISIAE IN COMPLEX WITH SORAPHEN A 1WQW ; 1.45 ; CRYSTAL STRUCTURE OF BIOTIN PROTEIN LIGASE FROM PYROCOCCUS HORIKOSHII OT3 IN COMPLEX WITH BIOTINYL-5-AMP 1WNL ; 1.60 ; CRYSTAL STRUCTURE OF BIOTIN-(ACETYL-COA-CARBOXYLASE) LIGASE FROM PIROCOCCUS HORIKOSHII OT3 IN COMPLEX WITH ADP 1WQ7 ; 1.60 ; CRYSTAL STRUCTURE OF BIOTIN-(ACETYL-COA-CARBOXYLASE) LIGASE FROM PYROCOCCUS HORIKOSHII OT3 1WPY ; 1.60 ; CRYSTAL STRUCTURE OF BIOTIN-(ACETYL-COA-CARBOXYLASE) LIGASE FROM PYROCOCCUS HORIKOSHII OT3 IN COMPLEX WITH BIOTIN 1Q7S ; 2.00 ; CRYSTAL STRUCTURE OF BIT1 1JWI ; 2.00 ; CRYSTAL STRUCTURE OF BITISCETIN, A VON WILLEBAND FACTOR- DEPENDENT PLATELET AGGREGATION INDUCER. 1VBW ; 0.93 ; CRYSTAL STRUCTURE OF BITTER GOURD TRYPSIN INHIBITOR 1WN5 ; 1.80 ; CRYSTAL STRUCTURE OF BLASTICIDIN S DEAMINASE (BSD) COMPLEXED WITH CACODYLIC ACID 1WN6 ; 1.80 ; CRYSTAL STRUCTURE OF BLASTICIDIN S DEAMINASE (BSD) COMPLEXED WITH TETRAHEDRAL INTERMEDIATE OF BLASTICIDIN S 1EWJ ; 2.50 ; CRYSTAL STRUCTURE OF BLEOMYCIN-BINDING PROTEIN COMPLEXED WITH BLEOMYCIN 1JIF ; 1.60 ; CRYSTAL STRUCTURE OF BLEOMYCIN-BINDING PROTEIN FROM BLEOMYCIN-PRODUCING STREPTOMYCES VERTICILLUS COMPLEXED WITH COPPER(II)-BLEOMYCIN 1JIE ; 1.80 ; CRYSTAL STRUCTURE OF BLEOMYCIN-BINDING PROTEIN FROM BLEOMYCIN-PRODUCING STREPTOMYCES VERTICILLUS COMPLEXED WITH METAL-FREE BLEOMYCIN 1P0S ; 2.80 ; CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEX WITH ECOTIN M84R 1V4U ; 2.00 ; CRYSTAL STRUCTURE OF BLUEFIN TUNA CARBONMONOXY-HEMOGLOBIN 1V4X ; 1.60 ; CRYSTAL STRUCTURE OF BLUEFIN TUNA HEMOGLOBIN DEOXY FORM AT PH5.0 1V4W ; 1.70 ; CRYSTAL STRUCTURE OF BLUEFIN TUNA HEMOGLOBIN DEOXY FORM AT PH7.5 1ZKZ ; 2.33 ; CRYSTAL STRUCTURE OF BMP9 1R8E ; 2.40 ; CRYSTAL STRUCTURE OF BMRR BOUND TO DEOXYRIBONUCLEIC ACID AT 2.4A RESOLUTION 1PC9 ; 2.50 ; CRYSTAL STRUCTURE OF BNSP-6, A LYS49-PHOSPHOLIPASE A2 1PA0 ; 2.20 ; CRYSTAL STRUCTURE OF BNSP-7, A LYS49-PHOSPHOLIPASE A2 1M4U ; 2.42 ; CRYSTAL STRUCTURE OF BONE MORPHOGENETIC PROTEIN-7 (BMP-7) IN COMPLEX WITH THE SECRETED ANTAGONIST NOGGIN 1XB2 ; 2.20 ; CRYSTAL STRUCTURE OF BOS TAURUS MITOCHONDRIAL ELONGATION FACTOR TU/TS COMPLEX 1Y4L ; 1.70 ; CRYSTAL STRUCTURE OF BOTHROPS ASPER MYOTOXIN II COMPLEXED WITH THE ANTI-TRYPANOSOMAL DRUG SURAMIN 1FVU ; 1.80 ; CRYSTAL STRUCTURE OF BOTROCETIN 3BTA ; 3.20 ; CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE A 1S0G ; 2.60 ; CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B APO FORM 1S0B ; 2.00 ; CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B AT PH 4.0 1S0C ; 2.20 ; CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B AT PH 5.0 1S0D ; 2.20 ; CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B AT PH 5.5 1S0E ; 1.90 ; CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B AT PH 6.0 1S0F ; 2.30 ; CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B AT PH 7.0 1ZB7 ; 2.35 ; CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE G LIGHT CHAIN 1KRM ; 2.50 ; CRYSTAL STRUCTURE OF BOVINE ADENOSINE DEAMINASE COMPLEXED WITH 6-HYDROXYL-1,6-DIHYDROPURINE RIBOSIDE 1FG5 ; 2.80 ; CRYSTAL STRUCTURE OF BOVINE ALPHA-1,3-GALACTOSYLTRANSFERASE CATALYTIC DOMAIN. 1F6S ; 2.20 ; CRYSTAL STRUCTURE OF BOVINE ALPHA-LACTALBUMIN 1JSY ; 2.90 ; CRYSTAL STRUCTURE OF BOVINE ARRESTIN-2 1G4M ; 1.90 ; CRYSTAL STRUCTURE OF BOVINE BETA-ARRESTIN 1 1G4R ; 2.20 ; CRYSTAL STRUCTURE OF BOVINE BETA-ARRESTIN 1 1BMG ; 2.50 ; CRYSTAL STRUCTURE OF BOVINE BETA2-MICROGLOBULIN 1AQL ; 2.80 ; CRYSTAL STRUCTURE OF BOVINE BILE-SALT ACTIVATED LIPASE COMPLEXED WITH TAUROCHOLATE 1PRW ; 1.70 ; CRYSTAL STRUCTURE OF BOVINE BRAIN CA++ CALMODULIN IN A COMPACT FORM 1EX3 ; 3.00 ; CRYSTAL STRUCTURE OF BOVINE CHYMOTRYPSINOGEN A (TETRAGONAL) 1E9Q ; 1.75 ; CRYSTAL STRUCTURE OF BOVINE CU ZN SOD - (1 OF 3) 1E9P ; 1.70 ; CRYSTAL STRUCTURE OF BOVINE CU, ZN SOD TO 1.7 ANGSTROM (3 OF 3) 1SDD ; 2.80 ; CRYSTAL STRUCTURE OF BOVINE FACTOR VAI 1AB9 ; 1.60 ; CRYSTAL STRUCTURE OF BOVINE GAMMA-CHYMOTRYPSIN 1AFQ ; 1.80 ; CRYSTAL STRUCTURE OF BOVINE GAMMA-CHYMOTRYPSIN COMPLEXED WITH A SYNTHETIC INHIBITOR 1M8U ; 1.65 ; CRYSTAL STRUCTURE OF BOVINE GAMMA-E AT 1.65 ANG RESOLUTION 1NQT ; 3.50 ; CRYSTAL STRUCTURE OF BOVINE GLUTAMATE DEHYDROGENASE-ADP COMPLEX 1TFJ ; 1.61 ; CRYSTAL STRUCTURE OF BOVINE GLYCOLIPID TRANSFER PROTEIN IN COMPLEX WITH A FATTY ACID 1KT3 ; 1.40 ; CRYSTAL STRUCTURE OF BOVINE HOLO-RBP AT PH 2.0 1KT4 ; 1.46 ; CRYSTAL STRUCTURE OF BOVINE HOLO-RBP AT PH 3.0 1KT5 ; 1.46 ; CRYSTAL STRUCTURE OF BOVINE HOLO-RBP AT PH 4.0 1KT7 ; 1.27 ; CRYSTAL STRUCTURE OF BOVINE HOLO-RBP AT PH 7.0 1KT6 ; 1.10 ; CRYSTAL STRUCTURE OF BOVINE HOLO-RBP AT PH 9.0 1YUW ; 2.60 ; CRYSTAL STRUCTURE OF BOVINE HSC70(AA1-554)E213A/D214A MUTANT 1HWX ; 2.50 ; CRYSTAL STRUCTURE OF BOVINE LIVER GLUTAMATE DEHYDROGENASE COMPLEXED WITH GTP, NADH, AND L-GLUTAMIC ACID 1DG9 ; 1.90 ; CRYSTAL STRUCTURE OF BOVINE LOW MOLECULAR WEIGHT PTPASE COMPLEXED WITH HEPES 1Z13 ; 2.20 ; CRYSTAL STRUCTURE OF BOVINE LOW MOLECULAR WEIGHT PTPASE COMPLEXED WITH MOLYBDATE 1Z12 ; 2.20 ; CRYSTAL STRUCTURE OF BOVINE LOW MOLECULAR WEIGHT PTPASE COMPLEXED WITH VANADATE 1FVA ; 1.70 ; CRYSTAL STRUCTURE OF BOVINE METHIONINE SULFOXIDE REDUCTASE 1V97 ; 1.94 ; CRYSTAL STRUCTURE OF BOVINE MILK XANTHINE DEHYDROGENASE FYX- 051 BOUND FORM 1QCR ; 2.70 ; CRYSTAL STRUCTURE OF BOVINE MITOCHONDRIAL CYTOCHROME BC1 COMPLEX, ALPHA CARBON ATOMS ONLY 2BN2 ; 2.80 ; CRYSTAL STRUCTURE OF BOVINE NEUROPHYSIN II COMPLEXED WITH THE VASOPRESSIN ANALOGUE PHE-TYR AMIDE 1HN2 ; 1.80 ; CRYSTAL STRUCTURE OF BOVINE OBP COMPLEXED WITH AMINOANTHRACENE 1G85 ; 1.80 ; CRYSTAL STRUCTURE OF BOVINE ODORANT BINDING PROTEIN COMPLEXED WITH IS NATURAL LIGAND 1HDU ; 1.75 ; CRYSTAL STRUCTURE OF BOVINE PANCREATIC CARBOXYPEPTIDASE A COMPLEXED WITH AMINOCARBONYLPHENYLALANINE AT 1.75 A 1HDQ ; 2.30 ; CRYSTAL STRUCTURE OF BOVINE PANCREATIC CARBOXYPEPTIDASE A COMPLEXED WITH D-N-HYDROXYAMINOCARBONYL PHENYLALANINE AT 2.3 A 1HEE ; 1.75 ; CRYSTAL STRUCTURE OF BOVINE PANCREATIC CARBOXYPEPTIDASE A COMPLEXED WITH L-N-HYDROXYAMINOCARBONYL PHENYLALANINE AT 2.3 A 1FVG ; 1.60 ; CRYSTAL STRUCTURE OF BOVINE PEPTIDE METHIONINE SULFOXIDE REDUCTASE 1TU5 ; 2.37 ; CRYSTAL STRUCTURE OF BOVINE PLASMA COPPER-CONTAINING AMINE OXIDASE 1FON ; 1.70 ; CRYSTAL STRUCTURE OF BOVINE PROCARBOXYPEPTIDASE A-S6 SUBUNIT III, A HIGHLY STRUCTURED TRUNCATED ZYMOGEN E 1G0W ; 2.30 ; CRYSTAL STRUCTURE OF BOVINE RETINAL CREATINE KINASE 1F88 ; 2.80 ; CRYSTAL STRUCTURE OF BOVINE RHODOPSIN 1HZX ; 2.80 ; CRYSTAL STRUCTURE OF BOVINE RHODOPSIN 1U19 ; 2.20 ; CRYSTAL STRUCTURE OF BOVINE RHODOPSIN AT 2.2 ANGSTROMS RESOLUTION 1L9H ; 2.60 ; CRYSTAL STRUCTURE OF BOVINE RHODOPSIN AT 2.6 ANGSTROMS RESOLUTION 1E9O ; 1.85 ; CRYSTAL STRUCTURE OF BOVINE SOD - 1 OF 3 1CBJ ; 1.65 ; CRYSTAL STRUCTURE OF BOVINE SUPEROXIDE DISMUTASE CRYSTAL. 1ID5 ; 2.50 ; CRYSTAL STRUCTURE OF BOVINE THROMBIN COMPLEX WITH PROTEASE INHIBITOR ECOTIN 1KW8 ; 2.00 ; CRYSTAL STRUCTURE OF BPHC-2,3-DIHYDROXYBIPHENYL-NO COMPLEX 1BP1 ; 2.40 ; CRYSTAL STRUCTURE OF BPI, THE HUMAN BACTERICIDAL PERMEABILITY-INCREASING PROTEIN 1I9X ; 2.18 ; CRYSTAL STRUCTURE OF BPS-U2 SNRNA DUPLEX 1UHJ ; 1.80 ; CRYSTAL STRUCTURE OF BR-AEQUORIN 1D7O ; 1.90 ; CRYSTAL STRUCTURE OF BRASSICA NAPUS ENOYL ACYL CARRIER PROTEIN REDUCTASE COMPLEXED WITH NAD AND TRICLOSAN 1D2V ; 1.75 ; CRYSTAL STRUCTURE OF BROMIDE-BOUND HUMAN MYELOPEROXIDASE ISOFORM C AT PH 5.5 1K2P ; 2.10 ; CRYSTAL STRUCTURE OF BRUTON'S TYROSINE KINASE DOMAIN 1L0H ; 2.00 ; CRYSTAL STRUCTURE OF BUTYRYL-ACP FROM E.COLI 1L0I ; 1.20 ; CRYSTAL STRUCTURE OF BUTYRYL-ACP I62M MUTANT 1GD2 ; 2.00 ; CRYSTAL STRUCTURE OF BZIP TRANSCRIPTION FACTOR PAP1 BOUND TO DEOXYRIBONUCLEIC ACID 2ERZ ; 2.20 ; CRYSTAL STRUCTURE OF C-AMP DEPENDENT KINASE (PKA) BOUND TO HYDROXYFASUDIL 1GUU ; 1.60 ; CRYSTAL STRUCTURE OF C-MYB R1 1GV5 ; 1.58 ; CRYSTAL STRUCTURE OF C-MYB R2 1GVD ; 1.45 ; CRYSTAL STRUCTURE OF C-MYB R2 V103L MUTANT 1GV2 ; 1.68 ; CRYSTAL STRUCTURE OF C-MYB R2R3 1GH0 ; 2.20 ; CRYSTAL STRUCTURE OF C-PHYCOCYANIN FROM SPIRULINA PLATENSIS 1KTP ; 1.60 ; CRYSTAL STRUCTURE OF C-PHYCOCYANIN OF SYNECHOCOCCUS VULCANUS AT 1.6 ANGSTROMS 1I7Y ; 2.50 ; CRYSTAL STRUCTURE OF C-PHYCOCYANIN OF SYNECHOCOCCUS VULCANUS AT 2.5 ANGSTROMS. 1GJI ; 2.85 ; CRYSTAL STRUCTURE OF C-REL BOUND TO DEOXYRIBONUCLEIC ACID 1F00 ; 1.90 ; CRYSTAL STRUCTURE OF C-TERMINAL 282-RESIDUE FRAGMENT OF ENTEROPATHOGENIC E. COLI INTIMIN 1F02 ; 2.90 ; CRYSTAL STRUCTURE OF C-TERMINAL 282-RESIDUE FRAGMENT OF INTIMIN IN COMPLEX WITH TRANSLOCATED INTIMIN RECEPTOR (TIR) INTIMIN-BINDING DOMAIN 1KO6 ; 3.00 ; CRYSTAL STRUCTURE OF C-TERMINAL AUTOPROTEOLYTIC DOMAIN OF NUCLEOPORIN NUP98 1RZQ ; 2.20 ; CRYSTAL STRUCTURE OF C-TERMINAL DESPENTAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT PH5.0 1RZP ; 1.90 ; CRYSTAL STRUCTURE OF C-TERMINAL DESPENTAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT PH6.2 2AVF ; 2.60 ; CRYSTAL STRUCTURE OF C-TERMINAL DESUNDECAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES 1WMZ ; 1.70 ; CRYSTAL STRUCTURE OF C-TYPE LECTIN CEL-I COMPLEXED WITH N- ACETYL-D-GALACTOSAMINE 1WMY ; 2.00 ; CRYSTAL STRUCTURE OF C-TYPE LECTIN CEL-I FROM CUCUMARIA ECHINATA 1KT9 ; 1.98 ; CRYSTAL STRUCTURE OF C. ELEGANS AP4A HYDROLASE 1SZH ; 1.50 ; CRYSTAL STRUCTURE OF C. ELEGANS HER-1 1NWQ ; 2.80 ; CRYSTAL STRUCTURE OF C/EBPALPHA-DEOXYRIBONUCLEIC ACID COMPLEX 1GU5 ; 2.10 ; CRYSTAL STRUCTURE OF C/EBPBETA BZIP HOMODIMER BOUND TO A DEOXYRIBONUCLEIC ACID FRAGMENT FROM THE MIM-1 PROMOTER 1GTW ; 1.85 ; CRYSTAL STRUCTURE OF C/EBPBETA BZIP HOMODIMER BOUND TO A DEOXYRIBONUCLEIC ACID FRAGMENT FROM THE TOM-1A PROMOTER 1GU4 ; 1.80 ; CRYSTAL STRUCTURE OF C/EBPBETA BZIP HOMODIMER BOUND TO A HIGH AFFINITY DEOXYRIBONUCLEIC ACID FRAGMENT 1GZL ; 1.80 ; CRYSTAL STRUCTURE OF C14LINKMID/IQN17: A CROSS-LINKED INHIBITOR OF HIV-1 ENTRY BOUND TO THE GP41 HYDROPHOBIC POCKET 1UF4 ; 2.15 ; CRYSTAL STRUCTURE OF C171A/V236A MUTANT OF N-CARBAMYL-D- AMINO ACID AMIDOHYDROLASE 1UF5 ; 1.60 ; CRYSTAL STRUCTURE OF C171A/V236A MUTANT OF N-CARBAMYL-D- AMINO ACID AMIDOHYDROLASE COMPLEXED WITH N-CARBAMYL-D- METHIONINE 1UF8 ; 1.80 ; CRYSTAL STRUCTURE OF C171A/V236A MUTANT OF N-CARBAMYL-D- AMINO ACID AMIDOHYDROLASE COMPLEXED WITH N-CARBAMYL-D- PHENYLALANINE 1UF7 ; 1.90 ; CRYSTAL STRUCTURE OF C171A/V236A MUTANT OF N-CARBAMYL-D- AMINO ACID AMIDOHYDROLASE COMPLEXED WITH N-CARBAMYL-D- VALINE 1TEE ; 2.90 ; CRYSTAL STRUCTURE OF C205F MUTANT OF PKS18 FROM MYCOBACTERIUM TUBERCULOSIS 1SJ5 ; 2.80 ; CRYSTAL STRUCTURE OF C38A MUTANT OF HYPOTHETICAL PROTEIN (TM0160) FROM THERMOTOGA MARITIMA AT 2.8 A RESOLUTION 1JQO ; 3.00 ; CRYSTAL STRUCTURE OF C4-FORM PHOSPHOENOLPYRUVATE CARBOXYLASE FROM MAIZE 1CM5 ; 2.30 ; CRYSTAL STRUCTURE OF C418A,C419A MUTANT OF PFL FROM E.COLI 1OQR ; 1.65 ; CRYSTAL STRUCTURE OF C73S MUTANT OF PUTIDAREDOXIN, A [2FE- 2S] FERREDOXIN FROM PSEUDOMONAS PUTIDA, AT 1.65A RESOLUTION 1OQQ ; 1.47 ; CRYSTAL STRUCTURE OF C73S/C85S MUTANT OF PUTIDAREDOXIN, A [2FE-2S] FERREDOXIN FROM PSEUDOMONAS PUTIDA, AT 1.47A RESOLUTION 1JS2 ; 1.90 ; CRYSTAL STRUCTURE OF C77S HIPIP: A SERINE LIGATED [4FE-4S} CLUSTER 1J35 ; 1.80 ; CRYSTAL STRUCTURE OF CA(II)-BOUND GLA DOMAIN OF FACTOR IX COMPLEXED WITH BINDING PROTEIN 1L7Z ; 2.30 ; CRYSTAL STRUCTURE OF CA2+/CALMODULIN COMPLEXED WITH MYRISTOYLATED CAP-23/NAP-22 PEPTIDE 1FE0 ; 1.75 ; CRYSTAL STRUCTURE OF CADMIUM-HAH1 1D4X ; 1.75 ; CRYSTAL STRUCTURE OF CAENORHABDITIS ELEGANS MG-ATP ACTIN COMPLEXED WITH HUMAN GELSOLIN SEGMENT 1 AT 1.75 A RESOLUTION. 1S2X ; 1.90 ; CRYSTAL STRUCTURE OF CAG-Z FROM HELICOBACTER PYLORI 1XVV ; 2.40 ; CRYSTAL STRUCTURE OF CAIB MUTANT D169A IN COMPLEX WITH CARNITINYL-COA 1XVU ; 2.40 ; CRYSTAL STRUCTURE OF CAIB MUTANT D169A IN COMPLEX WITH COENZYME A 1XA3 ; 1.85 ; CRYSTAL STRUCTURE OF CAIB, A TYPE III COA TRANSFERASE IN CARNITINE METABOLISM 1XA4 ; 1.90 ; CRYSTAL STRUCTURE OF CAIB, A TYPE III COA TRANSFERASE IN CARNITINE METABOLISM 1M63 ; 2.80 ; CRYSTAL STRUCTURE OF CALCINEURIN-CYCLOPHILIN-CYCLOSPORIN SHOWS COMMON BUT DISTINCT RECOGNITION OF IMMUNOPHILIN-DRUG COMPLEXES 1Y1A ; 2.30 ; CRYSTAL STRUCTURE OF CALCIUM AND INTEGRIN BINDING PROTEIN 1SU4 ; 2.40 ; CRYSTAL STRUCTURE OF CALCIUM ATPASE WITH TWO BOUND CALCIUM IONS 1K96 ; 1.44 ; CRYSTAL STRUCTURE OF CALCIUM BOUND HUMAN S100A6 1K9K ; 1.76 ; CRYSTAL STRUCTURE OF CALCIUM BOUND HUMAN S100A6 1K9P ; 1.90 ; CRYSTAL STRUCTURE OF CALCIUM FREE (OR APO) HUMAN S100A6 1UD4 ; 2.15 ; CRYSTAL STRUCTURE OF CALCIUM FREE ALPHA AMYLASE FROM BACILLUS SP. STRAIN KSM-K38 (AMYK38, IN CALCIUM CONTAINING SOLUTION) 1KXR ; 2.07 ; CRYSTAL STRUCTURE OF CALCIUM-BOUND PROTEASE CORE OF CALPAIN I 1MDW ; 1.95 ; CRYSTAL STRUCTURE OF CALCIUM-BOUND PROTEASE CORE OF CALPAIN II REVEALS THE BASIS FOR INTRINSIC INACTIVATION 1LJ7 ; 3.15 ; CRYSTAL STRUCTURE OF CALCIUM-DEPLETED HUMAN C-REACTIVE PROTEIN FROM PERFECTLY TWINNED DATA 1K8U ; 1.15 ; CRYSTAL STRUCTURE OF CALCIUM-FREE (OR APO) HUMAN S100A6; CYS3MET MUTANT (SELENOMETHIONINE DERIVATIVE) 1UD2 ; 2.13 ; CRYSTAL STRUCTURE OF CALCIUM-FREE ALPHA-AMYLASE FROM BACILLUS SP. STRAIN KSM-K38 (AMYK38) 1JUO ; 2.20 ; CRYSTAL STRUCTURE OF CALCIUM-FREE HUMAN SORCIN: A MEMBER OF THE PENTA-EF-HAND PROTEIN FAMILY 1SL7 ; 2.20 ; CRYSTAL STRUCTURE OF CALCIUM-LOADED APO-OBELIN FROM OBELIA LONGISSIMA 1DTL ; 2.15 ; CRYSTAL STRUCTURE OF CALCIUM-SATURATED (3CA2+) CARDIAC TROPONIN C COMPLEXED WITH THE CALCIUM SENSITIZER BEPRIDIL AT 2.15 A RESOLUTION 1TCF ; 1.90 ; CRYSTAL STRUCTURE OF CALCIUM-SATURATED RABBIT SKELETAL TROPONIN C 1HKX ; 2.65 ; CRYSTAL STRUCTURE OF CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE 1PMJ ; 1.55 ; CRYSTAL STRUCTURE OF CALDICELLULOSIRUPTOR SACCHAROLYTICUS CBM27-1 1PMH ; 1.06 ; CRYSTAL STRUCTURE OF CALDICELLULOSIRUPTOR SACCHAROLYTICUS CBM27-1 IN COMPLEX WITH MANNOHEXAOSE 1LV8 ; 2.30 ; CRYSTAL STRUCTURE OF CALF SPLEEN PURINE NUCLEOSIDE PHOSPHORYLASE IN A NEW SPACE GROUP WITH FULL TRIMER IN THE ASYMMETRIC UNIT 1LVU ; 2.05 ; CRYSTAL STRUCTURE OF CALF SPLEEN PURINE NUCLEOSIDE PHOSPHORYLASE IN A NEW SPACE GROUP WITH FULL TRIMER IN THE ASYMMETRIC UNIT 1A8Y ; 2.40 ; CRYSTAL STRUCTURE OF CALSEQUESTRIN FROM RABBIT SKELETAL MUSCLE SARCOPLASMIC RETICULUM AT 2.4 A RESOLUTION 1OUW ; 1.37 ; CRYSTAL STRUCTURE OF CALYSTEGIA SEPIUM AGGLUTININ 1REJ ; 2.20 ; CRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH BALANOL ANALOG 1 1RE8 ; 2.10 ; CRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH BALANOL ANALOG 2 1REK ; 2.30 ; CRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH BALANOL ANALOG 8 1RL3 ; 2.70 ; CRYSTAL STRUCTURE OF CAMP-FREE R1A SUBUNIT OF PKA 1D6R ; 2.30 ; CRYSTAL STRUCTURE OF CANCER CHEMOPREVENTIVE BOWMAN-BIRK INHIBITOR IN TERNARY COMPLEX WITH BOVINE TRYPSIN AT 2.3 A RESOLUTION. STRUCTURAL BASIS OF JANUS-FACED SERINE PROTEASE INHIBITOR SPECIFICITY 1IYK ; 2.30 ; CRYSTAL STRUCTURE OF CANDIDA ALBICANS N- MYRISTOYLTRANSFERASE WITH MYRISTOYL-COA AND PEPTIDIC INHIBITOR 1IYL ; 3.20 ; CRYSTAL STRUCTURE OF CANDIDA ALBICANS N- MYRISTOYLTRANSFERASE WITH NON-PEPTIDIC INHIBITOR 1XVP ; 2.60 ; CRYSTAL STRUCTURE OF CAR/RXR HETERODIMER BOUND WITH SRC1 PEPTIDE, FATTY ACID AND CITCO 1XV9 ; 2.70 ; CRYSTAL STRUCTURE OF CAR/RXR HETERODIMER BOUND WITH SRC1 PEPTIDE, FATTY ACID, AND 5B-PREGNANE-3,20-DIONE. 1CS0 ; 2.00 ; CRYSTAL STRUCTURE OF CARBAMOYL PHOSPHATE SYNTHETASE COMPLEXED AT CYS269 IN THE SMALL SUBUNIT WITH THE TETRAHEDRAL MIMIC L-GLUTAMATE GAMMA-SEMIALDEHYDE 1C30 ; 2.00 ; CRYSTAL STRUCTURE OF CARBAMOYL PHOSPHATE SYNTHETASE: SMALL SUBUNIT MUTATION C269S 1JQK ; 2.80 ; CRYSTAL STRUCTURE OF CARBON MONOXIDE DEHYDROGENASE FROM RHODOSPIRILLUM RUBRUM 1VPZ ; 2.05 ; CRYSTAL STRUCTURE OF CARBON STORAGE REGULATOR HOMOLOG (NP_249596.1) FROM PSEUDOMONAS AERUGINOSA AT 2.05 A RESOLUTION 1YM3 ; 1.75 ; CRYSTAL STRUCTURE OF CARBONIC ANHYDRASE RV3588C FROM MYCOBACTERIUM TUBERCULOSIS 1T1N ; 2.20 ; CRYSTAL STRUCTURE OF CARBONMONOXY HEMOGLOBIN 1VKE ; 1.56 ; CRYSTAL STRUCTURE OF CARBOXYMUCONOLACTONE DECARBOXYLASE FAMILY PROTEIN POSSIBLY INVOLVED IN ANTIOXIDATIVE RESPONSE (TM1620) FROM THERMOTOGA MARITIMA AT 1.56 A RESOLUTION 1WGZ ; 2.60 ; CRYSTAL STRUCTURE OF CARBOXYPEPTIDASE 1 FROM THERMUS THERMOPHILUS 1WPX ; 2.70 ; CRYSTAL STRUCTURE OF CARBOXYPEPTIDASE Y INHIBITOR COMPLEXED WITH THE COGNATE PROTEINASE 1UG4 ; 1.60 ; CRYSTAL STRUCTURE OF CARDIOTOXIN VI FROM TAIWAN COBRA (NAJA ATRA) VENOM 1TW2 ; 2.50 ; CRYSTAL STRUCTURE OF CARMINOMYCIN-4-O-METHYLTRANSFERASE (DNRK) IN COMPLEX WITH S-ADENOSYL-L-HOMOCYSTEIN (SAH) AND 4-METHOXY-E-RHODOMYCIN T (M-ET) 1TW3 ; 2.35 ; CRYSTAL STRUCTURE OF CARMINOMYCIN-4-O-METHYLTRANSFERASE (DNRK) IN COMPLEX WITH S-ADENOSYL-L-HOMOCYSTEIN (SAH) AND 4-METHOXY-E-RHODOMYCIN T (M-ET) 1NDB ; 1.80 ; CRYSTAL STRUCTURE OF CARNITINE ACETYLTRANSFERASE 1M72 ; 2.30 ; CRYSTAL STRUCTURE OF CASPASE-1 FROM SPODOPTERA FRUGIPERDA 1RE1 ; 2.50 ; CRYSTAL STRUCTURE OF CASPASE-3 WITH A NICOTINIC ACID ALDEHYDE INHIBITOR 1K86 ; 2.60 ; CRYSTAL STRUCTURE OF CASPASE-7 1I51 ; 2.45 ; CRYSTAL STRUCTURE OF CASPASE-7 COMPLEXED WITH XIAP 1F1J ; 2.35 ; CRYSTAL STRUCTURE OF CASPASE-7 IN COMPLEX WITH ACETYL-ASP- GLU-VAL-ASP-CHO 1V0D ; 2.60 ; CRYSTAL STRUCTURE OF CASPASE-ACTIVATED DNASE (CAD) 1GGJ ; 1.92 ; CRYSTAL STRUCTURE OF CATALASE HPII FROM ESCHERICHIA COLI, ASN201ALA VARIANT. 1GGK ; 2.26 ; CRYSTAL STRUCTURE OF CATALASE HPII FROM ESCHERICHIA COLI, ASN201HIS VARIANT. 1GGH ; 2.15 ; CRYSTAL STRUCTURE OF CATALASE HPII FROM ESCHERICHIA COLI, HIS128ALA VARIANT. 1GG9 ; 1.89 ; CRYSTAL STRUCTURE OF CATALASE HPII FROM ESCHERICHIA COLI, HIS128ASN VARIANT. 1GGE ; 1.89 ; CRYSTAL STRUCTURE OF CATALASE HPII FROM ESCHERICHIA COLI, NATIVE STRUCTURE AT 1.9 A RESOLUTION. 1GGF ; 2.28 ; CRYSTAL STRUCTURE OF CATALASE HPII FROM ESCHERICHIA COLI, VARIANT HIS128ASN, COMPLEX WITH HYDROGEN PEROXIDE. 1ITK ; 2.00 ; CRYSTAL STRUCTURE OF CATALASE-PEROXIDASE FROM HALOARCULA MARISMORTUI 1UB2 ; 2.40 ; CRYSTAL STRUCTURE OF CATALASE-PEROXIDASE FROM SYNECHOCOCCUS PCC 7942 1MWV ; 1.70 ; CRYSTAL STRUCTURE OF CATALASE-PEROXIDASE KATG OF BURKHOLDERIA PSEUDOMALLEI 2A97 ; 1.80 ; CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF CLOSTRIDIUM BOTULINUM NEUROTOXIN SEROTYPE F 1WOK ; 3.00 ; CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF HUMAN POLY(ADP- RIBOSE) POLYMERASE COMPLEXED WITH A QUINOXALINE-TYPE INHIBITOR 1UK0 ; 3.00 ; CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF HUMAN POLY(ADP- RIBOSE) POLYMERASE WITH A NOVEL INHIBITOR 1V9F ; 1.70 ; CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF PSEUDOURIDINE SYNTHASE RLUD FROM ESCHERICHIA COLI 1ZXC ; 2.28 ; CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TNF-ALPHA CONVERTING ENZYME (TACE) WITH INHIBITOR 2AZQ ; 2.65 ; CRYSTAL STRUCTURE OF CATECHOL 1,2-DIOXYGENASE FROM PSEUDOMONAS ARVILLA C-1 1MEM ; 1.80 ; CRYSTAL STRUCTURE OF CATHEPSIN K COMPLEXED WITH A POTENT VINYL SULFONE INHIBITOR 2COV ; 1.25 ; CRYSTAL STRUCTURE OF CBM31 FROM BETA-1,3-XYLANASE 1IXC ; 2.20 ; CRYSTAL STRUCTURE OF CBNR, A LYSR FAMILY TRANSCRIPTIONAL REGULATOR 1IZ1 ; 2.50 ; CRYSTAL STRUCTURE OF CBNR, A LYSR FAMILY TRANSCRIPTIONAL REGULATOR 1VR9 ; 1.70 ; CRYSTAL STRUCTURE OF CBS DOMAIN PROTEIN/ACT DOMAIN PROTEIN (TM0892) FROM THERMOTOGA MARITIMA AT 1.70 A RESOLUTION 1O50 ; 1.87 ; CRYSTAL STRUCTURE OF CBS DOMAIN-CONTAINING PREDICTED PROTEIN (TM0935) FROM THERMOTOGA MARITIMA AT 1.87 A RESOLUTION 1Q82 ; 2.98 ; CRYSTAL STRUCTURE OF CC-PUROMYCIN BOUND TO THE A-SITE OF THE 50S RIBOSOMAL SUBUNIT 1Q86 ; 3.00 ; CRYSTAL STRUCTURE OF CCA-PHE-CAP-BIOTIN BOUND SIMULTANEOUSLY AT HALF OCCUPANCY TO BOTH THE A-SITE AND P- SITE OF THE THE 50S RIBOSOMAL SUBUNIT. 1Q7Y ; 3.20 ; CRYSTAL STRUCTURE OF CCDAP-PUROMYCIN BOUND AT THE PEPTIDYL TRANSFERASE CENTER OF THE 50S RIBOSOMAL SUBUNIT 1KNG ; 1.14 ; CRYSTAL STRUCTURE OF CCMG REDUCING OXIDOREDUCTASE AT 1.14 A 1FA7 ; 1.90 ; CRYSTAL STRUCTURE OF CD(II)-BOUND GLYOXALASE I OF ESCHERICHIA COLI 1WWL ; 2.50 ; CRYSTAL STRUCTURE OF CD14 1ONQ ; 2.15 ; CRYSTAL STRUCTURE OF CD1A IN COMPLEX WITH A SULFATIDE 1XZ0 ; 2.80 ; CRYSTAL STRUCTURE OF CD1A IN COMPLEX WITH A SYNTHETIC MYCOBACTIN LIPOPEPTIDE 1SY6 ; 2.10 ; CRYSTAL STRUCTURE OF CD3GAMMAEPSILON HETERODIMER IN COMPLEX WITH OKT3 FAB FRAGMENT 1YYL ; 2.75 ; CRYSTAL STRUCTURE OF CD4M33, A SCORPION-TOXIN MIMIC OF CD4, IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B 1FNN ; 2.00 ; CRYSTAL STRUCTURE OF CDC6P FROM PYROBACULUM AEROPHILUM 1PYE ; 2.00 ; CRYSTAL STRUCTURE OF CDK2 WITH INHIBITOR 1ORR ; 1.50 ; CRYSTAL STRUCTURE OF CDP-TYVELOSE 2-EPIMERASE COMPLEXED WITH NAD AND CDP 1LF1 ; 1.70 ; CRYSTAL STRUCTURE OF CEL5 FROM ALKALOPHILIC BACILLUS SP. 1VMA ; 1.60 ; CRYSTAL STRUCTURE OF CELL DIVISION PROTEIN FTSY (TM0570) FROM THERMOTOGA MARITIMA AT 1.60 A RESOLUTION 1HLV ; 2.50 ; CRYSTAL STRUCTURE OF CENP-B(1-129) COMPLEXED WITH THE CENP- B BOX DEOXYRIBONUCLEIC ACID 1N57 ; 1.60 ; CRYSTAL STRUCTURE OF CHAPERONE HSP31 1IOK ; 3.20 ; CRYSTAL STRUCTURE OF CHAPERONIN-60 FROM PARACOCCUS DENITRIFICANS 1B3Q ; 2.60 ; CRYSTAL STRUCTURE OF CHEA-289, A SIGNAL TRANSDUCING HISTIDINE KINASE 1F2L ; 2.00 ; CRYSTAL STRUCTURE OF CHEMOKINE DOMAIN OF FRACTALKINE 1U8T ; 1.50 ; CRYSTAL STRUCTURE OF CHEY D13K Y106W ALONE AND IN COMPLEX WITH A FLIM PEPTIDE 1D4Z ; 1.90 ; CRYSTAL STRUCTURE OF CHEY-95IV, A HYPERACTIVE CHEY MUTANT 1EM8 ; 2.10 ; CRYSTAL STRUCTURE OF CHI AND PSI SUBUNIT HETERODIMER FROM DEOXYRIBONUCLEIC ACID POL III 1U06 ; 1.49 ; CRYSTAL STRUCTURE OF CHICKEN ALPHA-SPECTRIN SH3 DOMAIN 1QH4 ; 1.41 ; CRYSTAL STRUCTURE OF CHICKEN BRAIN-TYPE CREATINE KINASE AT 1.41 ANGSTROM RESOLUTION 1TW4 ; 2.00 ; CRYSTAL STRUCTURE OF CHICKEN LIVER BASIC FATTY ACID BINDING PROTEIN (BILE ACID BINDING PROTEIN) COMPLEXED WITH CHOLIC ACID 1PXU ; 2.20 ; CRYSTAL STRUCTURE OF CHICKEN NTA FROM A EUKARYOTIC SOURCE AT 2.2A RESOLUTION 1V6Y ; 2.20 ; CRYSTAL STRUCTURE OF CHIMERIC XYLANASE BETWEEN STREPTOMYCES OLIVACEOVIRIDIS E-86 FXYN AND CELLULOMONAS FIMI CEX 1FFQ ; 1.90 ; CRYSTAL STRUCTURE OF CHITINASE A COMPLEXED WITH ALLOSAMIDIN 1EDQ ; 1.55 ; CRYSTAL STRUCTURE OF CHITINASE A FROM S. MARCESCENS AT 1.55 ANGSTROMS 1EIB ; 1.80 ; CRYSTAL STRUCTURE OF CHITINASE A MUTANT D313A COMPLEXED WITH OCTA-N-ACETYLCHITOOCTAOSE (NAG)8. 1EHN ; 1.90 ; CRYSTAL STRUCTURE OF CHITINASE A MUTANT E315Q COMPLEXED WITH OCTA-N-ACETYLCHITOOCTAOSE (NAG)8. 1FFR ; 1.80 ; CRYSTAL STRUCTURE OF CHITINASE A MUTANT Y390F COMPLEXED WITH HEXA-N-ACETYLCHITOHEXAOSE (NAG)6 1CNS ; 1.91 ; CRYSTAL STRUCTURE OF CHITINASE AT 1.91A RESOLUTION 1WVU ; 2.45 ; CRYSTAL STRUCTURE OF CHITINASE C FROM STREPTOMYCES GRISEUS HUT6037 1WVV ; 2.00 ; CRYSTAL STRUCTURE OF CHITINASE C MUTANT E147Q 1Q23 ; 2.18 ; CRYSTAL STRUCTURE OF CHLORAMPHENICOL ACETYLTRANSFERASE I COMPLEXED WITH FUSIDIC ACID AT 2.18 A RESOLUTION 1FVI ; 2.00 ; CRYSTAL STRUCTURE OF CHLORELLA VIRUS DEOXYRIBONUCLEIC ACID LIGASE-ADENYLATE 1IYN ; 1.60 ; CRYSTAL STRUCTURE OF CHLOROPLASTIC ASCORBATE PEROXIDASE FROM TOBACCO PLANTS AND STRUCTURAL INSIGHTS FOR ITS INSTABILITY 1I19 ; 1.70 ; CRYSTAL STRUCTURE OF CHOLESTEROL OXIDASE FROM B.STEROLICUM 1NW1 ; 2.02 ; CRYSTAL STRUCTURE OF CHOLINE KINASE 1HN0 ; 1.90 ; CRYSTAL STRUCTURE OF CHONDROITIN ABC LYASE I FROM PROTEUS VULGARIS AT 1.9 ANGSTROMS RESOLUTION 1DBG ; 1.70 ; CRYSTAL STRUCTURE OF CHONDROITINASE B 1DBO ; 1.70 ; CRYSTAL STRUCTURE OF CHONDROITINASE B 1OFM ; 1.80 ; CRYSTAL STRUCTURE OF CHONDROITINASE B COMPLEXED TO CHONDROITIN 4-SULFATE TETRASACCHARIDE 1OFL ; 1.70 ; CRYSTAL STRUCTURE OF CHONDROITINASE B COMPLEXED TO DERMATAN SULFATE HEXASACCHARIDE 1Q1L ; 2.05 ; CRYSTAL STRUCTURE OF CHORISMATE SYNTHASE 1UMF ; 2.25 ; CRYSTAL STRUCTURE OF CHORISMATE SYNTHASE 1UM0 ; 1.95 ; CRYSTAL STRUCTURE OF CHORISMATE SYNTHASE COMPLEXED WITH FMN 1QXO ; 2.00 ; CRYSTAL STRUCTURE OF CHORISMATE SYNTHASE COMPLEXED WITH OXIDIZED FMN AND EPSP 1LTZ ; 1.40 ; CRYSTAL STRUCTURE OF CHROMOBACTERIUM VIOLACEUM PHENYLALANINE HYDROXYLASE, STRUCTURE HAS BOUND IRON (III) AND OXIDIZED COFACTOR 7,8-DIHYDROBIOPTERIN 1LTV ; 2.00 ; CRYSTAL STRUCTURE OF CHROMOBACTERIUM VIOLACEUM PHENYLALANINE HYDROXYLASE, STRUCTURE WITH BOUND OXIDIZED FE(III) 1LTU ; 1.74 ; CRYSTAL STRUCTURE OF CHROMOBACTERIUM VIOLACEUM, APO (NO IRON BOUND) STRUCTURE 1EYG ; 2.80 ; CRYSTAL STRUCTURE OF CHYMOTRYPTIC FRAGMENT OF E. COLI SSB BOUND TO TWO 35-MER SINGLE STRAND DNAS 1XO5 ; 1.99 ; CRYSTAL STRUCTURE OF CIB1, AN EF-HAND, INTEGRIN AND KINASE- BINDING PROTEIN 1SQK ; 2.50 ; CRYSTAL STRUCTURE OF CIBOULOT IN COMPLEX WITH SKELETAL ACTIN 1NTF ; 1.80 ; CRYSTAL STRUCTURE OF CIMEX NITROPHORIN 1SI6 ; 1.45 ; CRYSTAL STRUCTURE OF CIMEX NITROPHORIN COMPLEX WITH CO 1YJH ; 1.65 ; CRYSTAL STRUCTURE OF CIMEX NITROPHORIN FERROUS NO COMPLEX 1Y21 ; 1.75 ; CRYSTAL STRUCTURE OF CIMEX NITROPHORIN NO COMPLEX 1R8J ; 2.03 ; CRYSTAL STRUCTURE OF CIRCADIAN CLOCK PROTEIN KAIA FROM SYNECHOCOCCUS ELONGATUS 1TF7 ; 2.80 ; CRYSTAL STRUCTURE OF CIRCADIAN CLOCK PROTEIN KAIC 1U9I ; 2.80 ; CRYSTAL STRUCTURE OF CIRCADIAN CLOCK PROTEIN KAIC WITH PHOSPHORYLATION SITES 1UN2 ; 2.40 ; CRYSTAL STRUCTURE OF CIRCULARLY PERMUTED CPDSBA_Q100T99 PRESERVED GLOBAL FOLD AND LOCAL STRUCTURAL ADJUSTMENTS 1RPU ; 2.50 ; CRYSTAL STRUCTURE OF CIRV P19 BOUND TO SIRNA 1XTE ; 1.60 ; CRYSTAL STRUCTURE OF CISK-PX DOMAIN 1XTN ; 2.20 ; CRYSTAL STRUCTURE OF CISK-PX DOMAIN WITH SULFATES 1SGJ ; 1.84 ; CRYSTAL STRUCTURE OF CITRATE LYASE BETA SUBUNIT 1IOM ; 1.50 ; CRYSTAL STRUCTURE OF CITRATE SYNTHASE FROM THERMUS THERMOPHILUS HB8 1IXE ; 2.30 ; CRYSTAL STRUCTURE OF CITRATE SYNTHASE FROM THERMUS THERMOPHILUS HB8 1HUY ; 2.20 ; CRYSTAL STRUCTURE OF CITRINE, AN IMPROVED YELLOW VARIANT OF GREEN FLUORESCENT PROTEIN 1KKO ; 1.33 ; CRYSTAL STRUCTURE OF CITROBACTER AMALONATICUS METHYLASPARTATE AMMONIA LYASE 1KKR ; 2.10 ; CRYSTAL STRUCTURE OF CITROBACTER AMALONATICUS METHYLASPARTATE AMMONIA LYASE CONTAINING (2S,3S)-3- METHYLASPARTIC ACID 1Y4I ; 1.90 ; CRYSTAL STRUCTURE OF CITROBACTER FREUNDII L-METHIONINE-LYASE 1CFR ; 2.15 ; CRYSTAL STRUCTURE OF CITROBACTER FREUNDII RESTRICTION ENDONUCLEASE CFR10I AT 2.15 ANGSTROMS RESOLUTION. 1IYS ; 1.65 ; CRYSTAL STRUCTURE OF CLASS A BETA-LACTAMASE TOHO-1 1WE4 ; 1.70 ; CRYSTAL STRUCTURE OF CLASS A BETA-LACTAMASE TOHO-1 G238C MUTANT 1NP3 ; 2.00 ; CRYSTAL STRUCTURE OF CLASS I ACETOHYDROXY ACID ISOMEROREDUCTASE FROM PSEUDOMONAS AERUGINOSA 1DL2 ; 1.54 ; CRYSTAL STRUCTURE OF CLASS I ALPHA-1,2-MANNOSIDASE FROM SACCHAROMYCES CEREVISIAE AT 1.54 ANGSTROM RESOLUTION 1IRX ; 2.60 ; CRYSTAL STRUCTURE OF CLASS I LYSYL-TRNA SYNTHETASE 1I7T ; 2.80 ; CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1049-5V 1I7U ; 1.80 ; CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1049-6V 1I7R ; 2.20 ; CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1058 1ZT7 ; 3.00 ; CRYSTAL STRUCTURE OF CLASS I MHC H-2KK IN COMPLEX WITH A NONAPEPTIDE 1ZT1 ; 2.50 ; CRYSTAL STRUCTURE OF CLASS I MHC H-2KK IN COMPLEX WITH AN OCTAPEPTIDE 1LNU ; 2.50 ; CRYSTAL STRUCTURE OF CLASS II MHC MOLECULE IAB BOUND TO EALPHA3K PEPTIDE 1KT2 ; 2.80 ; CRYSTAL STRUCTURE OF CLASS II MHC MOLECULE IEK BOUND TO MOTH CYTOCHROME C PEPTIDE 1KTD ; 2.40 ; CRYSTAL STRUCTURE OF CLASS II MHC MOLECULE IEK BOUND TO PIGEON CYTOCHROME C PEPTIDE 1EKE ; 2.00 ; CRYSTAL STRUCTURE OF CLASS II RIBONUCLEASE H (RNASE HII) WITH MES LIGAND 1DS0 ; 1.63 ; CRYSTAL STRUCTURE OF CLAVAMINATE SYNTHASE 1DS1 ; 1.08 ; CRYSTAL STRUCTURE OF CLAVAMINATE SYNTHASE IN COMPLEX WITH FE(II) AND 2-OXOGLUTARATE 1DRY ; 1.40 ; CRYSTAL STRUCTURE OF CLAVAMINATE SYNTHASE IN COMPLEX WITH FE(II), 2-OXOGLUTARATE AND N-ALPHA-L-ACETYL ARGININE 1DRT ; 2.10 ; CRYSTAL STRUCTURE OF CLAVAMINATE SYNTHASE IN COMPLEX WITH FE(II), 2-OXOGLUTARATE AND PROCLAVAMINIC ACID 1GVG ; 1.54 ; CRYSTAL STRUCTURE OF CLAVAMINATE SYNTHASE WITH NITRIC OXIDE 2A49 ; 1.43 ; CRYSTAL STRUCTURE OF CLAVULANIC ACID BOUND TO E166A VARIANT OF SHV-1 BETA-LACTAMASE 1D5S ; 3.00 ; CRYSTAL STRUCTURE OF CLEAVED ANTITRYPSIN POLYMER 1LQ8 ; 2.40 ; CRYSTAL STRUCTURE OF CLEAVED PROTEIN C INHIBITOR 1YJN ; 3.00 ; CRYSTAL STRUCTURE OF CLINDAMYCIN BOUND TO THE G2099A MUTANT 50S RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI 2EU9 ; 1.53 ; CRYSTAL STRUCTURE OF CLK3 1F31 ; 2.60 ; CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH A TRISACCHARIDE 1G9B ; 2.00 ; CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH AN INHIBITOR (EXPERIMENT 1) 1G9D ; 2.20 ; CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH AN INHIBITOR (EXPERIMENT 2) 1G9A ; 2.10 ; CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH AN INHIBITOR (EXPERIMENT 3) 1G9C ; 2.35 ; CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH AN INHIBITOR (EXPERIMENT 4) 1I1E ; 2.50 ; CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH DOXORUBICIN 2A8A ; 2.00 ; CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN SEROTYPE F LIGHT CHAIN 1T3A ; 2.16 ; CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN TYPE E CATALYTIC DOMAIN 1NQJ ; 1.00 ; CRYSTAL STRUCTURE OF CLOSTRIDIUM HISTOLYTICUM COLG COLLAGENASE COLLAGEN-BINDING DOMAIN 3B AT 1.0 ANGSTROM RESOLUTION IN ABSENCE OF CALCIUM 1NQD ; 1.65 ; CRYSTAL STRUCTURE OF CLOSTRIDIUM HISTOLYTICUM COLG COLLAGENASE COLLAGEN-BINDING DOMAIN 3B AT 1.65 ANGSTROM RESOLUTION IN PRESENCE OF CALCIUM 1EPW ; 1.90 ; CRYSTAL STRUCTURE OF CLOSTRIDIUM NEUROTOXIN TYPE B 1K6K ; 1.80 ; CRYSTAL STRUCTURE OF CLPA, AN AAA+ CHAPERONE-LIKE REGULATOR OF CLPAP PROTEASE IMPLICATION TO THE FUNCTIONAL DIFFERENCE OF TWO ATPASE DOMAINS 1KSF ; 2.60 ; CRYSTAL STRUCTURE OF CLPA, AN HSP100 CHAPERONE AND REGULATOR OF CLPAP PROTEASE: STRUCTURAL BASIS OF DIFFERENCES IN FUNCTION OF THE TWO AAA+ ATPASE DOMAINS 1VH1 ; 2.60 ; CRYSTAL STRUCTURE OF CMP-KDO SYNTHETASE 1VH3 ; 2.70 ; CRYSTAL STRUCTURE OF CMP-KDO SYNTHETASE 1VIC ; 1.80 ; CRYSTAL STRUCTURE OF CMP-KDO SYNTHETASE 1JL7 ; 1.40 ; CRYSTAL STRUCTURE OF CN-LIGATED COMPONENT III GLYCERA DIBRANCHIATA MONOMERIC HEMOGLOBIN 1JL6 ; 1.40 ; CRYSTAL STRUCTURE OF CN-LIGATED COMPONENT IV GLYCERA DIBRANCHIATA MONOMERIC HEMOGLOBIN 1NWI ; 2.50 ; CRYSTAL STRUCTURE OF CO-HBI TRANSFORMED TO AN UNLIGATED STATE 1UGP ; 1.63 ; CRYSTAL STRUCTURE OF CO-TYPE NITRILE HYDRATASE COMPLEXED WITH N-BUTYRIC ACID 1IRE ; 1.80 ; CRYSTAL STRUCTURE OF CO-TYPE NITRILE HYDRATASE FROM PSEUDONOCARDIA THERMOPHILA 1BJ3 ; 2.60 ; CRYSTAL STRUCTURE OF COAGULATION FACTOR IX-BINDING PROTEIN (IX-BP) FROM VENOM OF HABU SNAKE WITH A HETERODIMER OF C- TYPE LECTIN DOMAINS 1IXX ; 2.50 ; CRYSTAL STRUCTURE OF COAGULATION FACTORS IX/X-BINDING PROTEIN (IX/X-BP) FROM VENOM OF HABU SNAKE WITH A HETERODIMER OF C-TYPE LECTIN DOMAINS 2BB3 ; 2.27 ; CRYSTAL STRUCTURE OF COBALAMIN BIOSYNTHESIS PRECORRIN-6Y METHYLASE (CBIE) FROM ARCHAEOGLOBUS FULGIDUS 1T7L ; 2.00 ; CRYSTAL STRUCTURE OF COBALAMIN-INDEPENDENT METHIONINE SYNTHASE FROM T. MARITIMA 1P24 ; 3.02 ; CRYSTAL STRUCTURE OF COBALT(II)-D(GGCGCC)2 1LFM ; 1.50 ; CRYSTAL STRUCTURE OF COBALT(III)-SUBSTITUTED CYTOCHROME C (TUNA) 1IQX ; 2.00 ; CRYSTAL STRUCTURE OF COBALT-SUBSTITUTED AMINE OXIDASE FROM ARTHROBACTER GLOBIFORMIS 1V6P ; 0.87 ; CRYSTAL STRUCTURE OF COBROTOXIN 1L4L ; 2.00 ; CRYSTAL STRUCTURE OF COBT COMPLEXED WITH 2,5- DIMETHYLANILINE AND NICOTINATE MONONUCLEOTIDE 1L4M ; 2.00 ; CRYSTAL STRUCTURE OF COBT COMPLEXED WITH 2-AMINO-P-CRESOL AND NICOTINATE MONONUCLEOTIDE 1L4N ; 2.00 ; CRYSTAL STRUCTURE OF COBT COMPLEXED WITH 2-AMINOPHENOL 1L4K ; 2.20 ; CRYSTAL STRUCTURE OF COBT COMPLEXED WITH 3,4- DIMETHYLANILINE AND NICOTINATE MONONUCLEOTIDE 1L5O ; 1.60 ; CRYSTAL STRUCTURE OF COBT COMPLEXED WITH 3,4-DIMETHYLPHENOL AND NICOTINATE MONONUCLEOTIDE 1L4G ; 2.10 ; CRYSTAL STRUCTURE OF COBT COMPLEXED WITH 4-METHYLCATECHOL AND NICOTINATE MONONUCLEOTIDE 1L5F ; 1.90 ; CRYSTAL STRUCTURE OF COBT COMPLEXED WITH BENZIMIDAZOLE 1L5N ; 1.90 ; CRYSTAL STRUCTURE OF COBT COMPLEXED WITH IMIDAZOLE 1L4H ; 2.10 ; CRYSTAL STRUCTURE OF COBT COMPLEXED WITH INDOLE AND NICOTINATE MONONUCLEOTIDE 1L5K ; 2.00 ; CRYSTAL STRUCTURE OF COBT COMPLEXED WITH N1-(5'- PHOSPHORIBOSYL)-BENZIMIDAZOLE AND NICOTINATE 1L5M ; 2.00 ; CRYSTAL STRUCTURE OF COBT COMPLEXED WITH N7-(5'- PHOSPHORIBOSYL)-2-AMINOPURINE AND NICOTINATE 1L5L ; 2.00 ; CRYSTAL STRUCTURE OF COBT COMPLEXED WITH N7-(5'- PHOSPHORIBOSYL)PURINE AND NICOTINATE 1J33 ; 2.00 ; CRYSTAL STRUCTURE OF COBT FROM THERMUS THERMOPHILUS HB8 1L4B ; 1.70 ; CRYSTAL STRUCTURE OF COBT IN APO STATE 1ZZB ; 2.30 ; CRYSTAL STRUCTURE OF COII HPPE IN COMPLEX WITH SUBSTRATE 1ZZC ; 1.80 ; CRYSTAL STRUCTURE OF COII HPPE IN COMPLEX WITH TRIS BUFFER 1V73 ; 1.82 ; CRYSTAL STRUCTURE OF COLD-ACTIVE PROTEIN-TYROSINE PHOSPHATASE OF A PSYCHROPHILE SHEWANELLA SP. 3EIP ; 1.80 ; CRYSTAL STRUCTURE OF COLICIN E3 IMMUNITY PROTEIN: AN INHIBITOR TO A RIBOSOME-INACTIVATING RNASE 1JCH ; 3.02 ; CRYSTAL STRUCTURE OF COLICIN E3 IN COMPLEX WITH ITS IMMUNITY PROTEIN 1EMV ; 1.70 ; CRYSTAL STRUCTURE OF COLICIN E9 DNASE DOMAIN WITH ITS COGNATE IMMUNITY PROTEIN IM9 (1.7 ANGSTROMS) 1T61 ; 1.50 ; CRYSTAL STRUCTURE OF COLLAGEN IV NC1 DOMAIN FROM PLACENTA BASEMENT MEMBRANE 456C ; 2.40 ; CRYSTAL STRUCTURE OF COLLAGENASE-3 (MMP-13) COMPLEXED TO A DIPHENYL-ETHER SULPHONE BASED HYDROXAMIC ACID 1D9K ; 3.20 ; CRYSTAL STRUCTURE OF COMPLEX BETWEEN D10 TCR AND PMHC I- AK/CA 1Z3G ; 3.30 ; CRYSTAL STRUCTURE OF COMPLEX BETWEEN PVS25 AND FAB FRAGMENT OF MALARIA TRANSMISSION BLOCKING ANTIBODY 2A8 1VBR ; 1.80 ; CRYSTAL STRUCTURE OF COMPLEX XYLANASE 10B FROM THERMOTOGA MARITIMA WITH XYLOBIOSE 1JF3 ; 1.40 ; CRYSTAL STRUCTURE OF COMPONENT III GLYCERA DIBRANCHIATA MONOMERIC HEMOGLOBIN 1JF4 ; 1.40 ; CRYSTAL STRUCTURE OF COMPONENT IV GLYCERA DIBRANCHIATA MONOMERIC HEMOGLOBIN 1CNV ; 1.65 ; CRYSTAL STRUCTURE OF CONCANAVALIN B AT 1.65 A RESOLUTION 2BJF ; 1.67 ; CRYSTAL STRUCTURE OF CONJUGATED BILE ACID HYDROLASE FROM CLOSTRIDIUM PERFRINGENS IN COMPLEX WITH REACTION PRODUCTS TAURINE AND DEOXYCHOLATE 2BJG ; 2.10 ; CRYSTAL STRUCTURE OF CONJUGATED BILE ACID HYDROLASE FROM CLOSTRIDIUM PERFRINGENS IN COMPLEX WITH REACTION PRODUCTS TAURINE AND DEOXYCHOLATE 1F9P ; 1.93 ; CRYSTAL STRUCTURE OF CONNECTIVE TISSUE ACTIVATING PEPTIDE- III(CTAP-III) COMPLEXED WITH POLYVINYLSULFONIC ACID 1TSJ ; 2.60 ; CRYSTAL STRUCTURE OF CONSERVED HYPOTHETICAL PROTEIN 1U05 ; 2.50 ; CRYSTAL STRUCTURE OF CONSERVED HYPOTHETICAL PROTEIN 1YQE ; 1.83 ; CRYSTAL STRUCTURE OF CONSERVED HYPOTHETICAL PROTEIN AF0625 1SFN ; 2.46 ; CRYSTAL STRUCTURE OF CONSERVED HYPOTHETICAL PROTEIN FROM DEINOCOCCUS RADIODURANS R1 1SEF ; 2.05 ; CRYSTAL STRUCTURE OF CONSERVED HYPOTHETICAL PROTEIN FROM ENTEROCOCCUS FAECALIS 1Z7A ; 1.71 ; CRYSTAL STRUCTURE OF CONSERVED HYPOTHETICAL PROTEIN FROM PSEUDOMONAS AERUGINOSA PAO1 1T07 ; 1.80 ; CRYSTAL STRUCTURE OF CONSERVED HYPOTHETICAL PROTEIN PA5148 FROM PSEUDOMONAS AERUGINOSA 1VKM ; 1.90 ; CRYSTAL STRUCTURE OF CONSERVED HYPOTHETICAL PROTEIN POSSIBLY INVOLVED IN CARBOHYDRATE METABOLISM (TM1464) FROM THERMOTOGA MARITIMA AT 1.90 A RESOLUTION 1RFE ; 2.00 ; CRYSTAL STRUCTURE OF CONSERVED HYPOTHETICAL PROTEIN RV2991 FROM MYCOBACTERIUM TUBERCULOSIS 1TLJ ; 2.80 ; CRYSTAL STRUCTURE OF CONSERVED HYPOTHETICAL PROTEIN SSO0622 FROM SULFOLOBUS SOLFATARICUS 2ESH ; 2.30 ; CRYSTAL STRUCTURE OF CONSERVED HYPOTHETICAL PROTEIN TM0937 1WWM ; 2.61 ; CRYSTAL STRUCTURE OF CONSERVED HYPOTHETICAL PROTEIN TT2028 FROM AN EXTREMELY THERMOPHILIC BACTERIUM THERMUS THERMOPHILUS HB8 1T62 ; 3.00 ; CRYSTAL STRUCTURE OF CONSERVED HYPOTHETICAL PROTEIN [GI:29377587] FROM ENTEROCOCCUS FAECALIS V583 2CWY ; 1.85 ; CRYSTAL STRUCTURE OF CONSERVED HYPOTHETICAL PROTEIN, TTHA0068 FROM THERMUS THERMOPHILUS HB8 1NOG ; 1.55 ; CRYSTAL STRUCTURE OF CONSERVED PROTEIN 0546 FROM THERMOPLASMA ACIDOPHILUM 2CWQ ; 1.90 ; CRYSTAL STRUCTURE OF CONSERVED PROTEIN TTHA0727 FROM THERMUS THERMOPHILUS HB8 1B3U ; 2.30 ; CRYSTAL STRUCTURE OF CONSTANT REGULATORY DOMAIN OF HUMAN PP2A, PR65ALPHA 1XNX ; 2.90 ; CRYSTAL STRUCTURE OF CONSTITUTIVE ANDROSTANE RECEPTOR 1IVV ; 2.10 ; CRYSTAL STRUCTURE OF COPPER AMINE OXIDASE FROM ARTHROBACTER GLOBIFORMIS: EARLY INTERMEDIATE IN TOPAQUINONE BIOGENESIS 1IVX ; 2.20 ; CRYSTAL STRUCTURE OF COPPER AMINE OXIDASE FROM ARTHROBACTER GLOBIFORMIS: HOLO FORM GENERATED BY BIOGENESIS IN CRYSTAL. 1IVU ; 1.90 ; CRYSTAL STRUCTURE OF COPPER AMINE OXIDASE FROM ARTHROBACTER GLOBIFORMIS: INITIAL INTERMEDIATE IN TOPAQUINONE BIOGENESIS 1IVW ; 1.80 ; CRYSTAL STRUCTURE OF COPPER AMINE OXIDASE FROM ARTHROBACTER GLOBIFORMIS: LATE INTERMEDIATE IN TOPAQUINONE BIOGENESIS 1CB4 ; 2.30 ; CRYSTAL STRUCTURE OF COPPER, ZINC SUPEROXIDE DISMUTASE 1ZMG ; 2.50 ; CRYSTAL STRUCTURE OF COPPER-BOUND ENGINEERED MALTOSE BINDING PROTEIN 1FEE ; 1.80 ; CRYSTAL STRUCTURE OF COPPER-HAH1 1TXN ; 1.70 ; CRYSTAL STRUCTURE OF COPROPORPHYRINOGEN III OXIDASE 1MOU ; 2.20 ; CRYSTAL STRUCTURE OF CORAL PIGMENT 1MOV ; 2.40 ; CRYSTAL STRUCTURE OF CORAL PROTEIN MUTANT 1GSK ; 1.70 ; CRYSTAL STRUCTURE OF COTA, AN ENDOSPORE COAT PROTEIN FROM BACILLUS SUBTILIS 1SMM ; 1.36 ; CRYSTAL STRUCTURE OF CP RD L41A MUTANT IN OXIDIZED STATE 1SMU ; 1.43 ; CRYSTAL STRUCTURE OF CP RD L41A MUTANT IN REDUCED STATE 1 (DROP-REDUCED) 1SMW ; 1.38 ; CRYSTAL STRUCTURE OF CP RD L41A MUTANT IN REDUCED STATE 2 (SOAKED) 1UHH ; 1.80 ; CRYSTAL STRUCTURE OF CP-AEQUORIN 1IY7 ; 2.00 ; CRYSTAL STRUCTURE OF CPA AND SULFAMIDE-BASED INHIBITOR COMPLEX 1MA7 ; 2.30 ; CRYSTAL STRUCTURE OF CRE SITE-SPECIFIC RECOMBINASE COMPLEXED WITH A MUTANT DEOXYRIBONUCLEIC ACID SUBSTRATE, LOXP-A8/T27 1I0E ; 3.50 ; CRYSTAL STRUCTURE OF CREATINE KINASE FROM HUMAN MUSCLE 1RL9 ; 1.45 ; CRYSTAL STRUCTURE OF CREATINE-ADP ARGININE KINASE TERNARY COMPLEX 1Q3K ; 2.10 ; CRYSTAL STRUCTURE OF CREATININE AMIDOHYDROLASE (CREATININASE) 1D1M ; 2.05 ; CRYSTAL STRUCTURE OF CRO K56-[DGEVK]-F58W MUTANT 1D1L ; 2.10 ; CRYSTAL STRUCTURE OF CRO-F58W MUTANT 1FZB ; 2.90 ; CRYSTAL STRUCTURE OF CROSSLINKED FRAGMENT D 1U9Q ; 2.30 ; CRYSTAL STRUCTURE OF CRUZAIN BOUND TO AN ALPHA-KETOESTER 1EWL ; 2.00 ; CRYSTAL STRUCTURE OF CRUZAIN BOUND TO WRR-99 1X9I ; 1.16 ; CRYSTAL STRUCTURE OF CRYSTAL STRUCTURE OF PHOSPHOGLUCOSE/PHOSPHOMANNOSE PHOSPHOGLUCOSE/PHOSPHOMANNOSEISOMERASE FROM PYROBACULUM AEROPHILUM IN COMPLEX WITH GLUCOSE 6-PHOSPHATE 1I29 ; 2.80 ; CRYSTAL STRUCTURE OF CSDB COMPLEXED WITH L-PROPARGYLGLYCINE 1TTU ; 2.85 ; CRYSTAL STRUCTURE OF CSL BOUND TO DEOXYRIBONUCLEIC ACID 1RCW ; 2.50 ; CRYSTAL STRUCTURE OF CT610 FROM CHLAMYDIA TRACHOMATIS 1MX3 ; 1.95 ; CRYSTAL STRUCTURE OF CTBP DEHYDROGENASE CORE HOLO FORM 1KV7 ; 1.40 ; CRYSTAL STRUCTURE OF CUEO, A MULTI-COPPER OXIDASE FROM E. COLI INVOLVED IN COPPER HOMEOSTASIS 1NAQ ; 1.70 ; CRYSTAL STRUCTURE OF CUTA1 FROM E.COLI AT 1.7 A RESOLUTION 1J2V ; 2.00 ; CRYSTAL STRUCTURE OF CUTA1 FROM PYROCOCCUS HORIKOSHII 1N2N ; 2.40 ; CRYSTAL STRUCTURE OF CYANIDE COMPLEX OF THE OXYGENASE DOMAIN OF INDUCIBLE NITRIC OXIDE SYNTHASE. 1D5L ; 1.90 ; CRYSTAL STRUCTURE OF CYANIDE-BOUND HUMAN MYELOPEROXIDASE ISOFORM C AT PH 5.5 1M5J ; 2.40 ; CRYSTAL STRUCTURE OF CYANOVIRIN-N COMPLEXED TO A SYNTHETIC HEXAMANNOSIDE 1M5M ; 2.50 ; CRYSTAL STRUCTURE OF CYANOVIRIN-N COMPLEXED TO OLIGOMANNOSE- 9 (MAN-9) 2B0R ; 2.60 ; CRYSTAL STRUCTURE OF CYCLASE-ASSOCIATED PROTEIN FROM CRYPTOSPORIDIUM PARVUM 1K6U ; 1.00 ; CRYSTAL STRUCTURE OF CYCLIC BOVINE PANCREATIC TRYPSIN INHIBITOR 1FSI ; 2.50 ; CRYSTAL STRUCTURE OF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE OF APPR>P FROM ARABIDOPSIS THALIANA 1C58 ; 0.99 ; CRYSTAL STRUCTURE OF CYCLOAMYLOSE 26 1UKQ ; 2.00 ; CRYSTAL STRUCTURE OF CYCLODEXTRIN GLUCANOTRANSFERASE COMPLEXED WITH A PSEUDO-MALTOTETRAOSE DERIVED FROM ACARBOSE 1I75 ; 2.00 ; CRYSTAL STRUCTURE OF CYCLODEXTRIN GLUCANOTRANSFERASE FROM ALKALOPHILIC BACILLUS SP.#1011 COMPLEXED WITH 1- DEOXYNOJIRIMYCIN 1Z81 ; 2.80 ; CRYSTAL STRUCTURE OF CYCLOPHILIN FROM PLASMODIUM YOELII. 1XO7 ; 1.61 ; CRYSTAL STRUCTURE OF CYCLOPHILLIN FROM TRYPANOSOMA CRUZI 1GLO ; 2.20 ; CRYSTAL STRUCTURE OF CYS25SER MUTANT OF HUMAN CATHEPSIN S 1C7N ; 1.90 ; CRYSTAL STRUCTURE OF CYSTALYSIN FROM TREPONEMA DENTICOLA CONTAINS A PYRIDOXAL 5'-PHOSPHATE COFACTOR 1C7O ; 2.50 ; CRYSTAL STRUCTURE OF CYSTALYSIN FROM TREPONEMA DENTICOLA CONTAINS A PYRIDOXAL 5'-PHOSPHATE-L-AMINOETHOXYVINYLGLYCINE COMPLEX 1IBJ ; 2.30 ; CRYSTAL STRUCTURE OF CYSTATHIONINE BETA-LYASE FROM ARABIDOPSIS THALIANA 1N8P ; 2.60 ; CRYSTAL STRUCTURE OF CYSTATHIONINE GAMMA-LYASE FROM YEAST 1AYW ; 2.40 ; CRYSTAL STRUCTURE OF CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT BENZYLOXYBENZOYLCARBOHYDRAZIDE INHIBITOR 1BGO ; 2.30 ; CRYSTAL STRUCTURE OF CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT PEPTIDOMIMETIC INHIBITOR 1AYU ; 2.20 ; CRYSTAL STRUCTURE OF CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT SYMMETRIC BISCARBOHYDRAZIDE INHIBITOR 1AYV ; 2.30 ; CRYSTAL STRUCTURE OF CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT THIAZOLHYDRAZIDE INHIBITOR 2BHS ; 2.67 ; CRYSTAL STRUCTURE OF CYSTEINE SYNTHASE B 1XT8 ; 2.00 ; CRYSTAL STRUCTURE OF CYSTEINE-BINDING PROTEIN FROM CAMPYLOBACTER JEJUNI AT 2.0 A RESOLUTION 1LI5 ; 2.30 ; CRYSTAL STRUCTURE OF CYSTEINYL-TRNA SYNTHETASE 1U0B ; 2.30 ; CRYSTAL STRUCTURE OF CYSTEINYL-TRNA SYNTHETASE BINARY COMPLEX WITH TRNACYS 1LI7 ; 2.60 ; CRYSTAL STRUCTURE OF CYSTEINYL-TRNA SYNTHETASE WITH CYSTEINE SUBSTRATE BOUND 1DBX ; 1.80 ; CRYSTAL STRUCTURE OF CYSTEINYL-TRNA(PRO) DEACYLASE FROM H. INFLUENZAE (HI1434) 1DBU ; 1.80 ; CRYSTAL STRUCTURE OF CYSTEINYL-TRNA(PRO) DEACYLASE PROTEIN FROM H. INFLUENZAE (HI1434) 1ALN ; 2.30 ; CRYSTAL STRUCTURE OF CYTIDINE DEAMINASE COMPLEXED WITH 3-DEAZACYTIDINE 1AF2 ; 2.30 ; CRYSTAL STRUCTURE OF CYTIDINE DEAMINASE COMPLEXED WITH URIDINE 1JTK ; 2.04 ; CRYSTAL STRUCTURE OF CYTIDINE DEAMINASE FROM BACILLUS SUBTILIS IN COMPLEX WITH THE INHIBITOR TETRAHYDRODEOXYURIDINE 1VF5 ; 3.00 ; CRYSTAL STRUCTURE OF CYTOCHROME B6F COMPLEX FROM M.LAMINOSUS 2D2C ; 3.80 ; CRYSTAL STRUCTURE OF CYTOCHROME B6F COMPLEX WITH DBMIB FROM M. LAMINOSUS 2B4Z ; 1.50 ; CRYSTAL STRUCTURE OF CYTOCHROME C FROM BOVINE HEART AT 1.5 A RESOLUTION. 1KXM ; 1.74 ; CRYSTAL STRUCTURE OF CYTOCHROME C PEROXIDASE WITH A PROPOSED ELECTRON TRANSFER PATHWAY EXCISED TO FORM A LIGAND BINDING CHANNEL. 1KXN ; 1.80 ; CRYSTAL STRUCTURE OF CYTOCHROME C PEROXIDASE WITH A PROPOSED ELECTRON TRANSFER PATHWAY EXCISED TO FORM A LIGAND BINDING CHANNEL. 1JAF ; 2.50 ; CRYSTAL STRUCTURE OF CYTOCHROME C' FROM RHODOCYCLUS GELATINOSUS AT 2.5 ANGSTOMS RESOLUTION 1VYD ; 2.30 ; CRYSTAL STRUCTURE OF CYTOCHROME C2 MUTANT G95E 1ETP ; 2.20 ; CRYSTAL STRUCTURE OF CYTOCHROME C4 FROM PSEUDOMONAS STUTZERI 1F1C ; 2.30 ; CRYSTAL STRUCTURE OF CYTOCHROME C549 1MZ4 ; 1.80 ; CRYSTAL STRUCTURE OF CYTOCHROME C550 FROM THERMOSYNECHOCOCCUS ELONGATUS 1CTJ ; 1.10 ; CRYSTAL STRUCTURE OF CYTOCHROME C6 1F1F ; 2.70 ; CRYSTAL STRUCTURE OF CYTOCHROME C6 FROM ARTHROSPIRA MAXIMA 1GDV ; 1.57 ; CRYSTAL STRUCTURE OF CYTOCHROME C6 FROM RED ALGA PORPHYRA YEZOENSIS AT 1.57 A RESOLUTION 1RF9 ; 8.00 ; CRYSTAL STRUCTURE OF CYTOCHROME P450-CAM WITH A FLUORESCENT PROBE D-4-AD (ADAMANTANE-1-CARBOXYLIC ACID-5-DIMETHYLAMINO- NAPHTHALENE-1-SULFONYLAMINO-BUTYL-AMIDE) 1LWL ; 2.20 ; CRYSTAL STRUCTURE OF CYTOCHROME P450-CAM WITH A FLUORESCENT PROBE D-8-AD (ADAMANTANE-1-CARBOXYLIC ACID-5-DIMETHYLAMINO- NAPHTHALENE-1-SULFONYLAMINO-OCTYL-AMIDE) 1RE9 ; 1.45 ; CRYSTAL STRUCTURE OF CYTOCHROME P450-CAM WITH A FLUORESCENT PROBE D-8-AD (ADAMANTANE-1-CARBOXYLIC ACID-5-DIMETHYLAMINO- NAPHTHALENE-1-SULFONYLAMINO-OCTYL-AMIDE) 1P2Y ; 2.30 ; CRYSTAL STRUCTURE OF CYTOCHROME P450CAM IN COMPLEX WITH (S)- (-)-NICOTINE 1C8J ; 2.10 ; CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F) 1J51 ; 2.20 ; CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/V247L/C334A) WITH 1,3,5-TRICHLOROBENZENE 1T2B ; 1.70 ; CRYSTAL STRUCTURE OF CYTOCHROME P450CIN COMPLEXED WITH ITS SUBSTRATE 1,8-CINEOLE 1URV ; 2.00 ; CRYSTAL STRUCTURE OF CYTOGLOBIN: THE FOURTH GLOBIN TYPE DISCOVERED IN MAN DISPLAYS HEME HEXA-COORDINATION 1UT0 ; 2.10 ; CRYSTAL STRUCTURE OF CYTOGLOBIN: THE FOURTH GLOBIN TYPE DISCOVERED IN MAN DISPLAYS HEME HEXA-COORDINATION 1LAY ; 2.50 ; CRYSTAL STRUCTURE OF CYTOMEGALOVIRUS PROTEASE 1YYP ; 2.50 ; CRYSTAL STRUCTURE OF CYTOMEGALOVIRUS UL44 BOUND TO C- TERMINAL PEPTIDE FROM CMV UL54 1U4E ; 2.09 ; CRYSTAL STRUCTURE OF CYTOPLASMIC DOMAINS OF GIRK1 CHANNEL 1U4F ; 2.41 ; CRYSTAL STRUCTURE OF CYTOPLASMIC DOMAINS OF IRK1 (KIR2.1) CHANNEL 1FBK ; 3.20 ; CRYSTAL STRUCTURE OF CYTOPLASMICALLY OPEN CONFORMATION OF BACTERIORHODOPSIN 2A2T ; 3.10 ; CRYSTAL STRUCTURE OF D(AAATATTT) 1BQJ ; 2.20 ; CRYSTAL STRUCTURE OF D(ACCCT) 1CN0 ; 2.20 ; CRYSTAL STRUCTURE OF D(ACCCT) 1UE4 ; 1.65 ; CRYSTAL STRUCTURE OF D(GCGAAAGC) 1UE3 ; 2.15 ; CRYSTAL STRUCTURE OF D(GCGAAAGC) CONTAINING HEXAAMMINECOBALT 1IXJ ; 2.50 ; CRYSTAL STRUCTURE OF D(GCGAAAGCT) CONTAINING PARALLEL- STRANDED DUPLEX WITH HOMO BASE PAIRS AND ANTI-PARALLEL DUPLEX WITH WATSON-CRICK BASE PAIRS 1UB8 ; 1.60 ; CRYSTAL STRUCTURE OF D(GCGAAGC), BENDING DUPLEX WITH A BULGE-IN RESIDUE 1UHX ; 2.00 ; CRYSTAL STRUCTURE OF D(GCGAGAGC): THE BASE-INTERCALATED DUPLEX 1V3P ; 2.30 ; CRYSTAL STRUCTURE OF D(GCGAGAGC): THE DEOXYRIBONUCLEIC ACID OCTAPLEX STRUCTURE WITH I-MOTIF OF G-QUARTET 1V3N ; 1.80 ; CRYSTAL STRUCTURE OF D(GCGAGAGC): THE DEOXYRIBONUCLEIC ACID QUADRUPLEX STRUCTURE SPLIT FROM THE OCTAPLEX 1V3O ; 1.70 ; CRYSTAL STRUCTURE OF D(GCGAGAGC): THE DEOXYRIBONUCLEIC ACID QUADRUPLEX STRUCTURE SPLIT FROM THE OCTAPLEX 1UHY ; 1.70 ; CRYSTAL STRUCTURE OF D(GCGATAGC): THE BASE-INTERCALATED DUPLEX 331D ; 1.65 ; CRYSTAL STRUCTURE OF D(GCGCGCG) WITH 5'-OVERHANG G'S 1UE2 ; 1.40 ; CRYSTAL STRUCTURE OF D(GI5CGAAAGCT) 1YGY ; 2.30 ; CRYSTAL STRUCTURE OF D-3-PHOSPHOGLYCERATE DEHYDROGENASE FROM MYCOBACTERIUM TUBERCULOSIS 1SKV ; 2.60 ; CRYSTAL STRUCTURE OF D-63 FROM SULFOLOBUS SPINDLE VIRUS 1 1RPJ ; 1.80 ; CRYSTAL STRUCTURE OF D-ALLOSE BINDING PROTEIN FROM ESCHERICHIA COLI 1C0I ; 1.90 ; CRYSTAL STRUCTURE OF D-AMINO ACID OXIDASE IN COMPLEX WITH TWO ANTHRANYLATE MOLECULES 1M7J ; 1.50 ; CRYSTAL STRUCTURE OF D-AMINOACYLASE DEFINES A NOVEL SUBSET OF AMIDOHYDROLASES 1RJP ; 1.80 ; CRYSTAL STRUCTURE OF D-AMINOACYLASE IN COMPLEX WITH 100MM CUCL2 1VFS ; 1.90 ; CRYSTAL STRUCTURE OF D-CYCLOSERINE-BOUND FORM OF ALANINE RACEMASE FROM D-CYCLOSERINE-PRODUCING STREPTOMYCES LAVENDULAE 1K1D ; 3.01 ; CRYSTAL STRUCTURE OF D-HYDANTOINASE 1F0X ; 1.90 ; CRYSTAL STRUCTURE OF D-LACTATE DEHYDROGENASE, A PERIPHERAL MEMBRANE RESPIRATORY ENZYME. 1LKZ ; 2.50 ; CRYSTAL STRUCTURE OF D-RIBOSE-5-PHOSPHATE ISOMERASE (RPIA) FROM ESCHERICHIA COLI. 1TQJ ; 1.60 ; CRYSTAL STRUCTURE OF D-RIBULOSE 5-PHOSPHATE 3-EPIMERASE FROM SYNECHOCYSTIS TO 1.6 ANGSTROM RESOLUTION 1NM1 ; 1.80 ; CRYSTAL STRUCTURE OF D. DICSOIDEUM ACTIN COMPLEXED WITH GELSOLIN SEGMENT 1 AND MG ATP AT 1.8 A RESOLUTION 1NMD ; 1.90 ; CRYSTAL STRUCTURE OF D. DISCOIDEUM ACTIN-GELSOLIN SEGMENT 1 COMPLEX CRYSTALLIZED IN PRESENCE OF LITHIUM ATP 1ZM7 ; 2.20 ; CRYSTAL STRUCTURE OF D. MELANOGASTER DEOXYRIBONUCLEOSIDE KINASE MUTANT N64D IN COMPLEX WITH DTTP 1ZMX ; 3.10 ; CRYSTAL STRUCTURE OF D. MELANOGASTER DEOXYRIBONUCLEOSIDE KINASE N64D MUTANT IN COMPLEX WITH THYMIDINE 1J6V ; 2.10 ; CRYSTAL STRUCTURE OF D. RADIODURANS LUXS, C2 1INN ; 1.80 ; CRYSTAL STRUCTURE OF D. RADIODURANS LUXS, P21 1CQS ; 1.90 ; CRYSTAL STRUCTURE OF D103E MUTANT WITH EQUILENINEOF KSI IN PSEUDOMONAS PUTIDA 1X08 ; 1.90 ; CRYSTAL STRUCTURE OF D26A MUTANT UPPS IN COMPLEX WITH MG, IPP AND FSPP 2EVT ; 1.99 ; CRYSTAL STRUCTURE OF D48V MUTANT OF HUMAN GLYCOLIPID TRANSFER PROTEIN 2B3E ; 1.36 ; CRYSTAL STRUCTURE OF DB819-D(CGCGAATTCGCG)2. 1SL5 ; 1.80 ; CRYSTAL STRUCTURE OF DC-SIGN CARBOHYDRATE RECOGNITION DOMAIN COMPLEXED WITH LNFP III (DEXTRA L504). 1SL4 ; 1.55 ; CRYSTAL STRUCTURE OF DC-SIGN CARBOHYDRATE RECOGNITION DOMAIN COMPLEXED WITH MAN4 1RU0 ; 1.60 ; CRYSTAL STRUCTURE OF DCOH2, A PARALOG OF DCOH, THE DIMERIZATION COFACTOR OF HNF-1 1Q67 ; 2.30 ; CRYSTAL STRUCTURE OF DCP1P 1D0G ; 2.40 ; CRYSTAL STRUCTURE OF DEATH RECEPTOR 5 (DR5) BOUND TO APO2L/TRAIL 1TSU ; 2.10 ; CRYSTAL STRUCTURE OF DECAMER NCP1 SUBSTRATE PEPTIDE IN COMPLEX WITH WILD-TYPE D25N HIV-1 PROTEASE VARIANT 1KY9 ; 2.80 ; CRYSTAL STRUCTURE OF DEGP (HTRA) 1VCW ; 3.05 ; CRYSTAL STRUCTURE OF DEGS AFTER BACKSOAKING THE ACTIVATING PEPTIDE 1SOZ ; 2.40 ; CRYSTAL STRUCTURE OF DEGS PROTEASE IN COMPLEX WITH AN ACTIVATING PEPTIDE 1DQS ; 1.80 ; CRYSTAL STRUCTURE OF DEHYDROQUINATE SYNTHASE (DHQS) COMPLEXED WITH CARBAPHOSPHONATE, NAD+ AND ZN2+ 1UJN ; 1.80 ; CRYSTAL STRUCTURE OF DEHYDROQUINATE SYNTHASE FROM THERMUS THERMOPHILUS HB8 2BHU ; 1.10 ; CRYSTAL STRUCTURE OF DEINOCOCCUS RADIODURANS MALTOOLIGOSYLTREHALOSE TREHALOHYDROLASE 2BHZ ; 1.20 ; CRYSTAL STRUCTURE OF DEINOCOCCUS RADIODURANS MALTOOLIGOSYLTREHALOSE TREHALOHYDROLASE IN COMPLEX WITH MALTOSE 2BHY ; 1.50 ; CRYSTAL STRUCTURE OF DEINOCOCCUS RADIODURANS MALTOOLIGOSYLTREHALOSE TREHALOHYDROLASE IN COMPLEX WITH TREHALOSE 2F4Q ; 1.75 ; CRYSTAL STRUCTURE OF DEINOCOCCUS RADIODURANS TOPOISOMERASE IB 2CWF ; 1.80 ; CRYSTAL STRUCTURE OF DELTA1-PIPERIDEINE-2-CARBOXYLATE REDUCTASE FROM PSEUDOMONAS SYRINGAE COMPLEXED WITH NADPH 2CWH ; 1.70 ; CRYSTAL STRUCTURE OF DELTA1-PIPERIDEINE-2-CARBOXYLATE REDUCTASE FROM PSEUDOMONAS SYRINGAE COMPLEXED WITH NADPH AND PYRROLE-2-CARBOXYLATE 1WTJ ; 1.55 ; CRYSTAL STRUCTURE OF DELTA1-PIPERIDEINE-2-CARBOXYLATE REDUCTASE FROM PSEUDOMONAS SYRINGAE PVAR.TOMATO 8CHO ; 2.30 ; CRYSTAL STRUCTURE OF DELTA5-3-KETOSTEROID ISOMERASE FROM PSEUDOMONAS TESTOSTERONI 1QJG ; 2.30 ; CRYSTAL STRUCTURE OF DELTA5-3-KETOSTEROID ISOMERASE FROM PSEUDOMONAS TESTOSTERONI IN COMPLEX WITH EQUILENIN 1XT9 ; 2.20 ; CRYSTAL STRUCTURE OF DEN1 IN COMPLEX WITH NEDD8 1BEF ; 2.10 ; CRYSTAL STRUCTURE OF DENGUE VIRUS NS3 SERINE PROTEASE 1J7S ; 2.20 ; CRYSTAL STRUCTURE OF DEOXY HBALPHAYQ, A MUTANT OF HBA 1J7W ; 2.00 ; CRYSTAL STRUCTURE OF DEOXY HBBETAYQ, A SITE DIRECTED MUTANT OF HBA 1F63 ; 1.80 ; CRYSTAL STRUCTURE OF DEOXY SPERM WHALE MYOGLOBIN MUTANT Y(B10)Q(E7)R(E10) 1R1Y ; 1.80 ; CRYSTAL STRUCTURE OF DEOXY-HUMAN HEMOGLOBIN BASSETT AT 1.8 ANGSTROM 6HBW ; 2.00 ; CRYSTAL STRUCTURE OF DEOXY-HUMAN HEMOGLOBIN BETA6 GLU->TRP 1NLF ; 1.95 ; CRYSTAL STRUCTURE OF DEOXYRIBONUCLEIC ACID HELICASE REPA IN COMPLEX WITH SULFATE AT 1.95 A RESOLUTION 1IQR ; 2.10 ; CRYSTAL STRUCTURE OF DEOXYRIBONUCLEIC ACID PHOTOLYASE FROM THERMUS THERMOPHILUS 1HUO ; 2.60 ; CRYSTAL STRUCTURE OF DEOXYRIBONUCLEIC ACID POLYMERASE BETA COMPLEXED WITH DEOXYRIBONUCLEIC ACID AND CR-TMPPCP 1HUZ ; 2.60 ; CRYSTAL STRUCTURE OF DEOXYRIBONUCLEIC ACID POLYMERASE COMPLEXED WITH DEOXYRIBONUCLEIC ACID AND CR-PCP 2AWA ; 2.50 ; CRYSTAL STRUCTURE OF DEOXYRIBONUCLEIC ACID POLYMERASE III, BETA CHAIN (EC 2.7.7.7) (NP_344555.1) FROM STREPTOCOCCUS PNEUMONIAE TIGR4 AT 2.50 A RESOLUTION 1VPK ; 2.00 ; CRYSTAL STRUCTURE OF DEOXYRIBONUCLEIC ACID POLYMERASE III, BETA SUBUNIT (TM0262) FROM THERMOTOGA MARITIMA AT 2.00 A RESOLUTION 1RZT ; 2.10 ; CRYSTAL STRUCTURE OF DEOXYRIBONUCLEIC ACID POLYMERASE LAMBDA COMPLEXED WITH A TWO NUCLEOTIDE GAP DEOXYRIBONUCLEIC ACID MOLECULE 1V33 ; 1.80 ; CRYSTAL STRUCTURE OF DEOXYRIBONUCLEIC ACID PRIMASE FROM PYROCOCCUS HORIKOSHII 1L8Q ; 2.70 ; CRYSTAL STRUCTURE OF DEOXYRIBONUCLEIC ACID REPLICATION INITIATION FACTOR 1EV7 ; 2.38 ; CRYSTAL STRUCTURE OF DEOXYRIBONUCLEIC ACID RESTRICTION ENDONUCLEASE NAEI 1D8X ; 1.20 ; CRYSTAL STRUCTURE OF DEOXYRIBONUCLEIC ACID SHEARED TANDEM G A BASE PAIRS 1D9R ; 1.50 ; CRYSTAL STRUCTURE OF DEOXYRIBONUCLEIC ACID SHEARED TANDEM G-A BASE PAIRS 1DCR ; 1.60 ; CRYSTAL STRUCTURE OF DEOXYRIBONUCLEIC ACID SHEARED TANDEM G-A BASE PAIRS 1O0Y ; 1.90 ; CRYSTAL STRUCTURE OF DEOXYRIBOSE-PHOSPHATE ALDOLASE (TM1559) FROM THERMOTOGA MARITIMA AT 1.9 A RESOLUTION 1VIY ; 1.89 ; CRYSTAL STRUCTURE OF DEPHOSPHO-COA KINASE 1VHL ; 1.65 ; CRYSTAL STRUCTURE OF DEPHOSPHO-COA KINASE WITH ADENOSINE-5'- DIPHOSPHATE 1VHT ; 1.59 ; CRYSTAL STRUCTURE OF DEPHOSPHO-COA KINASE WITH BIS(ADENOSINE)-5'-TRIPHOSPHATE 1N3B ; 1.80 ; CRYSTAL STRUCTURE OF DEPHOSPHOCOENZYME A KINASE FROM ESCHERICHIA COLI 1CQJ ; 2.90 ; CRYSTAL STRUCTURE OF DEPHOSPHORYLATED E. COLI SUCCINYL-COA SYNTHETASE 1EUC ; 2.10 ; CRYSTAL STRUCTURE OF DEPHOSPHORYLATED PIG HEART, GTP- SPECIFIC SUCCINYL-COA SYNTHETASE 1K94 ; 1.70 ; CRYSTAL STRUCTURE OF DES(1-52)GRANCALCIN WITH BOUND CALCIUM 1K95 ; 1.90 ; CRYSTAL STRUCTURE OF DES(1-52)GRANCALCIN WITH BOUND CALCIUM 1R66 ; 1.44 ; CRYSTAL STRUCTURE OF DESIV (DTDP-GLUCOSE 4,6-DEHYDRATASE) FROM STREPTOMYCES VENEZUELAE WITH NAD AND TYD BOUND 1R6D ; 1.35 ; CRYSTAL STRUCTURE OF DESIV DOUBLE MUTANT (DTDP-GLUCOSE 4,6- DEHYDRATASE) FROM STREPTOMYCES VENEZUELAE WITH NAD AND DAU BOUND 1HTV ; 1.90 ; CRYSTAL STRUCTURE OF DESTRIPEPTIDE (B28-B30) INSULIN 1DXG ; 1.80 ; CRYSTAL STRUCTURE OF DESULFOREDOXIN FROM DESULFOVIBRIO GIGAS AT 1.8 A RESOLUTION 1LKO ; 1.63 ; CRYSTAL STRUCTURE OF DESULFOVIBRIO VULGARIS RUBRERYTHRIN ALL-IRON(II) FORM 1LKP ; 1.64 ; CRYSTAL STRUCTURE OF DESULFOVIBRIO VULGARIS RUBRERYTHRIN ALL-IRON(II) FORM, AZIDE ADDUCT 1LKM ; 1.69 ; CRYSTAL STRUCTURE OF DESULFOVIBRIO VULGARIS RUBRERYTHRIN ALL-IRON(III) FORM 1Y89 ; 2.00 ; CRYSTAL STRUCTURE OF DEVB PROTEIN 1E1A ; 1.80 ; CRYSTAL STRUCTURE OF DFPASE FROM LOLIGO VULGARIS 1MDF ; 2.50 ; CRYSTAL STRUCTURE OF DHBE IN ABSENCE OF SUBSTRATE 1MD9 ; 2.80 ; CRYSTAL STRUCTURE OF DHBE IN COMPLEX WITH DHB AND AMP 1MDB ; 2.15 ; CRYSTAL STRUCTURE OF DHBE IN COMPLEX WITH DHB-ADENYLATE 1QZF ; 2.80 ; CRYSTAL STRUCTURE OF DHFR-TS FROM CRYPTOSPORIDIUM HOMINIS 1IQC ; 1.80 ; CRYSTAL STRUCTURE OF DI-HEME PEROXIDASE FROM NITROSOMONAS EUROPAEA 1KNW ; 2.10 ; CRYSTAL STRUCTURE OF DIAMINOPIMELATE DECARBOXYLASE 1TUF ; 2.40 ; CRYSTAL STRUCTURE OF DIAMINOPIMELATE DECARBOXYLASE FROM M. JANNASCHI 1TWI ; 2.00 ; CRYSTAL STRUCTURE OF DIAMINOPIMELATE DECARBOXYLASE FROM M. JANNASCHII IN CO-COMPLEX WITH L-LYSINE 1SE0 ; 1.75 ; CRYSTAL STRUCTURE OF DIAP1 BIR1 BOUND TO A GRIM PEPTIDE 1SDZ ; 1.78 ; CRYSTAL STRUCTURE OF DIAP1 BIR1 BOUND TO A REAPER PEPTIDE 1JD4 ; 2.70 ; CRYSTAL STRUCTURE OF DIAP1-BIR2 1JD5 ; 1.90 ; CRYSTAL STRUCTURE OF DIAP1-BIR2/GRIM 1JD6 ; 2.70 ; CRYSTAL STRUCTURE OF DIAP1-BIR2/HID COMPLEX 1PXX ; 2.90 ; CRYSTAL STRUCTURE OF DICLOFENAC BOUND TO THE CYCLOOXYGENASE ACTIVE SITE OF COX-2 1C0F ; 2.40 ; CRYSTAL STRUCTURE OF DICTYOSTELIUM CAATP-ACTIN IN COMPLEX WITH GELSOLIN SEGMENT 1 1NLV ; 1.80 ; CRYSTAL STRUCTURE OF DICTYOSTELIUM DISCOIDEUM ACTIN COMPLEXED WITH CA ATP AND HUMAN GELSOLIN SEGMENT 1 1YKQ ; 3.50 ; CRYSTAL STRUCTURE OF DIELS-ALDER RIBOZYME 1FE2 ; 3.00 ; CRYSTAL STRUCTURE OF DIHOMO-GAMMA-LINOLEIC ACID BOUND IN THE CYCLOOXYGENASE CHANNEL OF PROSTAGLANDIN ENDOPEROXIDE H SYNTHASE-1. 1VM6 ; 2.27 ; CRYSTAL STRUCTURE OF DIHYDRODIPICOLINATE REDUCTASE (TM1520) FROM THERMOTOGA MARITIMA AT 2.27 A RESOLUTION 1O5K ; 1.80 ; CRYSTAL STRUCTURE OF DIHYDRODIPICOLINATE SYNTHASE (TM1521) FROM THERMOTOGA MARITIMA AT 1.80 A RESOLUTION 1XKY ; 1.94 ; CRYSTAL STRUCTURE OF DIHYDRODIPICOLINATE SYNTHASE DAPA-2 (BA3935) FROM BACILLUS ANTHRACIS AT 1.94A RESOLUTION. 1XL9 ; 2.23 ; CRYSTAL STRUCTURE OF DIHYDRODIPICOLINATE SYNTHASE DAPA-2 (BA3935) FROM BACILLUS ANTHRACIS. 1SEJ ; 2.87 ; CRYSTAL STRUCTURE OF DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE FROM CRYPTOSPORIDIUM HOMINIS BOUND TO 1843U89/NADPH/DUMP 1K8C ; 2.10 ; CRYSTAL STRUCTURE OF DIMERIC XYLOSE REDUCTASE IN COMPLEX WITH NADP(H) 1JB6 ; 1.70 ; CRYSTAL STRUCTURE OF DIMERIZATION DOMAIN (1-33) OF HNF- 1ALPHA 1PJ5 ; 1.61 ; CRYSTAL STRUCTURE OF DIMETHYLGLYCINE OXIDASE OF ARTHROBACTER GLOBIFORMIS IN COMPLEX WITH ACETATE 1PJ6 ; 1.65 ; CRYSTAL STRUCTURE OF DIMETHYLGLYCINE OXIDASE OF ARTHROBACTER GLOBIFORMIS IN COMPLEX WITH FOLIC ACID 1K1S ; 2.80 ; CRYSTAL STRUCTURE OF DINB FROM SULFOLOBUS SOLFATARICUS 1H9P ; 2.00 ; CRYSTAL STRUCTURE OF DIOCLEA GUIANENSIS SEED LECTIN 1IWB ; 1.85 ; CRYSTAL STRUCTURE OF DIOL DEHYDRATASE 1EGM ; 1.85 ; CRYSTAL STRUCTURE OF DIOL DEHYDRATASE-CYANOCOBALAMIN COMPLEX AT 100K. 1WN1 ; 2.25 ; CRYSTAL STRUCTURE OF DIPEPTIASE FROM PYROCOCCUS HORIKOSHII OT3 1W1I ; 3.03 ; CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE IV (DPPIV OR CD26) IN COMPLEX WITH ADENOSINE DEAMINASE 1VHV ; 1.75 ; CRYSTAL STRUCTURE OF DIPHTHINE SYNTHASE 2ERX ; 1.65 ; CRYSTAL STRUCTURE OF DIRAS2 IN COMPLEX WITH GDP AND INORGANIC PHOSPHATE 1Y6P ; 2.25 ; CRYSTAL STRUCTURE OF DISULFIDE ENGINEERED PORCINE PANCRATIC PHOSPHOLIPASE A2 TO GROUP-X ISOZYME 1Y6O ; 2.00 ; CRYSTAL STRUCTURE OF DISULFIDE ENGINEERED PORCINE PANCREATIC PHOSPHOLIPASE A2 TO GROUP-X ISOZYME IN COMPLEX WITH INHIBITOR MJ33 AND PHOSPHATE IONS 1PS4 ; 1.60 ; CRYSTAL STRUCTURE OF DJ-1 1Q2U ; 1.60 ; CRYSTAL STRUCTURE OF DJ-1/RS AND IMPLICATION ON FAMILIAL PARKINSON'S DISEASE 1WLZ ; 1.60 ; CRYSTAL STRUCTURE OF DJBP FRAGMENT WHICH WAS OBTAINED BY LIMITED PROTEOLYSIS 1J1V ; 2.10 ; CRYSTAL STRUCTURE OF DNAA DOMAINIV COMPLEXED WITH DNAABOX DEOXYRIBONUCLEIC ACID 1SBZ ; 2.00 ; CRYSTAL STRUCTURE OF DODECAMERIC FMN-DEPENDENT UBIX-LIKE DECARBOXYLASE FROM ESCHERICHIA COLI O157:H7 1K8Q ; 2.70 ; CRYSTAL STRUCTURE OF DOG GASTRIC LIPASE IN COMPLEX WITH A PHOSPHONATE INHIBITOR 1P5T ; 2.35 ; CRYSTAL STRUCTURE OF DOK1 PTB DOMAIN 1UEF ; 2.50 ; CRYSTAL STRUCTURE OF DOK1 PTB DOMAIN COMPLEX 1EJ8 ; 1.55 ; CRYSTAL STRUCTURE OF DOMAIN 2 OF THE YEAST COPPER CHAPERONE FOR SUPEROXIDE DISMUTASE (LYS7) AT 1.55 A RESOLUTION 353D ; 2.40 ; CRYSTAL STRUCTURE OF DOMAIN A OF THERMUS FLAVUS 5S RRNA AND THE CONTRIBUTION OF WATER MOLECULES TO ITS STRUCTURE 361D ; 3.00 ; CRYSTAL STRUCTURE OF DOMAIN E OF THERMUS FLAVUS 5S RRNA: A HELICAL RIBONUCLEIC ACID-STRUCTURE INCLUDING A TETRALOOP 1MI7 ; 2.50 ; CRYSTAL STRUCTURE OF DOMAIN SWAPPED TRP APOREPRESSOR IN 30%(V/V) ISOPROPANOL 1JS6 ; 2.60 ; CRYSTAL STRUCTURE OF DOPA DECARBOXYLASE 1JS3 ; 2.25 ; CRYSTAL STRUCTURE OF DOPA DECARBOXYLASE IN COMPLEX WITH THE INHIBITOR CARBIDOPA 1KEB ; 1.80 ; CRYSTAL STRUCTURE OF DOUBLE MUTANT M37L,P40S E.COLI THIOREDOXIN 1TDW ; 2.10 ; CRYSTAL STRUCTURE OF DOUBLE TRUNCATED HUMAN PHENYLALANINE HYDROXYLASE BH4-RESPONSIVE PKU MUTANT A313T. 1DMW ; 2.00 ; CRYSTAL STRUCTURE OF DOUBLE TRUNCATED HUMAN PHENYLALANINE HYDROXYLASE WITH BOUND 7,8-DIHYDRO-L-BIOPTERIN 1UMN ; 1.95 ; CRYSTAL STRUCTURE OF DPS-LIKE PEROXIDE RESISTANCE PROTEIN (DPR) FROM STREPTOCOCCUS SUIS 1J36 ; 2.40 ; CRYSTAL STRUCTURE OF DROSOPHILA ANCE 1J37 ; 2.40 ; CRYSTAL STRUCTURE OF DROSOPHILA ANCE 1J38 ; 2.60 ; CRYSTAL STRUCTURE OF DROSOPHILA ANCE 1J90 ; 2.56 ; CRYSTAL STRUCTURE OF DROSOPHILA DEOXYRIBONUCLEOSIDE KINASE 1OE0 ; 2.40 ; CRYSTAL STRUCTURE OF DROSOPHILA DEOXYRIBONUCLEOSIDE KINASE IN COMPLEX WITH DTTP 1OT3 ; 2.50 ; CRYSTAL STRUCTURE OF DROSOPHILA DEOXYRIBONUCLEOTIDE KINASE COMPLEXED WITH THE SUBSTRATE DEOXYTHYMIDINE 1MG5 ; 1.63 ; CRYSTAL STRUCTURE OF DROSOPHILA MELANOGASTER ALCOHOL DEHYDROGENASE COMPLEXED WITH NADH AND ACETATE AT 1.6 A 1JPE ; 1.90 ; CRYSTAL STRUCTURE OF DSBD-ALPHA; THE N-TERMINAL DOMAIN OF DSBD 1UC7 ; 1.90 ; CRYSTAL STRUCTURE OF DSBDGAMMA 1I8K ; 1.80 ; CRYSTAL STRUCTURE OF DSFV MR1 IN COMPLEX WITH THE PEPTIDE ANTIGEN OF THE MUTANT EPIDERMAL GROWTH FACTOR RECEPTOR, EGFRVIII, AT LIQUID NITROGEN TEMPERATURE 1I8I ; 2.40 ; CRYSTAL STRUCTURE OF DSFV MR1 IN COMPLEX WITH THE PEPTIDE ANTIGEN OF THE MUTANT EPIDERMAL GROWTH FACTOR RECEPTOR, EGFRVIII, AT ROOM TEMPERATURE 1G7K ; 2.00 ; CRYSTAL STRUCTURE OF DSRED, A RED FLUORESCENT PROTEIN FROM DISCOSOMA SP. RED 1WLT ; 1.90 ; CRYSTAL STRUCTURE OF DTDP-4-DEHYDRORHAMNOSE 3,5-EPIMERASE HOMOLOGUE FROM SULFOLOBUS TOKODAII 1VL0 ; 2.05 ; CRYSTAL STRUCTURE OF DTDP-4-DEHYDRORHAMNOSE REDUCTASE, RFBD ORTHOLOG (CAC2315) FROM CLOSTRIDIUM ACETOBUTYLICUM AT 2.05 A RESOLUTION 1EPZ ; 1.75 ; CRYSTAL STRUCTURE OF DTDP-6-DEOXY-D-XYLO-4-HEXULOASE 3,5- EPIMERASE FROM METHANOBACTERIUM THERMOAUTOTROPHICUM WITH BOUND LIGAND. 1N2S ; 2.00 ; CRYSTAL STRUCTURE OF DTDP-6-DEOXY-L-LYXO-4-HEXULOSE REDUCTASE (RMLD) IN COMPLEX WITH NADH 1KC1 ; 2.60 ; CRYSTAL STRUCTURE OF DTDP-6-DEOXY-L-LYXO-4-HEXULOSE REDUCTASE (RMLD) IN COMPLEX WITH NADPH 1KC3 ; 2.70 ; CRYSTAL STRUCTURE OF DTDP-6-DEOXY-L-LYXO-4-HEXULOSE REDUCTASE (RMLD) IN COMPLEX WITH NADPH AND DTDP-L-RHAMNOSE 1YZ4 ; 2.40 ; CRYSTAL STRUCTURE OF DUSP15 1RN8 ; 1.93 ; CRYSTAL STRUCTURE OF DUTPASE COMPLEXED WITH SUBSTRATE ANALOGUE IMIDO-DUTP 1MQ7 ; 1.95 ; CRYSTAL STRUCTURE OF DUTPASE FROM MYCOBACTERIUM TUBERCULOSIS (RV2697C) 1Q0L ; 2.65 ; CRYSTAL STRUCTURE OF DXR IN COMPLEX WITH FOSMIDOMYCIN 1Q0Q ; 1.90 ; CRYSTAL STRUCTURE OF DXR IN COMPLEX WITH THE SUBSTRATE 1- DEOXY-D-XYLULOSE-5-PHOSPHATE 1C14 ; 2.00 ; CRYSTAL STRUCTURE OF E COLI ENOYL REDUCTASE-NAD+-TRICLOSAN COMPLEX 1G1T ; 1.50 ; CRYSTAL STRUCTURE OF E-SELECTIN LECTIN/EGF DOMAINS COMPLEXED WITH SLEX 1KZN ; 2.30 ; CRYSTAL STRUCTURE OF E. COLI 24KDA DOMAIN IN COMPLEX WITH CLOROBIOCIN 1DIZ ; 2.50 ; CRYSTAL STRUCTURE OF E. COLI 3-METHYLADENINE DEOXYRIBONUCLEIC ACID GLYCOSYLASE (ALKA) COMPLEXED WITH DEOXYRIBONUCLEIC ACID 2BH2 ; 2.15 ; CRYSTAL STRUCTURE OF E. COLI 5-METHYLURIDINE METHYLTRANSFERASE RUMA IN COMPLEX WITH RIBOSOMAL RIBONUCLEIC ACID SUBSTRATE AND S-ADENOSYLHOMOCYSTEINE. 1L5J ; 2.40 ; CRYSTAL STRUCTURE OF E. COLI ACONITASE B. 1D6U ; 2.40 ; CRYSTAL STRUCTURE OF E. COLI AMINE OXIDASE ANAEROBICALLY REDUCED WITH BETA-PHENYLETHYLAMINE 1LVN ; 2.40 ; CRYSTAL STRUCTURE OF E. COLI AMINE OXIDASE COMPLEXED WITH TRANYLCYPROMINE 1T8R ; 2.70 ; CRYSTAL STRUCTURE OF E. COLI AMP NUCLEOSIDASE 1T8W ; 2.80 ; CRYSTAL STRUCTURE OF E. COLI AMP NUCLEOSIDASE 1K97 ; 2.00 ; CRYSTAL STRUCTURE OF E. COLI ARGININOSUCCINATE SYNTHETASE IN COMPLEX WITH ASPARTATE AND CITRULLINE 1KP2 ; 2.00 ; CRYSTAL STRUCTURE OF E. COLI ARGININOSUCCINATE SYNTHETASE IN COMPLEX WITH ATP 1KP3 ; 2.00 ; CRYSTAL STRUCTURE OF E. COLI ARGININOSUCCINATE SYNTHETASE IN COMPLEX WITH ATP AND CITRULLINE 1U9J ; 2.40 ; CRYSTAL STRUCTURE OF E. COLI ARNA (PMRI) DECARBOXYLASE DOMAIN 1Z73 ; 2.50 ; CRYSTAL STRUCTURE OF E. COLI ARNA DEHYDROGENASE (DECARBOXYLASE) DOMAIN, S433A MUTANT 1F1B ; 2.30 ; CRYSTAL STRUCTURE OF E. COLI ASPARTATE TRANSCARBAMOYLASE P268A MUTANT IN THE R-STATE IN THE PRESENCE OF N- PHOSPHONACETYL-L-ASPARTATE 1EZZ ; 2.70 ; CRYSTAL STRUCTURE OF E. COLI ASPARTATE TRANSCARBAMOYLASE P268A MUTANT IN THE T-STATE 1I6O ; 2.20 ; CRYSTAL STRUCTURE OF E. COLI BETA CARBONIC ANHYDRASE 1I6P ; 2.00 ; CRYSTAL STRUCTURE OF E. COLI BETA CARBONIC ANHYDRASE 1HXD ; 2.40 ; CRYSTAL STRUCTURE OF E. COLI BIOTIN REPRESSOR WITH BOUND BIOTIN 1T36 ; 2.10 ; CRYSTAL STRUCTURE OF E. COLI CARBAMOYL PHOSPHATE SYNTHETASE SMALL SUBUNIT MUTANT C248D COMPLEXED WITH URIDINE 5'- MONOPHOSPHATE 1D6Y ; 2.40 ; CRYSTAL STRUCTURE OF E. COLI COPPER-CONTAINING AMINE OXIDASE ANAEROBICALLY REDUCED WITH BETA-PHENYLETHYLAMINE AND COMPLEXED WITH NITRIC OXIDE. 1S1M ; 2.30 ; CRYSTAL STRUCTURE OF E. COLI CTP SYNTHETASE 1D6M ; 3.00 ; CRYSTAL STRUCTURE OF E. COLI DEOXYRIBONUCLEIC ACID TOPOISOMERASE III 1SEH ; 1.47 ; CRYSTAL STRUCTURE OF E. COLI DUTPASE COMPLEXED WITH THE PRODUCT DUMP 1QG6 ; 1.90 ; CRYSTAL STRUCTURE OF E. COLI ENOYL ACYL CARRIER PROTEIN REDUCTASE IN COMPLEX WITH NAD AND TRICLOSAN 1LXC ; 2.40 ; CRYSTAL STRUCTURE OF E. COLI ENOYL REDUCTASE-NAD+ WITH A BOUND ACRYLAMIDE INHIBITOR 1LX6 ; 2.40 ; CRYSTAL STRUCTURE OF E. COLI ENOYL REDUCTASE-NAD+ WITH A BOUND BENZAMIDE INHIBITOR 1FW4 ; 1.70 ; CRYSTAL STRUCTURE OF E. COLI FRAGMENT TR2C FROM CALMODULIN TO 1.7 A RESOLUTION 1SZ2 ; 2.20 ; CRYSTAL STRUCTURE OF E. COLI GLUCOKINASE IN COMPLEX WITH GLUCOSE 2BZ0 ; 2.60 ; CRYSTAL STRUCTURE OF E. COLI GTP CYCLOHYDROLASE II IN COMPLEX WITH GTP ANALOGUE, GMPCPP, AND ZINC 1NXU ; 1.80 ; CRYSTAL STRUCTURE OF E. COLI HYPOTHETICAL OXIDOREDUCTASE YIAK NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET ER82. 1SEO ; 1.90 ; CRYSTAL STRUCTURE OF E. COLI ISOASPARTYL AMINOPEPTIDASE IN COMPLEX WITH L-ASPARTATE 2AQO ; 1.95 ; CRYSTAL STRUCTURE OF E. COLI ISOASPARTYL DIPEPTIDASE MUTANT E77Q 2AQV ; 1.95 ; CRYSTAL STRUCTURE OF E. COLI ISOASPARTYL DIPEPTIDASE MUTANT Y137F 1O89 ; 2.25 ; CRYSTAL STRUCTURE OF E. COLI K-12 YHDH 1O8C ; 2.60 ; CRYSTAL STRUCTURE OF E. COLI K-12 YHDH WITH BOUND NADPH 1JRL ; 1.95 ; CRYSTAL STRUCTURE OF E. COLI LYSOPHOSPHOLIASE L1/ACYL-COA THIOESTERASE I/PROTEASE I L109P MUTANT 1Q1B ; 2.80 ; CRYSTAL STRUCTURE OF E. COLI MALK IN THE NUCLEOTIDE-FREE FORM 1D5N ; 1.55 ; CRYSTAL STRUCTURE OF E. COLI MNSOD AT 100K 1JYS ; 1.90 ; CRYSTAL STRUCTURE OF E. COLI MTA/ADOHCY NUCLEOSIDASE 1NC1 ; 2.00 ; CRYSTAL STRUCTURE OF E. COLI MTA/ADOHCY NUCLEOSIDASE COMPLEXED WITH 5'-METHYLTHIOTUBERCIDIN (MTH) 1NC3 ; 2.20 ; CRYSTAL STRUCTURE OF E. COLI MTA/ADOHCY NUCLEOSIDASE COMPLEXED WITH FORMYCIN A (FMA) 1K4K ; 2.00 ; CRYSTAL STRUCTURE OF E. COLI NICOTINIC ACID MONONUCLEOTIDE ADENYLYLTRANSFERASE 1DUV ; 1.70 ; CRYSTAL STRUCTURE OF E. COLI ORNITHINE TRANSCARBAMOYLASE COMPLEXED WITH NDELTA-L-ORNITHINE-DIAMINOPHOSPHINYL-N- SULPHONIC ACID (PSORN) 1QWI ; 1.80 ; CRYSTAL STRUCTURE OF E. COLI OSMC 1SQ5 ; 2.20 ; CRYSTAL STRUCTURE OF E. COLI PANTOTHENATE KINASE 1DJ8 ; 2.00 ; CRYSTAL STRUCTURE OF E. COLI PERIPLASMIC PROTEIN HDEA 2AB0 ; 1.10 ; CRYSTAL STRUCTURE OF E. COLI PROTEIN YAJL (THIJ) 1QYA ; 2.00 ; CRYSTAL STRUCTURE OF E. COLI PROTEIN YDDE 1QCZ ; 1.50 ; CRYSTAL STRUCTURE OF E. COLI PURE, AN UNUSUAL MUTASE THAT CATALYZES THE CONVERSION OF N5-CARBOXYAMINOIMIDAZOLE RIBONUCLEOTIDE (N5-CAIR) TO 4-CARBOXYAMINOIMIDAZOLE RIBONUCLEOTIDE (CAIR) IN THE PURINE BIOSYNTHETIC PATHWAY 1D7A ; 2.50 ; CRYSTAL STRUCTURE OF E. COLI PURE-MONONUCLEOTIDE COMPLEX. 1PKE ; 2.30 ; CRYSTAL STRUCTURE OF E. COLI PURINE NUCLEOSIDE PHOSPHORYLASE COMPLEXED WITH 2-FLUORO-2'-DEOXYADENOSINE AND SULFATE/PHOSPHATE 1PK9 ; 1.90 ; CRYSTAL STRUCTURE OF E. COLI PURINE NUCLEOSIDE PHOSPHORYLASE COMPLEXED WITH 2-FLUOROADENOSINE AND SULFATE/PHOSPHATE 1PW7 ; 2.00 ; CRYSTAL STRUCTURE OF E. COLI PURINE NUCLEOSIDE PHOSPHORYLASE COMPLEXED WITH 9-BETA-D- ARABINOFURANOSYLADENINE AND SULFATE/PHOSPHATE 1PK7 ; 2.50 ; CRYSTAL STRUCTURE OF E. COLI PURINE NUCLEOSIDE PHOSPHORYLASE COMPLEXED WITH ADENOSINE AND SULFATE/PHOSPHATE 1TJ0 ; 2.10 ; CRYSTAL STRUCTURE OF E. COLI PUTA PROLINE DEHYDROGENASE DOMAIN (RESIDUES 86-669) CO-CRYSTALLIZED WITH L-LACTATE 1TJ2 ; 2.05 ; CRYSTAL STRUCTURE OF E. COLI PUTA PROLINE DEHYDROGENASE DOMAIN (RESIDUES 86-669) COMPLEXED WITH ACETATE 1TJ1 ; 2.00 ; CRYSTAL STRUCTURE OF E. COLI PUTA PROLINE DEHYDROGENASE DOMAIN (RESIDUES 86-669) COMPLEXED WITH L-LACTATE 1TIW ; 2.00 ; CRYSTAL STRUCTURE OF E. COLI PUTA PROLINE DEHYDROGENASE DOMAIN (RESIDUES 86-669) COMPLEXED WITH L-TETRAHYDRO-2- FUROIC ACID 1U94 ; 1.90 ; CRYSTAL STRUCTURE OF E. COLI RECA IN A COMPRESSED HELICAL FILAMENT FORM 2 1QY9 ; 2.05 ; CRYSTAL STRUCTURE OF E. COLI SE-MET PROTEIN YDDE 1LRR ; 2.65 ; CRYSTAL STRUCTURE OF E. COLI SEQA COMPLEXED WITH HEMIMETHYLATED DEOXYRIBONUCLEIC ACID 1KOG ; 3.50 ; CRYSTAL STRUCTURE OF E. COLI THREONYL-TRNA SYNTHETASE INTERACTING WITH THE ESSENTIAL DOMAIN OF ITS MRNA OPERATOR 1F4D ; 2.15 ; CRYSTAL STRUCTURE OF E. COLI THYMIDYLATE SYNTHASE C146S, L143C COVALENTLY MODIFIED AT C143 WITH N-[TOSYL-D- PROLINYL]AMINO-ETHANETHIOL 1F4F ; 2.00 ; CRYSTAL STRUCTURE OF E. COLI THYMIDYLATE SYNTHASE COMPLEXED WITH SP-722 1F4G ; 1.75 ; CRYSTAL STRUCTURE OF E. COLI THYMIDYLATE SYNTHASE COMPLEXED WITH SP-876 1F4E ; 1.90 ; CRYSTAL STRUCTURE OF E. COLI THYMIDYLATE SYNTHASE COMPLEXED WITH TOSYL-D-PROLINE 1F4C ; 2.00 ; CRYSTAL STRUCTURE OF E. COLI THYMIDYLATE SYNTHASE COVALENTLY MODIFIED AT C146 WITH N-[TOSYL-D-PROLINYL]AMINO- ETHANETHIOL 1S16 ; 2.10 ; CRYSTAL STRUCTURE OF E. COLI TOPOISOMERASE IV PARE 43KDA SUBUNIT COMPLEXED WITH ADPNP 1X13 ; 1.90 ; CRYSTAL STRUCTURE OF E. COLI TRANSHYDROGENASE DOMAIN I 1X14 ; 1.94 ; CRYSTAL STRUCTURE OF E. COLI TRANSHYDROGENASE DOMAIN I WITH BOUND NAD 1X15 ; 2.04 ; CRYSTAL STRUCTURE OF E. COLI TRANSHYDROGENASE DOMAIN I WITH BOUND NADH 1SZW ; 2.00 ; CRYSTAL STRUCTURE OF E. COLI TRNA PSEUDOURIDINE SYNTHASE TRUD 1LRJ ; 1.90 ; CRYSTAL STRUCTURE OF E. COLI UDP-GALACTOSE 4-EPIMERASE COMPLEXED WITH UDP-N-ACETYLGLUCOSAMINE 1KK9 ; 2.10 ; CRYSTAL STRUCTURE OF E. COLI YCIO 1LN4 ; 1.50 ; CRYSTAL STRUCTURE OF E. COLI YHBY 1X8D ; 1.80 ; CRYSTAL STRUCTURE OF E. COLI YIIL PROTEIN CONTAINING L- RHAMNOSE 1SI8 ; 2.30 ; CRYSTAL STRUCTURE OF E. FAECALIS CATALASE 1T8S ; 2.60 ; CRYSTAL STRUCTURE OF E.COLI AMP NUCLEOSIDASE COMPLEXED WITH FORMICIN 5'-MONOPHOSPHATE 1T8Y ; 3.00 ; CRYSTAL STRUCTURE OF E.COLI AMP NUCLEOSIDASE COMPLEXED WITH PHOSPHATE 1RTZ ; 1.33 ; CRYSTAL STRUCTURE OF E.COLI APO-HPPK(V83G/DEL84-89) AT 1.33 ANGSTROM RESOLUTION 1TMJ ; 1.45 ; CRYSTAL STRUCTURE OF E.COLI APO-HPPK(W89A) AT 1.45 ANGSTROM RESOLUTION 1Z7B ; 2.31 ; CRYSTAL STRUCTURE OF E.COLI ARNA DEHYDROGENASE (DECARBOXYLASE) DOMAIN, R619E MUTANT 1Z74 ; 2.70 ; CRYSTAL STRUCTURE OF E.COLI ARNA DEHYDROGENASE (DECARBOXYLASE) DOMAIN, R619Y MUTANT 1YRW ; 1.70 ; CRYSTAL STRUCTURE OF E.COLI ARNA TRANSFORMYLASE DOMAIN 1X29 ; 2.20 ; CRYSTAL STRUCTURE OF E.COLI ASPAT COMPLEXED WITH N- PHOSPHOPYRIDOXYL-2-METHYL-L-GLUTAMIC ACID 1X2A ; 2.20 ; CRYSTAL STRUCTURE OF E.COLI ASPAT COMPLEXED WITH N- PHOSPHOPYRIDOXYL-D-GLUTAMIC ACID 1X28 ; 2.40 ; CRYSTAL STRUCTURE OF E.COLI ASPAT COMPLEXED WITH N- PHOSPHOPYRIDOXYL-L-GLUTAMIC ACID 1PD5 ; 2.50 ; CRYSTAL STRUCTURE OF E.COLI CHLORAMPHENICOL ACETYLTRANSFERASE TYPE I AT 2.5 ANGSTROM RESOLUTION 1K82 ; 2.10 ; CRYSTAL STRUCTURE OF E.COLI FORMAMIDOPYRIMIDINE-DEOXYRIBONUCLEIC ACID GLYCOSYLASE (FPG) COVALENTLY TRAPPED WITH DEOXYRIBONUCLEIC ACID 1Q18 ; 2.36 ; CRYSTAL STRUCTURE OF E.COLI GLUCOKINASE (GLK) 1G9T ; 2.80 ; CRYSTAL STRUCTURE OF E.COLI HPRT-GMP COMPLEX 1HX3 ; 2.10 ; CRYSTAL STRUCTURE OF E.COLI ISOPENTENYL DIPHOSPHATE:DIMETHYLALLYL DIPHOSPHATE ISOMERASE 1RRE ; 1.75 ; CRYSTAL STRUCTURE OF E.COLI LON PROTEOLYTIC DOMAIN 1K4M ; 1.90 ; CRYSTAL STRUCTURE OF E.COLI NICOTINIC ACID MONONUCLEOTIDE ADENYLYLTRANSFERASE COMPLEXED TO DEAMIDO-NAD 1PS6 ; 2.25 ; CRYSTAL STRUCTURE OF E.COLI PDXA 1PS7 ; 2.47 ; CRYSTAL STRUCTURE OF E.COLI PDXA 1PTM ; 1.96 ; CRYSTAL STRUCTURE OF E.COLI PDXA 1LRU ; 2.10 ; CRYSTAL STRUCTURE OF E.COLI PEPTIDE DEFORMYLASE COMPLEXED WITH ANTIBIOTIC ACTINONIN 1JQN ; 2.35 ; CRYSTAL STRUCTURE OF E.COLI PHOSPHOENOLPYRUVATE CARBOXYLASE IN COMPLEX WITH MN2+ AND DCDP 1G27 ; 2.10 ; CRYSTAL STRUCTURE OF E.COLI POLYPEPTIDE DEFORMYLASE COMPLEXED WITH THE INHIBITOR BB-3497 1K87 ; 2.00 ; CRYSTAL STRUCTURE OF E.COLI PUTA (RESIDUES 1-669) 1DFU ; 1.80 ; CRYSTAL STRUCTURE OF E.COLI RIBOSOMAL PROTEIN L25 COMPLEXED WITH A 5S RRNA FRAGMENT AT 1.8 A RESOLUTION 1WSH ; 1.90 ; CRYSTAL STRUCTURE OF E.COLI RNASE HI ACTIVE SITE MUTANT (E48A/K87A) 1WSI ; 2.00 ; CRYSTAL STRUCTURE OF E.COLI RNASE HI ACTIVE SITE MUTANT (E48A/K87A/D134N) 1WSJ ; 2.00 ; CRYSTAL STRUCTURE OF E.COLI RNASE HI ACTIVE SITE MUTANT (K87A/H124A) 1XNF ; 1.98 ; CRYSTAL STRUCTURE OF E.COLI TPR-PROTEIN NLPI 1T0U ; 2.20 ; CRYSTAL STRUCTURE OF E.COLI URIDINE PHOSPHORYLASE AT 2.2 A RESOLUTION (TYPE-A NATIVE) 1QOJ ; 3.00 ; CRYSTAL STRUCTURE OF E.COLI UVRB C-TERMINAL DOMAIN, AND A MODEL FOR UVRB-UVRC INTERACTION. 1FUX ; 1.81 ; CRYSTAL STRUCTURE OF E.COLI YBCL, A NEW MEMBER OF THE MAMMALIAN PEBP FAMILY 1FJJ ; 1.66 ; CRYSTAL STRUCTURE OF E.COLI YBHB PROTEIN, A NEW MEMBER OF THE MAMMALIAN PEBP FAMILY 1KON ; 2.20 ; CRYSTAL STRUCTURE OF E.COLI YEBC 1SO5 ; 1.80 ; CRYSTAL STRUCTURE OF E112Q MUTANT OF 3-KETO-L-GULONATE 6- PHOSPHATE DECARBOXYLASE WITH BOUND L-THREONOHYDROXAMATE 4- PHOSPHATE 1SO6 ; 1.90 ; CRYSTAL STRUCTURE OF E112Q/H136A DOUBLE MUTANT OF 3-KETO-L- GULONATE 6-PHOSPHATE DECARBOXYLASE WITH BOUND L- THREONOHYDROXAMATE 4-PHOSPHATE 1L7G ; 1.85 ; CRYSTAL STRUCTURE OF E119G MUTANT INFLUENZA VIRUS NEURAMINIDASE IN COMPLEX WITH BCX-1812 1RCJ ; 1.63 ; CRYSTAL STRUCTURE OF E166A MUTANT OF SHV-1 BETA-LACTAMASE WITH THE TRANS-ENAMINE INTERMEDIATE OF TAZOBACTAM 1SYK ; 2.80 ; CRYSTAL STRUCTURE OF E230Q MUTANT OF CAMP-DEPENDENT PROTEIN KINASE REVEALS UNEXPECTED APOENZYME CONFORMATION 1N8F ; 1.75 ; CRYSTAL STRUCTURE OF E24Q MUTANT OF PHENYLALANINE-REGULATED 3-DEOXY-D-ARABINO-HEPTULOSONATE-7-PHOSPHATE SYNTHASE (DAHP SYNTHASE) FROM ESCHERICHIA COLI IN COMPLEX WITH MN2+ AND PEP 1M2M ; 1.80 ; CRYSTAL STRUCTURE OF E44A/E48A/E56A/D60A MUTANT OF CYTOCHROME B5 1M2I ; 1.80 ; CRYSTAL STRUCTURE OF E44A/E56A MUTANT OF CYTOCHROME B5 1PY0 ; 2.00 ; CRYSTAL STRUCTURE OF E51C/E54C PSAZ FROM A.FAECALIS WITH CLANP PROBE 1TR1 ; 2.20 ; CRYSTAL STRUCTURE OF E96K MUTATED BETA-GLUCOSIDASE A FROM BACILLUS POLYMYXA, AN ENZYME WITH INCREASED THERMORESISTANCE 1M9U ; 2.30 ; CRYSTAL STRUCTURE OF EARTHWORM FIBRINOLYTIC ENZYME COMPONENT A FROM EISENIA FETIDA 1YM0 ; 2.06 ; CRYSTAL STRUCTURE OF EARTHWORM FIBRINOLYTIC ENZYME COMPONENT B: A NOVEL, GLYCOSYLATED TWO-CHAINED TRYPSIN 1ZRL ; 2.30 ; CRYSTAL STRUCTURE OF EBA-175 REGION II (RII) 1ZRO ; 2.25 ; CRYSTAL STRUCTURE OF EBA-175 REGION II (RII) CRYSTALLIZED IN THE PRESENCE OF (ALPHA)2,3-SIALYLLACTOSE 1K77 ; 1.63 ; CRYSTAL STRUCTURE OF EC1530, HYPOTHETICAL PROTEIN FROM ESCHERICHIA COLI 1OZ7 ; 2.40 ; CRYSTAL STRUCTURE OF ECHICETIN FROM THE VENOM OF INDIAN SAW- SCALED VIPER (ECHIS CARINATUS) AT 2.4 RESOLUTION 1EZS ; 2.30 ; CRYSTAL STRUCTURE OF ECOTIN MUTANT M84R, W67A, G68A, Y69A, D70A BOUND TO RAT ANIONIC TRYPSIN II 1KZJ ; 2.60 ; CRYSTAL STRUCTURE OF ECTS W80G/DUMP/CB3717 COMPLEX 1KZI ; 1.75 ; CRYSTAL STRUCTURE OF ECTS/DUMP/THF COMPLEX 1RJ7 ; 2.30 ; CRYSTAL STRUCTURE OF EDA-A1 1QU1 ; 1.90 ; CRYSTAL STRUCTURE OF EHA2 (23-185) 1P72 ; 2.10 ; CRYSTAL STRUCTURE OF EHV4-TK COMPLEXED WITH THY AND ADP 1P6X ; 2.00 ; CRYSTAL STRUCTURE OF EHV4-TK COMPLEXED WITH THY AND SO4 1P73 ; 2.70 ; CRYSTAL STRUCTURE OF EHV4-TK COMPLEXED WITH TP4A 1P75 ; 3.02 ; CRYSTAL STRUCTURE OF EHV4-TK COMPLEXED WITH TP5A 1IGX ; 3.10 ; CRYSTAL STRUCTURE OF EICOSAPENTANOIC ACID BOUND IN THE CYCLOOXYGENASE CHANNEL OF PROSTAGLANDIN ENDOPEROXIDE H SYNTHASE-1. 1ZXE ; 2.60 ; CRYSTAL STRUCTURE OF EIF2ALPHA PROTEIN KINASE GCN2: D835N INACTIVATING MUTANT IN APO FORM 1ZY5 ; 2.00 ; CRYSTAL STRUCTURE OF EIF2ALPHA PROTEIN KINASE GCN2: R794G HYPERACTIVATING MUTANT COMPLEXED WITH AMPPNP. 1ZY4 ; 1.95 ; CRYSTAL STRUCTURE OF EIF2ALPHA PROTEIN KINASE GCN2: R794G HYPERACTIVATING MUTANT IN APO FORM. 1ZYD ; 2.75 ; CRYSTAL STRUCTURE OF EIF2ALPHA PROTEIN KINASE GCN2: WILD- TYPE COMPLEXED WITH ATP. 1ZYC ; 3.00 ; CRYSTAL STRUCTURE OF EIF2ALPHA PROTEIN KINASE GCN2: WILD- TYPE IN APO FORM. 1FLE ; 1.90 ; CRYSTAL STRUCTURE OF ELAFIN COMPLEXED WITH PORCINE PANCREATIC ELASTASE 1N0V ; 2.85 ; CRYSTAL STRUCTURE OF ELONGATION FACTOR 2 1KTV ; 3.80 ; CRYSTAL STRUCTURE OF ELONGATION FACTOR G DIMER WITHOUT NUCLEOTIDE 1D8T ; 2.35 ; CRYSTAL STRUCTURE OF ELONGATION FACTOR, TU (EF-TU-MGGDP) COMPLEXED WITH GE2270A, A THIAZOLYL PEPTIDE ANTIBIOTIC 1UKM ; 1.90 ; CRYSTAL STRUCTURE OF EMS16, AN ANTAGONIST OF COLLAGEN RECEPTOR INTEGRIN ALPHA2BETA1 (GPIA/IIA) 1EOK ; 1.80 ; CRYSTAL STRUCTURE OF ENDO-BETA-N-ACETYLGLUCOSAMINIDASE F3 1VJZ ; 2.05 ; CRYSTAL STRUCTURE OF ENDOGLUCANASE (TM1752) FROM THERMOTOGA MARITIMA AT 2.05 A RESOLUTION 1XP3 ; 2.57 ; CRYSTAL STRUCTURE OF ENDONUCLEASE IV (BA4508) FROM BACILLUS ANTHRACIS AT 2.57A RESOLUTION. 1ZWW ; 2.30 ; CRYSTAL STRUCTURE OF ENDOPHILIN-A1 BAR DOMAIN 1NIW ; 2.05 ; CRYSTAL STRUCTURE OF ENDOTHELIAL NITRIC OXIDE SYNTHASE PEPTIDE BOUND TO CALMODULIN 1P7I ; 2.10 ; CRYSTAL STRUCTURE OF ENGRAILED HOMEODOMAIN MUTANT K52A 1P7J ; 2.10 ; CRYSTAL STRUCTURE OF ENGRAILED HOMEODOMAIN MUTANT K52E 1CV7 ; 2.50 ; CRYSTAL STRUCTURE OF ENHANCED CYAN-EMISSION VARIANT OF GFP 1WZ7 ; 2.10 ; CRYSTAL STRUCTURE OF ENHANCER OF RUDIMENTARY HOMOLOGUE (ERH) 1VHQ ; 1.65 ; CRYSTAL STRUCTURE OF ENHANCING LYCOPENE BIOSYNTHESIS PROTEIN 2 1IYX ; 2.80 ; CRYSTAL STRUCTURE OF ENOLASE FROM ENTEROCOCCUS HIRAE 1QSG ; 1.75 ; CRYSTAL STRUCTURE OF ENOYL REDUCTASE INHIBITION BY TRICLOSAN 1UH5 ; 2.20 ; CRYSTAL STRUCTURE OF ENOYL-ACP REDUCTASE WITH TRICLOSAN AT 2.2ANGSTROMS 1JVF ; 2.50 ; CRYSTAL STRUCTURE OF ENOYL-ACYL CARRIER PROTEIN REDUCTASE FROM HELICOBACTER PYLORI 1JW7 ; 2.30 ; CRYSTAL STRUCTURE OF ENOYL-ACYL CARRIER PROTEIN REDUCTASE FROM HELICOBACTER PYLORI 1UIY ; 2.85 ; CRYSTAL STRUCTURE OF ENOYL-COA HYDRATASE FROM THERMUS THERMOPHILUS HB8 1Q9Y ; 2.80 ; CRYSTAL STRUCTURE OF ENTEROBACTERIA PHAGE RB69 GP43 DEOXYRIBONUCLEIC ACID POLYMERASE COMPLEXED WITH 8-OXOGUANOSINE CONTAINING DEOXYRIBONUCLEIC ACID 1Q9X ; 2.69 ; CRYSTAL STRUCTURE OF ENTEROBACTERIA PHAGE RB69 GP43 DEOXYRIBONUCLEIC ACID POLYMERASE COMPLEXED WITH TETRAHYDROFURAN CONTAINING DEOXYRIBONUCLEIC ACID 2B20 ; 2.95 ; CRYSTAL STRUCTURE OF ENTEROCHELIN ESTERASE FROM SHIGELLA FLEXNERI ENTEROCHELIN ESTERASE 2F7F ; 2.00 ; CRYSTAL STRUCTURE OF ENTEROCOCCUS FAECALIS PUTATIVE NICOTINATE PHOSPHORIBOSYLTRANSFERASE, NEW YORK STRUCTURAL GENOMICS CONSORTIUM 1YJ7 ; 1.80 ; CRYSTAL STRUCTURE OF ENTEROPATHOGENIC E.COLI (EPEC) TYPE III SECRETION SYSTEM PROTEIN ESCJ 1H1H ; 2.00 ; CRYSTAL STRUCTURE OF EOSINOPHIL CATIONIC PROTEIN IN COMPLEX WITH 2',5'-ADP AT 2.0 A RESOLUTION REVEALS THE DETAILS OF THE RIBONUCLEOLYTIC ACTIVE SITE 1V35 ; 2.50 ; CRYSTAL STRUCTURE OF EOYL-ACP REDUCTASE WITH NADH 1MQB ; 2.30 ; CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE 1QDA ; 1.60 ; CRYSTAL STRUCTURE OF EPIDOXORUBICIN-FORMALDEHYDE VIRTUAL CROSSLINK OF DEOXYRIBONUCLEIC ACID 1PKF ; 2.10 ; CRYSTAL STRUCTURE OF EPOTHILONE D-BOUND CYTOCHROME P450EPOK 1G65 ; 2.25 ; CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHA,BETA-EPOXYKETONE PROTEASOME INHIBITORS 1Y6M ; 2.80 ; CRYSTAL STRUCTURE OF EPSTEIN-BARR VIRUS IL-10 COMPLEXED WITH THE SOLUBLE IL-10R1 CHAIN 1Y6N ; 2.70 ; CRYSTAL STRUCTURE OF EPSTEIN-BARR VIRUS IL-10 MUTANT (A87I) COMPLEXED WITH THE SOLUBLE IL-10R1 CHAIN 1HEK ; 2.80 ; CRYSTAL STRUCTURE OF EQUINE INFECTIOUS ANAEMIA VIRUS MATRIX ANTIGEN (EIAV MA) 2A91 ; 2.50 ; CRYSTAL STRUCTURE OF ERBB2 DOMAINS 1-3 2AHX ; 2.40 ; CRYSTAL STRUCTURE OF ERBB4/HER4 EXTRACELLULAR DOMAIN 2ERC ; 3.00 ; CRYSTAL STRUCTURE OF ERMC' A RRNA-METHYL TRANSFERASE 1JR8 ; 1.50 ; CRYSTAL STRUCTURE OF ERV2P 1JRA ; 2.00 ; CRYSTAL STRUCTURE OF ERV2P 1JSL ; 1.70 ; CRYSTAL STRUCTURE OF ERWINIA CHRYSANTHEMI L-ASPARAGINASE COMPLEXED WITH 6-HYDROXY-D-NORLEUCINE 1JSR ; 1.70 ; CRYSTAL STRUCTURE OF ERWINIA CHRYSANTHEMI L-ASPARAGINASE COMPLEXED WITH 6-HYDROXY-L-NORLEUCINE 1FYU ; 2.60 ; CRYSTAL STRUCTURE OF ERYTHRINA CORALLODENDRON LECTIN IN HEXAGONAL CRYSTAL FORM 1YI2 ; 2.65 ; CRYSTAL STRUCTURE OF ERYTHROMYCIN BOUND TO THE G2099A MUTANT 50S RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI 1IYD ; 2.15 ; CRYSTAL STRUCTURE OF ESCHELICHIA COLI BRANCHED-CHAIN AMINO ACID AMINOTRANSFERASE 1IYE ; 1.82 ; CRYSTAL STRUCTURE OF ESCHELICHIA COLI BRANCHED-CHAIN AMINO ACID AMINOTRANSFERASE 1I1K ; 2.10 ; CRYSTAL STRUCTURE OF ESCHELICHIA COLI BRANCHED-CHAIN AMINO ACID AMINOTRANSFERASE. 1I1L ; 2.40 ; CRYSTAL STRUCTURE OF ESCHELICHIA COLI BRANCHED-CHAIN AMINO ACID AMINOTRANSFERASE. 1NR9 ; 2.70 ; CRYSTAL STRUCTURE OF ESCHERICHIA COLI 1262 (APC5008), PUTATIVE ISOMERASE 1M41 ; 2.30 ; CRYSTAL STRUCTURE OF ESCHERICHIA COLI ALKANESULFONATE MONOOXYGENASE SSUD AT 2.3 A RESOLUTION 1T4D ; 1.95 ; CRYSTAL STRUCTURE OF ESCHERICHIA COLI ASPARTATE BETA- SEMIALDEHYDE DEHYDROGENASE (ECASADH), AT 1.95 ANGSTROM RESOLUTION 1T75 ; 2.50 ; CRYSTAL STRUCTURE OF ESCHERICHIA COLI BETA CARBONIC ANHYDRASE 1I1M ; 2.40 ; CRYSTAL STRUCTURE OF ESCHERICHIA COLI BRANCHED-CHAIN AMINO ACID AMINOTRANSFERASE. 1EW4 ; 1.40 ; CRYSTAL STRUCTURE OF ESCHERICHIA COLI CYAY PROTEIN REVEALS A NOVEL FOLD FOR THE FRATAXIN FAMILY 1Q8I ; 2.00 ; CRYSTAL STRUCTURE OF ESCHERICHIA COLI DEOXYRIBONUCLEIC ACID POLYMERASE II 1QUM ; 1.55 ; CRYSTAL STRUCTURE OF ESCHERICHIA COLI ENDONUCLEASE IV IN COMPLEX WITH DAMAGED DEOXYRIBONUCLEIC ACID 1PMM ; 2.00 ; CRYSTAL STRUCTURE OF ESCHERICHIA COLI GADB (LOW PH) 1PMO ; 2.30 ; CRYSTAL STRUCTURE OF ESCHERICHIA COLI GADB (NEUTRAL PH) 1J2R ; 1.30 ; CRYSTAL STRUCTURE OF ESCHERICHIA COLI GENE PRODUCT YECD AT 1.3 A RESOLUTION 1ONS ; 2.20 ; CRYSTAL STRUCTURE OF ESCHERICHIA COLI HEAT SHOCK PROTEIN YEDU 1NJK ; 1.90 ; CRYSTAL STRUCTURE OF ESCHERICHIA COLI HYPOTHETICAL PROTEIN YBAW 1YBQ ; 2.00 ; CRYSTAL STRUCTURE OF ESCHERICHIA COLI ISOASPARTYL DIPEPTIDASE MUTANT D285N COMPLEXED WITH BETA- ASPARTYLHISTIDINE 1NP6 ; 1.90 ; CRYSTAL STRUCTURE OF ESCHERICHIA COLI MOBB 1P9N ; 2.80 ; CRYSTAL STRUCTURE OF ESCHERICHIA COLI MOBB. 1G8L ; 1.95 ; CRYSTAL STRUCTURE OF ESCHERICHIA COLI MOEA 1TXK ; 2.50 ; CRYSTAL STRUCTURE OF ESCHERICHIA COLI OPGG 1NT4 ; 2.40 ; CRYSTAL STRUCTURE OF ESCHERICHIA COLI PERIPLASMIC GLUCOSE-1- PHOSPHATASE H18A MUTANT COMPLEXED WITH GLUCOSE-1-PHOSPHATE 1DKL ; 2.30 ; CRYSTAL STRUCTURE OF ESCHERICHIA COLI PHYTASE AT PH 4.5 (NO LIGAND BOUND) 1DKN ; 2.40 ; CRYSTAL STRUCTURE OF ESCHERICHIA COLI PHYTASE AT PH 5.0 WITH HG2+ CATION ACTING AS AN INTERMOLECULAR BRIDGE 1DKM ; 2.25 ; CRYSTAL STRUCTURE OF ESCHERICHIA COLI PHYTASE AT PH 6.6 WITH HG2+ CATION ACTING AS AN INTERMOLECULAR BRIDGE 1XDO ; 3.00 ; CRYSTAL STRUCTURE OF ESCHERICHIA COLI POLYPHOSPHATE KINASE 2AA4 ; 2.20 ; CRYSTAL STRUCTURE OF ESCHERICHIA COLI PUTATIVE N- ACETYLMANNOSAMINE KINASE, NEW YORK STRUCTURAL GENOMICS CONSORTIUM 1YT3 ; 1.60 ; CRYSTAL STRUCTURE OF ESCHERICHIA COLI RNASE D, AN EXORIBONUCLEASE INVOLVED IN STRUCTURED RIBONUCLEIC ACID PROCESSING 1OR7 ; 2.00 ; CRYSTAL STRUCTURE OF ESCHERICHIA COLI SIGMAE WITH THE CYTOPLASMIC DOMAIN OF ITS ANTI-SIGMA RSEA 2D2A ; 2.70 ; CRYSTAL STRUCTURE OF ESCHERICHIA COLI SUFA INVOLVED IN BIOSYNTHESIS OF IRON-SULFUR CLUSTERS 1QXH ; 2.20 ; CRYSTAL STRUCTURE OF ESCHERICHIA COLI THIOL PEROXIDASE IN THE OXIDIZED STATE 1TDF ; 2.30 ; CRYSTAL STRUCTURE OF ESCHERICHIA COLI THIOREDOXIN REDUCTASE REFINED AT 2 ANGSTROM RESOLUTION: IMPLICATIONS FOR A LARGE CONFORMATIONAL CHANGE DURING CATALYSIS 1F4B ; 1.75 ; CRYSTAL STRUCTURE OF ESCHERICHIA COLI THYMIDYLATE SYNTHASE 1JG0 ; 2.00 ; CRYSTAL STRUCTURE OF ESCHERICHIA COLI THYMIDYLATE SYNTHASE COMPLEXED WITH 2'-DEOXYURIDINE-5'-MONOPHOSPHATE AND N,O- DIDANSYL-L-TYROSINE 1S14 ; 2.00 ; CRYSTAL STRUCTURE OF ESCHERICHIA COLI TOPOISOMERASE IV PARE 24KDA SUBUNIT 1I2P ; 2.05 ; CRYSTAL STRUCTURE OF ESCHERICHIA COLI TRANSALDOLASE B MUTANT D17A 1I2O ; 2.05 ; CRYSTAL STRUCTURE OF ESCHERICHIA COLI TRANSALDOLASE B MUTANT E96A 1I2N ; 2.05 ; CRYSTAL STRUCTURE OF ESCHERICHIA COLI TRANSALDOLASE B MUTANT N35A 1I2R ; 2.10 ; CRYSTAL STRUCTURE OF ESCHERICHIA COLI TRANSALDOLASE B MUTANT S176A 1I2Q ; 2.05 ; CRYSTAL STRUCTURE OF ESCHERICHIA COLI TRANSALDOLASE B MUTANT T156A 1T7D ; 2.47 ; CRYSTAL STRUCTURE OF ESCHERICHIA COLI TYPE I SIGNAL PEPTIDASE IN COMPLEX WITH A LIPOPEPTIDE INHIBITOR 1LRK ; 1.75 ; CRYSTAL STRUCTURE OF ESCHERICHIA COLI UDP-GALACTOSE 4- EPIMERASE MUTANT Y299C COMPLEXED WITH UDP-N- ACETYLGLUCOSAMINE 1GG4 ; 2.30 ; CRYSTAL STRUCTURE OF ESCHERICHIA COLI UDPMURNAC-TRIPEPTIDE D-ALANYL-D-ALANINE-ADDING ENZYME (MURF) AT 2.3 ANGSTROM RESOLUTION 1EUG ; 1.60 ; CRYSTAL STRUCTURE OF ESCHERICHIA COLI URACIL DEOXYRIBONUCLEIC ACID GLYCOSYLASE AND ITS COMPLEXES WITH URACIL AND GLYCEROL: STRUCTURE AND GLYCOSYLASE MECHANISM REVISITED 2EUG ; 1.50 ; CRYSTAL STRUCTURE OF ESCHERICHIA COLI URACIL DEOXYRIBONUCLEIC ACID GLYCOSYLASE AND ITS COMPLEXES WITH URACIL AND GLYCEROL: STRUCTURE AND GLYCOSYLASE MECHANISM REVISITED 3EUG ; 1.43 ; CRYSTAL STRUCTURE OF ESCHERICHIA COLI URACIL DEOXYRIBONUCLEIC ACID GLYCOSYLASE AND ITS COMPLEXES WITH URACIL AND GLYCEROL: STRUCTURE AND GLYCOSYLASE MECHANISM REVISITED 1X7R ; 2.00 ; CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR ALPHA COMPLEXED WITH GENISTEIN 1X7E ; 2.80 ; CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR ALPHA COMPLEXED WITH WAY-244 1U3Q ; 2.40 ; CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH CL-272 1X7B ; 2.30 ; CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH ERB-041 1X7J ; 2.30 ; CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH GENISTEIN 1X78 ; 2.30 ; CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-244 1U3R ; 2.21 ; CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-338 1U9E ; 2.40 ; CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-397 1X76 ; 2.20 ; CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-697 1U3S ; 2.50 ; CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-797 1IPB ; 2.00 ; CRYSTAL STRUCTURE OF EUKARYOTIC INITIATION FACTOR 4E COMPLEXED WITH 7-METHYL GPPPA 1IPC ; 2.00 ; CRYSTAL STRUCTURE OF EUKARYOTIC INITIATION FACTOR 4E COMPLEXED WITH 7-METHYL GTP 1DUA ; 2.00 ; CRYSTAL STRUCTURE OF EXFOLIATIVE TOXIN A 1DUE ; 2.00 ; CRYSTAL STRUCTURE OF EXFOLIATIVE TOXIN A S195A MUTANT 1DT2 ; 2.80 ; CRYSTAL STRUCTURE OF EXFOLIATIVE TOXIN B 1QTF ; 2.40 ; CRYSTAL STRUCTURE OF EXFOLIATIVE TOXIN B 1H4P ; 1.75 ; CRYSTAL STRUCTURE OF EXO-1,3-BETA GLUCANSE FROM SACCHAROMYCES CEREVISIAE 1Y9G ; 1.87 ; CRYSTAL STRUCTURE OF EXO-INULINASE FROM ASPERGILLUS AWAMORI COMPLEXED WITH FRUCTOSE 1Y4W ; 1.55 ; CRYSTAL STRUCTURE OF EXO-INULINASE FROM ASPERGILLUS AWAMORI IN SPACEGROUP P21 1Y9M ; 1.89 ; CRYSTAL STRUCTURE OF EXO-INULINASE FROM ASPERGILLUS AWAMORI IN SPACEGROUP P212121 1KFQ ; 2.40 ; CRYSTAL STRUCTURE OF EXOCYTOSIS-SENSITIVE PHOSPHOPROTEIN, PP63/PARAFUSIN (PHOSPHOGLUCOMUTSE) FROM PARAMECIUM. OPEN FORM 1VP7 ; 2.40 ; CRYSTAL STRUCTURE OF EXODEOXYRIBONUCLEASE VII SMALL SUBUNIT (NP_881400.1) FROM BORDETELLA PERTUSSIS AT 2.40 A RESOLUTION 1IR6 ; 2.90 ; CRYSTAL STRUCTURE OF EXONUCLEASE RECJ BOUND TO MANGANESE 1N8Z ; 2.52 ; CRYSTAL STRUCTURE OF EXTRACELLULAR DOMAIN OF HUMAN HER2 COMPLEXED WITH HERCEPTIN FAB 1XQX ; 2.10 ; CRYSTAL STRUCTURE OF F1-MUTANT S105A COMPLEX WITH PCK 1XQW ; 2.00 ; CRYSTAL STRUCTURE OF F1-MUTANT S105A COMPLEX WITH PHE-LEU 1XQY ; 3.20 ; CRYSTAL STRUCTURE OF F1-MUTANT S105A COMPLEX WITH PRO-LEU- GLY-GLY 1EIC ; 1.40 ; CRYSTAL STRUCTURE OF F120A MUTANT OF BOVINE PANCREATIC RIBONUCLEASE A 1EID ; 1.40 ; CRYSTAL STRUCTURE OF F120G MUTANT OF BOVINE PANCREATIC RIBONUCLEASE A 1EIE ; 1.40 ; CRYSTAL STRUCTURE OF F120W MUTANT OF BOVINE PANCREATIC RIBONUCLEASE A 2BS8 ; 2.25 ; CRYSTAL STRUCTURE OF F17B-G IN COMPLEX WITH N-ACETYL-D- GLUCOSAMINE 1UKS ; 1.90 ; CRYSTAL STRUCTURE OF F183L/F259L MUTANT CYCLODEXTRIN GLUCANOTRANSFERASE COMPLEXED WITH A PSEUDO-MALTOTETRAOSE DERIVED FROM ACARBOSE 1YYM ; 2.20 ; CRYSTAL STRUCTURE OF F23, A SCORPION-TOXIN MIMIC OF CD4, IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B 1F5C ; 1.75 ; CRYSTAL STRUCTURE OF F25H FERREDOXIN 1 MUTANT FROM AZOTOBACTER VINELANDII AT 1.75 ANGSTROM RESOLUTION 1V3J ; 2.00 ; CRYSTAL STRUCTURE OF F283L MUTANT CYCLODEXTRIN GLYCOSYLTRANSFERASE 1V3L ; 2.10 ; CRYSTAL STRUCTURE OF F283L MUTANT CYCLODEXTRIN GLYCOSYLTRANSFERASE COMPLEXED WITH A PSEUDO-TETRAOSE DERIVED FROM ACARBOSE 1V3K ; 2.00 ; CRYSTAL STRUCTURE OF F283Y MUTANT CYCLODEXTRIN GLYCOSYLTRANSFERASE 1V3M ; 2.00 ; CRYSTAL STRUCTURE OF F283Y MUTANT CYCLODEXTRIN GLYCOSYLTRANSFERASE COMPLEXED WITH A PSEUDO-TETRAOSE DERIVED FROM ACARBOSE 1F5B ; 1.62 ; CRYSTAL STRUCTURE OF F2H FERREDOXIN 1 MUTANT FROM AZOTOBACTER VINELANDII AT 1.75 ANGSTROM RESOLUTION 1M20 ; 1.80 ; CRYSTAL STRUCTURE OF F35Y MUTANT OF TRYPSIN-SOLUBILIZED FRAGMENT OF CYTOCHROME B5 1IO1 ; 2.00 ; CRYSTAL STRUCTURE OF F41 FRAGMENT OF FLAGELLIN 1U9M ; 2.00 ; CRYSTAL STRUCTURE OF F58W MUTANT OF CYTOCHROME B5 1U9U ; 1.86 ; CRYSTAL STRUCTURE OF F58Y MUTANT OF CYTOCHROME B5 1KEQ ; 1.88 ; CRYSTAL STRUCTURE OF F65A/Y131C CARBONIC ANHYDRASE V, COVALENTLY MODIFIED WITH 4-CHLOROMETHYLIMIDAZOLE 1RIH ; 2.50 ; CRYSTAL STRUCTURE OF FAB 14F7, A UNIQUE ANTI-TUMOR ANTIBODY SPECIFIC FOR N-GLYCOLYL GM3 1OP3 ; 1.75 ; CRYSTAL STRUCTURE OF FAB 2G12 BOUND TO MAN1->2MAN 1OP5 ; 3.00 ; CRYSTAL STRUCTURE OF FAB 2G12 BOUND TO MAN9GLCNAC2 1JPT ; 1.85 ; CRYSTAL STRUCTURE OF FAB D3H44 1KFA ; 2.80 ; CRYSTAL STRUCTURE OF FAB FRAGMENT COMPLEXED WITH GIBBERELLIN A4 1NDM ; 2.10 ; CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTIBODY HYHEL-26 COMPLEXED WITH LYSOZYME 1NDG ; 1.90 ; CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTIBODY HYHEL-8 COMPLEXED WITH ITS ANTIGEN LYSOZYME 1DQD ; 2.10 ; CRYSTAL STRUCTURE OF FAB HGR-2 F6, A COMPETITIVE ANTAGONIST OF THE GLUCAGON RECEPTOR 2F5A ; 2.05 ; CRYSTAL STRUCTURE OF FAB' FROM THE HIV-1 NEUTRALIZING ANTIBODY 2F5 2F5B ; 2.00 ; CRYSTAL STRUCTURE OF FAB' FROM THE HIV-1 NEUTRALIZING ANTIBODY 2F5 IN COMPLEX WITH ITS GP41 EPITOPE 1JN6 ; 2.70 ; CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES 1JNH ; 2.85 ; CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES 1JNL ; 3.00 ; CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES 1JNN ; 3.20 ; CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES 1E6O ; 1.80 ; CRYSTAL STRUCTURE OF FAB13B5 AGAINST HIV-1 CAPSID PROTEIN P24 1FN4 ; 2.80 ; CRYSTAL STRUCTURE OF FAB198, AN EFFICIENT PROTECTOR OF ACETYLCHOLINE RECEPTOR AGAINST MYASTHENOGENIC ANTIBODIES 1P1V ; 1.40 ; CRYSTAL STRUCTURE OF FALS-ASSOCIATED HUMAN COPPER-ZINC SUPEROXIDE DISMUTASE (CUZNSOD) MUTANT D125H TO 1.4A 1OZU ; 1.30 ; CRYSTAL STRUCTURE OF FAMILIAL ALS MUTANT S134N OF HUMAN CU, ZN SUPEROXIDE DISMUTASE (CUZNSOD) TO 1.3A RESOLUTION 1TE1 ; 2.50 ; CRYSTAL STRUCTURE OF FAMILY 11 XYLANASE IN COMPLEX WITH INHIBITOR (XIP-I) 1WMX ; 2.00 ; CRYSTAL STRUCTURE OF FAMILY 30 CARBOHYDRATE BINDING MODULE 1WZX ; 3.52 ; CRYSTAL STRUCTURE OF FAMILY 30 CARBOHYDRATE BINDING MODULE. 1WNS ; 3.00 ; CRYSTAL STRUCTURE OF FAMILY B DEOXYRIBONUCLEIC ACID POLYMERASE FROM HYPERTHERMOPHILIC ARCHAEON PYROCOCCUS KODAKARAENSIS KOD1 1MT5 ; 2.80 ; CRYSTAL STRUCTURE OF FATTY ACID AMIDE HYDROLASE 1ZZ9 ; 2.40 ; CRYSTAL STRUCTURE OF FEII HPPE 1ZZ7 ; 2.10 ; CRYSTAL STRUCTURE OF FEII HPPE IN COMPLEX WITH SUBSTRATE FORM 1 1ZZ8 ; 2.30 ; CRYSTAL STRUCTURE OF FEII HPPE IN COMPLEX WITH SUBSTRATE FORM 2 1PUO ; 1.85 ; CRYSTAL STRUCTURE OF FEL D 1- THE MAJOR CAT ALLERGEN 2FIV ; 2.00 ; CRYSTAL STRUCTURE OF FELINE IMMUNODEFICIENCY VIRUS PROTEASE COMPLEXED WITH A SUBSTRATE 3FIV ; 1.85 ; CRYSTAL STRUCTURE OF FELINE IMMUNODEFICIENCY VIRUS PROTEASE COMPLEXED WITH A SUBSTRATE 1D3W ; 1.70 ; CRYSTAL STRUCTURE OF FERREDOXIN 1 D15E MUTANT FROM AZOTOBACTER VINELANDII AT 1.7 ANGSTROM RESOLUTION. 1VCK ; 1.90 ; CRYSTAL STRUCTURE OF FERREDOXIN COMPONENT OF CARBAZOLE 1,9A- DIOXYGENASE OF PSEUDOMONAS RESINOVORANS STRAIN CA10 1WRI ; 1.20 ; CRYSTAL STRUCTURE OF FERREDOXIN ISOFORM II FROM E. ARVENSE 1DJ7 ; 1.60 ; CRYSTAL STRUCTURE OF FERREDOXIN THIOREDOXIN REDUCTASE 1PO3 ; 3.40 ; CRYSTAL STRUCTURE OF FERRIC CITRATE TRANSPORTER FECA IN COMPLEX WITH FERRIC CITRATE 1PO0 ; 2.15 ; CRYSTAL STRUCTURE OF FERRIC CITRATE TRANSPORTER FECA IN COMPLEX WITH IRON-FREE CITRATE 1PNZ ; 2.50 ; CRYSTAL STRUCTURE OF FERRIC CITRATE TRANSPORTER FECA IN THE UNLIGANDED FORM 1I0R ; 1.50 ; CRYSTAL STRUCTURE OF FERRIC REDUCTASE FROM ARCHAEOGLOBUS FULGIDUS 1IO3 ; 1.90 ; CRYSTAL STRUCTURE OF FERRICYTOCHROME C2 FROM RHODOPSEUDOMONAS VIRIDIS 1VLG ; 2.00 ; CRYSTAL STRUCTURE OF FERRITIN (TM1128) FROM THERMOTOGA MARITIMA AT 2.00 A RESOLUTION 1DOZ ; 1.80 ; CRYSTAL STRUCTURE OF FERROCHELATASE 1L8X ; 2.70 ; CRYSTAL STRUCTURE OF FERROCHELATASE FROM THE YEAST, SACCHAROMYCES CEREVISIAE, WITH COBALT(II) AS THE SUBSTRATE ION 1N0I ; 2.00 ; CRYSTAL STRUCTURE OF FERROCHELATASE WITH CADMIUM BOUND AT ACTIVE SITE 1SHR ; 1.88 ; CRYSTAL STRUCTURE OF FERROCYANIDE BOUND HUMAN HEMOGLOBIN A2 AT 1.88A RESOLUTION 1CO6 ; 1.60 ; CRYSTAL STRUCTURE OF FERROCYTOCHROME C2 FROM RHODOPSEUDOMONAS VIRIDIS 2A1N ; 1.90 ; CRYSTAL STRUCTURE OF FERROUS DIOXYGEN COMPLEX OF D251N CYTOCHROME P450CAM 2A1O ; 1.55 ; CRYSTAL STRUCTURE OF FERROUS DIOXYGEN COMPLEX OF T252A CYTOCHROME P450CAM 2A1M ; 2.10 ; CRYSTAL STRUCTURE OF FERROUS DIOXYGEN COMPLEX OF WILD-TYPE CYTOCHROME P450CAM 1R65 ; 1.95 ; CRYSTAL STRUCTURE OF FERROUS SOAKED RIBONUCLEOTIDE REDUCTASE R2 SUBUNIT (WILDTYPE) AT PH 5 FROM E. COLI 1USW ; 2.50 ; CRYSTAL STRUCTURE OF FERULIC ACID ESTERASE FROM ASPERGILLUS NIGER 1R6V ; 1.70 ; CRYSTAL STRUCTURE OF FERVIDOLYSIN FROM FERVIDOBACTERIUM PENNIVORANS, A KERATINOLYTIC ENZYME RELATED TO SUBTILISIN 1ZPU ; 2.80 ; CRYSTAL STRUCTURE OF FET3P, A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT 1Q04 ; 1.80 ; CRYSTAL STRUCTURE OF FGF-1, S50E/V51N 1Q03 ; 2.05 ; CRYSTAL STRUCTURE OF FGF-1, S50G/V51G MUTANT 1PZZ ; 2.00 ; CRYSTAL STRUCTURE OF FGF-1, V51N MUTANT 1EVT ; 2.80 ; CRYSTAL STRUCTURE OF FGF1 IN COMPLEX WITH THE EXTRACELLULAR LIGAND BINDING DOMAIN OF FGF RECEPTOR 1 (FGFR1) 1EV2 ; 2.20 ; CRYSTAL STRUCTURE OF FGF2 IN COMPLEX WITH THE EXTRACELLULAR LIGAND BINDING DOMAIN OF FGF RECEPTOR 2 (FGFR2) 1NT2 ; 2.90 ; CRYSTAL STRUCTURE OF FIBRILLARIN/NOP5P COMPLEX 1FZA ; 2.90 ; CRYSTAL STRUCTURE OF FIBRINOGEN FRAGMENT D 966C ; 1.90 ; CRYSTAL STRUCTURE OF FIBROBLAST COLLAGENASE-1 COMPLEXED TO A DIPHENYL-ETHER SULPHONE BASED HYDROXAMIC ACID 1PWA ; 1.30 ; CRYSTAL STRUCTURE OF FIBROBLAST GROWTH FACTOR 19 1IJT ; 1.80 ; CRYSTAL STRUCTURE OF FIBROBLAST GROWTH FACTOR 4 (FGF4) 1IHK ; 2.20 ; CRYSTAL STRUCTURE OF FIBROBLAST GROWTH FACTOR 9 (FGF9) 1SLM ; 1.90 ; CRYSTAL STRUCTURE OF FIBROBLAST STROMELYSIN-1: THE C-TRUNCATED HUMAN PROENZYME 1RWR ; 1.72 ; CRYSTAL STRUCTURE OF FILAMENTOUS HEMAGGLUTININ SECRETION DOMAIN 2BP3 ; 2.32 ; CRYSTAL STRUCTURE OF FILAMIN A DOMAIN 17 AND GPIB ALPHA CYTOPLASMIC DOMAIN COMPLEX 1OSY ; 1.70 ; CRYSTAL STRUCTURE OF FIP-FVE FUNGAL IMMUNOMODULATORY PROTEIN 1EQ9 ; 1.70 ; CRYSTAL STRUCTURE OF FIRE ANT CHYMOTRYPSIN COMPLEXED TO PMSF 1VOQ ; 11.50 ; CRYSTAL STRUCTURE OF FIVE 70S RIBOSOMES FROM ESCHERICHIA COLI IN COMPLEX WITH PROTEIN Y. THIS FILE CONTAINS THE 30S SUBUNIT OF ONE 70S RIBOSOME. THE ENTIRE CRYSTAL STRUCTURE CONTAINS FIVE 70S RIBOSOMES AND IS DESCRIBED IN REMARK 400. 1VOS ; 11.50 ; CRYSTAL STRUCTURE OF FIVE 70S RIBOSOMES FROM ESCHERICHIA COLI IN COMPLEX WITH PROTEIN Y. THIS FILE CONTAINS THE 30S SUBUNIT OF ONE 70S RIBOSOME. THE ENTIRE CRYSTAL STRUCTURE CONTAINS FIVE 70S RIBOSOMES AND IS DESCRIBED IN REMARK 400. 1VOV ; 11.50 ; CRYSTAL STRUCTURE OF FIVE 70S RIBOSOMES FROM ESCHERICHIA COLI IN COMPLEX WITH PROTEIN Y. THIS FILE CONTAINS THE 30S SUBUNIT OF ONE 70S RIBOSOME. THE ENTIRE CRYSTAL STRUCTURE CONTAINS FIVE 70S RIBOSOMES AND IS DESCRIBED IN REMARK 400. 1VOX ; 11.50 ; CRYSTAL STRUCTURE OF FIVE 70S RIBOSOMES FROM ESCHERICHIA COLI IN COMPLEX WITH PROTEIN Y. THIS FILE CONTAINS THE 30S SUBUNIT OF ONE 70S RIBOSOME. THE ENTIRE CRYSTAL STRUCTURE CONTAINS FIVE 70S RIBOSOMES AND IS DESCRIBED IN REMARK 400. 1VOZ ; 11.50 ; CRYSTAL STRUCTURE OF FIVE 70S RIBOSOMES FROM ESCHERICHIA COLI IN COMPLEX WITH PROTEIN Y. THIS FILE CONTAINS THE 30S SUBUNIT OF ONE 70S RIBOSOME. THE ENTIRE CRYSTAL STRUCTURE CONTAINS FIVE 70S RIBOSOMES AND IS DESCRIBED IN REMARK 400. 1VOR ; 11.50 ; CRYSTAL STRUCTURE OF FIVE 70S RIBOSOMES FROM ESCHERICHIA COLI IN COMPLEX WITH PROTEIN Y. THIS FILE CONTAINS THE 50S SUBUNIT OF ONE 70S RIBOSOME. THE ENTIRE CRYSTAL STRUCTURE CONTAINS FIVE 70S RIBOSOMES AND IS DESCRIBED IN REMARK 400. 1VOU ; 11.50 ; CRYSTAL STRUCTURE OF FIVE 70S RIBOSOMES FROM ESCHERICHIA COLI IN COMPLEX WITH PROTEIN Y. THIS FILE CONTAINS THE 50S SUBUNIT OF ONE 70S RIBOSOME. THE ENTIRE CRYSTAL STRUCTURE CONTAINS FIVE 70S RIBOSOMES AND IS DESCRIBED IN REMARK 400. 1VOW ; 11.50 ; CRYSTAL STRUCTURE OF FIVE 70S RIBOSOMES FROM ESCHERICHIA COLI IN COMPLEX WITH PROTEIN Y. THIS FILE CONTAINS THE 50S SUBUNIT OF ONE 70S RIBOSOME. THE ENTIRE CRYSTAL STRUCTURE CONTAINS FIVE 70S RIBOSOMES AND IS DESCRIBED IN REMARK 400. 1VOY ; 11.50 ; CRYSTAL STRUCTURE OF FIVE 70S RIBOSOMES FROM ESCHERICHIA COLI IN COMPLEX WITH PROTEIN Y. THIS FILE CONTAINS THE 50S SUBUNIT OF ONE 70S RIBOSOME. THE ENTIRE CRYSTAL STRUCTURE CONTAINS FIVE 70S RIBOSOMES AND IS DESCRIBED IN REMARK 400. 1VP0 ; 11.50 ; CRYSTAL STRUCTURE OF FIVE 70S RIBOSOMES FROM ESCHERICHIA COLI IN COMPLEX WITH PROTEIN Y. THIS FILE CONTAINS THE 50S SUBUNIT OF ONE 70S RIBOSOME. THE ENTIRE CRYSTAL STRUCTURE CONTAINS FIVE 70S RIBOSOMES AND IS DESCRIBED IN REMARK 400. 1DBW ; 1.60 ; CRYSTAL STRUCTURE OF FIXJ-N 1C9H ; 2.00 ; CRYSTAL STRUCTURE OF FKBP12.6 IN COMPLEX WITH RAPAMYCIN 1P5Q ; 2.80 ; CRYSTAL STRUCTURE OF FKBP52 C-TERMINAL DOMAIN 1QZ2 ; 3.00 ; CRYSTAL STRUCTURE OF FKBP52 C-TERMINAL DOMAIN COMPLEX WITH THE C-TERMINAL PEPTIDE MEEVD OF HSP90 1Q6U ; 2.45 ; CRYSTAL STRUCTURE OF FKPA FROM ESCHERICHIA COLI 1MC8 ; 3.10 ; CRYSTAL STRUCTURE OF FLAP ENDONUCLEASE-1 R42E MUTANT FROM PYROCOCCUS HORIKOSHII 1S4M ; 2.10 ; CRYSTAL STRUCTURE OF FLAVIN BINDING TO FAD SYNTHETASE FROM THERMOTOGA MARITINA 1C3A ; 2.50 ; CRYSTAL STRUCTURE OF FLAVOCETIN-A FROM THE HABU SNAKE VENOM, A NOVEL CYCLIC TETRAMER OF C-TYPE LECTIN-LIKE HETERODIMERS 1VME ; 1.80 ; CRYSTAL STRUCTURE OF FLAVOPROTEIN (TM0755) FROM THERMOTOGA MARITIMA AT 1.80 A RESOLUTION 1WLG ; 1.80 ; CRYSTAL STRUCTURE OF FLGE31, A MAJOR FRAGMENT OF THE HOOK PROTEIN 1G8E ; 1.80 ; CRYSTAL STRUCTURE OF FLHD FROM ESCHERICHIA COLI 1RJB ; 2.10 ; CRYSTAL STRUCTURE OF FLT3 1Z6L ; 2.50 ; CRYSTAL STRUCTURE OF FMS1 IN COMPLEX WITH ITS SUBSTRATE 1XPQ ; 2.60 ; CRYSTAL STRUCTURE OF FMS1, A POLYAMINE OXIDASE FROM YEAST 1YY5 ; 2.30 ; CRYSTAL STRUCTURE OF FMS1, A POLYAMINE OXIDASE FROM YEAST 1MP8 ; 1.60 ; CRYSTAL STRUCTURE OF FOCAL ADHESION KINASE (FAK) 1O5Z ; 2.10 ; CRYSTAL STRUCTURE OF FOLYLPOLYGLUTAMATE SYNTHASE (TM0166) FROM THERMOTOGA MARITIMA AT 2.10 A RESOLUTION 1WAV ; 2.50 ; CRYSTAL STRUCTURE OF FORM B MONOCLINIC CRYSTAL OF INSULIN 1KOL ; 1.65 ; CRYSTAL STRUCTURE OF FORMALDEHYDE DEHYDROGENASE 1O5H ; 2.80 ; CRYSTAL STRUCTURE OF FORMIMINOTETRAHYDROFOLATE CYCLODEAMINASE (TM1560) FROM THERMOTOGA MARITIMA AT 2.80 A RESOLUTION 1P5H ; 2.20 ; CRYSTAL STRUCTURE OF FORMYL-COA TRANSFERASE (APOENZYME) FROM OXALOBACTER FORMIGENES 1R9C ; 1.83 ; CRYSTAL STRUCTURE OF FOSFOMYCIN RESISTANCE PROTEIN FOSX FROM MESORHIZOBIUM LOTI 1EC5 ; 2.50 ; CRYSTAL STRUCTURE OF FOUR-HELIX BUNDLE MODEL 1JM0 ; 1.70 ; CRYSTAL STRUCTURE OF FOUR-HELIX BUNDLE MODEL 1JMB ; 2.20 ; CRYSTAL STRUCTURE OF FOUR-HELIX BUNDLE MODEL 1MFT ; 2.50 ; CRYSTAL STRUCTURE OF FOUR-HELIX BUNDLE MODEL 1OVU ; 3.10 ; CRYSTAL STRUCTURE OF FOUR-HELIX BUNDLE MODEL DI-CO(II)-DF1- L13A (FORM I) 1OVV ; 2.90 ; CRYSTAL STRUCTURE OF FOUR-HELIX BUNDLE MODEL DI-CO(II)-DF1- L13A (FORM II) 1OVR ; 2.99 ; CRYSTAL STRUCTURE OF FOUR-HELIX BUNDLE MODEL DI-MN(II)-DF1- L13 1FZG ; 2.50 ; CRYSTAL STRUCTURE OF FRAGMENT D FROM HUMAN FIBRINOGEN WITH THE PEPTIDE LIGAND GLY-HIS-ARG-PRO-AMIDE 1LWU ; 2.80 ; CRYSTAL STRUCTURE OF FRAGMENT D FROM LAMPREY FIBRINOGEN COMPLEXED WITH THE PEPTIDE GLY-HIS-ARG-PRO-AMIDE 1RE4 ; 2.70 ; CRYSTAL STRUCTURE OF FRAGMENT D OF BBETAD398A FIBRINOGEN 1RE3 ; 2.45 ; CRYSTAL STRUCTURE OF FRAGMENT D OF BBETAD398A FIBRINOGEN WITH THE PEPTIDE LIGAND GLY-HIS-ARG-PRO-AMIDE 1RF0 ; 2.81 ; CRYSTAL STRUCTURE OF FRAGMENT D OF GAMMAE132A FIBRINOGEN 1RF1 ; 2.53 ; CRYSTAL STRUCTURE OF FRAGMENT D OF GAMMAE132A FIBRINOGEN WITH THE PEPTIDE LIGAND GLY-HIS-ARG-PRO-AMIDE 1FZE ; 3.00 ; CRYSTAL STRUCTURE OF FRAGMENT DOUBLE-D FROM HUMAN FIBRIN 1FZF ; 2.70 ; CRYSTAL STRUCTURE OF FRAGMENT DOUBLE-D FROM HUMAN FIBRIN WITH THE PEPTIDE LIGAND GLY-HIS-ARG-PRO-AMIDE 1FZC ; 2.30 ; CRYSTAL STRUCTURE OF FRAGMENT DOUBLE-D FROM HUMAN FIBRIN WITH TWO DIFFERENT BOUND LIGANDS 1Z7L ; 2.80 ; CRYSTAL STRUCTURE OF FRAGMENT OF MOUSE UBIQUITIN-ACTIVATING ENZYME 1EQR ; 2.70 ; CRYSTAL STRUCTURE OF FREE ASPARTYL-TRNA SYNTHETASE FROM ESCHERICHIA COLI 1ES8 ; 2.30 ; CRYSTAL STRUCTURE OF FREE BGLII 1ST8 ; 2.35 ; CRYSTAL STRUCTURE OF FRUCTAN 1-EXOHYDROLASE IIA FROM CICHORIUM INTYBUS 2ABQ ; 2.10 ; CRYSTAL STRUCTURE OF FRUCTOSE-1-PHOSPHATE KINASE FROM BACILLUS HALODURANS 1LR8 ; 2.10 ; CRYSTAL STRUCTURE OF FS1, THE HEPARIN-BINDING DOMAIN OF FOLLISTATIN, COMPLEXED WITH THE HEPARIN ANALOGUE D-MYO- INOSITOL HEXASULPHATE (INS6S) 1LR7 ; 1.50 ; CRYSTAL STRUCTURE OF FS1, THE HEPARIN-BINDING DOMAIN OF FOLLISTATIN, COMPLEXED WITH THE HEPARIN ANALOGUE SUCROSE OCTASULPHATE (SOS) 1U04 ; 2.25 ; CRYSTAL STRUCTURE OF FULL LENGTH ARGONAUTE FROM PYROCOCCUS FURIOSUS 1Z7E ; 3.00 ; CRYSTAL STRUCTURE OF FULL LENGTH ARNA 2ETF ; 2.29 ; CRYSTAL STRUCTURE OF FULL LENGTH BOTULINUM NEUROTOXIN (TYPE B) LIGHT CHAIN 1SRU ; 3.30 ; CRYSTAL STRUCTURE OF FULL LENGTH E. COLI SSB PROTEIN 1ZP9 ; 2.00 ; CRYSTAL STRUCTURE OF FULL-LEGNTH A.FULGIDUS RIO1 SERINE KINASE BOUND TO ATP AND MN2+ IONS. 1VPJ ; 1.69 ; CRYSTAL STRUCTURE OF FUMARASE (FUM-1) (NP_069927.1) FROM ARCHAEOGLOBUS FULGIDUS AT 1.69 A RESOLUTION 1VDK ; 1.80 ; CRYSTAL STRUCTURE OF FUMARASE FROM THERMUS THERMOPHILUS HB8 1QCN ; 1.90 ; CRYSTAL STRUCTURE OF FUMARYLACETOACETATE HYDROLASE 1HYO ; 1.30 ; CRYSTAL STRUCTURE OF FUMARYLACETOACETATE HYDROLASE COMPLEXED WITH 4-(HYDROXYMETHYLPHOSPHINOYL)-3-OXO-BUTANOIC ACID 1QCO ; 1.90 ; CRYSTAL STRUCTURE OF FUMARYLACETOACETATE HYDROLASE COMPLEXED WITH FUMARATE AND ACETOACETATE 1OFZ ; 1.50 ; CRYSTAL STRUCTURE OF FUNGAL LECTIN: SIX-BLADED BETA-PROPELLER FOLD AND NOVEL FUCOSE RECOGNITION MODE FOR ALEURIA AURANTIA LECTIN 1LPK ; 2.20 ; CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125. 1LPZ ; 2.40 ; CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41. 1LQD ; 2.70 ; CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45. 1LPG ; 2.00 ; CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79. 1G83 ; 2.60 ; CRYSTAL STRUCTURE OF FYN SH3-SH2 1ZCA ; 2.90 ; CRYSTAL STRUCTURE OF G ALPHA 12 IN COMPLEX WITH GDP, MG2+ AND ALF4- 1ZCB ; 2.00 ; CRYSTAL STRUCTURE OF G ALPHA 13 IN COMPLEX WITH GDP 2BCJ ; 3.06 ; CRYSTAL STRUCTURE OF G PROTEIN-COUPLED RECEPTOR KINASE 2 IN COMPLEX WITH GALPHA-Q AND GBETAGAMMA SUBUNITS 1JWV ; 1.85 ; CRYSTAL STRUCTURE OF G238A MUTANT OF TEM-1 BETA-LACTAMASE IN COMPLEX WITH A BORONIC ACID INHIBITOR (SEFB4) 1IL1 ; 2.20 ; CRYSTAL STRUCTURE OF G3-519, AN ANTI-HIV MONOCLONAL ANTIBODY 1JR7 ; 2.00 ; CRYSTAL STRUCTURE OF GAB REVEALS OXIDOREDUCTASE FOLD 1GA8 ; 2.00 ; CRYSTAL STRUCTURE OF GALACOSYLTRANSFERASE LGTC IN COMPLEX WITH DONOR AND ACCEPTOR SUGAR ANALOGS. 1MMX ; 1.80 ; CRYSTAL STRUCTURE OF GALACTOSE MUTAROTASE FROM LACTOCOCCUS LACTIS COMPLEXED WITH D-FUCOSE 1MMU ; 1.80 ; CRYSTAL STRUCTURE OF GALACTOSE MUTAROTASE FROM LACTOCOCCUS LACTIS COMPLEXED WITH D-GLUCOSE 1MMY ; 1.85 ; CRYSTAL STRUCTURE OF GALACTOSE MUTAROTASE FROM LACTOCOCCUS LACTIS COMPLEXED WITH D-QUINOVOSE 1MN0 ; 1.90 ; CRYSTAL STRUCTURE OF GALACTOSE MUTAROTASE FROM LACTOCOCCUS LACTIS COMPLEXED WITH D-XYLOSE 1MMZ ; 1.80 ; CRYSTAL STRUCTURE OF GALACTOSE MUTAROTASE FROM LACTOCOCCUS LACTIS COMPLEXED WITH L-ARABINOSE 1NSM ; 1.85 ; CRYSTAL STRUCTURE OF GALACTOSE MUTAROTASE FROM LACTOCOCCUS LACTIS MUTANT D243A COMPLEXED WITH GALACTOSE 1NSS ; 1.85 ; CRYSTAL STRUCTURE OF GALACTOSE MUTAROTASE FROM LACTOCOCCUS LACTIS MUTANT D243A COMPLEXED WITH GLUCOSE 1NS8 ; 1.80 ; CRYSTAL STRUCTURE OF GALACTOSE MUTAROTASE FROM LACTOCOCCUS LACTIS MUTANT D243N COMPLEXED WITH GALACTOSE 1NSR ; 1.80 ; CRYSTAL STRUCTURE OF GALACTOSE MUTAROTASE FROM LACTOCOCCUS LACTIS MUTANT D243N COMPLEXED WITH GLUCOSE 1NS2 ; 1.95 ; CRYSTAL STRUCTURE OF GALACTOSE MUTAROTASE FROM LACTOCOCCUS LACTIS MUTANT E304A COMPLEXED WITH GALACTOSE 1NS7 ; 1.85 ; CRYSTAL STRUCTURE OF GALACTOSE MUTAROTASE FROM LACTOCOCCUS LACTIS MUTANT E304A COMPLEXED WITH GLUCOSE 1NS0 ; 1.85 ; CRYSTAL STRUCTURE OF GALACTOSE MUTAROTASE FROM LACTOCOCCUS LACTIS MUTANT E304Q COMPLEXED WITH GALACTOSE 1NS4 ; 1.85 ; CRYSTAL STRUCTURE OF GALACTOSE MUTAROTASE FROM LACTOCOCCUS LACTIS MUTANT E304Q COMPLEXED WITH GLUCOSE 1NSX ; 1.75 ; CRYSTAL STRUCTURE OF GALACTOSE MUTAROTASE FROM LACTOCOCCUS LACTIS MUTANT H170N COMPLEXED WITH GALACTOSE 1NSZ ; 1.75 ; CRYSTAL STRUCTURE OF GALACTOSE MUTAROTASE FROM LACTOCOCCUS LACTIS MUTANT H170N COMPLEXED WITH GLUCOSE 1NSU ; 1.80 ; CRYSTAL STRUCTURE OF GALACTOSE MUTAROTASE FROM LACTOCOCCUS LACTIS MUTANT H96N COMPLEXED WITH GALACTOSE 1NSV ; 1.80 ; CRYSTAL STRUCTURE OF GALACTOSE MUTAROTASE FROM LACTOCOCCUS LACTIS MUTANT H96N COMPLEXED WITH GLUCOSE 1G9R ; 2.00 ; CRYSTAL STRUCTURE OF GALACTOSYLTRANSFERASE LGTC IN COMPLEX WITH MN AND UDP-2F-GALACTOSE 1UI5 ; 2.40 ; CRYSTAL STRUCTURE OF GAMMA-BUTYROLACTONE RECEPTOR (ARPA LIKE PROTEIN) 1UI6 ; 2.40 ; CRYSTAL STRUCTURE OF GAMMA-BUTYROLACTONE RECEPTOR (ARPA- LIKE PROTEIN) 1K2I ; 1.80 ; CRYSTAL STRUCTURE OF GAMMA-CHYMOTRYPSIN IN COMPLEX WITH 7- HYDROXYCOUMARIN 1O20 ; 2.00 ; CRYSTAL STRUCTURE OF GAMMA-GLUTAMYL PHOSPHATE REDUCTASE (TM0293) FROM THERMOTOGA MARITIMA AT 2.00 A RESOLUTION 1VLU ; 2.29 ; CRYSTAL STRUCTURE OF GAMMA-GLUTAMYL PHOSPHATE REDUCTASE (YOR323C) FROM SACCHAROMYCES CEREVISIAE AT 2.40 A RESOLUTION 1V4G ; 2.50 ; CRYSTAL STRUCTURE OF GAMMA-GLUTAMYLCYSTEINE SYNTHETASE FROM ESCHERICHIA COLI B 1VA6 ; 2.10 ; CRYSTAL STRUCTURE OF GAMMA-GLUTAMYLCYSTEINE SYNTHETASE FROM ESCHERICHIA COLI B COMPLEXED WITH TRANSITION-STATE ANALOGUE 1Z5W ; 3.00 ; CRYSTAL STRUCTURE OF GAMMA-TUBULIN BOUND TO GTP 1EO6 ; 1.80 ; CRYSTAL STRUCTURE OF GATE-16 1PIQ ; 1.80 ; CRYSTAL STRUCTURE OF GCN4-PIQ, A TRIMERIC COILED COIL WITH BURIED POLAR RESIDUES 1BWS ; 2.20 ; CRYSTAL STRUCTURE OF GDP-4-KETO-6-DEOXY-D-MANNOSE EPIMERASE/REDUCTASE FROM ESCHERICHIA COLI A KEY ENZYME IN THE BIOSYNTHESIS OF GDP-L-FUCOSE 1RPN ; 2.15 ; CRYSTAL STRUCTURE OF GDP-D-MANNOSE 4,6-DEHYDRATASE IN COMPLEXES WITH GDP AND NADPH 1N7H ; 1.80 ; CRYSTAL STRUCTURE OF GDP-MANNOSE 4,6-DEHYDRATASE TERNARY COMPLEX WITH NADPH AND GDP 1QIB ; 2.80 ; CRYSTAL STRUCTURE OF GELATINASE A CATALYTIC DOMAIN 1RGI ; 3.00 ; CRYSTAL STRUCTURE OF GELSOLIN DOMAINS G1-G3 BOUND TO ACTIN 1UII ; 2.00 ; CRYSTAL STRUCTURE OF GEMININ COILED-COIL DOMAIN 1PT5 ; 2.00 ; CRYSTAL STRUCTURE OF GENE YFDW OF E. COLI 1MWL ; 2.40 ; CRYSTAL STRUCTURE OF GENETICIN BOUND TO THE EUBACTERIAL 16S RRNA A SITE 1T1J ; 1.70 ; CRYSTAL STRUCTURE OF GENOMICS APC5043 1YOC ; 1.70 ; CRYSTAL STRUCTURE OF GENOMICS APC5556 1YNB ; 1.76 ; CRYSTAL STRUCTURE OF GENOMICS APC5600 1WMW ; 1.55 ; CRYSTAL STRUCTURE OF GERANULGERANYL DIPHOSPHATE SYNTHASE FROM THERMUS THERMOPHILUS 1FI2 ; 1.60 ; CRYSTAL STRUCTURE OF GERMIN (OXALATE OXIDASE) 1J2J ; 1.60 ; CRYSTAL STRUCTURE OF GGA1 GAT N-TERMINAL REGION IN COMPLEX WITH ARF1 GTP FORM 1P4U ; 2.20 ; CRYSTAL STRUCTURE OF GGA3 GAE DOMAIN IN COMPLEX WITH RABAPTIN-5 PEPTIDE 1WR6 ; 2.60 ; CRYSTAL STRUCTURE OF GGA3 GAT DOMAIN IN COMPLEX WITH UBIQUITIN 1IH2 ; 2.80 ; CRYSTAL STRUCTURE OF GGBR5CGBR5CC 1DQN ; 1.75 ; CRYSTAL STRUCTURE OF GIARDIA GUANINE PHOSPHORIBOSYLTRANSFERASE COMPLEXED WITH A TRANSITION STATE ANALOGUE 1DQP ; 1.75 ; CRYSTAL STRUCTURE OF GIARDIA GUANINE PHOSPHORIBOSYLTRANSFERASE COMPLEXED WITH IMMUCILLING 1OXS ; 1.65 ; CRYSTAL STRUCTURE OF GLCV, THE ABC-ATPASE OF THE GLUCOSE ABC TRANSPORTER FROM SULFOLOBUS SOLFATARICUS 1OXT ; 2.10 ; CRYSTAL STRUCTURE OF GLCV, THE ABC-ATPASE OF THE GLUCOSE ABC TRANSPORTER FROM SULFOLOBUS SOLFATARICUS 1OXU ; 2.10 ; CRYSTAL STRUCTURE OF GLCV, THE ABC-ATPASE OF THE GLUCOSE ABC TRANSPORTER FROM SULFOLOBUS SOLFATARICUS 1OXV ; 1.95 ; CRYSTAL STRUCTURE OF GLCV, THE ABC-ATPASE OF THE GLUCOSE ABC TRANSPORTER FROM SULFOLOBUS SOLFATARICUS 1OXX ; 1.45 ; CRYSTAL STRUCTURE OF GLCV, THE ABC-ATPASE OF THE GLUCOSE ABC TRANSPORTER FROM SULFOLOBUS SOLFATARICUS 1VKK ; 1.35 ; CRYSTAL STRUCTURE OF GLIA MATURATION FACTOR-GAMMA (GMFG) FROM MUS MUSCULUS AT 1.50 A RESOLUTION 2BV7 ; 1.79 ; CRYSTAL STRUCTURE OF GLTP WITH BOUND GM3 1UBZ ; 2.00 ; CRYSTAL STRUCTURE OF GLU102-MUTANT HUMAN LYSOZYME DOUBLY LABELED WITH 2',3'-EPOXYPROPYL BETA-GLYCOSIDE OF N- ACETYLLACTOSAMINE 1ZKX ; 2.52 ; CRYSTAL STRUCTURE OF GLU158ALA/THR159ALA/ASN160ALA- A TRIPLE MUTANT OF CLOSTRIDIUM BOTULINUM NEUROTOXIN E CATALYTIC DOMAIN 1ZN3 ; 2.60 ; CRYSTAL STRUCTURE OF GLU335ALA MUTANT OF CLOSTRIDIUM BOTULINUM NEUROTOXIN TYPE E 1ZL5 ; 2.60 ; CRYSTAL STRUCTURE OF GLU335GLN MUTANT OF CLOSTRIDIUM BOTULINUM NEUROTOXIN E CATALYTIC DOMAIN 1AYX ; 1.70 ; CRYSTAL STRUCTURE OF GLUCOAMYLASE FROM SACCHAROMYCOPSIS FIBULIGERA AT 1.7 ANGSTROMS 1ULV ; 2.42 ; CRYSTAL STRUCTURE OF GLUCODEXTRANASE COMPLEXED WITH ACARBOSE 1UG9 ; 2.50 ; CRYSTAL STRUCTURE OF GLUCODEXTRANASE FROM ARTHROBACTER GLOBIFORMIS I42 1VL8 ; 2.07 ; CRYSTAL STRUCTURE OF GLUCONATE 5-DEHYDROGENASE (TM0441) FROM THERMOTOGA MARITIMA AT 2.07 A RESOLUTION 1KNQ ; 2.00 ; CRYSTAL STRUCTURE OF GLUCONATE KINASE 1KO1 ; 2.09 ; CRYSTAL STRUCTURE OF GLUCONATE KINASE 1KO4 ; 2.50 ; CRYSTAL STRUCTURE OF GLUCONATE KINASE 1KO5 ; 2.28 ; CRYSTAL STRUCTURE OF GLUCONATE KINASE 1KO8 ; 2.40 ; CRYSTAL STRUCTURE OF GLUCONATE KINASE 1KOF ; 2.80 ; CRYSTAL STRUCTURE OF GLUCONATE KINASE 2AXR ; 1.98 ; CRYSTAL STRUCTURE OF GLUCOOLIGOSACCHARIDE OXIDASE FROM ACREMONIUM STRICTUM: A NOVEL FLAVINYLATION OF 6-S- CYSTEINYL, 8ALPHA-N1-HISTIDYL FAD 1J5X ; 1.80 ; CRYSTAL STRUCTURE OF GLUCOSAMINE-6-PHOSPHATE DEAMINASE (TM0813) FROM THERMOTOGA MARITIMA AT 1.8 A RESOLUTION 1GCO ; 1.70 ; CRYSTAL STRUCTURE OF GLUCOSE DEHYDROGENASE COMPLEXED WITH NAD+ 1G6K ; 2.00 ; CRYSTAL STRUCTURE OF GLUCOSE DEHYDROGENASE MUTANT E96A COMPLEXED WITH NAD+ 1GEE ; 1.60 ; CRYSTAL STRUCTURE OF GLUCOSE DEHYDROGENASE MUTANT Q252L COMPLEXED WITH NAD+ 1SPX ; 2.10 ; CRYSTAL STRUCTURE OF GLUCOSE DEHYDROGENASE OF CAENORHABDITIS ELEGANS IN THE APO-FORM 1LVW ; 1.70 ; CRYSTAL STRUCTURE OF GLUCOSE-1-PHOSPHATE THYMIDYLYLTRANSFERASE, RMLA, COMPLEX WITH DTDP 1EVJ ; 2.70 ; CRYSTAL STRUCTURE OF GLUCOSE-FRUCTOSE OXIDOREDUCTASE (GFOR) DELTA1-22 S64D 1RYD ; 2.20 ; CRYSTAL STRUCTURE OF GLUCOSE-FRUCTOSE OXIDOREDUCTASE FROM ZYMOMONAS MOBILIS 1LBC ; 1.80 ; CRYSTAL STRUCTURE OF GLUR2 LIGAND BINDING CORE (S1S2J-N775S) IN COMPLEX WITH CYCLOTHIAZIDE (CTZ) AS WELL AS GLUTAMATE AT 1.8 A RESOLUTION 1POI ; 2.50 ; CRYSTAL STRUCTURE OF GLUTACONATE COENZYME A-TRANSFERASE FROM ACIDAMINOCOCCUS FERMENTANS TO 2.55 ANGSTOMS RESOLUTION 2AKO ; 2.20 ; CRYSTAL STRUCTURE OF GLUTAMATE 5-KINASE FROM CAMPYLOBACTER JEJUNI 1MY3 ; 1.75 ; CRYSTAL STRUCTURE OF GLUTAMATE RECEPTOR LIGAND-BINDING CORE IN COMPLEX WITH BROMO-WILLARDIINE IN THE ZN CRYSTAL FORM 1MY4 ; 1.90 ; CRYSTAL STRUCTURE OF GLUTAMATE RECEPTOR LIGAND-BINDING CORE IN COMPLEX WITH IODO-WILLARDIINE IN THE ZN CRYSTAL FORM 4GSA ; 2.50 ; CRYSTAL STRUCTURE OF GLUTAMATE-1-SEMIALDEHYDE AMINOMUTASE (AMINOTRANSFERASE) REDUCED WITH CYANOBOROHYDRATE 2GSA ; 2.40 ; CRYSTAL STRUCTURE OF GLUTAMATE-1-SEMIALDEHYDE AMINOMUTASE (AMINOTRANSFERASE, WILD-TYPE FORM) 3GSB ; 3.00 ; CRYSTAL STRUCTURE OF GLUTAMATE-1-SEMIALDEHYDE AMINOMUTASE IN COMPLEX WITH GABACULINE 1F52 ; 2.49 ; CRYSTAL STRUCTURE OF GLUTAMINE SYNTHETASE FROM SALMONELLA TYPHIMURIUM CO-CRYSTALLIZED WITH ADP 1FPY ; 2.89 ; CRYSTAL STRUCTURE OF GLUTAMINE SYNTHETASE FROM SALMONELLA TYPHIMURIUM WITH INHIBITOR PHOSPHINOTHRICIN 1F1H ; 2.67 ; CRYSTAL STRUCTURE OF GLUTAMINE SYNTHETASE FROM SALMONELLA TYPHIMURIUM WITH THALLIUM IONS 1EUQ ; 3.10 ; CRYSTAL STRUCTURE OF GLUTAMINYL-TRNA SYNTHETASE COMPLEXED WITH A TRNA-GLN MUTANT AND AN ACTIVE-SITE INHIBITOR 1J08 ; 2.30 ; CRYSTAL STRUCTURE OF GLUTAREDOXIN-LIKE PROTEIN FROM PYROCOCCUS HORIKOSHII 1U3I ; 1.89 ; CRYSTAL STRUCTURE OF GLUTATHIONE S-TRANFERASE FROM SCHISTOSOMA MANSONI 1A0F ; 2.10 ; CRYSTAL STRUCTURE OF GLUTATHIONE S-TRANSFERASE FROM ESCHERICHIA COLI COMPLEXED WITH GLUTATHIONESULFONIC ACID 1PA3 ; 2.70 ; CRYSTAL STRUCTURE OF GLUTATHIONE-S-TRANSFERASE FROM PLASMODIUM FALCIPARUM 1U8X ; 2.05 ; CRYSTAL STRUCTURE OF GLVA FROM BACILLUS SUBTILIS, A METAL- REQUIRING, NAD-DEPENDENT 6-PHOSPHO-ALPHA-GLUCOSIDASE 1VC2 ; 2.60 ; CRYSTAL STRUCTURE OF GLYCERALDEHYDE 3-PHOSPHATE DEHYDROGENASE FROM THERMUS THERMOPHILUS HB8 2B4R ; 2.25 ; CRYSTAL STRUCTURE OF GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE FROM PLASMODIUM FALCIPARUM AT 2.25 ANGSTROM RESOLUTION REVEALS INTRIGUING EXTRA ELECTRON DENSITY IN THE ACTIVE SITE 2B4T ; 2.50 ; CRYSTAL STRUCTURE OF GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE FROM PLASMODIUM FALCIPARUM AT 2.25 ANGSTROM RESOLUTION REVEALS INTRIGUING EXTRA ELECTRON DENSITY IN THE ACTIVE SITE 2B8N ; 2.53 ; CRYSTAL STRUCTURE OF GLYCERATE KINASE (EC 2.7.1.31) (TM1585) FROM THERMOTOGA MARITIMA AT 2.70 A RESOLUTION 1O0U ; 2.95 ; CRYSTAL STRUCTURE OF GLYCERATE KINASE (TM1585) FROM THERMOTOGA MARITIMA AT 2.95 A RESOLUTION 1KQ3 ; 1.50 ; CRYSTAL STRUCTURE OF GLYCEROL DEHYDROGENASE (TM0423) FROM THERMOTOGA MARITIMA AT 1.5 A RESOLUTION 1TA9 ; 1.90 ; CRYSTAL STRUCTURE OF GLYCEROL DEHYDROGENASE FROM SCHIZOSACCHAROMYCES POMBE 1VKF ; 1.65 ; CRYSTAL STRUCTURE OF GLYCEROL UPTAKE OPERON ANTITERMINATOR- RELATED PROTEIN (TM1436) FROM THERMOTOGA MARITIMA AT 1.65 A RESOLUTION 1Z82 ; 2.00 ; CRYSTAL STRUCTURE OF GLYCEROL-3-PHOSPHATE DEHYDROGENASE (TM0378) FROM THERMOTOGA MARITIMA AT 2.00 A RESOLUTION 1O1Z ; 1.60 ; CRYSTAL STRUCTURE OF GLYCEROPHOSPHODIESTER PHOSPHODIESTERASE (GDPD) (TM1621) FROM THERMOTOGA MARITIMA AT 1.60 A RESOLUTION 1ZCC ; 2.50 ; CRYSTAL STRUCTURE OF GLYCEROPHOSPHODIESTER PHOSPHODIESTERASE FROM AGROBACTERIUM TUMEFACIENS STR.C58 1VD6 ; 1.30 ; CRYSTAL STRUCTURE OF GLYCEROPHOSPHORYL DIESTER PHOSPHODIESTERASE COMPLEXED WITH GLYCEROL 1V8E ; 1.50 ; CRYSTAL STRUCTURE OF GLYCEROPHOSPHORYL DIESTER PHOSPHODIESTERASE FROM THERMUS THERMOPHILUS HB8 1KJQ ; 1.05 ; CRYSTAL STRUCTURE OF GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE IN COMPLEX WITH MG-ADP 1KJI ; 1.60 ; CRYSTAL STRUCTURE OF GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE IN COMPLEX WITH MG-AMPPCP 1ZKO ; 1.65 ; CRYSTAL STRUCTURE OF GLYCINE CLEAVAGE SYSTEM H PROTEIN (TM0212) FROM THERMOTOGA MARITIMA AT 1.65 A RESOLUTION 1WYT ; 2.40 ; CRYSTAL STRUCTURE OF GLYCINE DECARBOXYLASE (P-PROTEIN) OF THE GLYCINE CLEAVAGE SYSTEM, IN APO FORM 1WYU ; 2.10 ; CRYSTAL STRUCTURE OF GLYCINE DECARBOXYLASE (P-PROTEIN) OF THE GLYCINE CLEAVAGE SYSTEM, IN HOLO FORM 1WYV ; 2.40 ; CRYSTAL STRUCTURE OF GLYCINE DECARBOXYLASE (P-PROTEIN) OF THE GLYCINE CLEAVAGE SYSTEM, IN INHIBITOR-BOUND FORM 1KIA ; 2.80 ; CRYSTAL STRUCTURE OF GLYCINE N-METHYLTRANSFERASE COMPLEXED WITH S-ADENOSYLMETHIONINE AND ACETATE 1OD5 ; 2.10 ; CRYSTAL STRUCTURE OF GLYCININ A3B4 SUBUNIT HOMOHEXAMER 1KJJ ; 1.75 ; CRYSTAL STRUCTURE OF GLYCNIAMIDE RIBONUCLEOTIDE TRANSFORMYLASE IN COMPLEX WITH MG-ATP-GAMMA-S 1P2D ; 1.94 ; CRYSTAL STRUCTURE OF GLYCOGEN PHOSPHORYLASE B IN COMPLEX WITH BETA CYCLODEXTRIN 1P4H ; 2.06 ; CRYSTAL STRUCTURE OF GLYCOGEN PHOSPHORYLASE B IN COMPLEX WITH C-(1-ACETAMIDO-ALPHA-D-GLUCOPYRANOSYL) FORMAMIDE 1P4G ; 2.10 ; CRYSTAL STRUCTURE OF GLYCOGEN PHOSPHORYLASE B IN COMPLEX WITH C-(1-AZIDO-ALPHA-D-GLUCOPYRANOSYL)FORMAMIDE 1P4J ; 2.00 ; CRYSTAL STRUCTURE OF GLYCOGEN PHOSPHORYLASE B IN COMPLEX WITH C-(1-HYDROXY-BETA-D-GLUCOPYRANOSYL)FORMAMIDE 1P2G ; 2.30 ; CRYSTAL STRUCTURE OF GLYCOGEN PHOSPHORYLASE B IN COMPLEX WITH GAMMA CYCLODEXTRIN 1P2B ; 2.20 ; CRYSTAL STRUCTURE OF GLYCOGEN PHOSPHORYLASE B IN COMPLEX WITH MALTOHEPTAOSE 1P29 ; 2.20 ; CRYSTAL STRUCTURE OF GLYCOGEN PHOSPHORYLASE B IN COMPLEX WITH MALTOPENTAOSE 1Q5K ; 1.94 ; CRYSTAL STRUCTURE OF GLYCOGEN SYNTHASE KINASE 3 IN COMPLEXED WITH INHIBITOR 2A6A ; 2.50 ; CRYSTAL STRUCTURE OF GLYCOPROTEIN ENDOPEPTIDASE (TM0874) FROM THERMOTOGA MARITIMA AT 2.50 A RESOLUTION 1GYQ ; 3.40 ; CRYSTAL STRUCTURE OF GLYCOSOMAL GLYCERALDEHYDE FROM LEISHMANIA MEXICANA IN COMPLEX WITH N6-BENZYL-NAD 1EHA ; 3.00 ; CRYSTAL STRUCTURE OF GLYCOSYLTREHALOSE TREHALOHYDROLASE FROM SULFOLOBUS SOLFATARICUS 1J5W ; 1.95 ; CRYSTAL STRUCTURE OF GLYCYL-TRNA SYNTHETASE ALPHA CHAIN (TM0216) FROM THERMOTOGA MARITIMA AT 1.95 A RESOLUTION 1ATI ; 2.75 ; CRYSTAL STRUCTURE OF GLYCYL-TRNA SYNTHETASE FROM THERMUS THERMOPHILUS 1SMB ; 1.55 ; CRYSTAL STRUCTURE OF GOLGI-ASSOCIATED PR-1 PROTEIN 1JE5 ; 1.90 ; CRYSTAL STRUCTURE OF GP2.5, A SINGLE-STRANDED DEOXYRIBONUCLEIC ACID BINDING PROTEIN ENCODED BY BACTERIOPHAGE T7 1WTH ; 2.80 ; CRYSTAL STRUCTURE OF GP5-S351L MUTANT AND GP27 COMPLEX 1J77 ; 1.50 ; CRYSTAL STRUCTURE OF GRAM-NEGATIVE BACTERIAL HEME OXYGENASE COMPLEXED WITH HEME 1XDZ ; 1.60 ; CRYSTAL STRUCTURE OF GRAM_POSITIVE BACILLUS SUBTILIS GLUCOSE INHIBITED DIVISION PROTEIN B (GIDB), STRUCTURAL GENOMICS, MCSG 1F4O ; 2.50 ; CRYSTAL STRUCTURE OF GRANCALCIN WITH BOUND CALCIUM 1GAK ; 1.85 ; CRYSTAL STRUCTURE OF GREEN ABALONE SP18 1PCQ ; 2.81 ; CRYSTAL STRUCTURE OF GROEL-GROES 1SVT ; 2.81 ; CRYSTAL STRUCTURE OF GROEL14-GROES7-(ADP-ALFX)7 1VR8 ; 1.75 ; CRYSTAL STRUCTURE OF GTP BINDING REGULATOR (TM1622) FROM THERMOTOGA MARITIMA AT 1.75 A RESOLUTION 1WF3 ; 1.88 ; CRYSTAL STRUCTURE OF GTP-BINDING PROTEIN TT1341 FROM THERMUS THERMOPHILUS HB8 1R4A ; 2.30 ; CRYSTAL STRUCTURE OF GTP-BOUND ADP-RIBOSYLATION FACTOR LIKE PROTEIN 1 (ARL1) AND GRIP DOMAIN OF GOLGIN245 COMPLEX 1KHH ; 2.50 ; CRYSTAL STRUCTURE OF GUANIDINOACETATE METHYLTRANSFERASE FROM RAT LIVER: A TEMPLATE STRUCTURE OF PROTEIN ARGININE METHYLTRANSFERASE 1S4Q ; 2.16 ; CRYSTAL STRUCTURE OF GUANYLATE KINASE FROM MYCOBACTERIUM TUBERCULOSIS (RV1389) 1Z6G ; 2.18 ; CRYSTAL STRUCTURE OF GUANYLATE KINASE FROM PLASMODIUM FALCIPARUM 1XSE ; 2.50 ; CRYSTAL STRUCTURE OF GUINEA PIG 11BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 1YM8 ; 1.55 ; CRYSTAL STRUCTURE OF GZZ SHOWS UP PUCKERING OF THE PROLINE RING IN THE XAA POSITION. 1LEG ; 1.75 ; CRYSTAL STRUCTURE OF H-2KB BOUND TO THE DEV8 PEPTIDE 1LEK ; 2.15 ; CRYSTAL STRUCTURE OF H-2KBM3 BOUND TO DEV8 1NXZ ; 2.00 ; CRYSTAL STRUCTURE OF H. INFLUENZAE HYPOTHETICAL PROTEIN YGGJ_HAEIN NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET IR73. 1FX3 ; 2.50 ; CRYSTAL STRUCTURE OF H. INFLUENZAE SECB 1MOG ; 1.70 ; CRYSTAL STRUCTURE OF H. SALINARUM DODECIN 1PU6 ; 1.64 ; CRYSTAL STRUCTURE OF H.PYLORI 3-METHYLADENINE DEOXYRIBONUCLEIC ACID GLYCOSYLASE (MAGIII) 1PU8 ; 2.13 ; CRYSTAL STRUCTURE OF H.PYLORI 3-METHYLADENINE DEOXYRIBONUCLEIC ACID GLYCOSYLASE (MAGIII) BOUND TO 1,N6-ETHENOADENINE 1PU7 ; 1.93 ; CRYSTAL STRUCTURE OF H.PYLORI 3-METHYLADENINE DEOXYRIBONUCLEIC ACID GLYCOSYLASE (MAGIII) BOUND TO 3,9-DIMETHYLADENINE 1R38 ; 2.20 ; CRYSTAL STRUCTURE OF H114A MUTANT OF CANDIDA TENUIS XYLOSE REDUCTASE 1WAE ; 1.95 ; CRYSTAL STRUCTURE OF H129V MUTANT OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE 1SO3 ; 1.90 ; CRYSTAL STRUCTURE OF H136A MUTANT OF 3-KETO-L-GULONATE 6- PHOSPHATE DECARBOXYLASE WITH BOUND L-THREONOHYDROXAMATE 4- PHOSPHATE 1NPJ ; 1.90 ; CRYSTAL STRUCTURE OF H145A MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS 1WNI ; 2.20 ; CRYSTAL STRUCTURE OF H2-PROTEINASE 1GS7 ; 1.85 ; CRYSTAL STRUCTURE OF H254F MUTANT OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE 1WA1 ; 1.65 ; CRYSTAL STRUCTURE OF H313Q MUTANT OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE 1WA2 ; 1.72 ; CRYSTAL STRUCTURE OF H313Q MUTANT OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE WITH NITRITE BOUND 1MW9 ; 1.67 ; CRYSTAL STRUCTURE OF H365R MUTANT OF 67 KDA N-TERMINAL FRAGMENT OF E. COLI DEOXYRIBONUCLEIC ACID TOPOISOMERASE I 1JSI ; 2.40 ; CRYSTAL STRUCTURE OF H9 HAEMAGGLUTININ BOUND TO LSTC RECEPTOR ANALOG 1JSH ; 2.40 ; CRYSTAL STRUCTURE OF H9 HAEMAGGLUTININ COMPLEXED WITH LSTA RECEPTOR ANALOG 1YBI ; 1.50 ; CRYSTAL STRUCTURE OF HA33A, A NEUROTOXIN-ASSOCIATED PROTEIN FROM CLOSTRIDIUM BOTULINUM TYPE A 1X2T ; 1.72 ; CRYSTAL STRUCTURE OF HABU IX-BP AT PH 6.5 1QVS ; 2.10 ; CRYSTAL STRUCTURE OF HAEMOPHILUS INFLUENZAE H9A MUTANT HOLO FERRIC ION-BINDING PROTEIN A 1YZY ; 2.10 ; CRYSTAL STRUCTURE OF HAEMOPHILUS INFLUENZAE HYPOTHETICAL PROTEIN HI1011, NEW YORK STRUCTURAL GENOMICS CONSORTIUM 1J6W ; 2.10 ; CRYSTAL STRUCTURE OF HAEMOPHILUS INFLUENZAE LUXS 1QW0 ; 1.90 ; CRYSTAL STRUCTURE OF HAEMOPHILUS INFLUENZAE N175L MUTANT HOLO FERRIC ION-BINDING PROTEIN A 1HJW ; 2.30 ; CRYSTAL STRUCTURE OF HCGP-39 IN COMPLEX WITH CHITIN OCTAMER 1HJV ; 2.75 ; CRYSTAL STRUCTURE OF HCGP-39 IN COMPLEX WITH CHITIN TETRAMER 1QCF ; 2.00 ; CRYSTAL STRUCTURE OF HCK IN COMPLEX WITH A SRC FAMILY- SELECTIVE TYROSINE KINASE INHIBITOR 1RTL ; 2.75 ; CRYSTAL STRUCTURE OF HCV NS3 PROTEASE DOMAIN: NS4A PEPTIDE COMPLEX WITH COVALENTLY BOUND PYRROLIDINE-5,5-TRANSLACTAM INHIBITOR 1N1L ; 2.60 ; CRYSTAL STRUCTURE OF HCV NS3 PROTEASE DOMAIN:NS4A PEPTIDE COMPLEX WITH COVALENTLY BOUND INHIBITOR (GW472467X) 1OS5 ; 2.20 ; CRYSTAL STRUCTURE OF HCV NS5B RIBONUCLEIC ACID POLYMERASE COMPLEXED WITH A NOVEL NON-COMPETITIVE INHIBITOR. 1NM3 ; 2.80 ; CRYSTAL STRUCTURE OF HEAMOPHILUS INFLUENZA HYBRID-PRX5 1M5N ; 2.90 ; CRYSTAL STRUCTURE OF HEAT REPEATS (1-11) OF IMPORTIN B BOUND TO THE NON-CLASSICAL NLS(67-94) OF PTHRP 1OHQ ; 2.00 ; CRYSTAL STRUCTURE OF HEL4, A SOLUBLE HUMAN VH ANTIBODY DOMAIN RESISTANT TO AGGREGATION 1C3K ; 2.00 ; CRYSTAL STRUCTURE OF HELIANTHUS TUBEROSUS LECTIN 1C3N ; 2.45 ; CRYSTAL STRUCTURE OF HELIANTHUS TUBEROSUS LECTIN COMPLEXED TO MAN(1-2)MAN 1UM8 ; 2.60 ; CRYSTAL STRUCTURE OF HELICOBACTER PYLORI CLPX 1J6X ; 2.38 ; CRYSTAL STRUCTURE OF HELICOBACTER PYLORI LUXS 1E9Z ; 3.00 ; CRYSTAL STRUCTURE OF HELICOBACTER PYLORI UREASE 1E9Y ; 3.00 ; CRYSTAL STRUCTURE OF HELICOBACTER PYLORI UREASE IN COMPLEX WITH ACETOHYDROXAMIC ACID 1DQF ; 2.20 ; CRYSTAL STRUCTURE OF HELIX II OF THE X. LAEVIS SOMATIC 5S RRNA WITH A CYTOSINE BULGE IN TWO CONFORMATIONS 1DQH ; 1.70 ; CRYSTAL STRUCTURE OF HELIX II OF THE X. LAEVIS SOMATIC 5S RRNA WITH A CYTOSINE BULGE IN TWO CONFORMATIONS 1C3M ; 2.00 ; CRYSTAL STRUCTURE OF HELTUBA COMPLEXED TO MAN(1-3)MAN 1OR4 ; 2.15 ; CRYSTAL STRUCTURE OF HEMAT SENSOR DOMAIN FROM B.SUBTILIS IN THE CYANO-LIGANDED FORM 1OR6 ; 2.71 ; CRYSTAL STRUCTURE OF HEMAT SENSOR DOMAIN FROM B.SUBTILIS IN THE UNLIGANDED FORM 1IYH ; 1.70 ; CRYSTAL STRUCTURE OF HEMATOPOIETIC PROSTAGLANDIN D SYNTHASE 1IYI ; 1.80 ; CRYSTAL STRUCTURE OF HEMATOPOIETIC PROSTAGLANDIN D SYNTHASE 1PD2 ; 2.30 ; CRYSTAL STRUCTURE OF HEMATOPOIETIC PROSTAGLANDIN D SYNTHASE COMPLEX WITH GLUTATHIONE 1WXR ; 2.20 ; CRYSTAL STRUCTURE OF HEME BINDING PROTEIN, AN AUTOTRANSPORTER HEMOGLOBINE PROTEASE FROM PATHOGENIC ESCHERICHIA COLI 1S66 ; 1.80 ; CRYSTAL STRUCTURE OF HEME DOMAIN OF DIRECT OXYGEN SENSOR FROM E. COLI 1S67 ; 1.50 ; CRYSTAL STRUCTURE OF HEME DOMAIN OF DIRECT OXYGEN SENSOR FROM E. COLI 1WE1 ; 2.50 ; CRYSTAL STRUCTURE OF HEME OXYGENASE-1 FROM CYANOBACTERIUM SYNECHOCYSTIS SP. PCC6803 IN COMPLEX WITH HEME 1WOW ; 2.20 ; CRYSTAL STRUCTURE OF HEME OXYGENASE-2 FROM SYNECHOCYSTIS SP. PCC 6803 COMPLEXED WITH HEME IN FERROUS FORM 1WOX ; 2.10 ; CRYSTAL STRUCTURE OF HEME OXYGENASE-2 FROM SYNECHOCYSTIS SP. PCC 6803 IN COMPLEX WITH HEME AND NO 1V75 ; 2.02 ; CRYSTAL STRUCTURE OF HEMOGLOBIN D FROM THE ALDABRA GIANT TORTOISE (GEOCHELONE GIGANTEA) AT 2.0 A RESOLUTION 1WMU ; 1.65 ; CRYSTAL STRUCTURE OF HEMOGLOBIN D FROM THE ALDABRA GIANT TORTOISE, GEOCHELONE GIGANTEA, AT 1.65 A RESOLUTION 1UC3 ; 2.30 ; CRYSTAL STRUCTURE OF HEMOGLOBINI FROM RIVER LAMPREY 1VCL ; 1.70 ; CRYSTAL STRUCTURE OF HEMOLYTIC LECTIN CEL-III 1G7I ; 1.80 ; CRYSTAL STRUCTURE OF HEN EGG WHITE LYSOZYME (HEL) COMPLEXED WITH THE MUTANT ANTI-HEL MONOCLONAL ANTIBODY D1.3 (VLW92F) 1G7J ; 1.75 ; CRYSTAL STRUCTURE OF HEN EGG WHITE LYSOZYME (HEL) COMPLEXED WITH THE MUTANT ANTI-HEL MONOCLONAL ANTIBODY D1.3 (VLW92H) 1G7L ; 2.00 ; CRYSTAL STRUCTURE OF HEN EGG WHITE LYSOZYME (HEL) COMPLEXED WITH THE MUTANT ANTI-HEL MONOCLONAL ANTIBODY D1.3 (VLW92S) 1G7M ; 1.90 ; CRYSTAL STRUCTURE OF HEN EGG WHITE LYSOZYME (HEL) COMPLEXED WITH THE MUTANT ANTI-HEL MONOCLONAL ANTIBODY D1.3 (VLW92V) 1G7H ; 1.85 ; CRYSTAL STRUCTURE OF HEN EGG WHITE LYSOZYME (HEL) COMPLEXED WITH THE MUTANT ANTI-HEL MONOCLONAL ANTIBODY D1.3(VLW92A) 1RYX ; 3.50 ; CRYSTAL STRUCTURE OF HEN SERUM TRANSFERRIN IN APO- FORM 1WP8 ; 2.20 ; CRYSTAL STRUCTURE OF HENDRA VIRUS FUSION CORE 1VKJ ; 2.50 ; CRYSTAL STRUCTURE OF HEPARAN SULFATE 3-O-SULFOTRANSFERASE ISOFORM 1 IN THE PRESENCE OF PAP 1FNH ; 2.80 ; CRYSTAL STRUCTURE OF HEPARIN AND INTEGRIN BINDING SEGMENT OF HUMAN FIBRONECTIN 2BRK ; 2.30 ; CRYSTAL STRUCTURE OF HEPATITIS C VIRUS POLYMERASE IN COMPLEX WITH AN ALLOSTERIC INHIBITOR (COMPOUND 1) 2BRL ; 2.40 ; CRYSTAL STRUCTURE OF HEPATITIS C VIRUS POLYMERASE IN COMPLEX WITH AN ALLOSTERIC INHIBITOR (COMPOUND 2) 1DML ; 2.70 ; CRYSTAL STRUCTURE OF HERPES SIMPLEX UL42 BOUND TO THE C- TERMINUS OF HSV POL 1R0N ; 2.60 ; CRYSTAL STRUCTURE OF HETERODIMERIC ECDSYONE RECEPTOR DEOXYRIBONUCLEIC ACID BINDING COMPLEX 1X31 ; 2.15 ; CRYSTAL STRUCTURE OF HETEROTETRAMERIC SARCOSINE OXIDASE FROM CORYNEBACTERIUM SP. U-96 1VRQ ; 2.20 ; CRYSTAL STRUCTURE OF HETEROTETRAMERIC SARCOSINE OXIDASE FROM CORYNEBACTERIUM SP. U-96 IN COMPLEX WITH FOLINIC ACID 1QTK ; 2.03 ; CRYSTAL STRUCTURE OF HEW LYSOZYME UNDER PRESSURE OF KRYPTON (55 BAR) 1C10 ; 2.03 ; CRYSTAL STRUCTURE OF HEW LYSOZYME UNDER PRESSURE OF XENON (8 BAR) 1KHI ; 1.78 ; CRYSTAL STRUCTURE OF HEX1 1PZM ; 2.10 ; CRYSTAL STRUCTURE OF HGPRT-ASE FROM LEISHMANIA TARENTOLAE IN COMPLEX WITH GMP 1TDI ; 2.40 ; CRYSTAL STRUCTURE OF HGSTA3-3 IN COMPLEX WITH GLUTATHIONE 3PGT ; 2.14 ; CRYSTAL STRUCTURE OF HGSTP1-1[I104] COMPLEXED WITH THE GSH CONJUGATE OF (+)-ANTI-BPDE 4PGT ; 2.10 ; CRYSTAL STRUCTURE OF HGSTP1-1[V104] COMPLEXED WITH THE GSH CONJUGATE OF (+)-ANTI-BPDE 1S7M ; 2.10 ; CRYSTAL STRUCTURE OF HIABD1 1MQA ; 2.50 ; CRYSTAL STRUCTURE OF HIGH AFFINITY ALPHAL I DOMAIN IN THE ABSENCE OF LIGAND OR METAL 1MQ9 ; 2.00 ; CRYSTAL STRUCTURE OF HIGH AFFINITY ALPHAL I DOMAIN WITH LIGAND MIMETIC CRYSTAL CONTACT 2AIF ; 1.90 ; CRYSTAL STRUCTURE OF HIGH MOBILITY LIKE PROTEIN, NHP2, PUTATIVE FROM CRYPTOSPORIDIUM PARVUM 1EYT ; 1.50 ; CRYSTAL STRUCTURE OF HIGH-POTENTIAL IRON-SULFUR PROTEIN FROM THERMOCHROMATIUM TEPIDUM 1YF8 ; 2.80 ; CRYSTAL STRUCTURE OF HIMALAYAN MISTLETOE RIP REVEALS THE PRESENCE OF A NATURAL INHIBITOR AND A NEW FUNCTIONALLY ACTIVE SUGAR-BINDING SITE 1KSS ; 1.80 ; CRYSTAL STRUCTURE OF HIS505ALA MUTANT FLAVOCYTOCHROME C3 FROM SHEWANELLA FRIGIDIMARINA 1KSU ; 2.00 ; CRYSTAL STRUCTURE OF HIS505TYR MUTANT FLAVOCYTOCHROME C3 FROM SHEWANELLA FRIGIDIMARINA 1WN0 ; 2.20 ; CRYSTAL STRUCTURE OF HISTIDINE-CONTAINING PHOSPHOTRANSFER PROTEIN, ZMHP2, FROM MAIZE 1GEX ; 2.20 ; CRYSTAL STRUCTURE OF HISTIDINOL-PHOSPHATE AMINOTRANSFERASE COMPLEXED WITH HISTIDINOL-PHOSPHATE 1GEY ; 2.30 ; CRYSTAL STRUCTURE OF HISTIDINOL-PHOSPHATE AMINOTRANSFERASE COMPLEXED WITH N-(5'-PHOSPHOPYRIDOXYL)-L-GLUTAMATE 1GEW ; 2.00 ; CRYSTAL STRUCTURE OF HISTIDINOL-PHOSPHATE AMINOTRANSFERASE COMPLEXED WITH PYRIDOXAL 5'-PHOSPHATE 1WU7 ; 2.40 ; CRYSTAL STRUCTURE OF HISTIDYL-TRNA SYNTHETASE FROM THERMOPLASMA ACIDOPHILUM 1U2Z ; 2.20 ; CRYSTAL STRUCTURE OF HISTONE K79 METHYLTRANSFERASE DOT1P FROM YEAST 1T7K ; 2.10 ; CRYSTAL STRUCTURE OF HIV PROTEASE COMPLEXED WITH ARYLSULFONAMIDE AZACYCLIC UREA 1NPW ; 2.00 ; CRYSTAL STRUCTURE OF HIV PROTEASE COMPLEXED WITH LGZ479 1ZTZ ; 2.15 ; CRYSTAL STRUCTURE OF HIV PROTEASE- METALLACARBORANE COMPLEX 1E6J ; 3.00 ; CRYSTAL STRUCTURE OF HIV-1 CAPSID PROTEIN (P24) IN COMPLEX WITH FAB13B5 2B4C ; 3.30 ; CRYSTAL STRUCTURE OF HIV-1 JR-FL GP120 CORE PROTEIN CONTAINING THE THIRD VARIABLE REGION (V3) COMPLEXED WITH CD4 AND THE X5 ANTIBODY 1TZG ; 2.20 ; CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH A 13-RESIDUE PEPTIDE CONTAINING THE 4E10 EPITOPE ON GP41 1IIQ ; 1.83 ; CRYSTAL STRUCTURE OF HIV-1 PROTEASE COMPLEXED WITH A HYDROXYETHYLAMINE PEPTIDOMIMETIC INHIBITOR 1SP5 ; 1.80 ; CRYSTAL STRUCTURE OF HIV-1 PROTEASE COMPLEXED WITH A PRODUCT OF AUTOPROTEOLYSIS 1NPV ; 2.00 ; CRYSTAL STRUCTURE OF HIV-1 PROTEASE COMPLEXED WITH LDC271 1MUI ; 2.80 ; CRYSTAL STRUCTURE OF HIV-1 PROTEASE COMPLEXED WITH LOPINAVIR. 1G35 ; 1.80 ; CRYSTAL STRUCTURE OF HIV-1 PROTEASE IN COMPLEX WITH INHIBITOR, AHA024 1NPA ; 2.00 ; CRYSTAL STRUCTURE OF HIV-1 PROTEASE-HUP 1S9G ; 2.80 ; CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R120394. 1S9E ; 2.60 ; CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R129385 1S6Q ; 3.00 ; CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R147681 2BAN ; 2.95 ; CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R157208 2B5J ; 2.90 ; CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R165481 1SUQ ; 3.00 ; CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R185545 2BE2 ; 2.43 ; CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH R221239 2B6A ; 2.65 ; CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH THR-50 1RT1 ; 2.55 ; CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH MKC-442 1RT2 ; 2.55 ; CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH TNK-651 1R0A ; 2.80 ; CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE COVALENTLY TETHERED TO DEOXYRIBONUCLEIC ACID TEMPLATE-PRIMER SOLVED TO 2.8 ANGSTROMS 1JLQ ; 3.00 ; CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 739W94 1HYS ; 3.00 ; CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A POLYPURINE TRACT RIBONUCLEIC ACID:DEOXYRIBONUCLEIC ACID 1C0T ; 2.70 ; CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH BM+21.1326 1C0U ; 2.52 ; CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH BM+50.0934 1FK9 ; 2.50 ; CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DMP-266(EFAVIRENZ) 1C1B ; 2.50 ; CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GCA-186 1TKT ; 2.60 ; CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW426318 1TKZ ; 2.81 ; CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW429576 1TL3 ; 2.80 ; CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW450557 1TL1 ; 2.90 ; CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW451211 1TKX ; 2.85 ; CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW490745 1DTQ ; 2.80 ; CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH PETT-1 (PETT131A94) 1DTT ; 3.00 ; CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH PETT-2 (PETT130A94) 1EP4 ; 2.50 ; CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH S-1153 1C1C ; 2.50 ; CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH TNK-6123 1FIR ; 3.30 ; CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTION PRIMER TRNA(LYS3) 2BGR ; 2.00 ; CRYSTAL STRUCTURE OF HIV-1 TAT DERIVED NONAPEPTIDES TAT(1-9) BOUND TO THE ACTIVE SITE OF DIPEPTIDYL PEPTIDASE IV (CD26) 1MU2 ; 2.35 ; CRYSTAL STRUCTURE OF HIV-2 REVERSE TRANSCRIPTASE 1M6O ; 1.60 ; CRYSTAL STRUCTURE OF HLA B4402 IN COMPLEX WITH HLA DPA0201 PEPTIDE 1SYS ; 2.40 ; CRYSTAL STRUCTURE OF HLA, B4403, AND PEPTIDE EEPTVIKKY 1B0R ; 2.90 ; CRYSTAL STRUCTURE OF HLA-A0201 COMPLEXED WITH A PEPTIDE WITH THE CARBOXYL-TERMINAL GROUP SUBSTITUTED BY A METHYL GROUP 1I4F ; 1.40 ; CRYSTAL STRUCTURE OF HLA-A0201/MAGE-A4-PEPTIDE COMPLEX 1DUY ; 2.15 ; CRYSTAL STRUCTURE OF HLA-A0201/OCTAMERIC TAX PEPTIDE COMPLEX 1X7Q ; 1.45 ; CRYSTAL STRUCTURE OF HLA-A1101 WITH SARS NUCLEOCAPSID PEPTIDE 1W72 ; 2.15 ; CRYSTAL STRUCTURE OF HLA-A1:MAGE-A1 IN COMPLEX WITH FAB- HYB3 1P7Q ; 3.40 ; CRYSTAL STRUCTURE OF HLA-A2 BOUND TO LIR-1, A HOST AND VIRAL MHC RECEPTOR 1JF1 ; 1.85 ; CRYSTAL STRUCTURE OF HLA-A20201 IN COMPLEX WITH A DECAMERIC ALTERED PEPTIDE LIGAND FROM THE MART-1/MELAN-A 1JHT ; 2.15 ; CRYSTAL STRUCTURE OF HLA-A20201 IN COMPLEX WITH A NONAMERIC ALTERED PEPTIDE LIGAND (ALGIGILTV) FROM THE MART- 1/MELAN-A. 2A83 ; 1.40 ; CRYSTAL STRUCTURE OF HLA-B2705 COMPLEXED WITH THE GLUCAGON RECEPTOR (GR) PEPTIDE (RESIDUES 412-420) 1UXS ; 1.55 ; CRYSTAL STRUCTURE OF HLA-B2705 COMPLEXED WITH THE LATENT MEMBRANE PROTEIN 2 PEPTIDE (LMP2)OF EPSTEIN-BARR VIRUS 1W0V ; 2.27 ; CRYSTAL STRUCTURE OF HLA-B2705 COMPLEXED WITH THE SELF-PEPTIDE TIS FROM EGF-RESPONSE FACTOR 1 1OGT ; 1.47 ; CRYSTAL STRUCTURE OF HLA-B2705 COMPLEXED WITH THE VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VIPR) PEPTIDE (RESIDUES 400-408) 1UXW ; 1.71 ; CRYSTAL STRUCTURE OF HLA-B2709 COMPLEXED WITH THE LATENT MEMBRANE PROTEIN 2 PEPTIDE (LMP2) OF EPSTEIN-BARR VIRUS 1W0W ; 2.10 ; CRYSTAL STRUCTURE OF HLA-B2709 COMPLEXED WITH THE SELF-PEPTIDE TIS FROM EGF-RESPONSE FACTOR 1 1OF2 ; 2.20 ; CRYSTAL STRUCTURE OF HLA-B2709 COMPLEXED WITH THE VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VIPR) PEPTIDE (RESIDUES 400-408) 1ZHK ; 1.60 ; CRYSTAL STRUCTURE OF HLA-B3501 PRESENTING 13-MER EBV ANTIGEN LPEPLPQGQLTAY 1ZSD ; 1.70 ; CRYSTAL STRUCTURE OF HLA-B3501 PRESENTING AN 11-MER EBV ANTIGEN EPLPQGQLTAY 1ZHL ; 1.50 ; CRYSTAL STRUCTURE OF HLA-B3508 PRESENTING 13-MER EBV ANTIGEN LPEPLPQGQLTAY 1QQD ; 2.70 ; CRYSTAL STRUCTURE OF HLA-CW4, A LIGAND FOR THE KIR2D NATURAL KILLER CELL INHIBITORY RECEPTOR 1UVQ ; 1.80 ; CRYSTAL STRUCTURE OF HLA-DQ0602 IN COMPLEX WITH A HYPOCRETIN PEPTIDE 1S9V ; 2.22 ; CRYSTAL STRUCTURE OF HLA-DQ2 COMPLEXED WITH DEAMIDATED GLIADIN PEPTIDE 1KLU ; 1.93 ; CRYSTAL STRUCTURE OF HLA-DR1/TPI(23-37) COMPLEXED WITH STAPHYLOCOCCAL ENTEROTOXIN C3 VARIANT 3B2 (SEC3-3B2) 1KLG ; 2.40 ; CRYSTAL STRUCTURE OF HLA-DR1/TPI(23-37, THR28-->ILE MUTANT) COMPLEXED WITH STAPHYLOCOCCAL ENTEROTOXIN C3 VARIANT 3B2 (SEC3-3B2) 1BX2 ; 2.60 ; CRYSTAL STRUCTURE OF HLA-DR2 (DRA0101,DRB11501) COMPLEXED WITH A PEPTIDE FROM HUMAN MYELIN BASIC PROTEIN 1D6E ; 2.45 ; CRYSTAL STRUCTURE OF HLA-DR4 COMPLEX WITH PEPTIDOMIMETIC AND SEB 1X9E ; 2.40 ; CRYSTAL STRUCTURE OF HMG-COA SYNTHASE FROM ENTEROCOCCUS FAECALIS 1YSL ; 1.90 ; CRYSTAL STRUCTURE OF HMG-COA SYNTHASE FROM ENTEROCOCCUS FAECALIS WITH ACETOACETYL-COA LIGAND. 1CKT ; 2.50 ; CRYSTAL STRUCTURE OF HMG1 DOMAIN A BOUND TO A CISPLATIN- MODIFIED DEOXYRIBONUCLEIC ACID DUPLEX 1J7D ; 1.85 ; CRYSTAL STRUCTURE OF HMMS2-HUBC13 1PZL ; 2.10 ; CRYSTAL STRUCTURE OF HNF4A LBD IN COMPLEX WITH THE LIGAND AND THE COACTIVATOR SRC-1 PEPTIDE 1M3Q ; 1.90 ; CRYSTAL STRUCTURE OF HOGG1 D268E MUTANT WITH BASE-EXCISED DEOXYRIBONUCLEIC ACID AND 8-AMINOGUANINE 1M3H ; 2.05 ; CRYSTAL STRUCTURE OF HOGG1 D268E MUTANT WITH PRODUCT OLIGONUCLEOTIDE 2BDD ; 2.28 ; CRYSTAL STRUCTURE OF HOLO-ACP-SYNTHASE FROM PLASMODIUM YOELII 1KQW ; 1.38 ; CRYSTAL STRUCTURE OF HOLO-CRBP FROM ZEBRAFISH 1PFF ; 2.50 ; CRYSTAL STRUCTURE OF HOMOCYSTEINE ALPHA-, GAMMA-LYASE AT 1.8 ANGSTROMS 1F1U ; 1.50 ; CRYSTAL STRUCTURE OF HOMOPROTOCATECHUATE 2,3-DIOXYGENASE FROM ARTHROBACTER GLOBIFORMIS (NATIVE, LOW TEMPERATURE) 1F1R ; 1.80 ; CRYSTAL STRUCTURE OF HOMOPROTOCATECHUATE 2,3-DIOXYGENASE FROM ARTHROBACTER GLOBIFORMIS (NATIVE, NON-CRYO) 1F1X ; 1.60 ; CRYSTAL STRUCTURE OF HOMOPROTOCATECHUATE 2,3-DIOXYGENASE FROM BREVIBACTERIUM FUSCUM 1Q0O ; 2.30 ; CRYSTAL STRUCTURE OF HOMOPROTOCATECHUATE 2,3-DIOXYGENASE FROM BREVIBACTERIUM FUSCUM (FULL LENGTH PROTEIN) 1FWL ; 2.25 ; CRYSTAL STRUCTURE OF HOMOSERINE KINASE 1FWK ; 2.10 ; CRYSTAL STRUCTURE OF HOMOSERINE KINASE COMPLEXED WITH ADP 1H72 ; 1.80 ; CRYSTAL STRUCTURE OF HOMOSERINE KINASE COMPLEXED WITH HSE 1H74 ; 1.90 ; CRYSTAL STRUCTURE OF HOMOSERINE KINASE COMPLEXED WITH ILE 1H73 ; 2.00 ; CRYSTAL STRUCTURE OF HOMOSERINE KINASE COMPLEXED WITH THREONINE 2B61 ; 1.65 ; CRYSTAL STRUCTURE OF HOMOSERINE TRANSACETYLASE 1JDN ; 2.90 ; CRYSTAL STRUCTURE OF HORMONE RECEPTOR 1JDP ; 2.00 ; CRYSTAL STRUCTURE OF HORMONE/RECEPTOR COMPLEX 1IWH ; 1.55 ; CRYSTAL STRUCTURE OF HORSE CARBONMONOXYHEMOGLOBIN- BEZAFIBRATE COMPLEX AT 1.55A RESOLUTION: A NOVEL ALLOSTERIC BINDING SITE IN R-STATE HEMOGLOBIN 1PUF ; 1.90 ; CRYSTAL STRUCTURE OF HOXA9 AND PBX1 HOMEODOMAINS BOUND TO DEOXYRIBONUCLEIC ACID 1GTT ; 1.70 ; CRYSTAL STRUCTURE OF HPCE 1I7O ; 1.70 ; CRYSTAL STRUCTURE OF HPCE 1U7B ; 1.88 ; CRYSTAL STRUCTURE OF HPCNA BOUND TO RESIDUES 331-350 OF THE FLAP ENDONUCLEASE-1 (FEN1) 1U76 ; 2.60 ; CRYSTAL STRUCTURE OF HPCNA BOUND TO RESIDUES 452-466 OF THE DEOXYRIBONUCLEIC ACID POLYMERASE-DELTA-P66 SUBUNIT 1XQZ ; 2.10 ; CRYSTAL STRUCTURE OF HPIM-1 KINASE AT 2.1 A RESOLUTION 1XR1 ; 2.10 ; CRYSTAL STRUCTURE OF HPIM-1 KINASE IN COMPLEX WITH AMP-PNP AT 2.1 A RESOLUTION 2B9D ; 1.60 ; CRYSTAL STRUCTURE OF HPV E7 CR3 DOMAIN 1ZKK ; 1.45 ; CRYSTAL STRUCTURE OF HSET8 IN TERNARY COMPLEX WITH H4 PEPTIDE (16-24) AND ADOHCY 1G41 ; 2.30 ; CRYSTAL STRUCTURE OF HSLU HAEMOPHILUS INFLUENZAE 1NED ; 3.80 ; CRYSTAL STRUCTURE OF HSLV (CLPQ) AT 3.8 ANGSTROMS RESOLUTION 1M4Y ; 2.10 ; CRYSTAL STRUCTURE OF HSLV FROM THERMOTOGA MARITIMA 1IZY ; 2.80 ; CRYSTAL STRUCTURE OF HSP31 1IZZ ; 2.31 ; CRYSTAL STRUCTURE OF HSP31 1P7C ; 2.10 ; CRYSTAL STRUCTURE OF HSV1-TK COMPLEXED WITH TP5A 1Y9Q ; 1.90 ; CRYSTAL STRUCTURE OF HTH_3 FAMILY TRANSCRIPTIONAL REGULATOR FROM VIBRIO CHOLERAE 2AV1 ; 1.95 ; CRYSTAL STRUCTURE OF HTLV-1 TAX PEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2 WITH THE E63Q AND K66A MUTATIONS IN THE HEAVY CHAIN. 2AV7 ; 2.05 ; CRYSTAL STRUCTURE OF HTLV-1 TAX PEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2 WITH THE K66A MUTATION IN THE HEAVY CHAIN. 1FXL ; 1.80 ; CRYSTAL STRUCTURE OF HUD AND AU-RICH ELEMENT OF THE C-FOS RIBONUCLEIC ACID 1G2E ; 2.30 ; CRYSTAL STRUCTURE OF HUD AND AU-RICH ELEMENT OF THE TUMOR NECROSIS FACTOR ALPHA RIBONUCLEIC ACID 1ZBQ ; 2.71 ; CRYSTAL STRUCTURE OF HUMAN 17-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 4 IN COMPLEX WITH NAD 1YB1 ; 1.95 ; CRYSTAL STRUCTURE OF HUMAN 17-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE XI 1XF0 ; 2.00 ; CRYSTAL STRUCTURE OF HUMAN 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 5 (AKR1C3) COMPLEXED WITH DELTA4- ANDROSTENE-3,17-DIONE AND NADP 1MRQ ; 1.59 ; CRYSTAL STRUCTURE OF HUMAN 20ALPHA-HSD IN TERNARY COMPLEX WITH NADP AND 20ALPHA-HYDROXY-PROGESTERONE 1T8T ; 1.85 ; CRYSTAL STRUCTURE OF HUMAN 3-O-SULFOTRANSFERASE-3 WITH BOUND PAP 1T8U ; 1.95 ; CRYSTAL STRUCTURE OF HUMAN 3-O-SULFOTRANSFERASE-3 WITH BOUND PAP AND TETRASACCHARIDE SUBSTRATE 1QRN ; 2.80 ; CRYSTAL STRUCTURE OF HUMAN A6 TCR COMPLEXED WITH HLA-A2 BOUND TO ALTERED HTLV-1 TAX PEPTIDE P6A 1NLN ; 1.60 ; CRYSTAL STRUCTURE OF HUMAN ADENOVIRUS 2 PROTEINASE WITH ITS 11 AMINO ACID COFACTOR AT 1.6 ANGSTROM RESOLUTION 2BBW ; 2.05 ; CRYSTAL STRUCTURE OF HUMAN ADENYLATE KINASE 4 (AK4) IN COMPLEX WITH DIGUANOSINE PENTAPHOSPHATE 2AR7 ; 2.15 ; CRYSTAL STRUCTURE OF HUMAN ADENYLATE KINASE 4, AK4 1TOW ; 2.00 ; CRYSTAL STRUCTURE OF HUMAN ADIPOCYTE FATTY ACID BINDING PROTEIN IN COMPLEX WITH A CARBOXYLIC ACID LIGAND 1TOU ; 2.00 ; CRYSTAL STRUCTURE OF HUMAN ADIPOCYTE FATTY ACID BINDING PROTEIN IN COMPLEX WITH A NON-COVALENT LIGAND 1Q33 ; 1.81 ; CRYSTAL STRUCTURE OF HUMAN ADP-RIBOSE PYROPHOSPHATASE NUDT9 1JV3 ; 2.20 ; CRYSTAL STRUCTURE OF HUMAN AGX1 COMPLEXED WITH UDPGALNAC 1JV1 ; 1.90 ; CRYSTAL STRUCTURE OF HUMAN AGX1 COMPLEXED WITH UDPGLCNAC 1JVG ; 2.30 ; CRYSTAL STRUCTURE OF HUMAN AGX2 COMPLEXED WITH UDPGALNAC 1JVD ; 2.40 ; CRYSTAL STRUCTURE OF HUMAN AGX2 COMPLEXED WITH UDPGLCNAC 1Z83 ; 1.90 ; CRYSTAL STRUCTURE OF HUMAN AK1A IN COMPLEX WITH AP5A 1U3T ; 2.49 ; CRYSTAL STRUCTURE OF HUMAN ALCOHOL DEHYDROGENASE ALPHA- ALPHA ISOFORM COMPLEXED WITH N-CYCLOPENTYL-N- CYCLOBUTYLFORMAMIDE DETERMINED TO 2.5 ANGSTROM RESOLUTION 1U3U ; 1.60 ; CRYSTAL STRUCTURE OF HUMAN ALCOHOL DEHYDROGENASE BETA-1- BETA-1 ISOFORM COMPLEXED WITH N-BENZYLFORMAMIDE DETERMINED TO 1.6 ANGSTROM RESOLUTION 1U3V ; 1.65 ; CRYSTAL STRUCTURE OF HUMAN ALCOHOL DEHYDROGENASE BETA-1- BETA-1 ISOFORM COMPLEXED WITH N-HEPTYLFORMAMIDE DETERMINED TO 1.65 ANGSTROM RESOLUTION 1U3W ; 1.45 ; CRYSTAL STRUCTURE OF HUMAN ALCOHOL DEHYDROGENASE GAMMA-2- GAMMA-2 ISOFORM COMPLEXED WITH N-1-METHYLHEPTYLFORMAMIDE DETERMINED TO 1.45 ANGSTROM RESOLUTION 1PWM ; 0.92 ; CRYSTAL STRUCTURE OF HUMAN ALDOSE REDUCTASE COMPLEXED WITH NADP AND FIDARESTAT 1T41 ; 1.05 ; CRYSTAL STRUCTURE OF HUMAN ALDOSE REDUCTASE COMPLEXED WITH NADP AND IDD552 1T40 ; 1.80 ; CRYSTAL STRUCTURE OF HUMAN ALDOSE REDUCTASE COMPLEXED WITH NADP AND IDD552 AT PH 5 1PWL ; 1.10 ; CRYSTAL STRUCTURE OF HUMAN ALDOSE REDUCTASE COMPLEXED WITH NADP AND MINALRESTAT 1IEI ; 2.50 ; CRYSTAL STRUCTURE OF HUMAN ALDOSE REDUCTASE COMPLEXED WITH THE INHIBITOR ZENARESTAT. 1D4P ; 2.07 ; CRYSTAL STRUCTURE OF HUMAN ALPHA THROMBIN IN COMPLEX WITH 5- AMIDINOINDOLE-4-BENZYLPIPERIDINE INHIBITOR 1D3D ; 2.04 ; CRYSTAL STRUCTURE OF HUMAN ALPHA THROMBIN IN COMPLEX WITH BENZOTHIOPHENE INHIBITOR 4 1D3T ; 3.00 ; CRYSTAL STRUCTURE OF HUMAN ALPHA THROMBIN IN COMPLEX WITH BENZO[B]THIOPHENE INHIBITOR 1 1D3Q ; 2.90 ; CRYSTAL STRUCTURE OF HUMAN ALPHA THROMBIN IN COMPLEX WITH BENZO[B]THIOPHENE INHIBITOR 2 1ZMK ; 1.30 ; CRYSTAL STRUCTURE OF HUMAN ALPHA-DEFENSIN-2 (VARIANT GLY16- > D-ALA), P 42 21 2 SPACE GROUP 1G37 ; 2.00 ; CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN COMPLEXED WITH BCH-10556 AND EXOSITE-DIRECTED PEPTIDE 7KME ; 2.10 ; CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN INHIBITED WITH SEL2711. 8KME ; 2.10 ; CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN INHIBITED WITH SEL2770. 1DOJ ; 1.70 ; CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBINRWJ-51438 COMPLEX AT 1.7 A 1R5L ; 1.50 ; CRYSTAL STRUCTURE OF HUMAN ALPHA-TOCOPHEROL TRANSFER PROTEIN BOUND TO ITS LIGAND 1ZMI ; 1.15 ; CRYSTAL STRUCTURE OF HUMAN ALPHA_DEFENSIN-2 (VARIANT GLY16- >D-ALA), P 32 2 1 SPACE GROUP ) 1B1I ; 1.80 ; CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN 1K5A ; 2.33 ; CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN DOUBLE VARIANT I119A/F120A 1H0D ; 2.00 ; CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN IN COMPLEX WITH FAB FRAGMENT OF ITS MONOCLONAL ANTIBODY MAB 26-2F 2ANG ; 2.00 ; CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN OF THE MET(-1) FORM 1K58 ; 2.70 ; CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT D116H 1K5B ; 1.80 ; CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT DES(121-123) 1B1J ; 2.00 ; CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT H13A. 1B1E ; 2.00 ; CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT K40Q 1K59 ; 1.80 ; CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT Q117G 1UN3 ; 1.70 ; CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT T44D 1UN4 ; 2.10 ; CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT T80A 1O8A ; 2.00 ; CRYSTAL STRUCTURE OF HUMAN ANGIOTENSIN CONVERING ENZYME (NATIVE). 1O86 ; 2.00 ; CRYSTAL STRUCTURE OF HUMAN ANGIOTENSIN CONVERING ENZYME IN COMPLEX WITH LISINOPRIL. 1RZG ; 2.00 ; CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120 REACTIVE ANTIBODY 412D 1RZ8 ; 2.30 ; CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 17B 1RZI ; 2.90 ; CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 47E FAB 1RZ7 ; 2.00 ; CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 48D 1RZF ; 1.70 ; CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY E51 1DEW ; 2.65 ; CRYSTAL STRUCTURE OF HUMAN APE1 BOUND TO ABASIC DEOXYRIBONUCLEIC ACID 1D3P ; 2.10 ; CRYSTAL STRUCTURE OF HUMAN APLHA-THROMBIN IN COMPLEX WITH BENZO[B]THIOPHENE INHIBITOR 3 1PFQ ; 1.90 ; CRYSTAL STRUCTURE OF HUMAN APO DIPEPTIDYL PEPTIDASE IV / CD26 1TK3 ; 2.00 ; CRYSTAL STRUCTURE OF HUMAN APO DIPEPTIDYL PEPTIDASE IV/CD26 1AV1 ; 4.00 ; CRYSTAL STRUCTURE OF HUMAN APOLIPOPROTEIN A-I 2AEB ; 1.29 ; CRYSTAL STRUCTURE OF HUMAN ARGINASE I AT 1.29 A RESOLUTION AND EXPLORATION OF INHIBITION IN IMMUNE RESPONSE. 1WVA ; 1.94 ; CRYSTAL STRUCTURE OF HUMAN ARGINASE I FROM TWINNED CRYSTAL 1WVB ; 2.30 ; CRYSTAL STRUCTURE OF HUMAN ARGINASE I: THE MUTANT E256Q 1ZJ6 ; 2.00 ; CRYSTAL STRUCTURE OF HUMAN ARL5 1P4R ; 2.55 ; CRYSTAL STRUCTURE OF HUMAN ATIC IN COMPLEX WITH FOLATE- BASED INHIBITOR BW1540U88UD 1PL0 ; 2.60 ; CRYSTAL STRUCTURE OF HUMAN ATIC IN COMPLEX WITH FOLATE- BASED INHIBITOR, BW2315U89UC 1PKX ; 1.90 ; CRYSTAL STRUCTURE OF HUMAN ATIC IN COMPLEX WITH XMP 1HZD ; 2.20 ; CRYSTAL STRUCTURE OF HUMAN AUH PROTEIN, AN RIBONUCLEIC ACID-BINDING HOMOLOGUE OF ENOYL-COA HYDRATASE 1JIQ ; 1.90 ; CRYSTAL STRUCTURE OF HUMAN AUTOCRINE MOTILITY FACTOR 1IRI ; 2.40 ; CRYSTAL STRUCTURE OF HUMAN AUTOCRINE MOTILITY FACTOR COMPLEXED WITH AN INHIBITOR 1YFK ; 2.70 ; CRYSTAL STRUCTURE OF HUMAN B TYPE PHOSPHOGLYCERATE MUTASE 1YJX ; 2.80 ; CRYSTAL STRUCTURE OF HUMAN B TYPE PHOSPHOGLYCERATE MUTASE 1XWW ; 1.63 ; CRYSTAL STRUCTURE OF HUMAN B-FORM LOW MOLECULAR WEIGHT PHOSPHOTYROSYL PHOSPHATASE AT 1.6 ANGSTROM RESOLUTION 1SZ7 ; 1.55 ; CRYSTAL STRUCTURE OF HUMAN BET3 2B8L ; 1.70 ; CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE COMPLEXED WITH L- 000384950 1TQF ; 1.80 ; CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE COMPLEXED WITH L- 124,671 1C1Z ; 2.87 ; CRYSTAL STRUCTURE OF HUMAN BETA-2-GLYCOPROTEIN-I (APOLIPOPROTEIN-H) 2B8V ; 1.80 ; CRYSTAL STRUCTURE OF HUMAN BETA-SECRETASE COMPLEXED WITH L- L000430,469 1FDQ ; 2.10 ; CRYSTAL STRUCTURE OF HUMAN BRAIN FATTY ACID BINDING PROTEIN 1FE3 ; 2.80 ; CRYSTAL STRUCTURE OF HUMAN BRAIN FATTY ACID BINDING PROTEIN OLEIC ACID 1EKP ; 2.50 ; CRYSTAL STRUCTURE OF HUMAN BRANCHED CHAIN AMINO ACID AMINOTRANSFERASE (MITOCHONDRIAL) COMPLEXED WITH PYRIDOXAL- 5'-PHOSPHATE AT 2.5 ANGSTROMS (MONOCLINIC FORM). 1P0I ; 2.00 ; CRYSTAL STRUCTURE OF HUMAN BUTYRYL CHOLINESTERASE 1P0M ; 2.38 ; CRYSTAL STRUCTURE OF HUMAN BUTYRYL CHOLINESTERASE IN COMPLEX WITH A CHOLINE MOLECULE 1MF8 ; 3.10 ; CRYSTAL STRUCTURE OF HUMAN CALCINEURIN COMPLEXED WITH CYCLOSPORIN A AND HUMAN CYCLOPHILIN 1XEG ; 1.81 ; CRYSTAL STRUCTURE OF HUMAN CARBONIC ANHYDRASE II COMPLEXED WITH AN ACETATE ION 1EOU ; 2.10 ; CRYSTAL STRUCTURE OF HUMAN CARBONIC ANHYDRASE II COMPLEXED WITH AN ANTICONVULSANT SUGAR SULFAMATE 1XEV ; 2.20 ; CRYSTAL STRUCTURE OF HUMAN CARBONIC ANHYDRASE II IN A NEW CRYSTAL FORM 1LJW ; 2.16 ; CRYSTAL STRUCTURE OF HUMAN CARBONMONOXY HEMOGLOBIN AT 2.16 A: A SNAPSHOT OF THE ALLOSTERIC TRANSITION 1IRD ; 1.25 ; CRYSTAL STRUCTURE OF HUMAN CARBONMONOXY-HAEMOGLOBIN AT 1.25 A RESOLUTION 1UWY ; 3.00 ; CRYSTAL STRUCTURE OF HUMAN CARBOXYPEPTIDASE M 1NWR ; 2.70 ; CRYSTAL STRUCTURE OF HUMAN CARTILAGE GP39 (HC-GP39) 1NWS ; 2.70 ; CRYSTAL STRUCTURE OF HUMAN CARTILAGE GP39 (HC-GP39) IN COMPLEX WITH CHITOBIOSE 1NWT ; 2.50 ; CRYSTAL STRUCTURE OF HUMAN CARTILAGE GP39 (HC-GP39) IN COMPLEX WITH CHITOPENTAOSE 1NWU ; 2.20 ; CRYSTAL STRUCTURE OF HUMAN CARTILAGE GP39 (HC-GP39) IN COMPLEX WITH CHITOTETRAOSE 1RWK ; 2.30 ; CRYSTAL STRUCTURE OF HUMAN CASPASE-1 IN COMPLEX WITH 3-(2- MERCAPTO-ACETYLAMINO)-4-OXO-PENTANOIC ACID 1RWN ; 2.00 ; CRYSTAL STRUCTURE OF HUMAN CASPASE-1 IN COMPLEX WITH 3-{2- ETHYL-6-[4-(QUINOXALIN-2-YLAMINO)-BENZOYLAMINO]- HEXANOYLAMINO}-4-OXO-BUTYRIC ACID 1RWP ; 2.20 ; CRYSTAL STRUCTURE OF HUMAN CASPASE-1 IN COMPLEX WITH 3-{6- [(8-HYDROXY-QUINOLINE-2-CARBONYL)-AMINO]-2-THIOPHEN-2-YL- HEXANOYLAMINO}-4-OXO-BUTYRIC ACID 1RWW ; 2.80 ; CRYSTAL STRUCTURE OF HUMAN CASPASE-1 IN COMPLEX WITH 4-OXO- 3-[(6-{[4-(QUINOXALIN-2-YLAMINO)-BENZOYLAMINO]-METHYL}- PYRIDINE-3-CARBONYL)-AMINO]-BUTYRIC ACID 1RWM ; 2.70 ; CRYSTAL STRUCTURE OF HUMAN CASPASE-1 IN COMPLEX WITH 4-OXO- 3-[2-(5-{[4-(QUINOXALIN-2-YLAMINO)-BENZOYLAMINO]-METHYL}- THIOPHEN-2-YL)-ACETYLAMINO]-PENTANOIC ACID 1RWO ; 2.10 ; CRYSTAL STRUCTURE OF HUMAN CASPASE-1 IN COMPLEX WITH 4-OXO- 3-{6-[4-(QUINOXALIN-2-YLAMINO)-BENZOYLAMINO]-2-THIOPHEN-2- YL-HEXANOYLAMINO}-PENTANOIC ACID 1RWX ; 1.85 ; CRYSTAL STRUCTURE OF HUMAN CASPASE-1 IN COMPLEX WITH 4-OXO- 3-{6-[4-(QUINOXALIN-2-YLOXY)-BENZOYLAMINO]-2-THIOPHEN-2-YL- HEXANOYLAMINO}-BUTYRIC ACID 1RWV ; 2.10 ; CRYSTAL STRUCTURE OF HUMAN CASPASE-1 IN COMPLEX WITH 5-[5- (1-CARBOXYMETHYL-2-OXO-PROPYLCARBAMOYL)-5-PHENYL- PENTYLSULFAMOYL]-2-HYDROXY-BENZOIC ACID 1PYO ; 1.65 ; CRYSTAL STRUCTURE OF HUMAN CASPASE-2 IN COMPLEX WITH ACETYL- LEU-ASP-GLU-SER-ASP-CHO 2AVD ; 1.70 ; CRYSTAL STRUCTURE OF HUMAN CATECHOL-O-METHYLTRANSFERASE DOMAIN CONTAINING 1 1M6D ; 1.70 ; CRYSTAL STRUCTURE OF HUMAN CATHEPSIN F 1FH0 ; 1.60 ; CRYSTAL STRUCTURE OF HUMAN CATHEPSIN V COMPLEXED WITH AN IRREVERSIBLE VINYL SULFONE INHIBITOR 1EF7 ; 2.67 ; CRYSTAL STRUCTURE OF HUMAN CATHEPSIN X 1WMA ; 1.24 ; CRYSTAL STRUCTURE OF HUMAN CBR1 IN COMPLEX WITH HYDROXY-PP 1OU5 ; 3.40 ; CRYSTAL STRUCTURE OF HUMAN CCA-ADDING ENZYME 1YJD ; 2.70 ; CRYSTAL STRUCTURE OF HUMAN CD28 IN COMPLEX WITH THE FAB FRAGMENT OF A MITOGENIC ANTIBODY (5.11A1) 1XIW ; 1.90 ; CRYSTAL STRUCTURE OF HUMAN CD3-E/D DIMER IN COMPLEX WITH A UCHT1 SINGLE-CHAIN ANTIBODY FRAGMENT 1YH3 ; 1.91 ; CRYSTAL STRUCTURE OF HUMAN CD38 EXTRACELLULAR DOMAIN 1ALY ; 2.00 ; CRYSTAL STRUCTURE OF HUMAN CD40 LIGAND 1FM5 ; 2.27 ; CRYSTAL STRUCTURE OF HUMAN CD69 1G8Q ; 1.60 ; CRYSTAL STRUCTURE OF HUMAN CD81 EXTRACELLULAR DOMAIN, A RECEPTOR FOR HEPATITIS C VIRUS 1JVP ; 1.53 ; CRYSTAL STRUCTURE OF HUMAN CDK2 (UNPHOSPHORYLATED) IN COMPLEX WITH PKF049-365 1Y8Y ; 2.00 ; CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A PYRAZOLO[1, 5-A]PYRIMIDINE INHIBITOR 1Y91 ; 2.15 ; CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A PYRAZOLO[1, 5-A]PYRIMIDINE INHIBITOR 1UA2 ; 3.02 ; CRYSTAL STRUCTURE OF HUMAN CDK7 1HKI ; 2.55 ; CRYSTAL STRUCTURE OF HUMAN CHITINASE IN COMPLEX WITH GLUCOALLOSAMIDIN B 1HKJ ; 2.60 ; CRYSTAL STRUCTURE OF HUMAN CHITINASE IN COMPLEX WITH METHYLALLOSAMIDIN 1LQ0 ; 2.20 ; CRYSTAL STRUCTURE OF HUMAN CHITOTRIOSIDASE AT 2.2 ANGSTROM RESOLUTION 1LG1 ; 2.78 ; CRYSTAL STRUCTURE OF HUMAN CHITOTRIOSIDASE IN COMPLEX WITH CHITOBIOSE 1LG2 ; 2.10 ; CRYSTAL STRUCTURE OF HUMAN CHITOTRIOSIDASE IN COMPLEX WITH ETHYLENE GLYCOL 1Q22 ; 2.50 ; CRYSTAL STRUCTURE OF HUMAN CHOLESTEROL SULFOTRANSFERASE (SULT2B1B) IN THE PRESENCE OF DHEA AND PAP 1Q1Z ; 2.40 ; CRYSTAL STRUCTURE OF HUMAN CHOLESTEROL SULFOTRANSFERASE (SULT2B1B) IN THE PRESENCE OF PAP 1Q20 ; 2.30 ; CRYSTAL STRUCTURE OF HUMAN CHOLESTEROL SULFOTRANSFERASE (SULT2B1B) IN THE PRESENCE OF PAP AND PREGNENOLONE 1X9D ; 1.41 ; CRYSTAL STRUCTURE OF HUMAN CLASS I ALPHA-1,2-MANNOSIDASE IN COMPLEX WITH THIO-DISACCHARIDE SUBSTRATE ANALOGUE 1FMI ; 1.90 ; CRYSTAL STRUCTURE OF HUMAN CLASS I ALPHA1,2-MANNOSIDASE 1FO2 ; 2.38 ; CRYSTAL STRUCTURE OF HUMAN CLASS I ALPHA1,2-MANNOSIDASE IN COMPLEX WITH 1-DEOXYMANNOJIRIMYCIN 1FO3 ; 1.75 ; CRYSTAL STRUCTURE OF HUMAN CLASS I ALPHA1,2-MANNOSIDASE IN COMPLEX WITH KIFUNENSINE 1I1F ; 2.80 ; CRYSTAL STRUCTURE OF HUMAN CLASS I MHC (HLA-A2.1) COMPLEXED WITH BETA 2- MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y 1I1Y ; 2.20 ; CRYSTAL STRUCTURE OF HUMAN CLASS I MHC (HLA-A2.1) COMPLEXED WITH BETA 2-MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y 1B0G ; 2.50 ; CRYSTAL STRUCTURE OF HUMAN CLASS I MHC (HLA-A2.1) COMPLEXED WITH BETA 2-MICROGLOBULIN AND HUMAN PEPTIDE P1049 1Z57 ; 1.70 ; CRYSTAL STRUCTURE OF HUMAN CLK1 IN COMPLEX WITH 10Z- HYMENIALDISINE 1KSN ; 2.10 ; CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH FXV673 1EZQ ; 2.20 ; CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515 1NFU ; 2.05 ; CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR132747 1NFY ; 2.10 ; CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR200095 1F0S ; 2.10 ; CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208707 1F0R ; 2.10 ; CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815 1NFX ; 2.15 ; CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208944 1NFW ; 2.10 ; CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR209685 1LF7 ; 1.20 ; CRYSTAL STRUCTURE OF HUMAN COMPLEMENT PROTEIN C8GAMMA AT 1.2 A RESOLUTION 1G5S ; 2.61 ; CRYSTAL STRUCTURE OF HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) IN COMPLEX WITH THE INHIBITOR H717 1PF8 ; 2.51 ; CRYSTAL STRUCTURE OF HUMAN CYCLIN-DEPENDENT KINASE 2 COMPLEXED WITH A NUCLEOSIDE INHIBITOR 2BIT ; 1.71 ; CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN D AT 1.7 A RESOLUTION 2BIU ; 1.71 ; CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN D AT 1.7 A RESOLUTION, DMSO COMPLEX 2ALF ; 1.90 ; CRYSTAL STRUCTURE OF HUMAN CYPA MUTANT K131A 1MQ0 ; 2.40 ; CRYSTAL STRUCTURE OF HUMAN CYTIDINE DEAMINASE 2F9Q ; 3.00 ; CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2D6 1W0E ; 2.80 ; CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 3A4 1W0F ; 2.65 ; CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 3A4 1W0G ; 2.74 ; CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 3A4 1V5H ; 2.40 ; CRYSTAL STRUCTURE OF HUMAN CYTOGLOBIN (FERRIC FORM) 1LQS ; 2.70 ; CRYSTAL STRUCTURE OF HUMAN CYTOMEGALOVIRUS IL-10 BOUND TO SOLUBLE HUMAN IL-10R1 1T09 ; 2.70 ; CRYSTAL STRUCTURE OF HUMAN CYTOSOLIC NADP(+)-DEPENDENT ISOCITRATE DEHYDROGENASE IN COMPLEX NADP 1T0L ; 2.41 ; CRYSTAL STRUCTURE OF HUMAN CYTOSOLIC NADP(+)-DEPENDENT ISOCITRATE DEHYDROGENASE IN COMPLEX WITH NADP, ISOCITRATE, AND CALCIUM(2+) 1NUR ; 2.15 ; CRYSTAL STRUCTURE OF HUMAN CYTOSOLIC NMN/NAMN ADENYLYLTRANSFERASE 1NUP ; 1.90 ; CRYSTAL STRUCTURE OF HUMAN CYTOSOLIC NMN/NAMN ADENYLYLTRANSFERASE COMPLEX WITH NMN 1NUT ; 1.90 ; CRYSTAL STRUCTURE OF HUMAN CYTOSOLIC NMN/NAMN ADENYLYLTRANSFERASE COMPLEXED WITH ATP ANALOG 1NUS ; 2.20 ; CRYSTAL STRUCTURE OF HUMAN CYTOSOLIC NMN/NAMN ADENYLYLTRANSFERASE COMPLEXED WITH ATP ANALOG AND NMN 1NUQ ; 1.90 ; CRYSTAL STRUCTURE OF HUMAN CYTOSOLIC NMN/NAMN ADENYLYLTRANSFERASE COMPLEXED WITH NAAD 1NUU ; 1.90 ; CRYSTAL STRUCTURE OF HUMAN CYTOSOLIC NMN/NAMN ADENYLYLTRANSFERASE COMPLEXED WITH NAD 1N86 ; 3.20 ; CRYSTAL STRUCTURE OF HUMAN D-DIMER FROM CROSS-LINKED FIBRIN COMPLEXED WITH GPR AND GHRPLDK PEPTIDE LIGANDS. 1J99 ; 1.99 ; CRYSTAL STRUCTURE OF HUMAN DEHYDROEPIANDROSTERONE SULFOTRANSFERASE IN COMPLEX WITH SUBSTRATE 1XMJ ; 2.30 ; CRYSTAL STRUCTURE OF HUMAN DELTAF508 HUMAN NBD1 DOMAIN WITH ATP 1JAG ; 2.80 ; CRYSTAL STRUCTURE OF HUMAN DEOXYGUANOSINE KINASE 1KD2 ; 1.87 ; CRYSTAL STRUCTURE OF HUMAN DEOXYHEMOGLOBIN IN ABSENCE OF ANY ANIONS 1X9N ; 3.00 ; CRYSTAL STRUCTURE OF HUMAN DEOXYRIBONUCLEIC ACID LIGASE I BOUND TO 5'- ADENYLATED, NICKED DEOXYRIBONUCLEIC ACID 1XSL ; 2.30 ; CRYSTAL STRUCTURE OF HUMAN DEOXYRIBONUCLEIC ACID POLYMERASE LAMBDA IN COMPLEX WITH A ONE NUCLEOTIDE DEOXYRIBONUCLEIC ACID GAP 1XSN ; 1.95 ; CRYSTAL STRUCTURE OF HUMAN DEOXYRIBONUCLEIC ACID POLYMERASE LAMBDA IN COMPLEX WITH A ONE NUCLEOTIDE DEOXYRIBONUCLEIC ACID GAP AND DDTTP 1XSP ; 2.20 ; CRYSTAL STRUCTURE OF HUMAN DEOXYRIBONUCLEIC ACID POLYMERASE LAMBDA IN COMPLEX WITH NICKED DEOXYRIBONUCLEIC ACID AND PYROPHOSPHATE 1OV4 ; 2.70 ; CRYSTAL STRUCTURE OF HUMAN DHEA-ST COMPLEXED WITH ANDROSTERONE 2AG5 ; 1.84 ; CRYSTAL STRUCTURE OF HUMAN DHRS6 1ZMC ; 2.53 ; CRYSTAL STRUCTURE OF HUMAN DIHYDROLIPOAMIDE DEHYDROGENASE COMPLEXED TO NAD+ 1ZMD ; 2.08 ; CRYSTAL STRUCTURE OF HUMAN DIHYDROLIPOAMIDE DEHYDROGENASE COMPLEXED TO NADH 1XBS ; 2.50 ; CRYSTAL STRUCTURE OF HUMAN DIM2: A DIM1-LIKE PROTEIN 1ZQ9 ; 1.90 ; CRYSTAL STRUCTURE OF HUMAN DIMETHYLADENOSINE TRANSFERASE 1K3B ; 2.15 ; CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE I (CATHEPSIN C): EXCLUSION DOMAIN ADDED TO AN ENDOPEPTIDASE FRAMEWORK CREATES THE MACHINE FOR ACTIVATION OF GRANULAR SERINE PROTEASES 1J2E ; 2.60 ; CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE IV 1NU6 ; 2.10 ; CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE IV (DPP-IV) 1NU8 ; 2.50 ; CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE IV (DPP-IV) IN COMPLEX WITH DIPROTIN A (ILI) 1WCY ; 2.20 ; CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE IV (DPPIV) COMPLEX WITH DIPROTIN A 1R9M ; 2.10 ; CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE IV AT 2.1 ANG. RESOLUTION. 1R9N ; 2.30 ; CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE IV IN COMPLEX WITH A DECAPEPTIDE (TNPY) AT 2.3 ANG. RESOLUTION 1J42 ; 2.50 ; CRYSTAL STRUCTURE OF HUMAN DJ-1 1P5F ; 1.10 ; CRYSTAL STRUCTURE OF HUMAN DJ-1 1PDW ; 2.20 ; CRYSTAL STRUCTURE OF HUMAN DJ-1, P 1 21 1 SPACE GROUP 1PDV ; 1.80 ; CRYSTAL STRUCTURE OF HUMAN DJ-1, P 31 2 1 SPACE GROUP 1PQ2 ; 2.70 ; CRYSTAL STRUCTURE OF HUMAN DRUG METABOLIZING CYTOCHROME P450 2C8 1QBG ; 2.30 ; CRYSTAL STRUCTURE OF HUMAN DT-DIAPHORASE (NAD(P)H OXIDOREDUCTASE) 1RZ4 ; 2.10 ; CRYSTAL STRUCTURE OF HUMAN EIF3K 1Y4M ; 1.60 ; CRYSTAL STRUCTURE OF HUMAN ENDOGENOUS RETROVIRUS HERV-FRD ENVELOPE PROTEIN (SYNCITIN-2) 1TDH ; 2.10 ; CRYSTAL STRUCTURE OF HUMAN ENDONUCLEASE VIII-LIKE 1 (NEIL1) 1ZS9 ; 1.70 ; CRYSTAL STRUCTURE OF HUMAN ENOLASE-PHOSPHATASE E1 1YNS ; 1.70 ; CRYSTAL STRUCTURE OF HUMAN ENOLASE-PHOSPHATASE E1 AND ITS COMPLEX WITH A SUBSTRATE ANALOG 1JL9 ; 3.00 ; CRYSTAL STRUCTURE OF HUMAN EPIDERMAL GROWTH FACTOR 1MOX ; 2.50 ; CRYSTAL STRUCTURE OF HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR (RESIDUES 1-501) IN COMPLEX WITH TGF-ALPHA 1WZY ; 2.50 ; CRYSTAL STRUCTURE OF HUMAN ERK2 COMPLEXED WITH A PYRAZOLOPYRIDAZINE DERIVATIVE 1T8P ; 2.50 ; CRYSTAL STRUCTURE OF HUMAN ERYTHROCYTE 2,3- BISPHOSPHOGLYCERATE MUTASE 1QQW ; 2.75 ; CRYSTAL STRUCTURE OF HUMAN ERYTHROCYTE CATALASE 1EER ; 1.90 ; CRYSTAL STRUCTURE OF HUMAN ERYTHROPOIETIN COMPLEXED TO ITS RECEPTOR AT 1.9 ANGSTROMS 1G3M ; 1.70 ; CRYSTAL STRUCTURE OF HUMAN ESTROGEN SULFOTRANSFERASE IN COMPLEX WITH IN-ACTIVE COFACTOR PAP AND 3,5,3',5'- TETRACHLORO-BIPHENYL-4,4'-DIOL 1HY3 ; 1.80 ; CRYSTAL STRUCTURE OF HUMAN ESTROGEN SULFOTRANSFERASE V269E MUTANT IN THE PRESENCE OF PAPS 1QYW ; 1.63 ; CRYSTAL STRUCTURE OF HUMAN ESTROGENIC 17BETA-HYDROXYSTEROID DEHYDROGENASE COMLEX WITH ANDROSTANEDIONE AND NADP 1QYX ; 1.89 ; CRYSTAL STRUCTURE OF HUMAN ESTROGENIC 17BETA-HYDROXYSTEROID DEHYDROGENASE COMPLEX WITH ANDROSTENEDIONE AND NADP 1QYV ; 1.81 ; CRYSTAL STRUCTURE OF HUMAN ESTROGENIC 17BETA-HYDROXYSTEROID DEHYDROGENASE COMPLEX WITH NADP 1XMI ; 2.25 ; CRYSTAL STRUCTURE OF HUMAN F508A NBD1 DOMAIN WITH ATP 1NL0 ; 2.20 ; CRYSTAL STRUCTURE OF HUMAN FACTOR IX GLA DOMAIN IN COMPLEX OF AN INHIBITORY ANTIBODY, 10C12 1DFC ; 2.90 ; CRYSTAL STRUCTURE OF HUMAN FASCIN, AN ACTIN-CROSSLINKING PROTEIN 2F73 ; 2.50 ; CRYSTAL STRUCTURE OF HUMAN FATTY ACID BINDING PROTEIN 1 (FABP1) 1OVZ ; 3.00 ; CRYSTAL STRUCTURE OF HUMAN FCARI 1OW0 ; 3.10 ; CRYSTAL STRUCTURE OF HUMAN FCARI BOUND TO IGA1-FC 1HRK ; 2.00 ; CRYSTAL STRUCTURE OF HUMAN FERROCHELATASE 1Q1U ; 1.70 ; CRYSTAL STRUCTURE OF HUMAN FHF1B (FGF12B) 1Z68 ; 2.60 ; CRYSTAL STRUCTURE OF HUMAN FIBROBLAST ACTIVATION PROTEIN ALPHA 1XWD ; 2.92 ; CRYSTAL STRUCTURE OF HUMAN FOLLICLE STIMULATING HORMONE COMPLEXED WITH ITS RECEPTOR 1G8I ; 1.90 ; CRYSTAL STRUCTURE OF HUMAN FREQUENIN (NEURONAL CALCIUM SENSOR 1) 1TR2 ; 2.90 ; CRYSTAL STRUCTURE OF HUMAN FULL-LENGTH VINCULIN (RESIDUES 1- 1066) 1WUU ; 2.50 ; CRYSTAL STRUCTURE OF HUMAN GALACTOKINASE COMPLEXED WITH MGAMPPNP AND GALACTOSE 1SO0 ; 2.30 ; CRYSTAL STRUCTURE OF HUMAN GALACTOSE MUTAROTASE COMPLEXED WITH GALACTOSE 2A8U ; 1.69 ; CRYSTAL STRUCTURE OF HUMAN GALACTOSYLTRANSFERASE (GTB) COMPLEXED WITH BETA-METHYL LACTOSIDE 1ZIZ ; 1.49 ; CRYSTAL STRUCTURE OF HUMAN GALACTOSYLTRANSFERASE (GTB) COMPLEXED WITH GALACTOSE 1ZJP ; 1.59 ; CRYSTAL STRUCTURE OF HUMAN GALACTOSYLTRANSFERASE (GTB) COMPLEXED WITH GALACTOSE-GREASE 1ZJ2 ; 1.69 ; CRYSTAL STRUCTURE OF HUMAN GALACTOSYLTRANSFERASE (GTB) COMPLEXED WITH H TYPE I TRISACCHARIDE 1ZJ3 ; 1.69 ; CRYSTAL STRUCTURE OF HUMAN GALACTOSYLTRANSFERASE (GTB) COMPLEXED WITH H TYPE II TRISACCHARIDE 1ZJ0 ; 1.67 ; CRYSTAL STRUCTURE OF HUMAN GALACTOSYLTRANSFERASE (GTB) COMPLEXED WITH LACTOSE 1ZJ1 ; 1.65 ; CRYSTAL STRUCTURE OF HUMAN GALACTOSYLTRANSFERASE (GTB) COMPLEXED WITH N-ACETYLLACTOSAMINE 1BKZ ; 1.90 ; CRYSTAL STRUCTURE OF HUMAN GALECTIN-7 3GAL ; 1.90 ; CRYSTAL STRUCTURE OF HUMAN GALECTIN-7 IN COMPLEX WITH GALACTOSAMINE 2GAL ; 2.00 ; CRYSTAL STRUCTURE OF HUMAN GALECTIN-7 IN COMPLEX WITH GALACTOSE 4GAL ; 1.95 ; CRYSTAL STRUCTURE OF HUMAN GALECTIN-7 IN COMPLEX WITH LACTOSE 5GAL ; 2.00 ; CRYSTAL STRUCTURE OF HUMAN GALECTIN-7 IN COMPLEX WITH N-ACETYLLACTOSAMINE 1Z5V ; 2.71 ; CRYSTAL STRUCTURE OF HUMAN GAMMA-TUBULIN BOUND TO GTPGAMMAS 1IU1 ; 1.80 ; CRYSTAL STRUCTURE OF HUMAN GAMMA1-ADAPTIN EAR DOMAIN 1HLG ; 3.00 ; CRYSTAL STRUCTURE OF HUMAN GASTRIC LIPASE 1T2A ; 1.84 ; CRYSTAL STRUCTURE OF HUMAN GDP-D-MANNOSE 4,6-DEHYDRATASE 1O3X ; 2.10 ; CRYSTAL STRUCTURE OF HUMAN GGA1 GAT DOMAIN 1X79 ; 2.41 ; CRYSTAL STRUCTURE OF HUMAN GGA1 GAT DOMAIN COMPLEXED WITH THE GAT-BINDING DOMAIN OF RABAPTIN5 1JWF ; 2.10 ; CRYSTAL STRUCTURE OF HUMAN GGA1 VHS DOMAIN. 1MHQ ; 2.20 ; CRYSTAL STRUCTURE OF HUMAN GGA2 VHS DOMAIN 1V82 ; 1.85 ; CRYSTAL STRUCTURE OF HUMAN GLCAT-P APO FORM 1V84 ; 1.82 ; CRYSTAL STRUCTURE OF HUMAN GLCAT-P IN COMPLEX WITH N- ACETYLLACTOSAMINE, UDP, AND MN2+ 1V83 ; 1.90 ; CRYSTAL STRUCTURE OF HUMAN GLCAT-P IN COMPLEX WITH UDP AND MN2+ 1V4S ; 2.30 ; CRYSTAL STRUCTURE OF HUMAN GLUCOKINASE 1V4T ; 3.40 ; CRYSTAL STRUCTURE OF HUMAN GLUCOKINASE 2AFM ; 1.66 ; CRYSTAL STRUCTURE OF HUMAN GLUTAMINYL CYCLASE AT PH 6.5 2AFO ; 2.35 ; CRYSTAL STRUCTURE OF HUMAN GLUTAMINYL CYCLASE AT PH 8.0 2AFX ; 1.64 ; CRYSTAL STRUCTURE OF HUMAN GLUTAMINYL CYCLASE IN COMPLEX WITH 1-BENZYLIMIDAZOLE 2AFZ ; 1.68 ; CRYSTAL STRUCTURE OF HUMAN GLUTAMINYL CYCLASE IN COMPLEX WITH 1-VINYLIMIDAZOLE 2AFU ; 2.22 ; CRYSTAL STRUCTURE OF HUMAN GLUTAMINYL CYCLASE IN COMPLEX WITH GLUTAMINE T-BUTYL ESTER 2AFW ; 1.56 ; CRYSTAL STRUCTURE OF HUMAN GLUTAMINYL CYCLASE IN COMPLEX WITH N-ACETYLHISTAMINE 1YJ6 ; 2.50 ; CRYSTAL STRUCTURE OF HUMAN GLUTATHIONE S-TRANSFERASE M1A-1A COMPLEXED WITH GLUTATHIONYL-ZINC-TRIHYDROXIDE 2PGT ; 1.90 ; CRYSTAL STRUCTURE OF HUMAN GLUTATHIONE S-TRANSFERASE P1-1[V104] COMPLEXED WITH (9R,10R)-9-(S-GLUTATHIONYL)-10- HYDROXY-9,10-DIHYDROPHENANTHRENE 1PGT ; 1.80 ; CRYSTAL STRUCTURE OF HUMAN GLUTATHIONE S-TRANSFERASE P1-1[V104] COMPLEXED WITH S-HEXYLGLUTATHIONE 1PKZ ; 2.10 ; CRYSTAL STRUCTURE OF HUMAN GLUTATHIONE TRANSFERASE (GST) A1- 1 1PL1 ; 1.75 ; CRYSTAL STRUCTURE OF HUMAN GLUTATHIONE TRANSFERASE (GST) A1- 1 IN COMPLEX WITH A DECARBOXY-GLUTATHIONE 1PKW ; 2.00 ; CRYSTAL STRUCTURE OF HUMAN GLUTATHIONE TRANSFERASE (GST) A1- 1 IN COMPLEX WITH GLUTATHIONE 1PL2 ; 1.80 ; CRYSTAL STRUCTURE OF HUMAN GLUTATHIONE TRANSFERASE (GST) A1- 1 T68E MUTANT IN COMPLEX WITH DECARBOXY-GLUTATHIONE 1R74 ; 2.55 ; CRYSTAL STRUCTURE OF HUMAN GLYCINE N-METHYLTRANSFERASE 1SX6 ; 1.95 ; CRYSTAL STRUCTURE OF HUMAN GLYCOLIPID TRANSFER PROTEIN IN LACTOSYLCERAMIDE-BOUND FORM 1OP8 ; 2.50 ; CRYSTAL STRUCTURE OF HUMAN GRANZYME A 1FQ3 ; 3.10 ; CRYSTAL STRUCTURE OF HUMAN GRANZYME B 1WAQ ; 2.28 ; CRYSTAL STRUCTURE OF HUMAN GROWTH AND DIFFERENTIATION FACTOR 5 (GDF-5) 2BHK ; 2.40 ; CRYSTAL STRUCTURE OF HUMAN GROWTH AND DIFFERENTIATION FACTOR 5 (GDF5) 1FB1 ; 3.10 ; CRYSTAL STRUCTURE OF HUMAN GTP CYCLOHYDROLASE I 2BZN ; 2.15 ; CRYSTAL STRUCTURE OF HUMAN GUANOSINE MONOPHOSPHATE REDUCTASE 2 GMPR2 IN COMPLEX WITH IMP 2C6Q ; 1.70 ; CRYSTAL STRUCTURE OF HUMAN GUANOSINE MONOPHOSPHATE REDUCTASE 2 GMPR2 IN COMPLEX WITH IMP AND NADPH 1KJY ; 2.70 ; CRYSTAL STRUCTURE OF HUMAN G[ALPHA]I1 BOUND TO THE GOLOCO MOTIF OF RGS14 1VKG ; 2.20 ; CRYSTAL STRUCTURE OF HUMAN HDAC8 COMPLEXED WITH CRA-19156 1T67 ; 2.31 ; CRYSTAL STRUCTURE OF HUMAN HDAC8 COMPLEXED WITH MS-344 1T69 ; 2.91 ; CRYSTAL STRUCTURE OF HUMAN HDAC8 COMPLEXED WITH SAHA 1T64 ; 1.90 ; CRYSTAL STRUCTURE OF HUMAN HDAC8 COMPLEXED WITH TRICHOSTATIN A 1ZC0 ; 1.85 ; CRYSTAL STRUCTURE OF HUMAN HEMATOPOIETIC TYROSINE PHOSPHATASE (HEPTP) CATALYTIC DOMAIN 1N3U ; 2.58 ; CRYSTAL STRUCTURE OF HUMAN HEME OXYGENASE 1 (HO-1) IN COMPLEX WITH ITS SUBSTRATE HEME, CRYSTAL FORM B 1S8C ; 2.19 ; CRYSTAL STRUCTURE OF HUMAN HEME OXYGENASE IN A COMPLEX WITH BILIVERDINE 1SI4 ; 2.20 ; CRYSTAL STRUCTURE OF HUMAN HEMOGLOBIN A2 (IN R2 STATE) AT 2.2 A RESOLUTION 1NQP ; 1.73 ; CRYSTAL STRUCTURE OF HUMAN HEMOGLOBIN E AT 1.73 A RESOLUTION 1ZRH ; 2.10 ; CRYSTAL STRUCTURE OF HUMAN HEPARAN SULFATE GLUCOSAMINE 3-O- SULFOTRANSFERASE 1 IN COMPLEX WITH PAP 2CW6 ; 2.10 ; CRYSTAL STRUCTURE OF HUMAN HMG-COA LYASE: INSIGHTS INTO CATALYSIS AND THE MOLECULAR BASIS FOR HYDROXYMETHYLGLUTARIC ACIDURIA 1YC3 ; 2.12 ; CRYSTAL STRUCTURE OF HUMAN HSP90ALPHA COMPLEXED WITH DIHYDROXYPHENYLPYRAZOLES 1YC4 ; 1.81 ; CRYSTAL STRUCTURE OF HUMAN HSP90ALPHA COMPLEXED WITH DIHYDROXYPHENYLPYRAZOLES 1Y6K ; 2.52 ; CRYSTAL STRUCTURE OF HUMAN IL-10 COMPLEXED WITH THE SOLUBLE IL-10R1 CHAIN 1M48 ; 1.95 ; CRYSTAL STRUCTURE OF HUMAN IL-2 COMPLEXED WITH (R)-N-[2-[1- (AMINOIMINOMETHYL)-3-PIPERIDINYL]-1-OXOETHYL]-4- (PHENYLETHYNYL)-L-PHENYLALANINE METHYL ESTER 1S6P ; 2.90 ; CRYSTAL STRUCTURE OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R100943 2A14 ; 1.70 ; CRYSTAL STRUCTURE OF HUMAN INDOLETHYLAMINE N- METHYLTRANSFERASE WITH SAH 2ILK ; 1.60 ; CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-10 AT 1.6 ANGSTROMS RESOLUTION 1N1F ; 1.95 ; CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-19 1M47 ; 1.99 ; CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-2 1M4C ; 2.40 ; CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-2 1M49 ; 2.00 ; CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-2 COMPLEXED WITH SP- 1985 1M4B ; 2.15 ; CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-2 K43C COVALENTLY MODIFIED AT C43 WITH 2-[2-(2-CYCLOHEXYL-2-GUANIDINO- ACETYLAMINO)-ACETYLAMINO]-N-(3-MERCAPTO-PROPYL)- PROPIONAMIDE 1M4A ; 2.18 ; CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-2 Y31C COVALENTLY MODIFIED AT C31 WITH (1H-INDOL-3-YL)-(2-MERCAPTO- ETHOXYIMINO)-ACETIC ACID 1NBP ; 2.20 ; CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-2 Y31C COVALENTLY MODIFIED AT C31 WITH 3-MERCAPTO-1-(1,3,4,9-TETRAHYDRO-B- CARBOLIN-2-YL)-PROPAN-1-ONE 1NBQ ; 2.90 ; CRYSTAL STRUCTURE OF HUMAN JUNCTIONAL ADHESION MOLECULE TYPE 1 1YZX ; 1.93 ; CRYSTAL STRUCTURE OF HUMAN KAPPA CLASS GLUTATHIONE TRANSFERASE 1W7L ; 2.00 ; CRYSTAL STRUCTURE OF HUMAN KYNURENINE AMINOTRANSFERASE I 1W7M ; 2.70 ; CRYSTAL STRUCTURE OF HUMAN KYNURENINE AMINOTRANSFERASE I IN COMPLEX WITH L-PHE 1W7N ; 2.90 ; CRYSTAL STRUCTURE OF HUMAN KYNURENINE AMINOTRANSFERASE I IN PMP FORM 9JDW ; 2.50 ; CRYSTAL STRUCTURE OF HUMAN L-ARGININE:GLYCINE AMIDINOTRANSFERASE IN COMPLEX WITH ALPHA-AMINO BUTYRIC ACID 7JDW ; 2.37 ; CRYSTAL STRUCTURE OF HUMAN L-ARGININE:GLYCINE AMIDINOTRANSFERASE IN COMPLEX WITH DELTA-AMINO VALERIC ACID 6JDW ; 2.50 ; CRYSTAL STRUCTURE OF HUMAN L-ARGININE:GLYCINE AMIDINOTRANSFERASE IN COMPLEX WITH GAMMA-AMINO BUTYRIC ACID 5JDW ; 2.60 ; CRYSTAL STRUCTURE OF HUMAN L-ARGININE:GLYCINE AMIDINOTRANSFERASE IN COMPLEX WITH GLYCINE 8JDW ; 2.30 ; CRYSTAL STRUCTURE OF HUMAN L-ARGININE:GLYCINE AMIDINOTRANSFERASE IN COMPLEX WITH L-ALANINE 1JDX ; 2.40 ; CRYSTAL STRUCTURE OF HUMAN L-ARGININE:GLYCINE AMIDINOTRANSFERASE IN COMPLEX WITH L-NORVALINE 2JDX ; 2.90 ; CRYSTAL STRUCTURE OF HUMAN L-ARGININE:GLYCINE AMIDINOTRANSFERASE, DELETIONMUTANT ATDELTAM302 1KR5 ; 2.10 ; CRYSTAL STRUCTURE OF HUMAN L-ISOASPARTYL METHYLTRANSFERASE 1YXJ ; 1.78 ; CRYSTAL STRUCTURE OF HUMAN LECTIN-LIKE OXIDIZED LOW-DENSITY LIPOPROTEIN RECEPTOR 1 (LOX-1) AT LOW PH 1YXK ; 2.40 ; CRYSTAL STRUCTURE OF HUMAN LECTIN-LIKE OXIDIZED LOW-DENSITY LIPOPROTEIN RECEPTOR 1 (LOX-1) DISULFIDE-LINKED DIMER 1EMR ; 3.50 ; CRYSTAL STRUCTURE OF HUMAN LEUKEMIA INHIBITORY FACTOR (LIF) 1QDD ; 1.30 ; CRYSTAL STRUCTURE OF HUMAN LITHOSTATHINE TO 1.3 A RESOLUTION 1K6M ; 2.40 ; CRYSTAL STRUCTURE OF HUMAN LIVER 6-PHOSPHOFRUCTO-2- KINASE/FRUCTOSE-2,6-BISPHOSPHATASE 1YA4 ; 3.20 ; CRYSTAL STRUCTURE OF HUMAN LIVER CARBOXYLESTERASE 1 IN COMPLEX WITH TAMOXIFEN 1YAH ; 3.00 ; CRYSTAL STRUCTURE OF HUMAN LIVER CARBOXYLESTERASE COMPLEXED TO ETYL ACETATE; A FATTY ACID ETHYL ESTER ANALOGUE 1YAJ ; 3.20 ; CRYSTAL STRUCTURE OF HUMAN LIVER CARBOXYLESTERASE IN COMPLEX WITH BENZIL 1YA8 ; 3.00 ; CRYSTAL STRUCTURE OF HUMAN LIVER CARBOXYLESTERASE IN COMPLEX WITH CLEAVAGE PRODUCTS OF MEVASTATIN 1MX1 ; 2.40 ; CRYSTAL STRUCTURE OF HUMAN LIVER CARBOXYLESTERASE IN COMPLEX WITH TACRINE 1MX5 ; 2.80 ; CRYSTAL STRUCTURE OF HUMAN LIVER CARBOXYLESTERASE IN COMPLEXED WITH HOMATROPINE, A COCAINE ANALOGUE 1MX9 ; 2.90 ; CRYSTAL STRUCTURE OF HUMAN LIVER CARBOXYLESTERASE IN COMPLEXED WITH NALOXONE METHIODIDE, A HEROIN ANALOGUE 1YOK ; 2.50 ; CRYSTAL STRUCTURE OF HUMAN LRH-1 BOUND WITH TIF-2 PEPTIDE AND PHOSPHATIDYLGLYCEROL 1JWR ; 1.40 ; CRYSTAL STRUCTURE OF HUMAN LYSOZYME AT 100 K 1KFX ; 3.15 ; CRYSTAL STRUCTURE OF HUMAN M-CALPAIN FORM I 1KFU ; 2.50 ; CRYSTAL STRUCTURE OF HUMAN M-CALPAIN FORM II 1PJL ; 2.90 ; CRYSTAL STRUCTURE OF HUMAN M-NAD-ME IN TERNARY COMPLEX WITH NAD AND LU3+ 2AH9 ; 2.00 ; CRYSTAL STRUCTURE OF HUMAN M340H-BETA-1,4- GALACTOSYLTRANSFERASE-I (M340H-B4GAL-T1) IN COMPLEX WITH CHITOTRIOSE 2AGD ; 1.90 ; CRYSTAL STRUCTURE OF HUMAN M340H-BETA-1,4- GALACTOSYLTRANSFERASE-I(M340H-B4GAL-T1) IN COMPLEX WITH GLCNAC-BETA1,4-MAN-ALPHA1,3-MAN-BETA-OR 2AES ; 2.00 ; CRYSTAL STRUCTURE OF HUMAN M340H-BETA1,4- GALACTOSYLTRANSFERASE-I (M340H-B4GAL-T1) IN COMPLEX WITH GLCNAC-BETA1,2-MAN-ALPHA1,3-MAN-BETA-OR 2AEC ; 2.00 ; CRYSTAL STRUCTURE OF HUMAN M340H-BETA1,4- GALACTOSYLTRANSFERASE-I (M340H-B4GAL-T1) IN COMPLEX WITH GLCNAC-BETA1,2-MAN-ALPHA1,6-MAN-BETA-OR 2AE7 ; 2.00 ; CRYSTAL STRUCTURE OF HUMAN M340H-BETA1,4- GALACTOSYLTRANSFERASE-I (M340H-B4GAL-T1) IN COMPLEX WITH PENTASACCHARIDE 1L6J ; 2.50 ; CRYSTAL STRUCTURE OF HUMAN MATRIX METALLOPROTEINASE MMP9 (GELATINASE B). 1RV1 ; 2.30 ; CRYSTAL STRUCTURE OF HUMAN MDM2 WITH AN IMIDAZOLINE INHIBITOR 2B3K ; 1.55 ; CRYSTAL STRUCTURE OF HUMAN METHIONINE AMINOPEPTIDASE TYPE I IN THE HOLO FORM 2B3H ; 1.10 ; CRYSTAL STRUCTURE OF HUMAN METHIONINE AMINOPEPTIDASE TYPE I WITH A THIRD COBALT IN THE ACTIVE SITE 2EX4 ; 1.75 ; CRYSTAL STRUCTURE OF HUMAN METHYLTRANSFERASE AD-003 IN COMPLEX WITH S-ADENOSYL-L-HOMOCYSTEINE 1HYR ; 2.70 ; CRYSTAL STRUCTURE OF HUMAN MICA IN COMPLEX WITH NATURAL KILLER CELL RECEPTOR NKG2D 1Z10 ; 1.90 ; CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH COUMARIN BOUND 1Z11 ; 2.05 ; CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH METHOXSALEN BOUND 1TQN ; 2.05 ; CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 3A4 1FV9 ; 3.00 ; CRYSTAL STRUCTURE OF HUMAN MICROUROKINASE IN COMPLEX WITH 2- AMINO-5-HYDROXY-BENZIMIDAZOLE 1SG4 ; 1.30 ; CRYSTAL STRUCTURE OF HUMAN MITOCHONDRIAL DELTA3-DELTA2- ENOYL-COA ISOMERASE 1Q91 ; 1.60 ; CRYSTAL STRUCTURE OF HUMAN MITOCHONDRIAL DEOXYRIBONUCLEOTIDASE IN COMPLEX WITH THE INHIBITOR DPB-T 1Q92 ; 1.40 ; CRYSTAL STRUCTURE OF HUMAN MITOCHONDRIAL DEOXYRIBONUCLEOTIDASE IN COMPLEX WITH THE INHIBITOR PMCP-U 1PJ4 ; 2.30 ; CRYSTAL STRUCTURE OF HUMAN MITOCHONDRIAL NAD(P)+-DEPENDENT MALIC ENZYME IN A PENTARY COMPLEX WITH NATURAL SUBSTRATE MALATE, ATP, MN++, AND ALLOSTERIC ACTIVATOR FUMARATE. 1PJ2 ; 2.30 ; CRYSTAL STRUCTURE OF HUMAN MITOCHONDRIAL NAD(P)+-DEPENDENT MALIC ENZYME IN A PENTARY COMPLEX WITH NATURAL SUBSTRATE MALATE, COFACTOR NADH, MN++, AND ALLOSTERIC ACTIVATOR FUMARATE 1PJ3 ; 2.10 ; CRYSTAL STRUCTURE OF HUMAN MITOCHONDRIAL NAD(P)+-DEPENDENT MALIC ENZYME IN A PENTARY COMPLEX WITH NATURAL SUBSTRATE PYRUVATE, COFACTOR NAD+, MN++, AND ALLOSTERIC ACTIVATOR FUMARATE. 2C60 ; 1.25 ; CRYSTAL STRUCTURE OF HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 3 ISOFORM 2 PHOX DOMAIN AT 1.25 A RESOLUTION 1I7K ; 1.95 ; CRYSTAL STRUCTURE OF HUMAN MITOTIC-SPECIFIC UBIQUITIN- CONJUGATING ENZYME, UBCH10 1JK3 ; 1.09 ; CRYSTAL STRUCTURE OF HUMAN MMP-12 (MACROPHAGE ELASTASE) AT TRUE ATOMIC RESOLUTION 1PM9 ; 1.70 ; CRYSTAL STRUCTURE OF HUMAN MNSOD H30N, Y166F MUTANT 1PL4 ; 1.47 ; CRYSTAL STRUCTURE OF HUMAN MNSOD Y166F MUTANT 1ESR ; 2.00 ; CRYSTAL STRUCTURE OF HUMAN MONOCYTE CHEMOTACTIC PROTEIN-2 1D7W ; 1.90 ; CRYSTAL STRUCTURE OF HUMAN MYELOPEROXIDASE ISOFORM C COMPLEXED WITH CYANIDE AND BROMIDE AT PH 4.0 1MHL ; 2.25 ; CRYSTAL STRUCTURE OF HUMAN MYELOPEROXIDASE ISOFORM C CRYSTALLIZED IN SPACE GROUP P2(1) AT PH 5.5 AND 20 DEG C 1RXT ; 3.00 ; CRYSTAL STRUCTURE OF HUMAN MYRISTOYL-COA:PROTEIN N- MYRISTOYLTRANSFERASE. 2A8W ; 1.59 ; CRYSTAL STRUCTURE OF HUMAN N- ACETYLGALACTOSAMINYLTRANSFERASE (GTA) COMPLEXED WITH BETA- METHYLLACTOSIDE 1ZHJ ; 1.59 ; CRYSTAL STRUCTURE OF HUMAN N- ACETYLGALACTOSAMINYLTRANSFERASE (GTA) COMPLEXED WITH GALACTOSE 1ZJO ; 1.64 ; CRYSTAL STRUCTURE OF HUMAN N- ACETYLGALACTOSAMINYLTRANSFERASE (GTA) COMPLEXED WITH GALACTOSE-GREASE 1ZI5 ; 1.55 ; CRYSTAL STRUCTURE OF HUMAN N- ACETYLGALACTOSAMINYLTRANSFERASE (GTA) COMPLEXED WITH H TYPE I TRISACCHARIDE 1ZI4 ; 1.85 ; CRYSTAL STRUCTURE OF HUMAN N- ACETYLGALACTOSAMINYLTRANSFERASE (GTA) COMPLEXED WITH H TYPE II TRISACCHARIDE 1ZI1 ; 1.57 ; CRYSTAL STRUCTURE OF HUMAN N- ACETYLGALACTOSAMINYLTRANSFERASE (GTA) COMPLEXED WITH LACTOSE 1ZI3 ; 1.69 ; CRYSTAL STRUCTURE OF HUMAN N- ACETYLGALACTOSAMINYLTRANSFERASE (GTA) COMPLEXED WITH N- ACETYLLACTOSAMINE 1ZSV ; 2.30 ; CRYSTAL STRUCTURE OF HUMAN NADP-DEPENDENT LEUKOTRIENE B4 12- HYDROXYDEHYDROGENASE 1D4A ; 1.70 ; CRYSTAL STRUCTURE OF HUMAN NAD[P]H-QUINONE OXIDOREDUCTASE AT 1.7 A RESOLUTION 1DXO ; 2.50 ; CRYSTAL STRUCTURE OF HUMAN NAD[P]H-QUINONE OXIDOREDUCTASE CO WITH 2,3,5,6,TETRAMETHYL-P-BENZOQUINONE (DUROQUINONE) AT 2.5 ANGSTROM RESOLUTION 1H69 ; 1.86 ; CRYSTAL STRUCTURE OF HUMAN NAD[P]H-QUINONE OXIDOREDUCTASE CO WITH 2,3,5,6,TETRAMETHYL-P-BENZOQUINONE (DUROQUINONE) AT 2.5 ANGSTROM RESOLUTION 1H66 ; 2.00 ; CRYSTAL STRUCTURE OF HUMAN NAD[P]H-QUINONE OXIDOREDUCTASE CO WITH 2,5-DIAZIRIDINYL-3-HYDROXYL-6-METHYL-1,4-BENZOQUINONE 1Y8J ; 2.25 ; CRYSTAL STRUCTURE OF HUMAN NEP COMPLEXED WITH AN IMIDAZO[4, 5-C]PYRIDINE INHIBITOR 1TE6 ; 1.80 ; CRYSTAL STRUCTURE OF HUMAN NEURON SPECIFIC ENOLASE AT 1.8 ANGSTROM 1H1B ; 2.00 ; CRYSTAL STRUCTURE OF HUMAN NEUTROPHIL ELASTASE COMPLEXED WITH AN INHIBITOR (GW475151) 1B0F ; 3.00 ; CRYSTAL STRUCTURE OF HUMAN NEUTROPHIL ELASTASE WITH MDL 101, 146 1DFV ; 2.60 ; CRYSTAL STRUCTURE OF HUMAN NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN MONOMER 1ZMH ; 1.50 ; CRYSTAL STRUCTURE OF HUMAN NEUTROPHIL PEPTIDE 2, HNP-2 (VARIANT GLY16-> D-ALA) 1S9K ; 3.10 ; CRYSTAL STRUCTURE OF HUMAN NFAT1 AND FOS-JUN ON THE IL-2 ARRE1 SITE 1OWR ; 3.00 ; CRYSTAL STRUCTURE OF HUMAN NFAT1 BOUND MONOMERICALLY TO DEOXYRIBONUCLEIC ACID 1GZU ; 2.90 ; CRYSTAL STRUCTURE OF HUMAN NICOTINAMIDE MONONUCLEOTIDE ADENYLYLTRANSFERASE IN COMPLEX WITH NMN 1KR2 ; 2.30 ; CRYSTAL STRUCTURE OF HUMAN NMN/NAMN ADENYLYL TRANSFERASE COMPLEXED WITH TIAZOFURIN ADENINE DINUCLEOTIDE (TAD) 1JXV ; 2.20 ; CRYSTAL STRUCTURE OF HUMAN NUCLEOSIDE DIPHOSPHATE KINASE A 2CV5 ; 2.50 ; CRYSTAL STRUCTURE OF HUMAN NUCLEOSOME CORE PARTICLE 1EVS ; 2.20 ; CRYSTAL STRUCTURE OF HUMAN ONCOSTATIN M 1D7K ; 2.10 ; CRYSTAL STRUCTURE OF HUMAN ORNITHINE DECARBOXYLASE AT 2.1 ANGSTROMS RESOLUTION 1OTH ; 1.85 ; CRYSTAL STRUCTURE OF HUMAN ORNITHINE TRANSCARBAMOYLASE COMPLEXED WITH N-PHOSPHONACETYL-L-ORNITHINE 1FVO ; 2.60 ; CRYSTAL STRUCTURE OF HUMAN ORNITHINE TRANSCARBAMYLASE COMPLEXED WITH CARBAMOYL PHOSPHATE 1P32 ; 2.25 ; CRYSTAL STRUCTURE OF HUMAN P32, A DOUGHNUT-SHAPED ACIDIC MITOCHONDRIAL MATRIX PROTEIN 1ET1 ; 0.90 ; CRYSTAL STRUCTURE OF HUMAN PARATHYROID HORMONE 1-34 AT 0.9 A RESOLUTION 1YCK ; 1.70 ; CRYSTAL STRUCTURE OF HUMAN PEPTIDOGLYCAN RECOGNITION PROTEIN (PGRP-S) 1WDA ; 2.30 ; CRYSTAL STRUCTURE OF HUMAN PEPTIDYLARGININE DEIMINASE TYPE4 (PAD4) IN COMPLEX WITH BENZOYL-L-ARGININE AMIDE 1LN1 ; 2.40 ; CRYSTAL STRUCTURE OF HUMAN PHOSPHATIDYLCHOLINE TRANSFER PROTEIN IN COMPLEX WITH DILINOLEOYLPHOSPHATIDYLCHOLINE 1LN2 ; 2.90 ; CRYSTAL STRUCTURE OF HUMAN PHOSPHATIDYLCHOLINE TRANSFER PROTEIN IN COMPLEX WITH DILINOLEOYLPHOSPHATIDYLCHOLINE (SELENO-MET PROTEIN) 1WOJ ; 1.80 ; CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 1UDT ; 2.30 ; CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 5 COMPLEXED WITH SILDENAFIL(VIAGRA) 1UDU ; 2.83 ; CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 5 COMPLEXED WITH TADALAFIL(CIALIS) 1UHO ; 2.50 ; CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 5 COMPLEXED WITH VARDENAFIL(LEVITRA) 1IAT ; 1.62 ; CRYSTAL STRUCTURE OF HUMAN PHOSPHOGLUCOSE ISOMERASE/NEUROLEUKIN/AUTOCRINE MOTILITY FACTOR/MATURATION FACTOR 1QZU ; 2.91 ; CRYSTAL STRUCTURE OF HUMAN PHOSPHOPANTOTHENOYLCYSTEINE DECARBOXYLASE 2C4K ; 2.65 ; CRYSTAL STRUCTURE OF HUMAN PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE-ASSOCIATED PROTEIN 39 (PAP39) 1NNL ; 1.53 ; CRYSTAL STRUCTURE OF HUMAN PHOSPHOSERINE PHOSPHATASE 2A4Z ; 2.90 ; CRYSTAL STRUCTURE OF HUMAN PI3KGAMMA COMPLEXED WITH AS604850 2A5U ; 2.70 ; CRYSTAL STRUCTURE OF HUMAN PI3KGAMMA COMPLEXED WITH AS605240 2C3I ; 1.90 ; CRYSTAL STRUCTURE OF HUMAN PIM1 IN COMPLEX WITH IMIDAZOPYRIDAZIN I 1J1L ; 2.10 ; CRYSTAL STRUCTURE OF HUMAN PIRIN: A BCL-3 AND NUCLEAR FACTOR I INTERACTING PROTEIN AND A CUPIN SUPERFAMILY MEMBER 1U8F ; 1.75 ; CRYSTAL STRUCTURE OF HUMAN PLACENTAL GLYCERALDEHYDE-3- PHOSPHATE DEHYDROGENASE AT 1.75 RESOLUTION 1DDJ ; 2.00 ; CRYSTAL STRUCTURE OF HUMAN PLASMINOGEN CATALYTIC DOMAIN 1HNN ; 2.40 ; CRYSTAL STRUCTURE OF HUMAN PNMT COMPLEXED WITH SK&F 29661 AND ADOHCY(SAH) 1M73 ; 2.30 ; CRYSTAL STRUCTURE OF HUMAN PNP AT 2.3A RESOLUTION 1V45 ; 2.86 ; CRYSTAL STRUCTURE OF HUMAN PNP COMPLEXED WITH 3- DEOXYGUANOSINE 1V41 ; 2.85 ; CRYSTAL STRUCTURE OF HUMAN PNP COMPLEXED WITH 8-AZAGUANINE 1PWY ; 2.80 ; CRYSTAL STRUCTURE OF HUMAN PNP COMPLEXED WITH ACYCLOVIR 1V2H ; 2.70 ; CRYSTAL STRUCTURE OF HUMAN PNP COMPLEXED WITH GUANINE 1PF7 ; 2.60 ; CRYSTAL STRUCTURE OF HUMAN PNP COMPLEXED WITH IMMUCILLIN H 1UK1 ; 3.00 ; CRYSTAL STRUCTURE OF HUMAN POLY(ADP-RIBOSE) POLYMERASE COMPLEXED WITH A POTENT INHIBITOR 1XJV ; 1.73 ; CRYSTAL STRUCTURE OF HUMAN POT1 BOUND TO TELOMERIC SINGLE- STRANDED DEOXYRIBONUCLEIC ACID (TTAGGGTTAG) 1ZSX ; 1.90 ; CRYSTAL STRUCTURE OF HUMAN POTASSIUM CHANNEL KV BETA- SUBUNIT (KCNAB2) 1ILH ; 2.76 ; CRYSTAL STRUCTURE OF HUMAN PREGNANE X RECEPTOR LIGAND BINDING DOMAIN BOUND TO SR12813 1Q1Q ; 2.91 ; CRYSTAL STRUCTURE OF HUMAN PREGNENOLONE SULFOTRANSFERASE (SULT2B1A) IN THE PRESENCE OF PAP 1XM2 ; 2.70 ; CRYSTAL STRUCTURE OF HUMAN PRL-1 1MZA ; 2.23 ; CRYSTAL STRUCTURE OF HUMAN PRO-GRANZYME K 1MZD ; 2.90 ; CRYSTAL STRUCTURE OF HUMAN PRO-GRANZYME K 1GQF ; 2.90 ; CRYSTAL STRUCTURE OF HUMAN PROCASPASE-7 2PBH ; 3.30 ; CRYSTAL STRUCTURE OF HUMAN PROCATHEPSIN B AT 3.3 ANGSTROM RESOLUTION 1DEU ; 1.70 ; CRYSTAL STRUCTURE OF HUMAN PROCATHEPSIN X: A CYSTEINE PROTEASE WITH THE PROREGION COVALENTLY LINKED TO THE ACTIVE SITE CYSTEINE 1D1J ; 2.20 ; CRYSTAL STRUCTURE OF HUMAN PROFILIN II 1CVI ; 3.20 ; CRYSTAL STRUCTURE OF HUMAN PROSTATIC ACID PHOSPHATASE 1JCQ ; 2.30 ; CRYSTAL STRUCTURE OF HUMAN PROTEIN FARNESYLTRANSFERASE COMPLEXED WITH FARNESYL DIPHOSPHATE AND THE PEPTIDOMIMETIC INHIBITOR L-739,750 1JWH ; 3.10 ; CRYSTAL STRUCTURE OF HUMAN PROTEIN KINASE CK2 HOLOENZYME 2C7S ; 1.95 ; CRYSTAL STRUCTURE OF HUMAN PROTEIN TYROSINE PHOSPHATASE KAPPA AT 1.95A RESOLUTION 1RFG ; 2.90 ; CRYSTAL STRUCTURE OF HUMAN PURINE NUCLEOSIDE PHOSPHORYLASE COMPLEXED WITH GUANOSINE 1RCT ; 2.80 ; CRYSTAL STRUCTURE OF HUMAN PURINE NUCLEOSIDE PHOSPHORYLASE COMPLEXED WITH INOSINE 2BQ8 ; 2.20 ; CRYSTAL STRUCTURE OF HUMAN PURPLE ACID PHOSPHATASE WITH AN INHIBITORY CONFORMATION OF THE REPRESSION LOOP 2AED ; 2.30 ; CRYSTAL STRUCTURE OF HUMAN RAB14 1X3S ; 1.32 ; CRYSTAL STRUCTURE OF HUMAN RAB18 IN COMPLEX WITH GPPNHP 2A5J ; 1.50 ; CRYSTAL STRUCTURE OF HUMAN RAB2B 1N6H ; 1.51 ; CRYSTAL STRUCTURE OF HUMAN RAB5A 1N6P ; 1.54 ; CRYSTAL STRUCTURE OF HUMAN RAB5A A30E MUTANT COMPLEX WITH GPPNHP 1N6O ; 1.80 ; CRYSTAL STRUCTURE OF HUMAN RAB5A A30K MUTANT COMPLEX WITH GPPNHP 1N6R ; 1.55 ; CRYSTAL STRUCTURE OF HUMAN RAB5A A30L MUTANT COMPLEX WITH GPPNHP 1N6I ; 1.60 ; CRYSTAL STRUCTURE OF HUMAN RAB5A A30P MUTANT COMPLEX WITH GDP 1N6K ; 1.55 ; CRYSTAL STRUCTURE OF HUMAN RAB5A A30P MUTANT COMPLEX WITH GDP AND ALUMINUM FLUORIDE 1N6L ; 1.60 ; CRYSTAL STRUCTURE OF HUMAN RAB5A A30P MUTANT COMPLEX WITH GTP 1N6N ; 1.60 ; CRYSTAL STRUCTURE OF HUMAN RAB5A A30R MUTANT COMPLEX WITH GPPNHP 1R2Q ; 1.05 ; CRYSTAL STRUCTURE OF HUMAN RAB5A GTPASE DOMAIN AT 1.05 A RESOLUTION 1U4R ; 2.20 ; CRYSTAL STRUCTURE OF HUMAN RANTES MUTANT 44-AANA-47 1U4P ; 1.70 ; CRYSTAL STRUCTURE OF HUMAN RANTES MUTANT K45E 1PBH ; 3.20 ; CRYSTAL STRUCTURE OF HUMAN RECOMBINANT PROCATHEPSIN B AT 3.2 ANGSTROM RESOLUTION 1YDE ; 2.40 ; CRYSTAL STRUCTURE OF HUMAN RETINAL SHORT-CHAIN DEHYDROGENASE/REDUCTASE 3 1CXZ ; 2.20 ; CRYSTAL STRUCTURE OF HUMAN RHOA COMPLEXED WITH THE EFFECTOR DOMAIN OF THE PROTEIN KINASE PKN/PRK1 1XCG ; 2.50 ; CRYSTAL STRUCTURE OF HUMAN RHOA IN COMPLEX WITH DH/PH FRAGMENT OF PDZRHOGEF 1NB0 ; 1.70 ; CRYSTAL STRUCTURE OF HUMAN RIBOFLAVIN KINASE 1DCY ; 2.70 ; CRYSTAL STRUCTURE OF HUMAN S-PLA2 IN COMPLEX WITH INDOLE 3 ACTIVE SITE INHIBITOR 1XV8 ; 3.00 ; CRYSTAL STRUCTURE OF HUMAN SALIVARY ALPHA-AMYLASE DIMER 1N69 ; 2.20 ; CRYSTAL STRUCTURE OF HUMAN SAPOSIN B 1N76 ; 3.40 ; CRYSTAL STRUCTURE OF HUMAN SEMINAL LACTOFERRIN AT 3.4 A RESOLUTION 1Z6Z ; 2.50 ; CRYSTAL STRUCTURE OF HUMAN SEPIAPTERIN REDUCTASE IN COMPLEX WITH NADP+ 1F3M ; 2.30 ; CRYSTAL STRUCTURE OF HUMAN SERINE/THREONINE KINASE PAK1 1AO6 ; 2.50 ; CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN 1BM0 ; 2.50 ; CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN 1E78 ; 2.60 ; CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN 1E7B ; 2.38 ; CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN COMPLEXED WITH THE GENERAL ANESTHETIC HALOTHANE 1E7A ; 2.20 ; CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN COMPLEXED WITH THE GENERAL ANESTHETIC PROPOFOL 1N7W ; 2.20 ; CRYSTAL STRUCTURE OF HUMAN SERUM TRANSFERRIN, N-LOBE L66W MUTANT 1T91 ; 1.90 ; CRYSTAL STRUCTURE OF HUMAN SMALL GTPASE RAB7(GTP) 1EZF ; 2.15 ; CRYSTAL STRUCTURE OF HUMAN SQUALENE SYNTHASE 1XW3 ; 1.65 ; CRYSTAL STRUCTURE OF HUMAN SULFIREDOXIN (SRX) 1XW4 ; 2.00 ; CRYSTAL STRUCTURE OF HUMAN SULFIREDOXIN (SRX) IN COMPLEX WITH ADP 2A3R ; 2.60 ; CRYSTAL STRUCTURE OF HUMAN SULFOTRANSFERASE SULT1A3 IN COMPLEX WITH DOPAMINE AND 3-PHOSPHOADENOSINE 5-PHOSPHATE 1WM2 ; 1.60 ; CRYSTAL STRUCTURE OF HUMAN SUMO-2 PROTEIN 1WM3 ; 1.20 ; CRYSTAL STRUCTURE OF HUMAN SUMO-2 PROTEIN 2B7F ; 2.60 ; CRYSTAL STRUCTURE OF HUMAN T-CELL LEUKEMIA VIRUS PROTEASE, A NOVEL TARGET FOR ANTI-CANCER DESIGN 1WSR ; 2.00 ; CRYSTAL STRUCTURE OF HUMAN T-PROTEIN OF GLYCINE CLEAVAGE SYSTEM 1WSV ; 2.60 ; CRYSTAL STRUCTURE OF HUMAN T-PROTEIN OF GLYCINE CLEAVAGE SYSTEM 2A8I ; 2.00 ; CRYSTAL STRUCTURE OF HUMAN TASPASE1 2A8J ; 1.90 ; CRYSTAL STRUCTURE OF HUMAN TASPASE1 (ACIVATED FORM) 2A8L ; 2.00 ; CRYSTAL STRUCTURE OF HUMAN TASPASE1 (T234A MUTANT) 2A8M ; 2.60 ; CRYSTAL STRUCTURE OF HUMAN TASPASE1 (T234S MUTANT) 1XKI ; 1.80 ; CRYSTAL STRUCTURE OF HUMAN TEAR LIPOCALIN/VON EBNERS GLAND PROTEIN 1M9Z ; 1.05 ; CRYSTAL STRUCTURE OF HUMAN TGF-BETA TYPE II RECEPTOR LIGAND BINDING DOMAIN 1S4B ; 2.00 ; CRYSTAL STRUCTURE OF HUMAN THIMET OLIGOPEPTIDASE. 1XBT ; 2.40 ; CRYSTAL STRUCTURE OF HUMAN THYMIDINE KINASE 1 1UOU ; 2.11 ; CRYSTAL STRUCTURE OF HUMAN THYMIDINE PHOSPHORYLASE IN COMPLEX WITH A SMALL MOLECULE INHIBITOR 1NN3 ; 1.55 ; CRYSTAL STRUCTURE OF HUMAN THYMIDYLATE KINASE WITH D4TMP + ADP 1NN5 ; 1.50 ; CRYSTAL STRUCTURE OF HUMAN THYMIDYLATE KINASE WITH D4TMP + APPNHP 1NN0 ; 1.60 ; CRYSTAL STRUCTURE OF HUMAN THYMIDYLATE KINASE WITH DDTMP AND ADP 1NN1 ; 1.90 ; CRYSTAL STRUCTURE OF HUMAN THYMIDYLATE KINASE WITH DDTMP AND APPNHP 1NMX ; 1.70 ; CRYSTAL STRUCTURE OF HUMAN THYMIDYLATE KINASE WITH FLTMP AND ADP 1NMY ; 1.60 ; CRYSTAL STRUCTURE OF HUMAN THYMIDYLATE KINASE WITH FLTMP AND APPNHP 1NMZ ; 1.75 ; CRYSTAL STRUCTURE OF HUMAN THYMIDYLATE KINASE WITH NH2TMP AND APPNHP 1HZW ; 2.00 ; CRYSTAL STRUCTURE OF HUMAN THYMIDYLATE SYNTHASE 1I00 ; 2.50 ; CRYSTAL STRUCTURE OF HUMAN THYMIDYLATE SYNTHASE, TERNARY COMPLEX WITH DUMP AND TOMUDEX 1Q4X ; 2.80 ; CRYSTAL STRUCTURE OF HUMAN THYROID HORMONE RECEPTOR BETA LBD IN COMPLEX WITH SPECIFIC AGONIST GC-24 2CW9 ; 1.90 ; CRYSTAL STRUCTURE OF HUMAN TIM44 C-TERMINAL DOMAIN 1EJ9 ; 2.60 ; CRYSTAL STRUCTURE OF HUMAN TOPOISOMERASE I DEOXYRIBONUCLEIC ACID COMPLEX 1N46 ; 2.20 ; CRYSTAL STRUCTURE OF HUMAN TR BETA LIGAND-BINDING DOMAIN COMPLEXED WITH A POTENT SUBTYPE-SELECTIVE THYROMIMETIC 1D2Q ; 2.80 ; CRYSTAL STRUCTURE OF HUMAN TRAIL 1F05 ; 2.45 ; CRYSTAL STRUCTURE OF HUMAN TRANSALDOLASE 1J1J ; 2.20 ; CRYSTAL STRUCTURE OF HUMAN TRANSLIN 1DVQ ; 2.00 ; CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN 1F41 ; 1.30 ; CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN AT 1.5A RESOLUTION 1DVU ; 1.90 ; CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN IN COMPLEX WITH DIBENZOFURAN-4,6-DICARBOXYLIC ACID 1DVX ; 2.00 ; CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN IN COMPLEX WITH DICLOFENAC 1DVT ; 1.90 ; CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN IN COMPLEX WITH FLURBIPROFEN 1DVZ ; 1.90 ; CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN IN COMPLEX WITH O- TRIFLUOROMETHYLPHENYL ANTHRANILIC ACID 1DVS ; 2.00 ; CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN IN COMPLEX WITH RESVERATROL 1ZD6 ; 1.90 ; CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN WITH BOUND CHLORIDE 1ZCR ; 1.80 ; CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN WITH BOUND IODIDE 1SMO ; 1.47 ; CRYSTAL STRUCTURE OF HUMAN TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1 (TREM-1) AT 1.47 . 1WOU ; 1.80 ; CRYSTAL STRUCTURE OF HUMAN TRP14 1MLW ; 1.71 ; CRYSTAL STRUCTURE OF HUMAN TRYPTOPHAN HYDROXYLASE WITH BOUND 7,8-DIHYDRO-L-BIOPTERIN COFACTOR AND FE(III) 1R6T ; 2.10 ; CRYSTAL STRUCTURE OF HUMAN TRYPTOPHANYL-TRNA SYNTHETASE 1XJB ; 1.90 ; CRYSTAL STRUCTURE OF HUMAN TYPE 3 3ALPHA-HYDROXYSTEROID DEHYDROGENASE IN COMPLEX WITH NADP(H), CITRATE AND ACETATE MOLECULES 1IHI ; 3.00 ; CRYSTAL STRUCTURE OF HUMAN TYPE III 3-ALPHA-HYDROXYSTEROID DEHYDROGENASE/BILE ACID BINDING PROTEIN (AKR1C2) COMPLEXED WITH NADP+ AND URSODEOXYCHOLATE 1RHF ; 1.96 ; CRYSTAL STRUCTURE OF HUMAN TYRO3-D1D2 2B3O ; 2.80 ; CRYSTAL STRUCTURE OF HUMAN TYROSINE PHOSPHATASE SHP-1 1FMK ; 1.50 ; CRYSTAL STRUCTURE OF HUMAN TYROSINE-PROTEIN KINASE C-SRC 2SRC ; 1.50 ; CRYSTAL STRUCTURE OF HUMAN TYROSINE-PROTEIN KINASE C-SRC, IN COMPLEX WITH AMP-PNP 1JY1 ; 1.69 ; CRYSTAL STRUCTURE OF HUMAN TYROSYL-DEOXYRIBONUCLEIC ACID PHOSPHODIESTERASE (TDP1) 1NOP ; 2.30 ; CRYSTAL STRUCTURE OF HUMAN TYROSYL-DEOXYRIBONUCLEIC ACID PHOSPHODIESTERASE (TDP1) IN COMPLEX WITH VANADATE, DEOXYRIBONUCLEIC ACID AND A HUMAN TOPOISOMERASE I-DERIVED PEPTIDE 1RFF ; 1.70 ; CRYSTAL STRUCTURE OF HUMAN TYROSYL-DEOXYRIBONUCLEIC ACID PHOSPHODIESTERASE COMPLEXED WITH VANADATE, OCTAPEPTIDE KLNYYDPR, AND TETRANUCLEOTIDE AGTT. 1RH0 ; 2.30 ; CRYSTAL STRUCTURE OF HUMAN TYROSYL-DEOXYRIBONUCLEIC ACID PHOSPHODIESTERASE COMPLEXED WITH VANADATE, OCTOPAMINE AND TRINUCLEOTIDE GTT 1RG2 ; 2.10 ; CRYSTAL STRUCTURE OF HUMAN TYROSYL-DEOXYRIBONUCLEIC ACID PHOSPHODIESTERASE COMPLEXED WITH VANADATE, OCTOPAMINE, AND TETRANUCLEOTIDE AGTA 1RGT ; 2.00 ; CRYSTAL STRUCTURE OF HUMAN TYROSYL-DEOXYRIBONUCLEIC ACID PHOSPHODIESTERASE COMPLEXED WITH VANADATE, OCTOPAMINE, AND TETRANUCLEOTIDE AGTC 1RG1 ; 2.10 ; CRYSTAL STRUCTURE OF HUMAN TYROSYL-DEOXYRIBONUCLEIC ACID PHOSPHODIESTERASE COMPLEXED WITH VANADATE, OCTOPAMINE, AND TETRANUCLEOTIDE AGTT 1RFI ; 2.20 ; CRYSTAL STRUCTURE OF HUMAN TYROSYL-DEOXYRIBONUCLEIC ACID PHOSPHODIESTERASE COMPLEXED WITH VANADATE, PENTAPEPTIDE KLNYK, AND TETRANUCLEOTIDE AGTC 1QK1 ; 2.70 ; CRYSTAL STRUCTURE OF HUMAN UBIQUITOUS MITOCHONDRIAL CREATINE KINASE 2B69 ; 1.21 ; CRYSTAL STRUCTURE OF HUMAN UDP-GLUCORONIC ACID DECARBOXYLASE 1EMH ; 1.80 ; CRYSTAL STRUCTURE OF HUMAN URACIL-DEOXYRIBONUCLEIC ACID GLYCOSYLASE BOUND TO UNCLEAVED SUBSTRATE-CONTAINING DEOXYRIBONUCLEIC ACID 1UGH ; 1.90 ; CRYSTAL STRUCTURE OF HUMAN URACIL-DEOXYRIBONUCLEIC ACID GLYCOSYLASE IN COMPLEX WITH A PROTEIN INHIBITOR: PROTEIN MIMICRY OF DEOXYRIBONUCLEIC ACID 1UDW ; 2.60 ; CRYSTAL STRUCTURE OF HUMAN URIDINE-CYTIDINE KINASE 2 COMPLEXED WITH A FEEDBACK-INHIBITOR, CTP 1UEI ; 2.60 ; CRYSTAL STRUCTURE OF HUMAN URIDINE-CYTIDINE KINASE 2 COMPLEXED WITH A FEEDBACK-INHIBITOR, UTP 1UEJ ; 2.61 ; CRYSTAL STRUCTURE OF HUMAN URIDINE-CYTIDINE KINASE 2 COMPLEXED WITH A SUBSTRATE, CYTIDINE 1UJ2 ; 1.80 ; CRYSTAL STRUCTURE OF HUMAN URIDINE-CYTIDINE KINASE 2 COMPLEXED WITH PRODUCTS, CMP AND ADP 1FLH ; 2.45 ; CRYSTAL STRUCTURE OF HUMAN UROPEPSIN AT 2.45 A RESOLUTION 1PU4 ; 3.20 ; CRYSTAL STRUCTURE OF HUMAN VASCULAR ADHESION PROTEIN-1 1US1 ; 2.90 ; CRYSTAL STRUCTURE OF HUMAN VASCULAR ADHESION PROTEIN-1 1KXP ; 2.10 ; CRYSTAL STRUCTURE OF HUMAN VITAMIN D-BINDING PROTEIN IN COMPLEX WITH SKELETAL ACTIN 1W24 ; 2.10 ; CRYSTAL STRUCTURE OF HUMAN VPS29 1FU1 ; 2.70 ; CRYSTAL STRUCTURE OF HUMAN XRCC4 1YB5 ; 1.85 ; CRYSTAL STRUCTURE OF HUMAN ZETA-CRYSTALLIN WITH BOUND NADP 1WPS ; 2.80 ; CRYSTAL STRUCTURE OF HUTP, AN RIBONUCLEIC ACID BINDING ANTI-TERMINATION PROTEIN 1WPT ; 2.70 ; CRYSTAL STRUCTURE OF HUTP, AN RIBONUCLEIC ACID BINDING ANTI-TERMINATION PROTEIN 1VEA ; 2.80 ; CRYSTAL STRUCTURE OF HUTP, AN RIBONUCLEIC ACID BINDING ANTITERMINATION PROTEIN 1WRQ ; 2.20 ; CRYSTAL STRUCTURE OF HUTP-ANTITERMINATION COMPLEX 1VLA ; 1.80 ; CRYSTAL STRUCTURE OF HYDROPEROXIDE RESISTANCE PROTEIN OSMC (TM0919) FROM THERMOTOGA MARITIMA AT 1.80 A RESOLUTION 1EKQ ; 1.50 ; CRYSTAL STRUCTURE OF HYDROXYETHYLTHIAZOLE KINASE IN R3 SPACE GROUP 1EKK ; 2.00 ; CRYSTAL STRUCTURE OF HYDROXYETHYLTHIAZOLE KINASE IN THE R3 FORM WITH HYDROXYETHYLTHIAZOLE 1DWP ; 2.20 ; CRYSTAL STRUCTURE OF HYDROXYNITRILE LYASE FROM MANIHOT ESCULENTA AT 2.2 ANGSTROM RESOLUTION 1DWO ; 2.20 ; CRYSTAL STRUCTURE OF HYDROXYNITRILE LYASE FROM MANIHOT ESCULENTA IN COMPLEX WITH SUBSTRATES ACETONE AND CHLOROACETONE:IMPLICATIONS FOR THE MECHANISM OF CYANOGENESIS 1DWQ ; 2.20 ; CRYSTAL STRUCTURE OF HYDROXYNITRILE LYASE FROM MANIHOT ESCULENTA IN COMPLEX WITH SUBSTRATES ACETONE AND CHLOROACETONE:IMPLICATIONS FOR THE MECHANISM OF CYANOGENESIS 1GXS ; 2.30 ; CRYSTAL STRUCTURE OF HYDROXYNITRILE LYASE FROM SORGHUM BICOLOR IN COMPLEX WITH INHIBITOR BENZOIC ACID: A NOVEL CYANOGENIC ENZYME 1TMX ; 1.75 ; CRYSTAL STRUCTURE OF HYDROXYQUINOL 1,2-DIOXYGENASE FROM NOCARDIOIDES SIMPLEX 3E 1J1P ; 1.80 ; CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT LS91A COMPLEXED WITH HEN EGG WHITE LYSOZYME 1J1X ; 1.80 ; CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT LS93A COMPLEXED WITH HEN EGG WHITE LYSOZYME 1J1O ; 1.80 ; CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT LY50F COMPLEXED WITH HEN EGG WHITE LYSOZYME 1UA6 ; 1.90 ; CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT SFSF COMPLEXED WITH HEN EGG WHITE LYSOZYME COMPLEX 1UAC ; 1.70 ; CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT SFSF COMPLEXED WITH TURKEY WHITE LYSOZYME 1IC4 ; 2.50 ; CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT(HD32A)-HEN LYSOZYME COMPLEX 1IC7 ; 2.10 ; CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT(HD32A99A)-HEN LYSOZYME COMPLEX 1IC5 ; 2.30 ; CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT(HD99A)-HEN LYSOZYME COMPLEX 1C08 ; 2.30 ; CRYSTAL STRUCTURE OF HYHEL-10 FV-HEN LYSOZYME COMPLEX 1NBY ; 1.80 ; CRYSTAL STRUCTURE OF HYHEL-63 COMPLEXED WITH HEL MUTANT K96A 1NBZ ; 1.85 ; CRYSTAL STRUCTURE OF HYHEL-63 COMPLEXED WITH HEL MUTANT K97A 1TWY ; 1.65 ; CRYSTAL STRUCTURE OF HYPOTHETICAL ABC-TYPE PHOSPHATE TRANSPORTER 2AH6 ; 1.60 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN (10174212) FROM BACILLUS HALODURANS AT 1.60 A RESOLUTION 1VMF ; 1.46 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN (10176122) FROM BACILLUS HALODURANS AT 1.46 A RESOLUTION 2AJ7 ; 1.67 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN (10176242) FROM BACILLUS HALODURANS AT 1.67 A RESOLUTION 1VPH ; 1.76 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN (13815834) FROM SULFOLOBUS SOLFATARICUS AT 1.76 A RESOLUTION 1VQR ; 2.25 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN (6967725) FROM CAMPYLOBACTER JEJUNI AT 2.25 A RESOLUTION 1VL7 ; 1.50 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN (ALR5027) FROM NOSTOC SP. AT 1.50 A RESOLUTION 1VKI ; 1.60 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN (ATU3699) FROM AGROBACTERIUM TUMEFACIENS AT 1.60 A RESOLUTION 1VL5 ; 1.95 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN (BH2331) FROM BACILLUS HALODURANS AT 1.95 A RESOLUTION 1VPY ; 2.52 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN (EF0366) FROM ENTEROCOCCUS FAECALIS V583 AT 2.52 A RESOLUTION 1VP8 ; 1.30 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN (NP_068944.1) FROM ARCHAEOGLOBUS FULGIDUS AT 1.30 A RESOLUTION 1VQS ; 1.50 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN (NP_356412.1) FROM AGROBACTERIUM TUMEFACIENS AT 1.50 A RESOLUTION 1VQY ; 2.40 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN (NP_396154.1) FROM AGROBACTERIUM TUMEFACIENS AT 2.40 A RESOLUTION 1O51 ; 2.50 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN (TM0021) FROM THERMOTOGA MARITIMA AT 2.50 A RESOLUTION 1O3U ; 1.75 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN (TM0613) FROM THERMOTOGA MARITIMA AT 1.75 A RESOLUTION 1VMJ ; 1.52 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN (TM0723) FROM THERMOTOGA MARITIMA AT 1.52 A RESOLUTION 1ZTC ; 2.10 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN (TM0894) FROM THERMOTOGA MARITIMA AT 2.10 A RESOLUTION 2AX3 ; 2.27 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN (TM0922) FROM THERMOTOGA MARITIMA AT 2.27 A RESOLUTION 2EWR ; 1.60 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN (TM1012) FROM THERMOTOGA MARITIMA AT 1.60 A RESOLUTION 1O1Y ; 1.70 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN (TM1158) FROM THERMOTOGA MARITIMA AT 1.70 A RESOLUTION 1VKD ; 2.10 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN (TM1225) FROM THERMOTOGA MARITIMA AT 2.10 A RESOLUTION 1ZX8 ; 1.90 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN (TM1367) FROM THERMOTOGA MARITIMA AT 1.90 A RESOLUTION 1Z85 ; 2.12 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN (TM1380) FROM THERMOTOGA MARITIMA AT 2.12 A RESOLUTION 2AAM ; 2.20 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN (TM1410) FROM THERMOTOGA MARITIMA AT 2.20 A RESOLUTION 1VK9 ; 2.70 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN (TM1506) FROM THERMOTOGA MARITIMA AT 2.70 A RESOLUTION 1VRM ; 1.58 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN (TM1553) FROM THERMOTOGA MARITIMA AT 1.58 A RESOLUTION 1VPQ ; 2.20 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN (TM1631) FROM THERMOTOGA MARITIMA AT 2.20 A RESOLUTION 1ZUP ; 2.20 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN (TM1739) FROM THERMOTOGA MARITIMA AT 2.20 A RESOLUTION 1TJN ; 2.01 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN AF0721 FROM ARCHAEOGLOBUS FULGIDUS 2B3M ; 1.85 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN AF1124 2B3N ; 1.25 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN AF1124 1S5A ; 1.70 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN APC1116 FROM BACILLUS SUBTILIS 1OQ1 ; 1.70 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN APC1120 FROM BACILLUS SUBTILIS 1TZ0 ; 1.84 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN APC24875 FROM BACILLUS CEREUS 1Q9U ; 1.80 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN APC35924 FROM BACILLUS STEAROTHERMOPHILUS 1WDV ; 1.70 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN APE2540 1ZHV ; 1.50 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN ATU071 FROM AGOBACTERIUM TUMEFACIENS. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET ATR8. 2B1Y ; 1.80 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN ATU1913 FROM AGROBACTERIUM TUMEFACIENS STR. C58 2F06 ; 2.10 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN BT0572 FROM BACTEROIDES THETAIOTAOMICRON 1S5U ; 1.70 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN EC709 FROM ESCHERICHIA COLI 1VBV ; 2.70 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN FROM ESHERICHIA COLI 1VKB ; 1.90 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN FROM MUS MUSCULUS AT 1.90 A RESOLUTION 2ARZ ; 2.00 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN FROM PSEUDOMONAS AERUGINOSA 1SG9 ; 2.30 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN HEMK 1NRI ; 1.90 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN HI0754 FROM HAEMOPHILUS INFLUENZAE 2ATZ ; 2.00 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN HP0184 FROM HELICOBACTER PYLORI 2B0A ; 1.45 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN MJ0783 FROM METHANOCOCCUS JANNASCHII, NEW YORK STRUCTURAL GENOMICS CONSORTIUM 1T5J ; 2.70 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN MJ1187 FROM METHANOCOCCUS JANNASCHII 2AJ6 ; 1.63 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN MW0638 FROM STAPHYLOCOCCUS AUREUS MW2 AT 1.63 A RESOLUTION 1ZPY ; 2.20 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN NE0167 FROM NITROSOMONAS EUROPAEA 1V96 ; 1.75 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN OF UNKNOWN FUNCTION FROM PYROCOCCUS HORIKOSHII OT3 1YE5 ; 2.00 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN OF UNKNOWN FUNCTION FROM PYROCOCCUS HORIKOSHII OT3 1J31 ; 1.60 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN PH0642 FROM PYROCOCCUS HORIKOSHII 1WR8 ; 1.60 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN PH1421 FROM PYROCOCCUS HORIKOSHII. 1TQ8 ; 2.40 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN RV1636 FROM MYCOBACTERIUM TUBERCULOSIS H37RV 1XG8 ; 2.10 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN SA0789 FROM STAPHYLOCOCCUS AUREUS (APC23712), STRUCTURAL GENOMICS, MCSG 1YUD ; 2.70 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN SO0799 FROM SHEWANELLA ONEIDENSIS 2A5Z ; 2.02 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN SO2946 FROM SHEWANELLA ONEIDENSIS MR-1 1WV8 ; 2.20 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN TTHA1013 FROM AN EXTREMELY THERMOPHILIC BACTERIUM THERMUS THERMOPHILUS HB8 1XMX ; 2.10 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN VC1899, MCSG APC26666 1R3D ; 1.90 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN VC1974 FROM VIBRIO CHOLERAE 1XM5 ; 2.70 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN YBEY FROM ESCHERICHIA COLI 1RW0 ; 2.00 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN YFIH 1XAF ; 2.01 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN YFIH FROM SHIGELLA FLEXNERI 2A STR. 2457T 1SED ; 2.10 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN YHAI, APC1180 FROM BACILLUS SUBTILIS 1U5W ; 2.30 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN YJJX FROM ESCHERICHIA COLI 1SGM ; 2.00 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN YXAF 1WY6 ; 2.20 ; CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN [ST1625P] FROM HYPERTHERMOPHILIC ARCHAEON SULFOLOBUS TOKODAII 2CWE ; 2.70 ; CRYSTAL STRUCTURE OF HYPOTHETICAL TRANSCRIPTIONAL REGULATOR PROTEIN, PH1932 FROM PYROCOCCUS HORIKOSHII OT3 1PB6 ; 2.50 ; CRYSTAL STRUCTURE OF HYPOTHETICAL TRANSCRIPTIONAL REGULATOR YCDC 1Z9T ; 1.54 ; CRYSTAL STRUCTURE OF HYPOTHETICAL UPF0124 PROTEIN YFIH (NP_417084.1) FROM ESCHERICHIA COLI K12 AT 1.54 A RESOLUTION 1ZWY ; 1.90 ; CRYSTAL STRUCTURE OF HYPOTHETICAL UPF0244 PROTEIN VC0702 1R3U ; 2.50 ; CRYSTAL STRUCTURE OF HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE FROM THERMOANAEROBACTER TENGCONGENSIS 1XKF ; 1.90 ; CRYSTAL STRUCTURE OF HYPOXIC RESPONSE PROTEIN I (HRPI) WITH TWO COORDINATED ZINC IONS 1UHI ; 1.80 ; CRYSTAL STRUCTURE OF I-AEQUORIN 1N3E ; 2.50 ; CRYSTAL STRUCTURE OF I-CREI BOUND TO A PALINDROMIC DEOXYRIBONUCLEIC ACID SEQUENCE I (PALINDROME OF LEFT SIDE OF WILDTYPE DEOXYRIBONUCLEIC ACID TARGET SEQUENCE) 1N3F ; 2.00 ; CRYSTAL STRUCTURE OF I-CREI BOUND TO A PALINDROMIC DEOXYRIBONUCLEIC ACID SEQUENCE II (PALINDROME OF RIGHT SIDE OF WILDTYPE DEOXYRIBONUCLEIC ACID TARGET SEQUENCE) 1WCD ; 3.00 ; CRYSTAL STRUCTURE OF IBDV T1 VIRUS-LIKE PARTICLE REVEALS A MISSING LINK IN ICOSAHEDRAL VIRUSES EVOLUTION 1A3A ; 1.80 ; CRYSTAL STRUCTURE OF IIA MANNITOL FROM ESCHERICHIA COLI 1IIB ; 1.80 ; CRYSTAL STRUCTURE OF IIBCELLOBIOSE FROM ESCHERICHIA COLI 1TPZ ; 2.00 ; CRYSTAL STRUCTURE OF IIGP1: A PARADIGM FOR INTERFERON INDUCIBLE P47 RESISTANCE GTPASES 1TQ2 ; 2.70 ; CRYSTAL STRUCTURE OF IIGP1: A PARADIGM FOR INTERFERON INDUCIBLE P47 RESISTANCE GTPASES 1TQ4 ; 1.95 ; CRYSTAL STRUCTURE OF IIGP1: A PARADIGM FOR INTERFERON INDUCIBLE P47 RESISTANCE GTPASES 1TQ6 ; 2.70 ; CRYSTAL STRUCTURE OF IIGP1: A PARADIGM FOR INTERFERON INDUCIBLE P47 RESISTANCE GTPASES 1TQD ; 2.30 ; CRYSTAL STRUCTURE OF IIGP1: A PARADIGM FOR INTERFERON INDUCIBLE P47 RESISTANCE GTPASES 1JPY ; 2.85 ; CRYSTAL STRUCTURE OF IL-17F 1JND ; 1.30 ; CRYSTAL STRUCTURE OF IMAGINAL DISC GROWTH FACTOR-2 1JNE ; 1.70 ; CRYSTAL STRUCTURE OF IMAGINAL DISC GROWTH FACTOR-2 1RHY ; 2.30 ; CRYSTAL STRUCTURE OF IMIDAZOLE GLYCEROL PHOSPHATE DEHYDRATASE 2A0N ; 1.64 ; CRYSTAL STRUCTURE OF IMIDAZOLE GLYCEROL PHOSPHATE SYNTHASE SUBUNIT HISF (EC 4.1.3.-) (TM1036) FROM THERMOTOGA MARITIMA AT 1.64 A RESOLUTION 1JVN ; 2.10 ; CRYSTAL STRUCTURE OF IMIDAZOLE GLYCEROL PHOSPHATE SYNTHASE: A TUNNEL THROUGH A (BETA/ALPHA)8 BARREL JOINS TWO ACTIVE SITES 1DP9 ; 2.60 ; CRYSTAL STRUCTURE OF IMIDAZOLE-BOUND FIXL HEME DOMAIN 2AE8 ; 2.01 ; CRYSTAL STRUCTURE OF IMIDAZOLEGLYCEROL-PHOSPHATE DEHYDRATASE FROM STAPHYLOCOCCUS AUREUS SUBSP. AUREUS N315 1JGL ; 2.15 ; CRYSTAL STRUCTURE OF IMMUNOGLOBULIN FAB FRAGMENT COMPLEXED WITH 17-BETA-ESTRADIOL 1DDK ; 3.10 ; CRYSTAL STRUCTURE OF IMP-1 METALLO BETA-LACTAMASE FROM PSEUDOMONAS AERUGINOSA 1UKL ; 3.00 ; CRYSTAL STRUCTURE OF IMPORTIN-BETA AND SREBP-2 COMPLEX 1XQV ; 2.30 ; CRYSTAL STRUCTURE OF INACTIVE F1-MUTANT G37A 1RNJ ; 1.70 ; CRYSTAL STRUCTURE OF INACTIVE MUTANT DUTPASE COMPLEXED WITH SUBSTRATE ANALOGUE IMIDO-DUTP 1SYL ; 1.95 ; CRYSTAL STRUCTURE OF INACTIVE MUTANT DUTPASE COMPLEXED WITH SUBSTRATE DUTP 1N5I ; 1.85 ; CRYSTAL STRUCTURE OF INACTIVE MYCOBACTERIUM TUBERCULOSIS THYMIDYLATE KINASE COMPLEXED WITH THYMIDINE MONOPHOSPHATE (TMP) AT PH 4.6 (RESOLUTION 1.85 A) 1LBF ; 2.05 ; CRYSTAL STRUCTURE OF INDOLE-3-GLYCEROL PHOSPHATE SYNTASE (IGPS)WITH REDUCED 1-(O-CABOXYPHENYLAMINO)-1-DEOXYRIBULOSE 5-PHOSPHATE (RCDRP) 1LBL ; 2.40 ; CRYSTAL STRUCTURE OF INDOLE-3-GLYCEROL PHOSPHATE SYNTHASE (IGPS) IN COMPLEX WITH 1-(O-CARBOXYPHENYLAMINO)-1- DEOXYRIBULOSE 5'-PHOSPHATE (CDRP) 1J5T ; 3.00 ; CRYSTAL STRUCTURE OF INDOLE-3-GLYCEROL PHOSPHATE SYNTHASE (TM0140) FROM THERMOTOGA MARITIMA AT 3.0 A RESOLUTION 1VC4 ; 1.80 ; CRYSTAL STRUCTURE OF INDOLE-3-GLYCEROL PHOSPHATE SYNTHASE (TRPC) FROM THERMUS THERMOPHILUS AT 1.8 A RESOLUTION 1I4N ; 2.50 ; CRYSTAL STRUCTURE OF INDOLEGLYCEROL PHOSPHATE SYNTHASE FROM THERMOTOGA MARITIMA 1OVM ; 2.65 ; CRYSTAL STRUCTURE OF INDOLEPYRUVATE DECARBOXYLASE FROM ENTEROBACTER CLOACAE 1L7F ; 1.80 ; CRYSTAL STRUCTURE OF INFLUENZA VIRUS NEURAMINIDASE IN COMPLEX WITH BCX-1812 1W22 ; 2.50 ; CRYSTAL STRUCTURE OF INHIBITED HUMAN HDAC8 1IBC ; 2.73 ; CRYSTAL STRUCTURE OF INHIBITED INTERLEUKIN-1BETA CONVERTING ENZYME 1T7J ; 2.20 ; CRYSTAL STRUCTURE OF INHIBITOR AMPRENAVIR IN COMPLEX WITH A MULTI-DRUG RESISTANT VARIANT OF HIV-1 PROTEASE (L63P/V82T/I84V) 1MXF ; 2.30 ; CRYSTAL STRUCTURE OF INHIBITOR COMPLEX OF PUTATIVE PTERIDINE REDUCTASE 2 (PTR2) FROM TRYPANOSOMA CRUZI 1HR0 ; 3.20 ; CRYSTAL STRUCTURE OF INITIATION FACTOR IF1 BOUND TO THE 30S RIBOSOMAL SUBUNIT 1WOQ ; 1.80 ; CRYSTAL STRUCTURE OF INORGANIC POLYPHOSPHATE/ATP- GLUCOMANNOKINASE FROM ARTHROBACTER SP. STRAIN KM AT 1.8 A RESOLUTION 1Y3H ; 2.80 ; CRYSTAL STRUCTURE OF INORGANIC POLYPHOSPHATE/ATP-NAD KINASE FROM MYCOBACTERIUM TUBERCULOSIS 1YGZ ; 2.60 ; CRYSTAL STRUCTURE OF INORGANIC PYROPHOSPHATASE FROM HELICOBACTER PYLORI 1JR1 ; 2.60 ; CRYSTAL STRUCTURE OF INOSINE MONOPHOSPHATE DEHYDROGENASE IN COMPLEX WITH MYCOPHENOLIC ACID 1VRD ; 2.18 ; CRYSTAL STRUCTURE OF INOSINE-5'-MONOPHOSPHATE DEHYDROGENASE (TM1347) FROM THERMOTOGA MARITIMA AT 2.18 A RESOLUTION 1I9Y ; 2.00 ; CRYSTAL STRUCTURE OF INOSITOL POLYPHOSPHATE 5-PHOSPHATASE DOMAIN (IPP5C) OF SPSYNAPTOJANIN 1I9Z ; 1.80 ; CRYSTAL STRUCTURE OF INOSITOL POLYPHOSPHATE 5-PHOSPHATASE DOMAIN (IPP5C) OF SPSYNAPTOJANIN IN COMPLEX WITH INOSITOL (1,4)-BISPHOSPHATE AND CALCIUM ION 1VKO ; 2.30 ; CRYSTAL STRUCTURE OF INOSITOL-3-PHOSPHATE SYNTHASE (CE21227) FROM CAENORHABDITIS ELEGANS AT 2.30 A RESOLUTION 1YKB ; 2.60 ; CRYSTAL STRUCTURE OF INSECT CELL EXPRESSED IL-22 1TBQ ; 3.10 ; CRYSTAL STRUCTURE OF INSECT DERIVED DOUBLE DOMAIN KAZAL INHIBITOR RHODNIIN IN COMPLEX WITH THROMBIN 1TBR ; 2.60 ; CRYSTAL STRUCTURE OF INSECT DERIVED DOUBLE DOMAIN KAZAL INHIBITOR RHODNIIN IN COMPLEX WITH THROMBIN 1HYU ; 2.00 ; CRYSTAL STRUCTURE OF INTACT AHPF 1YZ6 ; 3.37 ; CRYSTAL STRUCTURE OF INTACT ALPHA SUBUNIT OF AIF2 FROM PYROCOCCUS ABYSSI 2F2B ; 1.68 ; CRYSTAL STRUCTURE OF INTEGRAL MEMBRANE PROTEIN AQUAPORIN AQPM AT 1.68A RESOLUTION 1L2H ; 1.54 ; CRYSTAL STRUCTURE OF INTERLEUKIN 1-BETA F42W/W120F MUTANT 1RY6 ; 1.60 ; CRYSTAL STRUCTURE OF INTERNAL KINESIN MOTOR DOMAIN 1M9S ; 2.65 ; CRYSTAL STRUCTURE OF INTERNALIN B (INLB), A LISTERIA MONOCYTOGENES VIRULENCE PROTEIN CONTAINING SH3-LIKE DOMAINS. 1XEU ; 2.05 ; CRYSTAL STRUCTURE OF INTERNALIN C FROM LISTERIA MONOCYTOGENES 1CWV ; 2.30 ; CRYSTAL STRUCTURE OF INVASIN: A BACTERIAL INTEGRIN-BINDING PROTEIN 1O80 ; 2.00 ; CRYSTAL STRUCTURE OF IP-10 H-FORM 1O7Y ; 3.00 ; CRYSTAL STRUCTURE OF IP-10 M-FORM 1O7Z ; 1.92 ; CRYSTAL STRUCTURE OF IP-10 T-FORM 1WPW ; 2.80 ; CRYSTAL STRUCTURE OF IPMDH FROM SULFOLOBUS TOKODAII 1VCF ; 2.60 ; CRYSTAL STRUCTURE OF IPP ISOMERASE AT I422 1VCG ; 3.02 ; CRYSTAL STRUCTURE OF IPP ISOMERASE AT P43212 1XVY ; 1.74 ; CRYSTAL STRUCTURE OF IRON-FREE SERRATIA MARCESCENS SFUA 1XVX ; 1.53 ; CRYSTAL STRUCTURE OF IRON-LOADED YERSINIA ENTEROCOLITICA YFUA 2F4F ; 1.80 ; CRYSTAL STRUCTURE OF IS200 TRANSPOSASE 2F5G ; 1.70 ; CRYSTAL STRUCTURE OF IS200 TRANSPOSASE 1R94 ; 2.30 ; CRYSTAL STRUCTURE OF ISCA (MERCURY DERIVATIVE) 1R95 ; 2.65 ; CRYSTAL STRUCTURE OF ISCA (NATIVE) 1Z2M ; 2.50 ; CRYSTAL STRUCTURE OF ISG15, THE INTERFERON-INDUCED UBIQUITIN CROSS REACTIVE PROTEIN 1POK ; 2.70 ; CRYSTAL STRUCTURE OF ISOASPARTYL DIPEPTIDASE 1ONW ; 1.65 ; CRYSTAL STRUCTURE OF ISOASPARTYL DIPEPTIDASE FROM E. COLI 1ONX ; 2.10 ; CRYSTAL STRUCTURE OF ISOASPARTYL DIPEPTIDASE FROM ESCHERICHIA COLI COMPLEXED WITH ASPARTATE 1RX0 ; 1.77 ; CRYSTAL STRUCTURE OF ISOBUTYRYL-COA DEHYDROGENASE COMPLEXED WITH SUBSTRATE/LIGAND. 2A67 ; 2.00 ; CRYSTAL STRUCTURE OF ISOCHORISMATASE FAMILY PROTEIN 1V94 ; 2.28 ; CRYSTAL STRUCTURE OF ISOCITRATE DEHYDROGENASE FROM AEROPYRUM PERNIX 1HQS ; 1.55 ; CRYSTAL STRUCTURE OF ISOCITRATE DEHYDROGENASE FROM BACILLUS SUBTILIS 1CW1 ; 2.10 ; CRYSTAL STRUCTURE OF ISOCITRATE DEHYDROGENASE MUTANT K230M BOUND TO ISOCITRATE AND MN2+ 1F61 ; 2.00 ; CRYSTAL STRUCTURE OF ISOCITRATE LYASE FROM MYCOBACTERIUM TUBERCULOSIS 1F8I ; 2.25 ; CRYSTAL STRUCTURE OF ISOCITRATE LYASE:NITROPROPIONATE:GLYOXYLATE COMPLEX FROM MYCOBACTERIUM TUBERCULOSIS 1WK8 ; 1.70 ; CRYSTAL STRUCTURE OF ISOLEUCYL-TRNA SYNTHETASE 1WNY ; 1.60 ; CRYSTAL STRUCTURE OF ISOLEUCYL-TRNA SYNTHETASE CP1 DOMAIN 1WNZ ; 1.70 ; CRYSTAL STRUCTURE OF ISOLEUCYL-TRNA SYNTHETASE CP1 DOMAIN 1WY5 ; 2.42 ; CRYSTAL STRUCTURE OF ISOLUECYL-TRNA LYSIDINE SYNTHETASE 1M53 ; 2.20 ; CRYSTAL STRUCTURE OF ISOMALTULOSE SYNTHASE (PALI) FROM KLEBSIELLA SP. LX3 1WMR ; 2.40 ; CRYSTAL STRUCTURE OF ISOPULLULANASE FROM ASPERGILLUS NIGER ATCC 9642 1KU8 ; 1.75 ; CRYSTAL STRUCTURE OF JACALIN 1KUJ ; 2.00 ; CRYSTAL STRUCTURE OF JACALIN COMPLEXED WITH 1-O-METHYL- ALPHA-D-MANNOSE 1UGW ; 1.70 ; CRYSTAL STRUCTURE OF JACALIN- GAL COMPLEX 1UH1 ; 2.80 ; CRYSTAL STRUCTURE OF JACALIN- GALNAC-BETA(1-3)-GAL-ALPHA-O- ME COMPLEX 1UH0 ; 2.80 ; CRYSTAL STRUCTURE OF JACALIN- ME-ALPHA-GALNAC COMPLEX 1WS4 ; 1.90 ; CRYSTAL STRUCTURE OF JACALIN- ME-ALPHA-MANNOSE COMPLEX: PROMISCUITY VS SPECIFICITY 1UGX ; 1.60 ; CRYSTAL STRUCTURE OF JACALIN- ME-ALPHA-T-ANTIGEN (GAL- BETA(1-3)-GALNAC-ALPHA-O-ME) COMPLEX 1UGY ; 2.40 ; CRYSTAL STRUCTURE OF JACALIN- MELLIBIOSE (GAL-ALPHA(1-6)- GLC) COMPLEX 1WS5 ; 1.90 ; CRYSTAL STRUCTURE OF JACALIN-ME-ALPHA-MANNOSE COMPLEX: PROMISCUITY VS SPECIFICITY 1M26 ; 1.62 ; CRYSTAL STRUCTURE OF JACALIN-T-ANTIGEN COMPLEX 1IQQ ; 1.50 ; CRYSTAL STRUCTURE OF JAPANESE PEAR S3-RNASE 1PMN ; 2.20 ; CRYSTAL STRUCTURE OF JNK3 IN COMPLEX WITH AN IMIDAZOLE- PYRIMIDINE INHIBITOR 1WRM ; 1.50 ; CRYSTAL STRUCTURE OF JSP-1 1PW3 ; 1.90 ; CRYSTAL STRUCTURE OF JTOR68S 1WD6 ; 2.90 ; CRYSTAL STRUCTURE OF JW1657 FROM ESCHERICHIA COLI 1SV5 ; 2.90 ; CRYSTAL STRUCTURE OF K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R165335 1CW4 ; 2.10 ; CRYSTAL STRUCTURE OF K230M ISOCITRATE DEHYDROGENASE IN COMPLEX WITH ALPHA- KETOGLUTARATE 1SO4 ; 1.70 ; CRYSTAL STRUCTURE OF K64A MUTANT OF 3-KETO-L-GULONATE 6- PHOSPHATE DECARBOXYLASE WITH BOUND L-THREONOHYDROXAMATE 4- PHOSPHATE 1WWJ ; 1.90 ; CRYSTAL STRUCTURE OF KAIB FROM SYNECHOCYSTIS SP. 1SQW ; 1.90 ; CRYSTAL STRUCTURE OF KD93, A NOVEL PROTEIN EXPRESSED IN THE HUMAN PRO 1O60 ; 1.80 ; CRYSTAL STRUCTURE OF KDO-8-PHOSPHATE SYNTHASE 1PHW ; 2.36 ; CRYSTAL STRUCTURE OF KDO8P SYNTHASE IN ITS BINARY COMPLEX WITH SUBSTRATE ANALOG 1-DEOXY-A5P 1PHQ ; 2.70 ; CRYSTAL STRUCTURE OF KDO8P SYNTHASE IN ITS BINARY COMPLEX WITH SUBSTRATE ANALOG E-FPEP 1PL9 ; 2.90 ; CRYSTAL STRUCTURE OF KDO8P SYNTHASE IN ITS BINARY COMPLEX WITH SUBSTRATE ANALOG Z-FPEP 1Q3N ; 2.70 ; CRYSTAL STRUCTURE OF KDO8P SYNTHASE IN ITS BINARY COMPLEX WITH SUBSTRATE PEP 1FWR ; 2.70 ; CRYSTAL STRUCTURE OF KDPG ALDOLASE DOUBLE MUTANT K133Q/T161K 1M3U ; 1.80 ; CRYSTAL STRUCTURE OF KETOPANTOATE HYDROXYMETHYLTRANSFERASE COMPLEXED THE PRODUCT KETOPANTOATE 1YJQ ; 2.09 ; CRYSTAL STRUCTURE OF KETOPANTOATE REDUCTASE IN COMPLEX WITH NADP+ 1OH0 ; 1.10 ; CRYSTAL STRUCTURE OF KETOSTEROID ISOMERASE COMPLEXED WITH EQUILENIN 1E3V ; 2.00 ; CRYSTAL STRUCTURE OF KETOSTEROID ISOMERASE FROM PSEDOMONAS PUTIDA COMPLEXED WITH DEOXYCHOLATE 1E97 ; 2.00 ; CRYSTAL STRUCTURE OF KETOSTEROID ISOMERASE FROM PSEUDOMONAS PUTIDA ; TRIPLE MUTANT Y16F/Y32F/Y57F 1E3R ; 2.50 ; CRYSTAL STRUCTURE OF KETOSTEROID ISOMERASE MUTANT D40N (D38N TI NUMBERING) FROM PSEUDOMONAS PUTIDA COMPLEXED WITH ANDROSTEN-3BETA-OL-17-ONE 1OHO ; 1.90 ; CRYSTAL STRUCTURE OF KETOSTEROID ISOMERASE Y16F/D40N MUTANT COMPLEXED WITH EQUILENIN 1AC5 ; 2.40 ; CRYSTAL STRUCTURE OF KEX1(DELTA)P, A PROHORMONE-PROCESSING CARBOXYPEPTIDASE FROM SACCHAROMYCES CEREVISIAE 2AXY ; 1.70 ; CRYSTAL STRUCTURE OF KH1 DOMAIN OF HUMAN POLY(C)-BINDING PROTEIN-2 WITH C-RICH STRAND OF HUMAN TELOMERIC DEOXYRIBONUCLEIC ACID 1FQ1 ; 3.00 ; CRYSTAL STRUCTURE OF KINASE ASSOCIATED PHOSPHATASE (KAP) IN COMPLEX WITH PHOSPHO-CDK2 1YXX ; 2.00 ; CRYSTAL STRUCTURE OF KINASE PIM1 IN COMPLEX WITH (3E)-3-[(4- HYDROXYPHENYL)IMINO]-1H-INDOL-2(3H)-ONE 1YXV ; 2.00 ; CRYSTAL STRUCTURE OF KINASE PIM1 IN COMPLEX WITH 3,4- DIHYDROXY-1-METHYLQUINOLIN-2(1H)-ONE 1YXU ; 2.24 ; CRYSTAL STRUCTURE OF KINASE PIM1 IN COMPLEX WITH AMP 1YXT ; 2.00 ; CRYSTAL STRUCTURE OF KINASE PIM1 IN COMPLEX WITH AMPPNP 1YXS ; 2.20 ; CRYSTAL STRUCTURE OF KINASE PIM1 WITH P123M MUTATION 1SDM ; 2.30 ; CRYSTAL STRUCTURE OF KINESIN-LIKE CALMODULIN BINDING PROTEIN 2A2L ; 2.20 ; CRYSTAL STRUCTURE OF KLEBSIELLA PNEUMONIAE HYPOTHETICAL PROTEIN ORFY, NEW YORK STRUCTURAL GENOMICS CONSORTIUM 1TC8 ; 2.70 ; CRYSTAL STRUCTURE OF KRAIT-VENOM PHOSPHOLIPASE A2 IN A COMPLEX WITH A NATURAL FATTY ACID TRIDECANOIC ACID 1K41 ; 2.20 ; CRYSTAL STRUCTURE OF KSI Y57S MUTANT 1YRS ; 2.50 ; CRYSTAL STRUCTURE OF KSP IN COMPLEX WITH INHIBITOR 1 1ZR0 ; 1.80 ; CRYSTAL STRUCTURE OF KUNITZ DOMAIN 1 OF TISSUE FACTOR PATHWAY INHIBITOR-2 WITH BOVINE TRYPSIN 1S1E ; 2.30 ; CRYSTAL STRUCTURE OF KV CHANNEL-INTERACTING PROTEIN 1 (KCHIP-1) 1S1G ; 2.60 ; CRYSTAL STRUCTURE OF KV4.3 T1 DOMAIN 2A0L ; 3.90 ; CRYSTAL STRUCTURE OF KVAP-33H1 FV COMPLEX 1F8R ; 2.00 ; CRYSTAL STRUCTURE OF L-AMINO ACID OXIDASE FROM CALLOSELASMA RHODOSTOMA COMPLEXED WITH CITRATE 1F8S ; 2.00 ; CRYSTAL STRUCTURE OF L-AMINO ACID OXIDASE FROM CALLOSELASMA RHODOSTOMA, COMPLEXED WITH THREE MOLECULES OF O- AMINOBENZOATE. 2AJT ; 2.60 ; CRYSTAL STRUCTURE OF L-ARABINOSE ISOMERASE FROM E.COLI 1WLS ; 2.16 ; CRYSTAL STRUCTURE OF L-ASPARAGINASE I HOMOLOGUE PROTEIN FROM PYROCOCCUS HORIKOSHII 1VC3 ; 1.50 ; CRYSTAL STRUCTURE OF L-ASPARTATE-ALPHA-DECARBOXYLASE 1VFT ; 2.30 ; CRYSTAL STRUCTURE OF L-CYCLOSERINE-BOUND FORM OF ALANINE RACEMASE FROM D-CYCLOSERINE-PRODUCING STREPTOMYCES LAVENDULAE 1YEY ; 2.34 ; CRYSTAL STRUCTURE OF L-FUCONATE DEHYDRATASE FROM XANTHOMONAS CAMPESTRIS PV. CAMPESTRIS STR. ATCC 33913 1O0C ; 2.70 ; CRYSTAL STRUCTURE OF L-GLUTAMATE AND AMPCPP BOUND TO GLUTAMINE AMINOACYL TRNA SYNTHETASE 1O0B ; 2.70 ; CRYSTAL STRUCTURE OF L-GLUTAMINE AND AMPCPP BOUND TO GLUTAMINE AMINOACYL TRNA SYNTHETASE 1FG3 ; 2.20 ; CRYSTAL STRUCTURE OF L-HISTIDINOL PHOSPHATE AMINOTRANSFERASE COMPLEXED WITH L-HISTIDINOL 1IJI ; 2.20 ; CRYSTAL STRUCTURE OF L-HISTIDINOL PHOSPHATE AMINOTRANSFERASE WITH PLP 1FG7 ; 1.50 ; CRYSTAL STRUCTURE OF L-HISTIDINOL PHOSPHATE AMINOTRANSFERASE WITH PYRIDOXAL-5'-PHOSPHATE 1JG2 ; 1.50 ; CRYSTAL STRUCTURE OF L-ISOASPARTYL (D-ASPARTYL) O- METHYLTRANSFERASE WITH ADENOSINE 1JG3 ; 2.10 ; CRYSTAL STRUCTURE OF L-ISOASPARTYL (D-ASPARTYL) O- METHYLTRANSFERASE WITH ADENOSINE & VYP(ISP)HA SUBSTRATE 1JG1 ; 1.20 ; CRYSTAL STRUCTURE OF L-ISOASPARTYL (D-ASPARTYL) O- METHYLTRANSFERASE WITH S-ADENOSYL-L-HOMOCYSTEINE 1JG4 ; 1.50 ; CRYSTAL STRUCTURE OF L-ISOASPARTYL (D-ASPARTYL) O- METHYLTRANSFERASE WITH S-ADENOSYLMETHIONINE 1V6A ; 2.30 ; CRYSTAL STRUCTURE OF L-LACTATE DEHYDROGENASE FROM CYPRINUS CARPIO 1PG8 ; 2.68 ; CRYSTAL STRUCTURE OF L-METHIONINE ALPHA-, GAMMA-LYASE 1Y56 ; 2.86 ; CRYSTAL STRUCTURE OF L-PROLINE DEHYDROGENASE FROM P.HORIKOSHII 1JDI ; 2.40 ; CRYSTAL STRUCTURE OF L-RIBULOSE-5-PHOSPHATE 4-EPIMERASE 1K0W ; 2.10 ; CRYSTAL STRUCTURE OF L-RIBULOSE-5-PHOSPHATE 4-EPIMERASE 1LC7 ; 1.80 ; CRYSTAL STRUCTURE OF L-THREONINE-O-3-PHOSPHATE DECARBOXYLASE FROM S. ENTERICA COMPLEXED WITH A SUBSTRATE 1LC8 ; 1.80 ; CRYSTAL STRUCTURE OF L-THREONINE-O-3-PHOSPHATE DECARBOXYLASE FROM S. ENTERICA COMPLEXED WITH ITS REACTION INTERMEDIATE 1LC5 ; 1.46 ; CRYSTAL STRUCTURE OF L-THREONINE-O-3-PHOSPHATE DECARBOXYLASE FROM S. ENTERICA IN ITS APO STATE 1LKC ; 1.80 ; CRYSTAL STRUCTURE OF L-THREONINE-O-3-PHOSPHATE DECARBOXYLASE FROM SALMONELLA ENTERICA 1I2A ; 1.85 ; CRYSTAL STRUCTURE OF L1 RIBOSOMAL PROTEIN FROM METHANOCOCCUS JANNASCHII WITH 1.85A RESOLUTION. 1S1U ; 3.00 ; CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE 1S1V ; 2.60 ; CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH TNK-651 1S1T ; 2.40 ; CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH UC-781 1I4J ; 1.80 ; CRYSTAL STRUCTURE OF L22 RIBOSOMAL PROTEIN MUTANT 1PXW ; 1.94 ; CRYSTAL STRUCTURE OF L7AE SRNP CORE PROTEIN FROM PYROCOCCUS ABYSSII 2AWD ; 2.00 ; CRYSTAL STRUCTURE OF LACC FROM ENTEROCOCCUS FAECALIS 2F02 ; 1.90 ; CRYSTAL STRUCTURE OF LACC FROM ENTEROCOCCUS FAECALIS IN COMPLEX WITH ATP 1GW0 ; 2.40 ; CRYSTAL STRUCTURE OF LACCASE FROM MELANOCARPUS ALBOMYCES IN FOUR COPPER FORM 1RRM ; 1.60 ; CRYSTAL STRUCTURE OF LACTALDEHYDE REDUCTASE 1V6T ; 1.70 ; CRYSTAL STRUCTURE OF LACTAM UTILIZATION PROTEIN FROM PYROCOCCUS HORIKOSHII OT3 1EP1 ; 2.20 ; CRYSTAL STRUCTURE OF LACTOCOCCUS LACTIS DIHYDROOROTATE DEHYDROGENASE B 1EP2 ; 2.40 ; CRYSTAL STRUCTURE OF LACTOCOCCUS LACTIS DIHYDROOROTATE DEHYDROGENASE B COMPLEXED WITH OROTATE 1EP3 ; 2.10 ; CRYSTAL STRUCTURE OF LACTOCOCCUS LACTIS DIHYDROOROTATE DEHYDROGENASE B. DATA COLLECTED UNDER CRYOGENIC CONDITIONS. 1KFV ; 2.55 ; CRYSTAL STRUCTURE OF LACTOCOCCUS LACTIS FORMAMIDO- PYRIMIDINE DEOXYRIBONUCLEIC ACID GLYCOSYLASE (ALIAS FPG OR MUTM) NON COVALENTLY BOUND TO AN AP SITE CONTAINING DEOXYRIBONUCLEIC ACID. 1PIE ; 2.10 ; CRYSTAL STRUCTURE OF LACTOCOCCUS LACTIS GALACTOKINASE COMPLEXED WITH GALACTOSE 1PV6 ; 3.50 ; CRYSTAL STRUCTURE OF LACTOSE PERMEASE 1PV7 ; 3.60 ; CRYSTAL STRUCTURE OF LACTOSE PERMEASE WITH TDG 1NHE ; 2.50 ; CRYSTAL STRUCTURE OF LACTOSE SYNTHASE COMPLEX WITH UDP 1NKH ; 2.00 ; CRYSTAL STRUCTURE OF LACTOSE SYNTHASE COMPLEX WITH UDP AND MANGANESE 1O23 ; 2.32 ; CRYSTAL STRUCTURE OF LACTOSE SYNTHASE IN THE PRESENCE OF UDP-GLUCOSE 1NQI ; 2.00 ; CRYSTAL STRUCTURE OF LACTOSE SYNTHASE, A 1:1 COMPLEX BETWEEN BETA1,4-GALACTOSYLTRANSFERASE AND ALPHA- LACTALBUMIN IN THE PRESENCE OF GLCNAC 1NF5 ; 2.00 ; CRYSTAL STRUCTURE OF LACTOSE SYNTHASE, COMPLEX WITH GLUCOSE 6CRO ; 3.00 ; CRYSTAL STRUCTURE OF LAMBDA-CRO BOUND TO A CONSENSUS OPERATOR AT 3.0 ANGSTROM RESOLUTION 1UGM ; 2.05 ; CRYSTAL STRUCTURE OF LC3 1IJR ; 2.20 ; CRYSTAL STRUCTURE OF LCK SH2 COMPLEXED WITH NONPEPTIDE PHOSPHOTYROSINE MIMETIC 1I8N ; 2.20 ; CRYSTAL STRUCTURE OF LEECH ANTI-PLATELET PROTEIN 1EVY ; 1.75 ; CRYSTAL STRUCTURE OF LEISHMANIA MEXICANA GLYCEROL-3- PHOSPHATE DEHYDROGENASE 1N1E ; 1.90 ; CRYSTAL STRUCTURE OF LEISHMANIA MEXICANA GLYCEROL-3- PHOSPHATE DEHYDROGENASE COMPLEXED WITH DHAP AND NAD 1JDJ ; 2.20 ; CRYSTAL STRUCTURE OF LEISHMANIA MEXICANA GLYCEROL-3- PHOSPHATE DEHYDROGENASE IN COMPLEX WITH 2-FLUORO-6- CHLOROPURINE 1EVZ ; 2.80 ; CRYSTAL STRUCTURE OF LEISHMANIA MEXICANA GLYCEROL-3- PHOSPHATE DEHYDROGENASE IN COMPLEX WITH NAD 1N1G ; 2.50 ; CRYSTAL STRUCTURE OF LEISHMANIA MEXICANA GLYCEROL-3- PHOSPHATE DEHYDROGENASE WITH INHIBITOR BCP 1M66 ; 1.90 ; CRYSTAL STRUCTURE OF LEISHMANIA MEXICANA GPDH COMPLEXED WITH INHIBITOR 2-BROMO-6-CHLORO-PURINE 1M67 ; 2.50 ; CRYSTAL STRUCTURE OF LEISHMANIA MEXICANA GPDH COMPLEXED WITH INHIBITOR 2-BROMO-6-HYDROXY-PURINE 2ETD ; 2.28 ; CRYSTAL STRUCTURE OF LEMA PROTEIN (TM0961) FROM THERMOTOGA MARITIMA AT 2.28 A RESOLUTION 1SR9 ; 2.00 ; CRYSTAL STRUCTURE OF LEUA FROM MYCOBACTERIUM TUBERCULOSIS 1WKB ; 2.05 ; CRYSTAL STRUCTURE OF LEUCYL-TRNA SYNTHETASE FROM THE ARCHAEON PYROCOCCUS HORIKOSHII REVEALS A NOVEL EDITING DOMAIN ORIENTATION 1PVH ; 2.50 ; CRYSTAL STRUCTURE OF LEUKEMIA INHIBITORY FACTOR IN COMPLEX WITH GP130 1V3T ; 2.30 ; CRYSTAL STRUCTURE OF LEUKOTRIENE B4 12- HYDROXYDEHYDROGENASE/15-OXO-PROSTAGLANDIN 13-REDUCTASE 1V3V ; 2.00 ; CRYSTAL STRUCTURE OF LEUKOTRIENE B4 12- HYDROXYDEHYDROGENASE/15-OXO-PROSTAGLANDIN 13-REDUCTASE COMPLEXED WITH NADP AND 15-OXO-PGE2 1V3U ; 2.00 ; CRYSTAL STRUCTURE OF LEUKOTRIENE B4 12- HYDROXYDEHYDROGENASE/15-OXO-PROSTAGLANDIN 13-REDUCTASE IN APO FORM 2A65 ; 1.65 ; CRYSTAL STRUCTURE OF LEUTAA, A BACTERIAL HOMOLOG OF NA+/CL-- DEPENDENT NEUROTRANSMITTER TRANSPORTERS 1PT2 ; 2.10 ; CRYSTAL STRUCTURE OF LEVANSUCRASE (E342A) COMPLEXED WITH SUCROSE 1W18 ; 2.50 ; CRYSTAL STRUCTURE OF LEVANSUCRASE FROM GLUCONACETOBACTER DIAZOTROPHICUS 1IY8 ; 1.60 ; CRYSTAL STRUCTURE OF LEVODIONE REDUCTASE 1NKZ ; 2.00 ; CRYSTAL STRUCTURE OF LH2 B800-850 FROM RPS. ACIDOPHILA AT 2.0 ANGSTROM RESOLUTION 1UFU ; 3.00 ; CRYSTAL STRUCTURE OF LIGAND BINDING DOMAIN OF IMMUNOGLOBULIN-LIKE TRANSCRIPT 2 (ILT2; LIR-1) 1J8E ; 1.85 ; CRYSTAL STRUCTURE OF LIGAND-BINDING REPEAT CR7 FROM LRP 1UFQ ; 2.50 ; CRYSTAL STRUCTURE OF LIGAND-FREE HUMAN URIDINE-CYTIDINE KINASE 2 1H34 ; 2.04 ; CRYSTAL STRUCTURE OF LIMA BEAN TRYPSIN INHIBITOR 1QTJ ; 3.00 ; CRYSTAL STRUCTURE OF LIMULUS POLYPHEMUS SAP 1IGZ ; 2.90 ; CRYSTAL STRUCTURE OF LINOLEIC ACID BOUND IN THE CYCLOOXYGENASE CHANNEL OF PROSTAGLANDIN ENDOPEROXIDE H SYNTHASE-1. 1X2G ; 2.40 ; CRYSTAL STRUCTURE OF LIPATE-PROTEIN LIGASE A FROM ESCHERICHIA COLI 1X2H ; 2.91 ; CRYSTAL STRUCTURE OF LIPATE-PROTEIN LIGASE A FROM ESCHERICHIA COLI COMPLEXED WITH LIPOIC ACID 1Y6H ; 2.20 ; CRYSTAL STRUCTURE OF LIPDF 2A8X ; 2.40 ; CRYSTAL STRUCTURE OF LIPOAMIDE DEHYDROGENASE FROM MYCOBACTERIUM TUBERCULOSIS 2ARU ; 2.50 ; CRYSTAL STRUCTURE OF LIPOATE-PROTEIN LIGASE A BOUND WITH ATP 2ART ; 2.40 ; CRYSTAL STRUCTURE OF LIPOATE-PROTEIN LIGASE A BOUND WITH LIPOYL-AMP 2ARS ; 2.04 ; CRYSTAL STRUCTURE OF LIPOATE-PROTEIN LIGASE A FROM THERMOPLASMA ACIDOPHILUM 1VDG ; 2.80 ; CRYSTAL STRUCTURE OF LIR1.01, ONE OF THE ALLELES OF LIR1 1UGN ; 1.80 ; CRYSTAL STRUCTURE OF LIR1.02, ONE OF THE ALLELES OF LIR1. 1IJ8 ; 2.00 ; CRYSTAL STRUCTURE OF LITE AVIDIN-BNI COMPLEX 2AML ; 1.50 ; CRYSTAL STRUCTURE OF LMO0035 PROTEIN (46906266) FROM LISTERIA MONOCYTOGENES 4B F2365 AT 1.50 A RESOLUTION 1MV5 ; 3.10 ; CRYSTAL STRUCTURE OF LMRA ATP-BINDING DOMAIN 1XCR ; 1.70 ; CRYSTAL STRUCTURE OF LONGER SPLICE VARIANT OF PTD012 FROM HOMO SAPIENS REVEALS A NOVEL ZINC-CONTAINING FOLD 1Y9I ; 1.80 ; CRYSTAL STRUCTURE OF LOW TEMPERATURE REQUIREMENT C PROTEIN FROM LISTERIA MONOCYTOGENES 1XDI ; 2.81 ; CRYSTAL STRUCTURE OF LPDA (RV3303C) FROM MYCOBACTERIUM TUBERCULOSIS 1NQX ; 1.82 ; CRYSTAL STRUCTURE OF LUMAZINE SYNTHASE FROM AQUIFEX AEOLICUS IN COMPLEX WITH INHIBITOR: 3-(7-HYDROXY-8- RIBITYLLUMAZINE-6-YL)PROPIONIC ACID 1NQW ; 2.20 ; CRYSTAL STRUCTURE OF LUMAZINE SYNTHASE FROM AQUIFEX AEOLICUS IN COMPLEX WITH INHIBITOR: 5-(6-D-RIBITYLAMINO-2, 4(1H,3H)PYRIMIDINEDIONE-5-YL)-1-PENTYL-PHOSPHONIC ACID 1NQV ; 2.05 ; CRYSTAL STRUCTURE OF LUMAZINE SYNTHASE FROM AQUIFEX AEOLICUS IN COMPLEX WITH INHIBITOR: 5-NITROSO-6-RIBITYL- AMINO-2,4(1H,3H)PYRIMIDINEDIONE 1NQU ; 1.75 ; CRYSTAL STRUCTURE OF LUMAZINE SYNTHASE FROM AQUIFEX AEOLICUS IN COMPLEX WITH INHIBITOR: 6,7-DIOXO-5H-8- RIBITYLAMINOLUMAZINE 1DI0 ; 2.70 ; CRYSTAL STRUCTURE OF LUMAZINE SYNTHASE FROM BRUCELLA ABORTUS 1XN1 ; 3.05 ; CRYSTAL STRUCTURE OF LUMAZINE SYNTHASE FROM BRUCELLA ABORTUS (ORTHORHOMBIC FORM AT 3.05 ANGSTROMS) 1T13 ; 2.90 ; CRYSTAL STRUCTURE OF LUMAZINE SYNTHASE FROM BRUCELLA ABORTUS BOUND TO 5-NITRO-6-(D-RIBITYLAMINO)-2,4(1H,3H) PYRIMIDINEDIONE 1OOI ; 2.04 ; CRYSTAL STRUCTURE OF LUSH FROM DROSOPHILA MELANOGASTER AT PH 6.5 1T14 ; 1.86 ; CRYSTAL STRUCTURE OF LUSH FROM DROSOPHILA MELANOGASTER: APO PROTEIN 1JX6 ; 1.50 ; CRYSTAL STRUCTURE OF LUXP FROM VIBRIO HARVEYI COMPLEXED WITH AUTOINDUCER-2 1IE0 ; 1.60 ; CRYSTAL STRUCTURE OF LUXS 1G5Z ; 2.51 ; CRYSTAL STRUCTURE OF LYME DISEASE ANTIGEN OUTER SURFACE PROTEIN C (OSPC) FROM BORRELIA BURGDORFERI STRAIN N40 1L8W ; 2.30 ; CRYSTAL STRUCTURE OF LYME DISEASE VARIABLE SURFACE ANTIGEN VLSE OF BORRELIA BURGDORFERI 1S8G ; 2.30 ; CRYSTAL STRUCTURE OF LYS49-PHOSPHOLIPASE A2 FROM AGKISTRODON CONTORTRIX LATICINCTUS, FATTY ACID BOUND FORM 1S8H ; 1.80 ; CRYSTAL STRUCTURE OF LYS49-PHOSPHOLIPASE A2 FROM AGKISTRODON CONTORTRIX LATICINCTUS, FIRST FATTY ACID FREE FORM 1S8I ; 1.61 ; CRYSTAL STRUCTURE OF LYS49-PHOSPHOLIPASE A2 FROM AGKISTRODON CONTORTRIX LATICINCTUS, SECOND FATTY ACID FREE FORM 1XRS ; 2.80 ; CRYSTAL STRUCTURE OF LYSINE 5,6-AMINOMUTASE IN COMPLEX WITH PLP, COBALAMIN, AND 5'-DEOXYADENOSINE 1MFR ; 2.80 ; CRYSTAL STRUCTURE OF M FERRITIN 1DF0 ; 2.60 ; CRYSTAL STRUCTURE OF M-CALPAIN 1X1R ; 1.30 ; CRYSTAL STRUCTURE OF M-RAS IN COMPLEX WITH GDP 1X1S ; 2.20 ; CRYSTAL STRUCTURE OF M-RAS IN COMPLEX WITH GPPNHP 1XHK ; 1.90 ; CRYSTAL STRUCTURE OF M. JANNASCHII LON PROTEOLYTIC DOMAIN 2A5V ; 2.20 ; CRYSTAL STRUCTURE OF M. TUBERCULOSIS BETA CARBONIC ANHYDRASE, RV3588C, TETRAMERIC FORM 1HX5 ; 3.50 ; CRYSTAL STRUCTURE OF M. TUBERCULOSIS CHAPERONIN-10 1I80 ; 2.00 ; CRYSTAL STRUCTURE OF M. TUBERCULOSIS PNP IN COMPLEX WITH IMINORIBITOL, 9-DEAZAHYPOXANTHINE AND PHOSPHATE ION 2A87 ; 3.00 ; CRYSTAL STRUCTURE OF M. TUBERCULOSIS THIOREDOXIN REDUCTASE 1G61 ; 1.30 ; CRYSTAL STRUCTURE OF M.JANNASCHII EIF6 1GS6 ; 2.20 ; CRYSTAL STRUCTURE OF M144A MUTANT OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE 1LWC ; 2.62 ; CRYSTAL STRUCTURE OF M184V MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE 1LWE ; 2.81 ; CRYSTAL STRUCTURE OF M41L/T215Y MUTANT HIV-1 REVERSE TRANSCRIPTASE (RTMN) IN COMPLEX WITH NEVIRAPINE 1MFI ; 1.80 ; CRYSTAL STRUCTURE OF MACROPHAGE MIGRATION INHIBITORY FACTOR COMPLEXED WITH (E)-2-FLUORO-P-HYDROXYCINNAMATE 1LJT ; 2.00 ; CRYSTAL STRUCTURE OF MACROPHAGE MIGRATION INHIBITORY FACTOR COMPLEXED WITH (S,R)-3-(4-HYDROXYPHENYL)-4,5-DIHYDRO-5- ISOXAZOLE-ACETIC ACID METHYL ESTER (ISO-1) 1UIZ ; 2.50 ; CRYSTAL STRUCTURE OF MACROPHAGE MIGRATION INHIBITORY FACTOR FROM XENOPUS LAEVIS. 1NLW ; 2.00 ; CRYSTAL STRUCTURE OF MAD-MAX RECOGNIZING DEOXYRIBONUCLEIC ACID 1GO4 ; 2.05 ; CRYSTAL STRUCTURE OF MAD1-MAD2 REVEALS A CONSERVED MAD2 BINDING MOTIF IN MAD1 AND CDC20. 2AMH ; 2.00 ; CRYSTAL STRUCTURE OF MAF-LIKE PROTEIN TBRU21784AAA FROM T.BRUCEI 1HXS ; 2.20 ; CRYSTAL STRUCTURE OF MAHONEY STRAIN OF POLIOVIRUS AT 2.2A RESOLUTION 1OM1 ; 1.68 ; CRYSTAL STRUCTURE OF MAIZE CK2 ALPHA IN COMPLEX WITH IQA 1IZ9 ; 2.00 ; CRYSTAL STRUCTURE OF MALATE DEHYDROGENASE FROM THERMUS THERMOPHILUS HB8 1LAX ; 1.85 ; CRYSTAL STRUCTURE OF MALE31, A DEFECTIVE FOLDING MUTANT OF MALTOSE-BINDING PROTEIN 1LLQ ; 2.30 ; CRYSTAL STRUCTURE OF MALIC ENZYME FROM ASCARIS SUUM COMPLEXED WITH NICOTINAMIDE ADENINE DINUCLEOTIDE 1WPC ; 1.90 ; CRYSTAL STRUCTURE OF MALTOHEXAOSE-PRODUCING AMYLASE COMPLEXED WITH PSEUDO-MALTONONAOSE 1WP6 ; 2.10 ; CRYSTAL STRUCTURE OF MALTOHEXAOSE-PRODUCING AMYLASE FROM ALKALOPHILIC BACILLUS SP.707. 1IV8 ; 1.90 ; CRYSTAL STRUCTURE OF MALTOOLIGOSYL TREHALOSE SYNTHASE 1FQD ; 2.30 ; CRYSTAL STRUCTURE OF MALTOTETRAITOL BOUND TO CLOSED-FORM MALTODEXTRIN BINDING PROTEIN 1FQC ; 2.30 ; CRYSTAL STRUCTURE OF MALTOTRIOTOL BOUND TO CLOSED-FORM MALTODEXTRIN BINDING PROTEIN 1WLE ; 1.65 ; CRYSTAL STRUCTURE OF MAMMALIAN MITOCHONDRIAL SERYL-TRNA SYNTHETASE COMPLEXED WITH SERYL-ADENYLATE 1F5A ; 2.50 ; CRYSTAL STRUCTURE OF MAMMALIAN POLY(A) POLYMERASE 1Q79 ; 2.15 ; CRYSTAL STRUCTURE OF MAMMALIAN POLY(A) POLYMERASE 1JKU ; 1.84 ; CRYSTAL STRUCTURE OF MANGANESE CATALASE FROM LACTOBACILLUS PLANTARUM 1JKV ; 1.39 ; CRYSTAL STRUCTURE OF MANGANESE CATALASE FROM LACTOBACILLUS PLANTARUM COMLEXED WITH AZIDE 1PM2 ; 1.80 ; CRYSTAL STRUCTURE OF MANGANESE SUBSTITUTED R2-D84E (D84E MUTANT OF THE R2 SUBUNIT OF E. COLI RIBONUCLEOTIDE REDUCTASE) 1Y67 ; 1.85 ; CRYSTAL STRUCTURE OF MANGANESE SUPEROXIDE DISMUTASE FROM DEINOCOCCUS RADIODURANS 1JR9 ; 2.80 ; CRYSTAL STRUCTURE OF MANGANESE SUPEROXIDE DISMUTASES FROM BACILLUS HALODENITRIFICANS 2CWL ; 1.65 ; CRYSTAL STRUCTURE OF MANGANESE-FREE FORM OF PSEUDOCATALASE FROM THERMUS THERMOPHILUS HB8 1EF2 ; 2.50 ; CRYSTAL STRUCTURE OF MANGANESE-SUBSTITUTED KLEBSIELLA AEROGENES UREASE 1J9Y ; 1.85 ; CRYSTAL STRUCTURE OF MANNANASE 26A FROM PSEUDOMONAS CELLULOSA 1SI0 ; 1.35 ; CRYSTAL STRUCTURE OF MANNHEIMIA HAEMOLYTICA FERRIC IRON- BINDING PROTEIN A IN A CLOSED CONFORMATION 1SI1 ; 1.45 ; CRYSTAL STRUCTURE OF MANNHEIMIA HAEMOLYTICA FERRIC IRON- BINDING PROTEIN A IN AN OPEN CONFORMATION 1LJ8 ; 1.70 ; CRYSTAL STRUCTURE OF MANNITOL DEHYDROGENASE IN COMPLEX WITH NAD 1S3E ; 1.60 ; CRYSTAL STRUCTURE OF MAOB IN COMPLEX WITH 6-HYDROXY-N- PROPARGYL-1(R)-AMINOINDAN 1S3B ; 1.65 ; CRYSTAL STRUCTURE OF MAOB IN COMPLEX WITH N-METHYL-N- PROPARGYL-1(R)-AMINOINDAN 1S2Q ; 2.07 ; CRYSTAL STRUCTURE OF MAOB IN COMPLEX WITH N-PROPARGYL-1(R)- AMINOINDAN (RASAGILINE) 1S2Y ; 2.12 ; CRYSTAL STRUCTURE OF MAOB IN COMPLEX WITH N-PROPARGYL-1(S)- AMINOINDAN 1LEZ ; 2.30 ; CRYSTAL STRUCTURE OF MAP KINASE P38 COMPLEXED TO THE DOCKING SITE ON ITS ACTIVATOR MKK3B 1LEW ; 2.30 ; CRYSTAL STRUCTURE OF MAP KINASE P38 COMPLEXED TO THE DOCKING SITE ON ITS NUCLEAR SUBSTRATE MEF2A 1KWP ; 2.80 ; CRYSTAL STRUCTURE OF MAPKAP2 1IWQ ; 2.00 ; CRYSTAL STRUCTURE OF MARCKS CALMODULIN BINDING DOMAIN PEPTIDE COMPLEXED WITH CA2+/CALMODULIN 2AS8 ; 1.95 ; CRYSTAL STRUCTURE OF MATURE AND FULLY ACTIVE DER P 1 ALLERGEN 1QYF ; 1.50 ; CRYSTAL STRUCTURE OF MATURED GREEN FLUORESCENT PROTEIN R96A VARIANT 1WS7 ; 1.90 ; CRYSTAL STRUCTURE OF MAVICYANIN FROM CUCURBITA PEPO MEDULLOSA (ZUCCHINI) 1WS8 ; 1.60 ; CRYSTAL STRUCTURE OF MAVICYANIN FROM CUCURBITA PEPO MEDULLOSA (ZUCCHINI) 1UB4 ; 1.70 ; CRYSTAL STRUCTURE OF MAZEF COMPLEX 1VMG ; 1.46 ; CRYSTAL STRUCTURE OF MAZG NUCLEOTIDE PYROPHOSPHOHYDROLASE (13816655) FROM SULFOLOBUS SOLFATARICUS AT 1.46 A RESOLUTION 1VR4 ; 2.09 ; CRYSTAL STRUCTURE OF MCSG TARGET APC22750 FROM BACILLUS CEREUS 1XPJ ; 2.30 ; CRYSTAL STRUCTURE OF MCSG TARGET APC26283 FROM VIBRIO CHOLERAE 1Y2I ; 2.30 ; CRYSTAL STRUCTURE OF MCSG TARGET APC27401 FROM SHIGELLA FLEXNERI 1XA0 ; 2.80 ; CRYSTAL STRUCTURE OF MCSG TARGET APC35536 FROM BACILLUS STEAROTHERMOPHILUS 2ETX ; 1.33 ; CRYSTAL STRUCTURE OF MDC1 TANDEM BRCT DOMAINS 1Z2C ; 3.00 ; CRYSTAL STRUCTURE OF MDIA1 GBD-FH3 IN COMPLEX WITH RHOC- GMPPNP 2ACV ; 2.00 ; CRYSTAL STRUCTURE OF MEDICAGO TRUNCATULA UGT71G1 2ACW ; 2.60 ; CRYSTAL STRUCTURE OF MEDICAGO TRUNCATULA UGT71G1 COMPLEXED WITH UDP-GLUCOSE 1UKW ; 2.40 ; CRYSTAL STRUCTURE OF MEDIUM-CHAIN ACYL-COA DEHYDROGENASE FROM THERMUS THERMOPHILUS HB8 1EGW ; 1.50 ; CRYSTAL STRUCTURE OF MEF2A CORE BOUND TO DEOXYRIBONUCLEIC ACID 1TVB ; 1.80 ; CRYSTAL STRUCTURE OF MELANOMA ANTIGEN GP100(209-217) BOUND TO HUMAN CLASS I MHC HLA-A2 1RJM ; 2.15 ; CRYSTAL STRUCTURE OF MENB (RV0548C) FROM MYCOBACTERIUM TUBERCULOSIS 1FMJ ; 2.00 ; CRYSTAL STRUCTURE OF MERCURY DERIVATIVE OF RETINOL DEHYDRATASE IN A COMPLEX WITH RETINOL AND PAP 1FE4 ; 1.75 ; CRYSTAL STRUCTURE OF MERCURY-HAH1 1ISN ; 2.90 ; CRYSTAL STRUCTURE OF MERLIN FERM DOMAIN 1S7C ; 2.04 ; CRYSTAL STRUCTURE OF MES BUFFER BOUND FORM OF GLYCERALDEHYDE 3-PHOSPHATE DEHYDROGENASE FROM ESCHERICHIA COLI 1JN2 ; 1.90 ; CRYSTAL STRUCTURE OF MESO-TETRASULPHONATOPHENYL PORPHYRIN COMPLEXED WITH CONCANAVALIN A 1RIR ; 2.90 ; CRYSTAL STRUCTURE OF MESO-TETRASULPHONATOPHENYLPORPHYRIN IN COMPLEX WITH PEANUT LECTIN. 1KOK ; 1.70 ; CRYSTAL STRUCTURE OF MESOPONE CYTOCHROME C PEROXIDASE (MPCCP) 1S73 ; 1.53 ; CRYSTAL STRUCTURE OF MESOPONE CYTOCHROME C PEROXIDASE (R- ISOMER) [MPCCP-R] 1GY2 ; 1.82 ; CRYSTAL STRUCTURE OF MET148LEU RUSTICYANIN 1J5O ; 3.50 ; CRYSTAL STRUCTURE OF MET184ILE MUTANT OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DOUBLE STRANDED DEOXYRIBONUCLEIC ACID TEMPLATE- PRIMER 1ISS ; 3.30 ; CRYSTAL STRUCTURE OF METABOTROPIC GLUTAMATE RECEPTOR SUBTYPE 1 COMPLEXED WITH AN ANTAGONIST 1EWK ; 2.20 ; CRYSTAL STRUCTURE OF METABOTROPIC GLUTAMATE RECEPTOR SUBTYPE 1 COMPLEXED WITH GLUTAMATE 1ISR ; 4.00 ; CRYSTAL STRUCTURE OF METABOTROPIC GLUTAMATE RECEPTOR SUBTYPE 1 COMPLEXED WITH GLUTAMATE AND GADOLINIUM ION 1EWT ; 3.70 ; CRYSTAL STRUCTURE OF METABOTROPIC GLUTAMATE RECEPTOR SUBTYPE 1 LIGAND FREE FORM I 1EWV ; 4.00 ; CRYSTAL STRUCTURE OF METABOTROPIC GLUTAMATE RECEPTOR SUBTYPE 1 LIGAND FREE FORM II 1J6P ; 1.90 ; CRYSTAL STRUCTURE OF METAL-DEPENDENT HYDROLASE OF CYTOSINEDEMANIASE/CHLOROHYDROLASE FAMILY (TM0936) FROM THERMOTOGA MARITIMA AT 1.9 A RESOLUTION 1HZT ; 1.45 ; CRYSTAL STRUCTURE OF METAL-FREE ISOPENTENYL DIPHOSPHATE:DIMETHYLALLYL DIPHOSPHATE ISOMERASE 1WUO ; 2.01 ; CRYSTAL STRUCTURE OF METALLO-BETA-LACTAMASE IMP-1 MUTANT (D81A) 1WUP ; 3.00 ; CRYSTAL STRUCTURE OF METALLO-BETA-LACTAMASE IMP-1 MUTANT (D81E) 1R5G ; 2.00 ; CRYSTAL STRUCTURE OF METAP2 COMPLEXED WITH A311263 1R5H ; 2.40 ; CRYSTAL STRUCTURE OF METAP2 COMPLEXED WITH A320282 1R58 ; 1.90 ; CRYSTAL STRUCTURE OF METAP2 COMPLEXED WITH A357300 1KUU ; 2.20 ; CRYSTAL STRUCTURE OF METHANOBACTERIUM THERMOAUTOTROPHICUM CONSERVED PROTEIN MTH1020 REVEALS AN NTN-HYDROLASE FOLD 1M8K ; 3.00 ; CRYSTAL STRUCTURE OF METHANOBACTERIUM THERMOAUTOTROPHICUM NICOTINAMIDE MONONUCLEOTIDE ADENYLYLTRANSFERASE MUTANT H19A COMPLEXED WITH NAD 1M8F ; 2.40 ; CRYSTAL STRUCTURE OF METHANOBACTERIUM THERMOAUTOTROPHICUM NICOTINAMIDE MONONUCLEOTIDE ADENYLYLTRANSFERASE MUTANT R11A COMPLEXED WITH NAD 1M8G ; 2.00 ; CRYSTAL STRUCTURE OF METHANOBACTERIUM THERMOAUTOTROPHICUM NICOTINAMIDE MONONUCLEOTIDE ADENYLYLTRANSFERASE MUTANT R11K COMPLEXED WITH NAD 1M8J ; 2.40 ; CRYSTAL STRUCTURE OF METHANOBACTERIUM THERMOAUTOTROPHICUM NICOTINAMIDE MONONUCLEOTIDE ADENYLYLTRANSFERASE MUTANT R136A COMPLEXED WITH NAD 1EJ2 ; 1.90 ; CRYSTAL STRUCTURE OF METHANOBACTERIUM THERMOAUTOTROPHICUM NICOTINAMIDE MONONUCLEOTIDE ADENYLYLTRANSFERASE WITH BOUND NAD+ 1ZPS ; 1.70 ; CRYSTAL STRUCTURE OF METHANOBACTERIUM THERMOAUTOTROPHICUM PHOSPHORIBOSYL-AMP CYCLOHYDROLASE HISI 1QWG ; 1.60 ; CRYSTAL STRUCTURE OF METHANOCOCCUS JANNASCHII PHOSPHOSULFOLACTATE SYNTHASE 1LRW ; 2.50 ; CRYSTAL STRUCTURE OF METHANOL DEHYDROGENASE FROM P. DENITRIFICANS 1SBQ ; 2.20 ; CRYSTAL STRUCTURE OF METHENYLTETRAHYDROFOLATE SYNTHETASE FROM MYCOPLASMA PNEUMONIAE AT 2.2 RESOLUTION 1O0X ; 1.90 ; CRYSTAL STRUCTURE OF METHIONINE AMINOPEPTIDASE (TM1478) FROM THERMOTOGA MARITIMA AT 1.90 A RESOLUTION 1WOY ; 2.00 ; CRYSTAL STRUCTURE OF METHIONYL TRNA SYNTHETASE Y225F MUTANT FROM THERMUS THERMOPHILUS 1Z1Y ; 2.00 ; CRYSTAL STRUCTURE OF METHYLATED PVS25, AN OOKINETE PROTEIN FROM PLASMODIUM VIVAX 1Z69 ; 2.61 ; CRYSTAL STRUCTURE OF METHYLENETETRAHYDROMETHANOPTERIN REDUCTASE (MER) IN COMPLEX WITH COENZYME F420 1VMD ; 2.06 ; CRYSTAL STRUCTURE OF METHYLGLYOXAL SYNTHASE (TM1185) FROM THERMOTOGA MARITIMA AT 2.06 A RESOLUTION 1WO8 ; 1.70 ; CRYSTAL STRUCTURE OF METHYLGLYOXAL SYNTHASE FROM THERMUS THERMOPHILUS HB8 1EF8 ; 1.85 ; CRYSTAL STRUCTURE OF METHYLMALONYL COA DECARBOXYLASE 1G60 ; 1.74 ; CRYSTAL STRUCTURE OF METHYLTRANSFERASE MBOIIA (MORAXELLA BOVIS) 2CWP ; 2.10 ; CRYSTAL STRUCTURE OF METRS RELATED PROTEIN FROM PYROCOCCUS HORIKOSHII 1VIS ; 2.69 ; CRYSTAL STRUCTURE OF MEVALONATE KINASE 1OF5 ; 2.80 ; CRYSTAL STRUCTURE OF MEX67-MTR2 1J34 ; 1.55 ; CRYSTAL STRUCTURE OF MG(II)-AND CA(II)-BOUND GLA DOMAIN OF FACTOR IX COMPLEXED WITH BINDING PROTEIN 1RC5 ; 2.30 ; CRYSTAL STRUCTURE OF MG(II)-COMPLEX OF RNASE III ENDONUCLEASE DOMAIN FROM AQUIFEX AEOLICUS AT 2.30 ANGSTROM RESOLUTION 1M74 ; 3.00 ; CRYSTAL STRUCTURE OF MG-ADP-BOUND SECA FROM BACILLUS SUBTILIS 1L5Y ; 2.10 ; CRYSTAL STRUCTURE OF MG2+ / BEF3-BOUND RECEIVER DOMAIN OF SINORHIZOBIUM MELILOTI DCTD 2AFI ; 3.10 ; CRYSTAL STRUCTURE OF MGADP BOUND AV2-AV1 COMPLEX 2AFK ; 2.30 ; CRYSTAL STRUCTURE OF MGAMPPCP-BOUND AV2-AV1 COMPLEX 1F3B ; 2.00 ; CRYSTAL STRUCTURE OF MGSTA1-1 IN COMPLEX WITH GLUTATHIONE CONJUGATE OF BENZO[A]PYRENE EPOXIDE 1F3A ; 1.90 ; CRYSTAL STRUCTURE OF MGSTA1-1 IN COMPLEX WITH GSH 1ML6 ; 1.90 ; CRYSTAL STRUCTURE OF MGSTA2-2 IN COMPLEX WITH THE GLUTATHIONE CONJUGATE OF BENZO[A]PYRENE-7(R),8(S)-DIOL- 9(S),10(R)-EPOXIDE 1B48 ; 2.60 ; CRYSTAL STRUCTURE OF MGSTA4-4 IN COMPLEX WITH GSH CONJUGATE OF 4-HYDROXYNONENAL IN ONE SUBUNIT AND GSH IN THE OTHER: EVIDENCE OF SIGNALING ACROSS DIMER INTERFACE IN MGSTA4-4 1G7Q ; 1.60 ; CRYSTAL STRUCTURE OF MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND MUC1 VNTR PEPTIDE SAPDTRPA 1G7P ; 1.50 ; CRYSTAL STRUCTURE OF MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND YEAST ALPHA- GLUCOSIDASE 1ICF ; 2.00 ; CRYSTAL STRUCTURE OF MHC CLASS II ASSOCIATED P41 II FRAGMENT IN COMPLEX WITH CATHEPSIN L 1WDF ; 2.50 ; CRYSTAL STRUCTURE OF MHV SPIKE PROTEIN FUSION CORE 1WDG ; 2.06 ; CRYSTAL STRUCTURE OF MHV SPIKE PROTEIN FUSION CORE 1K9O ; 2.30 ; CRYSTAL STRUCTURE OF MICHAELIS SERPIN-TRYPSIN COMPLEX 1L4D ; 2.30 ; CRYSTAL STRUCTURE OF MICROPLASMINOGEN-STREPTOKINASE ALPHA DOMAIN COMPLEX 1W94 ; 2.00 ; CRYSTAL STRUCTURE OF MIL (MTH680), AN ARCHAEAL IMP4-LIKE PROTEIN 1OX3 ; 2.00 ; CRYSTAL STRUCTURE OF MINI-FIBRITIN 1TGR ; 1.42 ; CRYSTAL STRUCTURE OF MINI-IGF-1(2) 1Q81 ; 2.95 ; CRYSTAL STRUCTURE OF MINIHELIX WITH 3' PUROMYCIN BOUND TO A- SITE OF THE 50S RIBOSOMAL SUBUNIT. 1R4W ; 2.50 ; CRYSTAL STRUCTURE OF MITOCHONDRIAL CLASS KAPPA GLUTATHIONE TRANSFERASE 1NTM ; 2.40 ; CRYSTAL STRUCTURE OF MITOCHONDRIAL CYTOCHROME BC1 COMPLEX AT 2.4 ANGSTROM 1NTZ ; 2.60 ; CRYSTAL STRUCTURE OF MITOCHONDRIAL CYTOCHROME BC1 COMPLEX BOUND WITH UBIQUINONE 1NU1 ; 3.20 ; CRYSTAL STRUCTURE OF MITOCHONDRIAL CYTOCHROME BC1 COMPLEXED WITH 2-NONYL-4-HYDROXYQUINOLINE N-OXIDE (NQNO) 1NTK ; 2.60 ; CRYSTAL STRUCTURE OF MITOCHONDRIAL CYTOCHROME BC1 IN COMPLEX WITH ANTIMYCIN A1 1D2E ; 1.94 ; CRYSTAL STRUCTURE OF MITOCHONDRIAL EF-TU IN COMPLEX WITH GDP 1ZP0 ; 3.50 ; CRYSTAL STRUCTURE OF MITOCHONDRIAL RESPIRATORY COMPLEX II BOUND WITH 3-NITROPROPIONATE AND 2-THENOYLTRIFLUOROACETONE 1ZOY ; 2.40 ; CRYSTAL STRUCTURE OF MITOCHONDRIAL RESPIRATORY COMPLEX II FROM PORCINE HEART AT 2.4 ANGSTROMS 1DK4 ; 2.60 ; CRYSTAL STRUCTURE OF MJ0109 GENE PRODUCT INOSITOL MONOPHOSPHATASE 1G0H ; 2.30 ; CRYSTAL STRUCTURE OF MJ0109 GENE PRODUCT INOSITOL MONOPHOSPHATASE-FRUCTOSE 1,6 BISPHOSPHATASE 1G0I ; 2.40 ; CRYSTAL STRUCTURE OF MJ0109 GENE PRODUCT INOSITOL MONOPHOSPHATASE-FRUCTOSE 1,6 BISPHOSPHATASE 1HYG ; 2.80 ; CRYSTAL STRUCTURE OF MJ0490 GENE PRODUCT, THE FAMILY OF LACTATE/MALATE DEHYDROGENASE 1F3O ; 2.70 ; CRYSTAL STRUCTURE OF MJ0796 ATP-BINDING CASSETTE 1Z6R ; 2.70 ; CRYSTAL STRUCTURE OF MLC FROM ESCHERICHIA COLI 1M45 ; 1.65 ; CRYSTAL STRUCTURE OF MLC1P BOUND TO IQ2 OF MYO2P, A CLASS V MYOSIN 1M46 ; 2.10 ; CRYSTAL STRUCTURE OF MLC1P BOUND TO IQ4 OF MYO2P, A CLASS V MYOSIN 1F9C ; 2.50 ; CRYSTAL STRUCTURE OF MLE D178N VARIANT 2AE0 ; 2.00 ; CRYSTAL STRUCTURE OF MLTA FROM ESCHERICHIA COLI REVEALS A UNIQUE LYTIC TRANSGLYCOSYLASE FOLD 1UTZ ; 2.50 ; CRYSTAL STRUCTURE OF MMP-12 COMPLEXED TO (2R)-3-({[4-[(PYRI DIN-4-YL)PHENYL]-THIEN-2-YL}CARBOXAMIDO)(PHENYL)PROPANOIC ACID 1UTT ; 2.20 ; CRYSTAL STRUCTURE OF MMP-12 COMPLEXED TO 2- (1,3-DIOXO-1,3-DIHYDRO-2H-ISOINDOL-2-YL)ETHYL-4- (4-ETHOXY[1,1-BIPHENYL]-4-YL)-4-OXOBUTANOIC ACID 1ROS ; 2.00 ; CRYSTAL STRUCTURE OF MMP-12 COMPLEXED TO 2-(1,3-DIOXO-1,3- DIHYDRO-2H-ISOINDOL-2-YL)ETHYL-4-(4-ETHOXY[1,1-BIPHENYL]-4- YL)-4-OXOBUTANOIC ACID 1JH1 ; 2.70 ; CRYSTAL STRUCTURE OF MMP-8 COMPLEXED WITH A 6H-1,3,4- THIADIAZINE DERIVED INHIBITOR 1D8M ; 2.44 ; CRYSTAL STRUCTURE OF MMP3 COMPLEXED WITH A HETEROCYCLE- BASED INHIBITOR 1D7X ; 2.00 ; CRYSTAL STRUCTURE OF MMP3 COMPLEXED WITH A MODIFIED PROLINE SCAFFOLD BASED INHIBITOR. 1D8F ; 2.40 ; CRYSTAL STRUCTURE OF MMP3 COMPLEXED WITH A PIPERAZINE BASED INHIBITOR. 1D5J ; 2.60 ; CRYSTAL STRUCTURE OF MMP3 COMPLEXED WITH A THIAZEPINE BASED INHIBITOR. 1BZS ; 1.70 ; CRYSTAL STRUCTURE OF MMP8 COMPLEXED WITH HMR2909 1JJ9 ; 2.00 ; CRYSTAL STRUCTURE OF MMP8-BARBITURATE COMPLEX REVEALS MECHANISM FOR COLLAGEN SUBSTRATE RECOGNITION 1J74 ; 1.90 ; CRYSTAL STRUCTURE OF MMS2 1QB4 ; 2.60 ; CRYSTAL STRUCTURE OF MN(2+)-BOUND PHOSPHOENOLPYRUVATE CARBOXYLASE 1XNZ ; 1.52 ; CRYSTAL STRUCTURE OF MN(II) FORM OF E. COLI. METHIONINE AMINOPEPTIDASE IN COMPLEX WITH 5-(2-CHLOROPHENYL)FURAN-2- CARBOXYLIC ACID 1JFZ ; 2.10 ; CRYSTAL STRUCTURE OF MN(II)-COMPLEX OF RNASE III ENDONUCLEASE DOMAIN FROM AQUIFEX AEOLICUS AT 2.10 ANGSTROM RESOLUTION 1XMO ; 3.25 ; CRYSTAL STRUCTURE OF MNM5U34T6A37-TRNALYSUUU COMPLEXED WITH AAG-MRNA IN THE DECODING CENTER 1NXD ; 1.90 ; CRYSTAL STRUCTURE OF MNMN CONCANAVALIN A 1UPL ; 2.60 ; CRYSTAL STRUCTURE OF MO25 ALPHA 1UPK ; 1.85 ; CRYSTAL STRUCTURE OF MO25 IN COMPLEX WITH A C-TERMINAL PEPTIDE OF STRAD 1R2K ; 2.10 ; CRYSTAL STRUCTURE OF MOAB FROM ESCHERICHIA COLI 1MKZ ; 1.60 ; CRYSTAL STRUCTURE OF MOAB PROTEIN AT 1.6 A RESOLUTION. 1V8C ; 1.60 ; CRYSTAL STRUCTURE OF MOAD RELATED PROTEIN FROM THERMUS THERMOPHILUS HB8 1WOD ; 1.75 ; CRYSTAL STRUCTURE OF MODA, A MOLYBDATE PROTEIN, COMPLEXED WITH TUNGSTATE 1AMF ; 1.75 ; CRYSTAL STRUCTURE OF MODA, A MOLYBDATE TRANSPORT PROTEIN, COMPLEXED WITH MOLYBDATE 1TVH ; 1.80 ; CRYSTAL STRUCTURE OF MODIFIED MELANOMA ANTIGEN GP100(209- T2M) BOUND TO HUMAN CLASS I MHC HLA-A2 1Y5E ; 1.90 ; CRYSTAL STRUCTURE OF MOLYBDENUM COFACTOR BIOSYNTHESIS PROTEIN B 1FC5 ; 2.20 ; CRYSTAL STRUCTURE OF MOLYBDOPTERIN BIOSYNTHESIS MOEA PROTEIN 1WU2 ; 2.30 ; CRYSTAL STRUCTURE OF MOLYBDOPTERIN BIOSYNTHESIS MOEA PROTEIN FROM PYROCOCCUS HORIKOSHII OT3 2F1R ; 2.10 ; CRYSTAL STRUCTURE OF MOLYBDOPTERIN-GUANINE BIOSYNTHESIS PROTEIN B (MOBB) 1JAZ ; 2.27 ; CRYSTAL STRUCTURE OF MONOCLINIC FORM OF D90E MUTANT OF ESCHERICHIA COLI ASPARAGINASE II 1JJ3 ; 1.90 ; CRYSTAL STRUCTURE OF MONOCLINIC LYSOZYME GROWN AT PH 4.6 1LJ3 ; 2.00 ; CRYSTAL STRUCTURE OF MONOCLINIC LYSOZYME GROWN AT PH 4.6 1LJ4 ; 1.95 ; CRYSTAL STRUCTURE OF MONOCLINIC LYSOZYME GROWN AT PH 4.6 1LJI ; 2.00 ; CRYSTAL STRUCTURE OF MONOCLINIC LYSOZYME GROWN IN PRESENCE 10% SORBITOL 1LJE ; 2.00 ; CRYSTAL STRUCTURE OF MONOCLINIC LYSOZYME GROWN IN PRESENCE OF 10% SUCROSE 1LJF ; 1.80 ; CRYSTAL STRUCTURE OF MONOCLINIC LYSOZYME GROWN IN PRESENCE OF 10% SUCROSE 1LJJ ; 2.00 ; CRYSTAL STRUCTURE OF MONOCLINIC LYSOZYME GROWN IN PRESENCE OF 10% TREHALOSE 1LJK ; 2.10 ; CRYSTAL STRUCTURE OF MONOCLINIC LYSOZYME GROWN IN PRESENCE OF 15% TREHALOSE 1LJG ; 1.90 ; CRYSTAL STRUCTURE OF MONOCLINIC LYSOZYME GROWN IN PRESENCE OF 5% GLYCEROL 1LJH ; 1.80 ; CRYSTAL STRUCTURE OF MONOCLINIC LYSOZYME GROWN IN PRESENCE OF 5% GLYCEROL 2ADG ; 2.50 ; CRYSTAL STRUCTURE OF MONOCLONAL ANTI-CD4 ANTIBODY Q425 2ADI ; 2.80 ; CRYSTAL STRUCTURE OF MONOCLONAL ANTI-CD4 ANTIBODY Q425 IN COMPLEX WITH BARIUM 2ADJ ; 2.90 ; CRYSTAL STRUCTURE OF MONOCLONAL ANTI-CD4 ANTIBODY Q425 IN COMPLEX WITH CALCIUM 1NC4 ; 2.25 ; CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY 2D12.5 FAB COMPLEXED WITH GD-DOTA 1NC2 ; 2.10 ; CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY 2D12.5 FAB COMPLEXED WITH Y-DOTA 1NWK ; 1.85 ; CRYSTAL STRUCTURE OF MONOMERIC ACTIN IN THE ATP STATE 1LDS ; 1.80 ; CRYSTAL STRUCTURE OF MONOMERIC HUMAN BETA-2-MICROGLOBULIN 2F0A ; 1.80 ; CRYSTAL STRUCTURE OF MONOMERIC UNCOMPLEXED FORM OF XENOPUS DISHEVELLED PDZ DOMAIN 1J06 ; 2.35 ; CRYSTAL STRUCTURE OF MOUSE ACETYLCHOLINESTERASE IN THE APO FORM 1ON6 ; 2.30 ; CRYSTAL STRUCTURE OF MOUSE ALPHA-1,4-N- ACETYLHEXOSAMINOTRANSFERASE (EXTL2) IN COMPLEX WITH UDPGLCNAC 1OMX ; 2.40 ; CRYSTAL STRUCTURE OF MOUSE ALPHA-1,4-N- ACETYLHEXOSAMINYLTRANSFERASE (EXTL2) 1OMZ ; 2.10 ; CRYSTAL STRUCTURE OF MOUSE ALPHA-1,4-N- ACETYLHEXOSAMINYLTRANSFERASE (EXTL2) IN COMPLEX WITH UDPGALNAC 1ON8 ; 2.70 ; CRYSTAL STRUCTURE OF MOUSE ALPHA-1,4-N- ACETYLHEXOSAMINYLTRANSFERASE (EXTL2) WITH UDP AND GLCUAB(1- 3)GALB(1-O)-NAPHTHALENELMETHANOL AN ACCEPTOR SUBSTRATE ANALOG 1O3Y ; 1.50 ; CRYSTAL STRUCTURE OF MOUSE ARF1 (DELTA17-Q71L), GTP FORM 1PQ0 ; 2.20 ; CRYSTAL STRUCTURE OF MOUSE BCL-XL 1XL7 ; 2.00 ; CRYSTAL STRUCTURE OF MOUSE CARNITINE OCTANOYLTRANSFERASE 1XL8 ; 2.20 ; CRYSTAL STRUCTURE OF MOUSE CARNITINE OCTANOYLTRANSFERASE IN COMPLEX WITH OCTANOYLCARNITINE 1ZHN ; 2.80 ; CRYSTAL STRUCTURE OF MOUSE CD1D BOUND TO THE SELF LIGAND PHOSPHATIDYLCHOLINE 1QQJ ; 1.55 ; CRYSTAL STRUCTURE OF MOUSE FUMARYLACETOACETATE HYDROLASE REFINED AT 1.55 ANGSTROM RESOLUTION 1R8Y ; 3.00 ; CRYSTAL STRUCTURE OF MOUSE GLYCINE N-METHYLTRANSFERASE (MONOCLINIC FORM) 1R8X ; 2.95 ; CRYSTAL STRUCTURE OF MOUSE GLYCINE N-METHYLTRANSFERASE (TETRAGONAL FORM) 2AGC ; 2.50 ; CRYSTAL STRUCTURE OF MOUSE GM2- ACTIVATOR PROTEIN 1LVG ; 2.10 ; CRYSTAL STRUCTURE OF MOUSE GUANYLATE KINASE IN COMPLEX WITH GMP AND ADP 1K8I ; 3.10 ; CRYSTAL STRUCTURE OF MOUSE H2-DM 1WNH ; 1.83 ; CRYSTAL STRUCTURE OF MOUSE LATEXIN (TISSUE CARBOXYPEPTIDASE INHIBITOR) 1I05 ; 2.00 ; CRYSTAL STRUCTURE OF MOUSE MAJOR URINARY PROTEIN (MUP-I) COMPLEXED WITH HYDROXY-METHYL-HEPTANONE 1I06 ; 1.90 ; CRYSTAL STRUCTURE OF MOUSE MAJOR URINARY PROTEIN (MUP-I) COMPLEXED WITH SEC-BUTYL-THIAZOLINE 1I04 ; 2.00 ; CRYSTAL STRUCTURE OF MOUSE MAJOR URINARY PROTEIN-I FROM MOUSE LIVER 1DXQ ; 2.80 ; CRYSTAL STRUCTURE OF MOUSE NAD[P]H-QUINONE OXIDOREDUCTASE 1JJO ; 3.06 ; CRYSTAL STRUCTURE OF MOUSE NEUROSERPIN (CLEAVED FORM) 1U0E ; 1.60 ; CRYSTAL STRUCTURE OF MOUSE PHOSPHOGLUCOSE ISOMERASE 1U0G ; 1.70 ; CRYSTAL STRUCTURE OF MOUSE PHOSPHOGLUCOSE ISOMERASE IN COMPLEX WITH ERYTHROSE 4-PHOSPHATE 1U0F ; 1.60 ; CRYSTAL STRUCTURE OF MOUSE PHOSPHOGLUCOSE ISOMERASE IN COMPLEX WITH GLUCOSE 6-PHOSPHATE 1KCM ; 2.00 ; CRYSTAL STRUCTURE OF MOUSE PITP ALPHA VOID OF BOUND PHOSPHOLIPID AT 2.0 ANGSTROMS RESOLUTION 1W68 ; 2.20 ; CRYSTAL STRUCTURE OF MOUSE RIBONUCLEOTIDE REDUCTASE SUBUNIT R2 UNDER OXIDIZING CONDITIONS. A FULLY OCCUPIED DINUCLEAR IRON CLUSTER. 1W69 ; 2.20 ; CRYSTAL STRUCTURE OF MOUSE RIBONUCLEOTIDE REDUCTASE SUBUNIT R2 UNDER REDUCING CONDITIONS. A FULLY OCCUPIED DINUCLEAR IRON CLUSTER AND BOUND ACETATE. 1U3H ; 2.42 ; CRYSTAL STRUCTURE OF MOUSE TCR 172.10 COMPLEXED WITH MHC CLASS II I-AU MOLECULE AT 2.4 A 1KEY ; 2.65 ; CRYSTAL STRUCTURE OF MOUSE TESTIS/BRAIN RIBONUCLEIC ACID-BINDING PROTEIN (TB-RBP) 1ZDL ; 3.00 ; CRYSTAL STRUCTURE OF MOUSE THIOREDOXIN REDUCTASE TYPE 2 1ZKQ ; 2.60 ; CRYSTAL STRUCTURE OF MOUSE THIOREDOXIN REDUCTASE TYPE 2 2CWN ; 2.10 ; CRYSTAL STRUCTURE OF MOUSE TRANSALDOLASE 1U9K ; 1.76 ; CRYSTAL STRUCTURE OF MOUSE TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1 (TREM-1) AT 1.76 1Z2X ; 2.22 ; CRYSTAL STRUCTURE OF MOUSE VPS29 1Z2W ; 2.00 ; CRYSTAL STRUCTURE OF MOUSE VPS29 COMPLEXED WITH MN2+ 1S8E ; 2.30 ; CRYSTAL STRUCTURE OF MRE11-3 1VLR ; 1.83 ; CRYSTAL STRUCTURE OF MRNA DECAPPING ENZYME (DCPS) FROM MUS MUSCULUS AT 1.83 A RESOLUTION 1MXM ; 3.90 ; CRYSTAL STRUCTURE OF MSCS AT 3.9 RESOLUTION 1HXR ; 1.65 ; CRYSTAL STRUCTURE OF MSS4 AT 1.65 ANGSTROMS 1Z5O ; 2.00 ; CRYSTAL STRUCTURE OF MTA/ADOHCY NUCLEOSIDASE ASP197ASN MUTANT COMPLEXED WITH 5'-METHYLTHIOADENOSINE 1Y6R ; 2.20 ; CRYSTAL STRUCTURE OF MTA/ADOHCY NUCLEOSIDASE COMPLEXED WITH MT-IMMA. 1Z5N ; 2.10 ; CRYSTAL STRUCTURE OF MTA/ADOHCY NUCLEOSIDASE GLU12GLN MUTANT COMPLEXED WITH 5-METHYLTHIORIBOSE AND ADENINE 1Z5P ; 2.00 ; CRYSTAL STRUCTURE OF MTA/ADOHCY NUCLEOSIDASE WITH A LIGAND- FREE PURINE BINDING SITE 1R8D ; 2.70 ; CRYSTAL STRUCTURE OF MTAN BOUND TO DEOXYRIBONUCLEIC ACID 1JBG ; 2.75 ; CRYSTAL STRUCTURE OF MTAN, THE BACILLUS SUBTILIS MULTIDRUG TRANSPORTER ACTIVATOR, N-TERMINUS 1A1X ; 2.00 ; CRYSTAL STRUCTURE OF MTCP-1 INVOLVED IN T CELL MALIGNANCIES 1LNQ ; 3.30 ; CRYSTAL STRUCTURE OF MTHK AT 3.3 A 1EAX ; 1.30 ; CRYSTAL STRUCTURE OF MTSP1 (MATRIPTASE) 1T98 ; 2.90 ; CRYSTAL STRUCTURE OF MUKF(1-287) 1WVL ; 2.60 ; CRYSTAL STRUCTURE OF MULTIMERIC DEOXYRIBONUCLEIC ACID-BINDING PROTEIN SAC7D- GCN4 WITH DEOXYRIBONUCLEIC ACID DECAMER 1WST ; 1.95 ; CRYSTAL STRUCTURE OF MULTIPLE SUBSTRATE AMINOTRANSFERASE (MSAT) FROM THERMOCOCCUS PROFUNDUS 1SBW ; 1.80 ; CRYSTAL STRUCTURE OF MUNG BEAN INHIBITOR LYSINE ACTIVE FRAGMENT COMPLEX WITH BOVINE BETA-TRYPSIN AT 1.8A RESOLUTION 1D02 ; 1.70 ; CRYSTAL STRUCTURE OF MUNI RESTRICTION ENDONUCLEASE IN COMPLEX WITH COGNATE DEOXYRIBONUCLEIC ACID 1NLM ; 2.50 ; CRYSTAL STRUCTURE OF MURG:GLCNAC COMPLEX 1GUK ; 2.90 ; CRYSTAL STRUCTURE OF MURINE ALPHA-CLASS GSTA4-4 1U5X ; 1.80 ; CRYSTAL STRUCTURE OF MURINE APRIL AT PH 5.0 1U5Y ; 2.30 ; CRYSTAL STRUCTURE OF MURINE APRIL, PH 8.0 1FZQ ; 1.70 ; CRYSTAL STRUCTURE OF MURINE ARL3-GDP 1L6Z ; 3.32 ; CRYSTAL STRUCTURE OF MURINE CEACAM1A[1,4]: A CORONAVIRUS RECEPTOR AND CELL ADHESION MOLECULE IN THE CEA FAMILY 1FFP ; 2.60 ; CRYSTAL STRUCTURE OF MURINE CLASS I H-2DB COMPLEXED WITH PEPTIDE GP33 (C9M/K1S) 1FFN ; 2.70 ; CRYSTAL STRUCTURE OF MURINE CLASS I H-2DB COMPLEXED WITH PEPTIDE GP33(C9M) 1FFO ; 2.65 ; CRYSTAL STRUCTURE OF MURINE CLASS I H-2DB COMPLEXED WITH SYNTHETIC PEPTIDE GP33 (C9M/K1A) 1BZ9 ; 2.80 ; CRYSTAL STRUCTURE OF MURINE CLASS I MHC H2-DB COMPLEXED WITH A SYNTHETIC PEPTIDE P1027 1MUJ ; 2.15 ; CRYSTAL STRUCTURE OF MURINE CLASS II MHC I-AB IN COMPLEX WITH A HUMAN CLIP PEPTIDE 2AQ5 ; 1.75 ; CRYSTAL STRUCTURE OF MURINE CORONIN-1 2B4E ; 2.30 ; CRYSTAL STRUCTURE OF MURINE CORONIN-1: MONOCLINIC FORM 1F5Q ; 2.50 ; CRYSTAL STRUCTURE OF MURINE GAMMA HERPESVIRUS CYCLIN COMPLEXED TO HUMAN CYCLIN DEPENDENT KINASE 2 1QW4 ; 2.40 ; CRYSTAL STRUCTURE OF MURINE INDUCIBLE NITRIC OXIDE SYNTHASE OXYGENASE DOMAIN IN COMPLEX WITH N-OMEGA-PROPYL-L-ARGININE. 1LDP ; 3.10 ; CRYSTAL STRUCTURE OF MURINE MHC CLASS I H-2LD WITH A MIXTURE OF BOUND PEPTIDES 1Q1F ; 1.50 ; CRYSTAL STRUCTURE OF MURINE NEUROGLOBIN 1JFM ; 2.85 ; CRYSTAL STRUCTURE OF MURINE NK CELL LIGAND RAE-1 BETA 1JSK ; 3.50 ; CRYSTAL STRUCTURE OF MURINE NK CELL LIGAND RAE-1 BETA IN COMPLEX WITH NKG2D 1F35 ; 2.30 ; CRYSTAL STRUCTURE OF MURINE OLFACTORY MARKER PROTEIN 1JOB ; 2.40 ; CRYSTAL STRUCTURE OF MURINE OLFACTORY MARKER PROTEIN IN SPACEGROUP P3121 1JOD ; 3.20 ; CRYSTAL STRUCTURE OF MURINE OLFACTORY MARKER PROTEIN IN SPACEGROUP P43212 1EK2 ; 3.00 ; CRYSTAL STRUCTURE OF MURINE SOLUBLE EPOXIDE HYDROLASE COMPLEXED WITH CDU INHIBITOR 1EK1 ; 3.10 ; CRYSTAL STRUCTURE OF MURINE SOLUBLE EPOXIDE HYDROLASE COMPLEXED WITH CIU INHIBITOR 1CR6 ; 2.80 ; CRYSTAL STRUCTURE OF MURINE SOLUBLE EPOXIDE HYDROLASE COMPLEXED WITH CPU INHIBITOR 1CQZ ; 2.80 ; CRYSTAL STRUCTURE OF MURINE SOLUBLE EPOXIDE HYDROLASE. 1JNP ; 2.50 ; CRYSTAL STRUCTURE OF MURINE TCL1 AT 2.5 RESOLUTION 1KEJ ; 3.00 ; CRYSTAL STRUCTURE OF MURINE TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE COMPLEXED WITH DDATP 1MZZ ; 2.00 ; CRYSTAL STRUCTURE OF MUTANT (M182T)OF NITRITE REDUCTASE 1GS8 ; 1.90 ; CRYSTAL STRUCTURE OF MUTANT D92N ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE 1F8U ; 2.90 ; CRYSTAL STRUCTURE OF MUTANT E202Q OF HUMAN ACETYLCHOLINESTERASE COMPLEXED WITH GREEN MAMBA VENOM PEPTIDE FASCICULIN-II 1W00 ; 2.20 ; CRYSTAL STRUCTURE OF MUTANT ENZYME D103L OF KETOSTEROID ISOMERASE FROM PSEUDOMONAS PUTIDA BIOTYPE B 1W02 ; 2.30 ; CRYSTAL STRUCTURE OF MUTANT ENZYME Y16F/D103L OF KETOSTEROID ISOMERASE FROM PSEUDOMONAS PUTIDA BIOTYPE B 1DMQ ; 2.15 ; CRYSTAL STRUCTURE OF MUTANT ENZYME Y32F OF KETOSTEROID ISOMERASE FROM PSEUDOMONAS PUTIDA BIOTYPE B 1VZZ ; 2.30 ; CRYSTAL STRUCTURE OF MUTANT ENZYME Y32F/D103L OF KETOSTEROID ISOMERASE FROM PSEUDOMONAS PUTIDA BIOTYPE B 1DMN ; 2.05 ; CRYSTAL STRUCTURE OF MUTANT ENZYME Y32F/Y57F OF KETOSTEROID ISOMERASE FROM PSEUDOMONAS PUTIDA BIOTYPE B 1W01 ; 2.20 ; CRYSTAL STRUCTURE OF MUTANT ENZYME Y57F/D103L OF KETOSTEROID ISOMERASE FROM PSEUDOMONAS PUTIDA BIOTYPE B 1X91 ; 1.50 ; CRYSTAL STRUCTURE OF MUTANT FORM A OF A PECTIN METHYLESTERASE INHIBITOR FROM ARABIDOPSIS 1X90 ; 2.68 ; CRYSTAL STRUCTURE OF MUTANT FORM B OF A PECTIN METHYLESTERASE INHIBITOR FROM ARABIDOPSIS 1GDW ; 1.80 ; CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT LEFT-HANDED HELICAL POSITIONS 1GDX ; 1.80 ; CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT LEFT-HANDED HELICAL POSITIONS 1GE0 ; 1.80 ; CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT LEFT-HANDED HELICAL POSITIONS 1GE1 ; 1.70 ; CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT LEFT-HANDED HELICAL POSITIONS 1GE2 ; 2.00 ; CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT LEFT-HANDED HELICAL POSITIONS 1GE3 ; 1.80 ; CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT LEFT-HANDED HELICAL POSITIONS 1GE4 ; 1.80 ; CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT LEFT-HANDED HELICAL POSITIONS 1GAY ; 1.80 ; CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS 1GAZ ; 1.80 ; CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS 1GB0 ; 1.80 ; CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS 1GB2 ; 1.80 ; CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS 1GB3 ; 1.80 ; CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS 1GB5 ; 1.80 ; CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS 1GB6 ; 1.80 ; CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS 1GB7 ; 1.80 ; CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS 1GB8 ; 1.80 ; CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS 1GB9 ; 1.80 ; CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS 1GBO ; 1.80 ; CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS 1GBW ; 1.80 ; CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS 1GBX ; 1.80 ; CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS 1GBY ; 1.80 ; CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS 1GBZ ; 1.80 ; CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS 1GF8 ; 1.80 ; CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS 1GF9 ; 1.80 ; CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS 1GFA ; 1.80 ; CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS 1GFE ; 1.80 ; CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS 1GFG ; 1.80 ; CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS 1GFH ; 1.80 ; CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS 1GFJ ; 1.80 ; CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS 1GFK ; 1.80 ; CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS 1GFR ; 1.80 ; CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS 1GFT ; 1.80 ; CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS 1GFU ; 1.80 ; CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS 1GFV ; 1.80 ; CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS 1INU ; 1.80 ; CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED AT THE SURFACE POSITIONS 1C7P ; 2.40 ; CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME WITH FOUR EXTRA RESIDUES (EAEA) AT THE N-TERMINAL 1IOC ; 2.40 ; CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME, EAEA-I56T 1T7A ; 1.50 ; CRYSTAL STRUCTURE OF MUTANT LYS8ASP OF SCORPION ALPHA-LIKE NEUROTOXIN BMK M1 FROM BUTHUS MARTENSII KARSCH 1T7B ; 1.85 ; CRYSTAL STRUCTURE OF MUTANT LYS8GLN OF SCORPION ALPHA-LIKE NEUROTOXIN BMK M1 FROM BUTHUS MARTENSII KARSCH 1QZ3 ; 2.30 ; CRYSTAL STRUCTURE OF MUTANT M211S/R215L OF CARBOXYLESTERASE EST2 COMPLEXED WITH HEXADECANESULFONATE 1J72 ; 2.50 ; CRYSTAL STRUCTURE OF MUTANT MACROPHAGE CAPPING PROTEIN (CAP G) WITH ACTIN-SEVERING ACTIVITY IN THE CA2+-FREE FORM 1T7E ; 1.40 ; CRYSTAL STRUCTURE OF MUTANT PRO9SER OF SCORPION ALPHA-LIKE NEUROTOXIN BMK M1 FROM BUTHUS MARTENSII KARSCH 1I5O ; 2.80 ; CRYSTAL STRUCTURE OF MUTANT R105A OF E. COLI ASPARTATE TRANSCARBAMOYLASE 1Z3M ; 2.00 ; CRYSTAL STRUCTURE OF MUTANT RIBONUCLEASE S (F8NVA) 1RM5 ; 2.10 ; CRYSTAL STRUCTURE OF MUTANT S188A OF PHOTOSYNTHETIC GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE A4 ISOFORM, COMPLEXED WITH NADP 1I2C ; 1.60 ; CRYSTAL STRUCTURE OF MUTANT T145A SQD1 PROTEIN COMPLEX WITH NAD AND UDP-GLUCOSE 1I2B ; 1.75 ; CRYSTAL STRUCTURE OF MUTANT T145A SQD1 PROTEIN COMPLEX WITH NAD AND UDP-SULFOQUINOVOSE/UDP-GLUCOSE 1RM3 ; 2.20 ; CRYSTAL STRUCTURE OF MUTANT T33A OF PHOTOSYNTHETIC GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE A4 ISOFORM, COMPLEXED WITH NADP 1WCX ; 2.00 ; CRYSTAL STRUCTURE OF MUTANT UROPORPHYRINOGEN III SYNTHASE FROM AN EXTREMELY THERMOPHILIC BACTERIUM THERMUS THERMOPHILUS HB8 (L75M/I193M/L248M, SEMET DERIVATIVE, FORM- 1 CRYSTAL) 1UWI ; 2.55 ; CRYSTAL STRUCTURE OF MUTATED BETA-GLYCOSIDASE FROM SULFOLOBUS SOLFATARICUS, WORKING AT MODERATE TEMPERATURE 2AOR ; 2.00 ; CRYSTAL STRUCTURE OF MUTH-HEMIMETHYLATED DEOXYRIBONUCLEIC ACID COMPLEX 2AOQ ; 2.20 ; CRYSTAL STRUCTURE OF MUTH-UNMETHYLATED DEOXYRIBONUCLEIC ACID COMPLEX 1EE8 ; 1.90 ; CRYSTAL STRUCTURE OF MUTM (FPG) PROTEIN FROM THERMUS THERMOPHILUS HB8 1DL3 ; 2.70 ; CRYSTAL STRUCTURE OF MUTUALLY GENERATED MONOMERS OF DIMERIC PHOSPHORIBOSYLANTRANILATE ISOMERASE FROM THERMOTOGA MARITIMA 1ZHS ; 1.80 ; CRYSTAL STRUCTURE OF MVL BOUND TO MAN3GLCNAC2 1NKP ; 1.80 ; CRYSTAL STRUCTURE OF MYC-MAX RECOGNIZING DEOXYRIBONUCLEIC ACID 1GU9 ; 1.90 ; CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS ALKYLPEROXIDASE AHPD 1ME5 ; 2.40 ; CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS ALKYLPEROXIDASE AHPD H132Q MUTANT 1LW1 ; 2.30 ; CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS ALKYLPEROXIDASE AHPD H137F MUTANT 1SJ2 ; 2.41 ; CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CATALASE- PEROXIDASE 2AF6 ; 2.01 ; CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS FLAVIN DEPENDENT THYMIDYLATE SYNTHASE (MTB THYX) IN THE PRESENCE OF CO-FACTOR FAD AND SUBSTRATE ANALOG 5-BROMO-2'- DEOXYURIDINE-5'-MONOPHOSPHATE (BRDUMP) 2BVC ; 2.10 ; CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS GLUTAMINE SYNTHETASE IN COMPLEX WITH A TRANSITION STATE MIMIC 1ZNY ; 2.30 ; CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS GUANYLATE KINASE IN COMPLEX WITH GDP 1ZNX ; 2.35 ; CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS GUANYLATE KINASE IN COMPLEX WITH GMP 1U2P ; 1.90 ; CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS LOW MOLECULAR PROTEIN TYROSINE PHOSPHATASE (MPTPA) AT 1.9A RESOLUTION 1U2Q ; 2.50 ; CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS LOW MOLECULAR WEIGHT PROTEIN TYROSINE PHOSPHATASE (MPTPA) AT 2.5A RESOLUTION WITH GLYCEROL IN THE ACTIVE SITE 1Q51 ; 2.30 ; CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS MENB IN COMPLEX WITH ACETOACETYL-COENZYME A, A KEY ENZYME IN VITAMIN K2 BIOSYNTHESIS 1Q52 ; 1.80 ; CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS MENB, A KEY ENZYME IN VITAMIN K2 BIOSYNTHESIS 1U0R ; 2.80 ; CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS NAD KINASE 1U0T ; 2.30 ; CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS NAD KINASE 1Y3I ; 2.60 ; CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS NAD KINASE- NAD COMPLEX 1K0R ; 1.70 ; CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS NUSA 1N3I ; 1.90 ; CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PNP WITH TRANSITION STATE ANALOG DADME-IMMH 1YWF ; 1.71 ; CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEIN TYROSINE PHOSPHATASE PTPB 1U8A ; 2.15 ; CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS SHIKIMATE KINASE IN COMPLEX WITH SHIKIMATE AND ADP AT 2.15 ANGSTROM RESOLUTION 1MRS ; 2.00 ; CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS THYMIDYLATE KINASE COMPLEXED WITH 5-CH2OH DEOXYURIDINE MONOPHOSPHATE 1W2H ; 2.00 ; CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS THYMIDYLATE KINASE COMPLEXED WITH AZIDOTHYMIDINE MONOPHOSPHATE (AZT-MP) (2.0 A RESOLUTION) 1MRN ; 2.45 ; CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS THYMIDYLATE KINASE COMPLEXED WITH BISUBSTRATE INHIBITOR (TP5A) 1W2G ; 2.10 ; CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS THYMIDYLATE KINASE COMPLEXED WITH DEOXYTHYMIDINE (DT) (2.1 A RESOLUTION) 1N5J ; 1.85 ; CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS THYMIDYLATE KINASE COMPLEXED WITH THYMIDINE DIPHOSPHATE (TDP) AND THYMIDINE TRIPHOSPHATE (TTP) AT PH 5.4 (1.85 A RESOLUTION) 1G3U ; 1.95 ; CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS THYMIDYLATE KINASE COMPLEXED WITH THYMIDINE MONOPHOSPHATE (TMP) 1GSI ; 1.60 ; CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS THYMIDYLATE KINASE COMPLEXED WITH THYMIDINE MONOPHOSPHATE (TMP) 1GTV ; 1.55 ; CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS THYMIDYLATE KINASE COMPLEXED WITH THYMIDINE-5'-DIPHOSPHATE (TDP) 1N5K ; 2.10 ; CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS THYMIDYLATE KINASE CRYSTALLIZED IN SODIUM MALONATE (RESOLUTION 2.1 A) 1N5L ; 2.30 ; CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS THYMIDYLATE KINASE CRYSTALLIZED IN SODIUM MALONATE, AFTER CATALYSIS IN THE CRYSTAL (2.3 A RESOLUTION) 1KPG ; 2.00 ; CRYSTAL STRUCTURE OF MYCOLIC ACID CYCLOPROPANE SYNTHASE CMAA1 COMPLEXED WITH SAH AND CTAB 1KPH ; 2.00 ; CRYSTAL STRUCTURE OF MYCOLIC ACID CYCLOPROPANE SYNTHASE CMAA1 COMPLEXED WITH SAH AND DDDMAB 1KP9 ; 2.21 ; CRYSTAL STRUCTURE OF MYCOLIC ACID CYCLOPROPANE SYNTHASE CMAA1, APO-FORM 1KPI ; 2.65 ; CRYSTAL STRUCTURE OF MYCOLIC ACID CYCLOPROPANE SYNTHASE CMAA2 COMPLEXED WITH SAH AND DDDMAB 1L1E ; 2.00 ; CRYSTAL STRUCTURE OF MYCOLIC ACID CYCLOPROPANE SYNTHASE PCAA COMPLEXED WITH S-ADENOSYL-L-HOMOCYSTEINE 1RM0 ; 2.05 ; CRYSTAL STRUCTURE OF MYO-INOSITOL 1-PHOSPHATE SYNTHASE FROM SACCHAROMYCES CEREVISIAE IN COMPLEX WITH NAD+ AND 2-DEOXY- D-GLUCITOL 6-(E)-VINYLHOMOPHOSPHONATE 1VJP ; 1.70 ; CRYSTAL STRUCTURE OF MYO-INOSITOL-1-PHOSPHATE SYNTHASE- RELATED PROTEIN (TM1419) FROM THERMOTOGA MARITIMA AT 1.70 A RESOLUTION 1W8J ; 2.70 ; CRYSTAL STRUCTURE OF MYOSIN V MOTOR DOMAIN - NUCLEOTIDE-FREE 1W7J ; 2.00 ; CRYSTAL STRUCTURE OF MYOSIN V MOTOR WITH ESSENTIAL LIGHT CHAIN + ADP-BEFX - NEAR RIGOR 1OE9 ; 2.05 ; CRYSTAL STRUCTURE OF MYOSIN V MOTOR WITH ESSENTIAL LIGHT CHAIN - NUCLEOTIDE-FREE 1W7I ; 3.00 ; CRYSTAL STRUCTURE OF MYOSIN V MOTOR WITHOUT NUCLEOTIDE SOAKED IN 10 MM MGADP 1LW3 ; 2.30 ; CRYSTAL STRUCTURE OF MYOTUBULARIN-RELATED PROTEIN 2 COMPLEXED WITH PHOSPHATE 1M7R ; 2.60 ; CRYSTAL STRUCTURE OF MYOTUBULARIN-RELATED PROTEIN-2 (MTMR2) COMPLEXED WITH PHOSPHATE 1Q1C ; 1.90 ; CRYSTAL STRUCTURE OF N(1-260) OF HUMAN FKBP52 1QO2 ; 1.85 ; CRYSTAL STRUCTURE OF N-((5'-PHOSPHORIBOSYL)-FORMIMINO)-5- AMINOIMIDAZOL-4-CARBOXAMID RIBONUCLEOTID ISOMERASE (EC 3.1.3.15, HISA) 1VKN ; 1.80 ; CRYSTAL STRUCTURE OF N-ACETYL-GAMMA-GLUTAMYL-PHOSPHATE REDUCTASE (TM1782) FROM THERMOTOGA MARITIMA AT 1.80 A RESOLUTION 1FXJ ; 2.25 ; CRYSTAL STRUCTURE OF N-ACETYLGLUCOSAMINE 1-PHOSPHATE URIDYLTRANSFERASE 1FWY ; 2.30 ; CRYSTAL STRUCTURE OF N-ACETYLGLUCOSAMINE 1-PHOSPHATE URIDYLTRANSFERASE BOUND TO UDP-GLCNAC 1O12 ; 2.50 ; CRYSTAL STRUCTURE OF N-ACETYLGLUCOSAMINE-6-PHOSPHATE DEACETYLASE (TM0814) FROM THERMOTOGA MARITIMA AT 2.5 A RESOLUTION 1FO8 ; 1.40 ; CRYSTAL STRUCTURE OF N-ACETYLGLUCOSAMINYLTRANSFERASE I 1FO9 ; 1.50 ; CRYSTAL STRUCTURE OF N-ACETYLGLUCOSAMINYLTRANSFERASE I 1FOA ; 1.80 ; CRYSTAL STRUCTURE OF N-ACETYLGLUCOSAMINYLTRANSFERASE I 1HL2 ; 1.80 ; CRYSTAL STRUCTURE OF N-ACETYLNEURAMINATE LYASE FROM E. COLI MUTANT L142R IN COMPLEX WITH B-HYDROXYPYRUVATE 1FP3 ; 2.00 ; CRYSTAL STRUCTURE OF N-ACYL-D-GLUCOSAMINE 2-EPIMERASE FROM PORCINE KIDNEY 1UHK ; 1.60 ; CRYSTAL STRUCTURE OF N-AEQUORIN 1ERZ ; 1.70 ; CRYSTAL STRUCTURE OF N-CARBAMYL-D-AMINO ACID AMIDOHYDROLASE WITH A NOVEL CATALYTIC FRAMEWORK COMMON TO AMIDOHYDROLASES 1YNF ; 1.90 ; CRYSTAL STRUCTURE OF N-SUCCINYLARGININE DIHYDROLASE, ASTB, BOUND TO SUBSTRATE AND PRODUCT, AN ENZYME FROM THE ARGININE CATABOLIC PATHWAY OF ESCHERICHIA COLI 1YNH ; 1.95 ; CRYSTAL STRUCTURE OF N-SUCCINYLARGININE DIHYDROLASE, ASTB, BOUND TO SUBSTRATE AND PRODUCT, AN ENZYME FROM THE ARGININE CATABOLIC PATHWAY OF ESCHERICHIA COLI 1YNI ; 2.20 ; CRYSTAL STRUCTURE OF N-SUCCINYLARGININE DIHYDROLASE, ASTB, BOUND TO SUBSTRATE AND PRODUCT, AN ENZYME FROM THE ARGININE CATABOLIC PATHWAY OF ESCHERICHIA COLI 1Q25 ; 1.80 ; CRYSTAL STRUCTURE OF N-TERMINAL 3 DOMAINS OF CI-MPR 1NHI ; 2.00 ; CRYSTAL STRUCTURE OF N-TERMINAL 40KD MUTL (LN40) COMPLEX WITH ADPNP AND ONE POTASSIUM 1NHH ; 2.40 ; CRYSTAL STRUCTURE OF N-TERMINAL 40KD MUTL PROTEIN (LN40) COMPLEX WITH ADPNP AND ONE RUBIDIUM 1NHJ ; 2.30 ; CRYSTAL STRUCTURE OF N-TERMINAL 40KD MUTL/A100P MUTANT PROTEIN COMPLEX WITH ADPNP AND ONE SODIUM 1HX8 ; 2.20 ; CRYSTAL STRUCTURE OF N-TERMINAL DOMAIN OF DROSOPHILA AP180 2ANE ; 2.03 ; CRYSTAL STRUCTURE OF N-TERMINAL DOMAIN OF E.COLI LON PROTEASE 1P9A ; 1.70 ; CRYSTAL STRUCTURE OF N-TERMINAL DOMAIN OF HUMAN PLATELET RECEPTOR GLYCOPROTEIN IB-ALPHA AT 1.7 ANGSTROM RESOLUTION 1QYY ; 2.80 ; CRYSTAL STRUCTURE OF N-TERMINAL DOMAIN OF HUMAN PLATELET RECEPTOR GLYCOPROTEIN IB-ALPHA AT 2.8 ANGSTROM RESOLUTION 1WV3 ; 1.75 ; CRYSTAL STRUCTURE OF N-TERMINAL DOMAIN OF HYPOTHETICAL PROTEIN SAV0287 FROM STAPHYLOCOCCUS AUREUS 1NPS ; 1.80 ; CRYSTAL STRUCTURE OF N-TERMINAL DOMAIN OF PROTEIN S 1TBU ; 2.20 ; CRYSTAL STRUCTURE OF N-TERMINAL DOMAIN OF YEAST PEROXISOMAL THIOESTERASE-1 1T92 ; 1.60 ; CRYSTAL STRUCTURE OF N-TERMINAL TRUNCATED PSEUDOPILIN PULG 1Z5M ; 2.17 ; CRYSTAL STRUCTURE OF N1-[3-[[5-BROMO-2-[[3-[(1- PYRROLIDINYLCARBONYL)AMINO]PHENYL]AMINO]-4- PYRIMIDINYL]AMINO]PROPYL]-2,2-DIMETHYLPROPANEDIAMIDE COMPLEXED WITH HUMAN PDK1 1XGK ; 1.40 ; CRYSTAL STRUCTURE OF N12G AND A18G MUTANT NMRA 1JVJ ; 1.73 ; CRYSTAL STRUCTURE OF N132A MUTANT OF TEM-1 BETA-LACTAMASE IN COMPLEX WITH A N-FORMIMIDOYL-THIENAMYCINE 1VQ1 ; 2.80 ; CRYSTAL STRUCTURE OF N5-GLUTAMINE METHYLTRANSFERASE, HEMK(EC 2.1.1.-) (TM0488) FROM THERMOTOGA MARITIMA AT 2.80 A RESOLUTION 1Q3I ; 2.60 ; CRYSTAL STRUCTURE OF NA,K-ATPASE N-DOMAIN 1WMB ; 2.00 ; CRYSTAL STRUCTURE OF NAD DEPENDENT D-3-HYDROXYBUTYLATE DEHYDROGENASE 1YT5 ; 2.30 ; CRYSTAL STRUCTURE OF NAD KINASE FROM THERMOTOGA MARITIMA 1RJW ; 2.35 ; CRYSTAL STRUCTURE OF NAD(+)-DEPENDENT ALCOHOL DEHYDROGENASE FROM BACILLUS STEAROTHERMOPHILUS STRAIN LLD-R 2CVQ ; 2.08 ; CRYSTAL STRUCTURE OF NAD(H)-DEPENDENT MALATE DEHYDROGENASE COMPLEXED WITH NADPH 1Y7T ; 1.65 ; CRYSTAL STRUCTURE OF NAD(H)-DEPENENT MALATE DEHYDROGENASE COMPLEXED WITH NADPH 1QFJ ; 2.20 ; CRYSTAL STRUCTURE OF NAD(P)H:FLAVIN OXIDOREDUCTASE FROM ESCHERICHIA COLI 1V9P ; 2.90 ; CRYSTAL STRUCTURE OF NAD+-DEPENDENT DEOXYRIBONUCLEIC ACID LIGASE 1DGS ; 2.90 ; CRYSTAL STRUCTURE OF NAD+-DEPENDENT DEOXYRIBONUCLEIC ACID LIGASE FROM T. FILIFORMIS 1VL6 ; 2.61 ; CRYSTAL STRUCTURE OF NAD-DEPENDENT MALIC ENZYME (TM0542) FROM THERMOTOGA MARITIMA AT 2.61 A RESOLUTION 1F8W ; 2.45 ; CRYSTAL STRUCTURE OF NADH PEROXIDASE MUTANT: R303M 1VK6 ; 2.20 ; CRYSTAL STRUCTURE OF NADH PYROPHOSPHATASE (1790429) FROM ESCHERICHIA COLI K12 AT 2.20 A RESOLUTION 1VLJ ; 1.78 ; CRYSTAL STRUCTURE OF NADH-DEPENDENT BUTANOL DEHYDROGENASE A (TM0820) FROM THERMOTOGA MARITIMA AT 1.78 A RESOLUTION 1D7Y ; 2.10 ; CRYSTAL STRUCTURE OF NADH-DEPENDENT FERREDOXIN REDUCTASE, BPHA4 1LWD ; 1.85 ; CRYSTAL STRUCTURE OF NADP-DEPENDENT ISOCITRATE DEHYDROGENASE FROM PORCINE HEART MITOCHONDRIA 1TH3 ; 2.80 ; CRYSTAL STRUCTURE OF NADPH DEPLETED BOVINE LIVE CATALASE COMPLEXED WITH CYANIDE 1TH4 ; 2.98 ; CRYSTAL STRUCTURE OF NADPH DEPLETED BOVINE LIVER CATALASE COMPLEXED WITH 3-AMINO-1,2,4-TRIAZOLE 1TH2 ; 2.80 ; CRYSTAL STRUCTURE OF NADPH DEPLETED BOVINE LIVER CATALASE COMPLEXED WITH AZIDE 1IAW ; 2.40 ; CRYSTAL STRUCTURE OF NAEI COMPLEXED WITH 17MER DEOXYRIBONUCLEIC ACID 2B1X ; 2.00 ; CRYSTAL STRUCTURE OF NAPHTHALENE 1,2-DIOXYGENASE FROM RHODOCOCCUS SP. 2B24 ; 3.00 ; CRYSTAL STRUCTURE OF NAPHTHALENE 1,2-DIOXYGENASE FROM RHODOCOCCUS SP. BOUND TO INDOLE 1R27 ; 2.00 ; CRYSTAL STRUCTURE OF NARGH COMPLEX 1T1F ; 2.75 ; CRYSTAL STRUCTURE OF NATIVE ANTITHROMBIN IN ITS MONOMERIC FORM 1XVT ; 2.30 ; CRYSTAL STRUCTURE OF NATIVE CAIB IN COMPLEX WITH COENZYME A 1EI3 ; 5.50 ; CRYSTAL STRUCTURE OF NATIVE CHICKEN FIBRINOGEN 1M1J ; 2.70 ; CRYSTAL STRUCTURE OF NATIVE CHICKEN FIBRINOGEN WITH TWO DIFFERENT BOUND LIGANDS 1FBB ; 3.20 ; CRYSTAL STRUCTURE OF NATIVE CONFORMATION OF BACTERIORHODOPSIN 1JMJ ; 2.35 ; CRYSTAL STRUCTURE OF NATIVE HEPARIN COFACTOR II 1E51 ; 2.83 ; CRYSTAL STRUCTURE OF NATIVE HUMAN ERYTHROCYTE 5-AMINOLAEVULINIC ACID DEHYDRATASE 1SD6 ; 2.65 ; CRYSTAL STRUCTURE OF NATIVE MECI AT 2.65 A 1JC5 ; 2.20 ; CRYSTAL STRUCTURE OF NATIVE METHYLMALONYL-COA EPIMERASE 1XQO ; 1.03 ; CRYSTAL STRUCTURE OF NATIVE PA-AGOG, 8-OXOGUANINE DEOXYRIBONUCLEIC ACID GLYCOSYLASE FROM PYROBACULUM AEROPHILUM 2A1S ; 2.60 ; CRYSTAL STRUCTURE OF NATIVE PARN NUCLEASE DOMAIN 1QXJ ; 1.80 ; CRYSTAL STRUCTURE OF NATIVE PHOSPHOGLUCOSE ISOMERASE FROM PYROCOCCUS FURIOSUS 1TZB ; 1.16 ; CRYSTAL STRUCTURE OF NATIVE PHOSPHOGLUCOSE/PHOSPHOMANNOSE ISOMERASE FROM PYROBACULUM AEROPHILUM 1DB2 ; 2.70 ; CRYSTAL STRUCTURE OF NATIVE PLASMINOGEN ACTIVATOR INHIBITOR- 1 2AIP ; 1.65 ; CRYSTAL STRUCTURE OF NATIVE PROTEIN C ACTIVATOR FROM THE VENOM OF COPPERHEAD SNAKE AGKISTRODON CONTORTRIX CONTORTRIX 1Z27 ; 2.08 ; CRYSTAL STRUCTURE OF NATIVE PVS25, AN OOKINETE PROTEIN FROM PLASMODIUM VIVAX. 1JOU ; 1.80 ; CRYSTAL STRUCTURE OF NATIVE S195A THROMBIN WITH AN UNOCCUPIED ACTIVE SITE 1Z1I ; 2.80 ; CRYSTAL STRUCTURE OF NATIVE SARS CLPRO 1U7S ; 1.40 ; CRYSTAL STRUCTURE OF NATIVE SPERM WHALE MYOGLOBIN FROM LOW IONIC STRENGTH ENVIROMENT (FORM 1) 1U7R ; 1.15 ; CRYSTAL STRUCTURE OF NATIVE SPERM WHALE MYOGLOBIN FROM LOW IONIC STRENGTH ENVIROMENT (FORM2 ) 1C3Q ; 2.00 ; CRYSTAL STRUCTURE OF NATIVE THIAZOLE KINASE IN THE MONOCLINIC FORM 2BF2 ; 2.10 ; CRYSTAL STRUCTURE OF NATIVE TOLUENE-4-MONOOXYGENASE CATALYTIC EFFECTOR PROTEIN, T4MOD 1EWX ; 1.70 ; CRYSTAL STRUCTURE OF NATIVE TRYPAREDOXIN I FROM CRITHIDIA FASCICULATA 1IDQ ; 2.03 ; CRYSTAL STRUCTURE OF NATIVE VANADIUM-CONTAINING CHLOROPEROXIDASE FROM CURVULARIA INAEQUALIS 1VBU ; 1.80 ; CRYSTAL STRUCTURE OF NATIVE XYLANASE 10B FROM THERMOTOGA MARITIMA 1XX5 ; 2.40 ; CRYSTAL STRUCTURE OF NATRIN FROM NAJA ATRA SNAKE VENOM 1XTA ; 1.58 ; CRYSTAL STRUCTURE OF NATRIN, A SNAKE VENOM CRISP FROM TAIWAN COBRA (NAJA ATRA) 1OJH ; 1.80 ; CRYSTAL STRUCTURE OF NBLA FROM PCC 7120 2BEF ; 2.30 ; CRYSTAL STRUCTURE OF NDP KINASE COMPLEXED WITH MG, ADP, AND BEF3 1P4T ; 2.55 ; CRYSTAL STRUCTURE OF NEISSERIAL SURFACE PROTEIN A (NSPA) 1J0I ; 2.40 ; CRYSTAL STRUCTURE OF NEOPULLULANASE COMPLEX WITH PANOSE 1J0K ; 3.20 ; CRYSTAL STRUCTURE OF NEOPULLULANASE E357Q COMPLEX WITH ISOPANOSE 1J0J ; 2.80 ; CRYSTAL STRUCTURE OF NEOPULLULANASE E357Q COMPLEX WITH MALTOTETRAOSE 1URQ ; 2.00 ; CRYSTAL STRUCTURE OF NEURONAL Q-SNARES IN COMPLEX WITH R-SNARE MOTIF OF TOMOSYN 1XTG ; 2.10 ; CRYSTAL STRUCTURE OF NEUROTOXIN BONT/A COMPLEXED WITH SYNAPTOSOMAL-ASSOCIATED PROTEIN 25 1OOA ; 2.45 ; CRYSTAL STRUCTURE OF NF-KB(P50)2 COMPLEXED TO A HIGH- AFFINITY RIBONUCLEIC ACID APTAMER 1NSY ; 2.00 ; CRYSTAL STRUCTURE OF NH3-DEPENDENT NAD+ SYNTHETASE FROM BACILLUS SUBTILIS 1FYD ; 2.25 ; CRYSTAL STRUCTURE OF NH3-DEPENDENT NAD+ SYNTHETASE FROM BACILLUS SUBTILIS COMPLEXED WITH ONE MOLECULE AMP, ONE PYROPHOSPHATE ION AND ONE MG2+ ION 1EE1 ; 2.06 ; CRYSTAL STRUCTURE OF NH3-DEPENDENT NAD+ SYNTHETASE FROM BACILLUS SUBTILIS COMPLEXED WITH ONE MOLECULE ATP, TWO MOLECULES DEAMIDO-NAD+ AND ONE MG2+ ION 1IFX ; 2.25 ; CRYSTAL STRUCTURE OF NH3-DEPENDENT NAD+ SYNTHETASE FROM BACILLUS SUBTILIS COMPLEXED WITH TWO MOLECULES DEAMIDO-NAD 2NSY ; 2.00 ; CRYSTAL STRUCTURE OF NH3-DEPENDENT NAD+ SYNTHETASE FROM BACILLUS SUBTILIS IN COMPLEX WITH NAD-ADENYLATE 1XNG ; 1.70 ; CRYSTAL STRUCTURE OF NH3-DEPENDENT NAD+ SYNTHETASE FROM HELICOBACTER PYLORI 1XNH ; 2.30 ; CRYSTAL STRUCTURE OF NH3-DEPENDENT NAD+ SYNTHETASE FROM HELICOBACTER PYLORI 1Q0D ; 2.20 ; CRYSTAL STRUCTURE OF NI-CONTAINING SUPEROXIDE DISMUTASE WITH NI-LIGATION CORRESPONDING TO THE OXIDIZED STATE 1Q0G ; 1.60 ; CRYSTAL STRUCTURE OF NI-CONTAINING SUPEROXIDE DISMUTASE WITH NI-LIGATION CORRESPONDING TO THE STATE AFTER FULL X- RAY-INDUCED REDUCTION 1Q0M ; 1.68 ; CRYSTAL STRUCTURE OF NI-CONTAINING SUPEROXIDE DISMUTASE WITH NI-LIGATION CORRESPONDING TO THE STATE AFTER FULL X- RAY-INDUCED REDUCTION 1Q0F ; 2.20 ; CRYSTAL STRUCTURE OF NI-CONTAINING SUPEROXIDE DISMUTASE WITH NI-LIGATION CORRESPONDING TO THE STATE AFTER PARTIAL X-RAY-INDUCED REDUCTION 1Q0K ; 2.10 ; CRYSTAL STRUCTURE OF NI-CONTAINING SUPEROXIDE DISMUTASE WITH NI-LIGATION CORRESPONDING TO THE THIOSULFATE-REDUCED STATE 1FN3 ; 2.48 ; CRYSTAL STRUCTURE OF NICKEL RECONSTITUTED HEMOGLOBIN-A CASE FOR PERMANENT, T-STATE HEMOGLOBIN 1P25 ; 2.90 ; CRYSTAL STRUCTURE OF NICKEL(II)-D(GGCGCC)2 1ZIU ; 2.00 ; CRYSTAL STRUCTURE OF NICKEL-BOUND ENGINEERED MALTOSE BINDING PROTEIN 1G3V ; 3.10 ; CRYSTAL STRUCTURE OF NICKEL-D[CGTGTACACG]2 1IQY ; 1.80 ; CRYSTAL STRUCTURE OF NICKEL-SUBSTITUTED AMINE OXIDASE FROM ARTHROBACTER GLOBIFORMIS 1IOO ; 1.55 ; CRYSTAL STRUCTURE OF NICOTIANA ALATA GEMETOPHYTIC SELF- INCOMPATIBILITY ASSOCIATED SF11-RNASE 1D0S ; 1.90 ; CRYSTAL STRUCTURE OF NICOTINATE MONONUCLEOTIDE : 5,6- DIMETHYLBENZIMIDAZOLE PHOSPHORIBOSYLTRANSFERASE (COBT) FROM SALMONELLA TYPHIMURIUM COMPLEXED WITH 5, 6- DIMETHYLBENZIMIDAZOLE 1D0V ; 1.90 ; CRYSTAL STRUCTURE OF NICOTINATE MONONUCLEOTIDE:5,6- DIMETHYLBENZIMIDAZOLE PHOSPHORIBOSYLTRANSFERASE (COBT) FROM SALMONELLA TYPHIMURIUM COMPLEXED WITH ITS REACTION PRODUCTS DETERMINED TO 1.9 A RESOLUTION 1VLP ; 1.75 ; CRYSTAL STRUCTURE OF NICOTINATE PHOSPHORIBOSYLTRANSFERASE (YOR209C) FROM SACCHAROMYCES CEREVISIAE AT 1.75 A RESOLUTION 1YUL ; 2.00 ; CRYSTAL STRUCTURE OF NICOTINIC ACID MONONUCLEOTIDE ADENYLYLTRANSFERASE FROM PSEUDOMONAS AERUGINOSA 1YUM ; 1.70 ; CRYSTAL STRUCTURE OF NICOTINIC ACID MONONUCLEOTIDE ADENYLYLTRANSFERASE FROM PSEUDOMONAS AERUGINOSA 1YUN ; 2.00 ; CRYSTAL STRUCTURE OF NICOTINIC ACID MONONUCLEOTIDE ADENYLYLTRANSFERASE FROM PSEUDOMONAS AERUGINOSA 1WX1 ; 1.97 ; CRYSTAL STRUCTURE OF NICTINATE-NUCLEOTIDE- DIMETHYLBENZIMIDAZOLE PHOSPHORIBOSYLTRANSFERASE FROM THERMUS THERMOPHILUS HB8 1NPE ; 2.30 ; CRYSTAL STRUCTURE OF NIDOGEN/LAMININ COMPLEX 1W3O ; 1.60 ; CRYSTAL STRUCTURE OF NIMA FROM D. RADIODURANS 1WP7 ; 2.20 ; CRYSTAL STRUCTURE OF NIPAH VIRUS FUSION CORE 1Q16 ; 1.90 ; CRYSTAL STRUCTURE OF NITRATE REDUCTASE A, NARGHI, FROM ESCHERICHIA COLI 2BII ; 1.70 ; CRYSTAL STRUCTURE OF NITRATE-REDUCING FRAGMENT OF ASSIMILATORY NITRATE REDUCTASE FROM PICHIA ANGUSTA 1ROM ; 2.00 ; CRYSTAL STRUCTURE OF NITRIC REDUCTASE FROM DENITRIFYING FUNGUS FUSARIUM OXYSPORUM 2ROM ; 2.00 ; CRYSTAL STRUCTURE OF NITRIC REDUCTASE FROM DENITRIFYING FUNGUS FUSARIUM OXYSPORUM COMPLEX WITH CARBON MONOXIDE 1V29 ; 2.60 ; CRYSTAL STRUCTURE OF NITRILE HYDRATASE FROM A THERMOPHILE BACILLUS SMITHII 1MZY ; 1.46 ; CRYSTAL STRUCTURE OF NITRITE REDUCTASE 1ET5 ; 1.90 ; CRYSTAL STRUCTURE OF NITRITE REDUCTASE ASP98ASN MUTANT FROM ALCALIGENES FAECALIS S-6 1ET8 ; 1.80 ; CRYSTAL STRUCTURE OF NITRITE REDUCTASE HIS255ASN MUTANT FROM ALCALIGENES FAECALIS 1ET7 ; 1.70 ; CRYSTAL STRUCTURE OF NITRITE REDUCTASE HIS255ASP MUTANT FROM ALCALIGENES FAECALIS S-6 1L9O ; 1.70 ; CRYSTAL STRUCTURE OF NITRITE SOAKED I257A VARIANT OF THE COPPER-CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS 1L9P ; 1.75 ; CRYSTAL STRUCTURE OF NITRITE SOAKED I257G VARIANT OF THE COPPER-CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIES S-6 1J9Q ; 1.65 ; CRYSTAL STRUCTURE OF NITRITE SOAKED OXIDIZED D98N AFNIR 1J9S ; 1.90 ; CRYSTAL STRUCTURE OF NITRITE SOAKED OXIDIZED H255N AFNIR 1J9R ; 2.00 ; CRYSTAL STRUCTURE OF NITRITE SOAKED REDUCED D98N AFNIR 1J9T ; 1.95 ; CRYSTAL STRUCTURE OF NITRITE SOAKED REDUCED H255N AFNIR 2A0J ; 2.50 ; CRYSTAL STRUCTURE OF NITROGEN REGULATORY PROTEIN IIA-NTR FROM NEISSERIA MENINGITIDIS 2NP1 ; 2.00 ; CRYSTAL STRUCTURE OF NITROPHORIN 1 FROM RHODNIUS PROLIXUS 1EUO ; 2.00 ; CRYSTAL STRUCTURE OF NITROPHORIN 2 (PROLIXIN-S) 1PEE ; 1.50 ; CRYSTAL STRUCTURE OF NITROPHORIN 2 COMPLEX WITH IMIDAZOLE 1T68 ; 1.45 ; CRYSTAL STRUCTURE OF NITROPHORIN 2 COMPLEX WITH NO 1PM1 ; 1.10 ; CRYSTAL STRUCTURE OF NITROPHORIN 2 L122V/L132V MUTANT COMPLEX WITH IMIDAZOLE 1ML7 ; 1.25 ; CRYSTAL STRUCTURE OF NITROPHORIN 4 COMPLEXED WITH 4- IODOPYRAZOLE 1EQD ; 1.60 ; CRYSTAL STRUCTURE OF NITROPHORIN 4 COMPLEXED WITH CN 1ERX ; 1.40 ; CRYSTAL STRUCTURE OF NITROPHORIN 4 COMPLEXED WITH NO 1NP4 ; 1.50 ; CRYSTAL STRUCTURE OF NITROPHORIN 4 FROM RHODNIUS PROLIXUS 1IKE ; 1.50 ; CRYSTAL STRUCTURE OF NITROPHORIN 4 FROM RHODNIUS PROLIXUS COMPLEXED WITH HISTAMINE AT 1.5 A RESOLUTION 1KOI ; 1.08 ; CRYSTAL STRUCTURE OF NITROPHORIN 4 FROM RHODNIUS PROLIXUS COMPLEXED WITH NITRIC OXIDE AT 1.08 A RESOLUTION 1U0X ; 1.45 ; CRYSTAL STRUCTURE OF NITROPHORIN 4 UNDER PRESSURE OF XENON (200 PSI) 1FWX ; 1.60 ; CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM P. DENITRIFICANS 1QNI ; 2.40 ; CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM PSEUDOMONAS NAUTICA, AT 2.4A RESOLUTION 1P4L ; 2.90 ; CRYSTAL STRUCTURE OF NK RECEPTOR LY49C MUTANT WITH ITS MHC CLASS I LIGAND H-2KB 1KQO ; 2.50 ; CRYSTAL STRUCTURE OF NMN/NAMN ADENYLYLTRANSFERASE COMPLEXED WITH DEAMIDO-NAD 1KQN ; 2.20 ; CRYSTAL STRUCTURE OF NMN/NAMN ADENYLYLTRANSFERASE COMPLEXED WITH NAD 1K6J ; 1.80 ; CRYSTAL STRUCTURE OF NMRA, A NEGATIVE TRANSCRIPTIONAL REGULATOR (MONOCLINIC FORM) 1K6I ; 1.80 ; CRYSTAL STRUCTURE OF NMRA, A NEGATIVE TRANSCRIPTIONAL REGULATOR (TRIGONAL FORM) 1K6X ; 1.50 ; CRYSTAL STRUCTURE OF NMRA, A NEGATIVE TRANSCRIPTIONAL REGULATOR IN COMPLEX WITH NAD AT 1.5 A RESOLUTION (TRIGONAL FORM) 1TI7 ; 1.70 ; CRYSTAL STRUCTURE OF NMRA, A NEGATIVE TRANSCRIPTIONAL REGULATOR, IN COMPLEX WITH NADP AT 1.7A RESOLUTION 1FKO ; 2.90 ; CRYSTAL STRUCTURE OF NNRTI RESISTANT K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DMP-266(EFAVIRENZ) 1FKP ; 2.90 ; CRYSTAL STRUCTURE OF NNRTI RESISTANT K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE 1F24 ; 1.40 ; CRYSTAL STRUCTURE OF NO COMPLEX OF THR243ALA MUTANTS OF CYTOCHROME P450NOR 1F25 ; 1.40 ; CRYSTAL STRUCTURE OF NO COMPLEX OF THR243ASN MUTANTS OF CYTOCHROME P450NOR 1F26 ; 1.40 ; CRYSTAL STRUCTURE OF NO COMPLEX OF THR243VAL MUTANTS OF CYTOCHROME P450NOR 1P8T ; 3.20 ; CRYSTAL STRUCTURE OF NOGO-66 RECEPTOR 1EZ4 ; 2.30 ; CRYSTAL STRUCTURE OF NON-ALLOSTERIC L-LACTATE DEHYDROGENASE FROM LACTOBACILLUS PENTOSUS AT 2.3 ANGSTROM RESOLUTION 1D8U ; 2.35 ; CRYSTAL STRUCTURE OF NON-SYMBIOTIC PLANT HEMOGLOBIN FROM RICE 1WQS ; 2.80 ; CRYSTAL STRUCTURE OF NOROVIRUS 3C-LIKE PROTEASE 1T5Y ; 2.50 ; CRYSTAL STRUCTURE OF NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET HR2118: A HUMAN HOMOLOG OF SACCHAROMYCES CEREVISIAE NIP7P 1XM3 ; 1.80 ; CRYSTAL STRUCTURE OF NORTHEAST STRUCTURAL GENOMICS TARGET SR156 1SH2 ; 2.30 ; CRYSTAL STRUCTURE OF NORWALK VIRUS POLYMERASE (METAL-FREE, CENTERED ORTHORHOMBIC) 1SH3 ; 2.95 ; CRYSTAL STRUCTURE OF NORWALK VIRUS POLYMERASE (MGSO4 CRYSTAL FORM) 1SH0 ; 2.17 ; CRYSTAL STRUCTURE OF NORWALK VIRUS POLYMERASE (TRICLINIC) 1DT4 ; 2.60 ; CRYSTAL STRUCTURE OF NOVA-1 KH3 K-HOMOLOGY RIBONUCLEIC ACID-BINDING DOMAIN 1DTJ ; 2.00 ; CRYSTAL STRUCTURE OF NOVA-2 KH3 K-HOMOLOGY RIBONUCLEIC ACID-BINDING DOMAIN 1EC6 ; 2.40 ; CRYSTAL STRUCTURE OF NOVA-2 KH3 K-HOMOLOGY RIBONUCLEIC ACID-BINDING DOMAIN BOUND TO 20-MER RIBONUCLEIC ACID HAIRPIN 1UZ3 ; 1.10 ; CRYSTAL STRUCTURE OF NOVEL PROTEIN EMSY 1UTU ; 2.00 ; CRYSTAL STRUCTURE OF NOVEL PROTEIN EMSY TRUNCATE 1SP4 ; 2.20 ; CRYSTAL STRUCTURE OF NS-134 IN COMPLEX WITH BOVINE CATHEPSIN B: A TWO HEADED EPOXYSUCCINYL INHIBITOR EXTENDS ALONG THE WHOLE ACTIVE SITE CLEFT 1JB4 ; 2.23 ; CRYSTAL STRUCTURE OF NTF2 M102E MUTANT 1JB5 ; 2.30 ; CRYSTAL STRUCTURE OF NTF2 M118E MUTANT 1JB2 ; 2.00 ; CRYSTAL STRUCTURE OF NTF2 M84E MUTANT 1BYS ; 2.00 ; CRYSTAL STRUCTURE OF NUC COMPLEXED WITH TUNGSTATE 1KKU ; 2.50 ; CRYSTAL STRUCTURE OF NUCLEAR HUMAN NICOTINAMIDE MONONUCLEOTIDE ADENYLYLTRANSFERASE 1OUN ; 2.30 ; CRYSTAL STRUCTURE OF NUCLEAR TRANSPORT FACTOR 2 (NTF2) 2A11 ; 2.10 ; CRYSTAL STRUCTURE OF NUCLEASE DOMAIN OF RIBONUCLASE III FROM MYCOBACTERIUM TUBERCULOSIS 1F8X ; 2.50 ; CRYSTAL STRUCTURE OF NUCLEOSIDE 2-DEOXYRIBOSYLTRANSFERASE 2F62 ; 1.50 ; CRYSTAL STRUCTURE OF NUCLEOSIDE 2-DEOXYRIBOSYLTRANSFERASE FROM TRYPANOSOMA BRUCEI AT 1.5 A RESOLUTION WITH (2- ETHYLPHENYL)METHANOL BOUND 2F64 ; 1.60 ; CRYSTAL STRUCTURE OF NUCLEOSIDE 2-DEOXYRIBOSYLTRANSFERASE FROM TRYPANOSOMA BRUCEI AT 1.6 A RESOLUTION WITH 1- METHYLQUINOLIN-2(1H)-ONE BOUND 2F67 ; 1.60 ; CRYSTAL STRUCTURE OF NUCLEOSIDE 2-DEOXYRIBOSYLTRANSFERASE FROM TRYPANOSOMA BRUCEI AT 1.6 A RESOLUTION WITH BENZO[CD]INDOL-2(1H)-ONE BOUND 2A0K ; 1.80 ; CRYSTAL STRUCTURE OF NUCLEOSIDE 2-DEOXYRIBOSYLTRANSFERASE FROM TRYPANOSOMA BRUCEI AT 1.8 A RESOLUTION 2F2T ; 1.70 ; CRYSTAL STRUCTURE OF NUCLEOSIDE 2-DESOXYRIBOSYLTRANSFERASE FROM TRYPANOSOMA BRUCEI AT 1.7 A RESOLUTION WITH 5- AMINOISOQUINOLINE BOUND 1S57 ; 1.80 ; CRYSTAL STRUCTURE OF NUCLEOSIDE DIPHOSPHATE KINASE 2 FROM ARABIDOPSIS 1NB2 ; 2.20 ; CRYSTAL STRUCTURE OF NUCLEOSIDE DIPHOSPHATE KINASE FROM BACILLUS HALODENITRIFICANS 1PKU ; 2.50 ; CRYSTAL STRUCTURE OF NUCLEOSIDE DIPHOSPHATE KINASE FROM RICE 1WKJ ; 2.00 ; CRYSTAL STRUCTURE OF NUCLEOSIDE DIPHOSPHATE KINASE FROM THERMUS THERMOPHILUS HB8 1WKL ; 2.20 ; CRYSTAL STRUCTURE OF NUCLEOSIDE DIPHOSPHATE KINASE FROM THERMUS THERMOPHILUS HB8 IN COMPLEX WITH ATP AND ADP 1WKK ; 2.70 ; CRYSTAL STRUCTURE OF NUCLEOSIDE DIPHOSPHATE KINASE FROM THERMUS THERMOPHILUS HB8 IN COMPLEX WITH GDP 1EZR ; 2.50 ; CRYSTAL STRUCTURE OF NUCLEOSIDE HYDROLASE FROM LEISHMANIA MAJOR 2CWK ; 1.75 ; CRYSTAL STRUCTURE OF NUCLEOTIDE DIPHOSPHATE KINASE FROM PYROCOCCUS HORIKOSHII 2AFH ; 2.10 ; CRYSTAL STRUCTURE OF NUCLEOTIDE-FREE AV2-AV1 COMPLEX 1SJY ; 1.39 ; CRYSTAL STRUCTURE OF NUDIX HYDROLASE DR1025 FROM DEINOCOCCUS RADIODURANS 1SOI ; 1.80 ; CRYSTAL STRUCTURE OF NUDIX HYDROLASE DR1025 IN COMPLEX WITH SM+3 1SZ3 ; 1.60 ; CRYSTAL STRUCTURE OF NUDIX HYDROLASE DR1025 IN COMPLEXED WITH GNP AND MG+2 1OVL ; 2.20 ; CRYSTAL STRUCTURE OF NURR1 LBD 1HH2 ; 2.10 ; CRYSTAL STRUCTURE OF NUSA FROM THERMOTOGA MARITIMA 1L2F ; 2.50 ; CRYSTAL STRUCTURE OF NUSA FROM THERMOTOGA MARITIMA: A STRUCTURE-BASED ROLE OF THE N-TERMINAL DOMAIN 1RKQ ; 1.40 ; CRYSTAL STRUCTURE OF NYSGRC TARGET T1436: A HYPOTHETICAL PROTEIN YIDA. 2CTZ ; 2.60 ; CRYSTAL STRUCTURE OF O-ACETYL HOMOSERINE SULFHYDRASE FROM THERMUS THERMOPHILUS HB8. 1O58 ; 1.80 ; CRYSTAL STRUCTURE OF O-ACETYLSERINE SULFHYDRYLASE (TM0665) FROM THERMOTOGA MARITIMA AT 1.80 A RESOLUTION 2BHT ; 2.10 ; CRYSTAL STRUCTURE OF O-ACETYLSERINE SULFHYDRYLASE B 1Z7W ; 2.20 ; CRYSTAL STRUCTURE OF O-ACETYLSERINE SULFHYDRYLASE FROM ARABIDOPSIS THALIANA 1WKV ; 2.00 ; CRYSTAL STRUCTURE OF O-PHOSPHOSERINE SULFHYDRYLASE 1WRJ ; 2.00 ; CRYSTAL STRUCTURE OF O6-METHYLGUANINE METHYLTRANSFERASE FROM SULFOLOBUS TOKODAII 1MGT ; 1.80 ; CRYSTAL STRUCTURE OF O6-METHYLGUANINE-DEOXYRIBONUCLEIC ACID METHYLTRANSFERASE FROM HYPERTHERMOPHILIC ARCHAEON PYROCOCCUS KODAKARAENSIS STRAIN KOD1 1FCJ ; 2.00 ; CRYSTAL STRUCTURE OF OASS COMPLEXED WITH CHLORIDE AND SULFATE 1E3O ; 1.90 ; CRYSTAL STRUCTURE OF OCT-1 POU DIMER BOUND TO MORE 1SP3 ; 2.20 ; CRYSTAL STRUCTURE OF OCTAHEME CYTOCHROME C FROM SHEWANELLA ONEIDENSIS 1W6T ; 2.10 ; CRYSTAL STRUCTURE OF OCTAMERIC ENOLASE FROM STREPTOCOCCUS PNEUMONIAE 2CWX ; 2.00 ; CRYSTAL STRUCTURE OF OCTAMERIC RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE (RUBISCO) FROM PYROCOCCUS HORIKOSHII OT3 (FORM-1 CRYSTAL) 1V4E ; 2.28 ; CRYSTAL STRUCTURE OF OCTAPRENYL PYROPHOSPHATE SYNTHASE FROM HYPERTHERMOPHILIC THERMOTOGA MARITIMA 1VG2 ; 3.10 ; CRYSTAL STRUCTURE OF OCTAPRENYL PYROPHOSPHATE SYNTHASE FROM HYPERTHERMOPHILIC THERMOTOGA MARITIMA A76Y MUTANT 1VG3 ; 2.70 ; CRYSTAL STRUCTURE OF OCTAPRENYL PYROPHOSPHATE SYNTHASE FROM HYPERTHERMOPHILIC THERMOTOGA MARITIMA A76Y/S77F MUTANT 1V4I ; 2.40 ; CRYSTAL STRUCTURE OF OCTAPRENYL PYROPHOSPHATE SYNTHASE FROM HYPERTHERMOPHILIC THERMOTOGA MARITIMA F132A MUTANT 1VG4 ; 3.30 ; CRYSTAL STRUCTURE OF OCTAPRENYL PYROPHOSPHATE SYNTHASE FROM HYPERTHERMOPHILIC THERMOTOGA MARITIMA F132A/L128A MUTANT 1VG6 ; 3.35 ; CRYSTAL STRUCTURE OF OCTAPRENYL PYROPHOSPHATE SYNTHASE FROM HYPERTHERMOPHILIC THERMOTOGA MARITIMA F132A/L128A/I123A MUTANT 1VG7 ; 3.40 ; CRYSTAL STRUCTURE OF OCTAPRENYL PYROPHOSPHATE SYNTHASE FROM HYPERTHERMOPHILIC THERMOTOGA MARITIMA F132A/L128A/I123A/D62A MUTANT 1V4H ; 2.80 ; CRYSTAL STRUCTURE OF OCTAPRENYL PYROPHOSPHATE SYNTHASE FROM HYPERTHERMOPHILIC THERMOTOGA MARITIMA F52A MUTANT 1WL1 ; 3.45 ; CRYSTAL STRUCTURE OF OCTAPRENYL PYROPHOSPHATE SYNTHASE FROM HYPERTHERMOPHILIC THERMOTOGA MARITIMA H74A MUTANT 1WKZ ; 3.40 ; CRYSTAL STRUCTURE OF OCTAPRENYL PYROPHOSPHATE SYNTHASE FROM HYPERTHERMOPHILIC THERMOTOGA MARITIMA K41A MUTANT 1WL0 ; 3.20 ; CRYSTAL STRUCTURE OF OCTAPRENYL PYROPHOSPHATE SYNTHASE FROM HYPERTHERMOPHILIC THERMOTOGA MARITIMA R44A MUTANT 1WL2 ; 2.80 ; CRYSTAL STRUCTURE OF OCTAPRENYL PYROPHOSPHATE SYNTHASE FROM HYPERTHERMOPHILIC THERMOTOGA MARITIMA R90A MUTANT 1WL3 ; 3.50 ; CRYSTAL STRUCTURE OF OCTAPRENYL PYROPHOSPHATE SYNTHASE FROM HYPERTHERMOPHILIC THERMOTOGA MARITIMA R91A MUTANT 1V4K ; 2.45 ; CRYSTAL STRUCTURE OF OCTAPRENYL PYROPHOSPHATE SYNTHASE FROM HYPERTHERMOPHILIC THERMOTOGA MARITIMA S77F MUTANT 1V4J ; 2.85 ; CRYSTAL STRUCTURE OF OCTAPRENYL PYROPHOSPHATE SYNTHASE FROM HYPERTHERMOPHILIC THERMOTOGA MARITIMA V73Y MUTANT 1KM6 ; 1.50 ; CRYSTAL STRUCTURE OF ODCASE MUTANT D70AK72A COMPLEXED WITH OMP 1KM5 ; 1.50 ; CRYSTAL STRUCTURE OF ODCASE MUTANT D75N COMPLEXED WITH 6- AZAUMP 1KM3 ; 1.50 ; CRYSTAL STRUCTURE OF ODCASE MUTANT K42A COMPLEXED WITH 6- AZAUMP 1KM4 ; 1.50 ; CRYSTAL STRUCTURE OF ODCASE MUTANT K72A COMPLEXED WITH UMP 1Z9C ; 2.64 ; CRYSTAL STRUCTURE OF OHRR BOUND TO THE OHRA PROMOTER: STRUCTURE OF MARR FAMILY PROTEIN WITH OPERATOR DEOXYRIBONUCLEIC ACID 1K02 ; 2.70 ; CRYSTAL STRUCTURE OF OLD YELLOW ENZYME MUTANT GLN114ASN 1K03 ; 2.70 ; CRYSTAL STRUCTURE OF OLD YELLOW ENZYME MUTANT GLN114ASN COMPLEXED WITH PARA-HYDROXY BENZALDEHYDE 2AN9 ; 2.35 ; CRYSTAL STRUCTURE OF OLIGOMERIC E.COLI GUANYLATE KINASE IN COMPLEX WITH GDP 2ANB ; 2.90 ; CRYSTAL STRUCTURE OF OLIGOMERIC E.COLI GUANYLATE KINASE IN COMPLEX WITH GMP 1VR5 ; 1.73 ; CRYSTAL STRUCTURE OF OLIGOPEPTIDE ABC TRANSPORTER, PERIPLASMIC OLIGOPEPTIDE-BINDING (TM1223) FROM THERMOTOGA MARITIMA AT 1.73 A RESOLUTION 1IRQ ; 1.50 ; CRYSTAL STRUCTURE OF OMEGA TRANSCRIPTIONAL REPRESSOR AT 1.5A RESOLUTION 1DS3 ; 1.65 ; CRYSTAL STRUCTURE OF OMTKY3-CH2-ASP19I 1M98 ; 2.10 ; CRYSTAL STRUCTURE OF ORANGE CAROTENOID PROTEIN 1VLV ; 2.25 ; CRYSTAL STRUCTURE OF ORNITHINE CARBAMOYLTRANSFERASE (TM1097) FROM THERMOTOGA MARITIMA AT 2.25 A RESOLUTION 2AEE ; 1.95 ; CRYSTAL STRUCTURE OF OROTATE PHOSPHORIBOSYLTRANSFERASE FROM STREPTOCOCCUS PYOGENES 1LOR ; 1.60 ; CRYSTAL STRUCTURE OF OROTIDINE 5'-MONOPHOSPHATE COMPLEXED WITH BMP 1DBT ; 2.40 ; CRYSTAL STRUCTURE OF OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE FROM BACILLUS SUBTILIS COMPLEXED WITH UMP 1DQW ; 2.10 ; CRYSTAL STRUCTURE OF OROTIDINE 5'-PHOSPHATE DECARBOXYLASE 1VQT ; 2.00 ; CRYSTAL STRUCTURE OF OROTIDINE 5'-PHOSPHATE DECARBOXYLASE (TM0332) FROM THERMOTOGA MARITIMA AT 2.00 A RESOLUTION 1DQX ; 2.40 ; CRYSTAL STRUCTURE OF OROTIDINE 5'-PHOSPHATE DECARBOXYLASE COMPLEXED TO 6-HYDROXYURIDINE 5'-PHOSPHATE (BMP) 1DV7 ; 1.80 ; CRYSTAL STRUCTURE OF OROTIDINE MONOPHOSPHATE DECARBOXYLASE 1LOL ; 1.90 ; CRYSTAL STRUCTURE OF OROTIDINE MONOPHOSPHATE DECARBOXYLASE COMPLEX WITH XMP 1DVJ ; 1.50 ; CRYSTAL STRUCTURE OF OROTIDINE MONOPHOSPHATE DECARBOXYLASE COMPLEXED WITH 6-AZAUMP 1LP6 ; 1.90 ; CRYSTAL STRUCTURE OF OROTIDINE MONOPHOSPHATE DECARBOXYLASE COMPLEXED WITH CMP 1LOQ ; 1.50 ; CRYSTAL STRUCTURE OF OROTIDINE MONOPHOSPHATE DECARBOXYLASE COMPLEXED WITH PRODUCT UMP 1KLZ ; 1.50 ; CRYSTAL STRUCTURE OF OROTIDINE MONOPHOSPHATE DECARBOXYLASE MUTANT D70A COMPLEXED WITH UMP 1KM0 ; 1.70 ; CRYSTAL STRUCTURE OF OROTIDINE MONOPHOSPHATE DECARBOXYLASE MUTANT D70N COMPLEXED WITH 6-AZAUMP 1LOS ; 1.90 ; CRYSTAL STRUCTURE OF OROTIDINE MONOPHOSPHATE DECARBOXYLASE MUTANT DELTAR203A COMPLEXED WITH 6-AZAUMP 1KM2 ; 1.50 ; CRYSTAL STRUCTURE OF OROTIDINE MONOPHOSPHATE MUTANT Q185A WITH 6-AZAUMP 1JJA ; 2.30 ; CRYSTAL STRUCTURE OF ORTHORHOMBIC FORM OF D90E MUTANT OF ESCHERICHIA COLI L-ASPARAGINASE II 1JJ1 ; 1.90 ; CRYSTAL STRUCTURE OF ORTHORHOMBIC LYSOZYME GROWN AT PH 4.6 IN PRESENCE OF 5% SORBITOL 1F0W ; 1.90 ; CRYSTAL STRUCTURE OF ORTHORHOMBIC LYSOZYME GROWN AT PH 6.5 1F10 ; 1.70 ; CRYSTAL STRUCTURE OF ORTHORHOMBIC LYSOZYME GROWN AT PH 6.5 AT 88% RELATIVE HUMIDITY 1NYE ; 2.40 ; CRYSTAL STRUCTURE OF OSMC FROM E. COLI 1LQL ; 2.85 ; CRYSTAL STRUCTURE OF OSMC LIKE PROTEIN FROM MYCOPLASMA PNEUMONIAE 1PCV ; 2.30 ; CRYSTAL STRUCTURE OF OSMOTIN, A PLANT ANTIFUNGAL PROTEIN 1THQ ; 1.90 ; CRYSTAL STRUCTURE OF OUTER MEMBRANE ENZYME PAGP 1I78 ; 2.60 ; CRYSTAL STRUCTURE OF OUTER MEMBRANE PROTEASE OMPT FROM ESCHERICHIA COLI 1OSP ; 1.95 ; CRYSTAL STRUCTURE OF OUTER SURFACE PROTEIN A OF BORRELIA BURGDORFERI COMPLEXED WITH A MURINE MONOCLONAL ANTIBODY FAB 1F1M ; 1.80 ; CRYSTAL STRUCTURE OF OUTER SURFACE PROTEIN C (OSPC) 1J58 ; 1.75 ; CRYSTAL STRUCTURE OF OXALATE DECARBOXYLASE 1UW8 ; 2.00 ; CRYSTAL STRUCTURE OF OXALATE DECARBOXYLASE 1L3J ; 1.90 ; CRYSTAL STRUCTURE OF OXALATE DECARBOXYLASE FORMATE COMPLEX 2C31 ; 1.73 ; CRYSTAL STRUCTURE OF OXALYL-COA DECARBOXYLASE IN COMPLEX WITH THE COFACTOR DERIVATIVE THIAMIN-2-THIAZOLONE DIPHOSPHATE AND ADENOSINE DIPHOSPHATE 1Z8U ; 2.40 ; CRYSTAL STRUCTURE OF OXIDIZED ALPHA HEMOGLOBIN BOUND TO AHSP 1XLN ; 2.03 ; CRYSTAL STRUCTURE OF OXIDIZED C73S/C85S PUTIDAREDOXIN, A [2FE-2S] FERREDOXIN FROM PSEUDOMONAS PUTIDA 1GU2 ; 1.19 ; CRYSTAL STRUCTURE OF OXIDIZED CYTOCHROME C" FROM METHYLOPHILUS METHYLOTROPHUS 1C6O ; 2.00 ; CRYSTAL STRUCTURE OF OXIDIZED CYTOCHROME C6 FROM THE GREEN ALGAE SCENEDESMUS OBLIQUUS 2FCR ; 1.80 ; CRYSTAL STRUCTURE OF OXIDIZED FLAVODOXIN FROM A RED ALGA CHONDRUS CRISPUS REFINED AT 1.8 ANGSTROMS RESOLUTION: DESCRIPTION OF THE FLAVIN MONONUCLEOTIDE BINDING SITE 2COG ; 2.10 ; CRYSTAL STRUCTURE OF OXIDIZED HUMAN CYTOSOLIC BRANCHED- CHAIN AMINOTRANSFERASE COMPLEXED WITH 4-METHYLVALERATE 2COI ; 1.90 ; CRYSTAL STRUCTURE OF OXIDIZED HUMAN CYTOSOLIC BRANCHED- CHAIN AMINOTRANSFERASE COMPLEXED WITH GABAPENTIN 1OSD ; 2.00 ; CRYSTAL STRUCTURE OF OXIDIZED MERP FROM RALSTONIA METALLIDURANS CH34 1M70 ; 1.25 ; CRYSTAL STRUCTURE OF OXIDIZED RECOMBINANT CYTOCHROME C4 FROM PSEUDOMONAS STUTZERI 1XR2 ; 2.35 ; CRYSTAL STRUCTURE OF OXIDIZED T. MARITIMA COBALAMIN- INDEPENDENT METHIONINE SYNTHASE COMPLEXED WITH METHYLTETRAHYDROFOLATE 1Z41 ; 1.30 ; CRYSTAL STRUCTURE OF OXIDIZED YQJM FROM BACILLUS SUBTILIS 1Z42 ; 1.85 ; CRYSTAL STRUCTURE OF OXIDIZED YQJM FROM BACILLUS SUBTILIS COMPLEXED WITH P-HYDROXYBENZALDEHYDE 1Z44 ; 1.40 ; CRYSTAL STRUCTURE OF OXIDIZED YQJM FROM BACILLUS SUBTILIS COMPLEXED WITH P-NITROPHENOL 1ZH8 ; 2.50 ; CRYSTAL STRUCTURE OF OXIDOREDUCTASE (TM0312) FROM THERMOTOGA MARITIMA AT 2.50 A RESOLUTION 1F65 ; 1.70 ; CRYSTAL STRUCTURE OF OXY SPERM WHALE MYOGLOBIN MUTANT Y(B10) Q(E7)R(E10) 1R1X ; 2.15 ; CRYSTAL STRUCTURE OF OXY-HUMAN HEMOGLOBIN BASSETT AT 2.15 ANGSTROM 1LFK ; 1.70 ; CRYSTAL STRUCTURE OF OXYB, A CYTOCHROME P450 IMPLICATED IN AN OXIDATIVE PHENOL COUPLING REACTION DURING VANCOMYCIN BIOSYNTHESIS 1LG9 ; 2.00 ; CRYSTAL STRUCTURE OF OXYB, A CYTOCHROME P450 IMPLICATED IN AN OXIDATIVE PHENOL COUPLING REACTION DURING VANCOMYCIN BIOSYNTHESIS 1LGF ; 2.20 ; CRYSTAL STRUCTURE OF OXYB, A CYTOCHROME P450 IMPLICATED IN AN OXIDATIVE PHENOL COUPLING REACTION DURING VANCOMYCIN BIOSYNTHESIS 1UED ; 1.90 ; CRYSTAL STRUCTURE OF OXYC A CYTOCHROME P450 IMPLICATED IN AN OXIDATIVE C-C COUPLING REACTION DURING VANCOMYCIN BIOSYNTHESIS. 1DII ; 2.50 ; CRYSTAL STRUCTURE OF P-CRESOL METHYLHYDROXYLASE AT 2.5 A RESOLUTION 1DIQ ; 2.75 ; CRYSTAL STRUCTURE OF P-CRESOL METHYLHYDROXYLASE WITH SUBSTRATE BOUND 1G1Q ; 2.40 ; CRYSTAL STRUCTURE OF P-SELECTIN LECTIN/EGF DOMAINS 1G1R ; 3.40 ; CRYSTAL STRUCTURE OF P-SELECTIN LECTIN/EGF DOMAINS COMPLEXED WITH SLEX 1N2F ; 2.01 ; CRYSTAL STRUCTURE OF P. AERUGINOSA OHR 1LRY ; 2.60 ; CRYSTAL STRUCTURE OF P. AERUGINOSA PEPTIDE DEFORMYLASE COMPLEXED WITH ANTIBIOTIC ACTINONIN 1M8P ; 2.60 ; CRYSTAL STRUCTURE OF P. CHRYSOGENUM ATP SULFURYLASE IN THE T-STATE 1II7 ; 2.20 ; CRYSTAL STRUCTURE OF P. FURIOSUS MRE11 WITH MANGANESE AND DAMP 1IX1 ; 1.85 ; CRYSTAL STRUCTURE OF P.AERUGINOSA PEPTIDE DEFORMYLASE COMPLEXED WITH ANTIBIOTIC ACTINONIN 1XTL ; 2.00 ; CRYSTAL STRUCTURE OF P104H MUTANT OF SOD-LIKE PROTEIN FROM BACILLUS SUBTILIS. 1IAP ; 1.90 ; CRYSTAL STRUCTURE OF P115RHOGEF RGRGS DOMAIN 1OYH ; 2.62 ; CRYSTAL STRUCTURE OF P13 ALANINE VARIANT OF ANTITHROMBIN 1VET ; 1.90 ; CRYSTAL STRUCTURE OF P14/MP1 AT 1.9 A RESOLUTION 1JSG ; 2.50 ; CRYSTAL STRUCTURE OF P14TCL1, AN ONCOGENE PRODUCT INVOLVED IN T-CELL PROLYMPHOCYTIC LEUKEMIA, REVEALS A NOVEL B-BARREL TOPOLOGY 1IHB ; 1.95 ; CRYSTAL STRUCTURE OF P18-INK4C(INK6) 1R9F ; 1.85 ; CRYSTAL STRUCTURE OF P19 COMPLEXED WITH 19-BP SMALL INTERFERING RIBONUCLEIC ACID 1XCF ; 1.80 ; CRYSTAL STRUCTURE OF P28L/Y173F TRYPTOPHAN SYNTHASE ALPHA- SUBUNITS FROM ESCHERICHIA COLI 1YQJ ; 2.00 ; CRYSTAL STRUCTURE OF P38 ALPHA IN COMPLEX WITH A SELECTIVE PYRIDAZINE INHIBITOR 1M7Q ; 2.40 ; CRYSTAL STRUCTURE OF P38 MAP KINASE IN COMPLEX WITH A DIHYDROQUINAZOLINONE INHIBITOR 1ZZL ; 2.00 ; CRYSTAL STRUCTURE OF P38 WITH TRIAZOLOPYRIDINE 1M59 ; 1.90 ; CRYSTAL STRUCTURE OF P40V MUTANT OF TRYPSIN-SOLUBILIZED FRAGMENT OF CYTOCHROME B5 1R9O ; 2.00 ; CRYSTAL STRUCTURE OF P4502C9 WITH FLURBIPROFEN BOUND 1XQD ; 1.80 ; CRYSTAL STRUCTURE OF P450NOR COMPLEXED WITH 3- PYRIDINEALDEHYDE ADENINE DINUCLEOTIDE 1ULW ; 2.00 ; CRYSTAL STRUCTURE OF P450NOR SER73GLY/SER75GLY MUTANT 1G6B ; 1.90 ; CRYSTAL STRUCTURE OF P47S MUTANT OF FERREDOXIN I 1C26 ; 1.70 ; CRYSTAL STRUCTURE OF P53 TETRAMERIZATION DOMAIN 1FYX ; 2.80 ; CRYSTAL STRUCTURE OF P681H MUTANT OF TIR DOMAIN OF HUMAN TLR2 2AZP ; 2.13 ; CRYSTAL STRUCTURE OF PA1268 SOLVED BY SULFUR SAD 1X7V ; 1.78 ; CRYSTAL STRUCTURE OF PA3566 FROM PSEUDOMONAS AERUGINOSA 1J1Y ; 1.70 ; CRYSTAL STRUCTURE OF PAAI FROM THERMUS THERMOPHILUS HB8 2FE1 ; 2.20 ; CRYSTAL STRUCTURE OF PAE0151 FROM PYROBACULUM AEROPHILUM 1V8O ; 2.80 ; CRYSTAL STRUCTURE OF PAE2754 FROM PYROBACULUM AEROPHILUM 1V8P ; 2.52 ; CRYSTAL STRUCTURE OF PAE2754 FROM PYROBACULUM AEROPHILUM 1YHW ; 1.80 ; CRYSTAL STRUCTURE OF PAK1 KINASE DOMAIN WITH ONE POINT MUTATIONS (K299R) 1YHV ; 1.80 ; CRYSTAL STRUCTURE OF PAK1 KINASE DOMAIN WITH TWO POINT MUTATIONS (K299R, T423E) 1EI9 ; 2.25 ; CRYSTAL STRUCTURE OF PALMITOYL PROTEIN THIOESTERASE 1 1EXW ; 2.40 ; CRYSTAL STRUCTURE OF PALMITOYL PROTEIN THIOESTERASE 1 COMPLEXED WITH HEXADECYLSULFONYL FLUORIDE 1EH5 ; 2.50 ; CRYSTAL STRUCTURE OF PALMITOYL PROTEIN THIOESTERASE 1 COMPLEXED WITH PALMITATE 1V8F ; 1.90 ; CRYSTAL STRUCTURE OF PANTOATE-BETA-ALANINE (PANTOTHENATE SYNTHETASE) FROM THERMUS THERMOPHILUS HB8 1N2I ; 1.70 ; CRYSTAL STRUCTURE OF PANTOTHENATE SYNTHETASE FROM M. TUBERCULOSIS IN COMPLEX WITH A REACTION INTERMEDIATE, PANTOYL ADENYLATE, DIFFERENT OCCUPANCIES OF PANTOYL ADENYLATE 1N2O ; 2.10 ; CRYSTAL STRUCTURE OF PANTOTHENATE SYNTHETASE FROM M. TUBERCULOSIS, LOW OCCUPANCY OF BETA-ALANINE AT THE PANTOATE BINDING SITES 1UFV ; 2.05 ; CRYSTAL STRUCTURE OF PANTOTHENATE SYNTHETASE FROM THERMUS THERMOPHILUS HB8 2A1R ; 2.60 ; CRYSTAL STRUCTURE OF PARN NUCLEASE DOMAIN 2F61 ; 2.50 ; CRYSTAL STRUCTURE OF PARTIALLY DEGLYCOSYLATED ACID BETA- GLUCOSIDASE 1J7Y ; 1.70 ; CRYSTAL STRUCTURE OF PARTIALLY LIGATED MUTANT OF HBA 1YEW ; 2.80 ; CRYSTAL STRUCTURE OF PARTICULATE METHANE MONOOXYGENASE 1Q35 ; 1.20 ; CRYSTAL STRUCTURE OF PASTEURELLA HAEMOLYTICA APO FERRIC ION- BINDING PROTEIN A 1XDF ; 1.90 ; CRYSTAL STRUCTURE OF PATHOGENESIS-RELATED PROTEIN LLPR- 10.2A FROM YELLOW LUPINE 1ICX ; 1.95 ; CRYSTAL STRUCTURE OF PATHOGENESIS-RELATED PROTEIN LLPR10.1A FROM YELLOW LUPINE 1IFV ; 2.25 ; CRYSTAL STRUCTURE OF PATHOGENESIS-RELATED PROTEIN LLPR10.1B FROM YELLOW LUPINE 1N0Y ; 1.75 ; CRYSTAL STRUCTURE OF PB-BOUND CALMODULIN 1W5D ; 2.10 ; CRYSTAL STRUCTURE OF PBP4A FROM BACILLUS SUBTILIS 1LYQ ; 1.50 ; CRYSTAL STRUCTURE OF PCOC, A METHIONINE RICH COPPER RESISTANCE PROTEIN FROM ESCHERICHIA COLI 1RO6 ; 2.00 ; CRYSTAL STRUCTURE OF PDE4B2B COMPLEXED WITH ROLIPRAM (R & S) 1MKD ; 2.90 ; CRYSTAL STRUCTURE OF PDE4D CATALYTIC DOMAIN AND ZARDAVERINE COMPLEX 1OYN ; 2.00 ; CRYSTAL STRUCTURE OF PDE4D2 IN COMPLEX WITH (R,S)-ROLIPRAM 1RKP ; 2.05 ; CRYSTAL STRUCTURE OF PDE5A1-IBMX 1TP5 ; 1.54 ; CRYSTAL STRUCTURE OF PDZ3 DOMAIN OF PSD-95 PROTEIN COMPLEXED WITH A PEPTIDE LIGAND KKETWV 1H65 ; 2.00 ; CRYSTAL STRUCTURE OF PEA TOC34 - A NOVEL GTPASE OF THE CHLOROPLAST PROTEIN TRANSLOCON 2ALG ; 2.30 ; CRYSTAL STRUCTURE OF PEACH PRU P3, THE PROTOTYPIC MEMBER OF THE FAMILY OF PLANT NON-SPECIFIC LIPID TRANSFER PROTEIN PAN-ALLERGENS 2B5S ; 2.35 ; CRYSTAL STRUCTURE OF PEACH PRU P3, THE PROTOTYPIC MEMBER OF THE FAMILY OF PLANT NON-SPECIFIC LIPID TRANSFER PROTEIN PAN-ALLERGENS 1RIT ; 2.85 ; CRYSTAL STRUCTURE OF PEANUT LECTIN IN COMPLEX WITH MESO- TETRASULPHONATOPHENYLPORPHYRIN AND LACTOSE 1JTA ; 1.80 ; CRYSTAL STRUCTURE OF PECTATE LYASE A (C2 FORM) 2EWE ; 2.20 ; CRYSTAL STRUCTURE OF PECTATE LYASE C R218K MUTANT IN COMPLEX WITH PENTAGALACTURONIC ACID 1EE6 ; 2.30 ; CRYSTAL STRUCTURE OF PECTATE LYASE FROM BACILLUS SP. STRAIN KSM-P15. 1RU4 ; 1.60 ; CRYSTAL STRUCTURE OF PECTATE LYASE PEL9A 1CP9 ; 2.50 ; CRYSTAL STRUCTURE OF PENICILLIN G ACYLASE FROM THE BRO1 MUTANT STRAIN OF PROVIDENCIA RETTGERI 1TVF ; 2.00 ; CRYSTAL STRUCTURE OF PENICILLIN-BINDING PROTEIN 4 (PBP4) FROM STAPHYLOCOCCUS AUREUS 1Z6F ; 1.60 ; CRYSTAL STRUCTURE OF PENICILLIN-BINDING PROTEIN 5 FROM E. COLI IN COMPLEX WITH A BORONIC ACID INHIBITOR 1RZN ; 2.30 ; CRYSTAL STRUCTURE OF PENICILLIN-BINDING PROTEIN-RELATED FACTOR A FROM BACILLUS SUBTILIS. 1ZBT ; 2.34 ; CRYSTAL STRUCTURE OF PEPTIDE CHAIN RELEASE FACTOR 1 (RF-1) (SMU.1085) FROM STREPTOCOCCUS MUTANS AT 2.34 A RESOLUTION 1VEV ; 2.51 ; CRYSTAL STRUCTURE OF PEPTIDE DEFORMYLASE FROM LEPTOSPIRA INTERROGANS (LIPDF) AT PH6.5 1VEY ; 3.30 ; CRYSTAL STRUCTURE OF PEPTIDE DEFORMYLASE FROM LEPTOSPIRA INTERROGANS (LIPDF) AT PH7.0 1SV2 ; 3.00 ; CRYSTAL STRUCTURE OF PEPTIDE DEFORMYLASE FROM LEPTOSPIRA INTERROGANS (LIPDF) AT PH7.5 1SZZ ; 3.30 ; CRYSTAL STRUCTURE OF PEPTIDE DEFORMYLASE FROM LEPTOSPIRA INTERROGANS COMPLEXED WITH INHIBITOR ACTINONIN 1VEZ ; 2.30 ; CRYSTAL STRUCTURE OF PEPTIDE DEFORMYLASE FROM LEPTOSPIRA INTERROGANS(LIPDF) AT PH8.0 1N5N ; 1.80 ; CRYSTAL STRUCTURE OF PEPTIDE DEFORMYLASE FROM PSEUDOMONAS AERUGINOSA 1LM6 ; 1.75 ; CRYSTAL STRUCTURE OF PEPTIDE DEFORMYLASE FROM STREPTOCOCCUS PNEUMONIAE 1LME ; 2.20 ; CRYSTAL STRUCTURE OF PEPTIDE DEFORMYLASE FROM THERMOTOGA MARITIMA 1RQ0 ; 2.65 ; CRYSTAL STRUCTURE OF PEPTIDE RELEASING FACTOR 1 1TJC ; 2.30 ; CRYSTAL STRUCTURE OF PEPTIDE-SUBSTRATE-BINDING DOMAIN OF HUMAN TYPE I COLLAGEN PROLYL 4-HYDROXYLASE 1LFW ; 1.80 ; CRYSTAL STRUCTURE OF PEPV 1QAH ; 1.80 ; CRYSTAL STRUCTURE OF PERCHLORIC ACID SOLUBLE PROTEIN-A TRANSLATIONAL INHIBITOR 1VHF ; 1.54 ; CRYSTAL STRUCTURE OF PERIPLASMIC DIVALENT CATION TOLERANCE PROTEIN 1O5J ; 1.95 ; CRYSTAL STRUCTURE OF PERIPLASMIC DIVALENT CATION TOLERANCE PROTEIN (TM1056) FROM THERMOTOGA MARITIMA AT 1.95 A RESOLUTION 1YDY ; 1.70 ; CRYSTAL STRUCTURE OF PERIPLASMIC GLYCEROPHOSPHODIESTER PHOSPHODIESTERASE FROM ESCHERICHIA COLI 1WE0 ; 2.90 ; CRYSTAL STRUCTURE OF PEROXIREDOXIN (AHPC) FROM AMPHIBACILLUS XYLANUS 1IS2 ; 2.20 ; CRYSTAL STRUCTURE OF PEROXISOMAL ACYL-COA OXIDASE-II FROM RAT LIVER 1HNO ; 2.50 ; CRYSTAL STRUCTURE OF PEROXISOMAL DELTA3-DELTA2-ENOYL-COA ISOMERASE FROM SACCHAROMYCES CEREVISIAE 1HNU ; 2.15 ; CRYSTAL STRUCTURE OF PEROXISOMAL DELTA3-DELTA2-ENOYL-COA ISOMERASE FROM SACCHAROMYCES CEREVISIAE 1YXM ; 1.90 ; CRYSTAL STRUCTURE OF PEROXISOMAL TRANS 2-ENOYL COA REDUCTASE 1JQQ ; 2.65 ; CRYSTAL STRUCTURE OF PEX13P(301-386) SH3 DOMAIN 1Q4J ; 2.20 ; CRYSTAL STRUCTURE OF PF-GST1 WITH ITS INHIBITOR S-HEXYL-GSH 1TQX ; 2.00 ; CRYSTAL STRUCTURE OF PFAL009167 A PUTATIVE D-RIBULOSE 5- PHOSPHATE 3-EPIMERASE FROM P.FALCIPARUM 1N81 ; 2.10 ; CRYSTAL STRUCTURE OF PFG27 FROM PLASMODIUM FALCIPARUM 1VK4 ; 1.91 ; CRYSTAL STRUCTURE OF PFKB CARBOHYDRATE KINASE (TM0415) FROM THERMOTOGA MARITIMA AT 1.91 A RESOLUTION 2PFL ; 2.90 ; CRYSTAL STRUCTURE OF PFL FROM E.COLI 3PFL ; 2.60 ; CRYSTAL STRUCTURE OF PFL FROM E.COLI IN COMPLEX WITH SUBSTRATE ANALOGUE OXAMATE 1ZD0 ; 1.70 ; CRYSTAL STRUCTURE OF PFU-542154 CONSERVED HYPOTHETICAL PROTEIN 1WNF ; 2.50 ; CRYSTAL STRUCTURE OF PH0066 FROM PYROCOCCUS HORIKOSHII 1VE3 ; 2.10 ; CRYSTAL STRUCTURE OF PH0226 PROTEIN FROM PYROCOCCUS HORIKOSHII OT3 1WMM ; 2.20 ; CRYSTAL STRUCTURE OF PH1033 FROM PYROCOCCUS HORIKOSHII OT3 1VBK ; 1.90 ; CRYSTAL STRUCTURE OF PH1313 FROM PYROCOCCUS HORIKOSHII OT3 1WL8 ; 1.45 ; CRYSTAL STRUCTURE OF PH1346 PROTEIN FROM PYROCOCCUS HORIKOSHII 1WR2 ; 2.00 ; CRYSTAL STRUCTURE OF PH1788 FROM PYROCOCCUS HORIKOSHII OT3 2AS0 ; 1.80 ; CRYSTAL STRUCTURE OF PH1915 (APC 5817): A HYPOTHETICAL RIBONUCLEIC ACID METHYLTRANSFERASE 1WWZ ; 1.75 ; CRYSTAL STRUCTURE OF PH1933 FROM PYROCOCCUS HORIKOSHII OT3 1DZB ; 2.00 ; CRYSTAL STRUCTURE OF PHAGE LIBRARY-DERIVED SINGLE-CHAIN FV FRAGMENT 1F9 IN COMPLEX WITH TURKEY EGG-WHITE LYSOZYME 1SSY ; 2.40 ; CRYSTAL STRUCTURE OF PHAGE T4 LYSOZYME MUTANT G28A/I29A/G30A/C54T/C97A 1T8G ; 1.80 ; CRYSTAL STRUCTURE OF PHAGE T4 LYSOZYME MUTANT L32A/L33A/T34A/C54T/C97A/E108V 1T8F ; 2.15 ; CRYSTAL STRUCTURE OF PHAGE T4 LYSOZYME MUTANT R14A/K16A/I17A/K19A/T21A/E22A/C54T/C97A 1SSW ; 2.13 ; CRYSTAL STRUCTURE OF PHAGE T4 LYSOZYME MUTANT Y24A/Y25A/T26A/I27A/C54T/C97A 1JME ; 2.00 ; CRYSTAL STRUCTURE OF PHE393HIS CYTOCHROME P450 BM3 1S7J ; 2.30 ; CRYSTAL STRUCTURE OF PHENAZINE BIOSYNTHESIS PROTEIN PHZF FAMILY (ENTEROCOCCUS FAECALIS) 1T6J ; 2.10 ; CRYSTAL STRUCTURE OF PHENYLALANINE AMMONIA LYASE FROM RHODOSPORIDIUM TORULOIDES 1T6P ; 2.70 ; CRYSTAL STRUCTURE OF PHENYLALANINE AMMONIA LYASE FROM RHODOSPORIDIUM TORULOIDES 1Y2M ; 1.60 ; CRYSTAL STRUCTURE OF PHENYLALANINE AMMONIA-LYASE FROM YEAST RHODODPORIDIUM TORULOIDES 1TG2 ; 2.20 ; CRYSTAL STRUCTURE OF PHENYLALANINE HYDROXYLASE A313T MUTANT WITH 7,8-DIHYDROBIOPTERIN BOUND 1KFL ; 2.80 ; CRYSTAL STRUCTURE OF PHENYLALANINE-REGULATED 3-DEOXY-D- ARABINO-HEPTULOSONATE-7-PHOSPHATE SYNTHASE (DAHP SYNTHASE) FROM E.COLI COMPLEXED WITH MN2+, PEP, AND PHE 1QR7 ; 2.60 ; CRYSTAL STRUCTURE OF PHENYLALANINE-REGULATED 3-DEOXY-D- ARABINO-HEPTULOSONATE-7-PHOSPHATE SYNTHASE FROM ESCHERICHIA COLI COMPLEXED WITH PB2+ AND PEP 2AMC ; 2.70 ; CRYSTAL STRUCTURE OF PHENYLALANYL-TRNA SYNTHETASE COMPLEXED WITH L-TYROSINE 1V72 ; 2.05 ; CRYSTAL STRUCTURE OF PHENYLSERINE ALDOLASE FROM PSEUDOMONAS PUTIDA 1N10 ; 2.90 ; CRYSTAL STRUCTURE OF PHL P 1, A MAJOR TIMOTHY GRASS POLLEN ALLERGEN 1NLX ; 2.80 ; CRYSTAL STRUCTURE OF PHL P 6, A MAJOR TIMOTHY GRASS POLLEN ALLERGEN CO-CRYSTALLIZED WITH ZINC 1A0A ; 2.80 ; CRYSTAL STRUCTURE OF PHO4 BHLH DOMAIN COMPLEXED WITH UASP2 (17) 1T72 ; 2.90 ; CRYSTAL STRUCTURE OF PHOSPHATE TRANSPORT SYSTEM PROTEIN PHOU FROM AQUIFEX AEOLICUS 1YR0 ; 2.00 ; CRYSTAL STRUCTURE OF PHOSPHINOTHRICIN ACETYLTRANSFERASE FROM AGROBACTERIUM TUMEFACIENS 1VR6 ; 1.92 ; CRYSTAL STRUCTURE OF PHOSPHO-2-DEHYDRO-3-DEOXYHEPTONATE ALDOLASE (DAHP SYNTHASE) (TM0343) FROM THERMOTOGA MARITIMA AT 1.92 A RESOLUTION 1TBM ; 2.23 ; CRYSTAL STRUCTURE OF PHOSPHODIESTERASE 9 SHOWS ORIENTATION VARIATION OF INHIBITOR IBMX BINDING 1II2 ; 2.00 ; CRYSTAL STRUCTURE OF PHOSPHOENOLPYRUVATE CARBOXYKINASE (PEPCK) FROM TRYPANOSOMA CRUZI 1YGG ; 1.85 ; CRYSTAL STRUCTURE OF PHOSPHOENOLPYRUVATE CARBOXYKINASE FROM ACTINOBACILLUS SUCCINOGENES 1YLH ; 1.70 ; CRYSTAL STRUCTURE OF PHOSPHOENOLPYRUVATE CARBOXYKINASE FROM ACTINOBACILLUS SUCCINOGENES IN COMPLEX WITH MANGANESE AND PYRUVATE 1S2V ; 2.10 ; CRYSTAL STRUCTURE OF PHOSPHOENOLPYRUVATE MUTASE COMPLEXED WITH MG(II) 1M1B ; 2.25 ; CRYSTAL STRUCTURE OF PHOSPHOENOLPYRUVATE MUTASE COMPLEXED WITH SULFOPYRUVATE 1S2W ; 1.69 ; CRYSTAL STRUCTURE OF PHOSPHOENOLPYRUVATE MUTASE IN HIGH IONIC STRENGTH 1QXR ; 1.70 ; CRYSTAL STRUCTURE OF PHOSPHOGLUCOSE ISOMERASE FROM PYROCOCCUS FURIOSUS IN COMPLEX WITH 5-PHOSPHOARABINONATE 1QY4 ; 1.80 ; CRYSTAL STRUCTURE OF PHOSPHOGLUCOSE ISOMERASE FROM PYROCOCCUS FURIOSUS IN COMPLEX WITH GLUCONATE 6-PHOSPHATE 1X82 ; 1.50 ; CRYSTAL STRUCTURE OF PHOSPHOGLUCOSE ISOMERASE FROM PYROCOCCUS FURIOSUS WITH BOUND 5-PHOSPHO-D-ARABINONATE 1TZC ; 1.45 ; CRYSTAL STRUCTURE OF PHOSPHOGLUCOSE/PHOSPHOMANNOSE ISOMERASE FROM PYROBACULUM AEROPHILUM IN COMPLEX WITH 5- PHOSPHOARABINONATE 1X9H ; 1.50 ; CRYSTAL STRUCTURE OF PHOSPHOGLUCOSE/PHOSPHOMANNOSE ISOMERASE FROM PYROBACULUM AEROPHILUM IN COMPLEX WITH FRUCTOSE 6-PHOSPHATE 1LTK ; 3.00 ; CRYSTAL STRUCTURE OF PHOSPHOGLYCERATE KINASE FROM PLASMODIUM FALCIPARUM, IN THE OPEN CONFORMATION 2CUN ; 2.10 ; CRYSTAL STRUCTURE OF PHOSPHOGLYCERATE KINASE FROM PYROCOCCUS HORIKOSHII OT3 1V6S ; 1.50 ; CRYSTAL STRUCTURE OF PHOSPHOGLYCERATE KINASE FROM THERMUS THERMOPHILUS HB8 1EQJ ; 1.70 ; CRYSTAL STRUCTURE OF PHOSPHOGLYCERATE MUTASE FROM BACILLUS STEAROTHERMOPHILUS COMPLEXED WITH 2-PHOSPHOGLYCERATE 1RII ; 1.70 ; CRYSTAL STRUCTURE OF PHOSPHOGLYCERATE MUTASE FROM M. TUBERCULOSIS 1V37 ; 1.40 ; CRYSTAL STRUCTURE OF PHOSPHOGLYCERATE MUTASE FROM THERMUS THERMOPHILUS HB8 1V7Q ; 1.59 ; CRYSTAL STRUCTURE OF PHOSPHOGLYCERATE MUTASE FROM THERMUS THERMOPHILUS HB8 1TK9 ; 2.10 ; CRYSTAL STRUCTURE OF PHOSPHOHEPTOSE ISOMERASE 1 1PWO ; 2.60 ; CRYSTAL STRUCTURE OF PHOSPHOLIPASE A2 (MIPLA2) FROM MICROPECHIS IKAHEKA 1OZY ; 2.70 ; CRYSTAL STRUCTURE OF PHOSPHOLIPASE A2 (MIPLA3) FROM MICROPECHIS IKAHEKA 1P7O ; 2.30 ; CRYSTAL STRUCTURE OF PHOSPHOLIPASE A2 (MIPLA4) FROM MICROPECHIS IKAHEKA 1CL5 ; 2.45 ; CRYSTAL STRUCTURE OF PHOSPHOLIPASE A2 FROM DABOIA RUSSELLI PULCHELLA 1TH6 ; 1.23 ; CRYSTAL STRUCTURE OF PHOSPHOLIPASE A2 IN COMPLEX WITH ATROPINE AT 1.23A RESOLUTION 1K35 ; 2.20 ; CRYSTAL STRUCTURE OF PHOSPHOMANNOMUTASE/PHOSPHOGLUCOMUTASE FROM P.AERUGINOSA 1K2Y ; 1.75 ; CRYSTAL STRUCTURE OF PHOSPHOMANNOMUTASE/PHOSPHOGLUCOMUTASE S108A MUTANT FROM P. AERUGINOSA 1MPL ; 1.12 ; CRYSTAL STRUCTURE OF PHOSPHONATE-INHIBITED D-ALA-D-ALA PEPTIDASE REVEALS AN ANALOG OF A TETRAHEDRAL TRANSITION STATE 1EI6 ; 2.10 ; CRYSTAL STRUCTURE OF PHOSPHONOACETATE HYDROLASE COMPLEXED WITH PHOSPHONOFORMATE 1VLH ; 2.20 ; CRYSTAL STRUCTURE OF PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE (TM0741) FROM THERMOTOGA MARITIMA AT 2.20 A RESOLUTION 1O6B ; 2.20 ; CRYSTAL STRUCTURE OF PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE WITH ADP 1P9O ; 2.30 ; CRYSTAL STRUCTURE OF PHOSPHOPANTOTHENOYLCYSTEINE SYNTHETASE 1LBM ; 2.80 ; CRYSTAL STRUCTURE OF PHOSPHORIBOSYL ANTHRANILATE ISOMERASE (PRAI) IN COMPLEX WITH REDUCED 1-(O-CARBOXYPHENYLAMINO)-1- DEOXYRIBULOSE 5-PHOSPHATE (RCDRP) 1NSJ ; 2.00 ; CRYSTAL STRUCTURE OF PHOSPHORIBOSYL ANTHRANILATE ISOMERASE FROM THERMOTOGA MARITIMA 1V5X ; 2.00 ; CRYSTAL STRUCTURE OF PHOSPHORIBOSYL ANTHRANILATE ISOMERASE FROM THERMUS THERMOPHILUS 1U9Z ; 2.80 ; CRYSTAL STRUCTURE OF PHOSPHORIBOSYL DIPHOSPHATE SYNTHASE COMPLEXED WITH AMP AND RIBOSE 5-PHOSPHATE 1U9Y ; 2.65 ; CRYSTAL STRUCTURE OF PHOSPHORIBOSYL DIPHOSPHATE SYNTHASE FROM METHANOCALDOCOCCUS JANNASCHII 2A7W ; 2.80 ; CRYSTAL STRUCTURE OF PHOSPHORIBOSYL-ATP PYROPHOSPHATASE FROM CHROMOBACTERIUM VIOLACEUM (ATCC 12472). NESG TARGET CVR7 1YXB ; 2.60 ; CRYSTAL STRUCTURE OF PHOSPHORIBOSYL-ATP PYROPHOSPHATASE FROM STREPTOMYCES COELICOLOR. NESG TARGET RR8. 1YVW ; 2.60 ; CRYSTAL STRUCTURE OF PHOSPHORIBOSYL-ATP PYROPHOSPHOHYDROLASE FROM BACILLUS CEREUS. NESGC TARGET BCR13. 1VKZ ; 2.30 ; CRYSTAL STRUCTURE OF PHOSPHORIBOSYLAMINE--GLYCINE LIGASE (TM1250) FROM THERMOTOGA MARITIMA AT 2.30 A RESOLUTION 1O4V ; 1.77 ; CRYSTAL STRUCTURE OF PHOSPHORIBOSYLAMINOIMIDAZOLE MUTASE PURE (TM0446) FROM THERMOTOGA MARITIMA AT 1.77 A RESOLUTION 1ZCZ ; 1.88 ; CRYSTAL STRUCTURE OF PHOSPHORIBOSYLAMINOIMIDAZOLECARBOXAMIDE FORMYLTRANSFERASE / IMP CYCLOHYDROLASE (TM1249) FROM THERMOTOGA MARITIMA AT 1.88 A RESOLUTION 1VK3 ; 2.15 ; CRYSTAL STRUCTURE OF PHOSPHORIBOSYLFORMYLGLYCINAMIDINE SYNTHASE II (TM1246) FROM THERMOTOGA MARITIMA AT 2.15 A RESOLUTION 1VQ3 ; 1.90 ; CRYSTAL STRUCTURE OF PHOSPHORIBOSYLFORMYLGLYCINAMIDINE SYNTHASE, PURS SUBUNIT (EC 6.3.5.3) (TM1244) FROM THERMOTOGA MARITIMA AT 1.90 A RESOLUTION 1EUD ; 2.10 ; CRYSTAL STRUCTURE OF PHOSPHORYLATED PIG HEART, GTP-SPECIFIC SUCCINYL-COA SYNTHETASE 1M9I ; 2.65 ; CRYSTAL STRUCTURE OF PHOSPHORYLATION-MIMICKING MUTANT T356D OF ANNEXIN VI 1I4A ; 2.00 ; CRYSTAL STRUCTURE OF PHOSPHORYLATION-MIMICKING MUTANT T6D OF ANNEXIN IV 1WRA ; 2.00 ; CRYSTAL STRUCTURE OF PHOSPHORYLCHOLINE ESTERASE DOMAIN OF THE VIRULENCE FACTOR CHOLINE BINDING PROTEIN E FROM STREPTOCOCCUS PNEUMONIAE 1W23 ; 1.08 ; CRYSTAL STRUCTURE OF PHOSPHOSERINE AMINOTRANSFERASE FROM BACILLUS ALCALOPHILUS 1W3U ; 1.50 ; CRYSTAL STRUCTURE OF PHOSPHOSERINE AMINOTRANSFERASE FROM BACILLUS CIRCULANS VAR. ALKALOPHILUS 1F5S ; 1.80 ; CRYSTAL STRUCTURE OF PHOSPHOSERINE PHOSPHATASE FROM METHANOCOCCUS JANNASCHII 1L7O ; 2.20 ; CRYSTAL STRUCTURE OF PHOSPHOSERINE PHOSPHATASE IN APO FORM 1P6C ; 2.00 ; CRYSTAL STRUCTURE OF PHOSPHOTRIESTERASE TRIPLE MUTANT H254G/H257W/L303T COMPLEXED WITH DIISOPROPYLMETHYLPHOSPHONATE 1RQL ; 2.40 ; CRYSTAL STRUCTURE OF PHOSPONOACETALDEHYDE HYDROLASE COMPLEXED WITH MAGNESIUM AND THE INHIBITOR VINYL SULFONATE 1IQU ; 2.20 ; CRYSTAL STRUCTURE OF PHOTOLYASE-THYMINE COMPLEX 1EYS ; 2.20 ; CRYSTAL STRUCTURE OF PHOTOSYNTHETIC REACTION CENTER FROM A THERMOPHILIC BACTERIUM, THERMOCHROMATIUM TEPIDUM 1JB0 ; 2.50 ; CRYSTAL STRUCTURE OF PHOTOSYSTEM I: A PHOTOSYNTHETIC REACTION CENTER AND CORE ANTENNA SYSTEM FROM CYANOBACTERIA 1IZL ; 3.70 ; CRYSTAL STRUCTURE OF PHOTOSYSTEM II 2AXT ; 3.00 ; CRYSTAL STRUCTURE OF PHOTOSYSTEM II FROM THERMOSYNECHOCOCCUS ELONGATUS 1QGW ; 1.63 ; CRYSTAL STRUCTURE OF PHYCOERYTHRIN 545 FROM THE MARINE CRYPTOPHYTE RHODOMONAS CS24 1QLG ; 2.20 ; CRYSTAL STRUCTURE OF PHYTASE WITH MAGNESIUM FROM BACILLUS AMYLOLIQUEFACIENS 1DKQ ; 2.05 ; CRYSTAL STRUCTURE OF PHYTATE COMPLEX ESCHERICHIA COLI PHYTASE AT PH 5.0. PHYTATE IS BOUND WITH ITS 3-PHOSPHATE IN THE ACTIVE SITE. HG2+ CATION ACTS AS AN INTERMOLECULAR BRIDGE 1DKP ; 2.28 ; CRYSTAL STRUCTURE OF PHYTATE COMPLEX OF ESCHERICHIA COLI PHYTASE AT PH 6.6. PHYTATE IS BOUND WITH ITS 3-PHOSPHATE IN THE ACTIVE SITE. HG2+ CATION ACTS AS AN INTERMOLECULAR BRIDGE 1NF8 ; 1.60 ; CRYSTAL STRUCTURE OF PHZD PROTEIN ACTIVE SITE MUTANT WITH SUBSTRATE 1NF9 ; 1.50 ; CRYSTAL STRUCTURE OF PHZD PROTEIN FROM PSEUDOMONAS AERUGINOSA 1T6K ; 1.80 ; CRYSTAL STRUCTURE OF PHZF FROM PSEUDOMONAS FLUORESCENS 2-79 1EOG ; 2.10 ; CRYSTAL STRUCTURE OF PI CLASS GLUTATHIONE TRANSFERASE 1DFA ; 2.00 ; CRYSTAL STRUCTURE OF PI-SCEI IN C2 SPACE GROUP 1EF0 ; 2.10 ; CRYSTAL STRUCTURE OF PI-SCEI MINIPRECURSOR 1N9E ; 1.65 ; CRYSTAL STRUCTURE OF PICHIA PASTORIS LYSYL OXIDASE PPLO 1IVI ; 8.00 ; CRYSTAL STRUCTURE OF PIG DIHYDROLIPOAMIDE DEHYDROGENASE 1KF0 ; 2.50 ; CRYSTAL STRUCTURE OF PIG MUSCLE PHOSPHOGLYCERATE KINASE TERNARY COMPLEX WITH AMP-PCP AND 3PG 1GZD ; 2.50 ; CRYSTAL STRUCTURE OF PIG PHOSPHOGLUCOSE ISOMERASE 1UL3 ; 2.00 ; CRYSTAL STRUCTURE OF PII FROM SYNECHOCYSTIS SP. PCC 6803 1YI3 ; 2.50 ; CRYSTAL STRUCTURE OF PIM-1 BOUND TO LY294002 1YHS ; 2.15 ; CRYSTAL STRUCTURE OF PIM-1 BOUND TO STAUROSPORINE 1O4W ; 1.90 ; CRYSTAL STRUCTURE OF PIN (PILT N-TERMINUS) DOMAIN (AF0591) FROM ARCHAEOGLOBUS FULGIDUS AT 1.90 A RESOLUTION 1Q2L ; 2.20 ; CRYSTAL STRUCTURE OF PITRILYSIN 1XJD ; 2.00 ; CRYSTAL STRUCTURE OF PKC-THETA COMPLEXED WITH STAUROSPORINE AT 2A RESOLUTION 2BEX ; 1.99 ; CRYSTAL STRUCTURE OF PLACENTAL RIBONUCLEASE INHIBITOR IN COMPLEX WITH HUMAN EOSINOPHIL DERIVED NEUROTOXIN AT 2A RESOLUTION 1QZV ; 4.44 ; CRYSTAL STRUCTURE OF PLANT PHOTOSYSTEM I 1LEE ; 1.90 ; CRYSTAL STRUCTURE OF PLASMEPSIN FROM P. FALCIPARUM IN COMPLEX WITH INHIBITOR RS367 1LF3 ; 2.70 ; CRYSTAL STRUCTURE OF PLASMEPSIN II FROM P FALCIPARUM IN COMPLEX WITH INHIBITOR EH58 1LF2 ; 1.80 ; CRYSTAL STRUCTURE OF PLASMEPSIN II FROM P FALCIPARUM IN COMPLEX WITH INHIBITOR RS370 1ME6 ; 2.70 ; CRYSTAL STRUCTURE OF PLASMEPSIN II, AN ASPARTYL PROTEASE FROM PLASMODIUM FALCIPARUM, IN COMPLEX WITH A STATINE- BASED INHIBITOR 1LS5 ; 2.80 ; CRYSTAL STRUCTURE OF PLASMEPSIN IV FROM P. FALCIPARUM IN COMPLEX WITH PEPSTATIN A 2FDS ; 1.72 ; CRYSTAL STRUCTURE OF PLASMODIUM BERGHEI OROTIDINE 5'- MONOPHOSPHATE DECARBOXYLASE (ORTHOLOG OF PLASMODIUM FALCIPARUM PF10_0225) 1XIY ; 1.80 ; CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM ANTIOXIDANT PROTEIN (1-CYS PEROXIREDOXIN) 1Z6B ; 2.09 ; CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM FABZ AT 2.1 A 1ONF ; 2.60 ; CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM GLUTATHIONE REDUCTASE 1Q1G ; 2.02 ; CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM PNP WITH 5'- METHYLTHIO-IMMUCILLIN-H 1NW4 ; 2.20 ; CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM PURINE NUCLEOSIDE PHOSPHORYLASE IN COMPLEX WITH IMMH AND SULFATE 1D5C ; 2.30 ; CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM RAB6 COMPLEXED WITH GDP 2AWP ; 2.00 ; CRYSTAL STRUCTURE OF PLASMODIUM KNOWLESI STRUCTURE OF IRON SUPER-OXIDE DISMUTASE 2AMX ; 2.02 ; CRYSTAL STRUCTURE OF PLASMODIUM YOELII ADENOSINE DEAMINASE (PY02076) 2AV4 ; 1.73 ; CRYSTAL STRUCTURE OF PLASMODIUM YOELII THIOREDOXIN-LIKE PROTEIN 4A (DIM1) 1F9Q ; 2.00 ; CRYSTAL STRUCTURE OF PLATELET FACTOR 4 1F9R ; 2.00 ; CRYSTAL STRUCTURE OF PLATELET FACTOR 4 MUTANT 1 1F9S ; 2.38 ; CRYSTAL STRUCTURE OF PLATELET FACTOR 4 MUTANT 2 1RV6 ; 2.45 ; CRYSTAL STRUCTURE OF PLGF IN COMPLEX WITH DOMAIN 2 OF VEGFR1 1VL4 ; 1.95 ; CRYSTAL STRUCTURE OF PMBA-RELATED PROTEIN (TM0727) FROM THERMOTOGA MARITIMA AT 1.95 A RESOLUTION 1M43 ; 2.40 ; CRYSTAL STRUCTURE OF PMII IN COMPLEX WITH PEPSTATIN A TO 2.4 A 1KLT ; 1.90 ; CRYSTAL STRUCTURE OF PMSF-TREATED HUMAN CHYMASE AT 1.9 ANGSTROMS RESOLUTION 1KLK ; 2.30 ; CRYSTAL STRUCTURE OF PNEUMOCYSTIS CARINII DIHYDROFOLATE REDUCTASE TERNARY COMPLEX WITH PT653 AND NADPH 1ULK ; 1.80 ; CRYSTAL STRUCTURE OF POKEWEED LECTIN-C 1ULN ; 1.65 ; CRYSTAL STRUCTURE OF POKEWEED LECTIN-D1 1UHA ; 1.50 ; CRYSTAL STRUCTURE OF POKEWEED LECTIN-D2 1ULM ; 1.80 ; CRYSTAL STRUCTURE OF POKEWEED LECTIN-D2 COMPLEXED WITH TRI- N-ACETYLCHITOTRIOSE 1Q78 ; 2.80 ; CRYSTAL STRUCTURE OF POLY(A) POLYMERASE IN COMPLEX WITH 3'- DATP AND MAGNESIUM CHLORIDE 1CVX ; 2.27 ; CRYSTAL STRUCTURE OF POLYAMIDE DIMER (IMPYHPPYBETADP)2 BOUND TO B-DEOXYRIBONUCLEIC ACID DECAMER CCAGATCTGG 1CVY ; 2.15 ; CRYSTAL STRUCTURE OF POLYAMIDE DIMER (IMPYPYPYBETADP)2 BOUND TO CCAGATCTGG 1UIR ; 2.00 ; CRYSTAL STRUCTURE OF POLYAMINE AMINOPROPYLTRANSFEASE FROM THERMUS THERMOPHILUS 1IB4 ; 2.00 ; CRYSTAL STRUCTURE OF POLYGALACTURONASE FROM ASPERGILLUS ACULEATUS AT PH4.5 1CWN ; 2.00 ; CRYSTAL STRUCTURE OF PORCINE ALDEHYDE REDUCTASE HOLOENZYME 1UHB ; 2.15 ; CRYSTAL STRUCTURE OF PORCINE ALPHA TRYPSIN BOUND WITH AUTO CATALYTICALY PRODUCED NATIVE PEPTIDE AT 2.15 A RESOLUTION 1FNI ; 1.60 ; CRYSTAL STRUCTURE OF PORCINE BETA TRYPSIN WITH 0.01% POLYDOCANOL 1FMG ; 1.90 ; CRYSTAL STRUCTURE OF PORCINE BETA TRYPSIN WITH 0.04% POLYDOCANOL 1FN6 ; 1.80 ; CRYSTAL STRUCTURE OF PORCINE BETA TRYPSIN WITH 0.1% POLYDOCANOL 1QQU ; 1.63 ; CRYSTAL STRUCTURE OF PORCINE BETA TRYPSIN WITH BOUND ACETATE ION 8PCH ; 2.10 ; CRYSTAL STRUCTURE OF PORCINE CATHEPSIN H DETERMINED AT 2.1 ANGSTROM RESOLUTION: LOCATION OF THE MINI-CHAIN C-TERMINAL CARBOXYL GROUP DEFINES CATHEPSIN H AMINOPEPTIDASE FUNCTION 1ORV ; 1.80 ; CRYSTAL STRUCTURE OF PORCINE DIPEPTIDYL PEPTIDASE IV (CD26) 1ORW ; 2.84 ; CRYSTAL STRUCTURE OF PORCINE DIPEPTIDYL PEPTIDASE IV (CD26) IN COMPLEX WITH A PEPTIDOMIMETIC INHIBITOR 1KZ8 ; 2.00 ; CRYSTAL STRUCTURE OF PORCINE FRUCTOSE-1,6-BISPHOSPHATASE COMPLEXED WITH A NOVEL ALLOSTERIC-SITE INHIBITOR 1Q8H ; 2.00 ; CRYSTAL STRUCTURE OF PORCINE OSTEOCALCIN 1B0E ; 1.80 ; CRYSTAL STRUCTURE OF PORCINE PANCREATIC ELASTASE WITH MDL 101,146 1N5D ; 2.30 ; CRYSTAL STRUCTURE OF PORCINE TESTICULAR CARBONYL REDUCTASE/ 20BETA-HYDROXYSTEROID DEHYDROGENASE 2AMP ; 2.70 ; CRYSTAL STRUCTURE OF PORCINE TRANSMISSIBLE GASTROENTERITIS VIRUS MPRO IN COMPLEX WITH AN INHIBITOR N1 1I8J ; 1.90 ; CRYSTAL STRUCTURE OF PORPHOBILINOGEN SYNTHASE COMPLEXED WITH THE INHIBITOR 4,7-DIOXOSEBACIC ACID 1L6S ; 1.70 ; CRYSTAL STRUCTURE OF PORPHOBILINOGEN SYNTHASE COMPLEXED WITH THE INHIBITOR 4,7-DIOXOSEBACIC ACID 1L6Y ; 1.90 ; CRYSTAL STRUCTURE OF PORPHOBILINOGEN SYNTHASE COMPLEXED WITH THE INHIBITOR 4-OXOSEBACIC ACID 1UER ; 1.60 ; CRYSTAL STRUCTURE OF PORPHYROMONAS GINGIVALIS SOD 1UES ; 1.60 ; CRYSTAL STRUCTURE OF PORPHYROMONAS GINGIVALIS SOD 2AJR ; 2.46 ; CRYSTAL STRUCTURE OF POSSIBLE 1-PHOSPHOFRUCTOKINASE (EC 2.7.1.56) (TM0828) FROM THERMOTOGA MARITIMA AT 2.46 A RESOLUTION 1O14 ; 3.20 ; CRYSTAL STRUCTURE OF POSSIBLE 1-PHOSPHOFRUCTOKINASE (TM0828) FROM THERMOTOGA MARITIMA AT 3.2 A RESOLUTION 1QZG ; 1.90 ; CRYSTAL STRUCTURE OF POT1 (PROTECTION OF TELOMERE)- SSDNA COMPLEX 1QZH ; 2.40 ; CRYSTAL STRUCTURE OF POT1 (PROTECTION OF TELOMERE)- SSDNA COMPLEX 1RFJ ; 2.00 ; CRYSTAL STRUCTURE OF POTATO CALMODULIN PCM6 1YP2 ; 2.11 ; CRYSTAL STRUCTURE OF POTATO TUBER ADP-GLUCOSE PYROPHOSPHORYLASE 1YP4 ; 2.30 ; CRYSTAL STRUCTURE OF POTATO TUBER ADP-GLUCOSE PYROPHOSPHORYLASE IN COMPLEX WITH ADP-GLUCOSE 1YP3 ; 2.60 ; CRYSTAL STRUCTURE OF POTATO TUBER ADP-GLUCOSE PYROPHOSPHORYLASE IN COMPLEX WITH ATP 1Y0S ; 2.65 ; CRYSTAL STRUCTURE OF PPAR DELTA COMPLEXED WITH GW2331 1OTW ; 2.30 ; CRYSTAL STRUCTURE OF PQQC IN COMPLEX WITH PQQ AND A PUTATIVE H2O2 1QXT ; 2.00 ; CRYSTAL STRUCTURE OF PRECYCLIZED INTERMEDIATE FOR THE GREEN FLUORESCENT PROTEIN R96A VARIANT (A) 1QY3 ; 2.00 ; CRYSTAL STRUCTURE OF PRECYCLIZED INTERMEDIATE FOR THE GREEN FLUORESCENT PROTEIN R96A VARIANT (B) 2ANU ; 2.40 ; CRYSTAL STRUCTURE OF PREDICTED METAL-DEPENDENT PHOSPHOESTERASE (PHP FAMILY) (TM0559) FROM THERMOTOGA MARITIMA AT 2.40 A RESOLUTION 1VJL ; 1.90 ; CRYSTAL STRUCTURE OF PREDICTED PROTEIN RELATED TO WOUND INDUCIVE PROTEINS IN PLANTS (TM0160) FROM THERMOTOGA MARITIMA AT 1.90 A RESOLUTION 1OMI ; 2.80 ; CRYSTAL STRUCTURE OF PRFA,THE TRANSCRIPTIONAL REGULATOR IN LISTERIA MONOCYTOGENES 2AXZ ; 3.00 ; CRYSTAL STRUCTURE OF PRGX/CCF10 COMPLEX 1WOC ; 2.00 ; CRYSTAL STRUCTURE OF PRIB 1V1Q ; 2.10 ; CRYSTAL STRUCTURE OF PRIB- A PRIMOSOMAL DEOXYRIBONUCLEIC ACID REPLICATION PROTEIN OF ESCHERICHIA COLI 1IIL ; 2.30 ; CRYSTAL STRUCTURE OF PRO253ARG APERT MUTANT FGF RECEPTOR 2 (FGFR2) IN COMPLEX WITH FGF2 1NSL ; 2.70 ; CRYSTAL STRUCTURE OF PROBABLE ACETYLTRANSFERASE 1V70 ; 1.30 ; CRYSTAL STRUCTURE OF PROBABLE ANTIBIOTICS SYNTHESIS PROTEIN FROM THERMUS THERMOPHILUS HB8 1WZ8 ; 1.80 ; CRYSTAL STRUCTURE OF PROBABLE ENOYL-COA DEHYDRATASE FROM THERMUS THERMOPHILUS HB8 1O13 ; 1.83 ; CRYSTAL STRUCTURE OF PROBABLE NIFB PROTEIN THAT IS INVOLVED IN FEMO-CO BIOSYNTHESIS TM1816 FROM THERMOTOGA MARITIMA AT 1.83 A RESOLUTION 1K88 ; 2.70 ; CRYSTAL STRUCTURE OF PROCASPASE-7 1CS8 ; 1.80 ; CRYSTAL STRUCTURE OF PROCATHEPSIN L 1UCX ; 3.20 ; CRYSTAL STRUCTURE OF PROGLYCININ C12G MUTANT 1UD1 ; 3.10 ; CRYSTAL STRUCTURE OF PROGLYCININ MUTANT C88S 1VCE ; 2.10 ; CRYSTAL STRUCTURE OF PROJECT ID PH0725 FROM PYROCOCCUS HORIKOSHII OT3 1WN2 ; 1.20 ; CRYSTAL STRUCTURE OF PROJECT ID PH1539 FROM PYROCOCCUS HORIKOSHII OT3 1WS9 ; 2.30 ; CRYSTAL STRUCTURE OF PROJECT ID TT0172 FROM THERMUS THERMOPHILUS HB8 1WU8 ; 2.60 ; CRYSTAL STRUCTURE OF PROJECT PH0463 FROM PYROCOCCUS HORIKOSHII OT3 1LWB ; 1.05 ; CRYSTAL STRUCTURE OF PROKARYOTIC PHOSPHOLIPASE A2 AT ATOMIC RESOLUTION 1RWZ ; 1.80 ; CRYSTAL STRUCTURE OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) FROM A. FULGIDUS 1UD9 ; 1.68 ; CRYSTAL STRUCTURE OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) HOMOLOG FROM SULFOLOBUS TOKODAII 1WM1 ; 2.10 ; CRYSTAL STRUCTURE OF PROLYL AMINOPEPTIDASE, COMPLEX WITH PRO-TBODA 1NJ8 ; 3.20 ; CRYSTAL STRUCTURE OF PROLYL-TRNA SYNTHETASE FROM METHANOCALDOCOCCUS JANASCHII 1NJ2 ; 3.11 ; CRYSTAL STRUCTURE OF PROLYL-TRNA SYNTHETASE FROM METHANOTHERMOBACTER THERMAUTOTROPHICUS 1NJ6 ; 2.85 ; CRYSTAL STRUCTURE OF PROLYL-TRNA SYNTHETASE FROM METHANOTHERMOBACTER THERMAUTOTROPHICUS BOUND TO ALANINE SULFAMOYL ADENYLATE 1NJ1 ; 2.55 ; CRYSTAL STRUCTURE OF PROLYL-TRNA SYNTHETASE FROM METHANOTHERMOBACTER THERMAUTOTROPHICUS BOUND TO CYSTEINE SULFAMOYL ADENYLATE 1NJ5 ; 2.80 ; CRYSTAL STRUCTURE OF PROLYL-TRNA SYNTHETASE FROM METHANOTHERMOBACTER THERMAUTOTROPHICUS BOUND TO PROLINE SULFAMOYL ADENYLATE 1QDM ; 2.30 ; CRYSTAL STRUCTURE OF PROPHYTEPSIN, A ZYMOGEN OF A BARLEY VACUOLAR ASPARTIC PROTEINASE. 1VRG ; 2.30 ; CRYSTAL STRUCTURE OF PROPIONYL-COA CARBOXYLASE, BETA SUBUNIT (TM0716) FROM THERMOTOGA MARITIMA AT 2.30 A RESOLUTION 1MIQ ; 2.50 ; CRYSTAL STRUCTURE OF PROPLASMEPSIN FROM THE HUMAN MALARIAL PATHOGEN PLASMODIUM VIVAX 1Z8L ; 3.50 ; CRYSTAL STRUCTURE OF PROSTATE-SPECIFIC MEMBRANE ANTIGEN, A TUMOR MARKER AND PEPTIDASE 1FT1 ; 2.25 ; CRYSTAL STRUCTURE OF PROTEIN FARNESYLTRANSFERASE AT 2.25 ANGSTROMS RESOLUTION 1WUF ; 2.90 ; CRYSTAL STRUCTURE OF PROTEIN GI:16801725, MEMBER OF ENOLASE SUPERFAMILY FROM LISTERIA INNOCUA CLIP11262 1WUE ; 2.10 ; CRYSTAL STRUCTURE OF PROTEIN GI:29375081, UNKNOWN MEMBER OF ENOLASE SUPERFAMILY FROM ENTEROCOCCUS FAECALIS V583 1SVE ; 2.49 ; CRYSTAL STRUCTURE OF PROTEIN KINASE A IN COMPLEX WITH AZEPANE DERIVATIVE 1 1SVG ; 2.02 ; CRYSTAL STRUCTURE OF PROTEIN KINASE A IN COMPLEX WITH AZEPANE DERIVATIVE 4 1VEB ; 2.89 ; CRYSTAL STRUCTURE OF PROTEIN KINASE A IN COMPLEX WITH AZEPANE DERIVATIVE 5 1SVH ; 2.30 ; CRYSTAL STRUCTURE OF PROTEIN KINASE A IN COMPLEX WITH AZEPANE DERIVATIVE 8 1ZOG ; 2.30 ; CRYSTAL STRUCTURE OF PROTEIN KINASE CK2 IN COMPLEX WITH TBB- DERIVATIVES 1ZOE ; 1.77 ; CRYSTAL STRUCTURE OF PROTEIN KINASE CK2 IN COMPLEX WITH TBB- DERIVATIVES INHIBITORS 1ZOH ; 1.81 ; CRYSTAL STRUCTURE OF PROTEIN KINASE CK2 IN COMPLEX WITH TBB- DERIVATIVES INHIBITORS 1VBF ; 2.80 ; CRYSTAL STRUCTURE OF PROTEIN L-ISOASPARTATE O- METHYLTRANSFERASE HOMOLOGUE FROM SULFOLOBUS TOKODAII 2B33 ; 2.30 ; CRYSTAL STRUCTURE OF PROTEIN SYNTHESIS INHIBITOR, PUTATIVE (TM0215) FROM THERMOTOGA MARITIMA AT 2.30 A RESOLUTION 1C86 ; 2.30 ; CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B (R47V, D48N) COMPLEXED WITH 2-(OXALYL-AMINO-4,7-DIHYDRO-5H- THIENO[2,3-C]PYRAN-3-CARBOXYLIC ACID 1C88 ; 1.80 ; CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH 2-(OXALYL-AMINO)-4,5,6,7-TETRAHYDRO-THIENO[2, 3-C]PYRIDINE-3-CARBOXYLIC ACID 1C85 ; 2.72 ; CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH 2-(OXALYL-AMINO)-BENZOIC ACID 1C87 ; 2.10 ; CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH 2-(OXALYL-AMINO-4,7-DIHYDRO-5H-THIENO[2,3- C]PYRAN-3-CARBOXYLIC ACID 1C84 ; 2.35 ; CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH 3-(OXALYL-AMINO)-NAPHTHALENE-2-CARBOXLIC ACID 1ECV ; 1.95 ; CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH 5-IODO-2-(OXALYL-AMINO)-BENZOIC ACID 1C83 ; 1.80 ; CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH 6-(OXALYL-AMINO)-1H-INDOLE-5-CARBOXYLIC ACID 1G1H ; 2.40 ; CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH A BIS-PHOSPHORYLATED PEPTIDE (ETD(PTR)(PTR) RKGGKGLL) FROM THE INSULIN RECEPTOR KINASE 1G1G ; 2.20 ; CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH A MONO-PHOSPHORYLATED PEPTIDE (ETDY(PTR) RKGGKGLL) FROM THE INSULIN RECEPTOR KINASE 1G1F ; 2.00 ; CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH A TRI-PHOSPHORYLATED PEPTIDE (RDI(PTR) ETD(PTR)(PTR)RK) FROM THE INSULIN RECEPTOR KINASE 1EEN ; 1.90 ; CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH ACETYL-D-A-D-BPA-PTYR-L-I-P-Q-Q-G 1EEO ; 1.80 ; CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH ACETYL-E-L-E-F-PTYR-M-D-Y-E-NH2 1PTV ; 2.30 ; CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH PHOSPHOTYROSINE 1PTU ; 2.60 ; CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH PHOSPHOTYROSINE-CONTAINING HEXA-PEPTIDE (DADEPYL-NH2) 1PTT ; 2.90 ; CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH PHOSPHOTYROSINE-CONTAINING TETRA-PEPTIDE (AC-DEPYL-NH2) 1AAX ; 1.90 ; CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH TWO BIS(PARA-PHOSPHOPHENYL)METHANE (BPPM) MOLECULES 1PTY ; 1.85 ; CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH TWO PHOSPHOTYROSINE MOLECULES 1PXH ; 2.15 ; CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B WITH POTENT AND SELECTIVE BIDENTATE INHIBITOR COMPOUND 2 1VK8 ; 1.80 ; CRYSTAL STRUCTURE OF PROTEIN WITH POSSIBLE ROLE IN CELL WALL BIOGENESIS (TM0486) FROM THERMOTOGA MARITIMA AT 1.80 A RESOLUTION 1YE9 ; 2.80 ; CRYSTAL STRUCTURE OF PROTEOLYTICALLY TRUNCATED CATALASE HPII FROM E. COLI 1SEZ ; 2.90 ; CRYSTAL STRUCTURE OF PROTOPORPHYRINOGEN IX OXIDASE 1SW2 ; 2.10 ; CRYSTAL STRUCTURE OF PROX FROM ARCHEOGLOBUS FULGIDUS IN COMPLEX WITH GLYCINE BETAINE 1SW1 ; 1.90 ; CRYSTAL STRUCTURE OF PROX FROM ARCHEOGLOBUS FULGIDUS IN COMPLEX WITH PROLINE BETAINE 1SW4 ; 1.90 ; CRYSTAL STRUCTURE OF PROX FROM ARCHEOGLOBUS FULGIDUS IN COMPLEX WITH TRIMETHYL AMMONIUM 1SW5 ; 1.80 ; CRYSTAL STRUCTURE OF PROX FROM ARCHEOGLOBUS FULGIDUS IN THE LIGAND FREE FORM 1V2B ; 1.60 ; CRYSTAL STRUCTURE OF PSBP PROTEIN IN THE OXYGEN-EVOLVING COMPLEX OF PHOTOSYSTEM II FROM HIGHER PLANTS 1NZE ; 1.95 ; CRYSTAL STRUCTURE OF PSBQ POLYPEPTIDE OF PHOTOSYSTEM II FROM HIGHER PLANTS 1VYK ; 1.49 ; CRYSTAL STRUCTURE OF PSBQ PROTEIN OF PHOTOSYSTEM II FROM HIGHER PLANTS 1DJP ; 1.90 ; CRYSTAL STRUCTURE OF PSEUDOMONAS 7A GLUTAMINASE- ASPARAGINASE WITH THE INHIBITOR DON COVALENTLY BOUND IN THE ACTIVE SITE 1DJO ; 2.00 ; CRYSTAL STRUCTURE OF PSEUDOMONAS 7A GLUTAMINASE- ASPARAGINASE WITH THE INHIBITOR DONV COVALENTLY BOUND IN THE ACTIVE SITE 1OKO ; 1.60 ; CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA LECTIN 1 COMPLEXED WITH GALACTOSE AT 1.6 A RESOLUTION 1L7L ; 1.50 ; CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA LECTIN 1 DETERMINED BY SINGLE WAVELENGTH ANOMALOUS SCATTERING PHASING METHOD 1UOJ ; 2.40 ; CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA LECTIN 1 IN THE CALCIUM-FREE STATE 1X92 ; 2.30 ; CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA PHOSPHOHEPTOSE ISOMERASE IN COMPLEX WITH REACTION PRODUCT D-GLYCERO-D- MANNOPYRANOSE-7-PHOSPHATE 1SB9 ; 2.50 ; CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA UDP-N- ACETYLGLUCOSAMINE 4-EPIMERASE COMPLEXED WITH UDP-GLUCOSE 1SB8 ; 2.10 ; CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA UDP-N- ACETYLGLUCOSAMINE 4-EPIMERASE COMPLEXED WITH UDP-N- ACETYLGALACTOSAMINE 1UKF ; 1.35 ; CRYSTAL STRUCTURE OF PSEUDOMONAS AVIRULENCE PROTEIN AVRPPHB 1CJX ; 2.40 ; CRYSTAL STRUCTURE OF PSEUDOMONAS FLUORESCENS HPPD 1QS0 ; 2.40 ; CRYSTAL STRUCTURE OF PSEUDOMONAS PUTIDA 2-OXOISOVALERATE DEHYDROGENASE (BRANCHED-CHAIN ALPHA-KETO ACID DEHYDROGENASE, E1B) 1NU5 ; 1.95 ; CRYSTAL STRUCTURE OF PSEUDOMONAS SP. P51 CHLOROMUCONATE LACTONIZING ENZYME 1PRZ ; 1.80 ; CRYSTAL STRUCTURE OF PSEUDOURIDINE SYNTHASE RLUD CATALYTIC MODULE 1VIO ; 1.59 ; CRYSTAL STRUCTURE OF PSEUDOURIDYLATE SYNTHASE 2BJV ; 1.70 ; CRYSTAL STRUCTURE OF PSPF(1-275) R168A MUTANT 1V6C ; 1.80 ; CRYSTAL STRUCTURE OF PSYCHROPHILIC SUBTILISIN-LIKE PROTEASE APA1 FROM ANTARCTIC PSYCHROTROPH PSEUDOALTEROMONAS SP. AS- 11 1L8G ; 2.50 ; CRYSTAL STRUCTURE OF PTP1B COMPLEXED WITH 7-(1,1-DIOXO-1H- BENZO[D]ISOTHIAZOL-3-YLOXYMETHYL)-2-(OXALYL-AMINO)-4,7- DIHYDRO-5H-THIENO[2,3-C]PYRAN-3-CARBOXYLIC ACID 2AZR ; 2.00 ; CRYSTAL STRUCTURE OF PTP1B WITH BICYCLIC THIOPHENE INHIBITOR 2B07 ; 2.10 ; CRYSTAL STRUCTURE OF PTP1B WITH TRICYCLIC THIOPHENE INHIBITOR. 1WCH ; 1.85 ; CRYSTAL STRUCTURE OF PTPL1 HUMAN TYROSINE PHOSPHATASE MUTATED IN COLORECTAL CANCER - EVIDENCE FOR A SECOND PHOSPHOTYROSINE SUBSTRATE RECOGNITION POCKET 1XMP ; 1.80 ; CRYSTAL STRUCTURE OF PURE (BA0288) FROM BACILLUS ANTHRACIS AT 1.8 RESOLUTION 1VHJ ; 2.23 ; CRYSTAL STRUCTURE OF PURINE NUCLEOSIDE PHOSPHORYLASE 1VMK ; 2.01 ; CRYSTAL STRUCTURE OF PURINE NUCLEOSIDE PHOSPHORYLASE (TM1596) FROM THERMOTOGA MARITIMA AT 2.01 A RESOLUTION 1XE3 ; 2.24 ; CRYSTAL STRUCTURE OF PURINE NUCLEOSIDE PHOSPHORYLASE DEOD FROM BACILLUS ANTHRACIS 1G2O ; 1.75 ; CRYSTAL STRUCTURE OF PURINE NUCLEOSIDE PHOSPHORYLASE FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH A TRANSITION- STATE INHIBITOR 1VHW ; 1.54 ; CRYSTAL STRUCTURE OF PURINE NUCLEOSIDE PHOSPHORYLASE WITH ADENOSINE 1VDM ; 2.50 ; CRYSTAL STRUCTURE OF PURINE PHOSPHORIBOSYLTRANSFERASE FROM PYROCOCCUS HORIKOSHII OT3 1KJ9 ; 1.60 ; CRYSTAL STRUCTURE OF PURT-ENCODED GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE COMPLEXED WITH MG-ATP 1KJ8 ; 1.60 ; CRYSTAL STRUCTURE OF PURT-ENCODED GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE IN COMPLEX WITH MG-ATP AND GAR 1ZME ; 2.50 ; CRYSTAL STRUCTURE OF PUT3/DEOXYRIBONUCLEIC ACID COMPLEX 2FFE ; 2.90 ; CRYSTAL STRUCTURE OF PUTATIVE 2-PHOSPHO-(S)-LACTATE TRANSFERASE FROM METHANOSARCINA MAZEI, NORTHEAST STRUCTURAL GENOMICS TARGET MAR46. 1VR0 ; 2.49 ; CRYSTAL STRUCTURE OF PUTATIVE 2-PHOSPHOSULFOLACTATE PHOSPHATASE (15026306) FROM CLOSTRIDIUM ACETOBUTYLICUM AT 2.49 A RESOLUTION 2FFI ; 2.61 ; CRYSTAL STRUCTURE OF PUTATIVE 2-PYRONE-4,6-DICARBOXYLIC ACID HYDROLASE FROM PSEUDOMONAS PUTIDA, NORTHEAST STRUCTURAL GENOMICS TARGET PPR23. 1ON0 ; 2.20 ; CRYSTAL STRUCTURE OF PUTATIVE ACETYLTRANSFERASE (YYCN) FROM BACILLUS SUBTILIS, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET SR144 1VIQ ; 2.40 ; CRYSTAL STRUCTURE OF PUTATIVE ADP RIBOSE PYROPHOSPHATASE 1VIU ; 2.40 ; CRYSTAL STRUCTURE OF PUTATIVE ADP RIBOSE PYROPHOSPHATASE 1VRB ; 2.60 ; CRYSTAL STRUCTURE OF PUTATIVE ASPARAGINYL HYDROXYLASE (2636534) FROM BACILLUS SUBTILIS AT 2.60 A RESOLUTION 1S7O ; 2.31 ; CRYSTAL STRUCTURE OF PUTATIVE DEOXYRIBONUCLEIC ACID BINDING PROTEIN SP_1288 FROM STREPTOCOCCUS PYGENES 1VJF ; 1.62 ; CRYSTAL STRUCTURE OF PUTATIVE DEOXYRIBONUCLEIC ACID-BINDING PROTEIN FROM CAULOBACTER CRESCENTUS AT 1.62 A RESOLUTION 1VJX ; 2.30 ; CRYSTAL STRUCTURE OF PUTATIVE FERRITIN-LIKE DIIRON- CARBOXYLATE PROTEIN (TM1526) FROM THERMOTOGA MARITIMA AT 2.30 A RESOLUTION 2A3N ; 1.23 ; CRYSTAL STRUCTURE OF PUTATIVE GLUCOSAMINE-FRUCTOSE-6- PHOSPHATE AMINOTRANSFERASE (16423107) FROM SALMONELLA TYPHIMURIUM LT2 AT 1.35 A RESOLUTION 1ZGM ; 1.90 ; CRYSTAL STRUCTURE OF PUTATIVE GLUTATHIONE S-TRANSFERASE (15162326) FROM AGROBACTERIUM TUMEFACIENS AT 2.25 A RESOLUTION 1U8S ; 2.45 ; CRYSTAL STRUCTURE OF PUTATIVE GLYCINE CLEAVAGE SYSTEM TRANSCRIPTIONAL REPRESSOR 1VHX ; 1.96 ; CRYSTAL STRUCTURE OF PUTATIVE HOLLIDAY JUNCTION RESOLVASE 1Z8H ; 2.02 ; CRYSTAL STRUCTURE OF PUTATIVE LIPASE FROM THE G-D-S-L FAMILY (17135349) FROM NOSTOC SP. PCC 7120 AT 2.02 A RESOLUTION 1VJG ; 2.01 ; CRYSTAL STRUCTURE OF PUTATIVE LIPASE FROM THE G-D-S-L FAMILY FROM NOSTOC SP. AT 2.01 A RESOLUTION 1VQZ ; 1.99 ; CRYSTAL STRUCTURE OF PUTATIVE LIPOATE-PROTEIN LIGASE (NP_345629.1) FROM STREPTOCOCCUS PNEUMONIAE TIGR4 AT 1.99 A RESOLUTION 1Y0E ; 1.95 ; CRYSTAL STRUCTURE OF PUTATIVE MANNAC-6-P EPIMERASE FROM STAPHYLOCOCCUS AUREUS (STRAIN N315) 1VPB ; 1.75 ; CRYSTAL STRUCTURE OF PUTATIVE MODULATOR OF DEOXYRIBONUCLEIC ACID GYRASE (BT3649) FROM BACTERIODES THETAIOTAOMICRON VPI-5482 AT 1.75 A RESOLUTION 2CVO ; 2.20 ; CRYSTAL STRUCTURE OF PUTATIVE N-ACETYL-GAMMA-GLUTAMYL- PHOSPHATE REDUCTASE (AK071544) FROM RICE (ORYZA SATIVA) 1ZC6 ; 2.20 ; CRYSTAL STRUCTURE OF PUTATIVE N-ACETYLGLUCOSAMINE KINASE FROM CHROMOBACTERIUM VIOLACEUM. NORTHEAST STRUCTURAL GENOMICS TARGET CVR23. 1YXY ; 1.60 ; CRYSTAL STRUCTURE OF PUTATIVE N-ACETYLMANNOSAMINE-6-P EPIMERASE FROM STREPTOCOCCUS PYOGENES (APC29713) STRUCTURAL GENOMICS, MCSG 1VJ1 ; 2.10 ; CRYSTAL STRUCTURE OF PUTATIVE NADPH-DEPENDENT OXIDOREDUCTASE FROM MUS MUSCULUS AT 2.10 A RESOLUTION 2AFA ; 2.15 ; CRYSTAL STRUCTURE OF PUTATIVE NAG ISOMERASE FROM SALMONELLA TYPHIMURIUM 1VKW ; 2.00 ; CRYSTAL STRUCTURE OF PUTATIVE NITROREDUCTASE (TM1586) FROM THERMOTOGA MARITIMA AT 2.00 A RESOLUTION 1YLQ ; 2.02 ; CRYSTAL STRUCTURE OF PUTATIVE NUCLEOTIDYLTRANSFERASE 1O4T ; 1.95 ; CRYSTAL STRUCTURE OF PUTATIVE OXALATE DECARBOXYLASE (TM1287) FROM THERMOTOGA MARITIMA AT 1.95 A RESOLUTION 1WVI ; 2.30 ; CRYSTAL STRUCTURE OF PUTATIVE PHOSPHATASE FROM STREPTOCOCCUS MUTANS UA159 1VMI ; 2.32 ; CRYSTAL STRUCTURE OF PUTATIVE PHOSPHATE ACETYLTRANSFERASE (NP_416953.1) FROM ESCHERICHIA COLI K12 AT 2.32 A RESOLUTION 1TUO ; 1.70 ; CRYSTAL STRUCTURE OF PUTATIVE PHOSPHOMANNOMUTASE FROM THERMUS THERMOPHILUS HB8 1VCT ; 1.85 ; CRYSTAL STRUCTURE OF PUTATIVE POTASSIUM CHANNEL RELATED PROTEIN FROM PYROCOCCUS HORIKOSHII 1VKH ; 1.85 ; CRYSTAL STRUCTURE OF PUTATIVE SERINE HYDROLASE (YDR428C) FROM SACCHAROMYCES CEREVISIAE AT 1.85 A RESOLUTION 2AMU ; 2.00 ; CRYSTAL STRUCTURE OF PUTATIVE SUPEROXIDE REDUCTASE (EC 1.15.1.2) (SOR) (TM0658) FROM THERMOTOGA MARITIMA AT 2.00 A RESOLUTION 1XHL ; 2.40 ; CRYSTAL STRUCTURE OF PUTATIVE TROPINONE REDUCTASE-II FROM CAENORHABDITIS ELEGANS WITH COFACTOR AND SUBSTRATE 1VP2 ; 1.78 ; CRYSTAL STRUCTURE OF PUTATIVE XANTHOSINE TRIPHOSPHATE PYROPHOSPHATASE/HAM1 PROTEIN HOMOLOG (TM0159) FROM THERMOTOGA MARITIMA AT 1.78 A RESOLUTION 1Q1R ; 1.91 ; CRYSTAL STRUCTURE OF PUTIDAREDOXIN REDUCTASE FROM PSEUDOMONAS PUTIDA 1Q1W ; 2.60 ; CRYSTAL STRUCTURE OF PUTIDAREDOXIN REDUCTASE FROM PSEUDOMONAS PUTIDA 1UGU ; 1.20 ; CRYSTAL STRUCTURE OF PYP E46Q MUTANT 1TT0 ; 1.80 ; CRYSTAL STRUCTURE OF PYRANOSE 2-OXIDASE 1TZL ; 2.35 ; CRYSTAL STRUCTURE OF PYRANOSE 2-OXIDASE FROM THE WHITE-ROT FUNGUS PENIOPHORA SP. 1IM5 ; 1.65 ; CRYSTAL STRUCTURE OF PYRAZINAMIDASE OF PYROCOCCUS HORIKOSHII IN COMPLEX WITH ZINC 1ILW ; 2.05 ; CRYSTAL STRUCTURE OF PYRAZINAMIDASE/NICOTINAMIDASE OF PYROCOCCUS HORIKOSHII 1RFV ; 2.80 ; CRYSTAL STRUCTURE OF PYRIDOXAL KINASE COMPLEXED WITH ADP 1RFU ; 2.80 ; CRYSTAL STRUCTURE OF PYRIDOXAL KINASE COMPLEXED WITH ADP AND PLP 1RFT ; 2.80 ; CRYSTAL STRUCTURE OF PYRIDOXAL KINASE COMPLEXED WITH AMP- PCP AND PYRIDOXAMINE 1LHR ; 2.60 ; CRYSTAL STRUCTURE OF PYRIDOXAL KINASE COMPLEXED WITH ATP 1LHP ; 2.10 ; CRYSTAL STRUCTURE OF PYRIDOXAL KINASE FROM SHEEP BRAIN 1YGJ ; 2.70 ; CRYSTAL STRUCTURE OF PYRIDOXAL KINASE IN COMPLEX WITH ROSCOVITINE AND DERIVATIVES 1YGK ; 2.60 ; CRYSTAL STRUCTURE OF PYRIDOXAL KINASE IN COMPLEX WITH ROSCOVITINE AND DERIVATIVES 1YHJ ; 2.80 ; CRYSTAL STRUCTURE OF PYRIDOXAL KINASE IN COMPLEX WITH ROSCOVITINE AND DERIVATIVES 1YXO ; 2.01 ; CRYSTAL STRUCTURE OF PYRIDOXAL PHOSPHATE BIOSYNTHETIC PROTEIN PDXA PA0593 1VI9 ; 1.96 ; CRYSTAL STRUCTURE OF PYRIDOXAMINE KINASE 1HO1 ; 2.00 ; CRYSTAL STRUCTURE OF PYRIDOXINE 5'-PHOSPHATE SYNTHASE 1HO4 ; 2.30 ; CRYSTAL STRUCTURE OF PYRIDOXINE 5'-PHOSPHATE SYNTHASE IN COMPLEX WITH PYRIDOXINE 5'-PHOSPHATE AND INORGANIC PHOSPHATE 1ZCO ; 2.25 ; CRYSTAL STRUCTURE OF PYROCOCCUS FURIOSUS 3-DEOXY-D-ARABINO- HEPTULOSONATE 7-PHOSPHATE SYNTHASE 1G71 ; 2.30 ; CRYSTAL STRUCTURE OF PYROCOCCUS FURIOSUS DEOXYRIBONUCLEIC ACID PRIMASE 1WP9 ; 2.90 ; CRYSTAL STRUCTURE OF PYROCOCCUS FURIOSUS HEF HELICASE DOMAIN 1X8E ; 2.80 ; CRYSTAL STRUCTURE OF PYROCOCCUS FURIOSUS PHOSPHOGLUCOSE ISOMERASE FREE ENZYME 1UMJ ; 1.60 ; CRYSTAL STRUCTURE OF PYROCOCCUS HORIKOSHII CUTA IN THE PRESENCE OF 3M GUANIDINE HYDROCHLORIDE 1V9B ; 2.00 ; CRYSTAL STRUCTURE OF PYROCOCCUS HORIKOSHII CUTA1 COMPLEXED WITH CO2+ 1UKU ; 1.45 ; CRYSTAL STRUCTURE OF PYROCOCCUS HORIKOSHII CUTA1 COMPLEXED WITH CU2+ 1V34 ; 2.70 ; CRYSTAL STRUCTURE OF PYROCOCCUS HORIKOSHII DEOXYRIBONUCLEIC ACID PRIMASE-UTP COMPLEX 1WQA ; 2.00 ; CRYSTAL STRUCTURE OF PYROCOCCUS HORIKOSHII PHOSPHOMANNOMUTASE/PHOSPHOGLUCOMUTASE COMPLEXED WITH MG2+ 1GDE ; 1.80 ; CRYSTAL STRUCTURE OF PYROCOCCUS PROTEIN A-1 E-FORM 1TI2 ; 2.35 ; CRYSTAL STRUCTURE OF PYROGALLOL-PHLOROGLUCINOL TRANSHYDROXYLASE FROM PELOBACTER ACIDIGALLICI 1VLD ; 2.35 ; CRYSTAL STRUCTURE OF PYROGALLOL-PHLOROGLUCINOL TRANSHYDROXYLASE FROM PELOBACTER ACIDIGALLICI 1TI6 ; 2.00 ; CRYSTAL STRUCTURE OF PYROGALLOL-PHLOROGLUCINOL TRANSHYDROXYLASE FROM PELOBACTER ACIDIGALLICI COMPLEXED WITH INHIBITOR 1,2,4,5-TETRAHYDROXY-BENZENE 1VLF ; 2.00 ; CRYSTAL STRUCTURE OF PYROGALLOL-PHLOROGLUCINOL TRANSHYDROXYLASE FROM PELOBACTER ACIDIGALLICI COMPLEXED WITH INHIBITOR 1,2,4,5-TETRAHYDROXY-BENZENE 1TI4 ; 2.20 ; CRYSTAL STRUCTURE OF PYROGALLOL-PHLOROGLUCINOL TRANSHYDROXYLASE FROM PELOBACTER ACIDIGALLICI COMPLEXED WITH PYROGALLOL 1VLE ; 2.20 ; CRYSTAL STRUCTURE OF PYROGALLOL-PHLOROGLUCINOL TRANSHYDROXYLASE FROM PELOBACTER ACIDIGALLICI COMPLEXED WITH PYROGALLOL 1O5Q ; 2.30 ; CRYSTAL STRUCTURE OF PYRUVATE AND MG2+ BOUND 2- METHYLISOCITRATE LYASE (PRPB) FROM SALMONELLA TYPHIMURIUM 1MZO ; 2.70 ; CRYSTAL STRUCTURE OF PYRUVATE FORMATE-LYASE WITH PYRUVATE 1V5F ; 1.80 ; CRYSTAL STRUCTURE OF PYRUVATE OXIDASE COMPLEXED WITH FAD AND TPP, FROM AEROCOCCUS VIRIDANS 1V5E ; 1.60 ; CRYSTAL STRUCTURE OF PYRUVATE OXIDASE CONTAINING FAD, FROM AEROCOCCUS VIRIDANS 1B0P ; 2.31 ; CRYSTAL STRUCTURE OF PYRUVATE-FERREDOXIN OXIDOREDUCTASE FROM DESULFOVIBRIO AFRICANUS 1M64 ; 1.80 ; CRYSTAL STRUCTURE OF Q363F MUTANT FLAVOCYTOCHROME C3 1LJ1 ; 2.00 ; CRYSTAL STRUCTURE OF Q363F/R402A MUTANT FLAVOCYTOCHROME C3 2ES7 ; 2.80 ; CRYSTAL STRUCTURE OF Q8ZP25 FROM SALMONELLA TYPHIMURIUM LT2. NESG TARGET STR70 2ES9 ; 2.00 ; CRYSTAL STRUCTURE OF Q8ZRJ2 FROM SALMONELLA TYPHIMURIUM. NESG TARGET STR65 1JUH ; 1.60 ; CRYSTAL STRUCTURE OF QUERCETIN 2,3-DIOXYGENASE 1H1M ; 1.90 ; CRYSTAL STRUCTURE OF QUERCETIN 2,3-DIOXYGENASE ANAEROBICALLY COMPLEXED WITH THE SUBSTRATE KAEMPFEROL 1H1I ; 1.75 ; CRYSTAL STRUCTURE OF QUERCETIN 2,3-DIOXYGENASE ANAEROBICALLY COMPLEXED WITH THE SUBSTRATE QUERCETN 2ASH ; 1.90 ; CRYSTAL STRUCTURE OF QUEUINE TRNA-RIBOSYLTRANSFERASE (EC 2.4.2.29) (TRNA-GUANINE (TM1561) FROM THERMOTOGA MARITIMA AT 1.90 A RESOLUTION 1KB0 ; 1.44 ; CRYSTAL STRUCTURE OF QUINOHEMOPROTEIN ALCOHOL DEHYDROGENASE FROM COMAMONAS TESTOSTERONI 1WZU ; 2.00 ; CRYSTAL STRUCTURE OF QUINOLINATE SYNTHASE (NADA) 1T3Q ; 1.80 ; CRYSTAL STRUCTURE OF QUINOLINE 2-OXIDOREDUCTASE FROM PSEUDOMONAS PUTIDA 86 1YJW ; 2.90 ; CRYSTAL STRUCTURE OF QUINUPRISTIN BOUND TO THE G2099A MUTANT 50S RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI 2BR6 ; 1.70 ; CRYSTAL STRUCTURE OF QUORUM-QUENCHING N-ACYL HOMOSERINE LACTONE LACTONASE 1RFY ; 1.60 ; CRYSTAL STRUCTURE OF QUORUM-SENSING ANTIACTIVATOR TRAM 1RXA ; 2.90 ; CRYSTAL STRUCTURE OF R(CCCCGGGG) IN TWO DISTINCT LATTICES 1RXB ; 1.80 ; CRYSTAL STRUCTURE OF R(CCCCGGGG) IN TWO DISTINCT LATTICES 332D ; 1.58 ; CRYSTAL STRUCTURE OF R(GUGUGUA)D(C) WITH TANDEM G-U/U-G WOBBLE PAIRS WITH STRAND SLIPPAGE 1NXQ ; 1.79 ; CRYSTAL STRUCTURE OF R-ALCOHOL DEHYDROGENASE (RADH) (APOENYZME) FROM LACTOBACILLUS BREVIS 1F99 ; 2.40 ; CRYSTAL STRUCTURE OF R-PHYCOCYANIN FROM POLYSIPHONIA AT 2.4 A RESOLUTION 1EYX ; 2.25 ; CRYSTAL STRUCTURE OF R-PHYCOERYTHRIN AT 2.2 ANGSTROMS 1LIA ; 2.80 ; CRYSTAL STRUCTURE OF R-PHYCOERYTHRIN FROM POLYSIPHONIA AT 2.8 A RESOLUTION 1L7E ; 1.90 ; CRYSTAL STRUCTURE OF R. RUBRUM TRANSHYDROGENASE DOMAIN I WITH BOUND NADH 1L7D ; 1.81 ; CRYSTAL STRUCTURE OF R. RUBRUM TRANSHYDROGENASE DOMAIN I WITHOUT BOUND NAD(H) 1PNO ; 2.10 ; CRYSTAL STRUCTURE OF R. RUBRUM TRANSHYDROGENASE DOMAIN III BOUND TO NADP 1PNQ ; 2.40 ; CRYSTAL STRUCTURE OF R. RUBRUM TRANSHYDROGENASE DOMAIN III BOUND TO NADPH 2A9C ; 2.50 ; CRYSTAL STRUCTURE OF R138Q MUTANT OF RECOMBINANT CHICKEN SULFITE OXIDASE WITH THE BOUND PRODUCT, SULFATE, AT THE ACTIVE SITE 2A9B ; 2.50 ; CRYSTAL STRUCTURE OF R138Q MUTANT OF RECOMBINANT SULFITE OXIDASE AT RESTING STATE 1IB6 ; 2.10 ; CRYSTAL STRUCTURE OF R153C E. COLI MALATE DEHYDROGENASE 1IE3 ; 2.50 ; CRYSTAL STRUCTURE OF R153C E. COLI MALATE DEHYDROGENASE 1D2H ; 3.00 ; CRYSTAL STRUCTURE OF R175K MUTANT GLYCINE N- METHYLTRANSFERASE COMPLEXED WITH S-ADENOSYLHOMOCYSTEINE 1D2G ; 2.50 ; CRYSTAL STRUCTURE OF R175K MUTANT GLYCINE N- METHYLTRANSFERASE FROM RAT LIVER 1L7H ; 1.85 ; CRYSTAL STRUCTURE OF R292K MUTANT INFLUENZA VIRUS NEURAMINIDASE IN COMPLEX WITH BCX-1812 1DJ1 ; 1.93 ; CRYSTAL STRUCTURE OF R48A MUTANT OF CYTOCHROME C PEROXIDASE 1DJ5 ; 1.93 ; CRYSTAL STRUCTURE OF R48A MUTANT OF CYTOCHROME C PEROXIDASE WITH N-HYDROXYGUANIDINE BOUND 1DCE ; 2.00 ; CRYSTAL STRUCTURE OF RAB GERANYLGERANYLTRANSFERASE FROM RAT BRAIN 2EW1 ; 2.00 ; CRYSTAL STRUCTURE OF RAB30 IN COMPLEX WITH A GTP ANALOGUE 1TU3 ; 2.31 ; CRYSTAL STRUCTURE OF RAB5 COMPLEX WITH RABAPTIN5 C-TERMINAL DOMAIN 1TU4 ; 2.20 ; CRYSTAL STRUCTURE OF RAB5-GDP COMPLEX 1S8F ; 1.77 ; CRYSTAL STRUCTURE OF RAB9 COMPLEXED TO GDP REVEALS A DIMER WITH AN ACTIVE CONFORMATION OF SWITCH II 1Q13 ; 2.08 ; CRYSTAL STRUCTURE OF RABBIT 20ALPHA HYROXYSTEROID DEHYDROGENASE IN TERNARY COMPLEX WITH NADP AND TESTOSTERONE 1CJ0 ; 2.80 ; CRYSTAL STRUCTURE OF RABBIT CYTOSOLIC SERINE HYDROXYMETHYLTRANSFERASE AT 2.8 ANGSTROM RESOLUTION 1KHV ; 2.50 ; CRYSTAL STRUCTURE OF RABBIT HEMORRHAGIC DISEASE VIRUS RIBONUCLEIC ACID- DEPENDENT RIBONUCLEIC ACID POLYMERASE COMPLEXED WITH LU3+ 1KHW ; 2.70 ; CRYSTAL STRUCTURE OF RABBIT HEMORRHAGIC DISEASE VIRUS RIBONUCLEIC ACID- DEPENDENT RIBONUCLEIC ACID POLYMERASE COMPLEXED WITH MN2+ 1RZY ; 1.80 ; CRYSTAL STRUCTURE OF RABBIT HINT COMPLEXED WITH N- ETHYLSULFAMOYLADENOSINE 1K4Y ; 2.50 ; CRYSTAL STRUCTURE OF RABBIT LIVER CARBOXYLESTERASE IN COMPLEX WITH 4-PIPERIDINO-PIPERIDINE 1BK4 ; 2.30 ; CRYSTAL STRUCTURE OF RABBIT LIVER FRUCTOSE-1,6- BISPHOSPHATASE AT 2.3 ANGSTROM RESOLUTION 1LWN ; 2.00 ; CRYSTAL STRUCTURE OF RABBIT MUSCLE GLYCOGEN PHOSPHORYLASE A IN COMPLEX WITH A POTENTIAL HYPOGLYCAEMIC DRUG AT 2.0 A RESOLUTION 1LWO ; 2.00 ; CRYSTAL STRUCTURE OF RABBIT MUSCLE GLYCOGEN PHOSPHORYLASE A IN COMPLEX WITH A POTENTIAL HYPOGLYCAEMIC DRUG AT 2.0 A RESOLUTION 1LL0 ; 3.43 ; CRYSTAL STRUCTURE OF RABBIT MUSCLE GLYCOGENIN 1LL3 ; 1.90 ; CRYSTAL STRUCTURE OF RABBIT MUSCLE GLYCOGENIN 1LL2 ; 1.90 ; CRYSTAL STRUCTURE OF RABBIT MUSCLE GLYCOGENIN COMPLEXED WITH UDP-GLUCOSE AND MANGANESE 1R2R ; 1.50 ; CRYSTAL STRUCTURE OF RABBIT MUSCLE TRIOSEPHOSPHATE ISOMERASE 1R2S ; 2.85 ; CRYSTAL STRUCTURE OF RABBIT MUSCLE TRIOSEPHOSPHATE ISOMERASE 1R2T ; 2.25 ; CRYSTAL STRUCTURE OF RABBIT MUSCLE TRIOSEPHOSPHATE ISOMERASE 1KOJ ; 1.90 ; CRYSTAL STRUCTURE OF RABBIT PHOSPHOGLUCOSE ISOMERASE COMPLEXED WITH 5-PHOSPHO-D-ARABINONOHYDROXAMIC ACID 1HOX ; 2.10 ; CRYSTAL STRUCTURE OF RABBIT PHOSPHOGLUCOSE ISOMERASE COMPLEXED WITH FRUCTOSE-6-PHOSPHATE 1XTB ; 2.00 ; CRYSTAL STRUCTURE OF RABBIT PHOSPHOGLUCOSE ISOMERASE COMPLEXED WITH SORBITOL-6-PHOSPHATE 1DQR ; 2.50 ; CRYSTAL STRUCTURE OF RABBIT PHOSPHOGLUCOSE ISOMERASE, A GLYCOLYTIC ENZYME THAT MOONLIGHTS AS NEUROLEUKIN, AUTOCRINE MOTILITY FACTOR, AND DIFFERENTIATION MEDIATOR 1FOE ; 2.80 ; CRYSTAL STRUCTURE OF RAC1 IN COMPLEX WITH THE GUANINE NUCLEOTIDE EXCHANGE REGION OF TIAM1 1KRL ; 1.90 ; CRYSTAL STRUCTURE OF RACEMIC DL-MONELLIN IN P-1 1F2U ; 1.60 ; CRYSTAL STRUCTURE OF RAD50 ABC-ATPASE 1K5G ; 3.10 ; CRYSTAL STRUCTURE OF RAN-GDP-ALFX-RANBP1-RANGAP COMPLEX 1K5D ; 2.70 ; CRYSTAL STRUCTURE OF RAN-GPPNHP-RANBP1-RANGAP COMPLEX 1C1Y ; 1.90 ; CRYSTAL STRUCTURE OF RAP.GMPPNP IN COMPLEX WITH THE RAS- BINDING-DOMAIN OF C-RAF1 KINASE (RAFRBD). 1J2X ; 2.00 ; CRYSTAL STRUCTURE OF RAP74 C-TERMINAL DOMAIN COMPLEXED WITH FCP1 C-TERMINAL PEPTIDE 1K8R ; 3.00 ; CRYSTAL STRUCTURE OF RAS-BRY2RBD COMPLEX 1LF5 ; 1.70 ; CRYSTAL STRUCTURE OF RASA59G IN THE GDP-BOUND FORM 1LF0 ; 1.70 ; CRYSTAL STRUCTURE OF RASA59G IN THE GTP-BOUND FORM 1CK4 ; 2.20 ; CRYSTAL STRUCTURE OF RAT A1B1 INTEGRIN I-DOMAIN. 1EDY ; 2.30 ; CRYSTAL STRUCTURE OF RAT ALPHA 1-MACROGLOBULIN RECEPTOR BINDING DOMAIN 1RWY ; 1.05 ; CRYSTAL STRUCTURE OF RAT ALPHA-PARVALBUMIN AT 1.05 RESOLUTION 1XVJ ; 1.80 ; CRYSTAL STRUCTURE OF RAT ALPHA-PARVALBUMIN D94S/G98E MUTANT 1S3P ; 2.00 ; CRYSTAL STRUCTURE OF RAT ALPHA-PARVALBUMIN S55D/E59D MUTANT 1I7P ; 2.00 ; CRYSTAL STRUCTURE OF RAT B5R IN COMPLEX WITH FAD 1IB0 ; 2.30 ; CRYSTAL STRUCTURE OF RAT B5R IN COMPLEX WITH FAD AND NAD 1GCU ; 1.40 ; CRYSTAL STRUCTURE OF RAT BILIVERDIN REDUCTASE AT 1.4 A 1L0B ; 2.30 ; CRYSTAL STRUCTURE OF RAT BRCA1 TANDEM-BRCT REGION 1Q6X ; 2.50 ; CRYSTAL STRUCTURE OF RAT CHOLINE ACETYLTRANSFERASE 1OSC ; 2.15 ; CRYSTAL STRUCTURE OF RAT CUTA1 AT 2.15 A RESOLUTION 1NL4 ; 2.70 ; CRYSTAL STRUCTURE OF RAT FARNESYL TRANSFERASE IN COMPLEX WITH A POTENT BIPHENYL INHIBITOR 1JG5 ; 2.60 ; CRYSTAL STRUCTURE OF RAT GTP CYCLOHYDROLASE I FEEDBACK REGULATORY PROTEIN, GFRP 1IS7 ; 2.80 ; CRYSTAL STRUCTURE OF RAT GTPCHI/GFRP STIMULATORY COMPLEX 1IS8 ; 2.70 ; CRYSTAL STRUCTURE OF RAT GTPCHI/GFRP STIMULATORY COMPLEX PLUS ZN 1J2C ; 2.40 ; CRYSTAL STRUCTURE OF RAT HEME OXYGENASE-1 IN COMPLEX WITH BILIVERDIN IXALPHA-IRON CLUSTER 1DVE ; 2.40 ; CRYSTAL STRUCTURE OF RAT HEME OXYGENASE-1 IN COMPLEX WITH HEME 1IX4 ; 1.80 ; CRYSTAL STRUCTURE OF RAT HEME OXYGENASE-1 IN COMPLEX WITH HEME BOUND TO CARBON MONOXIDE 1IX3 ; 2.00 ; CRYSTAL STRUCTURE OF RAT HEME OXYGENASE-1 IN COMPLEX WITH HEME BOUND TO CYANIDE 1DVG ; 2.20 ; CRYSTAL STRUCTURE OF RAT HEME OXYGENASE-1 IN COMPLEX WITH HEME; SELELENO-METHIONINE DERIVATIVE, MUTATED AT M51T,M93L, M155L,M191L. 1J02 ; 1.70 ; CRYSTAL STRUCTURE OF RAT HEME OXYGENASE-1-HEME BOUND TO NO 1IVJ ; 1.90 ; CRYSTAL STRUCTURE OF RAT HEMEOXYGENASE-1 IN COMPLEX WITH HEME AND AZIDE. 1UBB ; 2.30 ; CRYSTAL STRUCTURE OF RAT HO-1 IN COMPLEX WITH FERROUS HEME 1ED3 ; 2.55 ; CRYSTAL STRUCTURE OF RAT MINOR HISTOCOMPATIBILITY ANTIGEN COMPLEX RT1-AA/MTF-E. 1XX4 ; 2.20 ; CRYSTAL STRUCTURE OF RAT MITOCHONDRIAL 3,2-ENOYL-COA 1F20 ; 1.90 ; CRYSTAL STRUCTURE OF RAT NEURONAL NITRIC-OXIDE SYNTHASE FAD/NADP+ DOMAIN AT 1.9A RESOLUTION. 1TLL ; 2.30 ; CRYSTAL STRUCTURE OF RAT NEURONAL NITRIC-OXIDE SYNTHASE REDUCTASE MODULE AT 2.3 A RESOLUTION. 1G33 ; 1.44 ; CRYSTAL STRUCTURE OF RAT PARVALBUMIN WITHOUT THE N-TERMINAL DOMAIN 1JCR ; 2.00 ; CRYSTAL STRUCTURE OF RAT PROTEIN FARNESYLTRANSFERASE COMPLEXED WITH THE NON-SUBSTRATE TETRAPEPTIDE INHIBITOR CVFM AND FARNESYL DIPHOSPHATE SUBSTRATE 1JCS ; 2.20 ; CRYSTAL STRUCTURE OF RAT PROTEIN FARNESYLTRANSFERASE COMPLEXED WITH THE PEPTIDE SUBSTRATE TKCVFM AND AN ANALOG OF FARNESYL DIPHOSPHATE 1JQI ; 2.25 ; CRYSTAL STRUCTURE OF RAT SHORT CHAIN ACYL-COA DEHYDROGENASE COMPLEXED WITH ACETOACETYL-COA 1PK8 ; 2.10 ; CRYSTAL STRUCTURE OF RAT SYNAPSIN I C DOMAIN COMPLEXED TO CA.ATP 1PX2 ; 2.23 ; CRYSTAL STRUCTURE OF RAT SYNAPSIN I C DOMAIN COMPLEXED TO CA.ATP (FORM 1) 1WT4 ; 1.90 ; CRYSTAL STRUCTURE OF RAT TOM20-ALDH PRESEQUENCE COMPLEX 1RV2 ; 2.80 ; CRYSTAL STRUCTURE OF RB69 GP43 IN COMPLEX WITH DEOXYRIBONUCLEIC ACID CONTAINING AN ABASIC SITE ANALOG 1PYH ; 4.80 ; CRYSTAL STRUCTURE OF RC-LH1 CORE COMPLEX FROM RHODOPSEUDOMONAS PALUSTRIS 1WDZ ; 2.63 ; CRYSTAL STRUCTURE OF RCB DOMAIN OF IRSP53 1APX ; 2.20 ; CRYSTAL STRUCTURE OF RECOMBINANT ASCORBATE PEROXIDASE 1E1H ; 1.80 ; CRYSTAL STRUCTURE OF RECOMBINANT BOTULINUM NEUROTOXIN TYPE A LIGHT CHAIN, SELF-INHIBITING ZN ENDOPEPTIDASE. 1BJF ; 2.40 ; CRYSTAL STRUCTURE OF RECOMBINANT BOVINE NEUROCALCIN DELTA AT 2.4 ANGSTROMS 2A99 ; 2.20 ; CRYSTAL STRUCTURE OF RECOMBINANT CHICKEN SULFITE OXIDASE AT RESTING STATE 2A9D ; 1.70 ; CRYSTAL STRUCTURE OF RECOMBINANT CHICKEN SULFITE OXIDASE WITH ARG AT RESIDUE 161 2A9A ; 2.00 ; CRYSTAL STRUCTURE OF RECOMBINANT CHICKEN SULFITE OXIDASE WITH THE BOUND PRODUCT, SULFATE, AT THE ACTIVE SITE 1SFY ; 2.55 ; CRYSTAL STRUCTURE OF RECOMBINANT ERYTHRINA CORALLODANDRON LECTIN 1KU5 ; 2.30 ; CRYSTAL STRUCTURE OF RECOMBINANT HISTONE HPHA FROM HYPERTHERMOPHILIC ARCHAEON PYROCOCCUS HORIKOSHII OT3 1HKB ; 2.80 ; CRYSTAL STRUCTURE OF RECOMBINANT HUMAN BRAIN HEXOKINASE TYPE I COMPLEXED WITH GLUCOSE AND GLUCOSE-6-PHOSPHATE 1XYH ; 2.60 ; CRYSTAL STRUCTURE OF RECOMBINANT HUMAN CYCLOPHILIN J 1LT9 ; 2.80 ; CRYSTAL STRUCTURE OF RECOMBINANT HUMAN FIBRINOGEN FRAGMENT D 1LTJ ; 2.80 ; CRYSTAL STRUCTURE OF RECOMBINANT HUMAN FIBRINOGEN FRAGMENT D WITH THE PEPTIDE LIGANDS GLY-PRO-ARG-PRO-AMIDE AND GLY- HIS-ARG-PRO-AMIDE 1M4R ; 2.00 ; CRYSTAL STRUCTURE OF RECOMBINANT HUMAN INTERLEUKIN-22 1HAK ; 3.00 ; CRYSTAL STRUCTURE OF RECOMBINANT HUMAN PLACENTAL ANNEXIN V COMPLEXED WITH K-201 AS A CALCIUM CHANNEL ACTIVITY INHIBITOR 1NM9 ; 2.10 ; CRYSTAL STRUCTURE OF RECOMBINANT HUMAN SALIVARY AMYLASE MUTANT W58A 1JYD ; 1.70 ; CRYSTAL STRUCTURE OF RECOMBINANT HUMAN SERUM RETINOL- BINDING PROTEIN AT 1.7 A RESOLUTION 1JV4 ; 1.75 ; CRYSTAL STRUCTURE OF RECOMBINANT MAJOR MOUSE URINARY PROTEIN (RMUP) AT 1.75 A RESOLUTION 1WU3 ; 2.15 ; CRYSTAL STRUCTURE OF RECOMBINANT MURINE INTERFERON BETA 1RM4 ; 2.00 ; CRYSTAL STRUCTURE OF RECOMBINANT PHOTOSYNTHETIC GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE A4 ISOFORM, COMPLEXED WITH NADP 1D4F ; 2.80 ; CRYSTAL STRUCTURE OF RECOMBINANT RAT-LIVER D244E MUTANT S- ADENOSYLHOMOCYSTEINE HYDROLASE 1EZK ; 1.90 ; CRYSTAL STRUCTURE OF RECOMBINANT TRYPAREDOXIN I 1EHB ; 1.90 ; CRYSTAL STRUCTURE OF RECOMBINANT TRYPSIN-SOLUBILIZED FRAGMENT OF CYTOCHROME B5 1VDD ; 2.50 ; CRYSTAL STRUCTURE OF RECOMBINATIONAL REPAIR PROTEIN RECR 1G0D ; 2.50 ; CRYSTAL STRUCTURE OF RED SEA BREAM TRANSGLUTAMINASE 1Y0O ; 1.89 ; CRYSTAL STRUCTURE OF REDUCED ATFKBP13 1XLQ ; 1.45 ; CRYSTAL STRUCTURE OF REDUCED C73S PUTIDAREDOXIN FROM PSEUDOMONAS PUTIDA 1C6R ; 1.90 ; CRYSTAL STRUCTURE OF REDUCED CYTOCHROME C6 FROM THE GREEN ALGAE SCENEDESMUS OBLIQUUS 2COJ ; 2.40 ; CRYSTAL STRUCTURE OF REDUCED HUMAN CYTOSOLIC BRANCHED-CHAIN AMINOTRANSFERASE COMPLEXED WITH GABAPENTIN 1SBM ; 1.69 ; CRYSTAL STRUCTURE OF REDUCED MESOPONE CYTOCHROME C PEROXIDASE (R-ISOMER) 1M6Z ; 1.35 ; CRYSTAL STRUCTURE OF REDUCED RECOMBINANT CYTOCHROME C4 FROM PSEUDOMONAS STUTZERI 1CL0 ; 2.50 ; CRYSTAL STRUCTURE OF REDUCED THIOREDOXIN REDUCTASE FROM ESCHERICHIA COLI. 1Z48 ; 1.80 ; CRYSTAL STRUCTURE OF REDUCED YQJM FROM BACILLUS SUBTILIS 1P7R ; 2.85 ; CRYSTAL STRUCTURE OF REDUCED, CO-EXPOSED COMPLEX OF CYTOCHROME P450CAM WITH (S)-(-)-NICOTINE 1WU4 ; 1.35 ; CRYSTAL STRUCTURE OF REDUCING-END-XYLOSE RELEASING EXO- OLIGOXYLANASE 1WU5 ; 2.20 ; CRYSTAL STRUCTURE OF REDUCING-END-XYLOSE RELEASING EXO- OLIGOXYLANASE COMPLEXED WITH XYLOSE 1WU6 ; 1.45 ; CRYSTAL STRUCTURE OF REDUCING-END-XYLOSE RELEASING EXO- OLIGOXYLANASE E70A MUTANT COMPLEXED WITH XYLOBIOSE 1S7D ; 2.17 ; CRYSTAL STRUCTURE OF REFINED TETRAGONAL CRYSTAL OF YODA FROM ESCHERICHIA COLI 1T8B ; 3.23 ; CRYSTAL STRUCTURE OF REFOLDED PHOU-LIKE PROTEIN (GI 2983430) FROM AQUIFEX AEOLICUS 1VI4 ; 1.87 ; CRYSTAL STRUCTURE OF REGULATOR OF RIBONUCLEASE ACIVITY A PROTEIN 1 1KKE ; 2.60 ; CRYSTAL STRUCTURE OF REOVIRUS ATTACHMENT PROTEIN SIGMA1 TRIMER 1U5P ; 2.00 ; CRYSTAL STRUCTURE OF REPEATS 15 AND 16 OF CHICKEN BRAIN ALPHA SPECTRIN 1U4Q ; 2.50 ; CRYSTAL STRUCTURE OF REPEATS 15, 16 AND 17 OF CHICKEN BRAIN ALPHA SPECTRIN 1CUN ; 2.00 ; CRYSTAL STRUCTURE OF REPEATS 16 AND 17 OF CHICKEN BRAIN ALPHA SPECTRIN 1S35 ; 2.40 ; CRYSTAL STRUCTURE OF REPEATS 8 AND 9 OF HUMAN ERYTHROID SPECTRIN 1REP ; 2.60 ; CRYSTAL STRUCTURE OF REPLICATION INITIATOR PROTEIN REPE54 OF MINI-F PLASMID COMPLEXED WITH AN ITERON DEOXYRIBONUCLEIC ACID 1RFX ; 2.00 ; CRYSTAL STRUCTURE OF RESISITIN 1RGX ; 1.79 ; CRYSTAL STRUCTURE OF RESISITIN 1RH7 ; 3.11 ; CRYSTAL STRUCTURE OF RESISTIN-LIKE BETA 1D2I ; 1.70 ; CRYSTAL STRUCTURE OF RESTRICTION ENDONUCLEASE BGLII COMPLEXED WITH DEOXYRIBONUCLEIC ACID 16-MER 1DFM ; 1.50 ; CRYSTAL STRUCTURE OF RESTRICTION ENDONUCLEASE BGLII COMPLEXED WITH DEOXYRIBONUCLEIC ACID 16-MER 1SDO ; 1.85 ; CRYSTAL STRUCTURE OF RESTRICTION ENDONUCLEASE BSTYI 1NA6 ; 2.10 ; CRYSTAL STRUCTURE OF RESTRICTION ENDONUCLEASE ECORII MUTANT R88A 1YNM ; 2.65 ; CRYSTAL STRUCTURE OF RESTRICTION ENDONUCLEASE HINP1I 1FML ; 2.75 ; CRYSTAL STRUCTURE OF RETINOL DEHYDRATASE IN A COMPLEX WITH RETINOL AND PAP 1X8L ; 2.10 ; CRYSTAL STRUCTURE OF RETINOL DEHYDRATASE IN COMPLEX WITH ALL-TRANS-4-OXORETINOL AND INACTIVE COFACTOR PAP 1X8J ; 2.35 ; CRYSTAL STRUCTURE OF RETINOL DEHYDRATASE IN COMPLEX WITH ANDROSTERONE AND INACTIVE COFACTOR PAP 1X8K ; 2.75 ; CRYSTAL STRUCTURE OF RETINOL DEHYDRATASE IN COMPLEX WITH ANHYDRORETINOL AND INACTIVE COFACTOR PAP 1A6Y ; 2.30 ; CRYSTAL STRUCTURE OF REVERB-DEOXYRIBONUCLEIC ACID BINDING COMPLEX 1MC3 ; 2.60 ; CRYSTAL STRUCTURE OF RFFH 1M6R ; 1.54 ; CRYSTAL STRUCTURE OF RGD(CGCGCG) FORMING HEXAMER Z-DEOXYRIBONUCLEIC ACID DUPLEX WITH 5'-(RG) OVERHANG 1UH7 ; 2.10 ; CRYSTAL STRUCTURE OF RHIZOPUSPEPSIN AT PH 4.6 1UH9 ; 2.00 ; CRYSTAL STRUCTURE OF RHIZOPUSPEPSIN AT PH 7.0 1UH8 ; 2.30 ; CRYSTAL STRUCTURE OF RHIZOPUSPEPSIN AT PH 8.0 1OW3 ; 1.80 ; CRYSTAL STRUCTURE OF RHOA.GDP.MGF3-IN COMPLEX WITH RHOGAP 1UAR ; 1.70 ; CRYSTAL STRUCTURE OF RHODANESE FROM THERMUS THERMOPHILUS HB8 1WV9 ; 2.00 ; CRYSTAL STRUCTURE OF RHODANESE HOMOLOG TT1651 FROM AN EXTREMELY THERMOPHILIC BACTERIUM THERMUS THERMOPHILUS HB8 1EG2 ; 1.75 ; CRYSTAL STRUCTURE OF RHODOBACTER SPHEROIDES (N6 ADENOSINE) METHYLTRANSFERASE (M.RSRI) 1HLQ ; 1.45 ; CRYSTAL STRUCTURE OF RHODOFERAX FERMENTANS HIGH POTENTIAL IRON-SULFUR PROTEIN REFINED TO 1.45 A 1KMT ; 1.30 ; CRYSTAL STRUCTURE OF RHOGDI GLU(154,155)ALA MUTANT 1QVY ; 1.60 ; CRYSTAL STRUCTURE OF RHOGDI K(199,200)R DOUBLE MUTANT 2BXW ; 2.40 ; CRYSTAL STRUCTURE OF RHOGDI LYS(135,138,141)TYR MUTANT 1T6Z ; 2.40 ; CRYSTAL STRUCTURE OF RIBOFLAVIN BOUND TM379 1NB9 ; 1.70 ; CRYSTAL STRUCTURE OF RIBOFLAVIN KINASE 1P4M ; 1.80 ; CRYSTAL STRUCTURE OF RIBOFLAVIN KINASE 1Q9S ; 2.42 ; CRYSTAL STRUCTURE OF RIBOFLAVIN KINASE WITH TERNARY PRODUCT COMPLEX 1I8D ; 2.00 ; CRYSTAL STRUCTURE OF RIBOFLAVIN SYNTHASE 1VM7 ; 2.15 ; CRYSTAL STRUCTURE OF RIBOKINASE (TM0960) FROM THERMOTOGA MARITIMA AT 2.15 A RESOLUTION 1WDY ; 1.80 ; CRYSTAL STRUCTURE OF RIBONUCLEASE 1JVU ; 1.78 ; CRYSTAL STRUCTURE OF RIBONUCLEASE A (COMPLEXED FORM) 1JVT ; 2.05 ; CRYSTAL STRUCTURE OF RIBONUCLEASE A (LIGAND-FREE FORM) 1JVV ; 2.20 ; CRYSTAL STRUCTURE OF RIBONUCLEASE A (RETRO-SOAKED FORM) 1EOW ; 2.00 ; CRYSTAL STRUCTURE OF RIBONUCLEASE A COMPLEXED WITH URIDYLYL(2',5')GUANOSINE (NON-PRODUCTIVE BINDING) 1EOS ; 2.00 ; CRYSTAL STRUCTURE OF RIBONUCLEASE A COMPLEXED WITH URIDYLYL(2',5')GUANOSINE (PRODUCTIVE BINDING) 1QHC ; 1.70 ; CRYSTAL STRUCTURE OF RIBONUCLEASE A IN COMPLEX WITH 5'- PHOSPHO-2'-DEOXYURIDINE-3'-PYROPHOSPHATE ADENOSINE-3'- PHOSPHATE 1AFK ; 1.70 ; CRYSTAL STRUCTURE OF RIBONUCLEASE A IN COMPLEX WITH 5'-DIPHOSPHOADENOSINE-3'-PHOSPHATE 2ETJ ; 1.74 ; CRYSTAL STRUCTURE OF RIBONUCLEASE HII (EC 3.1.26.4) (RNASE HII) (TM0915) FROM THERMOTOGA MARITIMA AT 1.74 A RESOLUTION 1O0W ; 2.00 ; CRYSTAL STRUCTURE OF RIBONUCLEASE III (TM1102) FROM THERMOTOGA MARITIMA AT 2.0 A RESOLUTION 1UCD ; 1.30 ; CRYSTAL STRUCTURE OF RIBONUCLEASE MC1 FROM BITTER GOURD SEEDS COMPLEXED WITH 5'-UMP 1UCG ; 1.65 ; CRYSTAL STRUCTURE OF RIBONUCLEASE MC1 N71T MUTANT 1RDS ; 1.80 ; CRYSTAL STRUCTURE OF RIBONUCLEASE MS (AS RIBONUCLEASE T1 HOMOLOGUE) COMPLEXED WITH A GUANYLYL-3',5'-CYTIDINE ANALOGUE 1X0T ; 1.60 ; CRYSTAL STRUCTURE OF RIBONUCLEASE P PROTEIN PH1601P FROM PYROCOCCUS HORIKOSHII OT3 1PY3 ; 1.80 ; CRYSTAL STRUCTURE OF RIBONUCLEASE SA2 1PYL ; 1.51 ; CRYSTAL STRUCTURE OF RIBONUCLEASE SA2 1IPA ; 2.40 ; CRYSTAL STRUCTURE OF RIBONUCLEIC ACID 2'-O RIBOSE METHYLTRANSFERASE 1QMH ; 2.10 ; CRYSTAL STRUCTURE OF RIBONUCLEIC ACID 3'-TERMINAL PHOSPHATE CYCLASE, AN UBIQUITOUS ENZYME WITH UNUSUAL TOPOLOGY 1QMI ; 2.80 ; CRYSTAL STRUCTURE OF RIBONUCLEIC ACID 3'-TERMINAL PHOSPHATE CYCLASE, AN UBIQUITOUS ENZYME WITH UNUSUAL TOPOLOGY 8OHM ; 2.30 ; CRYSTAL STRUCTURE OF RIBONUCLEIC ACID HELICASE FROM GENOTYPE 1B HEPATITIS C VIRUS: MECHANISM OF UNWINDING DUPLEX RIBONUCLEIC ACID 2A0P ; 1.95 ; CRYSTAL STRUCTURE OF RIBONUCLEIC ACID OLIGOMER CONTAINING 4'-THIORIBOSE 2CWO ; 3.30 ; CRYSTAL STRUCTURE OF RIBONUCLEIC ACID SILENCING SUPPRESSOR P21 FROM BEET YELLOWS VIRUS 1XR7 ; 2.30 ; CRYSTAL STRUCTURE OF RIBONUCLEIC ACID-DEPENDENT RIBONUCLEIC ACID POLYMERASE 3D FROM HUMAN RHINOVIRUS SEROTYPE 16 1XR6 ; 2.50 ; CRYSTAL STRUCTURE OF RIBONUCLEIC ACID-DEPENDENT RIBONUCLEIC ACID POLYMERASE 3D FROM HUMAN RHINOVIRUS SEROTYPE 1B 1S49 ; 3.00 ; CRYSTAL STRUCTURE OF RIBONUCLEIC ACID-DEPENDENT RIBONUCLEIC ACID POLYMERASE CONSTRUCT 1 (RESIDUES 71-679) FROM BOVINE VIRAL DIARRHEA VIRUS COMPLEXED WITH GTP 1S48 ; 3.00 ; CRYSTAL STRUCTURE OF RIBONUCLEIC ACID-DEPENDENT RIBONUCLEIC ACID POLYMERASE CONSTRUCT 1 (RESIDUES 71-679) FROM BVDV 1S4F ; 3.00 ; CRYSTAL STRUCTURE OF RIBONUCLEIC ACID-DEPENDENT RIBONUCLEIC ACID POLYMERASE CONSTRUCT 2 FROM BOVINE VIRAL DIARRHEA VIRUS (BVDV) 1O1X ; 1.90 ; CRYSTAL STRUCTURE OF RIBOSE-5-PHOSPHATE ISOMERASE RPIB (TM1080) FROM THERMOTOGA MARITIMA AT 1.90 A RESOLUTION 1CJS ; 2.30 ; CRYSTAL STRUCTURE OF RIBOSOMAL PROTEIN L1 FROM METHANOCOCCUS JANNASCHII 1DD3 ; 2.00 ; CRYSTAL STRUCTURE OF RIBOSOMAL PROTEIN L12 FROM THERMOTOGA MARITIMA 1DD4 ; 2.40 ; CRYSTAL STRUCTURE OF RIBOSOMAL PROTEIN L12 FROM THERMOTOGA MARITIMA 1J3A ; 1.60 ; CRYSTAL STRUCTURE OF RIBOSOMAL PROTEIN L13 FROM PYROCOCCUS HORIKOSHII 1V8Q ; 2.80 ; CRYSTAL STRUCTURE OF RIBOSOMAL PROTEIN L27 FROM THERMUS THERMOPHILUS HB8 1BXY ; 1.90 ; CRYSTAL STRUCTURE OF RIBOSOMAL PROTEIN L30 FROM THERMUS THERMOPHILUS AT 1.9 A RESOLUTION: CONFORMATIONAL FLEXIBILITY OF THE MOLECULE. 1DMG ; 1.70 ; CRYSTAL STRUCTURE OF RIBOSOMAL PROTEIN L4 1VI5 ; 2.65 ; CRYSTAL STRUCTURE OF RIBOSOMAL PROTEIN S2P 1VI6 ; 1.95 ; CRYSTAL STRUCTURE OF RIBOSOMAL PROTEIN S2P 1FEU ; 2.30 ; CRYSTAL STRUCTURE OF RIBOSOMAL PROTEIN TL5, ONE OF THE CTC FAMILY PROTEINS, COMPLEXED WITH A FRAGMENT OF 5S RRNA. 1WQF ; 2.65 ; CRYSTAL STRUCTURE OF RIBOSOME RECYCLING FACTOR FROM MYCOBACTERIUM TUBERCULOSIS 1WQG ; 2.15 ; CRYSTAL STRUCTURE OF RIBOSOME RECYCLING FACTOR FROM MYCOBACTERIUM TUBERCULOSIS 1WQH ; 2.90 ; CRYSTAL STRUCTURE OF RIBOSOME RECYCLING FACTOR FROM MYCOBACTERIUM TUBERCULOSIS 1IS1 ; 2.20 ; CRYSTAL STRUCTURE OF RIBOSOME RECYCLING FACTOR FROM VIBRIO PARAHAEMOLYTICUS 1JBS ; 1.97 ; CRYSTAL STRUCTURE OF RIBOTOXIN RESTRICTOCIN AND A 29-MER SRD RIBONUCLEIC ACID ANALOG 1JBT ; 2.70 ; CRYSTAL STRUCTURE OF RIBOTOXIN RESTRICTOCIN COMPLEXED WITH A 29-MER SARCIN/RICIN DOMAIN RIBONUCLEIC ACID ANALOG 1UAS ; 1.50 ; CRYSTAL STRUCTURE OF RICE ALPHA-GALACTOSIDASE 1YHU ; 3.15 ; CRYSTAL STRUCTURE OF RIFTIA PACHYPTILA C1 HEMOGLOBIN REVEALS NOVEL ASSEMBLY OF 24 SUBUNITS. 1P91 ; 2.80 ; CRYSTAL STRUCTURE OF RLMA(I) ENZYME: 23S RRNA N1-G745 METHYLTRANSFERASE (NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET ER19) 1I4S ; 2.15 ; CRYSTAL STRUCTURE OF RNASE III ENDONUCLEASE DOMAIN FROM AQUIFEX AEOLICUS AT 2.15 ANGSTROM RESOLUTION 1YYW ; 2.80 ; CRYSTAL STRUCTURE OF RNASE III FROM AQUIFEX AEOLICUS COMPLEXED WITH DOUBLE STRANDED RIBONUCLEIC ACID AT 2.8-ANGSTROM RESOLUTION 1YYK ; 2.50 ; CRYSTAL STRUCTURE OF RNASE III FROM AQUIFEX AEOLICUS COMPLEXED WITH DOUBLE-STRANDED RIBONUCLEIC ACID AT 2.5-ANGSTROM RESOLUTION 1YYO ; 2.90 ; CRYSTAL STRUCTURE OF RNASE III MUTANT E110K FROM AQUIFEX AEOLICUS COMPLEXED WITH DOUBLE-STRANDED RIBONUCLEIC ACID AT 2.9- ANGSTROM RESOLUTION 1RC7 ; 2.15 ; CRYSTAL STRUCTURE OF RNASE III MUTANT E110K FROM AQUIFEX AEOLICUS COMPLEXED WITH DS-RIBONUCLEIC ACID AT 2.15 ANGSTROM RESOLUTION 1YZ9 ; 2.10 ; CRYSTAL STRUCTURE OF RNASE III MUTANT E110Q FROM AQUIFEX AEOLICUS COMPLEXED WITH DOUBLE STRANDED RIBONUCLEIC ACID AT 2.1- ANGSTROM RESOLUTION 1DIX ; 1.65 ; CRYSTAL STRUCTURE OF RNASE LE 1VD1 ; 1.80 ; CRYSTAL STRUCTURE OF RNASE NT IN COMPLEX WITH 5'-AMP 1I8V ; 1.25 ; CRYSTAL STRUCTURE OF RNASE SA Y80F MUTANT 1I70 ; 1.70 ; CRYSTAL STRUCTURE OF RNASE SA Y86F MUTANT 1MGW ; 2.00 ; CRYSTAL STRUCTURE OF RNASE SA3, CYTOTOXIC MICROBIAL RIBONUCLEASE 1MGR ; 1.70 ; CRYSTAL STRUCTURE OF RNASE SA3,CYTOTOXIC MICROBIAL RIBONUCLEASE 1Y44 ; 2.10 ; CRYSTAL STRUCTURE OF RNASE Z 1M7B ; 2.00 ; CRYSTAL STRUCTURE OF RND3/RHOE: FUNCTIONAL IMPLICATIONS 1T4O ; 2.50 ; CRYSTAL STRUCTURE OF RNT1P DSRBD 2ESM ; 3.20 ; CRYSTAL STRUCTURE OF ROCK 1 BOUND TO FASUDIL 2ETK ; 2.96 ; CRYSTAL STRUCTURE OF ROCK 1 BOUND TO HYDROXYFASUDIL 2ETO ; 3.30 ; CRYSTAL STRUCTURE OF ROCK I BOUND TO H-1152P A DI- METHYLATED VARIANT OF FASUDIL 2ETR ; 2.60 ; CRYSTAL STRUCTURE OF ROCK I BOUND TO Y-27632 1NE4 ; 2.40 ; CRYSTAL STRUCTURE OF RP-CAMP BINDING R1A SUBUNIT OF CAMP- DEPENDENT PROTEIN KINASE 1WOM ; 2.50 ; CRYSTAL STRUCTURE OF RSBQ 1WPR ; 2.60 ; CRYSTAL STRUCTURE OF RSBQ INHIBITED BY PMSF 1C0M ; 2.53 ; CRYSTAL STRUCTURE OF RSV TWO-DOMAIN INTEGRASE 1C1A ; 3.10 ; CRYSTAL STRUCTURE OF RSV TWO-DOMAIN INTEGRASE 1JYB ; 2.20 ; CRYSTAL STRUCTURE OF RUBRERYTHRIN 1UWV ; 1.95 ; CRYSTAL STRUCTURE OF RUMA, THE IRON-SULFUR CLUSTER CONTAINING E. COLI 23S RIBOSOMAL RIBONUCLEIC ACID 5-METHYLURIDINE METHYLTRANSFERASE 1HJB ; 3.00 ; CRYSTAL STRUCTURE OF RUNX-1/AML1/CBFALPHA RUNT DOMAIN AND C/EBPBETA BZIP HOMODIMER BOUND TO A DEOXYRIBONUCLEIC ACID FRAGMENT FROM THE CSF-1R PROMOTER 1HJC ; 2.65 ; CRYSTAL STRUCTURE OF RUNX-1/AML1/CBFALPHA RUNT DOMAIN BOUND TO A DEOXYRIBONUCLEIC ACID FRAGMENT FROM THE CSF-1R PROMOTER 1IO4 ; 3.00 ; CRYSTAL STRUCTURE OF RUNX-1/AML1/CBFALPHA RUNT DOMAIN- CBFBETA CORE DOMAIN HETERODIMER AND C/EBPBETA BZIP HOMODIMER BOUND TO A DEOXYRIBONUCLEIC ACID FRAGMENT FROM THE CSF-1R PROMOTER 1OYF ; 2.45 ; CRYSTAL STRUCTURE OF RUSSELLES VIPER (DABOIA RUSSELLII PULCHELLA) PHOSPHOLIPASE A2 IN A COMPLEX WITH VENOM 6- METHYL HEPTANOL 1TK4 ; 1.10 ; CRYSTAL STRUCTURE OF RUSSELLS VIPER PHOSPHOLIPASE A2 IN COMPLEX WITH A SPECIFICALLY DESIGNED TETRAPEPTIDE ALA-ILE- ARG-SER AT 1.1 A RESOLUTION 1OZP ; 1.70 ; CRYSTAL STRUCTURE OF RV0819 FROM MYCOBACTERIUM TUBERCULOSIS MSHD-MYCOTHIOL SYNTHASE ACETYL-COENZYME A COMPLEX. 1P0H ; 1.60 ; CRYSTAL STRUCTURE OF RV0819 FROM MYCOBACTERIUM TUBERCULOSIS MSHD-MYCOTHIOL SYNTHASE COENZYME A COMPLEX 1Y8T ; 2.00 ; CRYSTAL STRUCTURE OF RV0983 FROM MYCOBACTERIUM TUBERCULOSIS- PROTEOLYTICALLY ACTIVE FORM 1W9A ; 1.80 ; CRYSTAL STRUCTURE OF RV1155 FROM MYCOBACTERIUM TUBERCULOSIS 1YLK ; 2.00 ; CRYSTAL STRUCTURE OF RV1284 FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH THIOCYANATE 1YK3 ; 2.20 ; CRYSTAL STRUCTURE OF RV1347C FROM MYCOBACTERIUM TUBERCULOSIS 1SD5 ; 1.68 ; CRYSTAL STRUCTURE OF RV1626 1S8N ; 1.48 ; CRYSTAL STRUCTURE OF RV1626 FROM MYCOBACTERIUM TUBERCULOSIS 1NFF ; 1.80 ; CRYSTAL STRUCTURE OF RV2002 GENE PRODUCT FROM MYCOBACTERIUM TUBERCULOSIS 1OQS ; 1.90 ; CRYSTAL STRUCTURE OF RV4/RV7 COMPLEX 1D4G ; 3.00 ; CRYSTAL STRUCTURE OF S-ADENOSYLHOMOCYSTEINE HYDROLASE (ADOHCYASE) COMPLEXED WITH A POTENT INHIBITOR D-ERITADENINE 1MHM ; 2.30 ; CRYSTAL STRUCTURE OF S-ADENOSYLMETHIONINE DECARBOXYLASE FROM POTATO 1VR7 ; 1.20 ; CRYSTAL STRUCTURE OF S-ADENOSYLMETHIONINE DECARBOXYLASE PROENZYME (TM0655) FROM THERMOTOGA MARITIMA AT 1.2 A RESOLUTION 1VKY ; 2.00 ; CRYSTAL STRUCTURE OF S-ADENOSYLMETHIONINE TRNA RIBOSYLTRANSFERASE (TM0574) FROM THERMOTOGA MARITIMA AT 2.00 A RESOLUTION 1FLJ ; 1.80 ; CRYSTAL STRUCTURE OF S-GLUTATHIOLATED CARBONIC ANHYDRASE III 1BUW ; 1.90 ; CRYSTAL STRUCTURE OF S-NITROSO-NITROSYL HUMAN HEMOGLOBIN A 1UHG ; 1.90 ; CRYSTAL STRUCTURE OF S-OVALBUMIN AT 1.9 ANGSTROM RESOLUTION 1ZOW ; 2.00 ; CRYSTAL STRUCTURE OF S. AUREUS FABH, BETA-KETOACYL CARRIER PROTEIN SYNTHASE III 1RTR ; 2.50 ; CRYSTAL STRUCTURE OF S. AUREUS FARNESYL PYROPHOSPHATE SYNTHASE 1QXY ; 1.04 ; CRYSTAL STRUCTURE OF S. AUREUS METHIONINE AMINOPEPTIDASE IN COMPLEX WITH A KETOHETEROCYCLE 618 1QXZ ; 1.68 ; CRYSTAL STRUCTURE OF S. AUREUS METHIONINE AMINOPEPTIDASE IN COMPLEX WITH A KETOHETEROCYCLE INHIBITOR 119 1HSK ; 2.30 ; CRYSTAL STRUCTURE OF S. AUREUS MURB 1LMH ; 1.90 ; CRYSTAL STRUCTURE OF S. AUREUS PEPTIDE DEFORMYLASE 1JII ; 3.20 ; CRYSTAL STRUCTURE OF S. AUREUS TYRRS IN COMPLEX WITH SB- 219383 1JIJ ; 3.20 ; CRYSTAL STRUCTURE OF S. AUREUS TYRRS IN COMPLEX WITH SB- 239629 1JIK ; 2.80 ; CRYSTAL STRUCTURE OF S. AUREUS TYRRS IN COMPLEX WITH SB- 243545 1JIL ; 2.20 ; CRYSTAL STRUCTURE OF S. AUREUS TYRRS IN COMPLEX WITH SB284485 1RD6 ; 2.60 ; CRYSTAL STRUCTURE OF S. MARCESCENS CHITINASE A MUTANT W167A 1X6L ; 1.90 ; CRYSTAL STRUCTURE OF S. MARCESCENS CHITINASE A MUTANT W167A 1X6N ; 2.00 ; CRYSTAL STRUCTURE OF S. MARCESCENS CHITINASE A MUTANT W167A IN COMPLEX WITH ALLOSAMIDIN 1W1P ; 2.10 ; CRYSTAL STRUCTURE OF S. MARCESCENS CHITINASE B IN COMPLEX WITH THE CYCLIC DIPEPTIDE INHIBITOR CYCLO-(GLY-L-PRO) AT 2.1 A RESOLUTION 1W1T ; 1.90 ; CRYSTAL STRUCTURE OF S. MARCESCENS CHITINASE B IN COMPLEX WITH THE CYCLIC DIPEPTIDE INHIBITOR CYCLO-(HIS-L-PRO) AT 1.9 A RESOLUTION 1W1V ; 1.85 ; CRYSTAL STRUCTURE OF S. MARCESCENS CHITINASE B IN COMPLEX WITH THE CYCLIC DIPEPTIDE INHIBITOR CYCLO-(L-ARG-L-PRO) AT 1.85 A RESOLUTION 1W1Y ; 1.85 ; CRYSTAL STRUCTURE OF S. MARCESCENS CHITINASE B IN COMPLEX WITH THE CYCLIC DIPEPTIDE INHIBITOR CYCLO-(L-TYR-L-PRO) AT 1.85 A RESOLUTION 1W3Y ; 1.65 ; CRYSTAL STRUCTURE OF S. PNEUMONIAE HYALURONATE LYASE IN COMPLEX WITH PALMITOYL-VITAMIN C 1LQW ; 1.87 ; CRYSTAL STRUCTURE OF S.AUREUS PEPTIDE DEFORMYLASE 1G62 ; 2.50 ; CRYSTAL STRUCTURE OF S.CEREVISIAE EIF6 1G95 ; 2.33 ; CRYSTAL STRUCTURE OF S.PNEUMONIAE GLMU, APO FORM 1HM0 ; 2.30 ; CRYSTAL STRUCTURE OF S.PNEUMONIAE N-ACETYLGLUCOSAMINE 1- PHOSPHATE URIDYLTRANSFERASE, GLMU 1HM8 ; 2.50 ; CRYSTAL STRUCTURE OF S.PNEUMONIAE N-ACETYLGLUCOSAMINE-1- PHOSPHATE URIDYLTRANSFERASE, GLMU, BOUND TO ACETYL COENZYME A 1HM9 ; 1.75 ; CRYSTAL STRUCTURE OF S.PNEUMONIAE N-ACETYLGLUCOSAMINE-1- PHOSPHATE URIDYLTRANSFERASE, GLMU, BOUND TO ACETYL COENZYME A AND UDP-N-ACETYLGLUCOSAMINE 2A6T ; 2.50 ; CRYSTAL STRUCTURE OF S.POMBE MRNA DECAPPING ENZYME DCP2P 1V71 ; 1.70 ; CRYSTAL STRUCTURE OF S.POMBE SERINE RACEMASE 1WTC ; 1.90 ; CRYSTAL STRUCTURE OF S.PONBE SERINE RACEMASE COMPLEX WITH AMPPCP 2BJH ; 2.54 ; CRYSTAL STRUCTURE OF S133A ANFAEA-FERULIC ACID COMPLEX 1K7W ; 1.96 ; CRYSTAL STRUCTURE OF S283A DUCK DELTA 2 CRYSTALLIN MUTANT 2AJ4 ; 2.40 ; CRYSTAL STRUCTURE OF SACCHAROMYCES CEREVISIAE GALACTOKINASE IN COMPLEX WITH GALACTOSE AND MG:AMPPNP 1I12 ; 1.30 ; CRYSTAL STRUCTURE OF SACCHAROMYCES CEREVISIAE GNA1 COMPLEXED WITH ACCOA 1IIC ; 2.20 ; CRYSTAL STRUCTURE OF SACCHAROMYCES CEREVISIAE N- MYRISTOYLTRANSFERASE WITH BOUND MYRISTOYLCOA 1IID ; 2.50 ; CRYSTAL STRUCTURE OF SACCHAROMYCES CEREVISIAE N- MYRISTOYLTRANSFERASE WITH BOUND S-(2-OXO)PENTADECYLCOA AND THE OCTAPEPTIDE GLYASKLA 1F89 ; 2.40 ; CRYSTAL STRUCTURE OF SACCHAROMYCES CEREVISIAE NIT3, A MEMBER OF BRANCH 10 OF THE NITRILASE SUPERFAMILY 1FZY ; 1.90 ; CRYSTAL STRUCTURE OF SACCHAROMYCES CEREVISIAE UBIQUITIN CONJUGATING ENZYME 1 1YGA ; 2.00 ; CRYSTAL STRUCTURE OF SACCHAROMYCES CEREVISIAE YN9A PROTEIN, NEW YORK STRUCTURAL GENOMICS CONSORTIUM 1M6E ; 3.00 ; CRYSTAL STRUCTURE OF SALICYLIC ACID CARBOXYL METHYLTRANSFERASE (SAMT) 1XKL ; 2.00 ; CRYSTAL STRUCTURE OF SALICYLIC ACID-BINDING PROTEIN 2 (SABP2) FROM NICOTIANA TABACUM, NESG TARGET AR2241 1TJY ; 1.30 ; CRYSTAL STRUCTURE OF SALMONELLA TYPHIMURIUM AI-2 RECEPTOR LSRB IN COMPLEX WITH R-THMF 1EQW ; 2.30 ; CRYSTAL STRUCTURE OF SALMONELLA TYPHIMURIUM CU,ZN SUPEROXIDE DISMUTASE 1LH0 ; 2.00 ; CRYSTAL STRUCTURE OF SALMONELLA TYPHIMURIUM OMP SYNTHASE IN COMPLEX WITH MGPRPP AND OROTATE 1VLM ; 2.20 ; CRYSTAL STRUCTURE OF SAM-DEPENDENT METHYLTRANSFERASE, POSSIBLE HISTAMINE N-METHYLTRANSFERASE (TM1293) FROM THERMOTOGA MARITIMA AT 2.20 A RESOLUTION 1O54 ; 1.65 ; CRYSTAL STRUCTURE OF SAM-DEPENDENT O-METHYLTRANSFERASE (TM0748) FROM THERMOTOGA MARITIMA AT 1.65 A RESOLUTION 1MJT ; 2.40 ; CRYSTAL STRUCTURE OF SANOS, A BACTERIAL NITRIC OXIDE SYNTHASE OXYGENASE PROTEIN, IN COMPLEX WITH NAD+ AND SEITU 1M27 ; 2.50 ; CRYSTAL STRUCTURE OF SAP/FYNSH3/SLAM TERNARY COMPLEX 1JZL ; 1.50 ; CRYSTAL STRUCTURE OF SAPHARCA INAEQUIVALVIS HBI, I114M MUTANT LIGATED TO CARBON MONOXIDE. 1F6B ; 1.70 ; CRYSTAL STRUCTURE OF SAR1-GDP COMPLEX 1Z1J ; 2.80 ; CRYSTAL STRUCTURE OF SARS 3CLPRO C145A MUTANT 1UJ1 ; 1.90 ; CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEINASE (3CLPRO) 1UK3 ; 2.40 ; CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEINASE (3CLPRO) AT PH7.6 1UK2 ; 2.20 ; CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEINASE (3CLPRO) AT PH8.0 1UK4 ; 2.50 ; CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEINASE (3CLPRO) COMPLEXED WITH AN INHIBITOR 2BX4 ; 2.79 ; CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEINASE (P21212) 2BX3 ; 2.00 ; CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEINASE (P43212) 1QZ8 ; 2.70 ; CRYSTAL STRUCTURE OF SARS CORONAVIRUS NSP9 1P4X ; 2.20 ; CRYSTAL STRUCTURE OF SARS PROTEIN FROM STAPHYLOCOCCUS AUREUS 2D2D ; 2.70 ; CRYSTAL STRUCTURE OF SARS-COV MPRO IN COMPLEX WITH AN INHIBITOR I2 1WOF ; 2.00 ; CRYSTAL STRUCTURE OF SARS-COV MPRO IN COMPLEX WITH AN INHIBITOR N1 2AHM ; 2.40 ; CRYSTAL STRUCTURE OF SARS-COV SUPER COMPLEX OF NON- STRUCTURAL PROTEINS: THE HEXADECAMER 2AMQ ; 2.30 ; CRYSTAL STRUCTURE OF SARS_COV MPRO IN COMPLEX WITH AN INHIBITOR N3 2AMD ; 1.85 ; CRYSTAL STRUCTURE OF SARS_COV MPRO IN COMPLEX WITH AN INHIBITOR N9 2AK4 ; 2.50 ; CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH HLA-B3508- 13MER PEPTIDE 1QVI ; 2.54 ; CRYSTAL STRUCTURE OF SCALLOP MYOSIN S1 IN THE PRE-POWER STROKE STATE TO 2.6 ANGSTROM RESOLUTION: FLEXIBILITY AND FUNCTION IN THE HEAD 1JZK ; 2.20 ; CRYSTAL STRUCTURE OF SCAPHARCA INAEQUIVALVIS HBI, I114F MUTANT (DEOXY) 1JWN ; 2.10 ; CRYSTAL STRUCTURE OF SCAPHARCA INAEQUIVALVIS HBI, I114F MUTANT LIGATED TO CARBON MONOXIDE. 1JZM ; 1.90 ; CRYSTAL STRUCTURE OF SCAPHARCA INAEQUIVALVIS HBI, I114M MUTANT IN THE ABSENCE OF LIGAND. 1P4I ; 2.80 ; CRYSTAL STRUCTURE OF SCFV AGAINST PEPTIDE GCN4 1RMR ; 2.50 ; CRYSTAL STRUCTURE OF SCHISTATIN, A DISINTEGRIN HOMODIMER FROM SAW-SCALED VIPER (ECHIS CARINATUS) AT 2.5 A RESOLUTION 1N05 ; 2.10 ; CRYSTAL STRUCTURE OF SCHIZOSACCHAROMYCES POMBE RIBOFLAVIN KINASE REVEALS A NOVEL ATP AND RIBOFLAVIN BINDING FOLD 1N06 ; 2.00 ; CRYSTAL STRUCTURE OF SCHIZOSACCHAROMYCES POMBE RIBOFLAVIN KINASE REVEALS A NOVEL ATP AND RIBOFLAVIN BINDING FOLD 1N07 ; 2.45 ; CRYSTAL STRUCTURE OF SCHIZOSACCHAROMYCES POMBE RIBOFLAVIN KINASE REVEALS A NOVEL ATP AND RIBOFLAVIN BINDING FOLD 1N08 ; 1.60 ; CRYSTAL STRUCTURE OF SCHIZOSACCHAROMYCES POMBE RIBOFLAVIN KINASE REVEALS A NOVEL ATP AND RIBOFLAVIN BINDING FOLD 1NEX ; 2.70 ; CRYSTAL STRUCTURE OF SCSKP1-SCCDC4-CPD PEPTIDE COMPLEX 1IDP ; 1.45 ; CRYSTAL STRUCTURE OF SCYTALONE DEHYDRATASE F162A MUTANT IN THE UNLIGATED STATE 1JC4 ; 2.00 ; CRYSTAL STRUCTURE OF SE-MET METHYLMALONYL-COA EPIMERASE 1T2O ; 2.30 ; CRYSTAL STRUCTURE OF SE-SRTA, C184-ALA 1SN2 ; 1.75 ; CRYSTAL STRUCTURE OF SEA BREAM TRANSTHYRETIN AT 1.90A RESOLUTION 1SN0 ; 1.90 ; CRYSTAL STRUCTURE OF SEA BREAM TRANSTHYRETIN IN COMPLEX WITH THYROXINE AT 1.9A RESOLUTION 1SN5 ; 1.90 ; CRYSTAL STRUCTURE OF SEA BREAM TRANSTHYRETIN IN COMPLEX WITH TRIIODOTHYRONINE AT 1.90A RESOLUTION 2A2F ; 2.50 ; CRYSTAL STRUCTURE OF SEC15 C-TERMINAL DOMAIN 1G16 ; 1.80 ; CRYSTAL STRUCTURE OF SEC4-GDP 1G17 ; 2.00 ; CRYSTAL STRUCTURE OF SEC4-GUANOSINE-5'-(BETA,GAMMA)- IMIDOTRIPHOSPHATE 1TF5 ; 2.18 ; CRYSTAL STRUCTURE OF SECA IN AN OPEN CONFORMATION FROM BACILLUS SUBTILIS 1TF2 ; 2.90 ; CRYSTAL STRUCTURE OF SECA:ADP IN AN OPEN CONFORMATION FROM BACILLUS SUBTILIS 1OZB ; 2.80 ; CRYSTAL STRUCTURE OF SECB COMPLEXED WITH SECA C-TERMINUS 1QYN ; 2.35 ; CRYSTAL STRUCTURE OF SECB FROM ESCHERICHIA COLI 1XJU ; 1.07 ; CRYSTAL STRUCTURE OF SECRETED INACTIVE FORM OF P1 PHAGE ENDOLYSIN LYZ 1YLS ; 3.00 ; CRYSTAL STRUCTURE OF SELENIUM-MODIFIED DIELS-ALDER RIBOZYME COMPLEXED WITH THE PRODUCT OF THE REACTION BETWEEN N- PENTYLMALEIMIDE AND COVALENTLY ATTACHED 9- HYDROXYMETHYLANTHRACENE 1JF9 ; 2.00 ; CRYSTAL STRUCTURE OF SELENOCYSTEINE LYASE 1IX2 ; 1.55 ; CRYSTAL STRUCTURE OF SELENOMETHIONINE PCOC, A COPPER RESISTANCE PROTEIN FROM ESCHERICHIA COLI 1Q0H ; 2.20 ; CRYSTAL STRUCTURE OF SELENOMETHIONINE-LABELLED DXR IN COMPLEX WITH FOSMIDOMYCIN 1U24 ; 2.00 ; CRYSTAL STRUCTURE OF SELENOMONAS RUMINANTIUM PHYTASE 1U26 ; 2.50 ; CRYSTAL STRUCTURE OF SELENOMONAS RUMINANTIUM PHYTASE COMPLEXED WITH PERSULFATED PHYTATE 1U25 ; 2.50 ; CRYSTAL STRUCTURE OF SELENOMONAS RUMINANTIUM PHYTASE COMPLEXED WITH PERSULFATED PHYTATE IN THE C2221 CRYSTAL FORM 1JGJ ; 2.40 ; CRYSTAL STRUCTURE OF SENSORY RHODOPSIN II AT 2.4 ANGSTROMS: INSIGHTS INTO COLOR TUNING AND TRANSDUCER INTERACTION 1II4 ; 2.70 ; CRYSTAL STRUCTURE OF SER252TRP APERT MUTANT FGF RECEPTOR 2 (FGFR2) IN COMPLEX WITH FGF2 1T3D ; 2.20 ; CRYSTAL STRUCTURE OF SERINE ACETYLTRANSFERASE FROM E.COLI AT 2.2A 1KL1 ; 1.93 ; CRYSTAL STRUCTURE OF SERINE HYDROXYMETHYLTRANSFERASE COMPLEXED WITH GLYCINE 1KL2 ; 2.70 ; CRYSTAL STRUCTURE OF SERINE HYDROXYMETHYLTRANSFERASE COMPLEXED WITH GLYCINE AND 5-FORMYL TETRAHYDROFOLATE 1KKP ; 1.93 ; CRYSTAL STRUCTURE OF SERINE HYDROXYMETHYLTRANSFERASE COMPLEXED WITH SERINE 1KKJ ; 1.93 ; CRYSTAL STRUCTURE OF SERINE HYDROXYMETHYLTRANSFERASE FROM B.STEAROTHERMOPHILUS 1V5I ; 1.50 ; CRYSTAL STRUCTURE OF SERINE PROTEASE INHIBITOR POIA1 IN COMPLEX WITH SUBTILISIN BPN' 1M4V ; 1.90 ; CRYSTAL STRUCTURE OF SET3, A SUPERANTIGEN-LIKE PROTEIN FROM STAPHYLOCOCCUS AUREUS 1DS2 ; 1.70 ; CRYSTAL STRUCTURE OF SGPB:OMTKY3-COO-LEU18I 1O4G ; 1.55 ; CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH DPI59. 1O4L ; 1.65 ; CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH FRAGMENT2. 1O4J ; 1.70 ; CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH ISO24. 1O4M ; 1.60 ; CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH MALONICACID. 1O4N ; 1.60 ; CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH OXALIC ACID. 1O4I ; 1.75 ; CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH PAS219. 1O4K ; 1.57 ; CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH PASBN. 1O4O ; 1.70 ; CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH PHENYLPHOSPHATE. 1O4C ; 1.80 ; CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH PHOSPHATE. 1O4D ; 1.85 ; CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU78262. 1O4E ; 2.00 ; CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU78299. 1O41 ; 1.70 ; CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU78300. 1O4R ; 1.50 ; CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU78783. 1O4P ; 1.90 ; CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU78791. 1O4H ; 2.25 ; CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU79072. 1O4F ; 2.00 ; CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU79073. 1O4Q ; 1.70 ; CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU79256. 1O42 ; 1.70 ; CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU81843. 1O43 ; 1.50 ; CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU82129. 1O4A ; 1.50 ; CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU82197. 1O47 ; 1.80 ; CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU82209. 1O4B ; 1.85 ; CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU83876. 1O45 ; 1.80 ; CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU84687. 1O44 ; 1.70 ; CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU85052 1O48 ; 1.55 ; CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU85053. 1O49 ; 1.70 ; CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU85493. 1O46 ; 2.00 ; CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU90395. 1WXD ; 2.10 ; CRYSTAL STRUCTURE OF SHIKIMATE 5-DEHYDROGENASE (AROE) FROM THERMUS THERMOPHILUS HB8 2CY0 ; 1.90 ; CRYSTAL STRUCTURE OF SHIKIMATE 5-DEHYDROGENASE (AROE) FROM THERMUS THERMOPHILUS HB8 IN COMPLEX WITH NADP 1NVT ; 2.35 ; CRYSTAL STRUCTURE OF SHIKIMATE DEHYDROGENASE (AROE OR MJ1084) IN COMPLEX WITH NADP+ 1P74 ; 2.40 ; CRYSTAL STRUCTURE OF SHIKIMATE DEHYDROGENASE (AROE) FROM HAEMOPHILUS INFLUENZAE 1P77 ; 1.95 ; CRYSTAL STRUCTURE OF SHIKIMATE DEHYDROGENASE (AROE) FROM HAEMOPHILUS INFLUENZAE 1VIA ; 1.57 ; CRYSTAL STRUCTURE OF SHIKIMATE KINASE 1L4U ; 1.80 ; CRYSTAL STRUCTURE OF SHIKIMATE KINASE FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH MGADP AND PT(II) AT 1.8 ANGSTROM RESOLUTION 1WE2 ; 2.30 ; CRYSTAL STRUCTURE OF SHIKIMATE KINASE FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH MGADP AND SHIKIMIC ACID 1L4Y ; 2.00 ; CRYSTAL STRUCTURE OF SHIKIMATE KINASE FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH MGADP AT 2.0 ANGSTROM RESOLUTION 1VI2 ; 2.10 ; CRYSTAL STRUCTURE OF SHIKIMATE-5-DEHYDROGENASE WITH NAD 1XKQ ; 2.10 ; CRYSTAL STRUCTURE OF SHORT-CHAIN DEHYDROGENASE/REDUCTASE OF UNKNOWN FUNCTION FROM CAENORHABDITIS ELEGANS WITH COFACTOR 1K7H ; 1.92 ; CRYSTAL STRUCTURE OF SHRIMP ALKALINE PHOSPHATASE 1SHQ ; 2.00 ; CRYSTAL STRUCTURE OF SHRIMP ALKALINE PHOSPHATASE WITH MAGNESIUM IN M3 1SHN ; 2.15 ; CRYSTAL STRUCTURE OF SHRIMP ALKALINE PHOSPHATASE WITH PHOSPHATE BOUND 2A25 ; 2.20 ; CRYSTAL STRUCTURE OF SIAH1 SBD BOUND TO THE PEPTIDE EKPAAVVAPITTG FROM SIP 1XUU ; 1.90 ; CRYSTAL STRUCTURE OF SIALIC ACID SYNTHASE (NEUB) IN COMPLEX WITH MN2+ AND MALATE FROM NEISSERIA MENINGITIDIS 1X89 ; 2.10 ; CRYSTAL STRUCTURE OF SIDEROCALIN (NGAL, LIPOCALIN 2) COMPLEXED WITH CARBOXYMYCOBACTIN S 1X8U ; 2.20 ; CRYSTAL STRUCTURE OF SIDEROCALIN (NGAL, LIPOCALIN 2) COMPLEXED WITH CARBOXYMYCOBACTIN T 1X71 ; 2.10 ; CRYSTAL STRUCTURE OF SIDEROCALIN (NGAL, LIPOCALIN 2) COMPLEXED WITH TRENCAM-3,2-HOPO, A CEPABACTIN ANALOGUE 1NY6 ; 3.10 ; CRYSTAL STRUCTURE OF SIGM54 ACTIVATOR (AAA+ ATPASE) IN THE ACTIVE STATE 1NY5 ; 2.40 ; CRYSTAL STRUCTURE OF SIGM54 ACTIVATOR (AAA+ ATPASE) IN THE INACTIVE STATE 1SYT ; 2.60 ; CRYSTAL STRUCTURE OF SIGNALLING PROTEIN FROM GOAT SPG-40 IN THE PRESENSE OF N,N',N''-TRIACETYL-CHITOTRIOSE AT 2.6A RESOLUTION 1SR0 ; 3.05 ; CRYSTAL STRUCTURE OF SIGNALLING PROTEIN FROM SHEEP(SPS-40) AT 3.0A RESOLUTION USING CRYSTAL GROWN IN THE PRESENCE OF POLYSACCHARIDES 1ED1 ; 2.10 ; CRYSTAL STRUCTURE OF SIMIAN IMMUNODEFICIENCY VIRUS MATRIX ANTIGEN (SIV MA) AT 100K. 1ECW ; 2.20 ; CRYSTAL STRUCTURE OF SIMIAN IMMUNODEFICIENCY VIRUS MATRIX ANTIGEN (SIV MA) AT 293K. 1IV7 ; 1.82 ; CRYSTAL STRUCTURE OF SINGLE CHAIN MONELLIN 1IV9 ; 1.90 ; CRYSTAL STRUCTURE OF SINGLE CHAIN MONELLIN 1Z9F ; 2.30 ; CRYSTAL STRUCTURE OF SINGLE STRANDED DEOXYRIBONUCLEIC ACID-BINDING PROTEIN (TM0604) FROM THERMOTOGA MARITIMA AT 2.60 A RESOLUTION 1DDG ; 2.01 ; CRYSTAL STRUCTURE OF SIR-FP60 1DDI ; 2.51 ; CRYSTAL STRUCTURE OF SIR-FP60 1YTZ ; 3.00 ; CRYSTAL STRUCTURE OF SKELETAL MUSCLE TROPONIN IN THE CA2+- ACTIVATED STATE 1YV0 ; 7.00 ; CRYSTAL STRUCTURE OF SKELETAL MUSCLE TROPONIN IN THE CA2+- FREE STATE 1U2M ; 2.30 ; CRYSTAL STRUCTURE OF SKP 2AST ; 2.30 ; CRYSTAL STRUCTURE OF SKP1-SKP2-CKS1 IN COMPLEX WITH A P27 PEPTIDE 1MQS ; 3.00 ; CRYSTAL STRUCTURE OF SLY1P IN COMPLEX WITH AN N-TERMINAL PEPTIDE OF SED5P 1G73 ; 2.00 ; CRYSTAL STRUCTURE OF SMAC BOUND TO XIAP-BIR3 DOMAIN 1FEW ; 2.20 ; CRYSTAL STRUCTURE OF SMAC/DIABLO 1DEV ; 2.20 ; CRYSTAL STRUCTURE OF SMAD2 MH2 DOMAIN BOUND TO THE SMAD- BINDING DOMAIN OF SARA 1OZJ ; 2.40 ; CRYSTAL STRUCTURE OF SMAD3-MH1 BOUND TO DEOXYRIBONUCLEIC ACID AT 2.4 A RESOLUTION 1ZWX ; 1.90 ; CRYSTAL STRUCTURE OF SMCL 1XUQ ; 1.80 ; CRYSTAL STRUCTURE OF SODA-1 (BA4499) FROM BACILLUS ANTHRACIS AT 1.8A RESOLUTION. 1XRE ; 1.80 ; CRYSTAL STRUCTURE OF SODA-2 (BA5696) FROM BACILLUS ANTHRACIS AT 1.8A RESOLUTION. 1E4K ; 3.20 ; CRYSTAL STRUCTURE OF SOLUBLE HUMAN IGG1 FC FRAGMENT-FC-GAMMA RECEPTOR III COMPLEX 1P0Q ; 2.43 ; CRYSTAL STRUCTURE OF SOMAN-AGED HUMAN BUTYRYL CHOLINESTERASE 1P0P ; 2.30 ; CRYSTAL STRUCTURE OF SOMAN-AGED HUMAN BUTYRYL CHOLINESTERASE IN COMPLEX WITH THE SUBSTRATE ANALOG BUTYRYLTHIOCHOLINE 1K2W ; 2.40 ; CRYSTAL STRUCTURE OF SORBITOL DEHYDROGENASE FROM R. SPHAEROIDES 1T2P ; 2.00 ; CRYSTAL STRUCTURE OF SORTASE A FROM STAPHYLOCOCCUS AUREUS 1T2W ; 1.80 ; CRYSTAL STRUCTURE OF SORTASE A IN COMPLEX WITH A LPETG PEPTIDE 1QX6 ; 2.70 ; CRYSTAL STRUCTURE OF SORTASE B COMPLEXED WITH E-64 1QXA ; 2.50 ; CRYSTAL STRUCTURE OF SORTASE B COMPLEXED WITH GLY3 1QWZ ; 1.75 ; CRYSTAL STRUCTURE OF SORTASE B FROM S. AUREUS COMPLEXED WITH MTSET 2C1D ; 1.92 ; CRYSTAL STRUCTURE OF SOXXA FROM P. PANTOTROPHUS 1Q6C ; 1.86 ; CRYSTAL STRUCTURE OF SOYBEAN BETA-AMYLASE COMPLEXED WITH MALTOSE 1Q6E ; 1.95 ; CRYSTAL STRUCTURE OF SOYBEAN BETA-AMYLASE MUTANT (E178Y) WITH INCREASED PH OPTIMUM AT PH 5.4 1Q6F ; 2.10 ; CRYSTAL STRUCTURE OF SOYBEAN BETA-AMYLASE MUTANT (E178Y) WITH INCREASED PH OPTIMUM AT PH 7.1 1Q6D ; 2.00 ; CRYSTAL STRUCTURE OF SOYBEAN BETA-AMYLASE MUTANT (M51T) WITH INCREASED PH OPTIMUM 1Q6G ; 2.00 ; CRYSTAL STRUCTURE OF SOYBEAN BETA-AMYLASE MUTANT (N340T) WITH INCREASED PH OPTIMUM 1UKO ; 2.10 ; CRYSTAL STRUCTURE OF SOYBEAN BETA-AMYLASE MUTANT SUBSTITUTED AT SURFACE REGION 1UKP ; 2.10 ; CRYSTAL STRUCTURE OF SOYBEAN BETA-AMYLASE MUTANT SUBSTITUTED AT SURFACE REGION 1UIK ; 2.30 ; CRYSTAL STRUCTURE OF SOYBEAN BETA-CONGLYCININ ALPHA PRIME HOMOTRIMER 1UIJ ; 2.50 ; CRYSTAL STRUCTURE OF SOYBEAN BETA-CONGLYCININ BETA HOMOTRIMER (I122M/K124W) 1FXZ ; 2.80 ; CRYSTAL STRUCTURE OF SOYBEAN PROGLYCININ A1AB1B HOMOTRIMER 1NE6 ; 2.30 ; CRYSTAL STRUCTURE OF SP-CAMP BINDING R1A SUBUNIT OF CAMP- DEPENDENT PROTEIN KINASE 1IY9 ; 2.30 ; CRYSTAL STRUCTURE OF SPERMIDINE SYNTHASE 1INL ; 1.50 ; CRYSTAL STRUCTURE OF SPERMIDINE SYNTHASE FROM THERMOTOGA MARITIMA 1JQ3 ; 1.80 ; CRYSTAL STRUCTURE OF SPERMIDINE SYNTHASE IN COMPLEX WITH TRANSITION STATE ANALOGUE ADODATO 1KMH ; 3.40 ; CRYSTAL STRUCTURE OF SPINACH CHLOROPLAST F1-ATPASE COMPLEXED WITH TENTOXIN 1RWT ; 2.72 ; CRYSTAL STRUCTURE OF SPINACH MAJOR LIGHT-HARVESTING COMPLEX AT 2.72 ANGSTROM RESOLUTION 1IR1 ; 1.80 ; CRYSTAL STRUCTURE OF SPINACH RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE (RUBISCO) COMPLEXED WITH CO2, MG2+ AND 2-CARBOXYARABINITOL-1,5-BISPHOSPHATE 1IXM ; 2.60 ; CRYSTAL STRUCTURE OF SPOOB FROM BACILLUS SUBTILIS 1NAT ; 2.45 ; CRYSTAL STRUCTURE OF SPOOF FROM BACILLUS SUBTILIS 1VLI ; 2.38 ; CRYSTAL STRUCTURE OF SPORE COAT POLYSACCHARIDE BIOSYNTHESIS PROTEIN SPSE (BSU37870) FROM BACILLUS SUBTILIS AT 2.38 A RESOLUTION 1Z3E ; 1.50 ; CRYSTAL STRUCTURE OF SPX IN COMPLEX WITH THE C-TERMINAL DOMAIN OF THE RIBONUCLEIC ACID POLYMERASE ALPHA SUBUNIT 1QRR ; 1.60 ; CRYSTAL STRUCTURE OF SQD1 PROTEIN COMPLEX WITH NAD AND UDP- GLUCOSE 1NZL ; 1.90 ; CRYSTAL STRUCTURE OF SRC SH2 DOMAIN BOUND TO DOUBLY PHOSPHORYLATED PEPTIDE PQPYEPYIPI 1NZV ; 2.10 ; CRYSTAL STRUCTURE OF SRC SH2 DOMAIN BOUND TO DOUBLY PHOSPHORYLATED PEPTIDE PQPYIPYVPA 1L9A ; 2.90 ; CRYSTAL STRUCTURE OF SRP19 IN COMPLEX WITH THE S DOMAIN OF SIGNAL RECOGNITION PARTICLE RIBONUCLEIC ACID 1OX8 ; 2.20 ; CRYSTAL STRUCTURE OF SSPB 1OX9 ; 2.90 ; CRYSTAL STRUCTURE OF SSPB-SSRA COMPLEX 1TBX ; 2.70 ; CRYSTAL STRUCTURE OF SSV1 F-93 1WSC ; 2.45 ; CRYSTAL STRUCTURE OF ST0229, FUNCTION UNKNOWN PROTEIN FROM SULFOLOBUS TOKODAII 1WOL ; 1.62 ; CRYSTAL STRUCTURE OF ST0689, AN ARCHAEAL HEPN HOMOLOGUE 1OQD ; 2.60 ; CRYSTAL STRUCTURE OF STALL-1 AND BCMA 1JH5 ; 3.00 ; CRYSTAL STRUCTURE OF STALL-1 OF TNF FAMILY LIGAND 1OQE ; 2.50 ; CRYSTAL STRUCTURE OF STALL-1 WITH BAFF-R 1UJ0 ; 1.70 ; CRYSTAL STRUCTURE OF STAM2 SH3 DOMAIN IN COMPLEX WITH A UBPY-DERIVED PEPTIDE 1XAH ; 2.20 ; CRYSTAL STRUCTURE OF STAPHLYOCOCCUS AUREUS 3-DEHYDROQUINATE SYNTHASE (DHQS) IN COMPLEX WITH ZN2+ AND NAD+ 1XAG ; 2.45 ; CRYSTAL STRUCTURE OF STAPHLYOCOCCUS AUREUS 3-DEHYDROQUINATE SYNTHASE (DHQS) IN COMPLEX WITH ZN2+, NAD+ AND CARBAPHOSPHONATE 1XAI ; 2.30 ; CRYSTAL STRUCTURE OF STAPHLYOCOCCUS AUREUS 3-DEHYDROQUINATE SYNTHASE (DHQS) IN COMPLEX WITH ZN2+, NAD+ AND CARBAPHOSPHONATE 1XAJ ; 2.35 ; CRYSTAL STRUCTURE OF STAPHLYOCOCCUS AUREUS 3-DEHYDROQUINATE SYNTHASE (DHQS) IN COMPLEX WITH ZN2+, NAD+ AND CARBAPHOSPHONATE 1XAL ; 2.80 ; CRYSTAL STRUCTURE OF STAPHLYOCOCCUS AUREUS 3-DEHYDROQUINATE SYNTHASE (DHQS) IN COMPLEX WITH ZN2+, NAD+ AND CARBAPHOSPHONATE (SOAK) 1QXW ; 1.67 ; CRYSTAL STRUCTURE OF STAPHYLOCCOCUS AUREUS IN COMPLEX WITH AN AMINOKETONE INHIBITOR 54135. 1I4G ; 2.10 ; CRYSTAL STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN A MUTANT H187A WITH REDUCED ZN2+ AFFINITY 1CQV ; 2.06 ; CRYSTAL STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN C2 AT 100K CRYSTALLIZED AT PH 5.0 1I4P ; 2.00 ; CRYSTAL STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN C2 AT 100K CRYSTALLIZED AT PH 5.5 1I4Q ; 2.20 ; CRYSTAL STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN C2 AT 100K CRYSTALLIZED AT PH 6.0 1I4R ; 2.10 ; CRYSTAL STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN C2 AT 100K CRYSTALLIZED AT PH 6.5 1ENF ; 1.69 ; CRYSTAL STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN H DETERMINED TO 1.69 A RESOLUTION 1HXY ; 2.60 ; CRYSTAL STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN H IN COMPLEX WITH HUMAN MHC CLASS II 1U9R ; 2.10 ; CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE MUTANT V66E/P117G/H124L/S128A AT ROOM TEMPERATURE 1XPL ; 2.00 ; CRYSTAL STRUCTURE OF STAPHYLOCOCCUS AUREUS HMG-COA SYNTHASE WITH ACETOACETYL-COA AND ACETYLATED CYSTEINE 1XPM ; 1.60 ; CRYSTAL STRUCTURE OF STAPHYLOCOCCUS AUREUS HMG-COA SYNTHASE WITH HMG-COA AND ACETOACETYL-COA AND ACETYLATED CYSTEINE 1XPK ; 2.00 ; CRYSTAL STRUCTURE OF STAPHYLOCOCCUS AUREUS HMG-COA SYNTHASE WITH HMG-COA AND WITH ACETOACETYL-COA AND ACETYLATED CYSTEINE 1XVH ; 2.00 ; CRYSTAL STRUCTURE OF STAPHYLOCOCCUS AUREUS HYPOTHETICAL PROTEIN (NP_646141.1, DOMAIN 3912-4037) SIMILAR TO STREPTOCOCCAL ADHESINS EMB AND EBHA/EBHB 1NXK ; 2.70 ; CRYSTAL STRUCTURE OF STAUROSPORINE BOUND TO MAP KAP KINASE 2 1RC9 ; 1.60 ; CRYSTAL STRUCTURE OF STECRISP, A MEMBER OF CRISP FAMILY FROM TRIMERESURUS STEJNEGERI REFINED AT 1.6 ANGSTROMS RESOLUTION: STRUCTUAL RELATIONSHIP OF THE TWO DOMAINS 1NB5 ; 2.40 ; CRYSTAL STRUCTURE OF STEFIN A IN COMPLEX WITH CATHEPSIN H 1NB3 ; 2.80 ; CRYSTAL STRUCTURE OF STEFIN A IN COMPLEX WITH CATHEPSIN H: N-TERMINAL RESIDUES OF INHIBITORS CAN ADAPT TO THE ACTIVE SITES OF ENDO-AND EXOPEPTIDASES 1Z1E ; 2.40 ; CRYSTAL STRUCTURE OF STILBENE SYNTHASE FROM ARACHIS HYPOGAEA 1Z1F ; 2.90 ; CRYSTAL STRUCTURE OF STILBENE SYNTHASE FROM ARACHIS HYPOGAEA (RESVERATROL-BOUND FORM) 1MEP ; 1.65 ; CRYSTAL STRUCTURE OF STREPTAVIDIN DOUBLE MUTANT S45A/D128A WITH BIOTIN: COOPERATIVE HYDROGEN-BOND INTERACTIONS IN THE STREPTAVIDIN-BIOTIN SYSTEM. 1RXJ ; 1.14 ; CRYSTAL STRUCTURE OF STREPTAVIDIN MUTANT (M2) WHERE THE L3, 4 LOOP WAS REPLACE BY THAT OF AVIDIN 1RXK ; 1.70 ; CRYSTAL STRUCTURE OF STREPTAVIDIN MUTANT (M3) A COMBINATION OF M1+M2 1RXH ; 2.90 ; CRYSTAL STRUCTURE OF STREPTAVIDIN MUTANT L124R (M1) COMPLEXED WITH BIOTINYL P-NITROANILIDE (BNI) 1FNW ; 3.90 ; CRYSTAL STRUCTURE OF STREPTOCOCCAL PYROGENIC EXOTOXIN A 1F1S ; 2.10 ; CRYSTAL STRUCTURE OF STREPTOCOCCUS AGALACTIAE HYALURONATE LYASE AT 2.1 ANGSTROM RESOLUTION. 1I8Q ; 2.20 ; CRYSTAL STRUCTURE OF STREPTOCOCCUS AGALACTIAE HYALURONATE LYASE COMPLEXED WITH ENZYME PRODUCT, UNSATURATED DISACCHARIDE HYALURONAN 1LXM ; 2.20 ; CRYSTAL STRUCTURE OF STREPTOCOCCUS AGALACTIAE HYALURONATE LYASE COMPLEXED WITH HEXASACCHARIDE UNIT OF HYALURONAN 1FTH ; 1.90 ; CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE ACYL CARRIER PROTEIN SYNTHASE (3'5'-ADP COMPLEX) 1FTE ; 2.40 ; CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE ACYL CARRIER PROTEIN SYNTHASE (NATIVE 1) 1FTF ; 2.05 ; CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE ACYL CARRIER PROTEIN SYNTHASE (NATIVE 2) 1EGU ; 1.56 ; CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE HYALURONATE LYASE AT 1.56 A RESOLUTION 1F9G ; 2.00 ; CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE HYALURONATE LYASE COCRYSTALLIZED WITH ASCORBIC ACID 1MR7 ; 1.80 ; CRYSTAL STRUCTURE OF STREPTOGRAMIN A ACETYLTRANSFERASE 1MR9 ; 3.00 ; CRYSTAL STRUCTURE OF STREPTOGRAMIN A ACETYLTRANSFERASE WITH ACETYL-COA BOUND 1MRL ; 2.80 ; CRYSTAL STRUCTURE OF STREPTOGRAMIN A ACETYLTRANSFERASE WITH DALFOPRISTIN 1QQR ; 2.30 ; CRYSTAL STRUCTURE OF STREPTOKINASE DOMAIN B 1S1F ; 1.50 ; CRYSTAL STRUCTURE OF STREPTOMYCES COELICOLOR A3(2) CYP158A2 FROM ANTIBIOTIC BIOSYNTHETIC PATHWAYS 1SE6 ; 1.75 ; CRYSTAL STRUCTURE OF STREPTOMYCES COELICOLOR A3(2) CYP158A2 FROM ANTIBIOTIC BIOSYNTHETIC PATHWAYS 1CLK ; 1.90 ; CRYSTAL STRUCTURE OF STREPTOMYCES DIASTATICUS NO.7 STRAIN M1033 XYLOSE ISOMERASE AT 1.9 A RESOLUTION WITH PSEUDO-I222 SPACE GROUP 1HP4 ; 2.20 ; CRYSTAL STRUCTURE OF STREPTOMYCES PLICATUS BETA-N- ACETYLHEXOSAMINIDASE 1HVB ; 1.17 ; CRYSTAL STRUCTURE OF STREPTOMYCES R61 DD-PEPTIDASE COMPLEXED WITH A NOVEL CEPHALOSPORIN ANALOG OF CELL WALL PEPTIDOGLYCAN 1YY7 ; 2.02 ; CRYSTAL STRUCTURE OF STRINGENT STARVATION PROTEIN A (SSPA), AN RIBONUCLEIC ACID POLYMERASE-ASSOCIATED TRANSCRIPTION FACTOR 1QIA ; 2.00 ; CRYSTAL STRUCTURE OF STROMELYSIN CATALYTIC DOMAIN 1QIC ; 2.00 ; CRYSTAL STRUCTURE OF STROMELYSIN CATALYTIC DOMAIN 1MXH ; 2.20 ; CRYSTAL STRUCTURE OF SUBSTRATE COMPLEX OF PUTATIVE PTERIDINE REDUCTASE 2 (PTR2) FROM TRYPANOSOMA CRUZI 1MMF ; 2.50 ; CRYSTAL STRUCTURE OF SUBSTRATE FREE FORM OF GLYCEROL DEHYDRATASE 1BFK ; 2.30 ; CRYSTAL STRUCTURE OF SUBTILISIN CARLSBERG IN 40% ACETONITRILE 1AF4 ; 2.60 ; CRYSTAL STRUCTURE OF SUBTILISIN CARLSBERG IN ANHYDROUS DIOXANE 1SCJ ; 2.00 ; CRYSTAL STRUCTURE OF SUBTILISIN-PROPEPTIDE COMPLEX 1U7L ; 1.75 ; CRYSTAL STRUCTURE OF SUBUNIT C (VMA5P) OF THE YEAST V-ATPASE 1R5Z ; 1.95 ; CRYSTAL STRUCTURE OF SUBUNIT C OF V-ATPASE 1XB4 ; 3.10 ; CRYSTAL STRUCTURE OF SUBUNIT VPS25 OF THE ENDOSOMAL TRAFFICKING COMPLEX ESCRT-II 1VGY ; 1.90 ; CRYSTAL STRUCTURE OF SUCCINYL DIAMINOPIMELATE DESUCCINYLASE 1YW6 ; 3.10 ; CRYSTAL STRUCTURE OF SUCCINYLGLUTAMATE DESUCCINYLASE FROM ESCHERICHIA COLI, NORTHEAST STRUCTURAL GENOMICS TARGET ET72. 1PVT ; 2.50 ; CRYSTAL STRUCTURE OF SUGAR-PHOSPHATE ALDOLASE FROM THERMOTOGA MARITIMA 1OFT ; 2.90 ; CRYSTAL STRUCTURE OF SULA FROM PSEUDOMONAS AERUGINOSA 1OFU ; 2.10 ; CRYSTAL STRUCTURE OF SULA:FTSZ FROM PSEUDOMONAS AERUGINOSA 2A3U ; 1.34 ; CRYSTAL STRUCTURE OF SULBACTAM BOUND TO E166A VARIANT OF SHV-1 BETA-LACTAMASE 1JNY ; 1.80 ; CRYSTAL STRUCTURE OF SULFOLOBUS SOLFATARICUS ELONGATION FACTOR 1 ALPHA IN COMPLEX WITH GDP 1EH9 ; 3.00 ; CRYSTAL STRUCTURE OF SULFOLOBUS SOLFATARICUS GLYCOSYLTREHALOSE TREHALOHYDROLASE 1XTY ; 1.80 ; CRYSTAL STRUCTURE OF SULFOLOBUS SOLFATARICUS PEPTIDYL-TRNA HYDROLASE 2BF8 ; 2.30 ; CRYSTAL STRUCTURE OF SUMO MODIFIED UBIQUITIN CONJUGATING ENZYME E2-25K 1WYW ; 2.10 ; CRYSTAL STRUCTURE OF SUMO1-CONJUGATED THYMINE DEOXYRIBONUCLEIC ACID GLYCOSYLASE 1P7G ; 1.80 ; CRYSTAL STRUCTURE OF SUPEROXIDE DISMUTASE FROM PYROBACULUM AEROPHILUM 1DQI ; 1.70 ; CRYSTAL STRUCTURE OF SUPEROXIDE REDUCTASE FROM P. FURIOSUS IN THE OXIDIZED STATE AT 1.7 ANGSTROMS RESOLUTION 1DO6 ; 2.00 ; CRYSTAL STRUCTURE OF SUPEROXIDE REDUCTASE IN THE OXIDIZED STATE AT 2.0 ANGSTROM RESOLUTION 1DQK ; 2.00 ; CRYSTAL STRUCTURE OF SUPEROXIDE REDUCTASE IN THE REDUCED STATE AT 2.0 ANGSTROMS RESOLUTION 1J9K ; 2.10 ; CRYSTAL STRUCTURE OF SURE PROTEIN FROM T.MARITIMA IN COMPLEX WITH TUNGSTATE 1J9L ; 1.90 ; CRYSTAL STRUCTURE OF SURE PROTEIN FROM T.MARITIMA IN COMPLEX WITH VANADATE 1JSD ; 1.80 ; CRYSTAL STRUCTURE OF SWINE H9 HAEMAGGLUTININ 1JYA ; 1.74 ; CRYSTAL STRUCTURE OF SYCE 1DQV ; 3.20 ; CRYSTAL STRUCTURE OF SYNAPTOTAGMIN III C2A/C2B 1RTX ; 1.80 ; CRYSTAL STRUCTURE OF SYNECHOCYSTIS HEMOGLOBIN WITH A COVALENT HEME LINKAGE 1WOO ; 2.40 ; CRYSTAL STRUCTURE OF T-PROTEIN OF THE GLYCINE CLEAVAGE SYSTEM 1WOP ; 2.00 ; CRYSTAL STRUCTURE OF T-PROTEIN OF THE GLYCINE CLEAVAGE SYSTEM 1WOR ; 1.95 ; CRYSTAL STRUCTURE OF T-PROTEIN OF THE GLYCINE CLEAVAGE SYSTEM 1WOS ; 1.84 ; CRYSTAL STRUCTURE OF T-PROTEIN OF THE GLYCINE CLEAVAGE SYSTEM 1LWJ ; 2.50 ; CRYSTAL STRUCTURE OF T. MARITIMA 4-ALPHA- GLUCANOTRANSFERASE/ACARBOSE COMPLEX 1LWH ; 2.60 ; CRYSTAL STRUCTURE OF T. MARITIMA 4-ALPHA-GLUCANOTRANSFERASE 1XDJ ; 2.20 ; CRYSTAL STRUCTURE OF T. MARITIMA COBALAMIN-INDEPENDENT METHIONINE SYNTHASE COMPLEXED WITH ZN2+ AND HOMOCYSTEINE 1XPG ; 2.59 ; CRYSTAL STRUCTURE OF T. MARITIMA COBALAMIN-INDEPENDENT METHIONINE SYNTHASE COMPLEXED WITH ZN2+ AND METHYLTETRAHYDROFOLATE 1V2D ; 1.90 ; CRYSTAL STRUCTURE OF T.TH HB8 GLUTAMINE AMINOTRANSFERASE 1V2F ; 2.35 ; CRYSTAL STRUCTURE OF T.TH HB8 GLUTAMINE AMINOTRANSFERASE COMPLEX WITH 3-PHENYLPROPIONATE 1V2E ; 2.60 ; CRYSTAL STRUCTURE OF T.TH HB8 GLUTAMINE AMINOTRANSFERASE COMPLEX WITH A-KETO-G-METHYLTHIOBUTYRATE 1VCM ; 2.35 ; CRYSTAL STRUCTURE OF T.TH. HB8 CTP SYNTHETASE 1VCO ; 2.15 ; CRYSTAL STRUCTURE OF T.TH. HB8 CTP SYNTHETASE COMPLEX WITH GLUTAMINE 1VCN ; 2.25 ; CRYSTAL STRUCTURE OF T.TH. HB8 CTP SYNTHETASE COMPLEX WITH SULFATE ANION 1VE1 ; 1.45 ; CRYSTAL STRUCTURE OF T.TH. HB8 O-ACETYLSERINE SULFHYDRYLASE 1VE5 ; 2.15 ; CRYSTAL STRUCTURE OF T.TH. HB8 THREONINE DEAMINASE 1WRV ; 1.50 ; CRYSTAL STRUCTURE OF T.TH.HB8 BRANCHED-CHAIN AMINO ACID AMINOTRANSFERASE 2ALY ; 2.60 ; CRYSTAL STRUCTURE OF T.THERMOPHILUS PHENYLALANYL-TRNA SYNTHETASE COMPLEXED WITH 5'-O-[N-(L-TYROSYL) SULPHAMOYL]ADENOSINE 2AKW ; 2.80 ; CRYSTAL STRUCTURE OF T.THERMOPHILUS PHENYLALANYL-TRNA SYNTHETASE COMPLEXED WITH P-CL-PHENYLALANINE 1R3H ; 2.50 ; CRYSTAL STRUCTURE OF T10 1TJV ; 2.00 ; CRYSTAL STRUCTURE OF T161D DUCK DELTA 2 CRYSTALLIN MUTANT 1TJW ; 2.00 ; CRYSTAL STRUCTURE OF T161D DUCK DELTA 2 CRYSTALLIN MUTANT WITH BOUND ARGININOSUCCINATE 1TJU ; 2.10 ; CRYSTAL STRUCTURE OF T161S DUCK DELTA 2 CRYSTALLIN MUTANT 1LW2 ; 3.00 ; CRYSTAL STRUCTURE OF T215Y MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 1051U91 1LW0 ; 2.80 ; CRYSTAL STRUCTURE OF T215Y MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE 1KUQ ; 2.84 ; CRYSTAL STRUCTURE OF T3C MUTANT S15 RIBOSOMAL PROTEIN IN COMPLEX WITH 16S RRNA 1G0G ; 1.90 ; CRYSTAL STRUCTURE OF T4 LYSOZYME MUTANT T152A 1G0K ; 1.85 ; CRYSTAL STRUCTURE OF T4 LYSOZYME MUTANT T152C 1G0M ; 1.70 ; CRYSTAL STRUCTURE OF T4 LYSOZYME MUTANT T152I 1G0J ; 1.80 ; CRYSTAL STRUCTURE OF T4 LYSOZYME MUTANT T152S 1G0L ; 1.80 ; CRYSTAL STRUCTURE OF T4 LYSOZYME MUTANT T152V 1G07 ; 1.70 ; CRYSTAL STRUCTURE OF T4 LYSOZYME MUTANT V149C 1G0P ; 1.80 ; CRYSTAL STRUCTURE OF T4 LYSOZYME MUTANT V149G 1G0Q ; 1.80 ; CRYSTAL STRUCTURE OF T4 LYSOZYME MUTANT V149I 1G06 ; 1.85 ; CRYSTAL STRUCTURE OF T4 LYSOZYME MUTANT V149S 1J39 ; 1.87 ; CRYSTAL STRUCTURE OF T4 PHAGE BGT IN COMPLEX WITH ITS UDP- GLUCOSE SUBSTRATE 1LTQ ; 2.33 ; CRYSTAL STRUCTURE OF T4 POLYNUCLEOTIDE KINASE 1VQ2 ; 2.20 ; CRYSTAL STRUCTURE OF T4-BACTERIOPHAGE DEOXYCYTIDYLATE DEAMINASE, MUTANT R115E 1XMQ ; 3.00 ; CRYSTAL STRUCTURE OF T6A37-ASLLYSUUU AAA-MRNA BOUND TO THE DECODING CENTER 1XPP ; 1.60 ; CRYSTAL STRUCTURE OF TA1416,DEOXYRIBONUCLEIC ACID-DIRECTED RIBONUCLEIC ACID POLYMERASE SUBUNIT L, FROM THERMOPLASMA ACIDOPHILUM 1J4J ; 2.55 ; CRYSTAL STRUCTURE OF TABTOXIN RESISTANCE PROTEIN (FORM II) COMPLEXED WITH AN ACYL COENZYME A 1GHE ; 1.55 ; CRYSTAL STRUCTURE OF TABTOXIN RESISTANCE PROTEIN COMPLEXED WITH AN ACYL COENZYME A 2BHI ; 2.31 ; CRYSTAL STRUCTURE OF TAIWAN COBRA CARDIOTOXIN A3 COMPLEXED WITH SULFOGALACTOCERAMIDE 1SJ8 ; 2.60 ; CRYSTAL STRUCTURE OF TALIN RESIDUES 482-789 1SJ7 ; 2.50 ; CRYSTAL STRUCTURE OF TALIN ROD 482-655 1P47 ; 2.20 ; CRYSTAL STRUCTURE OF TANDEM ZIF268 MOLECULES COMPLEXED TO DEOXYRIBONUCLEIC ACID 1CMW ; 2.60 ; CRYSTAL STRUCTURE OF TAQ DEOXYRIBONUCLEIC ACID-POLYMERASE SHOWS A NEW ORIENTATION FOR THE STRUCTURE-SPECIFIC NUCLEASE DOMAIN 1EWR ; 3.19 ; CRYSTAL STRUCTURE OF TAQ MUTS 1XWY ; 2.00 ; CRYSTAL STRUCTURE OF TATD DEOXYRIBONUCLEASE FROM ESCHERICHIA COLI K12 AT 2.0 A RESOLUTION 1J6O ; 1.80 ; CRYSTAL STRUCTURE OF TATD-RELATED DEOXYRIBONUCLEASE (TM0667) FROM THERMOTOGA MARITIMA AT 1.8 A RESOLUTION 1OS7 ; 2.50 ; CRYSTAL STRUCTURE OF TAUD WITH IRON, ALPHA-KETOGLUTARATE AND TAURINE BOUND AT PH 7.5 1JL2 ; 1.76 ; CRYSTAL STRUCTURE OF TCEO RNASE H-A CHIMERA COMBINING THE FOLDING CORE FROM T. THERMOPHILUS RNASE H AND THE REMAINING REGION OF E. COLI RNASE H 1PN3 ; 2.80 ; CRYSTAL STRUCTURE OF TDP-EPI-VANCOSAMINYLTRANSFERASE GTFA IN COMPLEXES WITH TDP AND THE ACCEPTOR SUBSTRATE DVV. 1PNV ; 2.80 ; CRYSTAL STRUCTURE OF TDP-EPI-VANCOSAMINYLTRANSFERASE GTFA IN COMPLEXES WITH TDP AND VANCOMYCIN 1HXC ; 2.25 ; CRYSTAL STRUCTURE OF TEAS C440W 1HX9 ; 3.50 ; CRYSTAL STRUCTURE OF TEAS W273S FORM 1 1HXA ; 2.32 ; CRYSTAL STRUCTURE OF TEAS W273S FORM 2 1HXG ; 2.90 ; CRYSTAL STRUCTURE OF TEAS W273S/C440W 1JI7 ; 1.45 ; CRYSTAL STRUCTURE OF TEL SAM POLYMER 1YIJ ; 2.60 ; CRYSTAL STRUCTURE OF TELITHROMYCIN BOUND TO THE G2099A MUTANT 50S RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI 1JTG ; 1.73 ; CRYSTAL STRUCTURE OF TEM-1 BETA-LACTAMASE / BETA-LACTAMASE INHIBITOR PROTEIN COMPLEX 1LHY ; 2.00 ; CRYSTAL STRUCTURE OF TEM-30 BETA-LACTAMASE AT 2.0 ANGSTROM 1LI0 ; 1.61 ; CRYSTAL STRUCTURE OF TEM-32 BETA-LACTAMASE AT 1.6 ANGSTROM 1LI9 ; 1.52 ; CRYSTAL STRUCTURE OF TEM-34 BETA-LACTAMASE AT 1.5 ANGSTROM 1JWZ ; 1.80 ; CRYSTAL STRUCTURE OF TEM-64 BETA-LACTAMASE IN COMPLEX WITH A BORONIC ACID INHIBITOR (105) 1YT4 ; 1.40 ; CRYSTAL STRUCTURE OF TEM-76 BETA-LACTAMASE AT 1.4 ANGSTROM RESOLUTION 1HTZ ; 2.40 ; CRYSTAL STRUCTURE OF TEM52 BETA-LACTAMASE 1OK0 ; 0.93 ; CRYSTAL STRUCTURE OF TENDAMISTAT 1WVH ; 1.50 ; CRYSTAL STRUCTURE OF TENSIN1 PTB DOMAIN 1TMM ; 1.25 ; CRYSTAL STRUCTURE OF TERNARY COMPLEX OF E.COLI HPPK(W89A) WITH MGAMPCPP AND 6-HYDROXYMETHYLPTERIN 5MDH ; 2.40 ; CRYSTAL STRUCTURE OF TERNARY COMPLEX OF PORCINE CYTOPLASMIC MALATE DEHYDROGENASE ALPHA-KETOMALONATE AND TNAD AT 2.4 ANGSTROMS RESOLUTION 1MMK ; 2.00 ; CRYSTAL STRUCTURE OF TERNARY COMPLEX OF THE CATALYTIC DOMAIN OF HUMAN PHENYLALANINE HYDROXYLASE ((FEII)) COMPLEXED WITH TETRAHYDROBIOPTERIN AND THIENYLALANINE 1MMT ; 2.00 ; CRYSTAL STRUCTURE OF TERNARY COMPLEX OF THE CATALYTIC DOMAIN OF HUMAN PHENYLALANINE HYDROXYLASE (FE(II)) COMPLEXED WITH TETRAHYDROBIOPTERIN AND NORLEUCINE 1LRT ; 2.20 ; CRYSTAL STRUCTURE OF TERNARY COMPLEX OF TRITRICHOMONAS FOETUS INOSINE-5'-MONOPHOSPHATE DEHYDROGENASE: STRUCTURAL CHARACTERIZATION OF NAD+ SITE IN MICROBIAL ENZYME 1H88 ; 2.80 ; CRYSTAL STRUCTURE OF TERNARY PROTEIN-DEOXYRIBONUCLEIC ACID COMPLEX1 1H89 ; 2.45 ; CRYSTAL STRUCTURE OF TERNARY PROTEIN-DEOXYRIBONUCLEIC ACID COMPLEX2 1H8A ; 2.23 ; CRYSTAL STRUCTURE OF TERNARY PROTEIN-DEOXYRIBONUCLEIC ACID COMPLEX3 1DU7 ; 2.51 ; CRYSTAL STRUCTURE OF TET REPRESSOR CLASS D WITH 4-EPI- TETRACYCLINE 1T56 ; 1.70 ; CRYSTAL STRUCTURE OF TETR FAMILY REPRESSOR M. TUBERCULOSIS ETHR 1QPI ; 2.50 ; CRYSTAL STRUCTURE OF TETRACYCLINE REPRESSOR/OPERATOR COMPLEX 3FYG ; 2.20 ; CRYSTAL STRUCTURE OF TETRADECA-(3-FLUOROTYROSYL)- GLUTATHIONE S-TRANSFERASE 1JIS ; 1.90 ; CRYSTAL STRUCTURE OF TETRAGONAL LYSOZYME GROWN AT PH 4.6 1JIY ; 1.90 ; CRYSTAL STRUCTURE OF TETRAGONAL LYSOZYME GROWN IN PRESENCE 20% SORBITOL 1JIT ; 1.90 ; CRYSTAL STRUCTURE OF TETRAGONAL LYSOZYME GROWN IN PRESENCE 30% TREHALOSE 1JJ0 ; 1.90 ; CRYSTAL STRUCTURE OF TETRAGONAL LYSOZYME GROWN IN PRESENCE OF 30% SUCROSE 1Y0Y ; 1.60 ; CRYSTAL STRUCTURE OF TETRAHEDRAL AMINOPEPTIDASE FROM P. HORIKOSHII IN COMPLEX WITH AMASTATIN 1KGQ ; 2.00 ; CRYSTAL STRUCTURE OF TETRAHYDRODIPICOLINATE N- SUCCINYLTRANSFERASE IN COMPLEX WITH L-2-AMINOPIMELATE AND SUCCINAMIDE-COA 1KGT ; 2.30 ; CRYSTAL STRUCTURE OF TETRAHYDRODIPICOLINATE N- SUCCINYLTRANSFERASE IN COMPLEX WITH PIMELATE AND SUCCINYL- COA 1QST ; 1.70 ; CRYSTAL STRUCTURE OF TETRAHYMENA GCN5 1QSR ; 2.00 ; CRYSTAL STRUCTURE OF TETRAHYMENA GCN5 WITH BOUND ACETYL- COENZYME A 1PU9 ; 2.30 ; CRYSTAL STRUCTURE OF TETRAHYMENA GCN5 WITH BOUND COENZYME A AND A 19-RESIDUE HISTONE H3 PEPTIDE 1Q2C ; 2.25 ; CRYSTAL STRUCTURE OF TETRAHYMENA GCN5 WITH BOUND COENZYME A AND A 19-RESIDUE HISTONE H4 PEPTIDE 1Q2D ; 2.25 ; CRYSTAL STRUCTURE OF TETRAHYMENA GCN5 WITH BOUND COENZYME A AND A 19-RESIDUE P53 PEPTIDE 1PUA ; 2.30 ; CRYSTAL STRUCTURE OF TETRAHYMENA GCN5 WITH BOUND COENZYME A AND A PHOSPHORYLATED, 19-RESIDUE HISTONE H3 PEPTIDE 1QSN ; 2.20 ; CRYSTAL STRUCTURE OF TETRAHYMENA GCN5 WITH BOUND COENZYME A AND HISTONE H3 PEPTIDE 1X0L ; 1.85 ; CRYSTAL STRUCTURE OF TETRAMERIC HOMOISOCITRATE DEHYDROGENASE FROM AN EXTREME THERMOPHILE, THERMUS THERMOPHILUS 1VGL ; 2.60 ; CRYSTAL STRUCTURE OF TETRAMERIC KAIB FROM T.ELONGATUS BP-1 1UB3 ; 1.40 ; CRYSTAL STRUCTURE OF TETRAMERIC STRUCTURE OF ALDOLASE FROM THERMUS THERMOPHILUS HB8 1HG3 ; 2.70 ; CRYSTAL STRUCTURE OF TETRAMERIC TIM FROM PYROCOCCUS WOESEI. 1RW8 ; 2.40 ; CRYSTAL STRUCTURE OF TGF-BETA RECEPTOR I KINASE WITH ATP SITE INHIBITOR 1PY5 ; 2.30 ; CRYSTAL STRUCTURE OF TGF-BETA RECEPTOR I KINASE WITH INHIBITOR 1Q4W ; 1.93 ; CRYSTAL STRUCTURE OF TGT IN COMPLEX WITH 2,6-DIAMINO-3H- QUINAZOLIN-4-ONE 1R5Y ; 1.20 ; CRYSTAL STRUCTURE OF TGT IN COMPLEX WITH 2,6-DIAMINO-3H- QUINAZOLIN-4-ONE CRYSTALLIZED AT PH 5.5 1Q63 ; 1.85 ; CRYSTAL STRUCTURE OF TGT IN COMPLEX WITH 2,6-DIAMINO-8-(1H- IMIDAZOL-2-YLSULFANYLMETHYL)-3H-QUINAZOLINE-4-ONE CRYSTALLIZED AT PH 5.5 1Q65 ; 2.10 ; CRYSTAL STRUCTURE OF TGT IN COMPLEX WITH 2,6-DIAMINO-8-(2- DIMETHYLAMINOETHYLSULFANYLMETHYL)-3H-QUINAZOLIN-4-ONE CRYSTALLIZED AT PH 5.5 1Q66 ; 1.75 ; CRYSTAL STRUCTURE OF TGT IN COMPLEX WITH 2-AMINO-6- AMINOMETHYL-8-PHENYLSULFANYLMETHYL-3H-QUINAZOLIN-4-ONE CRYSTALLIZED AT PH 5.5 1S38 ; 1.81 ; CRYSTAL STRUCTURE OF TGT IN COMPLEX WITH 2-AMINO-8- METHYLQUINAZOLIN-4(3H)-ONE 1S39 ; 1.95 ; CRYSTAL STRUCTURE OF TGT IN COMPLEX WITH 2-AMINOQUINAZOLIN- 4(3H)-ONE 1N2V ; 2.10 ; CRYSTAL STRUCTURE OF TGT IN COMPLEX WITH 2-BUTYL-5,6- DIHYDRO-1H-IMIDAZO[4,5-D]PYRIDAZINE-4,7-DIONE 1LR2 ; 1.80 ; CRYSTAL STRUCTURE OF THAUMATIN AT HIGH HYDROSTATIC PRESSURE 1LR3 ; 1.80 ; CRYSTAL STRUCTURE OF THAUMATIN AT HIGH HYDROSTATIC PRESSURE 1G5C ; 2.10 ; CRYSTAL STRUCTURE OF THE 'CAB' TYPE BETA CLASS CARBONIC ANHYDRASE FROM METHANOBACTERIUM THERMOAUTOTROPHICUM 1X0S ; 2.50 ; CRYSTAL STRUCTURE OF THE 13-CIS ISOMER OF BACTERIORHODOPSIN 1IB1 ; 2.70 ; CRYSTAL STRUCTURE OF THE 14-3-3 ZETA:SEROTONIN N- ACETYLTRANSFERASE COMPLEX 1DVL ; 2.40 ; CRYSTAL STRUCTURE OF THE 1:1 NETROPSIN-DECAMER D(CCIICICCII) 2 COMPLEX WITH ONLY ONE DRUG BOUND AT ONE END 1P1J ; 1.70 ; CRYSTAL STRUCTURE OF THE 1L-MYO-INOSITOL 1-PHOSPHATE SYNTHASE COMPLEXED WITH NADH 1P1K ; 2.10 ; CRYSTAL STRUCTURE OF THE 1L-MYO-INOSITOL 1-PHOSPHATE SYNTHASE COMPLEXED WITH NADH IN THE PRESENCE OF EDTA 1P1H ; 1.95 ; CRYSTAL STRUCTURE OF THE 1L-MYO-INOSITOL/NAD+ COMPLEX 1PX5 ; 1.74 ; CRYSTAL STRUCTURE OF THE 2'-SPECIFIC AND DOUBLE-STRANDED RIBONUCLEIC ACID-ACTIVATED INTERFERON-INDUCED ANTIVIRAL PROTEIN 2'-5'- OLIGOADENYLATE SYNTHETASE 1OQF ; 1.93 ; CRYSTAL STRUCTURE OF THE 2-METHYLISOCITRATE LYASE 1RYP ; 1.90 ; CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION 1FNT ; 3.20 ; CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION 1Z7Q ; 3.22 ; CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION 1YA9 ; 2.09 ; CRYSTAL STRUCTURE OF THE 22KDA N-TERMINAL FRAGMENT OF MOUSE APOLIPOPROTEIN E 1M9B ; 2.60 ; CRYSTAL STRUCTURE OF THE 26 KDA GLUTATHIONE S-TRANSFERASE FROM SCHISTOSOMA JAPONICUM COMPLEXED WITH GAMMA-GLUTAMYL[S- (2-IODOBENZYL)CYSTEINYL]GLYCINE 1M99 ; 2.30 ; CRYSTAL STRUCTURE OF THE 26 KDA GLUTATHIONE S-TRANSFERASE FROM SCHISTOSOMA JAPONICUM COMPLEXED WITH GLUTATHIONE SULFONIC ACID 1M9A ; 2.10 ; CRYSTAL STRUCTURE OF THE 26 KDA GLUTATHIONE S-TRANSFERASE FROM SCHISTOSOMA JAPONICUM COMPLEXED WITH S- HEXYLGLUTATHIONE 1U87 ; 3.50 ; CRYSTAL STRUCTURE OF THE 26 KDA GLUTATHIONE S-TRANSFERASE Y7F MUTANT FROM SCHISTOSOMA JAPONICUM COMPLEXED WITH GLUTATHIONE 1U88 ; 3.50 ; CRYSTAL STRUCTURE OF THE 26 KDA GLUTATHIONE S-TRANSFERASE Y7F MUTANT FROM SCHISTOSOMA JAPONICUM COMPLEXED WITH S- OCTYL GLUTATHIONE 358D ; 2.50 ; CRYSTAL STRUCTURE OF THE 2:1 NETROPSIN-DEOXYRIBONUCLEIC ACID DECAMER D(CBRCCCCIIIII) COMPLEX WITH END-TO-END BINDING 1RY7 ; 3.20 ; CRYSTAL STRUCTURE OF THE 3 IG FORM OF FGFR3C IN COMPLEX WITH FGF1 1CYY ; 2.15 ; CRYSTAL STRUCTURE OF THE 30 KDA FRAGMENT OF E. COLI DEOXYRIBONUCLEIC ACID TOPOISOMERASE I. HEXAGONAL FORM 1CY9 ; 1.80 ; CRYSTAL STRUCTURE OF THE 30 KDA FRAGMENT OF E. COLI DEOXYRIBONUCLEIC ACID TOPOISOMERASE I. MONOCLINIC FORM 1I95 ; 4.50 ; CRYSTAL STRUCTURE OF THE 30S RIBOSOMAL SUBUNIT FROM THERMUS THERMOPHILUS IN COMPLEX WITH EDEINE 1I97 ; 4.50 ; CRYSTAL STRUCTURE OF THE 30S RIBOSOMAL SUBUNIT FROM THERMUS THERMOPHILUS IN COMPLEX WITH TETRACYCLINE 1I96 ; 4.20 ; CRYSTAL STRUCTURE OF THE 30S RIBOSOMAL SUBUNIT FROM THERMUS THERMOPHILUS IN COMPLEX WITH THE TRANSLATION INITIATION FACTOR IF3 (C-TERMINAL DOMAIN) 1QR0 ; 1.90 ; CRYSTAL STRUCTURE OF THE 4'-PHOSPHOPANTETHEINYL TRANSFERASE SFP-COENZYME A COMPLEX 1KIJ ; 2.30 ; CRYSTAL STRUCTURE OF THE 43K ATPASE DOMAIN OF THERMUS THERMOPHILUS GYRASE B IN COMPLEX WITH NOVOBIOCIN 1J1D ; 2.61 ; CRYSTAL STRUCTURE OF THE 46KDA DOMAIN OF HUMAN CARDIAC TROPONIN IN THE CA2+ SATURATED FORM 1J1E ; 3.30 ; CRYSTAL STRUCTURE OF THE 52KDA DOMAIN OF HUMAN CARDIAC TROPONIN IN THE CA2+ SATURATED FORM 1KZY ; 2.50 ; CRYSTAL STRUCTURE OF THE 53BP1 BRCT REGION COMPLEXED TO TUMOR SUPPRESSOR P53 1QSA ; 1.65 ; CRYSTAL STRUCTURE OF THE 70 KDA SOLUBLE LYTIC TRANSGLYCOSYLASE SLT70 FROM ESCHERICHIA COLI AT 1.65 ANGSTROMS RESOLUTION 1QTE ; 1.90 ; CRYSTAL STRUCTURE OF THE 70 KDA SOLUBLE LYTIC TRANSGLYCOSYLASE SLT70 FROM ESCHERICHIA COLI AT 1.90 A RESOLUTION IN COMPLEX WITH A 1,6-ANHYDROMUROTRIPEPTIDE 1U07 ; 1.13 ; CRYSTAL STRUCTURE OF THE 92-RESIDUE C-TERM. PART OF TONB WITH SIGNIFICANT STRUCTURAL CHANGES COMPARED TO SHORTER FRAGMENTS 1QNC ; 2.30 ; CRYSTAL STRUCTURE OF THE A(-31) ADENOVIRUS MAJOR LATE PROMOTER TATA BOX VARIANT BOUND TO WILD-TYPE TBP (ARABIDOPSIS THALIANA TBP ISOFORM 2). TATA ELEMENT RECOGNITION BY THE TATA BOX-BINDING PROTEIN HAS BEEN CONSERVED THROUGHOUT EVOLUTION. 1YI5 ; 4.20 ; CRYSTAL STRUCTURE OF THE A-COBRATOXIN-ACHBP COMPLEX 1QPH ; 2.50 ; CRYSTAL STRUCTURE OF THE A-DEOXYRIBONUCLEIC ACID DODECAMER GACCACGTGGTC 1Y9S ; 1.55 ; CRYSTAL STRUCTURE OF THE A-DEOXYRIBONUCLEIC ACID GCGTATCGC WITH A 2'-O- PROPARGYL THYMIDINE (T) 1Y8V ; 1.50 ; CRYSTAL STRUCTURE OF THE A-DEOXYRIBONUCLEIC ACID GCGTATCGC WITH A 2'-O- PROPYL THYMIDINE (T) 1Y9F ; 1.60 ; CRYSTAL STRUCTURE OF THE A-DEOXYRIBONUCLEIC ACID GCGTATCGC WITH A 2'-O-ALLYL THYMIDINE (T) 1YBC ; 1.80 ; CRYSTAL STRUCTURE OF THE A-DEOXYRIBONUCLEIC ACID GCGTATCGC WITH A 2'-O-[2- (BENZYLOXY)ETHYL] THYMIDINE (T) 1Y86 ; 1.70 ; CRYSTAL STRUCTURE OF THE A-DEOXYRIBONUCLEIC ACID GCGTATCGC WITH A 2'-O-[2- (FLUORO)ETHYL] THYMIDINE (T) 1Y84 ; 1.60 ; CRYSTAL STRUCTURE OF THE A-DEOXYRIBONUCLEIC ACID GCGTATCGC WITH A 2'-O-[2- (IMIDAZOLYL)ETHYL] THYMIDINE (T) 1Y8L ; 1.50 ; CRYSTAL STRUCTURE OF THE A-DEOXYRIBONUCLEIC ACID GCGTATCGC WITH A 2'-O-[2- (TRIFLUORO)ETHYL] THYMIDINE (T) 1Y7F ; 1.60 ; CRYSTAL STRUCTURE OF THE A-DEOXYRIBONUCLEIC ACID GCGTATCGC WITH A 2'-O-[2- [HYDROXY(METHYLENEAMINO)OXY]ETHYL] THYMIDINE (T) 1YB9 ; 1.65 ; CRYSTAL STRUCTURE OF THE A-DEOXYRIBONUCLEIC ACID GCGTATCGC WITH A 2'-O-[2-(N, N-DIMETHYLAMINOOXY)ETHYL] THYMIDINE (T) 1F6E ; 2.00 ; CRYSTAL STRUCTURE OF THE A-DEOXYRIBONUCLEIC ACID HEXAMER GGCGM5CC 281D ; 2.38 ; CRYSTAL STRUCTURE OF THE A-DEOXYRIBONUCLEIC ACID OCTAMER D(GGCATGCC) 1LV7 ; 1.50 ; CRYSTAL STRUCTURE OF THE AAA DOMAIN OF FTSH 1EHK ; 2.40 ; CRYSTAL STRUCTURE OF THE ABERRANT BA3-CYTOCHROME-C OXIDASE FROM THERMUS THERMOPHILUS 1BBZ ; 1.65 ; CRYSTAL STRUCTURE OF THE ABL-SH3 DOMAIN COMPLEXED WITH A DESIGNED HIGH-AFFINITY PEPTIDE LIGAND: IMPLICATIONS FOR SH3-LIGAND INTERACTIONS 1G5H ; 1.95 ; CRYSTAL STRUCTURE OF THE ACCESSORY SUBUNIT OF MURINE MITOCHONDRIAL POLYMERASE GAMMA 1G5I ; 2.30 ; CRYSTAL STRUCTURE OF THE ACCESSORY SUBUNIT OF MURINE MITOCHONDRIAL POLYMERASE GAMMA 1X0I ; 2.30 ; CRYSTAL STRUCTURE OF THE ACID BLUE FORM OF BACTERIORHODOPSIN 1HUX ; 3.00 ; CRYSTAL STRUCTURE OF THE ACIDAMINOCOCCUS FERMENTANS (R)-2- HYDROXYGLUTARYL-COA DEHYDRATASE COMPONENT A 1MB8 ; 2.15 ; CRYSTAL STRUCTURE OF THE ACTIN BINDING DOMAIN OF PLECTIN 1PEV ; 2.00 ; CRYSTAL STRUCTURE OF THE ACTIN INTERACTING PROTEIN FROM CAENORHABDITIS ELEGANS 1PXY ; 2.40 ; CRYSTAL STRUCTURE OF THE ACTIN-CROSSLINKING CORE OF ARABIDOPSIS FIMBRIN 1RT8 ; 2.00 ; CRYSTAL STRUCTURE OF THE ACTIN-CROSSLINKING CORE OF SCHIZOSACCHAROMYCES POMBE FIMBRIN 1LFD ; 2.10 ; CRYSTAL STRUCTURE OF THE ACTIVE RAS PROTEIN COMPLEXED WITH THE RAS-INTERACTING DOMAIN OF RALGDS 1JGI ; 2.00 ; CRYSTAL STRUCTURE OF THE ACTIVE SITE MUTANT GLU328GLN OF AMYLOSUCRASE FROM NEISSERIA POLYSACCHAREA IN COMPLEX WITH THE NATURAL SUBSTRATE SUCROSE 1AXE ; 2.00 ; CRYSTAL STRUCTURE OF THE ACTIVE-SITE MUTANT PHE93->TRP OF HORSE LIVER ALCOHOL DEHYDROGENASE IN COMPLEX WITH NAD AND INHIBITOR TRIFLUOROETHANOL 1S4Y ; 2.30 ; CRYSTAL STRUCTURE OF THE ACTIVIN/ACTRIIB EXTRACELLULAR DOMAIN 1KZF ; 1.80 ; CRYSTAL STRUCTURE OF THE ACYL-HOMOSERINE LACTONE SYNTHASE, ESAI 1K4J ; 2.50 ; CRYSTAL STRUCTURE OF THE ACYL-HOMOSERINELACTONE SYNTHASE ESAI COMPLEXED WITH RHENATE 1XKZ ; 1.75 ; CRYSTAL STRUCTURE OF THE ACYLATED BETA-LACTAM SENSOR DOMAIN OF BLAR1 FROM S. AUREUS 1QNE ; 1.90 ; CRYSTAL STRUCTURE OF THE ADENOVIRUS MAJOR LATE PROMOTER TATA BOX BOUND TO WILD-TYPE TBP (ARABIDOPSIS THALIANA TBP ISOFORM 2). 1K8T ; 2.60 ; CRYSTAL STRUCTURE OF THE ADENYLYL CYCLASE DOMAIN OF ANTHRAX EDEMA FACTOR (EF) 1K93 ; 2.95 ; CRYSTAL STRUCTURE OF THE ADENYLYL CYCLASE DOMAIN OF ANTHRAX EDEMA FACTOR (EF) IN COMPLEX WITH CALMODULIN 1LVC ; 3.60 ; CRYSTAL STRUCTURE OF THE ADENYLYL CYCLASE DOMAIN OF ANTHRAX EDEMA FACTOR (EF) IN COMPLEX WITH CALMODULIN AND 2' DEOXY, 3' ANTHRANILOYL ATP 1K90 ; 2.75 ; CRYSTAL STRUCTURE OF THE ADENYLYL CYCLASE DOMAIN OF ANTHRAX EDEMA FACTOR (EF) IN COMPLEX WITH CALMODULIN AND 3' DEOXY- ATP 1SK6 ; 3.20 ; CRYSTAL STRUCTURE OF THE ADENYLYL CYCLASE DOMAIN OF ANTHRAX EDEMA FACTOR (EF) IN COMPLEX WITH CALMODULIN, 3',5' CYCLIC AMP (CAMP), AND PYROPHOSPHATE 1G6H ; 1.60 ; CRYSTAL STRUCTURE OF THE ADP CONFORMATION OF MJ1267, AN ATP- BINDING CASSETTE OF AN ABC TRANSPORTER 2AWO ; 2.80 ; CRYSTAL STRUCTURE OF THE ADP-MG-BOUND E. COLI MALK (CRYSTALLIZED WITH ADP-MG) 2AWN ; 2.30 ; CRYSTAL STRUCTURE OF THE ADP-MG-BOUND E. COLI MALK (CRYSTALLIZED WITH ATP-MG) 1GA7 ; 2.71 ; CRYSTAL STRUCTURE OF THE ADP-RIBOSE PYROPHOSPHATASE IN COMPLEX WITH GD+3 1D6Z ; 2.10 ; CRYSTAL STRUCTURE OF THE AEROBICALLY FREEZE TRAPPED RATE- DETERMINING CATALYTIC INTERMEDIATE OF E. COLI COPPER- CONTAINING AMINE OXIDASE. 1Q06 ; 2.07 ; CRYSTAL STRUCTURE OF THE AG(I) FORM OF E. COLI CUER, A COPPER EFFLUX REGULATOR 1P93 ; 2.70 ; CRYSTAL STRUCTURE OF THE AGONIST FORM OF GLUCOCORTICOID RECEPTOR 1XIU ; 2.50 ; CRYSTAL STRUCTURE OF THE AGONIST-BOUND LIGAND-BINDING DOMAIN OF BIOMPHALARIA GLABRATA RXR 1RO5 ; 2.30 ; CRYSTAL STRUCTURE OF THE AHL SYNTHASE LASI 1FEV ; 2.25 ; CRYSTAL STRUCTURE OF THE ALA4AIB MUTATION IN RNASE S 2BKY ; 1.70 ; CRYSTAL STRUCTURE OF THE ALBA1:ALBA2 HETERODIMER FROM SULFOLOBUS SOLFATARICUS 1H2B ; 1.62 ; CRYSTAL STRUCTURE OF THE ALCOHOL DEHYDROGENASE FROM THE HYPERTHERMOPHILIC ARCHAEON AEROPYRUM PERNIX AT 1.65A RESOLUTION 1SIJ ; 2.30 ; CRYSTAL STRUCTURE OF THE ALDEHYDE DEHYDROGENASE (A.K.A. AOR OR MOP) OF DESULFOVIBRIO GIGAS COVALENTLY BOUND TO [ASO3]- 1DGJ ; 2.80 ; CRYSTAL STRUCTURE OF THE ALDEHYDE OXIDOREDUCTASE FROM DESULFOVIBRIO DESULFURICANS ATCC 27774 1UAI ; 1.20 ; CRYSTAL STRUCTURE OF THE ALGINATE LYASE FROM CORYNEBACTERIUM SP. 1OIJ ; 2.10 ; CRYSTAL STRUCTURE OF THE ALKYLSULFATASE ATSK, A NON-HEME FE (II) ALPHAKETOGLUTARATE DEPENDENT DIOXYGENASE IN COMPLEX WITH ALPHAKETOGLUTARATE 1OIH ; 1.89 ; CRYSTAL STRUCTURE OF THE ALKYLSULFATASE ATSK, A NON-HEME FE(II) ALPHAKETOGLUTARATE DEPENDENT DIOXYGENASE 1OIK ; 2.06 ; CRYSTAL STRUCTURE OF THE ALKYLSULFATASE ATSK, A NON-HEME FE(II) ALPHAKETOGLUTARATE DEPENDENT DIOXYGENASE IN COMPLEX WITH FE, ALPHAKETOGLUTARATE AND 2-ETHYL-1-HEXANESULFURIC ACID 1OII ; 2.19 ; CRYSTAL STRUCTURE OF THE ALKYLSULFATASE ATSK, A NON-HEME FE(II) ALPHAKETOGLUTARATE DEPENDENT DIOXYGENASE IN COMPLEX WITH IRON AND ALPHAKETOGLUTARATE 1F0Q ; 2.63 ; CRYSTAL STRUCTURE OF THE ALPHA SUBUNIT OF PROTEIN KINASE CK2 IN COMPLEX WITH THE NUCLEOTIDE COMPETITIVE INHIBITOR EMODIN 1W80 ; 1.90 ; CRYSTAL STRUCTURE OF THE ALPHA-ADAPTIN APPENDAGE DOMAIN, FROM THE AP2 ADAPTOR COMPLEX, BOUND TO 2 PEPTIDES FROM SYNAPTOJANIN170 1DOV ; 3.00 ; CRYSTAL STRUCTURE OF THE ALPHA-CATENIN DIMERIZATION DOMAIN 1FP4 ; 2.50 ; CRYSTAL STRUCTURE OF THE ALPHA-H195Q MUTANT OF NITROGENASE 1N3Y ; 1.65 ; CRYSTAL STRUCTURE OF THE ALPHA-X BETA2 INTEGRIN I DOMAIN 1O5T ; 2.50 ; CRYSTAL STRUCTURE OF THE AMINOACYLATION CATALYTIC FRAGMENT OF HUMAN TRYPTOPHANYL-TRNA SYNTHETASE 1T5Z ; 2.30 ; CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN (LBD) WITH DHT AND A PEPTIDE DERIVED FROM ITS PHYSIOLOGICAL COACTIVATOR ARA70 1T7T ; 1.70 ; CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH 5-ALPHA DIHYDROTESTOSTERONE 1T73 ; 2.20 ; CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH A FXXFF MOTIF 1T7R ; 1.40 ; CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH A FXXLF MOTIF 1T79 ; 1.80 ; CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH A FXXLW MOTIF 1T7M ; 1.60 ; CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH A FXXYF MOTIF 1T7F ; 1.60 ; CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH A LXXLL MOTIF 1T74 ; 2.00 ; CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH A WXXLF MOTIF 1T76 ; 2.10 ; CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH A WXXVW MOTIF 2AX9 ; 1.65 ; CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH R-3 2AXA ; 1.80 ; CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH S-1 2AX6 ; 1.50 ; CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN T877A MUTANT IN COMPLEX WITH HYDROXYFLUTAMIDE 2AX7 ; 1.90 ; CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN T877A MUTANT IN COMPLEX WITH S-1 2AX8 ; 1.70 ; CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN W741L MUTANT IN COMPLEX WITH S-1 1T65 ; 1.66 ; CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN WITH DHT AND A PEPTIDE DERIVED FORM ITS PHYSIOLOGICAL COACTIVATOR GRIP1 NR BOX 2 BOUND IN A NON- HELICAL CONFORMATION 1T63 ; 2.07 ; CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN WITH DHT AND A PEPTIDE DERIVED FROM ITS PHYSIOLOGICAL COACTIVATOR GRIP1 NR BOX3 1Z95 ; 1.80 ; CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND-BINDING DOMAIN W741L MUTANT COMPLEX WITH R-BICALUTAMIDE 1BG5 ; 2.60 ; CRYSTAL STRUCTURE OF THE ANKYRIN BINDING DOMAIN OF ALPHA-NA,K-ATPASE AS A FUSION PROTEIN WITH GLUTATHIONE S-TRANSFERASE 1K1A ; 1.86 ; CRYSTAL STRUCTURE OF THE ANKYRIN REPEAT DOMAIN OF BCL-3: A UNIQUE MEMBER OF THE IKAPPAB PROTEIN FAMILY 1K1B ; 1.90 ; CRYSTAL STRUCTURE OF THE ANKYRIN REPEAT DOMAIN OF BCL-3: A UNIQUE MEMBER OF THE IKAPPAB PROTEIN FAMILY 1AEI ; 2.80 ; CRYSTAL STRUCTURE OF THE ANNEXIN XII HEXAMER 1NHZ ; 2.30 ; CRYSTAL STRUCTURE OF THE ANTAGONIST FORM OF GLUCOCORTICOID RECEPTOR 1JKY ; 3.90 ; CRYSTAL STRUCTURE OF THE ANTHRAX LETHAL FACTOR (LF): WILD- TYPE LF COMPLEXED WITH THE N-TERMINAL SEQUENCE OF MAPKK2 1PWP ; 2.90 ; CRYSTAL STRUCTURE OF THE ANTHRAX LETHAL FACTOR COMPLEXED WITH SMALL MOLECULE INHIBITOR NSC 12155 1TZO ; 3.60 ; CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE 1TZN ; 4.30 ; CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2, AN ANTHRAX TOXIN RECEPTOR 1L7I ; 1.80 ; CRYSTAL STRUCTURE OF THE ANTI-ERBB2 FAB2C4 1JHK ; 2.51 ; CRYSTAL STRUCTURE OF THE ANTI-ESTRADIOL ANTIBODY 57-2 1KTR ; 2.70 ; CRYSTAL STRUCTURE OF THE ANTI-HIS TAG ANTIBODY 3D5 SINGLE- CHAIN FRAGMENT (SCFV) IN COMPLEX WITH A OLIGOHISTIDINE PEPTIDE 1DQJ ; 2.00 ; CRYSTAL STRUCTURE OF THE ANTI-LYSOZYME ANTIBODY HYHEL-63 COMPLEXED WITH HEN EGG WHITE LYSOZYME 1CR9 ; 2.00 ; CRYSTAL STRUCTURE OF THE ANTI-PRION FAB 3F4 1CU4 ; 2.90 ; CRYSTAL STRUCTURE OF THE ANTI-PRION FAB 3F4 IN COMPLEX WITH ITS PEPTIDE EPITOPE 1MH0 ; 2.80 ; CRYSTAL STRUCTURE OF THE ANTICOAGULANT SLOW FORM OF THROMBIN 1SGI ; 2.30 ; CRYSTAL STRUCTURE OF THE ANTICOAGULANT SLOW FORM OF THROMBIN 1TQ7 ; 2.40 ; CRYSTAL STRUCTURE OF THE ANTICOAGULANT THROMBIN MUTANT W215A/E217A BOUND TO PPACK 1UYW ; 2.00 ; CRYSTAL STRUCTURE OF THE ANTIFLAVIVIRUS FAB4G2 1QTP ; 1.60 ; CRYSTAL STRUCTURE OF THE AP-2 CLATHRIN ADAPTOR ALPHA- APPENDAGE 1QTS ; 1.40 ; CRYSTAL STRUCTURE OF THE AP-2 CLATHRIN ADAPTOR ALPHA- APPENDAGE 1CY5 ; 1.30 ; CRYSTAL STRUCTURE OF THE APAF-1 CARD 1JHJ ; 1.60 ; CRYSTAL STRUCTURE OF THE APC10/DOC1 SUBUNIT OF THE HUMAN ANAPHASE-PROMOTING COMPLEX 1FA8 ; 1.70 ; CRYSTAL STRUCTURE OF THE APO FORM GLYOXALASE I OF ESCHERICHIA COLI 1INJ ; 1.55 ; CRYSTAL STRUCTURE OF THE APO FORM OF 4-DIPHOSPHOCYTIDYL-2-C- METHYLERYTHRITOL (CDP-ME) SYNTHETASE (YGBP) INVOLVED IN MEVALONATE INDEPENDENT ISOPRENOID BIOSYNTHESIS 1O62 ; 2.10 ; CRYSTAL STRUCTURE OF THE APO FORM OF A PLP-DEPENDENT ENZYME 1UR3 ; 2.57 ; CRYSTAL STRUCTURE OF THE APO FORM OF THE E.COLI YDHF PROTEIN 1TM2 ; 1.90 ; CRYSTAL STRUCTURE OF THE APO FORM OF THE SALMONELLA TYPHIMURIUM AI-2 RECEPTOR LSRB 1ZHH ; 1.94 ; CRYSTAL STRUCTURE OF THE APO FORM OF VIBRIO HARVEYI LUXP COMPLEXED WITH THE PERIPLASMIC DOMAIN OF LUXQ 1FMV ; 2.10 ; CRYSTAL STRUCTURE OF THE APO MOTOR DOMAIN OF DICTYOSTELLIUM MYOSIN II 1M61 ; 2.50 ; CRYSTAL STRUCTURE OF THE APO SH2 DOMAINS OF ZAP-70 1PT7 ; 1.80 ; CRYSTAL STRUCTURE OF THE APO-FORM OF THE YFDW GENE PRODUCT OF E. COLI 1FFL ; 2.94 ; CRYSTAL STRUCTURE OF THE APO-THYMIDYLATE SYNTHASE R166Q MUTANT 1SUL ; 2.00 ; CRYSTAL STRUCTURE OF THE APO-YSXC 1SIW ; 2.20 ; CRYSTAL STRUCTURE OF THE APOMOLYBDO-NARGHI 1JIW ; 1.74 ; CRYSTAL STRUCTURE OF THE APR-APRIN COMPLEX 1J4N ; 2.20 ; CRYSTAL STRUCTURE OF THE AQP1 WATER CHANNEL 2AU3 ; 2.00 ; CRYSTAL STRUCTURE OF THE AQUIFEX AEOLICUS PRIMASE (ZINC BINDING AND RIBONUCLEIC ACID POLYMERASE DOMAINS) 1Z7Y ; 2.70 ; CRYSTAL STRUCTURE OF THE ARABIDOPSIS THALIANA O- ACETYLSERINE SULFHYDRYLASE K46A MUTANT 1GEF ; 2.00 ; CRYSTAL STRUCTURE OF THE ARCHAEAL HOLLIDAY JUNCTION RESOLVASE HJC 1IPI ; 2.16 ; CRYSTAL STRUCTURE OF THE ARCHAEAL HOLLIDAY JUNCTION RESOLVASE HJC FROM PYROCOCCUS FURIOSUS FORM II 1TS9 ; 1.70 ; CRYSTAL STRUCTURE OF THE ARCHAEAL HOMOLOG OF HUMAN RNASE P PROTEIN RPP29 FROM ARCHAEOGLOBUS FULGIDUS 1TSF ; 1.70 ; CRYSTAL STRUCTURE OF THE ARCHAEAL HOMOLOG OF HUMAN RNASE P PROTEIN RPP29 FROM ARCHAEOGLOBUS FULGIDUS 1DCQ ; 2.10 ; CRYSTAL STRUCTURE OF THE ARF-GAP DOMAIN AND ANKYRIN REPEATS OF PAPBETA. 1CVR ; 2.00 ; CRYSTAL STRUCTURE OF THE ARG SPECIFIC CYSTEINE PROTEINASE GINGIPAIN R (RGPB) 1F7U ; 2.20 ; CRYSTAL STRUCTURE OF THE ARGINYL-TRNA SYNTHETASE COMPLEXED WITH THE TRNA(ARG) AND L-ARG 1RW9 ; 1.35 ; CRYSTAL STRUCTURE OF THE ARTHROBACTER AURESCENS CHONDROITIN AC LYASE 1AON ; 3.00 ; CRYSTAL STRUCTURE OF THE ASYMMETRIC CHAPERONIN COMPLEX GROEL/GROES/(ADP)7 1YS3 ; 1.90 ; CRYSTAL STRUCTURE OF THE ATP BINDING DOMAIN OF PRRB FROM MYCOBACTERIUM TUBERCULOSIS 1VCI ; 2.90 ; CRYSTAL STRUCTURE OF THE ATP-BINDING CASSETTE OF MULTISUGAR TRANSPORTER FROM PYROCOCCUS HORIKOSHII OT3 COMPLEXED WITH ATP 1Q12 ; 2.60 ; CRYSTAL STRUCTURE OF THE ATP-BOUND E. COLI MALK 1XEF ; 2.50 ; CRYSTAL STRUCTURE OF THE ATP/MG2+ BOUND COMPOSITE DIMER OF HLYB-NBD 1QDE ; 2.00 ; CRYSTAL STRUCTURE OF THE ATPASE DOMAIN OF TRANSLATION INITIATION FACTOR 4A FROM SACCHAROMYCES CEREVISIAE-THE PROTOTYPE OF THE DEAD BOX PROTEIN FAMILY 1PVG ; 1.80 ; CRYSTAL STRUCTURE OF THE ATPASE REGION OF SACCHAROMYCES CEREVISIAE TOPOISOMERASE II 1QZR ; 1.90 ; CRYSTAL STRUCTURE OF THE ATPASE REGION OF SACCHAROMYCES CEREVISIAE TOPOISOMERASE II BOUND TO ICRF-187 (DEXRAZOXANE) 1CC7 ; 1.20 ; CRYSTAL STRUCTURE OF THE ATX1 METALLOCHAPERONE PROTEIN 1CC8 ; 1.02 ; CRYSTAL STRUCTURE OF THE ATX1 METALLOCHAPERONE PROTEIN 1IAH ; 2.40 ; CRYSTAL STRUCTURE OF THE ATYPICAL PROTEIN KINASE DOMAIN OF A TRP CA-CHANNEL, CHAK (ADP-MG COMPLEX) 1IA9 ; 2.00 ; CRYSTAL STRUCTURE OF THE ATYPICAL PROTEIN KINASE DOMAIN OF A TRP CA-CHANNEL, CHAK (AMPPNP COMPLEX) 1IAJ ; 2.80 ; CRYSTAL STRUCTURE OF THE ATYPICAL PROTEIN KINASE DOMAIN OF A TRP CA-CHANNEL, CHAK (APO) 1Q07 ; 2.50 ; CRYSTAL STRUCTURE OF THE AU(I) FORM OF E. COLI CUER, A COPPER EFFLUX REGULATOR 1N8N ; 1.69 ; CRYSTAL STRUCTURE OF THE AU3+ COMPLEX OF APHA CLASS B ACID PHOSPHATASE/PHOSPHOTRANSFERASE FROM E. COLI AT 1.69 A RESOLUTION 2BDW ; 1.80 ; CRYSTAL STRUCTURE OF THE AUTO-INHIBITED KINASE DOMAIN OF CALCIUM/CALMODULIN ACTIVATED KINASE II 1K2D ; 2.20 ; CRYSTAL STRUCTURE OF THE AUTOIMMUNE MHC CLASS II I-AU COMPLEXED WITH MYELIN BASIC PROTEIN 1-11 AT 2.2A 1SOF ; 2.60 ; CRYSTAL STRUCTURE OF THE AZOTOBACTER VINELANDII BACTERIOFERRITIN AT 2.6 A RESOLUTION 1B44 ; 3.30 ; CRYSTAL STRUCTURE OF THE B SUBUNIT OF HEAT-LABILE ENTEROTOXIN FROM E. COLI CARRYING A PEPTIDE WITH ANTI-HSV ACTIVITY 1LTR ; 3.04 ; CRYSTAL STRUCTURE OF THE B SUBUNIT OF HUMAN HEAT-LABILE ENTEROTOXIN FROM E. COLI CARRYING A PEPTIDE WITH ANTI-HSV ACTIVITY 1R29 ; 1.30 ; CRYSTAL STRUCTURE OF THE B-CELL LYMPHOMA 6 (BCL6) BTB DOMAIN TO 1.3 ANGSTROM 1R28 ; 2.20 ; CRYSTAL STRUCTURE OF THE B-CELL LYMPHOMA 6 (BCL6) BTB DOMAIN TO 2.2 ANGSTROM 252D ; 2.30 ; CRYSTAL STRUCTURE OF THE B-DEOXYRIBONUCLEIC ACID DECAMER D(CGCAATTGCG)2; SEQUENCE-DEPENDENT CROSSED HELIX PACKING 478D ; 2.20 ; CRYSTAL STRUCTURE OF THE B-DEOXYRIBONUCLEIC ACID DODECAMER 5'-D(CGCGAA(TAF) TCGCG), WHERE TAF IS 2'-DEOXY-2'-FLUORO-ARABINO-FURANOSYL THYMINE 1JO2 ; 1.50 ; CRYSTAL STRUCTURE OF THE B-DEOXYRIBONUCLEIC ACID HEXAMER (CGATCG).DAUNOMYCIN COMPLEX CONTAINING A RIBOSE AT THE INTERCALATION SITE 1F69 ; 2.60 ; CRYSTAL STRUCTURE OF THE B-DEOXYRIBONUCLEIC ACID HEXAMER GGCGCC WITH COBALT HEXAMINE 1IH1 ; 2.00 ; CRYSTAL STRUCTURE OF THE B-DEOXYRIBONUCLEIC ACID HEXAMER GGCGCC WITH COBALT HEXAMINE RESOLVED TO 2.0 ANGSTROMS 1F6C ; 2.70 ; CRYSTAL STRUCTURE OF THE B-DEOXYRIBONUCLEIC ACID HEXAMER GGCGCC WITH SPERMINE 253D ; 2.20 ; CRYSTAL STRUCTURE OF THE B-DEOXYRIBONUCLEIC ACID NONAMER D(GCGTACGCG) WITH A NOVEL D[G(G(DOT)C)] BASE-TRIPLET INVOLVING THE MINOR GROOVE 1Y7M ; 2.05 ; CRYSTAL STRUCTURE OF THE B. SUBTILIS YKUD PROTEIN AT 2 A RESOLUTION 2ACJ ; 2.60 ; CRYSTAL STRUCTURE OF THE B/Z JUNCTION CONTAINING DEOXYRIBONUCLEIC ACID BOUND TO Z-DEOXYRIBONUCLEIC ACID BINDING PROTEINS 1KEX ; 1.90 ; CRYSTAL STRUCTURE OF THE B1 DOMAIN OF HUMAN NEUROPILIN-1 1YVK ; 3.01 ; CRYSTAL STRUCTURE OF THE BACILLIS SUBTILIS ACETYLTRANSFERASE IN COMPLEX WITH COA, NORTHEAST STRUCTURAL GENOMICS TARGET SR237. 1YDO ; 2.71 ; CRYSTAL STRUCTURE OF THE BACILLIS SUBTILIS HMG-COA LYASE, NORTHEAST STRUCTURAL GENOMICS TARGET SR181. 1L0O ; 2.90 ; CRYSTAL STRUCTURE OF THE BACILLUS STEAROTHERMOPHILUS ANTI- SIGMA FACTOR SPOIIAB WITH THE SPORULATION SIGMA FACTOR SIGMAF 1VZY ; 1.97 ; CRYSTAL STRUCTURE OF THE BACILLUS SUBTILIS HSP33 1FSE ; 2.05 ; CRYSTAL STRUCTURE OF THE BACILLUS SUBTILIS REGULATORY PROTEIN GERE 2BAS ; 2.61 ; CRYSTAL STRUCTURE OF THE BACILLUS SUBTILIS YKUI PROTEIN, WITH AN EAL DOMAIN. 1HF2 ; 2.20 ; CRYSTAL STRUCTURE OF THE BACTERIAL CELL-DIVISION INHIBITOR MINC FROM T. MARITIMA 1T16 ; 2.60 ; CRYSTAL STRUCTURE OF THE BACTERIAL FATTY ACID TRANSPORTER FADL FROM ESCHERICHIA COLI 1JFX ; 1.65 ; CRYSTAL STRUCTURE OF THE BACTERIAL LYSOZYME FROM STREPTOMYCES COELICOLOR AT 1.65 A RESOLUTION 2AVY ; 3.46 ; CRYSTAL STRUCTURE OF THE BACTERIAL RIBOSOME FROM ESCHERICHIA COLI AT 3.5 A RESOLUTION. THIS FILE CONTAINS THE 30S SUBUNIT OF ONE 70S RIBOSOME. THE ENTIRE CRYSTAL STRUCTURE CONTAINS TWO 70S RIBOSOMES AND IS DESCRIBED IN REMARK 400. 2AW7 ; 3.46 ; CRYSTAL STRUCTURE OF THE BACTERIAL RIBOSOME FROM ESCHERICHIA COLI AT 3.5 A RESOLUTION. THIS FILE CONTAINS THE 30S SUBUNIT OF THE SECOND 70S RIBOSOME. THE ENTIRE CRYSTAL STRUCTURE CONTAINS TWO 70S RIBOSOMES AND IS DESCRIBED IN REMARK 400. 2AW4 ; 3.46 ; CRYSTAL STRUCTURE OF THE BACTERIAL RIBOSOME FROM ESCHERICHIA COLI AT 3.5 A RESOLUTION. THIS FILE CONTAINS THE 50S SUBUNIT OF ONE 70S RIBOSOME. THE ENTIRE CRYSTAL STRUCTURE CONTAINS TWO 70S RIBOSOMES AND IS DESCRIBED IN REMARK 400. 2AWB ; 3.46 ; CRYSTAL STRUCTURE OF THE BACTERIAL RIBOSOME FROM ESCHERICHIA COLI AT 3.5 A RESOLUTION. THIS FILE CONTAINS THE 50S SUBUNIT OF THE SECOND 70S RIBOSOME. THE ENTIRE CRYSTAL STRUCTURE CONTAINS TWO 70S RIBOSOMES AND IS DESCRIBED IN REMARK 400. 1KSA ; 2.50 ; CRYSTAL STRUCTURE OF THE BACTERIOCHLOROPHYLL A PROTEIN FROM CHLOROBIUM TEPIDUM 1M50 ; 2.20 ; CRYSTAL STRUCTURE OF THE BACTERIOCHLOROPHYLL A PROTEIN FROM CHLOROBIUM TEPIDUM 1ZMA ; 1.25 ; CRYSTAL STRUCTURE OF THE BACTEROCIN TRANSPORT ACCESSORY PROTEIN FROM STREPTOCOCCUS PNEUMONIAE 1OTZ ; 3.30 ; CRYSTAL STRUCTURE OF THE BAFF-BAFF-R COMPLEX (PART I) 1P0T ; 3.30 ; CRYSTAL STRUCTURE OF THE BAFF-BAFF-R COMPLEX (PART II) 1R2B ; 2.20 ; CRYSTAL STRUCTURE OF THE BCL6 BTB DOMAIN COMPLEXED WITH A SMRT CO-REPRESSOR PEPTIDE 1XHF ; 2.15 ; CRYSTAL STRUCTURE OF THE BEF3-ACTIVATED RECEIVER DOMAIN OF REDOX RESPONSE REGULATOR ARCA 1XA7 ; 2.40 ; CRYSTAL STRUCTURE OF THE BENZYLPENICILLIN-ACYLATED BLAR1 SENSOR DOMAIN FROM STAPHYLOCOCCUS AUREUS 1LUJ ; 2.50 ; CRYSTAL STRUCTURE OF THE BETA-CATENIN/ICAT COMPLEX 2ASU ; 1.85 ; CRYSTAL STRUCTURE OF THE BETA-CHAIN OF HGFL/MSP 1QVB ; 2.40 ; CRYSTAL STRUCTURE OF THE BETA-GLYCOSIDASE FROM THE HYPERTHERMOPHILE THERMOSPHAERA AGGREGANS 1K7X ; 1.70 ; CRYSTAL STRUCTURE OF THE BETA-SER178PRO MUTANT OF TRYPTOPHAN SYNTHASE 1F7C ; 2.40 ; CRYSTAL STRUCTURE OF THE BH DOMAIN FROM GRAF, THE GTPASE REGULATOR ASSOCIATED WITH FOCAL ADHESION KINASE 1VJ7 ; 2.10 ; CRYSTAL STRUCTURE OF THE BIFUNCTIONAL CATALYTIC FRAGMENT OF RELSEQ, THE RELA/SPOT HOMOLOG FROM STREPTOCOCCUS EQUISIMILIS. 1R52 ; 2.89 ; CRYSTAL STRUCTURE OF THE BIFUNCTIONAL CHORISMATE SYNTHASE FROM SACCHAROMYCES CEREVISIAE 1R53 ; 2.20 ; CRYSTAL STRUCTURE OF THE BIFUNCTIONAL CHORISMATE SYNTHASE FROM SACCHAROMYCES CEREVISIAE 1B1U ; 2.20 ; CRYSTAL STRUCTURE OF THE BIFUNCTIONAL INHIBITOR RAGI 1VZW ; 1.80 ; CRYSTAL STRUCTURE OF THE BIFUNCTIONAL PROTEIN PRIA 1K9B ; 2.80 ; CRYSTAL STRUCTURE OF THE BIFUNCTIONAL SOYBEAN BOWMAN-BIRK INHIBITOR AT 0.28 NM RESOLUTION. STRUCTURAL PECULIARITIES IN A FOLDED PROTEIN CONFORMATION 1P0F ; 1.80 ; CRYSTAL STRUCTURE OF THE BINARY COMPLEX: NADP(H)-DEPENDENT VERTEBRATE ALCOHOL DEHYDROGENASE (ADH8) WITH THE COFACTOR NADP 1D3V ; 1.70 ; CRYSTAL STRUCTURE OF THE BINUCLEAR MANGANESE METALLOENZYME ARGINASE COMPLEXED WITH 2(S)-AMINO-6-BORONOHEXANOIC ACID, AN L-ARGININE ANALOG 1HQF ; 2.90 ; CRYSTAL STRUCTURE OF THE BINUCLEAR MANGANESE METALLOENZYME ARGINASE COMPLEXED WITH N-HYDROXY-L-ARGININE 1HQH ; 2.80 ; CRYSTAL STRUCTURE OF THE BINUCLEAR MANGANESE METALLOENZYME ARGINASE COMPLEXED WITH NOR-N-HYDROXY-L-ARGININE 1HQ5 ; 2.30 ; CRYSTAL STRUCTURE OF THE BINUCLEAR MANGANESE METALLOENZYME ARGINASE COMPLEXED WITH S-(2-BORONOETHYL)-L-CYSTEINE, AN L- ARGININE ANALOGUE 1ULZ ; 2.20 ; CRYSTAL STRUCTURE OF THE BIOTIN CARBOXYLASE SUBUNIT OF PYRUVATE CARBOXYLASE 1FM4 ; 1.97 ; CRYSTAL STRUCTURE OF THE BIRCH POLLEN ALLERGEN BET V 1L 1XSD ; 2.70 ; CRYSTAL STRUCTURE OF THE BLAI REPRESSOR IN COMPLEX WITH DEOXYRIBONUCLEIC ACID 1FL3 ; 2.45 ; CRYSTAL STRUCTURE OF THE BLUE FLUORESCENT ANTIBODY (19G2) IN COMPLEX WITH STILBENE HAPTEN AT 277K 1LX5 ; 3.30 ; CRYSTAL STRUCTURE OF THE BMP7/ACTRII EXTRACELLULAR DOMAIN COMPLEX 1N93 ; 1.76 ; CRYSTAL STRUCTURE OF THE BORNA DISEASE VIRUS NUCLEOPROTEIN 1PP1 ; 1.90 ; CRYSTAL STRUCTURE OF THE BORNA DISEASE VIRUS NUCLEOPROTEIN 1FGX ; 2.40 ; CRYSTAL STRUCTURE OF THE BOVINE BETA 1,4 GALACTOSYLTRANSFERASE (B4GALT1) CATALYTIC DOMAIN COMPLEXED WITH UMP 1FR8 ; 2.40 ; CRYSTAL STRUCTURE OF THE BOVINE BETA 1,4 GALACTOSYLTRANSFERASE (B4GALT1) CATALYTIC DOMAIN COMPLEXED WITH URIDINE DIPHOSPHOGALACTOSE 1G93 ; 2.50 ; CRYSTAL STRUCTURE OF THE BOVINE CATALYTIC DOMAIN OF ALPHA-1, 3-GALACTOSYLTRANSFERASE IN THE PRESENCE OF UDP-GALACTOSE 1G4I ; 0.97 ; CRYSTAL STRUCTURE OF THE BOVINE PANCREATIC PHOSPHOLIPASE A2 AT 0.97A 1OX1 ; 2.00 ; CRYSTAL STRUCTURE OF THE BOVINE TRYPSIN COMPLEX WITH A SYNTHETIC 11 PEPTIDE INHIBITOR 1EJM ; 1.85 ; CRYSTAL STRUCTURE OF THE BPTI ALA16LEU MUTANT IN COMPLEX WITH BOVINE TRYPSIN 1T15 ; 1.85 ; CRYSTAL STRUCTURE OF THE BRCA1 BRCT DOMAINS IN COMPLEX WITH THE PHOSPHORYLATED INTERACTING REGION FROM BACH1 HELICASE 1T29 ; 2.30 ; CRYSTAL STRUCTURE OF THE BRCA1 BRCT REPEATS BOUND TO A PHOSPHORYLATED BACH1 PEPTIDE 1GZH ; 2.60 ; CRYSTAL STRUCTURE OF THE BRCT DOMAINS OF HUMAN 53BP1 BOUND TO THE P53 TUMOR SUPRESSOR 1JNX ; 2.50 ; CRYSTAL STRUCTURE OF THE BRCT REPEAT REGION FROM THE BREAST CANCER ASSOCIATED PROTEIN, BRCA1 2ADO ; 1.45 ; CRYSTAL STRUCTURE OF THE BRCT REPEAT REGION FROM THE MEDIATOR OF DEOXYRIBONUCLEIC ACID DAMAGE CHECKPOINT PROTEIN 1, MDC1 1RHH ; 1.90 ; CRYSTAL STRUCTURE OF THE BROADLY HIV-1 NEUTRALIZING FAB X5 AT 1.90 ANGSTROM RESOLUTION 1U6A ; 2.81 ; CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTI-HIV FAB F105 1TJH ; 2.10 ; CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY 2F5 IN COMPLEX WITH A GP41 11MER EPITOPE 1TJI ; 2.20 ; CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY 2F5 IN COMPLEX WITH A GP41 17MER EPITOPE 1TJG ; 2.00 ; CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY 2F5 IN COMPLEX WITH A GP41 7MER EPITOPE 1N9K ; 2.20 ; CRYSTAL STRUCTURE OF THE BROMIDE ADDUCT OF APHA CLASS B ACID PHOSPHATASE/PHOSPHOTRANSFERASE FROM E. COLI AT 2.2 A RESOLUTION 1Q0U ; 1.85 ; CRYSTAL STRUCTURE OF THE BSTDEAD N-TERMINAL DOMAIN 1V9M ; 1.85 ; CRYSTAL STRUCTURE OF THE C SUBUNIT OF V-TYPE ATPASE FROM THERMUS THERMOPHILUS 1QN3 ; 1.95 ; CRYSTAL STRUCTURE OF THE C(-25) ADENOVIRUS MAJOR LATE PROMOTER TATA BOX VARIANT BOUND TO WILD-TYPE TBP (ARABIDOPSIS THALIANA TBP ISOFORM 2). TATA ELEMENT RECOGNITION BY THE TATA BOX-BINDING PROTEIN HAS BEEN CONSERVED THROUGHOUT EVOLUTION. 1QN9 ; 1.90 ; CRYSTAL STRUCTURE OF THE C(-29) ADENOVIRUS MAJOR LATE PROMOTER TATA BOX VARIANT BOUND TO WILD-TYPE TBP (ARABIDOPSIS THALIANA TBP ISOFORM 2). TATA ELEMENT RECOGNITION BY THE TATA BOX-BINDING PROTEIN HAS BEEN CONSERVED THROUGHOUT EVOLUTION. 1M52 ; 2.60 ; CRYSTAL STRUCTURE OF THE C-ABL KINASE DOMAIN IN COMPLEX WITH PD173955 1IEP ; 2.10 ; CRYSTAL STRUCTURE OF THE C-ABL KINASE DOMAIN IN COMPLEX WITH STI-571. 1U2E ; 2.10 ; CRYSTAL STRUCTURE OF THE C-C BOND HYDROLASE MHPC 1YVH ; 2.05 ; CRYSTAL STRUCTURE OF THE C-CBL TKB DOMAIN IN COMPLEX WITH THE APS PTYR-618 PHOSPHOPEPTIDE 1Q89 ; 2.75 ; CRYSTAL STRUCTURE OF THE C-DOMAIN OF THE T.VAGINALIS INR BINDING PROTEIN, IBP39 (CUBIC CRYSTAL FORM) 1Q88 ; 2.42 ; CRYSTAL STRUCTURE OF THE C-DOMAIN OF THE T.VAGINALIS INR BINDING PROTEIN, IBP39 (MONOCLINIC FORM) 1Q87 ; 2.32 ; CRYSTAL STRUCTURE OF THE C-DOMAIN OF THE T.VAGINALIS INR BINDING PROTEIN, IBP39 (TETRAGONAL FORM) 1IOZ ; 2.00 ; CRYSTAL STRUCTURE OF THE C-HA-RAS PROTEIN PREPARED BY THE CELL-FREE SYNTHESIS 1UD0 ; 3.45 ; CRYSTAL STRUCTURE OF THE C-TERMINAL 10-KDA SUBDOMAIN OF HSC70 1Q5Z ; 1.80 ; CRYSTAL STRUCTURE OF THE C-TERMINAL ACTIN BINDING DOMAIN OF SALMONELLA INVASION PROTEIN A (SIPA) 1JJ7 ; 2.40 ; CRYSTAL STRUCTURE OF THE C-TERMINAL ATPASE DOMAIN OF HUMAN TAP1 1U2K ; 2.00 ; CRYSTAL STRUCTURE OF THE C-TERMINAL DOMAIN FROM THE CATALASE-PEROXIDASE KATG OF ESCHERICHIA COLI (I41) 1U2L ; 2.30 ; CRYSTAL STRUCTURE OF THE C-TERMINAL DOMAIN FROM THE CATALASE-PEROXIDASE KATG OF ESCHERICHIA COLI (P1) 1U2J ; 2.30 ; CRYSTAL STRUCTURE OF THE C-TERMINAL DOMAIN FROM THE CATALASE-PEROXIDASE KATG OF ESCHERICHIA COLI (P21 21 21) 1IU9 ; 2.04 ; CRYSTAL STRUCTURE OF THE C-TERMINAL DOMAIN OF ASPARTATE RACEMASE FROM PYROCOCCUS HORIKOSHII OT3 1WCK ; 1.36 ; CRYSTAL STRUCTURE OF THE C-TERMINAL DOMAIN OF BCLA, THE MAJOR ANTIGEN OF THE EXOSPORIUM OF THE BACILLUS ANTHRACIS SPORE. 1WP5 ; 1.79 ; CRYSTAL STRUCTURE OF THE C-TERMINAL DOMAIN OF DEOXYRIBONUCLEIC ACID TOPOISOMERASE IV 1YSP ; 1.80 ; CRYSTAL STRUCTURE OF THE C-TERMINAL DOMAIN OF E. COLI TRANSCRIPTIONAL REGULATOR KDGR. 1WU9 ; 1.54 ; CRYSTAL STRUCTURE OF THE C-TERMINAL DOMAIN OF THE END- BINDING PROTEIN 1 (EB1) 1O9Y ; 2.29 ; CRYSTAL STRUCTURE OF THE C-TERMINAL DOMAIN OF THE HRCQB PROTEIN FROM PSEUDOMONAS SYRINGAE PV. PHASEOLICOLA 1I27 ; 1.02 ; CRYSTAL STRUCTURE OF THE C-TERMINAL DOMAIN OF THE RAP74 SUBUNIT OF HUMAN TRANSCRIPTION FACTOR IIF (TFIIF) 1R62 ; 1.60 ; CRYSTAL STRUCTURE OF THE C-TERMINAL DOMAIN OF THE TWO- COMPONENT SYSTEM TRANSMITTER PROTEIN NRII (NTRB) 1V2Z ; 1.80 ; CRYSTAL STRUCTURE OF THE C-TERMINAL DOMAIN OF THERMOSYNECHOCOCCUS ELONGATUS BP-1 KAIA 1QXX ; 2.70 ; CRYSTAL STRUCTURE OF THE C-TERMINAL DOMAIN OF TONB 1T5I ; 1.90 ; CRYSTAL STRUCTURE OF THE C-TERMINAL DOMAIN OF UAP56 1O6A ; 1.85 ; CRYSTAL STRUCTURE OF THE C-TERMINAL FRAGMENT OF THE PUTATIVE FLAGELAR MOTOR SWITCH PROTEIN FLIN (TM0680A) FROM THERMOTOGA MARITIMA AT 1.85 A RESOLUTION 1L1D ; 1.85 ; CRYSTAL STRUCTURE OF THE C-TERMINAL METHIONINE SULFOXIDE REDUCTASE DOMAIN (MSRB) OF N. GONORRHOEAE PILB 1SK3 ; 2.80 ; CRYSTAL STRUCTURE OF THE C-TERMINAL PEPTIDOGLYCAN-BINDING DOMAIN OF HUMAN PEPTIDOGLYCAN RECOGNITION PROTEIN IALPHA 1SK4 ; 1.65 ; CRYSTAL STRUCTURE OF THE C-TERMINAL PEPTIDOGLYCAN-BINDING DOMAIN OF HUMAN PEPTIDOGLYCAN RECOGNITION PROTEIN IALPHA 1TWQ ; 2.30 ; CRYSTAL STRUCTURE OF THE C-TERMINAL PGN-BINDING DOMAIN OF HUMAN PGRP-IALPHA IN COMPLEX WITH PGN ANALOG MURAMYL TRIPEPTIDE 1KQL ; 2.70 ; CRYSTAL STRUCTURE OF THE C-TERMINAL REGION OF STRIATED MUSCLE ALPHA-TROPOMYOSIN AT 2.7 ANGSTROM RESOLUTION 1QAD ; 1.80 ; CRYSTAL STRUCTURE OF THE C-TERMINAL SH2 DOMAIN OF THE P85 ALPHA REGULATORY SUBUNIT OF PHOSPHOINOSITIDE 3-KINASE: AN SH2 DOMAIN MIMICKING ITS OWN SUBSTRATE 1DXS ; 2.54 ; CRYSTAL STRUCTURE OF THE C-TERMINAL STERILE ALPHA MOTIF (SAM) DOMAIN OF HUMAN P73 ALPHA SPLICE VARIANT 1R5M ; 1.55 ; CRYSTAL STRUCTURE OF THE C-TERMINAL WD40 DOMAIN OF SIF2 1ERJ ; 2.30 ; CRYSTAL STRUCTURE OF THE C-TERMINAL WD40 DOMAIN OF TUP1 1SZI ; 2.80 ; CRYSTAL STRUCTURE OF THE C-TERMINUS OF TIP47 1Q40 ; 1.95 ; CRYSTAL STRUCTURE OF THE C. ALBICANS MTR2-MEX67 M DOMAIN COMPLEX 1EMS ; 2.80 ; CRYSTAL STRUCTURE OF THE C. ELEGANS NITFHIT PROTEIN 1DLG ; 1.90 ; CRYSTAL STRUCTURE OF THE C115S ENTEROBACTER CLOACAE MURA IN THE UN-LIGANDED STATE 1Y55 ; 1.00 ; CRYSTAL STRUCTURE OF THE C122S MUTANT OF E. COLI EXPRESSED AVIDIN RELATED PROTEIN 4 (AVR4)-BIOTIN COMPLEX 1XG4 ; 1.60 ; CRYSTAL STRUCTURE OF THE C123S 2-METHYLISOCITRATE LYASE MUTANT FROM ESCHERICHIA COLI IN COMPLEX WITH THE INHIBITOR ISOCITRATE 1XG3 ; 1.90 ; CRYSTAL STRUCTURE OF THE C123S 2-METHYLISOCITRATE LYASE MUTANT FROM ESCHERICHIA COLI IN COMPLEX WITH THE REACTION PRODUCT, MG(II)-PYRUVATE AND SUCCINATE 1GGV ; 2.50 ; CRYSTAL STRUCTURE OF THE C123S MUTANT OF DIENELACTONE HYDROLASE (DLH) BOUND WITH THE PMS MOIETY OF THE PROTEASE INHIBITOR, PHENYLMETHYLSULFONYL FLUORIDE (PMSF) 1PQP ; 2.06 ; CRYSTAL STRUCTURE OF THE C136S MUTANT OF ASPARTATE SEMIALDEHYDE DEHYDROGENASE FROM HAEMOPHILUS INFLUENZAE BOUND WITH ASPARTATE SEMIALDEHYDE AND PHOSPHATE 2B3R ; 2.30 ; CRYSTAL STRUCTURE OF THE C2 DOMAIN OF CLASS II PHOSPHATIDYLINOSITIDE 3-KINASE C2 1CZT ; 1.87 ; CRYSTAL STRUCTURE OF THE C2 DOMAIN OF HUMAN COAGULATION FACTOR V 1CZS ; 1.90 ; CRYSTAL STRUCTURE OF THE C2 DOMAIN OF HUMAN COAGULATION FACTOR V: COMPLEX WITH PHENYLMERCURY 1CZV ; 2.40 ; CRYSTAL STRUCTURE OF THE C2 DOMAIN OF HUMAN COAGULATION FACTOR V: DIMERIC CRYSTAL FORM 1D7P ; 1.50 ; CRYSTAL STRUCTURE OF THE C2 DOMAIN OF HUMAN FACTOR VIII AT 1.5 A RESOLUTION AT 1.5 A 1PA1 ; 1.60 ; CRYSTAL STRUCTURE OF THE C215D MUTANT OF PROTEIN TYROSINE PHOSPHATASE 1B 2A9K ; 1.73 ; CRYSTAL STRUCTURE OF THE C3BOT-NAD-RALA COMPLEX REVEALS A NOVEL TYPE OF ACTION OF A BACTERIAL EXOENZYME 2A78 ; 1.81 ; CRYSTAL STRUCTURE OF THE C3BOT-RALA COMPLEX REVEALS A NOVEL TYPE OF ACTION OF A BACTERIAL EXOENZYME 1FF2 ; 2.30 ; CRYSTAL STRUCTURE OF THE C42D MUTANT OF AZOTOBACTER VINELANDII 7FE FERREDOXIN (FDI) 1O77 ; 3.20 ; CRYSTAL STRUCTURE OF THE C713S MUTANT OF THE TIR DOMAIN OF HUMAN TLR2 1K9U ; 1.75 ; CRYSTAL STRUCTURE OF THE CALCIUM-BINDING POLLEN ALLERGEN PHL P 7 (POLCALCIN) AT 1.75 ANGSTROEM 1ZH2 ; 2.00 ; CRYSTAL STRUCTURE OF THE CALCIUM-BOUND RECEIVER DOMAIN OF KDP POTASSIUM TRANSPORT SYSTEM RESPONSE REGULATOR KDPE 1GGZ ; 1.50 ; CRYSTAL STRUCTURE OF THE CALMODULIN-LIKE PROTEIN (HCLP) FROM HUMAN EPITHELIAL CELLS 1P2X ; 2.21 ; CRYSTAL STRUCTURE OF THE CALPONIN-HOMOLOGY DOMAIN OF RNG2 FROM SCHIZOSACCHAROMYCES POMBE 1RI8 ; 1.85 ; CRYSTAL STRUCTURE OF THE CAMELID SINGLE DOMAIN ANTIBODY 1D2L19 IN COMPLEX WITH HEN EGG WHITE LYSOZYME 1RJC ; 1.40 ; CRYSTAL STRUCTURE OF THE CAMELID SINGLE DOMAIN ANTIBODY CAB- LYS2 IN COMPLEX WITH HEN EGG WHITE LYSOZYME 1U6G ; 3.10 ; CRYSTAL STRUCTURE OF THE CAND1-CUL1-ROC1 COMPLEX 1C3O ; 2.10 ; CRYSTAL STRUCTURE OF THE CARBAMOYL PHOSPHATE SYNTHETASE: SMALL SUBUNIT MUTANT C269S WITH BOUND GLUTAMINE 1DV8 ; 2.30 ; CRYSTAL STRUCTURE OF THE CARBOHYDRATE RECOGNITION DOMAIN OF THE H1 SUBUNIT OF THE ASIALOGLYCOPROTEIN RECEPTOR 1FUK ; 1.75 ; CRYSTAL STRUCTURE OF THE CARBOXY TERMINAL DOMAIN OF YEAST EIF4A 1SF8 ; 2.60 ; CRYSTAL STRUCTURE OF THE CARBOXY-TERMINAL DOMAIN OF HTPG, THE E. COLI HSP90 1W2X ; 2.80 ; CRYSTAL STRUCTURE OF THE CARBOXYLTRANSFERASE DOMAIN OF ACETYL-COENZYME A CARBOXYLASE IN COMPLEX WITH CP-640186 1PIX ; 2.20 ; CRYSTAL STRUCTURE OF THE CARBOXYLTRANSFERASE SUBUNIT OF THE BACTERIAL ION PUMP GLUTACONYL-COENZYME A DECARBOXYLASE 1JQG ; 2.50 ; CRYSTAL STRUCTURE OF THE CARBOXYPEPTIDASE A FROM HELICOVERPA ARMIGERA 1KMC ; 2.90 ; CRYSTAL STRUCTURE OF THE CASPASE-7 / XIAP-BIR2 COMPLEX 1I4E ; 3.00 ; CRYSTAL STRUCTURE OF THE CASPASE-8/P35 COMPLEX 1SY7 ; 1.75 ; CRYSTAL STRUCTURE OF THE CATALASE-1 FROM NEUROSPORA CRASSA, NATIVE STRUCTURE AT 1.75A RESOLUTION. 2AQX ; 2.50 ; CRYSTAL STRUCTURE OF THE CATALYTIC AND CAM-BINDING DOMAINS OF INOSITOL 1,4,5-TRISPHOSPHATE 3-KINASE B 1T94 ; 2.40 ; CRYSTAL STRUCTURE OF THE CATALYTIC CORE OF HUMAN DEOXYRIBONUCLEIC ACID POLYMERASE KAPPA 1TZD ; 2.20 ; CRYSTAL STRUCTURE OF THE CATALYTIC CORE OF INOSITOL 1,4,5- TRISPHOSPHATE 3-KINASE 1JMS ; 2.36 ; CRYSTAL STRUCTURE OF THE CATALYTIC CORE OF MURINE TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE 1GH2 ; 2.22 ; CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF A NEW HUMAN THIOREDOXIN-LIKE PROTEIN 1TML ; 1.80 ; CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF A THERMOPHILIC ENDOCELLULASE 1ZY7 ; 1.70 ; CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF AN ADENOSINE DEAMINASE THAT ACTS ON RIBONUCLEIC ACID (HADAR2) BOUND TO INOSITOL HEXAKISPHOSPHATE (IHP) 1ZRZ ; 3.00 ; CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF ATYPICAL PROTEIN KINASE C-IOTA 1O0R ; 2.30 ; CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF BOVINE BETA1,4- GALACTOSYLTRANSFERASE COMPLEX WITH UDP-GALACTOSE 1ZHR ; 1.73 ; CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF COAGULATION FACTOR XI IN COMPLEX WITH BENZAMIDINE (S434A-T475A-C482S- K437A MUTANT) 1ZHP ; 2.70 ; CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF COAGULATION FACTOR XI IN COMPLEX WITH BENZAMIDINE (S434A-T475A-K505 MUTANT) 1ZJD ; 2.60 ; CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF COAGULATION FACTOR XI IN COMPLEX WITH KUNITZ PROTEASE INHIBITOR DOMAIN OF PROTEASE NEXIN II 1XPI ; 2.20 ; CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF E. COLI PSEUDOURIDINE SYNTHASE RLUC 1HQ0 ; 1.83 ; CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF E.COLI CYTOTOXIC NECROTIZING FACTOR TYPE 1 1R55 ; 1.58 ; CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN ADAM 33 1R54 ; 1.85 ; CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN ADAM33 1ELV ; 1.70 ; CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN COMPLEMENT C1S PROTEASE 1SLN ; 2.27 ; CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST STROMELYSIN-1 INHIBITED WITH THE N-CARBOXY-ALKYL INHIBITOR L-702,842 1HFS ; 1.70 ; CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST STROMELYSIN-1 INHIBITED WITH THE N-CARBOXY-ALKYL INHIBITOR L-764,004 2USN ; 2.20 ; CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST STROMELYSIN-1 INHIBITED WITH THIADIAZOLE INHIBITOR PNU-141803 1USN ; 1.80 ; CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST STROMELYSIN-1 INHIBITED WITH THIADIAZOLE INHIBITOR PNU-142372 2A98 ; 2.60 ; CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN INOSITOL 1,4,5-TRISPHOSPHATE 3-KINASE C 1Q3A ; 2.10 ; CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MATRIX METALLOPROTEINASE 10 1Y93 ; 1.03 ; CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 COMPLEXED WITH ACETOHYDROXAMIC ACID AT ATOMIC RESOLUTION 1RMZ ; 1.34 ; CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 COMPLEXED WITH THE INHIBITOR NNGH AT 1.3 A RESOLUTION 2A8B ; 2.30 ; CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN TYROSINE PHOSPHATASE RECEPTOR, TYPE R 2AHS ; 2.10 ; CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN TYROSINE RECEPTOR PHOSPHATASE BETA 1YOU ; 2.30 ; CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-13 COMPLEXED WITH A POTENT PYRIMIDINETRIONE INHIBITOR 1RM8 ; 1.80 ; CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-16/MT3- MMP: CHARACTERIZATION OF MT-MMP SPECIFIC FEATURES 1JLN ; 1.81 ; CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF PROTEIN TYROSINE PHOSPHATASE PTP-SL/BR7 2B49 ; 1.54 ; CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 3 1ZHM ; 1.96 ; CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF THE COAGULATION FACTOR XIA IN COMPLEX WITH BENZAMIDINE (S434A- T475A-K437 MUTANT) 1GWZ ; 2.50 ; CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF THE PROTEIN TYROSINE PHOSPHATASE SHP-1 2BVL ; 2.20 ; CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF TOXIN B FROM CLOSTRIDIUM DIFFICILE IN COMPLEX WITH UDP, GLC AND MANGANESE ION 2BVM ; 2.55 ; CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF TOXIN B FROM CLOSTRIDIUM DIFFICILE IN COMPLEX WITH UDP, GLC AND MANGANESE ION 1NQ6 ; 1.78 ; CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF XYLANASE A FROM STREPTOMYCES HALSTEDII JM8 1HY5 ; 2.25 ; CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF YOPE-YERSINIA PESTIS GAP EFFECTOR PROTEIN. 1YGB ; 2.48 ; CRYSTAL STRUCTURE OF THE CATALYTIC FRAGMENT OF ALANYL-TRNA SYNTHETASE IN COMPLEX WITH L-SERINE 1PAQ ; 2.30 ; CRYSTAL STRUCTURE OF THE CATALYTIC FRAGMENT OF EUKARYOTIC INITIATION FACTOR 2B EPSILON 1GS0 ; 2.80 ; CRYSTAL STRUCTURE OF THE CATALYTIC FRAGMENT OF MURINE POLY (ADP-RIBOSE) POLYMERASE-2 1EFY ; 2.20 ; CRYSTAL STRUCTURE OF THE CATALYTIC FRAGMENT OF POLY (ADP- RIBOSE) POLYMERASE COMPLEXED WITH A BENZIMIDAZOLE INHIBITOR 1Q3X ; 2.23 ; CRYSTAL STRUCTURE OF THE CATALYTIC REGION OF HUMAN MASP-2 1IEC ; 2.20 ; CRYSTAL STRUCTURE OF THE CATALYTIC SITE MUTANT (H157A) OF THE HUMAN CYTOMEGALOVIRUS PROTEASE 1IED ; 2.00 ; CRYSTAL STRUCTURE OF THE CATALYTIC SITE MUTANT (H157E) OF THE HUMAN CYTOMEGALOVIRUS PROTEASE 1ID4 ; 2.20 ; CRYSTAL STRUCTURE OF THE CATALYTIC SITE MUTANT (H157Q) OF THE HUMAN CYTOMEGALOVIRUS PROTEASE 1IEF ; 2.30 ; CRYSTAL STRUCTURE OF THE CATALYTIC SITE MUTANT S134A OF THE HUMAN CYTOMEGALOVIRUS PROTEASE 1IEG ; 2.00 ; CRYSTAL STRUCTURE OF THE CATALYTIC SITE MUTANT S134A/H157A OF THE HUMAN CYTOMEGALOVIRUS PROTEASE 1JLU ; 2.25 ; CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF CAMP- DEPENDENT PROTEIN KINASE COMPLEXED WITH A PHOSPHORYLATED SUBSTRATE PEPTIDE AND DETERGENT 1JBP ; 2.20 ; CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF CAMP- DEPENDENT PROTEIN KINASE COMPLEXED WITH A SUBSTRATE PEPTIDE, ADP AND DETERGENT 1NA7 ; 2.40 ; CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF HUMAN PROTEIN KINASE CK2 1JSC ; 2.60 ; CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF YEAST ACETOHYDROXYACID SYNTHASE: A TARGET FOR HERBICIDAL INHIBITORS 1LXE ; 2.50 ; CRYSTAL STRUCTURE OF THE CATHELICIDIN MOTIF OF PROTEGRINS 2AA1 ; 1.80 ; CRYSTAL STRUCTURE OF THE CATHODIC HEMOGLOBIN ISOLATED FROM THE ANTARCTIC FISH TREMATOMUS NEWNESI 1CCZ ; 1.80 ; CRYSTAL STRUCTURE OF THE CD2-BINDING DOMAIN OF CD58 (LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN 3) AT 1.8-A RESOLUTION 1YMK ; 1.70 ; CRYSTAL STRUCTURE OF THE CDC25B PHOSPHATASE CATALYTIC DOMAIN IN THE APO FORM 1YS0 ; 2.00 ; CRYSTAL STRUCTURE OF THE CDC25B PHOSPHATASE CATALYTIC DOMAIN WITH THE ACTIVE SITE CYSTEINE IN THE DISULFIDE FORM 1YML ; 1.70 ; CRYSTAL STRUCTURE OF THE CDC25B PHOSPHATASE CATALYTIC DOMAIN WITH THE ACTIVE SITE CYSTEINE IN THE SULFENIC FORM 1YM9 ; 2.00 ; CRYSTAL STRUCTURE OF THE CDC25B PHOSPHATASE CATALYTIC DOMAIN WITH THE ACTIVE SITE CYSTEINE IN THE SULFINIC FORM 1YMD ; 1.70 ; CRYSTAL STRUCTURE OF THE CDC25B PHOSPHATASE CATALYTIC DOMAIN WITH THE ACTIVE SITE CYSTEINE IN THE SULFONIC FORM 1GRN ; 2.10 ; CRYSTAL STRUCTURE OF THE CDC42/CDC42GAP/ALF3 COMPLEX. 1XFP ; 1.50 ; CRYSTAL STRUCTURE OF THE CDR2 GERMLINE REVERSION MUTANT OF CAB-LYS3 IN COMPLEX WITH HEN EGG WHITE LYSOZYME 1QB3 ; 3.00 ; CRYSTAL STRUCTURE OF THE CELL CYCLE REGULATORY PROTEIN CKS1 1R77 ; 1.75 ; CRYSTAL STRUCTURE OF THE CELL WALL TARGETING DOMAIN OF PEPTIDYLGLYCAN HYDROLASE ALE-1 1FSZ ; 2.80 ; CRYSTAL STRUCTURE OF THE CELL-DIVISION PROTEIN FTSZ AT 2.8A RESOLUTION 1FBO ; 2.30 ; CRYSTAL STRUCTURE OF THE CELLULASE CEL48F FROM C. CELLULOLYTICUM IN COMPLEX WITH CELLOBIITOL 1FAE ; 2.00 ; CRYSTAL STRUCTURE OF THE CELLULASE CEL48F FROM C. CELLULOLYTICUM IN COMPLEX WITH CELLOBIOSE 1FBW ; 2.00 ; CRYSTAL STRUCTURE OF THE CELLULASE CEL48F FROM C. CELLULOLYTICUM IN COMPLEX WITH CELLOHEXAOSE 1F9D ; 2.30 ; CRYSTAL STRUCTURE OF THE CELLULASE CEL48F FROM C. CELLULOLYTICUM IN COMPLEX WITH CELLOTETRAOSE 1F9O ; 2.50 ; CRYSTAL STRUCTURE OF THE CELLULASE CEL48F FROM C. CELLULOLYTICUM WITH THE THIOOLIGOSACCHARIDE INHIBITOR PIPS- IG3 1IA7 ; 2.00 ; CRYSTAL STRUCTURE OF THE CELLULASE CEL9M OF C. CELLULOLYTICIUM IN COMPLEX WITH CELLOBIOSE 1IA6 ; 1.80 ; CRYSTAL STRUCTURE OF THE CELLULASE CEL9M OF C. CELLULOLYTICUM 2A1I ; 1.90 ; CRYSTAL STRUCTURE OF THE CENTRAL DOMAIN OF HUMAN ERCC1 1JY2 ; 1.40 ; CRYSTAL STRUCTURE OF THE CENTRAL REGION OF BOVINE FIBRINOGEN (E5 FRAGMENT) AT 1.4 ANGSTROMS RESOLUTION 1JY3 ; 1.60 ; CRYSTAL STRUCTURE OF THE CENTRAL REGION OF BOVINE FIBRINOGEN (E5 FRAGMENT) AT 1.4 ANGSTROMS RESOLUTION 1XOU ; 2.80 ; CRYSTAL STRUCTURE OF THE CESA-ESPA COMPLEX 1CQK ; 2.20 ; CRYSTAL STRUCTURE OF THE CH3 DOMAIN FROM THE MAK33 ANTIBODY 1WE3 ; 2.80 ; CRYSTAL STRUCTURE OF THE CHAPERONIN COMPLEX CPN60/CPN10/(ADP)7 FROM THERMUS THERMOPHILUS 1WF4 ; 2.80 ; CRYSTAL STRUCTURE OF THE CHAPERONIN COMPLEX CPN60/CPN10/(ADP)7 FROM THERMUS THERMOPHILUS 1Q3S ; 3.00 ; CRYSTAL STRUCTURE OF THE CHAPERONIN FROM THERMOCOCCUS STRAIN KS-1 (FORMIII CRYSTAL COMPLEXED WITH ADP) 1Q3R ; 2.90 ; CRYSTAL STRUCTURE OF THE CHAPERONIN FROM THERMOCOCCUS STRAIN KS-1 (NUCLEOTIDE-FREE FORM OF SINGLE MUTANT) 1Q2V ; 2.40 ; CRYSTAL STRUCTURE OF THE CHAPERONIN FROM THERMOCOCCUS STRAIN KS-1 (NUCLEOTIDE-FREE FORM) 1Q3Q ; 2.30 ; CRYSTAL STRUCTURE OF THE CHAPERONIN FROM THERMOCOCCUS STRAIN KS-1 (TWO-POINT MUTANT COMPLEXED WITH AMP-PNP) 1MDU ; 2.20 ; CRYSTAL STRUCTURE OF THE CHICKEN ACTIN TRIMER COMPLEXED WITH HUMAN GELSOLIN SEGMENT 1 (GS-1) 1EVP ; 1.80 ; CRYSTAL STRUCTURE OF THE CHIMERICAL DECAMER D(CCACTAGTG)R(G) 2C2L ; 3.30 ; CRYSTAL STRUCTURE OF THE CHIP U-BOX E3 UBIQUITIN LIGASE 2C2V ; 2.90 ; CRYSTAL STRUCTURE OF THE CHIP-UBC13-UEV1A COMPLEX 1FX0 ; 3.20 ; CRYSTAL STRUCTURE OF THE CHLOROPLAST F1-ATPASE FROM SPINACH 1RYB ; 1.70 ; CRYSTAL STRUCTURE OF THE CHLOROPLAST GROUP II INTRON SPLICING FACTOR CRS2 1SQ1 ; 2.80 ; CRYSTAL STRUCTURE OF THE CHORISMATE SYNTHASE FROM CAMPYLOBACTER JEJUNI, NORTHEAST STRUCTURAL GENOMICS TARGET BR19 1IQP ; 2.80 ; CRYSTAL STRUCTURE OF THE CLAMP LOADER SMALL SUBUNIT FROM PYROCOCCUS FURIOSUS 1N4O ; 1.85 ; CRYSTAL STRUCTURE OF THE CLASS A BETA-LACTAMASE L2 FROM STENOTROPHOMONAS MALTOPHILIA 1O7E ; 1.51 ; CRYSTAL STRUCTURE OF THE CLASS A BETA-LACTAMSE L2 FROM STENOTROPHOMONAS MALTOPHILIA AT 1.51 ANGSTROM 1FOF ; 2.00 ; CRYSTAL STRUCTURE OF THE CLASS D BETA-LACTAMASE OXA-10 1K4F ; 1.60 ; CRYSTAL STRUCTURE OF THE CLASS D BETA-LACTAMASE OXA-10 AT 1.6 A RESOLUTION 1H8Z ; 1.80 ; CRYSTAL STRUCTURE OF THE CLASS D BETA-LACTAMASE OXA-13 1H5X ; 1.90 ; CRYSTAL STRUCTURE OF THE CLASS D BETA-LACTAMASE OXA-13 COMPLEXED WITH IMIPENEM 1H8Y ; 2.00 ; CRYSTAL STRUCTURE OF THE CLASS D BETA-LACTAMASE OXA-13 IN COMPLEX WITH MEROPENEM 1K38 ; 1.50 ; CRYSTAL STRUCTURE OF THE CLASS D BETA-LACTAMASE OXA-2 1K4E ; 2.00 ; CRYSTAL STRUCTURE OF THE CLASS D BETA-LACTAMASES OXA-10 DETERMINED BY MAD PHASING WITH SELENOMETHIONINE 1UZR ; 2.20 ; CRYSTAL STRUCTURE OF THE CLASS IB RIBONUCLEOTIDE REDUCTASE R2F-2 SUBUNIT FROM MYCOBACTERIUM TUBERCULOSIS 1KPK ; 3.50 ; CRYSTAL STRUCTURE OF THE CLC CHLORIDE CHANNEL FROM E. COLI 1KPL ; 3.00 ; CRYSTAL STRUCTURE OF THE CLC CHLORIDE CHANNEL FROM S. TYPHIMURIUM 1LV5 ; 1.95 ; CRYSTAL STRUCTURE OF THE CLOSED CONFORMATION OF BACILLUS DEOXYRIBONUCLEIC ACID POLYMERASE I FRAGMENT BOUND TO DEOXYRIBONUCLEIC ACID AND DCTP 1GZ7 ; 1.97 ; CRYSTAL STRUCTURE OF THE CLOSED STATE OF LIPASE 2 FROM CANDIDA RUGOSA 2F6I ; 2.45 ; CRYSTAL STRUCTURE OF THE CLPP PROTEASE CATALYTIC DOMAIN FROM PLASMODIUM FALCIPARUM 1LT0 ; 2.40 ; CRYSTAL STRUCTURE OF THE CN-BOUND BJFIXL HEME DOMAIN 1FA6 ; 1.90 ; CRYSTAL STRUCTURE OF THE CO(II)-BOUND GLYOXALASE I OF ESCHERICHIA COLI 1LSV ; 2.40 ; CRYSTAL STRUCTURE OF THE CO-BOUND BJFIXL HEME DOMAIN 1C0W ; 3.20 ; CRYSTAL STRUCTURE OF THE COBALT-ACTIVATED DIPHTHERIA TOXIN REPRESSOR-DEOXYRIBONUCLEIC ACID COMPLEX REVEALS A METAL BINDING SH-LIKE DOMAIN 1XTO ; 2.80 ; CRYSTAL STRUCTURE OF THE COENZYME PQQ SYNTHESIS PROTEIN (PQQB) FROM PSEUDOMONAS PUTIDA, NORTHEAST STRUCTURAL GENOMICS TARGET PPR6 1M5I ; 2.00 ; CRYSTAL STRUCTURE OF THE COILED COIL REGION 129-250 OF THE TUMOR SUPPRESSOR GENE PRODUCT APC 1T6F ; 1.47 ; CRYSTAL STRUCTURE OF THE COILED-COIL DIMERIZATION MOTIF OF GEMININ 1NYH ; 3.10 ; CRYSTAL STRUCTURE OF THE COILED-COIL DIMERIZATION MOTIF OF SIR4 2AKF ; 1.20 ; CRYSTAL STRUCTURE OF THE COILED-COIL DOMAIN OF CORONIN 1 1V14 ; 2.90 ; CRYSTAL STRUCTURE OF THE COLICIN E9, MUTANT HIS103ALA, IN COMPLEX WITH MG+2 AND DSDNA (RESOLUTION 2.9A) 1V15 ; 2.40 ; CRYSTAL STRUCTURE OF THE COLICIN E9, MUTANT HIS103ALA, IN COMPLEX WITH ZN+2 AND DSDNA (RESOLUTION 2.4A) 1XWR ; 2.56 ; CRYSTAL STRUCTURE OF THE COLIPHAGE LAMBDA TRANSCRIPTION ACTIVATOR PROTEIN CII 1K6F ; 1.30 ; CRYSTAL STRUCTURE OF THE COLLAGEN TRIPLE HELIX MODEL [(PRO- PRO-GLY)10]3 1P9H ; 1.55 ; CRYSTAL STRUCTURE OF THE COLLAGEN-BINDING DOMAIN OF YERSINIA ADHESIN YADA 1Y2T ; 1.50 ; CRYSTAL STRUCTURE OF THE COMMON EDIBLE MUSHROOM (AGARICUS BISPORUS) LECTIN 1Y2U ; 1.85 ; CRYSTAL STRUCTURE OF THE COMMON EDIBLE MUSHROOM (AGARICUS BISPORUS) LECTIN IN COMPLEX WITH LACTO-N-BIOSE 1Y2V ; 1.90 ; CRYSTAL STRUCTURE OF THE COMMON EDIBLE MUSHROOM (AGARICUS BISPORUS) LECTIN IN COMPLEX WITH T-ANTIGEN 1QZW ; 4.10 ; CRYSTAL STRUCTURE OF THE COMPLETE CORE OF ARCHAEAL SRP AND IMPLICATIONS FOR INTER-DOMAIN COMMUNICATION 1QZX ; 4.00 ; CRYSTAL STRUCTURE OF THE COMPLETE CORE OF ARCHAEAL SRP AND IMPLICATIONS FOR INTER-DOMAIN COMMUNICATION 1GH7 ; 3.00 ; CRYSTAL STRUCTURE OF THE COMPLETE EXTRACELLULAR DOMAIN OF THE BETA-COMMON RECEPTOR OF IL-3, IL-5, AND GM-CSF 2BIB ; 1.92 ; CRYSTAL STRUCTURE OF THE COMPLETE MODULAR TEICHIOIC ACID PHOSPHORYLCHOLINE ESTERASE PCE (CBPE) FROM STREPTOCOCCUS PNEUMONIAE 1DTO ; 1.90 ; CRYSTAL STRUCTURE OF THE COMPLETE TRANSACTIVATION DOMAIN OF E2 PROTEIN FROM THE HUMAN PAPILLOMAVIRUS TYPE 16 1KXH ; 2.30 ; CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN AN INACTIVE MUTANT OF PSYCHROPHILIC ALPHA-AMYLASE (D174N) AND ACARBOSE 1IT6 ; 2.00 ; CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CALYCULIN A AND THE CATALYTIC SUBUNIT OF PROTEIN PHOSPHATASE 1 1BO5 ; 3.20 ; CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN ESCHERICHIA COLI GLYCEROL KINASE AND THE ALLOSTERIC REGULATOR FRUCTOSE 1,6- BISPHOSPHATE. 1BOT ; 3.05 ; CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN ESCHERICHIA COLI GLYCEROL KINASE AND THE ALLOSTERIC REGULATOR FRUCTOSE 1,6- BISPHOSPHATE. 1GAQ ; 2.59 ; CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN FERREDOXIN AND FERREDOXIN-NADP+ REDUCTASE 1OMW ; 2.50 ; CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN G PROTEIN-COUPLED RECEPTOR KINASE 2 AND HETEROTRIMERIC G PROTEIN BETA 1 AND GAMMA 2 SUBUNITS 1XK4 ; 1.80 ; CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN HUMAN S100A8 (MRP8) AND S100A9 (MRP14) 1S6C ; 2.00 ; CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN KCHIP1 AND KV4.2 N1-30 1NYY ; 1.90 ; CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN M182T MUTANT OF TEM-1 AND A BORONIC ACID INHIBITOR (105) 1NYM ; 1.20 ; CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN M182T MUTANT OF TEM-1 AND A BORONIC ACID INHIBITOR (CXB) 1NY0 ; 1.75 ; CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN M182T MUTANT OF TEM-1 AND A BORONIC ACID INHIBITOR (NBF) 1NXY ; 1.60 ; CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN M182T MUTANT OF TEM-1 AND A BORONIC ACID INHIBITOR (SM2) 1ZP5 ; 1.80 ; CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN MMP-8 AND A N- HYDROXYUREA INHIBITOR 1U6S ; 2.30 ; CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN MYCOBACTERIUM TUBERCULOSIS BETA-KETOACYL-ACYL CARRIER PROTEIN SYNTHASE III AND LAUROYL COENZYME A 1XG2 ; 1.90 ; CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN PECTIN METHYLESTERASE AND ITS INHIBITOR PROTEIN 2PDA ; 3.00 ; CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN PYRUVATE- FERREDOXIN OXIDOREDUCTASE FROM DESULFOVIBRIO AFRICANUS AND PYRUVATE. 1O07 ; 1.71 ; CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN Q120L/Y150E MUTANT OF AMPC AND A BETA-LACTAM INHIBITOR (MXG) 1LS3 ; 2.70 ; CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN RABBIT CYTOSOLIC SERINE HYDROXYMETHYLTRANSFERASE AND TRIGLU-5-FORMYL- TETRAHYDROFOLATE 1DP2 ; 2.01 ; CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN RHODANESE AND LIPOATE 2A1J ; 2.70 ; CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE C-TERMINAL DOMAINS OF HUMAN XPF AND ERCC1 1IOD ; 2.30 ; CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE COAGULATION FACTOR X BINDING PROTEIN FROM SNAKE VENOM AND THE GLA DOMAIN OF FACTOR X 1HE1 ; 2.00 ; CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE GAP DOMAIN OF THE PSEUDOMONAS AERUGINOSA EXOS TOXIN AND HUMAN RAC 1GZS ; 2.30 ; CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE GEF DOMAIN OF THE SALMONELLA TYPHIMURIUM SOPE TOXIN AND HUMAN CDC42 1S1C ; 2.60 ; CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE HUMAN RHOA AND RHO-BINDING DOMAIN OF HUMAN ROCKI 1DTD ; 1.65 ; CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE LEECH CARBOXYPEPTIDASE INHIBITOR AND THE HUMAN CARBOXYPEPTIDASE A2 (LCI-CPA2) 1F3V ; 2.00 ; CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE N-TERMINAL DOMAIN OF TRADD AND THE TRAF DOMAIN OF TRAF2 1N83 ; 1.63 ; CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE ORPHAN NUCLEAR HORMONE RECEPTOR ROR(ALPHA)-LBD AND CHOLESTEROL 1DVA ; 3.00 ; CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE PEPTIDE EXOSITE INHIBITOR E-76 AND COAGULATION FACTOR VIIA 1CZY ; 2.00 ; CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE TRAF DOMAIN OF HUMAN TRAF2 AND AN LMP1 BINDING PEPTIDE 1QVH ; 3.65 ; CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THROMBIN AND THE CENTRAL "E" REGION OF FIBRIN 1TJQ ; 1.25 ; CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN A GROUP II PHOSPHOLIPASE A2 AND DESIGNED PEPTIDE INHIBITOR CARBOBENZOXY-DEHYDRO-VAL-ALA-ARG-SER AT 1.2 A RESOLUTION 1TK2 ; 1.54 ; CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN ALKALINE PROTEINASE SAVINASE AND GRAMICIDIN S AT 1.5A RESOLUTION 1F2S ; 1.79 ; CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN BOVINE BETA- TRYPSIN AND MCTI-A, A TRYPSIN INHIBITOR OF SQUASH FAMILY AT 1.8 A RESOLUTION 2B2Z ; 2.28 ; CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN GOAT SIGNALLING PROTEIN AND THE HEXASACCHARIDE AT 2.28 A RESOLUTION 2B40 ; 2.90 ; CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN GOAT SIGNALLING PROTEIN WITH PENTASACCHARIDE AT 2.9A RESOLUTION. 2B31 ; 3.10 ; CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN GOAT SIGNALLING PROTEIN WITH PENTASACCHARIDE AT 3.1 A RESOLUTION REVEALS LARGE SCALE CONFORMATIONAL CHANGES IN THE RESIDUES OF TIM BARREL 1ZR8 ; 2.03 ; CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN GROUP II PHOSPHOLIPASE A2 AND A PLANT ALKALOID AJMALINE AT 2.0A RESOLUTION 1TJK ; 1.25 ; CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN GROUP II PHOSPHOLIPASE A2 WITH A DESIGNED PENTAPEPTIDE, PHE- LEU- SER- THR- LYS AT 1.2 A RESOLUTION 1SV9 ; 2.71 ; CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN GROUPII PHOSPHOLIPASE A2 AND ANTI-INFLAMMATORY AGENT 2-[(2,6- DICHLOROPHENYL)AMINO] BENZENEACETIC ACID AT 2.7A RESOLUTION 1Y38 ; 2.44 ; CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN PHOSPHOLIPASE A2 DIMER AND GLYCEROPHOSPHATE AT 2.4 A RESOLUTION 1Q7A ; 1.60 ; CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN RUSSELL'S VIPER PHOSPHOLIPASE A2 AND AN ANTIINFLAMMATORY AGENT OXYPHENBUTAZONE AT 1.6A RESOLUTION 1TG1 ; 1.25 ; CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN RUSSELLS VIPER PHOSPHOLIPASE A2 AND A DESIGNED PEPTIDE INHIBITOR CBZ-DEHYDRO-LEU-VAL-ARG-TYR AT 1.2A RESOLUTION 1ZBW ; 2.80 ; CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN SIGNALLING PROTEIN FROM GOAT MAMMARY GLAND (SPG-40) AND A TRIPEPTIDE TRP-PRO-TRP AT 2.8A RESOLUTION 1FPR ; 2.50 ; CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN THE CATALYTIC DOMAIN OF SHP-1 AND AN IN VITRO PEPTIDE SUBSTRATE PY469 DERIVED FROM SHPS-1. 1ZM6 ; 2.60 ; CRYSTAL STRUCTURE OF THE COMPLEX FORMED BEWEEN A GROUP I PHOSPHOLIPASE A2 AND DESIGNED PENTA PEPTIDE LEU-ALA-ILE- TYR-SER AT 2.6A RESOLUTION 1D7R ; 2.00 ; CRYSTAL STRUCTURE OF THE COMPLEX OF 2,2-DIALKYLGLYCINE DECARBOXYLASE WITH 5PA 1D7S ; 2.05 ; CRYSTAL STRUCTURE OF THE COMPLEX OF 2,2-DIALKYLGLYCINE DECARBOXYLASE WITH DCS 1D7U ; 1.95 ; CRYSTAL STRUCTURE OF THE COMPLEX OF 2,2-DIALKYLGLYCINE DECARBOXYLASE WITH LCS 1D7V ; 2.80 ; CRYSTAL STRUCTURE OF THE COMPLEX OF 2,2-DIALKYLGLYCINE DECARBOXYLASE WITH NMA 1A05 ; 2.00 ; CRYSTAL STRUCTURE OF THE COMPLEX OF 3-ISOPROPYLMALATE DEHYDROGENASE FROM THIOBACILLUS FERROOXIDANS WITH 3-ISOPROPYLMALATE 1ZYX ; 1.95 ; CRYSTAL STRUCTURE OF THE COMPLEX OF A GROUP IIA PHOSPHOLIPASE A2 WITH A SYNTHETIC ANTI-INFLAMMATORY AGENT LICOFELONE AT 1.9A RESOLUTION 1LOT ; 2.50 ; CRYSTAL STRUCTURE OF THE COMPLEX OF ACTIN WITH VITAMIN D- BINDING PROTEIN 1CQI ; 3.30 ; CRYSTAL STRUCTURE OF THE COMPLEX OF ADP AND MG2+ WITH DEPHOSPHORYLATED E. COLI SUCCINYL-COA SYNTHETASE 1PAU ; 2.50 ; CRYSTAL STRUCTURE OF THE COMPLEX OF APOPAIN WITH THE TETRAPEPTIDE ALDEHYDE INHIBITOR AC-DEVD-CHO 1CP3 ; 2.30 ; CRYSTAL STRUCTURE OF THE COMPLEX OF APOPAIN WITH THE TETRAPEPTIDE INHIBITOR ACE-DVAD-FMC 1CX9 ; 2.30 ; CRYSTAL STRUCTURE OF THE COMPLEX OF BACTERIAL TRYPTOPHAN SYNTHASE WITH THE TRANSITION STATE ANALOGUE INHIBITOR 4-(2- AMINOPHENYLTHIO)-BUTYLPHOSPHONIC ACID 1C9D ; 2.30 ; CRYSTAL STRUCTURE OF THE COMPLEX OF BACTERIAL TRYPTOPHAN SYNTHASE WITH THE TRANSITION STATE ANALOGUE INHIBITOR 4-(2- HYDROXY-4-FLUOROPHENYLTHIO)-BUTYLPHOSPHONIC ACID 1CW2 ; 2.00 ; CRYSTAL STRUCTURE OF THE COMPLEX OF BACTERIAL TRYPTOPHAN SYNTHASE WITH THE TRANSITION STATE ANALOGUE INHIBITOR 4-(2- HYDROXYPHENYLSULFINYL)-BUTYLPHOSPHONIC ACID 1C29 ; 2.30 ; CRYSTAL STRUCTURE OF THE COMPLEX OF BACTERIAL TRYPTOPHAN SYNTHASE WITH THE TRANSITION STATE ANALOGUE INHIBITOR 4-(2- HYDROXYPHENYLTHIO)-1-BUTENYLPHOSPHONIC ACID 1C8V ; 2.20 ; CRYSTAL STRUCTURE OF THE COMPLEX OF BACTERIAL TRYPTOPHAN SYNTHASE WITH THE TRANSITION STATE ANALOGUE INHIBITOR 4-(2- HYDROXYPHENYLTHIO)-BUTYLPHOSPHONIC ACID 2FA7 ; 2.38 ; CRYSTAL STRUCTURE OF THE COMPLEX OF BOVINE LACTOFERRIN C- LOBE WITH A PENTASACCHARIDE AT 2.38 A RESOLUTION 2B65 ; 1.50 ; CRYSTAL STRUCTURE OF THE COMPLEX OF C-LOBE OF BOVINE LACTOFERRIN WITH MALTOSE AT 1.5A RESOLUTION 1RHU ; 2.51 ; CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A 5,6,7 TRICYCLIC PEPTIDOMIMETIC INHIBITOR 1RHQ ; 3.00 ; CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A BROMOMETHOXYPHENYL INHIBITOR 1RHR ; 3.00 ; CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A CINNAMIC ACID METHYL ESTER INHIBITOR 1RHM ; 2.50 ; CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A NICOTINIC ACID ALDEHYDE INHIBITOR 1RHK ; 2.50 ; CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A PHENYL- PROPYL-KETONE INHIBITOR 1RHJ ; 2.20 ; CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A PRYAZINONE INHIBITOR 1QTN ; 1.20 ; CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-8 WITH THE TETRAPEPTIDE INHIBITOR ACE-IETD-ALDEHYDE 1QDU ; 2.80 ; CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-8 WITH THE TRIPEPTIDE KETONE INHIBITOR ZEVD-DCBMK 1JW6 ; 1.93 ; CRYSTAL STRUCTURE OF THE COMPLEX OF CONCANAVALIN A AND HEXAPEPTIDE 1HQW ; 2.40 ; CRYSTAL STRUCTURE OF THE COMPLEX OF CONCANAVALIN A WITH A TRIPEPTIDE YPY 1K9G ; 1.40 ; CRYSTAL STRUCTURE OF THE COMPLEX OF CRYPTOLEPINE-D(CCTAGG)2 1D8Y ; 2.08 ; CRYSTAL STRUCTURE OF THE COMPLEX OF DEOXYRIBONUCLEIC ACID POLYMERASE I KLENOW FRAGMENT WITH DEOXYRIBONUCLEIC ACID 1D9F ; 3.00 ; CRYSTAL STRUCTURE OF THE COMPLEX OF DEOXYRIBONUCLEIC ACID POLYMERASE I KLENOW FRAGMENT WITH DEOXYRIBONUCLEIC ACID TETRAMER CARRYING 2'-O-(3-AMINOPROPYL)- RIBONUCLEIC ACID MODIFICATION 5'-D(TT)-AP(U)-D(T)-3' 1EOM ; 2.10 ; CRYSTAL STRUCTURE OF THE COMPLEX OF ENDO-BETA-N- ACETYLGLUCOSAMINIDASE F3 WITH A BIANTENNARY COMPLEX OCTASACCHARIDE 1XEY ; 2.05 ; CRYSTAL STRUCTURE OF THE COMPLEX OF ESCHERICHIA COLI GADA WITH GLUTARATE AT 2.05 A RESOLUTION 1M10 ; 3.10 ; CRYSTAL STRUCTURE OF THE COMPLEX OF GLYCOPROTEIN IB ALPHA AND THE VON WILLEBRAND FACTOR A1 DOMAIN 2B41 ; 2.09 ; CRYSTAL STRUCTURE OF THE COMPLEX OF GOAT SIGNALLING PROTEIN WITH TETRASACCHARIDE AT 2.09 A RESOLUTION 2A09 ; 2.45 ; CRYSTAL STRUCTURE OF THE COMPLEX OF GOAT SIGNALLING PROTEIN WITH THE TRIMER OF N-ACETYLGLUCOSAMINE AT 2.45A RESOLUTION 1TP2 ; 2.40 ; CRYSTAL STRUCTURE OF THE COMPLEX OF GROUP II PHOSPHOLIPASEA2 DIMER WITH A FATTY ACID TRIDECANOIC ACID AT 2.4 A RESOLUTION 1FQX ; 3.10 ; CRYSTAL STRUCTURE OF THE COMPLEX OF HIV-1 PROTEASE WITH A PEPTIDOMIMETIC INHIBITOR 1QRV ; 2.20 ; CRYSTAL STRUCTURE OF THE COMPLEX OF HMG-D AND DEOXYRIBONUCLEIC ACID 1IVO ; 3.30 ; CRYSTAL STRUCTURE OF THE COMPLEX OF HUMAN EPIDERMAL GROWTH FACTOR AND RECEPTOR EXTRACELLULAR DOMAINS. 1MA9 ; 2.40 ; CRYSTAL STRUCTURE OF THE COMPLEX OF HUMAN VITAMIN D BINDING PROTEIN AND RABBIT MUSCLE ACTIN 1BMQ ; 2.50 ; CRYSTAL STRUCTURE OF THE COMPLEX OF INTERLEUKIN-1BETA CONVERTING ENZYME (ICE) WITH A PEPTIDE BASED INHIBITOR, (3S )-N-METHANESULFONYL-3-({1-[N-(2-NAPHTOYL)-L-VALYL]-L-PROLYL }AMINO)-4-OXOBUTANAMIDE 1PXD ; 1.80 ; CRYSTAL STRUCTURE OF THE COMPLEX OF JACALIN WITH MESO- TETRASULPHONATOPHENYLPORPHYRIN. 1LZQ ; 2.20 ; CRYSTAL STRUCTURE OF THE COMPLEX OF MUTANT HIV-1 PROTEASE (A71V, V82T, I84V) WITH AN ETHYLENAMINE PEPTIDOMIMETIC INHIBITOR BOC-PHE-PSI[CH2CH2NH]-PHE-GLU-PHE-NH2 3NP1 ; 2.30 ; CRYSTAL STRUCTURE OF THE COMPLEX OF NITROPHORIN 1 FROM RHODNIUS PROLIXUS WITH CYANIDE 1NP1 ; 2.00 ; CRYSTAL STRUCTURE OF THE COMPLEX OF NITROPHORIN 1 FROM RHODNIUS PROLIXUS WITH HISTAMINE 1OBY ; 1.85 ; CRYSTAL STRUCTURE OF THE COMPLEX OF PDZ2 OF SYNTENIN WITH A SYNDECAN-4 PEPTIDE. 1OBX ; 1.35 ; CRYSTAL STRUCTURE OF THE COMPLEX OF PDZ2 OF SYNTENIN WITH AN INTERLEUKIN 5 RECEPTOR ALPHA PEPTIDE. 2ARM ; 1.23 ; CRYSTAL STRUCTURE OF THE COMPLEX OF PHOSPHOLIPASE A2 WITH A NATURAL COMPOUND ATROPINE AT 1.2 A RESOLUTION 1P8V ; 2.60 ; CRYSTAL STRUCTURE OF THE COMPLEX OF PLATELET RECEPTOR GPIB- ALPHA AND ALPHA-THROMBIN AT 2.6A 1OOK ; 2.30 ; CRYSTAL STRUCTURE OF THE COMPLEX OF PLATELET RECEPTOR GPIB- ALPHA AND HUMAN ALPHA-THROMBIN 1P7W ; 1.02 ; CRYSTAL STRUCTURE OF THE COMPLEX OF PROTEINASE K WITH A DESIGNED HEPTAPEPTIDE INHIBITOR PRO-ALA-PRO-PHE-ALA-SER- ALA AT ATOMIC RESOLUTION 1RL8 ; 2.00 ; CRYSTAL STRUCTURE OF THE COMPLEX OF RESISTANT STRAIN OF HIV- 1 PROTEASE(V82A MUTANT) WITH RITONAVIR 1ZL1 ; 3.50 ; CRYSTAL STRUCTURE OF THE COMPLEX OF SIGNALLING PROTEIN FROM SHEEP (SPS-40) WITH A DESIGNED PEPTIDE TRP-HIS-TRP REVEALS SIGNIFICANCE OF ASN79 AND TRP191 IN THE COMPLEX FORMATION 1TM1 ; 1.70 ; CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' WITH CHYMOTRYPSIN INHIBITOR 2 1LW6 ; 1.50 ; CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' WITH CHYMOTRYPSIN INHIBITOR 2 AT 1.5 ANGSTROM RESOLUTION 1Y34 ; 1.55 ; CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' WITH CHYMOTRYPSIN INHIBITOR 2 E60A MUTANT 1Y3B ; 1.80 ; CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' WITH CHYMOTRYPSIN INHIBITOR 2 E60S MUTANT 1Y3F ; 1.72 ; CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' WITH CHYMOTRYPSIN INHIBITOR 2 F69A MUTANT 1TM5 ; 1.45 ; CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' WITH CHYMOTRYPSIN INHIBITOR 2 M59A MUTANT 1TMG ; 1.67 ; CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' WITH CHYMOTRYPSIN INHIBITOR 2 M59F MUTANT 1TM3 ; 1.57 ; CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' WITH CHYMOTRYPSIN INHIBITOR 2 M59K MUTANT 1TO2 ; 1.30 ; CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' WITH CHYMOTRYPSIN INHIBITOR 2 M59K, IN PH 9 CRYOSOAK 1Y4A ; 1.60 ; CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' WITH CHYMOTRYPSIN INHIBITOR 2 M59R/E60S MUTANT 1Y4D ; 2.00 ; CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' WITH CHYMOTRYPSIN INHIBITOR 2 M59R/E60S MUTANT 1TM7 ; 1.59 ; CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' WITH CHYMOTRYPSIN INHIBITOR 2 M59Y MUTANT 1Y3C ; 1.69 ; CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' WITH CHYMOTRYPSIN INHIBITOR 2 R62A MUTANT 1Y48 ; 1.84 ; CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' WITH CHYMOTRYPSIN INHIBITOR 2 R65A MUTANT 1Y3D ; 1.80 ; CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' WITH CHYMOTRYPSIN INHIBITOR 2 R67A MUTANT 1Y1K ; 1.56 ; CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' WITH CHYMOTRYPSIN INHIBITOR 2 T58A MUTANT 1Y33 ; 1.80 ; CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' WITH CHYMOTRYPSIN INHIBITOR 2 T58P MUTANT 1TO1 ; 1.68 ; CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' WITH CHYMOTRYPSIN INHIBITOR 2 Y61A MUTANT 1TM4 ; 1.70 ; CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILSIN BPN'WITH CHYMOTRYPSIN INHIBITOR 2 M59G MUTANT 1ABO ; 2.00 ; CRYSTAL STRUCTURE OF THE COMPLEX OF THE ABL TYROSINE KINASE SH3 DOMAIN WITH 3BP-1 SYNTHETIC PEPTIDE 1MJ7 ; 2.25 ; CRYSTAL STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS5-393 AND A TRANSITION-STATE ANALOG 1JWS ; 2.60 ; CRYSTAL STRUCTURE OF THE COMPLEX OF THE MHC CLASS II MOLECULE HLA-DR1 (HA PEPTIDE 306-318) WITH THE SUPERANTIGEN SEC3 VARIANT 3B1 1JWU ; 2.30 ; CRYSTAL STRUCTURE OF THE COMPLEX OF THE MHC CLASS II MOLECULE HLA-DR1 (HA PEPTIDE 306-318) WITH THE SUPERANTIGEN SEC3 VARIANT 3B2 1JWM ; 2.70 ; CRYSTAL STRUCTURE OF THE COMPLEX OF THE MHC CLASS II MOLECULE HLA-DR1(HA PEPTIDE 306-318) WITH THE SUPERANTIGEN SEC3 1OBZ ; 1.69 ; CRYSTAL STRUCTURE OF THE COMPLEX OF THE PDZ TANDEM OF SYNTENIN WITH AN INTERLEUKIN 5 RECEPTOR ALPHA PEPTIDE. 1SQ0 ; 2.60 ; CRYSTAL STRUCTURE OF THE COMPLEX OF THE WILD-TYPE VON WILLEBRAND FACTOR A1 DOMAIN AND GLYCOPROTEIN IB ALPHA AT 2.6 ANGSTROM RESOLUTION 1QD2 ; 1.86 ; CRYSTAL STRUCTURE OF THE COMPLEX OF TRICHOSANTHIN WITH ADENINE, OBTAINED FROM TRICHOSANTHIN COMPLEXED WITH THE DINUCLEOTIDE APG 1I3O ; 2.70 ; CRYSTAL STRUCTURE OF THE COMPLEX OF XIAP-BIR2 AND CASPASE 3 1EP5 ; 2.30 ; CRYSTAL STRUCTURE OF THE CONSERVED CORE DOMAIN OF VENEZUALAN EQUINE ENCEPHALITIS CAPSID PROTEIN 1EP6 ; 2.45 ; CRYSTAL STRUCTURE OF THE CONSERVED CORE DOMAIN OF VENEZUALAN EQUINE ENCEPHALITIS CAPSID PROTEIN 1F3L ; 2.03 ; CRYSTAL STRUCTURE OF THE CONSERVED CORE OF PROTEIN ARGININE METHYLTRANSFERASE PRMT3 1DUH ; 2.70 ; CRYSTAL STRUCTURE OF THE CONSERVED DOMAIN IV OF E. COLI 4.5S RIBONUCLEIC ACID 1WUS ; 2.18 ; CRYSTAL STRUCTURE OF THE CONSERVED DOMAIN OF MS0278 1WDE ; 2.00 ; CRYSTAL STRUCTURE OF THE CONSERVED HYPOTHETICAL PROTEIN APE0931 FROM AEROPYRUM PERNIX K1 2EVE ; 1.60 ; CRYSTAL STRUCTURE OF THE CONSERVED HYPOTHETICAL PROTEIN FROM PSEUDOMONAS SYRINGAE, NORTHEAST STRUCTURAL GENOMICS TARGET PSR62 1TD6 ; 2.50 ; CRYSTAL STRUCTURE OF THE CONSERVED HYPOTHETICAL PROTEIN MP506/MPN330 (GI: 1674200)FROM MYCOPLASMA PNEUMONIAE 1SQS ; 1.50 ; CRYSTAL STRUCTURE OF THE CONSERVED HYPOTHETICAL PROTEIN OF STREPTOCOCCUS PNEUMONIAE, NORTHEAST STRUCTURAL GENOMICS TARGET SPR27 1Z1S ; 1.49 ; CRYSTAL STRUCTURE OF THE CONSERVED HYPOTHETICAL PROTEIN PA3332 FROM PSEUDOMONAS AERUGINOSA 1YLL ; 1.64 ; CRYSTAL STRUCTURE OF THE CONSERVED HYPOTHETICAL PROTEIN PA5104 FROM PSEUDOMONAS AERUGINOSA PAO1 2AV9 ; 2.40 ; CRYSTAL STRUCTURE OF THE CONSERVED HYPOTHETICAL PROTEIN PA5185 FROM PSEUDOMONAS AERUGINOSA STRAIN PAO1 2D2Y ; 1.58 ; CRYSTAL STRUCTURE OF THE CONSERVED HYPOTHETICAL PROTEIN RV1873 FROM MYCOBACTERIUM TUBERCULOSIS AT 1.58 A 2ASF ; 1.60 ; CRYSTAL STRUCTURE OF THE CONSERVED HYPOTHETICAL PROTEIN RV2074 FROM MYCOBACTERIUM TUBERCULOSIS 1.6 A 1WEK ; 2.20 ; CRYSTAL STRUCTURE OF THE CONSERVED HYPOTHETICAL PROTEIN TT1465 FROM THERMUS THERMOPHILUS HB8 2CU5 ; 1.84 ; CRYSTAL STRUCTURE OF THE CONSERVED HYPOTHETICAL PROTEIN TT1486 FROM THERMUS THERMOPHILUS HB8 1VGG ; 1.75 ; CRYSTAL STRUCTURE OF THE CONSERVED HYPOTHETICAL PROTEIN TT1634 FROM THERMUS THERMOPHILUS HB8 1V8D ; 2.16 ; CRYSTAL STRUCTURE OF THE CONSERVED HYPOTHETICAL PROTEIN TT1679 FROM THERMUS THERMOPHILUS 1J3M ; 2.00 ; CRYSTAL STRUCTURE OF THE CONSERVED HYPOTHETICAL PROTEIN TT1751 FROM THERMUS THERMOPHILUS HB8 1WEH ; 1.80 ; CRYSTAL STRUCTURE OF THE CONSERVED HYPOTHETICAL PROTEIN TT1887 FROM THERMUS THERMOPHILUS HB8 1YZH ; 2.02 ; CRYSTAL STRUCTURE OF THE CONSERVED HYPOTHETICAL PROTEIN, METHYLTRANSFERASE FROM STREPTOCOCCUS PNEUMONIAE TIGR4 1T57 ; 2.30 ; CRYSTAL STRUCTURE OF THE CONSERVED PROTEIN MTH1675 FROM METHANOBACTERIUM THERMOAUTOTROPHICUM 1UDX ; 2.07 ; CRYSTAL STRUCTURE OF THE CONSERVED PROTEIN TT1381 FROM THERMUS THERMOPHILUS HB8 1UAN ; 2.00 ; CRYSTAL STRUCTURE OF THE CONSERVED PROTEIN TT1542 FROM THERMUS THERMOPHILUS HB8 1QB2 ; 2.10 ; CRYSTAL STRUCTURE OF THE CONSERVED SUBDOMAIN OF HUMAN PROTEIN SRP54M AT 2.1A RESOLUTION: EVIDENCE FOR THE MECHANISM OF SIGNAL PEPTIDE BINDING 1PD1 ; 2.60 ; CRYSTAL STRUCTURE OF THE COPII COAT SUBUNIT, SEC24, COMPLEXED WITH A PEPTIDE CONTAINING THE DXE CARGO SORTING SIGNAL OF YEAST SYS1 PROTEIN 1PCX ; 2.50 ; CRYSTAL STRUCTURE OF THE COPII COAT SUBUNIT, SEC24, COMPLEXED WITH A PEPTIDE FROM THE SNARE PROTEIN BET1 1PD0 ; 2.60 ; CRYSTAL STRUCTURE OF THE COPII COAT SUBUNIT, SEC24, COMPLEXED WITH A PEPTIDE FROM THE SNARE PROTEIN SED5 (YEAST SYNTAXIN-5) 1QUP ; 1.80 ; CRYSTAL STRUCTURE OF THE COPPER CHAPERONE FOR SUPEROXIDE DISMUTASE 2BBJ ; 3.90 ; CRYSTAL STRUCTURE OF THE CORA MG2+ TRANSPORTER 1Z21 ; 1.50 ; CRYSTAL STRUCTURE OF THE CORE DOMAIN OF YERSINIA PESTIS VIRULENCE FACTOR YOPR 1V9D ; 2.60 ; CRYSTAL STRUCTURE OF THE CORE FH2 DOMAIN OF MOUSE MDIA1 1KG2 ; 1.20 ; CRYSTAL STRUCTURE OF THE CORE FRAGMENT OF MUTY FROM E.COLI AT 1.2A RESOLUTION 1KG3 ; 1.55 ; CRYSTAL STRUCTURE OF THE CORE FRAGMENT OF MUTY FROM E.COLI AT 1.55A RESOLUTION 1TZY ; 1.90 ; CRYSTAL STRUCTURE OF THE CORE-HISTONE OCTAMER TO 1.90 ANGSTROM RESOLUTION 1WNR ; 2.90 ; CRYSTAL STRUCTURE OF THE CPN10 FROM THERMUS THERMOPHILUS HB8 1I85 ; 3.20 ; CRYSTAL STRUCTURE OF THE CTLA-4/B7-2 COMPLEX 1Q05 ; 2.20 ; CRYSTAL STRUCTURE OF THE CU(I) FORM OF E. COLI CUER, A COPPER EFFLUX REGULATOR 1N63 ; 1.21 ; CRYSTAL STRUCTURE OF THE CU,MO-CO DEHYDROGENASE (CODH); CARBON MONOXIDE REDUCED STATE 1N60 ; 1.19 ; CRYSTAL STRUCTURE OF THE CU,MO-CO DEHYDROGENASE (CODH); CYANIDE-INACTIVATED FORM 1N61 ; 1.30 ; CRYSTAL STRUCTURE OF THE CU,MO-CO DEHYDROGENASE (CODH); DITHIONITE REDUCED STATE 1N5W ; 1.50 ; CRYSTAL STRUCTURE OF THE CU,MO-CO DEHYDROGENASE (CODH); OXIDIZED FORM 1NZI ; 1.50 ; CRYSTAL STRUCTURE OF THE CUB1-EGF INTERACTION DOMAIN OF COMPLEMENT PROTEASE C1S 1NT0 ; 2.70 ; CRYSTAL STRUCTURE OF THE CUB1-EGF-CUB2 REGION OF MASP2 1R22 ; 2.30 ; CRYSTAL STRUCTURE OF THE CYANOBACTERIAL METALLOTHIONEIN REPRESSOR SMTB (C14S/C61S/C121S MUTANT) IN THE ZN2ALPHA5- FORM 1R1T ; 1.70 ; CRYSTAL STRUCTURE OF THE CYANOBACTERIAL METALLOTHIONEIN REPRESSOR SMTB IN THE APO-FORM 1R23 ; 2.00 ; CRYSTAL STRUCTURE OF THE CYANOBACTERIAL METALLOTHIONEIN REPRESSOR SMTB IN THE ZN1-FORM (ONE ZN(II) PER DIMER) 1K66 ; 1.75 ; CRYSTAL STRUCTURE OF THE CYANOBACTERIAL PHYTOCHROME RESPONSE REGULATOR, RCPB 1QYQ ; 1.80 ; CRYSTAL STRUCTURE OF THE CYCLIZED S65G Y66G GFP VARIANT 1C5F ; 2.47 ; CRYSTAL STRUCTURE OF THE CYCLOPHILIN-LIKE DOMAIN FROM BRUGIA MALAYI COMPLEXED WITH CYCLOSPORIN A 1ZKC ; 1.65 ; CRYSTAL STRUCTURE OF THE CYCLOPHILN_RING DOMAIN OF HUMAN PEPTIDYLPROLYL ISOMERASE (CYCLOPHILIN)-LIKE 2 ISOFORM B 1NL6 ; 2.80 ; CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT AZEPANONE INHIBITOR 1NLJ ; 2.40 ; CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT AZEPANONE INHIBITOR 1AU2 ; 2.60 ; CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT PROPANONE INHIBITOR 1AU3 ; 2.50 ; CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT PYRROLIDINONE INHIBITOR 1AU4 ; 2.30 ; CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT PYRROLIDINONE INHIBITOR 1AU0 ; 2.60 ; CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT SYMMETRIC DIACYLAMINOMETHYL KETONE INHIBITOR 1ATK ; 2.20 ; CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH THE COVALENT INHIBITOR E-64 1U9V ; 2.20 ; CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH THE COVALENT INHIBITOR NVP-ABE854 1U9W ; 2.30 ; CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH THE COVALENT INHIBITOR NVP-ABI491 1U9X ; 2.10 ; CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH THE COVALENT INHIBITOR NVP-ABJ688 1DQG ; 1.70 ; CRYSTAL STRUCTURE OF THE CYSTEINE RICH DOMAIN OF MANNOSE RECEPTOR 1DQO ; 2.20 ; CRYSTAL STRUCTURE OF THE CYSTEINE RICH DOMAIN OF MANNOSE RECEPTOR COMPLEXED WITH ACETYLGALACTOSAMINE-4-SULFATE 1FWV ; 2.20 ; CRYSTAL STRUCTURE OF THE CYSTEINE-RICH DOMAIN OF MANNOSE RECEPTOR COMPLEXED WITH 3-SO4-LEWIS(A) 1FWU ; 1.90 ; CRYSTAL STRUCTURE OF THE CYSTEINE-RICH DOMAIN OF MANNOSE RECEPTOR COMPLEXED WITH 3-SO4-LEWIS(X) 1IJY ; 1.35 ; CRYSTAL STRUCTURE OF THE CYSTEINE-RICH DOMAIN OF MOUSE FRIZZLED 8 (MFZ8) 1IJX ; 1.90 ; CRYSTAL STRUCTURE OF THE CYSTEINE-RICH DOMAIN OF SECRETED FRIZZLED-RELATED PROTEIN 3 (SFRP-3;FZB) 1ELQ ; 1.80 ; CRYSTAL STRUCTURE OF THE CYSTINE C-S LYASE C-DES 1YNR ; 2.00 ; CRYSTAL STRUCTURE OF THE CYTOCHROME C-552 FROM HYDROGENOBACTER THERMOPHILUS AT 2.0 RESOLUTION 1XAW ; 1.45 ; CRYSTAL STRUCTURE OF THE CYTOPLASMIC DISTAL C-TERMINAL DOMAIN OF OCCLUDIN 1N9P ; 1.80 ; CRYSTAL STRUCTURE OF THE CYTOPLASMIC DOMAIN OF G-PROTEIN ACTIVATED INWARD RECTIFIER POTASSIUM CHANNEL 1 1HYN ; 2.60 ; CRYSTAL STRUCTURE OF THE CYTOPLASMIC DOMAIN OF HUMAN ERYTHROCYTE BAND-3 PROTEIN 1B6C ; 2.60 ; CRYSTAL STRUCTURE OF THE CYTOPLASMIC DOMAIN OF THE TYPE I TGF-BETA RECEPTOR IN COMPLEX WITH FKBP12 2BDE ; 2.90 ; CRYSTAL STRUCTURE OF THE CYTOSOLIC IMP-GMP SPECIFIC 5'- NUCLEOTIDASE (LPG0095) FROM LEGIONELLA PNEUMOPHILA, NORTHEAST STRUCTURAL GENOMICS TARGET LGR1 1RH1 ; 2.50 ; CRYSTAL STRUCTURE OF THE CYTOTOXIC BACTERIAL PROTEIN COLICIN B AT 2.5 A RESOLUTION 1CZQ ; 1.50 ; CRYSTAL STRUCTURE OF THE D10-P1/IQN17 COMPLEX: A D-PEPTIDE INHIBITOR OF HIV-1 ENTRY BOUND TO THE GP41 COILED-COIL POCKET. 1SWV ; 2.30 ; CRYSTAL STRUCTURE OF THE D12A MUTANT OF PHOSPHONOACETALDEHYDE HYDROLASE COMPLEXED WITH MAGNESIUM 1GOI ; 1.45 ; CRYSTAL STRUCTURE OF THE D140N MUTANT OF CHITINASE B FROM SERRATIA MARCESCENS AT 1.45 A RESOLUTION 1S08 ; 2.10 ; CRYSTAL STRUCTURE OF THE D147N MUTANT OF 7,8- DIAMINOPELARGONIC ACID SYNTHASE 1P7Y ; 2.40 ; CRYSTAL STRUCTURE OF THE D181A VARIANT OF CATALASE HPII FROM E. COLI 1P81 ; 1.81 ; CRYSTAL STRUCTURE OF THE D181E VARIANT OF CATALASE HPII FROM E. COLI 1P80 ; 1.65 ; CRYSTAL STRUCTURE OF THE D181Q VARIANT OF CATALASE HPII FROM E. COLI 1P7Z ; 2.21 ; CRYSTAL STRUCTURE OF THE D181S VARIANT OF CATALASE HPII FROM E. COLI 1B34 ; 2.50 ; CRYSTAL STRUCTURE OF THE D1D2 SUB-COMPLEX FROM THE HUMAN SNRNP CORE DOMAIN 1P15 ; 2.00 ; CRYSTAL STRUCTURE OF THE D2 DOMAIN OF RPTPA 1EJR ; 2.00 ; CRYSTAL STRUCTURE OF THE D221A VARIANT OF KLEBSIELLA AEROGENES UREASE 1LO5 ; 3.20 ; CRYSTAL STRUCTURE OF THE D227A VARIANT OF STAPHYLOCOCCAL ENTEROTOXIN A IN COMPLEX WITH HUMAN MHC CLASS II 1X09 ; 1.87 ; CRYSTAL STRUCTURE OF THE D26A MUTANT UPPS IN COMPLEX WITH MAGNESIUM AND ISOPENTENYL PYROPHOSPHATE 1D3B ; 2.00 ; CRYSTAL STRUCTURE OF THE D3B SUBCOMPLEX OF THE HUMAN CORE SNRNP DOMAIN AT 2.0A RESOLUTION 1GMZ ; 2.40 ; CRYSTAL STRUCTURE OF THE D49 PHOSPHOLIPASE A2 PIRATOXIN III FROM BOTHROPS PIRAJAI. 1S2U ; 2.00 ; CRYSTAL STRUCTURE OF THE D58A PHOSPHOENOLPYRUVATE MUTASE MUTANT PROTEIN 1OQG ; 1.90 ; CRYSTAL STRUCTURE OF THE D63E MUTANT OF THE N-LOBE HUMAN TRANSFERRIN 1SBX ; 1.65 ; CRYSTAL STRUCTURE OF THE DACHSHUND-HOMOLOGY DOMAIN OF HUMAN SKI 1XMZ ; 1.38 ; CRYSTAL STRUCTURE OF THE DARK STATE OF KINDLING FLUORESCENT PROTEIN KFP FROM ANEMONIA SULCATA 2B0K ; 1.64 ; CRYSTAL STRUCTURE OF THE DB921- D(CGCGAATTCGCG)2 COMPLEX. 1LB1 ; 2.81 ; CRYSTAL STRUCTURE OF THE DBL AND PLECKSTRIN HOMOLOGY DOMAINS OF DBS IN COMPLEX WITH RHOA 1W79 ; 1.80 ; CRYSTAL STRUCTURE OF THE DD-TRANSPEPTIDASE-CARBOXYPEPTIDASE FROM ACTINOMADURA R39 1W8Q ; 2.85 ; CRYSTAL STRUCTURE OF THE DD-TRANSPEPTIDASE-CARBOXYPEPTIDASE FROM ACTINOMADURA R39 1S2M ; 2.10 ; CRYSTAL STRUCTURE OF THE DEAD BOX PROTEIN DHH1P 1SOT ; 2.30 ; CRYSTAL STRUCTURE OF THE DEGS STRESS SENSOR 1A5T ; 2.20 ; CRYSTAL STRUCTURE OF THE DELTA PRIME SUBUNIT OF THE CLAMP-LOADER COMPLEX OF ESCHERICHIA COLI DEOXYRIBONUCLEIC ACID POLYMERASE III 1FY8 ; 1.70 ; CRYSTAL STRUCTURE OF THE DELTAILE16VAL17 RAT ANIONIC TRYPSINOGEN-BPTI COMPLEX 1OK8 ; 2.00 ; CRYSTAL STRUCTURE OF THE DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN IN THE POSTFUSION CONFORMATION 1OAN ; 2.75 ; CRYSTAL STRUCTURE OF THE DENGUE 2 VIRUS ENVELOPE PROTEIN 1OKE ; 2.40 ; CRYSTAL STRUCTURE OF THE DENGUE 2 VIRUS ENVELOPE PROTEIN IN COMPLEX WITH N-OCTYL-BETA-D-GLUCOSIDE 1UZG ; 3.60 ; CRYSTAL STRUCTURE OF THE DENGUE TYPE 3 VIRUS ENVELOPE PROTEIN 1R71 ; 2.20 ; CRYSTAL STRUCTURE OF THE DEOXYRIBONUCLEIC ACID BINDING DOMAIN OF KORB IN COMPLEX WITH THE OPERATOR DEOXYRIBONUCLEIC ACID 238D ; 2.00 ; CRYSTAL STRUCTURE OF THE DEOXYRIBONUCLEIC ACID DECAMER D(AGG(BR)CATGCCT): COMPARISON WITH D(AGGCATGCCT) AND IMPLICATIONS FOR COBALT HEXAMMINE BINDING TO DEOXYRIBONUCLEIC ACID 261D ; 2.40 ; CRYSTAL STRUCTURE OF THE DEOXYRIBONUCLEIC ACID DECAMER D(CGCAATTGCG) COMPLEXED WITH THE MINOR GROOVE BINDING DRUG NETROPSIN 1C4O ; 1.50 ; CRYSTAL STRUCTURE OF THE DEOXYRIBONUCLEIC ACID NUCLEOTIDE EXCISION REPAIR ENZYME UVRB FROM THERMUS THERMOPHILUS 1Q3C ; 2.30 ; CRYSTAL STRUCTURE OF THE DEOXYRIBONUCLEIC ACID REPAIR ENZYME ENDONUCLEASE- VIII (NEI) FROM E. COLI: THE E2A MUTANT AT 2.3 RESOLUTION. 1Q3B ; 2.05 ; CRYSTAL STRUCTURE OF THE DEOXYRIBONUCLEIC ACID REPAIR ENZYME ENDONUCLEASE- VIII (NEI) FROM E. COLI: THE R252A MUTANT AT 2.05 RESOLUTION. 1Q39 ; 2.80 ; CRYSTAL STRUCTURE OF THE DEOXYRIBONUCLEIC ACID REPAIR ENZYME ENDONUCLEASE- VIII (NEI) FROM E. COLI: THE WT ENZYME AT 2.8 RESOLUTION. 1D9X ; 2.60 ; CRYSTAL STRUCTURE OF THE DEOXYRIBONUCLEIC ACID REPAIR PROTEIN UVRB 1D9Z ; 3.15 ; CRYSTAL STRUCTURE OF THE DEOXYRIBONUCLEIC ACID REPAIR PROTEIN UVRB IN COMPLEX WITH ATP 1T5L ; 2.60 ; CRYSTAL STRUCTURE OF THE DEOXYRIBONUCLEIC ACID REPAIR PROTEIN UVRB POINT MUTANT Y96A REVEALING A NOVEL FOLD FOR DOMAIN 2 1I3J ; 2.20 ; CRYSTAL STRUCTURE OF THE DEOXYRIBONUCLEIC ACID-BINDING DOMAIN OF INTRON ENDONUCLEASE I-TEVI WITH ITS SUBSTRATE 1T2T ; 2.50 ; CRYSTAL STRUCTURE OF THE DEOXYRIBONUCLEIC ACID-BINDING DOMAIN OF INTRON ENDONUCLEASE I-TEVI WITH OPERATOR SITE 1HF0 ; 2.70 ; CRYSTAL STRUCTURE OF THE DEOXYRIBONUCLEIC ACID-BINDING DOMAIN OF OCT-1 BOUND TO DEOXYRIBONUCLEIC ACID AS A DIMER 1R9W ; 1.80 ; CRYSTAL STRUCTURE OF THE DEOXYRIBONUCLEIC ACID-BINDING DOMAIN OF THE HUMAN PAPILLOMAVIRUS TYPE 18 (HPV-18) REPLICATION INITIATION PROTEIN E1 1F08 ; 1.90 ; CRYSTAL STRUCTURE OF THE DEOXYRIBONUCLEIC ACID-BINDING DOMAIN OF THE REPLICATION INITIATION PROTEIN E1 FROM PAPILLOMAVIRUS 1J75 ; 1.85 ; CRYSTAL STRUCTURE OF THE DEOXYRIBONUCLEIC ACID-BINDING DOMAIN ZALPHA OF DLM-1 BOUND TO Z-DEOXYRIBONUCLEIC ACID 1R7J ; 1.47 ; CRYSTAL STRUCTURE OF THE DEOXYRIBONUCLEIC ACID-BINDING PROTEIN SSO10A FROM SULFOLOBUS SOLFATARICUS 1XD4 ; 3.64 ; CRYSTAL STRUCTURE OF THE DH-PH-CAT MODULE OF SON OF SEVENLESS (SOS) 1X86 ; 3.22 ; CRYSTAL STRUCTURE OF THE DH/PH DOMAINS OF LEUKEMIA- ASSIOCIATED RHOGEF IN COMPLEX WITH RHOA 1TXD ; 2.13 ; CRYSTAL STRUCTURE OF THE DH/PH DOMAINS OF LEUKEMIA- ASSOCIATED RHOGEF 1RJ2 ; 3.00 ; CRYSTAL STRUCTURE OF THE DH/PH FRAGMENT OF DBS WITHOUT BOUND GTPASE 1KZ7 ; 2.40 ; CRYSTAL STRUCTURE OF THE DH/PH FRAGMENT OF MURINE DBS IN COMPLEX WITH THE PLACENTAL ISOFORM OF HUMAN CDC42 1EB7 ; 2.40 ; CRYSTAL STRUCTURE OF THE DI-HAEM CYTOCHROME C PEROXIDASE FROM PSEUDOMONAS AERUGINOSA 1GYO ; 1.20 ; CRYSTAL STRUCTURE OF THE DI-TETRAHEME CYTOCHROME C3 FROM DESULFOVIBRIO GIGAS AT 1.2 ANG RESOLUTION 1YKV ; 3.30 ; CRYSTAL STRUCTURE OF THE DIELS-ALDER RIBOZYME COMPLEXED WITH THE PRODUCT OF THE REACTION BETWEEN N-PENTYLMALEIMIDE AND COVALENTLY ATTACHED 9-HYDROXYMETHYLANTHRACENE 1UN9 ; 3.10 ; CRYSTAL STRUCTURE OF THE DIHYDROXYACETONE KINASE FROM C. FREUNDII IN COMPLEX WITH AMP-PNP AND MG2+ 1UOD ; 1.90 ; CRYSTAL STRUCTURE OF THE DIHYDROXYACETONE KINASE FROM E. COLI IN COMPLEX WITH DIHYDROXYACETONE-PHOSPHATE 1UOE ; 2.00 ; CRYSTAL STRUCTURE OF THE DIHYDROXYACETONE KINASE FROM E. COLI IN COMPLEX WITH GLYCERALDEHYDE 1UN8 ; 2.50 ; CRYSTAL STRUCTURE OF THE DIHYDROXYACETONE KINASE OF C. FREUNDII (NATIVE FORM) 1IHR ; 1.55 ; CRYSTAL STRUCTURE OF THE DIMERIC C-TERMINAL DOMAIN OF TONB 1XKU ; 2.15 ; CRYSTAL STRUCTURE OF THE DIMERIC PROTEIN CORE OF DECORIN, THE ARCHETYPAL SMALL LEUCINE-RICH REPEAT PROTEOGLYCAN 2BNX ; 2.40 ; CRYSTAL STRUCTURE OF THE DIMERIC REGULATORY DOMAIN OF MOUSE DIAPHANEOUS-RELATED FORMIN (DRF), MDIA1 1RPY ; 2.30 ; CRYSTAL STRUCTURE OF THE DIMERIC SH2 DOMAIN OF APS 1N1C ; 2.40 ; CRYSTAL STRUCTURE OF THE DIMERIC TORD CHAPERONE FROM SHEWANELLA MASSILIA 1R3M ; 2.20 ; CRYSTAL STRUCTURE OF THE DIMERIC UNSWAPPED FORM OF BOVINE SEMINAL RIBONUCLEASE 1ZV1 ; 1.60 ; CRYSTAL STRUCTURE OF THE DIMERIZATION DOMAIN OF DOUBLESEX PROTEIN FROM D. MELANOGASTER 1UFI ; 1.65 ; CRYSTAL STRUCTURE OF THE DIMERIZATION DOMAIN OF HUMAN CENP-B 1EGV ; 1.75 ; CRYSTAL STRUCTURE OF THE DIOL DEHYDRATASE- ADENINYLPENTYLCOBALAMIN COMPLEX FROM KLEBSELLA OXYTOCA UNDER THE ILLUMINATED CONDITION. 1EEX ; 1.70 ; CRYSTAL STRUCTURE OF THE DIOL DEHYDRATASE- ADENINYLPENTYLCOBALAMIN COMPLEX FROM KLEBSIELLA OXYTOCA 1V8X ; 1.85 ; CRYSTAL STRUCTURE OF THE DIOXYGEN-BOUND HEME OXYGENASE FROM CORYNEBACTERIUM DIPHTHERIAE 1NTV ; 1.50 ; CRYSTAL STRUCTURE OF THE DISABLED-1 (DAB1) PTB DOMAIN- APOER2 PEPTIDE COMPLEX 1ZGP ; 1.90 ; CRYSTAL STRUCTURE OF THE DISCOSOMA RED FLUORESCENT PROTEIN (DSRED) VARIANT K70M 1ZGQ ; 1.90 ; CRYSTAL STRUCTURE OF THE DISCOSOMA RED FLUORESCENT PROTEIN (DSRED) VARIANT Q66M 1J2L ; 1.70 ; CRYSTAL STRUCTURE OF THE DISINTEGRIN, TRIMESTATIN 1V57 ; 2.00 ; CRYSTAL STRUCTURE OF THE DISULFIDE BOND ISOMERASE DSBG 1VRS ; 2.85 ; CRYSTAL STRUCTURE OF THE DISULFIDE-LINKED COMPLEX BETWEEN THE N-TERMINAL AND C-TERMINAL DOMAIN OF THE ELECTRON TRANSFER CATALYST DSBD 1Z5Y ; 1.94 ; CRYSTAL STRUCTURE OF THE DISULFIDE-LINKED COMPLEX BETWEEN THE N-TERMINAL DOMAIN OF THE ELECTRON TRANSFER CATALYST DSBD AND THE CYTOCHROME C BIOGENESIS PROTEIN CCMG 1EZL ; 2.00 ; CRYSTAL STRUCTURE OF THE DISULPHIDE BOND-DEFICIENT AZURIN MUTANT C3A/C26A: HOW IMPORTANT IS THE S-S BOND FOR FOLDING AND STABILITY? 1EQF ; 2.10 ; CRYSTAL STRUCTURE OF THE DOUBLE BROMODOMAIN MODULE FROM HUMAN TAFII250 1GR7 ; 1.80 ; CRYSTAL STRUCTURE OF THE DOUBLE MUTANT CYS3SER/SER100PRO FROM PSEUDOMONAS AERUGINOSA AT 1.8 A RESOLUTION 1XTM ; 1.60 ; CRYSTAL STRUCTURE OF THE DOUBLE MUTANT Y88H-P104H OF A SOD- LIKE PROTEIN FROM BACILLUS SUBTILIS. 1M0U ; 1.75 ; CRYSTAL STRUCTURE OF THE DROSOPHILA GLUTATHIONE S- TRANSFERASE-2 IN COMPLEX WITH GLUTATHIONE 1OO0 ; 1.85 ; CRYSTAL STRUCTURE OF THE DROSOPHILA MAGO NASHI-Y14 COMPLEX 1S2J ; 2.20 ; CRYSTAL STRUCTURE OF THE DROSOPHILA PATTERN-RECOGNITION RECEPTOR PGRP-SA 1WP1 ; 2.56 ; CRYSTAL STRUCTURE OF THE DRUG-DISCHARGE OUTER MEMBRANE PROTEIN, OPRM 2CU6 ; 2.00 ; CRYSTAL STRUCTURE OF THE DTDP-4-KETO-L-RHAMNOSE REDUCTASE- RELATED PROTEIN FROM THERMUS THERMOPHILUS HB8 1JWY ; 2.30 ; CRYSTAL STRUCTURE OF THE DYNAMIN A GTPASE DOMAIN COMPLEXED WITH GDP, DETERMINED AS MYOSIN FUSION 1F6J ; 2.25 ; CRYSTAL STRUCTURE OF THE E-DEOXYRIBONUCLEIC ACID HEXAMER GGCGBR5CC 1F6I ; 2.20 ; CRYSTAL STRUCTURE OF THE E-DEOXYRIBONUCLEIC ACID HEXAMER GGCGM5CC 1FCO ; 2.20 ; CRYSTAL STRUCTURE OF THE E. COLI AMPC BETA-LACTAMASE COVALENTLY ACYLATED WITH THE INHIBITORY BETA-LACTAM, MOXALACTAM 1I5Q ; 1.83 ; CRYSTAL STRUCTURE OF THE E. COLI AMPC BETA-LACTAMASE MUTANT N152A COVALENTLY ACYLATED WITH THE INHIBITORY BETA-LACTAM, MOXALACTAM 1FCN ; 2.35 ; CRYSTAL STRUCTURE OF THE E. COLI AMPC BETA-LACTAMASE MUTANT Q120L/Y150E COVALENTLY ACYLATED WITH THE SUBSTRATE BETA- LACTAM LORACARBEF 1C0A ; 2.40 ; CRYSTAL STRUCTURE OF THE E. COLI ASPARTYL-TRNA SYNTHETASE : TRNAASP : ASPARTYL-ADENYLATE COMPLEX 1IL2 ; 2.60 ; CRYSTAL STRUCTURE OF THE E. COLI ASPARTYL-TRNA SYNTHETASE:YEAST TRNAASP:ASPARTYL-ADENYLATE COMPLEX 1RYA ; 1.30 ; CRYSTAL STRUCTURE OF THE E. COLI GDP-MANNOSE MANNOSYL HYDROLASE IN COMPLEX WITH GDP AND MG 1LDF ; 2.10 ; CRYSTAL STRUCTURE OF THE E. COLI GLYCEROL FACILITATOR (GLPF) MUTATION W48F, F200T 1FX8 ; 2.20 ; CRYSTAL STRUCTURE OF THE E. COLI GLYCEROL FACILITATOR (GLPF) WITH SUBSTRATE GLYCEROL 1LDA ; 2.80 ; CRYSTAL STRUCTURE OF THE E. COLI GLYCEROL FACILITATOR (GLPF) WITHOUT SUBSTRATE GLYCEROL 1LDI ; 2.70 ; CRYSTAL STRUCTURE OF THE E. COLI GLYCEROL FACILITATOR (GLPF) WITHOUT SUBSTRATE GLYCEROL 1TF1 ; 1.80 ; CRYSTAL STRUCTURE OF THE E. COLI GLYOXYLATE REGULATORY PROTEIN LIGAND BINDING DOMAIN 1MUL ; 2.30 ; CRYSTAL STRUCTURE OF THE E. COLI HU ALPHA2 PROTEIN 1IX9 ; 0.90 ; CRYSTAL STRUCTURE OF THE E. COLI MANGANASE(III) SUPEROXIDE DISMUTASE MUTANT Y174F AT 0.90 ANGSTROMS RESOLUTION. 1I0H ; 1.35 ; CRYSTAL STRUCTURE OF THE E. COLI MANGANESE SUPEROXIDE DISMUTASE MUTANT Y174F AT 1.35 ANGSTROMS RESOLUTION. 1IXB ; 0.90 ; CRYSTAL STRUCTURE OF THE E. COLI MANGANESE(II) SUPEROXIDE DISMUTASE MUTANT Y174F AT 0.90 ANGSTROMS RESOLUTION. 1K8W ; 1.85 ; CRYSTAL STRUCTURE OF THE E. COLI PSEUDOURIDINE SYNTHASE TRUB BOUND TO A T STEM-LOOP RIBONUCLEIC ACID 1D5Y ; 2.70 ; CRYSTAL STRUCTURE OF THE E. COLI ROB TRANSCRIPTION FACTOR IN COMPLEX WITH DEOXYRIBONUCLEIC ACID 1CRZ ; 1.95 ; CRYSTAL STRUCTURE OF THE E. COLI TOLB PROTEIN 1FCM ; 2.46 ; CRYSTAL STRUCTURE OF THE E.COLI AMPC BETA-LACTAMASE MUTANT Q120L/Y150E COVALENTLY ACYLATED WITH THE INHIBITORY BETA- LACTAM, CLOXACILLIN 1Y79 ; 2.00 ; CRYSTAL STRUCTURE OF THE E.COLI DIPEPTIDYL CARBOXYPEPTIDASE DCP IN COMPLEX WITH A PEPTIDIC INHIBITOR 1T3W ; 2.80 ; CRYSTAL STRUCTURE OF THE E.COLI DNAG C-TERMINAL DOMAIN (RESIDUES 434 TO 581) 1EUM ; 2.05 ; CRYSTAL STRUCTURE OF THE E.COLI FERRITIN ECFTNA 1F4L ; 1.85 ; CRYSTAL STRUCTURE OF THE E.COLI METHIONYL-TRNA SYNTHETASE COMPLEXED WITH METHIONINE 1XDP ; 2.50 ; CRYSTAL STRUCTURE OF THE E.COLI POLYPHOSPHATE KINASE IN COMPLEX WITH AMPPNP 1SB7 ; 2.20 ; CRYSTAL STRUCTURE OF THE E.COLI PSEUDOURIDINE SYNTHASE TRUD 1Q8F ; 1.70 ; CRYSTAL STRUCTURE OF THE E.COLI PYRIMIDINE NUCLEOSIDE HYDROLASE YEIK 1IU3 ; 3.00 ; CRYSTAL STRUCTURE OF THE E.COLI SEQA PROTEIN COMPLEXED WITH HEMIMETHYLATED DEOXYRIBONUCLEIC ACID 1J3E ; 2.50 ; CRYSTAL STRUCTURE OF THE E.COLI SEQA PROTEIN COMPLEXED WITH N6-METHYLADENINE- GUANINE MISMATCH DEOXYRIBONUCLEIC ACID 1C8U ; 1.90 ; CRYSTAL STRUCTURE OF THE E.COLI THIOESTERASE II, A HOMOLOGUE OF THE HUMAN NEF-BINDING ENZYME 1LSJ ; 2.50 ; CRYSTAL STRUCTURE OF THE E110Q MUTANT OF L-3-HYDROXYACYL- COA DEHYDROGENASE IN COMPLEX WITH NAD 1L5Z ; 2.00 ; CRYSTAL STRUCTURE OF THE E121K SUBSTITUTION OF THE RECEIVER DOMAIN OF SINORHIZOBIUM MELILOTI DCTD 1KG7 ; 1.50 ; CRYSTAL STRUCTURE OF THE E161A MUTANT OF E.COLI MUTY (CORE FRAGMENT) 1BY9 ; 2.20 ; CRYSTAL STRUCTURE OF THE E2 DEOXYRIBONUCLEIC ACID-BINDING DOMAIN FROM HUMAN PAPILLOMAVIRUS TYPE-16: IMPLICATIONS FOR ITS DEOXYRIBONUCLEIC ACID BINDING-SITE SELECTION MECHANISM 1Q2X ; 2.05 ; CRYSTAL STRUCTURE OF THE E243D MUTANT OF ASPARTATE SEMIALDEHYDE DEHYDROGENASE FROM HAEMOPHILUS INFLUENZAE BOUND WITH SUBSTRATE ASPARTATE SEMIALDEHYDE 2HLP ; 2.59 ; CRYSTAL STRUCTURE OF THE E267R MUTANT OF A HALOPHILIC MALATE DEHYDROGENASE IN THE APO FORM 1UJZ ; 2.10 ; CRYSTAL STRUCTURE OF THE E7_C/IM7_C COMPLEX; A COMPUTATIONALLY DESIGNED INTERFACE BETWEEN THE COLICIN E7 DNASE AND THE IM7 IMMUNITY PROTEIN 1FSJ ; 1.80 ; CRYSTAL STRUCTURE OF THE E9 DNASE DOMAIN 1FR2 ; 1.60 ; CRYSTAL STRUCTURE OF THE E9 DNASE DOMAIN WITH A MUTANT IMMUNITY PROTEIN IM9(E41A) 1TXQ ; 1.80 ; CRYSTAL STRUCTURE OF THE EB1 C-TERMINAL DOMAIN COMPLEXED WITH THE CAP-GLY DOMAIN OF P150GLUED 1EBO ; 3.00 ; CRYSTAL STRUCTURE OF THE EBOLA VIRUS MEMBRANE-FUSION SUBUNIT, GP2, FROM THE ENVELOPE GLYCOPROTEIN ECTODOMAIN 1Z6I ; 2.50 ; CRYSTAL STRUCTURE OF THE ECTODOMAIN OF DROSOPHILA TRANSMEMBRANE RECEPTOR PGRP-LCA 1FJR ; 2.30 ; CRYSTAL STRUCTURE OF THE ECTODOMAIN OF METHUSELAH 1TJE ; 1.50 ; CRYSTAL STRUCTURE OF THE EDITING DOMAIN OF THREONYL-TRNA SYNTHETASE 1TKG ; 1.50 ; CRYSTAL STRUCTURE OF THE EDITING DOMAIN OF THREONYL-TRNA SYNTHETASE COMPLEXED WITH AN ANALOG OF SERYLADENYLATE 1TKE ; 1.46 ; CRYSTAL STRUCTURE OF THE EDITING DOMAIN OF THREONYL-TRNA SYNTHETASE COMPLEXED WITH SERINE 1TKY ; 1.48 ; CRYSTAL STRUCTURE OF THE EDITING DOMAIN OF THREONYL-TRNA SYNTHETASE COMPLEXED WITH SERYL-3'-AMINOADENOSINE 1Y2Q ; 1.95 ; CRYSTAL STRUCTURE OF THE EDITING DOMAIN OF THREONYL-TRNA SYNTHETASE FROM PYROCOCCUS ABYSSI 1PK0 ; 3.30 ; CRYSTAL STRUCTURE OF THE EF3-CAM COMPLEXED WITH PMEAPP 1Q46 ; 2.86 ; CRYSTAL STRUCTURE OF THE EIF2 ALPHA SUBUNIT FROM SACCHAROMYCES CEREVISIA 1NTG ; 2.21 ; CRYSTAL STRUCTURE OF THE EMAP II-LIKE CYTOKINE RELEASED FROM HUMAN TYROSYL-TRNA SYNTHETASE 1E7Z ; 2.05 ; CRYSTAL STRUCTURE OF THE EMAP2/RIBONUCLEIC ACID BINDING DOMAIN OF THE P43 PROTEIN FROM HUMAN AMINOACYL-TRNA SYNTHETASE COMPLEX 1FL0 ; 1.50 ; CRYSTAL STRUCTURE OF THE EMAP2/RIBONUCLEIC ACID-BINDING DOMAIN OF THE P43 PROTEIN FROM HUMAN AMINOACYL-TRNA SYNTHETASE COMPLEX 1L8J ; 2.00 ; CRYSTAL STRUCTURE OF THE ENDOTHELIAL PROTEIN C RECEPTOR AND BOUND PHOSPHOLIPID MOLECULE 1LQV ; 1.60 ; CRYSTAL STRUCTURE OF THE ENDOTHELIAL PROTEIN C RECEPTOR WITH PHOSPHOLIPID IN THE GROOVE IN COMPLEX WITH GLA DOMAIN OF PROTEIN C. 1U0A ; 1.64 ; CRYSTAL STRUCTURE OF THE ENGINEERED BETA-1,3-1,4- ENDOGLUCANASE H(A16-M) IN COMPLEX WITH BETA-GLUCAN TETRASACCHARIDE 1EDU ; 1.80 ; CRYSTAL STRUCTURE OF THE ENTH DOMAIN OF RAT EPSIN 1 1GIQ ; 1.80 ; CRYSTAL STRUCTURE OF THE ENZYMATIC COMPONET OF IOTA-TOXIN FROM CLOSTRIDIUM PERFRINGENS WITH NADH 1GIR ; 2.10 ; CRYSTAL STRUCTURE OF THE ENZYMATIC COMPONET OF IOTA-TOXIN FROM CLOSTRIDIUM PERFRINGENS WITH NADPH 1H8U ; 1.80 ; CRYSTAL STRUCTURE OF THE EOSINOPHIL MAJOR BASIC PROTEIN AT 1.8A: AN ATYPICAL LECTIN WITH A PARADIGM SHIFT IN SPECIFICITY 1KGY ; 2.70 ; CRYSTAL STRUCTURE OF THE EPHB2-EPHRINB2 COMPLEX 1EYH ; 1.56 ; CRYSTAL STRUCTURE OF THE EPSIN N-TERMINAL HOMOLOGY (ENTH) DOMAIN AT 1.56 ANGSTROM RESOLUTION 1TZQ ; 2.30 ; CRYSTAL STRUCTURE OF THE EQUINATOXIN II 8-69 DOUBLE CYSTEINE MUTANT 1F48 ; 2.30 ; CRYSTAL STRUCTURE OF THE ESCHERICHIA COLI ARSENITE- TRANSLOCATING ATPASE 1II0 ; 2.40 ; CRYSTAL STRUCTURE OF THE ESCHERICHIA COLI ARSENITE- TRANSLOCATING ATPASE 1II9 ; 2.60 ; CRYSTAL STRUCTURE OF THE ESCHERICHIA COLI ARSENITE- TRANSLOCATING ATPASE IN COMPLEX WITH AMP-PNP 1IHU ; 2.15 ; CRYSTAL STRUCTURE OF THE ESCHERICHIA COLI ARSENITE- TRANSLOCATING ATPASE IN COMPLEX WITH MG-ADP-ALF3 1BXI ; 2.05 ; CRYSTAL STRUCTURE OF THE ESCHERICHIA COLI COLICIN E9 DNASE DOMAIN WITH ITS COGNATE IMMUNITY PROTEIN IM9 1JSX ; 2.40 ; CRYSTAL STRUCTURE OF THE ESCHERICHIA COLI GLUCOSE-INHIBITED DIVISION PROTEIN B (GIDB) 1JYH ; 1.80 ; CRYSTAL STRUCTURE OF THE ESCHERICHIA COLI SBMC PROTEIN (AKA GYRASE INHIBITORY PROTEIN GYRI, AKA YEEB) 1KAG ; 2.05 ; CRYSTAL STRUCTURE OF THE ESCHERICHIA COLI SHIKIMATE KINASE I (AROK) 1VBM ; 2.70 ; CRYSTAL STRUCTURE OF THE ESCHERICHIA COLI TYROSYL-TRNA SYNTHETASE COMPLEXED WITH TYR-AMS 1Y0G ; 2.20 ; CRYSTAL STRUCTURE OF THE ESCHERICHIA COLI YCEI PROTEIN, STRUCTURAL GENOMICS 1OKJ ; 2.28 ; CRYSTAL STRUCTURE OF THE ESSENTIAL E. COLI YEAZ PROTEIN BY MAD METHOD USING THE GADOLINIUM COMPLEX "DOTMA" 1OG1 ; 2.00 ; CRYSTAL STRUCTURE OF THE EUCARYOTIC MONO-ADP-RIBOSYLTRANSFERASE ART2.2 IN COMPLEX WITH TAD 1OG4 ; 2.60 ; CRYSTAL STRUCTURE OF THE EUCARYOTIC MONO-ADP-RIBOSYLTRANSFERASE ART2.2 MUTANT E189A IN COMPLEX WITH NADH 1OG3 ; 2.60 ; CRYSTAL STRUCTURE OF THE EUCARYOTIC MONO-ADP-RIBOSYLTRANSFERASE ART2.2 MUTANT E189I IN COMPLEX WITH NAD 1GXY ; 1.71 ; CRYSTAL STRUCTURE OF THE EUCARYOTIC MONO-ADP-RIBOSYLTRANSFERASE ART2.2; CRYSTAL FORM A (P21) 1GXZ ; 2.10 ; CRYSTAL STRUCTURE OF THE EUCARYOTIC MONO-ADP-RIBOSYLTRANSFERASE ART2.2; CRYSTAL FORM B (P212121) 1GY0 ; 2.08 ; CRYSTAL STRUCTURE OF THE EUCARYOTIC MONO-ADP-RIBOSYLTRANSFERASE ART2.2; CRYSTAL FORM C (P3121) 1SXJ ; 2.85 ; CRYSTAL STRUCTURE OF THE EUKARYOTIC CLAMP LOADER (REPLICATION FACTOR C, RFC) BOUND TO THE DEOXYRIBONUCLEIC ACID SLIDING CLAMP (PROLIFERATING CELL NUCLEAR ANTIGEN, PCNA) 2A0U ; 2.10 ; CRYSTAL STRUCTURE OF THE EUKARYOTIC INITIATION FACTOR 2B FROM LEISHMANIA MAJOR AT 2.1 A RESOLUTION 2D2S ; 2.85 ; CRYSTAL STRUCTURE OF THE EXO84P C-TERMINAL DOMAINS 1KFI ; 2.40 ; CRYSTAL STRUCTURE OF THE EXOCYTOSIS-SENSITIVE PHOSPHOPROTEIN, PP63/PARAFUSIN (PHOSPHOGLUCOMUTASE) FROM PARAMECIUM 1WA5 ; 2.00 ; CRYSTAL STRUCTURE OF THE EXPORTIN CSE1P COMPLEXED WITH ITS CARGO (KAP60P) AND RANGTP 1N26 ; 2.40 ; CRYSTAL STRUCTURE OF THE EXTRA-CELLULAR DOMAINS OF HUMAN INTERLEUKIN-6 RECEPTOR ALPHA CHAIN 1FNL ; 1.80 ; CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF A HUMAN FCGRIII 1JCZ ; 1.55 ; CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF HUMAN CARBONIC ANHYDRASE XII 1JD0 ; 1.50 ; CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF HUMAN CARBONIC ANHYDRASE XII COMPLEXED WITH ACETAZOLAMIDE 1IQA ; 2.20 ; CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF MOUSE RANK LIGAND 1RJ5 ; 2.81 ; CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF MURINE CARBONIC ANHYDRASE XIV 1RJ6 ; 2.90 ; CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF MURINE CARBONIC ANHYDRASE XIV IN COMPLEX WITH ACETAZOLAMIDE 1NPU ; 2.00 ; CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF MURINE PD-1 1BTE ; 1.50 ; CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE TYPE II ACTIVIN RECEPTOR 1UCT ; 2.10 ; CRYSTAL STRUCTURE OF THE EXTRACELLULAR FRAGMENT OF FC ALPHA RECEPTOR I (CD89) 1PC3 ; 2.16 ; CRYSTAL STRUCTURE OF THE EXTRACELLULAR PHOSPHATE ABC TRANSPORT RECEPTOR (PSTS-1) AND IMMUNODOMINANT ANTIGEN OF M. TUBERCULOSIS. 1N8Y ; 2.40 ; CRYSTAL STRUCTURE OF THE EXTRACELLULAR REGION OF RAT HER2 1Z8G ; 1.55 ; CRYSTAL STRUCTURE OF THE EXTRACELLULAR REGION OF THE TRANSMEMBRANE SERINE PROTEASE HEPSIN WITH COVALENTLY BOUND PREFERRED SUBSTRATE. 1M1X ; 3.30 ; CRYSTAL STRUCTURE OF THE EXTRACELLULAR SEGMENT OF INTEGRIN ALPHA VBETA3 BOUND TO MN2+ 1JV2 ; 3.10 ; CRYSTAL STRUCTURE OF THE EXTRACELLULAR SEGMENT OF INTEGRIN ALPHAVBETA3 1L5G ; 3.20 ; CRYSTAL STRUCTURE OF THE EXTRACELLULAR SEGMENT OF INTEGRIN AVB3 IN COMPLEX WITH AN ARG-GLY-ASP LIGAND 1R85 ; 1.45 ; CRYSTAL STRUCTURE OF THE EXTRACELLULAR XYLANASE FROM GEOBACILLUS STEAROTHERMOPHILUS T-6 (XT6): THE WT ENZYME (MONOCLINIC FORM) AT 1.45A RESOLUTION 1R87 ; 1.67 ; CRYSTAL STRUCTURE OF THE EXTRACELLULAR XYLANASE FROM GEOBACILLUS STEAROTHERMOPHILUS T-6 (XT6, MONOCLINIC FORM): THE COMPLEX OF THE WT ENZYME WITH XYLOPENTAOSE AT 1.67A RESOLUTION 1R86 ; 1.80 ; CRYSTAL STRUCTURE OF THE EXTRACELLULAR XYLANASE FROM GEOBACILLUS STEAROTHERMOPHILUS T-6 (XT6, MONOCLINIC FORM): THE E159A/E265A MUTANT AT 1.8A RESOLUTION 1T7Q ; 1.80 ; CRYSTAL STRUCTURE OF THE F565A MUTANT OF MURINE CARNITINE ACETYLTRANSFERASE IN COMPLEX WITH CARNITINE AND COA 1YY8 ; 2.00 ; CRYSTAL STRUCTURE OF THE FAB FRAGMENT FROM THE MONOCLONAL ANTIBODY CETUXIMAB/ERBITUX/IMC-C225 1QLR ; 2.83 ; CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A HUMAN MONOCLONAL IGM COLD AGGLUTININ 1MIE ; 1.95 ; CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS5-393 1FH5 ; 2.90 ; CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE MONOCLONAL ANTIBODY MAK33 1IQW ; 2.50 ; CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE MOUSE ANTI- HUMAN FAS ANTIBODY HFE7A 1TZH ; 2.60 ; CRYSTAL STRUCTURE OF THE FAB YADS1 COMPLEXED WITH H-VEGF 1TZI ; 2.80 ; CRYSTAL STRUCTURE OF THE FAB YADS2 COMPLEXED WITH H-VEGF 1K40 ; 2.25 ; CRYSTAL STRUCTURE OF THE FAT DOMAIN OF FOCAL ADHESION KINASE 1U7N ; 2.26 ; CRYSTAL STRUCTURE OF THE FATTY ACID/PHOSPHOLIPID SYNTHESIS PROTEIN PLSX FROM ENTEROCOCCUS FAECALIS V583 1H4R ; 1.80 ; CRYSTAL STRUCTURE OF THE FERM DOMAIN OF MERLIN, THE NEUROFIBROMATOSIS 2 TUMOR SUPPRESSOR PROTEIN. 1RGV ; 2.90 ; CRYSTAL STRUCTURE OF THE FERREDOXIN FROM THAUERA AROMATICA 1JB9 ; 1.70 ; CRYSTAL STRUCTURE OF THE FERREDOXIN:NADP+ REDUCTASE FROM MAIZE ROOT AT 1.7 ANGSTROMS 1LSW ; 2.20 ; CRYSTAL STRUCTURE OF THE FERROUS BJFIXL HEME DOMAIN 1T87 ; 1.80 ; CRYSTAL STRUCTURE OF THE FERROUS CO-BOUND CYTOCHROME P450CAM (C334A) 1T85 ; 1.80 ; CRYSTAL STRUCTURE OF THE FERROUS CO-BOUND CYTOCHROME P450CAM MUTANT (L358P/C334A) 1T88 ; 1.90 ; CRYSTAL STRUCTURE OF THE FERROUS CYTOCHROME P450CAM (C334A) 1T86 ; 1.90 ; CRYSTAL STRUCTURE OF THE FERROUS CYTOCHROME P450CAM MUTANT (L358P/C334A) 2BRF ; 1.40 ; CRYSTAL STRUCTURE OF THE FHA DOMAIN OF HUMAN POLYNUCLEOTIDE KINASE 3' PHOSPHATASE 1YJM ; 2.20 ; CRYSTAL STRUCTURE OF THE FHA DOMAIN OF MOUSE POLYNUCLEOTIDE KINASE IN COMPLEX WITH AN XRCC4-DERIVED PHOSPHOPEPTIDE. 1LGQ ; 2.10 ; CRYSTAL STRUCTURE OF THE FHA DOMAIN OF THE CHFR MITOTIC CHECKPOINT PROTEIN 1LGP ; 2.00 ; CRYSTAL STRUCTURE OF THE FHA DOMAIN OF THE CHFR MITOTIC CHECKPOINT PROTEIN COMPLEXED WITH TUNGSTATE 1QU0 ; 2.35 ; CRYSTAL STRUCTURE OF THE FIFTH LAMININ G-LIKE MODULE OF THE MOUSE LAMININ ALPHA2 CHAIN 1AKS ; 1.80 ; CRYSTAL STRUCTURE OF THE FIRST ACTIVE AUTOLYSATE FORM OF THE PORCINE ALPHA TRYPSIN 1NTY ; 1.70 ; CRYSTAL STRUCTURE OF THE FIRST DH/PH DOMAIN OF TRIO TO 1.7 A 1JBK ; 1.80 ; CRYSTAL STRUCTURE OF THE FIRST NUCELOTIDE BINDING DOMAIN OF CLPB 1R3O ; 1.90 ; CRYSTAL STRUCTURE OF THE FIRST RIBONUCLEIC ACID DUPLEX IN L-CONFORMATION AT 1.9A RESOLUTION 1JI3 ; 2.20 ; CRYSTAL STRUCTURE OF THE FIRST THERMOSTABLE BACTERIAL LIPASE FROM BACILLUS STEAROTHERMOPHILUS 1KDG ; 1.50 ; CRYSTAL STRUCTURE OF THE FLAVIN DOMAIN OF CELLOBIOSE DEHYDROGENASE 1D4E ; 2.80 ; CRYSTAL STRUCTURE OF THE FLAVOCYTOCHROME C FUMARATE REDUCTASE OF SHEWANELLA PUTREFACIENS STRAIN MR-1 COMPLEXED WITH FUMARATE 1CQX ; 1.75 ; CRYSTAL STRUCTURE OF THE FLAVOHEMOGLOBIN FROM ALCALIGENES EUTROPHUS AT 1.75 A RESOLUTION 1ETE ; 2.20 ; CRYSTAL STRUCTURE OF THE FLT3 LIGAND 1B1C ; 1.93 ; CRYSTAL STRUCTURE OF THE FMN-BINDING DOMAIN OF HUMAN CYTOCHROME P450 REDUCTASE AT 1.93A RESOLUTION 1K04 ; 1.95 ; CRYSTAL STRUCTURE OF THE FOCAL ADHESION TARGETING DOMAIN OF FOCAL ADHESION KINASE 1K05 ; 2.90 ; CRYSTAL STRUCTURE OF THE FOCAL ADHESION TARGETING DOMAIN OF FOCAL ADHESION KINASE 1LQP ; 1.19 ; CRYSTAL STRUCTURE OF THE FOSFOMYCIN RESISTANCE PROTEIN (FOSA) CONTAINING BOUND SUBSTRATE 1NPB ; 2.50 ; CRYSTAL STRUCTURE OF THE FOSFOMYCIN RESISTANCE PROTEIN FROM TRANSPOSON TN2921 1W7Z ; 1.67 ; CRYSTAL STRUCTURE OF THE FREE (UNCOMPLEXED) ECBALLIUM ELATERIUM TRYPSIN INHIBITOR (EETI-II) 1MPU ; 2.50 ; CRYSTAL STRUCTURE OF THE FREE HUMAN NKG2D IMMUNORECEPTOR 1KEK ; 1.90 ; CRYSTAL STRUCTURE OF THE FREE RADICAL INTERMEDIATE OF PYRUVATE:FERREDOXIN OXIDOREDUCTASE 1IXZ ; 2.20 ; CRYSTAL STRUCTURE OF THE FTSH ATPASE DOMAIN FROM THERMUS THERMOPHILUS 1IY2 ; 3.20 ; CRYSTAL STRUCTURE OF THE FTSH ATPASE DOMAIN FROM THERMUS THERMOPHILUS 1IY1 ; 2.80 ; CRYSTAL STRUCTURE OF THE FTSH ATPASE DOMAIN WITH ADP FROM THERMUS THERMOPHILUS 1IY0 ; 2.95 ; CRYSTAL STRUCTURE OF THE FTSH ATPASE DOMAIN WITH AMP-PNP FROM THERMUS THERMOPHILUS 1L3P ; 1.98 ; CRYSTAL STRUCTURE OF THE FUNCTIONAL DOMAIN OF THE MAJOR GRASS POLLEN ALLERGEN PHL P 5B 1DVK ; 2.15 ; CRYSTAL STRUCTURE OF THE FUNCTIONAL DOMAIN OF THE SPLICING FACTOR PRP18 1I9W ; 3.00 ; CRYSTAL STRUCTURE OF THE FUSION GLYCOPROTEIN E1 FROM SEMLIKI FOREST VIRUS 1XXF ; 2.60 ; CRYSTAL STRUCTURE OF THE FXIA CATALYTIC DOMAIN IN COMPLEX WITH ECOTIN MUTANT (ECOTINP) 1XX9 ; 2.20 ; CRYSTAL STRUCTURE OF THE FXIA CATALYTIC DOMAIN IN COMPLEX WITH ECOTINM84R 1XXD ; 2.91 ; CRYSTAL STRUCTURE OF THE FXIA CATALYTIC DOMAIN IN COMPLEX WITH MUTATED ECOTIN 1QN5 ; 1.93 ; CRYSTAL STRUCTURE OF THE G(-26) ADENOVIRUS MAJOR LATE PROMOTER TATA BOX VARIANT BOUND TO WILD-TYPE TBP (ARABIDOPSIS THALIANA TBP ISOFORM 2). TATA ELEMENT RECOGNITION BY THE TATA BOX-BINDING PROTEIN HAS BEEN CONSERVED THROUGHOUT EVOLUTION. 1OBI ; 2.20 ; CRYSTAL STRUCTURE OF THE G130A MUTANT OF MALONAMIDASE E2 FROM BRADYRHIZOBIUM JAPONICUM 1Y94 ; 2.20 ; CRYSTAL STRUCTURE OF THE G16S/N17T/P19A/S20A/N67D VARIANT OF BOVINE SEMINAL RIBONUCLEASE 1M6V ; 2.10 ; CRYSTAL STRUCTURE OF THE G359F (SMALL SUBUNIT) POINT MUTANT OF CARBAMOYL PHOSPHATE SYNTHETASE 1TF0 ; 2.70 ; CRYSTAL STRUCTURE OF THE GA MODULE COMPLEXED WITH HUMAN SERUM ALBUMIN 1KJT ; 2.00 ; CRYSTAL STRUCTURE OF THE GABA(A) RECEPTOR ASSOCIATED PROTEIN, GABARAP 2D0N ; 1.57 ; CRYSTAL STRUCTURE OF THE GADS-CSH3 DOMAIN IN COMPLEX WITH SLP-76 MOTIF PEPTIDE REVEALS A NOVEL DIMERIZATION MODE WITHIN THE SH3 PROTEIN DOMAINS 1Z45 ; 1.85 ; CRYSTAL STRUCTURE OF THE GAL10 FUSION PROTEIN GALACTOSE MUTAROTASE/UDP-GALACTOSE 4-EPIMERASE FROM SACCHAROMYCES CEREVISIAE COMPLEXED WITH NAD, UDP-GLUCOSE, AND GALACTOSE 1LUR ; 1.85 ; CRYSTAL STRUCTURE OF THE GALM/ALDOSE EPIMERASE HOMOLOGUE FROM C. ELEGANS, NORTHEAST STRUCTURAL GENOMICS TARGET WR66 2AF7 ; 2.81 ; CRYSTAL STRUCTURE OF THE GAMMA-CARBOXYMUCONOLACTONE DECARBOXYLASE FROM METHANOBACTERIUM THERMOAUTOTROPHICUM. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET TT747. 1HE9 ; 2.40 ; CRYSTAL STRUCTURE OF THE GAP DOMAIN OF THE PSEUDOMONAS AERUGINOSA EXOS TOXIN 1XJ0 ; 1.70 ; CRYSTAL STRUCTURE OF THE GDP-BOUND FORM OF THE RASG60A MUTANT 1N7G ; 2.20 ; CRYSTAL STRUCTURE OF THE GDP-MANNOSE 4,6-DEHYDRATASE TERNARY COMPLEX WITH NADPH AND GDP-RHAMNOSE. 1Y96 ; 2.00 ; CRYSTAL STRUCTURE OF THE GEMIN6/GEMIN7 HETERODIMER FROM THE HUMAN SMN COMPLEX 2AFS ; 2.22 ; CRYSTAL STRUCTURE OF THE GENETIC MUTANT R54W OF HUMAN GLUTAMINYL CYCLASE 1YD6 ; 2.00 ; CRYSTAL STRUCTURE OF THE GIY-YIG N-TERMINAL ENDONUCLEASE DOMAIN OF UVRC FROM BACILLUS CALDOTENAX 1YCZ ; 1.80 ; CRYSTAL STRUCTURE OF THE GIY-YIG N-TERMINAL ENDONUCLEASE DOMAIN OF UVRC FROM THERMOTOGA MARITIMA 1YD1 ; 1.80 ; CRYSTAL STRUCTURE OF THE GIY-YIG N-TERMINAL ENDONUCLEASE DOMAIN OF UVRC FROM THERMOTOGA MARITIMA BOUND TO ITS CATALYTIC DIVALENT CATION: MAGNESIUM 1YD0 ; 1.50 ; CRYSTAL STRUCTURE OF THE GIY-YIG N-TERMINAL ENDONUCLEASE DOMAIN OF UVRC FROM THERMOTOGA MARITIMA BOUND TO ITS CATALYTIC DIVALENT CATION: MANGANESE 1YD5 ; 1.80 ; CRYSTAL STRUCTURE OF THE GIY-YIG N-TERMINAL ENDONUCLEASE DOMAIN OF UVRC FROM THERMOTOGA MARITIMA: POINT MUTANT N88A BOUND TO ITS CATALYTIC DIVALENT CATION 1YD2 ; 1.60 ; CRYSTAL STRUCTURE OF THE GIY-YIG N-TERMINAL ENDONUCLEASE DOMAIN OF UVRC FROM THERMOTOGA MARITIMA: POINT MUTANT Y19F BOUND TO THE CATALYTIC DIVALENT CATION 1YD4 ; 1.90 ; CRYSTAL STRUCTURE OF THE GIY-YIG N-TERMINAL ENDONUCLEASE DOMAIN OF UVRC FROM THERMOTOGA MARITIMA: POINT MUTANT Y29F BOUND TO ITS CATALYTIC DIVALENT CATION 1YD3 ; 1.60 ; CRYSTAL STRUCTURE OF THE GIY-YIG N-TERMINAL ENDONUCLEASE DOMAIN OF UVRC FROM THERMOTOGA MARITIMA: POINT MUTANT Y43F BOUND TO ITS CATALYTIC DIVALENT CATION 1G6W ; 2.50 ; CRYSTAL STRUCTURE OF THE GLOBULAR REGION OF THE PRION PROTEIN URE2 FROM THE YEAST SACCAROMYCES CEREVISIAE 1G6Y ; 2.80 ; CRYSTAL STRUCTURE OF THE GLOBULAR REGION OF THE PRION PROTIEN URE2 FROM YEAST SACCHAROMYCES CEREVISIAE 1II5 ; 1.60 ; CRYSTAL STRUCTURE OF THE GLUR0 LIGAND BINDING CORE COMPLEX WITH L-GLUTAMATE 1FTK ; 1.60 ; CRYSTAL STRUCTURE OF THE GLUR2 LIGAND BINDING CORE (S1S2I) IN COMPLEX WITH KAINATE AT 1.6 A RESOLUTION 1FTM ; 1.70 ; CRYSTAL STRUCTURE OF THE GLUR2 LIGAND BINDING CORE (S1S2J) IN COMPLEX WITH AMPA AT 1.7 RESOLUTION 1MXU ; 1.80 ; CRYSTAL STRUCTURE OF THE GLUR2 LIGAND BINDING CORE (S1S2J) IN COMPLEX WITH BROMO-WILLARDIINE (CONTROL FOR THE CRYSTAL TITRATION EXPERIMENTS) 1MQH ; 1.80 ; CRYSTAL STRUCTURE OF THE GLUR2 LIGAND BINDING CORE (S1S2J) IN COMPLEX WITH BROMO-WILLARDIINE AT 1.8 ANGSTROMS RESOLUTION 2AL5 ; 1.65 ; CRYSTAL STRUCTURE OF THE GLUR2 LIGAND BINDING CORE (S1S2J) IN COMPLEX WITH FLUORO-WILLARDIINE AND ANIRACETAM 1MQI ; 1.35 ; CRYSTAL STRUCTURE OF THE GLUR2 LIGAND BINDING CORE (S1S2J) IN COMPLEX WITH FLUORO-WILLARDIINE AT 1.35 ANGSTROMS RESOLUTION 1FTJ ; 1.90 ; CRYSTAL STRUCTURE OF THE GLUR2 LIGAND BINDING CORE (S1S2J) IN COMPLEX WITH GLUTAMATE AT 1.9 RESOLUTION 1MQG ; 2.15 ; CRYSTAL STRUCTURE OF THE GLUR2 LIGAND BINDING CORE (S1S2J) IN COMPLEX WITH IODO-WILLARDIINE AT 2.15 ANGSTROMS RESOLUTION 1FW0 ; 1.90 ; CRYSTAL STRUCTURE OF THE GLUR2 LIGAND BINDING CORE (S1S2J) IN COMPLEX WITH KAINATE AT 2.0 A RESOLUTION 2AL4 ; 1.70 ; CRYSTAL STRUCTURE OF THE GLUR2 LIGAND BINDING CORE (S1S2J) IN COMPLEX WITH QUISQUALATE AND CX614. 1MM6 ; 2.15 ; CRYSTAL STRUCTURE OF THE GLUR2 LIGAND BINDING CORE (S1S2J) IN COMPLEX WITH QUISQUALATE IN A NON ZINC CRYSTAL FORM AT 2.15 ANGSTROMS RESOLUTION 1MM7 ; 1.65 ; CRYSTAL STRUCTURE OF THE GLUR2 LIGAND BINDING CORE (S1S2J) IN COMPLEX WITH QUISQUALATE IN A ZINC CRYSTAL FORM AT 1.65 ANGSTROMS RESOLUTION 1FTL ; 1.80 ; CRYSTAL STRUCTURE OF THE GLUR2 LIGAND BINDING CORE (S1S2J) IN COMPLEX WITH THE ANTAGONIST DNQX AT 1.8 A RESOLUTION 1MQJ ; 1.65 ; CRYSTAL STRUCTURE OF THE GLUR2 LIGAND BINDING CORE (S1S2J) IN COMPLEX WITH WILLARDIINE AT 1.65 ANGSTROMS RESOLUTION 1FTO ; 2.00 ; CRYSTAL STRUCTURE OF THE GLUR2 LIGAND BINDING CORE (S1S2J) IN THE APO STATE AT 2.0 A RESOLUTION 1P1Q ; 2.00 ; CRYSTAL STRUCTURE OF THE GLUR2 LIGAND BINDING CORE (S1S2J) L650T MUTANT IN COMPLEX WITH AMPA 2ANJ ; 2.10 ; CRYSTAL STRUCTURE OF THE GLUR2 LIGAND BINDING CORE (S1S2J- Y450W) MUTANT IN COMPLEX WITH THE PARTIAL AGONIST KAINIC ACID AT 2.1 A RESOLUTION 1LBB ; 2.10 ; CRYSTAL STRUCTURE OF THE GLUR2 LIGAND BINDING DOMAIN MUTANT (S1S2J-N754D) IN COMPLEX WITH KAINATE AT 2.1 A RESOLUTION 1P1U ; 2.00 ; CRYSTAL STRUCTURE OF THE GLUR2 LIGAND-BINDING CORE (S1S2J) L650T MUTANT IN COMPLEX WITH AMPA (AMMONIUM SULFATE CRYSTAL FORM) 1P1O ; 1.60 ; CRYSTAL STRUCTURE OF THE GLUR2 LIGAND-BINDING CORE (S1S2J) MUTANT L650T IN COMPLEX WITH QUISQUALATE 1P1W ; 1.80 ; CRYSTAL STRUCTURE OF THE GLUR2 LIGAND-BINDING CORE (S1S2J) WITH THE L483Y AND L650T MUTATIONS AND IN COMPLEX WITH AMPA 1TXF ; 2.10 ; CRYSTAL STRUCTURE OF THE GLUR5 LIGAND BINDING CORE IN COMPLEX WITH GLUTAMATE AT 2.1 ANGSTROM RESOLUTION 1SD3 ; 1.80 ; CRYSTAL STRUCTURE OF THE GLUR6 LIGAND BINDING CORE IN COMPLEX WITH 2S,4R-4-METHYLGLUTAMATE AT 1.8 ANGSTROM RESOLUTION 1S7Y ; 1.75 ; CRYSTAL STRUCTURE OF THE GLUR6 LIGAND BINDING CORE IN COMPLEX WITH GLUTAMATE AT 1.75 A RESOLUTION ORTHORHOMBIC FORM 1TT1 ; 1.93 ; CRYSTAL STRUCTURE OF THE GLUR6 LIGAND BINDING CORE IN COMPLEX WITH KAINATE 1.93 A RESOLUTION 1S9T ; 1.80 ; CRYSTAL STRUCTURE OF THE GLUR6 LIGAND BINDING CORE IN COMPLEX WITH QUISQUALATE AT 1.8A RESOLUTION 1T1V ; 1.60 ; CRYSTAL STRUCTURE OF THE GLUTAREDOXIN-LIKE PROTEIN SH3BGRL3 AT 1.6 A RESOLUTION 1GHD ; 2.40 ; CRYSTAL STRUCTURE OF THE GLUTARYL-7-AMINOCEPHALOSPORANIC ACID ACYLASE BY MAD PHASING 1ZGN ; 2.10 ; CRYSTAL STRUCTURE OF THE GLUTATHIONE TRANSFERASE PI IN COMPLEX WITH DINITROSYL-DIGLUTATHIONYL IRON COMPLEX 1X6M ; 2.35 ; CRYSTAL STRUCTURE OF THE GLUTATHIONE-DEPENDENT FORMALDEHYDE- ACTIVATING ENZYME (GFA) 1PW4 ; 3.30 ; CRYSTAL STRUCTURE OF THE GLYCEROL-3-PHOSPHATE TRANSPORTER FROM E.COLI 1RZU ; 2.30 ; CRYSTAL STRUCTURE OF THE GLYCOGEN SYNTHASE FROM A. TUMEFACIENS IN COMPLEX WITH ADP 1RZV ; 2.30 ; CRYSTAL STRUCTURE OF THE GLYCOGEN SYNTHASE FROM AGROBACTERIUM TUMEFACIENS (NON-COMPLEXED FORM) 1P4K ; 1.90 ; CRYSTAL STRUCTURE OF THE GLYCOSYLASPARAGINASE PRECURSOR D151N MUTANT 1P4V ; 1.90 ; CRYSTAL STRUCTURE OF THE GLYCOSYLASPARAGINASE PRECURSOR D151N MUTANT WITH GLYCINE 1QUB ; 2.70 ; CRYSTAL STRUCTURE OF THE GLYCOSYLATED FIVE-DOMAIN HUMAN BETA2-GLYCOPROTEIN I PURIFIED FROM BLOOD PLASMA 1SS4 ; 1.84 ; CRYSTAL STRUCTURE OF THE GLYOXALASE FAMILY PROTEIN APC24694 FROM BACILLUS CEREUS 1JXM ; 2.00 ; CRYSTAL STRUCTURE OF THE GMP BOUND SH3-HOOK-GK FRAGMENT OF PSD-95 1ZBV ; 3.21 ; CRYSTAL STRUCTURE OF THE GOAT SIGNALLING PROTEIN (SPG-40) COMPLEXED WITH A DESIGNED PEPTIDE TRP-PRO-TRP AT 3.2A RESOLUTION 1ZU8 ; 3.05 ; CRYSTAL STRUCTURE OF THE GOAT SIGNALLING PROTEIN WITH A BOUND TRISACCHARIDE REVEALS THAT TRP78 REDUCES THE CARBOHYDRATE BINDING SITE TO HALF 1XCM ; 1.84 ; CRYSTAL STRUCTURE OF THE GPPNHP-BOUND H-RAS G60A MUTANT 2AUH ; 3.20 ; CRYSTAL STRUCTURE OF THE GRB14 BPS REGION IN COMPLEX WITH THE INSULIN RECEPTOR TYROSINE KINASE 2AUG ; 2.30 ; CRYSTAL STRUCTURE OF THE GRB14 SH2 DOMAIN 1F0B ; 2.10 ; CRYSTAL STRUCTURE OF THE GREEN FLUORESCENT PROTEIN (GFP) VARIANT YFP-H148Q 1F09 ; 2.14 ; CRYSTAL STRUCTURE OF THE GREEN FLUORESCENT PROTEIN (GFP) VARIANT YFP-H148Q WITH TWO BOUND IODIDES 1IW6 ; 2.30 ; CRYSTAL STRUCTURE OF THE GROUND STATE OF BACTERIORHODOPSIN 1NHY ; 3.00 ; CRYSTAL STRUCTURE OF THE GST-LIKE DOMAIN OF ELONGATION FACTOR 1-GAMMA FROM SACCHAROMYCES CEREVISIAE. 1SVI ; 1.95 ; CRYSTAL STRUCTURE OF THE GTP-BINDING PROTEIN YSXC COMPLEXED WITH GDP 1KGD ; 1.31 ; CRYSTAL STRUCTURE OF THE GUANYLATE KINASE-LIKE DOMAIN OF HUMAN CASK 1G3K ; 1.90 ; CRYSTAL STRUCTURE OF THE H. INFLUENZAE PROTEASE HSLV AT 1.9 A RESOLUTION 1HQG ; 2.00 ; CRYSTAL STRUCTURE OF THE H141C ARGINASE VARIANT COMPLEXED WITH PRODUCTS ORNITHINE AND UREA 1EJS ; 2.00 ; CRYSTAL STRUCTURE OF THE H219N VARIANT OF KLEBSIELLA AEROGENES UREASE 1EJT ; 2.00 ; CRYSTAL STRUCTURE OF THE H219Q VARIANT OF KLEBSIELLA AEROGENES UREASE 1PQU ; 1.92 ; CRYSTAL STRUCTURE OF THE H277N MUTANT OF ASPARTATE SEMIALDEHYDE DEHYDROGENASE FROM HAEMOPHILUS INFLUENZAE BOUND WITH NADP, S-METHYL CYSTEINE SULFOXIDE AND CACODYLATE 1EJU ; 2.00 ; CRYSTAL STRUCTURE OF THE H320N VARIANT OF KLEBSIELLA AEROGENES UREASE 1EJV ; 2.40 ; CRYSTAL STRUCTURE OF THE H320Q VARIANT OF KLEBSIELLA AEROGENES UREASE 1N28 ; 1.50 ; CRYSTAL STRUCTURE OF THE H48Q MUTANT OF HUMAN GROUP IIA PHOSPHOLIPASE A2 1S94 ; 3.34 ; CRYSTAL STRUCTURE OF THE HABC DOMAIN OF NEURONAL SYNTAXIN FROM THE SQUID LOLIGO PEALEI 1SR4 ; 2.00 ; CRYSTAL STRUCTURE OF THE HAEMOPHILUS DUCREYI CYTOLETHAL DISTENDING TOXIN 1PWZ ; 2.50 ; CRYSTAL STRUCTURE OF THE HALOALCOHOL DEHALOGENASE HHEC COMPLEXED WITH (R)-STYRENE OXIDE AND CHLORIDE 1PWX ; 1.80 ; CRYSTAL STRUCTURE OF THE HALOALCOHOL DEHALOGENASE HHEC COMPLEXED WITH BROMIDE 1PX0 ; 1.90 ; CRYSTAL STRUCTURE OF THE HALOALCOHOL DEHALOGENASE HHEC COMPLEXED WITH THE HALOALCOHOL MIMIC (R)-1-PARA-NITRO- PHENYL-2-AZIDO-ETHANOL 1LKT ; 2.60 ; CRYSTAL STRUCTURE OF THE HEAD-BINDING DOMAIN OF PHAGE P22 TAILSPIKE PROTEIN 1YU5 ; 1.40 ; CRYSTAL STRUCTURE OF THE HEADPIECE DOMAIN OF CHICKEN VILLIN 1CR2 ; 2.30 ; CRYSTAL STRUCTURE OF THE HELICASE DOMAIN OF THE GENE 4 PROTEIN OF BACTERIOPHAGE T7: COMPLEX WITH DATP 1CR4 ; 2.50 ; CRYSTAL STRUCTURE OF THE HELICASE DOMAIN OF THE GENE 4 PROTEIN OF BACTERIOPHAGE T7: COMPLEX WITH DTDP 1CR1 ; 2.30 ; CRYSTAL STRUCTURE OF THE HELICASE DOMAIN OF THE GENE 4 PROTEIN OF BACTERIOPHAGE T7: COMPLEX WITH DTTP 1CR0 ; 2.30 ; CRYSTAL STRUCTURE OF THE HELICASE DOMAIN OF THE GENE4 PROTEIN OF BACTERIOPHAGE T7 1G6O ; 2.50 ; CRYSTAL STRUCTURE OF THE HELICOBACTER PYLORI ATPASE, HP0525, IN COMPLEX WITH ADP 1V9Y ; 1.32 ; CRYSTAL STRUCTURE OF THE HEME PAS SENSOR DOMAIN OF EC DOS (FERRIC FORM) 1V9Z ; 1.90 ; CRYSTAL STRUCTURE OF THE HEME PAS SENSOR DOMAIN OF EC DOS (FERROUS FORM) 1VB6 ; 1.56 ; CRYSTAL STRUCTURE OF THE HEME PAS SENSOR DOMAIN OF EC DOS (OXYGEN-BOUND FORM) 1W3F ; 2.58 ; CRYSTAL STRUCTURE OF THE HEMOLYTIC LECTIN FROM THE MUSHROOM LAETIPORUS SULPHUREUS COMPLEXED WITH N-ACETYLLACTOSAMINE IN THE GAMMA MOTIF 1DK0 ; 1.77 ; CRYSTAL STRUCTURE OF THE HEMOPHORE HASA FROM SERRATIA MARCESCENS CRYSTAL FORM P2(1), PH8 1DKH ; 3.20 ; CRYSTAL STRUCTURE OF THE HEMOPHORE HASA, PH 6.5 1JMO ; 2.20 ; CRYSTAL STRUCTURE OF THE HEPARIN COFACTOR II-S195A THROMBIN COMPLEX 1W3C ; 2.30 ; CRYSTAL STRUCTURE OF THE HEPATITIS C VIRUS NS3 PROTEASE IN COMPLEX WITH A PEPTIDOMIMETIC INHIBITOR 1VBY ; 2.90 ; CRYSTAL STRUCTURE OF THE HEPATITIS DELTA VIRUS GEMONIC RIBOZYME PRECURSOR, WITH C75U MUTAION, AND MN2+ BOUND 1VBZ ; 2.80 ; CRYSTAL STRUCTURE OF THE HEPATITIS DELTA VIRUS GEMONIC RIBOZYME PRECURSOR, WITH C75U MUTAION, IN BA2+ SOLUTION 1SJF ; 2.75 ; CRYSTAL STRUCTURE OF THE HEPATITIS DELTA VIRUS GEMONIC RIBOZYME PRECURSOR, WITH C75U MUTAION, IN COBALT HEXAMMINE SOLUTION 1VBX ; 2.70 ; CRYSTAL STRUCTURE OF THE HEPATITIS DELTA VIRUS GEMONIC RIBOZYME PRECURSOR, WITH C75U MUTAION, IN EDTA SOLUTION 1VC0 ; 2.50 ; CRYSTAL STRUCTURE OF THE HEPATITIS DELTA VIRUS GEMONIC RIBOZYME PRECURSOR, WITH C75U MUTAION, IN IMIDAZOLE AND SR2+ SOLUTION 1VC7 ; 2.45 ; CRYSTAL STRUCTURE OF THE HEPATITIS DELTA VIRUS GEMONIC RIBOZYME PRECURSOR, WITH C75U MUTAION, IN SR2+ SOLUTION 1VC6 ; 2.80 ; CRYSTAL STRUCTURE OF THE HEPATITIS DELTA VIRUS GEMONIC RIBOZYME PRODUCT WITH C75U MUTAION, CLEAVED IN IMIDAZOLE AND MG2+ SOLUTIONS 1JMA ; 2.65 ; CRYSTAL STRUCTURE OF THE HERPES SIMPLEX VIRUS GLYCOPROTEIN D BOUND TO THE CELLULAR RECEPTOR HVEA/HVEM 1FQK ; 2.30 ; CRYSTAL STRUCTURE OF THE HETERODIMERIC COMPLEX OF THE RGS DOMAIN OF RGS9, AND THE GT/I1 CHIMERA ALPHA SUBUNIT [(RGS9)- (GT/I1ALPHA)-(GDP)-(ALF4-)-(MG2+)] 1R0O ; 2.24 ; CRYSTAL STRUCTURE OF THE HETERODIMERIC ECDYSONE RECEPTOR DEOXYRIBONUCLEIC ACID-BINDING COMPLEX 1OGY ; 3.20 ; CRYSTAL STRUCTURE OF THE HETERODIMERIC NITRATE REDUCTASE FROM RHODOBACTER SPHAEROIDES 1FQJ ; 2.02 ; CRYSTAL STRUCTURE OF THE HETEROTRIMERIC COMPLEX OF THE RGS DOMAIN OF RGS9, THE GAMMA SUBUNIT OF PHOSPHODIESTERASE AND THE GT/I1 CHIMERA ALPHA SUBUNIT [(RGS9)-(PDEGAMMA)- (GT/I1ALPHA)-(GDP)-(ALF4-)-(MG2+)] 1FY9 ; 2.20 ; CRYSTAL STRUCTURE OF THE HEXA-SUBSTITUTED MUTANT OF THE MOLECULAR CHAPERONIN GROEL APICAL DOMAIN 1FYA ; 2.20 ; CRYSTAL STRUCTURE OF THE HEXA-SUBSTITUTED MUTANT OF THE MOLECULAR CHAPERONIN GROEL APICAL DOMAIN 1P9M ; 3.65 ; CRYSTAL STRUCTURE OF THE HEXAMERIC HUMAN IL-6/IL-6 ALPHA RECEPTOR/GP130 COMPLEX 1G8Y ; 2.40 ; CRYSTAL STRUCTURE OF THE HEXAMERIC REPLICATIVE HELICASE REPA OF PLASMID RSF1010 1HK9 ; 2.15 ; CRYSTAL STRUCTURE OF THE HFQ PROTEIN FROM ESCHERICHIA COLI 1G1O ; 2.30 ; CRYSTAL STRUCTURE OF THE HIGHLY AMYLOIDOGENIC TRANSTHYRETIN MUTANT TTR G53S/E54D/L55S 1LNT ; 1.70 ; CRYSTAL STRUCTURE OF THE HIGHLY CONSERVED RIBONUCLEIC ACID INTERNAL LOOP OF SRP 1KWB ; 2.00 ; CRYSTAL STRUCTURE OF THE HIS145ALA MUTANT OF 2,3- DIHYDROXYBIPHENY DIOXYGENASE (BPHC) 2AC4 ; 2.10 ; CRYSTAL STRUCTURE OF THE HIS183CYS MUTANT VARIANT OF BACILLUS SUBTILIS FERROCHELATASE 1ROC ; 1.50 ; CRYSTAL STRUCTURE OF THE HISTONE DEPOSITION PROTEIN ASF1 1Q9C ; 3.21 ; CRYSTAL STRUCTURE OF THE HISTONE DOMAIN OF SON OF SEVENLESS 1F1E ; 1.37 ; CRYSTAL STRUCTURE OF THE HISTONE FROM METHANOPYRUS KANDLERI 1B67 ; 1.48 ; CRYSTAL STRUCTURE OF THE HISTONE HMFA FROM METHANOTHERMUS FERVIDUS 1HTA ; 1.55 ; CRYSTAL STRUCTURE OF THE HISTONE HMFA FROM METHANOTHERMUS FERVIDUS 1A7W ; 1.55 ; CRYSTAL STRUCTURE OF THE HISTONE HMFB FROM METHANOTHERMUS FERVIDUS 1H3I ; 2.10 ; CRYSTAL STRUCTURE OF THE HISTONE METHYLTRANSFERASE SET7/9 1HQ3 ; 2.15 ; CRYSTAL STRUCTURE OF THE HISTONE-CORE-OCTAMER IN KCL/PHOSPHATE 1U8H ; 2.10 ; CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ALDKWAS 1U92 ; 2.24 ; CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ANALOG E-[DAP]-DKWQS (CYCLIC) 1U91 ; 2.24 ; CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ANALOG ENDKW-[DAP]-S (CYCLIC) 1U93 ; 2.37 ; CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ANALOG EQDKW-[DAP]-S (CYCLIC) 1U8L ; 2.60 ; CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE DLDRWAS 1U8P ; 3.23 ; CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ECDKWCS 1U95 ; 2.24 ; CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDHWAS 1U8N ; 2.56 ; CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKFAS 1U8O ; 3.02 ; CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKHAS 1U8J ; 2.24 ; CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKWAG 1U8I ; 2.00 ; CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKWAN 1U8M ; 2.40 ; CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKYAS 1U8Q ; 2.24 ; CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELEKWAS 1U8K ; 2.24 ; CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE LELDKWASL 462D ; 2.30 ; CRYSTAL STRUCTURE OF THE HIV-1 GENOMIC RIBONUCLEIC ACID DIMERIZATION INITIATION SITE 1EXQ ; 1.60 ; CRYSTAL STRUCTURE OF THE HIV-1 INTEGRASE CATALYTIC CORE DOMAIN 1YDN ; 2.30 ; CRYSTAL STRUCTURE OF THE HMG-COA LYASE FROM BRUCELLA MELITENSIS, NORTHEAST STRUCTURAL GENOMICS TARGET LR35. 1MIJ ; 2.05 ; CRYSTAL STRUCTURE OF THE HOMEO-PROSPERO DOMAIN OF D. MELANOGASTER PROSPERO 1DDV ; 1.90 ; CRYSTAL STRUCTURE OF THE HOMER EVH1 DOMAIN WITH BOUND MGLUR PEPTIDE 1M5X ; 2.25 ; CRYSTAL STRUCTURE OF THE HOMING ENDONUCLEASE I-MSOI BOUND TO ITS DEOXYRIBONUCLEIC ACID SUBSTRATE 1OZ0 ; 2.50 ; CRYSTAL STRUCTURE OF THE HOMODIMERIC BIFUNCTIONAL TRANSFORMYLASE AND CYCLOHYDROLASE ENZYME AVIAN ATIC IN COMPLEX WITH A MULTISUBSTRATE ADDUCT INHIBITOR BETA-DADF. 1M9N ; 1.93 ; CRYSTAL STRUCTURE OF THE HOMODIMERIC BIFUNCTIONAL TRANSFORMYLASE AND CYCLOHYDROLASE ENZYME AVIAN ATIC IN COMPLEX WITH AICAR AND XMP AT 1.93 ANGSTROMS. 1RER ; 3.20 ; CRYSTAL STRUCTURE OF THE HOMOTRIMER OF FUSION GLYCOPROTEIN E1 FROM SEMLIKI FOREST VIRUS. 1J7J ; 2.30 ; CRYSTAL STRUCTURE OF THE HPRT FROM SALMONELLA TYPHIMURIUM 1F9F ; 1.90 ; CRYSTAL STRUCTURE OF THE HPV-18 E2 DEOXYRIBONUCLEIC ACID-BINDING DOMAIN 1G3I ; 3.41 ; CRYSTAL STRUCTURE OF THE HSLUV PROTEASE-CHAPERONE COMPLEX 1I7F ; 2.70 ; CRYSTAL STRUCTURE OF THE HSP33 DOMAIN WITH CONSTITUTIVE CHAPERONE ACTIVITY 1XQR ; 2.10 ; CRYSTAL STRUCTURE OF THE HSPBP1 CORE DOMAIN 1XQS ; 2.90 ; CRYSTAL STRUCTURE OF THE HSPBP1 CORE DOMAIN COMPLEXED WITH THE FRAGMENT OF HSP70 ATPASE DOMAIN 1EBM ; 2.10 ; CRYSTAL STRUCTURE OF THE HUMAN 8-OXOGUANINE GLYCOSYLASE (HOGG1) BOUND TO A SUBSTRATE OLIGONUCLEOTIDE 1EWN ; 2.10 ; CRYSTAL STRUCTURE OF THE HUMAN AAG DEOXYRIBONUCLEIC ACID REPAIR GLYCOSYLASE COMPLEXED WITH 1,N6-ETHENOADENINE-DEOXYRIBONUCLEIC ACID 1F4R ; 2.40 ; CRYSTAL STRUCTURE OF THE HUMAN AAG DEOXYRIBONUCLEIC ACID REPAIR GLYCOSYLASE COMPLEXED WITH 1,N6-ETHENOADENINE-DEOXYRIBONUCLEIC ACID 1F6O ; 2.40 ; CRYSTAL STRUCTURE OF THE HUMAN AAG DEOXYRIBONUCLEIC ACID REPAIR GLYCOSYLASE COMPLEXED WITH DEOXYRIBONUCLEIC ACID 1FJ2 ; 1.50 ; CRYSTAL STRUCTURE OF THE HUMAN ACYL PROTEIN THIOESTERASE 1 AT 1.5 A RESOLUTION 1E0F ; 3.10 ; CRYSTAL STRUCTURE OF THE HUMAN ALPHA-THROMBIN-HAEMADIN COMPLEX: AN EXOSITE II-BINDING INHIBITOR 1XOW ; 1.80 ; CRYSTAL STRUCTURE OF THE HUMAN ANDROGEN RECEPTOR LIGAND BINDING DOMAIN BOUND WITH AN ANDROGEN RECEPTOR NH2- TERMINAL PEPTIDE, AR20-30, AND R1881 1XQ3 ; 2.25 ; CRYSTAL STRUCTURE OF THE HUMAN ANDROGEN RECEPTOR LIGAND BINDING DOMAIN BOUND WITH R1881 2AO6 ; 1.89 ; CRYSTAL STRUCTURE OF THE HUMAN ANDROGEN RECEPTOR LIGAND BINDING DOMAIN BOUND WITH TIF2(III) 740-753 PEPTIDE AND R1881 1K62 ; 2.65 ; CRYSTAL STRUCTURE OF THE HUMAN ARGININOSUCCINATE LYASE Q286R MUTANT 1XA6 ; 3.20 ; CRYSTAL STRUCTURE OF THE HUMAN BETA2-CHIMAERIN 2AW2 ; 2.80 ; CRYSTAL STRUCTURE OF THE HUMAN BTLA-HVEM COMPLEX 1K8F ; 2.80 ; CRYSTAL STRUCTURE OF THE HUMAN C-TERMINAL CAP1-ADENYLYL CYCLASE ASSOCIATED PROTEIN 1SC4 ; 2.10 ; CRYSTAL STRUCTURE OF THE HUMAN CASPASE-1 C285A MUTANT AFTER REMOVAL OF MALONATE 1SC3 ; 1.80 ; CRYSTAL STRUCTURE OF THE HUMAN CASPASE-1 C285A MUTANT IN COMPLEX WITH MALONATE 1IMJ ; 2.20 ; CRYSTAL STRUCTURE OF THE HUMAN CCG1/TAFII250-INTERACTING FACTOR B (CIB) 1JL4 ; 4.30 ; CRYSTAL STRUCTURE OF THE HUMAN CD4 N-TERMINAL TWO DOMAIN FRAGMENT COMPLEXED TO A CLASS II MHC MOLECULE 2C68 ; 1.95 ; CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR 2C69 ; 2.10 ; CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR 2C6I ; 1.80 ; CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR 2C6K ; 1.90 ; CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR 2C6L ; 2.30 ; CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR 2C6M ; 1.90 ; CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR 2C6O ; 2.10 ; CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR 2C6T ; 2.61 ; CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR 1BUH ; 2.60 ; CRYSTAL STRUCTURE OF THE HUMAN CDK2 KINASE COMPLEX WITH CELL CYCLE-REGULATORY PROTEIN CKSHS1 1EJF ; 2.49 ; CRYSTAL STRUCTURE OF THE HUMAN CO-CHAPERONE P23 1PTZ ; 1.80 ; CRYSTAL STRUCTURE OF THE HUMAN CU, ZN SUPEROXIDE DISMUTASE, FAMILIAL AMYOTROPHIC LATERAL SCLEROSIS (FALS) MUTANT H43R 1T6L ; 1.85 ; CRYSTAL STRUCTURE OF THE HUMAN CYTOMEGALOVIRUS DEOXYRIBONUCLEIC ACID POLYMERASE SUBUNIT, UL44 1IM3 ; 2.20 ; CRYSTAL STRUCTURE OF THE HUMAN CYTOMEGALOVIRUS PROTEIN US2 BOUND TO THE MHC CLASS I MOLECULE HLA-A2/TAX 1V5W ; 3.20 ; CRYSTAL STRUCTURE OF THE HUMAN DMC1 PROTEIN 1YIB ; 1.80 ; CRYSTAL STRUCTURE OF THE HUMAN EB1 C-TERMINAL DIMERIZATION DOMAIN 1YIG ; 2.00 ; CRYSTAL STRUCTURE OF THE HUMAN EB1 C-TERMINAL DIMERIZATION DOMAIN 2A1U ; 2.11 ; CRYSTAL STRUCTURE OF THE HUMAN ETF E165BETAA MUTANT 1UL1 ; 2.90 ; CRYSTAL STRUCTURE OF THE HUMAN FEN1-PCNA COMPLEX 1KJR ; 1.55 ; CRYSTAL STRUCTURE OF THE HUMAN GALECTIN-3 CRD IN COMPLEX WITH A 3'-DERIVATIVE OF N-ACETYLLACTOSAMINE 1NAF ; 2.80 ; CRYSTAL STRUCTURE OF THE HUMAN GGA1 GAT DOMAIN 1OXZ ; 2.80 ; CRYSTAL STRUCTURE OF THE HUMAN GGA1 GAT DOMAIN 1F2Q ; 2.40 ; CRYSTAL STRUCTURE OF THE HUMAN HIGH-AFFINITY IGE RECEPTOR 1EFH ; 2.40 ; CRYSTAL STRUCTURE OF THE HUMAN HYDROXYSTEROID SULFOTRANSFERASE IN THE PRESENCE OF PAP 1H3X ; 2.44 ; CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (G0F)2 1H3W ; 2.85 ; CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (G2F)2, SG C2221 1H3V ; 3.10 ; CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (G2F)2,SG P212121 1H3U ; 2.40 ; CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (M3N2F)2 1H3T ; 2.40 ; CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (MN2F)2 2AXN ; 2.10 ; CRYSTAL STRUCTURE OF THE HUMAN INDUCIBLE FORM 6- PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE 1B6U ; 3.00 ; CRYSTAL STRUCTURE OF THE HUMAN KILLER CELL INHIBITORY RECEPTOR (KIR2DL3) SPECIFIC FOR HLA-CW3 RELATED ALLELES 1UPV ; 2.10 ; CRYSTAL STRUCTURE OF THE HUMAN LIVER X RECEPTOR BETA LIGAND BINDING DOMAIN IN COMPLEX WITH A SYNTHETIC AGONIST 1UPW ; 2.40 ; CRYSTAL STRUCTURE OF THE HUMAN LIVER X RECEPTOR BETA LIGAND BINDING DOMAIN IN COMPLEX WITH A SYNTHETIC AGONIST 1SZB ; 2.50 ; CRYSTAL STRUCTURE OF THE HUMAN MBL-ASSOCIATED PROTEIN 19 (MAP19) 1EXU ; 2.70 ; CRYSTAL STRUCTURE OF THE HUMAN MHC-RELATED FC RECEPTOR 1Y9R ; 1.96 ; CRYSTAL STRUCTURE OF THE HUMAN MINERALOCORTICOID RECEPTOR LIGAND-BINDING DOMAIN BOUND TO DEOXYCORTICOSTERONE AND HARBORING THE S810L MUTATION RESPONSIBLE FOR A SEVERE FORM OF HYPERTENSION 1YA3 ; 2.34 ; CRYSTAL STRUCTURE OF THE HUMAN MINERALOCORTICOID RECEPTOR LIGAND-BINDING DOMAIN BOUND TO PROGESTERONE AND HARBORING THE S810L MUTATION RESPONSIBLE FOR A SEVERE FORM OF HYPERTENSION 1U5B ; 1.83 ; CRYSTAL STRUCTURE OF THE HUMAN MITOCHONDRIAL BRANCHED-CHAIN ALPHA-KETOACID DEHYDROGENASE 1X7W ; 1.73 ; CRYSTAL STRUCTURE OF THE HUMAN MITOCHONDRIAL BRANCHED-CHAIN ALPHA-KETOACID DEHYDROGENASE 1X7X ; 2.10 ; CRYSTAL STRUCTURE OF THE HUMAN MITOCHONDRIAL BRANCHED-CHAIN ALPHA-KETOACID DEHYDROGENASE 1X7Y ; 1.57 ; CRYSTAL STRUCTURE OF THE HUMAN MITOCHONDRIAL BRANCHED-CHAIN ALPHA-KETOACID DEHYDROGENASE 1X7Z ; 1.72 ; CRYSTAL STRUCTURE OF THE HUMAN MITOCHONDRIAL BRANCHED-CHAIN ALPHA-KETOACID DEHYDROGENASE 1X80 ; 2.00 ; CRYSTAL STRUCTURE OF THE HUMAN MITOCHONDRIAL BRANCHED-CHAIN ALPHA-KETOACID DEHYDROGENASE 1Q8M ; 2.60 ; CRYSTAL STRUCTURE OF THE HUMAN MYELOID CELL ACTIVATING RECEPTOR TREM-1 1M4K ; 2.30 ; CRYSTAL STRUCTURE OF THE HUMAN NATURAL KILLER CELL ACTIVATOR RECEPTOR KIR2DS2 (CD158J) 1IM9 ; 2.80 ; CRYSTAL STRUCTURE OF THE HUMAN NATURAL KILLER CELL INHIBITORY RECEPTOR KIR2DL1 BOUND TO ITS MHC LIGAND HLA-CW4 1YYH ; 1.90 ; CRYSTAL STRUCTURE OF THE HUMAN NOTCH 1 ANKYRIN DOMAIN 2BVA ; 2.30 ; CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 4 2F57 ; 1.80 ; CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 5 1UOL ; 1.90 ; CRYSTAL STRUCTURE OF THE HUMAN P53 CORE DOMAIN MUTANT M133L/V203A/N239Y/N268D AT 1.9 A RESOLUTION. 6PAX ; 2.50 ; CRYSTAL STRUCTURE OF THE HUMAN PAX-6 PAIRED DOMAIN-DEOXYRIBONUCLEIC ACID COMPLEX REVEALS A GENERAL MODEL FOR PAX PROTEIN-DEOXYRIBONUCLEIC ACID INTERACTIONS 2BZH ; 1.90 ; CRYSTAL STRUCTURE OF THE HUMAN PIM1 IN COMPLEX WITH A RUTHENIUM ORGANOMETALLIC LIGAND RU1 2BZI ; 1.90 ; CRYSTAL STRUCTURE OF THE HUMAN PIM1 IN COMPLEX WITH A RUTHENIUM ORGANOMETALLIC LIGAND RU2 2BZJ ; 2.05 ; CRYSTAL STRUCTURE OF THE HUMAN PIM1 IN COMPLEX WITH A RUTHENIUM ORGANOMETALLIC LIGAND RU3 2BZK ; 2.45 ; CRYSTAL STRUCTURE OF THE HUMAN PIM1 IN COMPLEX WITH AMPPNP AND PIMTIDE 1XWS ; 1.80 ; CRYSTAL STRUCTURE OF THE HUMAN PIM1 KINASE DOMAIN 1KKQ ; 3.00 ; CRYSTAL STRUCTURE OF THE HUMAN PPAR-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH AN ANTAGONIST GW6471 AND A SMRT COREPRESSOR MOTIF 1M13 ; 2.15 ; CRYSTAL STRUCTURE OF THE HUMAN PREGANE X RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH HYPERFORIN, A CONSTITUENT OF ST. JOHN'S WORT 1I4M ; 2.00 ; CRYSTAL STRUCTURE OF THE HUMAN PRION PROTEIN REVEALS A MECHANISM FOR OLIGOMERIZATION 2BZL ; 1.65 ; CRYSTAL STRUCTURE OF THE HUMAN PROTEIN TYROSINE PHOSPHATASE N14 AT 1.65 A RESOLUTION 2BIJ ; 2.05 ; CRYSTAL STRUCTURE OF THE HUMAN PROTEIN TYROSINE PHOSPHATASE PTPN5 (STEP, STRIATUM ENRICHED ENRICHED PHOSPHATASE) 2BV5 ; 1.80 ; CRYSTAL STRUCTURE OF THE HUMAN PROTEIN TYROSINE PHOSPHATASE PTPN5 AT 1.8A RESOLUTION 2A3K ; 2.55 ; CRYSTAL STRUCTURE OF THE HUMAN PROTEIN TYROSINE PHOSPHATASE, PTPN7 (HEPTP, HEMATOPOIETIC PROTEIN TYROSINE PHOSPHATASE) 1NRL ; 2.00 ; CRYSTAL STRUCTURE OF THE HUMAN PXR-LBD IN COMPLEX WITH AN SRC-1 COACTIVATOR PEPTIDE AND SR12813 2C2H ; 1.85 ; CRYSTAL STRUCTURE OF THE HUMAN RAC3 IN COMPLEX WITH GDP 1KN0 ; 2.85 ; CRYSTAL STRUCTURE OF THE HUMAN RAD52 PROTEIN 1FTN ; 2.10 ; CRYSTAL STRUCTURE OF THE HUMAN RHOA/GDP COMPLEX 2C46 ; 1.60 ; CRYSTAL STRUCTURE OF THE HUMAN RIBONUCLEIC ACID GUANYLYLTRANSFERASE AND 5'-PHOSPHATASE 1S0X ; 2.20 ; CRYSTAL STRUCTURE OF THE HUMAN RORALPHA LIGAND BINDING DOMAIN IN COMPLEX WITH CHOLESTEROL SULFATE AT 2.2A 1FBY ; 2.25 ; CRYSTAL STRUCTURE OF THE HUMAN RXR ALPHA LIGAND BINDING DOMAIN BOUND TO 9-CIS RETINOIC ACID 1MV9 ; 1.90 ; CRYSTAL STRUCTURE OF THE HUMAN RXR ALPHA LIGAND BINDING DOMAIN BOUND TO THE EICOSANOID DHA (DOCOSA HEXAENOIC ACID) AND A COACTIVATOR PEPTIDE 1MVC ; 1.90 ; CRYSTAL STRUCTURE OF THE HUMAN RXR ALPHA LIGAND BINDING DOMAIN BOUND TO THE SYNTHETIC AGONIST COMPOUND BMS 649 AND A COACTIVATOR PEPTIDE 2BUJ ; 2.60 ; CRYSTAL STRUCTURE OF THE HUMAN SERINE-THREONINE KINASE 16 IN COMPLEX WITH STAUROSPORINE 1U6T ; 1.90 ; CRYSTAL STRUCTURE OF THE HUMAN SH3 BINDING GLUTAMIC-RICH PROTEIN LIKE 1YWT ; 2.40 ; CRYSTAL STRUCTURE OF THE HUMAN SIGMA ISOFORM OF 14-3-3 IN COMPLEX WITH A MODE-1 PHOSPHOPEPTIDE 1H3O ; 2.30 ; CRYSTAL STRUCTURE OF THE HUMAN TAF4-TAF12 (TAFII135-TAFII20) COMPLEX 1YDL ; 2.30 ; CRYSTAL STRUCTURE OF THE HUMAN TFIIH, NORTHEAST STRUCTURAL GENOMICS TARGET HR2045. 1KTZ ; 2.15 ; CRYSTAL STRUCTURE OF THE HUMAN TGF-BETA TYPE II RECEPTOR EXTRACELLULAR DOMAIN IN COMPLEX WITH TGF-BETA3 1TEV ; 2.10 ; CRYSTAL STRUCTURE OF THE HUMAN UMP/CMP KINASE IN OPEN CONFORMATION 1P27 ; 2.00 ; CRYSTAL STRUCTURE OF THE HUMAN Y14/MAGOH COMPLEX 1S3R ; 2.60 ; CRYSTAL STRUCTURE OF THE HUMAN-SPECIFIC TOXIN INTERMEDILYSIN 1WPU ; 1.48 ; CRYSTAL STRUCTURE OF THE HUTP ANTITERMINATION COMPLEX BOUND TO A SINGLE STRANDED REGION OF HUT MRNA 2BW0 ; 1.70 ; CRYSTAL STRUCTURE OF THE HYDROLASE DOMAIN OF HUMAN 10-FORMYLTETRAHYDROFOLATE 2 DEHYDROGENASE 1TV2 ; 2.00 ; CRYSTAL STRUCTURE OF THE HYDROXYLAMINE MTMB COMPLEX 1JU2 ; 1.47 ; CRYSTAL STRUCTURE OF THE HYDROXYNITRILE LYASE FROM ALMOND 1UDV ; 1.85 ; CRYSTAL STRUCTURE OF THE HYPERTHERMOPHILIC ARCHAEAL DEOXYRIBONUCLEIC ACID- BINDING PROTEIN SSO10B2 AT 1.85 A 1ZBM ; 2.30 ; CRYSTAL STRUCTURE OF THE HYPOTHETICAL PROTEIN AF1704 FROM ARCHAEOGLOBUS FULGIDUS, NORTHEAST STRUCTURAL GENOMICS TARGET GR62A 2AXO ; 1.80 ; CRYSTAL STRUCTURE OF THE HYPOTHETICAL PROTEIN AGR_C_4864 FROM AGROBACTERIUM TUMEFACIENS, NESG TARGET ATR35 1ZCE ; 1.30 ; CRYSTAL STRUCTURE OF THE HYPOTHETICAL PROTEIN ATU2648 FROM AGROBACTERIUM TUMEFACIENS, NORTHEAST STRUCTURAL GENOMICS TARGET ATR33 2AEG ; 2.30 ; CRYSTAL STRUCTURE OF THE HYPOTHETICAL PROTEIN ATU5096 FROM AGROBACTERIUM TUMEFACIENS, NORTHEAST STRUCTURAL GENOMICS TARGET ATR63 1ZBO ; 2.60 ; CRYSTAL STRUCTURE OF THE HYPOTHETICAL PROTEIN BPP1347 FROM BORDETELLA PARAPERTUSSIS, NORTHEAST STRUCTURAL GENOMICS TARGET BOR27. 2AXP ; 2.50 ; CRYSTAL STRUCTURE OF THE HYPOTHETICAL PROTEIN BSU20280 FROM BACILLUS SUBTILIS, NESG TARGET SR256 1Z94 ; 2.10 ; CRYSTAL STRUCTURE OF THE HYPOTHETICAL PROTEIN CV1439 FROM CHROMOBACTERIUM VIOLACEUM. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET CVR12. 1XUV ; 2.10 ; CRYSTAL STRUCTURE OF THE HYPOTHETICAL PROTEIN FROM METHANOSARCINA MAZEI, NORTHEAST STRCUTURAL GENOMICS TARGET MAR10 1XFS ; 1.70 ; CRYSTAL STRUCTURE OF THE HYPOTHETICAL PROTEIN FROM NITROSOMONAS EUROPAEA, NESG TARGET NER5 2EVV ; 2.59 ; CRYSTAL STRUCTURE OF THE HYPOTHETICAL PROTEIN HP0218 FROM HELICOBACTER PYLORI 1JEO ; 2.00 ; CRYSTAL STRUCTURE OF THE HYPOTHETICAL PROTEIN MJ1247 FROM METHANOCOCCUS JANNASCHII AT 2.0 A RESOLUTION INFERS A MOLECULAR FUNCTION OF 3-HEXULOSE-6-PHOSPHATE ISOMERASE. 1K3R ; 2.30 ; CRYSTAL STRUCTURE OF THE HYPOTHETICAL PROTEIN MT0001 FROM METHANOBACTERIUM THERMOAUTOTROPHICUM 2AUW ; 1.85 ; CRYSTAL STRUCTURE OF THE HYPOTHETICAL PROTEIN NE0471 FROM NITROSOMONAS EUROPAEA ATCC 19718 2FFM ; 2.51 ; CRYSTAL STRUCTURE OF THE HYPOTHETICAL PROTEIN SAV1430 FROM STAPHYLOCOCCUS AUREUS, NORTHEAST STRUCTURAL GENOMICS ZR18. 1ZEE ; 2.31 ; CRYSTAL STRUCTURE OF THE HYPOTHETICAL PROTEIN SO4414 FROM SHEWANELLA ONEIDENSIS, NESG TARGET SOR52 1Z0P ; 1.70 ; CRYSTAL STRUCTURE OF THE HYPOTHETICAL PROTEIN SPY1572 FROM STREPTOCOCCUS PYOGENES 1WN9 ; 1.58 ; CRYSTAL STRUCTURE OF THE HYPOTHETICAL PROTEIN TT1805 FROM THERMUS THERMOPHILLUS HB8 1WNA ; 1.58 ; CRYSTAL STRUCTURE OF THE HYPOTHETICAL PROTEIN TT1805 FROM THERMUS THERMOPHILLUS HB8 1ZBP ; 2.40 ; CRYSTAL STRUCTURE OF THE HYPOTHETICAL PROTEIN VPA1032 FROM VIBRIO PARAHAEMOLYTICUS, NORTHEAST STRUCTURAL GENOMICS TARGET VPR44 1ZXJ ; 2.80 ; CRYSTAL STRUCTURE OF THE HYPTHETICAL MYCOPLASMA PROTEIN, MPN555 1YDK ; 1.95 ; CRYSTAL STRUCTURE OF THE I219A MUTANT OF HUMAN GLUTATHIONE TRANSFERASE A1-1 WITH S-HEXYLGLUTATHIONE 1L9Q ; 1.70 ; CRYSTAL STRUCTURE OF THE I257L VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6 1L9R ; 1.78 ; CRYSTAL STRUCTURE OF THE I257M VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6 1L9S ; 1.78 ; CRYSTAL STRUCTURE OF THE I257T VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6 1L9T ; 1.75 ; CRYSTAL STRUCTURE OF THE I257V VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6 1QZ1 ; 2.00 ; CRYSTAL STRUCTURE OF THE IG 1-2-3 FRAGMENT OF NCAM 1NRZ ; 1.75 ; CRYSTAL STRUCTURE OF THE IIBSOR DOMAIN OF THE SORBOSE PERMEASE FROM KLEBSIELLA PNEUMONIAE SOLVED TO 1.75A RESOLUTION 1BT5 ; 1.80 ; CRYSTAL STRUCTURE OF THE IMIPENEM INHIBITED TEM-1 BETA- LACTAMASE FROM ESCHERICHIA COLI 1IQ1 ; 2.80 ; CRYSTAL STRUCTURE OF THE IMPORTIN-ALPHA(44-54)-IMPORTIN- ALPHA(70-529) COMPLEX 1HZG ; 1.86 ; CRYSTAL STRUCTURE OF THE INACTIVE C866S MUTANT OF THE CATALYTIC DOMAIN OF E. COLI CYTOTOXIC NECROTIZING FACTOR 1 1H49 ; 1.90 ; CRYSTAL STRUCTURE OF THE INACTIVE DOUBLE MUTANT OF THE MAIZE BETA-GLUCOSIDASE ZMGLU1-E191D-F198V IN COMPLEX WITH DIMBOA-GLUCOSIDE 1E4L ; 2.20 ; CRYSTAL STRUCTURE OF THE INACTIVE MUTANT MONOCOT (MAIZE ZMGLU1) BETA-GLUCOSIDASE ZM GLU191ASP 1E4N ; 2.10 ; CRYSTAL STRUCTURE OF THE INACTIVE MUTANT MONOCOT (MAIZE ZMGLU1) BETA-GLUCOSIDASE ZMGLU E191D IN COMPLEX WITH THE NATURAL AGLYCONE DIMBOA 1E55 ; 2.00 ; CRYSTAL STRUCTURE OF THE INACTIVE MUTANT MONOCOT (MAIZE ZMGLU1) BETA-GLUCOSIDASE ZMGLUE191D IN COMPLEX WITH THE COMPETITIVE INHIBITOR DHURRIN 1E56 ; 2.10 ; CRYSTAL STRUCTURE OF THE INACTIVE MUTANT MONOCOT (MAIZE ZMGLU1) BETA-GLUCOSIDASE ZMGLUE191D IN COMPLEX WITH THE NATURAL SUBSTRATE DIMBOA-BETA-D-GLUCOSIDE 1IIZ ; 2.40 ; CRYSTAL STRUCTURE OF THE INDUCED ANTIBACTERIAL PROTEIN FROM TASAR SILKWORM, ANTHERAEA MYLITTA 1FJS ; 1.92 ; CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031) COMPLEXED WITH FACTOR XA 1WPL ; 2.80 ; CRYSTAL STRUCTURE OF THE INHIBITORY FORM OF RAT GTP CYCLOHYDROLASE I/GFRP COMPLEX 1UDE ; 2.66 ; CRYSTAL STRUCTURE OF THE INORGANIC PYROPHOSPHATASE FROM THE HYPERTHERMOPHILIC ARCHAEON PYROCOCCUS HORIKOSHII OT3 1N4K ; 2.20 ; CRYSTAL STRUCTURE OF THE INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR BINDING CORE IN COMPLEX WITH IP3 1BIH ; 3.10 ; CRYSTAL STRUCTURE OF THE INSECT IMMUNE PROTEIN HEMOLIN: A NEW DOMAIN ARRANGEMENT WITH IMPLICATIONS FOR HOMOPHILIC ADHESION 1JI6 ; 2.40 ; CRYSTAL STRUCTURE OF THE INSECTICIDAL BACTERIAL DEL ENDOTOXIN CRY3BB1 BACILLUS THURINGIENSIS 1GAG ; 2.70 ; CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH A BISUBSTRATE INHIBITOR 1RQQ ; 2.60 ; CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH THE SH2 DOMAIN OF APS 1HZH ; 2.70 ; CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-1 ISOLATES: A TEMPLATE FOR HIV VACCINE DESIGN 1LWS ; 3.50 ; CRYSTAL STRUCTURE OF THE INTEIN HOMING ENDONUCLEASE PI-SCEI BOUND TO ITS RECOGNITION SEQUENCE 1LWT ; 3.20 ; CRYSTAL STRUCTURE OF THE INTEIN HOMING ENDONUCLEASE PI-SCEI BOUND TO ITS SUBSTRATE DEOXYRIBONUCLEIC ACID (CA2+ FREE) 1XU9 ; 1.55 ; CRYSTAL STRUCTURE OF THE INTERFACE CLOSED CONFORMATION OF 11B-HYDROXYSTEROID DEHYDROGENASE ISOZYME 1 1XU7 ; 1.80 ; CRYSTAL STRUCTURE OF THE INTERFACE OPEN CONFORMATION OF TETRAMERIC 11B-HSD1 1MJN ; 1.30 ; CRYSTAL STRUCTURE OF THE INTERMEDIATE AFFINITY AL I DOMAIN MUTANT 1FX7 ; 2.00 ; CRYSTAL STRUCTURE OF THE IRON-DEPENDENT REGULATOR (IDER) FROM MYCOBACTERIUM TUBERCULOSIS 2A6M ; 2.40 ; CRYSTAL STRUCTURE OF THE ISHP608 TRANSPOSASE 2A6O ; 2.60 ; CRYSTAL STRUCTURE OF THE ISHP608 TRANSPOSASE IN COMPLEX WITH STEM-LOOP DEOXYRIBONUCLEIC ACID 1DQU ; 2.80 ; CRYSTAL STRUCTURE OF THE ISOCITRATE LYASE FROM ASPERGILLUS NIDULANS 1IGW ; 2.10 ; CRYSTAL STRUCTURE OF THE ISOCITRATE LYASE FROM THE A219C MUTANT OF ESCHERICHIA COLI 1YVJ ; 2.55 ; CRYSTAL STRUCTURE OF THE JAK3 KINASE DOMAIN IN COMPLEX WITH A STAUROSPORINE ANALOGUE 1JNM ; 2.20 ; CRYSTAL STRUCTURE OF THE JUN/CRE COMPLEX 1IXF ; 2.60 ; CRYSTAL STRUCTURE OF THE K INTERMEDIATE OF BACTERIORHODOPSIN 1PE0 ; 1.70 ; CRYSTAL STRUCTURE OF THE K130R MUTANT OF HUMAN DJ-1 1R6W ; 1.62 ; CRYSTAL STRUCTURE OF THE K133R MUTANT OF O-SUCCINYLBENZOATE SYNTHASE (OSBS) FROM ESCHERICHIA COLI. COMPLEX WITH SHCHC 1KG4 ; 1.60 ; CRYSTAL STRUCTURE OF THE K142A MUTANT OF E. COLI MUTY (CORE FRAGMENT) 1KG5 ; 1.35 ; CRYSTAL STRUCTURE OF THE K142Q MUTANT OF E.COLI MUTY (CORE FRAGMENT) 1KG6 ; 1.50 ; CRYSTAL STRUCTURE OF THE K142R MUTANT OF E.COLI MUTY (CORE FRAGMENT) 1PU2 ; 2.06 ; CRYSTAL STRUCTURE OF THE K246R MUTANT OF ASPARTATE SEMIALDEHYDE DEHYDROGENASE FROM HAEMOPHILUS INFLUENZAE 1LUZ ; 1.80 ; CRYSTAL STRUCTURE OF THE K3L PROTEIN FROM VACCINIA VIRUS (WISCONSIN STRAIN) 1D6S ; 2.30 ; CRYSTAL STRUCTURE OF THE K41A MUTANT OF O-ACETYLSERINE SULFHYDRYLASE COMPLEXED IN EXTERNAL ALDIMINE LINKAGE WITH METHIONINE 1O9N ; 2.00 ; CRYSTAL STRUCTURE OF THE K62A MUTANT OF MALONAMIDASE E2 FROM BRADYRHIZOBIUM JAPONICUM 1YCJ ; 1.95 ; CRYSTAL STRUCTURE OF THE KAINATE RECEPTOR GLUR5 LIGAND- BINDING CORE IN COMPLEX WITH (S)-GLUTAMATE 1U6D ; 1.85 ; CRYSTAL STRUCTURE OF THE KELCH DOMAIN OF HUMAN KEAP1 1VFX ; 2.55 ; CRYSTAL STRUCTURE OF THE KIF1A MOTOR DOMAIN COMPLEXED WITH ADP-MG-ALFX 1VFZ ; 2.24 ; CRYSTAL STRUCTURE OF THE KIF1A MOTOR DOMAIN COMPLEXED WITH ADP-MG-VO4 1I5S ; 2.20 ; CRYSTAL STRUCTURE OF THE KIF1A MOTOR DOMAIN COMPLEXED WITH MG-ADP 1I6I ; 2.00 ; CRYSTAL STRUCTURE OF THE KIF1A MOTOR DOMAIN COMPLEXED WITH MG-AMPPCP 1VFV ; 1.85 ; CRYSTAL STRUCTURE OF THE KIF1A MOTOR DOMAIN COMPLEXED WITH MG-AMPPNP 1VFW ; 2.30 ; CRYSTAL STRUCTURE OF THE KIF1A MOTOR DOMAIN COMPLEXED WITH MG-AMPPNP 2AX4 ; 2.50 ; CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF HUMAN 3'- PHOSPHOADENOSINE 5'-PHOSPHOSULPHATE SYNTHETASE 2 1T4H ; 1.80 ; CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF WNK1, A KINASE THAT CAUSES A HEREDITARY FORM OF HYPERTENSION 1JEQ ; 2.70 ; CRYSTAL STRUCTURE OF THE KU HETERODIMER 1JEY ; 2.50 ; CRYSTAL STRUCTURE OF THE KU HETERODIMER BOUND TO DEOXYRIBONUCLEIC ACID 1UCQ ; 2.40 ; CRYSTAL STRUCTURE OF THE L INTERMEDIATE OF BACTERIORHODOPSIN 1GAO ; 2.20 ; CRYSTAL STRUCTURE OF THE L44S MUTANT OF FERREDOXIN I 1EFA ; 2.60 ; CRYSTAL STRUCTURE OF THE LAC REPRESSOR DIMER BOUND TO OPERATOR AND THE ANTI-INDUCER ONPF 2PUA ; 2.90 ; CRYSTAL STRUCTURE OF THE LACI FAMILY MEMBER, PURR, BOUND TO DEOXYRIBONUCLEIC ACID: MINOR GROOVE BINDING BY ALPHA HELICES 2PUB ; 2.70 ; CRYSTAL STRUCTURE OF THE LACI FAMILY MEMBER, PURR, BOUND TO DEOXYRIBONUCLEIC ACID: MINOR GROOVE BINDING BY ALPHA HELICES 2PUC ; 2.60 ; CRYSTAL STRUCTURE OF THE LACI FAMILY MEMBER, PURR, BOUND TO DEOXYRIBONUCLEIC ACID: MINOR GROOVE BINDING BY ALPHA HELICES 2PUD ; 2.60 ; CRYSTAL STRUCTURE OF THE LACI FAMILY MEMBER, PURR, BOUND TO DEOXYRIBONUCLEIC ACID: MINOR GROOVE BINDING BY ALPHA HELICES 2PUE ; 2.70 ; CRYSTAL STRUCTURE OF THE LACI FAMILY MEMBER, PURR, BOUND TO DEOXYRIBONUCLEIC ACID: MINOR GROOVE BINDING BY ALPHA HELICES 2PUF ; 3.00 ; CRYSTAL STRUCTURE OF THE LACI FAMILY MEMBER, PURR, BOUND TO DEOXYRIBONUCLEIC ACID: MINOR GROOVE BINDING BY ALPHA HELICES 2PUG ; 2.70 ; CRYSTAL STRUCTURE OF THE LACI FAMILY MEMBER, PURR, BOUND TO DEOXYRIBONUCLEIC ACID: MINOR GROOVE BINDING BY ALPHA HELICES 1P7D ; 2.95 ; CRYSTAL STRUCTURE OF THE LAMBDA INTEGRASE (RESIDUES 75-356) BOUND TO DEOXYRIBONUCLEIC ACID 1F39 ; 1.90 ; CRYSTAL STRUCTURE OF THE LAMBDA REPRESSOR C-TERMINAL DOMAIN 1KCA ; 2.91 ; CRYSTAL STRUCTURE OF THE LAMBDA REPRESSOR C-TERMINAL DOMAIN OCTAMER 1NKW ; 3.10 ; CRYSTAL STRUCTURE OF THE LARGE RIBOSOMAL SUBUNIT FROM DEINOCOCCUS RADIODURANS 1FFK ; 2.40 ; CRYSTAL STRUCTURE OF THE LARGE RIBOSOMAL SUBUNIT FROM HALOARCULA MARISMORTUI AT 2.4 ANGSTROM RESOLUTION 1JPF ; 2.18 ; CRYSTAL STRUCTURE OF THE LCMV PEPTIDIC EPITOPE GP276 IN COMPLEX WITH THE MURINE CLASS I MHC MOLECULE H-2DB 1FG2 ; 2.75 ; CRYSTAL STRUCTURE OF THE LCMV PEPTIDIC EPITOPE GP33 IN COMPLEX WITH THE MURINE CLASS I MHC MOLECULE H-2DB 1JPG ; 2.20 ; CRYSTAL STRUCTURE OF THE LCMV PEPTIDIC EPITOPE NP396 IN COMPLEX WITH THE MURINE CLASS I MHC MOLECULE H-2DB 1IJQ ; 1.50 ; CRYSTAL STRUCTURE OF THE LDL RECEPTOR YWTD-EGF DOMAIN PAIR 1JXN ; 2.30 ; CRYSTAL STRUCTURE OF THE LECTIN I FROM ULEX EUROPAEUS IN COMPLEX WITH THE METHYL GLYCOSIDE OF ALPHA-L-FUCOSE 1I7G ; 2.20 ; CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN FROM HUMAN PPAR-ALPHA IN COMPLEX WITH THE AGONIST AZ 242 1TD5 ; 2.30 ; CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN OF E. COLI ICLR. 1I7I ; 2.35 ; CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN OF HUMAN PPAR-GAMMA IN COMPLEX WITH THE AGONIST AZ 242 1G0X ; 2.10 ; CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN OF LIR-1 (ILT2) 1G2N ; 1.65 ; CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN OF THE ULTRASPIRACLE PROTEIN USP, THE ORTHOLOG OF RXRS IN INSECTS 1XZZ ; 1.80 ; CRYSTAL STRUCTURE OF THE LIGAND BINDING SUPPRESSOR DOMAIN OF TYPE 1 INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR 1DRM ; 2.40 ; CRYSTAL STRUCTURE OF THE LIGAND FREE BJFIXL HEME DOMAIN 1NUK ; 2.90 ; CRYSTAL STRUCTURE OF THE LIGAND-BINDING DOMAIN OF THE EPHB2 RECEPTOR TYROSINE KINASE 1S9Q ; 2.20 ; CRYSTAL STRUCTURE OF THE LIGAND-BINDING DOMAIN OF THE ESTROGEN-RELATED RECEPTOR GAMMA IN COMPLEX WITH 4- HYDROXYTAMOXIFEN 1VJB ; 3.20 ; CRYSTAL STRUCTURE OF THE LIGAND-BINDING DOMAIN OF THE ESTROGEN-RELATED RECEPTOR GAMMA IN COMPLEX WITH 4- HYDROXYTAMOXIFEN 1TFC ; 2.40 ; CRYSTAL STRUCTURE OF THE LIGAND-BINDING DOMAIN OF THE ESTROGEN-RELATED RECEPTOR GAMMA IN COMPLEX WITH A STEROID RECEPTOR COACTIVATOR-1 PEPTIDE 1S9P ; 2.13 ; CRYSTAL STRUCTURE OF THE LIGAND-BINDING DOMAIN OF THE ESTROGEN-RELATED RECEPTOR GAMMA IN COMPLEX WITH DIETHYLSTILBESTROL 1R1K ; 2.90 ; CRYSTAL STRUCTURE OF THE LIGAND-BINDING DOMAINS OF THE HETERODIMER ECR/USP BOUND TO PONASTERONE A 1R20 ; 3.00 ; CRYSTAL STRUCTURE OF THE LIGAND-BINDING DOMAINS OF THE HETERODIMER ECR/USP BOUND TO THE SYNTHETIC AGONIST BYI06830 1LGH ; 2.40 ; CRYSTAL STRUCTURE OF THE LIGHT-HARVESTING COMPLEX II (B800-850) FROM RHODOSPIRILLUM MOLISCHIANUM 1YZF ; 1.90 ; CRYSTAL STRUCTURE OF THE LIPASE/ACYLHYDROLASE FROM ENTEROCOCCUS FAECALIS 1IWL ; 1.65 ; CRYSTAL STRUCTURE OF THE LIPOPROTEIN LOCALIZATION FACTOR, LOLA 1UA8 ; 1.90 ; CRYSTAL STRUCTURE OF THE LIPOPROTEIN LOCALIZATION FACTOR, LOLA 1T1L ; 2.80 ; CRYSTAL STRUCTURE OF THE LONG-CHAIN FATTY ACID TRANSPORTER FADL 1I1G ; 2.90 ; CRYSTAL STRUCTURE OF THE LRP-LIKE TRANSCRIPTIONAL REGULATOR FROM THE ARCHAEON PYROCOCCUS FURIOSUS 2B81 ; 2.50 ; CRYSTAL STRUCTURE OF THE LUCIFERASE-LIKE MONOOXYGENASE FROM BACILLUS CEREUS 1JHN ; 2.90 ; CRYSTAL STRUCTURE OF THE LUMENAL DOMAIN OF CALNEXIN 1UHL ; 2.90 ; CRYSTAL STRUCTURE OF THE LXRALFA-RXRBETA LBD HETERODIMER 1QPJ ; 2.20 ; CRYSTAL STRUCTURE OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN COMPLEX WITH STAUROSPORINE. 1YE4 ; 2.40 ; CRYSTAL STRUCTURE OF THE LYS-274 TO ARG MUTANT OF CANDIDA TENUIS XYLOSE REDUCTASE (AKR2B5) BOUND TO NAD+ 1YE6 ; 2.30 ; CRYSTAL STRUCTURE OF THE LYS-274 TO ARG MUTANT OF CANDIDA TENUIS XYLOSE REDUCTASE (AKR2B5) BOUND TO NADP+ 1IW9 ; 2.50 ; CRYSTAL STRUCTURE OF THE M INTERMEDIATE OF BACTERIORHODOPSIN 1XK5 ; 2.40 ; CRYSTAL STRUCTURE OF THE M3G-CAP-BINDING DOMAIN OF SNURPORTIN1 IN COMPLEX WITH A M3GPPPG-CAP DINUCLEOTIDE 1T7O ; 2.30 ; CRYSTAL STRUCTURE OF THE M564G MUTANT OF MURINE CARNITINE ACETYLTRANSFERASE IN COMPLEX WITH CARNITINE 1T7N ; 1.90 ; CRYSTAL STRUCTURE OF THE M564G MUTANT OF MURINE CRAT 1ZQ0 ; 2.54 ; CRYSTAL STRUCTURE OF THE MACRO-DOMAIN OF HUMAN CORE HISTONE VARIANT MACROH2A1.1 (FORM A) 1ZR5 ; 2.92 ; CRYSTAL STRUCTURE OF THE MACRO-DOMAIN OF HUMAN CORE HISTONE VARIANT MACROH2A1.2 1KEZ ; 2.80 ; CRYSTAL STRUCTURE OF THE MACROCYCLE-FORMING THIOESTERASE DOMAIN OF ERYTHROMYCIN POLYKETIDE SYNTHASE (DEBS TE) 1FD9 ; 2.41 ; CRYSTAL STRUCTURE OF THE MACROPHAGE INFECTIVITY POTENTIATOR PROTEIN (MIP) A MAJOR VIRULENCE FACTOR FROM LEGIONELLA PNEUMOPHILA 1HXJ ; 2.05 ; CRYSTAL STRUCTURE OF THE MAIZE ZM-P60.1 BETA-GLUCOSIDASE 2BK0 ; 2.90 ; CRYSTAL STRUCTURE OF THE MAJOR CELERY ALLERGEN API G 1 1EW3 ; 2.30 ; CRYSTAL STRUCTURE OF THE MAJOR HORSE ALLERGEN EQU C 1 1XKG ; 1.61 ; CRYSTAL STRUCTURE OF THE MAJOR HOUSE DUST MITE ALLERGEN DER P 1 IN ITS PRO FORM AT 1.61 A RESOLUTION 1F1T ; 2.80 ; CRYSTAL STRUCTURE OF THE MALACHITE GREEN APTAMER COMPLEXED WITH TETRAMETHYL-ROSAMINE 1L5V ; 2.00 ; CRYSTAL STRUCTURE OF THE MALTODEXTRIN PHOSPHORYLASE COMPLEXED WITH GLUCOSE-1-PHOSPHATE 1L6I ; 2.20 ; CRYSTAL STRUCTURE OF THE MALTODEXTRIN PHOSPHORYLASE COMPLEXED WITH THE PRODUCTS OF THE ENZYMATIC REACTION BETWEEN GLUCOSE-1-PHOSPHATE AND MALTOPENTAOSE 1L5W ; 1.80 ; CRYSTAL STRUCTURE OF THE MALTODEXTRIN PHOSPHORYLASE COMPLEXED WITH THE PRODUCTS OF THE ENZYMATIC REACTION BETWEEN GLUCOSE-1-PHOSPHATE AND MALTOTETRAOSE 1R5I ; 2.60 ; CRYSTAL STRUCTURE OF THE MAM-MHC COMPLEX 1IRU ; 2.75 ; CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION 1NQ3 ; 2.20 ; CRYSTAL STRUCTURE OF THE MAMMALIAN TUMOR ASSOCIATED ANTIGEN UK114 1LE8 ; 2.30 ; CRYSTAL STRUCTURE OF THE MATA1/MATALPHA2-3A HETERODIMER BOUND TO DEOXYRIBONUCLEIC ACID COMPLEX 1ES6 ; 2.00 ; CRYSTAL STRUCTURE OF THE MATRIX PROTEIN OF EBOLA VIRUS 1OI1 ; 1.78 ; CRYSTAL STRUCTURE OF THE MBT DOMAINS OF HUMAN SCML2 1OKS ; 1.80 ; CRYSTAL STRUCTURE OF THE MEASLES VIRUS PHOSPHOPROTEIN XD DOMAIN 2D45 ; 3.80 ; CRYSTAL STRUCTURE OF THE MECI-MECA REPRESSOR-OPERATOR COMPLEX 1VF7 ; 2.40 ; CRYSTAL STRUCTURE OF THE MEMBRANE FUSION PROTEIN, MEXA OF THE MULTIDRUG TRANSPORTER 1E30 ; 1.50 ; CRYSTAL STRUCTURE OF THE MET148GLN MUTANT OF RUSTICYANIN AT 1.5 ANGSTROM RESOLUTION 1R1U ; 2.00 ; CRYSTAL STRUCTURE OF THE METAL-SENSING TRANSCRIPTIONAL REPRESSOR CZRA FROM STAPHYLOCOCCUS AUREUS IN THE APO-FORM 1R1V ; 2.30 ; CRYSTAL STRUCTURE OF THE METAL-SENSING TRANSCRIPTIONAL REPRESSOR CZRA FROM STAPHYLOCOCCUS AUREUS IN THE ZN2-FORM 1KR3 ; 2.50 ; CRYSTAL STRUCTURE OF THE METALLO BETA-LACTAMASE FROM BACTEROIDES FRAGILIS (CFIA) IN COMPLEX WITH THE TRICYCLIC INHIBITOR SB-236050. 1M2X ; 1.50 ; CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE BLAB OF CHRYSEOBACTERIUM MENINGOSEPTICUM IN COMPLEX WITH THE INHIBITOR D-CAPTOPRIL 2APO ; 1.95 ; CRYSTAL STRUCTURE OF THE METHANOCOCCUS JANNASCHII CBF5 NOP10 COMPLEX 1RA4 ; 1.86 ; CRYSTAL STRUCTURE OF THE METHANOCOCCUS JANNASCHII L7AE PROTEIN 1KKH ; 2.40 ; CRYSTAL STRUCTURE OF THE METHANOCOCCUS JANNASCHII MEVALONATE KINASE 1L2Q ; 1.70 ; CRYSTAL STRUCTURE OF THE METHANOSARCINA BARKERI MONOMETHYLAMINE METHYLTRANSFERASE (MTMB) 1NTH ; 1.55 ; CRYSTAL STRUCTURE OF THE METHANOSARCINA BARKERI MONOMETHYLAMINE METHYLTRANSFERASE (MTMB) 1U8B ; 2.10 ; CRYSTAL STRUCTURE OF THE METHYLATED N-ADA/DEOXYRIBONUCLEIC ACID COMPLEX 1LSX ; 2.70 ; CRYSTAL STRUCTURE OF THE METHYLIMIDAZOLE-BOUND BJFIXL HEME DOMAIN 1LNW ; 2.10 ; CRYSTAL STRUCTURE OF THE MEXR REPRESSOR OF THE MEXAB-OPRM MULTIDRUG EFFLUX OPERON OF PSEUDOMONAS AERUGINOSA 1ZH4 ; 2.20 ; CRYSTAL STRUCTURE OF THE MG+2/BEF3-BOUND RECEIVER DOMAIN OF KDP POTASSIUM TRANSPORT SYSTEM RESPONSE REGULATOR KDPE 1VAQ ; 2.00 ; CRYSTAL STRUCTURE OF THE MG2+-(CHROMOMYCIN A3)2-D(TTGGCCAA) 2 COMPLEX REVEALS GGCC BINDING SPECIFICITY OF THE DRUG DIMER CHELATED BY METAL ION 1FMW ; 2.15 ; CRYSTAL STRUCTURE OF THE MGATP COMPLEX FOR THE MOTOR DOMAIN OF DICTYOSTELIUM MYOSIN II 1LKV ; 2.80 ; CRYSTAL STRUCTURE OF THE MIDDLE AND C-TERMINAL DOMAINS OF THE FLAGELLAR ROTOR PROTEIN FLIG 1RR7 ; 2.20 ; CRYSTAL STRUCTURE OF THE MIDDLE OPERON REGULATOR PROTEIN OF BACTERIOPHAGE MU 1LCY ; 2.00 ; CRYSTAL STRUCTURE OF THE MITOCHONDRIAL SERINE PROTEASE HTRA2 1II6 ; 2.10 ; CRYSTAL STRUCTURE OF THE MITOTIC KINESIN EG5 IN COMPLEX WITH MG-ADP. 1HYE ; 1.90 ; CRYSTAL STRUCTURE OF THE MJ0490 GENE PRODUCT, THE FAMILY OF LACTATE/MALATE DEHYDROGENASE, DIMERIC STRUCTURE 1JLK ; 2.30 ; CRYSTAL STRUCTURE OF THE MN(2+)-BOUND FORM OF RESPONSE REGULATOR RCP1 1N62 ; 1.09 ; CRYSTAL STRUCTURE OF THE MO,CU-CO DEHYDROGENASE (CODH), N- BUTYLISOCYANIDE-BOUND STATE 1EF1 ; 1.90 ; CRYSTAL STRUCTURE OF THE MOESIN FERM DOMAIN/TAIL DOMAIN COMPLEX 1E5K ; 1.35 ; CRYSTAL STRUCTURE OF THE MOLYBDENUM COFACTOR BIOSYNTHESIS PROTEIN MOBA (PROTEIN FA) FROM ESCHERICHIA COLI AT NEAR ATOMIC RESOLUTION 2BIH ; 2.60 ; CRYSTAL STRUCTURE OF THE MOLYBDENUM-CONTAINING NITRATE REDUCING FRAGMENT OF PICHIA ANGUSTA ASSIMILATORY NITRATE REDUCTASE 1X8G ; 1.70 ; CRYSTAL STRUCTURE OF THE MONO-ZINC CARBAPENEMASE CPHA FROM AEROMONAS HYDROPHYLA 1RU3 ; 2.20 ; CRYSTAL STRUCTURE OF THE MONOMERIC ACETYL-COA SYNTHASE FROM CARBOXYDOTHERMUS HYDROGENOFORMANS 1ITW ; 1.95 ; CRYSTAL STRUCTURE OF THE MONOMERIC ISOCITRATE DEHYDROGENASE IN COMPLEX WITH ISOCITRATE AND MN 1J1W ; 3.20 ; CRYSTAL STRUCTURE OF THE MONOMERIC ISOCITRATE DEHYDROGENASE IN COMPLEX WITH NADP+ 1T5C ; 2.50 ; CRYSTAL STRUCTURE OF THE MOTOR DOMAIN OF HUMAN KINETOCHORE PROTEIN CENP-E 1Q0B ; 1.90 ; CRYSTAL STRUCTURE OF THE MOTOR PROTEIN KSP IN COMPLEX WITH ADP AND MONASTROL 1J07 ; 2.35 ; CRYSTAL STRUCTURE OF THE MOUSE ACETYLCHOLINESTERASE- DECIDIUM COMPLEX 1N5M ; 2.20 ; CRYSTAL STRUCTURE OF THE MOUSE ACETYLCHOLINESTERASE- GALLAMINE COMPLEX 1N5R ; 2.25 ; CRYSTAL STRUCTURE OF THE MOUSE ACETYLCHOLINESTERASE- PROPIDIUM COMPLEX 1Q84 ; 2.45 ; CRYSTAL STRUCTURE OF THE MOUSE ACETYLCHOLINESTERASE-TZ2PA6 ANTI COMPLEX 1Q83 ; 2.65 ; CRYSTAL STRUCTURE OF THE MOUSE ACETYLCHOLINESTERASE-TZ2PA6 SYN COMPLEX 1XLS ; 2.96 ; CRYSTAL STRUCTURE OF THE MOUSE CAR/RXR LBD HETERODIMER BOUND TO TCPOBOP AND 9CRA AND A TIF2 PEPTIDE CONTAING THE THIRD LXXLL MOTIFS 1GN1 ; 2.80 ; CRYSTAL STRUCTURE OF THE MOUSE CCT GAMMA APICAL DOMAIN (MONOCLINIC) 1GML ; 2.20 ; CRYSTAL STRUCTURE OF THE MOUSE CCT GAMMA APICAL DOMAIN (TRICLINIC) 1HU8 ; 2.70 ; CRYSTAL STRUCTURE OF THE MOUSE P53 CORE DEOXYRIBONUCLEIC ACID-BINDING DOMAIN AT 2.7A RESOLUTION 1LOO ; 2.20 ; CRYSTAL STRUCTURE OF THE MOUSE-MUSCLE ADENYLOSUCCINATE SYNTHETASE LIGATED WITH GTP 1WWH ; 2.70 ; CRYSTAL STRUCTURE OF THE MPPN DOMAIN OF MOUSE NUP35 1IRJ ; 2.10 ; CRYSTAL STRUCTURE OF THE MRP14 COMPLEXED WITH CHAPS 1BQQ ; 2.75 ; CRYSTAL STRUCTURE OF THE MT1-MMP--TIMP-2 COMPLEX 1BUV ; 2.75 ; CRYSTAL STRUCTURE OF THE MT1-MMP-TIMP-2 COMPLEX 1EAW ; 2.93 ; CRYSTAL STRUCTURE OF THE MTSP1 (MATRIPTASE)-BPTI (APROTININ) COMPLEX 1Z96 ; 1.80 ; CRYSTAL STRUCTURE OF THE MUD1 UBA DOMAIN 1JT6 ; 2.54 ; CRYSTAL STRUCTURE OF THE MULTIDRUG BINDING PROTEIN QACR BOUND TO DEQUALINIUM 1RPW ; 2.90 ; CRYSTAL STRUCTURE OF THE MULTIDRUG BINDING PROTEIN QACR BOUND TO THE DIAMIDINE HEXAMIDINE 1JTX ; 2.85 ; CRYSTAL STRUCTURE OF THE MULTIDRUG BINDING TRANSCRIPTIONAL REGULATOR QACR BOUND TO CRYSTAL VIOLET 1JTY ; 2.97 ; CRYSTAL STRUCTURE OF THE MULTIDRUG BINDING TRANSCRIPTIONAL REGULATOR QACR BOUND TO ETHIDIUM 1JUP ; 2.95 ; CRYSTAL STRUCTURE OF THE MULTIDRUG BINDING TRANSCRIPTIONAL REPRESSOR QACR BOUND TO MALACHITE GREEN 1RKW ; 2.62 ; CRYSTAL STRUCTURE OF THE MULTIDRUG BINDING TRANSCRIPTIONAL REPRESSOR QACR BOUND TO PENTAMADINE 1JUS ; 2.84 ; CRYSTAL STRUCTURE OF THE MULTIDRUG BINDING TRANSCRIPTIONAL REPRESSOR QACR BOUND TO RHODAMINE 6G 1QVT ; 2.89 ; CRYSTAL STRUCTURE OF THE MULTIDRUG BINDING TRANSCRIPTIONAL REPRESSOR QACR BOUND TO THE DRUG PROFLAVINE 1JUM ; 2.98 ; CRYSTAL STRUCTURE OF THE MULTIDRUG BINDING TRANSCRIPTIONAL REPRESSOR QACR BOUND TO THE NATURAL DRUG BERBERINE 1QVU ; 2.96 ; CRYSTAL STRUCTURE OF THE MULTIDRUG BINDING TRANSCRIPTIONAL REPRESSOR QACR BOUND TO TWO DRUGS: ETHIDIUM AND PROFLAVINE 1EZJ ; 1.90 ; CRYSTAL STRUCTURE OF THE MULTIMERIZATION DOMAIN OF THE PHOSPHOPROTEIN FROM SENDAI VIRUS 1N5A ; 2.85 ; CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2DB, B2-MICROGLOBULIN, AND A 9-RESIDUE IMMUNODOMINANT PEPTIDE EPITOPE GP33 DERIVED FROM LCMV 1ZHB ; 2.70 ; CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2DB, B2-MICROGLOBULIN, AND A 9-RESIDUE PEPTIDE DERIVED FROM RAT DOPAMINE BETA- MONOOXIGENASE 1N59 ; 2.95 ; CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2KB, B2-MICROGLOBULIN, AND A 9-RESIDUE IMMUNODOMINANT PEPTIDE EPITOPE GP33 DERIVED FROM LCMV 1ES0 ; 2.60 ; CRYSTAL STRUCTURE OF THE MURINE CLASS II ALLELE I-A(G7) COMPLEXED WITH THE GLUTAMIC ACID DECARBOXYLASE (GAD65) PEPTIDE 207-220 1U58 ; 1.90 ; CRYSTAL STRUCTURE OF THE MURINE CYTOMEGALOVIRUS MHC-I HOMOLOG M144 1NU2 ; 1.90 ; CRYSTAL STRUCTURE OF THE MURINE DISABLED-1 (DAB1) PTB DOMAIN-APOER2 PEPTIDE-PI-4,5P2 TERNARY COMPLEX 1IKO ; 1.92 ; CRYSTAL STRUCTURE OF THE MURINE EPHRIN-B2 ECTODOMAIN 1ZS8 ; 3.00 ; CRYSTAL STRUCTURE OF THE MURINE MHC CLASS IB MOLECULE M10.5 1JA3 ; 3.00 ; CRYSTAL STRUCTURE OF THE MURINE NK CELL INHIBITORY RECEPTOR LY-49I 1HQ8 ; 1.95 ; CRYSTAL STRUCTURE OF THE MURINE NK CELL-ACTIVATING RECEPTOR NKG2D AT 1.95 A 1JSS ; 2.20 ; CRYSTAL STRUCTURE OF THE MUS MUSCULUS CHOLESTEROL-REGULATED START PROTEIN 4 (STARD4). 1LUF ; 2.05 ; CRYSTAL STRUCTURE OF THE MUSK TYROSINE KINASE: INSIGHTS INTO RECEPTOR AUTOREGULATION 1YJ9 ; 2.90 ; CRYSTAL STRUCTURE OF THE MUTANT 50S RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI CONTAINING A THREE RESIDUE DELETION IN L22 1OG0 ; 2.70 ; CRYSTAL STRUCTURE OF THE MUTANT G226S OF THE TYROSINE-REGULATED 3-DEOXY-D-ARABINO-HEPTULOSONATE-7-PHOSPHATE SYNTHASE FROM SACCHAROMYCES CEREVISIAE COMPLEXED WITH PHENYLALANINE AND MANGANESE 1V13 ; 2.00 ; CRYSTAL STRUCTURE OF THE MUTANT HIS103ALA OF THE COLICIN E9 DNASE DOMAIN IN COMPLEX WITH ZN+2 (2.0 ANGSTROMS) 1MKQ ; 1.64 ; CRYSTAL STRUCTURE OF THE MUTANT VARIANT OF CYTOCHROME C PEROXIDASE IN THE 'OPEN' UNCROSS-LINKED FORM 1PXG ; 1.70 ; CRYSTAL STRUCTURE OF THE MUTATED TRNA-GUANINE TRANSGLYCOSYLASE (TGT) D280E COMPLEXED WITH PREQ1 1OZQ ; 1.90 ; CRYSTAL STRUCTURE OF THE MUTATED TRNA-GUANINE TRANSGLYCOSYLASE (TGT)Y106F COMPLEXED WITH PREQ1 1X9Z ; 2.10 ; CRYSTAL STRUCTURE OF THE MUTL C-TERMINAL DOMAIN 1NNE ; 3.11 ; CRYSTAL STRUCTURE OF THE MUTS-ADPBEF3-DEOXYRIBONUCLEIC ACID COMPLEX 1SFR ; 2.70 ; CRYSTAL STRUCTURE OF THE MYCOBACTERIUM TUBERCULOSIS ANTIGEN 85A PROTEIN 1HZP ; 2.10 ; CRYSTAL STRUCTURE OF THE MYCOBACTERIUM TUBERCULOSIS BETA- KETOACYL-ACYL CARRIER PROTEIN SYNTHASE III 1P3H ; 2.80 ; CRYSTAL STRUCTURE OF THE MYCOBACTERIUM TUBERCULOSIS CHAPERONIN 10 TETRADECAMER 1TXO ; 1.95 ; CRYSTAL STRUCTURE OF THE MYCOBACTERIUM TUBERCULOSIS SERINE/THREONINE PHOSPHATASE PSTP/PPP AT 1.95 A. 1S3I ; 2.30 ; CRYSTAL STRUCTURE OF THE N TERMINAL HYDROLASE DOMAIN OF 10- FORMYLTETRAHYDROFOLATE DEHYDROGENASE 1BG6 ; 1.80 ; CRYSTAL STRUCTURE OF THE N-(1-D-CARBOXYLETHYL)-L-NORVALINE DEHYDROGENASE FROM ARTHROBACTER SP. STRAIN 1C 1YMY ; 2.60 ; CRYSTAL STRUCTURE OF THE N-ACETYLGLUCOSAMINE-6-PHOSPHATE DEACETYLASE FROM ESCHERICHIA COLI K12 1U2O ; 2.10 ; CRYSTAL STRUCTURE OF THE N-DOMAIN OF GRP94 LACKING THE CHARGED DOMAIN IN COMPLEX WITH NECA 1QYE ; 2.10 ; CRYSTAL STRUCTURE OF THE N-DOMAIN OF THE ER HSP90 CHAPERONE GRP94 IN COMPLEX WITH 2-CHLORODIDEOXYADENOSINE 1QY8 ; 1.85 ; CRYSTAL STRUCTURE OF THE N-DOMAIN OF THE ER HSP90 CHAPERONE GRP94 IN COMPLEX WITH RADICICOL 1QY5 ; 1.75 ; CRYSTAL STRUCTURE OF THE N-DOMAIN OF THE ER HSP90 CHAPERONE GRP94 IN COMPLEX WITH THE SPECIFIC LIGAND NECA 1TV3 ; 2.20 ; CRYSTAL STRUCTURE OF THE N-METHYL-HYDROXYLAMINE MTMB COMPLEX 1M4J ; 1.60 ; CRYSTAL STRUCTURE OF THE N-TERMINAL ADF-H DOMAIN OF MOUSE TWINFILIN ISOFORM-1 1M4Z ; 2.20 ; CRYSTAL STRUCTURE OF THE N-TERMINAL BAH DOMAIN OF ORC1P 1DEB ; 2.40 ; CRYSTAL STRUCTURE OF THE N-TERMINAL COILED COIL DOMAIN FROM APC 1WPN ; 1.30 ; CRYSTAL STRUCTURE OF THE N-TERMINAL CORE OF BACILLUS SUBTILIS INORGANIC PYROPHOSPHATASE 1OV9 ; 2.30 ; CRYSTAL STRUCTURE OF THE N-TERMINAL DIMERISATION DOMAIN OF VICH, THE H-NS PROTEIN FROM VIBRIO CHOLERAE 1YWM ; 1.86 ; CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF GROUP B STREPTOCOCCUS ALPHA C PROTEIN 1N1A ; 2.40 ; CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF HUMAN FKBP52 1YA0 ; 2.55 ; CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF HUMAN SMG7 1T6N ; 1.94 ; CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF HUMAN UAP56 2BTL ; 1.95 ; CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF IBV CORONAVIRUS NUCLEOCAPSID 2BXX ; 1.85 ; CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF IBV CORONAVIRUS NUCLEOCAPSID. NATIVE CRYSTAL FORM 1QHL ; 2.20 ; CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF MUKB AT 2.2A RESOLUTION 1XIP ; 2.50 ; CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF NUP159 1K8G ; 2.60 ; CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF OXYTRICHA NOVA TELOMERE END BINDING PROTEIN ALPHA SUBUNIT BOTH UNCOMPLEXED AND COMPLEXED WITH TELOMERIC SSDNA 1VEC ; 2.01 ; CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF RCK/P54, A HUMAN DEAD-BOX PROTEIN 1HUF ; 2.00 ; CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF THE TYROSINE PHOSPHATASE YOPH FROM YERSINIA PESTIS. 1YZE ; 2.00 ; CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF USP7/HAUSP. 1G3P ; 1.46 ; CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAINS OF BACTERIOPHAGE MINOR COAT PROTEIN G3P 1F5F ; 1.70 ; CRYSTAL STRUCTURE OF THE N-TERMINAL G-DOMAIN OF SHBG IN COMPLEX WITH ZINC 1D2S ; 1.55 ; CRYSTAL STRUCTURE OF THE N-TERMINAL LAMININ G-LIKE DOMAIN OF SHBG IN COMPLEX WITH DIHYDROTESTOSTERONE 1LHW ; 1.75 ; CRYSTAL STRUCTURE OF THE N-TERMINAL LG-DOMAIN OF SHBG IN COMPLEX WITH 2-METHOXYESTRADIOL 1LHN ; 2.00 ; CRYSTAL STRUCTURE OF THE N-TERMINAL LG-DOMAIN OF SHBG IN COMPLEX WITH 5ALPHA-ANDROSTANE-3BETA,17ALPHA-DIOL 1LHO ; 2.00 ; CRYSTAL STRUCTURE OF THE N-TERMINAL LG-DOMAIN OF SHBG IN COMPLEX WITH 5ALPHA-ANDROSTANE-3BETA,17BETA-DIOL 1LHU ; 1.80 ; CRYSTAL STRUCTURE OF THE N-TERMINAL LG-DOMAIN OF SHBG IN COMPLEX WITH ESTRADIOL 1LHV ; 2.00 ; CRYSTAL STRUCTURE OF THE N-TERMINAL LG-DOMAIN OF SHBG IN COMPLEX WITH NORGESTREL 1IHJ ; 1.80 ; CRYSTAL STRUCTURE OF THE N-TERMINAL PDZ DOMAIN OF INAD IN COMPLEX WITH A NORPA C-TERMINAL PEPTIDE 1WRB ; 2.40 ; CRYSTAL STRUCTURE OF THE N-TERMINAL RECA-LIKE DOMAIN OF DJVLGB, A PRANARIAN VASA-LIKE RIBONUCLEIC ACID HELICASE 1KL9 ; 1.90 ; CRYSTAL STRUCTURE OF THE N-TERMINAL SEGMENT OF HUMAN EUKARYOTIC INITIATION FACTOR 2ALPHA 1WM5 ; 1.95 ; CRYSTAL STRUCTURE OF THE N-TERMINAL TPR DOMAIN (1-203) OF P67PHOX 2A26 ; 1.20 ; CRYSTAL STRUCTURE OF THE N-TERMINAL, DIMERIZATION DOMAIN OF SIAH INTERACTING PROTEIN 1EOF ; 2.38 ; CRYSTAL STRUCTURE OF THE N136A MUTANT OF A SHAKER T1 DOMAIN 1EOD ; 2.45 ; CRYSTAL STRUCTURE OF THE N136D MUTANT OF A SHAKER T1 DOMAIN 1N29 ; 2.60 ; CRYSTAL STRUCTURE OF THE N1A MUTANT OF HUMAN GROUP IIA PHOSPHOLIPASE A2 1M75 ; 2.30 ; CRYSTAL STRUCTURE OF THE N208S MUTANT OF L-3-HYDROXYACYL- COA DEHYDROGENASE IN COMPLEX WITH NAD AND ACETOACETYL-COA 1ZCD ; 3.45 ; CRYSTAL STRUCTURE OF THE NA+/H+ ANTIPORTER NHAA 1DHS ; 2.20 ; CRYSTAL STRUCTURE OF THE NAD COMPLEX OF HUMAN DEOXYHYPUSINE SYNTHASE 1P1I ; 2.40 ; CRYSTAL STRUCTURE OF THE NAD+-BOUND 1L-MYO-INOSITOL 1- PHOSPHATE SYNTHASE 1EE9 ; 3.00 ; CRYSTAL STRUCTURE OF THE NAD-DEPENDENT 5,10- METHYLENETETRAHYDROFOLATE DEHYDROGENASE FROM SACCHAROMYCES CEREVISIAE COMPLEXED WITH NAD 1PS0 ; 3.01 ; CRYSTAL STRUCTURE OF THE NADP(H)-DEPENDENT CINNAMYL ALCOHOL DEHYDROGENASE FROM SACCHAROMYCES CEREVISIAE 1P0C ; 2.20 ; CRYSTAL STRUCTURE OF THE NADP(H)-DEPENDENT VERTEBRATE ALCOHOL DEHYDROGENASE (ADH8) 1EYY ; 2.50 ; CRYSTAL STRUCTURE OF THE NADP+ DEPENDENT ALDEHYDE DEHYDROGENASE FROM VIBRIO HARVEYI. 1EZ0 ; 2.10 ; CRYSTAL STRUCTURE OF THE NADP+ DEPENDENT ALDEHYDE DEHYDROGENASE FROM VIBRIO HARVEYI. 2C4C ; 2.90 ; CRYSTAL STRUCTURE OF THE NADPH-TREATED MONOOXYGENASE DOMAIN OF MICAL 1Z9S ; 2.20 ; CRYSTAL STRUCTURE OF THE NATIVE CHAPERONE:SUBUNIT:SUBUNIT CAF1M:CAF1:CAF1 COMPLEX 1Y54 ; 2.10 ; CRYSTAL STRUCTURE OF THE NATIVE CLASS C BETA-LACTAMASE FROM ENTEROBACTER CLOACAE 908R COMPLEXED WITH BRL42715 1X7I ; 1.70 ; CRYSTAL STRUCTURE OF THE NATIVE COPPER HOMEOSTASIS PROTEIN (CUTCM) WITH CALCIUM BINDING FROM SHIGELLA FLEXNERI 2A STR. 301 1VA0 ; 1.97 ; CRYSTAL STRUCTURE OF THE NATIVE FORM OF UROPORPHYRIN III C- METHYL TRANSFERASE FROM THERMUS THERMOPHILUS 2ARO ; 2.10 ; CRYSTAL STRUCTURE OF THE NATIVE HISTONE OCTAMER TO 2.1 ANGSTROM RESOLUTION, CRYSTALISED IN THE PRESENCE OF S- NITROSOGLUTATHIONE 2BRY ; 1.45 ; CRYSTAL STRUCTURE OF THE NATIVE MONOOXYGENASE DOMAIN OF MICAL AT 1.45 A RESOLUTION 1JFI ; 2.62 ; CRYSTAL STRUCTURE OF THE NC2-TBP-DEOXYRIBONUCLEIC ACID TERNARY COMPLEX 1OJ5 ; 2.20 ; CRYSTAL STRUCTURE OF THE NCO-A1 PAS-B DOMAIN BOUND TO THE STAT6 TRANSACTIVATION DOMAIN LXXLL MOTIF 2BJQ ; 1.75 ; CRYSTAL STRUCTURE OF THE NEMATODE SPERM CELL MOTILITY PROTEIN MFP2 2BJR ; 1.80 ; CRYSTAL STRUCTURE OF THE NEMATODE SPERM CELL MOTILITY PROTEIN MFP2B 1I1A ; 2.80 ; CRYSTAL STRUCTURE OF THE NEONATAL FC RECEPTOR COMPLEXED WITH A HETERODIMERIC FC 1KR7 ; 1.50 ; CRYSTAL STRUCTURE OF THE NERVE TISSUE MINI-HEMOGLOBIN FROM THE NEMERTEAN WORM CEREBRATULUS LACTEUS 1EZ3 ; 1.90 ; CRYSTAL STRUCTURE OF THE NEURONAL T-SNARE SYNTAXIN-1A 1DN1 ; 2.60 ; CRYSTAL STRUCTURE OF THE NEURONAL-SEC1/SYNTAXIN 1A COMPLEX 1USX ; 2.70 ; CRYSTAL STRUCTURE OF THE NEWCASTLE DISEASE VIRUS HEMAGGLUTININ-NEURAMINIDASE COMPLEXED WITH THIOSIALOSIDE 1N1J ; 1.67 ; CRYSTAL STRUCTURE OF THE NF-YB/NF-YC HISTONE PAIR 1VKX ; 2.90 ; CRYSTAL STRUCTURE OF THE NFKB P50/P65 HETERODIMER COMPLEXED TO THE IMMUNOGLOBULIN KB DEOXYRIBONUCLEIC ACID 1F9Z ; 1.50 ; CRYSTAL STRUCTURE OF THE NI(II)-BOUND GLYOXALASE I FROM ESCHERICHIA COLI 1FRF ; 2.70 ; CRYSTAL STRUCTURE OF THE NI-FE HYDROGENASE FROM DESULFOVIBRIO FRUCTOSOVORANS 1IYB ; 1.50 ; CRYSTAL STRUCTURE OF THE NICOTIANA GLUTINOSA RIBONUCLEASE NW 1DP8 ; 2.50 ; CRYSTAL STRUCTURE OF THE NITRIC OXIDE BOUND FIXL HEME DOMAIN 1W8Y ; 2.40 ; CRYSTAL STRUCTURE OF THE NITROCEFIN ACYL-DD-PEPTIDASE FROM ACTINOMADURA R39. 1HQO ; 2.30 ; CRYSTAL STRUCTURE OF THE NITROGEN REGULATION FRAGMENT OF THE YEAST PRION PROTEIN URE2P 1XDB ; 2.80 ; CRYSTAL STRUCTURE OF THE NITROGENASE FE PROTEIN ASP129GLU 1XD8 ; 2.70 ; CRYSTAL STRUCTURE OF THE NITROGENASE FE PROTEIN ASP39ASN 1XD9 ; 2.80 ; CRYSTAL STRUCTURE OF THE NITROGENASE FE PROTEIN ASP39ASN WITH MGADP BOUND 1XCP ; 3.20 ; CRYSTAL STRUCTURE OF THE NITROGENASE FE PROTEIN PHE135TRP WITH MGADP BOUND 2B67 ; 2.05 ; CRYSTAL STRUCTURE OF THE NITROREDUCTASE FAMILY PROTEIN FROM STREPTOCOCCUS PNEUMONIAE TIGR4 1K8D ; 2.30 ; CRYSTAL STRUCTURE OF THE NON-CLASSICAL MHC CLASS IB QA-2 COMPLEXED WITH A SELF PEPTIDE 1LB8 ; 2.30 ; CRYSTAL STRUCTURE OF THE NON-DESENSITIZING GLUR2 LIGAND BINDING CORE MUTANT (S1S2J-L483Y) IN COMPLEX WITH AMPA AT 2.3 RESOLUTION 1LB9 ; 2.30 ; CRYSTAL STRUCTURE OF THE NON-DESENSITIZING GLUR2 LIGAND BINDING CORE MUTANT (S1S2J-L483Y) IN COMPLEX WITH ANTAGONIST DNQX AT 2.3 A RESOLUTION 1N9W ; 2.30 ; CRYSTAL STRUCTURE OF THE NON-DISCRIMINATING AND ARCHAEAL- TYPE ASPARTYL-TRNA SYNTHETASE FROM THERMUS THERMOPHILUS 1KY8 ; 2.40 ; CRYSTAL STRUCTURE OF THE NON-PHOSPHORYLATING GLYCERALDEHYDE- 3-PHOSPHATE DEHYDROGENASE 1JN0 ; 3.00 ; CRYSTAL STRUCTURE OF THE NON-REGULATORY A4 ISOFORM OF SPINACH CHLOROPLAST GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE COMPLEXED WITH NADP 2B43 ; 2.30 ; CRYSTAL STRUCTURE OF THE NORWALK VIRUS RIBONUCLEIC ACID DEPENDENT RIBONUCLEIC ACID POLYMERASE FROM STRAIN HU/NLV/DRESDEN174/1997/GE 1XRV ; 2.10 ; CRYSTAL STRUCTURE OF THE NOVEL SECRETORY SIGNALLING PROTEIN FROM PORCINE (SPP-40) AT 2.1A RESOLUTION. 1PBQ ; 1.90 ; CRYSTAL STRUCTURE OF THE NR1 LIGAND BINDING CORE IN COMPLEX WITH 5,7-DICHLOROKYNURENIC ACID (DCKA) AT 1.90 ANGSTROMS RESOLUTION 1Y1Z ; 1.50 ; CRYSTAL STRUCTURE OF THE NR1 LIGAND BINDING CORE IN COMPLEX WITH ACBC 1Y1M ; 1.80 ; CRYSTAL STRUCTURE OF THE NR1 LIGAND BINDING CORE IN COMPLEX WITH CYCLOLEUCINE 1PB9 ; 1.60 ; CRYSTAL STRUCTURE OF THE NR1 LIGAND BINDING CORE IN COMPLEX WITH D-CYCLOSERINE AT 1.60 ANGSTROMS RESOLUTION 1PB8 ; 1.45 ; CRYSTAL STRUCTURE OF THE NR1 LIGAND BINDING CORE IN COMPLEX WITH D-SERINE AT 1.45 ANGSTROMS RESOLUTION 1PB7 ; 1.35 ; CRYSTAL STRUCTURE OF THE NR1 LIGAND BINDING CORE IN COMPLEX WITH GLYCINE AT 1.35 ANGSTROMS RESOLUTION 1Y20 ; 1.40 ; CRYSTAL STRUCTURE OF THE NR1 LIGAND-BINDING CORE IN COMPLEX WITH ACPC 2A5T ; 2.00 ; CRYSTAL STRUCTURE OF THE NR1/NR2A LIGAND-BINDING CORES COMPLEX 2A5S ; 1.70 ; CRYSTAL STRUCTURE OF THE NR2A LIGAND BINDING CORE IN COMPLEX WITH GLUTAMATE 1DB1 ; 1.80 ; CRYSTAL STRUCTURE OF THE NUCLEAR RECEPTOR FOR VITAMIN D COMPLEXED TO VITAMIN D 1IE8 ; 1.52 ; CRYSTAL STRUCTURE OF THE NUCLEAR RECEPTOR FOR VITAMIN D LIGAND BINDING DOMAIN BOUND TO KH1060 1IE9 ; 1.40 ; CRYSTAL STRUCTURE OF THE NUCLEAR RECEPTOR FOR VITAMIN D LIGAND BINDING DOMAIN BOUND TO MC1288 1P65 ; 2.60 ; CRYSTAL STRUCTURE OF THE NUCLEOCAPSID PROTEIN OF PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS (PRRSV) 1U35 ; 3.00 ; CRYSTAL STRUCTURE OF THE NUCLEOSOME CORE PARTICLE CONTAINING THE HISTONE DOMAIN OF MACROH2A 1ID0 ; 1.60 ; CRYSTAL STRUCTURE OF THE NUCLEOTIDE BOND CONFORMATION OF PHOQ KINASE DOMAIN 1DKG ; 2.80 ; CRYSTAL STRUCTURE OF THE NUCLEOTIDE EXCHANGE FACTOR GRPE BOUND TO THE ATPASE DOMAIN OF THE MOLECULAR CHAPERONE DNAK 1SKY ; 3.20 ; CRYSTAL STRUCTURE OF THE NUCLEOTIDE FREE ALPHA3BETA3 SUB-COMPLEX OF F1-ATPASE FROM THE THERMOPHILIC BACILLUS PS3 1JX2 ; 2.30 ; CRYSTAL STRUCTURE OF THE NUCLEOTIDE-FREE DYNAMIN A GTPASE DOMAIN, DETERMINED AS MYOSIN FUSION 1SU2 ; 1.60 ; CRYSTAL STRUCTURE OF THE NUDIX HYDROLASE DR1025 IN COMPLEX WITH ATP 1G1I ; 2.00 ; CRYSTAL STRUCTURE OF THE OLIGOMERIZATION DOMAIN FROM ROTAVIRUS NSP4 1G1J ; 1.86 ; CRYSTAL STRUCTURE OF THE OLIGOMERIZATION DOMAIN FROM ROTAVIRUS NSP4 1OME ; 2.30 ; CRYSTAL STRUCTURE OF THE OMEGA LOOP DELETION MUTANT (RESIDUES 163 - 178 DELETED) OF BETA-LACTAMASE FROM STAPHYLOCOCCUS AUREUS PC1 1CSO ; 1.90 ; CRYSTAL STRUCTURE OF THE OMTKY3 P1 VARIANT OMTKY3-ILE18I IN COMPLEX WITH SGPB 1CT0 ; 1.80 ; CRYSTAL STRUCTURE OF THE OMTKY3 P1 VARIANT OMTKY3-SER18I IN COMPLEX WITH SGPB 1CT2 ; 1.65 ; CRYSTAL STRUCTURE OF THE OMTKY3 P1 VARIANT OMTKY3-THR18I IN COMPLEX WITH SGPB 1CT4 ; 1.60 ; CRYSTAL STRUCTURE OF THE OMTKY3 P1 VARIANT OMTKY3-VAL18I IN COMPLEX WITH SGPB 1K24 ; 2.03 ; CRYSTAL STRUCTURE OF THE OPCA OUTER MEMBRANE ADHESIN/INVASIN FROM NEISSERIA MENINGITIDIS 1PK5 ; 2.40 ; CRYSTAL STRUCTURE OF THE ORPHAN NUCLEAR RECEPTOR LRH-1 1GA5 ; 2.40 ; CRYSTAL STRUCTURE OF THE ORPHAN NUCLEAR RECEPTOR REV- ERB(ALPHA) DEOXYRIBONUCLEIC ACID-BINDING DOMAIN BOUND TO ITS COGNATE RESPONSE ELEMENT 1HLZ ; 2.80 ; CRYSTAL STRUCTURE OF THE ORPHAN NUCLEAR RECEPTOR REV- ERB(ALPHA) DEOXYRIBONUCLEIC ACID-BINDING DOMAIN BOUND TO ITS COGNATE RESPONSE ELEMENT 1Y2W ; 1.74 ; CRYSTAL STRUCTURE OF THE ORTHORHOMBIC FORM OF THE COMMON EDIBLE MUSHROOM (AGARICUS BISPORUS) LECTIN IN COMPLEX WITH T-ANTIGEN AND N-ACETYLGLUCOSAMINE 1IWN ; 2.20 ; CRYSTAL STRUCTURE OF THE OUTER MEMBRANE LIPOPROTEIN RECEPTOR LOLB COMPLEXED WITH PEGMME2000 1IWM ; 1.90 ; CRYSTAL STRUCTURE OF THE OUTER MEMBRANE LIPOPROTEIN RECEPTOR, LOLB 1QJ8 ; 1.90 ; CRYSTAL STRUCTURE OF THE OUTER MEMBRANE PROTEIN OMPX FROM ESCHERICHIA COLI 1QJ9 ; 2.10 ; CRYSTAL STRUCTURE OF THE OUTER MEMBRANE PROTEIN OMPX FROM ESCHERICHIA COLI 1KMO ; 2.00 ; CRYSTAL STRUCTURE OF THE OUTER MEMBRANE TRANSPORTER FECA 1KMP ; 2.50 ; CRYSTAL STRUCTURE OF THE OUTER MEMBRANE TRANSPORTER FECA COMPLEXED WITH FERRIC CITRATE 1GZ2 ; 1.50 ; CRYSTAL STRUCTURE OF THE OVOCLEIDIN-17 A MAJOR PROTEIN OF THE GALLUS GALLUS EGGSHELL CALCIFIED LAYER. 1EWZ ; 2.40 ; CRYSTAL STRUCTURE OF THE OXA-10 BETA-LACTAMASE FROM PSEUDOMONAS AERUGINOSA 1FRV ; 2.85 ; CRYSTAL STRUCTURE OF THE OXIDIZED FORM OF NI-FE HYDROGENASE 2FRV ; 2.54 ; CRYSTAL STRUCTURE OF THE OXIDIZED FORM OF NI-FE HYDROGENASE 2A5W ; 2.10 ; CRYSTAL STRUCTURE OF THE OXIDIZED GAMMA-SUBUNIT OF THE DISSIMILATORY SULFITE REDUCTASE (DSRC) FROM ARCHAEOGLOBUS FULGIDUS 1I9T ; 1.70 ; CRYSTAL STRUCTURE OF THE OXIDIZED RIBONUCLEIC ACID TRIPHOSPHATASE DOMAIN OF MOUSE MRNA CAPPING ENZYME 1FT5 ; 1.60 ; CRYSTAL STRUCTURE OF THE OXIDIZED STATE OF CYTOCHROME C554 FROM NITROSOMONAS EUROPAEA 1PHJ ; 2.50 ; CRYSTAL STRUCTURE OF THE OXYTRICHA NOVA TELOMERE END- BINDING PROTEIN COMPLEXED WITH NONCOGNATE SSDNA GG(3DR) GTTTTGGGG 1PH2 ; 3.10 ; CRYSTAL STRUCTURE OF THE OXYTRICHA NOVA TELOMERE END- BINDING PROTEIN COMPLEXED WITH NONCOGNATE SSDNA GGGGTTTTG 1PH5 ; 2.30 ; CRYSTAL STRUCTURE OF THE OXYTRICHA NOVA TELOMERE END- BINDING PROTEIN COMPLEXED WITH NONCOGNATE SSDNA GGGGTTTTG(3DR)GG 1PA6 ; 2.45 ; CRYSTAL STRUCTURE OF THE OXYTRICHA NOVA TELOMERE END- BINDING PROTEIN COMPLEXED WITH NONCOGNATE SSDNA GGGGTTTTGAGG 1PH9 ; 2.50 ; CRYSTAL STRUCTURE OF THE OXYTRICHA NOVA TELOMERE END- BINDING PROTEIN COMPLEXED WITH NONCOGNATE SSDNA GGGGTTTTGAGG 1PH8 ; 2.36 ; CRYSTAL STRUCTURE OF THE OXYTRICHA NOVA TELOMERE END- BINDING PROTEIN COMPLEXED WITH NONCOGNATE SSDNA GGGGTTTTGCGG 1PH4 ; 2.30 ; CRYSTAL STRUCTURE OF THE OXYTRICHA NOVA TELOMERE END- BINDING PROTEIN COMPLEXED WITH NONCOGNATE SSDNA GGGGTTTTGGCG 1PH1 ; 2.51 ; CRYSTAL STRUCTURE OF THE OXYTRICHA NOVA TELOMERE END- BINDING PROTEIN COMPLEXED WITH NONCOGNATE SSDNA GGGGTTTTGGGGT 1PH3 ; 2.30 ; CRYSTAL STRUCTURE OF THE OXYTRICHA NOVA TELOMERE END- BINDING PROTEIN COMPLEXED WITH NONCOGNATE SSDNA GGGGTTTTGGTG 1PH7 ; 2.90 ; CRYSTAL STRUCTURE OF THE OXYTRICHA NOVA TELOMERE END- BINDING PROTEIN COMPLEXED WITH NONCOGNATE SSDNA GGGGTTTTGIGG 1PH6 ; 2.10 ; CRYSTAL STRUCTURE OF THE OXYTRICHA NOVA TELOMERE END- BINDING PROTEIN COMPLEXED WITH NONCOGNATE SSDNA GGGGTTTTGTGG 1JPQ ; 1.60 ; CRYSTAL STRUCTURE OF THE OXYTRICHA TELOMERIC DEOXYRIBONUCLEIC ACID AT 1.6A 1II8 ; 3.02 ; CRYSTAL STRUCTURE OF THE P. FURIOSUS RAD50 ATPASE DOMAIN 1QS8 ; 2.50 ; CRYSTAL STRUCTURE OF THE P. VIVAX ASPARTIC PROTEINASE PLASMEPSIN COMPLEXED WITH THE INHIBITOR PEPSTATIN A 1LNX ; 2.05 ; CRYSTAL STRUCTURE OF THE P.AEROPHILUM SMAP1 HEPTAMER IN A NEW CRYSTAL FORM (C2221) 1I5N ; 2.14 ; CRYSTAL STRUCTURE OF THE P1 DOMAIN OF CHEA FROM SALMONELLA TYPHIMURIUM 1T7C ; 1.85 ; CRYSTAL STRUCTURE OF THE P1 GLU BPTI MUTANT- BOVINE CHYMOTRYPSIN COMPLEX 1T8M ; 1.80 ; CRYSTAL STRUCTURE OF THE P1 HIS BPTI MUTANT- BOVINE CHYMOTRYPSIN COMPLEX 1T8L ; 1.75 ; CRYSTAL STRUCTURE OF THE P1 MET BPTI MUTANT- BOVINE CHYMOTRYPSIN COMPLEX 1T8N ; 1.75 ; CRYSTAL STRUCTURE OF THE P1 THR BPTI MUTANT- BOVINE CHYMOTRYPSIN COMPLEX 1T8O ; 1.70 ; CRYSTAL STRUCTURE OF THE P1 TRP BPTI MUTANT- BOVINE CHYMOTRYPSIN COMPLEX 1SHZ ; 2.85 ; CRYSTAL STRUCTURE OF THE P115RHOGEF RGRGS DOMAIN IN A COMPLEX WITH GALPHA(13):GALPHA(I1) CHIMERA 1VEU ; 2.15 ; CRYSTAL STRUCTURE OF THE P14/MP1 COMPLEX AT 2.15 A RESOLUTION 1Y92 ; 2.20 ; CRYSTAL STRUCTURE OF THE P19A/N67D VARIANT OF BOVINE SEMINAL RIBONUCLEASE 1PC4 ; 1.65 ; CRYSTAL STRUCTURE OF THE P50A MUTANT OF FERREDOXIN I AT 1.65 A RESOLUTION 1PC5 ; 1.80 ; CRYSTAL STRUCTURE OF THE P50G MUTANT OF FERREDOXIN I AT 1.8 A RESOLUTION 1D7E ; 1.39 ; CRYSTAL STRUCTURE OF THE P65 CRYSTAL FORM OF PHOTOACTIVE YELLOW PROTEIN 1GSV ; 1.75 ; CRYSTAL STRUCTURE OF THE P65 CRYSTAL FORM OF PHOTOACTIVE YELLOW PROTEIN G47S MUTANT 1GSX ; 1.79 ; CRYSTAL STRUCTURE OF THE P65 CRYSTAL FORM OF PHOTOACTIVE YELLOW PROTEIN G47S/G51S MUTANT 1GSW ; 1.85 ; CRYSTAL STRUCTURE OF THE P65 CRYSTAL FORM OF PHOTOACTIVE YELLOW PROTEIN G51S MUTANT 1N0L ; 2.30 ; CRYSTAL STRUCTURE OF THE PAPD CHAPERONE (C-TERMINALLY 6X HISTIDINE-TAGGED) BOUND TO THE PAPE PILUS SUBUNIT (N- TERMINAL-DELETED) FROM UROPATHOGENIC E. COLI 1N12 ; 1.87 ; CRYSTAL STRUCTURE OF THE PAPE (N-TERMINAL-DELETED) PILUS SUBUNIT BOUND TO A PEPTIDE CORRESPONDING TO THE N-TERMINAL EXTENSION OF THE PAPK PILUS SUBUNIT (RESIDUES 1-11) FROM UROPATHOGENIC E. COLI 1Y4J ; 1.86 ; CRYSTAL STRUCTURE OF THE PARALOGUE OF THE HUMAN FORMYLGLYCINE GENERATING ENZYME 1ZGR ; 2.50 ; CRYSTAL STRUCTURE OF THE PARKIA PLATYCEPHALA SEED LECTIN 1WA9 ; 3.15 ; CRYSTAL STRUCTURE OF THE PAS REPEAT REGION OF THE DROSOPHILA CLOCK PROTEIN PERIOD 1SI3 ; 2.60 ; CRYSTAL STRUCTURE OF THE PAZ DOMAIN OF HUMAN EIF2C1 IN COMPLEX WITH A 9-MER SIRNA-LIKE DUPLEX 1SI2 ; 2.60 ; CRYSTAL STRUCTURE OF THE PAZ DOMAIN OF HUMAN EIF2C1 IN COMPLEX WITH A 9-MER SIRNA-LIKE DUPLEX OF DEOXYNUCLEOTIDE OVERHANG 1CM0 ; 2.30 ; CRYSTAL STRUCTURE OF THE PCAF/COENZYME-A COMPLEX 1W1H ; 1.45 ; CRYSTAL STRUCTURE OF THE PDK1 PLECKSTRIN HOMOLOGY (PH) DOMAIN 1W1G ; 1.45 ; CRYSTAL STRUCTURE OF THE PDK1 PLECKSTRIN HOMOLOGY (PH) DOMAIN BOUND TO DIC4-PHOSPHATIDYLINOSITOL (3,4,5)- TRISPHOSPHATE 1W1D ; 1.50 ; CRYSTAL STRUCTURE OF THE PDK1 PLECKSTRIN HOMOLOGY (PH) DOMAIN BOUND TO INOSITOL (1,3,4,5)-TETRAKISPHOSPHATE 1Y8N ; 2.60 ; CRYSTAL STRUCTURE OF THE PDK3-L2 COMPLEX 1Y8O ; 2.48 ; CRYSTAL STRUCTURE OF THE PDK3-L2 COMPLEX 1Y8P ; 2.63 ; CRYSTAL STRUCTURE OF THE PDK3-L2 COMPLEX 1TD2 ; 2.22 ; CRYSTAL STRUCTURE OF THE PDXY PROTEIN FROM ESCHERICHIA COLI 2F5Y ; 2.39 ; CRYSTAL STRUCTURE OF THE PDZ DOMAIN FROM HUMAN RGS-3 1N99 ; 1.94 ; CRYSTAL STRUCTURE OF THE PDZ TANDEM OF HUMAN SYNTENIN 1V1T ; 1.80 ; CRYSTAL STRUCTURE OF THE PDZ TANDEM OF HUMAN SYNTENIN IN COMPLEX WITH TNEYKV PEPTIDE 1UPR ; 2.27 ; CRYSTAL STRUCTURE OF THE PEPP1 PLECKSTRIN HOMOLOGY DOMAIN IN COMPLEX WITH INOSITOL 1,3,4,5-TETRAKISPHOSPHATE 2A2N ; 1.65 ; CRYSTAL STRUCTURE OF THE PEPTIDYLPROLYL ISOMERASE DOMAIN OF HUMAN PPWD1 1L4I ; 2.20 ; CRYSTAL STRUCTURE OF THE PERIPLASMIC CHAPERONE SFAE 1SG2 ; 2.35 ; CRYSTAL STRUCTURE OF THE PERIPLASMIC CHAPERONE SKP 1V99 ; 1.80 ; CRYSTAL STRUCTURE OF THE PERIPLASMIC DIVALENT CATION TOLERANCE PROTEIN CUTA FROM PYROCOCCUS HORIKOSHII OT3 IN THE PRESENCE OF CUCL2 1OUO ; 2.30 ; CRYSTAL STRUCTURE OF THE PERIPLASMIC ENDONUCLEASE VVN 1OUP ; 2.30 ; CRYSTAL STRUCTURE OF THE PERIPLASMIC ENDONUCLEASE VVN COMPLEXED WITH OCTAMER DOUBLE STRANDED DEOXYRIBONUCLEIC ACID 1IDU ; 2.24 ; CRYSTAL STRUCTURE OF THE PEROXIDE FORM OF THE VANADIUM- CONTAINING CHLOROPEROXIDASE FROM CURVULARIA INAEQUALIS 1UNR ; 1.25 ; CRYSTAL STRUCTURE OF THE PH DOMAIN OF PKB ALPHA IN COMPLEX WITH A SULFATE MOLECULE 1U5G ; 2.10 ; CRYSTAL STRUCTURE OF THE PH DOMAIN OF SKAP-HOM 1U5F ; 1.90 ; CRYSTAL STRUCTURE OF THE PH DOMAIN OF SKAP-HOM WITH 8 VECTOR-DERIVED N-TERMINAL RESIDUES 1U5D ; 1.70 ; CRYSTAL STRUCTURE OF THE PH DOMAIN OF SKAP55 1MI1 ; 2.90 ; CRYSTAL STRUCTURE OF THE PH-BEACH DOMAIN OF HUMAN NEUROBEACHIN 1T77 ; 2.40 ; CRYSTAL STRUCTURE OF THE PH-BEACH DOMAINS OF HUMAN LRBA/BGL 1QQG ; 2.30 ; CRYSTAL STRUCTURE OF THE PH-PTB TARGETING REGION OF IRS-1 1WY1 ; 1.80 ; CRYSTAL STRUCTURE OF THE PH0671 PROTEIN FROM PYROCOCCUS HORIKOSHII OT3 1V77 ; 1.80 ; CRYSTAL STRUCTURE OF THE PH1877 PROTEIN 1KA8 ; 2.95 ; CRYSTAL STRUCTURE OF THE PHAGE P4 ORIGIN-BINDING DOMAIN 2BDV ; 2.20 ; CRYSTAL STRUCTURE OF THE PHAGE-RELATED CONSERVED HYPOTHETICAL PROTEIN BB2244 FROM BORDETELLA BRONCHISEPTICA, NORTHEAST STRUCTURAL GENOMICS TARGET BOR24. 1GXQ ; 2.00 ; CRYSTAL STRUCTURE OF THE PHOB EFFECTOR DOMAIN 1MVO ; 1.60 ; CRYSTAL STRUCTURE OF THE PHOP RECEIVER DOMAIN FROM BACILLUS SUBTILIS 2BG5 ; 1.82 ; CRYSTAL STRUCTURE OF THE PHOSPHOENOLPYRUVATE-BINDING ENZYME I-DOMAIN FROM THE THERMOANAEROBACTER TENGCONGENSIS PEP: SUGAR PHOSPHOTRANSFERASE SYSTEM (PTS) 1EAZ ; 1.40 ; CRYSTAL STRUCTURE OF THE PHOSPHOINOSITOL (3,4)-BISPHOSPHATE BINDING PH DOMAIN OF TAPP1 FROM HUMAN. 1SWW ; 2.30 ; CRYSTAL STRUCTURE OF THE PHOSPHONOACETALDEHYDE HYDROLASE D12A MUTANT COMPLEXED WITH MAGNESIUM AND SUBSTRATE PHOSPHONOACETALDEHYDE 1OYP ; 2.76 ; CRYSTAL STRUCTURE OF THE PHOSPHOROLYTIC EXORIBONUCLEASE RNASE PH FROM BACILLUS SUBTILIS 1OYR ; 3.10 ; CRYSTAL STRUCTURE OF THE PHOSPHOROLYTIC EXORIBONUCLEASE RNASE PH FROM BACILLUS SUBTILIS 1OYS ; 2.40 ; CRYSTAL STRUCTURE OF THE PHOSPHOROLYTIC EXORIBONUCLEASE RNASE PH FROM BACILLUS SUBTILIS 2EXE ; 2.35 ; CRYSTAL STRUCTURE OF THE PHOSPHORYLATED CLK3 1K68 ; 1.90 ; CRYSTAL STRUCTURE OF THE PHOSPHORYLATED CYANOBACTERIAL PHYTOCHROME RESPONSE REGULATOR RCPA 1SM2 ; 2.30 ; CRYSTAL STRUCTURE OF THE PHOSPHORYLATED INTERLEUKIN-2 TYROSINE KINASE CATALYTIC DOMAIN 1ZY2 ; 3.03 ; CRYSTAL STRUCTURE OF THE PHOSPHORYLATED RECEIVER DOMAIN OF THE TRANSCRIPTION REGULATOR NTRC1 FROM AQUIFEX AEOLICUS 1U7V ; 2.70 ; CRYSTAL STRUCTURE OF THE PHOSPHORYLATED SMAD2/SMAD4 HETEROTRIMERIC COMPLEX 1U7F ; 2.60 ; CRYSTAL STRUCTURE OF THE PHOSPHORYLATED SMAD3/SMAD4 HETEROTRIMERIC COMPLEX 1P3R ; 2.10 ; CRYSTAL STRUCTURE OF THE PHOSPHOTYROSIN BINDING DOMAIN(PTB) OF MOUSE DISABLED 1(DAB1) 1OQN ; 2.30 ; CRYSTAL STRUCTURE OF THE PHOSPHOTYROSINE BINDING DOMAIN (PTB) OF MOUSE DISABLED 1 (DAB1) 1M7E ; 2.45 ; CRYSTAL STRUCTURE OF THE PHOSPHOTYROSINE BINDING DOMAIN(PTB) OF MOUSE DISABLED 2(DAB2):IMPLICATIONS FOR REELING SIGNALING 1N9O ; 2.80 ; CRYSTAL STRUCTURE OF THE PHOT-LOV1 DOMAIN FROM CHLAMYDOMONAS REINHARDTII IN ILLUMINATED STATE. COMPOSITE DATA SET. 1N9N ; 2.30 ; CRYSTAL STRUCTURE OF THE PHOT-LOV1 DOMAIN FROM CHLAMYDOMONAS REINHARDTII IN ILLUMINATED STATE. DATA SET OF A SINGLE CRYSTAL. 1N9L ; 1.90 ; CRYSTAL STRUCTURE OF THE PHOT-LOV1 DOMAIN FROM CHLAMYDOMONAS REINHARDTII IN THE DARK STATE. 1MZU ; 2.00 ; CRYSTAL STRUCTURE OF THE PHOTOACTIVE YELLOW PROTEIN DOMAIN FROM THE SENSOR HISTIDINE KINASE PPR FROM RHODOSPIRILLUM CENTENUM 1F98 ; 1.15 ; CRYSTAL STRUCTURE OF THE PHOTOACTIVE YELLOW PROTEIN MUTANT T50V 1F9I ; 1.10 ; CRYSTAL STRUCTURE OF THE PHOTOACTIVE YELLOW PROTEIN MUTANT Y42F 1KOU ; 1.16 ; CRYSTAL STRUCTURE OF THE PHOTOACTIVE YELLOW PROTEIN RECONSTITUTED WITH CAFFEIC ACID AT 1.16 A RESOLUTION 1U3C ; 2.60 ; CRYSTAL STRUCTURE OF THE PHR DOMAIN OF CRYPTOCHROME 1 FROM ARABIDOPSIS THALIANA 1U3D ; 2.45 ; CRYSTAL STRUCTURE OF THE PHR DOMAIN OF CRYPTOCHROME 1 FROM ARABIDOPSIS THALIANA WITH AMPPNP BOUND 1UA3 ; 2.01 ; CRYSTAL STRUCTURE OF THE PIG PANCREATIC A-AMYLASE COMPLEXED WITH MALTO-OLIGOSACCHARIDES 1WO2 ; 2.01 ; CRYSTAL STRUCTURE OF THE PIG PANCREATIC ALPHA-AMYLASE COMPLEXED WITH MALTO-OLIGOSAACHARIDES UNDER THE EFFECT OF THE CHLORIDE ION 1VAH ; 2.40 ; CRYSTAL STRUCTURE OF THE PIG PANCREATIC-AMYLASE COMPLEXED WITH R-NITROPHENYL-A-D-MALTOSIDE 1GVN ; 1.95 ; CRYSTAL STRUCTURE OF THE PLASMID MAINTENANCE SYSTEM EPSILON/ZETA: MEACHNISM OF TOXIN INACTIVATION AND TOXIN FUNCTION 2BSX ; 2.00 ; CRYSTAL STRUCTURE OF THE PLASMODIUM FALCIPARUM PURINE NUCLEOSIDE PHOSPHORYLASE COMPLEXED WITH INOSINE 1UMR ; 2.40 ; CRYSTAL STRUCTURE OF THE PLATELET ACTIVATOR CONVULXIN, A DISULFIDE LINKED A4B4 CYCLIC TETRAMER FROM THE VENOM OF CROTALUS DURISSUS TERRIFICUS 1UPQ ; 1.48 ; CRYSTAL STRUCTURE OF THE PLECKSTRIN HOMOLOGY (PH) DOMAIN OF PEPP1 1UNP ; 1.65 ; CRYSTAL STRUCTURE OF THE PLECKSTRIN HOMOLOGY DOMAIN OF PKB ALPHA 1DJE ; 1.71 ; CRYSTAL STRUCTURE OF THE PLP-BOUND FORM OF 8-AMINO-7- OXONANOATE SYNTHASE 1RSG ; 1.90 ; CRYSTAL STRUCTURE OF THE POLYAMINE OXIDASE FMS1 FROM YEAST 1WUB ; 1.65 ; CRYSTAL STRUCTURE OF THE POLYISOPRENOID-BINDING PROTEIN, TT1927B, FROM THERMUS THERMOPHILUS HB8 1ZBC ; 2.29 ; CRYSTAL STRUCTURE OF THE PORCINE SIGNALLING PROTEIN LIGANDED WITH THE PEPTIDE TRP-PRO-TRP (WPW) AT 2.3 A RESOLUTION 1TQ0 ; 2.80 ; CRYSTAL STRUCTURE OF THE POTENT ANTICOAGULANT THROMBIN MUTANT W215A/E217A IN FREE FORM 1BX6 ; 2.10 ; CRYSTAL STRUCTURE OF THE POTENT NATURAL PRODUCT INHIBITOR BALANOL IN COMPLEX WITH THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE 1NO4 ; 2.20 ; CRYSTAL STRUCTURE OF THE PRE-ASSEMBLY SCAFFOLDING PROTEIN GP7 FROM THE DOUBLE-STRANDED DEOXYRIBONUCLEIC ACID BACTERIOPHAGE PHI29 1K3I ; 1.40 ; CRYSTAL STRUCTURE OF THE PRECURSOR OF GALACTOSE OXIDASE 1NUI ; 2.90 ; CRYSTAL STRUCTURE OF THE PRIMASE FRAGMENT OF BACTERIOPHAGE T7 PRIMASE-HELICASE PROTEIN 1MZJ ; 2.10 ; CRYSTAL STRUCTURE OF THE PRIMING BETA-KETOSYNTHASE FROM THE R1128 POLYKETIDE BIOSYNTHETIC PATHWAY 1YX2 ; 2.08 ; CRYSTAL STRUCTURE OF THE PROBABLE AMINOMETHYLTRANSFERASE FROM BACILLUS SUBTILIS 1CZD ; 2.45 ; CRYSTAL STRUCTURE OF THE PROCESSIVITY CLAMP GP45 FROM BACTERIOPHAGE T4 1JR3 ; 2.70 ; CRYSTAL STRUCTURE OF THE PROCESSIVITY CLAMP LOADER GAMMA COMPLEX OF E. COLI DEOXYRIBONUCLEIC ACID POLYMERASE III 1SG8 ; 2.30 ; CRYSTAL STRUCTURE OF THE PROCOAGULANT FAST FORM OF THROMBIN 1WY2 ; 1.70 ; CRYSTAL STRUCTURE OF THE PROLIDASE FROM PYROCOCCUS HORIKOSHII OT3 1P8J ; 2.60 ; CRYSTAL STRUCTURE OF THE PROPROTEIN CONVERTASE FURIN 1L1J ; 2.80 ; CRYSTAL STRUCTURE OF THE PROTEASE DOMAIN OF AN ATP- INDEPENDENT HEAT SHOCK PROTEASE HTRA 1GG3 ; 2.80 ; CRYSTAL STRUCTURE OF THE PROTEIN 4.1R MEMBRANE BINDING DOMAIN 1EEJ ; 1.90 ; CRYSTAL STRUCTURE OF THE PROTEIN DISULFIDE BOND ISOMERASE, DSBC, FROM ESCHERICHIA COLI 2EUE ; 2.20 ; CRYSTAL STRUCTURE OF THE PROTEIN KINASE DOMAIN OF YEAST AMP- ACTIVATED PROTEIN KINASE SNF1 1TZZ ; 1.86 ; CRYSTAL STRUCTURE OF THE PROTEIN L1841, UNKNOWN MEMBER OF ENOLASE SUPERFAMILY FROM BRADYRHIZOBIUM JAPONICUM 1A6Q ; 2.00 ; CRYSTAL STRUCTURE OF THE PROTEIN SERINE/THREONINE PHOSPHATASE 2C AT 2 A RESOLUTION 1Q2Y ; 2.00 ; CRYSTAL STRUCTURE OF THE PROTEIN YJCF FROM BACILLUS SUBTILIS: A MEMBER OF THE GCN5-RELATED N-ACETYLTRANSFERASE SUPERFAMILY FOLD 2B0Z ; 2.70 ; CRYSTAL STRUCTURE OF THE PROTEIN-PROTEIN COMPLEX BETWEEN F82I CYTOCHROME C AND CYTOCHROME C PEROXIDASE 2B10 ; 2.80 ; CRYSTAL STRUCTURE OF THE PROTEIN-PROTEIN COMPLEX BETWEEN F82S CYTOCHROME C AND CYTOCHROME C PEROXIDASE 2B11 ; 2.30 ; CRYSTAL STRUCTURE OF THE PROTEIN-PROTEIN COMPLEX BETWEEN F82W CYTOCHROME C AND CYTOCHROME C PEROXIDASE 2B12 ; 3.02 ; CRYSTAL STRUCTURE OF THE PROTEIN-PROTEIN COMPLEX BETWEEN F82Y CYTOCHROME C AND CYTOCHROME C PEROXIDASE 1W4S ; 1.55 ; CRYSTAL STRUCTURE OF THE PROXIMAL BAH DOMAIN OF POLYBROMO 1EX9 ; 2.54 ; CRYSTAL STRUCTURE OF THE PSEUDOMONAS AERUGINOSA LIPASE COMPLEXED WITH RC-(RP,SP)-1,2-DIOCTYLCARBAMOYL-GLYCERO-3-O- OCTYLPHOSPHONATE 1D5R ; 2.10 ; CRYSTAL STRUCTURE OF THE PTEN TUMOR SUPPRESSOR 1NWL ; 2.40 ; CRYSTAL STRUCTURE OF THE PTP1B COMPLEXED WITH SP7343-SP7964, A PTYR MIMETIC 1FCH ; 2.20 ; CRYSTAL STRUCTURE OF THE PTS1 COMPLEXED TO THE TPR REGION OF HUMAN PEX5 1M8X ; 2.20 ; CRYSTAL STRUCTURE OF THE PUMILIO-HOMOLOGY DOMAIN FROM HUMAN PUMILIO1 IN COMPLEX WITH NRE1-14 RIBONUCLEIC ACID 1M8W ; 2.20 ; CRYSTAL STRUCTURE OF THE PUMILIO-HOMOLOGY DOMAIN FROM HUMAN PUMILIO1 IN COMPLEX WITH NRE1-19 RIBONUCLEIC ACID 1M8Y ; 2.60 ; CRYSTAL STRUCTURE OF THE PUMILIO-HOMOLOGY DOMAIN FROM HUMAN PUMILIO1 IN COMPLEX WITH NRE2-10 RIBONUCLEIC ACID 1TD1 ; 1.90 ; CRYSTAL STRUCTURE OF THE PURINE NUCLEOSIDE PHOSPHORYLASE FROM SCHISTOSOMA MANSONI IN COMPLEX WITH ACETATE 1TCV ; 1.75 ; CRYSTAL STRUCTURE OF THE PURINE NUCLEOSIDE PHOSPHORYLASE FROM SCHISTOSOMA MANSONI IN COMPLEX WITH NON-DETERGENT SULFOBETAINE 195 AND ACETATE 1TCU ; 2.00 ; CRYSTAL STRUCTURE OF THE PURINE NUCLEOSIDE PHOSPHORYLASE FROM SCHISTOSOMA MANSONI IN COMPLEX WITH PHOSPHATE AND ACETATE 1O57 ; 2.20 ; CRYSTAL STRUCTURE OF THE PURINE OPERON REPRESSOR OF BACILLUS SUBTILIS 1P4A ; 2.22 ; CRYSTAL STRUCTURE OF THE PURR COMPLEXED WITH CPRPP 2EW2 ; 2.00 ; CRYSTAL STRUCTURE OF THE PUTATIVE 2-DEHYDROPANTOATE 2- REDUCTASE FROM ENTEROCOCCUS FAECALIS 1ZMB ; 2.61 ; CRYSTAL STRUCTURE OF THE PUTATIVE ACETYLXYLAN ESTERASE FROM CLOSTRIDIUM ACETOBUTYLICUM, NORTHEAST STRUCTURAL GENOMICS TARGET CAR6 1XQ4 ; 2.70 ; CRYSTAL STRUCTURE OF THE PUTATIVE APAA PROTEIN FROM BORDETELLA PERTUSSIS, NORTHEAST STRUCTURAL GENOMICS TARGET BER40 1ZBR ; 2.60 ; CRYSTAL STRUCTURE OF THE PUTATIVE ARGININE DEIMINASE FROM PORPHYROMONAS GINGIVALIS, NORTHEAST STRUCTURAL GENOMICS TARGET PGR3 1Y0U ; 1.60 ; CRYSTAL STRUCTURE OF THE PUTATIVE ARSENICAL RESISTANCE OPERON REPRESSOR FROM ARCHAEOGLOBUS FULGIDUS 1YO6 ; 2.60 ; CRYSTAL STRUCTURE OF THE PUTATIVE CARBONYL REDUCTASE SNIFFER OF CAENORHABDITIS ELEGANS 1TWD ; 1.70 ; CRYSTAL STRUCTURE OF THE PUTATIVE COPPER HOMEOSTASIS PROTEIN (CUTC) FROM SHIGELLA FLEXNERI, NORTHEAST STRUCTURAL GENOMICS TARGET SFR33 2BDQ ; 2.30 ; CRYSTAL STRUCTURE OF THE PUTATIVE COPPER HOMEOSTASIS PROTEIN CUTC FROM STREPTOCOCCUS AGALACTIAE, NORTHEAST STRUCURAL GENOMICS TARGET SAR15. 2BDT ; 2.40 ; CRYSTAL STRUCTURE OF THE PUTATIVE GLUCONATE KINASE FROM BACILLUS HALODURANS, NORTHEAST STRUCTURAL GENOMICS TARGET BHR61 1SQ4 ; 2.70 ; CRYSTAL STRUCTURE OF THE PUTATIVE GLYOXYLATE INDUCED PROTEIN FROM PSEUDOMONAS AERUGINOSA, NORTHEAST STRUCTURAL GENOMICS TARGET PAR14 1TZ9 ; 2.90 ; CRYSTAL STRUCTURE OF THE PUTATIVE MANNONATE DEHYDRATASE FROM ENTEROCOCCUS FAECALIS, NORTHEAST STRUCTURAL GENOMICS TARGET EFR41 1ZBS ; 2.30 ; CRYSTAL STRUCTURE OF THE PUTATIVE N-ACETYLGLUCOSAMINE KINASE (PG1100) FROM PORPHYROMONAS GINGIVALIS, NORTHEAST STRUCTURAL GENOMICS TARGET PGR18 1RU8 ; 2.70 ; CRYSTAL STRUCTURE OF THE PUTATIVE N-TYPE ATP PYROPHOSPHATASE FROM PYROCOCCUS FURIOSUS, THE NORTHEAST STRUCTURAL GENOMICS TARGET PFR23 1YW3 ; 2.30 ; CRYSTAL STRUCTURE OF THE PUTATIVE NITROREDUCTASE IN COMPLEX WITH FMN FROM STREPTOCOCCUS MUTANS, NORTHEAST STRUCTURAL GENOMICS TARGET SMR5. 2CSG ; 2.90 ; CRYSTAL STRUCTURE OF THE PUTATIVE OXIDOREDUCTASE FROM SALMONELLA TYPHIMURIUM LT2 1XKN ; 1.60 ; CRYSTAL STRUCTURE OF THE PUTATIVE PEPTIDYL-ARGININE DEIMINASE FROM CHLOROBIUM TEPIDUM, NESG TARGET CTR21 1SPV ; 2.00 ; CRYSTAL STRUCTURE OF THE PUTATIVE PHOSPHATASE OF ESCHERICHIA COLI, NORTHEAST STRUCTURAL GENOMOICS TARGET ER58 1TM0 ; 2.80 ; CRYSTAL STRUCTURE OF THE PUTATIVE PROLINE RACEMASE FROM BRUCELLA MELITENSIS, NORTHEAST STRUCTURAL GENOMICS TARGET LR31 2AP1 ; 1.90 ; CRYSTAL STRUCTURE OF THE PUTATIVE REGULATORY PROTEIN 1T82 ; 1.70 ; CRYSTAL STRUCTURE OF THE PUTATIVE THIOESTERASE FROM SHEWANELLA ONEIDENSIS, NORTHEAST STRUCTURAL GENOMICS TARGET SOR51 1Z2Z ; 2.60 ; CRYSTAL STRUCTURE OF THE PUTATIVE TRNA PSEUDOURIDINE SYNTHASE D (TRUD) FROM METHANOSARCINA MAZEI, NORTHEAST STRUCTURAL GENOMICS TARGET MAR1 2BDR ; 1.60 ; CRYSTAL STRUCTURE OF THE PUTATIVE UREIDOGLYCOLATE HYDROLASE PP4288 FROM PSEUDOMONAS PUTIDA, NORTHEAST STRUCTURAL GENOMICS TARGET PPR49 1YPX ; 2.60 ; CRYSTAL STRUCTURE OF THE PUTATIVE VITAMIN-B12 INDEPENDENT METHIONINE SYNTHASE FROM LISTERIA MONOCYTOGENES, NORTHEAST STRUCTURAL GENOMICS TARGET LMR13 1Z7U ; 2.20 ; CRYSTAL STRUCTURE OF THE PUTITIVE TRANSCRIPTIONAL REGULATOR OF MARR FAMILY FROM ENTEROCOCCUS FAECALIS V583 1K0Z ; 2.05 ; CRYSTAL STRUCTURE OF THE PVUII ENDONUCLEASE WITH PR3+ AND SO4 IONS BOUND IN THE ACTIVE SITE AT 2.05A. 1KHC ; 1.80 ; CRYSTAL STRUCTURE OF THE PWWP DOMAIN OF MAMMALIAN DEOXYRIBONUCLEIC ACID METHYLTRANSFERASE DNMT3B 1GC0 ; 1.70 ; CRYSTAL STRUCTURE OF THE PYRIDOXAL-5'-PHOSPHATE DEPENDENT L- METHIONINE GAMMA-LYASE FROM PSEUDOMONAS PUTIDA 1GC2 ; 2.00 ; CRYSTAL STRUCTURE OF THE PYRIDOXAL-5'-PHOSPHATE DEPENDENT L- METHIONINE GAMMA-LYASE FROM PSEUDOMONAS PUTIDA 1AUG ; 2.00 ; CRYSTAL STRUCTURE OF THE PYROGLUTAMYL PEPTIDASE I FROM BACILLUS AMYLOLIQUEFACIENS 1MQV ; 1.78 ; CRYSTAL STRUCTURE OF THE Q1A/F32W/W72F MUTANT OF RHODOPSEUDOMONAS PALUSTRIS CYTOCHROME C' ' EXPRESSED IN E. COLI 2F20 ; 2.10 ; CRYSTAL STRUCTURE OF THE Q8A8E9_BACTIN HYPOTHETICAL PROTEIN FROM BACTEROIDES THETAIOTAOMICRON. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET BTR8. 1L1H ; 1.75 ; CRYSTAL STRUCTURE OF THE QUADRUPLEX DEOXYRIBONUCLEIC ACID-DRUG COMPLEX 1FLG ; 2.60 ; CRYSTAL STRUCTURE OF THE QUINOPROTEIN ETHANOL DEHYDROGENASE FROM PSEUDOMONAS AERUGINOSA 1UPG ; 1.80 ; CRYSTAL STRUCTURE OF THE QUORUM-SENSING PROTEIN TRAM FROM AGROBACTERIUM TUMEFACIENS 1US6 ; 1.65 ; CRYSTAL STRUCTURE OF THE QUORUM-SENSING PROTEIN TRAM FROM AGROBACTERIUM TUMEFACIENS AT 1.65 ANG. RESOLUTION 1PR3 ; 2.15 ; CRYSTAL STRUCTURE OF THE R103K MUTANT OF ASPARTATE SEMIALDEHYDE DEHYDROGENASE FROM HAEMOPHILUS INFLUENZAE 1OZA ; 2.06 ; CRYSTAL STRUCTURE OF THE R103L MUTANT OF ASPARTATE SEMIALDEHYDE DEHYDROGENASE FROM HAEMOPHILUS INFLUENZAE 1OQH ; 2.40 ; CRYSTAL STRUCTURE OF THE R124A MUTANT OF THE N-LOBE HUMAN TRANSFERRIN 1OBK ; 2.20 ; CRYSTAL STRUCTURE OF THE R158Q MUTANT OF MALONAMIDASE E2 FROM BRADYRHIZOBIUM JAPONICUM 1SYY ; 1.70 ; CRYSTAL STRUCTURE OF THE R2 SUBUNIT OF RIBONUCLEOTIDE REDUCTASE FROM CHLAMYDIA TRACHOMATIS 1Y28 ; 2.10 ; CRYSTAL STRUCTURE OF THE R220A METBJFIXL HEME DOMAIN 1S07 ; 2.42 ; CRYSTAL STRUCTURE OF THE R253A MUTANT OF 7,8- DIAMINOPELARGONIC ACID SYNTHASE 1S06 ; 2.20 ; CRYSTAL STRUCTURE OF THE R253K MUTANT OF 7,8- DIAMINOPELARGONIC ACID SYNTHASE 1PS8 ; 2.40 ; CRYSTAL STRUCTURE OF THE R270K MUTANT OF ASPARTATE SEMIALDEHYDE DEHYDROGENASE FROM HAEMOPHILUS INFLUENZAE 1JRG ; 2.10 ; CRYSTAL STRUCTURE OF THE R3 FORM OF PECTATE LYASE A, ERWINIA CHRYSANTHEMI 1YU8 ; 1.45 ; CRYSTAL STRUCTURE OF THE R37A MUTANT OF VILLIN HEADPIECE 1MGV ; 2.10 ; CRYSTAL STRUCTURE OF THE R391A MUTANT OF 7,8- DIAMINOPELARGONIC ACID SYNTHASE 1NR1 ; 3.30 ; CRYSTAL STRUCTURE OF THE R463A MUTANT OF HUMAN GLUTAMATE DEHYDROGENASE 1LV0 ; 2.00 ; CRYSTAL STRUCTURE OF THE RAB EFFECTOR GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR (GDI) IN COMPLEX WITH A GERANYLGERANYL (GG) PEPTIDE 1J0X ; 2.40 ; CRYSTAL STRUCTURE OF THE RABBIT MUSCLE GLYCERALDEHYDE-3- PHOSPHATE DEHYDROGENASE (GAPDH) 2CVF ; 2.60 ; CRYSTAL STRUCTURE OF THE RADB RECOMBINASE 2CVH ; 2.20 ; CRYSTAL STRUCTURE OF THE RADB RECOMBINASE 1GC7 ; 2.80 ; CRYSTAL STRUCTURE OF THE RADIXIN FERM DOMAIN 1GC6 ; 2.90 ; CRYSTAL STRUCTURE OF THE RADIXIN FERM DOMAIN COMPLEXED WITH INOSITOL-(1,4,5)-TRIPHOSPHATE 1J19 ; 2.40 ; CRYSTAL STRUCTURE OF THE RADXIN FERM DOMAIN COMPLEXED WITH THE ICAM-2 CYTOPLASMIC PEPTIDE 1ZC3 ; 2.00 ; CRYSTAL STRUCTURE OF THE RAL-BINDING DOMAIN OF EXO84 IN COMPLEX WITH THE ACTIVE RALA 1ZC4 ; 2.50 ; CRYSTAL STRUCTURE OF THE RAL-BINDING DOMAIN OF EXO84 IN COMPLEX WITH THE ACTIVE RALA 1UAD ; 2.10 ; CRYSTAL STRUCTURE OF THE RALA-GPPNHP-SEC5 RAL-BINDING DOMAIN COMPLEX 1SRQ ; 2.90 ; CRYSTAL STRUCTURE OF THE RAP1GAP CATALYTIC DOMAIN 1F3U ; 1.70 ; CRYSTAL STRUCTURE OF THE RAP30/74 INTERACTION DOMAINS OF HUMAN TFIIF 1XDK ; 2.90 ; CRYSTAL STRUCTURE OF THE RARBETA/RXRALPHA LIGAND BINDING DOMAIN HETERODIMER IN COMPLEX WITH 9-CIS RETINOIC ACID AND A FRAGMENT OF THE TRAP220 COACTIVATOR 1LXD ; 2.40 ; CRYSTAL STRUCTURE OF THE RAS INTERACTING DOMAIN OF RALGDS, A GUANINE NUCLEOTIDE DISSOCIATION STIMULATOR OF RAL PROTEIN 1I37 ; 2.00 ; CRYSTAL STRUCTURE OF THE RAT ANDROGEN RECEPTOR LIGAND BINDING DOMAIN COMPLEX WITH DIHYDROTESTOSTERONE 1XNN ; 2.20 ; CRYSTAL STRUCTURE OF THE RAT ANDROGEN RECEPTOR LIGAND BINDING DOMAIN T877A MUTANT COMPLEX WITH (3A-ALPHA-,4- ALPHA 7-ALPHA-,7A-ALPHA-)-3A,4,7,7A-TETRAHYDRO-2-(4-NITRO- 1-NAPHTHALENYL)-4,7-ETHANO-1H-ISOINDOLE-1,3(2H)-DIONE. 1I38 ; 2.00 ; CRYSTAL STRUCTURE OF THE RAT ANDROGEN RECEPTOR LIGAND BINDING DOMAIN T877A MUTANT COMPLEX WITH DIHYDROTESTOSTERONE 1RK3 ; 2.20 ; CRYSTAL STRUCTURE OF THE RAT VITAMIN D RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH 1,25-DIHYDROXYVITAMIN D3 AND A SYNTHETIC PEPTIDE CONTAINING THE NR2 BOX OF DRIP 205 1RKH ; 2.28 ; CRYSTAL STRUCTURE OF THE RAT VITAMIN D RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH 2AM20R AND A SYNTHETIC PEPTIDE CONTAINING THE NR2 BOX OF DRIP 205 1RKG ; 1.90 ; CRYSTAL STRUCTURE OF THE RAT VITAMIN D RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH 2MBISP AND A SYNTHETIC PEPTIDE CONTAINING THE NR2 BOX OF DRIP 205 1RJK ; 1.99 ; CRYSTAL STRUCTURE OF THE RAT VITAMIN D RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH 2MD AND A SYNTHETIC PEPTIDE CONTAINING THE NR2 BOX OF DRIP 205 1GPO ; 1.95 ; CRYSTAL STRUCTURE OF THE RATIONALLY DESIGNED ANTIBODY M41 AS A FAB FRAGMENT 1T0H ; 1.97 ; CRYSTAL STRUCTURE OF THE RATTUS NORVEGICUS VOLTAGE GATED CALCIUM CHANNEL BETA SUBUNIT ISOFORM 2A 1ID1 ; 2.40 ; CRYSTAL STRUCTURE OF THE RCK DOMAIN FROM E.COLI POTASSIUM CHANNEL 1V5G ; 1.96 ; CRYSTAL STRUCTURE OF THE REACTION INTERMEDIATE BETWEEN PYRUVATE OXIDASE CONTAINING FAD AND TPP, AND SUBSTRATE PYRUVATE 1ZRM ; 2.00 ; CRYSTAL STRUCTURE OF THE REACTION INTERMEDIATE OF L-2-HALOACID DEHALOGENASE WITH 2-CHLORO-N-BUTYRATE 1QKK ; 1.70 ; CRYSTAL STRUCTURE OF THE RECEIVER DOMAIN AND LINKER REGION OF DCTD FROM SINORHIZOBIUM MELILOTI 1XHE ; 2.50 ; CRYSTAL STRUCTURE OF THE RECEIVER DOMAIN OF REDOX RESPONSE REGULATOR ARCA 1DCF ; 2.50 ; CRYSTAL STRUCTURE OF THE RECEIVER DOMAIN OF THE ETHYLENE RECEPTOR OF ARABIDOPSIS THALIANA 1ZGZ ; 1.80 ; CRYSTAL STRUCTURE OF THE RECEIVER DOMAIN OF TMAO RESPIRATORY SYSTEM RESPONSE REGULATOR TORR 1SG1 ; 2.40 ; CRYSTAL STRUCTURE OF THE RECEPTOR-LIGAND COMPLEX BETWEEN NERVE GROWTH FACTOR AND THE COMMON NEUROTROPHIN RECEPTOR P75 1FXW ; 2.10 ; CRYSTAL STRUCTURE OF THE RECOMBINANT ALPHA1/ALPHA2 CATALYTIC HETERODIMER OF BOVINE BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB. 1LON ; 2.10 ; CRYSTAL STRUCTURE OF THE RECOMBINANT MOUSE-MUSCLE ADENYLOSUCCINATE SYNTHETASE COMPLEXED WITH 6-PHOSPHORYL- IMP, GDP AND HADACIDIN 1LNY ; 2.20 ; CRYSTAL STRUCTURE OF THE RECOMBINANT MOUSE-MUSCLE ADENYLOSUCCINATE SYNTHETASE COMPLEXED WITH 6-PHOSPHORYL- IMP, GDP AND MG 1MI0 ; 1.85 ; CRYSTAL STRUCTURE OF THE REDESIGNED PROTEIN G VARIANT NUG2 1OAE ; 1.95 ; CRYSTAL STRUCTURE OF THE REDUCED FORM OF CYTOCHROME C" FROM METHYLOPHILUS METHYLOTROPHUS 1ZNZ ; 2.50 ; CRYSTAL STRUCTURE OF THE REDUCED FORM OF MYCOBACTERIUM TUBERCULOSIS GUANYLATE KINASE IN COMPLEX WITH GDP 1I69 ; 2.70 ; CRYSTAL STRUCTURE OF THE REDUCED FORM OF OXYR 1V58 ; 1.70 ; CRYSTAL STRUCTURE OF THE REDUCED PROTEIN DISULFIDE BOND ISOMERASE DSBG 1T1R ; 2.30 ; CRYSTAL STRUCTURE OF THE REDUCTOISOMERASE COMPLEXED WITH A BISPHOSPHONATE 1T1S ; 2.40 ; CRYSTAL STRUCTURE OF THE REDUCTOISOMERASE COMPLEXED WITH A BISPHOSPHONATE 1O7F ; 2.50 ; CRYSTAL STRUCTURE OF THE REGULATORY DOMAIN OF EPAC2 1HO8 ; 2.95 ; CRYSTAL STRUCTURE OF THE REGULATORY SUBUNIT H OF THE V-TYPE ATPASE OF SACCHAROMYCES CEREVISIAE 1JMU ; 2.80 ; CRYSTAL STRUCTURE OF THE REOVIRUS MU1/SIGMA3 COMPLEX 1FN9 ; 1.80 ; CRYSTAL STRUCTURE OF THE REOVIRUS OUTER CAPSID PROTEIN SIGMA 3 1J0R ; 2.50 ; CRYSTAL STRUCTURE OF THE REPLICATION TERMINATION PROTEIN MUTANT C110S 1F4K ; 2.50 ; CRYSTAL STRUCTURE OF THE REPLICATION TERMINATOR PROTEIN/B- SITE DEOXYRIBONUCLEIC ACID COMPLEX 1M5T ; 1.60 ; CRYSTAL STRUCTURE OF THE RESPONSE REGULATOR DIVK 1MAV ; 1.60 ; CRYSTAL STRUCTURE OF THE RESPONSE REGULATOR DIVK AT PH 6.0 IN COMPLEX WITH MN2+ 1MB0 ; 2.00 ; CRYSTAL STRUCTURE OF THE RESPONSE REGULATOR DIVK AT PH 8.0 IN COMPLEX WITH MN2+ 1MB3 ; 1.41 ; CRYSTAL STRUCTURE OF THE RESPONSE REGULATOR DIVK AT PH 8.5 IN COMPLEX WITH MG2+ 1M5U ; 1.87 ; CRYSTAL STRUCTURE OF THE RESPONSE REGULATOR DIVK. STRUCTURE AT PH 8.0 IN THE APO-FORM 1PEY ; 2.25 ; CRYSTAL STRUCTURE OF THE RESPONSE REGULATOR SPO0F COMPLEXED WITH MN2+ 1DMU ; 2.20 ; CRYSTAL STRUCTURE OF THE RESTRICTION ENDONUCLEASE BGLI BOUND TO ITS DEOXYRIBONUCLEIC ACID RECOGNITION SEQUENCE 1VRR ; 2.70 ; CRYSTAL STRUCTURE OF THE RESTRICTION ENDONUCLEASE BSTYI COMPLEX WITH DEOXYRIBONUCLEIC ACID 1O9K ; 2.60 ; CRYSTAL STRUCTURE OF THE RETINOBLASTOMA TUMOUR SUPPRESSOR PROTEIN BOUND TO E2F PEPTIDE 1DUQ ; 2.10 ; CRYSTAL STRUCTURE OF THE REV BINDING ELEMENT OF HIV-1 1DK8 ; 1.57 ; CRYSTAL STRUCTURE OF THE RGS-HOMOLOGOUS DOMAIN OF AXIN 1KQR ; 1.40 ; CRYSTAL STRUCTURE OF THE RHESUS ROTAVIRUS VP4 SIALIC ACID BINDING DOMAIN IN COMPLEX WITH 2-O-METHYL-ALPHA-D-N-ACETYL NEURAMINIC ACID 1CC0 ; 5.00 ; CRYSTAL STRUCTURE OF THE RHOA.GDP-RHOGDI COMPLEX 1UAX ; 2.00 ; CRYSTAL STRUCTURE OF THE RIBONUCLEASE H2 FROM PYROCOCCUS HORIKOSHII OT3 1UCA ; 1.48 ; CRYSTAL STRUCTURE OF THE RIBONUCLEASE MC1 FROM BITTER GOURD SEEDS COMPLEXED WITH 2'-UMP 1UCC ; 1.77 ; CRYSTAL STRUCTURE OF THE RIBONUCLEASE MC1 FROM BITTER GOURD SEEDS COMPLEXED WITH 3'-UMP. 1UTY ; 2.40 ; CRYSTAL STRUCTURE OF THE RIBONUCLEIC ACID BINDING DOMAIN OF BLUETONGUE VIRUS NON-STRUCTURAL PROTEIN 2(NS2) 1QUV ; 2.50 ; CRYSTAL STRUCTURE OF THE RIBONUCLEIC ACID DIRECTED RIBONUCLEIC ACID POLYMERASE OF HEPATITIS C VIRUS 1SA9 ; 2.86 ; CRYSTAL STRUCTURE OF THE RIBONUCLEIC ACID OCTAMER GGCGAGCC 1SAQ ; 2.70 ; CRYSTAL STRUCTURE OF THE RIBONUCLEIC ACID OCTAMER GIC(GA)GCC 1IW7 ; 2.60 ; CRYSTAL STRUCTURE OF THE RIBONUCLEIC ACID POLYMERASE HOLOENZYME FROM THERMUS THERMOPHILUS AT 2.6A RESOLUTION 2A2E ; 3.85 ; CRYSTAL STRUCTURE OF THE RIBONUCLEIC ACID SUBUNIT OF RIBONUCLEASE P. BACTERIAL A-TYPE. 1I9S ; 1.65 ; CRYSTAL STRUCTURE OF THE RIBONUCLEIC ACID TRIPHOSPHATASE DOMAIN OF MOUSE MRNA CAPPING ENZYME 1FO1 ; 2.90 ; CRYSTAL STRUCTURE OF THE RIBONUCLEIC ACID-BINDING DOMAIN OF THE MRNA EXPORT FACTOR TAP 1FT8 ; 3.15 ; CRYSTAL STRUCTURE OF THE RIBONUCLEIC ACID-BINDING DOMAIN OF THE MRNA EXPORT FACTOR TAP 1A62 ; 1.55 ; CRYSTAL STRUCTURE OF THE RIBONUCLEIC ACID-BINDING DOMAIN OF THE TRANSCRIPTIONAL TERMINATOR PROTEIN RHO 1XR5 ; 2.80 ; CRYSTAL STRUCTURE OF THE RIBONUCLEIC ACID-DEPENDENT RIBONUCLEIC ACID POLYMERASE 3D FROM HUMAN RHINOVIRUS SEROTYPE 14 1TP7 ; 2.40 ; CRYSTAL STRUCTURE OF THE RIBONUCLEIC ACID-DEPENDENT RIBONUCLEIC ACID POLYMERASE FROM HUMAN RHINOVIRUS 16 1CSJ ; 2.80 ; CRYSTAL STRUCTURE OF THE RIBONUCLEIC ACID-DEPENDENT RIBONUCLEIC ACID POLYMERASE OF HEPATITIS C VIRUS 404D ; 2.50 ; CRYSTAL STRUCTURE OF THE RIBONUCLEIC ACID/DEOXYRIBONUCLEIC ACID HYBRID R(GAAGAGAAGC). D(GCTTCTCTTC) 1MMS ; 2.57 ; CRYSTAL STRUCTURE OF THE RIBOSOMAL PROTEIN L11-RIBONUCLEIC ACID COMPLEX 1GIX ; 5.50 ; CRYSTAL STRUCTURE OF THE RIBOSOME AT 5.5 A RESOLUTION. THIS FILE, 1GIX, CONTAINS THE 30S RIBOSOME SUBUNIT, THREE TRNA, AND MRNA MOLECULES. 50S RIBOSOME SUBUNIT IS IN THE FILE 1GIY 1GIY ; 5.50 ; CRYSTAL STRUCTURE OF THE RIBOSOME AT 5.5 A RESOLUTION. THIS FILE, 1GIY, CONTAINS THE 50S RIBOSOME SUBUNIT. THE 30S RIBOSOME SUBUNIT, THREE TRNA, AND MRNA MOLECULES ARE IN THE FILE 1GIX 1EK8 ; 2.30 ; CRYSTAL STRUCTURE OF THE RIBOSOME RECYCLING FACTOR (RRF) FROM ESCHERICHIA COLI 1JBR ; 2.15 ; CRYSTAL STRUCTURE OF THE RIBOTOXIN RESTRICTOCIN AND A 31- MER SRD RIBONUCLEIC ACID INHIBITOR 1NYK ; 1.31 ; CRYSTAL STRUCTURE OF THE RIESKE PROTEIN FROM THERMUS THERMOPHILUS 1FQT ; 1.60 ; CRYSTAL STRUCTURE OF THE RIESKE-TYPE FERREDOXIN ASSOCIATED WITH BIPHENYL DIOXYGENASE 2BWQ ; 1.41 ; CRYSTAL STRUCTURE OF THE RIM2 C2A-DOMAIN AT 1.4 ANGSTROM RESOLUTION 1J1G ; 1.60 ; CRYSTAL STRUCTURE OF THE RNASE MC1 MUTANT N71S IN COMPLEX WITH 5'-GMP 1J1F ; 1.60 ; CRYSTAL STRUCTURE OF THE RNASE MC1 MUTANT N71T IN COMPLEX WITH 5'-GMP 1V9H ; 2.00 ; CRYSTAL STRUCTURE OF THE RNASE MC1 MUTANT Y101A IN COMPLEX WITH 5'-UMP 1VCZ ; 1.80 ; CRYSTAL STRUCTURE OF THE RNASE NT IN COMPLEX WITH 5'-GMP 1TTO ; 2.10 ; CRYSTAL STRUCTURE OF THE RNASE T1 VARIANT R2 1YJE ; 2.40 ; CRYSTAL STRUCTURE OF THE RNGFI-B LIGAND-BINDING DOMAIN 1HCI ; 2.80 ; CRYSTAL STRUCTURE OF THE ROD DOMAIN OF ALPHA-ACTININ 1Z05 ; 2.00 ; CRYSTAL STRUCTURE OF THE ROK FAMILY TRANSCRIPTIONAL REGULATOR, HOMOLOG OF E.COLI MLC PROTEIN. 2BF0 ; 2.30 ; CRYSTAL STRUCTURE OF THE RPR OF PCF11 1CSL ; 1.60 ; CRYSTAL STRUCTURE OF THE RRE HIGH AFFINITY SITE 1QCP ; 1.80 ; CRYSTAL STRUCTURE OF THE RWJ-51084 BOVINE PANCREATIC BETA- TRYPSIN AT 1.8 A 1XTZ ; 2.10 ; CRYSTAL STRUCTURE OF THE S. CEREVISIAE D-RIBOSE-5-PHOSPHATE ISOMERASE: COMPARISON WITH THE ARCHEAL AND BACTERIAL ENZYMES 2B7M ; 3.50 ; CRYSTAL STRUCTURE OF THE S. CEREVISIAE EXOCYST COMPONENT EXO70P 1QVV ; 2.35 ; CRYSTAL STRUCTURE OF THE S. CEREVISIAE YDR533C PROTEIN 1QVW ; 1.90 ; CRYSTAL STRUCTURE OF THE S. CEREVISIAE YDR533C PROTEIN 1QVZ ; 1.85 ; CRYSTAL STRUCTURE OF THE S. CEREVISIAE YDR533C PROTEIN 1GPP ; 1.35 ; CRYSTAL STRUCTURE OF THE S.CEREVISIAE HOMING ENDONUCLEASE PI-SCEI DOMAIN I 1SMX ; 1.80 ; CRYSTAL STRUCTURE OF THE S1 DOMAIN OF RNASE E FROM E. COLI (NATIVE) 1SN8 ; 2.00 ; CRYSTAL STRUCTURE OF THE S1 DOMAIN OF RNASE E FROM E. COLI (PB DERIVATIVE) 1O9O ; 2.30 ; CRYSTAL STRUCTURE OF THE S131A MUTANT OF MALONAMIDASE E2 COMPLEXED WITH MALONAMATE FROM BRADYRHIZOBIUM JAPONICUM 1O9P ; 1.80 ; CRYSTAL STRUCTURE OF THE S131A MUTANT OF MALONAMIDASE E2 COMPLEXED WITH MALONATE FROM BRADYRHIZOBIUM JAPONICUM 1OBL ; 2.00 ; CRYSTAL STRUCTURE OF THE S133A MUTANT OF MALONAMIDASE E2 COMPLEXED WITH MALONATE FROM BRADYRHIZOBIUM JAPONICUM 1LSO ; 2.60 ; CRYSTAL STRUCTURE OF THE S137A MUTANT OF L-3-HYDROXYACYL- COA DEHYDROGENASE IN COMPLEX WITH NAD 1M76 ; 2.15 ; CRYSTAL STRUCTURE OF THE S137C MUTANT OF L-3-HYDROXYACYL- COA DEHYDROGENASE IN COMPLEX WITH NAD AND ACETOACETYL-COA 1O9Q ; 1.80 ; CRYSTAL STRUCTURE OF THE S155C MUTANT OF MALONAMIDASE E2 FROM BRADYRHIZOBIUM JAPONICUM 1OCH ; 1.80 ; CRYSTAL STRUCTURE OF THE S155C MUTANT OF MALONAMIDASE E2 FROM BRADYRHIZOBIUM JAPONICUM 1X7U ; 1.90 ; CRYSTAL STRUCTURE OF THE S324T OF CATALASE-PEROXIDASE KATG 1O99 ; 2.65 ; CRYSTAL STRUCTURE OF THE S62A MUTANT OF PHOSPHOGLYCERATE MUTASE FROM BACILLUS STEAROTHERMOPHILUS COMPLEXED WITH 2-PHOSPHOGLYCERATE 1Q99 ; 2.11 ; CRYSTAL STRUCTURE OF THE SACCHAROMYCES CEREVISIAE SR PROTEIN KINSAE, SKY1P, COMPLEXED WITH THE NON-HYDROLYZABLE ATP ANALOGUE, AMP-PNP 1AYZ ; 2.60 ; CRYSTAL STRUCTURE OF THE SACCHAROMYCES CEREVISIAE UBIQUITIN-CONJUGATING ENZYME RAD6 (UBC2) AT 2.6A RESOLUTION 1G4W ; 2.20 ; CRYSTAL STRUCTURE OF THE SALMONELLA TYROSINE PHOSPHATASE AND GTPASE ACTIVATING PROTEIN SPTP 1G4U ; 2.30 ; CRYSTAL STRUCTURE OF THE SALMONELLA TYROSINE PHOSPHATASE AND GTPASE ACTIVATING PROTEIN SPTP BOUND TO RAC1 1OQJ ; 1.55 ; CRYSTAL STRUCTURE OF THE SAND DOMAIN FROM GLUCOCORTICOID MODULATORY ELEMENT BINDING PROTEIN-1 (GMEB1) 480D ; 1.50 ; CRYSTAL STRUCTURE OF THE SARCIN/RICIN DOMAIN FROM E. COLI 23 S RRNA 483D ; 1.11 ; CRYSTAL STRUCTURE OF THE SARCIN/RICIN DOMAIN FROM E. COLI 23 S RRNA 1Q9A ; 1.04 ; CRYSTAL STRUCTURE OF THE SARCIN/RICIN DOMAIN FROM E.COLI 23S RRNA AT 1.04 RESOLUTION 1WNC ; 2.80 ; CRYSTAL STRUCTURE OF THE SARS-COV SPIKE PROTEIN FUSION CORE 1R1G ; 1.72 ; CRYSTAL STRUCTURE OF THE SCORPION TOXIN BMBKTTX1 1M2O ; 2.50 ; CRYSTAL STRUCTURE OF THE SEC23-SAR1 COMPLEX 1KU1 ; 1.93 ; CRYSTAL STRUCTURE OF THE SEC7 DOMAIN OF YEAST GEA2 1NKT ; 2.60 ; CRYSTAL STRUCTURE OF THE SECA PROTEIN TRANSLOCATION ATPASE FROM MYCOBACTERIUM TUBERCULOSIS COMPLEX WITH ADPBS 1NL3 ; 2.80 ; CRYSTAL STRUCTURE OF THE SECA PROTEIN TRANSLOCATION ATPASE FROM MYCOBACTERIUM TUBERCULOSIS IN APO FORM 1M6N ; 2.70 ; CRYSTAL STRUCTURE OF THE SECA TRANSLOCATION ATPASE FROM BACILLUS SUBTILIS 2F8A ; 1.50 ; CRYSTAL STRUCTURE OF THE SELENOCYSTEINE TO GLYCINE MUTANT OF HUMAN GLUTATHIONE PEROXIDASE 1 1B6W ; 2.05 ; CRYSTAL STRUCTURE OF THE SELENOMETHIONINE VARIANT OF HISTONE HMFB FROM METHANOTHERMUS FERVIDUS 260D ; 1.90 ; CRYSTAL STRUCTURE OF THE SELF-COMPLEMENTARY 5'-PURINE START DECAMER D(GCACGCGTGC) IN THE A-DEOXYRIBONUCLEIC ACID CONFORMATION - PART II 279D ; 1.90 ; CRYSTAL STRUCTURE OF THE SELF-COMPLEMENTARY 5'-PURINE START DECAMER D(GCGCGCGCGC) IN THE Z-DEOXYRIBONUCLEIC ACID CONFORMATION - PART I 1QC1 ; 2.50 ; CRYSTAL STRUCTURE OF THE SELF-FITTED B-DEOXYRIBONUCLEIC ACID DECAMER D(CCGCCGGCGG) 1X8C ; 2.10 ; CRYSTAL STRUCTURE OF THE SEMET-DERIVATIVE COPPER HOMEOSTASIS PROTEIN (CUTCM) WITH CALCIUM BINDING FROM SHIGELLA FLEXNERI 2A STR. 301 1XA1 ; 1.80 ; CRYSTAL STRUCTURE OF THE SENSOR DOMAIN OF BLAR1 FROM STAPHYLOCOCCUS AUREUS IN ITS APO FORM 2BEM ; 1.55 ; CRYSTAL STRUCTURE OF THE SERRATIA MARCESCENS CHITIN-BINDING PROTEIN CBP21 2BEN ; 1.80 ; CRYSTAL STRUCTURE OF THE SERRATIA MARCESCENS CHITIN-BINDING PROTEIN CBP21 Y54A MUTANT. 1OZV ; 2.65 ; CRYSTAL STRUCTURE OF THE SET DOMAIN OF LSMT BOUND TO LYSINE AND ADOHCY 1P0Y ; 2.55 ; CRYSTAL STRUCTURE OF THE SET DOMAIN OF LSMT BOUND TO MELYSINE AND ADOHCY 1NRV ; 1.65 ; CRYSTAL STRUCTURE OF THE SH2 DOMAIN OF GRB10 1OOT ; 1.39 ; CRYSTAL STRUCTURE OF THE SH3 DOMAIN FROM A S. CEREVISIAE HYPOTHETICAL 40.4 KDA PROTEIN AT 1.39 A RESOLUTION 1SSH ; 1.40 ; CRYSTAL STRUCTURE OF THE SH3 DOMAIN FROM A S. CEREVISIAE HYPOTHETICAL 40.4 KDA PROTEIN IN COMPLEX WITH A PEPTIDE 1BB9 ; 2.20 ; CRYSTAL STRUCTURE OF THE SH3 DOMAIN FROM RAT AMPHIPHYSIN 2 1RUW ; 1.80 ; CRYSTAL STRUCTURE OF THE SH3 DOMAIN FROM S. CEREVISIAE MYO3 1JXO ; 2.30 ; CRYSTAL STRUCTURE OF THE SH3-HOOK-GK FRAGMENT OF PSD-95 1Q3O ; 1.80 ; CRYSTAL STRUCTURE OF THE SHANK PDZ-LIGAND COMPLEX REVEALS A CLASS I PDZ INTERACTION AND A NOVEL PDZ-PDZ DIMERIZATION 1Q3P ; 2.25 ; CRYSTAL STRUCTURE OF THE SHANK PDZ-LIGAND COMPLEX REVEALS A CLASS I PDZ INTERACTION AND A NOVEL PDZ-PDZ DIMERIZATION 1RYE ; 2.30 ; CRYSTAL STRUCTURE OF THE SHIFTED FORM OF THE GLUCOSE- FRUCTOSE OXIDOREDUCTASE FROM ZYMOMONAS MOBILIS 1T95 ; 1.90 ; CRYSTAL STRUCTURE OF THE SHWACHMAN-BODIAN-DIAMOND SYNDROME PROTEIN ORTHOLOGUE FROM ARCHAEOGLOBUS FULGIDUS 1JP5 ; 2.70 ; CRYSTAL STRUCTURE OF THE SINGLE-CHAIN FV FRAGMENT 1696 IN COMPLEX WITH THE EPITOPE PEPTIDE CORRESPONDING TO N- TERMINUS OF HIV-1 PROTEASE 1SVZ ; 1.89 ; CRYSTAL STRUCTURE OF THE SINGLE-CHAIN FV FRAGMENT 1696 IN COMPLEX WITH THE EPITOPE PEPTIDE CORRESPONDING TO N- TERMINUS OF HIV-2 PROTEASE 2CWA ; 1.96 ; CRYSTAL STRUCTURE OF THE SINGLE-STRANDED DEOXYRIBONUCLEIC ACID BINDING PROTEIN FROM THERMUS THERMOPHILUS HB8 1X3E ; 2.15 ; CRYSTAL STRUCTURE OF THE SINGLE-STRANDED DEOXYRIBONUCLEIC ACID-BINDING PROTEIN FROM MYCOBACTERIUM SMEGMATIS 1X3F ; 2.70 ; CRYSTAL STRUCTURE OF THE SINGLE-STRANDED DEOXYRIBONUCLEIC ACID-BINDING PROTEIN FROM MYCOBACTERIUM SMEGMATIS 1X3G ; 3.00 ; CRYSTAL STRUCTURE OF THE SINGLE-STRANDED DEOXYRIBONUCLEIC ACID-BINDING PROTEIN FROM MYCOBACTERIUM SMEGMATIS 1UE1 ; 2.50 ; CRYSTAL STRUCTURE OF THE SINGLE-STRANDED DEOXYRIBONUCLEIC ACID-BINDING PROTEIN FROM MYCOBACTERIUM TUBERCULOSIS 1UE5 ; 2.60 ; CRYSTAL STRUCTURE OF THE SINGLE-STRANDED DEOXYRIBONUCLEIC ACID-BINDING PROTEIN FROM MYCOBACTERIUM TUBERCULOSIS 1UE6 ; 2.70 ; CRYSTAL STRUCTURE OF THE SINGLE-STRANDED DEOXYRIBONUCLEIC ACID-BINDING PROTEIN FROM MYCOBACTERIUM TUBERCULOSIS 1UE7 ; 3.20 ; CRYSTAL STRUCTURE OF THE SINGLE-STRANDED DEOXYRIBONUCLEIC ACID-BINDING PROTEIN FROM MYCOBACTERIUM TUBERCULOSIS 1N7E ; 1.50 ; CRYSTAL STRUCTURE OF THE SIXTH PDZ DOMAIN OF GRIP1 1N7F ; 1.80 ; CRYSTAL STRUCTURE OF THE SIXTH PDZ DOMAIN OF GRIP1 IN COMPLEX WITH LIPRIN C-TERMINAL PEPTIDE 2ASS ; 3.00 ; CRYSTAL STRUCTURE OF THE SKP1-SKP2-CKS1 COMPLEX 1H64 ; 1.90 ; CRYSTAL STRUCTURE OF THE SM-RELATED PROTEIN OF P. ABYSSI THE BIOLOGICAL UNIT IS A HEPTAMER 1YGS ; 2.10 ; CRYSTAL STRUCTURE OF THE SMAD4 TUMOR SUPPRESSOR C-TERMINAL DOMAIN 1KAO ; 1.70 ; CRYSTAL STRUCTURE OF THE SMALL G PROTEIN RAP2A WITH GDP 1OXJ ; 1.80 ; CRYSTAL STRUCTURE OF THE SMAUG RIBONUCLEIC ACID BINDING DOMAIN 1KBW ; 2.40 ; CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE 1JM1 ; 1.11 ; CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF THE RIESKE PROTEIN II (SOXF) FROM SULFOLOBUS ACIDOCALDARIUS 1JFU ; 1.60 ; CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF TLPA FROM BRADYRHIZOBIUM JAPONICUM 1E4J ; 2.50 ; CRYSTAL STRUCTURE OF THE SOLUBLE HUMAN FC-GAMMA RECEPTOR III 1C9U ; 2.20 ; CRYSTAL STRUCTURE OF THE SOLUBLE QUINOPROTEIN GLUCOSE DEHYDROGENASE IN COMPLEX WITH PQQ 1V02 ; 1.90 ; CRYSTAL STRUCTURE OF THE SORGHUM BICOLOR DHURRINASE 1 1V03 ; 2.00 ; CRYSTAL STRUCTURE OF THE SORGHUM BICOLOR DHURRINASE 1 1G9F ; 2.50 ; CRYSTAL STRUCTURE OF THE SOYBEAN AGGLUTININ IN A COMPLEX WITH A BIANTENNARY BLOOD GROUP ANTIGEN ANALOG 1U9S ; 2.90 ; CRYSTAL STRUCTURE OF THE SPECIFICITY DOMAIN OF RIBONUCLEASE P OF THE A-TYPE 1NBS ; 3.15 ; CRYSTAL STRUCTURE OF THE SPECIFICITY DOMAIN OF RIBONUCLEASE P RIBONUCLEIC ACID 1DTM ; 2.13 ; CRYSTAL STRUCTURE OF THE SPERM-WHALE MYOGLOBIN MUTANT H93G COMPLEXED WITH 4-METHYLIMIDAZOLE, METAQUO FORM 1Z98 ; 2.10 ; CRYSTAL STRUCTURE OF THE SPINACH AQUAPORIN SOPIP2;1 IN A CLOSED CONFORMATION 2B5F ; 3.90 ; CRYSTAL STRUCTURE OF THE SPINACH AQUAPORIN SOPIP2;1 IN AN OPEN CONFORMATION TO 3.9 RESOLUTION 1TEF ; 1.90 ; CRYSTAL STRUCTURE OF THE SPINACH PLASTOCYANIN MUTANTS G8D/K30C/T69C AND K30C/T69C- A STUDY OF THE EFFECT ON CRYSTAL PACKING AND THERMOSTABILITY FROM THE INTRODUCTION OF A NOVEL DISULFIDE BOND 1TEG ; 1.96 ; CRYSTAL STRUCTURE OF THE SPINACH PLASTOCYANIN MUTANTS G8D/K30C/T69C AND K30C/T69C- A STUDY OF THE EFFECT ON CRYSTAL PACKING AND THERMOSTABILITY FROM THE INTRODUCTION OF A NOVEL DISULFIDE BOND 1E7K ; 2.90 ; CRYSTAL STRUCTURE OF THE SPLICEOSOMAL 15.5KD PROTEIN BOUND TO A U4 SNRNA FRAGMENT 1OW1 ; 1.80 ; CRYSTAL STRUCTURE OF THE SPOC DOMAIN OF THE HUMAN TRANSCRIPTIONAL COREPRESSOR, SHARP. 1X7O ; 2.37 ; CRYSTAL STRUCTURE OF THE SPOU METHYLTRANSFERASE AVIRB FROM STREPTOMYCES VIRIDOCHROMOGENES 1X7P ; 2.55 ; CRYSTAL STRUCTURE OF THE SPOU METHYLTRANSFERASE AVIRB FROM STREPTOMYCES VIRIDOCHROMOGENES IN COMPLEX WITH THE COFACTOR ADOMET 1IWO ; 3.10 ; CRYSTAL STRUCTURE OF THE SR CA2+-ATPASE IN THE ABSENCE OF CA2+ 2AGV ; 2.40 ; CRYSTAL STRUCTURE OF THE SR CA2+-ATPASE WITH BHQ AND TG 1VFP ; 2.90 ; CRYSTAL STRUCTURE OF THE SR CA2+-ATPASE WITH BOUND AMPPCP 1WPG ; 2.30 ; CRYSTAL STRUCTURE OF THE SR CA2+-ATPASE WITH MGF4 1WPE ; 2.70 ; CRYSTAL STRUCTURE OF THE SR CALCIUM PUMP WITH BOUND ALUMINIUM FLUORIDE, ADP AND CALCIUM 1P13 ; 1.63 ; CRYSTAL STRUCTURE OF THE SRC SH2 DOMAIN COMPLEXED WITH PEPTIDE (SDPYANFK) 1LNG ; 2.30 ; CRYSTAL STRUCTURE OF THE SRP19-7S.S SRP RIBONUCLEIC ACID COMPLEX OF M. JANNASCHII 1U2W ; 1.90 ; CRYSTAL STRUCTURE OF THE STAPHYLOCOCCUS AUREUS PI258 CADC 2BBD ; 2.04 ; CRYSTAL STRUCTURE OF THE STIV MCP 1PVJ ; 3.00 ; CRYSTAL STRUCTURE OF THE STREPTOCOCCAL PYROGENIC EXOTOXIN B (SPEB)- INHIBITOR COMPLEX 1TY0 ; 1.75 ; CRYSTAL STRUCTURE OF THE STREPTOCOCCAL PYROGENIC EXOTOXIN J (SPE-J) 1TY2 ; 2.00 ; CRYSTAL STRUCTURE OF THE STREPTOCOCCAL PYROGENIC EXOTOXIN J (SPE-J) 1AN8 ; 2.40 ; CRYSTAL STRUCTURE OF THE STREPTOCOCCAL SUPERANTIGEN SPE-C 1K47 ; 2.42 ; CRYSTAL STRUCTURE OF THE STREPTOCOCCUS PNEUMONIAE PHOSPHOMEVALONATE KINASE (PMK) 1JFR ; 1.90 ; CRYSTAL STRUCTURE OF THE STREPTOMYCES EXFOLIATUS LIPASE AT 1.9A RESOLUTION: A MODEL FOR A FAMILY OF PLATELET- ACTIVATING FACTOR ACETYLHYDROLASES 1F2O ; 1.70 ; CRYSTAL STRUCTURE OF THE STREPTOMYCES GRISEUS AMINOPEPTIDASE COMPLEXED WITH L-LEUCINE 1F2P ; 1.80 ; CRYSTAL STRUCTURE OF THE STREPTOMYCES GRISEUS AMINOPEPTIDASE COMPLEXED WITH L-PHENYLALANINE 1SKF ; 2.00 ; CRYSTAL STRUCTURE OF THE STREPTOMYCES K15 DD-TRANSPEPTIDASE 1CQR ; 2.00 ; CRYSTAL STRUCTURE OF THE STROMELYSIN CATALYTIC DOMAIN AT 2.0 A RESOLUTION 1HV5 ; 2.60 ; CRYSTAL STRUCTURE OF THE STROMELYSIN-3 (MMP-11) CATALYTIC DOMAIN COMPLEXED WITH A PHOSPHINIC INHIBITOR 1YU6 ; 1.55 ; CRYSTAL STRUCTURE OF THE SUBTILISIN CARLSBERG:OMTKY3 COMPLEX 1D4D ; 2.50 ; CRYSTAL STRUCTURE OF THE SUCCINATE COMPLEXED FORM OF THE FLAVOCYTOCHROME C FUMARATE REDUCTASE OF SHEWANELLA PUTREFACIENS STRAIN MR-1 1YW4 ; 2.00 ; CRYSTAL STRUCTURE OF THE SUCCINYLGLUTAMATE DESUCCINYLASE FROM CHROMOBACTERIUM VIOLACEUM, NORTHEAST STRUCTURAL GENOMICS TARGET CVR22. 1TV4 ; 1.80 ; CRYSTAL STRUCTURE OF THE SULFITE MTMB COMPLEX 1EU3 ; 1.68 ; CRYSTAL STRUCTURE OF THE SUPERANTIGEN SMEZ-2 (ZINC BOUND) FROM STREPTOCOCCUS PYOGENES 1ET6 ; 1.90 ; CRYSTAL STRUCTURE OF THE SUPERANTIGEN SMEZ-2 FROM STREPTOCOCCUS PYOGENES 1EU4 ; 2.50 ; CRYSTAL STRUCTURE OF THE SUPERANTIGEN SPE-H (ZINC BOUND) FROM STREPTOCOCCUS PYOGENES 1ET9 ; 1.90 ; CRYSTAL STRUCTURE OF THE SUPERANTIGEN SPE-H FROM STREPTOCOCCUS PYOGENES 1Y07 ; 1.55 ; CRYSTAL STRUCTURE OF THE SUPEROXIDE REDUCTASE FROM TREPONEMA PALLIDUM 1N25 ; 2.80 ; CRYSTAL STRUCTURE OF THE SV40 LARGE T ANTIGEN HELICASE DOMAIN 1XBB ; 1.57 ; CRYSTAL STRUCTURE OF THE SYK TYROSINE KINASE DOMAIN WITH GLEEVEC 1XBC ; 2.00 ; CRYSTAL STRUCTURE OF THE SYK TYROSINE KINASE DOMAIN WITH STAUROSPORIN 2C5M ; 2.80 ; CRYSTAL STRUCTURE OF THE SYNTHETASE DOMAIN OF HUMAN CTP SYNTHETASE 1QN4 ; 1.86 ; CRYSTAL STRUCTURE OF THE T(-24) ADENOVIRUS MAJOR LATE PROMOTER TATA BOX VARIANT BOUND TO WILD-TYPE TBP (ARABIDOPSIS THALIANA TBP ISOFORM 2). TATA ELEMENT RECOGNITION BY THE TATA BOX-BINDING PROTEIN HAS BEEN CONSERVED THROUGHOUT EVOLUTION. 1QNB ; 2.23 ; CRYSTAL STRUCTURE OF THE T(-25) ADENOVIRUS MAJOR LATE PROMOTER TATA BOX VARIANT BOUND TO WILD-TYPE TBP (ARABIDOPSIS THALIANA TBP ISOFORM 2). TATA ELEMENT RECOGNITION BY THE TATA BOX-BINDING PROTEIN HAS BEEN CONSERVED THROUGHOUT EVOLUTION. 1QN6 ; 2.10 ; CRYSTAL STRUCTURE OF THE T(-26) ADENOVIRUS MAJOR LATE PROMOTER TATA BOX VARIANT BOUND TO WILD-TYPE TBP (ARABIDOPSIS THALIANA TBP ISOFORM 2). TATA ELEMENT RECOGNITION BY THE TATA BOX-BINDING PROTEIN HAS BEEN CONSERVED THROUGHOUT EVOLUTION. 1QN7 ; 2.30 ; CRYSTAL STRUCTURE OF THE T(-27) ADENOVIRUS MAJOR LATE PROMOTER TATA BOX VARIANT BOUND TO WILD-TYPE TBP (ARABIDOPSIS THALIANA TBP ISOFORM 2). TATA ELEMENT RECOGNITION BY THE TATA BOX-BINDING PROTEIN HAS BEEN CONSERVED THROUGHOUT EVOLUTION. 1QN8 ; 2.10 ; CRYSTAL STRUCTURE OF THE T(-28) ADENOVIRUS MAJOR LATE PROMOTER TATA BOX VARIANT BOUND TO WILD-TYPE TBP (ARABIDOPSIS THALIANA TBP ISOFORM 2). TATA ELEMENT RECOGNITION BY THE TATA BOX-BINDING PROTEIN HAS BEEN CONSERVED THROUGHOUT EVOLUTION. 1QNA ; 1.80 ; CRYSTAL STRUCTURE OF THE T(-30) ADENOVIRUS MAJOR LATE PROMOTER TATA BOX VARIANT BOUND TO WILD-TYPE TBP (ARABIDOPSIS THALIANA TBP ISOFORM 2). TATA ELEMENT RECOGNITION BY THE TATA BOX-BINDING PROTEIN HAS BEEN CONSERVED THROUGHOUT EVOLUTION. 2A6E ; 2.80 ; CRYSTAL STRUCTURE OF THE T. THERMOPHILUS RIBONUCLEIC ACID POLYMERASE HOLOENZYME 2A68 ; 2.50 ; CRYSTAL STRUCTURE OF THE T. THERMOPHILUS RIBONUCLEIC ACID POLYMERASE HOLOENZYME IN COMPLEX WITH ANTIBIOTIC RIFABUTIN 2A69 ; 2.50 ; CRYSTAL STRUCTURE OF THE T. THERMOPHILUS RIBONUCLEIC ACID POLYMERASE HOLOENZYME IN COMPLEX WITH ANTIBIOTIC RIFAPENTIN 2A6H ; 2.40 ; CRYSTAL STRUCTURE OF THE T. THERMOPHILUS RIBONUCLEIC ACID POLYMERASE HOLOENZYME IN COMPLEX WITH ANTIBIOTIC STERPTOLYDIGIN 2BE5 ; 2.40 ; CRYSTAL STRUCTURE OF THE T. THERMOPHILUS RIBONUCLEIC ACID POLYMERASE HOLOENZYME IN COMPLEX WITH INHIBITOR TAGETITOXIN 1PP8 ; 3.05 ; CRYSTAL STRUCTURE OF THE T. VAGINALIS IBP39 INITIATOR BINDING DOMAIN (IBD) BOUND TO THE ALPHA-SCS INR ELEMENT 1PP7 ; 2.45 ; CRYSTAL STRUCTURE OF THE T. VAGINALIS INITIATOR BINDING PROTEIN BOUND TO THE FERREDOXIN INR 1WCE ; 7.00 ; CRYSTAL STRUCTURE OF THE T13 IBDV VIRAL PARTICLE REVEALS A MISSING LINK IN ICOSAHEDRAL VIRUSES EVOLUTION 1OBJ ; 1.90 ; CRYSTAL STRUCTURE OF THE T150A MUTANT OF MALONAMIDASE E2 FROM BRADYRHIZOBIUM JAPONICUM 1V0B ; 2.20 ; CRYSTAL STRUCTURE OF THE T198A MUTANT OF PFPK5 1YKD ; 1.90 ; CRYSTAL STRUCTURE OF THE TANDEM GAF DOMAINS FROM A CYANOBACTERIAL ADENYLYL CYCLASE: NOVEL MODES OF LIGAND- BINDING AND DIMERIZATION 1YGR ; 2.90 ; CRYSTAL STRUCTURE OF THE TANDEM PHOSPHATASE DOMAIN OF RPTP CD45 1YGU ; 2.90 ; CRYSTAL STRUCTURE OF THE TANDEM PHOSPHATASE DOMAINS OF RPTP CD45 WITH A PTYR PEPTIDE 1LAR ; 2.00 ; CRYSTAL STRUCTURE OF THE TANDEM PHOSPHATASE DOMAINS OF RPTP LAR 1A81 ; 3.00 ; CRYSTAL STRUCTURE OF THE TANDEM SH2 DOMAIN OF THE SYK KINASE BOUND TO A DUALLY TYROSINE-PHOSPHORYLATED ITAM 2A90 ; 2.15 ; CRYSTAL STRUCTURE OF THE TANDEM WWE DOMAIN OF DROSOPHILA DELTEX 1U5Q ; 2.10 ; CRYSTAL STRUCTURE OF THE TAO2 KINASE DOMAIN: ACTIVATION AND SPECIFITY OF A STE20P MAP3K 1U5R ; 2.10 ; CRYSTAL STRUCTURE OF THE TAO2 KINASE DOMAIN: ACTIVATION AND SPECIFITY OF A STE20P MAP3K 1YB4 ; 2.40 ; CRYSTAL STRUCTURE OF THE TARTRONIC SEMIALDEHYDE REDUCTASE FROM SALMONELLA TYPHIMURIUM LT2 2ATX ; 2.65 ; CRYSTAL STRUCTURE OF THE TC10 GPPNHP COMPLEX 1WW9 ; 1.95 ; CRYSTAL STRUCTURE OF THE TERMINAL OXYGENASE COMPONENT OF CARBAZOLE 1,9A-DIOXYGENASE, A NON-HEME IRON OXYGENASE SYSTEM CATALYZING THE NOVEL ANGULAR DIOXYGENATION FOR CARBAZOLE AND DIOXIN 1F6F ; 2.30 ; CRYSTAL STRUCTURE OF THE TERNARY COMPLEX BETWEEN OVINE PLACENTAL LACTOGEN AND THE EXTRACELLULAR DOMAIN OF THE RAT PROLACTIN RECEPTOR 1F9Y ; 0.89 ; CRYSTAL STRUCTURE OF THE TERNARY COMPLEX OF E. COLI HPPK WITH MGAMPCPP AND 6-HYDROXYMETHYLPTERIN 1F9H ; 1.50 ; CRYSTAL STRUCTURE OF THE TERNARY COMPLEX OF E. COLI HPPK(R92A) WITH MGAMPCPP AND 6-HYDROXYMETHYL-7,8- DIHYDROPTERIN AT 1.50 ANGSTROM RESOLUTION 1WKW ; 2.10 ; CRYSTAL STRUCTURE OF THE TERNARY COMPLEX OF EIF4E-M7GPPPA- 4EBP1 PEPTIDE 1ZE3 ; 1.84 ; CRYSTAL STRUCTURE OF THE TERNARY COMPLEX OF FIMD (N- TERMINAL DOMAIN) WITH FIMC AND THE PILIN DOMAIN OF FIMH 1Y2X ; 2.36 ; CRYSTAL STRUCTURE OF THE TETRAGONAL FORM OF THE COMMON EDIBLE MUSHROOM (AGARICUS BISPORUS) LECTIN IN COMPLEX WITH T-ANTIGEN AND N-ACETYLGLUCOSAMINE 1Y0R ; 1.75 ; CRYSTAL STRUCTURE OF THE TETRAHEDRAL AMINOPEPTIDASE FROM P. HORIKOSHII 1A68 ; 1.80 ; CRYSTAL STRUCTURE OF THE TETRAMERIZATION DOMAIN OF THE SHAKER POTASSIUM CHANNEL 1T1D ; 1.51 ; CRYSTAL STRUCTURE OF THE TETRAMERIZATION DOMAIN OF THE SHAKER POTASSIUM CHANNEL 1NN7 ; 2.10 ; CRYSTAL STRUCTURE OF THE TETRAMERIZATION DOMAIN OF THE SHAL VOLTAGE-GATED POTASSIUM CHANNEL 1GTG ; 2.30 ; CRYSTAL STRUCTURE OF THE THERMOSTABLE SERINE-CARBOXYL TYPE PROTEINASE, KUMAMOLISIN (KSCP) 1GTJ ; 1.75 ; CRYSTAL STRUCTURE OF THE THERMOSTABLE SERINE-CARBOXYL TYPE PROTEINASE, KUMAMOLISIN (KSCP) - COMPLEX WITH AC-ILE-ALA-PHE-CHO 1MKM ; 2.20 ; CRYSTAL STRUCTURE OF THE THERMOTOGA MARITIMA ICLR 2CWZ ; 1.85 ; CRYSTAL STRUCTURE OF THE THERMUS THERMOPHILUS HYPOTHETICAL PROTEIN TTHA0967, A THIOESTERASE SUPERFAMILY MEMBER 1ZZK ; 0.95 ; CRYSTAL STRUCTURE OF THE THIRD KH DOMAIN OF HNRNP K AT 0.95A RESOLUTION 1PDR ; 2.80 ; CRYSTAL STRUCTURE OF THE THIRD PDZ DOMAIN FROM THE HUMAN HOMOLOG OF DISCS LARGE PROTEIN 1TWX ; 2.40 ; CRYSTAL STRUCTURE OF THE THROMBIN MUTANT D221A/D222K 1Z8I ; 2.00 ; CRYSTAL STRUCTURE OF THE THROMBIN MUTANT G193A BOUND TO PPACK 1Z8J ; 2.00 ; CRYSTAL STRUCTURE OF THE THROMBIN MUTANT G193P BOUND TO PPACK 1DX5 ; 2.30 ; CRYSTAL STRUCTURE OF THE THROMBIN-THROMBOMODULIN COMPLEX 1LSL ; 1.90 ; CRYSTAL STRUCTURE OF THE THROMBOSPONDIN-1 TYPE 1 REPEATS 1FWM ; 2.20 ; CRYSTAL STRUCTURE OF THE THYMIDYLATE SYNTHASE R166Q MUTANT 1R6G ; 3.00 ; CRYSTAL STRUCTURE OF THE THYROID HORMONE RECEPTOR BETA LIGAND BINDING DOMAIN IN COMPLEX WITH A BETA SELECTIVE COMPOUND 1ZLH ; 1.70 ; CRYSTAL STRUCTURE OF THE TICK CARBOXYPEPTIDASE INHIBITOR IN COMPLEX WITH BOVINE CARBOXYPEPTIDASE A 1ZLI ; 2.09 ; CRYSTAL STRUCTURE OF THE TICK CARBOXYPEPTIDASE INHIBITOR IN COMPLEX WITH HUMAN CARBOXYPEPTIDASE B 1FYV ; 2.90 ; CRYSTAL STRUCTURE OF THE TIR DOMAIN OF HUMAN TLR1 1FYW ; 3.00 ; CRYSTAL STRUCTURE OF THE TIR DOMAIN OF HUMAN TLR2 1YA5 ; 2.44 ; CRYSTAL STRUCTURE OF THE TITIN DOMAINS Z1Z2 IN COMPLEX WITH TELETHONIN 1VC1 ; 2.00 ; CRYSTAL STRUCTURE OF THE TM1442 PROTEIN FROM THERMOTOGA MARITIMA, A HOMOLOG OF THE BACILLUS SUBTILIS GENERAL STRESS RESPONSE ANTI-ANTI-SIGMA FACTOR RSBV 1T0F ; 1.85 ; CRYSTAL STRUCTURE OF THE TNSA/TNSC(504-555) COMPLEX 1Q31 ; 2.70 ; CRYSTAL STRUCTURE OF THE TOBACCO ETCH VIRUS PROTEASE C151A MUTANT 1T3G ; 2.30 ; CRYSTAL STRUCTURE OF THE TOLL/INTERLEUKIN-1 RECEPTOR (TIR) DOMAIN OF HUMAN IL-1RAPL 1T0R ; 2.30 ; CRYSTAL STRUCTURE OF THE TOLUENE/O-XYLENE MONOOXYGENASE HYDROXUYLASE FROM PSEUDOMONAS STUTZERI-AZIDE BOUND 1AHS ; 2.30 ; CRYSTAL STRUCTURE OF THE TOP DOMAIN OF AFRICAN HORSE SICKNESS VIRUS VP7 1ELW ; 1.60 ; CRYSTAL STRUCTURE OF THE TPR1 DOMAIN OF HOP IN COMPLEX WITH A HSC70 PEPTIDE 1ELR ; 1.90 ; CRYSTAL STRUCTURE OF THE TPR2A DOMAIN OF HOP IN COMPLEX WITH THE HSP90 PEPTIDE MEEVD 1QSC ; 2.40 ; CRYSTAL STRUCTURE OF THE TRAF DOMAIN OF TRAF2 IN A COMPLEX WITH A PEPTIDE FROM THE CD40 RECEPTOR 1OPX ; 2.80 ; CRYSTAL STRUCTURE OF THE TRAFFIC ATPASE (HP0525) OF THE HELICOBACTER PYLORI TYPE IV SECRETION SYSTEM BOUND BY SULFATE 1NLY ; 2.80 ; CRYSTAL STRUCTURE OF THE TRAFFIC ATPASE OF THE HELICOBACTER PYLORI TYPE IV SECRETION SYSTEM IN COMPLEX WITH ATPGAMMAS 1U9O ; 3.30 ; CRYSTAL STRUCTURE OF THE TRANSCRIPTIONAL REGULATOR ETHR IN A LIGAND BOUND CONFORMATION 1U9N ; 2.30 ; CRYSTAL STRUCTURE OF THE TRANSCRIPTIONAL REGULATOR ETHR IN A LIGAND BOUND CONFORMATION OPENS THERAPEUTIC PERSPECTIVES AGAINST TUBERCULOSIS AND LEPROSY 1T5O ; 1.90 ; CRYSTAL STRUCTURE OF THE TRANSLATION INITIATION FACTOR EIF- 2B, SUBUNIT DELTA, FROM A. FULGIDUS 1SOQ ; 2.10 ; CRYSTAL STRUCTURE OF THE TRANSTHYRETIN MUTANT A108Y/L110E SOLVED IN SPACE GROUP C2 1SOK ; 1.60 ; CRYSTAL STRUCTURE OF THE TRANSTHYRETIN MUTANT A108Y/L110E SOLVED IN SPACE GROUP P21212 1IJN ; 1.70 ; CRYSTAL STRUCTURE OF THE TRANSTHYRETIN MUTANT TTR C10A/Y114C 1IIK ; 2.00 ; CRYSTAL STRUCTURE OF THE TRANSTHYRETIN MUTANT TTR Y114C- DATA COLLECTED AT CRYO TEMPERATURE 1III ; 2.00 ; CRYSTAL STRUCTURE OF THE TRANSTHYRETIN MUTANT TTR Y114C- DATA COLLECTED AT ROOM TEMPERATURE 1MTZ ; 1.80 ; CRYSTAL STRUCTURE OF THE TRICORN INTERACTING FACTOR F1 1MU0 ; 2.40 ; CRYSTAL STRUCTURE OF THE TRICORN INTERACTING FACTOR F1 COMPLEX WITH PCK 1MT3 ; 2.00 ; CRYSTAL STRUCTURE OF THE TRICORN INTERACTING FACTOR SELENOMETHIONINE-F1 1K32 ; 2.00 ; CRYSTAL STRUCTURE OF THE TRICORN PROTEASE 1SLQ ; 3.20 ; CRYSTAL STRUCTURE OF THE TRIMERIC STATE OF THE RHESUS ROTAVIRUS VP4 MEMBRANE INTERACTION DOMAIN, VP5CT 1QSU ; 1.75 ; CRYSTAL STRUCTURE OF THE TRIPLE-HELICAL COLLAGEN-LIKE PEPTIDE, (PRO-HYP-GLY)4-GLU-LYS-GLY(PRO-HYP-GLY)5 1T6E ; 1.70 ; CRYSTAL STRUCTURE OF THE TRITICUM AESTIVUM XYLANASE INHIBITOR I 1T6G ; 1.80 ; CRYSTAL STRUCTURE OF THE TRITICUM AESTIVUM XYLANASE INHIBITOR-I IN COMPLEX WITH ASPERGILLUS NIGER XYLANASE-I 1P6V ; 3.20 ; CRYSTAL STRUCTURE OF THE TRNA DOMAIN OF TRANSFER-MESSENGER RIBONUCLEIC ACID IN COMPLEX WITH SMPB 1UDN ; 2.30 ; CRYSTAL STRUCTURE OF THE TRNA PROCESSING ENZYME RNASE PH FROM AQUIFEX AEOLICUS 1R6L ; 1.90 ; CRYSTAL STRUCTURE OF THE TRNA PROCESSING ENZYME RNASE PH FROM PSEUDOMONAS AERUGINOSA 1R6M ; 2.00 ; CRYSTAL STRUCTURE OF THE TRNA PROCESSING ENZYME RNASE PH FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH PHOSPHATE 1UDS ; 2.30 ; CRYSTAL STRUCTURE OF THE TRNA PROCESSING ENZYME RNASE PH R126A MUTANT FROM AQUIFEX AEOLICUS 1UDO ; 2.30 ; CRYSTAL STRUCTURE OF THE TRNA PROCESSING ENZYME RNASE PH R86A MUTANT FROM AQUIFEX AEOLICUS 1UDQ ; 2.30 ; CRYSTAL STRUCTURE OF THE TRNA PROCESSING ENZYME RNASE PH T125A MUTANT FROM AQUIFEX AEOLICUS 1A79 ; 2.28 ; CRYSTAL STRUCTURE OF THE TRNA SPLICING ENDONUCLEASE FROM METHANOCOCCUS JANNASCHII 1QVE ; 1.54 ; CRYSTAL STRUCTURE OF THE TRUNCATED K122-4 PILIN FROM PSEUDOMONAS AERUGINOSA 1IDR ; 1.90 ; CRYSTAL STRUCTURE OF THE TRUNCATED-HEMOGLOBIN-N FROM MYCOBACTERIUM TUBERCULOSIS 1YW0 ; 2.70 ; CRYSTAL STRUCTURE OF THE TRYPTOPHAN 2,3-DIOXYGENASE FROM XANTHOMONAS CAMPESTRIS. NORTHEAST STRUCTURAL GENOMICS TARGET XCR13. 1K8Y ; 1.50 ; CRYSTAL STRUCTURE OF THE TRYPTOPHAN SYNTHASE BETA-SER178PRO MUTANT COMPLEXED WITH D,L-ALPHA-GLYCEROL-3-PHOSPHATE 1K8Z ; 1.70 ; CRYSTAL STRUCTURE OF THE TRYPTOPHAN SYNTHASE BETA-SER178PRO MUTANT COMPLEXED WITH N-[1H-INDOL-3-YL-ACETYL]GLYCINE ACID 1SM3 ; 1.95 ; CRYSTAL STRUCTURE OF THE TUMOR SPECIFIC ANTIBODY SM3 COMPLEX WITH ITS PEPTIDE EPITOPE 1JK7 ; 1.90 ; CRYSTAL STRUCTURE OF THE TUMOR-PROMOTER OKADAIC ACID BOUND TO PROTEIN PHOSPHATASE-1 1EPF ; 1.85 ; CRYSTAL STRUCTURE OF THE TWO N-TERMINAL IMMUNOGLOBULIN DOMAINS OF THE NEURAL CELL ADHESION MOLECULE (NCAM) 1WUC ; 1.80 ; CRYSTAL STRUCTURE OF THE TYPE 1 RIP BOUGANIN 1J2Y ; 2.60 ; CRYSTAL STRUCTURE OF THE TYPE II 3-DEHYDROQUINASE 1NH1 ; 2.20 ; CRYSTAL STRUCTURE OF THE TYPE III EFFECTOR AVRB FROM PSEUDOMONAS SYRINGAE. 2BSI ; 2.01 ; CRYSTAL STRUCTURE OF THE TYPE III SECRETION CHAPERONE SYCT FROM YERSINIA ENTEROCOLITICA (CRYSTAL FORM 1) 2BSH ; 1.90 ; CRYSTAL STRUCTURE OF THE TYPE III SECRETION CHAPERONE SYCT FROM YERSINIA ENTEROCOLITICA (CRYSTAL FORM 2) 1K46 ; 2.20 ; CRYSTAL STRUCTURE OF THE TYPE III SECRETORY DOMAIN OF YERSINIA YOPH REVEALS A DOMAIN-SWAPPED DIMER 2AC2 ; 2.50 ; CRYSTAL STRUCTURE OF THE TYR13PHE MUTANT VARIANT OF BACILLUS SUBTILIS FERROCHELATASE WITH ZN(2+) BOUND AT THE ACTIVE SITE 2FGI ; 2.50 ; CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FGF RECEPTOR 1 IN COMPLEX WITH INHIBITOR PD173074 1FGK ; 2.00 ; CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 1AGW ; 2.40 ; CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 IN COMPLEX WITH SU4984 INHIBITOR 1FGI ; 2.50 ; CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 IN COMPLEX WITH SU5402 INHIBITOR 1R1W ; 1.80 ; CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET 1R0P ; 1.80 ; CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET IN COMPLEX WITH THE MICROBIAL ALKALOID K-252A 1OFO ; 1.85 ; CRYSTAL STRUCTURE OF THE TYROSINE REGULATED 3-DEOXY-D-ARABINO-HEPTULOSONATE-7-PHOSPHATE SYNTHASE FROM SACCHAROMYCES CEREVISIAE IN COMPLEX WITH 2-PHOSPHOGLYCOLATE 1OAB ; 1.90 ; CRYSTAL STRUCTURE OF THE TYROSINE REGULATED 3-DEOXY-D-ARABINO-HEPTULOSONATE-7-PHOSPHATE SYNTHASE FROM SACCHAROMYCES CEREVISIAE IN COMPLEX WITH PHOSPHOENOLPYRUVATE AND MANGANESE(II) 1OFP ; 2.10 ; CRYSTAL STRUCTURE OF THE TYROSINE-REGULATED 3-DEOXY-D-ARABINO-HEPTULOSONATE-7-PHOSPHATE SYNTHASE FROM SACCHAROMYCES CEREVISIAE 1OFR ; 2.70 ; CRYSTAL STRUCTURE OF THE TYROSINE-REGULATED 3-DEOXY-D-ARABINO-HEPTULOSONATE-7-PHOSPHATE SYNTHASE FROM SACCHAROMYCES CEREVISIAE COMPLEXED WITH PHENYLALANINE AND MANGANESE 1HFB ; 1.90 ; CRYSTAL STRUCTURE OF THE TYROSINE-REGULATED 3-DEOXY-D-ARABINO-HEPTULOSONATE-7-PHOSPHATE SYNTHASE FROM SACCHAROMYCES CEREVISIAE COMPLEXED WITH PHOSPHOENOLPYRUVATE 1OF6 ; 2.10 ; CRYSTAL STRUCTURE OF THE TYROSINE-REGULATED 3-DEOXY-D-ARABINO-HEPTULOSONATE-7-PHOSPHATE SYNTHASE FROM SACCHAROMYCES CEREVISIAE COMPLEXED WITH TYROSINE AND MANGANESE 1OFB ; 2.00 ; CRYSTAL STRUCTURE OF THE TYROSINE-REGULATED 3-DEOXY-D-ARABINO-HEPTULOSONATE-7-PHOSPHATE SYNTHASE FROM SACCHAROMYCES CEREVISIAE IN COMPLEX WITH MANGANESE(II) 1OFQ ; 2.70 ; CRYSTAL STRUCTURE OF THE TYROSINE-REGULATED 3-DEOXY-D-ARABINO-HEPTULOSONATE-7-PHOSPHATE SYNTHASE FROM SACCHAROMYCES CEREVISIAE IN COMPLEX WITH MANGANESE(II) 1OFA ; 2.01 ; CRYSTAL STRUCTURE OF THE TYROSINE-REGULATED 3-DEOXY-D-ARABINO-HEPTULOSONATE-7-PHOSPHATE SYNTHASE FROM SACCHAROMYCES CEREVISIAE IN COMPLEX WITH PHOSPHOENOLPYRUVATE AND COBALT(II) 1M08 ; 2.10 ; CRYSTAL STRUCTURE OF THE UNBOUND NUCLEASE DOMAIN OF COLE7 1WMG ; 2.10 ; CRYSTAL STRUCTURE OF THE UNC5H2 DEATH DOMAIN 1D4C ; 2.90 ; CRYSTAL STRUCTURE OF THE UNCOMPLEXED FORM OF THE FLAVOCYTOCHROME C FUMARATE REDUCTASE OF SHEWANELLA PUTREFACIENS STRAIN MR-1 1IK7 ; 2.30 ; CRYSTAL STRUCTURE OF THE UNCOMPLEXED PELLE DEATH DOMAIN 1ABQ ; 2.80 ; CRYSTAL STRUCTURE OF THE UNLIGANDED ABL TYROSINE KINASE SH3 DOMAIN 1YT2 ; 3.25 ; CRYSTAL STRUCTURE OF THE UNLIGANDED FORM OF GRP94, THE ER HSP90: BASIS FOR NUCLEOTIDE-INDUCED CONFORMATIONAL CHANGE, GRP94N APO CRYSTAL 1YT1 ; 2.20 ; CRYSTAL STRUCTURE OF THE UNLIGANDED FORM OF GRP94, THE ER HSP90: BASIS FOR NUCLEOTIDE-INDUCED CONFORMATIONAL CHANGE, GRP94N(DELTA)41 APO CRYSTAL 1YT0 ; 2.40 ; CRYSTAL STRUCTURE OF THE UNLIGANDED FORM OF GRP94, THE ER HSP90: BASIS FOR NUCLEOTIDE-INDUCED CONFORMATIONAL CHANGE, GRP94N(DELTA)41 APO CRYSTAL SOAKED WITH ADP 1YSZ ; 2.65 ; CRYSTAL STRUCTURE OF THE UNLIGANDED FORM OF GRP94, THE ER HSP90: BASIS FOR NUCLEOTIDE-INDUCED CONFORMATIONAL CHANGE, GRP94N(DELTA)41 APO CRYSTAL SOAKED WITH NECA 1MQK ; 1.28 ; CRYSTAL STRUCTURE OF THE UNLIGANDED FV-FRAGMENT OF THE ANTI- CYTOCHROME C OXIDASE ANTIBODY 7E2 1PG5 ; 2.60 ; CRYSTAL STRUCTURE OF THE UNLIGATED (T-STATE) ASPARTATE TRANSCARBAMOYLASE FROM THE EXTREMELY THERMOPHILIC ARCHAEON SULFOLOBUS ACIDOCALDARIUS 1SNU ; 2.50 ; CRYSTAL STRUCTURE OF THE UNPHOSPHORYLATED INTERLEUKIN-2 TYROSINE KINASE CATALYTIC DOMAIN 1U46 ; 2.00 ; CRYSTAL STRUCTURE OF THE UNPHOSPHORYLATED KINASE DOMAIN OF THE TYROSINE KINASE ACK1 1Y1T ; 1.77 ; CRYSTAL STRUCTURE OF THE URIDINE PHOSPHORYLASE FROM SALMONELLA TYPHIMURIUM AT 1.77A RESOLUTION 1SJ9 ; 2.50 ; CRYSTAL STRUCTURE OF THE URIDINE PHOSPHORYLASE FROM SALMONELLA TYPHIMURIUM AT 2.5A RESOLUTION 1Y1R ; 2.11 ; CRYSTAL STRUCTURE OF THE URIDINE PHOSPHORYLASE FROM SALMONELLA TYPHIMURIUM IN COMPLEX WITH INHIBITOR AND PHOSPHATE ION AT 2.11A RESOLUTION 1Y1S ; 2.55 ; CRYSTAL STRUCTURE OF THE URIDINE PHOSPHORYLASE FROM SALMONELLA TYPHIMURIUM IN COMPLEX WITH URACIL AND SULFATE ION AT 2.55A RESOLUTION 1Y1Q ; 2.35 ; CRYSTAL STRUCTURE OF THE URIDINE PHOSPHORYLASE FROM SALMONELLA TYPHIMURIUM IN COMPLEX WITH URIDINE-5P- MONOPHOSPHATE AND SULFATE ION AT 2.35A RESOLUTION 1RIF ; 2.00 ; CRYSTAL STRUCTURE OF THE UVSW HELICASE FROM BACTERIOPHAGE T4 1JMM ; 2.40 ; CRYSTAL STRUCTURE OF THE V-REGION OF STREPTOCOCCUS MUTANS ANTIGEN I/II 1EOE ; 1.70 ; CRYSTAL STRUCTURE OF THE V135R MUTANT OF A SHAKER T1 DOMAIN 1AXG ; 2.50 ; CRYSTAL STRUCTURE OF THE VAL203->ALA MUTANT OF LIVER ALCOHOL DEHYDROGENASE COMPLEXED WITH COFACTOR NAD AND INHIBITOR TRIFLUOROETHANOL SOLVED TO 2.5 ANGSTROM RESOLUTION 1S0Z ; 2.50 ; CRYSTAL STRUCTURE OF THE VDR LBD COMPLEXED TO SEOCALCITOL. 1TXI ; 1.90 ; CRYSTAL STRUCTURE OF THE VDR LIGAND BINDING DOMAIN COMPLEXED TO TX522 1QQE ; 2.90 ; CRYSTAL STRUCTURE OF THE VESICULAR TRANSPORT PROTEIN SEC17 1DVP ; 2.00 ; CRYSTAL STRUCTURE OF THE VHS AND FYVE TANDEM DOMAINS OF HRS, A PROTEIN INVOLVED IN MEMBRANE TRAFFICKING AND SIGNAL TRANSDUCTION 1XEZ ; 2.30 ; CRYSTAL STRUCTURE OF THE VIBRIO CHOLERAE CYTOLYSIN (HLYA) PRO-TOXIN WITH OCTYLGLUCOSIDE BOUND 1QKR ; 1.80 ; CRYSTAL STRUCTURE OF THE VINCULIN TAIL AND A PATHWAY FOR ACTIVATION 1SFU ; 2.00 ; CRYSTAL STRUCTURE OF THE VIRAL ZALPHA DOMAIN BOUND TO LEFT- HANDED Z-DEOXYRIBONUCLEIC ACID 1XKP ; 1.70 ; CRYSTAL STRUCTURE OF THE VIRULENCE FACTOR YOPN IN COMPLEX WITH ITS HETERODIMERIC CHAPERONE SYCN-YSCB 1JVA ; 2.10 ; CRYSTAL STRUCTURE OF THE VMA1-DERIVED ENDONUCLEASE BEARING THE N AND C EXTEIN PROPEPTIDES 1UM2 ; 2.90 ; CRYSTAL STRUCTURE OF THE VMA1-DERIVED ENDONUCLEASE WITH THE LIGATED EXTEIN SEGMENT 1FNS ; 2.00 ; CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR (VWF) A1 DOMAIN I546V MUTANT IN COMPLEX WITH THE FUNCTION BLOCKING FAB NMC4 1OAK ; 2.20 ; CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR (VWF) A1 DOMAIN IN COMPLEX WITH THE FUNCTION BLOCKING NMC-4 FAB 1SHT ; 1.81 ; CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A DOMAIN OF HUMAN CAPILLARY MORPHOGENESIS PROTEIN 2: AN ANTHRAX TOXIN RECEPTOR 1SHU ; 1.50 ; CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A DOMAIN OF HUMAN CAPILLARY MORPHOGENESIS PROTEIN 2: AN ANTHRAX TOXIN RECEPTOR 1FE8 ; 2.03 ; CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A FAB FRAGMENT OF IGG RU5 THAT INHIBITS COLLAGEN BINDING 1M0Z ; 1.85 ; CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR BINDING DOMAIN OF GLYCOPROTEIN IB ALPHA 1O06 ; 1.45 ; CRYSTAL STRUCTURE OF THE VPS27P UBIQUITIN INTERACTING MOTIF (UIM) 1TXU ; 2.35 ; CRYSTAL STRUCTURE OF THE VPS9 DOMAIN OF RABEX-5 1YU7 ; 1.50 ; CRYSTAL STRUCTURE OF THE W64Y MUTANT OF VILLIN HEADPIECE 1GWY ; 1.71 ; CRYSTAL STRUCTURE OF THE WATER-SOLUBLE STATE OF THE PORE-FORMING CYTOLYSIN STICHOLYSIN II 1O71 ; 2.26 ; CRYSTAL STRUCTURE OF THE WATER-SOLUBLE STATE OF THE PORE-FORMING CYTOLYSIN STICHOLYSIN II COMPLEXED WITH GLYCEROL 1O72 ; 2.41 ; CRYSTAL STRUCTURE OF THE WATER-SOLUBLE STATE OF THE PORE-FORMING CYTOLYSIN STICHOLYSIN II COMPLEXED WITH PHOSPHORYLCHOLINE 1D3A ; 2.94 ; CRYSTAL STRUCTURE OF THE WILD TYPE HALOPHILIC MALATE DEHYDROGENASE IN THE APO FORM 1VC5 ; 3.40 ; CRYSTAL STRUCTURE OF THE WILD TYPE HEPATITIS DELTA VIRUS GEMONIC RIBOZYME PRECURSOR, IN EDTA SOLUTION 1PNX ; 9.50 ; CRYSTAL STRUCTURE OF THE WILD TYPE RIBOSOME FROM E. COLI, 30S SUBUNIT OF 70S RIBOSOME. THIS FILE, 1PNX, CONTAINS ONLY MOLECULES OF THE 30S RIBOSOMAL SUBUNIT. THE 50S SUBUNIT IS IN THE PDB FILE 1PNY. 1PNY ; 9.50 ; CRYSTAL STRUCTURE OF THE WILD TYPE RIBOSOME FROM E. COLI, 50S SUBUNIT OF 70S RIBOSOME. THIS FILE, 1PNY, CONTAINS ONLY MOLECULES OF THE 50S RIBOSOMAL SUBUNIT. THE 30S SUBUNIT IS IN THE PDB FILE 1PNX. 2BIV ; 1.70 ; CRYSTAL STRUCTURE OF THE WILD-TYPE MBT DOMAINS OF HUMAN SCML2 1TJ6 ; 1.65 ; CRYSTAL STRUCTURE OF THE XENOPUS TROPICALIS SPRED1 EVH-1 DOMAIN 1I4O ; 2.40 ; CRYSTAL STRUCTURE OF THE XIAP/CASPASE-7 COMPLEX 1D1Z ; 1.40 ; CRYSTAL STRUCTURE OF THE XLP PROTEIN SAP 1D4T ; 1.10 ; CRYSTAL STRUCTURE OF THE XLP PROTEIN SAP IN COMPLEX WITH A SLAM PEPTIDE 1D4W ; 1.80 ; CRYSTAL STRUCTURE OF THE XLP PROTEIN SAP IN COMPLEX WITH SLAM PHOSPHOPEPTIDE 1G3J ; 2.10 ; CRYSTAL STRUCTURE OF THE XTCF3-CBD/BETA-CATENIN ARMADILLO REPEAT COMPLEX 1FHD ; 1.90 ; CRYSTAL STRUCTURE OF THE XYLANASE CEX WITH XYLOBIOSE- DERIVED IMIDAZOLE INHIBITOR 1FH7 ; 1.82 ; CRYSTAL STRUCTURE OF THE XYLANASE CEX WITH XYLOBIOSE- DERIVED INHIBITOR DEOXYNOJIRIMYCIN 1J01 ; 2.00 ; CRYSTAL STRUCTURE OF THE XYLANASE CEX WITH XYLOBIOSE- DERIVED INHIBITOR ISOFAGOMINE LACTAM 1FH8 ; 1.95 ; CRYSTAL STRUCTURE OF THE XYLANASE CEX WITH XYLOBIOSE- DERIVED ISOFAGOMINE INHIBITOR 1FH9 ; 1.72 ; CRYSTAL STRUCTURE OF THE XYLANASE CEX WITH XYLOBIOSE- DERIVED LACTAM OXIME INHIBITOR 1YFD ; 1.90 ; CRYSTAL STRUCTURE OF THE Y122H MUTANT OF RIBONUCLEOTIDE REDUCTASE R2 PROTEIN FROM E. COLI 2AG9 ; 2.20 ; CRYSTAL STRUCTURE OF THE Y137S MUTANT OF GM2-ACTIVATOR PROTEIN 1S09 ; 1.83 ; CRYSTAL STRUCTURE OF THE Y144F MUTANT OF 7,8- DIAMINOPELARGONIC ACID SYNTHASE 1S0A ; 1.71 ; CRYSTAL STRUCTURE OF THE Y17F MUTANT OF 7,8- DIAMINOPELARGONIC ACID SYNTHASE 1O9I ; 1.33 ; CRYSTAL STRUCTURE OF THE Y42F MUTANT OF MANGANESE CATALASE FROM LACTOBACILLUS PLANTARUM AT 1.33A RESOLUTION 1AQE ; 2.20 ; CRYSTAL STRUCTURE OF THE Y73E MUTANT OF CYTOCHROME C OF CLASS III (AMBLER) 26 KD 1JD2 ; 3.00 ; CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON-COVALENT PROTEASOME INHIBITOR 1G6I ; 1.59 ; CRYSTAL STRUCTURE OF THE YEAST ALPHA-1,2-MANNOSIDASE WITH BOUND 1-DEOXYMANNOJIRIMYCIN AT 1.59 A RESOLUTION 1F60 ; 1.67 ; CRYSTAL STRUCTURE OF THE YEAST ELONGATION FACTOR COMPLEX EEF1A:EEF1BA 1KCF ; 2.30 ; CRYSTAL STRUCTURE OF THE YEAST MITOCHONDRIAL HOLLIDAY JUNCTION RESOLVASE, YDC2 1ID3 ; 3.10 ; CRYSTAL STRUCTURE OF THE YEAST NUCLEOSOME CORE PARTICLE REVEALS FUNDAMENTAL DIFFERENCES IN INTER-NUCLEOSOME INTERACTIONS 1QSP ; 2.70 ; CRYSTAL STRUCTURE OF THE YEAST PHOSPHORELAY PROTEIN YPD1 1OCS ; 2.03 ; CRYSTAL STRUCTURE OF THE YEAST PX-DOAMIN PROTEIN GRD19P (SORTING NEXIN3) COMPLEXED TO PHOSPHATIDYLINOSYTOL-3-PHOSPHATE. 1OCU ; 2.30 ; CRYSTAL STRUCTURE OF THE YEAST PX-DOMAIN PROTEIN GRD19P (SORTING NEXIN 3) COMPLEXED TO PHOSPHATIDYLINOSYTOL-3-PHOSPAHTE. 1M2V ; 2.75 ; CRYSTAL STRUCTURE OF THE YEAST SEC23/24 HETERODIMER 1N5B ; 2.00 ; CRYSTAL STRUCTURE OF THE YERSINIA ENTEROCOLITICA MOLECULAR CHAPERONE SYCE 2BHO ; 2.61 ; CRYSTAL STRUCTURE OF THE YERSINIA ENTEROCOLITICA TYPE III SECRETION CHAPERONE SYCT 1QZ0 ; 1.50 ; CRYSTAL STRUCTURE OF THE YERSINIA PESTIS PHOSPHATASE YOPH IN COMPLEX WITH A PHOSPHOTYROSYL MIMETIC-CONTAINING HEXAPEPTIDE 1TTW ; 2.38 ; CRYSTAL STRUCTURE OF THE YERSINIA PESTIS TYPE III SECRETION CHAPERONE SYCH IN COMPLEX WITH A STABLE FRAGMENT OF YSCM2 1K6Z ; 2.00 ; CRYSTAL STRUCTURE OF THE YERSINIA SECRETION CHAPERONE SYCE 1ZW0 ; 1.80 ; CRYSTAL STRUCTURE OF THE YERSINIA TYPE III SECRETION PROTEIN YSCE 1L2W ; 2.00 ; CRYSTAL STRUCTURE OF THE YERSINIA VIRULENCE EFFECTOR YOPE CHAPERONE-BINDING DOMAIN IN COMPLEX WITH ITS SECRETION CHAPERONE, SYCE 1PT8 ; 2.20 ; CRYSTAL STRUCTURE OF THE YFDW GENE PRODUCT OF E. COLI, IN COMPLEX WITH OXALATE AND ACETYL-COA 1XE7 ; 1.75 ; CRYSTAL STRUCTURE OF THE YML079W PROTEIN FROM SACCHAROMYCES CEREVISIAE REVEALS A NEW SEQUENCE FAMILY OF THE JELLY ROLL FOLD 1XE8 ; 2.80 ; CRYSTAL STRUCTURE OF THE YML079W PROTEIN FROM SACCHAROMYCES CEREVISIAE REVEALS A NEW SEQUENCE FAMILY OF THE JELLY ROLL FOLD. 1FKM ; 1.90 ; CRYSTAL STRUCTURE OF THE YPT/RAB-GAP DOMAIN OF GYP1P 1QBJ ; 2.10 ; CRYSTAL STRUCTURE OF THE ZALPHA Z-DEOXYRIBONUCLEIC ACID COMPLEX 1U59 ; 2.30 ; CRYSTAL STRUCTURE OF THE ZAP-70 KINASE DOMAIN IN COMPLEX WITH STAUROSPORINE 1V08 ; 1.90 ; CRYSTAL STRUCTURE OF THE ZEA MAZE BETA-GLUCOSIDASE-1 IN COMPLEX WITH GLUCO-TETRAZOLE 1X8I ; 1.90 ; CRYSTAL STRUCTURE OF THE ZINC CARBAPENEMASE CPHA IN COMPLEX WITH THE ANTIBIOTIC BIAPENEM 1PZW ; 2.00 ; CRYSTAL STRUCTURE OF THE ZINC FINGER ASSOCIATED DOMAIN OF THE DROSOPHILA TRANSCRIPTION FACTOR GRAUZONE 1C7K ; 1.00 ; CRYSTAL STRUCTURE OF THE ZINC PROTEASE 1SDX ; 2.06 ; CRYSTAL STRUCTURE OF THE ZINC SATURATED C-TERMINAL HALF OF BOVINE LACTOFERRIN AT 2.0 A RESOLUTION REVEALS TWO ADDITIONAL ZINC BINDING SITES 1Q0A ; 2.00 ; CRYSTAL STRUCTURE OF THE ZN(II) FORM OF E. COLI ZNTR, A ZINC-SENSING TRANSCRIPTIONAL REGULATOR (SPACE GROUP C222) 1Q09 ; 2.50 ; CRYSTAL STRUCTURE OF THE ZN(II) FORM OF E. COLI ZNTR, A ZINC-SENSING TRANSCRIPTIONAL REGULATOR (SPACE GROUP I4122) 1Q08 ; 1.90 ; CRYSTAL STRUCTURE OF THE ZN(II) FORM OF E. COLI ZNTR, A ZINC-SENSING TRANSCRIPTIONAL REGULATOR, AT 1.9 A RESOLUTION (SPACE GROUP P212121) 1FA5 ; 1.80 ; CRYSTAL STRUCTURE OF THE ZN(II)-BOUND GLYOXALASE I OF ESCHERICHIA COLI 1ZJK ; 2.18 ; CRYSTAL STRUCTURE OF THE ZYMOGEN CATALYTIC REGION OF HUMAN MASP-2 1DKI ; 1.60 ; CRYSTAL STRUCTURE OF THE ZYMOGEN FORM OF STREPTOCOCCAL PYROGENIC EXOTOXIN B ACTIVE SITE (C47S) MUTANT 1SIZ ; 2.25 ; CRYSTAL STRUCTURE OF THE [FE3S4]-FERREDOXIN FROM THE HYPERTHERMOPHILIC ARCHAEON PYROCOCCUS FURIOSUS 1N3Z ; 1.65 ; CRYSTAL STRUCTURE OF THE [S-CARBOXYAMIDOMETHYL-CYS31, S- CARBOXYAMIDOMETHYL-CYS32] MONOMERIC DERIVATIVE OF THE BOVINE SEMINAL RIBONUCLEASE IN THE LIGANDED STATE 1YE8 ; 1.40 ; CRYSTAL STRUCTURE OF THEP1 FROM THE HYPERTHERMOPHILE AQUIFEX AEOLICUS 1JF5 ; 3.20 ; CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA- AMYLASE 2 MUTANT F286A 1VFK ; 2.90 ; CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA- AMYLASE 2/ACARBOSE COMPLEX 1VFM ; 2.90 ; CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA- AMYLASE 2/ALPHA-CYCLODEXTRIN COMPLEX 1VFO ; 2.81 ; CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA- AMYLASE 2/BETA-CYCLODEXTRIN COMPLEX 1VB9 ; 2.20 ; CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA- AMYLASE II (TVA II) COMPLEXED WITH TRANSGLYCOSYLATED PRODUCT 1JF6 ; 3.20 ; CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA- AMYLASE MUTANT F286Y 1VFU ; 3.10 ; CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 AMYLASE 2/GAMMA-CYCLODEXTRIN COMPLEX 1K1Y ; 2.40 ; CRYSTAL STRUCTURE OF THERMOCOCCUS LITORALIS 4-ALPHA- GLUCANOTRANSFERASE COMPLEXED WITH ACARBOSE 1J3P ; 2.02 ; CRYSTAL STRUCTURE OF THERMOCOCCUS LITORALIS PHOSPHOGLUCOSE ISOMERASE 1J3R ; 2.18 ; CRYSTAL STRUCTURE OF THERMOCOCCUS LITORALIS PHOSPHOGRUCOSE ISOMERASE COMPLEXED WITH GLUCONATE-6-PHOSPHATE 1J3Q ; 1.85 ; CRYSTAL STRUCTURE OF THERMOCOCCUS LITORALIS PHOSPHOGRUCOSE ISOMERASE SOAKED WITH FESO4 1UE8 ; 3.00 ; CRYSTAL STRUCTURE OF THERMOPHILIC CYTOCHROME P450 FROM SULFOLOBUS TOKODAII 1L6R ; 1.40 ; CRYSTAL STRUCTURE OF THERMOPLASMA ACIDOPHILUM 0175 (APC0014) 1KYT ; 1.70 ; CRYSTAL STRUCTURE OF THERMOPLASMA ACIDOPHILUM 0175 (APC014) 1NE2 ; 1.75 ; CRYSTAL STRUCTURE OF THERMOPLASMA ACIDOPHILUM 1320 (APC5513) 1NP2 ; 2.40 ; CRYSTAL STRUCTURE OF THERMOSTABLE BETA-GLYCOSIDASE FROM THERMOPHILIC EUBACTERIUM THERMUS NONPROTEOLYTICUS HG102 1NC7 ; 1.55 ; CRYSTAL STRUCTURE OF THERMOTOGA MARITIMA 1070 1HL8 ; 2.40 ; CRYSTAL STRUCTURE OF THERMOTOGA MARITIMA ALPHA-FUCOSIDASE 1HL9 ; 2.25 ; CRYSTAL STRUCTURE OF THERMOTOGA MARITIMA ALPHA-FUCOSIDASE IN COMPLEX WITH A MECHANISM BASED INHIBITOR 1ODU ; 2.80 ; CRYSTAL STRUCTURE OF THERMOTOGA MARITIMA ALPHA-FUCOSIDASE IN COMPLEX WITH FUCOSE 1DD5 ; 2.55 ; CRYSTAL STRUCTURE OF THERMOTOGA MARITIMA RIBOSOME RECYCLING FACTOR, RRF 1TLU ; 1.55 ; CRYSTAL STRUCTURE OF THERMOTOGA MARITIMA S- ADENOSYLMETHIONINE DECARBOXYLASE 1KU7 ; 2.40 ; CRYSTAL STRUCTURE OF THERMUS AQUATICS RIBONUCLEIC ACID POLYMERASE SIGMAA SUBUNIT REGION 4 BOUND TO-35 ELEMENT DEOXYRIBONUCLEIC ACID 1HQM ; 3.30 ; CRYSTAL STRUCTURE OF THERMUS AQUATICUS CORE RIBONUCLEIC ACID POLYMERASE- INCLUDES COMPLETE STRUCTURE WITH SIDE-CHAINS -FURTHER REFINED FROM ORIGINAL DEPOSITION-CONTAINS ADDITIONAL SEQUENCE INFORMATION 1KU2 ; 2.90 ; CRYSTAL STRUCTURE OF THERMUS AQUATICUS RIBONUCLEIC ACID POLYMERASE SIGMA SUBUNIT FRAGMENT CONTAINING REGIONS 1.2 TO 3.1 1KU3 ; 1.80 ; CRYSTAL STRUCTURE OF THERMUS AQUATICUS RIBONUCLEIC ACID POLYMERASE SIGMA SUBUNIT FRAGMENT, REGION 4 1KWG ; 1.60 ; CRYSTAL STRUCTURE OF THERMUS THERMOPHILUS A4 BETA- GALACTOSIDASE 1KWK ; 2.20 ; CRYSTAL STRUCTURE OF THERMUS THERMOPHILUS A4 BETA- GALACTOSIDASE IN COMPLEX WITH GALACTOSE 1EXM ; 1.70 ; CRYSTAL STRUCTURE OF THERMUS THERMOPHILUS ELONGATION FACTOR TU (EF-TU) IN COMPLEX WITH THE GTP ANALOGUE GPPNHP. 1J09 ; 1.80 ; CRYSTAL STRUCTURE OF THERMUS THERMOPHILUS GLUTAMYL-TRNA SYNTHETASE COMPLEXED WITH ATP AND GLU 1N75 ; 1.90 ; CRYSTAL STRUCTURE OF THERMUS THERMOPHILUS GLUTAMYL-TRNA SYNTHETASE COMPLEXED WITH ATP. 1N77 ; 2.40 ; CRYSTAL STRUCTURE OF THERMUS THERMOPHILUS GLUTAMYL-TRNA SYNTHETASE COMPLEXED WITH TRNA(GLU) AND ATP. 1N78 ; 2.10 ; CRYSTAL STRUCTURE OF THERMUS THERMOPHILUS GLUTAMYL-TRNA SYNTHETASE COMPLEXED WITH TRNA(GLU) AND GLUTAMOL-AMP. 1KH1 ; 2.30 ; CRYSTAL STRUCTURE OF THERMUS THERMOPHILUS HB8 ARGININOSUCCINATE SYNTHETASE 1KH2 ; 2.30 ; CRYSTAL STRUCTURE OF THERMUS THERMOPHILUS HB8 ARGININOSUCCINATE SYNTHETASE IN COMPLEX WITH ATP 1J21 ; 2.20 ; CRYSTAL STRUCTURE OF THERMUS THERMOPHILUS HB8 ARGININOSUCCINATE SYNTHETASE IN COMPLEX WITH ATP AND CITRULLINE 1KH3 ; 2.15 ; CRYSTAL STRUCTURE OF THERMUS THERMOPHILUS HB8 ARGININOSUCCINATE SYNTHETASE IN COMPLEX WITH INHIBITOR 1KOR ; 1.95 ; CRYSTAL STRUCTURE OF THERMUS THERMOPHILUS HB8 ARGININOSUCCINATE SYNTHETASE IN COMPLEX WITH INHIBITORS 1J20 ; 2.00 ; CRYSTAL STRUCTURE OF THERMUS THERMOPHILUS HB8 ARGININOSUCCINATE SYNTHETASE IN COMPLEX WITH PRODUCT 1J1Z ; 2.10 ; CRYSTAL STRUCTURE OF THERMUS THERMOPHILUS HB8 ARGININOSUCCINATE SYNTHETASE IN COMPLEX WITH SUBSTRATE 1ONL ; 2.50 ; CRYSTAL STRUCTURE OF THERMUS THERMOPHILUS HB8 H-PROTEIN OF THE GLYCINE CLEAVAGE SYSTEM 2CUW ; 2.30 ; CRYSTAL STRUCTURE OF THERMUS THERMOPHILUS PURS, ONE OF THE SUBUNITS OF FORMYLGLYCINAMIDE RIBONUCLEOTIDE AMIDOTRANSFERASE IN THE PURINE BIOSYNTHETIC PATHWAY 2CW0 ; 3.30 ; CRYSTAL STRUCTURE OF THERMUS THERMOPHILUS RIBONUCLEIC ACID POLYMERASE HOLOENZYME AT 3.3 ANGSTROMS RESOLUTION 1UJ4 ; 1.80 ; CRYSTAL STRUCTURE OF THERMUS THERMOPHILUS RIBOSE-5- PHOSPHATE ISOMERASE 1UJ6 ; 1.74 ; CRYSTAL STRUCTURE OF THERMUS THERMOPHILUS RIBOSE-5- PHOSPHATE ISOMERASE COMPLEXED WITH ARABINOSE-5-PHOSPHATE 1UJ5 ; 2.00 ; CRYSTAL STRUCTURE OF THERMUS THERMOPHILUS RIBOSE-5- PHOSPHATE ISOMERASE COMPLEXED WITH RIBOSE-5-PHOSPHATE 2CVK ; 2.00 ; CRYSTAL STRUCTURE OF THERMUS THERMOPHILUS THIOREDOXIN 2CWW ; 2.60 ; CRYSTAL STRUCTURE OF THERMUS THERMOPHILUS TTHA1280, A PUTATIVE SAM-DEPENDENT RIBONUCLEIC ACID METHYLTRANSFERASE, IN COMPLEX WITH S-ADENOSYL-L-HOMOCYSTEINE 1GAX ; 2.90 ; CRYSTAL STRUCTURE OF THERMUS THERMOPHILUS VALYL-TRNA SYNTHETASE COMPLEXED WITH TRNA(VAL) AND VALYL-ADENYLATE ANALOGUE 1IVS ; 2.90 ; CRYSTAL STRUCTURE OF THERMUS THERMOPHILUS VALYL-TRNA SYNTHETASE COMPLEXED WITH TRNA(VAL) AND VALYL-ADENYLATE ANALOGUE 1TO9 ; 2.40 ; CRYSTAL STRUCTURE OF THI-4 PROTEIN FROM BACILLUS SUBTILIS 1RP0 ; 1.60 ; CRYSTAL STRUCTURE OF THI1 PROTEIN FROM ARABIDOPSIS THALIANA 1WV2 ; 2.90 ; CRYSTAL STRUCTURE OF THIAMINE BIOSYNTHESIS PROTEIN FROM PSEUDOMONAS AERUGINOSA 1VQV ; 2.65 ; CRYSTAL STRUCTURE OF THIAMINE MONOPHOSPHATE KINASE (THIL) FROM AQUIFEX AEOLICUS 1ESJ ; 1.80 ; CRYSTAL STRUCTURE OF THIAZOLE KINASE MUTANT (C198S) 1ESQ ; 2.50 ; CRYSTAL STRUCTURE OF THIAZOLE KINASE MUTANT (C198S) WITH ATP AND THIAZOLE PHOSPHATE. 1XVQ ; 1.75 ; CRYSTAL STRUCTURE OF THIOL PEROXIDASE FROM MYCOBACTERIUM TUBERCULOSIS 1KTE ; 2.20 ; CRYSTAL STRUCTURE OF THIOLTRANSFERASE AT 2.2 ANGSTROM RESOLUTION 2BZG ; 1.58 ; CRYSTAL STRUCTURE OF THIOPURINE S-METHYLTRANSFERASE. 1FAA ; 1.85 ; CRYSTAL STRUCTURE OF THIOREDOXIN F FROM SPINACH CHLOROPLAST (LONG FORM) 1F9M ; 1.86 ; CRYSTAL STRUCTURE OF THIOREDOXIN F FROM SPINACH CHLOROPLAST (SHORT FORM) 1R26 ; 1.40 ; CRYSTAL STRUCTURE OF THIOREDOXIN FROM TRYPANOSOMA BRUCEI BRUCEI 1FB6 ; 2.10 ; CRYSTAL STRUCTURE OF THIOREDOXIN M FROM SPINACH CHLOROPLAST (OXIDIZED FORM) 1FB0 ; 2.26 ; CRYSTAL STRUCTURE OF THIOREDOXIN M FROM SPINACH CHLOROPLAST (REDUCED FORM) 2FCH ; 2.60 ; CRYSTAL STRUCTURE OF THIOREDOXIN MUTANT G74S 1ZZY ; 2.50 ; CRYSTAL STRUCTURE OF THIOREDOXIN MUTANT L7V 2FD3 ; 2.45 ; CRYSTAL STRUCTURE OF THIOREDOXIN MUTANT P34H 2CVJ ; 2.00 ; CRYSTAL STRUCTURE OF THIOREDOXIN REDUCTASE-RELATED PROTEIN TTHA0370 FROM THERMUS THERMOPHILUS HB8 1YT8 ; 1.90 ; CRYSTAL STRUCTURE OF THIOSULFATE SULFURTRANSFERASE FROM PSEUDOMONAS AERUGINOSA 1V07 ; 1.70 ; CRYSTAL STRUCTURE OF THRE11VAL MUTANT OF THE NERVE TISSUE MINI-HEMOGLOBIN FROM THE NEMERTEAN WORM CEREBRATULUS LACTEUS 1KLO ; 2.10 ; CRYSTAL STRUCTURE OF THREE CONSECUTIVE LAMININ-TYPE EPIDERMAL GROWTH FACTOR-LIKE (LE) MODULES OF LAMININ GAMMA1 CHAIN HARBORING THE NIDOGEN BINDING SITE 1M6S ; 1.80 ; CRYSTAL STRUCTURE OF THREONINE ALDOLASE 1JG8 ; 1.80 ; CRYSTAL STRUCTURE OF THREONINE ALDOLASE (LOW-SPECIFICITY) 2C2G ; 2.61 ; CRYSTAL STRUCTURE OF THREONINE SYNTHASE FROM ARABIDOPSIS THALIANA IN COMPLEX WITH ITS COFACTOR PYRIDOXAL PHOSPHATE 1VB3 ; 2.20 ; CRYSTAL STRUCTURE OF THREONINE SYNTHASE FROM ESCHERICHIA COLI 1V7C ; 2.00 ; CRYSTAL STRUCTURE OF THREONINE SYNTHASE FROM THERMUS THERMOPHILUS HB8 IN COMPLEX WITH A SUBSTRATE ANALOGUE 1UIM ; 2.15 ; CRYSTAL STRUCTURE OF THREONINE SYNTHASE FROM THERMUS THERMOPHILUS HB8, ORTHORHOMBIC CRYSTAL FORM 1UIN ; 2.25 ; CRYSTAL STRUCTURE OF THREONINE SYNTHASE FROM THERMUS THERMOPHILUS HB8, TRIGONAL CRYSTAL FORM 1KL7 ; 2.70 ; CRYSTAL STRUCTURE OF THREONINE SYNTHASE FROM YEAST 1RKU ; 1.47 ; CRYSTAL STRUCTURE OF THRH GENE PRODUCT OF PSEUDOMONAS AERUGINOSA 1XMN ; 1.85 ; CRYSTAL STRUCTURE OF THROMBIN BOUND TO HEPARIN 1QBV ; 1.80 ; CRYSTAL STRUCTURE OF THROMBIN COMPLEXED WITH AN GUANIDINE- MIMETIC INHIBITOR 1JWT ; 2.50 ; CRYSTAL STRUCTURE OF THROMBIN IN COMPLEX WITH A NOVEL BICYCLIC LACTAM INHIBITOR 1TA2 ; 2.30 ; CRYSTAL STRUCTURE OF THROMBIN IN COMPLEX WITH COMPOUND 1 1TA6 ; 1.90 ; CRYSTAL STRUCTURE OF THROMBIN IN COMPLEX WITH COMPOUND 14B 1MU6 ; 1.99 ; CRYSTAL STRUCTURE OF THROMBIN IN COMPLEX WITH L-378,622 1KQ4 ; 2.25 ; CRYSTAL STRUCTURE OF THY1-COMPLEMENTING PROTEIN (TM0449) FROM THERMOTOGA MARITIMA AT 2.25 A RESOLUTION 1KI4 ; 2.34 ; CRYSTAL STRUCTURE OF THYMIDINE KINASE FROM HERPES SIMPLEX VIRUS TYPE I COMPLEXED WITH 5-BROMOTHIENYLDEOXYURIDINE 1KI8 ; 2.20 ; CRYSTAL STRUCTURE OF THYMIDINE KINASE FROM HERPES SIMPLEX VIRUS TYPE I COMPLEXED WITH 5-BROMOVINYLDEOXYURIDINE 1KI7 ; 2.20 ; CRYSTAL STRUCTURE OF THYMIDINE KINASE FROM HERPES SIMPLEX VIRUS TYPE I COMPLEXED WITH 5-IODODEOXYURIDINE 1KI6 ; 2.37 ; CRYSTAL STRUCTURE OF THYMIDINE KINASE FROM HERPES SIMPLEX VIRUS TYPE I COMPLEXED WITH A 5-IODOURACIL ANHYDROHEXITOL NUCLEOSIDE 1KIM ; 2.14 ; CRYSTAL STRUCTURE OF THYMIDINE KINASE FROM HERPES SIMPLEX VIRUS TYPE I COMPLEXED WITH DEOXYTHYMIDINE 1KI2 ; 2.20 ; CRYSTAL STRUCTURE OF THYMIDINE KINASE FROM HERPES SIMPLEX VIRUS TYPE I COMPLEXED WITH GANCICLOVIR 1KI3 ; 2.37 ; CRYSTAL STRUCTURE OF THYMIDINE KINASE FROM HERPES SIMPLEX VIRUS TYPE I COMPLEXED WITH PENCICLOVIR 2B8T ; 2.00 ; CRYSTAL STRUCTURE OF THYMIDINE KINASE FROM U.UREALYTICUM IN COMPLEX WITH THYMIDINE 1XMR ; 2.50 ; CRYSTAL STRUCTURE OF THYMIDINE KINASE WITH DTTP FROM U. UREALYTICUM 1B02 ; 2.50 ; CRYSTAL STRUCTURE OF THYMIDYLATE SYNTHASE A FROM BACILLUS SUBTILIS 1O24 ; 2.00 ; CRYSTAL STRUCTURE OF THYMIDYLATE SYNTHASE COMPLEMENTING PROTEIN (TM0449) FROM THERMOTOGA MARITIMA AT 2.0 A RESOLUTION 1O25 ; 2.40 ; CRYSTAL STRUCTURE OF THYMIDYLATE SYNTHASE COMPLEMENTING PROTEIN (TM0449) FROM THERMOTOGA MARITIMA WITH DUMP AT 2.4 A RESOLUTION 1O27 ; 2.30 ; CRYSTAL STRUCTURE OF THYMIDYLATE SYNTHASE COMPLEMENTING PROTEIN (TM0449) FROM THERMOTOGA MARITIMA WITH FAD AND BRDUMP AT 2.3 A RESOLUTION 1O26 ; 1.60 ; CRYSTAL STRUCTURE OF THYMIDYLATE SYNTHASE COMPLEMENTING PROTEIN (TM0449) FROM THERMOTOGA MARITIMA WITH FAD AND DUMP AT 1.6 A RESOLUTION 1O29 ; 2.00 ; CRYSTAL STRUCTURE OF THYMIDYLATE SYNTHASE COMPLEMENTING PROTEIN (TM0449) FROM THERMOTOGA MARITIMA WITH FAD AND FDUMP AT 2.0 A RESOLUTION 1O2B ; 2.45 ; CRYSTAL STRUCTURE OF THYMIDYLATE SYNTHASE COMPLEMENTING PROTEIN (TM0449) FROM THERMOTOGA MARITIMA WITH FAD AND PO4 AT 2.45 A RESOLUTION 1O2A ; 1.80 ; CRYSTAL STRUCTURE OF THYMIDYLATE SYNTHASE COMPLEMENTING PROTEIN (TM0449) FROM THERMOTOGA MARITIMA WITH FAD AT 1.8 A RESOLUTION 1O28 ; 2.10 ; CRYSTAL STRUCTURE OF THYMIDYLATE SYNTHASE COMPLEMENTING PROTEIN (TM0449) FROM THERMOTOGA MARITIMA WITH FDUMP AT 2.1 A RESOLUTION 1F28 ; 1.90 ; CRYSTAL STRUCTURE OF THYMIDYLATE SYNTHASE FROM PNEUMOCYSTIS CARINII BOUND TO DUMP AND BW1843U89 1AIQ ; 2.20 ; CRYSTAL STRUCTURE OF THYMIDYLATE SYNTHASE R126E MUTANT 1AJM ; 2.40 ; CRYSTAL STRUCTURE OF THYMIDYLATE SYNTHASE R126E MUTANT 1D0D ; 1.62 ; CRYSTAL STRUCTURE OF TICK ANTICOAGULANT PROTEIN COMPLEXED WITH BOVINE PANCREATIC TRYPSIN INHIBITOR 1JPS ; 1.85 ; CRYSTAL STRUCTURE OF TISSUE FACTOR IN COMPLEX WITH HUMANIZED FAB D3H44 1J9C ; 2.90 ; CRYSTAL STRUCTURE OF TISSUE FACTOR-FACTOR VIIA COMPLEX 1S12 ; 2.00 ; CRYSTAL STRUCTURE OF TM1457 1P8C ; 2.30 ; CRYSTAL STRUCTURE OF TM1620 (APC4843) FROM THERMOTOGA MARITIMA 1H2H ; 2.60 ; CRYSTAL STRUCTURE OF TM1643 1MM8 ; 2.80 ; CRYSTAL STRUCTURE OF TN5 TRANSPOSASE COMPLEXED WITH ME DEOXYRIBONUCLEIC ACID 1MUS ; 1.90 ; CRYSTAL STRUCTURE OF TN5 TRANSPOSASE COMPLEXED WITH RESOLVED OUTSIDE END DEOXYRIBONUCLEIC ACID 1MUH ; 2.30 ; CRYSTAL STRUCTURE OF TN5 TRANSPOSASE COMPLEXED WITH TRANSPOSON END DEOXYRIBONUCLEIC ACID 1ZK7 ; 1.60 ; CRYSTAL STRUCTURE OF TN501 MERA 1ZX9 ; 1.90 ; CRYSTAL STRUCTURE OF TN501 MERA 2AZ5 ; 2.10 ; CRYSTAL STRUCTURE OF TNF-ALPHA WITH A SMALL MOLECULE INHIBITOR 1P6P ; 2.50 ; CRYSTAL STRUCTURE OF TOAD LIVER BASIC FATTY ACID-BINDING PROTEIN 1LC4 ; 2.54 ; CRYSTAL STRUCTURE OF TOBRAMYCIN BOUND TO THE EUBACTERIAL 16S RRNA A SITE 1WRD ; 1.75 ; CRYSTAL STRUCTURE OF TOM1 GAT DOMAIN IN COMPLEX WITH UBIQUITIN 1OYV ; 2.50 ; CRYSTAL STRUCTURE OF TOMATO INHIBITOR-II IN A TERNARY COMPLEX WITH SUBTILISIN CARLSBERG 1QYS ; 2.50 ; CRYSTAL STRUCTURE OF TOP7: A COMPUTATIONALLY DESIGNED PROTEIN WITH A NOVEL FOLD 1WMN ; 1.80 ; CRYSTAL STRUCTURE OF TOPAQUINONE-CONTAINING AMINE OXIDASE ACTIVATED BY COBALT ION 1WMO ; 1.80 ; CRYSTAL STRUCTURE OF TOPAQUINONE-CONTAINING AMINE OXIDASE ACTIVATED BY NICKEL ION 1ZGB ; 2.30 ; CRYSTAL STRUCTURE OF TORPEDO CALIFORNICA ACETYLCHOLINESTERASE IN COMPLEX WITH AN (R)-TACRINE(10)- HUPYRIDONE INHIBITOR. 1ZGC ; 2.10 ; CRYSTAL STRUCTURE OF TORPEDO CALIFORNICA ACETYLCHOLINESTERASE IN COMPLEX WITH AN (RS)-TACRINE(10)- HUPYRIDONE INHIBITOR. 1R8I ; 3.00 ; CRYSTAL STRUCTURE OF TRAC 1D4V ; 2.20 ; CRYSTAL STRUCTURE OF TRAIL-DR5 COMPLEX 1DU3 ; 2.20 ; CRYSTAL STRUCTURE OF TRAIL-SDR5 1JTZ ; 2.60 ; CRYSTAL STRUCTURE OF TRANCE/RANKL CYTOKINE. 1VPX ; 2.40 ; CRYSTAL STRUCTURE OF TRANSALDOLASE (EC 2.2.1.2) (TM0295) FROM THERMOTOGA MARITIMA AT 2.40 A RESOLUTION 1WX0 ; 2.27 ; CRYSTAL STRUCTURE OF TRANSALDOLASE FROM THERMUS THERMOPHILUS HB8 1EXJ ; 3.00 ; CRYSTAL STRUCTURE OF TRANSCRIPTION ACTIVATOR BMRR, FROM B. SUBTILIS, BOUND TO 21 BASE PAIR BMR OPERATOR AND TPP 1EXI ; 3.12 ; CRYSTAL STRUCTURE OF TRANSCRIPTION ACTIVATOR BMRR, FROM B. SUBTILIS, BOUND TO 21 BASE PAIR BMR OPERATOR AND TPSB 1TJL ; 2.00 ; CRYSTAL STRUCTURE OF TRANSCRIPTION FACTOR DKSA FROM E. COLI 1HZ4 ; 1.45 ; CRYSTAL STRUCTURE OF TRANSCRIPTION FACTOR MALT DOMAIN III 1ZYB ; 2.15 ; CRYSTAL STRUCTURE OF TRANSCRIPTION REGULATOR FROM BACTERIODES THETAIOTAOMICRON VPI-5482 AT 2.15 A RESOLUTION 1TYH ; 2.54 ; CRYSTAL STRUCTURE OF TRANSCRIPTIONAL ACTIVATOR TENA FROM BACILLUS SUBTILIS 1O5L ; 2.30 ; CRYSTAL STRUCTURE OF TRANSCRIPTIONAL REGULATOR (TM1171) FROM THERMOTOGA MARITIMA AT 2.30 A RESOLUTION 1J5Y ; 2.30 ; CRYSTAL STRUCTURE OF TRANSCRIPTIONAL REGULATOR (TM1602) FROM THERMOTOGA MARITIMA AT 2.3 A RESOLUTION 1ZK8 ; 2.15 ; CRYSTAL STRUCTURE OF TRANSCRIPTIONAL REGULATOR FROM BACILLUS CEREUS ATCC 14579 1Z4E ; 2.00 ; CRYSTAL STRUCTURE OF TRANSCRIPTIONAL REGULATOR FROM BACILLUS HALODURANS C-125 1Z77 ; 2.00 ; CRYSTAL STRUCTURE OF TRANSCRIPTIONAL REGULATOR PROTEIN FROM THERMOTOGA MARITIMA. 2COH ; 1.50 ; CRYSTAL STRUCTURE OF TRANSCRIPTIONAL REGULATOR TTHA1359 FORM THERMUS THERMOPHILUS HB8 2ETH ; 2.30 ; CRYSTAL STRUCTURE OF TRANSCRIPTIONAL REGULATOR, PUTATIVE, MAR FAMILY (TM0816) FROM THERMOTOGA MARITIMA AT 2.30 A RESOLUTION 1ZKG ; 2.30 ; CRYSTAL STRUCTURE OF TRANSCRIPTIONAL REGULATOR, TETR FAMILY (TM1030) FROM THERMOTOGA MARITIMA AT 2.30 A RESOLUTION 1Z0X ; 2.40 ; CRYSTAL STRUCTURE OF TRANSCRIPTIONAL REGULATOR, TETR FAMILY FROM ENTEROCOCCUS FAECALIS V583 1RZR ; 2.80 ; CRYSTAL STRUCTURE OF TRANSCRIPTIONAL REGULATOR- PHOSPHOPROTEIN-DEOXYRIBONUCLEIC ACID COMPLEX 1SGX ; 2.00 ; CRYSTAL STRUCTURE OF TRANSGLUTAMINASE 3 IN COMPLEX WITH BOUND GMP: STRUCTURAL BASIS FOR ALTERATION IN NUCLEOTIDE SPECIFICITY 1D4O ; 1.21 ; CRYSTAL STRUCTURE OF TRANSHYDROGENASE DOMAIN III AT 1.2 ANGSTROMS RESOLUTION 1XLT ; 3.10 ; CRYSTAL STRUCTURE OF TRANSHYDROGENASE [(DOMAIN I)2:DOMAIN III] HETEROTRIMER COMPLEX 1UEB ; 1.65 ; CRYSTAL STRUCTURE OF TRANSLATION ELONGATION FACTOR P FROM THERMUS THERMOPHILUS HB8 1WB1 ; 3.00 ; CRYSTAL STRUCTURE OF TRANSLATION ELONGATION FACTOR SELB FROM METHANOCOCCUS MARIPALUDIS IN COMPLEX WITH GDP 1WB3 ; 3.20 ; CRYSTAL STRUCTURE OF TRANSLATION ELONGATION FACTOR SELB FROM METHANOCOCCUS MARIPALUDIS IN COMPLEX WITH THE GTP ANALOGUE GPPNHP 1WB2 ; 3.10 ; CRYSTAL STRUCTURE OF TRANSLATION ELONGATION FACTOR SELB FROM METHANOCOCCUS MARIPALUDIS, APO FORM 1IZ6 ; 2.00 ; CRYSTAL STRUCTURE OF TRANSLATION INITIATION FACTOR 5A FROM PYROCOCCUS HORIKOSHII 1TXJ ; 2.00 ; CRYSTAL STRUCTURE OF TRANSLATIONALLY CONTROLLED TUMOUR- ASSOCIATED PROTEIN (TCTP) FROM PLASMODIUM KNOWLESI 1OO2 ; 1.56 ; CRYSTAL STRUCTURE OF TRANSTHYRETIN FROM SPARUS AURATA 1Y1D ; 1.70 ; CRYSTAL STRUCTURE OF TRANSTHYRETIN IN COMPLEX WITH IODODIFLUNISAL 1DVY ; 1.90 ; CRYSTAL STRUCTURE OF TRANSTHYRETIN IN COMPLEX WITH N-(M- TRIFLUOROMETHYLPHENYL) PHENOXAZINE-4,6-DICARBOXYLIC ACID 1PXF ; 1.87 ; CRYSTAL STRUCTURE OF TRBP111: A STRUCTURE SPECIFIC TRNA BINDING PROTEIN 1U02 ; 1.92 ; CRYSTAL STRUCTURE OF TREHALOSE-6-PHOSPHATE PHOSPHATASE RELATED PROTEIN 1L5P ; 2.20 ; CRYSTAL STRUCTURE OF TRICHOMONAS VAGINALIS FERREDOXIN 1Z33 ; 2.70 ; CRYSTAL STRUCTURE OF TRICHOMONAS VAGINALIS PURINE NUCLEOSIDE PHOSPHORYLASE 1Z39 ; 2.60 ; CRYSTAL STRUCTURE OF TRICHOMONAS VAGINALIS PURINE NUCLEOSIDE PHOSPHORYLASE COMPLEXED WITH 2'-DEOXYINOSINE 1Z34 ; 2.40 ; CRYSTAL STRUCTURE OF TRICHOMONAS VAGINALIS PURINE NUCLEOSIDE PHOSPHORYLASE COMPLEXED WITH 2-FLUORO-2'- DEOXYADENOSINE 1Z35 ; 2.50 ; CRYSTAL STRUCTURE OF TRICHOMONAS VAGINALIS PURINE NUCLEOSIDE PHOSPHORYLASE COMPLEXED WITH 2-FLUOROADENOSINE 1Z37 ; 2.90 ; CRYSTAL STRUCTURE OF TRICHOMONAS VAGINALIS PURINE NUCLEOSIDE PHOSPHORYLASE COMPLEXED WITH ADENOSINE 1Z36 ; 2.60 ; CRYSTAL STRUCTURE OF TRICHOMONAS VAGINALIS PURINE NUCLEOSIDE PHOSPHORYLASE COMPLEXED WITH FORMYCIN A 1Z38 ; 2.50 ; CRYSTAL STRUCTURE OF TRICHOMONAS VAGINALIS PURINE NUCLEOSIDE PHOSPHORYLASE COMPLEXED WITH INOSINE 1Z6O ; 1.91 ; CRYSTAL STRUCTURE OF TRICHOPLUSIA NI SECRETED FERRITIN 1GGP ; 2.70 ; CRYSTAL STRUCTURE OF TRICHOSANTHES KIRILOWII LECTIN-1 AND ITS RELATION TO THE TYPE 2 RIBOSOME INACTIVATING PROTEINS 1IHD ; 2.65 ; CRYSTAL STRUCTURE OF TRIGONAL FORM OF D90E MUTANT OF ESCHERICHIA COLI ASPARAGINASE II 1DRG ; 2.55 ; CRYSTAL STRUCTURE OF TRIMERIC CRE RECOMBINASE-LOX COMPLEX 1F44 ; 2.05 ; CRYSTAL STRUCTURE OF TRIMERIC CRE RECOMBINASE-LOX COMPLEX 1DKW ; 2.65 ; CRYSTAL STRUCTURE OF TRIOSE-PHOSPHATE ISOMERASE WITH MODIFIED SUBSTRATE BINDING SITE 1M6J ; 1.50 ; CRYSTAL STRUCTURE OF TRIOSEPHOSPHATE ISOMERASE FROM ENTAMOEBA HISTOLYTICA 1CI1 ; 2.00 ; CRYSTAL STRUCTURE OF TRIOSEPHOSPHATE ISOMERASE FROM TRYPANOSOMA CRUZI IN HEXANE 1D3R ; 1.80 ; CRYSTAL STRUCTURE OF TRIPLEX DEOXYRIBONUCLEIC ACID 1HCF ; 2.70 ; CRYSTAL STRUCTURE OF TRKB-D5 BOUND TO NEUROTROPHIN-4/5 1OY5 ; 2.60 ; CRYSTAL STRUCTURE OF TRNA (M1G37) METHYLTRANSFERASE FROM AQUIFEX AEOLICUS 1WWR ; 1.80 ; CRYSTAL STRUCTURE OF TRNA ADENOSINE DEAMINASE TADA FROM AQUIFEX AEOLICUS 1VFG ; 2.80 ; CRYSTAL STRUCTURE OF TRNA NUCLEOTIDYLTRANSFERASE COMPLEXED WITH A PRIMER TRNA AND AN INCOMING ATP ANALOG 1R3E ; 2.10 ; CRYSTAL STRUCTURE OF TRNA PSEUDOURIDINE SYNTHASE TRUB AND ITS RIBONUCLEIC ACID COMPLEX: RIBONUCLEIC ACID-PROTEIN RECOGNITION THROUGH A COMBINATION OF RIGID DOCKING AND INDUCED FIT 1R3F ; 1.85 ; CRYSTAL STRUCTURE OF TRNA PSEUDOURIDINE SYNTHASE TRUB AND ITS RIBONUCLEIC ACID COMPLEX: RIBONUCLEIC ACID-PROTEIN RECOGNITION THROUGH A COMBINATION OF RIGID DOCKING AND INDUCED FIT 1UAJ ; 1.85 ; CRYSTAL STRUCTURE OF TRNA(M1G37)METHYLTRANSFERASE: INSIGHT INTO TRNA RECOGNITION 1UAK ; 2.05 ; CRYSTAL STRUCTURE OF TRNA(M1G37)METHYLTRANSFERASE: INSIGHT INTO TRNA RECOGNITION 1UAL ; 1.80 ; CRYSTAL STRUCTURE OF TRNA(M1G37)METHYLTRANSFERASE: INSIGHT INTO TRNA RECOGNITION 1UAM ; 2.20 ; CRYSTAL STRUCTURE OF TRNA(M1G37)METHYLTRANSFERASE: INSIGHT INTO TRNA RECOGNITION 1K4G ; 1.70 ; CRYSTAL STRUCTURE OF TRNA-GUANINE TRANSGLYCOSYLASE (TGT) COMPLEXED WITH 2,6-DIAMINO-8-(1H-IMIDAZOL-2- YLSULFANYLMETHYL)-3H-QUINAZOLINE-4-ONE 1K4H ; 1.80 ; CRYSTAL STRUCTURE OF TRNA-GUANINE TRANSGLYCOSYLASE (TGT) COMPLEXED WITH 2,6-DIAMINO-8-PROPYLSULFANYLMETHYL-3H- QUINAZOLINE-4-ONE 1P0B ; 1.70 ; CRYSTAL STRUCTURE OF TRNA-GUANINE TRANSGLYCOSYLASE (TGT) FROM ZYMOMONAS MOBILIS COMPLEXED WITH ARCHAEOSINE PRECURSOR, PREQ0 2CV8 ; 2.80 ; CRYSTAL STRUCTURE OF TRNA-INTRON ENDONUCLEASE FROM SULFOLOBUS TOKODAII 1WW1 ; 2.60 ; CRYSTAL STRUCTURE OF TRNASE Z FROM THERMOTOGA MARITIMA 1IO0 ; 1.45 ; CRYSTAL STRUCTURE OF TROPOMODULIN C-TERMINAL HALF 1C1G ; 7.00 ; CRYSTAL STRUCTURE OF TROPOMYOSIN AT 7 ANGSTROMS RESOLUTION IN THE SPERMINE-INDUCED CRYSTAL FORM 1YDG ; 2.00 ; CRYSTAL STRUCTURE OF TRP REPRESSOR BINDING PROTEIN WRBA 1YRH ; 3.11 ; CRYSTAL STRUCTURE OF TRP REPRESSOR BINDING PROTEIN WRBA IN COMPLEX WITH FMN 1OKI ; 1.40 ; CRYSTAL STRUCTURE OF TRUNCATED HUMAN BETA-B1-CRYSTALLIN 1FT0 ; 2.60 ; CRYSTAL STRUCTURE OF TRUNCATED HUMAN RHOGDI K113A MUTANT 1FSO ; 2.00 ; CRYSTAL STRUCTURE OF TRUNCATED HUMAN RHOGDI QUADRUPLE MUTANT 1FST ; 2.70 ; CRYSTAL STRUCTURE OF TRUNCATED HUMAN RHOGDI TRIPLE MUTANT 1FT3 ; 2.80 ; CRYSTAL STRUCTURE OF TRUNCATED RHOGDI K141A MUTANT 1Y5H ; 1.50 ; CRYSTAL STRUCTURE OF TRUNCATED SE-MET HYPOXIC RESPONSE PROTEIN I (HRPI) 1QU4 ; 2.90 ; CRYSTAL STRUCTURE OF TRYPANOSOMA BRUCEI ORNITHINE DECARBOXYLASE 1F3T ; 2.00 ; CRYSTAL STRUCTURE OF TRYPANOSOMA BRUCEI ORNITHINE DECARBOXYLASE (ODC) COMPLEXED WITH PUTRESCINE, ODC'S REACTION PRODUCT. 1QXS ; 2.75 ; CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI GLYCERALDEHYDE-3- PHOSPHATE DEHYDROGENASE COMPLEXED WITH AN ANALOGUE OF 1,3- BISPHOSPHO-D-GLYCERIC ACID 1GXF ; 2.70 ; CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI TRYPANOTHIONE REDUCTASE IN COMPLEX WITH THE INHIBITOR QUINACRINE MUSTARD 1BZL ; 2.40 ; CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI TRYPANOTHIONE REDUCTASE IN COMPLEX WITH TRYPANOTHIONE, AND THE STRUCTURE- BASED DISCOVERY OF NEW NATURAL PRODUCT INHIBITORS 1JIR ; 2.00 ; CRYSTAL STRUCTURE OF TRYPSIN COMPLEX WITH AMYLAMINE IN CYCLOHEXANE 1LQE ; 2.20 ; CRYSTAL STRUCTURE OF TRYPSIN IN COMPLEX WITH 79. 1Z7K ; 1.90 ; CRYSTAL STRUCTURE OF TRYPSIN- OVOMUCOID TURKEY EGG WHITE INHIBITOR COMPLEX 1YF4 ; 1.98 ; CRYSTAL STRUCTURE OF TRYPSIN-VASOPRESSIN COMPLEX 1UJP ; 1.34 ; CRYSTAL STRUCTURE OF TRYPTOPHAN SYNTHASE A-SUBUNIT FROM THERMUS THERMOPHILUS HB8 1WXJ ; 1.70 ; CRYSTAL STRUCTURE OF TRYPTOPHAN SYNTHASE A-SUBUNIT WITH INDOLE-3-PROPANOL PHOSPHATE FROM THERMUS THERMOPHILUS HB8 1RD5 ; 2.02 ; CRYSTAL STRUCTURE OF TRYPTOPHAN SYNTHASE ALPHA CHAIN HOMOLOG BX1: A MEMBER OF THE CHEMICAL PLANT DEFENSE SYSTEM 1WQ5 ; 2.30 ; CRYSTAL STRUCTURE OF TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT FROM ESCHERICHIA COLI 1V7Y ; 2.50 ; CRYSTAL STRUCTURE OF TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT FROM ESCHERICHIA COLI AT ROOM TEMPERATURE 1KFK ; 2.40 ; CRYSTAL STRUCTURE OF TRYPTOPHAN SYNTHASE FROM SALMONELLA TYPHIMURIUM 1YIA ; 3.70 ; CRYSTAL STRUCTURE OF TRYPTOPHANYL TRNA SYNTHETASE II FROM DEINOCOCCUS RADIODURANS IN COMPLEX WITH 5-HYDROXY TRYPTOPHAN. 1YID ; 2.40 ; CRYSTAL STRUCTURE OF TRYPTOPHANYL TRNA SYNTHETASE II FROM DEINOCOCCUS RADIODURANS IN COMPLEX WITH ATP. 1YI8 ; 2.10 ; CRYSTAL STRUCTURE OF TRYPTOPHANYL TRRNA SYNTHETASE II FROM DEINOCOCCUS RADIODURANS IN COMPLEX WITH L-TRP 1MAU ; 2.15 ; CRYSTAL STRUCTURE OF TRYPTOPHANYL-TRNA SYNTHETASE COMPLEXED WITH ATP AND TRYPTOPHANAMIDE IN A PRE-TRANSITION STATE CONFORMATION 1M83 ; 2.20 ; CRYSTAL STRUCTURE OF TRYPTOPHANYL-TRNA SYNTHETASE COMPLEXED WITH ATP IN A CLOSED, PRE-TRANSITION STATE CONFORMATION 1MAW ; 3.00 ; CRYSTAL STRUCTURE OF TRYPTOPHANYL-TRNA SYNTHETASE COMPLEXED WITH ATP IN AN OPEN CONFORMATION 1MB2 ; 2.70 ; CRYSTAL STRUCTURE OF TRYPTOPHANYL-TRNA SYNTHETASE COMPLEXED WITH TRYPTOPHAN IN AN OPEN CONFORMATION 1W3M ; 1.00 ; CRYSTAL STRUCTURE OF TSUSHIMYCIN 1V9S ; 2.10 ; CRYSTAL STRUCTURE OF TT0130 PROTEIN FROM THERMUS THERMOPHILUS HB8 1ULS ; 2.40 ; CRYSTAL STRUCTURE OF TT0140 FROM THERMUS THERMOPHILUS HB8 1ULU ; 2.00 ; CRYSTAL STRUCTURE OF TT0143 FROM THERMUS THERMOPHILUS HB8 1ULT ; 2.55 ; CRYSTAL STRUCTURE OF TT0168 FROM THERMUS THERMOPHILUS HB8 1V25 ; 2.30 ; CRYSTAL STRUCTURE OF TT0168 FROM THERMUS THERMOPHILUS HB8 1V26 ; 2.50 ; CRYSTAL STRUCTURE OF TT0168 FROM THERMUS THERMOPHILUS HB8 1ULQ ; 3.00 ; CRYSTAL STRUCTURE OF TT0182 FROM THERMUS THERMOPHILUS HB8 1WLU ; 1.45 ; CRYSTAL STRUCTURE OF TT0310 PROTEIN FROM THERMUS THERMOPHILUS HB8 1WLV ; 1.90 ; CRYSTAL STRUCTURE OF TT0310 PROTEIN FROM THERMUS THERMOPHILUS HB8 1WM6 ; 2.40 ; CRYSTAL STRUCTURE OF TT0310 PROTEIN FROM THERMUS THERMOPHILUS HB8 1WN3 ; 2.10 ; CRYSTAL STRUCTURE OF TT0310 PROTEIN FROM THERMUS THERMOPHILUS HB8 1V8H ; 1.20 ; CRYSTAL STRUCTURE OF TT0351 PROTEIN FROM THERMUS THERMOPHILUS HB8 1YYA ; 1.60 ; CRYSTAL STRUCTURE OF TT0473, PUTATIVE TRIOSEPHOSPHATE ISOMERASE FROM THERMUS THERMOPHILUS HB8 1ULR ; 1.30 ; CRYSTAL STRUCTURE OF TT0497 FROM THERMUS THERMOPHILUS HB8 1IUH ; 2.50 ; CRYSTAL STRUCTURE OF TT0787 OF THERMUS THERMOPHILUS HB8 1UFK ; 1.90 ; CRYSTAL STRUCTURE OF TT0836 1WDI ; 2.10 ; CRYSTAL STRUCTURE OF TT0907 FROM THERMUS THERMOPHILUS HB8 1UFL ; 2.70 ; CRYSTAL STRUCTURE OF TT1020 FROM THERMUS THERMOPHILUS HB8 1V3R ; 1.85 ; CRYSTAL STRUCTURE OF TT1020 FROM THERMUS THERMOPHILUS HB8 1V3S ; 1.85 ; CRYSTAL STRUCTURE OF TT1020 FROM THERMUS THERMOPHILUS HB8 1V9O ; 2.00 ; CRYSTAL STRUCTURE OF TT1020 FROM THERMUS THERMOPHILUS HB8 1VFJ ; 1.70 ; CRYSTAL STRUCTURE OF TT1020 FROM THERMUS THERMOPHILUS HB8 1UFR ; 2.60 ; CRYSTAL STRUCTURE OF TT1027 FROM THERMUS THERMOPHILUS HB8 1UF9 ; 2.80 ; CRYSTAL STRUCTURE OF TT1252 FROM THERMUS THERMOPHILUS 1WD5 ; 2.00 ; CRYSTAL STRUCTURE OF TT1426 FROM THERMUS THERMOPHILUS HB8 1UFA ; 2.20 ; CRYSTAL STRUCTURE OF TT1467 FROM THERMUS THERMOPHILUS HB8 1UF3 ; 2.10 ; CRYSTAL STRUCTURE OF TT1561 OF THERMUS THERMOPHILUS HB8 1V6Z ; 2.00 ; CRYSTAL STRUCTURE OF TT1573 FROM THERMUS THERMOPHILUS 1WXW ; 2.55 ; CRYSTAL STRUCTURE OF TT1595, A PUTATIVE SAM-DEPENDENT METHYLTRANSFERASE FROM THERMUS THERMOPHILLUS HB8 1WXX ; 1.80 ; CRYSTAL STRUCTURE OF TT1595, A PUTATIVE SAM-DEPENDENT METHYLTRANSFERASE FROM THERMUS THERMOPHILLUS HB8 1UFO ; 1.60 ; CRYSTAL STRUCTURE OF TT1662 FROM THERMUS THERMOPHILUS 1UFB ; 1.90 ; CRYSTAL STRUCTURE OF TT1696 FROM THERMUS THERMOPHILUS HB8 1WDJ ; 2.00 ; CRYSTAL STRUCTURE OF TT1808 FROM THERMUS THERMOPHILUS HB8 2CSL ; 2.50 ; CRYSTAL STRUCTURE OF TTHA0137 FROM THERMUS THERMOPHILUS HB8 2CVL ; 1.65 ; CRYSTAL STRUCTURE OF TTHA0137 FROM THERMUS THERMOPHILUS HB8 2CW4 ; 1.80 ; CRYSTAL STRUCTURE OF TTHA0137 FROM THERMUS THERMOPHILUS HB8 2D4R ; 2.40 ; CRYSTAL STRUCTURE OF TTHA0849 FROM THERMUS THERMOPHILUS HB8 1WDT ; 2.20 ; CRYSTAL STRUCTURE OF TTK003000868 FROM THERMUS THERMOPHILUS HB8 1WWI ; 1.58 ; CRYSTAL STRUCTURE OF TTK003001566 FROM THERMUS THERMOPHILUS HB8 1WK4 ; 2.80 ; CRYSTAL STRUCTURE OF TTK003001606 1WWP ; 2.11 ; CRYSTAL STRUCTURE OF TTK003001694 FROM THERMUS THERMOPHILUS HB8 1LJN ; 1.19 ; CRYSTAL STRUCTURE OF TUEKEY EGG LYSOZYME COMPLEX WITH DI-N- ACETYLCHITOBIOSE AT 1.19A RESOLUTION 1DKO ; 2.38 ; CRYSTAL STRUCTURE OF TUNGSTATE COMPLEX OF ESCHERICHIA COLI PHYTASE AT PH 6.6 WITH TUNGSTATE BOUND AT THE ACTIVE SITE AND WITH HG2+ CATION ACTING AS AN INTERMOLECULAR BRIDGE 1D2P ; 2.50 ; CRYSTAL STRUCTURE OF TWO B REPEAT UNITS (B1B2) OF THE COLLAGEN BINDING PROTEIN (CNA) OF STAPHYLOCOCCUS AUREUS 1QUU ; 2.50 ; CRYSTAL STRUCTURE OF TWO CENTRAL SPECTRIN-LIKE REPEATS FROM ALPHA-ACTININ 1IHX ; 2.80 ; CRYSTAL STRUCTURE OF TWO D-GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE COMPLEXES: A CASE OF ASYMMETRY 1B12 ; 1.95 ; CRYSTAL STRUCTURE OF TYPE 1 SIGNAL PEPTIDASE FROM ESCHERICHIA COLI IN COMPLEX WITH A BETA-LACTAM INHIBITOR 1VBI ; 1.80 ; CRYSTAL STRUCTURE OF TYPE 2 MALATE/LACTATE DEHYDROGENASE FROM THERMUS THERMOPHILUS HB8 1IO2 ; 2.00 ; CRYSTAL STRUCTURE OF TYPE 2 RIBONUCLEASE H FROM HYPERTHERMOPHILIC ARCHAEON, THERMOCOCCUS KODAKARAENSIS KOD1 2BQ4 ; 1.68 ; CRYSTAL STRUCTURE OF TYPE I CYTOCHROME C3 FROM DESULFOVIBRIO AFRICANUS 2B3L ; 1.50 ; CRYSTAL STRUCTURE OF TYPE I HUMAN METHIONINE AMINOPEPTIDASE IN THE APO FORM 2AR0 ; 2.80 ; CRYSTAL STRUCTURE OF TYPE I RESTRICTION ENZYME ECOKI M PROTEIN (EC 2.1.1.72) (M.ECOKI) 1UAY ; 1.40 ; CRYSTAL STRUCTURE OF TYPE II 3-HYDROXYACYL-COA DEHYDROGENASE FROM THERMUS THERMOPHILUS HB8 1GU0 ; 2.00 ; CRYSTAL STRUCTURE OF TYPE II DEHYDROQUINASE FROM STREPTOMYCES COELICOLOR 1GU1 ; 1.80 ; CRYSTAL STRUCTURE OF TYPE II DEHYDROQUINASE FROM STREPTOMYCES COELICOLOR COMPLEXED WITH 2,3-ANYDRO-QUINIC ACID 1D0I ; 1.80 ; CRYSTAL STRUCTURE OF TYPE II DEHYDROQUINASE FROM STREPTOMYCES COELICOLOR COMPLEXED WITH PHOSPHATE IONS 1V1J ; 2.20 ; CRYSTAL STRUCTURE OF TYPE II DEHYDROQUINTAE DEHYDRATASE FROM STREPTOMYCES COELICOLOR IN COMPLEX WITH 3-FLUORO 1O4U ; 2.50 ; CRYSTAL STRUCTURE OF TYPE II QUINOLIC ACID PHOSPHORIBOSYLTRANSFERASE (TM1645) FROM THERMOTOGA MARITIMA AT 2.50 A RESOLUTION 1WTE ; 1.90 ; CRYSTAL STRUCTURE OF TYPE II RESTRCITION ENDONUCLEASE, ECOO109I COMPLEXED WITH COGNATE DEOXYRIBONUCLEIC ACID 1WTD ; 2.40 ; CRYSTAL STRUCTURE OF TYPE II RESTRCITION ENDONUCLEASE, ECOO109I DEOXYRIBONUCLEIC ACID-FREE FORM 1AME ; 1.65 ; CRYSTAL STRUCTURE OF TYPE III ANTIFREEZE PROTEIN AT 4 C 1GZI ; 1.80 ; CRYSTAL STRUCTURE OF TYPE III ANTIFREEZE PROTEIN FROM OCEAN POUT, AT 1.8 ANGSTROM RESOLUTION 1T60 ; 1.50 ; CRYSTAL STRUCTURE OF TYPE IV COLLAGEN NC1 DOMAIN FROM BOVINE LENS CAPSULE 1YDX ; 2.30 ; CRYSTAL STRUCTURE OF TYPE-I RESTRICTION-MODIFICATION SYSTEM S SUBUNIT FROM M. GENITALIUM 1ZL6 ; 2.40 ; CRYSTAL STRUCTURE OF TYR350ALA MUTANT OF CLOSTRIDIUM BOTULINUM NEUROTOXIN E CATALYTIC DOMAIN 1BW0 ; 2.50 ; CRYSTAL STRUCTURE OF TYROSINE AMINOTRANSFERASE FROM TRYPANOSOMA CRUZI 2CYB ; 1.80 ; CRYSTAL STRUCTURE OF TYROSYL-TRNA SYNTHETASE COMPLEXED WITH L-TYROSINE FROM ARCHAEOGLOBUS FULGIDUS 2CYC ; 2.20 ; CRYSTAL STRUCTURE OF TYROSYL-TRNA SYNTHETASE COMPLEXED WITH L-TYROSINE FROM PYROCOCCUS HORIKOSHII 2CYA ; 2.20 ; CRYSTAL STRUCTURE OF TYROSYL-TRNA SYNTHETASE FROM AEROPYRUM PERNIX 1X23 ; 1.85 ; CRYSTAL STRUCTURE OF UBCH5C 1WZV ; 2.10 ; CRYSTAL STRUCTURE OF UBCH8 1WZW ; 2.40 ; CRYSTAL STRUCTURE OF UBCH8 2AVN ; 2.35 ; CRYSTAL STRUCTURE OF UBIQUINONE/MENAQUINONE BIOSYNTHESIS METHYLTRANSFERASE-RELATED PROTEIN (TM1389) FROM THERMOTOGA MARITIMA AT 2.35 A RESOLUTION 1VJV ; 1.74 ; CRYSTAL STRUCTURE OF UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 6 (YFR010W) FROM SACCHAROMYCES CEREVISIAE AT 1.74 A RESOLUTION 2BEP ; 1.80 ; CRYSTAL STRUCTURE OF UBIQUITIN CONJUGATING ENZYME E2-25K 1XD3 ; 1.45 ; CRYSTAL STRUCTURE OF UCHL3-UBVME COMPLEX 1LRL ; 1.80 ; CRYSTAL STRUCTURE OF UDP-GALACTOSE 4-EPIMERASE MUTANT Y299C COMPLEXED WITH UDP-GLUCOSE 1IIR ; 1.80 ; CRYSTAL STRUCTURE OF UDP-GLUCOSYLTRANSFERASE GTFB 1O6C ; 2.90 ; CRYSTAL STRUCTURE OF UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE 1V4V ; 1.80 ; CRYSTAL STRUCTURE OF UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE FROM THERMUS THERMOPHILUS HB8 1J2Z ; 2.10 ; CRYSTAL STRUCTURE OF UDP-N-ACETYLGLUCOSAMINE ACYLTRANSFERASE 1VM8 ; 2.50 ; CRYSTAL STRUCTURE OF UDP-N-ACETYLGLUCOSAMINE PYROPHOSPHORYLASE (AGX2) FROM MUS MUSCULUS AT 2.50 A RESOLUTION 1VGV ; 2.31 ; CRYSTAL STRUCTURE OF UDP-N-ACETYLGLUCOSAMINE_2 EPIMERASE 1J6U ; 2.30 ; CRYSTAL STRUCTURE OF UDP-N-ACETYLMURAMATE-ALANINE LIGASE MURC (TM0231) FROM THERMOTOGA MARITIMA AT 2.3 A RESOLUTION 1P31 ; 1.85 ; CRYSTAL STRUCTURE OF UDP-N-ACETYLMURAMIC ACID:L-ALANINE LIGASE (MURC) FROM HAEMOPHILUS INFLUENZAE 1P3D ; 1.70 ; CRYSTAL STRUCTURE OF UDP-N-ACETYLMURAMIC ACID:L-ALANINE LIGASE (MURC) IN COMPLEX WITH UMA AND ANP. 1M7N ; 2.70 ; CRYSTAL STRUCTURE OF UNACTIVATED APO INSULIN-LIKE GROWTH FACTOR-1 RECEPTOR KINASE DOMAIN 1EJ7 ; 2.45 ; CRYSTAL STRUCTURE OF UNACTIVATED TOBACCO RUBISCO WITH BOUND PHOSPHATE IONS 1SGZ ; 2.00 ; CRYSTAL STRUCTURE OF UNBOUND BETA-SECRETASE CATALYTIC DOMAIN. 2A5A ; 2.08 ; CRYSTAL STRUCTURE OF UNBOUND SARS CORONAVIRUS MAIN PEPTIDASE IN THE SPACE GROUP C2 1VMH ; 1.31 ; CRYSTAL STRUCTURE OF UNCHARACTERIZED CONSERVED PROTEIN YJBQ/UPF0047 FAMILY, ORTHOLOG YUGU B.SUBTILIS (15023806) FROM CLOSTRIDIUM ACETOBUTYLICUM AT 1.31 A RESOLUTION 1VAJ ; 1.82 ; CRYSTAL STRUCTURE OF UNCHARACTERIZED PROTEIN PH0010 FROM PYROCOCCUS HORIKOSHII 1V30 ; 1.40 ; CRYSTAL STRUCTURE OF UNCHARACTERIZED PROTEIN PH0828 FROM PYROCOCCUS HORIKOSHII 1IXL ; 1.94 ; CRYSTAL STRUCTURE OF UNCHARACTERIZED PROTEIN PH1136 FROM PYROCOCCUS HORIKOSHII 1WOZ ; 1.94 ; CRYSTAL STRUCTURE OF UNCHARACTERIZED PROTEIN ST1454 FROM SULFOLOBUS TOKODAII 1VE0 ; 2.00 ; CRYSTAL STRUCTURE OF UNCHARACTERIZED PROTEIN ST2072 FROM SULFOLOBUS TOKODAII 1K92 ; 1.60 ; CRYSTAL STRUCTURE OF UNCOMPLEXED E. COLI ARGININOSUCCINATE SYNTHETASE 1KW2 ; 2.15 ; CRYSTAL STRUCTURE OF UNCOMPLEXED VITAMIN D-BINDING PROTEIN 1F75 ; 2.20 ; CRYSTAL STRUCTURE OF UNDECAPRENYL DIPHOSPHATE SYNTHASE FROM MICROCOCCUS LUTEUS B-P 26 1X07 ; 2.20 ; CRYSTAL STRUCTURE OF UNDECAPRENYL PYROPHOSPHATE SYNTHASE IN COMPLEX WITH MG AND IPP 1X06 ; 1.90 ; CRYSTAL STRUCTURE OF UNDECAPRENYL PYROPHOSPHATE SYNTHASE IN COMPLEX WITH MG, IPP AND FSPP 1V7U ; 2.35 ; CRYSTAL STRUCTURE OF UNDECAPRENYL PYROPHOSPHATE SYNTHASE WITH FARNESYL PYROPHOSPHATE 1KLJ ; 2.44 ; CRYSTAL STRUCTURE OF UNINHIBITED FACTOR VIIA 1VLY ; 1.30 ; CRYSTAL STRUCTURE OF UNKNOWN PROTEIN FROM 2D-PAGE (SPOT PR51) (B2898) FROM ESCHERICHIA COLI K12 AT 1.30 A RESOLUTION 1T4K ; 2.50 ; CRYSTAL STRUCTURE OF UNLIGANDED ALDOLASE ANTIBODY 93F3 FAB 1EX6 ; 2.30 ; CRYSTAL STRUCTURE OF UNLIGANDED FORM OF GUANYLATE KINASE FROM YEAST 1ZNW ; 2.10 ; CRYSTAL STRUCTURE OF UNLIGANDED FORM OF MYCOBACTERIUM TUBERCULOSIS GUANYLATE KINASE 2ANC ; 3.20 ; CRYSTAL STRUCTURE OF UNLIGANDED FORM OF OLIGOMERIC E.COLI GUANYLATE KINASE 1LY2 ; 1.80 ; CRYSTAL STRUCTURE OF UNLIGANDED HUMAN CD21 SCR1-SCR2 (COMPLEMENT RECEPTOR TYPE 2) 1LLS ; 1.80 ; CRYSTAL STRUCTURE OF UNLIGANDED MALTOSE BINDING PROTEIN WITH XENON 1EJD ; 1.55 ; CRYSTAL STRUCTURE OF UNLIGANDED MURA (TYPE1) 1EJC ; 1.80 ; CRYSTAL STRUCTURE OF UNLIGANDED MURA (TYPE2) 1NLZ ; 3.00 ; CRYSTAL STRUCTURE OF UNLIGANDED TRAFFIC ATPASE OF THE TYPE IV SECRETION SYSTEM OF HELICOBACTER PYLORI 1IM6 ; 1.74 ; CRYSTAL STRUCTURE OF UNLIGATED HPPK(R82A) FROM E.COLI AT 1.74 ANGSTROM RESOLUTION 1KBR ; 1.55 ; CRYSTAL STRUCTURE OF UNLIGATED HPPK(R92A) FROM E.COLI AT 1.55 ANGSTROM RESOLUTION 1JPA ; 1.91 ; CRYSTAL STRUCTURE OF UNPHOSPHORYLATED EPHB2 RECEPTOR TYROSINE KINASE AND JUXTAMEMBRANE REGION 1VD5 ; 1.80 ; CRYSTAL STRUCTURE OF UNSATURATED GLUCURONYL HYDROLASE, RESPONSIBLE FOR THE DEGRADATION OF GLYCOSAMINOGLYCAN, FROM BACILLUS SP. GL1 AT 1.8 A RESOLUTION 1PO6 ; 2.10 ; CRYSTAL STRUCTURE OF UP1 COMPLEXED WITH D(TAGG(6MI)TTAGGG): A HUMAN TELOMERIC REPEAT CONTAINING 6-METHYL-8-(2-DEOXY- BETA-RIBOFURANOSYL)ISOXANTHOPTERIDINE (6MI) 1U1K ; 2.00 ; CRYSTAL STRUCTURE OF UP1 COMPLEXED WITH D(TTAGGGTT 7DA GGG); A HUMAN TELOMERIC REPEAT CONTAINING 7-DEAZA-ADENINE 1U1L ; 2.00 ; CRYSTAL STRUCTURE OF UP1 COMPLEXED WITH D(TTAGGGTT PRN GGG); A HUMAN TELOMERIC REPEAT CONTAINING NEBULARINE 1U1N ; 2.10 ; CRYSTAL STRUCTURE OF UP1 COMPLEXED WITH D(TTAGGGTTA (PRN) GG); A HUMAN TELOMERIC REPEAT CONTAINING NEBULARINE 1U1P ; 1.90 ; CRYSTAL STRUCTURE OF UP1 COMPLEXED WITH D(TTAGGGTTA 2PR GG); A HUMAN TELOMERIC REPEAT CONTAINING 2-AMINOPURINE 1U1M ; 2.00 ; CRYSTAL STRUCTURE OF UP1 COMPLEXED WITH D(TTAGGGTTA 7GU GG); A HUMAN TELOMERIC REPEAT CONTAINING 7-DEAZA-GUANINE 1U1Q ; 1.80 ; CRYSTAL STRUCTURE OF UP1 COMPLEXED WITH D(TTAGGGTTA(DI)GG); A HUMAN TELOMERIC REPEAT CONTAINING INOSINE 1U1R ; 1.80 ; CRYSTAL STRUCTURE OF UP1 COMPLEXED WITH D(TTAGGGTTAG(2PR) G); A HUMAN TELOMERIC REPEAT CONTAINING 2-AMINOPURINE 1PGZ ; 2.60 ; CRYSTAL STRUCTURE OF UP1 COMPLEXED WITH D(TTAGGGTTAG(6-MI) G); A HUMAN TELOMERIC REPEAT CONTAINING 6-METHYL-8-(2- DEOXY-BETA-RIBOFURANOSYL)ISOXANTHOPTERIDINE (6-MI) 1U1O ; 2.00 ; CRYSTAL STRUCTURE OF UP1 COMPLEXED WITH D(TTAGGGTTAG(DI)G); A HUMAN TELOMERIC REPEAT CONTAINING INOSINE 1VPV ; 2.45 ; CRYSTAL STRUCTURE OF UPF0230 PROTEIN TM1468 (TM1468) FROM THERMOTOGA MARITIMA AT 2.45 A RESOLUTION 2B0O ; 2.06 ; CRYSTAL STRUCTURE OF UPLC1 GAP DOMAIN 1O5O ; 2.30 ; CRYSTAL STRUCTURE OF URACIL PHOSPHORIBOSYLTRANSFERASE (TM0721) FROM THERMOTOGA MARITIMA AT 2.30 A RESOLUTION 1VK2 ; 1.90 ; CRYSTAL STRUCTURE OF URACIL-DEOXYRIBONUCLEIC ACID GLYCOSYLASE (TM0511) FROM THERMOTOGA MARITIMA AT 1.90 A RESOLUTION 1OKB ; 1.90 ; CRYSTAL STRUCTURE OF URACIL-DEOXYRIBONUCLEIC ACID GLYCOSYLASE FROM ATLANTIC COD (GADUS MORHUA) 1L9G ; 2.50 ; CRYSTAL STRUCTURE OF URACIL-DEOXYRIBONUCLEIC ACID GLYCOSYLASE FROM T. MARITIMA 1UI0 ; 1.50 ; CRYSTAL STRUCTURE OF URACIL-DEOXYRIBONUCLEIC ACID GLYCOSYLASE FROM THERMUS THERMOPHILUS HB8 1UI1 ; 2.80 ; CRYSTAL STRUCTURE OF URACIL-DEOXYRIBONUCLEIC ACID GLYCOSYLASE FROM THERMUS THERMOPHILUS HB8 1J2G ; 2.20 ; CRYSTAL STRUCTURE OF URATE OXIDASE FROM BACILLUS SP. TB-90 CO-CRYSTALLIZED WITH 8-AZAXANTHINE 1UBP ; 1.65 ; CRYSTAL STRUCTURE OF UREASE FROM BACILLUS PASTEURII INHIBITED WITH BETA-MERCAPTOETHANOL AT 1.65 ANGSTROMS RESOLUTION 1XRH ; 2.25 ; CRYSTAL STRUCTURE OF UREIDOGLYCOLATE DEHYDROGENASE FROM ESCHERICHIA COLI 1YQC ; 1.71 ; CRYSTAL STRUCTURE OF UREIDOGLYCOLATE HYDROLASE (ALLA) FROM ESCHERICHIA COLI O157:H7 1XSQ ; 1.60 ; CRYSTAL STRUCTURE OF UREIDOGLYCOLATE HYDROLASE FROM E.COLI. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET ET81. 1VAX ; 1.99 ; CRYSTAL STRUCTURE OF URICASE FROM ARTHROBACTER GLOBIFORMIS 1VAY ; 2.24 ; CRYSTAL STRUCTURE OF URICASE FROM ARTHROBACTER GLOBIFORMIS WITH INHIBITOR 8-AZAXANTHINE 2A1F ; 2.10 ; CRYSTAL STRUCTURE OF URIDYLATE KINASE 1YWH ; 2.70 ; CRYSTAL STRUCTURE OF UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR 1J5S ; 2.85 ; CRYSTAL STRUCTURE OF URONATE ISOMERASE (TM0064) FROM THERMOTOGA MARITIMA AT 2.85 A RESOLUTION 1V9A ; 2.00 ; CRYSTAL STRUCTURE OF UROPORPHYRIN-III C-METHYL TRANSFERASE FROM THERMUS THERMOPHILUS COMPLEXED WITH S-ADENYL HOMOCYSTEINE 1VE2 ; 1.80 ; CRYSTAL STRUCTURE OF UROPORPHYRIN-III-C-METHYLTRANSFERASE FROM THERMUS THERMOPHILUS 1WCW ; 1.30 ; CRYSTAL STRUCTURE OF UROPORPHYRINOGEN III SYNTHASE FROM AN EXTREMELY THERMOPHILIC BACTERIUM THERMUS THERMOPHILUS HB8 (WILD TYPE, NATIVE, FORM-1 CRYSTAL) 1WD7 ; 1.60 ; CRYSTAL STRUCTURE OF UROPORPHYRINOGEN III SYNTHASE FROM AN EXTREMELY THERMOPHILIC BACTERIUM THERMUS THERMOPHILUS HB8 (WILD TYPE, NATIVE, FORM-2 CRYSTAL) 1IQB ; 1.90 ; CRYSTAL STRUCTURE OF URTICA DIOICA AGGLUTININ ISOLECTIN I 1EHD ; 1.50 ; CRYSTAL STRUCTURE OF URTICA DIOICA AGGLUTININ ISOLECTIN VI 1EHH ; 1.90 ; CRYSTAL STRUCTURE OF URTICA DIOICA AGGLUTININ ISOLECTIN VI COMPLEX WITH TRI-N-ACETYLCHITOTRIOSE 1S1W ; 2.70 ; CRYSTAL STRUCTURE OF V106A MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH UC-781 1S1X ; 2.80 ; CRYSTAL STRUCTURE OF V108I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE 1G3O ; 1.65 ; CRYSTAL STRUCTURE OF V19E MUTANT OF FERREDOXIN I 1T9P ; 1.50 ; CRYSTAL STRUCTURE OF V44A, G45P CP RUBREDOXIN 1T9O ; 2.00 ; CRYSTAL STRUCTURE OF V44G CP RUBREDOXIN 1T9Q ; 1.80 ; CRYSTAL STRUCTURE OF V44L CP RUBREDOXIN 1LQX ; 1.80 ; CRYSTAL STRUCTURE OF V45E MUTANT OF CYTOCHROME B5 1LR6 ; 1.90 ; CRYSTAL STRUCTURE OF V45Y MUTANT OF CYTOCHROME B5 1YPY ; 1.51 ; CRYSTAL STRUCTURE OF VACCINIA VIRUS L1 PROTEIN 1ES1 ; 2.10 ; CRYSTAL STRUCTURE OF VAL61HIS MUTANT OF TRYPSIN-SOLUBILIZED FRAGMENT OF CYTOCHROME B5 1WQ8 ; 1.90 ; CRYSTAL STRUCTURE OF VAMMIN, A VEGF-F FROM A SNAKE VENOM 1GHG ; 0.98 ; CRYSTAL STRUCTURE OF VANCOMYCIN AGLYCON 1SHO ; 1.09 ; CRYSTAL STRUCTURE OF VANCOMYCIN AT ATOMIC RESOLUTION 1R44 ; 2.25 ; CRYSTAL STRUCTURE OF VANX 1JZA ; 2.20 ; CRYSTAL STRUCTURE OF VARIANT 2 SCORPION TOXIN FROM CENTRUROIDES SCULPTURATUS EWING 1JZB ; 2.81 ; CRYSTAL STRUCTURE OF VARIANT 2 SCORPION TOXIN FROM CENTRUROIDES SCULPTURATUS EWING 1OSN ; 3.20 ; CRYSTAL STRUCTURE OF VARICELLA ZOSTER VIRUS THYMIDINE KINASE IN COMPLEX WITH BVDU-MP AND ADP 1KK6 ; 2.50 ; CRYSTAL STRUCTURE OF VAT(D) (FORM I) 1KK5 ; 2.70 ; CRYSTAL STRUCTURE OF VAT(D) (FORM II) 1KK4 ; 2.70 ; CRYSTAL STRUCTURE OF VAT(D) IN COMPLEX WITH ACETYL-COA 1KHR ; 2.80 ; CRYSTAL STRUCTURE OF VAT(D) IN COMPLEX WITH VIRGINIAMYCIN AND COENZYME A 1GCQ ; 1.68 ; CRYSTAL STRUCTURE OF VAV AND GRB2 SH3 DOMAINS 1GCP ; 2.10 ; CRYSTAL STRUCTURE OF VAV SH3 DOMAIN 1XT5 ; 1.15 ; CRYSTAL STRUCTURE OF VCBP3, DOMAIN 1, FROM BRANCHIOSTOMA FLORIDAE 1KB4 ; 2.80 ; CRYSTAL STRUCTURE OF VDR DEOXYRIBONUCLEIC ACID-BINDING DOMAIN BOUND TO A CANONICAL DIRECT REPEAT WITH THREE BASE PAIR SPACER (DR3) RESPONSE ELEMENT 1KB2 ; 2.70 ; CRYSTAL STRUCTURE OF VDR DEOXYRIBONUCLEIC ACID-BINDING DOMAIN BOUND TO MOUSE OSTEOPONTIN (SPP) RESPONSE ELEMENT 1KB6 ; 2.70 ; CRYSTAL STRUCTURE OF VDR DEOXYRIBONUCLEIC ACID-BINDING DOMAIN BOUND TO RAT OSTEOCALCIN (OC) RESPONSE ELEMENT 1S19 ; 2.10 ; CRYSTAL STRUCTURE OF VDR LIGAND BINDING DOMAIN COMPLEXED TO CALCIPOTRIOL. 1QS1 ; 1.50 ; CRYSTAL STRUCTURE OF VEGETATIVE INSECTICIDAL PROTEIN2 (VIP2) 1Y6A ; 2.10 ; CRYSTAL STRUCTURE OF VEGFR2 IN COMPLEX WITH A 2-ANILINO-5- ARYL-OXAZOLE INHIBITOR 1Y6B ; 2.10 ; CRYSTAL STRUCTURE OF VEGFR2 IN COMPLEX WITH A 2-ANILINO-5- ARYL-OXAZOLE INHIBITOR 2BOQ ; 1.33 ; CRYSTAL STRUCTURE OF VERSATILE PEROXIDASE 1LG7 ; 1.96 ; CRYSTAL STRUCTURE OF VESICULAR STOMATITIS VIRUS MATRIX PROTEIN 1L5A ; 2.55 ; CRYSTAL STRUCTURE OF VIBH, AN NRPS CONDENSATION ENZYME 1P9R ; 2.50 ; CRYSTAL STRUCTURE OF VIBRIO CHOLERAE PUTATIVE NTPASE EPSE 1P9W ; 2.70 ; CRYSTAL STRUCTURE OF VIBRIO CHOLERAE PUTATIVE NTPASE EPSE 1V7V ; 1.80 ; CRYSTAL STRUCTURE OF VIBRIO PROTEOLYTICUS CHITOBIOSE PHOSPHORYLASE 1V7W ; 1.60 ; CRYSTAL STRUCTURE OF VIBRIO PROTEOLYTICUS CHITOBIOSE PHOSPHORYLASE IN COMPLEX WITH GLCNAC 1V7X ; 2.00 ; CRYSTAL STRUCTURE OF VIBRIO PROTEOLYTICUS CHITOBIOSE PHOSPHORYLASE IN COMPLEX WITH GLCNAC AND SULFATE 2BGH ; 2.60 ; CRYSTAL STRUCTURE OF VINORINE SYNTHASE 1QS2 ; 2.70 ; CRYSTAL STRUCTURE OF VIP2 WITH NAD 1CM9 ; 2.10 ; CRYSTAL STRUCTURE OF VIRAL MACROPHAGE INFLAMMATORY PROTEIN- II 2BHM ; 2.40 ; CRYSTAL STRUCTURE OF VIRB8 FROM BRUCELLA SUIS 1YIT ; 2.80 ; CRYSTAL STRUCTURE OF VIRGINIAMYCIN M AND S BOUND TO THE 50S RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI 1YNW ; 3.00 ; CRYSTAL STRUCTURE OF VITMAIN D RECEPTOR AND 9-CIS RETINOIC ACID RECEPTOR DEOXYRIBONUCLEIC ACID-BINDING DOMAINS BOUND TO A DR3 RESPONSE ELEMENT 1UEX ; 2.85 ; CRYSTAL STRUCTURE OF VON WILLEBRAND FACTOR A1 DOMAIN COMPLEXED WITH SNAKE VENOM BITISCETIN 1QHD ; 1.95 ; CRYSTAL STRUCTURE OF VP6, THE MAJOR CAPSID PROTEIN OF GROUP A ROTAVIRUS 1XWI ; 2.80 ; CRYSTAL STRUCTURE OF VPS4B 1WQ9 ; 2.00 ; CRYSTAL STRUCTURE OF VR-1, A VEGF-F FROM A SNAKE VENOM 1TD3 ; 2.37 ; CRYSTAL STRUCTURE OF VSHP_BPP21 IN SPACE GROUP C2 1TD4 ; 1.50 ; CRYSTAL STRUCTURE OF VSHP_BPP21 IN SPACE GROUP H3 WITH HIGH RESOLUTION. 1WA0 ; 1.60 ; CRYSTAL STRUCTURE OF W138H MUTANT OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE 1SC6 ; 2.09 ; CRYSTAL STRUCTURE OF W139G D-3-PHOSPHOGLYCERATE DEHYDROGENASE COMPLEXED WITH NAD+ 1PZT ; 1.92 ; CRYSTAL STRUCTURE OF W314A-BETA-1,4-GALACTOSYLTRANSFERASE (B4GAL-T1) CATALYTIC DOMAIN WITHOUT SUBSTRATE 1JF2 ; 1.72 ; CRYSTAL STRUCTURE OF W92F OBELIN MUTANT FROM OBELIA LONGISSIMA AT 1.72 ANGSTROM RESOLUTION 1XE4 ; 1.95 ; CRYSTAL STRUCTURE OF WEISSELLA VIRIDESCENS FEMX (K36M) MUTANT 1XF8 ; 1.90 ; CRYSTAL STRUCTURE OF WEISSELLA VIRIDESCENS FEMX (Y254F) MUTANT 1NE9 ; 1.70 ; CRYSTAL STRUCTURE OF WEISSELLA VIRIDESCENS FEMX AT 1.7 ANG RESOLUTION 1XIX ; 2.00 ; CRYSTAL STRUCTURE OF WEISSELLA VIRIDESCENS FEMX FORM II 1P4N ; 1.90 ; CRYSTAL STRUCTURE OF WEISSELLA VIRIDESCENS FEMX:UDP-MURNAC- PENTAPEPTIDE COMPLEX 1NZB ; 3.10 ; CRYSTAL STRUCTURE OF WILD TYPE CRE RECOMBINASE-LOXP SYNAPSE 1HY0 ; 2.20 ; CRYSTAL STRUCTURE OF WILD TYPE DUCK DELTA 1 CRYSTALLIN (EYE LENS PROTEIN) 1HY1 ; 2.30 ; CRYSTAL STRUCTURE OF WILD TYPE DUCK DELTA 2 CRYSTALLIN (EYE LENS PROTEIN) 7PCK ; 3.20 ; CRYSTAL STRUCTURE OF WILD TYPE HUMAN PROCATHEPSIN K 1PJI ; 1.90 ; CRYSTAL STRUCTURE OF WILD TYPE LACTOCOCCUS LACTIS FPG COMPLEXED TO A 1,3 PROPANEDIOL CONTAINING DEOXYRIBONUCLEIC ACID 1PM5 ; 1.95 ; CRYSTAL STRUCTURE OF WILD TYPE LACTOCOCCUS LACTIS FPG COMPLEXED TO A TETRAHYDROFURAN CONTAINING DEOXYRIBONUCLEIC ACID 1I0A ; 2.50 ; CRYSTAL STRUCTURE OF WILD TYPE TURKEY DELTA 1 CRYSTALLIN (EYE LENS PROTEIN) 1XAE ; 2.70 ; CRYSTAL STRUCTURE OF WILD TYPE YELLOW FLUORESCENT PROTEIN ZFP538 FROM ZOANTHUS 1QRX ; 1.60 ; CRYSTAL STRUCTURE OF WILD-TYPE ALPHA-LYTIC PROTEASE AT 1.6 A, PH 5.14 1FS3 ; 1.40 ; CRYSTAL STRUCTURE OF WILD-TYPE BOVINE PANCREATIC RIBONUCLEASE A 1TJR ; 2.30 ; CRYSTAL STRUCTURE OF WILD-TYPE BX1 COMPLEXED WITH A SULFATE ION 1OUQ ; 3.20 ; CRYSTAL STRUCTURE OF WILD-TYPE CRE RECOMBINASE-LOXP SYNAPSE 1UC0 ; 1.85 ; CRYSTAL STRUCTURE OF WILD-TYPE HEN-EGG WHITE LYSOZYME SINGLY LABELED WITH 2',3'-EPOXYPROPYL BETA-GLYCOSIDE OF N- ACETYLLACTOSAMINE 1EJX ; 1.60 ; CRYSTAL STRUCTURE OF WILD-TYPE KLEBSIELLA AEROGENES UREASE AT 100K 1EJW ; 1.90 ; CRYSTAL STRUCTURE OF WILD-TYPE KLEBSIELLA AEROGENES UREASE AT 298K 2WSY ; 2.30 ; CRYSTAL STRUCTURE OF WILD-TYPE TRYPTOPHAN SYNTHASE 1XC4 ; 2.80 ; CRYSTAL STRUCTURE OF WILD-TYPE TRYPTOPHAN SYNTHASE ALPHA- SUBUNITS FROM ESCHERICHIA COLI 1TJP ; 1.50 ; CRYSTAL STRUCTURE OF WILD-TYPE TRYPTOPHAN SYNTHASE COMPLEXED WITH 1-[(2-HYDROXYLPHENYL)AMINO]3- GLYCEROLPHOSPHATE 1A50 ; 2.30 ; CRYSTAL STRUCTURE OF WILD-TYPE TRYPTOPHAN SYNTHASE COMPLEXED WITH 5-FLUOROINDOLE PROPANOL PHOSPHATE 1A5S ; 2.30 ; CRYSTAL STRUCTURE OF WILD-TYPE TRYPTOPHAN SYNTHASE COMPLEXED WITH 5-FLUOROINDOLE PROPANOL PHOSPHATE AND L-SER BOUND AS AMINO ACRYLATE TO THE BETA SITE 1QOQ ; 1.80 ; CRYSTAL STRUCTURE OF WILD-TYPE TRYPTOPHAN SYNTHASE COMPLEXED WITH INDOLE GLYCEROL PHOSPHATE 1QOP ; 1.40 ; CRYSTAL STRUCTURE OF WILD-TYPE TRYPTOPHAN SYNTHASE COMPLEXED WITH INDOLE PROPANOL PHOSPHATE 1KFJ ; 1.80 ; CRYSTAL STRUCTURE OF WILD-TYPE TRYPTOPHAN SYNTHASE COMPLEXED WITH L-SERINE 1K3U ; 1.70 ; CRYSTAL STRUCTURE OF WILD-TYPE TRYPTOPHAN SYNTHASE COMPLEXED WITH N-[1H-INDOL-3-YL-ACETYL]ASPARTIC ACID 1K7E ; 2.30 ; CRYSTAL STRUCTURE OF WILD-TYPE TRYPTOPHAN SYNTHASE COMPLEXED WITH N-[1H-INDOL-3-YL-ACETYL]GLYCINE ACID 1K7F ; 1.90 ; CRYSTAL STRUCTURE OF WILD-TYPE TRYPTOPHAN SYNTHASE COMPLEXED WITH N-[1H-INDOL-3-YL-ACETYL]VALINE ACID 1OWG ; 2.10 ; CRYSTAL STRUCTURE OF WT IHF COMPLEXED WITH AN ALTERED H' SITE (T44A) 1EP7 ; 2.10 ; CRYSTAL STRUCTURE OF WT THIOREDOXIN H FROM CHLAMYDOMONAS REINHARDTII 1XOD ; 1.15 ; CRYSTAL STRUCTURE OF X. TROPICALIS SPRED1 EVH-1 DOMAIN 1X1H ; 2.30 ; CRYSTAL STRUCTURE OF XANTHAN LYASE (N194A) 1X1I ; 1.80 ; CRYSTAL STRUCTURE OF XANTHAN LYASE (N194A) COMPLEXED WITH A PRODUCT 1X1J ; 2.10 ; CRYSTAL STRUCTURE OF XANTHAN LYASE (N194A) WITH A SUBSTRATE. 1JRO ; 2.70 ; CRYSTAL STRUCTURE OF XANTHINE DEHYDROGENASE FROM RHODOBACTER CAPSULATUS 1JRP ; 3.00 ; CRYSTAL STRUCTURE OF XANTHINE DEHYDROGENASE INHIBITED BY ALLOXANTHINE FROM RHODOBACTER CAPSULATUS 1FO4 ; 2.10 ; CRYSTAL STRUCTURE OF XANTHINE DEHYDROGENASE ISOLATED FROM BOVINE MILK 1FIQ ; 2.50 ; CRYSTAL STRUCTURE OF XANTHINE OXIDASE FROM BOVINE MILK 1Y0B ; 1.80 ; CRYSTAL STRUCTURE OF XANTHINE PHOSPHORIBOSYLTRANSFERASE FROM BACILLUS SUBTILIS. 1VGI ; 1.90 ; CRYSTAL STRUCTURE OF XENON BOUND RAT HEME-HEME OXYGENASE-1 COMPLEX 1U20 ; 2.10 ; CRYSTAL STRUCTURE OF XENOPUS LAEVIS NUDIX HYDROLASE NUCLEAR SNORNA DECAPPING PROTEIN X29 1MG7 ; 1.55 ; CRYSTAL STRUCTURE OF XOL-1 1YRZ ; 2.00 ; CRYSTAL STRUCTURE OF XYLAN BETA-1,4-XYLOSIDASE FROM BACILLUS HALODURANS C-125 1TA3 ; 1.70 ; CRYSTAL STRUCTURE OF XYLANASE (GH10) IN COMPLEX WITH INHIBITOR (XIP) 1V6W ; 2.00 ; CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH 2(2)-4-O-METHYL-ALPHA- D-GLUCURONOSYL-XYLOBIOSE 1V6U ; 2.10 ; CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH 2(2)-ALPHA-L- ARABINOFURANOSYL-XYLOBIOSE 1V6V ; 2.10 ; CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH 3(2)-ALPHA-L- ARABINOFURANOSYL-XYLOTRIOSE 1V6X ; 2.10 ; CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH 3(3)-4-O-METHYL-ALPHA- D-GLUCURONOSYL-XYLOTRIOSE 1ISZ ; 2.00 ; CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH GALACTOSE 1ISY ; 2.10 ; CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH GLUCOSE 1IT0 ; 2.00 ; CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH LACTOSE 1ISW ; 2.10 ; CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH XYLOBIOSE 1ISV ; 2.10 ; CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH XYLOSE 1ISX ; 2.10 ; CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH XYLOTRIOSE 1OM0 ; 1.80 ; CRYSTAL STRUCTURE OF XYLANASE INHIBITOR PROTEIN (XIP-I) FROM WHEAT 1QT1 ; 1.85 ; CRYSTAL STRUCTURE OF XYLOSE ISOMERASE FROM STREPTOMYCES DIASTATICUS NO.7 M1033 AT 1.85 A RESOLUTION 1F5J ; 1.80 ; CRYSTAL STRUCTURE OF XYNB, A HIGHLY THERMOSTABLE BETA-1,4- XYLANASE FROM DICTYOGLOMUS THERMOPHILUM RT46B.1, AT 1.8 A RESOLUTION 1UKT ; 2.20 ; CRYSTAL STRUCTURE OF Y100L MUTANT CYCLODEXTRIN GLUCANOTRANSFERASE COMPEXED WITH AN ACARBOSE 1JKH ; 2.50 ; CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DMP-266(EFAVIRENZ) 1JLB ; 3.00 ; CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE 1JLC ; 3.00 ; CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH PETT-2 1JLA ; 2.50 ; CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH TNK-651 1JLE ; 2.80 ; CRYSTAL STRUCTURE OF Y188C MUTANT HIV-1 REVERSE TRANSCRIPTASE 1JLF ; 2.60 ; CRYSTAL STRUCTURE OF Y188C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE 1JLG ; 2.60 ; CRYSTAL STRUCTURE OF Y188C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH UC-781 1SV4 ; 2.15 ; CRYSTAL STRUCTURE OF YAN-SAM 1SV0 ; 2.07 ; CRYSTAL STRUCTURE OF YAN-SAM/MAE-SAM COMPLEX 1RLM ; 1.90 ; CRYSTAL STRUCTURE OF YBIV FROM ESCHERICHIA COLI K12 1YIX ; 1.90 ; CRYSTAL STRUCTURE OF YCFH, TATD HOMOLOG FROM ESCHERICHIA COLI K12, AT 1.9 A RESOLUTION 1JX7 ; 2.80 ; CRYSTAL STRUCTURE OF YCHN PROTEIN FROM E.COLI 1M3S ; 1.95 ; CRYSTAL STRUCTURE OF YCKF FROM BACILLUS SUBTILIS 2F9C ; 2.80 ; CRYSTAL STRUCTURE OF YDCK FROM SALMONELLA CHOLERAE. NESG TARGET SCR6 1RW7 ; 1.80 ; CRYSTAL STRUCTURE OF YDR533CP 1N0H ; 2.80 ; CRYSTAL STRUCTURE OF YEAST ACETOHYDROXYACID SYNTHASE IN COMPLEX WITH A SULFONYLUREA HERBICIDE, CHLORIMURON ETHYL 1T9B ; 2.20 ; CRYSTAL STRUCTURE OF YEAST ACETOHYDROXYACID SYNTHASE IN COMPLEX WITH A SULFONYLUREA HERBICIDE, CHLORSULFURON 1T9D ; 2.30 ; CRYSTAL STRUCTURE OF YEAST ACETOHYDROXYACID SYNTHASE IN COMPLEX WITH A SULFONYLUREA HERBICIDE, METSULFURON METHYL 1T9C ; 2.34 ; CRYSTAL STRUCTURE OF YEAST ACETOHYDROXYACID SYNTHASE IN COMPLEX WITH A SULFONYLUREA HERBICIDE, SULFOMETURON METHYL 1T9A ; 2.59 ; CRYSTAL STRUCTURE OF YEAST ACETOHYDROXYACID SYNTHASE IN COMPLEX WITH A SULFONYLUREA HERBICIDE, TRIBENURON METHYL 1RY2 ; 2.30 ; CRYSTAL STRUCTURE OF YEAST ACETYL-COENZYME A SYNTHETASE IN COMPLEX WITH AMP 1S4N ; 2.01 ; CRYSTAL STRUCTURE OF YEAST ALPHA1,2-MANNOSYLTRANSFERASE KRE2P/MNT1P 1S4O ; 2.01 ; CRYSTAL STRUCTURE OF YEAST ALPHA1,2-MANNOSYLTRANSFERASE KRE2P/MNT1P: BINARY COMPLEX WITH GDP/MN 1S4P ; 2.01 ; CRYSTAL STRUCTURE OF YEAST ALPHA1,2-MANNOSYLTRANSFERASE KRE2P/MNT1P: TERNARY COMPLEX WITH GDP/MN AND METHYL-ALPHA- MANNOSIDE ACCEPTOR 1G6Q ; 2.90 ; CRYSTAL STRUCTURE OF YEAST ARGININE METHYLTRANSFERASE, HMT1 1F7V ; 2.90 ; CRYSTAL STRUCTURE OF YEAST ARGINYL-TRNA SYNTHETASE COMPLEXED WITH THE TRNAARG 1J70 ; 2.30 ; CRYSTAL STRUCTURE OF YEAST ATP SULFURYLASE 1F18 ; 1.70 ; CRYSTAL STRUCTURE OF YEAST COPPER-ZINC SUPEROXIDE DISMUTASE MUTANT GLY85ARG 1F1G ; 1.35 ; CRYSTAL STRUCTURE OF YEAST CUZNSOD EXPOSED TO NITRIC OXIDE 1VDN ; 1.60 ; CRYSTAL STRUCTURE OF YEAST CYCLOPHILIN A COMPLEXED WITH ACE- ALA-ALA-PRO-ALA-7-AMINO-4-METHYLCOUMARIN 1IST ; 1.90 ; CRYSTAL STRUCTURE OF YEAST CYCLOPHILIN A, CPR1 1OX7 ; 1.43 ; CRYSTAL STRUCTURE OF YEAST CYTOSINE DEAMINASE APO-ENZYME: INORGANIC ZINC BOUND 1JEH ; 2.40 ; CRYSTAL STRUCTURE OF YEAST E3, LIPOAMIDE DEHYDROGENASE 1N0U ; 2.12 ; CRYSTAL STRUCTURE OF YEAST ELONGATION FACTOR 2 IN COMPLEX WITH SORDARIN 1MJA ; 2.26 ; CRYSTAL STRUCTURE OF YEAST ESA1 HISTONE ACETYLTRANSFERASE DOMAIN COMPLEXED WITH ACETYL COENZYME A 1FY7 ; 2.00 ; CRYSTAL STRUCTURE OF YEAST ESA1 HISTONE ACETYLTRANSFERASE DOMAIN COMPLEXED WITH COENZYME A 1MJB ; 2.50 ; CRYSTAL STRUCTURE OF YEAST ESA1 HISTONE ACETYLTRANSFERASE E338Q MUTANT COMPLEXED WITH ACETYL COENZYME A 1MJ9 ; 2.50 ; CRYSTAL STRUCTURE OF YEAST ESA1(C304S) MUTANT COMPLEXED WITH COENZYME A 1YCD ; 1.70 ; CRYSTAL STRUCTURE OF YEAST FSH1/YHR049W, A MEMBER OF THE SERINE HYDROLASE FAMILY 1I21 ; 2.40 ; CRYSTAL STRUCTURE OF YEAST GNA1 1I1D ; 1.80 ; CRYSTAL STRUCTURE OF YEAST GNA1 BOUND TO COA AND GLNAC-6P 1EX7 ; 1.90 ; CRYSTAL STRUCTURE OF YEAST GUANYLATE KINASE IN COMPLEX WITH GUANOSINE-5'-MONOPHOSPHATE 1F1D ; 2.10 ; CRYSTAL STRUCTURE OF YEAST H46C CUZNSOD MUTANT 1F1A ; 1.80 ; CRYSTAL STRUCTURE OF YEAST H48Q CUZNSOD FALS MUTANT ANALOG 1IG8 ; 2.20 ; CRYSTAL STRUCTURE OF YEAST HEXOKINASE PII WITH THE CORRECT AMINO ACID SEQUENCE 1CT5 ; 2.00 ; CRYSTAL STRUCTURE OF YEAST HYPOTHETICAL PROTEIN YBL036C- SELENOMET CRYSTAL 1TY8 ; 2.10 ; CRYSTAL STRUCTURE OF YEAST HYPOTHETICAL PROTEIN YMX7 COMPLEXED WITH ADP 1TXZ ; 2.05 ; CRYSTAL STRUCTURE OF YEAST HYPOTHETICAL PROTEIN YMX7 COMPLEXED WITH ADP-RIBOSE 1NKQ ; 2.20 ; CRYSTAL STRUCTURE OF YEAST HYPOTHETICAL PROTEIN YNQ8_YEAST 1JZT ; 1.94 ; CRYSTAL STRUCTURE OF YEAST HYPOTHETICAL PROTEIN YNU0_YEAST 1NJR ; 1.90 ; CRYSTAL STRUCTURE OF YEAST HYPOTHETICAL PROTEIN, YMX7 1EE4 ; 2.10 ; CRYSTAL STRUCTURE OF YEAST KARYOPHERIN (IMPORTIN) ALPHA IN A COMPLEX WITH A C-MYC NLS PEPTIDE 1UN0 ; 2.60 ; CRYSTAL STRUCTURE OF YEAST KARYOPHERIN (IMPORTIN) ALPHA IN COMPLEX WITH A NUP2P N-TERMINAL FRAGMENT 1V59 ; 2.20 ; CRYSTAL STRUCTURE OF YEAST LIPOAMIDE DEHYDROGENASE COMPLEXED WITH NAD+ 1EVV ; 2.00 ; CRYSTAL STRUCTURE OF YEAST PHENYLALANINE TRANSFER RIBONUCLEIC ACID AT 2.0 A RESOLUTION 1K83 ; 2.80 ; CRYSTAL STRUCTURE OF YEAST RIBONUCLEIC ACID POLYMERASE II COMPLEXED WITH THE INHIBITOR ALPHA AMANITIN 1N9S ; 3.50 ; CRYSTAL STRUCTURE OF YEAST SMF IN SPACEGROUP P43212 1Y14 ; 2.30 ; CRYSTAL STRUCTURE OF YEAST SUBCOMPLEX OF RPB4 AND RPB7 1FIO ; 2.10 ; CRYSTAL STRUCTURE OF YEAST T-SNARE PROTEIN SSO1 1IG0 ; 1.80 ; CRYSTAL STRUCTURE OF YEAST THIAMIN PYROPHOSPHOKINASE 3TMK ; 2.00 ; CRYSTAL STRUCTURE OF YEAST THYMIDYLATE KINASE COMPLEXED WITH THE BISUBSTRATE INHIBITOR TP5A AT 2.0 A RESOLUTION: IMPLICATIONS FOR CATALYSIS AND AZT ACTIVATION 1ZX2 ; 2.10 ; CRYSTAL STRUCTURE OF YEAST UBP3-ASSOCIATED PROTEIN BRE5 2C5Q ; 1.70 ; CRYSTAL STRUCTURE OF YEAST YER010CP 1C02 ; 1.80 ; CRYSTAL STRUCTURE OF YEAST YPD1P 1W2W ; 1.75 ; CRYSTAL STRUCTURE OF YEAST YPR118W, A METHYLTHIORIBOSE-1- PHOSPHATE ISOMERASE RELATED TO REGULATORY EIF2B SUBUNITS 1IM8 ; 2.20 ; CRYSTAL STRUCTURE OF YECO FROM HAEMOPHILUS INFLUENZAE (HI0319), A METHYLTRANSFERASE WITH A BOUND S- ADENOSYLHOMOCYSTEINE 1XVI ; 2.26 ; CRYSTAL STRUCTURE OF YEDP, PHOSPHATASE-LIKE DOMAIN PROTEIN FROM ESCHERICHIA COLI K12 2A6Q ; 2.05 ; CRYSTAL STRUCTURE OF YEFM-YOEB COMPLEX 1YKS ; 1.80 ; CRYSTAL STRUCTURE OF YELLOW FEVER VIRUS NS3 HELICASE 1YMF ; 2.60 ; CRYSTAL STRUCTURE OF YELLOW FEVER VIRUS NS3 HELICASE COMPLEXED WITH ADP 1XA9 ; 2.50 ; CRYSTAL STRUCTURE OF YELLOW FLUORESCENT PROTEIN ZFP538 K66M GREEN MUTANT 1JD1 ; 1.70 ; CRYSTAL STRUCTURE OF YEO7_YEAST 1PM4 ; 1.75 ; CRYSTAL STRUCTURE OF YERSINIA PSEUDOTUBERCULOSIS-DERIVED MITOGEN (YPM) 1Q7E ; 1.60 ; CRYSTAL STRUCTURE OF YFDW PROTEIN FROM E. COLI 1RKT ; 1.95 ; CRYSTAL STRUCTURE OF YFIR, A PUTATIVE TRANSCRIPTIONAL REGULATOR FROM BACILLUS SUBTILIS 2EUC ; 2.50 ; CRYSTAL STRUCTURE OF YFMB FROM BACILLUS SUBTILIS. NESG TARGET SR324 1X6I ; 1.20 ; CRYSTAL STRUCTURE OF YGFY FROM ESCHERICHIA COLI 1X6J ; 2.00 ; CRYSTAL STRUCTURE OF YGFY FROM ESCHERICHIA COLI 1R6Y ; 2.20 ; CRYSTAL STRUCTURE OF YGIN FROM ESCHERICHIA COLI 1TUV ; 1.70 ; CRYSTAL STRUCTURE OF YGIN IN COMPLEX WITH MENADIONE 1OI4 ; 2.03 ; CRYSTAL STRUCTURE OF YHBO FROM ESCHERICHIA COLI 1TQ5 ; 1.76 ; CRYSTAL STRUCTURE OF YHHW FROM ESCHERICHIA COLI 1YM5 ; 2.05 ; CRYSTAL STRUCTURE OF YHI9, THE YEAST MEMBER OF THE PHENAZINE BIOSYNTHESIS PHZF ENZYME SUPERFAMILY. 1U0L ; 2.80 ; CRYSTAL STRUCTURE OF YJEQ FROM THERMOTOGA MARITIMA 1ZZM ; 1.80 ; CRYSTAL STRUCTURE OF YJJV, TATD HOMOLOG FROM ESCHERICHIA COLI K12, AT 1.8 A RESOLUTION 1RC6 ; 2.60 ; CRYSTAL STRUCTURE OF YLBA, A HYPOTHETICAL PROTEIN FROM E. COLI 1UQW ; 2.72 ; CRYSTAL STRUCTURE OF YLIB PROTEIN FROM ESCHERICHIA COI 2A6S ; 1.77 ; CRYSTAL STRUCTURE OF YOEB UNDER ISOPROPANOL CONDITION 2A6R ; 2.05 ; CRYSTAL STRUCTURE OF YOEB UNDER PEG CONDITION 1G9U ; 2.35 ; CRYSTAL STRUCTURE OF YOPM-LEUCINE RICH EFFECTOR PROTEIN FROM YERSINIA PESTIS 1C03 ; 2.30 ; CRYSTAL STRUCTURE OF YPD1P (TRICLINIC FORM) 1SVW ; 2.80 ; CRYSTAL STRUCTURE OF YSXC COMPLEXED WITH GMPPNP 1R0U ; 1.75 ; CRYSTAL STRUCTURE OF YWIB PROTEIN FROM BACILLUS SUBTILIS 1Y3T ; 2.40 ; CRYSTAL STRUCTURE OF YXAG, A DIOXYGENASE FROM BACILLUS SUBTILIS 1J91 ; 2.22 ; CRYSTAL STRUCTURE OF Z. MAYS CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE ATP-COMPETITIVE INHIBITOR 4,5,6,7- TETRABROMOBENZOTRIAZOLE 1P26 ; 2.92 ; CRYSTAL STRUCTURE OF ZINC(II)-D(GGCGCC)2 1ZJL ; 2.00 ; CRYSTAL STRUCTURE OF ZINC-BOUND ENGINEERED MALTOSE BINDING PROTEIN 1FBX ; 2.80 ; CRYSTAL STRUCTURE OF ZINC-CONTAINING E.COLI GTP CYCLOHYDROLASE I 1Y2G ; 1.90 ; CRYSTAL STRUCTURE OF ZIPA IN COMPLEX WITH AN INHIBITOR 1S1S ; 2.10 ; CRYSTAL STRUCTURE OF ZIPA IN COMPLEX WITH INDOLOQUINOLIZIN 10B 1S1J ; 2.18 ; CRYSTAL STRUCTURE OF ZIPA IN COMPLEX WITH INDOLOQUINOLIZIN INHIBITOR 1 1Y2F ; 2.00 ; CRYSTAL STRUCTURE OF ZIPA WITH AN INHIBITOR 1K0F ; 2.50 ; CRYSTAL STRUCTURE OF ZN(II)-FREE T. PALLIDUM TROA 1VJN ; 2.00 ; CRYSTAL STRUCTURE OF ZN-DEPENDENT HYDROLASE OF METALLO-BETA- LACTAMASE SUPERFAMILY (TM0207) FROM THERMOTOGA MARITIMA AT 2.00 A RESOLUTION 1EWC ; 1.95 ; CRYSTAL STRUCTURE OF ZN2+ LOADED STAPHYLOCOCCAL ENTEROTOXIN H 1I4H ; 2.90 ; CRYSTAL STRUCTURE OF ZN2+ SOAKED STAPHYLOCOCCAL ENTEROTOXIN A MUTANT H187A 1PQ4 ; 1.90 ; CRYSTAL STRUCTURE OF ZNUA 1P0E ; 2.40 ; CRYSTAL STRUCTURE OF ZYMOMONAS MOBILIS TRNA-GUANINE TRANSGLYCOSYLASE (TGT) COCRYSTALLISED WITH PREQ1 AT PH 5.5 1P0D ; 1.90 ; CRYSTAL STRUCTURE OF ZYMOMONAS MOBILIS TRNA-GUANINE TRANSGLYCOSYLASE (TGT) CRYSTALLISED AT PH 5.5 1Z5T ; 1.60 ; CRYSTAL STRUCTURE OF [D(CGCGAA(Z3DU)(Z3DU)CGCG)]2, Z3DU:5- (3-AMINOPROPYL)-2'-DEOXYURIDINE, IN PRESENCE OF THALLIUM I. 7ODC ; 1.60 ; CRYSTAL STRUCTURE ORNITHINE DECARBOXYLASE FROM MOUSE, TRUNCATED 37 RESIDUES FROM THE C-TERMINUS, TO 1.6 ANGSTROM RESOLUTION 1FE1 ; 3.80 ; CRYSTAL STRUCTURE PHOTOSYSTEM II 1OYJ ; 1.95 ; CRYSTAL STRUCTURE SOLUTION OF RICE GST1 (OSGSTU1) IN COMPLEX WITH GLUTATHIONE. 1T6H ; 2.01 ; CRYSTAL STRUCTURE T4 LYSOZYME INCORPORATING AN UNNATURAL AMINO ACID P-IODO-L-PHENYLALANINE AT POSITION 153 1EWQ ; 2.20 ; CRYSTAL STRUCTURE TAQ MUTS COMPLEXED WITH A HETERODUPLEX DEOXYRIBONUCLEIC ACID AT 2.2 A RESOLUTION 1XK7 ; 1.60 ; CRYSTAL STRUCTURE- C2 FORM- OF ESCHERICHIA COLI CROTONOBETAINYL-COA: CARNITINE COA TRANSFERASE (CAIB) 1XK6 ; 1.85 ; CRYSTAL STRUCTURE- P1 FORM- OF ESCHERICHIA COLI CROTONOBETAINYL-COA: CARNITINE COA TRANSFERASE (CAIB) 2BSR ; 2.30 ; CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT VIRAL PEPTIDES COMPLEXED TO HLA-B2705 2BSS ; 2.00 ; CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT VIRAL PEPTIDES COMPLEXED TO HLA-B2705 2BST ; 2.10 ; CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT VIRAL PEPTIDES COMPLEXED TO HLA-B2705 2AHR ; 2.15 ; CRYSTAL STRUCTURES OF 1-PYRROLINE-5-CARBOXYLATE REDUCTASE FROM HUMAN PATHOGEN STREPTOCOCCUS PYOGENES 1UX5 ; 2.50 ; CRYSTAL STRUCTURES OF A FORMIN HOMOLOGY-2 DOMAIN REVEAL A FLEXIBLY TETHERED DIMER ARCHITECTURE 1UX4 ; 3.30 ; CRYSTAL STRUCTURES OF A FORMIN HOMOLOGY-2 DOMAIN REVEAL A TETHERED-DIMER ARCHITECTURE 2AOA ; 1.99 ; CRYSTAL STRUCTURES OF A HIGH-AFFINITY MACROCYCLIC PEPTIDE MIMETIC IN COMPLEX WITH THE GRB2 SH2 DOMAIN 2AOB ; 1.80 ; CRYSTAL STRUCTURES OF A HIGH-AFFINITY MACROCYCLIC PEPTIDE MIMETIC IN COMPLEX WITH THE GRB2 SH2 DOMAIN 1RPI ; 1.86 ; CRYSTAL STRUCTURES OF A MULTIDRUG-RESISTANT HIV-1 PROTEASE REVEAL AN EXPANDED ACTIVE SITE CAVITY 1RQ9 ; 2.60 ; CRYSTAL STRUCTURES OF A MULTIDRUG-RESISTANT HIV-1 PROTEASE REVEAL AN EXPANDED ACTIVE SITE CAVITY 1RV7 ; 2.70 ; CRYSTAL STRUCTURES OF A MULTIDRUG-RESISTANT HIV-1 PROTEASE REVEAL AN EXPANDED ACTIVE SITE CAVITY 1S3Q ; 2.10 ; CRYSTAL STRUCTURES OF A NOVEL OPEN PORE FERRITIN FROM THE HYPERTHERMOPHILIC ARCHAEON ARCHAEOGLOBUS FULGIDUS 1SQ3 ; 2.70 ; CRYSTAL STRUCTURES OF A NOVEL OPEN PORE FERRITIN FROM THE HYPERTHERMOPHILIC ARCHAEON ARCHAEOGLOBUS FULGIDUS. 1C2Y ; 3.30 ; CRYSTAL STRUCTURES OF A PENTAMERIC FUNGAL AND AN ICOSAHEDRAL PLANT LUMAZINE SYNTHASE REVEALS THE STRUCTURAL BASIS FOR DIFFERENCES IN ASSEMBLY 1C41 ; 3.10 ; CRYSTAL STRUCTURES OF A PENTAMERIC FUNGAL AND AN ICOSAHEDRAL PLANT LUMAZINE SYNTHASE REVEALS THE STRUCTURAL BASIS FOR DIFFERENCES IN ASSEMBLY 1QB8 ; 2.00 ; CRYSTAL STRUCTURES OF ADENINE PHOSPHORIBOSYLTRANSFERASE FROM LEISHMANIA DONOVANI 1QCC ; 1.98 ; CRYSTAL STRUCTURES OF ADENINE PHOSPHORIBOSYLTRANSFERASE FROM LEISHMANIA DONOVANI 1QCD ; 2.48 ; CRYSTAL STRUCTURES OF ADENINE PHOSPHORIBOSYLTRANSFERASE FROM LEISHMANIA DONOVANI 1QB7 ; 1.50 ; CRYSTAL STRUCTURES OF ADENINE PHOSPHORIBOSYLTRANSFERASE FROM LEISHMANIA DONOVANI. 1V78 ; 2.50 ; CRYSTAL STRUCTURES OF ADENOSINE DEAMINASE COMPLEXED WITH POTENT INHIBITORS 1V79 ; 2.50 ; CRYSTAL STRUCTURES OF ADENOSINE DEAMINASE COMPLEXED WITH POTENT INHIBITORS 1V7A ; 2.50 ; CRYSTAL STRUCTURES OF ADENOSINE DEAMINASE COMPLEXED WITH POTENT INHIBITORS 2A46 ; 1.65 ; CRYSTAL STRUCTURES OF AMFP486, A CYAN FLUORESCENT PROTEIN FROM ANEMONIA MAJANO, AND VARIANTS 247D ; 2.80 ; CRYSTAL STRUCTURES OF AN A-FORM DUPLEX WITH SINGLE-ADENOSINE BULGES AND A CONFORMATIONAL BASIS FOR SITE SPECIFIC RIBONUCLEIC ACID SELF-CLEAVAGE 248D ; 1.83 ; CRYSTAL STRUCTURES OF AN A-FORM DUPLEX WITH SINGLE-ADENOSINE BULGES AND A CONFORMATIONAL BASIS FOR SITE SPECIFIC RIBONUCLEIC ACID SELF-CLEAVAGE 1R8B ; 2.00 ; CRYSTAL STRUCTURES OF AN ARCHAEAL CLASS I CCA-ADDING ENZYME AND ITS NUCLEOTIDE 1R8C ; 1.90 ; CRYSTAL STRUCTURES OF AN ARCHAEAL CLASS I CCA-ADDING ENZYME AND ITS NUCLEOTIDE 1R89 ; 1.80 ; CRYSTAL STRUCTURES OF AN ARCHAEAL CLASS I CCA-ADDING ENZYME AND ITS NUCLEOTIDE COMPLEXES 1R8A ; 2.10 ; CRYSTAL STRUCTURES OF AN ARCHAEAL CLASS I CCA-ADDING ENZYME AND ITS NUCLEOTIDE COMPLEXES 1DKR ; 2.30 ; CRYSTAL STRUCTURES OF BACILLUS SUBTILIS PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE: MOLECULAR BASIS OF ALLOSTERIC INHIBITION AND ACTIVATION. 1DKU ; 2.20 ; CRYSTAL STRUCTURES OF BACILLUS SUBTILIS PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE: MOLECULAR BASIS OF ALLOSTERIC INHIBITION AND ACTIVATION. 1M8S ; 1.90 ; CRYSTAL STRUCTURES OF CADMIUM-BINDING ACIDIC PHOSPHOLIPASE A2 FROM THE VENOM OF AGKISTRODON HALYS PALLAS AT 1.9 RESOLUTION (CRYSTAL GROWN AT PH 5.9) 1M8R ; 1.90 ; CRYSTAL STRUCTURES OF CADMIUM-BINDING ACIDIC PHOSPHOLIPASE A2 FROM THE VENOM OF AGKISTRODON HALYS PALLAS AT 1.9 RESOLUTION (CRYSTAL GROWN AT PH 7.4) 1NPZ ; 2.00 ; CRYSTAL STRUCTURES OF CATHEPSIN S INHIBITOR COMPLEXES 1NQC ; 1.80 ; CRYSTAL STRUCTURES OF CATHEPSIN S INHIBITOR COMPLEXES 1YII ; 1.42 ; CRYSTAL STRUCTURES OF CHICKEN ANNEXIN V IN COMPLEX WITH CA2+ 1YJ0 ; 2.95 ; CRYSTAL STRUCTURES OF CHICKEN ANNEXIN V IN COMPLEX WITH ZN2+ 1B4P ; 1.70 ; CRYSTAL STRUCTURES OF CLASS MU CHIMERIC GST ISOENZYMES M1-2 AND M2-1 1V7H ; 1.25 ; CRYSTAL STRUCTURES OF COLLAGEN MODEL PEPTIDES WITH PRO-HYP- GLY SEQUENCE AT 1.26 A 1V6Q ; 1.25 ; CRYSTAL STRUCTURES OF COLLAGEN MODEL PEPTIDES WITH PRO-HYP- GLY SEQUENCE AT 1.3 A 1V4F ; 1.26 ; CRYSTAL STRUCTURES OF COLLAGEN MODEL PEPTIDES WITH PRO-HYP- GLY SEQUENCE AT 1.3A 1EHE ; 1.70 ; CRYSTAL STRUCTURES OF CYTOCHROME P450NOR AND ITS MUTANTS (SER286 VAL, THR) IN THE FERRIC RESTING STATE AT CRYOGENIC TEMPERATURE: A COMPARATIVE ANALYSIS WITH MONOOXYGENASE CYTOCHROME P450S 1EHF ; 1.70 ; CRYSTAL STRUCTURES OF CYTOCHROME P450NOR AND ITS MUTANTS (SER286 VAL, THR) IN THE FERRIC RESTING STATE AT CRYOGENIC TEMPERATURE: A COMPARATIVE ANALYSIS WITH MONOOXYGENASE CYTOCHROME P450S 1EHG ; 1.70 ; CRYSTAL STRUCTURES OF CYTOCHROME P450NOR AND ITS MUTANTS (SER286 VAL, THR) IN THE FERRIC RESTING STATE AT CRYOGENIC TEMPERATURE: A COMPARATIVE ANALYSIS WITH MONOOXYGENASE CYTOCHROME P450S 319D ; 2.20 ; CRYSTAL STRUCTURES OF D(CCGGG(BR)5CCCGG) - ORTHOGONAL FORM 318D ; 2.00 ; CRYSTAL STRUCTURES OF D(CCGGGCC(BR)5CGG) - HEXAGONAL FORM 320D ; 2.15 ; CRYSTAL STRUCTURES OF D(CCGGGCCCGG) - ORTHOGONAL FORM 321D ; 2.15 ; CRYSTAL STRUCTURES OF D(CCGGGCCCGG) - ORTHOGONAL FORM 322D ; 2.50 ; CRYSTAL STRUCTURES OF D(CCGGGCCM5CGG) - HEXAGONAL FORM 323D ; 2.15 ; CRYSTAL STRUCTURES OF D(CCGGGCCM5CGG) - ORTHOGONAL FORM 324D ; 2.15 ; CRYSTAL STRUCTURES OF D(CCGGGCCM5CGG) - ORTHOGONAL FORM 325D ; 2.50 ; CRYSTAL STRUCTURES OF D(CM5CGGGCCM5CGG) - HEXAGONAL FORM 326D ; 2.15 ; CRYSTAL STRUCTURES OF D(CM5CGGGCCM5CGG) - ORTHOGONAL FORM 1R3Z ; 1.70 ; CRYSTAL STRUCTURES OF D(GM5CGM5CGCGC) AND D(GCGCGM5CGM5C): EFFECTS OF METHYLATION ON ALTERNATING DEOXYRIBONUCLEIC ACID OCTAMERS 1R41 ; 1.90 ; CRYSTAL STRUCTURES OF D(GM5CGM5CGCGC) AND D(GCGCGM5CGM5C): EFFECTS OF METHYLATION ON ALTERNATING DEOXYRIBONUCLEIC ACID OCTAMERS 327D ; 1.94 ; CRYSTAL STRUCTURES OF D(GM5CGM5CGCGCGC) 1YN3 ; 1.35 ; CRYSTAL STRUCTURES OF EAP DOMAINS FROM STAPHYLOCOCCUS AUREUS REVEAL AN UNEXPECTED HOMOLOGY TO BACTERIAL SUPERANTIGENS 1YN4 ; 1.80 ; CRYSTAL STRUCTURES OF EAP DOMAINS FROM STAPHYLOCOCCUS AUREUS REVEAL AN UNEXPECTED HOMOLOGY TO BACTERIAL SUPERANTIGENS 1YN5 ; 2.20 ; CRYSTAL STRUCTURES OF EAP DOMAINS FROM STAPHYLOCOCCUS AUREUS REVEAL AN UNEXPECTED HOMOLOGY TO BACTERIAL SUPERANTIGENS 1BU6 ; 2.37 ; CRYSTAL STRUCTURES OF ESCHERICHIA COLI GLYCEROL KINASE AND THE MUTANT A65T IN AN INACTIVE TETRAMER: CONFORMATIONAL CHANGES AND IMPLICATIONS FOR ALLOSTERIC REGULATION 1GLF ; 2.62 ; CRYSTAL STRUCTURES OF ESCHERICHIA COLI GLYCEROL KINASE AND THE MUTANT A65T IN AN INACTIVE TETRAMER: CONFORMATIONAL CHANGES AND IMPLICATIONS FOR ALLOSTERIC REGULATION 1F7D ; 1.40 ; CRYSTAL STRUCTURES OF FELINE IMMUNODEFICIENCY VIRUS DUTP PYROPHOSPHATASE AND ITS NUCLEOTIDE COMPLEXES IN THREE CRYSTAL FORMS 1F7K ; 2.20 ; CRYSTAL STRUCTURES OF FELINE IMMUNODEFICIENCY VIRUS DUTP PYROPHOSPHATASE AND ITS NUCLEOTIDE COMPLEXES IN THREE CRYSTAL FORMS. 1F7N ; 2.20 ; CRYSTAL STRUCTURES OF FELINE IMMUNODEFICIENCY VIRUS DUTP PYROPHOSPHATASE AND ITS NUCLEOTIDE COMPLEXES IN THREE CRYSTAL FORMS. 1F7O ; 2.20 ; CRYSTAL STRUCTURES OF FELINE IMMUNODEFICIENCY VIRUS DUTP PYROPHOSPHATASE AND ITS NUCLEOTIDE COMPLEXES IN THREE CRYSTAL FORMS. 1F7P ; 2.30 ; CRYSTAL STRUCTURES OF FELINE IMMUNODEFICIENCY VIRUS DUTP PYROPHOSPHATASE AND ITS NUCLEOTIDE COMPLEXES IN THREE CRYSTAL FORMS. 1F7Q ; 2.26 ; CRYSTAL STRUCTURES OF FELINE IMMUNODEFICIENCY VIRUS DUTP PYROPHOSPHATASE AND ITS NUCLEOTIDE COMPLEXES IN THREE CRYSTAL FORMS. 1F7R ; 2.50 ; CRYSTAL STRUCTURES OF FELINE IMMUNODEFICIENCY VIRUS DUTP PYROPHOSPHATASE AND ITS NUCLEOTIDE COMPLEXES IN THREE CRYSTAL FORMS. 1CL6 ; 1.70 ; CRYSTAL STRUCTURES OF FERRIC-NO COMPLEXES OF FUNGAL NITRIC OXIDE REDUCTASE AND ITS SER286 MUTANTS AT CRYOGENIC TEMPERATURE 1CMJ ; 1.70 ; CRYSTAL STRUCTURES OF FERRIC-NO COMPLEXES OF FUNGAL NITRIC OXIDE REDUCTASE AND THEIR SER286 MUTANTS AT CRYOGENIC TEMPERATURE 1CMN ; 1.70 ; CRYSTAL STRUCTURES OF FERRIC-NO COMPLEXES OF FUNGAL NITRIC OXIDE REDUCTASE AND THEIR SER286 MUTANTS AT CRYOGENIC TEMPERATURE 1TWN ; 2.20 ; CRYSTAL STRUCTURES OF FERROUS AND FERROUS-NO FORMS OF VERDOHEME IN A COMPLEX WITH HUMAN HEME OXYGENASE-1: CATALYTIC IMPLICATIONS FOR HEME CLEAVAGE 1TWR ; 2.10 ; CRYSTAL STRUCTURES OF FERROUS AND FERROUS-NO FORMS OF VERDOHEME IN A COMPLEX WITH HUMAN HEME OXYGENASE-1: CATALYTIC IMPLICATIONS FOR HEME CLEAVAGE 1OQZ ; 2.50 ; CRYSTAL STRUCTURES OF GLUTARYL 7-AMINOCEPHALOSPORANIC ACID ACYLASE: INSIGHT INTO AUTOPROTEOLYTIC ACTIVATION 1OR0 ; 2.00 ; CRYSTAL STRUCTURES OF GLUTARYL 7-AMINOCEPHALOSPORANIC ACID ACYLASE: INSIGHT INTO AUTOPROTEOLYTIC ACTIVATION 1SDT ; 1.30 ; CRYSTAL STRUCTURES OF HIV PROTEASE V82A AND L90M MUTANTS REVEAL CHANGES IN INDINAVIR BINDING SITE. 1SDU ; 1.25 ; CRYSTAL STRUCTURES OF HIV PROTEASE V82A AND L90M MUTANTS REVEAL CHANGES IN INDINAVIR BINDING SITE. 1SDV ; 1.40 ; CRYSTAL STRUCTURES OF HIV PROTEASE V82A AND L90M MUTANTS REVEAL CHANGES IN INDINAVIR BINDING SITE. 1XR8 ; 2.30 ; CRYSTAL STRUCTURES OF HLA-B1501 IN COMPLEX WITH PEPTIDES FROM HUMAN UBCH6 AND EPSTEIN-BARR VIRUS EBNA-3 1XR9 ; 1.79 ; CRYSTAL STRUCTURES OF HLA-B1501 IN COMPLEX WITH PEPTIDES FROM HUMAN UBCH6 AND EPSTEIN-BARR VIRUS EBNA-3 1EAV ; 2.60 ; CRYSTAL STRUCTURES OF HUMAN GEPHYRIN AND PLANT CNX1 G DOMAINS - COMPARATIVE ANALYSIS AND FUNCTIONAL IMPLICATIONS 1YC1 ; 1.70 ; CRYSTAL STRUCTURES OF HUMAN HSP90ALPHA COMPLEXED WITH DIHYDROXYPHENYLPYRAZOLES 1ND5 ; 2.90 ; CRYSTAL STRUCTURES OF HUMAN PROSTATIC ACID PHOSPHATASE IN COMPLEX WITH A PHOSPHATE ION AND ALPHA- BENZYLAMINOBENZYLPHOSPHONIC ACID UPDATE THE MECHANISTIC PICTURE AND OFFER NEW INSIGHTS INTO INHIBITOR DESIGN 1ND6 ; 2.40 ; CRYSTAL STRUCTURES OF HUMAN PROSTATIC ACID PHOSPHATASE IN COMPLEX WITH A PHOSPHATE ION AND ALPHA- BENZYLAMINOBENZYLPHOSPHONIC ACID UPDATE THE MECHANISTIC PICTURE AND OFFER NEW INSIGHTS INTO INHIBITOR DESIGN 1G7U ; 2.80 ; CRYSTAL STRUCTURES OF KDO8P SYNTHASE IN ITS BINARY COMPLEX WITH SUBSTRATE PHOSPHOENOL PYRUVATE 1G7V ; 2.40 ; CRYSTAL STRUCTURES OF KDO8P SYNTHASE IN ITS BINARY COMPLEXES WITH THE MECHANISM-BASED INHIBITOR 1F9T ; 1.50 ; CRYSTAL STRUCTURES OF KINESIN MUTANTS REVEAL A SIGNALLING PATHWAY FOR ACTIVATION OF THE MOTOR ATPASE 1WBX ; 1.90 ; CRYSTAL STRUCTURES OF MURINE MHC CLASS I H-2 DB AND KB MOLECULES IN COMPLEX WITH CTL EPITOPES FROM INFLUENZA A VIRUS: IMPLICATIONS FOR TCR REPERTOIRE SELECTION AND IMMUNODOMINANCE 1WBY ; 2.30 ; CRYSTAL STRUCTURES OF MURINE MHC CLASS I H-2 DB AND KB MOLECULES IN COMPLEX WITH CTL EPITOPES FROM INFLUENZA A VIRUS: IMPLICATIONS FOR TCR REPERTOIRE SELECTION AND IMMUNODOMINANCE 1WBZ ; 2.00 ; CRYSTAL STRUCTURES OF MURINE MHC CLASS I H-2 DB AND KB MOLECULES IN COMPLEX WITH CTL EPITOPES FROM INFLUENZA A VIRUS: IMPLICATIONS FOR TCR REPERTOIRE SELECTION AND IMMUNODOMINANCE 2TRS ; 2.04 ; CRYSTAL STRUCTURES OF MUTANT (BETAK87T) TRYPTOPHAN SYNTHASE ALPHA2 BETA2 COMPLEX WITH LIGANDS BOUND TO THE ACTIVE SITES OF THE ALPHA AND BETA SUBUNITS REVEAL LIGAND-INDUCED CONFORMATIONAL CHANGES 2TSY ; 2.50 ; CRYSTAL STRUCTURES OF MUTANT (BETAK87T) TRYPTOPHAN SYNTHASE ALPHA2 BETA2 COMPLEX WITH LIGANDS BOUND TO THE ACTIVE SITES OF THE ALPHA AND BETA SUBUNITS REVEAL LIGAND-INDUCED CONFORMATIONAL CHANGES 2TYS ; 1.90 ; CRYSTAL STRUCTURES OF MUTANT (BETAK87T) TRYPTOPHAN SYNTHASE ALPHA2 BETA2 COMPLEX WITH LIGANDS BOUND TO THE ACTIVE SITES OF THE ALPHA AND BETA SUBUNITS REVEAL LIGAND-INDUCED CONFORMATIONAL CHANGES 1FQE ; 1.80 ; CRYSTAL STRUCTURES OF MUTANT (K206A) THAT ABOLISH THE DILYSINE INTERACTION IN THE N-LOBE OF HUMAN TRANSFERRIN 1FQF ; 2.10 ; CRYSTAL STRUCTURES OF MUTANT (K296A) THAT ABOLISH THE DILYSINE INTERACTION IN THE N-LOBE OF HUMAN TRANSFERRIN 1DMM ; 1.90 ; CRYSTAL STRUCTURES OF MUTANT ENZYMES Y57F OF KETOSTEROID ISOMERASE FROM PSEUDOMONAS PUTIDA BIOTYPE B 1F9U ; 1.70 ; CRYSTAL STRUCTURES OF MUTANTS REVEAL A SIGNALLING PATHWAY FOR ACTIVATION OF THE KINESIN MOTOR ATPASE 1F9V ; 1.30 ; CRYSTAL STRUCTURES OF MUTANTS REVEAL A SIGNALLING PATHWAY FOR ACTIVATION OF THE KINESIN MOTOR ATPASE 1F9W ; 2.50 ; CRYSTAL STRUCTURES OF MUTANTS REVEAL A SIGNALLING PATHWAY FOR ACTIVATION OF THE KINESIN MOTOR ATPASE 1GMN ; 2.30 ; CRYSTAL STRUCTURES OF NK1-HEPARIN COMPLEXES REVEAL THE BASIS FOR NK1 ACTIVITY AND ENABLE ENGINEERING OF POTENT AGONISTS OF THE MET RECEPTOR 1GMO ; 3.00 ; CRYSTAL STRUCTURES OF NK1-HEPARIN COMPLEXES REVEAL THE BASIS FOR NK1 ACTIVITY AND ENABLE ENGINEERING OF POTENT AGONISTS OF THE MET RECEPTOR 1XD5 ; 2.00 ; CRYSTAL STRUCTURES OF NOVEL MONOMERIC MONOCOT MANNOSE- BINDING LECTINS FROM GASTRODIA ELATA 1XD6 ; 2.00 ; CRYSTAL STRUCTURES OF NOVEL MONOMERIC MONOCOT MANNOSE- BINDING LECTINS FROM GASTRODIA ELATA 1PT3 ; 2.50 ; CRYSTAL STRUCTURES OF NUCLEASE-COLE7 COMPLEXED WITH OCTAMER DEOXYRIBONUCLEIC ACID 290D ; 2.50 ; CRYSTAL STRUCTURES OF OLIGODEOXYRIBONUCLEOTIDES CONTAINING 6'-ALPHA-METHYL AND 6'-ALPHA-HYDROXY CARBOCYCLIC THYMIDINES 291D ; 2.14 ; CRYSTAL STRUCTURES OF OLIGODEOXYRIBONUCLEOTIDES CONTAINING 6'-ALPHA-METHYL AND 6'-ALPHA-HYDROXY CARBOCYCLIC THYMIDINES 5FD1 ; 1.90 ; CRYSTAL STRUCTURES OF OXIDIZED AND REDUCED AZOTOBACTER VINELANDII FERREDOXIN AT PH 8 AND PH 6 1GK9 ; 1.30 ; CRYSTAL STRUCTURES OF PENICILLIN ACYLASE ENZYME-SUBSTRATE COMPLEXES: STRUCTURAL INSIGHTS INTO THE CATALYTIC MECHANISM 1GKF ; 1.41 ; CRYSTAL STRUCTURES OF PENICILLIN ACYLASE ENZYME-SUBSTRATE COMPLEXES: STRUCTURAL INSIGHTS INTO THE CATALYTIC MECHANISM 1GM7 ; 1.45 ; CRYSTAL STRUCTURES OF PENICILLIN ACYLASE ENZYME-SUBSTRATE COMPLEXES: STRUCTURAL INSIGHTS INTO THE CATALYTIC MECHANISM 1GM8 ; 2.00 ; CRYSTAL STRUCTURES OF PENICILLIN ACYLASE ENZYME-SUBSTRATE COMPLEXES: STRUCTURAL INSIGHTS INTO THE CATALYTIC MECHANISM 1GM9 ; 1.80 ; CRYSTAL STRUCTURES OF PENICILLIN ACYLASE ENZYME-SUBSTRATE COMPLEXES: STRUCTURAL INSIGHTS INTO THE CATALYTIC MECHANISM 1Q1Y ; 1.90 ; CRYSTAL STRUCTURES OF PEPTIDE DEFORMYLASE FROM STAPHYLOCOCCUS AUREUS COMPLEXED WITH ACTINONIN 1QYC ; 2.20 ; CRYSTAL STRUCTURES OF PINORESINOL-LARICIRESINOL AND PHENYLCOUMARAN BENZYLIC ETHER REDUCTASES, AND THEIR RELATIONSHIP TO ISOFLAVONE REDUCTASES 1QYD ; 2.50 ; CRYSTAL STRUCTURES OF PINORESINOL-LARICIRESINOL AND PHENYLCOUMARAN BENZYLIC ETHER REDUCTASES, AND THEIR RELATIONSHIP TO ISOFLAVONE REDUCTASES 1TG5 ; 1.90 ; CRYSTAL STRUCTURES OF PLANT 4-HYDROXYPHENYLPYRUVATE DIOXYGENASES COMPLEXED WITH DAS645 1S1P ; 1.20 ; CRYSTAL STRUCTURES OF PROSTAGLANDIN D2 11-KETOREDUCTASE (AKR1C3) IN COMPLEX WITH THE NON-STEROIDAL ANTI- INFLAMMATORY DRUGS FLUFENAMIC ACID AND INDOMETHACIN 1S1R ; 2.00 ; CRYSTAL STRUCTURES OF PROSTAGLANDIN D2 11-KETOREDUCTASE (AKR1C3) IN COMPLEX WITH THE NON-STEROIDAL ANTI- INFLAMMATORY DRUGS FLUFENAMIC ACID AND INDOMETHACIN 1S2A ; 1.70 ; CRYSTAL STRUCTURES OF PROSTAGLANDIN D2 11-KETOREDUCTASE IN COMPLEX WITH THE NON-STEROIDAL ANTI-INFLAMMATORY DRUGS FLUFENAMIC ACID AND INDOMETHACIN 1S2C ; 1.80 ; CRYSTAL STRUCTURES OF PROSTAGLANDIN D2 11-KETOREDUCTASE IN COMPLEX WITH THE NON-STEROIDAL ANTI-INFLAMMATORY DRUGS FLUFENAMIC ACID AND INDOMETHACIN 1XH4 ; 2.45 ; CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORS IN COMPLEX WITH PROTEIN KINASE A AND MUTANTS 1XH5 ; 2.05 ; CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORS IN COMPLEX WITH PROTEIN KINASE A AND MUTANTS 1XH6 ; 1.90 ; CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORS IN COMPLEX WITH PROTEIN KINASE A AND MUTANTS 1XH7 ; 2.47 ; CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORS IN COMPLEX WITH PROTEIN KINASE A AND MUTANTS 1XH8 ; 1.60 ; CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORS IN COMPLEX WITH PROTEIN KINASE A AND MUTANTS 1XH9 ; 1.64 ; CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORS IN COMPLEX WITH PROTEIN KINASE A AND MUTANTS 1XHA ; 2.46 ; CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORS IN COMPLEX WITH PROTEIN KINASE A AND MUTANTS 1YWV ; 2.00 ; CRYSTAL STRUCTURES OF PROTO-ONCOGENE KINASE PIM1: A TARGET OF ABERRANT SOMATIC HYPERMUTATIONS IN DIFFUSE LARGE CELL LYMPHOMA 1U8Y ; 1.55 ; CRYSTAL STRUCTURES OF RAL-GPPNHP AND RAL-GDP REVEAL TWO NOVEL BINDING SITES THAT ARE ALSO PRESENT IN RAS AND RAP 1U8Z ; 1.50 ; CRYSTAL STRUCTURES OF RAL-GPPNHP AND RAL-GDP REVEAL TWO NOVEL BINDING SITES THAT ARE ALSO PRESENT IN RAS AND RAP 1U90 ; 2.00 ; CRYSTAL STRUCTURES OF RAL-GPPNHP AND RAL-GDP REVEAL TWO NOVEL BINDING SITES THAT ARE ALSO PRESENT IN RAS AND RAP 1IPK ; 2.70 ; CRYSTAL STRUCTURES OF RECOMBINANT AND NATIVE SOYBEAN BETA- CONGLYCININ BETA HOMOTRIMERS 1IPJ ; 2.70 ; CRYSTAL STRUCTURES OF RECOMBINANT AND NATIVE SOYBEAN BETA- CONGLYCININ BETA HOMOTRIMERS COMPLEXES WITH N-ACETYL-D- GLUCOSAMINE 1RMS ; 1.90 ; CRYSTAL STRUCTURES OF RIBONUCLEASE MS COMPLEXED WITH 3'- GUANYLIC ACID A GPC ANALOGUE, 2'-DEOXY-2'-FLUOROGUANYLYL- 3',5'-CYTIDINE 1EQ4 ; 1.80 ; CRYSTAL STRUCTURES OF SALT BRIDGE MUTANTS OF HUMAN LYSOZYME 1EQ5 ; 1.80 ; CRYSTAL STRUCTURES OF SALT BRIDGE MUTANTS OF HUMAN LYSOZYME 1EQE ; 1.80 ; CRYSTAL STRUCTURES OF SALT BRIDGE MUTANTS OF HUMAN LYSOZYME 1FZP ; 2.95 ; CRYSTAL STRUCTURES OF SARA: A PLEIOTROPIC REGULATOR OF VIRULENCE GENES IN S. AUREUS 2A5K ; 2.30 ; CRYSTAL STRUCTURES OF SARS CORONAVIRUS MAIN PEPTIDASE INHIBITED BY AN AZA-PEPTIDE EPOXIDE IN SPACE GROUP P212121 2A5I ; 1.88 ; CRYSTAL STRUCTURES OF SARS CORONAVIRUS MAIN PEPTIDASE INHIBITED BY AN AZA-PEPTIDE EPOXIDE IN THE SPACE GROUP C2 1QPP ; 2.60 ; CRYSTAL STRUCTURES OF SELF CAPPING PAPD CHAPERONE HOMODIMERS 1QPX ; 2.40 ; CRYSTAL STRUCTURES OF SELF-CAPPING PAPD CHAPERONE HOMODIMERS 1GY1 ; 1.65 ; CRYSTAL STRUCTURES OF SER86ASP AND MET148LEU RUSTICYANIN 2AXH ; 2.70 ; CRYSTAL STRUCTURES OF T CELL RECEPTOR BETA CHAINS RELATED TO RHEUMATOID ARTHRITIS 2AXJ ; 2.65 ; CRYSTAL STRUCTURES OF T CELL RECEPTOR BETA CHAINS RELATED TO RHEUMATOID ARTHRITIS 1THN ; 2.50 ; CRYSTAL STRUCTURES OF THE ADP AND ATP BOUND FORMS OF THE BACILLUS ANTI-SIGMA FACTOR SPOIIAB IN COMPLEX WITH THE ANTI-ANTI-SIGMA SPOIIAA: INHIBITORY COMPLEX WITH ADP, CRYSTAL FORM I 1TH8 ; 2.40 ; CRYSTAL STRUCTURES OF THE ADP AND ATP BOUND FORMS OF THE BACILLUS ANTI-SIGMA FACTOR SPOIIAB IN COMPLEX WITH THE ANTI-ANTI-SIGMA SPOIIAA: INHIBITORY COMPLEX WITH ADP, CRYSTAL FORM II 1TID ; 2.50 ; CRYSTAL STRUCTURES OF THE ADP AND ATP BOUND FORMS OF THE BACILLUS ANTI-SIGMA FACTOR SPOIIAB IN COMPLEX WITH THE ANTI-ANTI-SIGMA SPOIIAA: POISED FOR PHOSPHORYLATION COMPLEX WITH ATP, CRYSTAL FORM I 1TIL ; 2.70 ; CRYSTAL STRUCTURES OF THE ADP AND ATP BOUND FORMS OF THE BACILLUS ANTI-SIGMA FACTOR SPOIIAB IN COMPLEX WITH THE ANTI-ANTI-SIGMA SPOIIAA:POISED FOR PHOSPHORYLATION COMPLEX WITH ATP, CRYSTAL FORM II 1HZ6 ; 1.70 ; CRYSTAL STRUCTURES OF THE B1 DOMAIN OF PROTEIN L FROM PEPTOSTREPTOCOCCUS MAGNUS WITH A TYROSINE TO TRYPTOPHAN SUBSTITUTION 1HZ5 ; 1.80 ; CRYSTAL STRUCTURES OF THE B1 DOMAIN OF PROTEIN L FROM PEPTOSTREPTOCOCCUS MAGNUS, WITH A TYROSINE TO TRYPTOPHAN SUBSTITUTION 1RO9 ; 2.13 ; CRYSTAL STRUCTURES OF THE CATALYTIC DOMAIN OF PHOSPHODIESTERASE 4B2B COMPLEXED WITH 8-BR-AMP 1ROR ; 2.00 ; CRYSTAL STRUCTURES OF THE CATALYTIC DOMAIN OF PHOSPHODIESTERASE 4B2B COMPLEXED WITH AMP 1C8C ; 1.45 ; CRYSTAL STRUCTURES OF THE CHROMOSOMAL PROTEINS SSO7D/SAC7D BOUND TO DEOXYRIBONUCLEIC ACID CONTAINING T-G MISMATCHED BASE PAIRS 1AV4 ; 2.20 ; CRYSTAL STRUCTURES OF THE COPPER-CONTAINING AMINE OXIDASE FROM ARTHROBACTER GLOBIFORMIS IN THE HOLO- AND APO-FORMS: IMPLICATIONS FOR THE BIOGENESIS OF TOPA QUINONE 1AVK ; 2.20 ; CRYSTAL STRUCTURES OF THE COPPER-CONTAINING AMINE OXIDASE FROM ARTHROBACTER GLOBIFORMIS IN THE HOLO- AND APO-FORMS: IMPLICATIONS FOR THE BIOGENESIS OF TOPA QUINONE 1AVL ; 2.80 ; CRYSTAL STRUCTURES OF THE COPPER-CONTAINING AMINE OXIDASE FROM ARTHROBACTER GLOBIFORMIS IN THE HOLO- AND APO-FORMS: IMPLICATIONS FOR THE BIOGENESIS OF TOPA QUINONE 1OZR ; 1.74 ; CRYSTAL STRUCTURES OF THE FERRIC, FERROUS AND FERROUS-NO FORMS OF THE ASP140ALA MUTANT OF HUMAN HEME OXYGENASE-1: CATALYTIC IMPLICATIONS 1OZW ; 1.55 ; CRYSTAL STRUCTURES OF THE FERRIC, FERROUS AND FERROUS-NO FORMS OF THE ASP140ALA MUTANT OF HUMAN HEME OXYGENASE-1: CATALYTIC IMPLICATIONS 1OZE ; 2.19 ; CRYSTAL STRUCTURES OF THE FERRIC, FERROUS, AND FERROUS-NO FORMS OF THE ASP140ALA MUTANT OF HUMAN HEME OXYGENASE- 1:CATALYTIC IMPLICATIONS 1OYK ; 2.59 ; CRYSTAL STRUCTURES OF THE FERRIC, FERROUS, AND FERROUS-NO FORMS OF THE ASP140ALA MUTANT OF HUMAN HEME OXYGENASE-1: CATALYTIC IMPLICATIONS 1OYL ; 1.59 ; CRYSTAL STRUCTURES OF THE FERRIC, FERROUS, AND FERROUS-NO FORMS OF THE ASP140ALA MUTANT OF HUMAN HEME OXYGENASE-1: CATALYTIC IMPLICATIONS 1OZL ; 1.58 ; CRYSTAL STRUCTURES OF THE FERRIC, FERROUS, AND FERROUS-NO FORMS OF THE ASP140ALA MUTANT OF HUMAN HEME OXYGENASE-1: CATALYTIC IMPLICATIONS 1XJZ ; 1.88 ; CRYSTAL STRUCTURES OF THE G139A, G139A-NO AND G143H MUTANTS OF HUMAN HEME OXYGENASE-1 1XK0 ; 2.18 ; CRYSTAL STRUCTURES OF THE G139A, G139A-NO AND G143H MUTANTS OF HUMAN HEME OXYGENASE-1 1XK1 ; 2.08 ; CRYSTAL STRUCTURES OF THE G139A, G139A-NO AND G143H MUTANTS OF HUMAN HEME OXYGENASE-1 1G4A ; 3.00 ; CRYSTAL STRUCTURES OF THE HSLVU PEPTIDASE-ATPASE COMPLEX REVEAL AN ATP-DEPENDENT PROTEOLYSIS MECHANISM 1G4B ; 7.00 ; CRYSTAL STRUCTURES OF THE HSLVU PEPTIDASE-ATPASE COMPLEX REVEAL AN ATP-DEPENDENT PROTEOLYSIS MECHANISM 1WD0 ; 1.90 ; CRYSTAL STRUCTURES OF THE HYPERTHERMOPHILIC CHROMOSOMAL PROTEIN SAC7D IN COMPLEX WITH DEOXYRIBONUCLEIC ACID DECAMERS 1WD1 ; 2.20 ; CRYSTAL STRUCTURES OF THE HYPERTHERMOPHILIC CHROMOSOMAL PROTEIN SAC7D IN COMPLEX WITH DEOXYRIBONUCLEIC ACID DECAMERS 1UIV ; 1.95 ; CRYSTAL STRUCTURES OF THE LIGANDED AND UNLIGANDED NICKEL BINDING PROTEIN NIKA FROM ESCHERICHIA COLI (NICKEL LIGANDED FORM) 1UIU ; 1.85 ; CRYSTAL STRUCTURES OF THE LIGANDED AND UNLIGANDED NICKEL BINDING PROTEIN NIKA FROM ESCHERICHIA COLI (NICKEL UNLIGANDED FORM) 2AEM ; 2.80 ; CRYSTAL STRUCTURES OF THE MTHK RCK DOMAIN 2AEF ; 1.70 ; CRYSTAL STRUCTURES OF THE MTHK RCK DOMAIN IN CA2+ BOUND FORM 2AEJ ; 2.10 ; CRYSTAL STRUCTURES OF THE MTHK RCK DOMAIN IN NO CA2+ BOUND FORM 1S7U ; 2.20 ; CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV- DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS 1S7V ; 2.20 ; CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV- DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS 1S7W ; 2.40 ; CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV- DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS 1S7X ; 2.41 ; CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV- DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS 1S7Q ; 1.99 ; CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2KB IN COMPLEX WITH LCMV- DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS 1S7R ; 2.95 ; CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2KB IN COMPLEX WITH LCMV- DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS 1S7S ; 1.99 ; CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2KB IN COMPLEX WITH LCMV- DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS 1S7T ; 2.30 ; CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2KB IN COMPLEX WITH LCMV- DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS 1D0E ; 3.00 ; CRYSTAL STRUCTURES OF THE N-TERMINAL FRAGMENT FROM MOLONEY MURINE LEUKEMIA VIRUS REVERSE TRANSCRIPTASE COMPLEXED WITH NUCLEIC ACID: FUNCTIONAL IMPLICATIONS FOR TEMPLATE-PRIMER BINDING TO THE FINGERS DOMAIN 1QAI ; 2.30 ; CRYSTAL STRUCTURES OF THE N-TERMINAL FRAGMENT FROM MOLONEY MURINE LEUKEMIA VIRUS REVERSE TRANSCRIPTASE COMPLEXED WITH NUCLEIC ACID: FUNCTIONAL IMPLICATIONS FOR TEMPLATE-PRIMER BINDING TO THE FINGERS DOMAIN 1QAJ ; 2.30 ; CRYSTAL STRUCTURES OF THE N-TERMINAL FRAGMENT FROM MOLONEY MURINE LEUKEMIA VIRUS REVERSE TRANSCRIPTASE COMPLEXED WITH NUCLEIC ACID: FUNCTIONAL IMPLICATIONS FOR TEMPLATE-PRIMER BINDING TO THE FINGERS DOMAIN 1P3T ; 2.10 ; CRYSTAL STRUCTURES OF THE NO-AND CO-BOUND HEME OXYGENASE FROM NEISSERIA MENINGITIDIS: IMPLICATIONS FOR OXYGEN ACTIVATION 1P3U ; 1.75 ; CRYSTAL STRUCTURES OF THE NO-AND CO-BOUND HEME OXYGENASE FROM NEISSERIA MENINGITIDIS: IMPLICATIONS FOR OXYGEN ACTIVATION 1P3V ; 2.25 ; CRYSTAL STRUCTURES OF THE NO-AND CO-BOUND HEME OXYGENASE FROM NEISSERIA MENINGITIDIS: IMPLICATIONS FOR OXYGEN ACTIVATION 1MZ8 ; 2.00 ; CRYSTAL STRUCTURES OF THE NUCLEASE DOMAIN OF COLE7/IM7 IN COMPLEX WITH A PHOSPHATE ION AND A ZINC ION 1U54 ; 2.80 ; CRYSTAL STRUCTURES OF THE PHOSPHORYLATED AND UNPHOSPHORYLATED KINASE DOMAINS OF THE CDC42-ASSOCIATED TYROSINE KINASE ACK1 BOUND TO AMP-PCP 1IYZ ; 2.80 ; CRYSTAL STRUCTURES OF THE QUINONE OXIDOREDUCTASE FROM THERMUS THERMOPHILUS HB8 AND ITS COMPLEX WITH NADPH 1IZ0 ; 2.30 ; CRYSTAL STRUCTURES OF THE QUINONE OXIDOREDUCTASE FROM THERMUS THERMOPHILUS HB8 AND ITS COMPLEX WITH NADPH 1MHX ; 1.80 ; CRYSTAL STRUCTURES OF THE REDESIGNED PROTEIN G VARIANT NUG1 1I94 ; 3.20 ; CRYSTAL STRUCTURES OF THE SMALL RIBOSOMAL SUBUNIT WITH TETRACYCLINE, EDEINE AND IF3 1Z1W ; 2.70 ; CRYSTAL STRUCTURES OF THE TRICORN INTERACTING FACOR F3 FROM THERMOPLASMA ACIDOPHILUM, A ZINC AMINOPEPTIDASE IN THREE DIFFERENT CONFORMATIONS 1Z5H ; 2.30 ; CRYSTAL STRUCTURES OF THE TRICORN INTERACTING FACTOR F3 FROM THERMOPLASMA ACIDOPHILUM 2AAG ; 1.85 ; CRYSTAL STRUCTURES OF THE WILD-TYPE, MUTANT-P1A AND INACTIVATED MALONATE SEMIALDEHYDE DECARBOXYLASE: A STRUCTURAL BASIS FOR THE DECARBOXYLASE AND HYDRATASE ACTIVITIES 2AAJ ; 2.74 ; CRYSTAL STRUCTURES OF THE WILD-TYPE, MUTANT-P1A AND INACTIVATED MALONATE SEMIALDEHYDE DECARBOXYLASE: A STRUCTURAL BASIS FOR THE DECARBOXYLASE AND HYDRATASE ACTIVITIES 2AAL ; 1.65 ; CRYSTAL STRUCTURES OF THE WILD-TYPE, MUTANT-P1A AND INACTIVATED MALONATE SEMIALDEHYDE DECARBOXYLASE: A STRUCTURAL BASIS FOR THE DECARBOXYLASE AND HYDRATASE ACTIVITIES 1A4W ; 1.80 ; CRYSTAL STRUCTURES OF THROMBIN WITH THIAZOLE-CONTAINING INHIBITORS: PROBES OF THE S1' BINDING SITE 1KSX ; 3.20 ; CRYSTAL STRUCTURES OF TWO INTERMEDIATES IN THE ASSEMBLY OF THE PAPILLOMAVIRUS REPLICATION INITIATION COMPLEX 1KSY ; 3.05 ; CRYSTAL STRUCTURES OF TWO INTERMEDIATES IN THE ASSEMBLY OF THE PAPILLOMAVIRUS REPLICATION INITIATION COMPLEX 395D ; 1.90 ; CRYSTAL STRUCTURES OF TWO ISOMORPHOUS A-DEOXYRIBONUCLEIC ACID DECAMERS D(GTACGCGTAC) AND D(GGCCGCGGCC) 396D ; 1.80 ; CRYSTAL STRUCTURES OF TWO ISOMORPHOUS A-DEOXYRIBONUCLEIC ACID DECAMERS D(GTACGCGTAC) AND D(GGCCGCGGCC) 1PZV ; 2.52 ; CRYSTAL STRUCTURES OF TWO UBC (E2) ENZYMES OF THE UBIQUITIN- CONJUGATING SYSTEM IN CAENORHABDITIS ELEGANS 1Q34 ; 2.90 ; CRYSTAL STRUCTURES OF TWO UBC (E2) ENZYMES OF THE UBIQUITIN- CONJUGATING SYSTEM IN CAENORHABDITIS ELEGANS 1UIW ; 1.50 ; CRYSTAL STRUCTURES OF UNLIGANDED AND HALF-LIGANDED HUMAN HEMOGLOBIN DERIVATIVES CROSS-LINKED BETWEEN LYS 82BETA1 AND LYS 82BETA2 1S2N ; 2.44 ; CRYSTAL STRUCURE OF A COLD ADAPTED SUBTILISIN-LIKE SERINE PROTEINASE 1UMG ; 1.80 ; CRYSTAL STRUCURE OF FRUCTOSE-1,6-BISPHOSPHATASE 1WOV ; 1.75 ; CRYSTAL STRUCURE OF HEME OXYGENASE-2 FROM SYNECHOCYSTIS SP. PCC 6803 IN COMPLEX WITH HEME 1NKI ; 0.95 ; CRYSTAL STRUCURE OF THE FOSFOMYCIN RESISTANCE PROTEIN A (FOSA) CONTAINING BOUND PHOSPHONOFORMATE 1ZYE ; 3.30 ; CRYSTAL STRUCUTRE ANALYSIS OF BOVINE MITOCHONDRIAL PEROXIREDOXIN III 1MXG ; 1.60 ; CRYSTAL STRUCUTRE OF A (CA,ZN)-DEPENDENT ALPHA-AMYLASE FROM THE HYPERTHERMOPHILIC ARCHAEON PYROCOCCUS WOESEI IN COMPLEX WITH ACARBOSE 1YVY ; 2.35 ; CRYSTAL STRUCUTRE OF ANAEROBIOSPIRILLUM SUCCINICIPRODUCENS PHOSPHOENOLPYRUVATE CARBOXYKINASE 1PF3 ; 1.50 ; CRYSTAL STRUCUTURE OF THE M441L MUTANT OF THE MULTICOPPER OXIDASE CUEO 1LQO ; 2.00 ; CRYSTAL STRUTCURE OF THE FOSFOMYCIN RESISTANCE PROTEIN A (FOSA) CONTAINING BOUND THALLIUM CATIONS 1X77 ; 2.70 ; CRYSTAL STRUTURE OF A NAD(P)H-DEPENDENT FMN REDUCTASE COMPLEXED WITH FMN 1FTX ; 2.20 ; CRYSTAL STUCTURE OF ALANINE RACEMASE IN COMPLEX WITH D- ALANINE PHOSPHONATE 1N97 ; 1.80 ; CRYSTAL STUCTURE OF CYP175A1 FROM THERMUS THERMOPHILLUS STRAIN HB27 1GG6 ; 1.40 ; CRYSTAL STUCTURE OF GAMMA CHYMOTRYPSIN WITH N-ACETYL- PHENYLALANINE TRIFLUOROMETHYL KETONE BOUND AT THE ACTIVE SITE 1GGD ; 1.50 ; CRYSTAL STUCTURE OF GAMMA CHYMOTRYPSIN WITH N-ACETYL-LEUCIL- PHENYLALANINE ALDEHYDE BOUND AT THE ACTIVE SITE 1U3Y ; 1.90 ; CRYSTAL STUCTURE OF ILAC MUTANT OF DIMERISATION DOMAIN OF NF-KB P50 TRANSCRIPTION FACTOR 1TUK ; 1.12 ; CRYSTAL STUCTURE OF LIGANTED TYPE 2 NON SPECIFIC LIPID TRANSFER PROTEIN FROM WHEAT 1U3Z ; 1.90 ; CRYSTAL STUCTURE OF MLAC MUTANT OF DIMERISATION DOMAIN OF NF-KB P50 TRANSCRIPTION FACTOR 1U42 ; 2.70 ; CRYSTAL STUCTURE OF MLAM MUTANT OF DIMERISATION DOMAIN OF NF-KB P50 TRANSCRIPTION FACTOR 1U3J ; 1.90 ; CRYSTAL STUCTURE OF MLAV MUTANT OF DIMERISATION DOMAIN OF NF-KB P50 TRANSCRIPTION FACTOR 1I6A ; 2.30 ; CRYSTAL STUCTURE OF THE OXIDIZED FORM OF OXYR 1U36 ; 1.89 ; CRYSTAL STUCTURE OF WLAC MUTANT OF DIMERISATION DOMAIN OF NF-KB P50 TRANSCRIPTION FACTOR 1U41 ; 2.20 ; CRYSTAL STUCTURE OF YLGV MUTANT OF DIMERISATION DOMAIN OF NF-KB P50 TRANSCRIPTION FACTOR 1H3Q ; 2.40 ; CRYSTAL STURCTURE OF SEDL AT 2.4 ANGSTROMS RESOLUTION 1I7H ; 1.70 ; CRYSTAL STURCUTURE OF FDX 1WJX ; 1.70 ; CRYSTAL STURUCTURE OF TT0801 FROM THERMUS THERMOPHILUS 1MY2 ; 1.80 ; CRYSTAL TITRATION EXPERIMENT (AMPA COMPLEX CONTROL) 1MXW ; 1.90 ; CRYSTAL TITRATION EXPERIMENTS (AMPA CO-CRYSTALS SOAKED IN 1 MM BRW) 1MXZ ; 1.90 ; CRYSTAL TITRATION EXPERIMENTS (AMPA CO-CRYSTALS SOAKED IN 1 UM BRW) 1MXV ; 1.95 ; CRYSTAL TITRATION EXPERIMENTS (AMPA CO-CRYSTALS SOAKED IN 10 MM BRW) 1MY1 ; 1.90 ; CRYSTAL TITRATION EXPERIMENTS (AMPA CO-CRYSTALS SOAKED IN 10 NM BRW) 1MXY ; 1.95 ; CRYSTAL TITRATION EXPERIMENTS (AMPA CO-CRYSTALS SOAKED IN 10 UM BRW) 1MY0 ; 1.90 ; CRYSTAL TITRATION EXPERIMENTS (AMPA CO-CRYSTALS SOAKED IN 100 NM BRW) 1MXX ; 2.00 ; CRYSTAL TITRATION EXPERIMENTS (AMPA CO-CRYSTALS SOAKED IN 100 UM BRW) 1XEQ ; 2.10 ; CRYSTAL TRUCTURE OF RIBONUCLEIC ACID BINDING DOMAIN OF INFLUENZA B VIRUS NON-STRUCTURAL PROTEIN 1GD9 ; 1.80 ; CRYSTALL STRUCTURE OF PYROCOCCUS PROTEIN-A1 1D9D ; 2.18 ; CRYSTALL STRUCTURE OF THE COMPLEX OF DEOXYRIBONUCLEIC ACID POLYMERASE I KLENOW FRAGMENT WITH SHORT DEOXYRIBONUCLEIC ACID FRAGMENT CARRYING 2'-0- AMINOPROPYL-RIBONUCLEIC ACID MODIFICATIONS 5'-D(TCG)-AP(AUC)-3' 1M9P ; 2.10 ; CRYSTALLINE HUMAN CARBONMONOXY HEMOGLOBIN C EXHIBITS THE R2 QUATERNARY STATE AT NEUTRAL PH IN THE PRESENCE OF POLYETHYLENE GLYCOL: THE 2.1 ANGSTROM RESOLUTION CRYSTAL STRUCTURE 1NEJ ; 2.10 ; CRYSTALLINE HUMAN CARBONMONOXY HEMOGLOBIN S (LIGANDED SICKLE CELL HEMOGLOBIN) EXHIBITS THE R2 QUATERNARY STATE AT NEUTRAL PH IN THE PRESENCE OF POLYETHYLENE GLYCOL: THE 2.1 ANGSTROM RESOLUTION CRYSTAL STRUCTURE 1PVX ; 1.59 ; CRYSTALLIZATION AND PRELIMINARY X-RAY CRYSTALLOGRAPHIC STUDIES OF THERMOSTABLE XYLANASE CRYSTALS ISOLATED FROM PAECILOMYCES VARIOTI 1JW1 ; 4.00 ; CRYSTALLIZATION AND STRUCTURE DETERMINATION OF GOAT LACTOFERRIN AT 4.0 RESOLUTION: A NEW FORM OF PACKING IN LACTOFERRINS WITH A HIGH SOLVENT CONTENT IN CRYSTALS 1DEH ; 2.20 ; CRYSTALLIZATION OF HUMAN BETA1 ALCOHOL DEHYDROGENASE (15 MG/ML) IN 50 MM SODIUM PHOSPHATE (PH 7.5), 2.0 MM NAD+ AND 1 MM 4-IODOPYRAZOLE AT 25 OC, 13% (W/V) PEG 8000 1HTB ; 2.40 ; CRYSTALLIZATION OF HUMAN BETA3 ALCOHOL DEHYDROGENASE (10 MG/ML) IN 100 MM SODIUM PHOSPHATE (PH 7.5), 7.5 MM NAD+ AND 1 MM 4-IODOPYRAZOLE AT 25 C 1HIX ; 2.00 ; CRYSTALLOGRAPHIC ANALYSES OF FAMILY 11 ENDO-BETA-1,4-XYLANASE XYL1 FROM STREPTOMYCES SP. S38 1A8K ; 2.00 ; CRYSTALLOGRAPHIC ANALYSIS OF HUMAN IMMUNODEFICIENCY VIRUS 1 PROTEASE WITH AN ANALOG OF THE CONSERVED CA-P2 SUBSTRATE: INTERACTIONS WITH FREQUENTLY OCCURRING GLUTAMIC ACID RESIDUE AT P2' POSITION OF SUBSTRATES 1VPE ; 2.00 ; CRYSTALLOGRAPHIC ANALYSIS OF PHOSPHOGLYCERATE KINASE FROM THE HYPERTHERMOPHILIC BACTERIUM THERMOTOGA MARITIMA 1AJA ; 2.50 ; CRYSTALLOGRAPHIC ANALYSIS OF REVERSIBLE METAL BINDING OBSERVED IN A MUTANT (ASP153-->GLY) OF ESCHERICHIA COLI 1AJC ; 2.50 ; CRYSTALLOGRAPHIC ANALYSIS OF REVERSIBLE METAL BINDING OBSERVED IN A MUTANT (ASP153-->GLY) OF ESCHERICHIA COLI ALKALINE PHOSPHATASE 1AJD ; 2.50 ; CRYSTALLOGRAPHIC ANALYSIS OF REVERSIBLE METAL BINDING OBSERVED IN A MUTANT (ASP153-->GLY) OF ESCHERICHIA COLI ALKALINE PHOSPHATASE 2YPI ; 2.50 ; CRYSTALLOGRAPHIC ANALYSIS OF THE COMPLEX BETWEEN TRIOSEPHOSPHATE ISOMERASE AND 2-PHOSPHOGLYCOLATE AT 2.5 1SUX ; 2.00 ; CRYSTALLOGRAPHIC ANALYSIS OF THE COMPLEX BETWEEN TRIOSEPHOSPHATE ISOMERASE FROM TRYPANOSOMA CRUZI AND 3-(2- BENZOTHIAZOLYLTHIO)-1-PROPANESULFONIC ACID 1GLG ; 2.00 ; CRYSTALLOGRAPHIC ANALYSIS OF THE EPIMERIC AND ANOMERIC SPECIFICITY OF THE PERIPLASMIC TRANSPORT(SLASH)CHEMOTACTIC PROTEIN RECEPTOR FOR D-GLUCOSE AND D-GALACTOSE 1J78 ; 2.31 ; CRYSTALLOGRAPHIC ANALYSIS OF THE HUMAN VITAMIN D BINDING PROTEIN 1RQ3 ; 1.91 ; CRYSTALLOGRAPHIC ANALYSIS OF THE INTERACTION OF NITRIC OXIDE WITH QUATERNARY-T HUMAN DEOXYHEMOGLOBIN, DEOXYHEMOGLOBIN 1RQ4 ; 2.11 ; CRYSTALLOGRAPHIC ANALYSIS OF THE INTERACTION OF NITRIC OXIDE WITH QUATERNARY-T HUMAN HEMOGLOBIN, HEMOGLOBIN EXPOSED TO NO UNDER AEROBIC CONDITIONS 1RQA ; 2.11 ; CRYSTALLOGRAPHIC ANALYSIS OF THE INTERACTION OF NITRIC OXIDE WITH QUATERNARY-T HUMAN HEMOGLOBIN. BETA W73E HEMOGLOBIN EXPOSED TO NO UNDER ANAEROBIC CONDITIONS 1RPS ; 2.11 ; CRYSTALLOGRAPHIC ANALYSIS OF THE INTERACTION OF NITRIC OXIDE WITH QUATERNARY-T HUMAN HEMOGLOBIN. HEMOGLOBIN EXPOSED TO NO UNDER ANEROBIC CONDITIONS 1R4O ; 2.50 ; CRYSTALLOGRAPHIC ANALYSIS OF THE INTERACTION OF THE GLUCOCORTICOID RECEPTOR WITH DEOXYRIBONUCLEIC ACID 1R4R ; 3.00 ; CRYSTALLOGRAPHIC ANALYSIS OF THE INTERACTION OF THE GLUCOCORTICOID RECEPTOR WITH DEOXYRIBONUCLEIC ACID 4EUG ; 1.40 ; CRYSTALLOGRAPHIC AND ENZYMATIC STUDIES OF AN ACTIVE SITE VARIANT H187Q OF ESCHERICHIA COLI URACIL DEOXYRIBONUCLEIC ACID GLYCOSYLASE: CRYSTAL STRUCTURES OF MUTANT H187Q AND ITS URACIL COMPLEX 5EUG ; 1.60 ; CRYSTALLOGRAPHIC AND ENZYMATIC STUDIES OF AN ACTIVE SITE VARIANT H187Q OF ESCHERICHIA COLI URACIL DEOXYRIBONUCLEIC ACID GLYCOSYLASE: CRYSTAL STRUCTURES OF MUTANT H187Q AND ITS URACIL COMPLEX 1UZ9 ; 1.60 ; CRYSTALLOGRAPHIC AND SOLUTION STUDIES OF N-LITHOCHOLYL INSULIN: A NEW GENERATION OF PROLONGED-ACTING INSULINS. 1ZLQ ; 1.80 ; CRYSTALLOGRAPHIC AND SPECTROSCOPIC EVIDENCE FOR HIGH AFFINITY BINDING OF FE EDTA (H2O)- TO THE PERIPLASMIC NICKEL TRANSPORTER NIKA 1K08 ; 2.26 ; CRYSTALLOGRAPHIC BINDING STUDY OF 10 MM N-BENZOYL-N'-BETA-D- GLUCOPYRANOSYL UREA TO GLYCOGEN PHOSPHORYLASE B 1K06 ; 1.80 ; CRYSTALLOGRAPHIC BINDING STUDY OF 100 MM N-BENZOYL-N'-BETA- D-GLUCOPYRANOSYL UREA TO GLYCOGEN PHOSPHORYLASE B 1RRX ; 2.10 ; CRYSTALLOGRAPHIC EVIDENCE FOR ISOMERIC CHROMOPHORES IN 3- FLUOROTYROSYL-GREEN FLUORESCENT PROTEIN 1TJX ; 1.04 ; CRYSTALLOGRAPHIC IDENTIFICATION OF CA2+ COORDINATION SITES IN SYNAPTOTAGMIN I C2B DOMAIN 1TJM ; 1.18 ; CRYSTALLOGRAPHIC IDENTIFICATION OF SR2+ COORDINATION SITE IN SYNAPTOTAGMIN I C2B DOMAIN 1SK8 ; 1.65 ; CRYSTALLOGRAPHIC SNAPSHOTS OF ASPERGILLUS FUMIGATUS PHYTASE REVEALING ITS ENZYMATIC DYNAMICS 1SK9 ; 1.64 ; CRYSTALLOGRAPHIC SNAPSHOTS OF ASPERGILLUS FUMIGATUS PHYTASE REVEALING ITS ENZYMATIC DYNAMICS 1SKA ; 1.69 ; CRYSTALLOGRAPHIC SNAPSHOTS OF ASPERGILLUS FUMIGATUS PHYTASE REVEALING ITS ENZYMATIC DYNAMICS 1SKB ; 1.58 ; CRYSTALLOGRAPHIC SNAPSHOTS OF ASPERGILLUS FUMIGATUS PHYTASE REVEALING ITS ENZYMATIC DYNAMICS 1TLP ; 2.30 ; CRYSTALLOGRAPHIC STRUCTURAL ANALYSIS OF PHOSPHORAMIDATES AS INHIBITORS AND TRANSITION-STATE ANALOGS OF THERMOLYSIN 1NDR ; 3.00 ; CRYSTALLOGRAPHIC STRUCTURE OF A BLUE COPPER NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS 1UZA ; 1.50 ; CRYSTALLOGRAPHIC STRUCTURE OF A FERULOYL ESTERASE FROM ASPERGILLUS NIGER 1T0T ; 1.75 ; CRYSTALLOGRAPHIC STRUCTURE OF A PUTATIVE CHLORITE DISMUTASE 1HTO ; 2.40 ; CRYSTALLOGRAPHIC STRUCTURE OF A RELAXED GLUTAMINE SYNTHETASE FROM MYCOBACTERIUM TUBERCULOSIS 1NDS ; 2.80 ; CRYSTALLOGRAPHIC STRUCTURE OF A SUBSTRATE BOUND BLUE COPPER NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS 1U9C ; 1.35 ; CRYSTALLOGRAPHIC STRUCTURE OF APC35852 2C2B ; 2.60 ; CRYSTALLOGRAPHIC STRUCTURE OF ARABIDOPSIS THALIANA THREONINE SYNTHASE COMPLEXED WITH PYRIDOXAL PHOSPHATE AND S-ADENOSYLMETHIONINE 1URX ; 1.70 ; CRYSTALLOGRAPHIC STRUCTURE OF BETA-AGARASE A IN COMPLEX WITH OLIGOAGAROSE 1DAA ; 1.94 ; CRYSTALLOGRAPHIC STRUCTURE OF D-AMINO ACID AMINOTRANSFERASE COMPLEXED WITH PYRIDOXAL-5'-PHOSPHATE 4DAA ; 2.40 ; CRYSTALLOGRAPHIC STRUCTURE OF D-AMINO ACID AMINOTRANSFERASE IN PYRIDOXAL-5'-PHOSPHATE (PLP) FORM 2DAA ; 2.10 ; CRYSTALLOGRAPHIC STRUCTURE OF D-AMINO ACID AMINOTRANSFERASE INACTIVATED BY D-CYCLOSERINE 3DAA ; 1.90 ; CRYSTALLOGRAPHIC STRUCTURE OF D-AMINO ACID AMINOTRANSFERASE INACTIVATED BY PYRIDOXYL-D-ALANINE 1EKF ; 1.95 ; CRYSTALLOGRAPHIC STRUCTURE OF HUMAN BRANCHED CHAIN AMINO ACID AMINOTRANSFERASE (MITOCHONDRIAL) COMPLEXED WITH PYRIDOXAL-5'-PHOSPHATE AT 1.95 ANGSTROMS (ORTHORHOMBIC FORM) 1PYZ ; 1.25 ; CRYSTALLOGRAPHIC STRUCTURE OF MIMOCHROME IV 1NGK ; 2.11 ; CRYSTALLOGRAPHIC STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS HEMOGLOBIN O 2PIL ; 2.60 ; CRYSTALLOGRAPHIC STRUCTURE OF PHOSPHORYLATED PILIN FROM NEISSERIA: PHOSPHOSERINE SITES MODIFY TYPE IV PILUS SURFACE CHEMISTRY 1YIO ; 2.20 ; CRYSTALLOGRAPHIC STRUCTURE OF RESPONSE REGULATOR STYR FROM PSEUDOMONAS FLUORESCENS 1M5Y ; 3.00 ; CRYSTALLOGRAPHIC STRUCTURE OF SURA, A MOLECULAR CHAPERONE THAT FACILITATES OUTER MEMBRANE PORIN FOLDING 43C9 ; 2.20 ; CRYSTALLOGRAPHIC STRUCTURE OF THE ESTEROLYTIC AND AMIDOLYTIC 43C9 ANTIBODY 43CA ; 2.30 ; CRYSTALLOGRAPHIC STRUCTURE OF THE ESTEROLYTIC AND AMIDOLYTIC 43C9 ANTIBODY WITH BOUND P-NITROPHENOL 1IJD ; 3.00 ; CRYSTALLOGRAPHIC STRUCTURE OF THE LH3 COMPLEX FROM RHODOPSEUDOMONAS ACIDOPHILA STRAIN 7050 1G8O ; 2.30 ; CRYSTALLOGRAPHIC STRUCTURE OF THE NATIVE BOVINE ALPHA-1,3- GALACTOSYLTRANSFERASE CATALYTIC DOMAIN 1W0H ; 1.59 ; CRYSTALLOGRAPHIC STRUCTURE OF THE NUCLEASE DOMAIN OF 3'HEXO, A DEDDH FAMILY MEMBER, BOUND TO RAMP 1YC6 ; 2.90 ; CRYSTALLOGRAPHIC STRUCTURE OF THE T1 PARTICLE OF BROME MOSAIC VIRUS 1HQ7 ; 2.10 ; CRYSTALLOGRAPHIC STUDIES OF A DODECAMER B-DEOXYRIBONUCLEIC ACID D- (GCAAACGTTTGC)2 1I44 ; 2.40 ; CRYSTALLOGRAPHIC STUDIES OF AN ACTIVATION LOOP MUTANT OF THE INSULIN RECEPTOR TYROSINE KINASE 1P34 ; 2.70 ; CRYSTALLOGRAPHIC STUDIES OF NUCLEOSOME CORE PARTICLES CONTAINING HISTONE 'SIN' MUTANTS 1P3A ; 3.00 ; CRYSTALLOGRAPHIC STUDIES OF NUCLEOSOME CORE PARTICLES CONTAINING HISTONE 'SIN' MUTANTS 1P3B ; 3.00 ; CRYSTALLOGRAPHIC STUDIES OF NUCLEOSOME CORE PARTICLES CONTAINING HISTONE 'SIN' MUTANTS 1P3F ; 2.90 ; CRYSTALLOGRAPHIC STUDIES OF NUCLEOSOME CORE PARTICLES CONTAINING HISTONE 'SIN' MUTANTS 1P3G ; 2.70 ; CRYSTALLOGRAPHIC STUDIES OF NUCLEOSOME CORE PARTICLES CONTAINING HISTONE 'SIN' MUTANTS 1P3I ; 2.30 ; CRYSTALLOGRAPHIC STUDIES OF NUCLEOSOME CORE PARTICLES CONTAINING HISTONE 'SIN' MUTANTS 1P3K ; 2.90 ; CRYSTALLOGRAPHIC STUDIES OF NUCLEOSOME CORE PARTICLES CONTAINING HISTONE 'SIN' MUTANTS 1P3L ; 2.40 ; CRYSTALLOGRAPHIC STUDIES OF NUCLEOSOME CORE PARTICLES CONTAINING HISTONE 'SIN' MUTANTS 1P3M ; 2.90 ; CRYSTALLOGRAPHIC STUDIES OF NUCLEOSOME CORE PARTICLES CONTAINING HISTONE 'SIN' MUTANTS 1P3O ; 2.75 ; CRYSTALLOGRAPHIC STUDIES OF NUCLEOSOME CORE PARTICLES CONTAINING HISTONE 'SIN' MUTANTS 1P3P ; 2.70 ; CRYSTALLOGRAPHIC STUDIES OF NUCLEOSOME CORE PARTICLES CONTAINING HISTONE 'SIN' MUTANTS 1WUY ; 2.26 ; CRYSTALLOGRAPHIC STUDIES ON ACYL UREAS, A NEW CLASS OF INHIBITORS OF GLYCOGEN PHOSPHORYLASE. BROAD SPECIFICITY OF THE ALLOSTERIC SITE 1WV0 ; 2.26 ; CRYSTALLOGRAPHIC STUDIES ON ACYL UREAS, A NEW CLASS OF INHIBITORS OF GLYCOGEN PHOSPHORYLASE. BROAD SPECIFICITY OF THE ALLOSTERIC SITE 1WV1 ; 2.26 ; CRYSTALLOGRAPHIC STUDIES ON ACYL UREAS, A NEW CLASS OF INHIBITORS OF GLYCOGENPHOSPHORYLASE. BROAD SPECIFICITY OF THE ALLOSTERIC SITE 1WW2 ; 1.90 ; CRYSTALLOGRAPHIC STUDIES ON TWO BIOISOSTERIC ANALOGUES, N- ACETYL-BETA-D-GLUCOPYRANOSYLAMINE AND N-TRIFLUOROACETYL- BETA-D-GLUCOPYRANOSYLAMINE, POTENT INHIBITORS OF MUSCLE GLYCOGEN PHOSPHORYLASE 1WW3 ; 1.80 ; CRYSTALLOGRAPHIC STUDIES ON TWO BIOISOSTERIC ANALOGUES, N- ACETYL-BETA-D-GLUCOPYRANOSYLAMINE AND N-TRIFLUOROACETYL- BETA-D-GLUCOPYRANOSYLAMINE, POTENT INHIBITORS OF MUSCLE GLYCOGEN PHOSPHORYLASE 1NWO ; 1.92 ; CRYSTALLOGRAPHIC STUDY OF AZURIN FROM PSEUDOMONAS PUTIDA 1NWP ; 1.60 ; CRYSTALLOGRAPHIC STUDY OF AZURIN FROM PSEUDOMONAS PUTIDA 1KBI ; 2.30 ; CRYSTALLOGRAPHIC STUDY OF THE RECOMBINANT FLAVIN-BINDING DOMAIN OF BAKER'S YEAST FLAVOCYTOCHROME B2: COMPARISON WITH THE INTACT WILD-TYPE ENZYME 1KBJ ; 2.50 ; CRYSTALLOGRAPHIC STUDY OF THE RECOMBINANT FLAVIN-BINDING DOMAIN OF BAKER'S YEAST FLAVOCYTOCHROME B2: COMPARISON WITH THE INTACT WILD-TYPE ENZYME 1TG6 ; 2.10 ; CRYSTALLOGRAPHY AND MUTAGENESIS POINT TO AN ESSENTIAL ROLE FOR THE N-TERMINUS OF HUMAN MITOCHONDRIAL CLPP 1NWN ; 2.80 ; CRYSTALS OF CO-HBI IN WHICH THE STRUCTURE WAS CONVERTED TO ITS UNLIGATED STATE, AND THEN CONVERTED BACK TO ITS ORIGINAL CO-LIGATED STATE. 1ENS ; 2.80 ; CRYSTALS OF DEMETALLIZED CONCANAVALIN A SOAKED WITH COBALT HAVING A COBALT ION BOUND IN THE S1 SITE 1CES ; 2.70 ; CRYSTALS OF DEMETALLIZED CONCANAVALIN A SOAKED WITH ZINC HAVE A ZINC ION BOUND IN THE S1 SITE 1JYM ; 2.80 ; CRYSTALS OF PEPTIDE DEFORMYLASE FROM PLASMODIUM FALCIPARUM WITH TEN SUBUNITS PER ASYMMETRIC UNIT REVEAL CRITICAL CHARACTERISTICS OF THE ACTIVE SITE FOR DRUG DESIGN 1RQC ; 2.80 ; CRYSTALS OF PEPTIDE DEFORMYLASE FROM PLASMODIUM FALCIPARUM WITH TEN SUBUNITS PER ASYMMETRIC UNIT REVEAL CRITICAL CHARACTERISTICS OF THE ACTIVE SITE FOR DRUG DESIGN 1W0X ; 2.20 ; CRYSTALS STRUCTURE OF HUMAN CDK2 IN COMPLEX WITH THE INHIBITOR OLOMOUCINE. 1CX8 ; 3.20 ; CRYTAL STRUCTURE OF THE ECTODOMAIN OF HUMAN TRANSFERRIN RECEPTOR 1PO9 ; 2.00 ; CRYTSAL STRUCTURE OF ISOASPARTYL DIPEPTIDASE 1C0N ; 2.80 ; CSDB PROTEIN, NIFS HOMOLOGUE 1HL3 ; 3.10 ; CTBP/BARS IN TERNARY COMPLEX WITH NAD(H) AND PIDLSKK PEPTIDE 1HKU ; 2.30 ; CTBP/BARS: A DUAL-FUNCTION PROTEIN INVOLVED IN TRANSCRIPTION COREPRESSION AND GOLGI MEMBRANE FISSION 1ZFG ; 1.75 ; CTC DUPLEX B-DEOXYRIBONUCLEIC ACID 1AH1 ; -1.00 ; CTLA-4, NMR, 20 STRUCTURES 1COZ ; 2.00 ; CTP:GLYCEROL-3-PHOSPHATE CYTIDYLYLTRANSFERASE FROM BACILLUS SUBTILIS 1ZV2 ; 1.74 ; CU-CONTAINING NITRITE REDUCTASE 2A3T ; 1.85 ; CU-CONTAINING NITRITE REDUCTASE 1AQS ; -1.00 ; CU-METALLOTHIONEIN FROM SACCHAROMYCES CEREVISIAE, NMR, 10 STRUCTURES 1AQR ; -1.00 ; CU-METALLOTHIONEIN FROM SACCHAROMYCES CEREVISIAE, NMR, MINIMIZED AVERAGE STRUCTURE 2APS ; 1.90 ; CU/ZN SUPEROXIDE DISMUTASE FROM ACTINOBACILLUS PLEUROPNEUMONIAE 1IER ; 2.26 ; CUBIC CRYSTAL STRUCTURE OF NATIVE HORSE SPLEEN FERRITIN 1DAT ; 2.05 ; CUBIC CRYSTAL STRUCTURE RECOMBINANT HORSE L APOFERRITIN 2CBP ; 1.80 ; CUCUMBER BASIC PROTEIN, A BLUE COPPER PROTEIN 1F15 ; 3.20 ; CUCUMBER MOSAIC VIRUS (STRAIN FNY) 1JER ; 1.60 ; CUCUMBER STELLACYANIN, CU2+, PH 7.0 1MN3 ; 2.30 ; CUE DOMAIN OF YEAST VPS9P 1WQL ; 2.20 ; CUMENE DIOXYGENASE (CUMA1A2) FROM PSEUDOMONAS FLUORESCENS IP01 1CUU ; 1.69 ; CUTINASE, A199C MUTANT 1CUV ; 2.01 ; CUTINASE, A85F MUTANT 1CUW ; 2.70 ; CUTINASE, G82A, A85F, V184I, A185L, L189F MUTANT 1CUX ; 1.75 ; CUTINASE, L114Y MUTANT 1CUY ; 1.69 ; CUTINASE, L189F MUTANT 1CUZ ; 2.10 ; CUTINASE, L81G, L182G MUTANT 1CUA ; 1.80 ; CUTINASE, N172K MUTANT 1CUB ; 1.75 ; CUTINASE, N172K, R196D MUTANT, MONOCLINIC CRYSTAL FORM 1CUD ; 2.70 ; CUTINASE, N172K, R196D MUTANT, MONOCLINIC CRYSTAL FORM WITH THREE MOLECULES PER ASYMMETRIC UNIT 1CUC ; 1.75 ; CUTINASE, N172K, R196D MUTANT, ORTHORHOMBIC CRYSTAL FORM 1CUE ; 2.70 ; CUTINASE, Q121L MUTANT 1CUF ; 1.75 ; CUTINASE, R156L MUTANT 1CUG ; 1.75 ; CUTINASE, R17E, N172K MUTANT 1CUH ; 1.75 ; CUTINASE, R196E MUTANT 1CUI ; 2.70 ; CUTINASE, S120A MUTANT 1CUJ ; 1.60 ; CUTINASE, S120C MUTANT 1ILP ; -1.00 ; CXCR-1 N-TERMINAL PEPTIDE BOUND TO INTERLEUKIN-8 1ILQ ; -1.00 ; CXCR-1 N-TERMINAL PEPTIDE BOUND TO INTERLEUKIN-8 (MINIMIZED MEAN) 1LV9 ; -1.00 ; CXCR3 BINDING CHEMOKINE IP-10/CXCL10 1O76 ; 1.80 ; CYANIDE COMPLEX OF P450CAM FROM PSEUDOMONAS PUTIDA 1EVA ; -1.00 ; CYANOBACTERIAL TOXIN, PHOSPHATASE-1/-2A INHIBITOR, NMR 1EVB ; -1.00 ; CYANOBACTERIAL TOXIN, PHOSPHATASE-1/-2A INHIBITOR, NMR 1EVC ; -1.00 ; CYANOBACTERIAL TOXIN, PHOSPHATASE-1/-2A INHIBITOR, NMR 1EVD ; -1.00 ; CYANOBACTERIAL TOXIN, PHOSPHATASE-1/-2A INHIBITOR, NMR 1O1I ; 2.30 ; CYANOMET HEMOGLOBIN (A-GLY-C:V1M,L29F,H58Q; B,D:V1M,L106W) 1ABY ; 2.60 ; CYANOMET RHB1.1 (RECOMBINANT HEMOGLOBIN) 1J4V ; -1.00 ; CYANOVIRIN-N 3EZM ; 1.50 ; CYANOVIRIN-N 1LOM ; 1.72 ; CYANOVIRIN-N DOUBLE MUTANT P51S S52P 1THF ; 1.45 ; CYCLASE SUBUNIT OF IMIDAZOLEGLYCEROLPHOSPHATE SYNTHASE FROM THERMOTOGA MARITIMA 1KP5 ; 2.60 ; CYCLIC GREEN FLUORESCENT PROTEIN 1BZH ; 2.10 ; CYCLIC PEPTIDE INHIBITOR OF HUMAN PTP1B 1RGR ; -1.00 ; CYCLIC PEPTIDES TARGETING PDZ DOMAINS OF PSD-95: STRUCTURAL BASIS FOR ENHANCED AFFINITY AND ENZYMATIC STABILITY 1FIN ; 2.30 ; CYCLIN A - CYCLIN-DEPENDENT KINASE 2 COMPLEX 1OKW ; 2.50 ; CYCLIN A BINDING GROOVE INHIBITOR AC-ARG-ARG-LEU-ASN- (M-CL-PHE)-NH2 1URC ; 2.60 ; CYCLIN A BINDING GROOVE INHIBITOR ACE-ARG-LYS-LEU- PHE-GLY 1OKU ; 2.90 ; CYCLIN A BINDING GROOVE INHIBITOR H-ALA-ALA-ABU-ARG-ER-LEU-ILE-(P-F-PHE)-NH2 1OL2 ; 2.60 ; CYCLIN A BINDING GROOVE INHIBITOR H-ARG-ARG-LEU-ASN- (P-F-PHE)-NH2 1OKV ; 2.30 ; CYCLIN A BINDING GROOVE INHIBITOR H-ARG-ARG-LEU-ILE-PHE-NH2 1OL1 ; 2.90 ; CYCLIN A BINDING GROOVE INHIBITOR H-CIT-CIT-LEU-ILE- (P-F-PHE)-NH2 1KXU ; 2.60 ; CYCLIN H, A POSITIVE REGULATORY SUBUNIT OF CDK ACTIVATING KINASE 1KE7 ; 2.00 ; CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH 3-{[(2,2- DIOXIDO-1,3-DIHYDRO-2-BENZOTHIEN-5-YL)AMINO]METHYLENE}-5- (1,3-OXAZOL-5-YL)-1,3-DIHYDRO-2H-INDOL-2-ONE 1KE9 ; 2.00 ; CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH 3-{[4- ({[AMINO(IMINO)METHYL]AMINOSULFONYL)ANILINO]METHYLENE}-2- OXO-2,3-DIHYDRO-1H-INDOLE 1KE8 ; 2.00 ; CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH 4-{[(2-OXO- 1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}-N-(1,3- THIAZOL-2-YL)BENZENESULFONAMIDE 1KE6 ; 2.00 ; CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH N-METHYL-{4- [2-(7-OXO-6,7-DIHYDRO-8H-[1,3]THIAZOLO[5,4-E]INDOL-8- YLIDENE)HYDRAZINO]PHENYL}METHANESULFONAMIDE 1YJF ; 1.35 ; CYCLIZED POST-TRANSLATIONAL PRODUCT FOR S65A Y66S (GFPHAL) GREEN FLUORESCENT PROTEIN VARIANT 1YJ2 ; 1.50 ; CYCLIZED, NON-DEHYDRATED POST-TRANSLATIONAL PRODUCT FOR S65A Y66S H148G GFP VARIANT 1FMQ ; 2.00 ; CYCLO-BUTYL-BIS-FURAMIDINE COMPLEXED WITH DCGCGAATTCGCG 1PAM ; 1.80 ; CYCLODEXTRIN GLUCANOTRANSFERASE 2CXG ; 2.50 ; CYCLODEXTRIN GLYCOSYLTRANSFERASE COMPLEXED TO THE INHIBITOR ACARBOSE 1TCM ; 2.20 ; CYCLODEXTRIN GLYCOSYLTRANSFERASE W616A MUTANT FROM BACILLUS CIRCULANS STRAIN 251 1EA9 ; 3.20 ; CYCLOMALTODEXTRINASE 1H3G ; 2.10 ; CYCLOMALTODEXTRINASE FROM FLAVOBACTERIUM SP. NO. 92: FROM DEOXYRIBONUCLEIC ACID SEQUENCE TO PROTEIN STRUCTURE 3PGH ; 3.00 ; CYCLOOXYGENASE-2 (PROSTAGLANDIN SYNTHASE-2) COMPLEXED WITH A NON-SELECTIVE INHIBITOR, FLURBIPROFEN 4COX ; 3.00 ; CYCLOOXYGENASE-2 (PROSTAGLANDIN SYNTHASE-2) COMPLEXED WITH A NON-SELECTIVE INHIBITOR, INDOMETHACIN 1CX2 ; 3.00 ; CYCLOOXYGENASE-2 (PROSTAGLANDIN SYNTHASE-2) COMPLEXED WITH A SELECTIVE INHIBITOR, SC-558 6COX ; 3.00 ; CYCLOOXYGENASE-2 (PROSTAGLANDIN SYNTHASE-2) COMPLEXED WITH A SELECTIVE INHIBITOR, SC-558 IN I222 SPACE GROUP 1E8K ; 1.90 ; CYCLOPHILIN 3 COMPLEXED WITH DIPEPTIDE ALA-PRO 1E3B ; 1.85 ; CYCLOPHILIN 3 FROM C.ELEGANS COMPLEXED WITH AUP(ET)3 1FGL ; 1.80 ; CYCLOPHILIN A COMPLEXED WITH A FRAGMENT OF HIV-1 GAG PROTEIN 2CYH ; 1.64 ; CYCLOPHILIN A COMPLEXED WITH DIPEPTIDE ALA-PRO 5CYH ; 2.10 ; CYCLOPHILIN A COMPLEXED WITH DIPEPTIDE GLY-PRO 4CYH ; 2.10 ; CYCLOPHILIN A COMPLEXED WITH DIPEPTIDE HIS-PRO 3CYH ; 1.90 ; CYCLOPHILIN A COMPLEXED WITH DIPEPTIDE SER-PRO 1LOP ; 1.80 ; CYCLOPHILIN A COMPLEXED WITH SUCCINYL-ALA-PRO-ALA-P-NITROANILIDE 1CYN ; 1.85 ; CYCLOPHILIN B COMPLEXED WITH [D-(CHOLINYLESTER)SER8]-CYCLOSPORIN 1A58 ; 1.95 ; CYCLOPHILIN FROM BRUGIA MALAYI 1H0P ; 1.75 ; CYCLOPHILIN_5 FROM C. ELEGANS 1ZCX ; 1.61 ; CYCLOPHILIN_ABH_LIKE DOMAIN OF PEPTIDYLPROLYL ISOMERASE E ISOFORM 1 [HOMO SAPIENS] 1XQ7 ; 2.07 ; CYCLOPHILLIN FROM TRYPANOSOMA CRUZI BOUND TO CYCLOSPORIN A 1PYC ; -1.00 ; CYP1 (HAP1) DEOXYRIBONUCLEIC ACID-BINDING DOMAIN (RESIDUES 60-100), NMR, 15 STRUCTURES 1AWR ; 1.58 ; CYPA COMPLEXED WITH HAGPIA 1AWQ ; 1.58 ; CYPA COMPLEXED WITH HAGPIA (PSEUDO-SYMMETRIC MONOMER) 1AWV ; 2.34 ; CYPA COMPLEXED WITH HVGPIA 1AWU ; 2.34 ; CYPA COMPLEXED WITH HVGPIA (PSEUDO-SYMMETRIC MONOMER) 1JA1 ; 1.80 ; CYPOR-TRIPLE MUTANT 1J9Z ; 2.70 ; CYPOR-W677G 1JA0 ; 2.60 ; CYPOR-W677X 1SOG ; 1.85 ; CYRSTAL STRUCTURE OF CYTOCHROME C PEROXIDASE MUTANT: CCPK2M2 1STQ ; 1.82 ; CYRSTAL STRUCTURE OF CYTOCHROME C PEROXIDASE MUTANT: CCPK2M3 1Y6Q ; 2.20 ; CYRSTAL STRUCTURE OF MTA/ADOHCY NUCLEOSIDASE COMPLEXED WITH MT-DADME-IMMA 1G3S ; 2.40 ; CYS102SER DTXR 1G3T ; 2.35 ; CYS102SER DTXR 1O04 ; 1.42 ; CYS302SER MUTANT OF HUMAN MITOCHONDRIAL ALDEHYDE DEHYDROGENASE COMPLEXED WITH NAD+ AND MG2+ 1NZW ; 2.65 ; CYS302SER MUTANT OF HUMAN MITOCHONDRIAL ALDEHYDE DEHYDROGENASE COMPLEXED WITH NADH AND MG2+ 1YAX ; 2.40 ; CYSTAL STRUCTURE ANALYSIS OF S.TYPHIMURIUM PHOQ SENSOR DOMAIN WITH CALCIUM 1CL1 ; 1.83 ; CYSTATHIONINE BETA-LYASE (CBL) FROM ESCHERICHIA COLI 1CL2 ; 2.20 ; CYSTATHIONINE BETA-LYASE (CBL) FROM ESCHERICHIA COLI IN COMPLEX WITH AMINOETHOXYVINYLGLYCINE 1CS1 ; 1.50 ; CYSTATHIONINE GAMMA-SYNTHASE (CGS) FROM ESCHERICHIA COLI 1QGN ; 2.90 ; CYSTATHIONINE GAMMA-SYNTHASE FROM NICOTIANA TABACUM 1I41 ; 3.20 ; CYSTATHIONINE GAMMA-SYNTHASE IN COMPLEX WITH THE INHIBITOR APPA 1I48 ; 3.25 ; CYSTATHIONINE GAMMA-SYNTHASE IN COMPLEX WITH THE INHIBITOR CTCPO 1I43 ; 3.10 ; CYSTATHIONINE GAMMA-SYNTHASE IN COMPLEX WITH THE INHIBITOR PPCA 1M54 ; 2.90 ; CYSTATHIONINE-BETA SYNTHASE: REDUCED VICINAL THIOLS 1IRC ; 2.17 ; CYSTEINE RICH INTESTINAL PROTEIN 1IML ; -1.00 ; CYSTEINE RICH INTESTINAL PROTEIN, NMR, 48 STRUCTURES 1R0W ; 2.20 ; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) NUCLEOTIDE-BINDING DOMAIN ONE (NBD1) APO 1R0Y ; 2.55 ; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) NUCLEOTIDE-BINDING DOMAIN ONE (NBD1) WITH ADP 1R0X ; 2.20 ; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) NUCLEOTIDE-BINDING DOMAIN ONE (NBD1) WITH ATP 1R10 ; 3.00 ; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) NUCLEOTIDE-BINDING DOMAIN ONE (NBD1) WITH ATP, I4122 SPACE GROUP 1CKW ; -1.00 ; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR: SOLUTION STRUCTURES OF PEPTIDES BASED ON THE PHE508 REGION, THE MOST COMMON SITE OF DISEASE-CAUSING DELTA-F508 MUTATION 1CKX ; -1.00 ; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR: SOLUTION STRUCTURES OF PEPTIDES BASED ON THE PHE508 REGION, THE MOST COMMON SITE OF DISEASE-CAUSING DELTA-F508 MUTATION 1CKY ; -1.00 ; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR: SOLUTION STRUCTURES OF PEPTIDES BASED ON THE PHE508 REGION, THE MOST COMMON SITE OF DISEASE-CAUSING DELTA-F508 MUTATION 1CKZ ; -1.00 ; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR: SOLUTION STRUCTURES OF PEPTIDES BASED ON THE PHE508 REGION, THE MOST COMMON SITE OF DISEASE-CAUSING DELTA-F508 MUTATION 1KDP ; 2.30 ; CYTIDINE MONOPHOSPHATE KINASE FROM E. COLI IN COMPLEX WITH 2'-DEOXY-CYTIDINE MONOPHOSPHATE 1KDO ; 1.90 ; CYTIDINE MONOPHOSPHATE KINASE FROM E. COLI IN COMPLEX WITH CYTIDINE MONOPHOSPHATE 1KDT ; 1.95 ; CYTIDINE MONOPHOSPHATE KINASE FROM E.COLI IN COMPLEX WITH 2',3'-DIDEOXY-CYTIDINE MONOPHOSPHATE 1KDR ; 2.25 ; CYTIDINE MONOPHOSPHATE KINASE FROM E.COLI IN COMPLEX WITH ARA-CYTIDINE MONOPHOSPHATE 2CMK ; 2.00 ; CYTIDINE MONOPHOSPHATE KINASE IN COMPLEX WITH CYTIDINE-DI- PHOSPHATE 1W97 ; 2.70 ; CYTO-EPSL: THE CYTOPLASMIC DOMAIN OF EPSL, AN INNER MEMBRANE COMPONENT OF THE TYPE II SECRETION SYSTEM OF VIBRIO CHOLERAE 1YF5 ; 2.75 ; CYTO-EPSL: THE CYTOPLASMIC DOMAIN OF EPSL, AN INNER MEMBRANE COMPONENT OF THE TYPE II SECRETION SYSTEM OF VIBRIO CHOLERAE 1BE3 ; 3.00 ; CYTOCHROME BC1 COMPLEX FROM BOVINE 1BGY ; 3.00 ; CYTOCHROME BC1 COMPLEX FROM BOVINE 1BCC ; 3.16 ; CYTOCHROME BC1 COMPLEX FROM CHICKEN 1OCD ; -1.00 ; CYTOCHROME C (OXIDIZED) FROM EQUUS CABALLUS, NMR, MINIMIZED AVERAGE STRUCTURE 2FRC ; -1.00 ; CYTOCHROME C (REDUCED) FROM EQUUS CABALLUS, NMR, MINIMIZED AVERAGE STRUCTURE 1I54 ; 1.50 ; CYTOCHROME C (TUNA) 2FE:1ZN MIXED-METAL PORPHYRINS 1I55 ; 2.00 ; CYTOCHROME C (TUNA) WITH 2ZN:1FE MIXED-METAL PORPHYRINS 1CRC ; 2.08 ; CYTOCHROME C AT LOW IONIC STRENGTH 1W2L ; 1.30 ; CYTOCHROME C DOMAIN OF CAA3 OXYGEN OXIDOREDUCTASE 1IRW ; 2.00 ; CYTOCHROME C ISOZYME 1, REDUCED, MUTANT WITH ASN 52 REPLACED BY ALA AND CYS 102 REPLACED BY THR 1IRV ; 1.90 ; CYTOCHROME C ISOZYME 1, REDUCED, MUTANT WITH ILE 75 REPLACED BY MET AND CYS 102 REPLACED BY THR 1QDB ; 1.90 ; CYTOCHROME C NITRITE REDUCTASE 1OAH ; 2.30 ; CYTOCHROME C NITRITE REDUCTASE FROM DESULFOVIBRIO DESULFURICANS ATCC 27774: THE RELEVANCE OF THE TWO CALCIUM SITES IN THE STRUCTURE OF THE CATALYTIC SUBUNIT (NRFA). 1FS7 ; 1.60 ; CYTOCHROME C NITRITE REDUCTASE FROM WOLINELLA SUCCINOGENES 1FS9 ; 2.00 ; CYTOCHROME C NITRITE REDUCTASE FROM WOLINELLA SUCCINOGENES- AZIDE COMPLEX 1FS8 ; 1.60 ; CYTOCHROME C NITRITE REDUCTASE FROM WOLINELLA SUCCINOGENES- SULFATE COMPLEX 1CZJ ; 2.16 ; CYTOCHROME C OF CLASS III (AMBLER) 26 KD 1DSG ; 2.56 ; CYTOCHROME C PEROXIDASE H175G MUTANT, IMIDAZOLE COMPLEX AT PH 5, ROOM TEMPERATURE. 1DSO ; 2.03 ; CYTOCHROME C PEROXIDASE H175G MUTANT, IMIDAZOLE COMPLEX AT PH 6, ROOM TEMPERATURE. 1DSP ; 2.03 ; CYTOCHROME C PEROXIDASE H175G MUTANT, IMIDAZOLE COMPLEX AT PH 7, ROOM TEMPERATURE. 1DS4 ; 2.02 ; CYTOCHROME C PEROXIDASE H175G MUTANT, IMIDAZOLE COMPLEX, PH 6, 100K 1DSE ; 2.00 ; CYTOCHROME C PEROXIDASE H175G MUTANT, IMIDAZOLE COMPLEX, WITH PHOSPHATE BOUND, PH 6, 100K 1RYC ; 1.80 ; CYTOCHROME C PEROXIDASE W191G FROM SACCHAROMYCES CEREVISIAE 1CGN ; 2.15 ; CYTOCHROME C' 1CGO ; 1.80 ; CYTOCHROME C' 1RCP ; 2.00 ; CYTOCHROME C' 1E83 ; 2.05 ; CYTOCHROME C' FROM ALCALIGENES XYLOSOXIDANS - OXIDIZED STRUCTURE 1E84 ; 1.90 ; CYTOCHROME C' FROM ALCALIGENES XYLOSOXIDANS - REDUCED STRUCTURE 1E86 ; 1.95 ; CYTOCHROME C' FROM ALCALIGENES XYLOSOXIDANS - REDUCED STRUCTURE WITH CO BOUND TO DISTAL SIDE OF HEME 1E85 ; 1.35 ; CYTOCHROME C' FROM ALCALIGENES XYLOSOXIDANS - REDUCED STRUCTURE WITH NO BOUND TO PROXIMAL SIDE OF HEME 1GQA ; 1.80 ; CYTOCHROME C' FROM RHODOBACTER SPHERIODES 1CPQ ; 1.72 ; CYTOCHROME C' FROM RHODOPSEUDOMONAS CAPSULATA 1A7V ; 2.30 ; CYTOCHROME C' FROM RHODOPSEUDOMONAS PALUSTRIS 1C2N ; -1.00 ; CYTOCHROME C2, NMR, 20 STRUCTURES 1W7O ; 1.81 ; CYTOCHROME C3 FROM DESULFOMICROBIUM BACULATUS 3CYR ; 1.60 ; CYTOCHROME C3 FROM DESULFOVIBRIO DESULFURICANS ATCC 27774P 1I77 ; 1.95 ; CYTOCHROME C3 FROM DESULFOVIBRIO DESULFURICANS ESSEX 6 2CTH ; 1.67 ; CYTOCHROME C3 FROM DESULFOVIBRIO VULGARIS HILDENBOROUGH 1WAD ; 1.80 ; CYTOCHROME C3 WITH 4 HEME GROUPS AND ONE CALCIUM ION 1NEW ; -1.00 ; CYTOCHROME C551.5, NMR, STRUCTURES 1 - 18 OF 35 2NEW ; -1.00 ; CYTOCHROME C551.5, NMR, STRUCTURES 19 - 35 OF 35 1FOC ; 3.00 ; CYTOCHROME C557: IMPROPERLY FOLDED THERMUS THERMOPHILUS C552 1CYI ; 1.90 ; CYTOCHROME C6 1CYJ ; 1.90 ; CYTOCHROME C6 1KIB ; 3.50 ; CYTOCHROME C6 FROM ARTHROSPIRA MAXIMA: AN ASSEMBLY OF 24 SUBUNITS IN THE FORM OF AN OBLATE SHELL 1OS6 ; 1.45 ; CYTOCHROME C7 (PPCA) FROM GEOBACTER SULFURREDUCENS 1HH5 ; 1.90 ; CYTOCHROME C7 FROM DESULFUROMONAS ACETOXIDANS 1AOQ ; 1.80 ; CYTOCHROME CD1 NITRITE REDUCTASE WITH SUBSTRATE AND PRODUCT BOUND 1DY7 ; 1.60 ; CYTOCHROME CD1 NITRITE REDUCTASE, CO COMPLEX 1HJ3 ; 1.60 ; CYTOCHROME CD1 NITRITE REDUCTASE, DIOXYGEN COMPLEX 1QKS ; 1.28 ; CYTOCHROME CD1 NITRITE REDUCTASE, OXIDISED FORM 1HCM ; 2.50 ; CYTOCHROME CD1 NITRITE REDUCTASE, OXIDISED FROM FROM TETRAGONAL CRYSTALS 1E2R ; 1.59 ; CYTOCHROME CD1 NITRITE REDUCTASE, REDUCED AND CYANIDE BOUND 1AOF ; 2.00 ; CYTOCHROME CD1 NITRITE REDUCTASE, REDUCED FORM 1H9X ; 2.10 ; CYTOCHROME CD1 NITRITE REDUCTASE, REDUCED FORM 1H9Y ; 2.40 ; CYTOCHROME CD1 NITRITE REDUCTASE, REDUCED FORM COMPLEXED TO CN 1HJ5 ; 1.46 ; CYTOCHROME CD1 NITRITE REDUCTASE, REOXIDISED ENZYME 1HJ4 ; 1.60 ; CYTOCHROME CD1 NITRITE REDUCTASE, X-RAY REDUCED DIOXYGEN COMPLEX 1GQ1 ; 1.40 ; CYTOCHROME CD1 NITRITE REDUCTASE, Y25S MUTANT, OXIDISED FORM 1QN2 ; 2.01 ; CYTOCHROME CH FROM METHYLOBACTERIUM EXTORQUENS 2C8S ; 1.60 ; CYTOCHROME CL FROM METHYLOBACTERIUM EXTORQUENS 1D7D ; 1.90 ; CYTOCHROME DOMAIN OF CELLOBIOSE DEHYDROGENASE, HP3 FRAGMENT, PH 7.5 1PL3 ; 1.90 ; CYTOCHROME DOMAIN OF CELLOBIOSE DEHYDROGENASE, M65H MUTANT 1D7C ; 1.90 ; CYTOCHROME DOMAIN OF CELLOBIOSE DEHYDROGENASE, PH 4.6 1D7B ; 1.90 ; CYTOCHROME DOMAIN OF CELLOBIOSE DEHYDROGENASE, PH 7.5 1CFM ; 2.00 ; CYTOCHROME F FROM CHLAMYDOMONAS REINHARDTII 1CI3 ; 1.90 ; CYTOCHROME F FROM THE B6F COMPLEX OF PHORMIDIUM LAMINOSUM 1OXA ; 2.10 ; CYTOCHROME P450 (DONOR:O2 OXIDOREDUCTASE) 1E9X ; 2.10 ; CYTOCHROME P450 14 ALPHA-STEROL DEMETHYLASE (CYP51) FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH 4-PHENYLIMIDAZOLE 1EA1 ; 2.21 ; CYTOCHROME P450 14 ALPHA-STEROL DEMETHYLASE (CYP51) FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH FLUCONAZOLE 1H5Z ; 2.05 ; CYTOCHROME P450 14 ALPHA-STEROL DEMETHYLASE (CYP51) FROM MYCOBACTERIUM TUBERCULOSIS IN FERRIC LOW-SPIN STATE 1IZO ; 2.10 ; CYTOCHROME P450 BS BETA COMPLEXED WITH FATTY ACID 1NOO ; 2.20 ; CYTOCHROME P450CAM COMPLEXED WITH 5-EXO-HYDROXYCAMPHOR 1AKD ; 1.80 ; CYTOCHROME P450CAM FROM PSEUDOMONAS PUTIDA, COMPLEXED WITH 1S-CAMPHOR 1K2O ; 1.65 ; CYTOCHROME P450CAM WITH BOUND BIS(2,2'-BIPYRIDINE)-(5- METHYL-2-2'-BIPYRIDINE)-C2-ADAMANTANE RUTHENIUM (II) 1EGY ; 2.35 ; CYTOCHROME P450ERYF WITH 9-AMINOPHENANTHRENE BOUND 1URY ; 2.40 ; CYTOGLOBIN CAVITIES 1BC9 ; -1.00 ; CYTOHESIN-1/B2-1 SEC7 DOMAIN, NMR, MINIMIZED AVERAGE STRUCTURE 2B5I ; 2.30 ; CYTOKINE RECEPTOR COMPLEX 1INR ; 2.00 ; CYTOKINE SYNTHESIS 1BQU ; 2.00 ; CYTOKYNE-BINDING REGION OF GP130 1IAS ; 2.90 ; CYTOPLASMIC DOMAIN OF UNPHOSPHORYLATED TYPE I TGF-BETA RECEPTOR CRYSTALLIZED WITHOUT FKBP12 1U47 ; 2.00 ; CYTOSINE-8-OXOGUANINE BASE PAIR AT THE POLYMERASE ACTIVE SITE 1NK6 ; 2.10 ; CYTOSINE-CYTOSINE MISMATCH AT THE POLYMERASE ACTIVE SITE 7MHT ; 2.87 ; CYTOSINE-SPECIFIC METHYLTRANSFERASE HHAI/DEOXYRIBONUCLEIC ACID COMPLEX 8MHT ; 2.76 ; CYTOSINE-SPECIFIC METHYLTRANSFERASE HHAI/DEOXYRIBONUCLEIC ACID COMPLEX 9MHT ; 2.39 ; CYTOSINE-SPECIFIC METHYLTRANSFERASE HHAI/DEOXYRIBONUCLEIC ACID COMPLEX 1NJZ ; 2.00 ; CYTOSINE-THYMINE MISMATCH AT THE POLYMERASE ACTIVE SITE 1NZN ; 2.00 ; CYTOSOLIC DOMAIN OF THE HUMAN MITCHONDRIAL FISSION PROTEIN FIS1 ADOPTS A TPR FOLD 1A5P ; 1.60 ; C[40,95]A VARIANT OF BOVINE PANCREATIC RIBONUCLEASE A 2CRS ; -1.00 ; Cardiotoxin III from Taiwan Cobra (Naja Naja Atra) Determination of Structure in Solution and Comparison with Short Neurotoxins 2CRT ; -1.00 ; Cardiotoxin III from Taiwan Cobra (Naja Naja Atra) Determination of Structure in Solution and Comparison with Short Neurotoxins 5GCH ; 2.70 ; Chemistry of Caged Enzymes /II. Photoactivation of Inhibited Chymotrypsin 3GCH ; 1.90 ; Chemistry of Caged Enzymes. Binding of Photoreversible Cinnamates to Chymotrypsin 5RXN ; 1.20 ; Combined Crystallographic Refinement and Energy Minimization of Rubredoxin at 1.2 Angstrom Resolution 2PAS ; -1.00 ; Comparison between the Crystal and the Solution Structures of the EF Hand Parvalbumin 3PAT ; -1.00 ; Comparison between the Crystal and the Solution Structures of the EF Hand Parvalbumin 1PVA ; 1.65 ; Comparison between the Crystal and the Solution Structures of the EF Hand Parvalbumin (Alpha Component from Pike Muscle) 3LYT ; 1.90 ; Comparison of Radiation-Induced Decay and Structure Refinement from X-Ray Data Collected from Lysozyme Crystals at Low and Ambient Temperatures 4LYT ; 1.90 ; Comparison of Radiation-Induced Decay and Structure Refinement from X-Ray Data Collected from Lysozyme Crystals at Low and Ambient Temperatures 5LYT ; 1.90 ; Comparison of Radiation-Induced Decay and Structure Refinement from X-Ray Data Collected from Lysozyme Crystals at Low and Ambient Temperatures 6LYT ; 1.90 ; Comparison of Radiation-Induced Decay and Structure Refinement from X-Ray Data Collected from Lysozyme Crystals at Low and Ambient Temperatures 5RSA ; 2.00 ; Comparison of Two Independently Refined Models of Ribonuclease-A 2HPE ; 2.00 ; Comparison of the Structures of HIV-2 Protease Complexes in Three Crystal Space Groups with an HIV-1 Protease Complex Structure 2HPF ; 3.00 ; Comparison of the Structures of HIV-2 Protease Complexes in Three Crystal Space Groups with an HIV-1 Protease Complex Structure 1CNB ; 2.35 ; Compensatory Plastic Effects in the Redesign of Protein-Zinc Binding Sites 2MRT ; -1.00 ; Conformation of Cd-7 Metallothionein-2 from Rat Liver in Aqueous Solution Determined by Nuclear Magnetic Resonance Spectroscopy 2TUN ; 3.10 ; Conformational Changes in the (Ala-84-Val) Mutant of Tumor Necrosis Factor 28DN ; 2.40 ; Crystal Structure Analysis of an A(DEOXYRIBONUCLEIC ACID) Octamer D(Gtacgtac) 2BOP ; 1.70 ; Crystal Structure at 1.7 Angstroms of the Bovine Papillomavirus-1 E2 DEOXYRIBONUCLEIC ACID- Binding Domain Bound to its DEOXYRIBONUCLEIC ACID Target 1NIT ; 2.05 ; Crystal Structure of Aconitase with Trans-Aconitate and Nitrocitrate Bound 215D ; 1.70 ; Crystal Structure of Four Morpholino-Doxorubicin Anticancer Drugs Complexed with D(Cgtacg) and D(Cgatcg): Implications in Drug-DEOXYRIBONUCLEIC ACID Crosslink 234D ; 1.80 ; Crystal Structure of Four Morpholino-Doxorubicin Anticancer Drugs Complexed with D(Cgtacg) and D(Cgatcg): Implications in Drug-DEOXYRIBONUCLEIC ACID Crosslink 235D ; 1.80 ; Crystal Structure of Four Morpholino-Doxorubicin Anticancer Drugs Complexed with D(Cgtacg) and D(Cgatcg): Implications in Drug-DEOXYRIBONUCLEIC ACID Crosslink 236D ; 1.80 ; Crystal Structure of Four Morpholino-Doxorubicin Anticancer Drugs Complexed with D(Cgtacg) and D(Cgatcg): Implications in Drug-DEOXYRIBONUCLEIC ACID Crosslink 2RIG ; 2.30 ; Crystal Structure of Recombinant Rabbit Interferon-Gamma at 2.7-Angstroms Resolution 6TNA ; 2.70 ; Crystal Structure of Yeast Phenylalanine T-RIBONUCLEIC ACID. I.Crystallographic Refinement 1THO ; 2.30 ; Crystal Structure of a Mutant Escherichia Coli Thioredoxin with an Arginine Insertion in the Active Site 2MTA ; 2.40 ; Crystal Structure of a Ternary Electron Transfer Complex between Methylamine Dehydrogenase, Amicyanin and a C-Type Cytochrome 1YTB ; 1.80 ; Crystal Structure of a Yeast TBP/TATA-Box Complex 2Q21 ; 2.20 ; Crystal Structures at 2.2 Angstroms Resolution of the Catalytic Domains of Normal Ras Protein and an Oncogenic Mutant Complexed with /Gsp 1DR4 ; 2.40 ; Crystal Structures of Organomercurial-Activated Chicken Liver Dihydrofolate Reductase Complexes 1DR5 ; 2.40 ; Crystal Structures of Organomercurial-Activated Chicken Liver Dihydrofolate Reductase Complexes 1DR6 ; 2.40 ; Crystal Structures of Organomercurial-Activated Chicken Liver Dihydrofolate Reductase Complexes 1DR7 ; 2.40 ; Crystal Structures of Organomercurial-Activated Chicken Liver Dihydrofolate Reductase Complexes 216D ; 1.73 ; Crystal Structures of the B-Form DEOXYRIBONUCLEIC ACID-RIBONUCLEIC ACID Chimers Complexed with Distamycin 217D ; 1.70 ; Crystal Structures of the B-Form DEOXYRIBONUCLEIC ACID-RIBONUCLEIC ACID Chimers Complexed with Distamycin 1D82 ; 2.50 ; Crystal and Molecular Structure of D(Gtctagac) 1BRG ; 2.20 ; Crystallographic Analysis of Phe->Leu Substitution in the Hydrophobic Core of Barnase 1APV ; 1.80 ; Crystallographic Analysis of Transition State Mimics Bound to Penicillopepsin: Difluorostatine-and Difluorostatone-Containing Peptides 1APW ; 1.80 ; Crystallographic Analysis of Transition State Mimics Bound to Penicillopepsin: Difluorostatine-and Difluorostatone-Containing Peptides 5HVP ; 2.00 ; Crystallographic Analysis of a Complex between Human Immunodeficiency Virus Type 1 Protease and Acetyl-Pepstatin at 2.0 Angstroms Resolution 1APT ; 1.80 ; Crystallographic Analysis of a Pepstatin Analogue Binding to the Aspartyl Proteinase Penicillopepsin at 1.8 Angstroms Resolution 1APU ; 1.80 ; Crystallographic Analysis of a Pepstatin Analogue Binding to the Aspartyl Proteinase Penicillopepsin at 1.8 Angstroms Resolution 2ACT ; 1.70 ; Crystallographic Refinement of the Structure of Actinidin at 1.7 Angstroms Resolution by Fast Fourier Least-Squares Methods 2EDA ; 2.19 ; Crystallographic and Fluorescence Studies of the Interaction of Haloalkane Dehalogenase with Halide Ions: Studies with Halide Compounds Reveal a Halide Binding Site in the Active Site 2CUT ; 1.90 ; Cutinase, a Lipolytic Enzyme with a Preformed Oxyanion Hole 1ZTW ; 1.80 ; D(CTTAATTCGAATTAAG) COMPLEXED WITH MOLONEY MURINE LEUKEMIA VIRUS REVERSE TRANSCRIPTASE CATALYTIC FRAGMENT 1R2O ; 2.38 ; D(GCATGCT) + NI2+ 432D ; 1.89 ; D(GGCCAATTGG) COMPLEXED WITH DAPI 1EHI ; 2.38 ; D-ALANINE:D-LACTATE LIGASE (LMDDL2) OF VANCOMYCIN-RESISTANT LEUCONOSTOC MESENTEROIDES 1E4E ; 2.50 ; D-ALANYL-D-LACATE LIGASE 1C0P ; 1.20 ; D-AMINO ACIC OXIDASE IN COMPLEX WITH D-ALANINE AND A PARTIALLY OCCUPIED BIATOMIC SPECIES 1AN9 ; 2.50 ; D-AMINO ACID OXIDASE COMPLEX WITH O-AMINOBENZOATE 1KIF ; 2.60 ; D-AMINO ACID OXIDASE FROM PIG KIDNEY 1C0L ; 1.73 ; D-AMINO ACID OXIDASE: STRUCTURE OF SUBSTRATE COMPLEXES AT VERY HIGH RESOLUTION REVEAL THE CHEMICAL REACTTION MECHANISM OF FLAVIN DEHYDROGENATION 1DPT ; 1.54 ; D-DOPACHROME TAUTOMERASE 1GKP ; 1.29 ; D-HYDANTOINASE (DIHYDROPYRIMIDINASE) FROM THERMUS SP. IN SPACE GROUP C2221 1GKQ ; 2.60 ; D-HYDANTOINASE (DIHYDROPYRIMIDINASE) FROM THERMUS SP. IN SPACE GROUP P212121 2DLD ; 2.70 ; D-LACTATE DEHYDROGENASE COMPLEXED WITH NADH AND OXAMATE 1NZQ ; 2.18 ; D-PHE-PRO-ARG-TYPE THROMBIN INHIBITOR 1URP ; 2.30 ; D-RIBOSE-BINDING PROTEIN FROM ESCHERICHIA COLI 1RPX ; 2.30 ; D-RIBULOSE-5-PHOSPHATE 3-EPIMERASE FROM SOLANUM TUBEROSUM CHLOROPLASTS 1JKE ; 1.55 ; D-TYR TRNATYR DEACYLASE FROM ESCHERICHIA COLI 1KIY ; 2.40 ; D100E TRICHODIENE SYNTHASE 1KIZ ; 2.60 ; D100E TRICHODIENE SYNTHASE COMPLEXED WITH PYROPHOSPHATE 1YYT ; 2.90 ; D100E TRICHODIENE SYNTHASE: COMPLEX WITH MG, PYROPHOSPHATE, AND (4R)-7-AZABISABOLENE 1YYU ; 2.95 ; D100E TRICHODIENE SYNTHASE: COMPLEX WITH MG, PYROPHOSPHATE, AND (4S)-7-AZABISABOLENE 1JL1 ; 1.30 ; D10A E. COLI RIBONUCLEASE HI 1WNV ; 1.85 ; D136A MUTANT OF HEME OXYGENASE FROM CORYNEBACTERIUM DIPHTHERIAE (HMUO) 1WNX ; 1.85 ; D136E MUTANT OF HEME OXYGENASE FROM CORYNEBACTERIUM DIPHTHERIAE (HMUO) 1WNW ; 1.70 ; D136N MUTANT OF HEME OXYGENASE FROM CORYNEBACTERIUM DIPHTHERIAE (HMUO) 1B0T ; 2.10 ; D15K/K84D MUTANT OF AZOTOBACTER VINELANDII FDI 1QQM ; 1.90 ; D199S MUTANT OF BOVINE 70 KILODALTON HEAT SHOCK PROTEIN 1D3L ; 3.25 ; D1D2-ICAM-1 FULLY GLYCOSYLATED, VARIATION OF D1-D2 INTERDOMAIN ANGLE IN DIFFERENT CRYSTAL STRUCTURES. 1D2N ; 1.75 ; D2 DOMAIN OF N-ETHYLMALEIMIDE-SENSITIVE FUSION PROTEIN 1NSF ; 1.90 ; D2 HEXAMERIZATION DOMAIN OF N-ETHYLMALEIMIDE SENSITIVE FACTOR (NSF) 1QQN ; 1.90 ; D206S MUTANT OF BOVINE 70 KILODALTON HEAT SHOCK PROTEIN 1QTZ ; 2.00 ; D20C MUTANT OF T4 LYSOZYME 1QT5 ; 1.80 ; D20E MUTANT STRUCTURE OF T4 LYSOZYME 1BJG ; 2.30 ; D221(169)N MUTANT DOES NOT PROMOTE OPENING OF THE COFACTOR IMIDAZOLIDINE RING 1DNA ; 2.20 ; D221(169)N MUTANT DOES NOT PROMOTE OPENING OF THE COFACTOR IMIDAZOLIDINE RING 1C9Z ; 2.40 ; D232-CGTACG 1KY5 ; 2.80 ; D244E MUTANT S-ADENOSYLHOMOCYSTEINE HYDROLASE REFINED WITH NONCRYSTALLOGRAPHIC RESTRAINTS 1XLM ; 2.40 ; D254E, D256E MUTANT OF D-XYLOSE ISOMERASE COMPLEXED WITH AL3 AND XYLITOL 1N11 ; 2.70 ; D34 REGION OF HUMAN ANKYRIN-R AND LINKER 3PVI ; 1.59 ; D34G MUTANT OF PVUII ENDONUCLEASE COMPLEXED WITH COGNATE DEOXYRIBONUCLEIC ACID SHOWS THAT ASP34 IS DIRECTLY INVOLVED IN DEOXYRIBONUCLEIC ACID RECOGNITION AND INDIRECTLY INVOLVED IN CATALYSIS 1OC5 ; 1.70 ; D405N MUTANT OF THE CELLOBIOHYDROLASE CEL6A FROM HUMICOLA INSOLENS IN COMPLEX WITH METHYL-CELLOBIOSYL-4-DEOXY-4-THIO-BETA-D-CELLOBIOSIDE 1OC7 ; 1.11 ; D405N MUTANT OF THE CELLOBIOHYDROLASE CEL6A FROM HUMICOLA INSOLENS IN COMPLEX WITH METHYL-TETRATHIO-ALPHA-D-CELLOPENTOSIDE AT 1.1 ANGSTROM RESOLUTION 1DSN ; 2.05 ; D60S N-TERMINAL LOBE HUMAN LACTOFERRIN 1BA2 ; 2.10 ; D67R MUTANT OF D-RIBOSE-BINDING PROTEIN FROM ESCHERICHIA COLI 1GY5 ; 2.30 ; D92N,D94N DOUBLE POINT MUTANT OF HUMAN NUCLEAR TRANSPORT FACTOR 2 (NTF2) 1AKU ; 1.90 ; D95A HYDROQUINONE FLAVODOXIN MUTANT FROM D. VULGARIS 1AKQ ; 1.90 ; D95A OXIDIZED FLAVODOXIN MUTANT FROM D. VULGARIS 1AKV ; 2.00 ; D95A SEMIQUINONE FLAVODOXIN MUTANT FROM D. VULGARIS 1C7E ; 2.25 ; D95E HYDROQUINONE FLAVODOXIN MUTANT FROM D. VULGARIS 1C7F ; 2.00 ; D95E OXIDIZED FLAVODOXIN MUTANT FROM D. VULGARIS 2BCM ; 1.48 ; DAAE ADHESIN 1XT7 ; -1.00 ; DAPTOMYCIN NMR STRUCTURE 1OWM ; 2.30 ; DATA1:DEOXYRIBONUCLEIC ACID PHOTOLYASE / RECEIVED X-RAYS DOSE 1.2 EXP15 PHOTONS/MM2 1OWN ; 2.30 ; DATA3:DEOXYRIBONUCLEIC ACID PHOTOLYASE / RECEIVED X-RAYS DOSE 4.8 EXP15 PHOTONS/MM2 1OWO ; 2.30 ; DATA4:PHOTOREDUCED DEOXYRIBONUCLEIC ACID PHOTOLYASE / RECEIVED X-RAYS DOSE 1.2 EXP15 PHOTONS/MM2 1OWP ; 2.30 ; DATA6:PHOTOREDUCED DEOXYRIBONUCLEIC ACID PHOLYASE / RECEIVED X-RAYS DOSE 4.8 EXP15 PHOTONS/MM2 1LUL ; 3.30 ; DB58, A LEGUME LECTIN FROM DOLICHOS BIFLORUS 1DBH ; 2.30 ; DBL AND PLECKSTRIN HOMOLOGY DOMAINS FROM HSOS1 1BY1 ; -1.00 ; DBL HOMOLOGY DOMAIN FROM BETA-PIX 1KZG ; 2.60 ; DBSCDC42(Y889F) 1VP9 ; 1.95 ; DC26 MUTANT OF VACCINIA VIRUS PROTEIN VP39 IN COMPLEX WITH S-ADENOSYLHOMOCYSTEINE 1P39 ; 2.00 ; DC26 MUTANT OF VACCINIA VIRUS PROTEIN VP39 IN COMPLEX WITH S-ADENOSYLHOMOCYSTEINE AND M7G(5')PPPG 1V39 ; 1.80 ; DC26 MUTANT OF VACCINIA VIRUS PROTEIN VP39 IN COMPLEX WITH S-ADENOSYLHOMOCYSTEINE AND M7G(5')PPPG 2VP3 ; 1.95 ; DC26 MUTANT OF VACCINIA VIRUS PROTEIN VP39 IN COMPLEX WITH S-ADENOSYLHOMOCYSTEINE AND M7G(5')PPPG 1B5E ; 1.60 ; DCMP HYDROXYMETHYLASE FROM T4 1B5D ; 2.20 ; DCMP HYDROXYMETHYLASE FROM T4 (INTACT) 1B49 ; 2.30 ; DCMP HYDROXYMETHYLASE FROM T4 (PHOSPHATE-BOUND) 1DCO ; 2.30 ; DCOH, A BIFUNCTIONAL PROTEIN-BINDING TRANSCRIPTIONAL COACTIVATOR 1DCP ; 2.30 ; DCOH, A BIFUNCTIONAL PROTEIN-BINDING TRANSCRIPTIONAL COACTIVATOR, COMPLEXED WITH BIOPTERIN 1USM ; 1.20 ; DCOH, A BIFUNCTIONAL PROTEIN-BINDING TRANSCRIPTIONAL COACTIVATOR, PRO9LEU MUTANT 1USO ; 1.30 ; DCOH, A BIFUNCTIONAL PROTEIN-BINDING TRANSCRIPTIONAL COACTIVATOR, PRO9LEU MUTANT 1XS1 ; 1.80 ; DCTP DEAMINASE FROM ESCHERICHIA COLI IN COMPLEX WITH DUTP 1XS4 ; 2.53 ; DCTP DEAMINASE FROM ESCHERICHIA COLI- E138A MUTANT ENZYME IN COMPLEX WITH DCTP 1XS6 ; 2.00 ; DCTP DEAMINASE FROM ESCHERICHIA COLI. E138A MUTANT ENZYME IN COMPLEX WITH DUTP 1H70 ; 1.80 ; DDAH FROM PSEUDOMONAS AERUGINOSA. C249S MUTANT COMPLEXED WITH CITRULLINE 1QSY ; 2.30 ; DDATP-TRAPPED CLOSED TERNARY COMPLEX OF THE LARGE FRAGMENT OF DEOXYRIBONUCLEIC ACID POLYMERASE I FROM THERMUS AQUATICUS 1QSS ; 2.30 ; DDGTP-TRAPPED CLOSED TERNARY COMPLEX OF THE LARGE FRAGMENT OF DEOXYRIBONUCLEIC ACID POLYMERASE I FROM THERMUS AQUATICUS 1QTM ; 2.30 ; DDTTP-TRAPPED CLOSED TERNARY COMPLEX OF THE LARGE FRAGMENT OF DEOXYRIBONUCLEIC ACID POLYMERASE I FROM THERMUS AQUATICUS 1PBZ ; -1.00 ; DE NOVO DESIGNED PEPTIDE-METALLOPORPHYRIN COMPLEX, SOLUTION STRUCTURE 1LQ7 ; -1.00 ; DE NOVO DESIGNED PROTEIN MODEL OF RADICAL ENZYMES 2AGA ; -1.00 ; DE-UBIQUITINATING FUNCTION OF ATAXIN-3: INSIGHTS FROM THE SOLUTION STRUCTURE OF THE JOSEPHIN DOMAIN 1W2N ; 2.70 ; DEACETOXYCEPHALOSPORIN C SYNTHASE (WITH A N-TERMINAL HIS- TAG) IN COMPLEX WITH FE(II) AND AMPICILLIN 1W2O ; 3.00 ; DEACETOXYCEPHALOSPORIN C SYNTHASE (WITH A N-TERMINAL HIS- TAG) IN COMPLEX WITH FE(II) AND DEACETOXYCEPHALOSPORIN C 1W2A ; 2.51 ; DEACETOXYCEPHALOSPORIN C SYNTHASE (WITH HIS-TAG) COMPLEXED WITH FE(II) AND ETHYLENE GLYCOL 1UNB ; 1.50 ; DEACETOXYCEPHALOSPORIN C SYNTHASE COMPLEXED WITH 2-OXOGLUTARATE AND AMPICILLIN 1UOB ; 1.70 ; DEACETOXYCEPHALOSPORIN C SYNTHASE COMPLEXED WITH 2-OXOGLUTARATE AND PENICILLIN G 1UOG ; 1.70 ; DEACETOXYCEPHALOSPORIN C SYNTHASE COMPLEXED WITH DEACETOXYCEPHALOSPORIN C 1RXF ; 1.50 ; DEACETOXYCEPHALOSPORIN C SYNTHASE COMPLEXED WITH FE(II) 1RXG ; 1.50 ; DEACETOXYCEPHALOSPORIN C SYNTHASE COMPLEXED WITH FE(II) AND 2-OXOGLUTARATE 1UOF ; 1.60 ; DEACETOXYCEPHALOSPORIN C SYNTHASE COMPLEXED WITH PENICILLIN G 1UO9 ; 1.50 ; DEACETOXYCEPHALOSPORIN C SYNTHASE COMPLEXED WITH SUCCINATE 1DCS ; 1.30 ; DEACETOXYCEPHALOSPORIN C SYNTHASE FROM S. CLAVULIGERUS 1DY5 ; 0.87 ; DEAMIDATED DERIVATIVE OF BOVINE PANCREATIC RIBONUCLEASE 1P4F ; 1.90 ; DEATH ASSOCIATED PROTEIN KINASE CATALYTIC DOMAIN WITH BOUND INHIBITOR FRAGMENT 1E3Y ; -1.00 ; DEATH DOMAIN FROM HUMAN FADD/MORT1 1E41 ; -1.00 ; DEATH DOMAIN FROM HUMAN FADD/MORT1 1FAD ; -1.00 ; DEATH DOMAIN OF FAS-ASSOCIATED DEATH DOMAIN PROTEIN, RESIDUES 89-183 1NGR ; -1.00 ; DEATH DOMAIN OF P75 LOW AFFINITY NEUROTROPHIN RECEPTOR, RESIDUES 334 - 418, NMR, 20 STRUCTURES 1A9B ; 3.20 ; DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE BOUND TO HLA-B 3501 DUE TO NONSTANDARD POSITIONING OF THE C-TERMINUS 1A9E ; 2.50 ; DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE BOUND TO HLA-B 3501 DUE TO NONSTANDARD POSITIONING OF THE C-TERMINUS 2A3X ; 3.00 ; DECAMERIC CRYSTAL STRUCTURE OF HUMAN SERUM AMYLOID P- COMPONENT BOUND TO BIS-1,2-{[(Z)-2CARBOXY- 2-METHYL-1,3- DIOXANE]- 5-YLOXYCARBONYL}-PIPERAZINE 1LGN ; 2.80 ; DECAMERIC DAMP COMPLEX OF HUMAN SERUM AMYLOID P COMPONENT 2A3W ; 2.20 ; DECAMERIC STRUCTURE OF HUMAN SERUM AMYLOID P-COMPONENT BOUND TO BIS-1,2-{[(Z)-2-CARBOXY-2-METHYL-1,3-DIOXANE]-5- YLOXYCARBAMOYL}-ETHANE 2HEX ; 2.10 ; DECAMERS OBSERVED IN THE CRYSTALS OF BOVINE PANCREATIC TRYPSIN INHIBITOR 1HH3 ; 1.00 ; DECAPLANIN FIRST P21-FORM 1HHA ; 1.90 ; DECAPLANIN FIRST P6122-FORM 1HHC ; 1.13 ; DECAPLANIN SECOND P21-FORM 1HHF ; 1.47 ; DECAPLANIN SECOND P6122-FORM 1C5B ; 2.10 ; DECARBOXYLASE CATALYTIC ANTIBODY 21D8 UNLIGANDED FORM 1C5C ; 1.61 ; DECARBOXYLASE CATALYTIC ANTIBODY 21D8-HAPTEN COMPLEX 1OK1 ; 2.60 ; DECAY ACCELERATING FACTOR (CD55): THE STRUCTURE OF AN INTACT COMPLEMENT REGULATOR. 1OJV ; 2.30 ; DECAY ACCELERATING FACTOR (CD55): THE STRUCTURE OF AN INTACT HUMAN COMPLEMENT REGULATOR. 1OJW ; 2.30 ; DECAY ACCELERATING FACTOR (CD55): THE STRUCTURE OF AN INTACT HUMAN COMPLEMENT REGULATOR. 1OJY ; 2.60 ; DECAY ACCELERATING FACTOR (CD55): THE STRUCTURE OF AN INTACT HUMAN COMPLEMENT REGULATOR. 1OK2 ; 2.50 ; DECAY ACCELERATING FACTOR (CD55): THE STRUCTURE OF AN INTACT HUMAN COMPLEMENT REGULATOR. 1OK3 ; 2.20 ; DECAY ACCELERATING FACTOR (CD55): THE STRUCTURE OF AN INTACT HUMAN COMPLEMENT REGULATOR. 1OK9 ; 3.00 ; DECAY ACCELERATING FACTOR (CD55): THE STRUCTURE OF AN INTACT HUMAN COMPLEMENT REGULATOR. 1IC2 ; 2.00 ; DECIPHERING THE DESIGN OF THE TROPOMYOSIN MOLECULE 1MVR ; 12.80 ; DECODING CENTER & PEPTIDYL TRANSFERASE CENTER FROM THE X- RAY STRUCTURE OF THE THERMUS THERMOPHILUS 70S RIBOSOME, ALIGNED TO THE LOW RESOLUTION CRYO-EM MAP OF E.COLI 70S RIBOSOME 1B8W ; -1.00 ; DEFENSIN-LIKE PEPTIDE 1 334D ; 1.80 ; DEFINING GC-SPECIFICITY IN THE MINOR GROOVE: SIDE-BY-SIDE BINDING OF THE DIIMIDAZOLE LEXITROPSIN TO C-A-T-G-G-C-C-A-T-G 1VJM ; 2.30 ; DEFORMATION OF HELIX C IN THE LOW-TEMPERATURE L- INTERMEDIATE OF BACTERIORHODOPSIN 1JTO ; 2.50 ; DEGENERATE INTERFACES IN ANTIGEN-ANTIBODY COMPLEXES 1JTP ; 1.90 ; DEGENERATE INTERFACES IN ANTIGEN-ANTIBODY COMPLEXES 1JTT ; 2.10 ; DEGENERATE INTERFACES IN ANTIGEN-ANTIBODY COMPLEXES 1HHY ; 0.89 ; DEGLUCOBALHIMYCIN IN COMPLEX WITH D-ALA-D-ALA 1HHZ ; 0.99 ; DEGLUCOBALHIMYCIN IN COPMLEX WITH CELL WALL PENTAPEPTIDE 1EWA ; 2.50 ; DEHALOPEROXIDASE AND 4-IODOPHENOL 1OS3 ; 1.95 ; DEHYDRATED T6 HUMAN INSULIN AT 100 K 1OS4 ; 2.25 ; DEHYDRATED T6 HUMAN INSULIN AT 295 K 1NVJ ; 2.15 ; DELETION MUTANT (DELTA 141) OF MOLYBDOPTERIN SYNTHASE 4CGT ; 2.60 ; DELETION MUTANT DELTA(145-150), F151D OF CYCLODEXTRIN GLYCOSYLTRANSFERASE 1OOZ ; 2.10 ; DELETION MUTANT OF SUCCINYL-COA:3-KETOACID COA TRANSFERASE FROM PIG HEART 1OPE ; 2.50 ; DELETION MUTANT OF SUCCINYL-COA:3-KETOACID COA TRANSFERASE FROM PIG HEART 1B21 ; 2.00 ; DELETION OF A BURIED SALT BRIDGE IN BARNASE 1B2Z ; 2.03 ; DELETION OF A BURIED SALT BRIDGE IN BARNASE 1B20 ; 1.70 ; DELETION OF A BURIED SALT-BRIDGE IN BARNASE 1U81 ; -1.00 ; DELTA-17 HUMAN ADP RIBOSYLATION FACTOR 1 COMPLEXED WITH GDP 1VTX ; -1.00 ; DELTA-ATRACOTOXIN-HV1 (VERSUTOXIN) FROM HADRONYCHE VERSUTA, NMR, 20 STRUCTURES 1CBY ; 2.60 ; DELTA-ENDOTOXIN 1E5I ; 2.10 ; DELTA-R306 DEACETOXYCEPHALOSPORIN C SYNTHASE COMPLEXED WITH IRON AND 2-OXOGLUTARATE. 1E5H ; 1.96 ; DELTA-R307A DEACETOXYCEPHALOSPORIN C SYNTHASE COMPLEXED WITH SUCCINATE AND CARBON DIOXIDE 1FD6 ; -1.00 ; DELTA0: A COMPUTATIONALLY DESIGNED CORE VARIANT OF THE B1 DOMAIN OF STREPTOCOCCAL PROTEIN G 1FCL ; -1.00 ; DELTA1.5: A COMPUTATIONALLY DESIGNED CORE VARIANT OF THE B1 DOMAIN OF STREPTOCOCCAL PROTEIN G 1L9K ; 2.40 ; DENGUE METHYLTRANSFERASE 1DF9 ; 2.10 ; DENGUE VIRUS NS3-PROTEASE COMPLEXED WITH MUNG-BEAN BOWMAN- BIRK INHIBITOR 2BHR ; 2.80 ; DENGUE VIRUS RIBONUCLEIC ACID HELICASE 2BMF ; 2.41 ; DENGUE VIRUS RIBONUCLEIC ACID HELICASE AT 2.4A 1GBU ; 1.80 ; DEOXY (BETA-(C93A,C112G)) HUMAN HEMOGLOBIN 1CG5 ; 1.60 ; DEOXY FORM HEMOGLOBIN FROM DASYATIS AKAJEI 1GCV ; 2.00 ; DEOXY FORM HEMOGLOBIN FROM MUSTELUS GRISEUS 1LFL ; 2.70 ; DEOXY HEMOGLOBIN (90% RELATIVE HUMIDITY) 1O1O ; 1.80 ; DEOXY HEMOGLOBIN (A,C:V1M,V62L; B,D:V1M,V67L) 1O1K ; 2.00 ; DEOXY HEMOGLOBIN (A,C:V1M; B,D:V1M,V67W) 1O1J ; 1.90 ; DEOXY HEMOGLOBIN (A-GLY-C:V1M,L29F,H58Q; B,D:V1M,L106W) 1O1L ; 1.80 ; DEOXY HEMOGLOBIN (A-GLY-C:V1M,L29W,H58Q; B,D:V1M) 1O1P ; 1.80 ; DEOXY HEMOGLOBIN (A-GLY-C:V1M; B,D:V1M,C93A,N108K) 1O1M ; 1.85 ; DEOXY HEMOGLOBIN (A-GLYGLYGLY-C:V1M,L29F,H58Q B,D:V1M,V67W) 1O1N ; 1.80 ; DEOXY HEMOGLOBIN (A-GLYGLYGLY-C:V1M,L29W; B,D:V1M) 1A3N ; 1.80 ; DEOXY HUMAN HEMOGLOBIN 1C7B ; 1.80 ; DEOXY RHB1.0 (RECOMBINANT HEMOGLOBIN) 1ABW ; 2.00 ; DEOXY RHB1.1 (RECOMBINANT HEMOGLOBIN) 1C7C ; 1.80 ; DEOXY RHB1.1 (RECOMBINANT HEMOGLOBIN) 1C7D ; 1.80 ; DEOXY RHB1.2 (RECOMBINANT HEMOGLOBIN) 1IBE ; 1.80 ; DEOXY-HAEMOGLOBIN TRAPPED IN THE HIGH-AFFINITY (R) STATE 1A6N ; 1.15 ; DEOXY-MYOGLOBIN, ATOMIC RESOLUTION 1I2L ; 2.30 ; DEOXYCHORISMATE LYASE FROM ESCHERICHIA COLI WITH INHIBITOR 1QI8 ; 1.80 ; DEOXYGENATED STRUCTURE OF A DISTAL POCKET HEMOGLOBIN MUTANT 1GLI ; 2.50 ; DEOXYHEMOGLOBIN T38W (ALPHA CHAINS), V1G (ALPHA AND BETA CHAINS) 1RLZ ; 2.15 ; DEOXYHYPUSINE SYNTHASE HOLOENZYME IN ITS HIGH IONIC STRENGTH, LOW PH CRYSTAL FORM 1ROZ ; 2.21 ; DEOXYHYPUSINE SYNTHASE HOLOENZYME IN ITS LOW IONIC STRENGTH, HIGH PH CRYSTAL FORM 1RQD ; 3.00 ; DEOXYHYPUSINE SYNTHASE HOLOENZYME IN ITS LOW IONIC STRENGTH, HIGH PH CRYSTAL FORM WITH THE INHIBITOR GC7 BOUND IN THE ACTIVE SITE 1DEK ; 2.00 ; DEOXYNUCLEOSIDE MONOPHOSPHATE KINASE COMPLEXED WITH DEOXY-GMP 1DEL ; 2.20 ; DEOXYNUCLEOSIDE MONOPHOSPHATE KINASE COMPLEXED WITH DEOXY-GMP AND AMP 1RME ; -1.00 ; DEOXYRIBONUCLEIC ACID (5'-D(5MCPCPTPCPC)-3') TETRAMER, NMR, 1 STRUCTURE 1ZHU ; -1.00 ; DEOXYRIBONUCLEIC ACID (5'-D(CPAPAPTPGPCPAPAPTPG)-3'), NMR, 10 STRUCTURES 1DCT ; 2.80 ; DEOXYRIBONUCLEIC ACID (CYTOSINE-5) METHYLASE FROM HAEIII COVALENTLY BOUND TO DEOXYRIBONUCLEIC ACID 2BQ3 ; 2.00 ; DEOXYRIBONUCLEIC ACID ADDUCT BYPASS POLYMERIZATION BY SULFOLOBUS SOLFATARICUS DPO4. ANALYSIS AND CRYSTAL STRUCTURES OF MULTIPLE BASE- PAIR SUBSTITUTION AND FRAMESHIFT PRODUCTS WITH THE ADDUCT 1,N2-ETHENOGUANINE 2BQR ; 2.37 ; DEOXYRIBONUCLEIC ACID ADDUCT BYPASS POLYMERIZATION BY SULFOLOBUS SOLFATARICUS DPO4. ANALYSIS AND CRYSTAL STRUCTURES OF MULTIPLE BASE- PAIR SUBSTITUTION AND FRAMESHIFT PRODUCTS WITH THE ADDUCT 1,N2-ETHENOGUANINE 2BQU ; 2.50 ; DEOXYRIBONUCLEIC ACID ADDUCT BYPASS POLYMERIZATION BY SULFOLOBUS SOLFATARICUS DPO4. ANALYSIS AND CRYSTAL STRUCTURES OF MULTIPLE BASE- PAIR SUBSTITUTION AND FRAMESHIFT PRODUCTS WITH THE ADDUCT 1,N2-ETHENOGUANINE 2BR0 ; 2.17 ; DEOXYRIBONUCLEIC ACID ADDUCT BYPASS POLYMERIZATION BY SULFOLOBUS SOLFATARICUS DPO4. ANALYSIS AND CRYSTAL STRUCTURES OF MULTIPLE BASE- PAIR SUBSTITUTION AND FRAMESHIFT PRODUCTS WITH THE ADDUCT 1,N2-ETHENOGUANINE 229D ; -1.00 ; DEOXYRIBONUCLEIC ACID ANALOG OF YEAST TRANSFER RIBONUCLEIC ACID PHE ANTICODON DOMAIN WITH MODIFIED BASES 5-METHYL CYTOSINE AND 1-METHYL GUANINE 1ILC ; 2.20 ; DEOXYRIBONUCLEIC ACID BENDING BY AN ADENINE-THYMINE TRACT AND ITS ROLE IN GENE REGULATION. 1U3E ; 2.92 ; DEOXYRIBONUCLEIC ACID BINDING AND CLEAVAGE BY THE HNH HOMING ENDONUCLEASE I- HMUI 1KAF ; 1.60 ; DEOXYRIBONUCLEIC ACID BINDING DOMAIN OF THE PHAGE T4 TRANSCRIPTION FACTOR MOTA (AA105-211) 1LQ1 ; 2.30 ; DEOXYRIBONUCLEIC ACID COMPLEXED STRUCTURE OF THE KEY TRANSCRIPTION FACTOR INITIATING DEVELOPMENT IN SPORULATION BACTERIA 1QKG ; -1.00 ; DEOXYRIBONUCLEIC ACID DECAMER DUPLEX CONTAINING T-T DEWAR PHOTOPRODUCT 1CFL ; -1.00 ; DEOXYRIBONUCLEIC ACID DECAMER DUPLEX CONTAINING T5-T6 PHOTOADDUCT 1QL5 ; -1.00 ; DEOXYRIBONUCLEIC ACID DECAMER DUPLEX CONTAINING T5-T6 PHOTOADDUCT 1CW9 ; 1.55 ; DEOXYRIBONUCLEIC ACID DECAMER WITH AN ENGINEERED CROSSLINK IN THE MINOR GROOVE 1WAN ; -1.00 ; DEOXYRIBONUCLEIC ACID DTA TRIPLEX, NMR, 7 STRUCTURES 1AXP ; -1.00 ; DEOXYRIBONUCLEIC ACID DUPLEX CONTAINING A PURINE-RICH STRAND, NMR, 6 STRUCTURES 1JB7 ; 1.86 ; DEOXYRIBONUCLEIC ACID G-QUARTETS IN A 1.86 A RESOLUTION STRUCTURE OF AN OXYTRICHA NOVA TELOMERIC PROTEIN-DEOXYRIBONUCLEIC ACID COMPLEX 459D ; 2.30 ; DEOXYRIBONUCLEIC ACID MINOR-GROOVE RECOGNITION OF A TRIS-BENZIMIDAZOLE DRUG 458D ; 2.30 ; DEOXYRIBONUCLEIC ACID MINOR-GROOVE RECOGNITION OF A TRIS-BENZIMIDAZOLE DRUG BY A NON-SELF-COMPLEMENTARY AT-RICH SEQUENCE 1AZO ; 1.70 ; DEOXYRIBONUCLEIC ACID MISMATCH REPAIR PROTEIN MUTH FROM E. COLI 2AZO ; 2.30 ; DEOXYRIBONUCLEIC ACID MISMATCH REPAIR PROTEIN MUTH FROM E. COLI 1KTQ ; 2.50 ; DEOXYRIBONUCLEIC ACID POLYMERASE 1ZQU ; 2.60 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) , 31-KD DOMAIN; SOAKED IN THE PRESENCE OF ARTIFICIAL MOTHER LIQUOR 1ZQV ; 2.70 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) , 31-KD DOMAIN; SOAKED IN THE PRESENCE OF CACL2 (150 MILLIMOLAR) 1ZQW ; 2.30 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) , 31-KD DOMAIN; SOAKED IN THE PRESENCE OF CSCL (150 MILLIMOLAR) 1ZQX ; 2.50 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) , 31-KD DOMAIN; SOAKED IN THE PRESENCE OF KCL (150 MILLIMOLAR) 1ZQY ; 2.30 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) , 31-KD DOMAIN; SOAKED IN THE PRESENCE OF MGCL2 (50 MILLIMOLAR) 1NOM ; 3.00 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) , 31-KD DOMAIN; SOAKED IN THE PRESENCE OF MNCL2 (5 MILLIMOLAR) 1ZQZ ; 2.70 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) , 31-KD DOMAIN; SOAKED IN THE PRESENCE OF MNCL2 (50 MILLIMOLAR) 9ICJ ; 3.10 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SEVEN BASE PAIRS OF DEOXYRIBONUCLEIC ACID 8ICC ; 2.80 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SEVEN BASE PAIRS OF DEOXYRIBONUCLEIC ACID (NO 5'-PHOSPHATE) 9ICY ; 3.00 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SEVEN BASE PAIRS OF DEOXYRIBONUCLEIC ACID (NON GAPPED DEOXYRIBONUCLEIC ACID ONLY) 1ZQG ; 3.10 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SEVEN BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF A SODIUM-FREE ARTIFICIAL MOTHER LIQUOR AT PH 6.5 1ZQH ; 3.10 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SEVEN BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF A SODIUM-FREE ARTIFICIAL MOTHER LIQUOR AT PH 7.5 8ICB ; 3.10 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SEVEN BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF ARTIFICIAL MOTHER LIQUOR 8ICN ; 2.80 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SEVEN BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF ATP (1 MILLIMOLAR) AND MNCL2 (5 MILLIMOLAR) 8ICO ; 2.70 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SEVEN BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF AZT-TP (1 MILLIMOLAR) AND MNCL2 (5 MILLIMOLAR) 1ZQN ; 3.00 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SEVEN BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF BACL2 (15 MILLIMOLAR) AND NACL (15 MILLIMOLAR) 1ZQB ; 3.20 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SEVEN BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF BACL2 (150 MILLIMOLAR) 1ZQC ; 3.20 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SEVEN BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF CACL2 (15 MILLIMOLAR) 1ZQJ ; 3.30 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SEVEN BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF CACL2 (15 MILLIMOLAR) AND MGCL2 (15 MILLIMOLAR) 1ZQO ; 3.20 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SEVEN BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF CACL2 (15 MILLIMOLAR) AND NACL (15 MILLIMOLAR) 1ZQD ; 3.50 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SEVEN BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF CACL2 (150 MILLIMOLAR) 1ZQE ; 3.70 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SEVEN BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF CRCL3 (SATURATED SOLUTION) 1ZQF ; 2.90 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SEVEN BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF CSCL (150 MILLIMOLAR) 1ZQT ; 3.40 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SEVEN BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF DATP (0.01 MILLIMOLAR) AND ZNCL2 (0.02 MILLIMOLAR) 9ICV ; 2.70 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SEVEN BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF DATP (0.1 MILLIMOLAR) AND ZNCL2 (0.2 MILLIMOLAR) 8ICA ; 3.00 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SEVEN BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF DATP (1 MILLIMOLAR) AND CACL2 (5 MILLIMOLAR) 8ICE ; 3.20 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SEVEN BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF DATP (1 MILLIMOLAR) AND CDCL2 (1 MILLIMOLAR) 9ICB ; 3.20 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SEVEN BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF DATP (1 MILLIMOLAR) AND COCL2 (5 MILLIMOLAR) 9ICC ; 3.10 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SEVEN BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF DATP (1 MILLIMOLAR) AND CRCL3 (5 MILLIMOLAR) 9ICE ; 3.30 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SEVEN BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF DATP (1 MILLIMOLAR) AND CUCL2 (0.1 MILLIMOLAR) 8ICG ; 3.30 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SEVEN BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF DATP (1 MILLIMOLAR) AND MGCL2 (5 MILLIMOLAR) 8ICP ; 2.90 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SEVEN BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF DATP (1 MILLIMOLAR) AND MNCL2 (5 MILLIMOLAR) 8ICR ; 2.90 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SEVEN BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF DATP (1 MILLIMOLAR) AND MNCL2 (5 MILLIMOLAR) 8ICL ; 3.10 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SEVEN BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF DATP (1 MILLIMOLAR) AND NICL2 (5 MILLIMOLAR) 9ICF ; 3.00 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SEVEN BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF DATP (1 MILLIMOLAR) AND ZNCL2 (1 MILLIMOLAR) 8ICK ; 2.70 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SEVEN BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF DATP (1 MILLIMOLAR), MGCL2 (5 MILLIMOLAR), AND MNCL2 (5 MILLIMOLAR) 8ICM ; 2.90 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SEVEN BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF DATP (1 MILLIMOLAR), MNCL2 (5 MILLIMOLAR), AND AMMONIUM SULFATE (75 MILLIMOLAR) 8ICF ; 2.90 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SEVEN BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF DATP (10 MILLIMOLAR) AND MGCL2 (50 MILLIMOLAR) 9ICA ; 3.00 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SEVEN BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF DATP(ALPHA)S (1 MILLIMOLAR) AND MNCL2 (5 MILLIMOLAR) 8ICH ; 3.30 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SEVEN BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF DCTP (1 MILLIMOLAR) AND MGCL2 (5 MILLIMOLAR) 8ICS ; 2.90 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SEVEN BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF DCTP (1 MILLIMOLAR) AND MNCL2 (5 MILLIMOLAR) 8ICT ; 3.10 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SEVEN BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF DCTP (1 MILLIMOLAR) AND MNCL2 (5 MILLIMOLAR) 9ICG ; 3.00 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SEVEN BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF DCTP (1 MILLIMOLAR) AND ZNCL2 (1 MILLIMOLAR) 8ICU ; 3.00 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SEVEN BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF DDATP (1 MILLIMOLAR) AND MNCL2 (5 MILLIMOLAR) 8ICI ; 2.80 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SEVEN BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF DGTP (1 MILLIMOLAR) AND MGCL2 (5 MILLIMOLAR) 8ICV ; 3.20 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SEVEN BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF DGTP (1 MILLIMOLAR) AND MNCL2 (5 MILLIMOLAR) 9ICH ; 2.90 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SEVEN BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF DGTP (1 MILLIMOLAR) AND ZNCL2 (1 MILLIMOLAR) 8ICW ; 3.30 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SEVEN BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF DTTP (1 MILLIMOLAR) AND MNCL2 (5 MILLIMOLAR) 8ICX ; 3.00 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SEVEN BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF DTTP (1 MILLIMOLAR) AND MNCL2 (5 MILLIMOLAR) 8ICY ; 3.10 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SEVEN BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF DTTP (1 MILLIMOLAR) AND MNCL2 (5 MILLIMOLAR) 9ICI ; 3.10 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SEVEN BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF DTTP (1 MILLIMOLAR) AND ZNCL2 (1 MILLIMOLAR) 1ZQI ; 2.70 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SEVEN BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF KCL (150 MILLIMOLAR) 1ZQA ; 2.70 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SEVEN BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF KCL (150 MILLIMOLAR) AT PH 7.5 1ZQK ; 3.20 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SEVEN BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF KCL (75 MILLIMOLAR) AND MGCL2 (75 MILLIMOLAR) 1ZQP ; 2.80 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SEVEN BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF KCL (75 MILLIMOLAR) AND NACL (75 MILLIMOLAR) 1ZQM ; 3.20 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SEVEN BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF MNCL2 (15 MILLIMOLAR) 1ZQL ; 3.30 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SEVEN BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF MNCL2 (15 MILLIMOLAR) AND MGCL2 (15 MILLIMOLAR) 1ZQQ ; 3.30 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SEVEN BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF MNCL2 (15 MILLIMOLAR) AND NACL (15 MILLIMOLAR) 8ICQ ; 3.00 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SEVEN BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF OF DATP (0.1 MILLIMOLAR) AND MNCL2 (0.5 MILLIMOLAR) 8ICZ ; 3.10 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SEVEN BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF OF DATP (1 MILLIMOLAR), MNCL2 (5 MILLIMOLAR), AND LITHIUM SULFATE (75 MILLIMOLAR) 1ZQS ; 3.30 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SEVEN BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF TLCL (0.5 MILLIMOLAR) 9ICX ; 2.60 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SIX BASE PAIRS OF DEOXYRIBONUCLEIC ACID (NON GAPPED DEOXYRIBONUCLEIC ACID ONLY) 9ICW ; 2.60 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SIX BASE PAIRS OF DEOXYRIBONUCLEIC ACID; NATIVE STRUCTURE 9ICK ; 2.70 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SIX BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF ARTIFICIAL MOTHER LIQUOR 7ICE ; 2.80 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SIX BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF CACL2 (0.1 MILLIMOLAR) 7ICG ; 3.00 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SIX BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF CDCL2 (0.01 MILLIMOLAR) 7ICU ; 3.30 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SIX BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF CDCL2 (0.1 MILLIMOLAR) 7ICF ; 3.10 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SIX BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF CDCL2 (0.1 MILLIMOLAR) (FOUR-DAY SOAK) 7ICH ; 2.90 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SIX BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF COCL2 (0.1 MILLIMOLAR) 7ICI ; 2.80 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SIX BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF CRCL3 (0.1 MILLIMOLAR) 7ICJ ; 3.50 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SIX BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF CUCL2 (0.1 MILLIMOLAR) 9ICQ ; 2.90 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SIX BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF DATP (1 MILLIMOLAR) AND MNCL2 (5 MILLIMOLAR) 9ICR ; 3.00 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SIX BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF DCTP (1 MILLIMOLAR) AND MNCL2 (5 MILLIMOLAR) 9ICS ; 2.90 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SIX BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF DDCTP (10 MILLIMOLAR) AND MNCL2 (10 MILLIMOLAR) 9ICN ; 3.00 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SIX BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF DDCTP (20 MILLIMOLAR) AND MGCL2 (20 MILLIMOLAR) 9ICT ; 3.00 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SIX BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF DGTP (1 MILLIMOLAR) AND MNCL2 (5 MILLIMOLAR) 9ICO ; 2.90 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SIX BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF DTTP (1 MILLIMOLAR) AND MGCL2 (5 MILLIMOLAR) 9ICU ; 2.90 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SIX BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF DTTP (1 MILLIMOLAR) AND MNCL2 (5 MILLIMOLAR) 7ICK ; 2.90 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SIX BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF MGCL2 (0.1 MILLIMOLAR) 7ICL ; 3.10 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SIX BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF MNCL2 (0.1 MILLIMOLAR) 7ICV ; 2.80 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SIX BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF MNCL2 (0.1 MILLIMOLAR) AND IN THE ABSENCE OF NACL 7ICM ; 3.00 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SIX BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF MNCL2 (1.0 MILLIMOLAR) 7ICN ; 2.80 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SIX BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF NICL2 (0.1 MILLIMOLAR) 9ICP ; 3.10 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SIX BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF PYROPHOSPHATE (1 MILLIMOLAR) AND MGCL2 (5 MILLIMOLAR) 9ICL ; 2.80 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SIX BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF PYROPHOSPHATE (1 MILLIMOLAR) AND MNCL2 (5 MILLIMOLAR) 7ICS ; 2.80 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SIX BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF ZNCL2 (0.001 MILLIMOLAR) 7ICP ; 3.00 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SIX BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF ZNCL2 (0.01 MILLIMOLAR) 7ICT ; 2.80 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SIX BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF ZNCL2 (0.01 MILLIMOLAR) AND MGCL2 (1 MILLIMOLAR) 7ICO ; 3.30 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SIX BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF ZNCL2 (0.1 MILLIMOLAR) 7ICQ ; 2.90 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SIX BASE PAIRS OF DEOXYRIBONUCLEIC ACID; SOAKED IN THE PRESENCE OF ZNCL2 (0.1 MILLIMOLAR) (FOUR-DAY SOAK) 9ICM ; 2.90 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA (POL B) COMPLEXED WITH SIX BASE PAIRS OF DOUBLE STRANDED DEOXYRIBONUCLEIC ACID (NO 5'-PHOSPHATE) 8ICJ ; 3.20 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA /DEOXYRIBONUCLEIC ACID COMPLEX + THYMIDINE- 5'-TRIPHOSPHATE, SOAKED IN THE PRESENCE OF DTTP AND MGCL2 1ZQR ; 3.70 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA /DEOXYRIBONUCLEIC ACID COMPLEX, SOAKED IN THE PRESENCE OF NICL2 7ICR ; 3.00 ; DEOXYRIBONUCLEIC ACID POLYMERASE BETA /DEOXYRIBONUCLEIC ACID COMPLEX, SOAKED IN THE PRESENCE OF ZNCL2 1WAF ; 3.20 ; DEOXYRIBONUCLEIC ACID POLYMERASE FROM BACTERIOPHAGE RB69 1WAJ ; 2.80 ; DEOXYRIBONUCLEIC ACID POLYMERASE FROM BACTERIOPHAGE RB69 1QHT ; 2.10 ; DEOXYRIBONUCLEIC ACID POLYMERASE FROM THERMOCOCCUS SP. 9ON-7 ARCHAEON 1JRE ; 2.65 ; DEOXYRIBONUCLEIC ACID PROTECTION AND BINDING BY E. COLI DPS PROTEIN 1JTS ; 2.60 ; DEOXYRIBONUCLEIC ACID PROTECTION AND BINDING BY E. COLI DPS PROTEIN 1L8H ; 3.20 ; DEOXYRIBONUCLEIC ACID PROTECTION AND BINDING BY E. COLI DPS PROTEIN 1L8I ; 3.00 ; DEOXYRIBONUCLEIC ACID PROTECTION AND BINDING BY E. COLI DPS PROTEIN 1A6H ; -1.00 ; DEOXYRIBONUCLEIC ACID QUADRUPLEX CONTAINING GCGC TETRAD, NMR, 4 STRUCTURES 1AFF ; -1.00 ; DEOXYRIBONUCLEIC ACID QUADRUPLEX CONTAINING GGGG TETRADS AND (T.A).A TRIADS, NMR, 8 STRUCTURES 1LJM ; 2.50 ; DEOXYRIBONUCLEIC ACID RECOGNITION IS MEDIATED BY CONFORMATIONAL TRANSITION AND BY DEOXYRIBONUCLEIC ACID BENDING 4KBD ; -1.00 ; DEOXYRIBONUCLEIC ACID STRUCTURE OF A MUTATED KB SITE 1BWG ; -1.00 ; DEOXYRIBONUCLEIC ACID TRIPLEX WITH 5' AND 3' JUNCTIONS, NMR, 10 STRUCTURES 1FZS ; -1.00 ; DEOXYRIBONUCLEIC ACID WITH PYRENE PAIRED AT ABASIC SITE 1FZL ; -1.00 ; DEOXYRIBONUCLEIC ACID WITH PYRENE PAIRED AT ABASIC SITES 2BBY ; -1.00 ; DEOXYRIBONUCLEIC ACID-BINDING DOMAIN FROM HUMAN RAP30, NMR, 30 STRUCTURES 1BBY ; -1.00 ; DEOXYRIBONUCLEIC ACID-BINDING DOMAIN FROM HUMAN RAP30, NMR, MINIMIZED AVERAGE 1DHM ; -1.00 ; DEOXYRIBONUCLEIC ACID-BINDING DOMAIN OF E2 FROM HUMAN PAPILLOMAVIRUS-31, NMR, MINIMIZED AVERAGE STRUCTURE 1FLI ; -1.00 ; DEOXYRIBONUCLEIC ACID-BINDING DOMAIN OF FLI-1 1BA5 ; -1.00 ; DEOXYRIBONUCLEIC ACID-BINDING DOMAIN OF HUMAN TELOMERIC PROTEIN, HTRF1, NMR, 18 STRUCTURES 1BM8 ; 1.71 ; DEOXYRIBONUCLEIC ACID-BINDING DOMAIN OF MBP1 1IGN ; 2.25 ; DEOXYRIBONUCLEIC ACID-BINDING DOMAIN OF RAP1 IN COMPLEX WITH TELOMERIC DEOXYRIBONUCLEIC ACID SITE 1CIT ; 2.70 ; DEOXYRIBONUCLEIC ACID-BINDING MECHANISM OF THE MONOMERIC ORPHAN NUCLEAR RECEPTOR NGFI-B 1CLD ; -1.00 ; DEOXYRIBONUCLEIC ACID-BINDING PROTEIN 1HUU ; 2.00 ; DEOXYRIBONUCLEIC ACID-BINDING PROTEIN HU FROM BACILLUS STEAROTHERMOPHILUS 1DBQ ; 2.20 ; DEOXYRIBONUCLEIC ACID-BINDING REGULATORY PROTEIN 245D ; 1.40 ; DEOXYRIBONUCLEIC ACID-DRUG REFINEMENT: A COMPARISON OF THE PROGRAMS NUCLSQ, PROLSQ, SHELXL93 AND X-PLOR, USING THE LOW TEMPERATURE D(TGATCA)-NOGALAMYCIN STRUCTURE 224D ; 1.40 ; DEOXYRIBONUCLEIC ACID-Drug Refinement: A Comparison of the Programs Nuclsq, Prolsq, Shelxl93 and X-Plor, Using the Low Temperature D(Tgatca)-Nogalamycin Structure 1OO7 ; -1.00 ; DEOXYRIBONUCLEIC ACID.RIBONUCLEIC ACID HYBRID DUPLEX CONTAINING A 5-PROPYNE DEOXYRIBONUCLEIC ACID STRAND AND PURINE-RICH RIBONUCLEIC ACID STRAND, NMR, 4 STRUCTURES 219D ; -1.00 ; DEOXYRIBONUCLEIC ACID/RIBONUCLEIC ACID HYBRID DUPLEX (5'-D(GPCPTPAPTPAPAPSTPGPG)-3')(DOT) (5'-R(CPCPAPUPUPAPUPAPGPC)-3') WITH A PHOSPHOROTHIOATE MOIETY 1DRR ; -1.00 ; DEOXYRIBONUCLEIC ACID/RIBONUCLEIC ACID HYBRID DUPLEX CONTAINING A PURINE-RICH DEOXYRIBONUCLEIC ACID STRAND, NMR, 10 STRUCTURES 1RRD ; -1.00 ; DEOXYRIBONUCLEIC ACID/RIBONUCLEIC ACID HYBRID DUPLEX CONTAINING A PURINE-RICH RIBONUCLEIC ACID STRAND, NMR, 10 STRUCTURES 2A4A ; 1.84 ; DEOXYRIBOSE-PHOSPHATE ALDOLASE FROM P. YOELII 1DUD ; 2.30 ; DEOXYURIDINE 5'-TRIPHOSPHATE NUCLEOTIDE HYDROLASE (D-UTPASE) COMPLEXED WITH THE SUBSTRATE ANALOGUE DEOXYURIDINE 5'- DIPHOSPHATE (D-UDP) 1DUP ; 1.90 ; DEOXYURIDINE 5'-TRIPHOSPHATE NUCLEOTIDO HYDROLASE (D-UTPASE) 1JJV ; 2.00 ; DEPHOSPHO-COA KINASE IN COMPLEX WITH ATP 1AHM ; -1.00 ; DER F 2, THE MAJOR MITE ALLERGEN FROM DERMATOPHAGOIDES FARINAE, NMR, 10 STRUCTURES 1AHK ; -1.00 ; DER F 2, THE MAJOR MITE ALLERGEN FROM DERMATOPHAGOIDES FARINAE, NMR, MINIMIZED AVERAGE STRUCTURE 1JK4 ; 2.30 ; DES 1-6 BOVINE NEUROPHYSIN II COMPLEX WITH VASOPRESSIN 1DEI ; 1.60 ; DESHEPTAPEPTIDE (B24-B30) INSULIN 1BIW ; 2.50 ; DESIGN AND SYNTHESIS OF CONFORMATIONALLY-CONSTRAINED MMP INHIBITORS 1GG8 ; 2.31 ; DESIGN OF INHIBITORS OF GLYCOGEN PHOSPHORYLASE: A STUDY OF ALPHA-AND BETA-C-GLUCOSIDES AND 1-THIO-BETA-D-GLUCOSE COMPOUNDS 1VL3 ; -1.00 ; DESIGN OF NEW MIMOCHROMES WITH UNIQUE TOPOLOGY 1MHW ; 1.90 ; DESIGN OF NON-COVALENT INHIBITORS OF HUMAN CATHEPSIN L. FROM THE 96-RESIDUE PROREGION TO OPTIMIZED TRIPEPTIDES 1EOJ ; 2.10 ; DESIGN OF P1' AND P3' RESIDUES OF TRIVALENT THROMBIN INHIBITORS AND THEIR CRYSTAL STRUCTURES 1EOL ; 2.10 ; DESIGN OF P1' AND P3' RESIDUES OF TRIVALENT THROMBIN INHIBITORS AND THEIR CRYSTAL STRUCTURES 1TG4 ; 1.70 ; DESIGN OF SPECIFIC INHIBITORS OF GROUPII PHOSPHOLIPASE A2(PLA2): CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN RUSSELLS VIPER PLA2 AND DESIGNED PEPTIDE PHE-LEU-ALA-TYR- LYS AT 1.7A RESOLUTION 1SQZ ; 1.20 ; DESIGN OF SPECIFIC INHIBITORS OF PHOPHOLIPASE A2: CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN GROUPII PHOPHOLIPASE A2 AND A DESIGNED PEPTIDE DEHYDRO-ILE-ALA-ARG- SER AT 1.2A RESOLUTION 1JQ8 ; 2.00 ; DESIGN OF SPECIFIC INHIBITORS OF PHOSPHOLIPASE A2: CRYSTAL STRUCTURE OF A COMPLEX FORMED BETWEEN PHOSPHOLIPASE A2 FROM DABOIA RUSSELLI PULCHELLA AND A DESIGNED PENTAPEPTIDE LEU-ALA-ILE-TYR-SER AT 2.0 RESOLUTION 1T37 ; 2.60 ; DESIGN OF SPECIFIC INHIBITORS OF PHOSPHOLIPASE A2: CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN GROUP I PHOSPHOLIPASE A2 AND A DESIGNED PENTAPEPTIDE LEU-ALA-ILE- TYR-SER AT 2.6A RESOLUTION 1NA0 ; 1.60 ; DESIGN OF STABLE ALPHA-HELICAL ARRAYS FROM AN IDEALIZED TPR MOTIF 1NA3 ; 1.55 ; DESIGN OF STABLE ALPHA-HELICAL ARRAYS FROM AN IDEALIZED TPR MOTIF 1NO9 ; 1.90 ; DESIGN OF WEAKLY BASIC THROMBIN INHIBITORS INCORPORATING NOVEL P1 BINDING FUNCTIONS: MOLECULAR AND X-RAY CRYSTALLOGRAPHIC STUDIES. 1E26 ; 2.00 ; DESIGN, SYNTHESIS AND X-RAY CRYSTAL STRUCTURE OF A POTENT DUAL INHIBITOR OF THYMIDYLATE SYNTHASE AND DIHYDROFOLATE REDUCTASE AS AN ANTITUMOR AGENT. 1QF4 ; 2.20 ; DESIGN, SYNTHESIS, AND X-RAY CRYSTAL STRUCTURE OF AN ENZYME BOUND BISUBSTRATE HYBRID INHIBITOR OF ADENYLOSUCCINATE SYNTHETASE 1QF5 ; 2.00 ; DESIGN, SYNTHESIS, AND X-RAY CRYSTAL STRUCTURE OF AN ENZYME BOUND BISUBSTRATE HYBRID INHIBITOR OF ADENYLOSUCCINATE SYNTHETASE 1Y4C ; 1.90 ; DESIGNED HELICAL PROTEIN FUSION MBP 1UTS ; -1.00 ; DESIGNED HIV-1 TAR BINDING LIGAND 1BYZ ; 0.90 ; DESIGNED PEPTIDE ALPHA-1, P1 FORM 3AL1 ; 0.75 ; DESIGNED PEPTIDE ALPHA-1, RACEMIC P1BAR FORM 1VJQ ; 2.10 ; DESIGNED PROTEIN BASED ON BACKBONE CONFORMATION OF PROCARBOXYPEPTIDASE-A (1AYE) WITH SIDECHAINS CHOSEN FOR MAXIMAL PREDICTED STABILITY. 1COI ; 2.10 ; DESIGNED TRIMERIC COILED COIL - VALD 1DDL ; 2.70 ; DESMODIUM YELLOW MOTTLE TYMOVIRUS 1AK7 ; -1.00 ; DESTRIN, NMR, 20 STRUCTURES 1AK6 ; -1.00 ; DESTRIN, NMR, MINIMIZED AVERAGE STRUCTURE 1DFX ; 1.90 ; DESULFOFERRODOXIN FROM DESULFOVIBRIO DESULFURICANS, ATCC 27774 1DCD ; 2.00 ; DESULFOREDOXIN COMPLEXED WITH CD2+ 1MJI ; 2.50 ; DETAILED ANALYSIS OF RIBONUCLEIC ACID-PROTEIN INTERACTIONS WITHIN THE BACTERIAL RIBOSOMAL PROTEIN L5/5S RRNA COMPLEX 1UKJ ; 1.80 ; DETAILED STRUCTURE OF L-METHIONINE-LYASE FROM PSEUDOMONAS PUTIDA 1DK1 ; 2.80 ; DETAILED VIEW OF A KEY ELEMENT OF THE RIBOSOME ASSEMBLY: CRYSTAL STRUCTURE OF THE S15-RRNA COMPLEX 2ALU ; 2.09 ; DETECTION OF NEW BINDING SITE IN THE C-TERMINAL LOBE OF LACTOFERRIN:CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN BOVINE LACTOFERRIN AND A TETRASACCHARIDE AT 2.1A RESOLUTION 344D ; 1.46 ; DETERMINATION BY MAD-DM OF THE STRUCTURE OF THE DEOXYRIBONUCLEIC ACID DUPLEX D(ACGTACG(5-BRU))2 AT 1.46A AND 100K 1NCV ; -1.00 ; DETERMINATION CC-CHEMOKINE MCP-3, NMR, 7 STRUCTURES 1Q7O ; -1.00 ; DETERMINATION OF F-MLF-OH PEPTIDE STRUCTURE WITH SOLID- STATE MAGIC-ANGLE SPINNING NMR SPECTROSCOPY 1BUB ; -1.00 ; DETERMINATION OF INTERNUCLEAR ANGLES OF DEOXYRIBONUCLEIC ACID USING PARAMAGNETIC ASSISTED MAGNETIC ALIGNMENT 1BK8 ; -1.00 ; DETERMINATION OF THE THREE-DIMENSIONAL SOLUTION STRUCTURE OF AESCULUS HIPPOCASTANUM ANTIMICROBIAL PROTEIN 1 (AH-AMP1) BY 1H NMR, 25 STRUCTURES 1AYJ ; -1.00 ; DETERMINATION OF THE THREE-DIMENSIONAL SOLUTION STRUCTURE OF RAPHANUS SATIVUS ANTIFUNGAL PROTEIN 1 (RS-AFP1) BY 1H NMR, 20 STRUCTURES 1CAU ; 2.30 ; DETERMINATION OF THREE CRYSTAL STRUCTURES OF CANAVALIN BY MOLECULAR REPLACEMENT 1CAW ; 2.60 ; DETERMINATION OF THREE CRYSTAL STRUCTURES OF CANAVALIN BY MOLECULAR REPLACEMENT 1CAX ; 2.60 ; DETERMINATION OF THREE CRYSTAL STRUCTURES OF CANAVALIN BY MOLECULAR REPLACEMENT 1DAE ; 1.70 ; DETHIOBIOTIN SYNTHETASE COMPLEXED WITH 3-(1-AMINOETHYL) NONANEDIOIC ACID 1DAH ; 1.64 ; DETHIOBIOTIN SYNTHETASE COMPLEXED WITH 7,8-DIAMINO-NONANOIC ACID, 5'-ADENOSYL-METHYLENE-TRIPHOSPHATE, AND MANGANESE 1DAI ; 1.64 ; DETHIOBIOTIN SYNTHETASE COMPLEXED WITH 7-(CARBOXYAMINO) -8-AMINO-NONANOIC ACID 1DAG ; 1.64 ; DETHIOBIOTIN SYNTHETASE COMPLEXED WITH 7-(CARBOXYAMINO) -8-AMINO-NONANOIC ACID AND 5'-ADENOSYL-METHYLENE-TRIPHOSPHATE 1DAF ; 1.70 ; DETHIOBIOTIN SYNTHETASE COMPLEXED WITH 7-(CARBOXYAMINO) -8-AMINO-NONANOIC ACID, ADP, AND CALCIUM 1DAD ; 1.60 ; DETHIOBIOTIN SYNTHETASE COMPLEXED WITH ADP 1BS1 ; 1.80 ; DETHIOBIOTIN SYNTHETASE COMPLEXED WITH DETHIOBIOTIN, ADP , INORGANIC PHOSPHATE AND MAGNESIUM 1DAM ; 1.80 ; DETHIOBIOTIN SYNTHETASE COMPLEXED WITH DETHIOBIOTIN, ADP, INORGANIC PHOSPHATE AND MAGNESIUM 1DAK ; 1.60 ; DETHIOBIOTIN SYNTHETASE FROM ESCHERICHIA COLI, COMPLEX REACTION INTERMEDIATE ADP AND MIXED ANHYDRIDE 1A82 ; 1.80 ; DETHIOBIOTIN SYNTHETASE FROM ESCHERICHIA COLI, COMPLEX WITH SUBSTRATES ATP AND DIAMINOPELARGONIC ACID 1UCH ; 1.80 ; DEUBIQUITINATING ENZYME UCH-L3 (HUMAN) AT 1.8 ANGSTROM RESOLUTION 1ZIQ ; 1.72 ; DEUTERATED GAMMAE CRYSTALLIN IN D2O SOLVENT 1ZIR ; 1.36 ; DEUTERATED GAMMAE CRYSTALLIN IN H2O SOLVENT 1EB6 ; 1.00 ; DEUTEROLYSIN FROM ASPERGILLUS ORYZAE 1OGM ; 1.80 ; DEX49A FROM PENICILLIUM MINIOLUTEUM 1OGO ; 1.65 ; DEX49A FROM PENICILLIUM MINIOLUTEUM COMPLEX WITH ISOMALTOSE 1CI9 ; 1.80 ; DFP-INHIBITED ESTERASE ESTB FROM BURKHOLDERIA GLADIOLI 1ZDR ; 2.00 ; DHFR FROM BACILLUS STEAROTHERMOPHILUS 1U68 ; 2.40 ; DHNA 7,8 DIHYDRONEOPTERIN COMPLEX 1RSI ; 2.20 ; DHNA COMPLEX WITH 2-AMINO-5-BROMO-3-HYDROXY-6- PHENYLPYRIMIDINE 1RRI ; 2.00 ; DHNA COMPLEX WITH 3-(5-AMINO-7-HYDROXY-[1,2,3] TRIAZOLO [4, 5-D]PYRIMIDIN-2-YL)-BENZOIC ACID 1RSD ; 2.50 ; DHNA COMPLEX WITH 3-(5-AMINO-7-HYDROXY-[1,2,3]TRIAZOLO[4,5- D]PYRIMIDIN-2-YL)-N-[2-(2-HYDROXYMETHYL-PHENYLSULFANYL)- BENZYL]-BENZAMIDE 1RS2 ; 2.31 ; DHNA COMPLEX WITH 8-AMINO-1,3-DIMETHYL-3,7-DIHYDROPURINE-2, 6-DIONE 1RRY ; 2.70 ; DHNA COMPLEXED WITH 2-AMINO-4-HYDROXY-5- CARBOXYETHYLPYRIMIDINE 1RRW ; 2.21 ; DHNA COMPLEXED WITH 9-METHYLGUANINE 1RS4 ; 2.70 ; DHNA, 7,8-DIHYDRONEOPTERIN ALDOLASE COMPLEXED WITH 3-(5- AMINO-7-HYDROXY-[1,2,3]TRIAZOLO[4,5-D]PYRIMIDIN-2-YL)-N-(3, 5-DICHLOROBENZYL)-BENZAMIDE 1RZ6 ; 2.20 ; DI-HAEM CYTOCHROME C PEROXIDASE, FORM IN 1RZ5 ; 2.40 ; DI-HAEM CYTOCHROME C PEROXIDASE, FORM OUT 1NML ; 2.20 ; DI-HAEMIC CYTOCHROME C PEROXIDASE FROM PSEUDOMONAS NAUTICA 617, FORM IN (PH 4.0) 1XW7 ; 2.30 ; DIABETES-ASSOCIATED MUTATIONS IN HUMAN INSULIN: CRYSTAL STRUCTURE AND PHOTO-CROSS-LINKING STUDIES OF A-CHAIN VARIANT INSULIN WAKAYAMA 3UBP ; 2.00 ; DIAMIDOPHOSPHATE INHIBITED BACILLUS PASTEURII UREASE 1BWZ ; 2.72 ; DIAMINOPIMELATE EPIMERASE FROM HEMOPHILUS INFLUENZAE 1Y59 ; 1.20 ; DIANHYDROSUGAR-BASED BENZAMIDINE, FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN MUTANT 1Y5A ; 1.40 ; DIANHYDROSUGAR-BASED BENZAMIDINE, FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN MUTANT 1Y5B ; 1.65 ; DIANHYDROSUGAR-BASED BENZAMIDINE, FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN MUTANT 1Y5U ; 1.60 ; DIANHYDROSUGAR-BASED BENZAMIDINE, FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN MUTANT 2DAU ; -1.00 ; DICKERSON-DREW DEOXYRIBONUCLEIC ACID DODECAMER, NMR, MINIMIZED AVERAGE STRUCTURE 1D0X ; 2.00 ; DICTYOSTELIUM MYOSIN S1DC (MOTOR DOMAIN FRAGMENT) COMPLEXED WITH M-NITROPHENYL AMINOETHYLDIPHOSPHATE BERYLLIUM TRIFLUORIDE. 1D1C ; 2.30 ; DICTYOSTELIUM MYOSIN S1DC (MOTOR DOMAIN FRAGMENT) COMPLEXED WITH N-METHYL-O-NITROPHENYL AMINOETHYLDIPHOSPHATE BERYLLIUM TRIFLUORIDE. 1D1A ; 2.00 ; DICTYOSTELIUM MYOSIN S1DC (MOTOR DOMAIN FRAGMENT) COMPLEXED WITH O,P-DINITROPHENYL AMINOETHYLDIPHOSPHATE BERYLLIUM TRIFLUORIDE. 1D1B ; 2.00 ; DICTYOSTELIUM MYOSIN S1DC (MOTOR DOMAIN FRAGMENT) COMPLEXED WITH O,P-DINITROPHENYL AMINOPROPYLDIPHOSPHATE BERYLLIUM TRIFLUORIDE. 1D0Y ; 2.00 ; DICTYOSTELIUM MYOSIN S1DC (MOTOR DOMAIN FRAGMENT) COMPLEXED WITH O-NITROPHENYL AMINOETHYLDIPHOSPHATE BERYLLIUM FLUORIDE. 1D0Z ; 2.00 ; DICTYOSTELIUM MYOSIN S1DC (MOTOR DOMAIN FRAGMENT) COMPLEXED WITH P-NITROPHENYL AMINOETHYLDIPHOSPHATE BERYLLIUM TRIFLUORIDE. 1A4J ; 2.10 ; DIELS ALDER CATALYTIC ANTIBODY GERMLINE PRECURSOR 1A4K ; 2.40 ; DIELS ALDER CATALYTIC ANTIBODY WITH TRANSITION STATE ANALOGUE 1DIN ; 1.80 ; DIENELACTONE HYDROLASE AT 2.8 ANGSTROMS 1DCI ; 1.50 ; DIENOYL-COA ISOMERASE 1XLW ; 2.10 ; DIETHYLPHOSPHORYLATED BUTYRYLCHOLINESTERASE (NONAGED) OBTAINED BY REACTION WITH ECHOTHIOPHATE 1N04 ; 2.80 ; DIFERRIC CHICKEN SERUM TRANSFERRIN AT 2.8 A RESOLUTION. 1N9U ; -1.00 ; DIFFERENCES AND SIMILARITIES IN SOLUTION STRUCTURES OF ANGIOTENSIN I & II: IMPLICATION FOR STRUCURE-FUNCTION RELATIONSHIP 1N9V ; -1.00 ; DIFFERENCES AND SIMILARITIES IN SOLUTION STRUCTURES OF ANGIOTENSIN I & II: IMPLICATION FOR STRUCURE-FUNCTION RELATIONSHIP. 1C3V ; 2.39 ; DIHYDRODIPICOLINATE REDUCTASE FROM MYCOBACTERIUM TUBERCULOSIS COMPLEXED WITH NADPH AND PDC 1DHP ; 2.50 ; DIHYDRODIPICOLINATE SYNTHASE 2A6N ; 1.94 ; DIHYDRODIPICOLINATE SYNTHASE (E. COLI)- MUTANT R138A 2A6L ; 2.05 ; DIHYDRODIPICOLINATE SYNTHASE (E. COLI)- MUTANT R138H 1VDR ; 2.55 ; DIHYDROFOLATE REDUCTASE 1DIS ; -1.00 ; DIHYDROFOLATE REDUCTASE COMPLEX WITH BRODIMOPRIM-4,6-DICARBOXYLATE 1DIU ; -1.00 ; DIHYDROFOLATE REDUCTASE COMPLEX WITH BRODIMOPRIM-4,6-DICARBOXYLATE 1RX5 ; 2.30 ; DIHYDROFOLATE REDUCTASE COMPLEXED WITH 5,10-DIDEAZATETRAHYDROFOLATE 1RX4 ; 2.20 ; DIHYDROFOLATE REDUCTASE COMPLEXED WITH 5,10-DIDEAZATETRAHYDROFOLATE AND 2'-MONOPHOSPHOADENOSINE 5'-DIPHOSPHORIBOSE 1RC4 ; 1.90 ; DIHYDROFOLATE REDUCTASE COMPLEXED WITH 5,10-DIDEAZATETRAHYDROFOLATE AND NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE (OXIDIZED FORM) 1RX6 ; 2.00 ; DIHYDROFOLATE REDUCTASE COMPLEXED WITH 5,10-DIDEAZATETRAHYDROFOLATE AND NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE (REDUCED FORM) 1RD7 ; 2.60 ; DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE 1RE7 ; 2.60 ; DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE 1RX8 ; 2.80 ; DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE AND 2'-MONOPHOSPHOADENOSINE 5'-DIPHOSPHORIBOSE 1RA8 ; 1.80 ; DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE AND 2-MONOPHOSPHOADENOSINE 5'-DIPHOSPHORIBOSE 1RA2 ; 1.60 ; DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE AND NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE (OXIDIZED FORM) 1RB2 ; 2.10 ; DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE AND NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE (OXIDIZED FORM) 1RG7 ; 2.00 ; DIHYDROFOLATE REDUCTASE COMPLEXED WITH METHOTREXATE 1DRE ; 2.60 ; DIHYDROFOLATE REDUCTASE COMPLEXED WITH METHOTREXATE AND NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE (OXIDIZED FORM) 1RA3 ; 1.80 ; DIHYDROFOLATE REDUCTASE COMPLEXED WITH METHOTREXATE AND NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE (OXIDIZED FORM) 1RB3 ; 2.30 ; DIHYDROFOLATE REDUCTASE COMPLEXED WITH METHOTREXATE AND NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE (OXIDIZED FORM) 1RH3 ; 2.40 ; DIHYDROFOLATE REDUCTASE COMPLEXED WITH METHOTREXATE AND NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE (REDUCED FORM) 1RX3 ; 2.20 ; DIHYDROFOLATE REDUCTASE COMPLEXED WITH METHOTREXATE AND NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE (REDUCED FORM) 1AO8 ; -1.00 ; DIHYDROFOLATE REDUCTASE COMPLEXED WITH METHOTREXATE, NMR, 21 STRUCTURES 1RA9 ; 1.55 ; DIHYDROFOLATE REDUCTASE COMPLEXED WITH NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE (OXIDIZED FORM) 1RX9 ; 1.90 ; DIHYDROFOLATE REDUCTASE COMPLEXED WITH NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE (OXIDIZED FORM) 1RA1 ; 1.90 ; DIHYDROFOLATE REDUCTASE COMPLEXED WITH NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE (REDUCED FORM) 1RX1 ; 2.00 ; DIHYDROFOLATE REDUCTASE COMPLEXED WITH NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE (REDUCED FORM) 1RX2 ; 1.80 ; DIHYDROFOLATE REDUCTASE COMPLEXED WITH WITH FOLATE AND NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE (OXIDIZED FORM) 1CZ3 ; 2.10 ; DIHYDROFOLATE REDUCTASE FROM THERMOTOGA MARITIMA 1D1G ; 2.10 ; DIHYDROFOLATE REDUCTASE FROM THERMOTOGA MARITIMA 1DG8 ; 2.00 ; DIHYDROFOLATE REDUCTASE OF MYCOBACTERIUM TUBERCULOSIS COMPLEXED WITH NADPH 1DG7 ; 1.80 ; DIHYDROFOLATE REDUCTASE OF MYCOBACTERIUM TUBERCULOSIS COMPLEXED WITH NADPH AND 4-BROMO WR99210 1DF7 ; 1.70 ; DIHYDROFOLATE REDUCTASE OF MYCOBACTERIUM TUBERCULOSIS COMPLEXED WITH NADPH AND METHOTREXATE 1DG5 ; 2.00 ; DIHYDROFOLATE REDUCTASE OF MYCOBACTERIUM TUBERCULOSIS COMPLEXED WITH NADPH AND TRIMETHOPRIM 1EBD ; 2.60 ; DIHYDROLIPOAMIDE DEHYDROGENASE COMPLEXED WITH THE BINDING DOMAIN OF THE DIHYDROLIPOAMIDE ACETYLASE 1DXL ; 3.15 ; DIHYDROLIPOAMIDE DEHYDROGENASE OF GLYCINE DECARBOXYLASE FROM PISUM SATIVUM 1B5S ; 4.40 ; DIHYDROLIPOYL TRANSACETYLASE CATALYTIC DOMAIN (RESIDUES 184-425) FROM BACILLUS STEAROTHERMOPHILUS 1XGE ; 1.90 ; DIHYDROOROTASE FROM ESCHERICHIA COLI: LOOP MOVEMENT AND COOPERATIVITY BETWEEN SUBUNITS 2B4G ; 1.95 ; DIHYDROOROTATE DEHYDROGENASE 1DOR ; 2.00 ; DIHYDROOROTATE DEHYDROGENASE A FROM LACTOCOCCUS LACTIS 2DOR ; 2.00 ; DIHYDROOROTATE DEHYDROGENASE A FROM LACTOCOCCUS LACTIS COMPLEXED WITH OROTATE 1AD1 ; 2.20 ; DIHYDROPTEROATE SYNTHETASE (APO FORM) FROM STAPHYLOCOCCUS AUREUS 1AD4 ; 2.40 ; DIHYDROPTEROATE SYNTHETASE COMPLEXED WITH OH-CH2-PTERIN-PYROPHOSPHATE FROM STAPHYLOCOCCUS AUREUS 1TWS ; 2.00 ; DIHYDROPTEROATE SYNTHETASE FROM BACILLUS ANTHRACIS 1TX2 ; 1.83 ; DIHYDROPTEROATE SYNTHETASE, WITH BOUND INHIBITOR MANIC, FROM BACILLUS ANTHRACIS 1TX0 ; 2.15 ; DIHYDROPTEROATE SYNTHETASE, WITH BOUND PRODUCT ANALOGUE PTEROIC ACID, FROM BACILLUS ANTHRACIS 1TWZ ; 2.75 ; DIHYDROPTEROATE SYNTHETASE, WITH BOUND SUBSTRATE ANALOGUE PTP, FROM BACILLUS ANTHRACIS 1TWW ; 2.50 ; DIHYDROPTEROATE SYNTHETASE, WITH BOUND SUBSTRATE ANALOGUE PTPP, FROM BACILLUS ANTHRACIS 1H7W ; 1.90 ; DIHYDROPYRIMIDINE DEHYDROGENASE (DPD) FROM PIG 1GTE ; 1.65 ; DIHYDROPYRIMIDINE DEHYDROGENASE (DPD) FROM PIG, BINARY COMPLEX WITH 5-IODOURACIL 1H7X ; 2.01 ; DIHYDROPYRIMIDINE DEHYDROGENASE (DPD) FROM PIG, TERNARY COMPLEX OF A MUTANT ENZYME (C671A), NADPH AND 5-FLUOROURACIL 1GTH ; 2.25 ; DIHYDROPYRIMIDINE DEHYDROGENASE (DPD) FROM PIG, TERNARY COMPLEX WITH NADPH AND 5-IODOURACIL 1GT8 ; 3.30 ; DIHYDROPYRIMIDINE DEHYDROGENASE (DPD) FROM PIG, TERNARY COMPLEX WITH NADPH AND URACIL-4-ACETIC ACID 1FYR ; 2.40 ; DIMER FORMATION THROUGH DOMAIN SWAPPING IN THE CRYSTAL STRUCTURE OF THE GRB2-SH2 AC-PYVNV COMPLEX 1JU1 ; -1.00 ; DIMER INITIATION SEQUENCE OF HIV-1LAI GENOMIC RIBONUCLEIC ACID: NMR SOLUTION STRUCTURE OF THE EXTENDED DUPLEX 1FLM ; 1.30 ; DIMER OF FMN-BINDING PROTEIN FROM DESULFOVIBRIO VULGARIS (MIYAZAKI F) 1XCD ; 2.31 ; DIMERIC BOVINE TISSUE-EXTRACTED DECORIN, CRYSTAL FORM 1 1XEC ; 2.30 ; DIMERIC BOVINE TISSUE-EXTRACTED DECORIN, CRYSTAL FORM 2 1DS5 ; 3.16 ; DIMERIC CRYSTAL STRUCTURE OF THE ALPHA SUBUNIT IN COMPLEX WITH TWO BETA PEPTIDES MIMICKING THE ARCHITECTURE OF THE TETRAMERIC PROTEIN KINASE CK2 HOLOENZYME. 1JVC ; -1.00 ; DIMERIC DEOXYRIBONUCLEIC ACID QUADRUPLEX CONTAINING MAJOR GROOVE-ALIGNED A.T.A.T AND G.C.G.C TETRADS STABILIZED BY INTER-SUBUNIT WATSON-CRICK A:T AND G:C PAIRS 1ITV ; 1.95 ; DIMERIC FORM OF THE HAEMOPEXIN DOMAIN OF MMP9 1Y8D ; -1.00 ; DIMERIC PARALLEL-STRANDED TETRAPLEX WITH 3+1 5' G-TETRAD INTERFACE, SINGLE-RESIDUE CHAIN REVERSAL LOOPS AND GAG TRIAD IN THE CONTEXT OF A(GGGG) PENTAD 1P7N ; 2.60 ; DIMERIC ROUS SARCOMA VIRUS CAPSID PROTEIN STRUCTURE WITH AN UPSTREAM 25-AMINO ACID RESIDUE EXTENSION OF C-TERMINAL OF GAG P10 PROTEIN 1EU6 ; -1.00 ; DIMERIC SOLUTION STRUCTURE OF THE CYCLIC OCTAMER CD(CATTCATT) 1N96 ; -1.00 ; DIMERIC SOLUTION STRUCTURE OF THE CYCLIC OCTAMER CD(CGCTCATT) 1EU2 ; -1.00 ; DIMERIC SOLUTION STRUCTURE OF THE CYCLIC OCTAMER CD(TGCTCGCT) 1IZ3 ; 2.80 ; DIMERIC STRUCTURE OF FIH (FACTOR INHIBITING HIF) 1L2T ; 1.90 ; DIMERIC STRUCTURE OF MJ0796, A BACTERIAL ABC TRANSPORTER CASSETTE 1X9V ; -1.00 ; DIMERIC STRUCTURE OF THE C-TERMINAL DOMAIN OF VPR 1F5W ; 1.70 ; DIMERIC STRUCTURE OF THE COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR D1 DOMAIN 1EAJ ; 1.35 ; DIMERIC STRUCTURE OF THE COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR D1 DOMAIN AT 1.35 ANGSTROM RESOLUTION 1KIX ; 2.70 ; DIMERIC STRUCTURE OF THE O. NOVA TELOMERE END BINDING PROTEIN ALPHA SUBUNIT WITH BOUND SSDNA 1AFO ; -1.00 ; DIMERIC TRANSMEMBRANE DOMAIN OF HUMAN GLYCOPHORIN A, NMR, 20 STRUCTURES 1H6O ; 2.90 ; DIMERISATION DOMAIN FROM HUMAN TRF1 1H6P ; 2.20 ; DIMERISTION DOMAIN FROM HUMAN TRF2 1TFE ; 1.70 ; DIMERIZATION DOMAIN OF EF-TS FROM T. THERMOPHILUS 1G2Z ; 1.15 ; DIMERIZATION DOMAIN OF HNF-1ALPHA WITH A LEU 13 SELENOMETHIONINE SUBSTITUTION 1EI1 ; 2.30 ; DIMERIZATION OF E. COLI DEOXYRIBONUCLEIC ACID GYRASE B PROVIDES A STRUCTURAL MECHANISM FOR ACTIVATING THE ATPASE CATALYTIC CENTER 1QFH ; 2.20 ; DIMERIZATION OF GELATION FACTOR FROM DICTYOSTELIUM DISCOIDEUM: CRYSTAL STRUCTURE OF ROD DOMAINS 5 AND 6 1V05 ; 1.43 ; DIMERIZATION OF HUMAN FILAMIN C: CRYSTAL STRUCTURE OF THE DOMAIN 24 1DP4 ; 2.00 ; DIMERIZED HORMONE BINDING DOMAIN OF THE ATRIAL NATRIURETIC PEPTIDE RECEPTOR 1MNY ; -1.00 ; DIMETHYL PROPIONATE ESTER HEME-CONTAINING CYTOCHROME B5 1DIO ; 2.20 ; DIOL DEHYDRATASE-CYANOCOBALAMIN COMPLEX FROM KLEBSIELLA OXYTOCA 1Y66 ; 1.65 ; DIOXANE CONTRIBUTES TO THE ALTERED CONFORMATION AND OLIGOMERIZATION STATE OF A DESIGNED ENGRAILED HOMEODOMAIN VARIANT 1DPP ; 3.20 ; DIPEPTIDE BINDING PROTEIN COMPLEX WITH GLYCYL-L-LEUCINE 1MS6 ; 1.90 ; DIPEPTIDE NITRILE INHIBITOR BOUND TO CATHEPSIN S. 1DPE ; 2.00 ; DIPEPTIDE-BINDING PROTEIN 1JQP ; 2.40 ; DIPEPTIDYL PEPTIDASE I (CATHEPSIN C), A TETRAMERIC CYSTEINE PROTEASE OF THE PAPAIN FAMILY 2TDX ; 2.40 ; DIPHTHERIA TOX REPRESSOR (C102D MUTANT) COMPLEXED WITH NICKEL 1F5T ; 3.00 ; DIPHTHERIA TOX REPRESSOR (C102D MUTANT) COMPLEXED WITH NICKEL AND DTXR CONSENSUS BINDING SEQUENCE 1DDN ; 3.00 ; DIPHTHERIA TOX REPRESSOR (C102D MUTANT) COMPLEXED WITH NICKEL AND WITH TOX DEOXYRIBONUCLEIC ACID OPERATOR 1TOX ; 2.30 ; DIPHTHERIA TOXIN DIMER COMPLEXED WITH NAD 1C57 ; 2.40 ; DIRECT DETERMINATION OF THE POSITIONS OF DEUTERIUM ATOMS OF BOUND WATER IN CONCANAVALIN A BY NEUTRON LAUE CRYSTALLOGRAPHY 1KGK ; 1.00 ; DIRECT OBSERVATION OF A CYTOSINE ANALOG THAT FORMS FIVE HYDROGEN BONDS TO GUANOSINE; GUANYL G-CLAMP 1J3Z ; 1.60 ; DIRECT OBSERVATION OF PHOTOLYSIS-INDUCED TERTIARY STRUCTURAL CHANGES IN HUMAN HAEMOGLOBIN; CRYSTAL STRUCTURE OF ALPHA(FE-CO)-BETA(NI) HEMOGLOBIN (LASER UNPHOTOLYSED) 1J41 ; 1.45 ; DIRECT OBSERVATION OF PHOTOLYSIS-INDUCED TERTIARY STRUCTURAL CHANGES IN HUMAN HAEMOGLOBIN; CRYSTAL STRUCTURE OF ALPHA(NI)-BETA(FE) HEMOGLOBIN (LASER PHOTOLYSED) 1J40 ; 1.45 ; DIRECT OBSERVATION OF PHOTOLYSIS-INDUCED TERTIARY STRUCTURAL CHANGES IN HUMAN HAEMOGLOBIN; CRYSTAL STRUCTURE OF ALPHA(NI)-BETA(FE-CO) HEMOGLOBIN (LASER UNPHOTOLYSED) 1J3Y ; 1.55 ; DIRECT OBSERVATION OF PHOTOLYSIS-INDUCED TERTIARY STRUCTURAL CHANGES IN HUMAN HEMOGLOBIN; CRYSTAL STRUCTURE OF ALPHA(FE)-BETA(NI) HEMOGLOBIN (LASER PHOTOLYSED) 1BQO ; 2.30 ; DISCOVERY OF POTENT, ACHIRAL MATRIX METALLOPROTEINASE INHIBITORS 2AB9 ; -1.00 ; DISCOVERY, STRUCTURAL DETERMINATION AND PROCESSING OF THE PRECURSOR PROTEIN THAT PRODUCES THE CYCLIC TRYPSIN INHIBITOR SFTI-1 3BIR ; 2.30 ; DISECTING HISTIDINE INTERACTIONS IN RIBONUCLEASE T1 BY ASN AND GLN SUBSTITUTIONS 5BIR ; 1.85 ; DISECTING HISTIDINE INTERACTIONS IN RIBONUCLEASE T1 USING ASN AND GLN MUTATIONS 464D ; 1.23 ; DISORDER AND TWIN REFINEMENT OF RIBONUCLEIC ACID HEPTAMER DOUBLE HELIX 466D ; 1.16 ; DISORDER AND TWIN REFINEMENT OF RIBONUCLEIC ACID HEPTAMER DOUBLE HELIX 1O5A ; 1.68 ; DISSECTING AND DESIGNING INHIBITOR SELECTIVITY DETERMINANTS AT THE S1 SITE USING AN ARTIFICIAL ALA190 PROTEASE (ALA190 UPA) 1O5B ; 1.85 ; DISSECTING AND DESIGNING INHIBITOR SELECTIVITY DETERMINANTS AT THE S1 SITE USING AN ARTIFICIAL ALA190 PROTEASE (ALA190 UPA) 1O5C ; 1.63 ; DISSECTING AND DESIGNING INHIBITOR SELECTIVITY DETERMINANTS AT THE S1 SITE USING AN ARTIFICIAL ALA190 PROTEASE (ALA190 UPA) 1O5D ; 2.05 ; DISSECTING AND DESIGNING INHIBITOR SELECTIVITY DETERMINANTS AT THE S1 SITE USING AN ARTIFICIAL ALA190 PROTEASE (ALA190 UPA) 1O5E ; 1.75 ; DISSECTING AND DESIGNING INHIBITOR SELECTIVITY DETERMINANTS AT THE S1 SITE USING AN ARTIFICIAL ALA190 PROTEASE (ALA190 UPA) 1O5F ; 1.78 ; DISSECTING AND DESIGNING INHIBITOR SELECTIVITY DETERMINANTS AT THE S1 SITE USING AN ARTIFICIAL ALA190 PROTEASE (ALA190 UPA) 1O5G ; 1.75 ; DISSECTING AND DESIGNING INHIBITOR SELECTIVITY DETERMINANTS AT THE S1 SITE USING AN ARTIFICIAL ALA190 PROTEASE (ALA190 UPA) 1HV0 ; 1.60 ; DISSECTING ELECTROSTATIC INTERACTIONS AND THE PH-DEPENDENT ACTIVITY OF A FAMILY 11 GLYCOSIDASE 1HV1 ; 1.80 ; DISSECTING ELECTROSTATIC INTERACTIONS AND THE PH-DEPENDENT ACTIVITY OF A FAMILY 11 GLYCOSIDASE 2AB4 ; 2.40 ; DISSECTING THE ROLES OF A STRICTLY CONSERVED TYROSINE IN SUBSTRATE RECOGNITION AND CATALYSIS BY PSEUDOURIDINE 55 SYNTHASE 2BO4 ; 1.95 ; DISSECTION OF MANNOSYLGLYCERATE SYNTHASE: AN ARCHETYPAL MANNOSYLTRANSFERASE 2BO6 ; 2.45 ; DISSECTION OF MANNOSYLGLYCERATE SYNTHASE: AN ARCHETYPAL MANNOSYLTRANSFERASE 2BO7 ; 2.95 ; DISSECTION OF MANNOSYLGLYCERATE SYNTHASE: AN ARCHETYPAL MANNOSYLTRANSFERASE 2BO8 ; 2.80 ; DISSECTION OF MANNOSYLGLYCERATE SYNTHASE: AN ARCHETYPAL MANNOSYLTRANSFERASE 2NAP ; 1.90 ; DISSIMILATORY NITRATE REDUCTASE (NAP) FROM DESULFOVIBRIO DESULFURICANS 4ATJ ; 2.50 ; DISTAL HEME POCKET MUTANT (H42E) OF RECOMBINANT HORSERADISH PEROXIDASE IN COMPLEX WITH BENZHYDROXAMIC ACID 1KZM ; 2.00 ; DISTAL HEME POCKET MUTANT (R38S/H42E) OF RECOMBINANT HORSERADISH PEROXIDASE C (HRP C). 1MMM ; 2.20 ; DISTINCT METAL ENVIRONMENT IN IRON-SUBSTITUTED MANGANESE SUPEROXIDE DISMUTASE PROVIDES A STRUCTURAL BASIS OF METAL SPECIFICITY 1MJV ; 2.10 ; DISULFIDE DEFICIENT MUTANT OF VASCULAR ENDOTHELIAL GROWTH FACTOR A (C51A AND C60A) 1MKG ; 2.50 ; DISULFIDE DEFICIENT MUTANT OF VASCULAR ENDOTHELIAL GROWTH FACTOR A (C57A AND C102A) 1MKK ; 1.32 ; DISULFIDE DEFICIENT MUTANT OF VASCULAR ENDOTHELIAL GROWTH FACTOR A (C61A AND C104A) 1LK0 ; 1.60 ; DISULFIDE INTERMEDIATE OF C89L ARSENATE REDUCTASE FROM PI258 1AR2 ; 2.80 ; DISULFIDE-FREE IMMUNOGLOBULIN FRAGMENT 1ZDC ; -1.00 ; DISULFIDE-STABILIZED MINI PROTEIN A DOMAIN, Z34C, NMR, 24 STRUCTURES 1ZDD ; -1.00 ; DISULFIDE-STABILIZED MINI PROTEIN A DOMAIN, Z34C, NMR, MINIMIZED MEAN STRUCTURE 1B0Q ; -1.00 ; DITHIOL ALPHA MELANOTROPIN PEPTIDE CYCLIZED VIA RHENIUM METAL COORDINATION 2DMR ; 2.80 ; DITHIONITE REDUCED DMSO REDUCTASE FROM RHODOBACTER CAPSULATUS 1PIM ; 2.00 ; DITHIONITE REDUCED E. COLI RIBONUCLEOTIDE REDUCTASE R2 SUBUNIT, D84E MUTANT 1NZA ; 1.70 ; DIVALENT CATION TOLERANCE PROTEIN (CUT A1) FROM THERMUS THERMOPHILUS HB8 1XK8 ; 2.70 ; DIVALENT CATION TOLERANT PROTEIN CUTA FROM HOMO SAPIENS O60888 1F21 ; 1.40 ; DIVALENT METAL COFACTOR BINDING IN THE KINETIC FOLDING TRAJECTORY OF E. COLI RIBONUCLEASE HI 1UT5 ; 2.75 ; DIVALENT METAL IONS (MANGANESE) BOUND TO T5 5'-EXONUCLEASE 1UT8 ; 2.75 ; DIVALENT METAL IONS (ZINC) BOUND TO T5 5'-EXONUCLEASE 1UET ; 2.00 ; DIVERGENT EVOLUTIONS OF TRINUCLEOTIDE POLYMERIZATION REVEALED BY AN ARCHAEAL CCA-ADDING ENZYME STRUCTURE 1UEU ; 2.00 ; DIVERGENT EVOLUTIONS OF TRINUCLEOTIDE POLYMERIZATION REVEALED BY AN ARCHAEAL CCA-ADDING ENZYME STRUCTURE 1UEV ; 2.70 ; DIVERGENT EVOLUTIONS OF TRINUCLEOTIDE POLYMERIZATION REVEALED BY AN ARCHAEAL CCA-ADDING ENZYME STRUCTURE 1JI5 ; 2.50 ; DLP-1 FROM BACILLUS ANTHRACIS 1JIG ; 1.46 ; DLP-2 FROM BACILLUS ANTHRACIS 1H5N ; 2.00 ; DMSO REDUCTASE MODIFIED BY THE PRESENCE OF DMS AND AIR 1Z8S ; -1.00 ; DNAB BINDING DOMAIN OF DNAG (P16) FROM BACILLUS STEAROTHERMOPHILUS (RESIDUES 452-597) 1IUR ; -1.00 ; DNAJ DOMAIN OF HUMAN KIAA0730 PROTEIN 1UTB ; 2.59 ; DNTR FROM BURKHOLDERIA SP. STRAIN DNT 1UTH ; 2.20 ; DNTR FROM BURKHOLDERIA SP. STRAIN DNT IN COMPLEX WITH THIOCYANATE 2NMB ; -1.00 ; DNUMB PTB DOMAIN COMPLEXED WITH A PHOSPHOTYROSINE PEPTIDE, NMR, ENSEMBLE OF STRUCTURES. 1MI6 ; 12.80 ; DOCKING OF THE MODIFIED RF2 X-RAY STRUCTURE INTO THE LOW RESOLUTION CRYO-EM MAP OF RF2 E.COLI 70S RIBOSOME 2BTM ; 2.40 ; DOES THE HIS12-LYS13 PAIR PLAY A ROLE IN THE ADAPTATION OF THERMOPHILIC TIMS TO HIGH TEMPERATURES? 1RP1 ; 2.10 ; DOG PANCREATIC LIPASE RELATED PROTEIN 1 1LU2 ; 2.80 ; DOLICHOS BIFLORUS SEED LECTIN IN COMPLEX WITH THE BLOOD GROUP A TRISACCHARIDE 1EGJ ; 2.80 ; DOMAIN 4 OF THE BETA COMMON CHAIN IN COMPLEX WITH AN ANTIBODY 1AD6 ; 2.30 ; DOMAIN A OF HUMAN RETINOBLASTOMA TUMOR SUPPRESSOR 1H4U ; 2.20 ; DOMAIN G2 OF MOUSE NIDOGEN-1 1AER ; 2.30 ; DOMAIN III OF PSEUDOMONAS AERUGINOSA EXOTOXIN COMPLEXED WITH BETA-TAD 1DMA ; 3.00 ; DOMAIN III OF PSEUDOMONAS AERUGINOSA EXOTOXIN COMPLEXED WITH NICOTINAMIDE AND AMP 1MNF ; 3.00 ; DOMAIN MOTIONS IN GROEL UPON BINDING OF AN OLIGOPEPTIDE 1HT9 ; 1.76 ; DOMAIN SWAPPING EF-HANDS 1HZU ; 2.70 ; DOMAIN SWING UPON HIS TO ALA MUTATION IN NITRITE REDUCTASE OF PSEUDOMONAS AERUGINOSA 1HZV ; 2.83 ; DOMAIN SWING UPON HIS TO ALA MUTATION IN NITRITE REDUCTASE OF PSEUDOMONAS AERUGINOSA 1L5B ; 2.00 ; DOMAIN-SWAPPED CYANOVIRIN-N DIMER 1H8X ; 2.00 ; DOMAIN-SWAPPED DIMER OF A HUMAN PANCREATIC RIBONUCLEASE VARIANT 1DZ3 ; 1.65 ; DOMAIN-SWAPPING IN THE SPORULATION RESPONSE REGULATOR SPO0A 1PN6 ; 10.80 ; DOMAIN-WISE FITTING OF THE CRYSTAL STRUCTURE OF T.THERMOPHILUS EF-G INTO THE LOW RESOLUTION MAP OF THE RELEASE COMPLEX.PUROMYCIN.EFG.GDPNP OF E.COLI 70S RIBOSOME. 1A7L ; 2.90 ; DOMINANT B-CELL EPITOPE FROM THE PRES2 REGION OF HEPATITIS B VIRUS IN THE FORM OF AN INSERTED PEPTIDE SEGMENT IN MALTODEXTRIN-BINDING PROTEIN 1PQN ; -1.00 ; DOMINANT NEGATIVE HUMAN HDIM1 (HDIM1 1-128) 1ECG ; 2.30 ; DON INACTIVATED ESCHERICHIA COLI GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATE (PRPP) AMIDOTRANSFERASE 1BVO ; 2.70 ; DORSAL HOMOLOGUE GAMBIF1 BOUND TO DEOXYRIBONUCLEIC ACID 1OF8 ; 1.50 ; DOUBLE COMPLEX OF THE TYROSINE SENSITIVE DAHP SYNTHASE FROM S. CEREVISIAE WITH CO2+, PEP AND THE E4P ANALOGOUE G3P 1J3J ; 2.30 ; DOUBLE MUTANT (C59R+S108N) PLASMODIUM FALCIPARUM DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE (PFDHFR-TS) COMPLEXED WITH PYRIMETHAMINE, NADPH, AND DUMP 2BXJ ; 2.40 ; DOUBLE MUTANT OF THE RIBOSOMAL PROTEIN S6 1PYY ; 2.42 ; DOUBLE MUTANT PBP2X T338A/M339F FROM STREPTOCOCCUS PNEUMONIAE STRAIN R6 AT 2.4 A RESOLUTION 2D3G ; 1.70 ; DOUBLE SIDED UBIQUITIN BINDING OF HRS-UIM 1STU ; -1.00 ; DOUBLE STRANDED RIBONUCLEIC ACID BINDING DOMAIN 1UIL ; -1.00 ; DOUBLE-STRANDED RIBONUCLEIC ACID-BINDING MOTIF OF HYPOTHETICAL PROTEIN BAB28848 1KZZ ; 3.50 ; DOWNSTREAM REGULATOR TANK BINDS TO THE CD40 RECOGNITION SITE ON TRAF3 1L0A ; 2.90 ; DOWNSTREAM REGULATOR TANK BINDS TO THE CD40 RECOGNITION SITE ON TRAF3 2DPM ; 1.80 ; DPNM DEOXYRIBONUCLEIC ACID ADENINE METHYLTRANSFERASE FROM STREPTOCCOCUS PNEUMONIAE COMPLEXED WITH S-ADENOSYLMETHIONINE 1S9F ; 2.00 ; DPO WITH AT MATCHED 1S97 ; 2.40 ; DPO4 WITH GT MISMATCH 1UT1 ; 1.70 ; DRAE ADHESIN FROM ESCHERICHIA COLI 1LPV ; -1.00 ; DROSOPHILA MELANOGASTER DOUBLESEX (DSX), NMR, 18 STRUCTURES 2BK9 ; 1.20 ; DROSOPHILA MELANOGASTER GLOBIN 1SXR ; 1.56 ; DROSOPHILA PEPTIDOGLYCAN RECOGNITION PROTEIN (PGRP)-SA 1R18 ; 2.20 ; DROSOPHILA PROTEIN ISOASPARTYL METHYLTRANSFERASE WITH S- ADENOSYL-L-HOMOCYSTEINE 1TAF ; 2.00 ; DROSOPHILA TBP ASSOCIATED FACTORS DTAFII42/DTAFII62 HETEROTETRAMER 1XW9 ; 2.30 ; DROSPOHILA THIOREDOXIN, OXIDIZED, P21 1XWA ; 2.20 ; DROSPOHILA THIOREDOXIN, OXIDIZED, P41212 1XWB ; 2.20 ; DROSPOHILA THIOREDOXIN, OXIDIZED, P42212 1XWC ; 2.30 ; DROSPOHILA THIOREDOXIN, REDUCED, P6522 1AZM ; 2.00 ; DRUG-PROTEIN INTERACTIONS: STRUCTURE OF SULFONAMIDE DRUG COMPLEXED WITH HUMAN CARBONIC ANHYDRASE I 1BZM ; 2.00 ; DRUG-PROTEIN INTERACTIONS: STRUCTURE OF SULFONAMIDE DRUG COMPLEXED WITH HUMAN CARBONIC ANHYDRASE I 1CZM ; 2.00 ; DRUG-PROTEIN INTERACTIONS: STRUCTURE OF SULFONAMIDE DRUG COMPLEXED WITH HUMAN CARBONIC ANHYDRASE I 1AC1 ; 2.00 ; DSBA MUTANT H32L 1ACV ; 1.90 ; DSBA MUTANT H32S 1BQ7 ; 2.80 ; DSBA MUTANT P151A, ROLE OF THE CIS-PROLINE IN THE ACTIVE SITE OF DSBA 1JZO ; 1.92 ; DSBC C101S 1G0T ; 2.60 ; DSBC MUTANT C101S 1JZD ; 2.30 ; DSBC-DSBDALPHA COMPLEX 1A1F ; 2.10 ; DSNR (ZIF268 VARIANT) ZINC FINGER-DEOXYRIBONUCLEIC ACID COMPLEX (GACC SITE) 1A1G ; 1.90 ; DSNR (ZIF268 VARIANT) ZINC FINGER-DEOXYRIBONUCLEIC ACID COMPLEX (GCGT SITE) 1BXK ; 1.90 ; DTDP-GLUCOSE 4,6-DEHYDRATASE FROM E. COLI 1H7L ; 1.98 ; DTDP-MAGNESIUM COMPLEX OF SPSA FROM BACILLUS SUBTILIS 1H7Q ; 2.00 ; DTDP-MANGANESE COMPLEX OF SPSA FROM BACILLUS SUBTILIS 1SZM ; 2.50 ; DUAL BINDING MODE OF BISINDOLYLMALEIMIDE 2 TO PROTEIN KINASE A (PKA) 2A4O ; 1.55 ; DUAL MODES OF MODIFICATION OF HEPATITIS A VIRUS 3C PROTEASE BY A SERINE DERIVED BETA-LACTONE: SELECTIVE CRYTSTALLIZATION AND HIGH RESOLUTION STRUCTURE OF THE HIS102 ADDUCT 2CXV ; 1.40 ; DUAL MODES OF MODIFICATION OF HEPATITIS A VIRUS 3C PROTEASE BY A SERINE-DERIVED BETALACTONE: SELECTIVE CRYSTALLIZATION AND HIGH-RESOLUTION STRUCTURE OF THE HIS-102 ADDUCT 1PYN ; 2.20 ; DUAL-SITE POTENT, SELECTIVE PROTEIN TYROSINE PHOSPHATASE 1B INHIBITOR USING A LINKED FRAGMENT STRATEGY AND A MALONATE HEAD ON THE FIRST SITE 1QMU ; 2.70 ; DUCK CARBOXYPEPTIDASE D DOMAIN II 1H8L ; 2.60 ; DUCK CARBOXYPEPTIDASE D DOMAIN II IN COMPLEX WITH GEMSA 1AG3 ; -1.00 ; DUPLEX OLIGODEOXYNUCLEOTIDE CONTAINING PROPANODEOXYGUANOSINE OPPOSITE A TWO-BASE DELETION, NMR, MINIMIZED AVERAGE STRUCTURE 410D ; 1.60 ; DUPLEX [5'-D(GCGTA)R(+T)D(ACGC)]2 WITH INCORPORATED 2'-O-ETHOXYMETHYLENE RIBONUCLEOSIDE 411D ; 1.93 ; DUPLEX [5'-D(GCGTA)R(+T)D(ACGC)]2 WITH INCORPORATED 2'-O-METHOXYETHYL RIBONUCLEOSIDE 412D ; 1.65 ; DUPLEX [5'-D(GCGTA)R(+T)D(ACGC)]2 WITH INCORPORATED 2'-O-METHYL-[TRI(OXYETHYL)] RIBONUCLEOSIDE 1P56 ; 1.80 ; DUPLICATION-EXTENSION OF HELIX A OF T4 LYSOZYME 1MFS ; -1.00 ; DYNAMICAL BEHAVIOR OF THE HIV-1 NUCLEOCAPSID PROTEIN; NMR, 30 STRUCTURES 2DYN ; 2.30 ; DYNAMIN (PLECKSTRIN HOMOLOGY DOMAIN) (DYNPH) 1YGT ; 1.70 ; DYNEIN LIGHT CHAIN TCTEX-1 9HVP ; 2.80 ; Design, Activity and 2.8 Angstroms Crystal Structure of a C2 Symmetric Inhibitor Complexed to HIV-1 Protease 2GYI ; 1.60 ; Design, Synthesis, and Characterization of a Potent Xylose Isomerase Inhibitor, D-Threonohydroxamic Acid, and High-Resolution X-Ray Crystallographic Structure of the Enzyme-Inhibitor Complex 2CCX ; -1.00 ; Determination of the Nuclear Magnetic Resonance Solution Structure of Cardiotoxin Ctx Iib from Naja Mossambica Mossambica 2CBH ; -1.00 ; Determination of the Three-Dimensional Structure of the C-Terminal Domain of Cellobiohydrolase I from Trichoderma Reesei. A Study Using Nuclear Magnetic Resonance and Hybrid Distance Geometry-Dynamical Simulated Annealing 2FB4 ; 1.90 ; Die Primaerstruktur Des Kristallisierbaren Monoklonalen Immunoglobulins Igg1 Kol. II. Aminosaeuresequenz Der L-Kette, Lambda-Typ, Subgruppe I (German) 2IG2 ; 3.00 ; Die Primaerstruktur Des Kristallisierbaren Monoklonalen Immunoglobulins Igg1 Kol. II. Aminosaeuresequenz Der L-Kette, Lambda-Typ, Subgruppe I (German) 1CCN ; -1.00 ; Direct Noe Refinement of Crambin from 2D NMR Data Using a Slow-Cooling Annealing Protocol 2BPJ ; 2.35 ; E COLI GLUCOSAMINE-6P SYNTHASE IN COMPLEX WITH GLUCOSE-6P AND 5-OXO-L-NORLEUCINE 2WRP ; 1.65 ; E COLI TRP REPRESSOR, ORTHORHOMBIC CRYSTAL FORM 1K6N ; 3.10 ; E(L212)A,D(L213)A DOUBLE MUTANT STRUCTURE OF PHOTOSYNTHETIC REACTION CENTER FROM RHODOBACTER SPHAEROIDES 1Q1P ; 3.20 ; E-CADHERIN ACTIVATION 1EDH ; 2.00 ; E-CADHERIN DOMAINS 1 AND 2 IN COMPLEX WITH CALCIUM 1MOW ; 2.40 ; E-DREI 1NOQ ; -1.00 ; E-MOTIF STRUCTURE 1F49 ; 2.50 ; E. COLI (LAC Z) BETA-GALACTOSIDASE (NCS CONSTRAINED MONOMER- MONOCLINIC) 1GHO ; 2.50 ; E. COLI (LAC Z) BETA-GALACTOSIDASE (NCS CONSTRAINED MONOMER- MONOCLINIC) 1HN1 ; 3.00 ; E. COLI (LAC Z) BETA-GALACTOSIDASE (ORTHORHOMBIC) 1JZ8 ; 1.50 ; E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH ALLOLACTOSE 1JYN ; 1.80 ; E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH LACTOSE 1JYV ; 1.75 ; E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH ONPG 1JYW ; 1.55 ; E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH PNPG 1PX3 ; 1.60 ; E. COLI (LACZ) BETA-GALACTOSIDASE (G794A) 1PX4 ; 1.60 ; E. COLI (LACZ) BETA-GALACTOSIDASE (G794A) WITH IPTG BOUND 1F4A ; 2.80 ; E. COLI (LACZ) BETA-GALACTOSIDASE (NCS CONSTRAINED MONOMER- ORTHORHOMBIC) 1F4H ; 2.80 ; E. COLI (LACZ) BETA-GALACTOSIDASE (ORTHORHOMBIC) 1JYY ; 2.70 ; E. COLI (LACZ) BETA-GALACTOSIDASE IN COMPLEX WITH 2-F- LACTOSE. CHAINS A-H, SEE REMARK 400. 1JYZ ; 2.70 ; E. COLI (LACZ) BETA-GALACTOSIDASE IN COMPLEX WITH 2-F- LACTOSE. CHAINS I-P, SEE REMARK 400. 1JZ5 ; 1.80 ; E. COLI (LACZ) BETA-GALACTOSIDASE IN COMPLEX WITH D- GALCTOPYRANOSYL-1-ON 1JZ6 ; 2.10 ; E. COLI (LACZ) BETA-GALACTOSIDASE IN COMPLEX WITH GALACTO- TETRAZOLE 1JZ7 ; 1.50 ; E. COLI (LACZ) BETA-GALACTOSIDASE IN COMPLEX WITH GALACTOSE 1JYX ; 1.75 ; E. COLI (LACZ) BETA-GALACTOSIDASE IN COMPLEX WITH IPTG 1JZ3 ; 1.75 ; E. COLI (LACZ) BETA-GALACTOSIDASE-TRAPPED 2-DEOXY- GALACTOSYL ENZYME INTERMEDIATE 1JZ4 ; 2.10 ; E. COLI (LACZ) BETA-GALACTOSIDASE-TRAPPED 2-DEOXY- GALACTOSYL-ENZYME INTERMEDIATE (LOW BIS-TRIS) 1JZ2 ; 2.10 ; E. COLI (LACZ) BETA-GALACTOSIDASE-TRAPPED 2-F-GALACTOSYL- ENZYME INTERMEDIATE (ORTHORHOMBIC) 1JZ0 ; 2.60 ; E. COLI (LACZ) BETA-GALACTOSIDASE-TRAPPED 2-F-GALACTOSYL- ENZYME INTERMEDIATE. CHAINS A-H, SEE REMARK 400 1JZ1 ; 2.60 ; E. COLI (LACZ) BETA-GALACTOSIDASE-TRAPPED 2-F-GALACTOSYL- ENZYME INTERMEDIATE. CHAINS I-P, SEE REMARK 400 1KH7 ; 2.40 ; E. COLI ALKALINE PHOSPHATASE MUTANT (D153GD330N) 1KH9 ; 2.50 ; E. COLI ALKALINE PHOSPHATASE MUTANT (D153GD330N) COMPLEX WITH PHOSPHATE 1KHK ; 2.50 ; E. COLI ALKALINE PHOSPHATASE MUTANT (D153HD330N) 1KHL ; 2.50 ; E. COLI ALKALINE PHOSPHATASE MUTANT (D153HD330N) COMPLEX WITH PHOSPHATE 1KHJ ; 2.30 ; E. COLI ALKALINE PHOSPHATASE MUTANT (D153HD330N) MIMIC OF THE TRANSITION STATES WITH ALUMINIUM FLUORIDE 1KHN ; 2.60 ; E. COLI ALKALINE PHOSPHATASE MUTANT (D153HD330N) ZINC FORM 1KH4 ; 2.40 ; E. COLI ALKALINE PHOSPHATASE MUTANT (D330N) IN COMPLEX WITH PHOSPHATE 1KH5 ; 2.00 ; E. COLI ALKALINE PHOSPHATASE MUTANT (D330N) MIMIC OF THE TRANSITION STATES WITH ALUMINIUM FLUORIDE 1ELX ; 2.60 ; E. COLI ALKALINE PHOSPHATASE MUTANT (S102A) 1ELY ; 2.80 ; E. COLI ALKALINE PHOSPHATASE MUTANT (S102C) 1ELZ ; 2.80 ; E. COLI ALKALINE PHOSPHATASE MUTANT (S102G) 1GYT ; 2.50 ; E. COLI AMINOPEPTIDASE A (PEPA) 2BHA ; 2.40 ; E. COLI AMINOPEPTIDASE P IN COMPLEX WITH SUBSTRATE 1SKU ; 2.60 ; E. COLI ASPARTATE TRANSCARBAMYLASE 240'S LOOP MUTANT (K244N) 1DP0 ; 1.70 ; E. COLI BETA-GALACTOSIDASE AT 1.7 ANGSTROM 1MKA ; 2.00 ; E. COLI BETA-HYDROXYDECANOYL THIOL ESTER DEHYDRASE MODIFIED BY ITS CLASSIC MECHANISM-BASED INACTIVATOR, 3-DECYNOYL-N-ACETYL CYSTEAMINE 2BUH ; 1.90 ; E. COLI BETA-KETOACYL (ACYL CARRIER PROTEIN) SYNTHASE I, 120 K 1H4F ; 2.00 ; E. COLI BETA-KETOACYL [ACYL CARRIER PROTEIN] SYNTHASE I K328R 1B23 ; 2.60 ; E. COLI CYSTEINYL-TRNA AND T. AQUATICUS ELONGATION FACTOR EF-TU:GTP TERNARY COMPLEX 1MMI ; 1.85 ; E. COLI DEOXYRIBONUCLEIC ACID POLYMERASE BETA SUBUNIT 2BVN ; 2.30 ; E. COLI EF-TU:GDPNP IN COMPLEX WITH THE ANTIBIOTIC ENACYLOXIN IIA 1OB2 ; 3.35 ; E. COLI ELONGATION FACTOR EF-TU COMPLEXED WITH THE ANTIBIOTIC KIRROMYCIN, A GTP ANALOG, AND PHE-TRNA 1I30 ; 2.40 ; E. COLI ENOYL REDUCTASE +NAD+SB385826 1I2Z ; 2.80 ; E. COLI ENOYL REDUCTASE IN COMPLEX WITH NAD AND BRL-12654 1MFP ; 2.33 ; E. COLI ENOYL REDUCTASE IN COMPLEX WITH NAD AND SB611113 1D8A ; 2.20 ; E. COLI ENOYL REDUCTASE/NAD+/TRICLOSAN COMPLEX 1QFG ; 2.50 ; E. COLI FERRIC HYDROXAMATE RECEPTOR (FHUA) 1QFF ; 2.70 ; E. COLI FERRIC HYDROXAMATE UPTAKE RECEPTOR (FHUA) IN COMPLEX WITH BOUND FERRICHROME-IRON 1AHN ; 2.60 ; E. COLI FLAVODOXIN AT 2.6 ANGSTROMS RESOLUTION 1ECQ ; 2.00 ; E. COLI GLUCARATE DEHYDRATASE BOUND TO 4-DEOXYGLUCARATE 1EC8 ; 1.90 ; E. COLI GLUCARATE DEHYDRATASE BOUND TO PRODUCT 2,3- DIHYDROXY-5-OXO-HEXANEDIOATE 1EC9 ; 2.00 ; E. COLI GLUCARATE DEHYDRATASE BOUND TO XYLAROHYDROXAMATE 1EC7 ; 1.90 ; E. COLI GLUCARATE DEHYDRATASE NATIVE ENZYME 1D8L ; 2.50 ; E. COLI HOLLIDAY JUNCTION BINDING PROTEIN RUVA NH2 REGION LACKING DOMAIN III 1YQN ; 3.11 ; E. COLI ISPF DOUBLE MUTANT 1KNP ; 2.60 ; E. COLI L-ASPARTATE OXIDASE: MUTANT R386L IN COMPLEX WITH SUCCINATE 1OCX ; 2.15 ; E. COLI MALTOSE-O-ACETYLTRANSFERASE 1K7Y ; 3.00 ; E. COLI METH C-TERMINAL FRAGMENT (649-1227) 1YVM ; 1.60 ; E. COLI METHIONINE AMINOPEPTIDASE IN COMPLEX WITH THIABENDAZOLE 1C21 ; 1.80 ; E. COLI METHIONINE AMINOPEPTIDASE: METHIONINE COMPLEX 1C24 ; 1.70 ; E. COLI METHIONINE AMINOPEPTIDASE: METHIONINE PHOSPHINATE COMPLEX 1C23 ; 2.00 ; E. COLI METHIONINE AMINOPEPTIDASE: METHIONINE PHOSPHONATE COMPLEX 1C22 ; 1.75 ; E. COLI METHIONINE AMINOPEPTIDASE: TRIFLUOROMETHIONINE COMPLEX 1C27 ; 1.95 ; E. COLI METHIONINE AMINOPEPTIDASE:NORLEUCINE PHOSPHONATE COMPLEX 1ZP3 ; 1.85 ; E. COLI METHYLENETETRAHYDROFOLATE REDUCTASE (OXIDIZED) 1KMJ ; 2.00 ; E. COLI NIFS/CSDB PROTEIN AT 2.0A WITH THE CYSTEINE PERSULFIDE INTERMEDIATE (RESIDUE CSS). 1KMK ; 2.20 ; E. COLI NIFS/CSDB PROTEIN AT 2.20A WITH THE CYSTEINE PERSELENIDE INTERMEDIATE (RESIDUE CSZ). 1K2V ; 1.97 ; E. COLI PERIPLASMIC PROTEIN FHUD COMPLEXED WITH DESFERAL 1TXY ; 2.00 ; E. COLI PRIB 1L8A ; 1.85 ; E. COLI PYRUVATE DEHYDROGENASE 1RP7 ; 2.09 ; E. COLI PYRUVATE DEHYDROGENASE INHIBITOR COMPLEX 1KF6 ; 2.70 ; E. COLI QUINOL-FUMARATE REDUCTASE WITH BOUND INHIBITOR HQNO 1WUD ; 2.20 ; E. COLI RECQ HRDC DOMAIN 1RKD ; 1.84 ; E. COLI RIBOKINASE COMPLEXED WITH RIBOSE AND ADP 1RK2 ; 2.25 ; E. COLI RIBOKINASE COMPLEXED WITH RIBOSE AND ADP, SOLVED IN SPACE GROUP P212121 1RKS ; 2.40 ; E. COLI RIBOKINASE IN COMPLEX WITH D-RIBOSE 1KVA ; 1.80 ; E. COLI RIBONUCLEASE HI D134A MUTANT 1KVB ; 1.90 ; E. COLI RIBONUCLEASE HI D134H MUTANT 1KVC ; 1.90 ; E. COLI RIBONUCLEASE HI D134N MUTANT 1BDX ; 6.00 ; E. COLI RUVA WITH BOUND DEOXYRIBONUCLEIC ACID HOLLIDAY JUNCTION, ALPHA CARBONS AND PHOSPHATE ATOMS ONLY 1JKJ ; 2.35 ; E. COLI SCS 1U8U ; 2.08 ; E. COLI THIOESTERASE I/PROTEASE I/LYSOPHOSPHOLIASE L1 IN COMPLEXED WITH OCTANOIC ACID 1J00 ; 2.00 ; E. COLI THIOESTERASE I/PROTEASE I/LYSOPHOSPHOLIPASE L1 IN COMPLEXED WITH DIETHYL PHOSPHONO MOIETY 1TJS ; 2.20 ; E. COLI THYMIDYLATE SYNTHASE 1JUT ; 2.70 ; E. COLI THYMIDYLATE SYNTHASE BOUND TO DUMP AND LY338529, A PYRROLO(2,3-D)PYRIMIDINE-BASED ANTIFOLATE 1AOB ; 2.10 ; E. COLI THYMIDYLATE SYNTHASE COMPLEXED WITH DDURD 1BID ; 2.20 ; E. COLI THYMIDYLATE SYNTHASE COMPLEXED WITH DUMP 1BDU ; 2.10 ; E. COLI THYMIDYLATE SYNTHASE COMPLEXED WITH DURD 1JTU ; 2.20 ; E. COLI THYMIDYLATE SYNTHASE IN A COMPLEX WITH DUMP AND LY338913, A POLYGLUTAMYLATED PYRROLO(2,3-D)PYRIMIDINE- BASED ANTIFOLATE 1SYN ; 2.00 ; E. COLI THYMIDYLATE SYNTHASE IN COMPLEX WITH BW1843U89 AND 2'-DEOXYURIDINE 5'-MONOPHOSPHATE (DUMP) 1AN5 ; 2.60 ; E. COLI THYMIDYLATE SYNTHASE IN COMPLEX WITH CB3717 1DDU ; 2.10 ; E. COLI THYMIDYLATE SYNTHASE IN COMPLEX WITH CB3717 AND 2',5'-DIDEOXYURIDINE (DDURD) 1TDU ; 2.10 ; E. COLI THYMIDYLATE SYNTHASE IN COMPLEX WITH CB3717 AND 2'-DEOXYURIDINE (DURD) 1AXW ; 1.70 ; E. COLI THYMIDYLATE SYNTHASE IN COMPLEX WITH METHOTREXATE (MTX) AND 2'-DEOXYURIDINE 5'-MONOPHOSPHATE (DUMP) 1TRG ; 1.90 ; E. COLI THYMIDYLATE SYNTHASE IN SYMMETRIC COMPLEX WITH CB3717 AND 2'-DEOXYURIDINE 5'-MONOPHOSPHATE (DUMP) 1KCE ; 2.00 ; E. COLI THYMIDYLATE SYNTHASE MUTANT E58Q IN COMPLEX WITH CB3717 AND 2'-DEOXYURIDINE 5'-MONOPHOSPHATE (DUMP) 1ZPR ; 2.50 ; E. COLI THYMIDYLATE SYNTHASE MUTANT E58Q IN COMPLEX WITH CB3717 AND 2'-DEOXYURIDINE 5'-MONOPHOSPHATE (DUMP) 1BQ2 ; 2.20 ; E. COLI THYMIDYLATE SYNTHASE MUTANT N177A 1BQ1 ; 2.50 ; E. COLI THYMIDYLATE SYNTHASE MUTANT N177A IN COMPLEX WITH CB3717 AND 2'-DEOXYURIDINE 5'-MONOPHOSPHATE (DUMP) 1P6Z ; 1.67 ; E. COLI TRP APO-REPRESSOR, MONOCLINIC CRYSTAL FORM 1JTQ ; 2.50 ; E. COLI TS COMPLEX WITH DUMP AND THE PYRROLO(2,3-D) PYRIMIDINE-BASED ANTIFOLATE LY341770 2A9W ; 1.65 ; E. COLI TS COMPLEXED WITH DUMP AND INHIBITOR GA9 1UEH ; 1.73 ; E. COLI UNDECAPRENYL PYROPHOSPHATE SYNTHASE IN COMPLEX WITH TRITON X-100, MAGNESIUM AND SULFATE 1RXS ; 2.80 ; E. COLI URIDINE PHOSPHORYLASE: 2'-DEOXYURIDINE PHOSPHATE COMPLEX 1RXC ; 2.35 ; E. COLI URIDINE PHOSPHORYLASE: 5-FLUOROURACIL RIBOSE-1- PHOSPHATE COMPLEX 1RXU ; 3.10 ; E. COLI URIDINE PHOSPHORYLASE: THYMIDINE PHOSPHATE COMPLEX 1RXY ; 1.70 ; E. COLI URIDINE PHOSPHORYLASE: TYPE-B NATIVE 2BUI ; 2.40 ; E.COLI BETA-KETOACYL (ACYL CARRIER PROTEIN) SYNTHASE I IN COMPLEX WITH OCTANOIC ACID, 120K 1E58 ; 1.25 ; E.COLI COFACTOR-DEPENDENT PHOSPHOGLYCERATE MUTASE 1E59 ; 1.30 ; E.COLI COFACTOR-DEPENDENT PHOSPHOGLYCERATE MUTASE COMPLEXED WITH VANADATE 1W7K ; 2.10 ; E.COLI FOLC IN COMPLEX WITH ADP, WITHOUT FOLATE SUBSTRATE 1W78 ; 1.82 ; E.COLI FOLC IN COMPLEX WITH DHPP AND ADP 1DB3 ; 2.30 ; E.COLI GDP-MANNOSE 4,6-DEHYDRATASE 2BPL ; 2.05 ; E.COLI GLUCOSAMINE-6P SYNTHASE IN COMPLEX WITH FRUCTOSE-6P 1QOY ; 2.00 ; E.COLI HEMOLYSIN E (HLYE, CLYA, SHEA) 1PVF ; 1.78 ; E.COLI IPP ISOMERASE IN COMPLEX WITH DIPHOSPHATE 1S98 ; 2.30 ; E.COLI ISCA CRYSTAL STRUCTURE TO 2.3 A 2MAT ; 1.90 ; E.COLI METHIONINE AMINOPEPTIDASE AT 1.9 ANGSTROM RESOLUTION 4MAT ; 2.00 ; E.COLI METHIONINE AMINOPEPTIDASE HIS79ALA MUTANT 3MAT ; 2.00 ; E.COLI METHIONINE AMINOPEPTIDASE TRANSITION-STATE INHIBITOR COMPLEX 1NG9 ; 2.60 ; E.COLI MUTS R697A: AN ATPASE-ASYMMETRY MUTANT 1WXF ; 2.30 ; E.COLI NAD SYNTHETASE 1WXE ; 1.90 ; E.COLI NAD SYNTHETASE, AMP 1WXI ; 1.70 ; E.COLI NAD SYNTHETASE, AMP.PP 1WXG ; 1.90 ; E.COLI NAD SYNTHETASE, DND 1WXH ; 1.90 ; E.COLI NAD SYNTHETASE, NAD 2AI8 ; 1.70 ; E.COLI POLYPEPTIDE DEFORMYLASE COMPLEXED WITH SB-485343 1EQN ; 2.90 ; E.COLI PRIMASE CATALYTIC CORE 1C7Y ; 3.10 ; E.COLI RUVA-HOLLIDAY JUNCTION COMPLEX 1IVN ; 1.90 ; E.COLI THIOESTERASE I/PROTEASE I/LYSOPHOSPHOLIASE L1 1QUG ; 1.90 ; E108V MUTANT OF T4 LYSOZYME 1QT6 ; 1.90 ; E11H MUTANT OF T4 LYSOZYME 1QT7 ; 1.80 ; E11N MUTANT OF T4 LYSOZYME 1QQO ; 1.90 ; E175S MUTANT OF BOVINE 70 KILODALTON HEAT SHOCK PROTEIN 5DAA ; 2.90 ; E177K MUTANT OF D-AMINO ACID AMINOTRANSFERASE COMPLEXED WITH PYRIDOXAMINE-5'-PHOSPHATE 1G2W ; 2.00 ; E177S MUTANT OF THE PYRIDOXAL-5'-PHOSPHATE ENZYME D-AMINO ACID AMINOTRANSFERASE 3PRN ; 1.90 ; E1M, A104W MUTANT OF RH. BLASTICA PORIN 1BH3 ; 2.19 ; E1M, A116K MUTANT OF RH. BLASTICA PORIN 7PRN ; 2.25 ; E1M, D97A, E99A MUTANT OF RH. BLASTICA PORIN 6PRN ; 2.04 ; E1M, K50A, R52A MUTANT OF RH. BLASTICA PORIN 8PRN ; 2.30 ; E1M, K50A, R52A, D97A, E99A MUTANT OF RH. BLASTICA PORIN 5PRN ; 2.00 ; E1M, Y96W, S119W MUTANT OF RH. BLASTICA PORIN 1JJH ; 2.50 ; E2 DEOXYRIBONUCLEIC ACID-BINDING DOMAIN FROM BOVINE PAPILLOMAVIRUS TYPE 1 1DBD ; -1.00 ; E2 DEOXYRIBONUCLEIC ACID-BINDING DOMAIN FROM PAPILLOMAVIRUS BPV-1 2E2C ; 2.00 ; E2-C, AN UBIQUITIN CONJUGATING ENZYME REQUIRED FOR THE DESTRUCTION OF MITOTIC CYCLINS 1E5N ; 3.20 ; E246C MUTANT OF P FLUORESCENS SUBSP. CELLULOSA XYLANASE A IN COMPLEX WITH XYLOPENTAOSE 1PI3 ; 1.20 ; E28Q MUTANT BENZOYLFORMATE DECARBOXYLASE FROM PSEUDOMONAS PUTIDA 1KQ7 ; 2.60 ; E315Q MUTANT FORM OF FUMARASE C FROM E.COLI 1BYP ; 1.75 ; E43K,D44K DOUBLE MUTANT PLASTOCYANIN FROM SILENE 1OTA ; 1.10 ; E46Q MUTANT OF PHOTOACTIVE YELLOW PROTEIN, P63 AT 295K 1OTE ; 1.40 ; E46Q MUTANT OF PHOTOACTIVE YELLOW PROTEIN, P65 AT 110K 1OTI ; 1.40 ; E46Q MUTANT OF PHOTOACTIVE YELLOW PROTEIN, P65 AT 295K 1RIJ ; -1.00 ; E6-BIND TRP-CAGE (E6APN1) 1RIK ; -1.00 ; E6-BINDING ZINC FINGER (E6APC1) 1RIM ; -1.00 ; E6-BINDING ZINC FINGER (E6APC2) 1RV4 ; 2.95 ; E75L MUTANT OF RABBIT CYTOSOLIC SERINE HYDROXYMETHYLTRANSFERASE 1RV3 ; 2.40 ; E75L MUTANT OF RABBIT CYTOSOLIC SERINE HYDROXYMETHYLTRANSFERASE, COMPLEX WITH GLYCINE 1RVU ; 2.50 ; E75Q MUTANT OF RABBIT CYTOSOLIC SERINE HYDROXYMETHYLTRANSFERASE 1RVY ; 2.90 ; E75Q MUTANT OF RABBIT CYTOSOLIC SERINE HYDROXYMETHYLTRANSFERASE, COMPLEX WITH GLYCINE 1OH3 ; 1.50 ; E78R MUTANT OF A CARBOHYDRATE BINDING MODULE FAMILY 29 1ADT ; 3.00 ; EARLY E2A DEOXYRIBONUCLEIC ACID-BINDING PROTEIN 1ADU ; 3.00 ; EARLY E2A DEOXYRIBONUCLEIC ACID-BINDING PROTEIN 1ADV ; 3.20 ; EARLY E2A DEOXYRIBONUCLEIC ACID-BINDING PROTEIN 1T18 ; 1.60 ; EARLY INTERMEDIATE IE1 FROM TIME-RESOLVED CRYSTALLOGRAPHY OF THE E46Q MUTANT OF PYP 1T19 ; 1.60 ; EARLY INTERMEDIATE IE2 FROM TIME-RESOLVED CRYSTALLOGRAPHY OF THE E46Q MUTANT OF PYP 1B3T ; 2.20 ; EBNA-1 NUCLEAR PROTEIN/DEOXYRIBONUCLEIC ACID COMPLEX 1H2C ; 1.60 ; EBOLA VIRUS MATRIX PROTEIN VP40 N-TERMINAL DOMAIN IN COMPLEX WITH RIBONUCLEIC ACID (HIGH-RESOLUTION VP40[55-194] VARIANT). 1H2D ; 2.60 ; EBOLA VIRUS MATRIX PROTEIN VP40 N-TERMINAL DOMAIN IN COMPLEX WITH RIBONUCLEIC ACID (LOW-RESOLUTION VP40[31-212] VARIANT). 1HWN ; 2.80 ; EBULIN COMPLEXED WITH GALACTOSE, TRIGONAL CRYSTAL FORM 1HWO ; 2.90 ; EBULIN COMPLEXED WITH LACTOSE, TRIGONAL CRYSTAL FORM 1HWP ; 3.10 ; EBULIN COMPLEXED WITH PTEROIC ACID, TRIGONAL CRYSTAL FORM 1HWM ; 2.80 ; EBULIN,ORTHORHOMBIC CRYSTAL FORM MODEL 1XVN ; 1.50 ; ECHINOMYCIN (ACGTACGT)2 COMPLEX 1XVR ; 1.40 ; ECHINOMYCIN (CGTACG)2 COMPLEX 1PFE ; 1.10 ; ECHINOMYCIN-(GCGTACGC)2 COMPLEX 1EV1 ; 3.55 ; ECHOVIRUS 1 1H8T ; 2.90 ; ECHOVIRUS 11 1EON ; 1.60 ; ECORV BOUND TO 3'-S-PHOSPHOROTHIOLATE DEOXYRIBONUCLEIC ACID AND CA2+ 1EOO ; 2.16 ; ECORV BOUND TO COGNATE DEOXYRIBONUCLEIC ACID 1EOP ; 2.60 ; ECORV BOUND TO COGNATE DEOXYRIBONUCLEIC ACID 1SX8 ; 2.15 ; ECORV BOUND TO COGNATE DEOXYRIBONUCLEIC ACID AND MN2+ 1EO4 ; 1.90 ; ECORV BOUND TO MN2+ AND COGNATE DEOXYRIBONUCLEIC ACID CONTAINING A 3'S SUBSTITION AT THE CLEAVAGE SITE 1BGB ; 2.00 ; ECORV ENDONUCLEASE COMPLEX WITH 5'-CGGGATATCCC DEOXYRIBONUCLEIC ACID 1AZ3 ; 2.40 ; ECORV ENDONUCLEASE, UNLIGANDED, FORM B 1AZ4 ; 2.40 ; ECORV ENDONUCLEASE, UNLIGANDED, FORM B, T93A MUTANT 2B0D ; 2.00 ; ECORV RESTRICTION ENDONUCLEASE/GAATTC/CA2+ 2B0E ; 1.90 ; ECORV RESTRICTION ENDONUCLEASE/GAAUTC/CA2+ 1BSS ; 2.15 ; ECORV-T93A/DEOXYRIBONUCLEIC ACID/CA2+ 1AZ0 ; 2.00 ; ECORV/DEOXYRIBONUCLEIC ACID/CA2+ 1BUA ; 2.15 ; ECORV/GACITC/CA2+ 1BSU ; 2.00 ; ECORV/GAMITC/CA2+ 1EZU ; 2.40 ; ECOTIN Y69F, D70P BOUND TO D102N TRYPSIN 1ECI ; -1.00 ; ECTATOMIN (WATER SOLUTION, NMR 20 STRUCTURES) 1FCG ; 2.00 ; ECTODOMAIN OF HUMAN FC GAMMA RECEPTOR, FCGRIIA 1GKS ; -1.00 ; ECTOTHIORHODOSPIRA HALOPHILA CYTOCHROME C551 (REDUCED), NMR, 37 STRUCTURES 1JOC ; 2.20 ; EEA1 HOMODIMER OF C-TERMINAL FYVE DOMAIN BOUND TO INOSITOL 1,3-DIPHOSPHATE 1H8B ; -1.00 ; EF-HANDS 3,4 FROM ALPHA-ACTININ / Z-REPEAT 7 FROM TITIN 1AIP ; 3.00 ; EF-TU EF-TS COMPLEX FROM THERMUS THERMOPHILUS 1QZD ; 10.00 ; EF-TU.KIRROMYCIN COORDINATES FITTED INTO THE CRYO-EM MAP OF EF-TU TERNARY COMPLEX (GDP.KIRROMYCIN) BOUND 70S RIBOSOME 1XQK ; 1.95 ; EFFECT OF A Y265F MUTANT ON THE TRANSAMINATION BASED CYCLOSERINE INACTIVATION OF ALANINE RACEMASE 1XQL ; 1.80 ; EFFECT OF A Y265F MUTANT ON THE TRANSAMINATION BASED CYCLOSERINE INACTIVATION OF ALANINE RACEMASE 1YKX ; 1.90 ; EFFECT OF ALCOHOLS ON PROTEIN HYDRATION 1YKY ; 1.90 ; EFFECT OF ALCOHOLS ON PROTEIN HYDRATION 1YKZ ; 1.80 ; EFFECT OF ALCOHOLS ON PROTEIN HYDRATION 1YL0 ; 1.90 ; EFFECT OF ALCOHOLS ON PROTEIN HYDRATION 1YL1 ; 1.90 ; EFFECT OF ALCOHOLS ON PROTEIN HYDRATION 1Z55 ; 1.90 ; EFFECT OF ALCOHOLS ON PROTEIN HYDRATION 329D ; 2.70 ; EFFECT OF CYTOSINE METHYLATION ON DEOXYRIBONUCLEIC ACID-DEOXYRIBONUCLEIC ACID RECOGNITION AT CPG STEPS 1YX9 ; 3.00 ; EFFECT OF DIMETHYL SULPHOXIDE ON THE CRYSTAL STRUCTURE OF PORCINE PEPSIN 240D ; 2.00 ; EFFECT OF END BASE STEPS ON DEOXYRIBONUCLEIC ACID FORM: CRYSTAL STRUCTURE OF THE A-DEOXYRIBONUCLEIC ACID DECAMER D( CCGGGCCCGG) 1P4Y ; 1.70 ; EFFECT OF SEQUENCE ON THE CONFORMATIONAL GEOMETRY OF DEOXYRIBONUCLEIC ACID HOLLIDAY JUNCTIONS 1P4Z ; 2.00 ; EFFECT OF SEQUENCE ON THE CONFORMATIONAL GEOMETRY OF DEOXYRIBONUCLEIC ACID HOLLIDAY JUNCTIONS 1P54 ; 1.90 ; EFFECT OF SEQUENCE ON THE CONFORMATIONAL GEOMETRY OF DEOXYRIBONUCLEIC ACID HOLLIDAY JUNCTIONS 1T9N ; 2.00 ; EFFECT OF SHUTTLE LOCATION AND PH ENVIRONMENT ON H+ TRANSFER IN HUMAN CARBONIC ANHYDRASE II 1TB0 ; 2.00 ; EFFECT OF SHUTTLE LOCATION AND PH ENVIRONMENT ON H+ TRANSFER IN HUMAN CARBONIC ANHYDRASE II 1TBT ; 2.00 ; EFFECT OF SHUTTLE LOCATION AND PH ENVIRONMENT ON H+ TRANSFER IN HUMAN CARBONIC ANHYDRASE II 1TE3 ; 2.00 ; EFFECT OF SHUTTLE LOCATION AND PH ENVIRONMENT ON H+ TRANSFER IN HUMAN CARBONIC ANHYDRASE II 1TEQ ; 2.00 ; EFFECT OF SHUTTLE LOCATION AND PH ENVIRONMENT ON H+ TRANSFER IN HUMAN CARBONIC ANHYDRASE II 1TEU ; 2.00 ; EFFECT OF SHUTTLE LOCATION AND PH ENVIRONMENT ON H+ TRANSFER IN HUMAN CARBONIC ANHYDRASE II 1TG3 ; 1.80 ; EFFECT OF SHUTTLE LOCATION AND PH ENVIRONMENT ON H+ TRANSFER IN HUMAN CARBONIC ANHYDRASE II 1TG9 ; 1.90 ; EFFECT OF SHUTTLE LOCATION AND PH ENVIRONMENT ON H+ TRANSFER IN HUMAN CARBONIC ANHYDRASE II 1TH9 ; 1.63 ; EFFECT OF SHUTTLE LOCATION AND PH ENVIRONMENT ON H+ TRANSFER IN HUMAN CARBONIC ANHYDRASE II 1THK ; 1.80 ; EFFECT OF SHUTTLE LOCATION AND PH ENVIRONMENT ON H+ TRANSFER IN HUMAN CARBONIC ANHYDRASE II 1BEK ; 2.20 ; EFFECT OF UNNATURAL HEME SUBSTITUTION ON KINETICS OF ELECTRON TRANSFER IN CYTOCHROME C PEROXIDASE 1BEP ; 2.20 ; EFFECT OF UNNATURAL HEME SUBSTITUTION ON KINETICS OF ELECTRON TRANSFER IN CYTOCHROME C PEROXIDASE 1BJ9 ; 2.20 ; EFFECT OF UNNATURAL HEME SUBSTITUTION ON KINETICS OF ELECTRON TRANSFER IN CYTOCHROME C PEROXIDASE 1BX3 ; 2.30 ; EFFECTS OF COMMONLY USED CRYOPROTECTANTS ON GLYCOGEN PHOSPHORYLASE ACTIVITY AND STRUCTURE 1S02 ; 1.90 ; EFFECTS OF ENGINEERED SALT BRIDGES ON THE STABILITY OF SUBTILISIN BPN' 1BKU ; -1.00 ; EFFECTS OF GLYCOSYLATION ON THE STRUCTURE AND DYNAMICS OF EEL CALCITONIN, NMR, 10 STRUCTURES 1FB9 ; -1.00 ; EFFECTS OF S-SULFONATION ON THE SOLUTION STRUCTURE OF SALMON CALCITONIN 2C22 ; 2.56 ; EFFICIENT AND HIGH FIDELITY INCORPORATION OF DCTP OPPOSITE 7,8-DIHYDRO-8-OXODEOXYGUANOSINE BY SULFOLOBUS SOLFATARICUS DEOXYRIBONUCLEIC ACID POLYMERASE DPO4 2C28 ; 2.27 ; EFFICIENT AND HIGH FIDELITY INCORPORATION OF DCTP OPPOSITE 7,8-DIHYDRO-8-OXODEOXYGUANOSINE BY SULFOLOBUS SOLFATARICUS DEOXYRIBONUCLEIC ACID POLYMERASE DPO4 2C2D ; 2.57 ; EFFICIENT AND HIGH FIDELITY INCORPORATION OF DCTP OPPOSITE 7,8-DIHYDRO-8-OXODEOXYGUANOSINE BY SULFOLOBUS SOLFATARICUS DEOXYRIBONUCLEIC ACID POLYMERASE DPO4 2C2E ; 2.61 ; EFFICIENT AND HIGH FIDELITY INCORPORATION OF DCTP OPPOSITE 7,8-DIHYDRO-8-OXODEOXYGUANOSINE BY SULFOLOBUS SOLFATARICUS DEOXYRIBONUCLEIC ACID POLYMERASE DPO4 2C2R ; 2.55 ; EFFICIENT AND HIGH FIDELITY INCORPORATION OF DCTP OPPOSITE 7,8-DIHYDRO-8-OXODEOXYGUANOSINE BY SULFOLOBUS SOLFATARICUS DEOXYRIBONUCLEIC ACID POLYMERASE DPO4 1XKK ; 2.40 ; EGFR KINASE DOMAIN COMPLEXED WITH A QUINAZOLINE INHIBITOR- GW572016 1DUC ; 2.05 ; EIAV DUTPASE DUDP/STRONTIUM COMPLEX 1DUN ; 1.90 ; EIAV DUTPASE NATIVE 2FMB ; 1.80 ; EIAV PROTEASE COMPLEXED WITH AN INHIBITOR LP-130 1FMB ; 1.80 ; EIAV PROTEASE COMPLEXED WITH THE INHIBITOR HBY-793 1S0U ; 2.40 ; EIF2GAMMA APO 1EJH ; 2.20 ; EIF4E/EIF4G PEPTIDE/7-METHYL-GDP 1O2G ; 1.58 ; ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS 1O2H ; 1.77 ; ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS 1O2I ; 1.50 ; ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS 1O2J ; 1.65 ; ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS 1O2K ; 1.63 ; ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS 1O2L ; 1.68 ; ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS 1O2M ; 1.69 ; ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS 1O2N ; 1.50 ; ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS 1O2O ; 1.63 ; ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS 1O2P ; 1.47 ; ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS 1O2Q ; 1.50 ; ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS 1O2R ; 1.45 ; ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS 1O2S ; 1.65 ; ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS 1O2T ; 1.62 ; ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS 1O2U ; 1.41 ; ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS 1O2V ; 1.50 ; ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS 1O2W ; 1.38 ; ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS 1O2X ; 1.46 ; ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS 1O2Y ; 1.45 ; ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS 1O2Z ; 1.65 ; ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS 1O30 ; 1.55 ; ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS 1O31 ; 1.66 ; ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS 1O32 ; 1.78 ; ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS 1O33 ; 1.46 ; ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS 1O34 ; 1.50 ; ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS 1O35 ; 1.41 ; ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS 1O36 ; 1.70 ; ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS 1O37 ; 1.45 ; ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS 1O38 ; 1.38 ; ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS 1O39 ; 1.59 ; ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS 1O3A ; 2.00 ; ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS 1O3B ; 1.75 ; ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS 1O3C ; 1.64 ; ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS 1O3D ; 1.33 ; ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS 1O3E ; 1.64 ; ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS 1O3F ; 1.55 ; ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS 1O3G ; 1.55 ; ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS 1O3H ; 1.53 ; ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS 1O3I ; 1.51 ; ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS 1O3J ; 1.40 ; ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS 1O3K ; 1.43 ; ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS 1O3L ; 1.40 ; ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS 1O3M ; 1.55 ; ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS 1O3N ; 1.55 ; ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS 1O3O ; 1.55 ; ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS 1O3P ; 1.81 ; ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS 2BLQ ; 1.33 ; ELASTASE AFTER A HIGH DOSE X-RAY "BURN" 2BLO ; 1.33 ; ELASTASE BEFORE A HIGH DOSE X-RAY "BURN" 1U4G ; 1.40 ; ELASTASE OF PSEUDOMONAS AERUGINOSA WITH AN INHIBITOR 2B6O ; 1.90 ; ELECTRON CRYSTALLOGRAPHIC STRUCTURE OF LENS AQUAPORIN-0 (AQP0) (LENS MIP) AT 1.9A RESOLUTION, IN A CLOSED PORE STATE 1U74 ; 2.40 ; ELECTRON TRANSFER COMPLEX BETWEEN CYTOCHROME C AND CYTOCHROME C PEROXIDASE 1U75 ; 2.55 ; ELECTRON TRANSFER COMPLEX BETWEEN HORSE HEART CYTOCHROME C AND ZINC-PORPHYRIN SUBSTITUTED CYTOCHROME C PEROXIDASE 1EFP ; 2.60 ; ELECTRON TRANSFER FLAVOPROTEIN (ETF) FROM PARACOCCUS DENITRIFICANS 3YPI ; 2.80 ; ELECTROPHILIC CATALYSIS IN TRIOSEPHOSPHASE ISOMERASE: THE ROLE OF HISTIDINE-95 1C2B ; 4.50 ; ELECTROPHORUS ELECTRICUS ACETYLCHOLINESTERASE 1C2O ; 4.20 ; ELECTROPHORUS ELECTRICUS ACETYLCHOLINESTERASE 1XYW ; -1.00 ; ELK PRION PROTEIN 1DUX ; 2.10 ; ELK-1/DEOXYRIBONUCLEIC ACID STRUCTURE REVEALS HOW RESIDUES DISTAL FROM DEOXYRIBONUCLEIC ACID- BINDING SURFACE AFFECT DEOXYRIBONUCLEIC ACID-RECOGNITION 1EFU ; 2.50 ; ELONGATION FACTOR COMPLEX EF-TU/EF-TS FROM ESCHERICHIA COLI 1DAR ; 2.40 ; ELONGATION FACTOR G IN COMPLEX WITH GDP 1ELO ; 2.85 ; ELONGATION FACTOR G WITHOUT NUCLEOTIDE 1ENW ; -1.00 ; ELONGATION FACTOR TFIIS DOMAIN II 1HA3 ; 2.00 ; ELONGATION FACTOR TU IN COMPLEX WITH AURODOX 1FA4 ; -1.00 ; ELUCIDATION OF THE PARAMAGNETIC RELAXATION OF HETERONUCLEI AND PROTONS IN CU(II) PLASTOCYANIN FROM ANABAENA VARIABILIS 1CHV ; -1.00 ; ELUCIDATION OF THE SOLUTION STRUCTURE OF CARDIOTOXIN ANALOGUE V FROM THE TAIWAN COBRA (NAJA NAJA ATRA) VENOM 2BRS ; 2.20 ; EMBP HEPARIN COMPLEX 1KVF ; -1.00 ; EMP-18 ERYTHROPOIETIN RECEPTOR AGONIST PEPTIDE 1EXA ; 1.59 ; ENANTIOMER DISCRIMINATION ILLUSTRATED BY CRYSTAL STRUCTURES OF THE HUMAN RETINOIC ACID RECEPTOR HRARGAMMA LIGAND BINDING DOMAIN: THE COMPLEX WITH THE ACTIVE R-ENANTIOMER BMS270394. 1EXX ; 1.67 ; ENANTIOMER DISCRIMINATION ILLUSTRATED BY CRYSTAL STRUCTURES OF THE HUMAN RETINOIC ACID RECEPTOR HRARGAMMA LIGAND BINDING DOMAIN: THE COMPLEX WITH THE INACTIVE S-ENANTIOMER BMS270395. 1Z3C ; 2.20 ; ENCEPHALITOZOOAN CUNICULI MRNA CAP (GUANINE-N7) METHYLTRANSFERASEIN COMPLEXED WITH AZOADOMET 1NLR ; 1.75 ; ENDO-1,4-BETA-GLUCANASE CELB2, CELLULASE, NATIVE STRUCTURE 1BK1 ; 2.00 ; ENDO-1,4-BETA-XYLANASE C 1XYF ; 1.90 ; ENDO-1,4-BETA-XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS 1REF ; 1.60 ; ENDO-1,4-BETA-XYLANASE II COMPLEX WITH 2,3-EPOXYPROPYL- BETA-D-XYLOSIDE 1REE ; 1.60 ; ENDO-1,4-BETA-XYLANASE II COMPLEX WITH 3,4-EPOXYBUTYL- BETA-D-XYLOSIDE 1RED ; 1.60 ; ENDO-1,4-BETA-XYLANASE II COMPLEX WITH 4,5-EPOXYPENTYL- BETA-D-XYLOSIDE 1YNA ; 1.55 ; ENDO-1,4-BETA-XYLANASE, ROOM TEMPERATURE, PH 4.0 1C8Y ; 2.00 ; ENDO-BETA-N-ACETYLGLUCOSAMINIDASE H, D130A MUTANT 1C8X ; 2.00 ; ENDO-BETA-N-ACETYLGLUCOSAMINIDASE H, D130E MUTANT 1C3F ; 2.10 ; ENDO-BETA-N-ACETYLGLUCOSAMINIDASE H, D130N MUTANT 1C93 ; 2.10 ; ENDO-BETA-N-ACETYLGLUCOSAMINIDASE H, D130N/E132Q DOUBLE MUTANT 1C92 ; 2.10 ; ENDO-BETA-N-ACETYLGLUCOSAMINIDASE H, E132A MUTANT 1C91 ; 2.10 ; ENDO-BETA-N-ACETYLGLUCOSAMINIDASE H, E132D 1C90 ; 2.10 ; ENDO-BETA-N-ACETYLGLUCOSAMINIDASE H, E132Q MUTANT 1CZF ; 1.68 ; ENDO-POLYGALACTURONASE II FROM ASPERGILLUS NIGER 1TF4 ; 1.90 ; ENDO/EXOCELLULASE FROM THERMOMONOSPORA 1JS4 ; 2.00 ; ENDO/EXOCELLULASE:CELLOBIOSE FROM THERMOMONOSPORA 4TF4 ; 2.00 ; ENDO/EXOCELLULASE:CELLOPENTAOSE FROM THERMOMONOSPORA 3TF4 ; 2.20 ; ENDO/EXOCELLULASE:CELLOTRIOSE FROM THERMOMONOSPORA 1VRX ; 2.40 ; ENDOCELLULASE E1 FROM ACIDOTHERMUS CELLULOLYTICUS MUTANT Y245G 1CEM ; 1.65 ; ENDOGLUCANASE A (CELA) CATALYTIC CORE, RESIDUES 33 - 395 1IS9 ; 1.03 ; ENDOGLUCANASE A FROM CLOSTRIDIUM THERMOCELLUM AT ATOMIC RESOLUTION 1H0B ; 1.80 ; ENDOGLUCANASE CEL12A FROM RHODOTHERMUS MARINUS 1W3K ; 1.20 ; ENDOGLUCANASE CEL5A FROM BACILLUS AGARADHAERENS IN COMPLEX WITH CELLOBIO DERIVED-TETRAHYDROOXAZINE 1W3L ; 1.04 ; ENDOGLUCANASE CEL5A FROM BACILLUS AGARADHAERENS IN COMPLEX WITH CELLOTRI DERIVED-TETRAHYDROOXAZINE 1HF6 ; 1.15 ; ENDOGLUCANASE CEL5A FROM BACILLUS AGARADHAERENS IN THE ORTHORHOMBIC CRYSTAL FORM IN COMPLEX WITH CELLOTRIOSE 1QI2 ; 1.75 ; ENDOGLUCANASE CEL5A FROM BACILLUS AGARADHAERENS IN THE TETRAGONAL CRYSTAL FORM IN COMPLEX WITH 2',4'-DINITROPHENYL 2-DEOXY-2-FLUORO-B-D-CELLOTRIOSIDE 1QI0 ; 2.10 ; ENDOGLUCANASE CEL5A FROM BACILLUS AGARADHAERENS IN THE TETRAGONAL CRYSTAL FORM IN COMPLEX WITH CELLOBIOSE 1E5J ; 1.85 ; ENDOGLUCANASE CEL5A FROM BACILLUS AGARADHAERENS IN THE TETRAGONAL CRYSTAL FORM IN COMPLEX WITH METHYL-4II-S-ALPHA-CELLOBIOSYL-4II-THIO BETA-CELLOBIOSIDE 1A3H ; 1.57 ; ENDOGLUCANASE CEL5A FROM BACILLUS AGARADHERANS AT 1.6A RESOLUTION 1H2J ; 1.15 ; ENDOGLUCANASE CEL5A IN COMPLEX WITH UNHYDROLYSED AND COVALENTLY LINKED 2,4-DINITROPHENYL-2-DEOXY-2- FLUORO-CELLOBIOSIDE AT 1.15 A RESOLUTION 1TVP ; 1.60 ; ENDOGLUCANASE CEL5G FROM PSEUDOALTEROMONAS HALOPLANKTIS IN COMPLEX WITH CELLOBIOSE 1DYS ; 1.60 ; ENDOGLUCANASE CEL6B FROM HUMICOLA INSOLENS 1HD5 ; 1.70 ; ENDOGLUCANASE FROM HUMICOLA INSOLENS AT 1.7A RESOLUTION 2OVW ; 2.30 ; ENDOGLUCANASE I COMPLEXED WITH CELLOBIOSE 4OVW ; 2.30 ; ENDOGLUCANASE I COMPLEXED WITH EPOXYBUTYL CELLOBIOSE 1OVW ; 2.70 ; ENDOGLUCANASE I COMPLEXED WITH NON-HYDROLYSABLE SUBSTRATE ANALOGUE 1EG1 ; 3.60 ; ENDOGLUCANASE I FROM TRICHODERMA REESEI 3OVW ; 2.30 ; ENDOGLUCANASE I NATIVE STRUCTURE 2ENG ; 1.50 ; ENDOGLUCANASE V 1VYB ; 1.80 ; ENDONUCLEASE DOMAIN OF HUMAN LINE1 ORF2P 1WDU ; 2.40 ; ENDONUCLEASE DOMAIN OF TRAS1, A TELOMERE-SPECIFIC NON-LTR RETROTRANSPOSON 1E7D ; 2.80 ; ENDONUCLEASE VII (ENDOVII) FROM PHAGE T4 1EN7 ; 2.40 ; ENDONUCLEASE VII (ENDOVII) FROM PHAGE T4 1E7L ; 1.32 ; ENDONUCLEASE VII (ENDOVII) N62D MUTANT FROM PHAGE T4 1SEN ; 1.20 ; ENDOPLASMIC RETICULUM PROTEIN RP19 O95881 1HG8 ; 1.73 ; ENDOPOLYGALACTURONASE FROM THE PHYTOPATHOGENIC FUNGUS FUSARIUM MONILIFORME 1K5C ; 0.96 ; ENDOPOLYGALACTURONASE I FROM STEREUM PURPUREUM AT 0.96 A RESOLUTION 1KCC ; 1.00 ; ENDOPOLYGALACTURONASE I FROM STEREUM PURPUREUM COMPLEXED WITH A GALACTURONATE AT 1.00 A RESOLUTION. 1KCD ; 1.15 ; ENDOPOLYGALACTURONASE I FROM STEREUM PURPUREUM COMPLEXED WITH TWO GALACTURONATE AT 1.15 A RESOLUTION. 1V0E ; 1.90 ; ENDOSIALIDASE OF BACTERIOPHAGE K1F 1V0F ; 2.55 ; ENDOSIALIDASE OF BACTERIOPHAGE K1F IN COMPLEX WITH OLIGOMERIC ALPHA-2,8-SIALIC ACID 1KOE ; 1.50 ; ENDOSTATIN 1GVT ; 0.98 ; ENDOTHIAPEPSIN COMPLEX WITH CP-80,794 1GVU ; 0.94 ; ENDOTHIAPEPSIN COMPLEX WITH H189 1E5O ; 2.05 ; ENDOTHIAPEPSIN COMPLEX WITH INHIBITOR DB2 1GVW ; 1.00 ; ENDOTHIAPEPSIN COMPLEX WITH PD-130,328 1E80 ; 2.05 ; ENDOTHIAPEPSIN COMPLEX WITH RENIN INHIBITOR MERCK-KGAA-EMD56133 1E82 ; 2.05 ; ENDOTHIAPEPSIN COMPLEX WITH RENIN INHIBITOR MERCK-KGAA-EMD59601 1E81 ; 2.05 ; ENDOTHIAPEPSIN COMPLEX WITH RENIN INHIBITOR MERCK-KGAA-EMD61395 1GVX ; 1.00 ; ENDOTHIAPEPSIN COMPLEXED WITH H256 1OD1 ; 1.37 ; ENDOTHIAPEPSIN PD135,040 COMPLEX 1NKO ; 1.45 ; ENERGETIC AND STRUCTURAL BASIS OF SIALYLATED OLIGOSACCHARIDE RECOGNITION BY THE NATURAL KILLER CELL INHIBITORY RECEPTOR P75/AIRM1 OR SIGLEC-7 1QHE ; 2.00 ; ENERGETICS OF A HYDROGEN BOND (CHARGED AND NEUTRAL) AND OF A CATION-PI INTERACTION IN APOFLAVODOXIN 1AXK ; 2.10 ; ENGINEERED BACILLUS BIFUNCTIONAL ENZYME GLUXYN-1 1BXM ; 2.15 ; ENGINEERED BETA-CRYPTOGEIN COMPLEXED WITH ERGOSTEROL 1N3W ; 2.60 ; ENGINEERED HIGH-AFFINITY MALTOSE-BINDING PROTEIN 1NL5 ; 2.10 ; ENGINEERED HIGH-AFFINITY MALTOSE-BINDING PROTEIN 1LK3 ; 1.91 ; ENGINEERED HUMAN INTERLEUKIN-10 MONOMER COMPLEXED TO 9D7 FAB FRAGMENT 1KXO ; 1.80 ; ENGINEERED LIPOCALIN DIGA16 : APO-FORM 1LKE ; 1.90 ; ENGINEERED LIPOCALIN DIGA16 IN COMPLEX WITH DIGOXIGENIN 1N0S ; 2.00 ; ENGINEERED LIPOCALIN FLUA IN COMPLEX WITH FLUORESCEIN 1A7B ; 3.10 ; ENGINEERING A MISFOLDED FORM OF CD2 1A64 ; 2.00 ; ENGINEERING A MISFOLDED FORM OF RAT CD2 1KRJ ; 2.00 ; ENGINEERING CALCIUM-BINDING SITE INTO CYTOCHROME C PEROXIDASE (CCP) 1GJ6 ; 1.50 ; ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS 1GJ7 ; 1.50 ; ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS 1GJ8 ; 1.64 ; ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS 1GJ9 ; 1.80 ; ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS 1GJA ; 1.56 ; ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS 1GJB ; 1.90 ; ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS 1GJC ; 1.73 ; ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS 1GJD ; 1.75 ; ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS 1A6P ; 2.08 ; ENGINEERING OF A MISFOLDED FORM OF CD2 1YQA ; -1.00 ; ENGINEERING THE STRUCTURAL STABILITY AND FUNCTIONAL PROPERTIES OF THE GI DOMAIN INTO THE INTRINSICALLY UNFOLDED GII DOMAIN OF THE YEAST LINKER HISTONE HHO1P 3HDD ; 2.20 ; ENGRAILED HOMEODOMAIN DEOXYRIBONUCLEIC ACID COMPLEX 1DU0 ; 2.00 ; ENGRAILED HOMEODOMAIN Q50A VARIANT DEOXYRIBONUCLEIC ACID COMPLEX 2HDD ; 1.90 ; ENGRAILED HOMEODOMAIN Q50K VARIANT DEOXYRIBONUCLEIC ACID COMPLEX 1S6Z ; 1.50 ; ENHANCED GREEN FLUORESCENT PROTEIN CONTAINING THE Y66L SUBSTITUTION 1CNM ; 2.20 ; ENHANCEMENT OF CATALYTIC EFFICIENCY OF PROTEINASE K THROUGH EXPOSURE TO ANHYDROUS ORGANIC SOLVENT AT 70 DEGREES CELSIUS 1EGQ ; 1.55 ; ENHANCEMENT OF ENZYME ACTIVITY THROUGH THREE-PHASE PARTITIONING: CRYSTAL STRUCTURE OF A MODIFIED SERINE PROTEINASE AT 1.5 A RESOLUTION 1RWE ; 1.80 ; ENHANCING THE ACTIVITY OF INSULIN AT RECEPTOR EDGE: CRYSTAL STRUCTURE AND PHOTO-CROSS-LINKING OF A8 ANALOGUES 1E9I ; 2.48 ; ENOLASE FROM E.COLI 1NAW ; 2.00 ; ENOLPYRUVYL TRANSFERASE 1H0K ; 2.11 ; ENOYL THIOESTER REDUCTASE 2 1GU7 ; 1.70 ; ENOYL THIOESTER REDUCTASE FROM CANDIDA TROPICALIS 1GUF ; 2.25 ; ENOYL THIOESTER REDUCTASE FROM CANDIDA TROPICALIS 2DUB ; 2.40 ; ENOYL-COA HYDRATASE COMPLEXED WITH OCTANOYL-COA 1MPE ; -1.00 ; ENSEMBLE OF 20 STRUCTURES OF THE TETRAMERIC MUTANT OF THE B1 DOMAIN OF STREPTOCOCCAL PROTEIN G 1Q10 ; -1.00 ; ENSEMBLE OF 40 STRUCTURES OF THE DIMERIC MUTANT OF THE B1 DOMAIN OF STREPTOCOCCAL PROTEIN G 1OV2 ; -1.00 ; ENSEMBLE OF THE SOLUTION STRUCTURES OF DOMAIN ONE OF RECEPTOR ASSOCIATED PROTEIN 1JOQ ; -1.00 ; ENSEMBLE STRUCTURES FOR STAPHYLOCOCCAL NUCLEASE-H124L IN TERNARY COMPLEX WITH CA2+ AND THYMIDINE-3',5'-BISPHOSPHATE 1JOR ; -1.00 ; ENSEMBLE STRUCTURES FOR UNLIGATED STAPHYLOCOCCAL NUCLEASE- H124L 1Q2Q ; 1.40 ; ENTEROBACTER CLOACAE GC1 CLASS C BETA-LACTAMASE COMPLEXED WITH PENEM WAY185229 1RGZ ; 1.37 ; ENTEROBACTER CLOACAE GC1 CLASS C BETA-LACTAMASE COMPLEXED WITH TRANSITION-STATE ANALOG OF CEFOTAXIME 1R59 ; 2.50 ; ENTEROCOCCUS CASSELIFLAVUS GLYCEROL KINASE 1XUP ; 2.75 ; ENTEROCOCCUS CASSELIFLAVUS GLYCEROL KINASE COMPLEXED WITH GLYCEROL 1NHT ; 2.50 ; ENTRAPMENT OF 6-THIOPHOSPHORYL-IMP IN THE ACTIVE SITE OF CRYSTALLINE ADENYLOSUCCINATE SYNTHETASE FROM ESCHERICHIA COLI DATA COLLECTED AT 100K 1KSZ ; 2.80 ; ENTRAPMENT OF 6-THIOPHOSPHORYL-IMP IN THE ACTIVE SITE OF CRYSTALLINE ADENYLOSUCCINATE SYNTHETASE FROM ESCHERICHIA COLI, DATA COLLECTED AT 298K 1GEQ ; 2.00 ; ENTROPIC STABILIZATION OF THE TRYPTOPHAN SYNTHASE A-SUBUNIT FROM A HYPERTHERMOPHILE, PYROCOCCUS FURIOSUS: X-RAY ANALYSIS AND CALORIMETRY 1SVB ; 1.90 ; ENVELOPE GLYCOPROTEIN FROM TICK-BORNE ENCEPHALITIS VIRUS 1W8M ; 1.65 ; ENZYMATIC AND STRUCTURAL CHARACTERISATION OF NON PEPTIDE LIGAND CYCLOPHILIN COMPLEXES 1W8L ; 1.80 ; ENZYMATIC AND STRUCTURAL CHARACTERIZATION OF NON PEPTIDE LIGAND CYCLOPHILIN COMPLEXES 1W8V ; 1.70 ; ENZYMATIC AND STRUCTURAL CHARACTERIZATION OF NON PEPTIDE LIGAND CYCLOPHILIN COMPLEXES 1E2A ; 2.30 ; ENZYME IIA FROM THE LACTOSE SPECIFIC PTS FROM LACTOCOCCUS LACTIS 1IXO ; 2.30 ; ENZYME-ANALOGUE SUBSTRATE COMPLEX OF PYRIDOXINE 5'- PHOSPHATE SYNTHASE 1P5D ; 1.60 ; ENZYME-LIGAND COMPLEX OF P. AERUGINOSA PMM/PGM 1P5G ; 1.61 ; ENZYME-LIGAND COMPLEX OF P. AERUGINOSA PMM/PGM 1PCJ ; 2.00 ; ENZYME-LIGAND COMPLEX OF P. AERUGINOSA PMM/PGM 1PCM ; 1.90 ; ENZYME-LIGAND COMPLEX OF P. AERUGINOSA PMM/PGM 1IXP ; 2.30 ; ENZYME-PHOSPHATE COMPLEX OF PYRIDOXINE 5'-PHOSPHATE SYNTHASE 1IXQ ; 2.30 ; ENZYME-PHOSPHATE2 COMPLEX OF PYRIDOXINE 5'-PHOSPHATE SYNTHASE 1QH9 ; 2.50 ; ENZYME-PRODUCT COMPLEX OF L-2-HALOACID DEHALOGENASE 1IXN ; 2.30 ; ENZYME-SUBSTRATE COMPLEX OF PYRIDOXINE 5'-PHOSPHATE SYNTHASE 1ZUX ; 1.85 ; EOSFP FLUORESCENT PROTEIN- GREEN FORM 1HI3 ; 1.80 ; EOSINOPHIL-DERIVED NEUROTOXIN (EDN) - ADENOSINE-2'-5'-DIPHOSPHATE COMPLEX 1HI4 ; 1.80 ; EOSINOPHIL-DERIVED NEUROTOXIN (EDN) - ADENOSINE-3'-5'-DIPHOSPHATE COMPLEX 1HI5 ; 1.80 ; EOSINOPHIL-DERIVED NEUROTOXIN (EDN) - ADENOSINE-5'-DIPHOSPHATE COMPLEX 1HI2 ; 1.60 ; EOSINOPHIL-DERIVED NEUROTOXIN (EDN) - SULPHATE COMPLEX 1SHW ; 2.20 ; EPHB2 / EPHRINA5 COMPLEX STRUCTURE 1SHX ; 2.10 ; EPHRIN A5 LIGAND STRUCTURE 2F01 ; 0.85 ; EPI-BIOTIN COMPLEX WITH CORE STREPTAVIDIN 1G5Q ; 2.57 ; EPID H67N COMPLEXED WITH SUBSTRATE PEPTIDE DSYTC 1FGD ; -1.00 ; EPIDERMAL GROWTH FACTOR (EGF) SUBDOMAIN OF HUMAN THROMBOMODULIN (NMR, 11 STRUCTURES) 1FGE ; -1.00 ; EPIDERMAL GROWTH FACTOR (EGF) SUBDOMAIN OF HUMAN THROMBOMODULIN (NMR, 14 STRUCTURES) 1M17 ; 2.60 ; EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE DOMAIN WITH 4-ANILINOQUINAZOLINE INHIBITOR ERLOTINIB 1EDM ; 1.50 ; EPIDERMAL GROWTH FACTOR-LIKE DOMAIN FROM HUMAN FACTOR IX 1AGJ ; 1.70 ; EPIDERMOLYTIC TOXIN A FROM STAPHYLOCOCCUS AUREUS 1KVG ; -1.00 ; EPO-3 BETA HAIRPIN PEPTIDE 1Q5D ; 1.93 ; EPOTHILONE B-BOUND CYTOCHROME P450EPOK 1R1B ; -1.00 ; EPRS SECOND REPEATED ELEMENT, NMR, MINIMIZED AVERAGE STRUCTURE 1I0C ; 2.00 ; EPS8 SH3 CLOSED MONOMER 1I07 ; 1.80 ; EPS8 SH3 DOMAIN INTERTWINED DIMER 1AQT ; 2.30 ; EPSILON SUBUNIT OF F1F0-ATP SYNTHASE FROM ESCHERICHIA COLI 1H0A ; 1.70 ; EPSIN ENTH BOUND TO INS(1,4,5)P3 1Q36 ; 1.60 ; EPSP SYNTHASE (ASP313ALA) LIGANDED WITH TETRAHEDRAL REACTION INTERMEDIATE 1X8T ; 1.90 ; EPSPS LIGANDED WITH THE (R)-PHOSPHONATE ANALOG OF THE TETRAHEDRAL REACTION INTERMEDIATE 1X8R ; 1.50 ; EPSPS LIGANDED WITH THE (S)-PHOSPHONATE ANALOG OF THE TETRAHEDRAL REACTION INTERMEDIATE 2BSY ; 1.50 ; EPSTEIN BARR VIRUS DUTPASE 2BT1 ; 2.70 ; EPSTEIN BARR VIRUS DUTPASE IN COMPLEX WITH A,B-IMINO DUTP 1VHI ; 2.50 ; EPSTEIN BARR VIRUS NUCLEAR ANTIGEN-1 DEOXYRIBONUCLEIC ACID-BINDING DOMAIN, RESIDUES 470 - 607 1O6E ; 2.30 ; EPSTEIN-BARR VIRUS PROTEASE 1IAZ ; 1.90 ; EQUINATOXIN II 1QKD ; 1.49 ; ERABUTOXIN 1QKE ; 1.50 ; ERABUTOXIN 1N7T ; -1.00 ; ERBIN PDZ DOMAIN BOUND TO A PHAGE-DERIVED PEPTIDE 1AXY ; 1.95 ; ERYTHRINA CORALLODENDRON LECTIN 1AXZ ; 1.95 ; ERYTHRINA CORALLODENDRON LECTIN IN COMPLEX WITH D-GALACTOSE 1AX1 ; 1.95 ; ERYTHRINA CORALLODENDRON LECTIN IN COMPLEX WITH LACTOSE 1AX2 ; 1.95 ; ERYTHRINA CORALLODENDRON LECTIN IN COMPLEX WITH N-ACETYLLACTOSAMINE 1AX0 ; 1.90 ; ERYTHRINA CORALLODENDRON LECTIN IN COMPLEX WITH N-ACTYLGALACTOSAMINE 1UZZ ; 2.13 ; ERYTHRINA CRISTAGALLI BOUND TO N-LINKED OLIGOSACCHARIDE AND LACTOSE 1V00 ; 1.70 ; ERYTHRINA CRISTAGALLI LECTIN 1UZY ; 2.00 ; ERYTHRINA CRYSTAGALLI LECTIN 1CN4 ; 2.80 ; ERYTHROPOIETIN COMPLEXED WITH EXTRACELLULAR DOMAINS OF ERYTHROPOIETIN RECEPTOR 2AAC ; 1.60 ; ESCHERCHIA COLI GENE REGULATORY PROTEIN ARAC COMPLEXED WITH D-FUCOSE 1MKB ; 2.00 ; ESCHERICHIA COLI BETA-HYDROXYDECANOYL THIOL ESTER DEHYDRASE AT PH 5 AND 21 DEGREES C 1DRV ; 2.20 ; ESCHERICHIA COLI DHPR/ACNADH COMPLEX 1DRU ; 2.20 ; ESCHERICHIA COLI DHPR/NADH COMPLEX 1DRW ; 2.20 ; ESCHERICHIA COLI DHPR/NHDH COMPLEX 1ARZ ; 2.60 ; ESCHERICHIA COLI DIHYDRODIPICOLINATE REDUCTASE IN COMPLEX WITH NADH AND 2,6 PYRIDINE DICARBOXYLATE 1F76 ; 2.50 ; ESCHERICHIA COLI DIHYDROOROTATE DEHYDROGENASE 1D8S ; 4.40 ; ESCHERICHIA COLI F1 ATPASE 1QKC ; 3.10 ; ESCHERICHIA COLI FERRIC HYDROXAMATE UPTAKE RECEPTOR (FHUA) IN COMPLEX DELTA TWO-ALBOMYCIN 1GMX ; 1.10 ; ESCHERICHIA COLI GLPE SULFURTRANSFERASE 1GN0 ; 1.80 ; ESCHERICHIA COLI GLPE SULFURTRANSFERASE SOAKED WITH KCN 1ECF ; 2.00 ; ESCHERICHIA COLI GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATE (PRPP) AMIDOTRANSFERASE 1ECJ ; 2.50 ; ESCHERICHIA COLI GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATE (PRPP) AMIDOTRANSFERASE COMPLEXED WITH 2 AMP PER TETRAMER 1ECB ; 2.70 ; ESCHERICHIA COLI GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATE (PRPP) AMIDOTRANSFERASE COMPLEXED WITH 2 GMP, 1 MG PER SUBUNIT 1ECC ; 2.40 ; ESCHERICHIA COLI GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATE (PRPP) AMIDOTRANSFERASE COMPLEXED WITH MN-CPRPP AND 5-OXO-NORLEUCINE 1BWF ; 3.00 ; ESCHERICHIA COLI GLYCEROL KINASE MUTANT WITH BOUND ATP ANALOG SHOWING SUBSTANTIAL DOMAIN MOTION 1GLJ ; 3.00 ; ESCHERICHIA COLI GLYCEROL KINASE MUTANT WITH BOUND ATP ANALOG SHOWING SUBSTANTIAL DOMAIN MOTION 1GLL ; 3.00 ; ESCHERICHIA COLI GLYCEROL KINASE MUTANT WITH BOUND ATP ANALOG SHOWING SUBSTANTIAL DOMAIN MOTION 1GPM ; 2.20 ; ESCHERICHIA COLI GMP SYNTHETASE COMPLEXED WITH AMP AND PYROPHOSPHATE 1TII ; 2.25 ; ESCHERICHIA COLI HEAT LABILE ENTEROTOXIN TYPE IIB 1QB5 ; 1.90 ; ESCHERICHIA COLI HEAT LABILE ENTEROTOXIN TYPE IIB B-PENTAMER 1QCB ; 2.20 ; ESCHERICHIA COLI HEAT LABILE ENTEROTOXIN TYPE IIB B-PENTAMER 1YRL ; 2.60 ; ESCHERICHIA COLI KETOL-ACID REDUCTOISOMERASE 1B5T ; 2.50 ; ESCHERICHIA COLI METHYLENETETRAHYDROFOLATE REDUCTASE 1ZRQ ; 2.20 ; ESCHERICHIA COLI METHYLENETETRAHYDROFOLATE REDUCTASE (REDUCED) COMPLEXED WITH NADH, PH 6.0 1ZPT ; 1.95 ; ESCHERICHIA COLI METHYLENETETRAHYDROFOLATE REDUCTASE (REDUCED) COMPLEXED WITH NADH, PH 7.25 1PR5 ; 2.50 ; ESCHERICHIA COLI PURINE NUCLEOSIDE PHOSPHORYLASE COMPLEXED WITH 7-DEAZAADENOSINE AND PHOSPHATE/SULFATE 1PR4 ; 2.40 ; ESCHERICHIA COLI PURINE NUCLEOSIDE PHOSPHORYLASE COMPLEXED WITH 9-BETA-D-RIBOFURANOSYL-6-METHYLTHIOPURINE AND PHOSPHATE/SULFATE 1PR6 ; 2.10 ; ESCHERICHIA COLI PURINE NUCLEOSIDE PHOSPHORYLASE COMPLEXED WITH 9-BETA-D-XYLOFURANOSYLADENINE AND PHOSPHATE/SULFATE 1PR2 ; 2.30 ; ESCHERICHIA COLI PURINE NUCLEOSIDE PHOSPHORYLASE COMPLEXED WITH 9-BETA-D-[2-DEOXYRIBOFURANOSYL]-6-METHYLPURINE AND PHOSPHATE/SULFATE 1PR1 ; 2.30 ; ESCHERICHIA COLI PURINE NUCLEOSIDE PHOSPHORYLASE COMPLEXED WITH FORMYCIN B AND PHOSPHATE/SULFATE 1PR0 ; 2.20 ; ESCHERICHIA COLI PURINE NUCLEOSIDE PHOSPHORYLASE COMPLEXED WITH INOSINE AND PHOSPHATE/SULFATE 1YQQ ; 2.60 ; ESCHERICHIA COLI PURINE NUCLEOSIDE PHOSPHORYLASE II, THE PRODUCT OF THE XAPA GENE 1YQU ; 3.10 ; ESCHERICHIA COLI PURINE NUCLEOSIDE PHOSPHORYLASE II, THE PRODUCT OF THE XAPA GENE 1YR3 ; 3.20 ; ESCHERICHIA COLI PURINE NUCLEOSIDE PHOSPHORYLASE II, THE PRODUCT OF THE XAPA GENE 1QHM ; 2.80 ; ESCHERICHIA COLI PYRUVATE FORMATE LYASE LARGE DOMAIN 3REC ; -1.00 ; ESCHERICHIA COLI RECA PROTEIN-BOUND DEOXYRIBONUCLEIC ACID, NMR, 1 STRUCTURE 2ARC ; 1.50 ; ESCHERICHIA COLI REGULATORY PROTEIN ARAC COMPLEXED WITH L-ARABINOSE 1ECR ; 2.70 ; ESCHERICHIA COLI REPLICATION TERMINATOR PROTEIN (TUS) COMPLEXED WITH DEOXYRIBONUCLEIC ACID 1CUK ; 1.90 ; ESCHERICHIA COLI RUVA PROTEIN AT PH 4.9 AND ROOM TEMPERATURE 1WQ3 ; 2.00 ; ESCHERICHIA COLI TYROSYL-TRNA SYNTHETASE MUTANT COMLEXED WITH 3-IODO-L-TYROSINE 1WQ4 ; 2.00 ; ESCHERICHIA COLI TYROSYL-TRNA SYNTHETASE MUTANT COMPLEXED WITH L-TYROSINE 1VBN ; 2.70 ; ESCHERICHIA COLI TYROSYL-TRNA SYNTHETASE MUTANT COMPLEXED WITH TYR-AMS 1LQJ ; 3.35 ; ESCHERICHIA COLI URACIL-DEOXYRIBONUCLEIC ACID GLYCOSYLASE 1LQG ; 2.90 ; ESCHERICHIA COLI URACIL-DEOXYRIBONUCLEIC ACID GLYCOSYLASE COMPLEX WITH URACIL- DEOXYRIBONUCLEIC ACID GLYCOSYLASE INHIBITOR PROTEIN 1LQM ; 3.20 ; ESCHERICHIA COLI URACIL-DEOXYRIBONUCLEIC ACID GLYCOSYLASE COMPLEX WITH URACIL- DEOXYRIBONUCLEIC ACID GLYCOSYLASE INHIBITOR PROTEIN 1EUI ; 3.20 ; ESCHERICHIA COLI URACIL-DEOXYRIBONUCLEIC ACID GLYCOSYLASE COMPLEX WITH URACIL-DEOXYRIBONUCLEIC ACID GLYCOSYLASE INHIBITOR PROTEIN 2UUG ; 2.60 ; ESCHERICHIA COLI URACIL-DEOXYRIBONUCLEIC ACID GLYCOSYLASE:INHIBITOR COMPLEX WITH H187D MUTANT UDG AND WILD-TYPE UGI 1UUG ; 2.40 ; ESCHERICHIA COLI URACIL-DEOXYRIBONUCLEIC ACID GLYCOSYLASE:INHIBITOR COMPLEX WITH WILD-TYPE UDG AND WILD-TYPE UGI 1WNB ; 2.20 ; ESCHERICHIA COLI YDCW GENE PRODUCT IS A MEDIUM-CHAIN ALDEHYDE DEHYDROGENASE (COMPLEXED WITH NADH AND BETAINE ALDEHYDE) 1WND ; 2.10 ; ESCHERICHIA COLI YDCW GENE PRODUCT IS A MEDIUM-CHAIN ALDEHYDE DEHYDROGENASE AS DETERMINED BY KINETICS AND CRYSTAL STUCTURE 1PIK ; -1.00 ; ESPERAMICIN A1 - DEOXYRIBONUCLEIC ACID COMPLEX, NMR, 4 STRUCTURES 1CI8 ; 2.00 ; ESTERASE ESTB FROM BURKHOLDERIA GLADIOLI: AN ESTERASE WITH (BETA)-LACTAMASE FOLD. 1X8V ; 1.55 ; ESTRIOL-BOUND AND LIGAND-FREE STRUCTURES OF STEROL 14ALPHA- DEMETHYLASE (CYP51) 2BJ4 ; 2.00 ; ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH A PHAGE-DISPLAY DERIVED PEPTIDE ANTAGONIST 1A52 ; 2.80 ; ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN COMPLEXED TO ESTRADIOL 1NDE ; 3.00 ; ESTROGEN RECEPTOR BETA WITH SELECTIVE TRIAZINE MODULATOR 1LO1 ; -1.00 ; ESTROGEN RELATED RECEPTOR 2 DEOXYRIBONUCLEIC ACID BINDING DOMAIN IN COMPLEX WITH DEOXYRIBONUCLEIC ACID 1AQU ; 1.60 ; ESTROGEN SULFOTRANSFERASE WITH BOUND INACTIVE COFACTOR PAP AND 17-BETA ESTRADIOL 1BO6 ; 2.10 ; ESTROGEN SULFOTRANSFERASE WITH INACTIVE COFACTOR PAP AND VANADATE 1AQY ; 1.75 ; ESTROGEN SULFOTRANSFERASE WITH PAP 1IOL ; 2.30 ; ESTROGENIC 17-BETA HYDROXYSTEROID DEHYDROGENASE COMPLEXED 17-BETA-ESTRADIOL 3DHE ; 2.30 ; ESTROGENIC 17-BETA HYDROXYSTEROID DEHYDROGENASE COMPLEXED DEHYDROEPIANDROSTERONE 1DHT ; 2.24 ; ESTROGENIC 17-BETA HYDROXYSTEROID DEHYDROGENASE COMPLEXED DIHYDROTESTOSTERONE 2ALC ; -1.00 ; ETHANOL REGULON TRANSCRIPTIONAL ACTIVATOR DEOXYRIBONUCLEIC ACID-BINDING DOMAIN FROM ASPERGILLUS NIDULANS 3ALC ; -1.00 ; ETHANOL REGULON TRANSCRIPTIONAL ACTIVATOR DEOXYRIBONUCLEIC ACID-BINDING DOMAIN FROM ASPERGILLUS NIDULANS 1XLV ; 2.25 ; ETHYLPHOSPHORYLATED BUTYRYLCHOLINESTERASE (AGED) OBTAINED BY REACTION WITH ECHOTHIOPHATE 1GVJ ; 1.53 ; ETS-1 DEOXYRIBONUCLEIC ACID BINDING AND AUTOINHIBITORY DOMAINS 1K79 ; 2.40 ; ETS-1(331-440)+GGAA DUPLEX 1K7A ; 2.80 ; ETS-1(331-440)+GGAG DUPLEX 1FYO ; -1.00 ; EUKARYOTIC DECODING REGION A-SITE RIBONUCLEIC ACID 1FYP ; -1.00 ; EUKARYOTIC DECODING REGION A-SITE RIBONUCLEIC ACID-PAROMOMYCIN COMPLEX 1EIF ; 1.90 ; EUKARYOTIC TRANSLATION INITIATION FACTOR 5A FROM METHANOCOCCUS JANNASCHII 2EIF ; 1.80 ; EUKARYOTIC TRANSLATION INITIATION FACTOR 5A FROM METHANOCOCCUS JANNASCHII 1JGG ; 2.00 ; EVEN-SKIPPED HOMEODOMAIN COMPLEXED TO AT-RICH DEOXYRIBONUCLEIC ACID 1QC6 ; 2.60 ; EVH1 DOMAIN FROM ENA/VASP-LIKE PROTEIN IN COMPLEX WITH ACTA PEPTIDE 1EVH ; 1.80 ; EVH1 DOMAIN FROM MURINE ENABLED IN COMPLEX WITH ACTA PEPTIDE 1I7A ; 2.24 ; EVH1 DOMAIN FROM MURINE HOMER 2B/VESL 2 1WPD ; -1.00 ; EVIDENCE FOR DOMAIN-SPECIFIC RECOGNITION OF SK AND KV CHANNELS BY MTX AND HSTX1 SCORPION TOXINS 1T93 ; 1.62 ; EVIDENCE FOR MULTIPLE SUBSTRATE RECOGNITION AND MOLECULAR MECHANISM OF C-C REACTION BY CYTOCHROME P450 CYP158A2 FROM STREPTOMYCES COELICOLOR A3(2) 1BZ5 ; 2.58 ; EVIDENCE OF A COMMON DECAMER IN THREE CRYSTAL STRUCTURES OF BPTI, CRYSTALLIZE FROM THIOCYANATE, CHLORIDE OR SULFATE 1B0C ; 2.80 ; EVIDENCE OF A COMMON DECAMER IN THREE CRYSTAL STRUCTURES OF BPTI, CRYSTALLIZED FROM THIOCYANATE, CHLORIDE OR SULFATE 1R5V ; 2.50 ; EVIDENCE THAT STRUCTURAL REARRANGEMENTS AND/OR FLEXIBILITY DURING TCR BINDING CAN CONTRIBUTE TO T-CELL ACTIVATION 1R5W ; 2.90 ; EVIDENCE THAT STRUCTURAL REARRANGEMENTS AND/OR FLEXIBILITY DURING TCR BINDING CAN CONTRIBUTE TO T-CELL ACTIVATION 1ML3 ; 2.50 ; EVIDENCES FOR A FLIP-FLOP CATALYTIC MECHANISM OF TRYPANOSOMA CRUZI GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE, FROM ITS CRYSTAL STRUCTURE IN COMPLEX WITH REACTED IRREVERSIBLE INHIBITOR 2-(2-PHOSPHONO-ETHYL)-ACRYLIC ACID 4-NITRO-PHENYL ESTER 1HDF ; 2.35 ; EVOLUTION OF THE EYE LENS BETA-GAMMA-CRYSTALLIN DOMAIN FOLD 1ILX ; 3.80 ; EXCITED STATE DYNAMICS IN PHOTOSYSTEM II REVISED. NEW INSIGHTS FROM THE X-RAY STRUCTURE. 1EXF ; 2.10 ; EXFOLIATIVE TOXIN A 1EQP ; 1.90 ; EXO-B-(1,3)-GLUCANASE FROM CANDIDA ALBICANS 1CZ1 ; 1.85 ; EXO-B-(1,3)-GLUCANASE FROM CANDIDA ALBICANS AT 1.85 A RESOLUTION 1EQC ; 1.85 ; EXO-B-(1,3)-GLUCANASE FROM CANDIDA ALBICANS IN COMPLEX WITH CASTANOSPERMINE AT 1.85 A 1UUQ ; 1.50 ; EXO-MANNOSIDASE FROM CELLVIBRIO MIXTUS 1AKO ; 1.70 ; EXONUCLEASE III FROM ESCHERICHIA COLI 1OXD ; 1.15 ; EXPANSION OF THE GENETIC CODE ENABLES DESIGN OF A NOVEL "GOLD" CLASS OF GREEN FLUORESCENT PROTEINS 1OXE ; 1.15 ; EXPANSION OF THE GENETIC CODE ENABLES DESIGN OF A NOVEL "GOLD" CLASS OF GREEN FLUORESCENT PROTEINS 1OXF ; 1.69 ; EXPANSION OF THE GENETIC CODE ENABLES DESIGN OF A NOVEL "GOLD" CLASS OF GREEN FLUORESCENT PROTEINS 1ODZ ; 1.40 ; EXPANSION OF THE GLYCOSYNTHASE REPERTOIRE TO PRODUCE DEFINED MANNO-OLIGOSACCHARIDES 1XDV ; 4.10 ; EXPERIMENTALLY PHASED STRUCTURE OF HUMAN THE SON OF SEVENLESS PROTEIN AT 4.1 ANG. 1WVJ ; 1.75 ; EXPLORING THE GLUR2 LIGAND-BINDING CORE IN COMPLEX WITH THE BICYCLIC AMPA ANALOGUE (S)-4-AHCP 1TDR ; 2.50 ; EXPRESSION, CHARACTERIZATION, AND CRYSTALLOGRAPHIC ANALYSIS OF TELLUROMETHIONYL DIHYDROFOLATE REDUCTASE 2ANY ; 1.40 ; EXPRESSION, CRYSTALLIZATION AND THE THREE-DIMENSIONAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN PLASMA KALLIKREIN: IMPLICATIONS FOR STRUCTURE-BASED DESIGN OF PROTEASE INHIBITORS 2ANW ; 1.85 ; EXPRESSION, CRYSTALLIZATION AND THREE-DIMENSIONAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN PLASMA KALLIKREIN: IMPLICATIONS FOR STRUCTURE-BASED DESIGN OF PROTEASE INHIBITORS 1PD7 ; -1.00 ; EXTENDED SID OF MAD1 BOUND TO THE PAH2 DOMAIN OF MSIN3B 1NMQ ; 2.40 ; EXTENDEND TETHERING: IN SITU ASSEMBLY OF INHIBITORS 1ROQ ; -1.00 ; EXTENDING THE FAMILY OF UNCG-LIKE TETRALOOP MOTIFS: NMR STRUCTURE OF A CACG TETRALOOP FROM COXSACKIEVIRUS B3 1U48 ; 2.10 ; EXTENSION OF A CYTOSINE-8-OXOGUANINE BASE PAIR 1U4B ; 1.60 ; EXTENSION OF AN ADENINE-8OXOGUANINE MISMATCH 1P57 ; 1.75 ; EXTRACELLULAR DOMAIN OF HUMAN HEPSIN 1TFH ; 2.40 ; EXTRACELLULAR DOMAIN OF HUMAN TISSUE FACTOR 1RWI ; 1.80 ; EXTRACELLULAR DOMAIN OF MYCOBACTERIUM TUBERCULOSIS PKND 1RWL ; 1.90 ; EXTRACELLULAR DOMAIN OF MYCOBACTERIUM TUBERCULOSIS PKND 1EXT ; 1.85 ; EXTRACELLULAR DOMAIN OF THE 55KDA TUMOR NECROSIS FACTOR RECEPTOR. CRYSTALLIZED AT PH3.7 IN P 21 21 21. 1N7D ; 3.70 ; EXTRACELLULAR DOMAIN OF THE LDL RECEPTOR 1BOY ; 2.20 ; EXTRACELLULAR REGION OF HUMAN TISSUE FACTOR 1OLL ; 1.93 ; EXTRACELLULAR REGION OF THE HUMAN RECEPTOR NKP46 1M6P ; 1.80 ; EXTRACYTOPLASMIC DOMAIN OF BOVINE CATION-DEPENDENT MANNOSE 6-PHOSPHATE RECEPTOR 1XI6 ; 2.80 ; EXTRAGENIC SUPPRESSOR FROM PYROCOCCUS FURIOSUS PFU-1862794- 001 2RAT ; 1.50 ; Effects of Temperature on Protein Structure and Dynamics: X-Ray Crystallographic Studies of the Protein Ribonuclease-A at Nine Different Temperatures from 98 to 320 K 3RAT ; 1.50 ; Effects of Temperature on Protein Structure and Dynamics: X-Ray Crystallographic Studies of the Protein Ribonuclease-A at Nine Different Temperatures from 98 to 320 K 4RAT ; 1.50 ; Effects of Temperature on Protein Structure and Dynamics: X-Ray Crystallographic Studies of the Protein Ribonuclease-A at Nine Different Temperatures from 98 to 320 K 5RAT ; 1.50 ; Effects of Temperature on Protein Structure and Dynamics: X-Ray Crystallographic Studies of the Protein Ribonuclease-A at Nine Different Temperatures from 98 to 320 K 6RAT ; 1.50 ; Effects of Temperature on Protein Structure and Dynamics: X-Ray Crystallographic Studies of the Protein Ribonuclease-A at Nine Different Temperatures from 98 to 320 K 7RAT ; 1.50 ; Effects of Temperature on Protein Structure and Dynamics: X-Ray Crystallographic Studies of the Protein Ribonuclease-A at Nine Different Temperatures from 98 to 320 K 8RAT ; 1.50 ; Effects of Temperature on Protein Structure and Dynamics: X-Ray Crystallographic Studies of the Protein Ribonuclease-A at Nine Different Temperatures from 98 to 320 K 9RAT ; 1.50 ; Effects of Temperature on Protein Structure and Dynamics: X-Ray Crystallographic Studies of the Protein Ribonuclease-A at Nine Different Temperatures from 98 to 320 K 3CMS ; 2.00 ; Engineering Enzyme Sub-Site Specificity: Preparation, Kinetic Characterization and X-Ray Analysis at 2.0-Angstroms Resolution of Val111Phe Site-Mutated Calf Chymosin 1P4D ; 2.60 ; F FACTOR TRAI RELAXASE DOMAIN 2A0I ; 2.72 ; F FACTOR TRAI RELAXASE DOMAIN BOUND TO F ORIT SINGLE- STRANDED DEOXYRIBONUCLEIC ACID 1SZL ; -1.00 ; F-SPONDIN TSR DOMAIN 1 1VEX ; -1.00 ; F-SPONDIN TSR DOMAIN 4 1TPG ; -1.00 ; F1-G MODULE PAIR RESIDUES 1-91 (C83S) OF TISSUE-TYPE PLASMINOGEN ACTIVATOR (T-PA) (NMR, 298K, PH2.95, REPRESENTATIVE STRUCTURE) 1NT5 ; -1.00 ; F1-GRAMICIDIN A IN SODIUM DODECYL SULFATE MICELLES (NMR) 1NT6 ; -1.00 ; F1-GRAMICIDIN C IN SODIUM DODECYL SULFATE MICELLES (NMR) 1F11 ; 3.00 ; F124 FAB FRAGMENT FROM A MONOCLONAL ANTI-PRES2 ANTIBODY 1O9Z ; 1.75 ; F17-AG LECTIN DOMAIN FROM ESCHERICHIA COLI (LIGAND FREE) 1O9V ; 1.75 ; F17-AG LECTIN DOMAIN FROM ESCHERICHIA COLI IN COMPLEX WITH A SELENIUM CARBOHYDRATE DERIVATIVE 1O9W ; 1.65 ; F17-AG LECTIN DOMAIN FROM ESCHERICHIA COLI IN COMPLEX WITH N-ACETYL-GLUCOSAMINE 1P8I ; 1.86 ; F219L BACTERIORHODOPSIN MUTANT 1P0V ; 2.05 ; F393A MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3 1P0W ; 2.00 ; F393W MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3 1P0X ; 2.00 ; F393Y MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3 1RHC ; 1.80 ; F420-DEPENDENT SECONDARY ALCOHOL DEHYDROGENASE IN COMPLEX WITH AN F420-ACETONE ADDUCT 1IZR ; 1.50 ; F46A MUTANT OF BOVINE PANCREATIC RIBONUCLEASE A 1IZP ; 1.50 ; F46L MUTANT OF BOVINE PANCREATIC RIBONUCLEASE A 1IZQ ; 1.80 ; F46V MUTANT OF BOVINE PANCREATIC RIBONUCLEASE A 5MSF ; 2.80 ; F5 APTAMER MS2 COAT PROTEIN COMPLEX 6MSF ; 2.80 ; F6 APTAMER MS2 COAT PROTEIN COMPLEX 7MSF ; 2.80 ; F7 APTAMER MS2 COAT PROTEIN COMPLEX 1S5I ; 2.70 ; FAB (LNKB-2) OF MONOCLONAL ANTIBODY TO HUMAN INTERLEUKIN-2, CRYSTAL STRUCTURE 1F8T ; 2.20 ; FAB (LNKB-2) OF MONOCLONAL ANTIBODY, CRYSTAL STRUCTURE 1ZLS ; 2.00 ; FAB 2G12 + MAN4 1ZLU ; 2.75 ; FAB 2G12 + MAN5 1ZLV ; 2.33 ; FAB 2G12 + MAN7 1ZLW ; 2.85 ; FAB 2G12 + MAN8 1OM3 ; 2.20 ; FAB 2G12 UNLIGANDED 1EMT ; 2.25 ; FAB ANTIBODY FRAGMENT OF AN C60 ANTIFULLERENE ANTIBODY 1RVF ; 4.00 ; FAB COMPLEXED WITH INTACT HUMAN RHINOVIRUS 1QBL ; 2.26 ; FAB E8 (FABE8A) X-RAY STRUCTURE AT 2.26 ANGSTROM RESOLUTION 1QBM ; 2.37 ; FAB E8B ANTIBODY, X-RAY STRUCTURE AT 2.37 ANGSTROMS RESOLUTION 1YUH ; 3.00 ; FAB FRAGMENT 1A3R ; 2.10 ; FAB FRAGMENT (ANTIBODY 8F5) COMPLEXED WITH PEPTIDE FROM HUMAN RHINOVIRUS (SEROTYPE 2) VIRAL CAPSID PROTEIN VP2 (RESIDUES 156 - 170) 1QKZ ; 1.95 ; FAB FRAGMENT (MN14C11.6) IN COMPLEX WITH A PEPTIDE ANTIGEN DERIVED FROM NEISSERIA MENINGITIDIS P1.7 SEROSUBTYPE ANTIGEN AND DOMAIN II FROM STREPTOCOCCAL PROTEIN G 1BZ7 ; 2.50 ; FAB FRAGMENT FROM MURINE ASCITES 1A5F ; 2.80 ; FAB FRAGMENT OF A MONOCLONAL ANTI-E-SELECTIN ANTIBODY 1NLD ; 2.90 ; FAB FRAGMENT OF A NEUTRALIZING ANTIBODY DIRECTED AGAINST AN EPITOPE OF GP41 FROM HIV-1 1Y18 ; 2.80 ; FAB FRAGMENT OF CATALYTIC ELIMINATION ANTIBODY 34E4 E(H50)D MUTANT IN COMPLEX WITH HAPTEN 1AD0 ; 2.50 ; FAB FRAGMENT OF ENGINEERED HUMAN MONOCLONAL ANTIBODY A5B7 1A6T ; 2.70 ; FAB FRAGMENT OF MAB1-IA MONOCLONAL ANTIBODY TO HUMAN RHINOVIRUS 14 NIM-IA SITE 1F90 ; 2.60 ; FAB FRAGMENT OF MONOCLONAL ANTIBODY (LNKB-2) AGAINST HUMAN INTERLEUKIN-2 IN COMPLEX WITH ANTIGENIC PEPTIDE 1EJO ; 2.30 ; FAB FRAGMENT OF NEUTRALISING MONOCLONAL ANTIBODY 4C4 COMPLEXED WITH G-H LOOP FROM FMDV. 1WC7 ; 2.33 ; FAB FRAGMENT OF PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH PHOSPHOPYRIDOXYL-L-ALANINE 1R24 ; 3.10 ; FAB FROM MURINE IGG3 KAPPA 1SEQ ; 1.78 ; FAB MNAC13 1DLE ; 2.10 ; FACTOR B SERINE PROTEASE DOMAIN 1DFP ; 2.40 ; FACTOR D INHIBITED BY DIISOPROPYL FLUOROPHOSPHATE 1H2N ; 2.84 ; FACTOR INHIBITING HIF-1 ALPHA 1H2K ; 2.15 ; FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH HIF-1 ALPHA FRAGMENT PEPTIDE 1H2L ; 2.25 ; FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH HIF-1 ALPHA FRAGMENT PEPTIDE 1H2M ; 2.50 ; FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH HIF-1 ALPHA FRAGMENT PEPTIDE 1YCI ; 2.70 ; FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH N- (CARBOXYCARBONYL)-D-PHENYLALANINE 2BOK ; 1.64 ; FACTOR XA - CATION 1XKA ; 2.30 ; FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3-BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID 1XKB ; 2.40 ; FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'-AMIDINO-3-BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID 1KYE ; 2.22 ; FACTOR XA IN COMPLEX WITH (R)-2-(3-ADAMANTAN-1-YL-UREIDO)-3- (3-CARBAMIMIDOYL-PHENYL)-N-PHENETHYL-PROPIONAMIDE 1V3X ; 2.20 ; FACTOR XA IN COMPLEX WITH THE INHIBITOR 1-[6-METHYL-4,5,6,7- TETRAHYDROTHIAZOLO(5,4-C)PYRIDIN-2-YL] CARBONYL-2- CARBAMOYL-4-(6-CHLORONAPHTH-2-YLSULPHONYL)PIPERAZINE 1WU1 ; 2.30 ; FACTOR XA IN COMPLEX WITH THE INHIBITOR 4-[(5-CHLOROINDOL-2- YL)SULFONYL]-2-(2-METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL) PYRIMIDIN-2-YL]CARBONYL]PIPERAZINE 1G2L ; 1.90 ; FACTOR XA INHIBITOR COMPLEX 1G2M ; 3.02 ; FACTOR XA INHIBITOR COMPLEX 1MTS ; 1.90 ; FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN 1MTU ; 1.90 ; FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN 1MTV ; 1.90 ; FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN 1MTW ; 1.90 ; FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN 1QL7 ; 2.10 ; FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN 1QL8 ; 3.00 ; FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN 1V2K ; 2.00 ; FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN VARIANT X(TRIPLE.GLU)BT.D2 1J17 ; 2.00 ; FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH RAT TRYPSIN MUTANT X99/175/190RT 1QL9 ; 2.30 ; FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH RAT TRYPSIN MUTANT X99RT 1W7X ; 1.80 ; FACTOR7 - 413 COMPLEX 1W8B ; 3.00 ; FACTOR7 - 413 COMPLEX 258D ; 1.58 ; FACTORS AFFECTING SEQUENCE SELECTIVITY ON NOGALAMYCIN INTERCALATION: THE CRYSTAL STRUCTURE OF D(TGTACA)-NOGALAMYCIN 1TVC ; -1.00 ; FAD AND NADH BINDING DOMAIN OF METHANE MONOOXYGENASE REDUCTASE FROM METHYLOCOCCUS CAPSULATUS (BATH) 1A1Z ; -1.00 ; FADD DEATH EFFECTOR DOMAIN, F25G MUTANT, NMR MINIMIZED AVERAGE STRUCTURE 1A1W ; -1.00 ; FADD DEATH EFFECTOR DOMAIN, F25Y MUTANT, NMR MINIMIZED AVERAGE STRUCTURE 1E2X ; 2.00 ; FADR, FATTY ACID RESPONSIVE TRANSCRIPTION FACTOR FROM E. COLI 1H9T ; 3.25 ; FADR, FATTY ACID RESPONSIVE TRANSCRIPTION FACTOR FROM E. COLI IN COMPLEX WITH FADB OPERATOR 1H9G ; 2.10 ; FADR, FATTY ACID RESPONSIVE TRANSCRIPTION FACTOR FROM E. COLI, IN COMPLEX WITH MYRISTOYL-COA 1HW2 ; 3.25 ; FADR-DEOXYRIBONUCLEIC ACID COMPLEX: TRANSCRIPTIONAL CONTROL OF FATTY ACID METABOLISM IN ECHERICHIA COLI 1AZV ; 1.90 ; FAMILIAL ALS MUTANT G37R CUZNSOD (HUMAN) 1OD0 ; 2.11 ; FAMILY 1 B-GLUCOSIDASE FROM THERMOTOGA MARITIMA 1OIF ; 2.12 ; FAMILY 1 B-GLUCOSIDASE FROM THERMOTOGA MARITIMA 1OIM ; 2.15 ; FAMILY 1 B-GLUCOSIDASE FROM THERMOTOGA MARITIMA 1OIN ; 2.15 ; FAMILY 1 B-GLUCOSIDASE FROM THERMOTOGA MARITIMA 1UZ1 ; 2.00 ; FAMILY 1 B-GLUCOSIDASE FROM THERMOTOGA MARITIMA IN COMPLEX WITH ISOFAGOMINE LACTAM 1W3J ; 2.00 ; FAMILY 1 B-GLUCOSIDASE FROM THERMOTOGA MARITIMA IN COMPLEX WITH TETRAHYDROOXAZINE 1GXM ; 1.32 ; FAMILY 10 POLYSACCHARIDE LYASE FROM CELLVIBRIO CELLULOSA 1GXN ; 1.50 ; FAMILY 10 POLYSACCHARIDE LYASE FROM CELLVIBRIO CELLULOSA 1V0A ; 1.98 ; FAMILY 11 CARBOHYDRATE-BINDING MODULE OF CELLULOSOMAL CELLULASE LIC26A-CEL5E OF CLOSTRIDIUM THERMOCELLUM 1IGO ; 2.20 ; FAMILY 11 XYLANASE 7TAA ; 1.98 ; FAMILY 13 ALPHA AMYLASE IN COMPLEX WITH ACARBOSE 2C24 ; 2.27 ; FAMILY 30 CARBOHYDRATE-BINDING MODULE OF CELLULOSOMAL CELLULASE CEL9D-CEL44B OF CLOSTRIDIUM THERMOCELLUM 1I8U ; 1.90 ; FAMILY 9 CARBOHYDRATE-BINDING MODULE FROM THERMOTOGA MARITIMA XYLANASE 10A 1I82 ; 1.90 ; FAMILY 9 CARBOHYDRATE-BINDING MODULE FROM THERMOTOGA MARITIMA XYLANASE 10A WITH CELLOBIOSE 1I8A ; 1.90 ; FAMILY 9 CARBOHYDRATE-BINDING MODULE FROM THERMOTOGA MARITIMA XYLANASE 10A WITH GLUCOSE 1RH9 ; 1.50 ; FAMILY GH5 ENDO-BETA-MANNANASE FROM LYCOPERSICON ESCULENTUM (TOMATO) 1KX7 ; -1.00 ; FAMILY OF 30 CONFORMERS OF A MONO-HEME FERROCYTOCHROME C FROM SHEWANELLA PUTREFACIENS SOLVED BY NMR 1N65 ; -1.00 ; FAMILY OF NMR SOLUTION STRUCTURES OF CA CE CALBINDIN D9K IN DENATURATING CONDITIONS 1KQV ; -1.00 ; FAMILY OF NMR SOLUTION STRUCTURES OF CA LN CALBINDIN D9K 1X81 ; 3.50 ; FARNESYL TRANSFERASE STRUCTURE OF JANSEN COMPOUND 1N9A ; 3.20 ; FARNESYLTRANSFERASE COMPLEX WITH TETRAHYDROPYRIDINE INHIBITORS 1DDF ; -1.00 ; FAS DEATH DOMAIN, NMR, MINIMIZED AVERAGE STRUCTURE 1KU6 ; 2.50 ; FASCICULIN 2-MOUSE ACETYLCHOLINESTERASE COMPLEX 1MAH ; 3.20 ; FASCICULIN2 - MOUSE ACETYLCHOLINESTERASE COMPLEX 2FHE ; 2.30 ; FASCIOLA HEPATICA GLUTATHIONE S-TRANSFERASE ISOFORM 1 IN COMPLEX WITH GLUTATHIONE 1SFQ ; 1.91 ; FAST FORM OF THROMBIN MUTANT R(77A)A BOUND TO PPACK 1WDK ; 2.50 ; FATTY ACID BETA-OXIDATION MULTIENZYME COMPLEX FROM PSEUDOMONAS FRAGI, FORM I (NATIVE2) 1WDM ; 3.80 ; FATTY ACID BETA-OXIDATION MULTIENZYME COMPLEX FROM PSEUDOMONAS FRAGI, FORM I (NATIVE3) 1WDL ; 3.50 ; FATTY ACID BETA-OXIDATION MULTIENZYME COMPLEX FROM PSEUDOMONAS FRAGI, FORM II (NATIVE4) 2B7Y ; 3.00 ; FAVA BEAN LECTIN-GLUCOSE COMPLEX 1E0L ; -1.00 ; FBP28WW DOMAIN FROM MUS MUSCULUS 1DN2 ; 2.70 ; FC FRAGMENT OF HUMAN IGG1 IN COMPLEX WITH AN ENGINEERED 13 RESIDUE PEPTIDE DCAWHLGELVWCT-NH2 1L6X ; 1.65 ; FC FRAGMENT OF RITUXIMAB BOUND TO A MINIMIZED VERSION OF THE B-DOMAIN FROM PROTEIN A CALLED Z34C 1FDM ; -1.00 ; FD MAJOR COAT PROTEIN IN SDS MICELLES, NMR, 20 STRUCTURES 1FEH ; 1.80 ; FE-ONLY HYDROGENASE FROM CLOSTRIDIUM PASTEURIANUM 1COJ ; 1.90 ; FE-SOD FROM AQUIFEX PYROPHILUS, A HYPERTHERMOPHILIC BACTERIUM 1VZ4 ; 2.50 ; FE-SUCCINATE COMPLEX OF ATSK 2CSE ; 7.00 ; FEATURES OF REOVIRUS OUTER-CAPSID PROTEIN MU1 REVEALED BY ELECTRON AND IMAGE RECONSTRUCTION OF THE VIRION AT 7.0-A RESOLUTION 1W7R ; 1.40 ; FEGLYMYCIN P64 CRYSTAL FORM 1W7Q ; 1.10 ; FEGLYMYCIN P65 CRYSTAL FORM 1C8E ; 3.00 ; FELINE PANLEUKOPENIA VIRUS EMPTY CAPSID STRUCTURE 1C8F ; 3.00 ; FELINE PANLEUKOPENIA VIRUS EMPTY CAPSID STRUCTURE 1C8G ; 3.00 ; FELINE PANLEUKOPENIA VIRUS EMPTY CAPSID STRUCTURE 1L5H ; 2.30 ; FEMO-COFACTOR DEFICIENT NITROGENASE MOFE PROTEIN 1B43 ; 2.00 ; FEN-1 FROM P. FURIOSUS 2AL6 ; 2.35 ; FERM DOMAIN OF FOCAL ADHESION KINASE 1QOA ; 1.70 ; FERREDOXIN MUTATION C49S 1QOB ; 1.80 ; FERREDOXIN MUTATION D62K 1QOF ; 1.80 ; FERREDOXIN MUTATION Q70K 1QOG ; 1.80 ; FERREDOXIN MUTATION S47A 1F3P ; 2.40 ; FERREDOXIN REDUCTASE (BPHA4)-NADH COMPLEX 1A8P ; 2.00 ; FERREDOXIN REDUCTASE FROM AZOTOBACTER VINELANDII 1E9M ; 2.07 ; FERREDOXIN VI FROM RHODOBACTER CAPSULATUS 1AWD ; 1.40 ; FERREDOXIN [2FE-2S] OXIDIZED FORM FROM CHLORELLA FUSCA 2B5O ; 2.50 ; FERREDOXIN-NADP REDUCTASE 1W34 ; 1.73 ; FERREDOXIN-NADP REDUCTASE (MUTATION: Y 303 S) 2BSA ; 1.92 ; FERREDOXIN-NADP REDUCTASE (MUTATION: Y 303 S) COMPLEXED WITH NADP 1W87 ; 3.00 ; FERREDOXIN-NADP REDUCTASE (MUTATION: Y 303 W) COMPLEXED WITH NADP BY COCRYSTALLIZATION 1B2R ; 1.80 ; FERREDOXIN-NADP+ REDUCTASE (MUTATION: E 301 A) 1W35 ; 1.90 ; FERREDOXIN-NADP+ REDUCTASE (MUTATION: Y 303 W) 1GJR ; 2.10 ; FERREDOXIN-NADP+ REDUCTASE COMPLEXED WITH NADP+ BY COCRYSTALLIZATION 1FRQ ; 1.95 ; FERREDOXIN:NADP+ OXIDOREDUCTASE (FERREDOXIN REDUCTASE) MUTANT E312A 1BX0 ; 1.90 ; FERREDOXIN:NADP+ OXIDOREDUCTASE (FERREDOXIN REDUCTASE) MUTANT E312L 1BX1 ; 1.90 ; FERREDOXIN:NADP+ OXIDOREDUCTASE (FERREDOXIN REDUCTASE) MUTANT E312Q 1BJK ; 2.30 ; FERREDOXIN:NADP+ REDUCTASE MUTANT WITH ARG 264 REPLACED BY GLU (R264E) 1OGJ ; 1.64 ; FERREDOXIN:NADP+ REDUCTASE MUTANT WITH LEU 263 REPLACED BY PRO (L263P) 1QH0 ; 1.93 ; FERREDOXIN:NADP+ REDUCTASE MUTANT WITH LEU 76 MUTATED BY ASP AND LEU 78 MUTATED BY ASP 1QGZ ; 2.30 ; FERREDOXIN:NADP+ REDUCTASE MUTANT WITH LEU 78 REPLACED BY ASP (L78D) 1E62 ; 2.30 ; FERREDOXIN:NADP+ REDUCTASE MUTANT WITH LYS 75 REPLACED BY ARG (K75R) 1E64 ; 2.30 ; FERREDOXIN:NADP+ REDUCTASE MUTANT WITH LYS 75 REPLACED BY GLN (K75Q) 1QGY ; 1.70 ; FERREDOXIN:NADP+ REDUCTASE MUTANT WITH LYS 75 REPLACED BY GLU (K75E) 1E63 ; 2.30 ; FERREDOXIN:NADP+ REDUCTASE MUTANT WITH LYS 75 REPLACED BY SER (K75S) 1BQE ; 2.45 ; FERREDOXIN:NADP+ REDUCTASE MUTANT WITH THR 155 REPLACED BY GLY (T155G) 1OGI ; 1.64 ; FERREDOXIN:NADP+ REDUCTASE MUTANT WITH THR 155 REPLACED BY GLY AND ALA 160 REPLACED BY THR (T155G-A160T) 1H42 ; 2.15 ; FERREDOXIN:NADP+ REDUCTASE MUTANT WITH THR 155 REPLACED BY GLY, ALA 160 REPLACED BY THR AND LEU 263 REPLACED BY PRO (T155G-A160T-L263P) 1H85 ; 2.30 ; FERREDOXIN:NADP+ REDUCTASE MUTANT WITH VAL 136 REPLACED BY LEU (V136L) 1Y4T ; 1.80 ; FERRIC BINDING PROTEIN FROM CAMPYLOBACTER JEJUNI 1FEP ; 2.40 ; FERRIC ENTEROBACTIN RECEPTOR 1W4W ; 1.55 ; FERRIC HORSERADISH PEROXIDASE C1A IN COMPLEX WITH FORMATE 1QJQ ; 2.95 ; FERRIC HYDROXAMATE RECEPTOR FROM ESCHERICHIA COLI (FHUA) 2FCP ; 2.50 ; FERRIC HYDROXAMATE UPTAKE RECEPTOR (FHUA) FROM E.COLI 1FCP ; 2.70 ; FERRIC HYDROXAMATE UPTAKE RECEPTOR (FHUA) FROM E.COLI IN COMPLEX WITH BOUND FERRICHROME-IRON 1MOH ; 1.90 ; FERRIC MONOMERIC HEMOGLOBIN I (HB I) 1DZ4 ; 1.60 ; FERRIC P450CAM FROM PSEUDOMONAS PUTIDA 1FSL ; 2.30 ; FERRIC SOYBEAN LEGHEMOGLOBIN COMPLEXED WITH NICOTINATE 1MZB ; 1.80 ; FERRIC UPTAKE REGULATOR 1MRP ; 1.60 ; FERRIC-BINDING PROTEIN FROM HAEMOPHILUS INFLUENZAE 1AXQ ; 2.10 ; FERRICYANIDE OXIDIZED FDI 1AK1 ; 1.90 ; FERROCHELATASE FROM BACILLUS SUBTILIS 1Z8P ; 1.85 ; FERROUS DIOXYGEN COMPLEX OF THE A245S CYTOCHROME P450ERYF 1Z8Q ; 2.00 ; FERROUS DIOXYGEN COMPLEX OF THE A245T CYTOCHROME P450ERYF 1Z8O ; 1.70 ; FERROUS DIOXYGEN COMPLEX OF THE WILD-TYPE CYTOCHROME P450ERYF 1W4Y ; 1.60 ; FERROUS HORSERADISH PEROXIDASE C1A IN COMPLEX WITH CARBON MONOXIDE 1DZ6 ; 1.90 ; FERROUS P450CAM FROM PSEUDOMONAS PUTIDA 1GKK ; 1.60 ; FERULOYL ESTERASE DOMAIN OF XYNY FROM CLOSTRIDIUM THERMOCELLUM 1UWC ; 1.08 ; FERULOYL ESTERASE FROM ASPERGILLUS NIGER 1JT1 ; 1.78 ; FEZ-1 METALLO-BETA-LACTAMASE FROM LEGIONELLA GORMANII MODELLED WITH D-CAPTOPRIL 1L9Y ; 2.01 ; FEZ-1-Y228A, A MUTANT OF THE METALLO-BETA-LACTAMASE FROM LEGIONELLA GORMANII 1OEC ; 2.40 ; FGFR2 KINASE DOMAIN 1GXC ; 2.70 ; FHA DOMAIN FROM HUMAN CHK2 KINASE IN COMPLEX WITH A SYNTHETIC PHOSPHOPEPTIDE 1FIT ; 1.85 ; FHIT (FRAGILE HISTIDINE TRIAD PROTEIN) 2FIT ; 1.90 ; FHIT (FRAGILE HISTIDINE TRIAD PROTEIN) 3FIT ; 2.40 ; FHIT (FRAGILE HISTIDINE TRIAD PROTEIN) IN COMPLEX WITH ADENOSINE/SULFATE AMP ANALOG 4FIT ; 2.50 ; FHIT-APO 5FIT ; 2.30 ; FHIT-SUBSTRATE ANALOG 6FIT ; 2.60 ; FHIT-TRANSITION STATE ANALOG 1BY3 ; 2.74 ; FHUA FROM E. COLI 1BY5 ; 2.60 ; FHUA FROM E. COLI, WITH ITS LIGAND FERRICHROME 1FI1 ; 2.90 ; FHUA IN COMPLEX WITH LIPOPOLYSACCHARIDE AND RIFAMYCIN CGP4832 1K7S ; 2.60 ; FHUD COMPLEXED WITH ALBOMYCIN-DELTA 2 1N73 ; 2.90 ; FIBRIN D-DIMER, LAMPREY COMPLEXED WITH THE PEPTIDE LIGAND: GLY-HIS-ARG-PRO-AMIDE 1AA0 ; 2.20 ; FIBRITIN DELETION MUTANT E (BACTERIOPHAGE T4) 1AVY ; 1.85 ; FIBRITIN DELETION MUTANT M (BACTERIOPHAGE T4) 1EF3 ; 2.80 ; FIDARESTAT BOUND TO HUMAN ALDOSE REDUCTASE 1AZZ ; 2.30 ; FIDDLER CRAB COLLAGENASE COMPLEXED TO ECOTIN 2AGO ; 2.85 ; FIDELITY OF DPO4: EFFECT OF METAL IONS, NUCLEOTIDE SELECTION AND PYROPHOSPHOROLYSIS 2AGP ; 2.90 ; FIDELITY OF DPO4: EFFECT OF METAL IONS, NUCLEOTIDE SELECTION AND PYROPHOSPHOROLYSIS 2AGQ ; 2.10 ; FIDELITY OF DPO4: EFFECT OF METAL IONS, NUCLEOTIDE SELECTION AND PYROPHOSPHOROLYSIS 1JN3 ; 2.35 ; FIDELITY PROPERTIES AND STRUCTURE OF M282L MUTATOR MUTANT OF DEOXYRIBONUCLEIC ACID POLYMERASE: SUBTLE STRUCTURAL CHANGES INFLUENCE THE MECHANISM OF NUCLEOTIDE DISCRIMINATION 1ADX ; -1.00 ; FIFTH EGF-LIKE DOMAIN OF THROMBOMODULIN (TMEGF5), NMR, 14 STRUCTURES 2ADX ; -1.00 ; FIFTH EGF-LIKE DOMAIN OF THROMBOMODULIN (TMEGF5), NMR, MINIMIZED AVERAGE STRUCTURE 1HGV ; 2.40 ; FILAMENTOUS BACTERIOPHAGE PH75 1HGZ ; 2.40 ; FILAMENTOUS BACTERIOPHAGE PH75 1HH0 ; 2.40 ; FILAMENTOUS BACTERIOPHAGE PH75 1KIU ; 3.00 ; FIMH ADHESIN Q133N MUTANT-FIMC CHAPERONE COMPLEX WITH METHYL-ALPHA-D-MANNOSE 1TR7 ; 2.10 ; FIMH ADHESIN RECEPTOR BINDING DOMAIN FROM UROPATHOGENIC E. COLI 1KLF ; 2.79 ; FIMH ADHESIN-FIMC CHAPERONE COMPLEX WITH D-MANNOSE 1LCI ; 2.00 ; FIREFLY LUCIFERASE 1BA3 ; 2.20 ; FIREFLY LUCIFERASE IN COMPLEX WITH BROMOFORM 1Q6V ; 1.86 ; FIRST CRYSTAL STRUCTURE OF A C49 MONOMER PLA2 FROM THE VENOM OF DABOIA RUSSELLI PULCHELLA AT 1.8 A RESOLUTION 2B7E ; -1.00 ; FIRST FF DOMAIN OF PRP40 YEAST PROTEIN 1V40 ; 1.90 ; FIRST INHIBITOR COMPLEX STRUCTURE OF HUMAN HEMATOPOIETIC PROSTAGLANDIN D SYNTHASE 1G9O ; 1.50 ; FIRST PDZ DOMAIN OF THE HUMAN NA+/H+ EXCHANGER REGULATORY FACTOR 1FU2 ; 3.24 ; FIRST PROTEIN STRUCTURE DETERMINED FROM X-RAY POWDER DIFFRACTION DATA 1FUB ; 3.09 ; FIRST PROTEIN STRUCTURE DETERMINED FROM X-RAY POWDER DIFFRACTION DATA 1SLP ; -1.00 ; FIRST STEM LOOP OF THE SL1 RIBONUCLEIC ACID FROM CAENORHABDITIS ELEGANS, NMR, 16 STRUCTURES 1SLO ; -1.00 ; FIRST STEM LOOP OF THE SL1 RIBONUCLEIC ACID FROM CAENORHABDITIS ELEGANS, NMR, MINIMIZED AVERAGE STRUCTURE 1KPM ; 1.80 ; FIRST STRUCTURAL EVIDENCE OF A SPECIFIC INHIBITION OF PHOSPHOLIPASE A2 BY VITAMIN E AND ITS IMPLICATIONS IN INFLAMMATION: CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN PHOSPHOLIPASE A2 AND VITAMIN E AT 1.8 A RESOLUTION. 1FV0 ; 1.70 ; FIRST STRUCTURAL EVIDENCE OF THE INHIBITION OF PHOSPHOLIPASE A2 BY ARISTOLOCHIC ACID: CRYSTAL STRUCTURE OF A COMPLEX FORMED BETWEEN PHOSPHOLIPASE A2 AND ARISTOLOCHIC ACID 6GST ; 2.20 ; FIRST-SPHERE AND SECOND-SPHERE ELECTROSTATIC EFFECTS IN THE ACTIVE SITE OF A CLASS MU GLUTATHIONE TRANSFERASE 6GSU ; 1.85 ; FIRST-SPHERE AND SECOND-SPHERE ELECTROSTATIC EFFECTS IN THE ACTIVE SITE OF A CLASS MU GLUTATHIONE TRANSFERASE 6GSV ; 1.75 ; FIRST-SPHERE AND SECOND-SPHERE ELECTROSTATIC EFFECTS IN THE ACTIVE SITE OF A CLASS MU GLUTATHIONE TRANSFERASE 6GSW ; 1.85 ; FIRST-SPHERE AND SECOND-SPHERE ELECTROSTATIC EFFECTS IN THE ACTIVE SITE OF A CLASS MU GLUTATHIONE TRANSFERASE 6GSX ; 2.10 ; FIRST-SPHERE AND SECOND-SPHERE ELECTROSTATIC EFFECTS IN THE ACTIVE SITE OF A CLASS MU GLUTATHIONE TRANSFERASE 6GSY ; 2.20 ; FIRST-SPHERE AND SECOND-SPHERE ELECTROSTATIC EFFECTS IN THE ACTIVE SITE OF A CLASS MU GLUTATHIONE TRANSFERASE 2BGY ; -1.00 ; FIT OF THE X-RAY STRUCUTRE OF THE BATERIAL FLAGELLAR HOOK FRAGMENT FLGE31 INTO AN EM MAP FROM THE HOOK OF CAULOBACTER CRESCENTUS. 1ZKU ; 15.00 ; FITTING GP9 STRUCTURE IN THE ME DENSITY OF NBACTERIOPHAGE T4 EXTENDED TAIL 1EG0 ; 11.50 ; FITTING OF COMPONENTS WITH KNOWN STRUCTURE INTO AN 11.5 A CRYO-EM MAP OF THE E.COLI 70S RIBOSOME 1LS2 ; 16.80 ; FITTING OF EF-TU AND TRNA IN THE LOW RESOLUTION CRYO-EM MAP OF AN EF-TU TERNARY COMPLEX (GDP AND KIRROMYCIN) BOUND TO E. COLI 70S RIBOSOME 1PDF ; 12.00 ; FITTING OF GP11 CRYSTAL STRUCTURE INTO 3D CRYO-EM RECONSTRUCTION OF BACTERIOPHAGE T4 BASEPLATE-TAIL TUBE COMPLEX 1PDJ ; 12.00 ; FITTING OF GP27 INTO CRYOEM RECONSTRUCTION OF BACTERIOPHAGE T4 BASEPLATE 1PDL ; 12.00 ; FITTING OF GP5 IN THE CRYOEM RECONSTRUCTION OF THE BACTERIOPHAGE T4 BASEPLATE 1PDM ; 12.00 ; FITTING OF GP8 STRUCTURE INTO THE CRYOEM RECONSTRUCTION OF THE BACTERIOPHAGE T4 BASEPLATE 1TJA ; 16.00 ; FITTING OF GP8, GP9, AND GP11 INTO THE CRYO-EM RECONSTRUCTION OF THE BACTERIOPHAGE T4 CONTRACTED TAIL 1PDP ; 12.00 ; FITTING OF GP9 STRUCTURE INTO THE BACTERIOPHAGE T4 BASEPLATE CRYOEM RECONSTRUCTION 1JQS ; -1.00 ; FITTING OF L11 PROTEIN AND ELONGATION FACTOR G (DOMAIN G' AND V) IN THE CRYO-EM MAP OF E. COLI 70S RIBOSOME BOUND WITH EF-G AND GMPPCP, A NONHYDROLYSABLE GTP ANALOG 1JQM ; -1.00 ; FITTING OF L11 PROTEIN AND ELONGATION FACTOR G (EF-G) IN THE CRYO-EM MAP OF E. COLI 70S RIBOSOME BOUND WITH EF-G, GDP AND FUSIDIC ACID 1JQT ; -1.00 ; FITTING OF L11 PROTEIN IN THE LOW RESOLUTION CRYO-EM MAP OF E.COLI 70S RIBOSOME 1PDI ; 12.00 ; FITTING OF THE C-TERMINAL PART OF THE SHORT TAIL FIBERS INTO THE CRYO-EM RECONSTRUCTION OF T4 BASEPLATE 1MJ1 ; 13.00 ; FITTING THE TERNARY COMPLEX OF EF-TU/TRNA/GTP AND RIBOSOMAL PROTEINS INTO A 13 A CRYO-EM MAP OF THE COLI 70S RIBOSOME 1DUT ; 1.90 ; FIV DUTP PYROPHOSPHATASE 4FIV ; 1.80 ; FIV PROTEASE COMPLEXED WITH AN INHIBITOR LP-130 1GVV ; 1.05 ; FIVE ATOMIC RESOLUTION STRUCTURES OF ENDOTHIAPEPSIN INHIBITOR COMPLEXES; IMPLICATIONS FOR THE ASPARTIC PROTEINASE MECHANISM 1QHP ; 1.70 ; FIVE-DOMAIN ALPHA-AMYLASE FROM BACILLUS STEAROTHERMOPHILUS, MALTOSE COMPLEX 1QHO ; 1.70 ; FIVE-DOMAIN ALPHA-AMYLASE FROM BACILLUS STEAROTHERMOPHILUS, MALTOSE/ACARBOSE COMPLEX 2GLI ; 2.60 ; FIVE-FINGER GLI-DEOXYRIBONUCLEIC ACID COMPLEX 1AJL ; -1.00 ; FIVE-NUCLEOTIDE BULGE LOOP FROM TETRAHYMENA THERMOPHILA GROUP I INTRON, NMR, 1 STRUCTURE 1AJT ; -1.00 ; FIVE-NUCLEOTIDE BULGE LOOP FROM TETRAHYMENA THERMOPHILA GROUP I INTRON, NMR, 1 STRUCTURE 1QPL ; 2.90 ; FK506 BINDING PROTEIN (12 KDA, HUMAN) COMPLEX WITH L-707,587 1QPF ; 2.50 ; FK506 BINDING PROTEIN (12 KDA, HUMAN) COMPLEX WITH L-709,858 1J4R ; 1.80 ; FK506 BINDING PROTEIN COMPLEXED WITH FKB-001 1BKF ; 1.60 ; FK506 BINDING PROTEIN FKBP MUTANT R42K/H87V COMPLEX WITH IMMUNOSUPPRESSANT FK506 1EYM ; 2.00 ; FK506 BINDING PROTEIN MUTANT, HOMODIMERIC COMPLEX 1R2J ; 2.10 ; FKBI FOR BIOSYNTHESIS OF METHOXYMALONYL EXTENDER UNIT OF FK520 POLYKETIDE IMMUNOSUPPRESANT 1D7J ; 1.85 ; FKBP COMPLEXED WITH 4-HYDROXY-2-BUTANONE 1D7H ; 1.90 ; FKBP COMPLEXED WITH DMSO 1D7I ; 1.90 ; FKBP COMPLEXED WITH METHYL METHYLSULFINYLMETHYL SULFIDE (DSS) 1BL4 ; 1.90 ; FKBP MUTANT F36V COMPLEXED WITH REMODELED SYNTHETIC LIGAND 1AUE ; 2.33 ; FKBP-RAPAMYCIN BINDING DOMAIN (FRB) OF THE FKBP-RAPAMYCIN ASSOCIATED PROTEIN 1A7X ; 2.00 ; FKBP12-FK1012 COMPLEX 1ORJ ; 2.25 ; FLAGELLAR EXPORT CHAPERONE 1ORY ; 2.45 ; FLAGELLAR EXPORT CHAPERONE IN COMPLEX WITH ITS COGNATE BINDING PARTNER 1A76 ; 2.00 ; FLAP ENDONUCLEASE-1 FROM METHANOCOCCUS JANNASCHII 1A77 ; 2.00 ; FLAP ENDONUCLEASE-1 FROM METHANOCOCCUS JANNASCHII 1RZ0 ; 2.20 ; FLAVIN REDUCTASE PHEA2 IN NATIVE STATE 1QCW ; 2.75 ; FLAVOCYTOCHROME B2, ARG289LYS MUTANT 1QJD ; 1.80 ; FLAVOCYTOCHROME C3 FROM SHEWANELLA FRIGIDIMARINA 1E39 ; 1.80 ; FLAVOCYTOCHROME C3 FROM SHEWANELLA FRIGIDIMARINA HISTIDINE 365 MUTATED TO ALANINE 1Y0P ; 1.50 ; FLAVOCYTOCHROME C3 WITH MESACONATE BOUND 1FUE ; 2.40 ; FLAVODOXIN FROM HELICOBACTER PYLORI 1WSB ; 1.80 ; FLAVODOXIN MUTANT- S64C 1FDR ; 1.70 ; FLAVODOXIN REDUCTASE FROM E. COLI 1AG9 ; 1.80 ; FLAVODOXINS THAT ARE REQUIRED FOR ENZYME ACTIVATION: THE STRUCTURE OF OXIDIZED FLAVODOXIN FROM ESCHERICHIA COLI AT 1.8 ANGSTROMS RESOLUTION. 1C8K ; 1.76 ; FLAVOPIRIDOL INHIBITS GLYCOGEN PHOSPHORYLASE BY BINDING AT THE INHIBITOR SITE 1E1Y ; 2.23 ; FLAVOPIRIDOL INHIBITS GLYCOGEN PHOSPHORYLASE BY BINDING AT THE INHIBITOR SITE 1GFZ ; 2.30 ; FLAVOPIRIDOL INHIBITS GLYCOGEN PHOSPHORYLASE BY BINDING AT THE INHIBITOR SITE 1FVP ; 2.70 ; FLAVOPROTEIN 390 1M3V ; -1.00 ; FLIN4: FUSION OF THE LIM BINDING DOMAIN OF LDB1 AND THE N- TERMINAL LIM DOMAIN OF LMO4 2AZ0 ; 2.69 ; FLOCK HOUSE VIRUS B2-DSRNA COMPLEX (P212121) 2AZ2 ; 2.60 ; FLOCK HOUSE VIRUS B2-DSRNA COMPLEX (P4122) 1WKP ; 2.60 ; FLOWERING LOCUS T (FT) FROM ARABIDOPSIS THALIANA 1FLO ; 2.65 ; FLP RECOMBINASE-HOLLIDAY JUNCTION COMPLEX I 1P4E ; 2.70 ; FLPE W330F MUTANT-DEOXYRIBONUCLEIC ACID HOLLIDAY JUNCTION COMPLEX 1M6X ; 2.80 ; FLPE-HOLLIDAY JUNCTION COMPLEX 2A53 ; 1.45 ; FLUORESCENT PROTEIN ASFP595, A143S, OFF-STATE 2A54 ; 1.45 ; FLUORESCENT PROTEIN ASFP595, A143S, ON-STATE, 1MIN IRRADIATION 2A56 ; 1.90 ; FLUORESCENT PROTEIN ASFP595, A143S, ON-STATE, 5MIN IRRADIATION 2A52 ; 1.70 ; FLUORESCENT PROTEIN ASFP595, S158V, ON-STATE 2A50 ; 1.30 ; FLUORESCENT PROTEIN ASFP595, WT, OFF-STATE 2BTJ ; 2.00 ; FLUORESCENT PROTEIN EOSFP - RED FORM 1E6A ; 1.90 ; FLUORIDE-INHIBITED SUBSTRATE COMPLEX OF SACCHAROMYCES CEREVISIAE INORGANIC PYROPHOSPHATASE 1QMY ; 1.90 ; FMDV LEADER PROTEASE (LBSHORT-C51A-C133S) 1AXJ ; -1.00 ; FMN-BINDING PROTEIN FROM DESULFOVIBRIO VULGARIS (MIYAZAKI F), NMR, 20 STRUCTURES 2AEH ; 2.53 ; FOCAL ADHESION KINASE 1 1CO1 ; -1.00 ; FOLD OF THE CBFA 1NSO ; -1.00 ; FOLDED MONOMER OF PROTEASE FROM MASON-PFIZER MONKEY VIRUS 1N15 ; 2.90 ; FOLLOWING THE C HEME REDUCTION IN NITRITE REDUCTASE FROM PSEUDOMONAS AERUGINOSA 1N50 ; 2.90 ; FOLLOWING THE C HEME REDUCTION IN NITRITE REDUCTASE FROM PSEUDOMONAS AERUGINOSA 1N90 ; 2.90 ; FOLLOWING THE C HEME REDUCTION IN NITRITE REDUCTASE FROM PSEUDOMONAS AERUGINOSA 1FGS ; 2.40 ; FOLYLPOLYGLUTAMATE SYNTHETASE FROM LACTOBACILLUS CASEI 1WNE ; 3.00 ; FOOT AND MOUTH DISEASE VIRUS RIBONUCLEIC ACID-DEPENDENT RIBONUCLEIC ACID POLYMERASE IN COMPLEX WITH A TEMPLATE-PRIMER RIBONUCLEIC ACID 1ZBE ; 3.00 ; FOOT-AND MOUTH DISEASE VIRUS SEROTYPE A1061 1ZBA ; 2.00 ; FOOT-AND-MOUTH DISEASE VIRUS SEROTYPE A1061 COMPLEXED WITH OLIGOSACCHARIDE RECEPTOR. 1QQP ; 1.90 ; FOOT-AND-MOUTH DISEASE VIRUS/ OLIGOSACCHARIDE RECEPTOR COMPLEX. 1U09 ; 1.91 ; FOOTAND MOUTH DISEASE VIRUS RIBONUCLEIC ACID-DEPENDENT RIBONUCLEIC ACID POLYMERASE 1B25 ; 1.85 ; FORMALDEHYDE FERREDOXIN OXIDOREDUCTASE FROM PYROCOCCUS FURIOSUS 1B4N ; 2.40 ; FORMALDEHYDE FERREDOXIN OXIDOREDUCTASE FROM PYROCOCCUS FURIOSUS, COMPLEXED WITH GLUTARATE 1KQF ; 1.60 ; FORMATE DEHYDROGENASE N FROM E. COLI 1KQG ; 2.80 ; FORMATE DEHYDROGENASE N FROM E. COLI 385D ; 1.60 ; FORMATION OF A NEW COMPOUND IN THE CRYSTAL STRUCTURE OF CYANOMORPHOLINODOXORUBICIN COMPLEXED WITH D(CGATCG) 1I6Q ; 2.70 ; FORMATION OF A PROTEIN INTERMEDIATE AND ITS TRAPPING BY THE SIMULTANEOUS CRYSTALLIZATION PROCESS: CRYSTAL STRUCTURE OF AN IRON-SATURATED INTERMEDIATE IN THE FE3+ BINDING PATHWAY OF CAMEL LACTOFERRIN AT 2.7 RESOLUTION 1H6N ; 2.11 ; FORMATION OF A TYROSYL RADICAL INTERMEDIATE IN PROTEUS MIRABILIS CATALASE BY DIRECTED MUTAGENESIS AND CONSEQUENCES FOR NUCLEOTIDE REACTIVITY 1H7K ; 2.40 ; FORMATION OF A TYROSYL RADICAL INTERMEDIATE IN PROTEUS MIRABILIS CATALASE BY DIRECTED MUTAGENESIS AND CONSEQUENCES FOR NUCLEOTIDE REACTIVITY 2ARG ; -1.00 ; FORMATION OF AN AMINO ACID BINDING POCKET THROUGH ADAPTIVE ZIPPERING-UP OF A LARGE DEOXYRIBONUCLEIC ACID HAIRPIN LOOP, NMR, 9 STRUCTURES 1T3Z ; 2.30 ; FORMYL-COA TRANFERASE MUTANT ASP169 TO SER 1P5R ; 2.50 ; FORMYL-COA TRANSFERASE IN COMPLEX WITH COENZYME A 1T4C ; 2.61 ; FORMYL-COA TRANSFERASE IN COMPLEX WITH OXALYL-COA 1VGQ ; 2.13 ; FORMYL-COA TRANSFERASE MUTANT ASP169 TO ALA 1VGR ; 2.10 ; FORMYL-COA TRANSFERASE MUTANT ASP169 TO GLU 2AFT ; 1.66 ; FORMYLGLYCINE GENERATING ENZYME C336S MUTANT 2AIJ ; 1.55 ; FORMYLGLYCINE GENERATING ENZYME C336S MUTANT COVALENTLY BOUND TO SUBSTRATE PEPTIDE CTPSR 2AIK ; 1.73 ; FORMYLGLYCINE GENERATING ENZYME C336S MUTANT COVALENTLY BOUND TO SUBSTRATE PEPTIDE LCTPSRA 2AFY ; 1.49 ; FORMYLGLYCINE GENERATING ENZYME C341S MUTANT 1M5H ; 2.00 ; FORMYLMETHANOFURAN:TETRAHYDROMETHANOPTERIN FORMYLTRANSFERASE FROM ARCHAEOGLOBUS FULGIDUS 1FTR ; 1.70 ; FORMYLMETHANOFURAN:TETRAHYDROMETHANOPTERIN FORMYLTRANSFERASE FROM METHANOPYRUS KANDLERI 1M5S ; 1.85 ; FORMYLMETHANOFURAN:TETRAHYDROMETHANOPTERIN FROMYLTRANSFERASE FROM METHANOSARCINA BARKERI 1TN4 ; 1.90 ; FOUR CALCIUM TNC 2TN4 ; 2.00 ; FOUR CALCIUM TNC 1QU7 ; 2.60 ; FOUR HELICAL-BUNDLE STRUCTURE OF THE CYTOPLASMIC DOMAIN OF A SERINE CHEMOTAXIS RECEPTOR 1HAQ ; -1.00 ; FOUR MODELS OF HUMAN FACTOR H DETERMINED BY SOLUTION SCATTERING CURVE-FITTING AND HOMOLOGY MODELLING 1ZF2 ; 1.95 ; FOUR-STRANDED DEOXYRIBONUCLEIC ACID HOLLIDAY JUNCTION (CCC) 1FBR ; -1.00 ; FOURTH AND FIFTH FIBRONECTIN TYPE I MODULE PAIR 1ZAQ ; -1.00 ; FOURTH EGF-LIKE DOMAIN OF THROMBOMODULIN, NMR, 12 STRUCTURES 1AW0 ; -1.00 ; FOURTH METAL-BINDING DOMAIN OF THE MENKES COPPER-TRANSPORTING ATPASE, NMR, 20 STRUCTURES 2AW0 ; -1.00 ; FOURTH METAL-BINDING DOMAIN OF THE MENKES COPPER-TRANSPORTING ATPASE, NMR, 20 STRUCTURES 1JBV ; 1.95 ; FPGS-AMPPCP COMPLEX 1JBW ; 1.85 ; FPGS-AMPPCP-FOLATE COMPLEX 1FRB ; 1.70 ; FR-1 PROTEIN/NADPH/ZOPOLRESTAT COMPLEX 1WBU ; 1.90 ; FRAGMENT BASED LEAD DISCOVERY USING CRYSTALLOGRAPHY 1WBN ; 2.40 ; FRAGMENT BASED P38 INHIBITORS 1WBO ; 2.16 ; FRAGMENT BASED P38 INHIBITORS 1N8E ; 4.50 ; FRAGMENT DOUBLE-D FROM HUMAN FIBRIN 1G5G ; 3.30 ; FRAGMENT OF FUSION PROTEIN FROM NEWCASTLE DISEASE VIRUS 1FNF ; 2.00 ; FRAGMENT OF HUMAN FIBRONECTIN ENCOMPASSING TYPE-III REPEATS 7 THROUGH 10 1HKL ; 2.70 ; FREE AND LIGANDED FORM OF AN ESTEROLYTIC CATALYTIC ANTIBODY 1EOV ; 2.30 ; FREE ASPARTYL-TRNA SYNTHETASE (ASPRS) FROM YEAST 1OAQ ; 1.50 ; FREE CONFORMATION AB1 OF THE IGE SPE-7 1OCW ; 2.01 ; FREE CONFORMATION AB2 OF THE IGE SPE-7 1Z7G ; 1.90 ; FREE HUMAN HGPRT 1BHH ; 1.90 ; FREE P56LCK SH2 DOMAIN 1AOL ; 2.00 ; FRIEND MURINE LEUKEMIA VIRUS RECEPTOR-BINDING DOMAIN 1QO5 ; 2.50 ; FRUCTOSE 1,6-BISPHOSPHATE ALDOLASE FROM HUMAN LIVER TISSUE 1FDJ ; 2.10 ; FRUCTOSE 1,6-BISPHOSPHATE ALDOLASE FROM RABBIT LIVER 1ADO ; 1.90 ; FRUCTOSE 1,6-BISPHOSPHATE ALDOLASE FROM RABBIT MUSCLE 1EWD ; 2.46 ; FRUCTOSE 1,6-BISPHOSPHATE ALDOLASE FROM RABBIT MUSCLE 1EWE ; 2.60 ; FRUCTOSE 1,6-BISPHOSPHATE ALDOLASE FROM RABBIT MUSCLE 1EWG ; 2.00 ; FRUCTOSE 1,6-BISPHOSPHATE ALDOLASE FROM RABBIT MUSCLE 1EX5 ; 2.20 ; FRUCTOSE 1,6-BISPHOSPHATE ALDOLASE FROM RABBIT MUSCLE 1UXD ; -1.00 ; FRUCTOSE REPRESSOR DEOXYRIBONUCLEIC ACID-BINDING DOMAIN, NMR, 34 STRUCTURES 1UXC ; -1.00 ; FRUCTOSE REPRESSOR DEOXYRIBONUCLEIC ACID-BINDING DOMAIN, NMR, MINIMIZED STRUCTURE 1FPI ; 2.30 ; FRUCTOSE-1,6-BISPHOSPHATASE (D-FRUCTOSE-1,6-BISPHOSPHATE 1-PHOSPHOHYDROLASE) COMPLEXED WITH AMP, 2,5-ANHYDRO-D-GLUCITOL-1,6-BISPHOSPHATE AND POTASSIUM IONS (100 MM) 1FPL ; 2.30 ; FRUCTOSE-1,6-BISPHOSPHATASE (D-FRUCTOSE-1,6-BISPHOSPHATE 1-PHOSPHOHYDROLASE) COMPLEXED WITH AMP, 2,5-ANHYDRO-D-GLUCITOL-1,6-BISPHOSPHATE AND THALLIUM IONS (10 MM) 1FPJ ; 2.20 ; FRUCTOSE-1,6-BISPHOSPHATASE (D-FRUCTOSE-1,6-BISPHOSPHATE 1-PHOSPHOHYDROLASE) COMPLEXED WITH AMP, 2,5-ANHYDRO-D-GLUCITOL-1,6-BISPHOSPHATE, THALLIUM (10 MM) AND LITHIUM IONS (10 MM) 1FPK ; 3.00 ; FRUCTOSE-1,6-BISPHOSPHATASE (D-FRUCTOSE-1,6-BISPHOSPHATE 1-PHOSPHOHYDROLASE) COMPLEXED WITH THALLIUM IONS (10 MM) 1FJ6 ; 2.50 ; FRUCTOSE-1,6-BISPHOSPHATASE (MUTANT Y57W) PRODUCT/ZN COMPLEX (R-STATE) 1FJ9 ; 2.50 ; FRUCTOSE-1,6-BISPHOSPHATASE (MUTANT Y57W) PRODUCTS/ZN/AMP COMPLEX (T-STATE) 1EYJ ; 2.28 ; FRUCTOSE-1,6-BISPHOSPHATASE COMPLEX WITH AMP, MAGNESIUM, FRUCTOSE-6-PHOSPHATE AND PHOSPHATE (T-STATE) 1NV7 ; 2.15 ; FRUCTOSE-1,6-BISPHOSPHATASE COMPLEX WITH AMP, MAGNESIUM, FRUCTOSE-6-PHOSPHATE, PHOSPHATE AND THALLIUM (20 MM) 1EYK ; 2.23 ; FRUCTOSE-1,6-BISPHOSPHATASE COMPLEX WITH AMP, ZINC, FRUCTOSE-6-PHOSPHATE AND PHOSPHATE (T-STATE) 1NUZ ; 1.90 ; FRUCTOSE-1,6-BISPHOSPHATASE COMPLEX WITH MAGNESIUM, FRUCTOSE-6-PHOSPHATE AND PHOSPHATE 1EYI ; 2.32 ; FRUCTOSE-1,6-BISPHOSPHATASE COMPLEX WITH MAGNESIUM, FRUCTOSE-6-PHOSPHATE AND PHOSPHATE (R-STATE) 1NUW ; 1.30 ; FRUCTOSE-1,6-BISPHOSPHATASE COMPLEX WITH MAGNESIUM, FRUCTOSE-6-PHOSPHATE AND PHOSPHATE AT PH 9.6 1NUY ; 1.30 ; FRUCTOSE-1,6-BISPHOSPHATASE COMPLEX WITH MAGNESIUM, FRUCTOSE-6-PHOSPHATE, AND PHOSPHATE 1NV0 ; 1.80 ; FRUCTOSE-1,6-BISPHOSPHATASE COMPLEX WITH MAGNESIUM, FRUCTOSE-6-PHOSPHATE, PHOSPHATE AND 1 MM THALLIUM 1NUX ; 1.60 ; FRUCTOSE-1,6-BISPHOSPHATASE COMPLEX WITH MAGNESIUM, FRUCTOSE-6-PHOSPHATE, PHOSPHATE AND INHIBITORY CONCENTRATIONS OF POTASSIUM (200MM) 1NV3 ; 2.00 ; FRUCTOSE-1,6-BISPHOSPHATASE COMPLEX WITH MAGNESIUM, FRUCTOSE-6-PHOSPHATE, PHOSPHATE AND THALLIUM (100 MM) 1NV2 ; 2.10 ; FRUCTOSE-1,6-BISPHOSPHATASE COMPLEX WITH MAGNESIUM, FRUCTOSE-6-PHOSPHATE, PHOSPHATE AND THALLIUM (20 MM) 1NV1 ; 1.90 ; FRUCTOSE-1,6-BISPHOSPHATASE COMPLEX WITH MAGNESIUM, FRUCTOSE-6-PHOSPHATE, PHOSPHATE AND THALLIUM (5 MM) 1NV4 ; 1.90 ; FRUCTOSE-1,6-BISPHOSPHATASE COMPLEX WITH MAGNESIUM, FRUCTOSE-6-PHOSPHATE, PHOSPHATE, EDTA AND THALLIUM (1 MM) 1NV6 ; 2.15 ; FRUCTOSE-1,6-BISPHOSPHATASE COMPLEX WITH MAGNESIUM, FRUCTOSE-6-PHOSPHATE, PHOSPHATE, EDTA AND THALLIUM (20 MM) 1NV5 ; 1.90 ; FRUCTOSE-1,6-BISPHOSPHATASE COMPLEX WITH MAGNESIUM, FRUCTOSE-6-PHOSPHATE, PHOSPHATE, EDTA AND THALLIUM (5 MM) 1Q9D ; 2.35 ; FRUCTOSE-1,6-BISPHOSPHATASE COMPLEXED WITH A NEW ALLOSTERIC SITE INHIBITOR (I-STATE) 1CNQ ; 2.27 ; FRUCTOSE-1,6-BISPHOSPHATASE COMPLEXED WITH FRUCTOSE-6- PHOSPHATE AND ZINC IONS 1FTA ; 2.30 ; FRUCTOSE-1,6-BISPHOSPHATASE(D-FRUCTOSE-1,6-BISPHOSPHATE, 1-PHOSPHOHYDROLASE) COMPLEXED WITH THE ALLOSTERIC INHIBITOR AMP 1J4E ; 2.65 ; FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE COVALENTLY BOUND TO THE SUBSTRATE DIHYDROXYACETONE PHOSPHATE 1A5C ; 3.00 ; FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE FROM PLASMODIUM FALCIPARUM 1ZAH ; 1.80 ; FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE FROM RABBIT MUSCLE 1ZAJ ; 1.89 ; FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE FROM RABBIT MUSCLE IN COMPLEX WITH MANNITOL-1,6-BISPHOSPHATE, A COMPETITIVE INHIBITOR 1ZAL ; 1.89 ; FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE FROM RABBIT MUSCLE IN COMPLEX WITH PARTIALLY DISORDERED TAGATOSE-1,6- BISPHOSPHATE, A WEAK COMPETITIVE INHIBITOR 1ZAI ; 1.76 ; FRUCTOSE-1,6-BISPHOSPHATE SCHIFF BASE INTERMEDIATE IN FBP ALDOLASE FROM RABBIT MUSCLE 1L6W ; 1.93 ; FRUCTOSE-6-PHOSPHATE ALDOLASE 1E4F ; 1.90 ; FTSA (APO FORM) FROM THERMOTOGA MARITIMA 1E4G ; 2.60 ; FTSA (ATP-BOUND FORM) FROM THERMOTOGA MARITIMA 1EIZ ; 1.70 ; FTSJ RIBONUCLEIC ACID METHYLTRANSFERASE COMPLEXED WITH S- ADENOSYLMETHIONINE 1EJ0 ; 1.50 ; FTSJ RIBONUCLEIC ACID METHYLTRANSFERASE COMPLEXED WITH S- ADENOSYLMETHIONINE, MERCURY DERIVATIVE 1W59 ; 2.70 ; FTSZ DIMER, EMPTY (M. JANNASCHII) 1W5B ; 2.20 ; FTSZ DIMER, GTP SOAK (M. JANNASCHII) 1W5A ; 2.40 ; FTSZ DIMER, MGGTP SOAK (M. JANNASCHII) 1W58 ; 2.50 ; FTSZ GMPCPP SOAK I213 (M. JANNASCHII) 1W5E ; 3.00 ; FTSZ W319Y MUTANT, P1 (M. JANNASCHII) 1W5F ; 2.00 ; FTSZ, T7 MUTATED, DOMAIN SWAPPED (T. MARITIMA) 1K12 ; 1.90 ; FUCOSE BINDING LECTIN 1IUB ; 2.31 ; FUCOSE-SPECIFIC LECTIN FROM ALEURIA AURANTIA (HG-DERIVATIVE FORM) 1IUC ; 2.24 ; FUCOSE-SPECIFIC LECTIN FROM ALEURIA AURANTIA WITH THREE LIGANDS 1LUG ; 0.95 ; FULL MATRIX ERROR ANALYSIS OF CARBONIC ANHYDRASE 1LUQ ; 0.96 ; FULL MATRIX ERROR ANALYSIS OF STREPTAVIDIN 1FSD ; -1.00 ; FULL SEQUENCE DESIGN 1 (FSD-1) OF BETA BETA ALPHA MOTIF, NMR, 41 STRUCTURES 1FSV ; -1.00 ; FULL SEQUENCE DESIGN 1 (FSD-1) OF BETA BETA ALPHA MOTIF, NMR, MINIMIZED AVERAGE STRUCTURE 1R8Q ; 1.86 ; FULL-LENGTH ARF1-GDP-MG IN COMPLEX WITH BREFELDIN A AND A SEC7 DOMAIN 1OQW ; 2.00 ; FULL-LENGTH PAK PILIN FROM PSEUDOMONAS AERUGINOSA 1JSF ; 1.15 ; FULL-MATRIX LEAST-SQUARES REFINEMENT OF HUMAN LYSOZYME 1JSE ; 1.12 ; FULL-MATRIX LEAST-SQUARES REFINEMENT OF TURKEY LYSOZYME 1YV1 ; 1.50 ; FULLY REDUCED STATE OF NIGERYTHRIN (ALL FERROUS) 1JJ2 ; 2.40 ; FULLY REFINED CRYSTAL STRUCTURE OF THE HALOARCULA MARISMORTUI LARGE RIBOSOMAL SUBUNIT AT 2.4 ANGSTROM RESOLUTION 1FUO ; 2.70 ; FUMARASE C WITH BOUND CITRATE 1FUR ; 1.95 ; FUMARASE MUTANT H188N WITH BOUND SUBSTRATE L-MALATE AT PUTATIVE ACTIVATOR SITE 1FUP ; 2.00 ; FUMARASE WITH BOUND PYROMELLITIC ACID 1FUQ ; 2.00 ; FUMARASE WITH BOUND PYROMELLITIC ACID 2AS9 ; 1.70 ; FUNCTIONAL AND STRUCTURAL CHARACTERIZATION OF SPL PROTEASES FROM STAPHYLOCOCCUS AUREUS 2ANP ; 1.90 ; FUNCTIONAL GLUTAMATE 151 TO HISTIDINE MUTANT OF THE AMINOPEPTIDASE FROM AEROMONAS PROTEOLYTICA. 1FN8 ; 0.81 ; FUSARIUM OXYSPORUM TRYPSIN AT ATOMIC RESOLUTION 1FY4 ; 0.81 ; FUSARIUM OXYSPORUM TRYPSIN AT ATOMIC RESOLUTION 1FY5 ; 0.81 ; FUSARIUM OXYSPORUM TRYPSIN AT ATOMIC RESOLUTION 1GDN ; 0.81 ; FUSARIUM OXYSPORUM TRYPSIN AT ATOMIC RESOLUTION 1GDQ ; 0.93 ; FUSARIUM OXYSPORUM TRYPSIN AT ATOMIC RESOLUTION 1GDU ; 1.07 ; FUSARIUM OXYSPORUM TRYPSIN AT ATOMIC RESOLUTION 1XZK ; 2.01 ; FUSARIUM SOLANI CUTINASE COMPLEX WITH DI(ISOPROPYL)PHOSPHATE 1XZL ; 1.69 ; FUSARIUM SOLANI CUTINASE COMPLEX WITH N-HEXYLPHOSPHONATE ETHYL ESTER 1XZM ; 1.75 ; FUSARIUM SOLANI CUTINASE COMPLEX WITH N-UNDECYL O-METHYL CHLORO PHOSPHONATE ESTER 1XZA ; 1.80 ; FUSARIUM SOLANI CUTINASE MUTANT WITH SER 129 REPLACED BY CYS 1XZB ; 1.75 ; FUSARIUM SOLANI CUTINASE MUTANT WITH SER 129 REPLACED BY CYS COMPLEX WITH MERCURY ACETATE 1XZC ; 1.75 ; FUSARIUM SOLANI CUTINASE MUTANT WITH SER 129 REPLACED BY CYS COMPLEX WITH PARA-SULFUROUSPHENYL MERCURY 1XZD ; 2.70 ; FUSARIUM SOLANI CUTINASE MUTANT WITH SER 213 REPLACED BY CYS 1XZE ; 1.75 ; FUSARIUM SOLANI CUTINASE MUTANT WITH SER 92 REPLACED BY CYS 1XZI ; 1.69 ; FUSARIUM SOLANI CUTINASE MUTANT WITH THR 119 REPLACED BY HIS 1XZF ; 1.69 ; FUSARIUM SOLANI CUTINASE MUTANT WITH THR 144 REPLACED BY CYS 1XZJ ; 1.69 ; FUSARIUM SOLANI CUTINASE MUTANT WITH THR 38 REPLACED BY PHE 1XZG ; 1.69 ; FUSARIUM SOLANI CUTINASE MUTANT WITH THR 45 REPLACED BY ALA 1XZH ; 1.69 ; FUSARIUM SOLANI CUTINASE MUTANT WITH THR 80 REPLACED BY PRO 1TOL ; 1.85 ; FUSION OF N-TERMINAL DOMAIN OF THE MINOR COAT PROTEIN FROM GENE III IN PHAGE M13, AND C-TERMINAL DOMAIN OF E. COLI PROTEIN-TOLA 1A7P ; 2.00 ; FV FRAGMENT OF MOUSE MONOCLONAL ANTIBODY D1.3 (BALB/C, IGG1, K) ENGINEERED MUTANT PRO95L->SER ON VARIANT CHAIN L GLU81->ASP AND CHAIN H LEU312->VAL 1A7Q ; 2.00 ; FV FRAGMENT OF MOUSE MONOCLONAL ANTIBODY D1.3 (BALB/C, IGG1, K) HIGH AFFINITY EXPRESSED VARIANT CONTAINING SER26L->GLY, ILE29L->THR, GLU81L->ASP, THR97L->SER, PRO240H->LEU, ASP258H->ALA, LYS281H->GLU, ASN283H->ASP AND LEU312H->VAL 1A7O ; 2.00 ; FV FRAGMENT OF MOUSE MONOCLONAL ANTIBODY D1.3 (BALB/C, IGG1, K) R96L DELETION MUTANT ON VARIANT FOR CHAIN L GLU81->ASP AND CHAIN H LEU312->VAL 1A7R ; 2.00 ; FV FRAGMENT OF MOUSE MONOCLONAL ANTIBODY D1.3 (BALB/C, IGG1, K) VARIANT CHAIN L GLU81->ASP 1A7N ; 2.00 ; FV FRAGMENT OF MOUSE MONOCLONAL ANTIBODY D1.3 (BALB/C, IGG1, K) VARIANT FOR CHAIN L GLU81->ASP AND CHAIN H LEU312->VAL 1OAR ; 2.22 ; FV IGE SPE-7 IN COMPLEX WITH ALIZARIN RED 1KIR ; 2.00 ; FV MUTANT Y(A 50)S (VL DOMAIN) OF MOUSE MONOCLONAL ANTIBODY D1.3 COMPLEXED WITH HEN EGG WHITE LYSOZYME 1KIQ ; 1.85 ; FV MUTANT Y(B 101)F (VH DOMAIN) OF MOUSE MONOCLONAL ANTIBODY D1.3 COMPLEXED WITH HEN EGG WHITE LYSOZYME 1KIP ; 2.10 ; FV MUTANT Y(B 32)A (VH DOMAIN) OF MOUSE MONOCLONAL ANTIBODY D1.3 COMPLEXED WITH HEN EGG WHITE LYSOZYME 1OAX ; 2.66 ; FV STRUCTURE OF THE IGE SPE-7 IN COMPLEX WITH ACENAPHTHENEQUINONE 1OAU ; 1.80 ; FV STRUCTURE OF THE IGE SPE-7 IN COMPLEX WITH DNP-SER (IMMUNISING HAPTEN) 1WFK ; -1.00 ; FYVE DOMAIN OF FYVE DOMAIN CONTAINING 19 PROTEIN FROM MUS MUSCULUS 1OFV ; 1.70 ; Flavodoxin from Anacystis Nidulans: Refinement of Two Forms of the Oxidized Protein 1GP2 ; 2.30 ; G PROTEIN HETEROTRIMER GI_ALPHA_1 BETA_1 GAMMA_2 WITH GDP BOUND 1GG2 ; 2.40 ; G PROTEIN HETEROTRIMER MUTANT GI_ALPHA_1(G203A) BETA_1 GAMMA_2 WITH GDP BOUND 1A13 ; -1.00 ; G PROTEIN-BOUND CONFORMATION OF MASTOPARAN-X, NMR, 14 STRUCTURES 1YM7 ; 4.50 ; G PROTEIN-COUPLED RECEPTOR KINASE 2 (GRK2) 1OQX ; 2.60 ; G-2 GLYCOVARIANT OF HUMAN IGG FC BOUND TO MINIMIZED VERSION OF PROTEIN A CALLED Z34C 1Y27 ; 2.40 ; G-RIBOSWITCH-GUANINE COMPLEX 1IP5 ; 1.80 ; G105A HUMAN LYSOZYME 1IP6 ; 1.80 ; G127A HUMAN LYSOZYME 1IP7 ; 1.90 ; G129A HUMAN LYSOZYME 1A4R ; 2.50 ; G12V MUTANT OF HUMAN PLACENTAL CDC42 GTPASE IN THE GDP FORM 1NG8 ; -1.00 ; G15-GRAMICIDIN A IN SODIUM DODECYL SULFATE MICELLES (NMR) 1GN6 ; 2.90 ; G152A MUTANT OF MYCOBACTERIUM TUBERCULOSIS IRON-SUPEROXIDE DISMUTASE. 1ZXH ; -1.00 ; G311 MUTANT PROTEIN 1IP1 ; 1.80 ; G37A HUMAN LYSOZYME 1IP2 ; 1.80 ; G48A HUMAN LYSOZYME 1A9M ; 2.30 ; G48H MUTANT OF HIV-1 PROTEASE IN COMPLEX WITH A PEPTIDIC INHIBITOR U-89360E 1RDF ; 2.80 ; G50P MUTANT OF PHOSPHONOACETALDEHYDE HYDROLASE IN COMPLEX WITH SUBSTRATE ANALOGUE VINYL SULFONATE 1AKR ; 1.58 ; G61A OXIDIZED FLAVODOXIN MUTANT 1AKW ; 1.75 ; G61L OXIDIZED FLAVODOXIN MUTANT 1AKT ; 1.80 ; G61N OXIDIZED FLAVODOXIN MUTANT 1AZL ; 1.80 ; G61V FLAVODOXIN MUTANT FROM DESULFOVIBRIO VULGARIS 1IP3 ; 1.80 ; G68A HUMAN LYSOZYME 1IP4 ; 1.80 ; G72A HUMAN LYSOZYME 1MUG ; 1.80 ; G:T/U MISMATCH-SPECIFIC DEOXYRIBONUCLEIC ACID GLYCOSYLASE FROM E.COLI 1CFW ; 1.90 ; GA-SUBSTITUTED DESULFOREDOXIN 1ZIF ; -1.00 ; GAAA RIBONUCLEIC ACID TETRALOOP, NMR, 10 STRUCTURES 1GNU ; 1.75 ; GABA(A) RECEPTOR ASSOCIATED PROTEIN GABARAP 1ZF7 ; 1.05 ; GAC DUPLEX B-DEOXYRIBONUCLEIC ACID 1H87 ; 1.72 ; GADOLINIUM DERIVATIVE OF TETRAGONAL HEN EGG-WHITE LYSOZYME AT 1.7 A RESOLUTION 1OIO ; 1.70 ; GAFD (F17C-TYPE) FIMBRIAL ADHESIN FROM ESCHERICHIA COLI 1ZIG ; -1.00 ; GAGA RIBONUCLEIC ACID TETRALOOP, NMR, 10 STRUCTURES 1AW6 ; -1.00 ; GAL4 (CD), NMR, 24 STRUCTURES 1A6R ; 2.05 ; GAL6 (YEAST BLEOMYCIN HYDROLASE) MUTANT C73A 3GCB ; 1.87 ; GAL6 (YEAST BLEOMYCIN HYDROLASE) MUTANT C73A/DELTAK454 1GCB ; 2.20 ; GAL6, YEAST BLEOMYCIN HYDROLASE DEOXYRIBONUCLEIC ACID-BINDING PROTEASE (THIOL) 2BZD ; 2.00 ; GALACTOSE RECOGNITION BY THE CARBOHYDRATE-BINDING MODULE OF A BACTERIAL SIALIDASE. 1KRR ; 2.50 ; GALACTOSIDE ACETYLTRANSFERASE IN COMPLEX WITH ACETYL- COENZYME A 1KRV ; 2.80 ; GALACTOSIDE ACETYLTRANSFERASE IN COMPLEX WITH COA AND PNP- BETA-GAL 1KQA ; 3.20 ; GALACTOSIDE ACETYLTRANSFERASE IN COMPLEX WITH COENZYME A 1KRU ; 2.80 ; GALACTOSIDE ACETYLTRANSFERASE IN COMPLEX WITH IPTG AND COENZYME A 1R0F ; 1.60 ; GALLIUM-SUBSTITUTED RUBREDOXIN 1DSL ; 1.55 ; GAMMA B CRYSTALLIN C-TERMINAL DOMAIN 1GAM ; 2.60 ; GAMMA B CRYSTALLIN TRUNCATED C-TERMINAL DOMAIN 1HL7 ; 1.73 ; GAMMA LACTAMASE FROM AN AUREOBACTERIUM SPECIES IN COMPLEX WITH 3A,4,7,7A-TETRAHYDRO-BENZO [1,3] DIOXOL-2-ONE 1A7H ; 2.56 ; GAMMA S CRYSTALLIN C-TERMINAL DOMAIN 1GYU ; 1.81 ; GAMMA-ADAPTIN APPENDAGE DOMAIN FROM CLATHRIN ADAPTOR AP1 1GYW ; 2.40 ; GAMMA-ADAPTIN APPENDAGE DOMAIN FROM CLATHRIN ADAPTOR AP1 A753D MUTANT 1GYV ; 1.71 ; GAMMA-ADAPTIN APPENDAGE DOMAIN FROM CLATHRIN ADAPTOR AP1, L762E MUTANT 4VGC ; 2.10 ; GAMMA-CHYMOTRYPSIN D-NAPHTHYL-1-ACETAMIDO BORONIC ACID INHIBITOR COMPLEX 2VGC ; 1.80 ; GAMMA-CHYMOTRYPSIN D-PARA-CHLORO-1-ACETAMIDO BORONIC ACID INHIBITOR COMPLEX 3VGC ; 1.67 ; GAMMA-CHYMOTRYPSIN L-NAPHTHYL-1-ACETAMIDO BORONIC ACID ACID INHIBITOR COMPLEX 1VGC ; 1.90 ; GAMMA-CHYMOTRYPSIN L-PARA-CHLORO-1-ACETAMIDO BORONIC ACID INHIBITOR COMPLEX 1ELP ; 1.95 ; GAMMA-D CRYSTALLIN STRUCTURE AT 1.95 A RESOLUTION 1A5D ; 2.30 ; GAMMAE CRYSTALLIN FROM RAT LENS 1A45 ; 2.30 ; GAMMAF CRYSTALLIN FROM BOVINE LENS 1HA4 ; 2.40 ; GAMMAS CRYSTALLIN C TERMINAL DOMAIN FROM HOMO SAPIENS 1IHY ; 3.00 ; GAPDH COMPLEXED WITH ADP-RIBOSE 1NWM ; 2.40 ; GAT DOMAIN OF HUMAN GGA1 1P7E ; -1.00 ; GB3 SOLUTION STRUCTURE OBTAINED BY REFINEMENT OF X-RAY STRUCTURE WITH DIPOLAR COUPLINGS 1P7F ; -1.00 ; GB3 SOLUTION STRUCTURE OBTAINED BY REFINEMENT OF X-RAY STRUCTURE WITH DIPOLAR COUPLINGS 1ONH ; 1.38 ; GC1 BETA-LACTAMASE WITH A PENEM INHIBITOR 1ZFE ; 2.50 ; GCA DUPLEX B-DEOXYRIBONUCLEIC ACID 1ZIH ; -1.00 ; GCAA RIBONUCLEIC ACID TETRALOOP, NMR, 10 STRUCTURES 1QYK ; 1.40 ; GCATGCT + BARIUM 1QZL ; 2.85 ; GCATGCT + COBALT 1QYL ; 1.00 ; GCATGCT + VANADIUM 1MF5 ; 1.10 ; GCATGCT QUADRUPLEX 2DGC ; 2.20 ; GCN4 BASIC DOMAIN, LEUCINE ZIPPER COMPLEXED WITH ATF/CREB SITE DEOXYRIBONUCLEIC ACID 1GCL ; 2.10 ; GCN4 LEUCINE ZIPPER CORE MUTANT P-LI 1GCM ; 1.80 ; GCN4 LEUCINE ZIPPER CORE MUTANT P-LI 1SWI ; 2.60 ; GCN4-LEUCINE ZIPPER CORE MUTANT AS N16A COMPLEXED WITH BENZENE 1RB1 ; 1.90 ; GCN4-LEUCINE ZIPPER CORE MUTANT AS N16A TRIGONAL AUTOMATIC SOLUTION 1ZII ; 1.80 ; GCN4-LEUCINE ZIPPER CORE MUTANT ASN16ABA IN THE DIMERIC STATE 1ZIJ ; 2.00 ; GCN4-LEUCINE ZIPPER CORE MUTANT ASN16ABA IN THE TRIMERIC STATE 1ZIL ; 2.25 ; GCN4-LEUCINE ZIPPER CORE MUTANT ASN16GLN IN THE DIMERIC STATE 1ZIM ; 2.00 ; GCN4-LEUCINE ZIPPER CORE MUTANT ASN16GLN IN THE TRIMERIC STATE 1ZIK ; 1.80 ; GCN4-LEUCINE ZIPPER CORE MUTANT ASN16LYS IN THE DIMERIC STATE 1IJ1 ; 1.86 ; GCN4-PVLT COILED-COIL TRIMER WITH THREONINE AT THE D(12) POSITION 1IJ3 ; 1.80 ; GCN4-PVSL COILED-COIL TRIMER WITH SERINE AT THE A(16) POSITION 1IJ2 ; 1.70 ; GCN4-PVTL COILED-COIL TRIMER WITH THREONINE AT THE A(16) POSITION 1ZF5 ; 0.99 ; GCT DUPLEX B-DEOXYRIBONUCLEIC ACID 1E6U ; 1.45 ; GDP 4-KETO-6-DEOXY-D-MANNOSE EPIMERASE REDUCTASE 1E7S ; 1.50 ; GDP 4-KETO-6-DEOXY-D-MANNOSE EPIMERASE REDUCTASE K140R 1E7Q ; 1.60 ; GDP 4-KETO-6-DEOXY-D-MANNOSE EPIMERASE REDUCTASE S107A 1E7R ; 1.60 ; GDP 4-KETO-6-DEOXY-D-MANNOSE EPIMERASE REDUCTASE Y136E 1AS3 ; 2.40 ; GDP BOUND G42V GIA1 1AS2 ; 2.80 ; GDP+PI BOUND G42V GIA1 1Z0F ; 2.15 ; GDP-BOUND RAB14 GTPASE 1Z0I ; 2.33 ; GDP-BOUND RAB21 GTPASE 1Z22 ; 2.06 ; GDP-BOUND RAB23 GTPASE CRYSTALLIZED IN C222(1) SPACE GROUP 1Z2A ; 1.90 ; GDP-BOUND RAB23 GTPASE CRYSTALLIZED IN P2(1)2(1)2(1) SPACE GROUP 1Z0A ; 2.12 ; GDP-BOUND RAB2A GTPASE 1Z0D ; 2.20 ; GDP-BOUND RAB5C GTPASE 1VG1 ; 1.90 ; GDP-BOUND RAB7 1KY3 ; 1.35 ; GDP-BOUND YPT7P AT 1.35 A RESOLUTION 1GFS ; 2.20 ; GDP-FUCOSE SYNTHETASE FROM E. COLI 1FXS ; 2.30 ; GDP-FUCOSE SYNTHETASE FROM ESCHERICHIA COLI COMPLEX WITH NADP 1BSV ; 2.20 ; GDP-FUCOSE SYNTHETASE FROM ESCHERICHIA COLI COMPLEX WITH NADPH 2C54 ; 1.50 ; GDP-MANNOSE-3', 5' -EPIMERASE (ARABIDOPSIS THALIANA), K178R, WITH GDP-BETA-L-GULOSE AND GDP-4-KETO-BETA-L-GULOSE BOUND IN ACTIVE SITE. 2C5E ; 1.70 ; GDP-MANNOSE-3', 5' -EPIMERASE (ARABIDOPSIS THALIANA), K217A, WITH GDP-ALPHA-D-MANNOSE BOUND IN THE ACTIVE SITE. 2C59 ; 2.00 ; GDP-MANNOSE-3', 5' -EPIMERASE (ARABIDOPSIS THALIANA), WITH GDP-ALPHA-D-MANNOSE AND GDP-BETA-L-GALACTOSE BOUND IN THE ACTIVE SITE. 2C5A ; 1.40 ; GDP-MANNOSE-3', 5' -EPIMERASE (ARABIDOPSIS THALIANA), Y174F, WITH GDP-BETA-L-GALACTOSE BOUND IN THE ACTIVE SITE 1A2K ; 2.50 ; GDPRAN-NTF2 COMPLEX 1CK7 ; 2.80 ; GELATINASE A (FULL-LENGTH) 1YET ; 1.90 ; GELDANAMYCIN BOUND TO THE HSP90 GELDANAMYCIN-BINDING DOMAIN 1NPH ; 3.00 ; GELSOLIN DOMAINS 4-6 IN ACTIVE, ACTIN FREE CONFORMATION IDENTIFIES SITES OF REGULATORY CALCIUM IONS 1H1V ; 3.00 ; GELSOLIN G4-G6/ACTIN COMPLEX 1VJH ; 2.10 ; GENE PRODUCT OF AT1G24000 FROM ARABIDOPSIS THALIANA 1VJI ; 2.00 ; GENE PRODUCT OF AT1G76680 FROM ARABIDOPSIS THALIANA 1Q4R ; 1.90 ; GENE PRODUCT OF AT3G17210 FROM ARABIDOPSIS THALIANA 1GVP ; 1.60 ; GENE V PROTEIN (SINGLE-STRANDED DEOXYRIBONUCLEIC ACID BINDING PROTEIN) 1VQB ; 1.80 ; GENE V PROTEIN (SINGLE-STRANDED DEOXYRIBONUCLEIC ACID BINDING PROTEIN) 1VQG ; 1.80 ; GENE V PROTEIN MUTANT WITH ILE 47 REPLACED BY LEU 47 (I47L) 1VQH ; 1.80 ; GENE V PROTEIN MUTANT WITH ILE 47 REPLACED BY MET 47 (I47M) 1VQI ; 1.80 ; GENE V PROTEIN MUTANT WITH ILE 47 REPLACED BY VAL 47 (I47V) 1VQA ; 1.80 ; GENE V PROTEIN MUTANT WITH VAL 35 REPLACED BY ALA 35 AND ILE 47 REPLACED BY LEU 47 (V35A, I47L) 1VQJ ; 1.80 ; GENE V PROTEIN MUTANT WITH VAL 35 REPLACED BY ILE 35 (V35I) 1VQD ; 1.80 ; GENE V PROTEIN MUTANT WITH VAL 35 REPLACED BY ILE 35 AND ILE 47 REPLACED BY LEU 47 (V35I, I47L) 1VQE ; 1.80 ; GENE V PROTEIN MUTANT WITH VAL 35 REPLACED BY ILE 35 AND ILE 47 REPLACED BY MET 47 (V35I, I47M) 1VQC ; 1.80 ; GENE V PROTEIN MUTANT WITH VAL 35 REPLACED BY ILE 35 AND ILE 47 REPLACED BY PHE 47 (V35I, I47F) 1VQF ; 1.80 ; GENE V PROTEIN MUTANT WITH VAL 35 REPLACED BY ILE 35 AND ILE 47 REPLACED BY VAL 47 (V35I, I47V) 220L ; 1.85 ; GENERATING LIGAND BINDING SITES IN T4 LYSOZYME USING DEFICIENCY-CREATING SUBSTITUTIONS 222L ; 1.90 ; GENERATING LIGAND BINDING SITES IN T4 LYSOZYME USING DEFICIENCY-CREATING SUBSTITUTIONS 223L ; 1.90 ; GENERATING LIGAND BINDING SITES IN T4 LYSOZYME USING DEFICIENCY-CREATING SUBSTITUTIONS 225L ; 1.90 ; GENERATING LIGAND BINDING SITES IN T4 LYSOZYME USING DEFICIENCY-CREATING SUBSTITUTIONS 226L ; 1.80 ; GENERATING LIGAND BINDING SITES IN T4 LYSOZYME USING DEFICIENCY-CREATING SUBSTITUTIONS 227L ; 2.00 ; GENERATING LIGAND BINDING SITES IN T4 LYSOZYME USING DEFICIENCY-CREATING SUBSTITUTIONS 228L ; 1.90 ; GENERATING LIGAND BINDING SITES IN T4 LYSOZYME USING DEFICIENCY-CREATING SUBSTITUTIONS 229L ; 1.80 ; GENERATING LIGAND BINDING SITES IN T4 LYSOZYME USING DEFICIENCY-CREATING SUBSTITUTIONS 252L ; 2.10 ; GENERATING LIGAND BINDING SITES IN T4 LYSOZYME USING DEFICIENCY-CREATING SUBSTITUTIONS 1BYJ ; -1.00 ; GENTAMICIN C1A A-SITE COMPLEX 1UMP ; 2.13 ; GEOMETRY OF TRITERPENE CONVERSION TO PENTACARBOCYCLIC HOPENE 1N7M ; 1.80 ; GERMLINE 7G12 WITH N-METHYLMESOPORPHYRIN 1ZFA ; 1.56 ; GGA DUPLEX A-DEOXYRIBONUCLEIC ACID 1JUQ ; 2.20 ; GGA3 VHS DOMAIN COMPLEXED WITH C-TERMINAL PEPTIDE FROM CATION-DEPENDENT MANNOSE 6-PHOSPHATE RECEPTOR 1JPL ; 2.40 ; GGA3 VHS DOMAIN COMPLEXED WITH C-TERMINAL PEPTIDE FROM CATION-INDEPENDENT MANNOSE 6-PHOSPHATE RECEPTOR 1ZFB ; 1.65 ; GGC DUPLEX B-DEOXYRIBONUCLEIC ACID 1ZF9 ; 1.38 ; GGG DUPLEX A-DEOXYRIBONUCLEIC ACID 1ZF8 ; 1.48 ; GGT DUPLEX A-DEOXYRIBONUCLEIC ACID 1BOF ; 2.20 ; GI-ALPHA-1 BOUND TO GDP AND MAGNESIUM 1CIP ; 1.50 ; GI-ALPHA-1 SUBUNIT OF GUANINE NUCLEOTIDE-BINDING PROTEIN COMPLEXED WITH A GTP ANALOGUE 1T2X ; 2.30 ; GLACTOSE OXIDASE C383S MUTANT IDENTIFIED BY DIRECTED EVOLUTION 1UPS ; 1.82 ; GLCNAC[ALPHA]1-4GAL RELEASING ENDO-[BETA]-GALACTOSIDASE FROM CLOSTRIDIUM PERFRINGENS 1AGQ ; 1.90 ; GLIAL CELL-DERIVED NEUROTROPHIC FACTOR FROM RAT 3SGQ ; 1.80 ; GLN 18 VARIANT OF TURKEY OVOMUCOID INHIBITOR THIRD DOMAIN COMPLEXED WITH STREPTOMYCES GRISEUS PROTEINASE B AT PH 10.7 2SGQ ; 1.80 ; GLN 18 VARIANT OF TURKEY OVOMUCOID INHIBITOR THIRD DOMAIN COMPLEXED WITH STREPTOMYCES GRISEUS PROTEINASE B AT PH 6.5 1Q5T ; 1.90 ; GLN48 PLA2 SEPARATED FROM VIPOXIN FROM THE VENOM OF VIPERA AMMODYTES MERIDIONALIS. 1GNK ; 2.00 ; GLNK, A SIGNAL PROTEIN FROM E. COLI 2GNK ; 2.00 ; GLNK, A SIGNAL PROTEIN FROM E. COLI 1EZO ; -1.00 ; GLOBAL FOLD OF MALTODEXTRIN BINDING PROTEIN COMPLEXED WITH BETA-CYCLODEXTRIN 1EZP ; -1.00 ; GLOBAL FOLD OF MALTODEXTRIN BINDING PROTEIN COMPLEXED WITH BETA-CYCLODEXTRIN USING PEPTIDE ORIENTATIONS FROM DIPOLAR COUPLINGS 1O8T ; -1.00 ; GLOBAL STRUCTURE AND DYNAMICS OF HUMAN APOLIPOPROTEIN CII IN COMPLEX WITH MICELLES: EVIDENCE FOR INCREASED MOBILITY OF THE HELIX INVOLVVED IN THE ACTIVATION OF LIPOPROTEIN LIPASE. 1PK6 ; 1.85 ; GLOBULAR HEAD OF THE COMPLEMENT SYSTEM PROTEIN C1Q 2SGE ; 1.80 ; GLU 18 VARIANT OF TURKEY OVOMUCOID INHIBITOR THIRD DOMAIN COMPLEXED WITH STREPTOMYCES GRISEUS PROTEINASE B AT PH 10.7 1SGE ; 1.80 ; GLU 18 VARIANT OF TURKEY OVOMUCOID INHIBITOR THIRD DOMAIN COMPLEXED WITH STREPTOMYCES GRISEUS PROTEINASE B AT PH 6.5 2BS3 ; 2.19 ; GLU C180 -> GLN VARIANT QUINOL:FUMARATE REDUCTASE FROM WOLINELLA SUCCINOGENES 2BS4 ; 2.76 ; GLU C180 -> ILE VARIANT QUINOL:FUMARATE REDUCTASE FROM WOLINELLA SUCCINOGENES 1FWZ ; 2.30 ; GLU20ALA DTXR 1ZP4 ; 1.85 ; GLU28GLN MUTANT OF E. COLI METHYLENETETRAHYDROFOLATE REDUCTASE (OXIDIZED) COMPLEX WITH METHYLTETRAHYDROFOLATE 1JDF ; 2.00 ; GLUCARATE DEHYDRATASE FROM E.COLI N341D MUTANT 1JCT ; 2.75 ; GLUCARATE DEHYDRATASE, N341L MUTANT ORTHORHOMBIC FORM 1ACZ ; -1.00 ; GLUCOAMYLASE, GRANULAR STARCH-BINDING DOMAIN COMPLEX WITH CYCLODEXTRIN, NMR, 5 STRUCTURES 1AC0 ; -1.00 ; GLUCOAMYLASE, GRANULAR STARCH-BINDING DOMAIN COMPLEX WITH CYCLODEXTRIN, NMR, MINIMIZED AVERAGE STRUCTURE 1KUL ; -1.00 ; GLUCOAMYLASE, GRANULAR STARCH-BINDING DOMAIN, NMR, 5 STRUCTURES 1KUM ; -1.00 ; GLUCOAMYLASE, GRANULAR STARCH-BINDING DOMAIN, NMR, MINIMIZED AVERAGE STRUCTURE 1GAH ; 2.00 ; GLUCOAMYLASE-471 COMPLEXED WITH ACARBOSE 1GAI ; 1.70 ; GLUCOAMYLASE-471 COMPLEXED WITH D-GLUCO-DIHYDROACARBOSE 1LAT ; 1.90 ; GLUCOCORTICOID RECEPTOR MUTANT (DEOXYRIBONUCLEIC ACID BINDING DOMAIN) COMPLEX WITH NON-COGNATE DEOXYRIBONUCLEIC ACID 1HOT ; 2.40 ; GLUCOSAMINE 6-PHOSPHATE DEAMINASE COMPLEXED WITH THE ALLOSTERIC ACTIVATOR N-ACETYL-GLUCOSAMINE-6-PHOSPHATE 1FQO ; 2.20 ; GLUCOSAMINE 6-PHOSPHATE DEAMINASE COMPLEXED WITH THE SUBSTRATE OF THE REVERSE REACTION FRUCTOSE 6-PHOSPHATE (OPEN FORM) 1JXA ; 3.10 ; GLUCOSAMINE 6-PHOSPHATE SYNTHASE WITH GLUCOSE 6-PHOSPHATE 1FRZ ; 2.20 ; GLUCOSAMINE-6-PHOSPHATE DEAMINASE FROM E.COLI, R CONFORMER. COMPLEXED WITH THE ALLOSTERIC ACTIVATOR N-ACETYL- GLUCOSAMINE-6-PHOSPHATE AT 2.2 A RESOLUTION 1CD5 ; 2.30 ; GLUCOSAMINE-6-PHOSPHATE DEAMINASE FROM E.COLI, T CONFORMER 1FSF ; 1.90 ; GLUCOSAMINE-6-PHOSPHATE DEAMINASE FROM E.COLI, T CONFORMER, AT 1.9A RESOLUTION 1FS6 ; 2.20 ; GLUCOSAMINE-6-PHOSPHATE DEAMINASE FROM E.COLI, T CONFORMER, AT 2.2A RESOLUTION 1DPG ; 2.00 ; GLUCOSE 6-PHOSPHATE DEHYDROGENASE FROM LEUCONOSTOC MESENTEROIDES 1OAD ; 1.50 ; GLUCOSE ISOMERASE FROM STREPTOMYCES RUBIGINOSUS IN P21212 CRYSTAL FORM 1CF3 ; 1.90 ; GLUCOSE OXIDASE FROM APERGILLUS NIGER 1GPE ; 1.80 ; GLUCOSE OXIDASE FROM PENICILLIUM AMAGASAKIENSE 1IBA ; -1.00 ; GLUCOSE PERMEASE (DOMAIN IIB), NMR, 11 STRUCTURES 2GPR ; 2.50 ; GLUCOSE PERMEASE IIA FROM MYCOPLASMA CAPRICOLUM 1OFG ; 2.70 ; GLUCOSE-FRUCTOSE OXIDOREDUCTASE 1BGG ; 2.30 ; GLUCOSIDASE A FROM BACILLUS POLYMYXA COMPLEXED WITH GLUCONATE 1IIT ; 1.90 ; GLUR0 LIGAND BINDING CORE COMPLEX WITH L-SERINE 1IIW ; 1.90 ; GLUR0 LIGAND BINDING CORE: CLOSED-CLEFT LIGAND-FREE STRUCTURE 1P1N ; 1.60 ; GLUR2 LIGAND BINDING CORE (S1S2J) MUTANT L650T IN COMPLEX WITH KAINATE 1AUP ; 2.50 ; GLUTAMATE DEHYDROGENASE 1B26 ; 3.00 ; GLUTAMATE DEHYDROGENASE 1BGV ; 1.90 ; GLUTAMATE DEHYDROGENASE 1HRD ; 1.96 ; GLUTAMATE DEHYDROGENASE 1BVU ; 2.50 ; GLUTAMATE DEHYDROGENASE FROM THERMOCOCCUS LITORALIS 1EUZ ; 2.25 ; GLUTAMATE DEHYDROGENASE FROM THERMOCOCCUS PROFUNDUS IN THE UNLIGATED STATE 1B1A ; -1.00 ; GLUTAMATE MUTASE (B12-BINDING SUBUNIT), NMR, MINIMIZED AVERAGE STRUCTURE 1BE1 ; -1.00 ; GLUTAMATE MUTASE (B12-BINDING SUBUNIT), NMR, MINIMIZED AVERAGE STRUCTURE 1CB7 ; 2.00 ; GLUTAMATE MUTASE FROM CLOSTRIDIUM COCHLEARIUM RECONSTITUTED WITH METHYL-COBALAMIN 1I9C ; 1.90 ; GLUTAMATE MUTASE FROM CLOSTRIDIUM COCHLEARIUM: COMPLEX WITH ADENOSYLCOBALAMIN AND SUBSTRATE 1B73 ; 2.30 ; GLUTAMATE RACEMASE FROM AQUIFEX PYROPHILUS 1B74 ; 2.30 ; GLUTAMATE RACEMASE FROM AQUIFEX PYROPHILUS 1OFE ; 2.45 ; GLUTAMATE SYNTHASE FROM SYNECHOCYSTIS SP IN COMPLEX WITH 2-OXOGLUTARATE AND L-DON AT 2.45 ANGSTROM RESOLUTION 1OFD ; 2.00 ; GLUTAMATE SYNTHASE FROM SYNECHOCYSTIS SP IN COMPLEX WITH 2-OXOGLUTARATE AT 2.0 ANGSTROM RESOLUTION 1XFF ; 1.80 ; GLUTAMINASE DOMAIN OF GLUCOSAMINE 6-PHOSPHATE SYNTHASE COMPLEXED WITH GLUTAMATE 1XFG ; 1.85 ; GLUTAMINASE DOMAIN OF GLUCOSAMINE 6-PHOSPHATE SYNTHASE COMPLEXED WITH L-GLU HYDROXAMATE 4PGA ; 1.70 ; GLUTAMINASE-ASPARAGINASE FROM PSEUDOMONAS 7A 1GGG ; 2.30 ; GLUTAMINE BINDING PROTEIN OPEN LIGAND-FREE STRUCTURE 1AO0 ; 2.80 ; GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATE (PRPP) AMIDOTRANSFERASE FROM B. SUBTILIS COMPLEXED WITH ADP AND GMP 1WDN ; 1.94 ; GLUTAMINE-BINDING PROTEIN 1ZJW ; 2.50 ; GLUTAMINYL-TRNA SYNTHETASE COMPLEXED TO GLUTAMINE AND 2'DEOXY A76 GLUTAMINE TRNA 1EUY ; 2.60 ; GLUTAMINYL-TRNA SYNTHETASE COMPLEXED WITH A TRNA MUTANT AND AN ACTIVE SITE INHIBITOR 1QTQ ; 2.40 ; GLUTAMINYL-TRNA SYNTHETASE COMPLEXED WITH TRNA AND AN AMINO ACID ANALOG 1QRT ; 2.70 ; GLUTAMINYL-TRNA SYNTHETASE MUTANT D235G COMPLEXED WITH GLUTAMINE TRANSFER RIBONUCLEIC ACID 1QRS ; 2.60 ; GLUTAMINYL-TRNA SYNTHETASE MUTANT D235N COMPLEXED WITH GLUTAMINE TRANSFER RIBONUCLEIC ACID 1QRU ; 3.00 ; GLUTAMINYL-TRNA SYNTHETASE MUTANT I129T COMPLEXED WITH GLUTAMINE TRANSFER RIBONUCLEIC ACID 1P3C ; 1.50 ; GLUTAMYL ENDOPEPTIDASE FROM BACILLUS INTERMEDIUS 1GPJ ; 1.95 ; GLUTAMYL-TRNA REDUCTASE FROM METHANOPYRUS KANDLERI 1G59 ; 2.40 ; GLUTAMYL-TRNA SYNTHETASE COMPLEXED WITH TRNA(GLU). 1FOV ; -1.00 ; GLUTAREDOXIN 3 FROM ESCHERICHIA COLI IN THE FULLY OXIDIZED FORM 1QFN ; -1.00 ; GLUTAREDOXIN-1-RIBONUCLEOTIDE REDUCTASE B1 MIXED DISULFIDE BOND 1R5A ; 2.50 ; GLUTATHIONE S-TRANSFERASE 1V2A ; 2.15 ; GLUTATHIONE S-TRANSFERASE 1-6 FROM ANOPHELES DIRUS SPECIES B 11GS ; 2.30 ; GLUTATHIONE S-TRANSFERASE COMPLEXED WITH ETHACRYNIC ACID-GLUTATHIONE CONJUGATE (FORM II) 12GS ; 2.10 ; GLUTATHIONE S-TRANSFERASE COMPLEXED WITH S-NONYL-GLUTATHIONE 13GS ; 1.90 ; GLUTATHIONE S-TRANSFERASE COMPLEXED WITH SULFASALAZINE 2GSQ ; 2.20 ; GLUTATHIONE S-TRANSFERASE FROM SQUID DIGESTIVE GLAND COMPLEXED WITH S-(3-IODOBENZYL)GLUTATHIONE 1B8X ; 2.70 ; GLUTATHIONE S-TRANSFERASE FUSED WITH THE NUCLEAR MATRIX TARGETING SIGNAL OF THE TRANSCRIPTION FACTOR AML-1 1BYE ; 2.80 ; GLUTATHIONE S-TRANSFERASE I FROM MAIS IN COMPLEX WITH ATRAZINE GLUTATHIONE CONJUGATE 1AQW ; 1.80 ; GLUTATHIONE S-TRANSFERASE IN COMPLEX WITH GLUTATHIONE 1BX9 ; 2.60 ; GLUTATHIONE S-TRANSFERASE IN COMPLEX WITH HERBICIDE 1AQX ; 2.00 ; GLUTATHIONE S-TRANSFERASE IN COMPLEX WITH MEISENHEIMER COMPLEX 1AQV ; 1.94 ; GLUTATHIONE S-TRANSFERASE IN COMPLEX WITH P-BROMOBENZYLGLUTATHIONE 17GS ; 1.90 ; GLUTATHIONE S-TRANSFERASE P1-1 19GS ; 1.90 ; GLUTATHIONE S-TRANSFERASE P1-1 14GS ; 2.80 ; GLUTATHIONE S-TRANSFERASE P1-1 APO FORM 1 16GS ; 1.90 ; GLUTATHIONE S-TRANSFERASE P1-1 APO FORM 3 18GS ; 1.90 ; GLUTATHIONE S-TRANSFERASE P1-1 COMPLEXED WITH 1-(S-GLUTATHIONYL)-2,4-DINITROBENZENE 20GS ; 2.45 ; GLUTATHIONE S-TRANSFERASE P1-1 COMPLEXED WITH CIBACRON BLUE 1BAY ; 2.00 ; GLUTATHIONE S-TRANSFERASE YFYF CYS 47-CARBOXYMETHYLATED CLASS PI, FREE ENZYME 1GSY ; 2.40 ; GLUTATHIONE S-TRANSFERASE YFYF, CLASS PI, COMPLEXED WITH GLUTATHIONE 1FHE ; 3.00 ; GLUTATHIONE TRANSFERASE (FH47) FROM FASCIOLA HEPATICA 1LJR ; 3.20 ; GLUTATHIONE TRANSFERASE (HGST T2-2) FROM HUMAN 3LJR ; 3.30 ; GLUTATHIONE TRANSFERASE (THETA CLASS) FROM HUMAN IN COMPLEX WITH THE GLUTATHIONE CONJUGATE OF 1-MENAPHTHYL SULFATE 1GSE ; 2.00 ; GLUTATHIONE TRANSFERASE A1-1 COMPLEXED WITH AN ETHACRYNIC ACID GLUTATHIONE CONJUGATE (MUTANT R15K) 1GSF ; 2.70 ; GLUTATHIONE TRANSFERASE A1-1 COMPLEXED WITH ETHACRYNIC ACID 1GSD ; 2.50 ; GLUTATHIONE TRANSFERASE A1-1 IN UNLIGANDED FORM 2LJR ; 3.20 ; GLUTATHIONE TRANSFERASE APO-FORM FROM HUMAN 1EEM ; 2.00 ; GLUTATHIONE TRANSFERASE FROM HOMO SAPIENS 1PMT ; 2.50 ; GLUTATHIONE TRANSFERASE FROM PROTEUS MIRABILIS 2PMT ; 2.70 ; GLUTATHIONE TRANSFERASE FROM PROTEUS MIRABILIS 1KBN ; 2.00 ; GLUTATHIONE TRANSFERASE MUTANT 1MTC ; 2.20 ; GLUTATHIONE TRANSFERASE MUTANT Y115F 1EOH ; 2.50 ; GLUTATHIONE TRANSFERASE P1-1 1FW1 ; 1.90 ; GLUTATHIONE TRANSFERASE ZETA/MALEYLACETOACETATE ISOMERASE 1TW9 ; 1.71 ; GLUTATHIONE TRANSFERASE-2, APO FORM, FROM THE NEMATODE HELIGMOSOMOIDES POLYGYRUS 1SGQ ; 1.90 ; GLY 18 VARIANT OF TURKEY OVOMUCOID INHIBITOR THIRD DOMAIN COMPLEXED WITH STREPTOMYCES GRISEUS PROTEINASE B 1JPK ; 2.20 ; GLY156ASP MUTANT OF HUMAN UROD, HUMAN UROPORPHYRINOGEN III DECARBOXYLASE 1CI5 ; -1.00 ; GLYCAN-FREE MUTANT ADHESION DOMAIN OF HUMAN CD58 (LFA-3) 1B7G ; 2.05 ; GLYCERALDEHYDE 3-PHOSPHATE DEHYDROGENASE 1DBV ; 2.50 ; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE MUTANT WITH ASP 32 REPLACED BY GLY, LEU 187 REPLACED BY ALA, AND PRO 188 REPLACED BY SER COMPLEXED WITH NAD+ 2DBV ; 2.20 ; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE MUTANT WITH ASP 32 REPLACED BY GLY, LEU 187 REPLACED BY ALA, AND PRO 188 REPLACED BY SER COMPLEXED WITH NADP+ 1NPT ; 2.18 ; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE MUTANT WITH CYS 149 REPLACED BY ALA COMPLEXED WITH NAD+ 1NQA ; 2.20 ; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE MUTANT WITH CYS 149 REPLACED BY ALA COMPLEXED WITH NAD+ AND D- GLYCERALDEHYDE-3-PHOSPHATE 1NQ5 ; 2.11 ; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE MUTANT WITH CYS 149 REPLACED BY SER COMPLEXED WITH NAD+ 1NQO ; 2.01 ; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE MUTANT WITH CYS 149 REPLACED BY SER COMPLEXED WITH NAD+ AND D- GLYCERALDEHYDE-3-PHOSPHATE 3DBV ; 2.45 ; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE MUTANT WITH LEU 33 REPLACED BY THR, THR 34 REPLACED BY GLY, ASP 36 REPLACED BY GLY, LEU 187 REPLACED BY ALA, AND PRO 188 REPLACED BY SER COMPLEXED WITH NAD+ 4DBV ; 2.50 ; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE MUTANT WITH LEU 33 REPLACED BY THR, THR 34 REPLACED BY GLY, ASP 36 REPLACED BY GLY, LEU 187 REPLACED BY ALA, AND PRO 188 REPLACED BY SER COMPLEXED WITH NADP+ 1TO6 ; 2.50 ; GLYCERATE KINASE FROM NEISSERIA MENINGITIDIS (SEROGROUP A) 1R9D ; 1.80 ; GLYCEROL BOUND FORM OF THE B12-INDEPENDENT GLYCEROL DEHYDRATASE FROM CLOSTRIDIUM BUTYRICUM 1NBW ; 2.40 ; GLYCEROL DEHYDRATASE REACTIVASE 1IWP ; 2.10 ; GLYCEROL DEHYDRATASE-CYANOCOBALAMIN COMPLEX OF KLEBSIELLA PNEUMONIAE 1N1D ; 2.00 ; GLYCEROL-3-PHOSPHATE CYTIDYLYLTRANSFERASE COMPLEXED WITH CDP-GLYCEROL 1GSO ; 1.60 ; GLYCINAMIDE RIBONUCLEOTIDE SYNTHETASE (GAR-SYN) FROM E. COLI. 1PQF ; 2.00 ; GLYCINE 24 TO SERINE MUTATION OF ASPARTATE DECARBOXYLASE 1Z6P ; 2.40 ; GLYCOGEN PHOSPHORYLASE AMP SITE INHIBITOR COMPLEX 1UZU ; 2.30 ; GLYCOGEN PHOSPHORYLASE B IN COMPLEX WITH INDIRUBIN-5'- SULPHONATE 1Z6Q ; 2.03 ; GLYCOGEN PHOSPHORYLASE WITH INHIBITOR IN THE AMP SITE 1UV5 ; 2.80 ; GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH 6-BROMOINDIRUBIN-3'-OXIME 1O9U ; 2.40 ; GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH AXIN PEPTIDE 1H8F ; 2.80 ; GLYCOGEN SYNTHASE KINASE 3 BETA. 1GNG ; 2.60 ; GLYCOGEN SYNTHASE KINASE-3 BETA (GSK3) COMPLEX WITH FRATTIDE PEPTIDE 1R0E ; 2.25 ; GLYCOGEN SYNTHASE KINASE-3 BETA IN COMPLEX WITH 3-INDOLYL-4- ARYLMALEIMIDE INHIBITOR 2F15 ; 2.00 ; GLYCOGEN-BINDING DOMAIN OF THE AMP-ACTIVATED PROTEIN KINASE BETA2 SUBUNIT 1A7K ; 2.80 ; GLYCOSOMAL GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE IN A MONOCLINIC CRYSTAL FORM 1AYY ; 2.32 ; GLYCOSYLASPARAGINASE 1BYV ; -1.00 ; GLYCOSYLATED EEL CALCITONIN 1BZB ; -1.00 ; GLYCOSYLATED EEL CALCITONIN 1BPL ; 2.20 ; GLYCOSYLTRANSFERASE 1LZ0 ; 1.80 ; GLYCOSYLTRANSFERASE A 1LZI ; 1.35 ; GLYCOSYLTRANSFERASE A + UDP + H ANTIGEN ACCEPTOR 1R7V ; 2.09 ; GLYCOSYLTRANSFERASE A IN COMPLEX WITH 3-AMINO-ACCEPTOR ANALOG INHIBITOR 1R7Y ; 1.75 ; GLYCOSYLTRANSFERASE A IN COMPLEX WITH 3-AMINO-ACCEPTOR ANALOG INHIBITOR AND URIDINE DIPHOSPHATE 1R81 ; 1.75 ; GLYCOSYLTRANSFERASE A IN COMPLEX WITH 3-AMINO-ACCEPTOR ANALOG INHIBITOR AND URIDINE DIPHOSPHATE-N-ACETYL-GALACTOSE 1R7T ; 2.09 ; GLYCOSYLTRANSFERASE A IN COMPLEX WITH 3-DEOXY-ACCEPTOR ANALOG INHIBITOR 1LZ7 ; 1.65 ; GLYCOSYLTRANSFERASE B 1LZJ ; 1.32 ; GLYCOSYLTRANSFERASE B + UDP + H ANTIGEN ACCEPTOR 1R7X ; 1.97 ; GLYCOSYLTRANSFERASE B IN COMPLEX WITH 3-AMINO-ACCEPTOR ANALOG INHIBITOR 1R80 ; 1.65 ; GLYCOSYLTRANSFERASE B IN COMPLEX WITH 3-AMINO-ACCEPTOR ANALOG INHIBITOR AND URIDINE DIPHOSPHATE 1R82 ; 1.55 ; GLYCOSYLTRANSFERASE B IN COMPLEX WITH 3-AMINO-ACCEPTOR ANALOG INHIBITOR, AND URIDINE DIPHOSPHATE-GALACTOSE 1R7U ; 1.61 ; GLYCOSYLTRANSFERASE B IN COMPLEX WITH 3-DEOXY-ACCEPTOR ANALOG INHIBITOR 1GEC ; 2.10 ; GLYCYL ENDOPEPTIDASE - COMPLEX WITH BENZYLOXYCARBONYL- LEUCINE-VALINE-GLYCINE-METHYLENE COVALENTLY BOUND TO CYSTEINE 25 1B76 ; 3.40 ; GLYCYL-TRNA SYNTHETASE FROM THERMUS THERMOPHILUS COMPLEXED WITH ATP 1GGM ; 3.40 ; GLYCYL-TRNA SYNTHETASE FROM THERMUS THERMOPHILUS COMPLEXED WITH GLYCYL-ADENYLATE 1MI4 ; 1.70 ; GLYPHOSATE INSENSITIVE G96A MUTANT EPSP SYNTHASE LIGANDED WITH SHIKIMATE-3-PHOSPHATE 1IHQ ; -1.00 ; GLYTM1BZIP: A CHIMERIC PEPTIDE MODEL OF THE N-TERMINUS OF A RAT SHORT ALPHA TROPOMYOSIN WITH THE N-TERMINUS ENCODED BY EXON 1B 1PU5 ; 1.90 ; GM2-ACTIVATOR PROTEIN CRYSTAL STRUCTURE 1PUB ; 2.51 ; GM2-ACTIVATOR PROTEIN CRYSTAL STRUCTURE 1JPJ ; 2.30 ; GMPPNP COMPLEX OF SRP GTPASE NG DOMAIN 1JPN ; 1.90 ; GMPPNP COMPLEX OF SRP GTPASE NG DOMAIN 1HTY ; 1.40 ; GOLGI ALPHA-MANNOSIDASE II 1R34 ; 1.95 ; GOLGI ALPHA-MANNOSIDASE II COMPLEX WITH 5-THIO-D- MANNOPYRANOSYLAMIDINIUM SALT 1R33 ; 1.80 ; GOLGI ALPHA-MANNOSIDASE II COMPLEX WITH 5-THIO-D- MANNOPYRANOSYLAMINE 1QWN ; 1.20 ; GOLGI ALPHA-MANNOSIDASE II COVALENT INTERMEDIATE COMPLEX WITH 5-FLUORO-GULOSYL-FLUORIDE 1QX1 ; 1.30 ; GOLGI ALPHA-MANNOSIDASE II D341N MUTANT COMPLEX WITH 2-F- MANNOSYL-F 1QWU ; 2.03 ; GOLGI ALPHA-MANNOSIDASE II D341N MUTANT COMPLEX WITH 5-F- GULOSIDE 1TQT ; 1.90 ; GOLGI ALPHA-MANNOSIDASE II IN COMPLEX WITH A DIASTEREOMER OF SALACINOL 1TQW ; 1.20 ; GOLGI ALPHA-MANNOSIDASE II IN COMPLEX WITH A DIASTEREOMER OF SELENO-SALACINOL 1HXK ; 1.50 ; GOLGI ALPHA-MANNOSIDASE II IN COMPLEX WITH DEOXYMANNOJIRIMICIN 1PS3 ; 1.80 ; GOLGI ALPHA-MANNOSIDASE II IN COMPLEX WITH KIFUNENSINE 1TQS ; 1.30 ; GOLGI ALPHA-MANNOSIDASE II IN COMPLEX WITH SALACINOL 1TQV ; 2.03 ; GOLGI ALPHA-MANNOSIDASE II IN COMPLEX WITH SELENO-SALACINOL (BLINTOL) 1HWW ; 1.87 ; GOLGI ALPHA-MANNOSIDASE II IN COMPLEX WITH SWAINSONINE 1TQU ; 2.03 ; GOLGI ALPHA-MANNOSIDASE II IN COMPLEX WITH THE SALACINOL ANALOG GHAVAMIOL 1G31 ; 2.30 ; GP31 CO-CHAPERONIN FROM BACTERIOPHAGE T4 1E0K ; 3.30 ; GP4D HELICASE FROM PHAGE T7 1E0J ; 3.00 ; GP4D HELICASE FROM PHAGE T7 ADPNP COMPLEX 1TX9 ; 3.31 ; GPD PRIOR TO CAPSID ASSEMBLY 1NAY ; 2.60 ; GPP-FOLDON:X-RAY STRUCTURE 1YZK ; 2.00 ; GPPNHP BOUND RAB11 GTPASE 1YZT ; 2.05 ; GPPNHP-BOUND RAB21 GTPASE AT 2.05 A RESOLUTION 1YZU ; 2.50 ; GPPNHP-BOUND RAB21 GTPASE AT 2.50 A RESOLUTION 1Z08 ; 1.80 ; GPPNHP-BOUND RAB21 Q53G MUTANT GTPASE 1YVD ; 1.93 ; GPPNHP-BOUND RAB22 GTPASE 1Z06 ; 1.81 ; GPPNHP-BOUND RAB33 GTPASE 3RAB ; 2.00 ; GPPNHP-BOUND RAB3A AT 2.0 A RESOLUTION 1YU9 ; 2.07 ; GPPNHP-BOUND RAB4A 1Z07 ; 1.81 ; GPPNHP-BOUND RAB5C G55Q MUTANT GTPASE 1YZQ ; 1.78 ; GPPNHP-BOUND RAB6 GTPASE 1VG8 ; 1.70 ; GPPNHP-BOUND RAB7 1YZL ; 1.85 ; GPPNHP-BOUND RAB9 GTPASE 1YZN ; 2.06 ; GPPNHP-BOUND YPT1P GTPASE 1EK0 ; 1.48 ; GPPNHP-BOUND YPT51 AT 1.48 A RESOLUTION 1KY2 ; 1.60 ; GPPNHP-BOUND YPT7P AT 1.6 A RESOLUTION 1NRM ; -1.00 ; GRAMICIDIN A IN DODECYL PHOSPHOCHOLINE MICELLES (NMR) 1NRU ; -1.00 ; GRAMICIDIN A IN DODECYL PHOSPHOCHOLINE MICELLES IN THE PRESENCE OF EXCESS NA+ (NMR) 1MAG ; -1.00 ; GRAMICIDIN A IN HYDRATED DMPC BILAYERS, SOLID STATE NMR 1JNO ; -1.00 ; GRAMICIDIN A IN SODIUM DODECYL SULFATE MICELLES (NMR) 1AV2 ; 1.40 ; GRAMICIDIN A/CSCL COMPLEX, ACTIVE AS A DIMER 1MIC ; -1.00 ; GRAMICIDIN A: LEFT-HANDED PARALLEL DOUBLE HELICAL FORM IN METHANOL IN THE PRESENCE OF CACL2, NMR, 20 STRUCTURES 1JO3 ; -1.00 ; GRAMICIDIN B IN SODIUM DODECYL SULFATE MICELLES (NMR) 1JO4 ; -1.00 ; GRAMICIDIN C IN SODIUM DODECYL SULFATE MICELLES (NMR) 1C4D ; 2.00 ; GRAMICIDIN CSCL COMPLEX 1BDW ; 1.70 ; GRAMICIDIN D FROM BACILLUS BREVIS (ACTIVE FORM) 1ALZ ; 0.86 ; GRAMICIDIN D FROM BACILLUS BREVIS (ETHANOL SOLVATE) 1W5U ; 1.14 ; GRAMICIDIN D FROM BACILLUS BREVIS (ETHANOL SOLVATE) 1ALX ; 1.20 ; GRAMICIDIN D FROM BACILLUS BREVIS (METHANOL SOLVATE) 1AL4 ; 1.13 ; GRAMICIDIN D FROM BACILLUS BREVIS (N-PROPANOL SOLVATE) 1GMK ; 2.50 ; GRAMICIDIN/KSCN COMPLEX 1L9L ; 0.92 ; GRANULYSIN FROM HUMAN CYTOLYTIC T LYMPHOCYTES 1FAW ; 3.09 ; GRAYLAG GOOSE HEMOGLOBIN (OXY FORM) 1GRI ; 3.10 ; GRB2 1BM2 ; 2.10 ; GRB2-SH2 DOMAIN IN COMPLEX WITH CYCLO-[N-ALPHA-ACETYL-L-THI ALYSYL-O-PHOSPHOTYROSYL-VALYL-ASPARAGYL-VALYL-PROLYL] (PKF273-791) 1BMB ; 1.80 ; GRB2-SH2 DOMAIN IN COMPLEX WITH KPFYVNVEF (PKF270-974) 1GRJ ; 2.20 ; GREA TRANSCRIPT CLEAVAGE FACTOR FROM ESCHERICHIA COLI 1EMG ; 2.00 ; GREEN FLUORESCENT PROTEIN (65-67 REPLACED BY CRO, S65T SUBSTITUTION, Q80R) 1EMB ; 2.13 ; GREEN FLUORESCENT PROTEIN (GFP) FROM AEQUOREA VICTORIA, GLN 80 REPLACED WITH ARG 1EMA ; 1.90 ; GREEN FLUORESCENT PROTEIN FROM AEQUOREA VICTORIA 1EMC ; 2.30 ; GREEN FLUORESCENT PROTEIN FROM AEQUOREA VICTORIA, MUTANT 1EME ; 2.50 ; GREEN FLUORESCENT PROTEIN FROM AEQUOREA VICTORIA, MUTANT 1EMF ; 2.40 ; GREEN FLUORESCENT PROTEIN FROM AEQUOREA VICTORIA, MUTANT 1EMK ; 2.10 ; GREEN FLUORESCENT PROTEIN FROM AEQUOREA VICTORIA, MUTANT 1EML ; 2.30 ; GREEN FLUORESCENT PROTEIN FROM AEQUOREA VICTORIA, MUTANT 1EMM ; 2.30 ; GREEN FLUORESCENT PROTEIN FROM AEQUOREA VICTORIA, MUTANT 2EMD ; 2.00 ; GREEN FLUORESCENT PROTEIN FROM AEQUOREA VICTORIA, MUTANT 2EMN ; 2.30 ; GREEN FLUORESCENT PROTEIN FROM AEQUOREA VICTORIA, MUTANT 2EMO ; 2.60 ; GREEN FLUORESCENT PROTEIN FROM AEQUOREA VICTORIA, MUTANT 1B9C ; 2.40 ; GREEN FLUORESCENT PROTEIN MUTANT F99S, M153T AND V163A 1C4F ; 2.25 ; GREEN FLUORESCENT PROTEIN S65T AT PH 4.6 1LA1 ; 2.06 ; GRO-EL FRAGMENT (APICAL DOMAIN) COMPRISING RESIDUES 188-379 1SS8 ; 2.70 ; GROEL 1KID ; 1.70 ; GROEL (HSP60 CLASS) FRAGMENT (APICAL DOMAIN) COMPRISING RESIDUES 191-376, MUTANT WITH ALA 262 REPLACED WITH LEU AND ILE 267 REPLACED WITH MET 1JON ; 2.50 ; GROEL (HSP60 CLASS) FRAGMENT COMPRISING RESIDUES 191 - 345 1PF9 ; 2.99 ; GROEL-GROES-ADP 1SX4 ; 3.00 ; GROEL-GROES-ADP7 1SX3 ; 2.00 ; GROEL14-(ATPGAMMAS)14 1AF5 ; 3.00 ; GROUP I MOBILE INTRON ENDONUCLEASE 1BP7 ; 3.00 ; GROUP I MOBILE INTRON ENDONUCLEASE I-CREI COMPLEXED WITH HOMING SITE DEOXYRIBONUCLEIC ACID 1CJ1 ; 3.00 ; GROWTH FACTOR RECEPTOR BINDING PROTEIN SH2 DOMAIN (HUMAN) COMPLEXED WITH A PHOSPHOTYROSYL DERIVATIVE 1ZFP ; 1.80 ; GROWTH FACTOR RECEPTOR BINDING PROTEIN SH2 DOMAIN COMPLEXED WITH A PHOSPHOTYROSYL PENTAPEPTIDE 1QG1 ; -1.00 ; GROWTH FACTOR RECEPTOR BINDING PROTEIN SH2 DOMAIN COMPLEXED WITH AN SHC-DERIVED PEPTIDE 1IO6 ; -1.00 ; GROWTH FACTOR RECEPTOR-BOUND PROTEIN 2 (GRB2) C-TERMINAL SH3 DOMAIN COMPLEXED WITH A LIGAND PEPTIDE (NMR, MINIMIZED MEAN STRUCTURE) 1BQF ; -1.00 ; GROWTH-BLOCKING PEPTIDE (GBP) FROM PSEUDALETIA SEPARATA 1FGZ ; 2.05 ; GRP1 PH DOMAIN (UNLIGANDED) 1FGY ; 1.50 ; GRP1 PH DOMAIN WITH INS(1,3,4,5)P4 1AZT ; 2.30 ; GS-ALPHA COMPLEXED WITH GTP-GAMMA-S 1Q3W ; 2.30 ; GSK-3 BETA COMPLEXED WITH ALSTERPAULLONE 1PYX ; 2.40 ; GSK-3 BETA COMPLEXED WITH AMP-PNP 1Q41 ; 2.10 ; GSK-3 BETA COMPLEXED WITH INDIRUBIN-3'-MONOXIME 1Q4L ; 2.77 ; GSK-3 BETA COMPLEXED WITH INHIBITOR I-5 1Q3D ; 2.20 ; GSK-3 BETA COMPLEXED WITH STAUROSPORINE 1GTP ; 3.00 ; GTP CYCLOHYDROLASE I 1A9C ; 2.90 ; GTP CYCLOHYDROLASE I (C110S MUTANT) IN COMPLEX WITH GTP 1A8R ; 2.10 ; GTP CYCLOHYDROLASE I (H112S MUTANT) IN COMPLEX WITH GTP 1AS0 ; 2.00 ; GTP-GAMMA-S BOUND G42V GIA1 2BMJ ; 2.10 ; GTPASE LIKE DOMAIN OF CENTAURIN GAMMA 1 (HUMAN) 1RGP ; 2.00 ; GTPASE-ACTIVATION DOMAIN FROM RHOGAP 1MSY ; 1.41 ; GUAA TETRALOOP MUTANT OF SARCIN/RICIN DOMAIN FROM E. COLI 23 S RRNA 1P1B ; 2.80 ; GUANIDINOACETATE METHYLTRANSFERASE 1XCL ; 2.00 ; GUANIDINOACETATE METHYLTRANSFERASE CONTAINING S- ADENOSYLHOMOCYSTEINE AND GUANIDINE 1XCJ ; 2.00 ; GUANIDINOACETATE METHYLTRANSFERASE CONTAINING S- ADENOSYLHOMOCYSTEINE AND GUANIDINOACETATE 1P1C ; 2.50 ; GUANIDINOACETATE METHYLTRANSFERASE WITH GD ION 1D5T ; 1.04 ; GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR, ALPHA-ISOFORM 1GND ; 1.81 ; GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR, ALPHA-ISOFORM 1KI1 ; 2.30 ; GUANINE NUCLEOTIDE EXCHANGE REGION OF INTERSECTIN IN COMPLEX WITH CDC42 1U8D ; 1.95 ; GUANINE RIBOSWITCH BOUND TO HYPOXANTHINE 1NK7 ; 1.90 ; GUANINE-ADENINE MISMATCH AT THE POLYMERASE ACTIVE SITE 1NK4 ; 1.60 ; GUANINE-GUANINE MISMATCH AT THE POLYMERASE ACTIVE SITE 1NJW ; 1.90 ; GUANINE-THYMINE MISMATCH AT THE POLYMERASE ACTIVE SITE 1Z8F ; 2.50 ; GUANYLATE KINASE DOUBLE MUTANT A58C, T157C FROM MYCOBACTERIUM TUBERCULOSIS (RV1389) 1C4E ; -1.00 ; GURMARIN FROM GYMNEMA SYLVESTRE 1GUR ; -1.00 ; GURMARIN, A SWEET TASTE-SUPPRESSING POLYPEPTIDE, NMR, 10 STRUCTURES 1GYF ; -1.00 ; GYF DOMAIN FROM HUMAN CD2BP2 PROTEIN 1AM2 ; 2.20 ; GYRA INTEIN FROM MYCOBACTERIUM XENOPI 1GPB ; 1.90 ; Glycogen Phosphorylase B: Description of the Protein Structure 1HNR ; -1.00 ; H-NS (DEOXYRIBONUCLEIC ACID-BINDING DOMAIN) 1HNS ; -1.00 ; H-NS (DEOXYRIBONUCLEIC ACID-BINDING DOMAIN) 1NI8 ; -1.00 ; H-NS DIMERIZATION MOTIF 1P2S ; 2.45 ; H-RAS 166 IN 50% 2,2,2 TRIFLOUROETHANOL 1P2V ; 2.30 ; H-RAS 166 IN 60 % 1,6 HEXANEDIOL 1P2T ; 2.00 ; H-RAS 166 IN AQUEOUS MOTHER LIQOUR, RT 1CLU ; 1.70 ; H-RAS COMPLEXED WITH DIAMINOBENZOPHENONE-BETA,GAMMA-IMIDO- GTP 1RVD ; 1.90 ; H-RAS COMPLEXED WITH DIAMINOBENZOPHENONE-BETA,GAMMA-IMIDO- GTP 1P2U ; 2.00 ; H-RAS IN 50% ISOPROPANOL 1JAH ; 1.80 ; H-RAS P21 PROTEIN MUTANT G12P, COMPLEXED WITH GUANOSINE-5'-[BETA,GAMMA-METHYLENE] TRIPHOSPHATE AND MAGNESIUM 1JAI ; 1.80 ; H-RAS P21 PROTEIN MUTANT G12P, COMPLEXED WITH GUANOSINE-5'-[BETA,GAMMA-METHYLENE] TRIPHOSPHATE AND MANGANESE 1L3Q ; -1.00 ; H. RUFESCENS ABALONE SHELL LUSTRIN A CONSENSUS REPEAT, FPGKNVNCTSGE, PH 7.4, 1-H NMR STRUCTURE 1C9X ; 1.80 ; H119A VARIANT OF RIBONUCLEASE A 1H9N ; 1.85 ; H119N CARBONIC ANHYDRASE II 1H9Q ; 2.20 ; H119Q CARBONIC ANHYDRASE II 1C9V ; 1.70 ; H12A VARIANT OF RIBONUCLEASE A 1TS3 ; 2.00 ; H135A MUTANT OF TOXIC SHOCK SYNDROME TOXIN-1 FROM S. AUREUS 1TBJ ; 2.80 ; H141A MUTANT OF RAT LIVER ARGINASE I 1TA1 ; 2.50 ; H141C MUTANT OF RAT LIVER ARGINASE I 1TBH ; 2.70 ; H141D MUTANT OF RAT LIVER ARGINASE I 1TBL ; 3.10 ; H141N MUTANT OF RAT LIVER ARGINASE I 1GN4 ; 2.50 ; H145E MUTANT OF MYCOBACTERIUM TUBERCULOSIS IRON-SUPEROXIDE DISMUTASE. 1GN3 ; 4.00 ; H145Q MUTANT OF MYCOBACTERIUM TUBERCULOSIS IRON-SUPEROXIDE DISMUTASE. 1HSE ; 2.20 ; H253M N TERMINAL LOBE OF HUMAN LACTOFERRIN 1B4T ; 1.80 ; H48C YEAST CU(II)/ZN SUPEROXIDE DISMUTASE ROOM TEMPERATURE (298K) STRUCTURE 1P2E ; 2.20 ; H61A MUTANT OF FLAVOCYTOCHROME C3 1P2H ; 2.10 ; H61M MUTANT OF FLAVOCYTOCHROME C3 1BJE ; 1.80 ; H64T VARIANT OF MYOGLOBIN (HORSE HEART) RECOMBINANT WILD-TYPE COMPLEXED WITH AZIDE 1TI8 ; 3.00 ; H7 HAEMAGGLUTININ 1AUW ; 2.50 ; H91N DELTA 2 CRYSTALLIN FROM DUCK 2H4N ; 1.90 ; H94N CARBONIC ANHYDRASE II COMPLEXED WITH ACETAZOLAMIDE 1H4N ; 2.00 ; H94N CARBONIC ANHYDRASE II COMPLEXED WITH TRIS 1S89 ; 2.22 ; H98N MUTANT OF METHYLGLYOXAL SYNTHASE FROM E. COLI COMPLEXED WITH PHOSPHOGLYCOLIC ACID 1S8A ; 2.20 ; H98Q MUTANT OF METHYLGLYOXAL SYNTHASE FROM E. COLI COMPLEXED WITH PHOSPHOGLYCOLIC ACID 1YMQ ; 1.90 ; HAD SUPERFAMILY PHOSPHOTRANSFERASE SUBSTRATE DIVERSIFICATION: STRUCTURE AND FUNCTION ANALYSIS OF THE HAD SUBCLASS IIB SUGAR PHOSPHATASE BT4131 1D9V ; 1.75 ; HAEMOPHILUS INFLUENZAE FERRIC-BINDING PROTEIN APO FORM 1IT3 ; 2.10 ; HAGFISH CO LIGAND HEMOGLOBIN 1IT2 ; 1.60 ; HAGFISH DEOXY HEMOGLOBIN 2HGF ; -1.00 ; HAIRPIN LOOP CONTAINING DOMAIN OF HEPATOCYTE GROWTH FACTOR, NMR, MINIMIZED AVERAGE STRUCTURE 1BJH ; -1.00 ; HAIRPIN LOOPS CONSISTING OF SINGLE ADENINE RESIDUES CLOSED BY SHEARED A(DOT)A AND G(DOT)G PAIRS FORMED BY THE DEOXYRIBONUCLEIC ACID TRIPLETS AAA AND GAG: SOLUTION STRUCTURE OF THE D(GTACAAAGTAC) HAIRPIN, NMR, 16 STRUCTURES 1JBF ; -1.00 ; HAIRPIN PEPTIDE THAT INHIBITS IGE ACTIVITY BY BINDING TO THE HIGH AFFINITY IGE RECEPTOR 1ATV ; -1.00 ; HAIRPIN WITH AGAA TETRALOOP, NMR, 4 STRUCTURES 1ATW ; -1.00 ; HAIRPIN WITH AGAU TETRALOOP, NMR, 3 STRUCTURES 1HVW ; -1.00 ; HAIRPINLESS MUTANT OF OMEGA-ATRACOTOXIN-HV1A 1T3P ; 1.60 ; HALF-SANDWICH ARENE RUTHENIUM(II)-ENZYME COMPLEX 1BE0 ; 1.96 ; HALOALKANE DEHALOGENASE AT PH 5.0 CONTAINING ACETIC ACID 1B6G ; 1.15 ; HALOALKANE DEHALOGENASE AT PH 5.0 CONTAINING CHLORIDE 1BN6 ; 1.50 ; HALOALKANE DEHALOGENASE FROM A RHODOCOCCUS SPECIES 1BN7 ; 1.50 ; HALOALKANE DEHALOGENASE FROM A RHODOCOCCUS SPECIES 1HDE ; 2.70 ; HALOALKANE DEHALOGENASE MUTANT WITH PHE 172 REPLACED WITH TRP 1BEE ; 2.60 ; HALOALKANE DEHALOGENASE MUTANT WITH TRP 175 REPLACED BY TYR 1BEZ ; 2.10 ; HALOALKANE DEHALOGENASE MUTANT WITH TRP 175 REPLACED BY TYR AT PH 5 1CIJ ; 2.30 ; HALOALKANE DEHALOGENASE SOAKED WITH HIGH CONCENTRATION OF BROMIDE 1E12 ; 1.80 ; HALORHODOPSIN, A LIGHT-DRIVEN CHLORIDE PUMP 1HMH ; 2.60 ; HAMMERHEAD RIBONUCLEIC ACID/DEOXYRIBONUCLEIC ACID/COMPLEX 1Q29 ; 3.00 ; HAMMERHEAD RIBOZYME WITH 5'-5' G-G LINKAGE: CONFORMATIONAL CHANGE EXPERIMENT 1D2D ; -1.00 ; HAMSTER EPRS SECOND REPEATED ELEMENT; NMR, 15 STRUCTURES 1YGH ; 1.90 ; HAT DOMAIN OF GCN5 FROM SACCHAROMYCES CEREVISIAE 1NB4 ; 2.00 ; HC-J4 RIBONUCLEIC ACID POLYMERASE APO-FORM 1NB7 ; 2.90 ; HC-J4 RIBONUCLEIC ACID POLYMERASE COMPLEXED WITH SHORT RIBONUCLEIC ACID TEMPLATE STRAND 1NB6 ; 2.60 ; HC-J4 RIBONUCLEIC ACID POLYMERASE COMPLEXED WITH UTP 1JQ7 ; 3.00 ; HCMV PROTEASE DIMER-INTERFACE MUTANT, S225Y COMPLEXED TO INHIBITOR BILC 408 2WPO ; 2.70 ; HCMV PROTEASE INHIBITOR COMPLEX 1Q43 ; 2.00 ; HCN2I 443-640 IN THE PRESENCE OF CAMP, SELENOMETHIONINE DERIVATIVE 1Q5O ; 2.30 ; HCN2J 443-645 IN THE PRESENCE OF CAMP, SELENOMETHIONINE DERIVATIVE 1Q3E ; 1.90 ; HCN2J 443-645 IN THE PRESENCE OF CGMP 1A1R ; 2.50 ; HCV NS3 PROTEASE DOMAIN:NS4A PEPTIDE COMPLEX 1P84 ; 2.50 ; HDBT INHIBITED YEAST CYTOCHROME BC1 COMPLEX 1BG8 ; 2.20 ; HDEA FROM ESCHERICHIA COLI 1QMS ; -1.00 ; HEAD-TO-TAIL DIMER OF CALICHEAMICIN GAMMA-1-I OLIGOSACCHARIDE BOUND TO DEOXYRIBONUCLEIC ACID DUPLEX, NMR, 9 STRUCTURES 1DM9 ; 2.00 ; HEAT SHOCK PROTEIN 15 KD 3HSF ; -1.00 ; HEAT SHOCK TRANSCRIPTION FACTOR (HSF) 1FBU ; 2.00 ; HEAT SHOCK TRANSCRIPTION FACTOR DEOXYRIBONUCLEIC ACID BINDING DOMAIN 1FBS ; 2.00 ; HEAT SHOCK TRANSCRIPTION FACTOR DEOXYRIBONUCLEIC ACID BINDING DOMAIN CONTAINING THE P237A MUTATION 1FBQ ; 2.00 ; HEAT SHOCK TRANSCRIPTION FACTOR DEOXYRIBONUCLEIC ACID BINDING DOMAIN CONTAINING THE P237K MUTATION 3HTS ; 1.75 ; HEAT SHOCK TRANSCRIPTION FACTOR/DEOXYRIBONUCLEIC ACID COMPLEX 1LTI ; 2.13 ; HEAT-LABILE ENTEROTOXIN (LT-I) COMPLEX WITH T-ANTIGEN 1EEF ; 1.80 ; HEAT-LABILE ENTEROTOXIN B-PENTAMER COMPLEXED WITH BOUND LIGAND PEPG 1DJR ; 1.30 ; HEAT-LABILE ENTEROTOXIN B-PENTAMER COMPLEXED WITH M- CARBOXYPHENYL-ALPHA-D-GALACTOSE 1LT6 ; 2.20 ; HEAT-LABILE ENTEROTOXIN B-PENTAMER COMPLEXED WITH METANITROPHENYLGALACTOSIDE 1PZI ; 1.99 ; HEAT-LABILE ENTEROTOXIN B-PENTAMER COMPLEXED WITH NITROPHENYL GALACTOSIDE 2A 1EFI ; 1.60 ; HEAT-LABILE ENTEROTOXIN B-PENTAMER COMPLEXED WITH PARA- AMINOPHENYL-ALPHA-D-GALACTOPYRANOSIDE 1LT5 ; 1.70 ; HEAT-LABILE ENTEROTOXIN B-PENTAMER COMPLEXED WITH THIODIGALACTOSIDE 1FD7 ; 1.80 ; HEAT-LABILE ENTEROTOXIN B-PENTAMER WITH BOUND LIGAND BMSC001 1JQY ; 2.14 ; HEAT-LABILE ENTEROTOXIN B-PENTAMER WITH LIGAND BMSC-0010 1LT3 ; 2.00 ; HEAT-LABILE ENTEROTOXIN DOUBLE MUTANT N40C/G166C 1LT4 ; 2.00 ; HEAT-LABILE ENTEROTOXIN MUTANT S63K 1HJO ; 2.30 ; HEAT-SHOCK 70KD PROTEIN 42KD ATPASE N-TERMINAL DOMAIN 1BA0 ; 1.90 ; HEAT-SHOCK COGNATE 70KD PROTEIN 44KD ATPASE N-TERMINAL 1NGE 3 1BA1 ; 1.70 ; HEAT-SHOCK COGNATE 70KD PROTEIN 44KD ATPASE N-TERMINAL MUTANT WITH CYS 17 REPLACED BY LYS 1XCE ; -1.00 ; HELICA STRUCTURE OF DEOXYRIBONUCLEIC ACID BY DESIGN: THE T(GGGG)T HEXAD ALIGNMENT 1DLB ; 2.00 ; HELICAL INTERACTIONS IN THE HIV-1 GP41 CORE REVEALS STRUCTURAL BASIS FOR THE INHIBITORY ACTIVITY OF GP41 PEPTIDES 1BDE ; -1.00 ; HELICAL STRUCTURE OF POLYPEPTIDES FROM THE C-TERMINAL HALF OF HIV-1 VPR, NMR, 20 STRUCTURES 2PJR ; 2.90 ; HELICASE PRODUCT COMPLEX 3PJR ; 3.30 ; HELICASE SUBSTRATE COMPLEX 1OUV ; 2.00 ; HELICOBACTER CYSTEINE RICH PROTEIN C (HCPC) 1KLX ; 1.95 ; HELICOBACTER PYLORI CYSTEINE RICH PROTEIN B (HCPB) 1WTT ; -1.00 ; HELIX 45 (16S RRNA) FROM B. STEAROTHERMOPHILUS, NMR, 11 STRUCTURES 1WTS ; -1.00 ; HELIX 45 (16S RRNA) FROM B. STEAROTHERMOPHILUS, NMR, MINIMIZED AVERAGE STRUCTURE 1FDF ; -1.00 ; HELIX 7 BOVINE RHODOPSIN 1NUB ; 2.80 ; HELIX C DELETION MUTANT OF BM-40 FS-EC DOMAIN PAIR 1CE9 ; 1.80 ; HELIX CAPPING IN THE GCN4 LEUCINE ZIPPER 1VRZ ; 1.05 ; HELIX TURN HELIX MOTIF 1EM7 ; 2.00 ; HELIX VARIANT OF THE B1 DOMAIN FROM STREPTOCOCCAL PROTEIN G 1PCG ; 2.70 ; HELIX-STABILIZED CYCLIC PEPTIDES AS SELECTIVE INHIBITORS OF STEROID RECEPTOR-COACTIVATOR INTERACTIONS 1HA0 ; 2.80 ; HEMAGGLUTININ PRECURSOR HA0 3ATJ ; 2.20 ; HEME LIGAND MUTANT OF RECOMBINANT HORSERADISH PEROXIDASE IN COMPLEX WITH BENZHYDROXAMIC ACID 1B2V ; 1.90 ; HEME-BINDING PROTEIN A 1UVY ; 2.40 ; HEME-LIGAND TUNNELING IN GROUP I TRUNCATED HEMOGLOBINS 1UVX ; 2.45 ; HEME-LIGAND TUNNELING ON GROUP I TRUNCATED HEMOGLOBINS 1BVB ; 2.60 ; HEME-PACKING MOTIFS REVEALED BY THE CRYSTAL STRUCTURE OF CYTOCHROME C554 FROM NITROSOMONAS EUROPAEA 1JRS ; 1.80 ; HEMIACETAL COMPLEX BETWEEN LEUPEPTIN AND TRYPSIN 1JRT ; 1.80 ; HEMIACETAL COMPLEX BETWEEN LEUPEPTIN AND TRYPSIN 1Z5X ; 3.07 ; HEMIPTERAN ECDYSONE RECEPTOR LIGAND-BINDING DOMAIN COMPLEXED WITH PONASTERONE A 1NV9 ; 2.36 ; HEMK, APO STRUCTURE 1DE4 ; 2.80 ; HEMOCHROMATOSIS PROTEIN HFE COMPLEXED WITH TRANSFERRIN RECEPTOR 1BZ1 ; 1.59 ; HEMOGLOBIN (ALPHA + MET) VARIANT 1BZZ ; 1.59 ; HEMOGLOBIN (ALPHA V1M) MUTANT 1A0U ; 2.14 ; HEMOGLOBIN (VAL BETA1 MET) MUTANT 1A0Z ; 2.00 ; HEMOGLOBIN (VAL BETA1 MET) MUTANT 1A01 ; 1.80 ; HEMOGLOBIN (VAL BETA1 MET, TRP BETA37 ALA) MUTANT 1A00 ; 2.00 ; HEMOGLOBIN (VAL BETA1 MET, TRP BETA37 TYR) MUTANT 1BZ0 ; 1.50 ; HEMOGLOBIN A (HUMAN, DEOXY, HIGH SALT) 1X9F ; 2.60 ; HEMOGLOBIN DODECAMER FROM LUMBRICUS ERYTHROCRUORIN 1EBT ; 1.90 ; HEMOGLOBIN I FROM THE CLAM LUCINA PECTINATA BOUND WITH CYANIDE 1B0B ; 1.43 ; HEMOGLOBIN I FROM THE CLAM LUCINA PECTINATA, CYANIDE COMPLEX AT 100 KELVIN 1W3G ; 2.68 ; HEMOLYTIC LECTIN FROM THE MUSHROOM LAETIPORUS SULPHUREUS COMPLEXED WITH TWO N-ACETYLLACTOSAMINE MOLECULES. 1FLQ ; 1.80 ; HEN EGG WHITE LYSOZYME MUTANT WITH ALANINE SUBSTITUTED FOR GLYCINE 1FLU ; 1.78 ; HEN EGG WHITE LYSOZYME MUTANT WITH ALANINE SUBSTITUTED FOR GLYCINE 1FLW ; 1.81 ; HEN EGG WHITE LYSOZYME MUTANT WITH ALANINE SUBSTITUTED FOR GLYCINE 1FLY ; 1.83 ; HEN EGG WHITE LYSOZYME MUTANT WITH ALANINE SUBSTITUTED FOR GLYCINE 1FN5 ; 1.78 ; HEN EGG WHITE LYSOZYME MUTANT WITH ALANINE SUBSTITUTED FOR GLYCINE 1LKS ; 1.10 ; HEN EGG WHITE LYSOZYME NITRATE 1AT6 ; 1.80 ; HEN EGG WHITE LYSOZYME WITH A ISOASPARTATE RESIDUE 1AT5 ; 1.80 ; HEN EGG WHITE LYSOZYME WITH A SUCCINIMIDE RESIDUE 1A2Y ; 1.50 ; HEN EGG WHITE LYSOZYME, D18A MUTANT, IN COMPLEX WITH MOUSE MONOCLONAL ANTIBODY D1.3 1UCO ; 2.00 ; HEN EGG-WHITE LYSOZYME, LOW HUMIDITY FORM 1KMX ; -1.00 ; HEPARIN-BINDING DOMAIN FROM VASCULAR ENDOTHELIAL GROWTH FACTOR 1VGH ; -1.00 ; HEPARIN-BINDING DOMAIN FROM VASCULAR ENDOTHELIAL GROWTH FACTOR, NMR, 20 STRUCTURES 2VGH ; -1.00 ; HEPARIN-BINDING DOMAIN FROM VASCULAR ENDOTHELIAL GROWTH FACTOR, NMR, MINIMIZED AVERAGE STRUCTURE 1AXM ; 3.00 ; HEPARIN-LINKED BIOLOGICALLY-ACTIVE DIMER OF FIBROBLAST GROWTH FACTOR 2AXM ; 3.00 ; HEPARIN-LINKED BIOLOGICALLY-ACTIVE DIMER OF FIBROBLAST GROWTH FACTOR 1HAV ; 2.00 ; HEPATITIS A VIRUS 3C PROTEINASE 1A1V ; 2.20 ; HEPATITIS C VIRUS NS3 HELICASE DOMAIN COMPLEXED WITH SINGLE STRANDED DEOXYRIBONUCLEIC ACID 1A1Q ; 2.40 ; HEPATITIS C VIRUS NS3 PROTEINASE 1C2P ; 1.90 ; HEPATITIS C VIRUS NS5B RIBONUCLEIC ACID-DEPENDENT RIBONUCLEIC ACID POLYMERASE 1YVF ; 2.50 ; HEPATITIS C VIRUS NS5B RIBONUCLEIC ACID-DEPENDENT RIBONUCLEIC ACID POLYMERASE COMPLEX WITH INHIBITOR PHA-00729145 1Z4U ; 2.80 ; HEPATITIS C VIRUS NS5B RIBONUCLEIC ACID-DEPENDENT RIBONUCLEIC ACID POLYMERASE COMPLEX WITH INHIBITOR PHA-00799585 1YUY ; 1.90 ; HEPATITIS C VIRUS NS5B RIBONUCLEIC ACID-DEPENDENT RIBONUCLEIC ACID POLYMERASE GENOTYPE 2A 1YV2 ; 2.50 ; HEPATITIS C VIRUS NS5B RIBONUCLEIC ACID-DEPENDENT RIBONUCLEIC ACID POLYMERASE GENOTYPE 2A 1YVX ; 2.00 ; HEPATITIS C VIRUS RIBONUCLEIC ACID POLYMERASE GENOTYPE 2A IN COMPLEX WITH NON- NUCLEOSIDE ANALOGUE INHIBITOR 1YVZ ; 2.20 ; HEPATITIS C VIRUS RIBONUCLEIC ACID POLYMERASE GENOTYPE 2A IN COMPLEX WITH NON- NUCLEOSIDE ANALOGUE INHIBITOR 1GX5 ; 1.70 ; HEPATITIS C VIRUS RIBONUCLEIC ACID POLYMERASE IN COMPLEX WITH GTP AND MANGANESE 1NHU ; 2.00 ; HEPATITIS C VIRUS RIBONUCLEIC ACID POLYMERASE IN COMPLEX WITH NON- NUCLEOSIDE ANALOGUE INHIBITOR 1NHV ; 2.90 ; HEPATITIS C VIRUS RIBONUCLEIC ACID POLYMERASE IN COMPLEX WITH NON- NUCLEOSIDE ANALOGUE INHIBITOR 1GX6 ; 1.85 ; HEPATITIS C VIRUS RIBONUCLEIC ACID POLYMERASE IN COMPLEX WITH UTP AND MANGANESE 1SJ3 ; 2.20 ; HEPATITIS DELTA VIRUS GEMONIC RIBOZYME PRECURSOR, WITH MG2+ BOUND 1CX0 ; 2.30 ; HEPATITIS DELTA VIRUS RIBOZYME 1IC8 ; 2.60 ; HEPATOCYTE NUCLEAR FACTOR 1A BOUND TO DEOXYRIBONUCLEIC ACID : MODY3 GENE PRODUCT 1LV2 ; 2.70 ; HEPATOCYTE NUCLEAR FACTOR 4 IS A TRANSCRIPTION FACTOR THAT CONSTITUTIVELY BINDS FATTY ACIDS 1JBM ; 1.85 ; HEPTAMERIC CRYSTAL STRUCTURE OF MTH649, AN SM-LIKE ARCHAEAL PROTEIN FROM METHANOBACTERIUM THERMAUTOTROPHICUM 1HAE ; -1.00 ; HEREGULIN-ALPHA EPIDERMAL GROWTH FACTOR-LIKE DOMAIN, NMR, 20 STRUCTURES 1HAF ; -1.00 ; HEREGULIN-ALPHA EPIDERMAL GROWTH FACTOR-LIKE DOMAIN, NMR, MINIMIZED AVERAGE STRUCTURE 2KI5 ; 1.90 ; HERPES SIMPLEX TYPE-1 THYMIDINE KINASE IN COMPLEX WITH THE DRUG ACICLOVIR AT 1.9A RESOLUTION 1AT3 ; 2.50 ; HERPES SIMPLEX VIRUS TYPE II PROTEASE 1QHI ; 1.90 ; HERPES SIMPLEX VIRUS TYPE-I THYMIDINE KINASE COMPLEXED WITH A NOVEL NON-SUBSTRATE INHIBITOR, 9-(4-HYDROXYBUTYL)-N2- PHENYLGUANINE 1PK1 ; 1.80 ; HETERO SAM DOMAIN STRUCTURE OF PH AND SCM. 1RSO ; -1.00 ; HETERO-TETRAMERIC L27 (LIN-2, LIN-7) DOMAIN COMPLEXES AS ORGANIZATION PLATFORMS OF SUPRA-MOLECULAR ASSEMBLIES 1G05 ; 2.45 ; HETEROCYCLE-BASED MMP INHIBITOR WITH P2'SUBSTITUENTS 1U9H ; 2.17 ; HETEROCYCLIC PEPTIDE BACKBONE MODIFICATION IN GCN4-PLI BASED COILED COILS: REPLACEMENT OF E(22)L(23) 1U9F ; 2.20 ; HETEROCYCLIC PEPTIDE BACKBONE MODIFICATION IN GCN4-PLI BASED COILED COILS: REPLACEMENT OF K(15)L(16) 1U9G ; 2.20 ; HETEROCYCLIC PEPTIDE BACKBONE MODIFICATION IN GCN4-PLI BASED COILED COILS: REPLACEMENT OF K(8)L(9) 1JK9 ; 2.90 ; HETERODIMER BETWEEN H48F-YSOD1 AND YCCS 1OEY ; 2.00 ; HETERODIMER OF P40PHOX AND P67PHOX PB1 DOMAINS FROM HUMAN NADPH OXIDASE 1ZT2 ; 3.33 ; HETERODIMERIC STRUCTURE OF THE CORE PRIMASE. 1K1H ; -1.00 ; HETERODUPLEX OF CHIRALLY PURE METHYLPHOSPHONATE/DEOXYRIBONUCLEIC ACID DUPLEX 1K1R ; -1.00 ; HETERODUPLEX OF CHIRALLY PURE R-METHYLPHOSPHONATE/DEOXYRIBONUCLEIC ACID DUPLEX 1TXP ; -1.00 ; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN (HNRNP) C OLIGOMERIZATION DOMAIN TETRAMER 1HD0 ; -1.00 ; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN D0 (HNRNP D0 RBD1), NMR 1HD1 ; -1.00 ; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN D0 (HNRNP D0 RBD1), NMR 1XOF ; 1.95 ; HETEROOLIGOMERIC BETA BETA ALPHA MINIPROTEIN 1GOT ; 2.00 ; HETEROTRIMERIC COMPLEX OF A GT-ALPHA/GI-ALPHA CHIMERA AND THE GT-BETA-GAMMA SUBUNITS 1A0R ; 2.80 ; HETEROTRIMERIC COMPLEX OF PHOSDUCIN/TRANSDUCIN BETA-GAMMA 1LLO ; 1.85 ; HEVAMINE A (A PLANT ENDOCHITINASE/LYSOZYME) COMPLEXED WITH ALLOSAMIDIN 2HVM ; 1.80 ; HEVAMINE A AT 1.8 ANGSTROM RESOLUTION 1KR1 ; 2.00 ; HEVAMINE MUTANT D125A/E127A IN COMPLEX WITH TETRA-NAG 1KQY ; 1.92 ; HEVAMINE MUTANT D125A/E127A/Y183F IN COMPLEX WITH PENTA-NAG 1KQZ ; 1.92 ; HEVAMINE MUTANT D125A/E127A/Y183F IN COMPLEX WITH TETRA-NAG 1KR0 ; 1.92 ; HEVAMINE MUTANT D125A/Y183F IN COMPLEX WITH TETRA-NAG 1LPI ; 2.00 ; HEW LYSOZYME: TRP...NA CATION-PI INTERACTION 2BLY ; 1.40 ; HEWL AFTER A HIGH DOSE X-RAY "BURN" 2BLX ; 1.40 ; HEWL BEFORE A HIGH DOSE X-RAY "BURN" 1GWS ; 2.42 ; HEXADECAHEME HIGH MOLECULAR WEIGHT CYTOCHROME HMC FROM DESULFOVIBRIO VULGARIS HILDENBOROUGH 1OLO ; 2.55 ; HEXAMERIC REPLICATIVE DEOXYRIBONUCLEIC ACID HELICASE REPA FROM PLASMID RSF1010 - CUBIC CRYSTAL STRUCTURE 1BDG ; 2.60 ; HEXOKINASE FROM SCHISTOSOMA MANSONI COMPLEXED WITH GLUCOSE 1A6Z ; 2.60 ; HFE (HUMAN) HEMOCHROMATOSIS PROTEIN 1U1T ; 1.90 ; HFQ PROTEIN FROM PSEUDOMONAS AERUGINOSA. HIGH-SALT CRYSTALS 1U1S ; 1.60 ; HFQ PROTEIN FROM PSEUDOMONAS AERUGINOSA. LOW-SALT CRYSTALS 1QML ; 3.00 ; HG COMPLEX OF YEAST 5-AMINOLAEVULINIC ACID DEHYDRATASE 1DHG ; 2.50 ; HG-SUBSTITUTED DESULFOREDOXIN 2C7R ; 1.90 ; HHAI DEOXYRIBONUCLEIC ACID METHYLTRANSFERASE (T250G MUTANT) COMPLEX WITH OLIGONUCLEOTIDE CONTAINING 2-AMINOPURINE AS A TARGET BASE (GPGC:GMGC) AND SAH 2C7O ; 1.90 ; HHAI DEOXYRIBONUCLEIC ACID METHYLTRANSFERASE COMPLEX WITH 13MER OLIGONUCLEOTIDE CONTAINING 2-AMINOPURINE ADJACENT TO THE TARGET BASE (PCGC:GMGC) AND SAH 2C7P ; 1.70 ; HHAI DEOXYRIBONUCLEIC ACID METHYLTRANSFERASE COMPLEX WITH OLIGONUCLEOTIDE CONTAINING 2-AMINOPURINE OPPOSITE TO THE TARGET BASE ( GCGC:GMPC) AND SAH 2C7Q ; 1.85 ; HHAI DEOXYRIBONUCLEIC ACID METHYLTRANSFERASE COMPLEX WITH OLIGONUCLEOTIDE CONTAINING 2-AMINOPURINE OUTSIDE THE RECOGNITION SEQUENCE (PAIRED WITH G) AND SAH 1SKM ; 2.20 ; HHAI METHYLTRANSFERASE IN COMPLEX WITH DEOXYRIBONUCLEIC ACID CONTAINING AN ABASIC SOUTH CARBOCYCLIC SUGAR AT ITS TARGET SITE 1QZE ; -1.00 ; HHR23A PROTEIN STRUCTURE BASED ON RESIDUAL DIPOLAR COUPLING DATA 1UZV ; 1.00 ; HIGH AFFINITY FUCOSE BINDING OF PSEUDOMONAS AERUGINOSA LECTIN II: 1.0 A CRYSTAL STRUCTURE OF THE COMPLEX 1RPQ ; 3.00 ; HIGH AFFINITY IGE RECEPTOR (ALPHA CHAIN) COMPLEXED WITH TIGHT-BINDING E131 'ZETA' PEPTIDE FROM PHAGE DISPLAY 1W6Z ; 1.65 ; HIGH ENERGY TETRAGONAL LYSOZYME X-RAY STRUCTURE 1TIO ; 1.93 ; HIGH PACKING DENSITY FORM OF BOVINE BETA-TRYPSIN IN CYCLOHEXANE 1NEH ; -1.00 ; HIGH POTENTIAL IRON-SULFUR PROTEIN 2LEU ; -1.00 ; HIGH RESOLUTION 1H NMR STUDY OF LEUCOCIN A IN 90% AQUEOUS TRIFLUOROETHANOL (TFE) (0.1% TFA), 18 STRUCTURES 3LEU ; -1.00 ; HIGH RESOLUTION 1H NMR STUDY OF LEUCOCIN A IN DODECYLPHOSPHOCHOLINE MICELLES, 19 STRUCTURES (1:40 RATIO OF LEUCOCIN A:DPC) (0.1% TFA) 440D ; 1.10 ; HIGH RESOLUTION A-DEOXYRIBONUCLEIC ACID CRYSTAL STRYCTURES OF D(AGGGGCCCCT): AN A-DEOXYRIBONUCLEIC ACID MODEL OF POLY(DG).POLY(DC) 441D ; 1.50 ; HIGH RESOLUTION A-DEOXYRIBONUCLEIC ACID CRYSTAL STRYCTURES OF D(AGGGGCCCCT): AN A-DEOXYRIBONUCLEIC ACID MODEL OF POLY(DG).POLY(DC) 1ME4 ; 1.20 ; HIGH RESOLUTION CRYSTAL STRUCTURE ANALYSIS OF CRUZAIN NON- COVALENTLY BOUND TO A HYDROXYMETHYL KETONE INHIBITOR (I) 1ME3 ; 1.20 ; HIGH RESOLUTION CRYSTAL STRUCTURE ANALYSIS OF CRUZAIN NON- COVALENTLY BOUND TO A HYDROXYMETHYL KETONE INHIBITOR (II) 4TSV ; 1.80 ; HIGH RESOLUTION CRYSTAL STRUCTURE OF A HUMAN TNF-ALPHA MUTANT 5TSW ; 2.50 ; HIGH RESOLUTION CRYSTAL STRUCTURE OF A HUMAN TNF-ALPHA MUTANT 1B4K ; 1.67 ; HIGH RESOLUTION CRYSTAL STRUCTURE OF A MG2-DEPENDENT 5- AMINOLEVULINIC ACID DEHYDRATASE 1GT9 ; 1.38 ; HIGH RESOLUTION CRYSTAL STRUCTURE OF A THERMOSTABLE SERINE-CARBOXYL TYPE PROTEINASE, KUMAMOLISIN (KSCP) 1TUX ; 1.80 ; HIGH RESOLUTION CRYSTAL STRUCTURE OF A THERMOSTABLE XYLANASE FROM THERMOASCUS AURANTIACUS 1PW9 ; 1.60 ; HIGH RESOLUTION CRYSTAL STRUCTURE OF AN ACTIVE RECOMBINANT FRAGMENT OF HUMAN LUNG SURFACTANT PROTEIN D 1PWB ; 1.40 ; HIGH RESOLUTION CRYSTAL STRUCTURE OF AN ACTIVE RECOMBINANT FRAGMENT OF HUMAN LUNG SURFACTANT PROTEIN D WITH MALTOSE 1XDN ; 1.20 ; HIGH RESOLUTION CRYSTAL STRUCTURE OF AN EDITOSOME ENZYME FROM TRYPANOSOMA BRUCEI: RIBONUCLEIC ACID EDITING LIGASE 1 1I71 ; 1.45 ; HIGH RESOLUTION CRYSTAL STRUCTURE OF APOLIPOPROTEIN(A) KRINGLE IV TYPE 7: INSIGHTS INTO LIGAND BINDING 1TLO ; 1.90 ; HIGH RESOLUTION CRYSTAL STRUCTURE OF CALPAIN I PROTEASE CORE IN COMPLEX WITH E64 1TL9 ; 1.80 ; HIGH RESOLUTION CRYSTAL STRUCTURE OF CALPAIN I PROTEASE CORE IN COMPLEX WITH LEUPEPTIN 1R6B ; 2.25 ; HIGH RESOLUTION CRYSTAL STRUCTURE OF CLPA 1G9V ; 1.85 ; HIGH RESOLUTION CRYSTAL STRUCTURE OF DEOXY HEMOGLOBIN COMPLEXED WITH A POTENT ALLOSTERIC EFFECTOR 1EP0 ; 1.50 ; HIGH RESOLUTION CRYSTAL STRUCTURE OF DTDP-6-DEOXY-D-XYLO-4- HEXULOSE 3,5-EPIMERASE FROM METHANOBACTERIUM THERMOAUTOTROPHICUM 1XEN ; 1.85 ; HIGH RESOLUTION CRYSTAL STRUCTURE OF ESCHERICHIA COLI IRON- PEPTIDE DEFORMYLASE BOUND TO FORMATE 1XEM ; 1.76 ; HIGH RESOLUTION CRYSTAL STRUCTURE OF ESCHERICHIA COLI ZINC- PEPTIDE DEFORMYLASE BOUND TO FORMATE 1HKM ; 2.55 ; HIGH RESOLUTION CRYSTAL STRUCTURE OF HUMAN CHITINASE IN COMPLEX WITH DEMETHYLALLOSAMIDIN 1WMS ; 1.25 ; HIGH RESOLUTION CRYSTAL STRUCTURE OF HUMAN RAB9 GTPASE: A NOVEL ANTIVIRAL DRUG TARGET 1PEW ; 1.60 ; HIGH RESOLUTION CRYSTAL STRUCTURE OF JTO2, A MUTANT OF THE NON-AMYLOIDOGENIC LAMBA6 LIGHT CHAIN, JTO 1OGX ; 2.00 ; HIGH RESOLUTION CRYSTAL STRUCTURE OF KETOSTEROID ISOMERASE MUTANT D40N(D38N, TI NUMBERING) FROM PSEUDOMONAS PUTIDA COMPLEXED WITH EQUILENIN AT 2.0 A RESOLUTION. 1GCY ; 1.60 ; HIGH RESOLUTION CRYSTAL STRUCTURE OF MALTOTETRAOSE-FORMING EXO-AMYLASE 1YYD ; 1.45 ; HIGH RESOLUTION CRYSTAL STRUCTURE OF MANGANESE PEROXIDASE 1MD6 ; 1.60 ; HIGH RESOLUTION CRYSTAL STRUCTURE OF MURINE IL-1F5 REVEALS UNIQUE LOOP CONFORMATION FOR SPECIFICITY 1T1G ; 1.18 ; HIGH RESOLUTION CRYSTAL STRUCTURE OF MUTANT E23A OF KUMAMOLISIN, A SEDOLISIN TYPE PROTEINASE (PREVIOUSLY CALLED KUMAMOLYSIN OR KSCP) 1T1I ; 1.28 ; HIGH RESOLUTION CRYSTAL STRUCTURE OF MUTANT W129A OF KUMAMOLISIN, A SEDOLISIN TYPE PROTEINASE (PREVIOUSLY CALLED KUMAMOLYSIN OR KSCP) 1XF6 ; 1.10 ; HIGH RESOLUTION CRYSTAL STRUCTURE OF PHYCOERYTHRIN 545 FROM THE MARINE CRYPTOPHYTE RHODOMONAS CS24 1XG0 ; 0.97 ; HIGH RESOLUTION CRYSTAL STRUCTURE OF PHYCOERYTHRIN 545 FROM THE MARINE CRYPTOPHYTE RHODOMONAS CS24 1GS3 ; 2.10 ; HIGH RESOLUTION CRYSTAL STRUCTURE OF PI DELTA-5-3-KETOSTEROID ISOMERASE MUTANTS Y30F/Y55F/Y115F/ D38N (Y32F/Y57F/Y119F/D40N, PI NUMBERING)COMPLEXED WITH EQUILENIN AT 2.1 A RESOLUTION 1QG5 ; 2.00 ; HIGH RESOLUTION CRYSTAL STRUCTURE OF THE BOVINE BETA- LACTOGLOBULIN (ISOFORM A) 1B8E ; 1.95 ; HIGH RESOLUTION CRYSTAL STRUCTURE OF THE BOVINE BETA- LACTOGLOBULIN (ISOFORMS A AND B) IN ORTHOROMBIC SPACE GROUP 1MJJ ; 2.10 ; HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS6-12 AND A TRANSITION- STATE ANALOG 1HYX ; 1.80 ; HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX OF THE HYDROLYTIC ANTIBODY FAB 6D9 AND A TRANSITION-STATE ANALOG 1ZGO ; 1.40 ; HIGH RESOLUTION CRYSTAL STRUCTURE OF THE DISCOSOMA RED FLUORESCENT PROTEIN (DSRED) 1MJ8 ; 1.75 ; HIGH RESOLUTION CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE ESTEROLYTIC ANTIBODY MS6-126 1DLF ; 1.45 ; HIGH RESOLUTION CRYSTAL STRUCTURE OF THE FV FRAGMENT FROM AN ANTI-DANSYL SWITCH VARIANT ANTIBODY IGG2A(S) CRYSTALLIZED AT PH 5.25 2DLF ; 1.55 ; HIGH RESOLUTION CRYSTAL STRUCTURE OF THE FV FRAGMENT FROM AN ANTI-DANSYL SWITCH VARIANT ANTIBODY IGG2A(S) CRYSTALLIZED AT PH 6.75 1H1W ; 2.00 ; HIGH RESOLUTION CRYSTAL STRUCTURE OF THE HUMAN PDK1 CATALYTIC DOMAIN 1T1E ; 1.18 ; HIGH RESOLUTION CRYSTAL STRUCTURE OF THE INTACT PRO- KUMAMOLISIN, A SEDOLISIN TYPE PROTEINASE (PREVIOUSLY CALLED KUMAMOLYSIN OR KSCP) 1KPV ; 1.71 ; HIGH RESOLUTION CRYSTAL STRUCTURE OF THE MHC CLASS I COMPLEX H-2KB/SEV9 1KPU ; 1.50 ; HIGH RESOLUTION CRYSTAL STRUCTURE OF THE MHC CLASS I COMPLEX H-2KB/VSV8 1UNQ ; 0.98 ; HIGH RESOLUTION CRYSTAL STRUCTURE OF THE PLECKSTRIN HOMOLOGY DOMAIN OF PROTEIN KINASE B/AKT BOUND TO INS (1,3,4,5)-TETRAKISPHOPHATE 1MHN ; 1.80 ; HIGH RESOLUTION CRYSTAL STRUCTURE OF THE SMN TUDOR DOMAIN 1J0O ; 1.15 ; HIGH RESOLUTION CRYSTAL STRUCTURE OF THE WILD TYPE TETRAHEME CYTOCHROME C3 FROM DESULFOVIBRIO VULGARIS MIYAZAKI F 1I24 ; 1.20 ; HIGH RESOLUTION CRYSTAL STRUCTURE OF THE WILD-TYPE PROTEIN SQD1, WITH NAD AND UDP-GLUCOSE 1NR2 ; 2.18 ; HIGH RESOLUTION CRYSTAL STRUCTURES OF THYMUS AND ACTIVATION- REGULATED CHEMOKINE 1NR4 ; 1.72 ; HIGH RESOLUTION CRYSTAL STRUCTURES OF THYMUS AND ACTIVATION- REGULATED CHEMOKINE 1XEO ; 1.30 ; HIGH RESOLUTION CRYSTALS STRUCTURE OF COBALT- PEPTIDE DEFORMYLASE BOUND TO FORMATE 1L7M ; 1.48 ; HIGH RESOLUTION LIGANDED STRUCTURE OF PHOSPHOSERINE PHOSPHATASE (PI COMPLEX) 1PS2 ; -1.00 ; HIGH RESOLUTION NMR SOLUTION STRUCTURE OF HUMAN PS2, 19 STRUCTURES 1U01 ; -1.00 ; HIGH RESOLUTION NMR STRUCTURE OF 5-D(GCGTGCG)-3/5- D(CGCACGC)-3 (TREPRESENTS A CYCLOHEXENYL NUCLEOTIDE) 1NAJ ; -1.00 ; HIGH RESOLUTION NMR STRUCTURE OF DEOXYRIBONUCLEIC ACID DODECAMER DETERMINED IN AQUEOUS DILUTE LIQUID CRYSTALLINE PHASE 8DRH ; -1.00 ; HIGH RESOLUTION NMR STRUCTURE OF THE D(GCGTCAGG)R(CCUGACGC) HYBRID, MINIMIZED AVERAGE STRUCTURE 8PSH ; -1.00 ; HIGH RESOLUTION NMR STRUCTURE OF THE STEREOREGULAR (ALL-RP)-PHOSPHOROTHIOATE-DEOXYRIBONUCLEIC ACID/RIBONUCLEIC ACID HYBRID D (GPSCPSGPSTPSCPSAPSGPSG)R(CCUGACGC), MINIMIZED AVERAGE STRUCTURE 1XF7 ; -1.00 ; HIGH RESOLUTION NMR STRUCTURE OF THE WILMS' TUMOR SUPPRESSOR PROTEIN (WT1) FINGER 3 1FHG ; 2.00 ; HIGH RESOLUTION REFINEMENT OF TELOKIN 1YFQ ; 1.10 ; HIGH RESOLUTION S. CEREVISIAE BUB3 MITOTIC CHECKPOINT PROTEIN 1MDJ ; -1.00 ; HIGH RESOLUTION SOLUTION NMR STRUCTURE OF MIXED DISULFIDE INTERMEDIATE BETWEEN HUMAN THIOREDOXIN (C35A, C62A, C69A, C73A) MUTANT AND A 13 RESIDUE PEPTIDE COMPRISING ITS TARGET SITE IN HUMAN NFKB (RESIDUES 56-68 OF THE P50 SUBUNIT OF NFKB) 1MDK ; -1.00 ; HIGH RESOLUTION SOLUTION NMR STRUCTURE OF MIXED DISULFIDE INTERMEDIATE BETWEEN HUMAN THIOREDOXIN (C35A, C62A, C69A, C73A) MUTANT AND A 13 RESIDUE PEPTIDE COMPRISING ITS TARGET SITE IN HUMAN NFKB (RESIDUES 56-68 OF THE P50 SUBUNIT OF NFKB) 1CQG ; -1.00 ; HIGH RESOLUTION SOLUTION NMR STRUCTURE OF MIXED DISULFIDE INTERMEDIATE BETWEEN HUMAN THIOREDOXIN (C35A, C62A, C69A, C73A) MUTANT AND A 13 RESIDUE PEPTIDE COMPRISING ITS TARGET SITE IN HUMAN REF-1 (RESIDUES 59 - 71 OF THE P50 SUBUNIT OF NFKB), NMR, 31 STRUCTURES 1CQH ; -1.00 ; HIGH RESOLUTION SOLUTION NMR STRUCTURE OF MIXED DISULFIDE INTERMEDIATE BETWEEN HUMAN THIOREDOXIN (C35A, C62A, C69A, C73A) MUTANT AND A 13 RESIDUE PEPTIDE COMPRISING ITS TARGET SITE IN HUMAN REF-1 (RESIDUES 59 - 71 OF THE P50 SUBUNIT OF NFKB), NMR, MINIMIZED AVERAGE STRUCTURE 1MDI ; -1.00 ; HIGH RESOLUTION SOLUTION NMR STRUCTURE OF MIXED DISULFIDE INTERMEDIATE BETWEEN MUTANT HUMAN THIOREDOXIN AND A 13 RESIDUE PEPTIDE COMPRISING ITS TARGET SITE IN HUMAN NFKB 1SAE ; -1.00 ; HIGH RESOLUTION SOLUTION NMR STRUCTURE OF THE OLIGOMERIZATION DOMAIN OF P53 BY MULTI-DIMENSIONAL NMR (SAC STRUCTURES) 1SAG ; -1.00 ; HIGH RESOLUTION SOLUTION NMR STRUCTURE OF THE OLIGOMERIZATION DOMAIN OF P53 BY MULTI-DIMENSIONAL NMR (SAC STRUCTURES) 1SAI ; -1.00 ; HIGH RESOLUTION SOLUTION NMR STRUCTURE OF THE OLIGOMERIZATION DOMAIN OF P53 BY MULTI-DIMENSIONAL NMR (SAC STRUCTURES) 1SAK ; -1.00 ; HIGH RESOLUTION SOLUTION NMR STRUCTURE OF THE OLIGOMERIZATION DOMAIN OF P53 BY MULTI-DIMENSIONAL NMR (SAC STRUCTURES) 3SAK ; -1.00 ; HIGH RESOLUTION SOLUTION NMR STRUCTURE OF THE OLIGOMERIZATION DOMAIN OF P53 BY MULTI-DIMENSIONAL NMR (SAC STRUCTURES) 1SAF ; -1.00 ; HIGH RESOLUTION SOLUTION NMR STRUCTURE OF THE OLIGOMERIZATION DOMAIN OF P53 BY MULTI-DIMENSIONAL NMR (SAD STRUCTURES) 1SAH ; -1.00 ; HIGH RESOLUTION SOLUTION NMR STRUCTURE OF THE OLIGOMERIZATION DOMAIN OF P53 BY MULTI-DIMENSIONAL NMR (SAD STRUCTURES) 1SAJ ; -1.00 ; HIGH RESOLUTION SOLUTION NMR STRUCTURE OF THE OLIGOMERIZATION DOMAIN OF P53 BY MULTI-DIMENSIONAL NMR (SAD STRUCTURES) 1SAL ; -1.00 ; HIGH RESOLUTION SOLUTION NMR STRUCTURE OF THE OLIGOMERIZATION DOMAIN OF P53 BY MULTI-DIMENSIONAL NMR (SAD STRUCTURES) 2CNP ; -1.00 ; HIGH RESOLUTION SOLUTION STRUCTURE OF APO RABBIT CALCYCLIN, NMR, 22 STRUCTURES 1E9T ; -1.00 ; HIGH RESOLUTION SOLUTION STRUCTURE OF HUMAN INTESTINAL TREFOIL FACTOR 1NB1 ; -1.00 ; HIGH RESOLUTION SOLUTION STRUCTURE OF KALATA B1 1CKR ; -1.00 ; HIGH RESOLUTION SOLUTION STRUCTURE OF THE HEAT SHOCK COGNATE-70 KD SUBSTRATE BINDING DOMAIN OBTAINED BY MULTIDIMENSIONAL NMR TECHNIQUES 7HSC ; -1.00 ; HIGH RESOLUTION SOLUTION STRUCTURE OF THE HEAT SHOCK COGNATE-70 KD SUBSTRATE BINDING DOMAIN OBTAINED BY MULTIDIMENSIONAL NMR TECHNIQUES 1FMY ; -1.00 ; HIGH RESOLUTION SOLUTION STRUCTURE OF THE PROTEIN PART OF CU7 METALLOTHIONEIN 1RXR ; -1.00 ; HIGH RESOLUTION SOLUTION STRUCTURE OF THE RETINOID X RECEPTOR DEOXYRIBONUCLEIC ACID BINDING DOMAIN, NMR, 20 STRUCTURE 1E93 ; 2.00 ; HIGH RESOLUTION STRUCTURE AND BIOCHEMICAL PROPERTIES OF A RECOMBINANT CATALASE DEPLETED IN IRON 1SB2 ; 1.90 ; HIGH RESOLUTION STRUCTURE DETERMINATION OF RHODOCETIN 1GTO ; 1.82 ; HIGH RESOLUTION STRUCTURE OF A HYPERSTABLE HELICAL BUNDLE PROTEIN MUTANT 1T28 ; -1.00 ; HIGH RESOLUTION STRUCTURE OF A PICORNAVIRAL INTERNAL CIS- ACTING REPLICATION ELEMENT 1SFI ; 1.65 ; HIGH RESOLUTION STRUCTURE OF A POTENT, CYCLIC PROTEASE INHIBITOR FROM SUNFLOWER SEEDS 1N7S ; 1.45 ; HIGH RESOLUTION STRUCTURE OF A TRUNCATED NEURONAL SNARE COMPLEX 1DZD ; -1.00 ; HIGH RESOLUTION STRUCTURE OF ACIDIC FIBROBLAST GROWTH FACTOR (27-154), 24 NMR STRUCTURES 1DZC ; -1.00 ; HIGH RESOLUTION STRUCTURE OF ACIDIC FIBROBLAST GROWTH FACTOR. MUTANT FGF-4-ALA-(23-154), 24 NMR STRUCTURES 1R6C ; 2.15 ; HIGH RESOLUTION STRUCTURE OF CLPN 1PO7 ; 1.20 ; HIGH RESOLUTION STRUCTURE OF E28A MUTANT BENZOYLFORMATE DECARBOXYLASE FROM PSEUDOMONAS PUTIDA 1Q6Z ; 1.00 ; HIGH RESOLUTION STRUCTURE OF E28A MUTANT BENZOYLFORMATE DECARBOXYLASE FROM PSEUDOMONAS PUTIDA COMPLEXED WITH THIAMIN THIAZOLONE DIPHOSPHATE 1LQK ; 1.35 ; HIGH RESOLUTION STRUCTURE OF FOSFOMYCIN RESISTANCE PROTEIN A (FOSA) 2BMD ; 1.80 ; HIGH RESOLUTION STRUCTURE OF GDP-BOUND HUMAN RAB4A 2BME ; 1.57 ; HIGH RESOLUTION STRUCTURE OF GPPNHP-BOUND HUMAN RAB4A 1HG7 ; 1.15 ; HIGH RESOLUTION STRUCTURE OF HPLC-12 TYPE III ANTIFREEZE PROTEIN FROM OCEAN POUT MACROZOARCES AMERICANUS 1XBI ; 1.45 ; HIGH RESOLUTION STRUCTURE OF METHANOCALDOCOCCUS JANNASCHII L7AE 2BJI ; 1.30 ; HIGH RESOLUTION STRUCTURE OF MYO-INOSITOL MONOPHOSPHATASE, THE TARGET OF LITHIUM THERAPY 1P4C ; 1.35 ; HIGH RESOLUTION STRUCTURE OF OXIDIZED ACTIVE MUTANT OF (S)- MANDELATE DEHYDROGENASE 1LP8 ; 1.65 ; HIGH RESOLUTION STRUCTURE OF RECOMBINANT DIANTHIN ANTIVIRAL PROTEIN-POTENT ANTI-HIV AGENT 1LPD ; 1.70 ; HIGH RESOLUTION STRUCTURE OF RECOMBINANT DIANTHIN ANTIVIRAL PROTEIN-POTENT ANTI-HIV AGENT (COMPLEX WITH ADENINE) 1LPC ; 1.70 ; HIGH RESOLUTION STRUCTURE OF RECOMBINANT DIANTHIN ANTIVIRAL PROTEIN-POTENT ANTI-HIV AGENT (COMPLEX WITH CYCLIC AMP) 2LYN ; 2.07 ; HIGH RESOLUTION STRUCTURE OF RED ABALONE LYSIN DIMER 1P5B ; 1.35 ; HIGH RESOLUTION STRUCTURE OF REDUCED ACTIVE MUTANT OF (S)- MANDELATE DEHYDROGENASE 1MXR ; 1.42 ; HIGH RESOLUTION STRUCTURE OF RIBONUCLEOTIDE REDUCTASE R2 FROM E. COLI IN ITS OXIDISED (MET) FORM 1O7S ; 1.75 ; HIGH RESOLUTION STRUCTURE OF SIGLEC-7 1O7V ; 1.90 ; HIGH RESOLUTION STRUCTURE OF SIGLEC-7 1JGM ; 1.30 ; HIGH RESOLUTION STRUCTURE OF THE CADMIUM-CONTAINING PHOSPHOTRIESTERASE FROM PSEUDOMONAS DIMINUTA 2B8A ; -1.00 ; HIGH RESOLUTION STRUCTURE OF THE HDGF PWWP DOMAIN 1XO0 ; 2.00 ; HIGH RESOLUTION STRUCTURE OF THE HOLLIDAY JUNCTION INTERMEDIATE IN CRE-LOXP SITE-SPECIFIC RECOMBINATION 1WKU ; 1.60 ; HIGH RESOLUTION STRUCTURE OF THE HUMAN ALPHA-ACTININ ISOFORM 3 1I0B ; 1.30 ; HIGH RESOLUTION STRUCTURE OF THE MANGANESE-CONTAINING PHOSPHOTRIESTERASE FROM PSEUDOMONAS DIMINUTA 1QJP ; 1.65 ; HIGH RESOLUTION STRUCTURE OF THE OUTER MEMBRANE PROTEIN A (OMPA) TRANSMEMBRANE DOMAIN 1WUK ; 1.10 ; HIGH RESOLUTION STRUCTURE OF THE OXIDIZED STATE OF [NIFE]HYDROGENASE FROM DESULUFOVIBRIO VULGARIS MIYAZAKI F 1H10 ; 1.40 ; HIGH RESOLUTION STRUCTURE OF THE PLECKSTRIN HOMOLOGY DOMAIN OF PROTEIN KINASE B/AKT BOUND TO INS(1,3,4,5)-TETRAKISPHOPHATE 1EYU ; 1.78 ; HIGH RESOLUTION STRUCTURE OF THE PVUII ENDONCULEASE/COGNATE DEOXYRIBONUCLEIC ACID COMPLEX AT PH 4.6 2LIS ; 1.35 ; HIGH RESOLUTION STRUCTURE OF THE RED ABALONE LYSIN MONOMER 1WUL ; 1.50 ; HIGH RESOLUTION STRUCTURE OF THE REDUCED STATE OF [NIFE]HYDROGENASE FROM DESULUFOVIBRIO VULGARIS MIYAZAKI F 1HZY ; 1.30 ; HIGH RESOLUTION STRUCTURE OF THE ZINC-CONTAINING PHOSPHOTRIESTERASE FROM PSEUDOMONAS DIMINUTA 1I0D ; 1.30 ; HIGH RESOLUTION STRUCTURE OF THE ZINC/CADMIUM-CONTAINING PHOSPHOTRIESTERASE FROM PSEUDOMONAS DIMINUTA 4STD ; 2.15 ; HIGH RESOLUTION STRUCTURES OF SCYTALONE DEHYDRATASE- INHIBITOR COMPLEXES CRYSTALLIZED AT PHYSIOLOGICAL PH 1QKO ; 2.10 ; HIGH RESOLUTION X-RAY STRUCTURE OF AN EARLY INTERMEDIATE IN THE BACTERIORHODOPSIN PHOTOCYCLE 1QKP ; 2.10 ; HIGH RESOLUTION X-RAY STRUCTURE OF AN EARLY INTERMEDIATE IN THE BACTERIORHODOPSIN PHOTOCYCLE 1KJL ; 1.40 ; HIGH RESOLUTION X-RAY STRUCTURE OF HUMAN GALECTIN-3 IN COMPLEX WITH LACNAC 1HKK ; 1.85 ; HIGH RESOULTION CRYSTAL STRUCTURE OF HUMAN CHITINASE IN COMPLEX WITH ALLOSAMIDIN 3HIP ; 2.80 ; HIGH-POTENTIAL IRON-SULFUR PROTEIN FROM CHROMATIUM PURPURATUM 363D ; 2.00 ; HIGH-RESOLUTION CRYSTAL STRUCTURE OF A FULLY MODIFIED N3'-> P5'PHOSPHORAMIDATE DEOXYRIBONUCLEIC ACID DODECAMER DUPLEX 1KUF ; 1.35 ; HIGH-RESOLUTION CRYSTAL STRUCTURE OF A SNAKE VENOM METALLOPROTEINASE FROM TAIWAN HABU 1ZBZ ; 1.29 ; HIGH-RESOLUTION CRYSTAL STRUCTURE OF COMPOUND I INTERMEDIATE OF CYTOCHROME C PEROXIDASE (CCP) 1GZ9 ; 1.70 ; HIGH-RESOLUTION CRYSTAL STRUCTURE OF ERYTHRINA CRISTAGALLI LECTIN IN COMPLEX WITH 2'-ALPHA-L-FUCOSYLLACTOSE 1GZC ; 1.58 ; HIGH-RESOLUTION CRYSTAL STRUCTURE OF ERYTHRINA CRISTAGALLI LECTIN IN COMPLEX WITH LACTOSE 1ZBY ; 1.20 ; HIGH-RESOLUTION CRYSTAL STRUCTURE OF NATIVE (RESTING) CYTOCHROME C PEROXIDASE (CCP) 1QTW ; 1.02 ; HIGH-RESOLUTION CRYSTAL STRUCTURE OF THE ESCHERICHIA COLI DEOXYRIBONUCLEIC ACID REPAIR ENZYME ENDONUCLEASE IV 1Y7Y ; 1.69 ; HIGH-RESOLUTION CRYSTAL STRUCTURE OF THE RESTRICTION- MODIFICATION CONTROLLER PROTEIN C.AHDI FROM AEROMONAS HYDROPHILA 1RHX ; -1.00 ; HIGH-RESOLUTION NMR STRUCTURE OF THE CONSERVED HYPOTHETICAL PROTEIN TM0979 FROM THERMOTOGA MARITIMA 1P98 ; -1.00 ; HIGH-RESOLUTION NMR STRUCTURE OF THE UBL-DOMAIN OF HHR23A 1NC8 ; -1.00 ; HIGH-RESOLUTION SOLUTION NMR STRUCTURE OF THE MINIMAL ACTIVE DOMAIN OF THE HUMAN IMMUNODEFICIENCY VIRUS TYPE-2 NUCLEOCAPSID PROTEIN, 15 STRUCTURES 1AQ5 ; -1.00 ; HIGH-RESOLUTION SOLUTION NMR STRUCTURE OF THE TRIMERIC COILED-COIL DOMAIN OF CHICKEN CARTILAGE MATRIX PROTEIN, 20 STRUCTURES 1MNL ; -1.00 ; HIGH-RESOLUTION SOLUTION STRUCTURE OF A SWEET PROTEIN SINGLE-CHAIN MONELLIN (SCM) DETERMINED BY NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY AND DYNAMICAL SIMULATED ANNEALING CALCULATIONS, 21 STRUCTURES 1NBJ ; -1.00 ; HIGH-RESOLUTION SOLUTION STRUCTURE OF CYCLOVIOLACIN O1 1EZT ; -1.00 ; HIGH-RESOLUTION SOLUTION STRUCTURE OF FREE RGS4 BY NMR 1EZY ; -1.00 ; HIGH-RESOLUTION SOLUTION STRUCTURE OF FREE RGS4 BY NMR 1Z2Q ; -1.00 ; HIGH-RESOLUTION SOLUTION STRUCTURE OF THE LM5-1 FYVE DOMAIN FROM LEISHMANIA MAJOR 1KUW ; -1.00 ; HIGH-RESOLUTION STRUCTURE AND LOCALIZATION OF AMYLIN NUCLEATION SITE IN DETERGENT MICELLES 1IH7 ; 2.21 ; HIGH-RESOLUTION STRUCTURE OF APO RB69 DEOXYRIBONUCLEIC ACID POLYMERASE 1LYV ; 1.36 ; HIGH-RESOLUTION STRUCTURE OF THE CATALYTICALLY INACTIVE YERSINIA TYROSINE PHOSPHATASE C403A MUTANT IN COMPLEX WITH PHOSPHATE. 1P9D ; -1.00 ; HIGH-RESOLUTION STRUCTURE OF THE COMPLEX OF HHR23A UBIQUITIN-LIKE DOMAIN AND THE C-TERMINAL UBIQUITIN- INTERACTING MOTIF OF PROTEASOME SUBUNIT S5A 4ZNF ; -1.00 ; HIGH-RESOLUTION THREE-DIMENSIONAL STRUCTURE OF A SINGLE ZINC FINGER FROM A HUMAN ENHANCER BINDING PROTEIN IN SOLUTION 1TQ3 ; 1.89 ; HIGHER RESOLUTION CRYSTAL STRUCTURE OF THE THIRD PDZ DOMAIN OF POST SYNAPTIC PSD-95 PROTEIN 1IJ9 ; 3.00 ; HIGHLY HYDRATED HUMAN VCAM-1 FRAGMENT 1TW8 ; 2.80 ; HINCII BOUND TO CA2+ AND COGNATE DEOXYRIBONUCLEIC ACID GTCGAC 1XHV ; 2.50 ; HINCII BOUND TO CLEAVED COGNATE DEOXYRIBONUCLEIC ACID GTCGAC AND MN2+ 1XHU ; 2.95 ; HINCII BOUND TO CLEAVED, COGNATE DEOXYRIBONUCLEIC ACID CONTAINING GTCGAC 1KC6 ; 2.60 ; HINCII BOUND TO COGNATE DEOXYRIBONUCLEIC ACID 1TX3 ; 2.50 ; HINCII BOUND TO COGNATE DEOXYRIBONUCLEIC ACID 1GUB ; 3.10 ; HINGE-BENDING MOTION OF D-ALLOSE BINDING PROTEIN FROM ESCHERICHIA COLI: THREE OPEN CONFORMATIONS 1GUD ; 1.70 ; HINGE-BENDING MOTION OF D-ALLOSE BINDING PROTEIN FROM ESCHERICHIA COLI: THREE OPEN CONFORMATIONS 1R0D ; 1.90 ; HIP1R THATCH DOMAIN CORE 5GDS ; 2.10 ; HIRUNORMS ARE TRUE HIRUDIN MIMETICS. THE CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN:HIRUNORM V COMPLEX 1BX7 ; 1.20 ; HIRUSTASIN FROM HIRUDO MEDICINALIS AT 1.2 ANGSTROMS 1BX8 ; 1.40 ; HIRUSTASIN FROM HIRUDO MEDICINALIS AT 1.4 ANGSTROMS 1CM3 ; 1.60 ; HIS15ASP HPR FROM E. COLI 1G8Z ; 2.00 ; HIS57ALA MUTANT OF CHOLERA TOXIN B-PENATMER 1H5Y ; 2.00 ; HISF PROTEIN FROM PYROBACULUM AEROPHILUM 1QFT ; 1.25 ; HISTAMINE BINDING PROTEIN FROM FEMALE BROWN EAR RHIPICEPHALUS APPENDICULATUS 1QFV ; 1.36 ; HISTAMINE BINDING PROTEIN FROM FEMALE BROWN EAR RHIPICEPHALUS APPENDICULATUS 2AOW ; 2.97 ; HISTAMINE METHYLTRANSFERASE (NATURAL VARIANT I105) COMPLEXED WITH THE ACETYLCHOLINESTERASE INHIBITOR AND ALTZHEIMER'S DISEASE DRUG TACRINE 2AOX ; 3.12 ; HISTAMINE METHYLTRANSFERASE (PRIMARY VARIANT T105) COMPLEXED WITH THE ACETYLCHOLINESTERASE INHIBITOR AND ALTZHEIMER'S DISEASE DRUG TACRINE 2AOV ; 2.48 ; HISTAMINE METHYLTRANSFERASE COMPLEXED WITH THE ANTIFOLATE DRUG METOPRINE 2AOT ; 1.90 ; HISTAMINE METHYLTRANSFERASE COMPLEXED WITH THE ANTIHISTAMINE DRUG DIPHENHYDRAMINE 2AOU ; 2.30 ; HISTAMINE METHYLTRANSFERASE COMPLEXED WITH THE ANTIMALARIAL DRUG AMODIAQUINE 1B8F ; 2.10 ; HISTIDINE AMMONIA-LYASE (HAL) FROM PSEUDOMONAS PUTIDA 1GKM ; 1.00 ; HISTIDINE AMMONIA-LYASE (HAL) FROM PSEUDOMONAS PUTIDA INHIBITED WITH L-CYSTEINE 1GK3 ; 2.25 ; HISTIDINE AMMONIA-LYASE (HAL) MUTANT D145A FROM PSEUDOMONAS PUTIDA 1EB4 ; 2.00 ; HISTIDINE AMMONIA-LYASE (HAL) MUTANT F329A FROM PSEUDOMONAS PUTIDA 1GK2 ; 1.90 ; HISTIDINE AMMONIA-LYASE (HAL) MUTANT F329G FROM PSEUDOMONAS PUTIDA 1GKJ ; 1.70 ; HISTIDINE AMMONIA-LYASE (HAL) MUTANT Y280F FROM PSEUDOMONAS PUTIDA 5RHN ; 2.31 ; HISTIDINE TRIAD NUCLEOTIDE-BINDING PROTEIN (HINT) FROM RABBIT COMPLEXED WITH 8-BR-AMP 4RHN ; 1.90 ; HISTIDINE TRIAD NUCLEOTIDE-BINDING PROTEIN (HINT) FROM RABBIT COMPLEXED WITH ADENOSINE 3RHN ; 2.10 ; HISTIDINE TRIAD NUCLEOTIDE-BINDING PROTEIN (HINT) FROM RABBIT COMPLEXED WITH GMP 6RHN ; 2.15 ; HISTIDINE TRIAD NUCLEOTIDE-BINDING PROTEIN (HINT) FROM RABBIT WITHOUT NUCLEOTIDE 2HPR ; 2.00 ; HISTIDINE-CONTAINING PHOSPHOCARRIER PROTEIN HPR MUTANT WITH MET 51 REPLACED BY VAL AND SER 83 REPLACED BY CYS (M51V, S83C) 1A0B ; 2.06 ; HISTIDINE-CONTAINING PHOSPHOTRANSFER DOMAIN OF ARCB FROM ESCHERICHIA COLI 2A0B ; 1.57 ; HISTIDINE-CONTAINING PHOSPHOTRANSFER DOMAIN OF ARCB FROM ESCHERICHIA COLI 1OPD ; 1.50 ; HISTIDINE-CONTAINING PROTEIN (HPR), MUTANT WITH SER 46 REPLACED BY ASP (S46D) 1H1C ; 2.85 ; HISTIDINOL-PHOSPHATE AMINOTRANSFERASE (HISC) FROM THERMOTOGA MARITIMA 1UU0 ; 2.85 ; HISTIDINOL-PHOSPHATE AMINOTRANSFERASE (HISC) FROM THERMOTOGA MARITIMA (APO-FORM) 1UU2 ; 2.80 ; HISTIDINOL-PHOSPHATE AMINOTRANSFERASE (HISC) FROM THERMOTOGA MARITIMA (APO-FORM) 1HTT ; 2.60 ; HISTIDYL-TRNA SYNTHETASE 1KMN ; 2.80 ; HISTIDYL-TRNA SYNTHETASE COMPLEXED WITH HISTIDINOL AND ATP 1KMM ; 2.60 ; HISTIDYL-TRNA SYNTHETASE COMPLEXED WITH HISTIDYL-ADENYLATE 1H4V ; 2.40 ; HISTIDYL-TRNA SYNTHETASE FROM THERMUS THERMOPHILUS (LIGAND FREE) 1ADJ ; 2.70 ; HISTIDYL-TRNA SYNTHETASE IN COMPLEX WITH HISTIDINE 1ADY ; 2.80 ; HISTIDYL-TRNA SYNTHETASE IN COMPLEX WITH HISTIDYL-ADENYLATE 1FNE ; 1.90 ; HISTOCOMPATIBILITY ANTIGEN 1FNG ; 1.90 ; HISTOCOMPATIBILITY ANTIGEN 1IEA ; 2.30 ; HISTOCOMPATIBILITY ANTIGEN 1IEB ; 2.70 ; HISTOCOMPATIBILITY ANTIGEN 1HDM ; 2.50 ; HISTOCOMPATIBILITY ANTIGEN HLA-DM 1F3J ; 3.10 ; HISTOCOMPATIBILITY ANTIGEN I-AG7 1IAK ; 1.90 ; HISTOCOMPATIBILITY ANTIGEN I-AK 1BOB ; 2.30 ; HISTONE ACETYLTRANSFERASE HAT1 FROM SACCHAROMYCES CEREVISIAE IN COMPLEX WITH ACETYL COENZYME A 1QSO ; 2.90 ; HISTONE ACETYLTRANSFERASE HPA2 FROM SACCHAROMYCES CEREVISIAE 1QSM ; 2.40 ; HISTONE ACETYLTRANSFERASE HPA2 FROM SACCHAROMYCES CEREVISIAE IN COMPLEX WITH ACETYL COENZYME A 1BFM ; -1.00 ; HISTONE B FROM METHANOTHERMUS FERVIDUS 2BYK ; 2.40 ; HISTONE FOLD HETERODIMER OF THE CHROMATIN ACCESSIBILITY COMPLEX 2BYM ; 2.80 ; HISTONE FOLD HETERODIMER OF THE CHROMATIN ACCESSIBILITY COMPLEX 2HIO ; 3.10 ; HISTONE OCTAMER (CHICKEN), CHROMOSOMAL PROTEIN 1HIO ; 3.10 ; HISTONE OCTAMER (CHICKEN), CHROMOSOMAL PROTEIN, ALPHA CARBONS ONLY 1HUE ; -1.00 ; HISTONE-LIKE PROTEIN 1XQU ; 2.30 ; HIT FAMILY HYDROLASE FROM CLOSTRIDIUM THERMOCELLUM CTH-393 1A8O ; 1.70 ; HIV CAPSID C-TERMINAL DOMAIN 1AUM ; 3.00 ; HIV CAPSID C-TERMINAL DOMAIN (CAC146) 1MEQ ; -1.00 ; HIV GP120 C5 1AIK ; 2.00 ; HIV GP41 CORE STRUCTURE 1HYZ ; 2.30 ; HIV INTEGRASE CORE DOMAIN COMPLEXED WITH A DERIVATIVE OF TETRAPHENYL ARSONIUM. 1HYV ; 1.70 ; HIV INTEGRASE CORE DOMAIN COMPLEXED WITH TETRAPHENYL ARSONIUM 1T3R ; 1.20 ; HIV PROTEASE WILD-TYPE IN COMPLEX WITH TMC114 INHIBITOR 1ZP8 ; 2.02 ; HIV PROTEASE WITH INHIBITOR AB-2 1YT9 ; 3.00 ; HIV PROTEASE WITH OXIMINOARYLSULFONAMIDE BOUND 1ZPA ; 2.02 ; HIV PROTEASE WITH SCRIPPS AB-3 INHIBITOR 1TCX ; 2.30 ; HIV TRIPLE MUTANT PROTEASE COMPLEXED WITH INHIBITOR SB203386 1BDR ; 2.80 ; HIV-1 (2: 31, 33-37) PROTEASE COMPLEXED WITH INHIBITOR SB203386 1BDL ; 2.80 ; HIV-1 (2:31-37) PROTEASE COMPLEXED WITH INHIBITOR SB203386 1BDQ ; 2.50 ; HIV-1 (2:31-37, 47, 82) PROTEASE COMPLEXED WITH INHIBITOR SB203386 2BUO ; 1.70 ; HIV-1 CAPSID C-TERMINAL DOMAIN IN COMPLEX WITH AN INHIBITOR OF PARTICLE ASSEMBLY 1AFV ; 3.70 ; HIV-1 CAPSID PROTEIN (P24) COMPLEX WITH FAB25.3 1BAJ ; 2.60 ; HIV-1 CAPSID PROTEIN C-TERMINAL FRAGMENT PLUS GAG P2 DOMAIN 1BMX ; -1.00 ; HIV-1 CAPSID PROTEIN MAJOR HOMOLOGY REGION PEPTIDE ANALOG, NMR, 8 STRUCTURES 1Y3O ; 2.70 ; HIV-1 DIS RIBONUCLEIC ACID SUBTYPE F- MN SOAKED 1Y3S ; 2.25 ; HIV-1 DIS RIBONUCLEIC ACID SUBTYPE F- MPD FORM 1Y6S ; 2.90 ; HIV-1 DIS(MAL) DUPLEX BA-SOAKED 1Y6T ; 2.60 ; HIV-1 DIS(MAL) DUPLEX CO HEXAMINE-SOAKED 1WVD ; 2.93 ; HIV-1 DIS(MAL) DUPLEX COCL2-SOAKED 1Y90 ; 3.08 ; HIV-1 DIS(MAL) DUPLEX MN-SOAKED 1Y95 ; 2.80 ; HIV-1 DIS(MAL) DUPLEX PB-SOAKED 1Y73 ; 2.90 ; HIV-1 DIS(MAL) DUPLEX PT-SOAKED 1O3Z ; 2.65 ; HIV-1 DIS(MAL) DUPLEX RU HEXAMINE-SOAKED 1NLC ; 1.85 ; HIV-1 DIS(MAL) DUPLEX ZN-SOAKED 1GC1 ; 2.50 ; HIV-1 GP120 CORE COMPLEXED WITH CD4 AND A NEUTRALIZING HUMAN ANTIBODY 1I5X ; 1.80 ; HIV-1 GP41 CORE 1I5Y ; 2.10 ; HIV-1 GP41 CORE 1G9M ; 2.20 ; HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B 1RZJ ; 2.20 ; HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B 1EX4 ; 2.80 ; HIV-1 INTEGRASE CATALYTIC CORE AND C-TERMINAL DOMAIN 1BIS ; 1.95 ; HIV-1 INTEGRASE CORE DOMAIN 1BIZ ; 1.95 ; HIV-1 INTEGRASE CORE DOMAIN 1BIU ; 2.50 ; HIV-1 INTEGRASE CORE DOMAIN COMPLEXED WITH MG++ 1MES ; 1.90 ; HIV-1 MUTANT (I84V) PROTEASE COMPLEXED WITH DMP323 1MER ; 1.90 ; HIV-1 MUTANT (I84V) PROTEASE COMPLEXED WITH DMP450 1MET ; 1.90 ; HIV-1 MUTANT (V82F) PROTEASE COMPLEXED WITH DMP323 1MEU ; 1.90 ; HIV-1 MUTANT (V82F, I84V) PROTEASE COMPLEXED WITH DMP323 1UPH ; -1.00 ; HIV-1 MYRISTOYLATED MATRIX 2NEF ; -1.00 ; HIV-1 NEF (REGULATORY FACTOR), NMR, 40 STRUCTURES 1QA4 ; -1.00 ; HIV-1 NEF ANCHOR DOMAIN, NMR, 2 STRUCTURES 1EFN ; 2.50 ; HIV-1 NEF PROTEIN IN COMPLEX WITH R96I MUTANT FYN SH3 DOMAIN 1AVV ; 3.00 ; HIV-1 NEF PROTEIN, UNLIGANDED CORE DOMAIN 1NXR ; -1.00 ; HIV-1 POLYPURINE HYBRID, R(GAGGACUG):D(CAGTCCTC), NMR, 18 STRUCTURES 1BV9 ; 2.00 ; HIV-1 PROTEASE (I84V) COMPLEXED WITH XV638 OF DUPONT PHARMACEUTICALS 1BWB ; 1.80 ; HIV-1 PROTEASE (V82F/I84V) DOUBLE MUTANT COMPLEXED WITH SD146 OF DUPONT PHARMACEUTICALS 1BWA ; 1.90 ; HIV-1 PROTEASE (V82F/I84V) DOUBLE MUTANT COMPLEXED WITH XV638 OF DUPONT PHARMACEUTICALS 1GNO ; 2.30 ; HIV-1 PROTEASE (WILD TYPE) COMPLEXED WITH U89360E (INHIBITOR) 1UPJ ; 2.22 ; HIV-1 PROTEASE COMPLEX WITH U095438 [3-[1-(4-BROMOPHENYL) ISOBUTYL]-4-HYDROXYCOUMARIN 2UPJ ; 3.00 ; HIV-1 PROTEASE COMPLEX WITH U100313 ([3-[[3-[CYCLOPROPYL [4-HYDROXY-2OXO-6-[1-(PHENYLMETHYL)PROPYL]-2H-PYRAN-3-YL] METHYL]PHENYL]AMINO]-3-OXO-PROPYL]CARBAMIC ACID TERT- BUTYL ESTER) 1MTR ; 1.75 ; HIV-1 PROTEASE COMPLEXED WITH A CYCLIC PHE-ILE-VAL PEPTIDOMIMETIC INHIBITOR 1D4K ; 1.85 ; HIV-1 PROTEASE COMPLEXED WITH A MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 1D4L ; 1.75 ; HIV-1 PROTEASE COMPLEXED WITH A MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 1A30 ; 2.00 ; HIV-1 PROTEASE COMPLEXED WITH A TRIPEPTIDE INHIBITOR 1ODY ; 2.00 ; HIV-1 PROTEASE COMPLEXED WITH AN INHIBITOR LP-130 1B6J ; 1.85 ; HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 1 1Z1R ; 1.85 ; HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 2 1Z1H ; 1.85 ; HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 3 1B6L ; 1.75 ; HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 4 1B6K ; 1.85 ; HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 5 1B6M ; 1.85 ; HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 6 1B6P ; 2.00 ; HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 7 1VIJ ; 2.40 ; HIV-1 PROTEASE COMPLEXED WITH THE INHIBITOR HOE/BAY 793 HEXAGONAL FORM 1VIK ; 2.40 ; HIV-1 PROTEASE COMPLEXED WITH THE INHIBITOR HOE/BAY 793 ORTHORHOMBIC FORM 1HPX ; 2.00 ; HIV-1 PROTEASE COMPLEXED WITH THE INHIBITOR KNI-272 1HXW ; 1.80 ; HIV-1 PROTEASE DIMER COMPLEXED WITH A-84538 1PRO ; 1.80 ; HIV-1 PROTEASE DIMER COMPLEXED WITH A-98881 1DIF ; 1.70 ; HIV-1 PROTEASE IN COMPLEX WITH A DIFLUOROKETONE CONTAINING INHIBITOR A79285 1XL5 ; 1.73 ; HIV-1 PROTEASE IN COMPLEX WITH AMIDHYROXYSULFONE 1M0B ; 2.45 ; HIV-1 PROTEASE IN COMPLEX WITH AN ETHYLENEAMINE INHIBITOR 1WBK ; 2.00 ; HIV-1 PROTEASE IN COMPLEX WITH ASYMMETRIC INHIBITOR, BEA568 1W5V ; 1.80 ; HIV-1 PROTEASE IN COMPLEX WITH FLUORO SUBSTITUTED DIOL- BASED C2-SYMMETRIC INHIBITOR 1W5W ; 1.80 ; HIV-1 PROTEASE IN COMPLEX WITH FLUORO SUBSTITUTED DIOL- BASED C2-SYMMETRIC INHIBITOR 1W5X ; 1.90 ; HIV-1 PROTEASE IN COMPLEX WITH FLUORO SUBSTITUTED DIOL- BASED C2-SYMMETRIC INHIBITOR 1W5Y ; 1.90 ; HIV-1 PROTEASE IN COMPLEX WITH FLUORO SUBSTITUTED DIOL- BASED C2-SYMMETRIC INHIBITOR 2BQV ; 2.10 ; HIV-1 PROTEASE IN COMPLEX WITH INHIBITOR AHA455 1XL2 ; 1.50 ; HIV-1 PROTEASE IN COMPLEX WITH PYRROLIDINMETHANAMINE 1A8G ; 2.50 ; HIV-1 PROTEASE IN COMPLEX WITH SDZ283-910 1WBM ; 2.00 ; HIV-1 PROTEASE IN COMPLEX WITH SYMMETRIC INHIBITOR, BEA450 1AJV ; 2.00 ; HIV-1 PROTEASE IN COMPLEX WITH THE CYCLIC SULFAMIDE INHIBITOR AHA006 1AJX ; 2.00 ; HIV-1 PROTEASE IN COMPLEX WITH THE CYCLIC UREA INHIBITOR AHA001 1EBW ; 1.81 ; HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA322 1EBY ; 2.29 ; HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA369 1EBZ ; 2.01 ; HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA388 1EC0 ; 1.79 ; HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA403 1EC1 ; 2.10 ; HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA409 1D4I ; 1.81 ; HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA425 1EC2 ; 2.00 ; HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA428 1D4H ; 1.81 ; HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA435 1EC3 ; 1.80 ; HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR MSA367 1D4J ; 1.81 ; HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR MSL370 1QBR ; 1.80 ; HIV-1 PROTEASE INHIBITORS WIIH LOW NANOMOLAR POTENCY 1QBS ; 1.80 ; HIV-1 PROTEASE INHIBITORS WIIH LOW NANOMOLAR POTENCY 1QBT ; 2.10 ; HIV-1 PROTEASE INHIBITORS WIIH LOW NANOMOLAR POTENCY 1QBU ; 1.80 ; HIV-1 PROTEASE INHIBITORS WIIH LOW NANOMOLAR POTENCY 1GNN ; 2.30 ; HIV-1 PROTEASE MUTANT WITH VAL 82 REPLACED BY ASN (V82N) COMPLEXED WITH U89360E (INHIBITOR) 1GNM ; 2.30 ; HIV-1 PROTEASE MUTANT WITH VAL 82 REPLACED BY ASP (V82D) COMPLEXED WITH U89360E (INHIBITOR) 1D4Y ; 1.97 ; HIV-1 PROTEASE TRIPLE MUTANT/TIPRANAVIR COMPLEX 1HPO ; 2.50 ; HIV-1 PROTEASE TRIPLE MUTANT/U103265 COMPLEX 1D4S ; 2.50 ; HIV-1 PROTEASE V82F/I84V DOUBLE MUTANT/TIPRANAVIR COMPLEX 1G2K ; 1.95 ; HIV-1 PROTEASE WITH CYCLIC SULFAMIDE INHIBITOR, AHA047 1BVG ; -1.00 ; HIV-1 PROTEASE-DMP323 COMPLEX IN SOLUTION, NMR MINIMIZED AVERAGE STRUCTURE 1BVE ; -1.00 ; HIV-1 PROTEASE-DMP323 COMPLEX IN SOLUTION, NMR, 28 STRUCTURES 2BPV ; 1.90 ; HIV-1 PROTEASE-INHIBITOR COMPLEX 2BPW ; 2.80 ; HIV-1 PROTEASE-INHIBITOR COMPLEX 2BPX ; 2.80 ; HIV-1 PROTEASE-INHIBITOR COMPLEX 2BPY ; 1.90 ; HIV-1 PROTEASE-INHIBITOR COMPLEX 2BPZ ; 2.50 ; HIV-1 PROTEASE-INHIBITOR COMPLEX 7UPJ ; 2.00 ; HIV-1 PROTEASE/U101935 COMPLEX 1HXB ; 2.30 ; HIV-1 PROTEINASE COMPLEXED WITH RO 31-8959 1ODX ; 2.00 ; HIV-1 PROTEINASE MUTANT A71T, V82A 1RPV ; -1.00 ; HIV-1 REV PROTEIN (RESIDUES 34 - 50) 1REV ; 2.60 ; HIV-1 REVERSE TRANSCRIPTASE 2HMI ; 2.80 ; HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH A DOUBLE-STRANDED DEOXYRIBONUCLEIC ACID AND FAB28 1KLM ; 2.65 ; HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH BHAP U-90152 1TV6 ; 2.80 ; HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH CP-94,707 1RT5 ; 2.90 ; HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH UC10 1RT6 ; 2.80 ; HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH UC38 1RT4 ; 2.90 ; HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH UC781 1RT7 ; 3.00 ; HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH UC84 1N5Y ; 3.10 ; HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO POST- TRANSLOCATION AZTMP-TERMINATED DEOXYRIBONUCLEIC ACID (COMPLEX P) 1N6Q ; 3.00 ; HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO PRE- TRANSLOCATION AZTMP-TERMINATED DEOXYRIBONUCLEIC ACID (COMPLEX N) 1T05 ; 3.00 ; HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO TEMPLATE-PRIMER WITH TENOFOVIR-DIPHOSPHATE BOUND AS THE INCOMING NUCLEOTIDE SUBSTRATE 1T03 ; 3.10 ; HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO TENOFOVIR TERMINATED TEMPLATE-PRIMER (COMPLEX P) 1IKY ; 3.00 ; HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH THE INHIBITOR MSC194 1EET ; 2.73 ; HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH THE INHIBITOR MSC204 1BVJ ; -1.00 ; HIV-1 RIBONUCLEIC ACID A-RICH HAIRPIN LOOP 1TVR ; 3.00 ; HIV-1 RT/9-CL TIBO 1BQM ; 3.10 ; HIV-1 RT/HBY 097 1Y99 ; 2.40 ; HIV-1 SUBTYPE A DIS RIBONUCLEIC ACID DUPLEX 1XPF ; 2.30 ; HIV-1 SUBTYPE A GENOMIC RIBONUCLEIC ACID DIMERIZATION INITIATION SITE 1XPE ; 1.94 ; HIV-1 SUBTYPE B GENOMIC RIBONUCLEIC ACID DIMERIZATION INITIATION SITE 1XP7 ; 2.50 ; HIV-1 SUBTYPE F GENOMIC RIBONUCLEIC ACID DIMERIZATION INITIATION SITE 1QD3 ; -1.00 ; HIV-1 TAR RIBONUCLEIC ACID/NEOMYCIN B COMPLEX 1TAC ; -1.00 ; HIV-1 TAT CYS-, NMR, 10 STRUCTURES 2BGN ; 3.15 ; HIV-1 TAT PROTEIN DERIVED N-TERMINAL NONAPEPTIDE TRP2-TAT (1-9) BOUND TO THE ACTIVE SITE OF DIPEPTIDYL PEPTIDASE IV (CD26) 1TBC ; -1.00 ; HIV-1 TAT, NMR, 10 STRUCTURES 1AI1 ; 2.80 ; HIV-1 V3 LOOP MIMIC 1G9N ; 2.90 ; HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B 1RZK ; 2.90 ; HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B 1K9W ; 3.10 ; HIV-1(MAL) RIBONUCLEIC ACID DIMERIZATION INITIATION SITE 5UPJ ; 2.30 ; HIV-2 PROTEASE/U99283 COMPLEX 6UPJ ; 2.34 ; HIV-2 PROTEASE/U99294 COMPLEX 1AJU ; -1.00 ; HIV-2 TAR-ARGININAMIDE COMPLEX, NMR, 20 STRUCTURES 1AKX ; -1.00 ; HIV-2 TRANS ACTIVATING REGION RIBONUCLEIC ACID COMPLEX WITH ARGININAMIDE, NMR, MINIMIZED AVERAGE STRUCTURE 2HLC ; 1.70 ; HL COLLAGENASE STRUCTURE AT 1.7A RESOLUTION 1M05 ; 1.90 ; HLA B8 IN COMPLEX WITH AN EPSTEIN BARR VIRUS DETERMINANT 1JGE ; 2.10 ; HLA-B2705 BOUND TO NONA-PEPTIDE M9 1JGD ; 1.90 ; HLA-B2709 BOUND TO DECA-PEPTIDE S10R 1K5N ; 1.09 ; HLA-B2709 BOUND TO NONA-PEPTIDE M9 1SYV ; 1.70 ; HLA-B4405 COMPLEXED TO THE DOMINANT SELF LIGAND EEFGRAYGF 1AQD ; 2.45 ; HLA-DR1 (DRA, DRB1 0101) HUMAN CLASS II HISTOCOMPATIBILITY PROTEIN (EXTRACELLULAR DOMAIN) COMPLEXED WITH ENDOGENOUS PEPTIDE 1SJH ; 2.25 ; HLA-DR1 COMPLEXED WITH A 13 RESIDUE HIV CAPSID PEPTIDE 1SJE ; 2.45 ; HLA-DR1 COMPLEXED WITH A 16 RESIDUE HIV CAPSID PEPTIDE BOUND IN A HAIRPIN CONFORMATION 1T5W ; 2.40 ; HLA-DR1 IN COMPLEX WITH A SYNTHETIC PEPTIDE (AAYSDQATPLLLSPR) 1T5X ; 2.50 ; HLA-DR1 IN COMPLEX WITH A SYNTHETIC PEPTIDE (AAYSDQATPLLLSPR) AND THE SUPERANTIGEN SEC3-3B2 1CG7 ; -1.00 ; HMG PROTEIN NHP6A FROM SACCHAROMYCES CEREVISIAE 1R7I ; 2.21 ; HMG-COA REDUCTASE FROM P. MEVALONII, NATIVE STRUCTURE AT 2.2 ANGSTROMS RESOLUTION. 1R31 ; 2.10 ; HMG-COA REDUCTASE FROM PSEUDOMONAS MEVALONII COMPLEXED WITH HMG-COA 1E7J ; -1.00 ; HMG-D COMPLEXED TO A BULGE DEOXYRIBONUCLEIC ACID 1G2Y ; 1.00 ; HNF-1ALPHA DIMERIZATION DOMAIN, WITH SELENOMETHIONINE SUBSTITUED AT LEU 12 1M7W ; 2.80 ; HNF4A LIGAND BINDING DOMAIN WITH BOUND FATTY ACID 1HA1 ; 1.75 ; HNRNP A1 (RBD1,2) FROM HOMO SAPIENS 1LWY ; 2.01 ; HOGG1 BOROHYDRIDE-TRAPPED INTERMEDIATE WITHOUT 8-OXOGUANINE 1HJP ; 2.50 ; HOLLIDAY JUNCTION BINDING PROTEIN RUVA FROM E. COLI 1OB8 ; 1.80 ; HOLLIDAY JUNCTION RESOLVING ENZYME 1OB9 ; 2.00 ; HOLLIDAY JUNCTION RESOLVING ENZYME 1L4J ; 1.85 ; HOLLIDAY JUNCTION TCGGTACCGA WITH NA AND CA BINDING SITES. 1JKF ; 2.40 ; HOLO 1L-MYO-INOSITOL-1-PHOSPHATE SYNTHASE 2EUH ; 2.60 ; HOLO FORM OF A NADP DEPENDENT ALDEHYDE DEHYDROGENASE COMPLEX WITH NADP+ 1IU7 ; 1.80 ; HOLO FORM OF COPPER-CONTAINING AMINE OXIDASE FROM ARTHROBACTER GLOBIFORMIS 1F7T ; 1.80 ; HOLO-(ACYL CARRIER PROTEIN) SYNTHASE AT 1.8A 1F7L ; 1.50 ; HOLO-(ACYL CARRIER PROTEIN) SYNTHASE IN COMPLEX WITH COENZYME A AT 1.5A 1F80 ; 2.30 ; HOLO-(ACYL CARRIER PROTEIN) SYNTHASE IN COMPLEX WITH HOLO- (ACYL CARRIER PROTEIN) 1QRY ; -1.00 ; HOMEOBOX PROTEIN VND (VENTRAL NERVOUS SYSTEM DEFECTIVE PROTEIN) 2LFB ; -1.00 ; HOMEODOMAIN FROM RAT LIVER LFB1/HNF1 TRANSCRIPTION FACTOR, NMR, 20 STRUCTURES 1FJL ; 2.00 ; HOMEODOMAIN FROM THE DROSOPHILA PAIRED PROTEIN BOUND TO A DEOXYRIBONUCLEIC ACID OLIGONUCLEOTIDE 1DDW ; 1.70 ; HOMER EVH1 DOMAIN UNLIGANDED 1G9Y ; 2.05 ; HOMING ENDONUCLEASE I-CREI / DEOXYRIBONUCLEIC ACID SUBSTRATE COMPLEX WITH CALCIUM 1OKK ; 2.05 ; HOMO-HETERODIMERIC COMPLEX OF THE SRP GTPASES 1PBK ; 2.50 ; HOMOLOGOUS DOMAIN OF HUMAN FKBP25 1TRJ ; 11.70 ; HOMOLOGY MODEL OF YEAST RACK1 PROTEIN FITTED INTO 11.7A CRYO-EM MAP OF YEAST 80S RIBOSOME 1DGV ; -1.00 ; HOMOLOGY-BASED MODEL OF APO CIB (CALCIUM-AND INTEGRIN- BINDING PROTEIN) 1DGU ; -1.00 ; HOMOLOGY-BASED MODEL OF CALCIUM-SATURATED CIB (CALCIUM-AND INTEGRIN-BINDING PROTEIN) 1K5K ; -1.00 ; HOMONUCLEAR 1H NUCLEAR MAGNETIC RESONANCE ASSIGNMENT AND STRUCTURAL CHARACTERIZATION OF HIV-1 TAT MAL PROTEIN 1JFW ; -1.00 ; HOMONUCLEAR AND HETERONUCLEAR 1H-13C NUCLEAR MAGNETIC RESONANCE ASSIGNMENT AND STRUCTURAL CHARACTERIZATION OF A HIV-1 TAT PROTEIN 1EBU ; 2.60 ; HOMOSERINE DEHYDROGENASE COMPLEX WITH NAD ANALOGUE AND L- HOMOSERINE 1EBF ; 2.30 ; HOMOSERINE DEHYDROGENASE FROM S. CEREVISIAE COMPLEX WITH NAD+ 1TVE ; 3.00 ; HOMOSERINE DEHYDROGENASE IN COMPLEX WITH 4-(4-HYDROXY-3- ISOPROPYLPHENYLTHIO)-2-ISOPROPYLPHENOL 1Q7G ; 2.60 ; HOMOSERINE DEHYDROGENASE IN COMPLEX WITH SUICIDE INHIBITOR COMPLEX NAD-5-HYDROXY-4-OXONORVALINE 1PRX ; 2.00 ; HORF6 A NOVEL HUMAN PEROXIDASE ENZYME 1A28 ; 1.80 ; HORMONE-BOUND HUMAN PROGESTERONE RECEPTOR LIGAND-BINDING DOMAIN 1QLJ ; 2.80 ; HORSE LIVER ALCOHOL DEHYDROGENASE APO ENZYME DOUBLE MUTANT OF GLY 293 ALA AND PRO 295 THR 1YE3 ; 1.59 ; HORSE LIVER ALCOHOL DEHYDROGENASE APOENZYME 1QLH ; 2.07 ; HORSE LIVER ALCOHOL DEHYDROGENASE COMPLEXED TO NAD DOUBLE MUTANT OF GLY 293 ALA AND PRO 295 THR 1BTO ; 2.00 ; HORSE LIVER ALCOHOL DEHYDROGENASE COMPLEXED TO NADH AND (1S,3R)3-BUTYLTHIOLANE 1-OXIDE 3BTO ; 1.66 ; HORSE LIVER ALCOHOL DEHYDROGENASE COMPLEXED TO NADH AND (1S,3S)3-BUTYLTHIOLANE 1-OXIDE 1LDY ; 2.50 ; HORSE LIVER ALCOHOL DEHYDROGENASE COMPLEXED TO NADH AND CYCLOHEXYL FORMAMIDE (CXF) 1LDE ; 2.50 ; HORSE LIVER ALCOHOL DEHYDROGENASE COMPLEXED TO NADH AND N-FORMYL PIPERDINE 1MG0 ; 1.80 ; HORSE LIVER ALCOHOL DEHYDROGENASE COMPLEXED WITH NAD+ AND 2, 3-DIFLUOROBENZYL ALCOHOL 1N92 ; 1.47 ; HORSE LIVER ALCOHOL DEHYDROGENASE COMPLEXED WITH NAD+ AND 4- IODOPYRAZOLE 1P1R ; 1.57 ; HORSE LIVER ALCOHOL DEHYDROGENASE COMPLEXED WITH NADH AND R- N-1-METHYLHEXYLFORMAMIDE 1QV7 ; 1.80 ; HORSE LIVER ALCOHOL DEHYDROGENASE HIS51GLN/LYS228ARG MUTANT COMPLEXED WITH NAD+ AND 2,3-DIFLUOROBENZYL ALCOHOL 1QV6 ; 1.80 ; HORSE LIVER ALCOHOL DEHYDROGENASE HIS51GLN/LYS228ARG MUTANT COMPLEXED WITH NAD+ AND 2,4-DIFLUOROBENZYL ALCOHOL 1MGO ; 1.20 ; HORSE LIVER ALCOHOL DEHYDROGENASE PHE93ALA MUTANT 1JU9 ; 2.00 ; HORSE LIVER ALCOHOL DEHYDROGENASE VAL292SER MUTANT 1N8K ; 1.13 ; HORSE LIVER ALCOHOL DEHYDROGENASE VAL292THR MUTANT COMPLEXED TO NAD+ AND PYRAZOLE 1Y8H ; 3.10 ; HORSE METHEMOGLOBIN LOW SALT, PH 7.0 1Y8K ; 2.30 ; HORSE METHEMOGLOBIN LOW SALT, PH 7.0 (88% RELATIVE HUMIDITY) 1Y8I ; 2.60 ; HORSE METHEMOGLOBIN LOW SALT, PH 7.0 (98% RELATIVE HUMIDITY) 1X1K ; 1.10 ; HOST-GUEST PEPTIDE (PRO-PRO-GLY)4-(PRO-ALLOHYP-GLY)-(PRO- PRO-GLY)4 1TFW ; 2.20 ; HOW CCA IS ADDED TO THE 3' END OF IMMATURE TRNA WITHOUT THE USE OF AN OLIGONUCLEOTIDE TEMPLATE 1TFY ; 3.20 ; HOW CCA IS ADDED TO THE 3' END OF IMMATURE TRNA WITHOUT THE USE OF AN OLIGONUCLEOTIDE TEMPLATE 1F7A ; 2.00 ; HOW DOES A SYMMETRIC DIMER RECOGNIZE AN ASYMMETRIC SUBSTRATE? A SUBSTRATE COMPLEX OF HIV-1 PROTEASE. 2BV9 ; 1.50 ; HOW FAMILY 26 GLYCOSIDE HYDROLASES ORCHESTRATE CATALYSIS ON DIFFERENT POLYSACCHARIDES. STRUCTURE AND ACTIVITY OF A CLOSTRIDIUM THERMOCELLUM LICHENASE, CTLIC26A 2BVD ; 1.60 ; HOW FAMILY 26 GLYCOSIDE HYDROLASES ORCHESTRATE CATALYSIS ON DIFFERENT POLYSACCHARIDES. STRUCTURE AND ACTIVITY OF A CLOSTRIDIUM THERMOCELLUM LICHENASE, CTLIC26A 1CCI ; 2.40 ; HOW FLEXIBLE ARE PROTEINS? TRAPPING OF A FLEXIBLE LOOP 6CGT ; 2.60 ; HOXA COMPLEX OF CYCLODEXTRIN GLYCOSYLTRANSFERASE MUTANT 1P0J ; -1.00 ; HP (2-20) SUBSTITUTION ASP TO TRP MODIFICATION IN SDS-D25 MICELLES 1P0L ; -1.00 ; HP (2-20) SUBSTITUTION GLN TO TRP MODIFICATION IN SDS-D25 MICELLES 1P0O ; -1.00 ; HP (2-20) SUBSTITUTION OF TRP FOR GLN AND ASP AT POSITION 17 AND 19 MODIFICATION IN SDS-D25 MICELLES 1P5L ; -1.00 ; HP (2-20) SUBSTITUTION PHE5 TO SER MODIFICATION IN SDS-D25 MICELLES 1P5K ; -1.00 ; HP (2-20) SUBSTITUTION SER TO LEU11 MODIFICATION IN SDS-D25 MICELLES 1S4Z ; -1.00 ; HP1 CHROMO SHADOW DOMAIN IN COMPLEX WITH PXVXL MOTIF OF CAF- 1 1H7U ; 2.70 ; HPMS2-ATPGS 1KNX ; 2.50 ; HPR KINASE/PHOSPHATASE FROM MYCOPLASMA PNEUMONIAE 1FYY ; -1.00 ; HPRT GENE MUTATION HOTSPOT WITH A BPDE2(10R) ADDUCT 1E2M ; 2.20 ; HPT + HMTT 1E2N ; 2.20 ; HPT + HMTT 1R8P ; -1.00 ; HPV-16 E2C SOLUTION STRUCTURE 1R6N ; 2.40 ; HPV11 E2 TAD COMPLEX CRYSTAL STRUCTURE 1R6K ; 2.50 ; HPV11 E2 TAD CRYSTAL STRUCTURE 1URF ; -1.00 ; HR1B DOMAIN FROM PRK1 1QKL ; -1.00 ; HRPABC14.4, ESSENTIAL SUBUNIT OF HUMAN RIBONUCLEIC ACID POLYMERASES I, II AND III 1HRV ; 3.00 ; HRV14/SDZ 35-682 COMPLEX 1VRH ; 3.00 ; HRV14/SDZ 880-061 COMPLEX 1FPO ; 1.80 ; HSC20 (HSCB), A J-TYPE CO-CHAPERONE FROM E. COLI 1U00 ; 1.95 ; HSCA SUBSTRATE BINDING DOMAIN COMPLEXED WITH THE ISCU RECOGNITION PEPTIDE ELPPVKIHC 1IM2 ; 2.80 ; HSLU, HAEMOPHILUS INFLUENZAE, SELENOMETHIONINE VARIANT 1KYI ; 3.10 ; HSLUV (H. INFLUENZAE)-NLVS VINYL SULFONE INHIBITOR COMPLEX 1E94 ; 2.80 ; HSLV-HSLU FROM E.COLI 1HW7 ; 2.20 ; HSP33, HEAT SHOCK PROTEIN WITH REDOX-REGULATED CHAPERONE ACTIVITY 1XAO ; 2.07 ; HSP40-YDJ1 DIMERIZATION DOMAIN 1BYQ ; 1.50 ; HSP90 N-TERMINAL DOMAIN BOUND TO ADP-MG 1JAS ; -1.00 ; HSUBC2B 1BH8 ; 3.00 ; HTAFII18/HTAFII28 HETERODIMER CRYSTAL STRUCTURE 1BH9 ; 2.60 ; HTAFII18/HTAFII28 HETERODIMER CRYSTAL STRUCTURE WITH BOUND PCMBS 1MG1 ; 2.50 ; HTLV-1 GP21 ECTODOMAIN/MALTOSE-BINDING PROTEIN CHIMERA 1W0T ; 2.00 ; HTRF1 DEOXYRIBONUCLEIC ACID-BINDING DOMAIN IN COMPLEX WITH TELOMERIC DEOXYRIBONUCLEIC ACID. 1W0U ; 1.80 ; HTRF2 DEOXYRIBONUCLEIC ACID-BINDING DOMAIN IN COMPLEX WITH TELOMERIC DEOXYRIBONUCLEIC ACID. 1B8Z ; 1.60 ; HU FROM THERMOTOGA MARITIMA 1RIY ; 1.80 ; HU MUTANT V42I FROM THERMOTOGA MARITIMA 1A27 ; 1.90 ; HUMAN 17-BETA-HYDROXYSTEROID-DEHYDROGENASE TYPE 1 C-TERMINAL DELETION MUTANT COMPLEXED WITH ESTRADIOL AND NADP+ 1FDS ; 1.70 ; HUMAN 17-BETA-HYDROXYSTEROID-DEHYDROGENASE TYPE 1 COMPLEXED WITH 17-BETA-ESTRADIOL 1FDT ; 2.20 ; HUMAN 17-BETA-HYDROXYSTEROID-DEHYDROGENASE TYPE 1 COMPLEXED WITH ESTRADIOL AND NADP+ 1FDU ; 2.70 ; HUMAN 17-BETA-HYDROXYSTEROID-DEHYDROGENASE TYPE 1 MUTANT H221L COMPLEXED WITH ESTRADIOL AND NADP+ 1FDV ; 3.10 ; HUMAN 17-BETA-HYDROXYSTEROID-DEHYDROGENASE TYPE 1 MUTANT H221L COMPLEXED WITH NAD+ 1FDW ; 2.70 ; HUMAN 17-BETA-HYDROXYSTEROID-DEHYDROGENASE TYPE 1 MUTANT H221Q COMPLEXED WITH ESTRADIOL 1BNK ; 2.70 ; HUMAN 3-METHYLADENINE DEOXYRIBONUCLEIC ACID GLYCOSYLASE COMPLEXED TO DEOXYRIBONUCLEIC ACID 1J96 ; 1.25 ; HUMAN 3ALPHA-HSD TYPE 3 IN TERNARY COMPLEX WITH NADP AND TESTOSTERONE 1YQK ; 2.50 ; HUMAN 8-OXOGUANINE GLYCOSYLASE CROSSLINKED WITH GUANINE CONTAINING DEOXYRIBONUCLEIC ACID 1B41 ; 2.76 ; HUMAN ACETYLCHOLINESTERASE COMPLEXED WITH FASCICULIN-II, GLYCOSYLATED PROTEIN 1OGS ; 2.00 ; HUMAN ACID-BETA-GLUCOSIDASE 1RG8 ; 1.10 ; HUMAN ACIDIC FIBROBLAST GROWTH FACTOR (HAFGF-1) AT 1.10 ANGSTROM RESOLUTION (140 AMINO ACID FORM) 1P63 ; 1.60 ; HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 140 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND LEU111 REPLACED WITH ILE (L111I) 1JT3 ; 1.95 ; HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO HISTIDINE TAG AND LEU 73 REPLACED BY VAL (L73V) 1JY0 ; 1.70 ; HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND CYS 117 REPLACED WITH VAL (C117V). 1JTC ; 1.70 ; HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND LEU 44 REPLACED BY PHE (L44F) 1JT7 ; 1.70 ; HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND LEU 44 REPLACED BY PHE AND LEU 73 REPLACED BY VAL AND VAL 109 REPLACED BY LEU (L44F/L73V/V109L) 1M16 ; 1.70 ; HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND LEU 44 REPLACED WITH PHE (L44F), LEU 73 REPLACED WITH VAL (L73V), VAL 109 REPLACED WITH LEU (V109L) AND CYS 117 REPLACED WITH VAL (C117V). 1JT5 ; 1.85 ; HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND LEU 73 REPLACED BY VAL AND VAL 109 REPLACED BY LEU (L73V/V109L) 1JT4 ; 1.78 ; HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND VAL 109 REPLACED BY LEU (V109L) 1K5V ; 2.10 ; HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG WITH ASN106 REPLACED BY GLY (N106G). 1K5U ; 2.00 ; HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG WITH HIS93 REPLACED BY GLY (H93G). 1JQZ ; 1.65 ; HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG. 1AUT ; 2.80 ; HUMAN ACTIVATED PROTEIN C 1ORE ; 2.10 ; HUMAN ADENINE PHOSPHORIBOSYLTRANSFERASE 1QHV ; 1.51 ; HUMAN ADENOVIRUS SEROTYPE 2 FIBRE HEAD 2BZU ; 1.50 ; HUMAN ADENOVIRUS SEROTYPE 41 FIBER HEAD 1HUR ; 2.00 ; HUMAN ADP-RIBOSYLATION FACTOR 1 COMPLEXED WITH GDP, FULL LENGTH NON-MYRISTOYLATED 1EL3 ; 1.70 ; HUMAN ALDOSE REDUCTASE COMPLEXED WITH IDD384 INHIBITOR 1US0 ; 0.66 ; HUMAN ALDOSE REDUCTASE IN COMPLEX WITH NADP+ AND THE INHIBITOR IDD594 AT 0.66 ANGSTROM 1HSO ; 2.50 ; HUMAN ALPHA ALCOHOL DEHYDROGENASE (ADH1A) 1NY2 ; 2.30 ; HUMAN ALPHA THROMBIN INHIBITED BY RPPGF AND HIRUGEN 1B9O ; 1.15 ; HUMAN ALPHA-LACTALBUMIN, LOW TEMPERATURE FORM 1HBT ; 2.00 ; HUMAN ALPHA-THROMBIN COMPLEXED WITH A PEPTIDYL PYRIDINIUM METHYL KETONE CONTAINING BIVALENT INHIBITOR 1LHF ; 2.40 ; HUMAN ALPHA-THROMBIN COMPLEXED WITH AC-(D)PHE-PRO-BORO-HOMOLYS-OH 1LHE ; 2.25 ; HUMAN ALPHA-THROMBIN COMPLEXED WITH AC-(D)PHE-PRO-BORO-N-BUTYL-AMIDINO-GLYCINE-OH 1LHC ; 1.95 ; HUMAN ALPHA-THROMBIN COMPLEXED WITH AC-(D)PHE-PRO-BOROARG-OH 1LHD ; 2.35 ; HUMAN ALPHA-THROMBIN COMPLEXED WITH AC-(D)PHE-PRO-BOROLYS-OH 1LHG ; 2.25 ; HUMAN ALPHA-THROMBIN COMPLEXED WITH AC-(D)PHE-PRO-BOROORNITHINE-OH 1BMN ; 2.80 ; HUMAN ALPHA-THROMBIN COMPLEXED WITH [S-(R,R)]-1- (AMINOIMINOMETHYL)-N-[[1-[N-[(2-NAPHTHALENYLSULFONYL)-L- SERYL]-PYRROLIDINYL]METHYL]-3-PIPERIDENECARBOXAMIDE (BMS-189090) 1BMM ; 2.60 ; HUMAN ALPHA-THROMBIN COMPLEXED WITH [S-(R,R)]-4- [(AMINOIMINOMETHYL)AMINO]-N-[[1-[3-HYDROXY-2-[(2- NAPHTHALENYLSULFONYL)AMINO]-1-OXOPROPYL]-2-PYRROLIDINYL] METHYL]BUTANAMIDE (BMS-186282) 1QUR ; 2.00 ; HUMAN ALPHA-THROMBIN IN COMPLEX WITH BIVALENT, BENZAMIDINE- BASED SYNTHETIC INHIBITOR 1AFE ; 2.00 ; HUMAN ALPHA-THROMBIN INHIBITION BY CBZ-PRO-AZALYS-ONP 1AE8 ; 2.00 ; HUMAN ALPHA-THROMBIN INHIBITION BY EOC-D-PHE-PRO-AZALYS-ONP 1AIX ; 2.10 ; HUMAN ALPHA-THROMBIN TERNARY COMPLEX WITH EXOSITE INHIBITOR HIRUGEN AND ACTIVE SITE INHIBITOR PHCH2OCO-D-DPA-PRO-BOROVAL 1AI8 ; 1.85 ; HUMAN ALPHA-THROMBIN TERNARY COMPLEX WITH THE EXOSITE INHIBITOR HIRUGEN AND ACTIVE SITE INHIBITOR PHCH2OCO-D-DPA-PRO-BOROMPG 1LTO ; 2.20 ; HUMAN ALPHA1-TRYPTASE 1E3G ; 2.40 ; HUMAN ANDROGEN RECEPTOR LIGAND BINDING IN COMPLEX WITH THE LIGAND METRIBOLONE (R1881) 1SAV ; 2.30 ; HUMAN ANNEXIN V WITH PROLINE SUBSTITUTION BY THIOPROLINE 1DE9 ; 3.00 ; HUMAN APE1 ENDONUCLEASE WITH BOUND ABASIC DEOXYRIBONUCLEIC ACID AND MN2+ ION 1IOJ ; -1.00 ; HUMAN APOLIPOPROTEIN C-I, NMR, 18 STRUCTURES 1RW6 ; 2.80 ; HUMAN APP CORE DOMAIN 1DE8 ; 2.95 ; HUMAN APURINIC/APYRIMIDINIC ENDONUCLEASE-1 (APE1) BOUND TO ABASIC DEOXYRIBONUCLEIC ACID 1PQ3 ; 2.70 ; HUMAN ARGINASE II: CRYSTAL STRUCTURE AND PHYSIOLOGICAL ROLE IN MALE AND FEMALE SEXUAL AROUSAL 1AOS ; 4.20 ; HUMAN ARGININOSUCCINATE LYASE 1X0O ; -1.00 ; HUMAN ARNT C-TERMINAL PAS DOMAIN 1AUK ; 2.10 ; HUMAN ARYLSULFATASE A 1APY ; 2.00 ; HUMAN ASPARTYLGLUCOSAMINIDASE 1APZ ; 2.30 ; HUMAN ASPARTYLGLUCOSAMINIDASE COMPLEX WITH REACTION PRODUCT 1I3E ; 1.86 ; HUMAN AZIDO-MET HEMOGLOBIN BART'S (GAMMA4) 1T2F ; 3.00 ; HUMAN B LACTATE DEHYDROGENASE COMPLEXED WITH NAD+ AND 4- HYDROXY-1,2,5-OXADIAZOLE-3-CARBOXYLIC ACID 1I8L ; 3.00 ; HUMAN B7-1/CTLA-4 CO-STIMULATORY COMPLEX 1G5M ; -1.00 ; HUMAN BCL-2, ISOFORM 1 1GJH ; -1.00 ; HUMAN BCL-2, ISOFORM 2 1R2E ; 2.10 ; HUMAN BCL-XL CONTAINING A GLU TO LEU MUTATION AT POSITION 92 1R2I ; 2.00 ; HUMAN BCL-XL CONTAINING A PHE TO LEU MUTATION AT POSITION 146 1R2G ; 2.70 ; HUMAN BCL-XL CONTAINING A PHE TO TRP MUTATION AT POSITION 97 1R2H ; 2.20 ; HUMAN BCL-XL CONTAINING AN ALA TO LEU MUTATION AT POSITION 142 1HSZ ; 2.20 ; HUMAN BETA-1 ALCOHOL DEHYDROGENASE (ADH1B1) 1FD3 ; 1.35 ; HUMAN BETA-DEFENSIN 2 1FD4 ; 1.70 ; HUMAN BETA-DEFENSIN 2 1IJU ; 1.40 ; HUMAN BETA-DEFENSIN-1 1IJV ; 1.20 ; HUMAN BETA-DEFENSIN-1 1BHG ; 2.60 ; HUMAN BETA-GLUCURONIDASE AT 2.6 A RESOLUTION 1O7A ; 2.25 ; HUMAN BETA-HEXOSAMINIDASE B 2BM2 ; 2.20 ; HUMAN BETA-II TRYPTASE IN COMPLEX WITH 4-(3-AMINOMETHYL- PHENYL)-PIPERIDIN-1-YL-(5-PHENETHYL- PYRIDIN-3-YL)- METHANONE 1A0L ; 3.00 ; HUMAN BETA-TRYPTASE: A RING-LIKE TETRAMER WITH ACTIVE SITES FACING A CENTRAL PORE 1HDO ; 1.15 ; HUMAN BILIVERDIN IX BETA REDUCTASE: NADP COMPLEX 1HE2 ; 1.20 ; HUMAN BILIVERDIN IX BETA REDUCTASE: NADP/BILIVERDIN IX ALPHA TERNARY COMPLEX 1HE4 ; 1.40 ; HUMAN BILIVERDIN IX BETA REDUCTASE: NADP/FMN TERNARY COMPLEX 1HE5 ; 1.50 ; HUMAN BILIVERDIN IX BETA REDUCTASE: NADP/LUMICHROME TERNARY COMPLEX 1HE3 ; 1.40 ; HUMAN BILIVERDIN IX BETA REDUCTASE: NADP/MESOBILIVERDIN IV ALPHA TERNARY COMPLEX 2CB5 ; 1.85 ; HUMAN BLEOMYCIN HYDROLASE, C73S/DELE455 MUTANT 1CB5 ; 2.59 ; HUMAN BLEOMYCIN HYDROLASE. 3BMP ; 2.70 ; HUMAN BONE MORPHOGENETIC PROTEIN-2 (BMP-2) 1XFB ; 3.00 ; HUMAN BRAIN FRUCTOSE 1,6-(BIS)PHOSPHATE ALDOLASE (C ISOZYME) 1OJ6 ; 1.95 ; HUMAN BRAIN NEUROGLOBIN THREE-DIMENSIONAL STRUCTURE 1KT8 ; 1.90 ; HUMAN BRANCHED CHAIN AMINO ACID AMINOTRANSFERASE (MITOCHONDRIAL): THREE DIMENSIONAL STRUCTURE OF ENZYME IN ITS KETIMINE FORM WITH THE SUBSTRATE L-ISOLEUCINE 1EKV ; 2.25 ; HUMAN BRANCHED CHAIN AMINO ACID AMINOTRANSFERASE (MITOCHONDRIAL): THREE DIMENSIONAL STRUCTURE OF ENZYME INACTIVATED BY TRIS BOUND TO THE PYRIDOXAL-5'-PHOSPHATE ON ONE END AND ACTIVE SITE LYS202 NZ ON THE OTHER. 1KTA ; 1.90 ; HUMAN BRANCHED CHAIN AMINO ACID AMINOTRANSFERASE : THREE DIMENSIONAL STRUCTURE OF THE ENZYME IN ITS PYRIDOXAMINE PHOSPHATE FORM. 1DTW ; 2.70 ; HUMAN BRANCHED-CHAIN ALPHA-KETO ACID DEHYDROGENASE 1AA9 ; -1.00 ; HUMAN C-HA-RAS(1-171)(DOT)GDP, NMR, MINIMIZED AVERAGE STRUCTURE 1GNH ; 3.00 ; HUMAN C-REACTIVE PROTEIN 1B09 ; 2.50 ; HUMAN C-REACTIVE PROTEIN COMPLEXED WITH PHOSPHOCHOLINE 1AUI ; 2.10 ; HUMAN CALCINEURIN HETERODIMER 1TTM ; 1.95 ; HUMAN CARBONIC ANHYDRASE II COMPLEXED WITH 667-COUMATE 1A42 ; 2.25 ; HUMAN CARBONIC ANHYDRASE II COMPLEXED WITH BRINZOLAMIDE 1KWR ; 2.25 ; HUMAN CARBONIC ANHYDRASE II COMPLEXED WITH INHIBITOR 0134-36 1KWQ ; 2.60 ; HUMAN CARBONIC ANHYDRASE II COMPLEXED WITH INHIBITOR 2000-07 1AVN ; 2.00 ; HUMAN CARBONIC ANHYDRASE II COMPLEXED WITH THE HISTAMINE ACTIVATOR 1BV3 ; 1.85 ; HUMAN CARBONIC ANHYDRASE II COMPLEXED WITH UREA 1UGC ; 2.00 ; HUMAN CARBONIC ANHYDRASE II [HCAII] MUTANT WITH ALA 65 REPLACED BY HIS (A65H) 1UGE ; 1.90 ; HUMAN CARBONIC ANHYDRASE II [HCAII] MUTANT WITH ALA 65 REPLACED BY LEU (A65L) 1UGF ; 2.00 ; HUMAN CARBONIC ANHYDRASE II [HCAII] MUTANT WITH ALA 65 REPLACED BY THR (A65T) 1Z97 ; 2.10 ; HUMAN CARBONIC ANHYDRASE III: STRUCTURAL AND KINETIC STUDY OF CATALYSIS AND PROTON TRANSFER. 1Z93 ; 2.10 ; HUMAN CARBONIC ANHYDRASE III:STRUCTURAL AND KINETIC STUDY OF CATALYSIS AND PROTON TRANSFER. 1UGB ; 2.00 ; HUMAN CARBONIC ANHYDRASE II[HCAII] MUTANT WITH ALA 65 REPLACED BY GLY (A65G) 1UGA ; 2.00 ; HUMAN CARBONIC ANHYDRASE II[HCAII] MUTANT WITH ALA 65 REPLACED BY PHE (A65F) 1UGD ; 2.00 ; HUMAN CARBONIC ANHYDRASE II[HCAII] MUTANT WITH ALA 65 REPLACED BY SER (A65S) 1UGG ; 2.20 ; HUMAN CARBONIC ANHYDRASE II[HCAII] MUTANT WITH ALA 65 REPLACED BY SER (A65S) - ORTHORHOMBIC FORM 1ZNC ; 2.80 ; HUMAN CARBONIC ANHYDRASE IV 1I3D ; 1.70 ; HUMAN CARBONMONOXY HEMOGLOBIN BART'S (GAMMA4) 2BO9 ; 1.60 ; HUMAN CARBOXYPEPTIDASE A4 IN COMPLEX WITH HUMAN LATEXIN. 1KWA ; 1.93 ; HUMAN CASK/LIN-2 PDZ DOMAIN 1LV4 ; -1.00 ; HUMAN CATESTATIN 21-MER 1AU8 ; 1.90 ; HUMAN CATHEPSIN G 1CGH ; 1.80 ; HUMAN CATHEPSIN G 1H03 ; 1.70 ; HUMAN CD55 DOMAINS 3 & 4 1H04 ; 2.00 ; HUMAN CD55 DOMAINS 3 & 4 1H2P ; 2.80 ; HUMAN CD55 DOMAINS 3 & 4 1H2Q ; 3.00 ; HUMAN CD55 DOMAINS 3 & 4 1UOT ; 3.00 ; HUMAN CD55 DOMAINS 3 & 4 1E8I ; 1.95 ; HUMAN CD69 - TETRAGONAL FORM 1E87 ; 1.50 ; HUMAN CD69 - TRIGONAL FORM 1B6E ; 2.60 ; HUMAN CD94 1C25 ; 2.30 ; HUMAN CDC25A CATALYTIC DOMAIN 1QB0 ; 1.91 ; HUMAN CDC25B CATALYTIC DOMAIN 1CWT ; 2.30 ; HUMAN CDC25B CATALYTIC DOMAIN WITH METHYL MERCURY 1CWS ; 2.00 ; HUMAN CDC25B CATALYTIC DOMAIN WITH TUNGSTATE 1CWR ; 2.10 ; HUMAN CDC25B CATALYTIC DOMAIN WITHOUT ION IN CATALYTIC SITE 2EXM ; 1.80 ; HUMAN CDK2 IN COMPLEX WITH ISOPENTENYLADENINE 1GGL ; 2.31 ; HUMAN CELLULAR RETINOL BINDING PROTEIN III 1BW6 ; -1.00 ; HUMAN CENTROMERE PROTEIN B (CENP-B) DEOXYRIBONUCLEIC ACID BINDIGN DOMAIN RP1 1QEW ; 2.20 ; HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A 0201) COMPLEX WITH A NONAMERIC PEPTIDE FROM MELANOMA-ASSOCIATED ANTIGEN 3 (RESIDUES 271-279) 1DUZ ; 1.80 ; HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A 0201) IN COMPLEX WITH A NONAMERIC PEPTIDE FROM HTLV-1 TAX PROTEIN 3HLA ; 2.60 ; HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN A2.1 (HLA-A2.1 HUMAN LEUCOCYTE ANTIGEN) 1PYW ; 2.10 ; HUMAN CLASS II MHC PROTEIN HLA-DR1 BOUND TO A DESIGNED PEPTIDE RELATED TO INFLUENZA VIRUS HEMAGGLUTININ, FVKQNA(MAA)AL, IN COMPLEX WITH STAPHYLOCOCCAL ENTEROTOXIN C3 VARIANT 3B2 (SEC3-3B2) 1RFN ; 2.80 ; HUMAN COAGULATION FACTOR IXA IN COMPLEX WITH P-AMINO BENZAMIDINE 1IQF ; 3.20 ; HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55165 1IQN ; 2.60 ; HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55192 1IQE ; 2.90 ; HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55590 2A73 ; 3.30 ; HUMAN COMPLEMENT COMPONENT C3 2A74 ; 2.40 ; HUMAN COMPLEMENT COMPONENT C3C 1HFD ; 2.30 ; HUMAN COMPLEMENT FACTOR D IN A P21 CRYSTAL FORM 1BIO ; 1.50 ; HUMAN COMPLEMENT FACTOR D IN COMPLEX WITH ISATOIC ANHYDRIDE INHIBITOR 1DO5 ; 2.75 ; HUMAN COPPER CHAPERONE FOR SUPEROXIDE DISMUTASE DOMAIN II 1LPJ ; 2.00 ; HUMAN CRBP IV 2B53 ; 2.00 ; HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH DIN- 234325 2B52 ; 1.88 ; HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH DPH- 042562 2B55 ; 1.85 ; HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH INDENOPYRAXOLE DIN-101312 2B54 ; 1.85 ; HUMAN CYCLIN DEPENDENT KINASE 2 (CKD2)COMPLEXED WITH DIN- 232305 1GIH ; 2.80 ; HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4 INHIBITOR 1GII ; 2.00 ; HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4 INHIBITOR 1GIJ ; 2.20 ; HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4 INHIBITOR 1GZ8 ; 1.30 ; HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 2-AMINO-6-(3'-METHYL-2'-OXO)BUTOXYPURINE 1PXM ; 2.53 ; HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 3-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2- YLAMINO]-PHENOL 1PXJ ; 2.30 ; HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YLAMINE 1PXI ; 1.95 ; HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 4-(2,5-DICHLORO-THIOPHEN-3-YL)-PYRIMIDIN-2- YLAMINE 1PXN ; 2.50 ; HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 4-[4-(4-METHYL-2-METHYLAMINO-THIAZOL-5-YL)- PYRIMIDIN-2-YLAMINO]-PHENOL 1PXP ; 2.30 ; HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]- N',N'-DIMETHYL-BENZENE-1,4-DIAMINE 1PXK ; 2.80 ; HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)PYRIMIDIN-2-YL]- N'-HYDROXYIMINOFORMAMIDE 1E1V ; 1.95 ; HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR NU2058 1E1X ; 1.85 ; HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR NU6027 1CKP ; 2.05 ; HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR PURVALANOL B 1AQ1 ; 2.00 ; HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR STAUROSPORINE 1PXL ; 2.50 ; HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR [4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]- (4-TRIFLUOROMETHYL-PHENYL)-AMINE 1PXO ; 1.96 ; HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR [4-(2-AMINO-4-METHYL-THIAZOL-5-YL)-PYRIMIDIN-2- YL]-(3-NITRO-PHENYL)-AMINE 1H0V ; 1.90 ; HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THE INHIBITOR 2-AMINO-6-[(R)-PYRROLIDINO-5'-YL]METHOXYPURINE 1H0W ; 2.10 ; HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THE INHIBITOR 2-AMINO-6-[CYCLOHEX-3-ENYL]METHOXYPURINE 2BHH ; 2.60 ; HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THE INHIBITOR 4-HYDROXYPIPERINDINESULFONYL-INDIRUBINE 2BHE ; 1.90 ; HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THE INHIBITOR 5-BROMO-INDIRUBINE 1B38 ; 2.00 ; HUMAN CYCLIN-DEPENDENT KINASE 2 1HCK ; 1.90 ; HUMAN CYCLIN-DEPENDENT KINASE 2 1HCL ; 1.80 ; HUMAN CYCLIN-DEPENDENT KINASE 2 1DM2 ; 2.10 ; HUMAN CYCLIN-DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR HYMENIALDISINE 1B39 ; 2.10 ; HUMAN CYCLIN-DEPENDENT KINASE 2 PHOSPHORYLATED ON THR 160 1AK4 ; 2.36 ; HUMAN CYCLOPHILIN A BOUND TO THE AMINO-TERMINAL DOMAIN OF HIV-1 CAPSID 1CWK ; 1.80 ; HUMAN CYCLOPHILIN A COMPLEXED WITH 1-(6,7-DIHYDRO)MEBMT 2-VAL 3-D-(2-S-METHYL)SARCOSINE CYCLOSPORIN 1BCK ; 1.80 ; HUMAN CYCLOPHILIN A COMPLEXED WITH 2-THR CYCLOSPORIN 1CWI ; 1.90 ; HUMAN CYCLOPHILIN A COMPLEXED WITH 2-VAL 3-(N-METHYL)-D-ALANINE CYCLOSPORIN 1CWJ ; 1.80 ; HUMAN CYCLOPHILIN A COMPLEXED WITH 2-VAL 3-S-METHYL-SARCOSINE CYCLOSPORIN 1CWF ; 1.86 ; HUMAN CYCLOPHILIN A COMPLEXED WITH 2-VAL CYCLOSPORIN 1CWH ; 1.86 ; HUMAN CYCLOPHILIN A COMPLEXED WITH 3-D-SER CYCLOSPORIN 1CWL ; 1.80 ; HUMAN CYCLOPHILIN A COMPLEXED WITH 4 4-HYDROXY-MELEU CYCLOSPORIN 1CWM ; 2.00 ; HUMAN CYCLOPHILIN A COMPLEXED WITH 4 MEILE CYCLOSPORIN 1CWO ; 1.86 ; HUMAN CYCLOPHILIN A COMPLEXED WITH THR2, LEU5, D-HIV8, LEU10 CYCLOSPORIN 1OCA ; -1.00 ; HUMAN CYCLOPHILIN A, UNLIGATED, NMR, 20 STRUCTURES 2ESL ; 1.90 ; HUMAN CYCLOPHILIN C IN COMPLEX WITH CYCLOSPORIN A 1G96 ; 2.50 ; HUMAN CYSTATIN C; DIMERIC FORM WITH 3D DOMAIN SWAPPING 1CMV ; 2.27 ; HUMAN CYTOMEGALOVIRUS PROTEASE 1JQ6 ; 2.30 ; HUMAN CYTOMEGALOVIRUS PROTEASE DIMER-INTERFACE MUTANT, S225Y 1WL5 ; 2.26 ; HUMAN CYTOSOLIC ACETOACETYL-COA THIOLASE 1WL4 ; 1.55 ; HUMAN CYTOSOLIC ACETOACETYL-COA THIOLASE COMPLEXED WITH COA 1CJY ; 2.50 ; HUMAN CYTOSOLIC PHOSPHOLIPASE A2 2BBS ; 2.05 ; HUMAN DELTAF508 NBD1 WITH THREE SOLUBILIZING MUTATIONS 2BBT ; 2.30 ; HUMAN DELTAF508 NBD1 WITH TWO SOLUBLIZING MUTATIONS. 1B86 ; 2.50 ; HUMAN DEOXYHAEMOGLOBIN-2,3-DIPHOSPHOGLYCERATE COMPLEX 1ZJM ; 2.10 ; HUMAN DEOXYRIBONUCLEIC ACID POLYMERASE BETA COMPLEXED WITH DEOXYRIBONUCLEIC ACID CONTAINING AN A-A MISMATCHED PRIMER TERMINUS 1ZJN ; 2.61 ; HUMAN DEOXYRIBONUCLEIC ACID POLYMERASE BETA COMPLEXED WITH DEOXYRIBONUCLEIC ACID CONTAINING AN A-A MISMATCHED PRIMER TERMINUS WITH DGTP 1BPX ; 2.40 ; HUMAN DEOXYRIBONUCLEIC ACID POLYMERASE BETA COMPLEXED WITH GAPPED DEOXYRIBONUCLEIC ACID 1BPY ; 2.20 ; HUMAN DEOXYRIBONUCLEIC ACID POLYMERASE BETA COMPLEXED WITH GAPPED DEOXYRIBONUCLEIC ACID AND DDCTP 1MQ2 ; 3.10 ; HUMAN DEOXYRIBONUCLEIC ACID POLYMERASE BETA COMPLEXED WITH GAPPED DEOXYRIBONUCLEIC ACID CONTAINING AN 8-OXO-7,8-DIHYDRO-GUANINE AND DAMP 1MQ3 ; 2.80 ; HUMAN DEOXYRIBONUCLEIC ACID POLYMERASE BETA COMPLEXED WITH GAPPED DEOXYRIBONUCLEIC ACID CONTAINING AN 8-OXO-7,8-DIHYDRO-GUANINE TEMPLATE PAIRED WITH DCTP 1BPZ ; 2.60 ; HUMAN DEOXYRIBONUCLEIC ACID POLYMERASE BETA COMPLEXED WITH NICKED DEOXYRIBONUCLEIC ACID 1TV9 ; 2.00 ; HUMAN DEOXYRIBONUCLEIC ACID POLYMERASE BETA COMPLEXED WITH NICKED DEOXYRIBONUCLEIC ACID CONTAINING A MISMATCHED TEMPLATE ADENINE AND INCOMING CYTIDINE 1TVA ; 2.60 ; HUMAN DEOXYRIBONUCLEIC ACID POLYMERASE BETA COMPLEXED WITH NICKED DEOXYRIBONUCLEIC ACID CONTAINING A MISMATCHED TEMPLATE THYMIDINE AND INCOMING CYTIDINE 1TL8 ; 3.10 ; HUMAN DEOXYRIBONUCLEIC ACID TOPOISOMERASE I (70 KDA) IN COMPLEX WITH THE INDENOISOQUINOLINE AI-III-52 AND COVALENT COMPLEX WITH A 22 BASE PAIR DEOXYRIBONUCLEIC ACID DUPLEX 1SC7 ; 3.00 ; HUMAN DEOXYRIBONUCLEIC ACID TOPOISOMERASE I (70 KDA) IN COMPLEX WITH THE INDENOISOQUINOLINE MJ-II-38 AND COVALENT COMPLEX WITH A 22 BASE PAIR DEOXYRIBONUCLEIC ACID DUPLEX 1SEU ; 3.00 ; HUMAN DEOXYRIBONUCLEIC ACID TOPOISOMERASE I (70 KDA) IN COMPLEX WITH THE INDOLOCARBAZOLE SA315F AND COVALENT COMPLEX WITH A 22 BASE PAIR DEOXYRIBONUCLEIC ACID DUPLEX 1T8I ; 3.00 ; HUMAN DEOXYRIBONUCLEIC ACID TOPOISOMERASE I (70 KDA) IN COMPLEX WITH THE POISON CAMPTOTHECIN AND COVALENT COMPLEX WITH A 22 BASE PAIR DEOXYRIBONUCLEIC ACID DUPLEX 1K4T ; 2.10 ; HUMAN DEOXYRIBONUCLEIC ACID TOPOISOMERASE I (70 KDA) IN COMPLEX WITH THE POISON TOPOTECAN AND COVALENT COMPLEX WITH A 22 BASE PAIR DEOXYRIBONUCLEIC ACID DUPLEX 1A36 ; 2.80 ; HUMAN DEOXYRIBONUCLEIC ACID TOPOISOMERASE I (70 KDA) IN NON-COVALENT COMPLEX WITH A 22 BASE PAIR DEOXYRIBONUCLEIC ACID DUPLEX 1LPQ ; 3.14 ; HUMAN DEOXYRIBONUCLEIC ACID TOPOISOMERASE I (70 KDA) IN NON-COVALENT COMPLEX WITH A 22 BASE PAIR DEOXYRIBONUCLEIC ACID DUPLEX CONTAINING AN 8-OXOG LESION 1K4S ; 3.20 ; HUMAN DEOXYRIBONUCLEIC ACID TOPOISOMERASE I IN COVALENT COMPLEX WITH A 22 BASE PAIR DEOXYRIBONUCLEIC ACID DUPLEX 1ZXN ; 2.51 ; HUMAN DEOXYRIBONUCLEIC ACID TOPOISOMERASE IIA ATPASE/ADP 1KMV ; 1.05 ; HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND (Z)- 6-(2-[2,5-DIMETHOXYPHENYL]ETHEN-1-YL)-2,4-DIAMINO-5- METHYLPYRIDO[2,3-D]PYRIMIDINE (SRI-9662), A LIPOPHILIC ANTIFOLATE 1KMS ; 1.09 ; HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 6- ([5-QUINOLYLAMINO]METHYL)-2,4-DIAMINO-5-METHYLPYRIDO[2,3- D]PYRIMIDINE (SRI-9439), A LIPOPHILIC ANTIFOLATE 1OHJ ; 2.50 ; HUMAN DIHYDROFOLATE REDUCTASE, MONOCLINIC (P21) CRYSTAL FORM 1OHK ; 2.50 ; HUMAN DIHYDROFOLATE REDUCTASE, ORTHORHOMBIC (P21 21 21) CRYSTAL FORM 2B0M ; 2.00 ; HUMAN DIHYDROOROTATE DEHYDROGENASE BOUND TO A NOVEL INHIBITOR 1D3H ; 1.80 ; HUMAN DIHYDROOROTATE DEHYDROGENASE COMPLEXED WITH ANTIPROLIFERATIVE AGENT A771726 1D3G ; 1.60 ; HUMAN DIHYDROOROTATE DEHYDROGENASE COMPLEXED WITH BREQUINAR ANALOG 1RWQ ; 2.20 ; HUMAN DIPEPTIDYL PEPTIDASE IV IN COMPLEX WITH 5-AMINOMETHYL- 6-(2,4-DICHLORO-PHENYL)-2-(3,5-DIMETHOXY-PHENYL)-PYRIMIDIN- 4-YLAMINE 1X70 ; 2.10 ; HUMAN DIPEPTIDYL PEPTIDASE IV IN COMPLEX WITH A BETA AMINO ACID INHIBITOR 1N1M ; 2.50 ; HUMAN DIPEPTIDYL PEPTIDASE IV/CD26 IN COMPLEX WITH AN INHIBITOR 1TKR ; 2.70 ; HUMAN DIPEPTIDYL PEPTIDASE IV/CD26 INHIBITED WITH DIISOPROPYL FLUOROPHOSPHATE 1U8E ; 2.20 ; HUMAN DIPEPTIDYL PEPTIDASE IV/CD26 MUTANT Y547F 1SOA ; 1.20 ; HUMAN DJ-1 WITH SULFINIC ACID 1Q5U ; 2.00 ; HUMAN DUTP PYROPHOSPHATASE 1Q5H ; 2.00 ; HUMAN DUTP PYROPHOSPHATASE COMPLEX WITH DUDP 1X88 ; 1.80 ; HUMAN EG5 MOTOR DOMAIN BOUND TO MG-ADP AND MONASTROL 1A9W ; 2.90 ; HUMAN EMBRYONIC GOWER II CARBONMONOXY HEMOGLOBIN 1M9R ; 2.56 ; HUMAN ENDOTHELIAL NITRIC OXIDE SYNTHASE WITH 3-BROMO-7- NITROINDAZOLE BOUND 1M9Q ; 2.01 ; HUMAN ENDOTHELIAL NITRIC OXIDE SYNTHASE WITH 5- NITROINDAZOLE BOUND 1M9M ; 1.96 ; HUMAN ENDOTHELIAL NITRIC OXIDE SYNTHASE WITH 6- NITROINDAZOLE BOUND 1M9K ; 2.01 ; HUMAN ENDOTHELIAL NITRIC OXIDE SYNTHASE WITH 7- NITROINDAZOLE BOUND 3NOS ; 2.40 ; HUMAN ENDOTHELIAL NITRIC OXIDE SYNTHASE WITH ARGININE SUBSTRATE 1M9J ; 2.43 ; HUMAN ENDOTHELIAL NITRIC OXIDE SYNTHASE WITH CHLORZOXAZONE BOUND 1EDN ; 2.18 ; HUMAN ENDOTHELIN-1 2BZV ; 1.15 ; HUMAN ENTERIC ADENOVIRUS SEROTYPE 41 SHORT FIBER HEAD (PH8) 1DGB ; 2.20 ; HUMAN ERYTHROCYTE CATALASE 1DGF ; 1.50 ; HUMAN ERYTHROCYTE CATALASE 1DGH ; 2.00 ; HUMAN ERYTHROCYTE CATALASE 3-AMINO-1,2,4-TRIAZOLE COMPLEX 1DGG ; 1.80 ; HUMAN ERYTHROCYTE CATALSE CYANIDE COMPLEX 1LIU ; 2.72 ; HUMAN ERYTHROCYTE PYRUVATE KINASE 1LIY ; 2.74 ; HUMAN ERYTHROCYTE PYRUVATE KINASE: ARG479HIS MUTANT 1LIX ; 2.87 ; HUMAN ERYTHROCYTE PYRUVATE KINASE: ARG486TRP MUTANT 1LIW ; 2.75 ; HUMAN ERYTHROCYTE PYRUVATE KINASE: THR384MET MUTANT 1BUY ; -1.00 ; HUMAN ERYTHROPOIETIN, NMR MINIMIZED AVERAGE STRUCTURE 1L2I ; 1.95 ; HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH (R,R)-5,11-CIS-DIETHYL-5,6,11,12- TETRAHYDROCHRYSENE-2,8-DIOL AND A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE 3ERT ; 1.90 ; HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH 4-HYDROXYTAMOXIFEN 1XP1 ; 1.80 ; HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH COMPOUND 15 1XP6 ; 1.70 ; HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH COMPOUND 16 1XP9 ; 1.80 ; HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH COMPOUND 18 1XPC ; 1.60 ; HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH COMPOUND 19 1YIN ; 2.20 ; HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH COMPOUND 3F 1YIM ; 1.90 ; HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH COMPOUND 4 3ERD ; 2.03 ; HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH DIETHYLSTILBESTROL AND A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE 1R5K ; 2.70 ; HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH GW5638 1SJ0 ; 1.90 ; HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE ANTAGONIST LIGAND 4-D 1L2J ; 2.95 ; HUMAN ESTROGEN RECEPTOR BETA LIGAND-BINDING DOMAIN IN COMPLEX WITH (R,R)-5,11-CIS-DIETHYL-5,6,11,12- TETRAHYDROCHRYSENE-2,8-DIOL 1ERE ; 3.10 ; HUMAN ESTROGEN RECEPTOR LIGAND-BINDING DOMAIN IN COMPLEX WITH 17BETA-ESTRADIOL 1ERR ; 2.60 ; HUMAN ESTROGEN RECEPTOR LIGAND-BINDING DOMAIN IN COMPLEX WITH RALOXIFENE 1BHS ; 2.20 ; HUMAN ESTROGENIC 17BETA-HYDROXYSTEROID DEHYDROGENASE 1DSU ; 2.00 ; HUMAN FACTOR D, COMPLEMENT ACTIVATING ENZYME 1MZE ; 2.20 ; HUMAN FACTOR INHIBITING HIF (FIH1) 1MZF ; 2.40 ; HUMAN FACTOR INHIBITING HIF (FIH1) IN COMPLEX WITH 2- OXOGLUTARATE 1WV7 ; 2.70 ; HUMAN FACTOR VIIA-TISSUE FACTOR COMPLEXED WITH ETHYLSULFONAMIDE-D-5-PROPOXY-TRP-GLN-P-AMINOBENZAMIDINE 1WTG ; 2.20 ; HUMAN FACTOR VIIA-TISSUE FACTOR COMPLEXED WITH ETHYLSULFONAMIDE-D-BIPHENYLALANINE-GLN-P-AMINOBENZAMIDINE 1WUN ; 2.40 ; HUMAN FACTOR VIIA-TISSUE FACTOR COMPLEXED WITH ETHYLSULFONAMIDE-D-TRP-GLN-P-AMINOBENZAMIDINE 1WQV ; 2.50 ; HUMAN FACTOR VIIA-TISSUE FACTOR COMPLEXED WITH PROPYLSULFONAMIDE-D-THR-MET-P-AMINOBENZAMIDINE 1WSS ; 2.60 ; HUMAN FACTOR VIIA-TISSUE FACTOR IN COMPLEX WITH PEPRID MIMETIC INHIBITOR THAT HAS TWO CHARGE GROUPS IN P2 AND P4 1IQD ; 2.00 ; HUMAN FACTOR VIII C2 DOMAIN COMPLEXED TO HUMAN MONOCLONAL BO2C11 FAB. 1EVU ; 2.01 ; HUMAN FACTOR XIII WITH CALCIUM BOUND IN THE ION SITE 1GGU ; 2.10 ; HUMAN FACTOR XIII WITH CALCIUM BOUND IN THE ION SITE 1QRK ; 2.50 ; HUMAN FACTOR XIII WITH STRONTIUM BOUND IN THE ION SITE 1GGY ; 2.50 ; HUMAN FACTOR XIII WITH YTTERBIUM BOUND IN THE ION SITE 1EX0 ; 2.00 ; HUMAN FACTOR XIII, MUTANT W279F ZYMOGEN 1YV5 ; 2.00 ; HUMAN FARNESYL DIPHOSPHATE SYNTHASE COMPLEXED WITH MG AND RISEDRONATE 1YQ7 ; 2.20 ; HUMAN FARNESYL DIPHOSPHATE SYNTHASE COMPLEXED WITH RISEDRONATE 1XKT ; 2.60 ; HUMAN FATTY ACID SYNTHASE: STRUCTURE AND SUBSTRATE SELECTIVITY OF THE THIOESTERASE DOMAIN 2FCB ; 1.74 ; HUMAN FC GAMMA RECEPTOR IIB ECTODOMAIN (CD32) 1H9V ; 3.00 ; HUMAN FC-GAMMA-RECEPTOR IIA (FCGRIIA), MONOCLINIC 1FL7 ; 3.00 ; HUMAN FOLLICLE STIMULATING HORMONE 1Y1E ; 1.73 ; HUMAN FORMYLGLYCINE GENERATING ENZYME 1Y1F ; 1.80 ; HUMAN FORMYLGLYCINE GENERATING ENZYME WITH CYSTEINE SULFENIC ACID 1Y1G ; 1.67 ; HUMAN FORMYLGLYCINE GENERATING ENZYME, DOUBLE SULFONIC ACID FORM 1Y1H ; 1.67 ; HUMAN FORMYLGLYCINE GENERATING ENZYME, OXIDISED CYS REFINED AS HYDROPEROXIDE 1Y1J ; 1.55 ; HUMAN FORMYLGLYCINE GENERATING ENZYME, SULFONIC ACID/DESULFURATED FORM 1HT0 ; 2.00 ; HUMAN GAMMA-2 ALCOHOL DEHYDROGENSE 1H4A ; 1.15 ; HUMAN GAMMA-D CRYSTALLIN R58H MUTANT STRUCTURE AT 1.15 A RESOLUTION 1HK0 ; 1.25 ; HUMAN GAMMA-D CRYSTALLIN STRUCTURE AT 1.25 A RESOLUTION 1UOH ; 2.00 ; HUMAN GANKYRIN 1RBQ ; 2.10 ; HUMAN GAR TFASE COMPLEX STRUCTURE WITH 10-(TRIFLUOROACETYL)- 5,10-DIDEAZAACYCLIC-5,6,7,8-TETRAHYDROFOLIC ACID 1RBY ; 2.10 ; HUMAN GAR TFASE COMPLEX STRUCTURE WITH 10-(TRIFLUOROACETYL)- 5,10-DIDEAZAACYCLIC-5,6,7,8-TETRAHYDROFOLIC ACID AND SUBSTRATE BETA-GAR 1RBM ; 2.30 ; HUMAN GAR TFASE COMPLEX STRUCTURE WITH POLYGLUTAMATED 10- (TRIFLUOROACETYL)-5,10-DIDEAZAACYCLIC-5,6,7,8- TETRAHYDROFOLIC ACID 1RBZ ; 2.10 ; HUMAN GAR TFASE COMPLEX STRUCTURE WITH POLYGLUTAMATED 10- (TRIFLUOROACETYL)-5,10-DIDEAZAACYCLIC-5,6,7,8- TETRAHYDROFOLIC ACID 1RC0 ; 2.05 ; HUMAN GAR TFASE COMPLEX STRUCTURE WITH POLYGLUTAMATED 10- (TRIFLUOROACETYL)-5,10-DIDEAZAACYCLIC-5,6,7,8- TETRAHYDROFOLIC ACID 1RC1 ; 2.25 ; HUMAN GAR TFASE COMPLEX STRUCTURE WITH POLYGLUTAMATED 10- (TRIFLUOROACETYL)-5,10-DIDEAZAACYCLIC-5,6,7,8- TETRAHYDROFOLIC ACID 1NJS ; 1.98 ; HUMAN GAR TFASE IN COMPLEX WITH HYDROLYZED FORM OF 10- TRIFLUOROACETYL-5,10-DIDEAZA-ACYCLIC-5,6,7,8- TETRAHYDROFOLIC ACID 1Z4R ; 1.74 ; HUMAN GCN5 ACETYLTRANSFERASE 1KCQ ; 1.65 ; HUMAN GELSOLIN DOMAIN 2 WITH A CD2+ BOUND 1NE7 ; 1.75 ; HUMAN GLUCOSAMINE-6-PHOSPHATE DEAMINASE ISOMERASE AT 1.75 A RESOLUTION COMPLEXED WITH N-ACETYL-GLUCOSAMINE-6-PHOSPHATE AND 2-DEOXY-2-AMINO-GLUCITOL-6-PHOSPHATE 1JLH ; 2.10 ; HUMAN GLUCOSE-6-PHOSPHATE ISOMERASE 1JHB ; -1.00 ; HUMAN GLUTAREDOXIN IN FULLY REDUCED FORM, NMR, 20 STRUCTURES 5GRT ; 2.40 ; HUMAN GLUTATHIONE REDUCTASE A34E, R37W MUTANT, GLUTATHIONYLSPERMIDINE COMPLEX 4GRT ; 2.80 ; HUMAN GLUTATHIONE REDUCTASE A34E, R37W MUTANT, MIXED DISULFIDE BETWEEN TRYPANOTHIONE AND THE ENZYME 2GRT ; 2.70 ; HUMAN GLUTATHIONE REDUCTASE A34E, R37W MUTANT, OXIDIZED GLUTATHIONE COMPLEX 3GRT ; 2.50 ; HUMAN GLUTATHIONE REDUCTASE A34E, R37W MUTANT, OXIDIZED TRYPANOTHIONE COMPLEX 1GRT ; 2.30 ; HUMAN GLUTATHIONE REDUCTASE A34E/R37W MUTANT 1XAN ; 2.00 ; HUMAN GLUTATHIONE REDUCTASE IN COMPLEX WITH A XANTHENE INHIBITOR 1K4Q ; 1.90 ; HUMAN GLUTATHIONE REDUCTASE INACTIVATED BY PEROXYNITRITE 1DNC ; 1.70 ; HUMAN GLUTATHIONE REDUCTASE MODIFIED BY DIGLUTATHIONE-DINITROSO-IRON 1GSN ; 1.70 ; HUMAN GLUTATHIONE REDUCTASE MODIFIED BY DINITROSOGLUTATHIONE 1XW5 ; 1.80 ; HUMAN GLUTATHIONE S-TRANSFERASE M2-2 COMPLEXED WITH GLUTATHIONE, MONOCLINIC CRYSTAL FORM 1YKC ; 2.10 ; HUMAN GLUTATHIONE S-TRANSFERASE M2-2 COMPLEXED WITH GLUTATHIONE-DISULFIDE 2AB6 ; 2.50 ; HUMAN GLUTATHIONE S-TRANSFERASE M2-2 COMPLEXED WITH S-METHYLGLUTATHIONE 21GS ; 1.90 ; HUMAN GLUTATHIONE S-TRANSFERASE P1-1 IN COMPLEX WITH CHLORAMBUCIL 2GSS ; 1.90 ; HUMAN GLUTATHIONE S-TRANSFERASE P1-1 IN COMPLEX WITH ETHACRYNIC ACID 3GSS ; 1.90 ; HUMAN GLUTATHIONE S-TRANSFERASE P1-1 IN COMPLEX WITH ETHACRYNIC ACID-GLUTATHIONE CONJUGATE 4GSS ; 2.50 ; HUMAN GLUTATHIONE S-TRANSFERASE P1-1 Y108F MUTANT 22GS ; 1.90 ; HUMAN GLUTATHIONE S-TRANSFERASE P1-1 Y49F MUTANT 5GSS ; 1.95 ; HUMAN GLUTATHIONE S-TRANSFERASE P1-1, COMPLEX WITH GLUTATHIONE 6GSS ; 1.90 ; HUMAN GLUTATHIONE S-TRANSFERASE P1-1, COMPLEX WITH GLUTATHIONE 7GSS ; 2.20 ; HUMAN GLUTATHIONE S-TRANSFERASE P1-1, COMPLEX WITH GLUTATHIONE 8GSS ; 1.90 ; HUMAN GLUTATHIONE S-TRANSFERASE P1-1, COMPLEX WITH GLUTATHIONE 9GSS ; 1.90 ; HUMAN GLUTATHIONE S-TRANSFERASE P1-1, COMPLEX WITH S-HEXYL GLUTATHIONE 10GS ; 2.20 ; HUMAN GLUTATHIONE S-TRANSFERASE P1-1, COMPLEX WITH TER117 2HGS ; 2.10 ; HUMAN GLUTATHIONE SYNTHETASE 1GUL ; 2.70 ; HUMAN GLUTATHIONE TRANSFERASE A4-4 COMPLEX WITH IODOBENZYL GLUTATHIONE 1GUM ; 3.00 ; HUMAN GLUTATHIONE TRANSFERASE A4-4 WITHOUT LIGANDS 1M6H ; 2.00 ; HUMAN GLUTATHIONE-DEPENDENT FORMALDEHYDE DEHYDROGENASE 2C4J ; 1.35 ; HUMAN GLUTATHIONE-S-TRANSFERASE M2-2 T210A MUTANT IN COMPLEX WITH GLUTATHIONE-STYRENE OXIDE CONJUGATE 2C3Q ; 1.85 ; HUMAN GLUTATHIONE-S-TRANSFERASE T1-1 W234R MUTANT, COMPLEX WITH S-HEXYLGLUTATHIONE 2C3N ; 1.50 ; HUMAN GLUTATHIONE-S-TRANSFERASE T1-1, APO FORM 2C3T ; 2.40 ; HUMAN GLUTATHIONE-S-TRANSFERASE T1-1, W234R MUTANT, APO FORM 1MEO ; 1.72 ; HUMAN GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE AT PH 4.2 1MEJ ; 2.00 ; HUMAN GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE DOMAIN AT PH 8.5 1GIF ; 1.90 ; HUMAN GLYCOSYLATION-INHIBITING FACTOR 1QIN ; 2.00 ; HUMAN GLYOXALASE I COMPLEXED WITH S-(N-HYDROXY-N-P- IODOPHENYLCARBAMOYL) GLUTATHIONE 1QIP ; 1.72 ; HUMAN GLYOXALASE I COMPLEXED WITH S-P- NITROBENZYLOXYCARBONYLGLUTATHIONE 1BH5 ; 2.20 ; HUMAN GLYOXALASE I Q33E, E172Q DOUBLE MUTANT 1FRO ; 2.20 ; HUMAN GLYOXALASE I WITH BENZYL-GLUTATHIONE INHIBITOR 1QH3 ; 1.90 ; HUMAN GLYOXALASE II WITH CACODYLATE AND ACETATE IONS PRESENT IN THE ACTIVE SITE 1QH5 ; 1.45 ; HUMAN GLYOXALASE II WITH S-(N-HYDROXY-N- BROMOPHENYLCARBAMOYL)GLUTATHIONE 1TJJ ; 2.00 ; HUMAN GM2 ACTIVATOR PROTEIN PAF COMPLEX 1G13 ; 2.00 ; HUMAN GM2 ACTIVATOR STRUCTURE 2GMF ; 2.40 ; HUMAN GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR 1IAU ; 2.00 ; HUMAN GRANZYME B IN COMPLEX WITH AC-IEPD-CHO 1HGU ; 2.50 ; HUMAN GROWTH HORMONE 1A22 ; 2.60 ; HUMAN GROWTH HORMONE BOUND TO SINGLE RECEPTOR 1XWG ; 1.85 ; HUMAN GST A1-1 T68E MUTANT 1ZX0 ; 1.86 ; HUMAN GUANIDINOACETATE N-METHYLTRANSFERASE WITH SAH 1F5N ; 1.70 ; HUMAN GUANYLATE BINDING PROTEIN-1 IN COMPLEX WITH THE GTP ANALOGUE, GMPPNP. 2FHA ; 1.90 ; HUMAN H CHAIN FERRITIN 4HCK ; -1.00 ; HUMAN HCK SH3 DOMAIN, NMR, 25 STRUCTURES 5HCK ; -1.00 ; HUMAN HCK SH3 DOMAIN, NMR, MINIMIZED AVERAGE STRUCTURE 1I0Z ; 2.10 ; HUMAN HEART L-LACTATE DEHYDROGENASE H CHAIN, TERNARY COMPLEX WITH NADH AND OXAMATE 1T5P ; 2.11 ; HUMAN HEME OXYGENASE OXIDATION OF ALPHA- AND GAMMA-MESO- PHENYLHEMES 1S13 ; 2.29 ; HUMAN HEME OXYGENASE OXIDATITION OF ALPHA- AND GAMMA-MESO- PHENYLHEMES 1AE5 ; 2.30 ; HUMAN HEPARIN BINDING PROTEIN 1QGT ; 3.30 ; HUMAN HEPATITIS B VIRAL CAPSID (HBCAG) 1QHA ; 2.25 ; HUMAN HEXOKINASE TYPE I COMPLEXED WITH ATP ANALOGUE AMP-PNP 1BZY ; 2.00 ; HUMAN HGPRTASE WITH TRANSITION STATE INHIBITOR 1J87 ; 3.20 ; HUMAN HIGH AFFINITY FC RECEPTOR FC(EPSILON)RI(ALPHA), HEXAGONAL CRYSTAL FORM 1 1J86 ; 3.20 ; HUMAN HIGH AFFINITY FC RECEPTOR FC(EPSILON)RI(ALPHA), MONOCLINIC CRYSTAL FORM 2 1J88 ; 3.20 ; HUMAN HIGH AFFINITY FC RECEPTOR FC(EPSILON)RI(ALPHA), TETRAGONAL CRYSTAL FORM 1 1J89 ; 4.10 ; HUMAN HIGH AFFINITY FC RECEPTOR FC(EPSILON)RI(ALPHA), TETRAGONAL CRYSTAL FORM 2 1EY2 ; 2.30 ; HUMAN HOMOGENTISATE DIOXYGENASE WITH FE(II) 1HDJ ; -1.00 ; HUMAN HSP40 (HDJ-1), NMR 1YER ; 1.65 ; HUMAN HSP90 GELDANAMYCIN-BINDING DOMAIN, "CLOSED" CONFORMATION 1YES ; 2.20 ; HUMAN HSP90 GELDANAMYCIN-BINDING DOMAIN, "OPEN" CONFORMATION 1OSF ; 1.75 ; HUMAN HSP90 IN COMPLEX WITH 17-DESMETHOXY-17-N,N- DIMETHYLAMINOETHYLAMINO-GELDANAMYCIN 1UYI ; 2.00 ; HUMAN HSP90-ALPHA WITH 8-(2,5-DIMETHOXY-BENZYL)-2-FLUORO-9- PENT-9H-PURIN-6-YLAMINE 1UYG ; 2.00 ; HUMAN HSP90-ALPHA WITH 8-(2,5-DIMETHOXY-BENZYL)-2-FLUORO-9H-PURIN-6-YLAMINE 1UYF ; 2.00 ; HUMAN HSP90-ALPHA WITH 8-(2-CHLORO-3,4,5-TRIMETHOXY-BENZYL) -2-FLUORO-9-PENT-4-YLNYL-9H-PURIN-6-YLAMINE 1UYE ; 2.00 ; HUMAN HSP90-ALPHA WITH 8-(2-CHLORO-3,4,5-TRIMETHOXY-BENZYL) -9-PENT-4-YLNYL-9H-PURIN-6-YLAMINE 1UYK ; 2.00 ; HUMAN HSP90-ALPHA WITH 8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUT YL-2-FLUORO-9H-PURIN-6-YLAMINE 1UY9 ; 2.00 ; HUMAN HSP90-ALPHA WITH 8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUTYL-9H-PURIN-6-YLAMINE 1UYH ; 2.20 ; HUMAN HSP90-ALPHA WITH 9-BUTYL-8- (2,5-DIMETHOXY-BENZYL)-2-FLUORO-9H-PURIN-6-YLAMINE 1UYD ; 2.00 ; HUMAN HSP90-ALPHA WITH 9-BUTYL-8- (2-CHLORO-3,4,5-TRIMETHOXY-BENZYL)-9H-PURIN-6-YLAMINE 1UYC ; 2.00 ; HUMAN HSP90-ALPHA WITH 9-BUTYL-8-(2,5-DIMETHOXY-BENZYL)-9H-PURIN-6-YLAMINE 1UY6 ; 1.90 ; HUMAN HSP90-ALPHA WITH 9-BUTYL-8-(3,4,5-TRIMETHOXY-BENZYL)-9H-PURIN-6-YLAMINE 1UY8 ; 1.98 ; HUMAN HSP90-ALPHA WITH 9-BUTYL-8-(3-TRIMETHOXY-BENZYL)-9H-PURIN-6YLAMINE 1UY7 ; 1.90 ; HUMAN HSP90-ALPHA WITH 9-BUTYL-8-(4-METHOXY-BENZYL)-9H-PURIN-6-YLAMINE 1UYM ; 2.45 ; HUMAN HSP90-BETA WITH PU3 (9-BUTYL-8(3,4,5-TRIMETHOXY-BENZYL)-9H-PURIN-6-YLAMINE) 1GP0 ; 1.40 ; HUMAN IGF2R DOMAIN 11 1GP3 ; 1.95 ; HUMAN IGF2R DOMAIN 11 1J7V ; 2.90 ; HUMAN IL-10 / IL-10R1 COMPLEX 1O1V ; -1.00 ; HUMAN ILEAL LIPID-BINDING PROTEIN (ILBP) IN COMPLEX WITH CHOLYLTAURINE 1O1U ; -1.00 ; HUMAN ILEAL LIPID-BINDING PROTEIN (ILBP) IN FREE FORM 1DLO ; 2.70 ; HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 1HPZ ; 3.00 ; HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 1HQE ; 2.70 ; HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 1HQU ; 2.70 ; HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 2HMX ; -1.00 ; HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 MATRIX PROTEIN 1HVU ; 4.75 ; HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE COMPLEXED WITH A 33-BASE NUCLEOTIDE RIBONUCLEIC ACID PSEUDOKNOT 3UPJ ; 2.50 ; HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 PROTEASE MUTANT WITH LYS 57 REPLACED BY LEU (K57L) COMPLEX WITH U096333 [4-HYDROXY-3-[1-(PHENYL)PROPYL]-7-METHOXYCOUMARIN] 4UPJ ; 1.90 ; HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 PROTEASE MUTANT WITH LYS 57 REPLACED BY LEU (K57L) COMPLEX WITH U097410 [4-HYDROXY-3-[1-[3-[[[[(TERT-BUTYLOXYCARBONYL) AMINOMETHYL]CARBONYL]AMINO]PHENYL]PROPYL]COUMARIN 1TAM ; -1.00 ; HUMAN IMMUNODEFICIENCY VIRUS, NMR, MINIMIZED AVERAGE STRUCTURE 1GTC ; -1.00 ; HUMAN IMMUNODEFICIENCY VIRUS-1 OKAZAKI FRAGMENT, DEOXYRIBONUCLEIC ACID-RIBONUCLEIC ACID CHIMERA, NMR, 11 STRUCTURES 4NOS ; 2.25 ; HUMAN INDUCIBLE NITRIC OXIDE SYNTHASE WITH INHIBITOR 1NSI ; 2.55 ; HUMAN INDUCIBLE NITRIC OXIDE SYNTHASE, ZN-BOUND, L-ARG COMPLEX 2NSI ; 3.00 ; HUMAN INDUCIBLE NITRIC OXIDE SYNTHASE, ZN-FREE, SEITU COMPLEX 1W2C ; 1.95 ; HUMAN INOSITOL (1,4,5) TRISPHOSPHATE 3-KINASE COMPLEXED WITH MN2+/AMPPNP/INS(1,4,5)P3 1W2D ; 1.94 ; HUMAN INOSITOL (1,4,5)-TRISPHOSPHATE 3-KINASE COMPLEXED WITH MN2+/ADP/INS(1,3,4,5)P4 1W2F ; 1.80 ; HUMAN INOSITOL (1,4,5)-TRISPHOSPHATE 3-KINASE SUBSTITUTED WITH SELENOMETHIONINE 1XGL ; -1.00 ; HUMAN INSULIN DISULFIDE ISOMER, NMR, 10 STRUCTURES 1QJ0 ; 2.40 ; HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR 1QIY ; 2.30 ; HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR COMPLEXED WITH PHENOL 1QIZ ; 2.00 ; HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR COMPLEXED WITH RESORCINOL 1B9E ; 2.50 ; HUMAN INSULIN MUTANT SERB9GLU 1VKT ; -1.00 ; HUMAN INSULIN TWO DISULFIDE MODEL, NMR, 10 STRUCTURES 1GZR ; 2.00 ; HUMAN INSULIN-LIKE GROWTH FACTOR; ESRF DATA 1GZZ ; 2.30 ; HUMAN INSULIN-LIKE GROWTH FACTOR; HAMBURG DATA 1GZY ; 2.54 ; HUMAN INSULIN-LIKE GROWTH FACTOR; IN-HOUSE DATA 1H02 ; 2.00 ; HUMAN INSULIN-LIKE GROWTH FACTOR; SRS DARESBURY DATA 1AU1 ; 2.20 ; HUMAN INTERFERON-BETA CRYSTAL STRUCTURE 1JLI ; -1.00 ; HUMAN INTERLEUKIN 3 (IL-3) MUTANT WITH TRUNCATION AT BOTH N- AND C-TERMINI AND 14 RESIDUE CHANGES, NMR, MINIMIZED AVERAGE STRUCTURE 9ILB ; 2.28 ; HUMAN INTERLEUKIN-1 BETA 1F45 ; 2.80 ; HUMAN INTERLEUKIN-12 1ALU ; 1.90 ; HUMAN INTERLEUKIN-6 2IL6 ; -1.00 ; HUMAN INTERLEUKIN-6, NMR, 32 STRUCTURES 1IL6 ; -1.00 ; HUMAN INTERLEUKIN-6, NMR, MINIMIZED AVERAGE STRUCTURE 1WLJ ; 1.90 ; HUMAN ISG20 1L2E ; 1.75 ; HUMAN KALLIKREIN 6 (HK6) ACTIVE FORM WITH BENZAMIDINE INHIBITOR 1LO6 ; 1.56 ; HUMAN KALLIKREIN 6 (HK6) ACTIVE FORM WITH BENZAMIDINE INHIBITOR AT 1.56 A RESOLUTION 1MKJ ; 2.70 ; HUMAN KINESIN MOTOR DOMAIN WITH DOCKED NECK LINKER 1PR9 ; 1.96 ; HUMAN L-XYLULOSE REDUCTASE HOLOENZYME 1Z6V ; -1.00 ; HUMAN LACTOFERRICIN 1Z6W ; -1.00 ; HUMAN LACTOFERRICIN 1VFD ; 2.30 ; HUMAN LACTOFERRIN, N-TERMINAL LOBE MUTANT WITH ARG 121 REPLACED BY GLU (R121E) 1VFE ; 2.30 ; HUMAN LACTOFERRIN, N-TERMINAL LOBE MUTANT WITH ARG 121 REPLACED BY SER (R121S) 1X8Y ; 2.20 ; HUMAN LAMIN COIL 2B 1LIT ; 1.55 ; HUMAN LITHOSTATHINE 1FA9 ; 2.40 ; HUMAN LIVER GLYCOGEN PHOSPHORYLASE A COMPLEXED WITH AMP 1L5Q ; 2.25 ; HUMAN LIVER GLYCOGEN PHOSPHORYLASE A COMPLEXED WITH CAFFEINE, N-ACETYL-BETA-D-GLUCOPYRANOSYLAMINE, AND CP- 403700 1XOI ; 2.10 ; HUMAN LIVER GLYCOGEN PHOSPHORYLASE A COMPLEXED WITH CHLOROINDOLOYL GLYCINE AMIDE 1EXV ; 2.40 ; HUMAN LIVER GLYCOGEN PHOSPHORYLASE A COMPLEXED WITH GLCNAC AND CP-403,700 1EM6 ; 2.20 ; HUMAN LIVER GLYCOGEN PHOSPHORYLASE A COMPLEXED WITH GLCNAC AND CP-526,423 1L5R ; 2.10 ; HUMAN LIVER GLYCOGEN PHOSPHORYLASE A COMPLEXED WITH RIBOFLAVIN, N-ACETYL-BETA-D-GLUCOPYRANOSYLAMINE AND CP-403, 700 1L7X ; 2.30 ; HUMAN LIVER GLYCOGEN PHOSPHORYLASE B COMPLEXED WITH CAFFEINE, N-ACETYL-BETA-D-GLUCOPYRANOSYLAMINE, AND CP-403, 700 1FC0 ; 2.40 ; HUMAN LIVER GLYCOGEN PHOSPHORYLASE COMPLEXED WITH N-ACETYL- BETA-D-GLUCOPYRANOSYLAMINE 1L5S ; 2.10 ; HUMAN LIVER GLYCOGEN PHOSPHORYLASE COMPLEXED WITH URIC ACID, N-ACETYL-BETA-D-GLUCOPYRANOSYLAMINE, AND CP-403,700 2A66 ; 2.20 ; HUMAN LIVER RECEPTOR HOMOLOGUE DEOXYRIBONUCLEIC ACID-BINDING DOMAIN (HLRH-1 DBD) IN COMPLEX WITH DSDNA FROM THE HCYP7A1 PROMOTER 1PQ6 ; 2.40 ; HUMAN LXR BETA HORMONE RECEPTOR / GW3965 COMPLEX 1PQC ; 2.80 ; HUMAN LXR BETA HORMONE RECEPTOR COMPLEXED WITH T0901317 1PQ9 ; 2.10 ; HUMAN LXR BETA HORMONE RECEPTOR COMPLEXED WITH T0901317 COMPLEX 1NOW ; 2.20 ; HUMAN LYSOSOMAL BETA-HEXOSAMINIDASE ISOFORM B IN COMPLEX WITH (2R,3R,4S,5R)-2-ACETAMIDO-3,4-DIHYDROXY-5- HYDROXYMETHYL-PIPERIDINIUM CHLORIDE (GALNAC-ISOFAGOMINE) 1NP0 ; 2.50 ; HUMAN LYSOSOMAL BETA-HEXOSAMINIDASE ISOFORM B IN COMPLEX WITH INTERMEDIATE ANALOGUE NAG-THIAZOLINE 1BB4 ; 2.23 ; HUMAN LYSOZYME DOUBLE MUTANT A96L, W109H 1D6Q ; 1.96 ; HUMAN LYSOZYME E102 MUTANT LABELLED WITH 2',3'-EPOXYPROPYL GLYCOSIDE OF N-ACETYLLACTOSAMINE 1D6P ; 2.23 ; HUMAN LYSOZYME L63 MUTANT LABELLED WITH 2',3'-EPOXYPROPYL N, N'-DIACETYLCHITOBIOSE 1RE2 ; 2.30 ; HUMAN LYSOZYME LABELLED WITH TWO 2',3'-EPOXYPROPYL BETA- GLYCOSIDE OF N-ACETYLLACTOSAMINE 1BB3 ; 1.80 ; HUMAN LYSOZYME MUTANT A96L 1BB5 ; 1.80 ; HUMAN LYSOZYME MUTANT A96L COMPLEXED WITH CHITOTRIOSE 1JKB ; 1.66 ; HUMAN LYSOZYME MUTANT WITH GLU 35 REPLACED BY ALA 1JKA ; 1.66 ; HUMAN LYSOZYME MUTANT WITH GLU 35 REPLACED BY ASP 1JKD ; 1.80 ; HUMAN LYSOZYME MUTANT WITH TRP 109 REPLACED BY ALA 1JKC ; 1.66 ; HUMAN LYSOZYME MUTANT WITH TRP 109 REPLACED BY PHE 1REM ; 2.10 ; HUMAN LYSOZYME WITH MAN-B1,4-GLCNAC COVALENTLY ATTACHED TO ASP53 1REY ; 1.70 ; HUMAN LYSOZYME-N,N'-DIACETYLCHITOBIOSE COMPLEX 1REZ ; 1.70 ; HUMAN LYSOZYME-N-ACETYLLACTOSAMINE COMPLEX 1GD0 ; 1.50 ; HUMAN MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) 1EFL ; 2.60 ; HUMAN MALIC ENZYME IN A QUATERNARY COMPLEX WITH NAD, MG, AND TARTRONATE 1QNM ; 2.30 ; HUMAN MANGANESE SUPEROXIDE DISMUTASE MUTANT Q143N 1BN5 ; 1.80 ; HUMAN METHIONINE AMINOPEPTIDASE 2 1BOA ; 1.80 ; HUMAN METHIONINE AMINOPEPTIDASE 2 COMPLEXED WITH ANGIOGENESIS INHIBITOR FUMAGILLIN 1B6A ; 1.60 ; HUMAN METHIONINE AMINOPEPTIDASE 2 COMPLEXED WITH TNP-470 2ADU ; 1.90 ; HUMAN METHIONINE AMINOPEPTIDASE COMPLEX WITH 4-ARYL-1,2,3- TRIAZOLE INHIBITOR 1QZY ; 1.60 ; HUMAN METHIONINE AMINOPEPTIDASE IN COMPLEX WITH BENGAMIDE INHIBITOR LAF153 AND COBALT 1KQ0 ; 2.00 ; HUMAN METHIONINE AMINOPEPTIDASE TYPE II IN COMPLEX WITH D- METHIONINE 1KQ9 ; 1.90 ; HUMAN METHIONINE AMINOPEPTIDASE TYPE II IN COMPLEX WITH L- METHIONINE 1DIA ; 2.20 ; HUMAN METHYLENETETRAHYDROFOLATE DEHYDROGENASE / CYCLOHYDROLASE COMPLEXED WITH NADP AND INHIBITOR LY249543 1DIB ; 2.70 ; HUMAN METHYLENETETRAHYDROFOLATE DEHYDROGENASE / CYCLOHYDROLASE COMPLEXED WITH NADP AND INHIBITOR LY345899 1DIG ; 2.20 ; HUMAN METHYLENETETRAHYDROFOLATE DEHYDROGENASE / CYCLOHYDROLASE COMPLEXED WITH NADP AND INHIBITOR LY374571 1XQ8 ; -1.00 ; HUMAN MICELLE-BOUND ALPHA-SYNUCLEIN 1M8A ; 1.70 ; HUMAN MIP-3ALPHA/CCL20 1E6F ; 1.75 ; HUMAN MIR-RECEPTOR, REPEAT 11 1GQB ; 1.80 ; HUMAN MIR-RECEPTOR, REPEAT 11 2F2S ; 2.00 ; HUMAN MITOCHONDRIAL ACETOACETYL-COA THIOLASE 1ZUM ; 2.10 ; HUMAN MITOCHONDRIAL ALDEHYDE DEHYDROGENASE ASIAN VARIANT, ALDH22, APO FORM 1O01 ; 2.15 ; HUMAN MITOCHONDRIAL ALDEHYDE DEHYDROGENASE COMPLEXED WITH CROTONALDEHYDE, NAD(H) AND MG2+ 1O00 ; 2.60 ; HUMAN MITOCHONDRIAL ALDEHYDE DEHYDROGENASE COMPLEXED WITH NAD+ AND MG2+ SHOWING DUAL NAD(H) CONFORMATIONS 1CW3 ; 2.58 ; HUMAN MITOCHONDRIAL ALDEHYDE DEHYDROGENASE COMPLEXED WITH NAD+ AND MN2+ 1NZX ; 2.45 ; HUMAN MITOCHONDRIAL ALDEHYDE DEHYDROGENASE COMPLEXED WITH NAD+ IN THE PRESENCE OF LOW MG2+ 1NZZ ; 2.45 ; HUMAN MITOCHONDRIAL ALDEHYDE DEHYDROGENASE COMPLEXED WITH NADH IN THE PRESENCE OF LOW MG2+ 1O02 ; 1.90 ; HUMAN MITOCHONDRIAL ALDEHYDE DEHYDROGENASE COMPLEXED WITH NADH IN THE PRESENCE OF MG2+ 1QR6 ; 2.10 ; HUMAN MITOCHONDRIAL NAD(P)-DEPENDENT MALIC ENZYME 2A7V ; 2.04 ; HUMAN MITOCHONDRIAL SERINE HYDROXYMETHYLTRANSFERASE 2 1S3O ; 2.47 ; HUMAN MITOCHONDRIAL SINGLE STRAND DEOXYRIBONUCLEIC ACID BINDING PROTEIN (HMSSB) 3ULL ; 2.40 ; HUMAN MITOCHONDRIAL SINGLE-STRANDED DEOXYRIBONUCLEIC ACID BINDING PROTEIN 2BXR ; 3.00 ; HUMAN MONOAMINE OXIDASE A IN COMPLEX WITH CLORGYLINE, CRYSTAL FORM A 2BXS ; 3.15 ; HUMAN MONOAMINE OXIDASE A IN COMPLEX WITH CLORGYLINE, CRYSTAL FORM B 1GOS ; 3.00 ; HUMAN MONOAMINE OXIDASE B 1OJ9 ; 2.30 ; HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH 1,4-DIPHENYL-2-BUTENE 2BYB ; 2.20 ; HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH DEPRENYL 2BK3 ; 1.80 ; HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH FARNESOL 1OJA ; 1.70 ; HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH ISATIN 1OJD ; 3.10 ; HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH LAURYLDIMETHYLAMINE-N-OXIDE (LDAO) 1OJC ; 2.40 ; HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH N-(2-AMINOETHYL)-P-CHLOROBENZAMIDE 1OJB ; 2.20 ; HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH TRANYLCYPROMINE 2BK5 ; 1.83 ; HUMAN MONOAMINE OXIDASE B: I199F MUTANT IN COMPLEX WITH ISATIN 2BK4 ; 1.90 ; HUMAN MONOAMINE OXIDASE B: I199F MUTANT IN COMPLEX WITH RASAGILINE 1IG6 ; -1.00 ; HUMAN MRF-2 DOMAIN, NMR, 11 STRUCTURES 2ALD ; 2.10 ; HUMAN MUSCLE ALDOLASE 4ALD ; 2.80 ; HUMAN MUSCLE FRUCTOSE 1,6-BISPHOSPHATE ALDOLASE COMPLEXED WITH FRUCTOSE 1,6-BISPHOSPHATE 1I10 ; 2.30 ; HUMAN MUSCLE L-LACTATE DEHYDROGENASE M CHAIN, TERNARY COMPLEX WITH NADH AND OXAMATE 1DNW ; 1.90 ; HUMAN MYELOPEROXIDASE-CYANIDE-THIOCYANATE COMPLEX 1AWB ; 2.50 ; HUMAN MYO-INOSITOL MONOPHOSPHATASE IN COMPLEX WITH D-INOSITOL-1-PHOSPHATE AND CALCIUM 2BBO ; 2.55 ; HUMAN NBD1 WITH PHE508 1HE7 ; 2.00 ; HUMAN NERVE GROWTH FACTOR RECEPTOR TRKA 1NT3 ; 2.40 ; HUMAN NEUROTROPHIN-3 1KBC ; 1.81 ; HUMAN NEUTROPHIL COLLAGENASE CATALYTIC DOMAIN IN COMPLEX WITH AN INHIBITOR 1NGL ; -1.00 ; HUMAN NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (HNGAL), REGULARISED AVERAGE NMR STRUCTURE 1A3Q ; 2.10 ; HUMAN NF-KAPPA-B P52 BOUND TO DEOXYRIBONUCLEIC ACID 2B9E ; 1.65 ; HUMAN NSUN5 PROTEIN 1YUC ; 1.90 ; HUMAN NUCLEAR RECEPTOR LIVER RECEPTOR HOMOLOGUE-1, LRH-1, BOUND TO PHOSPHOLIPID AND A FRAGMENT OF HUMAN SHP 1EHW ; 2.40 ; HUMAN NUCLEOSIDE DIPHOSPHATE KINASE 4 1EH6 ; 2.00 ; HUMAN O6-ALKYLGUANINE-DEOXYRIBONUCLEIC ACID ALKYLTRANSFERASE 1T38 ; 3.20 ; HUMAN O6-ALKYLGUANINE-DEOXYRIBONUCLEIC ACID ALKYLTRANSFERASE BOUND TO DEOXYRIBONUCLEIC ACID CONTAINING O6-METHYLGUANINE 1T39 ; 3.30 ; HUMAN O6-ALKYLGUANINE-DEOXYRIBONUCLEIC ACID ALKYLTRANSFERASE COVALENTLY CROSSLINKED TO DEOXYRIBONUCLEIC ACID 1AX8 ; 2.40 ; HUMAN OBESITY PROTEIN, LEPTIN 1GWR ; 2.40 ; HUMAN OESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH 17BETA-OESTRADIOL AND TIF2 NRBOX3 PEPTIDE 1GWQ ; 2.45 ; HUMAN OESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH RALOXIFENE CORE AND TIF2 NRBOX2 PEPTIDE 1QKM ; 1.80 ; HUMAN OESTROGEN RECEPTOR BETA LIGAND-BINDING DOMAIN IN COMPLEX WITH PARTIAL AGONIST GENISTEIN 2CAN ; 2.30 ; HUMAN ORNITHINE AMINOTRANSFERASE COMPLEXED WITH L-CANALINE 1GBN ; 2.30 ; HUMAN ORNITHINE AMINOTRANSFERASE COMPLEXED WITH THE NEUROTOXIN GABACULINE 1C9Y ; 1.90 ; HUMAN ORNITHINE TRANSCARBAMYLASE: CRYSTALLOGRAPHIC INSIGHTS INTO SUBSTRATE RECOGNITION AND CATALYTIC MECHANISM 1EP9 ; 2.40 ; HUMAN ORNITHINE TRANSCARBAMYLASE: CRYSTALLOGRAPHIC INSIGHTS INTO SUBSTRATE RECOGNITION AND CONFORMATIONAL CHANGE 1YPU ; 2.05 ; HUMAN OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR LOX-1 C2 SPACE GROUP 1YPQ ; 1.40 ; HUMAN OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR LOX-1 DIOXANE COMPLEX 1YPO ; 3.00 ; HUMAN OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR LOX-1 P3 1 21 SPACE GROUP 1KV2 ; 2.80 ; HUMAN P38 MAP KINASE IN COMPLEX WITH BIRB 796 1ZYJ ; 2.00 ; HUMAN P38 MAP KINASE IN COMPLEX WITH INHIBITOR 1A 1IAN ; 2.00 ; HUMAN P38 MAP KINASE INHIBITOR COMPLEX 1O7K ; 2.00 ; HUMAN P47 PX DOMAIN COMPLEX WITH SULPHATES 2BIN ; 1.90 ; HUMAN P53 CORE DOMAIN MUTANT M133L-H168R-V203A-N239Y-N268D 2BIP ; 1.80 ; HUMAN P53 CORE DOMAIN MUTANT M133L-H168R-V203A-N239Y-R249S- N268D 2BIM ; 1.98 ; HUMAN P53 CORE DOMAIN MUTANT M133L-V203A-N239Y-N268D-R273H 2BIO ; 1.90 ; HUMAN P53 CORE DOMAIN MUTANT M133L-V203A-N239Y-R249S-N268D 2BIQ ; 1.80 ; HUMAN P53 CORE DOMAIN MUTANT T123A-M133L-H168R-V203A-N239Y- R249S-N268D 1LKL ; 1.80 ; HUMAN P56-LCK TYROSINE KINASE SH2 DOMAIN IN COMPLEX WITH THE PHOSPHOTYROSYL PEPTIDE AC-PTYR-GLU-GLU-GLY (PYEEG PEPTIDE) 1LKK ; 1.00 ; HUMAN P56-LCK TYROSINE KINASE SH2 DOMAIN IN COMPLEX WITH THE PHOSPHOTYROSYL PEPTIDE AC-PTYR-GLU-GLU-ILE (PYEEI PEPTIDE) 1CWD ; 2.25 ; HUMAN P56LCK TYROSINE KINASE COMPLEXED WITH PHOSPHONOPEPTIDE 1CWE ; 2.30 ; HUMAN P56LCK TYROSINE KINASE COMPLEXED WITH PHOSPHONOPEPTIDE 1BSI ; 2.00 ; HUMAN PANCREATIC ALPHA-AMYLASE FROM PICHIA PASTORIS, GLYCOSYLATED PROTEIN 1JJ4 ; 2.40 ; HUMAN PAPILLOMAVIRUS TYPE 18 E2 DEOXYRIBONUCLEIC ACID-BINDING DOMAIN BOUND TO ITS DEOXYRIBONUCLEIC ACID TARGET 1FJD ; -1.00 ; HUMAN PARVULIN-LIKE PEPTIDYL PROLYL CIS/TRANS ISOMERASE, HPAR14 1AXC ; 2.60 ; HUMAN PCNA 1QRP ; 1.96 ; HUMAN PEPSIN 3A IN COMPLEX WITH A PHOSPHONATE INHIBITOR IVA- VAL-VAL-LEU(P)-(O) PHE-ALA-ALA-OME 1HD2 ; 1.50 ; HUMAN PEROXIREDOXIN 5 1OC3 ; 2.00 ; HUMAN PEROXIREDOXIN 5 1URM ; 1.70 ; HUMAN PEROXIREDOXIN 5, C47S MUTANT 3PAH ; 2.00 ; HUMAN PHENYLALANINE HYDROXYLASE CATALYTIC DOMAIN DIMER WITH BOUND ADRENALINE INHIBITOR 5PAH ; 2.10 ; HUMAN PHENYLALANINE HYDROXYLASE CATALYTIC DOMAIN DIMER WITH BOUND DOPAMINE INHIBITOR 6PAH ; 2.15 ; HUMAN PHENYLALANINE HYDROXYLASE CATALYTIC DOMAIN DIMER WITH BOUND L-DOPA (3,4-DIHYDROXYPHENYLALANINE) INHIBITOR 4PAH ; 2.00 ; HUMAN PHENYLALANINE HYDROXYLASE CATALYTIC DOMAIN DIMER WITH BOUND NOR-ADRENALINE INHIBITOR 1PAH ; 2.00 ; HUMAN PHENYLALANINE HYDROXYLASE DIMER, RESIDUES 117 - 424 1BD9 ; 2.05 ; HUMAN PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN 1BEH ; 1.75 ; HUMAN PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN IN COMPLEX WITH CACODYLATE 1KVO ; 2.00 ; HUMAN PHOSPHOLIPASE A2 COMPLEXED WITH A HIGHLY POTENT SUBSTRATE ANOLOGUE 1KQU ; 2.10 ; HUMAN PHOSPHOLIPASE A2 COMPLEXED WITH A SUBSTRATE ANOLOGUE 2A1X ; 2.50 ; HUMAN PHYTANOYL-COA 2-HYDROXYLASE IN COMPLEX WITH IRON AND 2-OXOGLUTARATE 2BIK ; 1.80 ; HUMAN PIM1 PHOSPHORYLATED ON SER261 1A7C ; 1.95 ; HUMAN PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 IN COMPLEX WITH A PENTAPEPTIDE 1BY7 ; 2.00 ; HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-2. LOOP (66-98) DELETION MUTANT 1JRR ; 1.60 ; HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-2.[LOOP (66-98) DELETIONMUTANT] COMPLEXED WITH PEPTIDE MIMICKING THE REACTIVE CENTER LOOP 1RJX ; 2.30 ; HUMAN PLASMINOGEN CATALYTIC DOMAIN, K698M MUTANT 1CF0 ; 2.20 ; HUMAN PLATELET PROFILIN COMPLEXED WITH AN L-PRO10- IODOTYROSINE PEPTIDE 1AWI ; 2.20 ; HUMAN PLATELET PROFILIN COMPLEXED WITH THE L-PRO10 PEPTIDE 1FIL ; 2.00 ; HUMAN PLATELET PROFILIN I CRYSTALLIZED IN HIGH SALT ACTIN-BINDING PROTEIN 1FIK ; 2.30 ; HUMAN PLATELET PROFILIN I CRYSTALLIZED IN LOW SALT 1QLX ; -1.00 ; HUMAN PRION PROTEIN 1QLZ ; -1.00 ; HUMAN PRION PROTEIN 1FKC ; -1.00 ; HUMAN PRION PROTEIN (MUTANT E200K) FRAGMENT 90-231 1H0L ; -1.00 ; HUMAN PRION PROTEIN 121-230 M166C/E221C 1OEH ; -1.00 ; HUMAN PRION PROTEIN 61-68 1OEI ; -1.00 ; HUMAN PRION PROTEIN 61-84 1HJM ; -1.00 ; HUMAN PRION PROTEIN AT PH 7.0 1HJN ; -1.00 ; HUMAN PRION PROTEIN AT PH 7.0 1QM2 ; -1.00 ; HUMAN PRION PROTEIN FRAGMENT 121-230 1QM3 ; -1.00 ; HUMAN PRION PROTEIN FRAGMENT 121-230 1QM0 ; -1.00 ; HUMAN PRION PROTEIN FRAGMENT 90-230 1QM1 ; -1.00 ; HUMAN PRION PROTEIN FRAGMENT 90-230 1FO7 ; -1.00 ; HUMAN PRION PROTEIN MUTANT E200K FRAGMENT 90-231 1E1G ; -1.00 ; HUMAN PRION PROTEIN VARIANT M166V 1E1J ; -1.00 ; HUMAN PRION PROTEIN VARIANT M166V 1E1U ; -1.00 ; HUMAN PRION PROTEIN VARIANT R220K 1E1W ; -1.00 ; HUMAN PRION PROTEIN VARIANT R220K 1E1P ; -1.00 ; HUMAN PRION PROTEIN VARIANT S170N 1E1S ; -1.00 ; HUMAN PRION PROTEIN VARIANT S170N 2BID ; -1.00 ; HUMAN PRO-APOPTOTIC PROTEIN BID 1NN6 ; 1.75 ; HUMAN PRO-CHYMASE 1AYE ; 1.80 ; HUMAN PROCARBOXYPEPTIDASE A2 2BOA ; 2.20 ; HUMAN PROCARBOXYPEPTIDASE A4. 1KWM ; 1.60 ; HUMAN PROCARBOXYPEPTIDASE B: THREE-DIMENSIONAL STRUCTURE AND IMPLICATIONS FOR THROMBIN-ACTIVATABLE FIBRINOLYSIS INHIBITOR (TAFI) 1E3K ; 2.80 ; HUMAN PROGESTERON RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH THE LIGAND METRIBOLONE (R1881) 1GVL ; 1.80 ; HUMAN PROKALLIKREIN 6 (HK6)/ PROZYME/ PROPROTEASE M/ PRONEUROSIN 1BJX ; -1.00 ; HUMAN PROTEIN DISULFIDE ISOMERASE, NMR, 24 STRUCTURES 1MEK ; -1.00 ; HUMAN PROTEIN DISULFIDE ISOMERASE, NMR, 40 STRUCTURES 1SA4 ; 2.10 ; HUMAN PROTEIN FARNESYLTRANSFERASE COMPLEXED WITH FPP AND R115777 1S63 ; 1.90 ; HUMAN PROTEIN FARNESYLTRANSFERASE COMPLEXED WITH L-778,123 AND FPP 1I1N ; 1.50 ; HUMAN PROTEIN L-ISOASPARTATE O-METHYLTRANSFERASE WITH S- ADENOSYL HOMOCYSTEINE 1PSR ; 1.05 ; HUMAN PSORIASIN (S100A7) 2PSR ; 2.05 ; HUMAN PSORIASIN (S100A7) CA2+ AND ZN2+ BOUND FORM (CRYSTAL FORM II) 3PSR ; 2.50 ; HUMAN PSORIASIN (S100A7) CA2+ BOUND FORM (CRYSTAL FORM I) 1G7F ; 1.80 ; HUMAN PTP1B CATALYTIC DOMAIN COMPLEXED WITH PNU177496 1JF7 ; 2.20 ; HUMAN PTP1B CATALYTIC DOMAIN COMPLEXED WITH PNU177836 1BZC ; 2.35 ; HUMAN PTP1B CATALYTIC DOMAIN COMPLEXED WITH TPI 1G7G ; 2.20 ; HUMAN PTP1B CATALYTIC DOMAIN COMPLEXES WITH PNU179326 1BZJ ; 2.25 ; HUMAN PTP1B COMPLEXED WITH TPICOOH 2B25 ; 2.50 ; HUMAN PUTATIVE TRNA(1-METHYLADENOSINE)METHYLTRANSFERASE 1NI4 ; 1.95 ; HUMAN PYRUVATE DEHYDROGENASE 1T5A ; 2.80 ; HUMAN PYRUVATE KINASE M2 1ZX1 ; 2.16 ; HUMAN QUINONE OXIDOREDUCTASE 2 (NQO2) IN COMPLEX WITH THE CYTOSTATIC PRODRUG CB1954 1QR2 ; 2.10 ; HUMAN QUINONE REDUCTASE TYPE 2 2QR2 ; 2.45 ; HUMAN QUINONE REDUCTASE TYPE 2, COMPLEX WITH MENADIONE 1H2I ; 2.70 ; HUMAN RAD52 PROTEIN, N-TERMINAL DOMAIN 1U4L ; 2.00 ; HUMAN RANTES COMPLEXED TO HEPARIN-DERIVED DISACCHARIDE I-S 1U4M ; 2.00 ; HUMAN RANTES COMPLEXED TO HEPARIN-DERIVED DISACCHARIDE III-S 1HRJ ; -1.00 ; HUMAN RANTES, NMR, 13 STRUCTURES 1GUA ; 2.00 ; HUMAN RAP1A, RESIDUES 1-167, DOUBLE MUTANT (E30D,K31E) COMPLEXED WITH GPPNHP AND THE RAS-BINDING-DOMAIN OF HUMAN C-RAF1, RESIDUES 51-131 1RPM ; 2.30 ; HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE MU, DOMAIN 1 1B56 ; 2.05 ; HUMAN RECOMBINANT EPIDERMAL FATTY ACID BINDING PROTEIN 1SCF ; 2.20 ; HUMAN RECOMBINANT STEM CELL FACTOR 1A31 ; 2.10 ; HUMAN RECONSTITUTED DEOXYRIBONUCLEIC ACID TOPOISOMERASE I IN COVALENT COMPLEX WITH A 22 BASE PAIR DEOXYRIBONUCLEIC ACID DUPLEX 1A35 ; 2.50 ; HUMAN RECONSTITUTED DEOXYRIBONUCLEIC ACID TOPOISOMERASE I IN NON-COVALENT COMPLEX WITH A 22 BASE PAIR DEOXYRIBONUCLEIC ACID DUPLEX 1ITQ ; 2.30 ; HUMAN RENAL DIPEPTIDASE 1ITU ; 2.00 ; HUMAN RENAL DIPEPTIDASE COMPLEXED WITH CILASTATIN 1EWI ; -1.00 ; HUMAN REPLICATION PROTEIN A: GLOBAL FOLD OF THE N-TERMINAL RPA-70 DOMAIN REVEALS A BASIC CLEFT AND FLEXIBLE C-TERMINAL LINKER 1G2C ; 2.30 ; HUMAN RESPIRATORY SYNCYTIAL VIRUS FUSION PROTEIN CORE 1AYN ; 2.90 ; HUMAN RHINOVIRUS 16 COAT PROTEIN 1AYM ; 2.15 ; HUMAN RHINOVIRUS 16 COAT PROTEIN AT HIGH RESOLUTION 1QJU ; 2.80 ; HUMAN RHINOVIRUS 16 COAT PROTEIN IN COMPLEX WITH ANTIVIRAL COMPOUND VP61209 1QJY ; 2.80 ; HUMAN RHINOVIRUS 16 COAT PROTEIN IN COMPLEX WITH ANTIVIRAL COMPOUND VP65099 1QJX ; 2.80 ; HUMAN RHINOVIRUS 16 COAT PROTEIN IN COMPLEX WITH ANTIVIRAL COMPOUND WIN68934 1V9U ; 3.60 ; HUMAN RHINOVIRUS 2 BOUND TO A FRAGMENT OF ITS CELLULAR RECEPTOR PROTEIN 1RHI ; 3.00 ; HUMAN RHINOVIRUS 3 COAT PROTEIN 1FPN ; 2.60 ; HUMAN RHINOVIRUS SEROTYPE 2 (HRV2) 1A2B ; 2.40 ; HUMAN RHOA COMPLEXED WITH GTP ANALOGUE 1LI4 ; 2.01 ; HUMAN S-ADENOSYLHOMOCYSTEINE HYDROLASE COMPLEXED WITH NEPLANOCIN 1JEN ; 2.25 ; HUMAN S-ADENOSYLMETHIONINE DECARBOXYLASE 1I7M ; 2.24 ; HUMAN S-ADENOSYLMETHIONINE DECARBOXYLASE WITH COVALENTLY BOUND PYRUVOYL GROUP AND COMPLEXED WITH 4-AMIDINOINDAN-1- ONE-2'-AMIDINOHYDRAZONE 1I7C ; 2.40 ; HUMAN S-ADENOSYLMETHIONINE DECARBOXYLASE WITH COVALENTLY BOUND PYRUVOYL GROUP AND COMPLEXED WITH METHYLGLYOXAL BIS- (GUANYLHYDRAZONE) 1I79 ; 2.01 ; HUMAN S-ADENOSYLMETHIONINE DECARBOXYLASE WITH COVALENTLY BOUND PYRUVOYL GROUP AND COVALENTLY BOUND 5'-DEOXY-5'-[(3- HYDRAZINOPROPYL)METHYLAMINO]ADENOSINE 1I72 ; 2.00 ; HUMAN S-ADENOSYLMETHIONINE DECARBOXYLASE WITH COVALENTLY BOUND PYRUVOYL GROUP AND COVALENTLY BOUND 5'-DEOXY-5'-[N- METHYL-N-(2-AMINOOXYETHYL) AMINO]ADENOSINE 1I7B ; 1.90 ; HUMAN S-ADENOSYLMETHIONINE DECARBOXYLASE WITH COVALENTLY BOUND PYRUVOYL GROUP AND COVALENTLY BOUND S- ADENOSYLMETHIONINE METHYL ESTER 1DB5 ; 2.80 ; HUMAN S-PLA2 IN COMPLEX WITH INDOLE 6 1DB4 ; 2.20 ; HUMAN S-PLA2 IN COMPLEX WITH INDOLE 8 1SMD ; 1.60 ; HUMAN SALIVARY AMYLASE 1WP0 ; 2.80 ; HUMAN SCO1 1PL8 ; 1.90 ; HUMAN SDH/NAD+ COMPLEX 1PL6 ; 2.00 ; HUMAN SDH/NADH/INHIBITOR COMPLEX 2BXA ; 2.35 ; HUMAN SERUM ALBUMIN COMPLEXED WITH 3-CARBOXY-4-METHYL-5- PROPYL-2-FURANPROPANOIC ACID (CMPF) 2BX8 ; 2.70 ; HUMAN SERUM ALBUMIN COMPLEXED WITH AZAPROPAZONE 1GNJ ; 2.60 ; HUMAN SERUM ALBUMIN COMPLEXED WITH CIS-5,8,11,14-EICOSATETRAENOIC ACID (ARACHIDONIC ACID) 1GNI ; 2.40 ; HUMAN SERUM ALBUMIN COMPLEXED WITH CIS-9-OCTADECENOIC ACID (OLEIC ACID) 1E7E ; 2.50 ; HUMAN SERUM ALBUMIN COMPLEXED WITH DECANOIC ACID (CAPRIC ACID) 2BXF ; 2.95 ; HUMAN SERUM ALBUMIN COMPLEXED WITH DIAZEPAM 2BXE ; 2.95 ; HUMAN SERUM ALBUMIN COMPLEXED WITH DIFLUNISAL 1E7F ; 2.43 ; HUMAN SERUM ALBUMIN COMPLEXED WITH DODECANOIC ACID (LAURIC ACID) 1E7H ; 2.43 ; HUMAN SERUM ALBUMIN COMPLEXED WITH HEXADECANOIC ACID (PALMITIC ACID) 2BXG ; 2.70 ; HUMAN SERUM ALBUMIN COMPLEXED WITH IBUPROFEN 2BXH ; 2.25 ; HUMAN SERUM ALBUMIN COMPLEXED WITH INDOXYL SULFATE 2BXL ; 2.60 ; HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND 3,5- DIIODOSALICYLIC ACID 2BXI ; 2.50 ; HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND AZAPROPAZONE 2BXM ; 2.50 ; HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND INDOMETHACIN 2BXN ; 2.65 ; HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND IODIPAMIDE 2BXO ; 2.60 ; HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND OXYPHENBUTAZONE 2BXP ; 2.30 ; HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND PHENYLBUTAZONE 2BXK ; 2.40 ; HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE, AZAPROPAZONE AND INDOMETHACIN 2BXQ ; 2.60 ; HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE, PHENYLBUTAZONE AND INDOMETHACIN 1BJ5 ; 2.50 ; HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID 1E7C ; 2.40 ; HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID AND THE GENERAL ANESTHETIC HALOTHANE 1H9Z ; 2.50 ; HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID AND THE R-(+) ENANTIOMER OF WARFARIN 1HA2 ; 2.50 ; HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID AND THE S- (-) ENANTIOMER OF WARFARIN 1E7I ; 2.70 ; HUMAN SERUM ALBUMIN COMPLEXED WITH OCTADECANOIC ACID (STEARIC ACID) 2BXB ; 3.20 ; HUMAN SERUM ALBUMIN COMPLEXED WITH OXYPHENBUTAZONE 2BXC ; 3.10 ; HUMAN SERUM ALBUMIN COMPLEXED WITH PHENYLBUTAZONE 1O9X ; 3.20 ; HUMAN SERUM ALBUMIN COMPLEXED WITH TETRADECANOIC ACID (MYRISTIC ACID) AND HEMIN 1E7G ; 2.50 ; HUMAN SERUM ALBUMIN COMPLEXED WITH TETRADECANOIC ACID (MYRISTIC ACID) HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID 1HK1 ; 2.65 ; HUMAN SERUM ALBUMIN COMPLEXED WITH THYROXINE (3,3',5,5'-TETRAIODO-L-THYRONINE) 1HK4 ; 2.40 ; HUMAN SERUM ALBUMIN COMPLEXED WITH THYROXINE (3,3',5,5'-TETRAIODO-L-THYRONINE) AND MYRISTIC ACID (TETRADECANOIC ACID) 2BXD ; 3.05 ; HUMAN SERUM ALBUMIN COMPLEXED WITH WARFARIN 1BKE ; 3.15 ; HUMAN SERUM ALBUMIN IN A COMPLEX WITH MYRISTIC ACID AND TRI-IODOBENZOIC ACID 1HK2 ; 2.80 ; HUMAN SERUM ALBUMIN MUTANT R218H COMPLEXED WITH THYROXINE (3,3',5,5'-TETRAIODO-L-THYRONINE) 1HK5 ; 2.70 ; HUMAN SERUM ALBUMIN MUTANT R218H COMPLEXED WITH THYROXINE (3,3',5,5'-TETRAIODO-L-THYRONINE) AND MYRISTIC ACID (TETRADECANOIC ACID) 1HK3 ; 2.80 ; HUMAN SERUM ALBUMIN MUTANT R218P COMPLEXED WITH THYROXINE (3,3',5,5'-TETRAIODO-L-THYRONINE) 1D3K ; 1.80 ; HUMAN SERUM TRANSFERRIN 1D4N ; 2.00 ; HUMAN SERUM TRANSFERRIN 1N84 ; 2.05 ; HUMAN SERUM TRANSFERRIN, N-LOBE 1RYO ; 1.20 ; HUMAN SERUM TRANSFERRIN, N-LOBE BOUND WITH OXALATE 1N7X ; 2.10 ; HUMAN SERUM TRANSFERRIN, N-LOBE Y45E MUTANT 1B3E ; 2.50 ; HUMAN SERUM TRANSFERRIN, N-TERMINAL LOBE, EXPRESSED IN PICHIA PASTORIS 1A8E ; 1.60 ; HUMAN SERUM TRANSFERRIN, RECOMBINANT N-TERMINAL LOBE 1A8F ; 1.80 ; HUMAN SERUM TRANSFERRIN, RECOMBINANT N-TERMINAL LOBE 1BP5 ; 2.20 ; HUMAN SERUM TRANSFERRIN, RECOMBINANT N-TERMINAL LOBE, APO FORM 1BTJ ; 3.20 ; HUMAN SERUM TRANSFERRIN, RECOMBINANT N-TERMINAL LOBE, APO FORM, CRYSTAL FORM 2 1J8F ; 1.70 ; HUMAN SIRT2 HISTONE DEACETYLASE 1S8O ; 2.60 ; HUMAN SOLUBLE EPOXIDE HYDROLASE 1VJ5 ; 2.35 ; HUMAN SOLUBLE EPOXIDE HYDROLASE- N-CYCLOHEXYL-N'-(4- IODOPHENYL)UREA COMPLEX 1PL7 ; 2.20 ; HUMAN SORBITOL DEHYDROGENASE (APO) 1AWE ; -1.00 ; HUMAN SOS1 PLECKSTRIN HOMOLOGY (PH) DOMAIN, NMR, 20 STRUCTURES 1ZDZ ; 2.12 ; HUMAN SPERMIDINE SYNTHASE 1QGV ; 1.40 ; HUMAN SPLICEOSOMAL PROTEIN U5-15KD 1AM9 ; 2.30 ; HUMAN SREBP-1A BOUND TO LDL RECEPTOR PROMOTER 1JID ; 1.80 ; HUMAN SRP19 IN COMPLEX WITH HELIX 6 OF HUMAN SRP RIBONUCLEIC ACID 1YOW ; 3.00 ; HUMAN STEROIDOGENIC FACTOR 1 LBD WITH BOUND CO-FACTOR PEPTIDE 1C8T ; 2.60 ; HUMAN STROMELYSIN-1 (E202Q) CATALYTIC DOMAIN COMPLEXED WITH RO-26-2812 1C3I ; 1.83 ; HUMAN STROMELYSIN-1 CATALYTIC DOMAIN COMPLEXED WITH RO-26- 2812 1ZD1 ; 2.24 ; HUMAN SULFORTRANSFERASE SULT4A1 1XV1 ; 2.10 ; HUMAN SULFOTRANSFERASE SULT1B1 IN COMPLEX WITH PAP 2ETG ; 1.80 ; HUMAN SULFOTRANSFERASE SULT1C1 IN COMPLEX WITH PAP 2AD1 ; 2.00 ; HUMAN SULFOTRANSFERASE SULT1C2 2D06 ; 2.30 ; HUMAN SULT1A1 COMPLEXED WITH PAP AND ESTRADIOL 1LS6 ; 1.90 ; HUMAN SULT1A1 COMPLEXED WITH PAP AND P-NITROPHENOL 1CJM ; 2.40 ; HUMAN SULT1A3 WITH SULFATE BOUND 1M1L ; 2.65 ; HUMAN SUPPRESSOR OF FUSED (N-TERMINAL DOMAIN) 1TGH ; 2.90 ; HUMAN TBP COMPLEX WITH TATA ELEMENT DEOXYRIBONUCLEIC ACID 1CDW ; 1.90 ; HUMAN TBP CORE DOMAIN COMPLEXED WITH DEOXYRIBONUCLEIC ACID 1H6F ; 1.70 ; HUMAN TBX3, A TRANSCRIPTION FACTOR RESPONSIBLE FOR ULNAR-MAMMARY SYNDROME , BOUND TO A PALINDROMIC DEOXYRIBONUCLEIC ACID SITE 1A4I ; 1.50 ; HUMAN TETRAHYDROFOLATE DEHYDROGENASE / CYCLOHYDROLASE 1HTN ; 2.80 ; HUMAN TETRANECTIN, A TRIMERIC PLASMINOGEN BINDING PROTEIN WITH AN ALPHA-HELICAL COILED COIL 1NVP ; 2.10 ; HUMAN TFIIA/TBP/DEOXYRIBONUCLEIC ACID COMPLEX 1AIU ; 2.00 ; HUMAN THIOREDOXIN (D60N MUTANT, REDUCED FORM) 1ERU ; 2.10 ; HUMAN THIOREDOXIN (OXIDIZED FORM) 1AUC ; 2.10 ; HUMAN THIOREDOXIN (OXIDIZED WITH DIAMIDE) 1ERT ; 1.70 ; HUMAN THIOREDOXIN (REDUCED FORM) 1ERW ; 1.80 ; HUMAN THIOREDOXIN DOUBLE MUTANT WITH CYS 32 REPLACED BY SER AND CYS 35 REPLACED BY SER 1ERV ; 1.65 ; HUMAN THIOREDOXIN MUTANT WITH CYS 73 REPLACED BY SER (REDUCED FORM) 1HXF ; 2.10 ; HUMAN THROMBIN COMPLEX WITH HIRUDIN VARIANT 1O0D ; 2.44 ; HUMAN THROMBIN COMPLEXED WITH A D-PHE-PRO-ARG-TYPE INHIBITOR AND A C-TERMINAL HIRUDIN DERIVED EXO-SITE INHIBITOR 1A5G ; 2.06 ; HUMAN THROMBIN COMPLEXED WITH NOVEL SYNTHETIC PEPTIDE MIMETIC INHIBITOR AND HIRUGEN 1B5G ; 2.07 ; HUMAN THROMBIN COMPLEXED WITH NOVEL SYNTHETIC PEPTIDE MIMETIC INHIBITOR AND HIRUGEN 1TBZ ; 2.30 ; HUMAN THROMBIN WITH ACTIVE SITE N-METHYL-D PHENYLALANYL-N- [5-(AMINOIMINOMETHYL)AMINO]-1-{{BENZOTHIAZOLYL)CARBONYL] BUTYL]-L-PROLINAMIDE TRIFLUROACETATE AND EXOSITE-HIRUGEN 1K21 ; 1.86 ; HUMAN THROMBIN-INHIBITOR COMPLEX 1K22 ; 1.93 ; HUMAN THROMBIN-INHIBITOR COMPLEX 1V7M ; 2.51 ; HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB 1V7N ; 3.30 ; HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB 1E2G ; 1.70 ; HUMAN THYMIDYLATE KINASE COMPLEXED WITH ADP, TDP AND A MAGNESIUM-ION 1E99 ; 1.80 ; HUMAN THYMIDYLATE KINASE COMPLEXED WITH AZTMP AND ADP 1E9B ; 1.70 ; HUMAN THYMIDYLATE KINASE COMPLEXED WITH AZTMP AND APPNP 1E9A ; 1.60 ; HUMAN THYMIDYLATE KINASE COMPLEXED WITH THE BISUBSTRATE INHIBITOR AZTP5A 1E2D ; 1.65 ; HUMAN THYMIDYLATE KINASE COMPLEXED WITH THYMIDINE MONOPHOSPHATE, ADENOSINE DIPHOSPHATE AND A MAGNESIUM-ION 1E2F ; 1.60 ; HUMAN THYMIDYLATE KINASE COMPLEXED WITH THYMIDINE MONOPHOSPHATE, ADENOSINE DIPHOSPHATE AND A MAGNESIUM-ION 1E2E ; 2.00 ; HUMAN THYMIDYLATE KINASE COMPLEXED WITH THYMIDINE MONOPHOSPHATE, ADENOSINE DIPHOSPHATE,A MAGNESIUM-ION AND ALF3 1E2Q ; 1.70 ; HUMAN THYMIDYLATE KINASE COMPLEXED WITH TP5A AND A MAGNESIUM-ION 1JUJ ; 3.00 ; HUMAN THYMIDYLATE SYNTHASE BOUND TO DUMP AND LY231514, A PYRROLO(2,3-D)PYRIMIDINE-BASED ANTIFOLATE 1JU6 ; 2.89 ; HUMAN THYMIDYLATE SYNTHASE COMPLEX WITH DUMP AND LY231514, A PYRROLO(2,3-D)PYRIMIDINE-BASED ANTIFOLATE 1HVY ; 1.90 ; HUMAN THYMIDYLATE SYNTHASE COMPLEXED WITH DUMP AND RALTITREXED, AN ANTIFOLATE DRUG, IS IN THE CLOSED CONFORMATION 1FAK ; 2.10 ; HUMAN TISSUE FACTOR COMPLEXED WITH COAGULATION FACTOR VIIA INHIBITED WITH A BPTI-MUTANT 1BR9 ; 2.10 ; HUMAN TISSUE INHIBITOR OF METALLOPROTEINASE-2 1KV3 ; 2.80 ; HUMAN TISSUE TRANSGLUTAMINASE IN GDP BOUND FORM 1ZIW ; 2.10 ; HUMAN TOLL-LIKE RECEPTOR 3 EXTRACELLULAR DOMAIN STRUCTURE 1ZXM ; 1.87 ; HUMAN TOPO IIA ATPASE/AMP-PNP 1R49 ; 3.13 ; HUMAN TOPOISOMERASE I (TOPO70) DOUBLE MUTANT K532R/Y723F 1NH3 ; 3.10 ; HUMAN TOPOISOMERASE I ARA-C COMPLEX 1NFA ; -1.00 ; HUMAN TRANSCRIPTION FACTOR NFATC DEOXYRIBONUCLEIC ACID BINDING DOMAIN, NMR, 10 STRUCTURES 1PCF ; 1.74 ; HUMAN TRANSCRIPTIONAL COACTIVATOR PC4 C-TERMINAL DOMAIN 1DTG ; 2.40 ; HUMAN TRANSFERRIN N-LOBE MUTANT H249E 1JQF ; 1.85 ; HUMAN TRANSFERRIN N-LOBE MUTANT H249Q 1TGK ; 3.30 ; HUMAN TRANSFORMING GROWTH FACTOR BETA 3, CRYSTALLIZED FROM PEG 4000 1TGJ ; 2.00 ; HUMAN TRANSFORMING GROWTH FACTOR-BETA 3, CRYSTALLIZED FROM DIOXANE 2IF1 ; -1.00 ; HUMAN TRANSLATION INITIATION FACTOR EIF1, NMR, 29 STRUCTURES 1D7Q ; -1.00 ; HUMAN TRANSLATION INITIATION FACTOR EIF1A 1Z7J ; 2.20 ; HUMAN TRANSTHYRETIN (ALSO CALLED PREALBUMIN) COMPLEX WITH 3, 3',5,5'-TETRAIODOTHYROACETIC ACID (T4AC) 1BMZ ; 2.00 ; HUMAN TRANSTHYRETIN (PREALBUMIN) 1BM7 ; 2.00 ; HUMAN TRANSTHYRETIN (PREALBUMIN) COMPLEX WITH FLUFENAMIC ACID (2-[[3-(TRIFLUOROMETHYL)PHENYL]AMINO] BENZOIC ACID) 2F8I ; 1.54 ; HUMAN TRANSTHYRETIN (TTR) COMPLEXED WITH BENZOXAZOLE 2FBR ; 1.46 ; HUMAN TRANSTHYRETIN (TTR) COMPLEXED WITH BIVALANT AMYLOID INHIBITOR (4 CORBON LINKER) 2F7I ; 1.60 ; HUMAN TRANSTHYRETIN (TTR) COMPLEXED WITH DIFLUNISAL ANALOGUES- TTR. 2',6'-DIFLUOROBIPHENYL-4-CARBOXYLIC ACID 2B77 ; 1.70 ; HUMAN TRANSTHYRETIN (TTR) COMPLEXED WITH DIFLUNISAL ANALOGUES- TTR.2',4'-DICHLORO-4-HYDROXY-1,1'-BIPHENYL-3- CARBOXYLIC ACID 2B9A ; 1.54 ; HUMAN TRANSTHYRETIN (TTR) COMPLEXED WITH DIFLUNISAL ANALOGUES- TTR.3',5'-DIFLUOROBIPHENYL-4-CARBOXYLIC ACID 1WYI ; 2.20 ; HUMAN TRIOSEPHOSPHATE ISOMERASE OF NEW CRYSTAL FORM 1H7C ; 1.80 ; HUMAN TUBULIN CHAPERONE COFACTOR A 1KAK ; 2.50 ; HUMAN TYROSINE PHOSPHATASE 1B COMPLEXED WITH AN INHIBITOR 1KAV ; 2.35 ; HUMAN TYROSINE PHOSPHATASE 1B COMPLEXED WITH AN INHIBITOR 1QZQ ; 2.40 ; HUMAN TYROSYL DEOXYRIBONUCLEIC ACID PHOSPHODIESTERASE 1A3S ; 2.80 ; HUMAN UBC9 1YQB ; 2.00 ; HUMAN UBIQUILIN 3 1Y6L ; 1.85 ; HUMAN UBIQUITIN CONJUGATING ENZYME E2E2 2ESO ; 1.50 ; HUMAN UBIQUITIN-CONJUGATING ENZYME (E2) UBCH5B MUTANT ILE37ALA 2ESP ; 1.52 ; HUMAN UBIQUITIN-CONJUGATING ENZYME (E2) UBCH5B MUTANT ILE88ALA 2ESQ ; 1.44 ; HUMAN UBIQUITIN-CONJUGATING ENZYME (E2) UBCH5B MUTANT SER94GLY 2ESK ; 1.36 ; HUMAN UBIQUITIN-CONJUGATING ENZYME (E2) UBCH5B, WILD-TYPE 1YH6 ; 2.10 ; HUMAN UBIQUITIN-CONJUGATING ENZYME E2 H 2F4W ; 2.00 ; HUMAN UBIQUITIN-CONJUGATING ENZYME E2 J2 1U9A ; 2.00 ; HUMAN UBIQUITIN-CONJUGATING ENZYME UBC9 1BG2 ; 1.80 ; HUMAN UBIQUITOUS KINESIN MOTOR DOMAIN 1HZJ ; 1.50 ; HUMAN UDP-GALACTOSE 4-EPIMERASE: ACCOMMODATION OF UDP-N- ACETYLGLUCOSAMINE WITHIN THE ACTIVE SITE 1AKZ ; 1.57 ; HUMAN URACIL-DEOXYRIBONUCLEIC ACID GLYCOSYLASE 1VR2 ; 2.40 ; HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 (KDR) KINASE DOMAIN 1USE ; 1.30 ; HUMAN VASP TETRAMERISATION DOMAIN 1USD ; 1.70 ; HUMAN VASP TETRAMERISATION DOMAIN L352M 1VHR ; 2.10 ; HUMAN VH1-RELATED DUAL-SPECIFICITY PHOSPHATASE 1J4X ; 2.75 ; HUMAN VH1-RELATED DUAL-SPECIFICITY PHOSPHATASE C124S MUTANT- PEPTIDE COMPLEX 1GK7 ; 1.40 ; HUMAN VIMENTIN COIL 1A FRAGMENT (1A) 1GK4 ; 2.30 ; HUMAN VIMENTIN COIL 2B FRAGMENT (CYS2) 1GK6 ; 1.90 ; HUMAN VIMENTIN COIL 2B FRAGMENT LINKED TO GCN4 LEUCINE ZIPPER (Z2B) 1RKE ; 2.35 ; HUMAN VINCULIN HEAD (1-258) IN COMPLEX WITH HUMAN VINCULIN TAIL (879-1066) 1RKC ; 2.70 ; HUMAN VINCULIN HEAD (1-258) IN COMPLEX WITH TALIN'S VINCULIN BINDING SITE 3 (RESIDUES 1944-1969) 1YDI ; 1.80 ; HUMAN VINCULIN HEAD DOMAIN (VH1, 1-258) IN COMPLEX WITH HUMAN ALPHA-ACTININ'S VINCULIN-BINDING SITE (RESIDUES 731- 760) 1ATZ ; 1.80 ; HUMAN VON WILLEBRAND FACTOR A3 DOMAIN 1ZAG ; 2.80 ; HUMAN ZINC-ALPHA-2-GLYCOPROTEIN 1BVL ; 2.87 ; HUMANIZED ANTI-LYSOZYME FV 1BVK ; 2.70 ; HUMANIZED ANTI-LYSOZYME FV COMPLEXED WITH LYSOZYME 1YZZ ; 2.70 ; HUMANIZED CABAN33 AT ROOM TEMPERATURE 1DYM ; 1.75 ; HUMICOLA INSOLENS ENDOCELLULASE CEL7B (EG 1) E197A MUTANT ENDOGLUCANASE, HYDROLASE, CELLULASE, CELLULOSE DEGRADATION, GLYCOSIDE HYDROLASE FAMILY 7, GLYCOSYNTHASE 2A39 ; 2.20 ; HUMICOLA INSOLENS ENDOCELLULASE EGI NATIVE STRUCTURE 1A39 ; 2.20 ; HUMICOLA INSOLENS ENDOCELLULASE EGI S37W, P39W DOUBLE-MUTANT 1IQM ; 2.60 ; HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54471 1IQL ; 2.70 ; HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54476 1IQK ; 3.20 ; HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55113 1IQJ ; 3.00 ; HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55124 1IQI ; 2.90 ; HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55125 1IQH ; 3.00 ; HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55143 1IQG ; 2.60 ; HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55159 1IOE ; 2.90 ; HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55532 1UUH ; 2.20 ; HYALURONAN BINDING DOMAIN OF HUMAN CD44 1GN9 ; 2.60 ; HYBRID CLUSTER PROTEIN FROM DESULFOVIBRIO DESULFURICANS ATCC 27774 X-RAY STRUCTURE AT 2.6A RESOLUTION USING SYNCHROTRON RADIATION AT A WAVELENGTH OF 1.722A 1GNL ; 1.25 ; HYBRID CLUSTER PROTEIN FROM DESULFOVIBRIO DESULFURICANS X-RAY STRUCTURE AT 1.25A RESOLUTION USING SYNCHROTRON RADIATION AT A WAVELENGTH OF 0.933A 1E1D ; 1.72 ; HYBRID CLUSTER PROTEIN FROM DESULFOVIBRIO VULGARIS 1GNT ; 1.25 ; HYBRID CLUSTER PROTEIN FROM DESULFOVIBRIO VULGARIS. X-RAY STRUCTURE AT 1.25A RESOLUTION USING SYNCHROTRON RADIATION. 383D ; 1.70 ; HYDRATION AND RECOGNITION OF METHYLATED CPG STEPS IN DEOXYRIBONUCLEIC ACID 384D ; 2.15 ; HYDRATION AND RECOGNITION OF METHYLATED CPG STEPS IN DEOXYRIBONUCLEIC ACID 382D ; 2.20 ; HYDRATION AND RECOGNITION OF METHYLATED CPG STEPS IN DEOXYRIBONUCLEIC ACID. 1CGD ; 1.85 ; HYDRATION STRUCTURE OF A COLLAGEN PEPTIDE 1TOI ; 1.90 ; HYDROCINNAMIC ACID-BOUND STRUCTURE OF HEXAMUTANT + A293D MUTANT OF E. COLI ASPARTATE AMINOTRANSFERASE 1TOG ; 2.31 ; HYDROCINNAMIC ACID-BOUND STRUCTURE OF SRHEPT + A293D MUTANT OF E. COLI ASPARTATE AMINOTRANSFERASE 1TOJ ; 1.90 ; HYDROCINNAMIC ACID-BOUND STRUCTURE OF SRHEPT MUTANT OF E. COLI ASPARTATE AMINOTRANSFERASE 1IO5 ; 2.00 ; HYDROGEN AND HYDRATION OF HEN EGG-WHITE LYSOZYME DETERMINED BY NEUTRON DIFFRACTION 1C5H ; 1.55 ; HYDROGEN BONDING AND CATALYSIS: AN UNEXPECTED EXPLANATION FOR HOW A SINGLE AMINO ACID SUBSTITUTION CAN CHANGE THE PH OPTIMUM OF A GLYCOSIDASE 1C5I ; 1.80 ; HYDROGEN BONDING AND CATALYSIS: AN UNEXPECTED EXPLANATION FOR HOW A SINGLE AMINO ACID SUBSTITUTION CAN CHANGE THE PH OPTIMUM OF A GLYCOSIDASE 1XDC ; 1.85 ; HYDROGEN BONDING IN HUMAN MANGANESE SUPEROXIDE DISMUTASE CONTAINING 3-FLUOROTYROSINE 1XIL ; 1.53 ; HYDROGEN BONDING IN HUMAN MANGANESE SUPEROXIDE DISMUTASE CONTAINING 3-FLUOROTYROSINE 1GJN ; 1.35 ; HYDROGEN PEROXIDE DERIVED MYOGLOBIN COMPOUND II AT PH 5.2 1CFZ ; 2.20 ; HYDROGENASE MATURATING ENDOPEPTIDASE HYBD FROM E. COLI 1GXU ; 1.27 ; HYDROGENASE MATURATION PROTEIN HYPF "ACYLPHOSPHATASE-LIKE" N-TERMINAL DOMAIN (HYPF-ACP) IN COMPLEX WITH A SUBSTRATE. CRYSTAL GROWN IN THE PRESENCE OF CARBAMOYLPHOSPHATE 1GXT ; 1.30 ; HYDROGENASE MATURATION PROTEIN HYPF "ACYLPHOSPHATASE-LIKE" N-TERMINAL DOMAIN (HYPF-ACP) IN COMPLEX WITH SULFATE 1ZIE ; 1.44 ; HYDROGENATED GAMMAE CRYSTALLIN IN D2O SOLVENT 1YTN ; 2.40 ; HYDROLASE 255L ; 1.80 ; HYDROLASE 1LBU ; 1.80 ; HYDROLASE METALLO (ZN) DD-PEPTIDASE 1BEL ; 1.60 ; HYDROLASE PHOSPHORIC DIESTER, RIBONUCLEIC ACID 1GOY ; 2.00 ; HYDROLASE(ENDORIBONUCLEASE)RIBONUCLEASE BI (G SPECIFIC ENDONUCLEASE) COMPLEXED WITH GUANOSINE-3'-PHOSPHATE (3'-GMP) 1RGE ; 1.15 ; HYDROLASE, GUANYLORIBONUCLEASE 1RGF ; 1.20 ; HYDROLASE, GUANYLORIBONUCLEASE 1RGG ; 1.20 ; HYDROLASE, GUANYLORIBONUCLEASE 1RGH ; 1.20 ; HYDROLASE, GUANYLORIBONUCLEASE 2AH5 ; 1.74 ; HYDROLASE, HALOACID DEHALOGENASE-LIKE FAMILY PROTEIN SP0104 FROM STREPTOCOCCUS PNEUMONIAE 1RDQ ; 1.26 ; HYDROLYSIS OF ATP IN THE CRYSTAL OF Y204A MUTANT OF CAMP- DEPENDENT PROTEIN KINASE 1WPO ; 2.00 ; HYDROLYTIC ENZYME HUMAN CYTOMEGALOVIRUS PROTEASE 1CV2 ; 1.58 ; HYDROLYTIC HALOALKANE DEHALOGENASE LINB FROM SPHINGOMONAS PAUCIMOBILIS UT26 AT 1.6 A RESOLUTION 1K5P ; 1.80 ; HYDROLYTIC HALOALKANE DEHALOGENASE LINB FROM SPHINGOMONAS PAUCIMOBILIS UT26 AT 1.8A RESOLUTION 1D07 ; 2.00 ; HYDROLYTIC HALOALKANE DEHALOGENASE LINB FROM SPHINGOMONAS PAUCIMOBILIS UT26 WITH 1,3-PROPANEDIOL, A PRODUCT OF DEBROMIDATION OF DIBROMPROPANE, AT 2.0A RESOLUTION 1HYM ; -1.00 ; HYDROLYZED TRYPSIN INHIBITOR (CMTI-V, MINIMIZED AVERAGE NMR STRUCTURE) 1LL1 ; 2.55 ; HYDROXO BRIDGE MET FORM HEMOCYANIN FROM LIMULUS 1A7E ; 1.80 ; HYDROXOMET MYOHEMERYTHRIN FROM THEMISTE ZOSTERICOLA 2YPN ; 2.30 ; HYDROXYMETHYLBILANE SYNTHASE 3YAS ; 1.85 ; HYDROXYNITRILE LYASE COMPLEXED WITH ACETONE 4YAS ; 2.00 ; HYDROXYNITRILE LYASE COMPLEXED WITH CHLORALHYDRATE 5YAS ; 2.20 ; HYDROXYNITRILE LYASE COMPLEXED WITH HEXAFLUOROACETONE 1YAS ; 1.90 ; HYDROXYNITRILE LYASE COMPLEXED WITH HISTIDINE 2YAS ; 1.72 ; HYDROXYNITRILE LYASE FROM HEVEA BRASILIENSIS COMPLEXED WITH RHODANIDE 1YB7 ; 1.76 ; HYDROXYNITRILE LYASE FROM HEVEA BRASILIENSIS IN COMPLEX WITH 2,3-DIMETHYL-2-HYDROXY-BUTYRONITRILE 1YB6 ; 1.54 ; HYDROXYNITRILE LYASE FROM HEVEA BRASILIENSIS IN COMPLEX WITH MANDELONITRILE 1SC9 ; 1.80 ; HYDROXYNITRILE LYASE FROM HEVEA BRASILIENSIS IN COMPLEX WITH THE NATURAL SUBSTRATE ACETONE CYANOHYDRIN 6YAS ; 2.20 ; HYDROXYNITRILE LYASE FROM HEVEA BRASILIENSIS, ROOM TEMPERATURE STRUCTURE 7YAS ; 1.75 ; HYDROXYNITRILE LYASE, LOW TEMPERATURE NATIVE STRUCTURE 1QJ4 ; 1.10 ; HYDROXYNITRILE-LYASE FROM HEVEA BRASILIENSIS AT ATOMIC RESOLUTION 1FL8 ; -1.00 ; HYPERMODIFIED NUCLEOSIDES IN THE ANTICODON OF TRNALYS STABILIZE A CANONICAL U-TURN STRUCTURE 1AZP ; 1.60 ; HYPERTHERMOPHILE CHROMOSOMAL PROTEIN SAC7D BOUND WITH KINKED DEOXYRIBONUCLEIC ACID DUPLEX 1AZQ ; 1.94 ; HYPERTHERMOPHILE CHROMOSOMAL PROTEIN SAC7D BOUND WITH KINKED DEOXYRIBONUCLEIC ACID DUPLEX 1WTO ; 1.50 ; HYPERTHERMOPHILE CHROMOSOMAL PROTEIN SAC7D DOUBLE MUTANT V26F/M29F IN COMPLEX WITH DEOXYRIBONUCLEIC ACID GCGATCGC 1XYI ; 1.45 ; HYPERTHERMOPHILE CHROMOSOMAL PROTEIN SAC7D DOUBLE MUTANT VAL26ALA/MET29ALA IN COMPLEX WITH DEOXYRIBONUCLEIC ACID GCGATCGC 1WTR ; 1.80 ; HYPERTHERMOPHILE CHROMOSOMAL PROTEIN SAC7D SINGLE MUTANT M29A IN COMPLEX WITH DEOXYRIBONUCLEIC ACID GCGATCGC 1WTV ; 1.60 ; HYPERTHERMOPHILE CHROMOSOMAL PROTEIN SAC7D SINGLE MUTANT M29A IN COMPLEX WITH DEOXYRIBONUCLEIC ACID GTAATTAC 1WTP ; 1.90 ; HYPERTHERMOPHILE CHROMOSOMAL PROTEIN SAC7D SINGLE MUTANT M29F IN COMPLEX WITH DEOXYRIBONUCLEIC ACID GCGA(UBR)CGC 1WTQ ; 1.70 ; HYPERTHERMOPHILE CHROMOSOMAL PROTEIN SAC7D SINGLE MUTANT M29F IN COMPLEX WITH DEOXYRIBONUCLEIC ACID GTAATTAC 1WTW ; 2.20 ; HYPERTHERMOPHILE CHROMOSOMAL PROTEIN SAC7D SINGLE MUTANT V26A IN COMPLEX WITH DEOXYRIBONUCLEIC ACID GCGATCGC 1WTX ; 2.20 ; HYPERTHERMOPHILE CHROMOSOMAL PROTEIN SAC7D SINGLE MUTANT V26A IN COMPLEX WITH DEOXYRIBONUCLEIC ACID GTAATTAC 1SAP ; -1.00 ; HYPERTHERMOPHILE PROTEIN, RELAXATION MATRIX REFINEMENT STRUCTURE 1GB4 ; -1.00 ; HYPERTHERMOPHILIC VARIANT OF THE B1 DOMAIN FROM STREPTOCOCCAL PROTEIN G, NMR, 47 STRUCTURES 1YVO ; 1.90 ; HYPOTHETICAL ACETYLTRANSFERASE FROM P.AERUGINOSA PA01 1G2R ; 1.35 ; HYPOTHETICAL CYTOSOLIC PROTEIN CODED BY GENE FROM NUSA/INFB, YLXR HOMOLOGUE 1YLM ; 1.83 ; HYPOTHETICAL CYTOSOLIC PROTEIN YUTE FROM BACILLUS SUBTILIS 1UC2 ; 2.15 ; HYPOTHETICAL EXTEIN PROTEIN OF PH1602 FROM PYROCOCCUS HORIKOSHII 1Y88 ; 1.85 ; HYPOTHETICAL PROTEIN AF1548 1PZX ; 2.00 ; HYPOTHETICAL PROTEIN APC36103 FROM BACILLUS STEAROTHERMOPHILUS: A LIPID BINDING PROTEIN 1T0G ; -1.00 ; HYPOTHETICAL PROTEIN AT2G24940.1 FROM ARABIDOPSIS THALIANA HAS A CYTOCHROME B5 LIKE FOLD 2A1V ; 2.15 ; HYPOTHETICAL PROTEIN FROM DEINOCOCCUS RADIODURANS 2B4W ; 1.98 ; HYPOTHETICAL PROTEIN FROM LEISHMANIA MAJOR 1VJU ; 1.40 ; HYPOTHETICAL PROTEIN FROM LEISHMANIA MAJOR LMAJ006828 1YQF ; 2.30 ; HYPOTHETICAL PROTEIN FROM LEISHMANIA MAJOR UNKNOWN FUNCTION SEQUENCE HOMOLOGUE TO HUMAN P32 PROTEIN 1ZSO ; 2.17 ; HYPOTHETICAL PROTEIN FROM PLASMODIUM FALCIPARUM 2APL ; 2.01 ; HYPOTHETICAL PROTEIN FROM PORPHYROMONAS GINGIVALIS 1NNW ; 1.90 ; HYPOTHETICAL PROTEIN FROM PYROCOCCUS FURIOSUS PFU-1218608 1NNH ; 1.65 ; HYPOTHETICAL PROTEIN FROM PYROCOCCUS FURIOSUS PFU-1801964 1XE1 ; 2.00 ; HYPOTHETICAL PROTEIN FROM PYROCOCCUS FURIOSUS PFU-880080-001 1YZV ; 2.00 ; HYPOTHETICAL PROTEIN FROM TRYPANOSOMA CRUZI 1U9D ; 1.70 ; HYPOTHETICAL PROTEIN FROM VIBRIO CHOLERAE O1 BIOVAR ELTOR STR. N16961 1ZX3 ; 2.50 ; HYPOTHETICAL PROTEIN NE0241 1U69 ; 1.60 ; HYPOTHETICAL PROTEIN PA2721 FROM PSEUDOMONAS AERUGINOSA PAO1 2ALI ; 1.75 ; HYPOTHETICAL PROTEIN PA2801 1YRE ; 2.15 ; HYPOTHETICAL PROTEIN PA3270 FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH COA 1Y0N ; 2.00 ; HYPOTHETICAL PROTEIN PA3463 FROM PSEUDOMONAS AERUGINOSA STRAIN PAO1 1Y0K ; 1.75 ; HYPOTHETICAL PROTEIN PA4535 FROM PSEUDOMONAS AERUGINOSA STRAIN PAO1 1ZL0 ; 1.10 ; HYPOTHETICAL PROTEIN PA5198 FROM PSEUDOMONAS AERUGINOSA. 1ZTD ; 2.00 ; HYPOTHETICAL PROTEIN PFU-631545-001 FROM PYROCOCCUS FURIOSUS 1YLO ; 2.15 ; HYPOTHETICAL PROTEIN S2589 FROM SHIGELLA FLEXNERI 2A STR. 2457T 1Z67 ; 1.45 ; HYPOTHETICAL PROTEIN S4005 FROM SHIGELLA FLEXNERI 2BBE ; 1.97 ; HYPOTHETICAL PROTEIN SO0527 2AI4 ; 1.57 ; HYPOTHETICAL PROTEIN SO1698 FROM SHEWANELLA ONEIDENSIS. 1MGP ; 2.00 ; HYPOTHETICAL PROTEIN TM841 FROM THERMOTOGA MARITIMA REVEALS FATTY ACID BINDING FUNCTION 1PQY ; 2.35 ; HYPOTHETICAL PROTEIN YFDW FROM E. COLI 1Q6Y ; 1.99 ; HYPOTHETICAL PROTEIN YFDW FROM E. COLI BOUND TO COENZYME A 1DBR ; 2.40 ; HYPOXANTHINE GUANINE XANTHINE 1GRV ; 2.90 ; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE FROM E. COLI 1P19 ; 2.30 ; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE FROM TRYPANOSOMA CRUZI, IN COMPLEX WITH THE PRODUCT IMP 1P17 ; 2.70 ; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE FROM TRYPANOSOMA CRUZI, K68R MUTANT, COMPLEXED WITH THE PRODUCT IMP 1P18 ; 2.00 ; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE FROM TRYPANOSOMA CRUZI, K68R MUTANT, TERNARY SUBSTRATES COMPLEX 1HGX ; 1.90 ; HYPOXANTHINE-GUANINE-XANTHINE PHOSPHORIBOSYLTRANSFERASE (HGXPRTASE) 1Y1I ; 2.61 ; HYUMAN FORMYLGLYCINE GENERATING ENZYME, REDUCED FORM 2CTV ; 1.95 ; High Resolution Crystallographic Studies of Native Concanavalin a Using Rapid Laue Data Collection Methods and the Introduction of a Monochromatic Large-Angle Oscillation Technique (Lot) 1MFB ; 2.10 ; High Resolution Structures of Antibody Fab Fragment Complexed with Cell- Surface Oligosaccharide of Pathogenic Salmonella 1MFC ; 2.10 ; High Resolution Structures of Antibody Fab Fragment Complexed with Cell- Surface Oligosaccharide of Pathogenic Salmonella 2HBC ; 2.10 ; High Resolution X-Ray Structures of Myoglobin-and Hemoglobin-Alkyl Isocyanide Complexes 2HBD ; 2.20 ; High Resolution X-Ray Structures of Myoglobin-and Hemoglobin-Alkyl Isocyanide Complexes 2HBE ; 2.00 ; High Resolution X-Ray Structures of Myoglobin-and Hemoglobin-Alkyl Isocyanide Complexes 2HBF ; 2.20 ; High Resolution X-Ray Structures of Myoglobin-and Hemoglobin-Alkyl Isocyanide Complexes 2MYA ; 2.00 ; High Resolution X-Ray Structures of Myoglobin-and Hemoglobin-Alkyl Isocyanide Complexes 2MYB ; 1.90 ; High Resolution X-Ray Structures of Myoglobin-and Hemoglobin-Alkyl Isocyanide Complexes 2MYC ; 1.80 ; High Resolution X-Ray Structures of Myoglobin-and Hemoglobin-Alkyl Isocyanide Complexes 2MYD ; 1.80 ; High Resolution X-Ray Structures of Myoglobin-and Hemoglobin-Alkyl Isocyanide Complexes 2MYE ; 1.68 ; High Resolution X-Ray Structures of Myoglobin-and Hemoglobin-Alkyl Isocyanide Complexes 2BCA ; -1.00 ; High-Resolution Solution Structure of Calcium-Loaded Calbindin D9K 2BCB ; -1.00 ; High-Resolution Solution Structure of Calcium-Loaded Calbindin D9K 1XNB ; 1.49 ; High-Resolution Structures of Xylanases from B. Circulans and T. Harzianum Identify a New Folding Pattern and Implications for the Atomic Basis of the Catalysis 1XND ; 1.80 ; High-Resolution Structures of Xylanases from B. Circulans and T. Harzianum Identify a New Folding Pattern and Implications for the Atomic Basis of the Catalysis 4RNT ; 2.20 ; His 92 Ala Mutation in Ribonuclease T1 Induces Segmental Flexibility. An X-Ray Study 5CCP ; 2.20 ; Histidine 52 is a Critical Residue for Rapid Formation of Cytochrome C Peroxidase Compound I 4HYA ; 3.00 ; Hyaluronic Acid, the Role of Divalent Cations in Conformation and Packing 2MB5 ; 1.80 ; Hydration in Protein Crystals. A Neutron Diffraction Analysis of Carbonmonoxymyoglobin 1PT6 ; 1.87 ; I DOMAIN FROM HUMAN INTEGRIN ALPHA1-BETA1 1QC5 ; 2.00 ; I DOMAIN FROM INTEGRIN ALPHA1-BETA1 1AOX ; 2.10 ; I DOMAIN FROM INTEGRIN ALPHA2-BETA1 1T9I ; 1.60 ; I-CREI(D20N)/DEOXYRIBONUCLEIC ACID COMPLEX 1T9J ; 2.00 ; I-CREI(Q47E)/DEOXYRIBONUCLEIC ACID COMPLEX 1B24 ; 2.20 ; I-DMOI, INTRON-ENCODED ENDONUCLEASE 1IDO ; 1.70 ; I-DOMAIN FROM INTEGRIN CR3, MG2+ BOUND 1JLM ; 2.00 ; I-DOMAIN FROM INTEGRIN CR3, MN2+ BOUND 1NFI ; 2.70 ; I-KAPPA-B-ALPHA/NF-KAPPA-B COMPLEX 1G1C ; 2.10 ; I1 DOMAIN FROM TITIN 1UXL ; 1.60 ; I113T MUTANT OF HUMAN SOD1 1TS5 ; 3.10 ; I140T MUTANT OF TOXIC SHOCK SYNDROME TOXIN-1 FROM S. AUREUS 1B0V ; 2.80 ; I40N MUTANT OF AZOTOBACTER VINELANDII FDI 1JXB ; 1.60 ; I53A, A POINT MUTANT OF THE CYSTEINE-FREE VARIANT OF E. COLI RNASE HI 1IX0 ; 1.80 ; I59A-3SS HUMAN LYSOZYME 1Y9K ; 2.39 ; IAA ACETYLTRANSFERASE FROM BACILLUS CEREUS ATCC 14579 1U0I ; -1.00 ; IAAL-E3/K3 HETERODIMER 1LVR ; -1.00 ; IC3 OF CB1 (L431A,A432L) BOUND TO G(ALPHA)I 1LVQ ; -1.00 ; IC3 OF CB1 BOUND TO G(ALPHA)I 1OPS ; 2.00 ; ICE-BINDING SURFACE ON A TYPE III ANTIFREEZE PROTEIN FROM OCEAN POUT 1C50 ; 2.30 ; IDENTIFICATION AND STRUCTURAL CHARACTERIZATION OF A NOVEL ALLOSTERIC BINDING SITE OF GLYCOGEN PHOSPHORYLASE B 2C3J ; 2.10 ; IDENTIFICATION OF A BURIED POCKET FOR POTENT AND SELECTIVE INHIBITION OF CHK1: PREDICTION AND VERIFICATION 2C3K ; 2.60 ; IDENTIFICATION OF A BURIED POCKET FOR POTENT AND SELECTIVE INHIBITION OF CHK1: PREDICTION AND VERIFICATION 2C3L ; 2.35 ; IDENTIFICATION OF A BURIED POCKET FOR POTENT AND SELECTIVE INHIBITION OF CHK1: PREDICTION AND VERIFICATION 1XZO ; 1.70 ; IDENTIFICATION OF A DISULFIDE SWITCH IN BSSCO, A MEMBER OF THE SCO FAMILY OF CYTOCHROME C OXIDASE ASSEMBLY PROTEINS 1UNS ; 2.00 ; IDENTIFICATION OF A SECONDARY ZINC-BINDING SITE IN STAPHYLOCOCCAL ENTEROTOXIN C2: IMPLICATIONS FOR SUPERANTIGEN RECOGNITION 1AY0 ; 2.60 ; IDENTIFICATION OF CATALYTICALLY IMPORTANT RESIDUES IN YEAST TRANSKETOLASE 1YNK ; 2.10 ; IDENTIFICATION OF KEY RESIDUES OF THE NC6.8 FAB ANTIBODY FRAGMENT BINDING TO SYNTHETIC SWEETENERS: CRYSTAL STRUCTURE OF NC6.8 CO-CRYSTALIZED WITH HIGH POTENCY SWEETENER COMPOUND SC45647 1YNL ; 1.70 ; IDENTIFICATION OF KEY RESIDUES OF THE NC6.8 FAB ANTIBODY FRAGMENT BINDING TO SYNTHETIC SWEETERNERS: CRYSTAL STRUCTURE OF NC6.8 CO-CRYSTALIZED WITH HIGH POTENCY SWEETENER COMPOUND SC45647 1C04 ; 5.00 ; IDENTIFICATION OF KNOWN PROTEIN AND RIBONUCLEIC ACID STRUCTURES IN A 5 A MAP OF THE LARGE RIBOSOMAL SUBUNIT FROM HALOARCULA MARISMORTUI 1WBS ; 1.80 ; IDENTIFICATION OF NOVEL P38 ALPHA MAP KINASE INHIBITORS USING FRAGMENT-BASED LEAD GENERATION. 1WBT ; 2.00 ; IDENTIFICATION OF NOVEL P38 ALPHA MAP KINASE INHIBITORS USING FRAGMENT-BASED LEAD GENERATION. 1WBV ; 2.00 ; IDENTIFICATION OF NOVEL P38 ALPHA MAP KINASE INHIBITORS USING FRAGMENT-BASED LEAD GENERATION. 1WBW ; 2.41 ; IDENTIFICATION OF NOVEL P38 ALPHA MAP KINASE INHIBITORS USING FRAGMENT-BASED LEAD GENERATION. 1S17 ; 1.95 ; IDENTIFICATION OF NOVEL POTENT BICYCLIC PEPTIDE DEFORMYLASE INHIBITORS 1Y1N ; 1.51 ; IDENTIFICATION OF SH3 MOTIF IN M. TUBERCULOSIS METHIONINE AMINOPEPTIDASE SUGGESTS A MODE OF INTERACTION WITH THE RIBOSOME 1CIC ; 2.50 ; IDIOTOPE-ANTI-IDIOTOPE FAB-FAB COMPLEX; D1.3-E225 1DVF ; 1.90 ; IDIOTOPIC ANTIBODY D1.3 FV FRAGMENT-ANTIIDIOTOPIC ANTIBODY E5.2 FV FRAGMENT COMPLEX 1IAI ; 2.90 ; IDIOTYPE-ANTI-IDIOTYPE FAB COMPLEX 1ZO1 ; 13.80 ; IF2, IF1, AND TRNA FITTED TO CRYO-EM DATA OF E. COLI 70S INITIATION COMPLEX 1OAZ ; 2.77 ; IGE FV SPE7 COMPLEXED WITH A RECOMBINANT THIOREDOXIN 1JQH ; 2.10 ; IGF-1 RECEPTOR KINASE DOMAIN 1LB7 ; -1.00 ; IGF-F1-1, A PEPTIDE ANTAGONIST OF IGF-1 1CLY ; 2.50 ; IGG FAB (HUMAN IGG1, KAPPA) CHIMERIC FRAGMENT (CBR96) COMPLEXED WITH LEWIS Y NONOATE METHYL ESTER 1CLZ ; 2.80 ; IGG FAB (IGG3, KAPPA) FRAGMENT (MBR96) COMPLEXED WITH LEWIS Y NONOATE METHYL ESTER 1MIM ; 2.60 ; IGG FAB FRAGMENT (CD25-BINDING) 1AD9 ; 2.80 ; IGG-FAB FRAGMENT OF ENGINEERED HUMAN MONOCLONAL ANTIBODY CTM01 1AE6 ; 3.00 ; IGG-FAB FRAGMENT OF MOUSE MONOCLONAL ANTIBODY CTM01 3F58 ; 2.80 ; IGG1 FAB FRAGMENT (58.2) COMPLEX WITH 12-RESIDUE CYCLIC PEPTIDE (INCLUDING RESIDUES 315-324 OF HIV-1 GP120 (MN ISOLATE); H315S MUTATION 2F58 ; 2.80 ; IGG1 FAB FRAGMENT (58.2) COMPLEX WITH 12-RESIDUE CYCLIC PEPTIDE (INCLUDING RESIDUES 315-324 OF HIV-1 GP120) (MN ISOLATE) 1F58 ; 2.00 ; IGG1 FAB FRAGMENT (58.2) COMPLEX WITH 24-RESIDUE PEPTIDE (RESIDUES 308-333 OF HIV-1 GP120 (MN ISOLATE) WITH ALA TO AIB SUBSTITUTION AT POSITION 323 1NAK ; 2.57 ; IGG1 FAB FRAGMENT (83.1) COMPLEX WITH 16-RESIDUE PEPTIDE (RESIDUES 304-321 OF HIV-1 GP120 (MN ISOLATE)) 1IGC ; 2.60 ; IGG1 FAB FRAGMENT (MOPC21) COMPLEX WITH DOMAIN III OF PROTEIN G FROM STREPTOCOCCUS 1WEJ ; 1.80 ; IGG1 FAB FRAGMENT (OF E8 ANTIBODY) COMPLEXED WITH HORSE CYTOCHROME C AT 1.8 A RESOLUTION 2F3G ; 2.13 ; IIAGLC CRYSTAL FORM III 1F3Z ; 1.98 ; IIAGLC-ZN COMPLEX 1IKN ; 2.30 ; IKAPPABALPHA/NF-KAPPAB COMPLEX 1G0Y ; 3.00 ; IL-1 RECEPTOR TYPE 1 COMPLEXED WITH ANTAGONIST PEPTIDE AF10847 1JPH ; 2.10 ; ILE260THR MUTANT OF HUMAN UROD, HUMAN UROPORPHYRINOGEN III DECARBOXYLASE 1EIO ; -1.00 ; ILEAL LIPID BINDING PROTEIN IN COMPLEX WITH GLYCOCHOLATE 1IR7 ; 1.90 ; IM MUTANT OF LYSOZYME 1IR8 ; 1.63 ; IM MUTANT OF LYSOZYME 1IR9 ; 1.90 ; IM MUTANT OF LYSOZYME 3VHB ; 2.10 ; IMIDAZOLE ADDUCT OF THE BACTERIAL HEMOGLOBIN FROM VITREOSCILLA SP. 1NI1 ; 2.30 ; IMIDAZOLE AND CYANOPHENYL FARNESYL TRANSFERASE INHIBITORS 1KA9 ; 2.30 ; IMIDAZOLE GLYCEROL PHOSPHATE SYNTHASE 1OIQ ; 2.31 ; IMIDAZOPYRIDINES: A POTENT AND SELECTIVE CLASS OF CYCLIN-DEPENDENT KINASE INHIBITORS IDENTIFIED THROUGH STRUCTURE-BASED HYBRIDISATION 1OIR ; 1.91 ; IMIDAZOPYRIDINES: A POTENT AND SELECTIVE CLASS OF CYCLIN-DEPENDENT KINASE INHIBITORS IDENTIFIED THROUGH STRUCTURE-BASED HYBRIDISATION 1OIT ; 1.60 ; IMIDAZOPYRIDINES: A POTENT AND SELECTIVE CLASS OF CYCLIN-DEPENDENT KINASE INHIBITORS IDENTIFIED THROUGH STRUCTURE-BASED HYBRIDISATION 1SLS ; -1.00 ; IMMOBILE SLIPPED-LOOP STRUCTURE (SLS) OF DEOXYRIBONUCLEIC ACID HOMODIMER IN SOLUTION, NMR, 9 STRUCTURES 1KGC ; 1.50 ; IMMUNE RECEPTOR 1YPZ ; 3.40 ; IMMUNE RECEPTOR 1AXT ; 2.15 ; IMMUNE VERSUS NATURAL SELECTION: ANTIBODY ALDOLASES WITH THE RATES OF NATURAL ENZYMES 2RCS ; 2.10 ; IMMUNOGLOBULIN 48G7 GERMLINE FAB - AFFINITY MATURATION OF AN ESTEROLYTIC ANTIBODY 1AJ7 ; 2.10 ; IMMUNOGLOBULIN 48G7 GERMLINE FAB ANTIBODY COMPLEXED WITH HAPTEN 5-(PARA-NITROPHENYL PHOSPHONATE)-PENTANOIC ACID. AFFINITY MATURATION OF AN ESTEROLYTIC ANTIBODY 1A8J ; 2.70 ; IMMUNOGLOBULIN LAMBDA LIGHT CHAIN DIMER (MCG) COMPLEX WITH ASPARTAME 1BRE ; 2.00 ; IMMUNOGLOBULIN LIGHT CHAIN PROTEIN 1CMO ; -1.00 ; IMMUNOGLOBULIN MOTIF DEOXYRIBONUCLEIC ACID-RECOGNITION AND HETERODIMERIZATION FOR THE PEBP2/CBF RUNT-DOMAIN 1BM3 ; 2.00 ; IMMUNOGLOBULIN OPG2 FAB-PEPTIDE COMPLEX 1KJX ; 2.60 ; IMP COMPLEX OF E. COLI ADENYLOSUCCINATE SYNTHETASE 1IWE ; 2.10 ; IMP COMPLEX OF THE RECOMBINANT MOUSE-MUSCLE ADENYLOSUCCINATE SYNTHETASE 1JJT ; 1.80 ; IMP-1 METALLO BETA-LACTAMASE FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH A BIARYL SUCCINIC ACID INHIBITOR (1) 1JJE ; 1.80 ; IMP-1 METALLO BETA-LACTAMASE FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH A BIARYL SUCCINIC ACID INHIBITOR (11) 1DD6 ; 2.00 ; IMP-1 METALLO BETA-LACTAMASE FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH A MERCAPTOCARBOXYLATE INHIBITOR 1BR8 ; 2.90 ; IMPLICATIONS FOR FUNCTION AND THERAPY OF A 2.9A STRUCTURE OF BINARY-COMPLEXED ANTITHROMBIN 1YA7 ; 2.30 ; IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX 1IAL ; 2.50 ; IMPORTIN ALPHA, MOUSE 1O6O ; 2.80 ; IMPORTIN BETA AA1-442 BOUND TO FIVE FXFG REPEATS FROM YEAST NSP1P. SECOND CRYSTAL FORM 1O6P ; 2.80 ; IMPORTIN BETA BOUND TO A GLFG NUCLEOPORIN PEPTIDE 1F59 ; 2.80 ; IMPORTIN-BETA-FXFG NUCLEOPORIN COMPLEX 1SCZ ; 2.20 ; IMPROVED STRUCTURAL MODEL FOR THE CATALYTIC DOMAIN OF E.COLI DIHYDROLIPOAMIDE SUCCINYLTRANSFERASE 1G8W ; 2.80 ; IMPROVED STRUCTURE OF PHYTOHEMAGGLUTININ-L FROM THE KIDNEY BEAN 1JI2 ; 2.30 ; IMPROVED X-RAY STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE 2 1U33 ; 1.95 ; IN SITU EXTENSION AS AN APPROACH FOR IDENTIFYING NOVEL ALPHA-AMYLASE INHIBITORS 1U2Y ; 1.95 ; IN SITU EXTENSION AS AN APPROACH FOR IDENTIFYING NOVEL ALPHA-AMYLASE INHIBITORS, STRUCTURE CONTAINING D- GLUCONHYDROXIMO-1,5-LACTAM 1U30 ; 1.90 ; IN SITU EXTENSION AS AN APPROACH FOR IDENTIFYING NOVEL ALPHA-AMYLASE INHIBITORS, STRUCTURE CONTAINING MALTOSYL- ALPHA (1,4)-D-GLUCONHYDROXIMO-1,5-LACTAM 1ZTN ; -1.00 ; INACTIVATION GATE OF POTASSIUM CHANNEL RAW3, NMR, 8 STRUCTURES 1ZTO ; -1.00 ; INACTIVATION GATE OF POTASSIUM CHANNEL RCK4, NMR, 8 STRUCTURES 1KEE ; 2.10 ; INACTIVATION OF THE AMIDOTRANSFERASE ACTIVITY OF CARBAMOYL PHOSPHATE SYNTHETASE BY THE ANTIBIOTIC ACIVICIN 1DCN ; 2.30 ; INACTIVE MUTANT H162N OF DELTA 2 CRYSTALLIN WITH BOUND ARGININOSUCCINATE 1QIL ; 2.50 ; INACTIVE MUTANT TOXIC SHOCK SYNDROME TOXIN-1 AT 2.5 A 1W1U ; 2.23 ; INACTIVE UROCANASE-SA COCRYSTALLIZED WITH UROCANATE 1IOP ; 1.90 ; INCORPORATION OF A HEMIN WITH THE SHORTEST ACID SIDE-CHAINS INTO MYOGLOBIN 1IGS ; 2.00 ; INDOLE-3-GLYCEROLPHOSPHATE SYNTHASE FROM SULFOLOBUS SOLFATARICUS AT 2.0 A RESOLUTION 1JUL ; 2.00 ; INDOLE-3-GLYCEROLPHOSPHATE SYNTHASE FROM SULFOLOBUS SOLFATARICUS IN A SECOND ORTHORHOMBIC CRYSTAL FORM 1JUK ; 2.50 ; INDOLE-3-GLYCEROLPHOSPHATE SYNTHASE FROM SULFOLOBUS SOLFATARICUS IN A TRIGONAL CRYSTAL FORM 1VAF ; 2.90 ; INDUCIBLE NITRIC OXIDE SYNTHASE OXYGENASE DOMAIN COMPLEXED WITH THE INHIBITOR AR-R17477 1M9T ; 2.40 ; INDUCIBLE NITRIC OXIDE SYNTHASE WITH 3-BROMO-7- NITROINDAZOLE BOUND 1M8I ; 2.70 ; INDUCIBLE NITRIC OXIDE SYNTHASE WITH 5-NITROINDAZOLE BOUND 1M8H ; 2.85 ; INDUCIBLE NITRIC OXIDE SYNTHASE WITH 6-NITROINDAZOLE BOUND 1M8E ; 2.90 ; INDUCIBLE NITRIC OXIDE SYNTHASE WITH 7-NITROINDAZOLE BOUND 1M8D ; 2.35 ; INDUCIBLE NITRIC OXIDE SYNTHASE WITH CHLORZOXAZONE BOUND 1ZBJ ; -1.00 ; INFERENTIAL STRUCTURE DETERMINATION OF THE FYN SH3 DOMAIN USING NOESY DATA FROM A 15N,H2 ENRICHED PROTEIN 1S1K ; 1.90 ; INFLUENCE OF GROOVE INTERACTIONS ON DEOXYRIBONUCLEIC ACID HOLLIDAY JUNCTION FORMATION 1S1L ; 2.20 ; INFLUENCE OF GROOVE INTERACTIONS ON THE FORMATION OF DEOXYRIBONUCLEIC ACID HOLLIDAY JUNCTIONS 1PD3 ; 2.60 ; INFLUENZA A NEP M1-BINDING DOMAIN 1ING ; 2.40 ; INFLUENZA A SUBTYPE N2 NEURAMINIDASE COMPLEXED WITH AROMATIC BANA109 INHIBITOR 1INH ; 2.40 ; INFLUENZA A SUBTYPE N2 NEURAMINIDASE COMPLEXED WITH AROMATIC BANA111 INHIBITOR 1VCJ ; 2.40 ; INFLUENZA B VIRUS NEURAMINIDASE COMPLEXED WITH 1-(4-CARBOXY- 2-(3-PENTYLAMINO)PHENYL)-5-AMINOMETHYL-5-HYDROXYMETHYL- PYRROLIDIN-2-ONE 1A4Q ; 1.90 ; INFLUENZA VIRUS B/BEIJING/1/87 NEURAMINIDASE COMPLEXED WITH DIHYDROPYRAN-PHENETHYL-PROPYL-CARBOXAMIDE 1A4G ; 2.20 ; INFLUENZA VIRUS B/BEIJING/1/87 NEURAMINIDASE COMPLEXED WITH ZANAMIVIR 1INF ; 2.40 ; INFLUENZA VIRUS B/LEE/40 NEURAMINIDASE COMPLEXED WITH BANA113 INHIBITOR 2VIU ; 2.50 ; INFLUENZA VIRUS HEMAGGLUTININ 1EO8 ; 2.80 ; INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH A NEUTRALIZING ANTIBODY 1QFU ; 2.80 ; INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH A NEUTRALIZING ANTIBODY 2VIR ; 3.25 ; INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH A NEUTRALIZING ANTIBODY 1KEN ; 3.50 ; INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH AN ANTIBODY THAT PREVENTS THE HEMAGGLUTININ LOW PH FUSOGENIC TRANSITION 2VIS ; 3.25 ; INFLUENZA VIRUS HEMAGGLUTININ, MUTANT WITH THR 131 REPLACED BY ILE, COMPLEXED WITH A NEUTRALIZING ANTIBODY 2VIT ; 3.25 ; INFLUENZA VIRUS HEMAGGLUTININ, MUTANT WITH THR 155 REPLACED BY ILE, COMPLEXED WITH A NEUTRALIZING ANTIBODY 1EA3 ; 2.30 ; INFLUENZA VIRUS M1 PROTEIN 1AA7 ; 2.08 ; INFLUENZA VIRUS MATRIX PROTEIN CRYSTAL STRUCTURE AT PH 4.0 1NNC ; 1.80 ; INFLUENZA VIRUS NEURAMINIDASE SUBTYPE N9 (TERN) COMPLEXED WITH 4-GUANIDINO-NEU5AC2EN INHIBITOR 1MDM ; 2.80 ; INHIBITED FRAGMENT OF ETS-1 AND PAIRED DOMAIN OF PAX5 BOUND TO DEOXYRIBONUCLEIC ACID 1EO3 ; 2.00 ; INHIBITION OF ECORV ENDONUCLEASE BY DEOXYRIBO-3'-S- PHOSPHOROTHIOLATES: A HIGH RESOLUTION X-RAY CRYSTALLOGRAPHIC STUDY 1QR8 ; 2.10 ; INHIBITION OF HIV-1 INFECTIVITY BY THE GP41 CORE: ROLE OF A CONSERVED HYDROPHOBIC CAVITY IN MEMBRANE FUSION 1QR9 ; 1.60 ; INHIBITION OF HIV-1 INFECTIVITY BY THE GP41 CORE: ROLE OF A CONSERVED HYDROPHOBIC CAVITY IN MEMBRANE FUSION 1W0C ; 2.60 ; INHIBITION OF LEISHMANIA MAJOR PTERIDINE REDUCTASE (PTR1) BY 2,4,6-TRIAMINOQUINAZOLINE; STRUCTURE OF THE NADP TERNARY COMPLEX. 1XBP ; 3.50 ; INHIBITION OF PEPTIDE BOND FORMATION BY PLEUROMUTILINS: THE STRUCTURE OF THE 50S RIBOSOMAL SUBUNIT FROM DEINOCOCCUS RADIODURANS IN COMPLEX WITH TIAMULIN 1OXL ; 1.80 ; INHIBITION OF PHOSPHOLIPASE A2 (PLA2) BY (2-CARBAMOYLMETHYL- 5-PROPYL-OCTAHYDRO-INDOL-7-YL)-ACETIC ACID (INDOLE): CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN PLA2 FROM RUSSELL'S VIPER AND INDOLE AT 1.8 RESOLUTION 1K0U ; 3.00 ; INHIBITION OF S-ADENOSYLHOMOCYSTEINE HYDROLASE BY "ACYCLIC SUGAR" ADENOSINE ANALOGUE D-ERITADENINE 359D ; 2.90 ; INHIBITION OF THE HAMMERHEAD RIBOZYME CLEAVAGE REACTION BY SITE-SPECIFIC BINDING OF TB(III) 1DXP ; 2.40 ; INHIBITION OF THE HEPATITIS C VIRUS NS3/4A PROTEASE. THE CRYSTAL STRUCTURES OF TWO PROTEASE-INHIBITOR COMPLEXES (APO STRUCTURE) 1DY9 ; 2.10 ; INHIBITION OF THE HEPATITIS C VIRUS NS3/4A PROTEASE. THE CRYSTAL STRUCTURES OF TWO PROTEASE-INHIBITOR COMPLEXES (INHIBITOR I) 1DY8 ; 2.40 ; INHIBITION OF THE HEPATITIS C VIRUS NS3/4A PROTEASE. THE CRYSTAL STRUCTURES OF TWO PROTEASE-INHIBITOR COMPLEXES (INHIBITOR II) 1YQS ; 1.05 ; INHIBITION OF THE R61 DD-PEPTIDASE BY N-BENZOYL-BETA-SULTAM 1ALW ; 2.03 ; INHIBITOR AND CALCIUM BOUND DOMAIN VI OF PORCINE CALPAIN 1R4L ; 3.00 ; INHIBITOR BOUND HUMAN ANGIOTENSIN CONVERTING ENZYME-RELATED CARBOXYPEPTIDASE (ACE2) 2C4B ; 1.30 ; INHIBITOR CYSTINE KNOT PROTEIN MCOEETI FUSED TO THE CATALYTICALLY INACTIVE BARNASE MUTANT H102A 1IZH ; 1.90 ; INHIBITOR OF HIV PROTEASE WITH UNUSUAL BINDING MODE POTENTLY INHIBITING MULTI-RESISTANT PROTEASE MUTANTS 1IZI ; 2.15 ; INHIBITOR OF HIV PROTEASE WITH UNUSUAL BINDING MODE POTENTLY INHIBITING MULTI-RESISTANT PROTEASE MUTANTS 1E0H ; -1.00 ; INHIBITOR PROTEIN IM9 BOUND TO ITS PARTNER E9 DNASE 1AYK ; -1.00 ; INHIBITOR-FREE CATALYTIC FRAGMENT OF HUMAN FIBROBLAST COLLAGENASE, NMR, 30 STRUCTURES 2AYK ; -1.00 ; INHIBITOR-FREE CATALYTIC FRAGMENT OF HUMAN FIBROBLAST COLLAGENASE, NMR, MINIMIZED AVERAGE STRUCTURE 1NKR ; 1.70 ; INHIBITORY RECEPTOR (P58-CL42) FOR HUMAN NATURAL KILLER CELLS 1Y63 ; 1.70 ; INITIAL CRYSTAL STRUCTURAL ANALYSIS OF A PROBABLE KINASE FROM LEISHMANIA MAJOR FRIEDLIN 2B30 ; 2.70 ; INITIAL CRYSTALLOGRAPHIC STRUCTURAL ANALYSIS OF A PUTATIVE HAD/COF-LIKE HYDROLASE FROM PLASMODIUM VIVAX 1YJ8 ; 2.85 ; INITIAL STRUCTURAL ANALYSIS OF PLASMODIUM FALCIPARUM GLYCEROL-3-PHOSPHATE DEHYDROGENASE 1SYR ; 2.95 ; INITIAL STRUCTURAL ANALYSIS OF PLASMODIUM FALCIPARUM THIOREDOXIN 1SVV ; 2.10 ; INITIAL STUCTURAL ANALYSIS OF LEISHMANIA MAJOR THREONINE ALDOLASE 1N1H ; 2.80 ; INITIATION COMPLEX OF POLYMERASE LAMBDA3 FROM REOVIRUS 1BKB ; 1.75 ; INITIATION FACTOR 5A FROM ARCHEBACTERIUM PYROBACULUM AEROPHILUM 1FYC ; -1.00 ; INNER LIPOYL DOMAIN FROM HUMAN PYRUVATE DEHYDROGENASE (PDH) COMPLEX, NMR, 1 STRUCTURE 1QJO ; -1.00 ; INNERMOST LIPOYL DOMAIN OF THE PYRUVATE DEHYDROGENASE FROM ESCHERICHIA COLI 1FAJ ; 2.15 ; INORGANIC PYROPHOSPHATASE 2EIP ; 2.20 ; INORGANIC PYROPHOSPHATASE 1K23 ; 3.00 ; INORGANIC PYROPHOSPHATASE (FAMILY II) FROM BACILLUS SUBTILIS 1K20 ; 1.50 ; INORGANIC PYROPHOSPHATASE (FAMILY II) FROM STREPTOCOCCUS GORDONII AT 1.5 A RESOLUTION 1IPW ; 2.30 ; INORGANIC PYROPHOSPHATASE FROM ESCHERICHIA COLI WITH THREE MAGNESIUM IONS 1TWL ; 2.20 ; INORGANIC PYROPHOSPHATASE FROM PYROCOCCUS FURIOSUS PFU- 264096-001 1BWD ; 3.10 ; INOSAMINE-PHOSPHATE AMIDINOTRANSFERASE STRB1 FROM STREPTOMYCES GRISEUS 1AK5 ; 2.30 ; INOSINE MONOPHOSPHATE DEHYDROGENASE (IMPDH) FROM TRITRICHOMONAS FOETUS 1MEH ; 1.95 ; INOSINE MONOPHOSPHATE DEHYDROGENASE (IMPDH) FROM TRITRICHOMONAS FOETUS WITH IMP AND MOA BOUND 1ME9 ; 2.20 ; INOSINE MONOPHOSPHATE DEHYDROGENASE (IMPDH) FROM TRITRICHOMONAS FOETUS WITH IMP BOUND 1ME7 ; 2.15 ; INOSINE MONOPHOSPHATE DEHYDROGENASE (IMPDH) FROM TRITRICHOMONAS FOETUS WITH RVP AND MOA BOUND 1ME8 ; 1.90 ; INOSINE MONOPHOSPHATE DEHYDROGENASE (IMPDH) FROM TRITRICHOMONAS FOETUS WITH RVP BOUND 1MEI ; 2.20 ; INOSINE MONOPHOSPHATE DEHYDROGENASE (IMPDH) FROM TRITRICHOMONAS FOETUS WITH XMP AND MYCOPHENOLIC ACID BOUND 1MEW ; 2.15 ; INOSINE MONOPHOSPHATE DEHYDROGENASE (IMPDH) FROM TRITRICHOMONAS FOETUS WITH XMP AND NAD BOUND 1ZFJ ; 1.90 ; INOSINE MONOPHOSPHATE DEHYDROGENASE (IMPDH; EC 1.1.1.205) FROM STREPTOCOCCUS PYOGENES 1KIE ; 2.00 ; INOSINE-ADENOSINE-GUANOSINE PREFERRING NUCLEOSIDE HYDROLASE FROM TRYPANOSOMA VIVAX: ASP10ALA MUTANT IN COMPLEX WITH 3- DEAZA-ADENOSINE 1KIC ; 1.60 ; INOSINE-ADENOSINE-GUANOSINE PREFERRING NUCLEOSIDE HYDROLASE FROM TRYPANOSOMA VIVAX: ASP10ALA MUTANT IN COMPLEX WITH INOSINE 1R4F ; 2.30 ; INOSINE-ADENOSINE-GUANOSINE PREFERRING NUCLEOSIDE HYDROLASE FROM TRYPANOSOMA VIVAX: TRP260ALA MUTANT IN COMPLEX WITH 3- DEAZA-ADENOSINE 1Z2N ; 1.20 ; INOSITOL 1,3,4-TRISPHOSPHATE 5/6-KINASE COMPLEXED MG2+/ADP 1Z2O ; 1.24 ; INOSITOL 1,3,4-TRISPHOSPHATE 5/6-KINASE IN COMPLEX WITH MG2+/ADP/INS(1,3,4,6)P4 1Z2P ; 1.22 ; INOSITOL 1,3,4-TRISPHOSPHATE 5/6-KINASE IN COMPLEX WITH MG2+/AMP-PCP/INS(1,3,4)P3 1QL1 ; 3.10 ; INOVIRUS (FILAMENTOUS BACTERIOPHAGE) STRAIN PF1 MAJOR COAT PROTEIN ASSEMBLY 1QL2 ; 3.10 ; INOVIRUS (FILAMENTOUS BACTERIOPHAGE) STRAIN PF1 MAJOR COAT PROTEIN ASSEMBLY 1IFP ; 3.10 ; INOVIRUS (FILAMENTOUS BACTERIOPHAGE) STRAIN PF3 MAJOR COAT PROTEIN ASSEMBLY 8TFV ; -1.00 ; INSECT DEFENSE PEPTIDE 1LQI ; -1.00 ; INSECTICIDAL ALPHA SCORPION TOXIN ISOLATED FROM THE VENOM OF SCORPION LEIURUS QUINQUESTRIATUS HEBRAEUS, NMR, 29 STRUCTURES 1LQH ; -1.00 ; INSECTICIDAL ALPHA SCORPION TOXIN ISOLATED FROM THE VENOM OF SCORPION LEIURUS QUINQUESTRIATUS HEBRAEUS, NMR, MINIMIZED AVERAGE STRUCTURE 1I5P ; 2.20 ; INSECTICIDAL CRYSTAL PROTEIN CRY2AA 1CIY ; 2.25 ; INSECTICIDAL TOXIN: STRUCTURE AND CHANNEL FORMATION 1S5J ; 2.40 ; INSIGHT IN DEOXYRIBONUCLEIC ACID REPLICATION: THE CRYSTAL STRUCTURE OF DEOXYRIBONUCLEIC ACID POLYMERASE B1 FROM THE ARCHAEON SULFOLOBUS SOLFATARICUS 1C12 ; 2.60 ; INSIGHT IN ODORANT PERCEPTION: THE CRYSTAL STRUCTURE AND BINDING CHARACTERISTICS OF ANTIBODY FRAGMENTS DIRECTED AGAINST THE MUSK ODORANT TRASEOLIDE 1J49 ; 2.20 ; INSIGHTS INTO DOMAIN CLOSURE, SUBSTRATE SPECIFICITY AND CATALYSIS OF D-LACTATE DEHYDROGENASE FROM LACTOBACILLUS BULGARICUS 1J4A ; 1.90 ; INSIGHTS INTO DOMAIN CLOSURE, SUBSTRATE SPECIFICITY AND CATALYSIS OF D-LACTATE DEHYDROGENASE FROM LACTOBACILLUS BULGARICUS 1FFY ; 2.20 ; INSIGHTS INTO EDITING FROM AN ILE-TRNA SYNTHETASE STRUCTURE WITH TRNA(ILE) AND MUPIROCIN 1QU2 ; 2.20 ; INSIGHTS INTO EDITING FROM AN ILE-TRNA SYNTHETASE STRUCTURE WITH TRNA(ILE) AND MUPIROCIN 1QU3 ; 2.90 ; INSIGHTS INTO EDITING FROM AN ILE-TRNA SYNTHETASE STRUCTURE WITH TRNA(ILE) AND MUPIROCIN 1S78 ; 3.25 ; INSIGHTS INTO ERBB SIGNALING FROM THE STRUCTURE OF THE ERBB2-PERTUZUMAB COMPLEX 1FQV ; 2.80 ; INSIGHTS INTO SCF UBIQUITIN LIGASES FROM THE STRUCTURE OF THE SKP1-SKP2 COMPLEX 1FS1 ; 1.80 ; INSIGHTS INTO SCF UBIQUITIN LIGASES FROM THE STRUCTURE OF THE SKP1-SKP2 COMPLEX 1FS2 ; 2.90 ; INSIGHTS INTO SCF UBIQUITIN LIGASES FROM THE STRUCTURE OF THE SKP1-SKP2 COMPLEX 1YOV ; 2.60 ; INSIGHTS INTO THE UBIQUITIN TRANSFER CASCADE FROM THE REFINED STRUCTURE OF THE ACTIVATING ENZYME FOR NEDD8 1ZNI ; 1.50 ; INSULIN 2BN1 ; 1.40 ; INSULIN AFTER A HIGH DOSE X-RAY BURN 1GUJ ; 1.62 ; INSULIN AT PH 2: STRUCTURAL ANALYSIS OF THE CONDITIONS PROMOTING INSULIN FIBRE FORMATION. 2BN3 ; 1.40 ; INSULIN BEFORE A HIGH DOSE X-RAY BURN 1BEN ; 1.40 ; INSULIN COMPLEXED WITH 4-HYDROXYBENZAMIDE 1HUI ; -1.00 ; INSULIN MUTANT (B1, B10, B16, B27)GLU, DES-B30, NMR, 25 STRUCTURES 1IOG ; -1.00 ; INSULIN MUTANT A3 GLY,(B1, B10, B16, B27)GLU, DES-B30, NMR, 19 STRUCTURES 1IOH ; -1.00 ; INSULIN MUTANT A8 HIS,(B1, B10, B16, B27)GLU, DES-B30, NMR, 26 STRUCTURES 1A7F ; -1.00 ; INSULIN MUTANT B16 GLU, B24 GLY, DES-B30, NMR, 20 STRUCTURES 1ZNJ ; 2.00 ; INSULIN, MONOCLINIC CRYSTAL FORM 1PMX ; -1.00 ; INSULIN-LIKE GROWTH FACTOR-I BOUND TO A PHAGE-DERIVED PEPTIDE 1B9G ; -1.00 ; INSULIN-LIKE-GROWTH-FACTOR-1 1EFC ; 2.05 ; INTACT ELONGATION FACTOR FROM E.COLI 1TUI ; 2.70 ; INTACT ELONGATION FACTOR TU IN COMPLEX WITH GDP 1LBH ; 3.20 ; INTACT LACTOSE OPERON REPRESSOR WITH GRATUITOUS INDUCER IPTG 1PSI ; 2.90 ; INTACT RECOMBINED ALPHA1-ANTITRYPSIN MUTANT PHE 51 TO LEU 1KZU ; 2.50 ; INTEGRAL MEMBRANE PERIPHERAL LIGHT HARVESTING COMPLEX FROM RHODOPSEUDOMONAS ACIDOPHILA STRAIN 10050 1MF7 ; 1.25 ; INTEGRIN ALPHA M I DOMAIN 1NA5 ; 1.50 ; INTEGRIN ALPHA M I DOMAIN 1N9Z ; 2.50 ; INTEGRIN ALPHA M I DOMAIN MUTANT 1DZI ; 2.10 ; INTEGRIN ALPHA2 I DOMAIN / COLLAGEN COMPLEX 1UZQ ; 2.40 ; INTEGRIN BINDING CBEGF22-TB4-CBEGF33 FRAGMENT OF HUMAN FIBRILLIN-1, APO FORM CBEGF23 DOMAIN ONLY. 1UZJ ; 2.25 ; INTEGRIN BINDING CBEGF22-TB4-CBEGF33 FRAGMENT OF HUMAN FIBRILLIN-1, HOLO FORM. 1UZP ; 1.78 ; INTEGRIN BINDING CBEGF22-TB4-CBEGF33 FRAGMENT OF HUMAN FIBRILLIN-1, SM BOUND FORM CBEGF23 DOMAIN ONLY. 1L3Y ; -1.00 ; INTEGRIN EGF-LIKE MODULE 3 FROM THE BETA-2 SUBUNIT 336D ; 1.00 ; INTERACTION BETWEEN LEFT-HANDED Z-DEOXYRIBONUCLEIC ACID AND POLYAMINE-3 THE CRYSTAL STRUCTURE OF THE D(CG)3 AND THERMOSPERMINE COMPLEX 1BEJ ; 2.40 ; INTERACTION BETWEEN PROXIMAL AND DISTALS REGIONS OF CYTOCHROME C PEROXIDASE 1BEM ; 2.20 ; INTERACTION BETWEEN PROXIMAL AND DISTALS REGIONS OF CYTOCHROME C PEROXIDASE 1BEQ ; 2.16 ; INTERACTION BETWEEN PROXIMAL AND DISTALS REGIONS OF CYTOCHROME C PEROXIDASE 1BES ; 2.00 ; INTERACTION BETWEEN PROXIMAL AND DISTALS REGIONS OF CYTOCHROME C PEROXIDASE 293D ; 1.00 ; INTERACTION BETWEEN THE LEFT-HANDED Z-DEOXYRIBONUCLEIC ACID AND POLYAMINE-2: THE CRYSTAL STRUCTURE OF THE D(CG)3 AND SPERMIDINE COMPLEX 292D ; 1.00 ; INTERACTION BETWEEN THE LEFT-HANDED Z-DEOXYRIBONUCLEIC ACID AND POLYAMINE: THE CRYSTAL STRUCTURE OF THE D(CG)3 AND N-(2-AMINOETHYL)-1,4-DIAMINOBUTANE COMPLEX 1X1L ; 13.50 ; INTERACTION OF ERA,A GTPASE PROTEIN, WITH THE 3'MINOR DOMAIN OF THE 16S RRNA WITHIN THE THERMUS THERMOPHILUS 30S SUBUNIT. 1DE7 ; 2.00 ; INTERACTION OF FACTOR XIII ACTIVATION PEPTIDE WITH ALPHA- THROMBIN: CRYSTAL STRUCTURE OF THE ENZYME-SUBSTRATE COMPLEX 1CN3 ; 2.20 ; INTERACTION OF POLYOMAVIRUS INTERNAL PROTEIN VP2 WITH MAJOR CAPSID PROTEIN VP1 AND IMPLICATIONS FOR PARTICIPATION OF VP2 IN VIRAL ENTRY 1DF4 ; 1.45 ; INTERACTIONS BETWEEN HIV-1 GP41 CORE AND DETERGENTS AND THEIR IMPLICATIONS FOR MEMBRANE FUSION 1DF5 ; 2.70 ; INTERACTIONS BETWEEN HIV-1 GP41 CORE AND DETERGENTS AND THEIR IMPLICATIONS FOR MEMBRANE FUSION 1IZ2 ; 2.20 ; INTERACTIONS CAUSING THE KINETIC TRAP IN SERPIN PROTEIN FOLDING 1UR8 ; 1.90 ; INTERACTIONS OF A FAMILY 18 CHITINASE WITH THE DESIGNED INHIBITOR HM508, AND ITS DEGRADATION PRODUCT, CHITOBIONO-DELTA-LACTONE 1UR9 ; 1.80 ; INTERACTIONS OF A FAMILY 18 CHITINASE WITH THE DESIGNED INHIBITOR HM508, AND ITS DEGRADATION PRODUCT, CHITOBIONO-DELTA-LACTONE 1TD7 ; 2.50 ; INTERACTIONS OF A SPECIFIC NON-STEROIDAL ANTI-INFLAMMATORY DRUG (NSAID) WITH GROUP I PHOSPHOLIPASE A2 (PLA2): CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN PLA2 AND NIFLUMIC ACID AT 2.5 A RESOLUTION 1AO1 ; -1.00 ; INTERACTIONS OF DEGLYCOSYLATED COBALT(III)-PEPLEOMYCIN WITH DEOXYRIBONUCLEIC ACID, NMR, MINIMIZED AVERAGE STRUCTURE 1D4U ; -1.00 ; INTERACTIONS OF HUMAN NUCLEOTIDE EXCISION REPAIR PROTEIN XPA WITH RPA70 AND DEOXYRIBONUCLEIC ACID: CHEMICAL SHIFT MAPPING AND 15N NMR RELAXATION STUDIES 2B2L ; 2.54 ; INTERACTIONS OF PROTECTIVE SIGNALLING FACTOR WITH CHITIN- LIKE POLYSACCHARIDE: CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN SIGNALLING PROTEIN FROM SHEEP (SPS-40) AND A HEXASACCHARIDE AT 2.5A RESOLUTION 294D ; 2.50 ; INTERCALATED CYTOSINE MOTIF AND NOVEL ADENINE CLUSTERS IN THE CRYSTAL STRUCTURE OF TETRAHYMENA TELOMERE 1C11 ; -1.00 ; INTERCALATED D(TCCCGTTTCCA) DIMER, NMR, 7 STRUCTURES 454D ; 1.20 ; INTERCALATION AND MAJOR GROOVE RECOGNITION IN THE 1.2 A RESOLUTION CRYSTAL STRUCTURE OF RH[ME2TRIEN]PHI BOUND TO 5'- G(5IU)TGCAAC-3' 1G3X ; 2.70 ; INTERCALATION OF AN 9ACRIDINE-PEPTIDE DRUG IN A DEOXYRIBONUCLEIC ACID DODECAMER 1CA5 ; 2.20 ; INTERCALATION SITE OF HYPERTHERMOPHILE CHROMOSOMAL PROTEIN SSO7D/SAC7D BOUND TO DEOXYRIBONUCLEIC ACID 1CA6 ; 2.20 ; INTERCALATION SITE OF HYPERTHERMOPHILE CHROMOSOMAL PROTEIN SSO7D/SAC7D BOUND TO DEOXYRIBONUCLEIC ACID 1ITF ; -1.00 ; INTERFERON ALPHA-2A, NMR, 24 STRUCTURES 1IF1 ; 3.00 ; INTERFERON REGULATORY FACTOR 1 (IRF-1) COMPLEX WITH DEOXYRIBONUCLEIC ACID 1IRG ; -1.00 ; INTERFERON REGULATORY FACTOR-2 DEOXYRIBONUCLEIC ACID BINDING DOMAIN, NMR, 20 STRUCTURES 1IRF ; -1.00 ; INTERFERON REGULATORY FACTOR-2 DEOXYRIBONUCLEIC ACID BINDING DOMAIN, NMR, MINIMIZED AVERAGE STRUCTURE 1T4Q ; 2.10 ; INTERLEUKIN 1 BETA F101W 1TWE ; 2.10 ; INTERLEUKIN 1 BETA MUTANT F101Y 1S0L ; 2.34 ; INTERLEUKIN 1 BETA MUTANT F42W 1TOO ; 2.10 ; INTERLEUKIN 1B MUTANT F146W 1IOB ; 2.00 ; INTERLEUKIN-1 BETA FROM JOINT X-RAY AND NMR REFINEMENT 1TWM ; 2.26 ; INTERLEUKIN-1 BETA MUTANT F146Y 1HIK ; 2.60 ; INTERLEUKIN-4 (WILD-TYPE) 1IAR ; 2.30 ; INTERLEUKIN-4 / RECEPTOR ALPHA CHAIN COMPLEX 1HZI ; 2.05 ; INTERLEUKIN-4 MUTANT E9A 1HIJ ; 3.00 ; INTERLEUKIN-4 MUTANT WITH ARG 88 REPLACED WITH GLN (R88Q) 1QE6 ; 2.35 ; INTERLEUKIN-8 WITH AN ADDED DISULFIDE BETWEEN RESIDUES 5 AND 33 (L5C/H33C) 1ICW ; 2.01 ; INTERLEUKIN-8, MUTANT WITH GLU 38 REPLACED BY CYS AND CYS 50 REPLACED BY ALA 1XL4 ; 2.60 ; INTERMEDIATE GATING STRUCTURE 1 OF THE INWARDLY RECTIFYING K+ CHANNEL KIRBAC3.1 1XL6 ; 2.85 ; INTERMEDIATE GATING STRUCTURE 2 OF THE INWARDLY RECTIFYING K+ CHANNEL KIRBAC3.1 1ZRN ; 1.83 ; INTERMEDIATE STRUCTURE OF L-2-HALOACID DEHALOGENASE WITH MONOCHLOROACETATE 1E5B ; -1.00 ; INTERNAL XYLAN BINDING DOMAIN FROM C. FIMI XYN10A, R262G MUTANT 1E5C ; -1.00 ; INTERNAL XYLAN BINDING DOMAIN FROM C. FIMI XYN10A, R262G MUTANT 1XBD ; -1.00 ; INTERNAL XYLAN BINDING DOMAIN FROM CELLULOMONAS FIMI XYLANASE D, NMR, 5 STRUCTURES 2XBD ; -1.00 ; INTERNAL XYLAN BINDING DOMAIN FROM CELLULOMONAS FIMI XYLANASE D, NMR, MINIMIZED AVERAGE STRUCTURE 1O6V ; 1.50 ; INTERNALIN (INLA,LISTERIA MONOCYTOGENES) - FUNCTIONAL DOMAIN, UNCOMPLEXED 1O6T ; 1.60 ; INTERNALIN (INLA,LISTERIA MONOCYTOGENES) - FUNCTIONAL DOMAIN,UNCOMPLEXED 1O6S ; 1.80 ; INTERNALIN (LISTERIA MONOCYTOGENES) / E-CADHERIN (HUMAN) RECOGNITION COMPLEX 1D0B ; 1.86 ; INTERNALIN B LEUCINE RICH REPEAT DOMAIN 1H6T ; 1.60 ; INTERNALIN B: CRYSTAL STRUCTURE OF FUSED N-TERMINAL DOMAINS. 1H6U ; 1.80 ; INTERNALIN H: CRYSTAL STRUCTURE OF FUSED N-TERMINAL DOMAINS. 1XZ4 ; 2.00 ; INTERSUBUNIT INTERACTIONS ASSOCIATED WITH TYR42ALPHA STABILIZE THE QUATERNARY-T TETRAMER BUT ARE NOT MAJOR QUATERNARY CONSTRAINTS IN DEOXYHEMOGLOBIN: ALPHAY42A DEOXYHEMOGLOBIN NO-SALT 1MRU ; 3.00 ; INTRACELLULAR SER/THR PROTEIN KINASE DOMAIN OF MYCOBACTERIUM TUBERCULOSIS PKNB. 1AO9 ; -1.00 ; INTRAMOLECULAR DEOXYRIBONUCLEIC ACID DUPLEX CONTAINING A NON-NUCLEOTIDE LINKER (GAGAGA-X-TCTCCT), NMR, 12 STRUCTURES 1AT4 ; -1.00 ; INTRAMOLECULAR DEOXYRIBONUCLEIC ACID TRIPLEX CONTAINING A NON-NUCLEOTIDE LINKER (GAGAGA-X-TCTCCT-X-CTCTCT), NMR, 7 STRUCTURES 1P3X ; -1.00 ; INTRAMOLECULAR DEOXYRIBONUCLEIC ACID TRIPLEX WITH 1-PROPYNYL DEOXYURIDINE IN THE THIRD STRAND, NMR, 10 STRUCTURES 1R3X ; -1.00 ; INTRAMOLECULAR DEOXYRIBONUCLEIC ACID TRIPLEX WITH RIBONUCLEIC ACID THIRD STRAND, NMR, 10 STRUCTURES 1D3X ; -1.00 ; INTRAMOLECULAR DEOXYRIBONUCLEIC ACID TRIPLEX, NMR, 10 STRUCTURES 1OZ8 ; -1.00 ; INTRAMOLECULAR HIGHER-ORDER PACKING OF PARALLEL QUADRUPLEXES COMPRISING A G:G:G:G TETRAD AND A G(:A):G(:A) :G(:A):G HEPTAD OF GGA TRIPLET REPEAT DEOXYRIBONUCLEIC ACID 1A83 ; -1.00 ; INTRAMOLECULAR I-MOTIF, NMR, 6 STRUCTURES 1AWJ ; -1.00 ; INTRAMOLECULAR ITK-PROLINE COMPLEX, NMR, MINIMIZED AVERAGE STRUCTURE 1FQP ; -1.00 ; INTRAMOLECULAR QUADRUPLEX DEOXYRIBONUCLEIC ACID WITH THREE GGGG REPEATS, NMR, PH 6.7, 0.1 M NA+ AND 4 MM (STRAND CONCENTRATION), 5 STRUCTURES 1BCB ; -1.00 ; INTRAMOLECULAR TRIPLEX, NMR, 10 STRUCTURES 1BCE ; -1.00 ; INTRAMOLECULAR TRIPLEX, NMR, 10 STRUCTURES 1IKK ; 1.60 ; INTRINSIC BENDING AND DEFORMABILITY AT THE T-A STEP OF CCTTTAAAGG: A COMPARATIVE ANALYSIS OF T-A AND A-T STEPS WITHIN A-TRACTS 1AEV ; 2.10 ; INTRODUCTION OF NOVEL SUBSTRATE OXIDATION INTO CYTOCHROME C PEROXIDASE BY CAVITY COMPLEMENTATION: OXIDATION OF 2-AMINOTHIAZOLE AND COVALENT MODIFICATION OF THE ENZYME (2-AMINOTHIAZOLE) 1CYQ ; 1.93 ; INTRON ENCODED HOMING ENDONUCLEASE I-PPOI (H98A)/DEOXYRIBONUCLEIC ACID HOMING SITE COMPLEX 1CZ0 ; 2.10 ; INTRON ENCODED HOMING ENDONUCLEASE I-PPOI/DEOXYRIBONUCLEIC ACID COMPLEX LACKING CATALYTIC METAL ION 1A73 ; 1.80 ; INTRON-ENCODED ENDONUCLEASE I-PPOI COMPLEXED WITH DEOXYRIBONUCLEIC ACID 1IPP ; 2.20 ; INTRON-ENCODED ENDONUCLEASE I-PPOI COMPLEXED WITH DEOXYRIBONUCLEIC ACID 1A74 ; 2.20 ; INTRON-ENCODED ENDONUCLEASE I-PPOI COMPLEXED WITH DEOXYRIBONUCLEIC ACID/ SUBSTRATE COMPLEX 1L0C ; 2.30 ; INVESTIGATION OF THE ROLES OF CATALYTIC RESIDUES IN SEROTONIN N-ACETYLTRANSFERASE 2AXE ; 1.80 ; IODINATED COMPLEX OF ACETYL XYLAN ESTERASE AT 1.80 ANGSTROMS 1VAT ; 1.60 ; IODINE DERIVATIVE OF HEN EGG-WHITE LYSOZYME 1KTW ; 2.00 ; IOTA-CARRAGEENASE COMPLEXED TO IOTA-CARRAGEENAN FRAGMENTS 1X84 ; 1.78 ; IPP ISOMERASE (WT) REACTED WITH (S)-BROMOHYDRINE OF IPP 1P0K ; 1.90 ; IPP:DMAPP ISOMERASE TYPE II APO STRUCTURE 1P0N ; 2.80 ; IPP:DMAPP ISOMERASE TYPE II, FMN COMPLEX 1B1B ; 2.60 ; IRON DEPENDENT REGULATOR 1AQO ; -1.00 ; IRON RESPONSIVE ELEMENT RIBONUCLEIC ACID HAIRPIN, NMR, 15 STRUCTURES 1NBR ; -1.00 ; IRON RESPONSIVE ELEMENT RIBONUCLEIC ACID HAIRPIN, NMR, 15 STRUCTURES 1BFR ; 2.94 ; IRON STORAGE AND ELECTRON TRANSPORT 1WB8 ; 2.30 ; IRON SUPEROXIDE DISMUTASE (FE-SOD) FROM THE HYPERTHERMOPHILE SULFOLOBUS SOLFATARICUS. 2.3 A RESOLUTION STRUCTURE OF RECOMBINANT PROTEIN WITH A COVALENTLY MODIFIED TYROSIN IN THE ACTIVE SITE. 1WB7 ; 2.24 ; IRON SUPEROXIDE DISMUTASE (FE-SOD) FROM THE HYPERTHERMOPHILE SULFOLOBUS SOLFATARICUS. CRYSTAL STRUCTURE OF THE Y41F MUTANT. 1TJO ; 1.60 ; IRON-OXO CLUSTERS BIOMINERALIZING ON PROTEIN SURFACES. STRUCTURAL ANALYSIS OF H.SALINARUM DPSA IN ITS LOW AND HIGH IRON STATES 1TK6 ; 2.20 ; IRON-OXO CLUSTERS BIOMINERALIZING ON PROTEIN SURFACES. STRUCTURAL ANALYSIS OF H.SALINARUM DPSA IN ITS LOW AND HIGH IRON STATES 1TKO ; 2.90 ; IRON-OXO CLUSTERS BIOMINERALIZING ON PROTEIN SURFACES. STRUCTURAL ANALYSIS OF H.SALINARUM DPSA IN ITS LOW AND HIGH IRON STATES 1TKP ; 2.20 ; IRON-OXO CLUSTERS BIOMINERALIZING ON PROTEIN SURFACES. STRUCTURAL ANALYSIS OF H.SALINARUM DPSA IN ITS LOW AND HIGH IRON STATES 1IRS ; -1.00 ; IRS-1 PTB DOMAIN COMPLEXED WITH A IL-4 RECEPTOR PHOSPHOPEPTIDE, NMR, MINIMIZED AVERAGE STRUCTURE 1POJ ; 3.30 ; ISOASPARTYL DIPEPTIDASE WITH BOUND INHIBITOR 1AI2 ; 1.90 ; ISOCITRATE DEHYDROGENASE COMPLEXED WITH ISOCITRATE, NADP+, AND CALCIUM (FLASH-COOLED) 1BL5 ; 2.50 ; ISOCITRATE DEHYDROGENASE FROM E. COLI SINGLE TURNOVER LAUE STRUCTURE OF RATE-LIMITED PRODUCT COMPLEX, 10 MSEC TIME RESOLUTION 1IDC ; 2.50 ; ISOCITRATE DEHYDROGENASE FROM E.COLI (MUTANT K230M), STEADY-STATE INTERMEDIATE COMPLEX DETERMINED BY LAUE CRYSTALLOGRAPHY 1XGV ; 2.20 ; ISOCITRATE DEHYDROGENASE FROM THE HYPERTHERMOPHILE AEROPYRUM PERNIX 1TYO ; 2.15 ; ISOCITRATE DEHYDROGENASE FROM THE HYPERTHERMOPHILE AEROPYRUM PERNIX IN COMPLEX WITH ETHENO-NADP 1IDF ; 2.50 ; ISOCITRATE DEHYDROGENASE K230M MUTANT APO ENZYME 1HJ6 ; 2.00 ; ISOCITRATE DEHYDROGENASE S113E MUTANT COMPLEXED WITH ISOPROPYLMALATE, NADP+ AND MAGNESIUM (FLASH-COOLED) 1IDD ; 2.50 ; ISOCITRATE DEHYDROGENASE Y160F MUTANT APO ENZYME 1IDE ; 2.50 ; ISOCITRATE DEHYDROGENASE Y160F MUTANT STEADY-STATE INTERMEDIATE COMPLEX (LAUE DETERMINATION) 1ISO ; 1.90 ; ISOCITRATE DEHYDROGENASE: STRUCTURE OF AN ENGINEERED NADP+ --> NAD+ SPECIFICITY-REVERSAL MUTANT 263D ; 2.20 ; ISOHELICITY AND PHASING IN DRUG-DEOXYRIBONUCLEIC ACID SEQUENCE RECOGNITION: CRYSTAL STRUCTURE OF A TRIS(BENZIMIDAZOLE)-OLIGONUCLEOTIDE COMPLEX 1W9N ; -1.00 ; ISOLATION AND CHARACTERIZATION OF EPILANCIN 15X, A NOVEL ANTIBIOTIC FROM A CLINICAL STRAIN OF STAPHYLOCOCCUS EPIDERMIDIS 1N47 ; 2.70 ; ISOLECTIN B4 FROM VICIA VILLOSA IN COMPLEX WITH THE TN ANTIGEN 1UE0 ; 2.00 ; ISOLEUCYL-TRNA SUNTHETASE CP1 DOMAIN COMPLEXED WITH L-VALINE 1ILE ; 2.50 ; ISOLEUCYL-TRNA SYNTHETASE 1JZQ ; 3.00 ; ISOLEUCYL-TRNA SYNTHETASE COMPLEXED WITH ISOLEUCYL- ADENYLATE ANALOGUE 1JZS ; 2.50 ; ISOLEUCYL-TRNA SYNTHETASE COMPLEXED WITH MUPIROCIN 1UDZ ; 1.80 ; ISOLEUCYL-TRNA SYNTHETASE CP1 DOMAIN 1MOS ; 2.00 ; ISOMERASE DOMAIN OF GLUCOSAMINE 6-PHOSPHATE SYNTHASE COMPLEXED WITH 2-AMINO-2-DEOXYGLUCITOL 6-PHOSPHATE 1MOQ ; 1.57 ; ISOMERASE DOMAIN OF GLUCOSAMINE 6-PHOSPHATE SYNTHASE COMPLEXED WITH GLUCOSAMINE 6-PHOSPHATE 1MOR ; 1.90 ; ISOMERASE DOMAIN OF GLUCOSAMINE 6-PHOSPHATE SYNTHASE COMPLEXED WITH GLUCOSE 6-PHOSPHATE 1W05 ; 2.46 ; ISOPENICILLIN N SYNTHASE AMINOADIPOYL-CYSTEINYL-ALANINE-FE COMPLEX 1W06 ; 1.65 ; ISOPENICILLIN N SYNTHASE AMINOADIPOYL-CYSTEINYL-ALANINE-FE NO COMPLEX 1OC1 ; 2.20 ; ISOPENICILLIN N SYNTHASE AMINOADIPOYL-CYSTEINYL-AMINOBUTYRATE-FE COMPLEX 1OBN ; 1.30 ; ISOPENICILLIN N SYNTHASE AMINOADIPOYL-CYSTEINYL-AMINOBUTYRATE-FE-NO COMPLEX 1W03 ; 2.10 ; ISOPENICILLIN N SYNTHASE AMINOADIPOYL-CYSTEINYL-GLYCINE-FE COMPLEX 1W04 ; 1.28 ; ISOPENICILLIN N SYNTHASE AMINOADIPOYL-CYSTEINYL-GLYCINE-FE-NO COMPLEX 2BU9 ; 1.30 ; ISOPENICILLIN N SYNTHASE COMPLEXED WITH L-AMINOADIPOYL-L- CYSTEINYL-L-HEXAFLUOROVALINE 1W3V ; 1.40 ; ISOPENICILLIN N SYNTHASE D-(L-A-AMINOADIPOYL)-(3R)-METHYL-L- CYSTEINE D-A-HYDROXYISOVALERYL ESTER COMPLEX (ANAEROBIC) 1W3X ; 1.46 ; ISOPENICILLIN N SYNTHASE D-(L-A-AMINOADIPOYL)-(3R)-METHYL-L- CYSTEINE D-A-HYDROXYISOVALERYL ESTER COMPLEX (OXYGEN EXPOSED 5 MINUTES 20 BAR) 1QIQ ; 1.50 ; ISOPENICILLIN N SYNTHASE FROM ASPERGILLUS NIDULANS (ACMC FE COMPLEX) 1BK0 ; 1.30 ; ISOPENICILLIN N SYNTHASE FROM ASPERGILLUS NIDULANS (ACV-FE COMPLEX) 1BLZ ; 1.45 ; ISOPENICILLIN N SYNTHASE FROM ASPERGILLUS NIDULANS (ACV-FE-NO COMPLEX) 1ODM ; 1.15 ; ISOPENICILLIN N SYNTHASE FROM ASPERGILLUS NIDULANS (ANAEROBIC AC-VINYLGLYCINE FE COMPLEX) 1HB1 ; 1.55 ; ISOPENICILLIN N SYNTHASE FROM ASPERGILLUS NIDULANS (ANAEROBIC ACOV FE COMPLEX) 1QJE ; 1.35 ; ISOPENICILLIN N SYNTHASE FROM ASPERGILLUS NIDULANS (IP1 - FE COMPLEX) 1IPS ; 2.50 ; ISOPENICILLIN N SYNTHASE FROM ASPERGILLUS NIDULANS (MANGANESE COMPLEX) 1QJF ; 1.40 ; ISOPENICILLIN N SYNTHASE FROM ASPERGILLUS NIDULANS (MONOCYCLIC SULFOXIDE - FE COMPLEX) 1HB2 ; 1.30 ; ISOPENICILLIN N SYNTHASE FROM ASPERGILLUS NIDULANS (OXYGEN EXPOSED PRODUCT FROM ANAEROBIC ACOV FE COMPLEX) 1HB3 ; 1.40 ; ISOPENICILLIN N SYNTHASE FROM ASPERGILLUS NIDULANS (OXYGEN EXPOSED PRODUCT FROM ANAEROBIC ACOV FE COMPLEX) 1HB4 ; 1.50 ; ISOPENICILLIN N SYNTHASE FROM ASPERGILLUS NIDULANS (OXYGEN EXPOSED PRODUCT FROM ANAEROBIC ACOV FE COMPLEX) 1ODN ; 1.60 ; ISOPENICILLIN N SYNTHASE FROM ASPERGILLUS NIDULANS (OXYGEN-EXPOSED PRODUCT FROM ANAEROBIC AC-VINYLGLYCINE FE COMPLEX) 1UZW ; 1.30 ; ISOPENICILLIN N SYNTHASE WITH L-D-(A-AMINOADIPOYL)-L-CYSTEINYL-D-ISODEHYDROVALINE 1PPV ; 1.70 ; ISOPENTENYLPYROPHOSPHATE-DIMETHYLALLYLPYROPHOSPHATE ISOMERASE IN COMPLEX WITH THE BROMOHYDRINE OF IPP 1PPW ; 2.21 ; ISOPENTENYLPYROPHOSPHATE-DIMETHYLALLYLPYROPHOSPHATE ISOMERASE IN COMPLEX WITH THE BROMOHYDRINE OF IPP 1FCZ ; 1.38 ; ISOTYPE SELECTIVITY OF THE HUMAN RETINOIC ACID NUCLEAR RECEPTOR HRAR: THE COMPLEX WITH THE PANAGONIST RETINOID BMS181156 1FCY ; 1.30 ; ISOTYPE SELECTIVITY OF THE HUMAN RETINOIC ACID NUCLEAR RECEPTOR HRAR: THE COMPLEX WITH THE RARBETA/GAMMA-SELECTIVE RETINOID CD564 1FCX ; 1.47 ; ISOTYPE SELECTIVITY OF THE HUMAN RETINOIC ACID NUCLEAR RECEPTOR HRAR: THE COMPLEX WITH THE RARGAMMA-SELECTIVE RETINOID BMS184394 1FD0 ; 1.38 ; ISOTYPE SELECTIVITY OF THE HUMAN RETINOIC ACID NUCLEAR RECEPTOR HRAR: THE COMPLEX WITH THE RARGAMMA-SELECTIVE RETINOID SR11254 1ONN ; 2.60 ; ISPC APO STRUCTURE 1ONP ; 2.50 ; ISPC COMPLEX WITH MN2+ AND FOSMIDOMYCIN 1ONO ; 2.50 ; ISPC MN2+ COMPLEX 1U3P ; 2.85 ; ISPF NATIVE 1U40 ; 2.80 ; ISPF WITH 4-DIPHOSPHOCYTIDYL-2C-METHYL-D-ERYTHRITOL 1U43 ; 3.20 ; ISPF WITH 4-DIPHOSPHOCYTIDYL-2C-METHYL-D-ERYTHRITOL 2- PHOSPHATE 1U3L ; 2.50 ; ISPF WITH MG AND CDP 1YIU ; -1.00 ; ITCH E3 UBIQUITIN LIGASE WW3 DOMAIN 1UUZ ; 1.80 ; IVY:A NEW FAMILY OF PROTEIN 256B ; 1.40 ; Improvement of the 2.5 Angstroms Resolution Model of Cytochrome B562 by Redetermining the Primary Structure and Using Molecular Graphics 2IRT ; 3.20 ; Initial Crystallographic Analyses of a Recombinant Interleukin-1 Receptor Antagonist Protein 6EST ; 1.80 ; Interaction of the Peptide /Cf3-Leu-Ala-/Nh-C6H4-Cf3(/Tfla) with Porcine Pancreatic Elastase. X-Ray Studies at 1.8 Angstroms 7EST ; 1.80 ; Interaction of the Peptide /Cf3-Leu-Ala-/Nh-C6H4-Cf3(/Tfla) with Porcine Pancreatic Elastase. X-Ray Studies at 1.8 Angstroms 1BQ0 ; -1.00 ; J-DOMAIN (RESIDUES 1-77) OF THE ESCHERICHIA COLI N-TERMINAL FRAGMENT (RESIDUES 1-104) OF THE MOLECULAR CHAPERONE DNAJ, NMR, 20 STRUCTURES 1BQZ ; -1.00 ; J-DOMAIN (RESIDUES 1-77) OF THE ESCHERICHIA COLI N-TERMINAL FRAGMENT (RESIDUES 1-78) OF THE MOLECULAR CHAPERONE DNAJ, NMR, 20 STRUCTURES 1TUT ; -1.00 ; J4/5 LOOP FROM THE CANDIDA ALBICANS AND CANDIDA DUBLINIENSIS GROUP I INTRONS 1R5X ; 2.30 ; JAMM: A METALLOPROTEASE-LIKE ZINC SITE IN THE PROTEASOME AND SIGNALOSOME 1AOC ; 2.00 ; JAPANESE HORSESHOE CRAB COAGULOGEN 1KZK ; 1.09 ; JE-2147-HIV PROTEASE COMPLEX 2JEL ; 2.50 ; JEL42 FAB/HPR COMPLEX 1T0K ; 3.24 ; JOINT X-RAY AND NMR REFINEMENT OF YEAST L30E-MRNA COMPLEX 1IKV ; 3.00 ; K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH EFIVARENZ 1IKX ; 2.80 ; K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH THE INHIBITOR PNU142721 1E6C ; 1.80 ; K15M MUTANT OF SHIKIMATE KINASE FROM ERWINIA CHRYSANTHEMI 1XWF ; 2.80 ; K185N MUTATED S-ADENOSYLHOMOCYSTEINE HYDROLASE 1A5M ; 2.00 ; K217A VARIANT OF KLEBSIELLA AEROGENES UREASE 1A5N ; 2.40 ; K217A VARIANT OF KLEBSIELLA AEROGENES UREASE, CHEMICALLY RESCUED BY FORMATE AND NICKEL 1A5L ; 2.20 ; K217C VARIANT OF KLEBSIELLA AEROGENES UREASE 1A5O ; 2.50 ; K217C VARIANT OF KLEBSIELLA AEROGENES UREASE, CHEMICALLY RESCUED BY FORMATE AND NICKEL 1A5K ; 2.20 ; K217E VARIANT OF KLEBSIELLA AEROGENES UREASE 1YJZ ; 2.10 ; K226M MUTANT OF SERINE HYDROXYMETHYLTRANSFERASE FROM B. STEAROTHERMOPHILUS 1YJY ; 2.25 ; K226M MUTANT OF SERINE HYDROXYMETHYLTRANSFERASE FROM B. STEAROTHERMOPHILUS, COMPLEX WITH SERINE 1YJS ; 2.00 ; K226Q MUTANT OF SERINE HYDROXYMETHYLTRANSFERASE FROM B. STEAROTHERMOPHILUS, COMPLEX WITH GLYCINE 1JDE ; 2.80 ; K22A MUTANT OF PYRUVATE, PHOSPHATE DIKINASE 1SCI ; 2.18 ; K236L MUTANT OF HYDROXYNITRILE LYASE FROM HEVEA BRASILIENSIS 1SCK ; 1.70 ; K236L MUTANT OF HYDROXYNITRILE LYASE FROM HEVEA BRASILIENSIS IN COMPLEX WITH ACETONE 1SCQ ; 2.90 ; K236L MUTANT OF HYDROXYNITRILE LYASE FROM HEVEA BRASILIENSIS IN COMPLEX WITH ACETONECYANOHYDRIN 1SX5 ; 1.50 ; K38A ECORV BOUND TO CLEAVED DEOXYRIBONUCLEIC ACID AND MN2+: P1 CRYSTAL FORM 1J9M ; 1.65 ; K38H MUTANT OF STREPTOMYCES K15 DD-TRANSPEPTIDASE 1NZ2 ; 1.90 ; K45E VARIANT OF HORSE HEART MYOGLOBIN 1NZ3 ; 1.60 ; K45E-K63E VARIANT OF HORSE HEART MYOGLOBIN 1K89 ; 2.05 ; K89L MUTANT OF GLUTAMATE DEHYDROGENASE 1HIA ; 2.40 ; KALLIKREIN COMPLEXED WITH HIRUSTASIN 1KNY ; 2.50 ; KANAMYCIN NUCLEOTIDYLTRANSFERASE 2BKU ; 2.70 ; KAP95P:RANGTP COMPLEX 1QP1 ; 2.06 ; KAPPA VARIABLE LIGHT CHAIN 1EK3 ; 1.90 ; KAPPA-4 IMMUNOGLOBULIN VL, REC 1HP9 ; -1.00 ; KAPPA-HEFUTOXINS: A NOVEL CLASS OF POTASSIUM CHANNEL TOXINS FROM SCORPION VENOM 1BK6 ; 2.80 ; KARYOPHERIN ALPHA (YEAST) + SV40 T ANTIGEN NLS 1BK5 ; 2.20 ; KARYOPHERIN ALPHA FROM SACCHAROMYCES CEREVISIAE 1OER ; 2.00 ; KAS I LYS328ALA MUTANT IN COMPLEX WITH FATTY ACID 1J95 ; 2.80 ; KCSA POTASSIUM CHANNEL WITH TBA (TETRABUTYLAMMONIUM) AND POTASSIUM 1JVM ; 2.80 ; KCSA POTASSIUM CHANNEL WITH TBA (TETRABUTYLAMMONIUM) AND RUBIDIUM 1X6U ; 2.70 ; KDO8P SYNTHASE IN IT'S BINARY COMPLEX WITH THE PRODUCT KDO8P 1FQ0 ; 2.10 ; KDPG ALDOLASE FROM ESCHERICHIA COLI 1KS9 ; 1.70 ; KETOPANTOATE REDUCTASE FROM ESCHERICHIA COLI 1E3J ; 2.30 ; KETOSE REDUCTASE (SORBITOL DEHYDROGENASE) FROM SILVERLEAF WHITEFLY 1MDV ; 2.30 ; KEY ROLE OF PHENYLALANINE 20 IN CYTOCHROME C3: STRUCTURE, STABILITY AND FUNCTION STUDIES 2FMR ; -1.00 ; KH1 FROM THE FRAGILE X PROTEIN FMR1, NMR, 18 STRUCTURES 1M1F ; 1.40 ; KID TOXIN PROTEIN FROM E.COLI PLASMID R1 1KBP ; 2.90 ; KIDNEY BEAN PURPLE ACID PHOSPHATASE 3KBP ; 3.00 ; KIDNEY BEAN PURPLE ACID PHOSPHATASE 4KBP ; 2.70 ; KIDNEY BEAN PURPLE ACID PHOSPHATASE 1IA0 ; 15.00 ; KIF1A HEAD-MICROTUBULE COMPLEX STRUCTURE IN ATP-FORM 2DL2 ; 3.00 ; KILLER IMMUNOGLOBULIN RECEPTOR 2DL2 2DLI ; 2.90 ; KILLER IMMUNOGLOBULIN RECEPTOR 2DL2,TRIGONAL FORM 1KVD ; 1.80 ; KILLER TOXIN FROM HALOTOLERANT YEAST 1KVE ; 1.80 ; KILLER TOXIN FROM HALOTOLERANT YEAST 1BYG ; 2.40 ; KINASE DOMAIN OF HUMAN C-TERMINAL SRC KINASE (CSK) IN COMPLEX WITH INHIBITOR STAUROSPORINE 1W53 ; 1.60 ; KINASE RECRUITMENT DOMAIN OF THE STRESS PHOSPHATASE RSBU 3KIN ; 3.10 ; KINESIN (DIMERIC) FROM RATTUS NORVEGICUS 2KIN ; 1.90 ; KINESIN (MONOMERIC) FROM RATTUS NORVEGICUS 1JA8 ; 2.12 ; KINETIC ANALYSIS OF PRODUCT INHIBITION IN HUMAN MANGANESE SUPEROXIDE DISMUTASE 1XKX ; 1.93 ; KINETIC AND CRYSTALLOGRAPHIC STUDIES ON 2-(BETA-D- GLUCOPYRANOSYL)-5-METHYL-1,3,4-OXADIAZOLE,-BENZOTHIAZOLE, AND-BENZIMIDAZOLE, INHIBITORS OF MUSCLE GLYCOGEN PHOSPHORYLASE B. EVIDENCE FOR A NEW BINDING SITE. 1XL0 ; 1.92 ; KINETIC AND CRYSTALLOGRAPHIC STUDIES ON 2-(BETA-D- GLUCOPYRANOSYL)-5-METHYL-1,3,4-OXADIAZOLE,-BENZOTHIAZOLE, AND-BENZIMIDAZOLE, INHIBITORS OF MUSCLE GLYCOGEN PHOSPHORYLASE B. EVIDENCE FOR A NEW BINDING SITE. 1XL1 ; 2.10 ; KINETIC AND CRYSTALLOGRAPHIC STUDIES ON 2-(BETA-D- GLUCOPYRANOSYL)-5-METHYL-1,3,4-OXADIAZOLE,-BENZOTHIAZOLE, AND-BENZIMIDAZOLE, INHIBITORS OF MUSCLE GLYCOGEN PHOSPHORYLASE B. EVIDENCE FOR A NEW BINDING SITE. 1OB0 ; 1.83 ; KINETIC STABILIZATION OF BACILLUS LICHENIFORMIS-AMYLASE THROUGH INTRODUCTION OF HYDROPHOBIC RESIDUES AT THE SURFACE 1OF1 ; 1.95 ; KINETICS AND CRYSTAL STRUCTURE OF THE HERPES SIMPLEX VIRUS TYPE 1 THYMIDINE KINASE INTERACTING WITH (SOUTH)-METHANOCARBA-THYMIDINE 1E2K ; 1.70 ; KINETICS AND CRYSTAL STRUCTURE OF THE WILD-TYPE AND THE ENGINEERED Y101F MUTANT OF HERPES SIMPLEX VIRUS TYPE 1 THYMIDINE KINASE INTERACTING WITH (NORTH)-METHANOCARBA-THYMIDINE 1E2L ; 2.40 ; KINETICS AND CRYSTAL STRUCTURE OF THE WILD-TYPE AND THE ENGINEERED Y101F MUTANT OF HERPES SIMPLEX VIRUS TYPE 1 THYMIDINE KINASE INTERACTING WITH (NORTH)-METHANOCARBA-THYMIDINE 1KDX ; -1.00 ; KIX DOMAIN OF MOUSE CBP (CREB BINDING PROTEIN) IN COMPLEX WITH PHOSPHORYLATED KINASE INDUCIBLE DOMAIN (PKID) OF RAT CREB (CYCLIC AMP RESPONSE ELEMENT BINDING PROTEIN), NMR 17 STRUCTURES 1DHY ; 2.30 ; KKS102 BPHC ENZYME 1FWB ; 2.00 ; KLEBSIELLA AEROGENES UREASE, C319A VARIANT AT PH 6.5 1FWA ; 2.00 ; KLEBSIELLA AEROGENES UREASE, C319A VARIANT AT PH 7.5 1FWC ; 2.00 ; KLEBSIELLA AEROGENES UREASE, C319A VARIANT AT PH 8.5 1FWD ; 2.00 ; KLEBSIELLA AEROGENES UREASE, C319A VARIANT AT PH 9.4 1FWE ; 2.00 ; KLEBSIELLA AEROGENES UREASE, C319A VARIANT WITH ACETOHYDROXAMIC ACID (AHA) BOUND 1FWF ; 2.00 ; KLEBSIELLA AEROGENES UREASE, C319D VARIANT 1FWG ; 2.00 ; KLEBSIELLA AEROGENES UREASE, C319S VARIANT 1FWH ; 2.00 ; KLEBSIELLA AEROGENES UREASE, C319Y VARIANT 1FWI ; 2.00 ; KLEBSIELLA AEROGENES UREASE, H134A VARIANT 1FWJ ; 2.20 ; KLEBSIELLA AEROGENES UREASE, NATIVE 1QSL ; 2.20 ; KLENOW FRAGMENT COMPLEXED WITH SINGLE-STRANDED SUBSTRATE AND EUROPIUM (III) ION 2KFN ; 2.03 ; KLENOW FRAGMENT WITH BRIDGING-SULFUR SUBSTRATE AND MANGANESE 2KFZ ; 2.03 ; KLENOW FRAGMENT WITH BRIDGING-SULFUR SUBSTRATE AND ZINC ONLY 2KZM ; 2.60 ; KLENOW FRAGMENT WITH NORMAL SUBSTRATE AND ZINC AND MANGANESE 2KZZ ; 2.25 ; KLENOW FRAGMENT WITH NORMAL SUBSTRATE AND ZINC ONLY 1NOB ; 2.60 ; KNOB DOMAIN FROM ADENOVIRUS SEROTYPE 12 1KAC ; 2.60 ; KNOB DOMAIN FROM ADENOVIRUS SEROTYPE 12 IN COMPLEX WITH DOMAIN 1 OF ITS CELLULAR RECEPTOR CAR 1B2I ; -1.00 ; KRINGLE 2 DOMAIN OF HUMAN PLASMINOGEN: NMR SOLUTION STRUCTURE OF TRANS-4-AMINOMETHYLCYCLOHEXANE-1-CARBOXYLIC ACID (AMCHA) COMPLEX 1FL1 ; 2.20 ; KSHV PROTEASE 1OPY ; 1.90 ; KSI 1LSU ; 2.85 ; KTN BSU222 CRYSTAL STRUCTURE IN COMPLEX WITH NADH 1LSS ; 2.30 ; KTN MJA218 CRYSTAL STRUCTURE IN COMPLEX WITH NAD+ 1SIU ; 2.31 ; KUMAMOLISIN-AS E78H MUTANT 1SN7 ; 2.00 ; KUMAMOLISIN-AS, APOENZYME 1DSX ; 1.60 ; KV1.2 T1 DOMAIN, RESIDUES 33-119, T46V MUTANT 1E0P ; 2.10 ; L INTERMEDIATE OF BACTERIORHODOPSIN 1JUD ; 2.50 ; L-2-HALOACID DEHALOGENASE 1F14 ; 2.30 ; L-3-HYDROXYACYL-COA DEHYDROGENASE (APO) 1F12 ; 2.40 ; L-3-HYDROXYACYL-COA DEHYDROGENASE COMPLEXED WITH 3- HYDROXYBUTYRYL-COA 1F0Y ; 1.80 ; L-3-HYDROXYACYL-COA DEHYDROGENASE COMPLEXED WITH ACETOACETYL-COA AND NAD+ 1F17 ; 2.30 ; L-3-HYDROXYACYL-COA DEHYDROGENASE COMPLEXED WITH NADH 1JPD ; 2.60 ; L-ALA-D/L-GLU EPIMERASE 1JPM ; 2.25 ; L-ALA-D/L-GLU EPIMERASE 1PJB ; 2.10 ; L-ALANINE DEHYDROGENASE 1PJC ; 2.00 ; L-ALANINE DEHYDROGENASE COMPLEXED WITH NAD 1SAY ; 2.10 ; L-ALANINE DEHYDROGENASE COMPLEXED WITH PYRUVATE 1TDO ; 3.00 ; L-AMINO ACID OXIDAE FROM AGKISTRODON HALYS IN COMPLEX WITH L-PHENYLALANINE 1TDN ; 2.70 ; L-AMINO ACID OXIDASE FROM AGKISTRODON HALYS IN COMPLEX WITH L-LEUCINE 1TDK ; 2.70 ; L-AMINO ACID OXIDASE FROM AGKISTRODON HALYS IN COMPLEX WITH SUICIDE SUBSTRATE L-VINYLGLYCINE 1REO ; 2.31 ; L-AMINO ACID OXIDASE FROM AGKISTRODON HALYS PALLAS 1NNS ; 1.95 ; L-ASPARAGINASE OF E. COLI IN C2 SPACE GROUP AND 1.95 A RESOLUTION 1KNR ; 2.50 ; L-ASPARTATE OXIDASE: R386L MUTANT 1AEW ; 1.95 ; L-CHAIN HORSE APOFERRITIN 1FUI ; 2.50 ; L-FUCOSE ISOMERASE FROM ESCHERICHIA COLI 1FUA ; 1.92 ; L-FUCULOSE 1-PHOSPHATE ALDOLASE CRYSTAL FORM T 2FUA ; 2.00 ; L-FUCULOSE 1-PHOSPHATE ALDOLASE CRYSTAL FORM T WITH COBALT 1E4A ; 2.15 ; L-FUCULOSE 1-PHOSPHATE ALDOLASE FROM ESCHERICHIA COLI MUTANT DEL(27) 1E47 ; 2.15 ; L-FUCULOSE 1-PHOSPHATE ALDOLASE FROM ESCHERICHIA COLI MUTANT E73Q 1E48 ; 1.97 ; L-FUCULOSE 1-PHOSPHATE ALDOLASE FROM ESCHERICHIA COLI MUTANT E73Q/Y113F/Y209F 1E46 ; 2.55 ; L-FUCULOSE 1-PHOSPHATE ALDOLASE FROM ESCHERICHIA COLI MUTANT E73S 1E49 ; 2.53 ; L-FUCULOSE 1-PHOSPHATE ALDOLASE FROM ESCHERICHIA COLI MUTANT N29L/S71A 1E4B ; 1.84 ; L-FUCULOSE 1-PHOSPHATE ALDOLASE FROM ESCHERICHIA COLI MUTANT N29Q 1E4C ; 1.66 ; L-FUCULOSE 1-PHOSPHATE ALDOLASE FROM ESCHERICHIA COLI MUTANT S71Q 4FUA ; 2.43 ; L-FUCULOSE-1-PHOSPHATE ALDOLASE COMPLEX WITH PGH 3FUA ; 2.67 ; L-FUCULOSE-1-PHOSPHATE ALDOLASE CRYSTAL FORM K 1DZY ; 2.44 ; L-FUCULOSE-1-PHOSPHATE ALDOLASE FROM ESCHERICHIA COLI MUTANT E214A 1DZW ; 2.17 ; L-FUCULOSE-1-PHOSPHATE ALDOLASE FROM ESCHERICHIA COLI MUTANT F131A 1DZX ; 2.18 ; L-FUCULOSE-1-PHOSPHATE ALDOLASE FROM ESCHERICHIA COLI MUTANT R212A 1DZU ; 2.09 ; L-FUCULOSE-1-PHOSPHATE ALDOLASE FROM ESCHERICHIA COLI MUTANT T26A 1DZZ ; 1.92 ; L-FUCULOSE-1-PHOSPHATE ALDOLASE FROM ESCHERICHIA COLI MUTANT Y113F 1DZV ; 1.86 ; L-FUCULOSE-1-PHOSPHATE ALDOLASE FROM ESCHERICHIA COLI MUTANT Y113F/Y209F 1V9L ; 2.80 ; L-GLUTAMATE DEHYDROGENASE FROM PYROBACULUM ISLANDICUM COMPLEXED WITH NAD 1KAR ; 2.10 ; L-HISTIDINOL DEHYDROGENASE (HISD) STRUCTURE COMPLEXED WITH HISTAMINE (INHIBITOR), ZINC AND NAD (COFACTOR) 1KAH ; 2.10 ; L-HISTIDINOL DEHYDROGENASE (HISD) STRUCTURE COMPLEXED WITH L-HISTIDINE (PRODUCT), ZN AND NAD (COFACTOR) 1KAE ; 1.70 ; L-HISTIDINOL DEHYDROGENASE (HISD) STRUCTURE COMPLEXED WITH L-HISTIDINOL (SUBSTRATE), ZINC AND NAD (COFACTOR) 1GKR ; 2.60 ; L-HYDANTOINASE (DIHYDROPYRIMIDINASE) FROM ARTHROBACTER AURESCENS 1Y6J ; 3.01 ; L-LACTATE DEHYDROGENASE FROM CLOSTRIDIUM THERMOCELLUM CTH- 1135 1USK ; 2.00 ; L-LEUCINE-BINDING PROTEIN WITH LEUCINE BOUND 1USI ; 1.80 ; L-LEUCINE-BINDING PROTEIN WITH PHENYLALANINE BOUND 1USG ; 1.53 ; L-LEUCINE-BINDING PROTEIN, APO FORM 1C1X ; 1.40 ; L-PHENYLALANINE DEHYDROGENASE STRUCTURE IN TERNARY COMPLEX WITH NAD+ AND L-3-PHENYLLACTATE 1C1D ; 1.25 ; L-PHENYLALANINE DEHYDROGENASE STRUCTURE IN TERNARY COMPLEX WITH NADH AND L-PHENYLALANINE 1D8W ; 1.60 ; L-RHAMNOSE ISOMERASE 1DE5 ; 2.20 ; L-RHAMNOSE ISOMERASE 1DE6 ; 2.10 ; L-RHAMNOSE ISOMERASE 1GT7 ; 2.70 ; L-RHAMNULOSE-1-PHOSPHATE ALDOLASE FROM ESCHERICHIA COLI 1OJR ; 1.35 ; L-RHAMNULOSE-1-PHOSPHATE ALDOLASE FROM ESCHERICHIA COLI (MUTANT E192A) 1VZB ; 2.50 ; L. CASEI THYMIDYLATE SYNTHASE MUTANT E60Q BINARY COMPLEX WITH DUMP 1VZC ; 2.50 ; L. CASEI THYMIDYLATE SYNTHASE MUTANT E60Q BINARY COMPLEX WITH FDUMP 1VZE ; 2.30 ; L. CASEI THYMIDYLATE SYNTHASE MUTANT E60Q TERNARY COMPLEX WITH DUMP AND CB3717 1VZD ; 2.50 ; L. CASEI THYMIDYLATE SYNTHASE MUTANT E60Q TERNARY COMPLEX WITH FDUMP AND CB3717 1TSL ; 2.50 ; L. CASEI THYMIDYLATE SYNTHASE WITH SPECIES SPECIFIC INHIBITOR 1TSM ; 3.00 ; L. CASEI THYMIDYLATE SYNTHASE WITH SPECIES SPECIFIC INHIBITOR 1KKL ; 2.80 ; L.CASEI HPRK/P IN COMPLEX WITH B.SUBTILIS HPR 1KKM ; 2.80 ; L.CASEI HPRK/P IN COMPLEX WITH B.SUBTILIS P-SER-HPR 1DZL ; 3.50 ; L1 PROTEIN OF HUMAN PAPILLOMAVIRUS 16 1ACI ; -1.00 ; L11 RIBOSOMAL PROTEIN RIBONUCLEIC ACID BINDING DOMAIN, NMR, 20 STRUCTURES 1EVW ; 3.10 ; L116A MUTANT OF THE HOMING ENDONUCLEASE I-PPOI COMPLEXED TO HOMING SITE DEOXYRIBONUCLEIC ACID. 1WLL ; 1.60 ; L122K MUTANT OF FMN-BINDING PROTEIN FROM DESULFOVIBRIO VULGARIS (MIYAZAKI F) 1WLI ; 1.60 ; L122Y MUTANT OF FMN-BINDING PROTEIN FROM DESULFOVIBRIO VULGARIS (MIYAZAKI F) 1WLK ; 1.90 ; L122Y MUTANT OF FMN-BINDING PROTEIN FROM DESULFOVIBRIO VULGARIS (MIYAZAKI F) 2DAB ; 2.00 ; L201A MUTANT OF D-AMINO ACID AMINOTRANSFERASE COMPLEXED WITH PYRIDOXAL-5'-PHOSPHATE 1A0G ; 2.00 ; L201A MUTANT OF D-AMINO ACID AMINOTRANSFERASE COMPLEXED WITH PYRIDOXAMINE-5'-PHOSPHATE 1SZE ; 3.00 ; L230A MUTANT FLAVOCYTOCHROME B2 WITH BENZOYLFORMATE 1UWA ; 2.30 ; L290F MUTANT RUBISCO FROM CHLAMYDOMONAS 1UW9 ; 2.05 ; L290F-A222T CHLAMYDOMONAS RUBISCO MUTANT 2BLI ; 1.70 ; L29W MB DEOXY 1MP3 ; 2.20 ; L89T VARIANT OF S. ENTERICA RMLA 1QUO ; 1.90 ; L99A/E108V MUTANT OF T4 LYSOZYME 1QUD ; 1.75 ; L99G MUTANT OF T4 LYSOZYME 1QUH ; 1.85 ; L99G/E108V MUTANT OF T4 LYSOZYME 1S29 ; 1.60 ; LA AUTOANTIGEN N-TERMINAL DOMAIN 1LBI ; 2.70 ; LAC REPRESSOR 1LQC ; -1.00 ; LAC REPRESSOR HEADPIECE (RESIDUES 1-56), NMR, 32 STRUCTURES 1K6C ; 2.20 ; LACK OF SYNERGY FOR INHIBITORS TARGETING A MULTI-DRUG RESISTANT HIV-1 PROTEASE 1K6P ; 2.20 ; LACK OF SYNERGY FOR INHIBITORS TARGETING A MULTI-DRUG RESISTANT HIV-1 PROTEASE 1K6T ; 2.25 ; LACK OF SYNERGY FOR INHIBITORS TARGETING A MULTI-DRUG RESISTANT HIV-1 PROTEASE 1K6V ; 2.00 ; LACK OF SYNERGY FOR INHIBITORS TARGETING A MULTI-DRUG RESISTANT HIV-1 PROTEASE 2BI4 ; 2.85 ; LACTALDEHYDE:1,2-PROPANEDIOL OXIDOREDUCTASE OF ESCHERICHIA COLI 2BL4 ; 2.85 ; LACTALDEHYDE:1,2-PROPANEDIOL OXIDOREDUCTASE OF ESCHERICHIA COLI 1OC4 ; 2.30 ; LACTATE DEHYDROGENASE FROM PLASMODIUM BERGHEI 1A5Z ; 2.10 ; LACTATE DEHYDROGENASE FROM THERMOTOGA MARITIMA (TMLDH) 1JB1 ; 2.80 ; LACTOBACILLUS CASEI HPRK/P BOUND TO PHOSPHATE 1LCB ; 2.50 ; LACTOBACILLUS CASEI THYMIDYLATE SYNTHASE TERNARY COMPLEX WITH DTMP AND H2FOLATE 1LCA ; 2.50 ; LACTOBACILLUS CASEI THYMIDYLATE SYNTHASE TERNARY COMPLEX WITH DUMP AND CB3717 1LCE ; 2.50 ; LACTOBACILLUS CASEI THYMIDYLATE SYNTHASE TERNARY COMPLEX WITH DUMP AND CH2THF 1IS3 ; 1.45 ; LACTOSE AND MES-LIGANDED CONGERIN II 1LBG ; 4.80 ; LACTOSE OPERON REPRESSOR BOUND TO 21-BASE PAIR SYMMETRIC OPERATOR DEOXYRIBONUCLEIC ACID, ALPHA CARBONS ONLY 1C1L ; 1.50 ; LACTOSE-LIGANDED CONGERIN I 1IS4 ; 1.90 ; LACTOSE-LIGANDED CONGERIN II 1G9Z ; 1.80 ; LAGLIDADG HOMING ENDONUCLEASE I-CREI / DEOXYRIBONUCLEIC ACID PRODUCT COMPLEX WITH MAGNESIUM 1Q5B ; 30.00 ; LAMBDA-SHAPED TRANS AND CIS INTERACTIONS OF CADHERINS MODEL BASED ON FITTING C-CADHERIN (1L3W) TO 3D MAP OF DESMOSOMES OBTAINED BY ELECTRON TOMOGRAPHY 1N35 ; 2.50 ; LAMBDA3 ELONGATION COMPLEX WITH FOUR PHOSPHODIESTER BOND FORMED 1DYK ; 2.00 ; LAMININ ALPHA 2 CHAIN LG4-5 DOMAIN PAIR 1OKQ ; 2.00 ; LAMININ ALPHA 2 CHAIN LG4-5 DOMAIN PAIR, CA1 SITE MUTANT 5KTQ ; 2.50 ; LARGE FRAGMENT OF TAQ DEOXYRIBONUCLEIC ACID POLYMERASE BOUND TO DCTP 1UXH ; 2.10 ; LARGE IMPROVEMENT IN THE THERMAL STABILITY OF A TETRAMERIC MALATE DEHYDROGENASE BY SINGLE POINT MUTATIONS AT THE DIMER-DIMER INTERFACE 1UXI ; 2.10 ; LARGE IMPROVEMENT IN THE THERMAL STABILITY OF A TETRAMERIC MALATE DEHYDROGENASE BY SINGLE POINT MUTATIONS AT THE DIMER-DIMER INTERFACE 1UXJ ; 1.75 ; LARGE IMPROVEMENT IN THE THERMAL STABILITY OF A TETRAMERIC MALATE DEHYDROGENASE BY SINGLE POINT MUTATIONS AT THE DIMER-DIMER INTERFACE 1UXK ; 1.80 ; LARGE IMPROVEMENT IN THE THERMAL STABILITY OF A TETRAMERIC MALATE DEHYDROGENASE BY SINGLE POINT MUTATIONS AT THE DIMER-DIMER INTERFACE 1UXG ; 1.90 ; LARGE IMPROVEMENT IN THE THERMAL STABILITY OF A TETRAMERIC MALATE DEHYDROGENASE BY SINGLE POINT MUTATIONS AT THE DIMER-DIMER INTERFACE. 1FG0 ; 3.00 ; LARGE RIBOSOMAL SUBUNIT COMPLEXED WITH A 13 BP MINIHELIX- PUROMYCIN COMPOUND 1FFZ ; 3.20 ; LARGE RIBOSOMAL SUBUNIT COMPLEXED WITH R(CC)-DA-PUROMYCIN 1MSS ; 2.40 ; LARGE SCALE STRUCTURAL REARRANGEMENTS OF THE FRONT LOOPS IN MONOMERISED TRIOSEPHOSPHATE ISOMERASE, AS DEDUCED FROM THE COMPARISON OF THE STRUCTURAL PROPERTIES OF MONOTIM AND ITS POINT MUTATION VARIANT MONOSS 1T1A ; 1.60 ; LATE INTERMEDIATE IL1 FROM TIME-RESOLVED CRYSTALLOGRAPHY OF THE E46Q MUTANT OF PYP 1T1B ; 1.60 ; LATE INTERMEDIATE IL2 FROM TIME-RESOLVED CRYSTALLOGRAPHY OF THE E46Q MUTANT OF PYP 1T1C ; 1.60 ; LATE INTERMEDIATE IL3 FROM TIME-RESOLVED CRYSTALLOGRAPHY OF THE E46Q MUTANT OF PYP 1DVN ; 2.10 ; LATENT FORM OF PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) 1QWY ; 1.30 ; LATENT LYTM AT 1.3 A RESOLUTION 1G5U ; 3.10 ; LATEX PROFILIN HEVB8 1EBE ; 2.20 ; LAUE DIFFRACTION STUDY ON THE STRUCTURE OF CYTOCHROME C PEROXIDASE COMPOUND I 2BWH ; 1.90 ; LAUE STRUCTURE OF A SHORT LIVED STATE OF L29W MYOGLOBIN 2BW9 ; 1.68 ; LAUE STRUCTURE OF L29W MBCO 1AJJ ; 1.70 ; LDL RECEPTOR LIGAND-BINDING MODULE 5, CALCIUM-COORDINATING 1D2J ; -1.00 ; LDL RECEPTOR LIGAND-BINDING MODULE 6 1TLE ; -1.00 ; LE (LAMININ-TYPE EGF-LIKE) MODULE GIII4 IN SOLUTION AT PH 3.5 AND 290 K, NMR, 14 STRUCTURES 1Q01 ; -1.00 ; LEBETIN PEPTIDES, A NEW CLASS OF POTENT AGGREGATION INHIBITORS 1OUS ; 1.20 ; LECB (PA-LII) CALCIUM-FREE 1OVS ; 1.75 ; LECB (PA-LII) IN COMPLEX WITH CORE TRIMANNOSIDE 1OVP ; 1.40 ; LECB (PA-LII) IN COMPLEX WITH FRUCTOSE 1OXC ; 1.20 ; LECB (PA-LII) IN COMPLEX WITH FUCOSE 1OUR ; 1.42 ; LECB (PA-LII) IN COMPLEX WITH MANNOSE 1OUX ; 2.00 ; LECB (PA-LII) SUGAR-FREE 1GSL ; 2.00 ; LECTIN (FOURTH ISOLATED FROM (GRIFFONIA SIMPLICIFOLIA)) COMPLEX WITH Y HUMAN BLOOD GROUP DETERMINANT 1DGL ; 2.40 ; LECTIN FROM DIOCLEA GRANDIFLORA COMPLEXED TO TRIMANNOSIDE 2BS5 ; 2.10 ; LECTIN FROM RALSTONIA SOLANACEARUM COMPLEXED WITH 2- FUCOSYLLACTOSE 2BT9 ; 0.94 ; LECTIN FROM RALSTONIA SOLANACEARUM COMPLEXED WITH ME-FUCOSIDE 2BS6 ; 1.80 ; LECTIN FROM RALSTONIA SOLANACEARUM COMPLEXED WITH XYLOGLUCAN FRAGMENT 1GNZ ; 2.50 ; LECTIN I-B4 FROM GRIFFONIA SIMPLICIFOLIA (GS I-B4)METAL FREE FORM 1QNW ; 2.35 ; LECTIN II FROM ULEX EUROPAEUS 1QOS ; 2.95 ; LECTIN UEA-II COMPLEXED WITH CHITOBIOSE 1QOT ; 3.00 ; LECTIN UEA-II COMPLEXED WITH FUCOSYLLACTOSE AND FUCOSYLGALACTOSE 1DZQ ; 2.85 ; LECTIN UEA-II COMPLEXED WITH GALACTOSE 1QOO ; 2.75 ; LECTIN UEA-II COMPLEXED WITH NAG 3SLI ; 1.80 ; LEECH INTRAMOLECULAR TRANS-SIALIDASE COMPLEXED WITH 2,7-ANHYDRO-NEU5AC PREPARED BY SOAKING WITH 3'-SIALYLLACTOSE 2SLI ; 1.80 ; LEECH INTRAMOLECULAR TRANS-SIALIDASE COMPLEXED WITH 2,7-ANHYDRO-NEU5AC, THE REACTION PRODUCT 4SLI ; 1.80 ; LEECH INTRAMOLECULAR TRANS-SIALIDASE COMPLEXED WITH 2-PROPENYL-NEU5AC, AN INACTIVE SUBSTRATE ANALOGUE 1SLI ; 2.00 ; LEECH INTRAMOLECULAR TRANS-SIALIDASE COMPLEXED WITH DANA 1AN1 ; 2.03 ; LEECH-DERIVED TRYPTASE INHIBITOR/TRYPSIN COMPLEX 2LEF ; -1.00 ; LEF1 HMG DOMAIN (FROM MOUSE), COMPLEXED WITH DEOXYRIBONUCLEIC ACID (15BP), NMR, 12 STRUCTURES 1ICK ; 0.95 ; LEFT-HANDED Z-DEOXYRIBONUCLEIC ACID HEXAMER DUPLEX D(CGCGCG)2 2GDM ; 1.70 ; LEGHEMOGLOBIN (OXY) 1BIN ; 2.20 ; LEGHEMOGLOBIN A (ACETOMET) 1FNY ; 1.81 ; LEGUME LECTIN OF THE BARK OF ROBINIA PSEUDOACACIA. 1R75 ; 1.86 ; LEISHMANIA MAJOR HYPOTHETICAL PROTEIN 2BF7 ; 2.40 ; LEISHMANIA MAJOR PTERIDINE REDUCTASE 1 IN COMPLEX WITH NADP AND BIOPTERIN 2BFA ; 2.70 ; LEISHMANIA MAJOR PTERIDINE REDUCTASE 1 IN COMPLEX WITH NADP AND CB3717 2BFP ; 2.55 ; LEISHMANIA MAJOR PTERIDINE REDUCTASE 1 IN COMPLEX WITH NADP AND TETRAHYDROBIOPTERIN 2BFM ; 2.60 ; LEISHMANIA MAJOR PTERIDINE REDUCTASE 1 IN COMPLEX WITH NADP AND TRIMETHOPRIM 2BFO ; 2.60 ; LEISHMANIA MAJOR PTERIDINE REDUCTASE 1 IN COMPLEX WITH NADPH 1I32 ; 2.60 ; LEISHMANIA MEXICANA GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE IN COMPLEX WITH INHIBITORS 1I33 ; 3.00 ; LEISHMANIA MEXICANA GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE IN COMPLEX WITH INHIBITORS 2C34 ; -1.00 ; LEISHMANIA MEXICANA ICP 1AMK ; 1.83 ; LEISHMANIA MEXICANA TRIOSE PHOSPHATE ISOMERASE 1LML ; 1.86 ; LEISHMANOLYSIN 1HDL ; -1.00 ; LEKTI DOMAIN ONE 1H0Z ; -1.00 ; LEKTI DOMAIN SIX 1JEI ; -1.00 ; LEM DOMAIN OF HUMAN INNER NUCLEAR MEMBRANE PROTEIN EMERIN 1H9F ; -1.00 ; LEM DOMAIN OF HUMAN INNER NUCLEAR MEMBRANE PROTEIN LAP2 1H9E ; -1.00 ; LEM-LIKE DOMAIN OF HUMAN INNER NUCLEAR MEMBRANE PROTEIN LAP2 4LVE ; 2.30 ; LEN K30T MUTANT: A DOMAIN FLIP AS A RESULT OF A SINGLE AMINO ACID SUBSTITUTION 3LVE ; 2.00 ; LEN Q38E MUTANT: A DOMAIN FLIP FROM A SINGLE AMINO ACID SUBSTITUTION 1LES ; 1.90 ; LENTIL LECTIN COMPLEXED WITH SUCROSE 1SGR ; 1.80 ; LEU 18 VARIANT OF TURKEY OVOMUCOID INHIBITOR THIRD DOMAIN COMPLEXED WITH STREPTOMYCES GRISEUS PROTEINASE B 5TTR ; 2.70 ; LEU 55 PRO TRANSTHYRETIN CRYSTAL STRUCTURE 1LAM ; 1.60 ; LEUCINE AMINOPEPTIDASE (UNLIGATED) 1LAN ; 1.90 ; LEUCINE AMINOPEPTIDASE COMPLEX WITH L-LEUCINAL 1LEH ; 2.20 ; LEUCINE DEHYDROGENASE FROM BACILLUS SPHAERICUS 2SSP ; 2.25 ; LEUCINE-272-ALANINE URACIL-DEOXYRIBONUCLEIC ACID GLYCOSYLASE BOUND TO ABASIC SITE-CONTAINING DEOXYRIBONUCLEIC ACID 1OBC ; 2.10 ; LEUCYL-TRNA SYNTHETASE FROM THERMUS THERMOPHILUS COMPLEXED WITH A POST-TRANSFER EDITING SUBSTRATE ANALOGUE 1OBH ; 2.20 ; LEUCYL-TRNA SYNTHETASE FROM THERMUS THERMOPHILUS COMPLEXED WITH A PRE-TRANSFER EDITING SUBSTRATE ANALOGUE IN BOTH SYNTHETIC ACTIVE SITE AND EDITING SITE 1H3N ; 2.00 ; LEUCYL-TRNA SYNTHETASE FROM THERMUS THERMOPHILUS COMPLEXED WITH A SULPHAMOYL ANALOGUE OF LEUCYL-ADENYLATE 1A7M ; -1.00 ; LEUKAEMIA INHIBITORY FACTOR CHIMERA (MH35-LIF), NMR, 20 STRUCTURES 1LKF ; 1.90 ; LEUKOCIDIN F (HLGB) FROM STAPHYLOCOCCUS AUREUS 2LKF ; 2.50 ; LEUKOCIDIN F (HLGB) FROM STAPHYLOCOCCUS AUREUS 3LKF ; 1.90 ; LEUKOCIDIN F (HLGB) FROM STAPHYLOCOCCUS AUREUS WITH PHOSPHOCHOLINE BOUND 1JHF ; 1.80 ; LEXA G85D MUTANT 1JHE ; 2.50 ; LEXA L89P Q92W E152A K156A MUTANT 1JHC ; 2.00 ; LEXA S119A C-TERMINAL TRYPTIC FRAGMENT 1JHH ; 2.10 ; LEXA S119A MUTANT 1M18 ; 2.45 ; LIGAND BINDING ALTERS THE STRUCTURE AND DYNAMICS OF NUCLEOSOMAL DEOXYRIBONUCLEIC ACID 1M19 ; 2.30 ; LIGAND BINDING ALTERS THE STRUCTURE AND DYNAMICS OF NUCLEOSOMAL DEOXYRIBONUCLEIC ACID 1M1A ; 2.65 ; LIGAND BINDING ALTERS THE STRUCTURE AND DYNAMICS OF NUCLEOSOMAL DEOXYRIBONUCLEIC ACID 3PRG ; 2.90 ; LIGAND BINDING DOMAIN OF HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR 1WWB ; 2.10 ; LIGAND BINDING DOMAIN OF HUMAN TRKB RECEPTOR 1PRG ; 2.20 ; LIGAND BINDING DOMAIN OF THE HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 1KNU ; 2.50 ; LIGAND BINDING DOMAIN OF THE HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA IN COMPLEX WITH A SYNTHETIC AGONIST 1NYX ; 2.65 ; LIGAND BINDING DOMAIN OF THE HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA IN COMPLEX WITH AN AGONIST 1VLS ; 1.85 ; LIGAND BINDING DOMAIN OF THE WILD-TYPE ASPARTATE RECEPTOR 1VLT ; 1.85 ; LIGAND BINDING DOMAIN OF THE WILD-TYPE ASPARTATE RECEPTOR WITH ASPARTATE 1IS5 ; 2.00 ; LIGAND FREE CONGERIN II 1CD2 ; 2.20 ; LIGAND INDUCED CONFORMATIONAL CHANGES IN THE CRYSTAL STRUCTURES OF PNEUMOCYSTIS CARINII DIHYDROFOLATE REDUCTASE COMPLEXES WITH FOLATE AND NADP+ 2CD2 ; 1.90 ; LIGAND INDUCED CONFORMATIONAL CHANGES IN THE CRYSTAL STRUCTURES OF PNEUMOCYSTIS CARINII DIHYDROFOLATE REDUCTASE COMPLEXES WITH FOLATE AND NADP+ 3CD2 ; 2.50 ; LIGAND INDUCED CONFORMATIONAL CHANGES IN THE CRYSTAL STRUCTURES OF PNEUMOCYSTIS CARINII DIHYDROFOLATE REDUCTASE COMPLEXES WITH FOLATE AND NADP+ 4CD2 ; 2.00 ; LIGAND INDUCED CONFORMATIONAL CHANGES IN THE CRYSTAL STRUCTURES OF PNEUMOCYSTIS CARINII DIHYDROFOLATE REDUCTASE COMPLEXES WITH FOLATE AND NADP+ 1TBW ; 2.15 ; LIGAND INDUCED CONFORMATIONAL SHIFT IN THE N-TERMINAL DOMAIN OF GRP94, OPEN CONFORMATION 1TC6 ; 1.87 ; LIGAND INDUCED CONFORMATIONAL SHIFT IN THE N-TERMINAL DOMAIN OF GRP94, OPEN CONFORMATION ADP-COMPLEX 1TC0 ; 2.20 ; LIGAND INDUCED CONFORMATIONAL SHIFTS IN THE N-TERMINAL DOMAIN OF GRP94, OPEN CONFORMATION COMPLEXED WITH THE PHYSIOLOGICAL PARTNER ATP 2BLH ; 1.77 ; LIGAND MIGRATION AND PROTEIN FLUCTUATIONS IN MYOGLOBIN MUTANT L29W 1PDU ; 2.30 ; LIGAND-BINDING DOMAIN OF DROSOPHILA ORPHAN NUCLEAR RECEPTOR DHR38 1LBD ; 2.70 ; LIGAND-BINDING DOMAIN OF THE HUMAN NUCLEAR RECEPTOR RXR-ALPHA 2PRG ; 2.30 ; LIGAND-BINDING DOMAIN OF THE HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 3LBD ; 2.40 ; LIGAND-BINDING DOMAIN OF THE HUMAN RETINOIC ACID RECEPTOR GAMMA BOUND TO 9-CIS RETINOIC ACID 2LBD ; 2.00 ; LIGAND-BINDING DOMAIN OF THE HUMAN RETINOIC ACID RECEPTOR GAMMA BOUND TO ALL-TRANS RETINOIC ACID 4LBD ; 2.40 ; LIGAND-BINDING DOMAIN OF THE HUMAN RETINOIC ACID RECEPTOR GAMMA BOUND TO THE SYNTHETIC AGONIST BMS961 1DJS ; 2.40 ; LIGAND-BINDING PORTION OF FIBROBLAST GROWTH FACTOR RECEPTOR 2 IN COMPLEX WITH FGF1 1C1F ; 1.60 ; LIGAND-FREE CONGERIN I 3GTU ; 2.80 ; LIGAND-FREE HETERODIMERIC HUMAN GLUTATHIONE S-TRANSFERASE M2-3 (EC 2.5.1.18), MONOCLINIC CRYSTAL FORM 1N3X ; 2.50 ; LIGAND-FREE HIGH-AFFINITY MALTOSE-BINDING PROTEIN 1PEB ; 2.60 ; LIGAND-FREE HIGH-AFFINITY MALTOSE-BINDING PROTEIN 4GTU ; 3.30 ; LIGAND-FREE HOMODIMERIC HUMAN GLUTATHIONE S-TRANSFERASE M4- 4 1GTU ; 2.68 ; LIGAND-FREE HUMAN GLUTATHIONE S-TRANSFERASE M1A-1A 2GTU ; 2.55 ; LIGAND-FREE HUMAN GLUTATHIONE S-TRANSFERASE M2-2 , MONOCLINIC CRYSTAL FORM 1HJX ; 1.85 ; LIGAND-INDUCED SIGNALLING AND CONFORMATIONAL CHANGE OF THE 39 KD GLYCOPROTEIN FROM HUMAN ARTICULAR CHONDROCYTES 1NXF ; 1.85 ; LIGAND-LINKED TRANSITIONS OF DEOXYHBI CRYSTALS EXPOSED TO CO. 1IKT ; 1.75 ; LIGANDED STEROL CARRIER PROTEIN TYPE 2 (SCP-2) LIKE DOMAIN OF HUMAN MULTIFUNCTIONAL ENZYME TYPE 2 (MFE-2) 1XRD ; -1.00 ; LIGHT-HARVESTING COMPLEX 1 ALFA SUBUNIT FROM WILD-TYPE RHODOSPIRILLUM RUBRUM 1DX7 ; -1.00 ; LIGHT-HARVESTING COMPLEX 1 BETA SUBUNIT FROM RHODOBACTER SPHAEROIDES 1WRG ; -1.00 ; LIGHT-HARVESTING COMPLEX 1 BETA SUBUNIT FROM WILD-TYPE RHODOSPIRILLUM RUBRUM 1B85 ; 1.85 ; LIGNIN PEROXIDASE 1LLP ; 1.70 ; LIGNIN PEROXIDASE (ISOZYME H2) PI4.15 1QPA ; 1.80 ; LIGNIN PEROXIDASE ISOZYME LIP4.65 (PI4.65) 1NWW ; 1.20 ; LIMONENE-1,2-EPOXIDE HYDROLASE 1NU3 ; 1.75 ; LIMONENE-1,2-EPOXIDE HYDROLASE IN COMPLEX WITH VALPROMIDE 1MJ5 ; 0.95 ; LINB (HALOALKANE DEHALOGENASE) FROM SPHINGOMONAS PAUCIMOBILIS UT26 AT ATOMIC RESOLUTION 1G4H ; 1.80 ; LINB COMPLEXED WITH BUTAN-1-OL 1LBS ; 2.60 ; LIPASE (TRIACYLGLYCEROL HYDROLASE) 1LBT ; 2.50 ; LIPASE (TRIACYLGLYCEROL HYDROLASE) 1LGY ; 2.20 ; LIPASE II FROM RHIZOPUS NIVEUS 1UVA ; 2.50 ; LIPID BINDING IN RICE NONSPECIFIC LIPID TRANSFER PROTEIN-1 COMPLEXES FROM ORYZA SATIVA 1UVB ; 2.10 ; LIPID BINDING IN RICE NONSPECIFIC LIPID TRANSFER PROTEIN-1 COMPLEXES FROM ORYZA SATIVA 1UVC ; 2.00 ; LIPID BINDING IN RICE NONSPECIFIC LIPID TRANSFER PROTEIN-1 COMPLEXES FROM ORYZA SATIVA 1MYU ; -1.00 ; LIPID INDUCED CONFORMATION OF THE TACHYKININ PEPTIDE KASSININ 1BE2 ; -1.00 ; LIPID TRANSFER PROTEIN COMPLEXED WITH PALMITATE, NMR, 10 STRUCTURES 1JTB ; -1.00 ; LIPID TRANSFER PROTEIN COMPLEXED WITH PALMITOYL COENZYME A, NMR, 16 STRUCTURES 1AFH ; -1.00 ; LIPID TRANSFER PROTEIN FROM MAIZE SEEDLINGS, NMR, 15 STRUCTURES 1BV2 ; -1.00 ; LIPID TRANSFER PROTEIN FROM RICE SEEDS, NMR, 14 STRUCTURES 1LSH ; 1.90 ; LIPID-PROTEIN INTERACTIONS IN LIPOVITELLIN 1OGV ; 2.35 ; LIPIDIC CUBIC PHASE CRYSTAL STRUCTURE OF THE PHOTOSYNTHETIC REACTION CENTRE FROM RHODOBACTER SPHAEROIDES 2BNS ; 2.50 ; LIPIDIC CUBIC PHASE GROWN REACTION CENTRE FROM RHODOBACTER SPHAEROIDES, EXCITED STATE 2BNP ; 2.70 ; LIPIDIC CUBIC PHASE GROWN REACTION CENTRE FROM RHODOBACTER SPHAEROIDES, GROUND STATE 1N8Q ; 2.10 ; LIPOXYGENASE IN COMPLEX WITH PROTOCATECHUIC ACID 1YGE ; 1.40 ; LIPOXYGENASE-1 (SOYBEAN) AT 100K 1Y4K ; 1.95 ; LIPOXYGENASE-1 (SOYBEAN) AT 100K, N694G MUTANT 1FGM ; 1.90 ; LIPOXYGENASE-1 (SOYBEAN) AT 100K, N694H MUTANT 1F8N ; 1.40 ; LIPOXYGENASE-1 (SOYBEAN) AT 100K, NEW REFINEMENT 1FGO ; 1.62 ; LIPOXYGENASE-1 (SOYBEAN) AT 100K, Q495A MUTANT 1FGQ ; 1.85 ; LIPOXYGENASE-1 (SOYBEAN) AT 100K, Q495E MUTANT 1FGR ; 1.60 ; LIPOXYGENASE-1 (SOYBEAN) AT 100K, Q697E MUTANT 1FGT ; 1.62 ; LIPOXYGENASE-1 (SOYBEAN) AT 100K, Q697N MUTANT 1IK3 ; 2.00 ; LIPOXYGENASE-3 (SOYBEAN) COMPLEX WITH 13(S)-HYDROPEROXY-9(Z) ,11(E)-OCTADECADIENOIC ACID 1HU9 ; 2.20 ; LIPOXYGENASE-3 (SOYBEAN) COMPLEX WITH 4-HYDROPEROXY-2- METHOXY-PHENOL 1JNQ ; 2.10 ; LIPOXYGENASE-3 (SOYBEAN) COMPLEX WITH EPIGALLOCATHECHIN (EGC) 1ROV ; 2.00 ; LIPOXYGENASE-3 TREATED WITH CUMENE HYDROPEROXIDE 1LNH ; 2.60 ; LIPOXYGENASE-3(SOYBEAN) NON-HEME FE(II) METALLOPROTEIN 1PMR ; -1.00 ; LIPOYL DOMAIN FROM THE DIHYDROLIPOYL SUCCINYLTRANSFERASE COMPONENT OF THE 2-OXOGLUTARATE DEHYDROGENASE MULTIENZYME COMPLEX OF ESCHERICHIA COLI, NMR, 25 STRUCTURES 1IYV ; -1.00 ; LIPOYL DOMAIN OF PYRUVATE DEHYDROGENASE COMPLEX, NMR, 29 STRUCTURES 1IYU ; -1.00 ; LIPOYL DOMAIN OF PYRUVATE DEHYDROGENASE COMPLEX, NMR, MINIMIZED AVERAGE STRUCTURE 1LFO ; 2.30 ; LIVER FATTY ACID BINDING PROTEIN - OLEATE COMPLEX 2ACL ; 2.80 ; LIVER X-RECEPTOR ALPHA LIGAND BINDING DOMAIN WITH SB313987 1HCV ; 1.85 ; LLAMA HEAVY CHAIN VARIABLE DOMAIN AGAINST ALPHA SUBUNIT OF HCG (HUMAN CHORIONIC GONADOTROPIN) 1ZMS ; 2.80 ; LMP1 PROTEIN BINDS TO TRAF3 AS A STRUCTURAL CD40 1LMW ; 2.50 ; LMW U-PA STRUCTURE COMPLEXED WITH EGRCMK (GLU-GLY-ARG CHLOROMETHYL KETONE) 1BJM ; 2.20 ; LOC NAKS, A LAMBDA 1 TYPE LIGHT-CHAIN DIMER (BENCE-JONES PROTEIN) CRYSTALLIZED IN NAKSO4 3BJL ; 2.30 ; LOC, A LAMBDA 1 TYPE LIGHT-CHAIN DIMER (BENCE-JONES PROTEIN) CRYSTALLIZED IN AMMONIUM SULFATE 1CB3 ; -1.00 ; LOCAL INTERACTIONS DRIVE THE FORMATION OF NON-NATIVE STRUCTURE IN THE DENATURED STATE OF HUMAN ALPHA- LACTALBUMIN: A HIGH RESOLUTION STRUCTURAL CHARACTERIZATION OF A PEPTIDE MODEL IN AQUEOUS SOLUTION 1RE6 ; -1.00 ; LOCALISATION OF DYNEIN LIGHT CHAINS 1 AND 2 AND THEIR PRO- APOPTOTIC LIGANDS 1YSH ; 9.50 ; LOCALIZATION AND DYNAMIC BEHAVIOR OF RIBOSOMAL PROTEIN L30E 1BG7 ; 1.85 ; LOCALIZED UNFOLDING AT THE JUNCTION OF THREE FERRITIN SUBUNITS. A MECHANISM FOR IRON RELEASE? 1DQ0 ; 1.70 ; LOCKED, METAL-FREE CONCANAVALIN A, A MINOR SPECIES IN SOLUTION 4BJL ; 2.40 ; LOCW, A LAMBDA 1 TYPE LIGHT-CHAIN DIMER (BENCE-JONES PROTEIN) CRYSTALLIZED IN DISTILLED WATER 1LHS ; 2.00 ; LOGGERHEAD SEA TURTLE MYOGLOBIN (AQUO-MET) 1LHT ; 2.00 ; LOGGERHEAD SEA TURTLE MYOGLOBIN (CYANO-MET) 1ZID ; 2.70 ; LONG FATTY ACID CHAIN ENOYL-ACP REDUCTASE (INHA) IN COMPLEX WITH AN ISONICOTINIC-ACYL-NADH INHIBITOR 1OYU ; 2.50 ; LONG-DISTANCE CONFORMATIONAL CHANGES IN A PROTEIN ENGINEERED BY MODULATED SEQUENCE DUPLICATION 1A51 ; -1.00 ; LOOP D/LOOP E ARM OF E. COLI 5S RRNA, NMR, 9 STRUCTURES 1A4D ; -1.00 ; LOOP D/LOOP E ARM OF ESCHERICHIA COLI 5S RRNA, NMR, MINIMIZED AVERAGE STRUCTURE 1JTI ; 2.30 ; LOOP-INSERTED STRUCTURE OF P1-P1' CLEAVED OVALBUMIN MUTANT R339T 1CR8 ; -1.00 ; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN COMPLEMENT REPEAT 8 1PW6 ; 2.60 ; LOW MICROMOLAR SMALL MOLECULE INHIBITOR OF IL-2 2TIO ; 1.93 ; LOW PACKING DENSITY FORM OF BOVINE BETA-TRYPSIN IN CYCLOHEXANE 1URZ ; 2.70 ; LOW PH INDUCED, MEMBRANE FUSION CONFORMATION OF THE ENVELOPE PROTEIN OF TICK-BORNE ENCEPHALITIS VIRUS 1L3D ; 2.85 ; LOW RESOLUTION CRYSTAL STRUCTURE OF A VIRAL RIBONUCLEIC ACID PSEUDOKNOT 1IUF ; -1.00 ; LOW RESOLUTION SOLUTION STRUCTURE OF THE TWO DEOXYRIBONUCLEIC ACID-BINDING DOMAINS IN SCHIZOSACCHAROMYCES POMBE ABP1 PROTEIN 1FB5 ; 3.50 ; LOW RESOLUTION STRUCTURE OF OVINE ORNITHINE TRANSCARBMOYLASE IN THE UNLIGANDED STATE 1ZN2 ; 2.91 ; LOW RESOLUTION STRUCTURE OF RESPONSE REGULATOR STYR 1J9E ; 1.44 ; LOW TEMPERATURE (100K) CRYSTAL STRUCTURE OF FLAVODOXIN D. VULGARIS S35C MUTANT AT 1.44 ANGSTROM RESOLUTION 1J9G ; 2.40 ; LOW TEMPERATURE (100K) CRYSTAL STRUCTURE OF FLAVODOXIN D. VULGARIS S64C MUTANT, MONOMER OXIDISED, AT 2.4 ANGSTROM RESOLUTION 1J8Q ; 1.35 ; LOW TEMPERATURE (100K) CRYSTAL STRUCTURE OF FLAVODOXIN D. VULGARIS WILD-TYPE AT 1.35 ANGSTROM RESOLUTION 1WSW ; 1.69 ; LOW TEMPERATURE (100K) CRYSTAL STRUCTURE OF FLAVODOXIN MUTANT S64C, DIMER, SEMIQUINONE STATE 1XYY ; 1.70 ; LOW TEMPERATURE (100K) CRYSTAL STRUCTURE OF FLAVODOXIN MUTANT S64C, HOMODIMER, OXIDISED STATE 1XYV ; 1.79 ; LOW TEMPERATURE (100K) CRYSTAL STRUCTURE OF FLAVODOXIN MUTANT S64C, MONOMER, SEMIQUINONE STATE 1QCJ ; 2.10 ; LOW TEMPERATURE COMPLEX OF POKEWEED ANTIVIRAL PROTEIN WITH PTEORIC ACID 1LPU ; 1.86 ; LOW TEMPERATURE CRYSTAL STRUCTURE OF THE APO-FORM OF THE CATALYTIC SUBUNIT OF PROTEIN KINASE CK2 FROM ZEA MAYS 1BHZ ; 3.90 ; LOW TEMPERATURE MIDDLE RESOLUTION STRUCTURE OF HEN EGG WHITE LYSOZYME FROM MASC DATA 1BHY ; 4.18 ; LOW TEMPERATURE MIDDLE RESOLUTION STRUCTURE OF P64K FROM MASC DATA 1BHW ; 4.10 ; LOW TEMPERATURE MIDDLE RESOLUTION STRUCTURE OF XYLOSE ISOMERASE FROM MASC DATA 1JPO ; 2.10 ; LOW TEMPERATURE ORTHORHOMBIC LYSOZYME 1QCG ; 2.10 ; LOW TEMPERATURE STRUCTURE OF POKEWEED ANTIVIRAL PROTEIN 1QCI ; 2.00 ; LOW TEMPERATURE STRUCTURE OF POKEWEED ANTIVIRAL PROTEIN COMPLEXED WITH ADENINE 1CW7 ; 2.60 ; LOW TEMPERATURE STRUCTURE OF WILD-TYPE IDH COMPLEXED WITH MG-ISOCITRATE 1E2U ; 1.60 ; LOW TEMPERATURE STUCTURE OF HYBRID CLUSTER PROTEIN FROM DESULFOVIBRIO VULGARIS TO 1.6A 1LIR ; -1.00 ; LQ2 FROM LEIURUS QUINQUESTRIATUS, NMR, 22 STRUCTURES 1LSI ; -1.00 ; LSIII (NMR, 23 STRUCTURES) 1W29 ; 2.30 ; LUMAZINE SYNTHASE FROM MYCOBACTERIUM TUBERCULOSIS BOUND TO 3-(1,3,7-TRIHYDRO-9-D-RIBITYL-2,6,8-PURINETRIONE-7-YL) BUTANE 1-PHOSPHATE 1W19 ; 2.00 ; LUMAZINE SYNTHASE FROM MYCOBACTERIUM TUBERCULOSIS BOUND TO 3-(1,3,7-TRIHYDRO-9-D-RIBITYL-2,6,8-PURINETRIONE-7-YL) PROPANE 1-PHOSPHATE 1KYX ; 2.60 ; LUMAZINE SYNTHASE FROM S.POMBE BOUND TO CARBOXYETHYLLUMAZINE 1KYY ; 2.40 ; LUMAZINE SYNTHASE FROM S.POMBE BOUND TO NITROPYRIMIDINEDIONE 1KYV ; 2.40 ; LUMAZINE SYNTHASE FROM S.POMBE BOUND TO RIBOFLAVIN 1EJB ; 1.85 ; LUMAZINE SYNTHASE FROM SACCHAROMYCES CEREVISIAE 1HCZ ; 1.96 ; LUMEN-SIDE DOMAIN OF REDUCED CYTOCHROME F AT -35 DEGREES CELSIUS 1B08 ; 2.30 ; LUNG SURFACTANT PROTEIN D (SP-D) (FRAGMENT) 1FJ1 ; 2.68 ; LYME DISEASE ANTIGEN OSPA IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB LA-2 1VYE ; -1.00 ; LYNX1 PROTEIN 1HJA ; 2.30 ; LYS 18 VARIANT OF TURKEY OVOMUCOID INHIBITOR THIRD DOMAIN COMPLEXED WITH ALPHA-CHYMOTRYPSIN 1LPH ; 2.30 ; LYS(B28)PRO(B29)-HUMAN INSULIN 1E0G ; -1.00 ; LYSM DOMAIN FROM E.COLI MLTD 253L ; 2.00 ; LYSOZYME 254L ; 1.90 ; LYSOZYME 2CDS ; 2.00 ; LYSOZYME 2IHL ; 1.40 ; LYSOZYME (JAPANESE QUAIL) 1HSW ; 2.00 ; LYSOZYME (MUCOPEPTIDE N-ACETYLMURAMYL HYDROLASE) 1BB7 ; 2.00 ; LYSOZYME COMPLEX WITH 4-METHYL-UMBELLIFERYL CHITOBIOSE 1BB6 ; 2.00 ; LYSOZYME COMPLEX WITH 4-METHYL-UMBELLIFERYL CHITOTRIOSE 1AM7 ; 2.30 ; LYSOZYME FROM BACTERIOPHAGE LAMBDA 1JUG ; 1.90 ; LYSOZYME FROM ECHIDNA MILK (TACHYGLOSSUS ACULEATUS) 1HSX ; 1.90 ; LYSOZYME GROWN AT BASIC PH AND ITS LOW HUMIDITY VARIANT 1LZ8 ; 1.53 ; LYSOZYME PHASED ON ANOMALOUS SIGNAL OF SULFURS AND CHLORINES 2AUB ; 1.70 ; LYSOZYME STRUCTURE DERIVED FROM THIN-FILM-BASED CRYSTALS 1BBW ; 2.70 ; LYSYL-TRNA SYNTHETASE (LYSS) 1BBU ; 2.70 ; LYSYL-TRNA SYNTHETASE (LYSS) COMPLEXED WITH LYSINE 1LYL ; 2.80 ; LYSYL-TRNA SYNTHETASE (LYSU) COMPLEXED WITH LYSINE 1E1O ; 2.12 ; LYSYL-TRNA SYNTHETASE (LYSU) HEXAGONAL FOR, COMPLEXED WITH LY 1E24 ; 2.35 ; LYSYL-TRNA SYNTHETASE (LYSU) HEXAGONAL FORM COMPLEXED WITH LYSINE AND ATP AND MN2+ 1E22 ; 2.43 ; LYSYL-TRNA SYNTHETASE (LYSU) HEXAGONAL FORM COMPLEXED WITH LYSINE AND THE NON-HYDROLYSABLE ATP ANALOGUE AMP-PCP 1E1T ; 2.40 ; LYSYL-TRNA SYNTHETASE (LYSU) HEXAGONAL FORM COMPLEXED WITH TH LYSYL_ADENYLATE INTERMEDIATE 2TGD ; 2.10 ; Lack of the Transition State Stabilization Site is a Factor in the Inactivity of Trypsinogen, a Serine Protease Zymogen. Structure of /Dfp Inhibited Bovine Trypsinogen at 2.1 Angstroms Resolution 1CWQ ; 2.25 ; M INTERMEDIATE STRUCTURE OF THE WILD TYPE BACTERIORHODOPSIN IN COMBINATION WITH THE GROUND STATE STRUCTURE 1A6S ; -1.00 ; M-DOMAIN FROM GAG POLYPROTEIN OF ROUS SARCOMA VIRUS, NMR, 20 STRUCTURES 1U12 ; 2.70 ; M. LOTI CYCLIC NUCLEOTIDE BINDING DOMAIN MUTANT 1GX3 ; 1.70 ; M. SMEGMATIS ARYLAMINE N-ACETYL TRANSFERASE 1SM8 ; 2.90 ; M. TUBERCULOSIS DUTPASE COMPLEXED WITH CHROMIUM AND DUTP 1VP6 ; 1.70 ; M.LOTI ION CHANNEL CYLIC NUCLEOTIDE BINDING DOMAIN 1BVR ; 2.80 ; M.TB. ENOYL-ACP REDUCTASE (INHA) IN COMPLEX WITH NAD+ AND C16-FATTY-ACYL-SUBSTRATE 1DXZ ; -1.00 ; M2 TRANSMEMBRANE SEGMENT OF ALPHA-SUBUNIT OF NICOTINIC ACETYLCHOLINE RECEPTOR FROM TORPEDO CALIFORNICA, NMR, 20 STRUCTURES 3MRA ; -1.00 ; M3 TRANSMEMBRANE SEGMENT OF ALPHA-SUBUNIT OF NICOTINIC ACETYLCHOLINE RECEPTOR FROM TORPEDO CALIFORNICA, NMR, 15 STRUCTURES 1XMD ; 2.10 ; M335V MUTANT STRUCTURE OF MOUSE CARNITINE OCTANOYLTRANSFERASE 1EEU ; 1.60 ; M4L/Y(27D)D/Q89D/T94H MUTANT OF LEN 1EEQ ; 1.50 ; M4L/Y(27D)D/T94H MUTANT OF LEN 1OV6 ; 2.40 ; M64V PNP + ALLO 1OVG ; 2.20 ; M64V PNP +MEPDR 1OUM ; 2.40 ; M64V PNP +TALO 1RGQ ; 2.90 ; M9A HCV PROTEASE COMPLEX WITH PENTAPEPTIDE KETO-AMIDE INHIBITOR 1DBN ; 2.75 ; MAACKIA AMURENSIS LEUKOAGGLUTININ (LECTIN) WITH SIALYLLACTOSE 1UZL ; 2.00 ; MABA FROM MYCOBACTERIUM TUBERCULOSIS 1UZM ; 1.49 ; MABA FROM MYCOBACTERIUM TUBERCULOSIS 1UZN ; 1.91 ; MABA FROM MYCOBACTERIUM TUBERCULOSIS 1BHQ ; 2.70 ; MAC-1 I DOMAIN CADMIUM COMPLEX 1BHO ; 2.70 ; MAC-1 I DOMAIN MAGNESIUM COMPLEX 1IDN ; 2.70 ; MAC-1 I DOMAIN METAL FREE 2BFQ ; 1.50 ; MACRO DOMAINS ARE ADP-RIBOSE BINDING MOLECULES 2MCM ; 1.50 ; MACROMOMYCIN 1FIM ; 2.20 ; MACROPHAGE MIGRATION INHIBITORY FACTOR 1MIF ; 2.60 ; MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) 1GCZ ; 1.90 ; MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) COMPLEXED WITH INHIBITOR. 1CGQ ; 2.00 ; MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) WITH ALANINE INSERTED BETWEEN PRO-1 AND MET-2 1CA7 ; 2.50 ; MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) WITH HYDROXPHENYLPYRUVATE 1P1G ; 2.50 ; MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) WITH PRO-1 MUTATED TO GLY-1 1MFF ; 2.00 ; MACROPHAGE MIGRATION INHIBITORY FACTOR Y95F MUTANT 1F6Y ; 2.20 ; MAD CRYSTAL STRUCTURE ANALYSIS OF METHYLTETRAHYDROFOLATE: CORRINOID/IRON-SULFUR PROTEIN METHYLTRANSFERASE (METR) 242D ; 1.65 ; MAD PHASING STRATEGIES EXPLORED WITH A BROMINATED OLIGONUCLEOTIDE CRYSTAL AT 1.65 A RESOLUTION 1E3U ; 1.66 ; MAD STRUCTURE OF OXA10 CLASS D BETA-LACTAMASE 1OAP ; 1.93 ; MAD STRUCTURE OF THE PERIPLASMIQUE DOMAIN OF THE ESCHERICHIA COLI PAL PROTEIN 3MDS ; 1.80 ; MAGANESE SUPEROXIDE DISMUTASE FROM THERMUS THERMOPHILUS 1U7O ; 1.90 ; MAGNESIUM DEPENDENT PHOSPHATASE 1 (MDP-1) 1QSH ; 1.70 ; MAGNESIUM(II)-AND ZINC(II)-PROTOPORPHYRIN IX'S STABILIZE THE LOWEST OXYGEN AFFINITY STATE OF HUMAN HEMOGLOBIN EVEN MORE STRONGLY THAN DEOXYHEME 1QSI ; 1.70 ; MAGNESIUM(II)-AND ZINC(II)-PROTOPORPHYRIN IX'S STABILIZE THE LOWEST OXYGEN AFFINITY STATE OF HUMAN HEMOGLOBIN EVEN MORE STRONGLY THAN DEOXYHEME 1UUN ; 2.50 ; MAIN PORIN FROM MYCOBACTERIA SMEGMATIS (MSPA) 1MZL ; 1.90 ; MAIZE NONSPECIFIC LIPID TRANSFER PROTEIN 1MZM ; 1.78 ; MAIZE NONSPECIFIC LIPID TRANSFER PROTEIN COMPLEXED WITH PALMITATE 1ITZ ; 2.30 ; MAIZE TRANSKETOLASE IN COMPLEX WITH TPP 3MEF ; -1.00 ; MAJOR COLD-SHOCK PROTEIN FROM ESCHERICHIA COLI SOLUTION NMR STRUCTURE 1NMF ; -1.00 ; MAJOR COLD-SHOCK PROTEIN, NMR, 20 STRUCTURES 1NMG ; -1.00 ; MAJOR COLD-SHOCK PROTEIN, NMR, MINIMIZED AVERAGE STRUCTURE 1MSP ; 2.50 ; MAJOR SPERM PROTEIN, ALPHA ISOFORM (RECOMBINANT), PH 4.6 2MSP ; 3.30 ; MAJOR SPERM PROTEIN, BETA ISOFORM, ENGINEERED C59S/T90C MUTANT, PUTATIVE SUBFILAMENT STRUCTURE, PH 8.5 1YU3 ; 2.52 ; MAJOR TROPISM DETERMINANT I1 VARIANT 1YU2 ; 1.86 ; MAJOR TROPISM DETERMINANT M1 VARIANT 1YU0 ; 1.56 ; MAJOR TROPISM DETERMINANT P1 VARIANT 1YU1 ; 2.07 ; MAJOR TROPISM DETERMINANT P3C VARIANT 1YU4 ; 1.87 ; MAJOR TROPISM DETERMINANT U1 VARIANT 1CJB ; 2.00 ; MALARIAL PURINE PHOSPHORIBOSYLTRANSFERASE 1B8P ; 1.90 ; MALATE DEHYDROGENASE FROM AQUASPIRILLUM ARCTICUM 1B8U ; 2.50 ; MALATE DEHYDROGENASE FROM AQUASPIRILLUM ARCTICUM 1B8V ; 2.10 ; MALATE DEHYDROGENASE FROM AQUASPIRILLUM ARCTICUM 1D8C ; 2.00 ; MALATE SYNTHASE G COMPLEXED WITH MAGNESIUM AND GLYOXYLATE 1TOK ; 1.85 ; MALEIC ACID-BOUND STRUCTURE OF SRHEPT MUTANT OF E. COLI ASPARTATE AMINOTRANSFERASE 1GQ2 ; 2.50 ; MALIC ENZYME FROM PIGEON LIVER 1G29 ; 1.90 ; MALK 4MBP ; 1.70 ; MALTODEXTRIN BINDING PROTEIN WITH BOUND MALTETROSE 1ANF ; 1.67 ; MALTODEXTRIN BINDING PROTEIN WITH BOUND MALTOSE 1MPB ; 2.00 ; MALTODEXTRIN-BINDING PROTEIN (MALTOSE-BINDING PROTEIN) MUTANT, WITH ARGININE REPLACING TRYPTOPHAN AT POSITION 230 (TRP-230-ARG) 1MPC ; 2.10 ; MALTODEXTRIN-BINDING PROTEIN (MALTOSE-BINDING PROTEIN) MUTANT, WITH ARGININE REPLACING TRYPTOPHAN AT POSITION 230 (TRP-230-ARG) 1MPD ; 2.30 ; MALTODEXTRIN-BINDING PROTEIN (MALTOSE-BINDING PROTEIN) MUTANT, WITH ARGININE REPLACING TRYPTOPHAN AT POSITION 230 (TRP-230-ARG), COMPLEXED WITH MALTOSE 1IUD ; 2.70 ; MALTODEXTRIN-BINDING PROTEIN INSERTION/DELETION MUTANT WITH AN INSERTED B-CELL EPITOPE FROM THE PRES2 REGION OF HEPATITIS B VIRUS 1JVX ; 2.50 ; MALTODEXTRIN-BINDING PROTEIN VARIANT D207C/A301GS/P316C CROSS-LINKED IN CRYSTAL 1JVY ; 1.90 ; MALTODEXTRIN-BINDING PROTEIN VARIANT D207C/A301GS/P316C WITH BETA-MERCAPTOETHANOL MIXED DISULFIDES 3MBP ; 1.70 ; MALTODEXTRIN-BINDING PROTEIN WITH BOUND MALTOTRIOSE 1MPR ; 2.80 ; MALTOPORIN FROM SALMONELLA TYPHIMURIUM 2MPR ; 2.40 ; MALTOPORIN FROM SALMONELLA TYPHIMURIUM 1MPO ; 2.80 ; MALTOPORIN MALTOHEXAOSE COMPLEX 1MPM ; 2.60 ; MALTOPORIN MALTOSE COMPLEX 1MPN ; 3.20 ; MALTOPORIN MALTOTRIOSE COMPLEX 1AF6 ; 2.40 ; MALTOPORIN SUCROSE COMPLEX 1MPQ ; 3.00 ; MALTOPORIN TREHALOSE COMPLEX 1MH3 ; 2.10 ; MALTOSE BINDING-A1 HOMEODOMAIN PROTEIN CHIMERA, CRYSTAL FORM I 1MH4 ; 2.30 ; MALTOSE BINDING-A1 HOMEODOMAIN PROTEIN CHIMERA, CRYSTAL FORM II 1H54 ; 2.15 ; MALTOSE PHOSPHORYLASE FROM LACTOBACILLUS BREVIS 1YTV ; 1.80 ; MALTOSE-BINDING PROTEIN FUSION TO A C-TERMINAL FRAGMENT OF THE V1A VASOPRESSIN RECEPTOR 1SO7 ; 1.49 ; MALTOSE-INDUCED STRUCTURE OF THE HUMAN CYTOLSOLIC SIALIDASE NEU2 1GJU ; 2.40 ; MALTOSYLTRANSFERASE FROM THERMOTOGA MARITIMA 1JDA ; 2.20 ; MALTOTETRAOSE-FORMING EXO-AMYLASE 5CGT ; 2.50 ; MALTOTRIOSE COMPLEX OF PRECONDITIONED CYCLODEXTRIN GLYCOSYLTRANSFERASE MUTANT 1IMT ; -1.00 ; MAMBA INTESTINAL TOXIN 1, NMR, 39 STRUCTURES 1QHU ; 2.30 ; MAMMALIAN BLOOD SERUM HAEMOPEXIN DEGLYCOSYLATED AND IN COMPLEX WITH ITS LIGAND HAEM 1QJS ; 2.90 ; MAMMALIAN BLOOD SERUM HAEMOPEXIN GLYCOSYLATED-NATIVE PROTEIN AND IN COMPLEX WITH ITS LIGAND HAEM 1Y7Q ; -1.00 ; MAMMALIAN SCAN DOMAIN DIMER IS A DOMAIN-SWAPPED HOMOLOGUE OF THE HIV CAPSID C-TERMINAL DOMAIN 2A79 ; 2.90 ; MAMMALIAN SHAKER KV1.2 POTASSIUM CHANNEL- BETA SUBUNIT COMPLEX 1H6V ; 3.00 ; MAMMALIAN THIOREDOXIN REDUCTASE 1QDO ; 2.80 ; MAN(APLHA1-3)MAN(ALPHA1-O)METHYL CONCANAVALIN A COMPLEX 1QDC ; 2.00 ; MAN(APLHA1-6)MAN(ALPHA1-O)METHYL CONCANAVALIN A COMPLEX 1DTN ; 2.10 ; MANDELATE RACEMASE MUTANT D270N CO-CRYSTALLIZED WITH (S)-ATROLACTATE 1MRA ; 2.10 ; MANDELATE RACEMASE MUTANT D270N CO-CRYSTALLIZED WITH (S)-ATROLACTATE 1MDL ; 1.85 ; MANDELATE RACEMASE MUTANT K166R CO-CRYSTALLIZED WITH (R)-MANDELATE 1BVA ; 1.89 ; MANGANESE BINDING MUTANT IN CYTOCHROME C PEROXIDASE 1MNP ; 2.06 ; MANGANESE PEROXIDASE 1YYG ; 1.60 ; MANGANESE PEROXIDASE COMPLEXED WITH CD(II) INHIBITOR 1MN1 ; 2.00 ; MANGANESE PEROXIDASE SUBSTRATE BINDING SITE MUTANT D179N 1MN2 ; 2.00 ; MANGANESE PEROXIDASE SUBSTRATE BINDING SITE MUTANT E35Q, D179N 1YZR ; 1.60 ; MANGANESE PEROXIDASE-SM(III) COMPLEX 1VEW ; 2.10 ; MANGANESE SUPEROXIDE DISMUTASE FROM ESCHERICHIA COLI 1DQ5 ; 2.00 ; MANGANESE;MANGANESE CONCANAVALIN A AT PH 5.0 1DQ6 ; 1.90 ; MANGANESE;MANGANESE CONCANAVALIN A AT PH 7.0 2BGO ; -1.00 ; MANNAN BINDING MODULE FROM MAN5C 2BGP ; -1.00 ; MANNAN BINDING MODULE FROM MAN5C IN BOUND CONFORMATION 1H5Q ; 1.50 ; MANNITOL DEHYDROGENASE FROM AGARICUS BISPORUS 3MAN ; 1.60 ; MANNOHEXAOSE COMPLEX OF THERMOMONOSPORA FUSCA BETA-MANNANASE 1RDO ; 1.70 ; MANNOSE-BINDING PROTEIN, SUBTILISIN DIGEST FRAGMENT 1RDL ; 1.70 ; MANNOSE-BINDING PROTEIN, SUBTILISIN DIGEST FRAGMENT COMPLEX WITH ALPHA-METHYL-D-MANNOPYRANOSIDE (0.2 M) 1RDM ; 1.90 ; MANNOSE-BINDING PROTEIN, SUBTILISIN DIGEST FRAGMENT COMPLEX WITH ALPHA-METHYL-D-MANNOPYRANOSIDE (1.3 M) 1RDN ; 1.80 ; MANNOSE-BINDING PROTEIN, SUBTILISIN DIGEST FRAGMENT COMPLEX WITH ALPHA-METHYL-D-N-ACETYLGLUCOSAMINIDE 1RDI ; 1.80 ; MANNOSE-BINDING PROTEIN, SUBTILISIN DIGEST FRAGMENT COMPLEX WITH ALPHA-METHYL-L-FUCOPYRANOSIDE 1RDJ ; 1.80 ; MANNOSE-BINDING PROTEIN, SUBTILISIN DIGEST FRAGMENT COMPLEX WITH BETA-METHYL-L-FUCOPYRANOSIDE 1RDK ; 1.80 ; MANNOSE-BINDING PROTEIN, SUBTILISIN DIGEST FRAGMENT COMPLEX WITH D-GALACTOSE 1BCH ; 2.00 ; MANNOSE-BINDING PROTEIN-A MUTANT (QPDWGH) COMPLEXED WITH N-ACETYL-D-GALACTOSAMINE 1BCJ ; 2.10 ; MANNOSE-BINDING PROTEIN-A MUTANT (QPDWGHV) COMPLEXED WITH N-ACETYL-D-GALACTOSAMINE 1NPL ; 2.00 ; MANNOSE-SPECIFIC AGGLUTININ (LECTIN) FROM DAFFODIL (NARCISSUS PSEUDONARCISSUS) BULBS IN COMPLEX WITH MANNOSE- ALPHA1,3-MANNOSE 1BWU ; 2.80 ; MANNOSE-SPECIFIC AGGLUTININ (LECTIN) FROM GARLIC (ALLIUM SATIVUM) BULBS COMPLEXED WITH ALPHA-D-MANNOSE 1KJ1 ; 2.20 ; MANNOSE-SPECIFIC AGGLUTININ (LECTIN) FROM GARLIC (ALLIUM SATIVUM) BULBS COMPLEXED WITH ALPHA-D-MANNOSE 1MSA ; 2.29 ; MANNOSE-SPECIFIC AGGLUTININ (LECTIN) FROM SNOWDROP (GALANTHUS NIVALIS) BULBS COMPLEXED WITH METHYL-ALPHA-D-MANNOSIDE 1NIV ; 3.00 ; MANNOSE-SPECIFIC AGGLUTININ (LECTIN) FROM SNOWDROP (GALANTHUS NIVALIS) BULBS IN COMPLEX WITH MANNOSE-ALPHA 1,3-METHYL-D-MANNOSE 1JPC ; 2.00 ; MANNOSE-SPECIFIC AGGLUTININ (LECTIN) FROM SNOWDROP (GALANTHUS NIVALIS) BULBS IN COMPLEX WITH MANNOSE-ALPHA1,6- (MANNOSE-ALPHA1,3)- MANNOSE-ALPHA1,6-(MANNOSE-ALPHA1,3)-MANNOSE 2MAN ; 1.90 ; MANNOTRIOSE COMPLEX OF THERMOMONOSPORA FUSCA BETA-MANNANASE 1UX9 ; 2.40 ; MAPPING PROTEIN MATRIX CAVITIES IN HUMAN CYTOGLOBIN THROUGH XE ATOM BINDING: A CRYSTALLOGRAPHIC INVESTIGATION 1BAX ; -1.00 ; MASON-PFIZER MONKEY VIRUS MATRIX PROTEIN, NMR, AVERAGE STRUCTURE 1YRN ; 2.50 ; MAT A1/ALPHA2/DEOXYRIBONUCLEIC ACID TERNARY COMPLEX (HOMEODOMAIN) 1K61 ; 2.10 ; MATALPHA2 HOMEODOMAIN BOUND TO DEOXYRIBONUCLEIC ACID 1MMP ; 2.30 ; MATRILYSIN COMPLEXED WITH CARBOXYLATE INHIBITOR 1MMQ ; 1.90 ; MATRILYSIN COMPLEXED WITH HYDROXAMATE INHIBITOR 1MMR ; 2.30 ; MATRILYSIN COMPLEXED WITH SULFODIIMINE INHIBITOR 1XUC ; 1.70 ; MATRIX METALLOPROTEINASE-13 COMPLEXED WITH NON-ZINC BINDING INHIBITOR 1XUD ; 1.80 ; MATRIX METALLOPROTEINASE-13 COMPLEXED WITH NON-ZINC BINDING INHIBITOR 1XUR ; 1.85 ; MATRIX METALLOPROTEINASE-13 COMPLEXED WITH NON-ZINC BINDING INHIBITOR 1SEV ; 2.55 ; MATURE AND TRANSLOCATABLE FORMS OF GLYOXYSOMAL MALATE DEHYDROGENASE HAVE DIFFERENT ACTIVITIES AND STABILITIES BUT SIMILAR CRYSTAL STRUCTURES 1SMK ; 2.50 ; MATURE AND TRANSLOCATABLE FORMS OF GLYOXYSOMAL MALATE DEHYDROGENASE HAVE DIFFERENT ACTIVITIES AND STABILITIES BUT SIMILAR CRYSTAL STRUCTURES 1EKG ; 1.80 ; MATURE HUMAN FRATAXIN 3FCT ; 2.40 ; MATURE METAL CHELATASE CATALYTIC ANTIBODY WITH HAPTEN 1AXS ; 2.60 ; MATURE OXY-COPE CATALYTIC ANTIBODY WITH HAPTEN 1C6W ; -1.00 ; MAUROCALCIN FROM SCORPIO MAURUS 1MVF ; 1.65 ; MAZE ADDICTION ANTIDOTE 1NMU ; 2.31 ; MBP-L30 1MB1 ; 2.10 ; MBP1 FROM SACCHAROMYCES CEREVISIAE 1DCL ; 2.30 ; MCG, A LAMBDA V TYPE LIGHT-CHAIN DIMER (BENCE-JONES PROTEIN), CRYSTALLIZED FROM AMMONIUM SULFATE 1NAN ; 2.30 ; MCH CLASS I H-2KB MOLECULE COMPLEXED WITH PBM1 PEPTIDE 1U60 ; 1.61 ; MCSG APC5046 PROBABLE GLUTAMINASE YBAS 1YCR ; 2.60 ; MDM2 BOUND TO THE TRANSACTIVATION DOMAIN OF P53 2BFX ; 1.80 ; MECHANISM OF AURORA-B ACTIVATION BY INCENP AND INHIBITION BY HESPERIDIN. 1SZ1 ; 6.21 ; MECHANISM OF CCA-ADDING ENZYMES SPECIFICITY REVEALED BY CRYSTAL STRUCTURES OF TERNARY COMPLEXES 1BI7 ; 3.40 ; MECHANISM OF G1 CYCLIN DEPENDENT KINASE INHIBITION FROM THE STRUCTURE OF THE CDK6-P16INK4A TUMOR SUPPRESSOR COMPLEX 1BI8 ; 2.80 ; MECHANISM OF G1 CYCLIN DEPENDENT KINASE INHIBITION FROM THE STRUCTURES CDK6-P19INK4D INHIBITOR COMPLEX 1C82 ; 1.70 ; MECHANISM OF HYALURONAN BINDING AND DEGRADATION: STRUCTURE OF STREPTOCOCCUS PNEUMONIAE HYALURONATE LYASE IN COMPLEX WITH HYALURONIC ACID DISACCHARIDE AT 1.7 A RESOLUTION 1JQL ; 2.50 ; MECHANISM OF PROCESSIVITY CLAMP OPENING BY THE DELTA SUBUNIT WRENCH OF THE CLAMP LOADER COMPLEX OF E. COLI DEOXYRIBONUCLEIC ACID POLYMERASE III: STRUCTURE OF BETA-DELTA (1-140) 1JQJ ; 2.90 ; MECHANISM OF PROCESSIVITY CLAMP OPENING BY THE DELTA SUBUNIT WRENCH OF THE CLAMP LOADER COMPLEX OF E. COLI DEOXYRIBONUCLEIC ACID POLYMERASE III: STRUCTURE OF THE BETA-DELTA COMPLEX 1TQE ; 2.70 ; MECHANISM OF RECRUITMENT OF CLASS II HISTONE DEACETYLASES BY MYOCYTE ENHANCER FACTOR-2 1WA3 ; 1.90 ; MECHANISM OF THE CLASS I KDPG ALDOLASE 2C0A ; 1.55 ; MECHANISM OF THE CLASS I KDPG ALDOLASE 1P3Q ; 1.70 ; MECHANISM OF UBIQUITIN RECOGNITION BY THE CUE DOMAIN OF VPS9 2AD5 ; 2.80 ; MECHANISMS OF FEEDBACK REGULATION AND DRUG RESISTANCE OF CTP SYNTHETASES: STRUCTURE OF THE E. COLI CTPS/CTP COMPLEX AT 2.8-ANGSTROM RESOLUTION. 1KBB ; 1.90 ; MECHANISTIC ANALYSES OF CATALYSIS IN HUMAN PANCREATIC ALPHA- AMYLASE: DETAILED KINETIC AND STRUCTURAL STUDIES OF MUTANTS OF THREE CONSERVED CARBOXYLIC ACIDS 1KBK ; 1.90 ; MECHANISTIC ANALYSES OF CATALYSIS IN HUMAN PANCREATIC ALPHA- AMYLASE: DETAILED KINETIC AND STRUCTURAL STUDIES OF MUTANTS OF THREE CONSERVED CARBOXYLIC ACIDS 1E8D ; 2.20 ; MECHANISTIC ASPECTS OF CYANOGENESIS FROM ACTIVE SITE MUTANT SER80ALA OF HYDROXYNITRILE LYASE FROM MANIHOT ESCULENTA IN COMPLEX WITH ACETONE CYANOHYDRIN 1UDY ; 2.40 ; MEDIUM-CHAIN ACYL-COA DEHYDROGENASE WITH 3-THIAOCTANOYL-COA 1F9B ; 2.70 ; MELANIN PROTEIN INTERACTION: X-RAY STRUCTURE OF THE COMPLEX OF MARE LACTOFERRIN WITH MELANIN MONOMERS 1HJD ; -1.00 ; MELANOMA INHIBITORY ACTIVITY (MIA) PROTEIN 1B6B ; 2.50 ; MELATONIN BIOSYNTHESIS: THE STRUCTURE OF SEROTONIN N- ACETYLTRANSFERASE AT 2.5 A RESOLUTION SUGGESTS A CATALYTIC MECHANISM 2MLT ; 2.00 ; MELITTIN 1SAZ ; 2.50 ; MEMBERSHIP IN THE ASKHA SUPERFAMILY: ENZYMOLOGICAL PROPERTIES AND CRYSTAL STRUCTURE OF BUTYRATE KINASE 2 FROM THERMOTOGA MARITIMA 1B9U ; -1.00 ; MEMBRANE DOMAIN OF THE SUBUNIT B OF THE E.COLI ATP SYNTHASE 1FGP ; -1.00 ; MEMBRANE PENETRATION DOMAIN OF THE MINOR COAT PROTEIN G3P OF PHAGE FD, NMR, 15 STRUCTURES 1DEP ; -1.00 ; MEMBRANE PROTEIN, NMR, 1 STRUCTURE 1U10 ; 2.40 ; MEPA, ACTIVE FORM WITH ZN IN P1 1TZP ; 1.40 ; MEPA, INACTIVE FORM WITHOUT ZN IN P21 1HT3 ; 1.80 ; MERCURY INDUCED MODIFICATIONS IN THE STEREOCHEMISTRY OF THE ACTIVE SITE THROUGH CYS-73 IN A SERINE PROTEASE: CRYSTAL STRUCTURE OF THE COMPLEX OF A PARTIALLY MODIFIED PROTEINASE K WITH MERCURY AT 1.8 A RESOLUTION 1R0G ; 1.60 ; MERCURY-SUBSTITUTED RUBREDOXIN 1QOW ; 1.06 ; MERSACIDIN FROM BACILLUS 1IS6 ; 1.70 ; MES-LIGANDED CONGERIN II 1XQ5 ; 1.90 ; MET-PERCH HEMOGLOBIN AT 1.9A 1EQT ; 1.60 ; MET-RANTES 1KYQ ; 2.20 ; MET8P: A BIFUNCTIONAL NAD-DEPENDENT DEHYDROGENASE AND FERROCHELATASE INVOLVED IN SIROHEME SYNTHESIS. 1IUO ; 2.00 ; META-CLEAVAGE PRODUCT HYDROLASE FROM PSEUDOMONAS FLUORESCENS IP01 (CUMD) S103A MUTANT COMPLEXED WITH ACETATES 1IUP ; 1.60 ; META-CLEAVAGE PRODUCT HYDROLASE FROM PSEUDOMONAS FLUORESCENS IP01 (CUMD) S103A MUTANT COMPLEXED WITH ISOBUTYRATES 1IUN ; 2.80 ; META-CLEAVAGE PRODUCT HYDROLASE FROM PSEUDOMONAS FLUORESCENS IP01 (CUMD) S103A MUTANT HEXAGONAL 302D ; 2.20 ; META-HYDROXY ANALOGUE OF HOECHST 33258 ('HYDROXYL IN' CONFORMATION) BOUND TO D(CGCGAATTCGCG)2 303D ; 2.20 ; META-HYDROXY ANALOGUE OF HOECHST 33258 ('HYDROXYL OUT' CONFORMATION) BOUND TO D(CGCGAATTCGCG)2 1WRN ; 2.30 ; METAL ION DEPENDENCY OF THE ANTITERMINATOR PROTEIN, HUTP, FOR BINDING TO THE TERMINATOR REGION OF HUT MRNA- A STRUCTURAL BASIS 1WRO ; 2.35 ; METAL ION DEPENDENCY OF THE ANTITERMINATOR PROTEIN, HUTP, FOR BINDING TO THE TERMINATOR REGION OF HUT MRNA- A STRUCTURAL BASIS 1O7T ; 1.65 ; METAL NANOCLUSTERS BOUND TO THE FERRIC BINDING PROTEIN FROM NEISSERIA GONORRHOEAE. 1IJ5 ; 3.00 ; METAL-FREE STRUCTURE OF MULTIDOMAIN EF-HAND PROTEIN, CBP40, FROM TRUE SLIME MOLD 1SML ; 1.70 ; METALLO BETA LACTAMASE L1 FROM STENOTROPHOMONAS MALTOPHILIA 2AIO ; 1.70 ; METALLO BETA LACTAMASE L1 FROM STENOTROPHOMONAS MALTOPHILIA COMPLEXED WITH HYDROLYZED MOXALACTAM 3BC2 ; 1.70 ; METALLO BETA-LACTAMASE II FROM BACILLUS CEREUS 569/H/9 AT PH 6.0, MONOCLINIC CRYSTAL FORM 2BC2 ; 1.70 ; METALLO BETA-LACTAMASE II FROM BACILLUS CEREUS 569/H/9 AT PH 6.0, TRIGONAL CRYSTAL FORM 1ZNB ; 1.85 ; METALLO-BETA-LACTAMASE 2BMI ; 2.00 ; METALLO-BETA-LACTAMASE 4ZNB ; 2.65 ; METALLO-BETA-LACTAMASE (C181S MUTANT) 2ZNB ; 2.15 ; METALLO-BETA-LACTAMASE (CADMIUM-BOUND FORM) 3ZNB ; 2.70 ; METALLO-BETA-LACTAMASE (ZN, HG-BOUND FORM) 1MQO ; 1.35 ; METALLO-BETA-LACTAMASE BCII CD SUBSTITUTED FROM BACILLUS CEREUS AT 1.35 ANGSTROMS RESOLUTION 1BVT ; 1.85 ; METALLO-BETA-LACTAMASE FROM BACILLUS CEREUS 569/H/9 1DXK ; 1.85 ; METALLO-BETA-LACTAMASE FROM BACILLUS CEREUS 569/H/9 C168S MUTANT 1HLK ; 2.50 ; METALLO-BETA-LACTAMASE FROM BACTEROIDES FRAGILIS IN COMPLEX WITH A TRICYCLIC INHIBITOR 1A8T ; 2.55 ; METALLO-BETA-LACTAMASE IN COMPLEX WITH L-159,061 1A7T ; 1.85 ; METALLO-BETA-LACTAMASE WITH MES 1DTH ; 2.00 ; METALLOPROTEASE 1QJK ; -1.00 ; METALLOTHIONEIN MTA FROM SEA URCHIN (ALPHA DOMAIN) 1QJL ; -1.00 ; METALLOTHIONEIN MTA FROM SEA URCHIN (BETA DOMAIN) 1LVZ ; -1.00 ; METARHODOPSIN II BOUND STRUCTURE OF C-TERMINAL PEPTIDE OF ALPHA-SUBUNIT OF TRANSDUCIN 2MOB ; -1.00 ; METHANE MONOOXYGENASE COMPONENT B 1MHY ; 2.00 ; METHANE MONOOXYGENASE HYDROXYLASE 1MHZ ; 2.70 ; METHANE MONOOXYGENASE HYDROXYLASE 1MTY ; 1.70 ; METHANE MONOOXYGENASE HYDROXYLASE FROM METHYLOCOCCUS CAPSULATUS (BATH) 1FZI ; 3.30 ; METHANE MONOOXYGENASE HYDROXYLASE, FORM I PRESSURIZED WITH XENON GAS 1FZ8 ; 2.10 ; METHANE MONOOXYGENASE HYDROXYLASE, FORM II COCRYSTALLIZED WITH DIBROMOMETHANE 1FZ9 ; 2.30 ; METHANE MONOOXYGENASE HYDROXYLASE, FORM II COCRYSTALLIZED WITH IODOETHANE 1FZ5 ; 2.40 ; METHANE MONOOXYGENASE HYDROXYLASE, FORM II CRYSTALLIZED ANAEROBICALLY FROM REDUCED ENZYME 1FZ2 ; 2.15 ; METHANE MONOOXYGENASE HYDROXYLASE, FORM II MIXED-VALENT GENERATED BY CRYSTAL SOAKING 1FZ0 ; 2.07 ; METHANE MONOOXYGENASE HYDROXYLASE, FORM II MIXED-VALENT GROWN ANAEROBICALLY 1FZH ; 2.60 ; METHANE MONOOXYGENASE HYDROXYLASE, FORM II PRESSURIZED WITH XENON GAS 1FYZ ; 2.15 ; METHANE MONOOXYGENASE HYDROXYLASE, FORM II REDUCED BY SOAKING 1FZ6 ; 2.05 ; METHANE MONOOXYGENASE HYDROXYLASE, FORM II SOAKED IN 1 M METHANOL 1FZ1 ; 1.96 ; METHANE MONOOXYGENASE HYDROXYLASE, FORM III OXIDIZED 1FZ3 ; 2.03 ; METHANE MONOOXYGENASE HYDROXYLASE, FORM III SOAK AT PH 6.2 (0.1 M PIPES) 1FZ4 ; 2.38 ; METHANE MONOOXYGENASE HYDROXYLASE, FORM III SOAKED AT PH 8.5 (0.1 M TRIS) 1FZ7 ; 1.96 ; METHANE MONOOXYGENASE HYDROXYLASE, FORM III SOAKED IN 0.9 M ETHANOL 1G8S ; 1.60 ; METHANOCOCCUS JANNASCHII FIBRILLARIN PRE-RRNA PROCESSING PROTEIN 4AAH ; 2.40 ; METHANOL DEHYDROGENASE FROM METHYLOPHILUS W3A1 1O90 ; 3.10 ; METHIONINE ADENOSYLTRANSFERASE COMPLEXED WITH A L-METHIONINE ANALOGOUS 1QM4 ; 2.66 ; METHIONINE ADENOSYLTRANSFERASE COMPLEXED WITH A L-METHIONINE ANALOGOUS 1O92 ; 3.19 ; METHIONINE ADENOSYLTRANSFERASE COMPLEXED WITH ADP AND A L-METHIONINE ANALOGOUS 1O93 ; 3.49 ; METHIONINE ADENOSYLTRANSFERASE COMPLEXED WITH ATP AND A L-METHIONINE ANALOGOUS 1O9T ; 2.90 ; METHIONINE ADENOSYLTRANSFERASE COMPLEXED WITH BOTH SUBSTRATES ATP AND METHIONINE 1XGM ; 2.80 ; METHIONINE AMINOPEPTIDASE FROM HYPERTHERMOPHILE PYROCOCCUS FURIOSUS 1XGN ; 2.90 ; METHIONINE AMINOPEPTIDASE FROM HYPERTHERMOPHILE PYROCOCCUS FURIOSUS 1XGO ; 3.50 ; METHIONINE AMINOPEPTIDASE FROM HYPERTHERMOPHILE PYROCOCCUS FURIOSUS 1XGS ; 1.75 ; METHIONINE AMINOPEPTIDASE FROM HYPERTHERMOPHILE PYROCOCCUS FURIOSUS 1MJM ; 2.20 ; METHIONINE APOREPRESSOR MUTANT (Q44K) COMPLEXED TO HALF OF THE CONSENSUS OPERATOR SEQUENCE 1MJP ; 3.40 ; METHIONINE APOREPRESSOR MUTANT (Q44K) COMPLEXED TO THE MINIMAL MET CONSENSUS OPERATOR 1CUP ; 1.89 ; METHIONINE CORE MUTANT OF T4 LYSOZYME 1KS3 ; 2.16 ; METHIONINE CORE MUTANT OF T4 LYSOZYME 1KW5 ; 1.75 ; METHIONINE CORE MUTANT OF T4 LYSOZYME 1KW7 ; 1.89 ; METHIONINE CORE MUTANT OF T4 LYSOZYME 1KY0 ; 1.97 ; METHIONINE CORE MUTANT OF T4 LYSOZYME 1KY1 ; 2.05 ; METHIONINE CORE MUTANT OF T4 LYSOZYME 1L0J ; 1.98 ; METHIONINE CORE MUTANT OF T4 LYSOZYME 1L0K ; 2.02 ; METHIONINE CORE MUTANT OF T4 LYSOZYME 1D3M ; 2.12 ; METHIONINE CORE MUTATION 1D3N ; 2.00 ; METHIONINE CORE MUTATION 1E5F ; 2.18 ; METHIONINE GAMMA-LYASE (MGL) FROM TRICHOMONAS VAGINALIS 1E5E ; 2.18 ; METHIONINE GAMMA-LYASE (MGL) FROM TRICHOMONAS VAGINALIS IN COMPLEX WITH PROPARGYLGLYCINE 1MJO ; 2.10 ; METHIONINE HOLOREPRESSOR MUTANT (Q44K) PLUS COREPRESSOR (S-ADENOSYL METHIONINE) COMPLEXED TO THE MINIMAL MET CONSENSUS OPERATOR WITH THE CENTRAL TA STEP MUTATED TO AT 1MJL ; 2.10 ; METHIONINE REPRESSOR MUTANT (Q44K) COMPLEX WITH THE COREPRESSOR SAM (S-ADENOSYL METHIONINE) FROM ESCHERICHIA COLI 1MJ2 ; 2.40 ; METHIONINE REPRESSOR MUTANT (Q44K) PLUS COREPRESSOR (S-ADENOSYL METHIONINE) COMPLEXED TO A CONSENSUS OPERATOR SEQUENCE 1MJQ ; 2.40 ; METHIONINE REPRESSOR MUTANT (Q44K) PLUS COREPRESSOR (S-ADENOSYL METHIONINE) COMPLEXED TO AN ALTERED MET CONSENSUS OPERATOR SEQUENCE 1MJK ; 2.15 ; METHIONINE REPRESSOR MUTANT APOREPRESSOR (Q44K) FROM ESCHERICHIA COLI 1MSK ; 1.80 ; METHIONINE SYNTHASE (ACTIVATION DOMAIN) 1ZGH ; 2.05 ; METHIONYL-TRNA FORMYLTRANSFERASE FROM CLOSTRIDIUM THERMOCELLUM 1QQT ; 2.03 ; METHIONYL-TRNA SYNTHETASE FROM ESCHERICHIA COLI 1PFV ; 1.70 ; METHIONYL-TRNA SYNTHETASE FROM ESCHERICHIA COLI COMPLEXED WITH DIFLUOROMETHIONINE 1PG2 ; 1.75 ; METHIONYL-TRNA SYNTHETASE FROM ESCHERICHIA COLI COMPLEXED WITH METHIONINE AND ADENOSINE 1PFU ; 1.91 ; METHIONYL-TRNA SYNTHETASE FROM ESCHERICHIA COLI COMPLEXED WITH METHIONINE PHOSPHINATE 1P7P ; 1.80 ; METHIONYL-TRNA SYNTHETASE FROM ESCHERICHIA COLI COMPLEXED WITH METHIONINE PHOSPHONATE 1PG0 ; 1.90 ; METHIONYL-TRNA SYNTHETASE FROM ESCHERICHIA COLI COMPLEXED WITH METHIONINYL ADENYLATE 1PFY ; 1.93 ; METHIONYL-TRNA SYNTHETASE FROM ESCHERICHIA COLI COMPLEXED WITH METHIONYL SULPHAMOYL ADENOSINE 1PFW ; 1.78 ; METHIONYL-TRNA SYNTHETASE FROM ESCHERICHIA COLI COMPLEXED WITH TRIFLUOROMETHIONINE 1RQG ; 2.90 ; METHIONYL-TRNA SYNTHETASE FROM PYROCOCCUS ABYSSI 1A8H ; 2.00 ; METHIONYL-TRNA SYNTHETASE FROM THERMUS THERMOPHILUS 2FMT ; 2.80 ; METHIONYL-TRNAFMET FORMYLTRANSFERASE COMPLEXED WITH FORMYL-METHIONYL-TRNAFMET 1FMT ; 2.00 ; METHIONYL-TRNAFMET FORMYLTRANSFERASE FROM ESCHERICHIA COLI 1HBN ; 1.16 ; METHYL-COENZYME M REDUCTASE 1MRO ; 1.16 ; METHYL-COENZYME M REDUCTASE 1HBM ; 1.80 ; METHYL-COENZYME M REDUCTASE ENZYME PRODUCT COMPLEX 1E6V ; 2.70 ; METHYL-COENZYME M REDUCTASE FROM METHANOPYRUS KANDLERI 1E6Y ; 1.60 ; METHYL-COENZYME M REDUCTASE FROM METHANOSARCINA BARKERI 1HBU ; 1.90 ; METHYL-COENZYME M REDUCTASE IN THE MCR-RED1-SILENT STATE IN COMPLEX WITH COENZYME M 1HBO ; 1.78 ; METHYL-COENZYME M REDUCTASE MCR-RED1-SILENT 1WPK ; -1.00 ; METHYLATED FORM OF N-TERMINAL TRANSCRIPTIONAL REGULATOR DOMAIN OF ESCHERICHIA COLI ADA PROTEIN 1EH7 ; 2.00 ; METHYLATED HUMAN O6-ALKYLGUANINE-DEOXYRIBONUCLEIC ACID ALKYLTRANSFERASE 1Y9H ; -1.00 ; METHYLATION OF CYTOSINE AT C5 IN A CPG SEQUENCE CONTEXT CAUSES A CONFORMATIONAL SWITCH OF A BENZO[A]PYRENE DIOL EPOXIDE-N2-GUANINE ADDUCT IN DEOXYRIBONUCLEIC ACID FROM A MINOR GROOVE ALIGNMENT TO INTERCALATION WITH BASE DISPLACEMENT 1B93 ; 1.90 ; METHYLGLYOXAL SYNTHASE FROM ESCHERICHIA COLI 1REQ ; 2.00 ; METHYLMALONYL-COA MUTASE 1E1C ; 2.62 ; METHYLMALONYL-COA MUTASE H244A MUTANT 4REQ ; 2.20 ; METHYLMALONYL-COA MUTASE SUBSTRATE COMPLEX 7REQ ; 2.20 ; METHYLMALONYL-COA MUTASE, 2-CARBOXYPROPYL-COA INHIBITOR COMPLEX 6REQ ; 2.20 ; METHYLMALONYL-COA MUTASE, 3-CARBOXYPROPYL-COA INHIBITOR COMPLEX 2REQ ; 2.50 ; METHYLMALONYL-COA MUTASE, NON-PRODUCTIVE COA COMPLEX, IN OPEN CONFORMATION REPRESENTING SUBSTRATE-FREE STATE 3REQ ; 2.70 ; METHYLMALONYL-COA MUTASE, SUBSTRATE-FREE STATE (POOR QUALITY STRUCTURE) 5REQ ; 2.20 ; METHYLMALONYL-COA MUTASE, Y89F MUTANT, SUBSTRATE COMPLEX 1H4I ; 1.94 ; METHYLOBACTERIUM EXTORQUENS METHANOL DEHYDROGENASE 1H4J ; 3.00 ; METHYLOBACTERIUM EXTORQUENS METHANOL DEHYDROGENASE D303E MUTANT 1VXO ; 2.40 ; METHYLPHOSPHONYLATED ACETYLCHOLINESTERASE (AGED) OBTAINED BY REACTION WITH O-ETHYL-S-[2-[BIS(1-METHYLETHYL) AMINO]ETHYL] METHYLPHOSPHONOTHIOATE (VX) 1CFJ ; 2.60 ; METHYLPHOSPHONYLATED ACETYLCHOLINESTERASE (AGED) OBTAINED BY REACTION WITH O-ISOPROPYLMETHYLPHOSPHONOFLUORIDATE (GB, SARIN) 1D2C ; 2.50 ; METHYLTRANSFERASE 1XVA ; 2.20 ; METHYLTRANSFERASE 1QOK ; 2.40 ; MFE-23 AN ANTI-CARCINOEMBRYONIC ANTIGEN SINGLE-CHAIN FV ANTIBODY 2BHD ; 2.50 ; MG SUBSTITUTED E. COLI AMINOPEPTIDASE P IN COMPLEX WITH PRODUCT 1L8P ; 2.10 ; MG-PHOSPHONOACETOHYDROXAMATE COMPLEX OF S39A YEAST ENOLASE 1 1WL6 ; 2.00 ; MG-SUBSTITUTED FORM OF E. COLI AMINOPEPTIDASE P 1G20 ; 2.20 ; MGATP-BOUND AND NUCLEOTIDE-FREE STRUCTURES OF A NITROGENASE PROTEIN COMPLEX BETWEEN LEU127DEL-FE PROTEIN AND THE MOFE PROTEIN 1G21 ; 3.00 ; MGATP-BOUND AND NUCLEOTIDE-FREE STRUCTURES OF A NITROGENASE PROTEIN COMPLEX BETWEEN LEU127DEL-FE PROTEIN AND THE MOFE PROTEIN 1MJS ; 1.91 ; MH2 DOMAIN OF TRANSCRIPTIONAL FACTOR SMAD3 1CE6 ; 2.90 ; MHC CLASS I H-2DB COMPLEXED WITH A SENDAI VIRUS NUCLEOPROTEIN PEPTIDE 1QLF ; 2.65 ; MHC CLASS I H-2DB COMPLEXED WITH GLYCOPEPTIDE K3G 1DDH ; 3.10 ; MHC CLASS I H-2DD HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND AN IMMUNODOMINANT PEPTIDE P18-I10 FROM THE HUMAN IMMUNODEFICIENCY VIRUS ENVELOPE GLYCOPROTEIN 120 1OSZ ; 2.10 ; MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND AN (L4V) MUTANT OF THE VESICULAR STOMATITIS VIRUS NUCLEOPROTEIN 1VAC ; 2.50 ; MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND CHICKEN OVALBUMIN 1RK0 ; 2.61 ; MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND HERPES SIMPLEX VIRUS GLYCOPROTEIN B PEPTIDE 2VAB ; 2.50 ; MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND SENDAI VIRUS NUCLEOPROTEIN 2VAA ; 2.30 ; MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND VESICULAR STOMATITIS VIRUS NUCLEOPROTEIN 1VAD ; 2.50 ; MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND YEAST ALPHA-GLUCOSIDASE 1KJ3 ; 2.30 ; MHC CLASS I H-2KB MOLECULE COMPLEXED WITH PKB1 PEPTIDE 1KBG ; 2.20 ; MHC CLASS I H-2KB PRESENTED GLYCOPEPTIDE RGY8-6H-GAL2 1A1N ; 2.00 ; MHC CLASS I MOLECULE B3501 COMPLEXED WITH PEPTIDE VPLRPMTY FROM THE NEF PROTEIN (75-82) OF HIV1 1A1O ; 2.30 ; MHC CLASS I MOLECULE B5301 COMPLEXED WITH PEPTIDE LS6 (KPIVQYDNF) FROM THE MALARIA PARASITE P. FALCIPARUM 1A1M ; 2.30 ; MHC CLASS I MOLECULE B5301 COMPLEXED WITH PEPTIDE TYPDINQML FROM GAG PROTEIN OF HIV2 1RK1 ; 2.10 ; MHC CLASS I NATURAL H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND HERPES SIMPLEX VIRUS MUTANT GLYCOPROTEIN B PEPTIDE 1FZK ; 1.70 ; MHC CLASS I NATURAL MUTANT H-2KBM1 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND SENDAI VIRUS NUCLEOPROTEIN 1FZJ ; 1.90 ; MHC CLASS I NATURAL MUTANT H-2KBM1 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND VESICULAR STOMATITIS VIRUS NUCLEOPROTEIN 1RJY ; 1.90 ; MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND HERPES SIMPLEX VIRUS GLYCOPROTEIN B PEPTIDE 1RJZ ; 2.60 ; MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND HERPIES SIMPLEX VIRUS MUTANT GLYCOPROTEIN B PEPTIDE 1FZO ; 1.80 ; MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND SENDAI VIRUS NUCLEOPROTEIN 1FZM ; 1.80 ; MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND VESICULAR STOMATITIS VIRUS NUCLEOPROTEIN 1IIE ; -1.00 ; MHC CLASS II-ASSOCIATED INVARIANT CHAIN (II) HUMAN ECTOPLASMIC TRIMERIZATION DOMAIN 1NXT ; 2.34 ; MICAREC PH 4.0 1NXV ; 2.00 ; MICAREC PH 4.2 1NXW ; 1.92 ; MICAREC PH 5.1 1NXX ; 1.90 ; MICAREC PH 5.5 1NXP ; 1.82 ; MICAREC PH4.5 1NXS ; 1.92 ; MICAREC PH4.9 1NXO ; 1.85 ; MICAREC PH7.0 1D3C ; 1.78 ; MICHAELIS COMPLEX OF BACILLUS CIRCULANS STRAIN 251 CYCLODEXTRIN GLYCOSYLTRANSFERASE WITH GAMMA-CYCLODEXTRIN 1C81 ; 2.50 ; MICHAELIS COMPLEX OF FRUCTOSE-2,6-BISPHOSPHATASE 1IKG ; 1.90 ; MICHAELIS COMPLEX OF STREPTOMYCES R61 DD-PEPTIDASE WITH A SPECIFIC PEPTIDOGLYCAN SUBSTRATE FRAGMENT 2MLP ; -1.00 ; MICROCIN LEADER PEPTIDE FROM E. COLI, NMR, 25 STRUCTURES 1LCM ; -1.00 ; MICROCYSTIN-LR, NMR, MINIMIZED AVERAGE STRUCTURE 1N6B ; 2.30 ; MICROSOMAL CYTOCHROME P450 2C5/3LVDH COMPLEX WITH A DIMETHYL DERIVATIVE OF SULFAPHENAZOLE 1NR6 ; 2.10 ; MICROSOMAL CYTOCHROME P450 2C5/3LVDH COMPLEX WITH DICLOFENAC 1Z9H ; 2.60 ; MICROSOMAL PROSTAGLANDIN E SYNTHASE TYPE-2 1HK7 ; 2.50 ; MIDDLE DOMAIN OF HSP90 1HU3 ; 2.37 ; MIDDLE DOMAIN OF HUMAN EIF4GII 1MR8 ; 1.90 ; MIGRATION INHIBITORY FACTOR-RELATED PROTEIN 8 FROM HUMAN 1HYQ ; 2.60 ; MIND BACTERIAL CELL DIVISION REGULATOR FROM A. FULGIDUS 2AAX ; 1.75 ; MINERALOCORTICOID RECEPTOR DOUBLE MUTANT WITH BOUND CORTISONE 2AB2 ; 1.85 ; MINERALOCORTICOID RECEPTOR DOUBLE MUTANT WITH BOUND SPIRONOLACTONE 2AA6 ; 1.95 ; MINERALOCORTICOID RECEPTOR S810L MUTANT WITH BOUND PROGESTERONE 2AA2 ; 1.95 ; MINERALOCORTICOID RECEPTOR WITH BOUND ALDOSTERONE 2AA7 ; 2.20 ; MINERALOCORTICOID RECEPTOR WITH BOUND DEOXYCORTICOSTERONE 2AA5 ; 2.20 ; MINERALOCORTICOID RECEPTOR WITH BOUND PROGESTERONE 1SJU ; -1.00 ; MINI-PROINSULIN, SINGLE CHAIN INSULIN ANALOG MUTANT: DES B30, HIS(B 10)ASP, PRO(B 28)ASP AND PEPTIDE BOND BETWEEN LYS B 29 AND GLY A 1, NMR, 20 STRUCTURES 1SJT ; -1.00 ; MINI-PROINSULIN, TWO CHAIN INSULIN ANALOG MUTANT: DES B30, HIS(B 10)ASP, PRO(B 28)ASP, NMR, 20 STRUCTURES 1G2G ; -1.00 ; MINIMAL CONFORMATION OF THE ALPHA-CONOTOXIN IMI FOR THE ALPHA7 NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR RECOGNITION 1K18 ; -1.00 ; MINIMIZED AVERAGE NMR STRUCTURE OF THE ZINC FINGER DOMAIN OF HUMAN DEOXYRIBONUCLEIC ACID POLYMERASE-ALPHA 1KX2 ; -1.00 ; MINIMIZED AVERAGE STRUCTURE OF A MONO-HEME FERROCYTOCHROME C FROM SHEWANELLA PUTREFACIENS 1J56 ; -1.00 ; MINIMIZED AVERAGE STRUCTURE OF BERYLLOFLUORIDE-ACTIVATED NTRC RECEIVER DOMAIN: MODEL STRUCTURE INCORPORATING ACTIVE SITE CONTACTS 1JY9 ; -1.00 ; MINIMIZED AVERAGE STRUCTURE OF DP-TT2 1IQS ; -1.00 ; MINIMIZED AVERAGE STRUCTURE OF MTH1880 FROM METHANOBACTERIUM THERMOAUTOTROPHICUM 1J4M ; -1.00 ; MINIMIZED AVERAGE STRUCTURE OF THE 14-RESIDUE PEPTIDE RG- KWTY-NG-ITYE-GR (MBH12) 1L2M ; -1.00 ; MINIMIZED AVERAGE STRUCTURE OF THE N-TERMINAL, DEOXYRIBONUCLEIC ACID-BINDING DOMAIN OF THE REPLICATION INITIATION PROTEIN FROM A GEMINIVIRUS (TOMATO YELLOW LEAF CURL VIRUS-SARDINIA) 1JXC ; -1.00 ; MINIMIZED NMR STRUCTURE OF ATT, AN ARABIDOPSIS TRYPSIN/CHYMOTRYPSIN INHIBITOR 1JFK ; -1.00 ; MINIMUM ENERGY REPRESENTATIVE STRUCTURE OF A CALCIUM BOUND EF-HAND PROTEIN FROM ENTAMOEBA HISTOLYTICA 1HY2 ; 2.00 ; MINIPROTEIN MP-1 COMPLEX WITH STREPTAVIDIN 1HQQ ; 1.70 ; MINIPROTEIN MP-2 (M9A) COMPLEX WITH STREPTAVIDIN 1HXL ; 1.80 ; MINIPROTEIN MP-2 (V10A) COMPLEX WITH STREPTAVIDIN 1HXZ ; 1.80 ; MINIPROTEIN MP-2 COMPLEX WITH STREPTAVIDIN 1BPS ; -1.00 ; MINOR CONFORMER OF A BENZO[A]PYRENE DIOL EPOXIDE ADDUCT OF DA IN DUPLEX DEOXYRIBONUCLEIC ACID 1T6D ; 2.15 ; MIRAS PHASING OF THE AQUIFEX AEOLICUS PPX/GPPA PHOSPHATASE: CRYSTAL STRUCTURE OF THE TYPE II VARIANT 1NGN ; 2.10 ; MISMATCH REPAIR IN METHYLATED DEOXYRIBONUCLEIC ACID. STRUCTURE OF THE MISMATCH-SPECIFIC THYMINE GLYCOSYLASE DOMAIN OF METHYL-CPG- BINDING PROTEIN MBD4 1XCI ; -1.00 ; MISPAIR ALIGNED N3T-BUTYL-N3T INTERSTRAND CROSSLINK 1U6O ; -1.00 ; MISPAIRING OF A SITE-SPECIFIC MAJOR GROOVE (2S,3S)-N6-(2,3, 4-TRIHYDROXYBUTYL)-2-DEOXYADENOSYL DEOXYRIBONUCLEIC ACID ADDUCT OF BUTADIENE DIOL EPOXIDE WITH DEOXYGUANOSINE: FORMATION OF A DA(ANTI) DG(ANTI) PAIRING INTERACTION 1CE7 ; 2.70 ; MISTLETOE LECTIN I FROM VISCUM ALBUM 1ONK ; 2.10 ; MISTLETOE LECTIN I FROM VISCUM ALBUM 2MLL ; 2.70 ; MISTLETOE LECTIN I FROM VISCUM ALBUM 1OQL ; 3.00 ; MISTLETOE LECTIN I FROM VISCUM ALBUM COMPLEXED WITH GALACTOSE 1M2T ; 1.89 ; MISTLETOE LECTIN I FROM VISCUM ALBUM IN COMPLEX WITH ADENINE MONOPHOSPHATE. CRYSTAL STRUCTURE AT 1.9 A RESOLUTION 1SZ6 ; 2.05 ; MISTLETOE LECTIN I FROM VISCUM ALBUM. CRYSTAL STRUCTURE AT 2.05 A RESOLUTION 1PUM ; 2.30 ; MISTLETOE LECTIN I IN COMPLEX WITH GALACTOSE 1PUU ; 2.30 ; MISTLETOE LECTIN I IN COMPLEX WITH LACTOSE 1N9G ; 1.98 ; MITOCHONDRIAL 2-ENOYL THIOESTER REDUCTASE ETR1P/ETR2P HETERODIMER FROM CANDIDA TROPICALIS 1CRK ; 3.00 ; MITOCHONDRIAL CREATINE KINASE 1VAR ; 2.50 ; MITOCHONDRIAL MANGANESE SUPEROXIDE DISMUTASE VARIANT WITH ILE 58 REPLACED BY THR 1T3J ; 2.50 ; MITOFUSIN DOMAIN HR2 V686M/I708M MUTANT 1YUX ; 1.60 ; MIXED VALANT STATE OF NIGERYTHRIN 2AEU ; 1.70 ; MJ0158, APO FORM 2AEV ; 2.00 ; MJ0158, NABH4-REDUCED FORM 1DUS ; 1.80 ; MJ0882-A HYPOTHETICAL PROTEIN FROM M. JANNASCHII 1UEA ; 2.80 ; MMP-3/TIMP-1 COMPLEX 1A85 ; 2.00 ; MMP8 WITH MALONIC AND ASPARAGINE BASED INHIBITOR 1A86 ; 2.00 ; MMP8 WITH MALONIC AND ASPARTIC ACID BASED INHIBITOR 1GKD ; 2.10 ; MMP9 ACTIVE SITE MUTANT-INHIBITOR COMPLEX 1GKC ; 2.30 ; MMP9-INHIBITOR COMPLEX 1JAT ; 1.60 ; MMS2/UBC13 UBIQUITIN CONJUGATING ENZYME COMPLEX 2BN7 ; 2.40 ; MN SUBSTITUTED E. COLI AMINOPEPTIDASE P IN COMPLEX WITH PRODUCT AND ZN 1JQC ; 1.61 ; MN SUBSTITUTED RIBONUCLEOTIDE REDUCTASE R2 FROM E. COLI OXIDIZED BY HYDROGEN PEROXIDE AND HYDROXYLAMINE 1JPR ; 1.88 ; MN SUBSTITUTED RIBONUCLEOTIDE REDUCTASE R2 FROM E. COLI OXIDIZED BY NITRIC OXIDE 1EKR ; 2.00 ; MOAC PROTEIN FROM E. COLI 1B92 ; 2.02 ; MOBILITY OF AN HIV-1 INTEGRASE ACTIVE SITE LOOP IS CORRELATED WITH CATALYTIC ACTIVITY 1B9D ; 1.70 ; MOBILITY OF AN HIV-1 INTEGRASE ACTIVE SITE LOOP IS CORRELATED WITH CATALYTIC ACTIVITY 1B9F ; 1.70 ; MOBILITY OF AN HIV-1 INTEGRASE ACTIVE SITE LOOP IS CORRELATED WITH CATALYTIC ACTIVITY 1N03 ; 20.00 ; MODEL FOR ACTIVE RECA FILAMENT 1OLN ; -1.00 ; MODEL FOR THIOSTREPTON ANTIBIOTIC BINDING TO L11 SUBSTRATE FROM 50S RIBOSOMAL RIBONUCLEIC ACID 1IGA ; -1.00 ; MODEL OF HUMAN IGA1 DETERMINED BY SOLUTION SCATTERING CURVE-FITTING AND HOMOLOGY MODELLING 1R70 ; -1.00 ; MODEL OF HUMAN IGA2 DETERMINED BY SOLUTION SCATTERING, CURVE FITTING AND HOMOLOGY MODELLING 1MHC ; 2.10 ; MODEL OF MHC CLASS I H2-M3 WITH NONAPEPTIDE FROM RAT ND1 REFINED AT 2.3 ANGSTROMS RESOLUTION 1NTL ; -1.00 ; MODEL OF MOUSE CRRY-IG DETERMINED BY SOLUTION SCATTERING, CURVE FITTING AND HOMOLOGY MODELLING 1MHS ; 8.00 ; MODEL OF NEUROSPORA CRASSA PROTON ATPASE 1NTJ ; -1.00 ; MODEL OF RAT CRRY DETERMINED BY SOLUTION SCATTERING, CURVE FITTING AND HOMOLOGY MODELLING 1EKY ; -1.00 ; MODEL STRUCTURE FROM NON-NOE BASED NMR STRUCTURE CALCULATION 1K2A ; 1.00 ; MODIFIED FORM OF EOSINOPHIL-DERIVED NEUROTOXIN 1GTI ; 3.00 ; MODIFIED GLUTATHIONE S-TRANSFERASE (PI) COMPLEXED WITH S (P-NITROBENZYL)GLUTATHIONE 1JZP ; -1.00 ; MODIFIED PEPTIDE A (D18-A1) OF THE RABBIT SKELETAL DIHYDROPYRIDINE RECEPTOR 1DE0 ; 2.40 ; MODULATING THE MIDPOINT POTENTIAL OF THE [4FE-4S] CLUSTER OF THE NITROGENASE FE PROTEIN 1PZ7 ; 1.42 ; MODULATION OF AGRIN FUNCTION BY ALTERNATIVE SPLICING AND CA2+ BINDING 1PZ8 ; 2.35 ; MODULATION OF AGRIN FUNCTION BY ALTERNATIVE SPLICING AND CA2+ BINDING 1PZ9 ; 2.80 ; MODULATION OF AGRIN FUNCTION BY ALTERNATIVE SPLICING AND CA2+ BINDING 1CH4 ; 2.50 ; MODULE-SUBSTITUTED CHIMERA HEMOGLOBIN BETA-ALPHA (F133V) 1G8R ; 2.65 ; MOEA 1SGH ; 3.50 ; MOESIN FERM DOMAIN BOUND TO EBP50 C-TERMINAL PEPTIDE 1J8L ; 1.60 ; MOLECULAR AND CRYSTAL STRUCTURE OF D(CGCAAATTMO4CGCG): THE WATSON-CRICK TYPE N4-METHOXYCYTIDINE/ADENOSINE BASE PAIR IN B-DEOXYRIBONUCLEIC ACID 1G75 ; 1.57 ; MOLECULAR AND CRYSTAL STRUCTURE OF D(CGCGAATF5UCGCG): 5- FORMYLURIDINE/ ADENOSINE BASE-PAIRS IN B-DEOXYRIBONUCLEIC ACID 1G8N ; 1.55 ; MOLECULAR AND CRYSTAL STRUCTURE OF D(CGCGAATF5UCGCG):5- FORMYLURIDINE/ ADENOSINE BASE-PAIRS IN B-DEOXYRIBONUCLEIC ACID 1G8U ; 1.85 ; MOLECULAR AND CRYSTAL STRUCTURE OF D(CGCGAATF5UCGCG):5- FORMYLURIDINE/ ADENOSINE BASE-PAIRS IN B-DEOXYRIBONUCLEIC ACID 1G8V ; 1.80 ; MOLECULAR AND CRYSTAL STRUCTURE OF D(CGCGAATF5UCGCG):5- FORMYLURIDINE/ ADENOSINE BASE-PAIRS IN B-DEOXYRIBONUCLEIC ACID 1I3T ; 1.60 ; MOLECULAR AND CRYSTAL STRUCTURE OF D(CGCGAATT(MO4)CGCG): THE WATSON-CRICK TYPE AND WOBBLE N4- METHOXYCYTIDINE/GUANOSINE BASE PAIRS IN B-DEOXYRIBONUCLEIC ACID 1I47 ; 2.10 ; MOLECULAR AND CRYSTAL STRUCTURE OF D(CGCGAATT(MO4)CGCG): THE WATSON-CRICK TYPE AND WOBBLE N4- METHOXYCYTIDINE/GUANOSINE BASE PAIRS IN B-DEOXYRIBONUCLEIC ACID 456D ; 1.60 ; MOLECULAR AND CRYSTAL STRUCTURE OF D(CGCGMO6AATCCGCG): THE WATSON-CRICK TYPE N6-METHOXYADENOSINE/CYTIDINE BASE-PAIRS IN B-DEOXYRIBONUCLEIC ACID 1EDR ; 1.60 ; MOLECULAR AND CRYSTAL STRUCTURE OF D(CGCGMO6AATTCGCG) AT 1.6 ANGSTROM 457D ; 2.00 ; MOLECULAR AND CRYSTAL STRUCTURE OF D(CGCGMO6AATTCGCG): N6- METHOXYADENOSINE/ THYMIDINE BASE-PAIRS IN B-DEOXYRIBONUCLEIC ACID 1YJ5 ; 2.80 ; MOLECULAR ARCHITECTURE OF MAMMALIAN POLYNUCLEOTIDE KINASE, A DEOXYRIBONUCLEIC ACID REPAIR ENZYME 1QO1 ; 3.90 ; MOLECULAR ARCHITECTURE OF THE ROTARY MOTOR IN ATP SYNTHASE FROM YEAST MITOCHONDRIA 2BFI ; 1.10 ; MOLECULAR BASIS FOR AMYLOID FIBRIL FORMATION AND STABILITY 1FLK ; 2.80 ; MOLECULAR BASIS FOR CD40 SIGNALING MEDIATED BY TRAF3 1FLL ; 3.50 ; MOLECULAR BASIS FOR CD40 SIGNALING MEDIATED BY TRAF3 1I3K ; 1.50 ; MOLECULAR BASIS FOR SEVERE EPIMERASE-DEFICIENCY GALACTOSEMIA: X-RAY STRUCTURE OF THE HUMAN V94M- SUBSTITUTED UDP-GALACTOSE 4-EPIMERASE 1I3L ; 1.50 ; MOLECULAR BASIS FOR SEVERE EPIMERASE-DEFICIENCY GALACTOSEMIA: X-RAY STRUCTURE OF THE HUMAN V94M- SUBSTITUTED UDP-GALACTOSE 4-EPIMERASE 1I3M ; 1.50 ; MOLECULAR BASIS FOR SEVERE EPIMERASE-DEFICIENCY GALACTOSEMIA: X-RAY STRUCTURE OF THE HUMAN V94M- SUBSTITUTED UDP-GALACTOSE 4-EPIMERASE 1I3N ; 1.50 ; MOLECULAR BASIS FOR SEVERE EPIMERASE-DEFICIENCY GALACTOSEMIA: X-RAY STRUCTURE OF THE HUMAN V94M- SUBSTITUTED UDP-GALACTOSE 4-EPIMERASE 1L8L ; 2.51 ; MOLECULAR BASIS FOR THE LOCAL CONFOMATIONAL REARRANGEMENT OF HUMAN PHOSPHOSERINE PHOSPHATASE 1L8O ; 2.80 ; MOLECULAR BASIS FOR THE LOCAL CONFORMATIONAL REARRANGEMENT OF HUMAN PHOSPHOSERINE PHOSPHATASE 2C1J ; 2.60 ; MOLECULAR BASIS FOR THE RECOGNITION OF PHOSPHORYLATED AND PHOSPHOACETYLATED HISTONE H3 BY 14-3-3 2C1N ; 2.00 ; MOLECULAR BASIS FOR THE RECOGNITION OF PHOSPHORYLATED AND PHOSPHOACETYLATED HISTONE H3 BY 14-3-3 1RLG ; 2.70 ; MOLECULAR BASIS OF BOX C/D RIBONUCLEIC ACID-PROTEIN INTERACTION: CO- CRYSTAL STRUCTURE OF THE ARCHAEAL SRNP INTIATION COMPLEX 2DBL ; 2.90 ; MOLECULAR BASIS OF CROSS-REACTIVITY AND THE LIMITS OF ANTIBODY-ANTIGEN COMPLEMENTARITY 1KLL ; 1.50 ; MOLECULAR BASIS OF MITOMYCIN C RESICTANCE IN STREPTOMYCES: CRYSTAL STRUCTURES OF THE MRD PROTEIN WITH AND WITHOUT A DRUG DERIVATIVE 1KMZ ; 1.50 ; MOLECULAR BASIS OF MITOMYCIN C RESICTANCE IN STREPTOMYCES: CRYSTAL STRUCTURES OF THE MRD PROTEIN WITH AND WITHOUT A DRUG DERIVATIVE 1H2S ; 1.93 ; MOLECULAR BASIS OF TRANSMENBRANE SIGNALLING BY SENSORY RHODOPSIN II-TRANSDUCER COMPLEX 1YIQ ; 2.20 ; MOLECULAR CLONING AND STRUCTURAL ANALYSIS OF QUINOHEMOPROTEIN ALCOHOL DEHYDROGENASE ADHIIG FROM PSEUDOMONAS PUTIDA HK5. COMPARIISON TO THE OTHER QUINOHEMOPROTEIN ALCOHOL DEHYDROGENASE ADHIIB FOUND IN THE SAME MICROORGANISM. 1D6G ; -1.00 ; MOLECULAR COMPLEX OF CHOLECYSTOKININ-8 AND N-TERMINUS OF THE CHOLECYSTOKININ A RECEPTOR BY NMR SPECTROSCOPY 1CL3 ; -1.00 ; MOLECULAR INSIGHTS INTO PEBP2/CBF-SMMHC ASSOCIATED ACUTE LEUKEMIA REVEALED FROM THE THREE-DIMENSIONAL STRUCTURE OF PEBP2/CBF BETA 1GZ3 ; 2.30 ; MOLECULAR MECHANISM FOR THE REGULATION OF HUMAN MITOCHONDRIAL NAD(P)+-DEPENDENT MALIC ENZYME BY ATP AND FUMARATE 1GZK ; 2.30 ; MOLECULAR MECHANISM FOR THE REGULATION OF PROTEIN KINASE B/ AKT BY HYDROPHOBIC MOTIF PHOSPHORYLATION 1UWE ; 2.67 ; MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9 1UWG ; 2.79 ; MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9 1GZ4 ; 2.20 ; MOLECULAR MECHANISM OF THE REGULATION OF HUMAN MITOCHONDRIAL NAD(P)+-DEPENDENT MALIC ENZYME BY ATP AND FUMARATE 1M8Q ; 70.00 ; MOLECULAR MODELS OF AVERAGED RIGOR CROSSBRIDGES FROM TOMOGRAMS OF INSECT FLIGHT MUSCLE 1MVW ; 70.00 ; MOLECULAR MODELS OF AVERAGED RIGOR CROSSBRIDGES FROM TOMOGRAMS OF INSECT FLIGHT MUSCLE 1O18 ; 70.00 ; MOLECULAR MODELS OF AVERAGED RIGOR CROSSBRIDGES FROM TOMOGRAMS OF INSECT FLIGHT MUSCLE 1O19 ; 70.00 ; MOLECULAR MODELS OF AVERAGED RIGOR CROSSBRIDGES FROM TOMOGRAMS OF INSECT FLIGHT MUSCLE 1O1A ; 70.00 ; MOLECULAR MODELS OF AVERAGED RIGOR CROSSBRIDGES FROM TOMOGRAMS OF INSECT FLIGHT MUSCLE 1O1B ; 70.00 ; MOLECULAR MODELS OF AVERAGED RIGOR CROSSBRIDGES FROM TOMOGRAMS OF INSECT FLIGHT MUSCLE 1O1C ; 70.00 ; MOLECULAR MODELS OF AVERAGED RIGOR CROSSBRIDGES FROM TOMOGRAMS OF INSECT FLIGHT MUSCLE 1O1D ; 70.00 ; MOLECULAR MODELS OF AVERAGED RIGOR CROSSBRIDGES FROM TOMOGRAMS OF INSECT FLIGHT MUSCLE 1O1E ; 70.00 ; MOLECULAR MODELS OF AVERAGED RIGOR CROSSBRIDGES FROM TOMOGRAMS OF INSECT FLIGHT MUSCLE 1O1F ; 70.00 ; MOLECULAR MODELS OF AVERAGED RIGOR CROSSBRIDGES FROM TOMOGRAMS OF INSECT FLIGHT MUSCLE 1O1G ; 70.00 ; MOLECULAR MODELS OF AVERAGED RIGOR CROSSBRIDGES FROM TOMOGRAMS OF INSECT FLIGHT MUSCLE 1DDY ; 3.00 ; MOLECULAR RECOGNITION BY THE VITAMIN B12 RIBONUCLEIC ACID APTAMER 1MPW ; 2.34 ; MOLECULAR RECOGNITION IN (+)-A-PINENE OXIDATION BY CYTOCHROME P450CAM 2BOV ; 2.66 ; MOLECULAR RECOGNITION OF AN ADP-RIBOSYLATING CLOSTRIDIUM BOTULINUM C3 EXOENZYME BY RALA GTPASE 1HWR ; 1.80 ; MOLECULAR RECOGNITION OF CYCLIC UREA HIV PROTEASE INHIBITORS 1GWX ; 2.50 ; MOLECULAR RECOGNITION OF FATTY ACIDS BY PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS 2GWX ; 2.30 ; MOLECULAR RECOGNITION OF FATTY ACIDS BY PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS 3GWX ; 2.40 ; MOLECULAR RECOGNITION OF FATTY ACIDS BY PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS 1ZX7 ; 2.15 ; MOLECULAR RECOGNITION OF RIBONUCLEIC ACID BY NEOMYCIN AND A RESTRICTED NEOMYCIN DERIVATIVE 1ZZ5 ; 3.00 ; MOLECULAR RECOGNITION OF RIBONUCLEIC ACID BY NEOMYCIN AND A RESTRICTED NEOMYCIN DERIVATIVE 2A04 ; 2.95 ; MOLECULAR RECOGNITION OF RIBONUCLEIC ACID BY NEOMYCIN AND A RESTRICTED NEOMYCIN DERIVATIVE 1S32 ; 2.05 ; MOLECULAR RECOGNITION OF THE NUCLEOSOMAL 'SUPERGROOVE' 1HRO ; 2.20 ; MOLECULAR STRUCTURE OF A HIGH POTENTIAL CYTOCHROME C2 ISOLATED FROM RHODOPILA GLOBIFORMIS 1YNY ; 2.30 ; MOLECULAR STRUCTURE OF D-HYDANTOINASE FROM A BACILLUS SP. AR9: EVIDENCE FOR MERCURY INHIBITION 1J79 ; 1.70 ; MOLECULAR STRUCTURE OF DIHYDROOROTASE: A PARADIGM FOR CATALYSIS THROUGH THE USE OF A BINUCLEAR METAL CENTER 2C0W ; 3.20 ; MOLECULAR STRUCTURE OF FD FILAMENTOUS BACTERIOPHAGE REFINED WITH RESPECT TO X-RAY FIBRE DIFFRACTION 2C0X ; -1.00 ; MOLECULAR STRUCTURE OF FD FILAMENTOUS BACTERIOPHAGE REFINED WITH RESPECT TO X-RAY FIBRE DIFFRACTION AND SOLID-STATE NMR DATA 1FQG ; 1.70 ; MOLECULAR STRUCTURE OF THE ACYL-ENZYME INTERMEDIATE IN TEM- 1 BETA-LACTAMASE 2A9I ; 1.70 ; MOLECULAR STRUCTURE OF THE INTERLEUKIN-1 RECEPTOR- ASSOCIATED KINASE-4 DEATH DOMAIN 1WLH ; 2.80 ; MOLECULAR STRUCTURE OF THE ROD DOMAIN OF DICTYOSTELIUM FILAMIN 1ETN ; 0.89 ; MOLECULAR STRUCTURE OF THE TOXIC DOMAIN OF HEAT-STABLE ENTEROTOXIN PRODUCED BY A PATHOGENIC STRAIN OF ESCHERICHIA COLI 1O55 ; 1.04 ; MOLECULAR STRUCTURE OF TWO CRYSTAL FORMS OF CYCLIC TRIADENYLIC ACID AT 1 ANGSTROM RESOLUTION 1O56 ; 0.90 ; MOLECULAR STRUCTURE OF TWO CRYSTAL FORMS OF CYCLIC TRIADENYLIC ACID AT 1 ANGSTROM RESOLUTION 6Q21 ; 1.95 ; MOLECULAR SWITCH FOR SIGNAL TRANSDUCTION: STRUCTURAL DIFFERENCES BETWEEN ACTIVE AND INACTIVE FORMS OF 1HWV ; -1.00 ; MOLECULAR TOPOLOGY OF POLYCYCLIC AROMATIC CARCINOGENS DETERMINES DEOXYRIBONUCLEIC ACID ADDUCT CONFORMATION: A LINK TO TUMORIGENIC ACTIVITY 1HX4 ; -1.00 ; MOLECULAR TOPOLOGY OF POLYCYCLIC AROMATIC CARCINOGENS DETERMINES DEOXYRIBONUCLEIC ACID ADDUCT CONFORMATION: A LINK TO TUMORIGENIC ACTIVITY 1DDS ; 2.20 ; MOLECULE: DIHYDROFOLATE REDUCTASE COMPLEXED WITH METHOTREXATE 1DDR ; 2.20 ; MOLECULE: DIHYDROFOLATE REDUCTASE COMPLEXED WITH METHOTREXATE AND UREA 1H9S ; 1.82 ; MOLYBDATE BOUND COMPLEX OF DIMOP DOMAIN OF MODE FROM E.COLI 1O7L ; 2.75 ; MOLYBDATE-ACTIVATED FORM OF MODE FROM ESCHERICHIA COLI 1XI8 ; 2.50 ; MOLYBDENUM COFACTOR BIOSYNTHESIS PROTEIN FROM PYROCOCCUS FURIOSUS PFU-1657500-001 1FM0 ; 1.45 ; MOLYBDOPTERIN SYNTHASE (MOAD/MOAE) 1FMA ; 1.58 ; MOLYBDOPTERIN SYNTHASE (MOAD/MOAE) 1BM4 ; -1.00 ; MOMLV CAPSID PROTEIN MAJOR HOMOLOGY REGION PEPTIDE ANALOG 1OEB ; 1.76 ; MONA/GADS SH3C DOMAIN 1UTI ; 1.50 ; MONA/GADS SH3C IN COMPLEX WITH HPK DERIVED PEPTIDE 1GO9 ; -1.00 ; MONITORING THE STRUCTURAL CONSEQUENCES OF PHE12-->D-PHE12 AND LEU15-->AIB15 SUBSTITUTION IN H/R CORTICOTROPIN RELEASING HORMONE: IMPLICATIONS FOR DESIGN OF CRH ANTAGONISTS. 1GOE ; -1.00 ; MONITORING THE STRUCTURAL CONSEQUENCES OF PHE12-->D-PHE12 AND LEU15-->AIB15 SUBSTITUTION IN H/R CORTICOTROPIN RELEASING HORMONE: IMPLICATIONS FOR DESIGN OF CRH ANTAGONISTS. 1QXK ; 2.30 ; MONOACID-BASED, CELL PERMEABLE, SELECTIVE INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE 1B 1RG0 ; 1.80 ; MONOCLINIC CRYSTAL FORM OF THE TRUNCATED K122-4 PILIN FROM PSEUDOMONAS AERUGINOSA 1H4O ; 1.95 ; MONOCLINIC FORM OF HUMAN PEROXIREDOXIN 5 1ICT ; 3.00 ; MONOCLINIC FORM OF HUMAN TRANSTHYRETIN COMPLEXED WITH THYROXINE (T4) 1KHP ; 2.00 ; MONOCLINIC FORM OF PAPAIN/ZLFG-DAM COVALENT COMPLEX 1MS3 ; 1.65 ; MONOCLINIC FORM OF TRYPANOSOMA CRUZI TRANS-SIALIDASE 1MS1 ; 1.80 ; MONOCLINIC FORM OF TRYPANOSOMA CRUZI TRANS-SIALIDASE, IN COMPLEX WITH 3-DEOXY-2,3-DEHYDRO-N-ACETYLNEURAMINIC ACID (DANA) 1MS0 ; 2.50 ; MONOCLINIC FORM OF TRYPANOSOMA CRUZI TRANS-SIALIDASE, IN COMPLEX WITH 3-DEOXY-2,3-DEHYDRO-N-ACETYLNEURAMINIC ACID (DANA)AND LACTOSE 1LKR ; 1.60 ; MONOCLINIC HEN EGG WHITE LYSOZYME IODIDE 1LCN ; 1.63 ; MONOCLINIC HEN EGG WHITE LYSOZYME, THIOCYANATE COMPLEX 1MLB ; 2.10 ; MONOCLONAL ANTIBODY FAB D44.1 RAISED AGAINST CHICKEN EGG-WHITE LYSOZYME 1MLC ; 2.10 ; MONOCLONAL ANTIBODY FAB D44.1 RAISED AGAINST CHICKEN EGG-WHITE LYSOZYME COMPLEXED WITH LYSOZYME 1BFV ; 2.10 ; MONOCLONAL ANTIBODY FRAGMENT FV4155 FROM E. COLI 1CFV ; 2.10 ; MONOCLONAL ANTIBODY FRAGMENT FV4155 FROM E. COLI 2BFV ; 2.50 ; MONOCLONAL ANTIBODY FRAGMENT FV4155 FROM E. COLI 1FGN ; 2.50 ; MONOCLONAL MURINE ANTIBODY 5G9 - ANTI-HUMAN TISSUE FACTOR 1DOL ; 2.40 ; MONOCYTE CHEMOATTRACTANT PROTEIN 1, I-FORM 1DOK ; 1.85 ; MONOCYTE CHEMOATTRACTANT PROTEIN 1, P-FORM 1BO0 ; -1.00 ; MONOCYTE CHEMOATTRACTANT PROTEIN-3, NMR, MINIMIZED AVERAGE STRUCTURE 1AG1 ; 2.36 ; MONOHYDROGEN PHOSPHATE BINDING TO TRYPANOSOMAL TRIOSEPHOSPHATE ISOMERASE 1ESO ; 2.00 ; MONOMERIC CU,ZN SUPEROXIDE DISMUTASE FROM ESCHERICHIA COLI 1MFM ; 1.02 ; MONOMERIC HUMAN SOD MUTANT F50E/G51E/E133Q AT ATOMIC RESOLUTION 1GOD ; 2.80 ; MONOMERIC LYS-49 PHOSPHOLIPASE A2 HOMOLOGUE ISOLATED FROM THE VENOM OF CERROPHIDION (BOTHROPS) GODMANI 1MC2 ; 0.85 ; MONOMERIC LYS-49 PHOSPHOLIPASE A2 HOMOLOGUE PURIFIED FROM AG 2A5P ; -1.00 ; MONOMERIC PARALLEL-STRANDED DEOXYRIBONUCLEIC ACID TETRAPLEX WITH SNAP-BACK 3+1 3' G-TETRAD, SINGLE-RESIDUE CHAIN REVERSAL LOOPS, GAG TRIAD IN THE CONTEXT OF GAAG DIAGONAL LOOP, NMR, 8 STRUCT. 1K53 ; 2.10 ; MONOMERIC PROTEIN L B1 DOMAIN WITH A G15A MUTATION 1K52 ; 1.80 ; MONOMERIC PROTEIN L B1 DOMAIN WITH A K54G MUTATION 1L9F ; 1.85 ; MONOMERIC SARCOSINE OXIDASE: STRUCTURE OF A COVALENTLY FLAVINYLATED AMINE OXIDIZING ENZYME 1MD8 ; 2.80 ; MONOMERIC STRUCTURE OF THE ACTIVE CATALYTIC DOMAIN OF COMPLEMENT PROTEASE C1R 1F0M ; 2.20 ; MONOMERIC STRUCTURE OF THE HUMAN EPHB2 SAM (STERILE ALPHA MOTIF) DOMAIN 1MD7 ; 3.20 ; MONOMERIC STRUCTURE OF THE ZYMOGEN OF COMPLEMENT PROTEASE C1R 9INS ; 1.70 ; MONOVALENT CATION BINDING IN CUBIC INSULIN CRYSTALS 1FP7 ; 3.20 ; MONOVALENT CATION BINDING SITES IN N10- FORMYLTETRAHYDROFOLATE SYNTHETASE FROM MOORELLA THERMOACETICA 1FPM ; 3.00 ; MONOVALENT CATION BINDING SITES IN N10- FORMYLTETRAHYDROFOLATE SYNTHETASE FROM MOORELLA THERMOACETICA 1DOU ; 1.82 ; MONOVALENT CATIONS SEQUESTER WITHIN THE A-TRACT MINOR GROOVE OF [D(CGCGAATTCGCG)]2 1GUS ; 1.80 ; MOPII FROM CLOSTRIDIUM PASTEURIANUM (APO1) 1GUT ; 1.50 ; MOPII FROM CLOSTRIDIUM PASTEURIANUM (APO2) 1GUO ; 2.50 ; MOPII FROM CLOSTRIDIUM PASTEURIANUM COMPLEXED WITH MOLYBDATE 1GUN ; 1.83 ; MOPII FROM CLOSTRIDIUM PASTEURIANUM COMPLEXED WITH MOLYBDATE (PARTIAL) 1GUG ; 1.60 ; MOPII FROM CLOSTRIDIUM PASTEURIANUM COMPLEXED WITH TUNGSTATE 1GWJ ; 2.20 ; MORPHINONE REDUCTASE 1W99 ; 1.75 ; MOSQUITO-LARVICIDAL TOXIN CRY4BA FROM BACILLUS THURINGIENSIS SSP. ISRAELENSIS 3MSP ; -1.00 ; MOTILE MAJOR SPERM PROTEIN (MSP) OF ASCARIS SUUM, NMR, 20 STRUCTURES 1CM4 ; 2.00 ; MOTIONS OF CALMODULIN - FOUR-CONFORMER REFINEMENT 1CM1 ; 2.00 ; MOTIONS OF CALMODULIN - SINGLE-CONFORMER REFINEMENT 1LKX ; 3.00 ; MOTOR DOMAIN OF MYOE, A CLASS-I MYOSIN 1MAA ; 2.90 ; MOUSE ACETYLCHOLINESTERASE CATALYTIC DOMAIN, GLYCOSYLATED PROTEIN 1MBE ; -1.00 ; MOUSE C-MYB DEOXYRIBONUCLEIC ACID-BINDING DOMAIN REPEAT 1 1MBF ; -1.00 ; MOUSE C-MYB DEOXYRIBONUCLEIC ACID-BINDING DOMAIN REPEAT 1 1MBG ; -1.00 ; MOUSE C-MYB DEOXYRIBONUCLEIC ACID-BINDING DOMAIN REPEAT 2 1MBH ; -1.00 ; MOUSE C-MYB DEOXYRIBONUCLEIC ACID-BINDING DOMAIN REPEAT 2 1MBJ ; -1.00 ; MOUSE C-MYB DEOXYRIBONUCLEIC ACID-BINDING DOMAIN REPEAT 3 1MBK ; -1.00 ; MOUSE C-MYB DEOXYRIBONUCLEIC ACID-BINDING DOMAIN REPEAT 3 1Q3H ; 2.50 ; MOUSE CFTR NBD1 WITH AMP.PNP 1E3E ; 2.12 ; MOUSE CLASS II ALCOHOL DEHYDROGENASE COMPLEX WITH NADH 1E3I ; 2.08 ; MOUSE CLASS II ALCOHOL DEHYDROGENASE COMPLEX WITH NADH AND INHIBITOR 1AWC ; 2.15 ; MOUSE GABP ALPHA/BETA DOMAIN BOUND TO DEOXYRIBONUCLEIC ACID 1AO5 ; 2.60 ; MOUSE GLANDULAR KALLIKREIN-13 (PRORENIN CONVERTING ENZYME) 1DZ1 ; -1.00 ; MOUSE HP1 (M31) C TERMINAL (SHADOW CHROMO) DOMAIN 1Q1S ; 2.30 ; MOUSE IMPORTIN ALPHA- PHOSPHORYLATED SV40 CN PEPTIDE COMPLEX 1PJM ; 2.50 ; MOUSE IMPORTIN ALPHA-BIPARTITE NLS FROM HUMAN RETINOBLASTOMA PROTEIN COMPLEX 1PJN ; 2.50 ; MOUSE IMPORTIN ALPHA-BIPARTITE NLS N1N2 FROM XENOPUS LAEVIS PHOSPHOPROTEIN COMPLEX 1EJY ; 2.90 ; MOUSE IMPORTIN ALPHA-NUCLEOPLASMIN NLS PEPTIDE COMPLEX 1EJL ; 2.80 ; MOUSE IMPORTIN ALPHA-SV40 LARGE T ANTIGEN NLS PEPTIDE COMPLEX 1Q1T ; 2.50 ; MOUSE IMPORTIN ALPHA: NON-PHOSPHORYLATED SV40 CN PEPTIDE COMPLEX 1XYX ; -1.00 ; MOUSE PRION PROTEIN FRAGMENT 121-231 1Y15 ; -1.00 ; MOUSE PRION PROTEIN WITH MUTATION N174T 1Y16 ; -1.00 ; MOUSE PRION PROTEIN WITH MUTATIONS S170N AND N174T 1S55 ; 1.90 ; MOUSE RANKL STRUCTURE AT 1.9A RESOLUTION 1OAA ; 1.25 ; MOUSE SEPIAPTERIN REDUCTASE COMPLEXED WITH NADP AND OXALOACETATE 1SEP ; 1.95 ; MOUSE SEPIAPTERIN REDUCTASE COMPLEXED WITH NADP AND SEPIAPTERIN 1YMT ; 1.20 ; MOUSE SF-1 LBD 1M4M ; 2.80 ; MOUSE SURVIVIN 1IG3 ; 1.90 ; MOUSE THIAMIN PYROPHOSPHOKINASE COMPLEXED WITH THIAMIN 2F17 ; 2.50 ; MOUSE THIAMIN PYROPHOSPHOKINASE IN A TERNARY COMPLEX WITH PYRITHIAMIN PYROPHOSPHATE AND AMP AT 2.5 ANGSTROM 1SKO ; 2.00 ; MP1-P14 COMPLEX 1JCE ; 2.10 ; MREB FROM THERMOTOGA MARITIMA 1JCG ; 3.10 ; MREB FROM THERMOTOGA MARITIMA, AMPPNP 1JCF ; 2.10 ; MREB FROM THERMOTOGA MARITIMA, TRIGONAL 1P3Y ; 2.54 ; MRSD FROM BACILLUS SP. HIL-Y85/54728 2C4Q ; 2.38 ; MS2-RIBONUCLEIC ACID HAIRPIN (2ONE -5) COMPLEX VIRUS 1HDW ; 2.60 ; MS2-RIBONUCLEIC ACID HAIRPIN (2THIO-U -5-6) COMPLEX 1HE0 ; 2.68 ; MS2-RIBONUCLEIC ACID HAIRPIN (2THIOURACIL-5) COMPLEX 1DZS ; 2.85 ; MS2-RIBONUCLEIC ACID HAIRPIN (4ONE -5) COMPLEX 2BU1 ; 2.20 ; MS2-RIBONUCLEIC ACID HAIRPIN (5BRU-5) COMPLEX 1HE6 ; 2.65 ; MS2-RIBONUCLEIC ACID HAIRPIN (ADE-5) VIRUS COMPLEX 1KUO ; 2.70 ; MS2-RIBONUCLEIC ACID HAIRPIN (C-10) COMPLEX 1GKV ; 3.30 ; MS2-RIBONUCLEIC ACID HAIRPIN (C-7) COMPLEX 1GKW ; 2.56 ; MS2-RIBONUCLEIC ACID HAIRPIN (G-10) COMPLEX 1H8J ; 2.80 ; MS2-RIBONUCLEIC ACID HAIRPIN (G-5) COMPLEX 1UBE ; 3.30 ; MSRECA-ADP COMPLEX 1UBF ; 3.50 ; MSRECA-ATPGS COMPLEX 1UBG ; 3.50 ; MSRECA-DATP COMPLEX 1IG7 ; 2.20 ; MSX-1 HOMEODOMAIN/DEOXYRIBONUCLEIC ACID COMPLEX STRUCTURE 1L3I ; 1.95 ; MT0146, THE PRECORRIN-6Y METHYLTRANSFERASE (CBIT) HOMOLOG FROM M. THERMOAUTOTROPHICUM, ADOHCY BINARY COMPLEX 1L3B ; 2.65 ; MT0146, THE PRECORRIN-6Y METHYLTRANSFERASE (CBIT) HOMOLOG FROM M. THERMOAUTOTROPHICUM, C2 SPACEGROUP W/ LONG CELL 1L3C ; 2.31 ; MT0146, THE PRECORRIN-6Y METHYLTRANSFERASE (CBIT) HOMOLOG FROM M. THERMOAUTOTROPHICUM, C2 SPACEGROUP WITH SHORT CELL 1KXZ ; 2.70 ; MT0146, THE PRECORRIN-6Y METHYLTRANSFERASE (CBIT) HOMOLOG FROM M. THERMOAUTOTROPHICUM, P1 SPACEGROUP 1IHN ; 2.20 ; MT938 1I36 ; 2.00 ; MTH1747-CONSERVED HYPOTHETICAL PROTEIN REVEALS STRUCTURAL SIMILARITY WITH 3-HYDROXYACID DEHYDROGENASES 1PM3 ; 3.15 ; MTH1859 1GIB ; -1.00 ; MU-CONOTOXIN GIIIB, NMR 1H6E ; 3.60 ; MU2 ADAPTIN SUBUNIT (AP50) OF AP2 ADAPTOR (SECOND DOMAIN), COMPLEXED WITH CTLA-4 INTERNALIZATION PEPTIDE TTGVYVKMPPT 1BW8 ; 2.65 ; MU2 ADAPTIN SUBUNIT (AP50) OF AP2 ADAPTOR (SECOND DOMAIN), COMPLEXED WITH EGFR INTERNALIZATION PEPTIDE FYRALM 2BP5 ; 2.80 ; MU2 ADAPTIN SUBUNIT (AP50) OF AP2 ADAPTOR (SECOND DOMAIN), COMPLEXED WITH NON-CANONICAL INTERNALIZATION PEPTIDE VEDYEQGLSG 1HES ; 3.00 ; MU2 ADAPTIN SUBUNIT (AP50) OF AP2 ADAPTOR (SECOND DOMAIN), COMPLEXED WITH P-SELECTIN INTERNALIZATION PEPTIDE SHLGTYGVFTNAA 1BXX ; 2.70 ; MU2 ADAPTIN SUBUNIT (AP50) OF AP2 ADAPTOR (SECOND DOMAIN), COMPLEXED WITH TGN38 INTERNALIZATION PEPTIDE DYQRLN 1I31 ; 2.50 ; MU2 ADAPTIN SUBUNIT (AP50) OF AP2 CLATHRIN ADAPTOR, COMPLEXED WITH EGFR INTERNALIZATION PEPTIDE FYRALM AT 2.5 A RESOLUTION 2MUC ; 2.30 ; MUCONATE CYCLOISOMERASE VARIANT F329I 3MUC ; 2.30 ; MUCONATE CYCLOISOMERASE VARIANT I54V 1BKH ; 2.10 ; MUCONATE LACTONIZING ENZYME FROM PSEUDOMONAS PUTIDA 1IH6 ; 1.45 ; MULTI-CONFORMATION CRYSTAL STRUCTURE OF GGBR5CGCC 1IH4 ; 1.90 ; MULTI-CONFORMATION CRYSTAL STRUCTURE OF GGM5CGCC 1IH3 ; 2.40 ; MULTI-CONFORMATION CRYSTAL STRUCTURE OF GGM5CGM5CC 3BBG ; -1.00 ; MULTI-CONFORMER STRUCTURE OF RAGWEED POLLEN ALLERGEN FROM AMBROSIA TRIFIDA V, NMR, 2 STRUCTURES 1HTQ ; 2.40 ; MULTICOPY CRYSTALLOGRAPHIC STRUCTURE OF A RELAXED GLUTAMINE SYNTHETASE FROM MYCOBACTERIUM TUBERCULOSIS 1BOW ; 2.70 ; MULTIDRUG-BINDING DOMAIN OF TRANSCRIPTION ACTIVATOR BMRR (APO FORM) 2BOW ; 2.80 ; MULTIDRUG-BINDING DOMAIN OF TRANSCRIPTION ACTIVATOR BMRR IN COMPLEX WITH A LIGAND, TETRAPHENYLPHOSPHONIUM 1H09 ; 2.10 ; MULTIMODULAR PNEUMOCOCCAL CELL WALL ENDOLYSIN FROM PHAGE CP-1 1OBA ; 2.45 ; MULTIMODULAR PNEUMOCOCCAL CELL WALL ENDOLYSIN FROM PHAGE CP-1 COMPLEXED WITH CHOLINE 1BL0 ; 2.30 ; MULTIPLE ANTIBIOTIC RESISTANCE PROTEIN (MARA)/DEOXYRIBONUCLEIC ACID COMPLEX 1JGS ; 2.30 ; MULTIPLE ANTIBIOTIC RESISTANCE REPRESSOR, MARR 2ULL ; 1.50 ; MULTIPLE CONFORMATION STRUCTURE OF ALPHA-LYTIC PROTEASE AT 120 K 2AIV ; -1.00 ; MULTIPLE CONFORMATIONS IN THE LIGAND-BINDING SITE OF THE YEAST NUCLEAR PORE TARGETING DOMAIN OF NUP116P 1ZKL ; 1.67 ; MULTIPLE DETERMINANTS FOR INHIBITOR SELECTIVITY OF CYCLIC NUCLEOTIDE PHOSPHODIESTERASES 1LW9 ; 1.45 ; MULTIPLE METHIONINE SUBSTITUTIONS ARE TOLERATED IN T4 LYSOZYME AND HAVE COUPLED EFFECTS ON FOLDING AND STABILITY 1LWG ; 1.70 ; MULTIPLE METHIONINE SUBSTITUTIONS ARE TOLERATED IN T4 LYSOZYME AND HAVE COUPLED EFFECTS ON FOLDING AND STABILITY 1LWK ; 2.10 ; MULTIPLE METHIONINE SUBSTITUTIONS ARE TOLERATED IN T4 LYSOZYME AND HAVE COUPLED EFFECTS ON FOLDING AND STABILITY 1LPY ; 1.65 ; MULTIPLE METHIONINE SUBSTITUTIONS IN T4 LYSOZYME 1Q3G ; 2.65 ; MURA (ASP305ALA) LIGANDED WITH TETRAHEDRAL REACTION INTERMEDIATE 1YBG ; 2.60 ; MURA INHIBITED BY A DERIVATIVE OF 5-SULFONOXY-ANTHRANILIC ACID 1UXY ; 1.80 ; MURB MUTANT WITH SER 229 REPLACED BY ALA, COMPLEX WITH ENOLPYRUVYL-UDP-N-ACETYLGLUCOSAMINE 2MBR ; 1.80 ; MURB WILD TYPE, COMPLEX WITH ENOLPYRUVYL-UDP-N-ACETYLGLUCOSAMINE 1GQQ ; 3.10 ; MURC - CRYSTAL STRUCTURE OF THE APO-ENZYME FROM HAEMOPHILUS INFLUENZAE 1GQY ; 1.80 ; MURC - CRYSTAL STRUCTURE OF THE ENZYME FROM HAEMOPHILUS INFLUENZAE COMPLEXED WITH AMPPCP 1PG7 ; 2.50 ; MURINE 6A6 FAB IN COMPLEX WITH HUMANIZED ANTI-TISSUE FACTOR D3H44 FAB 1FKW ; 2.40 ; MURINE ADENOSINE DEAMINASE (D295E) 1FKX ; 2.40 ; MURINE ADENOSINE DEAMINASE (D296A) 1FO0 ; 2.50 ; MURINE ALLOREACTIVE SCFV TCR-PEPTIDE-MHC CLASS I MOLECULE COMPLEX 1KJ2 ; 2.71 ; MURINE ALLOREACTIVE SCFV TCR-PEPTIDE-MHC CLASS I MOLECULE COMPLEX 1NAM ; 2.70 ; MURINE ALLOREACTIVE SCFV TCR-PEPTIDE-MHC CLASS I MOLECULE COMPLEX 2BWL ; 1.62 ; MURINE ANGIOGENIN, PHOSPHATE COMPLEX 2BWK ; 1.50 ; MURINE ANGIOGENIN, SULPHATE COMPLEX 1GV4 ; 2.00 ; MURINE APOPTOSIS-INDUCING FACTOR (AIF) 2ZNC ; 2.80 ; MURINE CARBONIC ANHYDRASE IV 3ZNC ; 2.80 ; MURINE CARBONIC ANHYDRASE IV COMPLEXED WITH BRINZOLAMIDE 1URT ; 2.80 ; MURINE CARBONIC ANHYDRASE V 1BQH ; 2.80 ; MURINE CD8AA ECTODOMAIN FRAGMENT IN COMPLEX WITH H-2KB/VSV8 1DY2 ; 2.00 ; MURINE COLLAGEN ALPHA1(XV), ENDOSTATIN DOMAIN 1PQZ ; 2.10 ; MURINE CYTOMEGALOVIRUS IMMUNOMODULATORY PROTEIN M144 1I3Z ; 2.15 ; MURINE EAT2 SH2 DOMAIN IN COMPLEX WITH SLAM PHOSPHOPEPTIDE 1DY0 ; 2.20 ; MURINE ENDOSTATIN, CRYSTAL FORM II 1DY1 ; 2.20 ; MURINE ENDOSTATIN, CRYSTAL FORM III 1QOM ; 2.70 ; MURINE INDUCIBLE NITRIC OXIDE SYNTHASE OXYGENASE DIMER (DELTA 65) WITH SWAPPED N-TERMINAL HOOK 3NOD ; 2.70 ; MURINE INDUCIBLE NITRIC OXIDE SYNTHASE OXYGENASE DIMER (DELTA 65) WITH TETRAHYDROBIOPTERIN AND PRODUCT ANALOGUE L-THIOCITRULLINE 1NOD ; 2.60 ; MURINE INDUCIBLE NITRIC OXIDE SYNTHASE OXYGENASE DIMER (DELTA 65) WITH TETRAHYDROBIOPTERIN AND SUBSTRATE L-ARGININE 2NOD ; 2.60 ; MURINE INDUCIBLE NITRIC OXIDE SYNTHASE OXYGENASE DIMER (DELTA 65) WITH TETRAHYDROBIOPTERIN AND WATER BOUND IN ACTIVE CENTER 1JWK ; 2.30 ; MURINE INDUCIBLE NITRIC OXIDE SYNTHASE OXYGENASE DIMER (DELTA 65) WITH W457A MUTATION AT TETRAHYDROBIOPTERIN BINDING SITE 1JWJ ; 2.60 ; MURINE INDUCIBLE NITRIC OXIDE SYNTHASE OXYGENASE DIMER (DELTA 65) WITH W457F MUTATION AT TETRAHYDROBIOPTERIN BINDING SITE 1DWV ; 2.35 ; MURINE INDUCIBLE NITRIC OXIDE SYNTHASE OXYGENASE DIMER N-HYDROXYARGININE AND 4-AMINO TETRAHYDROBIOPTERIN 1DWW ; 2.35 ; MURINE INDUCIBLE NITRIC OXIDE SYNTHASE OXYGENASE DIMER N-HYDROXYARGININE AND DIHYDROBIOPTERIN 1DWX ; 2.60 ; MURINE INDUCIBLE NITRIC OXIDE SYNTHASE OXYGENASE DIMER N-HYDROXYARGININE AND TETRAHYDROBIOPTERIN 1R35 ; 2.30 ; MURINE INDUCIBLE NITRIC OXIDE SYNTHASE OXYGENASE DIMER, TETRAHYDROBIOPTERIN AND 4R-FLUORO-N6-ETHANIMIDOYL-L-LYSINE 1DD7 ; 2.25 ; MURINE INDUCIBLE NITRIC OXIDE SYNTHASE OXYGENASE DOMAIN (DELTA 114) (N-[(1,3-BENZODIOXOL-5-YL)METHYL]-1-[2-(1H- IMIDAZOL-1-YL)PYRIMIDIN-4-YL]-4-(METHOXYCARBONYL)- PIPERAZINE-2-ACETAMIDE COMPLEX 1NOC ; 2.60 ; MURINE INDUCIBLE NITRIC OXIDE SYNTHASE OXYGENASE DOMAIN (DELTA 114) COMPLEXED WITH TYPE I E. COLI CHLORAMPHENICOL ACETYL TRANSFERASE AND IMIDAZOLE 2NOS ; 2.30 ; MURINE INDUCIBLE NITRIC OXIDE SYNTHASE OXYGENASE DOMAIN (DELTA 114), AMINOGUANIDINE COMPLEX 1NOS ; 2.10 ; MURINE INDUCIBLE NITRIC OXIDE SYNTHASE OXYGENASE DOMAIN (DELTA 114), IMIDAZOLE COMPLEX 1QW5 ; 2.70 ; MURINE INDUCIBLE NITRIC OXIDE SYNTHASE OXYGENASE DOMAIN IN COMPLEX WITH W1400 INHIBITOR. 2BHJ ; 3.20 ; MURINE INO SYNTHASE WITH COUMARIN INHIBITOR 1DF1 ; 2.35 ; MURINE INOSOXY DIMER WITH ISOTHIOUREA BOUND IN THE ACTIVE SITE 1DMX ; 2.45 ; MURINE MITOCHONDRIAL CARBONIC ANYHDRASE V AT 2.45 ANGSTROMS RESOLUTION 1KN3 ; 1.80 ; MURINE PEBP-2 (PHOSPHATIDYLETHANOLAMINE-BINDING PROTEIN-2) 1SID ; 3.65 ; MURINE POLYOMAVIRUS COMPLEXED WITH 3'SIALYL LACTOSE 1SIE ; 3.65 ; MURINE POLYOMAVIRUS COMPLEXED WITH A DISIALYLATED OLIGOSACCHARIDE 1MBY ; 2.00 ; MURINE SAK POLO DOMAIN 1TCR ; 2.50 ; MURINE T-CELL ANTIGEN RECEPTOR 2C CLONE 1KB5 ; 2.50 ; MURINE T-CELL RECEPTOR VARIABLE DOMAIN/FAB COMPLEX 1U9B ; 2.00 ; MURINE/HUMAN UBIQUITIN-CONJUGATING ENZYME UBC9 2MSS ; -1.00 ; MUSASHI1 RBD2, NMR 2MST ; -1.00 ; MUSASHI1 RBD2, NMR 2CRK ; 2.35 ; MUSCLE CREATINE KINASE 1EFZ ; 2.00 ; MUTAGENESIS AND CRYSTALLOGRAPHIC STUDIES OF ZYMOMONAS MOBILIS TRNA-GUANINE TRANSGLYCOSYLASE TO ELUCIDATE THE ROLE OF SERINE 103 FOR ENZYMATIC ACTIVITY 1WCQ ; 2.10 ; MUTAGENESIS OF THE NUCLEOPHILIC TYROSINE IN A BACTERIAL SIALIDASE TO PHENYLALANINE. 1QPK ; 2.00 ; MUTANT (D193G) MALTOTETRAOSE-FORMING EXO-AMYLASE IN COMPLEX WITH MALTOTETRAOSE 1QI3 ; 2.00 ; MUTANT (D193N) MALTOTETRAOSE-FORMING EXO-AMYLASE IN COMPLEX WITH MALTOTETRAOSE 1QI5 ; 2.00 ; MUTANT (D294N) MALTOTETRAOSE-FORMING EXO-AMYLASE IN COMPLEX WITH MALTOTETRAOSE 1QI4 ; 2.00 ; MUTANT (E219G) MALTOTETRAOSE-FORMING EXO-AMYLASE IN COMPLEX WITH MALTOTETRAOSE 1JDC ; 1.90 ; MUTANT (E219Q) MALTOTETRAOSE-FORMING EXO-AMYLASE COCRYSTALLIZED WITH MALTOTETRAOSE (CRYSTAL TYPE 1) 1JDD ; 1.90 ; MUTANT (E219Q) MALTOTETRAOSE-FORMING EXO-AMYLASE COCRYSTALLIZED WITH MALTOTETRAOSE (CRYSTAL TYPE 2) 1XZ6 ; 1.55 ; MUTANT ABO(H) BLOOD GROUP GLYCOSYLTRANSFERASE A 1WT1 ; 1.55 ; MUTANT ABO(H) BLOOD GROUP GLYCOSYLTRANSFERASE WITH BOUND UDP AND ACCEPTOR 1GXO ; 2.05 ; MUTANT D189A OF FAMILY 10 POLYSACCHARIDE LYASE FROM CELLVIBRIO CELLULOSA IN COMPLEX WITH TRIGALATURONIC ACID 1OCN ; 1.31 ; MUTANT D416A OF THE CELLOBIOHYDROLASE CEL6A FROM HUMICOLA INSOLENS IN COMPLEX WITH A CELLOBIO-DERIVED ISOFAGOMINE AT 1.3 ANGSTROM RESOLUTION 1OCJ ; 1.30 ; MUTANT D416A OF THE CELLOBIOHYDROLASE CEL6A FROM HUMICOLA INSOLENS IN COMPLEX WITH A THIOPENTASACCHARIDE AT 1.3 ANGSTROM RESOLUTION 1GZ1 ; 1.90 ; MUTANT D416A OF THE CELLOBIOHYDROLASE CEL6A FROM HUMICOLA INSOLENS IN COMPLEX WITH METHYL-CELLOBIOSYL-4-DEOXY-4-THIO-BETA-D-CELLOBIOSIDE 1U3A ; 2.00 ; MUTANT DSBA 1KZ9 ; 3.10 ; MUTANT ENZYME L119F LUMAZINE SYNTHASE FROM S.POMBE 1KZ1 ; 2.00 ; MUTANT ENZYME W27G LUMAZINE SYNTHASE FROM S.POMBE 1KZ4 ; 3.10 ; MUTANT ENZYME W63Y LUMAZINE SYNTHASE FROM S.POMBE 1KZ6 ; 2.70 ; MUTANT ENZYME W63Y/L119F LUMAZINE SYNTHASE FROM S.POMBE 1QKT ; 2.20 ; MUTANT ESTROGEN NUCLEAR RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH ESTRADIOL 1GYR ; 2.60 ; MUTANT FORM OF ENOYL THIOESTER REDUCTASE FROM CANDIDA TROPICALIS 1E4V ; 1.85 ; MUTANT G10V OF ADENYLATE KINASE FROM E. COLI, MODIFIED IN THE GLY-LOOP 1CJ2 ; 2.80 ; MUTANT GLN34ARG OF PARA-HYDROXYBENZOATE HYDROXYLASE 1B0Y ; 0.93 ; MUTANT H42Q OF HIPIP FROM CHROMATIUM VINOSUM AT 0.93A 1WT0 ; 1.80 ; MUTANT HUMAN ABO(H) BLOOD GROUP GLYCOSYLTRANSFERASE A 1WT2 ; 1.90 ; MUTANT HUMAN ABO(H) BLOOD GROUP GLYCOSYLTRANSFERASE A WITH BOUND UDP AND INHIBITOR 1WT3 ; 1.80 ; MUTANT HUMAN ABO(H) BLOOD GROUP GLYCOSYLTRANSFERASE WITH BOUND UDP AND ACCEPTOR 1WSZ ; 1.59 ; MUTANT HUMAN ABO(H) BLOOD GROUP TRANSFERASE A 1I22 ; 1.80 ; MUTANT HUMAN LYSOZYME (A83K/Q86D/A92D) 1I20 ; 1.90 ; MUTANT HUMAN LYSOZYME (A92D) 1I1Z ; 1.80 ; MUTANT HUMAN LYSOZYME (Q86D) 207L ; 1.80 ; MUTANT HUMAN LYSOZYME C77A 208L ; 2.20 ; MUTANT HUMAN LYSOZYME C77A 1C43 ; 1.80 ; MUTANT HUMAN LYSOZYME WITH FOREIGN N-TERMINAL RESIDUES 1C45 ; 1.80 ; MUTANT HUMAN LYSOZYME WITH FOREIGN N-TERMINAL RESIDUES 1C46 ; 2.20 ; MUTANT HUMAN LYSOZYME WITH FOREIGN N-TERMINAL RESIDUES 1E9D ; 1.70 ; MUTANT HUMAN THYMIDYLATE KINASE (F105Y) COMPLEXED WITH AZTMP AND ADP 1E9E ; 1.60 ; MUTANT HUMAN THYMIDYLATE KINASE (F105Y) COMPLEXED WITH DTMP AND ADP 1E9F ; 1.90 ; MUTANT HUMAN THYMIDYLATE KINASE COMPLEXED WITH TMP AND ADP 1E9C ; 1.60 ; MUTANT HUMAN THYMIDYLATE KINASE COMPLEXED WITH TMP AND APPNP 1GKH ; 1.70 ; MUTANT K69H OF GENE V PROTEIN (SINGLE-STRANDED DEOXYRIBONUCLEIC ACID BINDING PROTEIN) 1AE2 ; 2.00 ; MUTANT L32R OF GENE V PROTEIN (SINGLE-STRANDED DEOXYRIBONUCLEIC ACID BINDING PROTEIN) 1CZA ; 1.90 ; MUTANT MONOMER OF RECOMBINANT HUMAN HEXOKINASE TYPE I COMPLEXED WITH GLUCOSE, GLUCOSE-6-PHOSPHATE, AND ADP 1DGK ; 2.80 ; MUTANT MONOMER OF RECOMBINANT HUMAN HEXOKINASE TYPE I WITH GLUCOSE AND ADP IN THE ACTIVE SITE 1DST ; 2.00 ; MUTANT OF FACTOR D WITH ENHANCED CATALYTIC ACTIVITY 1D1T ; 2.40 ; MUTANT OF HUMAN SIGMA ALCOHOL DEHYDROGENASE WITH LEUCINE AT POSITION 141 1FXH ; 1.97 ; MUTANT OF PENICILLIN ACYLASE IMPAIRED IN CATALYSIS WITH PHENYLACETIC ACID IN THE ACTIVE SITE 2BVZ ; 2.20 ; MUTANT OF THE RIBOSOMAL PROTEIN S6 1E4Y ; 1.85 ; MUTANT P9L OF ADENYLATE KINASE FROM E. COLI, MODIFIED IN THE GLY-LOOP 1E0Q ; -1.00 ; MUTANT PEPTIDE FROM THE FIRST N-TERMINAL 17 AMINO-ACID OF UBIQUITIN 1CJ4 ; 2.40 ; MUTANT Q34T OF PARA-HYDROXYBENZOATE HYDROXYLASE 1CXX ; -1.00 ; MUTANT R122A OF QUAIL CYSTEINE AND GLYCINE-RICH PROTEIN, NMR, MINIMIZED STRUCTURE 1AE3 ; 2.00 ; MUTANT R82C OF GENE V PROTEIN (SINGLE-STRANDED DEOXYRIBONUCLEIC ACID BINDING PROTEIN) 1M03 ; 1.90 ; MUTANT STREPTOMYCES PLICATUS BETA-HEXOSAMINIDASE (D313A) IN COMPLEX WITH PRODUCT (GLCNAC) 1M04 ; 1.95 ; MUTANT STREPTOMYCES PLICATUS BETA-HEXOSAMINIDASE (D313N) IN COMPLEX WITH PRODUCT (GLCNAC) 1O8X ; 1.30 ; MUTANT TRYPAREDOXIN-I CYS43ALA 1CJ3 ; 2.50 ; MUTANT TYR38GLU OF PARA-HYDROXYBENZOATE HYDROXYLASE 1UCI ; 1.80 ; MUTANTS OF RNASE SA 1UCJ ; 1.81 ; MUTANTS OF RNASE SA 1UCK ; 1.80 ; MUTANTS OF RNASE SA 1UCL ; 1.82 ; MUTANTS OF RNASE SA 1UYQ ; 2.20 ; MUTATED B-GLUCOSIDASE A FROM PAENIBACILLUS POLYMYXA SHOWING INCREASED STABILITY 1YW2 ; 2.01 ; MUTATED MUS MUSCULUS P38 KINASE (MP38) 3KBD ; -1.00 ; MUTATED NF KAPPA-B SITE, BI MODEL 1D1K ; 2.00 ; MUTATED SHIGA-LIKE TOXIN B SUBUNIT (D17E/W34A) COMPLEXED WITH RECEPTOR GB3 ANALOGUE 1C4Q ; 1.52 ; MUTATED SHIGA-LIKE TOXIN B SUBUNIT (F30A/W34A) COMPLEXED WITH RECEPTOR GB3 ANALOGUE 1C48 ; 1.60 ; MUTATED SHIGA-LIKE TOXIN B SUBUNIT (G62T) 1D1I ; 1.70 ; MUTATED SHIGA-LIKE TOXIN B SUBUNIT (W34A) COMPLEXED WITH RECEPTOR GB3 ANALOGUE 1MG2 ; 2.25 ; MUTATION OF ALPHA PHE55 OF METHYLAMINE DEHYDROGENASE ALTERS THE REORGANIZATION ENERGY AND ELECTRONIC COUPLING FOR ITS ELECTRON TRANSFER REACTION WITH AMICYANIN 1MG3 ; 2.40 ; MUTATION OF ALPHA PHE55 OF METHYLAMINE DEHYDROGENASE ALTERS THE REORGANIZATION ENERGY AND ELECTRONIC COUPLING FOR ITS ELECTRON TRANSFER REACTION WITH AMICYANIN 2HBI ; 1.70 ; MUTATION OF RESIDUE PHE 97 LEU DISRUPTS THE CENTRAL ALLOSTERIC PATHWAY IN SCAPHARCA DIMERIC HEMOGLOBIN 3HBI ; 1.50 ; MUTATION OF RESIDUE PHE 97 TO LEU DISRUPTS THE CENTRAL ALLOSTERIC PATHWAY OF SCAPHARCA DIMERIC HEMOGLOBIN 1JQ0 ; 1.70 ; MUTATION THAT DESTABILIZE THE GP41 CORE: DETERMINANTS FOR STABILIZING THE SIV/CPMAC ENVELOPE GLYCOPROTEIN COMPLEX. MUTANT STRUCTURE. 1JPX ; 2.30 ; MUTATION THAT DESTABILIZE THE GP41 CORE: DETERMINANTS FOR STABILIZING THE SIV/CPMAC ENVELOPE GLYCOPROTEIN COMPLEX. WILD TYPE. 1OOC ; 2.94 ; MUTATIONS IN THE T1.5 LOOP OF PECTATE LYASE A 1PE9 ; 1.60 ; MUTATIONS IN THE T1.5 LOOP OF PECTATE LYASE A 2FUS ; 2.30 ; MUTATIONS OF FUMARASE THAT DISTINGUISH BETWEEN THE ACTIVE SITE AND A NEARBY DICARBOXYLIC ACID BINDING SITE 1B62 ; 2.10 ; MUTL COMPLEXED WITH ADP 1B63 ; 1.90 ; MUTL COMPLEXED WITH ADPNP 1R2Z ; 1.63 ; MUTM (FPG) BOUND TO 5,6-DIHYDROURACIL (DHU) CONTAINING DEOXYRIBONUCLEIC ACID 1R2Y ; 2.34 ; MUTM (FPG) BOUND TO 8-OXOGUANINE (OXOG) CONTAINING DEOXYRIBONUCLEIC ACID 1L1T ; 1.80 ; MUTM (FPG) BOUND TO ABASIC-SITE CONTAINING DEOXYRIBONUCLEIC ACID 1L1Z ; 1.70 ; MUTM (FPG) COVALENT-DEOXYRIBONUCLEIC ACID INTERMEDIATE 1L2B ; 2.40 ; MUTM (FPG) DEOXYRIBONUCLEIC ACID END-PRODUCT STRUCTURE 1L2D ; 2.00 ; MUTM (FPG)-DEOXYRIBONUCLEIC ACID ESTRANGED GUANINE MISMATCH RECOGNITION COMPLEX 1L2C ; 2.20 ; MUTM (FPG)-DEOXYRIBONUCLEIC ACID ESTRANGED THYMINE MISMATCH RECOGNITION COMPLEX 1TUM ; -1.00 ; MUTT PYROPHOSPHOHYDROLASE-METAL-NUCLEOTIDE-METAL COMPLEX, NMR, 16 STRUCTURES 1KBH ; -1.00 ; MUTUAL SYNERGISTIC FOLDING IN THE INTERACTION BETWEEN NUCLEAR RECEPTOR COACTIVATORS CBP AND ACTR 1VRL ; 2.50 ; MUTY ADENINE GLYCOSYLASE IN COMPLEX WITH DEOXYRIBONUCLEIC ACID AND SOAKED ADENINE FREE BASE 1RRQ ; 2.22 ; MUTY ADENINE GLYCOSYLASE IN COMPLEX WITH DEOXYRIBONUCLEIC ACID CONTAINING AN A:OXOG PAIR 1RRS ; 2.40 ; MUTY ADENINE GLYCOSYLASE IN COMPLEX WITH DEOXYRIBONUCLEIC ACID CONTAINING AN ABASIC SITE 1MVM ; 3.50 ; MVM(STRAIN I), COMPLEX(VIRAL COAT/DEOXYRIBONUCLEIC ACID), VP2, PH7.5, T4 DEGREES C 1Y11 ; 3.30 ; MYCOBACTERIAL ADENYLYL CYCLASE RV1264, HOLOENZYME, ACTIVE STATE 1Y10 ; 2.30 ; MYCOBACTERIAL ADENYLYL CYCLASE RV1264, HOLOENZYME, INHIBITED STATE 1HKV ; 2.60 ; MYCOBACTERIUM DIAMINOPIMELATE DICARBOXYLASE (LYSA) 1HKW ; 2.80 ; MYCOBACTERIUM DIAMINOPIMELATE DICARBOXYLASE (LYSA) 1VEI ; 2.85 ; MYCOBACTERIUM SMEGMATIS DPS 1VEQ ; 3.98 ; MYCOBACTERIUM SMEGMATIS DPS HEXAGONAL FORM 1VEL ; 2.99 ; MYCOBACTERIUM SMEGMATIS DPS TETRAGONAL FORM 1TEX ; 2.60 ; MYCOBACTERIUM SMEGMATIS STF0 SULFOTRANSFERASE WITH TREHALOSE 1YBU ; 2.40 ; MYCOBACTERIUM TUBERCULOSIS ADENYLYL CYCLASE RV1900C CHD, IN COMPLEX WITH A SUBSTRATE ANALOG. 1YBT ; 2.31 ; MYCOBACTERIUM TUBERCULOSIS ADENYLYL CYCLASE, RV1900C CHD 2BMX ; 2.40 ; MYCOBACTERIUM TUBERCULOSIS AHPC 1F0N ; 1.80 ; MYCOBACTERIUM TUBERCULOSIS ANTIGEN 85B 1F0P ; 1.90 ; MYCOBACTERIUM TUBERCULOSIS ANTIGEN 85B WITH TREHALOSE 1SJP ; 3.20 ; MYCOBACTERIUM TUBERCULOSIS CHAPERONIN60.2 1SMC ; 2.10 ; MYCOBACTERIUM TUBERCULOSIS DUTPASE COMPLEXED WITH DUTP IN THE ABSENCE OF METAL ION. 1SIX ; 1.30 ; MYCOBACTERIUM TUBERCULOSIS DUTPASE COMPLEXED WITH MAGNESIUM AND ALPHA,BETA-IMIDO-DUTP 1SJN ; 1.80 ; MYCOBACTERIUM TUBERCULOSIS DUTPASE COMPLEXED WITH MAGNESIUM AND ALPHA,BETA-IMIDO-DUTP 1SNF ; 1.85 ; MYCOBACTERIUM TUBERCULOSIS DUTPASE COMPLEXED WITH MAGNESIUM AND DEOXYURIDINE 5'-MONOPHOSPHATE 1SLH ; 3.00 ; MYCOBACTERIUM TUBERCULOSIS DUTPASE COMPLEXED WITH MAGNESIUM AND DUDP 1LQU ; 1.25 ; MYCOBACTERIUM TUBERCULOSIS FPRA IN COMPLEX WITH NADPH 1RQ2 ; 1.86 ; MYCOBACTERIUM TUBERCULOSIS FTSZ IN COMPLEX WITH CITRATE 1RQ7 ; 2.60 ; MYCOBACTERIUM TUBERCULOSIS FTSZ IN COMPLEX WITH GDP 1RLU ; 2.08 ; MYCOBACTERIUM TUBERCULOSIS FTSZ IN COMPLEX WITH GTP-GAMMA-S 1K44 ; 2.60 ; MYCOBACTERIUM TUBERCULOSIS NUCLEOSIDE DIPHOSPHATE KINASE 1UPI ; 1.70 ; MYCOBACTERIUM TUBERCULOSIS RMLC EPIMERASE (RV3465) 1PKO ; 1.45 ; MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG) 1PKQ ; 3.00 ; MYELIN OLIGODENDROCYTE GLYCOPROTEIN-(8-18C5) FAB-COMPLEX 1GR0 ; 1.95 ; MYO-INOSITOL 1-PHOSPHATE SYNTHASE FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH NAD AND ZINC. 1U1I ; 1.90 ; MYO-INOSITOL PHOSPHATE SYNTHASE MIPS FROM A. FULGIDUS 1JKI ; 2.20 ; MYO-INOSITOL-1-PHOSPHATE SYNTHASE COMPLEXED WITH AN INHIBITOR, 2-DEOXY-GLUCITOL-6-PHOSPHATE 1XCH ; 1.70 ; MYOGLOBIN (HORSE HEART) MUTANT WITH LEU 104 REPLACED BY ASN (L104N) 1RSE ; 1.70 ; MYOGLOBIN (HORSE HEART) MUTANT WITH SER 92 REPLACED BY ASP (S92D) 1WLA ; 1.70 ; MYOGLOBIN (HORSE HEART) RECOMBINANT WILD-TYPE 1AZI ; 2.00 ; MYOGLOBIN (HORSE HEART) RECOMBINANT WILD-TYPE COMPLEXED WITH AZIDE 1DWR ; 1.45 ; MYOGLOBIN (HORSE HEART) WILD-TYPE COMPLEXED WITH CO 1NPF ; 1.90 ; MYOGLOBIN (HORSE HEART) WILD-TYPE COMPLEXED WITH NITRIC OXIDE 1NPG ; 1.70 ; MYOGLOBIN (HORSE HEART) WILD-TYPE COMPLEXED WITH NITROSOETHANE 1B7T ; 2.50 ; MYOSIN DIGESTED BY PAPAIN 2MYS ; 2.80 ; MYOSIN SUBFRAGMENT-1, ALPHA CARBON COORDINATES ONLY FOR THE TWO LIGHT CHAINS 2BKH ; 2.40 ; MYOSIN VI NUCLEOTIDE-FREE (MDINSERT2) CRYSTAL STRUCTURE 2BKI ; 2.90 ; MYOSIN VI NUCLEOTIDE-FREE (MDINSERT2-IQ) CRYSTAL STRUCTURE 2NMT ; 2.90 ; MYRISTOYL-COA:PROTEIN N-MYRISTOYLTRANSFERASE BOUND TO MYRISTOYL-COA AND PEPTIDE ANALOGS 1QA5 ; -1.00 ; MYRISTOYLATED HIV-1 NEF ANCHOR DOMAIN, NMR, 2 STRUCTURES 1IKU ; -1.00 ; MYRISTOYLATED RECOVERIN IN THE CALCIUM-FREE STATE, NMR, 22 STRUCTURES 1JSA ; -1.00 ; MYRISTOYLATED RECOVERIN WITH TWO CALCIUMS BOUND, NMR, 24 STRUCTURES 1E4M ; 1.20 ; MYROSINASE FROM SINAPIS ALBA 1MYR ; 1.64 ; MYROSINASE FROM SINAPIS ALBA 1E6X ; 1.60 ; MYROSINASE FROM SINAPIS ALBA WITH A BOUND TRANSITION STATE ANALOGUE,D-GLUCONO-1,5-LACTONE 1E71 ; 1.50 ; MYROSINASE FROM SINAPIS ALBA WITH BOUND ASCORBATE 1E6S ; 1.35 ; MYROSINASE FROM SINAPIS ALBA WITH BOUND GLUCO-HYDROXIMOLACTAM AND SULFATE 1E72 ; 1.60 ; MYROSINASE FROM SINAPIS ALBA WITH BOUND GLUCO-HYDROXIMOLACTAM AND SULFATE OR ASCORBATE 1E6Q ; 1.35 ; MYROSINASE FROM SINAPIS ALBA WITH THE BOUND TRANSITION STATE ANALOGUE GLUCO-TETRAZOLE 1HDS ; 1.98 ; Macromolecular Structure Refinement by Restrained Least-Squares and Interactive Graphics as Applied to Sickling Deer Type III Hemoglobin 1NSQ ; 2.20 ; Mechanism of Phosphate Transfer by Nucleoside Diphosphate Kinase: X-Ray Structures of a Phospho-Histidine Intermediate of the Enzymes from Drosophila and Dictyostelium 2BMH ; 2.00 ; Modeling Protein-Substrate Interactions in the Heme Domain of Cytochrome P450Bm-3 2GLR ; 2.20 ; Molecular Structure at 1.8 Angstroms of Mouse Liver Class Pi Glutathione S-Transferase Complexed with S-(P-Nitrobenzyl)Glutathione and Other Inhibitors 1FFH ; 2.05 ; N AND GTPASE DOMAINS OF THE SIGNAL SEQUENCE RECOGNITION PROTEIN FFH FROM THERMUS AQUATICUS 1NG1 ; 2.03 ; N AND GTPASE DOMAINS OF THE SIGNAL SEQUENCE RECOGNITION PROTEIN FFH FROM THERMUS AQUATICUS 2NG1 ; 2.02 ; N AND GTPASE DOMAINS OF THE SIGNAL SEQUENCE RECOGNITION PROTEIN FFH FROM THERMUS AQUATICUS 3NG1 ; 2.30 ; N AND GTPASE DOMAINS OF THE SIGNAL SEQUENCE RECOGNITION PROTEIN FFH FROM THERMUS AQUATICUS 1GS5 ; 1.50 ; N-ACETYL-L-GLUTAMATE KINASE FROM ESCHERICHIA COLI COMPLEXED WITH ITS SUBSTRATE N-ACETYLGLUTAMATE AND ITS SUBSTRATE ANALOG AMPPNP 1FIH ; 1.95 ; N-ACETYLGALACTOSAMINE BINDING MUTANT OF MANNOSE-BINDING PROTEIN A (QPDWG-HDRPY), COMPLEX WITH N-ACETYLGALACTOSAMINE 1FIF ; 1.95 ; N-ACETYLGALACTOSAMINE-SELECTIVE MUTANT OF MANNOSE-BINDING PROTEIN-A (QPDWG-HDRPY) 1FDY ; 2.45 ; N-ACETYLNEURAMINATE LYASE IN COMPLEX WITH HYDROXYPYRUVATE 1FDZ ; 2.60 ; N-ACETYLNEURAMINATE LYASE IN COMPLEX WITH PYRUVATE VIA BOROHYDRIDE REDUCTION 1NBB ; 2.40 ; N-BUTYLISOCYANIDE BOUND RHODOBACTER CAPSULATUS CYTOCHROME C' 1NCJ ; 3.40 ; N-CADHERIN, TWO-DOMAIN FRAGMENT 1U0Y ; 2.30 ; N-DOMAIN OF GRP94 LACKING IN COMPLEX WITH THE NOVEL LIGAND N-PROPYL CARBOXYAMIDO ADENOSINE, NPCA 1U0Z ; 1.90 ; N-DOMAIN OF GRP94 LACKING THE CHARGED DOMAIN IN COMPLEX WITH RADICICOL 1ZAC ; -1.00 ; N-DOMAIN OF TROPONIN C FROM CHICKEN SKELETAL MUSCLE, NMR, MINIMIZED AVERAGE STRUCTURE 1GYA ; -1.00 ; N-GLYCAN AND POLYPEPTIDE NMR SOLUTION STRUCTURES OF THE ADHESION DOMAIN OF HUMAN CD2 1NMT ; 2.45 ; N-MYRISTOYL TRANSFERASE FROM CANDIDA ALBICANS AT 2.45 A 1SKH ; -1.00 ; N-TERMINAL (1-30) OF BOVINE PRION PROTEIN 1SYO ; 2.20 ; N-TERMINAL 3 DOMAINS OF CI-MPR BOUND TO MANNOSE 6-PHOSPHATE 1SZ0 ; 2.10 ; N-TERMINAL 3 DOMAINS OF CI-MPR BOUND TO MANNOSE 6-PHOSPHATE 1H7S ; 1.95 ; N-TERMINAL 40KDA FRAGMENT OF HUMAN PMS2 1EA6 ; 2.70 ; N-TERMINAL 40KDA FRAGMENT OF NHPMS2 COMPLEXED WITH ADP 1DXX ; 2.60 ; N-TERMINAL ACTIN-BINDING DOMAIN OF HUMAN DYSTROPHIN 1AOA ; 2.40 ; N-TERMINAL ACTIN-CROSSLINKING DOMAIN FROM HUMAN FIMBRIN 1ULP ; -1.00 ; N-TERMINAL CELLULOSE-BINDING DOMAIN FROM CELLULOMONAS FIMI BETA-1,4-GLUCANASE C, NMR, 25 STRUCTURES 1ULO ; -1.00 ; N-TERMINAL CELLULOSE-BINDING DOMAIN FROM CELLULOMONAS FIMI BETA-1,4-GLUCANASE C, NMR, MINIMIZED AVERAGE STRUCTURE 1GJJ ; -1.00 ; N-TERMINAL CONSTANT REGION OF THE NUCLEAR ENVELOPE PROTEIN LAP2 1BB8 ; -1.00 ; N-TERMINAL DEOXYRIBONUCLEIC ACID BINDING DOMAIN FROM TN916 INTEGRASE, NMR, 25 STRUCTURES 2BB8 ; -1.00 ; N-TERMINAL DEOXYRIBONUCLEIC ACID BINDING DOMAIN FROM TN916 INTEGRASE, NMR, MINIMIZED AVERAGE STRUCTURE 1D2W ; 1.89 ; N-TERMINAL DOMAIN CORE METHIONINE MUTATION 1D2Y ; 2.06 ; N-TERMINAL DOMAIN CORE METHIONINE MUTATION 1D3F ; 2.05 ; N-TERMINAL DOMAIN CORE METHIONINE MUTATION 1D3J ; 1.97 ; N-TERMINAL DOMAIN CORE METHIONINE MUTATION 2CBL ; 2.10 ; N-TERMINAL DOMAIN OF CBL IN COMPLEX WITH ITS BINDING SITE ON ZAP-70 1B79 ; 2.30 ; N-TERMINAL DOMAIN OF DEOXYRIBONUCLEIC ACID REPLICATION PROTEIN DNAB 1AOY ; -1.00 ; N-TERMINAL DOMAIN OF ESCHERICHIA COLI ARGININE REPRESSOR NMR, 23 STRUCTURES 1UUJ ; 1.75 ; N-TERMINAL DOMAIN OF LISSENCEPHALY-1 PROTEIN (LIS-1) 1QCS ; 1.90 ; N-TERMINAL DOMAIN OF N-ETHYLMALEIMIDE SENSITIVE FACTOR (NSF) 1QHK ; -1.00 ; N-TERMINAL DOMAIN OF SACCHAROMYCES CEREVISIAE RNASE HI REVEALS A FOLD WITH A RESEMBLANCE TO THE N-TERMINAL DOMAIN OF RIBOSOMAL PROTEIN L9 1CR5 ; 2.30 ; N-TERMINAL DOMAIN OF SEC18P 1QFP ; 2.80 ; N-TERMINAL DOMAIN OF SIALOADHESIN (MOUSE) 1QFO ; 1.85 ; N-TERMINAL DOMAIN OF SIALOADHESIN (MOUSE) IN COMPLEX WITH 3'SIALYLLACTOSE 1URL ; 2.40 ; N-TERMINAL DOMAIN OF SIALOADHESIN (MOUSE) IN COMPLEX WITH GLYCOPEPTIDE 1PFT ; -1.00 ; N-TERMINAL DOMAIN OF TFIIB, NMR 1MWP ; 1.80 ; N-TERMINAL DOMAIN OF THE AMYLOID PRECURSOR PROTEIN 1ABV ; -1.00 ; N-TERMINAL DOMAIN OF THE DELTA SUBUNIT OF THE F1F0-ATP SYNTHASE FROM ESCHERICHIA COLI, NMR, MINIMIZED AVERAGE STRUCTURE 2B29 ; 1.60 ; N-TERMINAL DOMAIN OF THE RPA70 SUBUNIT OF HUMAN REPLICATION PROTEIN A. 2TMP ; -1.00 ; N-TERMINAL DOMAIN OF TISSUE INHIBITOR OF METALLOPROTEINASE-2 (N-TIMP-2), NMR, 49 STRUCTURES 1QDW ; 2.10 ; N-TERMINAL DOMAIN, VOLTAGE-GATED POTASSIUM CHANNEL KV1.2 RESIDUES 33-119 1QDV ; 1.60 ; N-TERMINAL DOMAIN, VOLTAGE-GATED POTASSIUM CHANNEL KV1.2 RESIDUES 33-131 1BF9 ; -1.00 ; N-TERMINAL EGF-LIKE DOMAIN FROM HUMAN FACTOR VII, NMR, 23 STRUCTURES 2BLN ; 1.20 ; N-TERMINAL FORMYLTRANSFERASE DOMAIN OF ARNA IN COMPLEX WITH N-5-FORMYLTETRAHYDROFOLATE AND UMP 1CS6 ; 1.80 ; N-TERMINAL FRAGMENT OF AXONIN-1 FROM CHICKEN 1GCJ ; 2.60 ; N-TERMINAL FRAGMENT OF IMPORTIN-BETA 1AIL ; 1.90 ; N-TERMINAL FRAGMENT OF NS1 PROTEIN FROM INFLUENZA A VIRUS 1H3L ; 2.37 ; N-TERMINAL FRAGMENT OF SIGR FROM STREPTOMYCES COELICOLOR 1MKN ; -1.00 ; N-TERMINAL HALF OF MIDKINE 1Z0H ; 2.00 ; N-TERMINAL HELIX REORIENTS IN RECOMBINANT C-FRAGMENT OF CLOSTRIDIUM BOTULINUM TYPE B 1BY0 ; -1.00 ; N-TERMINAL LEUCINE-REPEAT REGION OF HEPATITIS DELTA ANTIGEN 1L6P ; 1.65 ; N-TERMINAL OF DSBD (RESIDUES 20-144) FROM E. COLI. 1ODA ; 3.31 ; N-TERMINAL OF SIALOADHESIN IN COMPLEX WITH ME-A-9-N- (BIPHENYL-4-CARBONYL)-AMINO-9-DEOXY-NEU5AC (BIP COMPOUND) 1OD7 ; 3.00 ; N-TERMINAL OF SIALOADHESIN IN COMPLEX WITH ME-A-9-N- (NAPHTHYL-2-CARBONYL)-AMINO-9-DEOXY-NEU5AC (NAP COMPOUND) 1OD9 ; 2.10 ; N-TERMINAL OF SIALOADHESIN IN COMPLEX WITH ME-A-9-N-BENZOYL-AMINO-9-DEOXY-NEU5AC (BENZ COMPOUND) 1S6J ; -1.00 ; N-TERMINAL REGION OF THE CA2+-SATURATED CALCIUM REGULATORY DOMAIN (CLD) FROM SOYBEAN CALCIUM-DEPENDENT PROTEIN KINASE- ALPHA (CDPK) 1E4U ; -1.00 ; N-TERMINAL RING FINGER DOMAIN OF HUMAN NOT-4 2BZ8 ; 2.00 ; N-TERMINAL SH3 DOMAIN OF CIN85 BOUND TO CBL-B PEPTIDE 1LOI ; -1.00 ; N-TERMINAL SPLICE REGION OF RAT C-AMP PHOSPHODIESTERASE, NMR, 7 STRUCTURES 1CKL ; 3.10 ; N-TERMINAL TWO DOMAINS OF HUMAN CD46 (MEMBRANE COFACTOR PROTEIN, MCP) 1E0E ; -1.00 ; N-TERMINAL ZINC-BINDING HHCC DOMAIN OF HIV-2 INTEGRASE 1QQF ; 1.45 ; N-TERMINALLY TRUNCATED C3D,G FRAGMENT OF THE COMPLEMENT SYSTEM 1QSJ ; 1.90 ; N-TERMINALLY TRUNCATED C3DG FRAGMENT 1BOI ; 2.20 ; N-TERMINALLY TRUNCATED RHODANESE 1R4C ; 2.18 ; N-TRUNCATED HUMAN CYSTATIN C; DIMERIC FORM WITH 3D DOMAIN SWAPPING 1MVJ ; -1.00 ; N-TYPE CALCIUM CHANNEL BLOCKER, OMEGA-CONOTOXIN MVIIA NMR, 15 STRUCTURES 1MVI ; -1.00 ; N-TYPE CALCIUM CHANNEL BLOCKER, OMEGA-CONOTOXIN MVIIA, NMR, 15 STRUCTURES 1DZG ; 2.80 ; N135Q-S380C-ANTITHROMBIN-III 1E2V ; 1.85 ; N153Q MUTANT OF CYTOCHROME F FROM CHLAMYDOMONAS REINHARDTII 1E2W ; 1.60 ; N168F MUTANT OF CYTOCHROME F FROM CHLAMYDOMONAS REINHARDTII 1NGQ ; 2.40 ; N1G9 (IGG1LAMBDA) FAB FRAGMENT 1NGP ; 2.40 ; N1G9 (IGG1LAMBDA) FAB FRAGMENT COMPLEXED WITH (4-HYDROXY-3-NITROPHENYL) ACETATE 1HM4 ; 3.47 ; N219L PENTALENENE SYNTHASE 1HM7 ; 2.90 ; N219L PENTALENENE SYNTHASE 1NTO ; 1.94 ; N249Y MUTANT OF ALCOHOL DEHYDROGENASE FROM THE ARCHAEON SULFOLOBUS SOLFATARICUS-MONOCLINIC CRYSTAL FORM 1NVG ; 2.50 ; N249Y MUTANT OF THE ALCOHOL DEHYDROGENASE FROM THE ARCHAEON SULFOLOBUS SOLFATARICUS-TETRAGONAL CRYSTAL FORM 1CK3 ; 2.28 ; N276D MUTANT OF ESCHERICHIA COLI TEM-1 BETA-LACTAMASE 1BOX ; 1.60 ; N39S MUTANT OF RNASE SA FROM STREPTOMYCES AUREOFACIENS 1B6R ; 2.10 ; N5-CARBOXYAMINOIMIDAZOLE RIBONUCLEOTIDE SYNTHETASE FROM E. COLI 1NV8 ; 2.20 ; N5-GLUTAMINE METHYLTRANSFERASE, HEMK 1JO1 ; -1.00 ; N7-GUANINE ADDUCT OF 2,7-DIAMINOMITOSENE WITH DEOXYRIBONUCLEIC ACID 1GY7 ; 1.60 ; N77Y POINT MUTANT OF S.CEREVISIAE NTF2 1GYB ; 1.90 ; N77Y POINT MUTANT OF YNTF2 BOUND TO FXFG NUCLEOPORIN REPEAT 1XOE ; 2.20 ; N9 TERN INFLUENZA NEURAMINIDASE COMPLEXED WITH (2R,4R,5R)-5- (1-ACETYLAMINO-3-METHYL-BUTYL-PYRROLIDINE-2, 4- DICAROBYXYLIC ACID 4-METHYL ESTERDASE COMPLEXED WITH 1XOG ; 2.80 ; N9 TERN INFLUENZA NEURAMINIDASE COMPLEXED WITH A 2,5- DISUBSTITUTED TETRAHYDROFURAN-5-CARBOXYLIC ACID 2BHC ; 2.40 ; NA SUBSTITUTED E. COLI AMINOPEPTIDASE P 1XDW ; 1.98 ; NAD+-DEPENDENT (R)-2-HYDROXYGLUTARATE DEHYDROGENASE FROM ACIDAMINOCOCCUS FERMENTANS 2NPX ; 2.40 ; NADH BINDING SITE AND CATALYSIS OF NADH PEROXIDASE 1XHC ; 2.35 ; NADH OXIDASE /NITRITE REDUCTASE FROM PYROCOCCUS FURIOSUS PFU-1140779-001 1NOX ; 1.59 ; NADH OXIDASE FROM THERMUS THERMOPHILUS 1JOA ; 2.80 ; NADH PEROXIDASE WITH CYSTEINE-SULFENIC ACID 2AG8 ; 2.10 ; NADP COMPLEX OF PYRROLINE-5-CARBOXYLATE REDUCTASE FROM NEISSERIA MENINGITIDIS 1YKF ; 2.50 ; NADP-DEPENDENT ALCOHOL DEHYDROGENASE FROM THERMOANAEROBIUM BROCKII 1MOK ; 2.80 ; NADPH DEPENDENT 2-KETOPROPYL COENZYME M OXIDOREDUCTASE/CARBOXYLASE 1MO9 ; 1.65 ; NADPH DEPENDENT 2-KETOPROPYL COENZYME M OXIDOREDUCTASE/CARBOXYLASE COMPLEXED WITH 2-KETOPROPYL COENZYME M 1XK2 ; 2.20 ; NADPH- AND ASCORBATE-SUPPORTED HEME OXYGENASE REACTIONS ARE DISTINCT. REGIOSPECIFICITY OF HEME CLEAVAGE BY THE R183E MUTANT 1XK3 ; 2.08 ; NADPH- AND ASCORBATE-SUPPORTED HEME OXYGENASE REACTIONS ARE DISTINCT. REGIOSPECIFICITY OF HEME CLEAVAGE BY THE R183E MUTANT 1BKJ ; 1.80 ; NADPH:FMN OXIDOREDUCTASE FROM VIBRIO HARVEYI 2BKJ ; 2.08 ; NADPH:FMN OXIDOREDUCTASE FROM VIBRIO HARVEYI COMPLEXED WITH NAD+ 1LW7 ; 2.90 ; NADR PROTEIN FROM HAEMOPHILUS INFLUENZAE 1CQW ; 1.50 ; NAI COCRYSTALLISED WITH HALOALKANE DEHALOGENASE FROM A RHODOCOCCUS SPECIES 1JI4 ; 2.52 ; NAP PROTEIN FROM HELICOBACTER PYLORI 1EG9 ; 1.60 ; NAPHTHALENE 1,2-DIOXYGENASE WITH INDOLE BOUND IN THE ACTIVE SITE. 1O7G ; 1.70 ; NAPHTHALENE 1,2-DIOXYGENASE WITH NAPHTHALENE BOUND IN THE ACTIVE SITE. 1UUV ; 1.65 ; NAPHTHALENE 1,2-DIOXYGENASE WITH NITRIC OXIDE AND INDOLE BOUND IN THE ACTIVE SITE. 1UUW ; 2.30 ; NAPHTHALENE 1,2-DIOXYGENASE WITH NITRIC OXIDE BOUND IN THE ACTIVE SITE. 1O7H ; 2.20 ; NAPHTHALENE 1,2-DIOXYGENASE WITH OXIDIZED RIESKE IRON SULPHUR CENTER SITE. 1O7M ; 1.75 ; NAPHTHALENE 1,2-DIOXYGENASE, BINARY COMPLEX WITH DIOXYGEN 1O7W ; 1.90 ; NAPHTHALENE 1,2-DIOXYGENASE, FULLY REDUCED FORM 1O7P ; 1.95 ; NAPHTHALENE 1,2-DIOXYGENASE, PRODUCT COMPLEX 1O7N ; 1.40 ; NAPHTHALENE 1,2-DIOXYGENASE, TERNARY COMPLEX WITH DIOXYGEN AND INDOLE 1NDO ; 2.25 ; NAPTHALENE 1,2-DIOXYGENASE 1ZG5 ; 2.30 ; NARL COMPLEXED TO NARG-89 PROMOTER PALINDROMIC TAIL-TO-TAIL DEOXYRIBONUCLEIC ACID SITE 1ZG1 ; 2.30 ; NARL COMPLEXED TO NIRB PROMOTER NON-PALINDROMIC TAIL-TO- TAIL DEOXYRIBONUCLEIC ACID SITE 1QG8 ; 1.50 ; NATIVE (MAGNESIUM-CONTAINING) SPSA FROM BACILLUS SUBTILIS 1A80 ; 2.10 ; NATIVE 2,5-DIKETO-D-GLUCONIC ACID REDUCTASE A FROM CORYNBACTERIUM SP. COMPLEXED WITH NADPH 1GQN ; 1.78 ; NATIVE 3-DEHYDROQUINASE FROM SALMONELLA TYPHI 1QO9 ; 2.70 ; NATIVE ACETYLCHOLINESTERASE FROM DROSOPHILA MELANOGASTER 2ACE ; 2.50 ; NATIVE ACETYLCHOLINESTERASE FROM TORPEDO CALIFORNICA 1EA5 ; 1.80 ; NATIVE ACETYLCHOLINESTERASE FROM TORPEDO CALIFORNICA AT 1.8A RESOLUTION 1R12 ; 1.70 ; NATIVE APLYSIA ADP RIBOSYL CYCLASE 1UV4 ; 1.50 ; NATIVE BACILLUS SUBTILIS ARABINANASE ARB43A 1ZOL ; 1.90 ; NATIVE BETA-PGM 1S0Q ; 1.02 ; NATIVE BOVINE PANCREATIC TRYPSIN 1B5F ; 1.72 ; NATIVE CARDOSIN A FROM CYNARA CARDUNCULUS L. 2BS9 ; 2.20 ; NATIVE CRYSTAL STRUCTURE OF A GH39 BETA-XYLOSIDASE XYNB1 FROM GEOBACILLUS STEAROTHERMOPHILUS 1TW0 ; 2.20 ; NATIVE CRYSTAL STRUCTURE OF SPE16 1I9I ; 2.72 ; NATIVE CRYSTAL STRUCTURE OF THE RECOMBINANT MONOCLONAL WILD TYPE ANTI-TESTOSTERONE FAB FRAGMENT 2BSJ ; 1.83 ; NATIVE CRYSTAL STRUCTURE OF THE TYPE III SECRETION CHAPERONE SYCT FROM YERSINIA ENTEROCOLITICA 1W1O ; 1.70 ; NATIVE CYTOKININ DEHYDROGENASE 1H9W ; 2.00 ; NATIVE DIOCLEA GUIANENSIS SEED LECTIN 7A3H ; 0.95 ; NATIVE ENDOGLUCANASE CEL5A CATALYTIC CORE DOMAIN AT 0.95 ANGSTROMS RESOLUTION 1K07 ; 1.65 ; NATIVE FEZ-1 METALLO-BETA-LACTAMASE FROM LEGIONELLA GORMANII 1D6O ; 1.85 ; NATIVE FKBP 1PV2 ; 2.71 ; NATIVE FORM 2 E.COLI CHAPERONE HSP31 1ODW ; 2.10 ; NATIVE HIV-1 PROTEINASE 1R42 ; 2.20 ; NATIVE HUMAN ANGIOTENSIN CONVERTING ENZYME-RELATED CARBOXYPEPTIDASE (ACE2) 1NOU ; 2.40 ; NATIVE HUMAN LYSOSOMAL BETA-HEXOSAMINIDASE ISOFORM B 1REX ; 1.50 ; NATIVE HUMAN LYSOZYME 1VYM ; 2.30 ; NATIVE HUMAN PCNA 1W60 ; 3.15 ; NATIVE HUMAN PCNA 1F8E ; 1.40 ; NATIVE INFLUENZA NEURAMINIDASE IN COMPLEX WITH 4,9-DIAMINO- 2-DEOXY-2,3-DEHYDRO-N-ACETYL-NEURAMINIC ACID 1F8C ; 1.70 ; NATIVE INFLUENZA NEURAMINIDASE IN COMPLEX WITH 4-AMINO-2- DEOXY-2,3-DEHYDRO-N-NEURAMINIC ACID 1F8D ; 1.40 ; NATIVE INFLUENZA NEURAMINIDASE IN COMPLEX WITH 9-AMINO-2- DEOXY-2,3-DEHYDRO-N-NEURAMINIC ACID 1F8B ; 1.80 ; NATIVE INFLUENZA VIRUS NEURAMINIDASE IN COMPLEX WITH NEU5AC2EN 7NN9 ; 2.00 ; NATIVE INFLUENZA VIRUS NEURAMINIDASE SUBTYPE N9 (TERN) 1JSW ; 2.80 ; NATIVE L-ASPARTATE AMMONIA LYASE 1B2P ; 1.70 ; NATIVE MANNOSE-SPECIFIC BULB LECTIN FROM SCILLA CAMPANULATA (BLUEBELL) AT 1.7 ANGSTROMS RESOLUTION 1W75 ; 2.40 ; NATIVE ORTHORHOMBIC FORM OF TORPEDO CALIFORNICA ACETYLCHOLINESTERASE (ACHE) 1OTY ; 2.50 ; NATIVE PNP +ALLO 1OU4 ; 2.50 ; NATIVE PNP +TALO 1PPY ; 1.95 ; NATIVE PRECURSOR OF PYRUVOYL DEPENDENT ASPARTATE DECARBOXYLASE 1VXA ; 2.00 ; NATIVE SPERM WHALE MYOGLOBIN 1VXB ; 2.00 ; NATIVE SPERM WHALE MYOGLOBIN 1VXC ; 1.70 ; NATIVE SPERM WHALE MYOGLOBIN 1VXD ; 1.70 ; NATIVE SPERM WHALE MYOGLOBIN 1VXE ; 1.70 ; NATIVE SPERM WHALE MYOGLOBIN 1VXF ; 1.70 ; NATIVE SPERM WHALE MYOGLOBIN 1VXG ; 1.70 ; NATIVE SPERM WHALE MYOGLOBIN 1VXH ; 1.70 ; NATIVE SPERM WHALE MYOGLOBIN 1TG7 ; 1.90 ; NATIVE STRUCTURE OF BETA-GALACTOSIDASE FROM PENICILLIUM SP. 1XC6 ; 2.10 ; NATIVE STRUCTURE OF BETA-GALACTOSIDASE FROM PENICILLIUM SP. IN COMPLEX WITH GALACTOSE 1L0N ; 2.60 ; NATIVE STRUCTURE OF BOVINE MITOCHONDRIAL CYTOCHROME BC1 COMPLEX 1E43 ; 1.70 ; NATIVE STRUCTURE OF CHIMAERIC AMYLASE FROM B. AMYLOLIQUEFACIENS AND B. LICHENIFORMIS AT 1.7A 1E3X ; 1.90 ; NATIVE STRUCTURE OF CHIMAERIC AMYLASE FROM B. AMYLOLIQUEFACIENS AND B. LICHENIFORMIS AT 1.92A 2BW8 ; 1.54 ; NATIVE STRUCTURE OF ENDOGLUCANASE 12A (CEL12A) FROM RHODOTHERMUS MARINUS 1R8W ; 2.50 ; NATIVE STRUCTURE OF THE B12-INDEPENDENT GLYCEROL DEHYDRATASE FROM CLOSTRIDIUM BUTYRICUM 1ERN ; 2.40 ; NATIVE STRUCTURE OF THE EXTRACELLULAR DOMAIN OF ERYTHROPOIETIN (EPO) RECEPTOR [EBP] 1KO9 ; 2.15 ; NATIVE STRUCTURE OF THE HUMAN 8-OXOGUANINE DEOXYRIBONUCLEIC ACID GLYCOSYLASE HOGG1 1ZCK ; 1.90 ; NATIVE STRUCTURE PRL-1 (PTP4A1) 1QHZ ; 1.95 ; NATIVE TETRAGONAL STRUCTURE OF THE ENDOGLUCANASE CEL5A FROM BACILLUS AGARADHAERENS 1US3 ; 1.85 ; NATIVE XYLANASE10C FROM CELLVIBRIO JAPONICUS 2NCD ; 2.50 ; NCD (NON-CLARET DISJUNCTIONAL) DIMER FROM D. MELANOGASTER 1KVH ; -1.00 ; NCSI-GB-BULGE-DEOXYRIBONUCLEIC ACID COMPLEX INDUCED FORMATION OF A DEOXYRIBONUCLEIC ACID BULGE STRUCTURE BY A MOLECULAR WEDGE LIGAND-POST-ACTIVATED NEOCARZINOSTATIN CHROMOPHORE 1S5Z ; 2.00 ; NDP KINASE IN COMPLEX WITH ADENOSINE PHOSPHONOACETIC ACID 1MN9 ; 2.90 ; NDP KINASE MUTANT (H122G) COMPLEX WITH RTP 1MN7 ; 2.15 ; NDP KINASE MUTANT (H122G;N119S;F64W) IN COMPLEX WITH ABAZTTP 1M77 ; 1.25 ; NEAR ATOMIC RESOLUTION CRYSTAL STRUCTURE OF AN A-DEOXYRIBONUCLEIC ACID DECAMER D(CCCGATCGGG): COBALT HEXAMMINE INTERACTIONS WITH A-DEOXYRIBONUCLEIC ACID 2BKR ; 1.90 ; NEDD8 NEDP1 COMPLEX 2BKQ ; 2.00 ; NEDD8 PROTEASE 2BYU ; 16.50 ; NEGATIVE STAIN EM RECONSTRUCTION OF M.TUBERCULOSIS ACR1(HSP 16.3) FITTED WITH WHEAT SHSP DIMER 1KOP ; 1.90 ; NEISSERIA GONORRHOEAE CARBONIC ANHYDRASE 1KOQ ; 1.90 ; NEISSERIA GONORRHOEAE CARBONIC ANHYDRASE 1D9Y ; 2.20 ; NEISSERIA GONORRHOEAE FERRIC BINDING PROTEIN 3FRU ; 2.20 ; NEONATAL FC RECEPTOR, PH 6.5 1ZTT ; 1.85 ; NETROPSIN BOUND TO D(CTTAATTCGAATTAAG) IN COMPLEX WITH MMLV RT CATALYTIC FRAGMENT 3NCM ; -1.00 ; NEURAL CELL ADHESION MOLECULE, MODULE 2, NMR, 20 STRUCTURES 2NCM ; -1.00 ; NEURAL CELL ADHESION MOLECULE, NMR, 20 STRUCTURES 1I1I ; 2.30 ; NEUROLYSIN (ENDOPEPTIDASE 24.16) CRYSTAL STRUCTURE 2NBT ; -1.00 ; NEURONAL BUNGAROTOXIN, NMR, 10 STRUCTURES 1VAG ; 2.00 ; NEURONAL NITRIC OXIDE SYNTHASE OXYGENASE DOMAIN COMPLEXED WITH THE INHIBITOR AR-R17477 1SFC ; 2.40 ; NEURONAL SYNAPTIC FUSION COMPLEX 1NPM ; 2.10 ; NEUROPSIN, A SERINE PROTEASE EXPRESSED IN THE LIMBIC SYSTEM OF MOUSE BRAIN 1JOF ; 2.50 ; NEUROSPORA CRASSA 3-CARBOXY-CIS,CIS-MUCOANTE LACTONIZING ENZYME 1B7D ; 1.73 ; NEUROTOXIN (TS1) FROM BRAZILIAN SCORPION TITYUS SERRULATUS 1XTF ; 2.20 ; NEUROTOXIN BONT/A E224Q Y366F MUTANT 1VYC ; -1.00 ; NEUROTOXIN FROM BUNGARUS CANDIDUS 1B98 ; 2.75 ; NEUROTROPHIN 4 (HOMODIMER) 1B8K ; 2.15 ; NEUROTROPHIN-3 FROM HUMAN 1ESP ; 2.80 ; NEUTRAL PROTEASE MUTANT E144S 1WQ2 ; 2.40 ; NEUTRON CRYSTAL STRUCTURE OF DISSIMILATORY SULFITE REDUCTASE D (DSRD) 1IU6 ; 1.60 ; NEUTRON CRYSTAL STRUCTURE OF THE RUBREDOXIN MUTANT FROM PYROCOCCUS FURIOSUS 1VCX ; 1.50 ; NEUTRON CRYSTAL STRUCTURE OF THE WILD TYPE RUBREDOXIN FROM PYROCOCCUS FURIOSUS AT 1.5A RESOLUTION 1V9G ; 1.80 ; NEUTRON CRYSTALLOGRAPHIC ANALYSIS OF THE Z-DEOXYRIBONUCLEIC ACID HEXAMER CGCGCG 1GKT ; 2.10 ; NEUTRON LAUE DIFFRACTION STRUCTURE OF ENDOTHIAPEPSIN COMPLEXED WITH TRANSITION STATE ANALOGUE INHIBITOR H261 1L2K ; 1.50 ; NEUTRON STRUCTURE DETERMINATION OF SPERM WHALE MET- MYOGLOBIN AT 1.5A RESOLUTION. 1LZN ; 1.70 ; NEUTRON STRUCTURE OF HEN EGG-WHITE LYSOZYME 1CQ2 ; 2.00 ; NEUTRON STRUTURE OF FULLY DEUTERATED SPERM WHALE MYOGLOBIN AT 2.0 ANGSTROM 1TVX ; 1.75 ; NEUTROPHIL ACTIVATING PEPTIDE-2 VARIANT FORM M6L WITH FIVE ADDITIONAL AMINO TERMINAL RESIDUES (DSDLY) 1QQS ; 2.40 ; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN HOMODIMER 1L6M ; 2.40 ; NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN IS A NOVEL BACTERIOSTATIC AGENT THAT INTERFERES WITH SIDEROPHORE- MEDIATED IRON ACQUISITION 1HO0 ; -1.00 ; NEW B-CHAIN MUTANT OF BOVINE INSULIN 1IV5 ; 2.60 ; NEW CRYSTAL FORM OF HUMAN CD81 LARGE EXTRACELLULAR LOOP. 1QGE ; 1.70 ; NEW CRYSTAL FORM OF PSEUDOMONAS GLUMAE (FORMERLY CHROMOBACTERIUM VISCOSUM ATCC 6918) LIPASE 2BP7 ; 2.90 ; NEW CRYSTAL FORM OF THE PSEUDOMONAS PUTIDA BRANCHED-CHAIN DEHYDROGENASE (E1) 1P8L ; 2.95 ; NEW CRYSTAL STRUCTURE OF CHLORELLA VIRUS DEOXYRIBONUCLEIC ACID LIGASE- ADENYLATE 1C2T ; 2.10 ; NEW INSIGHTS INTO INHIBITOR DESIGN FROM THE CRYSTAL STRUCTURE AND NMR STUDIES OF E. COLI GAR TRANSFORMYLASE IN COMPLEX WITH BETA-GAR AND 10-FORMYL-5,8,10-TRIDEAZAFOLIC ACID. 1C3E ; 2.10 ; NEW INSIGHTS INTO INHIBITOR DESIGN FROM THE CRYSTAL STRUCTURE AND NMR STUDIES OF E. COLI GAR TRANSFORMYLATE IN COMPLEX WITH BETA-GAR AND 10-FORMYL-5,8,10-TRIDEAZAFOLIC ACID. 1H98 ; 1.64 ; NEW INSIGHTS INTO THERMOSTABILITY OF BACTERIAL FERREDOXINS: HIGH RESOLUTION CRYSTAL STRUCTURE OF THE SEVEN-IRON FERREDOXIN FROM THERMUS THERMOPHILUS 1RO3 ; -1.00 ; NEW STRUCTURAL INSIGHTS ON SHORT DISINTEGRIN ECHISTATIN BY NMR 1XN2 ; 1.90 ; NEW SUBSTRATE BINDING POCKETS FOR BETA-SECRETASE. 1USR ; 2.00 ; NEWCASTLE DISEASE VIRUS HEMAGGLUTININ-NEURAMINIDASE: EVIDENCE FOR A SECOND SIALIC ACID BINDING SITE AND IMPLICATIONS FOR FUSION 1MY5 ; 1.80 ; NF-KAPPAB P65 SUBUNIT DIMERIZATION DOMAIN HOMODIMER 1MY7 ; 1.49 ; NF-KAPPAB P65 SUBUNIT DIMERIZATION DOMAIN HOMODIMER N202R MUTATION 1ZK9 ; 2.18 ; NF-KB RELB FORMS AN INTERTWINED HOMODIMER 1ZKA ; 2.20 ; NF-KB RELB FORMS AN INTERTWINED HOMODIMER, Y300S MUTANT 1SVC ; 2.60 ; NFKB P50 HOMODIMER BOUND TO DEOXYRIBONUCLEIC ACID 1WWA ; 2.50 ; NGF BINDING DOMAIN OF HUMAN TRKA RECEPTOR 1WWW ; 2.20 ; NGF IN COMPLEX WITH DOMAIN 5 OF THE TRKA RECEPTOR 1KQP ; 1.03 ; NH3-DEPENDENT NAD+ SYNTHETASE FROM BACILLUS SUBTILIS AT 1 A RESOLUTION 1IH8 ; 1.90 ; NH3-DEPENDENT NAD+ SYNTHETASE FROM BACILLUS SUBTILIS COMPLEXED WITH AMP-CPP AND MG2+ IONS. 1DKE ; 2.10 ; NI BETA HEME HUMAN HEMOGLOBIN 473D ; 1.58 ; NI2+/GUANINE INTERACTIONS AND NETROPSIN/GUANINE STACKING IN D(CGTATATACG)2 1G1N ; -1.00 ; NICKED DECAMER DEOXYRIBONUCLEIC ACID WITH PEG6 TETHER, NMR, 30 STRUCTURES 1T6I ; 2.81 ; NICKEL SUPEROXIDE DISMUTASE (NISOD) APO STRUCTURE 1T6Q ; 2.05 ; NICKEL SUPEROXIDE DISMUTASE (NISOD) CN-TREATED APO STRUCTURE 1T6U ; 1.30 ; NICKEL SUPEROXIDE DISMUTASE (NISOD) NATIVE 1.30 A STRUCTURE 1Q5Y ; 1.40 ; NICKEL-BOUND C-TERMINAL REGULATORY DOMAIN OF NIKR 1R0J ; 2.00 ; NICKEL-SUBSTITUTED RUBREDOXIN 1GL4 ; 2.00 ; NIDOGEN-1 G2/PERLECAN IG3 COMPLEX 1ECX ; 2.70 ; NIFS-LIKE PROTEIN 1EG5 ; 2.00 ; NIFS-LIKE PROTEIN 2BJ8 ; 2.10 ; NIKR IN CLOSED CONFORMATION AND NICKEL BOUND TO HIGH AND LOW-AFFINITY SITES 2BJ7 ; 2.10 ; NIKR IN CLOSED CONFORMATION AND NICKEL BOUND TO HIGH- AFFINITY SITES 2BJ1 ; 3.00 ; NIKR IN OPEN CONFORMATION AND NICKEL BOUND TO HIGH-AFFINITY SITES 2BJ9 ; 3.00 ; NIKR WITH BOUND NICKEL AND PHOSPHATE 2BJ3 ; 2.20 ; NIKR-APO 1W3P ; 1.80 ; NIMA FROM D. RADIODURANS WITH A HIS71-PYRUVATE RESIDUE 1W3Q ; 1.88 ; NIMA FROM D. RADIODURANS WITH COVALENLY BOUND LACTATE 1W3R ; 1.90 ; NIMA FROM D. RADIODURANS WITH METRONIDAZOLE AND PYRUVATE 19HC ; 1.80 ; NINE-HAEM CYTOCHROME C FROM DESULFOVIBRIO DESULFURICANS ATCC 27774 1S8J ; 2.30 ; NITRATE-BOUND D85S MUTANT OF BACTERIORHODOPSIN 1SNR ; 1.31 ; NITRIC OXIDE BOUND TO CU NITRITE REDUCTASE 1AHJ ; 2.65 ; NITRILE HYDRATASE 2AHJ ; 1.70 ; NITRILE HYDRATASE COMPLEXED WITH NITRIC OXIDE 1SJM ; 1.40 ; NITRITE BOUND COPPER CONTAINING NITRITE REDUCTASE 1NDT ; 2.10 ; NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS 1BQ5 ; 2.05 ; NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS GIFU 1051 1KBV ; 1.95 ; NITRITE-SOAKED CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE 1A6J ; 2.35 ; NITROGEN REGULATORY BACTERIAL PROTEIN IIA-NITROGEN 1M34 ; 2.30 ; NITROGENASE COMPLEX FROM AZOTOBACTER VINELANDII STABILIZED BY ADP-TETRAFLUOROALUMINATE 1N2C ; 3.00 ; NITROGENASE COMPLEX FROM AZOTOBACTER VINELANDII STABILIZED BY ADP-TETRAFLUOROALUMINATE 1RW4 ; 2.50 ; NITROGENASE FE PROTEIN L127 DELETION VARIANT 1G5P ; 2.20 ; NITROGENASE IRON PROTEIN FROM AZOTOBACTER VINELANDII 2NIP ; 2.20 ; NITROGENASE IRON PROTEIN FROM AZOTOBACTER VINELANDII 1CP2 ; 1.93 ; NITROGENASE IRON PROTEIN FROM CLOSTRIDIUM PASTEURIANUM 1QGU ; 1.60 ; NITROGENASE MO-FE PROTEIN FROM KLEBSIELLA PNEUMONIAE, DITHIONITE-REDUCED STATE 1H1L ; 1.90 ; NITROGENASE MO-FE PROTEIN FROM KLEBSIELLA PNEUMONIAE, NIFV MUTANT 1M1N ; 1.16 ; NITROGENASE MOFE PROTEIN FROM AZOTOBACTER VINELANDII 2MIN ; 2.03 ; NITROGENASE MOFE PROTEIN FROM AZOTOBACTER VINELANDII, OXIDIZED STATE 3MIN ; 2.03 ; NITROGENASE MOFE PROTEIN FROM AZOTOBACTER VINELANDII, OXIDIZED STATE 1QH8 ; 1.60 ; NITROGENASE MOFE PROTEIN FROM KLEBSIELLA PNEUMONIAE, AS- CRYSTALLIZED (MIXED OXIDATION) STATE 1QH1 ; 1.60 ; NITROGENASE MOFE PROTEIN FROM KLEBSIELLA PNEUMONIAE, PHENOSAFRANIN OXIDIZED STATE 4NP1 ; 2.30 ; NITROPHORIN 1 COMPLEX WITH NITRIC OXIDE 1OO6 ; 2.00 ; NITROREDUCTASE FROM E-COLI IN COMPLEX WITH THE DINITROBENZAMIDE PRODRUG SN23862 1OON ; 2.49 ; NITROREDUCTASE FROM E-COLI IN COMPLEX WITH THE DINITROBENZAMIDE PRODRUG SN27217 1OOQ ; 2.00 ; NITROREDUCTASE FROM E-COLI IN COMPLEX WITH THE INHIBITOR DICOUMAROL 1NEC ; 1.95 ; NITROREDUCTASE FROM ENTEROBACTER CLOACAE 1OAO ; 1.90 ; NIZN[FE4S4] AND NINI[FE4S4] CLUSTERS IN CLOSED AND OPEN ALPHA SUBUNITS OF ACETYL-COA SYNTHASE/CARBON MONOXIDE DEHYDROGENASE 1NKL ; -1.00 ; NK-LYSIN FROM PIG, NMR, 20 STRUCTURES 1BHT ; 2.00 ; NK1 FRAGMENT OF HUMAN HEPATOCYTE GROWTH FACTOR 1NK1 ; 2.50 ; NK1 FRAGMENT OF HUMAN HEPATOCYTE GROWTH FACTOR/SCATTER FACTOR (HGF/SF) AT 2.5 ANGSTROM RESOLUTION 1KCG ; 2.60 ; NKG2D IN COMPLEX WITH ULBP3 1BUE ; 1.64 ; NMC-A CARBAPENEMASE FROM ENTEROBACTER CLOACAE 1ONU ; -1.00 ; NMDA RECEPTOR ANTAGONIST, CONANTOKIN-G, NMR, 17 STRUCTURES 1ONT ; -1.00 ; NMDA RECEPTOR ANTAGONIST, CONANTOKIN-T, NMR, 17 STRUCTURES 1AB7 ; -1.00 ; NMR 15N RELAXATION AND STRUCTURAL STUDIES REVEAL CONFORMATIONAL EXCHANGE IN BARSTAR C40/82A, 30 STRUCTURES 1QWP ; -1.00 ; NMR ANALYSIS OF 25-35 FRAGMENT OF BETA AMYLOID PEPTIDE 1EKA ; -1.00 ; NMR AND MOLECULAR MODELING REVEAL THAT DIFFERENT HYDROGEN BONDING PATTERNS ARE POSSIBLE FOR GU PAIRS: ONE HYDROGEN BOND FOR EACH GU PAIR IN R(GGCGUGCC)2 AND TWO FOR EACH GU PAIR IN R(GAGUGCUC)2 1EKD ; -1.00 ; NMR AND MOLECULAR MODELING REVEAL THAT DIFFERENT HYDROGEN BONDING PATTERNS ARE POSSIBLE FOR GU PAIRS: ONE HYDROGEN BOND FOR EACH GU PAIR IN R(GGCGUGCC)2 AND TWO FOR EACH GU PAIR IN R(GAGUGCUC)2 1UR6 ; -1.00 ; NMR BASED STRUCTURAL MODEL OF THE UBCH5B-CNOT4 COMPLEX 1JWW ; -1.00 ; NMR CHARACTERIZATION OF THE N-TERMINAL DOMAIN OF A POTENTIAL COPPER-TRANSLOCATING P-TYPE ATPASE FROM BACILLUS SUBTILIS 1RFL ; -1.00 ; NMR DATA DRIVEN STRUCTURAL MODEL OF G-DOMAIN OF MNME PROTEIN 1BLK ; -1.00 ; NMR ENSEMBLE OF BLK SH2 DOMAIN USING CHEMICAL SHIFT REFINEMENT, 20 STRUCTURES 1BLJ ; -1.00 ; NMR ENSEMBLE OF BLK SH2 DOMAIN, 20 STRUCTURES 1I6Y ; -1.00 ; NMR ENSEMBLE OF ION-SELECTIVE LIGAND A1 FOR PLATELET INTEGRIN ALPHAIIB-BETA3 1I8E ; -1.00 ; NMR ENSEMBLE OF ION-SELECTIVE LIGAND A22 FOR PLATELET INTEGRIN ALPHAIIB-BETA3 1I93 ; -1.00 ; NMR ENSEMBLE OF ION-SELECTIVE LIGAND D16 FOR PLATELET INTEGRIN ALPHAIIB-BETA3 1I98 ; -1.00 ; NMR ENSEMBLE OF ION-SELECTIVE LIGAND D18 FOR PLATELET INTEGRIN ALPHAIIB-BETA3 1EIJ ; -1.00 ; NMR ENSEMBLE OF METHANOBACTERIUM THERMOAUTOTROPHICUM PROTEIN 1615 3HCK ; -1.00 ; NMR ENSEMBLE OF THE UNCOMPLEXED HUMAN HCK SH2 DOMAIN, 20 STRUCTURES 1ORM ; -1.00 ; NMR FOLD OF THE OUTER MEMBRANE PROTEIN OMPX IN DHPC MICELLES 1L1K ; -1.00 ; NMR IDENTIFICATION AND CHARACTERIZATION OF THE FLEXIBLE REGIONS IN THE 160 KD MOLTEN GLOBULE-LIKE AGGREGATE OF BARSTAR AT LOW PH 1K2J ; -1.00 ; NMR MINIMIZED AVERAGE STRUCTURE OF D(CGTACG)2 1K2K ; -1.00 ; NMR MINIMIZED AVERAGE STRUCTURE OF D(CGTACG)2 1EVO ; -1.00 ; NMR OBSERVATION OF A NOVEL C-TETRAD 1EVM ; -1.00 ; NMR OBSERVATION OF A-TETRAD 1EVN ; -1.00 ; NMR OBSERVATION OF A-TETRAD 1EMQ ; -1.00 ; NMR OBSERVATION OF T-TETRADS IN A PARALLEL STRANDED DEOXYRIBONUCLEIC ACID QUADRUPLEX FORMED BY SACCHAROMYCES CEREVISIAE TELOMERE REPEATS 1MKL ; -1.00 ; NMR REFINED STRUCTURE OF THE 8,9-DIHYDRO-8-(N7-GUANYL)-9- HYDROXY-AFLATOXIN B1 ADDUCT IN A 5'-CPAFBG-3' SEQUENCE 1E5U ; -1.00 ; NMR REPRESENTATIVE STRUCTURE OF INTIMIN-190 (INT190) FROM ENTEROPATHOGENIC E. COLI 1QS3 ; -1.00 ; NMR SOLUTION CONFORMATION OF AN ANTITOXIC ANALOG OF ALPHA- CONOTOXIN GI 1BZF ; -1.00 ; NMR SOLUTION STRUCTURE AND DYNAMICS OF THE COMPLEX OF LACTOBACILLUS CASEI DIHYDROFOLATE REDUCTASE WITH THE NEW LIPOPHILIC ANTIFOLATE DRUG TRIMETREXATE, 22 STRUCTURES 3BTB ; -1.00 ; NMR SOLUTION STRUCTURE OF A BAND 3 PEPTIDE INHIBITOR BOUND TO GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE, 20 STRUCTURES 1MVZ ; -1.00 ; NMR SOLUTION STRUCTURE OF A BOWMAN BIRK INHIBITOR ISOLATED FROM SNAIL MEDIC SEEDS (MEDICAGO SCUTELLATA) 1FC8 ; -1.00 ; NMR SOLUTION STRUCTURE OF A CHIMERIC OLIGONUCLEOTIDE HAIRPIN R(GGAC)D(TTCG)2'F-A(GTCC) 1CMR ; -1.00 ; NMR SOLUTION STRUCTURE OF A CHIMERIC PROTEIN, DESIGNED BY TRANSFERRING A FUNCTIONAL SNAKE BETA-HAIRPIN INTO A SCORPION ALPHA/BETA SCAFFOLD (PH 3.5, 20C), NMR, 18 STRUCTURES 1CFF ; -1.00 ; NMR SOLUTION STRUCTURE OF A COMPLEX OF CALMODULIN WITH A BINDING PEPTIDE OF THE CA2+-PUMP 1A84 ; -1.00 ; NMR SOLUTION STRUCTURE OF A DEOXYRIBONUCLEIC ACID DODECAMER DUPLEX CONTAINING A CIS-DIAMMINEPLATINUM(II) D(GPG) INTRASTRAND CROSS-LINK, THE MAJOR ADDUCT OF THE ANTICANCER DRUG CISPLATIN, 1 STRUCTURE 1JU0 ; -1.00 ; NMR SOLUTION STRUCTURE OF A DEOXYRIBONUCLEIC ACID KISSING COMPLEX 1FMH ; -1.00 ; NMR SOLUTION STRUCTURE OF A DESIGNED HETERODIMERIC LEUCINE ZIPPER 1U2U ; -1.00 ; NMR SOLUTION STRUCTURE OF A DESIGNED HETERODIMERIC LEUCINE ZIPPER 1T9E ; -1.00 ; NMR SOLUTION STRUCTURE OF A DISULFIDE ANALOGUE OF THE CYCLIC SUNFLOWER TRYPSIN INHIBITOR SFTI-1 1H0Q ; -1.00 ; NMR SOLUTION STRUCTURE OF A FULLY MODIFIED LOCKED NUCLEIC ACID (LNA) HYBRIDIZED TO RIBONUCLEIC ACID 1R57 ; -1.00 ; NMR SOLUTION STRUCTURE OF A GCN5-LIKE PUTATIVE N- ACETYLTRANSFERASE FROM STAPHYLOCOCCUS AUREUS. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET ZR31 1ZA8 ; -1.00 ; NMR SOLUTION STRUCTURE OF A LEAF-SPECIFIC-EXPRESSED CYCLOTIDE VHL-1 1S9L ; -1.00 ; NMR SOLUTION STRUCTURE OF A PARALLEL LNA QUADRUPLEX 1Q2F ; -1.00 ; NMR SOLUTION STRUCTURE OF A PEPTIDE FROM THE MDM-2 BINDING DOMAIN OF THE P53 PROTEIN THAT IS SELECTIVELY CYTOTOXIC TO CANCER CELLS 1Q2I ; -1.00 ; NMR SOLUTION STRUCTURE OF A PEPTIDE FROM THE MDM-2 BINDING DOMAIN OF THE P53 PROTEIN THAT IS SELECTIVELY CYTOTOXIC TO CANCER CELLS 1QFD ; -1.00 ; NMR SOLUTION STRUCTURE OF ALPHA-AMYLASE INHIBITOR (AAI) 1E76 ; -1.00 ; NMR SOLUTION STRUCTURE OF ALPHA-CONOTOXIN IM1 POINT MUTATION VARIANT D5N 1E74 ; -1.00 ; NMR SOLUTION STRUCTURE OF ALPHA-CONOTOXIN IM1 POINT MUTATION VARIANT R11E 1E75 ; -1.00 ; NMR SOLUTION STRUCTURE OF ALPHA-CONOTOXIN IM1 POINT MUTATION VARIANT R7L 1IM1 ; -1.00 ; NMR SOLUTION STRUCTURE OF ALPHA-CONOTOXIN IM1, 20 STRUCTURES 1JFJ ; -1.00 ; NMR SOLUTION STRUCTURE OF AN EF-HAND CALCIUM BINDING PROTEIN FROM ENTAMOEBA HISTOLYTICA 1IE1 ; -1.00 ; NMR SOLUTION STRUCTURE OF AN IN VITRO SELECTED RIBONUCLEIC ACID WHICH IS SEQUENCE SPECIFICALLY RECOGNIZED BY HAMSTER NUCLEOLIN RBD12. 1PG9 ; -1.00 ; NMR SOLUTION STRUCTURE OF AN OXALIPLATIN 1,2-D(GG) INTRASTRAND CROSS-LINK IN A DEOXYRIBONUCLEIC ACID DODECAMER DUPLEX 1PGC ; -1.00 ; NMR SOLUTION STRUCTURE OF AN OXALIPLATIN 1,2-D(GG) INTRASTRAND CROSS-LINK IN A DEOXYRIBONUCLEIC ACID DODECAMER DUPLEX 1CCV ; -1.00 ; NMR SOLUTION STRUCTURE OF APIS MELLIFERA CHYMOTRYPSIN INHIBITOR (AMCI). 1T50 ; -1.00 ; NMR SOLUTION STRUCTURE OF APLYSIA ATTRACTIN 1KCY ; -1.00 ; NMR SOLUTION STRUCTURE OF APO CALBINDIN D9K (F36G + P43M MUTANT) 1CMF ; -1.00 ; NMR SOLUTION STRUCTURE OF APO CALMODULIN CARBOXY-TERMINAL DOMAIN 1FSP ; -1.00 ; NMR SOLUTION STRUCTURE OF BACILLUS SUBTILIS SPO0F PROTEIN, 20 STRUCTURES 2FSP ; -1.00 ; NMR SOLUTION STRUCTURE OF BACILLUS SUBTILIS SPO0F PROTEIN, MINIMIZED AVERAGE STRUCTURE 1PUX ; -1.00 ; NMR SOLUTION STRUCTURE OF BEF3-ACTIVATED SPO0F, 20 CONFORMERS 1MXJ ; -1.00 ; NMR SOLUTION STRUCTURE OF BENZ[A]ANTHRACENE-DG IN RAS CODON 12,2; GGCAGXTGGTG 1GIO ; -1.00 ; NMR SOLUTION STRUCTURE OF BOVINE ANGIOGENIN, 10 STRUCTURES 1C55 ; -1.00 ; NMR SOLUTION STRUCTURE OF BUTANTOXIN 1C56 ; -1.00 ; NMR SOLUTION STRUCTURE OF BUTANTOXIN 1KJS ; -1.00 ; NMR SOLUTION STRUCTURE OF C5A AT PH 5.2, 303K, 20 STRUCTURES 1CMG ; -1.00 ; NMR SOLUTION STRUCTURE OF CALCIUM-LOADED CALMODULIN CARBOXY-TERMINAL DOMAIN 1NYA ; -1.00 ; NMR SOLUTION STRUCTURE OF CALERYTHRIN, AN EF-HAND CALCIUM- BINDING PROTEIN 1G6M ; -1.00 ; NMR SOLUTION STRUCTURE OF CBT2 1AK8 ; -1.00 ; NMR SOLUTION STRUCTURE OF CERIUM-LOADED CALMODULIN AMINO-TERMINAL DOMAIN (CE2-TR1C), 23 STRUCTURES 1MVG ; -1.00 ; NMR SOLUTION STRUCTURE OF CHICKEN LIVER BASIC FATTY ACID BINDING PROTEIN (LB-FABP) 1DEY ; -1.00 ; NMR SOLUTION STRUCTURE OF CO(II)-BLEOMYCIN A2 1D2L ; -1.00 ; NMR SOLUTION STRUCTURE OF COMPLEMENT-LIKE REPEAT CR3 FROM THE LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN (LRP). EVIDENCE FOR SPECIFIC BINDING TO THE RECEPTOR BINDING DOMAIN OF HUMAN ALPHA-2 MACROGLOBULIN 1KKV ; -1.00 ; NMR SOLUTION STRUCTURE OF D(CCACGCGTGG)2, PARENT TO G-T MISMATCH STRUCTURE 1KKW ; -1.00 ; NMR SOLUTION STRUCTURE OF D(CCATGCGTGG)2, G-T MISMATCH STRUCTURE 1G7Z ; -1.00 ; NMR SOLUTION STRUCTURE OF D(CGCTAGCG)2 1G80 ; -1.00 ; NMR SOLUTION STRUCTURE OF D(GCGTACGC)2 1HS5 ; -1.00 ; NMR SOLUTION STRUCTURE OF DESIGNED P53 DIMER 1BO9 ; -1.00 ; NMR SOLUTION STRUCTURE OF DOMAIN 1 OF HUMAN ANNEXIN I 1Q27 ; -1.00 ; NMR SOLUTION STRUCTURE OF DR0079: AN HYPOTHETICAL NUDIX PROTEIN FROM D. RADIODURANS 1KX6 ; -1.00 ; NMR SOLUTION STRUCTURE OF GLUCAGON IN A LIPID-WATER INTERPHASE 1GHU ; -1.00 ; NMR SOLUTION STRUCTURE OF GROWTH FACTOR RECEPTOR-BOUND PROTEIN 2 (GRB2) SH2 DOMAIN, 24 STRUCTURES 1E8L ; -1.00 ; NMR SOLUTION STRUCTURE OF HEN LYSOZYME 1BLR ; -1.00 ; NMR SOLUTION STRUCTURE OF HUMAN CELLULAR RETINOIC ACID BINDING PROTEIN-TYPE II, 22 STRUCTURES 1RON ; -1.00 ; NMR SOLUTION STRUCTURE OF HUMAN NEUROPEPTIDE Y 1M12 ; -1.00 ; NMR SOLUTION STRUCTURE OF HUMAN SAPOSIN C 1SN6 ; -1.00 ; NMR SOLUTION STRUCTURE OF HUMAN SAPOSIN C IN SDS MICELLES 1LBJ ; -1.00 ; NMR SOLUTION STRUCTURE OF MOTILIN IN PHOSPHOLIPID BICELLAR SOLUTION 1HA6 ; -1.00 ; NMR SOLUTION STRUCTURE OF MURINE CCL20/MIP-3A CHEMOKINE 1MPZ ; -1.00 ; NMR SOLUTION STRUCTURE OF NATIVE VIPERIDAE LEBETINA OBTUSA PROTEIN 1ZEC ; -1.00 ; NMR SOLUTION STRUCTURE OF NEF1-25, 20 STRUCTURES 1L0R ; -1.00 ; NMR SOLUTION STRUCTURE OF NOGALAMYCIN INTERCALATION BETWEEN CO-AXIALLY STACKED HAIRPINS 1JE9 ; -1.00 ; NMR SOLUTION STRUCTURE OF NT2 1TTK ; -1.00 ; NMR SOLUTION STRUCTURE OF OMEGA-CONOTOXIN MVIIA, A N-TYPE CALCIUM CHANNEL BLOCKER 1TR6 ; -1.00 ; NMR SOLUTION STRUCTURE OF OMEGA-CONOTOXIN [K10]GVIA, A CYCLIC CYSTEINE KNOT PEPTIDE 1G90 ; -1.00 ; NMR SOLUTION STRUCTURE OF OUTER MEMBRANE PROTEIN A TRANSMEMBRANE DOMAIN: 10 CONFORMERS 1K3G ; -1.00 ; NMR SOLUTION STRUCTURE OF OXIDIZED CYTOCHROME C-553 FROM BACILLUS PASTEURII 1K3H ; -1.00 ; NMR SOLUTION STRUCTURE OF OXIDIZED CYTOCHROME C-553 FROM BACILLUS PASTEURII 1QFR ; -1.00 ; NMR SOLUTION STRUCTURE OF PHOSPHOCARRIER PROTEIN HPR FROM ENTEROCOCCUS FAECALIS 1FJK ; -1.00 ; NMR SOLUTION STRUCTURE OF PHOSPHOLAMBAN (C41F) 1FJP ; -1.00 ; NMR SOLUTION STRUCTURE OF PHOSPHOLAMBAN (C41F) 1R9I ; -1.00 ; NMR SOLUTION STRUCTURE OF PIIIA TOXIN, NMR, 20 STRUCTURES 1JKZ ; -1.00 ; NMR SOLUTION STRUCTURE OF PISUM SATIVUM DEFENSIN 1 (PSD1) 2B3I ; -1.00 ; NMR SOLUTION STRUCTURE OF PLASTOCYANIN FROM THE PHOTOSYNTHETIC PROKARYOTE, PROCHLOROTHRIX HOLLANDICA (19 STRUCTURES) 1B3I ; -1.00 ; NMR SOLUTION STRUCTURE OF PLASTOCYANIN FROM THE PHOTOSYNTHETIC PROKARYOTE, PROCHLOROTHRIX HOLLANDICA (MINIMIZED AVERAGE STRUCTURE) 1Z64 ; -1.00 ; NMR SOLUTION STRUCTURE OF PLEUROCIDIN IN DPC MICELLES 1QBF ; -1.00 ; NMR SOLUTION STRUCTURE OF PORCINE PEPTIDE YY 2FB7 ; -1.00 ; NMR SOLUTION STRUCTURE OF PROTEIN FROM ZEBRA FISH DR.13312 1XYD ; -1.00 ; NMR SOLUTION STRUCTURE OF RAT ZINC-CALCIUM-S100B, 20 STRUCTURES 1G7O ; -1.00 ; NMR SOLUTION STRUCTURE OF REDUCED E. COLI GLUTAREDOXIN 2 1ROO ; -1.00 ; NMR SOLUTION STRUCTURE OF SHK TOXIN, NMR, 20 STRUCTURES 1K7B ; -1.00 ; NMR SOLUTION STRUCTURE OF STVA47, THE VIRAL-BINDING DOMAIN OF TVA 1S3A ; -1.00 ; NMR SOLUTION STRUCTURE OF SUBUNIT B8 FROM HUMAN NADH- UBIQUINONE OXIDOREDUCTASE COMPLEX I (CI-B8) 1U6F ; -1.00 ; NMR SOLUTION STRUCTURE OF TCUBP1, A SINGLE RBD-UNIT FROM TRYPANOSOMA CRUZI 1TE7 ; -1.00 ; NMR SOLUTION STRUCTURE OF THE 14KDA HYPOTHETICAL PROTEIN YQFB FROM ESCHERICHIA COLI: THE NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET ET99 1D6K ; -1.00 ; NMR SOLUTION STRUCTURE OF THE 5S RRNA E-LOOP/L25 COMPLEX 1O6X ; -1.00 ; NMR SOLUTION STRUCTURE OF THE ACTIVATION DOMAIN OF HUMAN PROCARBOXYPEPTIDASE A2 1N37 ; -1.00 ; NMR SOLUTION STRUCTURE OF THE ANTHRACYCLINE RESPINOMYCIN D INTERCALATION COMPLEX WITH A DOUBLE STRANDED DEOXYRIBONUCLEIC ACID MOLECULE (AGACGTCT)2 1FEQ ; -1.00 ; NMR SOLUTION STRUCTURE OF THE ANTICODON OF TRNA(LYS3) WITH T6A MODIFICATION AT POSITION 37 1LUX ; -1.00 ; NMR SOLUTION STRUCTURE OF THE ANTICODON OF YEAST TRNA-PHE WITH 3 MODIFICATIONS (OMC32 OMG34 M5C40) 1LUU ; -1.00 ; NMR SOLUTION STRUCTURE OF THE ANTICODON OF YEAST TRNA-PHE WITH 4 MODIFICATIONS (OMC32 OMG34 1MG37 5MC40) 1T23 ; -1.00 ; NMR SOLUTION STRUCTURE OF THE ARCHAEBACTERIAL CHROMOSOMAL PROTEIN MC1 1PV3 ; -1.00 ; NMR SOLUTION STRUCTURE OF THE AVIAN FAT-DOMAIN OF FOCAL ADHESION KINASE 1F68 ; -1.00 ; NMR SOLUTION STRUCTURE OF THE BROMODOMAIN FROM HUMAN GCN5 2A93 ; -1.00 ; NMR SOLUTION STRUCTURE OF THE C-MYC-MAX HETERODIMERIC LEUCINE ZIPPER, 40 STRUCTURES 1A93 ; -1.00 ; NMR SOLUTION STRUCTURE OF THE C-MYC-MAX HETERODIMERIC LEUCINE ZIPPER, NMR, MINIMIZED AVERAGE STRUCTURE 1P9C ; -1.00 ; NMR SOLUTION STRUCTURE OF THE C-TERMINAL UBIQUITIN- INTERACTING MOTIF OF THE PROTEASOME SUBUNIT S5A 1SNL ; -1.00 ; NMR SOLUTION STRUCTURE OF THE CALCIUM-BINDING DOMAIN OF NUCLEOBINDIN (CALNUC) 1C7V ; -1.00 ; NMR SOLUTION STRUCTURE OF THE CALCIUM-BOUND C-TERMINAL DOMAIN (W81-S161) OF CALCIUM VECTOR PROTEIN FROM AMPHIOXUS 1C7W ; -1.00 ; NMR SOLUTION STRUCTURE OF THE CALCIUM-BOUND C-TERMINAL DOMAIN (W81-S161) OF CALCIUM VECTOR PROTEIN FROM AMPHIOXUS 1D1D ; -1.00 ; NMR SOLUTION STRUCTURE OF THE CAPSID PROTEIN FROM ROUS SARCOMA VIRUS 1TDP ; -1.00 ; NMR SOLUTION STRUCTURE OF THE CARNOBACTERIOCIN B2 IMMUNITY PROTEIN 1K19 ; -1.00 ; NMR SOLUTION STRUCTURE OF THE CHEMOSENSORY PROTEIN CSP2 FROM MOTH MAMESTRA BRASSICAE 1KQH ; -1.00 ; NMR SOLUTION STRUCTURE OF THE CIS PRO30 ISOMER OF ACTX- HI:OB4219 1GP8 ; -1.00 ; NMR SOLUTION STRUCTURE OF THE COAT PROTEIN-BINDING DOMAIN OF BACTERIOPHAGE P22 SCAFFOLDING PROTEIN 2GP8 ; -1.00 ; NMR SOLUTION STRUCTURE OF THE COAT PROTEIN-BINDING DOMAIN OF BACTERIOPHAGE P22 SCAFFOLDING PROTEIN 1FZX ; -1.00 ; NMR SOLUTION STRUCTURE OF THE DEOXYRIBONUCLEIC ACID DODECAMER GGCAAAAAACGG 1G14 ; -1.00 ; NMR SOLUTION STRUCTURE OF THE DEOXYRIBONUCLEIC ACID DODECAMER GGCAAGAAACGG 1DHH ; -1.00 ; NMR SOLUTION STRUCTURE OF THE DEOXYRIBONUCLEIC ACID DUPLEX CONTAINING DEOXYRIBONUCLEIC ACID/RIBONUCLEIC ACID HYBRID REGION, D(GG)R(AGAU)D(GAC)/D(GTCATCTCC) 1DRN ; -1.00 ; NMR SOLUTION STRUCTURE OF THE DEOXYRIBONUCLEIC ACID DUPLEX CONTAINING DEOXYRIBONUCLEIC ACID/RIBONUCLEIC ACID HYBRID REGION, D(GGAGA)R(UGAC)/D(GTCATCTCC) 1IC9 ; -1.00 ; NMR SOLUTION STRUCTURE OF THE DESIGNED BETA-SHEET MINI- PROTEIN TH10AOX 1HI7 ; -1.00 ; NMR SOLUTION STRUCTURE OF THE DISULPHIDE-LINKED HOMODIMER OF HUMAN TFF1, 10 STRUCTURES 2A7U ; -1.00 ; NMR SOLUTION STRUCTURE OF THE E.COLI F-ATPASE DELTA SUBUNIT N-TERMINAL DOMAIN IN COMPLEX WITH ALPHA SUBUNIT N-TERMINAL 22 RESIDUES 1T0V ; -1.00 ; NMR SOLUTION STRUCTURE OF THE ENGINEERED LIPOCALIN FLUA(R95K) 1NAU ; -1.00 ; NMR SOLUTION STRUCTURE OF THE GLUCAGON ANTAGONIST [DESHIS1, DESPHE6, GLU9]GLUCAGON AMIDE IN THE PRESENCE OF PERDEUTERATED DODECYLPHOSPHOCHOLINE MICELLES 1VPU ; -1.00 ; NMR SOLUTION STRUCTURE OF THE HIV-1 VPU CYTOPLASMIC DOMAIN, 9 STRUCTURES 1JNJ ; -1.00 ; NMR SOLUTION STRUCTURE OF THE HUMAN BETA2-MICROGLOBULIN 1R4H ; -1.00 ; NMR SOLUTION STRUCTURE OF THE IIIC DOMAIN OF GB VIRUS B IRES ELEMENT 1I6F ; -1.00 ; NMR SOLUTION STRUCTURE OF THE INSECT-SPECIFIC NEUROTOXIN VARIANT 5 (CSE-V5) FROM THE SCORPION CENTRUROIDES SCULPTURATUS EWING 1I6G ; -1.00 ; NMR SOLUTION STRUCTURE OF THE INSECT-SPECIFIC NEUROTOXIN VARIANT 5 (CSE-V5) FROM THE SCORPION CENTRUROIDES SCULPTURATUS EWING 1DGQ ; -1.00 ; NMR SOLUTION STRUCTURE OF THE INSERTED DOMAIN OF HUMAN LEUKOCYTE FUNCTION ASSOCIATED ANTIGEN-1 1EHX ; -1.00 ; NMR SOLUTION STRUCTURE OF THE LAST UNKNOWN MODULE OF THE CELLULOSOMAL SCAFFOLDIN PROTEIN CIPC OF CLOSTRIDUM CELLULOLYTICUM 1PYV ; -1.00 ; NMR SOLUTION STRUCTURE OF THE MITOCHONDRIAL F1B PRESEQUENCE PEPTIDE FROM NICOTIANA PLUMBAGINIFOLIA 1BNP ; -1.00 ; NMR SOLUTION STRUCTURE OF THE N-TERMINAL DOMAIN OF DEOXYRIBONUCLEIC ACID POLYMERASE BETA, 55 STRUCTURES 1BNO ; -1.00 ; NMR SOLUTION STRUCTURE OF THE N-TERMINAL DOMAIN OF DEOXYRIBONUCLEIC ACID POLYMERASE BETA, MINIMIZED AVERAGE STRUCTURE 1VIB ; -1.00 ; NMR SOLUTION STRUCTURE OF THE NEUROTOXIN B-IV, 20 STRUCTURES 2HQI ; -1.00 ; NMR SOLUTION STRUCTURE OF THE OXIDIZED FORM OF MERP, 14 STRUCTURES 1WVK ; -1.00 ; NMR SOLUTION STRUCTURE OF THE PARTIALLY DISORDERED PROTEIN AT2G23090 FROM ARABIDOPSIS THALIANA 1RY3 ; -1.00 ; NMR SOLUTION STRUCTURE OF THE PRECURSOR FOR CARNOBACTERIOCIN B2, AN ANTIMICROBIAL PEPTIDE FROM CARNOBACTERIUM PISCICOLA 1D1R ; -1.00 ; NMR SOLUTION STRUCTURE OF THE PRODUCT OF THE E. COLI YCIH GENE. 1T2Y ; -1.00 ; NMR SOLUTION STRUCTURE OF THE PROTEIN PART OF CU6- NEUROSPORA CRASSA MT 1SG7 ; -1.00 ; NMR SOLUTION STRUCTURE OF THE PUTATIVE CATION TRANSPORT REGULATOR CHAB 1RFA ; -1.00 ; NMR SOLUTION STRUCTURE OF THE RAS-BINDING DOMAIN OF C-RAF-1 1YLB ; -1.00 ; NMR SOLUTION STRUCTURE OF THE REDUCED SPINACH PLASTOCYANIN 1JU7 ; -1.00 ; NMR SOLUTION STRUCTURE OF THE RIBONUCLEIC ACID HAIRPIN BINDING SITE FOR THE HISTONE STEM-LOOP BINDING PROTEIN 1JWC ; -1.00 ; NMR SOLUTION STRUCTURE OF THE RIBONUCLEIC ACID HAIRPIN BINDING SITE FOR THE HISTONE STEM-LOOP BINDING PROTEIN 1XNA ; -1.00 ; NMR SOLUTION STRUCTURE OF THE SINGLE-STRAND BREAK REPAIR PROTEIN XRCC1-N-TERMINAL DOMAIN 1XNT ; -1.00 ; NMR SOLUTION STRUCTURE OF THE SINGLE-STRAND BREAK REPAIR PROTEIN XRCC1-N-TERMINAL DOMAIN 1HZN ; -1.00 ; NMR SOLUTION STRUCTURE OF THE THIRD EXTRACELLULAR LOOP OF THE CHOLECYSTOKININ A RECEPTOR 1KQI ; -1.00 ; NMR SOLUTION STRUCTURE OF THE TRANS PRO30 ISOMER OF ACTX- HI:OB4219 1JAU ; -1.00 ; NMR SOLUTION STRUCTURE OF THE TRP-RICH PEPTIDE OF HIV GP41 BOUND TO DPC MICELLES 1T1H ; -1.00 ; NMR SOLUTION STRUCTURE OF THE U BOX DOMAIN FROM ATPUB14, AN ARMADILLO REPEAT CONTAINING PROTEIN FROM ARABIDOPSIS THALIANA 1W4U ; -1.00 ; NMR SOLUTION STRUCTURE OF THE UBIQUITIN CONJUGATING ENZYME UBCH5B 1JRF ; -1.00 ; NMR SOLUTION STRUCTURE OF THE VIRAL RECEPTOR DOMAIN OF TVA 1MQZ ; -1.00 ; NMR SOLUTION STRUCTURE OF TYPE-B LANTIBIOTICS MERSACIDIN BOUND TO LIPID II IN DPC MICELLES 1MQY ; -1.00 ; NMR SOLUTION STRUCTURE OF TYPE-B LANTIBIOTICS MERSACIDIN IN DPC MICELLES 1MQX ; -1.00 ; NMR SOLUTION STRUCTURE OF TYPE-B LANTIBIOTICS MERSACIDIN IN MEOH/H2O MIXTURE 1K0T ; -1.00 ; NMR SOLUTION STRUCTURE OF UNBOUND, OXIDIZED PHOTOSYSTEM I SUBUNIT PSAC, CONTAINING [4FE-4S] CLUSTERS FA AND FB 1HFG ; -1.00 ; NMR SOLUTION STRUCTURE OF VMIP-II 1-71 FROM KAPOSI'S SARCOMA-ASSOCIATED HERPESVIRUS (MINIMIZED AVERAGE STRUCTURE). 1DSJ ; -1.00 ; NMR SOLUTION STRUCTURE OF VPR50_75, 20 STRUCTURES 1DSK ; -1.00 ; NMR SOLUTION STRUCTURE OF VPR59_86, 20 STRUCTURES 1NKU ; -1.00 ; NMR SOLUTION STRUCTURE OF ZINC-BINDING PROTEIN 3- METHYLADENINE DEOXYRIBONUCLEIC ACID GLYCOSYLASE I (TAG) 1BX5 ; -1.00 ; NMR SOLUTION STRUCTURE OF [D(GCGAAT-3'-3'-ALPHAT-5'-5'-CGC) 2] 1BWT ; -1.00 ; NMR SOLUTION STRUCTURE OF [D(GCGAATCGC)2] 1I2V ; -1.00 ; NMR SOLUTION STRUCTURES OF AN ANTIFUNGAL AND ANTIBACTERIAL MUTANT OF HELIOMICIN 1I2U ; -1.00 ; NMR SOLUTION STRUCTURES OF ANTIFUNGAL HELIOMICIN 2EVN ; -1.00 ; NMR SOLUTION STRUCTURES OF AT1G77540 1G1P ; -1.00 ; NMR SOLUTION STRUCTURES OF DELTA-CONOTOXIN EVIA FROM CONUS ERMINEUS THAT SELECTIVELY ACTS ON VERTEBRATE NEURONAL NA+ CHANNELS 1G1Z ; -1.00 ; NMR SOLUTION STRUCTURES OF DELTA-CONOTOXIN EVIA FROM CONUS ERMINEUS THAT SELECTIVELY ACTS ON VERTEBRATE NEURONAL NA+ CHANNELS, LEU12-PRO13 CIS ISOMER 1KRI ; -1.00 ; NMR SOLUTION STRUCTURES OF THE RHESUS ROTAVIRUS VP4 SIALIC ACID BINDING DOMAIN WITHOUT LIGAND 1HFF ; -1.00 ; NMR SOLUTION STRUCTURES OF THE VMIP-II 1-10 PEPTIDE FROM KAPOSI'S SARCOMA-ASSOCIATED HERPESVIRUS. 1HFN ; -1.00 ; NMR SOLUTION STRUCTURES OF VMIP-II 1-71 FROM KAPOSI'S SARCOMA-ASSOCIATED HERPESVIRUS. 1LFU ; -1.00 ; NMR SOLUTION STUCTURE OF THE EXTENDED PBX HOMEODOMAIN BOUND TO DEOXYRIBONUCLEIC ACID 1TT3 ; -1.00 ; NMR SOULUTION STRUCTURE OF OMEGA-CONOTOXIN [K10]MVIIA 1XY4 ; -1.00 ; NMR STRCUTRE OF SST1-SELECTIVE SOMATOSTATIN (SRIF) ANALOG 1 1XY5 ; -1.00 ; NMR STRCUTRE OF SST1-SELECTIVE SOMATOSTATIN (SRIF) ANALOG 1 1XY6 ; -1.00 ; NMR STRCUTRE OF SST1-SELECTIVE SOMATOSTATIN (SRIF) ANALOG 1 1XY8 ; -1.00 ; NMR STRCUTRE OF SST1-SELECTIVE SOMATOSTATIN (SRIF) ANALOG 1 1XY9 ; -1.00 ; NMR STRCUTRE OF SST1-SELECTIVE SOMATOSTATIN (SRIF) ANALOG 1 1G5K ; -1.00 ; NMR STRUCTRURE OF D(CCAAAGXACTGGG), X IS A 3'- PHOSPHOGLYCOLATE, 5'-PHOSPHATE GAPPED LESION, 10 STRUCTURES 1K64 ; -1.00 ; NMR STRUCTUE OF ALPHA-CONOTOXIN EI 2A2Y ; -1.00 ; NMR STRUCTUE OF SSO10B2 FROM SULFOLOBUS SOLFATARICUS 2AQC ; -1.00 ; NMR STRUCTURAL ANALYSIS OF ARCHAEAL NOP10 2AQA ; -1.00 ; NMR STRUCTURAL ANALYSIS OF NOP10P FROM SACCHAROMYCES CEREVISIAE 1KC4 ; -1.00 ; NMR STRUCTURAL ANALYSIS OF THE COMPLEX FORMED BETWEEN ALPHA- BUNGAROTOXIN AND THE PRINCIPAL ALPHA-NEUROTOXIN BINDING SEQUENCE ON THE ALPHA7 SUBUNIT OF A NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR 1KL8 ; -1.00 ; NMR STRUCTURAL ANALYSIS OF THE COMPLEX FORMED BETWEEN ALPHA- BUNGAROTOXIN AND THE PRINCIPAL ALPHA-NEUROTOXIN BINDING SEQUENCE ON THE ALPHA7 SUBUNIT OF A NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR 2AWV ; -1.00 ; NMR STRUCTURAL ANALYSIS OF THE DIMER OF 5MCCTCATCC 1LM2 ; -1.00 ; NMR STRUCTURAL CHARACTERIZATION OF THE REDUCTION OF CHROMIUM(VI) TO CHROMIUM(III) BY CYTOCHROME C7 1ED0 ; -1.00 ; NMR STRUCTURAL DETERMINATION OF VISCOTOXIN A3 FROM VISCUM ALBUM L. 1TUQ ; -1.00 ; NMR STRUCTURE ANALYSIS OF THE B-DEOXYRIBONUCLEIC ACID DODECAMER CTCTCACGTGGAG WITH A TRICYCLIC CYTOSIN BASE ANALOGUE 1DK6 ; -1.00 ; NMR STRUCTURE ANALYSIS OF THE DEOXYRIBONUCLEIC ACID NINE BASE PAIR DUPLEX D(CATGAGTAC) D(GTAC(NP3)CATG) 1U62 ; -1.00 ; NMR STRUCTURE ANALYSIS OF THE LACTOFERRIN-BASED PEPTIDE FQWQRNIRKVR IN COMPLEX WITH LIPOPOLYSACCHARIDE 1K8B ; -1.00 ; NMR STRUCTURE ANALYSIS OF THE N-TERMINAL DOMAIN OF ARCHAEAL TRANSLATION INITIATION FACTOR 2 SUBUNIT BETA 1SJ6 ; -1.00 ; NMR STRUCTURE AND REGULATED EXPRESSION IN APL CELL OF HUMAN SH3BGRL3 1WAZ ; -1.00 ; NMR STRUCTURE DETERMINATION OF THE BACTERIAL MERCURY TRANSPORTER, MERF, IN MICELLES 1RDU ; -1.00 ; NMR STRUCTURE DETERMINATION OF THE HYPOTHETICAL PROTEIN TM1290 FROM THERMOTOGA MARITIMA USING AUTOMATED NOESY ANALYSIS 1QXB ; -1.00 ; NMR STRUCTURE DETERMINATION OF THE SELF COMPLEMENTARY DEOXYRIBONUCLEIC ACID DODECAMER CGCGAATTCGCG IN WHICH A RIBOSE IS INSERTED BETWEEN THE 3'-OH OF T8 AND THE 5'-PHOSPHATE GROUP OF C9 1QEY ; -1.00 ; NMR STRUCTURE DETERMINATION OF THE TETRAMERIZATION DOMAIN OF THE MNT REPRESSOR: AN ASYMMETRIC A-HELICAL ASSEMBLY IN SLOW EXCHANGE 1WWD ; -1.00 ; NMR STRUCTURE DETERMINED FOR MLV NC COMPLEX WITH RIBONUCLEIC ACID SEQUENCE AACAGU 1WWF ; -1.00 ; NMR STRUCTURE DETERMINED FOR MLV NC COMPLEX WITH RIBONUCLEIC ACID SEQUENCE CCUCCGU 1WWG ; -1.00 ; NMR STRUCTURE DETERMINED FOR MLV NC COMPLEX WITH RIBONUCLEIC ACID SEQUENCE UAUCUG 1WWE ; -1.00 ; NMR STRUCTURE DETERMINED FOR MLV NC COMPLEX WITH RIBONUCLEIC ACID SEQUENCE UUUUGCU 1IYR ; -1.00 ; NMR STRUCTURE ENSEMBLE OF DFF-C DOMAIN 1Y7J ; -1.00 ; NMR STRUCTURE FAMILY OF HUMAN AGOUTI SIGNALLING PROTEIN (80- 132: Q115Y, S124Y) 1Y7K ; -1.00 ; NMR STRUCTURE FAMILY OF HUMAN AGOUTI SIGNALLING PROTEIN (80- 132: Q115Y, S124Y) 1N1K ; -1.00 ; NMR STRUCTURE FOR D(CCGCGG)2 1P82 ; -1.00 ; NMR STRUCTURE OF 1-25 FRAGMENT OF MYCOBACTERIUM TUBERCULOSIS CPN10 1P83 ; -1.00 ; NMR STRUCTURE OF 1-25 FRAGMENT OF MYCOBACTERIUM TUBERCULOSIS CPN10 1FW7 ; -1.00 ; NMR STRUCTURE OF 15N-LABELED BARNASE 1PPQ ; -1.00 ; NMR STRUCTURE OF 16TH MODULE OF IMMUNE ADHERENCE RECEPTOR, CR1 (CD35) 1DVW ; -1.00 ; NMR STRUCTURE OF 18 RESIDUE PEPTIDE FROM MERP PROTEIN 1OLD ; -1.00 ; NMR STRUCTURE OF 24-MER DEOXYRIBONUCLEIC ACID, 7 STRUCTURES 1QWA ; -1.00 ; NMR STRUCTURE OF 5'-R(GGAUGCCUCCCGAGUGCAUCC): AN RIBONUCLEIC ACID HAIRPIN DERIVED FROM THE MOUSE 5'ETS THAT BINDS NUCLEOLIN RBD12. 1BDZ ; -1.00 ; NMR STRUCTURE OF A 14 MER EXTENDED C-MYB COGNATE DEOXYRIBONUCLEIC ACID SEQUENCE 5'D(APCPAPAP CPTPGPCP APGPTPTP GPT)3', MINIMIZED AVERAGE STRUCTURE 1LEJ ; -1.00 ; NMR STRUCTURE OF A 1:1 COMPLEX OF POLYAMIDE (IM-PY-BETA-IM- BETA-IM-PY-BETA-DP) WITH THE TRIDECAMER DEOXYRIBONUCLEIC ACID DUPLEX 5'- CCAAAGAGAAGCG-3' 2ADT ; -1.00 ; NMR STRUCTURE OF A 30 KDA GAAA TETRALOOP-RECEPTOR COMPLEX. 1G3F ; -1.00 ; NMR STRUCTURE OF A 9 RESIDUE PEPTIDE FROM SMAC/DIABLO COMPLEXED TO THE BIR3 DOMAIN OF XIAP 1T3K ; -1.00 ; NMR STRUCTURE OF A CDC25-LIKE DUAL-SPECIFICITY TYROSINE PHOSPHATASE OF ARABIDOPSIS THALIANA 1A60 ; -1.00 ; NMR STRUCTURE OF A CLASSICAL PSEUDOKNOT: INTERPLAY OF SINGLE- AND DOUBLE-STRANDED RIBONUCLEIC ACID, 24 STRUCTURES 1TTV ; -1.00 ; NMR STRUCTURE OF A COMPLEX BETWEEN MDM2 AND A SMALL MOLECULE INHIBITOR 1ONV ; -1.00 ; NMR STRUCTURE OF A COMPLEX CONTAINING THE TFIIF SUBUNIT RAP74 AND THE RNAP II CTD PHOSPHATASE FCP1 1F5Y ; -1.00 ; NMR STRUCTURE OF A CONCATEMER OF THE FIRST AND SECOND LIGAND-BINDING MODULES OF THE HUMAN LDL RECEPTOR 1PQQ ; -1.00 ; NMR STRUCTURE OF A CYCLIC POLYAMIDE-DEOXYRIBONUCLEIC ACID COMPLEX 1S4A ; -1.00 ; NMR STRUCTURE OF A D,L ALTERNATING DECAMER OF NORLEUCINE: DOUBLE ANTIPARALLEL BETA-HELIX 1S1O ; -1.00 ; NMR STRUCTURE OF A D,L ALTERNATING PENTADECAMER OF NORLEUCINE: DOUBLE ANTIPARALLEL BETA-HELIX 1R9V ; -1.00 ; NMR STRUCTURE OF A D,L-ALTERNATING DODECAMER OF NORLEUCINE 1S88 ; -1.00 ; NMR STRUCTURE OF A DEOXYRIBONUCLEIC ACID DUPLEX WITH TWO INA NUCLEOTIDES INSERTED OPPOSITE EACH OTHER, DCTCAACXCAAGCT:DAGCTTGXGTTGAG 1EKW ; -1.00 ; NMR STRUCTURE OF A DEOXYRIBONUCLEIC ACID THREE-WAY JUNCTION 1DNG ; -1.00 ; NMR STRUCTURE OF A MODEL HYDROPHILIC AMPHIPATHIC HELICAL ACIDIC PEPTIDE 1DJF ; -1.00 ; NMR STRUCTURE OF A MODEL HYDROPHILIC AMPHIPATHIC HELICAL BASIC PEPTIDE 1DN3 ; -1.00 ; NMR STRUCTURE OF A MODEL HYDROPHILIC AMPHIPATHIC HELICAL BASIC PEPTIDE 1QU5 ; -1.00 ; NMR STRUCTURE OF A NEW PHOSPHOTYROSINE BINDING DOMAIN CONTAINING THE FHA2 DOMAIN OF RAD 53 1JUU ; -1.00 ; NMR STRUCTURE OF A PARALLEL STRANDED DEOXYRIBONUCLEIC ACID DUPLEX AT ATOMIC RESOLUTION 1SBU ; -1.00 ; NMR STRUCTURE OF A PEPTIDE CONTAINING A DIMETYLTHIAZOLIDINE : AN ANALOG OF DELTA CONOTOXIN EVIA LOOP 2 1TBO ; -1.00 ; NMR STRUCTURE OF A PROTEIN KINASE C-G PHORBOL-BINDING DOMAIN, 30 STRUCTURES 1TBN ; -1.00 ; NMR STRUCTURE OF A PROTEIN KINASE C-G PHORBOL-BINDING DOMAIN, MINIMIZED AVERAGE STRUCTURE 2BJC ; -1.00 ; NMR STRUCTURE OF A PROTEIN-DEOXYRIBONUCLEIC ACID COMPLEX OF AN ALTERED SPECIFICITY MUTANT OF THE LAC REPRESSOR HEADPIECE THAT MIMICS THE GAL REPRESSOR 1PB5 ; -1.00 ; NMR STRUCTURE OF A PROTOTYPE LNR MODULE FROM HUMAN NOTCH1 1K5I ; -1.00 ; NMR STRUCTURE OF A RIBOSOMAL RIBONUCLEIC ACID HAIRPIN CONTAINING A CONSERVED CUCAA PENTALOOP 1L1W ; -1.00 ; NMR STRUCTURE OF A SRP19 BINDING DOMAIN IN HUMAN SRP RIBONUCLEIC ACID 1UUI ; -1.00 ; NMR STRUCTURE OF A SYNTHETIC SMALL MOLECULE, RBT158, BOUND TO HIV-1 TAR RIBONUCLEIC ACID 1UUD ; -1.00 ; NMR STRUCTURE OF A SYNTHETIC SMALL MOLECULE, RBT203, BOUND TO HIV-1 TAR RIBONUCLEIC ACID 1ILO ; -1.00 ; NMR STRUCTURE OF A THIOREDOXIN, MTH895, FROM THE ARCHEON METHANOBACTERIUM THERMOAUTOTROPHICUM STRAIN DELTA H. 1U6U ; -1.00 ; NMR STRUCTURE OF A V3 (IIIB ISOLATE) PEPTIDE BOUND TO 447- 52D, A HUMAN HIV-1 NEUTRALIZING ANTIBODY 1U6V ; -1.00 ; NMR STRUCTURE OF A V3 (IIIB ISOLATE) PEPTIDE BOUND TO 447- 52D, A HUMAN HIV-1 NEUTRALIZING ANTIBODY 1NIZ ; -1.00 ; NMR STRUCTURE OF A V3 (MN ISOLATE) PEPTIDE BOUND TO 447-52D, A HUMAN HIV-1 NEUTRALIZING ANTIBODY 1NJ0 ; -1.00 ; NMR STRUCTURE OF A V3 (MN ISOLATE) PEPTIDE BOUND TO 447-52D, A HUMAN HIV-1 NEUTRALIZING ANTIBODY 1SP2 ; -1.00 ; NMR STRUCTURE OF A ZINC FINGER DOMAIN FROM TRANSCRIPTION FACTOR SP1F2, MINIMIZED AVERAGE STRUCTURE 1SP1 ; -1.00 ; NMR STRUCTURE OF A ZINC FINGER DOMAIN FROM TRANSCRIPTION FACTOR SP1F3, MINIMIZED AVERAGE STRUCTURE 1XRZ ; -1.00 ; NMR STRUCTURE OF A ZINC FINGER WITH CYCLOHEXANYLALANINE SUBSTITUTED FOR THE CENTRAL AROMATIC RESIDUE 1OVF ; -1.00 ; NMR STRUCTURE OF ACTD/5'-CCGTTTTGTGG-3' COMPLEX 1YX3 ; -1.00 ; NMR STRUCTURE OF ALLOCHROMATIUM VINOSUM DSRC: NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET OP4 1IK8 ; -1.00 ; NMR STRUCTURE OF ALPHA-BUNGAROTOXIN 1IKC ; -1.00 ; NMR STRUCTURE OF ALPHA-BUNGAROTOXIN 1L4W ; -1.00 ; NMR STRUCTURE OF AN ACHR-PEPTIDE (TORPEDO CALIFORNICA, ALPHA-SUBUNIT RESIDUES 182-202) IN COMPLEX WITH ALPHA- BUNGAROTOXIN 1LJZ ; -1.00 ; NMR STRUCTURE OF AN ACHR-PEPTIDE (TORPEDO CALIFORNICA, ALPHA-SUBUNIT RESIDUES 182-202) IN COMPLEX WITH ALPHA- BUNGAROTOXIN 1OKF ; -1.00 ; NMR STRUCTURE OF AN ALPHA-L-LNA:RIBONUCLEIC ACID HYBRID 1TFQ ; -1.00 ; NMR STRUCTURE OF AN ANTAGONISTS OF THE XIAP-CASPASE-9 INTERACTION COMPLEXED TO THE BIR3 DOMAIN OF XIAP 1TFT ; -1.00 ; NMR STRUCTURE OF AN ANTAGONISTS OF THE XIAP-CASPASE-9 INTERACTION COMPLEXED TO THE BIR3 DOMAIN OF XIAP 1JVE ; -1.00 ; NMR STRUCTURE OF AN AT-RICH DEOXYRIBONUCLEIC ACID WITH THE GAA-HAIRPIN LOOP 1D7T ; -1.00 ; NMR STRUCTURE OF AN ENGINEERED CONTRYPHAN CYCLIC PEPTIDE (MOTIF CPXXPXC) 1EQ1 ; -1.00 ; NMR STRUCTURE OF AN EXCHANGEABLE APOLIPOPROTEIN-MANDUCA SEXTA APOLIPOPHORIN-III 1GN7 ; -1.00 ; NMR STRUCTURE OF AN INTRAMOLECULAR DEOXYRIBONUCLEIC ACID TRIPLEX CONTAINING AN N7-GLYCOSYLATED GUANINE, 8 STRUCTURES 1G5D ; -1.00 ; NMR STRUCTURE OF AN OLIGONUCLEOTIDE CONTAINING AN ABASIC SITE: ALPHA ANOMER 1GIZ ; -1.00 ; NMR STRUCTURE OF AN OLIGONUCLEOTIDE CONTAINING AN ABASIC SITE: ALPHA ANOMER 1G5E ; -1.00 ; NMR STRUCTURE OF AN OLIGONUCLEOTIDE CONTAINING AN ABASIC SITE: BETA ANOMER 1GJ0 ; -1.00 ; NMR STRUCTURE OF AN OLIGONUCLEOTIDE CONTAINING AN ABASIC SITE: BETA ANOMER 1OZZ ; -1.00 ; NMR STRUCTURE OF ANTIFUNGAL DEFENSIN ARD1 FROM ARCHAEOPREPONA DEMOPHON 1XKM ; -1.00 ; NMR STRUCTURE OF ANTIMICROBIAL PEPTIDE DISTINCTIN IN WATER 1ZO0 ; -1.00 ; NMR STRUCTURE OF ANTIZYME ISOFORM 1 FROM RAT 1LKJ ; -1.00 ; NMR STRUCTURE OF APO CALMODULIN FROM YEAST SACCHAROMYCES CEREVISIAE 1ILF ; -1.00 ; NMR STRUCTURE OF APO CBFB 1B4M ; -1.00 ; NMR STRUCTURE OF APO CELLULAR RETINOL-BINDING PROTEIN II, 24 STRUCTURES 1AEL ; -1.00 ; NMR STRUCTURE OF APO INTESTINAL FATTY ACID-BINDING PROTEIN, 20 STRUCTURES 1LS4 ; -1.00 ; NMR STRUCTURE OF APOLIPOPHORIN-III FROM LOCUSTA MIGRATORIA 1SOU ; -1.00 ; NMR STRUCTURE OF AQUIFEX AEOLICUS 5,10- METHENYLTETRAHYDROFOLATE SYNTHETASE: NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET QR46 1T8J ; -1.00 ; NMR STRUCTURE OF BBA5, A COMPACT, INDEPENDENTLY FOLDED BBA MOTIF 1LXL ; -1.00 ; NMR STRUCTURE OF BCL-XL, AN INHIBITOR OF PROGRAMMED CELL DEATH, MINIMIZED AVERAGE STRUCTURE 1HKO ; -1.00 ; NMR STRUCTURE OF BOVINE CYTOCHROME B5 1JV8 ; -1.00 ; NMR STRUCTURE OF BPTI MUTANT G37A 1JV9 ; -1.00 ; NMR STRUCTURE OF BPTI MUTANT G37A 1BI6 ; -1.00 ; NMR STRUCTURE OF BROMELAIN INHIBITOR VI FROM PINEAPPLE STEM 1RQS ; -1.00 ; NMR STRUCTURE OF C-TERMINAL DOMAIN OF RIBOSOMAL PROTEIN L7 FROM E.COLI 1XWE ; -1.00 ; NMR STRUCTURE OF C345C (NTR) DOMAIN OF C5 OF COMPLEMENT 1AWY ; -1.00 ; NMR STRUCTURE OF CALCIUM BOUND CONFORMER OF CONANTOKIN G, MINIMIZED AVERAGE STRUCTURE 1CFI ; -1.00 ; NMR STRUCTURE OF CALCIUM ION-BOUND GAMMA-CARBOXY-GLUTAMIC ACID-RICH DOMAIN OF FACTOR IX 1YX8 ; -1.00 ; NMR STRUCTURE OF CALSENSIN, 20 LOW ENERGY STRUCTURES. 1YX7 ; -1.00 ; NMR STRUCTURE OF CALSENSIN, ENERGY MINIMIZED AVERAGE STRUCTURE. 1FFJ ; -1.00 ; NMR STRUCTURE OF CARDIOTOXIN IN DPC-MICELLE 1JSP ; -1.00 ; NMR STRUCTURE OF CBP BROMODOMAIN IN COMPLEX WITH P53 PEPTIDE 1R8U ; -1.00 ; NMR STRUCTURE OF CBP TAZ1/CITED2 COMPLEX 1DFY ; -1.00 ; NMR STRUCTURE OF CONTRYPHAN-SM CYCLIC PEPTIDE (MAJOR FORM- CIS) 1DFZ ; -1.00 ; NMR STRUCTURE OF CONTRYPHAN-SM CYCLIC PEPTIDE (MINOR FORM- TRANS) 1S4J ; -1.00 ; NMR STRUCTURE OF CROSS-REACTIVE PEPTIDES FROM HOMO SAPIENS 1S4H ; -1.00 ; NMR STRUCTURE OF CROSS-REACTIVE PEPTIDES FROM L. BRAZILIENSIS 1I02 ; -1.00 ; NMR STRUCTURE OF CTX A3 AT NEUTRAL PH (20 STRUCTURES) 1RJT ; -1.00 ; NMR STRUCTURE OF CXC CHEMOKINE CXCL11/ITAC 1H9C ; -1.00 ; NMR STRUCTURE OF CYSTEINYL-PHOSPHORYLATED ENZYME IIB OF THE N,N'-DIACETYLCHITOBIOSE SPECIFIC PHOSPHOENOLPYRUVATE-DEPENDENT PHOSPHOTRANSFERASE SYSTEM OF ESCHERICHIA COLI. 1GJ1 ; -1.00 ; NMR STRUCTURE OF D(CCAAAGXACTGGG), X IS A 3'PHOSPHOGLYCOLATE, 5'PHOSPHATE GAPPED LESION 1N0O ; -1.00 ; NMR STRUCTURE OF D(CCAAGGXCTTGGG), X IS A 3'- PHOSPHOGLYCOLATE, 5'-PHOSPHATE GAPPED LESION, 10 STRUCTURES 1SKP ; -1.00 ; NMR STRUCTURE OF D(GCATATGATAG)(DOT)D(CTATCATATGC): A CONSENSUS SEQUENCE FOR PROMOTERS RECOGNIZED BY SIGMA-K RIBONUCLEIC ACID POLYMERASE, 4 STRUCTURES 1EKH ; -1.00 ; NMR STRUCTURE OF D(TTGGCCAA)2 BOUND TO CHROMOMYCIN-A3 AND COBALT 1HOD ; -1.00 ; NMR STRUCTURE OF D130I MUTANT T3-I2, A 32 RESIDUE PEPTIDE FROM THE ALPHA 2A ADRENERGIC RECEPTOR 1CP8 ; -1.00 ; NMR STRUCTURE OF DEOXYRIBONUCLEIC ACID (5'-D(TTGGCCAA)2-3') COMPLEXED WITH NOVEL ANTITUMOR DRUG UCH9 1TQR ; -1.00 ; NMR STRUCTURE OF DEOXYRIBONUCLEIC ACID 17-MER GGAAAATCTCTAGCAGT CORRESPONDING TO THE EXTREMITY OF THE U5 LTR OF THE HIV-1 GENOME 1K9H ; -1.00 ; NMR STRUCTURE OF DEOXYRIBONUCLEIC ACID TGTGAGCGCTCACA 1UAO ; -1.00 ; NMR STRUCTURE OF DESIGNED PROTEIN, CHIGNOLIN, CONSISTING OF ONLY TEN AMINO ACIDS (ENSEMBLES) 1DG0 ; -1.00 ; NMR STRUCTURE OF DES[GLY1]-CONTRYPHAN-R CYCLIC PEPTIDE (MAJOR FORM) 1KOY ; -1.00 ; NMR STRUCTURE OF DFF-C DOMAIN 1IBX ; -1.00 ; NMR STRUCTURE OF DFF40 AND DFF45 N-TERMINAL DOMAIN COMPLEX 1RQT ; -1.00 ; NMR STRUCTURE OF DIMERIC N-TERMINAL DOMAIN OF RIBOSOMAL PROTEIN L7 FROM E.COLI 1S6N ; -1.00 ; NMR STRUCTURE OF DOMAIN III OF THE WEST NILE VIRUS ENVELOPE PROTEIN, STRAIN 385-99 1N0K ; -1.00 ; NMR STRUCTURE OF DUPLEX DEOXYRIBONUCLEIC ACID D(CCAAGGXCTTGGG), X IS A 3' PHOSPHOGLYCOLATE, 5'PHOSPHATE GAPPED LESION 1ZGW ; -1.00 ; NMR STRUCTURE OF E. COLI ADA PROTEIN IN COMPLEX WITH DEOXYRIBONUCLEIC ACID 1TVM ; -1.00 ; NMR STRUCTURE OF ENZYME GATB OF THE GALACTITOL-SPECIFIC PHOSPHOENOLPYRUVATE-DEPENDENT PHOSPHOTRANSFERASE SYSTEM 1G7D ; -1.00 ; NMR STRUCTURE OF ERP29 C-DOMAIN 3GRX ; -1.00 ; NMR STRUCTURE OF ESCHERICHIA COLI GLUTAREDOXIN 3-GLUTATHIONE MIXED DISULFIDE COMPLEX, 20 STRUCTURES 1P0A ; -1.00 ; NMR STRUCTURE OF ETD135, MUTANT OF THE ANTIFUNGAL DEFENSIN ARD1 FROM ARCHAEOPREPONA DEMOPHON 1P00 ; -1.00 ; NMR STRUCTURE OF ETD151, MUTANT OF THE ANTIFUNGAL DEFENSIN ARD1 FROM ARCHAEOPREPONA DEMOPHON 1MOT ; -1.00 ; NMR STRUCTURE OF EXTENDED SECOND TRANSMEMBRANE DOMAIN OF GLYCINE RECEPTOR ALPHA1 SUBUNIT IN SDS MICELLES 1VDB ; -1.00 ; NMR STRUCTURE OF FMBP-1 TANDEM REPEAT 1 IN 30%(V/V) TFE SOLUTION 1WNM ; -1.00 ; NMR STRUCTURE OF FMBP-1 TANDEM REPEAT 2 IN 30%(V/V) TFE SOLUTION 1WNK ; -1.00 ; NMR STRUCTURE OF FMBP-1 TANDEM REPEAT 3 IN 30%(V/V) TFE SOLUTION 1WNN ; -1.00 ; NMR STRUCTURE OF FMBP-1 TANDEM REPEAT 4 IN 30%(V/V) TFE SOLUTION 1XOO ; -1.00 ; NMR STRUCTURE OF G1S MUTANT OF INFLUENZA HEMAGGLUTININ FUSION PEPTIDE IN DPC MICELLES AT PH 5 1XOP ; -1.00 ; NMR STRUCTURE OF G1V MUTANT OF INFLUENZA HEMAGGLUTININ FUSION PEPTIDE IN DPC MICELLES AT PH 5 1TM9 ; -1.00 ; NMR STRUCTURE OF GENE TARGET NUMBER GI3844938 FROM MYCOPLASMA GENITALIUM: BERKELEY STRUCTURAL GENOMICS CENTER 1IYY ; -1.00 ; NMR STRUCTURE OF GLN25-RIBONUCLEASE T1, 24 STRUCTURES 1ID8 ; -1.00 ; NMR STRUCTURE OF GLUTAMATE MUTASE (B12-BINDING SUBUNIT) COMPLEXED WITH THE VITAMIN B12 NUCLEOTIDE 1EGS ; -1.00 ; NMR STRUCTURE OF GROES MOBILE LOOP RESIDUES 19 - 27 IN THE SYNTHETIC PEPTIDE (RESIDUES 13 - 32) BOUND TO GROEL, 20 STRUCTURES 1X0N ; -1.00 ; NMR STRUCTURE OF GROWTH FACTOR RECEPTOR BINDING PROTEIN SH2 DOMAIN COMPLEXED WITH THE INHIBITOR 1IDV ; -1.00 ; NMR STRUCTURE OF HCV IRES RIBONUCLEIC ACID DOMAIN IIIC 1X93 ; -1.00 ; NMR STRUCTURE OF HELICOBACTER PYLORI HP0222 1NBL ; -1.00 ; NMR STRUCTURE OF HELLETHIONIN D 1IBN ; -1.00 ; NMR STRUCTURE OF HEMAGGLUTININ FUSION PEPTIDE IN DPC MICELLES AT PH 5 1IBO ; -1.00 ; NMR STRUCTURE OF HEMAGGLUTININ FUSION PEPTIDE IN DPC MICELLES AT PH 7.4 1OQ2 ; -1.00 ; NMR STRUCTURE OF HEMIMETHYLATED GATC SITE 1UAB ; -1.00 ; NMR STRUCTURE OF HEMIMETHYLATED GATC SITE 1B9P ; -1.00 ; NMR STRUCTURE OF HEPARIN BINDING SITE OF NON COLLAGENOUS DOMAIN I (NC1) OF COLLAGEN FACIT XIV 1B9Q ; -1.00 ; NMR STRUCTURE OF HEPARIN BINDING SITE OF NON COLLAGENOUS DOMAIN I (NC1) OF COLLAGEN FACIT XIV 1XAX ; -1.00 ; NMR STRUCTURE OF HI0004, A PUTATIVE ESSENTIAL GENE PRODUCT FROM HAEMOPHILUS INFLUENZAE 1JEM ; -1.00 ; NMR STRUCTURE OF HISTIDINE PHOSPHORYLATED FORM OF THE PHOSPHOCARRIER HISTIDINE CONTAINING PROTEIN FROM BACILLUS SUBTILIS, NMR, 25 STRUCTURES 1LB0 ; -1.00 ; NMR STRUCTURE OF HIV-1 GP41 659-671 13-MER PEPTIDE 1LCX ; -1.00 ; NMR STRUCTURE OF HIV-1 GP41 659-671 13MER PEPTIDE 1MTG ; -1.00 ; NMR STRUCTURE OF HO2-CO(III)BLEOMYCIN A(2) BOUND TO D(GAGCTC)(2) 1MXK ; -1.00 ; NMR STRUCTURE OF HO2-CO(III)BLEOMYCIN A(2) BOUND TO D(GGAAGCTTCC)(2) 1EII ; -1.00 ; NMR STRUCTURE OF HOLO CELLULAR RETINOL-BINDING PROTEIN II 1I5J ; -1.00 ; NMR STRUCTURE OF HUMAN APOLIPOPROTEIN C-II IN THE PRESENCE OF SDS 1IOX ; -1.00 ; NMR STRUCTURE OF HUMAN BETACELLULIN-2 1IP0 ; -1.00 ; NMR STRUCTURE OF HUMAN BETACELLULIN-2 1WNJ ; -1.00 ; NMR STRUCTURE OF HUMAN COACTOSIN-LIKE PROTEIN 1Q8G ; -1.00 ; NMR STRUCTURE OF HUMAN COFILIN 1Q8X ; -1.00 ; NMR STRUCTURE OF HUMAN COFILIN 1IMO ; -1.00 ; NMR STRUCTURE OF HUMAN DEOXYRIBONUCLEIC ACID LIGASE IIIALPHA BRCT DOMAIN 1IN1 ; -1.00 ; NMR STRUCTURE OF HUMAN DEOXYRIBONUCLEIC ACID LIGASE IIIALPHA BRCT DOMAIN 1K36 ; -1.00 ; NMR STRUCTURE OF HUMAN EPIREGULIN 1K37 ; -1.00 ; NMR STRUCTURE OF HUMAN EPIREGULIN 1TEY ; -1.00 ; NMR STRUCTURE OF HUMAN HISTONE CHAPERONE, ASF1A 2HIU ; -1.00 ; NMR STRUCTURE OF HUMAN INSULIN IN 20% ACETIC ACID, ZINC-FREE, 10 STRUCTURES 1LNP ; -1.00 ; NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS-B10-ASP, PRO-B28- LYS, LYS-B29-PRO, 20 STRUCTURES 1T1Q ; -1.00 ; NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS-B10-ASP, VAL-B12- ABA, PRO-B28-LYS, LYS-B29-PRO, 15 STRUCTURES 1T1K ; -1.00 ; NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS-B10-ASP, VAL-B12- ALA, PRO-B28-LYS, LYS-B29-PRO, 15 STRUCTURES 1T1P ; -1.00 ; NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS-B10-ASP, VAL-B12- THR, PRO-B28-LYS, LYS-B29-PRO, 15 STRUCTURES 1K3M ; -1.00 ; NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE-A2-ALA, HIS-B10- ASP, PRO-B28-LYS, LYS-B29-PRO, 15 STRUCTURES 1KMF ; -1.00 ; NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE-A2-ALLO-ILE, HIS- B10-ASP, PRO-B28-LYS, LYS-B29-PRO, 15 STRUCTURES 1LKQ ; -1.00 ; NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE-A2-GLY, VAL-A3- GLY, HIS-B10-ASP, PRO-B28-LYS, LYS-B29-PRO, 20 STRUCTURES 1SF1 ; -1.00 ; NMR STRUCTURE OF HUMAN INSULIN UNDER AMYLOIDOGENIC CONDITION, 15 STRUCTURES 1B50 ; -1.00 ; NMR STRUCTURE OF HUMAN MIP-1A D26A, 10 STRUCTURES 1B53 ; -1.00 ; NMR STRUCTURE OF HUMAN MIP-1A D26A, MINIMIZED AVERAGE STRUCTURE 1EQ3 ; -1.00 ; NMR STRUCTURE OF HUMAN PARVULIN HPAR14 1Y32 ; -1.00 ; NMR STRUCTURE OF HUMANIN IN 30% TFE SOLUTION 1NYN ; -1.00 ; NMR STRUCTURE OF HYPOTHETICAL YEAST PROTEIN YHR087W. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET YTYST425 1JJS ; -1.00 ; NMR STRUCTURE OF IBID, A DOMAIN OF CBP/P300 1GA3 ; -1.00 ; NMR STRUCTURE OF INTERLEUKIN-13 1URE ; -1.00 ; NMR STRUCTURE OF INTESTINAL FATTY ACID-BINDING PROTEIN COMPLEXED WITH PALMITATE, 20 STRUCTURES 1C89 ; -1.00 ; NMR STRUCTURE OF INTRAMOLECULAR DIMER ANTIFREEZE PROTEIN RD3, 40 SA STRUCTURES 1C8A ; -1.00 ; NMR STRUCTURE OF INTRAMOLECULAR DIMER ANTIFREEZE PROTEIN RD3, 40 SA STRUCTURES 1F53 ; -1.00 ; NMR STRUCTURE OF KILLER TOXIN-LIKE PROTEIN SKLP 1MZK ; -1.00 ; NMR STRUCTURE OF KINASE-INTERACTING FHA DOMAIN OF KINASE ASSOCIATED PROTEIN PHOSPHATASE, KAPP IN ARABIDOPSIS 1FOX ; -1.00 ; NMR STRUCTURE OF L11-C76, THE C-TERMINAL DOMAIN OF 50S RIBOSOMAL PROTEIN L11, 33 STRUCTURES 1FOW ; -1.00 ; NMR STRUCTURE OF L11-C76, THE C-TERMINAL DOMAIN OF 50S RIBOSOMAL PROTEIN L11, MINIMIZED AVERAGE STRUCTURE 1ZL8 ; -1.00 ; NMR STRUCTURE OF L27 HETERODIMER FROM C. ELEGANS LIN-7 AND H. SAPIENS LIN-2 SCAFFOLD PROTEINS 1RQU ; -1.00 ; NMR STRUCTURE OF L7 DIMER FROM E.COLI 1CJG ; -1.00 ; NMR STRUCTURE OF LAC REPRESSOR HP62-DEOXYRIBONUCLEIC ACID COMPLEX 2BGF ; -1.00 ; NMR STRUCTURE OF LYS48-LINKED DI-UBIQUITIN USING CHEMICAL SHIFT PERTURBATION DATA TOGETHER WITH RDCS AND 15N- RELAXATION DATA 2MAG ; -1.00 ; NMR STRUCTURE OF MAGAININ 2 IN DPC MICELLES, 10 STRUCTURES 1ZPX ; -1.00 ; NMR STRUCTURE OF MCOL1-[13-33] FROM HYDRA 1A11 ; -1.00 ; NMR STRUCTURE OF MEMBRANE SPANNING SEGMENT 2 OF THE ACETYLCHOLINE RECEPTOR IN DPC MICELLES, 10 STRUCTURES 1AD7 ; -1.00 ; NMR STRUCTURE OF METAL-FREE CONANTOKIN G, 1 STRUCTURE 1PLX ; -1.00 ; NMR STRUCTURE OF METHIONINE-ENKEPHALIN IN FAST TUMBLING BICELLES/DMPG 1PLW ; -1.00 ; NMR STRUCTURE OF METHIONINE-ENKEPHALIN IN FAST TUMBLING DMPC/DHPC BICELLES 1YGM ; -1.00 ; NMR STRUCTURE OF MISTIC 1RSF ; -1.00 ; NMR STRUCTURE OF MONOMERIC CAR D1 DOMAIN 1I17 ; -1.00 ; NMR STRUCTURE OF MOUSE DOPPEL 51-157 1JRM ; -1.00 ; NMR STRUCTURE OF MTH0637. ONTARIO CENTRE FOR STRUCTURAL PROTEOMICS TARGET MTH0637_1_104; NORTHEAST STRUCTURAL GENOMICS TARGET TT135 1SIY ; -1.00 ; NMR STRUCTURE OF MUNG BEAN NON-SPECIFIC LIPID TRANSFER PROTEIN 1 1ZWM ; -1.00 ; NMR STRUCTURE OF MURINE GAMMA-S CRYSTALLIN 1ZWO ; -1.00 ; NMR STRUCTURE OF MURINE GAMMA-S CRYSTALLIN 2A5M ; -1.00 ; NMR STRUCTURE OF MURINE GAMMA-S CRYSTALLIN FROM JOINT REFINEMENT WITH SAXS DATA 1G7E ; -1.00 ; NMR STRUCTURE OF N-DOMAIN OF ERP29 PROTEIN 1YSM ; -1.00 ; NMR STRUCTURE OF N-TERMINAL DOMAIN (RESIDUES 1-77) OF SIAH- INTERACTING PROTEIN. 1G03 ; -1.00 ; NMR STRUCTURE OF N-TERMINAL DOMAIN OF HTLV-I CA1-134 1P9F ; -1.00 ; NMR STRUCTURE OF NEUROKININ B FROM DYANA 1WN8 ; -1.00 ; NMR STRUCTURE OF OANTR 1DW4 ; -1.00 ; NMR STRUCTURE OF OMEGA-CONOTOXIN MVIIA: CONSTRAINTS ON DISULPHIDE BRIDGES 1DW5 ; -1.00 ; NMR STRUCTURE OF OMEGA-CONOTOXIN MVIIA: NO CONSTRAINTS ON DISULPHIDE BRIDGES 1L6U ; -1.00 ; NMR STRUCTURE OF OXIDIZED ADRENODOXIN 1XPN ; -1.00 ; NMR STRUCTURE OF P. AERUGINOSA PROTEIN PA1324: NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET PAP1 1YWW ; -1.00 ; NMR STRUCTURE OF P. AERUGINOSA PROTEIN PA4738: NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET PAP2 1JM4 ; -1.00 ; NMR STRUCTURE OF P/CAF BROMODOMAIN IN COMPLEX WITH HIV-1 TAT PEPTIDE 1L3H ; -1.00 ; NMR STRUCTURE OF P41ICF, A POTENT INHIBITOR OF HUMAN CATHEPSIN L 1P94 ; -1.00 ; NMR STRUCTURE OF PARG SYMMETRIC DIMER 1YT6 ; -1.00 ; NMR STRUCTURE OF PEPTIDE SD 1YTR ; -1.00 ; NMR STRUCTURE OF PLANTARICIN A IN DPC MICELLES, 20 STRUCTURES 1B1V ; -1.00 ; NMR STRUCTURE OF PSP1, PLASMATOCYTE-SPREADING PEPTIDE FROM PSEUDOPLUSIA INCLUDENS 1B5N ; -1.00 ; NMR STRUCTURE OF PSP1, PLASMATOCYTE-SPREADING PEPTIDE FROM PSEUDOPLUSIA INCLUDENS 1NGO ; -1.00 ; NMR STRUCTURE OF PUTATIVE 3' TERMINATOR FOR B. ANTHRACIS PAGA GENE CODING STRAND 1NGU ; -1.00 ; NMR STRUCTURE OF PUTATIVE 3'TERMINATOR FOR B. ANTHRACIS PAGA GENE NONCODING STRAND 1M02 ; -1.00 ; NMR STRUCTURE OF PW2 BOUND TO SDS MICELLES: A TRYPTOPHAN- RICH ANTICOCIDIAL PEPTIDE SELECTED FROM PHAGE DISPLAY LIBRARIES 1AAB ; -1.00 ; NMR STRUCTURE OF RAT HMG1 HMGA FRAGMENT 2ATG ; -1.00 ; NMR STRUCTURE OF RETROCYCLIN-2 IN SDS 1YGW ; -1.00 ; NMR STRUCTURE OF RIBONUCLEASE T1, 34 STRUCTURES 1GO0 ; -1.00 ; NMR STRUCTURE OF RIBOSOMAL PROTEIN L30E FROM THERMOCOCCUS CELER 1GO1 ; -1.00 ; NMR STRUCTURE OF RIBOSOMAL PROTEIN L30E FROM THERMOCOCCUS CELER. 1DFE ; -1.00 ; NMR STRUCTURE OF RIBOSOMAL PROTEIN L36 FROM THERMUS THERMOPHILUS 1KKG ; -1.00 ; NMR STRUCTURE OF RIBOSOME-BINDING FACTOR A (RBFA) 1SJQ ; -1.00 ; NMR STRUCTURE OF RRM1 FROM HUMAN POLYPYRIMIDINE TRACT BINDING PROTEIN ISOFORM 1 (PTB1) 1SJR ; -1.00 ; NMR STRUCTURE OF RRM2 FROM HUMAN POLYPYRIMIDINE TRACT BINDING PROTEIN ISOFORM 1 (PTB1) 1JDM ; -1.00 ; NMR STRUCTURE OF SARCOLIPIN 1K8H ; -1.00 ; NMR STRUCTURE OF SMALL PROTEIN B (SMPB) FROM AQUIFEX AEOLICUS 1AG4 ; -1.00 ; NMR STRUCTURE OF SPHERULIN 3A (S3A) FROM PHYSARUM POLYCEPHALUM, MINIMIZED AVERAGE STRUCTURE 1CQ5 ; -1.00 ; NMR STRUCTURE OF SRP RIBONUCLEIC ACID DOMAIN IV 1CQL ; -1.00 ; NMR STRUCTURE OF SRP RIBONUCLEIC ACID DOMAIN IV 1XSX ; -1.00 ; NMR STRUCTURE OF SSO10A, A HYPERTHERMOPHILE DEOXYRIBONUCLEIC ACID-BINDING PROTEIN WITH AN EXTENDED ANTI-PARALLEL COILED COIL 1ESY ; -1.00 ; NMR STRUCTURE OF STEM LOOP SL2 OF THE HIV-1 PSI RIBONUCLEIC ACID PACKAGING SIGNAL REVEALS A NOVEL A-U-A BASE-TRIPLE PLATFORM 1HLL ; -1.00 ; NMR STRUCTURE OF T3-I2, A 32 RESIDUE PEPTIDE FROM THE ALPHA- 2A ADRENERGIC RECEPTOR 1HOF ; -1.00 ; NMR STRUCTURE OF T3-I2, A 32 RESIDUE PEPTIDE FROM THE ALPHA- 2A ADRENERGIC RECEPTOR 1QC8 ; -1.00 ; NMR STRUCTURE OF TAU EXON 10 SPLICING REGULATORY ELEMENT RIBONUCLEIC ACID 1CEU ; -1.00 ; NMR STRUCTURE OF THE (1-51) N-TERMINAL DOMAIN OF THE HIV-1 REGULATORY PROTEIN 1U57 ; -1.00 ; NMR STRUCTURE OF THE (345-392)GAG SEQUENCE FROM HIV-1 1QNZ ; -1.00 ; NMR STRUCTURE OF THE 0.5B ANTI-HIV ANTIBODY COMPLEX WITH THE GP120 V3 PEPTIDE 1R84 ; -1.00 ; NMR STRUCTURE OF THE 13-CIS-15-SYN RETINAL IN DARK_ADAPTED BACTERIORHODOPSIN 1HZ0 ; -1.00 ; NMR STRUCTURE OF THE 2-AMINO-1-METHYL-6-PHENYLIMIDAZO[4,5- B]PYRIDINE (PHIP) C8-DEOXYGUANOSINE ADDUCT IN DUPLEX DEOXYRIBONUCLEIC ACID 1RFR ; -1.00 ; NMR STRUCTURE OF THE 30MER STEMLOOP-D OF COXSACKIEVIRAL RIBONUCLEIC ACID 1FHK ; -1.00 ; NMR STRUCTURE OF THE 690 LOOP OF 16 S RRNA OF E. COLI 1OW9 ; -1.00 ; NMR STRUCTURE OF THE ACTIVE CONFORMATION OF THE VS RIBOZYME CLEAVAGE SITE 1JQR ; -1.00 ; NMR STRUCTURE OF THE AFRICAN SWINE FEVER VIRUS DEOXYRIBONUCLEIC ACID POLYMERASE X 1R2N ; -1.00 ; NMR STRUCTURE OF THE ALL-TRANS RETINAL IN DARK-ADAPTED BACTERIORHODOPSIN 1EI0 ; -1.00 ; NMR STRUCTURE OF THE ALPHA-HELICAL HAIRPIN OF P8MTCP1 1Y5O ; -1.00 ; NMR STRUCTURE OF THE AMINO-TERMINAL DOMAIN FROM THE TFB1 SUBUNIT OF YEAST TFIIH 1Z30 ; -1.00 ; NMR STRUCTURE OF THE APICAL PART OF STEMLOOP D FROM CLOVERLEAF 1 OF BOVINE ENTEROVIRUS 1 RIBONUCLEIC ACID 1YLG ; -1.00 ; NMR STRUCTURE OF THE APOB MRNA STEM-LOOP AND ITS INTERACTION WITH THE C TO U EDITING APOBEC1 COMPLEMENTARY FACTOR 1YNC ; -1.00 ; NMR STRUCTURE OF THE APOB MRNA STEM-LOOP AND ITS INTERACTION WITH THE C TO U EDITING APOBEC1 COMPLEMENTARY FACTOR 1YNE ; -1.00 ; NMR STRUCTURE OF THE APOB MRNA STEM-LOOP AND ITS INTERACTION WITH THE C TO U EDITING APOBEC1 COMPLEMENTARY FACTOR 1YNG ; -1.00 ; NMR STRUCTURE OF THE APOB MRNA STEM-LOOP AND ITS INTERACTION WITH THE C TO U EDITING APOBEC1 COMPLEMENTARY FACTOR 1PC0 ; -1.00 ; NMR STRUCTURE OF THE ARCHAEAL HOMOLOGUE OF RNASE P PROTEIN RPP29 1Q56 ; -1.00 ; NMR STRUCTURE OF THE B0 ISOFORM OF THE AGRIN G3 DOMAIN IN ITS CA2+ BOUND STATE 1P6U ; -1.00 ; NMR STRUCTURE OF THE BEF3-ACTIVATED STRUCTURE OF THE RESPONSE REGULATOR CHEY2-MG2+ FROM SINORHIZOBIUM MELILOTI 1SCV ; -1.00 ; NMR STRUCTURE OF THE C TERMINAL DOMAIN OF CARDIAC TROPONIN C BOUND TO THE N TERMINAL DOMAIN OF CARDIAC TROPONIN I 1FI5 ; -1.00 ; NMR STRUCTURE OF THE C TERMINAL DOMAIN OF CARDIAC TROPONIN C BOUND TO THE N TERMINAL DOMAIN OF CARDIAC TROPONIN I. 1GCF ; -1.00 ; NMR STRUCTURE OF THE C-TERMINAL DOMAIN OF THE LIGAND-BINDING REGION OF MURINE GRANULOCYTE COLONY-STIMULATING FACTOR RECEPTOR, 12 STRUCTURES 1CTO ; -1.00 ; NMR STRUCTURE OF THE C-TERMINAL DOMAIN OF THE LIGAND-BINDING REGION OF MURINE GRANULOCYTE COLONY-STIMULATING FACTOR RECEPTOR, MINIMIZED AVERAGE STRUCTURE 1P97 ; -1.00 ; NMR STRUCTURE OF THE C-TERMINAL PAS DOMAIN OF HIF2A 1E2B ; -1.00 ; NMR STRUCTURE OF THE C10S MUTANT OF ENZYME IIB CELLOBIOSE OF THE PHOSPHOENOL-PYRUVATE DEPENDENT PHOSPHOTRANSFERASE SYSTEM OF ESCHERICHIA COLI, 17 STRUCTURES 1C9F ; -1.00 ; NMR STRUCTURE OF THE CAD DOMAIN OF CASPASE-ACTIVATED DNASE 1XYK ; -1.00 ; NMR STRUCTURE OF THE CANINE PRION PROTEIN 1XI7 ; -1.00 ; NMR STRUCTURE OF THE CARBOXYL-TERMINAL CYSTEINE DOMAIN OF THE VHV1.1 POLYDNAVIRAL GENE PRODUCT 1WCL ; -1.00 ; NMR STRUCTURE OF THE CARBOXYTERMINAL DOMAINS OF ESCHERICHIA COLI NUSA 1WCN ; -1.00 ; NMR STRUCTURE OF THE CARBOXYTERMINAL DOMAINS OF ESCHERICHIA COLI NUSA 1XYJ ; -1.00 ; NMR STRUCTURE OF THE CAT PRION PROTEIN 1H67 ; -1.00 ; NMR STRUCTURE OF THE CH DOMAIN OF CALPONIN 1U3M ; -1.00 ; NMR STRUCTURE OF THE CHICKEN PRION PROTEIN FRAGMENT 128-242 1K8J ; -1.00 ; NMR STRUCTURE OF THE CK14 DEOXYRIBONUCLEIC ACID DUPLEX: A PORTION OF THE KNOWN NF-KB SEQUENCE CK1 1HOY ; -1.00 ; NMR STRUCTURE OF THE COMPLEX BETWEEN A-BUNGAROTOXIN AND A MIMOTOPE OF THE NICOTINIC ACETILCHOLINE RECEPTOR 1JBD ; -1.00 ; NMR STRUCTURE OF THE COMPLEX BETWEEN ALPHA-BUNGAROTOXIN AND A MIMOTOPE OF THE NICOTINIC ACETILCHOLINE RECEPTOR 1RGJ ; -1.00 ; NMR STRUCTURE OF THE COMPLEX BETWEEN ALPHA-BUNGAROTOXIN AND MIMOTOPE OF THE NICOTINIC ACETILCHOLINE RECEPTOR WITH ENHANCED ACTIVITY 1U5S ; -1.00 ; NMR STRUCTURE OF THE COMPLEX BETWEEN NCK-2 SH3 DOMAIN AND PINCH-1 LIM4 DOMAIN 1AZE ; -1.00 ; NMR STRUCTURE OF THE COMPLEX BETWEEN THE C32S-Y7V MUTANT OF THE NSH3 DOMAIN OF GRB2 WITH A PEPTIDE FROM SOS, 10 STRUCTURES 1EKZ ; -1.00 ; NMR STRUCTURE OF THE COMPLEX BETWEEN THE THIRD DSRBD FROM DROSOPHILA STAUFEN AND A RIBONUCLEIC ACID HAIRPIN 1A6B ; -1.00 ; NMR STRUCTURE OF THE COMPLEX BETWEEN THE ZINC FINGER PROTEIN NCP10 OF MOLONEY MURINE LEUKEMIA VIRUS AND A SEQUENCE OF THE PSI-PACKAGING DOMAIN OF HIV-1, 20 STRUCTURES 1LV3 ; -1.00 ; NMR STRUCTURE OF THE CONSERVED HYPOTHETICAL ZINC FINGER PROTEIN YACG FROM ESCHERICHIA COLI, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET ET92 1RY4 ; -1.00 ; NMR STRUCTURE OF THE CRIB-PDZ MODULE OF PAR-6 1JJD ; -1.00 ; NMR STRUCTURE OF THE CYANOBACTERIAL METALLOTHIONEIN SMTA 1Q3Y ; -1.00 ; NMR STRUCTURE OF THE CYS28HIS MUTANT (D FORM) OF THE NUCLEOCAPSID PROTEIN NCP7 OF HIV-1. 1Q3Z ; -1.00 ; NMR STRUCTURE OF THE CYS28HIS MUTANT (E FORM) OF THE NUCLEOCAPSID PROTEIN NCP7 OF HIV-1. 1S4W ; -1.00 ; NMR STRUCTURE OF THE CYTOPLASMIC DOMAIN OF INTEGRIN AIIB IN DPC MICELLES 1DRO ; -1.00 ; NMR STRUCTURE OF THE CYTOSKELETON/SIGNAL TRANSDUCTION PROTEIN 1Z2K ; -1.00 ; NMR STRUCTURE OF THE D1 DOMAIN OF THE NATURAL KILLER CELL RECEPTOR, 2B4 1BUT ; -1.00 ; NMR STRUCTURE OF THE DEOXYRIBONUCLEIC ACID DECAMER D(CATGGCCATG)2, 10 STRUCTURES 1L3G ; -1.00 ; NMR STRUCTURE OF THE DEOXYRIBONUCLEIC ACID-BINDING DOMAIN OF CELL CYCLE PROTEIN, MBP1(2-124) FROM SACCHAROMYCES CEREVISIAE 1TUZ ; -1.00 ; NMR STRUCTURE OF THE DIACYLGLYCEROL KINASE ALPHA, NESGC TARGET HR532 1BAU ; -1.00 ; NMR STRUCTURE OF THE DIMER INITIATION COMPLEX OF HIV-1 GENOMIC RIBONUCLEIC ACID, MINIMIZED AVERAGE STRUCTURE 1KMA ; -1.00 ; NMR STRUCTURE OF THE DOMAIN-I OF THE KAZAL-TYPE THROMBIN INHIBITOR DIPETALIN 1OVX ; -1.00 ; NMR STRUCTURE OF THE E. COLI CLPX CHAPERONE ZINC BINDING DOMAIN DIMER 1JNS ; -1.00 ; NMR STRUCTURE OF THE E. COLI PEPTIDYL-PROLYL CIS/TRANS- ISOMERASE PARVULIN 10 1JNT ; -1.00 ; NMR STRUCTURE OF THE E. COLI PEPTIDYL-PROLYL CIS/TRANS- ISOMERASE PARVULIN 10 2B3W ; -1.00 ; NMR STRUCTURE OF THE E.COLI PROTEIN YBIA, NORTHEAST STRUCTURAL GENOMICS TARGET ET24. 1MZT ; -1.00 ; NMR STRUCTURE OF THE FD BACTERIOPHAGE PVIII COAT PROTEIN IN LIPID BILAYER MEMBRANES 2A0T ; -1.00 ; NMR STRUCTURE OF THE FHA1 DOMAIN OF RAD53 IN COMPLEX WITH A BIOLOGICAL RELEVANT PHOSPHOPEPTIDE DERIVED FROM MADT1 1J4P ; -1.00 ; NMR STRUCTURE OF THE FHA1 DOMAIN OF RAD53 IN COMPLEX WITH A RAD9-DERIVED PHOSPHOTHREONINE (AT T155) PEPTIDE 1K3N ; -1.00 ; NMR STRUCTURE OF THE FHA1 DOMAIN OF RAD53 IN COMPLEX WITH A RAD9-DERIVED PHOSPHOTHREONINE (AT T155) PEPTIDE 1J4Q ; -1.00 ; NMR STRUCTURE OF THE FHA1 DOMAIN OF RAD53 IN COMPLEX WITH A RAD9-DERIVED PHOSPHOTHREONINE (AT T192) PEPTIDE 1K3Q ; -1.00 ; NMR STRUCTURE OF THE FHA1 DOMAIN OF RAD53 IN COMPLEX WITH A RAD9-DERIVED PHOSPHOTHREONINE (AT T192) PEPTIDE 1G3G ; -1.00 ; NMR STRUCTURE OF THE FHA1 DOMAIN OF YEAST RAD53 2FNB ; -1.00 ; NMR STRUCTURE OF THE FIBRONECTIN ED-B DOMAIN, NMR, 20 STRUCTURES 1J8K ; -1.00 ; NMR STRUCTURE OF THE FIBRONECTIN EDA DOMAIN, NMR, 20 STRUCTURES 1G4F ; -1.00 ; NMR STRUCTURE OF THE FIFTH DOMAIN OF HUMAN BETA2- GLYCOPROTEIN I 1G4G ; -1.00 ; NMR STRUCTURE OF THE FIFTH DOMAIN OF HUMAN BETA2- GLYCOPROTEIN I 1XWH ; -1.00 ; NMR STRUCTURE OF THE FIRST PHD FINGER OF AUTOIMMUNE REGULATOR PROTEIN (AIRE1): INSIGHTS INTO APECED 1M9O ; -1.00 ; NMR STRUCTURE OF THE FIRST ZINC BINDING DOMAIN OF NUP475/TTP/TIS11 1QXC ; -1.00 ; NMR STRUCTURE OF THE FRAGMENT 25-35 OF BETA AMYLOID PEPTIDE IN 20/80 V:V HEXAFLUOROISOPROPANOL/WATER MIXTURE 1TM6 ; -1.00 ; NMR STRUCTURE OF THE FREE ZINC BINDING C-TERMINAL DOMAIN OF SECA 1AOU ; -1.00 ; NMR STRUCTURE OF THE FYN SH2 DOMAIN COMPLEXED WITH A PHOSPHOTYROSYL PEPTIDE, 22 STRUCTURES 1AOT ; -1.00 ; NMR STRUCTURE OF THE FYN SH2 DOMAIN COMPLEXED WITH A PHOSPHOTYROSYL PEPTIDE, MINIMIZED AVERAGE STRUCTURE 1CYZ ; -1.00 ; NMR STRUCTURE OF THE GAACTGGTTC/TRI-IMIDAZOLE POLYAMIDE COMPLEX 1XFN ; -1.00 ; NMR STRUCTURE OF THE GROUND STATE OF THE PHOTOACTIVE YELLOW PROTEIN LACKING THE N-TERMINAL PART 1F2R ; -1.00 ; NMR STRUCTURE OF THE HETERODIMERIC COMPLEX BETWEEN CAD DOMAINS OF CAD AND ICAD 1BXD ; -1.00 ; NMR STRUCTURE OF THE HISTIDINE KINASE DOMAIN OF THE E. COLI OSMOSENSOR ENVZ 1F6U ; -1.00 ; NMR STRUCTURE OF THE HIV-1 NUCLEOCAPSID PROTEIN BOUND TO STEM-LOOP SL2 OF THE PSI-RIBONUCLEIC ACID PACKAGING SIGNAL. IMPLICATIONS FOR GENOME RECOGNITION 1M8L ; -1.00 ; NMR STRUCTURE OF THE HIV-1 REGULATORY PROTEIN VPR 1D8B ; -1.00 ; NMR STRUCTURE OF THE HRDC DOMAIN FROM SACCHAROMYCES CEREVISIAE RECQ HELICASE 1SGO ; -1.00 ; NMR STRUCTURE OF THE HUMAN C14ORF129 GENE PRODUCT, HSPC210. NORTHEAST STRUCTURAL GENOMICS TARGET HR969. 1QZP ; -1.00 ; NMR STRUCTURE OF THE HUMAN DEMATIN HEADPIECE DOMAIN 1LG4 ; -1.00 ; NMR STRUCTURE OF THE HUMAN DOPPEL PROTEIN FRAGMENT 24-152 1HLS ; -1.00 ; NMR STRUCTURE OF THE HUMAN INSULIN-HIS(B16) 1G1E ; -1.00 ; NMR STRUCTURE OF THE HUMAN MAD1 TRANSREPRESSION DOMAIN SID IN COMPLEX WITH MAMMALIAN SIN3A PAH2 DOMAIN 1TOZ ; -1.00 ; NMR STRUCTURE OF THE HUMAN NOTCH-1 LIGAND BINDING REGION 1HCS ; -1.00 ; NMR STRUCTURE OF THE HUMAN SRC SH2 DOMAIN COMPLEX 1HCT ; -1.00 ; NMR STRUCTURE OF THE HUMAN SRC SH2 DOMAIN COMPLEX 1VDY ; -1.00 ; NMR STRUCTURE OF THE HYPOTHETICAL ENTH-VHS DOMAIN AT3G16270 FROM ARABIDOPSIS THALIANA 1RYK ; -1.00 ; NMR STRUCTURE OF THE HYPOTHETICAL PROTEIN ENCODED BY THE YJBJ GENE FROM ESCHERICHIA COLI. ONTARIO CENTRE FOR STRUCTURAL PROTEOMICS TARGET EC0298_1_69; NORTHEAST STRUCTURAL GENOMICS TARGET ET93 1VEE ; -1.00 ; NMR STRUCTURE OF THE HYPOTHETICAL RHODANESE DOMAIN AT4G01050 FROM ARABIDOPSIS THALIANA 1M6A ; -1.00 ; NMR STRUCTURE OF THE I-MOTIF TETRAMER FORMED BY XC2 1YBL ; -1.00 ; NMR STRUCTURE OF THE I-MOTIF TETRAMER OF D(AACCCC) 2AJJ ; -1.00 ; NMR STRUCTURE OF THE IN-PLANE MEMBRANE ANCHOR DOMAIN [1-28] OF THE MONOTOPIC NON STRUCTURAL PROTEIN 5A (NS5A) OF BOVINE VIRAL DIARRHEA VIRUS (BVDV) 2AJM ; -1.00 ; NMR STRUCTURE OF THE IN-PLANE MEMBRANE ANCHOR DOMAIN [1-28] OF THE MONOTOPIC NONSTRUCTURAL PROTEIN 5A (NS5A) FROM THE BOVINE VIRAL DIARRHEA VIRUS (BVDV) 2AJN ; -1.00 ; NMR STRUCTURE OF THE IN-PLANE MEMBRANE ANCHOR DOMAIN [1-28] OF THE MONOTOPIC NONSTRUCTURAL PROTEIN 5A (NS5A) FROM THE BOVINE VIRAL DIARRHEA VIRUS (BVDV) 2AJO ; -1.00 ; NMR STRUCTURE OF THE IN-PLANE MEMBRANE ANCHOR DOMAIN [1-28] OF THE MONOTOPIC NONSTRUCTURAL PROTEIN 5A (NS5A) FROM THE BOVINE VIRAL DIARRHEA VIRUS (BVDV) 1S4X ; -1.00 ; NMR STRUCTURE OF THE INTEGRIN B3 CYTOPLASMIC DOMAIN IN DPC MICELLES 1N6U ; -1.00 ; NMR STRUCTURE OF THE INTERFERON-BINDING ECTODOMAIN OF THE HUMAN INTERFERON RECEPTOR 1J5L ; -1.00 ; NMR STRUCTURE OF THE ISOLATED BETA_C DOMAIN OF LOBSTER METALLOTHIONEIN-1 1LUK ; -1.00 ; NMR STRUCTURE OF THE ITK SH2 DOMAIN, PRO287CIS, ENERGY MINIMIZED AVERAGE STRUCTURE 1LUM ; -1.00 ; NMR STRUCTURE OF THE ITK SH2 DOMAIN, PRO287TRANS, 20 LOW ENERGY STRUCTURES 1LUN ; -1.00 ; NMR STRUCTURE OF THE ITK SH2 DOMAIN, PRO287TRANS, ENERGY MINIMIZED AVERAGE STRUCTURE 1XBL ; -1.00 ; NMR STRUCTURE OF THE J-DOMAIN (RESIDUES 2-76) IN THE ESCHERICHIA COLI N-TERMINAL FRAGMENT (RESIDUES 2-108) OF THE MOLECULAR CHAPERONE DNAJ, 20 STRUCTURES 1N4C ; -1.00 ; NMR STRUCTURE OF THE J-DOMAIN AND CLATHRIN SUBSTRATE BINDING DOMAIN OF BOVINE AUXILIN 1S7A ; -1.00 ; NMR STRUCTURE OF THE LA MOTIF OF HUMAN LA PROTEIN 1AJ1 ; -1.00 ; NMR STRUCTURE OF THE LANTIBIOTIC ACTAGARDINE, 15 STRUCTURES 1JBI ; -1.00 ; NMR STRUCTURE OF THE LCCL DOMAIN 1DTV ; -1.00 ; NMR STRUCTURE OF THE LEECH CARBOXYPEPTIDASE INHIBITOR (LCI) 1C8P ; -1.00 ; NMR STRUCTURE OF THE LIGAND BINDING DOMAIN OF THE COMMON BETA-CHAIN IN THE GM-CSF, IL-3 AND IL-5 RECEPTORS 1JOX ; -1.00 ; NMR STRUCTURE OF THE LP5.1 HAIRPIN FROM BACILLUS RNASE P RIBONUCLEIC ACID REFINED WITH RESIDUAL DIPOLAR COUPLINGS 1JP0 ; -1.00 ; NMR STRUCTURE OF THE LP5.1 HAIRPIN FROM BACILLUS RNASE P RIBONUCLEIC ACID REFINED WITHOUT RESIDUAL DIPOLAR COUPLINGS 1R7F ; -1.00 ; NMR STRUCTURE OF THE MEMBRANE ANCHOR DOMAIN (1-31) OF THE NONSTRUCTURAL PROTEIN 5A (NS5A) OF HEPATITIS C VIRUS (ENSEMBLE OF 43 STRUCTURES. SAMPLE IN 100MM SDS) 1R7D ; -1.00 ; NMR STRUCTURE OF THE MEMBRANE ANCHOR DOMAIN (1-31) OF THE NONSTRUCTURAL PROTEIN 5A (NS5A) OF HEPATITIS C VIRUS (ENSEMBLE OF 51 STRUCTURES, SAMPLE IN 50% TFE) 1R7G ; -1.00 ; NMR STRUCTURE OF THE MEMBRANE ANCHOR DOMAIN (1-31) OF THE NONSTRUCTURAL PROTEIN 5A (NS5A) OF HEPATITIS C VIRUS (MINIMIZED AVERAGE STRUCTURE, SAMPLE IN 100MM DPC) 1R7C ; -1.00 ; NMR STRUCTURE OF THE MEMBRANE ANCHOR DOMAIN (1-31) OF THE NONSTRUCTURAL PROTEIN 5A (NS5A) OF HEPATITIS C VIRUS (MINIMIZED AVERAGE STRUCTURE, SAMPLE IN 50% TFE) 1R7E ; -1.00 ; NMR STRUCTURE OF THE MEMBRANE ANCHOR DOMAIN (1-31) OF THE NONSTRUCTURAL PROTEIN 5A (NS5A) OF HEPATITIS C VIRUS (MINIMIZED AVERAGE STRUCTURE. SAMPLE IN 100MM SDS). 1PEH ; -1.00 ; NMR STRUCTURE OF THE MEMBRANE-BINDING DOMAIN OF CTP PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE, 10 STRUCTURES 1PEI ; -1.00 ; NMR STRUCTURE OF THE MEMBRANE-BINDING DOMAIN OF CTP PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE, 10 STRUCTURES 1SBJ ; -1.00 ; NMR STRUCTURE OF THE MG2+-LOADED C TERMINAL DOMAIN OF CARDIAC TROPONIN C BOUND TO THE N TERMINAL DOMAIN OF CARDIAC TROPONIN I 1U6P ; -1.00 ; NMR STRUCTURE OF THE MLV ENCAPSIDATION SIGNAL BOUND TO THE NUCLEOCAPSID PROTEIN 28SP ; -1.00 ; NMR STRUCTURE OF THE MOST CONSERVED RIBONUCLEIC ACID MOTIF IN SRP RIBONUCLEIC ACID 28SR ; -1.00 ; NMR STRUCTURE OF THE MOST CONSERVED RIBONUCLEIC ACID MOTIF IN SRP RIBONUCLEIC ACID 1QPM ; -1.00 ; NMR STRUCTURE OF THE MU BACTERIOPHAGE REPRESSOR DEOXYRIBONUCLEIC ACID-BINDING DOMAIN 1G4D ; -1.00 ; NMR STRUCTURE OF THE MU BACTERIOPHAGE REPRESSOR DEOXYRIBONUCLEIC ACID-BINDING DOMAIN/DEOXYRIBONUCLEIC ACID COMPLEX 1R2U ; -1.00 ; NMR STRUCTURE OF THE N DOMAIN OF TROUT CARDIAC TROPONIN C AT 30 C 1FU6 ; -1.00 ; NMR STRUCTURE OF THE N-SH2 DOMAIN OF THE P85 SUBUNIT OF PI3- KINASE 1FU5 ; -1.00 ; NMR STRUCTURE OF THE N-SH2 DOMAIN OF THE P85 SUBUNIT OF PI3- KINASE COMPLEXED TO A DOUBLY PHOSPHORYLATED PEPTIDE DERIVED FROM POLYOMAVIRUS MIDDLE T ANTIGEN 1JWE ; -1.00 ; NMR STRUCTURE OF THE N-TERMINAL DOMAIN OF E. COLI DNAB HELICASE 1R6P ; -1.00 ; NMR STRUCTURE OF THE N-TERMINAL DOMAIN OF TROUT CARDIAC TROPONIN C AT 7 C 3NLA ; -1.00 ; NMR STRUCTURE OF THE N-TERMINAL DOMAIN WITH A LINKER PORTION OF ANTARCTIC EEL POUT ANTIFREEZE PROTEIN RD3, 40 STRUCTURES 3RDN ; -1.00 ; NMR STRUCTURE OF THE N-TERMINAL DOMAIN WITH A LINKER PORTION OF ANTARCTIC EEL POUT ANTIFREEZE PROTEIN RD3, MINIMIZED AVERAGE STRUCTURE 1RI0 ; -1.00 ; NMR STRUCTURE OF THE N-TERMINAL HATH DOMAIN OF HUMAN HDGF 1FAF ; -1.00 ; NMR STRUCTURE OF THE N-TERMINAL J DOMAIN OF MURINE POLYOMAVIRUS T ANTIGENS. 1P1T ; -1.00 ; NMR STRUCTURE OF THE N-TERMINAL RRM DOMAIN OF CLEAVAGE STIMULATION FACTOR 64 KDA SUBUNIT 2AZS ; -1.00 ; NMR STRUCTURE OF THE N-TERMINAL SH3 DOMAIN OF DRK (CALCULATED WITHOUT NOE RESTRAINTS) 1PN5 ; -1.00 ; NMR STRUCTURE OF THE NALP1 PYRIN DOMAIN (PYD) 1KG1 ; -1.00 ; NMR STRUCTURE OF THE NIP1 ELICITOR PROTEIN FROM RHYNCHOSPORIUM SECALIS 1YSY ; -1.00 ; NMR STRUCTURE OF THE NONSTRUCTURAL PROTEIN 7 (NSP7) FROM THE SARS CORONAVIRUS 1UAP ; -1.00 ; NMR STRUCTURE OF THE NTR DOMAIN FROM HUMAN PCOLCE1 1Q9F ; -1.00 ; NMR STRUCTURE OF THE OUTER MEMBRANE PROTEIN OMPX IN DHPC MICELLES 1Q9G ; -1.00 ; NMR STRUCTURE OF THE OUTER MEMBRANE PROTEIN OMPX IN DHPC MICELLES 1CQO ; -1.00 ; NMR STRUCTURE OF THE PALINDROMIC DEOXYRIBONUCLEIC ACID DECAMER D(GCGTTAACGC)2 1NZM ; -1.00 ; NMR STRUCTURE OF THE PARALLEL-STRANDED DEOXYRIBONUCLEIC ACID QUADRUPLEX D(TTAGGGT)4 COMPLEXED WITH THE TELOMERASE INHIBITOR RHPS4 1EE7 ; -1.00 ; NMR STRUCTURE OF THE PEPTAIBOL CHRYSOSPERMIN C BOUND TO DPC MICELLES 1W3D ; -1.00 ; NMR STRUCTURE OF THE PERIPHERAL-SUBUNIT BINDING DOMAIN OF BACILLUS STEAROTHERMOPHILUS E2P 1TWO ; -1.00 ; NMR STRUCTURE OF THE PHEROMONE BINDING PROTEIN FROM ANTHERAEA POLYPHEMUS AT ACIDIC PH 1XYQ ; -1.00 ; NMR STRUCTURE OF THE PIG PRION PROTEIN 1HO2 ; -1.00 ; NMR STRUCTURE OF THE POTASSIUM CHANNEL FRAGMENT L45 IN MICELLES 1HO7 ; -1.00 ; NMR STRUCTURE OF THE POTASSIUM CHANNEL FRAGMENT L45 IN TFE 1UCP ; -1.00 ; NMR STRUCTURE OF THE PYRIN DOMAIN OF HUMAN ASC 1R7W ; -1.00 ; NMR STRUCTURE OF THE R(GGAGGACAUCCCUCACGGGUGACCGUGGUCCUCC), DOMAIN IV STEM-LOOP B OF ENTEROVIRAL IRES WITH AUCCCU BULGE 1R7Z ; -1.00 ; NMR STRUCTURE OF THE R(GGAGGACAUUCCUCACGGGUGACCGUGGUCCUCC), DOMAIN IV STEM-LOOP B OF ENTEROVIRAL IRES WITH AUUCCU BULGE 1UG8 ; -1.00 ; NMR STRUCTURE OF THE R3H DOMAIN FROM POLY(A)-SPECIFIC RIBONUCLEASE 3CRD ; -1.00 ; NMR STRUCTURE OF THE RAIDD CARD DOMAIN, 15 STRUCTURES 1XJH ; -1.00 ; NMR STRUCTURE OF THE REDOX SWITCH DOMAIN OF THE E. COLI HSP33 1P6Q ; -1.00 ; NMR STRUCTURE OF THE RESPONSE REGULATOR CHEY2 FROM SINORHIZOBIUM MELILOTI, COMPLEXED WITH MG++ 1AQG ; -1.00 ; NMR STRUCTURE OF THE RHODOPSIN-BOUND C-TERMINAL PEPTIDE OF THE TRANSDUCIN ALPHA-SUBUNIT, 20 STRUCTURES 1N88 ; -1.00 ; NMR STRUCTURE OF THE RIBOSOMAL PROTEIN L23 FROM THERMUS THERMOPHILUS. 1OW5 ; -1.00 ; NMR STRUCTURE OF THE SACCHAROMYCES CEREVISIAE SAM (STERILE ALPHA MOTIF) DOMAIN 1GL5 ; -1.00 ; NMR STRUCTURE OF THE SH3 DOMAIN FROM THE TEC PROTEIN TYROSINE KINASE 1NJQ ; -1.00 ; NMR STRUCTURE OF THE SINGLE QALGGH ZINC FINGER DOMAIN FROM ARABIDOPSIS THALIANA SUPERMAN PROTEIN 1F8Z ; -1.00 ; NMR STRUCTURE OF THE SIXTH LIGAND-BINDING MODULE OF THE LDL RECEPTOR 1Q5L ; -1.00 ; NMR STRUCTURE OF THE SUBSTRATE BINDING DOMAIN OF DNAK BOUND TO THE PEPTIDE NRLLLTG 1DG4 ; -1.00 ; NMR STRUCTURE OF THE SUBSTRATE BINDING DOMAIN OF DNAK IN THE APO FORM 2BPR ; -1.00 ; NMR STRUCTURE OF THE SUBSTRATE BINDING DOMAIN OF DNAK, 25 STRUCTURES 1BPR ; -1.00 ; NMR STRUCTURE OF THE SUBSTRATE BINDING DOMAIN OF DNAK, MINIMIZED AVERAGE STRUCTURE 1XV3 ; -1.00 ; NMR STRUCTURE OF THE SYNTHETIC PENAEIDIN 4 1IE5 ; -1.00 ; NMR STRUCTURE OF THE THIRD IMMUNOGLOBULIN DOMAIN FROM THE NEURAL CELL ADHESION MOLECULE. 1SV1 ; -1.00 ; NMR STRUCTURE OF THE THKAIA180C-CIIABD COMPLEX (25- STRUCTURE ENSEMBLE) 1SUY ; -1.00 ; NMR STRUCTURE OF THE THKAIA180C-CIIABD COMPLEX (AVERAGE MINIMIZED STRUCTURE) 1RDE ; -1.00 ; NMR STRUCTURE OF THE THROMBIN-BINDING DEOXYRIBONUCLEIC ACID APTAMER STABILIZED BY SR2+ 1MUZ ; -1.00 ; NMR STRUCTURE OF THE TUMOR SUPPRESSOR BIN1: ALTERNATIVE SPLICING IN MELANOMA AND INTERACTION WITH C-MYC 1MV0 ; -1.00 ; NMR STRUCTURE OF THE TUMOR SUPPRESSOR BIN1: ALTERNATIVE SPLICING IN MELANOMA AND INTERACTION WITH C-MYC 1MV3 ; -1.00 ; NMR STRUCTURE OF THE TUMOR SUPPRESSOR BIN1: ALTERNATIVE SPLICING IN MELANOMA AND INTERACTION WITH C-MYC 1M0V ; -1.00 ; NMR STRUCTURE OF THE TYPE III SECRETORY DOMAIN OF YERSINIA YOPH COMPLEXED WITH THE SKAP-HOM PHOSPHO-PEPTIDE N-ACETYL- DEPYDDPF-NH2 1Q02 ; -1.00 ; NMR STRUCTURE OF THE UBA DOMAIN OF P62 (SQSTM1) 1I42 ; -1.00 ; NMR STRUCTURE OF THE UBX DOMAIN FROM P47 1JRU ; -1.00 ; NMR STRUCTURE OF THE UBX DOMAIN FROM P47 (ENERGY MINIMISED AVERAGE) 1LS8 ; -1.00 ; NMR STRUCTURE OF THE UNLIGANDED BOMBYX MORI PHEROMONE- BINDING PROTEIN AT PHYSIOLOGICAL PH 1TBK ; -1.00 ; NMR STRUCTURE OF THE VS RIBOZYME STEM-LOOP V RIBONUCLEIC ACID IN THE ABSENCE OF MULTIVALENT IONS. 1XX8 ; -1.00 ; NMR STRUCTURE OF THE W24A MUTANT OF THE HYPERTHERMOPHILE SAC7D PROTEIN 1K8N ; -1.00 ; NMR STRUCTURE OF THE XBY2 DEOXYRIBONUCLEIC ACID DUPLEX, AN ANALOG OF CK14 CONTAINING PHOSPHORODITHIOATE GROUPS AT C22 AND C24 1F5X ; -1.00 ; NMR STRUCTURE OF THE Y174 AUTOINHIBITED DBL HOMOLOGY DOMAIN 1QGP ; -1.00 ; NMR STRUCTURE OF THE Z-ALPHA DOMAIN OF ADAR1, 15 STRUCTURES 1KLR ; -1.00 ; NMR STRUCTURE OF THE ZFY-6T[Y10F] ZINC FINGER 1KLS ; -1.00 ; NMR STRUCTURE OF THE ZFY-6T[Y10L] ZINC FINGER 1K81 ; -1.00 ; NMR STRUCTURE OF THE ZINC-RIBBON DOMAIN WITHIN TRANSLATION INITIATION FACTOR 2 SUBUNIT BETA 1DQB ; -1.00 ; NMR STRUCTURE OF THROMBOMODULIN EGF(4-5) 1Y4E ; -1.00 ; NMR STRUCTURE OF TRANSMEMBRANE SEGMENT IV OF THE NHE1 ISOFORM OF THE NA+/H+ EXCHANGER 1L2Y ; -1.00 ; NMR STRUCTURE OF TRP-CAGE MINIPROTEIN CONSTRUCT TC5B 1LE0 ; -1.00 ; NMR STRUCTURE OF TRYPTOPHAN ZIPPER 1: A STABLE, MONOMERIC BETA-HAIRPIN WITH A TYPE II' TURN 1LE1 ; -1.00 ; NMR STRUCTURE OF TRYPTOPHAN ZIPPER 2: A STABLE, MONOMERIC BETA-HAIRPIN WITH A TYPE I' TURN 1LE3 ; -1.00 ; NMR STRUCTURE OF TRYPTOPHAN ZIPPER 4: A STABLE BETA-HAIRPIN PEPTIDE BASED ON THE C-TERMINAL HAIRPIN OF THE B1 DOMAIN OF PROTEIN G 1Q5F ; -1.00 ; NMR STRUCTURE OF TYPE IVB PILIN (PILS) FROM SALMONELLA TYPHI 1MG8 ; -1.00 ; NMR STRUCTURE OF UBIQUITIN-LIKE DOMAIN IN MURINE PARKIN 1P1A ; -1.00 ; NMR STRUCTURE OF UBIQUITIN-LIKE DOMAIN OF HHR23B 1Z1M ; -1.00 ; NMR STRUCTURE OF UNLIAGNDED MDM2 1OPQ ; -1.00 ; NMR STRUCTURE OF UNMETHYLATED GATC SITE 1ZLL ; -1.00 ; NMR STRUCTURE OF UNPHOSPHORYLATED HUMAN PHOSPHOLAMBAN PENTAMER 1CZ4 ; -1.00 ; NMR STRUCTURE OF VAT-N: THE N-TERMINAL DOMAIN OF VAT (VCP- LIKE ATPASE OF THERMOPLASMA) 1CZ5 ; -1.00 ; NMR STRUCTURE OF VAT-N: THE N-TERMINAL DOMAIN OF VAT (VCP- LIKE ATPASE OF THERMOPLASMA) 1WN4 ; -1.00 ; NMR STRUCTURE OF VONTR 1YXR ; -1.00 ; NMR STRUCTURE OF VPS4A MIT DOMAIN 1TK7 ; -1.00 ; NMR STRUCTURE OF WW DOMAINS (WW3-4) FROM SUPPRESSOR OF DELTEX 1RKL ; -1.00 ; NMR STRUCTURE OF YEAST OLIGOSACCHARYLTRANSFERASE SUBUNIT OST4P 1IH9 ; -1.00 ; NMR STRUCTURE OF ZERVAMICIN IIB (PEPTAIBOL ANTIBIOTIC) BOUND TO DPC MICELLES 1N1U ; -1.00 ; NMR STRUCTURE OF [ALA1,15]KALATA B1 1DUM ; -1.00 ; NMR STRUCTURE OF [F5Y, F16W] MAGAININ 2 BOUND TO PHOSPHOLIPID VESICLES 1RL5 ; -1.00 ; NMR STRUCTURE WITH TIGHTLY BOUND WATER MOLECULE OF CYTOTOXIN I FROM NAJA OXIANA IN AQUEOUS SOLUTION (MAJOR FORM) 1CB9 ; -1.00 ; NMR STRUCTURE WITH TIGHTLY BOUND WATER MOLECULES OF CYTOTOXIN II (CARDIOTOXIN) FROM NAJA NAJA OXIANA IN AQUEOUS SOLUTION (MAJOR FORM). 1CCQ ; -1.00 ; NMR STRUCTURE WITH TIGHTLY BOUND WATER MOLECULES OF CYTOTOXIN II (CARDIOTOXIN) FROM NAJA NAJA OXIANA IN AQUEOUS SOLUTION (MINOR FORM). 1CS2 ; -1.00 ; NMR STRUCTURES OF B-DEOXYRIBONUCLEIC ACID D(CTACTGCTTTAG).D(CTAAAGCAGTAG) 1DBY ; -1.00 ; NMR STRUCTURES OF CHLOROPLAST THIOREDOXIN M CH2 FROM THE GREEN ALGA CHLAMYDOMONAS REINHARDTII 1LUI ; -1.00 ; NMR STRUCTURES OF ITK SH2 DOMAIN, PRO287CIS ISOFORM, ENSEMBLE OF 20 LOW ENERGY STRUCTURES 1FH3 ; -1.00 ; NMR STRUCTURES OF LQH III ALPHA-LIKE SCORPION TOXIN FROM LEIURUS QUINQUESTRIATUS CORRESPONDING TO THE MAJOR CONFORMER IN SOLUTION 1DE1 ; -1.00 ; NMR STRUCTURES OF OXIDIZED BACTERIOPHAGE T4 GLUTAREDOXIN 1NZS ; -1.00 ; NMR STRUCTURES OF PHOSPHORYLATED CARBOXY TERMINUS OF BOVINE RHODOPSIN IN ARRESTIN-BOUND STATE 1DE2 ; -1.00 ; NMR STRUCTURES OF REDUCED BACTERIOPHAGE T4 GLUTAREDOXIN 1IVT ; -1.00 ; NMR STRUCTURES OF THE C-TERMINAL GLOBULAR DOMAIN OF HUMAN LAMIN A/C 1AIW ; -1.00 ; NMR STRUCTURES OF THE CELLULOSE-BINDING DOMAIN OF THE ENDOGLUCANASE Z FROM ERWINIA CHRYSANTHEMI, 23 STRUCTURES 1L3E ; -1.00 ; NMR STRUCTURES OF THE HIF-1ALPHA CTAD/P300 CH1 COMPLEX 1K0P ; -1.00 ; NMR STRUCTURES OF THE ZINC FINGER DOMAIN OF HUMAN DEOXYRIBONUCLEIC ACID POLYMERASE-ALPHA 1N5G ; -1.00 ; NMR STRUCTURES OF THE ZINC FINGER DOMAIN OF HUMAN DEOXYRIBONUCLEIC ACID POLYMERASE-ALPHA 1GH1 ; -1.00 ; NMR STRUCTURES OF WHEAT NONSPECIFIC LIPID TRANSFER PROTEIN 1QWB ; -1.00 ; NMR STRUCUTRE OF 5'-R(GGACACGAAAUCCCGAAGUAGUGUCC)-3' : AN RIBONUCLEIC ACID HAIRPIN CONTAINING THE IN VITRO SELECTED CONSENSUS SEQUENCE FOR NUCLEOLIN RBD12 1TFB ; -1.00 ; NMR STUDIES OF HUMAN GENERAL TRANSCRIPTION FACTOR TFIIB: DYNAMICS AND INTERACTION WITH VP16 ACTIVATION DOMAIN, 20 STRUCTURES 1ROE ; -1.00 ; NMR STUDY OF 2FE-2S FERREDOXIN OF SYNECHOCOCCUS ELONGATUS 1ROF ; -1.00 ; NMR STUDY OF 4FE-4S FERREDOXIN OF THERMOTOGA MARITIMA 1EMO ; -1.00 ; NMR STUDY OF A PAIR OF FIBRILLIN CA2+ BINDING EPIDERMAL GROWTH FACTOR-LIKE DOMAINS, 22 STRUCTURES 1EMN ; -1.00 ; NMR STUDY OF A PAIR OF FIBRILLIN CA2+ BINDING EPIDERMAL GROWTH FACTOR-LIKE DOMAINS, MINIMIZED AVERAGE STRUCTURE 1HJ7 ; -1.00 ; NMR STUDY OF A PAIR OF LDL RECEPTOR CA2+ BINDING EPIDERMAL GROWTH FACTOR-LIKE DOMAINS, 20 STRUCTURES 1RML ; -1.00 ; NMR STUDY OF ACID FIBROBLAST GROWTH FACTOR BOUND TO 1,3,6-NAPHTHALENE TRISULPHONATE, 26 STRUCTURES 1FJB ; -1.00 ; NMR STUDY OF AN 11-MER DEOXYRIBONUCLEIC ACID DUPLEX CONTAINING 7,8-DIHYDRO-8-OXOADENINE (AOXO) OPPOSITE THYMINE 1FV8 ; -1.00 ; NMR STUDY OF AN HETEROCHIRAL HAIRPIN 1WRT ; -1.00 ; NMR STUDY OF APO TRP REPRESSOR 1FKY ; -1.00 ; NMR STUDY OF B-DEOXYRIBONUCLEIC ACID CONTAINING A MISMATCHED BASE PAIR IN THE 29-39 K-RAS GENE SEQUENCE: CC CT C+C C+T, 2 STRUCTURES 1FKZ ; -1.00 ; NMR STUDY OF B-DEOXYRIBONUCLEIC ACID CONTAINING A MISMATCHED BASE PAIR IN THE 29-39 K-RAS GENE SEQUENCE: CC CT C+C C+T, 2 STRUCTURES 1KXS ; -1.00 ; NMR STUDY OF B-DEOXYRIBONUCLEIC ACID CONTAINING A MODIFIED BASE PAIR: THE 2'- DEOXYADENOSINE 3-(2-HYDROXYETHYL-2'-DEOXYURIDINE) 1BWY ; -1.00 ; NMR STUDY OF BOVINE HEART FATTY ACID BINDING PROTEIN 2BI6 ; -1.00 ; NMR STUDY OF BROMELAIN INHIBITOR VI FROM PINEAPPLE STEM 1JUN ; -1.00 ; NMR STUDY OF C-JUN HOMODIMER 1AL9 ; -1.00 ; NMR STUDY OF DEOXYRIBONUCLEIC ACID (5'-D(APCPGPTPAPCPGPT)-3') SELF-COMPLEMENTARY DUPLEX COMPLEXED WITH A BIS-DAUNORUBICIN, MINIMIZED AVERAGE STRUCTURE 1DSC ; -1.00 ; NMR STUDY OF DEOXYRIBONUCLEIC ACID (5'-D(GPAPAPGPCPTPTPC)-3') SELF-COMPLEMENTARY DUPLEX COMPLEXED WITH ACTINOMYCIN D, MINIMIZED AVERAGE STRUCTURE 1DSD ; -1.00 ; NMR STUDY OF DEOXYRIBONUCLEIC ACID (5'-D(GPAPTPGPCPTPTPC)-3') T:T MISMATCHED DUPLEX COMPLEXED WITH ACTINOMYCIN D, MINIMIZED AVERAGE STRUCTURE 1AMD ; -1.00 ; NMR STUDY OF DEOXYRIBONUCLEIC ACID (5'-D(TPGPTPAPCPA)-3') SELF-COMPLEMENTARY DUPLEX COMPLEXED WITH A BIS-DAUNORUBICIN WP-652, MINIMIZED AVERAGE STRUCTURE 1FJA ; -1.00 ; NMR STUDY OF DEOXYRIBONUCLEIC ACID COMPLEXED WITH ACTINOMYCIN D 1WRS ; -1.00 ; NMR STUDY OF HOLO TRP REPRESSOR 3IFB ; -1.00 ; NMR STUDY OF HUMAN INTESTINAL FATTY ACID BINDING PROTEIN 1EAL ; -1.00 ; NMR STUDY OF ILEAL LIPID BINDING PROTEIN 1CV9 ; -1.00 ; NMR STUDY OF ITAM PEPTIDE SUBSTRATE 1IKM ; -1.00 ; NMR STUDY OF MONOMERIC HUMAN INTERLEUKIN-8 (30 STRUCTURES) 1IKL ; -1.00 ; NMR STUDY OF MONOMERIC HUMAN INTERLEUKIN-8 (MINIMIZED AVERAGE STRUCTURE) 1EIT ; -1.00 ; NMR STUDY OF MU-AGATOXIN 1MUT ; -1.00 ; NMR STUDY OF MUTT ENZYME, A NUCLEOSIDE TRIPHOSPHATE PYROPHOSPHOHYDROLASE 2BTA ; -1.00 ; NMR STUDY OF N-TERMINAL HUMAN BAND 3 PEPTIDE, RESIDUES 1 - 15 2BTB ; -1.00 ; NMR STUDY OF N-TERMINAL HUMAN BAND 3 PEPTIDE, RESIDUES 1 - 15 1OMG ; -1.00 ; NMR STUDY OF OMEGA-CONOTOXIN MVIIA 1NOE ; -1.00 ; NMR STUDY OF REDUCED HIGH POTENTIAL IRON SULFUR PROTEIN 1B4O ; -1.00 ; NMR STUDY OF SSO7D MUTANT (F31A) MINIMIZED AVERAGE STRUCTURE 1NCS ; -1.00 ; NMR STUDY OF SWI5 ZINC FINGER DOMAIN 1 1SOC ; -1.00 ; NMR STUDY OF THE BACKBONE CONFORMATIONAL EQUILIBRIA OF SANDOSTATIN, MINIMIZED AVERAGE BETA-SHEET STRUCTURE 2SOC ; -1.00 ; NMR STUDY OF THE BACKBONE CONFORMATIONAL EQUILIBRIA OF SANDOSTATIN, TWO REPRESENTATIVE MINIMUM ENERGY PARTIALLY HELICAL STRUCTURES 1LMJ ; -1.00 ; NMR STUDY OF THE FIBRILLIN-1 CBEGF12-13 PAIR OF CA2+ BINDING EPIDERMAL GROWTH FACTOR-LIKE DOMAINS 1SUT ; -1.00 ; NMR STUDY OF THE PROLINE REPEAT FROM TUS 1QLY ; -1.00 ; NMR STUDY OF THE SH3 DOMAIN FROM BRUTON'S TYROSINE KINASE, 20 STRUCTURES 1A0N ; -1.00 ; NMR STUDY OF THE SH3 DOMAIN FROM FYN PROTO-ONCOGENE TYROSINE KINASE COMPLEXED WITH THE SYNTHETIC PEPTIDE P2L CORRESPONDING TO RESIDUES 91-104 OF THE P85 SUBUNIT OF PI3-KINASE, FAMILY OF 25 STRUCTURES 1AZG ; -1.00 ; NMR STUDY OF THE SH3 DOMAIN FROM FYN PROTO-ONCOGENE TYROSINE KINASE KINASE COMPLEXED WITH THE SYNTHETIC PEPTIDE P2L CORRESPONDING TO RESIDUES 91-104 OF THE P85 SUBUNIT OF PI3-KINASE, MINIMIZED AVERAGE (PROBMAP) STRUCTURE 1NYG ; -1.00 ; NMR STUDY OF THE SH3 DOMAIN FROM FYN PROTO-ONCOGENE TYROSINE KINASE, FAMILY OF 20 STRUCTURES 1NYF ; -1.00 ; NMR STUDY OF THE SH3 DOMAIN FROM FYN PROTO-ONCOGENE TYROSINE KINASE, MINIMIZED AVERAGE (PROBMAP) STRUCTURE 1KSQ ; -1.00 ; NMR STUDY OF THE THIRD TB DOMAIN FROM LATENT TRANSFORMING GROWTH FACTOR-BETA BINDING PROTEIN-1 1APJ ; -1.00 ; NMR STUDY OF THE TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN-LIKE DOMAIN (TB MODULE/8-CYS DOMAIN), NMR, 21 STRUCTURES 1CO0 ; -1.00 ; NMR STUDY OF TRP REPRESSOR-MTR OPERATOR DEOXYRIBONUCLEIC ACID COMPLEX 1RCS ; -1.00 ; NMR STUDY OF TRP REPRESSOR-OPERATOR DEOXYRIBONUCLEIC ACID COMPLEX 1VIG ; -1.00 ; NMR STUDY OF VIGILIN, REPEAT 6, 40 STRUCTURES 1VIH ; -1.00 ; NMR STUDY OF VIGILIN, REPEAT 6, MINIMIZED AVERAGE STRUCTURE 1TNE ; -1.00 ; NMR STUDY OF Z-DEOXYRIBONUCLEIC ACID AT PHYSIOLOGICAL SALT CONDITIONS, MINIMIZED AVERAGE STRUCTURE 1FQZ ; -1.00 ; NMR VALIDATED MODEL OF DOMAIN IIID OF HEPATITIS C VIRUS INTERNAL RIBOSOME ENTRY SITE 1QM9 ; -1.00 ; NMR, REPRESENTATIVE STRUCTURE 1R36 ; -1.00 ; NMR-BASED STRUCTURE OF AUTOINHIBITED MURINE ETS-1 DELTAN301 1IIO ; -1.00 ; NMR-BASED STRUCTURE OF THE CONSERVED PROTEIN MTH865 FROM THE ARCHEA METHANOBACTERIUM THERMOAUTOTROPHICUM 1M4O ; -1.00 ; NMR-DERIVED MODEL FOR THE SOLUTION STRUCTURE OF NICKEL- CONTAINING ACIREDUCTONE DIOXYGENASE FROM KLEBSIELLA 1QSK ; -1.00 ; NMR-DERIVED SOLUTION STRUCTURE OF A FIVE-ADENINE BULGE LOOP WITHIN A DEOXYRIBONUCLEIC ACID DUPLEX 1OKD ; -1.00 ; NMR-STRUCTURE OF TRYPAREDOXIN 1 1S05 ; -1.00 ; NMR-VALIDATED STRUCTURAL MODEL FOR OXIDIZED R.PALUSTRIS CYTOCHROME C556 1NOV ; 3.30 ; NODAMURA VIRUS 1AY3 ; -1.00 ; NODULARIN FROM NODULARIA SPUMIGENA 1L9V ; 2.60 ; NON STRUCTURAL PROTEIN ENCODED BY GENE SEGMENT 8 OF ROTAVIRUS (NSP2), AN NTPASE, SSRNA BINDING AND NUCLEIC ACID HELIX-DESTABILIZING PROTEIN 1RCX ; 2.40 ; NON-ACTIVATED SPINACH RUBISCO IN COMPLEX WITH ITS SUBSTRATE RIBULOSE-1,5-BISPHOSPHATE 1PH0 ; 2.20 ; NON-CARBOXYLIC ACID-CONTAINING INHIBITOR OF PTP1B TARGETING THE SECOND PHOSPHOTYROSINE SITE 1GXG ; -1.00 ; NON-COGNATE PROTEIN-PROTEIN INTERACTIONS: THE NMR STRUCTURE OF THE COLICIN E8 INHIBITOR PROTEIN IM8 AND ITS INTERACTION WITH THE DNASE DOMAIN OF COLICIN E9 1OPH ; 2.30 ; NON-COVALENT COMPLEX BETWEEN ALPHA-1-PI-PITTSBURGH AND S195A TRYPSIN 1PW1 ; 1.20 ; NON-COVALENT COMPLEX OF STREPTOMYCES R61 DD-PEPTIDASE WITH A HIGHLY SPECIFIC PENICILLIN 1TQ9 ; 2.00 ; NON-COVALENT SWAPPED DIMER OF BOVINE SEMINAL RIBONUCLEASE IN COMPLEX WITH 2'-DEOXYCYTIDINE-2'-DEOXYADENOSINE-3',5'- MONOPHOSPHATE 1I1C ; 2.70 ; NON-FCRN BINDING FC FRAGMENT OF RAT IGG2A 1UA5 ; 2.50 ; NON-FUSION GST FROM S. JAPONICUM IN COMPLEX WITH GLUTATHIONE 1OMV ; 1.90 ; NON-MYRISTOYLATED BOVINE RECOVERIN (E85Q MUTANT) WITH CALCIUM BOUND TO EF-HAND 3 1RRG ; 2.40 ; NON-MYRISTOYLATED RAT ADP-RIBOSYLATION FACTOR-1 COMPLEXED WITH GDP, DIMERIC CRYSTAL FORM 1RRF ; 3.00 ; NON-MYRISTOYLATED RAT ADP-RIBOSYLATION FACTOR-1 COMPLEXED WITH GDP, MONOMERIC CRYSTAL FORM 1OMR ; 1.50 ; NON-MYRISTOYLATED WILD-TYPE BOVINE RECOVERIN WITH CALCIUM BOUND TO EF-HAND 3 1LIQ ; -1.00 ; NON-NATIVE SOLUTION STRUCTURE OF A FRAGMENT OF THE CH1 DOMAIN OF CBP 1MTL ; 2.80 ; NON-PRODUCTIVE MUG-DEOXYRIBONUCLEIC ACID COMPLEX 1TDV ; 1.70 ; NON-SPECIFIC BINDING TO PHOSPHOLIPASE A2:CRYSTAL STRUCTURE OF THE COMPLEX OF PLA2 WITH A DESIGNED PEPTIDE TYR-TRP-ALA- ALA-ALA-ALA AT 1.7A RESOLUTION 1MID ; 1.71 ; NON-SPECIFIC LIPID TRANSFER PROTEIN 1 FROM BARLEY IN COMPLEX WITH L-ALFA-LYSOPHOSPHATIDYLCHOLINE, LAUDOYL 1BBX ; -1.00 ; NON-SPECIFIC PROTEIN-DEOXYRIBONUCLEIC ACID INTERACTIONS IN THE SSO7D-DEOXYRIBONUCLEIC ACID COMPLEX, NMR, 1 STRUCTURE 1JCA ; 2.50 ; NON-STANDARD DESIGN OF UNSTABLE INSULIN ANALOGUES WITH ENHANCED ACTIVITY 1XM1 ; 2.30 ; NONBASIC THROMBIN INHIBITOR COMPLEX 1I7D ; 2.05 ; NONCOVALENT COMPLEX OF E.COLI DEOXYRIBONUCLEIC ACID TOPOISOMERASE III WITH AN 8-BASE SINGLE-STRANDED DEOXYRIBONUCLEIC ACID OLIGONUCLEOTIDE 1HVH ; 1.80 ; NONPEPTIDE CYCLIC CYANOGUANIDINES AS HIV PROTEASE INHIBITORS 1OJ1 ; 2.10 ; NONPRODUCTIVE AND NOVEL BINDING MODES IN CYTOTOXIC RIBONUCLEASES FROM RANA CATESBEIANA OF TWO CRYSTAL STRUCTURES COMPLEXED WITH (2,5 CPG) AND D(APCPGPA) 1E27 ; 2.20 ; NONSTANDARD PEPTIDE BINDING OF HLA-B5101 COMPLEXED WITH HIV IMMUNODOMINANT EPITOPE KM1(LPPVVAKEI) 1E28 ; 3.00 ; NONSTANDARD PEPTIDE BINDING OF HLA-B5101 COMPLEXED WITH HIV IMMUNODOMINANT EPITOPE KM2(TAFTIPSI) 2AKH ; 14.90 ; NORMAL MODE-BASED FLEXIBLE FITTED COORDINATES OF A NON- TRANSLOCATING SECYEG PROTEIN-CONDUCTING CHANNEL INTO THE CRYO-EM MAP OF A SECYEG-NASCENT CHAIN-70S RIBOSOME COMPLEX FROM E. COLI 2AKI ; 14.90 ; NORMAL MODE-BASED FLEXIBLE FITTED COORDINATES OF A TRANSLOCATING SECYEG PROTEIN-CONDUCTING CHANNEL INTO THE CRYO-EM MAP OF A SECYEG-NASCENT CHAIN-70S RIBOSOME COMPLEX FROM E. COLI 1KDE ; -1.00 ; NORTH-ATLANTIC OCEAN POUT ANTIFREEZE PROTEIN TYPE III ISOFORM HPLC12 MUTANT, NMR, 22 STRUCTURES 1KDF ; -1.00 ; NORTH-ATLANTIC OCEAN POUT ANTIFREEZE PROTEIN TYPE III ISOFORM HPLC12 MUTANT, NMR, MINIMIZED AVERAGE STRUCTURE 1NI7 ; -1.00 ; NORTHEAST STRUCTURAL GENOMIC CONSORTIUM TARGET ER75 1M0S ; 1.90 ; NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG ID IR21) 1GTD ; 2.56 ; NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG ID TT50) STRUCTURE OF MTH169, THE PURS SUBUNIT OF FGAM SYNTHETASE 2NOT ; 3.00 ; NOTECHIS II-5, NEUROTOXIC PHOSPHOLIPASE A2 FROM NOTECHIS SCUTATUS SCUTATUS 1AE7 ; 2.00 ; NOTEXIN, A PRESYNAPTIC NEUROTOXIC PHOSPHOLIPASE A2 1OJ8 ; 1.70 ; NOVEL AND RETRO BINDING MODES IN CYTOTOXIC RIBONUCLEASES FROM RANA CATESBEIANA OF TWO CRYSTAL STRUCTURES COMPLEXED WITH D(APCPGPA) AND (2',5'CPG) 1B9V ; 2.35 ; NOVEL AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE MAKE SELECTIVE INTERACTIONS WITH CONSERVED RESIDUES AND WATER MOLECULES IN TEH ACTIVE SITE 1B9S ; 2.50 ; NOVEL AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE MAKE SELECTIVE INTERACTIONS WITH CONSERVED RESIDUES AND WATER MOLECULES IN THE ACTIVE SITE 1B9T ; 2.40 ; NOVEL AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE MAKE SELECTIVE INTERACTIONS WITH CONSERVED RESIDUES AND WATER MOLECULES IN THE ACTIVE SITE 2D6B ; 1.25 ; NOVEL BROMATE SPECIES TRAPPED WITHIN A PROTEIN CRYSTAL 1TL0 ; 1.94 ; NOVEL CARBOHYDRATE BINDING SITE IDENTIFIED IN A HYBRID OF CHOLERA TOXIN AND ESCHERICHIA COLI HEAT-LABILE ENTEROTOXIN B-SUBUNITS: 1.9 CRYSTAL STRUCTURE REVEALS THE DETAILS 1QHR ; 2.20 ; NOVEL COVALENT ACTIVE SITE THROMBIN INHIBITORS 1QJ1 ; 2.00 ; NOVEL COVALENT ACTIVE SITE THROMBIN INHIBITORS 1QJ6 ; 2.20 ; NOVEL COVALENT ACTIVE SITE THROMBIN INHIBITORS 1QJ7 ; 2.20 ; NOVEL COVALENT ACTIVE SITE THROMBIN INHIBITORS 1AWF ; 2.20 ; NOVEL COVALENT THROMBIN INHIBITOR FROM PLANT EXTRACT 1AWH ; 3.00 ; NOVEL COVALENT THROMBIN INHIBITOR FROM PLANT EXTRACT 1O70 ; 2.60 ; NOVEL FOLD REVEALED BY THE STRUCTURE OF A FAS1 DOMAIN PAIR FROM THE INSECT CELL ADHESION MOLECULE FASCICLIN I 1YFZ ; 2.20 ; NOVEL IMP BINDING IN FEEDBACK INHIBITION OF HYPOXANTHINE- GUANINE PHOSPHORIBOSYLTRANSFERASE FROM THERMOANAEROBACTER TENGCONGENSIS 1VYQ ; 2.40 ; NOVEL INHIBITORS OF PLASMODIUM FALCIPARUM DUTPASE PROVIDE A PLATFORM FOR ANTI-MALARIAL DRUG DESIGN 1JL5 ; 2.10 ; NOVEL MOLECULAR ARCHITECTURE OF YOPM-A LEUCINE-RICH EFFECTOR PROTEIN FROM YERSINIA PESTIS 1SB1 ; 1.90 ; NOVEL NON-COVALENT THROMBIN INHIBITORS INCORPORATING P1 4,5, 6,7-TETRAHYDROBENZOTHIAZOLE ARGININE SIDE CHAIN MIMETICS 1ZN6 ; 1.80 ; NOVEL STRUCTURE OF THE HYPOTHETICAL PROTEIN Q7WLM8 FROM BORDETELLA BRONCHISEPTICA. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET BOR19. 1YRV ; 2.18 ; NOVEL UBIQUITIN-CONJUGATING ENZYME 2EW0 ; 1.40 ; NOVEL X-RAY STRUCTURE OF HYPOTHETICAL PROTEIN Q6FF54 AT THE RESOLUTION 1.4 A. NORTHEAST STRUCTURAL GENOMICS TARGET ASR1. 1U53 ; 1.56 ; NOVEL X-RAY STRUCTURE OF NA-ASP-2, A PR-1 PROTEIN FROM THE NEMATODE PARASITE NECATOR AMERICANUS AND A VACCINE ANTIGEN FOR HUMAN HOOKWORM INFECTION 2FFG ; 2.31 ; NOVEL X-RAY STRUCTURE OF THE YKUJ PROTEIN FROM BACILLUS SUBTILIS. NORTHEAST STRUCTURAL GENOMICS TARGET SR360. 2BSM ; 2.05 ; NOVEL, POTENT SMALL MOLECULE INHIBITORS OF THE MOLECULAR CHAPERONE HSP90 DISCOVERED THROUGH STRUCTURE-BASED DESIGN 2BT0 ; 1.90 ; NOVEL, POTENT SMALL MOLECULE INHIBITORS OF THE MOLECULAR CHAPERONE HSP90 DISCOVERED THROUGH STRUCTURE-BASED DESIGN 1AJ6 ; 2.30 ; NOVOBIOCIN-RESISTANT MUTANT (R136H) OF THE N-TERMINAL 24 KDA FRAGMENT OF DEOXYRIBONUCLEIC ACID GYRASE B COMPLEXED WITH NOVOBIOCIN AT 2.3 ANGSTROMS RESOLUTION 1Z6U ; 2.10 ; NP95-LIKE RING FINGER PROTEIN ISOFORM B [HOMO SAPIENS] 1R7H ; 2.69 ; NRDH-REDOXIN OF CORYNEBACTERIUM AMMONIAGENES FORMS A DOMAIN- SWAPPED DIMER 1MBM ; 2.00 ; NSP4 PROTEINASE FROM EQUINE ARTERITIS VIRUS 1UW7 ; 2.80 ; NSP9 PROTEIN FROM SARS-CORONAVIRUS. 1WWC ; 1.90 ; NT3 BINDING DOMAIN OF HUMAN TRKC RECEPTOR 1GY6 ; 1.60 ; NTF2 FROM RAT, AMMONIUM SULPHATE CONDITIONS 1H6K ; 2.00 ; NUCLEAR CAP BINDING COMPLEX 1WFI ; -1.00 ; NUCLEAR MOVE DOMAIN OF NUCLEAR DISTRIBUTION GENE C HOMOLOG 1AR0 ; 2.30 ; NUCLEAR TRANSPORT FACTOR 2 (NTF2) E42K MUTANT 1ASK ; 2.30 ; NUCLEAR TRANSPORT FACTOR 2 (NTF2) H66A MUTANT 1QMA ; 2.50 ; NUCLEAR TRANSPORT FACTOR 2 (NTF2) W7A MUTANT 1CL4 ; -1.00 ; NUCLEOCAPSID PROTEIN FROM MASON-PFIZER MONKEY VIRUS (MPMV) 1T6O ; 2.00 ; NUCLEOCAPSID-BINDING DOMAIN OF THE MEASLES VIRUS P PROTEIN (AMINO ACIDS 457-507) IN COMPLEX WITH AMINO ACIDS 486-505 OF THE MEASLES VIRUS N PROTEIN 1V1D ; -1.00 ; NUCLEOPHILIC AND GENERAL ACID CATALYSIS AT PHYSIOLOGICAL PH BY A DESIGNED MINIATURE ESTERASE 1PAE ; 2.70 ; NUCLEOSIDE DIPHOSPHATE KINASE 1BHN ; 2.40 ; NUCLEOSIDE DIPHOSPHATE KINASE ISOFORM A FROM BOVINE RETINA 1BE4 ; 2.40 ; NUCLEOSIDE DIPHOSPHATE KINASE ISOFORM B FROM BOVINE RETINA 1OFC ; 1.90 ; NUCLEOSOME RECOGNITION MODULE OF ISWI ATPASE 1NJF ; 2.30 ; NUCLEOTIDE BOUND FORM OF AN ISOLATED E. COLI CLAMP LOADER GAMMA SUBUNIT 1IJE ; 2.40 ; NUCLEOTIDE EXCHANGE INTERMEDIATES IN THE EEF1A-EEF1BA COMPLEX 1IJF ; 3.00 ; NUCLEOTIDE EXCHANGE MECHANISMS IN THE EEF1A-EEF1BA COMPLEX 1HXP ; 1.80 ; NUCLEOTIDE TRANSFERASE 1HQY ; 2.80 ; NUCLEOTIDE-DEPENDENT CONFORMATIONAL CHANGES IN A PROTEASE- ASSOCIATED ATPASE HSLU 1HT1 ; 2.80 ; NUCLEOTIDE-DEPENDENT CONFORMATIONAL CHANGES IN A PROTEASE- ASSOCIATED ATPASE HSLU 1HT2 ; 2.80 ; NUCLEOTIDE-DEPENDENT CONFORMATIONAL CHANGES IN A PROTEASE- ASSOCIATED ATPASE HSLU 1SGK ; 2.30 ; NUCLEOTIDE-FREE DIPHTHERIA TOXIN 1NJG ; 2.20 ; NUCLEOTIDE-FREE FORM OF AN ISOLATED E. COLI CLAMP LOADER GAMMA SUBUNIT 1DFK ; 4.20 ; NUCLEOTIDE-FREE SCALLOP MYOSIN S1-NEAR RIGOR STATE 2B0V ; 1.55 ; NUDIX HYDROLASE FROM NITROSOMONAS EUROPAEA. 1J57 ; -1.00 ; NUIA 1KTU ; -1.00 ; NUIA 2C1M ; 2.20 ; NUP50:IMPORTIN-ALPHA COMPLEX 1Y7L ; 1.55 ; O-ACETYLSERINE SULFHYDRYLASE COMPLEX 1OAS ; 2.20 ; O-ACETYLSERINE SULFHYDRYLASE FROM SALMONELLA TYPHIMURIUM 1VXR ; 2.20 ; O-ETHYLMETHYLPHOSPHONYLATED ACETYLCHOLINESTERASE OBTAINED BY REACTION WITH O-ETHYL-S-[2-[BIS(1-METHYLETHYL) AMINO]ETHYL] METHYLPHOSPHONOTHIOATE (VX) 1SL9 ; 1.17 ; OBELIN FROM OBELIA LONGISSIMA 1JCJ ; 1.10 ; OBSERVATION OF COVALENT INTERMEDIATES IN AN ENZYME MECHANISM AT ATOMIC RESOLUTION 1JCL ; 1.05 ; OBSERVATION OF COVALENT INTERMEDIATES IN AN ENZYME MECHANISM AT ATOMIC RESOLUTION 419D ; 2.20 ; OCTAMER 5'-R(GPUPAPUPAPCPA)-D(PC)-3' WITH SIX WATSON-CRICK BASE-PAIRS AND TWO 3' OVERHANG RESIDUES 1L4X ; 2.00 ; OCTAMERIC DE NOVO DESIGNED PEPTIDE 1A3Y ; 2.25 ; ODORANT BINDING PROTEIN FROM NASAL MUCOSA OF PIG 1OBP ; 2.00 ; ODORANT-BINDING PROTEIN FROM BOVINE NASAL MUCOSA 2BML ; 2.60 ; OFLOXACIN-LIKE ANTIBIOTICS INHIBIT PNEUMOCOCCAL CELL WALL DEGRADING VIRULENCE FACTORS 1BWL ; 2.70 ; OLD YELLOW ENZYME (OYE1) DOUBLE MUTANT H191N:N194H 1BWK ; 2.30 ; OLD YELLOW ENZYME (OYE1) MUTANT H191N 1JET ; 1.20 ; OLIGO-PEPTIDE BINDING PROTEIN (OPPA) COMPLEXED WITH KAK 1B4Z ; 1.75 ; OLIGO-PEPTIDE BINDING PROTEIN (OPPA) COMPLEXED WITH KDK 1JEU ; 1.25 ; OLIGO-PEPTIDE BINDING PROTEIN (OPPA) COMPLEXED WITH KEK 1B40 ; 2.20 ; OLIGO-PEPTIDE BINDING PROTEIN (OPPA) COMPLEXED WITH KFK 1B3L ; 2.00 ; OLIGO-PEPTIDE BINDING PROTEIN (OPPA) COMPLEXED WITH KGK 1B3F ; 1.80 ; OLIGO-PEPTIDE BINDING PROTEIN (OPPA) COMPLEXED WITH KHK 1B3G ; 2.00 ; OLIGO-PEPTIDE BINDING PROTEIN (OPPA) COMPLEXED WITH KIK 1B9J ; 1.80 ; OLIGO-PEPTIDE BINDING PROTEIN (OPPA) COMPLEXED WITH KLK 1B32 ; 1.75 ; OLIGO-PEPTIDE BINDING PROTEIN (OPPA) COMPLEXED WITH KMK 1B5I ; 1.90 ; OLIGO-PEPTIDE BINDING PROTEIN (OPPA) COMPLEXED WITH KNK 1B46 ; 1.80 ; OLIGO-PEPTIDE BINDING PROTEIN (OPPA) COMPLEXED WITH KPK 1B5J ; 1.80 ; OLIGO-PEPTIDE BINDING PROTEIN (OPPA) COMPLEXED WITH KQK 1QKA ; 1.80 ; OLIGO-PEPTIDE BINDING PROTEIN (OPPA) COMPLEXED WITH KRK 1B51 ; 1.80 ; OLIGO-PEPTIDE BINDING PROTEIN (OPPA) COMPLEXED WITH KSK 1B52 ; 2.30 ; OLIGO-PEPTIDE BINDING PROTEIN (OPPA) COMPLEXED WITH KTK 1QKB ; 1.80 ; OLIGO-PEPTIDE BINDING PROTEIN (OPPA) COMPLEXED WITH KVK 1JEV ; 1.30 ; OLIGO-PEPTIDE BINDING PROTEIN (OPPA) COMPLEXED WITH KWK 1B58 ; 1.80 ; OLIGO-PEPTIDE BINDING PROTEIN (OPPA) COMPLEXED WITH KYK 1OLC ; 2.10 ; OLIGO-PEPTIDE BINDING PROTEIN (OPPA) COMPLEXED WITH LYS-LYS-LYS-ALA 1B3H ; 2.00 ; OLIGO-PEPTIDE BINDING PROTEIN COMPLEXED WITH LYSYL- CYCLOHEXYLALANYL-LYSINE 1B4H ; 1.90 ; OLIGO-PEPTIDE BINDING PROTEIN COMPLEXED WITH LYSYL- DIAMINOBUTYRIC ACID-LYSINE 1B5H ; 1.90 ; OLIGO-PEPTIDE BINDING PROTEIN COMPLEXED WITH LYSYL- DIAMINOPROPANOIC ACID-LYSINE 1B0H ; 1.90 ; OLIGO-PEPTIDE BINDING PROTEIN COMPLEXED WITH LYSYL- NAPTHYLALANYL-LYSINE 1B7H ; 2.00 ; OLIGO-PEPTIDE BINDING PROTEIN COMPLEXED WITH LYSYL- NORLEUCYL-LYSINE 1B6H ; 1.80 ; OLIGO-PEPTIDE BINDING PROTEIN COMPLEXED WITH LYSYL-NORVALYL- LYSINE 1B2H ; 1.90 ; OLIGO-PEPTIDE BINDING PROTEIN COMPLEXED WITH LYSYL-ORNITHYL- LYSINE 1B1H ; 1.80 ; OLIGO-PEPTIDE BINDING PROTEIN/TRIPEPTIDE (LYS HPE LYS) COMPLEX 1B4F ; 1.95 ; OLIGOMERIC STRUCTURE OF THE HUMAN EPHB2 RECEPTOR SAM DOMAIN 1A92 ; 1.80 ; OLIGOMERIZATION DOMAIN OF HEPATITIS DELTA ANTIGEN 1XCU ; 2.00 ; OLIGONUCLEOTID/DRUG COMPLEX 2OLB ; 1.40 ; OLIGOPEPTIDE BINDING PROTEIN (OPPA) COMPLEXED WITH TRI-LYSINE 1J9A ; 2.50 ; OLIGORIBONUCLEASE 1AHP ; 3.00 ; OLIGOSACCHARIDE SUBSTRATE BINDING IN ESCHERICHIA COLI MALTODEXTRIN PHSPHORYLASE 1H4G ; 1.10 ; OLIGOSACCHARIDE-BINDING TO FAMILY 11 XYLANASES: BOTH COVALENT INTERMEDIATE AND MUTANT-PRODUCT COMPLEXES DISPLAY 2,5B CONFORMATIONS AT THE ACTIVE-CENTRE 1H4H ; 1.90 ; OLIGOSACCHARIDE-BINDING TO FAMILY 11 XYLANASES: BOTH COVALENT INTERMEDIATE AND MUTANT-PRODUCT COMPLEXES DISPLAY 2,5B CONFORMATIONS AT THE ACTIVE-CENTRE 1OAV ; -1.00 ; OMEGA-AGATOXIN IVA 1OAW ; -1.00 ; OMEGA-AGATOXIN IVA 1TTL ; -1.00 ; OMEGA-CONOTOXIN GVIA, A N-TYPE CALCIUM CHANNEL BLOCKER 1CNN ; -1.00 ; OMEGA-CONOTOXIN MVIIC FROM CONUS MAGUS 2OMF ; 2.40 ; OMPF PORIN 1GFM ; 3.50 ; OMPF PORIN (MUTANT D113G) 1GFO ; 3.30 ; OMPF PORIN (MUTANT R132P) 1GFP ; 2.70 ; OMPF PORIN (MUTANT R42C) 1GFQ ; 2.80 ; OMPF PORIN (MUTANT R82C) 1GFN ; 3.10 ; OMPF PORIN DELETION (MUTANT DELTA 109-114) 1BT9 ; 3.00 ; OMPF PORIN MUTANT D74A 1HXU ; 3.00 ; OMPF PORIN MUTANT KK 1HXT ; 2.40 ; OMPF PORIN MUTANT NQAAA 1HXX ; 2.20 ; OMPF PORIN MUTANT Y106F 1ODD ; 2.20 ; OMPR C-TERMINAL DOMAIN (OMPR-C) FROM ESCHERICHIA COLI 1OPC ; 1.95 ; OMPR DEOXYRIBONUCLEIC ACID-BINDING DOMAIN, ESCHERICHIA COLI 1E89 ; 2.10 ; ON THE MECHANISM OF CYANOGENESIS CATALYZED BY HYDROXYNITRILE LYASE FROM MANIHOT ESCULENTA. CRYSTAL STRUCTURE OF ACTIVE SITE MUTANT SER80ALA IN COMPLEX WITH ACETONE CYANOHYDRIN 2A7A ; 1.75 ; ON THE ROUTINE USE OF SOFT X-RAYS IN MACROMOLECULAR CRYSTALLOGRAPHY, PART III- THE OPTIMAL DATA COLLECTION WAVELENGTH 2A7B ; 1.65 ; ON THE ROUTINE USE OF SOFT X-RAYS IN MACROMOLECULAR CRYSTALLOGRAPHY, PART III- THE OPTIMAL DATA COLLECTION WAVELENGTH 2A7C ; 1.65 ; ON THE ROUTINE USE OF SOFT X-RAYS IN MACROMOLECULAR CRYSTALLOGRAPHY, PART III- THE OPTIMAL DATA COLLECTION WAVELENGTH 2A7D ; 1.66 ; ON THE ROUTINE USE OF SOFT X-RAYS IN MACROMOLECULAR CRYSTALLOGRAPHY, PART III- THE OPTIMAL DATA COLLECTION WAVELENGTH 2A7E ; 1.66 ; ON THE ROUTINE USE OF SOFT X-RAYS IN MACROMOLECULAR CRYSTALLOGRAPHY, PART III- THE OPTIMAL DATA COLLECTION WAVELENGTH 2A7F ; 1.85 ; ON THE ROUTINE USE OF SOFT X-RAYS IN MACROMOLECULAR CRYSTALLOGRAPHY, PART III- THE OPTIMAL DATA COLLECTION WAVELENGTH 2A7G ; 1.85 ; ON THE ROUTINE USE OF SOFT X-RAYS IN MACROMOLECULAR CRYSTALLOGRAPHY, PART III- THE OPTIMAL DATA COLLECTION WAVELENGTH 2A7H ; 2.10 ; ON THE ROUTINE USE OF SOFT X-RAYS IN MACROMOLECULAR CRYSTALLOGRAPHY, PART III- THE OPTIMAL DATA COLLECTION WAVELENGTH 2A7I ; 1.75 ; ON THE ROUTINE USE OF SOFT X-RAYS IN MACROMOLECULAR CRYSTALLOGRAPHY, PART III- THE OPTIMAL DATA COLLECTION WAVELENGTH 2A7J ; 1.65 ; ON THE ROUTINE USE OF SOFT X-RAYS IN MACROMOLECULAR CRYSTALLOGRAPHY, PART III- THE OPTIMAL DATA COLLECTION WAVELENGTH 1E7W ; 1.75 ; ONE ACTIVE SITE, TWO MODES OF REDUCTION CORRELATE THE MECHANISM OF LEISHMANIA PTERIDINE REDUCTASE WITH PTERIN METABOLISM AND ANTIFOLATE DRUG RESISTANCE IN TRPANOSOMES 1BUU ; 1.90 ; ONE HO3+ FORM OF RAT MANNOSE-BINDING PROTEIN A 1PWF ; 1.16 ; ONE SUGAR PUCKER FITS ALL: PAIRING VERSATILITY DESPITE CONFORMATIONAL UNIFORMITY IN TNA 2D2H ; 1.80 ; OPDA FROM AGROBACTERIUM RADIOBACTER WITH BOUND INHIBITOR TRIMETHYL PHOSPHATE AT 1.8 A RESOLUTION 2D2G ; 1.85 ; OPDA FROM AGROBACTERIUM RADIOBACTER WITH BOUND PRODUCT DIMETHYLTHIOPHOSPHATE 2D2J ; 1.75 ; OPDA FROM AGROBACTERIUM RADIOBACTER WITHOUT INHIBITOR/PRODUCT PRESENT AT 1.75 A RESOLUTION 3LIP ; 2.00 ; OPEN CONFORMATION OF PSEUDOMONAS CEPACIA LIPASE 2KTQ ; 2.30 ; OPEN TERNARY COMPLEX OF THE LARGE FRAGMENT OF DEOXYRIBONUCLEIC ACID POLYMERASE I FROM THERMUS AQUATICUS 1OPG ; 2.00 ; OPG2 FAB FRAGMENT 1QMQ ; 1.55 ; OPTICAL DETECTION OF CYTOCHROME P450 BY SENSITIZER-LINKED SUBSTRATES 1YUO ; 1.95 ; OPTIMISATION OF THE SURFACE ELECTROSTATICS AS A STRATEGY FOR COLD ADAPTATION OF URACIL-DEOXYRIBONUCLEIC ACID N-GLYCOSYLASE (UNG)FROM ATLANTIC COD (GADUS MORHUA) 1AI3 ; 1.90 ; ORBITAL STEERING IN THE CATALYTIC POWER OF ENZYMES: SMALL STRUCTURAL CHANGES WITH LARGE CATALYTIC CONSEQUENCES 1USP ; 1.90 ; ORGANIC HYDROPEROXIDE RESISTANCE PROTEIN FROM DEINOCOCCUS RADIODURANS 1OO9 ; -1.00 ; ORIENTATION IN SOLUTION OF MMP-3 CATALYTIC DOMAIN AND N- TIMP-1 FROM RESIDUAL DIPOLAR COUPLINGS 1VZ6 ; 2.75 ; ORNITHINE ACETYLTRANSFERASE (ORF6 GENE PRODUCT - CLAVULANIC ACID BIOSYNTHESIS) FROM STREPTOMYCES CLAVULIGERUS 1VZ7 ; 3.00 ; ORNITHINE ACETYLTRANSFERASE (ORF6 GENE PRODUCT - CLAVULANIC ACID BIOSYNTHESIS) FROM STREPTOMYCES CLAVULIGERUS 1VZ8 ; 2.75 ; ORNITHINE ACETYLTRANSFERASE (ORF6 GENE PRODUCT - CLAVULANIC ACID BIOSYNTHESIS) FROM STREPTOMYCES CLAVULIGERUS (SEMET STRUCTURE) 1OAT ; 2.50 ; ORNITHINE AMINOTRANSFERASE 2OAT ; 1.95 ; ORNITHINE AMINOTRANSFERASE COMPLEXED WITH 5-FLUOROMETHYLORNITHINE 2BYJ ; 3.02 ; ORNITHINE AMINOTRANSFERASE MUTANT Y85I 1Z7D ; 2.10 ; ORNITHINE AMINOTRANSFERASE PY00104 FROM PLASMODIUM YOELII 1A1S ; 2.70 ; ORNITHINE CARBAMOYLTRANSFERASE FROM PYROCOCCUS FURIOSUS 2TOD ; 2.00 ; ORNITHINE DECARBOXYLASE FROM TRYPANOSOMA BRUCEI K69A MUTANT IN COMPLEX WITH ALPHA-DIFLUOROMETHYLORNITHINE 1C4K ; 2.70 ; ORNITHINE DECARBOXYLASE MUTANT (GLY121TYR) 2OTC ; 2.80 ; ORNITHINE TRANSCARBAMOYLASE COMPLEXED WITH N-(PHOSPHONACETYL)-L-ORNITHINE 1ORT ; 3.00 ; ORNITHINE TRANSCARBAMOYLASE FROM PSEUDOMONAS AERUGINOSA 1AKM ; 2.80 ; ORNITHINE TRANSCARBAMYLASE FROM ESCHERICHIA COLI 1X1Z ; 1.45 ; OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE (ODCASE) COMPLEXED WITH BMP (PRODUCED FROM 6-CYANOUMP) 1L2U ; 2.50 ; OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE FROM E. COLI 1KLY ; 1.50 ; OROTIDINE MONOPHOSPHATE DECARBOXYLASE D70G MUTANT COMPLEXED WITH 6-AZAUMP 1KM1 ; 1.60 ; OROTIDINE MONOPHOSPHATE DECARBOXYLASE MUTANT S127A CRYSTAL STRUCTURE 1OK6 ; 2.40 ; ORTHORHOMBIC CRYSTAL FORM OF AN ARCHAEAL FRUCTOSE 1,6-BISPHOSPHATE ALDOLASE 1DO0 ; 3.00 ; ORTHORHOMBIC CRYSTAL FORM OF HEAT SHOCK LOCUS U (HSLU) FROM ESCHERICHIA COLI 1NVI ; 1.90 ; ORTHORHOMBIC CRYSTAL FORM OF MOLYBDOPTERIN SYNTHASE 1ZK2 ; 1.55 ; ORTHORHOMBIC CRYSTAL STRUCTURE OF THE APO-FORM OF R- SPECIFIC ALCOHOL DEHYDROGENASE (MUTANT G37D) FROM LACTOBACILLUS BREVIS 1JRN ; 2.00 ; ORTHORHOMBIC FORM OF OXYTRICHA TELOMERIC DEOXYRIBONUCLEIC ACID AT 2.0A 1KHQ ; 1.60 ; ORTHORHOMBIC FORM OF PAPAIN/ZLFG-DAM COVALENT COMPLEX 1W76 ; 2.30 ; ORTHORHOMBIC FORM OF TORPEDO CALIFORNICA ACETYLCHOLINESTERASE (ACHE) COMPLEXED WITH BIS-ACTING GALANTHAMINE DERIVATIVE 1MR5 ; 2.25 ; ORTHORHOMBIC FORM OF TRYPANOSOMA CRUZI TRANS-SIALIDASE 1Y6E ; 3.00 ; ORTHORHOMBIC GLUTATHIONE S-TRANSFERASE OF SCHISTOSOMA JAPONICUM 1BGI ; 1.70 ; ORTHORHOMBIC LYSOZYME CRYSTALLIZED AT HIGH TEMPERATURE (310K) 4MON ; 2.30 ; ORTHORHOMBIC MONELLIN 1J7Z ; 2.25 ; OSMOLYTE STABILIZATION OF RIBONUCLEASE 1J80 ; 2.10 ; OSMOLYTE STABILIZATION OF RNASE 1J81 ; 2.20 ; OSMOLYTE STABILIZATION OF RNASE 1J82 ; 2.30 ; OSMOLYTE STABILIZATION OF RNASE 1OSM ; 3.20 ; OSMOPORIN (OMPK36) FROM KLEBSIELLA PNEUMONIAE 1VZM ; 1.40 ; OSTEOCALCIN FROM FISH ARGYROSOMUS REGIUS 1NQE ; 2.00 ; OUTER MEMBRANE COBALAMIN TRANSPORTER (BTUB) FROM E. COLI 1NQF ; 2.70 ; OUTER MEMBRANE COBALAMIN TRANSPORTER (BTUB) FROM E. COLI, METHIONINE SUBSTIUTION CONSTRUCT FOR SE-MET SAD PHASING 1NQG ; 3.31 ; OUTER MEMBRANE COBALAMIN TRANSPORTER (BTUB) FROM E. COLI, WITH BOUND CALCIUM 1NQH ; 3.10 ; OUTER MEMBRANE COBALAMIN TRANSPORTER (BTUB) FROM E. COLI, WITH BOUND CALCIUM AND CYANOCOBALAMIN (VITAMIN B12) SUBSTRATE 1FW2 ; 2.60 ; OUTER MEMBRANE PHOSPHOLIPASE A FROM ESCHERICHIA COLI 1FW3 ; 2.80 ; OUTER MEMBRANE PHOSPHOLIPASE A FROM ESCHERICHIA COLI 1QD5 ; 2.17 ; OUTER MEMBRANE PHOSPHOLIPASE A FROM ESCHERICHIA COLI 1QD6 ; 2.10 ; OUTER MEMBRANE PHOSPHOLIPASE A FROM ESCHERICHIA COLI 1ILD ; 2.80 ; OUTER MEMBRANE PHOSPHOLIPASE A FROM ESCHERICHIA COLI N156A ACTIVE SITE MUTANT PH 4.6 1ILZ ; 2.50 ; OUTER MEMBRANE PHOSPHOLIPASE A FROM ESCHERICHIA COLI N156A ACTIVE SITE MUTANT PH 6.1 1IM0 ; 2.98 ; OUTER MEMBRANE PHOSPHOLIPASE A FROM ESCHERICHIA COLI N156A ACTIVE SITE MUTANT PH 8.3 1BXW ; 2.50 ; OUTER MEMBRANE PROTEIN A (OMPA) TRANSMEMBRANE DOMAIN 1P4P ; 2.00 ; OUTER SURFACE PROTEIN B OF B. BURGDORFERI: CRYSTAL STRUCTURE OF THE C-TERMINAL FRAGMENT 1GGQ ; 2.51 ; OUTER SURFACE PROTEIN C (OSPC) OF BORRELIA BURGDORFERI STRAIN B31 1B5L ; 2.10 ; OVINE INTERFERON TAU 1EBV ; 3.20 ; OVINE PGHS-1 COMPLEXED WITH SALICYL HYDROXAMIC ACID 1Y2S ; -1.00 ; OVINE PRION PROTEIN VARIANT R168 1TPX ; 2.56 ; OVINE RECOMBINANT PRP(114-234), ARQ VARIANT IN COMPLEX WITH THE FAB OF THE VRQ14 ANTIBODY 1TQC ; 2.80 ; OVINE RECOMBINANT PRP(114-234), ARR VARIANT IN COMPLEX WITH THE VRQ14 FAB FRAGMENT (IGG2A) 1TQB ; 2.55 ; OVINE RECOMBINANT PRP(114-234), VRQ VARIANT IN COMPLEX WITH THE FAB OF THE VRQ14 ANTIBODY 1IQ7 ; 2.30 ; OVOTRANSFERRIN, C-TERMINAL LOBE, APO FORM 1TFA ; 1.90 ; OVOTRANSFERRIN, N-TERMINAL LOBE, APO FORM 1IEJ ; 1.65 ; OVOTRANSFERRIN, N-TERMINAL LOBE, HOLO FORM, AT 1.65 A RESOLUTION 1NFT ; 2.10 ; OVOTRANSFERRIN, N-TERMINAL LOBE, IRON LOADED OPEN FORM 1K57 ; 1.90 ; OXA 10 CLASS D BETA-LACTAMASE AT PH 6.0 1K56 ; 1.70 ; OXA 10 CLASS D BETA-LACTAMASE AT PH 6.5 1K55 ; 1.39 ; OXA 10 CLASS D BETA-LACTAMASE AT PH 7.5 1K54 ; 1.70 ; OXA-10 CLASS D BETA-LACTAMASE PARTIALLY ACYLATED WITH REACTED 6BETA-(1-HYDROXY-1-METHYLETHYL) PENICILLANIC ACID 2ET1 ; 1.60 ; OXALATE OXIDASE IN COMPLEX WITH SUBSTRATE ANALOGUE GLYCOLATE 1BKA ; 2.40 ; OXALATE-SUBSTITUTED DIFERRIC LACTOFERRIN 1ONY ; 2.15 ; OXALYL-ARYL-AMINO BENZOIC ACID INHIBITORS OF PTP1B, COMPOUND 17 1ONZ ; 2.40 ; OXALYL-ARYL-AMINO BENZOIC ACID INHIBITORS OF PTP1B, COMPOUND 8B 1OES ; 2.20 ; OXIDATION STATE OF PROTEIN TYROSINE PHOSPHATASE 1B 1OET ; 2.30 ; OXIDATION STATE OF PROTEIN TYROSINE PHOSPHATASE 1B 1OEU ; 2.50 ; OXIDATION STATE OF PROTEIN TYROSINE PHOSPHATASE 1B 1OEV ; 2.20 ; OXIDATION STATE OF PROTEIN TYROSINE PHOSPHATASE 1B 1DYZ ; 1.75 ; OXIDISED AZURIN II FROM ALCALIGENES XYLOSOXIDANS 1DFD ; -1.00 ; OXIDISED DESULFOVIBRIO AFRICANUS FERREDOXIN I, NMR, 19 STRUCTURES 1DAX ; -1.00 ; OXIDISED DESULFOVIBRIO AFRICANUS FERREDOXIN I, NMR, MINIMIZED AVERAGE STRUCTURE 1H31 ; 2.55 ; OXIDISED SOXAX COMPLEX FROM RHODOVULUM SULFIDOPHILUM 1H33 ; 1.75 ; OXIDISED SOXAX COMPLEX FROM RHODOVULUM SULFIDOPHILUM 1GM4 ; 2.05 ; OXIDISED STRUCTURE OF CYTOCHROME C3 FROM DESULFOVIBRIO DESULFURICANS ATCC 27774 AT PH 7.6 3CAO ; 1.60 ; OXIDISED STRUCTURE OF THE ACIDIC CYTOCHROME C3 FROM DESULFOVIBRIO AFRICANUS 1OPM ; 2.10 ; OXIDIZED (CU2+) PEPTIDYLGLYCINE ALPHA-HYDROXYLATING MONOOXYGENASE (PHM) WITH BOUND SUBSTRATE 1YCF ; 3.00 ; OXIDIZED (DI-FERRIC) FPRA FROM MOORELLA THERMOACETICA 1E60 ; 2.00 ; OXIDIZED DMSO REDUCTASE EXPOSED TO HEPES - STRUCTURE II BUFFER 1E61 ; 1.90 ; OXIDIZED DMSO REDUCTASE EXPOSED TO HEPES - STRUCTURE II BUFFER 1E5V ; 2.40 ; OXIDIZED DMSO REDUCTASE EXPOSED TO HEPES BUFFER 1DMR ; 1.82 ; OXIDIZED DMSO REDUCTASE FROM RHODOBACTER CAPSULATUS 1A2M ; 2.70 ; OXIDIZED DSBA AT 2.7 ANGSTROMS RESOLUTION, CRYSTAL FORM III 1A2J ; 2.00 ; OXIDIZED DSBA CRYSTAL FORM II 1SFD ; 0.99 ; OXIDIZED FORM OF AMICYANIN MUTANT P94F 1FDO ; 2.80 ; OXIDIZED FORM OF FORMATE DEHYDROGENASE H FROM E. COLI 1FDI ; 2.90 ; OXIDIZED FORM OF FORMATE DEHYDROGENASE H FROM E. COLI COMPLEXED WITH THE INHIBITOR NITRITE 1KDJ ; 1.70 ; OXIDIZED FORM OF PLASTOCYANIN FROM DRYOPTERIS CRASSIRHIZOMA 1LT7 ; 2.15 ; OXIDIZED HOMO SAPIENS BETAINE-HOMOCYSTEINE S- METHYLTRANSFERASE IN COMPLEX WITH FOUR SM(III) IONS 4PAZ ; 1.76 ; OXIDIZED MUTANT P80A PSEUDOAZURIN FROM A. FAECALIS 6PAZ ; 1.91 ; OXIDIZED MUTANT P80I PSEUDOAZURIN FROM A. FAECALIS 8PAZ ; 1.60 ; OXIDIZED NATIVE PSEUDOAZURIN FROM A. FAECALIS 1D9Q ; 2.40 ; OXIDIZED PEA FRUCTOSE-1,6-BISPHOSPHATASE FORM 1 2PVA ; 2.50 ; OXIDIZED PENICILLIN V ACYLASE FROM B. SPHAERICUS 1YIP ; 2.20 ; OXIDIZED PEPTIDYLGLYCINE ALPHA-HYDROXYLATING MONOOXYGENASE (PHM) IN A NEW CRYSTAL FORM 1BXU ; 1.90 ; OXIDIZED PLASTOCYANIN FROM SYNECHOCOCCUS SP. 1H6D ; 2.05 ; OXIDIZED PRECURSOR FORM OF GLUCOSE-FRUCTOSE OXIDOREDUCTASE FROM ZYMOMONAS MOBILIS COMPLEXED WITH GLYCEROL 1H6C ; 2.20 ; OXIDIZED PRECURSOR FORM OF GLUCOSE-FRUCTOSE OXIDOREDUCTASE FROM ZYMOMONAS MOBILIS COMPLEXED WITH SUCCINATE 1BQK ; 1.35 ; OXIDIZED PSEUDOAZURIN 1ZIA ; 1.54 ; OXIDIZED PSEUDOAZURIN 1PIU ; 2.20 ; OXIDIZED RIBONUCLEOTIDE REDUCTASE R2-D84E MUTANT CONTAINING OXO-BRIDGED DIFERRIC CLUSTER 1UPD ; 1.40 ; OXIDIZED STRUCTURE OF CYTOCHROME C3 FROM DESULFOVIBRIO DESULFURICANS ATCC 27774 AT PH 7.6 1ZYN ; 2.30 ; OXIDIZED STRUCTURE OF THE N-TERMINAL DOMAIN OF SALMONELLA TYPHIMURIUM AHPF 1QT9 ; 1.30 ; OXIDIZED [2FE-2S] FERREDOXIN FROM ANABAENA PCC7119 1IQZ ; 0.92 ; OXIDIZED [4FE-4S] FERREDOXIN FROM BACILLUS THERMOPROTEOLYTICUS (FORM I) 1IR0 ; 1.00 ; OXIDIZED [4FE-4S] FERREDOXIN FROM BACILLUS THERMOPROTEOLYTICUS (FORM II) 1MBB ; 2.30 ; OXIDOREDUCTASE 1MBT ; 3.00 ; OXIDOREDUCTASE 1XC1 ; 1.51 ; OXO ZIRCONIUM(IV) CLUSTER IN THE FERRIC BINDING PROTEIN (FBP) 2C07 ; 1.50 ; OXOACYL-ACP REDUCTASE OF PLASMODIUM FALCIPARUM 1LFZ ; 3.10 ; OXY HEMOGLOBIN (25% METHANOL) 1LFY ; 3.30 ; OXY HEMOGLOBIN (84% RELATIVE HUMIDITY) 1LFV ; 2.80 ; OXY HEMOGLOBIN (88% RELATIVE HUMIDITY) 1LFT ; 2.60 ; OXY HEMOGLOBIN (90% RELATIVE HUMIDITY) 1LFQ ; 2.60 ; OXY HEMOGLOBIN (93% RELATIVE HUMIDITY) 1GZX ; 2.10 ; OXY T STATE HAEMOGLOBIN: OXYGEN BOUND AT ALL FOUR HAEMS 1A6M ; 1.00 ; OXY-MYOGLOBIN, ATOMIC RESOLUTION 1NIR ; 2.15 ; OXYDIZED NITRITE REDUCTASE FROM PSEUDOMONAS AERUGINOSA 2HHD ; 2.20 ; OXYGEN AFFINITY MODULATION BY THE N-TERMINI OF THE BETA- CHAINS IN HUMAN AND BOVINE HEMOGLOBIN 1TES ; 1.70 ; OXYGEN BINDING MUSCLE PROTEIN 1DZ8 ; 1.90 ; OXYGEN COMPLEX OF P450CAM FROM PSEUDOMONAS PUTIDA 1DP6 ; 2.30 ; OXYGEN-BINDING COMPLEX OF FIXL HEME DOMAIN 1NOL ; 2.40 ; OXYGENATED HEMOCYANIN (SUBUNIT TYPE II) 1TGC ; 1.80 ; On the Disordered Activation Domain in Trypsinogen. Chemical Labelling and Low-Temperature Crystallography 1TGT ; 1.70 ; On the Disordered Activation Domain in Trypsinogen. Chemical Labelling and Low-Temperature Crystallography 2PTN ; 1.55 ; On the Disordered Activation Domain in Trypsinogen. Chemical Labelling and Low-Temperature Crystallography 2TGA ; 1.80 ; On the Disordered Activation Domain in Trypsinogen. Chemical Labelling and Low-Temperature Crystallography 2TGT ; 1.70 ; On the Disordered Activation Domain in Trypsinogen. Chemical Labelling and Low-Temperature Crystallography 2TPI ; 2.10 ; On the Disordered Activation Domain in Trypsinogen. Chemical Labelling and Low-Temperature Crystallography 3PTN ; 1.70 ; On the Disordered Activation Domain in Trypsinogen. Chemical Labelling and Low-Temperature Crystallography 2HHE ; 2.20 ; Oxygen Affinity Modulation by the N-Termini of the Beta Chains in Human and Bovine Hemoglobin 1WVE ; 1.85 ; P-CRESOL METHYLHYDROXYLASE: ALTERATION OF THE STRUCTURE OF THE FLAVOPROTEIN SUBUNIT UPON ITS BINDING TO THE CYTOCHROME SUBUNIT 1WVF ; 1.30 ; P-CRESOL METHYLHYDROXYLASE: ALTERATION OF THE STRUCTURE OF THE FLAVOPROTEIN SUBUNIT UPON ITS BINDING TO THE CYTOCHROME SUBUNIT 2BN6 ; -1.00 ; P-ELEMENT SOMATIC INHIBITOR PROTEIN 2BN5 ; -1.00 ; P-ELEMENT SOMATIC INHIBITOR PROTEIN COMPLEX WITH U1-70K PROLINE-RICH PEPTIDE 1BGN ; 2.00 ; P-HYDROXYBENZOATE HYDROXYLASE (PHBH) MUTANT WITH CYS 116 REPLACED BY SER (C116S) AND ARG 269 REPLACED BY THR (R269T), IN COMPLEX WITH FAD AND 4-HYDROXYBENZOIC ACID 1BF3 ; 2.20 ; P-HYDROXYBENZOATE HYDROXYLASE (PHBH) MUTANT WITH CYS 116 REPLACED BY SER (C116S) AND ARG 42 REPLACED BY LYS (R42K), IN COMPLEX WITH FAD AND 4-HYDROXYBENZOIC ACID 1BGJ ; 3.00 ; P-HYDROXYBENZOATE HYDROXYLASE (PHBH) MUTANT WITH CYS 116 REPLACED BY SER (C116S) AND HIS 162 REPLACED BY ARG (H162R), IN COMPLEX WITH FAD AND 4-HYDROXYBENZOIC ACID 1BKW ; 2.20 ; P-HYDROXYBENZOATE HYDROXYLASE (PHBH) MUTANT WITH CYS116 REPLACED BY SER (C116S) AND ARG44 REPLACED BY LYS (R44K), IN COMPLEX WITH FAD AND 4-HYDROXYBENZOIC ACID 1IUV ; 2.50 ; P-HYDROXYBENZOATE HYDROXYLASE COMPLEXED WITH 4-4-HYDROXYBENZOATE AT PH 5.0 1IUW ; 2.00 ; P-HYDROXYBENZOATE HYDROXYLASE COMPLEXED WITH 4-4-HYDROXYBENZOATE AT PH 7.4 1IUX ; 2.00 ; P-HYDROXYBENZOATE HYDROXYLASE COMPLEXED WITH 4-4-HYDROXYBENZOATE AT PH 9.4 1IUS ; 2.20 ; P-HYDROXYBENZOATE HYDROXYLASE COMPLEXED WITH 4-AMINOBENZOATE AT PH 5.0 1IUT ; 2.00 ; P-HYDROXYBENZOATE HYDROXYLASE COMPLEXED WITH 4-AMINOBENZOATE AT PH 7.4 1IUU ; 2.00 ; P-HYDROXYBENZOATE HYDROXYLASE COMPLEXED WITH 4-AMINOBENZOATE AT PH 9.4 1G1S ; 1.90 ; P-SELECTIN LECTIN/EGF DOMAINS COMPLEXED WITH PSGL-1 PEPTIDE 1BSM ; 1.35 ; P.SHERMANII SOD(FE+3) 140K PH8 1BS3 ; 1.55 ; P.SHERMANII SOD(FE+3) FLUORIDE 1BT8 ; 1.85 ; P.SHERMANII SOD(FE+3) PH 10.0 1HLX ; -1.00 ; P1 HELIX NUCLEIC ACIDS (DEOXYRIBONUCLEIC ACID/RIBONUCLEIC ACID) RIBONUCLEIC ACID 1AK0 ; 1.80 ; P1 NUCLEASE IN COMPLEX WITH A SUBSTRATE ANALOG 1UWX ; 2.20 ; P1.2 SEROSUBTYPE ANTIGEN DERIVED FROM N. MENINGITIDIS PORA IN COMPLEX WITH FAB FRAGMENT 1ASJ ; 2.90 ; P1/MAHONEY POLIOVIRUS, AT CRYOGENIC TEMPERATURE 1AR7 ; 2.90 ; P1/MAHONEY POLIOVIRUS, DOUBLE MUTANT P1095S + H2142Y 1AR6 ; 2.90 ; P1/MAHONEY POLIOVIRUS, DOUBLE MUTANT V1160I +P1095S 1AR8 ; 2.90 ; P1/MAHONEY POLIOVIRUS, MUTANT P1095S 1AR9 ; 2.90 ; P1/MAHONEY POLIOVIRUS, SINGLE SITE MUTANT H2142Y 1AL2 ; 2.90 ; P1/MAHONEY POLIOVIRUS, SINGLE SITE MUTANT V1160I 1LEO ; 2.60 ; P100S NUCLEOSIDE DIPHOSPHATE KINASE 1A4P ; 2.25 ; P11 (S100A10), LIGAND OF ANNEXIN II 1BT6 ; 2.40 ; P11 (S100A10), LIGAND OF ANNEXIN II IN COMPLEX WITH ANNEXIN II N-TERMINUS 1PUC ; 1.95 ; P13SUC1 IN A STRAND-EXCHANGED DIMER 1DZH ; 2.85 ; P14-FLUORESCEIN-N135Q-S380C-ANTITHROMBIN-III 1CFE ; -1.00 ; P14A, NMR, 20 STRUCTURES 1AP7 ; -1.00 ; P19-INK4D FROM MOUSE, NMR, 20 STRUCTURES 1BLX ; 1.90 ; P19INK4D/CDK6 COMPLEX 1M1P ; 1.55 ; P21 CRYSTAL STRUCTURE OF THE TETRAHEME CYTOCHROME C3 FROM SHEWANELLA ONEIDENSIS MR1 1M1Q ; 0.97 ; P222 OXIDIZED STRUCTURE OF THE TETRAHEME CYTOCHROME C FROM SHEWANELLA ONEIDENSIS MR1 1JSU ; 2.30 ; P27(KIP1)/CYCLIN A/CDK2 COMPLEX 1F4M ; 2.25 ; P3(2) CRYSTAL STRUCTURE OF ALA2ILE2-6, A VERSION OF ROP WITH A REPACKED HYDROPHOBIC CORE AND A NEW FOLD. 1HX6 ; 1.65 ; P3, THE MAJOR COAT PROTEIN OF THE LIPID-CONTAINING BACTERIOPHAGE PRD1. 1W7H ; 2.21 ; P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE INHIBITOR 1W82 ; 2.20 ; P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE INHIBITOR 1W83 ; 2.50 ; P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE INHIBITOR 1W84 ; 2.20 ; P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE INHIBITOR 1KV1 ; 2.50 ; P38 MAP KINASE IN COMPLEX WITH INHIBITOR 1 1OZ1 ; 2.10 ; P38 MITOGEN-ACTIVATED KINASE IN COMPLEX WITH 4-AZAINDOLE INHIBITOR 2BAJ ; 2.25 ; P38ALPHA BOUND TO PYRAZOLOUREA 2BAQ ; 2.80 ; P38ALPHA BOUND TO RO3201195 2BAK ; 2.20 ; P38ALPHA MAP KINASE BOUND TO MPAQ 2BAL ; 2.10 ; P38ALPHA MAP KINASE BOUND TO PYRAZOLOAMINE 1OO3 ; -1.00 ; P395S MUTANT OF THE P85 REGULATORY SUBUNIT OF THE N- TERMINAL SRC HOMOLOGY 2 DOMAIN OF PI3-KINASE 1OO4 ; -1.00 ; P395S MUTANT OF THE P85 REGULATORY SUBUNIT OF THE N- TERMINAL SRC HOMOLOGY 2 DOMAIN OF PI3-KINASE COMPLEXED TO A PEPTIDE DERIVED FROM PDGFR 1W4C ; 2.50 ; P4 PROTEIN FROM BACTERIOPHAGE PHI12 APO STATE 1W44 ; 2.00 ; P4 PROTEIN FROM BACTERIOPHAGE PHI12 IN COMPLEX WITH ADP 1W46 ; 2.70 ; P4 PROTEIN FROM BACTERIOPHAGE PHI12 IN COMPLEX WITH ADP AND MG 1W47 ; 2.50 ; P4 PROTEIN FROM BACTERIOPHAGE PHI12 IN COMPLEX WITH ADP AND MN 1W48 ; 2.30 ; P4 PROTEIN FROM BACTERIOPHAGE PHI12 IN COMPLEX WITH AMPCPP 1W49 ; 2.40 ; P4 PROTEIN FROM BACTERIOPHAGE PHI12 IN COMPLEX WITH AMPCPP AND MG 1W4A ; 2.40 ; P4 PROTEIN FROM PHI12 IN COMPLEX WITH AMPCPP AND MN 1W4B ; 2.30 ; P4 PROTEIN FROM PHI12 IN COMPLEX WITH PRODUCT (AMPCPP MG 22C) 6CP4 ; 1.90 ; P450CAM D251N MUTANT 1JIP ; 2.00 ; P450ERYF(A245S)/KETOCONAZOLE 1JIO ; 2.10 ; P450ERYF/6DEB 1JIN ; 2.30 ; P450ERYF/KETOCONAZOLE 1E3L ; 2.50 ; P47H MUTANT OF MOUSE CLASS II ALCOHOL DEHYDROGENASE COMPLEX WITH NADH 1KQ6 ; 1.18 ; P47PHOX PX DOMAIN 1TSR ; 2.20 ; P53 CORE DOMAIN IN COMPLEX WITH DEOXYRIBONUCLEIC ACID 1AIE ; 1.50 ; P53 TETRAMERIZATION DOMAIN CRYSTAL STRUCTURE 1YCS ; 2.20 ; P53-53BP2 COMPLEX 2B3G ; 1.60 ; P53N (FRAGMENT 33-60) BOUND TO RPA70N 1BHF ; 1.80 ; P56LCK SH2 DOMAIN INHIBITOR COMPLEX 1GV9 ; 1.46 ; P58/ERGIC-53 1OQ0 ; -1.00 ; P6.1 STEM LOOP FROM THE ACTIVATION DOMAIN OF HTR 1A5Q ; 2.30 ; P93A VARIANT OF BOVINE PANCREATIC RIBONUCLEASE A 1VYH ; 3.40 ; PAF-AH HOLOENZYME: LIS1/ALFA2 1J1A ; 2.20 ; PANCREATIC SECRETORY PHOSPHOLIPASE A2 (IIA) WITH ANTI- INFLAMMATORY ACTIVITY 1UV0 ; 1.78 ; PANCREATITIS-ASSOCIATED PROTEIN 1 FROM HUMAN 2PTA ; -1.00 ; PANDINUS TOXIN K-A (PITX-KA) FROM PANDINUS IMPERATOR, NMR, 20 STRUCTURES 1PDK ; 2.40 ; PAPD-PAPK CHAPERONE-PILUS SUBUNIT COMPLEX FROM E.COLI P PILUS 1J8S ; 2.10 ; PAPG ADHESIN RECEPTOR BINDING DOMAIN-UNBOUND FORM 1N4F ; 1.78 ; PARA-ARSANILATE DERIVATIVE OF HEN EGG-WHITE LYSOZYME 1Z4Y ; 2.60 ; PARAINFLUENZA VIRUS 5 (SV5) HEMAGGLUTININ-NEURAMINIDASE (HN) (PH 8.0) 1Z4V ; 2.30 ; PARAINFLUENZA VIRUS 5 (SV5) HEMAGGLUTININ-NEURAMINIDASE (HN) WITH LIGAND DANA (SOAKED WITH DANA, PH 7.0) 1Z4W ; 2.70 ; PARAINFLUENZA VIRUS 5 (SV5) HEMAGGLUTININ-NEURAMINIDASE (HN) WITH LIGAND DANA (SOAKED WITH DANA, PH8.0) 1Z50 ; 2.80 ; PARAINFLUENZA VIRUS 5 (SV5) HEMAGGLUTININ-NEURAMINIDASE (HN) WITH LIGAND DANA (SOAKED WITH SIALIC ACID, PH 8.0) 1Z4Z ; 2.50 ; PARAINFLUENZA VIRUS 5 (SV5) HEMAGGLUTININ-NEURAMINIDASE (HN) WITH LIGAND DANA(SOAKED WITH SIALIC ACID, PH7.0)) 1Z4X ; 2.50 ; PARAINFLUENZA VIRUS 5 (SV5) HEMAGGLUTININ-NEURAMINIDASE (HN) WITH LIGAND SIALYLLACTOSE (SOAKED WITH SIALYLLACTOSE, PH8.0) 272D ; 2.00 ; PARALLEL AND ANTIPARALLEL (G(DOT)GC)2 TRIPLE HELIX FRAGMENTS IN A CRYSTAL STRUCTURE 1SVF ; 1.40 ; PARAMYXOVIRUS SV5 FUSION PROTEIN CORE 1ZGS ; 2.50 ; PARKIA PLATYCEPHALA SEED LECTIN IN COMPLEX WITH 5-BROMO-4- CHLORO-3-INDOLYL-A-D-MANNOSE 1MWM ; 2.00 ; PARM FROM PLASMID R1 ADP FORM 1MWK ; 2.30 ; PARM FROM PLASMID R1 APO FORM 1A3M ; -1.00 ; PAROMOMYCIN BINDING INDUCES A LOCAL CONFORMATIONAL CHANGE IN THE A SITE OF 16S RRNA, NMR, 20 STRUCTURES 1QD7 ; 5.50 ; PARTIAL MODEL FOR 30S RIBOSOMAL SUBUNIT 1DV4 ; 4.50 ; PARTIAL STRUCTURE OF 16S RIBONUCLEIC ACID OF THE SMALL RIBOSOMAL SUBUNIT FROM THERMUS THERMOPHILUS 1ULX ; 2.00 ; PARTIALLY PHOTOLYZED STRUCTURE OF CO-BOUND HEME-HEME OXYGENASE COMPLEX 1YUZ ; 1.40 ; PARTIALLY REDUCED STATE OF NIGERYTHRIN 1MFZ ; 2.80 ; PARTIALLY REFINED 2.8 A CRYSTAL STRUCTURE OF GDP-MANNOSE DEHYDROGENASE FROM P. AERUGINOSA 1B8C ; 2.00 ; PARVALBUMIN 1B8R ; 1.90 ; PARVALBUMIN 1B9A ; 2.00 ; PARVALBUMIN (MUTATION;D51A, F102W) 1DNV ; 3.60 ; PARVOVIRUS (DENSOVIRUS) FROM GALLERIA MELLONELLA 1AUN ; 1.80 ; PATHOGENESIS-RELATED PROTEIN 5D FROM NICOTIANA TABACUM 1K78 ; 2.25 ; PAX5(1-149)+ETS-1(331-440)+DEOXYRIBONUCLEIC ACID 1OW8 ; 2.85 ; PAXILLIN LD2 MOTIF BOUND TO THE FOCAL ADHESION TARGETING (FAT) DOMAIN OF THE FOCAL ADHESION KINASE 1OW6 ; 2.35 ; PAXILLIN LD4 MOTIF BOUND TO THE FOCAL ADHESION TARGETING (FAT) DOMAIN OF THE FOCAL ADHESION KINASE 1OW7 ; 2.60 ; PAXILLIN LD4 MOTIF BOUND TO THE FOCAL ADHESION TARGETING (FAT) DOMAIN OF THE FOCAL ADHESION KINASE 1M4X ; 28.00 ; PBCV-1 VIRUS CAPSID, QUASI-ATOMIC MODEL 1K25 ; 3.20 ; PBP2X FROM A HIGHLY PENICILLIN-RESISTANT STREPTOCOCCUS PNEUMONIAE CLINICAL ISOLATE 1RP5 ; 3.00 ; PBP2X FROM STREPTOCOCCUS PNEUMONIAE STRAIN 5259 WITH REDUCED SUSCEPTIBILITY TO BETA-LACTAM ANTIBIOTICS 1B72 ; 2.35 ; PBX1, HOMEOBOX PROTEIN HOX-B1/DEOXYRIBONUCLEIC ACID TERNARY COMPLEX 1GY3 ; 2.70 ; PCDK2/CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE SUBSTRATE 1PDT ; -1.00 ; PD235, PNA-DEOXYRIBONUCLEIC ACID DUPLEX, NMR, 8 STRUCTURES 1ICJ ; 1.90 ; PDF PROTEIN IS CRYSTALLIZED AS NI2+ CONTAINING FORM, COCRYSTALLIZED WITH INHIBITOR POLYETHYLENE GLYCOL (PEG) 1R8K ; 2.10 ; PDXA PROTEIN; NAD-DEPENDENT DEHYDROGENASE/CARBOXYLASE; SUBUNIT OF PYRIDOXINE PHOSPHATE BIOSYNTHETIC PROTEIN PDXJ- PDXA [SALMONELLA TYPHIMURIUM] 1WFG ; -1.00 ; PDZ DOMAIN OF HUMAN RIM2B 1ZOK ; -1.00 ; PDZ1 DOMAIN OF SYNAPSE ASSOCIATED PROTEIN 97 1KEF ; -1.00 ; PDZ1 OF SAP90 1VJ6 ; -1.00 ; PDZ2 FROM PTP-BL IN COMPLEX WITH THE C-TERMINAL LIGAND FROM THE APC PROTEIN 1TP3 ; 1.99 ; PDZ3 DOMAIN OF PSD-95 PROTEIN COMPLEXED WITH KKETPV PEPTIDE LIGAND 1QFY ; 1.80 ; PEA FNR Y308S MUTANT IN COMPLEX WITH NADP+ 1QFZ ; 1.70 ; PEA FNR Y308S MUTANT IN COMPLEX WITH NADPH 1QGA ; 2.00 ; PEA FNR Y308W MUTANT IN COMPLEX WITH NADP+ 1OFS ; 1.80 ; PEA LECTIN-SUCROSE COMPLEX 2PEL ; 2.25 ; PEANUT LECTIN 1V6O ; 3.00 ; PEANUT LECTIN COMPLEXED WITH 10MER PEPTIDE (PVRIWSSATG) 1BZW ; 2.70 ; PEANUT LECTIN COMPLEXED WITH C-LACTOSE 1QF3 ; 2.80 ; PEANUT LECTIN COMPLEXED WITH METHYL-BETA-GALACTOSE 1CIW ; 2.70 ; PEANUT LECTIN COMPLEXED WITH N-ACETYLLACTOSAMINE 2TEP ; 2.50 ; PEANUT LECTIN COMPLEXED WITH T-ANTIGENIC DISACCHARIDE 1V6M ; 2.70 ; PEANUT LECTIN WITH 9MER PEPTIDE (IWSSAGNVA) 1V6N ; 3.50 ; PEANUT LECTIN WITH 9MER PEPTIDE (PVIWSSATG) 1V6J ; 2.90 ; PEANUT LECTIN-LACTOSE COMPLEX CRYSTALLIZED IN ORTHORHOMBIC FORM AT ACIDIC PH 1V6I ; 2.15 ; PEANUT LECTIN-LACTOSE COMPLEX IN ACIDIC PH 1V6L ; 2.50 ; PEANUT LECTIN-LACTOSE COMPLEX IN THE PRESENCE OF 9MER PEPTIDE (PVIWSSATG) 1V6K ; 2.40 ; PEANUT LECTIN-LACTOSE COMPLEX IN THE PRESENCE OF PEPTIDE(IWSSAGNVA) 1CR7 ; 2.60 ; PEANUT LECTIN-LACTOSE COMPLEX MONOCLINIC FORM 1CQ9 ; 3.50 ; PEANUT LECTIN-TRICLINIC FORM 1SCH ; 2.70 ; PEANUT PEROXIDASE 1AIR ; 2.20 ; PECTATE LYASE C FROM ERWINIA CHRYSANTHEMI (EC16) TO A RESOLUTION OF 2.2 ANGSTROMS WITH 128 WATERS 1O8E ; 2.20 ; PECTATE LYASE C FROM ERWINIA CHRYSANTHEMI AT PH 11.2 WITH 1MM CA2+ 1O88 ; 2.20 ; PECTATE LYASE C FROM ERWINIA CHRYSANTHEMI AT PH 11.2 WITH 30MM CA2+ 1O8D ; 2.20 ; PECTATE LYASE C FROM ERWINIA CHRYSANTHEMI AT PH 11.2 WITH 5MM CA2+ 1O8K ; 2.20 ; PECTATE LYASE C FROM ERWINIA CHRYSANTHEMI AT PH 4.5 WITH 20MM CA2+ 1O8J ; 2.20 ; PECTATE LYASE C FROM ERWINIA CHRYSANTHEMI AT PH 4.5 WITH 30MM CA2+ 1O8L ; 2.20 ; PECTATE LYASE C FROM ERWINIA CHRYSANTHEMI AT PH 4.5 WITH 5MM CA2+ 1O8M ; 2.20 ; PECTATE LYASE C FROM ERWINIA CHRYSANTHEMI AT PH 4.5 WITH NO CA2+ ADDED 1O8H ; 2.20 ; PECTATE LYASE C FROM ERWINIA CHRYSANTHEMI AT PH 9.5 WITH 0.3MM CA2+ ADDED 1O8F ; 2.20 ; PECTATE LYASE C FROM ERWINIA CHRYSANTHEMI AT PH 9.5 WITH 30MM CA2+ 1O8G ; 2.20 ; PECTATE LYASE C FROM ERWINIA CHRYSANTHEMI AT PH 9.5 WITH 5MM CA2+ 1O8I ; 2.20 ; PECTATE LYASE C FROM ERWINIA CHRYSANTHEMI AT PH 9.5 WITH NO CA2+ ADDED 1PLU ; 2.20 ; PECTATE LYASE C FROM ERWINIA CHRYSANTHEMI WITH 1 LU+3 ION IN THE PUTATIVE CALCIUM BINDING SITE 1IDJ ; 2.40 ; PECTIN LYASE A 1IDK ; 1.90 ; PECTIN LYASE A 1QCX ; 1.70 ; PECTIN LYASE B 1GQ8 ; 1.75 ; PECTIN METHYLESTERASE FROM CARROT 1QJV ; 2.37 ; PECTIN METHYLESTERASE PEMA FROM ERWINIA CHRYSANTHEMI 1KPZ ; -1.00 ; PEMV-1 P1-P2 FRAMESHIFTING PSEUDOKNOT REGULARIZED AVERAGE STRUCTURE 1KPY ; -1.00 ; PEMV-1 P1-P2 FRAMESHIFTING PSEUDOKNOT, 15 LOWEST ENERGY STRUCTURES 1AJP ; 2.31 ; PENICILLIN ACYLASE COMPLEXED WITH 2,5-DIHYDROXYPHENYLACETIC ACID 1AI4 ; 2.35 ; PENICILLIN ACYLASE COMPLEXED WITH 3,4-DIHYDROXYPHENYLACETIC ACID 1AI5 ; 2.36 ; PENICILLIN ACYLASE COMPLEXED WITH M-NITROPHENYLACETIC ACID 1AJN ; 2.36 ; PENICILLIN ACYLASE COMPLEXED WITH P-NITROPHENYLACETIC ACID 1AI7 ; 2.50 ; PENICILLIN ACYLASE COMPLEXED WITH PHENOL 1AJQ ; 2.05 ; PENICILLIN ACYLASE COMPLEXED WITH THIOPHENEACETIC ACID 1FXV ; 2.25 ; PENICILLIN ACYLASE MUTANT IMPAIRED IN CATALYSIS WITH PENICILLIN G IN THE ACTIVE SITE 1K7D ; 2.15 ; PENICILLIN ACYLASE MUTANT WITH PHENYL PROPRIONIC ACID 1KEC ; 2.30 ; PENICILLIN ACYLASE MUTANT WITH PHENYL PROPRIONIC ACID 1AI6 ; 2.55 ; PENICILLIN ACYLASE WITH P-HYDROXYPHENYLACETIC ACID 1JX9 ; 2.28 ; PENICILLIN ACYLASE, MUTANT 1K5Q ; 2.34 ; PENICILLIN ACYLASE, MUTANT COMPLEXED WITH PAA 1K5S ; 2.43 ; PENICILLIN ACYLASE, MUTANT COMPLEXED WITH PPA 3PVA ; 2.80 ; PENICILLIN V ACYLASE FROM B. SPHAERICUS 2C5W ; 2.55 ; PENICILLIN-BINDING PROTEIN 1A (PBP-1A) ACYL-ENZYME COMPLEX (CEFOTAXIME) FROM STREPTOCOCCUS PNEUMONIAE 2C6W ; 2.61 ; PENICILLIN-BINDING PROTEIN 1A (PBP-1A) FROM STREPTOCOCCUS PNEUMONIAE 1PMD ; 3.50 ; PENICILLIN-BINDING PROTEIN 2X (PBP-2X) 1QME ; 2.40 ; PENICILLIN-BINDING PROTEIN 2X (PBP-2X) 1QMF ; 2.80 ; PENICILLIN-BINDING PROTEIN 2X (PBP-2X) ACYL-ENZYME COMPLEX 1PWC ; 1.10 ; PENICILLOYL ACYL ENZYME COMPLEX OF THE STREPTOMYCES R61 DD- PEPTIDASE WITH PENICILLIN G 1PS1 ; 2.60 ; PENTALENENE SYNTHASE 2A3Y ; 2.00 ; PENTAMERIC CRYSTAL STRUCTURE OF HUMAN SERUM AMYLOID P- COMPONENT BOUND TO BIS-1,2-{[(Z)-2CARBOXY-2-METHYL-1,3- DIOXANE]-5-YLOXYCARBAMOYL}-ETHANE. 1FOQ ; 20.00 ; PENTAMERIC MODEL OF THE BACTERIOPHAGE PHI29 PROHEAD RIBONUCLEIC ACID 1KHG ; 2.34 ; PEPCK 1M51 ; 2.25 ; PEPCK COMPLEX WITH A GTP-COMPETITIVE INHIBITOR 1NHX ; 2.10 ; PEPCK COMPLEX WITH A GTP-COMPETITIVE INHIBITOR 1KHE ; 2.40 ; PEPCK COMPLEX WITH NONHYDROLYZABLE GTP ANALOG, MAD DATA 1KHB ; 1.85 ; PEPCK COMPLEX WITH NONHYDROLYZABLE GTP ANALOG, NATIVE DATA 1KHF ; 2.02 ; PEPCK COMPLEX WITH PEP 1FNO ; 2.40 ; PEPTIDASE T (TRIPEPTIDASE) 1IMW ; -1.00 ; PEPTIDE ANTAGONIST OF IGFBP-1 1GJE ; -1.00 ; PEPTIDE ANTAGONIST OF IGFBP-1, MINIMIZED AVERAGE STRUCTURE 1IN2 ; -1.00 ; PEPTIDE ANTAGONIST OF IGFBP1, (I,I+7) COVALENTLY RESTRAINED ANALOG 1GJF ; -1.00 ; PEPTIDE ANTAGONIST OF IGFBP1, (I,I+7) COVALENTLY RESTRAINED ANALOG, MINIMIZED AVERAGE STRUCTURE 1IN3 ; -1.00 ; PEPTIDE ANTAGONIST OF IGFBP1, (I,I+8) COVALENTLY RESTRAINED ANALOG 1GJG ; -1.00 ; PEPTIDE ANTAGONIST OF IGFBP1, (I,I+8) COVALENTLY RESTRAINED ANALOG, MINIMIZED AVERAGE STRUCTURE 1DSR ; -1.00 ; PEPTIDE ANTIBIOTIC, NMR, 6 STRUCTURES 1DFF ; 2.88 ; PEPTIDE DEFORMYLASE 1BSZ ; 1.90 ; PEPTIDE DEFORMYLASE AS FE2+ CONTAINING FORM (NATIVE) IN COMPLEX WITH INHIBITOR POLYETHYLENE GLYCOL 1BS7 ; 2.50 ; PEPTIDE DEFORMYLASE AS NI2+ CONTAINING FORM 1BS6 ; 2.10 ; PEPTIDE DEFORMYLASE AS NI2+ CONTAINING FORM IN COMPLEX WITH TRIPEPTIDE MET-ALA-SER 1BS5 ; 2.50 ; PEPTIDE DEFORMYLASE AS ZN2+ CONTAINING FORM 1BS4 ; 1.90 ; PEPTIDE DEFORMYLASE AS ZN2+ CONTAINING FORM (NATIVE) IN COMPLEX WITH INHIBITOR POLYETHYLENE GLYCOL 1BS8 ; 2.20 ; PEPTIDE DEFORMYLASE AS ZN2+ CONTAINING FORM IN COMPLEX WITH TRIPEPTIDE MET-ALA-SER 2DEF ; -1.00 ; PEPTIDE DEFORMYLASE CATALYTIC CORE (RESIDUES 1 - 147), NMR, 20 STRUCTURES 1DEF ; -1.00 ; PEPTIDE DEFORMYLASE CATALYTIC CORE (RESIDUES 1 - 147), NMR, 9 STRUCTURES 1PEF ; 1.50 ; PEPTIDE F (EQLLKALEFLLKELLEKL), AMPHIPHILIC OCTADECAPEPTIDE 1DU1 ; -1.00 ; PEPTIDE FRAGMENT THR671-LEU690 OF THE RABBIT SKELETAL DIHYDROPYRIDINE RECEPTOR 1PNN ; 2.50 ; PEPTIDE NUCLEIC ACID (PNA) COMPLEXED WITH DEOXYRIBONUCLEIC ACID 1ODQ ; -1.00 ; PEPTIDE OF HUMAN APOA-I RESIDUES 166 - 185. NMR, 5 STRUCTURES AT PH 3.7, 37 DEGREES CELSIUS AND PEPTIDE:SDS MOLE RATIO OF 1:40 1ODR ; -1.00 ; PEPTIDE OF HUMAN APOA-I RESIDUES 166 - 185. NMR, 5 STRUCTURES AT PH 6.0, 37 DEGREES CELSIUS AND PEPTIDE:DPC MOLE RATIO OF 1:40 1ODP ; -1.00 ; PEPTIDE OF HUMAN APOA-I RESIDUES 166 - 185. NMR, 5 STRUCTURES AT PH 6.6, 37 DEGREES CELSIUS AND PEPTIDE:SDS MOLE RATIO OF 1:40 1OEF ; -1.00 ; PEPTIDE OF HUMAN APOE RESIDUES 263 - 286, NMR, 5 STRUCTURES AT PH 4.8, 37 DEGREES CELSIUS AND PEPTIDE:SDS MOLE RATIO OF 1:90 1OEG ; -1.00 ; PEPTIDE OF HUMAN APOE RESIDUES 267 - 289, NMR, 5 STRUCTURES AT PH 6.0, 37 DEGREES CELSIUS AND PEPTIDE:SDS MOLE RATIO OF 1:90 1OPP ; -1.00 ; PEPTIDE OF HUMAN APOLIPOPROTEIN C-I RESIDUES 1-38, NMR, 28 STRUCTURES 1BY6 ; -1.00 ; PEPTIDE OF HUMAN APOLIPOPROTEIN C-II 1XNS ; 2.80 ; PEPTIDE TRAPPED HOLLIDAY JUNCTION INTERMEDIATE IN CRE-LOXP RECOMBINATION 1C9I ; 2.90 ; PEPTIDE-IN-GROOVE INTERACTIONS LINK TARGET PROTEINS TO THE B-PROPELLER OF CLATHRIN 1C9L ; 2.90 ; PEPTIDE-IN-GROOVE INTERACTIONS LINK TARGET PROTEINS TO THE B-PROPELLER OF CLATHRIN 1OHT ; 2.00 ; PEPTIDOGLYCAN RECOGNITION PROTEIN-LB 1G63 ; 2.50 ; PEPTIDYL-CYSTEINE DECARBOXYLASE EPID 1YW5 ; 1.60 ; PEPTIDYL-PROLYL ISOMERASE ESS1 FROM CANDIDA ALBICANS 2PTH ; 1.20 ; PEPTIDYL-TRNA HYDROLASE FROM ESCHERICHIA COLI 1PHM ; 1.90 ; PEPTIDYLGLYCINE ALPHA-HYDROXYLATING MONOOXYGENASE (PHM) FROM RAT 2NUL ; 2.10 ; PEPTIDYLPROLYL ISOMERASE FROM E. COLI 1A33 ; 2.15 ; PEPTIDYLPROLYL ISOMERASE, CYCLOPHILIN-LIKE DOMAIN FROM BRUGIA MALAYI 1PFO ; 2.20 ; PERFRINGOLYSIN O 1M3I ; 2.90 ; PERFRINGOLYSIN O, NEW CRYSTAL FORM 1PPR ; 2.00 ; PERIDININ-CHLOROPHYLL-PROTEIN OF AMPHIDINIUM CARTERAE 1W4G ; -1.00 ; PERIPHERAL-SUBUNIT BINDING DOMAINS FROM MESOPHILIC, THERMOPHILIC, AND HYPERTHERMOPHILIC BACTERIA FOLD BY ULTRAFAST, APPARENTLY TWO-STATE FOLDING TRANSITIONS 1W4E ; -1.00 ; PERIPHERAL-SUBUNIT BINDING DOMAINS FROM MESOPHILIC, THERMOPHILIC, AND HYPERTHERMOPHILIC BACTERIA FOLD BY ULTRAFAST, APPARENTLY TWO-STATE TRANSITIONS 1W4I ; -1.00 ; PERIPHERAL-SUBUNIT BINDING DOMAINS FROM MESOPHILIC, THERMOPHILIC, AND HYPERTHERMOPHILIC BACTERIA FOLD BY ULTRAFAST, APPARENTLY TWO-STATE TRANSITIONS 1W4J ; -1.00 ; PERIPHERAL-SUBUNIT BINDING DOMAINS FROM MESOPHILIC, THERMOPHILIC, AND HYPERTHERMOPHILIC BACTERIA FOLD BY ULTRAFAST, APPARENTLY TWO-STATE TRANSITIONS 1W4K ; -1.00 ; PERIPHERAL-SUBUNIT BINDING DOMAINS FROM MESOPHILIC, THERMOPHILIC, AND HYPERTHERMOPHILIC BACTERIA FOLD BY ULTRAFAST, APPARENTLY TWO-STATE TRANSITIONS 1W4F ; -1.00 ; PERIPHERAL-SUBUNIT FROM MESOPHILIC, THERMOPHILIC AND HYPERTHERMOPHILIC BACTERIA FOLD BY ULTRAFAST, APPARENTLY TWO-STATE TRANSITIONS 1W4H ; -1.00 ; PERIPHERAL-SUBUNIT FROM MESOPHILIC, THERMOPHILIC AND HYPERTHERMOPHILIC BACTERIA FOLD BY ULTRAFAST, APPARENTLY TWO-STATE TRANSITIONS 1BF8 ; -1.00 ; PERIPLASMIC CHAPERONE FIMC, NMR, 20 STRUCTURES 1UV7 ; 1.70 ; PERIPLASMIC DOMAIN OF EPSM FROM VIBRIO CHOLERAE 1EFD ; 1.90 ; PERIPLASMIC FERRIC SIDEROPHORE BINDING PROTEIN FHUD COMPLEXED WITH GALLICHROME 1TOA ; 1.80 ; PERIPLASMIC ZINC BINDING PROTEIN TROA FROM TREPONEMA PALLIDUM 1U9P ; 1.90 ; PERMUTED SINGLE-CHAIN ARC 1GZA ; 2.06 ; PEROXIDASE 1GZB ; 1.80 ; PEROXIDASE 1PFM ; -1.00 ; PF4-M2 CHIMERIC MUTANT WITH THE FIRST 10 N-TERMINAL RESIDUES OF R-PF4 REPLACED BY THE N-TERMINAL RESIDUES OF THE IL8 SEQUENCE. MODELS 1 - 15 OF A 27-MODEL SET. 1PFN ; -1.00 ; PF4-M2 CHIMERIC MUTANT WITH THE FIRST 10 N-TERMINAL RESIDUES OF R-PF4 REPLACED BY THE N-TERMINAL RESIDUES OF THE IL8 SEQUENCE. MODELS 16 - 27 OF A 27-MODEL SET. 1QFX ; 2.40 ; PH 2.5 ACID PHOSPHATASE FROM ASPERGILLUS NIGER 1B17 ; 1.70 ; PH AFFECTS GLU B13 SWITCHING AND SULFATE BINDING IN CUBIC INSULIN CRYSTALS (PH 5.00 COORDINATES) 1B18 ; 1.80 ; PH AFFECTS GLU B13 SWITCHING AND SULFATE BINDING IN CUBIC INSULIN CRYSTALS (PH 5.53 COORDINATES) 1B19 ; 1.80 ; PH AFFECTS GLU B13 SWITCHING AND SULFATE BINDING IN CUBIC INSULIN CRYSTALS (PH 5.80 COORDINATES) 1B2A ; 1.70 ; PH AFFECTS GLU B13 SWITCHING AND SULFATE BINDING IN CUBIC INSULIN CRYSTALS (PH 6.00 COORDINATES) 1B2B ; 1.80 ; PH AFFECTS GLU B13 SWITCHING AND SULFATE BINDING IN CUBIC INSULIN CRYSTALS (PH 6.16 COORDINATES) 1B2C ; 1.80 ; PH AFFECTS GLU B13 SWITCHING AND SULFATE BINDING IN CUBIC INSULIN CRYSTALS (PH 6.26 COORDINATES) 1B2D ; 1.70 ; PH AFFECTS GLU B13 SWITCHING AND SULFATE BINDING IN CUBIC INSULIN CRYSTALS (PH 6.35 COORDINATES) 1B2E ; 1.90 ; PH AFFECTS GLU B13 SWITCHING AND SULFATE BINDING IN CUBIC INSULIN CRYSTALS (PH 6.50 COORDINATES) 1B2F ; 1.90 ; PH AFFECTS GLU B13 SWITCHING AND SULFATE BINDING IN CUBIC INSULIN CRYSTALS (PH 6.98 COORDINATES) 1B2G ; 1.80 ; PH AFFECTS GLU B13 SWITCHING AND SULFATE BINDING IN CUBIC INSULIN CRYSTALS (PH 9.00 COORDINATES) 1BWN ; 2.10 ; PH DOMAIN AND BTK MOTIF FROM BRUTON'S TYROSINE KINASE MUTANT E41K IN COMPLEX WITH INS(1,3,4,5)P4 1BTK ; 1.60 ; PH DOMAIN AND BTK MOTIF FROM BRUTON'S TYROSINE KINASE MUTANT R28C 1B55 ; 2.40 ; PH DOMAIN FROM BRUTON'S TYROSINE KINASE IN COMPLEX WITH INOSITOL 1,3,4,5-TETRAKISPHOSPHATE 5UKD ; 1.90 ; PH INFLUENCES FLUORIDE COORDINATION NUMBER OF THE ALFX PHOSPHORYL TRANSFER TRANSITION STATE ANALOG 1QF9 ; 1.70 ; PH INFLUENCES FLUORIDE COORDINATION NUMBER OF THE ALFX PHOSPHORYL TRANSFER TRANSITION STATE ANALOG IN UMP/CMP KINASE 1KF9 ; 2.60 ; PHAGE DISPLAY DERIVED VARIANT OF HUMAN GROWTH HORMONE COMPLEXED WITH TWO COPIES OF THE EXTRACELLULAR DOMAIN OF ITS RECEPTOR 1FR5 ; 3.50 ; PHAGE FR CAPSIDS WITH A FOUR RESIDUE DELETION IN THE COAT PROTEIN FG LOOP 206L ; 1.75 ; PHAGE T4 LYSOZYME 1ZDA ; -1.00 ; PHAGE-SELECTED MINI PROTEIN A DOMAIN, Z38, NMR, 24 STRUCTURES 1ZDB ; -1.00 ; PHAGE-SELECTED MINI PROTEIN A DOMAIN, Z38, NMR, MINIMIZED MEAN STRUCTURE 2SGF ; 1.75 ; PHE 18 VARIANT OF TURKEY OVOMUCOID INHIBITOR THIRD DOMAIN COMPLEXED WITH STREPTOMYCES GRISEUS PROTEINASE B 1TTT ; 2.70 ; PHE-TRNA, ELONGATION FACTOR EF-TU:GDPNP TERNARY COMPLEX 1CC4 ; 2.00 ; PHE161 AND ARG166 VARIANTS OF P-HYDROXYBENZOATE HYDROXYLASE. IMPLICATIONS FOR NADPH RECOGNITION AND STRUCTURAL STABILITY. 1CC6 ; 2.20 ; PHE161 AND ARG166 VARIANTS OF P-HYDROXYBENZOATE HYDROXYLASE. IMPLICATIONS FOR NADPH RECOGNITION AND STRUCTURAL STABILITY. 1JPI ; 2.30 ; PHE232LEU MUTANT OF HUMAN UROD, HUMAN UROPORPHYRINOGEN III DECARBOXYLASE 1A18 ; 2.40 ; PHENANTHROLINE MODIFIED MURINE ADIPOCYTE LIPID BINDING PROTEIN 1FOH ; 2.40 ; PHENOL HYDROXYLASE FROM TRICHOSPORON CUTANEUM 1PN0 ; 1.70 ; PHENOL HYDROXYLASE FROM TRICHOSPORON CUTANEUM 1W4X ; 1.70 ; PHENYLACETONE MONOOXYGENASE, A BAEYER-VILLIGER MONOOXYGENASE 1AMU ; 1.90 ; PHENYLALANINE ACTIVATING DOMAIN OF GRAMICIDIN SYNTHETASE 1 IN A COMPLEX WITH AMP AND PHENYLALANINE 1W27 ; 1.70 ; PHENYLALANINE AMMONIA-LYASE (PAL) FROM PETROSELINUM CRISPUM 1BXG ; 2.30 ; PHENYLALANINE DEHYDROGENASE STRUCTURE IN TERNARY COMPLEX WITH NAD+ AND BETA-PHENYLPROPIONATE 1BW9 ; 1.50 ; PHENYLALANINE DEHYDROGENASE STRUCTURE IN TERNARY COMPLEX WITH NAD+ AND PHENYLPYRUVATE 1Q2H ; 1.70 ; PHENYLALANINE ZIPPER MEDIATES APS DIMERIZATION 1B70 ; 2.70 ; PHENYLALANYL TRNA SYNTHETASE COMPLEXED WITH PHENYLALANINE 1B7Y ; 2.50 ; PHENYLALANYL TRNA SYNTHETASE COMPLEXED WITH PHENYLALANINYL- ADENYLATE 1PYS ; 2.90 ; PHENYLALANYL-TRNA SYNTHETASE FROM THERMUS THERMOPHILUS 2ERL ; 1.00 ; PHEROMONE ER-1 FROM 1ERY ; -1.00 ; PHEROMONE ER-11, NMR 1HD6 ; -1.00 ; PHEROMONE ER-22, NMR 1HA8 ; -1.00 ; PHEROMONE ER-23 FROM EUPLOTES RAIKOVI 1XI1 ; 2.20 ; PHI29 DEOXYRIBONUCLEIC ACID POLYMERASE SSDNA COMPLEX, MONOCLINIC CRYSTAL FORM 1XHX ; 2.35 ; PHI29 DEOXYRIBONUCLEIC ACID POLYMERASE, ORTHORHOMBIC CRYSTAL FORM 1XHZ ; 2.70 ; PHI29 DEOXYRIBONUCLEIC ACID POLYMERASE, ORTHORHOMBIC CRYSTAL FORM, SSDNA COMPLEX 1GXP ; 2.50 ; PHOB EFFECTOR DOMAIN IN COMPLEX WITH PHO BOX DEOXYRIBONUCLEIC ACID. 1B00 ; 1.88 ; PHOB RECEIVER DOMAIN FROM ESCHERICHIA COLI 2TRC ; 2.40 ; PHOSDUCIN/TRANSDUCIN BETA-GAMMA COMPLEX 1IE7 ; 1.85 ; PHOSPHATE INHIBITED BACILLUS PASTEURII UREASE CRYSTAL STRUCTURE 1IXH ; 0.98 ; PHOSPHATE-BINDING PROTEIN (PBP) COMPLEXED WITH PHOSPHATE 2ABH ; 1.70 ; PHOSPHATE-BINDING PROTEIN (RE-REFINED) 1A55 ; 2.40 ; PHOSPHATE-BINDING PROTEIN MUTANT A197C 1A54 ; 1.60 ; PHOSPHATE-BINDING PROTEIN MUTANT A197C LABELLED WITH A COUMARIN FLUOROPHORE AND BOUND TO DIHYDROGENPHOSPHATE ION 1OIB ; 2.40 ; PHOSPHATE-BINDING PROTEIN MUTANT T141D 1QUK ; 1.70 ; PHOSPHATE-BINDING PROTEIN MUTANT WITH ASP 137 REPLACED BY ASN COMPLEX WITH PHOSPHATE 1QUI ; 1.90 ; PHOSPHATE-BINDING PROTEIN MUTANT WITH ASP 137 REPLACED BY GLY COMPLEX WITH BROMINE AND PHOSPHATE 1QUJ ; 1.90 ; PHOSPHATE-BINDING PROTEIN MUTANT WITH ASP 137 REPLACED BY GLY COMPLEX WITH CHLORINE AND PHOSPHATE 1QUL ; 1.70 ; PHOSPHATE-BINDING PROTEIN MUTANT WITH ASP 137 REPLACED BY THR COMPLEX WITH CHLORINE AND PHOSPHATE 1IXI ; 1.89 ; PHOSPHATE-BINDING PROTEIN MUTANT WITH ASP 56 REPLACED BY ASN COMPLEX WITH MONOBASIC PHOSPHATE ION 1IXG ; 1.05 ; PHOSPHATE-BINDING PROTEIN MUTANT WITH THR 141 REPLACED BY ASP (T141D), COMPLEXED WITH PHOSPATE 1A40 ; 1.70 ; PHOSPHATE-BINDING PROTEIN WITH ALA 197 REPLACED WITH TRP 1A44 ; 1.84 ; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN FROM CALF BRAIN 1PHT ; 2.00 ; PHOSPHATIDYLINOSITOL 3-KINASE P85-ALPHA SUBUNIT SH3 DOMAIN, RESIDUES 1-85 1H9O ; 1.79 ; PHOSPHATIDYLINOSITOL 3-KINASE, P85-ALPHA SUBUNIT: C-TERMINAL SH2 DOMAIN COMPLEXED WITH A TYR751 PHOSPHOPEPTIDE FROM THE PDGF RECEPTOR, CRYSTAL STRUCTURE AT 1.79 A 1PIC ; -1.00 ; PHOSPHATIDYLINOSITOL 3-KINASE, P85-ALPHA SUBUNIT: C-TERMINAL SH2 DOMAIN COMPLEXED WITH A TYR751 PHOSPHOPEPTIDE FROM THE PDGF RECEPTOR, NMR, MINIMIZED MEAN STRUCTURE 1BO1 ; 3.00 ; PHOSPHATIDYLINOSITOL PHOSPHATE KINASE TYPE II BETA 1AUA ; 2.50 ; PHOSPHATIDYLINOSITOL TRANSFER PROTEIN SEC14P FROM SACCHAROMYCES CEREVISIAE 1VFY ; 1.15 ; PHOSPHATIDYLINOSITOL-3-PHOSPHATE BINDING FYVE DOMAIN OF VPS27P PROTEIN FROM SACCHAROMYCES CEREVISIAE 1PTD ; 2.60 ; PHOSPHATIDYLINOSITOL-SPECIFIC PHOSPHOLIPASE C 1AOD ; 2.60 ; PHOSPHATIDYLINOSITOL-SPECIFIC PHOSPHOLIPASE C FROM LISTERIA MONOCYTOGENES 2PLC ; 2.00 ; PHOSPHATIDYLINOSITOL-SPECIFIC PHOSPHOLIPASE C FROM LISTERIA MONOCYTOGENES 1GYM ; 2.20 ; PHOSPHATIDYLINOSITOL-SPECIFIC PHOSPHOLIPASE C IN COMPLEX WITH GLUCOSAMINE-(ALPHA-1-6)-MYO-INOSITOL 1PTG ; 2.60 ; PHOSPHATIDYLINOSITOL-SPECIFIC PHOSPHOLIPASE C IN COMPLEX WITH MYO-INOSITOL 2PTD ; 2.00 ; PHOSPHATIDYLINOSITOL-SPECIFIC PHOSPHOLIPASE C MUTANT D198E 4PTD ; 2.30 ; PHOSPHATIDYLINOSITOL-SPECIFIC PHOSPHOLIPASE C MUTANT D274N 3PTD ; 2.20 ; PHOSPHATIDYLINOSITOL-SPECIFIC PHOSPHOLIPASE C MUTANT D274S 5PTD ; 2.70 ; PHOSPHATIDYLINOSITOL-SPECIFIC PHOSPHOLIPASE C MUTANT H32A 6PTD ; 2.60 ; PHOSPHATIDYLINOSITOL-SPECIFIC PHOSPHOLIPASE C MUTANT H32L 7PTD ; 2.60 ; PHOSPHATIDYLINOSITOL-SPECIFIC PHOSPHOLIPASE C MUTANT R163K 1SUR ; 2.00 ; PHOSPHO-ADENYLYL-SULFATE REDUCTASE 1J97 ; 1.50 ; PHOSPHO-ASPARTYL INTERMEDIATE ANALOGUE OF PHOSPHOSERINE PHOSPHATASE 1RLO ; 2.00 ; PHOSPHO-ASPARTYL INTERMEDIATE ANALOGUE OF YBIV FROM E. COLI K12 1AQ2 ; 1.90 ; PHOSPHOENOLPYRUVATE CARBOXYKINASE 1AYL ; 1.80 ; PHOSPHOENOLPYRUVATE CARBOXYKINASE 1OEN ; 1.90 ; PHOSPHOENOLPYRUVATE CARBOXYKINASE 1K3D ; 2.00 ; PHOSPHOENOLPYRUVATE CARBOXYKINASE IN COMPLEX WITH ADP AND ALF3 1K3C ; 2.00 ; PHOSPHOENOLPYRUVATE CARBOXYKINASE IN COMPLEX WITH ADP, ALF3 AND PYRUVATE 1PYM ; 1.80 ; PHOSPHOENOLPYRUVATE MUTASE FROM MOLLUSK IN WITH BOUND MG2- OXALATE 1BLE ; 2.90 ; PHOSPHOENOLPYRUVATE-DEPENDENT PHOSPHOTRANSFERASE SYSTEM 1PDO ; 1.70 ; PHOSPHOENOLPYRUVATE-DEPENDENT PHOSPHOTRANSFERASE SYSTEM 6PFK ; 2.60 ; PHOSPHOFRUCTOKINASE, INHIBITED T-STATE 1C4G ; 2.70 ; PHOSPHOGLUCOMUTASE VANADATE BASED TRANSITION STATE ANALOG COMPLEX 1T10 ; 2.35 ; PHOSPHOGLUCOSE ISOMERASE FROM LEISHMANIA MEXICANA IN COMPLEX WITH SUBSTRATE D-FRUCTOSE-6-PHOSPHATE 1Q50 ; 2.60 ; PHOSPHOGLUCOSE ISOMERASE FROM LEISHMANIA MEXICANA. 16PK ; 1.60 ; PHOSPHOGLYCERATE KINASE FROM TRYPANOSOMA BRUCEI BISUBSTRATE ANALOG 2ISD ; 2.50 ; PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT 1DJH ; 2.50 ; PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH BARIUM 1DJI ; 2.50 ; PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH CALCIUM 1DJX ; 2.30 ; PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH INOSITOL-1,4,5-TRISPHOSPHATE 1DJY ; 2.80 ; PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH INOSITOL-2,4,5-TRISPHOSPHATE 1DJW ; 2.45 ; PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH INOSITOL-2-METHYLENE-1,2-CYCLIC-MONOPHOSPHONATE 1DJZ ; 2.95 ; PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH INOSITOL-4,5-BISPHOSPHATE 1DJG ; 2.60 ; PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH LANTHANUM 1A3D ; 1.80 ; PHOSPHOLIPASE A2 (PLA2) FROM NAJA NAJA VENOM 1A3F ; 2.65 ; PHOSPHOLIPASE A2 (PLA2) FROM NAJA NAJA VENOM 1RGB ; 3.30 ; PHOSPHOLIPASE A2 FROM VIPERA AMMODYTES MERIDIONALIS 1VPI ; 1.76 ; PHOSPHOLIPASE A2 INHIBITOR FROM VIPOXIN 1BK9 ; 2.00 ; PHOSPHOLIPASE A2 MODIFIED BY PBPB 1AH7 ; 1.50 ; PHOSPHOLIPASE C FROM BACILLUS CEREUS 1YWP ; 1.60 ; PHOSPHOLIPASE CGAMMA1 SH3 1YWO ; 1.81 ; PHOSPHOLIPASE CGAMMA1 SH3 IN COMPLEX WITH A SLP-76 MOTIF 1V0T ; 1.53 ; PHOSPHOLIPASE D FROM STREPTOMYCES SP. STRAIN PMF SOAKED WITH THE PRODUCT GLYCEROPHOSPHATE 1V0U ; 1.42 ; PHOSPHOLIPASE D FROM STREPTOMYCES SP. STRAIN PMF SOAKED WITH THE PRODUCT GLYCEROPHOSPHATE. 1V0V ; 1.70 ; PHOSPHOLIPASE D FROM STREPTOMYCES SP. STRAIN PMF SOAKED WITH THE SUBSTRATE DIBUTYRYLPHOSPHATIDYLCHOLINE. 1V0W ; 1.35 ; PHOSPHOLIPASE D FROM STREPTOMYCES SP. STRAIN PMF SOAKED WITH THE SUBSTRATE DIBUTYRYLPHOSPHATIDYLCHOLINE. 1V0Y ; 1.71 ; PHOSPHOLIPASE D FROM STREPTOMYCES SP. STRAIN PMF SOAKED WITH THE SUBSTRATE DIBUTYRYLPHOSPHATIDYLCHOLINE. 1PMI ; 1.70 ; PHOSPHOMANNOSE ISOMERASE 1RQN ; 2.80 ; PHOSPHONOACETALDEHYDE HYDROLASE COMPLEXED WITH MAGNESIUM 1TFU ; 1.99 ; PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE FROM MYCOBACTERIUM TUBERCULOSIS 1B6T ; 1.80 ; PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE IN COMPLEX WITH 3'- DEPHOSPHO-COA FROM ESCHERICHIA COLI 1H1T ; 1.78 ; PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE IN COMPLEX WITH COENZYME A FROM ESCHERICHIA COLI 1GN8 ; 1.83 ; PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE IN COMPLEX WITH MN2+ ATP FROM ESCHERICHIA COLI 1QJC ; 1.64 ; PHOSPHOPANTETHEINE ADENYLYTRANSFERASE FROM ESCHERICHIA COLI IN COMPLEX WITH 4'-PHOSPHOPANTETHEINE 1U7U ; 2.40 ; PHOSPHOPANTOTHENOYLCYSTEINE SYNTHETASE FROM E. COLI 1U7Z ; 2.30 ; PHOSPHOPANTOTHENOYLCYSTEINE SYNTHETASE FROM E. COLI, 4'- PHOSPHOPANTOTHENOYL-CMP COMPLEX 1U80 ; 2.85 ; PHOSPHOPANTOTHENOYLCYSTEINE SYNTHETASE FROM E. COLI, CMP COMPLEX 1U7W ; 2.50 ; PHOSPHOPANTOTHENOYLCYSTEINE SYNTHETASE FROM E. COLI, CTP- COMPLEX 1IBS ; 2.80 ; PHOSPHORIBOSYLDIPHOSPHATE SYNTHETASE IN COMPLEX WITH CADMIUM IONS 1A7J ; 2.50 ; PHOSPHORIBULOKINASE FROM RHODOBACTER SPHEROIDES 1E4O ; 2.90 ; PHOSPHORYLASE RECOGNITION AND PHOSPHOROLYSIS OF ITS OLIGOSACCHARIDE SUBSTRATE: ANSWERS TO A LONG OUTSTANDING QUESTION 1QM5 ; 2.00 ; PHOSPHORYLASE RECOGNITION AND PHOSPHORYLYSIS OF ITS OLIGOSACCHARIDE SUBSTRATE: ANSWERS TO A LONG OUTSTANDING QUESTION 1CNU ; 2.25 ; PHOSPHORYLATED ACTOPHORIN FROM ACANTAMOEBA POLYPHAGA 1QMP ; 2.00 ; PHOSPHORYLATED ASPARTATE IN THE CRYSTAL STRUCTURE OF THE SPORULATION RESPONSE REGULATOR, SPO0A 1QMZ ; 2.20 ; PHOSPHORYLATED CDK2-CYCLYIN A-SUBSTRATE PEPTIDE COMPLEX 1JST ; 2.60 ; PHOSPHORYLATED CYCLIN-DEPENDENT KINASE-2 BOUND TO CYCLIN A 1R0Z ; 2.35 ; PHOSPHORYLATED CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) NUCLEOTIDE-BINDING DOMAIN ONE (NBD1) WITH ATP 1D5W ; 2.30 ; PHOSPHORYLATED FIXJ RECEIVER DOMAIN 1YGP ; 2.80 ; PHOSPHORYLATED FORM OF YEAST GLYCOGEN PHOSPHORYLASE WITH PHOSPHATE BOUND IN THE ACTIVE SITE. 1IR3 ; 1.90 ; PHOSPHORYLATED INSULIN RECEPTOR TYROSINE KINASE IN COMPLEX WITH PEPTIDE SUBSTRATE AND ATP ANALOG 2ERK ; 2.40 ; PHOSPHORYLATED MAP KINASE ERK2 1CM8 ; 2.40 ; PHOSPHORYLATED MAP KINASE P38-GAMMA 1BT4 ; 2.30 ; PHOSPHOSERINE AMINOTRANSFERASE FROM BACILLUS CIRCULANS SUBSP. ALKALOPHILUS 1QZT ; 2.70 ; PHOSPHOTRANSACETYLASE FROM METHANOSARCINA THERMOPHILA 1FYN ; 2.30 ; PHOSPHOTRANSFERASE 1ZIO ; 1.96 ; PHOSPHOTRANSFERASE 1PSC ; 2.00 ; PHOSPHOTRIESTERASE FROM PSEUDOMONAS DIMINUTA 1BF6 ; 1.70 ; PHOSPHOTRIESTERASE HOMOLOGY PROTEIN FROM ESCHERICHIA COLI 1S1Y ; 1.60 ; PHOTOACTIVATED CHROMOPHORE CONFORMATION IN PHOTOACTIVE YELLOW PROTEIN (E46Q MUTANT) FROM 10 MICROSECONDS TO 3 MILLISECONDS 1S1Z ; 1.60 ; PHOTOACTIVATED CHROMOPHORE CONFORMATION IN PHOTOACTIVE YELLOW PROTEIN (E46Q MUTANT) FROM 10 TO 500 NANOSECONDS 1ODV ; 1.14 ; PHOTOACTIVE YELLOW PROTEIN 1-25 DELETION MUTANT 2PYR ; 1.90 ; PHOTOACTIVE YELLOW PROTEIN, 1 NANOSECOND INTERMEDIATE (287K) 3PYP ; 0.85 ; PHOTOACTIVE YELLOW PROTEIN, CRYOTRAPPED EARLY LIGHT CYCLE INTERMEDIATE 2PHY ; 1.40 ; PHOTOACTIVE YELLOW PROTEIN, DARK STATE (UNBLEACHED) 3PHY ; -1.00 ; PHOTOACTIVE YELLOW PROTEIN, DARK STATE (UNBLEACHED), SOLUTION STRUCTURE, NMR, 26 STRUCTURES 2PYP ; 1.90 ; PHOTOACTIVE YELLOW PROTEIN, PHOTOSTATIONARY STATE, 50% GROUND STATE, 50% BLEACHED 1FT4 ; 2.90 ; PHOTOCHEMICALLY-ENHANCED BINDING OF SMALL MOLECULES TO THE TUMOR NECROSIS FACTOR RECEPTOR-1 1JNU ; 2.60 ; PHOTOEXCITED STRUCTURE OF THE PLANT PHOTORECEPTOR DOMAIN, PHY3 LOV2 1ABS ; 1.50 ; PHOTOLYSED CARBONMONOXY-MYOGLOBIN AT 20 K 1DWS ; 1.45 ; PHOTOLYZED CARBONMONOXY MYOGLOBIN (HORSE HEART) 1DXD ; 1.40 ; PHOTOLYZED CO COMPLEX OF MYOGLOBIN MB-YQR AT 20K 1AJH ; 1.70 ; PHOTOPRODUCT OF CARBONMONOXY MYOGLOBIN AT 40 K 1HCJ ; 1.80 ; PHOTOPRODUCT OF THE WILD-TYPE AEQUOREA VICTORIA GREEN FLUORESCENT PROTEIN 1W7U ; 1.85 ; PHOTOPRODUCT OF THE WILD-TYPE AEQUOREA VICTORIA GREEN FLUORESCENT PROTEIN AFTER STRUCTURAL ANNEALING AT 170K 1W7T ; 1.85 ; PHOTOPRODUCT OF THE WILD-TYPE AEQUOREA VICTORIA GREEN FLUORESCENT PROTEIN AT 100 K 1DWT ; 1.40 ; PHOTORELAXED HORSE HEART MYOGLOBIN CO COMPLEX 1K6L ; 3.10 ; PHOTOSYNETHETIC REACTION CENTER FROM RHODOBACTER SPHAEROIDES 1C51 ; 4.00 ; PHOTOSYNTHETIC REACTION CENTER AND CORE ANTENNA SYSTEM (TRIMERIC), ALPHA CARBON ONLY 2PPS ; 4.00 ; PHOTOSYNTHETIC REACTION CENTER AND CORE ANTENNA SYSTEM (TRIMERIC), ALPHA CARBON ONLY 1R2C ; 2.86 ; PHOTOSYNTHETIC REACTION CENTER BLASTOCHLORIS VIRIDIS (ATCC) 1VRN ; 2.20 ; PHOTOSYNTHETIC REACTION CENTER BLASTOCHLORIS VIRIDIS (ATCC) 1RVJ ; 2.75 ; PHOTOSYNTHETIC REACTION CENTER DOUBLE MUTANT FROM RHODOBACTER SPHAEROIDES WITH ASP L213 REPLACED WITH ASN AND ARG H177 REPLACED WITH HIS 1RZZ ; 2.40 ; PHOTOSYNTHETIC REACTION CENTER DOUBLE MUTANT FROM RHODOBACTER SPHAEROIDES WITH ASP L213 REPLACED WITH ASN AND ARG M233 REPLACED WITH CYS IN THE CHARGE-NEUTRAL DQAQB STATE (TETRAGONAL FORM) 1RZH ; 1.80 ; PHOTOSYNTHETIC REACTION CENTER DOUBLE MUTANT FROM RHODOBACTER SPHAEROIDES WITH ASP L213 REPLACED WITH ASN AND ARG M233 REPLACED WITH CYS IN THE CHARGE-NEUTRAL DQAQB STATE (TRIGONAL FORM) 1S00 ; 2.60 ; PHOTOSYNTHETIC REACTION CENTER DOUBLE MUTANT FROM RHODOBACTER SPHAEROIDES WITH ASP L213 REPLACED WITH ASN AND ARG M233 REPLACED WITH CYS IN THE CHARGE-SEPARATED D+QAQB- STATE 1M3X ; 2.55 ; PHOTOSYNTHETIC REACTION CENTER FROM RHODOBACTER SPHAEROIDES 1Z9J ; 4.50 ; PHOTOSYNTHETIC REACTION CENTER FROM RHODOBACTER SPHAEROIDES 1Z9K ; 4.60 ; PHOTOSYNTHETIC REACTION CENTER FROM RHODOBACTER SPHAEROIDES 1AIJ ; 2.20 ; PHOTOSYNTHETIC REACTION CENTER FROM RHODOBACTER SPHAEROIDES IN THE CHARGE-NEUTRAL DQAQB STATE 1DS8 ; 2.50 ; PHOTOSYNTHETIC REACTION CENTER FROM RHODOBACTER SPHAEROIDES IN THE CHARGE-NEUTRAL DQAQB STATE WITH THE PROTON TRANSFER INHIBITOR CD2+ 1DV6 ; 2.50 ; PHOTOSYNTHETIC REACTION CENTER FROM RHODOBACTER SPHAEROIDES IN THE CHARGE-NEUTRAL DQAQB STATE WITH THE PROTON TRANSFER INHIBITOR ZN2+ 1DV3 ; 2.50 ; PHOTOSYNTHETIC REACTION CENTER FROM RHODOBACTER SPHAEROIDES IN THE CHARGE-SEPARATED D+QAQB- STATE WITH THE PROTON TRANSFER INHIBITOR CD2+ 1AIG ; 2.60 ; PHOTOSYNTHETIC REACTION CENTER FROM RHODOBACTER SPHAEROIDES IN THE D+QB- CHARGE SEPARATED STATE 5PRC ; 2.35 ; PHOTOSYNTHETIC REACTION CENTER FROM RHODOPSEUDOMONAS VIRIDIS (ATRAZINE COMPLEX) 6PRC ; 2.30 ; PHOTOSYNTHETIC REACTION CENTER FROM RHODOPSEUDOMONAS VIRIDIS (DG-420314 (TRIAZINE) COMPLEX) 7PRC ; 2.65 ; PHOTOSYNTHETIC REACTION CENTER FROM RHODOPSEUDOMONAS VIRIDIS (DG-420315 (TRIAZINE) COMPLEX) 3PRC ; 2.40 ; PHOTOSYNTHETIC REACTION CENTER FROM RHODOPSEUDOMONAS VIRIDIS (QB-DEPLETED) 4PRC ; 2.40 ; PHOTOSYNTHETIC REACTION CENTER FROM RHODOPSEUDOMONAS VIRIDIS (STIGMATELLIN COMPLEX) 2PRC ; 2.45 ; PHOTOSYNTHETIC REACTION CENTER FROM RHODOPSEUDOMONAS VIRIDIS (UBIQUINONE-2 COMPLEX) 1DXR ; 2.00 ; PHOTOSYNTHETIC REACTION CENTER FROM RHODOPSEUDOMONAS VIRIDIS - HIS L168 PHE MUTANT (TERBUTRYN COMPLEX) 1RY5 ; 2.10 ; PHOTOSYNTHETIC REACTION CENTER MUTANT FROM RHODOBACTER SPHAEROIDES WITH ASP L213 REPLACED WITH ASN 1QOV ; 2.10 ; PHOTOSYNTHETIC REACTION CENTER MUTANT WITH ALA M260 REPLACED WITH TRP (CHAIN M, A260W) 1UMX ; 2.80 ; PHOTOSYNTHETIC REACTION CENTER MUTANT WITH ARG M267 REPLACED WITH LEU (CHAIN M, R267L) 1JH0 ; 3.50 ; PHOTOSYNTHETIC REACTION CENTER MUTANT WITH GLU L 205 REPLACED TO LEU 2BOZ ; 2.40 ; PHOTOSYNTHETIC REACTION CENTER MUTANT WITH GLY M203 REPLACED WITH LEU 1MPS ; 2.55 ; PHOTOSYNTHETIC REACTION CENTER MUTANT WITH PHE M 197 REPLACED WITH ARG AND TYR M 177 REPLACED WITH PHE (CHAIN M, Y177F, F197R) 1E14 ; 2.70 ; PHOTOSYNTHETIC REACTION CENTER MUTANT WITH PHE M197 REPLACED WITH ARG (CHAIN M, FM197R) AND GLY M203 REPLACED WITH ASP (CHAIN M, GM203D) 1JGX ; 3.01 ; PHOTOSYNTHETIC REACTION CENTER MUTANT WITH THR M 21 REPLACED WITH ASP 1JGW ; 2.80 ; PHOTOSYNTHETIC REACTION CENTER MUTANT WITH THR M 21 REPLACED WITH LEU 1E6D ; 2.30 ; PHOTOSYNTHETIC REACTION CENTER MUTANT WITH TRP M115 REPLACED WITH PHE (CHAIN M, WM115F) PHE M197 REPLACED WITH ARG (CHAIN M, FM197R) 1JGZ ; 2.70 ; PHOTOSYNTHETIC REACTION CENTER MUTANT WITH TYR M 76 REPLACED WITH LYS 1JGY ; 2.70 ; PHOTOSYNTHETIC REACTION CENTER MUTANT WITH TYR M 76 REPLACED WITH PHE 1FC6 ; 1.80 ; PHOTOSYSTEM II D1 C-TERMINAL PROCESSING PROTEASE 1FC7 ; 2.00 ; PHOTOSYSTEM II D1 C-TERMINAL PROCESSING PROTEASE 1FC9 ; 1.90 ; PHOTOSYSTEM II D1 C-TERMINAL PROCESSING PROTEASE 1FCF ; 2.10 ; PHOTOSYSTEM II D1 C-TERMINAL PROCESSING PROTEASE 1W5C ; 3.20 ; PHOTOSYSTEM II FROM THERMOSYNECHOCOCCUS ELONGATUS 1E57 ; 3.20 ; PHYSALIS MOTTLE VIRUS: EMPTY CAPSID 2BL0 ; 1.75 ; PHYSARUM POLYCEPHALUM MYOSIN II REGULATORY DOMAIN 1IVY ; 2.20 ; PHYSIOLOGICAL DIMER HPP PRECURSOR 1FAT ; 2.80 ; PHYTOHEMAGGLUTININ-L 1VDE ; 2.40 ; PI-SCEI, A HOMING ENDONUCLEASE WITH PROTEIN SPLICING ACTIVITY 1RXI ; 1.50 ; PI258 ARSENATE REDUCTASE (ARSC) TRIPLE MUTANT C10S/C15A/C82S 1EKO ; 2.20 ; PIG ALDOSE REDUCTASE COMPLEXED WITH IDD384 INHIBITOR 1AH0 ; 2.30 ; PIG ALDOSE REDUCTASE COMPLEXED WITH SORBINIL 1AH4 ; 2.00 ; PIG ALDOSE REDUCTASE, HOLO FORM 1PIF ; 2.30 ; PIG ALPHA-AMYLASE 3HDH ; 2.80 ; PIG HEART SHORT CHAIN L-3-HYDROXYACYL COA DEHYDROGENASE REVISITED: SEQUENCE ANALYSIS AND CRYSTAL STRUCTURE DETERMINATION 1HDI ; 1.80 ; PIG MUSCLE 3-PHOSPHOGLYCERATE KINASE COMPLEXED WITH 3-PG AND MGADP. 1PIG ; 2.20 ; PIG PANCREATIC ALPHA-AMYLASE COMPLEXED WITH THE OLIGOSACCHARIDE V-1532 1BVN ; 2.50 ; PIG PANCREATIC ALPHA-AMYLASE IN COMPLEX WITH THE PROTEINACEOUS INHIBITOR TENDAMISTAT 1UTE ; 1.55 ; PIG PURPLE ACID PHOSPHATASE COMPLEXED WITH PHOSPHATE 2PII ; 1.90 ; PII, GLNB PRODUCT 2PVB ; 0.91 ; PIKE PARVALBUMIN (PI 4.10) AT LOW TEMPERATURE (100K) AND ATOMIC RESOLUTION (0.91 A). 1PIN ; 1.35 ; PIN1 PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FROM HOMO SAPIENS 1QLL ; 2.04 ; PIRATOXIN-II (PRTX-II) - A K49 PLA2 FROM BOTHROPS PIRAJAI 1AU7 ; 2.30 ; PIT-1 POU DOMAIN COMPLEXED TO A 28 BASE PAIR DEOXYRIBONUCLEIC ACID ELEMENT 1Q62 ; 2.30 ; PKA DOUBLE MUTANT MODEL OF PKB 1Q24 ; 2.60 ; PKA DOUBLE MUTANT MODEL OF PKB IN COMPLEX WITH MGATP 1Q61 ; 2.10 ; PKA TRIPLE MUTANT MODEL OF PKB 1KPB ; 2.00 ; PKCI-1-APO 1KPC ; 2.20 ; PKCI-1-APO+ZINC 1KPA ; 2.00 ; PKCI-1-ZINC 1AV5 ; 2.00 ; PKCI-SUBSTRATE ANALOG 1KPF ; 1.50 ; PKCI-SUBSTRATE ANALOG 1KPE ; 1.80 ; PKCI-TRANSITION STATE ANALOG 1B4R ; -1.00 ; PKD DOMAIN 1 FROM HUMAN POLYCYSTEIN-1 2A19 ; 2.50 ; PKR KINASE DOMAIN- EIF2ALPHA- AMP-PNP COMPLEX. 2A1A ; 2.80 ; PKR KINASE DOMAIN-EIF2ALPHA COMPLEX 1LD4 ; 11.40 ; PLACEMENT OF THE STRUCTURAL PROTEINS IN SINDBIS VIRUS 1W1S ; 2.00 ; PLANT CYTOKININ DEHYDROGENASE IN COMPLEX WITH BENZYLAMINOPURINE 1W1Q ; 1.80 ; PLANT CYTOKININ DEHYDROGENASE IN COMPLEX WITH ISOPENTENYLADENINE 1W1R ; 1.90 ; PLANT CYTOKININ DEHYDROGENASE IN COMPLEX WITH TRANS-ZEATIN 1E05 ; 2.62 ; PLASMA ALPHA ANTITHROMBIN-III 1E03 ; 2.90 ; PLASMA ALPHA ANTITHROMBIN-III AND PENTASACCHARIDE 1E04 ; 2.60 ; PLASMA BETA ANTITHROMBIN-III 2BJU ; 1.56 ; PLASMEPSIN II COMPLEXED WITH A HIGHLY ACTIVE ACHIRAL INHIBITOR 1SME ; 2.70 ; PLASMEPSIN II, A HEMOGLOBIN-DEGRADING ENZYME FROM PLASMODIUM FALCIPARUM, IN COMPLEX WITH PEPSTATIN A 1GKI ; 3.00 ; PLASMID COUPLING PROTEIN TRWB IN COMPLEX WITH ADP AND MG2+. 1GL7 ; 3.00 ; PLASMID COUPLING PROTEIN TRWB IN COMPLEX WITH THE NON-HYDROLISABLE ATP-ANALOGUE ADPNP. 1GL6 ; 2.80 ; PLASMID COUPLING PROTEIN TRWB IN COMPLEX WITH THE NON-HYDROLYSABLE GTP ANALOGUE GDPNP 1BQY ; 2.50 ; PLASMINOGEN ACTIVATOR (TSV-PA) FROM SNAKE VENOM 1B3K ; 2.99 ; PLASMINOGEN ACTIVATOR INHIBITOR-1 1C5G ; 2.60 ; PLASMINOGEN ACTIVATOR INHIBITOR-1 1OC0 ; 2.28 ; PLASMINOGEN ACTIVATOR INHIBITOR-1 COMPLEX WITH SOMATOMEDIN B DOMAIN OF VITRONECTIN 1QNH ; 2.10 ; PLASMODIUM FALCIPARUM CYCLOPHILIN (DOUBLE MUTANT) COMPLEXED WITH CYCLOSPORIN A 1QNG ; 2.10 ; PLASMODIUM FALCIPARUM CYCLOPHILIN COMPLEXED WITH CYCLOSPORIN A 1TV5 ; 2.40 ; PLASMODIUM FALCIPARUM DIHYDROOROTATE DEHYDROGENASE WITH A BOUND INHIBITOR 1SQ6 ; 2.40 ; PLASMODIUM FALCIPARUM HOMOLOG OF URIDINE PHOSPHORYLASE/PURINE NUCLEOSIDE PHOSPHORYLASE 1LDG ; 1.74 ; PLASMODIUM FALCIPARUM L-LACTATE DEHYDROGENASE COMPLEXED WITH NADH AND OXAMATE 1U4O ; 1.70 ; PLASMODIUM FALCIPARUM LACTATE DEHYDROGENASE COMPLEXED WITH 2,6-NAPHTHALENEDICARBOXYLIC ACID 1U4S ; 2.00 ; PLASMODIUM FALCIPARUM LACTATE DEHYDROGENASE COMPLEXED WITH 2,6-NAPHTHALENEDISULPHONIC ACID 1XIV ; 1.70 ; PLASMODIUM FALCIPARUM LACTATE DEHYDROGENASE COMPLEXED WITH 2-({4-CHLORO-[HYDROXY(METHOXY)METHYL]CYCLOHEXYL}AMINO) ETHANE-1,1,2-TRIOL 1U5A ; 1.80 ; PLASMODIUM FALCIPARUM LACTATE DEHYDROGENASE COMPLEXED WITH 3,5-DIHYDROXY-2-NAPHTHOIC ACID 1U5C ; 2.65 ; PLASMODIUM FALCIPARUM LACTATE DEHYDROGENASE COMPLEXED WITH 3,7-DIHYDROXYNAPHTHALENE-2-CARBOXYLIC ACID AND NAD+ 1T24 ; 1.70 ; PLASMODIUM FALCIPARUM LACTATE DEHYDROGENASE COMPLEXED WITH NAD+ AND 4-HYDROXY-1,2,5-OXADIAZOLE-3-CARBOXYLIC ACID 1T2D ; 1.10 ; PLASMODIUM FALCIPARUM LACTATE DEHYDROGENASE COMPLEXED WITH NAD+ AND OXALATE 1T2C ; 2.01 ; PLASMODIUM FALCIPARUM LACTATE DEHYDROGENASE COMPLEXED WITH NADH 1T25 ; 1.90 ; PLASMODIUM FALCIPARUM LACTATE DEHYDROGENASE COMPLEXED WITH NADH AND 3-HYDROXYISOXAZOLE-4-CARBOXYLIC ACID 1T26 ; 1.80 ; PLASMODIUM FALCIPARUM LACTATE DEHYDROGENASE COMPLEXED WITH NADH AND 4-HYDROXY-1,2,5-THIADIAZOLE-3-CARBOXYLIC ACID 1T2E ; 1.85 ; PLASMODIUM FALCIPARUM LACTATE DEHYDROGENASE S245A, A327P MUTANT COMPLEXED WITH NADH AND OXAMATE 1XIQ ; 3.05 ; PLASMODIUM FALCIPARUM NUCLEOSIDE DIPHOSPHATE KINASE B 1RL4 ; 2.18 ; PLASMODIUM FALCIPARUM PEPTIDE DEFORMYLASE COMPLEX WITH INHIBITOR 1O5X ; 1.10 ; PLASMODIUM FALCIPARUM TIM COMPLEXED TO 2-PHOSPHOGLYCERATE 1M7O ; 2.40 ; PLASMODIUM FALCIPARUM TRIOSEPHOSPHATE ISOMERASE (PFTIM) COMPLED TO SUBSTRATE ANALOG 3-PHOSPHOGLYCERATE (3PG) 1M7P ; 2.40 ; PLASMODIUM FALCIPARUM TRIOSEPHOSPHATE ISOMERASE (PFTIM) COMPLED TO SUBSTRATE ANALOG GLYCEROL-3-PHOSPHATE (G3P). 1LYX ; 1.90 ; PLASMODIUM FALCIPARUM TRIOSEPHOSPHATE ISOMERASE (PFTIM)- PHOSPHOGLYCOLATE COMPLEX 1LZO ; 2.80 ; PLASMODIUM FALCIPARUM TRIOSEPHOSPHATE ISOMERASE- PHOSPHOGLYCOLATE COMPLEX 2B71 ; 2.50 ; PLASMODIUM YOELII CYCLOPHILIN-LIKE PROTEIN 1QRB ; 2.00 ; PLASTICITY AND STERIC STRAIN IN A PARALLEL BETA-HELIX: RATIONAL MUTATIONS IN P22 TAILSPIKE PROTEIN 1IUZ ; 1.60 ; PLASTOCYANIN 1NIN ; -1.00 ; PLASTOCYANIN FROM ANABAENA VARIABILIS, NMR, 20 STRUCTURES 1BAW ; 2.80 ; PLASTOCYANIN FROM PHORMIDIUM LAMINOSUM 1AG6 ; 1.70 ; PLASTOCYANIN FROM SPINACH 1M8O ; -1.00 ; PLATELET INTEGRIN ALFAIIB-BETA3 CYTOPLASMIC DOMAIN 1WAB ; 1.70 ; PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE 1MPH ; -1.00 ; PLECKSTRIN HOMOLOGY DOMAIN FROM MOUSE BETA-SPECTRIN, NMR, 50 STRUCTURES 1PMS ; -1.00 ; PLECKSTRIN HOMOLOGY DOMAIN OF SON OF SEVENLESS 1 (SOS1) WITH GLYCINE-SERINE ADDED TO THE N-TERMINUS, NMR, 20 STRUCTURES 1ZFU ; -1.00 ; PLECTASIN:A PEPTIDE ANTIBIOTIC WITH THERAPEUTIC POTENTIAL FROM A SAPROPHYTIC FUNGUS 2BNI ; 1.50 ; PLI MUTANT E20C L16G Y17H, ANTIPARALLEL 1BS0 ; 1.65 ; PLP-DEPENDENT ACYL-COA SYNTHASE 1AUR ; 2.50 ; PMSF-INHIBITED CARBOXYLESTERASE FROM PSEUDOMONAS FLUORESCENS 1QE3 ; 1.50 ; PNB ESTERASE 1C7J ; 1.60 ; PNB ESTERASE 56C8 1PSZ ; 2.00 ; PNEUMOCOCCAL SURFACE ANTIGEN PSAA 1PNF ; 2.00 ; PNGASE F COMPLEX WITH DI-N-ACETYLCHITOBIOSE 1CI0 ; 2.70 ; PNP OXIDASE FROM SACCHAROMYCES CEREVISIAE 1BQV ; -1.00 ; POINTED DOMAIN AND MAP KINASE PHOSPHORYLATION SITE FROM MURINE ETS-1 TRANSCRIPTION FACTOR, NMR, 28 STRUCTURES 1GIK ; 1.80 ; POKEWEED ANTIVIRAL PROTEIN FROM SEEDS 1J1S ; 2.00 ; POKEWEED ANTIVIRAL PROTEIN FROM SEEDS (PAP-S1) COMPLEXED WITH FORMYCIN 1VBD ; 2.90 ; POLIOVIRUS (TYPE 1, MAHONEY STRAIN) COMPLEXED WITH R78206 1PO2 ; 2.90 ; POLIOVIRUS (TYPE 1, MAHONEY) IN COMPLEX WITH R77975, AN INHIBITOR OF VIRAL REPLICATION 1PO1 ; 2.90 ; POLIOVIRUS (TYPE 1, MAHONEY) IN COMPLEX WITH R80633, AN INHIBITOR OF VIRAL REPLICATION 1VBC ; 2.80 ; POLIOVIRUS (TYPE 3, SABIN STRAIN) (P3/SABIN, P3/LEON/12A(1)B) COMPLEXED WITH R77975 1VBA ; 2.90 ; POLIOVIRUS (TYPE 3, SABIN STRAIN) (P3/SABIN, P3/LEON/12A(1)B) COMPLEXED WITH R78206 1VBB ; 2.80 ; POLIOVIRUS (TYPE 3, SABIN STRAIN) (P3/SABIN, P3/LEON/12A(1)B) COMPLEXED WITH R80633 1VBE ; 2.80 ; POLIOVIRUS (TYPE 3, SABIN STRAIN, MUTANT 242-H2) COMPLEXED WITH R78206 1XYR ; 11.00 ; POLIOVIRUS 135S CELL ENTRY INTERMEDIATE 1L1N ; 2.10 ; POLIOVIRUS 3C PROTEINASE 1RDR ; 2.40 ; POLIOVIRUS 3D POLYMERASE 1RA6 ; 2.00 ; POLIOVIRUS POLYMERASE FULL LENGTH APO STRUCTURE 1TQL ; 2.30 ; POLIOVIRUS POLYMERASE G1A MUTANT 1RAJ ; 2.50 ; POLIOVIRUS POLYMERASE WITH A 68 RESIDUE N-TERMINAL TRUNCATION 1RA7 ; 2.35 ; POLIOVIRUS POLYMERASE WITH GTP 1PDQ ; 1.76 ; POLYCOMB CHROMODOMAIN COMPLEXED WITH THE HISTONE H3 TAIL CONTAINING TRIMETHYLLYSINE 27. 1IA5 ; 2.00 ; POLYGALACTURONASE FROM ASPERGILLUS ACULEATUS 1BHE ; 1.90 ; POLYGALACTURONASE FROM ERWINIA CAROTOVORA SSP. CAROTOVORA 1KW4 ; 1.75 ; POLYHOMEOTIC SAM DOMAIN STRUCTURE 1LCU ; 3.50 ; POLYLYSINE INDUCES AN ANTIPARALLEL ACTIN DIMER THAT NUCLEATES FILAMENT ASSEMBLY: CRYSTAL STRUCTURE AT 3.5 A RESOLUTION 239D ; 2.05 ; POLYMORPHISM IN LEFT HANDED DEOXYRIBONUCLEIC ACID: THE CRYSTAL STRUCTURE OF D(CCCGGG)2 1VPS ; 1.90 ; POLYOMAVIRUS VP1 PENTAMER COMPLEXED WITH A DISIALYLATED HEXASACCHARIDE 1GQE ; 1.81 ; POLYPEPTIDE CHAIN RELEASE FACTOR 2 (RF2) FROM ESCHERICHIA COLI 1RKK ; -1.00 ; POLYPHEMUSIN I NMR SOLUTION STRUCTURE 1QR1 ; 2.40 ; POOR BINDING OF A HER-2/NEU EPITOPE (GP2) TO HLA-A2.1 IS DUE TO A LACK OF INTERACTIONS IN THE CENTER OF THE PEPTIDE 1SDB ; 1.65 ; PORCINE DESB1-2 DESPENTAPEPTIDE(B26-B30) INSULIN 1LVY ; 1.87 ; PORCINE ELASTASE 1C1M ; 2.20 ; PORCINE ELASTASE UNDER XENON PRESSURE (8 BAR) 1PFX ; 3.00 ; PORCINE FACTOR IXA 1X7A ; 2.90 ; PORCINE FACTOR IXA COMPLEXED TO 1-{3-[AMINO(IMINO) METHYL]PHENYL}-N-[4-(1H-BENZIMIDAZOL-1-YL)-2-FLUOROPHENYL]- 3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-5-CARBOXAMIDE 1VE9 ; 2.50 ; PORCINE KIDNEY D-AMINO ACID OXIDASE 1LEV ; 2.15 ; PORCINE KIDNEY FRUCTOSE-1,6-BISPHOSPHATASE COMPLEXED WITH AN AMP-SITE INHIBITOR 1F8P ; -1.00 ; PORCINE NEUROPEPTIDE Y BOUND TO DPC MICELLES 1E00 ; 1.83 ; PORCINE ODORANT BINDING PROTEIN COMPLEXED WITH 2,6-DIMETHYL-7-OCTEN-2-OL 1DZJ ; 2.00 ; PORCINE ODORANT BINDING PROTEIN COMPLEXED WITH 2-AMINO-4-BUTYL-5-PROPYLSELENAZOLE 1E06 ; 2.12 ; PORCINE ODORANT BINDING PROTEIN COMPLEXED WITH 5-METHYL-2-(1-METHYLETHYL)PHENOL 1DZM ; 1.93 ; PORCINE ODORANT BINDING PROTEIN COMPLEXED WITH BENZOIC ACID PHENYLMETHYLESTER 1DZP ; 1.83 ; PORCINE ODORANT BINDING PROTEIN COMPLEXED WITH DIPHENYLMETHANONE 1DZK ; 1.48 ; PORCINE ODORANT BINDING PROTEIN COMPLEXED WITH PYRAZINE (2-ISOBUTYL-3-METOXYPYRAZINE) 1E02 ; 2.15 ; PORCINE ODORANT BINDING PROTEIN COMPLEXED WITH UNDECANAL 1SFW ; -1.00 ; PORCINE PANCREAS PHOSPHOLIPASE A2, NMR, 18 STRUCTURES 1SFV ; -1.00 ; PORCINE PANCREAS PHOSPHOLIPASE A2, NMR, MINIMIZED AVERAGE STRUCTURE 1OSE ; 2.30 ; PORCINE PANCREATIC ALPHA-AMYLASE COMPLEXED WITH ACARBOSE 1GVK ; 0.94 ; PORCINE PANCREATIC ELASTASE ACYL ENZYME AT 0.95 A RESOLUTION 1QGF ; 1.70 ; PORCINE PANCREATIC ELASTASE COMPLEXED WITH (3R, 4S)N-PARA- TOLUENESULPHONYL-3-ETHYL-4-(CARBOXYLIC ACID)PYRROLIDIN-2-ONE 1BTU ; 1.60 ; PORCINE PANCREATIC ELASTASE COMPLEXED WITH (3S, 4R)-1-TOLUENESULPHONYL-3-ETHYL-AZETIDIN-2-ONE-4-CARBOXYLIC ACID 1E34 ; 1.80 ; PORCINE PANCREATIC ELASTASE COMPLEXED WITH (3S, 4S)N-PARA- TOLUENESULPHONYL-3-ETHYL-4-(CARBOXYLIC ACID) PYRROLIDIN-2-ONE SOAKED IN PH 9 BUFFER FOR ONE MINUTE 1E36 ; 1.70 ; PORCINE PANCREATIC ELASTASE COMPLEXED WITH (3S, 4S)N-PARA-NITROBENZENESULPHONYL -3-ETHYL-4-(CARBOXYLIC ACID)PYRROLIDIN-2-ONE 1E37 ; 1.75 ; PORCINE PANCREATIC ELASTASE COMPLEXED WITH (3S, 4S)N-PARA-NITROBENZENESULPHONYL -3-ETHYL-4-(CARBOXYLIC ACID)PYRROLIDIN-2-ONE SOAKED IN PH 9 BUFFER FOR 1 MINUTE 1E38 ; 1.70 ; PORCINE PANCREATIC ELASTASE COMPLEXED WITH (3S, 4S)N-PARA-NITROBENZENESULPHONYL -3-ETHYL-4-(CARBOXYLIC ACID)PYRROLIDIN-2-ONE SOAKED IN PH 9 BUFFER FOR 2 MINUTES 1E35 ; 1.90 ; PORCINE PANCREATIC ELASTASE COMPLEXED WITH (3S, 4S)N-PARA-TOLUENESULPHONYL -3-ETHYL-4-(CARBOXYLIC ACID)PYRROLIDIN-2-ONE SOAKED IN PH 9 BUFFER FOR TWO MINUTES 1MMJ ; 2.20 ; PORCINE PANCREATIC ELASTASE COMPLEXED WITH A POTENT PEPTIDYL INHIBITOR, FR136706 1H9L ; 1.67 ; PORCINE PANCREATIC ELASTASE COMPLEXED WITH ACETYL-VAL-GLU-PRO-ILE-COOH 1HV7 ; 1.70 ; PORCINE PANCREATIC ELASTASE COMPLEXED WITH GW311616A 1QIX ; 1.90 ; PORCINE PANCREATIC ELASTASE COMPLEXED WITH HUMAN BETA-CASOMORPHIN-7 1LKA ; 1.70 ; PORCINE PANCREATIC ELASTASE/CA-COMPLEX 1LKB ; 1.70 ; PORCINE PANCREATIC ELASTASE/NA-COMPLEX 1UO6 ; 1.65 ; PORCINE PANCREATIC ELASTASE/XE-COMPLEX 2PSP ; 1.95 ; PORCINE PANCREATIC SPASMOLYTIC POLYPEPTIDE 1K3V ; 3.50 ; PORCINE PARVOVIRUS CAPSID 2BNH ; 2.30 ; PORCINE RIBONUCLEASE INHIBITOR 1S83 ; 1.25 ; PORCINE TRYPSIN COMPLEXED WITH 4-AMINO PROPANOL 1S82 ; 1.85 ; PORCINE TRYPSIN COMPLEXED WITH BORATE AND ETHYLENE GLYCOL 1S5S ; 1.40 ; PORCINE TRYPSIN COMPLEXED WITH GUANIDINE-3-PROPANOL INHIBITOR 1S6H ; 1.45 ; PORCINE TRYPSIN COMPLEXED WITH GUANIDINE-3-PROPANOL INHIBITOR 1S85 ; 2.20 ; PORCINE TRYPSIN COMPLEXED WITH P-HYDROXYMETHYL BENZAMIDINE AND BORATE 1S84 ; 1.85 ; PORCINE TRYPSIN COVALENT COMPLEX WITH 4-AMINO BUTANOL, BORATE AND ETHYLENE GLYCOL 1S6F ; 1.80 ; PORCINE TRYPSIN COVALENT COMPLEX WITH BORATE AND GUANIDINE- 3 INHIBITOR 1S81 ; 1.70 ; PORCINE TRYPSIN WITH NO INHIBITOR BOUND 1WYY ; 2.20 ; POST-FUSION HAIRPIN CONFORMATION OF THE SARS CORONAVIRUS SPIKE GLYCOPROTEIN 1BL8 ; 3.20 ; POTASSIUM CHANNEL (KCSA) FROM STREPTOMYCES LIVIDANS 1F6G ; -1.00 ; POTASSIUM CHANNEL (KCSA) FULL-LENGTH FOLD 1JQ1 ; -1.00 ; POTASSIUM CHANNEL (KCSA) OPEN GATE MODEL 1JQ2 ; -1.00 ; POTASSIUM CHANNEL (KCSA) OPEN GATE MODEL 1AV3 ; -1.00 ; POTASSIUM CHANNEL BLOCKER KAPPA CONOTOXIN PVIIA FROM C. PURPURASCENS, NMR, 20 STRUCTURES 1R3L ; 2.41 ; POTASSIUM CHANNEL KCSA-FAB COMPLEX IN CS+ 1K4C ; 2.00 ; POTASSIUM CHANNEL KCSA-FAB COMPLEX IN HIGH CONCENTRATION OF K+ 1R3J ; 1.90 ; POTASSIUM CHANNEL KCSA-FAB COMPLEX IN HIGH CONCENTRATION OF TL+ 1K4D ; 2.30 ; POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LOW CONCENTRATION OF K+ 1R3K ; 2.80 ; POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LOW CONCENTRATION OF TL+ 1R3I ; 2.40 ; POTASSIUM CHANNEL KCSA-FAB COMPLEX IN RB+ 2BOB ; 2.76 ; POTASSIUM CHANNEL KCSA-FAB COMPLEX IN THALLIUM WITH TETRABUTYLAMMONIUM (TBA) 2BOC ; 3.01 ; POTASSIUM CHANNEL KCSA-FAB COMPLEX IN THALLIUM WITH TETRAETHYLARSONIUM (TEAS) 1S5H ; 2.20 ; POTASSIUM CHANNEL KCSA-FAB COMPLEX T75C MUTANT IN K+ 1K4X ; -1.00 ; POTASSIUM FORM OF OXY-1.5 QUADRUPLEX DEOXYRIBONUCLEIC ACID 1V2N ; 1.80 ; POTENT FACTOR XA INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN VARIANT X(99/175/190)BT 1JLD ; 2.50 ; POTENT HIV PROTEASE INHIBITORS CONTAINING A NOVEL (HYDROXYETHYL)AMIDE ISOSTERE 1NZ7 ; 2.40 ; POTENT, SELECTIVE INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE 1B USING A SECOND PHOSPHOTYROSINE BINDING SITE, COMPLEXED WITH COMPOUND 19. 1NL9 ; 2.40 ; POTENT, SELECTIVE PROTEIN TYROSINE PHOSPHATASE 1B INHIBITOR COMPOUND 12 USING A LINKED-FRAGMENT STRATEGY 1NNY ; 2.40 ; POTENT, SELECTIVE PROTEIN TYROSINE PHOSPHATASE 1B INHIBITOR COMPOUND 23 USING A LINKED-FRAGMENT STRATEGY 1NO6 ; 2.40 ; POTENT, SELECTIVE PROTEIN TYROSINE PHOSPHATASE 1B INHIBITOR COMPOUND 5 USING A LINKED-FRAGMENT STRATEGY 1NC6 ; 1.90 ; POTENT, SMALL MOLECULE INHIBITORS OF HUMAN MAST CELL TRYPTASE. ANTI-ASTHMATIC ACTION OF A DIPEPTIDE-BASED TRANSITION STATE ANALOGUE CONTAINING BENZOTHIAZOLE KETONE 1WAO ; 2.90 ; PP5 STRUCTURE 1WM0 ; 2.90 ; PPARGAMMA IN COMPLEX WITH A 2-BABA COMPOUND 1MVL ; 2.00 ; PPC DECARBOXYLASE MUTANT C175S 1MVN ; 2.21 ; PPC DECARBOXYLASE MUTANT C175S COMPLEXED WITH PANTOTHENOYLAMINOETHENETHIOL 1HXV ; -1.00 ; PPIASE DOMAIN OF THE MYCOPLASMA GENITALIUM TRIGGER FACTOR 1RKY ; 1.68 ; PPLO + XE 1HKQ ; 2.75 ; PPS10 PLASMID DEOXYRIBONUCLEIC ACID REPLICATION INITIATOR PROTEIN REPA. REPLICATION INACTIVE, DIMERIC N-TERMINAL DOMAIN. 1OTV ; 2.10 ; PQQC, PYRROLOQUINOLINQUINONE SYNTHASE C 1FUJ ; 2.20 ; PR3 (MYELOBLASTIN) 1H99 ; 1.55 ; PRD OF LICT ANTITERMINATOR FROM BACILLUS SUBTILIS 1PDN ; 2.50 ; PRD PAIRED DOMAIN BOUND TO DEOXYRIBONUCLEIC ACID 1YQ5 ; 2.00 ; PRD1 VERTEX PROTEIN P5 1YQ6 ; 2.40 ; PRD1 VERTEX PROTEIN P5 1YQ8 ; 2.60 ; PRD1 VERTEX PROTEIN P5 1CKQ ; 1.85 ; PRE-TRANSITION STATE ECO RI ENDONUCLEASE/COGNATE DEOXYRIBONUCLEIC ACID (TCGCGAATTCGCG) COMPLEX 1OU0 ; 2.10 ; PRECORRIN-8X METHYLMUTASE RELATED PROTEIN 9GAA ; 2.10 ; PRECURSOR OF THE T152A MUTANT GLYCOSYLASPARAGINASE FROM FLAVOBACTERIUM MENINGOSEPTICUM 9GAC ; 1.90 ; PRECURSOR OF THE T152C MUTANT GLYCOSYLASPARAGINASE FROM FLAVOBACTERIUM MENINGOSEPTICUM 9GAF ; 1.90 ; PRECURSOR OF THE W11F MUTANT GLYCOSYLASPARAGINASE FROM FLAVOBACTERIUM MENINGOSEPTICUM 1KEH ; 2.50 ; PRECURSOR STRUCTURE OF CEPHALOSPORIN ACYLASE 1YOZ ; 2.00 ; PREDICTED CODING REGION AF0941 FROM ARCHAEOGLOBUS FULGIDUS 1YOY ; 2.00 ; PREDICTED CODING REGION AF1432 FROM ARCHAEOGLOBUS FULGIDUS 2B6C ; 2.10 ; PREDICTED DEOXYRIBONUCLEIC ACID ALKYLATION REPAIR ENZYME FROM ENTEROCOCCUS FAECALIS. 1IYW ; 4.00 ; PRELIMINARY STRUCTURE OF THERMUS THERMOPHILUS LIGAND-FREE VALYL-TRNA SYNTHETASE 2BEO ; 2.70 ; PRFA, TRANSCRIPTIONAL REGULATOR IN LISTERIA MONOCYTOGENES 2BGC ; 2.30 ; PRFA-G145S, A CONSTITUTIVE ACTIVE MUTANT OF THE TRANSCRIPTIONAL REGULATOR IN L.MONOCYTOGENES 1A56 ; -1.00 ; PRIMARY SEQUENCE AND SOLUTION CONFORMATION OF FERRICYTOCHROME C-552 FROM NITROSOMONAS EUROPAEA, NMR, MEAN STRUCTURE REFINED WITH EXPLICIT HYDROGEN BOND CONSTRAINTS 1A8C ; -1.00 ; PRIMARY SEQUENCE AND SOLUTION CONFORMATION OF FERROCYTOCHROME C-552 FROM NITROSOMONAS EUROPAEA, NMR, MEAN STRUCTURE REFINED WITHOUT HYDROGEN BOND CONSTRAINTS 1AG2 ; -1.00 ; PRION PROTEIN DOMAIN PRP(121-231) FROM MOUSE, NMR, 2 MINIMIZED AVERAGE STRUCTURE 1B82 ; 1.80 ; PRISTINE RECOMB. LIGNIN PEROXIDASE H8 1X24 ; 3.20 ; PRL-1 (PTP4A) 1ZCL ; 2.90 ; PRL-1 C104S MUTANT IN COMPLEX WITH SULFATE 2SGP ; 1.80 ; PRO 18 VARIANT OF TURKEY OVOMUCOID INHIBITOR THIRD DOMAIN COMPLEXED WITH STREPTOMYCES GRISEUS PROTEINASE B AT PH 6.5 1BOQ ; 2.10 ; PRO REGION C-TERMINUS: PROTEASE ACTIVE SITE INTERACTIONS ARE CRITICAL IN CATALYZING THE FOLDING OF ALPHA-LYTIC PROTEASE 2PRO ; 3.00 ; PRO REGION OF ALPHA-LYTIC PROTEASE 1PRE ; 2.80 ; PROAEROLYSIN 1MFU ; 2.00 ; PROBING THE ROLE OF A MOBILE LOOP IN HUMAN SALIVARY AMYLASE: STRUCTURAL STUDIES ON THE LOOP-DELETED MUTANT 1MFV ; 2.00 ; PROBING THE ROLE OF A MOBILE LOOP IN HUMAN SLAIVARY AMYLASE: STRUCTURAL STUDIES ON THE LOOP-DELETED ENZYME 1RM9 ; 2.90 ; PROBING THE ROLE OF TRYPTOPHANS IN AEQUOREA VICTORIA GREEN FLUORESCENT PROTEINS WITH AN EXPANDED GENETIC CODE 1RMM ; 1.90 ; PROBING THE ROLE OF TRYPTOPHANS IN AEQUOREA VICTORIA GREEN FLUORESCENT PROTEINS WITH AN EXPANDED GENETIC CODE 1RMO ; 1.80 ; PROBING THE ROLE OF TRYPTOPHANS IN AEQUOREA VICTORIA GREEN FLUORESCENT PROTEINS WITH AN EXPANDED GENETIC CODE 1RMP ; 3.00 ; PROBING THE ROLE OF TRYPTOPHANS IN AEQUOREA VICTORIA GREEN FLUORESCENT PROTEINS WITH AN EXPANDED GENETIC CODE 1A2F ; 2.10 ; PROBING THE STRENGTH AND CHARACTER OF AN ASP-HIS-X HYDROGEN BOND BY INTRODUCING BURIED CHARGES 1A2G ; 2.10 ; PROBING THE STRENGTH AND CHARACTER OF AN ASP-HIS-X HYDROGEN BOND BY INTRODUCING BURIED CHARGES 1CCL ; 2.00 ; PROBING THE STRENGTH AND CHARACTER OF AN ASP-HIS-X HYDROGEN BOND BY INTRODUCING BURIED CHARGES 1BWP ; 2.10 ; PROBING THE SUBSTRATE SPECIFICITY OF THE INTRACELLULAR BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE 1BWQ ; 2.30 ; PROBING THE SUBSTRATE SPECIFICITY OF THE INTRACELLULAR BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE 1BWR ; 2.40 ; PROBING THE SUBSTRATE SPECIFICITY OF THE INTRACELLULAR BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE 1AL0 ; 3.50 ; PROCAPSID OF BACTERIOPHAGE PHIX174 1CD3 ; 3.50 ; PROCAPSID OF BACTERIOPHAGE PHIX174 1PCI ; 3.20 ; PROCARICAIN 1PYU ; 1.90 ; PROCESSED ASPARTATE DECARBOXYLASE MUTANT WITH SER25 MUTATED TO CYS 1FCE ; 2.00 ; PROCESSIVE ENDOCELLULASE CELF OF CLOSTRIDIUM CELLULOLYTICUM 1GQ6 ; 1.75 ; PROCLAVAMINATE AMIDINO HYDROLASE FROM STREPTOMYCES CLAVULIGERUS 1GQ7 ; 2.45 ; PROCLAVAMINATE AMIDINO HYDROLASE FROM STREPTOMYCES CLAVULIGERUS 1R0C ; 2.37 ; PRODUCTS IN THE T STATE OF ASPARTATE TRANSCARBAMYLASE: CRYSTAL STRUCTURE OF THE PHOSPHATE AND N-CARBAMYL-L- ASPARTATE LIGATED ENZYME 1FDP ; 2.10 ; PROENZYME OF HUMAN COMPLEMENT FACTOR D, RECOMBINANT PROFACTOR D 1CJF ; 2.30 ; PROFILIN BINDS PROLINE-RICH LIGANDS IN TWO DISTINCT AMIDE BACKBONE ORIENTATIONS 1A0K ; 2.20 ; PROFILIN I FROM ARABIDOPSIS THALIANA 3NUL ; 1.60 ; PROFILIN I FROM ARABIDOPSIS THALIANA 1SR7 ; 1.46 ; PROGESTERONE RECEPTOR HORMONE BINDING DOMAIN WITH BOUND MOMETASONE FUROATE 1ZUC ; 2.00 ; PROGESTERONE RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH THE NONSTEROIDAL AGONIST TANAPROGET 1SQN ; 1.45 ; PROGESTERONE RECEPTOR LIGAND BINDING DOMAIN WITH BOUND NORETHINDRONE 1PV9 ; 2.00 ; PROLIDASE FROM PYROCOCCUS FURIOSUS 1GE8 ; 2.10 ; PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) HOMOLOG FROM PYROCOCCUS FURIOSUS 1E5S ; 2.40 ; PROLINE 3-HYDROXYLASE (TYPE II) - IRON FORM 1E5R ; 2.30 ; PROLINE 3-HYDROXYLASE (TYPE II) -APO FORM 1AZW ; 2.70 ; PROLINE IMINOPEPTIDASE FROM XANTHOMONAS CAMPESTRIS PV. CITRI 1H2W ; 1.39 ; PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN 1O6F ; 1.60 ; PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN, D641A MUTANT WITH BOUND PEPTIDE LIGAND SUC-GLY-PRO 1O6G ; 1.40 ; PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN, D641N MUTANT WITH BOUND PEPTIDE LIGAND SUC-GLY-PRO 1E5T ; 1.70 ; PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN, MUTANT 1E8M ; 1.50 ; PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN, MUTANT, COMPLEXED WITH INHIBITOR 1E8N ; 1.50 ; PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN, MUTANT, COMPLEXED WITH PEPTIDE 1UOQ ; 2.10 ; PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN, S554A MUTANT WITH BOUND PEPTIDE LIGAND GLU-PHE-SER-PRO 1UOO ; 2.35 ; PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN, S554A MUTANT WITH BOUND PEPTIDE LIGAND GLY-PHE-ARG-PRO 1UOP ; 1.85 ; PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN, S554A MUTANT WITH BOUND PEPTIDE LIGAND GLY-PHE-GLU-PRO 1H2Z ; 1.65 ; PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN, S554A MUTANT WITH BOUND PEPTIDE LIGAND SUC-GLY-PRO 1VZ3 ; 1.60 ; PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN, T597C MUTANT 1H2X ; 1.49 ; PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN, Y473F MUTANT 1H2Y ; 1.78 ; PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN, Y473F MUTANT WITH COVALENTLY BOUND INHIBITOR Z-PRO-PROLINAL 1VZ2 ; 2.20 ; PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN, Y73C/V427C/C255T MUTANT 1QFM ; 1.40 ; PROLYL OLIGOPEPTIDASE FROM PORCINE MUSCLE 1QFS ; 2.00 ; PROLYL OLIGOPEPTIDASE FROM PORCINE MUSCLE WITH COVALENTLY BOUND INHIBITOR Z-PRO-PROLINAL 1HC7 ; 2.43 ; PROLYL-TRNA SYNTHETASE FROM THERMUS THERMOPHILUS 1H4T ; 2.90 ; PROLYL-TRNA SYNTHETASE FROM THERMUS THERMOPHILUS COMPLEXED WITH L-PROLINE 1H4S ; 2.85 ; PROLYL-TRNA SYNTHETASE FROM THERMUS THERMOPHILUS COMPLEXED WITH TRNAPRO(CGG) AND A PROLYL-ADENYLATE ANALOGUE 1H4Q ; 3.00 ; PROLYL-TRNA SYNTHETASE FROM THERMUS THERMOPHILUS COMPLEXED WITH TRNAPRO(CGG), ATP AND PROLINOL 1GXD ; 3.10 ; PROMMP-2/TIMP-2 COMPLEX 1JMW ; 1.90 ; PROPAGATING CONFORMATIONAL CHANGES OVER LONG (AND SHORT) DISTANCES 1DC9 ; 2.10 ; PROPERTIES AND CRYSTAL STRUCTURE OF A BETA-BARREL FOLDING MUTANT, V60N INTESTINAL FATTY ACID BINDING PROTEIN (IFABP) 1HN4 ; 1.50 ; PROPHOSPHOLIPASE A2 DIMER COMPLEXED WITH MJ33, SULFATE, AND CALCIUM 1RQB ; 1.90 ; PROPIONIBACTERIUM SHERMANII TRANSCARBOXYLASE 5S SUBUNIT 1S3H ; 2.50 ; PROPIONIBACTERIUM SHERMANII TRANSCARBOXYLASE 5S SUBUNIT A59T 1RR2 ; 2.00 ; PROPIONIBACTERIUM SHERMANII TRANSCARBOXYLASE 5S SUBUNIT BOUND TO 2-KETOBUTYRIC ACID 1RQE ; 2.50 ; PROPIONIBACTERIUM SHERMANII TRANSCARBOXYLASE 5S SUBUNIT BOUND TO OXALOACETATE 1RQH ; 2.00 ; PROPIONIBACTERIUM SHERMANII TRANSCARBOXYLASE 5S SUBUNIT BOUND TO PYRUVIC ACID 1U5J ; 2.80 ; PROPIONIBACTERIUM SHERMANII TRANSCARBOXYLASE 5S SUBUNIT, MET186ILE 1PFZ ; 1.85 ; PROPLASMEPSIN II FROM PLASMODIUM FALCIPARUM 1IWD ; 1.63 ; PROPOSED AMINO ACID SEQUENCE AND THE 1.63 ANGSTROM X-RAY CRYSTAL STRUCTURE OF A PLANT CYSTEINE PROTEASE ERVATAMIN B: INSIGHT INTO THE STRUCTURAL BASIS OF ITS STABILITY AND SUBSTRATE SPECIFICITY. 1RY8 ; 1.69 ; PROSTAGLANDIN F SYNTHASE COMPLEXED WITH NADPH AND RUTIN 1CQE ; 3.10 ; PROSTAGLANDIN H2 SYNTHASE-1 COMPLEX WITH FLURBIPROFEN 1PGF ; 4.50 ; PROSTAGLANDIN H2 SYNTHASE-1 COMPLEXED WITH 1-(4-IODOBENZOYL)-5-METHOXY-2-METHYLINDOLE-3-ACETIC ACID (IODOINDOMETHACIN), CIS MODEL 1PGG ; 4.50 ; PROSTAGLANDIN H2 SYNTHASE-1 COMPLEXED WITH 1-(4-IODOBENZOYL)-5-METHOXY-2-METHYLINDOLE-3-ACETIC ACID (IODOINDOMETHACIN), TRANS MODEL 1PGE ; 3.50 ; PROSTAGLANDIN H2 SYNTHASE-1 COMPLEXED WITH P-(2'-IODO-5'-THENOYL)HYDROTROPIC ACID (IODOSUPROFEN) 1GVZ ; 1.42 ; PROSTATE SPECIFIC ANTIGEN (PSA) FROM STALLION SEMINAL PLASMA 1YBW ; 2.70 ; PROTEASE DOMAIN OF HGFA WITH NO INHIBITOR 1SKZ ; 1.90 ; PROTEASE INHIBITOR 1ECY ; 2.19 ; PROTEASE INHIBITOR ECOTIN 1ECZ ; 2.68 ; PROTEASE INHIBITOR ECOTIN 1SI5 ; 2.53 ; PROTEASE-LIKE DOMAIN FROM 2-CHAIN HEPATOCYTE GROWTH FACTOR 1AVO ; 2.80 ; PROTEASOME ACTIVATOR REG(ALPHA) 1PMA ; 3.40 ; PROTEASOME FROM THERMOPLASMA ACIDOPHILUM 1PG1 ; -1.00 ; PROTEGRIN 1 (PG1) FROM PORCINE LEUKOCYTES, NMR, 20 STRUCTURES 1QJH ; 2.20 ; PROTEIN AGGREGATION AND ALZHEIMER'S DISEASE. CRYSTALLOGRAPHIC ANALYSIS OF THE PHENOMENON. ENGINEERED VERSION OF THE RIBOSOMAL PROTEIN S6 USED AS A STABLE SCAFFOLD TO STUDY OLIGOMERIZATION. 1CQM ; 1.65 ; PROTEIN AGGREGATION AND ALZHEIMER'S DISEASE: CRYSTALLOGRAPHIC ANALYSIS OF THE PHENOMENON. ENGINEERED VERSION OF THE RIBOSOMAL PROTEIN S6 USED AS A STABLE SCAFFOLD TO STUDY OLIGOMERIZATION. 1CQN ; 2.10 ; PROTEIN AGGREGATION AND ALZHEIMER'S DISEASE: CRYSTALLOGRAPHIC ANALYSIS OF THE PHENOMENON. ENGINEERED VERSION OF THE RIBOSOMAL PROTEIN S6 USED AS A STABLE SCAFFOLD TO STUDY OLIGOMERIZATION. 1Z3D ; 2.50 ; PROTEIN CRYSTAL GROWTH IMPROVEMENT LEADING TO THE 2.5A CRYSTALLOGRAPHIC STRUCTURE OF UBIQUITIN-CONJUGATING ENZYME (UBC-1) FROM CAENORHABDITIS ELEGANS 2BJX ; -1.00 ; PROTEIN DISULFIDE ISOMERASE 1A8L ; 1.90 ; PROTEIN DISULFIDE OXIDOREDUCTASE FROM ARCHAEON PYROCOCCUS FURIOSUS 1ML1 ; 2.60 ; PROTEIN ENGINEERING WITH MONOMERIC TRIOSEPHOSPHATE ISOMERASE: THE MODELLING AND STRUCTURE VERIFICATION OF A SEVEN RESIDUE LOOP 1FPP ; 2.75 ; PROTEIN FARNESYLTRANSFERASE COMPLEX WITH FARNESYL DIPHOSPHATE 1KZP ; 2.10 ; PROTEIN FARNESYLTRANSFERASE COMPLEXED WITH A FARNESYLATED K- RAS4B PEPTIDE PRODUCT 1TN8 ; 2.25 ; PROTEIN FARNESYLTRANSFERASE COMPLEXED WITH A H-RAS PEPTIDE SUBSTRATE AND A FPP ANALOG AT 2.25A RESOLUTION 1TN6 ; 1.80 ; PROTEIN FARNESYLTRANSFERASE COMPLEXED WITH A RAP2A PEPTIDE SUBSTRATE AND A FPP ANALOG AT 1.8A RESOLUTION 1TN7 ; 2.30 ; PROTEIN FARNESYLTRANSFERASE COMPLEXED WITH A TC21 PEPTIDE SUBSTRATE AND A FPP ANALOG AT 2.3A RESOLUTION 1KZO ; 2.20 ; PROTEIN FARNESYLTRANSFERASE COMPLEXED WITH FARNESYLATED K- RAS4B PEPTIDE PRODUCT AND FARNESYL DIPHOSPHATE SUBSTRATE BOUND SIMULTANEOUSLY 1N4R ; 2.80 ; PROTEIN GERANYLGERANYLTRANSFERASE TYPE-I COMPLEXED WITH A GERANYLGERANYLATED KKKSKTKCVIL PEPTIDE PRODUCT 1N4Q ; 2.40 ; PROTEIN GERANYLGERANYLTRANSFERASE TYPE-I COMPLEXED WITH A GGPP ANALOG AND A KKKSKTKCVIL PEPTIDE 1N4P ; 2.65 ; PROTEIN GERANYLGERANYLTRANSFERASE TYPE-I COMPLEXED WITH GERANYLGERANYL DIPHOSPHATE 1N4S ; 2.60 ; PROTEIN GERANYLGERANYLTRANSFERASE TYPE-I COMPLEXED WITH GGPP AND A GERANYLGERANYLATED KKKSKTKCVIL PEPTIDE PRODUCT 1SMH ; 2.04 ; PROTEIN KINASE A VARIANT COMPLEX WITH COMPLETELY ORDERED N- TERMINAL HELIX 1PTQ ; 1.95 ; PROTEIN KINASE C DELTA CYS2 DOMAIN 1PTR ; 2.20 ; PROTEIN KINASE C DELTA CYS2 DOMAIN COMPLEXED WITH PHORBOL-13-ACETATE 2UGI ; 2.20 ; PROTEIN MIMICRY OF DEOXYRIBONUCLEIC ACID FROM CRYSTAL STRUCTURES OF THE URACIL GLYCOSYLASE INHIBITOR PROTEIN AND ITS COMPLEX WITH ESCHERICHIA COLI URACIL-DEOXYRIBONUCLEIC ACID GLYCOSYLASE 1JHS ; 1.90 ; PROTEIN MOG1 E65A MUTANT 1XSM ; 2.30 ; PROTEIN R2 OF RIBONUCLEOTIDE REDUCTASE FROM MOUSE 1FJM ; 2.10 ; PROTEIN SERINE/THREONINE PHOSPHATASE-1 (ALPHA ISOFORM, TYPE I) COMPLEXED WITH MICROCYSTIN-LR TOXIN 1SNO ; 1.70 ; PROTEIN STABILITY IN STAPHYLOCOCCAL NUCLEASE 1SNP ; 1.95 ; PROTEIN STABILITY IN STAPHYLOCOCCAL NUCLEASE 1SNQ ; 1.95 ; PROTEIN STABILITY IN STAPHYLOCOCCAL NUCLEASE 209L ; 2.70 ; PROTEIN STRUCTURE PLASTICITY EXEMPLIFIED BY INSERTION AND DELETION MUTANTS IN T4 LYSOZYME 210L ; 1.95 ; PROTEIN STRUCTURE PLASTICITY EXEMPLIFIED BY INSERTION AND DELETION MUTANTS IN T4 LYSOZYME 211L ; 1.72 ; PROTEIN STRUCTURE PLASTICITY EXEMPLIFIED BY INSERTION AND DELETION MUTANTS IN T4 LYSOZYME 212L ; 1.80 ; PROTEIN STRUCTURE PLASTICITY EXEMPLIFIED BY INSERTION AND DELETION MUTANTS IN T4 LYSOZYME 213L ; 2.15 ; PROTEIN STRUCTURE PLASTICITY EXEMPLIFIED BY INSERTION AND DELETION MUTANTS IN T4 LYSOZYME 214L ; 1.89 ; PROTEIN STRUCTURE PLASTICITY EXEMPLIFIED BY INSERTION AND DELETION MUTANTS IN T4 LYSOZYME 215L ; 2.00 ; PROTEIN STRUCTURE PLASTICITY EXEMPLIFIED BY INSERTION AND DELETION MUTANTS IN T4 LYSOZYME 218L ; 2.10 ; PROTEIN STRUCTURE PLASTICITY EXEMPLIFIED BY INSERTION AND DELETION MUTANTS IN T4 LYSOZYME 219L ; 1.72 ; PROTEIN STRUCTURE PLASTICITY EXEMPLIFIED BY INSERTION AND DELETION MUTANTS IN T4 LYSOZYME 1A5Y ; 2.50 ; PROTEIN TYROSINE PHOSPHATASE 1B CYSTEINYL-PHOSPHATE INTERMEDIATE 1WAX ; 2.20 ; PROTEIN TYROSINE PHOSPHATASE 1B WITH ACTIVE SITE INHIBITOR 2F6T ; 1.70 ; PROTEIN TYROSINE PHOSPHATASE 1B WITH SULFAMIC ACID INHIBITORS 2F6V ; 1.70 ; PROTEIN TYROSINE PHOSPHATASE 1B WITH SULFAMIC ACID INHIBITORS 2F6W ; 2.20 ; PROTEIN TYROSINE PHOSPHATASE 1B WITH SULFAMIC ACID INHIBITORS 2F6Y ; 2.15 ; PROTEIN TYROSINE PHOSPHATASE 1B WITH SULFAMIC ACID INHIBITORS 2F6Z ; 1.70 ; PROTEIN TYROSINE PHOSPHATASE 1B WITH SULFAMIC ACID INHIBITORS 2F70 ; 2.12 ; PROTEIN TYROSINE PHOSPHATASE 1B WITH SULFAMIC ACID INHIBITORS 2F71 ; 1.55 ; PROTEIN TYROSINE PHOSPHATASE 1B WITH SULFAMIC ACID INHIBITORS 1LP1 ; 2.30 ; PROTEIN Z IN COMPLEX WITH AN IN VITRO SELECTED AFFIBODY 1O3Q ; 3.00 ; PROTEIN-DEOXYRIBONUCLEIC ACID RECOGNITION AND DEOXYRIBONUCLEIC ACID DEFORMATION REVEALED IN CRYSTAL STRUCTURES OF CAP-DEOXYRIBONUCLEIC ACID COMPLEXES 1O3R ; 3.00 ; PROTEIN-DEOXYRIBONUCLEIC ACID RECOGNITION AND DEOXYRIBONUCLEIC ACID DEFORMATION REVEALED IN CRYSTAL STRUCTURES OF CAP-DEOXYRIBONUCLEIC ACID COMPLEXES 1O3S ; 3.00 ; PROTEIN-DEOXYRIBONUCLEIC ACID RECOGNITION AND DEOXYRIBONUCLEIC ACID DEFORMATION REVEALED IN CRYSTAL STRUCTURES OF CAP-DEOXYRIBONUCLEIC ACID COMPLEXES 1O3T ; 2.80 ; PROTEIN-DEOXYRIBONUCLEIC ACID RECOGNITION AND DEOXYRIBONUCLEIC ACID DEFORMATION REVEALED IN CRYSTAL STRUCTURES OF CAP-DEOXYRIBONUCLEIC ACID COMPLEXES 1DL5 ; 1.80 ; PROTEIN-L-ISOASPARTATE O-METHYLTRANSFERASE 2AOS ; 2.90 ; PROTEIN-PROTEIN INTERACTIONS OF PROTECTIVE SIGNALLING FACTOR: CRYSTAL STRUCTURE OF TERNARY COMPLEX INVOLVING SIGNALLING PROTEIN FROM GOAT (SPG-40), TETRASACCHARIDE AND A TRIPEPTIDE TRP-PRO-TRP AT 2.9 A RESOLUTION 1EGP ; 2.00 ; PROTEINASE INHIBITOR EGLIN C WITH HYDROLYSED REACTIVE CENTER 1PMC ; -1.00 ; PROTEINASE INHIBITOR PMP-C (NMR, 36 STRUCTURES) 3SSI ; 2.30 ; PROTEINASE INHIBITOR SSI (STREPTOMYCES SUBTILISIN, INHIBITOR) FROM STREPTOMYCES ALBOGRISEOLUS 1W9C ; 2.30 ; PROTEOLYTIC FRAGMENT OF CRM1 SPANNING SIX C-TERMINAL HEAT REPEATS 1NM0 ; 2.30 ; PROTEUS MIRABILIS CATALASE IN COMPLEX WITH FORMIATE 1YKK ; 2.06 ; PROTOCATECHUATE 3,4-DIOXYGENASE Y408C MUTANT 1YKL ; 2.25 ; PROTOCATECHUATE 3,4-DIOXYGENASE Y408C MUTANT BOUND TO DHB 1YKM ; 2.22 ; PROTOCATECHUATE 3,4-DIOXYGENASE Y408E MUTANT 1YKN ; 2.06 ; PROTOCATECHUATE 3,4-DIOXYGENASE Y408E MUTANT BOUND TO DHB 1YKO ; 2.54 ; PROTOCATECHUATE 3,4-DIOXYGENASE Y408H MUTANT 1YKP ; 2.41 ; PROTOCATECHUATE 3,4-DIOXYGENASE Y408H MUTANT BOUND TO DHB 3PCD ; 2.10 ; PROTOCATECHUATE 3,4-DIOXYGENASE Y447H MUTANT 1B4U ; 2.20 ; PROTOCATECHUATE 4,5-DIOXYGENASE (LIGAB) IN COMPLEX WITH PROTOCATECHUATE (PCA) 1YO0 ; 1.80 ; PROTON TRANSFER FROM HIS200 IN HUMAN CARBONIC ANHYDRASE II 1YO1 ; 1.70 ; PROTON TRANSFER FROM HIS200 IN HUMAN CARBONIC ANHYDRASE II 1YO2 ; 1.80 ; PROTON TRANSFER FROM HIS200 IN HUMAN CARBONIC ANHYDRASE II 1E0M ; -1.00 ; PROTOTYPE WW DOMAIN 1K7G ; 2.00 ; PRTC FROM ERWINIA CHRYSANTHEMI 1K7Q ; 1.80 ; PRTC FROM ERWINIA CHRYSANTHEMI: E189A MUTANT 1K7I ; 1.59 ; PRTC FROM ERWINIA CHRYSANTHEMI: Y228F MUTANT 1TP9 ; 1.62 ; PRX D (TYPE II) FROM POPULUS TREMULA 1GXI ; -1.00 ; PSAE SUB-UNIT OF THE PHOTOSYSTEM I OF THE CYANOBACTERIUM SYNECHOCYSTIS SP. PCC 6803 1W2Z ; 2.24 ; PSAO AND XENON 1G6A ; 1.75 ; PSE-4 CARBENICILLINASE, R234K MUTANT 1G68 ; 1.95 ; PSE-4 CARBENICILLINASE, WILD TYPE 1YXN ; 7.90 ; PSEUDO-ATOMIC MODEL OF A FIBERLESS ISOMETRIC VARIANT OF BACTERIOPHAGE PHI29 1IF0 ; 12.00 ; PSEUDO-ATOMIC MODEL OF BACTERIOPHAGE HK97 PROCAPSID (PROHEAD II) 1ADW ; 2.50 ; PSEUDOAZURIN 1XK9 ; 2.10 ; PSEUDOMANAS EXOTOXIN A IN COMPLEX WITH THE PJ34 INHIBITOR 1JZJ ; 1.80 ; PSEUDOMONAS AERUGINOSA AZURIN OS(BPY)2(IM)(HIS83) 1JZI ; 1.62 ; PSEUDOMONAS AERUGINOSA AZURIN RE(PHEN)(CO)3(HIS83) 1JZE ; 1.60 ; PSEUDOMONAS AERUGINOSA AZURIN RU(BPY)2(IM)(HIS83) 1JZH ; 1.70 ; PSEUDOMONAS AERUGINOSA AZURIN RU(TPY)(BPY)(HIS83) 1GJQ ; 2.70 ; PSEUDOMONAS AERUGINOSA CD1 NITRITE REDUCTASE REDUCED CYANIDE COMPLEX 1IKP ; 1.45 ; PSEUDOMONAS AERUGINOSA EXOTOXIN A, P201Q, W281A MUTANT 1IKQ ; 1.62 ; PSEUDOMONAS AERUGINOSA EXOTOXIN A, WILD TYPE 1W8F ; 1.05 ; PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) COMPLEXED WITH LACTO-N-NEO-FUCOPENTAOSE V(LNPFV) 1GZT ; 1.30 ; PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) TOGETHER WITH FUCOSE 1JZF ; 1.50 ; PSEUDOMONAS AERUGINOSA OXIDIZED AZURIN(CU2+) RU(TPY)(PHEN) (HIS83) 1K0L ; 2.00 ; PSEUDOMONAS AERUGINOSA PHBH R220Q FREE OF P-OHB 1K0I ; 1.80 ; PSEUDOMONAS AERUGINOSA PHBH R220Q IN COMPLEX WITH 100MM PHB 1K0J ; 2.20 ; PSEUDOMONAS AERUGINOSA PHBH R220Q IN COMPLEX WITH NADPH AND FREE OF P-OHB 1JZG ; 1.40 ; PSEUDOMONAS AERUGINOSA REDUCED AZURIN (CU1+) RU(TPY)(PHEN) (HIS83) 1LR0 ; 1.91 ; PSEUDOMONAS AERUGINOSA TOLA DOMAIN III, SELENO-METHIONINE DERIVATIVE 1R1C ; 1.90 ; PSEUDOMONAS AERUGINOSA W48F/Y72F/H83Q/Y108W-AZURIN RE(PHEN) (CO)3(HIS107) 1H41 ; 1.50 ; PSEUDOMONAS CELLULOSA E292A ALPHA-D-GLUCURONIDASE MUTANT COMPLEXED WITH ALDOTRIURONIC ACID 1HQD ; 2.30 ; PSEUDOMONAS CEPACIA LIPASE COMPLEXED WITH TRANSITION STATE ANALOGUE OF 1-PHENOXY-2-ACETOXY BUTANE 1VA4 ; 1.80 ; PSEUDOMONAS FLUORESCENS ARYL ESTERASE 1M2W ; 1.80 ; PSEUDOMONAS FLUORESCENS MANNITOL 2-DEHYDROGENASE TERNARY COMPLEX WITH NAD AND D-MANNITOL 5LIP ; 2.90 ; PSEUDOMONAS LIPASE COMPLEXED WITH RC-(RP, SP)-1,2-DIOCTYLCARBAMOYLGLYCERO-3-O-OCTYLPHOSPHONATE 4LIP ; 1.75 ; PSEUDOMONAS LIPASE COMPLEXED WITH RC-(RP, SP)-DIBUTYLCARBAMOYLGLYCERO-3-O-BUTYLPHOSPHONATE 2LIP ; 2.10 ; PSEUDOMONAS LIPASE OPEN CONFORMATION 1NLU ; 1.30 ; PSEUDOMONAS SEDOLISIN (SERINE-CARBOXYL PROTEINASE) COMPLEXED WITH TWO MOLECULES OF PSEUDO-IODOTYROSTATIN 1KDV ; 1.10 ; PSEUDOMONAS SERINE-CARBOXYL PROTEINASE COMPLEXED WITH THE INHIBITOR AIAF (THIS ENZYME RENAMED "SEDOLISIN" IN 2003) 1KDY ; 1.10 ; PSEUDOMONAS SERINE-CARBOXYL PROTEINASE COMPLEXED WITH THE INHIBITOR AIPF (THIS ENZYME RENAMED "SEDOLISIN" IN 2003) 1KE2 ; 2.00 ; PSEUDOMONAS SERINE-CARBOXYL PROTEINASE COMPLEXED WITH THE INHIBITOR CHYMOSTATIN (THIS ENZYME RENAMED "SEDOLISIN" IN 2003) 1KE1 ; 1.80 ; PSEUDOMONAS SERINE-CARBOXYL PROTEINASE COMPLEXED WITH THE INHIBITOR PSEUDOTYROSTATIN (THIS ENZYME RENAMED "SEDOLISIN" IN 2003) 1KDZ ; 1.40 ; PSEUDOMONAS SERINE-CARBOXYL PROTEINASE COMPLEXED WITH THE INHIBITOR TYROSTATIN (THIS ENZYME RENAMED "SEDOLISIN" IN 2003) 1EA2 ; 1.80 ; PSEUDOREVERSION OF THE CATALYTIC ACTIVITY OF Y14F BY THE ADDITIONAL TYROSIN- TO -PHENYLALANINE SUBSTITUTION(S) IN THE HYDROGEN BOND NETWORK OF DELTA-5-3-KETOSTEROID ISOMERASE FROM PHEUDOMONAS PUTIDA BIOTYPE B 1E29 ; 1.21 ; PSII ASSOCIATED CYTOCHROME C549 FROM SYNECHOCYSTIS SP. 1U83 ; 2.20 ; PSL SYNTHASE FROM BACILLUS SUBTILIS 1FHY ; 2.20 ; PSORALEN CROSS-LINKED D(CCGCTAGCGG) FORMS HOLLIDAY JUNCTION 1FHZ ; 2.20 ; PSORALEN CROSS-LINKED D(CCGGTACCGG) FORMS HOLLIDAY JUNCTION 2BJW ; 1.75 ; PSPF AAA DOMAIN 1H71 ; 2.10 ; PSYCHROPHILIC PROTEASE FROM PSEUDOALTEROMONAS 'TAC II 18' 1E92 ; 2.20 ; PTERIDINE REDUCTASE 1 FROM LEISHMANIA MAJOR COMPLEXED WITH NADP+ AND DIHYDROBIOPTERIN 1P33 ; 2.86 ; PTERIDINE REDUCTASE FROM LEISHMANIA TARENTOLAE COMPLEX WITH NADPH AND MTX 1N3O ; 2.00 ; PTEROCARCPUS ANGOLENSIS LECTIN IN COMPLEX WITH ALPHA-METHYL GLUCOSE 1UKG ; 1.70 ; PTEROCARPS ANGOLENSIS LECTIN PAL IN COMPLEX WITH METHYL- ALPHA-MANNOSE 1Q8Q ; 2.05 ; PTEROCARPUS ANGOLENSIS LECTIN (PAL) IN COMPLEX WITH THE DIMANNOSIDE MAN(ALPHA1-4)MAN 1Q8S ; 2.05 ; PTEROCARPUS ANGOLENSIS LECTIN (PAL) IN COMPLEX WITH THE DIMANNOSIDE MAN(ALPHA1-6)MAN 1Q8V ; 1.85 ; PTEROCARPUS ANGOLENSIS LECTIN (PAL) IN COMPLEX WITH THE TRIMANNOSIDE [MAN(ALPHA1-3)]MAN(ALPHA1-6)MAN 1N3Q ; 2.20 ; PTEROCARPUS ANGOLENSIS LECTIN COMPLEXED WITH TURANOSE 1N3P ; 2.10 ; PTEROCARPUS ANGOLENSIS LECTIN IN COMPLEX WITH SUCROSE 1Q8P ; 1.75 ; PTEROCARPUS ANGOLENSIS LECTIN PAL IN COMPLEX WITH THE DIMANNOSIDE MAN(ALPHA1-3)MAN 1S1A ; 1.80 ; PTEROCARPUS ANGOLENSIS SEED LECTIN (PAL) WITH ONE BINDING SITE FREE AND ONE BINDING SITE CONTAINING THE DISACCHARIDE MAN(A1-3)MANME 1Q8O ; 2.20 ; PTEROCARTPUS ANGOLENSIS LECTIN PAL IN COMPLEX WITH THE DIMMANOSIDE MAN(ALPHA1-2)MAN 1BL1 ; -1.00 ; PTH RECEPTOR N-TERMINUS FRAGMENT, NMR, 1 STRUCTURE 1XBO ; 2.50 ; PTP1B COMPLEXED WITH ISOXAZOLE CARBOXYLIC ACID 1NWE ; 3.10 ; PTP1B R47C MODIFIED AT C47 WITH N-[4-(2-{2-[3-(2-BROMO- ACETYLAMINO)-PROPIONYLAMINO]-3-HYDROXY-PROPIONYLAMINO}- ETHYL)-PHENYL]-OXALAMIC ACID 1OEM ; 1.80 ; PTP1B WITH THE CATALYTIC CYSTEINE OXIDIZED TO A SULFENYL-AMIDE BOND 1OEO ; 2.15 ; PTP1B WITH THE CATALYTIC CYSTEINE OXIDIZED TO SULFONIC ACID 1PUE ; 2.10 ; PU.1 ETS DOMAIN - DEOXYRIBONUCLEIC ACID COMPLEX 1U11 ; 1.55 ; PURE (N5-CARBOXYAMINOIMIDAZOLE RIBONUCLEOTIDE MUTASE) FROM THE ACIDOPHILE ACETOBACTER ACETI 1OFN ; 1.50 ; PURIFICATION, CRYSTALLISATION AND PRELIMINARY STRUCTURAL STUDIES OF DTDP-4-KETO-6-DEOXY-GLUCOSE-5-EPIMERASE (EVAD) FROM AMYCOLATOPSIS ORIENTALIS; THE FOURTH ENZYME IN THE DTDP-L-EPIVANCOSAMINE BIOSYNTHETIC PATHWAY. 1S2D ; 2.10 ; PURINE 2'-DEOXYRIBOSYL COMPLEX WITH ARABINOSIDE: RIBOSYLATED INTERMEDIATE (ARAA) 1S3F ; 2.20 ; PURINE 2'-DEOXYRIBOSYLTRANSFERASE + SELENOINOSINE 1S2G ; 2.10 ; PURINE 2'DEOXYRIBOSYLTRANSFERASE + 2'-DEOXYADENOSINE 1S2I ; 2.24 ; PURINE 2'DEOXYRIBOSYLTRANSFERASE + BROMOPURINE 1S2L ; 2.10 ; PURINE 2'DEOXYRIBOSYLTRANSFERASE NATIVE STRUCTURE 1MAS ; 2.50 ; PURINE NUCLEOSIDE HYDROLASE 2MAS ; 2.30 ; PURINE NUCLEOSIDE HYDROLASE WITH A TRANSITION STATE INHIBITOR 1B8N ; 2.00 ; PURINE NUCLEOSIDE PHOSPHORYLASE 1B8O ; 1.50 ; PURINE NUCLEOSIDE PHOSPHORYLASE 1ECP ; 2.00 ; PURINE NUCLEOSIDE PHOSPHORYLASE 1PBN ; 2.00 ; PURINE NUCLEOSIDE PHOSPHORYLASE 1VFN ; 2.15 ; PURINE NUCLEOSIDE PHOSPHORYLASE 2AI1 ; 2.00 ; PURINE NUCLEOSIDE PHOSPHORYLASE FROM CALF SPLEEN 2AI2 ; 1.70 ; PURINE NUCLEOSIDE PHOSPHORYLASE FROM CALF SPLEEN 2AI3 ; 1.70 ; PURINE NUCLEOSIDE PHOSPHORYLASE FROM CALF SPLEEN 1FXU ; 2.20 ; PURINE NUCLEOSIDE PHOSPHORYLASE FROM CALF SPLEEN IN COMPLEX WITH N(7)-ACYCLOGUANOSINE INHIBITOR AND A PHOSPHATE ION 1C3X ; 2.40 ; PURINE NUCLEOSIDE PHOSPHORYLASE FROM CELLULOMONAS SP. IN COMPLEX WITH 8-IODO-GUANINE 1QE5 ; 2.20 ; PURINE NUCLEOSIDE PHOSPHORYLASE FROM CELLULOMONAS SP. IN COMPLEX WITH PHOSPHATE 1K9S ; 2.00 ; PURINE NUCLEOSIDE PHOSPHORYLASE FROM E. COLI IN COMPLEX WITH FORMYCIN A DERIVATIVE AND PHOSPHATE 1ODI ; 2.40 ; PURINE NUCLEOSIDE PHOSPHORYLASE FROM THERMUS THERMOPHILUS 1ODJ ; 2.40 ; PURINE NUCLEOSIDE PHOSPHORYLASE FROM THERMUS THERMOPHILUS 1ODK ; 1.90 ; PURINE NUCLEOSIDE PHOSPHORYLASE FROM THERMUS THERMOPHILUS 1ODL ; 2.10 ; PURINE NUCLEOSIDE PHOSPHORYLASE FROM THERMUS THERMOPHILUS 1A69 ; 2.10 ; PURINE NUCLEOSIDE PHOSPHORYLASE IN COMPLEX WITH FORMYCIN B AND SULPHATE (PHOSPHATE) 1OTX ; 2.70 ; PURINE NUCLEOSIDE PHOSPHORYLASE M64V MUTANT 1PRU ; -1.00 ; PURINE REPRESSOR DEOXYRIBONUCLEIC ACID-BINDING DOMAIN DEOXYRIBONUCLEIC ACID BINDING 1PRV ; -1.00 ; PURINE REPRESSOR DEOXYRIBONUCLEIC ACID-BINDING DOMAIN DEOXYRIBONUCLEIC ACID BINDING 1JHZ ; 2.40 ; PURINE REPRESSOR MUTANT COREPRESSOR BINDING DOMAIN STRUCTURE 1BDH ; 2.70 ; PURINE REPRESSOR MUTANT-HYPOXANTHINE-PALINDROMIC OPERATOR COMPLEX 1QP7 ; 2.90 ; PURINE REPRESSOR MUTANT-HYPOXANTHINE-PALINDROMIC OPERATOR COMPLEX 1QQA ; 3.00 ; PURINE REPRESSOR MUTANT-HYPOXANTHINE-PALINDROMIC OPERATOR COMPLEX 1QQB ; 2.70 ; PURINE REPRESSOR MUTANT-HYPOXANTHINE-PALINDROMIC OPERATOR COMPLEX 1JFS ; 2.90 ; PURINE REPRESSOR MUTANT-HYPOXANTHINE-PURF OPERATOR COMPLEX 1JFT ; 2.50 ; PURINE REPRESSOR MUTANT-HYPOXANTHINE-PURF OPERATOR COMPLEX 1JH9 ; 2.55 ; PURINE REPRESSOR MUTANT-HYPOXANTHINE-PURF OPERATOR COMPLEX 1ZAY ; 2.70 ; PURINE REPRESSOR-HYPOXANTHINE-MODIFIED-PURF-OPERATOR COMPLEX 1BDI ; 3.00 ; PURINE REPRESSOR-HYPOXANTHINE-PALINDROMIC OPERATOR COMPLEX 1QP0 ; 2.90 ; PURINE REPRESSOR-HYPOXANTHINE-PALINDROMIC OPERATOR COMPLEX 1QP4 ; 3.00 ; PURINE REPRESSOR-HYPOXANTHINE-PALINDROMIC OPERATOR COMPLEX 1QPZ ; 2.50 ; PURINE REPRESSOR-HYPOXANTHINE-PALINDROMIC OPERATOR COMPLEX 1PNR ; 2.70 ; PURINE REPRESSOR-HYPOXANTHINE-PURF-OPERATOR COMPLEX 1QHW ; 2.20 ; PURPLE ACID PHOSPHATASE FROM RAT BONE 1CC3 ; 1.65 ; PURPLE CUA CENTER 1SGW ; 1.70 ; PUTATIVE ABC TRANSPORTER (ATP-BINDING PROTEIN) FROM PYROCOCCUS FURIOSUS PFU-867808-001 1VKC ; 1.89 ; PUTATIVE ACETYL TRANSFERASE FROM PYROCOCCUS FURIOSUS 1CE3 ; -1.00 ; PUTATIVE ANCESTRAL PROTEIN ENCODED BY A SINGLE SEQUENCE REPEAT OF THE MULTIDOMAIN PROTEINASE INHIBITOR FROM NICOTIANA ALATA 1S4K ; 1.90 ; PUTATIVE CYTOPLASMIC PROTEIN FROM SALMONELLA TYPHIMURIUM 1RYQ ; 1.38 ; PUTATIVE DEOXYRIBONUCLEIC ACID-DIRECTED RIBONUCLEIC ACID POLYMERASE, SUBUNIT E'' FROM PYROCOCCUS FURIOSUS PFU-263306-001 1PQW ; 2.66 ; PUTATIVE ENOYL REDUCTASE DOMAIN OF POLYKETIDE SYNTHASE 1US4 ; 1.75 ; PUTATIVE GLUR0 LIGAND BINDING CORE WITH L-GLUTAMATE 1US5 ; 1.50 ; PUTATIVE GLUR0 LIGAND BINDING CORE WITH L-GLUTAMATE 1X9G ; 2.41 ; PUTATIVE MAR1 RIBONUCLEASE FROM LEISHMANIA DONOVANI 1XN4 ; 3.80 ; PUTATIVE MAR1 RIBONUCLEASE FROM LEISHMANIA MAJOR 1VJK ; 1.51 ; PUTATIVE MOLYBDOPTERIN CONVERTING FACTOR, SUBUNIT 1 FROM PYROCOCCUS FURIOSUS, PFU-562899-001 1PW5 ; 2.80 ; PUTATIVE NAGD PROTEIN 1DZ9 ; 1.90 ; PUTATIVE OXO COMPLEX OF P450CAM FROM PSEUDOMONAS PUTIDA 1TE2 ; 1.76 ; PUTATIVE PHOSPHATASE YNIC FROM ESCHERICHIA COLI K12 1T6T ; 1.80 ; PUTATIVE PROTEIN FROM AQUIFEX AEOLICUS 1K7K ; 1.50 ; PUTATIVE RIBOSOMAL PROTEIN 1MJF ; 1.80 ; PUTATIVE SPERMIDINE SYNTHETASE FROM PYROCOCCUS FURIOSUS PFU- 132382 1USC ; 1.24 ; PUTATIVE STYRENE MONOOXYGENASE SMALL COMPONENT 1USF ; 1.30 ; PUTATIVE STYRENE MONOOXYGENASE SMALL COMPONENT WITH BOUND NADP+ 1YYV ; 2.35 ; PUTATIVE TRANSCRIPTIONAL REGULATOR YTFH FROM SALMONELLA TYPHIMURIUM 1PDX ; -1.00 ; PUTIDAREDOXIN 1R7S ; 1.91 ; PUTIDAREDOXIN (FE2S2 FERREDOXIN), C73G MUTANT 1IWI ; 2.00 ; PUTIDAREDOXIN-BINDING STABLILIZES AN ACTIVE CONFORMER OF CYTOCHROME P450CAM IN ITS REDUCED STATE; CRYSTAL STRUCTURE OF CYTOCHROME P450CAM 1IWJ ; 2.00 ; PUTIDAREDOXIN-BINDING STABLILIZES AN ACTIVE CONFORMER OF CYTOCHROME P450CAM IN ITS REDUCED STATE; CRYSTAL STRUCTURE OF MUTANT(109K) CYTOCHROME P450CAM 1IWK ; 2.00 ; PUTIDAREDOXIN-BINDING STABLILIZES AN ACTIVE CONFORMER OF CYTOCHROME P450CAM IN ITS REDUCED STATE; CRYSTAL STRUCTURE OF MUTANT(112K) CYTOCHROME P450CAM 1A99 ; 2.20 ; PUTRESCINE RECEPTOR (POTF) FROM E. COLI 1EAH ; 2.90 ; PV2L COMPLEXED WITH ANTIVIRAL AGENT SCH48973 1X7K ; -1.00 ; PV5 NMR SOLUTION STRUCTURE 2B5K ; -1.00 ; PV5 NMR SOLUTION STRUCTURE IN DPC MICELLES 1BOO ; 2.80 ; PVUII DEOXYRIBONUCLEIC ACID METHYLTRANSFERASE (CYTOSINE-N4-SPECIFIC) 2PVI ; 1.76 ; PVUII ENDONUCLEASE COMPLEXED TO AN IODINATED COGNATE DEOXYRIBONUCLEIC ACID 1F0O ; 2.50 ; PVUII ENDONUCLEASE/COGNATE DEOXYRIBONUCLEIC ACID COMPLEX (GLUTARALDEHYDE- CROSSLINKED CRYSTAL) AT PH 7.5 WITH TWO CALCIUM IONS AT EACH ACTIVE SITE 2FEG ; 2.29 ; PY00414- PLASMODIUM YOELII THIOREDOXIN PEROXIDASE I 1XKW ; 2.00 ; PYOCHELIN OUTER MEMBRANE RECEPTOR FPTA FROM PSEUDOMONAS AERUGINOSA 1XKH ; 3.60 ; PYOVERDINE OUTER MEMBRANE RECEPTOR FPVA FROM PSEUDOMONAS AERUGINOSA PAO1 BOUND TO PYOVERDINE 1NWZ ; 0.82 ; PYP ULTRA-HIGH RESOLUTION STRUCTURE OF A BACTERIAL PHOTORECEPTOR 2SKC ; 2.40 ; PYRIDOXAL PHOSPHORYLASE B IN COMPLEX WITH FLUOROPHOSPHATE, GLUCOSE AND INOSINE-5'-MONOPHOSPHATE 2SKD ; 2.40 ; PYRIDOXAL PHOSPHORYLASE B IN COMPLEX WITH PHOSPHATE, GLUCOSE AND INOSINE-5'-MONOPHOSPHATE 2SKE ; 2.46 ; PYRIDOXAL PHOSPHORYLASE B IN COMPLEX WITH PHOSPHITE, GLUCOSE AND INOSINE-5'-MONOPHOSPHATE 1A2D ; 2.40 ; PYRIDOXAMINE MODIFIED MURINE ADIPOCYTE LIPID BINDING PROTEIN 1S4E ; 2.90 ; PYROCOCCUS FURIOSUS GALACTOKINASE IN COMPLEX WITH GALACTOSE, ADP AND MAGNESIUM 1ISQ ; 2.30 ; PYROCOCCUS FURIOSUS PCNA COMPLEXED WITH RFCL PIP-BOX PEPTIDE 1IZ5 ; 1.80 ; PYROCOCCUS FURIOSUS PCNA MUTANT (MET73LEU, ASP143ALA, ASP147ALA): ORTHORHOMBIC FORM 1IZ4 ; 2.00 ; PYROCOCCUS FURIOSUS PCNA MUTANT (MET73LEU/ASP143ALA): TETRAGONAL FORM 1G8A ; 1.40 ; PYROCOCCUS HORIKOSHII FIBRILLARIN PRE-RRNA PROCESSING PROTEIN 1QLV ; 2.10 ; PYRONE SYNTHASE (PYS) FROM GERBERA HYBRIDA 1W30 ; 1.90 ; PYRR OF MYCOBACTERIUM TUBERCULOSIS AS A POTENTIAL DRUG TARGET 1A3C ; 1.60 ; PYRR, THE BACILLUS SUBTILIS PYRIMIDINE BIOSYNTHETIC OPERON REPRESSOR, DIMERIC FORM 1A4X ; 2.30 ; PYRR, THE BACILLUS SUBTILIS PYRIMIDINE BIOSYNTHETIC OPERON REPRESSOR, HEXAMERIC FORM 1NON ; 2.40 ; PYRR, THE REGULATOR OF THE PYRIMIDINE BIOSYNTHETIC OPERON IN BACILLUS CALDOLYTICUS 1XZ8 ; 2.80 ; PYRR, THE REGULATOR OF THE PYRIMIDINE BIOSYNTHETIC OPERON IN BACILLUS CALDOLYTICUS, NUCLEOTIDE-BOUND FORM 1XZN ; 2.27 ; PYRR, THE REGULATOR OF THE PYRIMIDINE BIOSYNTHETIC OPERON IN BACILLUS CALDOLYTICUS, SULFATE-BOUND FORM 1A2Z ; 1.73 ; PYRROLIDONE CARBOXYL PEPTIDASE FROM THERMOCOCCUS LITORALIS 1ZPD ; 1.86 ; PYRUVATE DECARBOXYLASE FROM ZYMOMONAS MOBILIS 1QPB ; 2.40 ; PYRUVATE DECARBOYXLASE FROM YEAST (FORM B) COMPLEXED WITH PYRUVAMIDE 1JM6 ; 2.50 ; PYRUVATE DEHYDROGENASE KINASE, ISOZYME 2, CONTAINING ADP 1H17 ; 1.75 ; PYRUVATE FORMATE-LYASE IN COMPLEX WITH COA AND THE SUBSTRATE ANALOG OXAMATE 1H18 ; 2.30 ; PYRUVATE FORMATE-LYASE IN COMPLEX WITH PYRUVATE 1H16 ; 1.53 ; PYRUVATE FORMATE-LYASE IN COMPLEX WITH PYRUVATE AND COA 1A5U ; 2.35 ; PYRUVATE KINASE COMPLEX WITH BIS MG-ATP-NA-OXALATE 1PKY ; 2.50 ; PYRUVATE KINASE FROM E. COLI IN THE T-STATE 1AQF ; 2.70 ; PYRUVATE KINASE FROM RABBIT MUSCLE WITH MG, K, AND L-PHOSPHOLACTATE 1A3W ; 3.00 ; PYRUVATE KINASE FROM SACCHAROMYCES CEREVISIAE COMPLEXED WITH FBP, PG, MN2+ AND K+ 1A3X ; 3.00 ; PYRUVATE KINASE FROM SACCHAROMYCES CEREVISIAE COMPLEXED WITH PG, MN2+ AND K+ 1Y9D ; 2.20 ; PYRUVATE OXIDASE VARIANT V265A FROM LACTOBACILLUS PLANTARUM 1DIK ; 2.30 ; PYRUVATE PHOSPHATE DIKINASE 1KBL ; 1.94 ; PYRUVATE PHOSPHATE DIKINASE 1VBG ; 2.30 ; PYRUVATE PHOSPHATE DIKINASE FROM MAIZE 1VBH ; 2.30 ; PYRUVATE PHOSPHATE DIKINASE WITH BOUND MG-PEP FROM MAIZE 1KC7 ; 2.20 ; PYRUVATE PHOSPHATE DIKINASE WITH BOUND MG-PHOSPHONOPYRUVATE 1AW8 ; 2.20 ; PYRUVOYL DEPENDENT ASPARTATE DECARBOXYLASE 2IFM ; 3.30 ; Pf1 Filamentous Bacteriophage: Refinement of a Molecular Model by Simulated Annealing Using 3.3 Angstroms Resolution X-Ray Fibre Diffraction Data 3IFM ; 3.30 ; Pf1 Filamentous Bacteriophage: Refinement of a Molecular Model by Simulated Annealing Using 3.3 Angstroms Resolution X-Ray Fibre Diffraction Data 4IFM ; 3.30 ; Pf1 Filamentous Bacteriophage: Refinement of a Molecular Model by Simulated Annealing Using 3.3 Angstroms Resolution X-Ray Fibre Diffraction Data 1L58 ; 1.65 ; Primary 7LYZ ; 2.50 ; Protein Model Building by the Use of a Constrained-Restrained Least-Squares Procedure 1AW7 ; 1.95 ; Q136A MUTANT OF TOXIC SHOCK SYNDROME TOXIN-1 FROM S. AUREUS 1TS4 ; 3.40 ; Q139K MUTANT OF TOXIC SHOCK SYNDROME TOXIN-1 FROM S. AUREUS 1E2Z ; 2.50 ; Q158L MUTANT OF CYTOCHROME F FROM CHLAMYDOMONAS REINHARDTII 1EFQ ; 1.60 ; Q38D MUTANT OF LEN 1A1H ; 1.60 ; QGSR (ZIF268 VARIANT) ZINC FINGER-DEOXYRIBONUCLEIC ACID COMPLEX (GCAC SITE) 1MZH ; 2.00 ; QR15, AN ALDOLASE 1J3K ; 2.10 ; QUADRUPLE MUTANT (N51I+C59R+S108N+I164L) PLASMODIUM FALCIPARUM DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE (PFDHFR-TS) COMPLEXED WITH WR99210, NADPH, AND DUMP 1QCA ; 2.20 ; QUADRUPLE MUTANT Q92C, N146F, Y168F, I172V TYPE III CAT COMPLEXED WITH FUSIDIC ACID. CRYSTALS GROWN AT PH 6.3. X-RAY DATA COLLECTED AT ROOM TEMPERATURE 1IBI ; -1.00 ; QUAIL CYSTEINE AND GLYCINE-RICH PROTEIN, NMR, 15 MINIMIZED MODEL STRUCTURES 1QLI ; -1.00 ; QUAIL CYSTEINE AND GLYCINE-RICH PROTEIN, NMR, MINIMIZED AVERAGE STRUCTURE 1GW7 ; 13.50 ; QUASI-ATOMIC RESOLUTION MODEL OF BACTERIOPHAGE PRD1 CAPSID, OBTAINED BY COMBINED CRYO-EM AND X-RAY CRYSTALLOGRAPHY. 1HB5 ; 12.00 ; QUASI-ATOMIC RESOLUTION MODEL OF BACTERIOPHAGE PRD1 P3-SHELL, OBTAINED BY COMBINED CRYO-EM AND X-RAY CRYSTALLOGRAPHY. 1HB7 ; 14.00 ; QUASI-ATOMIC RESOLUTION MODEL OF BACTERIOPHAGE PRD1 SUS1 MUTANT, OBTAINED BY COMBINED CRYO-EM AND X-RAY CRYSTALLOGRAPHY. 1GW8 ; 13.30 ; QUASI-ATOMIC RESOLUTION MODEL OF BACTERIOPHAGE PRD1 SUS607 MUTANT, OBTAINED BY COMBINED CRYO-EM AND X-RAY CRYSTALLOGRAPHY. 1HB9 ; 25.00 ; QUASI-ATOMIC RESOLUTION MODEL OF BACTERIOPHAGE PRD1 WILD TYPE VIRION, OBTAINED BY COMBINED CRYO-EM AND X-RAY CRYSTALLOGRAPHY. 1GQG ; 1.70 ; QUERCETIN 2,3-DIOXYGENASE IN COMPLEX WITH THE INHIBITOR DIETHYLDITHIOCARBAMATE 1GQH ; 2.15 ; QUERCETIN 2,3-DIOXYGENASE IN COMPLEX WITH THE INHIBITOR KOJIC ACID 1O9B ; 2.50 ; QUINATE/SHIKIMATE DEHYDROGENASE YDIB COMPLEXED WITH NADH 1CYX ; 2.30 ; QUINOL OXIDASE (PERIPLASMIC FRAGMENT OF SUBUNIT II WITH ENGINEERED CU-A BINDING SITE)(CYOA) 1CYW ; 2.50 ; QUINOL OXIDASE (PERIPLASMIC FRAGMENT OF SUBUNIT II) (CYOA) 1L0V ; 3.30 ; QUINOL-FUMARATE REDUCTASE WITH MENAQUINOL MOLECULES 1KFY ; 3.60 ; QUINOL-FUMARATE REDUCTASE WITH QUINOL INHIBITOR 2-[1-(4- CHLORO-PHENYL)-ETHYL]-4,6-DINITRO-PHENOL 1E7P ; 3.10 ; QUINOL:FUMARATE REDUCTASE FROM WOLINELLA SUCCINOGENES 1QPO ; 2.40 ; QUINOLINATE PHOSPHORIBOSYL TRANSFERASE (QAPRTASE) APO- ENZYME FROM MYCOBACTERIUM TUBERCULOSIS 1QPN ; 2.60 ; QUINOLINATE PHOSPHORIBOSYL TRANSFERASE FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH NCNN 1QPR ; 2.45 ; QUINOLINATE PHOSPHORIBOSYLTRANSFERASE (QAPRTASE) FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH PHTHALATE AND PRPCP 1QAP ; 2.80 ; QUINOLINIC ACID PHOSPHORIBOSYLTRANSFERASE WITH BOUND QUINOLINIC ACID 1XI2 ; 1.50 ; QUINONE REDUCTASE 2 IN COMPLEX WITH CANCER PRODRUG CB1954 1QRD ; 2.40 ; QUINONE REDUCTASE/FAD/CIBACRON BLUE/DUROQUINONE COMPLEX 1RVW ; 2.50 ; R STATE HUMAN HEMOGLOBIN [ALPHA V96W], CARBONMONOXY 1YXI ; 2.00 ; R-STATE AMP COMPLEX REVEALS INITIAL STEPS OF THE QUATERNARY TRANSITION OF FRUCTOSE-1,6-BISPHOSPHATASE 1YYZ ; 1.85 ; R-STATE AMP COMPLEX REVEALS INITIAL STEPS OF THE QUATERNARY TRANSITION OF FRUCTOSE-1,6-BISPHOSPHATASE 1YZ0 ; 2.07 ; R-STATE AMP COMPLEX REVEALS INITIAL STEPS OF THE QUATERNARY TRANSITION OF FRUCTOSE-1,6-BISPHOSPHATASE 1HBR ; 2.30 ; R-STATE FORM OF CHICKEN HEMOGLOBIN D 1AJ9 ; 2.20 ; R-STATE HUMAN CARBONMONOXYHEMOGLOBIN ALPHA-A53S 1RDX ; 2.75 ; R-STATE STRUCTURE OF THE ARG 243 TO ALA MUTANT OF PIG KIDNEY FRUCTOSE 1,6-BISPHOSPHATASE EXPRESSED IN E. COLI 1UCU ; 4.00 ; R-TYPE STRAIGHT FLAGELLAR FILAMENT MADE OF FULL-LENGTH FLAGELLIN 1NM5 ; 2.40 ; R. RUBRUM TRANSHYDROGENASE (DI.Q132N)2(DIII)1 ASYMMETRIC COMPLEX 1U28 ; 2.30 ; R. RUBRUM TRANSHYDROGENASE ASYMMETRIC COMPLEX (DI.NAD+) 2(DIII.NADP+)1 1T96 ; 1.85 ; R106G KDO8PS WITH PEP 1T8X ; 1.80 ; R106G KDO8PS WITH PEP AND A5P 1T99 ; 1.85 ; R106G KDO8PS WITHOUT SUBSTRATES 1CO7 ; 1.90 ; R117H MUTANT RAT ANIONIC TRYPSIN COMPLEXED WITH BOVINE PANCREATIC TRYPSIN INHIBITOR (BPTI) 1GT2 ; 2.91 ; R207S,R292S MUTANT OF MALATE DEHYDROGENASE FROM THE HALOPHILIC ARCHAEON HALOARCULA MARISMORTUI (HOLO FORM) 1H43 ; 2.20 ; R210E N-TERMINAL LOBE HUMAN LACTOFERRIN 1H45 ; 1.95 ; R210G N-TERMINAL LOBE HUMAN LACTOFERRIN 1EH3 ; 2.00 ; R210K N-TERMINAL LOBE HUMAN LACTOFERRIN 1H44 ; 2.00 ; R210L N-TERMINAL LOBE HUMAN LACTOFERRIN 1ESI ; 1.80 ; R248L MUTANT OF STREPTOMYCES K15 DD-TRANSPEPTIDASE 1E0T ; 1.80 ; R292D MUTANT OF E. COLI PYRUVATE KINASE 1KGP ; 2.00 ; R2F FROM CORYNEBACTERIUM AMMONIAGENES IN ITS MN SUBSTITUTED FORM 1KGN ; 1.85 ; R2F FROM CORYNEBACTERIUM AMMONIAGENES IN ITS OXIDISED, FE CONTAINING, FORM 1KGO ; 2.25 ; R2F FROM CORYNEBACTERIUM AMMONIAGENES IN ITS REDUCED, FE CONTAINING, FORM 2AEK ; 2.90 ; R304K TRICHODIENE SYNTHASE 2AEL ; 2.50 ; R304K TRICHODIENE SYNTHASE: COMPLEX WITH MG, PYROPHOSPHATE, AND (4R)-7-AZABISABOLENE 2AET ; 2.75 ; R304K TRICHODIENE SYNTHASE: COMPLEX WITH MG, PYROPHOSPHATE, AND (4S)-7-AZABISABOLENE 1HQX ; 3.00 ; R308K ARGINASE VARIANT 1GYG ; 1.90 ; R32 CLOSED FORM OF ALPHA-TOXIN FROM CLOSTRIDIUM PERFRINGENS STRAIN CER89L43 1QM6 ; 2.50 ; R32 FORM OF CLOSTRIDIUM PERFRINGENS ALPHA-TOXIN STRAIN 2DIK ; 2.50 ; R337A MUTANT OF PYRUVATE PHOSPHATE DIKINASE 1AI0 ; -1.00 ; R6 HUMAN INSULIN HEXAMER (NON-SYMMETRIC), NMR, 10 STRUCTURES 4AIY ; -1.00 ; R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 'GREEN' SUBSTATE, AVERAGE STRUCTURE 5AIY ; -1.00 ; R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 'RED' SUBSTATE, AVERAGE STRUCTURE 1AIY ; -1.00 ; R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 10 STRUCTURES 2AIY ; -1.00 ; R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 20 STRUCTURES 3AIY ; -1.00 ; R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, REFINED AVERAGE STRUCTURE 1WGY ; -1.00 ; RA DOMAIN OF GUANINE NUCLEOTIDE EXCHANGE FACTOR FOR RAP1 1RAX ; -1.00 ; RA-DOMAIN OF RAL GUANOSINE-NUCLEOTIDE DISSOCIATION STIMULATOR 6ALD ; 2.30 ; RABBIT MUSCLE ALDOLASE A/FRUCTOSE-1,6-BISPHOSPHATE COMPLEX 1JDY ; 2.70 ; RABBIT MUSCLE PHOSPHOGLUCOMUTASE 1VKL ; 2.70 ; RABBIT MUSCLE PHOSPHOGLUCOMUTASE 1LOX ; 2.40 ; RABBIT RETICULOCYTE 15-LIPOXYGENASE 1JNF ; 2.60 ; RABBIT SERUM TRANSFERRIN AT 2.6 A RESOLUTION. 1HH4 ; 2.70 ; RAC1-RHOGDI COMPLEX INVOLVED IN NADPH OXIDASE ACTIVATION 1L8D ; 2.20 ; RAD50 COILED-COIL ZN HOOK 1B22 ; -1.00 ; RAD51 (N-TERMINAL DOMAIN) 1PZN ; 2.85 ; RAD51 (RADA) 1Z4B ; 2.10 ; RADA RECOMBINASE IN COMPLEX WITH ADP 1Z4D ; 2.00 ; RADA RECOMBINASE IN COMPLEX WITH AMP-PNP AND HIGH CONCENTRATION OF K+ 1Z4C ; 2.30 ; RADA RECOMBINASE IN COMPLEX WITH AMP-PNP AND LOW CONCENTRATION OF K+ 2BHX ; 1.68 ; RADIATION DAMAGE OF THE SCHIFF BASE IN PHOSPHOSERINE AMINOTRANSFERASE (STRUCTURE A) 2BI1 ; 1.69 ; RADIATION DAMAGE OF THE SCHIFF BASE IN PHOSPHOSERINE AMINOTRANSFERASE (STRUCTURE B) 2BI2 ; 1.69 ; RADIATION DAMAGE OF THE SCHIFF BASE IN PHOSPHOSERINE AMINOTRANSFERASE (STRUCTURE C) 2BI3 ; 1.69 ; RADIATION DAMAGE OF THE SCHIFF BASE IN PHOSPHOSERINE AMINOTRANSFERASE (STRUCTURE D) 2BI5 ; 1.73 ; RADIATION DAMAGE OF THE SCHIFF BASE IN PHOSPHOSERINE AMINOTRANSFERASE (STRUCTURE E) 2BI9 ; 1.73 ; RADIATION DAMAGE OF THE SCHIFF BASE IN PHOSPHOSERINE AMINOTRANSFERASE (STRUCTURE F) 2BIA ; 1.77 ; RADIATION DAMAGE OF THE SCHIFF BASE IN PHOSPHOSERINE AMINOTRANSFERASE (STRUCTURE G) 2BIE ; 1.30 ; RADIATION DAMAGE OF THE SCHIFF BASE IN PHOSPHOSERINE AMINOTRANSFERASE (STRUCTURE H) 2BIG ; 1.30 ; RADIATION DAMAGE OF THE SCHIFF BASE IN PHOSPHOSERINE AMINOTRANSFERASE (STRUCTURE I) 1O7U ; 1.50 ; RADIATION INDUCED TRYPAREDOXIN-I 1O85 ; 1.50 ; RADIATION-REDUCED TRYPAREDOXIN-I 1O8W ; 1.69 ; RADIATION-REDUCED TRYPAREDOXIN-I 1BGQ ; 2.50 ; RADICICOL BOUND TO THE ATP BINDING SITE OF THE N-TERMINAL DOMAIN OF THE YEAST HSP90 CHAPERONE 1A1K ; 1.90 ; RADR (ZIF268 VARIANT) ZINC FINGER-DEOXYRIBONUCLEIC ACID COMPLEX (GACC SITE) 1A1I ; 1.60 ; RADR (ZIF268 VARIANT) ZINC FINGER-DEOXYRIBONUCLEIC ACID COMPLEX (GCAC SITE) 1A1J ; 2.00 ; RADR (ZIF268 VARIANT) ZINC FINGER-DEOXYRIBONUCLEIC ACID COMPLEX (GCGT SITE) 1FAQ ; -1.00 ; RAF-1 CYSTEINE RICH DOMAIN, NMR, 27 STRUCTURES 1FAR ; -1.00 ; RAF-1 CYSTEINE RICH DOMAIN, NMR, MINIMIZED AVERAGE STRUCTURE 1RMD ; 2.10 ; RAG1 DIMERIZATION DOMAIN 2BBG ; -1.00 ; RAGWEED POLLEN ALLERGEN FROM AMBROSIA TRIFIDA V, NMR, 30 STRUCTURES 1BBG ; -1.00 ; RAGWEED POLLEN ALLERGEN FROM AMBROSIA TRIFIDA V, NMR, MINIMIZED AVERAGE STRUCTURE 1HK6 ; -1.00 ; RAL BINDING DOMAIN FROM SEC5 1VYY ; 1.00 ; RALSTONIA SOLANACEARUM HIGH-AFFINITY MANNOSE-BINDING LECTIN AT 1.0A RESOLUTION IN COMPLEX WITH D-MANNOSE 1UQX ; 1.70 ; RALSTONIA SOLANACEARUM LECTIN (RS-IIL) IN COMPLEX WITH ALPHA-METHYLMANNOSIDE 7CGT ; 3.00 ; RAMEB COMPLEX OF CYCLODEXTRIN GLYCOSYLTRANSFERASE MUTANT 1I2M ; 1.76 ; RAN-RCC1-SO4 COMPLEX 1XRJ ; 2.00 ; RAPID STRUCTURE DETERMINATION OF HUMAN URIDINE-CYTIDINE KINASE 2 USING A CONVENTIONAL LABORATORY X-RAY SOURCE AND A SINGLE SAMARIUM DERIVATIVE 1HE8 ; 3.00 ; RAS G12V - PI 3-KINASE GAMMA COMPLEX 1WER ; 1.60 ; RAS-GTPASE-ACTIVATING DOMAIN OF HUMAN P120GAP 1WQ1 ; 2.50 ; RAS-RASGAP COMPLEX 1SLU ; 1.80 ; RAT ANIONIC N143H, E151H TRYPSIN COMPLEXED TO A86H ECOTIN 1SLV ; 2.30 ; RAT ANIONIC N143H, E151H TRYPSIN COMPLEXED TO A86H ECOTIN; COPPER-BOUND 1SLW ; 2.00 ; RAT ANIONIC N143H, E151H TRYPSIN COMPLEXED TO A86H ECOTIN; NICKEL-BOUND 1SLX ; 2.20 ; RAT ANIONIC N143H, E151H TRYPSIN COMPLEXED TO A86H ECOTIN; ZINC-BOUND 1A8B ; 1.90 ; RAT ANNEXIN V COMPLEXED WITH GLYCEROPHOSPHOETHANOLAMINE 1A8A ; 1.90 ; RAT ANNEXIN V COMPLEXED WITH GLYCEROPHOSPHOSERINE 1AF3 ; 2.50 ; RAT BCL-XL AN APOPTOSIS INHIBITORY PROTEIN 1E3S ; 2.00 ; RAT BRAIN 3-HYDROXYACYL-COA DEHYDROGENASE BINARY COMPLEX WITH NADH 1E3W ; 2.00 ; RAT BRAIN 3-HYDROXYACYL-COA DEHYDROGENASE BINARY COMPLEX WITH NADH AND 3-KETO BUTYRATE 1E6W ; 1.70 ; RAT BRAIN 3-HYDROXYACYL-COA DEHYDROGENASE BINARY COMPLEX WITH NADH AND ESTRADIOL 1BG3 ; 2.80 ; RAT BRAIN HEXOKINASE TYPE I COMPLEX WITH GLUCOSE AND INHIBITOR GLUCOSE-6-PHOSPHATE 1UUM ; 2.30 ; RAT DIHYDROOROTATE DEHYDROGENASE (DHOD)IN COMPLEX WITH ATOVAQUONE 1UUO ; 2.44 ; RAT DIHYDROOROTATE DEHYDROGENASE (DHOD)IN COMPLEX WITH BREQUINAR 1B5A ; -1.00 ; RAT FERROCYTOCHROME B5 A CONFORMATION, NMR, 1 STRUCTURE 1B5B ; -1.00 ; RAT FERROCYTOCHROME B5 B CONFORMATION, NMR, 1 STRUCTURE 1EV9 ; 2.20 ; RAT GLUTATHIONE S-TRANSFERASE A1-1 MUTANT W21F WITH GSO3 BOUND 1EV4 ; 2.20 ; RAT GLUTATHIONE S-TRANSFERASE A1-1: MUTANT W21F/F220Y WITH GSO3 BOUND 1FI8 ; 2.20 ; RAT GRANZYME B [N66Q] COMPLEXED TO ECOTIN [81-84 IEPD] 1MAB ; 2.80 ; RAT LIVER F1-ATPASE 1PWE ; 2.80 ; RAT LIVER L-SERINE DEHYDRATASE APO ENZYME 1PWH ; 2.60 ; RAT LIVER L-SERINE DEHYDRATASE- COMPLEX WITH PYRIDOXYL-(O- METHYL-SERINE)-5-MONOPHOSPHATE 1B3R ; 2.80 ; RAT LIVER S-ADENOSYLHOMOCYSTEIN HYDROLASE 1KWT ; 1.95 ; RAT MANNOSE BINDING PROTEIN A (NATIVE, MPD) 1KWV ; 2.00 ; RAT MANNOSE BINDING PROTEIN A COMPLEXED WITH A-ME-GLCNAC 1KWU ; 1.95 ; RAT MANNOSE BINDING PROTEIN A COMPLEXED WITH A-ME-MAN 1KX0 ; 2.00 ; RAT MANNOSE PROTEIN A (H189V I207V) COMPLEXED WITH MAN-A13- MAN 1KWZ ; 1.90 ; RAT MANNOSE PROTEIN A (H189V) COMPLEXED WITH MAN-A13-MAN 1KWW ; 1.90 ; RAT MANNOSE PROTEIN A COMPLEXED WITH A-ME-FUC. 1KWX ; 2.00 ; RAT MANNOSE PROTEIN A COMPLEXED WITH B-ME-FUC. 1KWY ; 2.00 ; RAT MANNOSE PROTEIN A COMPLEXED WITH MAN-A13-MAN. 1KX1 ; 2.80 ; RAT MANNOSE PROTEIN A COMPLEXED WITH MAN6-GLCNAC2-ASN 1ZVI ; 2.00 ; RAT NEURONAL NITRIC OXIDE SYNTHASE OXYGENASE DOMAIN 1ZVL ; 2.50 ; RAT NEURONAL NITRIC OXIDE SYNTHASE OXYGENASE DOMAIN COMPLEXED WITH NATURAL SUBSTRATE L-ARG. 1QW6 ; 2.10 ; RAT NEURONAL NITRIC OXIDE SYNTHASE OXYGENASE DOMAIN IN COMPLEX WITH N-OMEGA-PROPYL-L-ARG. 1QWC ; 2.30 ; RAT NEURONAL NITRIC OXIDE SYNTHASE OXYGENASE DOMAIN IN COMPLEX WITH W1400 INHIBITOR. 1P6K ; 1.78 ; RAT NEURONAL NOS D597N MUTANT HEME DOMAIN WITH L-N(OMEGA)- NITROARGININE-2,4-L-DIAMINOBUTYRIC AMIDE BOUND 1P6I ; 1.90 ; RAT NEURONAL NOS HEME DOMAIN WITH (4S)-N-(4-AMINO-5- [AMINOETHYL]AMINOPENTYL)-N'-NITROGUANIDINE BOUND 1RS6 ; 1.95 ; RAT NEURONAL NOS HEME DOMAIN WITH D-LYSINE-D-NITROARGININE AMIDE BOUND 1RS7 ; 1.95 ; RAT NEURONAL NOS HEME DOMAIN WITH D-PHENYLALANINE-D- NITROARGININE AMIDE BOUND 1P6J ; 2.00 ; RAT NEURONAL NOS HEME DOMAIN WITH L-N(OMEGA)-NITROARGININE- (4R)-AMINO-L-PROLINE AMIDE BOUND 1P6H ; 1.98 ; RAT NEURONAL NOS HEME DOMAIN WITH L-N(OMEGA)-NITROARGININE- 2,4-L-DIAMINOBUTYRIC AMIDE BOUND 1M00 ; 2.05 ; RAT NEURONAL NOS HEME DOMAIN WITH N-BUTYL-N'- HYDROXYGUANIDINE BOUND 1LZZ ; 2.05 ; RAT NEURONAL NOS HEME DOMAIN WITH N-ISOPROPYL-N'- HYDROXYGUANIDINE BOUND 1LZX ; 2.00 ; RAT NEURONAL NOS HEME DOMAIN WITH NG-HYDROXY-L-ARGININE BOUND 1MMV ; 2.00 ; RAT NEURONAL NOS HEME DOMAIN WITH NG-PROPYL-L-ARGININE BOUND 1MMW ; 2.00 ; RAT NEURONAL NOS HEME DOMAIN WITH VINYL-L-NIO BOUND 1ZZQ ; 1.90 ; RAT NNOS D597N MUTANT WITH L-N(OMEGA)-NITROARGININE-(4R)- AMINO-L-PROLINE AMIDE BOUND 1ZZR ; 2.05 ; RAT NNOS D597N/M336V DOUBLE MUTANT WITH L-N(OMEGA)- NITROARGININE-(4R)-AMINO-L-PROLINE AMIDE BOUND 1ZZU ; 1.90 ; RAT NNOS D597N/M336V DOUBLE MUTANT WITH L-N(OMEGA)- NITROARGININE-2,4-L-DIAMINOBUTYRIC AMIDE BOUND 1QKN ; 2.25 ; RAT OESTROGEN RECEPTOR BETA LIGAND-BINDING DOMAIN IN COMPLEX WITH ANTAGONIST RALOXIFENE 1HJ1 ; 2.30 ; RAT OESTROGEN RECEPTOR BETA LIGAND-BINDING DOMAIN IN COMPLEX WITH PURE ANTIOESTROGEN ICI164,384 1AWP ; 2.00 ; RAT OUTER MITOCHONDRIAL MEMBRANE CYTOCHROME B5 1B5M ; 2.70 ; RAT OUTER MITOCHONDRIAL MEMBRANE CYTOCHROME B5 1EUE ; 1.80 ; RAT OUTER MITOCHONDRIAL MEMBRANE CYTOCHROME B5 1ICC ; 2.00 ; RAT OUTER MITOCHONDRIAL MEMBRANE CYTOCHROME B5 1BU8 ; 1.80 ; RAT PANCREATIC LIPASE RELATED PROTEIN 2 2A1L ; 2.18 ; RAT PITP-BETA COMPLEXED TO PHOSPHATIDYLCHOLINE 1MIR ; 2.80 ; RAT PROCATHEPSIN B 1SA5 ; 2.60 ; RAT PROTEIN FARNESYLTRANSFERASE COMPLEXED WITH FPP AND BMS- 214662 1TNY ; 2.70 ; RAT PROTEIN GERANYLGERANYLTRANSFERASE TYPE-I COMPLEXED WITH A GGPP ANALOG AND A FREKKFFCAIL PEPTIDE DERIVED FROM THE HETEROTRIMERIC G PROTEIN GAMMA-2 SUBUNIT 1TNU ; 2.70 ; RAT PROTEIN GERANYLGERANYLTRANSFERASE TYPE-I COMPLEXED WITH A GGPP ANALOG AND A GCINCCKVL PEPTIDE DERIVED FROM RHOB 1TNO ; 2.70 ; RAT PROTEIN GERANYLGERANYLTRANSFERASE TYPE-I COMPLEXED WITH A GGPP ANALOG AND A KKKSKTKCVIM PEPTIDE DERIVED FROM K- RAS4B 1TNZ ; 2.90 ; RAT PROTEIN GERANYLGERANYLTRANSFERASE TYPE-I COMPLEXED WITH A GGPP ANALOG AND A RRCVLL PEPTIDE DERIVED FROM CDC42 SPLICE ISOFORM-2 1TNB ; 2.85 ; RAT PROTEIN GERANYLGERANYLTRANSFERASE TYPE-I COMPLEXED WITH A GGPP ANALOG AND A SUBSTRATE KKSKTKCVIF PEPTIDE DERIVED FROM TC21 1S64 ; 2.55 ; RAT PROTEIN GERANYLGERANYLTRANSFERASE TYPE-I COMPLEXED WITH L-778,123 AND A SULFATE ANION 1W16 ; 2.30 ; RAT SYNAPTOTAGMIN 4 C2B DOMAIN IN THE ABSENCE OF CALCIUM 1W15 ; 1.93 ; RAT SYNAPTOTAGMIN 4 C2B DOMAIN IN THE PRESENCE OF CALCIUM 1GKE ; 2.50 ; RAT TRANSTHYRETIN 1KGJ ; 2.30 ; RAT TRANSTHYRETIN (ALSO CALLED PREALBUMIN) COMPLEX WITH 3', 5'-DIBROMOFLAVONE (EMD21388) 1KGI ; 1.80 ; RAT TRANSTHYRETIN (ALSO CALLED PREALBUMIN) COMPLEX WITH 3, 3',5,5'-TETRAIODOTHYROACETIC ACID (T4AC) 1IE4 ; 2.50 ; RAT TRANSTHYRETIN COMPLEX WITH THYROXINE (T4) 1F7Z ; 1.55 ; RAT TRYPSINOGEN K15A COMPLEXED WITH BOVINE PANCREATIC TRYPSIN INHIBITOR 1F5R ; 1.65 ; RAT TRYPSINOGEN MUTANT COMPLEXED WITH BOVINE PANCREATIC TRYPSIN INHIBITOR 1AB8 ; 2.60 ; RAT TYPE II ADENYLYL CYCLASE C2 DOMAIN/FORSKOLIN COMPLEX 1T6W ; -1.00 ; RATIONAL DESIGN OF A CALCIUM-BINDING ADHESION PROTEIN NMR, 20 STRUCTURES 1USB ; 2.07 ; RATIONAL DESIGN OF A NOVEL ENZYME - EFFICIENT THIOESTER HYDROLYSIS ENABLED BY THE INCORPORATION OF A SINGLE HIS RESIDUE INTO HUMAN GLUTATHIONE TRANSFERASE A1-1 1GUX ; 1.85 ; RB POCKET BOUND TO E7 LXCXE MOTIF 2RGF ; -1.00 ; RBD OF RAL GUANOSINE-NUCLEOTIDE EXCHANGE FACTOR (PROTEIN), NMR, 10 STRUCTURES 1QSD ; 2.20 ; RBL2P, BETA-TUBULIN BINDING POST-CHAPERONIN COFACTOR 1XXE ; -1.00 ; RDC REFINED SOLUTION STRUCTURE OF THE AALPXC/TU-514 COMPLEX 1RO4 ; -1.00 ; RDC-DERIVED MODELS OF THE ZINC RIBBON DOMAIN OF HUMAN GENERAL TRANSCRIPTION FACTOR TFIIB (ZINC FREE STRUCTURES) 1RLY ; -1.00 ; RDC-DERIVED MODELS OF THE ZINC RIBBON DOMAIN OF HUMAN GENERAL TRANSCRIPTION TFIIB (ZINC BOUND STRUCTURES) 1NTI ; -1.00 ; RDC-REFINED NMR STRUCTURE OF BOVINE ACYL-COENZYME A BINDING PROTEIN, ACBP 1NVL ; -1.00 ; RDC-REFINED NMR STRUCTURE OF BOVINE ACYL-COENZYME A BINDING PROTEIN, ACBP, IN COMPLEX WITH PALMITOYL-COENZYME A 1YJJ ; -1.00 ; RDC-REFINED SOLUTION NMR STRUCTURE OF OXIDIZED PUTIDAREDOXIN 1YJI ; -1.00 ; RDC-REFINED SOLUTION NMR STRUCTURE OF REDUCED PUTIDAREDOXIN 1I53 ; 1.80 ; RE(I)-TRICARBONLY DIIMINE (Q107H)) AZURIN 1YO7 ; 2.80 ; RE-ENGINEERING TOPOLOGY OF THE HOMODIMERIC ROP PROTEIN INTO A SINGLE-CHAIN 4-HELIX BUNDLE 1IZ7 ; 1.58 ; RE-REFINEMENT OF THE STRUCTURE OF HYDROLYTIC HALOALKANE DEHALOGENASE LINB FROM SPHINGOMONAS PAUCIMOBILIS UT26 AT 1.6 A RESOLUTION 1IZ8 ; 2.00 ; RE-REFINEMENT OF THE STRUCTURE OF HYDROLYTIC HALOALKANE DEHALOGENASE LINB FROM SPHINGOMONAS PAUCIMOBILIS UT26 WITH 1,3-PROPANEDIOL, A PRODUCT OF DEBROMIDATION OF DIBROMPROPANE, AT 2.0A RESOLUTION 1S4S ; 1.90 ; REACTION INTERMEDIATE IN THE PHOTOCYCLE OF PYP, INTERMEDIATE OCCUPIED BETWEEN 100 MICRO-SECONDS TO 5 MILLI- SECONDS 1P6G ; 12.30 ; REAL SPACE REFINED COORDINATES OF THE 30S SUBUNIT FITTED INTO THE LOW RESOLUTION CRYO-EM MAP OF THE EF-G.GTP STATE OF E. COLI 70S RIBOSOME 1P87 ; 11.50 ; REAL SPACE REFINED COORDINATES OF THE 30S SUBUNIT FITTED INTO THE LOW RESOLUTION CRYO-EM MAP OF THE INITIATION-LIKE STATE OF E. COLI 70S RIBOSOME 1P85 ; 12.30 ; REAL SPACE REFINED COORDINATES OF THE 50S SUBUNIT FITTED INTO THE LOW RESOLUTION CRYO-EM MAP OF THE EF-G.GTP STATE OF E. COLI 70S RIBOSOME 1P86 ; 11.50 ; REAL SPACE REFINED COORDINATES OF THE 50S SUBUNIT FITTED INTO THE LOW RESOLUTION CRYO-EM MAP OF THE INITIATION-LIKE STATE OF E. COLI 70S RIBOSOME 1B80 ; 1.73 ; REC. LIGNIN PEROXIDASE H8 OXIDATIVELY PROCESSED 2REC ; -1.00 ; RECA HEXAMER MODEL, ELECTRON MICROSCOPY 1EW1 ; -1.00 ; RECA PROTEIN-BOUND SINGLE-STRANDED DEOXYRIBONUCLEIC ACID 1MO3 ; 3.10 ; RECA-ADP COMPLEX 1G18 ; 3.80 ; RECA-ADP-ALF4 COMPLEX 1MO4 ; 3.20 ; RECA-ATP-GAMMA-S COMPLEX 1MO5 ; 3.25 ; RECA-ATP-GAMMA-S-MG COMPLEX 1MO6 ; 3.20 ; RECA-DATP-MG COMPLEX 1W36 ; 3.10 ; RECBCD:DEOXYRIBONUCLEIC ACID COMPLEX 1LRE ; -1.00 ; RECEPTOR ASSOCIATED PROTEIN (RAP) DOMAIN 1, NMR, 20 STRUCTURES 1NRE ; -1.00 ; RECEPTOR ASSOCIATED PROTEIN (RAP) DOMAIN 1, NMR, MINIMIZED AVERAGE STRUCTURE 1AYO ; 1.90 ; RECEPTOR BINDING DOMAIN OF BOVINE ALPHA-2-MACROGLOBULIN 1BV8 ; -1.00 ; RECEPTOR DOMAIN FROM ALPHA-2-MACROGLOBULIN 1YFO ; 2.25 ; RECEPTOR PROTEIN TYROSINE PHOSPHATASE ALPHA, DOMAIN 1 FROM MOUSE 1LCS ; 2.50 ; RECEPTOR-BINDING DOMAIN FROM SUBGROUP B FELINE LEUKEMIA VIRUS 1GEA ; -1.00 ; RECEPTOR-BOUND CONFORMATION OF PACAP21 1AN2 ; 2.90 ; RECOGNITION BY MAX OF ITS COGNATE DEOXYRIBONUCLEIC ACID 1LJ2 ; 2.38 ; RECOGNITION OF EIF4G BY ROTAVIRUS NSP3 REVEALS A BASIS FOR MRNA CIRCULARIZATION 1ZB5 ; 2.45 ; RECOGNITION OF PEPTIDE LIGANDS BY SIGNALLING PROTEIN FROM PORCINE MAMMARY GLAND (SPP-40): CRYSTAL STRUCTURE OF THE COMPLEX OF SPP-40 WITH A PEPTIDE TRP-PRO-TRP AT 2.45A RESOLUTION 1ZBK ; 2.90 ; RECOGNITION OF SPECIFIC PEPTIDE SEQUENCES BY SIGNALLING PROTEIN FROM SHEEP MAMMARY GLAND (SPS-40): CRYSTAL STRUCTURE OF THE COMPLEX OF SPS-40 WITH A PEPTIDE TRP-PRO- TRP AT 2.9A RESOLUTION 1KNZ ; 2.45 ; RECOGNITION OF THE ROTAVIRUS MRNA 3' CONSENSUS BY AN ASYMMETRIC NSP3 HOMODIMER 1AHQ ; 2.30 ; RECOMBINANT ACTOPHORIN 1VNS ; 1.66 ; RECOMBINANT APO-CHLOROPEROXIDASE FROM CURVULARIA INAEQUALIS 1RAV ; 2.20 ; RECOMBINANT AVIDIN 1BFA ; 2.20 ; RECOMBINANT BIFUNCTIONAL HAGEMAN FACTOR/AMYLASE INHIBITOR FROM MAIZE 1CKI ; 2.30 ; RECOMBINANT CASEIN KINASE I DELTA TRUNCATION MUTANT CONTAINING RESIDUES 1 - 317 1MIT ; -1.00 ; RECOMBINANT CUCURBITA MAXIMA TRYPSIN INHIBITOR V (RCMTI-V) (NMR, MINIMIZED AVERAGE STRUCTURE) 1RMH ; 2.40 ; RECOMBINANT CYCLOPHILIN A FROM HUMAN T CELL 3ERA ; 1.70 ; RECOMBINANT ERABUTOXIN A (S8T MUTANT) 2ERA ; 1.80 ; RECOMBINANT ERABUTOXIN A, S8G MUTANT 1HMK ; 2.00 ; RECOMBINANT GOAT ALPHA-LACTALBUMIN 1FKV ; 2.00 ; RECOMBINANT GOAT ALPHA-LACTALBUMIN T29I 1FKQ ; 1.80 ; RECOMBINANT GOAT ALPHA-LACTALBUMIN T29V 6ATJ ; 2.00 ; RECOMBINANT HORSERADISH PEROXIDASE C COMPLEX WITH FERULIC ACID 1ATJ ; 2.15 ; RECOMBINANT HORSERADISH PEROXIDASE C1A 1GWU ; 1.31 ; RECOMBINANT HORSERADISH PEROXIDASE C1A ALA140GLY 1GWO ; 2.07 ; RECOMBINANT HORSERADISH PEROXIDASE C1A ALA170GLN 7ATJ ; 1.47 ; RECOMBINANT HORSERADISH PEROXIDASE C1A COMPLEX WITH CYANIDE AND FERULIC ACID 1GWT ; 1.70 ; RECOMBINANT HORSERADISH PEROXIDASE C1A PHE221MET 1GW2 ; 2.15 ; RECOMBINANT HORSERADISH PEROXIDASE C1A THR171SER IN COMPLEX WITH FERULIC ACID 2ATJ ; 2.00 ; RECOMBINANT HORSERADISH PEROXIDASE COMPLEX WITH BENZHYDROXAMIC ACID 1GX2 ; 2.20 ; RECOMBINANT HORSERADISH PEROXIDASE PHE209SER COMPLEX WITH BENZHYDROXAMIC ACID 1F13 ; 2.10 ; RECOMBINANT HUMAN CELLULAR COAGULATION FACTOR XIII 1FIE ; 2.50 ; RECOMBINANT HUMAN COAGULATION FACTOR XIII 1B0L ; 2.20 ; RECOMBINANT HUMAN DIFERRIC LACTOFERRIN 1QMT ; 2.40 ; RECOMBINANT HUMAN EOSINOPHIL CATIONIC PROTEIN 1FIB ; 2.10 ; RECOMBINANT HUMAN GAMMA-FIBRINOGEN CARBOXYL TERMINAL FRAGMENT (RESIDUES 143-411) BOUND TO CALCIUM AT PH 6.0 3FIB ; 2.10 ; RECOMBINANT HUMAN GAMMA-FIBRINOGEN CARBOXYL TERMINAL FRAGMENT (RESIDUES 143-411) BOUND TO CALCIUM AT PH 6.0: A FURTHER REFINEMENT OF PDB ENTRY 1FIB, AND DIFFERS FROM 1FIB BY THE MODELLING OF A CIS PEPTIDE BOND BETWEEN RESIDUES K338 AND C339 2FIB ; 2.10 ; RECOMBINANT HUMAN GAMMA-FIBRINOGEN CARBOXYL TERMINAL FRAGMENT (RESIDUES 143-411) COMPLEXED TO THE PEPTIDE GLY-PRO-ARG-PRO AT PH 6.0 1U31 ; 2.20 ; RECOMBINANT HUMAN HEART TRANSHYDROGENASE DIII BOUND WITH NADPH 1HKC ; 2.80 ; RECOMBINANT HUMAN HEXOKINASE TYPE I COMPLEXED WITH GLUCOSE AND PHOSPHATE 1RH2 ; 2.90 ; RECOMBINANT HUMAN INTERFERON-ALPHA 2B 1WAR ; 2.22 ; RECOMBINANT HUMAN PURPLE ACID PHOSPHATASE EXPRESSED IN PICHIA PASTORIS 1INO ; 2.20 ; RECOMBINANT INORGANIC PYROPHOSPHATASE FROM ESCHERICHIA COLI 1KIV ; 2.10 ; RECOMBINANT KRINGLE IV-10/M66 VARIANT OF HUMAN APOLIPOPROTEIN(A) 3KIV ; 1.80 ; RECOMBINANT KRINGLE IV-10/M66 VARIANT OF HUMAN APOLIPOPROTEIN(A) 4KIV ; 2.20 ; RECOMBINANT KRINGLE IV-10/W72R MUTANT OF HUMAN APOLIPOPROTEIN(A) 2LVE ; 2.70 ; RECOMBINANT LEN 1H96 ; 1.60 ; RECOMBINANT MOUSE L-CHAIN FERRITIN 1J4B ; 2.50 ; RECOMBINANT MOUSE-MUSCLE ADENYLOSUCCINATE SYNTHETASE 1A90 ; -1.00 ; RECOMBINANT MUTANT CHICKEN EGG WHITE CYSTATIN, NMR, 31 STRUCTURES 2ETE ; 1.75 ; RECOMBINANT OXALATE OXIDASE IN COMPLEX WITH GLYCOLATE 1F3W ; 3.00 ; RECOMBINANT RABBIT MUSCLE PYRUVATE KINASE 1BC1 ; 2.05 ; RECOMBINANT RAT ANNEXIN V, QUADRUPLE MUTANT (T72K, S144K, S228K, S303K) 1BCW ; 2.10 ; RECOMBINANT RAT ANNEXIN V, T72A MUTANT 1BCY ; 1.95 ; RECOMBINANT RAT ANNEXIN V, T72K MUTANT 1BCZ ; 2.20 ; RECOMBINANT RAT ANNEXIN V, T72S MUTANT 1BC3 ; 1.95 ; RECOMBINANT RAT ANNEXIN V, TRIPLE MUTANT (T72K, S144K, S228K) 1BC0 ; 2.00 ; RECOMBINANT RAT ANNEXIN V, W185A MUTANT 1AFS ; 2.50 ; RECOMBINANT RAT LIVER 3-ALPHA-HYDROXYSTEROID DEHYDROGENASE (3-ALPHA-HSD) COMPLEXED WITH NADP AND TESTOSTERONE 1RNW ; 1.80 ; RECOMBINANT RIBONUCLEASE A CRYSTALLIZED FROM 80% AMMONIUM SULPHATE 1BJ4 ; 2.65 ; RECOMBINANT SERINE HYDROXYMETHYLTRANSFERASE (HUMAN) 1EJI ; 2.90 ; RECOMBINANT SERINE HYDROXYMETHYLTRANSFERASE (MOUSE) 2MBW ; 1.50 ; RECOMBINANT SPERM WHALE MYOGLOBIN (MET) 1OBM ; 1.85 ; RECOMBINANT SPERM WHALE MYOGLOBIN 29F/64Q/68F/122N MUTANT (MET) 1LTW ; 1.70 ; RECOMBINANT SPERM WHALE MYOGLOBIN 29W MUTANT (OXY) 1OFK ; 1.80 ; RECOMBINANT SPERM WHALE MYOGLOBIN F43H, H64L MUTANT (MET) 1LUE ; 1.70 ; RECOMBINANT SPERM WHALE MYOGLOBIN H64D/V68A/D122N MUTANT (MET) 1O16 ; 1.95 ; RECOMBINANT SPERM WHALE MYOGLOBIN H64D/V68S/D122N MUTANT (MET) 1DTI ; 1.70 ; RECOMBINANT SPERM WHALE MYOGLOBIN H97D, D122N MUTANT (MET) 1CH7 ; 1.90 ; RECOMBINANT SPERM WHALE MYOGLOBIN H97F MUTANT (MET) 1CH9 ; 1.80 ; RECOMBINANT SPERM WHALE MYOGLOBIN H97Q MUTANT (MET) 1CH5 ; 2.10 ; RECOMBINANT SPERM WHALE MYOGLOBIN H97V MUTANT (MET) 1CIK ; 1.70 ; RECOMBINANT SPERM WHALE MYOGLOBIN I99A MUTANT (MET) 1CIO ; 1.60 ; RECOMBINANT SPERM WHALE MYOGLOBIN I99V MUTANT (MET) 1J52 ; 1.90 ; RECOMBINANT SPERM WHALE MYOGLOBIN IN THE PRESENCE OF 7ATM XENON 1CO8 ; 1.80 ; RECOMBINANT SPERM WHALE MYOGLOBIN L104A MUTANT (MET) 1CP5 ; 2.10 ; RECOMBINANT SPERM WHALE MYOGLOBIN L104F MUTANT (MET) 1CP0 ; 2.00 ; RECOMBINANT SPERM WHALE MYOGLOBIN L104N MUTANT (MET) 1CO9 ; 1.60 ; RECOMBINANT SPERM WHALE MYOGLOBIN L104V MUTANT (MET) 1CPW ; 2.20 ; RECOMBINANT SPERM WHALE MYOGLOBIN L104W MUTANT (MET) 1OFJ ; 1.80 ; RECOMBINANT SPERM WHALE MYOGLOBIN L29H/H64L/D122N MUTANT (WITH INITIATOR MET) 1CH2 ; 1.80 ; RECOMBINANT SPERM WHALE MYOGLOBIN L89F MUTANT (MET) 1CH1 ; 1.90 ; RECOMBINANT SPERM WHALE MYOGLOBIN L89G MUTANT (MET) 1CH3 ; 2.00 ; RECOMBINANT SPERM WHALE MYOGLOBIN L89W MUTANT (MET) 1OS8 ; 1.55 ; RECOMBINANT STREPTOMYCES GRISEUS TRYPSIN 1X35 ; 4.10 ; RECOMBINANT T3 CAPSID OF A SITE SPECIFIC MUTANT OF SEMV CP 1UP8 ; 2.20 ; RECOMBINANT VANADIUM-DEPENDENT BROMOPEROXIDASE FROM RED ALGAE CORALLINA PILULIFERA 1YFM ; 2.60 ; RECOMBINANT YEAST FUMARASE 1U5K ; 2.00 ; RECOMBINATIONAL REPAIR PROTEIN RECO 1ZXI ; 1.70 ; RECONSTITUTED CO DEHYDROGENASE FROM OLIGOTROPHA CARBOXIDOVORANS 1C1N ; 1.40 ; RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES 1C1O ; 1.40 ; RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES 1C1P ; 1.37 ; RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES 1C1Q ; 1.37 ; RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES 1C1R ; 1.37 ; RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES 1C1S ; 1.63 ; RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES 1C1T ; 1.37 ; RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES 1C1U ; 1.75 ; RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES 1C1V ; 1.98 ; RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES 1C1W ; 1.90 ; RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES 1C2D ; 1.65 ; RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES 1C2E ; 1.65 ; RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES 1C2F ; 1.70 ; RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES 1C2G ; 1.65 ; RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES 1C2H ; 1.40 ; RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES 1C2I ; 1.47 ; RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES 1C2J ; 1.40 ; RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES 1C2K ; 1.65 ; RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES 1C2L ; 1.50 ; RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES 1C2M ; 1.40 ; RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES 1IBY ; 1.65 ; RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA 1IBZ ; 2.30 ; RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA 1IC0 ; 2.10 ; RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA 1GGX ; 1.90 ; RED FLUORESCENT PROTEIN (FP583 OR DSRED(CLONTECH)) FROM DISCOSOMA SP. 1DCU ; 2.20 ; REDOX SIGNALING IN THE CHLOROPLAST: STRUCTURE OF OXIDIZED PEA FRUCTOSE-1,6-BISPHOSPHATE PHOSPHATASE 3PHM ; 2.10 ; REDUCED (CU+) PEPTIDYLGLYCINE ALPHA-HYDROXYLATING MONOOXYGENASE (PHM) 1SDW ; 1.85 ; REDUCED (CU+) PEPTIDYLGLYCINE ALPHA-HYDROXYLATING MONOOXYGENASE WITH BOUND PEPTIDE AND DIOXYGEN 1DZ0 ; 1.75 ; REDUCED AZURIN II FROM ALCALIGENES XYLOSOXIDANS 1FOL ; 2.20 ; REDUCED BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH L-ARG(H4B-FREE) 1SXN ; 1.90 ; REDUCED BOVINE SUPEROXIDE DISMUTASE AT PH 5.0 1SXZ ; 2.05 ; REDUCED BOVINE SUPEROXIDE DISMUTASE AT PH 5.0 COMPLEXED WITH AZIDE 1SXS ; 2.00 ; REDUCED BOVINE SUPEROXIDE DISMUTASE AT PH 5.0 COMPLEXED WITH THIOCYANATE 1JCV ; 1.55 ; REDUCED BRIDGE-BROKEN YEAST CU/ZN SUPEROXIDE DISMUTASE LOW TEMPERATURE (-180C) STRUCTURE 2JCW ; 1.70 ; REDUCED BRIDGE-BROKEN YEAST CU/ZN SUPEROXIDE DISMUTASE ROOM TEMPERATURE (298K) STRUCTURE 1DDO ; 3.10 ; REDUCED D-AMINO ACID OXIDASE FROM PIG KIDNEY IN COMPLEX WITH IMINO-TRP 4DMR ; 1.90 ; REDUCED DMSO REDUCTASE FROM RHODOBACTER CAPSULATUS WITH BOUND DMSO SUBSTRATE 1A2L ; 2.70 ; REDUCED DSBA AT 2.7 ANGSTROMS RESOLUTION 1RZ1 ; 2.10 ; REDUCED FLAVIN REDUCTASE PHEA2 IN COMPLEX WITH NAD 1YPN ; 2.30 ; REDUCED FORM HYDROXYMETHYLBILANE SYNTHASE (K59Q MUTANT) CRYSTAL STRUCTURE AFTER 2 HOURS IN A FLOW CELL DETERMINED BY TIME-RESOLVED LAUE DIFFRACTION 1AA6 ; 2.30 ; REDUCED FORM OF FORMATE DEHYDROGENASE H FROM E. COLI 1KDI ; 1.80 ; REDUCED FORM OF PLASTOCYANIN FROM DRYOPTERIS CRASSIRHIZOMA 1DXM ; 2.60 ; REDUCED FORM OF THE H PROTEIN FROM GLYCINE DECARBOXYLASE COMPLEX 1AH5 ; 2.40 ; REDUCED FORM SELENOMETHIONINE-LABELLED HYDROXYMETHYLBILANE SYNTHASE DETERMINED BY MAD 1LT8 ; 2.05 ; REDUCED HOMO SAPIENS BETAINE-HOMOCYSTEINE S- METHYLTRANSFERASE IN COMPLEX WITH S-(DELTA-CARBOXYBUTYL)-L- HOMOCYSTEINE 1OA1 ; 1.55 ; REDUCED HYBRID CLUSTER PROTEIN (HCP) FROM DESULFOVIBRIO VULGARIS HILDENBOROUGH STRUCTURE AT 1.55A RESOLUTION USING SYNCHROTRON RADIATION. 1OA0 ; 1.25 ; REDUCED HYBRID CLUSTER PROTEIN FROM DESULFOVIBRIO DESULFURICANS X-RAY STRUCTURE AT 1.25A RESOLUTION 5PAZ ; 1.76 ; REDUCED MUTANT P80A PSEUDOAZURIN FROM A. FAECALIS 7PAZ ; 2.00 ; REDUCED MUTANT P80I PSEUDOAZURIN FROM A. FAECALIS 3PAZ ; 1.73 ; REDUCED NATIVE PSEUDOAZURIN FROM A. FAECALIS 1M1R ; 1.02 ; REDUCED P222 CRYSTAL STRUCTURE OF THE TETRAHEME CYTOCHROME C OF SHEWANELLA ONEIDENSIS MR1 1YJK ; 2.00 ; REDUCED PEPTIDYLGLYCINE ALPHA-HYDROXYLATING MONOOXYGENASE (PHM) IN A NEW CRYSTAL FORM 1YJL ; 2.40 ; REDUCED PEPTIDYLGLYCINE ALPHA-HYDROXYLATING MONOOXYGENASE IN A NEW CRYSTAL FORM 1BXV ; 1.80 ; REDUCED PLASTOCYANIN FROM SYNECHOCOCCUS SP. 1H6A ; 2.50 ; REDUCED PRECURSOR FORM OF GLUCOSE-FRUCTOSE OXIDOREDUCTASE FROM ZYMOMONAS MOBILIS 1H6B ; 2.60 ; REDUCED PRECURSOR FORM OF GLUCOSE-FRUCTOSE OXIDOREDUCTASE FROM ZYMOMONAS MOBILIS COMPLEXED WITH GLYCEROL 1BQR ; 1.60 ; REDUCED PSEUDOAZURIN 1ZIB ; 2.00 ; REDUCED PSEUDOAZURIN 1A3Z ; 1.90 ; REDUCED RUSTICYANIN AT 1.9 ANGSTROMS 1CUR ; -1.00 ; REDUCED RUSTICYANIN, NMR 1H32 ; 1.50 ; REDUCED SOXAX COMPLEX FROM RHODOVULUM SULFIDOPHILUM 1SFH ; 1.05 ; REDUCED STATE OF AMICYANIN MUTANT P94F 1FT6 ; 1.80 ; REDUCED STATE OF CYTOCHROME C554 FROM NITROSOMONAS EUROPAEA 1GMB ; 2.00 ; REDUCED STRUCTURE OF CYTOCHROME C3 FROM DESULFOVIBRIO DESULFURICANS ATCC 27774 AT PH 7.6 1UP9 ; 1.35 ; REDUCED STRUCTURE OF CYTOCHROME C3 FROM DESULFOVIBRIO DESULFURICANS ATCC 27774 AT PH 7.6 3CAR ; 1.90 ; REDUCED STRUCTURE OF THE ACIDIC CYTOCHROME C3 FROM DESULFOVIBRIO AFRICANUS 1SU9 ; 1.95 ; REDUCED STRUCTURE OF THE SOLUBLE DOMAIN OF RESA 2GLS ; 3.50 ; REFINED ATOMIC MODEL OF GLUTAMINE SYNTHETASE AT 3.5 ANGSTROMS RESOLUTION 2WBC ; 2.30 ; REFINED CRYSTAL STRUCTURE (2.3 ANGSTROM) OF A WINGED BEAN CHYMOTRYPSIN INHIBITOR AND LOCATION OF ITS SECOND REACTIVE SITE 1JUY ; 2.60 ; REFINED CRYSTAL STRUCTURE OF ADENYLOSUCCINATE SYNTHETASE FROM ESCHERICHIA COLI COMPLEXED WITH HYDANTOCIDIN 5'-PHOSPHATE GDP, HPO4(2-), MG2+, AND HADACIDIN 1FR1 ; 2.00 ; REFINED CRYSTAL STRUCTURE OF BETA-LACTAMASE FROM CITROBACTER FREUNDII INDICATES A MECHANISM FOR BETA-LACTAM HYDROLYSIS 1FR6 ; 2.50 ; REFINED CRYSTAL STRUCTURE OF BETA-LACTAMASE FROM CITROBACTER FREUNDII INDICATES A MECHANISM FOR BETA-LACTAM HYDROLYSIS 1BU3 ; 1.65 ; REFINED CRYSTAL STRUCTURE OF CALCIUM-BOUND SILVER HAKE (PI 4.2) PARVALBUMIN AT 1.65 A. 1DGR ; 2.60 ; REFINED CRYSTAL STRUCTURE OF CANAVALIN FROM JACK BEAN 2OXI ; 2.10 ; REFINED CRYSTAL STRUCTURE OF CU-SUBSTITUTED ALCOHOL DEHYDROGENASE AT 2.1 ANGSTROMS RESOLUTION 1HH7 ; 1.40 ; REFINED CRYSTAL STRUCTURE OF CYTOCHROME C2 FROM RHODOPSEUDOMONAS PALUSTRIS AT 1.4 ANGSTROM RESOLUTION 3PBH ; 2.50 ; REFINED CRYSTAL STRUCTURE OF HUMAN PROCATHEPSIN B AT 2.5 ANGSTROM RESOLUTION 1C8M ; 2.80 ; REFINED CRYSTAL STRUCTURE OF HUMAN RHINOVIRUS 16 COMPLEXED WITH VP63843 (PLECONARIL), AN ANTI-PICORNAVIRAL DRUG CURRENTLY IN CLINICAL TRIALS 1S72 ; 2.40 ; REFINED CRYSTAL STRUCTURE OF THE HALOARCULA MARISMORTUI LARGE RIBOSOMAL SUBUNIT AT 2.4 ANGSTROM RESOLUTION 1GLM ; 2.40 ; REFINED CRYSTAL STRUCTURES OF GLUCOAMYLASE FROM ASPERGILLUS AWAMORI VAR. X100 1DV0 ; -1.00 ; REFINED NMR SOLUTION STRUCTURE OF THE C-TERMINAL UBA DOMAIN OF THE HUMAN HOMOLOGUE OF RAD23A (HHR23A) 2HID ; -1.00 ; REFINED NMR STRUCTURE OF PHOSPHOCARRIER HISTIDINE CONTAINING PROTEIN FROM BACILLUS SUBTILIS 1J4O ; -1.00 ; REFINED NMR STRUCTURE OF THE FHA1 DOMAIN OF YEAST RAD53 1K3J ; -1.00 ; REFINED NMR STRUCTURE OF THE FHA1 DOMAIN OF YEAST RAD53 1Y1V ; 3.80 ; REFINED RIBONUCLEIC ACID POLYMERASE II-TFIIS COMPLEX 1Q2N ; -1.00 ; REFINED SOLUTION NMR STRUCTURE OF THE Z DOMAIN OF STAPHYLOCOCCAL PROTEIN A 1F3C ; -1.00 ; REFINED SOLUTION STRUCTURE OF 8KDA DYNEIN LIGHT CHAIN (DLC8) 1F71 ; -1.00 ; REFINED SOLUTION STRUCTURE OF CALMODULIN C-TERMINAL DOMAIN 1F70 ; -1.00 ; REFINED SOLUTION STRUCTURE OF CALMODULIN N-TERMINAL DOMAIN 1WRF ; -1.00 ; REFINED SOLUTION STRUCTURE OF DER F 2, THE MAJOR MITE ALLERGEN FROM DERMATOPHAGOIDES FARINAE 1KA5 ; -1.00 ; REFINED SOLUTION STRUCTURE OF HISTIDINE CONTAINING PHOSPHOCARRIER PROTEIN FROM STAPHYLOCCOCUS AUREUS 1GD3 ; -1.00 ; REFINED SOLUTION STRUCTURE OF HUMAN CYSTATIN A 1CW6 ; -1.00 ; REFINED SOLUTION STRUCTURE OF LEUCOCIN A 1FMF ; -1.00 ; REFINED SOLUTION STRUCTURE OF THE (13C,15N-LABELED) B12- BINDING SUBUNIT OF GLUTAMATE MUTASE FROM CLOSTRIDIUM TETANOMORPHUM 1FHQ ; -1.00 ; REFINED SOLUTION STRUCTURE OF THE FHA2 DOMAIN OF RAD53 1O7B ; -1.00 ; REFINED SOLUTION STRUCTURE OF THE HUMAN TSG-6 LINK MODULE 1DK2 ; -1.00 ; REFINED SOLUTION STRUCTURE OF THE N-TERMINAL DOMAIN OF DEOXYRIBONUCLEIC ACID POLYMERASE BETA 1DK3 ; -1.00 ; REFINED SOLUTION STRUCTURE OF THE N-TERMINAL DOMAIN OF DEOXYRIBONUCLEIC ACID POLYMERASE BETA 1SY4 ; -1.00 ; REFINED SOLUTION STRUCTURE OF THE S. CEREVISIAE U6 INTRAMOLECULAR STEM LOOP (ISL) RIBONUCLEIC ACID USING RESIDUAL DIPOLAR COUPLINGS (RDCS) 1JJZ ; -1.00 ; REFINED STRUCTURE AND DISULFIDE PAIRING OF THE KALATA B1 PEPTIDE 1K48 ; -1.00 ; REFINED STRUCTURE AND DISULFIDE PAIRING OF THE KALATA B1 PEPTIDE 1JFF ; 3.50 ; REFINED STRUCTURE OF ALPHA-BETA TUBULIN FROM ZINC-INDUCED SHEETS STABILIZED WITH TAXOL 5CRO ; 2.30 ; REFINED STRUCTURE OF CRO REPRESSOR PROTEIN FROM BACTERIOPHAGE LAMBDA 1N4Y ; -1.00 ; REFINED STRUCTURE OF KISTRIN 1R9U ; -1.00 ; REFINED STRUCTURE OF PEPTAIBOL ZERVAMICIN IIB IN METHANOL SOLUTION FROM TRANS-HYDROGEN BOND J COUPLINGS 1PVV ; 1.87 ; REFINED STRUCTURE OF PYROCOCCUS FURIOSUS ORNITHINE CARBAMOYLTRANSFERASE AT 1.87 A 1A34 ; 1.81 ; REFINED STRUCTURE OF SATELLITE TOBACCO MOSAIC VIRUS AT 1.8 ANGSTROMS RESOLUTION 1NO3 ; 2.15 ; REFINED STRUCTURE OF SOYBEAN LIPOXYGENASE-3 WITH 4- NITROCATECHOL AT 2.15 ANGSTROM RESOLUTION 2VIL ; -1.00 ; REFINED STRUCTURE OF THE ACTIN-SEVERING DOMAIN VILLIN 14T, DETERMINED BY SOLUTION NMR, 11 STRUCTURES 2VIK ; -1.00 ; REFINED STRUCTURE OF THE ACTIN-SEVERING DOMAIN VILLIN 14T, DETERMINED BY SOLUTION NMR, MINIMIZED AVERAGE STRUCTURE 1EYF ; -1.00 ; REFINED STRUCTURE OF THE DEOXYRIBONUCLEIC ACID METHYL PHOSPHOTRIESTER REPAIR DOMAIN OF E. COLI ADA 2BG9 ; 4.00 ; REFINED STRUCTURE OF THE NICOTINIC ACETYLCHOLINE RECEPTOR AT 4A RESOLUTION. 1HUJ ; 2.10 ; REFINED STRUCTURE OF YEAST INORGANIC PYROPHOSPHATASE AND ITS K61R MUTANT 1HUK ; 2.20 ; REFINED STRUCTURE OF YEAST INORGANIC PYROPHOSPHATASE AND ITS K61R MUTANT 1CZN ; 1.70 ; REFINED STRUCTURES OF OXIDIZED FLAVODOXIN FROM ANACYSTIS NIDULANS 1CZU ; 2.00 ; REFINED STRUCTURES OF OXIDIZED FLAVODOXIN FROM ANACYSTIS NIDULANS 1D03 ; 1.85 ; REFINED STRUCTURES OF OXIDIZED FLAVODOXIN FROM ANACYSTIS NIDULANS 1AJR ; 1.74 ; REFINEMENT AND COMPARISON OF THE CRYSTAL STRUCTURES OF PIG CYTOSOLIC ASPARTATE AMINOTRANSFERASE AND ITS COMPLEX WITH 2-METHYLASPARTATE 1AJS ; 1.60 ; REFINEMENT AND COMPARISON OF THE CRYSTAL STRUCTURES OF PIG CYTOSOLIC ASPARTATE AMINOTRANSFERASE AND ITS COMPLEX WITH 2-METHYLASPARTATE 1I1P ; 1.63 ; REFINEMENT INCLUDING EXPERIMENTAL MAD PHASES ALLOWS AN EXHAUSTIVE STUDY OF ORDERED SOLVENT MOLECULES FOR A PLATINATED DECANUCLEOTIDE 1P2Z ; 2.20 ; REFINEMENT OF ADENOVIRUS TYPE 2 HEXON WITH CNS 1P30 ; 2.50 ; REFINEMENT OF ADENOVIRUS TYPE 5 HEXON WITH CNS 1LXI ; 2.00 ; REFINEMENT OF BMP7 CRYSTAL STRUCTURE 1PQT ; -1.00 ; REFINEMENT OF D(GCGAAGC) HAIRPIN STRUCTURE USING ONE- AND TWO-BOND RESIDUAL DIPOLAR COUPLINGS 1KR8 ; -1.00 ; REFINEMENT OF D(GCGAAGC) HAIRPIN STRUCTURE USING ONE-AND TWO-BONDS RESIDUAL DIPOLAR COUPLINGS 1GQZ ; 1.75 ; REFINEMENT OF HAEMOPHILUS INFLUENZAE DIAMINOPIMELATE EPIMERASE AT 1.7A 1XX2 ; 1.88 ; REFINEMENT OF P99 BETA-LACTAMASE FROM ENTEROBACTER CLOACAE 2ABK ; 1.85 ; REFINEMENT OF THE NATIVE STRUCTURE OF ENDONUCLEASE III TO A RESOLUTION OF 1.85 ANGSTROM 3LZT ; 0.92 ; REFINEMENT OF TRICLINIC LYSOZYME AT ATOMIC RESOLUTION 1UTX ; 1.90 ; REGULATION OF CYTOLYSIN EXPRESSION BY ENTEROCOCCUS FAECALIS: ROLE OF CYLR2 1LX8 ; -1.00 ; REGULATION OF DIRECTIONALITY IN BACTERIOPHAGE LAMBDA SITE- SPECIFIC RECOMBINATION: STRUCTURE OF THE XIS PROTEIN 1OYO ; 2.02 ; REGULATION OF PROTEASE ACTIVITY BY MELANIN: CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN PROTEINASE K AND MELANIN MONOMERS AT 2.0 RESOLUTION 1ZVD ; 2.10 ; REGULATION OF SMURF2 UBIQUITIN LIGASE ACTIVITY BY ANCHORING THE E2 TO THE HECT DOMAIN 1B9M ; 1.75 ; REGULATOR FROM ESCHERICHIA COLI 1B9N ; 2.09 ; REGULATOR FROM ESCHERICHIA COLI 1A12 ; 1.70 ; REGULATOR OF CHROMOSOME CONDENSATION (RCC1) OF HUMAN 2BV1 ; 2.00 ; REGULATOR OF G-PROTEIN SIGNALLING 1 (HUMAN) 2AAO ; 2.00 ; REGULATORY APPARATUS OF CALCIUM DEPENDENT PROTEIN KINASE FROM ARABIDOPSIS THALIANA 1C7Z ; 2.60 ; REGULATORY COMPLEX OF FRUCTOSE-2,6-BISPHOSPHATASE 1C80 ; 2.20 ; REGULATORY COMPLEX OF FRUCTOSE-2,6-BISPHOSPHATASE 1SPY ; -1.00 ; REGULATORY DOMAIN OF HUMAN CARDIAC TROPONIN C IN THE CALCIUM-FREE STATE, NMR, 40 STRUCTURES 1AP4 ; -1.00 ; REGULATORY DOMAIN OF HUMAN CARDIAC TROPONIN C IN THE CALCIUM-SATURATED STATE, NMR, 40 STRUCTURES 1QAW ; 2.50 ; REGULATORY FEATURES OF THE TRP OPERON AND THE CRYSTAL STRUCTURE OF THE TRP RIBONUCLEIC ACID-BINDING ATTENUATION PROTEIN FROM BACILLUS STEAROTHERMOPHILUS. 1MC0 ; 2.86 ; REGULATORY SEGMENT OF MOUSE 3',5'-CYCLIC NUCLEOTIDE PHOSPHODIESTERASE 2A, CONTAINING THE GAF A AND GAF B DOMAINS 1RGS ; 2.80 ; REGULATORY SUBUNIT OF CAMP DEPENDENT PROTEIN KINASE 1KSB ; -1.00 ; RELATIONSHIP OF SOLUTION AND PROTEIN-BOUND STRUCTURES OF DEOXYRIBONUCLEIC ACID DUPLEXES WITH THE MAJOR INTRASTRAND CROSS-LINK LESIONS FORMED ON CISPLATIN BINDING TO DEOXYRIBONUCLEIC ACID 1M9L ; -1.00 ; RELAXATION-BASED REFINED STRUCTURE OF CHLAMYDOMONAS OUTER ARM DYNEIN LIGHT CHAIN 1 482D ; 1.54 ; RELEASE OF THE CYANO MOIETY IN THE CRYSTAL STRUCTURE OF N- CYANOMETHYL-N-(2-METHOXYETHYL)-DAUNOMYCIN COMPLEXED WITH D(CGATCG) 1EJ6 ; 3.60 ; REOVIRUS CORE 1MUK ; 2.50 ; REOVIRUS LAMBDA3 NATIVE STRUCTURE 1UON ; 7.60 ; REOVIRUS POLYMERASE LAMBDA-3 LOCALIZED BY ELECTRON CRYOMICROSCOPY OF VIRIONS AT 7.6-A RESOLUTION 1MWH ; 2.50 ; REOVIRUS POLYMERASE LAMBDA3 BOUND TO MRNA CAP ANALOG 1N38 ; 2.80 ; REOVIRUS POLYMERASE LAMBDA3 ELONGATION COMPLEX WITH ONE PHOSPHODIESTER BOND FORMED 1PQK ; 2.00 ; REPACKING OF THE CORE OF T4 LYSOZYME BY AUTOMATED DESIGN 1DUR ; 2.00 ; REPLACEMENT FOR 1FDX 2(4FE4S) FERREDOXIN FROM (NOW) PEPTOSTREPTOCOCCUS ASACCHAROLYTICUS 1RYR ; 2.28 ; REPLICATION OF A CIS-SYN THYMINE DIMER AT ATOMIC RESOLUTION 1RYS ; 2.03 ; REPLICATION OF A CIS-SYN THYMINE DIMER AT ATOMIC RESOLUTION 1BM9 ; 2.00 ; REPLICATION TERMINATOR PROTEIN FROM BACILLUS SUBTILIS 1R9K ; -1.00 ; REPRESENTATIVE SOLUTION STRUCTURE OF THE CATALYTIC DOMAIN OF SOPE2 1ZRR ; -1.00 ; RESIDUAL DIPOLAR COUPLING REFINEMENT OF ACIREDUCTONE DIOXYGENASE FROM KLEBSIELLA 1GFY ; 2.13 ; RESIDUE 259 IS A KEY DETERMINANT OF SUBSTRATE SPECIFICITY OF PROTEIN-TYROSINE PHOSPHATASE 1B AND ALPHA 1M07 ; 1.80 ; RESIDUES INVOLVED IN THE CATALYSIS AND BASE SPECIFICITY OF CYTOTOXIC RIBONUCLEASE FROM BULLFROG (RANA CATESBEIANA) 1QLA ; 2.20 ; RESPIRATORY COMPLEX II-LIKE FUMARATE REDUCTASE FROM WOLINELLA SUCCINOGENES 1QLB ; 2.33 ; RESPIRATORY COMPLEX II-LIKE FUMARATE REDUCTASE FROM WOLINELLA SUCCINOGENES 1BN9 ; -1.00 ; RESPONSE ELEMENT OF THE ORPHAN NUCLEAR RECEPTOR REV-ERB BETA 1I3C ; 1.90 ; RESPONSE REGULATOR FOR CYANOBACTERIAL PHYTOCHROME, RCP1 1W25 ; 2.70 ; RESPONSE REGULATOR PLED IN COMPLEX WITH C-DIGMP 1ESG ; 1.90 ; RESTRICTION ENDONUCLEASE BAMHI BOUND TO A NON-SPECIFIC DEOXYRIBONUCLEIC ACID. 1BHM ; 2.20 ; RESTRICTION ENDONUCLEASE BAMHI COMPLEX WITH DEOXYRIBONUCLEIC ACID 2BAM ; 2.00 ; RESTRICTION ENDONUCLEASE BAMHI COMPLEX WITH DEOXYRIBONUCLEIC ACID AND CALCIUM IONS (PRE-REACTIVE COMPLEX). 3BAM ; 1.80 ; RESTRICTION ENDONUCLEASE BAMHI COMPLEX WITH DEOXYRIBONUCLEIC ACID AND MANGANESE IONS (POST-REACTIVE COMPLEX) 1B97 ; 1.90 ; RESTRICTION ENDONUCLEASE ECORV MUTANT Q69L 1B94 ; 1.90 ; RESTRICTION ENDONUCLEASE ECORV WITH CALCIUM 1DC1 ; 1.70 ; RESTRICTION ENZYME BSOBI/DEOXYRIBONUCLEIC ACID COMPLEX STRUCTURE: ENCIRCLEMENT OF THE DEOXYRIBONUCLEIC ACID AND HISTIDINE-CATALYZED HYDROLYSIS WITHIN A CANONICAL RESTRICTION ENZYME FOLD 1BI9 ; 2.70 ; RETINAL DEHYDROGENASE TYPE TWO WITH NAD BOUND 1GH6 ; 3.20 ; RETINOBLASTOMA POCKET COMPLEXED WITH SV40 LARGE T ANTIGEN 2NLL ; 1.90 ; RETINOID X RECEPTOR-THYROID HORMONE RECEPTOR DEOXYRIBONUCLEIC ACID-BINDING DOMAIN HETERODIMER BOUND TO THYROID RESPONSE ELEMENT DEOXYRIBONUCLEIC ACID 1RLB ; 3.10 ; RETINOL BINDING PROTEIN COMPLEXED WITH TRANSTHYRETIN 1AQB ; 1.65 ; RETINOL-BINDING PROTEIN (RBP) FROM PIG PLASMA 1LO2 ; 2.00 ; RETRO-DIELS-ALDERASE CATALYTIC ANTIBODY 1LO4 ; 2.40 ; RETRO-DIELS-ALDERASE CATALYTIC ANTIBODY 9D9 1LO3 ; 2.30 ; RETRO-DIELS-ALDERASE CATALYTIC ANTIBODY: PRODUCT ANALOGUE 1BFW ; -1.00 ; RETRO-INVERSO ANALOGUE OF THE G-H LOOP OF VP1 IN FOOT- AND-MOUTH-DISEASE (FMD) VIRUS, NMR, 10 STRUCTURES 1ETG ; -1.00 ; REV RESPONSE ELEMENT (RRE) RIBONUCLEIC ACID COMPLEXED WITH REV PEPTIDE, NMR, 19 STRUCTURES 1ETF ; -1.00 ; REV RESPONSE ELEMENT (RRE) RIBONUCLEIC ACID COMPLEXED WITH REV PEPTIDE, NMR, MINIMIZED AVERAGE STRUCTURE 1GKU ; 2.70 ; REVERSE GYRASE FROM ARCHAEOGLOBUS FULGIDUS 1P43 ; 1.80 ; REVERSE PROTONATION IS THE KEY TO GENERAL ACID-BASE CATALYSIS IN ENOLASE 1P48 ; 2.00 ; REVERSE PROTONATION IS THE KEY TO GENERAL ACID-BASE CATALYSIS IN ENOLASE 1C94 ; 2.08 ; REVERSING THE SEQUENCE OF THE GCN4 LEUCINE ZIPPER DOES NOT AFFECT ITS FOLD. 1ZUE ; -1.00 ; REVISED SOLUTION STRUCTURE OF DLP-2 1FQI ; 1.94 ; RGS9 RGS DOMAIN 1TGG ; 2.00 ; RH3 DESIGNED RIGHT-HANDED COILED COIL TRIMER 1RH4 ; 1.90 ; RH4 DESIGNED RIGHT-HANDED COILED COIL TETRAMER 1DEO ; 1.55 ; RHAMNOGALACTURONAN ACETYLESTERASE FROM ASPERGILLUS ACULEATUS AT 1.55 A RESOLUTION WITH SO4 IN THE ACTIVE SITE 1DEX ; 1.90 ; RHAMNOGALACTURONAN ACETYLESTERASE FROM ASPERGILLUS ACULEATUS AT 1.9 A RESOLUTION 1K7C ; 1.12 ; RHAMNOGALACTURONAN ACETYLESTERASE WITH SEVEN N-LINKED CARBOHYDRATE RESIDUES DISTRIBUTED AT TWO N-GLYCOSYLATION SITES REFINED AT 1.12 A RESOLUTION 1NKG ; 1.50 ; RHAMNOGALACTURONAN LYASE FROM ASPERGILLUS ACULEATUS 1RMG ; 2.00 ; RHAMNOGALACTURONASE A FROM ASPERGILLUS ACULEATUS 1YBK ; 1.45 ; RHCC COCRYSTALLIZED WITH CAPB 1RUF ; 2.90 ; RHINOVIRUS 14 (HRV14) (MUTANT WITH ASN 1 219 REPLACED BY ALA (N219A IN CHAIN 1) 1RUC ; 3.10 ; RHINOVIRUS 14 MUTANT N1105S COMPLEXED WITH ANTIVIRAL COMPOUND WIN 52035 1RUD ; 2.90 ; RHINOVIRUS 14 MUTANT N1105S COMPLEXED WITH ANTIVIRAL COMPOUND WIN 52084 1RUG ; 3.00 ; RHINOVIRUS 14 MUTANT N1219S COMPLEXED WITH ANTIVIRAL COMPOUND WIN 52035 1RUH ; 3.00 ; RHINOVIRUS 14 MUTANT N1219S COMPLEXED WITH ANTIVIRAL COMPOUND WIN 52084 1RUI ; 3.00 ; RHINOVIRUS 14 MUTANT S1223G COMPLEXED WITH ANTIVIRAL COMPOUND WIN 52084 1RUJ ; 3.00 ; RHINOVIRUS 14 MUTANT WITH SER 1 223 REPLACED BY GLY (S1223G) 1RUE ; 2.90 ; RHINOVIRUS 14 SITE DIRECTED MUTANT N1219A COMPLEXED WITH ANTIVIRAL COMPOUND WIN 52035 2A8V ; 2.40 ; RHO TRANSCRIPTION TERMINATION FACTOR/RIBONUCLEIC ACID COMPLEX 1TX4 ; 1.65 ; RHO/RHOGAP/GDP(DOT)ALF4 COMPLEX 2ORA ; 2.00 ; RHODANESE (THIOSULFATE: CYANIDE SULFURTRANSFERASE) 1ZRT ; 3.50 ; RHODOBACTER CAPSULATUS CYTOCHROME BC1 COMPLEX WITH STIGMATELLIN BOUND 1JO5 ; -1.00 ; RHODOBACTER SPHAEROIDES LIGHT HARVESTING 1 BETA SUBUNIT IN DETERGENT MICELLES 2PRN ; 1.93 ; RHODOPSEUDOMONAS BLASTICA PORIN, TRIPLE MUTANT E1M, E99W, A116W 1I8O ; 1.15 ; RHODOPSEUDOMONAS PALUSTRIS CYT C2 AMMONIA COMPLEX AT 1.15 ANGSTROM RESOLUTION 1RMV ; 2.90 ; RIBGRASS MOSAIC VIRUS, FIBER DIFFRACTION 1KZL ; 2.10 ; RIBOFLAVIN SYNTHASE FROM S.POMBE BOUND TO CARBOXYETHYLLUMAZINE 1RSN ; 2.00 ; RIBONUCLEASE (RNASE SA) COMPLEXED WITH EXO-2',3'-CYCLOPHOSPHOROTHIOATE 1BU4 ; 1.90 ; RIBONUCLEASE 1 COMPLEX WITH 2'GMP 1E21 ; 1.90 ; RIBONUCLEASE 1 DES1-7 CRYSTAL STRUCTURE AT 1.9A 1RNM ; 2.00 ; RIBONUCLEASE A COMPLEX WITH CYTIDYLIC ACID (5'CMP) CRYSTALLIZED FROM 80% AMMONIUM SULPHATE 1RNN ; 1.80 ; RIBONUCLEASE A COMPLEX WITH CYTIDYLIC ACID (5'CMP) CRYSTALLIZED FROM 8M SODIUM FORMATE 1RBX ; 1.69 ; RIBONUCLEASE A CONTROL 1AQP ; 2.00 ; RIBONUCLEASE A COPPER COMPLEX 1RNZ ; 1.90 ; RIBONUCLEASE A CRYSTALLIZED FROM 2.5M SODIUM CHLORIDE, 3.3M SODIUM FORMATE 1RNY ; 2.00 ; RIBONUCLEASE A CRYSTALLIZED FROM 3M CESIUM CHLORIDE, 30% AMMONIUM SULFATE 1RNX ; 1.90 ; RIBONUCLEASE A CRYSTALLIZED FROM 3M SODIUM CHLORIDE, 30% AMMONIUM SULFATE 1RNO ; 1.90 ; RIBONUCLEASE A CRYSTALLIZED FROM 80% AMMONIUM SULPHATE 1RNQ ; 2.00 ; RIBONUCLEASE A CRYSTALLIZED FROM 8M SODIUM FORMATE 1RRA ; 2.50 ; RIBONUCLEASE A FROM RATTUS NORVEGICUS (COMMON RAT) 1O0H ; 1.20 ; RIBONUCLEASE A IN COMPLEX WITH 5'-ADP 1AFL ; 1.70 ; RIBONUCLEASE A IN COMPLEX WITH 5'-DIPHOSPHOADENOSINE 2'-PHOSPHATE AT 1.7 ANGSTROM RESOLUTION 1O0O ; 1.20 ; RIBONUCLEASE A IN COMPLEX WITH ADENOSINE-2',5'-DIPHOSPHATE 1O0M ; 1.50 ; RIBONUCLEASE A IN COMPLEX WITH URIDINE-2'-PHOSPHATE 1O0N ; 1.50 ; RIBONUCLEASE A IN COMPLEX WITH URIDINE-3'-PHOSPHATE 1LSQ ; 1.90 ; RIBONUCLEASE A WITH ASN 67 REPLACED BY A BETA-ASPARTYL RESIDUE 1RBW ; 1.69 ; RIBONUCLEASE A WITH GUANIDINIUM 1Z6S ; 1.50 ; RIBONUCLEASE A- AMP COMPLEX 1Z6D ; 1.54 ; RIBONUCLEASE A- IMP COMPLEX 1RUV ; 1.30 ; RIBONUCLEASE A-URIDINE VANADATE COMPLEX: HIGH RESOLUTION RESOLUTION X-RAY STRUCTURE (1.3 A) 1RBJ ; 2.70 ; RIBONUCLEASE B COMPLEX WITH D(TETRA-(DEOXY-ADENYLATE)) 1GOV ; 2.00 ; RIBONUCLEASE BI(G SPECIFIC ENDONUCLEASE) COMPLEXED WITH SULFATE IONS 1GOU ; 1.65 ; RIBONUCLEASE BINASE (G SPECIFIC ENDONUCLEASE) UNLIGANDED FORM 1E44 ; 2.40 ; RIBONUCLEASE DOMAIN OF COLICIN E3 IN COMPLEX WITH ITS IMMUNITY PROTEIN 1TFO ; 2.30 ; RIBONUCLEASE FROM ESCHERICHIA COLI COMPLEXED WITH ITS INHIBITOR PROTEIN 1TFK ; 2.10 ; RIBONUCLEASE FROM ESCHERICHIA COLI COMPLEXED WITH ITS INHIBTOR PROTEIN 1DFJ ; 2.50 ; RIBONUCLEASE INHIBITOR COMPLEXED WITH RIBONUCLEASE A 1A4Y ; 2.00 ; RIBONUCLEASE INHIBITOR-ANGIOGENIN COMPLEX 1BK7 ; 1.75 ; RIBONUCLEASE MC1 FROM THE SEEDS OF BITTER GOURD 1VD3 ; 1.80 ; RIBONUCLEASE NT IN COMPLEX WITH 2'-UMP 1AY7 ; 1.70 ; RIBONUCLEASE SA COMPLEX WITH BARSTAR 5HOH ; 2.00 ; RIBONUCLEASE T1 (ASN9ALA/THR93ALA DOUBLEMUTANT) COMPLEXED WITH 2'GMP 2HOH ; 1.90 ; RIBONUCLEASE T1 (N9A MUTANT) COMPLEXED WITH 2'GMP 4HOH ; 2.05 ; RIBONUCLEASE T1 (THR93ALA MUTANT) COMPLEXED WITH 2'GMP 3HOH ; 1.95 ; RIBONUCLEASE T1 (THR93GLN MUTANT) COMPLEXED WITH 2'GMP 1BVI ; 1.90 ; RIBONUCLEASE T1 (WILDTYPE) COMPLEXED WITH 2'GMP 1DET ; 1.80 ; RIBONUCLEASE T1 CARBOXYMETHYLATED AT GLU 58 IN COMPLEX WITH 2'GMP 2BU4 ; 1.95 ; RIBONUCLEASE T1 COMPLEX WITH 2'GMP 3BU4 ; 1.77 ; RIBONUCLEASE T1 COMPLEX WITH 2'GMP 4BU4 ; 1.80 ; RIBONUCLEASE T1 COMPLEX WITH 2'GMP 5BU4 ; 1.77 ; RIBONUCLEASE T1 COMPLEX WITH 2'GMP 3GSP ; 1.90 ; RIBONUCLEASE T1 COMPLEXED WITH 2',3'-CGPS + 3'-GMP, 4 DAYS 4GSP ; 1.65 ; RIBONUCLEASE T1 COMPLEXED WITH 2',3'-CGPS + 3'-GMP, 7 DAYS 1GSP ; 2.20 ; RIBONUCLEASE T1 COMPLEXED WITH 2',3'-CGPS, 1 DAY 1RHL ; 1.95 ; RIBONUCLEASE T1 COMPLEXED WITH 2'GMP/G23A MUTANT 1I0V ; 1.23 ; RIBONUCLEASE T1 IN COMPLEX WITH 2'GMP (FORM I CRYSTAL) 1I0X ; 1.65 ; RIBONUCLEASE T1 IN COMPLEX WITH 2'GMP (FORM II CRYSTAL) 1HZ1 ; 1.80 ; RIBONUCLEASE T1 V16A MUTANT IN COMPLEX WITH MG2+ 1HYF ; 1.70 ; RIBONUCLEASE T1 V16A MUTANT IN COMPLEX WITH SR2+ 1I2E ; 1.80 ; RIBONUCLEASE T1 V16A MUTANT, FORM I 1I2F ; 1.95 ; RIBONUCLEASE T1 V16A MUTANT, FORM II 1FYS ; 2.00 ; RIBONUCLEASE T1 V16C MUTANT 1G02 ; 1.86 ; RIBONUCLEASE T1 V16S MUTANT 1I2G ; 1.85 ; RIBONUCLEASE T1 V16T MUTANT 1I3I ; 1.76 ; RIBONUCLEASE T1 V78T MUTANT 1I3F ; 2.35 ; RIBONUCLEASE T1 V89S MUTANT 1BIR ; 1.80 ; RIBONUCLEASE T1, PHE 100 TO ALA MUTANT COMPLEXED WITH 2' GMP 2GSP ; 1.80 ; RIBONUCLEASE T1/2',3'-CGPS AND 3'-GMP, 2 DAYS 7GSP ; 1.90 ; RIBONUCLEASE T1/2',3'-CGPS, NON-PRODUCTIVE 6GSP ; 2.20 ; RIBONUCLEASE T1/3'- GMP, 15 WEEKS 5GSP ; 1.80 ; RIBONUCLEASE T1/3'-GMP, 9 WEEKS 4BIR ; 1.70 ; RIBONUCLEASE T1: FREE HIS92GLN MUTANT 1V74 ; 2.00 ; RIBONUCLEASE-INHIBITOR COMPLEX 1KOC ; -1.00 ; RIBONUCLEIC ACID APTAMER COMPLEXED WITH ARGININE, NMR 1KOD ; -1.00 ; RIBONUCLEIC ACID APTAMER COMPLEXED WITH CITRULLINE, NMR 1ULL ; -1.00 ; RIBONUCLEIC ACID APTAMER COMPLEXED WITH HIV-1 REV PEPTIDE, NMR, 7 STRUCTURES 2U1A ; -1.00 ; RIBONUCLEIC ACID BINDING DOMAIN 2 OF HUMAN U1A PROTEIN, NMR, 20 STRUCTURES 1HHS ; 2.00 ; RIBONUCLEIC ACID DEPENDENT RIBONUCLEIC ACID POLYMERASE FROM DSRNA BACTERIOPHAGE PHI6 1HI8 ; 2.50 ; RIBONUCLEIC ACID DEPENDENT RIBONUCLEIC ACID POLYMERASE FROM DSRNA BACTERIOPHAGE PHI6 1HI1 ; 3.00 ; RIBONUCLEIC ACID DEPENDENT RIBONUCLEIC ACID POLYMERASE FROM DSRNA BACTERIOPHAGE PHI6 PLUS BOUND NTP 1HI0 ; 3.00 ; RIBONUCLEIC ACID DEPENDENT RIBONUCLEIC ACID POLYMERASE FROM DSRNA BACTERIOPHAGE PHI6 PLUS INITIATION COMPLEX 1HHT ; 2.90 ; RIBONUCLEIC ACID DEPENDENT RIBONUCLEIC ACID POLYMERASE FROM DSRNA BACTERIOPHAGE PHI6 PLUS TEMPLATE 1RRR ; -1.00 ; RIBONUCLEIC ACID DUPLEX CONTAINING A PURINE-RICH STRAND, NMR, 10 STRUCTURES 259D ; 1.46 ; RIBONUCLEIC ACID HYDRATION: A DETAILED LOOK 1BJ2 ; -1.00 ; RIBONUCLEIC ACID LOOP-LOOP COMPLEX: THE COLE1 INVERTED LOOP SEQUENCE, NMR, 8 STRUCTURES 2BJ2 ; -1.00 ; RIBONUCLEIC ACID LOOP-LOOP COMPLEX: THE COLE1 INVERTED LOOP SEQUENCE, NMR, MINIMIZED AVERAGE STRUCTURE 1G2J ; 1.97 ; RIBONUCLEIC ACID OCTAMER R(CCCPGGGG) CONTAINING PHENYL RIBONUCLEOTIDE 1TWH ; 3.40 ; RIBONUCLEIC ACID POLYMERASE II COMPLEXED WITH 2'DATP 1TWA ; 3.20 ; RIBONUCLEIC ACID POLYMERASE II COMPLEXED WITH ATP 1TWG ; 3.30 ; RIBONUCLEIC ACID POLYMERASE II COMPLEXED WITH CTP 1TWC ; 3.00 ; RIBONUCLEIC ACID POLYMERASE II COMPLEXED WITH GTP 1TWF ; 2.30 ; RIBONUCLEIC ACID POLYMERASE II COMPLEXED WITH UTP AT 2.3 A RESOLUTION 1I3Q ; 3.10 ; RIBONUCLEIC ACID POLYMERASE II CRYSTAL FORM I AT 3.1 A RESOLUTION 1I50 ; 2.80 ; RIBONUCLEIC ACID POLYMERASE II CRYSTAL FORM II AT 2.8 A RESOLUTION 1I6H ; 3.30 ; RIBONUCLEIC ACID POLYMERASE II ELONGATION COMPLEX 1SFO ; 3.61 ; RIBONUCLEIC ACID POLYMERASE II STRAND SEPARATED ELONGATION COMPLEX 1R9S ; 4.25 ; RIBONUCLEIC ACID POLYMERASE II STRAND SEPARATED ELONGATION COMPLEX, MATCHED NUCLEOTIDE 1R9T ; 3.50 ; RIBONUCLEIC ACID POLYMERASE II STRAND SEPARATED ELONGATION COMPLEX, MISMATCHED NUCLEOTIDE 1R5U ; 4.50 ; RIBONUCLEIC ACID POLYMERASE II TFIIB COMPLEX 1PQV ; 3.80 ; RIBONUCLEIC ACID POLYMERASE II-TFIIS COMPLEX 1Y1Y ; 4.00 ; RIBONUCLEIC ACID POLYMERASE II-TFIIS-DEOXYRIBONUCLEIC ACID/RIBONUCLEIC ACID COMPLEX 387D ; 3.10 ; RIBONUCLEIC ACID PSEUDOKNOT WITH 3D DOMAIN SWAPPING 1NS1 ; -1.00 ; RIBONUCLEIC ACID-BINDING DOMAIN OF NON-STRUCTURAL PROTEIN 1 FROM INFLUENZA VIRUS, NMR, 16 STRUCTURES 1FHT ; -1.00 ; RIBONUCLEIC ACID-BINDING DOMAIN OF THE U1A SPLICEOSOMAL PROTEIN U1A117, NMR, 43 STRUCTURES 1I6U ; 2.60 ; RIBONUCLEIC ACID-PROTEIN INTERACTIONS: THE CRYSTAL STRUCTURE OF RIBOSOMAL PROTEIN S8/RRNA COMPLEX FROM METHANOCOCCUS JANNASCHII 1OKA ; -1.00 ; RIBONUCLEIC ACID/DEOXYRIBONUCLEIC ACID CHIMERA, NMR 1DNX ; 1.70 ; RIBONUCLEIC ACID/DEOXYRIBONUCLEIC ACID DODECAMER R(G)D(CGTATACGC) WITH MAGNESIUM BINDING SITES 1DNT ; 1.70 ; RIBONUCLEIC ACID/DEOXYRIBONUCLEIC ACID DODECAMER R(GC)D(GTATACGC) WITH MAGNESIUM BINDING SITES 1G4Q ; 1.15 ; RIBONUCLEIC ACID/DEOXYRIBONUCLEIC ACID HYBRID DECAMER OF CAAAGAAAAG/CTTTTCTTTG 1PJG ; 1.15 ; RIBONUCLEIC ACID/DEOXYRIBONUCLEIC ACID HYBRID DECAMER OF CAAAGAAAAG/CTTTTCTTTG 205D ; 2.64 ; RIBONUCLEIC ACID: SEQUENCE R-PGGACUUUGGUCC (5'-->3') 1PFR ; 2.20 ; RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE 1 BETA CHAIN 1XIK ; 1.70 ; RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE 1 BETA CHAIN 1BIQ ; 2.05 ; RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE 1 BETA CHAIN MUTANT E238A 5R1R ; 3.10 ; RIBONUCLEOTIDE REDUCTASE E441A MUTANT R1 PROTEIN FROM ESCHERICHIA COLI 6R1R ; 3.10 ; RIBONUCLEOTIDE REDUCTASE E441D MUTANT R1 PROTEIN FROM ESCHERICHIA COLI 7R1R ; 3.10 ; RIBONUCLEOTIDE REDUCTASE E441Q MUTANT R1 PROTEIN FROM ESCHERICHIA COLI 1PEM ; 2.99 ; RIBONUCLEOTIDE REDUCTASE PROTEIN R1E FROM SALMONELLA TYPHIMURIUM 1PEO ; 3.00 ; RIBONUCLEOTIDE REDUCTASE PROTEIN R1E FROM SALMONELLA TYPHIMURIUM 1PEQ ; 2.80 ; RIBONUCLEOTIDE REDUCTASE PROTEIN R1E FROM SALMONELLA TYPHIMURIUM 1PEU ; 3.20 ; RIBONUCLEOTIDE REDUCTASE PROTEIN R1E FROM SALMONELLA TYPHIMURIUM 1R1R ; 2.90 ; RIBONUCLEOTIDE REDUCTASE R1 PROTEIN MUTANT Y730F WITH A REDUCED ACTIVE SITE FROM ESCHERICHIA COLI 3R1R ; 3.00 ; RIBONUCLEOTIDE REDUCTASE R1 PROTEIN WITH AMPPNP OCCUPYING THE ACTIVITY SITE FROM ESCHERICHIA COLI 2R1R ; 3.00 ; RIBONUCLEOTIDE REDUCTASE R1 PROTEIN WITH DTTP OCCUPYING THE SPECIFICITY SITE FROM ESCHERICHIA COLI 4R1R ; 3.20 ; RIBONUCLEOTIDE REDUCTASE R1 PROTEIN WITH SUBSTRATE, GDP AND EFFECTOR DTTP FROM ESCHERICHIA COLI 1PIZ ; 1.90 ; RIBONUCLEOTIDE REDUCTASE R2 D84E MUTANT SOAKED WITH FERROUS IONS AT NEUTRAL PH 2ALX ; 2.60 ; RIBONUCLEOTIDE REDUCTASE R2 FROM ESCHERICHIA COLI IN SPACE GROUP P6(1)22 1PIY ; 1.68 ; RIBONUCLEOTIDE REDUCTASE R2 SOAKED WITH FERROUS ION AT NEUTRAL PH 1AV8 ; 2.80 ; RIBONUCLEOTIDE REDUCTASE R2 SUBUNIT FROM E. COLI 1PJ0 ; 1.90 ; RIBONUCLEOTIDE REDUCTASE R2-D84E/W48F MUTANT SOAKED WITH FERROUS IONS AT NEUTRAL PH 1PJ1 ; 1.95 ; RIBONUCLEOTIDE REDUCTASE R2-D84E/W48F SOAKED WITH FERROUS IONS AT PH 5 1R2F ; 2.10 ; RIBONUCLEOTIDE REDUCTASE R2F PROTEIN FROM SALMONELLA TYPHIMURIUM 2R2F ; 2.25 ; RIBONUCLEOTIDE REDUCTASE R2F PROTEIN FROM SALMONELLA TYPHIMURIUM (OXIDIZED) 1JK0 ; 2.80 ; RIBONUCLEOTIDE REDUCTASE Y2Y4 HETERODIMER 2F8M ; 2.09 ; RIBOSE 5-PHOSPHATE ISOMERASE FROM PLASMODIUM FALCIPARUM 1DGZ ; -1.00 ; RIBOSMAL PROTEIN L36 FROM THERMUS THERMOPHILUS: NMR STRUCTURE ENSEMBLE 2BM1 ; 2.60 ; RIBOSOMAL ELONGATION FACTOR G (EF-G) FUSIDIC ACID RESISTANT MUTANT G16V 2BM0 ; 2.40 ; RIBOSOMAL ELONGATION FACTOR G (EF-G) FUSIDIC ACID RESISTANT MUTANT T84A 1S7N ; 2.10 ; RIBOSOMAL L7/L12 ALPHA-N-PROTEIN ACETYLTRANSFERASE IN COMPLEX WITH COENZYME A (COA FREE SULFHYDRYL) 1DWU ; 2.80 ; RIBOSOMAL PROTEIN L1 1AD2 ; 1.90 ; RIBOSOMAL PROTEIN L1 MUTANT WITH SERINE 179 REPLACED BY CYSTEINE 1ZAV ; 1.90 ; RIBOSOMAL PROTEIN L10-L12(NTD) COMPLEX, SPACE GROUP P21 1ZAW ; 2.30 ; RIBOSOMAL PROTEIN L10-L12(NTD) COMPLEX, SPACE GROUP P212121, FORM A 1ZAX ; 2.10 ; RIBOSOMAL PROTEIN L10-L12(NTD) COMPLEX, SPACE GROUP P212121, FORM B 1WHI ; 1.50 ; RIBOSOMAL PROTEIN L14 1RL2 ; 2.30 ; RIBOSOMAL PROTEIN L2 RIBONUCLEIC ACID-BINDING DOMAIN FROM BACILLUS STEAROTHERMOPHILUS 1BXE ; 1.90 ; RIBOSOMAL PROTEIN L22 FROM THERMUS THERMOPHILUS 1CK5 ; -1.00 ; RIBOSOMAL PROTEIN L30-MRNA COMPLEX FROM YEAST 1CN8 ; -1.00 ; RIBOSOMAL PROTEIN L30-MRNA COMPLEX FROM YEAST 1H7M ; 1.96 ; RIBOSOMAL PROTEIN L30E FROM THERMOCOCCUS CELER 1RL6 ; 2.00 ; RIBOSOMAL PROTEIN L6 1DIV ; 2.60 ; RIBOSOMAL PROTEIN L9 1A32 ; 2.10 ; RIBOSOMAL PROTEIN S15 FROM BACILLUS STEAROTHERMOPHILUS 1AB3 ; -1.00 ; RIBOSOMAL PROTEIN S15 FROM THERMUS THERMOPHILUS, NMR, 26 STRUCTURES 1LOU ; 1.95 ; RIBOSOMAL PROTEIN S6 1HUS ; 2.50 ; RIBOSOMAL PROTEIN S7 1RSS ; 1.90 ; RIBOSOMAL PROTEIN S7 FROM THERMUS THERMOPHILUS 1AN7 ; 2.90 ; RIBOSOMAL PROTEIN S8 FROM THERMUS THERMOPHILUS 1JOS ; 1.70 ; RIBOSOME BINDING FACTOR A(RBFA) 1P9Y ; 2.15 ; RIBOSOME BINDING OF E. COLI TRIGGER FACTOR MUTANT F44L. 1EH1 ; 2.60 ; RIBOSOME RECYCLING FACTOR FROM THERMUS THERMOPHILUS 1RZL ; 1.60 ; RICE NONSPECIFIC LIPID TRANSFER PROTEIN 1F2N ; 2.80 ; RICE YELLOW MOTTLE VIRUS 1BR5 ; 2.50 ; RICIN A CHAIN (RECOMBINANT) COMPLEX WITH NEOPTERIN 1BR6 ; 2.30 ; RICIN A CHAIN (RECOMBINANT) COMPLEX WITH PTEROIC ACID 1IFT ; 1.80 ; RICIN A-CHAIN (RECOMBINANT) 1J1M ; 1.50 ; RICIN A-CHAIN (RECOMBINANT) AT 100K 1IFS ; 2.00 ; RICIN A-CHAIN (RECOMBINANT) COMPLEX WITH ADENOSINE (ADENOSINE BECOMES ADENINE IN THE COMPLEX) 1IFU ; 2.40 ; RICIN A-CHAIN (RECOMBINANT) COMPLEX WITH FORMYCIN 1UQ5 ; 1.40 ; RICIN A-CHAIN (RECOMBINANT) N122A MUTANT 1UQ4 ; 1.90 ; RICIN A-CHAIN (RECOMBINANT) R213D MUTANT 1RFS ; 1.83 ; RIESKE SOLUBLE FRAGMENT FROM SPINACH 1S7K ; 1.80 ; RIML- RIBOSOMAL L7/L12 ALPHA-N-PROTEIN ACETYLTRANSFERASE CRYSTAL FORM 2 (APO) 1S7F ; 2.00 ; RIML- RIBOSOMAL L7/L12 ALPHA-N-PROTEIN ACETYLTRANSFERASE CRYSTAL FORM I (APO) 1S7L ; 2.30 ; RIML- RIBOSOMAL L7/L12 ALPHA-N-PROTEIN ACETYLTRANSFERASE IN COMPLEX WITH COENZYME A (COA-CYS134 DISULFIDE) 1IYM ; -1.00 ; RING-H2 FINGER DOMAIN OF EL5 1N6X ; 1.40 ; RIP-PHASING ON BOVINE TRYPSIN 1N6Y ; 1.40 ; RIP-PHASING ON BOVINE TRYPSIN 1N7A ; 1.20 ; RIP-RADIATION-DAMAGE INDUCED PHASING 1N7B ; 1.40 ; RIP-RADIATION-DAMAGE INDUCED PHASING 1RTV ; 2.50 ; RMLC (DTDP-6-DEOXY-D-XYLO-4-HEXULOSE 3,5-EPIMERASE) CRYSTAL STRUCTURE FROM PSEUDOMONAS AERUGINOSA, APO STRUCTURE 1PM7 ; 2.20 ; RMLC (DTDP-6-DEOXY-D-XYLO-4-HEXULOSE 3,5-EPIMERASE) STRUCTURE FROM MYCOBACTERIUM TUBERCULOSIS AND INHIBITOR DESIGN. THE APO STRUCTURE. 1DZR ; 2.17 ; RMLC FROM SALMONELLA TYPHIMURIUM 1DZT ; 2.20 ; RMLC FROM SALMONELLA TYPHIMURIUM 2RMP ; 2.70 ; RMP-PEPSTATIN A COMPLEX 1O0F ; 1.50 ; RNASE A IN COMPLEX WITH 3',5'-ADP 2BLZ ; 1.40 ; RNASE AFTER A HIGH DOSE X-RAY "BURN" 2BLP ; 1.40 ; RNASE BEFORE UNATTENUATED X-RAY BURN 1TFR ; 2.06 ; RNASE H FROM BACTERIOPHAGE T4 1I39 ; 1.95 ; RNASE HII FROM ARCHAEOGLOBUS FULGIDUS 1I3A ; 2.15 ; RNASE HII FROM ARCHAEOGLOBUS FULGIDUS WITH COBALT HEXAMMINE CHLORIDE 1A6F ; 2.60 ; RNASE P PROTEIN FROM BACILLUS SUBTILIS 1D6T ; -1.00 ; RNASE P PROTEIN FROM STAPHYLOCOCCUS AUREUS 1NZ0 ; 1.20 ; RNASE P PROTEIN FROM THERMOTOGA MARITIMA 2BR2 ; 2.80 ; RNASE PH CORE OF THE ARCHAEAL EXOSOME 2C38 ; 3.10 ; RNASE PH CORE OF THE ARCHAEAL EXOSOME IN COMPLEX WITH A5 RIBONUCLEIC ACID 2C39 ; 3.30 ; RNASE PH CORE OF THE ARCHAEAL EXOSOME IN COMPLEX WITH ADP 2C37 ; 2.80 ; RNASE PH CORE OF THE ARCHAEAL EXOSOME IN COMPLEX WITH U8 RIBONUCLEIC ACID 1D5H ; 2.25 ; RNASE S(F8A). MUTANT RIBONUCLEASE S. 1FZU ; 1.80 ; RNASE T1 V78A MUTANT 1Q9E ; 1.70 ; RNASE T1 VARIANT WITH ADENINE SPECIFICITY 1CH0 ; 2.30 ; RNASE T1 VARIANT WITH ALTERED GUANINE BINDING SEGMENT 1YQT ; 1.90 ; RNASE-L INHIBITOR 1JY5 ; 2.05 ; RNASE-RELATED PROTEIN FROM CALYSTEGIA SEPIUM 1YVR ; 1.95 ; RO AUTOANTIGEN 1YVP ; 2.20 ; RO AUTOANTIGEN COMPLEXED WITH RNAS 1HHQ ; 2.10 ; ROLE OF ACTIVE SITE RESIUDE LYS16 IN NUCLEOSIDE DIPHOSPHATE KINASE 1DI3 ; 1.80 ; ROLE OF AMINO ACID RESIDUES AT TURNS IN THE CONFORMATIONAL STABILITY AND FOLDING OF HUMAN LYSOZYME 1DI4 ; 2.00 ; ROLE OF AMINO ACID RESIDUES AT TURNS IN THE CONFORMATIONAL STABILITY AND FOLDING OF HUMAN LYSOZYME 1DI5 ; 2.20 ; ROLE OF AMINO ACID RESIDUES AT TURNS IN THE CONFORMATIONAL STABILITY AND FOLDING OF HUMAN LYSOZYME 1NUF ; 2.70 ; ROLE OF CALCIUM IONS IN THE ACTIVATION AND ACTIVITY OF THE TRANSGLUTAMINASE 3 ENZYME 1NUG ; 2.40 ; ROLE OF CALCIUM IONS IN THE ACTIVATION AND ACTIVITY OF THE TRANSGLUTAMINASE 3 ENZYME (2 CALCIUMS, 1 MG, INACTIVE FORM) 1NUD ; 2.70 ; ROLE OF CALCIUM IONS IN THE ACTIVATION AND ACTIVITY OF THE TRANSGLUTAMINASE 3 ENZYME (3 CALCIUMS, ACTIVE FORM) 1JXK ; 1.90 ; ROLE OF ETHE MOBILE LOOP IN THE MEHANISM OF HUMAN SALIVARY AMYLASE 1L9C ; 1.90 ; ROLE OF HISTIDINE 269 IN CATALYSIS BY MONOMERIC SARCOSINE OXIDASE 1L9D ; 1.95 ; ROLE OF HISTIDINE 269 IN CATALYSIS BY MONOMERIC SARCOSINE OXIDASE 1L9E ; 1.85 ; ROLE OF HISTIDINE 269 IN CATALYSIS BY MONOMERIC SARCOSINE OXIDASE 1SZX ; 1.95 ; ROLE OF HYDROGEN BONDING IN THE ACTIVE SITE OF HUMAN MANGANESE SUPEROXIDE DISMUTASE 1JXJ ; 1.99 ; ROLE OF MOBILE LOOP IN THE MECHANISM OF HUMAN SALIVARY AMYLASE 1A3P ; -1.00 ; ROLE OF THE 6-20 DISULFIDE BRIDGE IN THE STRUCTURE AND ACTIVITY OF EPIDERMAL GROWTH FACTOR, NMR, 20 STRUCTURES 1R68 ; 1.20 ; ROLE OF THE AMINO SUGAR IN DEOXYRIBONUCLEIC ACID BINDING OF DISACCHARIDE ANTHRACYCLINES: CRYSTAL STRUCTURE OF MAR70/D(CGATCG) COMPLEX 1VZU ; 1.97 ; ROLES OF ACTIVE SITE TRYPTOPHANS IN SUBSTRATE BINDING AND CATALYSIS BY ALPHA-1,3 GALACTOSYLTRANSFERASE 1VZX ; 1.97 ; ROLES OF ACTIVE SITE TRYPTOPHANS IN SUBSTRATE BINDING AND CATALYSIS BY ALPHA-1,3 GALACTOSYLTRANSFERASE 1OLS ; 1.85 ; ROLES OF HIS291-ALPHA AND HIS146-BETA' IN THE REDUCTIVE ACYLATION REACTION CATALYZED BY HUMAN BRANCHED-CHAIN ALPHA-KETOACID DEHYDROGENASE 1OLU ; 1.90 ; ROLES OF HIS291-ALPHA AND HIS146-BETA' IN THE REDUCTIVE ACYLATION REACTION CATALYZED BY HUMAN BRANCHED-CHAIN ALPHA-KETOACID DEHYDROGENASE 1OLX ; 2.25 ; ROLES OF HIS291-ALPHA AND HIS146-BETA' IN THE REDUCTIVE ACYLATION REACTION CATALYZED BY HUMAN BRANCHED-CHAIN ALPHA-KETOACID DEHYDROGENASE 1O7O ; 1.97 ; ROLES OF INDIVIDUAL RESIDUES OF ALPHA-1,3 GALACTOSYLTRANSFERASES IN SUBSTRATE BINDING AND CATALYSIS 1O7Q ; 1.30 ; ROLES OF INDIVIDUAL RESIDUES OF ALPHA-1,3 GALACTOSYLTRANSFERASES IN SUBSTRATE BINDING AND CATALYSIS 1VZT ; 2.00 ; ROLES OF INDIVIDUAL RESIDUES OF ALPHA-1,3 GALACTOSYLTRANSFERASES IN SUBSTRATE BINDING AND CATALYSIS 1I1O ; 2.00 ; ROOM TEMPERATURE CRYSTAL STRUCTURE FLAVODOXIN D. VULGARIS MUTANT Y98H AT 2.0 ANG. RESOLUTION 1LR4 ; 2.00 ; ROOM TEMPERATURE CRYSTAL STRUCTURE OF THE APO-FORM OF THE CATALYTIC SUBUNIT OF PROTEIN KINASE CK2 FROM ZEA MAYS 1QGL ; 2.66 ; ROOM TEMPERATURE STRUCTURE OF CONCANAVALIN A COMPLEXED TO BIVALENT LIGAND 1TR5 ; 2.10 ; ROOM TEMPERATURE STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT TRUNCATED DELTA+PHS I92E 1C3T ; -1.00 ; ROTAMER STRAIN AS A DETERMINANT OF PROTEIN STRUCTURAL SPECIFICITY 1T34 ; 2.95 ; ROTATION MECHANISM FOR TRANSMEMBRANE SIGNALING BY THE ATRIAL NATRIURETIC PEPTIDE RECEPTOR 1N6M ; 2.50 ; ROTATION OF THE STALK/NECK AND ONE HEAD IN A NEW CRYSTAL STRUCTURE OF THE KINESIN MOTOR PROTEIN, NCD 1EOQ ; -1.00 ; ROUS SARCOMA VIRUS CAPSID PROTEIN: C-TERMINAL DOMAIN 1EM9 ; 2.05 ; ROUS SARCOMA VIRUS CAPSID PROTEIN: N-TERMINAL DOMAIN 1KRP ; 2.20 ; RP ISOMER PHOSPHOROTHIOATE DEOXYRIBONUCLEIC ACID COMPLEXED TO THE 3'-5' EXONUCLEASE OF DEOXYRIBONUCLEIC ACID POLYMERASE I FROM E. COLI 1GPL ; 2.10 ; RP2 LIPASE 1DZF ; 1.90 ; RPB5 FROM S.CEREVISIAE 1CN9 ; -1.00 ; RPL30-MRNA COMPLEX 1CK8 ; -1.00 ; RPL30-MRNA COMPLEX FROM YEAST 1Y69 ; 3.33 ; RRF DOMAIN I IN COMPLEX WITH THE 50S RIBOSOMAL SUBUNIT FROM DEINOCOCCUS RADIODURANS 1O9G ; 1.50 ; RRNA METHYLTRANSFERASE AVIRA FROM STREPTOMYCES VIRIDOCHROMOGENES AT 1.5A 1O9H ; 2.40 ; RRNA METHYLTRANSFERASE AVIRA FROM STREPTOMYCES VIRIDOCHROMOGENES AT 2.4A 1HVZ ; -1.00 ; RTD-1, A CYCLIC ANTIMICROBIAL DEFENSIN FROM RHESUS MACAQUE LEUKOCYTES 1GK8 ; 1.40 ; RUBISCO FROM CHLAMYDOMONAS REINHARDTII 1IWA ; 2.60 ; RUBISCO FROM GALDIERIA PARTITA 1BQ9 ; 1.20 ; RUBREDOXIN (FORMYL METHIONINE MUTANT) FROM PYROCOCCUS FURIOSUS 1BQ8 ; 1.10 ; RUBREDOXIN (METHIONINE MUTANT) FROM PYROCOCCUS FURIOSUS 1IRO ; 1.10 ; RUBREDOXIN (OXIDIZED, FE(III)) AT 1.1 ANGSTROMS RESOLUTION 1BRF ; 0.95 ; RUBREDOXIN (WILD TYPE) FROM PYROCOCCUS FURIOSUS 1IRN ; 1.20 ; RUBREDOXIN (ZN-SUBSTITUTED) AT 1.2 ANGSTROMS RESOLUTION 1S24 ; -1.00 ; RUBREDOXIN DOMAIN II FROM PSEUDOMONAS OLEOVORANS 2RDV ; 1.90 ; RUBREDOXIN FROM DESULFOVIBRIO VULGARIS MIYAZAKI F, MONOCLINIC CRYSTAL FORM 1RDV ; 2.00 ; RUBREDOXIN FROM DESULFOVIBRIO VULGARIS MIYAZAKI F, TRIGONAL CRYSTAL FORM 1RB9 ; 0.92 ; RUBREDOXIN FROM DESULFOVIBRIO VULGARIS REFINED ANISOTROPICALLY AT 0.92 ANGSTROMS RESOLUTION 1DX8 ; -1.00 ; RUBREDOXIN FROM GUILLARDIA THETA 1H7V ; -1.00 ; RUBREDOXIN FROM GUILLARDIA THETA 1E5D ; 2.50 ; RUBREDOXIN OXYGEN:OXIDOREDUCTASE (ROO) FROM ANAEROBE DESULFOVIBRIO GIGAS 1C09 ; 1.60 ; RUBREDOXIN V44A CP 1QCV ; -1.00 ; RUBREDOXIN VARIANT (PFRD-XC4) FOLDS WITHOUT IRON 1B71 ; 1.90 ; RUBRERYTHRIN 1DVB ; 1.90 ; RUBRERYTHRIN 1RYT ; 2.10 ; RUBRERYTHRIN 1NNQ ; 2.35 ; RUBRERYTHRIN FROM PYROCOCCUS FURIOSUS PFU-1210814 1RCY ; 1.90 ; RUSTICYANIN (RC) FROM THIOBACILLUS FERROOXIDANS 1BVS ; 3.00 ; RUVA COMPLEXED TO A HOLLIDAY JUNCTION. 1IXR ; 3.30 ; RUVA-RUVB COMPLEX 2BI0 ; 1.90 ; RV0216, A CONSERVED HYPOTHETICAL PROTEIN FROM MYCOBACTERIUM TUBERCULOSIS THAT IS ESSENTIAL FOR BACTERIAL SURVIVAL DURING INFECTION, HAS A DOUBLE HOTDOGFOLD 1Q7T ; 1.90 ; RV1170 (MSHB) FROM MYCOBACTERIUM TUBERCULOSIS 1NFQ ; 2.40 ; RV2002 GENE PRODUCT FROM MYCOBACTERIUM TUBERCULOSIS 1NFR ; 2.10 ; RV2002 GENE PRODUCT FROM MYCOBACTERIUM TUBERCULOSIS 1BGS ; 2.60 ; Recognition between a Bacterial Ribonuclease, Barnase, and its Natural Inhibitor, Barstar 5TIM ; 1.83 ; Refined 1.83 Angstroms Structure of Trypanosomal Triosephosphate Isomerase, Crystallized in the Presence of 2.4 M-Ammonium Sulphate. A Comparison with the Structure of the Trypanosomal Triosephosphate Isomerase-Glycerol-3-Phosphate Complex 2PKA ; 2.05 ; Refined 2 Angstroms X-Ray Crystal Structure of Porcine Pancreatic Kallikrein A, a Specific Trypsin-Like Serine Proteinase. Crystallization, Structure Determination, Crystallographic Refinement, Structure and its Comparison with Bovine Trypsin 2KAI ; 2.50 ; Refined 2.5 Angstroms X-Ray Crystal Structure of the Complex Formed by Porcine Kallikrein a and the Bovine Pancreatic Trypsin Inhibitor. Crystallization, Patterson Search, Structure Determination, Refinement, Structure and Comparison with its Components and with the Bovine Trypsin-Pancreatic Trypsin Inhibitor Complex 1GPR ; 1.90 ; Refined Crystal Structure of Iia Domain of the Glucose Permease of Bacillus Subtilis at 1.9 Angstroms Resolution 2OHX ; 1.80 ; Refined Crystal Structure of Liver Alcohol Dehydrogenase-Nadh Complex at 1.8 Angstroms Resolution 2FBJ ; 1.95 ; Refined Crystal Structure of the Galactan-Binding Immunoglobulin Fab J539 at 1.95-Angstroms Resolution 2MCP ; 3.10 ; Refined Crystal Structure of the Mcpc603 Fab-Phosphocholine Complex at 3.1 Angstroms Resolution 8DFR ; 1.70 ; Refined Crystal Structures of Chicken Liver Dihydrofolate Reductase. 3 Angstroms Apo-Enzyme and 1.7 Angstroms /Nadph Holo-Enzyme Complex 3CD4 ; 2.20 ; Refinement and Analysis of the First Two Domains of Human Cd4 3EBX ; 1.40 ; Refinement at 1.4 Angstroms Resolution of a Model of Erabutoxin B. Treatment of Ordered Solvent and Discrete Disorder 1ERI ; 2.70 ; Refinement of EcoRI Endonuclease Crystal Structure: A Revised Protein Chain Tracing 4MBN ; 2.00 ; Refinement of Myoglobin and Cytochrome C 5CYT ; 1.50 ; Refinement of Myoglobin and Cytochrome C 5MBN ; 2.00 ; Refinement of Myoglobin and Cytochrome C 1LEN ; 1.80 ; Refinement of Two Crystal Forms of Lentil Lectin at 1.8 Angstroms Resolution 2C2C ; 2.00 ; Refinement of the Crystal Structure of Oxidized Rhodospirillum Rubrum Cytochrome C2 3C2C ; 1.68 ; Refinement of the Crystal Structure of Oxidized Rhodospirillum Rubrum Cytochrome C2 1PVC ; 2.40 ; Refinement of the Sabin Strain of Type 3 Poliovirus at 2.4 Angstroms and the Crystal Structures of its Variants at 2.9 Angstroms Resolution 1ARQ ; -1.00 ; Relaxation Matrix Refinement of the Solution Structure of the Arc Repressor 1ARR ; -1.00 ; Relaxation Matrix Refinement of the Solution Structure of the Arc Repressor 3AIT ; -1.00 ; Restrained Energy Refinement with Two Different Algorithms and Force Fields of the Structure of the Alpha-Amylase Inhibitor Tendamistat Determined by /NMR in Solution 4AIT ; -1.00 ; Restrained Energy Refinement with Two Different Algorithms and Force Fields of the Structure of the Alpha-Amylase Inhibitor Tendamistat Determined by /NMR in Solution 1RNT ; 1.90 ; Restrained Least-Squares Refinement of the Crystal Structure of the Ribonuclease T1 2'-Guanylic Acid Complex at 1.9 Angstroms Resolution 3PEP ; 2.30 ; Revised 2.3 Angstroms Structure of Porcine Pepsin. Evidence for a Flexible Subdomain 2CEP ; 2.20 ; Role of met-230 in Intramolecular Electron Transfer between the Oxyferryl Heme and Trp 191 in Cytochrome C Peroxidase Compound II 1KY4 ; 2.80 ; S-ADENOSYLHOMOCYSTEINE HYDROLASE REFINED WITH NONCRYSTALLOGRAPHIC RESTRAINTS 1FUG ; 3.20 ; S-ADENOSYLMETHIONINE SYNTHETASE 1XRB ; 3.00 ; S-ADENOSYLMETHIONINE SYNTHETASE (MAT, ATP: L-METHIONINE S-ADENOSYLTRANSFERASE, E.C.2.5.1.6) IN WHICH MET RESIDUES ARE REPLACED WITH SELENOMETHIONINE RESIDUES (MSE) 1P7L ; 2.50 ; S-ADENOSYLMETHIONINE SYNTHETASE COMPLEXED WITH AMPPNP AND MET. 1RG9 ; 2.50 ; S-ADENOSYLMETHIONINE SYNTHETASE COMPLEXED WITH SAM AND PPNP 1MXC ; 3.00 ; S-ADENOSYLMETHIONINE SYNTHETASE WITH 8-BR-ADP 1MXB ; 2.80 ; S-ADENOSYLMETHIONINE SYNTHETASE WITH ADP 1MXA ; 2.80 ; S-ADENOSYLMETHIONINE SYNTHETASE WITH PPI 1Q5C ; 30.00 ; S-S-LAMBDA-SHAPED TRANS AND CIS INTERACTIONS OF CADHERINS MODEL BASED ON FITTING C-CADHERIN (1L3W) TO 3D MAP OF DESMOSOMES OBTAINED BY ELECTRON TOMOGRAPHY 1Q5A ; 30.00 ; S-SHAPED TRANS INTERACTIONS OF CADHERINS MODEL BASED ON FITTING C-CADHERIN (1L3W) TO 3D MAP OF DESMOSOMES OBTAINED BY ELECTRON TOMOGRAPHY 1W9B ; 1.70 ; S. ALBA MYROSINASE IN COMPLEX WITH CARBA-GLUCOTROPAEOLIN 1W9D ; 1.60 ; S. ALBA MYROSINASE IN COMPLEX WITH S-ETHYL PHENYLACETOTHIOHYDROXIMATE-O-SULFATE 1C3G ; 2.70 ; S. CEREVISIAE HEAT SHOCK PROTEIN 40 SIS1 1Z1A ; 2.50 ; S. CEREVISIAE SIR1 ORC-INTERACTION DOMAIN 1SW6 ; 2.10 ; S. CEREVISIAE SWI6 ANKYRIN-REPEAT FRAGMENT 2AI9 ; 2.50 ; S.AUREUS POLYPEPTIDE DEFORMYLASE 1G97 ; 1.96 ; S.PNEUMONIAE GLMU COMPLEXED WITH UDP-N-ACETYLGLUCOSAMINE AND MG2+ 2AIA ; 1.70 ; S.PNEUMONIAE PDF COMPLEXED WITH SB-543668 2AI7 ; 2.00 ; S.PNEUMONIAE POLYPEPTIDE DEFORMYLASE COMPLEXED WITH SB- 485345 2AIE ; 1.70 ; S.PNEUMONIAE POLYPEPTIDE DEFORMYLASE COMPLEXED WITH SB- 505684 1SRO ; -1.00 ; S1 RIBONUCLEIC ACID BINDING DOMAIN, NMR, 20 STRUCTURES 1CFP ; -1.00 ; S100B (S100BETA) NMR DATA WAS COLLECTED FROM A SAMPLE OF CALCIUM FREE PROTEIN AT PH 6.3 AND A TEMPERATURE OF 311 K AND 1.7-6.9 MM CONCENTRATION, 25 STRUCTURES 1QLS ; 2.30 ; S100C (S100A11),OR CALGIZZARIN, IN COMPLEX WITH ANNEXIN I N-TERMINUS 1GN2 ; 3.40 ; S123C MUTANT OF THE IRON-SUPEROXIDE DISMUTASE FROM MYCOBACTERIUM TUBERCULOSIS. 1GT6 ; 2.20 ; S146A MUTANT OF THERMOMYCES (HUMICOLA) LANUGINOSA LIPASE COMPLEX WITH OLEIC ACID 1Q5P ; 1.60 ; S156E/S166D VARIANT OF BACILLUS LENTUS SUBTILISIN 3TGJ ; 2.20 ; S195A TRYPSINOGEN COMPLEXED WITH BOVINE PANCREATIC TRYPSIN INHIBITOR (BPTI) 1ES5 ; 1.40 ; S216A MUTANT OF STREPTOMYCES K15 DD-TRANSPEPTIDASE 1ESU ; 2.00 ; S235A MUTANT OF TEM1 BETA-LACTAMASE 1Q9K ; 1.96 ; S25-2 FAB UNLIGANDED 1 1Q9L ; 2.28 ; S25-2 FAB UNLIGANDED 2 1Q9T ; 1.74 ; S25-2- A(2-4)KDO DISACCHARIDE COMPLEX 1Q9Q ; 1.49 ; S25-2- A(2-8)-A(2-4)KDO TRISACCHARIDE COMPLEX 1Q9R ; 1.45 ; S25-2- A(2-8)KDO DISACCHARIDE COMPLEX 1Q9V ; 1.73 ; S25-2- KDO MONOSACCHARIDE COMPLEX 1PQE ; 1.95 ; S25A MUTANT OF PYRUVOYL DEPENDENT ASPARTATE DECARBOXYLASE 1XT6 ; 1.80 ; S35C FLAVODOXIN MUTANT IN THE SEMIQUINONE STATE 1F3X ; 2.80 ; S402P MUTANT OF RABBIT MUSCLE PYRUVATE KINASE 1Q9W ; 1.75 ; S45-18 FAB PENTASACCHARIDE BISPHOSPHATE COMPLEX 1Q9O ; 1.79 ; S45-18 FAB UNLIGANDED 1DF8 ; 1.51 ; S45A MUTANT OF STREPTAVIDIN IN COMPLEX WITH BIOTIN 1G88 ; 3.00 ; S4AFL3ARG515 MUTANT 1C96 ; 1.81 ; S642A:CITRATE COMPLEX OF ACONITASE 1B0K ; 2.50 ; S642A:FLUOROCITRATE COMPLEX OF ACONITASE 1C97 ; 1.98 ; S642A:ISOCITRATE COMPLEX OF ACONITASE 1Q4B ; 1.48 ; S65T Q80R GREEN FLUORESCENT PROTEIN (GFP) PH 5.5 1Q4A ; 1.45 ; S65T Q80R GREEN FLUORESCENT PROTEIN (GFP) PH 8.5 1Q4D ; 1.58 ; S65T Q80R T203C GREEN FLUORESCENT PROTEIN (GFP) PH 5.5 1Q4C ; 1.55 ; S65T Q80R T203C GREEN FLUORESCENT PROTEIN (GFP) PH 8.5 1Q4E ; 1.38 ; S65T Q80R Y145C GREEN FLUORESCENT PROTEIN (GFP) PH 8.5 1Q73 ; 1.60 ; S65T Q80R Y145C T203C GREEN FLUORESCENT PROTEIN (GFP) PH 8.5 1BGZ ; -1.00 ; S8 RRNA BINDING SITE FROM E. COLI, NMR, 6 STRUCTURES 1GKL ; 1.40 ; S954A MUTANT OF THE FERULOYL ESTERASE MODULE FROM CLOSTRIDIUM THERMOCELLUM COMPLEXED WITH FERULIC ACID 1WB4 ; 1.40 ; S954A MUTANT OF THE FERULOYL ESTERASE MODULE FROM CLOSTRIDIUM THERMOCELLUM COMPLEXED WITH SINAPINATE 1WB5 ; 1.40 ; S954A MUTANT OF THE FERULOYL ESTERASE MODULE FROM CLOSTRIDIUM THERMOCELLUM COMPLEXED WITH SYRINGATE 1ES2 ; 1.55 ; S96A MUTANT OF STREPTOMYCES K15 DD-TRANSPEPTIDASE 1TOB ; -1.00 ; SACCHARIDE-RIBONUCLEIC ACID RECOGNITION IN AN AMINOGLYCOSIDE ANTIBIOTIC-RIBONUCLEIC ACID APTAMER COMPLEX, NMR, 7 STRUCTURES 1NEM ; -1.00 ; SACCHARIDE-RIBONUCLEIC ACID RECOGNITION IN THE NEOMYCIN B-RIBONUCLEIC ACID APTAMER COMPLEX 1YPR ; 2.30 ; SACCHAROMYCES CEREVISIAE (YEAST) PROFILIN 1MR3 ; 1.60 ; SACCHAROMYCES CEREVISIAE ADP-RIBOSYLATION FACTOR 2 (SCARF2) COMPLEXED WITH GDP-3'P AT 1.6A RESOLUTION 4PGM ; 2.30 ; SACCHAROMYCES CEREVISIAE PHOSPHOGLYCERATE MUTASE 5PGM ; 2.12 ; SACCHAROMYCES CEREVISIAE PHOSPHOGLYCERATE MUTASE 1BQ4 ; 2.50 ; SACCHAROMYCES CEREVISIAE PHOSPHOGLYCERATE MUTASE IN COMPLEX WITH BENZENE HEXACARBOXYLATE 1BQ3 ; 2.70 ; SACCHAROMYCES CEREVISIAE PHOSPHOGLYCERATE MUTASE IN COMPLEX WITH INOSITOL HEXAKISPHOSPHATE 1A48 ; 1.90 ; SAICAR SYNTHASE 1OBD ; 1.40 ; SAICAR-SYNTHASE COMPLEXED WITH ATP 1OBG ; 2.05 ; SAICAR-SYNTHASE COMPLEXED WITH ATP 1OHM ; -1.00 ; SAKACIN P VARIANT THAT IS STRUCTURALLY STABILIZED BY AN INSERTED C-TERMINAL DISULFIDE BRIDGE. 1UQV ; -1.00 ; SAM DOMAIN FROM STE50P 1MJ0 ; 2.03 ; SANK E3_5: AN ARTIFICIAL ANKYRIN REPEAT PROTEIN 1KA6 ; -1.00 ; SAP/SH2D1A BOUND TO PEPTIDE N-PY 1KA7 ; -1.00 ; SAP/SH2D1A BOUND TO PEPTIDE N-Y-C 1HSJ ; 2.30 ; SARR MBP FUSION STRUCTURE 1STM ; 1.90 ; SATELLITE PANICUM MOSAIC VIRUS 2BUK ; 2.45 ; SATELLITE TOBACCO NECROSIS VIRUS 1SVN ; 1.40 ; SAVINASE 1W1W ; 2.90 ; SC SMC1HD:SCC1-C COMPLEX, ATPGS 1KK8 ; 2.30 ; SCALLOP MYOSIN (S1-ADP-BEFX) IN THE ACTIN-DETACHED CONFORMATION 1KK7 ; 3.20 ; SCALLOP MYOSIN IN THE NEAR RIGOR CONFORMATION 1WDC ; 2.00 ; SCALLOP MYOSIN REGULATORY DOMAIN 1DFL ; 4.20 ; SCALLOP MYOSIN S1 COMPLEXED WITH MGADP:VANADATE-TRANSITION STATE 1L2O ; 2.80 ; SCALLOP MYOSIN S1-ADP-P-PDM IN THE ACTIN-DETACHED CONFORMATION 1KQM ; 3.00 ; SCALLOP MYOSIN S1-AMPPNP IN THE ACTIN-DETACHED CONFORMATION 1KWO ; 3.80 ; SCALLOP MYOSIN S1-ATPGAMMAS-P-PDM IN THE ACTIN-DETACHED CONFORMATION 5HBI ; 1.60 ; SCAPHARCA DIMERIC HEMOGLOBIN, MUTANT T72I, CO-LIGANDED FORM 4HBI ; 1.60 ; SCAPHARCA DIMERIC HEMOGLOBIN, MUTANT T72I, DEOXY FORM 7HBI ; 1.60 ; SCAPHARCA DIMERIC HEMOGLOBIN, MUTANT T72V, CO-LIGANDED FORM 6HBI ; 1.80 ; SCAPHARCA DIMERIC HEMOGLOBIN, MUTANT T72V, DEOXY FORM 1SCT ; 2.00 ; SCAPHARCA TETRAMERIC HEMOGLOBIN, CO-STATE 1EUA ; 1.95 ; SCHIFF BASE INTERMEDIATE IN KDPG ALDOLASE FROM ESCHERICHIA COLI 1H7P ; 1.64 ; SCHIFF-BASE COMPLEX OF YEAST 5-AMINOLAEVULINIC ACID DEHYDRATASE WITH 4-KETO-5-AMINO-HEXANOIC (KAH) AT 1.64 A RESOLUTION 1GJP ; 1.80 ; SCHIFF-BASE COMPLEX OF YEAST 5-AMINOLAEVULINIC ACID DEHYDRATASE WITH 4-OXOSEBACIC ACID 1H7O ; 1.75 ; SCHIFF-BASE COMPLEX OF YEAST 5-AMINOLAEVULINIC ACID DEHYDRATASE WITH 5-AMINOLAEVULINIC ACID AT 1.7 A RESOLUTION 1YLV ; 2.15 ; SCHIFF-BASE COMPLEX OF YEAST 5-AMINOLAEVULINIC ACID DEHYDRATASE WITH LAEVULINIC ACID 1H7N ; 1.60 ; SCHIFF-BASE COMPLEX OF YEAST 5-AMINOLAEVULINIC ACID DEHYDRATASE WITH LAEVULINIC ACID AT 1.6 A RESOLUTION 1H7R ; 2.00 ; SCHIFF-BASE COMPLEX OF YEAST 5-AMINOLAEVULINIC ACID DEHYDRATASE WITH SUCCINYLACETONE AT 2.0 A RESOLUTION. 1VYG ; 2.40 ; SCHISTOSOMA MANSONI FATTY ACID BINDING PROTEIN IN COMPLEX WITH ARACHIDONIC ACID 1VYF ; 1.85 ; SCHISTOSOMA MANSONI FATTY ACID BINDING PROTEIN IN COMPLEX WITH OLEIC ACID 1PK3 ; 1.85 ; SCM SAM DOMAIN 1WMT ; -1.00 ; SCORPION TOXIN (ISTX) FROM OPISTHACANTHUS MADAGASCARIENSIS 1TXM ; -1.00 ; SCORPION TOXIN (MAUROTOXIN) FROM SCORPIO MAURUS, NMR, 35 STRUCTURES 1SXM ; -1.00 ; SCORPION TOXIN (NOXIUSTOXIN) WITH HIGH AFFINITY FOR VOLTAGE DEPENDENT POTASSIUM CHANNEL AND LOW AFFINITY FOR CALCIUM DEPENDENT POTASSIUM CHANNEL (NMR AT 20 DEGREES, PH3.5, 39 STRUCTURES) 1SCO ; -1.00 ; SCORPION TOXIN (OSK1 TOXIN) WITH HIGH AFFINITY FOR SMALL CONDUCTANCE CA(2+)-ACTIVATED K+ CHANNEL IN NEUROBLASTOMA-X-GLUOMA NG 108-15 HYBRID CELLS, NMR, 30 STRUCTURES 1TSK ; -1.00 ; SCORPION TOXIN (TS KAPPA) FROM TITYUS SERRULATUS ACTIVE ON SMALL CONDUCTANCE POTASSIUM CHANNEL, NMR, 30 STRUCTURES 1BCG ; 2.10 ; SCORPION TOXIN BJXTR-IT 1BIG ; -1.00 ; SCORPION TOXIN BMTX1 FROM BUTHUS MARTENSII KARSCH, NMR, 25 STRUCTURES 2BMT ; -1.00 ; SCORPION TOXIN BMTX2 FROM BUTHUS MARTENSII KARSCH, NMR, 25 STRUCTURES 1WCC ; 2.20 ; SCREENING FOR FRAGMENT BINDING BY X-RAY CRYSTALLOGRAPHY 3STD ; 1.65 ; SCYTALONE DEHYDRATASE AND CYANOCINNOLINE INHIBITOR 2STD ; 2.10 ; SCYTALONE DEHYDRATASE COMPLEXED WITH TIGHT-BINDING INHIBITOR CARPROPAMID 5STD ; 1.95 ; SCYTALONE DEHYDRATASE PLUS INHIBITOR 2 6STD ; 1.80 ; SCYTALONE DEHYDRATASE PLUS INHIBITOR 3 7STD ; 1.80 ; SCYTALONE DEHYDRATASE PLUS INHIBITOR 4 1A15 ; 2.20 ; SDF-1ALPHA 1BGK ; -1.00 ; SEA ANEMONE TOXIN (BGK) WITH HIGH AFFINITY FOR VOLTAGE DEPENDENT POTASSIUM CHANNEL, NMR, 15 STRUCTURES 1IFQ ; 2.40 ; SEC22B N-TERMINAL DOMAIN 1R8M ; 1.70 ; SEC7 DOMAIN OF THE ARF EXCHANGE FACTOR ARNO WITH BREFELDIN A-SENSITIZING MUTATIONS 1PBV ; 2.00 ; SEC7 DOMAIN OF THE EXCHANGE FACTOR ARNO 1VRY ; -1.00 ; SECOND AND THIRD TRANSMEMBRANE DOMAINS OF THE ALPHA-1 SUBUNIT OF HUMAN GLYCINE RECEPTOR 1QI6 ; 2.50 ; SECOND APO FORM OF AN NADP DEPENDENT ALDEHYDE DEHYDROGENASE WITH GLU250 SITUATED 3.7 A FROM CYS284 1BHD ; 2.00 ; SECOND CALPONIN HOMOLOGY DOMAIN FROM UTROPHIN 1Q8L ; -1.00 ; SECOND METAL BINDING DOMAIN OF THE MENKES ATPASE 1CX1 ; -1.00 ; SECOND N-TERMINAL CELLULOSE-BINDING DOMAIN FROM CELLULOMONAS FIMI BETA-1,4-GLUCANASE C, NMR, 22 STRUCTURES 1GM1 ; -1.00 ; SECOND PDZ DOMAIN (PDZ2) OF PTP-BL 1QG9 ; -1.00 ; SECOND REPEAT (IS2MIC) FROM VOLTAGE-GATED SODIUM CHANNEL 1LDR ; -1.00 ; SECOND REPEAT OF THE LDL RECEPTOR LIGAND-BINDING DOMAIN 1ZAP ; 2.50 ; SECRETED ASPARTIC PROTEASE FROM C. ALBICANS 1EAG ; 2.10 ; SECRETED ASPARTIC PROTEINASE (SAP2) FROM CANDIDA ALBICANS COMPLEXED WITH A70450 1AWT ; 2.55 ; SECYPA COMPLEXED WITH HAGPIA 1AWS ; 1.58 ; SECYPA COMPLEXED WITH HAGPIA (PSEUDO-SYMMETRIC MONOMER) 3RN3 ; 1.45 ; SEGMENTED ANISOTROPIC REFINEMENT OF BOVINE RIBONUCLEASEA BY THE APPLICATION OF THE RIGID-BODY TLS MODEL 1KMB ; 2.10 ; SELECTIN-LIKE MUTANT OF MANNOSE-BINDING PROTEIN A 1WO9 ; -1.00 ; SELECTIVE INHIBITION OF TRYPSINS BY INSECT PEPTIDES: ROLE OF P6-P10 LOOP 1C4U ; 2.10 ; SELECTIVE NON ELECTROPHILIC THROMBIN INHIBITORS WITH CYCLOHEXYL MOIETIES. 1C4V ; 2.10 ; SELECTIVE NON ELECTROPHILIC THROMBIN INHIBITORS WITH CYCLOHEXYL MOIETIES. 1C4Y ; 2.70 ; SELECTIVE NON-ELECTROPHILIC THROMBIN INHIBITORS 1GJ4 ; 1.81 ; SELECTIVITY AT S1, H2O DISPLACEMENT, UPA, TPA, SER190/ALA190 PROTEASE, STRUCTURE-BASED DRUG DESIGN 1GJ5 ; 1.73 ; SELECTIVITY AT S1, H2O DISPLACEMENT, UPA, TPA, SER190/ALA190 PROTEASE, STRUCTURE-BASED DRUG DESIGN 316D ; 3.00 ; SELECTIVITY OF F8-ACTINOMYCIN D FOR RIBONUCLEIC ACID:DEOXYRIBONUCLEIC ACID HYBRIDS AND ITS ANTI-LEUKEMIA ACTIVITY 1VRO ; 1.10 ; SELENIUM-ASSISTED NUCLEIC ACID CRYSTALLOGRAPHY: USE OF PHOSPHOROSELENOATES FOR MAD PHASING OF A DEOXYRIBONUCLEIC ACID STRUCTURE 1GSJ ; 1.85 ; SELENOMETHIONINE SUBSTITUTED N-ACETYL-L-GLUTAMATE KINASE FROM ESCHERICHIA COLI COMPLEXED WITH ITS SUBSTRATE N-ACETYL-L-GLUTAMATE AND ITS SUBSTRATE ANALOG AMPPNP 1JJK ; 3.00 ; SELENOMETHIONINE SUBSTITUTION OF OROTIDINE-5'-MONOPHOSPHATE DECARBOXYLASE FROM E. COLI CAUSES A CHANGE IN CRYSTAL CONTACTS AND SPACE GROUP 1UBN ; 2.40 ; SELENOSUBTILISIN BPN 1BKL ; 2.10 ; SELF-ASSOCIATED APO SRC SH2 DOMAIN 1HVV ; 2.40 ; SELF-ASSOCIATION OF THE H3 REGION OF SYNTAXIN 1A: IMPLICATIONS FOR SNARE COMPLEX ASSEMBLY 1BUF ; -1.00 ; SELF-COMPLEMENTARY DEOXYRIBONUCLEIC ACID 5'-D(CAATTG)2, NMR, MINIMIZED AVERAGE STRUCTURE 1UQC ; -1.00 ; SELF-COMPLEMENTARY DEOXYRIBONUCLEIC ACID 5'-D(CACGTG)2, NMR, MINIMIZED AVERAGE STRUCTURE 1UQB ; -1.00 ; SELF-COMPLEMENTARY DEOXYRIBONUCLEIC ACID 5'-D(CAGCTG)2, NMR, MINIMIZED AVERAGE STRUCTURE 1UQA ; -1.00 ; SELF-COMPLEMENTARY DEOXYRIBONUCLEIC ACID 5'-D(CATATG)2, NMR, MINIMIZED AVERAGE STRUCTURE 1UQD ; -1.00 ; SELF-COMPLEMENTARY DEOXYRIBONUCLEIC ACID 5'-D(CGATCG)2, NMR, MINIMIZED AVERAGE STRUCTURE 1UQG ; -1.00 ; SELF-COMPLEMENTARY DEOXYRIBONUCLEIC ACID 5'-D(CGCGCG)2, NMR, MINIMIZED AVERAGE STRUCTURE 1UQF ; -1.00 ; SELF-COMPLEMENTARY DEOXYRIBONUCLEIC ACID 5'-D(CGGCCG)2, NMR, MINIMIZED AVERAGE STRUCTURE 1UQE ; -1.00 ; SELF-COMPLEMENTARY DEOXYRIBONUCLEIC ACID 5'-D(CGTACG)2, NMR, MINIMIZED AVERAGE STRUCTURE 2SEM ; 2.20 ; SEM5 SH3 DOMAIN COMPLEXED WITH PEPTOID INHIBITOR 3SEM ; 2.20 ; SEM5 SH3 DOMAIN COMPLEXED WITH PEPTOID INHIBITOR 1USZ ; 3.28 ; SEMET AFAE-3 ADHESIN FROM ESCHERICHIA COLI 1W3Z ; 3.20 ; SEMET DERIVATIVE OF BBCRASP-1 FROM BORRELIA BURGDORFERI 1E3H ; 2.60 ; SEMET DERIVATIVE OF STREPTOMYCES ANTIBIOTICUS PNPASE/GPSI ENZYME 1I8X ; -1.00 ; SEMI-AUTOMATIC STRUCTURE DETERMINATION OF THE CG1 1-30 PEPTIDE BASED ON ARIA 1I8Y ; -1.00 ; SEMI-AUTOMATIC STRUCTURE DETERMINATION OF THE CG1 3-30 PEPTIDE BASED ON ARIA 1ZVO ; -1.00 ; SEMI-EXTENDED SOLUTION STRUCTURE OF HUMAN MYELOMA IMMUNOGLOBULIN D DETERMINED BY CONSTRAINED X-RAY SCATTERING 1XSS ; 1.60 ; SEMI-RATIONAL ENGINEERING OF A GREEN-EMITTING CORAL FLUORESCENT PROTEIN INTO AN EFFICIENT HIGHLIGHTER. 1JH6 ; 1.80 ; SEMI-REDUCED CYCLIC NUCLEOTIDE PHOSPHODIESTERASE FROM ARABIDOPSIS THALIANA 1JH7 ; 2.40 ; SEMI-REDUCED INHIBITOR-BOUND CYCLIC NUCLEOTIDE PHOSPHODIESTERASE FROM ARABIDOPSIS THALIANA 1VCP ; 3.00 ; SEMLIKI FOREST VIRUS CAPSID PROTEIN (CRYSTAL FORM I) 1VCQ ; 3.10 ; SEMLIKI FOREST VIRUS CAPSID PROTEIN (CRYSTAL FORM II) 2BZP ; 2.45 ; SENP1 STRUCTURE 2BZO ; 3.20 ; SENP1-SUMO2 COMPLEX 1P0Z ; 1.60 ; SENSOR KINASE CITA BINDING DOMAIN 1OJG ; -1.00 ; SENSORY DOMAIN OF THE MEMBRANEOUS TWO-COMPONENT FUMARATE SENSOR DCUS OF E. COLI 1GU8 ; 2.27 ; SENSORY RHODOPSIN II 1GUE ; 2.27 ; SENSORY RHODOPSIN II 1H68 ; 2.10 ; SENSORY RHODOPSIN II 1LU3 ; 16.80 ; SEPARATE FITTING OF THE ANTICODON LOOP REGION OF TRNA (NUCLEOTIDE 26-42) IN THE LOW RESOLUTION CRYO-EM MAP OF AN EF-TU TERNARY COMPLEX (GDP AND KIRROMYCIN) BOUND TO E. COLI 70S RIBOSOME 1NAS ; 2.10 ; SEPIAPTERIN REDUCTASE COMPLEXED WITH N-ACETYL SEROTONIN 1FE5 ; 2.45 ; SEQUENCE AND CRYSTAL STRUCTURE OF A BASIC PHOSPHOLIPASE A2 FROM COMMON KRAIT (BUNGARUS CAERULEUS) AT 2.4 RESOLUTION: IDENTIFICATION AND CHARACTERIZATION OF ITS PHARMACOLOGICAL SITES. 1G2X ; 2.50 ; SEQUENCE INDUCED TRIMERIZATION OF KRAIT PLA2: CRYSTAL STRUCTURE OF THE TRIMERIC FORM OF KRAIT PLA2 1VJ4 ; 1.80 ; SEQUENCE-DEPENDENT CONFORMATION OF AN A-DEOXYRIBONUCLEIC ACID DOUBLE HELIX: THE CRYSTAL STRUCTURE OF THE OCTAMER D(G-G-T-A-T-A-C-C) 296D ; 2.25 ; SEQUENCE-DEPENDENT EFFECTS IN DRUG-DEOXYRIBONUCLEIC ACID INTERACTION: THE CRYSTAL STRUCTURE OF HOECHST 33258 BOUND TO THE D(CGCAAATTTGCG)2 DUPLEX 2ALT ; 2.20 ; SEQUESTRATION OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) BY LACTOFERRIN: CRYSTAL STRUCTURE OF THE COMPLEX OF C-TERMINAL LOBE OF BOVINE LACTOFERRIN WITH INDOMETHACIN AT 2.2 A RESOLUTION 1L7Q ; 1.76 ; SER117ALA MUTANT OF BACTERIAL COCAINE ESTERASE COCE 1ZDG ; 2.30 ; SER159 MUTANT OF GLYCOGENIN COMPLEXED WITH UDP-GLUCOSE AND MANGANESE 1ZDF ; 2.45 ; SER162 MUTANT OF GLYCOGENIN COMPLEXED WITH UDP-GLUCOSE AND MANGANESE 1DM4 ; 2.50 ; SER195ALA MUTANT OF HUMAN THROMBIN COMPLEXED WITH FIBRINOPEPTIDE A (7-16) 1FYL ; 2.10 ; SERENDIPITOUS CRYSTAL STRUCTURE CONTAINING THE HEAT SHOCK TRANSCRIPTION FACTOR'S DEOXYRIBONUCLEIC ACID BINDING DOMAIN AND COGNATE DEOXYRIBONUCLEIC ACID IN A HEAD-TO-HEAD ORIENTATION 1FYM ; 2.20 ; SERENDIPITOUS CRYSTAL STRUCTURE CONTAINING THE HEAT SHOCK TRANSCRIPTION FACTOR'S DEOXYRIBONUCLEIC ACID BINDING DOMAIN AND COGNATE DEOXYRIBONUCLEIC ACID IN A TAIL-TO-TAIL ORIENTATION 1FYK ; 2.50 ; SERENDIPITOUS CRYSTAL STRUCTURE CONTAINING THE HEAT SHOCK TRANSCRIPTION FACTOR'S DEOXYRIBONUCLEIC ACID BINDING DOMAIN AND COGNATE DEOXYRIBONUCLEIC ACID THAT IS TRANSLATIONALLY DISORDERED 1PQH ; 1.29 ; SERINE 25 TO THREONINE MUTATION OF ASPARTATE DECARBOXYLASE 1SSM ; 2.15 ; SERINE ACETYLTRANSFERASE- APOENZYME (TRUNCATED) 1SST ; 2.00 ; SERINE ACETYLTRANSFERASE- COMPLEX WITH COA 1SSQ ; 1.85 ; SERINE ACETYLTRANSFERASE- COMPLEX WITH CYSTEINE 1HXE ; 2.10 ; SERINE PROTEASE 1AH2 ; -1.00 ; SERINE PROTEASE PB92 FROM BACILLUS ALCALOPHILUS, NMR, 18 STRUCTURES 2SFA ; 1.60 ; SERINE PROTEINASE FROM STREPTOMYCES FRADIAE ATCC 14544 1CJW ; 1.80 ; SEROTONIN N-ACETYLTRANFERASE COMPLEXED WITH A BISUBSTRATE ANALOG 1YXA ; 2.10 ; SERPINA3N, A MURINE ORTHOLOGUE OF HUMAN ANTICHYMOTRYPSIN 1AF0 ; 1.80 ; SERRATIA PROTEASE IN COMPLEX WITH INHIBITOR 1GYK ; 2.20 ; SERUM AMYLOID P COMPONENT CO-CRYSTALLISED WITH MOBDG AT NEUTRAL PH 1V04 ; 2.20 ; SERUM PARAOXONASE BY DIRECTED EVOLUTION 1SRS ; 3.20 ; SERUM RESPONSE FACTOR (SRF) CORE COMPLEXED WITH SPECIFIC SRE DEOXYRIBONUCLEIC ACID 487D ; 7.50 ; SEVEN RIBOSOMAL PROTEINS FITTED TO A CRYO-ELECTRON MICROSCOPIC MAP OF THE LARGE 50S SUBUNIT AT 7.5 ANGSTROMS RESOLUTION 1B1Y ; 2.50 ; SEVENFOLD MUTANT OF BARLEY BETA-AMYLASE 1SVY ; 1.75 ; SEVERIN DOMAIN 2, 1.75 ANGSTROM CRYSTAL STRUCTURE 2SXL ; -1.00 ; SEX-LETHAL RBD1, NMR, MINIMIZED AVERAGE STRUCTURE 3SXL ; 2.70 ; SEX-LETHAL RIBONUCLEIC ACID RECOGNITION DOMAINS 1 AND 2 FROM DROSOPHILA MELANOGASTER 1LCJ ; 1.80 ; SH2 (SRC HOMOLOGY-2) DOMAIN OF HUMAN P56-LCK TYROSINE KINASE COMPLEXED WITH THE 11 RESIDUE PHOSPHOTYROSYL PEPTIDE EPQPYEEIPIYL 1AWW ; -1.00 ; SH3 DOMAIN FROM BRUTON'S TYROSINE KINASE, NMR, 42 STRUCTURES 1AWX ; -1.00 ; SH3 DOMAIN FROM BRUTON'S TYROSINE KINASE, NMR, MINIMIZED AVERAGE STRUCTURE 1ARK ; -1.00 ; SH3 DOMAIN FROM HUMAN NEBULIN, NMR, 15 STRUCTURES 1NEB ; -1.00 ; SH3 DOMAIN FROM HUMAN NEBULIN, NMR, MINIMIZED AVERAGE STRUCTURE 1H92 ; -1.00 ; SH3 DOMAIN OF HUMAN LCK TYROSINE KINASE 1W1F ; -1.00 ; SH3 DOMAIN OF HUMAN LYN TYROSINE KINASE 1WA7 ; -1.00 ; SH3 DOMAIN OF HUMAN LYN TYROSINE KINASE IN COMPLEX WITH A HERPESVIRAL LIGAND 1S1N ; -1.00 ; SH3 DOMAIN OF HUMAN NEPHROCYSTIN 1UG1 ; -1.00 ; SH3 DOMAIN OF HYPOTHETICAL PROTEIN BAA76854.1 1KIK ; -1.00 ; SH3 DOMAIN OF LYMPHOCYTE SPECIFIC KINASE (LCK) 1W70 ; 1.46 ; SH3 DOMAIN OF P40PHOX COMPLEXED WITH C-TERMINAL POLYPROLINE REGION OF P47PHOX 1W6X ; 2.00 ; SH3 DOMAIN OF P40PHOX, COMPONENT OF THE NADPH OXIDASE 1KJW ; 1.80 ; SH3-GUANYLATE KINASE MODULE FROM PSD-95 2ABL ; 2.50 ; SH3-SH2 DOMAIN FRAGMENT OF HUMAN BCR-ABL TYROSINE KINASE 1LCK ; 2.50 ; SH3-SH2 DOMAIN FRAGMENT OF HUMAN P56-LCK TYROSINE KINASE COMPLEXED WITH THE 10 RESIDUE SYNTHETIC PHOSPHOTYROSYL PEPTIDE TEGQPYQPQPA 1SHC ; -1.00 ; SHC PTB DOMAIN COMPLEXED WITH A TRKA RECEPTOR PHOSPHOPEPTIDE, NMR, MINIMIZED AVERAGE STRUCTURE 1MUV ; -1.00 ; SHEARED A(ANTI)-A(ANTI) BASE PAIRS IN A DESTABILIZING 2X2 INTERNAL LOOP: THE NMR STRUCTURE OF 5'(RGGCAAGCCU)2 1P0U ; -1.00 ; SHEARED G/C BASE PAIR 1BXS ; 2.35 ; SHEEP LIVER CLASS 1 ALDEHYDE DEHYDROGENASE WITH NAD BOUND 1DM0 ; 2.50 ; SHIGA TOXIN 1R4Q ; 2.50 ; SHIGA TOXIN 1R4P ; 1.77 ; SHIGA TOXIN TYPE 2 1BOS ; 2.80 ; SHIGA-LIKE TOXIN COMPLEXED WITH ITS RECEPTOR 1QNU ; 2.23 ; SHIGA-LIKE TOXIN I B SUBUNIT COMPLEXED WITH THE BRIDGED-STARFISH INHIBITOR 1NYT ; 1.50 ; SHIKIMATE DEHYDROGENASE AROE COMPLEXED WITH NADP+ 1BEI ; -1.00 ; SHK-DNP22: A POTENT KV1.3-SPECIFIC IMMUNOSUPPRESSIVE POLYPEPTIDE, NMR, 20 STRUCTURES 1YGC ; 2.00 ; SHORT FACTOR VIIA WITH A SMALL MOLECULE INHIBITOR 1YC0 ; 2.60 ; SHORT FORM HGFA WITH FIRST KUNITZ DOMAIN FROM HAI-1 1ONG ; 1.10 ; SHV-1 BETA-LACTAMASE WITH A PENEM INHIBITOR 1Q2P ; 2.00 ; SHV-1 CLASS A BETA-LACTAMASE COMPLEXED WITH PENEM WAY185229 1AB1 ; 0.89 ; SI FORM CRAMBIN 1K2F ; 2.60 ; SIAH, SEVEN IN ABSENTIA HOMOLOG 1EUR ; 1.82 ; SIALIDASE 1EUS ; 2.00 ; SIALIDASE COMPLEXED WITH 2-DEOXY-2,3-DEHYDRO-N- ACETYLNEURAMINIC ACID 3SIL ; 1.05 ; SIALIDASE FROM SALMONELLA TYPHIMURIUM 1DIL ; 1.90 ; SIALIDASE FROM SALMONELLA TYPHIMURIUM COMPLEXED WITH APANA AND EPANA INHIBITORS 1DIM ; 1.60 ; SIALIDASE FROM SALMONELLA TYPHIMURIUM COMPLEXED WITH EPANA INHIBITOR 1SLL ; 2.00 ; SIALIDASE L FROM LEECH MACROBDELLA DECORA 1EUU ; 2.50 ; SIALIDASE OR NEURAMINIDASE, LARGE 68KD FORM 1EUT ; 2.50 ; SIALIDASE, LARGE 68KD FORM, COMPLEXED WITH GALACTOSE 304D ; 1.90 ; SIDE-BY-SIDE BINDING OF DISTAMYCIN MOLECULES TO D(ICATATIC) IN THE MONOCLINIC FORM 305D ; 2.17 ; SIDE-BY-SIDE BINDING OF DISTAMYCIN MOLECULES TO D(ICATATIC) IN THE TETRAGONAL FORM 306D ; 1.60 ; SIDE-BY-SIDE BINDING OF DISTAMYCIN MOLECULES TO D(ICITACIC) 1SC5 ; 3.26 ; SIGMA-28(FLIA)/FLGM COMPLEX 1914 ; 2.53 ; SIGNAL RECOGNITION PARTICLE ALU RIBONUCLEIC ACID BINDING HETERODIMER, SRP9/14 1J8M ; 2.00 ; SIGNAL RECOGNITION PARTICLE CONSERVED GTPASE DOMAIN FROM A. AMBIVALENS 1J8Y ; 2.00 ; SIGNAL RECOGNITION PARTICLE CONSERVED GTPASE DOMAIN FROM A. AMBIVALENS T112A MUTANT 1NRJ ; 1.70 ; SIGNAL RECOGNITION PARTICLE RECEPTOR BETA-SUBUNIT IN COMPLEX WITH THE SRX DOMAIN FROM THE ALPHA-SUBUNIT 1FTS ; 2.20 ; SIGNAL RECOGNITION PARTICLE RECEPTOR FROM E. COLI 1TZE ; 2.10 ; SIGNAL TRANSDUCTION ADAPTOR GROWTH FACTOR, GRB2 SH2 DOMAIN COMPLEXED WITH PHOSPHOTYROSYL HEPTAPEPTIDE LYS-PRO-PHE-PTYR-VAL-ASN-VAL-NH2 (KFPPYVNC-NH2) 1BAK ; -1.00 ; SIGNAL TRANSDUCTION PLECKSTRIN HOMOLOGY DOMAIN OF G-PROTEIN COUPLED RECEPTOR KINASE 2 (BETA-ADRENERGIC RECEPTOR KINASE 1), C-TERMINAL EXTENDED, NMR, 20 STRUCTURES 1YMU ; 2.30 ; SIGNAL TRANSDUCTION PROTEIN CHEY MUTANT WITH MET 17 REPLACED BY GLY (M17G) 1YMV ; 1.90 ; SIGNAL TRANSDUCTION PROTEIN CHEY MUTANT WITH PHE 14 REPLACED BY GLY, SER 15 REPLACED BY GLY, AND MET 17 REPLACED BY GLY 1SVA ; 3.10 ; SIMIAN VIRUS 40 1EQV ; 1.94 ; SIMPLIFICATION OF A PROTEIN LOOP IN STAPHYLOCOCCAL NUCLEASE 1F2M ; 2.00 ; SIMPLIFICATION OF A PROTEIN LOOP IN STAPHYLOCOCCAL NUCLEASE 1F2Y ; 2.00 ; SIMPLIFICATION OF A PROTEIN LOOP IN STAPHYLOCOCCAL NUCLEASE 1F2Z ; 1.80 ; SIMPLIFICATION OF A PROTEIN LOOP IN STAPHYLOCOCCAL NUCLEASE 1XQQ ; -1.00 ; SIMULTANEOUS DETERMINATION OF PROTEIN STRUCTURE AND DYNAMICS 1YQX ; 2.50 ; SINAPYL ALCOHOL DEHYDROGENASE AT 2.5 ANGSTROM RESOLUTION 1YQD ; 1.65 ; SINAPYL ALCOHOL DEHYDROGENASE COMPLEXED WITH NADP+ 1KXC ; 3.10 ; SINDBIS VIRUS CAPSID (N190K MUTANT), TETRAGONAL CRYSTAL FORM 1KXD ; 3.10 ; SINDBIS VIRUS CAPSID (N222L MUTANT), TETRAGONAL CRYSTAL FORM 1KXB ; 2.90 ; SINDBIS VIRUS CAPSID (S215A MUTANT), TETRAGONAL CRYSTAL FORM 1KXE ; 3.10 ; SINDBIS VIRUS CAPSID (Y180S, E183G DOUBLE MUTANT), TETRAGONAL CRYSTAL FORM 1SVP ; 2.00 ; SINDBIS VIRUS CAPSID PROTEIN 1WYK ; 2.00 ; SINDBIS VIRUS CAPSID PROTEIN (114-264) 2SNW ; 2.70 ; SINDBIS VIRUS CAPSID PROTEIN, TYPE3 CRYSTAL FORM 1KXF ; 2.38 ; SINDBIS VIRUS CAPSID, (WILD-TYPE) RESIDUES 1-264, TETRAGONAL CRYSTAL FORM (FORM II) 1KXA ; 3.10 ; SINDBIS VIRUS CAPSID, (WILD-TYPE) RESIDUES 106-264, TETRAGONAL CRYSTAL FORM 1AP2 ; 2.40 ; SINGLE CHAIN FV OF C219 1MVU ; 1.78 ; SINGLE CHAIN FV OF C219 HEAVY CHAIN V101L MUTANT IN COMPLEX WITH SYNTHETIC EPITOPE PEPTIDE 2AP2 ; 2.40 ; SINGLE CHAIN FV OF C219 IN COMPLEX WITH SYNTHETIC EPITOPE PEPTIDE 1AOH ; 1.70 ; SINGLE COHESIN DOMAIN FROM THE SCAFFOLDING PROTEIN CIPA OF THE CLOSTRIDIUM THERMOCELLUM CELLULOSOME 251D ; 1.90 ; SINGLE CRYSTAL AND MOLECULAR STRUCTURE OF D(CTCGAG) 1EDG ; 1.60 ; SINGLE CRYSTAL STRUCTURE DETERMINATION OF THE CATALYTIC DOMAIN OF CELCCA CARRIED OUT AT 15 DEGREE C 1H2A ; 1.80 ; SINGLE CRYSTALS OF HYDROGENASE FROM DESULFOVIBRIO VULGARIS 1EQQ ; 3.20 ; SINGLE STRANDED DEOXYRIBONUCLEIC ACID BINDING PROTEIN AND SSDNA COMPLEX 1JMC ; 2.40 ; SINGLE STRANDED DEOXYRIBONUCLEIC ACID-BINDING DOMAIN OF HUMAN REPLICATION PROTEIN A BOUND TO SINGLE STRANDED DEOXYRIBONUCLEIC ACID, RPA70 SUBUNIT, RESIDUES 183 - 420 1URJ ; 3.00 ; SINGLE STRANDED DEOXYRIBONUCLEIC ACID-BINDING PROTEIN(ICP8) FROM HERPES SIMPLEX VIRUS-1 1B0N ; 1.90 ; SINR PROTEIN/SINI PROTEIN COMPLEX 1M2K ; 1.47 ; SIR2 HOMOLOGUE F159A MUTANT-ADP RIBOSE COMPLEX 1M2J ; 1.70 ; SIR2 HOMOLOGUE H80N MUTANT-ADP RIBOSE COMPLEX 1M2H ; 1.80 ; SIR2 HOMOLOGUE S24A MUTANT-ADP RIBOSE COMPLEX 1M2G ; 1.70 ; SIR2 HOMOLOGUE-ADP RIBOSE COMPLEX 1M2N ; 2.60 ; SIR2 HOMOLOGUES (D102G/F159A/R170A) MUTANT-2'-O-ACETYL ADP RIBOSE COMPLEX 1YC5 ; 1.40 ; SIR2-P53 PEPTIDE-NICOTINAMIDE 1YC2 ; 2.40 ; SIR2AF2-NAD-ADPRIBOSE-NICOTINAMIDE 1PON ; -1.00 ; SITE III - SITE IV TROPONIN C HETERODIMER, NMR 1MOO ; 1.05 ; SITE SPECIFIC MUTANT (H64A) OF HUMAN CARBONIC ANHYDRASE II AT HIGH RESOLUTION 1UI7 ; 2.00 ; SITE-DIRECTED MUTAGENESIS OF HIS433 INVOLVED IN BINDING OF COPPER ION IN ARTHROBACTER GLOBIFORMIS AMINE OXIDASE 1UI8 ; 1.80 ; SITE-DIRECTED MUTAGENESIS OF HIS592 INVOLVED IN BINDING OF COPPER ION IN ARTHROBACTER GLOBIFORMIS AMINE OXIDASE 1G0F ; 1.60 ; SITE-SPECIFIC MUTANT (HIS64 REPLACED WITH ALA) OF HUMAN CARBONIC ANHYDRASE II 1G0E ; 1.60 ; SITE-SPECIFIC MUTANT (HIS64 REPLACED WITH ALA) OF HUMAN CARBONIC ANHYDRASE II COMPLEXED WITH 4-METHYLIMIDAZOLE 1LZV ; 2.30 ; SITE-SPECIFIC MUTANT (TYR7 REPLACED WITH HIS) OF HUMAN CARBONIC ANHYDRASE II 1A0P ; 2.50 ; SITE-SPECIFIC RECOMBINASE, XERD 1PB3 ; 1.70 ; SITES OF BINDING AND ORIENTATION IN A FOUR LOCATION MODEL FOR PROTEIN STEREOSPECIFICITY. 2SIV ; 2.20 ; SIV GP41 CORE STRUCTURE 1C6V ; 3.00 ; SIV INTEGRASE (CATALYTIC DOMAIN + DEOXYRIBONUCLEIC ACID BIDING DOMAIN COMPRISING RESIDUES 50-293) MUTANT WITH PHE 185 REPLACED BY HIS (F185H) 1TCW ; 2.40 ; SIV PROTEASE COMPLEXED WITH INHIBITOR SB203386 1YTG ; 2.30 ; SIV PROTEASE CRYSTALLIZED WITH PEPTIDE PRODUCT 1YTH ; 2.20 ; SIV PROTEASE CRYSTALLIZED WITH PEPTIDE PRODUCT 1YTI ; 2.20 ; SIV PROTEASE CRYSTALLIZED WITH PEPTIDE PRODUCT 1YTJ ; 2.50 ; SIV PROTEASE CRYSTALLIZED WITH PEPTIDE PRODUCT 1BN0 ; -1.00 ; SL3 HAIRPIN FROM THE PACKAGING SIGNAL OF HIV-1, NMR, 11 STRUCTURES 1B8H ; 3.00 ; SLIDING CLAMP, DEOXYRIBONUCLEIC ACID POLYMERASE 1LT1 ; 1.91 ; SLIDING HELIX INDUCED CHANGE OF COORDINATION GEOMETRY IN A MODEL DI-MN(II) PROTEIN 1SHH ; 1.55 ; SLOW FORM OF THROMBIN BOUND WITH PPACK 1G8T ; 1.10 ; SM ENDONUCLEASE FROM SERATIA MARCENSCENS AT 1.1 A RESOLUTION 1QL0 ; 1.10 ; SM ENDONUCLEASE FROM SERATIA MARCENSCENS AT ATOMIC RESOLUTION 1KHU ; 2.50 ; SMAD1 CRYSTAL STRUCTURE REVEALS THE DETAILS OF BMP SIGNALING PATHWAY 1MK2 ; 2.74 ; SMAD3 SBD COMPLEX 1E0S ; 2.28 ; SMALL G PROTEIN ARF6-GDP 1MH1 ; 1.38 ; SMALL G-PROTEIN 1SHS ; 2.90 ; SMALL HEAT SHOCK PROTEIN FROM METHANOCOCCUS JANNASCHII 1AFT ; -1.00 ; SMALL SUBUNIT C-TERMINAL INHIBITORY PEPTIDE OF MOUSE RIBONUCLEOTIDE REDUCTASE AS BOUND TO THE LARGE SUBUNIT, NMR, 26 STRUCTURES 1E69 ; 3.10 ; SMC HEAD DOMAIN FROM THERMOTOGA MARITIMA 1GXJ ; 2.00 ; SMC HINGE DOMAIN FROM T. MARITIMA W/O COILED COIL 1GXK ; 3.00 ; SMC HINGE DOMAIN FROM T. MARITIMA W/O COILED COIL, P212121 CRYSTAL FORM 1GXL ; 3.00 ; SMC HINGE DOMAIN FROM T. MARITIMA WITH COILED COIL 1BR2 ; 2.90 ; SMOOTH MUSCLE MYOSIN MOTOR DOMAIN COMPLEXED WITH MGADP.ALF4 1BR1 ; 3.50 ; SMOOTH MUSCLE MYOSIN MOTOR DOMAIN-ESSENTIAL LIGHT CHAIN COMPLEX WITH MGADP.ALF4 BOUND AT THE ACTIVE SITE 1BR4 ; 3.62 ; SMOOTH MUSCLE MYOSIN MOTOR DOMAIN-ESSENTIAL LIGHT CHAIN COMPLEX WITH MGADP.BEF3 BOUND AT THE ACTIVE SITE 1L2N ; -1.00 ; SMT3 SOLUTION STRUCTURE 1SMT ; 2.20 ; SMTB REPRESSOR FROM SYNECHOCOCCUS PCC7942 2SOB ; -1.00 ; SN-OB, OB-FOLD SUB-DOMAIN OF STAPHYLOCOCCAL NUCLEASE, NMR, 10 STRUCTURES 1NHL ; 2.30 ; SNAP-23N STRUCTURE 1S0N ; 2.80 ; SNAPSHOTS OF REPLICATION THROUGH AN ABASIC LESION: STRUCTURAL BASIS FOR BASE SUBSTITUTION AND FRAMESHIFT 1S0O ; 2.10 ; SNAPSHOTS OF REPLICATION THROUGH AN ABASIC LESION: STRUCTURAL BASIS FOR BASE SUBSTITUTION AND FRAMESHIFT 1S10 ; 2.10 ; SNAPSHOTS OF REPLICATION THROUGH AN ABASIC LESION: STRUCTURAL BASIS FOR BASE SUBSTITUTION AND FRAMESHIFT 1HAX ; 1.60 ; SNAPSHOTS OF SERINE PROTEASE CATALYSIS: (A) ACYL-ENZYME INTERMEDIATE BETWEEN PORCINE PANCREATIC ELASTASE AND HUMAN BETA-CASOMORPHIN-7 AT PH 5 1HAY ; 1.70 ; SNAPSHOTS OF SERINE PROTEASE CATALYSIS: (B) ACYL-ENZYME INTERMEDIATE BETWEEN PORCINE PANCREATIC ELASTASE AND HUMAN BETA-CASOMORPHIN-7 JUMPED TO PH 10 FOR 10 SECONDS 1HAZ ; 1.40 ; SNAPSHOTS OF SERINE PROTEASE CATALYSIS: (C) ACYL-ENZYME INTERMEDIATE BETWEEN PORCINE PANCREATIC ELASTASE AND HUMAN BETA-CASOMORPHIN-7 JUMPED TO PH 9 FOR 1 MINUTE 1HB0 ; 2.05 ; SNAPSHOTS OF SERINE PROTEASE CATALYSIS: (D) ACYL-ENZYME INTERMEDIATE BETWEEN PORCINE PANCREATIC ELASTASE AND HUMAN BETA-CASOMORPHIN-7 JUMPED TO PH 10 FOR 2 MINUTES 1BYY ; -1.00 ; SODIUM CHANNEL IIA INACTIVATION GATE 1R5R ; 1.60 ; SOFT-SAD CRYSTAL STRUCTURE OF A PHEROMONE BINDING PROTEIN FROM THE HONEYBEE APIS MELLIFERA L. 1ZN5 ; -1.00 ; SOLID STATE NMR STRUCTURE OF THE LOW-TEMPERATURE FORM OF THE PF1 MAJOR COAT PROTEIN IN MAGNETICALLY ALIGNED BACTERIOPHAGE 1PJF ; -1.00 ; SOLID STATE NMR STRUCTURE OF THE PF1 MAJOR COAT PROTEIN IN MAGNETICALLY ALIGNED BACTERIOPHAGE 1M8M ; -1.00 ; SOLID-STATE MAS NMR STRUCTURE OF THE A-SPECTRIN SH3 DOMAIN 1WC0 ; 2.40 ; SOLUBLE ADENYLYL CYCLASE CYAC FROM S. PLATENSIS IN COMPLEX WITH ALPHA,BETA-METHYLENE-ATP 1WC4 ; 3.00 ; SOLUBLE ADENYLYL CYCLASE CYAC FROM S. PLATENSIS IN COMPLEX WITH ALPHA,BETA-METHYLENE-ATP AND EUROPIUM 1WC3 ; 1.90 ; SOLUBLE ADENYLYL CYCLASE CYAC FROM S. PLATENSIS IN COMPLEX WITH ALPHA,BETA-METHYLENE-ATP AND STRONTIUM 1WC5 ; 2.30 ; SOLUBLE ADENYLYL CYCLASE CYAC FROM S. PLATENSIS IN COMPLEX WITH ALPHA,BETA-METHYLENE-ATP IN PRESENCE OF BICARBONATE 1WC1 ; 1.93 ; SOLUBLE ADENYLYL CYCLASE CYAC FROM S. PLATENSIS IN COMPLEX WITH RP-ATPALPHAS 1WC6 ; 2.51 ; SOLUBLE ADENYLYL CYCLASE CYAC FROM S. PLATENSIS IN COMPLEX WITH RP-ATPALPHAS IN PRESENCE OF BICARBONATE 1XU5 ; 1.96 ; SOLUBLE METHANE MONOOXYGENASE HYDROXYLASE-PHENOL SOAKED 1XU3 ; 2.30 ; SOLUBLE METHANE MONOOXYGENASE HYDROXYLASE-SOAKED WITH BROMOPHENOL 1XVE ; 2.40 ; SOLUBLE METHANE MONOOXYGENASE HYDROXYLASE: 3-BROMO-3- BUTENOL SOAKED STRUCTURE 1XVD ; 2.30 ; SOLUBLE METHANE MONOOXYGENASE HYDROXYLASE: 4-FLUOROPHENOL SOAKED STRUCTURE 1XVB ; 1.80 ; SOLUBLE METHANE MONOOXYGENASE HYDROXYLASE: 6-BROMOHEXANOL SOAKED STRUCTURE 1XVC ; 2.00 ; SOLUBLE METHANE MONOOXYGENASE HYDROXYLASE: 8-BROMOOCTANOL SOAKED STRUCTURE 1XVG ; 1.96 ; SOLUBLE METHANE MONOOXYGENASE HYDROXYLASE: BROMOETHANOL SOAKED STRUCTURE 1XVF ; 2.00 ; SOLUBLE METHANE MONOOXYGENASE HYDROXYLASE: CHLOROPROPANOL SOAKED STRUCTURE 1F97 ; 2.50 ; SOLUBLE PART OF THE JUNCTION ADHESION MOLECULE FROM MOUSE 1QBI ; 1.72 ; SOLUBLE QUINOPROTEIN GLUCOSE DEHYDROGENASE FROM ACINETOBACTER CALCOACETICUS 1CRU ; 1.50 ; SOLUBLE QUINOPROTEIN GLUCOSE DEHYDROGENASE FROM ACINETOBACTER CALCOACETICUS IN COMPLEX WITH PQQ AND METHYLHYDRAZINE 1CQ1 ; 1.90 ; SOLUBLE QUINOPROTEIN GLUCOSE DEHYDROGENASE FROM ACINETOBACTER CALCOACETICUS IN COMPLEX WITH PQQH2 AND GLUCOSE 1WJZ ; -1.00 ; SOLUIOTN STRUCTURE OF J-DOMAIN OF MOUSE DNAJ LIKE PROTEIN 2CU8 ; -1.00 ; SOLUSION STRUCTURE OF THE LIM DOMAIN OF THE CYSTEINE-RICH PROTEIN 2 2CU7 ; -1.00 ; SOLUSION STRUCTURE OF THE SANT DOMAIN OF THE KIAA1915 PROTEIN 226D ; -1.00 ; SOLUTION CONFORMATION OF A BIZELESIN A-TRACT DUPLEX ADDUCT, NMR, 1 STRUCTURE 1DG2 ; -1.00 ; SOLUTION CONFORMATION OF A-CONOTOXIN AUIB 1UL2 ; -1.00 ; SOLUTION CONFORMATION OF ALPHA-CONOTOXIN GIC 1PQR ; -1.00 ; SOLUTION CONFORMATION OF ALPHAA-CONOTOXIN EIVA 1CR3 ; -1.00 ; SOLUTION CONFORMATION OF THE (+)TRANS-ANTI-BENZO[G]CHRYSENE- DA ADDUCT OPPOSITE DT IN A DEOXYRIBONUCLEIC ACID DUPLEX 1AXL ; -1.00 ; SOLUTION CONFORMATION OF THE (-)-TRANS-ANTI-[BP]DG ADDUCT OPPOSITE A DELETION SITE IN DEOXYRIBONUCLEIC ACID DUPLEX D(CCATC-[BP]G-CTACC)D(GGTAG--GATGG), NMR, 6 STRUCTURES 1I34 ; -1.00 ; SOLUTION DEOXYRIBONUCLEIC ACID QUADRUPLEX WITH DOUBLE CHAIN REVERSAL LOOP AND TWO DIAGONAL LOOPS CONNECTING GGGG TETRADS FLANKED BY G-(T- T) TRIAD AND T-T-T TRIPLE 1D6D ; -1.00 ; SOLUTION DEOXYRIBONUCLEIC ACID STRUCTURE CONTAINING (A-A)-T TRIADS INTERDIGITATED BETWEEN A-T BASE PAIRS AND GGGG TETRADS; NMR, 8 STRUCT. 1MZI ; -1.00 ; SOLUTION ENSEMBLE STRUCTURES OF HIV-1 GP41 2F5 MAB EPITOPE 1SX0 ; -1.00 ; SOLUTION NMR STRUCTURE AND X-RAY ABSORPTION ANALYSIS OF THE C-TERMINAL ZINC-BINDING DOMAIN OF THE SECA ATPASE 1SX1 ; -1.00 ; SOLUTION NMR STRUCTURE AND X-RAY ABSORPTION ANALYSIS OF THE C-TERMINAL ZINC-BINDING DOMAIN OF THE SECA ATPASE 1W6B ; -1.00 ; SOLUTION NMR STRUCTURE OF A LONG NEUROTOXIN FROM THE VENOM OF THE ASIAN COBRA, 20 STRUCTURES 2A9L ; -1.00 ; SOLUTION NMR STRUCTURE OF A SUBSTRATE FOR THE ARCHAEAL PRE-TRNA SPLICING ENDONUCLEASES: THE BULGE-HELIX-BULGE MOTIF, MINIMIZED AVERAGE STRUCTURE 2NEO ; -1.00 ; SOLUTION NMR STRUCTURE OF A TWO-BASE DEOXYRIBONUCLEIC ACID BULGE COMPLEXED WITH AN ENEDIYNE CLEAVING ANALOG, 11 STRUCTURES 1YFC ; -1.00 ; SOLUTION NMR STRUCTURE OF A YEAST ISO-1-FERROCYTOCHROME C 1MR0 ; -1.00 ; SOLUTION NMR STRUCTURE OF AGRP(87-120; C105A) 1BJB ; -1.00 ; SOLUTION NMR STRUCTURE OF AMYLOID BETA[E16], RESIDUES 1-28, 14 STRUCTURES 1BJC ; -1.00 ; SOLUTION NMR STRUCTURE OF AMYLOID BETA[F16], RESIDUES 1-28, 15 STRUCTURES 1AFZ ; -1.00 ; SOLUTION NMR STRUCTURE OF AN 11 BASE-PAIR OLIGONUCLEOTIDE FROM THE HUMAN N-RAS PROTOONCOGENE ENCODING FOR AMINO ACIDS 11 - 13 OF P21, MINIMIZED AVERAGE STRUCTURE 1KOS ; -1.00 ; SOLUTION NMR STRUCTURE OF AN ANALOG OF THE YEAST TRNA PHE T STEM LOOP CONTAINING RIBOTHYMIDINE AT ITS NATURALLY OCCURRING POSITION 1GUC ; -1.00 ; SOLUTION NMR STRUCTURE OF AN RIBONUCLEIC ACID WITH TANDEM, SYMMETRIC GU MISMATCHES, 30 STRUCTURES 1YDU ; -1.00 ; SOLUTION NMR STRUCTURE OF AT5G01610, AN ARABIDOPSIS THALIANA PROTEIN CONTAINING DUF538 DOMAIN 1AX3 ; -1.00 ; SOLUTION NMR STRUCTURE OF B. SUBTILIS IIAGLC, 16 STRUCTURES 1BVM ; -1.00 ; SOLUTION NMR STRUCTURE OF BOVINE PANCREATIC PHOSPHOLIPASE A2, 20 STRUCTURES 1L7B ; -1.00 ; SOLUTION NMR STRUCTURE OF BRCT DOMAIN OF T. THERMOPHILUS: NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET WR64TT 1L7Y ; -1.00 ; SOLUTION NMR STRUCTURE OF C. ELEGANS PROTEIN ZK652.3. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET WR41. 1MUX ; -1.00 ; SOLUTION NMR STRUCTURE OF CALMODULIN/W-7 COMPLEX: THE BASIS OF DIVERSITY IN MOLECULAR RECOGNITION, 30 STRUCTURES 1IIY ; -1.00 ; SOLUTION NMR STRUCTURE OF COMPLEX OF 1:2 CYANOVIRIN-N:MAN- ALPHA1,2-MAN-ALPHA RESTRAINED REGULARIZED MEAN COORDINATES 2EZN ; -1.00 ; SOLUTION NMR STRUCTURE OF CYANOVIRIN-N ENSEMBLE OF 40 SIMULATED ANNEALING STRUCTURES 2EZM ; -1.00 ; SOLUTION NMR STRUCTURE OF CYANOVIRIN-N, RESTRAINED REGULARIZED MEAN COORDINATES 1OP1 ; -1.00 ; SOLUTION NMR STRUCTURE OF DOMAIN 1 OF RECEPTOR ASSOCIATED PROTEIN 2EZP ; -1.00 ; SOLUTION NMR STRUCTURE OF ECTODOMAIN OF SIV GP41, MODELS 1 - 10 OF AN ENSEMBLE OF 40 SIMULATED ANNEALING STRUCTURES 2EZQ ; -1.00 ; SOLUTION NMR STRUCTURE OF ECTODOMAIN OF SIV GP41, MODELS 11 - 20 OF AN ENSEMBLE OF 40 SIMULATED ANNEALING STRUCTURES 2EZR ; -1.00 ; SOLUTION NMR STRUCTURE OF ECTODOMAIN OF SIV GP41, MODELS 21 - 30 OF AN ENSEMBLE OF 40 SIMULATED ANNEALING STRUCTURES 2EZS ; -1.00 ; SOLUTION NMR STRUCTURE OF ECTODOMAIN OF SIV GP41, MODELS 31 - 40 OF AN ENSEMBLE OF 40 SIMULATED ANNEALING STRUCTURES 2EZO ; -1.00 ; SOLUTION NMR STRUCTURE OF ECTODOMAIN OF SIV GP41, RESTRAINED REGULARIZED MEAN STRUCTURE 1QCE ; -1.00 ; SOLUTION NMR STRUCTURE OF ECTODOMAIN OF SIV GP41, RESTRAINED REGULARIZED MEAN STRUCTURE PLUS 29 SIMULATED ANNEALING STRUCTURES 1EOT ; -1.00 ; SOLUTION NMR STRUCTURE OF EOTAXIN, MINIMIZED AVERAGE STRUCTURE 1XPW ; -1.00 ; SOLUTION NMR STRUCTURE OF HUMAN PROTEIN HSPCO34. NORTHEAST STRUCTURAL GENOMICS TARGET HR1958 1DVD ; -1.00 ; SOLUTION NMR STRUCTURE OF HUMAN STEFIN A AT PH 5.5 AND 308K, NMR, 17 STRUCTURES 1DVC ; -1.00 ; SOLUTION NMR STRUCTURE OF HUMAN STEFIN A AT PH 5.5 AND 308K, NMR, MINIMIZED AVERAGE STRUCTURE 1PUZ ; -1.00 ; SOLUTION NMR STRUCTURE OF HYPOTHETICAL PROTEIN NMA1147: NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET MR19 1PAV ; -1.00 ; SOLUTION NMR STRUCTURE OF HYPOTHETICAL PROTEIN TA1414 OF THERMOPLASMA ACIDOPHILUM 2MFN ; -1.00 ; SOLUTION NMR STRUCTURE OF LINKED CELL ATTACHMENT MODULES OF MOUSE FIBRONECTIN CONTAINING THE RGD AND SYNERGY REGIONS, 10 STRUCTURES 1MFN ; -1.00 ; SOLUTION NMR STRUCTURE OF LINKED CELL ATTACHMENT MODULES OF MOUSE FIBRONECTIN CONTAINING THE RGD AND SYNERGY REGIONS, 20 STRUCTURES 1XM0 ; -1.00 ; SOLUTION NMR STRUCTURE OF METHIONINE SULFOXIDE REDUCTASE B USING MINIMAL CONSTRAINT STRATEGY; NORTHEAST STRUCTURAL GENOMICS TARGET SR10 1ACW ; -1.00 ; SOLUTION NMR STRUCTURE OF P01, A NATURAL SCORPION PEPTIDE STRUCTURALLY ANALOGOUS TO SCORPION TOXINS SPECIFIC FOR APAMIN-SENSITIVE POTASSIUM CHANNEL, 25 STRUCTURES 1N7L ; -1.00 ; SOLUTION NMR STRUCTURE OF PHOSPHOLAMBAN IN DETERGENT MICELLES 2B95 ; -1.00 ; SOLUTION NMR STRUCTURE OF PROTEIN DYNEIN LIGHT CHAIN 2A, CYTOPLASMIC; NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET HR2106 1YWU ; -1.00 ; SOLUTION NMR STRUCTURE OF PSEUDOMONAS AERUGINOSA PROTEIN PA4608. NORTHEAST STRUCTURAL GENOMICS TARGET PAT7 1CYU ; -1.00 ; SOLUTION NMR STRUCTURE OF RECOMBINANT HUMAN CYSTATIN A UNDER THE CONDITION OF PH 3.8 AND 310K 1CYV ; -1.00 ; SOLUTION NMR STRUCTURE OF RECOMBINANT HUMAN CYSTATIN A UNDER THE CONDITION OF PH 3.8 AND 310K 1JIC ; -1.00 ; SOLUTION NMR STRUCTURE OF RECOMBINANT SSO7D WITH RNASE ACTIVITY, MINIMIZED AVERAGE STRUCTURE 1B10 ; -1.00 ; SOLUTION NMR STRUCTURE OF RECOMBINANT SYRIAN HAMSTER PRION PROTEIN RPRP(90-231) , 25 STRUCTURES 1A24 ; -1.00 ; SOLUTION NMR STRUCTURE OF REDUCED DSBA FROM ESCHERICHIA COLI, FAMILY OF 20 STRUCTURES 1A23 ; -1.00 ; SOLUTION NMR STRUCTURE OF REDUCED DSBA FROM ESCHERICHIA COLI, MINIMIZED AVERAGE STRUCTURE 1RCH ; -1.00 ; SOLUTION NMR STRUCTURE OF RIBONUCLEASE HI FROM ESCHERICHIA COLI, 8 STRUCTURES 1XV0 ; -1.00 ; SOLUTION NMR STRUCTURE OF RIBONUCLEIC ACID INTERNAL LOOP WITH THREE CONSECUTIVE SHEARED GA PAIRS IN 5'GGUGGAGGCU/3'PCCGAAGCCG 1MWN ; -1.00 ; SOLUTION NMR STRUCTURE OF S100B BOUND TO THE HIGH-AFFINITY TARGET PEPTIDE TRTK-12 1HZ2 ; -1.00 ; SOLUTION NMR STRUCTURE OF SELF-COMPLEMENTARY DUPLEX 5'- D(AGGCGCCT)2 CONTAINING A TRIMETHYLENE CROSSLINK AT THE N2 POSITION OF G. MODEL OF A MALONDIALDEHYDE CROSSLINK 1LUH ; -1.00 ; SOLUTION NMR STRUCTURE OF SELF-COMPLIMENTARY DUPLEX 5'- D(TCCGCGGA)2 CONTAINING A TRIMETHYLENE CROSSLINK AT THE N2 POSITION OF G 2SDF ; -1.00 ; SOLUTION NMR STRUCTURE OF STROMAL CELL-DERIVED FACTOR-1 (SDF-1), 30 STRUCTURES 1KMR ; -1.00 ; SOLUTION NMR STRUCTURE OF SURFACTANT PROTEIN B (11-25) (SP- B11-25) 1QSX ; -1.00 ; SOLUTION NMR STRUCTURE OF THE 2:1 HOECHST 33258- D(CTTTTGCAAAAG)2 COMPLEX 3GAT ; -1.00 ; SOLUTION NMR STRUCTURE OF THE C-TERMINAL DOMAIN OF CHICKEN GATA-1 BOUND TO DEOXYRIBONUCLEIC ACID, 34 STRUCTURES 1L4T ; -1.00 ; SOLUTION NMR STRUCTURE OF THE CCK2E3 1G6P ; -1.00 ; SOLUTION NMR STRUCTURE OF THE COLD SHOCK PROTEIN FROM THE HYPERTHERMOPHILIC BACTERIUM THERMOTOGA MARITIMA 1BXP ; -1.00 ; SOLUTION NMR STRUCTURE OF THE COMPLEX OF ALPHA-BUNGAROTOXIN WITH A LIBRARY DERIVED PEPTIDE, 20 STRUCTURES 2BTX ; -1.00 ; SOLUTION NMR STRUCTURE OF THE COMPLEX OF ALPHA-BUNGAROTOXIN WITH A LIBRARY DERIVED PEPTIDE, NMR, MINIMIZED AVERAGE STRUCTURE 1GCC ; -1.00 ; SOLUTION NMR STRUCTURE OF THE COMPLEX OF GCC-BOX BINDING DOMAIN OF ATERF1 AND GCC-BOX DEOXYRIBONUCLEIC ACID, MINIMIZED AVERAGE STRUCTURE 1A66 ; -1.00 ; SOLUTION NMR STRUCTURE OF THE CORE NFATC1/DEOXYRIBONUCLEIC ACID COMPLEX, 18 STRUCTURES 1HBW ; -1.00 ; SOLUTION NMR STRUCTURE OF THE DIMERIZATION DOMAIN OF THE YEAST TRANSCRIPTIONAL ACTIVATOR GAL4 (RESIDUES 50-106) 1YUJ ; -1.00 ; SOLUTION NMR STRUCTURE OF THE GAGA FACTOR/DEOXYRIBONUCLEIC ACID COMPLEX, 50 STRUCTURES 1YUI ; -1.00 ; SOLUTION NMR STRUCTURE OF THE GAGA FACTOR/DEOXYRIBONUCLEIC ACID COMPLEX, REGULARIZED MEAN STRUCTURE 2FN2 ; -1.00 ; SOLUTION NMR STRUCTURE OF THE GLYCOSYLATED SECOND TYPE TWO MODULE OF FIBRONECTIN, 20 STRUCTURES 2GBQ ; -1.00 ; SOLUTION NMR STRUCTURE OF THE GRB2 N-TERMINAL SH3 DOMAIN COMPLEXED WITH A TEN-RESIDUE PEPTIDE DERIVED FROM SOS DIRECT REFINEMENT AGAINST NOES, J-COUPLINGS, AND 1H AND 13C CHEMICAL SHIFTS, 15 STRUCTURES 4GBQ ; -1.00 ; SOLUTION NMR STRUCTURE OF THE GRB2 N-TERMINAL SH3 DOMAIN COMPLEXED WITH A TEN-RESIDUE PEPTIDE DERIVED FROM SOS DIRECT REFINEMENT AGAINST NOES, J-COUPLINGS, AND 1H AND 13C CHEMICAL SHIFTS, 15 STRUCTURES 1GBQ ; -1.00 ; SOLUTION NMR STRUCTURE OF THE GRB2 N-TERMINAL SH3 DOMAIN COMPLEXED WITH A TEN-RESIDUE PEPTIDE DERIVED FROM SOS DIRECT REFINEMENT AGAINST NOES, J-COUPLINGS, AND 1H AND 13C CHEMICAL SHIFTS, MINIMIZED AVERAGE STRUCTURE 3GBQ ; -1.00 ; SOLUTION NMR STRUCTURE OF THE GRB2 N-TERMINAL SH3 DOMAIN COMPLEXED WITH A TEN-RESIDUE PEPTIDE DERIVED FROM SOS DIRECT REFINEMENT AGAINST NOES, J-COUPLINGS, AND 1H AND 13C CHEMICAL SHIFTS, MINIMIZED AVERAGE STRUCTURE 1R9P ; -1.00 ; SOLUTION NMR STRUCTURE OF THE HAEMOPHILUS INFLUENZAE IRON- SULFUR CLUSTER ASSEMBLY PROTEIN U (ISCU) WITH ZINC BOUND AT THE ACTIVE SITE. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET IR24. 1Q48 ; -1.00 ; SOLUTION NMR STRUCTURE OF THE HAEMOPHILUS INFLUENZAE IRON- SULFUR CLUSTER ASSEMBLY PROTEIN U (ISCU) WITH ZINC BOUND AT THE ACTIVE SITE. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET IR24. THIS PROTEIN IS NOT APO, IT IS A MODEL WITHOUT ZINC BINDING CONSTRAINTS. 2STT ; -1.00 ; SOLUTION NMR STRUCTURE OF THE HUMAN ETS1/DEOXYRIBONUCLEIC ACID COMPLEX, 25 STRUCTURES 2STW ; -1.00 ; SOLUTION NMR STRUCTURE OF THE HUMAN ETS1/DEOXYRIBONUCLEIC ACID COMPLEX, RESTRAINED REGULARIZED MEAN STRUCTURE 1HPJ ; -1.00 ; SOLUTION NMR STRUCTURE OF THE HUMAN PLASMINOGEN KRINGLE 1 DOMAIN COMPLEXED WITH 6-AMINOHEXANOIC ACID AT PH 5.3, 310K, DERIVED FROM RANDOMLY GENERATED STRUCTURES USING SIMULATED ANNEALING, 12 STRUCTURES 1HPK ; -1.00 ; SOLUTION NMR STRUCTURE OF THE HUMAN PLASMINOGEN KRINGLE 1 DOMAIN COMPLEXED WITH 6-AMINOHEXANOIC ACID AT PH 5.3, 310K, DERIVED FROM RANDOMLY GENERATED STRUCTURES USING SIMULATED ANNEALING, MINIMIZED AVERAGE STRUCTURE 2EZL ; -1.00 ; SOLUTION NMR STRUCTURE OF THE IBETA SUBDOMAIN OF THE MU END DEOXYRIBONUCLEIC ACID BINDING DOMAIN OF PHAGE MU TRANSPOSASE, 29 STRUCTURES 2EZK ; -1.00 ; SOLUTION NMR STRUCTURE OF THE IBETA SUBDOMAIN OF THE MU END DEOXYRIBONUCLEIC ACID BINDING DOMAIN OF PHAGE MU TRANSPOSASE, REGULARIZED MEAN STRUCTURE 2EZI ; -1.00 ; SOLUTION NMR STRUCTURE OF THE IGAMMA SUBDOMAIN OF THE MU END DEOXYRIBONUCLEIC ACID BINDING DOMAIN OF MU PHAGE TRANSPOSASE, 30 STRUCTURES 2EZH ; -1.00 ; SOLUTION NMR STRUCTURE OF THE IGAMMA SUBDOMAIN OF THE MU END DEOXYRIBONUCLEIC ACID BINDING DOMAIN OF MU PHAGE TRANSPOSASE, MINIMIZED AVERAGE STRUCTURE 1BRV ; -1.00 ; SOLUTION NMR STRUCTURE OF THE IMMUNODOMINANT REGION OF PROTEIN G OF BOVINE RESPIRATORY SYNCYTIAL VIRUS, 48 STRUCTURES 7GAT ; -1.00 ; SOLUTION NMR STRUCTURE OF THE L22V MUTANT DEOXYRIBONUCLEIC ACID BINDING DOMAIN OF AREA COMPLEXED TO A 13 BP DEOXYRIBONUCLEIC ACID CONTAINING A TGATA SITE, 34 STRUCTURES 6GAT ; -1.00 ; SOLUTION NMR STRUCTURE OF THE L22V MUTANT DEOXYRIBONUCLEIC ACID BINDING DOMAIN OF AREA COMPLEXED TO A 13 BP DEOXYRIBONUCLEIC ACID CONTAINING A TGATA SITE, REGULARIZED MEAN STRUCTURE 1ZZA ; -1.00 ; SOLUTION NMR STRUCTURE OF THE MEMBRANE PROTEIN STANNIN 1OM2 ; -1.00 ; SOLUTION NMR STRUCTURE OF THE MITOCHONDRIAL PROTEIN IMPORT RECEPTOR TOM20 FROM RAT IN A COMPLEX WITH A PRESEQUENCE PEPTIDE DERIVED FROM RAT ALDEHYDE DEHYDROGENASE (ALDH) 1MM4 ; -1.00 ; SOLUTION NMR STRUCTURE OF THE OUTER MEMBRANE ENZYME PAGP IN DPC MICELLES 1MM5 ; -1.00 ; SOLUTION NMR STRUCTURE OF THE OUTER MEMBRANE ENZYME PAGP IN OG MICELLES 1ZU2 ; -1.00 ; SOLUTION NMR STRUCTURE OF THE PLANT TOM20 MITOCHONDRIAL IMPORT RECEPTOR FROM ARABIDOPSIS THALIANA 1YWL ; -1.00 ; SOLUTION NMR STRUCTURE OF THE PROTEIN EF2693 FROM E. FAECALIS: NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET EFR36 1TCE ; -1.00 ; SOLUTION NMR STRUCTURE OF THE SHC SH2 DOMAIN COMPLEXED WITH A TYROSINE-PHOSPHORYLATED PEPTIDE FROM THE T-CELL RECEPTOR, MINIMIZED AVERAGE STRUCTURE 1PFS ; -1.00 ; SOLUTION NMR STRUCTURE OF THE SINGLE-STRANDED DEOXYRIBONUCLEIC ACID BINDING PROTEIN OF THE FILAMENTOUS PSEUDOMONAS PHAGE PF3, MINIMIZED AVERAGE STRUCTURE 2BRZ ; -1.00 ; SOLUTION NMR STRUCTURE OF THE SWEET PROTEIN BRAZZEIN, MINIMIZED AVERAGE STRUCTURE 1ZG2 ; -1.00 ; SOLUTION NMR STRUCTURE OF THE UPF0213 PROTEIN BH0048 FROM BACILLUS HALODURANS. NORTHEAST STRUCTURAL GENOMICS TARGET BHR2. 5GAT ; -1.00 ; SOLUTION NMR STRUCTURE OF THE WILD TYPE DEOXYRIBONUCLEIC ACID BINDING DOMAIN OF AREA COMPLEXED TO A 13BP DEOXYRIBONUCLEIC ACID CONTAINING A CGATA SITE, 35 STRUCTURES 4GAT ; -1.00 ; SOLUTION NMR STRUCTURE OF THE WILD TYPE DEOXYRIBONUCLEIC ACID BINDING DOMAIN OF AREA COMPLEXED TO A 13BP DEOXYRIBONUCLEIC ACID CONTAINING A CGATA SITE, REGULARIZED MEAN STRUCTURE 1AXU ; -1.00 ; SOLUTION NMR STRUCTURE OF THE [AP]DG ADDUCT OPPOSITE DA IN A DEOXYRIBONUCLEIC ACID DUPLEX, NMR, 9 STRUCTURES 1AXV ; -1.00 ; SOLUTION NMR STRUCTURE OF THE [BP]DA ADDUCT OPPOSITE DT IN A DEOXYRIBONUCLEIC ACID DUPLEX, 6 STRUCTURES 1TXB ; -1.00 ; SOLUTION NMR STRUCTURE OF TOXIN B, A LONG NEUROTOXIN FROM THE VENOM OF THE KING COBRA, 10 STRUCTURES 1TXA ; -1.00 ; SOLUTION NMR STRUCTURE OF TOXIN B, A LONG NEUROTOXIN FROM THE VENOM OF THE KING COBRA, MINIMIZED AVERAGE STRUCTURE 1A5E ; -1.00 ; SOLUTION NMR STRUCTURE OF TUMOR SUPPRESSOR P16INK4A, 18 STRUCTURES 1DC2 ; -1.00 ; SOLUTION NMR STRUCTURE OF TUMOR SUPPRESSOR P16INK4A, 20 STRUCTURES 2A5E ; -1.00 ; SOLUTION NMR STRUCTURE OF TUMOR SUPPRESSOR P16INK4A, RESTRAINED MINIMIZED MEAN STRUCTURE 4ULL ; -1.00 ; SOLUTION NMR STRUCTURE OF VEROTOXIN-1 B-SUBUNIT FROM E. COLI, 5 STRUCTURES 2CPB ; -1.00 ; SOLUTION NMR STRUCTURES OF THE MAJOR COAT PROTEIN OF FILAMENTOUS BACTERIOPHAGE M13 SOLUBILIZED IN DODECYLPHOSPHOCHOLINE MICELLES, 25 LOWEST ENERGY STRUCTURES 2CPS ; -1.00 ; SOLUTION NMR STRUCTURES OF THE MAJOR COAT PROTEIN OF FILAMENTOUS BACTERIOPHAGE M13 SOLUBILIZED IN SODIUM DODECYL SULPHATE MICELLES, 25 LOWEST ENERGY STRUCTURES 1Y8B ; -1.00 ; SOLUTION NMR-DERIVED GLOBAL FOLD OF MALATE SYNTHASE G FROM E.COLI 1LMR ; -1.00 ; SOLUTION OF ADO1, A TOXIN FROM THE ASSASSIN BUGS AGRIOSPHODRUS DOHRNI THAT BLOCKS THE VOLTAGE SENSITIVE CALCIUM CHANNEL L-TYPE 2D1A ; -1.00 ; SOLUTION RIBONUCLEIC ACID STRUCTURE MODEL OF THE HIV-1 DIMERIZATION INITIATION SITE IN THE EXTENDED-DUPLEX DIMER 2D1B ; -1.00 ; SOLUTION RIBONUCLEIC ACID STRUCTURE MODEL OF THE HIV-1 DIMERIZATION INITIATION SITE IN THE KISSING-LOOP DIMER 2D18 ; -1.00 ; SOLUTION RIBONUCLEIC ACID STRUCTURE OF LOOP REGION OF THE HIV-1 DIMERIZATION INITIATION SITE IN THE EXTENDED-DUPLEX DIMER 2D19 ; -1.00 ; SOLUTION RIBONUCLEIC ACID STRUCTURE OF LOOP REGION OF THE HIV-1 DIMERIZATION INITIATION SITE IN THE KISSING-LOOP DIMER 2D17 ; -1.00 ; SOLUTION RIBONUCLEIC ACID STRUCTURE OF STEM-BULGE-STEM REGION OF THE HIV- 1 DIMERIZATION INITIATION SITE 2D1U ; -1.00 ; SOLUTION STRCUTURE OF THE PERIPLASMIC SIGNALING DOMAIN OF FECA FROM ESCHERICHIA COLI 1WFH ; -1.00 ; SOLUTION STRUCTRUE OF THE ZF-AN1 DOMAIN FROM ARABIDOPSIS THALIANA AT2G36320 PROTEIN 1OWA ; -1.00 ; SOLUTION STRUCTURAL STUDIES ON HUMAN ERYTHROCYTE ALPHA SPECTRIN N TERMINAL TETRAMERIZATION DOMAIN 1DK9 ; -1.00 ; SOLUTION STRUCTURE ANALYSIS OF THE DEOXYRIBONUCLEIC ACID DUPLEX D(CATGAGTAC) D(GTACTCATG) 1D7N ; -1.00 ; SOLUTION STRUCTURE ANALYSIS OF THE MASTOPARAN WITH DETERGENTS 1XS3 ; -1.00 ; SOLUTION STRUCTURE ANALYSIS OF THE XC975 PROTEIN 1FJN ; -1.00 ; SOLUTION STRUCTURE AND ACTIVITY OF THE FOUR DISULFIDE BOND MEDITERRANEAN MUSSEL DEFENSIN MGD-1 1HZ8 ; -1.00 ; SOLUTION STRUCTURE AND BACKBONE DYNAMICS OF A CONCATEMER OF EGF-HOMOLOGY MODULES OF THE HUMAN LOW DENSITY LIPOPROTEIN RECEPTOR 1I0U ; -1.00 ; SOLUTION STRUCTURE AND BACKBONE DYNAMICS OF A CONCATEMER OF EGF-HOMOLOGY MODULES OF THE HUMAN LOW DENSITY LIPOPROTEIN RECEPTOR 1FUW ; -1.00 ; SOLUTION STRUCTURE AND BACKBONE DYNAMICS OF A DOUBLE MUTANT SINGLE-CHAIN MONELLIN(SCM) DETERMINED BY NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY 1KRW ; -1.00 ; SOLUTION STRUCTURE AND BACKBONE DYNAMICS OF BERYLLOFLUORIDE- ACTIVATED NTRC RECEIVER DOMAIN 1KLV ; -1.00 ; SOLUTION STRUCTURE AND BACKBONE DYNAMICS OF GABARAP, GABAA RECEPTOR ASSOCIATED PROTEIN 1KM7 ; -1.00 ; SOLUTION STRUCTURE AND BACKBONE DYNAMICS OF GABARAP, GABAA RECEPTOR ASSOCIATED PROTEIN 3LRI ; -1.00 ; SOLUTION STRUCTURE AND BACKBONE DYNAMICS OF HUMAN LONG- [ARG3]INSULIN-LIKE GROWTH FACTOR 1 1S6O ; -1.00 ; SOLUTION STRUCTURE AND BACKBONE DYNAMICS OF THE APO-FORM OF THE SECOND METAL-BINDING DOMAIN OF THE MENKES PROTEIN ATP7A 1S6U ; -1.00 ; SOLUTION STRUCTURE AND BACKBONE DYNAMICS OF THE CU(I) FORM OF THE SECOND METAL-BINDING DOMAIN OF THE MENKES PROTEIN ATP7A 1J7Q ; -1.00 ; SOLUTION STRUCTURE AND BACKBONE DYNAMICS OF THE DEFUNCT EF- HAND DOMAIN OF CALCIUM VECTOR PROTEIN 1J7R ; -1.00 ; SOLUTION STRUCTURE AND BACKBONE DYNAMICS OF THE DEFUNCT EF- HAND DOMAIN OF CALCIUM VECTOR PROTEIN 1RJA ; -1.00 ; SOLUTION STRUCTURE AND BACKBONE DYNAMICS OF THE NONRECEPTOR TYROSINE KINASE PTK6/BRK SH2 DOMAIN 1P7M ; -1.00 ; SOLUTION STRUCTURE AND BASE PERTURBATION STUDIES REVEAL A NOVEL MODE OF ALKYLATED BASE RECOGNITION BY 3- METHYLADENINE DEOXYRIBONUCLEIC ACID GLYCOSYLASE I 1J6Q ; -1.00 ; SOLUTION STRUCTURE AND CHARACTERIZATION OF THE HEME CHAPERONE CCME 1LM0 ; -1.00 ; SOLUTION STRUCTURE AND CHARACTERIZATION OF THE HEME CHAPERONE CCME 1UMQ ; -1.00 ; SOLUTION STRUCTURE AND DEOXYRIBONUCLEIC ACID BINDING OF THE EFFECTOR DOMAIN FROM THE GLOBAL REGULATOR PRRA(REGA) FROM R. SPHAEROIDES: INSIGHTS INTO DEOXYRIBONUCLEIC ACID BINDING SPECIFICITY 1FZT ; -1.00 ; SOLUTION STRUCTURE AND DYNAMICS OF AN OPEN B-SHEET, GLYCOLYTIC ENZYME-MONOMERIC 23.7 KDA PHOSPHOGLYCERATE MUTASE FROM SCHIZOSACCHAROMYCES POMBE 1Y6D ; -1.00 ; SOLUTION STRUCTURE AND DYNAMICS OF LUXU FROM VIBRIO HARVEYI, A PHOSPHOTRANSFERASE PROTEIN INVOLVED IN BACTERIAL QUORUM SENSING 1Q80 ; -1.00 ; SOLUTION STRUCTURE AND DYNAMICS OF NEREIS SARCOPLASMIC CALCIUM BINDING PROTEIN 1P9J ; -1.00 ; SOLUTION STRUCTURE AND DYNAMICS OF THE EGF/TGF-ALPHA CHIMERA T1E 1M7T ; -1.00 ; SOLUTION STRUCTURE AND DYNAMICS OF THE HUMAN-ESCHERICHIA COLI THIOREDOXIN CHIMERA: INSIGHTS INTO THERMODYNAMIC STABILITY 1IB8 ; -1.00 ; SOLUTION STRUCTURE AND FUNCTION OF A CONSERVED PROTEIN SP14.3 ENCODED BY AN ESSENTIAL STREPTOCOCCUS PNEUMONIAE GENE 1Q3T ; -1.00 ; SOLUTION STRUCTURE AND FUNCTION OF AN ESSENTIAL CMP KINASE OF STREPTOCOCCUS PNEUMONIAE 1G9E ; -1.00 ; SOLUTION STRUCTURE AND RELAXATION MEASUREMENTS OF AN ANTIGEN-FREE HEAVY CHAIN VARIABLE DOMAIN (VHH) FROM LLAMA 1V90 ; -1.00 ; SOLUTION STRUCTURE BY NMR MEANS OF DELTA-PALUIT1-NH2 1EQX ; -1.00 ; SOLUTION STRUCTURE DETERMINATION AND MUTATIONAL ANALYSIS OF THE PAPILLOMAVIRUS E6-INTERACTING PEPTIDE OF E6AP 1A1U ; -1.00 ; SOLUTION STRUCTURE DETERMINATION OF A P53 MUTANT DIMERIZATION DOMAIN, NMR, MINIMIZED AVERAGE STRUCTURE 1L3O ; -1.00 ; SOLUTION STRUCTURE DETERMINATION OF THE FULLY OXIDIZED DOUBLE MUTANT K9-10A CYTOCHROME C7 FROM DESULFUROMONAS ACETOXIDANS, ENSEMBLE OF 35 STRUCTURES 1KWJ ; -1.00 ; SOLUTION STRUCTURE DETERMINATION OF THE FULLY OXIDIZED DOUBLE MUTANT K9-10A CYTOCHROME C7 FROM DESULFUROMONAS ACETOXIDANS, MINIMIZED AVERAGE STRUCTURE 1PUL ; -1.00 ; SOLUTION STRUCTURE FOR THE 21KDA CAENORHABDITIS ELEGANS PROTEIN CE32E8.3. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET WR33 2EXN ; -1.00 ; SOLUTION STRUCTURE FOR THE PROTEIN CODED BY GENE LOCUS BB0938 OF BORDETELLA BRONCHISEPTICA. NORTHEAST STRUCTURAL GENOMICS TARGET BOR11. 1JD8 ; -1.00 ; SOLUTION STRUCTURE OD LACTAM ANALOGUE DAPD OF HIV GP41 600- 612 LOOP. 1RKN ; -1.00 ; SOLUTION STRUCTURE OF 1-110 FRAGMENT OF STAPHYLOCOCCAL NUCLEASE WITH G88W MUTATION 1YYB ; -1.00 ; SOLUTION STRUCTURE OF 1-26 FRAGMENT OF HUMAN PROGRAMMED CELL DEATH 5 PROTEIN 1I5V ; -1.00 ; SOLUTION STRUCTURE OF 2-(PYRIDO[1,2-E]PURIN-4-YL)AMINO- ETHANOL INTERCALATED IN THE DEOXYRIBONUCLEIC ACID DUPLEX D(CGATCG)2 1EDV ; -1.00 ; SOLUTION STRUCTURE OF 2ND INTRADISKAL LOOP OF BOVINE RHODOPSIN (RESIDUES 172-205) 1IEZ ; -1.00 ; SOLUTION STRUCTURE OF 3,4-DIHYDROXY-2-BUTANONE 4-PHOSPHATE SYNTHASE OF RIBOFLAVIN BIOSYNTHESIS 1LMZ ; -1.00 ; SOLUTION STRUCTURE OF 3-METHYLADENINE DEOXYRIBONUCLEIC ACID GLYCOSYLASE I (TAG) 1QXF ; -1.00 ; SOLUTION STRUCTURE OF 30S RIBOSOMAL PROTEIN S27E FROM ARCHAEOGLOBUS FULGIDUS: GR2, A NESG TARGET PROTEIN 1EQ0 ; -1.00 ; SOLUTION STRUCTURE OF 6-HYDROXYMETHYL-7,8-DIHYDROPTERIN PYROPHOSPHOKINASE COMPLEXED WITH MGAMPPCP 1E88 ; -1.00 ; SOLUTION STRUCTURE OF 6F11F22F2, A COMPACT THREE-MODULE FRAGMENT OF THE GELATIN-BINDING DOMAIN OF HUMAN FIBRONECTIN 1E8B ; -1.00 ; SOLUTION STRUCTURE OF 6F11F22F2, A COMPACT THREE-MODULE FRAGMENT OF THE GELATIN-BINDING DOMAIN OF HUMAN FIBRONECTIN 1N2W ; -1.00 ; SOLUTION STRUCTURE OF 8OG:G MISMATCH CONTAINING DUPLEX 1KBD ; -1.00 ; SOLUTION STRUCTURE OF A 16 BASE-PAIR DEOXYRIBONUCLEIC ACID RELATED TO THE HIV- 1 KAPPA B SITE 1F9L ; -1.00 ; SOLUTION STRUCTURE OF A 22-NUCLEOTIDE HAIRPIN SIMILAR TO THE P5ABC REGION OF A GROUP I RIBOZYME WITH COBALT(III) HEXAMMINE COMPLEXED TO THE GAAA TETRALOOP 1EOR ; -1.00 ; SOLUTION STRUCTURE OF A 22-NUCLEOTIDE HAIRPIN SIMILAR TO THE P5ABC REGION OF GROUP I RIBOZYME 1GH9 ; -1.00 ; SOLUTION STRUCTURE OF A 8.3 KDA PROTEIN (GENE MTH1184) FROM METHANOBACTERIUM THERMOAUTOTROPHICUM 1QBH ; -1.00 ; SOLUTION STRUCTURE OF A BACULOVIRAL INHIBITOR OF APOPTOSIS (IAP) REPEAT 1K3K ; -1.00 ; SOLUTION STRUCTURE OF A BCL-2 HOMOLOG FROM KAPOSI'S SARCOMA VIRUS 1B3C ; -1.00 ; SOLUTION STRUCTURE OF A BETA-NEUROTOXIN FROM THE NEW WORLD SCORPION CENTRUROIDES SCULPTURATUS EWING 2B3C ; -1.00 ; SOLUTION STRUCTURE OF A BETA-NEUROTOXIN FROM THE NEW WORLD SCORPION CENTRUROIDES SCULPTURATUS EWING 1HT4 ; -1.00 ; SOLUTION STRUCTURE OF A BISTRAND ABASIC SITE LESION STAGGERED IN A 3'-ORIENTATION. 1V9J ; -1.00 ; SOLUTION STRUCTURE OF A BOLA-LIKE PROTEIN FROM MUS MUSCULUS 1TIZ ; -1.00 ; SOLUTION STRUCTURE OF A CALMODULIN-LIKE CALCIUM-BINDING DOMAIN FROM ARABIDOPSIS THALIANA 1HOV ; -1.00 ; SOLUTION STRUCTURE OF A CATALYTIC DOMAIN OF MMP-2 COMPLEXED WITH SC-74020 1M36 ; -1.00 ; SOLUTION STRUCTURE OF A CCHC ZINC FINGER FROM MOZ 1JN7 ; -1.00 ; SOLUTION STRUCTURE OF A CCHH MUTANT OF THE NINTH CCHC ZINC FINGER OF U-SHAPED 1PXE ; -1.00 ; SOLUTION STRUCTURE OF A CCHHC DOMAIN OF NEURAL ZINC FINGER FACTOR-1 1UUC ; -1.00 ; SOLUTION STRUCTURE OF A CHIMERIC LEKTI-DOMAIN 1ON5 ; -1.00 ; SOLUTION STRUCTURE OF A CHOLIC ACID-CAPPED DEOXYRIBONUCLEIC ACID DUPLEX 1M3B ; -1.00 ; SOLUTION STRUCTURE OF A CIRCULAR FORM OF THE N-TERMINAL SH3 DOMAIN (A134C, E135G, R191G MUTANT) FROM ONCOGENE PROTEIN C-CRK. 1M3C ; -1.00 ; SOLUTION STRUCTURE OF A CIRCULAR FORM OF THE N-TERMINAL SH3 DOMAIN (E132C, E133G, R191G MUTANT) FROM ONCOGENE PROTEIN C-CRK 1M3A ; -1.00 ; SOLUTION STRUCTURE OF A CIRCULAR FORM OF THE TRUNCATED N- TERMINAL SH3 DOMAIN FROM ONCOGENE PROTEIN C-CRK. 1N02 ; -1.00 ; SOLUTION STRUCTURE OF A CIRCULAR-PERMUTED VARIANT OF THE POTENT HIV-INACTIVATING PROTEIN CYANOVIRIN-N 1N8C ; -1.00 ; SOLUTION STRUCTURE OF A CIS-OPENED (10R)-N6-DEOXYADENOSINE ADDUCT OF (9S,10R)-(9,10)-EPOXY-7,8,9,10- TETRAHYDROBENZO[A]PYRENE IN A DEOXYRIBONUCLEIC ACID DUPLEX 1DDP ; -1.00 ; SOLUTION STRUCTURE OF A CISPLATIN-INDUCED [CATAGCTATG]2 INTERSTRAND CROSS-LINK 1CX3 ; -1.00 ; SOLUTION STRUCTURE OF A COMPLEX BETWEEN D(ATGCAT)2 AND THE ANTITUMOR BISNAPHTHALIMIDE LU-79553 2EZE ; -1.00 ; SOLUTION STRUCTURE OF A COMPLEX OF THE SECOND DEOXYRIBONUCLEIC ACID BINDING DOMAIN OF HUMAN HMG-I(Y) BOUND TO DEOXYRIBONUCLEIC ACID DODECAMER CONTAINING THE PRDII SITE OF THE INTERFERON-BETA PROMOTER, NMR, 35 STRUCTURES 2EZD ; -1.00 ; SOLUTION STRUCTURE OF A COMPLEX OF THE SECOND DEOXYRIBONUCLEIC ACID BINDING DOMAIN OF HUMAN HMG-I(Y) BOUND TO DEOXYRIBONUCLEIC ACID DODECAMER CONTAINING THE PRDII SITE OF THE INTERFERON-BETA PROMOTER, NMR, MINIMIZED AVERAGE STRUCTURE 2EZG ; -1.00 ; SOLUTION STRUCTURE OF A COMPLEX OF THE THIRD DEOXYRIBONUCLEIC ACID BINDING DOMAIN OF HUMAN HMG-I(Y) BOUND TO DEOXYRIBONUCLEIC ACID DODECAMER CONTAINING THE PRDII SITE OF THE INTERFERON-BETA PROMOTER, NMR, 35 STRUCTURES 2EZF ; -1.00 ; SOLUTION STRUCTURE OF A COMPLEX OF THE THIRD DEOXYRIBONUCLEIC ACID BINDING DOMAIN OF HUMAN HMG-I(Y) BOUND TO DEOXYRIBONUCLEIC ACID DODECAMER CONTAINING THE PRDII SITE OF THE INTERFERON-BETA PROMOTER, NMR, MINIMIZED AVERAGE STRUCTURE 1OTR ; -1.00 ; SOLUTION STRUCTURE OF A CUE-UBIQUITIN COMPLEX 1SB6 ; -1.00 ; SOLUTION STRUCTURE OF A CYANOBACTERIAL COPPER METALLOCHAPERONE, SCATX1 2A3D ; -1.00 ; SOLUTION STRUCTURE OF A DE NOVO DESIGNED SINGLE CHAIN THREE- HELIX BUNDLE (A3D) 1AC9 ; -1.00 ; SOLUTION STRUCTURE OF A DEOXYRIBONUCLEIC ACID DECAMER CONTAINING THE ANTIVIRAL DRUG GANCICLOVIR: COMBINED USE OF NMR, RESTRAINED MOLECULAR DYNAMICS, AND FULL RELAXATION REFINEMENT, 6 STRUCTURES 1BJD ; -1.00 ; SOLUTION STRUCTURE OF A DEOXYRIBONUCLEIC ACID DODECAMER CONTAINING SINGLE GT MISMATCHES USING RELAXATION MATRIX ANALYSIS AND RESTRAINED MOLECULAR DYNAMICS, NMR, 1 STRUCTURE 1BW7 ; -1.00 ; SOLUTION STRUCTURE OF A DEOXYRIBONUCLEIC ACID DUPLEX CONTAINING A REPLICABLE DIFLUOROTOLUENE-ADENINE PAIR 1ONM ; -1.00 ; SOLUTION STRUCTURE OF A DEOXYRIBONUCLEIC ACID DUPLEX CONTAINING A:G MISMATCH. D(GCTTCAGTCGT):D(ACGACGGAAGC) 1S0T ; -1.00 ; SOLUTION STRUCTURE OF A DEOXYRIBONUCLEIC ACID DUPLEX CONTAINING AN ALPHA- ANOMERIC ADENOSINE: INSIGHTS INTO SUBSTRATE RECOGNITION BY ENDONUCLEASE IV 1S74 ; -1.00 ; SOLUTION STRUCTURE OF A DEOXYRIBONUCLEIC ACID DUPLEX CONTAINING AN ALPHA- ANOMERIC ADENOSINE: INSIGHTS INTO SUBSTRATE RECOGNITION BY ENDONUCLEASE IV 1S75 ; -1.00 ; SOLUTION STRUCTURE OF A DEOXYRIBONUCLEIC ACID DUPLEX CONTAINING AN ALPHA- ANOMERIC ADENOSINE: INSIGHTS INTO SUBSTRATE RECOGNITION BY ENDONUCLEASE IV 1K29 ; -1.00 ; SOLUTION STRUCTURE OF A DEOXYRIBONUCLEIC ACID DUPLEX CONTAINING M1G OPPOSITE A 2 BASE PAIR DELETION 1EZN ; -1.00 ; SOLUTION STRUCTURE OF A DEOXYRIBONUCLEIC ACID THREE-WAY JUNCTION 1C2Q ; -1.00 ; SOLUTION STRUCTURE OF A DEOXYRIBONUCLEIC ACID.RIBONUCLEIC ACID HYBRID CONTAINING AN ALPHAT- ANOMERIC THYMIDINE AND POLARITY REVERSALS 1U7J ; -1.00 ; SOLUTION STRUCTURE OF A DIIRON PROTEIN MODEL 1U7M ; -1.00 ; SOLUTION STRUCTURE OF A DIIRON PROTEIN MODEL: DUE FERRI(II) TURN MUTANT 1L1M ; -1.00 ; SOLUTION STRUCTURE OF A DIMER OF LAC REPRESSOR DEOXYRIBONUCLEIC ACID-BINDING DOMAIN COMPLEXED TO ITS NATURAL OPERATOR O1 1OSL ; -1.00 ; SOLUTION STRUCTURE OF A DIMERIC LACTOSE DEOXYRIBONUCLEIC ACID-BINDING DOMAIN COMPLEXED TO A NONSPECIFIC DEOXYRIBONUCLEIC ACID SEQUENCE 1GJZ ; -1.00 ; SOLUTION STRUCTURE OF A DIMERIC N-TERMINAL FRAGMENT OF HUMAN UBIQUITIN 1DSI ; -1.00 ; SOLUTION STRUCTURE OF A DUOCARMYCIN SA-INDOLE-ALKYLATED DEOXYRIBONUCLEIC ACID DUPLEX 1NVO ; -1.00 ; SOLUTION STRUCTURE OF A FOUR-HELIX BUNDLE MODEL, APO-DF1 1NWV ; -1.00 ; SOLUTION STRUCTURE OF A FUNCTIONALLY ACTIVE COMPONENT OF DECAY ACCELERATING FACTOR 1JHI ; -1.00 ; SOLUTION STRUCTURE OF A HEDAMYCIN-DEOXYRIBONUCLEIC ACID COMPLEX 1EC4 ; -1.00 ; SOLUTION STRUCTURE OF A HEXITOL NUCLEIC ACID DUPLEX WITH FOUR CONSECUTIVE T:T BASE PAIRS 1AUL ; -1.00 ; SOLUTION STRUCTURE OF A HIGHLY STABLE DEOXYRIBONUCLEIC ACID DUPLEX CONJUGATED TO A MINOR GROOVE BINDER, NMR, MINIMIZED AVERAGE STRUCTURE 1EJZ ; -1.00 ; SOLUTION STRUCTURE OF A HNA-RIBONUCLEIC ACID HYBRID 1RJJ ; -1.00 ; SOLUTION STRUCTURE OF A HOMODIMERIC HYPOTHETICAL PROTEIN, AT5G22580, A STRUCTURAL GENOMICS TARGET FROM ARABIDOPSIS THALIANA 1ZR9 ; -1.00 ; SOLUTION STRUCTURE OF A HUMAN C2H2-TYPE ZINC FINGER PROTEIN 1CQ0 ; -1.00 ; SOLUTION STRUCTURE OF A HUMAN HYPOCRETIN-2/OREXIN- B'SOLUTION STRUCTURE OF A HUMAN HYPOCRETIN-2/OREXIN-B ' 1ZKH ; -1.00 ; SOLUTION STRUCTURE OF A HUMAN UBIQUITIN-LIKE DOMAIN IN SF3A1 1J5B ; -1.00 ; SOLUTION STRUCTURE OF A HYDROPHOBIC ANALOGUE OF THE WINTER FLOUNDER ANTIFREEZE PROTEIN 1MY9 ; -1.00 ; SOLUTION STRUCTURE OF A K+ CATION STABILIZED DIMERIC RIBONUCLEIC ACID QUADRUPLEX CONTAINING TWO G:G(:A):G:G(:A) HEXADS, G:G:G:G TETRADS AND UUUU LOOPS 1JLZ ; -1.00 ; SOLUTION STRUCTURE OF A K+-CHANNEL BLOCKER FROM THE SCORPION TOXIN OF TITYUS CAMBRIDGEI 1J9V ; -1.00 ; SOLUTION STRUCTURE OF A LACTAM ANALOGUE (DABD) OF HIV GP41 600-612 LOOP. 1N89 ; -1.00 ; SOLUTION STRUCTURE OF A LIGANDED TYPE 2 WHEAT NON-SPECIFIC LIPID TRANSFER PROTEIN 1KQE ; -1.00 ; SOLUTION STRUCTURE OF A LINKED SHORTENED GRAMICIDIN A IN BENZENE/ACETONE 10:1 1TKQ ; -1.00 ; SOLUTION STRUCTURE OF A LINKED UNSYMMETRIC GRAMICIDIN IN A MEMBRANE-ISOELECTRICAL SOLVENTS MIXTURE IN THE PRESENCE OF CSCL 1SPW ; -1.00 ; SOLUTION STRUCTURE OF A LOOP TRUNCATED MUTANT FROM D. GIGAS RUBREDOXIN, NMR 1VM3 ; -1.00 ; SOLUTION STRUCTURE OF A MEMBRANE-TARGETING PEPTIDE DESIGNED BASED ON THE N-TERMINAL SEQUENCE OF E. COLI ENZYME IIA (GLUCOSE) 1D5Q ; -1.00 ; SOLUTION STRUCTURE OF A MINI-PROTEIN REPRODUCING THE CORE OF THE CD4 SURFACE INTERACTING WITH THE HIV-1 ENVELOPE GLYCOPROTEIN 1G22 ; -1.00 ; SOLUTION STRUCTURE OF A MODIFIED HUMAN CENTROMERIC FRAGMENT 1EL2 ; -1.00 ; SOLUTION STRUCTURE OF A MODIFIED HUMAN TELOMERE FRAGMENT (STRUCTURE "A") 1ELN ; -1.00 ; SOLUTION STRUCTURE OF A MODIFIED HUMAN TELOMERE FRAGMENT (STRUCTURE "S") 1Y4O ; -1.00 ; SOLUTION STRUCTURE OF A MOUSE CYTOPLASMIC ROADBLOCK/LC7 DYNEIN LIGHT CHAIN 2AXL ; -1.00 ; SOLUTION STRUCTURE OF A MULTIFUNCTIONAL DEOXYRIBONUCLEIC ACID- AND PROTEIN- BINDING DOMAIN OF HUMAN WERNER SYNDROME PROTEIN 1UGJ ; -1.00 ; SOLUTION STRUCTURE OF A MURINE HYPOTHETICAL PROTEIN FROM RIKEN CDNA 2310057J16 1EXE ; -1.00 ; SOLUTION STRUCTURE OF A MUTANT OF TRANSCRIPTION FACTOR 1. 1V6E ; -1.00 ; SOLUTION STRUCTURE OF A N-TERMINAL UBIQUITIN-LIKE DOMAIN IN MOUSE TUBULIN-SPECIFIC CHAPERONE B 1A8N ; -1.00 ; SOLUTION STRUCTURE OF A NA+ CATION STABILIZED DEOXYRIBONUCLEIC ACID QUADRUPLEX CONTAINING G.G.G.G AND G.C.G.C TETRADS FORMED BY G-G-G-C REPEATS OBSERVED IN AAV AND HUMAN CHROMOSOME 19, NMR, 8 STRUCTURES 1T12 ; -1.00 ; SOLUTION STRUCTURE OF A NEW LTP1 1M2S ; -1.00 ; SOLUTION STRUCTURE OF A NEW POTASSIUM CHANNELS BLOCKER FROM THE VENOM OF CHINESE SCORPION BUTHUS MARTENSI KARSCH 1EEK ; -1.00 ; SOLUTION STRUCTURE OF A NONPOLAR, NON HYDROGEN BONDED BASE PAIR SURROGATE IN DEOXYRIBONUCLEIC ACID. 1WF9 ; -1.00 ; SOLUTION STRUCTURE OF A NOVEL BETA-GRASP FOLD LIKE DOMAIN OF HYPOTHETICAL PROTEIN (ARABIDOPSIS THALIANA) 2BEY ; -1.00 ; SOLUTION STRUCTURE OF A NOVEL C2 SYMMETRICAL BIFUNCTIONAL BICYCLIC INHIBITOR BASED ON SFTI-1 1J5I ; -1.00 ; SOLUTION STRUCTURE OF A NOVEL CHROMOPROTEIN DERIVED FROM APO-NEOCARZINOSTATIN AND A SYNTHETIC CHROMOPHORE 1X22 ; -1.00 ; SOLUTION STRUCTURE OF A NOVEL MORICIN ANALOGUE, AN ANTIBACTERIAL PEPTIDE FROM A LEPIDOPTERAN INSECT, SPODOPTERA LITURA 1QO6 ; -1.00 ; SOLUTION STRUCTURE OF A PAIR OF MODULES FROM THE GELATIN-BINDING DOMAIN OF FIBRONECTIN 1HKY ; -1.00 ; SOLUTION STRUCTURE OF A PAN MODULE FROM EIMERIA TENELLA 1KAT ; -1.00 ; SOLUTION STRUCTURE OF A PHAGE-DERIVED PEPTIDE ANTAGONIST IN COMPLEX WITH VASCULAR ENDOTHELIAL GROWTH FACTOR 1D0T ; -1.00 ; SOLUTION STRUCTURE OF A PHOSPHOROTHIOATE MODIFIED RIBONUCLEIC ACID BINDING SITE FOR PHAGE MS2 COAT PROTEIN 1XRW ; -1.00 ; SOLUTION STRUCTURE OF A PLATINUM-ACRIDINE MODIFIED OCTAMER 1F16 ; -1.00 ; SOLUTION STRUCTURE OF A PRO-APOPTOTIC PROTEIN BAX 1YYC ; -1.00 ; SOLUTION STRUCTURE OF A PUTATIVE LATE EMBRYOGENESIS ABUNDANT (LEA) PROTEIN AT2G46140.1 1J26 ; -1.00 ; SOLUTION STRUCTURE OF A PUTATIVE PEPTIDYL-TRNA HYDROLASE DOMAIN IN A MOUSE HYPOTHETICAL PROTEIN 1PA4 ; -1.00 ; SOLUTION STRUCTURE OF A PUTATIVE RIBOSOME-BINDING FACTOR FROM MYCOPLASMA PNEUMONIAE (MPN156) 1J03 ; -1.00 ; SOLUTION STRUCTURE OF A PUTATIVE STEROID-BINDING PROTEIN FROM ARABIDOPSIS 1H3Z ; -1.00 ; SOLUTION STRUCTURE OF A PWWP DOMAIN FROM SCHIZOSACCHAROMYCES POMBE 1C38 ; -1.00 ; SOLUTION STRUCTURE OF A QUADRUPLEX FORMING DEOXYRIBONUCLEIC ACID AND ITS INTERMEDIATE 1C32 ; -1.00 ; SOLUTION STRUCTURE OF A QUADRUPLEX FORMING DEOXYRIBONUCLEIC ACID AND ITS INTERMIDIATE 1C34 ; -1.00 ; SOLUTION STRUCTURE OF A QUADRUPLEX FORMING DEOXYRIBONUCLEIC ACID AND ITS INTERMIDIATE 1C35 ; -1.00 ; SOLUTION STRUCTURE OF A QUADRUPLEX FORMING DEOXYRIBONUCLEIC ACID AND ITS INTERMIDIATE 1KSE ; -1.00 ; SOLUTION STRUCTURE OF A QUINOLONE-CAPPED DEOXYRIBONUCLEIC ACID DUPLEX 1DF3 ; -1.00 ; SOLUTION STRUCTURE OF A RECOMBINANT MOUSE MAJOR URINARY PROTEIN 1Y03 ; -1.00 ; SOLUTION STRUCTURE OF A RECOMBINANT TYPE I SCULPIN ANTIFREEZE PROTEIN 1Y04 ; -1.00 ; SOLUTION STRUCTURE OF A RECOMBINANT TYPE I SCULPIN ANTIFREEZE PROTEIN 1XSF ; -1.00 ; SOLUTION STRUCTURE OF A RESUSCITATION PROMOTING FACTOR DOMAIN FROM MYCOBACTERIUM TUBERCULOSIS 1ZXF ; -1.00 ; SOLUTION STRUCTURE OF A SELF-SACRIFICING RESISTANCE PROTEIN, CALC FROM MICROMONOSPORA ECHINOSPORA 1CFA ; -1.00 ; SOLUTION STRUCTURE OF A SEMI-SYNTHETIC C5A RECEPTOR ANTAGONIST AT PH 5.2, 303K, NMR, 20 STRUCTURES 1IEH ; -1.00 ; SOLUTION STRUCTURE OF A SOLUBLE SINGLE-DOMAIN ANTIBODY WITH HYDROPHOBIC RESIDUES TYPICAL OF A VL/VH INTERFACE 1A9L ; -1.00 ; SOLUTION STRUCTURE OF A SUBSTRATE FOR THE ARCHAEAL PRE-TRNA SPLICING ENDONUCLEASES: THE BULGE-HELIX-BULGE MOTIF, NMR, 12 STRUCTURES 1POQ ; -1.00 ; SOLUTION STRUCTURE OF A SUPERANTIGEN FROM YERSINIA PSEUDOTUBERCULOSIS 1TBA ; -1.00 ; SOLUTION STRUCTURE OF A TBP-TAFII230 COMPLEX: PROTEIN MIMICRY OF THE MINOR GROOVE SURFACE OF THE TATA BOX UNWOUND BY TBP, NMR, 25 STRUCTURES 1J1H ; -1.00 ; SOLUTION STRUCTURE OF A TMRNA-BINDING PROTEIN, SMPB, FROM THERMUS THERMOPHILUS 1LUP ; -1.00 ; SOLUTION STRUCTURE OF A TOXIN (GSMTX2) FROM THE TARANTULA, GRAMMOSTOLA SPATULATA, WHICH INHIBITS MECHANOSENSITIVE ION CHANNELS 1HP2 ; -1.00 ; SOLUTION STRUCTURE OF A TOXIN FROM THE SCORPION TITYUS SERRULATUS (TSTX-K ALPHA) DETERMINED BY NMR. 1TYK ; -1.00 ; SOLUTION STRUCTURE OF A TOXIN FROM THE TARANTULA, GRAMMOSTOLA SPATULATA, WHICH INHIBITS MECHANOSENSITIVE ION CHANNELS 1JDG ; -1.00 ; SOLUTION STRUCTURE OF A TRANS-OPENED (10S)-DA ADDUCT OF (+)- (7S,8R,9S,10R)-7,8-DIHYDROXY-9,10-EPOXY-7,8,9,10- TETRAHYDROBENZO[A]PYRENE IN A FULLY COMPLEMENTARY DEOXYRIBONUCLEIC ACID DUPLEX 1UUB ; -1.00 ; SOLUTION STRUCTURE OF A TRUNCATED BOVINE PANCREATIC TRYPSIN INHIBITOR MUTANT, 3-58 BPTI (K15R, R17A, R42S) 1UUA ; -1.00 ; SOLUTION STRUCTURE OF A TRUNCATED BOVINE PANCREATIC TRYPSIN INHIBITOR, 3-58 BPTI 1Y7X ; -1.00 ; SOLUTION STRUCTURE OF A TWO-REPEAT FRAGMENT OF MAJOR VAULT PROTEIN 1T0Y ; -1.00 ; SOLUTION STRUCTURE OF A UBIQUITIN-LIKE DOMAIN FROM TUBULIN- BINDING COFACTOR B 1DGO ; -1.00 ; SOLUTION STRUCTURE OF A URACIL CONTAINING HAIRPIN DEOXYRIBONUCLEIC ACID 1QE7 ; -1.00 ; SOLUTION STRUCTURE OF A URACIL CONTAINING HAIRPIN DEOXYRIBONUCLEIC ACID 1P96 ; -1.00 ; SOLUTION STRUCTURE OF A WEDGE-SHAPED SYNTHETIC MOLECULE AT A TWO-BASE BULGE SITE IN DEOXYRIBONUCLEIC ACID 1CO4 ; -1.00 ; SOLUTION STRUCTURE OF A ZINC DOMAIN CONSERVED IN YEAST COPPER-REGULATED TRANSCRIPTION FACTORS 1ZXG ; -1.00 ; SOLUTION STRUCTURE OF A219 1JEX ; -1.00 ; SOLUTION STRUCTURE OF A67V MUTANT OF RAT FERRO CYTOCHROME B5 1XWU ; -1.00 ; SOLUTION STRUCTURE OF ACAUAGA LOOP 1VDJ ; -1.00 ; SOLUTION STRUCTURE OF ACTIN-BINDING DOMAIN OF TROPONIN IN CA2+-BOUND STATE 1VDI ; -1.00 ; SOLUTION STRUCTURE OF ACTIN-BINDING DOMAIN OF TROPONIN IN CA2+-FREE STATE 1ST7 ; -1.00 ; SOLUTION STRUCTURE OF ACYL COENZYME A BINDING PROTEIN FROM YEAST 1IJP ; -1.00 ; SOLUTION STRUCTURE OF ALA20PRO/PRO64ALA SUBSTITUTED SUBUNIT C OF ESCHERICHIA COLI ATP SYNTHASE 1GV6 ; -1.00 ; SOLUTION STRUCTURE OF ALFA-L-LNA:DEOXYRIBONUCLEIC ACID DUPLEX 1Q3J ; -1.00 ; SOLUTION STRUCTURE OF ALO3: A NEW KNOTTIN-TYPE ANTIFUNGAL PEPTIDE FROM THE INSECT ACROCINUS LONGIMANUS 1Q8K ; -1.00 ; SOLUTION STRUCTURE OF ALPHA SUBUNIT OF HUMAN EIF2 1KFH ; -1.00 ; SOLUTION STRUCTURE OF ALPHA-BUNGAROTOXIN BY NMR SPECTROSCOPY 1LXH ; -1.00 ; SOLUTION STRUCTURE OF ALPHA-COBRATOXIN COMPLEXED WITH A COGNATE PEPTIDE (MINIMIZED AVERAGE STRUCTURE) 1LXG ; -1.00 ; SOLUTION STRUCTURE OF ALPHA-COBRATOXIN COMPLEXED WITH A COGNATE PEPTIDE (STRUCTURE ENSEMBLE) 1MXN ; -1.00 ; SOLUTION STRUCTURE OF ALPHA-CONOTOXIN AUIB 1IMI ; -1.00 ; SOLUTION STRUCTURE OF ALPHA-CONOTOXIN IM1 1MII ; -1.00 ; SOLUTION STRUCTURE OF ALPHA-CONOTOXIN MII 1QMW ; -1.00 ; SOLUTION STRUCTURE OF ALPHA-CONOTOXIN SI 1QP6 ; -1.00 ; SOLUTION STRUCTURE OF ALPHA2D 1EDX ; -1.00 ; SOLUTION STRUCTURE OF AMINO TERMINUS OF BOVINE RHODOPSIN (RESIDUES 1-40) 1KB1 ; -1.00 ; SOLUTION STRUCTURE OF AN 11-MER DEOXYRIBONUCLEIC ACID DUPLEX CONTAINING 6- THIOGUANINE OPPOSITE CYTOSINE 1KBM ; -1.00 ; SOLUTION STRUCTURE OF AN 11-MER DEOXYRIBONUCLEIC ACID DUPLEX CONTAINING 6- THIOGUANINE OPPOSITE THYMINE 1VM4 ; -1.00 ; SOLUTION STRUCTURE OF AN ANTIBACTERIAL AND ANTITUMOR PEPTIDE DESIGNED BASED ON THE N-TERMINAL MEMBRANE ANCHOR OF E. COLI ENZYME IIA (GLUCOSE) 1VM2 ; -1.00 ; SOLUTION STRUCTURE OF AN ANTICANCER PEPTIDE DESIGNED BASED ON THE N-TERMINAL SEQUENCE OF E. COLI ENZYME IIA (GLUCOSE) 1W86 ; -1.00 ; SOLUTION STRUCTURE OF AN DSDNA:LNA TRIPLEX 1CEJ ; -1.00 ; SOLUTION STRUCTURE OF AN EGF MODULE PAIR FROM THE PLASMODIUM FALCIPARUM MEROZOITE SURFACE PROTEIN 1 1Z6C ; -1.00 ; SOLUTION STRUCTURE OF AN EGF PAIR (EGF34) FROM VITAMIN K- DEPENDENT PROTEIN S 1JR6 ; -1.00 ; SOLUTION STRUCTURE OF AN ENGINEERED ARGININE-RICH SUBDOMAIN 2 OF THE HEPATITIS C VIRUS NS3 RIBONUCLEIC ACID HELICASE 1ONB ; -1.00 ; SOLUTION STRUCTURE OF AN ENGINEERED ARGININE-RICH SUBDOMAIN 2 OF THE HEPATITIS C VIRUS NS3 RIBONUCLEIC ACID HELICASE 1ALG ; -1.00 ; SOLUTION STRUCTURE OF AN HGR INHIBITOR, NMR, 10 STRUCTURES 1IE2 ; -1.00 ; SOLUTION STRUCTURE OF AN IN VITRO SELECTED RIBONUCLEIC ACID WHICH IS SEQUENCE SPECIFICALLY RECOGNIZED BY RBD12 OF HAMSTER NUCLEOLIN.SNRE (ANTI) 1PYJ ; -1.00 ; SOLUTION STRUCTURE OF AN O6-[4-OXO-4-(3-PYRIDYL) BUTYL]GUANINE ADDUCT IN AN 11MER DEOXYRIBONUCLEIC ACID DUPLEX 1U6N ; -1.00 ; SOLUTION STRUCTURE OF AN OLIGODEOXYNUCLEOTIDE CONTAINING A BUTADIENE DERIVED N1 B-HYDROXYALKYL ADDUCT ON DEOXYINOSINE IN THE HUMAN N-RAS CODON 61 SEQUENCE 1FUV ; -1.00 ; SOLUTION STRUCTURE OF AN RGD PEPTIDE ISOMER-A 1FUL ; -1.00 ; SOLUTION STRUCTURE OF AN RGD PEPTIDE ISOMER-B 1NAO ; -1.00 ; SOLUTION STRUCTURE OF AN RIBONUCLEIC ACID 2'-O-METHYLATED RIBONUCLEIC ACID DUPLEX CONTAINING AN RIBONUCLEIC ACID/DEOXYRIBONUCLEIC ACID HYBRID SEGMENT AT THE CENTER, NMR, MINIMIZED AVERAGE STRUCTURE 1D0U ; -1.00 ; SOLUTION STRUCTURE OF AN RIBONUCLEIC ACID BINDING SITE FOR PHAGE MS2 COAT PROTEIN 1C4L ; -1.00 ; SOLUTION STRUCTURE OF AN RIBONUCLEIC ACID DUPLEX INCLUDING A C-U BASE- PAIR 1IK1 ; -1.00 ; SOLUTION STRUCTURE OF AN RIBONUCLEIC ACID HAIRPIN FROM HRV-14 1WKS ; -1.00 ; SOLUTION STRUCTURE OF AN RIBONUCLEIC ACID STEM-LOOP DERIVED FROM THE 3' CONSERVED REGION OF EEL LINE UNAL2 1AC3 ; -1.00 ; SOLUTION STRUCTURE OF AN RIBONUCLEIC ACID-DEOXYRIBONUCLEIC ACID HYBRID DUPLEX CONTAINING A 3'-THIOFORMACETAL LINKER AND AN RIBONUCLEIC ACID A-TRACT, NMR, 8 STRUCTURES 1YUB ; -1.00 ; SOLUTION STRUCTURE OF AN RRNA METHYLTRANSFERASE (ERMAM) THAT CONFERS MACROLIDE-LINCOSAMIDE-STREPTOGRAMIN ANTIBIOTIC RESISTANCE, NMR, MINIMIZED AVERAGE STRUCTURE 1CZ6 ; -1.00 ; SOLUTION STRUCTURE OF ANDROCTONIN 1Y1B ; -1.00 ; SOLUTION STRUCTURE OF ANEMONIA ELASTASE INHIBITOR 1Y1C ; -1.00 ; SOLUTION STRUCTURE OF ANEMONIA ELASTASE INHIBITOR ANALOGUE 1QWV ; -1.00 ; SOLUTION STRUCTURE OF ANTHERAEA POLYPHEMUS PHEROMONE BINDING PROTEIN (APOLPBP) 1GQ0 ; -1.00 ; SOLUTION STRUCTURE OF ANTIAMOEBIN I, A MEMBRANE CHANNEL-FORMING POLYPEPTIDE; NMR, 20 STRUCTURES 1KV4 ; -1.00 ; SOLUTION STRUCTURE OF ANTIBACTERIAL PEPTIDE (MORICIN) 1V95 ; -1.00 ; SOLUTION STRUCTURE OF ANTICODON BINDING DOMAIN FROM NUCLEAR RECEPTOR COACTIVATOR 5 (HUMAN KIAA1637 PROTEIN) 1IYC ; -1.00 ; SOLUTION STRUCTURE OF ANTIFUNGAL PEPTIDE, SCARABAECIN 1XV7 ; -1.00 ; SOLUTION STRUCTURE OF ANTIMICROBIAL AND ENDOTOXIN- NEUTRALIZING PEPTIDE LF11 IN DPC MICELLES 1XV4 ; -1.00 ; SOLUTION STRUCTURE OF ANTIMICROBIAL AND ENDOTOXIN- NEUTRALIZING PEPTIDE LF11 IN SDS MICELLES 1C15 ; -1.00 ; SOLUTION STRUCTURE OF APAF-1 CARD 1WQK ; -1.00 ; SOLUTION STRUCTURE OF APETX1, A SPECIFIC PEPTIDE INHIBITOR OF HUMAN ETHER-A-GO-GO-RELATED GENE POTASSIUM CHANNELS FROM THE VENOM OF THE SEA ANEMONE ANTHOPLEURA ELEGANTISSIMA: A NEW FOLD FOR AN HERG TOXIN 1WXN ; -1.00 ; SOLUTION STRUCTURE OF APETX2, A SPECIFIC PEPTIDE INHIBITOR OF ASIC3 PROTON-GATED CHANNELS 1RK7 ; -1.00 ; SOLUTION STRUCTURE OF APO CU,ZN SUPEROXIDE DISMUTASE: ROLE OF METAL IONS IN PROTEIN FOLDING 1GR5 ; 7.90 ; SOLUTION STRUCTURE OF APO GROEL BY CRYO-ELECTRON MICROSCOPY 1SKT ; -1.00 ; SOLUTION STRUCTURE OF APO N-DOMAIN OF TROPONIN C, NMR, 40 STRUCTURES 1U97 ; -1.00 ; SOLUTION STRUCTURE OF APO YEAST COX17 1Z2G ; -1.00 ; SOLUTION STRUCTURE OF APO, OXIDIZED YEAST COX17 3BDO ; -1.00 ; SOLUTION STRUCTURE OF APO-BIOTINYL DOMAIN FROM ACETYL COENZYME A CARBOXYLASE OF ESCHERICHIA COLI DETERMINED BY TRIPLE-RESONANCE NMR SPECTROSCOPY 1X7L ; -1.00 ; SOLUTION STRUCTURE OF APO-DR1885 FROM DEINOCOCCUS RADIODURANS 1J5H ; -1.00 ; SOLUTION STRUCTURE OF APO-NEOCARZINOSTATIN 1YUS ; -1.00 ; SOLUTION STRUCTURE OF APO-S100A13 1YUR ; -1.00 ; SOLUTION STRUCTURE OF APO-S100A13 (MINIMIZED MEAN STRUCTURE) 1IT5 ; -1.00 ; SOLUTION STRUCTURE OF APO-TYPE PLA2 FROM STREPTOMYCES VIOLACERUBER A-2688. 1M42 ; -1.00 ; SOLUTION STRUCTURE OF APOCOPC FROM PSEUDOMONAS SYRINGAE 1SP0 ; -1.00 ; SOLUTION STRUCTURE OF APOCOX11 1SO9 ; -1.00 ; SOLUTION STRUCTURE OF APOCOX11, 30 STRUCTURES 1TL5 ; -1.00 ; SOLUTION STRUCTURE OF APOHAH1 1Y9X ; -1.00 ; SOLUTION STRUCTURE OF ARCHAEON DEOXYRIBONUCLEIC ACID-BINDING PROTEIN SSH10B 2CRR ; -1.00 ; SOLUTION STRUCTURE OF ARFGAP DOMAIN FROM HUMAN SMAP1 1KN5 ; -1.00 ; SOLUTION STRUCTURE OF ARID DOMAIN OF ADR6 FROM SACCHAROMYCES CEREVISIAE 1IRZ ; -1.00 ; SOLUTION STRUCTURE OF ARR10-B BELONGING TO THE GARP FAMILY OF PLANT MYB-RELATED DEOXYRIBONUCLEIC ACID BINDING MOTIFS OF THE ARABIDOPSIS RESPONSE REGULATORS 1IW4 ; -1.00 ; SOLUTION STRUCTURE OF ASCIDIAN TRYPSIN INHIBITOR 2AFD ; -1.00 ; SOLUTION STRUCTURE OF ASL1650, AN ACYL CARRIER PROTEIN FROM ANABAENA SP. PCC 7120 WITH A VARIANT PHOSPHOPANTETHEINYLATION-SITE SEQUENCE 2AFE ; -1.00 ; SOLUTION STRUCTURE OF ASL1650, AN ACYL CARRIER PROTEIN FROM ANABAENA SP. PCC 7120 WITH A VARIANT PHOSPHOPANTETHEINYLATION-SITE SEQUENCE 1XO8 ; -1.00 ; SOLUTION STRUCTURE OF AT1G01470 FROM ARABIDOPSIS THALIANA 1XO9 ; -1.00 ; SOLUTION STRUCTURE OF AT3G03773 FROM ARABIDOPSIS THALIANA 1XOY ; -1.00 ; SOLUTION STRUCTURE OF AT3G04780.1, AN ARABIDOPSIS ORTHOLOG OF THE C-TERMINAL DOMAIN OF HUMAN THIOREDOXIN-LIKE PROTEIN 1TQ1 ; -1.00 ; SOLUTION STRUCTURE OF AT5G66040, A PUTATIVE PROTEIN FROM ARABIDOSIS THALIANA 1XWP ; -1.00 ; SOLUTION STRUCTURE OF AUCGCA LOOP 2CQY ; -1.00 ; SOLUTION STRUCTURE OF B DOMAIN FROM HUMAN PROPIONYL-COA CARBOXYLASE ALPHA SUBUNIT 1HY8 ; -1.00 ; SOLUTION STRUCTURE OF B. SUBTILIS ACYL CARRIER PROTEIN 1N53 ; -1.00 ; SOLUTION STRUCTURE OF B. SUBTILIS T BOX ANTITERMINATOR RIBONUCLEIC ACID 1XN5 ; -1.00 ; SOLUTION STRUCTURE OF BACILLUS HALODURANS PROTEIN BH1534: THE NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET BHR29 1Z2E ; -1.00 ; SOLUTION STRUCTURE OF BACILLUS SUBTILIS ARSC IN OXIDIZED STATE 1Z2D ; -1.00 ; SOLUTION STRUCTURE OF BACILLUS SUBTILIS ARSC IN REDUCED STATE 1ZTS ; -1.00 ; SOLUTION STRUCTURE OF BACILLUS SUBTILIS PROTEIN YQBG: NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET SR215 1XN8 ; -1.00 ; SOLUTION STRUCTURE OF BACILLUS SUBTILIS PROTEIN YQBG: THE NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET SR215 1YX0 ; -1.00 ; SOLUTION STRUCTURE OF BACILLUS SUBTILIS PROTEIN YSNE: THE NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET SR220 1E68 ; -1.00 ; SOLUTION STRUCTURE OF BACTERIOCIN AS-48 1K0H ; -1.00 ; SOLUTION STRUCTURE OF BACTERIOPHAGE LAMBDA GPFII 1HYW ; -1.00 ; SOLUTION STRUCTURE OF BACTERIOPHAGE LAMBDA GPW 1L0M ; -1.00 ; SOLUTION STRUCTURE OF BACTERIORHODOPSIN 1DJM ; -1.00 ; SOLUTION STRUCTURE OF BEF3-ACTIVATED CHEY FROM ESCHERICHIA COLI 1KRX ; -1.00 ; SOLUTION STRUCTURE OF BERYLLOFLUORIDE-ACTIVATED NTRC RECEIVER DOMAIN: MODEL STRUCTURES INCORPORATING ACTIVE SITE CONTACTS 1J8Z ; -1.00 ; SOLUTION STRUCTURE OF BETA3 ANALOGUE PEPTIDE (HCYS) OF HIV GP41 600-612 LOOP. 1J8N ; -1.00 ; SOLUTION STRUCTURE OF BETA3-ANALOGUE PEPTIDE CORRESPONDING TO THE GP41 600-612 LOOP OF HIV. 1K09 ; -1.00 ; SOLUTION STRUCTURE OF BETACORE, A DESIGNED WATER SOLUBLE FOUR-STRANDED ANTIPARALLEL B-SHEET PROTEIN 1ZBN ; -1.00 ; SOLUTION STRUCTURE OF BIV TAR HAIRPIN COMPLEXED TO JDV TAT ARGININE-RICH MOTIF 1Q2K ; -1.00 ; SOLUTION STRUCTURE OF BMBKTX1 A NEW POTASSIUM CHANNEL BLOCKER FROM THE CHINESE SCORPION BUTHUS MARTENSI KARSCH 1S8K ; -1.00 ; SOLUTION STRUCTURE OF BMKK4, A NOVEL POTASSIUM CHANNEL BLOCKER FROM SCORPION BUTHUS MARTENSII KARSCH, 25 STRUCTURES 1RJI ; -1.00 ; SOLUTION STRUCTURE OF BMKX, A NOVEL POTASSIUM CHANNEL BLOCKER FROM THE CHINESE SCORPION BUTHUS MARTENSI KARSCH 1WM7 ; -1.00 ; SOLUTION STRUCTURE OF BMP01 FROM THE VENOM OF SCORPION BUTHUS MARTENSII KARSCH, 9 STRUCTURES 1DU9 ; -1.00 ; SOLUTION STRUCTURE OF BMP02, A NATURAL SCORPION TOXIN WHICH BLOCKS APAMIN-SENSITIVE CALCIUM-ACTIVATED POTASSIUM CHANNELS, 25 STRUCTURES 1WM8 ; -1.00 ; SOLUTION STRUCTURE OF BMP03 FROM THE VENOM OF SCORPION BUTHUS MARTENSII KARSCH, 10 STRUCTURES 1PVZ ; -1.00 ; SOLUTION STRUCTURE OF BMP07, A NOVEL POTASSIUM CHANNEL BLOCKER FROM SCORPION BUTHUS MARTENSI KARSCH, 15 STRUCTURES 1WT8 ; -1.00 ; SOLUTION STRUCTURE OF BMP08 FROM THE VENOM OF SCORPION BUTHUS MARTENSII KARSCH, 20 STRUCTURES 1V60 ; -1.00 ; SOLUTION STRUCTURE OF BOLA1 PROTEIN FROM MUS MUSCULUS 1JJQ ; -1.00 ; SOLUTION STRUCTURE OF BRADYKININ-PENTA-O-GALLOYL-D- GLUCOPYRANOSE COMPLEX DETERMINED BY NMR 2COK ; -1.00 ; SOLUTION STRUCTURE OF BRCT DOMAIN OF POLY(ADP-RIBOSE) POLYMERASE-1 2COE ; -1.00 ; SOLUTION STRUCTURE OF BRCT DOMAIN OF TERMINAL DEOXYNUCLEOTIDYLTRANSFERASE 1HX2 ; -1.00 ; SOLUTION STRUCTURE OF BSTI, A TRYPSIN INHIBITOR FROM BOMBINA BOMBINA. 1IJC ; -1.00 ; SOLUTION STRUCTURE OF BUCANDIN, A NEUROTOXIN FROM THE VENOM OF THE MALAYAN KRAIT 1JC6 ; -1.00 ; SOLUTION STRUCTURE OF BUNGARUS FACIATUS IX, A KUNITZ-TYPE CHYMOTRYPSIN INHIBITOR 1WT7 ; -1.00 ; SOLUTION STRUCTURE OF BUTX-MTX: A BUTANTOXIN-MAUROTOXIN CHIMERA 1NMR ; -1.00 ; SOLUTION STRUCTURE OF C-TERMINAL DOMAIN FROM TRYPANOSOMA CRUZI POLY(A)-BINDING PROTEIN 2CRV ; -1.00 ; SOLUTION STRUCTURE OF C-TERMINAL DOMAIN OF MITOCHONDRIAL TRANSLATIONAL INITIATIONFACTOR 2 1TH5 ; -1.00 ; SOLUTION STRUCTURE OF C-TERMINAL DOMAIN OF NIFU-LIKE PROTEIN FROM ORYZA SATIVA 1IFW ; -1.00 ; SOLUTION STRUCTURE OF C-TERMINAL DOMAIN OF POLY(A) BINDING PROTEIN FROM SACCHAROMYCES CEREVISIAE 2CRQ ; -1.00 ; SOLUTION STRUCTURE OF C-TERMINAL DOMAIN OF RIKEN CDNA 2810012L14 1F7W ; -1.00 ; SOLUTION STRUCTURE OF C-TERMINAL DOMAIN ZIPA 1F7X ; -1.00 ; SOLUTION STRUCTURE OF C-TERMINAL DOMAIN ZIPA 1WFT ; -1.00 ; SOLUTION STRUCTURE OF C-TERMINAL FIBRONECTIN TYPE III DOMAIN OF MOUSE 1700129L13RIK PROTEIN 1KFZ ; -1.00 ; SOLUTION STRUCTURE OF C-TERMINAL SEM-5 SH3 DOMAIN (ENSEMBLE OF 16 STRUCTURES) 1WH3 ; -1.00 ; SOLUTION STRUCTURE OF C-TERMINAL UBIQUITIN LIKE DOMAIN OF HUMAN 2'-5'-OLIGOADENYLATE SYNTHETASE-LIKE PROTAIN (P59 OASL) 1FYB ; -1.00 ; SOLUTION STRUCTURE OF C1-T1, A TWO-DOMAIN PROTEINASE INHIBITOR DERIVED FROM THE CIRCULAR PRECURSOR PROTEIN NA- PROPI FROM NICOTIANA ALATA 1QLK ; -1.00 ; SOLUTION STRUCTURE OF CA(2+)-LOADED RAT S100B (BETABETA) NMR, 20 STRUCTURES 1I56 ; -1.00 ; SOLUTION STRUCTURE OF CA2+-BOUND STATE OF CANINE MILK LYSOZYME 1NWD ; -1.00 ; SOLUTION STRUCTURE OF CA2+/CALMODULIN BOUND TO THE C- TERMINAL DOMAIN OF PETUNIA GLUTAMATE DECARBOXYLASE 1J7P ; -1.00 ; SOLUTION STRUCTURE OF CALCIUM CALMODULIN C-TERMINAL DOMAIN 1PSB ; -1.00 ; SOLUTION STRUCTURE OF CALCIUM LOADED S100B COMPLEXED TO A PEPTIDE FROM N-TERMINAL REGULATORY DOMAIN OF NDR KINASE. 1LA0 ; -1.00 ; SOLUTION STRUCTURE OF CALCIUM SATURATED CARDIAC TROPONIN C IN THE TROPONIN C-TROPONIN I COMPLEX 1J7O ; -1.00 ; SOLUTION STRUCTURE OF CALCIUM-CALMODULIN N-TERMINAL DOMAIN 1YUU ; -1.00 ; SOLUTION STRUCTURE OF CALCIUM-S100A13 1YUT ; -1.00 ; SOLUTION STRUCTURE OF CALCIUM-S100A13 (MINIMIZED MEAN STRUCTURE) 1K9C ; -1.00 ; SOLUTION STRUCTURE OF CALRETICULIN P-DOMAIN SUBDOMAIN (RESIDUES 189-261) 1K91 ; -1.00 ; SOLUTION STRUCTURE OF CALRETICULIN P-DOMAIN SUBDOMAIN (RESIDUES 221-256) 1JGK ; -1.00 ; SOLUTION STRUCTURE OF CANDOXIN 1TKN ; -1.00 ; SOLUTION STRUCTURE OF CAPPD, AN INDEPENDENTLY FOLDED EXTRACELLULAR DOMAIN OF HUMAN AMYLOID-BETA PRECURSOR PROTEIN 1KBS ; -1.00 ; SOLUTION STRUCTURE OF CARDIOTOXIN IV, NMR, 1 STRUCTURE 1KBT ; -1.00 ; SOLUTION STRUCTURE OF CARDIOTOXIN IV, NMR, 12 STRUCTURES 1CW5 ; -1.00 ; SOLUTION STRUCTURE OF CARNOBACTERIOCIN B2 1V46 ; -1.00 ; SOLUTION STRUCTURE OF CCAP (CRUSTACEAN CARDIOACTIVE PEPTIDE) FROM DROSOPHILA MELANOGASTER 1Y49 ; -1.00 ; SOLUTION STRUCTURE OF CCAP (CRUSTACEAN CARDIOACTIVE PEPTIDE) FROM DROSOPHILA MELANOGASTER 1CEE ; -1.00 ; SOLUTION STRUCTURE OF CDC42 IN COMPLEX WITH THE GTPASE BINDING DOMAIN OF WASP 1EES ; -1.00 ; SOLUTION STRUCTURE OF CDC42HS COMPLEXED WITH A PEPTIDE DERIVED FROM P-21 ACTIVATED KINASE, NMR, 20 STRUCTURES 1D9L ; -1.00 ; SOLUTION STRUCTURE OF CECROPIN A(1-8)-MAGAININ 2 HYBRID PEPTIDE ANALOGUE(P1) 1D9M ; -1.00 ; SOLUTION STRUCTURE OF CECROPIN A(1-8)-MAGAININ 2 HYBRID PEPTIDE ANALOGUE(P2) 1D9J ; -1.00 ; SOLUTION STRUCTURE OF CECROPIN A(1-8)-MAGAININ 2(1-12) HYBRID PEPTIDE 1D9O ; -1.00 ; SOLUTION STRUCTURE OF CECROPIN A(1-8)-MAGAININ 2(1-12) HYBRID PEPTIDE ANALOGUE(P3) 1D9P ; -1.00 ; SOLUTION STRUCTURE OF CECROPIN A(1-8)-MAGAININ 2(1-12) HYBRID PEPTIDE ANALOGUE(P4) 1KGL ; -1.00 ; SOLUTION STRUCTURE OF CELLULAR RETINOL BINDING PROTEIN TYPE- I IN COMPLEX WITH ALL-TRANS-RETINOL 1JBH ; -1.00 ; SOLUTION STRUCTURE OF CELLULAR RETINOL BINDING PROTEIN TYPE- I IN THE LIGAND-FREE STATE 1E5G ; -1.00 ; SOLUTION STRUCTURE OF CENTRAL CP MODULE PAIR OF A POX VIRUS COMPLEMENT INHIBITOR 1Z2F ; -1.00 ; SOLUTION STRUCTURE OF CFAFP-501 1CS9 ; -1.00 ; SOLUTION STRUCTURE OF CGGIRGERA IN CONTACT WITH THE MONOCLONAL ANTIBODY MAB 4X11, NMR, 7 STRUCTURES 1CT6 ; -1.00 ; SOLUTION STRUCTURE OF CGGIRGERG IN CONTACT WITH THE MONOCLONAL ANTIBODY MAB 4X11, NMR, 11 STRUCTURES 1TVJ ; -1.00 ; SOLUTION STRUCTURE OF CHICK COFILIN 1DS9 ; -1.00 ; SOLUTION STRUCTURE OF CHLAMYDOMONAS OUTER ARM DYNEIN LIGHT CHAIN 1 1W9R ; -1.00 ; SOLUTION STRUCTURE OF CHOLINE BINDING PROTEIN A, DOMAIN R2, THE MAJOR ADHESIN OF STREPTOCOCCUS PNEUMONIAE 2ERI ; -1.00 ; SOLUTION STRUCTURE OF CIRCULIN B 1J3G ; -1.00 ; SOLUTION STRUCTURE OF CITROBACTER FREUNDII AMPD 1UDM ; -1.00 ; SOLUTION STRUCTURE OF COACTOSIN-LIKE PROTEIN (COFILIN FAMILY) FROM MUS MUSCULUS 1VRE ; -1.00 ; SOLUTION STRUCTURE OF COMPONENT IV GLYCERA DIBRANCHIATA MONOMERIC HEMOGLOBIN-CO 1VRF ; -1.00 ; SOLUTION STRUCTURE OF COMPONENT IV GLYCERA DIBRANCHIATA MONOMERIC HEMOGLOBIN-CO 1RMK ; -1.00 ; SOLUTION STRUCTURE OF CONOTOXIN MRVIB 1EYO ; -1.00 ; SOLUTION STRUCTURE OF CONOTOXIN TVIIA FROM CONUS TULIPA 1AS5 ; -1.00 ; SOLUTION STRUCTURE OF CONOTOXIN Y-PIIIE FROM CONUS PURPURASCENS, NMR, 14 STRUCTURES 1K6G ; -1.00 ; SOLUTION STRUCTURE OF CONSERVED AGNN TETRALOOPS: INSIGHTS INTO RNT1P RIBONUCLEIC ACID PROCESSING 1K6H ; -1.00 ; SOLUTION STRUCTURE OF CONSERVED AGNN TETRALOOPS: INSIGHTS INTO RNT1P RIBONUCLEIC ACID PROCESSING 1RWU ; -1.00 ; SOLUTION STRUCTURE OF CONSERVED PROTEIN YBED FROM E. COLI 1NXN ; -1.00 ; SOLUTION STRUCTURE OF CONTRYPHAN-VN 1OQ6 ; -1.00 ; SOLUTION STRUCTURE OF COPPER-S46V COPA FROM BACILLUS SUBTILIS 1V5A ; -1.00 ; SOLUTION STRUCTURE OF COVALITOXIN I 1J2M ; -1.00 ; SOLUTION STRUCTURE OF CPI-17(22-120) 1J2N ; -1.00 ; SOLUTION STRUCTURE OF CPI-17(22-120) T38D 1W2R ; -1.00 ; SOLUTION STRUCTURE OF CR2 SCR 1-2 BY X-RAY SCATTERING 1W2S ; -1.00 ; SOLUTION STRUCTURE OF CR2 SCR 1-2 IN ITS COMPLEX WITH C3D BY X-RAY SCATTERING 1K1C ; -1.00 ; SOLUTION STRUCTURE OF CRH, THE BACILLUS SUBTILIS CATABOLITE REPRESSION HPR 1H5O ; -1.00 ; SOLUTION STRUCTURE OF CROTAMINE, A NEUROTOXIN FROM CROTALUS DURISSUS TERRIFICUS 1TV0 ; -1.00 ; SOLUTION STRUCTURE OF CRYPTDIN-4, THE MOST POTENT ALPHA- DEFENSIN FROM MOUSE PANETH CELLS 1T3O ; -1.00 ; SOLUTION STRUCTURE OF CSRA, A BACTERIAL CARBON STORAGE REGULATORY PROTEIN 1TL4 ; -1.00 ; SOLUTION STRUCTURE OF CU(I) HAH1 1NM4 ; -1.00 ; SOLUTION STRUCTURE OF CU(I)-COPC FROM PSEUDOMONAS SYRINGAE 1OT4 ; -1.00 ; SOLUTION STRUCTURE OF CU(II)-COPC FROM PSEUDOMONAS SYRINGAE 1WGL ; -1.00 ; SOLUTION STRUCTURE OF CUE DOMAIN IN THE C-TERMINAL OF HUMAN TOLL-INTERACTING PROTEIN (TOLLIP) 1X9L ; -1.00 ; SOLUTION STRUCTURE OF CUI-DR1885 FROM DEINOCOCCUS RADIODURANS 1I5T ; -1.00 ; SOLUTION STRUCTURE OF CYANOFERRICYTOCHROME C 1XWN ; -1.00 ; SOLUTION STRUCTURE OF CYCLOPHILIN LIKE 1(PPIL1) AND INSIGHTS INTO ITS INTERACTION WITH SKIP 1I5U ; -1.00 ; SOLUTION STRUCTURE OF CYTOCHROME B5 TRIPLE MUTANT (E48A/E56A/D60A) 1AYG ; -1.00 ; SOLUTION STRUCTURE OF CYTOCHROME C-552, NMR, 20 STRUCTURES 1M58 ; -1.00 ; SOLUTION STRUCTURE OF CYTOTOXIC RC-RNASE2 1KVZ ; -1.00 ; SOLUTION STRUCTURE OF CYTOTOXIC RC-RNASE4 1Q2T ; -1.00 ; SOLUTION STRUCTURE OF D(5MCCTCTCC)4 1JRV ; -1.00 ; SOLUTION STRUCTURE OF DAATAA DEOXYRIBONUCLEIC ACID BULGE 1JRW ; -1.00 ; SOLUTION STRUCTURE OF DAATAA DEOXYRIBONUCLEIC ACID BULGE 1JS5 ; -1.00 ; SOLUTION STRUCTURE OF DAAUAA DEOXYRIBONUCLEIC ACID BULGE 1JS7 ; -1.00 ; SOLUTION STRUCTURE OF DAAUAA DEOXYRIBONUCLEIC ACID BULGE 1V5N ; -1.00 ; SOLUTION STRUCTURE OF DC1 DOMAIN OF PDI-LIKE HYPOTHETICAL PROTEIN FROM ARABIDOPSIS THALIANA 1D6B ; -1.00 ; SOLUTION STRUCTURE OF DEFENSIN-LIKE PEPTIDE-2 (DLP-2) FROM PLATYPUS VENOM 1BUQ ; -1.00 ; SOLUTION STRUCTURE OF DELTA-5-3-KETOSTEROID ISOMERASE COMPLEXED WITH THE STEROID 19-NORTESTOSTERONE-HEMISUCCINATE 1R6R ; -1.00 ; SOLUTION STRUCTURE OF DENGUE VIRUS CAPSID PROTEIN REVEALS A NEW FOLD 1PIB ; -1.00 ; SOLUTION STRUCTURE OF DEOXYRIBONUCLEIC ACID CONTAINING CPD OPPOSITED BY GA 1AU6 ; -1.00 ; SOLUTION STRUCTURE OF DEOXYRIBONUCLEIC ACID D(CATGCATG) INTERSTRAND-CROSSLINKED BY BISPLATIN COMPOUND (1,1/T,T), NMR, MINIMIZED AVERAGE STRUCTURE 1JAJ ; -1.00 ; SOLUTION STRUCTURE OF DEOXYRIBONUCLEIC ACID POLYMERASE X FROM THE AFRICAN SWINE FEVER VIRUS 1NYD ; -1.00 ; SOLUTION STRUCTURE OF DEOXYRIBONUCLEIC ACID QUADRUPLEX GCGGTGGAT 1F3S ; -1.00 ; SOLUTION STRUCTURE OF DEOXYRIBONUCLEIC ACID SEQUENCE GGGTTCAGG FORMS GGGG TETRADE AND G(C-A) TRIAD. 1K9L ; -1.00 ; SOLUTION STRUCTURE OF DEOXYRIBONUCLEIC ACID TATGAGCGCTCATA 1HG9 ; -1.00 ; SOLUTION STRUCTURE OF DEOXYRIBONUCLEIC ACID:RIBONUCLEIC ACID HYBRID 1ICO ; -1.00 ; SOLUTION STRUCTURE OF DESIGNED BETA-SHEET MINI-PROTEIN TH10BOX 1ICL ; -1.00 ; SOLUTION STRUCTURE OF DESIGNED BETA-SHEET MINI-PROTEIN TH1OX 1WO5 ; -1.00 ; SOLUTION STRUCTURE OF DESIGNED FUNCTIONAL FINGER 2 (DFF2): DESIGNED MUTANT BASED ON NON-NATIVE CHANCE DOMAIN 1WO6 ; -1.00 ; SOLUTION STRUCTURE OF DESIGNED FUNCTIONAL FINGER 5 (DFF5): DESIGNED MUTANT BASED ON NON-NATIVE CHANCE DOMAIN 1WO7 ; -1.00 ; SOLUTION STRUCTURE OF DESIGNED FUNCTIONAL FINGER 7 (DFF7): DESIGNED MUTANT BASED ON NON-NATIVE CHANCE DOMAIN 1QN1 ; -1.00 ; SOLUTION STRUCTURE OF DESULFOVIBRIO GIGAS FERRICYTOCHROME C3, NMR, 15 STRUCTURES 1QN0 ; -1.00 ; SOLUTION STRUCTURE OF DESULFOVIBRIO GIGAS FERROCYTOCHROME C3, NMR, 20 STRUCTURES 1E8J ; -1.00 ; SOLUTION STRUCTURE OF DESULFOVIBRIO GIGAS ZINC RUBREDOXIN, NMR, 20 STRUCTURES 1A2I ; -1.00 ; SOLUTION STRUCTURE OF DESULFOVIBRIO VULGARIS (HILDENBOROUGH) FERROCYTOCHROME C3, NMR, 20 STRUCTURES 1LUD ; -1.00 ; SOLUTION STRUCTURE OF DIHYDROFOLATE REDUCTASE COMPLEXED WITH TRIMETHOPRIM AND NADPH, 24 STRUCTURES 1W0R ; -1.00 ; SOLUTION STRUCTURE OF DIMERIC FORM OF PROPERDIN BY X-RAY SOLUTION SCATTERING AND ANALYTICAL ULTRACENTRIFUGATION 1X9X ; -1.00 ; SOLUTION STRUCTURE OF DIMERIC SAM DOMAIN FROM MAPKKK STE11 1GHH ; -1.00 ; SOLUTION STRUCTURE OF DINI 2AF2 ; -1.00 ; SOLUTION STRUCTURE OF DISULFIDE REDUCED AND COPPER DEPLETED HUMAN SUPEROXIDE DISMUTASE 1ZUF ; -1.00 ; SOLUTION STRUCTURE OF DLP-4 1YSX ; -1.00 ; SOLUTION STRUCTURE OF DOMAIN 3 FROM HUMAN SERUM ALBUMIN COMPLEXED TO AN ANTI-APOPTOTIC LIGAND DIRECTED AGAINST BCL- XL AND BCL-2 1R2P ; -1.00 ; SOLUTION STRUCTURE OF DOMAIN 5 FROM THE AI5(GAMMA) GROUP II INTRON 1T4L ; -1.00 ; SOLUTION STRUCTURE OF DOUBLE-STRANDED RIBONUCLEIC ACID BINDING DOMAIN OF S. CEREVISIAE RNASE III (RNT1P) IN COMPLEX WITH THE 5' TERMINAL RIBONUCLEIC ACID HAIRPIN OF SNR47 PRECURSOR 1MYN ; -1.00 ; SOLUTION STRUCTURE OF DROSOMYCIN, THE FIRST INDUCIBLE ANTIFUNGAL PROTEIN FROM INSECTS, NMR, 15 STRUCTURES 1X47 ; -1.00 ; SOLUTION STRUCTURE OF DSRM DOMAIN IN DGCR8 PROTEIN 1UHZ ; -1.00 ; SOLUTION STRUCTURE OF DSRNA BINDING DOMAIN IN STAUFEN HOMOLOG 2 1F95 ; -1.00 ; SOLUTION STRUCTURE OF DYNEIN LIGHT CHAIN 8 (DLC8) AND BIM PEPTIDE COMPLEX 1F96 ; -1.00 ; SOLUTION STRUCTURE OF DYNEIN LIGHT CHAIN 8 (DLC8) AND NNOS PEPTIDE COMPLEX 1XN7 ; -1.00 ; SOLUTION STRUCTURE OF E.COLI PROTEIN YHGG: THE NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET ET95 1XSG ; -1.00 ; SOLUTION STRUCTURE OF E.COLI RNASE P RIBONUCLEIC ACID P4 STEM OLIGORIBONUCLEOTIDE, U69A MUTATION 1XSH ; -1.00 ; SOLUTION STRUCTURE OF E.COLI RNASE P RIBONUCLEIC ACID P4 STEM OLIGORIBONUCLEOTIDE, U69C/C70U MUTATION 1XST ; -1.00 ; SOLUTION STRUCTURE OF E.COLI RNASE P RIBONUCLEIC ACID P4 STEM, U69A MUTATION, COMPLEXED WITH COBALT (III) HEXAMMINE. 1XSU ; -1.00 ; SOLUTION STRUCTURE OF E.COLI RNASE P RIBONUCLEIC ACID P4 STEM, U69C/C70U MUTATION, COMPLEXED WITH COBALT (III) HEXAMMINE. 1ECU ; -1.00 ; SOLUTION STRUCTURE OF E2F BINDING DEOXYRIBONUCLEIC ACID FRAGMENT GCGCGAAAC-T- GTTTCGCGC 1JE3 ; -1.00 ; SOLUTION STRUCTURE OF EC005 FROM ESCHERICHIA COLI 1V6R ; -1.00 ; SOLUTION STRUCTURE OF ENDOTHELIN-1 WITH ITS C-TERMINAL FOLDING 1ZTR ; -1.00 ; SOLUTION STRUCTURE OF ENGRAILED HOMEODOMAIN L16A MUTANT 2EOT ; -1.00 ; SOLUTION STRUCTURE OF EOTAXIN, AN ENSEMBLE OF 32 NMR SOLUTION STRUCTURES 1G2S ; -1.00 ; SOLUTION STRUCTURE OF EOTAXIN-3 1G2T ; -1.00 ; SOLUTION STRUCTURE OF EOTAXIN-3 1EY1 ; -1.00 ; SOLUTION STRUCTURE OF ESCHERICHIA COLI NUSB 1XX3 ; -1.00 ; SOLUTION STRUCTURE OF ESCHERICHIA COLI TONB-CTD 1E52 ; -1.00 ; SOLUTION STRUCTURE OF ESCHERICHIA COLI UVRB C-TERMINAL DOMAIN 1JRJ ; -1.00 ; SOLUTION STRUCTURE OF EXENDIN-4 IN 30-VOL% TRIFLUOROETHANOL 1R4T ; -1.00 ; SOLUTION STRUCTURE OF EXOENZYME S 1IB7 ; -1.00 ; SOLUTION STRUCTURE OF F35Y MUTANT OF RAT FERRO CYTOCHROME B5, A CONFORMATION, ENSEMBLE OF 20 STRUCTURES 1KTM ; -1.00 ; SOLUTION STRUCTURE OF FAT DOMAIN OF FOCAL ADHESION KINASE 2B9Z ; -1.00 ; SOLUTION STRUCTURE OF FHV B2, A VIRAL SUPPRESSOR OF RNAI 1WK0 ; -1.00 ; SOLUTION STRUCTURE OF FIBRONECTIN TYPE III DOMAIN DERIVED FROM HUMAN KIAA0970 PROTEIN 1WFU ; -1.00 ; SOLUTION STRUCTURE OF FIBRONECTIN TYPE III DOMAIN OF MOUSE HYPOTHETICAL PROTEIN 1F40 ; -1.00 ; SOLUTION STRUCTURE OF FKBP12 COMPLEXED WITH GPI-1046, A NEUROTROPHIC LIGAND 1VD7 ; -1.00 ; SOLUTION STRUCTURE OF FMBP-1 TANDEM REPEAT 1 1VD8 ; -1.00 ; SOLUTION STRUCTURE OF FMBP-1 TANDEM REPEAT 2 1VD9 ; -1.00 ; SOLUTION STRUCTURE OF FMBP-1 TANDEM REPEAT 3 1VDA ; -1.00 ; SOLUTION STRUCTURE OF FMBP-1 TANDEM REPEAT 4 1FMN ; -1.00 ; SOLUTION STRUCTURE OF FMN-RIBONUCLEIC ACID APTAMER COMPLEX, NMR, 5 STRUCTURES 1UG7 ; -1.00 ; SOLUTION STRUCTURE OF FOUR HELICAL UP-AND-DOWN BUNDLE DOMAIN OF THE HYPOTHETICAL PROTEIN 2610208M17RIK SIMILAR TO THE PROTEIN FLJ12806 1QYT ; -1.00 ; SOLUTION STRUCTURE OF FRAGMENT (25-35) OF BETA AMYLOID PEPTIDE IN SDS MICELLAR SOLUTION 1EMZ ; -1.00 ; SOLUTION STRUCTURE OF FRAGMENT (350-370) OF THE TRANSMEMBRANE DOMAIN OF HEPATITIS C ENVELOPE GLYCOPROTEIN E1 1FME ; -1.00 ; SOLUTION STRUCTURE OF FSD-EY, A NOVEL PEPTIDE ASSUMING A BETA-BETA-ALPHA FOLD 1PM6 ; -1.00 ; SOLUTION STRUCTURE OF FULL-LENGTH EXCISIONASE (XIS) FROM BACTERIOPHAGE HK022 1HU6 ; -1.00 ; SOLUTION STRUCTURE OF G10 NOVISPIRIN 1M9G ; -1.00 ; SOLUTION STRUCTURE OF G16A-MNEI, A STRUCTURAL MUTANT OF SINGLE CHAIN MONELLIN MNEI 1CMZ ; -1.00 ; SOLUTION STRUCTURE OF GAIP (GALPHA INTERACTING PROTEIN): A REGULATOR OF G PROTEIN SIGNALING 1MR6 ; -1.00 ; SOLUTION STRUCTURE OF GAMMA-BUNGAROTOXIN:IMPLICATION FOR THE ROLE OF THE RESIDUES ADJACENT TO RGD IN INTEGRIN BINDING 1T5Q ; -1.00 ; SOLUTION STRUCTURE OF GIP(1-30)AMIDE IN TFE/WATER 1RRZ ; -1.00 ; SOLUTION STRUCTURE OF GLGS PROTEIN FROM E. COLI 1V6F ; -1.00 ; SOLUTION STRUCTURE OF GLIA MATURATION FACTOR-BETA FROM MUS MUSCULUS 1WFS ; -1.00 ; SOLUTION STRUCTURE OF GLIA MATURATION FACTOR-GAMMA FROM MUS MUSCULUS 1D0R ; -1.00 ; SOLUTION STRUCTURE OF GLUCAGON-LIKE PEPTIDE-1-(7-36)-AMIDE IN TRIFLUOROETHANOL/WATER 1GR6 ; 9.70 ; SOLUTION STRUCTURE OF GROEL(D398A)+ 250UM ATP BY CRYO-ELECTRON MICROSCOPY 1GRU ; 12.50 ; SOLUTION STRUCTURE OF GROES-ADP7-GROEL-ATP7 COMPLEX BY CRYO-EM 1YKA ; -1.00 ; SOLUTION STRUCTURE OF GRX4, A MONOTHIOL GLUTAREDOXIN FROM E. COLI. 1LU8 ; -1.00 ; SOLUTION STRUCTURE OF GSMTX-4 1WJF ; -1.00 ; SOLUTION STRUCTURE OF H12C MUTANT OF THE N-TERMINAL ZN BINDING DOMAIN OF HIV-1 INTEGRASE COMPLEXED TO CADMIUM, NMR, 40 STRUCTURES 1WJE ; -1.00 ; SOLUTION STRUCTURE OF H12C MUTANT OF THE N-TERMINAL ZN BINDING DOMAIN OF HIV-1 INTEGRASE COMPLEXED TO CADMIUM, NMR, MINIMIZED AVERAGE STRUCTURE 1D1H ; -1.00 ; SOLUTION STRUCTURE OF HANATOXIN 1 1S5R ; -1.00 ; SOLUTION STRUCTURE OF HBP1 SID-MSIN3A PAH2 COMPLEX 1UFZ ; -1.00 ; SOLUTION STRUCTURE OF HBS1-LIKE DOMAIN IN HYPOTHETICAL PROTEIN BAB28515 1P5O ; -1.00 ; SOLUTION STRUCTURE OF HCV IRES DOMAIN II 1P5P ; -1.00 ; SOLUTION STRUCTURE OF HCV IRES DOMAIN II (MINIMIZED AVERAGE STRUCTURE) 1P5M ; -1.00 ; SOLUTION STRUCTURE OF HCV IRES DOMAIN IIA 1P5N ; -1.00 ; SOLUTION STRUCTURE OF HCV IRES DOMAIN IIB 1F84 ; -1.00 ; SOLUTION STRUCTURE OF HCV IRES RIBONUCLEIC ACID DOMAIN IIID 1F85 ; -1.00 ; SOLUTION STRUCTURE OF HCV IRES RIBONUCLEIC ACID DOMAIN IIIE 1JUR ; -1.00 ; SOLUTION STRUCTURE OF HELIX III IN XENOPUS OOCYTE 5S RRNA. 1JW2 ; -1.00 ; SOLUTION STRUCTURE OF HEMOLYSIN EXPRESSION MODULATING PROTEIN HHA FROM ESCHERICHIA COLI. ONTARIO CENTRE FOR STRUCTURAL PROTEOMICS TARGET EC0308_1_72; NORTHEAST STRUCTURAL GENOMICS TARGET ET88 1M4E ; -1.00 ; SOLUTION STRUCTURE OF HEPCIDIN-20 1M4F ; -1.00 ; SOLUTION STRUCTURE OF HEPCIDIN-25 1J5J ; -1.00 ; SOLUTION STRUCTURE OF HERG-SPECIFIC SCORPION TOXIN BEKM-1 1LGL ; -1.00 ; SOLUTION STRUCTURE OF HERG-SPECIFIC SCORPION TOXIN BEKM-1 1IMU ; -1.00 ; SOLUTION STRUCTURE OF HI0257, A RIBOSOME BINDING PROTEIN 1J7H ; -1.00 ; SOLUTION STRUCTURE OF HI0719, A HYPOTHETICAL PROTEIN FROM HAEMOPHILUS INFLUENZAE 1QR5 ; -1.00 ; SOLUTION STRUCTURE OF HISTIDINE CONTAINING PROTEIN (HPR) FROM STAPHYLOCOCCUS CARNOSUS 484D ; -1.00 ; SOLUTION STRUCTURE OF HIV-1 REV PEPTIDE-RIBONUCLEIC ACID APTAMER COMPLEX 1N8X ; -1.00 ; SOLUTION STRUCTURE OF HIV-1 STEM LOOP SL1 1FI0 ; -1.00 ; SOLUTION STRUCTURE OF HIV-1 VPR (13-33) PEPTIDE IN MICELLS 1JTJ ; -1.00 ; SOLUTION STRUCTURE OF HIV-1LAI MUTATED SL1 HAIRPIN 1L8Y ; -1.00 ; SOLUTION STRUCTURE OF HMG BOX 5 IN HUMAN UPSTREAM BINDING FACTOR 1L8Z ; -1.00 ; SOLUTION STRUCTURE OF HMG BOX 5 IN HUMAN UPSTREAM BINDING FACTOR 1S7E ; -1.00 ; SOLUTION STRUCTURE OF HNF-6 2BDO ; -1.00 ; SOLUTION STRUCTURE OF HOLO-BIOTINYL DOMAIN FROM ACETYL COENZYME A CARBOXYLASE OF ESCHERICHIA COLI DETERMINED BY TRIPLE-RESONANCE NMR SPECTROSCOPY 1O5P ; -1.00 ; SOLUTION STRUCTURE OF HOLO-NEOCARZINOSTATIN 1WH7 ; -1.00 ; SOLUTION STRUCTURE OF HOMEOBOX DOMAIN OF ARABIDOPSIS THALIANA HYPOTHETICAL PROTEIN F22K18.140 1WH5 ; -1.00 ; SOLUTION STRUCTURE OF HOMEOBOX DOMAIN OF ARABIDOPSISTHALIANA ZINC FINGER HOMEOBOX FAMILY PROTEIN 1HLY ; -1.00 ; SOLUTION STRUCTURE OF HONGOTOXIN 1 1ZHC ; -1.00 ; SOLUTION STRUCTURE OF HP1242 FROM HELICOBACTER PYLORI 1EMX ; -1.00 ; SOLUTION STRUCTURE OF HPTX2, A TOXIN FROM HETEROPODA VENATORIA SPIDER VENOM THAT BLOCKS KV4.2 POTASSIUM CHANNEL 1Y2P ; -1.00 ; SOLUTION STRUCTURE OF HSTX3P 1EXY ; -1.00 ; SOLUTION STRUCTURE OF HTLV-1 PEPTIDE BOUND TO ITS RIBONUCLEIC ACID APTAMER TARGET 1QRJ ; -1.00 ; SOLUTION STRUCTURE OF HTLV-I CAPSID PROTEIN 1RK9 ; -1.00 ; SOLUTION STRUCTURE OF HUMAN ALPHA-PARVALBUMIN (MINIMIZED AVERAGE STRUCTURE) 1RJV ; -1.00 ; SOLUTION STRUCTURE OF HUMAN ALPHA-PARVALBUMIN REFINED WITH A PARAMAGNETISM-BASED STRATEGY 1JFN ; -1.00 ; SOLUTION STRUCTURE OF HUMAN APOLIPOPROTEIN(A) KRINGLE IV TYPE 6 2EZZ ; -1.00 ; SOLUTION STRUCTURE OF HUMAN BARRIER-TO-AUTOINTEGRATION FACTOR BAF NMR, ENSEMBLE OF 20 SIMULATED ANNEALING STRUCTURES 2EZY ; -1.00 ; SOLUTION STRUCTURE OF HUMAN BARRIER-TO-AUTOINTEGRATION FACTOR BAF, NMR, ENSEMBLE OF 20 SIMULATED ANNEALING STRUCTURES 2EZX ; -1.00 ; SOLUTION STRUCTURE OF HUMAN BARRIER-TO-AUTOINTEGRATION FACTOR BAF, NMR, REGULARIZED MEAN STRUCTURE 1QCK ; -1.00 ; SOLUTION STRUCTURE OF HUMAN BARRIER-TO-AUTOINTEGRATION FACTOR BAF, NMR, REGULARIZED MEAN STRUCTURE PLUS 20 INDIVIDUAL SIMULATED ANNEALING STRUCTURES 1MK3 ; -1.00 ; SOLUTION STRUCTURE OF HUMAN BCL-W PROTEIN 1KJ5 ; -1.00 ; SOLUTION STRUCTURE OF HUMAN BETA-DEFENSIN 1 1KJ6 ; -1.00 ; SOLUTION STRUCTURE OF HUMAN BETA-DEFENSIN 3 1FQQ ; -1.00 ; SOLUTION STRUCTURE OF HUMAN BETA-DEFENSIN-2 1TMW ; -1.00 ; SOLUTION STRUCTURE OF HUMAN COACTOSIN LIKE PROTEIN D123N 1YHO ; -1.00 ; SOLUTION STRUCTURE OF HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH TRIMETHOPRIM AND NADPH, 25 STRUCTURES 1KOT ; -1.00 ; SOLUTION STRUCTURE OF HUMAN GABA RECEPTOR ASSOCIATED PROTEIN GABARAP 1G5W ; -1.00 ; SOLUTION STRUCTURE OF HUMAN HEART-TYPE FATTY ACID BINDING PROTEIN 1IJZ ; -1.00 ; SOLUTION STRUCTURE OF HUMAN IL-13 1IK0 ; -1.00 ; SOLUTION STRUCTURE OF HUMAN IL-13 1KZW ; -1.00 ; SOLUTION STRUCTURE OF HUMAN INTESTINAL FATTY ACID BINDING PROTEIN 1KZX ; -1.00 ; SOLUTION STRUCTURE OF HUMAN INTESTINAL FATTY ACID BINDING PROTEIN WITH A NATURALLY-OCCURRING SINGLE AMINO ACID SUBSTITUTION (A54T) 1R21 ; -1.00 ; SOLUTION STRUCTURE OF HUMAN KI67 FHA DOMAIN 1J8I ; -1.00 ; SOLUTION STRUCTURE OF HUMAN LYMPHOTACTIN 1J9O ; -1.00 ; SOLUTION STRUCTURE OF HUMAN LYMPHOTACTIN 1PC2 ; -1.00 ; SOLUTION STRUCTURE OF HUMAN MITOCHONDRIA FISSION PROTEIN FIS1 1FWQ ; -1.00 ; SOLUTION STRUCTURE OF HUMAN MSS4, A GUANINE NUCLEOTIDE EXCHANGE FACTOR FOR RAB PROTEINS 1TR4 ; -1.00 ; SOLUTION STRUCTURE OF HUMAN ONCOGENIC PROTEIN GANKYRIN 1R02 ; -1.00 ; SOLUTION STRUCTURE OF HUMAN OREXIN-A:REGULATOR OF APPETITE AND WAKEFULNESS 1V66 ; -1.00 ; SOLUTION STRUCTURE OF HUMAN P53 BINDING DOMAIN OF PIAS-1 2HP8 ; -1.00 ; SOLUTION STRUCTURE OF HUMAN P8-MTCP1, A CYSTEINE-RICH PROTEIN ENCODED BY THE MTCP1 ONCOGENE,REVEALS A NEW ALPHA-HELICAL ASSEMBLY MOTIF, NMR, 30 STRUCTURES 1HP8 ; -1.00 ; SOLUTION STRUCTURE OF HUMAN P8-MTCP1, A CYSTEINE-RICH PROTEIN ENCODED BY THE MTCP1 ONCOGENE,REVEALS A NEW ALPHA-HELICAL ASSEMBLY MOTIF, NMR, MINIMIZED AVERAGE STRUCTURE 1NMV ; -1.00 ; SOLUTION STRUCTURE OF HUMAN PIN1 1R6H ; -1.00 ; SOLUTION STRUCTURE OF HUMAN PRL-3 1O8R ; -1.00 ; SOLUTION STRUCTURE OF HUMAN PROGUANYLIN 1T0C ; -1.00 ; SOLUTION STRUCTURE OF HUMAN PROINSULIN C-PEPTIDE 1N9D ; -1.00 ; SOLUTION STRUCTURE OF HUMAN PROLACTIN 1RW5 ; -1.00 ; SOLUTION STRUCTURE OF HUMAN PROLACTIN 1YWZ ; -1.00 ; SOLUTION STRUCTURE OF HUMAN PROTEIN CGI-126 (HSPC155): THE NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET HR41 1RL1 ; -1.00 ; SOLUTION STRUCTURE OF HUMAN SGT1 CS DOMAIN 2ETT ; -1.00 ; SOLUTION STRUCTURE OF HUMAN SORTING NEXIN 22 PX DOMAIN 1YZS ; -1.00 ; SOLUTION STRUCTURE OF HUMAN SULFIREDOXIN (SRX) 1WZ0 ; -1.00 ; SOLUTION STRUCTURE OF HUMAN SUMO-2 (SMT3B), A UBIQUITIN- LIKE PROTEIN 1U4A ; -1.00 ; SOLUTION STRUCTURE OF HUMAN SUMO-3 C47S 1XOX ; -1.00 ; SOLUTION STRUCTURE OF HUMAN SURVIVIN 1DL6 ; -1.00 ; SOLUTION STRUCTURE OF HUMAN TFIIB N-TERMINAL DOMAIN 1B4Q ; -1.00 ; SOLUTION STRUCTURE OF HUMAN THIOLTRANSFERASE COMPLEX WITH GLUTATHIONE 1Y41 ; -1.00 ; SOLUTION STRUCTURE OF HUMAN TRANSLATIONALLY CONTROLLED TUMOR PROTEIN 1VF9 ; -1.00 ; SOLUTION STRUCTURE OF HUMAN TRF2 1QK6 ; -1.00 ; SOLUTION STRUCTURE OF HUWENTOXIN-I BY NMR 1S6W ; -1.00 ; SOLUTION STRUCTURE OF HYBRID WHITE STRIPED BASS HEPCIDIN 1Q53 ; -1.00 ; SOLUTION STRUCTURE OF HYPOTHETICAL ARABIDOPSIS THALIANA PROTEIN AT3G17210. CENTER FOR EUKARYOTIC STRUCTURAL GENOMICS TARGET 13081 1X9B ; -1.00 ; SOLUTION STRUCTURE OF HYPOTHETICAL MEMBRANE PROTEIN TA0354_69_121 FROM THERMOPLASMA ACIDOPHILUM. ONTARIO CENTER FOR STRUCTURAL PROTEOMICS TARGET TA0354_69_121; NORTHEAST STRUCTURAL GENOMICS TARGET TAT38. 1WJK ; -1.00 ; SOLUTION STRUCTURE OF HYPOTHETICAL PROTEIN C330018D20RIK FROM MUS MUSCULUS 1NEI ; -1.00 ; SOLUTION STRUCTURE OF HYPOTHETICAL PROTEIN DIMER ENCODED BY THE YOAG GENE FROM ESCHERICHIA COLI. ONTARIO CENTRE FOR STRUCTURAL PROTEOMICS TARGET EC0264_1_60; NORTHEAST STRUCTURAL GENOMICS TARGET ET94. 1WJJ ; -1.00 ; SOLUTION STRUCTURE OF HYPOTHETICAL PROTEIN F20O9.120 FROM ARABIDOPSIS THALIANA 1EO1 ; -1.00 ; SOLUTION STRUCTURE OF HYPOTHETICAL PROTEIN MTH1175 FROM METHANOBACTERIUM THERMOAUTOTROPHICUM 1RYJ ; -1.00 ; SOLUTION STRUCTURE OF HYPOTHETICAL PROTEIN MTH1743 FROM METHANOBACTERIUM THERMOAUTOTROPHICUM. ONTARIO CENTRE FOR STRUCTURAL PROTEOMICS TARGET MTH1743_1_70; NORTHEAST STRUCTURAL GENOMICS TARGET TT526 1EIW ; -1.00 ; SOLUTION STRUCTURE OF HYPOTHETICAL PROTEIN MTH538 FROM METHANOBACTERIUM THERMOAUTOTROPHICUM 1LKN ; -1.00 ; SOLUTION STRUCTURE OF HYPOTHETICAL PROTEIN TM1112. ONTARIO CENTRE FOR STRUCTURAL PROTEOMICS TARGET TM1112_1_89; NORTHEAST STRUCTURAL GENOMICS TARGET VT74 1DGN ; -1.00 ; SOLUTION STRUCTURE OF ICEBERG, AN INHIBITOR OF INTERLEUKIN- 1BETA GENERATION 1ZYI ; -1.00 ; SOLUTION STRUCTURE OF ICLN, A MULTIFUNCTIONAL PROTEIN INVOLVED IN REGULATORY MECHANISMS AS DIFFERENT AS CELL VOLUME REGULATION AND RIBONUCLEIC ACID SPLICING 1ZFL ; -1.00 ; SOLUTION STRUCTURE OF III-A, THE MAJOR INTERMEDIATE IN THE OXIDATIVE FOLDING OF LEECH CARBOXYPEPTIDASE INHIBITOR 1UFG ; -1.00 ; SOLUTION STRUCTURE OF IMMUNOGLOBULIN LIKE DOMAIN OF MOUSE NUCLEAR LAMIN 1IE6 ; -1.00 ; SOLUTION STRUCTURE OF IMPERATOXIN A 1MFY ; -1.00 ; SOLUTION STRUCTURE OF INFLUENZA A VIRUS C4 PROMOTER 1JO7 ; -1.00 ; SOLUTION STRUCTURE OF INFLUENZA A VIRUS PROMOTER 1V91 ; -1.00 ; SOLUTION STRUCTURE OF INSECTIDAL TOXIN DELTA-PALUIT2-NH2 1EDS ; -1.00 ; SOLUTION STRUCTURE OF INTRADISKAL LOOP 1 OF BOVINE RHODOPSIN (RHODOPSIN RESIDUES 92-123) 1AU5 ; -1.00 ; SOLUTION STRUCTURE OF INTRASTRAND CISPLATIN-CROSSLINKED DEOXYRIBONUCLEIC ACID OCTAMER D(CCTGGTCC):D(GGACCAGG), NMR, MINIMIZED AVERAGE STRUCTURE 1XJS ; -1.00 ; SOLUTION STRUCTURE OF IRON-SULFUR CLUSTER ASSEMBLY PROTEIN ISCU FROM BACILLUS SUBTILIS, WITH ZINC BOUND AT THE ACTIVE SITE. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET SR17 2AZH ; -1.00 ; SOLUTION STRUCTURE OF IRON-SULFUR CLUSTER ASSEMBLY PROTEIN SUFU FROM BACILLUS SUBTILIS, WITH ZINC BOUND AT THE ACTIVE SITE. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET SR17 1WFZ ; -1.00 ; SOLUTION STRUCTURE OF IRON-SULFUR CLUSTER PROTEIN U (ISCU) 1X4T ; -1.00 ; SOLUTION STRUCTURE OF ISY1 DOMAIN IN HYPOTHETICAL PROTEIN 1SZY ; -1.00 ; SOLUTION STRUCTURE OF ITALY1 ("INITIATOR TRNA ANTICODON LOOP FROM YEAST"), AN UNMODIFIED 21-NT RIBONUCLEIC ACID WITH THE SEQUENCE OF THE ANTICODON STEM-LOOP OF YEAST INITIATOR TRNA 2CTP ; -1.00 ; SOLUTION STRUCTURE OF J-DOMAIN FROM HUMAN DNAJ SUBFAMILY B MENBER 12 2CTR ; -1.00 ; SOLUTION STRUCTURE OF J-DOMAIN FROM HUMAN DNAJ SUBFAMILY B MENBER 9 2CTQ ; -1.00 ; SOLUTION STRUCTURE OF J-DOMAIN FROM HUMAN DNAJ SUBFAMILY C MENBER 12 2CTW ; -1.00 ; SOLUTION STRUCTURE OF J-DOMAIN FROM MOUSE DNAJ SUBFAMILY C MENBER 5 1ZJQ ; -1.00 ; SOLUTION STRUCTURE OF JINGZHAOTOXIN-VII 2AAP ; -1.00 ; SOLUTION STRUCTURE OF JINGZHAOTOXIN-VII 1X4M ; -1.00 ; SOLUTION STRUCTURE OF KH DOMAIN IN FAR UPSTREAM ELEMENT BINDING PROTEIN 1 1X4N ; -1.00 ; SOLUTION STRUCTURE OF KH DOMAIN IN FUSE BINDING PROTEIN 1 1WE8 ; -1.00 ; SOLUTION STRUCTURE OF KH DOMAIN IN PROTEIN BAB28342 1UL7 ; -1.00 ; SOLUTION STRUCTURE OF KINASE ASSOCIATED DOMAIN 1 OF MOUSE MAP/MICROTUBULE AFFINITY-REGULATING KINASE 3 1V5S ; -1.00 ; SOLUTION STRUCTURE OF KINASE ASSOCIATED DOMAIN 1 OF MOUSE MAP/MICROTUBULE AFFINITY-REGULATING KINASE 3 1Z09 ; -1.00 ; SOLUTION STRUCTURE OF KM23 1T1T ; -1.00 ; SOLUTION STRUCTURE OF KURTOXIN 1JAA ; -1.00 ; SOLUTION STRUCTURE OF LACTAM ANALOGUE (DAPE) OF HIV GP41 600-612 LOOP. 1JAR ; -1.00 ; SOLUTION STRUCTURE OF LACTAM ANALOGUE (DDAB)OF HIV GP41 600- 612 LOOP. 1JC8 ; -1.00 ; SOLUTION STRUCTURE OF LACTAM ANALOGUE (DDAP) OF GP41 600- 612 LOOP OF HIV 1JDK ; -1.00 ; SOLUTION STRUCTURE OF LACTAM ANALOGUE (EDAP) OF HIV GP41 600-612 LOOP. 1D1F ; -1.00 ; SOLUTION STRUCTURE OF LACTAM-BRIDGED C-TERMINAL ANALOGUE- III OF NEUROPEPTIDE Y 1D0W ; -1.00 ; SOLUTION STRUCTURE OF LACTAM-BRIDGED C-TERMINAL ANALOGUE-I OF NEUROPEPTIDE Y 1D1E ; -1.00 ; SOLUTION STRUCTURE OF LACTAM-BRIDGED C-TERMINAL ANALOGUE-II OF NEUROPEPTIDE Y 1WK1 ; -1.00 ; SOLUTION STRUCTURE OF LECTIN C-TYPE DOMAIN DERIVED FROM A HYPOTHETICAL PROTEIN FROM C. ELEGANS 1JU8 ; -1.00 ; SOLUTION STRUCTURE OF LEGINSULIN, A PLANT HORMON 1X4L ; -1.00 ; SOLUTION STRUCTURE OF LIM DOMAIN IN FOUR AND A HALF LIM DOMAINS PROTEIN 2 1X4K ; -1.00 ; SOLUTION STRUCTURE OF LIM DOMAIN IN LIM-PROTEIN 3 1DWM ; -1.00 ; SOLUTION STRUCTURE OF LINUM USITATISSINUM TRYPSIN INHIBITOR (LUTI) 1HHW ; -1.00 ; SOLUTION STRUCTURE OF LNA1:RIBONUCLEIC ACID HYBRID 1HHX ; -1.00 ; SOLUTION STRUCTURE OF LNA3:RIBONUCLEIC ACID HYBRID 1GXV ; -1.00 ; SOLUTION STRUCTURE OF LYSOZYME AT LOW AND HIGH PRESSURE 1GXX ; -1.00 ; SOLUTION STRUCTURE OF LYSOZYME AT LOW AND HIGH PRESSURE 1S5Q ; -1.00 ; SOLUTION STRUCTURE OF MAD1 SID-MSIN3A PAH2 COMPLEX 1IXU ; -1.00 ; SOLUTION STRUCTURE OF MARINOSTATIN, A PROTEASE INHIBITOR, CONTAINING TWO ESTER LINKAGES 1YCM ; -1.00 ; SOLUTION STRUCTURE OF MATRIX METALLOPROTEINASE 12 (MMP12) IN THE PRESENCE OF N-ISOBUTYL-N-[4- METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID (NNGH) 1R05 ; -1.00 ; SOLUTION STRUCTURE OF MAX B-HLH-LZ 1WSX ; -1.00 ; SOLUTION STRUCTURE OF MCL-1 1IB9 ; -1.00 ; SOLUTION STRUCTURE OF MCOTI-II, A MACROCYCLIC TRYPSIN INHIBITOR 1MC7 ; -1.00 ; SOLUTION STRUCTURE OF MDVL1 PDZ DOMAIN 1K0X ; -1.00 ; SOLUTION STRUCTURE OF MELANOMA INHIBITORY ACTIVITY PROTEIN 1FW5 ; -1.00 ; SOLUTION STRUCTURE OF MEMBRANE BINDING PEPTIDE OF SEMLIKI FOREST VIRUS MRNA CAPPING ENZYME NSP1 1S6L ; -1.00 ; SOLUTION STRUCTURE OF MERB, THE ORGANOMERCURIAL LYASE INVOLVED IN THE BACTERIAL MERCURY RESISTANCE SYSTEM 1JW3 ; -1.00 ; SOLUTION STRUCTURE OF METHANOBACTERIUM THERMOAUTOTROPHICUM PROTEIN 1598. ONTARIO CENTRE FOR STRUCTURAL PROTEOMICS TARGET MTH1598_1_140; NORTHEAST STRUCTURAL GENOMICS TARGET TT6 1YWX ; -1.00 ; SOLUTION STRUCTURE OF METHANOCOCCUS MARIPALUDIS PROTEIN MMP0443: THE NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET MRR16 1XN9 ; -1.00 ; SOLUTION STRUCTURE OF METHANOSARCINA MAZEI PROTEIN RPS24E: THE NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET MAR11 1E8E ; -1.00 ; SOLUTION STRUCTURE OF METHYLOPHILUS METHYLOTROPHUS CYTOCHROME C''. INSIGHTS INTO THE STRUCTURAL BASIS OF HAEM-LIGAND DETACHMENT 1C01 ; -1.00 ; SOLUTION STRUCTURE OF MIAMP1, A PLANT ANTIMICROBIAL PROTEIN 1VM5 ; -1.00 ; SOLUTION STRUCTURE OF MICELLE-BOUND AUREIN 1.2, AN ANTIMICROBIAL AND ANTICANCER PEPTIDE FROM AN AUSTRALIAN FROG 2ARI ; -1.00 ; SOLUTION STRUCTURE OF MICELLE-BOUND FUSION DOMAIN OF HIV-1 GP41 1V49 ; -1.00 ; SOLUTION STRUCTURE OF MICROTUBULE-ASSOCIATED PROTEIN LIGHT CHAIN-3 1WO3 ; -1.00 ; SOLUTION STRUCTURE OF MINIMAL MUTANT 1 (MM1): MULTIPLE ALANINE MUTANT OF NON-NATIVE CHANCE DOMAIN 1WO4 ; -1.00 ; SOLUTION STRUCTURE OF MINIMAL MUTANT 2 (MM2): MULTIPLE ALANINE MUTANT OF NON-NATIVE CHANCE DOMAIN 2CPT ; -1.00 ; SOLUTION STRUCTURE OF MIT DOMAIN FROM HUMAN SKD1 2CRB ; -1.00 ; SOLUTION STRUCTURE OF MIT DOMAIN FROM MOUSE NRBF-2 1WI0 ; -1.00 ; SOLUTION STRUCTURE OF MITOGEN ACTIVATED PROTEIN KINASE KINASE 5 (MAP2K5) 1Y74 ; -1.00 ; SOLUTION STRUCTURE OF MLIN-2/MLIN-7 L27 DOMAIN COMPLEX 1S9S ; -1.00 ; SOLUTION STRUCTURE OF MLV PSI SITE 1Z3J ; -1.00 ; SOLUTION STRUCTURE OF MMP12 IN THE PRESENCE OF N-ISOBUTYL-N- 4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID (NNGH) 1FA3 ; -1.00 ; SOLUTION STRUCTURE OF MNEI, A SWEET PROTEIN 1WLM ; -1.00 ; SOLUTION STRUCTURE OF MOUSE CGI-38 PROTEIN 1WM4 ; -1.00 ; SOLUTION STRUCTURE OF MOUSE COACTOSIN, AN ACTIN FILAMENT BINDING PROTEIN 1UHS ; -1.00 ; SOLUTION STRUCTURE OF MOUSE HOMEODOMAIN-ONLY PROTEIN HOP 1J0G ; -1.00 ; SOLUTION STRUCTURE OF MOUSE HYPOTHETICAL 9.1 KDA PROTEIN, A UBIQUITIN-LIKE FOLD 1UG2 ; -1.00 ; SOLUTION STRUCTURE OF MOUSE HYPOTHETICAL GENE (2610100B20RIK) PRODUCT HOMOLOGOUS TO MYB DEOXYRIBONUCLEIC ACID-BINDING DOMAIN 1V2Y ; -1.00 ; SOLUTION STRUCTURE OF MOUSE HYPOTHETICAL GENE (RIKEN CDNA 3300001G02) PRODUCT HOMOLOGOUS TO UBIQUITIN FOLD 1WGK ; -1.00 ; SOLUTION STRUCTURE OF MOUSE HYPOTHETICAL PROTEIN 2900073H19RIK 1WIA ; -1.00 ; SOLUTION STRUCTURE OF MOUSE HYPOTHETICAL UBIQUITIN-LIKE PROTEIN BAB25500 1IVM ; -1.00 ; SOLUTION STRUCTURE OF MOUSE LYSOZYME M 1WFD ; -1.00 ; SOLUTION STRUCTURE OF MOUSE MIT DOMAIN 1WYJ ; -1.00 ; SOLUTION STRUCTURE OF MOUSE PROTOCADHERIN BETA 14 (26-137) 1V9W ; -1.00 ; SOLUTION STRUCTURE OF MOUSE PUTATIVE 42-9-9 PROTEIN 1WGH ; -1.00 ; SOLUTION STRUCTURE OF MOUSE UBIQUITIN-LIKE 3 PROTEIN 2EW4 ; -1.00 ; SOLUTION STRUCTURE OF MRIA 1IEO ; -1.00 ; SOLUTION STRUCTURE OF MRIB-NH2 1Z9V ; -1.00 ; SOLUTION STRUCTURE OF MTH0776 FROM METHANOBACTERIUM THERMOAUTOTROPHICUM (STRAIN H) 1JCU ; -1.00 ; SOLUTION STRUCTURE OF MTH1692 PROTEIN FROM METHANOBACTERIUM THERMOAUTOTROPHICUM 1TE4 ; -1.00 ; SOLUTION STRUCTURE OF MTH187. ONTARIO CENTRE FOR STRUCTURAL PROTEOMICS TARGET MTH0187_1_111; NORTHEAST STRUCTURAL GENOMICS TARGET TT740 1IQO ; -1.00 ; SOLUTION STRUCTURE OF MTH1880 FROM METHANOBACTERIUM THERMOAUTOTROPHICUM 1FYJ ; -1.00 ; SOLUTION STRUCTURE OF MULTI-FUNCTIONAL PEPTIDE MOTIF-1 PRESENT IN HUMAN GLUTAMYL-PROLYL TRNA SYNTHETASE (EPRS). 1MI2 ; -1.00 ; SOLUTION STRUCTURE OF MURINE MACROPHAGE INFLAMMATORY PROTEIN-2, NMR, 20 STRUCTURES 1FEX ; -1.00 ; SOLUTION STRUCTURE OF MYB-DOMAIN OF HUMAN RAP1 1XG1 ; -1.00 ; SOLUTION STRUCTURE OF MYB-DOMAIN OF HUMAN TRF2 1P4S ; -1.00 ; SOLUTION STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS ADENYLATE KINASE 1G91 ; -1.00 ; SOLUTION STRUCTURE OF MYELOID PROGENITOR INHIBITORY FACTOR- 1 (MPIF-1) 1MYO ; -1.00 ; SOLUTION STRUCTURE OF MYOTROPHIN, NMR, 44 STRUCTURES 2MYO ; -1.00 ; SOLUTION STRUCTURE OF MYOTROPHIN, NMR, MINIMIZED AVERAGE STRUCTURE 1JJG ; -1.00 ; SOLUTION STRUCTURE OF MYXOMA VIRUS PROTEIN M156R 2CS4 ; -1.00 ; SOLUTION STRUCTURE OF N-TERMINAL DOMAIN OF CHROMOSOME 12 OPEN READING FRAME 2 2CR2 ; -1.00 ; SOLUTION STRUCTURE OF N-TERMINAL DOMAIN OF SPECKLE-TYPE POZ PROTEIN 2CSJ ; -1.00 ; SOLUTION STRUCTURE OF N-TERMINAL PDZ DOMAIN FROM MOUSE TJP2 1M30 ; -1.00 ; SOLUTION STRUCTURE OF N-TERMINAL SH3 DOMAIN FROM ONCOGENE PROTEIN C-CRK 1K1Z ; -1.00 ; SOLUTION STRUCTURE OF N-TERMINAL SH3 DOMAIN MUTANT(P33G) OF MURINE VAV 1MR4 ; -1.00 ; SOLUTION STRUCTURE OF NAD1 FROM NICOTIANA ALATA 1UDK ; -1.00 ; SOLUTION STRUCTURE OF NAWAPRIN 1ESK ; -1.00 ; SOLUTION STRUCTURE OF NCP7 FROM HIV-1 1TQZ ; -1.00 ; SOLUTION STRUCTURE OF NECAP1 PROTEIN 1OP4 ; -1.00 ; SOLUTION STRUCTURE OF NEURAL CADHERIN PRODOMAIN 1C98 ; -1.00 ; SOLUTION STRUCTURE OF NEUROMEDIN B 1C9A ; -1.00 ; SOLUTION STRUCTURE OF NEUROMEDIN B 1FMM ; -1.00 ; SOLUTION STRUCTURE OF NFGF-1 1XN6 ; -1.00 ; SOLUTION STRUCTURE OF NORTHEAST STRUCTURAL GENOMICS TARGET PROTEIN BCR68 ENCODED IN GENE Q816V6 OF B. CEREUS 1XPV ; -1.00 ; SOLUTION STRUCTURE OF NORTHEAST STRUCTURAL GENOMICS TARGET PROTEIN XCR50 FROM X. CAMPESTRIS 1L3X ; -1.00 ; SOLUTION STRUCTURE OF NOVEL DISINTEGRIN SALMOSIN 2CR0 ; -1.00 ; SOLUTION STRUCTURE OF NUCLEAR MOVE DOMAIN OF NUCLEAR DISTRIBUTION GENE C 1FJ7 ; -1.00 ; SOLUTION STRUCTURE OF NUCLEOLIN RBD1 1FJE ; -1.00 ; SOLUTION STRUCTURE OF NUCLEOLIN RBD12 IN COMPLEX WITH SNRE RIBONUCLEIC ACID 1FJC ; -1.00 ; SOLUTION STRUCTURE OF NUCLEOLIN RBD2 1OCP ; -1.00 ; SOLUTION STRUCTURE OF OCT3 POU-HOMEODOMAIN 1SS3 ; -1.00 ; SOLUTION STRUCTURE OF OLE E 6, AN ALLERGEN FROM OLIVE TREE POLLEN 1JYT ; -1.00 ; SOLUTION STRUCTURE OF OLFACTORY MARKER PROTEIN FROM RAT 1FYG ; -1.00 ; SOLUTION STRUCTURE OF OMEGA CONOTOXIN SO3 DETERMINED BY 1H- NMR 1FEO ; -1.00 ; SOLUTION STRUCTURE OF OMEGA-CONOTOXIN MVIIA WITH C-TERMINAL GLY 1KOZ ; -1.00 ; SOLUTION STRUCTURE OF OMEGA-GRAMMOTOXIN SIA 1IY6 ; -1.00 ; SOLUTION STRUCTURE OF OMSVP3 VARIANT, P14C/N39C 1EQK ; -1.00 ; SOLUTION STRUCTURE OF ORYZACYSTATIN-I, A CYSTEINE PROTEINASE INHIBITOR OF THE RICE, ORYZA SATIVA L. JAPONICA 1HU5 ; -1.00 ; SOLUTION STRUCTURE OF OVISPIRIN-1 1OMU ; -1.00 ; SOLUTION STRUCTURE OF OVOMUCOID (THIRD DOMAIN) FROM DOMESTIC TURKEY (298K, PH 4.1) (NMR, 50 STRUCTURES) (REFINED MODEL USING NETWORK EDITING ANALYSIS) 1OMT ; -1.00 ; SOLUTION STRUCTURE OF OVOMUCOID (THIRD DOMAIN) FROM DOMESTIC TURKEY (298K, PH 4.1) (NMR, 50 STRUCTURES) (STANDARD NOESY ANALYSIS) 1NX7 ; -1.00 ; SOLUTION STRUCTURE OF OXIDIZED BOVINE MICROSOMAL CYTOCHROME B5 1F03 ; -1.00 ; SOLUTION STRUCTURE OF OXIDIZED BOVINE MICROSOMAL CYTOCHROME B5 MUTANT (E44A, E48A, E56A, D60A) AND ITS INTERACTION WITH CYTOCHROME C 1F04 ; -1.00 ; SOLUTION STRUCTURE OF OXIDIZED BOVINE MICROSOMAL CYTOCHROME B5 MUTANT (E44A, E48A, E56A, D60A) AND ITS INTERACTION WITH CYTOCHROME C 1SH4 ; -1.00 ; SOLUTION STRUCTURE OF OXIDIZED BOVINE MICROSOMAL CYTOCHROME B5 MUTANT V45H 1J0Q ; -1.00 ; SOLUTION STRUCTURE OF OXIDIZED BOVINE MICROSOMAL CYTOCHROME B5 MUTANT V61H 1QPU ; -1.00 ; SOLUTION STRUCTURE OF OXIDIZED ESCHERICHIA COLI CYTOCHROME B562 1AKK ; -1.00 ; SOLUTION STRUCTURE OF OXIDIZED HORSE HEART CYTOCHROME C, NMR, MINIMIZED AVERAGE STRUCTURE 1DO9 ; -1.00 ; SOLUTION STRUCTURE OF OXIDIZED MICROSOMAL RABBIT CYTOCHROME B5. FACTORS DETERMINING THE HETEROGENEOUS BINDING OF THE HEME. 1J5C ; -1.00 ; SOLUTION STRUCTURE OF OXIDIZED PARAMAGNETIC CU(II) PLASTOCYANIN FROM SYNECHOCYSTIS PCC6803 1J5D ; -1.00 ; SOLUTION STRUCTURE OF OXIDIZED PARAMAGNETIC CU(II) PLASTOCYANIN FROM SYNECHOCYSTIS PCC6803-MINIMIZED AVERAGE STRUCTURE 1BLV ; -1.00 ; SOLUTION STRUCTURE OF OXIDIZED RAT MICROSOMAL CYTOCHROME B5 IN THE PRESENCE OF 2 M GUANIDINIUM CHLORIDE: MONITORING THE EARLY STEPS IN PROTEIN UNFOLDING 1NQ4 ; -1.00 ; SOLUTION STRUCTURE OF OXYTETRACYCLINE ACYL CARRIER PROTEIN 1BU9 ; -1.00 ; SOLUTION STRUCTURE OF P18-INK4C, 21 STRUCTURES 1RZS ; -1.00 ; SOLUTION STRUCTURE OF P22 CRO 1GD4 ; -1.00 ; SOLUTION STRUCTURE OF P25S CYSTATIN A 1P8B ; -1.00 ; SOLUTION STRUCTURE OF PA1B, A 37-AMINO ACID INSECTICIDAL PROTEIN EXTRACTED FROM PEA SEEDS (PISUM SATIVUM) 1DKC ; -1.00 ; SOLUTION STRUCTURE OF PAFP-S, AN ANTIFUNGAL PEPTIDE FROM THE SEEDS OF PHYTOLACCA AMERICANA 1IRR ; -1.00 ; SOLUTION STRUCTURE OF PARALYTIC PEPTIDE OF THE SILKWORM, BOMBYX MORI 1V28 ; -1.00 ; SOLUTION STRUCTURE OF PARALYTIC PEPTIDE OF THE WILD SILKMOTH, ANTHERAEA YAMAMAI 1Y76 ; -1.00 ; SOLUTION STRUCTURE OF PATJ/PALS1 L27 DOMAIN COMPLEX 1DNY ; -1.00 ; SOLUTION STRUCTURE OF PCP, A PROTOTYPE FOR THE PEPTIDYL CARRIER DOMAINS OF MODULAR PEPTIDE SYNTHETASES 1WG6 ; -1.00 ; SOLUTION STRUCTURE OF PDZ DOMAIN IN PROTEIN XP_110852 1V5L ; -1.00 ; SOLUTION STRUCTURE OF PDZ DOMAIN OF MOUSE ALPHA-ACTININ-2 ASSOCIATED LIM PROTEIN 1WJL ; -1.00 ; SOLUTION STRUCTURE OF PDZ DOMAIN OF MOUSE CYPHER PROTEIN 2CS5 ; -1.00 ; SOLUTION STRUCTURE OF PDZ DOMAIN OF PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 4 1A4T ; -1.00 ; SOLUTION STRUCTURE OF PHAGE P22 N PEPTIDE-BOX B RIBONUCLEIC ACID COMPLEX, NMR, 20 STRUCTURES 1WEM ; -1.00 ; SOLUTION STRUCTURE OF PHD DOMAIN IN DEATH INDUCER- OBLITERATOR 1(DIO-1) 1WEW ; -1.00 ; SOLUTION STRUCTURE OF PHD DOMAIN IN DEOXYRIBONUCLEIC ACID-BINDING FAMILY PROTEIN AAM98074 1WEU ; -1.00 ; SOLUTION STRUCTURE OF PHD DOMAIN IN ING1-LIKE PROTEIN BAC25009 1WEN ; -1.00 ; SOLUTION STRUCTURE OF PHD DOMAIN IN ING1-LIKE PROTEIN BAC25079 1WES ; -1.00 ; SOLUTION STRUCTURE OF PHD DOMAIN IN INHIBITOR OF GROWTH FAMILY, MEMBER 1-LIKE 1X4I ; -1.00 ; SOLUTION STRUCTURE OF PHD DOMAIN IN LAP4 PROTEIN 1WE9 ; -1.00 ; SOLUTION STRUCTURE OF PHD DOMAIN IN NUCLEIC ACID BINDING PROTEIN-LIKE NP_197993 1WEE ; -1.00 ; SOLUTION STRUCTURE OF PHD DOMAIN IN PHD FINGER FAMILY PROTEIN 1WEQ ; -1.00 ; SOLUTION STRUCTURE OF PHD DOMAIN IN PHD FINGER PROTEIN 7 1WEP ; -1.00 ; SOLUTION STRUCTURE OF PHD DOMAIN IN PHF8 1WEV ; -1.00 ; SOLUTION STRUCTURE OF PHD DOMAIN IN PROTEIN NP_082203 1N3K ; -1.00 ; SOLUTION STRUCTURE OF PHOSPHOPROTEIN ENRICHED IN ASTROCYTES 15 KDA (PEA-15) 1V50 ; -1.00 ; SOLUTION STRUCTURE OF PHOSPHORYLATED N-TERMINAL FRAGMENT OF S100C/A11 PROTEIN 1WJ1 ; -1.00 ; SOLUTION STRUCTURE OF PHOSPHOTYROSINE INTERACTION DOMAIN OF MOUSE NUMB PROTEIN 1QP2 ; -1.00 ; SOLUTION STRUCTURE OF PHOTOSYSTEM I ACCESSORY PROTEIN E FROM THE CYANOBACTERIUM NOSTOC SP. STRAIN PCC 8009 1QP3 ; -1.00 ; SOLUTION STRUCTURE OF PHOTOSYSTEM I ACCESSORY PROTEIN E FROM THE CYANOBACTERIUM NOSTOC SP. STRAIN PCC 8009 1V7F ; -1.00 ; SOLUTION STRUCTURE OF PHRIXOTOXIN 1 1WZ5 ; -1.00 ; SOLUTION STRUCTURE OF PI1-3P 1N8M ; -1.00 ; SOLUTION STRUCTURE OF PI4, A FOUR DISULFIDE BRIDGED SCORPION TOXIN ACTIVE ON POTASSIUM CHANNELS 1QKY ; -1.00 ; SOLUTION STRUCTURE OF PI7, A NON TOXIC PEPTIDE ISOLATED FROM THE SCORPION PANDINUS IMPERATOR. 1I6C ; -1.00 ; SOLUTION STRUCTURE OF PIN1 WW DOMAIN 1I8G ; -1.00 ; SOLUTION STRUCTURE OF PIN1 WW DOMAIN COMPLEXED WITH CDC25 PHOSPHOTHREONINE PEPTIDE 1I8H ; -1.00 ; SOLUTION STRUCTURE OF PIN1 WW DOMAIN COMPLEXED WITH HUMAN TAU PHOSPHOTHREONINE PEPTIDE 1J6Y ; -1.00 ; SOLUTION STRUCTURE OF PIN1AT FROM ARABIDOPSIS THALIANA 1TI5 ; -1.00 ; SOLUTION STRUCTURE OF PLANT DEFENSIN 1L6H ; -1.00 ; SOLUTION STRUCTURE OF PLANT NSLTP2 PURIFIED FROM RICE (ORYZA SATIVA) 1HN6 ; -1.00 ; SOLUTION STRUCTURE OF PLASMODIUM FALCIPARUM APICAL MEMBRANE ANTIGEN 1 (RESIDUES 436-545) 1WG7 ; -1.00 ; SOLUTION STRUCTURE OF PLECKSTRIN HOMOLOGY DOMAIN FROM HUMAN KIAA1058 PROTEIN 1WJM ; -1.00 ; SOLUTION STRUCTURE OF PLECKSTRIN HOMOLOGY DOMAIN OF HUMAN BETA III SPECTRIN. 1ITP ; -1.00 ; SOLUTION STRUCTURE OF POIA1 2AD9 ; -1.00 ; SOLUTION STRUCTURE OF POLYPYRIMIDINE TRACT BINDING PROTEIN RBD1 COMPLEXED WITH CUCUCU RIBONUCLEIC ACID 2ADB ; -1.00 ; SOLUTION STRUCTURE OF POLYPYRIMIDINE TRACT BINDING PROTEIN RBD2 COMPLEXED WITH CUCUCU RIBONUCLEIC ACID 2ADC ; -1.00 ; SOLUTION STRUCTURE OF POLYPYRIMIDINE TRACT BINDING PROTEIN RBD34 COMPLEXED WITH CUCUCU RIBONUCLEIC ACID 1G92 ; -1.00 ; SOLUTION STRUCTURE OF PONERATOXIN 1XHH ; -1.00 ; SOLUTION STRUCTURE OF PORCINE BETA-MICROSEMINOPROTEIN 1RU5 ; -1.00 ; SOLUTION STRUCTURE OF PORCINE PEPTIDE YY (PPYY) 1RUU ; -1.00 ; SOLUTION STRUCTURE OF PORCINE PEPTIDE YY (PPYY) BOUND TO DPC MICELLES 2CRU ; -1.00 ; SOLUTION STRUCTURE OF PROGRAMMED CELL DEATH 5 1KVV ; -1.00 ; SOLUTION STRUCTURE OF PROTEIN SRP19 OF THE ARCHAEOGLOBUS FULGIDUS SIGNAL RECOGNITION PARTICLE, MINIMIZED AVERAGE STRUCTURE 1KVN ; -1.00 ; SOLUTION STRUCTURE OF PROTEIN SRP19 OF THE ARHAEOGLOBUS FULGIDUS SIGNAL RECOGNITION PARTICLE, 10 STRUCTURES 1NY8 ; -1.00 ; SOLUTION STRUCTURE OF PROTEIN YRBA FROM ESCHERICHIA COLI: NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET ER115 1YWY ; -1.00 ; SOLUTION STRUCTURE OF PSEUDOMONAS AERUGINOSA PROTEIN PA2021. THE NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET PAT85. 1LMM ; -1.00 ; SOLUTION STRUCTURE OF PSMALMOTOXIN 1, THE FIRST CHARACTERIZED SPECIFIC BLOCKER OF ASIC1A NA+ CHANNEL 1I26 ; -1.00 ; SOLUTION STRUCTURE OF PTU-1, A TOXIN FROM THE ASSASSIN BUGS PEIRATES TURPIS THAT BLOCKS THE VOLTAGE SENSITIVE CALCIUM CHANNEL N-TYPE 1SBO ; -1.00 ; SOLUTION STRUCTURE OF PUTATIVE ANTI SIGMA FACTOR ANTAGONIST FROM THERMOTOGA MARITIMA (TM1442) 1V9V ; -1.00 ; SOLUTION STRUCTURE OF PUTATIVE DOMAIN OF HUMAN KIAA0561 PROTEIN 1X4Q ; -1.00 ; SOLUTION STRUCTURE OF PWI DOMAIN IN U4/U6 SMALL NUCLEAR RIBONUCLEOPROTEIN PRP3(HPRP3) 2CSK ; -1.00 ; SOLUTION STRUCTURE OF PX DOMAIN FROM HUMAN SNX12 1JI8 ; -1.00 ; SOLUTION STRUCTURE OF PYROBACULUM AEROPHILUM DSRC/GAMMA SUBUNIT OF DISSIMILATORY SULFITE REDUCTASE 1XNE ; -1.00 ; SOLUTION STRUCTURE OF PYROCOCCUS FURIOSUS PROTEIN PF0470: THE NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET PFR14 2REL ; -1.00 ; SOLUTION STRUCTURE OF R-ELAFIN, A SPECIFIC INHIBITOR OF ELASTASE, NMR, 11 STRUCTURES 1K5E ; -1.00 ; SOLUTION STRUCTURE OF R-STYRENE ADDUCT IN THE RAS61 SEQUENCE 1NSH ; -1.00 ; SOLUTION STRUCTURE OF RABBIT APO-S100A11 (19 MODELS) 1WXA ; -1.00 ; SOLUTION STRUCTURE OF RAS-BINDING DOMAIN IN MOUSE AF-6 PROTEIN 1B4C ; -1.00 ; SOLUTION STRUCTURE OF RAT APO-S100B USING DIPOLAR COUPLINGS 1U3O ; -1.00 ; SOLUTION STRUCTURE OF RAT KALIRIN N-TERMINAL SH3 DOMAIN 1JJX ; -1.00 ; SOLUTION STRUCTURE OF RECOMBINANT HUMAN BRAIN-TYPE FATTY ACID BINDING PROTEIN 1JJJ ; -1.00 ; SOLUTION STRUCTURE OF RECOMBINANT HUMAN EPIDERMAL-TYPE FATTY ACID BINDING PROTEIN 1LA3 ; -1.00 ; SOLUTION STRUCTURE OF RECOVERIN MUTANT, E85Q 1BFY ; -1.00 ; SOLUTION STRUCTURE OF REDUCED CLOSTRIDIUM PASTEURIANUM RUBREDOXIN, NMR, 20 STRUCTURES 1JXD ; -1.00 ; SOLUTION STRUCTURE OF REDUCED CU(I) PLASTOCYANIN FROM SYNECHOCYSTIS PCC6803 1JXF ; -1.00 ; SOLUTION STRUCTURE OF REDUCED CU(I) PLASTOCYANIN FROM SYNECHOCYSTIS PCC6803 1LC2 ; -1.00 ; SOLUTION STRUCTURE OF REDUCED HORSE HEART CYTOCHROME C IN 30% ACETONITRILE SOLUTION, NMR 30 STRUCTURES 1LC1 ; -1.00 ; SOLUTION STRUCTURE OF REDUCED HORSE HEART CYTOCHROME C IN 30% ACETONITRILE SOLUTION, NMR MINIMIZED AVERAGE STRUCTURE 2GIW ; -1.00 ; SOLUTION STRUCTURE OF REDUCED HORSE HEART CYTOCHROME C, NMR, 40 STRUCTURES 1GIW ; -1.00 ; SOLUTION STRUCTURE OF REDUCED HORSE HEART CYTOCHROME C, NMR, MINIMIZED AVERAGE STRUCTURE 1AQA ; -1.00 ; SOLUTION STRUCTURE OF REDUCED MICROSOMAL RAT CYTOCHROME B5, NMR, MINIMIZED AVERAGE STRUCTURE 1FO5 ; -1.00 ; SOLUTION STRUCTURE OF REDUCED MJ0307 1J3S ; -1.00 ; SOLUTION STRUCTURE OF REDUCED RECOMBINANT HUMAN CYTOCHROME C 1S34 ; -1.00 ; SOLUTION STRUCTURE OF RESIDUES 907-929 FROM ROUS SARCOMA VIRUS 1JYP ; -1.00 ; SOLUTION STRUCTURE OF RHODOSTOMIN 1U4I ; -1.00 ; SOLUTION STRUCTURE OF RHODOSTOMIN D51E MUTANT 1XAZ ; -1.00 ; SOLUTION STRUCTURE OF RHODOSTOMIN P48A MUTANT 1C54 ; -1.00 ; SOLUTION STRUCTURE OF RIBONUCLEASE SA 2CPZ ; -1.00 ; SOLUTION STRUCTURE OF RIBONUCLEIC ACID BINDING DOMAIN 3 IN CUG TRIPLET REPEAT RIBONUCLEIC ACID-BINDING PROTEIN 1 2CPY ; -1.00 ; SOLUTION STRUCTURE OF RIBONUCLEIC ACID BINDING DOMAIN 3 IN RIBONUCLEIC ACID BINDING MOTIF PROTEIN 12 1WG1 ; -1.00 ; SOLUTION STRUCTURE OF RIBONUCLEIC ACID BINDING DOMAIN IN BAB13405(HOMOLOG EXC-7) 2CQ0 ; -1.00 ; SOLUTION STRUCTURE OF RIBONUCLEIC ACID BINDING DOMAIN IN EUKARYOTIC TRANSLATION INITIATION FACTOR 3 SUBUNIT 4 2CPX ; -1.00 ; SOLUTION STRUCTURE OF RIBONUCLEIC ACID BINDING DOMAIN IN HYPOTHETICAL PROTEIN FLJ11016 2CQ2 ; -1.00 ; SOLUTION STRUCTURE OF RIBONUCLEIC ACID BINDING DOMAIN IN HYPOTHETICAL PROTEIN LOC91801 1WEL ; -1.00 ; SOLUTION STRUCTURE OF RIBONUCLEIC ACID BINDING DOMAIN IN NP_006038 2CQ1 ; -1.00 ; SOLUTION STRUCTURE OF RIBONUCLEIC ACID BINDING DOMAIN IN PTB-LIKE PROTEIN L 2CQ4 ; -1.00 ; SOLUTION STRUCTURE OF RIBONUCLEIC ACID BINDING DOMAIN IN RIBONUCLEIC ACID BINDING MOTIF PROTEIN 23 2CQ3 ; -1.00 ; SOLUTION STRUCTURE OF RIBONUCLEIC ACID BINDING DOMAIN IN RIBONUCLEIC ACID BINDING MOTIF PROTEIN 9 1HS8 ; -1.00 ; SOLUTION STRUCTURE OF RIBONUCLEIC ACID HAIRPIN LOOP UCAAUU AS PART OF HAIRPIN R(GCGUCAAUUCGCA) 1HS4 ; -1.00 ; SOLUTION STRUCTURE OF RIBONUCLEIC ACID HAIRPIN LOOP UUAAAU AS PART OF HAIRPIN R(GCGUUAAAUCGCA) 1HS1 ; -1.00 ; SOLUTION STRUCTURE OF RIBONUCLEIC ACID HAIRPIN LOOP UUAACU AS PART OF HAIRPIN R(GCGUUAACUCGCA) 1HS2 ; -1.00 ; SOLUTION STRUCTURE OF RIBONUCLEIC ACID HAIRPIN LOOP UUAAGU AS PART OF HAIRPIN R(GCGUUAAGUCGCA) 1HS3 ; -1.00 ; SOLUTION STRUCTURE OF RIBONUCLEIC ACID HAIRPIN LOOP UUAAUU AS PART OF HAIRPIN R(GCGUUAAUUCGCA) 1HMJ ; -1.00 ; SOLUTION STRUCTURE OF RIBONUCLEIC ACID POLYMERASE SUBUNIT H 1EIK ; -1.00 ; SOLUTION STRUCTURE OF RIBONUCLEIC ACID POLYMERASE SUBUNIT RPB5 FROM METHANOBACTERIUM THERMOAUTOTROPHICUM 1WKI ; -1.00 ; SOLUTION STRUCTURE OF RIBOSOMAL PROTEIN L16 FROM THERMUS THERMOPHILUS HB8 1OVY ; -1.00 ; SOLUTION STRUCTURE OF RIBOSOMAL PROTEIN L18 FROM BACILLUS STEAROTHERMOPHILUS 1ILY ; -1.00 ; SOLUTION STRUCTURE OF RIBOSOMAL PROTEIN L18 OF THERMUS THERMOPHILUS 1B75 ; -1.00 ; SOLUTION STRUCTURE OF RIBOSOMAL PROTEIN L25 FROM ESCHERICHIA COLI 1RQ6 ; -1.00 ; SOLUTION STRUCTURE OF RIBOSOMAL PROTEIN S17E FROM METHANOBACTERIUM THERMOAUTOTROPHICUM, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET TT802 / ONTARIO CENTER FOR STRUCTURAL PROTEOMICS TARGET MTH0803 1NE3 ; -1.00 ; SOLUTION STRUCTURE OF RIBOSOMAL PROTEIN S28E FROM METHANOBACTERIUM THERMOAUTOTROPHICUM. ONTARIO CENTRE FOR STRUCTURAL PROTEOMICS TARGET MTH0256_1_68; NORTHEAST STRUCTURAL GENOMICS TARGET TT744 1C06 ; -1.00 ; SOLUTION STRUCTURE OF RIBOSOMAL PROTEIN S4 DELTA 41, REFINED WITH DIPOLAR COUPLINGS (ENSEMBLE OF 16 STRUCTURES) 1C05 ; -1.00 ; SOLUTION STRUCTURE OF RIBOSOMAL PROTEIN S4 DELTA 41, REFINED WITH DIPOLAR COUPLINGS (MINIMIZED AVERAGE STRUCTURE) 1L4S ; -1.00 ; SOLUTION STRUCTURE OF RIBOSOME ASSOCIATED FACTOR Y 2A20 ; -1.00 ; SOLUTION STRUCTURE OF RIM2 ZINC FINGER DOMAIN 1X4J ; -1.00 ; SOLUTION STRUCTURE OF RING FINGER IN RING FINGER PROTEIN 38 1WEO ; -1.00 ; SOLUTION STRUCTURE OF RING-FINGER IN THE CATALYTIC SUBUNIT (IRX3) OF CELLULOSE SYNTHASE 1F79 ; -1.00 ; SOLUTION STRUCTURE OF RNASE P RIBONUCLEIC ACID (M1 RIBONUCLEIC ACID) P4 STEM C70U MUTANT OLIGORIBONUCLEOTIDE COMPLEXED WITH COBALT(III) HEXAMMINE, NMR, MINIMIZED AVERAGE STRUCTURE 1F78 ; -1.00 ; SOLUTION STRUCTURE OF RNASE P RIBONUCLEIC ACID (M1 RIBONUCLEIC ACID) P4 STEM OLIGORIBONUCLEOTIDE COMPLEXED WITH COBALT (III) HEXAMINE, NMR, MINIMIZED AVERAGE STRUCTURE 1UFW ; -1.00 ; SOLUTION STRUCTURE OF RNP DOMAIN IN SYNAPTOJANIN 2 1T4N ; -1.00 ; SOLUTION STRUCTURE OF RNT1P DSRBD 1QDP ; -1.00 ; SOLUTION STRUCTURE OF ROBUSTOXIN, THE LETHAL NEUROTOXIN FROM THE FUNNEL WEB SPIDER ATRAX ROBUSTUS, NMR, 20 STRUCTURES 1X5S ; -1.00 ; SOLUTION STRUCTURE OF RRM DOMAIN IN A18 HNRNP 1WEY ; -1.00 ; SOLUTION STRUCTURE OF RRM DOMAIN IN CALCIPRESSIN 1 1X4B ; -1.00 ; SOLUTION STRUCTURE OF RRM DOMAIN IN HETEROGENEOUS NUCLEAR RIBONUCLEAOPROTEINS A2/B1 1WEZ ; -1.00 ; SOLUTION STRUCTURE OF RRM DOMAIN IN HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN H' 1WF2 ; -1.00 ; SOLUTION STRUCTURE OF RRM DOMAIN IN HNRPC PROTEIN 1X4D ; -1.00 ; SOLUTION STRUCTURE OF RRM DOMAIN IN MATRIN 3 1X4G ; -1.00 ; SOLUTION STRUCTURE OF RRM DOMAIN IN NUCLEOLYSIN TIAR 1X5P ; -1.00 ; SOLUTION STRUCTURE OF RRM DOMAIN IN PARP14 1WEX ; -1.00 ; SOLUTION STRUCTURE OF RRM DOMAIN IN PROTEIN BAB28521 1WG4 ; -1.00 ; SOLUTION STRUCTURE OF RRM DOMAIN IN PROTEIN BAB31986 1X5O ; -1.00 ; SOLUTION STRUCTURE OF RRM DOMAIN IN RIBONUCLEIC ACID BINDING MOTIF, SINGLE-STRANDED INTERACTING PROTEIN 1 1X4E ; -1.00 ; SOLUTION STRUCTURE OF RRM DOMAIN IN RIBONUCLEIC ACID BINDING MOTIF, SINGLE-STRANDED INTERACTING PROTEIN 2 1X4H ; -1.00 ; SOLUTION STRUCTURE OF RRM DOMAIN IN RIBONUCLEIC ACID-BINDING PROTEIN 28 1WF1 ; -1.00 ; SOLUTION STRUCTURE OF RRM DOMAIN IN RIBONUCLEIC ACID-BINDING PROTEIN NP_057951 1X4C ; -1.00 ; SOLUTION STRUCTURE OF RRM DOMAIN IN SPLICING FACTOR 2 1X5U ; -1.00 ; SOLUTION STRUCTURE OF RRM DOMAIN IN SPLICING FACTOR 3B 1X4A ; -1.00 ; SOLUTION STRUCTURE OF RRM DOMAIN IN SPLICING FACTOR SF2 1WF0 ; -1.00 ; SOLUTION STRUCTURE OF RRM DOMAIN IN TAR DEOXYRIBONUCLEIC ACID-BINDING PROTEIN- 43 1IYG ; -1.00 ; SOLUTION STRUCTURE OF RSGI RUH-001, A FIS1P-LIKE AND CGI- 135 HOMOLOGOUS DOMAIN FROM A MOUSE CDNA 1UHC ; -1.00 ; SOLUTION STRUCTURE OF RSGI RUH-002, A SH3 DOMAIN OF KIAA1010 PROTEIN [HOMO SAPIENS] 1UJD ; -1.00 ; SOLUTION STRUCTURE OF RSGI RUH-003, A PDZ DOMAIN OF HYPOTHETICAL KIAA0559 PROTEIN FROM HUMAN CDNA 1Q60 ; -1.00 ; SOLUTION STRUCTURE OF RSGI RUH-004, A GTF2I DOMAIN IN MOUSE CDNA 1UHP ; -1.00 ; SOLUTION STRUCTURE OF RSGI RUH-005, A PDZ DOMAIN IN HUMAN CDNA, KIAA1095 1UIT ; -1.00 ; SOLUTION STRUCTURE OF RSGI RUH-006, THE THIRD PDZ DOMAIN OF HDLG5 (KIAA0583) PROTEIN [HOMO SAPIENS] 1UM1 ; -1.00 ; SOLUTION STRUCTURE OF RSGI RUH-007, PDZ DOMAIN IN HUMAN CDNA 1V5J ; -1.00 ; SOLUTION STRUCTURE OF RSGI RUH-008, FN3 DOMAIN IN HUMAN CDNA 1VCS ; -1.00 ; SOLUTION STRUCTURE OF RSGI RUH-009, AN N-TERMINAL DOMAIN OF VTI1A [MUS MUSCULUS] 1SPK ; -1.00 ; SOLUTION STRUCTURE OF RSGI RUH-010, AN SH3 DOMAIN FROM MOUSE CDNA 1VEK ; -1.00 ; SOLUTION STRUCTURE OF RSGI RUH-011, A UBA DOMAIN FROM ARABIDOPSIS CDNA 1VEG ; -1.00 ; SOLUTION STRUCTURE OF RSGI RUH-012, A UBA DOMAIN FROM MOUSE CDNA 1VDL ; -1.00 ; SOLUTION STRUCTURE OF RSGI RUH-013, A UBA DOMAIN IN MOUSE CDNA 1VG5 ; -1.00 ; SOLUTION STRUCTURE OF RSGI RUH-014, A UBA DOMAIN FROM ARABIDOPSIS CDNA 1WJ7 ; -1.00 ; SOLUTION STRUCTURE OF RSGI RUH-015, A UBA DOMAIN FROM MOUSE CDNA 1VEJ ; -1.00 ; SOLUTION STRUCTURE OF RSGI RUH-016, A UBA DOMAIN FROM MOUSE CDNA 1VEH ; -1.00 ; SOLUTION STRUCTURE OF RSGI RUH-018, A NIFU-LIKE DOMAIN OF HIRIP5 PROTEIN FROM MOUSE CDNA 1WIG ; -1.00 ; SOLUTION STRUCTURE OF RSGI RUH-019, A LIM DOMAIN OF ACTIN BINDING LIM PROTEIN 2 (KIAA1808 PROTEIN) FROM HUMAN CDNA 1WIH ; -1.00 ; SOLUTION STRUCTURE OF RSGI RUH-021, A DOMAIN II OF RIBOSOME RECYCLING FACTOR FROM MOUSE CDNA 1WGX ; -1.00 ; SOLUTION STRUCTURE OF RSGI RUH-022, A MYB DEOXYRIBONUCLEIC ACID-BINDING DOMAIN IN HUMAN CDNA 1WIV ; -1.00 ; SOLUTION STRUCTURE OF RSGI RUH-023, A UBA DOMAIN FROM ARABIDOPSIS CDNA 1WJ6 ; -1.00 ; SOLUTION STRUCTURE OF RSGI RUH-024, A PB1 DOMAIN IN HUMAN CDNA, KIAA0049 1WII ; -1.00 ; SOLUTION STRUCTURE OF RSGI RUH-025, A DUF701 DOMAIN FROM MOUSE CDNA 1WHC ; -1.00 ; SOLUTION STRUCTURE OF RSGI RUH-027, A UBA DOMAIN FROM MOUSE CDNA 1WQI ; -1.00 ; SOLUTION STRUCTURE OF RSGI RUH-028, A HOMEOBOX DOMAIN FROM HUMAN CDNA 2CPC ; -1.00 ; SOLUTION STRUCTURE OF RSGI RUH-030, AN IG LIKE DOMAIN FROM HUMAN CDNA 2CPW ; -1.00 ; SOLUTION STRUCTURE OF RSGI RUH-031, A UBA DOMAIN FROM HUMAN CDNA 2CQ7 ; -1.00 ; SOLUTION STRUCTURE OF RSGI RUH-032, A CYSTEIN-RICH DOMAIN OF CRISP-2 FROM HUMAN CDNA 2CQ8 ; -1.00 ; SOLUTION STRUCTURE OF RSGI RUH-033, A PP-BINDING DOMAIN OF 10-FTHFDH FROM HUMAN CDNA 2CQX ; -1.00 ; SOLUTION STRUCTURE OF RSGI RUH-034, A HOMEODOMAIN FROM MOUSE CDNA 2CON ; -1.00 ; SOLUTION STRUCTURE OF RSGI RUH-035, A ZN-RIBBON MODULE IN MOUSE CDNA 2CRE ; -1.00 ; SOLUTION STRUCTURE OF RSGI RUH-036, AN SH3 DOMAIN FROM HUMAN CDNA 2CQQ ; -1.00 ; SOLUTION STRUCTURE OF RSGI RUH-037, A MYB DEOXYRIBONUCLEIC ACID-BINDING DOMAIN IN HUMAN CDNA 2COS ; -1.00 ; SOLUTION STRUCTURE OF RSGI RUH-038, A UBA DOMAIN FROM MOUSE LATS2 (LARGE TUMOR SUPPRESSOR HOMOLOG 2) 2CQA ; -1.00 ; SOLUTION STRUCTURE OF RSGI RUH-039, A FRAGMENT OF C- TERMINAL DOMAIN OF RUVB-LIKE 2 FROM HUMAN CDNA 2COP ; -1.00 ; SOLUTION STRUCTURE OF RSGI RUH-040, AN ACBP DOMAIN FROM HUMAN CDNA 2CQW ; -1.00 ; SOLUTION STRUCTURE OF RSGI RUH-041, A SMB-LIKE DOMAIN FROM MOUSE CDNA 2CP9 ; -1.00 ; SOLUTION STRUCTURE OF RSGI RUH-042, A UBA DOMAIN FROM HUMAN MITOCHONDRIAL ELONGATION FACTOR TS 2CQR ; -1.00 ; SOLUTION STRUCTURE OF RSGI RUH-043, A MYB DEOXYRIBONUCLEIC ACID-BINDING DOMAIN IN HUMAN CDNA 2CQ9 ; -1.00 ; SOLUTION STRUCTURE OF RSGI RUH-044, AN N-TERMINAL DOMAIN OF GLUTAREDOXIN 2 FROM HUMAN CDNA 2CQU ; -1.00 ; SOLUTION STRUCTURE OF RSGI RUH-045, A HUMAN ACYL-COA BINDING PROTEIN 1P68 ; -1.00 ; SOLUTION STRUCTURE OF S-824, A DE NOVO DESIGNED FOUR HELIX BUNDLE 1YX5 ; -1.00 ; SOLUTION STRUCTURE OF S5A UIM-1/UBIQUITIN COMPLEX 1YX6 ; -1.00 ; SOLUTION STRUCTURE OF S5A UIM-2/UBIQUITIN COMPLEX 1UGL ; -1.00 ; SOLUTION STRUCTURE OF S8-SP11 1L4V ; -1.00 ; SOLUTION STRUCTURE OF SAPECIN 2CUQ ; -1.00 ; SOLUTION STRUCTURE OF SECOND LIM DOMAIN FROM HUMAN SKELETAL MUSCLE LIM-PROTEIN 2 1QK7 ; -1.00 ; SOLUTION STRUCTURE OF SELENOCOSMIA HUWENA LECTIN-I(SHL-I) BY 2D-NMR 2A2P ; -1.00 ; SOLUTION STRUCTURE OF SELM FROM MUS MUSCULUS 1SS6 ; -1.00 ; SOLUTION STRUCTURE OF SEP DOMAIN FROM HUMAN P47 2A4H ; -1.00 ; SOLUTION STRUCTURE OF SEP15 FROM DROSOPHILA MELANOGASTER 1O8Z ; -1.00 ; SOLUTION STRUCTURE OF SFTI-1(6,5), AN ACYCLIC PERMUTANT OF THE PROTEINASE INHIBITOR SFTI-1, CIS-TRANS-TRANS CONFORMER (CT-A) 1O8Y ; -1.00 ; SOLUTION STRUCTURE OF SFTI-1(6,5), AN ACYCLIC PERMUTANT OF THE PROTEINASE INHIBITOR SFTI-1, TRANS-TRANS-TRANS CONFORMER (TT-A) 1JBL ; -1.00 ; SOLUTION STRUCTURE OF SFTI-1, A CYCLIC TRYPSIN INHIBITOR FROM SUNFLOWER SEEDS 1LA4 ; -1.00 ; SOLUTION STRUCTURE OF SGTX1 1UJY ; -1.00 ; SOLUTION STRUCTURE OF SH3 DOMAIN IN RAC/CDC42 GUANINE NUCLEOTIDE EXCHANGE FACTOR(GEF) 6 1WFW ; -1.00 ; SOLUTION STRUCTURE OF SH3 DOMAIN OF MOUSE KALIRIN-9A PROTEIN 1TTY ; -1.00 ; SOLUTION STRUCTURE OF SIGMA A REGION 4 FROM THERMOTOGA MARITIMA 2CUR ; -1.00 ; SOLUTION STRUCTURE OF SKELETAL MUSCLE LIM-PROTEIN 1 1ON4 ; -1.00 ; SOLUTION STRUCTURE OF SOLUBLE DOMAIN OF SCO1 FROM BACILLUS SUBTILIS 1UT3 ; -1.00 ; SOLUTION STRUCTURE OF SPHENISCIN-2, A BETA-DEFENSIN FROM PENGUIN STOMACH PRESERVING FOOD 1ZRW ; -1.00 ; SOLUTION STRUCTURE OF SPINIGERIN IN H20/TFE 10% 1ZRV ; -1.00 ; SOLUTION STRUCTURE OF SPINIGERIN IN H20/TFE 50% 1BUZ ; -1.00 ; SOLUTION STRUCTURE OF SPOIIAA, A PHOSPHORYLATABLE COMPONENT OF THE SYSTEM THAT REGULATES TRANSCRIPTION FACTOR SIGMA-F OF BACILLUS SUBTILIS NMR, MINIMIZED AVERAGE STRUCTURE 1AUZ ; -1.00 ; SOLUTION STRUCTURE OF SPOIIAA, A PHOSPHORYLATABLE COMPONENT OF THE SYSTEM THAT REGULATES TRANSCRIPTION FACTOR SIGMA-F OF BACILLUS SUBTILIS, NMR, 24 STRUCTURES 1EWW ; -1.00 ; SOLUTION STRUCTURE OF SPRUCE BUDWORM ANTIFREEZE PROTEIN AT 30 DEGREES CELSIUS 1N4I ; -1.00 ; SOLUTION STRUCTURE OF SPRUCE BUDWORM ANTIFREEZE PROTEIN AT 5 DEGREES CELSIUS 1LWA ; -1.00 ; SOLUTION STRUCTURE OF SRY_DNA 1N2Y ; -1.00 ; SOLUTION STRUCTURE OF SS-CYCLIZED CATESTATIN FRAGMENT FROM CHROMOGRANIN A 1R83 ; -1.00 ; SOLUTION STRUCTURE OF SSO7D MUTANT (K12L), NMR, 4 STRUCTURES 1XXZ ; -1.00 ; SOLUTION STRUCTURE OF SST1-SELECTIVE SOMATOSTATIN (SRIF) ANALOG 1OH1 ; -1.00 ; SOLUTION STRUCTURE OF STAPHOSTATIN A FORM STAPHYLOCOCCUS AUREUS CONFIRMS THE DISCOVERY OF A NOVEL CLASS OF CYSTEINE PROTEINASE INHIBITORS. 1ZRX ; -1.00 ; SOLUTION STRUCTURE OF STOMOXYN IN H20/TFE 50% 1V4R ; -1.00 ; SOLUTION STRUCTURE OF STREPTMYCAL REPRESSOR TRAR 1SDF ; -1.00 ; SOLUTION STRUCTURE OF STROMAL CELL-DERIVED FACTOR-1 (SDF-1), NMR, MINIMIZED AVERAGE STRUCTURE 1WU0 ; -1.00 ; SOLUTION STRUCTURE OF SUBUNIT C OF F1FO-ATP SYNTHASE FROM THE THERMOPHILIC BACILLUS PS3 1VZS ; -1.00 ; SOLUTION STRUCTURE OF SUBUNIT F6 FROM THE PERIPHERAL STALK REGION OF ATP SYNTHASE FROM BOVINE HEART MITOCHONDRIA 2ASQ ; -1.00 ; SOLUTION STRUCTURE OF SUMO-1 IN COMPLEX WITH A SUMO-BINDING MOTIF (SBM) 1UG0 ; -1.00 ; SOLUTION STRUCTURE OF SURP DOMAIN IN BAB30904 1X4P ; -1.00 ; SOLUTION STRUCTURE OF SURP DOMAIN IN SFRS14 PROTEI 1X4O ; -1.00 ; SOLUTION STRUCTURE OF SURP DOMAIN IN SPLICING FACTOR 4 2CUJ ; -1.00 ; SOLUTION STRUCTURE OF SWIRM DOMAIN OF MOUSE TRANSCRIPTIONAL ADAPTOR 2-LIKE 1NLA ; -1.00 ; SOLUTION STRUCTURE OF SWITCH ARC, A MUTANT WITH 3(10) HELICES REPLACING A WILD-TYPE BETA-RIBBON 1S4T ; -1.00 ; SOLUTION STRUCTURE OF SYNTHETIC 21MER PEPTIDE SPANNING REGION 135-155 (IN HUMAN NUMBERING) OF SHEEP PRION PROTEIN 1G04 ; -1.00 ; SOLUTION STRUCTURE OF SYNTHETIC 26-MER PEPTIDE CONTAINING 145-169 SHEEP PRION PROTEIN SEGMENT AND C-TERMINAL CYSTEINE 1IM7 ; -1.00 ; SOLUTION STRUCTURE OF SYNTHETIC CYCLIC PEPTIDE MIMICKING THE LOOP OF HIV-1 GP41 GLYCOPROTEIN ENVELOPE 1ID7 ; -1.00 ; SOLUTION STRUCTURE OF SYR6 1Q68 ; -1.00 ; SOLUTION STRUCTURE OF T-CELL SURFACE GLYCOPROTEIN CD4 AND PROTO-ONCOGENE TYROSINE-PROTEIN KINASE LCK FRAGMENTS 1Q69 ; -1.00 ; SOLUTION STRUCTURE OF T-CELL SURFACE GLYCOPROTEIN CD8 ALPHA CHAIN AND PROTO-ONCOGENE TYROSINE-PROTEIN KINASE LCK FRAGMENTS 1TKV ; -1.00 ; SOLUTION STRUCTURE OF T4 ASIA DIMER 1TL6 ; -1.00 ; SOLUTION STRUCTURE OF T4 BACTERIPHAGE ASIA MONOMER 1SJG ; -1.00 ; SOLUTION STRUCTURE OF T4MOC, THE RIESKE FERREDOXIN COMPONENT OF THE TOLUENE 4-MONOOXYGENASE COMPLEX 1HU7 ; -1.00 ; SOLUTION STRUCTURE OF T7 NOVISPIRIN 1DQC ; -1.00 ; SOLUTION STRUCTURE OF TACHYCITIN, AN ANTIMICROBIAL PROTEIN WITH CHITIN-BINDING FUNCTION 1WO0 ; -1.00 ; SOLUTION STRUCTURE OF TACHYPLESIN I IN H2O 1MA4 ; -1.00 ; SOLUTION STRUCTURE OF TACHYPLESIN I MUTANT TPY4 IN WATER 1XUT ; -1.00 ; SOLUTION STRUCTURE OF TACI-CRD2 2CS8 ; -1.00 ; SOLUTION STRUCTURE OF TANDEM REPEAT OF THE FIFTH AND SIXTH ZINC-FINGER C2HC DOMAINS FROM HUMAN ST18 2CSH ; -1.00 ; SOLUTION STRUCTURE OF TANDEM REPEAT OF THE ZF-C2H2 DOMAINS OF HUMAN ZINC FINGER PROTEIN 297B 1Q0V ; -1.00 ; SOLUTION STRUCTURE OF TANDEM UIMS OF VPS27 1MM0 ; -1.00 ; SOLUTION STRUCTURE OF TERMICIN, AN ANTIMICROBIAL PEPTIDE FROM THE TERMITE PSEUDACANTHOTERMES SPINIGER 1TLR ; -1.00 ; SOLUTION STRUCTURE OF TETRALOOP RECEPTOR RIBONUCLEIC ACID, NMR, 20 STRUCTURES 1KLC ; -1.00 ; SOLUTION STRUCTURE OF TGF-B1, NMR, MINIMIZED AVERAGE STRUCTURE 1KLA ; -1.00 ; SOLUTION STRUCTURE OF TGF-B1, NMR, MODELS 1-17 OF 33 STRUCTURES 1KLD ; -1.00 ; SOLUTION STRUCTURE OF TGF-B1, NMR, MODELS 18-33 OF 33 STRUCTURES 2CTK ; -1.00 ; SOLUTION STRUCTURE OF THE 12TH KH TYPE I DOMAIN FROM HUMAN VIGILIN 2CTL ; -1.00 ; SOLUTION STRUCTURE OF THE 13TH KH TYPE I DOMAIN FROM HUMAN VIGILIN 2CTM ; -1.00 ; SOLUTION STRUCTURE OF THE 14TH KH TYPE I DOMAIN FROM HUMAN VIGILIN 1UVG ; -1.00 ; SOLUTION STRUCTURE OF THE 15TH DOMAIN OF LEKTI 1IR5 ; -1.00 ; SOLUTION STRUCTURE OF THE 17MER TF1 BINDING SITE 1T17 ; -1.00 ; SOLUTION STRUCTURE OF THE 18 KDA PROTEIN CC1736 FROM CAULOBACTER CRESCENTUS: THE NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET CCR19 2CP2 ; -1.00 ; SOLUTION STRUCTURE OF THE 1ST CAP-GLY DOMAIN IN HUMAN CLIP- 115/CYLN2 2CP0 ; -1.00 ; SOLUTION STRUCTURE OF THE 1ST CAP-GLY DOMAIN IN HUMAN CLIP- 170-RELATED PROTEIN CLIPR59 2CP5 ; -1.00 ; SOLUTION STRUCTURE OF THE 1ST CAP-GLY DOMAIN IN HUMAN CLIP- 170/RESTIN 1WHL ; -1.00 ; SOLUTION STRUCTURE OF THE 1ST CAP-GLY DOMAIN IN HUMAN CYLINDROMATOSIS TUMOR SUPPRESSOR CYLD 1WHJ ; -1.00 ; SOLUTION STRUCTURE OF THE 1ST CAP-GLY DOMAIN IN MOUSE 1700024K14RIK HYPOTHETICAL PROTEIN 2CP7 ; -1.00 ; SOLUTION STRUCTURE OF THE 1ST CAP-GLY DOMAIN IN MOUSE CLIP- 170/RESTIN 2CTE ; -1.00 ; SOLUTION STRUCTURE OF THE 1ST KH TYPE I DOMAIN FROM HUMAN VIGILIN 1X3V ; -1.00 ; SOLUTION STRUCTURE OF THE 1ST SH3 DOMAIN FROM HUMAN NEUTROPHIL CYTOSOL FACTOR 2 (NCF-2) 1H7J ; -1.00 ; SOLUTION STRUCTURE OF THE 26 AA PRESEQUENCE OF 5-ALAS 2CP3 ; -1.00 ; SOLUTION STRUCTURE OF THE 2ND CAP-GLY DOMAIN IN HUMAN CLIP- 115/CYLN2 2CP6 ; -1.00 ; SOLUTION STRUCTURE OF THE 2ND CAP-GLY DOMAIN IN HUMAN CLIP- 170/RESTIN 1WHM ; -1.00 ; SOLUTION STRUCTURE OF THE 2ND CAP-GLY DOMAIN IN HUMAN CYLINDROMATOSIS TUMOR SUPPRESSOR CYLD 1WHH ; -1.00 ; SOLUTION STRUCTURE OF THE 2ND CAP-GLY DOMAIN IN MOUSE CLIP170-RELATED 59KDA PROTEIN CLIPR-59 1X4Z ; -1.00 ; SOLUTION STRUCTURE OF THE 2ND FIBRONECTIN TYPE III DOMAIN FROM MOUSE BIREGIONAL CELL ADHESION MOLECULE-RELATED/DOWN- REGULATED ONCOGENES (CDON) BINDING PROTEIN 1WJR ; -1.00 ; SOLUTION STRUCTURE OF THE 2ND MBT DOMAIN FROM HUMAN KIAA1617 PROTEIN 1MM2 ; -1.00 ; SOLUTION STRUCTURE OF THE 2ND PHD DOMAIN FROM MI2B 1MM3 ; -1.00 ; SOLUTION STRUCTURE OF THE 2ND PHD DOMAIN FROM MI2B WITH C- TERMINAL LOOP REPLACED BY CORRESPONDING LOOP FROM WSTF 1WFE ; -1.00 ; SOLUTION STRUCTURE OF THE 2ND ZF-AN1 DOMAIN OF MOUSE RIKEN CDNA 2310008M20 PROTEIN 1YBN ; -1.00 ; SOLUTION STRUCTURE OF THE 3'E TOPOLOGY OF THE I-MOTIF TETRAMER OF D(CCCCAA) 1QXN ; -1.00 ; SOLUTION STRUCTURE OF THE 30 KDA POLYSULFIDE-SULFUR TRANSFERASE HOMODIMER FROM WOLINELLA SUCCINOGENES 1NY4 ; -1.00 ; SOLUTION STRUCTURE OF THE 30S RIBOSOMAL PROTEIN S28E FROM PYROCOCCUS HORIKOSHII. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET JR19. 2CUH ; -1.00 ; SOLUTION STRUCTURE OF THE 31ST FIBRONECTIN TYPE III DOMAIN OF THE HUMAN TENASCIN X 2CUI ; -1.00 ; SOLUTION STRUCTURE OF THE 31ST FIBRONECTIN TYPE III DOMAIN OF THE HUMAN TENASCIN X 1N9J ; -1.00 ; SOLUTION STRUCTURE OF THE 3D DOMAIN SWAPPED DIMER OF STEFIN A 1WHK ; -1.00 ; SOLUTION STRUCTURE OF THE 3RD CAP-GLY DOMAIN IN MOUSE 1700024K14RIK HYPOTHETICAL PROTEIN 1X4Y ; -1.00 ; SOLUTION STRUCTURE OF THE 3RD FIBRONECTIN TYPE III DOMAIN FROM MOUSE BIREGIONAL CELL ADHESION MOLECULE-RELATED/DOWN- REGULATED ONCOGENES (CDON) BINDING PROTEIN 1V64 ; -1.00 ; SOLUTION STRUCTURE OF THE 3RD HMG BOX OF MOUSE UBF1 1V62 ; -1.00 ; SOLUTION STRUCTURE OF THE 3RD PDZ DOMAIN OF GRIP2 1H7D ; -1.00 ; SOLUTION STRUCTURE OF THE 49 AA PRESEQUENCE OF 5-ALAS 1WGF ; -1.00 ; SOLUTION STRUCTURE OF THE 4TH HMG-BOX OF MOUSE UBF1 2CTF ; -1.00 ; SOLUTION STRUCTURE OF THE 4TH KH TYPE I DOMAIN FROM HUMAN VIGILIN 1YBR ; -1.00 ; SOLUTION STRUCTURE OF THE 5'E TOPOLOGY OF THE I-MOTIF TETRAMER OF D(CCCCAA) 1SQR ; -1.00 ; SOLUTION STRUCTURE OF THE 50S RIBOSOMAL PROTEIN L35AE FROM PYROCOCCUS FURIOSUS. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET PFR48. 1X4X ; -1.00 ; SOLUTION STRUCTURE OF THE 6TH FIBRONECTIN TYPE III DOMAIN FROM HUMAN FIBRONECTIN TYPE III DOMAIN CONTAINING PROTEIN 3 1V63 ; -1.00 ; SOLUTION STRUCTURE OF THE 6TH HMG BOX OF MOUSE UBF1 1MK6 ; -1.00 ; SOLUTION STRUCTURE OF THE 8,9-DIHYDRO-8-(N7-GUANYL)-9- HYDROXY-AFLATOXIN B1 ADDUCT MISPAIRED WITH DEOXYADENOSINE 2CTJ ; -1.00 ; SOLUTION STRUCTURE OF THE 8TH KH TYPE I DOMAIN FROM HUMAN VIGILIN 1I3X ; -1.00 ; SOLUTION STRUCTURE OF THE A LOOP OF 23S RIBOSOMAL RIBONUCLEIC ACID 1I3Y ; -1.00 ; SOLUTION STRUCTURE OF THE A LOOP OF 23S RIBOSOMAL RIBONUCLEIC ACID. 1E9J ; -1.00 ; SOLUTION STRUCTURE OF THE A-SUBUNIT OF HUMAN CHORIONIC GONADOTROPIN [INCLUDING A SINGLE GLCNAC RESIDUE AT ASN52 AND ASN78] 1HD4 ; -1.00 ; SOLUTION STRUCTURE OF THE A-SUBUNIT OF HUMAN CHORIONIC GONADOTROPIN [MODELED WITH DIANTENNARY GLYCAN AT ASN78] 1DZ7 ; -1.00 ; SOLUTION STRUCTURE OF THE A-SUBUNIT OF HUMAN CHORIONIC GONADOTROPIN [MODELED WITHOUT CARBOHYDRATE RESIDUES] 1TJZ ; -1.00 ; SOLUTION STRUCTURE OF THE ACTIVE SITE STEM-LOOP OF THE VS RIBOZYME 1TXE ; -1.00 ; SOLUTION STRUCTURE OF THE ACTIVE-CENTRE MUTANT ILE14ALA OF THE HISTIDINE-CONTAINING PHOSPHOCARRIER PROTEIN (HPR) FROM STAPHYLOCOCCUS CARNOSUS 1ORX ; -1.00 ; SOLUTION STRUCTURE OF THE ACYCLIC PERMUTANT DES-(24-28)- KALATA B1. 1GJS ; -1.00 ; SOLUTION STRUCTURE OF THE ALBUMIN BINDING DOMAIN OF STREPTOCOCCAL PROTEIN G 1GJT ; -1.00 ; SOLUTION STRUCTURE OF THE ALBUMIN BINDING DOMAIN OF STREPTOCOCCAL PROTEIN G 1M0G ; -1.00 ; SOLUTION STRUCTURE OF THE ALPHA DOMAIN OF MT_NC 1DFS ; -1.00 ; SOLUTION STRUCTURE OF THE ALPHA-DOMAIN OF MOUSE METALLOTHIONEIN-1 1JI9 ; -1.00 ; SOLUTION STRUCTURE OF THE ALPHA-DOMAIN OF MOUSE METALLOTHIONEIN-3 1WHU ; -1.00 ; SOLUTION STRUCTURE OF THE ALPHA-HELICAL DOMAIN FROM MOUSE HYPOTHETICAL PNPASE 1Q7X ; -1.00 ; SOLUTION STRUCTURE OF THE ALTERNATIVELY SPLICED PDZ2 DOMAIN (PDZ2B) OF PTP-BAS (HPTP1E) 1IYT ; -1.00 ; SOLUTION STRUCTURE OF THE ALZHEIMER'S DISEASE AMYLOID BETA- PEPTIDE (1-42) 1C95 ; -1.00 ; SOLUTION STRUCTURE OF THE AMINOACYL-CAPPED OLIGODEOXYRIBONUCLEOTIDE DUPLEX TRP-D(TGCGCAC)2 1KDL ; -1.00 ; SOLUTION STRUCTURE OF THE AMPHIPATHIC DOMAIN OF YOPD FROM YERSINIA 1CW8 ; -1.00 ; SOLUTION STRUCTURE OF THE ANALOGUE RETRO-INVERSO (MA-R) REGRIGGC IN CONTACT WITH THE MONOCLONAL ANTIBODY MAB 4X11, NMR, 6 STRUCTURES 1CWZ ; -1.00 ; SOLUTION STRUCTURE OF THE ANALOGUE RETRO-INVERSO (MA-S) REGRIGGC IN CONTACT WITH THE MONOCLONAL ANTIBODY MAB 4X11, NMR, 7 STRUCTURES 1CVQ ; -1.00 ; SOLUTION STRUCTURE OF THE ANALOGUE RETRO-INVERSO MGREGRIGGC IN CONTACT WITH THE MONOCLONAL ANTIBODY MAB 4X11, NMR, 7 STRUCTURES 1YSW ; -1.00 ; SOLUTION STRUCTURE OF THE ANTI-APOPTOTIC PROTEIN BCL-2 COMPLEXED WITH AN ACYL-SULFONAMIDE-BASED LIGAND 1YSN ; -1.00 ; SOLUTION STRUCTURE OF THE ANTI-APOPTOTIC PROTEIN BCL-XL COMPLEXED WITH AN ACYL-SULFONAMIDE-BASED LIGAND 1YSG ; -1.00 ; SOLUTION STRUCTURE OF THE ANTI-APOPTOTIC PROTEIN BCL-XL IN COMPLEX WITH "SAR BY NMR" LIGANDS 1YSI ; -1.00 ; SOLUTION STRUCTURE OF THE ANTI-APOPTOTIC PROTEIN BCL-XL IN COMPLEX WITH AN ACYL-SULFONAMIDE-BASED LIGAND 1JR5 ; -1.00 ; SOLUTION STRUCTURE OF THE ANTI-SIGMA FACTOR ASIA HOMODIMER 1B03 ; -1.00 ; SOLUTION STRUCTURE OF THE ANTIBODY-BOUND HIV-1IIIB V3 PEPTIDE 1NYO ; -1.00 ; SOLUTION STRUCTURE OF THE ANTIGENIC TB PROTEIN MPT70/MPB70 1KFP ; -1.00 ; SOLUTION STRUCTURE OF THE ANTIMICROBIAL 18-RESIDUE GOMESIN 1QJT ; -1.00 ; SOLUTION STRUCTURE OF THE APO EH1 DOMAIN OF MOUSE EPIDERMAL GROWTH FACTOR RECEPTOR SUBSTRATE 15, EPS15 1Y3K ; -1.00 ; SOLUTION STRUCTURE OF THE APO FORM OF THE FIFTH DOMAIN OF MENKES PROTEIN 1FES ; -1.00 ; SOLUTION STRUCTURE OF THE APO FORM OF THE YEAST METALLOCHAPERONE, ATX1 1F54 ; -1.00 ; SOLUTION STRUCTURE OF THE APO N-TERMINAL DOMAIN OF YEAST CALMODULIN 1GH8 ; -1.00 ; SOLUTION STRUCTURE OF THE ARCHAEAL TRANSLATION ELONGATION FACTOR 1BETA FROM METHANOBACTERIUM THERMOAUTOTROPHICUM 2CRW ; -1.00 ; SOLUTION STRUCTURE OF THE ARFGAP DOMAIN OF ADP-RIBOSYLATION FACTOR GTPASEACTIVATING PROTEIN 3 (ARFGAP 3) 1EJ5 ; -1.00 ; SOLUTION STRUCTURE OF THE AUTOINHIBITED CONFORMATION OF WASP 1V52 ; -1.00 ; SOLUTION STRUCTURE OF THE B' DOMAIN OF THERMOPHILIC FUNGAL PROTEIN DISULFIDE ISOMERASE 1LAI ; -1.00 ; SOLUTION STRUCTURE OF THE B-DEOXYRIBONUCLEIC ACID DUPLEX CGCGGTGTCCGCG. 1LAQ ; -1.00 ; SOLUTION STRUCTURE OF THE B-DEOXYRIBONUCLEIC ACID DUPLEX CGCGGTXTCCGCG (XPDG) CONTAINING THE 1,N2-PROPANODEOXYGUANOSINE ADDUCT WITH THE DEOXYRIBOSE AT C20 OPPOSITE PDG IN THE C2' ENDO CONFORMATION. 1LAS ; -1.00 ; SOLUTION STRUCTURE OF THE B-DEOXYRIBONUCLEIC ACID DUPLEX CGCGGTXTCCGCG (XPDG) CONTAINING THE 1,N2-PROPANODEOXYGUANOSINE ADDUCT WITH THE DEOXYRIBOSE AT C20 OPPOSITE PDG IN THE C3' ENDO CONFORMATION. 1X95 ; -1.00 ; SOLUTION STRUCTURE OF THE B-DEOXYRIBONUCLEIC ACID HEXAMER ATGCAT COMPLEXED WITH MLN944, A BISPHENAZINE ANTICANCER DRUG 1WID ; -1.00 ; SOLUTION STRUCTURE OF THE B3 DEOXYRIBONUCLEIC ACID-BINDING DOMAIN OF RAV1 1SOY ; -1.00 ; SOLUTION STRUCTURE OF THE BACTERIAL FRATAXIN ORTHOLOGUE, CYAY 1NYB ; -1.00 ; SOLUTION STRUCTURE OF THE BACTERIOPHAGE PHI21 N PEPTIDE- BOXB RIBONUCLEIC ACID COMPLEX 1M62 ; -1.00 ; SOLUTION STRUCTURE OF THE BAG DOMAIN FROM BAG4/SODD 1WIN ; -1.00 ; SOLUTION STRUCTURE OF THE BAND 7 DOMAIN OF THE MOUSE FLOTILLIN 2 PROTEIN 1M0J ; -1.00 ; SOLUTION STRUCTURE OF THE BETA DOMAIN OF MT_NC 1DFT ; -1.00 ; SOLUTION STRUCTURE OF THE BETA-DOMAIN OF MOUSE METALLOTHIONEIN-1 1Q59 ; -1.00 ; SOLUTION STRUCTURE OF THE BHRF1 PROTEIN FROM EPSTEIN-BARR VIRUS, A HOMOLOG OF HUMAN BCL-2 1XAV ; -1.00 ; SOLUTION STRUCTURE OF THE BIOLOGICALLY RELEVANT G- QUADRUPLEX ELEMENT IN THE HUMAN C-MYC PROMOTER. 1H4B ; -1.00 ; SOLUTION STRUCTURE OF THE BIRCH POLLEN ALLERGEN BET V 4 2BUN ; -1.00 ; SOLUTION STRUCTURE OF THE BLUF DOMAIN OF APPA 5-125 1XFR ; -1.00 ; SOLUTION STRUCTURE OF THE BOMBYX MORI PHEROMONE-BINDING PROTEIN FRAGMENT BMPBP(1-128) AT PH 6.5 1JM7 ; -1.00 ; SOLUTION STRUCTURE OF THE BRCA1/BARD1 RING-DOMAIN HETERODIMER 1OQA ; -1.00 ; SOLUTION STRUCTURE OF THE BRCT-C DOMAIN FROM HUMAN BRCA1 1X3A ; -1.00 ; SOLUTION STRUCTURE OF THE BSD DOMAIN OF THE SYNAPSE ASSOCIATED PROTEIN 1 1M8B ; -1.00 ; SOLUTION STRUCTURE OF THE C STATE OF TURKEY OVOMUCOID AT PH 2.5 1F6V ; -1.00 ; SOLUTION STRUCTURE OF THE C TERMINAL OF MU B TRANSPOSITION PROTEIN 1R48 ; -1.00 ; SOLUTION STRUCTURE OF THE C-TERMINAL CYTOPLASMIC DOMAIN RESIDUES 468-497 OF ESCHERICHIA COLI PROTEIN PROP 2A4J ; -1.00 ; SOLUTION STRUCTURE OF THE C-TERMINAL DOMAIN (T94-Y172) OF THE HUMAN CENTRIN 2 IN COMPLEX WITH A 17 RESIDUES PEPTIDE (P1-XPC) FROM XERODERMA PIGMENTOSUM GROUP C PROTEIN 2GAT ; -1.00 ; SOLUTION STRUCTURE OF THE C-TERMINAL DOMAIN OF CHICKEN GATA-1 BOUND TO DEOXYRIBONUCLEIC ACID, NMR, REGULARIZED MEAN STRUCTURE 1QW1 ; -1.00 ; SOLUTION STRUCTURE OF THE C-TERMINAL DOMAIN OF DTXR RESIDUES 110-226 1Z00 ; -1.00 ; SOLUTION STRUCTURE OF THE C-TERMINAL DOMAIN OF ERCC1 COMPLEXED WITH THE C-TERMINAL DOMAIN OF XPF 1DPU ; -1.00 ; SOLUTION STRUCTURE OF THE C-TERMINAL DOMAIN OF HUMAN RPA32 COMPLEXED WITH UNG2(73-88) 1RG6 ; -1.00 ; SOLUTION STRUCTURE OF THE C-TERMINAL DOMAIN OF P63 1WJW ; -1.00 ; SOLUTION STRUCTURE OF THE C-TERMINAL DOMAIN OF PHOSPHOACETYLGLUCOSAMINE MUTASE (PAGM) 1J3C ; -1.00 ; SOLUTION STRUCTURE OF THE C-TERMINAL DOMAIN OF THE HMGB2 1J3D ; -1.00 ; SOLUTION STRUCTURE OF THE C-TERMINAL DOMAIN OF THE HMGB2 1PBU ; -1.00 ; SOLUTION STRUCTURE OF THE C-TERMINAL DOMAIN OF THE HUMAN EEF1BGAMMA SUBUNIT 1Q6A ; -1.00 ; SOLUTION STRUCTURE OF THE C-TERMINAL DOMAIN OF THERMOSYNECHOCOCCUS ELONGATUS KAIA (THKAIA180C); AVERAGED MINIMIZED STRUCTURE 1Q6B ; -1.00 ; SOLUTION STRUCTURE OF THE C-TERMINAL DOMAIN OF THERMOSYNECHOCOCCUS ELONGATUS KAIA (THKAIA180C); ENSEMBLE OF 25 STRUCTURES 1KFT ; -1.00 ; SOLUTION STRUCTURE OF THE C-TERMINAL DOMAIN OF UVRC FROM E- COLI 1M39 ; -1.00 ; SOLUTION STRUCTURE OF THE C-TERMINAL FRAGMENT (F86-I165) OF THE HUMAN CENTRIN 2 IN CALCIUM SATURATED FORM 1X50 ; -1.00 ; SOLUTION STRUCTURE OF THE C-TERMINAL GAL-BIND LECTIN DOMAIN FROM HUMAN GALECTIN-4 1DT7 ; -1.00 ; SOLUTION STRUCTURE OF THE C-TERMINAL NEGATIVE REGULATORY DOMAIN OF P53 IN A COMPLEX WITH CA2+-BOUND S100B(BB) 1PQS ; -1.00 ; SOLUTION STRUCTURE OF THE C-TERMINAL OPCA DOMAIN OF YCDC24P 1JH4 ; -1.00 ; SOLUTION STRUCTURE OF THE C-TERMINAL PABC DOMAIN OF HUMAN POLY(A)-BINDING PROTEIN IN COMPLEX WITH THE PEPTIDE FROM PAIP1 1JGN ; -1.00 ; SOLUTION STRUCTURE OF THE C-TERMINAL PABC DOMAIN OF HUMAN POLY(A)-BINDING PROTEIN IN COMPLEX WITH THE PEPTIDE FROM PAIP2 2COC ; -1.00 ; SOLUTION STRUCTURE OF THE C-TERMINAL PH DOMAIN OF FYVE, RHOGEF AND PH DOMAIN CONTAINING PROTEIN 3 (FGD3) FROM HUMAN 1X05 ; -1.00 ; SOLUTION STRUCTURE OF THE C-TERMINAL PH DOMAIN OF HUMAN PLECKSTRIN 1X1G ; -1.00 ; SOLUTION STRUCTURE OF THE C-TERMINAL PH DOMAIN OF HUMAN PLECKSTRIN 2 2COF ; -1.00 ; SOLUTION STRUCTURE OF THE C-TERMINAL PH DOMAIN OF HYPOTHETICAL PROTEIN KIAA1914 FROM HUMAN 1WGU ; -1.00 ; SOLUTION STRUCTURE OF THE C-TERMINAL PHOSPHOTYROSINE INTERACTION DOMAIN OF APBB2 FROM MOUSE 1V5U ; -1.00 ; SOLUTION STRUCTURE OF THE C-TERMINAL PLECKSTRIN HOMOLOGY DOMAIN OF SBF1 FROM MOUSE 2CPH ; -1.00 ; SOLUTION STRUCTURE OF THE C-TERMINAL RIBONUCLEIC ACID RECOGNITION MOTIF OF HYPOTHETICAL RIBONUCLEIC ACID-BINDING PROTEIN RBM19 1IQT ; -1.00 ; SOLUTION STRUCTURE OF THE C-TERMINAL RIBONUCLEIC ACID-BINDING DOMAIN OF HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN D0 (AUF1) 1WD2 ; -1.00 ; SOLUTION STRUCTURE OF THE C-TERMINAL RING FROM A RING-IBR- RING (TRIAD) MOTIF 1UTA ; -1.00 ; SOLUTION STRUCTURE OF THE C-TERMINAL RNP DOMAIN FROM THE DIVISOME PROTEIN FTSN 2AHQ ; -1.00 ; SOLUTION STRUCTURE OF THE C-TERMINAL RPON DOMAIN OF SIGMA- 54 FROM AQUIFEX AEOLICUS 1OWX ; -1.00 ; SOLUTION STRUCTURE OF THE C-TERMINAL RRM OF HUMAN LA (LA225- 334) 1K76 ; -1.00 ; SOLUTION STRUCTURE OF THE C-TERMINAL SEM-5 SH3 DOMAIN (MINIMIZED AVERAGE STRUCTURE) 1BFI ; -1.00 ; SOLUTION STRUCTURE OF THE C-TERMINAL SH2 DOMAIN OF THE P85ALPHA REGULATORY SUBUNIT OF PHOSPHOINOSITIDE 3-KINASE, NMR, 30 STRUCTURES 1BFJ ; -1.00 ; SOLUTION STRUCTURE OF THE C-TERMINAL SH2 DOMAIN OF THE P85ALPHA REGULATORY SUBUNIT OF PHOSPHOINOSITIDE 3-KINASE, NMR, MINIMIZED AVERAGE STRUCTURE 1K4U ; -1.00 ; SOLUTION STRUCTURE OF THE C-TERMINAL SH3 DOMAIN OF P67PHOX COMPLEXED WITH THE C-TERMINAL TAIL REGION OF P47PHOX 1WJN ; -1.00 ; SOLUTION STRUCTURE OF THE C-TERMINAL UBIQUITIN-LIKE DOMAIN OF MOUSE TUBULIN-SPECIFIC CHAPERONE E 1WJ2 ; -1.00 ; SOLUTION STRUCTURE OF THE C-TERMINAL WRKY DOMAIN OF ATWRKY4 1RFH ; -1.00 ; SOLUTION STRUCTURE OF THE C1 DOMAIN OF NORE1, A NOVEL RAS EFFECTOR 1R79 ; -1.00 ; SOLUTION STRUCTURE OF THE C1 DOMAIN OF THE HUMAN DIACYLGLYCEROL KINASE DELTA 1Z9B ; -1.00 ; SOLUTION STRUCTURE OF THE C1-SUBDOMAIN OF BACILLUS STEAROTHERMOPHILUS TRANSLATION INITIATION FACTOR IF2 1X3C ; -1.00 ; SOLUTION STRUCTURE OF THE C2H2 TYPE ZINC-BINDING DOMAIN OF THE ZINC FINGER PROTEIN 292 1X5W ; -1.00 ; SOLUTION STRUCTURE OF THE C2H2 TYPE ZINC-BINDING DOMAIN OF THE ZINC FINGER PROTEIN 64, ISOFORMS 1 AND 2 1WIR ; -1.00 ; SOLUTION STRUCTURE OF THE C2H2 ZINC FINGER DOMAIN OF THE PROTEIN ARGININE N-METHYLTRANSFERASE 3 FROM MUS MUSCULUS 1J9W ; 2.60 ; SOLUTION STRUCTURE OF THE CAI MICHIGAN 1 VARIANT 1F55 ; -1.00 ; SOLUTION STRUCTURE OF THE CALCIUM BOUND N-TERMINAL DOMAIN OF YEAST CALMODULIN 1BYN ; -1.00 ; SOLUTION STRUCTURE OF THE CALCIUM-BOUND FIRST C2-DOMAIN OF SYNAPTOTAGMIN I 2AMI ; -1.00 ; SOLUTION STRUCTURE OF THE CALCIUM-LOADED N-TERMINAL SENSOR DOMAIN OF CENTRIN 1KKD ; -1.00 ; SOLUTION STRUCTURE OF THE CALMODULIN BINDING DOMAIN (CAMBD) OF SMALL CONDUCTANCE CA2+-ACTIVATED POTASSIUM CHANNELS (SK2) 1IXD ; -1.00 ; SOLUTION STRUCTURE OF THE CAP-GLY DOMAIN FROM HUMAN CYLINDROMATOSIS TOMOUR-SUPPRESSOR CYLD 2COZ ; -1.00 ; SOLUTION STRUCTURE OF THE CAP-GLY DOMAIN IN HUMAN CENTROSOME-ASSOCIATED PROTEIN CAP350 2COY ; -1.00 ; SOLUTION STRUCTURE OF THE CAP-GLY DOMAIN IN HUMAN DYNACTIN 1 2COW ; -1.00 ; SOLUTION STRUCTURE OF THE CAP-GLY DOMAIN IN HUMAN KINESIN- LIKE PROTEIN KIF13B 1WHG ; -1.00 ; SOLUTION STRUCTURE OF THE CAP-GLY DOMAIN IN MOUSE TUBULIN SPECIFIC CHAPERONE B 1Y00 ; -1.00 ; SOLUTION STRUCTURE OF THE CARBON STORAGE REGULATOR PROTEIN CSRA 1Z60 ; -1.00 ; SOLUTION STRUCTURE OF THE CARBOXY-TERMINAL DOMAIN OF HUMAN TFIIH P44 SUBUNIT 1UC6 ; -1.00 ; SOLUTION STRUCTURE OF THE CARBOXYL TERMINAL DOMAIN OF THE CILIARY NEUROTROPHIC FACTOR RECEPTOR 1NHA ; -1.00 ; SOLUTION STRUCTURE OF THE CARBOXYL-TERMINAL DOMAIN OF RAP74 AND NMR CHARACTERIZATION OF THE FCP-BINDING SITES OF RAP74 AND CTD OF RAP74, THE SUBUNIT OF HUMAN TFIIF 1X0H ; -1.00 ; SOLUTION STRUCTURE OF THE CARBOXYL-TERMINAL RGC DOMAIN IN HUMAN IQGAP1 1CWW ; -1.00 ; SOLUTION STRUCTURE OF THE CASPASE RECRUITMENT DOMAIN (CARD) FROM APAF-1 1N4T ; -1.00 ; SOLUTION STRUCTURE OF THE CATALYTIC DOMAIN FROM RAT CNP 1GHT ; -1.00 ; SOLUTION STRUCTURE OF THE CATALYTIC DOMAIN OF GAMMA DELTA RESOLVASE 1HX7 ; -1.00 ; SOLUTION STRUCTURE OF THE CATALYTIC DOMAIN OF GAMMA DELTA RESOLVASE 1EUB ; -1.00 ; SOLUTION STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN COLLAGENASE-3 (MMP-13) COMPLEXED TO A POTENT NON-PEPTIDIC SULFONAMIDE INHIBITOR 1BM6 ; -1.00 ; SOLUTION STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN STROMELYSIN-1 COMPLEXED TO A POTENT NON-PEPTIDIC INHIBITOR, NMR, 20 STRUCTURES 1M3G ; -1.00 ; SOLUTION STRUCTURE OF THE CATALYTIC DOMAIN OF MAPK PHOSPHATASE PAC-1: INSIGHTS INTO SUBSTRATE-INDUCED ENZYMATIC ACTIVATION 1R6E ; -1.00 ; SOLUTION STRUCTURE OF THE CATALYTIC DOMAIN OF SOPE2 1FLS ; -1.00 ; SOLUTION STRUCTURE OF THE CATALYTIC FRAGMENT OF HUMAN COLLAGENASE-3 (MMP-13) COMPLEXED WITH A HYDROXAMIC ACID INHIBITOR 1FM1 ; -1.00 ; SOLUTION STRUCTURE OF THE CATALYTIC FRAGMENT OF HUMAN COLLAGENASE-3 (MMP-13) COMPLEXED WITH A HYDROXAMIC ACID INHIBITOR 1N5P ; -1.00 ; SOLUTION STRUCTURE OF THE CATHELIN-LIKE DOMAIN OF PROTEGRINS (ALL AMIDE BONDS INVOLVING PROLINE RESIDUES ARE IN TRANS CONFORMATION) 1N5H ; -1.00 ; SOLUTION STRUCTURE OF THE CATHELIN-LIKE DOMAIN OF PROTEGRINS (THE R87-P88 AND D118-P119 AMIDE BONDS ARE IN THE CIS CONFORMATION) 1S40 ; -1.00 ; SOLUTION STRUCTURE OF THE CDC13 DEOXYRIBONUCLEIC ACID-BINDING DOMAIN COMPLEXED WITH A SINGLE-STRANDED TELOMERIC DEOXYRIBONUCLEIC ACID 11-MER 1KXL ; -1.00 ; SOLUTION STRUCTURE OF THE CDC13 DEOXYRIBONUCLEIC ACID-BINDING DOMAIN IN A COMPLEX WITH SINGLE-STRANDED TELOMERIC DEOXYRIBONUCLEIC ACID (DEOXYRIBONUCLEIC ACID STRUCTURE NOT MODELED) 1KWE ; -1.00 ; SOLUTION STRUCTURE OF THE CENTRAL CONSERVED REGION OF HUMAN RESPIRATORY SYNCYTIAL VIRUS ATTACHMENT GLYCOPROTEIN G 1KWD ; -1.00 ; SOLUTION STRUCTURE OF THE CENTRAL CONSERVED REGION OF HUMAN RESPIRATORY SYNCYTIAL VIRUS ATTACHMENT GLYCOPROTEIN G 187 1D8J ; -1.00 ; SOLUTION STRUCTURE OF THE CENTRAL CORE DOMAIN OF TFIIE BETA 1D8K ; -1.00 ; SOLUTION STRUCTURE OF THE CENTRAL CORE DOMAIN OF TFIIE BETA 1YSV ; -1.00 ; SOLUTION STRUCTURE OF THE CENTRAL REGION OF THE HUMAN GLUR- B R/G PRE-MRNA 1S79 ; -1.00 ; SOLUTION STRUCTURE OF THE CENTRAL RRM OF HUMAN LA PROTEIN 1WA8 ; -1.00 ; SOLUTION STRUCTURE OF THE CFP-10.ESAT-6 COMPLEX. MAJOR VIRULENCE DETERMINANTS OF PATHOGENIC MYCOBACTERIA 1V5K ; -1.00 ; SOLUTION STRUCTURE OF THE CH DOMAIN FROM MOUSE EB-1 1UJO ; -1.00 ; SOLUTION STRUCTURE OF THE CH DOMAIN FROM MOUSE TRANGELIN 1WYP ; -1.00 ; SOLUTION STRUCTURE OF THE CH DOMAIN OF HUMAN CALPONIN 1 1WYN ; -1.00 ; SOLUTION STRUCTURE OF THE CH DOMAIN OF HUMAN CALPONIN-2 1WYO ; -1.00 ; SOLUTION STRUCTURE OF THE CH DOMAIN OF HUMAN MICROTUBULE- ASSOCIATED PROTEIN RP/EB FAMILY MEMBER 3 1WYL ; -1.00 ; SOLUTION STRUCTURE OF THE CH DOMAIN OF HUMAN NEDD9 INTERACTING PROTEIN WITH CALPONIN HOMOLOGY AND LIM DOMAINS 1WYR ; -1.00 ; SOLUTION STRUCTURE OF THE CH DOMAIN OF HUMAN RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 6 1WYM ; -1.00 ; SOLUTION STRUCTURE OF THE CH DOMAIN OF HUMAN TRANSGELIN-2 1DLZ ; -1.00 ; SOLUTION STRUCTURE OF THE CHANNEL-FORMER ZERVAMICIN IIB (PEPTAIBOL ANTIBIOTIC) 1XEE ; -1.00 ; SOLUTION STRUCTURE OF THE CHEMOTAXIS INHIBITORY PROTEIN OF STAPHYLOCOCCUS AUREUS 1K0S ; -1.00 ; SOLUTION STRUCTURE OF THE CHEMOTAXIS PROTEIN CHEW FROM THE THERMOPHILIC ORGANISM THERMOTOGA MARITIMA 1B8T ; -1.00 ; SOLUTION STRUCTURE OF THE CHICKEN CRP1 1R4D ; -1.00 ; SOLUTION STRUCTURE OF THE CHIMERIC L/D DEOXYRIBONUCLEIC ACID OLIGONUCLEOTIDE D(C8METGCGC(L)G(L)CGCG)2 1ED7 ; -1.00 ; SOLUTION STRUCTURE OF THE CHITIN-BINDING DOMAIN OF BACILLUS CIRCULANS WL-12 CHITINASE A1 1W09 ; -1.00 ; SOLUTION STRUCTURE OF THE CIS FORM OF THE HUMAN ALPHA- HEMOGLOBIN STABILIZING PROTEIN (AHSP) 1P4Q ; -1.00 ; SOLUTION STRUCTURE OF THE CITED2 TRANSACTIVATION DOMAIN IN COMPLEX WITH THE P300 CH1 DOMAIN 1G6Z ; -1.00 ; SOLUTION STRUCTURE OF THE CLR4 CHROMO DOMAIN 1WGP ; -1.00 ; SOLUTION STRUCTURE OF THE CNMP-BINDING DOMAIN FROM ARABIDOPSIS THALIANA CYCLIC NUCLEOTIDE-REGULATED ION CHANNEL 1X67 ; -1.00 ; SOLUTION STRUCTURE OF THE COFILIN HOMOLOGY DOMAIN OF HIP-55 (DREBRIN-LIKE PROTEIN) 1ZXA ; -1.00 ; SOLUTION STRUCTURE OF THE COILED-COIL DOMAIN OF CGMP- DEPENDENT PROTEIN KINASE IA 1M7L ; -1.00 ; SOLUTION STRUCTURE OF THE COILED-COIL TRIMERIZATION DOMAIN FROM LUNG SURFACTANT PROTEIN D 1M82 ; -1.00 ; SOLUTION STRUCTURE OF THE COMPLEMENTARY RIBONUCLEIC ACID PROMOTER OF INFLUENZA A VIRUS 1R4E ; -1.00 ; SOLUTION STRUCTURE OF THE COMPLEX FORMED BETWEEN A LEFT- HANDED WEDGE-SHAPED SPIROCYCLIC MOLECULE AND BULGED DEOXYRIBONUCLEIC ACID 1RKJ ; -1.00 ; SOLUTION STRUCTURE OF THE COMPLEX FORMED BY THE TWO N- TERMINAL RIBONUCLEIC ACID-BINDING DOMAINS OF NUCLEOLIN AND A PRE-RRNA TARGET 1O9A ; -1.00 ; SOLUTION STRUCTURE OF THE COMPLEX OF 1F12F1 FROM FIBRONECTIN WITH B3 FROM FNBB FROM S. DYSGALACTIAE 2A7Y ; -1.00 ; SOLUTION STRUCTURE OF THE CONSERVED HYPOTHETICAL PROTEIN RV2302 FROM THE BACTERIUM MYCOBACTERIUM TUBERCULOSIS 1WFR ; -1.00 ; SOLUTION STRUCTURE OF THE CONSERVED HYPOTHETICAL PROTEIN TT1886, POSSIBLY STEROL CARRIER PROTEIN, FROM THERMUS THERMOPHILUS HB8 1Z8M ; -1.00 ; SOLUTION STRUCTURE OF THE CONSERVED HYPOTHTICAL PROTEIN HP0894 FROM HELICOBACTER PYLORI 1YEZ ; -1.00 ; SOLUTION STRUCTURE OF THE CONSERVED PROTEIN FROM THE GENE LOCUS MM1357 OF METHANOSARCINA MAZEI. NORTHEAST STRUCTURAL GENOMICS TARGET MAR30. 1YVC ; -1.00 ; SOLUTION STRUCTURE OF THE CONSERVED PROTEIN FROM THE GENE LOCUS MMP0076 OF METHANOCOCCUS MARIPALUDIS. NORTHEAST STRUCTURAL GENOMICS TARGET MRR5. 1DPQ ; -1.00 ; SOLUTION STRUCTURE OF THE CONSTITUTIVELY ACTIVE MUTANT OF THE INTEGRIN ALPHA IIB CYTOPLASMIC DOMAIN. 1Y3J ; -1.00 ; SOLUTION STRUCTURE OF THE COPPER(I) FORM OF THE FIFTH DOMAIN OF MENKES PROTEIN 1X5M ; -1.00 ; SOLUTION STRUCTURE OF THE CORE DOMAIN OF CALCYCLIN BINDING PROTEIN; SIAH-INTERACTING PROTEIN (SIP) 1WGV ; -1.00 ; SOLUTION STRUCTURE OF THE CS DOMAIN OF HUMAN KIAA1068 PROTEIN 1WH0 ; -1.00 ; SOLUTION STRUCTURE OF THE CS DOMAIN OF HUMAN USP19 1KVJ ; -1.00 ; SOLUTION STRUCTURE OF THE CU(I) BOUND FORM OF THE FIRST HEAVY METAL BINDING MOTIF OF THE MENKES PROTEIN 1FD8 ; -1.00 ; SOLUTION STRUCTURE OF THE CU(I) FORM OF THE YEAST METALLOCHAPERONE, ATX1 1IUY ; -1.00 ; SOLUTION STRUCTURE OF THE CULLIN-3 HOMOLOGUE 1X2L ; -1.00 ; SOLUTION STRUCTURE OF THE CUT DOMAIN OF HUMAN HOMEOBOX PROTEIN CUX-2 (CUT-LIKE 2) 1B2T ; -1.00 ; SOLUTION STRUCTURE OF THE CX3C CHEMOKINE DOMAIN OF FRACTALKINE 1R1F ; -1.00 ; SOLUTION STRUCTURE OF THE CYCLOTIDE PALICOUREIN: IMPLICATIONS FOR THE DEVELOPMENT OF PHARMACEUTICAL AND AGRICULTURAL APPLICATIONS 1YP8 ; -1.00 ; SOLUTION STRUCTURE OF THE CYCLOTIDE TRICYCLON A 1KBE ; -1.00 ; SOLUTION STRUCTURE OF THE CYSTEINE-RICH C1 DOMAIN OF KINASE SUPPRESSOR OF RAS 1KBF ; -1.00 ; SOLUTION STRUCTURE OF THE CYSTEINE-RICH C1 DOMAIN OF KINASE SUPPRESSOR OF RAS 1EXK ; -1.00 ; SOLUTION STRUCTURE OF THE CYSTEINE-RICH DOMAIN OF THE ESCHERICHIA COLI CHAPERONE PROTEIN DNAJ. 1PLP ; -1.00 ; SOLUTION STRUCTURE OF THE CYTOPLASMIC DOMAIN OF PHOSPHOLAMBAN 1DPK ; -1.00 ; SOLUTION STRUCTURE OF THE CYTOPLASMIC DOMAIN OF THE INTEGRIN ALPHA-IIB SUBUNIT 1JO6 ; -1.00 ; SOLUTION STRUCTURE OF THE CYTOPLASMIC N-TERMINUS OF THE BK BETA-SUBUNIT KCNMB2 1DE3 ; -1.00 ; SOLUTION STRUCTURE OF THE CYTOTOXIC RIBONUCLEASE ALPHA- SARCIN 2CW1 ; -1.00 ; SOLUTION STRUCTURE OF THE DE NOVO-DESIGNED LAMBDA CRO FOLD PROTEIN 1KQQ ; -1.00 ; SOLUTION STRUCTURE OF THE DEAD RINGER ARID-DEOXYRIBONUCLEIC ACID COMPLEX 1WH4 ; -1.00 ; SOLUTION STRUCTURE OF THE DEATH DOMAIN OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE4 (IRAK4) FROM MUS MUSCULUS 1WXP ; -1.00 ; SOLUTION STRUCTURE OF THE DEATH DOMAIN OF NUCLEAR MATRIX PROTEIN P84 1R4Y ; -1.00 ; SOLUTION STRUCTURE OF THE DELETION MUTANT DELTA(7-22) OF THE CYTOTOXIC RIBONUCLEASE ALPHA-SARCIN 1LAE ; -1.00 ; SOLUTION STRUCTURE OF THE DEOXYRIBONUCLEIC ACID 13-MER HAIRPIN CGCGGTXTCCGCG (XPDG) CONTAINING THE 1,N2-PROPANODEOXYGUANOSINE ADDUCT AT THE SEVENTH POSITION 1DB6 ; -1.00 ; SOLUTION STRUCTURE OF THE DEOXYRIBONUCLEIC ACID APTAMER 5'- CGACCAACGTGTCGCCTGGTCG-3' COMPLEXED WITH ARGININAMIDE 1IHW ; -1.00 ; SOLUTION STRUCTURE OF THE DEOXYRIBONUCLEIC ACID BINDING DOMAIN OF HIV-1 INTEGRASE, NMR, 40 STRUCTURES 1IHV ; -1.00 ; SOLUTION STRUCTURE OF THE DEOXYRIBONUCLEIC ACID BINDING DOMAIN OF HIV-1 INTEGRASE, NMR, MINIMIZED AVERAGE STRUCTURE 1ITY ; -1.00 ; SOLUTION STRUCTURE OF THE DEOXYRIBONUCLEIC ACID BINDING DOMAIN OF HUMAN TRF1 1E17 ; -1.00 ; SOLUTION STRUCTURE OF THE DEOXYRIBONUCLEIC ACID BINDING DOMAIN OF THE HUMAN FORKHEAD TRANSCRIPTION FACTOR AFX (FOXO4) 1P6R ; -1.00 ; SOLUTION STRUCTURE OF THE DEOXYRIBONUCLEIC ACID BINDING DOMAIN OF THE REPRESSOR BLAI. 1DP3 ; -1.00 ; SOLUTION STRUCTURE OF THE DEOXYRIBONUCLEIC ACID BINDING DOMAIN OF THE TRAM PROTEIN 1I11 ; -1.00 ; SOLUTION STRUCTURE OF THE DEOXYRIBONUCLEIC ACID BINDING DOMAIN, SOX-5 HMG BOX FROM MOUSE 1IV6 ; -1.00 ; SOLUTION STRUCTURE OF THE DEOXYRIBONUCLEIC ACID COMPLEX OF HUMAN TRF1 1VFC ; -1.00 ; SOLUTION STRUCTURE OF THE DEOXYRIBONUCLEIC ACID COMPLEX OF HUMAN TRF2 1SNH ; -1.00 ; SOLUTION STRUCTURE OF THE DEOXYRIBONUCLEIC ACID DECAMER DUPLEX CONTAINING DOUBLE TG MISMATCHES OF CIS-SYN CYCLOBUTANE PYRIMIDINE DIMER 1RVI ; -1.00 ; SOLUTION STRUCTURE OF THE DEOXYRIBONUCLEIC ACID DODECAMER CGTTTTAAAACG 1RVH ; -1.00 ; SOLUTION STRUCTURE OF THE DEOXYRIBONUCLEIC ACID DODECAMER GCAAAATTTTGC 1IEY ; -1.00 ; SOLUTION STRUCTURE OF THE DEOXYRIBONUCLEIC ACID DUPLEX D(CCACC+GGAAC) .(GTTCCGGTGG) WITH A CHIRAL ALKYL-PHOSPHONATE MOIETY (DIAESTEREOISOMER R) 1IEK ; -1.00 ; SOLUTION STRUCTURE OF THE DEOXYRIBONUCLEIC ACID DUPLEX D(CCACC+GGAAC) .(GTTCCGGTGG) WITH A CHIRAL ALKYL-PHOSPHONATE MOIETY (DIAESTEREOISOMER S) 1X6W ; -1.00 ; SOLUTION STRUCTURE OF THE DEOXYRIBONUCLEIC ACID DUPLEX TGCGCA:TGCGCA CAPPED BY TRIMETHOXYSTILBENE RESIDUES 1LA8 ; -1.00 ; SOLUTION STRUCTURE OF THE DEOXYRIBONUCLEIC ACID HAIRPIN 13-MER CGCGGTGTCCGCG 1SNJ ; -1.00 ; SOLUTION STRUCTURE OF THE DEOXYRIBONUCLEIC ACID THREE-WAY JUNCTION WITH THE A/C-STACKED CONFORMATION 1XPA ; -1.00 ; SOLUTION STRUCTURE OF THE DEOXYRIBONUCLEIC ACID- AND RPA-BINDING DOMAIN OF THE HUMAN REPAIR FACTOR XPA, NMR, 1 STRUCTURE 1QQI ; -1.00 ; SOLUTION STRUCTURE OF THE DEOXYRIBONUCLEIC ACID-BINDING AND TRANSACTIVATION DOMAIN OF PHOB FROM ESCHERICHIA COLI 1C20 ; -1.00 ; SOLUTION STRUCTURE OF THE DEOXYRIBONUCLEIC ACID-BINDING DOMAIN FROM THE DEAD RINGER PROTEIN 1KKX ; -1.00 ; SOLUTION STRUCTURE OF THE DEOXYRIBONUCLEIC ACID-BINDING DOMAIN OF ADR6 1WIJ ; -1.00 ; SOLUTION STRUCTURE OF THE DEOXYRIBONUCLEIC ACID-BINDING DOMAIN OF ETHYLENE- INSENSITIVE3-LIKE3 1JXS ; -1.00 ; SOLUTION STRUCTURE OF THE DEOXYRIBONUCLEIC ACID-BINDING DOMAIN OF INTERLEUKIN ENHANCER BINDING FACTOR 1K1V ; -1.00 ; SOLUTION STRUCTURE OF THE DEOXYRIBONUCLEIC ACID-BINDING DOMAIN OF MAFG 1NTC ; -1.00 ; SOLUTION STRUCTURE OF THE DEOXYRIBONUCLEIC ACID-BINDING DOMAIN OF NTRC WITH THREE ALANINE SUBSTITUTIONS 1WJ0 ; -1.00 ; SOLUTION STRUCTURE OF THE DEOXYRIBONUCLEIC ACID-BINDING DOMAIN OF SQUAMOSA PROMOTER BINDING PROTEIN-LIKE 12 LACKING THE SECOND ZINC- BINDING SITE 1UL4 ; -1.00 ; SOLUTION STRUCTURE OF THE DEOXYRIBONUCLEIC ACID-BINDING DOMAIN OF SQUAMOSA PROMOTER BINDING PROTEIN-LIKE 4 1UL5 ; -1.00 ; SOLUTION STRUCTURE OF THE DEOXYRIBONUCLEIC ACID-BINDING DOMAIN OF SQUAMOSA PROMOTER BINDING PROTEIN-LIKE 7 1P4W ; -1.00 ; SOLUTION STRUCTURE OF THE DEOXYRIBONUCLEIC ACID-BINDING DOMAIN OF THE ERWINIA AMYLOVORA RCSB PROTEIN 1G2H ; -1.00 ; SOLUTION STRUCTURE OF THE DEOXYRIBONUCLEIC ACID-BINDING DOMAIN OF THE TYRR PROTEIN OF HAEMOPHILUS INFLUENZAE 1JUA ; -1.00 ; SOLUTION STRUCTURE OF THE DEOXYRIBOSE HIV-1LAI INITIATION SEQUENCE STABLE DIMER 2CSO ; -1.00 ; SOLUTION STRUCTURE OF THE DEP DOMAIN OF HUMAN PLECKSTRIN 1UHW ; -1.00 ; SOLUTION STRUCTURE OF THE DEP DOMAIN OF MOUSE PLECKSTRIN 1V3F ; -1.00 ; SOLUTION STRUCTURE OF THE DEP DOMAIN OF MOUSE PLECKSTRIN2 1UD7 ; -1.00 ; SOLUTION STRUCTURE OF THE DESIGNED HYDROPHOBIC CORE MUTANT OF UBIQUITIN, 1D7 1PE3 ; -1.00 ; SOLUTION STRUCTURE OF THE DISULPHIDE-LINKED DIMER OF HUMAN INTESTINAL TREFOIL FACTOR (TFF3) 1L6E ; -1.00 ; SOLUTION STRUCTURE OF THE DOCKING AND DIMERIZATION DOMAIN OF PROTEIN KINASE A II-ALPHA (RIIALPHA D/D). ALTERNATIVELY CALLED THE N-TERMINAL DIMERIZATION DOMAIN OF THE REGULATORY SUBUNIT OF PROTEIN KINASE A. 1PJW ; -1.00 ; SOLUTION STRUCTURE OF THE DOMAIN III OF THE JAPAN ENCEPHALITIS VIRUS ENVELOPE PROTEIN 1R4K ; -1.00 ; SOLUTION STRUCTURE OF THE DROSOPHILA ARGONAUTE 1 PAZ DOMAIN 1WHN ; -1.00 ; SOLUTION STRUCTURE OF THE DSRBD FROM HYPOTHETICAL PROTEIN BAB26260 1WWY ; -1.00 ; SOLUTION STRUCTURE OF THE DUF1000 DOMAIN OF A THIOREDOXIN- LIKE PROTEIN 1 1Q75 ; -1.00 ; SOLUTION STRUCTURE OF THE DYSKERATOSIS CONGENITA MUTANT P2B HAIRPIN FROM HUMAN TELOMERASE RIBONUCLEIC ACID 1SE7 ; -1.00 ; SOLUTION STRUCTURE OF THE E. COLI BACTERIOPHAGE P1 ENCODED HOT PROTEIN: A HOMOLOGUE OF THE THETA SUBUNIT OF E. COLI DEOXYRIBONUCLEIC ACID POLYMERASE III 2COO ; -1.00 ; SOLUTION STRUCTURE OF THE E3_BINDING DOMAIN OF DIHYDROLIPOAMIDE BRANCHED CHAINTRANSACYLASE 1HYJ ; -1.00 ; SOLUTION STRUCTURE OF THE EEA1 FYVE DOMAIN 1HYI ; -1.00 ; SOLUTION STRUCTURE OF THE EEA1 FYVE DOMAIN COMPLEXED WITH INOSITOL 1,3-BISPHOSPHATE 2CQV ; -1.00 ; SOLUTION STRUCTURE OF THE EIGHTH IG-LIKE DOMAIN OF HUMAN MYOSIN LIGHT CHAIN KINASE 1EGX ; -1.00 ; SOLUTION STRUCTURE OF THE ENA-VASP HOMOLOGY 1 (EVH1) DOMAIN OF HUMAN VASODILATOR-STIMULATED PHOSPHOPROTEIN (VASP) 1RXL ; -1.00 ; SOLUTION STRUCTURE OF THE ENGINEERED PROTEIN AFAE-DSC 1IQ3 ; -1.00 ; SOLUTION STRUCTURE OF THE EPS15 HOMOLOGY DOMAIN OF A HUMAN POB1 1BSH ; -1.00 ; SOLUTION STRUCTURE OF THE EPSILON SUBUNIT OF THE F1- ATPSYNTHASE FROM ESCHERICHIA COLI AND ORIENTATION OF THE SUBUNIT RELATIVE TO THE BETA SUBUNITS OF THE COMPLEX 1BSN ; -1.00 ; SOLUTION STRUCTURE OF THE EPSILON SUBUNIT OF THE F1- ATPSYNTHASE FROM ESCHERICHIA COLI AND ORIENTATION OF THE SUBUNIT RELATIVE TO THE BETA SUBUNITS OF THE COMPLEX 1INZ ; -1.00 ; SOLUTION STRUCTURE OF THE EPSIN N-TERMINAL HOMOLOGY (ENTH) DOMAIN OF HUMAN EPSIN 1S62 ; -1.00 ; SOLUTION STRUCTURE OF THE ESCHERICHIA COLI TOLA C-TERMINAL DOMAIN 1SR2 ; -1.00 ; SOLUTION STRUCTURE OF THE ESCHERICHIA COLI YOJN HISTIDINE- PHOSPHOTRANSFERASE (HPT) DOMAIN 1EF4 ; -1.00 ; SOLUTION STRUCTURE OF THE ESSENTIAL RIBONUCLEIC ACID POLYMERASE SUBUNIT RPB10 FROM METHANOBACTERIUM THERMOAUTOTROPHICUM 1WWX ; -1.00 ; SOLUTION STRUCTURE OF THE ETS-DOMAIN OF THE ETS DOMAIN TRANSCRIPTION FACTOR 1KD6 ; -1.00 ; SOLUTION STRUCTURE OF THE EUKARYOTIC PORE-FORMING CYTOLYSIN EQUINATOXIN II 1B8Q ; -1.00 ; SOLUTION STRUCTURE OF THE EXTENDED NEURONAL NITRIC OXIDE SYNTHASE PDZ DOMAIN COMPLEXED WITH AN ASSOCIATED PEPTIDE 1XHP ; -1.00 ; SOLUTION STRUCTURE OF THE EXTENDED U6 ISL AS OBSERVED IN THE U2/U6 COMPLEX FROM SACCHAROMYCES CEREVISIAE 1OSX ; -1.00 ; SOLUTION STRUCTURE OF THE EXTRACELLULAR DOMAIN OF BLYS RECEPTOR 3 (BR3) 1ZZP ; -1.00 ; SOLUTION STRUCTURE OF THE F-ACTIN BINDING DOMAIN OF BCR- ABL/C-ABL 1X3B ; -1.00 ; SOLUTION STRUCTURE OF THE FAS1 DOMAIN OF THE TRANSFORMING GROWTH FACTOR-BETA INDUCED PROTEIN IG-H3 1QVX ; -1.00 ; SOLUTION STRUCTURE OF THE FAT DOMAIN OF FOCAL ADHESION KINASE 2CQN ; -1.00 ; SOLUTION STRUCTURE OF THE FF DOMAIN OF HUMAN FORMIN-BINDING PROTEIN 3 1UHT ; -1.00 ; SOLUTION STRUCTURE OF THE FHA DOMAIN OF ARABIDOPSIS THALIANA HYPOTHETICAL PROTEIN 2CSW ; -1.00 ; SOLUTION STRUCTURE OF THE FHA DOMAIN OF HUMAN UBIQUITIN LIGASE PROTEIN RNF8 1WLN ; -1.00 ; SOLUTION STRUCTURE OF THE FHA DOMAIN OF MOUSE AFADIN 6 1J4L ; -1.00 ; SOLUTION STRUCTURE OF THE FHA2 DOMAIN OF RAD53 COMPLEXED WITH A PHOSPHOTHREONYL PEPTIDE DERIVED FROM RAD9 1K2N ; -1.00 ; SOLUTION STRUCTURE OF THE FHA2 DOMAIN OF RAD53 COMPLEXED WITH A PHOSPHOTHREONYL PEPTIDE DERIVED FROM RAD9 1FHR ; -1.00 ; SOLUTION STRUCTURE OF THE FHA2 DOMAIN OF RAD53 COMPLEXED WITH A PHOSPHOTYROSYL PEPTIDE 1J4K ; -1.00 ; SOLUTION STRUCTURE OF THE FHA2 DOMAIN OF RAD53 COMPLEXED WITH A PHOSPHOTYROSYL PEPTIDE DERIVED FROM RAD9 1K2M ; -1.00 ; SOLUTION STRUCTURE OF THE FHA2 DOMAIN OF RAD53 COMPLEXED WITH A PHOSPHOTYROSYL PEPTIDE DERIVED FROM RAD9 1K85 ; -1.00 ; SOLUTION STRUCTURE OF THE FIBRONECTIN TYPE III DOMAIN FROM BACILLUS CIRCULANS WL-12 CHITINASE A1. 1X5X ; -1.00 ; SOLUTION STRUCTURE OF THE FIBRONECTIN TYPE-III DOMAIN OF THE FIBRONECTIN TYPE III DOMAIN CONTAINING PROTEIN 3 1X3D ; -1.00 ; SOLUTION STRUCTURE OF THE FIBRONECTIN TYPE-III DOMAIN OF THE FIBRONECTIN TYPE III DOMAIN CONTAINING PROTEIN 3A 1X5Y ; -1.00 ; SOLUTION STRUCTURE OF THE FIBRONECTIN TYPE-III DOMAIN OF THE MYOSIN-BINDING PROTEIN C, FAST-TYPE HOMOLOG 1X5Z ; -1.00 ; SOLUTION STRUCTURE OF THE FIBRONECTIN TYPE-III DOMAIN OF THE PROTEIN TYROSINE PHOSPHATASE, RECEPTOR TYPE, D ISOFORM 4 VARIANT 1WIS ; -1.00 ; SOLUTION STRUCTURE OF THE FIFTH FNIII DOMAIN FROM HUMAN KIAA1514 PROTEIN 2CRZ ; -1.00 ; SOLUTION STRUCTURE OF THE FIFTH FNIII DOMAIN OF HUMAN FIBRONECTIN TYPE III DOMAIN CONTAINING PROTEIN 3A 2CRY ; -1.00 ; SOLUTION STRUCTURE OF THE FIFTH IG-LIKE DOMAIN OF HUMAN KIN OF IRRE LIKE 3 1WFV ; -1.00 ; SOLUTION STRUCTURE OF THE FIFTH PDZ DOMAIN OF HUMAN MEMBRANE ASSOCIATED GUANYLATE KINASE INVERTED-2 (KIAA0705 PROTEIN) 2COT ; -1.00 ; SOLUTION STRUCTURE OF THE FIRST AND SECOND ZF-C2H2 DOMAIN OF ZINC FINGER PROTEIN 435 1V27 ; -1.00 ; SOLUTION STRUCTURE OF THE FIRST C2 DOMAIN OF RIM2 1UGK ; -1.00 ; SOLUTION STRUCTURE OF THE FIRST C2 DOMAIN OF SYNAPTOTAGMIN IV FROM HUMAN FETAL BRAIN (KIAA1342) 1WFQ ; -1.00 ; SOLUTION STRUCTURE OF THE FIRST COLD-SHOCK DOMAIN OF THE HUMAN KIAA0885 PROTEIN (UNR PROTEIN) 1WIZ ; -1.00 ; SOLUTION STRUCTURE OF THE FIRST CUT DOMAIN OF KIAA1034 PROTEIN 1X49 ; -1.00 ; SOLUTION STRUCTURE OF THE FIRST DSRM DOMAIN IN INTERFERON- INDUCED, DOUBLE-STRANDED RIBONUCLEIC ACID-ACTIVATED PROTEIN KINASE 1UEY ; -1.00 ; SOLUTION STRUCTURE OF THE FIRST FIBRONECTIN TYPE III DOMAIN OF HUMAN KIAA0343 PROTEIN 1UEM ; -1.00 ; SOLUTION STRUCTURE OF THE FIRST FIBRONECTIN TYPE III DOMAIN OF HUMAN KIAA1568 PROTEIN 1WF5 ; -1.00 ; SOLUTION STRUCTURE OF THE FIRST FN3 DOMAIN OF SIDEKICK-2 PROTEIN 1K99 ; -1.00 ; SOLUTION STRUCTURE OF THE FIRST HMG BOX IN HUMAN UPSTREAM BINDING FACTOR 2CR3 ; -1.00 ; SOLUTION STRUCTURE OF THE FIRST IG-LIKE DOMAIN OF HUMAN FIBROBLAST GROWTH FACTOR RECEPTOR 1 1X61 ; -1.00 ; SOLUTION STRUCTURE OF THE FIRST LIM DOMAIN OF THYROID RECEPTOR INTERACTING PROTEIN 6 (TRIP6) 1WJS ; -1.00 ; SOLUTION STRUCTURE OF THE FIRST MBT DOMAIN FROM HUMAN KIAA1798 PROTEIN 1UGO ; -1.00 ; SOLUTION STRUCTURE OF THE FIRST MURINE BAG DOMAIN OF BCL2- ASSOCIATED ATHANOGENE 5 2CR7 ; -1.00 ; SOLUTION STRUCTURE OF THE FIRST PAH DOMAIN OF THE MOUSE TRANSCRIPTIONAL REPRESSOR SIN3B 1X45 ; -1.00 ; SOLUTION STRUCTURE OF THE FIRST PDZ DOMAIN OF AMYLOID BETA A4 PRECURSOR PROTEIN-BINDING FAMILY A, MEMBER 1 1UEQ ; -1.00 ; SOLUTION STRUCTURE OF THE FIRST PDZ DOMAIN OF HUMAN ATROPHIN-1 INTERACTING PROTEIN 1 (KIAA0705 PROTEIN) 1UEZ ; -1.00 ; SOLUTION STRUCTURE OF THE FIRST PDZ DOMAIN OF HUMAN KIAA1526 PROTEIN 1X5Q ; -1.00 ; SOLUTION STRUCTURE OF THE FIRST PDZ DOMAIN OF SCRIBBLE HOMOLOG PROTEIN (HSCRIB) 1D8Z ; -1.00 ; SOLUTION STRUCTURE OF THE FIRST RIBONUCLEIC ACID-BINDING DOMAIN (RBD1) OF HU ANTIGEN C (HUC) 1U2F ; -1.00 ; SOLUTION STRUCTURE OF THE FIRST RIBONUCLEIC ACID-BINDING DOMAIN OF HU2AF65 1WG5 ; -1.00 ; SOLUTION STRUCTURE OF THE FIRST RRM DOMAIN IN HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN H 1UFF ; -1.00 ; SOLUTION STRUCTURE OF THE FIRST SH3 DOMAIN OF HUMAN INTERSECTIN2 (KIAA1256) 1WIE ; -1.00 ; SOLUTION STRUCTURE OF THE FIRST SH3 DOMAIN OF KIAA0318 PROTEIN 1OWW ; -1.00 ; SOLUTION STRUCTURE OF THE FIRST TYPE III MODULE OF HUMAN FIBRONECTIN DETERMINED BY 1H, 15N NMR SPECTROSCOPY 1WR3 ; -1.00 ; SOLUTION STRUCTURE OF THE FIRST WW DOMAIN OF NEDD4-2 1WYS ; -1.00 ; SOLUTION STRUCTURE OF THE FIRST ZF-AN1 DOMAIN OF MOUSE RIKEN CDNA 2310008M20 PROTEIN 1FV5 ; -1.00 ; SOLUTION STRUCTURE OF THE FIRST ZINC FINGER FROM THE DROSOPHILA U-SHAPED TRANSCRIPTION FACTOR 1N0Z ; -1.00 ; SOLUTION STRUCTURE OF THE FIRST ZINC-FINGER DOMAIN FROM ZNF265 1V9X ; -1.00 ; SOLUTION STRUCTURE OF THE FIRST ZN-FINGER DOMAIN OF POLY(ADP-RIBOSE) POLYMERASE-1 1YKG ; -1.00 ; SOLUTION STRUCTURE OF THE FLAVODOXIN-LIKE DOMAIN FROM THE ESCHERICHIA COLI SULFITE REDUCTASE 1D1N ; -1.00 ; SOLUTION STRUCTURE OF THE FMET-TRNAFMET BINDING DOMAIN OF BECILLUS STEAROTHERMOPHILLUS TRANSLATION INITIATION FACTOR IF2 2CSP ; -1.00 ; SOLUTION STRUCTURE OF THE FNIII DOMAIN OF HUMAN RIM-BINDING PROTEIN 2 1R5E ; -1.00 ; SOLUTION STRUCTURE OF THE FOLDED CORE OF PSEUDOMONAS SYRINGAE EFFECTOR PROTEIN, AVRPTO 1D5V ; -1.00 ; SOLUTION STRUCTURE OF THE FORKHEAD DOMAIN OF THE ADIPOCYTE- TRANSCRIPTION FACTOR FREAC-11 (S12) 1WJO ; -1.00 ; SOLUTION STRUCTURE OF THE FORTH CH DOMAIN FROM HUMAN PLASTIN 3 T-ISOFORM 2CRM ; -1.00 ; SOLUTION STRUCTURE OF THE FORTH FNIII DOMAIN OF HUMAN 1UEW ; -1.00 ; SOLUTION STRUCTURE OF THE FORTH PDZ DOMAIN OF HUMAN ATROPHIN-1 INTERACTING PROTEIN 1 (KIAA0705 PROTEIN) 1WJ3 ; -1.00 ; SOLUTION STRUCTURE OF THE FOURTH FN3 DOMAIN OF KIAA1496 PROTEIN 1X5R ; -1.00 ; SOLUTION STRUCTURE OF THE FOURTH PDZ DOMAIN OF GLUTAMATE RECEPTOR INTERACTING PROTEIN 2 1UJU ; -1.00 ; SOLUTION STRUCTURE OF THE FOURTH PDZ DOMAIN OF HUMAN SCRIBBLE (KIAA0147 PROTEIN) 1WH1 ; -1.00 ; SOLUTION STRUCTURE OF THE FOURTH PDZ DOMAIN OF KIAA1095 PROTEIN 1UE9 ; -1.00 ; SOLUTION STRUCTURE OF THE FOURTH SH3 DOMAIN OF HUMAN INTERSECTIN 2 (KIAA1256) 1I6E ; -1.00 ; SOLUTION STRUCTURE OF THE FUNCTIONAL DOMAIN OF PARACOCCUS DENITRIFICANS CYTOCHROME C552 IN THE OXIDIZED STATE 1C7M ; -1.00 ; SOLUTION STRUCTURE OF THE FUNCTIONAL DOMAIN OF PARACOCCUS DENITRIFICANS CYTOCHROME C552 IN THE REDUCED STATE 1I6D ; -1.00 ; SOLUTION STRUCTURE OF THE FUNCTIONAL DOMAIN OF PARACOCCUS DENITRIFICANS CYTOCHROME C552 IN THE REDUCED STATE 1ZAE ; -1.00 ; SOLUTION STRUCTURE OF THE FUNCTIONAL DOMAIN OF PHI29 REPLICATION ORGANIZER P16.7C 1X4U ; -1.00 ; SOLUTION STRUCTURE OF THE FYVE DOMAIN FROM HUMAN FYVE DOMAIN CONTAINING 27 ISOFORM B PROTEIN 1V5R ; -1.00 ; SOLUTION STRUCTURE OF THE GAS2 DOMAIN OF THE GROWTH ARREST SPECIFIC 2 PROTEIN 3GCC ; -1.00 ; SOLUTION STRUCTURE OF THE GCC-BOX BINDING DOMAIN, NMR, 46 STRUCTURES 2GCC ; -1.00 ; SOLUTION STRUCTURE OF THE GCC-BOX BINDING DOMAIN, NMR, MINIMIZED MEAN STRUCTURE 2F09 ; -1.00 ; SOLUTION STRUCTURE OF THE GENE PRODUCT OF E. COLI GENE YDHA 1UHM ; -1.00 ; SOLUTION STRUCTURE OF THE GLOBULAR DOMAIN OF LINKER HISTONE HOMOLOG HHO1P FROM S. CEREVISIAE 1B64 ; -1.00 ; SOLUTION STRUCTURE OF THE GUANINE NUCLEOTIDE EXCHANGE FACTOR DOMAIN FROM HUMAN ELONGATION FACTOR-ONE BETA, NMR, 20 STRUCTURES 1WH2 ; -1.00 ; SOLUTION STRUCTURE OF THE GYF DOMAIN OF A HYPOTHETICAL PROTEIN FROM ARABIDOPSIS THALIANA 1B36 ; -1.00 ; SOLUTION STRUCTURE OF THE HAIRPIN RIBOZYME LOOP B DOMAIN RIBONUCLEIC ACID, NMR, 10 STRUCTURES 1QQV ; -1.00 ; SOLUTION STRUCTURE OF THE HEADPIECE DOMAIN OF CHICKEN VILLIN 1SR3 ; -1.00 ; SOLUTION STRUCTURE OF THE HEME CHAPERONE CCME OF ESCHERICHIA COLI 1CWX ; -1.00 ; SOLUTION STRUCTURE OF THE HEPATITIS C VIRUS N-TERMINAL CAPSID PROTEIN 2-45 [C-HCV(2-45)] 1UJL ; -1.00 ; SOLUTION STRUCTURE OF THE HERG K+ CHANNEL S5-P EXTRACELLULAR LINKER 1F4I ; -1.00 ; SOLUTION STRUCTURE OF THE HHR23A UBA(2) MUTANT P333E, DEFICIENT IN BINDING THE HIV-1 ACCESSORY PROTEIN VPR 1FR0 ; -1.00 ; SOLUTION STRUCTURE OF THE HISTIDINE-CONTAINING PHOSPHOTRANSFER DOMAIN OF ANAEROBIC SENSOR KINASE ARCB FROM ESCHERICHIA COLI. 1Z2J ; -1.00 ; SOLUTION STRUCTURE OF THE HIV-1 FRAMESHIFT INDUCING ELEMENT 1PJY ; -1.00 ; SOLUTION STRUCTURE OF THE HIV-1 FRAMESHIFT INDUCING STEM- LOOP RIBONUCLEIC ACID 1Z9E ; -1.00 ; SOLUTION STRUCTURE OF THE HIV-1 INTEGRASE-BINDING DOMAIN IN LEDGF/P75 2CTO ; -1.00 ; SOLUTION STRUCTURE OF THE HMG BOX LIKE DOMAIN FROM HUMAN HYPOTHETICAL PROTEIN FLJ14904 2CS1 ; -1.00 ; SOLUTION STRUCTURE OF THE HMG DOMAIN OF HUMAN DEOXYRIBONUCLEIC ACID MISMATCH REPAIR PROTEIN 2CRJ ; -1.00 ; SOLUTION STRUCTURE OF THE HMG DOMAIN OF MOUSE HMG DOMAIN PROTEIN HMGX2 1WXL ; -1.00 ; SOLUTION STRUCTURE OF THE HMG-BOX DOMAIN IN THE SSRP1 SUBUNIT OF FACT 1WZ6 ; -1.00 ; SOLUTION STRUCTURE OF THE HMG_BOX DOMAIN OF MURINE BOBBY SOX HOMOLOG 2CO9 ; -1.00 ; SOLUTION STRUCTURE OF THE HMG_BOX DOMAIN OF THYMUS HIGH MOBILITY GROUP BOX PROTEIN TOX FROM MOUSE 1IRY ; -1.00 ; SOLUTION STRUCTURE OF THE HMTH1, A NUCLEOTIDE POOL SANITIZATION ENZYME 1OR5 ; -1.00 ; SOLUTION STRUCTURE OF THE HOLO-FORM OF THE FRENOLICIN ACYL CARRIER PROTEIN, MINIMIZED MEAN STRUCTURE 2CRA ; -1.00 ; SOLUTION STRUCTURE OF THE HOMEOBOX DOMAIN OF HUMAN HOMEO BOX B13 1X2N ; -1.00 ; SOLUTION STRUCTURE OF THE HOMEOBOX DOMAIN OF HUMAN HOMEOBOX PROTEIN PKNOX1 1WJH ; -1.00 ; SOLUTION STRUCTURE OF THE HOMEOBOX DOMAIN OF HUMAN HOMEODOMAIN LEUCINE ZIPPER-ENCODING GENE (HOMEZ) 1X2M ; -1.00 ; SOLUTION STRUCTURE OF THE HOMEOBOX DOMAIN OF MOUSE LAG1 LONGEVITY ASSURANCE HOMOLOG 6 2CUF ; -1.00 ; SOLUTION STRUCTURE OF THE HOMEOBOX DOMAIN OF THE HUMAN HYPOTHETICAL PROTEIN FLJ21616 2CUE ; -1.00 ; SOLUTION STRUCTURE OF THE HOMEOBOX DOMAIN OF THE HUMAN PAIRED BOX PROTEIN PAX-6 1WI3 ; -1.00 ; SOLUTION STRUCTURE OF THE HOMEODOMAIN OF KIAA1034 PROTEIN 1JOY ; -1.00 ; SOLUTION STRUCTURE OF THE HOMODIMERIC DOMAIN OF ENVZ FROM ESCHERICHIA COLI BY MULTI-DIMENSIONAL NMR. 1TUJ ; -1.00 ; SOLUTION STRUCTURE OF THE HONEY BEE GENERAL ODORANT BINDING PROTEIN ASP2 IN COMPLEX WITH TRIMETHYLSILYL-D4 PROPIONATE 1NIQ ; -1.00 ; SOLUTION STRUCTURE OF THE HOO-BM BOUND BLMT, TRANSPOSON TN5- ENCODING BLEOMYCIN-BINDING PROTEIN 2CPR ; -1.00 ; SOLUTION STRUCTURE OF THE HRDC DOMAIN OF HUMAN EXOSOME COMPONENT 10 2A7O ; -1.00 ; SOLUTION STRUCTURE OF THE HSET2/HYPB SRI DOMAIN 1FNX ; -1.00 ; SOLUTION STRUCTURE OF THE HUC RBD1-RBD2 COMPLEXED WITH THE AU-RICH ELEMENT 1UND ; -1.00 ; SOLUTION STRUCTURE OF THE HUMAN ADVILLIN C-TERMINAL HEADPIECE SUBDOMAIN 1W0B ; -1.00 ; SOLUTION STRUCTURE OF THE HUMAN ALPHA-HEMOGLOBIN STABILIZING PROTEIN (AHSP) P30A MUTANT 1KUN ; -1.00 ; SOLUTION STRUCTURE OF THE HUMAN ALPHA3-CHAIN TYPE VI COLLAGEN C-TERMINAL KUNITZ DOMAIN, NMR, 20 STRUCTURES 2D46 ; -1.00 ; SOLUTION STRUCTURE OF THE HUMAN BETA4A-A DOMAIN 1EL0 ; -1.00 ; SOLUTION STRUCTURE OF THE HUMAN CC CHEMOKINE, I-309 1WBR ; -1.00 ; SOLUTION STRUCTURE OF THE HUMAN CD4 (403-419) RECEPTOR PEPTIDE, NMR, 32 STRUCTURES 1EIG ; -1.00 ; SOLUTION STRUCTURE OF THE HUMAN CHEMOKINE EOTAXIN-2 1EIH ; -1.00 ; SOLUTION STRUCTURE OF THE HUMAN CHEMOKINE EOTAXIN-2 2HCC ; -1.00 ; SOLUTION STRUCTURE OF THE HUMAN CHEMOKINE HCC-2, NMR, 30 STRUCTURES 1E4S ; -1.00 ; SOLUTION STRUCTURE OF THE HUMAN DEFENSIN HBD-1 1E4Q ; -1.00 ; SOLUTION STRUCTURE OF THE HUMAN DEFENSIN HBD-2 1WQU ; -1.00 ; SOLUTION STRUCTURE OF THE HUMAN FES SH2 DOMAIN 1MW4 ; -1.00 ; SOLUTION STRUCTURE OF THE HUMAN GRB7-SH2 DOMAIN IN COMPLEX WITH A 10 AMINO ACID PEPTIDE PY1139 2C55 ; -1.00 ; SOLUTION STRUCTURE OF THE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 P6 PROTEIN 1J0S ; -1.00 ; SOLUTION STRUCTURE OF THE HUMAN INTERLEUKIN-18 1IY4 ; -1.00 ; SOLUTION STRUCTURE OF THE HUMAN LYSOZYME AT 35 DEGREE C 1IY3 ; -1.00 ; SOLUTION STRUCTURE OF THE HUMAN LYSOZYME AT 4 DEGREE C 1H5P ; -1.00 ; SOLUTION STRUCTURE OF THE HUMAN SP100B SAND DOMAIN BY HETERONUCLEAR NMR. 1O7C ; -1.00 ; SOLUTION STRUCTURE OF THE HUMAN TSG-6 LINK MODULE IN THE PRESENCE OF A HYALURONAN OCTASACCHARIDE 1UNC ; -1.00 ; SOLUTION STRUCTURE OF THE HUMAN VILLIN C-TERMINAL HEADPIECE SUBDOMAIN 1POZ ; -1.00 ; SOLUTION STRUCTURE OF THE HYALURONAN BINDING DOMAIN OF HUMAN CD44 1WJ5 ; -1.00 ; SOLUTION STRUCTURE OF THE HYPOTHETICAL DOMAIN OF RIKEN CDNA 0610009H20 1NWB ; -1.00 ; SOLUTION STRUCTURE OF THE HYPOTHETICAL PROTEIN AQ_1857 FROM AQUIFEX AEOLICUS: NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET QR6 1WLO ; -1.00 ; SOLUTION STRUCTURE OF THE HYPOTHETICAL PROTEIN FROM THERMUS THERMOPHILUS HB8 1PU1 ; -1.00 ; SOLUTION STRUCTURE OF THE HYPOTHETICAL PROTEIN MTH677 FROM METHANOTHERMOBACTER THERMAUTOTROPHICUS 1S04 ; -1.00 ; SOLUTION STRUCTURE OF THE HYPOTHETICAL PROTEIN PF0455 FROM PYROCOCCUS FURIOSUS: NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET PFR13 1RQ8 ; -1.00 ; SOLUTION STRUCTURE OF THE HYPOTHETICAL PROTEIN SAV1595 FROM STAPHYLOCOCCUS AUREUS, A PUTATIVE RIBONUCLEIC ACID BINDING PROTEIN 1X9A ; -1.00 ; SOLUTION STRUCTURE OF THE HYPOTHETICAL PROTEIN TM0979 FROM THERMOTOGA MARITIMA. ONTARIO CENTER FOR STRUCTURAL PROTEOMICS TARGET TM0979_1_87; NORTHEAST STRUCTURAL GENOMICS TARGET VT98. 1N91 ; -1.00 ; SOLUTION STRUCTURE OF THE HYPOTHETICAL PROTEIN YGGU FROM E. COLI. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET ER14. 1YH5 ; -1.00 ; SOLUTION STRUCTURE OF THE HYPOTHETICAL PROTEIN YGGU FROM E. COLI. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET ER14. 1OVQ ; -1.00 ; SOLUTION STRUCTURE OF THE HYPOTHETICAL PROTEIN YQGF FROM ESCHERICHIA COLI 1XHS ; -1.00 ; SOLUTION STRUCTURE OF THE HYPOTHETICAL PROTEIN YTFP FROM ESCHERICHIA COLI. NORTHEAST STRUCTURAL GENOMICS TARGET ER111. 1PQX ; -1.00 ; SOLUTION STRUCTURE OF THE HYPOTHETICAL STAPHYLOCOCCUS AUREUS PROTEIN SAV1430. NORTHEST STRUCUTRAL GENOMICS CONSORTIUM TARGET ZR18 2CT7 ; -1.00 ; SOLUTION STRUCTURE OF THE IBR DOMAIN OF THE RING FINGER PROTEIN 31 PROTEIN 2CR6 ; -1.00 ; SOLUTION STRUCTURE OF THE IG DOMAIN (2998-3100) OF HUMAN OBSCURIN 1FI7 ; -1.00 ; SOLUTION STRUCTURE OF THE IMIDAZOLE COMPLEX OF CYTOCHROME C 1FI9 ; -1.00 ; SOLUTION STRUCTURE OF THE IMIDAZOLE COMPLEX OF CYTOCHROME C 1NMI ; -1.00 ; SOLUTION STRUCTURE OF THE IMIDAZOLE COMPLEX OF ISO-1 CYTOCHROME C 1G9P ; -1.00 ; SOLUTION STRUCTURE OF THE INSECTICIDAL CALCIUM CHANNEL BLOCKER OMEGA-ATRACOTOXIN-HV2A 1DL0 ; -1.00 ; SOLUTION STRUCTURE OF THE INSECTICIDAL NEUROTOXIN J- ATRACOTOXIN-HV1C 1IFY ; -1.00 ; SOLUTION STRUCTURE OF THE INTERNAL UBA DOMAIN OF HHR23A 2CUG ; -1.00 ; SOLUTION STRUCTURE OF THE J DOMAIN OF THE PSEUDO DNAJ PROTEIN, MOUSE HYPOTHETICAL MKIAA0962 1YZB ; -1.00 ; SOLUTION STRUCTURE OF THE JOSEPHIN DOMAIN OF ATAXIN-3 1RQM ; -1.00 ; SOLUTION STRUCTURE OF THE K18G/R82E ALICYCLOBACILLUS ACIDOCALDARIUS THIOREDOXIN MUTANT 1YZ8 ; -1.00 ; SOLUTION STRUCTURE OF THE K50 CLASS HOMEODOMAIN PITX2 BOUND TO DEOXYRIBONUCLEIC ACID AND IMPLICATIONS FOR MUTATIONS THAT CAUSE RIEGER SYNDROME 1WH9 ; -1.00 ; SOLUTION STRUCTURE OF THE KH DOMAIN OF HUMAN RIBOSOMAL PROTEIN S3 2BL5 ; -1.00 ; SOLUTION STRUCTURE OF THE KH-QUA2 REGION OF THE XENOPUS STAR-GSG QUAKING PROTEIN. 1F5U ; -1.00 ; SOLUTION STRUCTURE OF THE KISSING DIMER OF H3 GACG STEM- LOOP IN THE 5'-END DIMERIZATION SIGNAL OF MOLONEY MURINE LEUKEMIA VIRUS GENOMIC RIBONUCLEIC ACID 1SB0 ; -1.00 ; SOLUTION STRUCTURE OF THE KIX DOMAIN OF CBP BOUND TO THE TRANSACTIVATION DOMAIN OF C-MYB 1V65 ; -1.00 ; SOLUTION STRUCTURE OF THE KRUPPEL-ASSOCIATED BOX (KRAB) DOMAIN 1VYX ; -1.00 ; SOLUTION STRUCTURE OF THE KSHV K3 N-TERMINAL DOMAIN 2CQK ; -1.00 ; SOLUTION STRUCTURE OF THE LA DOMAIN OF C-MPL BINDING PROTEIN 1XFE ; -1.00 ; SOLUTION STRUCTURE OF THE LA7-EGFA PAIR FROM THE LDL RECEPTOR 1JCP ; -1.00 ; SOLUTION STRUCTURE OF THE LACTAM ANALOGUE EDAP OF HIV GP41 600-612 LOOP. 1KJK ; -1.00 ; SOLUTION STRUCTURE OF THE LAMBDA INTEGRASE AMINO-TERMINAL DOMAIN 1LDZ ; -1.00 ; SOLUTION STRUCTURE OF THE LEAD-DEPENDENT RIBOZYME, NMR, 25 STRUCTURES 2LDZ ; -1.00 ; SOLUTION STRUCTURE OF THE LEAD-DEPENDENT RIBOZYME, NMR, MINIMIZED AVERAGE STRUCTURE 1ZFI ; -1.00 ; SOLUTION STRUCTURE OF THE LEECH CARBOXYPEPTIDASE INHIBITOR 1WYH ; -1.00 ; SOLUTION STRUCTURE OF THE LIM DOMAIN FROM HUMAN SKELETAL MUSCLE LIM-PROTEIN 2 1X64 ; -1.00 ; SOLUTION STRUCTURE OF THE LIM DOMAIN OF ALPHA-ACTININ-2 ASSOCIATED LIM PROTEIN 1X62 ; -1.00 ; SOLUTION STRUCTURE OF THE LIM DOMAIN OF CARBOXYL TERMINAL LIM DOMAIN PROTEIN 1 1V6G ; -1.00 ; SOLUTION STRUCTURE OF THE LIM DOMAIN OF THE HUMAN ACTIN BINDING LIM PROTEIN 2 1X3H ; -1.00 ; SOLUTION STRUCTURE OF THE LIM DOMAIN OF THE LEUPAXIN 1K8M ; -1.00 ; SOLUTION STRUCTURE OF THE LIPOIC ACID-BEARING DOMAIN OF THE E2 COMPONENT OF HUMAN, MITOCHONDRIAL BRANCHED-CHAIN ALPHA- KETOACID DEHYDROGENASE 1K8O ; -1.00 ; SOLUTION STRUCTURE OF THE LIPOIC ACID-BEARING DOMAIN OF THE E2 COMPONENT OF HUMAN, MITOCHONDRIAL BRANCHED-CHAIN ALPHA- KETOACID DEHYDROGENASE 1GHK ; -1.00 ; SOLUTION STRUCTURE OF THE LIPOYL DOMAIN OF THE 2-OXOGLUTARATE DEHYDROGENASE COMPLEX FROM AZOTOBACTER VINELAND II, NMR, 25 STRUCTURES 1GHJ ; -1.00 ; SOLUTION STRUCTURE OF THE LIPOYL DOMAIN OF THE 2-OXOGLUTARATE DEHYDROGENASE COMPLEX FROM AZOTOBACTER VINELAND II, NMR, MINIMIZED AVERAGE STRUCTURE 1GJX ; -1.00 ; SOLUTION STRUCTURE OF THE LIPOYL DOMAIN OF THE CHIMERIC DIHYDROLIPOYL DEHYDROGENASE P64K FROM NEISSERIA MENINGITIDIS 1P8A ; -1.00 ; SOLUTION STRUCTURE OF THE LOW MOLECULAR WEIGHT PROTEIN TYROSINE PHOSPHATASE FROM TRITRICHOMONAS FOETUS 1NZP ; -1.00 ; SOLUTION STRUCTURE OF THE LYASE DOMAIN OF HUMAN DEOXYRIBONUCLEIC ACID POLYMERASE LAMBDA 1FI3 ; -1.00 ; SOLUTION STRUCTURE OF THE M61H MUTANT OF PSEUDOMONAS STUTZERI SUBSTRAIN ZOBELL FERROCYTOCHROME C-551 1HTX ; -1.00 ; SOLUTION STRUCTURE OF THE MAIN ALPHA-AMYLASE INHIBITOR FROM AMARANTH SEEDS 1E09 ; -1.00 ; SOLUTION STRUCTURE OF THE MAJOR CHERRY ALLERGEN PRU AV 1 1H2O ; -1.00 ; SOLUTION STRUCTURE OF THE MAJOR CHERRY ALLERGEN PRU AV 1 MUTANT E45W 1Q8N ; -1.00 ; SOLUTION STRUCTURE OF THE MALACHITE GREEN RIBONUCLEIC ACID BINDING APTAMER 1F43 ; -1.00 ; SOLUTION STRUCTURE OF THE MATA1 HOMEODOMAIN 1UB1 ; -1.00 ; SOLUTION STRUCTURE OF THE MATRIX ATTACHMENT REGION-BINDING DOMAIN OF CHICKEN MECP2 1Q9P ; -1.00 ; SOLUTION STRUCTURE OF THE MATURE HIV-1 PROTEASE MONOMER 1KUP ; -1.00 ; SOLUTION STRUCTURE OF THE MEMBRANE PROXIMAL REGIONS OF ALPHA-IIB AND BETA-3 INTEGRINS 1KUZ ; -1.00 ; SOLUTION STRUCTURE OF THE MEMBRANE PROXIMAL REGIONS OF ALPHA-IIB AND BETA-3 INTEGRINS 202D ; -1.00 ; SOLUTION STRUCTURE OF THE MENOGARIL-DEOXYRIBONUCLEIC ACID COMPLEX 1IX5 ; -1.00 ; SOLUTION STRUCTURE OF THE METHANOCOCCUS THERMOLITHOTROPHICUS FKBP 1BA6 ; -1.00 ; SOLUTION STRUCTURE OF THE METHIONINE-OXIDIZED AMYLOID BETA-PEPTIDE (1-40). DOES OXIDATION AFFECT CONFORMATIONAL SWITCHING? NMR, 10 STRUCTURES 1IG4 ; -1.00 ; SOLUTION STRUCTURE OF THE METHYL-CPG-BINDING DOMAIN OF HUMAN MBD1 IN COMPLEX WITH METHYLATED DEOXYRIBONUCLEIC ACID 1D9N ; -1.00 ; SOLUTION STRUCTURE OF THE METHYL-CPG-BINDING DOMAIN OF THE METHYLATION-DEPENDENT TRANSCRIPTIONAL REPRESSOR MBD1/PCM1 1EV0 ; -1.00 ; SOLUTION STRUCTURE OF THE MINE TOPOLOGICAL SPECIFICITY DOMAIN 2CQM ; -1.00 ; SOLUTION STRUCTURE OF THE MITOCHONDRIAL RIBOSOMAL PROTEIN L17 ISOLOG 1PT4 ; -1.00 ; SOLUTION STRUCTURE OF THE MOEBIUS CYCLOTIDE KALATA B2 1DON ; -1.00 ; SOLUTION STRUCTURE OF THE MONOCYTE CHEMOATTRACTANT PROTEIN-1 DIMER USING HETERONUCLEAR, NMR, 20 STRUCTURES 1DOM ; -1.00 ; SOLUTION STRUCTURE OF THE MONOCYTE CHEMOATTRACTANT PROTEIN-1 DIMER USING HETERONUCLEAR, NMR, MINIMIZED AVERAGE STRUCTURE 1L5C ; -1.00 ; SOLUTION STRUCTURE OF THE MONOMERIC FORM OF A MUTANT UNLIGANDED BOVINE NEUROPHYSIN, 20 STRUCTURES 1L5D ; -1.00 ; SOLUTION STRUCTURE OF THE MONOMERIC FORM OF A MUTANT UNLIGANDED BOVINE NEUROPHYSIN, MINIMIZED AVERAGE STRUCTURE 1QWQ ; -1.00 ; SOLUTION STRUCTURE OF THE MONOMERIC N67D MUTANT OF BOVINE SEMINAL RIBONUCLEASE 1JE4 ; -1.00 ; SOLUTION STRUCTURE OF THE MONOMERIC VARIANT OF THE CHEMOKINE MIP-1BETA 1JCO ; -1.00 ; SOLUTION STRUCTURE OF THE MONOMERIC [THR(B27)->PRO,PRO(B28)- >THR] INSULIN MUTANT (PT INSULIN) 1SSF ; -1.00 ; SOLUTION STRUCTURE OF THE MOUSE 53BP1 FRAGMENT (RESIDUES 1463-1617) 1E4T ; -1.00 ; SOLUTION STRUCTURE OF THE MOUSE DEFENSIN MBD-7 1E4R ; -1.00 ; SOLUTION STRUCTURE OF THE MOUSE DEFENSIN MBD-8 1WGE ; -1.00 ; SOLUTION STRUCTURE OF THE MOUSE DESR1 1KN6 ; -1.00 ; SOLUTION STRUCTURE OF THE MOUSE PROHORMONE CONVERTASE 1 PRO- DOMAIN 2CRI ; -1.00 ; SOLUTION STRUCTURE OF THE MSP DOMAIN OF MOUSE VAMP- ASSOCIATED PROTEINA 1WIC ; -1.00 ; SOLUTION STRUCTURE OF THE MSP DOMAIN OF RIKEN CDNA 6030424E15 1NEQ ; -1.00 ; SOLUTION STRUCTURE OF THE MU NER PROTEIN BY MULTIDIMENSIONAL NMR 1NER ; -1.00 ; SOLUTION STRUCTURE OF THE MU NER PROTEIN BY MULTIDIMENSIONAL NMR 1Y8F ; -1.00 ; SOLUTION STRUCTURE OF THE MUNC13-1 C1-DOMAIN 1UK5 ; -1.00 ; SOLUTION STRUCTURE OF THE MURINE BAG DOMAIN OF BCL2- ASSOCIATED ATHANOGENE 3 1UH6 ; -1.00 ; SOLUTION STRUCTURE OF THE MURINE UBIQUITIN-LIKE 5 PROTEIN FROM RIKEN CDNA 0610031K06 1PPX ; -1.00 ; SOLUTION STRUCTURE OF THE MUTT PYROPHOSPHOHYDROLASE COMPLEXED WITH MG(2+) AND 8-OXO-DGMP, A TIGHTLY-BOUND PRODUCT 1PUN ; -1.00 ; SOLUTION STRUCTURE OF THE MUTT PYROPHOSPHOHYDROLASE COMPLEXED WITH MG(2+) AND 8-OXO-DGMP, A TIGHTLY-BOUND PRODUCT 1PUQ ; -1.00 ; SOLUTION STRUCTURE OF THE MUTT PYROPHOSPHOHYDROLASE COMPLEXED WITH MG(2+) AND 8-OXO-DGMP, A TIGHTLY-BOUND PRODUCT 1PUS ; -1.00 ; SOLUTION STRUCTURE OF THE MUTT PYROPHOSPHOHYDROLASE COMPLEXED WITH MG(2+) AND 8-OXO-DGMP, A TIGHTLY-BOUND PRODUCT 1X41 ; -1.00 ; SOLUTION STRUCTURE OF THE MYB-LIKE DEOXYRIBONUCLEIC ACID BINDING DOMAIN OF HUMAN TRANSCRIPTIONAL ADAPTOR 2-LIKE, ISOFORM B 2CRG ; -1.00 ; SOLUTION STRUCTURE OF THE MYB-LIKE DEOXYRIBONUCLEIC ACID-BINDING DOMAIN OF MOUSE MTA3 PROTEIN 1HN3 ; -1.00 ; SOLUTION STRUCTURE OF THE N-TERMINAL 37 AMINO ACIDS OF THE MOUSE ARF TUMOR SUPPRESSOR PROTEIN 1UF0 ; -1.00 ; SOLUTION STRUCTURE OF THE N-TERMINAL DCX DOMAIN OF HUMAN DOUBLECORTIN-LIKE KINASE 1Z0R ; -1.00 ; SOLUTION STRUCTURE OF THE N-TERMINAL DEOXYRIBONUCLEIC ACID RECOGNITION DOMAIN OF THE BACILLUS SUBTILIS TRANSCRIPTION-STATE REGULATOR ABRB 1WIB ; -1.00 ; SOLUTION STRUCTURE OF THE N-TERMINAL DOMAIN FROM MOUSE HYPOTHETICAL PROTEIN BAB22488 1WJT ; -1.00 ; SOLUTION STRUCTURE OF THE N-TERMINAL DOMAIN I OF MOUSE TRANSCRIPTION ELONGATION FACTOR S-II PROTEIN 3 1KQK ; -1.00 ; SOLUTION STRUCTURE OF THE N-TERMINAL DOMAIN OF A POTENTIAL COPPER-TRANSLOCATING P-TYPE ATPASE FROM BACILLUS SUBTILIS IN THE CU(I)LOADED STATE 1SW8 ; -1.00 ; SOLUTION STRUCTURE OF THE N-TERMINAL DOMAIN OF HUMAN N60D CALMODULIN REFINED WITH PARAMAGNETISM BASED STRATEGY 2CQL ; -1.00 ; SOLUTION STRUCTURE OF THE N-TERMINAL DOMAIN OF HUMAN RIBOSOMAL PROTEIN L9 1WGW ; -1.00 ; SOLUTION STRUCTURE OF THE N-TERMINAL DOMAIN OF MOUSE PUTATIVE SIGNAL RECOGINITION PARTICLE 54 (SRP54) 1IWF ; -1.00 ; SOLUTION STRUCTURE OF THE N-TERMINAL DOMAIN OF PIG GASTRIC H/K-ATPASE 1HZE ; -1.00 ; SOLUTION STRUCTURE OF THE N-TERMINAL DOMAIN OF RIBOFLAVIN SYNTHASE FROM E. COLI 1I18 ; -1.00 ; SOLUTION STRUCTURE OF THE N-TERMINAL DOMAIN OF RIBOFLAVIN SYNTHASE FROM E. COLI 1CQU ; -1.00 ; SOLUTION STRUCTURE OF THE N-TERMINAL DOMAIN OF RIBOSOMAL PROTEIN L9 1M2E ; -1.00 ; SOLUTION STRUCTURE OF THE N-TERMINAL DOMAIN OF SYNECHOCOCCUS ELONGATUS KAIA (KAIA135N); AVERAGE MINIMIZED STRUCTURE. 1M2F ; -1.00 ; SOLUTION STRUCTURE OF THE N-TERMINAL DOMAIN OF SYNECHOCOCCUS ELONGATUS KAIA (KAIA135N); FAMILY OF 25 STRUCTURES 1T4Z ; -1.00 ; SOLUTION STRUCTURE OF THE N-TERMINAL DOMAIN OF SYNECHOCOCCUS ELONGATUS SASA (25-STRUCTURES ENSEMBLE) 1T4Y ; -1.00 ; SOLUTION STRUCTURE OF THE N-TERMINAL DOMAIN OF SYNECHOCOCCUS ELONGATUS SASA (AVERAGE MINIMIZED STRUCTURE) 1J3X ; -1.00 ; SOLUTION STRUCTURE OF THE N-TERMINAL DOMAIN OF THE HMGB2 1G25 ; -1.00 ; SOLUTION STRUCTURE OF THE N-TERMINAL DOMAIN OF THE HUMAN TFIIH MAT1 SUBUNIT 1F2H ; -1.00 ; SOLUTION STRUCTURE OF THE N-TERMINAL DOMAIN OF THE TNFR1 ASSOCIATED PROTEIN, TRADD. 1MWY ; -1.00 ; SOLUTION STRUCTURE OF THE N-TERMINAL DOMAIN OF ZNTA IN THE APO-FORM 1MWZ ; -1.00 ; SOLUTION STRUCTURE OF THE N-TERMINAL DOMAIN OF ZNTA IN THE ZN(II)-FORM 1WHQ ; -1.00 ; SOLUTION STRUCTURE OF THE N-TERMINAL DSRBD FROM HYPOTHETICAL PROTEIN BAB28848 1QGB ; -1.00 ; SOLUTION STRUCTURE OF THE N-TERMINAL F1 MODULE PAIR FROM HUMAN FIBRONECTIN 1V4Z ; -1.00 ; SOLUTION STRUCTURE OF THE N-TERMINAL FRAGMENT OF S100C/A11 PROTEIN 2CPQ ; -1.00 ; SOLUTION STRUCTURE OF THE N-TERMINAL KH DOMAIN OF HUMAN FXR1 1O53 ; -1.00 ; SOLUTION STRUCTURE OF THE N-TERMINAL MEMBRANE ANCHOR OF E. COLI ENZYME IIA(GLUCOSE) 1PFJ ; -1.00 ; SOLUTION STRUCTURE OF THE N-TERMINAL PH/PTB DOMAIN OF THE TFIIH P62 SUBUNIT 1V5P ; -1.00 ; SOLUTION STRUCTURE OF THE N-TERMINAL PLECKSTRIN HOMOLOGY DOMAIN OF TAPP2 FROM MOUSE 1WXM ; -1.00 ; SOLUTION STRUCTURE OF THE N-TERMINAL RAS-BINDING DOMAIN (RBD) IN HUMAN A-RAF KINASE 1NTR ; -1.00 ; SOLUTION STRUCTURE OF THE N-TERMINAL RECEIVER DOMAIN OF NTRC 1WHW ; -1.00 ; SOLUTION STRUCTURE OF THE N-TERMINAL RIBONUCLEIC ACID BINDING DOMAIN FROM HYPOTHETICAL PROTEIN BAB23448 2CPJ ; -1.00 ; SOLUTION STRUCTURE OF THE N-TERMINAL RIBONUCLEIC ACID RECOGNITION MOTIF OF NONO 1UAW ; -1.00 ; SOLUTION STRUCTURE OF THE N-TERMINAL RIBONUCLEIC ACID-BINDING DOMAIN OF MOUSE MUSASHI1 2A36 ; -1.00 ; SOLUTION STRUCTURE OF THE N-TERMINAL SH3 DOMAIN OF DRK 1ND9 ; -1.00 ; SOLUTION STRUCTURE OF THE N-TERMINAL SUBDOMAIN OF TRANSLATION INITIATION FACTOR IF2 1WY8 ; -1.00 ; SOLUTION STRUCTURE OF THE N-TERMINAL UBIQUITIN-LIKE DOMAIN IN HUMAN NP95/ICBP90-LIKE RING FINGER PROTEIN (NIRF) 1X1M ; -1.00 ; SOLUTION STRUCTURE OF THE N-TERMINAL UBIQUITIN-LIKE DOMAIN IN MOUSE UBIQUITIN-LIKE PROTEIN SB132 1WX8 ; -1.00 ; SOLUTION STRUCTURE OF THE N-TERMINAL UBIQUITIN-LIKE DOMAIN IN THE 4931431F19RIK PROTEIN 1WX9 ; -1.00 ; SOLUTION STRUCTURE OF THE N-TERMINAL UBIQUITIN-LIKE DOMAIN IN THE HUMAN BAT3 PROTEIN 1WX7 ; -1.00 ; SOLUTION STRUCTURE OF THE N-TERMINAL UBIQUITIN-LIKE DOMAIN IN THE HUMAN UBIQUILIN 3 (UBQLN3) 1WGG ; -1.00 ; SOLUTION STRUCTURE OF THE N-TERMINAL UBIQUITIN-LIKE DOMAIN OF MOUSE UBIQUITIN SPECIFIC PROTEASE 14 (USP14) 1WJU ; -1.00 ; SOLUTION STRUCTURE OF THE N-TERMINAL UBIQUITIN-LIKE DOMAIN OF NEDD8 ULTIMATE BUSTER-1 1WJV ; -1.00 ; SOLUTION STRUCTURE OF THE N-TERMINAL ZINC FINGER DOMAIN OF CELL GROWTH REGULATING NUCLEOLAR PROTEIN LYAR 1GNF ; -1.00 ; SOLUTION STRUCTURE OF THE N-TERMINAL ZINC FINGER OF MURINE GATA-1, NMR, 25 STRUCTURES 1ZU1 ; -1.00 ; SOLUTION STRUCTURE OF THE N-TERMINAL ZINC FINGERS OF THE XENOPUS LAEVIS DOUBLE STRANDED RIBONUCLEIC ACID BINDING PROTEIN ZFA 1WJB ; -1.00 ; SOLUTION STRUCTURE OF THE N-TERMINAL ZN BINDING DOMAIN OF HIV-1 INTEGRASE (D FORM), NMR, 40 STRUCTURES 1WJA ; -1.00 ; SOLUTION STRUCTURE OF THE N-TERMINAL ZN BINDING DOMAIN OF HIV-1 INTEGRASE (D FORM), NMR, REGULARIZED MEAN STRUCTURE 1WJD ; -1.00 ; SOLUTION STRUCTURE OF THE N-TERMINAL ZN BINDING DOMAIN OF HIV-1 INTEGRASE (E FORM), NMR, 38 STRUCTURES 1WJC ; -1.00 ; SOLUTION STRUCTURE OF THE N-TERMINAL ZN BINDING DOMAIN OF HIV-1 INTEGRASE (E FORM), NMR, REGULARIZED MEAN STRUCTURE 1NZ9 ; -1.00 ; SOLUTION STRUCTURE OF THE N-UTILISATION SUBSTANCE G (NUSG) C-TERMINAL (NGC) DOMAIN FROM THERMUS THERMOPHILUS 1NZ8 ; -1.00 ; SOLUTION STRUCTURE OF THE N-UTILISATION SUBSTANCE G (NUSG) N-TERMINAL (NGN) DOMAIN FROM THERMUS THERMOPHILUS 1E3T ; -1.00 ; SOLUTION STRUCTURE OF THE NADP(H) BINDING COMPONENT (DIII) OF PROTON-TRANSLOCATING TRANSHYDROGENASE FROM RHODOSPIRILLUM RUBRUM 1PX9 ; -1.00 ; SOLUTION STRUCTURE OF THE NATIVE CNERG1 ERGTOXIN, A HIGHLY SPECIFIC INHIBITOR OF HERG CHANNEL 1LWR ; -1.00 ; SOLUTION STRUCTURE OF THE NCAM FIBRONECTIN TYPE III MODULE 2 1IIJ ; -1.00 ; SOLUTION STRUCTURE OF THE NEU/ERBB-2 MEMBRANE SPANNING SEGMENT 1FU9 ; -1.00 ; SOLUTION STRUCTURE OF THE NINTH ZINC-FINGER DOMAIN OF THE U- SHAPED TRANSCRIPTION FACTOR 1S9N ; -1.00 ; SOLUTION STRUCTURE OF THE NITROUS ACID (G)-(G) CROSS-LINKED DEOXYRIBONUCLEIC ACID DODECAMER DUPLEX GCATCC(G)GATGC 1S9O ; -1.00 ; SOLUTION STRUCTURE OF THE NITROUS ACID INDUCED DEOXYRIBONUCLEIC ACID INTERSTRAND CROSS-LINKED DODECAMER DUPLEX CGCTAC(G)TAGCG WITH THE CROSS-LINKED GUANINES DENOTED (G) 1J5N ; -1.00 ; SOLUTION STRUCTURE OF THE NON-SEQUENCE-SPECIFIC HMGB PROTEIN NHP6A IN COMPLEX WITH SRY DEOXYRIBONUCLEIC ACID 1JLO ; -1.00 ; SOLUTION STRUCTURE OF THE NONCOMPETITIVE SKELETAL MUSCLE NICOTINIC ACETYLCHOLINE RECEPTOR ANTAGONIST PSI-CONOTOXIN PIIIE 1JLP ; -1.00 ; SOLUTION STRUCTURE OF THE NONCOMPETITIVE SKELETAL MUSCLE NICOTINIC ACETYLCHOLINE RECEPTOR ANTAGONIST PSI-CONOTOXIN PIIIF 2CZY ; -1.00 ; SOLUTION STRUCTURE OF THE NRSF/REST-MSIN3B PAH1 COMPLEX 1NO8 ; -1.00 ; SOLUTION STRUCTURE OF THE NUCLEAR FACTOR ALY RBD DOMAIN 1J9N ; -1.00 ; SOLUTION STRUCTURE OF THE NUCLEOPEPTIDE [AC-LYS-TRP-LYS- HSE(P3DGCATCG)-ALA]-[P5DCGTAGC] 1X51 ; -1.00 ; SOLUTION STRUCTURE OF THE NUDIX DOMAIN FROM HUMAN A/G- SPECIFIC ADENINE DEOXYRIBONUCLEIC ACID GLYCOSYLASE ALPHA-3 SPLICE ISOFORM 1JKN ; -1.00 ; SOLUTION STRUCTURE OF THE NUDIX ENZYME DIADENOSINE TETRAPHOSPHATE HYDROLASE FROM LUPINUS ANGUSTIFOLIUS COMPLEXED WITH ATP 1F3Y ; -1.00 ; SOLUTION STRUCTURE OF THE NUDIX ENZYME DIADENOSINE TETRAPHOSPHATE HYDROLASE FROM LUPINUS ANGUSTIFOLIUS L. 1DDM ; -1.00 ; SOLUTION STRUCTURE OF THE NUMB PTB DOMAIN COMPLEXED TO A NAK PEPTIDE 1LR1 ; -1.00 ; SOLUTION STRUCTURE OF THE OLIGOMERIZATION DOMAIN OF THE BACTERIAL CHROMATIN-STRUCTURING PROTEIN H-NS 1QTT ; -1.00 ; SOLUTION STRUCTURE OF THE ONCOPROTEIN P13MTCP1 1QTU ; -1.00 ; SOLUTION STRUCTURE OF THE ONCOPROTEIN P13MTCP1 1TBD ; -1.00 ; SOLUTION STRUCTURE OF THE ORIGIN DEOXYRIBONUCLEIC ACID BINDING DOMAIN OF SV40 T-ANTIGEN, NMR, MINIMIZED AVERAGE STRUCTURE 1FVY ; -1.00 ; SOLUTION STRUCTURE OF THE OSTEOGENIC 1-31 FRAGMENT OF THE HUMAN PARATHYROID HORMONE 1SSE ; -1.00 ; SOLUTION STRUCTURE OF THE OXIDIZED FORM OF THE YAP1 REDOX DOMAIN 1WLP ; -1.00 ; SOLUTION STRUCTURE OF THE P22PHOX-P47PHOX COMPLEX 1NA2 ; -1.00 ; SOLUTION STRUCTURE OF THE P2B HAIRPIN FROM HUMAN TELOMERASE RIBONUCLEIC ACID 1YMO ; -1.00 ; SOLUTION STRUCTURE OF THE P2B-P3 PSEUDOKNOT FROM HUMAN TELOMERASE RIBONUCLEIC ACID 1XZY ; -1.00 ; SOLUTION STRUCTURE OF THE P30-TRANS FORM OF ALPHA HEMOGLOBIN STABILIZING PROTEIN (AHSP) 1C0O ; -1.00 ; SOLUTION STRUCTURE OF THE P5 HAIRPIN FROM A GROUP I INTRON COMPLEXED WITH COBALT (III) HEXAMMINE, NMR, 19 CONVERGED STRUCTURES 1AJF ; -1.00 ; SOLUTION STRUCTURE OF THE P5B STEM LOOP FROM A GROUP I INTRON COMPLEXED WITH COBALT (III) HEXAMMINE, NMR, MINIMIZED AVERAGE STRUCTURE 1G9L ; -1.00 ; SOLUTION STRUCTURE OF THE PABC DOMAIN OF HUMAN POLY(A) BINDING PROTEIN 1IP9 ; -1.00 ; SOLUTION STRUCTURE OF THE PB1 DOMAIN OF BEM1P 1IPG ; -1.00 ; SOLUTION STRUCTURE OF THE PB1 DOMAIN OF BEM1P 1Q1O ; -1.00 ; SOLUTION STRUCTURE OF THE PB1 DOMAIN OF CDC24P (LONG FORM) 1TZ1 ; -1.00 ; SOLUTION STRUCTURE OF THE PB1 DOMAIN OF CDC24P (SHORT FORM) 2CU1 ; -1.00 ; SOLUTION STRUCTURE OF THE PB1 DOMAIN OF HUMAN PROTEIN KINASE MEKK2B 1VD2 ; -1.00 ; SOLUTION STRUCTURE OF THE PB1 DOMAIN OF PKCIOTA 1UFM ; -1.00 ; SOLUTION STRUCTURE OF THE PCI DOMAIN 1WI9 ; -1.00 ; SOLUTION STRUCTURE OF THE PCI DOMAIN FROM MOUSE HYPOTHETICAL PROTEIN AAH51541 1V5Q ; -1.00 ; SOLUTION STRUCTURE OF THE PDZ DOMAIN FROM MOUSE GLUTAMATE RECEPTOR INTERACTING PROTEIN 1A-L (GRIP1) HOMOLOG 1WI2 ; -1.00 ; SOLUTION STRUCTURE OF THE PDZ DOMAIN FROM RIKEN CDNA 2700099C19 1T2M ; -1.00 ; SOLUTION STRUCTURE OF THE PDZ DOMAIN OF AF-6 1WF7 ; -1.00 ; SOLUTION STRUCTURE OF THE PDZ DOMAIN OF ENIGMA HOMOLOGUE PROTEIN 2CSS ; -1.00 ; SOLUTION STRUCTURE OF THE PDZ DOMAIN OF HUMAN KIAA0340 PROTEIN 1VAE ; -1.00 ; SOLUTION STRUCTURE OF THE PDZ DOMAIN OF MOUSE RHOPHILIN-2 1VA8 ; -1.00 ; SOLUTION STRUCTURE OF THE PDZ DOMAIN OF PALS1 PROTEIN 1VB7 ; -1.00 ; SOLUTION STRUCTURE OF THE PDZ DOMAIN OF PDZ AND LIM DOMAIN 2 1WHD ; -1.00 ; SOLUTION STRUCTURE OF THE PDZ DOMAIN OF RGS3 1WF8 ; -1.00 ; SOLUTION STRUCTURE OF THE PDZ DOMAIN OF SPINOPHILIN/NEURABINII PROTEIN 1WI4 ; -1.00 ; SOLUTION STRUCTURE OF THE PDZ DOMAIN OF SYNTAXIN BINDING PROTEIN 4 3PDZ ; -1.00 ; SOLUTION STRUCTURE OF THE PDZ2 DOMAIN FROM HUMAN PHOSPHATASE HPTP1E 1D5G ; -1.00 ; SOLUTION STRUCTURE OF THE PDZ2 DOMAIN FROM HUMAN PHOSPHATASE HPTP1E COMPLEXED WITH A PEPTIDE 1YGO ; -1.00 ; SOLUTION STRUCTURE OF THE PELLE DEATH DOMAIN 2CPF ; -1.00 ; SOLUTION STRUCTURE OF THE PENULTIMATE RIBONUCLEIC ACID RECOGNITION MOTIF OF HYPOTHETICAL RIBONUCLEIC ACID-BINDING PROTEIN RBM19 1X60 ; -1.00 ; SOLUTION STRUCTURE OF THE PEPTIDOGLYCAN BINDING DOMAIN OF B. SUBTILIS CELL WALL LYTIC ENZYME CWLC 1FHO ; -1.00 ; SOLUTION STRUCTURE OF THE PH DOMAIN FROM THE C. ELEGANS MUSCLE PROTEIN UNC-89 1WI1 ; -1.00 ; SOLUTION STRUCTURE OF THE PH DOMAIN OF HUMAN CALCIUM- DEPENDENT ACTIVATOR PROTEIN FOR SECRETION (CAPS) 1X1F ; -1.00 ; SOLUTION STRUCTURE OF THE PH DOMAIN OF HUMAN DOCKING PROTEIN BRDG1 2COA ; -1.00 ; SOLUTION STRUCTURE OF THE PH DOMAIN OF PROTEIN KINASE C, D2 TYPE FROM HUMAN 1FP0 ; -1.00 ; SOLUTION STRUCTURE OF THE PHD DOMAIN FROM THE KAP-1 COREPRESSOR 1WIK ; -1.00 ; SOLUTION STRUCTURE OF THE PICOT HOMOLOGY 2 DOMAIN OF THE MOUSE PKC-INTERACTING COUSIN OF THIOREDOXIN PROTEIN 1WGO ; -1.00 ; SOLUTION STRUCTURE OF THE PKD DOMAIN FROM HUMAN VPS10 DOMAIN-CONTAINING RECEPTOR SORCS2 1V61 ; -1.00 ; SOLUTION STRUCTURE OF THE PLECKSTRIN HOMOLOGY DOMAIN OF ALPHA-PIX 1V89 ; -1.00 ; SOLUTION STRUCTURE OF THE PLECKSTRIN HOMOLOGY DOMAIN OF HUMAN KIAA0053 PROTEIN 1P6S ; -1.00 ; SOLUTION STRUCTURE OF THE PLECKSTRIN HOMOLOGY DOMAIN OF HUMAN PROTEIN KINASE B BETA (PKB/AKT) 1V5M ; -1.00 ; SOLUTION STRUCTURE OF THE PLECKSTRIN HOMOLOGY DOMAIN OF MOUSE APS 1WGQ ; -1.00 ; SOLUTION STRUCTURE OF THE PLECKSTRIN HOMOLOGY DOMAIN OF MOUSE ETHANOL DECREASED 4 PROTEIN 1V88 ; -1.00 ; SOLUTION STRUCTURE OF THE PLECKSTRIN HOMOLOGY DOMAIN OF OXYSTEROL-BINDING PROTEIN-RELATED PROTEIN 8 (KIAA1451 PROTEIN) 1SXD ; -1.00 ; SOLUTION STRUCTURE OF THE POINTED (PNT) DOMAIN FROM MGABPA 1OF9 ; -1.00 ; SOLUTION STRUCTURE OF THE PORE FORMING TOXIN OF ENTAMOEBA HISTOLYTICA (AMOEBAPORE A) 1QUZ ; -1.00 ; SOLUTION STRUCTURE OF THE POTASSIUM CHANNEL SCORPION TOXIN HSTX1 1H20 ; -1.00 ; SOLUTION STRUCTURE OF THE POTATO CARBOXYPEPTIDASE INHIBITOR 1L1P ; -1.00 ; SOLUTION STRUCTURE OF THE PPIASE DOMAIN FROM E. COLI TRIGGER FACTOR 1NMW ; -1.00 ; SOLUTION STRUCTURE OF THE PPIASE DOMAIN OF HUMAN PIN1 1IT4 ; -1.00 ; SOLUTION STRUCTURE OF THE PROKARYOTIC PHOSPHOLIPASE A2 FROM STREPTOMYCES VIOLACEORUBER 1NR3 ; -1.00 ; SOLUTION STRUCTURE OF THE PROTEIN MTH0916: THE NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET TT212 1O6W ; -1.00 ; SOLUTION STRUCTURE OF THE PRP40 WW DOMAIN PAIR OF THE YEAST SPLICING FACTOR PRP40 1E95 ; -1.00 ; SOLUTION STRUCTURE OF THE PSEUDOKNOT OF SRV-1 RIBONUCLEIC ACID, INVOLVED IN RIBOSOMAL FRAMESHIFTING 1SSL ; -1.00 ; SOLUTION STRUCTURE OF THE PSI DOMAIN FROM THE MET RECEPTOR 1MP1 ; -1.00 ; SOLUTION STRUCTURE OF THE PWI MOTIF FROM SRM160 1N27 ; -1.00 ; SOLUTION STRUCTURE OF THE PWWP DOMAIN OF MOUSE HEPATOMA- DERIVED GROWTH FACTOR, RELATED PROTEIN 3 1GD5 ; -1.00 ; SOLUTION STRUCTURE OF THE PX DOMAIN FROM HUMAN P47PHOX NADPH OXIDASE 1DVV ; -1.00 ; SOLUTION STRUCTURE OF THE QUINTUPLE MUTANT OF CYTOCHROME C- 551 FROM PSEUDOMONAS AERUGINOSA 1WHR ; -1.00 ; SOLUTION STRUCTURE OF THE R3H DOMAIN FROM HUMAN HYPOTHETICAL PROTEIN BAA76846 1MSZ ; -1.00 ; SOLUTION STRUCTURE OF THE R3H DOMAIN FROM HUMAN SMUBP-2 2CPM ; -1.00 ; SOLUTION STRUCTURE OF THE R3H DOMAIN OF HUMAN SPERM- ASSOCIATED ANTIGEN 7 1WGR ; -1.00 ; SOLUTION STRUCTURE OF THE RA DOMAIN OF HUMAN GRB7 PROTEIN 2CRF ; -1.00 ; SOLUTION STRUCTURE OF THE RAN_BP1 DOMAIN OF RAN-BINDING PROTEIN-3 1WFY ; -1.00 ; SOLUTION STRUCTURE OF THE RAS-BINDING DOMAIN OF MOUSE RGS14 1EF5 ; -1.00 ; SOLUTION STRUCTURE OF THE RAS-BINDING DOMAIN OF RGL 1I35 ; -1.00 ; SOLUTION STRUCTURE OF THE RAS-BINDING DOMAIN OF THE PROTEIN KINASE BYR2 FROM SCHIZOSACCHAROMYCES POMBE 1Y9J ; -1.00 ; SOLUTION STRUCTURE OF THE RAT SLY1 N-TERMINAL DOMAIN 2B68 ; -1.00 ; SOLUTION STRUCTURE OF THE RECOMBINANT CRASSOSTREA GIGAS DEFENSIN 1MWB ; -1.00 ; SOLUTION STRUCTURE OF THE RECOMBINANT HEMOGLOBIN FROM THE CYANOBACTERIUM SYNECHOCYSTIS SP. PCC 6803 IN ITS HEMICHROME STATE 1SM7 ; -1.00 ; SOLUTION STRUCTURE OF THE RECOMBINANT PRONAPIN PRECURSOR, BNIB. 1KVI ; -1.00 ; SOLUTION STRUCTURE OF THE REDUCED FORM OF THE FIRST HEAVY METAL BINDING MOTIF OF THE MENKES PROTEIN 1FI6 ; -1.00 ; SOLUTION STRUCTURE OF THE REPS1 EH DOMAIN 1UHU ; -1.00 ; SOLUTION STRUCTURE OF THE RETROVIRAL GAG MA-LIKE DOMAIN OF RIKEN CDNA 3110009E22 2CRP ; -1.00 ; SOLUTION STRUCTURE OF THE RGS DOMAIN OF REGULATOR OF G- PROTEIN SIGNALLING 5 (RGS 5) 1WHB ; -1.00 ; SOLUTION STRUCTURE OF THE RHODANESE-LIKE DOMAIN IN HUMAN UBIQUITIN SPECIFIC PROTEASE 8 (UBP8) 1MXP ; -1.00 ; SOLUTION STRUCTURE OF THE RIBBON DISULFIDE BOND ISOMER OF ALPHA-CONOTOXIN AUIB 1WHV ; -1.00 ; SOLUTION STRUCTURE OF THE RIBONUCLEIC ACID BINDING DOMAIN FROM HYPOTHETICAL PROTEIN BAB23382 1WI6 ; -1.00 ; SOLUTION STRUCTURE OF THE RIBONUCLEIC ACID BINDING DOMAIN FROM MOUSE HYPOTHETICAL PROTEIN BAB23670 1WI8 ; -1.00 ; SOLUTION STRUCTURE OF THE RIBONUCLEIC ACID BINDING DOMAIN OF EUKARYOTIC INITIATION FACTOR 4B 2CQH ; -1.00 ; SOLUTION STRUCTURE OF THE RIBONUCLEIC ACID BINDING DOMAIN OF IGF-II MRNA- BINDING PROTEIN 2 2CQI ; -1.00 ; SOLUTION STRUCTURE OF THE RIBONUCLEIC ACID BINDING DOMAIN OF NUCLEOLYSIN TIAR 2CQP ; -1.00 ; SOLUTION STRUCTURE OF THE RIBONUCLEIC ACID BINDING DOMAIN OF RIBONUCLEIC ACID-BINDING PROTEIN 12 2CQG ; -1.00 ; SOLUTION STRUCTURE OF THE RIBONUCLEIC ACID BINDING DOMAIN OF TAR DEOXYRIBONUCLEIC ACID- BINDING PROTEIN-43 1WHY ; -1.00 ; SOLUTION STRUCTURE OF THE RIBONUCLEIC ACID RECOGNITION MOTIF FROM HYPOTHETICAL RIBONUCLEIC ACID BINDING PROTEIN BC052180 2CQC ; -1.00 ; SOLUTION STRUCTURE OF THE RIBONUCLEIC ACID RECOGNITION MOTIF IN ARGININE/SERINE-RICH SPLICING FACTOR 10 2CQB ; -1.00 ; SOLUTION STRUCTURE OF THE RIBONUCLEIC ACID RECOGNITION MOTIF IN PEPTIDYL- PROLYL CIS-TRANS ISOMERASE E 2CQD ; -1.00 ; SOLUTION STRUCTURE OF THE RIBONUCLEIC ACID RECOGNITION MOTIF IN RIBONUCLEIC ACID- BINDING REGION CONTAINING PROTEIN 1 2CPI ; -1.00 ; SOLUTION STRUCTURE OF THE RIBONUCLEIC ACID RECOGNITION MOTIF OF CNOT4 2CPE ; -1.00 ; SOLUTION STRUCTURE OF THE RIBONUCLEIC ACID RECOGNITION MOTIF OF EWING SARCOMA(EWS) PROTEIN 2CPD ; -1.00 ; SOLUTION STRUCTURE OF THE RIBONUCLEIC ACID RECOGNITION MOTIF OF HUMAN APOBEC-1 COMPLEMENTATION FACTOR, ACF 1AUU ; -1.00 ; SOLUTION STRUCTURE OF THE RIBONUCLEIC ACID-BINDING DOMAIN OF THE ANTITERMINATOR PROTEIN SACY, NMR, 10 STRUCTURES 1EMW ; -1.00 ; SOLUTION STRUCTURE OF THE RIBOSOMAL PROTEIN S16 FROM THERMUS THERMOPHILUS 1QKF ; -1.00 ; SOLUTION STRUCTURE OF THE RIBOSOMAL PROTEIN S19 FROM THERMUS THERMOPHILUS 1QKH ; -1.00 ; SOLUTION STRUCTURE OF THE RIBOSOMAL PROTEIN S19 FROM THERMUS THERMOPHILUS 1GE9 ; -1.00 ; SOLUTION STRUCTURE OF THE RIBOSOME RECYCLING FACTOR 1N3G ; -1.00 ; SOLUTION STRUCTURE OF THE RIBOSOME-ASSOCIATED COLD SHOCK RESPONSE PROTEIN YFIA OF ESCHERICHIA COLI 1ZUB ; -1.00 ; SOLUTION STRUCTURE OF THE RIM1ALPHA PDZ DOMAIN IN COMPLEX WITH AN ELKS1B C-TERMINAL PEPTIDE 2CT0 ; -1.00 ; SOLUTION STRUCTURE OF THE RING DOMAIN OF THE NON-SMC ELEMENT 1 PROTEIN 2CSZ ; -1.00 ; SOLUTION STRUCTURE OF THE RING DOMAIN OF THE SYNAPTOTAGMIN- LIKE PROTEIN 4 2CT2 ; -1.00 ; SOLUTION STRUCTURE OF THE RING DOMAIN OF THE TRIPARTITE MOTIF PROTEIN 32 2CSY ; -1.00 ; SOLUTION STRUCTURE OF THE RING DOMAIN OF THE ZINC FINGER PROTEIN 183-LIKE 1 1WIL ; -1.00 ; SOLUTION STRUCTURE OF THE RING FINGER DOMAIN OF THE HUMAN KIAA1045 PROTEIN 1WIM ; -1.00 ; SOLUTION STRUCTURE OF THE RING FINGER DOMAIN OF THE HUMAN UBCM4-INTERACTING PROTEIN 4 1V87 ; -1.00 ; SOLUTION STRUCTURE OF THE RING-H2 FINGER DOMAIN OF MOUSE DELTEX PROTEIN 2 1O1W ; -1.00 ; SOLUTION STRUCTURE OF THE RNASE H DOMAIN OF THE HIV-1 REVERSE TRANSCRIPTASE IN THE PRESENCE OF MAGNESIUM 1F6Z ; -1.00 ; SOLUTION STRUCTURE OF THE RNASE P RIBONUCLEIC ACID (M1 RIBONUCLEIC ACID) P4 STEM C70U MUTANT OLIGORIBONUCLEOTIDE 1F7I ; -1.00 ; SOLUTION STRUCTURE OF THE RNASE P RIBONUCLEIC ACID (M1 RIBONUCLEIC ACID) P4 STEM C70U MUTANT OLIGORIBONUCLEOTIDE COMPLEXED WITH COBALT (III) HEXAMINE ,NMR, ENSEMBLE OF 12 STRUCTURES 1F7G ; -1.00 ; SOLUTION STRUCTURE OF THE RNASE P RIBONUCLEIC ACID (M1 RIBONUCLEIC ACID) P4 STEM C70U MUTANT OLIGORIBONUCLEOTIDE, ENSEMBLE OF 17 STRUCTURES 1F6X ; -1.00 ; SOLUTION STRUCTURE OF THE RNASE P RIBONUCLEIC ACID (M1 RIBONUCLEIC ACID) P4 STEM OLIGORIBONUCLEOTIDE 1F7H ; -1.00 ; SOLUTION STRUCTURE OF THE RNASE P RIBONUCLEIC ACID (M1 RIBONUCLEIC ACID) P4 STEM OLIGORIBONUCLEOTIDE COMPLEXED WITH COBALT (III) HEXAMINE, NMR, ENSEMBLE OF 11 STRUCTURES 1F7F ; -1.00 ; SOLUTION STRUCTURE OF THE RNASE P RIBONUCLEIC ACID (M1 RIBONUCLEIC ACID) P4 STEM OLIGORIBONUCLEOTIDE, NMR, ENSEMBLE OF 9 STRUCTURES 1I5H ; -1.00 ; SOLUTION STRUCTURE OF THE RNEDD4 WWIII DOMAIN-RENAC BP2 PEPTIDE COMPLEX 2CP8 ; -1.00 ; SOLUTION STRUCTURE OF THE RSGI RUH-046, A UBA DOMAIN FROM HUMAN NEXT TO BRCA1 GENE 1 PROTEIN (KIAA0049 PROTEIN) R923H VARIANT 1UKX ; -1.00 ; SOLUTION STRUCTURE OF THE RWD DOMAIN OF MOUSE GCN2 1K5F ; -1.00 ; SOLUTION STRUCTURE OF THE S-STYRENE ADDUCT IN THE RAS61 SEQUENCE 1SYZ ; -1.00 ; SOLUTION STRUCTURE OF THE S. CEREVISIAE U6 INTRAMOLECULAR STEM LOOP (ISL) RIBONUCLEIC ACID AT PH 5.7 1NZ1 ; -1.00 ; SOLUTION STRUCTURE OF THE S. CEREVISIAE U6 INTRAMOLECULAR STEM-LOOP CONTAINING AN SP PHOSPHOROTHIOATE AT NUCLEOTIDE U80 1SLJ ; -1.00 ; SOLUTION STRUCTURE OF THE S1 DOMAIN OF RNASE E FROM E. COLI 1WI5 ; -1.00 ; SOLUTION STRUCTURE OF THE S1 RIBONUCLEIC ACID BINDING DOMAIN FROM HUMAN HYPOTHETICAL PROTEIN BAA11502 2CQO ; -1.00 ; SOLUTION STRUCTURE OF THE S1 RIBONUCLEIC ACID BINDING DOMAIN OF HUMAN HYPOTHETICAL PROTEIN FLJ11067 2CQJ ; -1.00 ; SOLUTION STRUCTURE OF THE S4 DOMAIN OF U3 SMALL NUCLEOLAR RIBONUCLEOPROTEIN PROTEIN IMP3 HOMOLOG 1X40 ; -1.00 ; SOLUTION STRUCTURE OF THE SAM DOMAIN OF HUMAN ARAP2 1WWV ; -1.00 ; SOLUTION STRUCTURE OF THE SAM DOMAIN OF HUMAN CONNECTOR ENHANCER OF KSR-LIKE PROTEIN CNK1 1WWU ; -1.00 ; SOLUTION STRUCTURE OF THE SAM_PNT DOMAIN OF HUMAN PROTEIN FLJ21935 1X66 ; -1.00 ; SOLUTION STRUCTURE OF THE SAM_PNT-DOMAIN OF THE HUMAN FRIEND LEUKEMIAINTEGRATION 1 TRANSCRIPTION FACTOR 1UFN ; -1.00 ; SOLUTION STRUCTURE OF THE SAND DOMAIN OF THE PUTATIVE NUCLEAR PROTEIN HOMOLOG (5830484A20RIK) 1ZRJ ; -1.00 ; SOLUTION STRUCTURE OF THE SAP DOMAIN OF HUMAN E1B-55KDA- ASSOCIATED PROTEIN 5 ISOFORM C 1NM7 ; -1.00 ; SOLUTION STRUCTURE OF THE SCPEX13P SH3 DOMAIN 1YG3 ; -1.00 ; SOLUTION STRUCTURE OF THE SCYLV P1-P2 FRAMESHIFTING PSEUDOKNOT, 20 LOWEST ENERGY STRUCTURES 1YG4 ; -1.00 ; SOLUTION STRUCTURE OF THE SCYLV P1-P2 FRAMESHIFTING PSEUDOKNOT, REGULARIZED AVERAGE STRUCTURE 1IVZ ; -1.00 ; SOLUTION STRUCTURE OF THE SEA DOMAIN FROM MURINE HYPOTHETICAL PROTEIN HOMOLOGOUS TO HUMAN MUCIN 16 2COU ; -1.00 ; SOLUTION STRUCTURE OF THE SECOND BRCT DOMAIN OF EPITHELIAL CELL TRANSFORMING 2 1WYQ ; -1.00 ; SOLUTION STRUCTURE OF THE SECOND CH DOMAIN OF HUMAN SPECTRIN BETA CHAIN, BRAIN 2 1SS2 ; -1.00 ; SOLUTION STRUCTURE OF THE SECOND COMPLEMENT CONTROL PROTEIN (CCP) MODULE OF THE GABA(B)R1A RECEPTOR, PRO-119 CIS CONFORMER 1SRZ ; -1.00 ; SOLUTION STRUCTURE OF THE SECOND COMPLEMENT CONTROL PROTEIN (CCP) MODULE OF THE GABA(B)R1A RECEPTOR, PRO-119 TRANS CONFORMER 1WH6 ; -1.00 ; SOLUTION STRUCTURE OF THE SECOND CUT DOMAIN OF HUMAN HOMEOBOX PROTEIN CUX-2 2CSF ; -1.00 ; SOLUTION STRUCTURE OF THE SECOND CUT DOMAIN OF HUMAN SATB2 2CPN ; -1.00 ; SOLUTION STRUCTURE OF THE SECOND DSRBD OF TAR RIBONUCLEIC ACID-BINDING PROTEIN 2 1X48 ; -1.00 ; SOLUTION STRUCTURE OF THE SECOND DSRM DOMAIN IN INTERFERON- INDUCED, DOUBLE-STRANDED RIBONUCLEIC ACID-ACTIVATED PROTEIN KINASE 1UJT ; -1.00 ; SOLUTION STRUCTURE OF THE SECOND FIBRONECTIN TYPE III DOMAIN OF HUMAN KIAA1568 PROTEIN 1X5L ; -1.00 ; SOLUTION STRUCTURE OF THE SECOND FN3 DOMAIN OF EPH RECEPTOR A8 PROTEIN 1VA9 ; -1.00 ; SOLUTION STRUCTURE OF THE SECOND FNIII DOMAIN OF DSCAML1 PROTEIN 1X63 ; -1.00 ; SOLUTION STRUCTURE OF THE SECOND LIM DOMAIN OF SKELETAL MUSCLE LIM PROTEIN 1 1X5N ; -1.00 ; SOLUTION STRUCTURE OF THE SECOND PDZ DOMAIN OF HARMONIN PROTEIN 1UF1 ; -1.00 ; SOLUTION STRUCTURE OF THE SECOND PDZ DOMAIN OF HUMAN KIAA1526 PROTEIN 1UJV ; -1.00 ; SOLUTION STRUCTURE OF THE SECOND PDZ DOMAIN OF HUMAN MEMBRANE ASSOCIATED GUANYLATE KINASE INVERTED-2 (MAGI-2) 1WHA ; -1.00 ; SOLUTION STRUCTURE OF THE SECOND PDZ DOMAIN OF HUMAN SCRIBBLE (KIAA0147 PROTEIN). 1QLC ; -1.00 ; SOLUTION STRUCTURE OF THE SECOND PDZ DOMAIN OF POSTSYNAPTIC DENSITY-95 1Y7N ; -1.00 ; SOLUTION STRUCTURE OF THE SECOND PDZ DOMAIN OF THE HUMAN NEURONAL ADAPTOR X11ALPHA 1XKE ; -1.00 ; SOLUTION STRUCTURE OF THE SECOND RAN-BINDING DOMAIN FROM HUMAN RANBP2 1WHX ; -1.00 ; SOLUTION STRUCTURE OF THE SECOND RIBONUCLEIC ACID BINDING DOMAIN FROM HYPOTHETICAL PROTEIN BAB23448 1D9A ; -1.00 ; SOLUTION STRUCTURE OF THE SECOND RIBONUCLEIC ACID-BINDING DOMAIN (RBD2) OF HU ANTIGEN C (HUC) 2U2F ; -1.00 ; SOLUTION STRUCTURE OF THE SECOND RIBONUCLEIC ACID-BINDING DOMAIN OF HU2AF65 1X4F ; -1.00 ; SOLUTION STRUCTURE OF THE SECOND RRM DOMAIN IN MATRIN 3 1X5T ; -1.00 ; SOLUTION STRUCTURE OF THE SECOND RRM DOMAIN IN SPLICING FACTOR 3B 1J3T ; -1.00 ; SOLUTION STRUCTURE OF THE SECOND SH3 DOMAIN OF HUMAN INTERSECTIN 2 (KIAA1256) 2CSQ ; -1.00 ; SOLUTION STRUCTURE OF THE SECOND SH3 DOMAIN OF HUMAN RIM- BINDING PROTEIN 2 1WR4 ; -1.00 ; SOLUTION STRUCTURE OF THE SECOND WW DOMAIN OF NEDD4-2 1WMV ; -1.00 ; SOLUTION STRUCTURE OF THE SECOND WW DOMAIN OF WWOX 2CS2 ; -1.00 ; SOLUTION STRUCTURE OF THE SECOND ZN-FINGER DOMAIN OF POLY(ADP-RIBOSE) POLYMERASE-1 1R4G ; -1.00 ; SOLUTION STRUCTURE OF THE SENDAI VIRUS PROTEIN X C-SUBDOMAIN 1LWM ; -1.00 ; SOLUTION STRUCTURE OF THE SEQUENCE-NON-SPECIFIC HMGB PROTEIN NHP6A 2CS0 ; -1.00 ; SOLUTION STRUCTURE OF THE SH2 DOMAIN OF HUMAN HSH2D PROTEIN 2CRH ; -1.00 ; SOLUTION STRUCTURE OF THE SH2 DOMAIN OF HUMAN PROTO- ONCOGENE PROTEIN VAV1 2CR4 ; -1.00 ; SOLUTION STRUCTURE OF THE SH2 DOMAIN OF HUMAN SH3BP2 PROTEIN 1J0F ; -1.00 ; SOLUTION STRUCTURE OF THE SH3 DOMAIN BINDING GLUTAMIC ACID- RICH PROTEIN LIKE 3 1JEG ; -1.00 ; SOLUTION STRUCTURE OF THE SH3 DOMAIN FROM C-TERMINAL SRC KINASE COMPLEXED WITH A PEPTIDE FROM THE TYROSINE PHOSPHATASE PEP 1WXB ; -1.00 ; SOLUTION STRUCTURE OF THE SH3 DOMAIN FROM HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR PATHWAY SUBSTRATE 8-LIKE PROTEIN 1X43 ; -1.00 ; SOLUTION STRUCTURE OF THE SH3 DOMAIN OF ENDOPHILIN B1 (SH3G1B1) 1UGV ; -1.00 ; SOLUTION STRUCTURE OF THE SH3 DOMAIN OF HUMAN OLYGOPHREIN-1 LIKE PROTEIN (KIAA0621) 1X2K ; -1.00 ; SOLUTION STRUCTURE OF THE SH3 DOMAIN OF HUMAN OSTEOCLAST STIMULATING FACTOR 1 (OSTF1) 1V1C ; -1.00 ; SOLUTION STRUCTURE OF THE SH3 DOMAIN OF OBSCURIN 1WI7 ; -1.00 ; SOLUTION STRUCTURE OF THE SH3 DOMAIN OF SH3-DOMAIN KINASE BINDING PROTEIN 1 2CUB ; -1.00 ; SOLUTION STRUCTURE OF THE SH3 DOMAIN OF THE HUMAN CYTOPLASMIC PROTEIN NCK1 1WX6 ; -1.00 ; SOLUTION STRUCTURE OF THE SH3 DOMAIN OF THE HUMAN CYTOPLASMIC PROTEIN NCK2 2CUD ; -1.00 ; SOLUTION STRUCTURE OF THE SH3 DOMAIN OF THE HUMAN SRC-LIKE ADOPTER PROTEIN (SLAP) 1WXT ; -1.00 ; SOLUTION STRUCTURE OF THE SH3 DOMAIN OF THE HYPOTHETICAL PROTEIN FLJ21522 2CUC ; -1.00 ; SOLUTION STRUCTURE OF THE SH3 DOMAIN OF THE MOUSE HYPOTHETICAL PROTEIN SH3RF2 1WXU ; -1.00 ; SOLUTION STRUCTURE OF THE SH3 DOMAIN OF THE PEROXISOMAL BIOGENESIS FACTOR 13 1X2P ; -1.00 ; SOLUTION STRUCTURE OF THE SH3 DOMAIN OF THE PROTEIN ARGININE N-METHYLTRANSFERASE 2 1X2Q ; -1.00 ; SOLUTION STRUCTURE OF THE SH3 DOMAIN OF THE SIGNAL TRANSDUCING ADAPTOR MOLECULE 2 2CT3 ; -1.00 ; SOLUTION STRUCTURE OF THE SH3 DOMAIN OF THE VINEXIN PROTEIN 1WRY ; -1.00 ; SOLUTION STRUCTURE OF THE SH3 DOMAIN-BINDING GLUTAMIC ACID- RICH-LIKE PROTEIN 2CT6 ; -1.00 ; SOLUTION STRUCTURE OF THE SH3 DOMAIN-BINDING GLUTAMIC ACID- RICH-LIKE PROTEIN 2 1XYU ; -1.00 ; SOLUTION STRUCTURE OF THE SHEEP PRION PROTEIN WITH POLYMORPHISM H168 1H95 ; -1.00 ; SOLUTION STRUCTURE OF THE SINGLE-STRANDED DEOXYRIBONUCLEIC ACID-BINDING COLD SHOCK DOMAIN (CSD) OF HUMAN Y-BOX PROTEIN 1 (YB1) DETERMINED BY NMR (10 LOWEST ENERGY STRUCTURES) 2CUP ; -1.00 ; SOLUTION STRUCTURE OF THE SKELETAL MUSCLE LIM-PROTEIN 1 1KGM ; -1.00 ; SOLUTION STRUCTURE OF THE SMALL SERINE PROTEASE INHIBITOR SGCI 1KIO ; -1.00 ; SOLUTION STRUCTURE OF THE SMALL SERINE PROTEASE INHIBITOR SGCI[L30R, K31M] 1KJ0 ; -1.00 ; SOLUTION STRUCTURE OF THE SMALL SERINE PROTEASE INHIBITOR SGTI 1XC5 ; -1.00 ; SOLUTION STRUCTURE OF THE SMRT DEACETYLASE ACTIVATION DOMAIN 1M7K ; -1.00 ; SOLUTION STRUCTURE OF THE SODD BAG DOMAIN 1GAT ; -1.00 ; SOLUTION STRUCTURE OF THE SPECIFIC DEOXYRIBONUCLEIC ACID COMPLEX OF THE ZINC CONTAINING DEOXYRIBONUCLEIC ACID BINDING DOMAIN OF THE ERYTHROID TRANSCRIPTION FACTOR GATA-1 BY MULTIDIMENSIONAL NMR 1GAU ; -1.00 ; SOLUTION STRUCTURE OF THE SPECIFIC DEOXYRIBONUCLEIC ACID COMPLEX OF THE ZINC CONTAINING DEOXYRIBONUCLEIC ACID BINDING DOMAIN OF THE ERYTHROID TRANSCRIPTION FACTOR GATA-1 BY MULTIDIMENSIONAL NMR 1AJ3 ; -1.00 ; SOLUTION STRUCTURE OF THE SPECTRIN REPEAT, NMR, 20 STRUCTURES 1DUJ ; -1.00 ; SOLUTION STRUCTURE OF THE SPINDLE ASSEMBLY CHECKPOINT PROTEIN HUMAN MAD2 1HA9 ; -1.00 ; SOLUTION STRUCTURE OF THE SQUASH TRYPSIN INHIBITOR MCOTI-II, NMR, 30 STRUCTURES. 1XHJ ; -1.00 ; SOLUTION STRUCTURE OF THE STAPHYLOCOCCUS EPIDERMIDIS PROTEIN SE0630. NORTHEST STRUCTURAL GENOMICS CONSORTIUM TARGET SER8. 1V38 ; -1.00 ; SOLUTION STRUCTURE OF THE STERILE ALPHA MOTIF (SAM) DOMAIN OF MOUSE SAMSN1 1UVF ; -1.00 ; SOLUTION STRUCTURE OF THE STRUCTURED PART OF THE 15TH DOMAIN OF LEKTI 1ZWV ; -1.00 ; SOLUTION STRUCTURE OF THE SUBUNIT BINDING DOMAIN (HBSBD) OF THE HUMAN MITOCHONDRIAL BRANCHED-CHAIN ALPHA-KETOACID DEHYDROGENASE 1BRZ ; -1.00 ; SOLUTION STRUCTURE OF THE SWEET PROTEIN BRAZZEIN, NMR, 43 STRUCTURES 1RYU ; -1.00 ; SOLUTION STRUCTURE OF THE SWI1 ARID 1UHR ; -1.00 ; SOLUTION STRUCTURE OF THE SWIB DOMAIN OF MOUSE BRG1- ASSOCIATED FACTOR 60A 1V32 ; -1.00 ; SOLUTION STRUCTURE OF THE SWIB/MDM2 DOMAIN OF THE HYPOTHETICAL PROTEIN AT5G08430 FROM ARABIDOPSIS THALIANA 1V31 ; -1.00 ; SOLUTION STRUCTURE OF THE SWIB/MDM2 DOMAIN OF THE HYPOTHETICAL PROTEIN AT5G14170 FROM ARABIDOPSIS THALIANA 1EJP ; -1.00 ; SOLUTION STRUCTURE OF THE SYNDECAN-4 WHOLE CYTOPLASMIC DOMAIN 1EJQ ; -1.00 ; SOLUTION STRUCTURE OF THE SYNDECAN-4 WHOLE CYTOPLASMIC DOMAIN IN THE PRESENCE OF PHOSPHATIDYLINOSITOL 4,5- BISPHOSPHATE 1J5M ; -1.00 ; SOLUTION STRUCTURE OF THE SYNTHETIC 113CD_3 BETA_N DOMAIN OF LOBSTER METALLOTHIONEIN-1 2PDZ ; -1.00 ; SOLUTION STRUCTURE OF THE SYNTROPHIN PDZ DOMAIN IN COMPLEX WITH THE PEPTIDE GVKESLV, NMR, 15 STRUCTURES 1M8C ; -1.00 ; SOLUTION STRUCTURE OF THE T STATE OF TURKEY OVOMUCOID AT PH 2.5 2AZV ; -1.00 ; SOLUTION STRUCTURE OF THE T22G MUTANT OF N-TERMINAL SH3 DOMAIN OF DRK (CALCULATED WITHOUT NOES) 2A37 ; -1.00 ; SOLUTION STRUCTURE OF THE T22G MUTANT OF N-TERMINAL SH3 DOMAIN OF DRK (DRKN SH3 DOMAIN) 1MXQ ; -1.00 ; SOLUTION STRUCTURE OF THE TACHYKININ PEPTIDE ELEDOISIN 1N6T ; -1.00 ; SOLUTION STRUCTURE OF THE TACHYKININ PEPTIDE NEUROKININ A 1KN7 ; -1.00 ; SOLUTION STRUCTURE OF THE TANDEM INACTIVATION DOMAIN (RESIDUES 1-75) OF POTASSIUM CHANNEL RCK4 (KV1.4) 1F81 ; -1.00 ; SOLUTION STRUCTURE OF THE TAZ2 DOMAIN OF THE TRANSCRIPTIONAL ADAPTOR PROTEIN CBP 1XDX ; -1.00 ; SOLUTION STRUCTURE OF THE TCTEX1 LIGHT CHAIN FROM CHLAMYDOMONAS INNER DYNEIN ARM I1 1L1I ; -1.00 ; SOLUTION STRUCTURE OF THE TENEBRIO MOLITOR ANTIFREEZE PROTEIN 1WWT ; -1.00 ; SOLUTION STRUCTURE OF THE TGS DOMAIN FROM HUMAN THREONYL- TRNA SYNTHETASE 1DU2 ; -1.00 ; SOLUTION STRUCTURE OF THE THETA SUBUNIT OF DEOXYRIBONUCLEIC ACID POLYMERASE III 2AE9 ; -1.00 ; SOLUTION STRUCTURE OF THE THETA SUBUNIT OF DEOXYRIBONUCLEIC ACID POLYMERASE III FROM E. COLI 1QUW ; -1.00 ; SOLUTION STRUCTURE OF THE THIOREDOXIN FROM BACILLUS ACIDOCALDARIUS 1TI3 ; -1.00 ; SOLUTION STRUCTURE OF THE THIOREDOXIN H1 FROM POPLAR, A CPPC ACTIVE SITE VARIANT 1X65 ; -1.00 ; SOLUTION STRUCTURE OF THE THIRD COLD-SHOCK DOMAIN OF THE HUMAN KIAA0885 PROTEIN (UNR PROTEIN) 1WH8 ; -1.00 ; SOLUTION STRUCTURE OF THE THIRD CUT DOMAIN OF HUMAN HOMEOBOX PROTEIN CUX-2 1UEN ; -1.00 ; SOLUTION STRUCTURE OF THE THIRD FIBRONECTIN III DOMAIN OF HUMAN KIAA0343 PROTEIN 1KZ0 ; -1.00 ; SOLUTION STRUCTURE OF THE THIRD HELIX OF ANTENNAPEDIA HOMEODOMAIN 1KZ2 ; -1.00 ; SOLUTION STRUCTURE OF THE THIRD HELIX OF ANTENNAPEDIA HOMEODOMAIN DERIVATIVE [W6F,W14F] 1KZ5 ; -1.00 ; SOLUTION STRUCTURE OF THE THIRD HELIX OF ANTENNAPEDIA HOMEODOMAIN DERIVATIVES (RQIKIWFRKWKK) 1X44 ; -1.00 ; SOLUTION STRUCTURE OF THE THIRD IG-LIKE DOMAIN OF MYOSIN- DINDING PROTEIN C, SLOW-TYPE 2COR ; -1.00 ; SOLUTION STRUCTURE OF THE THIRD LIM DOMAIN OF PARTICULARLY INTERESTING NEW CYS-HIS PROTEIN 1WJQ ; -1.00 ; SOLUTION STRUCTURE OF THE THIRD MBT DOMAIN FROM HUMAN KIAA1798 PROTEIN 1UEP ; -1.00 ; SOLUTION STRUCTURE OF THE THIRD PDZ DOMAIN OF HUMAN ATROPHIN-1 INTERACTING PROTEIN 1 (KIAA0705 PROTEIN) 1UFX ; -1.00 ; SOLUTION STRUCTURE OF THE THIRD PDZ DOMAIN OF HUMAN KIAA1526 PROTEIN 1V6B ; -1.00 ; SOLUTION STRUCTURE OF THE THIRD PDZ DOMAIN OF MOUSE HARMONIN 1UM7 ; -1.00 ; SOLUTION STRUCTURE OF THE THIRD PDZ DOMAIN OF SYNAPSE- ASSOCIATED PROTEIN 102 1O0P ; -1.00 ; SOLUTION STRUCTURE OF THE THIRD RIBONUCLEIC ACID RECOGNITION MOTIF (RRM) OF U2AF65 IN COMPLEX WITH AN N-TERMINAL SF1 PEPTIDE 1OPI ; -1.00 ; SOLUTION STRUCTURE OF THE THIRD RIBONUCLEIC ACID RECOGNITION MOTIF (RRM) OF U2AF65 IN COMPLEX WITH AN N-TERMINAL SF1 PEPTIDE 1UHF ; -1.00 ; SOLUTION STRUCTURE OF THE THIRD SH3 DOMAIN OF HUMAN INTERSECTIN 2(KIAA1256) 2CSI ; -1.00 ; SOLUTION STRUCTURE OF THE THIRD SH3 DOMAIN OF HUMAN RIM- BINDING PROTEIN 2 1WLX ; -1.00 ; SOLUTION STRUCTURE OF THE THIRD SPECTRIN REPEAT OF ALPHA- ACTININ-4 1WR7 ; -1.00 ; SOLUTION STRUCTURE OF THE THIRD WW DOMAIN OF NEDD4-2 1SRK ; -1.00 ; SOLUTION STRUCTURE OF THE THIRD ZINC FINGER DOMAIN OF FOG-1 2TOB ; -1.00 ; SOLUTION STRUCTURE OF THE TOBRAMYCIN-RIBONUCLEIC ACID APTAMER COMPLEX, NMR, 13 STRUCTURES 1W0A ; -1.00 ; SOLUTION STRUCTURE OF THE TRANS FORM OF THE HUMAN ALPHA- HEMOGLOBIN STABILIZING PROTEIN (AHSP) 1I1S ; -1.00 ; SOLUTION STRUCTURE OF THE TRANSCRIPTIONAL ACTIVATION DOMAIN OF THE BACTERIOPHAGE T4 PROTEIN MOTA 1MH6 ; -1.00 ; SOLUTION STRUCTURE OF THE TRANSPOSON TN5-ENCODING BLEOMYCIN- BINDING PROTEIN, BLMT 1DU6 ; -1.00 ; SOLUTION STRUCTURE OF THE TRUNCATED PBX HOMEODOMAIN 1WGS ; -1.00 ; SOLUTION STRUCTURE OF THE TUDOR DOMAIN FROM MOUSE HYPOTHETICAL PROTEIN HOMOLOGOUS TO HISTONE ACETYLTRANSFERASE 1G5V ; -1.00 ; SOLUTION STRUCTURE OF THE TUDOR DOMAIN OF THE HUMAN SMN PROTEIN 1ICH ; -1.00 ; SOLUTION STRUCTURE OF THE TUMOR NECROSIS FACTOR RECEPTOR-1 DEATH DOMAIN 1U5L ; -1.00 ; SOLUTION STRUCTURE OF THE TURTLE PRION PROTEIN FRAGMENT (121-226) 2A55 ; -1.00 ; SOLUTION STRUCTURE OF THE TWO N-TERMINAL CCP MODULES OF C4B- BINDING PROTEIN (C4BP) ALPHA-CHAIN. 1ZDX ; -1.00 ; SOLUTION STRUCTURE OF THE TYPE 1 PILUS ASSEMBLY PLATFORM FIMD(25-125) 1ZDV ; -1.00 ; SOLUTION STRUCTURE OF THE TYPE 1 PILUS ASSEMBLY PLATFORM FIMD(25-139) 1DAV ; -1.00 ; SOLUTION STRUCTURE OF THE TYPE I DOCKERIN DOMAIN FROM THE CLOSTRIDIUM THERMOCELLUM CELLULOSOME (20 STRUCTURES) 1DAQ ; -1.00 ; SOLUTION STRUCTURE OF THE TYPE I DOCKERIN DOMAIN FROM THE CLOSTRIDIUM THERMOCELLUM CELLULOSOME (MINIMIZED AVERAGE STRUCTURE) 1WGM ; -1.00 ; SOLUTION STRUCTURE OF THE U-BOX IN HUMAN UBIQUITIN CONJUGATION FACTOR E4A 1N87 ; -1.00 ; SOLUTION STRUCTURE OF THE U-BOX OF PRP19 1LC6 ; -1.00 ; SOLUTION STRUCTURE OF THE U6 INTRAMOLECULAR STEM-LOOP RIBONUCLEIC ACID 1V92 ; -1.00 ; SOLUTION STRUCTURE OF THE UBA DOMAIN FROM P47, A MAJOR COFACTOR OF THE AAA ATPASE P97 1PGY ; -1.00 ; SOLUTION STRUCTURE OF THE UBA DOMAIN IN SACCHAROMYCES CEREVISIAE PROTEIN, SWA2P 1WJI ; -1.00 ; SOLUTION STRUCTURE OF THE UBA DOMAIN OF HUMAN TUDOR DOMAIN CONTAINING PROTEIN 3 2CRN ; -1.00 ; SOLUTION STRUCTURE OF THE UBA DOMAIN OF HUMAN UBASH3A PROTEIN 1V86 ; -1.00 ; SOLUTION STRUCTURE OF THE UBIQUITIN DOMAIN FROM MOUSE D7WSU128E PROTEIN 1WXV ; -1.00 ; SOLUTION STRUCTURE OF THE UBIQUITIN DOMAIN OF BCL-2 BINDING ATHANOGENE-1 1V5O ; -1.00 ; SOLUTION STRUCTURE OF THE UBIQUITIN-LIKE DOMAIN FROM MOUSE HYPOTHETICAL 1700011N24RIK PROTEIN 1V5T ; -1.00 ; SOLUTION STRUCTURE OF THE UBIQUITIN-LIKE DOMAIN FROM MOUSE HYPOTHETICAL 8430435I17RIK PROTEIN 1J8C ; -1.00 ; SOLUTION STRUCTURE OF THE UBIQUITIN-LIKE DOMAIN OF HPLIC-2 1TTN ; -1.00 ; SOLUTION STRUCTURE OF THE UBIQUITIN-LIKE DOMAIN OF HUMAN DC- UBP FROM DENDRITIC CELLS 1WGD ; -1.00 ; SOLUTION STRUCTURE OF THE UBL-DOMAIN OF HERP 1WJ4 ; -1.00 ; SOLUTION STRUCTURE OF THE UBX DOMAIN OF KIAA0794 PROTEIN 1I4V ; -1.00 ; SOLUTION STRUCTURE OF THE UMUD' HOMODIMER 1N4B ; -1.00 ; SOLUTION STRUCTURE OF THE UNDECAMER CGAAACTTTCG 1J4Y ; -1.00 ; SOLUTION STRUCTURE OF THE UNMODIFIED ANTICODON STEM-LOOP FROM E. COLI TRNA(PHE) 1KKA ; -1.00 ; SOLUTION STRUCTURE OF THE UNMODIFIED ANTICODON STEM-LOOP FROM E. COLI TRNA(PHE) 1LMV ; -1.00 ; SOLUTION STRUCTURE OF THE UNMODIFIED U2 SNRNA-INTRON BRANCH SITE HELIX FROM S. CEREVISIAE 1KMD ; -1.00 ; SOLUTION STRUCTURE OF THE VAM7P PX DOMAIN 1UJS ; -1.00 ; SOLUTION STRUCTURE OF THE VILLIN HEADPIECE DOMAIN OF HUMAN ACTIN-BINDING LIM PROTEIN HOMOLOGUE (KIAA0843 PROTEIN) 1JMN ; -1.00 ; SOLUTION STRUCTURE OF THE VISCOTOXIN A2 1JMP ; -1.00 ; SOLUTION STRUCTURE OF THE VISCOTOXIN B 1HWQ ; -1.00 ; SOLUTION STRUCTURE OF THE VS RIBOZYME SUBSTRATE STEM-LOOP 1I87 ; -1.00 ; SOLUTION STRUCTURE OF THE WATER-SOLUBLE FRAGMENT OF RAT HEPATIC APOCYTOCHROME B5 1I8C ; -1.00 ; SOLUTION STRUCTURE OF THE WATER-SOLUBLE FRAGMENT OF RAT HEPATIC APOCYTOCHROME B5 1T84 ; -1.00 ; SOLUTION STRUCTURE OF THE WISKOTT-ALDRICH SYNDROME PROTEIN (WASP) AUTOINHIBITED CORE DOMAIN COMPLEXED WITH (S)- WISKOSTATIN, A SMALL MOLECULE INHIBITOR 1TP4 ; -1.00 ; SOLUTION STRUCTURE OF THE XPC BINDING DOMAIN OF HHR23A PROTEIN 1FVS ; -1.00 ; SOLUTION STRUCTURE OF THE YEAST COPPER TRANSPORTER DOMAIN CCC2A IN THE APO AND CU(I) LOAD STATES 1FVQ ; -1.00 ; SOLUTION STRUCTURE OF THE YEAST COPPER TRANSPORTER DOMAIN CCC2A IN THE APO AND CU(I) LOADED STATES 1LPW ; -1.00 ; SOLUTION STRUCTURE OF THE YEAST SPLICEOSOMAL U2 SNRNA- INTRON BRANCH SITE HELIX FEATURING A CONSERVED PSEUDOURIDINE 1RF8 ; -1.00 ; SOLUTION STRUCTURE OF THE YEAST TRANSLATION INITIATION FACTOR EIF4E IN COMPLEX WITH M7GDP AND EIF4GI RESIDUES 393 TO 490 1M94 ; -1.00 ; SOLUTION STRUCTURE OF THE YEAST UBIQUITIN-LIKE MODIFIER PROTEIN HUB1 1IV0 ; -1.00 ; SOLUTION STRUCTURE OF THE YQGF-FAMILY PROTEIN (N-TERMINAL FRAGMENT) 1OYI ; -1.00 ; SOLUTION STRUCTURE OF THE Z-DEOXYRIBONUCLEIC ACID BINDING DOMAIN OF THE VACCINIA VIRUS GENE E3L 1WFP ; -1.00 ; SOLUTION STRUCTURE OF THE ZF-AN1 DOMAIN FROM ARABIOPSIS THALIANA F5O11.17 PROTEIN 1X4W ; -1.00 ; SOLUTION STRUCTURE OF THE ZF-AN1 DOMAIN FROM HUMAN HYPOTHETICAL PROTEIN FLJ13222 1X4V ; -1.00 ; SOLUTION STRUCTURE OF THE ZF-AN1 DOMAIN FROM HUMAN HYPOTHETICAL PROTEIN LOC130617 1WFF ; -1.00 ; SOLUTION STRUCTURE OF THE ZF-AN1 DOMAIN FROM MOUSE RIKEN CDNA 2810002D23 PROTEIN 1WFL ; -1.00 ; SOLUTION STRUCTURE OF THE ZF-AN1 DOMAIN FROM MOUSE ZINC FINGER PROTEIN 216 2CSV ; -1.00 ; SOLUTION STRUCTURE OF THE ZF-B_BOX TYPE2 DOMAIN OF HUMAN TRIPARTITE MOTIF PROTEIN TRIM29 ISOFORM ALPHA 2CS3 ; -1.00 ; SOLUTION STRUCTURE OF THE ZF-C3HC4 DOMAIN OF HUMAN KIAA1865 2CR8 ; -1.00 ; SOLUTION STRUCTURE OF THE ZF-RANBP DOMAIN OF P53-BINDING PROTEIN MDM4 2CRC ; -1.00 ; SOLUTION STRUCTURE OF THE ZF-RANBP DOMAIN OF THE PROTEIN HBV ASSOCIATED FACTOR 2CT5 ; -1.00 ; SOLUTION STRUCTURE OF THE ZINC FINGER BED DOMAIN OF THE ZINC FINGER BED DOMAIN CONTAINING PROTEIN 1 1VD4 ; -1.00 ; SOLUTION STRUCTURE OF THE ZINC FINGER DOMAIN OF TFIIE ALPHA 2CT1 ; -1.00 ; SOLUTION STRUCTURE OF THE ZINC FINGER DOMAIN OF TRANSCRIPTIONAL REPRESSOR CTCF PROTEIN 1UW0 ; -1.00 ; SOLUTION STRUCTURE OF THE ZINC-FINGER DOMAIN FROM DEOXYRIBONUCLEIC ACID LIGASE IIIA 2CQE ; -1.00 ; SOLUTION STRUCTURE OF THE ZINC-FINGER DOMAIN IN KIAA1064 PROTEIN 2CQF ; -1.00 ; SOLUTION STRUCTURE OF THE ZINC-FINGER DOMAIN IN LIN-28 1AX6 ; -1.00 ; SOLUTION STRUCTURE OF THE [AF]-C8-DG ADDUCT OPPOSITE A -2 DELETION SITE IN THE NARI HOT SPOT SEQUENCE CONTEXT; NMR, 6 STRUCTURES 1AX7 ; -1.00 ; SOLUTION STRUCTURE OF THE [AF]-C8-DG ADDUCT POSITIONED AT A TEMPLATE-PRIMER JUNCTION, NMR, 6 STRUCTURES 1C0Y ; -1.00 ; SOLUTION STRUCTURE OF THE [AF]-C8-DG ADDUCT POSITIONED OPPOSITE DA AT A TEMPLATE-PRIMER JUNCTION 1UEO ; -1.00 ; SOLUTION STRUCTURE OF THE [T8A]-PENAEIDIN-3 1S7P ; -1.00 ; SOLUTION STRUCTURE OF THERMOLYSIN DIGESTED MICROCIN J25 1PJZ ; -1.00 ; SOLUTION STRUCTURE OF THIOPURINE METHYLTRANSFERASE FROM PSEUDOMONAS SYRINGAE 1XFL ; -1.00 ; SOLUTION STRUCTURE OF THIOREDOXIN H1 FROM ARABIDOPSIS THALIANA 1GL8 ; -1.00 ; SOLUTION STRUCTURE OF THIOREDOXIN M FROM SPINACH, OXIDIZED FORM 1WMJ ; -1.00 ; SOLUTION STRUCTURE OF THIOREDOXIN TYPE H FROM ORYZA SATIVA 1EDW ; -1.00 ; SOLUTION STRUCTURE OF THIRD INTRADISKAL LOOP OF BOVINE RHODOPSIN (RESIDUES 268-293) 1F0Z ; -1.00 ; SOLUTION STRUCTURE OF THIS, THE SULFUR CARRIER PROTEIN IN E.COLI THIAMIN BIOSYNTHESIS 1IEN ; -1.00 ; SOLUTION STRUCTURE OF TIA 1JDQ ; -1.00 ; SOLUTION STRUCTURE OF TM006 PROTEIN FROM THERMOTOGA MARITIMA 1T6R ; -1.00 ; SOLUTION STRUCTURE OF TM1442, A PUTATIVE ANTI SIGMA FACTOR ANTAGONIST IN PHOSPHORYLATED STATE 1R73 ; -1.00 ; SOLUTION STRUCTURE OF TM1492, THE L29 RIBOSOMAL PROTEIN FROM THERMOTOGA MARITIMA 1TVI ; -1.00 ; SOLUTION STRUCTURE OF TM1509 FROM THERMOTOGA MARITIMA: VT1, A NESGC TARGET PROTEIN 1CN2 ; -1.00 ; SOLUTION STRUCTURE OF TOXIN 2 FROM CENTRUROIDES NOXIUS HOFFMANN, A BETA SCORPION NEUROTOXIN ACTING ON SODIUM CHANNELS, NMR, 15 STRUCTURES 1PE4 ; -1.00 ; SOLUTION STRUCTURE OF TOXIN CN12 FROM CENTRUROIDES NOXIUS ALFA SCORPION TOXIN ACTING ON SODIUM CHANNELS. NMR STRUCTURE 1VA1 ; -1.00 ; SOLUTION STRUCTURE OF TRANSCRIPTION FACTOR SP1 DEOXYRIBONUCLEIC ACID BINDING DOMAIN (ZINC FINGER 1) 1VA2 ; -1.00 ; SOLUTION STRUCTURE OF TRANSCRIPTION FACTOR SP1 DEOXYRIBONUCLEIC ACID BINDING DOMAIN (ZINC FINGER 2) 1VA3 ; -1.00 ; SOLUTION STRUCTURE OF TRANSCRIPTION FACTOR SP1 DEOXYRIBONUCLEIC ACID BINDING DOMAIN (ZINC FINGER 3) 1W0S ; -1.00 ; SOLUTION STRUCTURE OF TRIMERIC FORM OF PROPERDIN BY X-RAY SOLUTION SCATTERING AND ANALYTICAL ULTRACENTRIFUGATION 2CTD ; -1.00 ; SOLUTION STRUCTURE OF TWO ZF-C2H2 DOMAINS FROM HUMAN ZINC FINGER PROTEIN 512 1E8R ; -1.00 ; SOLUTION STRUCTURE OF TYPE X CBD 1QLD ; -1.00 ; SOLUTION STRUCTURE OF TYPE X CBM 1JH3 ; -1.00 ; SOLUTION STRUCTURE OF TYROSYL-TRNA SYNTHETASE C-TERMINAL DOMAIN. 1WGN ; -1.00 ; SOLUTION STRUCTURE OF UBA DOMAIN OF HUMAN UBIQUITIN ASSOCIATED PROTEIN 1 (UBAP1) 1XO3 ; -1.00 ; SOLUTION STRUCTURE OF UBIQUITIN LIKE PROTEIN FROM MUS MUSCULUS 1WE7 ; -1.00 ; SOLUTION STRUCTURE OF UBIQUITIN-LIKE DOMAIN IN SF3A120 1WE6 ; -1.00 ; SOLUTION STRUCTURE OF UBIQUITIN-LIKE DOMAIN IN SPLICING FACTOR AAL91182 1UEL ; -1.00 ; SOLUTION STRUCTURE OF UBIQUITIN-LIKE DOMAIN OF HHR23B COMPLEXED WITH UBIQUITIN-INTERACTING MOTIF OF PROTEASOME SUBUNIT S5A 1IYF ; -1.00 ; SOLUTION STRUCTURE OF UBIQUITIN-LIKE DOMAIN OF HUMAN PARKIN 1P0R ; -1.00 ; SOLUTION STRUCTURE OF UBL5 A HUMAN UBIQUITIN-LIKE PROTEIN 1VFI ; -1.00 ; SOLUTION STRUCTURE OF VANABIN2 (RUH-017), A VANADIUM- BINDING PROTEIN FROM ASCIDIA SYDNEIENSIS SAMEA 1U89 ; -1.00 ; SOLUTION STRUCTURE OF VBS2 FRAGMENT OF TALIN 1VB8 ; -1.00 ; SOLUTION STRUCTURE OF VHR1, THE FIRST CYCLOTIDE FROM ROOT TISSUE 1NXI ; -1.00 ; SOLUTION STRUCTURE OF VIBRIO CHOLERAE PROTEIN VC0424 1HHV ; -1.00 ; SOLUTION STRUCTURE OF VIRUS CHEMOKINE VMIP-II 1Q0W ; -1.00 ; SOLUTION STRUCTURE OF VPS27 AMINO-TERMINAL UIM-UBIQUITIN COMPLEX 1S6X ; -1.00 ; SOLUTION STRUCTURE OF VSTX 2CR9 ; -1.00 ; SOLUTION STRUCTURE OF WGR DOMAIN OF POLY(ADP-RIBOSE) POLYMERASE-1 1CZ2 ; -1.00 ; SOLUTION STRUCTURE OF WHEAT NS-LTP COMPLEXED WITH PROSTAGLANDIN B2. 1IY5 ; -1.00 ; SOLUTION STRUCTURE OF WILD TYPE OMSVP3 1KQ8 ; -1.00 ; SOLUTION STRUCTURE OF WINGED HELIX PROTEIN HFH-1 1UJR ; -1.00 ; SOLUTION STRUCTURE OF WWE DOMAIN IN BAB28015 1X4R ; -1.00 ; SOLUTION STRUCTURE OF WWE DOMAIN IN PARP14 PROTEIN 1R3B ; -1.00 ; SOLUTION STRUCTURE OF XENOPUS LAEVIS MOB1 1XU0 ; -1.00 ; SOLUTION STRUCTURE OF XENOPUS LEAVIS PRION PROTEIN 1PVE ; -1.00 ; SOLUTION STRUCTURE OF XPC BINDING DOMAIN OF HHR23B 1SG5 ; -1.00 ; SOLUTION STRUCTURE OF YAEO, A RHO-SPECIFIC INHIBITOR OF TRANSCRIPTION TERMINATION 1YWS ; -1.00 ; SOLUTION STRUCTURE OF YBL071W-A FROM SACCHAROMYCES CEREVISIAE. 2ASY ; -1.00 ; SOLUTION STRUCTURE OF YDHR PROTEIN FROM ESCHERICHIA COLI 1U96 ; -1.00 ; SOLUTION STRUCTURE OF YEAST COX17 WITH COPPER BOUND 1HV2 ; -1.00 ; SOLUTION STRUCTURE OF YEAST ELONGIN C IN COMPLEX WITH A VON HIPPEL-LINDAU PEPTIDE 1Y8M ; -1.00 ; SOLUTION STRUCTURE OF YEAST MITOCHONDRIA FISSION PROTEIN FIS1 1CK9 ; -1.00 ; SOLUTION STRUCTURE OF YEAST RIBOSOMAL PROTEIN L30 1XS8 ; -1.00 ; SOLUTION STRUCTURE OF YGGX PROTEIN OF SALMONELLA ENTERICA 1DCJ ; -1.00 ; SOLUTION STRUCTURE OF YHHP, A NOVEL ESCHERICHIA COLI PROTEIN IMPLICATED IN THE CELL DIVISION 1WPI ; -1.00 ; SOLUTION STRUCTURE OF YKR049C, A HYPOTHETICAL PROTEIN FROM SACCHAROMYCES CEREVISIAE. ONTARIO CENTRE FOR STRUCTURAL PROTEOMICS TARGET YST0250_1_133; NORTHEAST STRUCTURAL GENOMICS TARGET YTYST250 1H8M ; -1.00 ; SOLUTION STRUCTURE OF YKT6 1IOU ; -1.00 ; SOLUTION STRUCTURE OF YKT6P (1-140) 1RGW ; -1.00 ; SOLUTION STRUCTURE OF ZASP'S PDZ DOMAIN 1WG2 ; -1.00 ; SOLUTION STRUCTURE OF ZF-AN1 DOMAIN FROM ARABIDOPSIS THALIANA 1WJP ; -1.00 ; SOLUTION STRUCTURE OF ZF-C2H2 DOMAINS FROM HUMAN ZINC FINGER PROTEIN 295 2CTT ; -1.00 ; SOLUTION STRUCTURE OF ZINC FINGER DOMAIN FROM HUMAN DNAJ SUBFAMILY A MENBER 3 2CTU ; -1.00 ; SOLUTION STRUCTURE OF ZINC FINGER DOMAIN FROM HUMAN ZN FINGER PROTEIN 483 1X4S ; -1.00 ; SOLUTION STRUCTURE OF ZINC FINGER HIT DOMAIN IN PROTEIN FON 1M60 ; -1.00 ; SOLUTION STRUCTURE OF ZINC-SUBSTITUTED CYTOCHROME C 1C2U ; -1.00 ; SOLUTION STRUCTURE OF [ABU3,35]SHK12-28,17-32 1GK5 ; -1.00 ; SOLUTION STRUCTURE THE MEGF/TGFALPHA44-50 CHIMERIC GROWTH FACTOR 2AB3 ; -1.00 ; SOLUTION STRUCTURES AND CHARACTERIZATION OF HIV RRE IIB RIBONUCLEIC ACID TARGETING ZINC FINGER PROTEINS 2AB7 ; -1.00 ; SOLUTION STRUCTURES AND CHARACTERIZATION OF HIV RRE IIB RIBONUCLEIC ACID TARGETING ZINC FINGER PROTEINS 1HZK ; -1.00 ; SOLUTION STRUCTURES OF C-1027 APOPROTEIN AND ITS COMPLEX WITH THE AROMATIZED CHROMOPHORE 1HZL ; -1.00 ; SOLUTION STRUCTURES OF C-1027 APOPROTEIN AND ITS COMPLEX WITH THE AROMATIZED CHROMOPHORE 1IT1 ; -1.00 ; SOLUTION STRUCTURES OF FERROCYTOCHROME C3 FROM DESULFOVIBRIO VULGARIS MIYAZAKI F 1R8T ; -1.00 ; SOLUTION STRUCTURES OF HIGH AFFINITY MINIPROTEIN LIGANDS TO STREPTAVIDIN 1ID6 ; -1.00 ; SOLUTION STRUCTURES OF SYR6 1BYM ; -1.00 ; SOLUTION STRUCTURES OF THE C-TERMINAL DOMAIN OF DIPHTHERIA TOXIN REPRESSOR 1X52 ; -1.00 ; SOLUTION STRUCTURES OF THE C-TERMINAL DOMAIN OF THE HUMAN PELOTA HOMOLOG (CGI-17) 1X68 ; -1.00 ; SOLUTION STRUCTURES OF THE C-TERMINAL LIM DOMAIN OF HUMAN FHL5 PROTEIN 1X6H ; -1.00 ; SOLUTION STRUCTURES OF THE C2H2 TYPE ZINC FINGER DOMAIN OF HUMAN TRANSCRIPTIONAL REPRESSOR CTCF 1X6E ; -1.00 ; SOLUTION STRUCTURES OF THE C2H2 TYPE ZINC FINGER DOMAIN OF HUMAN ZINC FINGER PROTEIN 24 1X6F ; -1.00 ; SOLUTION STRUCTURES OF THE C2H2 TYPE ZINC FINGER DOMAIN OF HUMAN ZINC FINGER PROTEIN 462 1X57 ; -1.00 ; SOLUTION STRUCTURES OF THE HTH DOMAIN OF HUMAN EDF-1 PROTEIN 2COB ; -1.00 ; SOLUTION STRUCTURES OF THE HTH DOMAIN OF HUMAN LCOR PROTEIN 2CO8 ; -1.00 ; SOLUTION STRUCTURES OF THE LIM DOMAIN OF HUMAN NEDD9 INTERACTING PROTEIN WITH CALPONIN HOMOLOGY AND LIM DOMAINS 1X58 ; -1.00 ; SOLUTION STRUCTURES OF THE MYB-LIKE DEOXYRIBONUCLEIC ACID BINDING DOMAIN OF 4930532D21RIK PROTEIN 1VAZ ; -1.00 ; SOLUTION STRUCTURES OF THE P47 SEP DOMAIN 1X6D ; -1.00 ; SOLUTION STRUCTURES OF THE PDZ DOMAIN OF HUMAN INTERLEUKIN- 16 1X6A ; -1.00 ; SOLUTION STRUCTURES OF THE SECOND LIM DOMAIN OF HUMAN LIM- KINASE 2 (LIMK2) 1X6C ; -1.00 ; SOLUTION STRUCTURES OF THE SH2 DOMAIN OF HUMAN PROTEIN- TYROSINE PHOSPHATASE SHP-1 1X6G ; -1.00 ; SOLUTION STRUCTURES OF THE SH3 DOMAIN OF HUMAN MEGAKARYOCYTE-ASSOCIATED TYROSINE-PROTEIN KINASE. 1X6B ; -1.00 ; SOLUTION STRUCTURES OF THE SH3 DOMAIN OF HUMAN RHO GUANINE EXCHANGE FACTOR (GEF) 16 1X69 ; -1.00 ; SOLUTION STRUCTURES OF THE SH3 DOMAIN OF HUMAN SRC SUBSTRATE CORTACTIN 1X59 ; -1.00 ; SOLUTION STRUCTURES OF THE WHEP-TRS DOMAIN OF HUMAN HISTIDYL-TRNA SYNTHETASE 1V80 ; -1.00 ; SOLUTION STRUCTURES OF UBIQUITIN AT 30 BAR AND 3 KBAR 1V81 ; -1.00 ; SOLUTION STRUCTURES OF UBIQUITIN AT 30 BAR AND 3 KBAR 1NE5 ; -1.00 ; SOLUTION STRUCUTURE OF HERG SPECIFIC SCORPION TOXIN CNERG1 2CT4 ; -1.00 ; SOLUTION STRUTCURE OF THE SH3 DOMAIN OF THE CDC42- INTERACTING PROTEIN 4 1JBN ; -1.00 ; SOLUTION STUCTURE OF AN ACYCLIC PERMUTANT OF SFTI-1, A TRYPSIN INHIBITOR FROM SUNFLOWER SEEDS 1TTX ; -1.00 ; SOLUTION STUCTURE OF HUMAN BETA PARVALBUMIN (ONCOMODULIN) REFINED WITH A PARAMAGNETISM BASED STRATEGY 1P7A ; -1.00 ; SOLUTION STUCTURE OF THE THIRD ZINC FINGER FROM BKLF 1TTD ; -1.00 ; SOLUTION-STATE STRUCTURE OF A DEOXYRIBONUCLEIC ACID DODECAMER DUPLEX CONTAINING A CIS-SYN THYMINE CYCLOBUTANE DIMER 1COC ; -1.00 ; SOLUTION-STATE STRUCTURE OF A DEOXYRIBONUCLEIC ACID DODECAMER DUPLEX CONTAINING A CIS-SYN THYMINE CYCLOBUTANE DIMER. 1B1G ; -1.00 ; SOLVATED REFINEMENT OF CA-LOADED CALBINDIN D9K 1ENN ; 0.89 ; SOLVENT ORGANIZATION IN AN OLIGONUCLEOTIDE CRYSTAL: THE STRUCTURE OF D(GCGAATTCG)2 AT ATOMIC RESOLUTION 1S4G ; -1.00 ; SOMATOMEDIN-B DOMAIN OF HUMAN PLASMA VITRONECTIN. 1VKA ; 1.60 ; SOUTHEAST COLLABORATORY FOR STRUCTURAL GENOMICS: HYPOTHETICAL HUMAN PROTEIN Q15691 N-TERMINAL FRAGMENT 1SBF ; 2.42 ; SOYBEAN AGGLUTININ 1SBD ; 2.52 ; SOYBEAN AGGLUTININ COMPLEXED WITH 2,4-PENTASACCHARIDE 2SBA ; 2.60 ; SOYBEAN AGGLUTININ COMPLEXED WITH 2,6-PENTASACCHARIDE 1SBE ; 2.80 ; SOYBEAN AGGLUTININ FROM GLYCINE MAX 1RRL ; 2.09 ; SOYBEAN LIPOXYGENASE (LOX-3) AT 93K AT 2.0 A RESOLUTION 1RRH ; 2.00 ; SOYBEAN LIPOXYGENASE (LOX-3) AT AMBIENT TEMPERATURES AT 2.0 A RESOLUTION 1BA7 ; 2.50 ; SOYBEAN TRYPSIN INHIBITOR 1KSP ; 2.30 ; SP ISOMER PHOSPHOROTHIOATE DEOXYRIBONUCLEIC ACID COMPLEXED TO THE 3'-5' EXONUCLEASE OF DEOXYRIBONUCLEIC ACID POLYMERASE I FROM E. COLI 1RG4 ; -1.00 ; SP-B C-TERMINAL PEPTIDE IN ORGANIC SOLVENT (HFIP) 1RG3 ; -1.00 ; SP-B C-TERMINAL PEPTIDE IN SDS MICELLES 2BLC ; 2.25 ; SP21 DOUBLE MUTANT P. VIVAX DIHYDROFOLATE REDUCTASE IN COMPLEX WITH DES-CHLOROPYRIMETHAMINE 2BLA ; 2.50 ; SP21 DOUBLE MUTANT P. VIVAX DIHYDROFOLATE REDUCTASE IN COMPLEX WITH PYRIMETHAMINE 1RY9 ; 1.82 ; SPA15, A TYPE III SECRETION CHAPERONE FROM SHIGELLA FLEXNERI 1RQV ; -1.00 ; SPATIAL MODEL OF L7 DIMER FROM E.COLI WITH ONE HINGE REGION IN HELICAL STATE 2BJM ; 2.15 ; SPE7:ANTHRONE COMPLEX 2B6D ; 1.40 ; SPECIFIC BINDING OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) TO LACTOFERRIN: CRYSTAL STRUCTURE OF THE COMPLEX OF C-TERMINAL LOBE OF BOVINE LACTOFERRIN WITH DICLOFENAC AT 1.4 A RESOLUTION 2B17 ; 2.71 ; SPECIFIC BINDING OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) TO PHOSPHOLIPASE A2: CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN PHOSPHOLIPASE A2 AND DICLOFENAC AT 2.7 A RESOLUTION: 1QID ; 2.05 ; SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT NINE TIME POINTS (POINT A) CAUSED BY INTENSE SYNCHROTRON RADIATION TO TORPEDO CALIFORNICA ACETYLCHOLINESTERASE 1QIE ; 2.10 ; SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT NINE TIME POINTS (POINT B) CAUSED BY INTENSE SYNCHROTRON RADIATION TO TORPEDO CALIFORNICA ACETYLCHOLINESTERASE 1QIF ; 2.10 ; SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT NINE TIME POINTS (POINT C) CAUSED BY INTENSE SYNCHROTRON RADIATION TO TORPEDO CALIFORNICA ACETYLCHOLINESTERASE 1QIG ; 2.30 ; SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT NINE TIME POINTS (POINT D) CAUSED BY INTENSE SYNCHROTRON RADIATION TO TORPEDO CALIFORNICA ACETYLCHOLINESTERASE 1QIH ; 2.50 ; SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT NINE TIME POINTS (POINT E) CAUSED BY INTENSE SYNCHROTRON RADIATION TO TORPEDO CALIFORNICA ACETYLCHOLINESTERASE 1QII ; 2.65 ; SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT NINE TIME POINTS (POINT F) CAUSED BY INTENSE SYNCHROTRON RADIATION TO TORPEDO CALIFORNICA ACETYLCHOLINESTERASE 1QIJ ; 2.80 ; SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT NINE TIME POINTS (POINT G) CAUSED BY INTENSE SYNCHROTRON RADIATION TO TORPEDO CALIFORNICA ACETYLCHOLINESTERASE 1QIK ; 2.90 ; SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT NINE TIME POINTS (POINT H) CAUSED BY INTENSE SYNCHROTRON RADIATION TO TORPEDO CALIFORNICA ACETYLCHOLINESTERASE 1QIM ; 3.00 ; SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT NINE TIME POINTS (POINT I) CAUSED BY INTENSE SYNCHROTRON RADIATION TO TORPEDO CALIFORNICA ACETYLCHOLINESTERASE 1QIO ; 1.20 ; SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE CAUSED BY INTENSE SYNCHROTRON RADIATION TO HEN EGG WHITE LYSOZYME 1G0Z ; 2.18 ; SPECIFIC MUTATIONS IN KRAIT PLA2 LEAD TO DIMERIZATION OF PROTEIN MOLECULES: CRYSTAL STRUCTURE OF KRAIT PLA2 AT 2.1 RESOLUTION 1W9V ; 2.00 ; SPECIFICITY AND AFFINITY OF NATURAL PRODUCT CYCLOPENTAPEPTIDE ARGIFIN AGAINST ASPERGILLUS FUMIGATUS 1WAW ; 1.75 ; SPECIFICITY AND AFFINITY OF NATURAL PRODUCT CYCLOPENTAPEPTIDE INHIBITOR ARGADIN AGAINST HUMAN CHITINASE 1WB0 ; 1.65 ; SPECIFICITY AND AFFINITY OF NATURAL PRODUCT CYCLOPENTAPEPTIDE INHIBITOR ARGIFIN AGAINST HUMAN CHITINASE 1W9P ; 1.70 ; SPECIFICITY AND AFFINITY OF NATURAL PRODUCT CYCLOPENTAPEPTIDE INHIBITORS AGAINST ASPERGILLUS FUMIGATUS, HUMAN AND BACTERIAL CHITINASEFRA 1W9U ; 1.85 ; SPECIFICITY AND AFFNITY OF NATURAL PRODUCT CYCLOPENTAPEPTIDE INHIBITOR ARGADIN AGAINST ASPERGILLUS FUMIGATUS CHITINASE 1OJO ; 1.75 ; SPECIFICITY AND MECHANISM OF STREPTOCOCCUS PNEUMONIAE HYALURONATE LYASE: COMPLEX OF THE TYR408PHE MUTANT WITH 4-SULPHATED CHONDROITIN DISACCHARIDE 1OJN ; 1.60 ; SPECIFICITY AND MECHANISM OF STREPTOCOCCUS PNEUMONIAE HYALURONATE LYASE: COMPLEX OF THE TYR408PHE MUTANT WITH 6-SULPHATED CHONDROITIN DISACCHARIDE 1OJP ; 1.90 ; SPECIFICITY AND MECHANISM OF STREPTOCOCCUS PNEUMONIAE HYALURONATE LYASE: COMPLEX WITH 6-SULPHATED CHONDROITIN DISACCHARIDE 1OJM ; 1.78 ; SPECIFICITY AND MECHANISM OF STREPTOCOCCUS PNEUMONIAE HYALURONATE LYASE: COMPLEX WITH UNSULPHATED CHONDROITIN DISACCHARIDE 1AA4 ; 2.10 ; SPECIFICITY OF LIGAND BINDING IN A BURIED POLAR CAVITY OF CYTOCHROME C PEROXIDASE 1AEU ; 2.10 ; SPECIFICITY OF LIGAND BINDING IN A POLAR CAVITY OF CYTOCHROME C PEROXIDASE (2-METHYLIMIDAZOLE) 1AEJ ; 2.10 ; SPECIFICITY OF LIGAND BINDING TO A BURIED POLAR CAVITY AT THE ACTIVE SITE OF CYTOCHROME C PEROXIDASE (1-VINYLIMIDAZOLE) 1AEH ; 2.10 ; SPECIFICITY OF LIGAND BINDING TO A BURIED POLAR CAVITY AT THE ACTIVE SITE OF CYTOCHROME C PEROXIDASE (2-AMINO-4-METHYLTHIAZOLE) 1AEN ; 2.10 ; SPECIFICITY OF LIGAND BINDING TO A BURIED POLAR CAVITY AT THE ACTIVE SITE OF CYTOCHROME C PEROXIDASE (2-AMINO-5-METHYLTHIAZOLE) 1AEO ; 2.10 ; SPECIFICITY OF LIGAND BINDING TO A BURIED POLAR CAVITY AT THE ACTIVE SITE OF CYTOCHROME C PEROXIDASE (2-AMINOPYRIDINE) 1AED ; 2.10 ; SPECIFICITY OF LIGAND BINDING TO A BURIED POLAR CAVITY AT THE ACTIVE SITE OF CYTOCHROME C PEROXIDASE (3,4-DIMETHYLTHIAZOLE) 1AEF ; 2.10 ; SPECIFICITY OF LIGAND BINDING TO A BURIED POLAR CAVITY AT THE ACTIVE SITE OF CYTOCHROME C PEROXIDASE (3-AMINOPYRIDINE) 1AEB ; 2.10 ; SPECIFICITY OF LIGAND BINDING TO A BURIED POLAR CAVITY AT THE ACTIVE SITE OF CYTOCHROME C PEROXIDASE (3-METHYLTHIAZOLE) 1AEG ; 2.10 ; SPECIFICITY OF LIGAND BINDING TO A BURIED POLAR CAVITY AT THE ACTIVE SITE OF CYTOCHROME C PEROXIDASE (4-AMINOPYRIDINE) 1AEE ; 2.10 ; SPECIFICITY OF LIGAND BINDING TO A BURIED POLAR CAVITY AT THE ACTIVE SITE OF CYTOCHROME C PEROXIDASE (ANILINE) 1AES ; 2.10 ; SPECIFICITY OF LIGAND BINDING TO A BURIED POLAR CAVITY AT THE ACTIVE SITE OF CYTOCHROME C PEROXIDASE (IMIDAZOLE) 1AEM ; 2.10 ; SPECIFICITY OF LIGAND BINDING TO A BURIED POLAR CAVITY AT THE ACTIVE SITE OF CYTOCHROME C PEROXIDASE (IMIDAZO[1,2-A]PYRIDINE) 1AEK ; 2.10 ; SPECIFICITY OF LIGAND BINDING TO A BURIED POLAR CAVITY AT THE ACTIVE SITE OF CYTOCHROME C PEROXIDASE (INDOLINE) 1VR1 ; 1.90 ; SPECIFITY FOR PLASMINOGEN ACTIVATOR INHIBITOR-1 1JP9 ; 1.70 ; SPERM WHALE MET-MYOGLOBIN (LOW TEMPERATURE; HIGH PRESSURE) 1JPB ; 1.70 ; SPERM WHALE MET-MYOGLOBIN (LOW TEMPERATURE; HIGH PRESSURE) 1JP8 ; 2.30 ; SPERM WHALE MET-MYOGLOBIN (ROOM TEMPERATURE; HIGH PRESSURE) 1JP6 ; 2.30 ; SPERM WHALE MET-MYOGLOBIN (ROOM TEMPERATURE; ROOM PRESSURE) 1EBC ; 1.80 ; SPERM WHALE MET-MYOGLOBIN:CYANIDE COMPLEX 1DUO ; 2.00 ; SPERM WHALE METAQUOMYOGLOBIN PROXIMAL HISTIDINE MUTANT H93G WITH 1-METHYLIMIDAZOLE AS PROXIMAL LIGAND. 1HJT ; 1.70 ; SPERM WHALE MYOGLOBIN (FERROUS, NITRIC OXIDE BOUND) 1JDO ; 1.90 ; SPERM WHALE MYOGLOBIN (FERROUS, NITRIC OXIDE BOUND) 1MCY ; 1.70 ; SPERM WHALE MYOGLOBIN (MUTANT WITH INITIATOR MET AND WITH HIS 64 REPLACED BY GLN, LEU 29 REPLACED BY PHE 109M ; 1.83 ; SPERM WHALE MYOGLOBIN D122N ETHYL ISOCYANIDE AT PH 9.0 110M ; 1.77 ; SPERM WHALE MYOGLOBIN D122N METHYL ISOCYANIDE AT PH 9.0 111M ; 1.88 ; SPERM WHALE MYOGLOBIN D122N N-BUTYL ISOCYANIDE AT PH 9.0 112M ; 2.34 ; SPERM WHALE MYOGLOBIN D122N N-PROPYL ISOCYANIDE AT PH 9.0 101M ; 2.07 ; SPERM WHALE MYOGLOBIN F46V N-BUTYL ISOCYANIDE AT PH 9.0 102M ; 1.84 ; SPERM WHALE MYOGLOBIN H64A AQUOMET AT PH 9.0 103M ; 2.07 ; SPERM WHALE MYOGLOBIN H64A N-BUTYL ISOCYANIDE AT PH 9.0 1H1X ; 1.40 ; SPERM WHALE MYOGLOBIN MUTANT T67R S92D 104M ; 1.71 ; SPERM WHALE MYOGLOBIN N-BUTYL ISOCYANIDE AT PH 7.0 105M ; 2.02 ; SPERM WHALE MYOGLOBIN N-BUTYL ISOCYANIDE AT PH 9.0 106M ; 1.99 ; SPERM WHALE MYOGLOBIN V68F ETHYL ISOCYANIDE AT PH 9.0 108M ; 2.67 ; SPERM WHALE MYOGLOBIN V68F N-BUTYL ISOCYANIDE AT PH 7.0 107M ; 2.09 ; SPERM WHALE MYOGLOBIN V68F N-BUTYL ISOCYANIDE AT PH 9.0 1SPE ; 2.00 ; SPERM WHALE NATIVE CO MYOGLOBIN AT PH 4.0, TEMP 4C 1POY ; 2.50 ; SPERMIDINE/PUTRESCINE-BINDING PROTEIN COMPLEXED WITH SPERMIDINE (DIMER FORM) 1POT ; 1.80 ; SPERMIDINE/PUTRESCINE-BINDING PROTEIN COMPLEXED WITH SPERMIDINE (MONOMER FORM) 1EA7 ; 0.93 ; SPHERICASE 1A70 ; 1.70 ; SPINACH FERREDOXIN 1F56 ; 2.05 ; SPINACH PLANTACYANIN 1UPP ; 2.30 ; SPINACH RUBISCO IN COMPLEX WITH 2-CARBOXYARABINITOL 2 BISPHOSPHATE AND CALCIUM. 1RBO ; 2.30 ; SPINACH RUBISCO IN COMPLEX WITH THE INHIBITOR 2-CARBOXYARABINITOL-1,5-DIPHOSPHATE 1RCO ; 2.30 ; SPINACH RUBISCO IN COMPLEX WITH THE INHIBITOR D-XYLULOSE-2,2-DIOL-1,5-BISPHOSPHATE 1A8I ; 1.78 ; SPIROHYDANTOIN INHIBITOR OF GLYCOGEN PHOSPHORYLASE 1H3B ; 2.80 ; SQUALENE-HOPENE CYCLASE 1O6H ; 2.80 ; SQUALENE-HOPENE CYCLASE 3SQC ; 2.80 ; SQUALENE-HOPENE CYCLASE 2SQC ; 2.00 ; SQUALENE-HOPENE CYCLASE FROM ALICYCLOBACILLUS ACIDOCALDARIUS 1SQC ; 2.85 ; SQUALENE-HOPENE-CYCLASE FROM ALICYCLOBACILLUS ACIDOCALDARIUS 1BU1 ; 2.60 ; SRC FAMILY KINASE HCK SH3 DOMAIN 1AD5 ; 2.60 ; SRC FAMILY KINASE HCK-AMP-PNP COMPLEX 2HCK ; 3.00 ; SRC FAMILY KINASE HCK-QUERCETIN COMPLEX 1F2F ; 1.70 ; SRC SH2 THREF1TRP MUTANT 1F1W ; 2.10 ; SRC SH2 THREF1TRP MUTANT COMPLEXED WITH THE PHOSPHOPEPTIDE S(PTR)VNVQN 1WBP ; 2.40 ; SRPK1 BOUND TO 9MER DOCKING MOTIF PEPTIDE 1FGU ; 2.50 ; SSDNA-BINDING DOMAIN OF THE LARGE SUBUNIT OF REPLICATION PROTEIN A 1BNZ ; 2.00 ; SSO7D HYPERTHERMOPHILE PROTEIN/DEOXYRIBONUCLEIC ACID COMPLEX 1BF4 ; 1.60 ; SSO7D-GCGAACGC COMPLEX 1TWB ; 1.90 ; SSPB DISULFIDE CROSSLINKED TO AN SSRA DEGRADATION TAG 1CPR ; 2.10 ; ST. LOUIS CYTOCHROME C' FROM THE PURPLE PHOTOTROPIC BACTERIUM, RHODOBACTER CAPSULATUS 1N0C ; -1.00 ; STABILITY OF CYCLIC BETA-HAIRPINS: ASYMMETRIC CONTIBUTIONS FROM SIDE CHAINS OF HYDROGEN BONDED CROSS-STRAND RESIDUE PAIR 1N0D ; -1.00 ; STABILITY OF CYCLIC BETA-HAIRPINS: ASYMMETRIC CONTIBUTIONS FROM SIDE CHAINS OF HYDROGEN BONDED CROSS-STRAND RESIDUE PAIR 1UR5 ; 1.75 ; STABILIZATION OF A TETRAMERIC MALATE DEHYDROGENASE BY INTRODUCTION OF A DISULFIDE BRIDGE AT THE DIMER/DIMER INTERFACE 1IOQ ; 1.79 ; STABILIZATION OF HEN EGG WHITE LYSOZYME BY A CAVITY-FILLING MUTATION 1IOR ; 1.76 ; STABILIZATION OF HEN EGG WHITE LYSOZYME BY A CAVITY-FILLING MUTATION 1IOS ; 1.76 ; STABILIZATION OF HEN EGG WHITE LYSOZYME BY A CAVITY-FILLING MUTATION 1IOT ; 1.75 ; STABILIZATION OF HEN EGG WHITE LYSOZYME BY A CAVITY-FILLING MUTATION 1BZU ; -1.00 ; STABILIZATION OF THE ANTICODON STEM-LOOP OF TRNALYS, 3 BY AN A+C BASE PAIR AND BY PSEUDOURIDINE, NMR, 1 STRUCTURE 1BZ2 ; -1.00 ; STABILIZATION OF THE ANTICODON STEM-LOOP OF TRNALYS,3 BY AN A+C BASE PAIR AND BY PSEUDOURIDINE, NMR, 1 STRUCTURE 1BZ3 ; -1.00 ; STABILIZATION OF THE ANTICODON STEM-LOOP OF TRNALYS,3 BY AN A+C BASE PAIR AND BY PSEUDOURIDINE, NMR, 1 STRUCTURE 1BZT ; -1.00 ; STABILIZATION OF THE ANTICODON STEM-LOOP OF TRNALYS,3 BY AN A+C BASE PAIR AND BY PSEUDOURIDINE, NMR, 1 STRUCTURE 1JCI ; 1.90 ; STABILIZATION OF THE ENGINEERED CATION-BINDING LOOP IN CYTOCHROME C PEROXIDASE (CCP) 1KNI ; 1.70 ; STABILIZING DISULFIDE BRIDGE MUTANT OF T4 LYSOZYME 1U0P ; -1.00 ; STABLE A-STATE HAIRPIN OF T4 FIBRITIN FOLDON 3NUC ; 1.90 ; STAPHLOCOCCAL NUCLEASE, 1-N-PROPANE THIOL DISULFIDE TO V23C VARIANT 2NUC ; 2.00 ; STAPHLOCOCCAL NUCLEASE, ETHANE THIOL DISULFIDE TO V23C VARIANT 1CV8 ; 1.75 ; STAPHOPAIN, CYSTEINE PROTEINASE FROM STAPHYLOCOCCUS AUREUS V8 1NYC ; 1.40 ; STAPHOSTATINS RESEMBLE LIPOCALINS, NOT CYSTATINS IN FOLD. 2A1D ; 3.50 ; STAPHYLOCOAGULASE BOUND TO BOVINE THROMBIN 1NU9 ; 2.20 ; STAPHYLOCOAGULASE-PRETHROMBIN-2 COMPLEX 1NU7 ; 2.20 ; STAPHYLOCOAGULASE-THROMBIN COMPLEX 1ESF ; 1.90 ; STAPHYLOCOCCAL ENTEROTOXIN A 1DYQ ; 1.50 ; STAPHYLOCOCCAL ENTEROTOXIN A MUTANT VACCINE 3SEB ; 1.48 ; STAPHYLOCOCCAL ENTEROTOXIN B 1SE3 ; 2.30 ; STAPHYLOCOCCAL ENTEROTOXIN B COMPLEXED WITH GM3 TRISACCHARIDE 1SE4 ; 1.90 ; STAPHYLOCOCCAL ENTEROTOXIN B COMPLEXED WITH LACTOSE 1STE ; 2.00 ; STAPHYLOCOCCAL ENTEROTOXIN C2 FROM STAPHYLOCOCCUS AUREUS 1SE2 ; 2.70 ; STAPHYLOCOCCAL ENTEROTOXIN C2, MONOCLINIC FORM 1I4X ; 2.40 ; STAPHYLOCOCCAL ENTEROTOXIN C2, MONOCLINIC FORM CRYSTALLIZED AT PH 8.0 1F77 ; 2.40 ; STAPHYLOCOCCAL ENTEROTOXIN H DETERMINED TO 2.4 A RESOLUTION 1SXT ; 2.70 ; STAPHYLOCOCCAL ENTEROTOXIN TYPE A (SEA) CO-CRYSTALLISED WITH ZINC 2SNS ; 1.50 ; STAPHYLOCOCCAL NUCLEASE COMPLEX WITH 2'-DEOXY-3'-5'-DIPHOSPHOTHYMIDINE 1SND ; 2.00 ; STAPHYLOCOCCAL NUCLEASE DIMER CONTAINING A DELETION OF RESIDUES 114-119 COMPLEXED WITH CALCIUM CHLORIDE AND THE COMPETITIVE INHIBITOR DEOXYTHYMIDINE-3',5'-DIPHOSPHATE 5NUC ; 2.10 ; STAPHYLOCOCCAL NUCLEASE, 1-N-PENTANE THIOL DISULFIDE TO V23C VARIANT 1A2T ; 1.96 ; STAPHYLOCOCCAL NUCLEASE, B-MERCAPTOETHANOL DISULFIDE TO V23C VARIANT 1A3U ; 2.05 ; STAPHYLOCOCCAL NUCLEASE, CYCLOHEXANE THIOL DISULFIDE TO V23C VARIANT 1A3V ; 2.20 ; STAPHYLOCOCCAL NUCLEASE, CYCLOPENTANE THIOL DISULFIDE TO V23C VARIANT 1AEX ; 2.10 ; STAPHYLOCOCCAL NUCLEASE, METHANE THIOL DISULFIDE TO V23C VARIANT 1NUC ; 1.90 ; STAPHYLOCOCCAL NUCLEASE, V23C VARIANT 1A2U ; 2.00 ; STAPHYLOCOCCAL NUCLEASE, V23C VARIANT, COMPLEX WITH 1-N-BUTANE THIOL AND 3',5'-THYMIDINE DIPHOSPHATE 1A3T ; 2.10 ; STAPHYLOCOCCAL NUCLEASE, V23C VARIANT, COMPLEX WITH 2-FLUOROETHANE THIOL AND 3',5'-THYMIDINE DIPHOSPHATE 1EDL ; -1.00 ; STAPHYLOCOCCAL PROTEIN A E-DOMAIN (-60), NMR, 20 STRUCTURES 1EDK ; -1.00 ; STAPHYLOCOCCAL PROTEIN A E-DOMAIN (-60), NMR, MINIMIZED AVERAGE STRUCTURE 1EDJ ; -1.00 ; STAPHYLOCOCCAL PROTEIN A E-DOMAIN (180), NMR, 20 STRUCTURES 1EDI ; -1.00 ; STAPHYLOCOCCAL PROTEIN A E-DOMAIN (180), NMR, MINIMIZED AVERAGE STRUCTURE 1SS1 ; -1.00 ; STAPHYLOCOCCAL PROTEIN A, B-DOMAIN, Y15W MUTANT, NMR, 25 STRUCTURES 2SPZ ; -1.00 ; STAPHYLOCOCCAL PROTEIN A, Z-DOMAIN, NMR, 10 STRUCTURES 1V1O ; 2.75 ; STAPHYLOCOCCAL SUPERANTIGEN-LIKE PROTEIN 7 1TXT ; 2.50 ; STAPHYLOCOCCUS AUREUS 3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE 1BDC ; -1.00 ; STAPHYLOCOCCUS AUREUS PROTEIN A, IMMUNOGLOBULIN-BINDING B DOMAIN, NMR, 10 STRUCTURES 1BDD ; -1.00 ; STAPHYLOCOCCUS AUREUS PROTEIN A, IMMUNOGLOBULIN-BINDING B DOMAIN, NMR, MINIMIZED AVERAGE STRUCTURE 1C77 ; 2.30 ; STAPHYLOKINASE (SAK) DIMER 1C78 ; 2.30 ; STAPHYLOKINASE (SAK) DIMER 1C79 ; 2.30 ; STAPHYLOKINASE (SAK) DIMER 1C76 ; 2.25 ; STAPHYLOKINASE (SAK) MONOMER 2SAK ; 1.80 ; STAPHYLOKINASE (SAKSTAR VARIANT) 1SSN ; -1.00 ; STAPHYLOKINASE, SAKSTAR VARIANT, NMR, 20 STRUCTURES 1EM2 ; 2.20 ; STAR-RELATED LIPID TRANSPORT DOMAIN OF MLN64 1CQY ; 1.95 ; STARCH BINDING DOMAIN OF BACILLUS CEREUS BETA-AMYLASE 1BF5 ; 2.90 ; STAT-1 DEOXYRIBONUCLEIC ACID COMPLEX 1BGF ; 1.45 ; STAT-4 N-DOMAIN 1AFR ; 2.40 ; STEAROYL-ACYL CARRIER PROTEIN DESATURASE FROM CASTOR SEEDS 2U2A ; -1.00 ; STEM LOOP IIA FROM U2 SNRNA OF SACCHAROMYCES CEREVISIAE, NMR, MINIMIZED AVERAGE STRUCTURE 1U2A ; -1.00 ; STEM LOOP IIA FROM U2SNRNA OF SACCHAROMYCES CEREVISIAE, NMR, MINIMIZED AVERAGE STRUCTURE 1TXS ; -1.00 ; STEM-LOOP D OF THE CLOVERLEAF DOMAIN OF ENTEROVIRAL 5'UTR RIBONUCLEIC ACID 1W54 ; 2.20 ; STEPWISE INTRODUCTION OF A ZINC BINDING SITE INTO PORPHOBILINOGEN SYNTHASE FROM PSEUDOMONAS AERUGINOSA (MUTATION D139C) 1W56 ; 1.70 ; STEPWISE INTRODUCTION OF ZINC BINDING SITE INTO PORPHOBILINOGEN SYNTHASE OF PSEUDOMONAS AERUGINOSA (MUTATIONS A129C AND D131C) 1W5M ; 1.60 ; STEPWISE INTRODUCTION OF ZINC BINDING SITE INTO PORPHOBILINOGEN SYNTHASE OF PSEUDOMONAS AERUGINOSA (MUTATIONS A129C AND D139C) 1W5O ; 1.85 ; STEPWISE INTRODUCTION OF ZINC BINDING SITE INTO PORPHOBILINOGEN SYNTHASE OF PSEUDOMONAS AERUGINOSA (MUTATIONS A129C, D131C AND D139C) 1W5P ; 1.55 ; STEPWISE INTRODUCTION OF ZINC BINDING SITE INTO PORPHOBILINOGEN SYNTHASE OF PSEUDOMONAS AERUGINOSA (MUTATIONS A129C, D131C, D139C, P132E) 1W5Q ; 1.40 ; STEPWISE INTRODUCTION OF ZINC BINDING SITE INTO PORPHOBILINOGEN SYNTHASE OF PSEUDOMONAS AERUGINOSA (MUTATIONS A129C, D131C, D139C, P132E, K229R) 1W5N ; 1.65 ; STEPWISE INTRODUCTION OF ZINC BINDING SITE INTO PORPHOBILINOGEN SYNTHASE OF PSEUDOMONAS AERUGINOSA (MUTATIONS D131C AND D139C) 1UCV ; -1.00 ; STERILE ALPHA MOTIF (SAM) DOMAIN OF EPHRIN TYPE-A RECEPTOR 8 1V85 ; -1.00 ; STERILE ALPHA MOTIF (SAM) DOMAIN OF MOUSE BIFUNCTIONAL APOPTOSIS REGULATOR 1ESS ; -1.00 ; STEROID TETHERED DEOXYRIBONUCLEIC ACID, NMR, MINIMIZED AVERAGE STRUCTURE 1C44 ; 1.80 ; STEROL CARRIER PROTEIN 2 (SCP2) FROM RABBIT 1QND ; -1.00 ; STEROL CARRIER PROTEIN-2, NMR, 20 STRUCTURES 3BCC ; 3.70 ; STIGMATELLIN AND ANTIMYCIN BOUND CYTOCHROME BC1 COMPLEX FROM CHICKEN 2BCC ; 3.50 ; STIGMATELLIN-BOUND CYTOCHROME BC1 COMPLEX FROM CHICKEN 1JXE ; 2.85 ; STOFFEL FRAGMENT OF TAQ DEOXYRIBONUCLEIC ACID POLYMERASE I 1MZ9 ; 1.70 ; STORAGE FUNCTION OF COMP:THE CRYSTAL STRUCTURE OF THE COILED-COIL DOMAIN IN COMPLEX WITH VITAMIN D3 1PFG ; 2.50 ; STRATEGY TO DESIGN INHIBITORS: STRUCTURE OF A COMPLEX OF PROTEINASE K WITH A DESIGNED OCTAPEPTIDE INHIBITOR N-AC- PRO-ALA-PRO-PHE-DALA-ALA-ALA-ALA-NH2 AT 2.5A RESOLUTION 1I8T ; 2.40 ; STRCUTURE OF UDP-GALACTOPYRANOSE MUTASE FROM E.COLI 1MC9 ; 1.70 ; STREPROMYCES LIVIDANS XYLAN BINDING DOMAIN CBM13 IN COMPLEX WITH XYLOPENTAOSE 1VWP ; 1.75 ; STREPTAVIDIN COMPLEXED WITH CYCLO-AC-[CHPQGPPC]-NH2 MONOMER, PH 2.5 1VWO ; 1.65 ; STREPTAVIDIN COMPLEXED WITH CYCLO-AC-[CHPQGPPC]-NH2 MONOMER, PH 2.85 1VWF ; 1.92 ; STREPTAVIDIN COMPLEXED WITH CYCLO-AC-[CHPQGPPC]-NH2 MONOMER, PH 3.67 1VWG ; 1.46 ; STREPTAVIDIN COMPLEXED WITH THE HEAD-TO-TAIL DISULFIDE-BONDED PEPTIDE DIMER OF CYCLO-AC-[CHPQGPPC]-NH2, PH 2.5 1VWH ; 1.48 ; STREPTAVIDIN COMPLEXED WITH THE HEAD-TO-TAIL DISULFIDE-BONDED PEPTIDE DIMER OF CYCLO-AC-[CHPQGPPC]-NH2, PH 3.5 1STR ; 1.80 ; STREPTAVIDIN DIMERIZED BY DISULFIDE-BONDED PEPTIDE AC-CHPQNT-NH2 DIMER 1STS ; 1.95 ; STREPTAVIDIN DIMERIZED BY DISULFIDE-BONDED PEPTIDE FCHPQNT-NH2 DIMER 1N4J ; 2.18 ; STREPTAVIDIN MUTANT N23A AT 2.18A 1N43 ; 1.89 ; STREPTAVIDIN MUTANT N23A WITH BIOTIN AT 1.89A 1N7Y ; 1.96 ; STREPTAVIDIN MUTANT N23E AT 1.96A 1N9Y ; 1.53 ; STREPTAVIDIN MUTANT S27A AT 1.5A RESOLUTION 1N9M ; 1.60 ; STREPTAVIDIN MUTANT S27A WITH BIOTIN AT 1.6A RESOLUTION 1MM9 ; 1.66 ; STREPTAVIDIN MUTANT WITH INSERTION OF FIBRONECTIN HEXAPEPTIDE, INCLUDING RGD 1MOY ; 1.55 ; STREPTAVIDIN MUTANT WITH OSTEOPONTIN HEXAPEPTIDE INSERTION INCLUDING RGD 1NBX ; 1.70 ; STREPTAVIDIN MUTANT Y43A AT 1.70A RESOLUTION 1NC9 ; 1.80 ; STREPTAVIDIN MUTANT Y43A WITH IMINOBIOTIN AT 1.8A RESOLUTION 1SWU ; 1.14 ; STREPTAVIDIN MUTANT Y43F 1NDJ ; 1.81 ; STREPTAVIDIN MUTANT Y43F WITH BIOTIN AT 1.81A RESOLUTION 1SLE ; 1.90 ; STREPTAVIDIN, PH 5.0, BOUND TO CYCLIC PEPTIDE AC-CHPQGPPC-NH2 1SLG ; 1.76 ; STREPTAVIDIN, PH 5.6, BOUND TO PEPTIDE FCHPQNT 1SLD ; 2.30 ; STREPTAVIDIN, PH 7.5, BOUND TO CYCLIC DISULFIDE-BONDED PEPTIDE LIGAND AC-CHPQFC-NH2 2RTN ; 1.80 ; STREPTAVIDIN-2-IMINOBIOTIN COMPLEX, PH 2.0, SPACE GROUP I222 2RTO ; 1.58 ; STREPTAVIDIN-2-IMINOBIOTIN COMPLEX, PH 2.6, SPACE GROUP I222 2RTP ; 1.50 ; STREPTAVIDIN-2-IMINOBIOTIN COMPLEX, PH 3.25, SPACE GROUP I222 2RTQ ; 1.39 ; STREPTAVIDIN-2-IMINOBIOTIN COMPLEX, PH 3.25, SPACE GROUP I222, CRYSTALLIZED FROM 4.3 M AMMONIUM SULFATE 2RTR ; 1.62 ; STREPTAVIDIN-2-IMINOBIOTIN COMPLEX, PH 4.0, SPACE GROUP I222 2IZL ; 1.48 ; STREPTAVIDIN-2-IMINOBIOTIN PH 7.3 I222 COMPLEX 2RTL ; 1.41 ; STREPTAVIDIN-2-IMINOBIOTIN-SULFATE COMPLEX, PH 2.50, SPACE GROUP I4122 2RTM ; 1.58 ; STREPTAVIDIN-2-IMINOBIOTIN-SULFATE COMPLEX, PH 3.50, SPACE GROUP I4122 1LCZ ; 1.95 ; STREPTAVIDIN-BCAP COMPLEX 2RTD ; 1.65 ; STREPTAVIDIN-BIOTIN COMPLEX, PH 1.39, SPACE GROUP I222 2RTE ; 1.50 ; STREPTAVIDIN-BIOTIN COMPLEX, PH 1.90, SPACE GROUP I222 2RTF ; 1.47 ; STREPTAVIDIN-BIOTIN COMPLEX, PH 2.00, SPACE GROUP I222 2RTG ; 1.39 ; STREPTAVIDIN-BIOTIN COMPLEX, PH 2.40, SPACE GROUP I222 2IZH ; 1.36 ; STREPTAVIDIN-BIOTIN PH 10.44 I222 COMPLEX 2IZG ; 1.36 ; STREPTAVIDIN-BIOTIN PH 2.0 I222 COMPLEX 2IZI ; 1.70 ; STREPTAVIDIN-BIOTIN PH 2.53 I4122 STRUCTURE 2IZJ ; 1.43 ; STREPTAVIDIN-BIOTIN PH 3.50 I4122 STRUCTURE 2IZF ; 1.58 ; STREPTAVIDIN-BIOTIN PH 4.0 I222 COMPLEX 1VWB ; 1.82 ; STREPTAVIDIN-CYCLO-AC-[CHPQFC]-NH2, PH 11.8 1VWC ; 1.86 ; STREPTAVIDIN-CYCLO-AC-[CHPQFC]-NH2, PH 2.0 1VWD ; 1.87 ; STREPTAVIDIN-CYCLO-AC-[CHPQFC]-NH2, PH 3.0 1VWE ; 1.50 ; STREPTAVIDIN-CYCLO-AC-[CHPQFC]-NH2, PH 3.6 1VWM ; 1.60 ; STREPTAVIDIN-CYCLO-AC-[CHPQFC]-NH2, PH 4.2 1VWN ; 1.85 ; STREPTAVIDIN-CYCLO-AC-[CHPQFC]-NH2, PH 4.8 1VWK ; 1.45 ; STREPTAVIDIN-CYCLO-[5-S-VALERAMIDE-HPQGPPC]K-NH2 1VWI ; 1.50 ; STREPTAVIDIN-CYCLO-[5-S-VALERAMIDE-HPQGPPC]K-NH2, PH 1.5, I222 COMPLEX 1VWJ ; 1.45 ; STREPTAVIDIN-CYCLO-[5-S-VALERAMIDE-HPQGPPC]K-NH2, PH 2.5, I222 COMPLEX 1VWQ ; 1.70 ; STREPTAVIDIN-CYCLO-[5-S-VALERAMIDE-HPQGPPC]K-NH2, PH 2.5, I4122 COMPLEX 1VWL ; 1.45 ; STREPTAVIDIN-CYCLO-[5-S-VALERAMIDE-HPQGPPC]K-NH2, PH 3.5, I222 COMPLEX 1VWR ; 1.50 ; STREPTAVIDIN-CYCLO-[5-S-VALERAMIDE-HPQGPPC]K-NH2, PH 3.5, I4122 COMPLEX 1VWA ; 1.85 ; STREPTAVIDIN-FSHPQNT 2RTH ; 1.56 ; STREPTAVIDIN-GLYCOLURIL COMPLEX, PH 2.50, SPACE GROUP I222 2RTI ; 1.40 ; STREPTAVIDIN-GLYCOLURIL COMPLEX, PH 2.50, SPACE GROUP I222 2RTJ ; 1.43 ; STREPTAVIDIN-GLYCOLURIL COMPLEX, PH 2.50, SPACE GROUP I4122 2RTK ; 1.82 ; STREPTAVIDIN-GLYCOLURIL COMPLEX, PH 2.58, SPACE GROUP I4122 PREPARED FROM AN APOSTREPTAVIDIN CRYSTAL 2IZK ; 1.50 ; STREPTAVIDIN-GLYCOLURIL PH 2.58 I4122 COMPLEX 1LCW ; 2.20 ; STREPTAVIDIN-HOMOBIOTIN COMPLEX 1LCV ; 2.30 ; STREPTAVIDIN-NORBIOTIN COMPLEX 1B1Z ; 2.57 ; STREPTOCOCCAL PYROGENIC EXOTOXIN A1 1BXT ; 1.85 ; STREPTOCOCCAL SUPERANTIGEN (SSA) FROM STREPTOCOCCUS PYOGENES 1I74 ; 2.20 ; STREPTOCOCCUS MUTANS INORGANIC PYROPHOSPHATASE 1N7O ; 1.50 ; STREPTOCOCCUS PNEUMONIAE HYALURONATE LYASE F343V MUTANT 1LOH ; 2.00 ; STREPTOCOCCUS PNEUMONIAE HYALURONATE LYASE IN COMPLEX WITH HEXASACCHARIDE HYALURONAN SUBSTRATE 1LXK ; 1.53 ; STREPTOCOCCUS PNEUMONIAE HYALURONATE LYASE IN COMPLEX WITH TETRASACCHARIDE HYALURONAN SUBSTRATE 1N7Q ; 2.30 ; STREPTOCOCCUS PNEUMONIAE HYALURONATE LYASE W291A/W292A DOUBLE MUTANT COMPLEX WITH HYALURONAN HEXASACCHRIDE 1N7R ; 2.20 ; STREPTOCOCCUS PNEUMONIAE HYALURONATE LYASE W291A/W292A/F343V MUTANT COMPLEX WITH HEXASACCHARIDE HYALURONAN 1N7N ; 1.55 ; STREPTOCOCCUS PNEUMONIAE HYALURONATE LYASE W292A MUTANT 1N7P ; 1.55 ; STREPTOCOCCUS PNEUMONIAE HYALURONATE LYASE W292A/F343V DOUBLE MUTANT 1TKJ ; 1.15 ; STREPTOMYCES GRISEUS AMINOPEPTIDASE COMPLEXED WITH D- METHIONINE 1TKH ; 1.25 ; STREPTOMYCES GRISEUS AMINOPEPTIDASE COMPLEXED WITH D- PHENYLALANINE 1TKF ; 1.20 ; STREPTOMYCES GRISEUS AMINOPEPTIDASE COMPLEXED WITH D- TRYPTOPHAN 1TF8 ; 1.30 ; STREPTOMYCES GRISEUS AMINOPEPTIDASE COMPLEXED WITH L- TRYPTOPHAN 1QQ9 ; 1.53 ; STREPTOMYCES GRISEUS AMINOPEPTIDASE COMPLEXED WITH METHIONINE 1XBU ; 1.20 ; STREPTOMYCES GRISEUS AMINOPEPTIDASE COMPLEXED WITH P-IODO-D- PHENYLALANINE 1TF9 ; 1.30 ; STREPTOMYCES GRISEUS AMINOPEPTIDASE COMPLEXED WITH P-IODO-L- PHENYLALANINE 2NLR ; 1.20 ; STREPTOMYCES LIVIDANS ENDOGLUCANASE (EC: 3.2.1.4) COMPLEX WITH MODIFIED GLUCOSE TRIMER 1KNL ; 1.20 ; STREPTOMYCES LIVIDANS XYLAN BINDING DOMAIN CBM13 1KNM ; 1.20 ; STREPTOMYCES LIVIDANS XYLAN BINDING DOMAIN CBM13 IN COMPLEX WITH LACTOSE 1CHK ; 2.40 ; STREPTOMYCES N174 CHITOSANASE PH5.5 298K 1HP5 ; 2.10 ; STREPTOMYCES PLICATUS BETA-N-ACETYLHEXOSAMINIDASE COMPLEXED WITH INTERMEDIATE ANALOUGE NAG-THIAZOLINE 1JAK ; 1.75 ; STREPTOMYCES PLICATUS BETA-N-ACETYLHEXOSAMINIDASE IN COMPLEX WITH (2R,3R,4S,5R)-2-ACETAMIDO-3,4-DIHYDROXY-5- HYDROXYMETHYL-PIPERIDINIUM CHLORIDE (IFG) 1QG7 ; 2.00 ; STROMA CELL-DERIVED FACTOR-1ALPHA (SDF-1ALPHA) 1VMC ; -1.00 ; STROMA CELL-DERIVED FACTOR-1ALPHA (SDF-1ALPHA) 1B3D ; 2.30 ; STROMELYSIN-1 1UMT ; -1.00 ; STROMELYSIN-1 CATALYTIC DOMAIN WITH HYDROPHOBIC INHIBITOR BOUND, PH 7.0, 32OC, 20 MM CACL2, 15% ACETONITRILE; NMR AVERAGE OF 20 STRUCTURES MINIMIZED WITH RESTRAINTS 1UMS ; -1.00 ; STROMELYSIN-1 CATALYTIC DOMAIN WITH HYDROPHOBIC INHIBITOR BOUND, PH 7.0, 32OC, 20 MM CACL2, 15% ACETONITRILE; NMR ENSEMBLE OF 20 STRUCTURES 1M6F ; 1.78 ; STRONG BINDING IN THE DEOXYRIBONUCLEIC ACID MINOR GROOVE BY AN AROMATIC DIAMIDINE WITH A SHAPE THAT DOES NOT MATCH THE CURVATURE OF THE GROOVE 1OTD ; 1.25 ; STRONG HYDROGEN BONDS IN PHOTOACTIVE YELLOW PROTEIN AND THEIR ROLE IN ITS PHOTOCYCLE 1ZND ; 1.60 ; STRONG SOLUTE-SOLUTE DISPERSIVE INTERACTIONS IN A PROTEIN- LIGAND COMPLEX 1ZNE ; 2.00 ; STRONG SOLUTE-SOLUTE DISPERSIVE INTERACTIONS IN A PROTEIN- LIGAND COMPLEX 1ZNG ; 1.60 ; STRONG SOLUTE-SOLUTE DISPERSIVE INTERACTIONS IN A PROTEIN- LIGAND COMPLEX 1ZNH ; 2.10 ; STRONG SOLUTE-SOLUTE DISPERSIVE INTERACTIONS IN A PROTEIN- LIGAND COMPLEX 1ZNK ; 1.60 ; STRONG SOLUTE-SOLUTE DISPERSIVE INTERACTIONS IN A PROTEIN- LIGAND COMPLEX 1ZNL ; 1.70 ; STRONG SOLUTE-SOLUTE DISPERSIVE INTERACTIONS IN A PROTEIN- LIGAND COMPLEX 1NVY ; 1.50 ; STRONTIUM BOUND TO THE HOLLIDAY JUNCTION SEQUENCE D(TCGGTACCGA)4 1U2D ; 3.00 ; STRUCTRE OF TRANSHYDROGENAES (DI.NADH)2(DIII.NADPH)1 ASYMMETRIC COMPLEX 1QX4 ; 1.80 ; STRUCTRUE OF S127P MUTANT OF CYTOCHROME B5 REDUCTASE 1QY6 ; 1.90 ; STRUCTUE OF V8 PROTEASE FROM STAPHYLOCOCCUS AUREUS 1AXO ; -1.00 ; STRUCTURAL ALIGNMENT OF THE (+)-TRANS-ANTI-[BP]DG ADDUCT POSITIONED OPPOSITE DC AT A DEOXYRIBONUCLEIC ACID TEMPLATE-PRIMER JUNCTION, NMR, 6 STRUCTURES 1DNU ; 1.85 ; STRUCTURAL ANALYSES OF HUMAN MYELOPEROXIDASE-THIOCYANATE COMPLEX 1Y1X ; 1.95 ; STRUCTURAL ANALYSIS OF A HOMOLOG OF PROGRAMMED CELL DEATH 6 PROTEIN FROM LEISHMANIA MAJOR FRIEDLIN 1TC5 ; 1.93 ; STRUCTURAL ANALYSIS OF A PROBABLE EUKARYOTIC D-AMINO ACID TRNA DEACYLASE 1TYC ; 2.50 ; STRUCTURAL ANALYSIS OF A SERIES OF MUTANTS OF TYROSYL-TRNA SYNTHETASE: ENHANCEMENT OF CATALYSIS BY HYDROPHOBIC INTERACTIONS 2A9M ; 2.10 ; STRUCTURAL ANALYSIS OF A TIGHT-BINDING FLUORESCEIN-SCFV; APO FORM 1FX2 ; 1.46 ; STRUCTURAL ANALYSIS OF ADENYLATE CYCLASES FROM TRYPANOSOMA BRUCEI IN THEIR MONOMERIC STATE 1TE0 ; 2.20 ; STRUCTURAL ANALYSIS OF DEGS, A STRESS SENSOR OF THE BACTERIAL PERIPLASM 1ZFN ; 2.75 ; STRUCTURAL ANALYSIS OF ESCHERICHIA COLI THIF 1ZKM ; 2.95 ; STRUCTURAL ANALYSIS OF ESCHERICHIA COLI THIF 1DC3 ; 2.50 ; STRUCTURAL ANALYSIS OF GLYCERALDEHYDE 3-PHOSPHATE DEHYDROGENASE FROM ESCHERICHIA COLI: DIRECT EVIDENCE FOR SUBSTRATE BINDING AND COFACTOR-INDUCED CONFORMATIONAL CHANGES 1DC4 ; 2.50 ; STRUCTURAL ANALYSIS OF GLYCERALDEHYDE 3-PHOSPHATE DEHYDROGENASE FROM ESCHERICHIA COLI: DIRECT EVIDENCE FOR SUBSTRATE BINDING AND COFACTOR-INDUCED CONFORMATIONAL CHANGES 1DC5 ; 2.00 ; STRUCTURAL ANALYSIS OF GLYCERALDEHYDE 3-PHOSPHATE DEHYDROGENASE FROM ESCHERICHIA COLI: DIRECT EVIDENCE FOR SUBSTRATE BINDING AND COFACTOR-INDUCED CONFORMATIONAL CHANGES 1DC6 ; 2.00 ; STRUCTURAL ANALYSIS OF GLYCERALDEHYDE 3-PHOSPHATE DEHYDROGENASE FROM ESCHERICHIA COLI: DIRECT EVIDENCE FOR SUBSTRATE BINDING AND COFACTOR-INDUCED CONFORMATIONAL CHANGES. 1Q7I ; -1.00 ; STRUCTURAL ANALYSIS OF INTEGRIN ALPHA IIB BETA 3- DISINTEGRIN WITH THE AKGDWN MOTIF 1Q7J ; -1.00 ; STRUCTURAL ANALYSIS OF INTEGRIN ALPHA IIB BETA 3- DISINTEGRIN WITH THE AKGDWN MOTIF 1X6O ; 1.60 ; STRUCTURAL ANALYSIS OF LEISHMANIA BRAZILIENSIS EUKARYOTIC INITIATION FACTOR 5A 1XTP ; 1.94 ; STRUCTURAL ANALYSIS OF LEISHMANIA MAJOR LMAJ004091AAA, A SAM-DEPENDENT METHYLTRANSFERASE OF THE DUF858/PFAM05891 FAMILY 1YF9 ; 2.00 ; STRUCTURAL ANALYSIS OF LEISHMANIA MAJOR UBIQUITIN CONJUGATING ENZYME E2 1XTD ; 2.70 ; STRUCTURAL ANALYSIS OF LEISHMANIA MEXICANA EUKARYOTIC INITIATION FACTOR 5A 1R1H ; 1.95 ; STRUCTURAL ANALYSIS OF NEPRILYSIN WITH VARIOUS SPECIFIC AND POTENT INHIBITORS 1R1I ; 2.60 ; STRUCTURAL ANALYSIS OF NEPRILYSIN WITH VARIOUS SPECIFIC AND POTENT INHIBITORS 1R1J ; 2.35 ; STRUCTURAL ANALYSIS OF NEPRILYSIN WITH VARIOUS SPECIFIC AND POTENT INHIBITORS 2B94 ; 1.85 ; STRUCTURAL ANALYSIS OF P KNOWLESI HOMOLOG OF P FALCIPARUM PNP 1B9X ; 3.00 ; STRUCTURAL ANALYSIS OF PHOSDUCIN AND ITS PHOSPHORYLATION- REGULATED INTERACTION WITH TRANSDUCIN 1B9Y ; 3.00 ; STRUCTURAL ANALYSIS OF PHOSDUCIN AND ITS PHOSPHORYLATION- REGULATED INTERACTION WITH TRANSDUCIN BETA-GAMMA 1Y13 ; 2.20 ; STRUCTURAL ANALYSIS OF PLASMODIUM FALCIPARUM 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASE (PTPS) 1W8X ; -1.00 ; STRUCTURAL ANALYSIS OF PRD1 1LA2 ; 2.65 ; STRUCTURAL ANALYSIS OF SACCHAROMYCES CEREVISIAE MYO- INOSITOL PHOSPHATE SYNTHASE 1YVG ; 2.60 ; STRUCTURAL ANALYSIS OF THE CATALYTIC DOMAIN OF TETANUS NEUROTOXIN 1MKY ; 1.90 ; STRUCTURAL ANALYSIS OF THE DOMAIN INTERACTIONS IN DER, A SWITCH PROTEIN CONTAINING TWO GTPASE DOMAINS 1QPC ; 1.60 ; STRUCTURAL ANALYSIS OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN COMPLEX WITH NON-SELECTIVE AND SRC FAMILY SELECTIVE KINASE INHIBITORS 1QPD ; 2.00 ; STRUCTURAL ANALYSIS OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN COMPLEX WITH NON-SELECTIVE AND SRC FAMILY SELECTIVE KINASE INHIBITORS 1QPE ; 2.00 ; STRUCTURAL ANALYSIS OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN COMPLEX WITH NON-SELECTIVE AND SRC FAMILY SELECTIVE KINASE INHIBITORS 1RO7 ; 1.80 ; STRUCTURAL ANALYSIS OF THE SIALYLTRANSFERASE CSTII FROM CAMPYLOBACTER JEJUNI IN COMPLEX WITH A SUBSTRATE ANALOGUE, CMP-3FNEUAC. 1RO8 ; 2.05 ; STRUCTURAL ANALYSIS OF THE SIALYLTRANSFERASE CSTII FROM CAMPYLOBACTER JEJUNI IN COMPLEX WITH A SUBSTRATE ANALOGUE, CYTIDINE-5'-MONOPHOSPHATE 1KVP ; 27.00 ; STRUCTURAL ANALYSIS OF THE SPIROPLASMA VIRUS, SPV4, IMPLICATIONS FOR EVOLUTIONARY VARIATION TO OBTAIN HOST DIVERSITY AMONG THE MICROVIRIDAE, ELECTRON MICROSCOPY, ALPHA CARBONS ONLY 1T3S ; 2.30 ; STRUCTURAL ANALYSIS OF THE VOLTAGE-DEPENDENT CALCIUM CHANNEL BETA SUBUNIT FUNCTIONAL CORE 1T3L ; 2.20 ; STRUCTURAL ANALYSIS OF THE VOLTAGE-DEPENDENT CALCIUM CHANNEL BETA SUBUNIT FUNCTIONAL CORE IN COMPLEX WITH ALPHA1 INTERACTION DOMAIN 1JO8 ; 1.30 ; STRUCTURAL ANALYSIS OF THE YEAST ACTIN BINDING PROTEIN ABP1 SH3 DOMAIN 1WG3 ; 3.00 ; STRUCTURAL ANALYSIS OF YEAST NUCLEOSOME-ASSEMBLY FACTOR CIA1P 2F6B ; 2.80 ; STRUCTURAL AND ACTIVE SITE MODIFICATION STUDIES IMPLICATE GLU, TRP AND ARG IN THE ACTIVITY OF XYLANASE FROM ALKALOPHILIC BACILLUS SP. (NCL 87-6-10). 1YEP ; 2.50 ; STRUCTURAL AND BIOCHEMICAL ANALYSIS OF THE LINK BETWEEN ENZYMATIC ACTIVITY AND OLGOMERIZATION IN AHPC, A BACTERIAL PEROXIREDOXIN. 1YEX ; 2.30 ; STRUCTURAL AND BIOCHEMICAL ANALYSIS OF THE LINK BETWEEN ENZYMATIC ACTIVITY AND OLIGOMERIZATION IN AHPC, A BACTERIAL PEROXIREDOXIN. 1YF0 ; 2.50 ; STRUCTURAL AND BIOCHEMICAL ANALYSIS OF THE LINK BETWEEN ENZYMATIC ACTIVITY AND OLIGOMERIZATION IN AHPC, A BACTERIAL PEROXIREDOXIN. 1YF1 ; 2.60 ; STRUCTURAL AND BIOCHEMICAL ANALYSIS OF THE LINK BETWEEN ENZYMATIC ACTIVITY AND OLIGOMERIZATION IN AHPC, A BACTERIAL PEROXIREDOXIN. 1ZGY ; 1.80 ; STRUCTURAL AND BIOCHEMICAL BASIS FOR SELECTIVE REPRESSION OF THE ORPHAN NUCLEAR RECEPTOR LRH-1 BY SHP 1ZH7 ; 2.50 ; STRUCTURAL AND BIOCHEMICAL BASIS FOR SELECTIVE REPRESSION OF THE ORPHAN NUCLEAR RECEPTOR LRH-1 BY SHP 1H56 ; 3.00 ; STRUCTURAL AND BIOCHEMICAL CHARACTERIZATION OF A NEW MAGNESIUM ION BINDING SITE NEAR TYR94 IN THE RESTRICTION ENDONUCLEASE PVUII 1DJQ ; 2.20 ; STRUCTURAL AND BIOCHEMICAL CHARACTERIZATION OF RECOMBINANT C30A MUTANT OF TRIMETHYLAMINE DEHYDROGENASE FROM METHYLOPHILUS METHYLOTROPHUS (SP. W3A1) 1DJN ; 2.20 ; STRUCTURAL AND BIOCHEMICAL CHARACTERIZATION OF RECOMBINANT WILD TYPE TRIMETHYLAMINE DEHYDROGENASE FROM METHYLOPHILUS METHYLOTROPHUS (SP. W3A1) 1SU1 ; 2.25 ; STRUCTURAL AND BIOCHEMICAL CHARACTERIZATION OF YFCE, A PHOSPHOESTERASE FROM E. COLI 1SSU ; -1.00 ; STRUCTURAL AND BIOCHEMICAL EVIDENCE FOR DISULFIDE BOND HETEROGENEITY IN ACTIVE FORMS OF THE SOMATOMEDIN B DOMAIN OF HUMAN VITRONECTIN 1N39 ; 2.20 ; STRUCTURAL AND BIOCHEMICAL EXPLORATION OF A CRITICAL AMINO ACID IN HUMAN 8-OXOGUANINE GLYCOSYLASE 1N3A ; 2.20 ; STRUCTURAL AND BIOCHEMICAL EXPLORATION OF A CRITICAL AMINO ACID IN HUMAN 8-OXOGUANINE GLYCOSYLASE 1N3C ; 2.70 ; STRUCTURAL AND BIOCHEMICAL EXPLORATION OF A CRITICAL AMINO ACID IN HUMAN 8-OXOGUANINE GLYCOSYLASE 1XDQ ; 2.55 ; STRUCTURAL AND BIOCHEMICAL IDENTIFICATION OF A NOVEL BACTERIAL OXIDOREDUCTASE 1XDY ; 2.20 ; STRUCTURAL AND BIOCHEMICAL IDENTIFICATION OF A NOVEL BACTERIAL OXIDOREDUCTASE, W-CONTAINING COFACTOR 2A3I ; 1.95 ; STRUCTURAL AND BIOCHEMICAL MECHANISMS FOR THE SPECIFICITY OF HORMONE BINDING AND COACTIVATOR ASSEMBLY BY MINERALOCORTICOID RECEPTOR 1Y7H ; 2.52 ; STRUCTURAL AND BIOCHEMICAL STUDIES IDENTIFY TOBACCO SABP2 AS A METHYLSALICYLATE ESTERASE AND FURTHER IMPLICATE IT IN PLANT INNATE IMMUNITY, NORTHEAST STRUCTURAL GENOMICS TARGET AR2241 1Y7I ; 2.10 ; STRUCTURAL AND BIOCHEMICAL STUDIES IDENTIFY TOBACCO SABP2 AS A METHYLSALICYLATE ESTERASE AND FURTHER IMPLICATE IT IN PLANT INNATE IMMUNITY, NORTHEAST STRUCTURAL GENOMICS TARGET AR2241 1VYJ ; 2.80 ; STRUCTURAL AND BIOCHEMICAL STUDIES OF HUMAN PCNA COMPLEXES PROVIDE THE BASIS FOR ASSOCIATION WITH CDK/CYCLIN AND RATIONALE FOR INHIBITOR DESIGN 1YBJ ; -1.00 ; STRUCTURAL AND DYNAMICS STUDIES OF BOTH APO AND HOLO FORMS OF THE HEMOPHORE HASA 1HQ1 ; 1.52 ; STRUCTURAL AND ENERGETIC ANALYSIS OF RIBONUCLEIC ACID RECOGNITION BY A UNIVERSALLY CONSERVED PROTEIN FROM THE SIGNAL RECOGNITION PARTICLE 2AQE ; -1.00 ; STRUCTURAL AND FUNCTIONAL ANALYSIS OF ADA2 ALPHA SWIRM DOMAIN 1TUW ; 1.90 ; STRUCTURAL AND FUNCTIONAL ANALYSIS OF TETRACENOMYCIN F2 CYCLASE FROM STREPTOMYCES GLAUCESCENS: A TYPE-II POLYKETIDE CYCLASE 1U3F ; 2.50 ; STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF A 5,10- METHENYLTETRAHYDROFOLATE SYNTHETASE FROM MYCOPLASMA PNEUMONIAE (GI: 13508087) 1U3G ; 2.50 ; STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF A 5,10- METHENYLTETRAHYDROFOLATE SYNTHETASE FROM MYCOPLASMA PNEUMONIAE (GI: 13508087) 1S3L ; 2.40 ; STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF A NOVEL ARCHAEAL PHOSPHODIESTERASE 1S3M ; 2.50 ; STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF A NOVEL ARCHAEAL PHOSPHODIESTERASE 1S3N ; 2.50 ; STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF A NOVEL ARCHAEAL PHOSPHODIESTERASE 1NHO ; -1.00 ; STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF A THIOREDOXIN- LIKE PROTEIN FROM METHANOBACTERIUM THERMOAUTOTROPHICUM 1BSQ ; 2.22 ; STRUCTURAL AND FUNCTIONAL CONSEQUENCES OF POINT MUTATIONS OF VARIANTS A AND B OF BOVINE BETA-LACTOGLOBULIN 1C49 ; -1.00 ; STRUCTURAL AND FUNCTIONAL DIFFERENCES OF TWO TOXINS FROM THE SCORPION PANDINUS IMPERATOR 1P8Q ; 2.95 ; STRUCTURAL AND FUNCTIONAL IMPORTANCE OF FIRST-SHELL METAL LIGANDS IN THE BINUCLEAR CLUSTER OF ARGINASE I. 1P8M ; 2.84 ; STRUCTURAL AND FUNCTIONAL IMPORTANCE OF FIRST-SHELL METAL LIGANDS IN THE BINUCLEAR MANGANESE CLUSTER OF ARGINASE I. 1P8N ; 2.90 ; STRUCTURAL AND FUNCTIONAL IMPORTANCE OF FIRST-SHELL METAL LIGANDS IN THE BINUCLEAR MANGANESE CLUSTER OF ARGINASE I. 1P8O ; 2.96 ; STRUCTURAL AND FUNCTIONAL IMPORTANCE OF FIRST-SHELL METAL LIGANDS IN THE BINUCLEAR MANGANESE CLUSTER OF ARGINASE I. 1P8P ; 2.50 ; STRUCTURAL AND FUNCTIONAL IMPORTANCE OF FIRST-SHELL METAL LIGANDS IN THE BINUCLEAR MANGANESE CLUSTER OF ARGINASE I. 1P8R ; 2.50 ; STRUCTURAL AND FUNCTIONAL IMPORTANCE OF FIRST-SHELL METAL LIGANDS IN THE BINUCLEAR MANGANESE CLUSTER OF ARGINASE I. 1P8S ; 3.20 ; STRUCTURAL AND FUNCTIONAL IMPORTANCE OF FIRST-SHELL METAL LIGANDS IN THE BINUCLEAR MANGANESE CLUSTER OF ARGINASE I. 1DAZ ; 1.55 ; STRUCTURAL AND KINETIC ANALYSIS OF DRUG RESISTANT MUTANTS OF HIV-1 PROTEASE 1DW6 ; 1.88 ; STRUCTURAL AND KINETIC ANALYSIS OF DRUG RESISTANT MUTANTS OF HIV-1 PROTEASE 1EBK ; 2.06 ; STRUCTURAL AND KINETIC ANALYSIS OF DRUG RESISTANT MUTANTS OF HIV-1 PROTEASE 2BNQ ; 1.70 ; STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES 2BNR ; 1.90 ; STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES 2BNU ; 1.40 ; STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES 1YR2 ; 1.80 ; STRUCTURAL AND MECHANISTIC ANALYSIS OF TWO PROLYL ENDOPEPTIDASES: ROLE OF INTER-DOMAIN DYNAMICS IN CATALYSIS AND SPECIFICITY 2BKL ; 1.50 ; STRUCTURAL AND MECHANISTIC ANALYSIS OF TWO PROLYL ENDOPEPTIDASES: ROLE OF INTER-DOMAIN DYNAMICS IN CATALYSIS AND SPECIFICITY 1J4Z ; 3.52 ; STRUCTURAL AND MECHANISTIC BASIS FOR ALLOSTERY IN THE BACTERIAL CHAPERONIN GROEL; SEE REMARK 400 1KPO ; 3.52 ; STRUCTURAL AND MECHANISTIC BASIS FOR ALLOSTERY IN THE BACTERIAL CHAPERONIN GROEL; SEE REMARK 400 1S5O ; 1.80 ; STRUCTURAL AND MUTATIONAL CHARACTERIZATION OF L-CARNITINE BINDING TO HUMAN CARNITINE ACETYLTRANSFERASE 2A8K ; 1.50 ; STRUCTURAL AND MUTATIONAL STUDIES OF THE CATALYTIC DOMAIN OF COLICIN E5A TRNA-SPECIFIC RIBONUCLEASE 2ET7 ; 1.70 ; STRUCTURAL AND SPECTROSCOPIC INSIGHTS INTO THE MECHANISM OF OXALATE OXIDASE 1AZY ; 3.00 ; STRUCTURAL AND THEORETICAL STUDIES SUGGEST DOMAIN MOVEMENT PRODUCES AN ACTIVE CONFORMATION OF THYMIDINE PHOSPHORYLASE 1OTP ; 2.80 ; STRUCTURAL AND THEORETICAL STUDIES SUGGEST DOMAIN MOVEMENT PRODUCES AN ACTIVE CONFORMATION OF THYMIDINE PHOSPHORYLASE 2TPT ; 2.60 ; STRUCTURAL AND THEORETICAL STUDIES SUGGEST DOMAIN MOVEMENT PRODUCES AN ACTIVE CONFORMATION OF THYMIDINE PHOSPHORYLASE 1OH4 ; 1.35 ; STRUCTURAL AND THERMODYNAMIC DISSECTION OF SPECIFIC MANNAN RECOGNITION BY A CARBOHYDRATE-BINDING MODULE 1OF3 ; 2.00 ; STRUCTURAL AND THERMODYNAMIC DISSECTION OF SPECIFIC MANNAN RECOGNITION BY A CARBOHYDRATE-BINDING MODULE, TMCBM27 1OF4 ; 1.60 ; STRUCTURAL AND THERMODYNAMIC DISSECTION OF SPECIFIC MANNAN RECOGNITION BY A CARBOHYDRATE-BINDING MODULE, TMCBM27 1T2R ; -1.00 ; STRUCTURAL BASIS FOR 3' END RECOGNITION OF NUCLEIC ACIDS BY THE DROSOPHILA ARGONAUTE 2 PAZ DOMAIN 1T2S ; -1.00 ; STRUCTURAL BASIS FOR 3' END RECOGNITION OF NUCLEIC ACIDS BY THE DROSOPHILA ARGONAUTE 2 PAZ DOMAIN 1OT7 ; 2.90 ; STRUCTURAL BASIS FOR 3-DEOXY-CDCA BINDING AND ACTIVATION OF FXR 1YTU ; 2.50 ; STRUCTURAL BASIS FOR 5'-END-SPECIFIC RECOGNITION OF THE GUIDE RIBONUCLEIC ACID STRAND BY THE A. FULGIDUS PIWI PROTEIN 1U9L ; 1.90 ; STRUCTURAL BASIS FOR A NUSA- PROTEIN N INTERACTION 1UXN ; 2.30 ; STRUCTURAL BASIS FOR ALLOSTERIC REGULATION AND SUBSTRATE SPECIFICITY OF THE NON-PHOSPHORYLATING GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE (GAPN) FROM THERMOPROTEUS TENAX 1UXP ; 2.55 ; STRUCTURAL BASIS FOR ALLOSTERIC REGULATION AND SUBSTRATE SPECIFICITY OF THE NON-PHOSPHORYLATING GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE (GAPN) FROM THERMOPROTEUS TENAX 1UXQ ; 2.40 ; STRUCTURAL BASIS FOR ALLOSTERIC REGULATION AND SUBSTRATE SPECIFICITY OF THE NON-PHOSPHORYLATING GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE (GAPN) FROM THERMOPROTEUS TENAX 1UXR ; 2.30 ; STRUCTURAL BASIS FOR ALLOSTERIC REGULATION AND SUBSTRATE SPECIFICITY OF THE NON-PHOSPHORYLATING GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE (GAPN) FROM THERMOPROTEUS TENAX 1UXT ; 2.20 ; STRUCTURAL BASIS FOR ALLOSTERIC REGULATION AND SUBSTRATE SPECIFICITY OF THE NON-PHOSPHORYLATING GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE (GAPN) FROM THERMOPROTEUS TENAX 1UXU ; 2.25 ; STRUCTURAL BASIS FOR ALLOSTERIC REGULATION AND SUBSTRATE SPECIFICITY OF THE NON-PHOSPHORYLATING GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE (GAPN) FROM THERMOPROTEUS TENAX 1UXV ; 2.35 ; STRUCTURAL BASIS FOR ALLOSTERIC REGULATION AND SUBSTRATE SPECIFICITY OF THE NON-PHOSPHORYLATING GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE (GAPN) FROM THERMOPROTEUS TENAX 1H7B ; 2.45 ; STRUCTURAL BASIS FOR ALLOSTERIC SUBSTRATE SPECIFICITY REGULATION IN CLASS III RIBONUCLEOTIDE REDUCTASES, NATIVE NRDD 1H7A ; 2.75 ; STRUCTURAL BASIS FOR ALLOSTERIC SUBSTRATE SPECIFICITY REGULATION IN CLASS III RIBONUCLEOTIDE REDUCTASES: NRDD IN COMPLEX WITH DATP 1H78 ; 2.50 ; STRUCTURAL BASIS FOR ALLOSTERIC SUBSTRATE SPECIFICITY REGULATION IN CLASS III RIBONUCLEOTIDE REDUCTASES: NRDD IN COMPLEX WITH DCTP. 1HK8 ; 2.45 ; STRUCTURAL BASIS FOR ALLOSTERIC SUBSTRATE SPECIFICITY REGULATION IN CLASS III RIBONUCLEOTIDE REDUCTASES: NRDD IN COMPLEX WITH DGTP 1H79 ; 2.90 ; STRUCTURAL BASIS FOR ALLOSTERIC SUBSTRATE SPECIFICITY REGULATION IN CLASS III RIBONUCLEOTIDE REDUCTASES: NRDD IN COMPLEX WITH DTTP 1TXV ; 2.75 ; STRUCTURAL BASIS FOR ALLOSTERY IN INTEGRINS AND BINDING OF LIGAND-MIMETIC THERAPEUTICS TO THE PLATELET RECEPTOR FOR FIBRINOGEN 1TY3 ; 2.80 ; STRUCTURAL BASIS FOR ALLOSTERY IN INTEGRINS AND BINDING OF LIGAND-MIMETIC THERAPEUTICS TO THE PLATELET RECEPTOR FOR FIBRINOGEN 1TY5 ; 2.90 ; STRUCTURAL BASIS FOR ALLOSTERY IN INTEGRINS AND BINDING OF LIGAND-MIMETIC THERAPEUTICS TO THE PLATELET RECEPTOR FOR FIBRINOGEN 1TY6 ; 2.90 ; STRUCTURAL BASIS FOR ALLOSTERY IN INTEGRINS AND BINDING OF LIGAND-MIMETIC THERAPEUTICS TO THE PLATELET RECEPTOR FOR FIBRINOGEN 1TY7 ; 3.10 ; STRUCTURAL BASIS FOR ALLOSTERY IN INTEGRINS AND BINDING OF LIGAND-MIMETIC THERAPEUTICS TO THE PLATELET RECEPTOR FOR FIBRINOGEN 1TYE ; 2.90 ; STRUCTURAL BASIS FOR ALLOSTERY IN INTEGRINS AND BINDING OF LIGAND-MIMETIC THERAPEUTICS TO THE PLATELET RECEPTOR FOR FIBRINOGEN 1SYQ ; 2.42 ; STRUCTURAL BASIS FOR AMPLIFYING VINCULIN ACTIVATION BY TALIN 1OSV ; 2.50 ; STRUCTURAL BASIS FOR BILE ACID BINDING AND ACTIVATION OF THE NUCLEAR RECEPTOR FXR 1XPY ; 2.30 ; STRUCTURAL BASIS FOR CATALYTIC RACEMIZATION AND SUBSTRATE SPECIFICITY OF AN N-ACYLAMINO ACID RACEMASE HOMOLOGUE FROM DEINOCOCCUS RADIODURANS 1XS2 ; 2.30 ; STRUCTURAL BASIS FOR CATALYTIC RACEMIZATION AND SUBSTRATE SPECIFICITY OF AN N-ACYLAMINO ACID RACEMASE HOMOLOGUE FROM DEINOCOCCUS RADIODURANS 2AGH ; -1.00 ; STRUCTURAL BASIS FOR COOPERATIVE TRANSCRIPTION FACTOR BINDING TO THE CBP COACTIVATOR 1T21 ; 2.19 ; STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9, MONOCLINIC CRYSTAL 1T22 ; 2.20 ; STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9, ORTHORHOMBIC CRYSTAL 1S8D ; 2.20 ; STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-3A 1T1W ; 2.20 ; STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-3F6I8V 1T1X ; 2.20 ; STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-4L 1T1Y ; 2.00 ; STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-5V 1T1Z ; 1.90 ; STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-6A 1T20 ; 2.20 ; STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-6I 2BZF ; 2.87 ; STRUCTURAL BASIS FOR DEOXYRIBONUCLEIC ACID BRIDGING BY BARRIER-TO- AUTOINTEGRATION FACTOR (BAF) 1R1P ; 1.80 ; STRUCTURAL BASIS FOR DIFFERENTIAL RECOGNITION OF TYROSINE PHOSPHORYLATED SITES IN THE LINKER FOR ACTIVATION OF T CELLS (LAT) BY THE ADAPTOR PROTEIN GADS 1R1Q ; 1.80 ; STRUCTURAL BASIS FOR DIFFERENTIAL RECOGNITION OF TYROSINE PHOSPHORYLATED SITES IN THE LINKER FOR ACTIVATION OF T CELLS (LAT) BY THE ADAPTOR PROTEIN GADS 1R1S ; 1.90 ; STRUCTURAL BASIS FOR DIFFERENTIAL RECOGNITION OF TYROSINE PHOSPHORYLATED SITES IN THE LINKER FOR ACTIVATION OF T CELLS (LAT) BY THE ADAPTOR PROTEIN GADS 1JGU ; 1.80 ; STRUCTURAL BASIS FOR DISFAVORED ELIMINATION REACTION IN CATALYTIC ANTIBODY 1D4 1JGV ; 1.85 ; STRUCTURAL BASIS FOR DISFAVORED ELIMINATION REACTION IN CATALYTIC ANTIBODY 1D4 1KPS ; 2.50 ; STRUCTURAL BASIS FOR E2-MEDIATED SUMO CONJUGATION REVEALED BY A COMPLEX BETWEEN UBIQUITIN CONJUGATING ENZYME UBC9 AND RANGAP1 365D ; 2.00 ; STRUCTURAL BASIS FOR G C RECOGNITION IN THE DEOXYRIBONUCLEIC ACID MINOR GROOVE 1KP8 ; 2.00 ; STRUCTURAL BASIS FOR GROEL-ASSISTED PROTEIN FOLDING FROM THE CRYSTAL STRUCTURE OF (GROEL-KMGATP)14 AT 2.0 A RESOLUTION 1TFZ ; 1.80 ; STRUCTURAL BASIS FOR HERBICIDAL INHIBITOR SELECTIVITY REVEALED BY COMPARISON OF CRYSTAL STRUCTURES OF PLANT AND MAMMALIAN 4-HYDROXYPHENYLPYRUVATE DIOXYGENASES 1L8C ; -1.00 ; STRUCTURAL BASIS FOR HIF-1ALPHA/CBP RECOGNITION IN THE CELLULAR HYPOXIC RESPONSE 1SQD ; 1.80 ; STRUCTURAL BASIS FOR INHIBITOR SELECTIVITY REVEALED BY CRYSTAL STRUCTURES OF PLANT AND MAMMALIAN 4- HYDROXYPHENYLPYRUVATE DIOXYGENASES 1SQI ; 2.15 ; STRUCTURAL BASIS FOR INHIBITOR SELECTIVITY REVEALED BY CRYSTAL STRUCTURES OF PLANT AND MAMMALIAN 4- HYDROXYPHENYLPYRUVATE DIOXYGENASES 1XX1 ; 1.75 ; STRUCTURAL BASIS FOR ION-COORDINATION AND THE CATALYTIC MECHANISM OF SPHINGOMYELINASES D 7MDH ; 2.40 ; STRUCTURAL BASIS FOR LIGHT ACITVATION OF A CHLOROPLAST ENZYME. THE STRUCTURE OF SORGHUM NADP-MALATE DEHYDROGENASE IN ITS OXIDIZED FORM 1A2O ; 2.40 ; STRUCTURAL BASIS FOR METHYLESTERASE CHEB REGULATION BY A PHOSPHORYLATION-ACTIVATED DOMAIN 1SZC ; 1.75 ; STRUCTURAL BASIS FOR NICOTINAMIDE CLEAVAGE AND ADP-RIBOSE TRANSFER BY NAD+-DEPENDENT SIR2 HISTONE/PROTEIN DEACETYLASES 1SZD ; 1.50 ; STRUCTURAL BASIS FOR NICOTINAMIDE CLEAVAGE AND ADP-RIBOSE TRANSFER BY NAD+-DEPENDENT SIR2 HISTONE/PROTEIN DEACETYLASES 1WK9 ; 1.75 ; STRUCTURAL BASIS FOR NON-COGNATE AMINO ACID DISCRIMINATION BY THE VALYL-TRNA SYNTHETASE EDITING DOMAIN 1WKA ; 1.70 ; STRUCTURAL BASIS FOR NON-COGNATE AMINO ACID DISCRIMINATION BY THE VALYL-TRNA SYNTHETASE EDITING DOMAIN 1SK7 ; 1.60 ; STRUCTURAL BASIS FOR NOVEL DELTA-REGIOSELECTIVE HEME OXYGENATION IN THE OPPORTUNISTIC PATHOGEN PSEUDOMONAS AERUGINOSA 1Y19 ; 2.60 ; STRUCTURAL BASIS FOR PHOSPHATIDYLINOSITOL PHOSPHATE KINASE TYPE I-GAMMA BINDING TO TALIN AT FOCAL ADHESIONS 1IDX ; -1.00 ; STRUCTURAL BASIS FOR POOR EXCISION FROM HAIRPIN DEOXYRIBONUCLEIC ACID: NMR STUDY 1II1 ; -1.00 ; STRUCTURAL BASIS FOR POOR URACIL EXCISION FROM HAIRPIN DEOXYRIBONUCLEIC ACID: NMR STUDY 1PKH ; 1.42 ; STRUCTURAL BASIS FOR RECOGNITION AND CATALYSIS BY THE BIFUNCTIONAL DCTP DEAMINASE AND DUTPASE FROM METHANOCOCCUS JANNASCHII 1PKJ ; 2.10 ; STRUCTURAL BASIS FOR RECOGNITION AND CATALYSIS BY THE BIFUNCTIONAL DCTP DEAMINASE AND DUTPASE FROM METHANOCOCCUS JANNASCHII 1PKK ; 1.77 ; STRUCTURAL BASIS FOR RECOGNITION AND CATALYSIS BY THE BIFUNCTIONAL DCTP DEAMINASE AND DUTPASE FROM METHANOCOCCUS JANNASCHII 407D ; 2.20 ; STRUCTURAL BASIS FOR RECOGNITION OF A-T AND T-A BASE PAIRS IN THE MINOR GROOVE OF B-DEOXYRIBONUCLEIC ACID 408D ; 2.10 ; STRUCTURAL BASIS FOR RECOGNITION OF A-T AND T-A BASE PAIRS IN THE MINOR GROOVE OF B-DEOXYRIBONUCLEIC ACID 1K1G ; -1.00 ; STRUCTURAL BASIS FOR RECOGNITION OF THE INTRON BRANCH SITE RIBONUCLEIC ACID BY SPLICING FACTOR 1 1RGO ; -1.00 ; STRUCTURAL BASIS FOR RECOGNITION OF THE MRNA CLASS II AU- RICH ELEMENT BY THE TANDEM ZINC FINGER DOMAIN OF TIS11D 1EI2 ; -1.00 ; STRUCTURAL BASIS FOR RECOGNITION OF THE RIBONUCLEIC ACID MAJOR GROOVE IN THE TAU EXON 10 SPLICING REGULATORY ELEMENT BY AMINOGLYCOSIDE ANTIBIOTICS 1Y8X ; 2.40 ; STRUCTURAL BASIS FOR RECRUITMENT OF UBC12 BY AN E2-BINDING DOMAIN IN NEDD8'S E1 1C5L ; 1.47 ; STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1- BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR 1C5M ; 1.95 ; STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1- BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR 1C5N ; 1.50 ; STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1- BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR 1C5O ; 1.90 ; STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1- BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR 1C5P ; 1.43 ; STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1- BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR 1C5Q ; 1.43 ; STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1- BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR 1C5R ; 1.47 ; STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1- BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR 1C5S ; 1.36 ; STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1- BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR 1C5T ; 1.37 ; STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1- BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR 1C5U ; 1.37 ; STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1- BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR 1C5V ; 1.48 ; STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1- BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR 1C5W ; 1.94 ; STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1- BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR 1C5X ; 1.75 ; STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1- BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR 1C5Y ; 1.65 ; STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1- BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR 1C5Z ; 1.85 ; STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1- BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR 1PFB ; 1.40 ; STRUCTURAL BASIS FOR SPECIFIC BINDING OF POLYCOMB CHROMODOMAIN TO HISTONE H3 METHYLATED AT K27 1H3H ; -1.00 ; STRUCTURAL BASIS FOR SPECIFIC RECOGNITION OF AN RXXK-CONTAINING SLP-76 PEPTIDE BY THE GADS C-TERMINAL SH3 DOMAIN 1A94 ; 2.00 ; STRUCTURAL BASIS FOR SPECIFICITY OF RETROVIRAL PROTEASES 1BAI ; 2.40 ; STRUCTURAL BASIS FOR SPECIFICITY OF RETROVIRAL PROTEASES 1S0V ; 3.20 ; STRUCTURAL BASIS FOR SUBSTRATE SELECTION BY T7 RIBONUCLEIC ACID POLYMERASE 1Q2J ; -1.00 ; STRUCTURAL BASIS FOR TETRODOTOXIN-RESISTANT SODIUM CHANNEL BINDING BY MU-CONOTOXIN SMIIIA 1K2G ; -1.00 ; STRUCTURAL BASIS FOR THE 3'-TERMINAL GUANOSINE RECOGNITION BY THE GROUP I INTRON 2A5D ; 1.80 ; STRUCTURAL BASIS FOR THE ACTIVATION OF CHOLERA TOXIN BY HUMAN ARF6-GTP 1GOZ ; 2.00 ; STRUCTURAL BASIS FOR THE ALTERED T-CELL RECEPTOR BINDING SPECIFICTY IN A SUPERANTIGENIC STAPHYLOCOCCUS AUREUS ENTEROTOXIN-B MUTANT 1OPJ ; 1.75 ; STRUCTURAL BASIS FOR THE AUTO-INHIBITION OF C-ABL TYROSINE KINASE 1OPK ; 1.80 ; STRUCTURAL BASIS FOR THE AUTO-INHIBITION OF C-ABL TYROSINE KINASE 1OPL ; 3.42 ; STRUCTURAL BASIS FOR THE AUTO-INHIBITION OF C-ABL TYROSINE KINASE 1T45 ; 1.90 ; STRUCTURAL BASIS FOR THE AUTOINHIBITION AND STI-571 INHIBITION OF C-KIT TYROSINE KINASE 1T46 ; 1.60 ; STRUCTURAL BASIS FOR THE AUTOINHIBITION AND STI-571 INHIBITION OF C-KIT TYROSINE KINASE 1FV1 ; 1.90 ; STRUCTURAL BASIS FOR THE BINDING OF AN IMMUNODOMINANT PEPTIDE FROM MYELIN BASIC PROTEIN IN DIFFERENT REGISTERS BY TWO HLA-DR2 ALLELES 1AKA ; 2.10 ; STRUCTURAL BASIS FOR THE CATALYTIC ACTIVITY OF ASPARTATE AMINOTRANSFERASE K258H LACKING ITS PYRIDOXAL-5'-PHOSPHATE- BINDING LYSINE RESIDUE 1AKB ; 2.30 ; STRUCTURAL BASIS FOR THE CATALYTIC ACTIVITY OF ASPARTATE AMINOTRANSFERASE K258H LACKING ITS PYRIDOXAL-5'-PHOSPHATE- BINDING LYSINE RESIDUE 1AKC ; 2.30 ; STRUCTURAL BASIS FOR THE CATALYTIC ACTIVITY OF ASPARTATE AMINOTRANSFERASE K258H LACKING ITS PYRIDOXAL-5'-PHOSPHATE- BINDING LYSINE RESIDUE 1AIA ; 2.20 ; STRUCTURAL BASIS FOR THE CATALYTIC ACTIVITY OF ASPARTATE AMINOTRANSFERASE K258H LACKING THE PYRIDOXAL-5'-PHOSPHATE BINDING LYSINE RESIDUE 1AIB ; 2.80 ; STRUCTURAL BASIS FOR THE CATALYTIC ACTIVITY OF ASPARTATE AMINOTRANSFERASE K258H LACKING THE PYRIDOXAL-5'-PHSOPHATE BINDING LYSINE RESIDUE 1AIC ; 2.40 ; STRUCTURAL BASIS FOR THE CATALYTIC ACTIVITY OF ASPARTATE AMINOTRANSFERASE K258H LACKING THE PYRIDOXAL-5'-PHSOPHATE BINDING LYSINE RESIDUE 1RLE ; 2.10 ; STRUCTURAL BASIS FOR THE COORDINATED REGULATION OF TRANSGLUTAMINASE 3 BY GUANINE NUCLEOTIDES AND CALCIUM/MAGNESIUM 1VJJ ; 1.90 ; STRUCTURAL BASIS FOR THE COORDINATED REGULATION OF TRANSGLUTAMINASE 3 BY GUANINE NUCLEOTIDES AND CALCIUM/MAGNESIUM 1JMK ; 1.71 ; STRUCTURAL BASIS FOR THE CYCLIZATION OF THE LIPOPEPTIDE ANTIBIOTIC SURFACTIN BY THE THIOESTERASE DOMAIN SRFTE 1RQ5 ; 2.40 ; STRUCTURAL BASIS FOR THE EXOCELLULASE ACTIVITY OF THE CELLOBIOHYDROLASE CBHA FROM C. THERMOCELLUM 1UT9 ; 2.10 ; STRUCTURAL BASIS FOR THE EXOCELLULASE ACTIVITY OF THE CELLOBIOHYDROLASE CBHA FROM C. THERMOCELLUM 1ESM ; 2.50 ; STRUCTURAL BASIS FOR THE FEEDBACK REGULATION OF ESCHERICHIA COLI PANTOTHENATE KINASE BY COENZYME A 1ESN ; 2.60 ; STRUCTURAL BASIS FOR THE FEEDBACK REGULATION OF ESCHERICHIA COLI PANTOTHENATE KINASE BY COENZYME A 1GS4 ; 1.95 ; STRUCTURAL BASIS FOR THE GLUCOCORTICOID RESPONSE IN A MUTANT HUMAN ANDROGEN RECEPTOR (ARCCR) DERIVED FROM AN ANDROGEN-INDEPENDENT PROSTATE CANCER 1U0H ; 2.90 ; STRUCTURAL BASIS FOR THE INHIBITION OF MAMMALIAN ADENYLYL CYCLASE BY MANT-GTP 1J5A ; 3.50 ; STRUCTURAL BASIS FOR THE INTERACTION OF ANTIBIOTICS WITH THE PEPTIDYL TRANSFERASE CENTER IN EUBACTERIA 1JZX ; 3.10 ; STRUCTURAL BASIS FOR THE INTERACTION OF ANTIBIOTICS WITH THE PEPTIDYL TRANSFERASE CENTER IN EUBACTERIA 1JZY ; 3.50 ; STRUCTURAL BASIS FOR THE INTERACTION OF ANTIBIOTICS WITH THE PEPTIDYL TRANSFERASE CENTER IN EUBACTERIA 1JZZ ; 3.80 ; STRUCTURAL BASIS FOR THE INTERACTION OF ANTIBIOTICS WITH THE PEPTIDYL TRANSFERASE CENTER IN EUBACTERIA 1K01 ; 3.50 ; STRUCTURAL BASIS FOR THE INTERACTION OF ANTIBIOTICS WITH THE PEPTIDYL TRANSFERASE CENTER IN EUBACTERIA 1TDQ ; 2.60 ; STRUCTURAL BASIS FOR THE INTERACTIONS BETWEEN TENASCINS AND THE C-TYPE LECTIN DOMAINS FROM LECTICANS: EVIDENCE FOR A CROSS-LINKING ROLE FOR TENASCINS 1S7G ; 2.30 ; STRUCTURAL BASIS FOR THE MECHANISM AND REGULATION OF SIR2 ENZYMES 1F8A ; 1.84 ; STRUCTURAL BASIS FOR THE PHOSPHOSERINE-PROLINE RECOGNITION BY GROUP IV WW DOMAINS 1QXD ; 2.25 ; STRUCTURAL BASIS FOR THE POTENT ANTISICKLING EFFECT OF A NOVEL CLASS OF 5-MEMBERED HETEROCYCLIC ALDEHYDIC COMPOUNDS 1QXE ; 1.85 ; STRUCTURAL BASIS FOR THE POTENT ANTISICKLING EFFECT OF A NOVEL CLASS OF 5-MEMBERED HETEROCYCLIC ALDEHYDIC COMPOUNDS 1PEG ; 2.59 ; STRUCTURAL BASIS FOR THE PRODUCT SPECIFICITY OF HISTONE LYSINE METHYLTRANSFERASES 2C26 ; 2.10 ; STRUCTURAL BASIS FOR THE PROMISCUOUS SPECIFICITY OF THE CARBOHYDRATE-BINDING MODULES FROM THE BETA-SANDWICH SUPER FAMILY 2C4X ; 2.00 ; STRUCTURAL BASIS FOR THE PROMISCUOUS SPECIFICITY OF THE CARBOHYDRATE-BINDING MODULES FROM THE BETA-SANDWICH SUPER FAMILY 2B4J ; 2.02 ; STRUCTURAL BASIS FOR THE RECOGNITION BETWEEN HIV-1 INTEGRASE AND LEDGF/P75 1JN5 ; 2.80 ; STRUCTURAL BASIS FOR THE RECOGNITION OF A NUCLEOPORIN FG- REPEAT BY THE NTF2-LIKE DOMAIN OF TAP-P15 MRNA EXPORT FACTOR 1JKG ; 1.90 ; STRUCTURAL BASIS FOR THE RECOGNITION OF A NUCLEOPORIN FG- REPEAT BY THE NTF2-LIKE DOMAIN OF TAP-P15 MRNA NUCLEAR EXPORT FACTOR 1WQJ ; 1.60 ; STRUCTURAL BASIS FOR THE REGULATION OF INSULIN-LIKE GROWTH FACTORS (IGFS) BY IGF BINDING PROTEINS (IGFBPS) 1UKH ; 2.35 ; STRUCTURAL BASIS FOR THE SELECTIVE INHIBITION OF JNK1 BY THE SCAFFOLDING PROTEIN JIP1 AND SP600125 1UKI ; 2.70 ; STRUCTURAL BASIS FOR THE SELECTIVE INHIBITION OF JNK1 BY THE SCAFFOLDING PROTEIN JIP1 AND SP600125 1CMX ; 2.25 ; STRUCTURAL BASIS FOR THE SPECIFICITY OF UBIQUITIN C- TERMINAL HYDROLASES 1JT2 ; 1.80 ; STRUCTURAL BASIS FOR THE SUBSTRATE SPECIFICITY OF THE FERUL DOMAIN OF THE CELLULOSOMAL XYLANASE Z FROM C. THERMOCELLUM 1JJF ; 1.75 ; STRUCTURAL BASIS FOR THE SUBSTRATE SPECIFICITY OF THE FERULOYL ESTERASE DOMAIN OF THE CELLULOSOMAL XYLANASE Z OF CLOSTRIDIUM THERMOCELLUM 1H75 ; 1.70 ; STRUCTURAL BASIS FOR THE THIOREDOXIN-LIKE ACTIVITY PROFILE OF THE GLUTAREDOXIN-LIKE PROTEIN NRDH-REDOXIN FROM ESCHERICHIA COLI. 1MSW ; 2.10 ; STRUCTURAL BASIS FOR THE TRANSITION FROM INITIATION TO ELONGATION TRANSCRIPTION IN T7 RIBONUCLEIC ACID POLYMERASE 1GUY ; 2.20 ; STRUCTURAL BASIS FOR THERMOPHILIC PROTEIN STABILITY: STRUCTURES OF THERMOPHILIC AND MESOPHILIC MALATE DEHYDROGENASES 1GUZ ; 2.00 ; STRUCTURAL BASIS FOR THERMOPHILIC PROTEIN STABILITY: STRUCTURES OF THERMOPHILIC AND MESOPHILIC MALATE DEHYDROGENASES 1GV0 ; 2.50 ; STRUCTURAL BASIS FOR THERMOPHILIC PROTEIN STABILITY: STRUCTURES OF THERMOPHILIC AND MESOPHILIC MALATE DEHYDROGENASES 1GV1 ; 2.50 ; STRUCTURAL BASIS FOR THERMOPHILIC PROTEIN STABILITY: STRUCTURES OF THERMOPHILIC AND MESOPHILIC MALATE DEHYDROGENASES 1SMY ; 2.70 ; STRUCTURAL BASIS FOR TRANSCRIPTION REGULATION BY ALARMONE PPGPP 2B4V ; 1.80 ; STRUCTURAL BASIS FOR UTP SPECIFICITY OF RIBONUCLEIC ACID EDITING TUTASES FROM TRYPANOSOMA BRUCEI 2B51 ; 2.05 ; STRUCTURAL BASIS FOR UTP SPECIFICITY OF RIBONUCLEIC ACID EDITING TUTASES FROM TRYPANOSOMA BRUCEI 2B56 ; 1.97 ; STRUCTURAL BASIS FOR UTP SPECIFICITY OF RIBONUCLEIC ACID EDITING TUTASES FROM TRYPANOSOMA BRUCEI 1P69 ; 3.10 ; STRUCTURAL BASIS FOR VARIATION IN ADENOVIRUS AFFINITY FOR THE CELLULAR RECEPTOR CAR (P417S MUTANT) 1P6A ; 2.90 ; STRUCTURAL BASIS FOR VARIATION IN ASDENOVIRUS AFFINITY FOR THE CELLULAR RECEPTOR CAR (S489Y MUTANT) 1T44 ; 2.00 ; STRUCTURAL BASIS OF ACTIN SEQUESTRATION BY THYMOSIN-B4: IMPLICATIONS FOR ARP2/3 ACTIVATION 2AAB ; 2.50 ; STRUCTURAL BASIS OF ANTIGEN MIMICRY IN A CLINICALLY RELEVANT MELANOMA ANTIGEN SYSTEM 1LZW ; 2.50 ; STRUCTURAL BASIS OF CLPS-MEDIATED SWITCH IN CLPA SUBSTRATE RECOGNITION 1G9W ; 1.30 ; STRUCTURAL BASIS OF COLLAGEN STABILIZATION INDUCED BY PROLINE HYDROXYLATION 1AW4 ; -1.00 ; STRUCTURAL BASIS OF DEOXYRIBONUCLEIC ACID FOLDING AND RECOGNITION IN AMP-DEOXYRIBONUCLEIC ACID APTAMER COMPLEX, NMR, 7 STRUCTURES 1CF7 ; 2.60 ; STRUCTURAL BASIS OF DEOXYRIBONUCLEIC ACID RECOGNITION BY THE HETERODIMERIC CELL CYCLE TRANSCRIPTION FACTOR E2F-DP 1D06 ; 1.40 ; STRUCTURAL BASIS OF DIMERIZATION AND SENSORY MECHANISMS OF OXYGEN-SENSING DOMAIN OF RHIZOBIUM MELILOTI FIXL DETERMINED AT 1.4A RESOLUTION 1T3E ; 3.25 ; STRUCTURAL BASIS OF DYNAMIC GLYCINE RECEPTOR CLUSTERING 1T0P ; 1.66 ; STRUCTURAL BASIS OF ICAM RECOGNITION BY INTEGRIN ALPAHLBETA2 REVEALED IN THE COMPLEX STRUCTURE OF BINDING DOMAINS OF ICAM-3 AND ALPHALBETA2 AT 1.65 A 1T9T ; 3.23 ; STRUCTURAL BASIS OF MULTIDRUG TRANSPORT BY THE ACRB MULTIDRUG EFFLUX PUMP 1T9U ; 3.11 ; STRUCTURAL BASIS OF MULTIDRUG TRANSPORT BY THE ACRB MULTIDRUG EFFLUX PUMP 1T9V ; 3.80 ; STRUCTURAL BASIS OF MULTIDRUG TRANSPORT BY THE ACRB MULTIDRUG EFFLUX PUMP 1T9W ; 3.23 ; STRUCTURAL BASIS OF MULTIDRUG TRANSPORT BY THE ACRB MULTIDRUG EFFLUX PUMP 1T9X ; 3.08 ; STRUCTURAL BASIS OF MULTIDRUG TRANSPORT BY THE ACRB MULTIDRUG EFFLUX PUMP 1T9Y ; 3.64 ; STRUCTURAL BASIS OF MULTIDRUG TRANSPORT BY THE ACRB MULTIDRUG EFFLUX PUMP 1OYD ; 3.80 ; STRUCTURAL BASIS OF MULTIPLE BINDING CAPACITY OF THE ACRB MULTIDRUG EFFLUX PUMP 1OYE ; 3.48 ; STRUCTURAL BASIS OF MULTIPLE BINDING CAPACITY OF THE ACRB MULTIDRUG EFFLUX PUMP 1OY8 ; 3.63 ; STRUCTURAL BASIS OF MULTIPLE DRUG BINDING CAPACITY OF THE ACRB MULTIDRUG EFFLUX PUMP 1OY9 ; 3.80 ; STRUCTURAL BASIS OF MULTIPLE DRUG BINDING CAPACITY OF THE ACRB MULTIDRUG EFFLUX PUMP 1WDW ; 3.00 ; STRUCTURAL BASIS OF MUTUAL ACTIVATION OF THE TRYPTOPHAN SYNTHASE A2B2 COMPLEX FROM A HYPERTHERMOPHILE, PYROCOCCUS FURIOSUS 1FK6 ; 1.90 ; STRUCTURAL BASIS OF NON-SPECIFIC LIPID BINDING IN MAIZE LIPID-TRANSFER PROTEIN COMPLEXES WITH ALPHA-LINOLENIC ACID REVEALED BY HIGH-RESOLUTION X-RAY CRYSTALLOGRAPHY 1FK0 ; 1.80 ; STRUCTURAL BASIS OF NON-SPECIFIC LIPID BINDING IN MAIZE LIPID-TRANSFER PROTEIN COMPLEXES WITH CAPRIC ACID REVEALED BY HIGH-RESOLUTION X-RAY CRYSTALLOGRAPHY 1FK1 ; 1.80 ; STRUCTURAL BASIS OF NON-SPECIFIC LIPID BINDING IN MAIZE LIPID-TRANSFER PROTEIN COMPLEXES WITH LAURIC ACID REVEALED BY HIGH-RESOLUTION X-RAY CRYSTALLOGRAPHY 1FK2 ; 1.80 ; STRUCTURAL BASIS OF NON-SPECIFIC LIPID BINDING IN MAIZE LIPID-TRANSFER PROTEIN COMPLEXES WITH MYRISTIC ACID REVEALED BY HIGH-RESOLUTION X-RAY CRYSTALLOGRAPHY 1FK5 ; 1.30 ; STRUCTURAL BASIS OF NON-SPECIFIC LIPID BINDING IN MAIZE LIPID-TRANSFER PROTEIN COMPLEXES WITH OLEIC ACID REVEALED BY HIGH-RESOLUTION X-RAY CRYSTALLOGRAPHY 1FK3 ; 1.80 ; STRUCTURAL BASIS OF NON-SPECIFIC LIPID BINDING IN MAIZE LIPID-TRANSFER PROTEIN COMPLEXES WITH PALMITOLEIC ACID REVEALED BY HIGH-RESOLUTION X-RAY CRYSTALLOGRAPHY 1FK7 ; 1.90 ; STRUCTURAL BASIS OF NON-SPECIFIC LIPID BINDING IN MAIZE LIPID-TRANSFER PROTEIN COMPLEXES WITH RICINOLEIC ACID REVEALED BY HIGH-RESOLUTION X-RAY CRYSTALLOGRAPHY 1FK4 ; 1.80 ; STRUCTURAL BASIS OF NON-SPECIFIC LIPID BINDING IN MAIZE LIPID-TRANSFER PROTEIN COMPLEXES WITH STEARIC ACID REVEALED BY HIGH-RESOLUTION X-RAY CRYSTALLOGRAPHY 1PZ5 ; 1.80 ; STRUCTURAL BASIS OF PEPTIDE-CARBOHYDRATE MIMICRY IN AN ANTIBODY COMBINING SITE 1T2V ; 3.30 ; STRUCTURAL BASIS OF PHOSPHO-PEPTIDE RECOGNITION BY THE BRCT DOMAIN OF BRCA1, STRUCTURE WITH PHOSPHOPEPTIDE 1T2U ; 2.80 ; STRUCTURAL BASIS OF PHOSPHOPEPTIDE RECOGNITION BY THE BRCT DOMAIN OF BRCA1: STRUCTURE OF BRCA1 MISSENSE VARIANT V1809F 1XPX ; 2.80 ; STRUCTURAL BASIS OF PROSPERO-DEOXYRIBONUCLEIC ACID INTERACTION; IMPLICATIONS FOR TRANSCRIPTION REGULATION IN DEVELOPING CELLS 1ZBD ; 2.60 ; STRUCTURAL BASIS OF RAB EFFECTOR SPECIFICITY: CRYSTAL STRUCTURE OF THE SMALL G PROTEIN RAB3A COMPLEXED WITH THE EFFECTOR DOMAIN OF RABPHILIN-3A 1N6J ; 2.20 ; STRUCTURAL BASIS OF SEQUENCE-SPECIFIC RECRUITMENT OF HISTONE DEACETYLASES BY MYOCYTE ENHANCER FACTOR-2 1XR0 ; -1.00 ; STRUCTURAL BASIS OF SNT PTB DOMAIN INTERACTIONS WITH DISTINCT NEUROTROPHIC RECEPTORS 1UMH ; 2.00 ; STRUCTURAL BASIS OF SUGAR-RECOGNIZING UBIQUITIN LIGASE 1UMI ; 2.40 ; STRUCTURAL BASIS OF SUGAR-RECOGNIZING UBIQUITIN LIGASE 2AKR ; 1.90 ; STRUCTURAL BASIS OF SULFATIDE PRESENTATION BY MOUSE CD1D 1H0J ; 1.90 ; STRUCTURAL BASIS OF THE MEMBRANE-INDUCED CARDIOTOXIN A3 OLIGOMERIZATION 1OY6 ; 3.68 ; STRUCTURAL BASIS OF THE MULTIPLE BINDING CAPACITY OF THE ACRB MULTIDRUG EFFLUX PUMP 1I92 ; 1.70 ; STRUCTURAL BASIS OF THE NHERF PDZ1-CFTR INTERACTION 1FSH ; -1.00 ; STRUCTURAL BASIS OF THE RECOGNITION OF THE DISHEVELLED DEP DOMAIN IN THE WNT SIGNALING PATHWAY 2C1C ; 2.30 ; STRUCTURAL BASIS OF THE RESISTANCE OF AN INSECT CARBOXYPEPTIDASE TO PLANT PROTEASE INHIBITORS 3BLG ; 2.56 ; STRUCTURAL BASIS OF THE TANFORD TRANSITION OF BOVINE BETA-LACTOGLOBULIN FROM CRYSTAL STRUCTURES AT THREE PH VALUES; PH 6.2 1BSY ; 2.24 ; STRUCTURAL BASIS OF THE TANFORD TRANSITION OF BOVINE BETA-LACTOGLOBULIN FROM CRYSTAL STRUCTURES AT THREE PH VALUES; PH 7.1 2BLG ; 2.46 ; STRUCTURAL BASIS OF THE TANFORD TRANSITION OF BOVINE BETA-LACTOGLOBULIN FROM CRYSTAL STRUCTURES AT THREE PH VALUES; PH 8.2 1XEW ; 2.00 ; STRUCTURAL BIOCHEMISTRY OF ATP-DRIVEN DIMERIZATION AND DEOXYRIBONUCLEIC ACID STIMULATED ACTIVATION OF SMC ATPASES. 1XEX ; 2.50 ; STRUCTURAL BIOCHEMISTRY OF ATP-DRIVEN DIMERIZATION AND DEOXYRIBONUCLEIC ACID STIMULATED ACTIVATION OF SMC ATPASES. 1DV9 ; -1.00 ; STRUCTURAL CHANGES ACCOMPANYING PH-INDUCED DISSOCIATION OF THE B-LACTOGLOBULIN DIMER 1H3P ; 2.60 ; STRUCTURAL CHARACTERISATION OF A MONOCLONAL ANTIBODY SPECIFIC FOR THE PRES1 REGION OF THE HEPATITIS B VIRUS 261L ; 2.50 ; STRUCTURAL CHARACTERISATION OF AN ENGINEERED TANDEM REPEAT CONTRASTS THE IMPORTANCE OF CONTEXT AND SEQUENCE IN PROTEIN FOLDING 262L ; 2.50 ; STRUCTURAL CHARACTERISATION OF AN ENGINEERED TANDEM REPEAT CONTRASTS THE IMPORTANCE OF CONTEXT AND SEQUENCE IN PROTEIN FOLDING 1NVN ; 1.80 ; STRUCTURAL CHARACTERISATION OF THE HOLLIDAY JUNCTION FORMED BY THE SEQUENCE CCGGTACCGG AT 1.8 A 1NT8 ; 2.00 ; STRUCTURAL CHARACTERISATION OF THE HOLLIDAY JUNCTION FORMED BY THE SEQUENCE CCGGTACCGG AT 2.00 A 1NQS ; 1.97 ; STRUCTURAL CHARACTERISATION OF THE HOLLIDAY JUNCTION FORMED BY THE SEQUENCE D(TCGGTACCGA) AT 1.97 A 1M6G ; 1.65 ; STRUCTURAL CHARACTERISATION OF THE HOLLIDAY JUNCTION TCGGTACCGA 1ETL ; 0.89 ; STRUCTURAL CHARACTERISTICS FOR BIOLOGICAL ACTIVITY OF HEAT- STABLE ENTEROTOXIN PRODUCED BY ENTEROTOXIGENIC ESCHERICHIA COLI: X-RAY CRYSTALLOGRAPHY OF WEAKLY TOXIC AND NONTOXIC ANALOGS 1ETM ; 0.89 ; STRUCTURAL CHARACTERISTICS FOR BIOLOGICAL ACTIVITY OF HEAT- STABLE ENTEROTOXIN PRODUCED BY ENTEROTOXIGENIC ESCHERICHIA COLI: X-RAY CRYSTALLOGRAPHY OF WEAKLY TOXIC AND NONTOXIC ANALOGS 1K2L ; 2.40 ; STRUCTURAL CHARACTERIZATION OF BISINTERCALATION IN HIGHER- ORDER DEOXYRIBONUCLEIC ACID AT A JUNCTION-LIKE QUADRUPLEX 1GEI ; 1.60 ; STRUCTURAL CHARACTERIZATION OF N-BUTYL-ISOCYANIDE COMPLEXES OF CYTOCHROMES P450NOR AND P450CAM 1GEJ ; 1.50 ; STRUCTURAL CHARACTERIZATION OF N-BUTYL-ISOCYANIDE COMPLEXES OF CYTOCHROMES P450NOR AND P450CAM 1GEK ; 1.70 ; STRUCTURAL CHARACTERIZATION OF N-BUTYL-ISOCYANIDE COMPLEXES OF CYTOCHROMES P450NOR AND P450CAM 1GEM ; 2.00 ; STRUCTURAL CHARACTERIZATION OF N-BUTYL-ISOCYANIDE COMPLEXES OF CYTOCHROMES P450NOR AND P450CAM 1Y2Y ; -1.00 ; STRUCTURAL CHARACTERIZATION OF NOP10P USING NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY 1I9F ; -1.00 ; STRUCTURAL CHARACTERIZATION OF THE COMPLEX OF THE REV RESPONSE ELEMENT RIBONUCLEIC ACID WITH A SELECTED PEPTIDE 1WR0 ; -1.00 ; STRUCTURAL CHARACTERIZATION OF THE MIT DOMAIN FROM HUMAN VPS4B 1DLP ; 3.30 ; STRUCTURAL CHARACTERIZATION OF THE NATIVE FETUIN-BINDING PROTEIN SCILLA CAMPANULATA AGGLUTININ (SCAFET): A NOVEL TWO- DOMAIN LECTIN 1T6C ; 1.53 ; STRUCTURAL CHARACTERIZATION OF THE PPX/GPPA PROTEIN FAMILY: CRYSTAL STRUCTURE OF THE AQUIFEX AEOLICUS FAMILY MEMBER 249D ; 2.25 ; STRUCTURAL COMPARISON BETWEEN THE D(CTAG) SEQUENCE IN OLIGONUCLEOTIDES AND TRP AND MET REPRESSOR-OPERATOR COMPLEXES 250D ; 2.47 ; STRUCTURAL COMPARISON BETWEEN THE D(CTAG) SEQUENCE IN OLIGONUCLEOTIDES AND TRP AND MET REPRESSOR-OPERATOR COMPLEXES 1B0W ; 1.80 ; STRUCTURAL COMPARISON OF AMYLOIDOGENIC LIGHT CHAIN DIMER IN TWO CRYSTAL FORMS WITH NONAMYLOIDOGENIC COUNTERPARTS 1WG0 ; 2.53 ; STRUCTURAL COMPARISON OF NAS6P PROTEIN STRUCTURES IN TWO DIFFERENT CRYSTAL FORMS 1N5O ; 2.80 ; STRUCTURAL CONSEQUENCES OF A CANCER-CAUSING BRCA1-BRCT MISSENSE MUTATION 1EI8 ; 2.00 ; STRUCTURAL CONSEQUENCES OF A DISCONTINUITY IN THE REPEATING TRIPEPTIDE SEQUENCE OF A COLLAGEN-LIKE TRIPLE-HELICAL PEPTIDE 1P2I ; 1.65 ; STRUCTURAL CONSEQUENCES OF ACCOMMODATION OF FOUR NON- COGNATE AMINO-ACID RESIDUES IN THE S1 POCKET OF BOVINE TRYPSIN AND CHYMOTRYPSIN 1P2J ; 1.35 ; STRUCTURAL CONSEQUENCES OF ACCOMMODATION OF FOUR NON- COGNATE AMINO-ACID RESIDUES IN THE S1 POCKET OF BOVINE TRYPSIN AND CHYMOTRYPSIN 1P2K ; 1.60 ; STRUCTURAL CONSEQUENCES OF ACCOMMODATION OF FOUR NON- COGNATE AMINO-ACID RESIDUES IN THE S1 POCKET OF BOVINE TRYPSIN AND CHYMOTRYPSIN 1P2M ; 1.75 ; STRUCTURAL CONSEQUENCES OF ACCOMMODATION OF FOUR NON- COGNATE AMINO-ACID RESIDUES IN THE S1 POCKET OF BOVINE TRYPSIN AND CHYMOTRYPSIN 1P2N ; 1.80 ; STRUCTURAL CONSEQUENCES OF ACCOMMODATION OF FOUR NON- COGNATE AMINO-ACID RESIDUES IN THE S1 POCKET OF BOVINE TRYPSIN AND CHYMOTRYPSIN 1P2O ; 2.00 ; STRUCTURAL CONSEQUENCES OF ACCOMMODATION OF FOUR NON- COGNATE AMINO-ACID RESIDUES IN THE S1 POCKET OF BOVINE TRYPSIN AND CHYMOTRYPSIN 1P2Q ; 1.80 ; STRUCTURAL CONSEQUENCES OF ACCOMMODATION OF FOUR NON- COGNATE AMINO-ACID RESIDUES IN THE S1 POCKET OF BOVINE TRYPSIN AND CHYMOTRYPSIN 1GQ5 ; 2.20 ; STRUCTURAL DETERMINANTS OF THE NHERF INTERACTION WITH BETA2-AR AND PDGFR 1GQ4 ; 1.90 ; STRUCTURAL DETERMINANTS OF THE NHERF INTERACTION WITH BETA2AR AND PDGFR 1Z14 ; 3.25 ; STRUCTURAL DETERMINANTS OF TISSUE TROPISM AND IN VIVO PATHOGENICITY FOR THE PARVOVIRUS MINUTE VIRUS OF MICE 1Z1C ; 3.50 ; STRUCTURAL DETERMINANTS OF TISSUE TROPISM AND IN VIVO PATHOGENICITY FOR THE PARVOVIRUS MINUTE VIRUS OF MICE 1T4W ; 2.10 ; STRUCTURAL DIFFERENCES IN THE DEOXYRIBONUCLEIC ACID BINDING DOMAINS OF HUMAN P53 AND ITS C. ELEGANS ORTHOLOG CEP-1: STRUCTURE OF C. ELEGANS CEP-1 1SKX ; 2.80 ; STRUCTURAL DISORDER IN THE COMPLEX OF HUMAN PXR AND THE MACROLIDE ANTIBIOTIC RIFAMPICIN 1B0D ; 1.84 ; STRUCTURAL EFFECTS OF MONOVALENT ANIONS ON POLYMORPHIC LYSOZYME CRYSTALS 1B2K ; 1.60 ; STRUCTURAL EFFECTS OF MONOVALENT ANIONS ON POLYMORPHIC LYSOZYME CRYSTALS 1HF4 ; 1.45 ; STRUCTURAL EFFECTS OF MONOVALENT ANIONS ON POLYMORPHIC LYSOZYME CRYSTALS 1K9V ; 2.40 ; STRUCTURAL EVIDENCE FOR AMMONIA TUNELLING ACROSS THE (BETA- ALPHA)8-BARREL OF THE IMIDAZOLE GLYCEROL PHOSPHATE SYNTHASE BIENZYME COMPLEX 1GPW ; 2.40 ; STRUCTURAL EVIDENCE FOR AMMONIA TUNNELING ACROSS THE (BETA/ALPHA)8 BARREL OF THE IMIDAZOLE GLYCEROL PHOSPHATE SYNTHASE BIENZYME COMPLEX. 1NVU ; 2.20 ; STRUCTURAL EVIDENCE FOR FEEDBACK ACTIVATION BY RASGTP OF THE RAS-SPECIFIC NUCLEOTIDE EXCHANGE FACTOR SOS 1NVV ; 2.18 ; STRUCTURAL EVIDENCE FOR FEEDBACK ACTIVATION BY RASGTP OF THE RAS-SPECIFIC NUCLEOTIDE EXCHANGE FACTOR SOS 1NVW ; 2.70 ; STRUCTURAL EVIDENCE FOR FEEDBACK ACTIVATION BY RASGTP OF THE RAS-SPECIFIC NUCLEOTIDE EXCHANGE FACTOR SOS 1NVX ; 3.20 ; STRUCTURAL EVIDENCE FOR FEEDBACK ACTIVATION BY RASGTP OF THE RAS-SPECIFIC NUCLEOTIDE EXCHANGE FACTOR SOS 1HA5 ; 2.82 ; STRUCTURAL FEATURES OF A ZINC-BINDING SITE IN THE SUPERANTIGEN STREPTOCOCCAL PYROGENIC EXOTOXIN A (SPEA1): IMPLICATIONS FOR MHC CLASS II RECOGNITION. 1AC7 ; -1.00 ; STRUCTURAL FEATURES OF THE DEOXYRIBONUCLEIC ACID HAIRPIN D(ATCCTAGTTATAGGAT): THE FORMATION OF A G-A BASE PAIR IN THE LOOP, NMR, 10 STRUCTURES 1ML8 ; 2.60 ; STRUCTURAL GENOMICS 1R9H ; 1.80 ; STRUCTURAL GENOMICS OF C.ELEGANS: FKBP-TYPE PEPTIDYLPROLYL ISOMERASE 1OOJ ; 2.11 ; STRUCTURAL GENOMICS OF CAENORHABDITIS ELEGANS : CALMODULIN 1OOE ; 1.65 ; STRUCTURAL GENOMICS OF CAENORHABDITIS ELEGANS : DIHYDROPTERIDINE REDUCTASE 1YIS ; 2.40 ; STRUCTURAL GENOMICS OF CAENORHABDITIS ELEGANS: ADENYLOSUCCINATE LYASE 1LPL ; 1.77 ; STRUCTURAL GENOMICS OF CAENORHABDITIS ELEGANS: CAP-GLY DOMAIN OF F53F4.3 1TOV ; 1.77 ; STRUCTURAL GENOMICS OF CAENORHABDITIS ELEGANS: CAP-GLY DOMAIN OF F53F4.3 1YQ1 ; 3.00 ; STRUCTURAL GENOMICS OF CAENORHABDITIS ELEGANS: GLUTATHIONE S-TRANSFERASE 1QWK ; 1.60 ; STRUCTURAL GENOMICS OF CAENORHABDITIS ELEGANS: HYPOTHETICAL 35.2 KDA PROTEIN (ALDOSE REDUCTASE FAMILY MEMBER) 1T9F ; 2.00 ; STRUCTURAL GENOMICS OF CAENORHABDITIS ELEGANS: STRUCTURE OF A PROTEIN WITH UNKNOWN FUNCTION 1T7S ; 2.80 ; STRUCTURAL GENOMICS OF CAENORHABDITIS ELEGANS: STRUCTURE OF BAG-1 PROTEIN 1MO0 ; 1.70 ; STRUCTURAL GENOMICS OF CAENORHABDITIS ELEGANS: TRIOSE PHOSPHATE ISOMERASE 1PGV ; 1.80 ; STRUCTURAL GENOMICS OF CAENORHABDITIS ELEGANS: TROPOMODULIN C-TERMINAL DOMAIN 1TUA ; 1.50 ; STRUCTURAL GENOMICS, 1.5A CRYSTAL STRUCTURE OF A HYPOTHETICAL PROTEIN APE0754 FROM AEROPYRUM PERNIX 1TP6 ; 1.50 ; STRUCTURAL GENOMICS, 1.5A CRYSTAL STRUCTURE OF A HYPOTHETICAL PROTEIN PA1314 FROM PSEUDOMONAS AERUGINOSA 2A35 ; 1.50 ; STRUCTURAL GENOMICS, 1.5A CRYSTAL STRUCTURE OF A HYPOTHETICAL PROTEIN PA4017 FROM PSEUDOMONAS AERUGINOSA PAO1 1SH8 ; 1.50 ; STRUCTURAL GENOMICS, 1.5A CRYSTAL STRUCTURE OF A HYPOTHETICAL PROTEIN PA5026 FROM PSEUDOMONAS AERUGINOSA 2AP3 ; 1.60 ; STRUCTURAL GENOMICS, 1.6A CRYSTAL STRUCTURE OF A CONSERVED HYPOTHETICAL PROTEIN FROM STAPHYLOCOCCUS AUREUS 1S7I ; 1.80 ; STRUCTURAL GENOMICS, 1.8A CRYSTAL STRUCTURE OF A HYPOTHETICAL PROTEIN PA1349 FROM PSEUDOMONAS AERUGINOSA 1Y7P ; 1.90 ; STRUCTURAL GENOMICS, 1.9A CRYSTAL STRUCTURE OF A HYPOTHETICAL PROTEIN AF1403 FROM ARCHAEOGLOBUS FULGIDUS 1T06 ; 1.90 ; STRUCTURAL GENOMICS, 1.9A CRYSTAL STRUCTURE OF A HYPOTHETICAL PROTEIN FROM BACILLUS CEREUS ATCC 14579 1Y9W ; 1.90 ; STRUCTURAL GENOMICS, 1.9A CRYSTAL STRUCTURE OF AN ACETYLTRANSFERASE FROM BACILLUS CEREUS ATCC 14579 1SR8 ; 1.90 ; STRUCTURAL GENOMICS, 1.9A CRYSTAL STRUCTURE OF COBALAMIN BIOSYNTHESIS PROTEIN (CBID) FROM ARCHAEOGLOBUS FULGIDUS 1TWU ; 2.00 ; STRUCTURAL GENOMICS, 2.0A CRYSTAL STRUCTURE OF A HYPOTHETICAL PROTEIN YYCE FROM BACILLUS SUBTILIS 1S7H ; 2.20 ; STRUCTURAL GENOMICS, 2.2A CRYSTAL STRUCTURE OF PROTEIN YKOF FROM BACILLUS SUBTILIS 1PVM ; 1.50 ; STRUCTURAL GENOMICS, A CONSERVED HYPOTHETICAL PROTEIN TA0289 1RLJ ; 2.00 ; STRUCTURAL GENOMICS, A FLAVOPROTEIN NRDI FROM BACILLUS SUBTILIS 1T5B ; 1.40 ; STRUCTURAL GENOMICS, A PROTEIN FROM SALMONELLA TYPHIMURIUM SIMILAR TO E. COLI ACYL CARRIER PROTEIN PHOSPHODIESTERASE 1NQK ; 2.20 ; STRUCTURAL GENOMICS, CRYSTAL STRUCTURE OF ALKANESULFONATE MONOOXYGENASE 1L7A ; 1.50 ; STRUCTURAL GENOMICS, CRYSTAL STRUCTURE OF CEPHALOSPORIN C DEACETYLASE 1T8Q ; 2.00 ; STRUCTURAL GENOMICS, CRYSTAL STRUCTURE OF GLYCEROPHOSPHORYL DIESTER PHOSPHODIESTERASE FROM E. COLI 1SQU ; 2.40 ; STRUCTURAL GENOMICS, CRYSTAL STRUCTURE OF THE CHEX PROTEIN FROM THERMOTOGA MARITIMA 1KYH ; 1.60 ; STRUCTURAL GENOMICS, HYPOTHETICAL PROTEIN IN SIGY-CYDD INTERGENIC REGION 1MK4 ; 1.70 ; STRUCTURAL GENOMICS, HYPOTHETICAL PROTEIN YQJY FROM BACILLUS SUBTILIS 1I60 ; 1.60 ; STRUCTURAL GENOMICS, IOLI PROTEIN 1PC6 ; 2.51 ; STRUCTURAL GENOMICS, NINB 1KTN ; 1.40 ; STRUCTURAL GENOMICS, PROTEIN EC1535 1K4N ; 1.60 ; STRUCTURAL GENOMICS, PROTEIN EC4020 1OTK ; 2.00 ; STRUCTURAL GENOMICS, PROTEIN PAAC 1K7J ; 1.40 ; STRUCTURAL GENOMICS, PROTEIN TF1 1KUT ; 2.20 ; STRUCTURAL GENOMICS, PROTEIN TM1243, (SAICAR SYNTHETASE) 1NMO ; 2.20 ; STRUCTURAL GENOMICS, PROTEIN YBGI, UNKNOWN FUNCTION 1Q8B ; 1.90 ; STRUCTURAL GENOMICS, PROTEIN YJCS 1PF5 ; 2.50 ; STRUCTURAL GENOMICS, PROTEIN YJGH 1NN4 ; 2.20 ; STRUCTURAL GENOMICS, RPIB/ALSB 2AO9 ; 1.90 ; STRUCTURAL GENOMICS, THE CRYSTAL STRUCTURE OF A PHAGE PROTEIN (PHBC6A51) FROM BACILLUS CEREUS ATCC 14579 2AN1 ; 2.00 ; STRUCTURAL GENOMICS, THE CRYSTAL STRUCTURE OF A PUTATIVE KINASE FROM SALMONELLA TYPHIMURIM LT2 1T33 ; 2.20 ; STRUCTURAL GENOMICS, THE CRYSTAL STRUCTURE OF A PUTATIVE TRANSCRIPTIONAL REPRESSOR (TETR/ACRR FAMILY) FROM SALMONELLA TYPHIMURIM LT2 1XIZ ; 2.00 ; STRUCTURAL GENOMICS, THE CRYSTAL STRUCTURE OF DOMAIN IIA OF PUTATIVE PHOSPHOTRANSFERASE SYSTEM SPECIFIC FOR MANNITOL/FRUCTOSE FROM SALMONELLA TYPHIMURIUM 1Z9U ; 2.20 ; STRUCTURAL GENOMICS, THE CRYSTAL STRUCTURE OF THE ACETYL TRANSFERASE, MODIFIES N-TERMINAL SERINE OF 50S RIBOSOMAL SUBUNIT PROTEIN L7/L12 FROM SALMONELLA TYPHIMURIUM 1XM7 ; 2.40 ; STRUCTURAL GENOMICS, THE CRYSTAL STRUCTURE OF THE HYPOTHETICAL PROTEIN AQ_1665 FROM AQUIFEX AEOLICUS 1YLN ; 2.20 ; STRUCTURAL GENOMICS, THE CRYSTAL STRUCTURE OF THE HYPOTHETICAL PROTEIN VCA0042 FROM VIBRIO CHOLERAE O1 1OJ7 ; 2.00 ; STRUCTURAL GENOMICS, UNKNOWN FUNCTION CRYSTAL STRUCTURE OF E. COLI K-12 YQHD 1NMP ; 2.20 ; STRUCTURAL GENOMICS, YBGI PROTEIN, UNKNOWN FUNCTION 1RYL ; 1.60 ; STRUCTURAL GENOMICS,THE CRYSTAL STRUCTURE OF A HYPOTHETICAL PROTEIN YFBM FROM E. COLI 1XV2 ; 2.00 ; STRUCTURAL GENOMICS; CRYSTAL STRUCTURE OF A HYPOTHETICAL PROTEIN SIMILAR TO ALPHA-ACETOLACTATE DECARBOXYLASE, FROM STAPHYLOCOCCUS AUREUS 1PZD ; 2.31 ; STRUCTURAL IDENTIFICATION OF A CONSERVED APPENDAGE DOMAIN IN THE CARBOXYL-TERMINUS OF THE COPI GAMMA-SUBUNIT. 1FFF ; 1.90 ; STRUCTURAL IMPLICATIONS OF DRUG RESISTANT MUTANTS OF HIV-1 PROTEASE : HIGH RESOLUTION CRYSTAL STRUCTURES OF THE MUTANT PROTEASE/SUBSTRATE ANALOG COMPLEXES. 1FEJ ; 1.78 ; STRUCTURAL IMPLICATIONS OF DRUG RESISTANT MUTANTS OF HIV-1 PROTEASE: HIGH RESOLUTION CRYSTAL STRUCTURES OF THE MUTANT PROTEASE/SUBSTRATE ANALOG COMPLEXES 1FFI ; 1.70 ; STRUCTURAL IMPLICATIONS OF DRUG RESISTANT MUTANTS OF HIV-1 PROTEASE: HIGH RESOLUTION CRYSTAL STRUCTURES OF THE MUTANT PROTEASE/SUBSTRATE ANALOG COMPLEXES 1FG6 ; 1.80 ; STRUCTURAL IMPLICATIONS OF DRUG RESISTANT MUTANTS OF HIV-1 PROTEASE: HIGH RESOLUTION CRYSTAL STRUCTURES OF THE MUTANT PROTEASE/SUBSTRATE ANALOG COMPLEXES 1FG8 ; 1.85 ; STRUCTURAL IMPLICATIONS OF DRUG RESISTANT MUTANTS OF HIV-1 PROTEASE: HIGH RESOLUTION CRYSTAL STRUCTURES OF THE MUTANT PROTEASE/SUBSTRATE ANALOG COMPLEXES 1FGC ; 1.90 ; STRUCTURAL IMPLICATIONS OF DRUG RESISTANT MUTANTS OF HIV-1 PROTEASE: HIGH RESOLUTION CRYSTAL STRUCTURES OF THE MUTANT PROTEASE/SUBSTRATE ANALOG COMPLEXES 1FF0 ; 1.85 ; STRUCTURAL IMPLICATIONS OF DRUG RESISTANT MUTANTS OF HIV-1 PROTEASE: HIGH RESOLUTION CRYSTAL STRUCTURES OF THE MUTANT PROTEASE/SUBSTRATE ANALOG COMPLEXES. 1Z3K ; -1.00 ; STRUCTURAL INSIGHT INTO THE BINDING DIVERSITY BETWEEN THE TYR-PHOSPHORYLATED HUMAN EPHRINBS AND NCK2 SH2 DOMAIN 1T1U ; 1.55 ; STRUCTURAL INSIGHTS AND FUNCTIONAL IMPLICATIONS OF CHOLINE ACETYLTRANSFERASE 1XXS ; 1.80 ; STRUCTURAL INSIGHTS FOR FATTY ACID BINDING IN A LYS49 PHOSPHOLIPASE A2: CRYSTAL STRUCTURE OF MYOTOXIN II FROM BOTHROPS MOOJENI COMPLEXED WITH STEARIC ACID 1E8X ; 2.20 ; STRUCTURAL INSIGHTS INTO PHOSHOINOSITIDE 3-KINASE ENZYMATIC MECHANISM AND SIGNALLING 1P1D ; -1.00 ; STRUCTURAL INSIGHTS INTO THE INTER-DOMAIN CHAPERONING OF TANDEM PDZ DOMAINS IN GLUTAMATE RECEPTOR INTERACTING PROTEINS 1P1E ; -1.00 ; STRUCTURAL INSIGHTS INTO THE INTER-DOMAIN CHAPERONING OF TANDEM PDZ DOMAINS IN GLUTAMATE RECEPTOR INTERACTING PROTEINS 1NHC ; 1.70 ; STRUCTURAL INSIGHTS INTO THE PROCESSIVITY OF ENDOPOLYGALACTURONASE I FROM ASPERGILLUS NIGER 1JH8 ; 1.80 ; STRUCTURAL INVESTIGATION OF THE BIOSYNTHESIS OF ALTERNATIVE LOWER LIGANDS FOR COBAMIDES BY NICOTINATE MONONUCLEOTIDE:5, 6-DIMETHYLBENZIMIDAZOLE PHOSPHORIBOSYLTRANSFERASE (COBT) FROM SALMONELLA ENTERICA 1JHA ; 2.00 ; STRUCTURAL INVESTIGATION OF THE BIOSYNTHESIS OF ALTERNATIVE LOWER LIGANDS FOR COBAMIDES BY NICOTINATE MONONUCLEOTIDE:5, 6-DIMETHYLBENZIMIDAZOLE PHOSPHORIBOSYLTRANSFERASE (COBT) FROM SALMONELLA ENTERICA 1UNL ; 2.20 ; STRUCTURAL MECHANISM FOR THE INHIBITION OF CD5-P25 FROM THE ROSCOVITINE, ALOISINE AND INDIRUBIN. 1UNG ; 2.30 ; STRUCTURAL MECHANISM FOR THE INHIBITION OF CDK5-P25 BY ROSCOVITINE, ALOISINE AND INDIRUBIN. 1UNH ; 2.35 ; STRUCTURAL MECHANISM FOR THE INHIBITION OF CDK5-P25 BY ROSCOVITINE, ALOISINE AND INDIRUBIN. 1XJF ; 2.40 ; STRUCTURAL MECHANISM OF ALLOSTERIC SUBSTRATE SPECIFICITY IN A RIBONUCLEOTIDE REDUCTASE: DATP COMPLEX 1XJN ; 2.25 ; STRUCTURAL MECHANISM OF ALLOSTERIC SUBSTRATE SPECIFICITY IN A RIBONUCLEOTIDE REDUCTASE: DATP-CDP COMPLEX 1XJG ; 2.50 ; STRUCTURAL MECHANISM OF ALLOSTERIC SUBSTRATE SPECIFICITY IN A RIBONUCLEOTIDE REDUCTASE: DATP-UDP COMPLEX 1XJJ ; 1.86 ; STRUCTURAL MECHANISM OF ALLOSTERIC SUBSTRATE SPECIFICITY IN A RIBONUCLEOTIDE REDUCTASE: DGTP COMPLEX 1XJK ; 2.12 ; STRUCTURAL MECHANISM OF ALLOSTERIC SUBSTRATE SPECIFICITY IN A RIBONUCLEOTIDE REDUCTASE: DGTP-ADP COMPLEX 1XJM ; 2.40 ; STRUCTURAL MECHANISM OF ALLOSTERIC SUBSTRATE SPECIFICITY IN A RIBONUCLEOTIDE REDUCTASE: DTTP COMPLEX 1XJE ; 1.90 ; STRUCTURAL MECHANISM OF ALLOSTERIC SUBSTRATE SPECIFICITY IN A RIBONUCLEOTIDE REDUCTASE: DTTP-GDP COMPLEX 1J04 ; 2.60 ; STRUCTURAL MECHANISM OF ENZYME MISTARGETING IN HEREDITARY KIDNEY STONE DISEASE IN VITRO 1XPU ; 3.05 ; STRUCTURAL MECHANISM OF INHIBITION OF THE RHO TRANSCRIPTION TERMINATION FACTOR BY THE ANTIBIOTIC 5A-(3- FORMYLPHENYLSULFANYL)-DIHYDROBICYCLOMYCIN (FPDB) 1XPR ; 3.15 ; STRUCTURAL MECHANISM OF INHIBITION OF THE RHO TRANSCRIPTION TERMINATION FACTOR BY THE ANTIBIOTIC 5A-FORMYLBICYCLOMYCIN (FB) 1XPO ; 3.15 ; STRUCTURAL MECHANISM OF INHIBITION OF THE RHO TRANSCRIPTION TERMINATION FACTOR BY THE ANTIBIOTIC BICYCLOMYCIN 1RR8 ; 2.60 ; STRUCTURAL MECHANISMS OF CAMPTOTHECIN RESISTANCE BY MUTATIONS IN HUMAN TOPOISOMERASE I 1RRJ ; 2.30 ; STRUCTURAL MECHANISMS OF CAMPTOTHECIN RESISTANCE BY MUTATIONS IN HUMAN TOPOISOMERASE I 1LMS ; -1.00 ; STRUCTURAL MODEL FOR AN ALKALINE FORM OF FERRICYTOCHROME C 1Z1D ; -1.00 ; STRUCTURAL MODEL FOR THE INTERACTION BETWEEN RPA32 C- TERMINAL DOMAIN AND SV40 T ANTIGEN ORIGIN BINDING DOMAIN. 1M11 ; 16.00 ; STRUCTURAL MODEL OF HUMAN DECAY-ACCELERATING FACTOR BOUND TO ECHOVIRUS 7 FROM CRYO-ELECTRON MICROSCOPY 1E08 ; -1.00 ; STRUCTURAL MODEL OF THE [FE]-HYDROGENASE/CYTOCHROME C553 COMPLEX COMBINING NMR AND SOFT-DOCKING 2HPA ; 2.90 ; STRUCTURAL ORIGINS OF L(+)-TARTRATE INHIBITION OF HUMAN PROSTATIC ACID PHOSPHATASE 1D9H ; 1.60 ; STRUCTURAL ORIGINS OF THE EXONUCLEASE RESISTANCE OF A ZWITTERIONIC RIBONUCLEIC ACID 337D ; 1.85 ; STRUCTURAL PARAMETERS FROM SINGLE-CRYSTAL STRUCTURES FOR ACCURATE MODELS OF A- DEOXYRIBONUCLEIC ACID 338D ; 1.85 ; STRUCTURAL PARAMETERS FROM SINGLE-CRYSTAL STRUCTURES FOR ACCURATE MODELS OF A- DEOXYRIBONUCLEIC ACID 339D ; 2.20 ; STRUCTURAL PARAMETERS FROM SINGLE-CRYSTAL STRUCTURES FOR ACCURATE MODELS OF A- DEOXYRIBONUCLEIC ACID 340D ; 1.60 ; STRUCTURAL PARAMETERS FROM SINGLE-CRYSTAL STRUCTURES FOR ACCURATE MODELS OF A- DEOXYRIBONUCLEIC ACID 341D ; 1.75 ; STRUCTURAL PARAMETERS FROM SINGLE-CRYSTAL STRUCTURES FOR ACCURATE MODELS OF A- DEOXYRIBONUCLEIC ACID 342D ; 2.10 ; STRUCTURAL PARAMETERS FROM SINGLE-CRYSTAL STRUCTURES FOR ACCURATE MODELS OF A- DEOXYRIBONUCLEIC ACID 343D ; 2.10 ; STRUCTURAL PARAMETERS FROM SINGLE-CRYSTAL STRUCTURES FOR ACCURATE MODELS OF A- DEOXYRIBONUCLEIC ACID 345D ; 1.85 ; STRUCTURAL PARAMETERS FROM SINGLE-CRYSTAL STRUCTURES FOR ACCURATE MODELS OF A-DEOXYRIBONUCLEIC ACID 346D ; 2.10 ; STRUCTURAL PARAMETERS FROM SINGLE-CRYSTAL STRUCTURES FOR ACCURATE MODELS OF A-DEOXYRIBONUCLEIC ACID 1AXI ; 2.10 ; STRUCTURAL PLASTICITY AT THE HGH:HGHBP INTERFACE 1KFR ; 1.85 ; STRUCTURAL PLASTICITY IN THE EIGHT-HELIX FOLD OF A TREMATODE HEMOGLOBIN 1W8P ; 2.08 ; STRUCTURAL PROPERTIES OF THE B25TYR-NME-B26PHE INSULIN MUTANT. 1XUW ; 1.25 ; STRUCTURAL RATIONALIZATION OF A LARGE DIFFERENCE IN RIBONUCLEIC ACID AFFINITY DESPITE A SMALL DIFFERENCE IN CHEMISTRY BETWEEN TWO 2'-O-MODIFIED NUCLEIC ACID ANALOGS 1XUX ; 1.30 ; STRUCTURAL RATIONALIZATION OF A LARGE DIFFERENCE IN RIBONUCLEIC ACID AFFINITY DESPITE A SMALL DIFFERENCE IN CHEMISTRY BETWEEN TWO 2'-O-MODIFIED NUCLEIC ACID ANALOGS 1TA8 ; 1.80 ; STRUCTURAL REARRANGEMENT ACCOMPANYING NAD+ SYNTHESIS WITHIN A BACTERIAL DEOXYRIBONUCLEIC ACID LIGASE CRYSTAL 1TAE ; 2.70 ; STRUCTURAL REARRANGEMENT ACCOMPANYING NAD+ SYNTHESIS WITHIN A BACTERIAL DEOXYRIBONUCLEIC ACID LIGASE CRYSTAL 1REW ; 1.86 ; STRUCTURAL REFINEMENT OF THE COMPLEX OF BONE MORPHOGENETIC PROTEIN 2 AND ITS TYPE IA RECEPTOR 1B27 ; 2.10 ; STRUCTURAL RESPONSE TO MUTATION AT A PROTEIN-PROTEIN INTERFACE 1B2S ; 1.82 ; STRUCTURAL RESPONSE TO MUTATION AT A PROTEIN-PROTEIN INTERFACE 1B2U ; 2.10 ; STRUCTURAL RESPONSE TO MUTATION AT A PROTEIN-PROTEIN INTERFACE 1B3S ; 2.39 ; STRUCTURAL RESPONSE TO MUTATION AT A PROTEIN-PROTEIN INTERFACE 1R63 ; -1.00 ; STRUCTURAL ROLE OF A BURIED SALT BRIDGE IN THE 434 REPRESSOR DEOXYRIBONUCLEIC ACID-BINDING DOMAIN, NMR, 20 STRUCTURES 2R63 ; -1.00 ; STRUCTURAL ROLE OF A BURIED SALT BRIDGE IN THE 434 REPRESSOR DEOXYRIBONUCLEIC ACID-BINDING DOMAIN, NMR, 20 STRUCTURES 1EZE ; -1.00 ; STRUCTURAL STUDIES OF A BABOON (PAPIO SP.) PLASMA PROTEIN INHIBITOR OF CHOLESTERYL ESTER TRANSFERASE. 1BE5 ; -1.00 ; STRUCTURAL STUDIES OF A STABLE PARALLEL-STRANDED DEOXYRIBONUCLEIC ACID DUPLEX INCORPORATING ISOGUANINE:CYTOSINE AND ISOCYTOSINE:GUANINE BASE PAIRS BY NMR, MINIMIZED AVERAGE STRUCTURE 1F1O ; 3.25 ; STRUCTURAL STUDIES OF ADENYLOSUCCINATE LYASES 1M0F ; 16.00 ; STRUCTURAL STUDIES OF BACTERIOPHAGE ALPHA3 ASSEMBLY, CRYO- ELECTRON MICROSCOPY 1M06 ; 3.50 ; STRUCTURAL STUDIES OF BACTERIOPHAGE ALPHA3 ASSEMBLY, X-RAY CRYSTALLOGRAPHY 1I9A ; 2.50 ; STRUCTURAL STUDIES OF CHOLESTEROL BIOSYNTHESIS: MEVALONATE 5-DIPHOSPHATE DECARBOXYLASE AND ISOPENTENYL DIPHOSPHATE ISOMERASE 1UGT ; -1.00 ; STRUCTURAL STUDIES OF CU(I)-BLEOMYCIN 1BH1 ; -1.00 ; STRUCTURAL STUDIES OF D-PRO MELITTIN, NMR, 20 STRUCTURES 1Y47 ; 2.70 ; STRUCTURAL STUDIES OF DESIGNED ALPHA-HELICAL HAIRPINS 5FIV ; 1.90 ; STRUCTURAL STUDIES OF HIV AND FIV PROTEASES COMPLEXED WITH AN EFFICIENT INHIBITOR OF FIV PR 6FIV ; 1.90 ; STRUCTURAL STUDIES OF HIV AND FIV PROTEASES COMPLEXED WITH AN EFFICIENT INHIBITOR OF FIV PR 3TLH ; 2.00 ; STRUCTURAL STUDIES OF HIV AND FIV PROTEASES COMPLEXED WITHAN EFFICIENT INHIBITOR OF FIV PR 1Q4N ; 2.07 ; STRUCTURAL STUDIES OF PHE256TRP OF HUMAN SALIVARY ALPHA- AMYLASE: IMPLICATIONS FOR THE ROLE OF A CONSERVED WATER MOLECULE AND ITS ASSOCIATED CHAIN IN ENZYME ACTIVITY 1RF6 ; 1.90 ; STRUCTURAL STUDIES OF STREPTOCOCCUS PNEUMONIAE EPSP SYNTHASE IN S3P-GLP BOUND STATE 1RF5 ; 2.30 ; STRUCTURAL STUDIES OF STREPTOCOCCUS PNEUMONIAE EPSP SYNTHASE IN UNLIGANDED STATE 1RF4 ; 2.20 ; STRUCTURAL STUDIES OF STREPTOCOCCUS PNEUMONIAE EPSP SYNTHASE, TETRAHEDRAL INTERMEDIATE BOUND STATE 1IDT ; 2.00 ; STRUCTURAL STUDIES ON A PRODRUG-ACTIVATING SYSTEM-CB1954 AND FMN-DEPENDENT NITROREDUCTASE 1VJ3 ; 2.10 ; STRUCTURAL STUDIES ON BIO-ACTIVE COMPOUNDS. CRYSTAL STRUCTURE AND MOLECULAR MODELING STUDIES ON THE PNEUMOCYSTIS CARINII DIHYDROFOLATE REDUCTASE COFACTOR COMPLEX WITH TAB, A HIGHLY SELECTIVE ANTIFOLATE. 1PJH ; 2.10 ; STRUCTURAL STUDIES ON DELTA3-DELTA2-ENOYL-COA ISOMERASE: THE VARIABLE MODE OF ASSEMBLY OF THE TRIMERIC DISKS OF THE CROTONASE SUPERFAMILY 265D ; 2.01 ; STRUCTURAL STUDIES ON NUCLEIC ACIDS 266D ; 2.03 ; STRUCTURAL STUDIES ON NUCLEIC ACIDS 267D ; 2.00 ; STRUCTURAL STUDIES ON NUCLEIC ACIDS 268D ; 2.02 ; STRUCTURAL STUDIES ON NUCLEIC ACIDS 269D ; 2.15 ; STRUCTURAL STUDIES ON NUCLEIC ACIDS 270D ; 2.01 ; STRUCTURAL STUDIES ON NUCLEIC ACIDS 271D ; 2.02 ; STRUCTURAL STUDIES ON NUCLEIC ACIDS 1SXG ; 2.75 ; STRUCTURAL STUDIES ON THE APO TRANSCRIPTION FACTOR FORM B. MEGATERIUM 1BNX ; -1.00 ; STRUCTURAL STUDIES ON THE EFFECTS OF THE DELETION IN THE RED CELL ANION EXCHANGER (BAND3, AE1) ASSOCIATED WITH SOUTH EAST ASIAN OVALOCYTOSIS. 1BZK ; -1.00 ; STRUCTURAL STUDIES ON THE EFFECTS OF THE DELETION IN THE RED CELL ANION EXCHANGER (BAND3, AE1) ASSOCIATED WITH SOUTH EAST ASIAN OVALOCYTOSIS. 1K6A ; 1.14 ; STRUCTURAL STUDIES ON THE MOBILITY IN THE ACTIVE SITE OF THE THERMOASCUS AURANTIACUS XYLANASE I 1LLW ; 2.70 ; STRUCTURAL STUDIES ON THE SYNCHRONIZATION OF CATALYTIC CENTERS IN GLUTAMATE SYNTHASE: COMPLEX WITH 2-OXOGLUTARATE 1LM1 ; 2.80 ; STRUCTURAL STUDIES ON THE SYNCHRONIZATION OF CATALYTIC CENTERS IN GLUTAMATE SYNTHASE: NATIVE ENZYME 1LLZ ; 3.00 ; STRUCTURAL STUDIES ON THE SYNCHRONIZATION OF CATALYTIC CENTERS IN GLUTAMATE SYNTHASE: REDUCED ENZYME 1OSR ; -1.00 ; STRUCTURAL STUDY OF DEOXYRIBONUCLEIC ACID DUPLEX CONTAINAING A N-(2-DEOXY- BETA-ERYTHO-PENTOFURANOSYL) FORMAMIDE FRAMESHIFT BY NMR AND RESTRAINED MOLECULAR DYNAMICS 1WNG ; 2.10 ; STRUCTURAL STUDY OF PROJECT ID PH0725 FROM PYROCOCCUS HORIKOSHII OT3 1T5N ; -1.00 ; STRUCTURAL TRANSITIONS AS DETERMINANTS OF CALCIUM-DEPENDENT ANTIBIOTIC DAPTOMYCIN 1T5M ; -1.00 ; STRUCTURAL TRANSITIONS AS DETERMINANTS OF THE ACTION OF THE CALCIUM-DEPENDENT ANTIBIOTIC DAPTOMYCIN 390D ; 2.00 ; STRUCTURAL VARIABILITY AND NEW INTERMOLECULAR INTERACTIONS OF Z-DEOXYRIBONUCLEIC ACID IN CRYSTALS OF D(PCPGPCPGPCPG) 391D ; 2.75 ; STRUCTURAL VARIABILITY AND NEW INTERMOLECULAR INTERACTIONS OF Z-DEOXYRIBONUCLEIC ACID IN CRYSTALS OF D(PCPGPCPGPCPG) 392D ; 3.00 ; STRUCTURAL VARIABILITY AND NEW INTERMOLECULAR INTERACTIONS OF Z-DEOXYRIBONUCLEIC ACID IN CRYSTALS OF D(PCPGPCPGPCPG) 368D ; 1.60 ; STRUCTURAL VARIABILITY OF A-DEOXYRIBONUCLEIC ACID IN CRYSTALS OF THE OCTAMER D(PCPCPCPGPCPGPGPG) 369D ; 1.90 ; STRUCTURAL VARIABILITY OF A-DEOXYRIBONUCLEIC ACID IN CRYSTALS OF THE OCTAMER D(PCPCPCPGPCPGPGPG) 370D ; 1.67 ; STRUCTURAL VARIABILITY OF A-DEOXYRIBONUCLEIC ACID IN CRYSTALS OF THE OCTAMER D(PCPCPCPGPCPGPGPG) 371D ; 1.90 ; STRUCTURAL VARIABILITY OF A-DEOXYRIBONUCLEIC ACID IN CRYSTALS OF THE OCTAMER D(PCPCPCPGPCPGPGPG) 372D ; 2.60 ; STRUCTURAL VARIABILITY OF A-DEOXYRIBONUCLEIC ACID IN CRYSTALS OF THE OCTAMER D(PCPCPCPGPCPGPGPG) 1O9C ; 2.60 ; STRUCTURAL VIEW OF A FUNGAL TOXIN ACTING ON A 14-3-3 REGULATORY COMPLEX 1O9D ; 2.30 ; STRUCTURAL VIEW OF A FUNGAL TOXIN ACTING ON A 14-3-3 REGULATORY COMPLEX 1O9E ; 2.60 ; STRUCTURAL VIEW OF A FUNGAL TOXIN ACTING ON A 14-3-3 REGULATORY COMPLEX 1O9F ; 2.70 ; STRUCTURAL VIEW OF A FUNGAL TOXIN ACTING ON A 14-3-3 REGULATORY COMPLEX 1RF3 ; 3.50 ; STRUCTURALLY DISTINCT RECOGNITION MOTIFS IN LYMPHOTOXIN-B RECEPTOR AND CD40 FOR TRAF-MEDIATED SIGNALING 1X6Z ; 0.78 ; STRUCTURE 1: CRYOCOOLED CRYSTAL STRUCTURE OF THE TRUNCATED PAK PILIN FROM PSEUDOMONAS AERUGINOSA AT 0.78A RESOLUTION 1X6X ; 0.96 ; STRUCTURE 2: CRYOCOLLED CRYSTAL STRUCTURE OF THE TRUNCATED PAK PILIN FROM PSEUDOMONAS AERUGINOSA AT 0.95A RESOLUTION 1X6Q ; 1.51 ; STRUCTURE 3: CRYOCOOLED CRYSTAL STRUCTURE OF THE TRUNCATED PAK PILIN FROM PSEUDOMONAS AERUGINOSA AT 1.51A RESOLUTION 1X6P ; 1.63 ; STRUCTURE 4; ROOM TEMPERATURE CRYSTAL STRUCTURE OF TRUNCATED PAK PILIN FROM PSEUDOMONAS AERUGINOSA AT 1.63A RESOLUTION 1X6R ; 1.82 ; STRUCTURE 5: ROOM TEMPERATURE CRYSTAL STRUCTURE OF THE TRUNCATED PAK PILIN FROM PSEUDOMONAS AERUGINOSA AT 1.80A RESOLUTION 1X6Y ; 1.55 ; STRUCTURE 6: ROOM TEMPERATURE CRYSTAL STRUCTURE OF THE TRUNCATED PAK PILIN FROM PSEUDOMONAS AERUGINOSA AT 1.80A RESOLUTION 1KWH ; 2.00 ; STRUCTURE ANALYSIS ALGQ2, A MACROMOLECULE(ALGINATE)-BINDING PERIPLASMIC PROTEIN OF SPHINGOMONAS SP. A1. 1FX4 ; 1.90 ; STRUCTURE ANALYSIS OF ADENYLATE CYCLASES FROM TRYPANOSOMA BRUCEI IN THEIR MONOMERIC STATE 1J1N ; 1.60 ; STRUCTURE ANALYSIS OF ALGQ2, A MACROMOLECULE(ALGINATE)- BINDING PERIPLASMIC PROTEIN OF SPHINGOMONAS SP. A1., COMPLEXED WITH AN ALGINATE TETRASACCHARIDE 1WS0 ; 1.70 ; STRUCTURE ANALYSIS OF PEPTIDE DEFORMYLASE FROM BACILLUS CEREUS 1WS1 ; 2.00 ; STRUCTURE ANALYSIS OF PEPTIDE DEFORMYLASE FROM BACILLUS CEREUS 1R9L ; 1.59 ; STRUCTURE ANALYSIS OF PROX IN COMPLEX WITH GLYCINE BETAINE 1R9Q ; 2.05 ; STRUCTURE ANALYSIS OF PROX IN COMPLEX WITH PROLINE BETAINE 1V8L ; 2.10 ; STRUCTURE ANALYSIS OF THE ADP-RIBOSE PYROPHOSPHATASE COMPLEXED WITH ADP-RIBOSE 1U7H ; 1.80 ; STRUCTURE AND A PROPOSED MECHANISM FOR ORNITHINE CYCLODEAMINASE FROM PSEUDOMONAS PUTIDA 1Q14 ; 2.50 ; STRUCTURE AND AUTOREGULATION OF THE YEAST HST2 HOMOLOG OF SIR2 1I5K ; 2.70 ; STRUCTURE AND BINDING DETERMINANTS OF THE RECOMBINANT KRINGLE-2 DOMAIN OF HUMAN PLASMINOGEN TO AN INTERNAL PEPTIDE FROM A GROUP A STREPTOCOCCAL SURFACE PROTEIN 1MLV ; 2.60 ; STRUCTURE AND CATALYTIC MECHANISM OF A SET DOMAIN PROTEIN METHYLTRANSFERASE 1CXY ; 1.65 ; STRUCTURE AND CHARACTERIZATION OF ECTOTHIORHODOSPIRA VACUOLATA CYTOCHROME B558, A PROKARYOTIC HOMOLOGUE OF CYTOCHROME B5 2C5Z ; -1.00 ; STRUCTURE AND CTD BINDING OF THE SET2 SRI DOMAIN 1N9C ; -1.00 ; STRUCTURE AND DYNAMICS OF REDUCED BACILLUS PASTEURII CYTOCHROME C: OXIDATION STATE DEPENDENT PROPERTIES AND IMPLICATIONS FOR ELECTRON TRANSFER PROCESSES 1N17 ; -1.00 ; STRUCTURE AND DYNAMICS OF THIOGUANINE-MODIFIED DUPLEX DEOXYRIBONUCLEIC ACID 1N14 ; -1.00 ; STRUCTURE AND DYNAMICS OF THIOGUANINE-MODIFIED DUPLEX DEOXYRIBONUCLEIC ACID IN COMPARISON WITH UNMODIFIED DEOXYRIBONUCLEIC ACID; STRUCTURE OF UNMODIFIED DUPLEX DEOXYRIBONUCLEIC ACID 1OXN ; 2.20 ; STRUCTURE AND FUNCTION ANALYSIS OF PEPTIDE ANTAGONISTS OF MELANOMA INHIBITOR OF APOPTOSIS (ML-IAP) 1OXQ ; 2.30 ; STRUCTURE AND FUNCTION ANALYSIS OF PEPTIDE ANTAGONISTS OF MELANOMA INHIBITOR OF APOPTOSIS (ML-IAP) 1OY7 ; 2.70 ; STRUCTURE AND FUNCTION ANALYSIS OF PEPTIDE ANTAGONISTS OF MELANOMA INHIBITOR OF APOPTOSIS (ML-IAP) 1PJQ ; 2.21 ; STRUCTURE AND FUNCTION OF CYSG, THE MULTIFUNCTIONAL METHYLTRANSFERASE/DEHYDROGENASE/FERROCHELATASE FOR SIROHEME SYNTHESIS 1U1V ; 1.70 ; STRUCTURE AND FUNCTION OF PHENAZINE-BIOSYNTHESIS PROTEIN PHZF FROM PSEUDOMONAS FLUORESCENS 2-79 1U1W ; 1.35 ; STRUCTURE AND FUNCTION OF PHENAZINE-BIOSYNTHESIS PROTEIN PHZF FROM PSEUDOMONAS FLUORESCENS 2-79 1U1X ; 1.88 ; STRUCTURE AND FUNCTION OF PHENAZINE-BIOSYNTHESIS PROTEIN PHZF FROM PSEUDOMONAS FLUORESCENS 2-79 1P5S ; 2.22 ; STRUCTURE AND FUNCTION OF THE CALPONIN-HOMOLOGY DOMAIN OF AN IQGAP PROTEIN FROM SCHIZOSACCHAROMYCES POMBE 1XUA ; 1.90 ; STRUCTURE AND FUNCTION OF THE PHENAZINE BIOSYNTHETIC PROTEIN PHZF FROM PSEUDOMONAS FLUORESCENS 1XUB ; 1.30 ; STRUCTURE AND FUNCTION OF THE PHENAZINE BIOSYNTHETIC PROTEIN PHZF FROM PSEUDOMONAS FLUORESCENS 1R8G ; 2.15 ; STRUCTURE AND FUNCTION OF YBDK 2ESY ; -1.00 ; STRUCTURE AND INFLUENCE ON STABILITY AND ACTIVITY OF THE N- TERMINAL PROPETIDE PART OF LUNG SURFACTANT PROTEIN C 1YXE ; -1.00 ; STRUCTURE AND INTER-DOMAIN INTERACTIONS OF DOMAIN II FROM THE BLOOD STAGE MALARIAL PROTEIN, APICAL MEMBRANE ANTIGEN 1 1BLQ ; -1.00 ; STRUCTURE AND INTERACTION SITE OF THE REGULATORY DOMAIN OF TROPONIN-C WHEN COMPLEXED WITH THE 96-148 REGION OF TROPONIN-I, NMR, 29 STRUCTURES 1LL8 ; -1.00 ; STRUCTURE AND INTERACTIONS OF PAS KINASE N-TERMINAL PAS DOMAIN: MODEL FOR INTRAMOLECULAR KINASE REGULATION 2BKV ; 1.50 ; STRUCTURE AND KINETICS OF A MONOMERIC GLUCOSAMINE-6- PHOSPHATE DEAMINASE: MISSING LINK OF THE NAGB SUPERFAMILY 2BKX ; 1.40 ; STRUCTURE AND KINETICS OF A MONOMERIC GLUCOSAMINE-6- PHOSPHATE DEAMINASE: MISSING LINK OF THE NAGB SUPERFAMILY 5HPG ; 1.66 ; STRUCTURE AND LIGAND DETERMINANTS OF THE RECOMBINANT KRINGLE 5 DOMAIN OF HUMAN PLASMINOGEN 1N72 ; -1.00 ; STRUCTURE AND LIGAND OF A HISTONE ACETYLTRANSFERASE BROMODOMAIN 1N7Z ; 2.00 ; STRUCTURE AND LOCATION OF GENE PRODUCT 8 IN THE BACTERIOPHAGE T4 BASEPLATE 1OW2 ; 2.00 ; STRUCTURE AND MECHANISM OF ACTION OF ISOPENTENYLPYROPHOSPHATE-DIMETHYLALLYLPYROPHOSPHATE ISOMERASE: COMPLEX OF C67A MUTANT WITH EIPP 1NFZ ; 1.97 ; STRUCTURE AND MECHANISM OF ACTION OF ISOPENTENYLPYROPHOSPHATE-DIMETHYLALLYLPYROPHOSPHATE ISOMERASE: COMPLEX WITH EIPP 1NFS ; 1.96 ; STRUCTURE AND MECHANISM OF ACTION OF ISOPENTENYLPYROPHOSPHATE-DIMETHYLALLYLPYROPHOSPHATE ISOMERASE: COMPLEX WITH NIPP 1Q54 ; 1.93 ; STRUCTURE AND MECHANISM OF ACTION OF ISOPENTENYLPYROPHOSPHATE-DIMETHYLALLYLPYROPHOSPHATE ISOMERASE: COMPLEX WITH THE BROMOHYDRINE OF IPP 1B4Y ; -1.00 ; STRUCTURE AND MECHANISM OF FORMATION OF THE H-Y5 ISOMER OF AN INTRAMOLECULAR DEOXYRIBONUCLEIC ACID TRIPLE HELIX. 1RI1 ; 2.50 ; STRUCTURE AND MECHANISM OF MRNA CAP (GUANINE N-7) METHYLTRANSFERASE 1RI2 ; 2.70 ; STRUCTURE AND MECHANISM OF MRNA CAP (GUANINE N-7) METHYLTRANSFERASE 1RI3 ; 2.50 ; STRUCTURE AND MECHANISM OF MRNA CAP (GUANINE N-7) METHYLTRANSFERASE 1RI4 ; 2.40 ; STRUCTURE AND MECHANISM OF MRNA CAP (GUANINE N-7) METHYLTRANSFERASE 1RI5 ; 2.10 ; STRUCTURE AND MECHANISM OF MRNA CAP (GUANINE N-7) METHYLTRANSFERASE 1S68 ; 1.90 ; STRUCTURE AND MECHANISM OF RIBONUCLEIC ACID LIGASE 1LY1 ; 2.00 ; STRUCTURE AND MECHANISM OF T4 POLYNUCLEOTIDE KINASE 1BY4 ; 2.10 ; STRUCTURE AND MECHANISM OF THE HOMODIMERIC ASSEMBLY OF THE RXR ON DEOXYRIBONUCLEIC ACID 1AJY ; -1.00 ; STRUCTURE AND MOBILITY OF THE PUT3 DIMER: A DEOXYRIBONUCLEIC ACID PINCER, NMR, 13 STRUCTURES 1W7W ; 2.80 ; STRUCTURE AND MUTATIONAL ANALYSIS OF A PLANT MITOCHONDRIAL NUCLEOSIDE DIPHOSPHATE KINASE: IDENTIFICATION OF RESIDUES INVOLVED IN SERINE PHOSPHORYLATION AND OLIGOMERIZATION. 1VYN ; -1.00 ; STRUCTURE AND NUCLEIC ACID BINDING OF THE DROSOPHILA ARGONAUTE2 PAZ DOMAIN 1KF1 ; 2.10 ; STRUCTURE AND PACKING OF HUMAN TELOMERIC DEOXYRIBONUCLEIC ACID 1NRG ; 1.95 ; STRUCTURE AND PROPERTIES OF RECOMBINANT HUMAN PYRIDOXINE-5'- PHOSPHATE OXIDASE 1MA1 ; 2.60 ; STRUCTURE AND PROPERTIES OF THE ATYPICAL IRON SUPEROXIDE DISMUTASE FROM METHANOBACTERIUM THERMOAUTOTROPHICUM 1S18 ; 1.70 ; STRUCTURE AND PROTEIN DESIGN OF HUMAN APYRASE 1S1D ; 1.60 ; STRUCTURE AND PROTEIN DESIGN OF HUMAN APYRASE 1H4L ; 2.65 ; STRUCTURE AND REGULATION OF THE CDK5-P25(NCK5A) COMPLEX 1F5V ; 1.70 ; STRUCTURE AND SITE-DIRECTED MUTAGENESIS OF A FLAVOPROTEIN FROM ESCHERICHIA COLI THAT REDUCES NITROCOMPOUNDS. ALTERATION OF PYRIDINE NUCLEOTIDE BINDING BY A SINGLE AMINO ACID SUBSTITUTION 1BSX ; 3.70 ; STRUCTURE AND SPECIFICITY OF NUCLEAR RECEPTOR-COACTIVATOR INTERACTIONS 1S5P ; 1.96 ; STRUCTURE AND SUBSTRATE BINDING PROPERTIES OF COBB, A SIR2 HOMOLOG PROTEIN DEACETYLASE FROM ESCHERICIA COLI. 1N3J ; -1.00 ; STRUCTURE AND SUBSTRATE OF A HISTONE H3 LYSINE METHYLTRANSFERASE FROM PARAMECIUM BURSARIA CHLORELLA VIRUS 1 1PJD ; -1.00 ; STRUCTURE AND TOPOLOGY OF A PEPTIDE SEGMENT OF THE 6TH TRANSMEMBRANE DOMAIN OF THE SACCHAROMYCES CEREVISIAE ALPHA- FACTOR RECEPTOR IN PHOSPHOLIPID BILAYERS 1NJ3 ; -1.00 ; STRUCTURE AND UBIQUITIN INTERACTIONS OF THE CONSERVED NZF DOMAIN OF NPL4 1KV9 ; 1.90 ; STRUCTURE AT 1.9 A RESOLUTION OF A QUINOHEMOPROTEIN ALCOHOL DEHYDROGENASE FROM PSEUDOMONAS PUTIDA HK5 1AR1 ; 2.70 ; STRUCTURE AT 2.7 ANGSTROM RESOLUTION OF THE PARACOCCUS DENITRIFICANS TWO-SUBUNIT CYTOCHROME C OXIDASE COMPLEXED WITH AN ANTIBODY FV FRAGMENT 1UNT ; 2.07 ; STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES 1UNU ; 2.07 ; STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES 1UNV ; 2.14 ; STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES 1UNW ; 2.20 ; STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES 1UNX ; 2.40 ; STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES 1UNY ; 2.30 ; STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES 1UNZ ; 2.30 ; STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES 1UO0 ; 2.40 ; STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES 1UO1 ; 2.50 ; STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES 1UO2 ; 1.99 ; STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES 1UO3 ; 1.92 ; STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES 1UO4 ; 1.70 ; STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES 1UO5 ; 2.07 ; STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES 1ZB1 ; 1.95 ; STRUCTURE BASIS FOR ENDOSOMAL TARGETING BY THE BRO1 DOMAIN 1YHN ; 3.00 ; STRUCTURE BASIS OF RILP RECRUITMENT BY RAB7 1XT3 ; 2.40 ; STRUCTURE BASIS OF VENOM CITRATE-DEPENDENT HEPARIN SULFATE- MEDIATED CELL SURFACE RETENTION OF COBRA CARDIOTOXIN A3 1U2N ; -1.00 ; STRUCTURE CBP TAZ1 DOMAIN 1P6T ; -1.00 ; STRUCTURE CHARACTERIZATION OF THE WATER SOLUBLE REGION OF P- TYPE ATPASE COPA FROM BACILLUS SUBTILIS 1E7U ; 2.00 ; STRUCTURE DETERMINANTS OF PHOSPHOINOSITIDE 3-KINASE INHIBITION BY WORTMANNIN, LY294002, QUERCETIN, MYRICETIN AND STAUROSPORINE 1E7V ; 2.40 ; STRUCTURE DETERMINANTS OF PHOSPHOINOSITIDE 3-KINASE INHIBITION BY WORTMANNIN, LY294002, QUERCETIN, MYRICETIN AND STAUROSPORINE 1E8W ; 2.50 ; STRUCTURE DETERMINANTS OF PHOSPHOINOSITIDE 3-KINASE INHIBITION BY WORTMANNIN, LY294002, QUERCETIN, MYRICETIN AND STAUROSPORINE 1E8Y ; 2.00 ; STRUCTURE DETERMINANTS OF PHOSPHOINOSITIDE 3-KINASE INHIBITION BY WORTMANNIN, LY294002, QUERCETIN, MYRICETIN AND STAUROSPORINE 1E8Z ; 2.40 ; STRUCTURE DETERMINANTS OF PHOSPHOINOSITIDE 3-KINASE INHIBITION BY WORTMANNIN, LY294002, QUERCETIN, MYRICETIN AND STAUROSPORINE 1E90 ; 2.70 ; STRUCTURE DETERMINANTS OF PHOSPHOINOSITIDE 3-KINASE INHIBITION BY WORTMANNIN, LY294002, QUERCETIN, MYRICETIN AND STAUROSPORINE 1EB8 ; 2.10 ; STRUCTURE DETERMINANTS OF SUBSTRATE SPECIFICITY OF HYDROXYNITRILE LYASE FROM MANIHOT ESCULENTA 1EB9 ; 2.10 ; STRUCTURE DETERMINANTS OF SUBSTRATE SPECIFICITY OF HYDROXYNITRILE LYASE FROM MANIHOT ESCULENTA 1GKG ; -1.00 ; STRUCTURE DETERMINATION AND RATIONAL MUTAGENESIS REVEAL BINDING SURFACE OF IMMUNE ADHERENCE RECEPTOR, CR1 (CD35) 1GKN ; -1.00 ; STRUCTURE DETERMINATION AND RATIONAL MUTAGENESIS REVEAL BINDING SURFACE OF IMMUNE ADHERENCE RECEPTOR, CR1 (CD35) 1TJ7 ; 2.44 ; STRUCTURE DETERMINATION AND REFINEMENT AT 2.44 A RESOLUTION OF ARGININOSUCCINATE LYASE FROM E. COLI 1OMS ; 2.30 ; STRUCTURE DETERMINATION BY MAD: E.COLI TRIGGER FACTOR BINDING AT THE RIBOSOMAL EXIT TUNNEL. 1A8Z ; 2.10 ; STRUCTURE DETERMINATION OF A 16.8KDA COPPER PROTEIN RUSTICYANIN AT 2.1A RESOLUTION USING ANOMALOUS SCATTERING DATA WITH DIRECT METHODS 1PRY ; 1.97 ; STRUCTURE DETERMINATION OF FIBRILLARIN HOMOLOGUE FROM HYPERTHERMOPHILIC ARCHAEON PYROCOCCUS FURIOSUS (PFU-65527) 1S0H ; 3.00 ; STRUCTURE DETERMINATION OF HAEMOGLOBIN FROM DONKEY(EQUUS ASINUS) AT 3.0 ANGSTROM RESOLUTION 1S3W ; 1.90 ; STRUCTURE DETERMINATION OF TETRAHYDROQUINAZOLINE ANTIFOALTES IN COMPLEX WITH HUMAN AND PNEUMOCYSTIS CARINII DIHYDROFOLATE REDUCTASE: CORRELATIONS OF ENZYME SELECTIVITY AND STEREOCHEMISTRY 1S3U ; 2.50 ; STRUCTURE DETERMINATION OF TETRAHYDROQUINAZOLINE ANTIFOLATES IN COMPLEX WITH HUMAN AND PNEUMOCYSTIS CARINII DIHYDROFOLATE REDUCTASE: CORRELATIONS OF ENZYME SELECTIVITY AND STEREOCHEMISTRY 1S3V ; 1.80 ; STRUCTURE DETERMINATION OF TETRAHYDROQUINAZOLINE ANTIFOLATES IN COMPLEX WITH HUMAN AND PNEUMOCYSTIS CARINII DIHYDROFOLATE REDUCTASE: CORRELATIONS OF ENZYME SELECTIVITY AND STEREOCHEMISTRY 1S3Y ; 2.25 ; STRUCTURE DETERMINATION OF TETRAHYDROQUINAZOLINE ANTIFOLATES IN COMPLEX WITH HUMAN AND PNEUMOCYSTIS CARINII DIHYDROFOLATE REDUCTASE: CORRELATIONS OF ENZYME SELECTIVITY AND STEREOCHEMISTRY 1CEI ; 1.80 ; STRUCTURE DETERMINATION OF THE COLICIN E7 IMMUNITY PROTEIN (IMME7) THAT BINDS SPECIFICALLY TO THE DNASE-TYPE COLICIN E7 AND INHIBITS ITS BACTERIOCIDAL ACTIVITY 1R11 ; 2.70 ; STRUCTURE DETERMINATION OF THE DIMERIC ENDONUCLEASE IN A PSEUDO-FACE-CENTERD P21 SPACE GROUP 1R0V ; 2.00 ; STRUCTURE DETERMINATION OF THE DIMERIC ENDONUCLEASE IN A PSEUDO-FACE-CENTERD P21212 SPACE GROUP 1FJ0 ; 1.70 ; STRUCTURE DETERMINATION OF THE FERRICYTOCHROME C2 FROM RHODOPSEUDOMONAS PALUSTRIS 1I8P ; 1.95 ; STRUCTURE DETERMINATION OF THE FERROCYTOCHROME C2 FROM RHODOPSEUDOMONAS PALUSTRIS 1RLF ; -1.00 ; STRUCTURE DETERMINATION OF THE RAS-BINDING DOMAIN OF THE RAL-SPECIFIC GUANINE NUCLEOTIDE EXCHANGE FACTOR RLF, NMR, 10 STRUCTURES 1A5R ; -1.00 ; STRUCTURE DETERMINATION OF THE SMALL UBIQUITIN-RELATED MODIFIER SUMO-1, NMR, 10 STRUCTURES 1OI6 ; 1.40 ; STRUCTURE DETERMINATION OF THE TMP-COMPLEX OF EVAD 1UMU ; 2.50 ; STRUCTURE DETERMINATION OF UMUD' BY MAD PHASING OF THE SELENOMETHIONYL PROTEIN 1XGP ; 2.10 ; STRUCTURE FOR ANTIBODY HYHEL-63 Y33A MUTANT COMPLEXED WITH HEN EGG LYSOZYME 1XGU ; 2.10 ; STRUCTURE FOR ANTIBODY HYHEL-63 Y33F MUTANT COMPLEXED WITH HEN EGG LYSOZYME 1XGR ; 2.10 ; STRUCTURE FOR ANTIBODY HYHEL-63 Y33I MUTANT COMPLEXED WITH HEN EGG LYSOZYME 1XGT ; 2.10 ; STRUCTURE FOR ANTIBODY HYHEL-63 Y33L MUTANT COMPLEXED WITH HEN EGG LYSOZYME 1XGQ ; 2.10 ; STRUCTURE FOR ANTIBODY HYHEL-63 Y33V MUTANT COMPLEXED WITH HEN EGG LYSOZYME 1KR4 ; 1.40 ; STRUCTURE GENOMICS, PROTEIN TM1056, CUTA 1S6D ; -1.00 ; STRUCTURE IN SOLUTION OF A METHIONINE-RICH 2S ALBUMIN PROTEIN FROM SUNFLOWER SEED 1OC6 ; 1.50 ; STRUCTURE NATIVE OF THE D405N MUTANT OF THE CELLOBIOHYDROLASE CEL6A FROM HUMICOLA INSOLENS AT 1.5 ANGSTROM RESOLUTION 1YFV ; -1.00 ; STRUCTURE OF (5'-R(GPGPCPGPAPGPCPC)-3')2 BY 2-D NMR, 1 STRUCTURE 1G42 ; 1.80 ; STRUCTURE OF 1,3,4,6-TETRACHLORO-1,4-CYCLOHEXADIENE HYDROLASE (LINB) FROM SPHINGOMONAS PAUCIMOBILIS COMPLEXED WITH 1,2-DICHLOROPROPANE 1PBR ; -1.00 ; STRUCTURE OF 16S RIBOSOMAL RIBONUCLEIC ACID, NMR, MINIMIZED AVERAGE STRUCTURE 1EMI ; 7.50 ; STRUCTURE OF 16S RRNA IN THE REGION AROUND RIBOSOMAL PROTEIN S8. 360D ; 1.85 ; STRUCTURE OF 2,5-BIS{[4-(N-ETHYLAMIDINO)PHENYL]}FURAN COMPLEXED TO 5'-D( CPGPCPGPAPAPTPTPCPGPCPG)-3'. A MINOR GROOVE DRUG COMPLEX, SHOWING PATTERNS OF GROOVE HYDRATION 1VCV ; 2.00 ; STRUCTURE OF 2-DEOXYRIBOSE-5-PHOSPHATE ALDOLASE FROM PYROBACULUM AEROPHILUM 1EUN ; 2.00 ; STRUCTURE OF 2-KETO-3-DEOXY-6-PHOSPHOGLUCONATE ALDOLASE FROM ESCHERICHIA COLI 1L8F ; 1.80 ; STRUCTURE OF 20K-ENDOGLUCANASE FROM MELANOCARPUS ALBOMYCES AT 1.8 A 1MT4 ; -1.00 ; STRUCTURE OF 23S RIBOSOMAL RIBONUCLEIC ACID HAIRPIN 35 1JN1 ; 2.90 ; STRUCTURE OF 2C-METHYL-D-ERYTHRITOL 2,4-CYCLODIPHOSPHATE SYNTHASE FROM HAEMOPHILUS INFLUENZAE (HI0671) 1GX1 ; 1.80 ; STRUCTURE OF 2C-METHYL-D-ERYTHRITOL-2,4-CYCLODIPHOSPHATE SYNTHASE 1IV1 ; 1.65 ; STRUCTURE OF 2C-METHYL-D-ERYTHRITOL-2,4-CYCLODIPHOSPHATE SYNTHASE 1IV2 ; 1.55 ; STRUCTURE OF 2C-METHYL-D-ERYTHRITOL-2,4-CYCLODIPHOSPHATE SYNTHASE (BOUND FORM CDP) 1IV3 ; 1.52 ; STRUCTURE OF 2C-METHYL-D-ERYTHRITOL-2,4-CYCLODIPHOSPHATE SYNTHASE (BOUND FORM MG ATOMS) 1IV4 ; 1.55 ; STRUCTURE OF 2C-METHYL-D-ERYTHRITOL-2,4-CYCLODIPHOSPHATE SYNTHASE (BOUND FORM SUBSTRATE) 1DIC ; 1.80 ; STRUCTURE OF 3,4-DICHLOROISOCOUMARIN-INHIBITED FACTOR D 1OSI ; 3.00 ; STRUCTURE OF 3-ISOPROPYLMALATE DEHYDROGENASE 1OSJ ; 2.35 ; STRUCTURE OF 3-ISOPROPYLMALATE DEHYDROGENASE 1V7L ; 1.98 ; STRUCTURE OF 3-ISOPROPYLMALATE ISOMERASE SMALL SUBUNIT FROM PYROCOCCUS HORIKOSHII 1XBX ; 1.81 ; STRUCTURE OF 3-KETO-L-GULONATE 6-PHOSPHATE DECARBOXYLASE E112D/R139V/T169A MUTANT WITH BOUND D-RIBULOSE 5-PHOSPHATE 1XBY ; 1.58 ; STRUCTURE OF 3-KETO-L-GULONATE 6-PHOSPHATE DECARBOXYLASE E112D/T169A MUTANT WITH BOUND D-RIBULOSE 5-PHOSPHATE 1Q6O ; 1.20 ; STRUCTURE OF 3-KETO-L-GULONATE 6-PHOSPHATE DECARBOXYLASE WITH BOUND L-GULONAET 6-PHOSPHATE 1Q6L ; 1.80 ; STRUCTURE OF 3-KETO-L-GULONATE 6-PHOSPHATE DECARBOXYLASE WITH BOUND L-THREONOHYDROXAMATE 4-PHOSPHATE 1Q6R ; 1.76 ; STRUCTURE OF 3-KETO-L-GULONATE 6-PHOSPHATE DECARBOXYLASE WITH BOUND L-XYLULOSE 5-PHOSPHATE 1Q6Q ; 1.70 ; STRUCTURE OF 3-KETO-L-GULONATE 6-PHOSPHATE DECARBOXYLASE WITH BOUND XYLITOL 5-PHOSPHATE 1SEI ; 1.90 ; STRUCTURE OF 30S RIBOSOMAL PROTEIN S8 1H3M ; 2.40 ; STRUCTURE OF 4-DIPHOSPHOCYTIDYL-2C-METHYL-D-ERYTHRITOL SYNTHETASE 1RM6 ; 1.60 ; STRUCTURE OF 4-HYDROXYBENZOYL-COA REDUCTASE FROM THAUERA AROMATICA 1SB3 ; 2.20 ; STRUCTURE OF 4-HYDROXYBENZOYL-COA REDUCTASE FROM THAUERA AROMATICA 1V4N ; 2.45 ; STRUCTURE OF 5'-DEOXY-5'-METHYLTHIOADENOSINE PHOSPHORYLASE HOMOLOGUE FROM SULFOLOBUS TOKODAII 2A59 ; 2.70 ; STRUCTURE OF 6,7-DIMETHYL-8-RIBITYLLUMAZINE SYNTHASE FROM SCHIZOSACCHAROMYCES POMBE MUTANT W27Y WITH BOUND LIGAND 5- NITROSO-6-RIBITYLAMINO-2,4(1H,3H)-PYRIMIDINEDIONE 2A58 ; 2.80 ; STRUCTURE OF 6,7-DIMETHYL-8-RIBITYLLUMAZINE SYNTHASE FROM SCHIZOSACCHAROMYCES POMBE MUTANT W27Y WITH BOUND RIBOFLAVIN 2A57 ; 2.75 ; STRUCTURE OF 6,7-DIMTHYL-8-RIBITYLLUMAZINE SYNTHASE FROM SCHIZOSACCHAROMYCES POMBE MUTANT W27Y WITH BOUND LIGAND 6- CARBOXYETHYL-7-OXO-8-RIBITYLLUMAZINE 1WYB ; 1.80 ; STRUCTURE OF 6-AMINOHEXANOATE-DIMER HYDROLASE 1KG9 ; 1.81 ; STRUCTURE OF A "MOCK-TRAPPED" EARLY-M INTERMEDIATE OF BACTERIORHOSOPSIN 1MXD ; 2.00 ; STRUCTURE OF A (CA,ZN)-DEPENDENT ALPHA-AMYLASE FROM THE HYPERTHERMOPHILIC ARCHAEON PYROCOCCUS WOESEI 405D ; 2.50 ; STRUCTURE OF A 16-MER RIBONUCLEIC ACID DUPLEX R(GCAGACUUAAAUCUGC)2 WITH WOBBLE LIKE A.C MISMATCHES 1PY2 ; 2.80 ; STRUCTURE OF A 60 NM SMALL MOLECULE BOUND TO A HOT SPOT ON IL-2 2AW6 ; 3.00 ; STRUCTURE OF A BACTERIAL PEPTIDE PHEROMONE/RECEPTOR COMPLEX AND ITS MECHANISM OF GENE REGULATION 1JIA ; 2.13 ; STRUCTURE OF A BASIC PHOSPHOLIPASE A2 FROM AGKISTRODON HALYS PALLAS AT 2.13A RESOLUTION 1W9S ; 1.59 ; STRUCTURE OF A BETA-1,3-GLUCAN BINDING CBM6 FROM BACILLUS HALODURANS 1W9W ; 2.10 ; STRUCTURE OF A BETA-1,3-GLUCAN BINDING CBM6 FROM BACILLUS HALODURANS IN COMPLEX WITH LAMINARIHEXAOSE 1W9T ; 1.62 ; STRUCTURE OF A BETA-1,3-GLUCAN BINDING CBM6 FROM BACILLUS HALODURANS IN COMPLEX WITH XYLOBIOSE 1P22 ; 2.95 ; STRUCTURE OF A BETA-TRCP1-SKP1-BETA-CATENIN COMPLEX: DESTRUCTION MOTIF BINDING AND LYSINE SPECIFICITY ON THE SCFBETA-TRCP1 UBIQUITIN LIGASE 1BVD ; 1.40 ; STRUCTURE OF A BILIVERDIN APOMYOGLOBIN COMPLEX (FORM B) AT 98 K 1BVC ; 1.50 ; STRUCTURE OF A BILIVERDIN APOMYOGLOBIN COMPLEX (FORM D) AT 118 K 109D ; 2.00 ; STRUCTURE OF A BIS-BENZIMIDAZOLE DRUG BOUND TO THE DEOXYRIBONUCLEIC ACID DUPLEX C-G-C-G-A-A-T-T-C-G-C-G 1IYJ ; 3.40 ; STRUCTURE OF A BRCA2-DSS1 COMPLEX 1MIU ; 3.10 ; STRUCTURE OF A BRCA2-DSS1 COMPLEX 1MJE ; 3.50 ; STRUCTURE OF A BRCA2-DSS1-SSDNA COMPLEX 1PKG ; 2.90 ; STRUCTURE OF A C-KIT KINASE PRODUCT COMPLEX 1L2G ; 2.85 ; STRUCTURE OF A C-TERMINALLY TRUNCATED FORM OF GLYCOPROTEIN D FROM HSV-1 1EGG ; 2.30 ; STRUCTURE OF A C-TYPE CARBOHYDRATE-RECOGNITION DOMAIN (CRD- 4) FROM THE MACROPHAGE MANNOSE RECEPTOR 1EGI ; 2.30 ; STRUCTURE OF A C-TYPE CARBOHYDRATE-RECOGNITION DOMAIN (CRD- 4) FROM THE MACROPHAGE MANNOSE RECEPTOR 1R1D ; 2.00 ; STRUCTURE OF A CARBOXYLESTERASE FROM BACILLUS STEAROTHERMOPHILUS 1YEC ; 1.90 ; STRUCTURE OF A CATALYTIC ANTIBODY IGG2A FAB FRAGMENT (D2.3) 1YED ; 3.10 ; STRUCTURE OF A CATALYTIC ANTIBODY IGG2A FAB FRAGMENT (D2.4) 1YEE ; 2.20 ; STRUCTURE OF A CATALYTIC ANTIBODY, IGG2A FAB FRAGMENT (D2.5) 1RTD ; 3.20 ; STRUCTURE OF A CATALYTIC COMPLEX OF HIV-1 REVERSE TRANSCRIPTASE: IMPLICATIONS FOR NUCLEOSIDE ANALOG DRUG RESISTANCE 1N31 ; 2.20 ; STRUCTURE OF A CATALYTICALLY INACTIVE MUTANT (K223A) OF C- DES WITH A SUBSTRATE (CYSTINE) LINKED TO THE CO-FACTOR 1FBV ; 2.90 ; STRUCTURE OF A CBL-UBCH7 COMPLEX: RING DOMAIN FUNCTION IN UBIQUITIN-PROTEIN LIGASES 2A5Y ; 2.60 ; STRUCTURE OF A CED-4/CED-9 COMPLEX 1RJ4 ; 2.00 ; STRUCTURE OF A CELL WALL INVERTASE INHIBITOR FROM TOBACCO IN COMPLEX WITH CD2+ 1U5M ; -1.00 ; STRUCTURE OF A CHORDIN-LIKE CYSTEINE-RICH REPEAT (VWC MODULE) FROM COLLAGEN IIA 1KH8 ; 2.00 ; STRUCTURE OF A CIS-PROLINE (P114) TO GLYCINE VARIANT OF RIBONUCLEASE A 1H12 ; 1.20 ; STRUCTURE OF A COLD-ADAPTED FAMILY 8 XYLANASE 1H13 ; 1.30 ; STRUCTURE OF A COLD-ADAPTED FAMILY 8 XYLANASE 1H14 ; 1.50 ; STRUCTURE OF A COLD-ADAPTED FAMILY 8 XYLANASE 1XW2 ; 1.76 ; STRUCTURE OF A COLD-ADAPTED FAMILY 8 XYLANASE 1XWQ ; 1.88 ; STRUCTURE OF A COLD-ADAPTED FAMILY 8 XYLANASE 1XWT ; 1.30 ; STRUCTURE OF A COLD-ADAPTED FAMILY 8 XYLANASE 2A8Z ; 3.20 ; STRUCTURE OF A COLD-ADAPTED FAMILY 8 XYLANASE 1EEL ; 2.40 ; STRUCTURE OF A COMPLEX BETWEEN THE DEOXYRIBONUCLEIC ACID SEQUENCE DCGCGAATTCGCG AND BIS[PIPERIDINO-ETHYL]-FURAMIDINE 1EFX ; 3.00 ; STRUCTURE OF A COMPLEX BETWEEN THE HUMAN NATURAL KILLER CELL RECEPTOR KIR2DL2 AND A CLASS I MHC LIGAND HLA-CW3 1P7V ; 1.08 ; STRUCTURE OF A COMPLEX FORMED BETWEEN PROTEINASE K AND A DESIGNED HEPTAPEPTIDE INHIBITOR PRO-ALA-PRO-PHE-ALA-ALA- ALA AT ATOMIC RESOLUTION 1UPT ; 1.70 ; STRUCTURE OF A COMPLEX OF THE GOLGIN-245 GRIP DOMAIN WITH ARL1 1FXT ; -1.00 ; STRUCTURE OF A CONJUGATING ENZYME-UBIQUITIN THIOLESTER COMPLEX 2AU5 ; 2.10 ; STRUCTURE OF A CONSERVED DOMAIN FROM LOCUS EF2947 FROM ENTEROCOCCUS FAECALIS V583 1Q7H ; 2.10 ; STRUCTURE OF A CONSERVED HYPOTHETICAL PROTEIN FROM T. ACIDOPHILUM 1RLH ; 1.80 ; STRUCTURE OF A CONSERVED PROTEIN FROM THERMOPLASMA ACIDOPHILUM 1Y80 ; 1.70 ; STRUCTURE OF A CORRINOID (FACTOR IIIM)-BINDING PROTEIN FROM MOORELLA THERMOACETICA 1X0P ; 2.00 ; STRUCTURE OF A CYANOBACTERIAL BLUF PROTEIN, TLL0078 1QX9 ; -1.00 ; STRUCTURE OF A CYCLIC INDOLICIDIN PEPTIDE DERIVATIVE WITH HIGHER CHARGE 1G2D ; 2.20 ; STRUCTURE OF A CYS2HIS2 ZINC FINGER/TATA BOX COMPLEX (CLONE #2) 1G2F ; 2.00 ; STRUCTURE OF A CYS2HIS2 ZINC FINGER/TATA BOX COMPLEX (TATAZF;CLONE #6) 1S6V ; 1.88 ; STRUCTURE OF A CYTOCHROME C PEROXIDASE-CYTOCHROME C SITE SPECIFIC CROSS-LINK 328D ; 2.60 ; STRUCTURE OF A D(CGCGAATTCGCG)2-SN7167 COMPLEX 1QVF ; 3.10 ; STRUCTURE OF A DEACYLATED TRNA MINIHELIX BOUND TO THE E SITE OF THE LARGE RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI 307D ; 1.85 ; STRUCTURE OF A DEOXYRIBONUCLEIC ACID ANALOG OF THE PRIMER FOR HIV-1 SECOND STRAND SYNTHESIS 1HT7 ; -1.00 ; STRUCTURE OF A DEOXYRIBONUCLEIC ACID DUPLEX CONTAINING A BISTRAND ABASIC SITE LESION STAGGERED IN A 5'-ORIENTATION. 401D ; 2.20 ; STRUCTURE OF A DEOXYRIBONUCLEIC ACID IN LOW SALT CONDITIONS D(GACCGCGGTC) 1AGL ; 2.20 ; STRUCTURE OF A DEOXYRIBONUCLEIC ACID-BISDAUNOMYCIN COMPLEX 1JYE ; 1.70 ; STRUCTURE OF A DIMERIC LAC REPRESSOR WITH C-TERMINAL DELETION AND K84L SUBSTITUTION 1EG3 ; 2.00 ; STRUCTURE OF A DYSTROPHIN WW DOMAIN FRAGMENT IN COMPLEX WITH A BETA-DYSTROGLYCAN PEPTIDE 1EG4 ; 2.00 ; STRUCTURE OF A DYSTROPHIN WW DOMAIN FRAGMENT IN COMPLEX WITH A BETA-DYSTROGLYCAN PEPTIDE 1XSI ; 2.20 ; STRUCTURE OF A FAMILY 31 ALPHA GLYCOSIDASE 1XSJ ; 2.10 ; STRUCTURE OF A FAMILY 31 ALPHA GLYCOSIDASE 1XSK ; 2.20 ; STRUCTURE OF A FAMILY 31 ALPHA GLYCOSIDASE GLYCOSYL-ENZYME INTERMEDIATE 1GOJ ; 2.30 ; STRUCTURE OF A FAST KINESIN: IMPLICATIONS FOR ATPASE MECHANISM AND INTERACTIONS WITH MICROTUBULES 1G28 ; 2.73 ; STRUCTURE OF A FLAVIN-BINDING DOMAIN, LOV2, FROM THE CHIMERIC PHYTOCHROME/PHOTOTROPIN PHOTORECEPTOR PHY3 2ARK ; 2.40 ; STRUCTURE OF A FLAVODOXIN FROM AQUIFEX AEOLICUS 1DCW ; 2.10 ; STRUCTURE OF A FOUR-WAY JUNCTION IN AN INVERTED REPEAT SEQUENCE. 1JS8 ; 2.30 ; STRUCTURE OF A FUNCTIONAL UNIT FROM OCTOPUS HEMOCYANIN 1G8X ; 2.80 ; STRUCTURE OF A GENETICALLY ENGINEERED MOLECULAR MOTOR 1BH0 ; 3.00 ; STRUCTURE OF A GLUCAGON ANALOG 1GR2 ; 1.90 ; STRUCTURE OF A GLUTAMATE RECEPTOR LIGAND BINDING CORE (GLUR2) COMPLEXED WITH KAINATE 2BE3 ; 2.40 ; STRUCTURE OF A GTP PYROPHOSPHOKINASE FAMILY PROTEIN FROM STREPTOCOCCUS PNEUMONIAE 2AZ1 ; 2.35 ; STRUCTURE OF A HALOPHILIC NUCLEOSIDE DIPHOSPHATE KINASE FROM HALOBACTERIUM SALINARUM 2AZ3 ; 2.20 ; STRUCTURE OF A HALOPHILIC NUCLEOSIDE DIPHOSPHATE KINASE FROM HALOBACTERIUM SALINARUM IN COMPLEX WITH CDP 2HAP ; 2.50 ; STRUCTURE OF A HAP1-18/DEOXYRIBONUCLEIC ACID COMPLEX REVEALS THAT PROTEIN/DEOXYRIBONUCLEIC ACID INTERACTIONS CAN HAVE DIRECT ALLOSTERIC EFFECTS ON TRANSCRIPTIONAL ACTIVATION 1HWT ; 2.50 ; STRUCTURE OF A HAP1/DEOXYRIBONUCLEIC ACID COMPLEX REVEALS DRAMATICALLY ASYMMETRIC DEOXYRIBONUCLEIC ACID BINDING BY A HOMODIMERIC PROTEIN 1RI9 ; -1.00 ; STRUCTURE OF A HELICALLY EXTENDED SH3 DOMAIN OF THE T CELL ADAPTER PROTEIN ADAP 1Y12 ; 1.95 ; STRUCTURE OF A HEMOLYSIN-CORREGULATED PROTEIN FROM PSEUDOMONAS AERUGINOSA 1QA9 ; 3.20 ; STRUCTURE OF A HETEROPHILIC ADHESION COMPLEX BETWEEN THE HUMAN CD2 AND CD58(LFA-3) COUNTER-RECEPTORS 1U7K ; 1.85 ; STRUCTURE OF A HEXAMERIC N-TERMINAL DOMAIN FROM MURINE LEUKEMIA VIRUS CAPSID 1LM8 ; 1.85 ; STRUCTURE OF A HIF-1A-PVHL-ELONGINB-ELONGINC COMPLEX 1XC9 ; 1.90 ; STRUCTURE OF A HIGH-FIDELITY POLYMERASE BOUND TO A BENZO[A]PYRENE ADDUCT THAT BLOCKS REPLICATION 1Z5L ; 2.20 ; STRUCTURE OF A HIGHLY POTENT SHORT-CHAIN GALACTOSYL CERAMIDE AGONIST BOUND TO CD1D 2BRC ; 1.60 ; STRUCTURE OF A HSP90 INHIBITOR BOUND TO THE N-TERMINUS OF YEAST HSP90. 2BRE ; 2.00 ; STRUCTURE OF A HSP90 INHIBITOR BOUND TO THE N-TERMINUS OF YEAST HSP90. 1XFD ; 3.00 ; STRUCTURE OF A HUMAN A-TYPE POTASSIUM CHANNEL ACCELERATING FACTOR DPPX, A MEMBER OF THE DIPEPTIDYL AMINOPEPTIDASE FAMILY 1LGV ; 1.95 ; STRUCTURE OF A HUMAN BENCE-JONES DIMER CRYSTALLIZED IN U.S. SPACE SHUTTLE MISSION STS-95: 100K 1LHZ ; 2.30 ; STRUCTURE OF A HUMAN BENCE-JONES DIMER CRYSTALLIZED IN U.S. SPACE SHUTTLE MISSION STS-95: 293K 1UMW ; 1.90 ; STRUCTURE OF A HUMAN PLK1 POLO-BOX DOMAIN/PHOSPHOPEPTIDE COMPLEX 1JL0 ; 1.50 ; STRUCTURE OF A HUMAN S-ADENOSYLMETHIONINE DECARBOXYLASE SELF-PROCESSING ESTER INTERMEDIATE AND MECHANISM OF PUTRESCINE STIMULATION OF PROCESSING AS REVEALED BY THE H243A MUTANT 1P9Q ; 2.00 ; STRUCTURE OF A HYPOTHETICAL PROTEIN AF0491 FROM ARCHAEOGLOBUS FULGIDUS 1HA7 ; 2.20 ; STRUCTURE OF A LIGHT-HARVESTING PHYCOBILIPROTEIN, C-PHYCOCYANIN FROM SPIRULINA PLATENSIS AT 2.2A RESOLUTION 1W66 ; 1.08 ; STRUCTURE OF A LIPOATE-PROTEIN LIGASE B FROM MYCOBACTERIUM TUBERCULOSIS 1U0Q ; 1.60 ; STRUCTURE OF A LLAMA VHH DOMAIN RAISED AGAINST A CARBAZOLE MOLECULE 1WOB ; 2.80 ; STRUCTURE OF A LOOP6 HINGE MUTANT OF PLASMODIUM FALCIPARUM TRIOSEPHOSPHATE ISOMERASE, W168F, COMPLEXED TO SULFATE 1XXQ ; 1.80 ; STRUCTURE OF A MANNOSE-SPECIFIC JACALIN-RELATED LECTIN FROM MORUS NIGRA 1XXR ; 2.00 ; STRUCTURE OF A MANNOSE-SPECIFIC JACALIN-RELATED LECTIN FROM MORUS NIGRA IN COMPLEX WITH MANNOSE 2C5D ; 3.30 ; STRUCTURE OF A MINIMAL GAS6-AXL COMPLEX 1UUX ; 1.60 ; STRUCTURE OF A MOLYBDOPTERIN-BOUND CNX1G DOMAIN LINKS MOLYBDENUM AND COPPER METABOLISM 1UUY ; 1.45 ; STRUCTURE OF A MOLYBDOPTERIN-BOUND CNX1G DOMAIN LINKS MOLYBDENUM AND COPPER METABOLISM 1AQ3 ; 2.80 ; STRUCTURE OF A MS2 COAT PROTEIN MUTANT IN COMPLEX WITH AN RIBONUCLEIC ACID OPERATOR 1AQ4 ; 3.00 ; STRUCTURE OF A MS2 COAT PROTEIN MUTANT IN COMPLEX WITH AN RIBONUCLEIC ACID OPERATOR 1FN0 ; 2.00 ; STRUCTURE OF A MUTANT WINGED BEAN CHYMOTRYPSIN INHIBITOR PROTEIN, N14D. 2ASB ; 1.50 ; STRUCTURE OF A MYCOBACTERIUM TUBERCULOSIS NUSA-RIBONUCLEIC ACID COMPLEX 2ATW ; 2.25 ; STRUCTURE OF A MYCOBACTERIUM TUBERCULOSIS NUSA-RIBONUCLEIC ACID COMPLEX 1QFA ; -1.00 ; STRUCTURE OF A NEUROPEPTIDE Y Y2 AGONIST 1F9J ; 2.70 ; STRUCTURE OF A NEW CRYSTAL FORM OF TETRAUBIQUITIN 1M7V ; 1.95 ; STRUCTURE OF A NITRIC OXIDE SYNTHASE HEME PROTEIN FROM BACILLUS SUBTILIS WITH TETRAHYDROFOLATE AND ARGININE BOUND 1P59 ; 2.50 ; STRUCTURE OF A NON-COVALENT ENDONUCLEASE III-DEOXYRIBONUCLEIC ACID COMPLEX 1AID ; 2.20 ; STRUCTURE OF A NON-PEPTIDE INHIBITOR COMPLEXED WITH HIV-1 PROTEASE: DEVELOPING A CYCLE OF STRUCTURE-BASED DRUG DESIGN 2AID ; 1.90 ; STRUCTURE OF A NON-PEPTIDE INHIBITOR COMPLEXED WITH HIV-1 PROTEASE: DEVELOPING A CYCLE OF STRUCTURE-BASED DRUG DESIGN 1IXT ; -1.00 ; STRUCTURE OF A NOVEL P-SUPERFAMILY SPASMODIC CONOTOXIN REVEALS AN INHIBITORY CYSTINE KNOT MOTIF 1YRX ; 2.30 ; STRUCTURE OF A NOVEL PHOTORECEPTOR: THE BLUF DOMAIN OF APPA FROM RHODOBACTER SPHAEROIDES 2F40 ; -1.00 ; STRUCTURE OF A NOVEL PROTEIN FROM BACKBONE-CENTERED NMR DATA AND NMR-ASSISTED STRUCTURE PREDICTION 1K26 ; 1.85 ; STRUCTURE OF A NUDIX PROTEIN FROM PYROBACULUM AEROPHILUM SOLVED BY THE SINGLE WAVELENGTH ANOMOLOUS SCATTERING METHOD 1G3N ; 2.90 ; STRUCTURE OF A P18(INK4C)-CDK6-K-CYCLIN TERNARY COMPLEX 1JFH ; 2.03 ; STRUCTURE OF A PANCREATIC ALPHA-AMYLASE BOUND TO A SUBSTRATE ANALOGUE AT 2.03 ANGSTROM RESOLUTION 1HRL ; -1.00 ; STRUCTURE OF A PARALYTIC PEPTIDE FROM AN INSECT, MANDUCA SEXTA 1R76 ; 2.65 ; STRUCTURE OF A PECTATE LYASE FROM AZOSPIRILLUM IRAKENSE 1X3W ; 3.00 ; STRUCTURE OF A PEPTIDE:N-GLYCANASE-RAD23 COMPLEX 1X3Z ; 2.80 ; STRUCTURE OF A PEPTIDE:N-GLYCANASE-RAD23 COMPLEX 1HPW ; -1.00 ; STRUCTURE OF A PILIN MONOMER FROM PSEUDOMONAS AERUGINOSA: IMPLICATIONS FOR THE ASSEMBLY OF PILI. 1XQA ; 1.80 ; STRUCTURE OF A POSSIBLE GLYOXALASE FROM BACILLUS CEREUS 1PSQ ; 2.30 ; STRUCTURE OF A PROBABLE THIOL PEROXIDASE FROM STREPTOCOCCUS PNEUMONIAE 1MVA ; 3.00 ; STRUCTURE OF A PROTEIN CAPSID OF THE T45A MUTANT OF PHAGE MS2 1MVB ; 3.00 ; STRUCTURE OF A PROTEIN CAPSID OF THE T59S MUTANT OF PHAGE MS2 2BEZ ; 1.60 ; STRUCTURE OF A PROTEOLITICALLY RESISTANT CORE FROM THE SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS S2 FUSION PROTEIN 2BEQ ; 1.60 ; STRUCTURE OF A PROTEOLYTICALLY RESISTANT CORE FROM THE SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS S2 FUSION PROTEIN 1XC3 ; 2.10 ; STRUCTURE OF A PUTATIVE FRUCTOKINASE FROM BACILLUS SUBTILIS 1RI6 ; 2.00 ; STRUCTURE OF A PUTATIVE ISOMERASE FROM E. COLI 1YB2 ; 2.01 ; STRUCTURE OF A PUTATIVE METHYLTRANSFERASE FROM THERMOPLASMA ACIDOPHILUM. 1Z72 ; 1.45 ; STRUCTURE OF A PUTATIVE TRANSCRIPTIONAL REGULATOR FROM STREPTOCOCCUS PNEUMONIAE 1KZH ; 2.55 ; STRUCTURE OF A PYROPHOSPHATE-DEPENDENT PHOSPHOFRUCTOKINASE FROM THE LYME DISEASE SPIROCHETE BORRELIA BURGDORFERI 1JJU ; 2.05 ; STRUCTURE OF A QUINOHEMOPROTEIN AMINE DEHYDROGENASE WITH A UNIQUE REDOX COFACTOR AND HIGHLY UNUSUAL CROSSLINKING 1YF6 ; 2.25 ; STRUCTURE OF A QUINTUPLE MUTANT OF PHOTOSYNTHETIC REACTION CENTER FROM RHODOBACTER SPHAEROIDES 1S4R ; 1.90 ; STRUCTURE OF A REACTION INTERMEDIATE IN THE PHOTOCYCLE OF PYP EXTRACTED BY A SVD-DRIVEN ANALYSIS 1EYL ; 1.90 ; STRUCTURE OF A RECOMBINANT WINGED BEAN CHYMOTRYPSIN INHIBITOR 1DW3 ; 2.10 ; STRUCTURE OF A REDUCED OXYGEN BINDING CYTOCHROME C 1NPQ ; -1.00 ; STRUCTURE OF A RHODAMINE-LABELED N-DOMAIN TROPONIN C MUTANT (CA2+ SATURATED) IN COMPLEX WITH SKELETAL TROPONIN I 115- 131 1FIX ; 2.30 ; STRUCTURE OF A RIBONUCLEIC ACID/DEOXYRIBONUCLEIC ACID HYBRID: A SUBSTRATE OF THE RIBONUCLEASE ACTIVITY OF HIV-1 REVERSE TRANSCRIPTASE 1IC6 ; 0.98 ; STRUCTURE OF A SERINE PROTEASE PROTEINASE K FROM TRITIRACHIUM ALBUM LIMBER AT 0.98 A RESOLUTION 1EYR ; 2.20 ; STRUCTURE OF A SIALIC ACID ACTIVATING SYNTHETASE, CMP ACYLNEURAMINATE SYNTHETASE IN THE PRESENCE AND ABSENCE OF CDP 1EZI ; 2.00 ; STRUCTURE OF A SIALIC ACID ACTIVATING SYNTHETASE, CMP ACYLNEURAMINATE SYNTHETASE IN THE PRESENCE AND ABSENCE OF CDP 1MA3 ; 2.00 ; STRUCTURE OF A SIR2 ENZYME BOUND TO AN ACETYLATED P53 PEPTIDE 1NFH ; 2.65 ; STRUCTURE OF A SIR2 SUBSTRATE, ALBA, REVEALS A MECHANISM FOR DEACTYLATION-INDUCED ENHANCEMENT OF DEOXYRIBONUCLEIC ACID-BINDING 1NFJ ; 2.00 ; STRUCTURE OF A SIR2 SUBSTRATE, ALBA, REVEALS A MECHANISM FOR DEACTYLATION-INDUCED ENHANCEMENT OF DEOXYRIBONUCLEIC ACID-BINDING 1CQ3 ; 1.85 ; STRUCTURE OF A SOLUBLE SECRETED CHEMOKINE INHIBITOR, VCCI, FROM COWPOX VIRUS 1I6X ; 2.20 ; STRUCTURE OF A STAR MUTANT CRP-CAMP AT 2.2 A 1ZR2 ; 3.90 ; STRUCTURE OF A SYNAPTIC GAMMA-DELTA RESOLVASE TETRAMER COVALENTLY LINKED TO TWO CLEAVED DNAS 1ZR4 ; 3.40 ; STRUCTURE OF A SYNAPTIC GAMMA-DELTA RESOLVASE TETRAMER COVALENTLY LINKED TO TWO CLEAVED DNAS 1H38 ; 2.90 ; STRUCTURE OF A T7 RIBONUCLEIC ACID POLYMERASE ELONGATION COMPLEX AT 2.9A RESOLUTION 1PJ8 ; 2.20 ; STRUCTURE OF A TERNARY COMPLEX OF PROTEINASE K, MERCURY AND A SUBSTRATE-ANALOGUE HEXAPEPTIDE AT 2.2 A RESOLUTION 1SNG ; 1.76 ; STRUCTURE OF A THERMOPHILIC SERPIN IN THE NATIVE STATE 1T4M ; 2.00 ; STRUCTURE OF A THERMOSTABLE DOUBLE MUTANT OF BACILLUS SUBTILIS LIPASE OBTAINED THROUGH DIRECTED EVOLUTION 1KEA ; 2.00 ; STRUCTURE OF A THERMOSTABLE THYMINE-DEOXYRIBONUCLEIC ACID GLYCOSYLASE 1T2N ; 1.80 ; STRUCTURE OF A THERMOSTABLE TRIPLE MUTANT OF BACILLUS SUBTILIS LIPASE OBTAINED THROUGH DIRECTED EVOLUTION 1Q98 ; 1.90 ; STRUCTURE OF A THIOL PEROXIDASE FROM HAEMOPHILUS INFLUENZAE RD 1F37 ; 2.30 ; STRUCTURE OF A THIOREDOXIN-LIKE [2FE-2S] FERREDOXIN FROM AQUIFEX AEOLICUS 1UX6 ; 1.90 ; STRUCTURE OF A THROMBOSPONDIN C-TERMINAL FRAGMENT REVEALS A NOVEL CALCIUM CORE IN THE TYPE 3 REPEATS 1QLN ; 2.40 ; STRUCTURE OF A TRANSCRIBING T7 RIBONUCLEIC ACID POLYMERASE INITIATION COMPLEX 1XMA ; 2.30 ; STRUCTURE OF A TRANSCRIPTIONAL REGULATOR FROM CLOSTRIDIUM THERMOCELLUM CTH-833 1DC7 ; -1.00 ; STRUCTURE OF A TRANSIENTLY PHOSPHORYLATED "SWITCH" IN BACTERIAL SIGNAL TRANSDUCTION 1DC8 ; -1.00 ; STRUCTURE OF A TRANSIENTLY PHOSPHORYLATED "SWITCH" IN BACTERIAL SIGNAL TRANSDUCTION 1ORP ; 2.20 ; STRUCTURE OF A TRAPPED ENDONUCLEASE III-DEOXYRIBONUCLEIC ACID COVALENT INTERMEDIATE: ESTRANGED-ADENINE COMPLEX 1ORN ; 1.70 ; STRUCTURE OF A TRAPPED ENDONUCLEASE III-DEOXYRIBONUCLEIC ACID COVALENT INTERMEDIATE: ESTRANGED-GUANINE COMPLEX 1TLG ; 2.20 ; STRUCTURE OF A TUNICATE C-TYPE LECTIN COMPLEXED WITH D-GALACTOSE 1W4R ; 1.83 ; STRUCTURE OF A TYPE II THYMIDINE KINASE WITH BOUND DTTP 1QRQ ; 2.80 ; STRUCTURE OF A VOLTAGE-DEPENDENT K+ CHANNEL BETA SUBUNIT 1RIE ; 1.50 ; STRUCTURE OF A WATER SOLUBLE FRAGMENT OF THE RIESKE IRON- SULFUR PROTEIN OF THE BOVINE HEART MITOCHONDRIAL CYTOCHROME BC1-COMPLEX 1RM1 ; 2.50 ; STRUCTURE OF A YEAST TFIIA/TBP/TATA-BOX DEOXYRIBONUCLEIC ACID COMPLEX 1BMC ; 2.50 ; STRUCTURE OF A ZINC METALLO-BETA-LACTAMASE FROM BACILLUS CEREUS 2BNM ; 1.70 ; STRUCTURE OF A ZN ENZYME 2BNN ; 2.50 ; STRUCTURE OF A ZN ENZYME 2BNO ; 1.90 ; STRUCTURE OF A ZN ENZYME 1QSF ; 2.80 ; STRUCTURE OF A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED HTLV-1 TAX PEPTIDE Y8A 1OED ; 4.00 ; STRUCTURE OF ACETYLCHOLINE RECEPTOR PORE FROM ELECTRON IMAGES 1GPK ; 2.10 ; STRUCTURE OF ACETYLCHOLINESTERASE COMPLEX WITH (+)-HUPERZINE A AT 2.1A RESOLUTION 1DX6 ; 2.30 ; STRUCTURE OF ACETYLCHOLINESTERASE COMPLEXED WITH (-)-GALANTHAMINE AT 2.3A RESOLUTION 1E66 ; 2.10 ; STRUCTURE OF ACETYLCHOLINESTERASE COMPLEXED WITH (-)-HUPRINE X AT 2.1A RESOLUTION 1H22 ; 2.15 ; STRUCTURE OF ACETYLCHOLINESTERASE COMPLEXED WITH (S,S)-(-)-BIS(10)-HUPYRIDONE AT 2.15A RESOLUTION 1H23 ; 2.15 ; STRUCTURE OF ACETYLCHOLINESTERASE COMPLEXED WITH (S,S)-(-)-BIS(12)-HUPYRIDONE AT 2.15A RESOLUTION 1GPN ; 2.35 ; STRUCTURE OF ACETYLCHOLINESTERASE COMPLEXED WITH HUPERZINE B AT 2.35A RESOLUTION 1ODC ; 2.20 ; STRUCTURE OF ACETYLCHOLINESTERASE COMPLEXED WITH N-4'-QUINOLYL-N'-9"-(1",2",3",4" -TETRAHYDROACRIDINYL)-1,8-DIAMINOOCTANE AT 2.2A RESOLUTION 1UT6 ; 2.40 ; STRUCTURE OF ACETYLCHOLINESTERASE COMPLEXED WITH N-9-(1',2',3',4'-TETRAHYDROACRIDINYL)-1,8- DIAMINOOCTANE AT 2.4 ANGSTROMS RESOLUTION. 1W4Z ; 2.50 ; STRUCTURE OF ACTINORHODIN POLYKETIDE (ACTIII) REDUCTASE 1O6K ; 1.70 ; STRUCTURE OF ACTIVATED FORM OF PKB KINASE DOMAIN S474D WITH GSK3 PEPTIDE AND AMP-PNP 1DSS ; 1.88 ; STRUCTURE OF ACTIVE-SITE CARBOXYMETHYLATED D-GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE FROM PALINURUS VERSICOLOR 1AQI ; 2.60 ; STRUCTURE OF ADENINE-N6-DEOXYRIBONUCLEIC ACID-METHYLTRANSFERASE TAQI 1AQJ ; 2.60 ; STRUCTURE OF ADENINE-N6-DEOXYRIBONUCLEIC ACID-METHYLTRANSFERASE TAQI 2BWJ ; 2.30 ; STRUCTURE OF ADENYLATE KINASE 5 1ADI ; 2.50 ; STRUCTURE OF ADENYLOSUCCINATE SYNTHETASE AT PH6.5 AND 25 DEGREES CELSIUS 1CH8 ; 2.50 ; STRUCTURE OF ADENYLOSUCCINATE SYNTHETASE FROM E. COLI COMPLEXED WITH A STRINGENT EFFECTOR, PPG2':3'P 1CIB ; 2.30 ; STRUCTURE OF ADENYLOSUCCINATE SYNTHETASE FROM E. COLI COMPLEXED WITH GDP, IMP, HADACIDIN, AND NO3 1CG0 ; 2.50 ; STRUCTURE OF ADENYLOSUCCINATE SYNTHETASE FROM E. COLI COMPLEXED WITH HADACIDIN, GDP, 6-PHOSPHORYL-IMP, AND MG2+ 1ADE ; 2.00 ; STRUCTURE OF ADENYLOSUCCINATE SYNTHETASE PH7 AT 25 DEGREES CELSIUS 1JNR ; 1.60 ; STRUCTURE OF ADENYLYLSULFATE REDUCTASE FROM THE HYPERTHERMOPHILIC ARCHAEOGLOBUS FULGIDUS AT 1.6 RESOLUTION 1JNZ ; 2.50 ; STRUCTURE OF ADENYLYLSULFATE REDUCTASE FROM THE HYPERTHERMOPHILIC ARCHAEOGLOBUS FULGIDUS AT 1.6 RESOLUTION 1ZM2 ; 3.07 ; STRUCTURE OF ADP-RIBOSYLATED EEF2 IN COMPLEX WITH CATALYTIC FRAGMENT OF ETA 1E1N ; 2.40 ; STRUCTURE OF ADRENODOXIN REDUCTASE AT 2.4 ANGSTROM IN CRYSTAL FORM A'' 1E1L ; 2.30 ; STRUCTURE OF ADRENODOXIN REDUCTASE IN COMPLEX WITH NADP OBTAINED BY COCRYSTALLISATION 1CJC ; 1.70 ; STRUCTURE OF ADRENODOXIN REDUCTASE OF MITOCHONDRIAL P450 SYSTEMS 1XZ9 ; -1.00 ; STRUCTURE OF AF-6 PDZ DOMAIN 1K4A ; -1.00 ; STRUCTURE OF AGAA RIBONUCLEIC ACID TETRALOOP, NMR, 20 STRUCTURES 1K4B ; -1.00 ; STRUCTURE OF AGUU RIBONUCLEIC ACID TETRALOOP, NMR, 20 STRUCTURES 1KNC ; 2.00 ; STRUCTURE OF AHPD FROM MYCOBACTERIUM TUBERCULOSIS, A NOVEL ENZYME WITH THIOREDOXIN-LIKE ACTIVITY. 1L6T ; -1.00 ; STRUCTURE OF ALA24/ASP61 TO ASP24/ASN61 SUBSTITUTED SUBUNIT C OF ESCHERICHIA COLI ATP SYNTHASE 1H0X ; 2.60 ; STRUCTURE OF ALBA: AN ARCHAEAL CHROMATIN PROTEIN MODULATED BY ACETYLATION 1H0Y ; 2.80 ; STRUCTURE OF ALBA: AN ARCHAEAL CHROMATIN PROTEIN MODULATED BY ACETYLATION 2AFN ; 2.00 ; STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE AND A COPPER SITE MUTANT, M150E, THAT CONTAINS ZINC 1AS7 ; 2.00 ; STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE 1NTD ; 2.00 ; STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE MUTANT M150E THAT CONTAINS ZINC 1AQ8 ; 2.00 ; STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE REDUCED WITH ASCORBATE 2AO0 ; 1.85 ; STRUCTURE OF ALDEHYDE REDUCTASE HOLOENZYME IN COMPLEX WITH THE POTENT ALDOSE REDUCTASE INHIBITOR FIDARESTAT: IMPLICATIONS FOR INHIBITOR BINDING AND SELECTIVITY 1Y3Q ; 1.90 ; STRUCTURE OF ALGQ1, ALGINATE-BINDING PROTEIN 1Y3N ; 1.60 ; STRUCTURE OF ALGQ1, ALGINATE-BINDING PROTEIN, COMPLEXED WITH AN ALGINATE DISACCHARIDE 1Y3P ; 2.00 ; STRUCTURE OF ALGQ1, ALGINATE-BINDING PROTEIN, COMPLEXED WITH AN ALGINATE TETRASACCHARIDE 1ZEF ; 1.90 ; STRUCTURE OF ALKALINE PHOSPHATASE FROM HUMAN PLACENTA IN COMPLEX WITH ITS UNCOMPETITIVE INHIBITOR L-PHE 1BSL ; 1.95 ; STRUCTURE OF ALKANAL MONOOXYGENASE BETA CHAIN 1SG3 ; 2.60 ; STRUCTURE OF ALLANTOICASE 2PLH ; 2.50 ; STRUCTURE OF ALPHA-1-PUROTHIONIN AT ROOM TEMPERATURE AND 2.8 ANGSTROMS RESOLUTION 1VJS ; 1.70 ; STRUCTURE OF ALPHA-AMYLASE PRECURSOR 2BYD ; 2.00 ; STRUCTURE OF AMINOADIPATE-SEMIALDEHYDE DEHYDROGENASE- PHOSPHOPANTETHEINYL TRANSFERASE 2C43 ; 1.93 ; STRUCTURE OF AMINOADIPATE-SEMIALDEHYDE DEHYDROGENASE- PHOSPHOPANTETHEINYL TRANSFERASE IN COMPLEX WITH COENZYME A 1UA1 ; 2.00 ; STRUCTURE OF AMINOFLUORENE ADDUCT PAIRED OPPOSITE CYTOSINE AT THE POLYMERASE ACTIVE SITE. 1XJO ; 1.75 ; STRUCTURE OF AMINOPEPTIDASE 1WL9 ; 1.90 ; STRUCTURE OF AMINOPEPTIDASE P FROM E. COLI 1FP9 ; 3.10 ; STRUCTURE OF AMYLOMALTASE FROM THERMUS THERMOPHILUS HB8 IN SPACE GROUP C2 1EXL ; -1.00 ; STRUCTURE OF AN 11-MER DEOXYRIBONUCLEIC ACID DUPLEX CONTAINING THE CARBOCYCLIC NUCLEOTIDE ANALOG: 2'-DEOXYARISTEROMYCIN 1OU8 ; 1.60 ; STRUCTURE OF AN AAA+ PROTEASE DELIVERY PROTEIN IN COMPLEX WITH A PEPTIDE DEGRADATION TAG 1M8T ; 2.10 ; STRUCTURE OF AN ACIDIC PHOSPHOLIPASE A2 FROM THE VENOM OF OPHIOPHAGUS HANNAH AT 2.1 RESOLUTION FROM A HEMIHEDRALLY TWINNED CRYSTAL FORM 1UUR ; 2.70 ; STRUCTURE OF AN ACTIVATED DICTYOSTELIUM STAT IN ITS DEOXYRIBONUCLEIC ACID-UNBOUND FORM 1UUS ; 2.80 ; STRUCTURE OF AN ACTIVATED DICTYOSTELIUM STAT IN ITS DEOXYRIBONUCLEIC ACID-UNBOUND FORM 32C2 ; 3.00 ; STRUCTURE OF AN ACTIVITY SUPPRESSING FAB FRAGMENT TO CYTOCHROME P450 AROMATASE 1GAB ; -1.00 ; STRUCTURE OF AN ALBUMIN-BINDING DOMAIN, NMR, 20 STRUCTURES 1PRB ; -1.00 ; STRUCTURE OF AN ALBUMIN-BINDING DOMAIN, NMR, MINIMIZED AVERAGE STRUCTURE 1GO3 ; 1.75 ; STRUCTURE OF AN ARCHEAL HOMOLOG OF THE EUKARYOTIC RIBONUCLEIC ACID POLYMERASE II RPB4/RPB7 COMPLEX 1U6Z ; 1.90 ; STRUCTURE OF AN E. COLI EXOPOLYPHOSPHATASE: INSIGHT INTO THE PROCESSIVE HYDROLYSIS OF POLYPHOSPHATE AND ITS REGULATION 1D5F ; 2.80 ; STRUCTURE OF AN E6AP-UBCH7 COMPLEX: INSIGHTS INTO THE UBIQUITINATION PATHWAY 1QW7 ; 1.90 ; STRUCTURE OF AN ENGINEERED ORGANOPHOSPHOROUS HYDROLASE WITH INCREASED ACTIVITY TOWARD HYDROLYSIS OF PHOSPHOTHIOLATE BONDS 1T0Z ; 2.60 ; STRUCTURE OF AN EXCITATORY INSECT-SPECIFIC TOXIN WITH AN ANALGESIC EFFECT ON MAMMALIAN FROM SCORPION BUTHUS MARTENSII KARSCH 2D2M ; 2.85 ; STRUCTURE OF AN EXTRACELLULAR GIANT HEMOGLOBIN OF THE GUTLESS BEARD WORM OLIGOBRACHIA MASHIKOI 2D2N ; 3.20 ; STRUCTURE OF AN EXTRACELLULAR GIANT HEMOGLOBIN OF THE GUTLESS BEARD WORM OLIGOBRACHIA MASHIKOI 1QXQ ; -1.00 ; STRUCTURE OF AN INDOLICIDIN PEPTIDE DERIVATIVE WITH HIGHER CHARGE 1HR1 ; -1.00 ; STRUCTURE OF AN INDOLICIDIN PEPTIDE DERIVATIVE WITH P-->A SUBSTITUTION 1XNQ ; 3.05 ; STRUCTURE OF AN INOSINE-ADENINE WOBBLE BASE PAIR COMPLEX IN THE CONTEXT OF THE DECODING CENTER 2BNG ; 2.50 ; STRUCTURE OF AN M.TUBERCULOSIS LEH-LIKE EPOXIDE HYDROLASE 1TW6 ; 1.71 ; STRUCTURE OF AN ML-IAP/XIAP CHIMERA BOUND TO A 9MER PEPTIDE DERIVED FROM SMAC 1P16 ; 2.70 ; STRUCTURE OF AN MRNA CAPPING ENZYME BOUND TO THE PHOSPHORYLATED CARBOXYL-TERMINAL DOMAIN OF RIBONUCLEIC ACID POLYMERASE II 472D ; 1.90 ; STRUCTURE OF AN OCTAMER RIBONUCLEIC ACID WITH TANDEM GG/UU MISPAIRS 438D ; 2.50 ; STRUCTURE OF AN RIBONUCLEIC ACID DUPLEX R(GGGCGCUCC)2 WITH NON-ADJACENT G.U BASE PAIRS 1UUU ; -1.00 ; STRUCTURE OF AN RIBONUCLEIC ACID HAIRPIN LOOP WITH A 5'-CGUUUCG-3' LOOP MOTIF BY HETERONUCLEAR NMR SPECTROSCOPY AND DISTANCE GEOMETRY, 15 STRUCTURES 402D ; 2.30 ; STRUCTURE OF AN RIBONUCLEIC ACID INTERNAL LOOP CONSISTING OF TANDEM C-A+ BASE PAIRS 2BF1 ; 4.00 ; STRUCTURE OF AN UNLIGANDED AND FULLY-GLYCOSYLATED SIV GP120 ENVELOPE GLYCOPROTEIN 1S26 ; 3.00 ; STRUCTURE OF ANTHRAX EDEMA FACTOR-CALMODULIN-ALPHA,BETA- METHYLENEADENOSINE 5'-TRIPHOSPHATE COMPLEX REVEALS AN ALTERNATIVE MODE OF ATP BINDING TO THE CATALYTIC SITE 1PP5 ; -1.00 ; STRUCTURE OF ANTIBACTERIAL PEPTIDE MICROCIN J25: A 21- RESIDUE LARIAT PROTOKNOT 1MSI ; 1.25 ; STRUCTURE OF ANTIFREEZE GLYCOPROTEIN QAE(HPLC 12) 1OT0 ; -1.00 ; STRUCTURE OF ANTIMICROBIAL PEPTIDE, HP (2-20) AND ITS ANALOGUES DERIVED FROM HELICOBACTER PYLORI, AS DETERMINED BY 1H NMR SPECTROSCOPY 1P0G ; -1.00 ; STRUCTURE OF ANTIMICROBIAL PEPTIDE, HP (2-20) AND ITS ANALOGUES DERIVED FROM HELICOBACTER PYLORI, AS DETERMINED BY 1H NMR SPECTROSCOPY 1WPH ; 2.10 ; STRUCTURE OF APC11001: HYPOTHETICAL MEMBER OF THE HD METAL- BINDING PHOSPHOHYDROLASE SUPERFAMILY 1LIO ; 2.50 ; STRUCTURE OF APO T. GONDII ADENOSINE KINASE 1SXI ; 3.00 ; STRUCTURE OF APO TRANSCRIPTION REGULATOR B. MEGATERIUM 1P4O ; 1.50 ; STRUCTURE OF APO UNACTIVATED IGF-1R KINASE DOMAIN AT 1.5A RESOLUTION. 1WFC ; 2.30 ; STRUCTURE OF APO, UNPHOSPHORYLATED, P38 MITOGEN ACTIVATED PROTEIN KINASE P38 (P38 MAP KINASE) THE MAMMALIAN HOMOLOGUE OF THE YEAST HOG1 PROTEIN 1BI0 ; 2.30 ; STRUCTURE OF APO- AND HOLO-DIPHTHERIA TOXIN REPRESSOR 1BI1 ; 2.20 ; STRUCTURE OF APO- AND HOLO-DIPHTHERIA TOXIN REPRESSOR 1BI2 ; 2.30 ; STRUCTURE OF APO- AND HOLO-DIPHTHERIA TOXIN REPRESSOR 1BI3 ; 2.40 ; STRUCTURE OF APO- AND HOLO-DIPHTHERIA TOXIN REPRESSOR 1AIZ ; 1.80 ; STRUCTURE OF APO-AZURIN FROM ALCALIGENES DENITRIFICANS AT 1.8 ANGSTROMS RESOLUTION 1BYI ; 0.97 ; STRUCTURE OF APO-DETHIOBIOTIN SYNTHASE AT 0.97 ANGSTROMS RESOLUTION 1FTG ; 2.00 ; STRUCTURE OF APOFLAVODOXIN: CLOSURE OF A TYROSINE/TRYPTOPHAN AROMATIC GATE LEADS TO A COMPACT FOLD 1OWL ; 1.80 ; STRUCTURE OF APOPHOTOLYASE FROM ANACYSTIS NIDULANS 1HQV ; 2.30 ; STRUCTURE OF APOPTOSIS-LINKED PROTEIN ALG-2 1TT5 ; 2.60 ; STRUCTURE OF APPBP1-UBA3-UBC12N26: A UNIQUE E1-E2 INTERACTION REQUIRED FOR OPTIMAL CONJUGATION OF THE UBIQUITIN-LIKE PROTEIN NEDD8 1FQY ; 3.80 ; STRUCTURE OF AQUAPORIN-1 AT 3.8 A RESOLUTION BY ELECTRON CRYSTALLOGRAPHY 1WNU ; 2.80 ; STRUCTURE OF ARCHAEAL TRANS-EDITING PROTEIN ALAX IN COMPLEX WITH L-SERINE 1WXO ; 1.88 ; STRUCTURE OF ARCHAEAL TRANS-EDITING PROTEIN ALAX IN COMPLEX WITH ZINC 1NEE ; -1.00 ; STRUCTURE OF ARCHAEAL TRANSLATION FACTOR AIF2BETA FROM METHANOBACTERIUM THERMOAUTROPHICUM 1YAR ; 1.90 ; STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX 1YAU ; 2.40 ; STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX 1RE0 ; 2.40 ; STRUCTURE OF ARF1-GDP BOUND TO SEC7 DOMAIN COMPLEXED WITH BREFELDIN A 1RXX ; 2.45 ; STRUCTURE OF ARGININE DEIMINASE 1SD0 ; 2.30 ; STRUCTURE OF ARGININE KINASE C271A MUTANT 1P52 ; 1.90 ; STRUCTURE OF ARGININE KINASE E314D MUTANT 1J4U ; 2.90 ; STRUCTURE OF ARTOCARPIN COMPLEXED WITH ME-ALPHA-MANNOSE 1J4S ; 2.50 ; STRUCTURE OF ARTOCARPIN: A LECTIN WITH MANNOSE SPECIFICITY (FORM 1) 1J4T ; 2.40 ; STRUCTURE OF ARTOCARPIN: A LECTIN WITH MANNOSE SPECIFICITY (FORM 2) 1IVR ; 2.40 ; STRUCTURE OF ASPARTATE AMINOTRANSFERASE 1YS4 ; 2.29 ; STRUCTURE OF ASPARTATE-SEMIALDEHYDE DEHYDROGENASE FROM METHANOCOCCUS JANNASCHII 1KS5 ; 2.10 ; STRUCTURE OF ASPERGILLUS NIGER ENDOGLUCANASE 1QO7 ; 1.80 ; STRUCTURE OF ASPERGILLUS NIGER EPOXIDE HYDROLASE 1QJJ ; 1.86 ; STRUCTURE OF ASTACIN WITH A HYDROXAMIC ACID INHIBITOR 1QJI ; 2.14 ; STRUCTURE OF ASTACIN WITH A TRANSITION-STATE ANALOGUE INHIBITOR 1SE9 ; -1.00 ; STRUCTURE OF AT3G01050, A UBIQUITIN-FOLD PROTEIN FROM ARABIDOPSIS THALIANA 1Q1K ; 2.90 ; STRUCTURE OF ATP-PHOSPHORIBOSYLTRANSFERASE FROM E. COLI COMPLEXED WITH PR-ATP 1OL5 ; 2.50 ; STRUCTURE OF AURORA-A 122-403, PHOSPHORYLATED ON THR287, THR288 AND BOUND TO TPX2 1-43 1NG2 ; 1.70 ; STRUCTURE OF AUTOINHIBITED P47PHOX 1JSO ; 2.40 ; STRUCTURE OF AVIAN H5 HAEMAGGLUTININ BOUND TO LSTC RECEPTOR ANALOG 1JSN ; 2.40 ; STRUCTURE OF AVIAN H5 HAEMAGGLUTININ COMPLEXED WITH LSTA RECEPTRO ANALOG 1NQN ; 1.80 ; STRUCTURE OF AVM-W110K (W110K MUTANT OF AVIDIN) 1YQY ; 2.30 ; STRUCTURE OF B. ANTHRAX LETHAL FACTOR IN COMPLEX WITH A HYDROXAMATE INHIBITOR 1T4A ; 2.00 ; STRUCTURE OF B. SUBTILIS PURS C2 CRYSTAL FORM 1PUJ ; 2.00 ; STRUCTURE OF B. SUBTILIS YLQF GTPASE 1ZEG ; 1.60 ; STRUCTURE OF B28 ASP INSULIN IN COMPLEX WITH PHENOL 4UBP ; 1.55 ; STRUCTURE OF BACILLUS PASTEURII UREASE INHIBITED WITH ACETOHYDROXAMIC ACID AT 1.55 A RESOLUTION 1WPM ; 2.05 ; STRUCTURE OF BACILLUS SUBTILIS INORGANIC PYROPHOSPHATASE 1X37 ; -1.00 ; STRUCTURE OF BACILLUS SUBTILIS LON PROTEASE SSD DOMAIN 1KAM ; 2.10 ; STRUCTURE OF BACILLUS SUBTILIS NICOTINIC ACID MONONUCLEOTIDE ADENYLYL TRANSFERASE 1KAQ ; 3.20 ; STRUCTURE OF BACILLUS SUBTILIS NICOTINIC ACID MONONUCLEOTIDE ADENYLYL TRANSFERASE 1W1A ; 2.25 ; STRUCTURE OF BACILLUS SUBTILIS PDAA IN COMPLEX WITH NAG, A FAMILY 4 CARBOHYDRATE ESTERASE. 1W1B ; 2.10 ; STRUCTURE OF BACILLUS SUBTILIS PDAA WITH CADMIUM, A FAMILY 4 CARBOHYDRATE ESTERASE. 1W17 ; 1.90 ; STRUCTURE OF BACILLUS SUBTILIS PDAA, A FAMILY 4 CARBOHYDRATE ESTERASE. 1ZDJ ; 2.90 ; STRUCTURE OF BACTERIOPHAGE COAT PROTEIN-LOOP RIBONUCLEIC ACID COMPLEX 1ZDK ; 2.86 ; STRUCTURE OF BACTERIOPHAGE COAT PROTEIN-LOOP RIBONUCLEIC ACID COMPLEX 1ZDH ; 2.70 ; STRUCTURE OF BACTERIOPHAGE COAT PROTEIN-OPERATOR COMPLEX 1RIO ; 2.30 ; STRUCTURE OF BACTERIOPHAGE LAMBDA CI-NTD IN COMPLEX WITH SIGMA-REGION4 OF THERMUS AQUATICUS BOUND TO DEOXYRIBONUCLEIC ACID 1ZPQ ; 2.80 ; STRUCTURE OF BACTERIOPHAGE LAMBDA CII PROTEIN 1ZS4 ; 1.70 ; STRUCTURE OF BACTERIOPHAGE LAMBDA CII PROTEIN IN COMPLEX WITH DEOXYRIBONUCLEIC ACID 1DWN ; 3.50 ; STRUCTURE OF BACTERIOPHAGE PP7 FROM PSEUDOMONAS AERUGINOSA AT 3.7 A RESOLUTION 1EL6 ; 2.00 ; STRUCTURE OF BACTERIOPHAGE T4 GENE PRODUCT 11, THE INTERFACE BETWEEN THE BASEPLATE AND SHORT TAIL FIBERS 1QM8 ; 2.50 ; STRUCTURE OF BACTERIORHODOPSIN AT 100 K 2AT9 ; 3.00 ; STRUCTURE OF BACTERIORHODOPSIN AT 3.0 ANGSTROM BY ELECTRON CRYSTALLOGRAPHY 1AT9 ; 3.00 ; STRUCTURE OF BACTERIORHODOPSIN AT 3.0 ANGSTROM DETERMINED BY ELECTRON CRYSTALLOGRAPHY 1TN0 ; 2.50 ; STRUCTURE OF BACTERORHODOPSIN MUTANT A51P 1TN5 ; 2.20 ; STRUCTURE OF BACTERORHODOPSIN MUTANT K41P 1TUH ; 1.85 ; STRUCTURE OF BAL32A FROM A SOIL-DERIVED MOBILE GENE CASSETTE 1X1V ; 2.45 ; STRUCTURE OF BANANA LECTIN- METHYL-ALPHA-MANNOSE COMPLEX 1W9Z ; 2.60 ; STRUCTURE OF BANNAVIRUS VP9 1BXL ; -1.00 ; STRUCTURE OF BCL-XL/BAK PEPTIDE COMPLEX, NMR, MINIMIZED AVERAGE STRUCTURE 1PBW ; 2.00 ; STRUCTURE OF BCR-HOMOLOGY (BH) DOMAIN 1BTV ; -1.00 ; STRUCTURE OF BET V 1, NMR, 20 STRUCTURES 1UG6 ; 0.99 ; STRUCTURE OF BETA-GLUCOSIDASE AT ATOMIC RESOLUTION FROM THERMUS THERMOPHILUS HB8 1UWQ ; 2.02 ; STRUCTURE OF BETA-GLYCOSIDASE FROM SULFOLOBUS SOLFATARICUS 1UWR ; 2.14 ; STRUCTURE OF BETA-GLYCOSIDASE FROM SULFOLOBUS SOLFATARICUS IN COMPLEX WITH 2-DEOXY-2-FLUORO-GALACTOSE 1UWS ; 1.95 ; STRUCTURE OF BETA-GLYCOSIDASE FROM SULFOLOBUS SOLFATARICUS IN COMPLEX WITH 2-DEOXY-2-FLUORO-GLUCOSE 1UWT ; 1.95 ; STRUCTURE OF BETA-GLYCOSIDASE FROM SULFOLOBUS SOLFATARICUS IN COMPLEX WITH D-GALACTOHYDROXIMO-1,5-LACTAM 1UWU ; 1.95 ; STRUCTURE OF BETA-GLYCOSIDASE FROM SULFOLOBUS SOLFATARICUS IN COMPLEX WITH D-GLUCOHYDROXIMO-1,5-LACTAM 1TR9 ; 1.80 ; STRUCTURE OF BETA-HEXOSAMINIDASE FROM VIBRIO CHOLERAE 1KGF ; 2.20 ; STRUCTURE OF BETA-LACTAMASE ASN 170 GLN MUTANT 1KGE ; 2.00 ; STRUCTURE OF BETA-LACTAMASE ASN 170 MET MUTANT 1GHI ; 2.30 ; STRUCTURE OF BETA-LACTAMASE GLU166ASP:ASN170GLN MUTANT 1KGG ; 2.30 ; STRUCTURE OF BETA-LACTAMASE GLU166GLN:ASN170ASP MUTANT 1DJA ; 1.90 ; STRUCTURE OF BETA-LACTAMASE PRECURSOR, K73H MUTANT, AT 298K 1DJC ; 2.00 ; STRUCTURE OF BETA-LACTAMASE PRECURSOR, S70A MUTANT, AT 120K 1DJB ; 2.10 ; STRUCTURE OF BETA-LACTAMASE PRECURSOR, S70A MUTANT, AT 298K 1XPB ; 1.90 ; STRUCTURE OF BETA-LACTAMASE TEM1 1Z4O ; 1.90 ; STRUCTURE OF BETA-PHOSPHOGLUCOMUTASE WITH INHIBITOR BOUND ALPHA-GALACTOSE 1-PHOSPHATE 1Z4N ; 1.97 ; STRUCTURE OF BETA-PHOSPHOGLUCOMUTASE WITH INHIBITOR BOUND ALPHA-GALACTOSE 1-PHOSPHATE COCRYSTALLIZED WITH FLUORIDE 1BHP ; 1.70 ; STRUCTURE OF BETA-PUROTHIONIN AT ROOM TEMPERATURE AND 1.7 ANGSTROMS RESOLUTION 1FKN ; 1.90 ; STRUCTURE OF BETA-SECRETASE COMPLEXED WITH INHIBITOR 1MPV ; -1.00 ; STRUCTURE OF BHPBR3, THE BAFF-BINDING LOOP OF BR3 EMBEDDED IN A BETA-HAIRPIN PEPTIDE 1AKN ; 2.80 ; STRUCTURE OF BILE-SALT ACTIVATED LIPASE 1LC0 ; 1.20 ; STRUCTURE OF BILIVERDIN REDUCTASE AND THE ENZYME-NADH COMPLEX 1BUJ ; -1.00 ; STRUCTURE OF BINASE IN SOLUTION 2RBI ; 2.20 ; STRUCTURE OF BINASE MUTANT HIS 101 ASN 1DV1 ; 1.90 ; STRUCTURE OF BIOTIN CARBOXYLASE (APO) 1XJ6 ; 1.90 ; STRUCTURE OF BJFIXLH IN THE UNLIGANDED FERROUS FORM 1HB6 ; 2.00 ; STRUCTURE OF BOVINE ACYL-COA BINDING PROTEIN IN ORTHORHOMBIC CRYSTAL FORM 1HB8 ; 2.00 ; STRUCTURE OF BOVINE ACYL-COA BINDING PROTEIN IN TETRAGONAL CRYSTAL FORM 1HLU ; 2.65 ; STRUCTURE OF BOVINE BETA-ACTIN-PROFILIN COMPLEX WITH ACTIN BOUND ATP PHOSPHATES SOLVENT ACCESSIBLE 1OCC ; 2.80 ; STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE 1L0L ; 2.35 ; STRUCTURE OF BOVINE MITOCHONDRIAL CYTOCHROME BC1 COMPLEX WITH A BOUND FUNGICIDE FAMOXADONE 1U1B ; 2.00 ; STRUCTURE OF BOVINE PANCREATIC RIBONUCLEASE A IN COMPLEX WITH 3'-PHOSPHOTHYMIDINE (3'-5')-PYROPHOSPHATE ADENOSINE 3'-PHOSPHATE 5PTI ; 1.00 ; STRUCTURE OF BOVINE PANCREATIC TRYPSIN INHIBITOR. RESULTS OF JOINT NEUTRON AND X-RAY REFINEMENT OF CRYSTAL FORM II 1ZWC ; -1.00 ; STRUCTURE OF BOVINE PARATHYROID HORMONE FRAGMENT 1-37, NMR, 10 STRUCTURES 1JFP ; -1.00 ; STRUCTURE OF BOVINE RHODOPSIN (DARK ADAPTED) 1LN6 ; -1.00 ; STRUCTURE OF BOVINE RHODOPSIN (METARHODOPSIN II) 1GZM ; 2.65 ; STRUCTURE OF BOVINE RHODOPSIN IN A TRIGONAL CRYSTAL FORM 1LD5 ; -1.00 ; STRUCTURE OF BPTI MUTANT A16V 1LD6 ; -1.00 ; STRUCTURE OF BPTI_8A MUTANT 1CS3 ; 2.00 ; STRUCTURE OF BTB/POZ TRANSCRIPTION REPRESSION DOMAIN FROM PROMELOCYTIC LEUKEMIA ZINC FINGER ONCOPROTEIN 2BTO ; 2.50 ; STRUCTURE OF BTUBA FROM PROSTHECOBACTER DEJONGEII 2BTQ ; 3.20 ; STRUCTURE OF BTUBAB HETERODIMER FROM PROSTHECOBACTER DEJONGEII 1X9J ; 3.00 ; STRUCTURE OF BUTYRATE KINASE 2 REVEALS BOTH OPEN- AND CITRATE-INDUCED CLOSED CONFORMATIONS: IMPLICATIONS FOR SUBSTRATE-INDUCED FIT CONFORMATIONAL CHANGES 1LL4 ; 2.80 ; STRUCTURE OF C. IMMITIS CHITINASE 1 COMPLEXED WITH ALLOSAMIDIN 2A9G ; 2.30 ; STRUCTURE OF C406A ARGININE DEIMINASE IN COMPLEX WITH L- ARGININE 1XF1 ; 1.90 ; STRUCTURE OF C5A PEPTIDASE- A KEY VIRULENCE FACTOR FROM STREPTOCOCCUS 1C1J ; 2.80 ; STRUCTURE OF CADMIUM-SUBSTITUTED PHOSPHOLIPASE A2 FROM AGKISTRONDON HALYS PALLAS AT 2.8 ANGSTROMS RESOLUTION 1OHU ; 2.03 ; STRUCTURE OF CAENORHABDITIS ELEGANS CED-9 1AJ4 ; -1.00 ; STRUCTURE OF CALCIUM-SATURATED CARDIAC TROPONIN C, NMR, 1 STRUCTURE 2CTN ; -1.00 ; STRUCTURE OF CALCIUM-SATURATED CARDIAC TROPONIN C, NMR, 30 STRUCTURES 3CTN ; -1.00 ; STRUCTURE OF CALCIUM-SATURATED CARDIAC TROPONIN C, NMR, 30 STRUCTURES 1SY9 ; -1.00 ; STRUCTURE OF CALMODULIN COMPLEXED WITH A FRAGMENT OF THE OLFACTORY CNG CHANNEL 1XA5 ; 2.12 ; STRUCTURE OF CALMODULIN IN COMPLEX WITH KAR-2, A BIS-INDOL ALKALOID 1NX0 ; 2.30 ; STRUCTURE OF CALPAIN DOMAIN 6 IN COMPLEX WITH CALPASTATIN DIC 1DTZ ; 2.65 ; STRUCTURE OF CAMEL APO-LACTOFERRIN DEMONSTRATES ITS DUAL ROLE IN SEQUESTERING AND TRANSPORTING FERRIC IONS SIMULTANEOUSLY:CRYSTAL STRUCTURE OF CAMEL APO-LACTOFERRIN AT 2.6A RESOLUTION. 2C1B ; 2.00 ; STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH ( 4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2- YLMETHANESULFONYL)ISOQUINOLINE 2C1A ; 1.95 ; STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY) ETHYLAMINO)ETHYL)AMIDE 1YDR ; 2.20 ; STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC SUBUNIT IN COMPLEX WITH H7 PROTEIN KINASE INHIBITOR 1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE 1YDS ; 2.20 ; STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC SUBUNIT IN COMPLEX WITH H8 PROTEIN KINASE INHIBITOR [N-(2-METHYLAMINO)ETHYL]-5-ISOQUINOLINESULFONAMIDE 1YDT ; 2.30 ; STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC SUBUNIT IN COMPLEX WITH H89 PROTEIN KINASE INHIBITOR N-[2-(4-BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE 1BXR ; 2.10 ; STRUCTURE OF CARBAMOYL PHOSPHATE SYNTHETASE COMPLEXED WITH THE ATP ANALOG AMPPNP 1NX8 ; 2.30 ; STRUCTURE OF CARBAPENEM SYNTHASE (CARC) COMPLEXED WITH N- ACETYL PROLINE 1YME ; 1.53 ; STRUCTURE OF CARBOXYPEPTIDASE 1MXL ; -1.00 ; STRUCTURE OF CARDIAC TROPONIN C-TROPONIN I COMPLEX 2C47 ; 2.40 ; STRUCTURE OF CASEIN KINASE 1 GAMMA 2 1NME ; 1.60 ; STRUCTURE OF CASP-3 WITH TETHERED SALICYLATE 1NW9 ; 2.40 ; STRUCTURE OF CASPASE-9 IN AN INHIBITORY COMPLEX WITH XIAP- BIR3 1IPH ; 2.80 ; STRUCTURE OF CATALASE HPII FROM ESCHERICHIA COLI 1KFW ; 1.74 ; STRUCTURE OF CATALYTIC DOMAIN OF PSYCHROPHILIC CHITINASE B FROM ARTHROBACTER TAD20 1DLM ; 2.00 ; STRUCTURE OF CATECHOL 1,2-DIOXYGENASE FROM ACINETOBACTER CALCOACETICUS NATIVE DATA 1DLQ ; 2.30 ; STRUCTURE OF CATECHOL 1,2-DIOXYGENASE FROM ACINETOBACTER SP. ADP1 INHIBITED BY BOUND MERCURY 1DMH ; 1.70 ; STRUCTURE OF CATECHOL 1,2-DIOXYGENASE FROM ACINETOBACTER SP. ADP1 WITH BOUND 4-METHYLCATECHOL 1DLT ; 1.90 ; STRUCTURE OF CATECHOL 1,2-DIOXYGENASE FROM ACINETOBACTER SP. ADP1 WITH BOUND CATECHOL 1MPY ; 2.80 ; STRUCTURE OF CATECHOL 2,3-DIOXYGENASE (METAPYROCATECHASE) FROM PSEUDOMONAS PUTIDA MT-2 1C39 ; 1.85 ; STRUCTURE OF CATION-DEPENDENT MANNOSE 6-PHOSPHATE RECEPTOR BOUND TO PENTAMANNOSYL PHOSPHATE 2C3W ; 1.81 ; STRUCTURE OF CBM25 FROM BACILLUS HALODURANS AMYLASE IN COMPLEX WITH MALTOTETRAOSE 2C3G ; 2.00 ; STRUCTURE OF CBM26 FROM BACILLUS HALODURANS AMYLASE 2C3H ; 2.24 ; STRUCTURE OF CBM26 FROM BACILLUS HALODURANS AMYLASE IN COMPLEX WITH MALTOSE 1QVG ; 2.90 ; STRUCTURE OF CCA OLIGONUCLEOTIDE BOUND TO THE TRNA BINDING SITES OF THE LARGE RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI 1I9R ; 3.10 ; STRUCTURE OF CD40L IN COMPLEX WITH THE FAB FRAGMENT OF HUMANIZED 5C8 ANTIBODY 1OHD ; 2.60 ; STRUCTURE OF CDC14 IN COMPLEX WITH TUNGSTATE 1OHE ; 2.20 ; STRUCTURE OF CDC14B PHOSPHATASE WITH A PEPTIDE LIGAND 1NF3 ; 2.10 ; STRUCTURE OF CDC42 IN A COMPLEX WITH THE GTPASE-BINDING DOMAIN OF THE CELL POLARITY PROTEIN, PAR6 1BD8 ; 1.80 ; STRUCTURE OF CDK INHIBITOR P19INK4D 1VYZ ; 2.21 ; STRUCTURE OF CDK2 COMPLEXED WITH PNU-181227 2BTR ; 1.85 ; STRUCTURE OF CDK2 COMPLEXED WITH PNU-198873 2BTS ; 1.99 ; STRUCTURE OF CDK2 COMPLEXED WITH PNU-230032 2C4G ; 2.70 ; STRUCTURE OF CDK2-CYCLIN A WITH PHA-533514 2BPM ; 2.40 ; STRUCTURE OF CDK2-CYCLIN A WITH PHA-630529 1VYW ; 2.30 ; STRUCTURE OF CDK2/CYCLIN A WITH PNU-292137 1WVG ; 1.80 ; STRUCTURE OF CDP-D-GLUCOSE 4,6-DEHYDRATASE FROM SALMONELLA TYPHI 1GYD ; 2.05 ; STRUCTURE OF CELLVIBRIO CELLULOSA ALPHA-L-ARABINANASE 1GYE ; 2.50 ; STRUCTURE OF CELLVIBRIO CELLULOSA ALPHA-L-ARABINANASE COMPLEXED WITH ARABINOHEXAOSE 1WRU ; 2.10 ; STRUCTURE OF CENTRAL HUB ELUCIDATED BY X-RAY ANALYSIS OF GENE PRODUCT 44; BASEPLATE COMPONENT OF BACTERIOPHAGE MU 1JW0 ; 2.50 ; STRUCTURE OF CEPHALOSPORIN ACYLASE IN COMPLEX WITH GLUTARATE 1JVZ ; 2.60 ; STRUCTURE OF CEPHALOSPORIN ACYLASE IN COMPLEX WITH GLUTARYL- 7-AMINOCEPHALOSPORANIC ACID 1I5C ; 1.90 ; STRUCTURE OF CHEA DOMAIN P4 IN COMPLEX WITH ADP 1I5A ; 1.90 ; STRUCTURE OF CHEA DOMAIN P4 IN COMPLEX WITH ADPCP AND MANGANESE 1I5B ; 1.94 ; STRUCTURE OF CHEA DOMAIN P4 IN COMPLEX WITH ADPNP AND MANGANESE 1I5D ; 2.90 ; STRUCTURE OF CHEA DOMAIN P4 IN COMPLEX WITH TNP-ATP 1WVP ; 1.53 ; STRUCTURE OF CHEMICALLY MODIFIED MYOGLOBIN WITH DISTAL N- TETRAZOLYL-HISTIDINE E7(64) 5CHY ; 2.00 ; STRUCTURE OF CHEMOTAXIS PROTEIN CHEY 6CHY ; 2.33 ; STRUCTURE OF CHEMOTAXIS PROTEIN CHEY 1AB5 ; 2.40 ; STRUCTURE OF CHEY MUTANT F14N, V21T 1AB6 ; 2.20 ; STRUCTURE OF CHEY MUTANT F14N, V86T 1NJI ; 3.00 ; STRUCTURE OF CHLORAMPHENICOL BOUND TO THE 50S RIBOSOMAL SUBUNIT 1U5V ; 1.85 ; STRUCTURE OF CITE COMPLEXED WITH TRIPHOSPHATE GROUP OF ATP FORM MYCOBACTERIUM TUBERCULOSIS 1U5H ; 1.65 ; STRUCTURE OF CITRATE LYASE BETA SUBUNIT FROM MYCOBACTERIUM TUBERCULOSIS 1RQF ; 2.89 ; STRUCTURE OF CK2 BETA SUBUNIT CRYSTALLIZED IN THE PRESENCE OF A P21WAF1 PEPTIDE 1HZO ; 1.75 ; STRUCTURE OF CLASS A CEPHALOSPORINASE FROM PROTEUS VULGARIS K1 1JXQ ; 2.80 ; STRUCTURE OF CLEAVED, CARD DOMAIN DELETED CASPASE-9 1XMH ; 2.32 ; STRUCTURE OF CO(II) RECONSTITUTED METHANE MONOOXYGENASE HYDROXYLASE FROM M. CAPSULATUS (BATH) 1F07 ; 2.00 ; STRUCTURE OF COENZYME F420 DEPENDENT TETRAHYDROMETHANOPTERIN REDUCTASE FROM METHANOBACTERIUM THERMOAUTOTROPHICUM 1EZW ; 1.65 ; STRUCTURE OF COENZYME F420 DEPENDENT TETRAHYDROMETHANOPTERIN REDUCTASE FROM METHANOPYRUS KANDLERI 1JAX ; 1.80 ; STRUCTURE OF COENZYME F420H2:NADP+ OXIDOREDUCTASE (FNO) 1JAY ; 1.65 ; STRUCTURE OF COENZYME F420H2:NADP+ OXIDOREDUCTASE (FNO) WITH ITS SUBSTRATES BOUND 1UNK ; 1.80 ; STRUCTURE OF COLICIN E7 IMMUNITY PROTEIN 2BHV ; 3.00 ; STRUCTURE OF COMB10 OF THE COM TYPE IV SECRETION SYSTEM OF HELICOBACTER PYLORI 1FMS ; 1.90 ; STRUCTURE OF COMPLEX BETWEEN CYCLOHEXYL-BIS-FURAMIDINE AND D(CGCGAATTCGCG) 1TEI ; 2.70 ; STRUCTURE OF CONCANAVALIN A COMPLEXED TO BETA-D-GLCNAC (1,2)ALPHA-D-MAN-(1,6)[BETA-D-GLCNAC(1,2)ALPHA-D-MAN (1,6)]ALPHA-D-MAN 1ZKI ; 1.70 ; STRUCTURE OF CONSERVED PROTEIN PA5202 FROM PSEUDOMONAS AERUGINOSA 1LVO ; 1.96 ; STRUCTURE OF CORONAVIRUS MAIN PROTEINASE REVEALS COMBINATION OF A CHYMOTRYPSIN FOLD WITH AN EXTRA ALPHA- HELICAL DOMAIN 1I5Z ; 1.90 ; STRUCTURE OF CRP-CAMP AT 1.9 A 1O8S ; 1.15 ; STRUCTURE OF CSCBM6-3 FROM CLOSTRIDIUM STERCORARIUM IN COMPLEX WITH CELLOBIOSE 1OD3 ; 1.00 ; STRUCTURE OF CSCBM6-3 FROM CLOSTRIDIUM STERCORARIUM IN COMPLEX WITH LAMINARIBIOSE 1NAE ; 2.05 ; STRUCTURE OF CSCBM6-3 FROM CLOSTRIDIUM STERCORARIUM IN COMPLEX WITH XYLOTRIOSE 1CEX ; 1.00 ; STRUCTURE OF CUTINASE 1OXM ; 2.30 ; STRUCTURE OF CUTINASE 1DW9 ; 1.65 ; STRUCTURE OF CYANASE REVEALS THAT A NOVEL DIMERIC AND DECAMERIC ARRANGEMENT OF SUBUNITS IS REQUIRED FOR FORMATION OF THE ENZYME ACTIVE SITE 1DWK ; 1.65 ; STRUCTURE OF CYANASE WITH THE DI-ANION OXALATE BOUND AT THE ENZYME ACTIVE SITE 2AK0 ; -1.00 ; STRUCTURE OF CYCLIC CONOTOXIN MII-7 1FOZ ; -1.00 ; STRUCTURE OF CYCLIC PEPTIDE INHIBITORS OF MAMMALIAN RIBONUCLEOTIDE REDUCTASE 1JKW ; 2.60 ; STRUCTURE OF CYCLIN MCS2 8CGT ; 2.40 ; STRUCTURE OF CYCLODEXTRIN GLYCOSYLTRANSFERASE COMPLEXED WITH A THIO-MALTOHEXAOSE 9CGT ; 2.50 ; STRUCTURE OF CYCLODEXTRIN GLYCOSYLTRANSFERASE COMPLEXED WITH A THIO-MALTOPENTAOSE 3CGT ; 2.40 ; STRUCTURE OF CYCLODEXTRIN GLYCOSYLTRANSFERASE COMPLEXED WITH ITS MAIN PRODUCT BETA-CYCLODEXTRIN 1VBS ; 2.00 ; STRUCTURE OF CYCLOPHILIN COMPLEXED WITH (D)ALA CONTAINING TETRAPEPTIDE 1VBT ; 2.30 ; STRUCTURE OF CYCLOPHILIN COMPLEXED WITH SULFUR-SUBSTITUTED TETRAPEPTIDE AAPF 1N4G ; 1.80 ; STRUCTURE OF CYP121, A MYCOBACTERIAL P450, IN COMPLEX WITH IODOPYRAZOLE 1AG0 ; 2.40 ; STRUCTURE OF CYS 112 ASP AZURIN FROM PSEUDOMONAS AERUGINOSA 1M57 ; 3.00 ; STRUCTURE OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES (EQ(I-286) MUTANT)) 1M56 ; 2.30 ; STRUCTURE OF CYTOCHROME C OXIDASE FROM RHODOBACTOR SPHAEROIDES (WILD TYPE) 1JDL ; 1.70 ; STRUCTURE OF CYTOCHROME C2 FROM RHODOSPIRILLUM CENTENUM 1EWH ; 2.35 ; STRUCTURE OF CYTOCHROME F FROM CHLAMYDOMONAS REINHARDTII 1FAG ; 2.70 ; STRUCTURE OF CYTOCHROME P450 1FAH ; 2.30 ; STRUCTURE OF CYTOCHROME P450 2BDM ; 2.30 ; STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND BIFONAZOLE 1KXI ; 2.19 ; STRUCTURE OF CYTOTOXIN HOMOLOG PRECURSOR 317D ; 1.90 ; STRUCTURE OF D(CCTAGGG): COMPARISON WITH NINE ISOMORPHOUS OCTAMER SEQUENCES REVEALS FOUR DISTINCT PATTERNS OF SEQUENCE-DEPENDENT INTERMOLECULAR INTERACTIONS 399D ; 1.90 ; STRUCTURE OF D(CGCCCGCGGGCG) 1DXY ; 1.90 ; STRUCTURE OF D-2-HYDROXYISOCAPROATE DEHYDROGENASE 1NFG ; 2.70 ; STRUCTURE OF D-HYDANTOINASE 1LK7 ; 2.00 ; STRUCTURE OF D-RIBOSE-5-PHOSPHATE ISOMERASE FROM IN COMPLEX WITH PHOSPHO-ERYTHRONIC ACID 1Y7A ; 1.77 ; STRUCTURE OF D153H/K328W E. COLI ALKALINE PHOSPHATASE IN PRESENCE OF COBALT AT 1.77 A RESOLUTION 1GYH ; 1.89 ; STRUCTURE OF D158A CELLVIBRIO CELLULOSA ALPHA-L-ARABINANASE MUTANT 2ACI ; 2.50 ; STRUCTURE OF D166A ARGININE DEIMINASE 2A0F ; 2.90 ; STRUCTURE OF D236A MUTANT E. COLI ASPARTATE TRANSCARBAMOYLASE IN PRESENCE OF PHOSPHONOACETAMIDE AT 2.90 A RESOLUTION 2ABR ; 2.90 ; STRUCTURE OF D280A ARGININE DEIMINASE WITH L-ARGININE FORMING A S-ALKYLTHIOURONIUM REACTION INTERMEDIATE 1XPH ; 1.41 ; STRUCTURE OF DC-SIGNR AND A PORTION OF REPEAT DOMAIN 8 1ST4 ; 2.02 ; STRUCTURE OF DCPS BOUND TO M7GPPPA 1ST0 ; 1.90 ; STRUCTURE OF DCPS BOUND TO M7GPPPG 1XTK ; 2.40 ; STRUCTURE OF DECD TO DEAD MUTATION OF HUMAN UAP56 1R0M ; 1.30 ; STRUCTURE OF DEINOCOCCUS RADIODURANS N-ACYLAMINO ACID RACEMASE AT 1.3 : INSIGHTS INTO A FLEXIBLE BINDING POCKET AND EVOLUTION OF ENZYMATIC ACTIVITY 1K4R ; 24.00 ; STRUCTURE OF DENGUE VIRUS 1LNL ; 3.30 ; STRUCTURE OF DEOXYGENATED HEMOCYANIN FROM RAPANA THOMASIANA 1DNP ; 2.30 ; STRUCTURE OF DEOXYRIBODIPYRIMIDINE PHOTOLYASE 1BAE ; -1.00 ; STRUCTURE OF DEOXYRIBONUCLEIC ACID (5'-D 5MCCTTTACC-3')2, NMR, 1 STRUCTURE 1XCY ; -1.00 ; STRUCTURE OF DEOXYRIBONUCLEIC ACID CONTAINING THE ALPHA-ANOMER OF A CARBOCYCLIC ABASIC SITE 1XCZ ; -1.00 ; STRUCTURE OF DEOXYRIBONUCLEIC ACID CONTAINING THE BETA-ANOMER OF A CARBOCYCLIC ABASIC SITE 1SUU ; 1.75 ; STRUCTURE OF DEOXYRIBONUCLEIC ACID GYRASE A C-TERMINAL DOMAIN 1PJR ; 2.50 ; STRUCTURE OF DEOXYRIBONUCLEIC ACID HELICASE 1QHG ; 2.50 ; STRUCTURE OF DEOXYRIBONUCLEIC ACID HELICASE MUTANT WITH ADPNP 1QHH ; 2.50 ; STRUCTURE OF DEOXYRIBONUCLEIC ACID HELICASE WITH ADPNP 1TAU ; 3.00 ; STRUCTURE OF DEOXYRIBONUCLEIC ACID POLYMERASE 1SY8 ; -1.00 ; STRUCTURE OF DEOXYRIBONUCLEIC ACID SEQUENCE D-TGATCA BY TWO-DIMENSIONAL NUCLEAR MAGNETIC RESONANCE SPEC AND RESTRAINED MOLECULAR DYNAMICS 1M0O ; 2.40 ; STRUCTURE OF DIALKYLGLYCINE DECARBOXYLASE COMPLEXED WITH 1- AMINO-1-METHYLPROPANEPHOSPHONATE 1M0P ; 2.60 ; STRUCTURE OF DIALKYLGLYCINE DECARBOXYLASE COMPLEXED WITH 1- AMINO-1-PHENYLETHANEPHOSPHONATE 1M0N ; 2.20 ; STRUCTURE OF DIALKYLGLYCINE DECARBOXYLASE COMPLEXED WITH 1- AMINOCYCLOPENTANEPHOSPHONATE 1M0Q ; 2.00 ; STRUCTURE OF DIALKYLGLYCINE DECARBOXYLASE COMPLEXED WITH S- 1-AMINOETHANEPHOSPHONATE 1FCK ; 2.20 ; STRUCTURE OF DICERIC HUMAN LACTOFERRIN 1BLF ; 2.80 ; STRUCTURE OF DIFERRIC BOVINE LACTOFERRIN AT 2.8 ANGSTROMS RESOLUTION 1BIY ; 3.37 ; STRUCTURE OF DIFERRIC BUFFALO LACTOFERRIN 1CE2 ; 2.50 ; STRUCTURE OF DIFERRIC BUFFALO LACTOFERRIN AT 2.5A RESOLUTION 1B1X ; 2.62 ; STRUCTURE OF DIFERRIC MARE LACTOFERRIN AT 2.62A RESOLUTION 1VIE ; 1.70 ; STRUCTURE OF DIHYDROFOLATE REDUCTASE 1VIF ; 1.80 ; STRUCTURE OF DIHYDROFOLATE REDUCTASE 1RF7 ; 1.80 ; STRUCTURE OF DIHYDROFOLATE REDUCTASE COMPLEXED WITH DIHYDROFOLATE 1RX7 ; 2.30 ; STRUCTURE OF DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE 1OJT ; 2.70 ; STRUCTURE OF DIHYDROLIPOAMIDE DEHYDROGENASE 1AJZ ; 2.00 ; STRUCTURE OF DIHYDROPTEROATE PYROPHOSPHORYLASE 1LK6 ; 2.80 ; STRUCTURE OF DIMERIC ANTITHROMBIN COMPLEXED WITH A P14-P9 REACTIVE LOOP PEPTIDE AND AN EXOGENOUS TRIPEPTIDE 1R1L ; 2.70 ; STRUCTURE OF DIMERIC ANTITHROMBIN COMPLEXED WITH A P14-P9 REACTIVE LOOP PEPTIDE AND AN EXOGENOUS TRIPEPTIDE (FORMYL- NORLEUCINE-LF) 1PJ7 ; 2.10 ; STRUCTURE OF DIMETHYLGLYCINE OXIDASE OF ARTHROBACTER GLOBIFORMIS IN COMPLEX WITH FOLINIC ACID 1UC5 ; 2.30 ; STRUCTURE OF DIOL DEHYDRATASE COMPLEXED WITH (R)-1,2- PROPANEDIOL 1UC4 ; 1.80 ; STRUCTURE OF DIOL DEHYDRATASE COMPLEXED WITH (S)-1,2- PROPANEDIOL 2DTR ; 2.00 ; STRUCTURE OF DIPHTHERIA TOXIN REPRESSOR 1BED ; 2.10 ; STRUCTURE OF DISULFIDE OXIDOREDUCTASE 1MZR ; 2.13 ; STRUCTURE OF DKGA FROM E.COLI AT 2.13 A RESOLUTION SOLVED BY MOLECULAR REPLACEMENT 1DMS ; 1.88 ; STRUCTURE OF DMSO REDUCTASE 3DMR ; 2.50 ; STRUCTURE OF DMSO REDUCTASE FROM RHODOBACTER CAPSULATUS AT PH 7.0 2AXW ; 1.05 ; STRUCTURE OF DRAD INVASIN FROM UROPATHOGENIC ESCHERICHIA COLI 1FF5 ; 2.93 ; STRUCTURE OF E-CADHERIN DOUBLE DOMAIN 1PSW ; 2.00 ; STRUCTURE OF E. COLI ADP-HEPTOSE LPS HEPTOSYLTRANSFERASE II 1Y6V ; 1.60 ; STRUCTURE OF E. COLI ALKALINE PHOSPHATASE IN PRESENCE OF COBALT AT 1.60 A RESOLUTION 1ED8 ; 1.75 ; STRUCTURE OF E. COLI ALKALINE PHOSPHATASE INHIBITED BY THE INORGANIC PHOSPHATE AT 1.75A RESOLUTION 1ED9 ; 1.75 ; STRUCTURE OF E. COLI ALKALINE PHOSPHATASE WITHOUT THE INORGANIC PHOSPHATE AT 1.75A RESOLUTION 1J2A ; 1.80 ; STRUCTURE OF E. COLI CYCLOPHILIN B K163T MUTANT 1VAI ; 1.80 ; STRUCTURE OF E. COLI CYCLOPHILIN B K163T MUTANT BOUND TO N- ACETYL-ALA-ALA-PRO-ALA-7-AMINO-4-METHYLCOUMARIN 1V9T ; 1.70 ; STRUCTURE OF E. COLI CYCLOPHILIN B K163T MUTANT BOUND TO SUCCINYL-ALA-PRO-ALA-P-NITROANILIDE 1YXD ; 2.00 ; STRUCTURE OF E. COLI DIHYDRODIPICOLINATE SYNTHASE BOUND WITH ALLOSTERIC INHIBITOR (S)-LYSINE TO 2.0 A 1YXC ; 1.90 ; STRUCTURE OF E. COLI DIHYDRODIPICOLINATE SYNTHASE TO 1.9 A 1EU5 ; 1.45 ; STRUCTURE OF E. COLI DUTPASE AT 1.45 A 1SF2 ; 2.40 ; STRUCTURE OF E. COLI GAMMA-AMINOBUTYRATE AMINOTRANSFERASE 1HV9 ; 2.10 ; STRUCTURE OF E. COLI GLMU: ANALYSIS OF PYROPHOSPHORYLASE AND ACETYLTRANSFERASE ACTIVE SITES 1GRX ; -1.00 ; STRUCTURE OF E. COLI GLUTAREDOXIN 1D9E ; 2.40 ; STRUCTURE OF E. COLI KDO8P SYNTHASE 1FR9 ; 1.65 ; STRUCTURE OF E. COLI MOBA 1FRW ; 1.75 ; STRUCTURE OF E. COLI MOBA WITH BOUND GTP AND MANGANESE 2AUK ; 2.30 ; STRUCTURE OF E. COLI RIBONUCLEIC ACID POLYMERASE BETA' G/G' INSERT 1QF6 ; 2.90 ; STRUCTURE OF E. COLI THREONYL-TRNA SYNTHETASE COMPLEXED WITH ITS COGNATE TRNA 1SI7 ; 2.20 ; STRUCTURE OF E. COLI TRNA PSI 13 PSEUDOURIDINE SYNTHASE TRUD 1LX7 ; 2.00 ; STRUCTURE OF E. COLI URIDINE PHOSPHORYLASE AT 2.0A 1U1E ; 2.00 ; STRUCTURE OF E. COLI URIDINE PHOSPHORYLASE COMPLEXED TO 5(PHENYLSELENO)ACYCLOURIDINE (PSAU) 1U1F ; 2.30 ; STRUCTURE OF E. COLI URIDINE PHOSPHORYLASE COMPLEXED TO 5- (M-(BENZYLOXY)BENZYL)ACYCLOURIDINE (BBAU) 1U1G ; 1.95 ; STRUCTURE OF E. COLI URIDINE PHOSPHORYLASE COMPLEXED TO 5- (M-(BENZYLOXY)BENZYL)BARBITURIC ACID (BBBA) 1U1D ; 2.00 ; STRUCTURE OF E. COLI URIDINE PHOSPHORYLASE COMPLEXED TO 5- (PHENYLTHIO)ACYCLOURIDINE (PTAU) 1U1C ; 2.20 ; STRUCTURE OF E. COLI URIDINE PHOSPHORYLASE COMPLEXED TO 5- BENZYLACYCLOURIDINE (BAU) 1TGV ; 2.20 ; STRUCTURE OF E. COLI URIDINE PHOSPHORYLASE COMPLEXED WITH 5- FLUOROURIDINE AND SULFATE 1TGY ; 2.20 ; STRUCTURE OF E. COLI URIDINE PHOSPHORYLASE COMPLEXED WITH URACIL AND RIBOSE 1-PHOSPHATE 1PUG ; 2.20 ; STRUCTURE OF E. COLI YBAB 1Q8R ; 1.90 ; STRUCTURE OF E.COLI RUSA HOLLIDAY JUNCTION RESOLVASE 1JP3 ; 1.80 ; STRUCTURE OF E.COLI UNDECAPRENYL PYROPHOSPHATE SYNTHASE 1KCN ; -1.00 ; STRUCTURE OF E109 ZETA PEPTIDE, AN ANTAGONIST OF THE HIGH- AFFINITY IGE RECEPTOR 1KCO ; -1.00 ; STRUCTURE OF E131 ZETA PEPTIDE, A POTENT ANTAGONIST OF THE HIGH-AFFINITY IGE RECEPTOR 1C4Z ; 2.60 ; STRUCTURE OF E6AP: INSIGHTS INTO UBIQUITINATION PATHWAY 1N9F ; 1.80 ; STRUCTURE OF EARTH-GROWN OXIDIZED MYOGLOBIN MUTANT YQR (ISS6A) 1N9I ; 1.60 ; STRUCTURE OF EARTH-GROWN OXIDIZED MYOGLOBIN MUTANT YQR (ISS8A) 1WUZ ; -1.00 ; STRUCTURE OF EC1 DOMAIN OF CNR 1ZM9 ; 2.80 ; STRUCTURE OF EEF2-ETA IN COMPLEX WITH PJ34 1VLX ; 1.90 ; STRUCTURE OF ELECTRON TRANSFER (COBALT-PROTEIN) 1O96 ; 3.10 ; STRUCTURE OF ELECTRON TRANSFERRING FLAVOPROTEIN FOR METHYLOPHILUS METHYLOTROPHUS. 1O97 ; 1.60 ; STRUCTURE OF ELECTRON TRANSFERRING FLAVOPROTEIN FROM METHYLOPHILUS METHYLOTROPHUS, RECOGNITION LOOP REMOVED BY LIMITED PROTEOLYSIS 1Z3F ; 1.50 ; STRUCTURE OF ELLIPTICINE IN COMPLEX WITH A 6-BP DEOXYRIBONUCLEIC ACID 1V7P ; 1.90 ; STRUCTURE OF EMS16-ALPHA2-I DOMAIN COMPLEX 1UKR ; 2.40 ; STRUCTURE OF ENDO-1,4-BETA-XYLANASE C 2BWC ; 2.15 ; STRUCTURE OF ENDOGLUCANASE 12A (CEL12A) FROM RHODOTHERMUS MARINUS IN COMPLEX WITH CELLOPENTAOSE (5 MINUTE SOAK) 2BWA ; 1.68 ; STRUCTURE OF ENDOGLUCANASE 12A (CEL12A) FROM RHODOTHERMUS MARINUS IN COMPLEX WITH CELLOPENTAOSE, 20 MINUTE SOAK. 3ENG ; 1.90 ; STRUCTURE OF ENDOGLUCANASE V CELLOBIOSE COMPLEX 4ENG ; 1.90 ; STRUCTURE OF ENDOGLUCANASE V CELLOHEXAOSE COMPLEX 1PUI ; 2.00 ; STRUCTURE OF ENGB GTPASE 1EY3 ; 2.30 ; STRUCTURE OF ENOYL-COA HYDRATASE COMPLEXED WITH THE SUBSTRATE DAC-COA 1G6T ; 1.60 ; STRUCTURE OF EPSP SYNTHASE LIGANDED WITH SHIKIMATE-3- PHOSPHATE 1G6S ; 1.50 ; STRUCTURE OF EPSP SYNTHASE LIGANDED WITH SHIKIMATE-3- PHOSPHATE AND GLYPHOSATE 1I6B ; 3.20 ; STRUCTURE OF EQUINE APOLACTOFERRIN AT 3.2 A RESOLUTION USING CRYSTALS GROWN AT 303K 1W9G ; 2.00 ; STRUCTURE OF ERH (ENHENCER OF RUDIMENTARY GENE) 1HZM ; -1.00 ; STRUCTURE OF ERK2 BINDING DOMAIN OF MAPK PHOSPHATASE MKP-3: STRUCTURAL INSIGHTS INTO MKP-3 ACTIVATION BY ERK2 1RP4 ; 2.20 ; STRUCTURE OF ERO1P, SOURCE OF DISULFIDE BONDS FOR OXIDATIVE PROTEIN FOLDING IN THE CELL 1RQ1 ; 2.80 ; STRUCTURE OF ERO1P, SOURCE OF DISULFIDE BONDS FOR OXIDATIVE PROTEIN FOLDING IN THE CELL 2BYW ; 1.70 ; STRUCTURE OF ESCHERICHIA COLI BETA-KETOACYL (ACYL CARRIER PROTEIN) SYNTHASE I LYS328ALA MUTANT 2GLT ; 2.20 ; STRUCTURE OF ESCHERICHIA COLI GLUTATHIONE SYNTHETASE AT PH 6.0. 1GSH ; 2.00 ; STRUCTURE OF ESCHERICHIA COLI GLUTATHIONE SYNTHETASE AT PH 7.5 1P7T ; 1.95 ; STRUCTURE OF ESCHERICHIA COLI MALATE SYNTHASE G:PYRUVATE:ACETYL-COENZYME A ABORTIVE TERNARY COMPLEX AT 1.95 ANGSTROM RESOLUTION 1EYZ ; 1.75 ; STRUCTURE OF ESCHERICHIA COLI PURT-ENCODED GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE COMPLEXED WITH MG AND AMPPNP 1EZ1 ; 1.75 ; STRUCTURE OF ESCHERICHIA COLI PURT-ENCODED GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE COMPLEXED WITH MG, AMPPNP, AND GAR 1BDF ; 2.50 ; STRUCTURE OF ESCHERICHIA COLI RIBONUCLEIC ACID POLYMERASE ALPHA SUBUNIT N-TERMINAL DOMAIN 1O8B ; 1.25 ; STRUCTURE OF ESCHERICHIA COLI RIBOSE-5-PHOSPHATE ISOMERASE, RPIA, COMPLEXED WITH ARABINOSE-5-PHOSPHATE. 1WPB ; 2.00 ; STRUCTURE OF ESCHERICHIA COLI YFBU GENE PRODUCT 1MX2 ; 2.25 ; STRUCTURE OF F71N MUTANT OF P18INK4C 1XF2 ; 2.30 ; STRUCTURE OF FAB DEOXYRIBONUCLEIC ACID-1 COMPLEXED WITH DT3 1J83 ; 1.70 ; STRUCTURE OF FAM17 CARBOHYDRATE BINDING MODULE FROM CLOSTRIDIUM CELLULOVORANS 1J84 ; 2.02 ; STRUCTURE OF FAM17 CARBOHYDRATE BINDING MODULE FROM CLOSTRIDIUM CELLULOVORANS WITH BOUND CELLOTETRAOSE 1UBV ; 2.50 ; STRUCTURE OF FARNESYL PYROPHOSPHATE SYNTHETASE 1UBW ; 2.50 ; STRUCTURE OF FARNESYL PYROPHOSPHATE SYNTHETASE 1UBX ; 2.50 ; STRUCTURE OF FARNESYL PYROPHOSPHATE SYNTHETASE 1UBY ; 2.40 ; STRUCTURE OF FARNESYL PYROPHOSPHATE SYNTHETASE 1T47 ; 2.50 ; STRUCTURE OF FE2-HPPD BOUND TO NTBC 1B11 ; 1.90 ; STRUCTURE OF FELINE IMMUNODEFICIENCY VIRUS PROTEASE COMPLEXED WITH TL-3-093 1XER ; 2.00 ; STRUCTURE OF FERREDOXIN 2CJO ; -1.00 ; STRUCTURE OF FERREDOXIN, NMR, 10 STRUCTURES 2CJN ; -1.00 ; STRUCTURE OF FERREDOXIN, NMR, MINIMIZED AVERAGE STRUCTURE 1GR1 ; 2.50 ; STRUCTURE OF FERREDOXIN-NADP+ REDUCTASE WITH GLU 139 REPLACED BY LYS (E139K) 1GO2 ; 1.70 ; STRUCTURE OF FERREDOXIN-NADP+ REDUCTASE WITH LYS 72 REPLACED BY GLU (K72E) 1H5A ; 1.60 ; STRUCTURE OF FERRIC HORSERADISH PEROXIDASE C1A IN COMPLEX WITH ACETATE 1V3W ; 1.50 ; STRUCTURE OF FERRIPYOCHELIN BINDING PROTEIN FROM PYROCOCCUS HORIKOSHII OT3 1V67 ; 2.30 ; STRUCTURE OF FERRIPYOCHELIN BINDING PROTEIN FROM PYROCOCCUS HORIKOSHII OT3 1C9E ; 2.30 ; STRUCTURE OF FERROCHELATASE WITH COPPER(II) N- METHYLMESOPORPHYRIN COMPLEX BOUND AT THE ACTIVE SITE 1H58 ; 1.70 ; STRUCTURE OF FERROUS HORSERADISH PEROXIDASE C1A 1G82 ; 2.60 ; STRUCTURE OF FIBROBLAST GROWTH FACTOR 9 1ROU ; -1.00 ; STRUCTURE OF FKBP59-I, THE N-TERMINAL DOMAIN OF A 59 KDA FK506-BINDING PROTEIN, NMR, 22 STRUCTURES 1ROT ; -1.00 ; STRUCTURE OF FKBP59-I, THE N-TERMINAL DOMAIN OF A 59 KDA FK506-BINDING PROTEIN, NMR, MINIMIZED AVERAGE STRUCTURE 1J2O ; -1.00 ; STRUCTURE OF FLIN2, A COMPLEX CONTAINING THE N-TERMINAL LIM DOMAIN OF LMO2 AND LDB1-LID 1T3T ; 1.90 ; STRUCTURE OF FORMYLGLYCINAMIDE SYNTHETASE 1O1R ; 2.30 ; STRUCTURE OF FPT BOUND TO GGPP 1O1S ; 2.30 ; STRUCTURE OF FPT BOUND TO ISOPRENOID ANALOG 3B 1O1T ; 2.10 ; STRUCTURE OF FPT BOUND TO THE CVIM-FPP PRODUCT 1O5M ; 2.30 ; STRUCTURE OF FPT BOUND TO THE INHIBITOR SCH66336 1QMO ; 3.50 ; STRUCTURE OF FRIL, A LEGUME LECTIN THAT DELAYS HEMATOPOIETIC PROGENITOR MATURATION 1DOS ; 1.67 ; STRUCTURE OF FRUCTOSE-BISPHOSPHATE ALDOLASE 1LR9 ; 2.50 ; STRUCTURE OF FS1, THE HEPARIN-BINDING DOMAIN OF FOLLISTATIN 1MCX ; 2.03 ; STRUCTURE OF FULL-LENGTH ANNEXIN A1 IN THE PRESENCE OF CALCIUM 1P9B ; 2.00 ; STRUCTURE OF FULLY LIGATED ADENYLOSUCCINATE SYNTHETASE FROM PLASMODIUM FALCIPARUM 1FKA ; 3.30 ; STRUCTURE OF FUNCTIONALLY ACTIVATED SMALL RIBOSOMAL SUBUNIT AT 3.3 A RESOLUTION 1BEG ; -1.00 ; STRUCTURE OF FUNGAL ELICITOR, NMR, 18 STRUCTURES 1PZQ ; -1.00 ; STRUCTURE OF FUSED DOCKING DOMAINS FROM THE ERYTHROMYCIN POLYKETIDE SYNTHASE (DEBS), A MODEL FOR THE INTERACTION BETWEEN DEBS 2 AND DEBS 3: THE A DOMAIN 1PZR ; -1.00 ; STRUCTURE OF FUSED DOCKING DOMAINS FROM THE ERYTHROMYCIN POLYKETIDE SYNTHASE (DEBS), A MODEL FOR THE INTERACTION BETWEEN DEBS2 AND DEBS3: THE B DOMAIN 1Y3A ; 2.50 ; STRUCTURE OF G-ALPHA-I1 BOUND TO A GDP-SELECTIVE PEPTIDE PROVIDES INSIGHT INTO GUANINE NUCLEOTIDE EXCHANGE 1SFF ; 1.90 ; STRUCTURE OF GAMMA-AMINOBUTYRATE AMINOTRANSFERASE COMPLEX WITH AMINOOXYACETATE 1L9X ; 1.60 ; STRUCTURE OF GAMMA-GLUTAMYL HYDROLASE 1ZQ1 ; 3.00 ; STRUCTURE OF GATDE TRNA-DEPENDENT AMIDOTRANSFERASE FROM PYROCOCCUS ABYSSI 1Y8A ; 1.40 ; STRUCTURE OF GENE PRODUCT AF1437 FROM ARCHAEOGLOBUS FULGIDUS 1J3W ; 1.50 ; STRUCTURE OF GLIDING PROTEIN-MGLB FROM THERMUS THERMOPHILUS HB8 1P3E ; 1.72 ; STRUCTURE OF GLU ENDOPEPTIDASE IN COMPLEX WITH MPD 1O1H ; 1.40 ; STRUCTURE OF GLUCOSE ISOMERASE DERIVATIZED WITH KR. 1GTM ; 2.20 ; STRUCTURE OF GLUTAMATE DEHYDROGENASE 1XFH ; 3.50 ; STRUCTURE OF GLUTAMATE TRANSPORTER HOMOLOG FROM PYROCOCCUS HORIKOSHII 1GNW ; 2.20 ; STRUCTURE OF GLUTATHIONE S-TRANSFERASE 1AW9 ; 2.20 ; STRUCTURE OF GLUTATHIONE S-TRANSFERASE III IN APO FORM 1AXD ; 2.50 ; STRUCTURE OF GLUTATHIONE S-TRANSFERASE-I BOUND WITH THE LIGAND LACTOYLGLUTATHIONE 1GSA ; 2.00 ; STRUCTURE OF GLUTATHIONE SYNTHETASE COMPLEXED WITH ADP AND GLUTATHIONE 1TXG ; 1.70 ; STRUCTURE OF GLYCEROL-3-PHOSPHATE DEHYDROGENASE FROM ARCHAEOGLOBUS FULGIDUS 1NBH ; 2.80 ; STRUCTURE OF GLYCINE N-METHYLTRANSFERASE COMPLEXED WITH S- ADENOSYLMETHIONINE AND ACETATE, GNMT:SAM:ACE 1RYI ; 1.80 ; STRUCTURE OF GLYCINE OXIDASE WITH BOUND INHIBITOR GLYCOLATE 2BIS ; 2.80 ; STRUCTURE OF GLYCOGEN SYNTHASE FROM PYROCOCCUS ABYSSI 1I09 ; 2.70 ; STRUCTURE OF GLYCOGEN SYNTHASE KINASE-3 (GSK3B) 1ZCT ; 2.60 ; STRUCTURE OF GLYCOGENIN TRUNCATED AT RESIDUE 270 IN A COMPLEX WITH UDP 1GWB ; 2.80 ; STRUCTURE OF GLYCOPROTEIN 1B 1K3T ; 1.95 ; STRUCTURE OF GLYCOSOMAL GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE FROM TRYPANOSOMA CRUZI COMPLEXED WITH CHALEPIN, A COUMARIN DERIVATIVE INHIBITOR 1YJP ; 1.80 ; STRUCTURE OF GNNQQNY FROM YEAST PRION SUP35 3LYN ; 1.70 ; STRUCTURE OF GREEN ABALONE LYSIN DIMER 1GFL ; 1.90 ; STRUCTURE OF GREEN FLUORESCENT PROTEIN 1KGB ; 1.65 ; STRUCTURE OF GROUND-STATE BACTERIORHODOPSIN 1XUE ; -1.00 ; STRUCTURE OF GTGGAATGCAATGGAAC HAIRPIN, NMR, 10 STRUCTURES 1WUR ; 1.82 ; STRUCTURE OF GTP CYCLOHYDROLASE I COMPLEXED WITH 8-OXO-DGTP 1WUQ ; 2.00 ; STRUCTURE OF GTP CYCLOHYDROLASE I COMPLEXED WITH 8-OXO-GTP 1WM9 ; 2.20 ; STRUCTURE OF GTP CYCLOHYDROLASE I FROM THERMUS THERMOPHILUS HB8 1GIT ; 2.60 ; STRUCTURE OF GTP-BINDING PROTEIN 1Z0J ; 1.32 ; STRUCTURE OF GTP-BOUND RAB22Q64L GTPASE IN COMPLEX WITH THE MINIMAL RAB BINDING DOMAIN OF RABENOSYN-5 1Z0K ; 1.92 ; STRUCTURE OF GTP-BOUND RAB4Q67L GTPASE IN COMPLEX WITH THE CENTRAL RAB BINDING DOMAIN OF RABENOSYN-5 1HOO ; 2.30 ; STRUCTURE OF GUANINE NUCLEOTIDE (GPPCP) COMPLEX OF ADENYLOSUCCINATE SYNTHETASE FROM E. COLI AT PH6.5 AND 25 DEGREES CELSIUS 1HON ; 2.30 ; STRUCTURE OF GUANINE NUCLEOTIDE (GPPCP) COMPLEX OF ADENYLOSUCCINATE SYNTHETASE FROM ESCHERICHIA COLI AT PH6.5 AND 25 DEGREE CELSIUS 1HOP ; 2.30 ; STRUCTURE OF GUANINE NUCLEOTIDE (GPPCP) COMPLEX OF ADENYLOSUCCINATE SYNTHETASE FROM ESCHERICHIA COLI AT PH6.5 AND 25 DEGREES CELSIUS 1CKN ; 2.50 ; STRUCTURE OF GUANYLYLATED MRNA CAPPING ENZYME COMPLEXED WITH GTP 1Z3X ; 1.50 ; STRUCTURE OF GUN4 FROM THERMOSYNECHOCOCCUS ELONGATUS 1Z3Y ; 1.70 ; STRUCTURE OF GUN4-1 FROM THERMOSYNECHOCOCCUS ELONGATUS 2AAF ; 2.30 ; STRUCTURE OF H278A ARGININE DEIMINASE WITH L-ARGININE FORMING A S-ALKYLTHIOURONIUM REACTION INTERMEDIATE 1JSM ; 1.90 ; STRUCTURE OF H5 AVIAN HAEMAGGLUTININ 1JJW ; 1.90 ; STRUCTURE OF HAEMOPHILUS INFLUENZAE HSLV PROTEIN AT 1.9 A RESOLUTION 1JMV ; 1.85 ; STRUCTURE OF HAEMOPHYLUS INFLUENZAE UNIVERSAL STRESS PROTEIN AT 1.85A RESOLUTION 1ZMT ; 1.70 ; STRUCTURE OF HALOALCOHOL DEHALOGENASE HHEC OF AGROBACTERIUM RADIOBACTER AD1 IN COMPLEX WITH (R)-PARA-NITRO STYRENE OXIDE, WITH A WATER MOLECULE IN THE HALIDE-BINDING SITE 1QP9 ; 2.80 ; STRUCTURE OF HAP1-PC7 COMPLEXED TO THE UAS OF CYC7 1NS3 ; 2.80 ; STRUCTURE OF HCV PROTEASE (BK STRAIN) 1QWL ; 1.60 ; STRUCTURE OF HELICOBACTER PYLORI CATALASE 1QWM ; 1.60 ; STRUCTURE OF HELICOBACTER PYLORI CATALASE WITH FORMIC ACID BOUND 1YIK ; 1.75 ; STRUCTURE OF HEN EGG WHITE LYSOZYME SOAKED WITH CU-CYCLAM 1YIL ; 1.60 ; STRUCTURE OF HEN EGG WHITE LYSOZYME SOAKED WITH CU2- XYLYLBICYCLAM 1DPX ; 1.65 ; STRUCTURE OF HEN EGG-WHITE LYSOZYME 1DPW ; 1.64 ; STRUCTURE OF HEN EGG-WHITE LYSOZYME IN COMPLEX WITH MPD 1DXW ; -1.00 ; STRUCTURE OF HETERO COMPLEX OF NON STRUCTURAL PROTEIN (NS) OF HEPATITIS C VIRUS (HCV) AND SYNTHETIC PEPTIDIC COMPOUND 1NO5 ; 1.80 ; STRUCTURE OF HI0073 FROM HAEMOPHILUS INFLUENZAE, THE NUCLEOTIDE BINDING DOMAIN OF THE HI0073/HI0074 TWO PROTEIN NUCLEOTIDYL TRANSFERASE. 1JOG ; 2.40 ; STRUCTURE OF HI0074 FROM HEAMOPHILUS INFLUENZAE REVEALS THE FOLD OF A SUBSTRATE BINDING DOMAIN OF A NUCLEOTIDYLTRANSFERASE 1YLI ; 1.95 ; STRUCTURE OF HI0827, A THIOESTERASE ACTING ON SHORT-CHAIN ACYL-COA COMPOUNDS 1MWQ ; 0.99 ; STRUCTURE OF HI0828, A HYPOTHETICAL PROTEIN FROM HAEMOPHILUS INFLUENZAE WITH A PUTATIVE ACTIVE-SITE PHOSPHOHISTIDINE 1JO0 ; 1.37 ; STRUCTURE OF HI1333, A HYPOTHETICAL PROTEIN FROM HAEMOPHILUS INFLUENZAE WITH STRUCTURAL SIMILARITY TO RIBONUCLEIC ACID- BINDING PROTEINS 1MW5 ; 2.10 ; STRUCTURE OF HI1480 FROM HAEMOPHILUS INFLUENZAE 1CM2 ; 1.80 ; STRUCTURE OF HIS15ASP HPR AFTER HYDROLYSIS OF RINGED SPECIES. 1MUF ; 2.26 ; STRUCTURE OF HISTONE H3 K4-SPECIFIC METHYLTRANSFERASE SET7/9 1MT6 ; 2.20 ; STRUCTURE OF HISTONE H3 K4-SPECIFIC METHYLTRANSFERASE SET7/9 WITH ADOHCY 1MRX ; 2.00 ; STRUCTURE OF HIV PROTEASE (MUTANT Q7K L33I L63I V82F I84V ) COMPLEXED WITH KNI-577 1MRW ; 2.00 ; STRUCTURE OF HIV PROTEASE (MUTANT Q7K L33I L63I) COMPLEXED WITH KNI-577 1DMP ; 2.00 ; STRUCTURE OF HIV-1 PROTEASE COMPLEX 2B8R ; 2.60 ; STRUCTURE OF HIV-1(LAI) GENOMIC RIBONUCLEIC ACID DIS 2B8S ; 2.76 ; STRUCTURE OF HIV-1(MAL) GENOMIC RIBONUCLEIC ACID DIS 2BB9 ; 1.35 ; STRUCTURE OF HIV1 PROTEASE AND AKC4P_133A COMPLEX. 2BBB ; 1.70 ; STRUCTURE OF HIV1 PROTEASE AND HH1_173_3A COMPLEX. 1SZJ ; 2.00 ; STRUCTURE OF HOLO-GLYCERALDEHYDE-3-PHOSPHATE-DEHYDROGENASE FROM PALINURUS VERSICOLOR REFINED 2.0 ANGSTROM RESOLUTION 1HCH ; 1.57 ; STRUCTURE OF HORSERADISH PEROXIDASE C1A COMPOUND I 1H55 ; 1.61 ; STRUCTURE OF HORSERADISH PEROXIDASE C1A COMPOUND II 1H57 ; 1.60 ; STRUCTURE OF HORSERADISH PEROXIDASE C1A COMPOUND III 2BEL ; 2.11 ; STRUCTURE OF HUMAN 11-BETA-HYDROXYSTEROID DEHYDROGENASE IN COMPLEX WITH NADP AND CARBENOXOLONE 1CB0 ; 1.70 ; STRUCTURE OF HUMAN 5'-DEOXY-5'-METHYLTHIOADENOSINE PHOSPHORYLASE AT 1.7 A RESOLUTION 1CG6 ; 1.70 ; STRUCTURE OF HUMAN 5'-DEOXY-5'-METHYLTHIOADENOSINE PHOSPHORYLASE COMPLEXED WITH 5'-DEOXY-5'- METHYLTHIOADENOSINE AND SULFATE AT 1.7 A RESOLUTION 1SD2 ; 2.10 ; STRUCTURE OF HUMAN 5'-DEOXY-5'-METHYLTHIOADENOSINE PHOSPHORYLASE COMPLEXED WITH 5'-METHYLTHIOTUBERCIDIN 1SD1 ; 2.03 ; STRUCTURE OF HUMAN 5'-DEOXY-5'-METHYLTHIOADENOSINE PHOSPHORYLASE COMPLEXED WITH FORMYCIN A 1QSE ; 2.80 ; STRUCTURE OF HUMAN A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED HTLV-1 TAX PEPTIDE V7R 1BX4 ; 1.50 ; STRUCTURE OF HUMAN ADENOSINE KINASE AT 1.50 ANGSTROMS 1AVP ; 2.60 ; STRUCTURE OF HUMAN ADENOVIRUS 2 PROTEINASE WITH ITS 11 AMINO ACID COFACTOR 1ZD8 ; 1.48 ; STRUCTURE OF HUMAN ADENYLATE KINASE 3 LIKE 1 1Z6X ; 2.70 ; STRUCTURE OF HUMAN ADP-RIBOSYLATION FACTOR 4 2B6H ; 1.76 ; STRUCTURE OF HUMAN ADP-RIBOSYLATION FACTOR 5 1ZD9 ; 1.70 ; STRUCTURE OF HUMAN ADP-RIBOSYLATION FACTOR-LIKE 10B 2AL7 ; 1.85 ; STRUCTURE OF HUMAN ADP-RIBOSYLATION FACTOR-LIKE 10C 1Z6Y ; 2.40 ; STRUCTURE OF HUMAN ADP-RIBOSYLATION FACTOR-LIKE 5 1YZG ; 2.00 ; STRUCTURE OF HUMAN ADP-RIBOSYLATION FACTOR-LIKE 8 1XDL ; 3.00 ; STRUCTURE OF HUMAN ALDOLASE B ASSOCIATED WITH HEREDITARY FRUCTOSE INTOLERANCE (A149P), AT 277K 1XDM ; 3.00 ; STRUCTURE OF HUMAN ALDOLASE B ASSOCIATED WITH HEREDITARY FRUCTOSE INTOLERANCE (A149P), AT 291K 1R46 ; 3.25 ; STRUCTURE OF HUMAN ALPHA-GALACTOSIDASE 1R47 ; 3.45 ; STRUCTURE OF HUMAN ALPHA-GALACTOSIDASE 2THF ; 2.10 ; STRUCTURE OF HUMAN ALPHA-THROMBIN Y225F MUTANT BOUND TO D-PHE-PRO-ARG-CHLOROMETHYLKETONE 1B7X ; 2.10 ; STRUCTURE OF HUMAN ALPHA-THROMBIN Y225I MUTANT BOUND TO D- PHE-PRO-ARG-CHLOROMETHYLKETONE 1THP ; 2.10 ; STRUCTURE OF HUMAN ALPHA-THROMBIN Y225P MUTANT BOUND TO D-PHE-PRO-ARG-CHLOROMETHYLKETONE 1XJL ; 2.59 ; STRUCTURE OF HUMAN ANNEXIN A2 IN THE PRESENCE OF CALCIUM IONS 1CB6 ; 2.00 ; STRUCTURE OF HUMAN APOLACTOFERRIN AT 2.0 A RESOLUTION. 1OL7 ; 2.75 ; STRUCTURE OF HUMAN AURORA-A 122-403 PHOSPHORYLATED ON THR287, THR288 1R2D ; 1.95 ; STRUCTURE OF HUMAN BCL-XL AT 1.95 ANGSTROMS 1KSW ; 2.80 ; STRUCTURE OF HUMAN C-SRC TYROSINE KINASE (THR338GLY MUTANT) IN COMPLEX WITH N6-BENZYL ADP 1XQ0 ; 1.76 ; STRUCTURE OF HUMAN CARBONIC ANHYDRASE II WITH 4-[(3-BROMO-4- O-SULFAMOYLBENZYL)(4-CYANOPHENYL)AMINO]-4H-[1,2,4]-TRIAZOLE 1XPZ ; 2.02 ; STRUCTURE OF HUMAN CARBONIC ANHYDRASE II WITH 4-[4-O- SULFAMOYLBENZYL)(4-CYANOPHENYL)AMINO]-4H-[1,2,4]-TRIAZOLE 1YFF ; 2.40 ; STRUCTURE OF HUMAN CARBONMONOXYHEMOGLOBIN C (BETA E6K): TWO QUATERNARY STATES (R2 AND R3) IN ONE CRYSTAL 1NM8 ; 1.60 ; STRUCTURE OF HUMAN CARNITINE ACETYLTRANSFERASE: MOLECULAR BASIS FOR FATTY ACYL TRANSFER 1GUV ; 2.35 ; STRUCTURE OF HUMAN CHITOTRIOSIDASE 1PU0 ; 1.70 ; STRUCTURE OF HUMAN CU,ZN SUPEROXIDE DISMUTASE 1YND ; 1.60 ; STRUCTURE OF HUMAN CYCLOPHILIN A IN COMPLEX WITH THE NOVEL IMMUNOSUPPRESSANT SANGLIFEHRIN A AT 1.6A RESOLUTION 1JBQ ; 2.60 ; STRUCTURE OF HUMAN CYSTATHIONINE BETA-SYNTHASE: A UNIQUE PYRIDOXAL 5'-PHOSPHATE DEPENDENT HEMEPROTEIN 1RN7 ; 2.50 ; STRUCTURE OF HUMAN CYSTATIN D 1ROA ; 1.80 ; STRUCTURE OF HUMAN CYSTATIN D 1OG2 ; 2.60 ; STRUCTURE OF HUMAN CYTOCHROME P450 CYP2C9 1OG5 ; 2.55 ; STRUCTURE OF HUMAN CYTOCHROME P450 CYP2C9 1P61 ; 2.21 ; STRUCTURE OF HUMAN DCK COMPLEXED WITH 2'-DEOXYCYTIDINE AND ADP, P 43 21 2 SPACE GROUP 1P60 ; 1.96 ; STRUCTURE OF HUMAN DCK COMPLEXED WITH 2'-DEOXYCYTIDINE AND ADP, SPACE GROUP C 2 2 21 1P5Z ; 1.60 ; STRUCTURE OF HUMAN DCK COMPLEXED WITH CYTARABINE AND ADP-MG 1P62 ; 1.90 ; STRUCTURE OF HUMAN DCK COMPLEXED WITH GEMCITABINE AND ADP-MG 1XML ; 2.00 ; STRUCTURE OF HUMAN DCPS 1XMM ; 2.50 ; STRUCTURE OF HUMAN DCPS BOUND TO M7GDP 1W6U ; 1.75 ; STRUCTURE OF HUMAN DECR TERNARY COMPLEX 1SQY ; 2.50 ; STRUCTURE OF HUMAN DIFERRIC LACTOFERRIN AT 2.5A RESOLUTION USING CRYSTALS GROWN AT PH 6.5 1G55 ; 1.80 ; STRUCTURE OF HUMAN DNMT2, AN ENIGMATIC DEOXYRIBONUCLEIC ACID METHYLTRANSFERASE HOMOLOGUE 1QFK ; 2.80 ; STRUCTURE OF HUMAN FACTOR VIIA AND ITS IMPLICATIONS FOR THE TRIGGERING OF BLOOD COAGULATION 1FIC ; 2.50 ; STRUCTURE OF HUMAN GAMMA FIBRINOGEN 30 KD CARBOXYL TERMINAL FRAGMENT 1FID ; 2.10 ; STRUCTURE OF HUMAN GAMMA FIBRINOGEN 30 KD CARBOXYL TERMINAL FRAGMENT 1L1F ; 2.70 ; STRUCTURE OF HUMAN GLUTAMATE DEHYDROGENASE-APO FORM 1BWC ; 2.10 ; STRUCTURE OF HUMAN GLUTATHIONE REDUCTASE COMPLEXED WITH AJOENE INHIBITOR AND SUBVERSIVE SUBSTRATE 2BLE ; 1.90 ; STRUCTURE OF HUMAN GUANOSINE MONOPHOSPHATE REDUCTASE GMPR1 IN COMPLEX WITH GMP 2BWG ; 2.40 ; STRUCTURE OF HUMAN GUANOSINE MONOPHOSPHATE REDUCTASE GMPR1 IN COMPLEX WITH GMP 1DG3 ; 1.80 ; STRUCTURE OF HUMAN GUANYLATE BINDING PROTEIN-1 IN NUCLEOTIDE FREE FORM 1KZS ; -1.00 ; STRUCTURE OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 VPR(34-51) PEPTIDE IN AQUEOUS TFE SOLUTION 1KZV ; -1.00 ; STRUCTURE OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 VPR(34-51) PEPTIDE IN CHLOROFORM METHANOL 1KZT ; -1.00 ; STRUCTURE OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 VPR(34-51) PEPTIDE IN DPC MICELLE CONTAINING AQUEOUS SOLUTION 1IVH ; 2.60 ; STRUCTURE OF HUMAN ISOVALERYL-COA DEHYDROGENASE AT 2.6 ANGSTROMS RESOLUTION: STRUCTURAL BASIS FOR SUBSTRATE SPECIFICITY 2CD0 ; 1.80 ; STRUCTURE OF HUMAN LAMBDA-6 LIGHT CHAIN DIMER WIL 1CD0 ; 1.90 ; STRUCTURE OF HUMAN LAMDA-6 LIGHT CHAIN DIMER JTO 1TEH ; 2.70 ; STRUCTURE OF HUMAN LIVER CHICHI ALCOHOL DEHYDROGENASE (A GLUTATHIONE-DEPENDENT FORMALDEHYDE DEHYDROGENASE) 1EFK ; 2.60 ; STRUCTURE OF HUMAN MALIC ENZYME IN COMPLEX WITH KETOMALONATE 1T4E ; 2.60 ; STRUCTURE OF HUMAN MDM2 IN COMPLEX WITH A BENZODIAZEPINE INHIBITOR 1T4F ; 1.90 ; STRUCTURE OF HUMAN MDM2 IN COMPLEX WITH AN OPTIMIZED P53 PEPTIDE 2AC3 ; 2.10 ; STRUCTURE OF HUMAN MNK2 KINASE DOMAIN 2AC5 ; 3.20 ; STRUCTURE OF HUMAN MNK2 KINASE DOMAIN MUTANT D228G 1ZJH ; 2.20 ; STRUCTURE OF HUMAN MUSCLE PYRUVATE KINASE (PKM2) 1DMT ; 2.10 ; STRUCTURE OF HUMAN NEUTRAL ENDOPEPTIDASE COMPLEXED WITH PHOSPHORAMIDON 1ZS6 ; 2.30 ; STRUCTURE OF HUMAN NUCLEOSIDE-DIPHOSPHATE KINASE 3 1W6K ; 2.10 ; STRUCTURE OF HUMAN OSC IN COMPLEX WITH LANOSTEROL 1W6J ; 2.20 ; STRUCTURE OF HUMAN OSC IN COMPLEX WITH RO 48-8071 1B2Y ; 3.20 ; STRUCTURE OF HUMAN PANCREATIC ALPHA-AMYLASE IN COMPLEX WITH THE CARBOHYDRATE INHIBITOR ACARBOSE 1ZWA ; -1.00 ; STRUCTURE OF HUMAN PARATHYROID HORMONE FRAGMENT 1-34, NMR, 10 STRUCTURES 1ZWB ; -1.00 ; STRUCTURE OF HUMAN PARATHYROID HORMONE FRAGMENT 2-37, NMR, 10 STRUCTURES 1ZWD ; -1.00 ; STRUCTURE OF HUMAN PARATHYROID HORMONE FRAGMENT 3-37, NMR, 10 STRUCTURES 1ZWE ; -1.00 ; STRUCTURE OF HUMAN PARATHYROID HORMONE FRAGMENT 4-37, NMR, 10 STRUCTURES 1UU8 ; 2.50 ; STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH BIM-1 1UU7 ; 1.90 ; STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH BIM-2 1UU9 ; 1.95 ; STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH BIM-3 1UVR ; 2.81 ; STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH BIM-8 1UU3 ; 1.70 ; STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH LY333531 1OKY ; 2.30 ; STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH STAUROSPORINE 1OKZ ; 2.51 ; STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH UCN-01 1LN3 ; 2.90 ; STRUCTURE OF HUMAN PHOSPHATIDYLCHOLINE TRANSFER PROTEIN IN COMPLEX WITH PALMITOYL-LINOLEOYL PHOSPHATIDYLCHOLINE (SELENO-MET PROTEIN) 1P49 ; 2.60 ; STRUCTURE OF HUMAN PLACENTAL ESTRONE/DHEA SULFATASE 1A7A ; 2.80 ; STRUCTURE OF HUMAN PLACENTAL S-ADENOSYLHOMOCYSTEINE HYDROLASE: DETERMINATION OF A 30 SELENIUM ATOM SUBSTRUCTURE FROM DATA AT A SINGLE WAVELENGTH 1V3Q ; 2.80 ; STRUCTURE OF HUMAN PNP COMPLEXED WITH DDI 1V3A ; -1.00 ; STRUCTURE OF HUMAN PRL-3, THE PHOSPHATASE ASSOCIATED WITH CANCER METASTASIS 1RSZ ; 2.20 ; STRUCTURE OF HUMAN PURINE NUCLEOSIDE PHOSPHORYLASE IN COMPLEX WITH DADME-IMMUCILLIN-H AND SULFATE 1RR6 ; 2.50 ; STRUCTURE OF HUMAN PURINE NUCLEOSIDE PHOSPHORYLASE IN COMPLEX WITH IMMUCILLIN-H AND PHOSPHATE 1RT9 ; 2.30 ; STRUCTURE OF HUMAN PURINE NUCLEOSIDE PHOSPHORYLASE IN COMPLEX WITH IMMUCILLIN-H AND SULFATE 1XG5 ; 1.53 ; STRUCTURE OF HUMAN PUTATIVE DEHYDROGENASE MGC4172 IN COMPLEX WITH NADP 1TH0 ; 2.20 ; STRUCTURE OF HUMAN SENP2 1TGZ ; 2.80 ; STRUCTURE OF HUMAN SENP2 IN COMPLEX WITH SUMO-1 1UVZ ; 2.01 ; STRUCTURE OF HUMAN THIOREDOXIN 2 1OGU ; 2.60 ; STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 2-ARYLAMINO-4-CYCLOHEXYLMETHYL-5-NITROSO-6-AMINOPYRIMIDINE INHIBITOR 1OI9 ; 2.10 ; STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 6-CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR 1OIU ; 2.00 ; STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 6-CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR 1OIY ; 2.40 ; STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 6-CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR 1H1P ; 2.10 ; STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH THE INHIBITOR NU2058 1H1R ; 2.00 ; STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH THE INHIBITOR NU6086 1H1Q ; 2.50 ; STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH THE INHIBITOR NU6094 1H1S ; 2.00 ; STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH THE INHIBITOR NU6102 1YPV ; 1.80 ; STRUCTURE OF HUMAN THYMIDYLATE SYNTHASE AT LOW SALT CONDITIONS 1HW3 ; 2.00 ; STRUCTURE OF HUMAN THYMIDYLATE SYNTHASE SUGGESTS ADVANTAGES OF CHEMOTHERAPY WITH NONCOMPETITIVE INHIBITORS 1SUV ; 7.50 ; STRUCTURE OF HUMAN TRANSFERRIN RECEPTOR-TRANSFERRIN COMPLEX 1E3F ; 1.90 ; STRUCTURE OF HUMAN TRANSTHYRETIN COMPLEXED WITH BROMOPHENOLS: A NEW MODE OF BINDING 1E4H ; 1.80 ; STRUCTURE OF HUMAN TRANSTHYRETIN COMPLEXED WITH BROMOPHENOLS: A NEW MODE OF BINDING 1E5A ; 1.80 ; STRUCTURE OF HUMAN TRANSTHYRETIN COMPLEXED WITH BROMOPHENOLS: A NEW MODE OF BINDING 1H4W ; 1.70 ; STRUCTURE OF HUMAN TRYPSIN IV (BRAIN TRYPSIN) 1XTJ ; 2.70 ; STRUCTURE OF HUMAN UAP56 IN COMPLEX WITH ADP 1ZUO ; 1.80 ; STRUCTURE OF HUMAN UBIQUITIN-CONJUGATING ENZYME (UBCI) INVOLVED IN EMBRYO ATTACHMENT AND IMPLANTATION 2AWF ; 2.10 ; STRUCTURE OF HUMAN UBIQUITIN-CONJUGATING ENZYME E2 G1 1EK6 ; 1.50 ; STRUCTURE OF HUMAN UDP-GALACTOSE 4-EPIMERASE COMPLEXED WITH NADH AND UDP-GLUCOSE 1EK5 ; 1.80 ; STRUCTURE OF HUMAN UDP-GALACTOSE 4-EPIMERASE IN COMPLEX WITH NAD+ 1VPF ; 2.50 ; STRUCTURE OF HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR 1X8B ; 1.81 ; STRUCTURE OF HUMAN WEE1A KINASE: KINASE DOMAIN COMPLEXED WITH INHIBITOR PD0407824 1ZGT ; 1.45 ; STRUCTURE OF HYDROGENATED RAT GAMMA E CRYSTALLIN IN H2O 2AMG ; 2.20 ; STRUCTURE OF HYDROLASE (GLYCOSIDASE) 5PTP ; 1.34 ; STRUCTURE OF HYDROLASE (SERINE PROTEINASE) 1V8A ; 1.85 ; STRUCTURE OF HYDROXYETHYLTHIAZOLE KINASE PROTEIN FROM PYROCOCCUS HORIKOSHII OT3 2CVZ ; 1.80 ; STRUCTURE OF HYDROXYISOBUTYRATE DEHYDROGENASE FROM THERMUS THERMOPHILUS HB8 1NG6 ; 1.40 ; STRUCTURE OF HYPOTHETICAL CYTOSOLIC PROTEIN YQEY 1QZ4 ; 2.00 ; STRUCTURE OF HYPOTHETICAL ESCHERICHIA COLI PROTEIN YCFC 1RFZ ; 2.80 ; STRUCTURE OF HYPOTHETICAL PROTEIN APC35681 FROM BACILLUS STEAROTHERMOPHILUS 1RZ3 ; 1.90 ; STRUCTURE OF HYPOTHETICAL PROTEIN FROM BACILLUS STEAROTHERMOPHILUS 2AR1 ; 1.60 ; STRUCTURE OF HYPOTHETICAL PROTEIN FROM LEISHMANIA MAJOR 2EWC ; 2.15 ; STRUCTURE OF HYPOTHETICAL PROTEIN FROM STREPTOCOCCUS PYOGENES M1 GAS, MEMBER OF HIGHLY CONSERVED YJGF FAMILY OF PROTEINS 1NC5 ; 1.60 ; STRUCTURE OF HYPOTHETICAL PROTEIN OF YTER FROM BACILLUS SUBTILIS 1PV5 ; 1.75 ; STRUCTURE OF HYPOTHETICAL PROTEIN YWQG FROM BACILLUS SUBTILIS 1YEH ; 2.55 ; STRUCTURE OF IGG2A FAB FRAGMENT 1YEG ; 2.00 ; STRUCTURE OF IGG2A FAB FRAGMENT (D2.3) COMPLEXED WITH REACTION PRODUCT 1YEF ; 2.00 ; STRUCTURE OF IGG2A FAB FRAGMENT (D2.3) COMPLEXED WITH SUBSTRATE ANALOGUE 1VKR ; -1.00 ; STRUCTURE OF IIB DOMAIN OF THE MANNITOL-SPECIFIC PERMEASE ENZYME II 3HVT ; 2.90 ; STRUCTURE OF IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE HETERODIMER 1IGT ; 2.80 ; STRUCTURE OF IMMUNOGLOBULIN 1IGY ; 3.20 ; STRUCTURE OF IMMUNOGLOBULIN 1QGK ; 2.50 ; STRUCTURE OF IMPORTIN BETA BOUND TO THE IBB DOMAIN OF IMPORTIN ALPHA 1QGR ; 2.30 ; STRUCTURE OF IMPORTIN BETA BOUND TO THE IBB DOMAIN OF IMPORTIN ALPHA (II CRYSTAL FORM, GROWN AT LOW PH) 1E9G ; 1.15 ; STRUCTURE OF INORGANIC PYROPHOSPHATASE 1I40 ; 1.10 ; STRUCTURE OF INORGANIC PYROPHOSPHATASE 1I6T ; 1.20 ; STRUCTURE OF INORGANIC PYROPHOSPHATASE 1JFD ; 2.15 ; STRUCTURE OF INORGANIC PYROPHOSPHATASE 1M38 ; 1.80 ; STRUCTURE OF INORGANIC PYROPHOSPHATASE 1OBW ; 1.90 ; STRUCTURE OF INORGANIC PYROPHOSPHATASE 1WGI ; 2.20 ; STRUCTURE OF INORGANIC PYROPHOSPHATASE 1WGJ ; 2.00 ; STRUCTURE OF INORGANIC PYROPHOSPHATASE 1MJW ; 1.95 ; STRUCTURE OF INORGANIC PYROPHOSPHATASE MUTANT D42N 1MJX ; 2.15 ; STRUCTURE OF INORGANIC PYROPHOSPHATASE MUTANT D65N 1MJY ; 2.15 ; STRUCTURE OF INORGANIC PYROPHOSPHATASE MUTANT D70N 1MJZ ; 2.15 ; STRUCTURE OF INORGANIC PYROPHOSPHATASE MUTANT D97N 1Y52 ; 1.70 ; STRUCTURE OF INSECT CELL (BACULOVIRUS) EXPRESSED AVR4 (C122S)-BIOTIN COMPLEX 1XDA ; 1.80 ; STRUCTURE OF INSULIN 1ZEH ; 1.50 ; STRUCTURE OF INSULIN 1I16 ; -1.00 ; STRUCTURE OF INTERLEUKIN 16: IMPLICATIONS FOR FUNCTION, NMR, 20 STRUCTURES 1Z92 ; 2.80 ; STRUCTURE OF INTERLEUKIN-2 WITH ITS ALPHA RECEPTOR 2C3V ; 1.39 ; STRUCTURE OF IODINATED CBM25 FROM BACILLUS HALODURANS AMYLASE 2C3X ; 2.70 ; STRUCTURE OF IODINATED CBM25 FROM BACILLUS HALODURANS AMYLASE IN COMPLEX WITH MALTOTETRAOSE 1E5W ; 2.70 ; STRUCTURE OF ISOLATED FERM DOMAIN AND FIRST LONG HELIX OF MOESIN 1GPQ ; 1.60 ; STRUCTURE OF IVY COMPLEXED WITH ITS TARGET, HEWL 1KRN ; 1.67 ; STRUCTURE OF KRINGLE 4 AT 4C TEMPERATURE AND 1.67 ANGSTROMS RESOLUTION 1SIO ; 1.80 ; STRUCTURE OF KUMAMOLISIN-AS COMPLEXED WITH A COVALENTLY- BOUND INHIBITOR, ACIPF 1AQ6 ; 1.95 ; STRUCTURE OF L-2-HALOACID DEHALOGENASE FROM XANTHOBACTER AUTOTROPHICUS 1QQ5 ; 1.52 ; STRUCTURE OF L-2-HALOACID DEHALOGENASE FROM XANTHOBACTER AUTOTROPHICUS 1QQ6 ; 2.10 ; STRUCTURE OF L-2-HALOACID DEHALOGENASE FROM XANTHOBACTER AUTOTROPHICUS WITH CHLOROACETIC ACID COVALENTLY BOUND 1QQ7 ; 1.70 ; STRUCTURE OF L-2-HALOACID DEHALOGENASE FROM XANTHOBACTER AUTOTROPHICUS WITH CHLOROPROPIONIC ACID COVALENTLY BOUND 1B65 ; 1.82 ; STRUCTURE OF L-AMINOPEPTIDASE D-ALA-ESTERASE/AMIDASE FROM OCHROBACTRUM ANTHROPI, A PROTOTYPE FOR THE SERINE AMINOPEPTIDASES, REVEALS A NEW VARIANT AMONG THE NTN HYDROLASE FOLD 1CHU ; 2.20 ; STRUCTURE OF L-ASPARTATE OXIDASE: IMPLICATIONS FOR THE SUCCINATE DEHYDROGENASE/ FUMARATE REDUCATSE FAMILY 2BLJ ; 1.80 ; STRUCTURE OF L29W MBCO 1NW8 ; 2.25 ; STRUCTURE OF L72P MUTANT BETA CLASS N6-ADENINE DEOXYRIBONUCLEIC ACID METHYLTRANSFERASE RSRI 2BSD ; 2.30 ; STRUCTURE OF LACTOCOCCAL BACTERIOPHAGE P2 RECEPTOR BINDING PROTEIN 2BSE ; 2.70 ; STRUCTURE OF LACTOCOCCAL BACTERIOPHAGE P2 RECEPTOR BINDING PROTEIN IN COMPLEX WITH A LLAMA VHH DOMAIN 1IFR ; 1.40 ; STRUCTURE OF LAMIN A/C GLOBULAR DOMAIN 1N8R ; 3.00 ; STRUCTURE OF LARGE RIBOSOMAL SUBUNIT IN COMPLEX WITH VIRGINIAMYCIN M 1HS6 ; 1.95 ; STRUCTURE OF LEUKOTRIENE A4 HYDROLASE COMPLEXED WITH BESTATIN. 1GW6 ; 2.20 ; STRUCTURE OF LEUKOTRIENE A4 HYDROLASE D375N MUTANT 1XF4 ; 2.50 ; STRUCTURE OF LIGAND-FREE FAB DEOXYRIBONUCLEIC ACID-1 IN SPACE GROUP P321 SOLVED FROM CRYSTALS WITH PERFECT HEMIHEDRAL TWINNING 1XF3 ; 2.30 ; STRUCTURE OF LIGAND-FREE FAB DEOXYRIBONUCLEIC ACID-1 IN SPACE GROUP P65 1JW4 ; 2.00 ; STRUCTURE OF LIGAND-FREE MALTODEXTRIN-BINDING PROTEIN 1B33 ; 2.30 ; STRUCTURE OF LIGHT HARVESTING COMPLEX OF ALLOPHYCOCYANIN ALPHA AND BETA CHAINS/ CORE-LINKER COMPLEX APLC7.8 1G5F ; 1.80 ; STRUCTURE OF LINB COMPLEXED WITH 1,2-DICHLOROETHANE 1OIL ; 2.10 ; STRUCTURE OF LIPASE 354D ; 1.50 ; STRUCTURE OF LOOP E FROM E. COLI 5S RRNA 1HC0 ; 1.82 ; STRUCTURE OF LYSOZYME WITH PERIODATE 1P9L ; 2.30 ; STRUCTURE OF M. TUBERCULOSIS DIHYDRODIPICOLINATE REDUCTASE IN COMPLEX WITH NADH AND 2,6 PDC 1JWP ; 1.75 ; STRUCTURE OF M182T MUTANT OF TEM-1 BETA-LACTAMASE 1BY2 ; 2.00 ; STRUCTURE OF M2BP SCAVENGER RECEPTOR CYSTEINE-RICH DOMAIN 1V9N ; 2.10 ; STRUCTURE OF MALATE DEHYDROGENASE FROM PYROCOCCUS HORIKOSHII OT3 1JW5 ; 2.00 ; STRUCTURE OF MALTOSE BOUND TO OPEN-FORM MALTODEXTRIN- BINDING PROTEIN IN P1 CRYSTAL 1EZ9 ; 1.90 ; STRUCTURE OF MALTOTETRAITOL BOUND TO OPEN-FORM MALTODEXTRIN BINDING PROTEIN IN P1 CRYSTAL FORM 1FQA ; 1.90 ; STRUCTURE OF MALTOTETRAITOL BOUND TO OPEN-FORM MALTODEXTRIN BINDING PROTEIN IN P2(1)CRYSTAL FORM 1FQB ; 1.90 ; STRUCTURE OF MALTOTRIOTOL BOUND TO OPEN-FORM MALTODEXTRIN BINDING PROTEIN IN P2(1)CRYSTAL FORM 1PO5 ; 1.60 ; STRUCTURE OF MAMMALIAN CYTOCHROME P450 2B4 1SUO ; 1.90 ; STRUCTURE OF MAMMALIAN CYTOCHROME P450 2B4 WITH BOUND 4-(4- CHLOROPHENYL)IMIDAZOLE 1DT6 ; 3.00 ; STRUCTURE OF MAMMALIAN CYTOCHROME P450 2C5 1Y2A ; 2.20 ; STRUCTURE OF MAMMALIAN IMPORTIN BOUND TO THE NON-CLASSICAL PLSCR1-NLS 2B34 ; 2.14 ; STRUCTURE OF MAR1 RIBONUCLEASE FROM CAENORHABDITIS ELEGANS 1SPJ ; 1.70 ; STRUCTURE OF MATURE HUMAN TISSUE KALLIKREIN (HUMAN KALLIKREIN 1 OR KLK1) AT 1.70 ANGSTROM RESOLUTION WITH VACANT ACTIVE SITE 1OA9 ; 2.00 ; STRUCTURE OF MELANOCARPUS ALBOMYCES ENDOGLUCANASE 1OA7 ; 2.00 ; STRUCTURE OF MELANOCARPUS ALBOMYCES ENDOGLUCANASE IN COMPLEX WITH CELLOBIOSE 1I1J ; 1.39 ; STRUCTURE OF MELANOMA INHIBITORY ACTIVITY PROTEIN: A MEMBER OF A NEW FAMILY OF SECRETED PROTEINS 2BSZ ; 2.00 ; STRUCTURE OF MESORHIZOBIUM LOTI ARYLAMINE N- ACETYLTRANSFERASE 1 1PXS ; 2.20 ; STRUCTURE OF MET56ALA MUTANT OF BACTERIORHODOPSIN 1MWU ; 2.60 ; STRUCTURE OF METHICILLIN ACYL-PENICILLIN BINDING PROTEIN 2A FROM METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS STRAIN 27R AT 2.60 A RESOLUTION. 1LU9 ; 1.90 ; STRUCTURE OF METHYLENE-TETRAHYDROMETHANOPTERIN DEHYDROGENASE FROM METHYLOBACTERIUM EXTORQUENS AM1 1LUA ; 1.90 ; STRUCTURE OF METHYLENE-TETRAHYDROMETHANOPTERIN DEHYDROGENASE FROM METHYLOBACTERIUM EXTORQUENS AM1 COMPLEXED WITH NADP 1EGH ; 2.00 ; STRUCTURE OF METHYLGLYOXAL SYNTHASE COMPLEXED WITH THE COMPETITIVE INHIBITOR 2-PHOSPHOGLYCOLATE 1N9H ; 1.80 ; STRUCTURE OF MICROGRAVITY-GROWN OXIDIZED MYOGLOBIN MUTANT YQR (ISS6A) 1N9X ; 1.60 ; STRUCTURE OF MICROGRAVITY-GROWN OXIDIZED MYOGLOBIN MUTANT YQR (ISS8A) 1NAZ ; 1.04 ; STRUCTURE OF MICROGRAVITY-GROWN OXIDIZED MYOGLOBIN MUTANT YQR (ISS8A) 1INQ ; 2.20 ; STRUCTURE OF MINOR HISTOCOMPATIBILITY ANTIGEN PEPTIDE, H13A, COMPLEXED TO H2-DB 1JUF ; 2.00 ; STRUCTURE OF MINOR HISTOCOMPATIBILITY ANTIGEN PEPTIDE, H13B, COMPLEXED TO H2-DB 1N1N ; -1.00 ; STRUCTURE OF MISPAIRING OF THE DEOXYCYTOSINE WITH DEOXYADENOSINE 5' TO THE 8,9-DIHYDRO-8-(N7-GUANYL)-9- HYDROXY-AFLATOXIN B1 ADDUCT 1OKC ; 2.20 ; STRUCTURE OF MITOCHONDRIAL ADP/ATP CARRIER IN COMPLEX WITH CARBOXYATRACTYLOSIDE 2C9H ; 1.80 ; STRUCTURE OF MITOCHONDRIAL BETA-KETOACYL SYNTHASE 1XMF ; 2.32 ; STRUCTURE OF MN(II)-SOAKED APO METHANE MONOOXYGENASE HYDROXYLASE CRYSTALS FROM M. CAPSULATUS (BATH) 1TV8 ; 2.20 ; STRUCTURE OF MOAA IN COMPLEX WITH S-ADENOSYLMETHIONINE 1DR8 ; 2.70 ; STRUCTURE OF MODIFIED 3-ISOPROPYLMALATE DEHYDROGENASE AT THE C-TERMINUS, HD177 1DR0 ; 2.20 ; STRUCTURE OF MODIFIED 3-ISOPROPYLMALATE DEHYDROGENASE AT THE C-TERMINUS, HD708 1MN8 ; 1.00 ; STRUCTURE OF MOLONEY MURINE LEUKAEMIA VIRUS MATRIX PROTEIN 1DDB ; -1.00 ; STRUCTURE OF MOUSE BID, NMR, 20 STRUCTURES 1NXC ; 1.51 ; STRUCTURE OF MOUSE GOLGI ALPHA-1,2-MANNOSIDASE IA REVEALS THE MOLECULAR BASIS FOR SUBSTRATE SPECIFICITY AMONG CLASS I ENZYMES (FAMILY 47 GLYCOSIDASES) 1CKO ; 3.10 ; STRUCTURE OF MRNA CAPPING ENZYME IN COMPLEX WITH THE CAP ANALOG GPPPG 1ZDI ; 2.70 ; STRUCTURE OF MS2 PROTEIN CAPSID 1JSQ ; 4.50 ; STRUCTURE OF MSBA FROM ESCHERICHIA COLI: A HOMOLOG OF THE MULTIDRUG RESISTANCE ATP BINDING CASSETTE (ABC) TRANSPORTERS 1PF4 ; 3.80 ; STRUCTURE OF MSBA FROM VIBRIO CHOLERA: A MULTIDRUG RESISTANCE ABC TRANSPORTER HOMOLOG IN A CLOSED CONFORMATION 1MP2 ; 2.30 ; STRUCTURE OF MT-ADPRASE (APOENZYME), A NUDIX HYDROLASE FROM MYCOBACTERIUM TUBERCULOSIS 1KJN ; 2.20 ; STRUCTURE OF MT0777 1ZZO ; 1.60 ; STRUCTURE OF MTB DSBF IN ITS OXIDIZED FORM. 1OQK ; -1.00 ; STRUCTURE OF MTH11: A HOMOLOGUE OF HUMAN RNASE P PROTEIN RPP29 1MUC ; 1.85 ; STRUCTURE OF MUCONATE LACTONIZING ENZYME AT 1.85 ANGSTROMS RESOLUTION 1EYN ; 1.70 ; STRUCTURE OF MURA LIGANDED WITH THE EXTRINSIC FLUORESCENCE PROBE ANS 1E8C ; 2.00 ; STRUCTURE OF MURE THE UDP-N-ACETYLMURAMYL TRIPEPTIDE SYNTHETASE FROM E. COLI 1K1K ; 2.00 ; STRUCTURE OF MUTANT HUMAN CARBONMONOXYHEMOGLOBIN C (BETA E6K) AT 2.0 ANGSTROM RESOLUTION IN PHOSPHATE BUFFER. 1IDZ ; -1.00 ; STRUCTURE OF MYB TRANSFORMING PROTEIN, NMR, 20 STRUCTURES 1IDY ; -1.00 ; STRUCTURE OF MYB TRANSFORMING PROTEIN, NMR, MINIMIZED AVERAGE STRUCTURE 1Y25 ; 2.10 ; STRUCTURE OF MYCOBACTERIAL THIOL PEROXIDASE TPX 1NWA ; 1.50 ; STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS METHIONINE SULFOXIDE REDUCTASE A IN COMPLEX WITH PROTEIN-BOUND METHIONINE 1ZJ8 ; 2.80 ; STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS NIRA PROTEIN 1ZJ9 ; 2.90 ; STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS NIRA PROTEIN 1USL ; 1.88 ; STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS RIBOSE-5-PHOSPHATE ISOMERASE, RPIB, RV2465C, COMPLEXED WITH PHOSPHATE. 2BET ; 2.20 ; STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS RIBOSE-5-PHOSPHATE ISOMERASE, RPIB, RV2465C, IN COMPLEX WITH 4-PHOSPHO-D- ERYTHRONATE. 2BES ; 2.10 ; STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS RIBOSE-5-PHOSPHATE ISOMERASE, RPIB, RV2465C, IN COMPLEX WITH 4-PHOSPHO-D- ERYTHRONOHYDROXAMIC ACID. 1NEU ; 1.90 ; STRUCTURE OF MYELIN MEMBRANE ADHESION MOLECULE P0 1YIV ; 2.10 ; STRUCTURE OF MYELIN P2 PROTEIN FROM EQUINE SPINAL CORD 1MZ0 ; 1.60 ; STRUCTURE OF MYOGLOBIN MB-YQR 316 NS AFTER PHOTOLYSIS OF CARBON MONOXIDE SOLVED FROM LAUE DATA AT RT. 1ZWF ; -1.00 ; STRUCTURE OF N-TERMINAL ACETYLATED HUMAN PARATHYROID HORMONE, NMR, 10 STRUCTURES 1Y2O ; 2.20 ; STRUCTURE OF N-TERMINAL DOMAIN IRSP53/BAIAP2 1MJD ; -1.00 ; STRUCTURE OF N-TERMINAL DOMAIN OF HUMAN DOUBLECORTIN 1MFW ; 1.60 ; STRUCTURE OF N-TERMINAL DOUBLECORTIN DOMAIN FROM DCLK: SELENOMETHIONINE LABELED PROTEIN 1MG4 ; 1.50 ; STRUCTURE OF N-TERMINAL DOUBLECORTIN DOMAIN FROM DCLK: WILD TYPE PROTEIN 2BRA ; 2.00 ; STRUCTURE OF N-TERMINAL FAD BINDING MOTIF OF MOUSE MICAL 1PI5 ; 1.49 ; STRUCTURE OF N289A MUTANT OF AMPC IN COMPLEX WITH SM2, CARBOXYPHENYLGLYCYLBORONIC ACID BEARING THE CEPHALOTHIN R1 SIDE CHAIN 1PI4 ; 1.39 ; STRUCTURE OF N289A MUTANT OF AMPC IN COMPLEX WITH SM3, A PHENYLGLYCLBORONIC ACID BEARING THE CEPHALOTHIN R1 SIDE CHAIN 1B6S ; 2.50 ; STRUCTURE OF N5-CARBOXYAMINOIMIDAZOLE RIBONUCLEOTIDE SYNTHETASE 1KEV ; 2.05 ; STRUCTURE OF NADP-DEPENDENT ALCOHOL DEHYDROGENASE 1VDC ; 2.50 ; STRUCTURE OF NADPH DEPENDENT THIOREDOXIN REDUCTASE 1PYF ; 1.80 ; STRUCTURE OF NADPH-DEPENDENT FAMILY 11 ALDO-KETO REDUCTASE AKR11A(APO) 1PZ0 ; 2.35 ; STRUCTURE OF NADPH-DEPENDENT FAMILY 11 ALDO-KETO REDUCTASE AKR11A(HOLO) 1PZ1 ; 2.20 ; STRUCTURE OF NADPH-DEPENDENT FAMILY 11 ALDO-KETO REDUCTASE AKR11B(HOLO) 1PNB ; -1.00 ; STRUCTURE OF NAPIN BNIB, NMR, 10 STRUCTURES 1M4L ; 1.25 ; STRUCTURE OF NATIVE CARBOXYPEPTIDASE A AT 1.25 RESOLUTION 1HQ4 ; 2.70 ; STRUCTURE OF NATIVE CATALYTIC ANTIBODY HA5-19A4 1FMU ; 2.70 ; STRUCTURE OF NATIVE PROTEINASE A IN P3221 SPACE GROUP. 1FMX ; 2.61 ; STRUCTURE OF NATIVE PROTEINASE A IN THE SPACE GROUP P21 2UBP ; 2.00 ; STRUCTURE OF NATIVE UREASE FROM BACILLUS PASTEURII 1XFA ; 3.10 ; STRUCTURE OF NBD1 FROM MURINE CFTR- F508R MUTANT 1XF9 ; 2.70 ; STRUCTURE OF NBD1 FROM MURINE CFTR- F508S MUTANT 1MN4 ; 2.20 ; STRUCTURE OF NDT80 (RESIDUES 59-340) DEOXYRIBONUCLEIC ACID-BINDING DOMAIN CORE 1NDD ; 1.60 ; STRUCTURE OF NEDD8 1VER ; 2.82 ; STRUCTURE OF NEW ANTIGEN RECEPTOR VARIABLE DOMAIN FROM SHARKS 1VES ; 2.18 ; STRUCTURE OF NEW ANTIGEN RECEPTOR VARIABLE DOMAIN FROM SHARKS 2COQ ; 2.10 ; STRUCTURE OF NEW ANTIGEN RECEPTOR VARIABLE DOMAIN FROM SHARKS 1BFS ; 2.20 ; STRUCTURE OF NF-KB P50 HOMODIMER BOUND TO A KB SITE 1BFT ; 2.00 ; STRUCTURE OF NF-KB P50 HOMODIMER BOUND TO A KB SITE 1P7H ; 2.60 ; STRUCTURE OF NFAT1 BOUND AS A DIMER TO THE HIV-1 LTR KB ELEMENT 1M7Z ; 2.14 ; STRUCTURE OF NITRIC OXIDE SYNTHASE HEME PROTEIN FROM BACILLUS SUBTILIS WITH N-HYDROXY-ARGININE AND TETRAHYDROFOLATE BOUND 1AS6 ; 2.00 ; STRUCTURE OF NITRITE BOUND TO OXIDIZED ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE 1AS8 ; 1.85 ; STRUCTURE OF NITRITE BOUND TO REDUCED ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE 1MWS ; 2.00 ; STRUCTURE OF NITROCEFIN ACYL-PENICILLIN BINDING PROTEIN 2A FROM METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS STRAIN 27R AT 2.00 A RESOLUTION. 1KQD ; 1.90 ; STRUCTURE OF NITROREDUCTASE FROM E. CLOACAE BOUND WITH 2E- REDUCED FLAVIN MONONUCLEOTIDE (FMN) 1KQC ; 1.80 ; STRUCTURE OF NITROREDUCTASE FROM E. CLOACAE COMPLEX WITH INHIBITOR ACETATE 1KQB ; 1.80 ; STRUCTURE OF NITROREDUCTASE FROM E. CLOACAE COMPLEX WITH INHIBITOR BENZOATE 1YJO ; 1.30 ; STRUCTURE OF NNQQNY FROM YEAST PRION SUP35 WITH ZINC ACETATE 1DUW ; 1.89 ; STRUCTURE OF NONAHEME CYTOCHROME C 1TT4 ; 2.80 ; STRUCTURE OF NP459575, A PREDICTED GLUTATHIONE SYNTHASE FROM SALMONELLA TYPHIMURIUM 1ZO2 ; 1.60 ; STRUCTURE OF NUCLEAR TRANSPORT FACTOR 2 (NTF2) FROM CRYPTOSPORIDIUM PARVUM 1KDN ; 2.00 ; STRUCTURE OF NUCLEOSIDE DIPHOSPHATE KINASE 1S59 ; 2.60 ; STRUCTURE OF NUCLEOSIDE DIPHOSPHATE KINASE 2 WITH BOUND DGTP FROM ARABIDOPSIS 1B4S ; 2.50 ; STRUCTURE OF NUCLEOSIDE DIPHOSPHATE KINASE H122G MUTANT 1V7R ; 1.40 ; STRUCTURE OF NUCLEOTIDE TRIPHOSPHATE PYROPHOSPHATASE FROM PYROCOCCUS HORIKOSHII OT3 1SR6 ; 2.75 ; STRUCTURE OF NUCLEOTIDE-FREE SCALLOP MYOSIN S1 1GUP ; 1.80 ; STRUCTURE OF NUCLEOTIDYLTRANSFERASE COMPLEXED WITH UDP-GALACTOSE 1GUQ ; 1.80 ; STRUCTURE OF NUCLEOTIDYLTRANSFERASE COMPLEXED WITH UDP-GLUCOSE 1QVJ ; 1.91 ; STRUCTURE OF NUDT9 COMPLEXED WITH RIBOSE-5-PHOSPHATE 1S7Z ; 1.83 ; STRUCTURE OF OCR FROM BACTERIOPHAGE T7 1B05 ; 2.00 ; STRUCTURE OF OLIGO-PEPTIDE BINDING PROTEIN COMPLEXED WITH LYS-CYS-LYS 1XCS ; 1.40 ; STRUCTURE OF OLIGONUCLEOTIDE/DRUG COMPLEX 1TU7 ; 1.50 ; STRUCTURE OF ONCHOCERCA VOLVULUS PI-CLASS GLUTATHIONE S- TRANSFERASE 1TU8 ; 1.80 ; STRUCTURE OF ONCHOVERCA VOLVULUS PI-CLASS GLUTATHIONE S- TRANSFERASE WITH ITS KOMPETITIVE INHIBITOR S-HEXYL-GSH 1RKM ; 2.40 ; STRUCTURE OF OPPA 2RKM ; 1.80 ; STRUCTURE OF OPPA COMPLEXED WITH LYS-LYS 2BYL ; 2.15 ; STRUCTURE OF ORNITHINE AMINOTRANSFERASE TRIPLE MUTANT Y85I Y55A G320F 1EIX ; 2.50 ; STRUCTURE OF OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE FROM E. COLI, CO-CRYSTALLISED WITH THE INHIBITOR BMP 1UKK ; 1.60 ; STRUCTURE OF OSMOTICALLY INDUCIBLE PROTEIN C FROM THERMUS THERMOPHILUS 1TFF ; 2.10 ; STRUCTURE OF OTUBAIN-2 1E4D ; 1.80 ; STRUCTURE OF OXA10 BETA-LACTAMASE AT PH 8.3 1B7Z ; 2.70 ; STRUCTURE OF OXALATE SUBSTITUTED DIFERRIC MARE LACTOFERRIN FROM COLOSTRUM 1XLP ; 2.00 ; STRUCTURE OF OXIDIZED C73S PUTIDAREDOXIN FROM PSEUDOMONAS PUTIDA 1DW0 ; 1.82 ; STRUCTURE OF OXIDIZED SHP, AN OXYGEN BINDING CYTOCHROME C 1SF5 ; 1.10 ; STRUCTURE OF OXIDIZED STATE OF THE P94A MUTANT OF AMICYANIN 1SPU ; 2.00 ; STRUCTURE OF OXIDOREDUCTASE 1VJW ; 1.75 ; STRUCTURE OF OXIDOREDUCTASE (NADP+(A),FERREDOXIN(A)) 1KKT ; 2.20 ; STRUCTURE OF P. CITRINUM ALPHA 1,2-MANNOSIDASE REVEALS THE BASIS FOR DIFFERENCES IN SPECIFICITY OF THE ER AND GOLGI CLASS I ENZYMES 1KRE ; 2.20 ; STRUCTURE OF P. CITRINUM ALPHA 1,2-MANNOSIDASE REVEALS THE BASIS FOR DIFFERENCES IN SPECIFICITY OF THE ER AND GOLGI CLASS I ENZYMES 1KRF ; 2.20 ; STRUCTURE OF P. CITRINUM ALPHA 1,2-MANNOSIDASE REVEALS THE BASIS FOR DIFFERENCES IN SPECIFICITY OF THE ER AND GOLGI CLASS I ENZYMES 1OB3 ; 1.90 ; STRUCTURE OF P. FALCIPARUM PFPK5 1V0O ; 1.90 ; STRUCTURE OF P. FALCIPARUM PFPK5-INDIRUBIN-5-SULPHONATE LIGAND COMPLEX 1V0P ; 2.00 ; STRUCTURE OF P. FALCIPARUM PFPK5-PURVALANOL B LIGAND COMPLEX 1Z25 ; 2.70 ; STRUCTURE OF P.FURIOSUS ARGONAUTE WITH BOUND MN2+ 1MX4 ; 2.00 ; STRUCTURE OF P18INK4C (F82Q) 1MX6 ; 2.00 ; STRUCTURE OF P18INK4C (F92N) 1CTQ ; 1.26 ; STRUCTURE OF P21RAS IN COMPLEX WITH GPPNHP AT 100 K 1QRA ; 1.60 ; STRUCTURE OF P21RAS IN COMPLEX WITH GTP AT 100 K 1YPW ; 3.50 ; STRUCTURE OF P97/VCP IN COMPLEX IN ADP/AMP-PNP 1YQ0 ; 4.50 ; STRUCTURE OF P97/VCP IN COMPLEX WITH ADP/ADP.ALFX 1RKI ; 1.60 ; STRUCTURE OF PAG5_736 FROM P. AEROPHILUM WITH THREE DISULPHIDE BONDS 1ZX4 ; 2.98 ; STRUCTURE OF PARB BOUND TO DEOXYRIBONUCLEIC ACID 1ZKN ; 2.10 ; STRUCTURE OF PDE4D2-IBMX 2BIY ; 1.95 ; STRUCTURE OF PDK1-S241A MUTANT KINASE DOMAIN 1HKD ; 2.09 ; STRUCTURE OF PEA LECTIN IN COMPLEX WITH ALPHA-METHYL-D-GLUCOPYRANOSIDE 1OMQ ; -1.00 ; STRUCTURE OF PENETRATIN IN BICELLAR SOLUTION 1VQQ ; 1.80 ; STRUCTURE OF PENICILLIN BINDING PROTEIN 2A FROM METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS STRAIN 27R AT 1.80 A RESOLUTION. 1MWT ; 2.45 ; STRUCTURE OF PENICILLIN G ACYL-PENICILLIN BINDING PROTEIN 2A FROM METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS STRAIN 27R AT 2.45 A RESOLUTION. 1PME ; 2.00 ; STRUCTURE OF PENTA MUTANT HUMAN ERK2 MAP KINASE COMPLEXED WITH A SPECIFIC INHIBITOR OF HUMAN P38 MAP KINASE 1H62 ; 1.90 ; STRUCTURE OF PENTAERYTHRITOL TETRANITRATE REDUCTASE IN COMPLEX WITH 1,4-ANDROSTADIEN-3,17-DIONE 1H61 ; 1.40 ; STRUCTURE OF PENTAERYTHRITOL TETRANITRATE REDUCTASE IN COMPLEX WITH PREDNISONE 1H60 ; 1.60 ; STRUCTURE OF PENTAERYTHRITOL TETRANITRATE REDUCTASE IN COMPLEX WITH PROGESTERONE 1O08 ; 1.20 ; STRUCTURE OF PENTAVALENT PHOSPHOROUS INTERMEDIATE OF AN ENZYME CATALYZED PHOSPHORYL TRANSFER REACTION OBSERVED ON COCRYSTALLIZATION WITH GLUCOSE 1-PHOSPHATE 1O03 ; 1.40 ; STRUCTURE OF PENTAVALENT PHOSPHOROUS INTERMEDIATE OF AN ENZYME CATALYZED PHOSPHORYL TRANSFER REACTION OBSERVED ON COCRYSTALLIZATION WITH GLUCOSE 6-PHOSPHATE 1LM4 ; 1.45 ; STRUCTURE OF PEPTIDE DEFORMYLASE FROM STAPHYLOCOCCUS AUREUS AT 1.45 A 1G6D ; 2.90 ; STRUCTURE OF PEPTIDYL-D(CGCAATTGCG) IN THE PRESENCE OF ZINC IONS 2ABB ; 1.00 ; STRUCTURE OF PETN REDUCTASE Y186F IN COMPLEX WITH CYANIDE 1ZUG ; -1.00 ; STRUCTURE OF PHAGE 434 CRO PROTEIN, NMR, 20 STRUCTURES 1Z3W ; 1.70 ; STRUCTURE OF PHANEROCHAETE CHRYSOSPORIUM CELLOBIOHYDROLASE CEL7D (CBH58) IN COMPLEX WITH CELLOBIOIMIDAZOLE 1Z3T ; 1.70 ; STRUCTURE OF PHANEROCHAETE CHRYSOSPORIUM CELLOBIOHYDROLASE CEL7D (CBH58) IN COMPLEX WITH CELLOBIOSE 1Z3V ; 1.61 ; STRUCTURE OF PHANEROCHAETE CHRYSOSPORIUM CELLOBIOHYDROLASE CEL7D (CBH58) IN COMPLEX WITH LACTOSE 2PHM ; 2.60 ; STRUCTURE OF PHENYLALANINE HYDROXYLASE DEPHOSPHORYLATED 1RKV ; 1.90 ; STRUCTURE OF PHOSPHATE COMPLEX OF THRH FROM PSEUDOMONAS AERUGINOSA 1OS1 ; 1.80 ; STRUCTURE OF PHOSPHOENOLPYRUVATE CARBOXYKINASE COMPLEXED WITH ATP,MG, CA AND PYRUVATE. 1XQ9 ; 2.58 ; STRUCTURE OF PHOSPHOGLYCERATE MUTASE FROM PLASMODIUM FALCIPARUM AT 2.6 RESOLUTION 1FB2 ; 1.95 ; STRUCTURE OF PHOSPHOLIPASE A2 FROM DABOIA RUSSELLI PULCHELLA AT 1.95 1IHP ; 2.50 ; STRUCTURE OF PHOSPHOMONOESTERASE 1VRV ; -1.00 ; STRUCTURE OF PHOSPHORYLATED IIB (C384(SEP)) DOMAIN OF THE MANNITOL-SPECIFIC PERMEASE ENZYME II 1PHZ ; 2.20 ; STRUCTURE OF PHOSPHORYLATED PHENYLALANINE HYDROXYLASE 1BJN ; 2.30 ; STRUCTURE OF PHOSPHOSERINE AMINOTRANSFERASE FROM ESCHERICHIA COLI 2ECK ; 2.80 ; STRUCTURE OF PHOSPHOTRANSFERASE 1LXT ; 2.70 ; STRUCTURE OF PHOSPHOTRANSFERASE PHOSPHOGLUCOMUTASE FROM RABBIT 1QNF ; 1.80 ; STRUCTURE OF PHOTOLYASE 1KBY ; 2.50 ; STRUCTURE OF PHOTOSYNTHETIC REACTION CENTER WITH BACTERIOCHLOROPHYLL-BACTERIOPHEOPHYTIN HETERODIMER 1PHN ; 1.65 ; STRUCTURE OF PHYCOCYANIN FROM CYANIDIUM CALDARIUM AT 1.65A RESOLUTION 1VJD ; 1.90 ; STRUCTURE OF PIG MUSCLE PGK COMPLEXED WITH ATP 1VJC ; 2.10 ; STRUCTURE OF PIG MUSCLE PGK COMPLEXED WITH MGATP 1HX0 ; 1.38 ; STRUCTURE OF PIG PANCREATIC ALPHA-AMYLASE COMPLEXED WITH THE "TRUNCATE" ACARBOSE MOLECULE (PSEUDOTRISACCHARIDE) 1HWU ; 2.10 ; STRUCTURE OF PII PROTEIN FROM HERBASPIRILLUM SEROPEDICAE 1YI4 ; 2.40 ; STRUCTURE OF PIM-1 BOUND TO ADENOSINE 1UW5 ; 2.90 ; STRUCTURE OF PITP-ALPHA COMPLEXED TO PHOSPHATIDYLINOSITOL 1GZN ; 2.50 ; STRUCTURE OF PKB KINASE DOMAIN 1LF4 ; 1.90 ; STRUCTURE OF PLASMEPSIN II 1XE5 ; 2.40 ; STRUCTURE OF PLASMEPSIN II IN COMPLEX OF AN PEPSTATIN ANALOGUE 1XE6 ; 2.80 ; STRUCTURE OF PLASMEPSIN II IN COMPLEX OF AN PEPSTATIN ANALOGUE 1XDH ; 1.70 ; STRUCTURE OF PLASMEPSIN II IN COMPLEX WITH PEPSTATIN A 1YB0 ; 1.86 ; STRUCTURE OF PLYL 1D6A ; 2.10 ; STRUCTURE OF POKEWEED ANTIVIRAL PROTEIN COMPLEXED WITH GUANINE 1J1Q ; 1.80 ; STRUCTURE OF POKEWEED ANTIVIRAL PROTEIN FROM SEEDS (PAP-S1) 1J1R ; 1.90 ; STRUCTURE OF POKEWEED ANTIVIRAL PROTEIN FROM SEEDS (PAP-S1) COMPLEXED WITH ADENINE 1H83 ; 1.90 ; STRUCTURE OF POLYAMINE OXIDASE IN COMPLEX WITH 1,8-DIAMINOOCTANE 1H82 ; 1.90 ; STRUCTURE OF POLYAMINE OXIDASE IN COMPLEX WITH GUAZATINE 1H81 ; 2.10 ; STRUCTURE OF POLYAMINE OXIDASE IN THE REDUCED STATE 1SJW ; 1.35 ; STRUCTURE OF POLYKETIDE CYCLASE SNOAL 1Q9J ; 2.75 ; STRUCTURE OF POLYKETIDE SYNTHASE ASSOCIATED PROTEIN 5 FROM MYCOBACTERIUM TUBERCULOSIS 1EXS ; 2.39 ; STRUCTURE OF PORCINE BETA-LACTOGLOBULIN 2GSR ; 2.11 ; STRUCTURE OF PORCINE CLASS PI GLUTATHIONE S-TRANSFERASE 1DHK ; 1.85 ; STRUCTURE OF PORCINE PANCREATIC ALPHA-AMYLASE 1BRU ; 2.30 ; STRUCTURE OF PORCINE PANCREATIC ELASTASE COMPLEXED WITH THE ELASTASE INHIBITOR GR143783 1QR3 ; 1.60 ; STRUCTURE OF PORCINE PANCREATIC ELASTASE IN COMPLEX WITH FR901277, A NOVEL MACROCYCLIC INHIBITOR OF ELASTASES AT 1.6 ANGSTROM RESOLUTION 1EJA ; 2.70 ; STRUCTURE OF PORCINE TRYPSIN COMPLEXED WITH BDELLASTASIN, AN ANTISTASIN-TYPE INHIBITOR 1RJD ; 1.80 ; STRUCTURE OF PPM1, A LEUCINE CARBOXY METHYLTRANSFERASE INVOLVED IN THE REGULATION OF PROTEIN PHOSPHATASE 2A ACTIVITY 1RJE ; 2.00 ; STRUCTURE OF PPM1, A LEUCINE CARBOXY METHYLTRANSFERASE INVOLVED IN THE REGULATION OF PROTEIN PHOSPHATASE 2A ACTIVITY 1RJF ; 2.25 ; STRUCTURE OF PPM1, A LEUCINE CARBOXY METHYLTRANSFERASE INVOLVED IN THE REGULATION OF PROTEIN PHOSPHATASE 2A ACTIVITY 1RJG ; 2.61 ; STRUCTURE OF PPM1, A LEUCINE CARBOXY METHYLTRANSFERASE INVOLVED IN THE REGULATION OF PROTEIN PHOSPHATASE 2A ACTIVITY 2AXU ; 2.90 ; STRUCTURE OF PRGX 2AWI ; 2.25 ; STRUCTURE OF PRGX Y153C MUTANT 2AXV ; 3.00 ; STRUCTURE OF PRGX Y153C MUTANT 1PXR ; 1.70 ; STRUCTURE OF PRO50ALA MUTANT OF BACTERIORHODOPSIN 1MFK ; -1.00 ; STRUCTURE OF PROKARYOTIC SECIS MRNA HAIRPIN 1RY0 ; 1.69 ; STRUCTURE OF PROSTAGLANDIN F SYNTHASE WITH PROSTAGLANDIN D2 1GZO ; 2.75 ; STRUCTURE OF PROTEIN KINASE B UNPHOSPHORYLATED 1SDS ; 1.80 ; STRUCTURE OF PROTEIN L7AE BOUND TO A K-TURN DERIVED FROM AN ARCHAEAL BOX H/ACA SRNA 2C8M ; 1.89 ; STRUCTURE OF PROTEIN TA0514, PUTATIVE LIPOATE PROTEIN LIGASE FROM T. ACIDOPHILUM WITH BOUND LIPOIC ACID 2C7I ; 2.10 ; STRUCTURE OF PROTEIN TA0514, PUTATIVE LIPOATE PROTEIN LIGASE FROM T. ACIDOPHILUM. 1M85 ; 2.00 ; STRUCTURE OF PROTEUS MIRABILIS CATALASE FOR THE NATIVE FORM 2CAH ; 2.70 ; STRUCTURE OF PROTEUS MIRABILIS PR CATALASE FOR THE NATIVE FORM (E-FE(III)) COMPLEXED WITH NADPH 3PCJ ; 2.13 ; STRUCTURE OF PROTOCATECHUATE 3,4-DIOXYGENASE COMPLEXED WITH 2-HYDROXYISONICOTINIC ACID N-OXIDE 3PCL ; 2.15 ; STRUCTURE OF PROTOCATECHUATE 3,4-DIOXYGENASE COMPLEXED WITH 2-HYDROXYISONICOTINIC ACID N-OXIDE AND CYANIDE 3PCA ; 2.20 ; STRUCTURE OF PROTOCATECHUATE 3,4-DIOXYGENASE COMPLEXED WITH 3,4-DIHYDROXYBENZOATE 3PCN ; 2.40 ; STRUCTURE OF PROTOCATECHUATE 3,4-DIOXYGENASE COMPLEXED WITH 3,4-DIHYDROXYPHENYLACETATE 3PCH ; 2.05 ; STRUCTURE OF PROTOCATECHUATE 3,4-DIOXYGENASE COMPLEXED WITH 3-CHLORO-4-HYDROXYBENZOATE 3PCF ; 2.15 ; STRUCTURE OF PROTOCATECHUATE 3,4-DIOXYGENASE COMPLEXED WITH 3-FLURO-4-HYDROXYBENZOATE 3PCB ; 2.19 ; STRUCTURE OF PROTOCATECHUATE 3,4-DIOXYGENASE COMPLEXED WITH 3-HYDROXYBENZOATE 3PCE ; 2.06 ; STRUCTURE OF PROTOCATECHUATE 3,4-DIOXYGENASE COMPLEXED WITH 3-HYDROXYPHENYLACETATE 3PCI ; 2.21 ; STRUCTURE OF PROTOCATECHUATE 3,4-DIOXYGENASE COMPLEXED WITH 3-IODO-4-HYDROXYBENZOATE 3PCC ; 1.98 ; STRUCTURE OF PROTOCATECHUATE 3,4-DIOXYGENASE COMPLEXED WITH 4-HYDROXYBENZOATE 3PCK ; 2.13 ; STRUCTURE OF PROTOCATECHUATE 3,4-DIOXYGENASE COMPLEXED WITH 6-HYDROXYNICOTINIC ACID N-OXIDE 3PCM ; 2.25 ; STRUCTURE OF PROTOCATECHUATE 3,4-DIOXYGENASE COMPLEXED WITH 6-HYDROXYNICOTINIC ACID N-OXIDE AND CYANIDE 3PCG ; 1.96 ; STRUCTURE OF PROTOCATECHUATE 3,4-DIOXYGENASE COMPLEXED WITH THE INHIBITOR 4-HYDROXYPHENYLACETATE 1W8H ; 1.75 ; STRUCTURE OF PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL) COMPLEXED WITH LEWISA TRISACCHARIDE 1GQI ; 1.48 ; STRUCTURE OF PSEUDOMONAS CELLULOSA ALPHA-D-GLUCURONIDASE 1GQK ; 1.90 ; STRUCTURE OF PSEUDOMONAS CELLULOSA ALPHA-D-GLUCURONIDASE COMPLEXED WITH GLUCURONIC ACID 1GQL ; 1.67 ; STRUCTURE OF PSEUDOMONAS CELLULOSA ALPHA-D-GLUCURONIDASE COMPLEXED WITH GLUCURONIC ACID AND XYLOTRIOSE 1GQJ ; 1.90 ; STRUCTURE OF PSEUDOMONAS CELLULOSA ALPHA-D-GLUCURONIDASE COMPLEXED WITH XYLOBIOSE 1JOI ; 2.05 ; STRUCTURE OF PSEUDOMONAS FLUORESCENS HOLO AZURIN 1BF2 ; 2.00 ; STRUCTURE OF PSEUDOMONAS ISOAMYLASE 1CNO ; 2.20 ; STRUCTURE OF PSEUDOMONAS NAUTICA CYTOCHROME C552, BY MAD METHOD 1LQF ; 2.50 ; STRUCTURE OF PTP1B IN COMPLEX WITH A PEPTIDIC BISPHOSPHONATE INHIBITOR 1UFH ; 2.20 ; STRUCTURE OF PUTATIVE ACETYLTRANSFERASE, YYCN PROTEIN OF BACILLUS SUBTILIS 1JN9 ; 2.30 ; STRUCTURE OF PUTATIVE ASPARAGINASE ENCODED BY ESCHERICHIA COLI YBIK GENE 1K2X ; 1.65 ; STRUCTURE OF PUTATIVE ASPARAGINASE ENCODED BY ESCHERICHIA COLI YBIK GENE 1WOT ; -1.00 ; STRUCTURE OF PUTATIVE MINIMAL NUCLEOTIDYLTRANSFERASE 2AQW ; 2.00 ; STRUCTURE OF PUTATIVE OROTIDINE-MONOPHOSPHATE-DECARBOXYLASE FROM PLASMODIUM YOELII (PY01515) 1M8V ; 2.60 ; STRUCTURE OF PYROCOCCUS ABYSSII SM PROTEIN IN COMPLEX WITH A URIDINE HEPTAMER 1Z26 ; 2.50 ; STRUCTURE OF PYROCOCCUS FURIOSUS ARGONAUTE WITH BOUND TUNGSTATE 1KA2 ; 2.20 ; STRUCTURE OF PYROCOCCUS FURIOSUS CARBOXYPEPTIDASE APO-MG 1K9X ; 2.30 ; STRUCTURE OF PYROCOCCUS FURIOSUS CARBOXYPEPTIDASE APO-YB 1KA4 ; 3.00 ; STRUCTURE OF PYROCOCCUS FURIOSUS CARBOXYPEPTIDASE NAT-PB 1HQ6 ; 2.70 ; STRUCTURE OF PYRUVOYL-DEPENDENT HISTIDINE DECARBOXYLASE AT PH 8 1QPQ ; 2.45 ; STRUCTURE OF QUINOLINIC ACID PHOSPHORIBOSYLTRANSFERASE FROM MYCOBACTERIUM TUBERCULOSIS: A POTENTIAL TB DRUG TARGET 1LJ0 ; 2.00 ; STRUCTURE OF QUINTUPLE MUTANT OF THE RAT OUTER MITOCONDRIAL CYTOCHROME B5. 1ZJZ ; 1.10 ; STRUCTURE OF R-SPECIFIC ALCOHOL DEHYDROGENASE (MUTANT G37D) FROM LACTOBACILLUS BREVIS IN COMPLEX WITH PHENYLETHANOL AND NAD 1ZK1 ; 1.78 ; STRUCTURE OF R-SPECIFIC ALCOHOL DEHYDROGENASE (MUTANT G37D) FROM LACTOBACILLUS BREVIS IN COMPLEX WITH PHENYLETHANOL AND NAD 1ZJY ; 1.05 ; STRUCTURE OF R-SPECIFIC ALCOHOL DEHYDROGENASE (MUTANT G37D) FROM LACTOBACILLUS BREVIS IN COMPLEX WITH PHENYLETHANOL AND NADH 1ZK0 ; 1.55 ; STRUCTURE OF R-SPECIFIC ALCOHOL DEHYDROGENASE (MUTANT G37D) FROM LACTOBACILLUS BREVIS IN COMPLEX WITH PHENYLETHANOL AND NADH 1ZK4 ; 1.00 ; STRUCTURE OF R-SPECIFIC ALCOHOL DEHYDROGENASE (WILDTYPE) FROM LACTOBACILLUS BREVIS IN COMPLEX WITH ACETOPHENONE AND NADP 1NBI ; 3.00 ; STRUCTURE OF R175K MUTATED GLYCINE N-METHYLTRANSFERASE COMPLEXED WITH S-ADENOSYLMETHIONINE, R175K:SAM. 1LTX ; 2.70 ; STRUCTURE OF RAB ESCORT PROTEIN-1 IN COMPLEX WITH RAB GERANYLGERANYL TRANSFERASE AND ISOPRENOID 1QZ6 ; 1.60 ; STRUCTURE OF RABBIT ACTIN IN COMPLEX WITH JASPISAMIDE A 1QZ5 ; 1.45 ; STRUCTURE OF RABBIT ACTIN IN COMPLEX WITH KABIRAMIDE C 2ASM ; 1.60 ; STRUCTURE OF RABBIT ACTIN IN COMPLEX WITH REIDISPONGIOLIDE A 2ASP ; 1.64 ; STRUCTURE OF RABBIT ACTIN IN COMPLEX WITH REIDISPONGIOLIDE C 2ASO ; 1.70 ; STRUCTURE OF RABBIT ACTIN IN COMPLEX WITH SPHINXOLIDE B 1YZM ; 1.50 ; STRUCTURE OF RABENOSYN (458-503), RAB4 BINDING DOMAIN 1UKV ; 1.50 ; STRUCTURE OF RABGDP-DISSOCIATION INHIBITOR IN COMPLEX WITH PRENYLATED YPT1 GTPASE 1K2S ; 2.55 ; STRUCTURE OF RAT BRAIN NNOS HEME DOMAIN COMPLEXED WITH NG- ALLYL-L-ARGININE 1K2R ; 2.15 ; STRUCTURE OF RAT BRAIN NNOS HEME DOMAIN COMPLEXED WITH NG- NITRO-L-ARGININE 1K2T ; 2.20 ; STRUCTURE OF RAT BRAIN NNOS HEME DOMAIN COMPLEXED WITH S- ETHYL-N-PHENYL-ISOTHIOUREA 1K2U ; 2.20 ; STRUCTURE OF RAT BRAIN NNOS HEME DOMAIN COMPLEXED WITH S- ETHYL-N-[4-(TRIFLUOROMETHYL)PHENYL] ISOTHIOUREA 1QBQ ; 2.40 ; STRUCTURE OF RAT FARNESYL PROTEIN TRANSFERASE COMPLEXED WITH A CVIM PEPTIDE AND ALPHA-HYDROXYFARNESYLPHOSPHONIC ACID. 1OM5 ; 2.30 ; STRUCTURE OF RAT NEURONAL NOS HEME DOMAIN WITH 3-BROMO-7- NITROINDAZOLE BOUND 1OM4 ; 1.75 ; STRUCTURE OF RAT NEURONAL NOS HEME DOMAIN WITH L-ARGININE BOUND 1QFC ; 2.70 ; STRUCTURE OF RAT PURPLE ACID PHOSPHATASE 1DPO ; 1.59 ; STRUCTURE OF RAT TRYPSIN 1N4M ; 2.20 ; STRUCTURE OF RB TUMOR SUPPRESSOR BOUND TO THE TRANSACTIVATION DOMAIN OF E2F-2 1G19 ; 3.00 ; STRUCTURE OF RECA PROTEIN 1UBC ; 3.80 ; STRUCTURE OF RECA PROTEIN 1GM5 ; 3.24 ; STRUCTURE OF RECG BOUND TO THREE-WAY DEOXYRIBONUCLEIC ACID JUNCTION 1FZD ; 2.10 ; STRUCTURE OF RECOMBINANT ALPHAEC DOMAIN FROM HUMAN FIBRINOGEN-420 1H3J ; 2.00 ; STRUCTURE OF RECOMBINANT COPRINUS CINEREUS PEROXIDASE DETERMINED TO 2.0 A 1XME ; 2.30 ; STRUCTURE OF RECOMBINANT CYTOCHROME BA3 OXIDASE FROM THERMUS THERMOPHILUS 2BJJ ; 2.40 ; STRUCTURE OF RECOMBINANT HUMAN LACTOFERRIN PRODUCED IN THE MILK OF TRANSGENIC COWS 1G6J ; -1.00 ; STRUCTURE OF RECOMBINANT HUMAN UBIQUITIN IN AOT REVERSE MICELLES 1CXV ; 2.00 ; STRUCTURE OF RECOMBINANT MOUSE COLLAGENASE-3 (MMP-13) 1LB3 ; 1.21 ; STRUCTURE OF RECOMBINANT MOUSE L CHAIN FERRITIN AT 1.2 A RESOLUTION 1L6V ; -1.00 ; STRUCTURE OF REDUCED BOVINE ADRENODOXIN 1XLO ; 1.84 ; STRUCTURE OF REDUCED C73S/C85S PUTIDAREDOXIN, A [2FE-2S] FERREDOXIN FROM PSEUDOMONAS PUTIDA 2ABA ; 1.05 ; STRUCTURE OF REDUCED PETN REDUCTASE IN COMPLEX WITH PROGESTERONE 1SDQ ; 1.69 ; STRUCTURE OF REDUCED-NO ADDUCT OF MESOPONE CYTOCHROME C PEROXIDASE 2FOK ; 2.30 ; STRUCTURE OF RESTRICTION ENDONUCLEASE FOKI 1FOK ; 2.80 ; STRUCTURE OF RESTRICTION ENDONUCLEASE FOKI BOUND TO DEOXYRIBONUCLEIC ACID 1RHO ; 2.50 ; STRUCTURE OF RHO GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR 1AJW ; -1.00 ; STRUCTURE OF RHOGDI: A C-TERMINAL BINDING DOMAIN TARGETS AN N-TERMINAL INHIBITORY PEPTIDE TO GTPASES, NMR, 20 STRUCTURES 1GDF ; -1.00 ; STRUCTURE OF RHOGDI: A C-TERMINAL BINDING DOMAIN TARGETS AN N-TERMINAL INHIBITORY PEPTIDE TO GTPASES, NMR, MINIMIZED AVERAGE STRUCTURE 1AFU ; 2.00 ; STRUCTURE OF RIBONUCLEASE A AT 2.0 ANGSTROMS FROM MONOCLINIC CRYSTALS 1EBQ ; -1.00 ; STRUCTURE OF RIBONUCLEIC ACID (5'-GGUGGGCGCAGCUUCGGCUGCGGUACCAC-3'), NMR, 5 STRUCTURES 1EBR ; -1.00 ; STRUCTURE OF RIBONUCLEIC ACID (5'-GGUGGGCGCAGCUUCGGCUGCGGUACCAC-3'), NMR, 5 STRUCTURES 1EBS ; -1.00 ; STRUCTURE OF RIBONUCLEIC ACID (5'-GGUGGGCGCAGCUUCGGCUGCGGUACCAC-3'), NMR, 5 STRUCTURES 1MIS ; -1.00 ; STRUCTURE OF RIBONUCLEIC ACID (5'-R(GPCPGPGPAPCPGPC)-3') ANTI-PARALLEL RIBONUCLEIC ACID DUPLEX WITH TANDEM G:A MISMATCHES, NMR, MINIMIZED AVERAGE STRUCTURE 1G3A ; -1.00 ; STRUCTURE OF RIBONUCLEIC ACID DUPLEXES (CIGCGICG)2 1PBL ; -1.00 ; STRUCTURE OF RIBONUCLEIC ACID, NMR, 1 STRUCTURE 1PBM ; -1.00 ; STRUCTURE OF RIBONUCLEIC ACID, NMR, 1 STRUCTURE 1MWG ; -1.00 ; STRUCTURE OF RIBONUCLEIC ACID, NMR, MINIMIZED AVERAGE STRUCTURE 1RLR ; 2.50 ; STRUCTURE OF RIBONUCLEOTIDE REDUCTASE PROTEIN R1 1G1X ; 2.60 ; STRUCTURE OF RIBOSOMAL PROTEINS S15, S6, S18, AND 16S RIBOSOMAL RIBONUCLEIC ACID 2D3O ; 3.35 ; STRUCTURE OF RIBOSOME BINDING DOMAIN OF THE TRIGGER FACTOR ON THE 50S RIBOSOMAL SUBUNIT FROM D. RADIODURANS 1PSY ; -1.00 ; STRUCTURE OF RICC3, NMR, 20 STRUCTURES 1IL5 ; 2.80 ; STRUCTURE OF RICIN A CHAIN BOUND WITH INHIBITOR 2,5-DIAMINO- 4,6-DIHYDROXYPYRIMIDINE (DDP) 1IL3 ; 2.80 ; STRUCTURE OF RICIN A CHAIN BOUND WITH INHIBITOR 7- DEAZAGUANINE 1IL9 ; 3.10 ; STRUCTURE OF RICIN A CHAIN BOUND WITH INHIBITOR 8-METHYL-9- OXOGUANINE 1IL4 ; 2.60 ; STRUCTURE OF RICIN A CHAIN BOUND WITH INHIBITOR 9- DEAZAGUANINE 1OBS ; 2.20 ; STRUCTURE OF RICIN A CHAIN MUTANT 1OBT ; 2.80 ; STRUCTURE OF RICIN A CHAIN MUTANT, COMPLEX WITH AMP 1V10 ; 1.70 ; STRUCTURE OF RIGIDOPORUS LIGNOSUS LACCASE FROM HEMIHEDRALLY TWINNED CRYSTALS 1Q5X ; 2.00 ; STRUCTURE OF RRAA (MENG), A PROTEIN INHIBITOR OF RIBONUCLEIC ACID PROCESSING 1KSK ; 2.00 ; STRUCTURE OF RSUA 1KSL ; 2.10 ; STRUCTURE OF RSUA 1KSV ; 2.65 ; STRUCTURE OF RSUA 1BEX ; 2.30 ; STRUCTURE OF RUTHENIUM-MODIFIED PSEUDOMONAS AERUGINOSA AZURIN 1IXS ; 3.20 ; STRUCTURE OF RUVB COMPLEXED WITH RUVA DOMAIN III 1HQC ; 3.20 ; STRUCTURE OF RUVB FROM THERMUS THERMOPHILUS HB8 1Y0H ; 1.60 ; STRUCTURE OF RV0793 FROM MYCOBACTERIUM TUBERCULOSIS 1NXJ ; 1.90 ; STRUCTURE OF RV3853 FROM MYCOBACTERIUM TUBERCULOSIS 1NH6 ; 2.05 ; STRUCTURE OF S. MARCESCENS CHITINASE A, E315L, COMPLEX WITH HEXASACCHARIDE 1IHZ ; 1.65 ; STRUCTURE OF S. NUCLEASE MUTANT QUINTUPLE MUTANT V23L/V66L/I72L/I92L/V99L 1II3 ; 1.72 ; STRUCTURE OF S. NUCLEASE QUINTUPLE MUTANT V23I/V66L/I72L/I92L/V99L 1EY7 ; 1.88 ; STRUCTURE OF S. NUCLEASE STABILIZING MUTANT S128A 1EY4 ; 1.60 ; STRUCTURE OF S. NUCLEASE STABILIZING MUTANT S59A 1EY5 ; 1.70 ; STRUCTURE OF S. NUCLEASE STABILIZING MUTANT T33V 1EZ8 ; 1.85 ; STRUCTURE OF S. NUCLEASE STABILIZING MUTANT T33V 1EY6 ; 1.75 ; STRUCTURE OF S. NUCLEASE STABILIZING MUTANT T41I 1EY9 ; 1.72 ; STRUCTURE OF S. NUCLEASE STABILIZING QUADRUPLE MUTANT T41I/P117G/H124L/S128A 1EYA ; 2.00 ; STRUCTURE OF S. NUCLEASE STABILIZING QUINTUPLE MUTANT T33V/T41I/P117G/H124L/S128A 1EYC ; 1.85 ; STRUCTURE OF S. NUCLEASE STABILIZING QUINTUPLE MUTANT T41I/S59A/P117G/H124L/S128A 1EZ6 ; 1.90 ; STRUCTURE OF S. NUCLEASE STABILIZING SEXTUPLE MUTANT T33V/T41I/S59A/P117G/H124L/S128A 1EY8 ; 1.75 ; STRUCTURE OF S. NUCLEASE STABILIZING TRIPLE MUTANT P117G/H124L/S128A 1YX4 ; -1.00 ; STRUCTURE OF S5A BOUND TO MONOUBIQUITIN PROVIDES A MODEL FOR POLYUBIQUITIN RECOGNITION 430D ; 2.10 ; STRUCTURE OF SARCIN/RICIN LOOP FROM RAT 28S RRNA 2AJF ; 2.90 ; STRUCTURE OF SARS CORONAVIRUS SPIKE RECEPTOR-BINDING DOMAIN COMPLEXED WITH ITS RECEPTOR 2C3S ; 1.90 ; STRUCTURE OF SARS COV MAIN PROTEINASE AT 1.9 A (PH6.5) 1NQM ; 1.70 ; STRUCTURE OF SAVM-W120K, STREPTAVIDIN MUTANT 1S5G ; 3.10 ; STRUCTURE OF SCALLOP MYOSIN S1 REVEALS A NOVEL NUCLEOTIDE CONFORMATION 1N4X ; 1.70 ; STRUCTURE OF SCFV 1696 AT ACIDIC PH 1SN1 ; 1.70 ; STRUCTURE OF SCORPION NEUROTOXIN BMK M1 1SN4 ; 1.30 ; STRUCTURE OF SCORPION NEUROTOXIN BMK M4 1SNB ; 1.90 ; STRUCTURE OF SCORPION NEUROTOXIN BMK M8 1S2K ; 2.00 ; STRUCTURE OF SCP-B A MEMBER OF THE EQOLISIN FAMILY OF PEPTIDASES IN A COMPLEX WITH A TRIPEPTIDE ALA-ILE-HIS 1S2B ; 2.10 ; STRUCTURE OF SCP-B THE FIRST MEMBER OF THE EQOLISIN FAMILY OF PEPTIDASES TO HAVE ITS STRUCTURE DETERMINED 1MWR ; 2.45 ; STRUCTURE OF SEMET PENICILLIN BINDING PROTEIN 2A FROM METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS STRAIN 27R (TRIGONAL FORM) AT 2.45 A RESOLUTION. 1TDL ; 1.80 ; STRUCTURE OF SER130GLY SHV-1 BETA-LACTAMASE 1S80 ; 2.70 ; STRUCTURE OF SERINE ACETYLTRANFERASE FROM HAEMOPHILIS INFLUENZAE RD 1TOC ; 3.10 ; STRUCTURE OF SERINE PROTEINASE 1S95 ; 1.60 ; STRUCTURE OF SERINE/THREONINE PROTEIN PHOSPHATASE 5 1N6A ; 1.70 ; STRUCTURE OF SET7/9 1N6C ; 2.30 ; STRUCTURE OF SET7/9 1NPY ; 1.75 ; STRUCTURE OF SHIKIMATE 5-DEHYDROGENASE-LIKE PROTEIN HI0607 1SHV ; 1.98 ; STRUCTURE OF SHV-1 BETA-LACTAMASE 1VM1 ; 2.02 ; STRUCTURE OF SHV-1 BETA-LACTAMASE INHIBITED BY TAZOBACTAM 1EHC ; 2.26 ; STRUCTURE OF SIGNAL TRANSDUCTION PROTEIN CHEY 1NLO ; -1.00 ; STRUCTURE OF SIGNAL TRANSDUCTION PROTEIN, NMR, MINIMIZED AVERAGE STRUCTURE 1NLP ; -1.00 ; STRUCTURE OF SIGNAL TRANSDUCTION PROTEIN, NMR, MINIMIZED AVERAGE STRUCTURE 1ERK ; 2.30 ; STRUCTURE OF SIGNAL-REGULATED KINASE 1KAW ; 2.90 ; STRUCTURE OF SINGLE STRANDED DEOXYRIBONUCLEIC ACID BINDING PROTEIN (SSB) 1SE8 ; 1.80 ; STRUCTURE OF SINGLE-STRANDED DEOXYRIBONUCLEIC ACID-BINDING PROTEIN (SSB) FROM D. RADIODURANS 1SQ9 ; 1.90 ; STRUCTURE OF SKI8P, A WD REPEAT PROTEIN INVOLVED IN MRNA DEGRADATION AND MEIOTIC RECOMBINATION 1JTW ; -1.00 ; STRUCTURE OF SL4 RIBONUCLEIC ACID FROM THE HIV-1 PACKAGING SIGNAL 1T3I ; 1.80 ; STRUCTURE OF SLR0077/SUFS, THE ESSENTIAL CYSTEINE DESULFURASE FROM SYNECHOCYSTIS PCC 6803 1XTQ ; 2.00 ; STRUCTURE OF SMALL GTPASE HUMAN RHEB IN COMPLEX WITH GDP 1XTR ; 2.65 ; STRUCTURE OF SMALL GTPASE HUMAN RHEB IN COMPLEX WITH GPPNHP 1XTS ; 2.80 ; STRUCTURE OF SMALL GTPASE HUMAN RHEB IN COMPLEX WITH GTP 1IJA ; -1.00 ; STRUCTURE OF SORTASE 1QVN ; 2.70 ; STRUCTURE OF SP4160 BOUND TO IL-2 V69A 1F2E ; 2.30 ; STRUCTURE OF SPHINGOMONAD, GLUTATHIONE S-TRANSFERASE COMPLEXED WITH GLUTATHIONE 1U4C ; 2.35 ; STRUCTURE OF SPINDLE CHECKPOINT PROTEIN BUB3 1ROW ; 2.00 ; STRUCTURE OF SSP-19, AN MSP-DOMAIN PROTEIN LIKE FAMILY MEMBER IN CAENORHABDITIS ELEGANS 1OU9 ; 1.80 ; STRUCTURE OF SSPB, A AAA+ PROTEASE DELIVERY PROTEIN 1CK1 ; 2.60 ; STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN C3 1NYQ ; 3.20 ; STRUCTURE OF STAPHYLOCOCCUS AUREUS THREONYL-TRNA SYNTHETASE COMPLEXED WITH AN ANALOGUE OF THREONYL ADENYLATE 1NYR ; 2.80 ; STRUCTURE OF STAPHYLOCOCCUS AUREUS THREONYL-TRNA SYNTHETASE COMPLEXED WITH ATP 1EXZ ; 2.30 ; STRUCTURE OF STEM CELL FACTOR 1FNU ; 1.94 ; STRUCTURE OF STREPTOCOCCAL PYROGENIC EXOTOXIN A 1FNV ; 3.60 ; STRUCTURE OF STREPTOCOCCAL PYROGENIC EXOTOXIN A 1WPP ; 2.05 ; STRUCTURE OF STREPTOCOCCUS GORDONII INORGANIC PYROPHOSPHATASE 2C1I ; 1.35 ; STRUCTURE OF STREPTOCOCCUS PNEMONIAE PEPTIDOGLYCAN DEACETYLASE (SPPGDA) D 275 N MUTANT. 2C1G ; 1.75 ; STRUCTURE OF STREPTOCOCCUS PNEUMONIAE PEPTIDOGLYCAN DEACETYLASE (SPPGDA) 1GTZ ; 1.60 ; STRUCTURE OF STREPTOMYCES COELICOLOR TYPE II DEHYDROQUINASE R23A MUTANT IN COMPLEX WITH DEHYDROSHIKIMATE 1PXQ ; -1.00 ; STRUCTURE OF SUBTILOSIN A 1VZG ; 1.69 ; STRUCTURE OF SUPEROXIDE REDUCTASE BOUND TO FERROCYANIDE AND ACTIVE SITE EXPANSION UPON X-RAY INDUCED PHOTOREDUCTION 1VZH ; 1.69 ; STRUCTURE OF SUPEROXIDE REDUCTASE BOUND TO FERROCYANIDE AND ACTIVE SITE EXPANSION UPON X-RAY INDUCED PHOTOREDUCTION 1VZI ; 1.15 ; STRUCTURE OF SUPEROXIDE REDUCTASE BOUND TO FERROCYANIDE AND ACTIVE SITE EXPANSION UPON X-RAY INDUCED PHOTOREDUCTION 1SVO ; 2.60 ; STRUCTURE OF SV40 LARGE T ANTIGEN HELICASE DOMAIN 1M25 ; -1.00 ; STRUCTURE OF SYNTHETIC 26-MER PEPTIDE CONTAINING 145-169 SHEEP PRION PROTEIN SEGMENT AND C-TERMINAL CYSTEINE IN TFE SOLUTION 1CDJ ; 2.50 ; STRUCTURE OF T-CELL SURFACE GLYCOPROTEIN CD4 1CDY ; 2.00 ; STRUCTURE OF T-CELL SURFACE GLYCOPROTEIN CD4 MUTANT WITH GLY 47 REPLACED BY SER 1CDU ; 2.70 ; STRUCTURE OF T-CELL SURFACE GLYCOPROTEIN CD4 MUTANT WITH PHE 43 REPLACED BY VAL 1WIP ; 4.00 ; STRUCTURE OF T-CELL SURFACE GLYCOPROTEIN CD4, MONOCLINIC CRYSTAL FORM 1WIO ; 3.90 ; STRUCTURE OF T-CELL SURFACE GLYCOPROTEIN CD4, TETRAGONAL CRYSTAL FORM 1WIQ ; 5.00 ; STRUCTURE OF T-CELL SURFACE GLYCOPROTEIN CD4, TRIGONAL CRYSTAL FORM 1LIK ; 2.55 ; STRUCTURE OF T. GONDII ADENOSINE KINASE BOUND TO ADENOSINE 1LII ; 1.73 ; STRUCTURE OF T. GONDII ADENOSINE KINASE BOUND TO ADENOSINE 2 AND AMP-PCP 1LIJ ; 1.86 ; STRUCTURE OF T. GONDII ADENOSINE KINASE BOUND TO PRODRUG 2 7-IODOTUBERCIDIN AND AMP-PCP 1YAB ; 3.40 ; STRUCTURE OF T. MARITIMA FLIN FLAGELLAR ROTOR PROTEIN 1EGD ; 2.40 ; STRUCTURE OF T255E, E376G MUTANT OF HUMAN MEDIUM CHAIN ACYL-COA DEHYDROGENASE 1EGE ; 2.75 ; STRUCTURE OF T255E, E376G MUTANT OF HUMAN MEDIUM CHAIN ACYL-COA DEHYDROGENASE 1EGC ; 2.60 ; STRUCTURE OF T255E, E376G MUTANT OF HUMAN MEDIUM CHAIN ACYL-COA DEHYDROGENASE COMPLEXED WITH OCTANOYL-COA 1W08 ; 2.50 ; STRUCTURE OF T70N HUMAN LYSOZYME 1GVF ; 1.45 ; STRUCTURE OF TAGATOSE-1,6-BISPHOSPHATE ALDOLASE 1TYU ; 1.80 ; STRUCTURE OF TAILSPIKE-PROTEIN 1TYV ; 1.80 ; STRUCTURE OF TAILSPIKE-PROTEIN 1TYW ; 1.80 ; STRUCTURE OF TAILSPIKE-PROTEIN 1TAQ ; 2.40 ; STRUCTURE OF TAQ DEOXYRIBONUCLEIC ACID POLYMERASE 1LVJ ; -1.00 ; STRUCTURE OF TAR RIBONUCLEIC ACID COMPLEXED WITH A TAT-TAR INTERACTION NANOMOLAR INHIBITOR THAT WAS IDENTIFIED BY COMPUTATIONAL SCREENING 1PCZ ; 2.20 ; STRUCTURE OF TATA-BINDING PROTEIN 1BYF ; 2.00 ; STRUCTURE OF TC14; A C-TYPE LECTIN FROM THE TUNICATE POLYANDROCARPA MISAKIENSIS 1OQV ; 1.30 ; STRUCTURE OF TCPA, THE TYPE IV PILIN SUBUNIT FROM THE TOXIN CO-REGULATED PILUS OF VIBRIO CHOLERAE CLASSICAL BIOTYPE 1YAF ; 2.60 ; STRUCTURE OF TENA FROM BACILLUS SUBTILIS 1JAE ; 1.65 ; STRUCTURE OF TENEBRIO MOLITOR LARVAL ALPHA-AMYLASE 1TMQ ; 2.50 ; STRUCTURE OF TENEBRIO MOLITOR LARVAL ALPHA-AMYLASE IN COMPLEX WITH RAGI BIFUNCTIONAL INHIBITOR 1YAD ; 2.10 ; STRUCTURE OF TENI FROM BACILLUS SUBTILIS 1FJX ; 2.26 ; STRUCTURE OF TERNARY COMPLEX OF HHAI METHYLTRANSFERASE MUTANT (T250G) IN COMPLEX WITH DEOXYRIBONUCLEIC ACID AND ADOHCY 1F4J ; 2.40 ; STRUCTURE OF TETRAGONAL CRYSTALS OF HUMAN ERYTHROCYTE CATALASE 1IEE ; 0.94 ; STRUCTURE OF TETRAGONAL HEN EGG WHITE LYSOZYME AT 0.94 A FROM CRYSTALS GROWN BY THE COUNTER-DIFFUSION METHOD 1LXZ ; 1.25 ; STRUCTURE OF THAUMATIN CRYSTALLIZED IN THE PRESENCE OF GLYCEROL 1LY0 ; 1.36 ; STRUCTURE OF THAUMATIN CRYSTALLIZED IN THE PRESENCE OF GLYCEROL 1PP3 ; 1.60 ; STRUCTURE OF THAUMATIN IN A HEXAGONAL SPACE GROUP 1T5T ; 2.90 ; STRUCTURE OF THE (SR)CA2+-ATPASE CA2-E1-ADP:ALF4- FORM 1T5S ; 2.60 ; STRUCTURE OF THE (SR)CA2+-ATPASE CA2-E1-AMPPCP FORM 1XP5 ; 3.00 ; STRUCTURE OF THE (SR)CA2+-ATPASE E2-ALF4- FORM 1MUM ; 1.90 ; STRUCTURE OF THE 2-METHYLISOCITRATE LYASE (PRPB) FROM ESCHERICHIA COLI 2CKB ; 3.20 ; STRUCTURE OF THE 2C/KB/DEV8 COMPLEX 1BLU ; 2.10 ; STRUCTURE OF THE 2[4FE-4S] FERREDOXIN FROM CHROMATIUM VINOSUM 3PHP ; -1.00 ; STRUCTURE OF THE 3' HAIRPIN OF THE TYMV PSEUDOKNOT: PREFORMATION IN RIBONUCLEIC ACID FOLDING 1ZBB ; 9.00 ; STRUCTURE OF THE 4_601_167 TETRANUCLEOSOME 1UP7 ; 2.40 ; STRUCTURE OF THE 6-PHOSPHO-BETA GLUCOSIDASE FROM THERMOTOGA MARITIMA AT 2.4 ANSTROM RESOLUTION IN THE TETRAGONAL FORM WITH NAD AND GLUCOSE-6-PHOSPHATE 1UP6 ; 2.55 ; STRUCTURE OF THE 6-PHOSPHO-BETA GLUCOSIDASE FROM THERMOTOGA MARITIMA AT 2.55 ANGSTROM RESOLUTION IN THE TETRAGONAL FORM WITH MANGANESE, NAD+ AND GLUCOSE-6-PHOSPHATE 1UP4 ; 2.85 ; STRUCTURE OF THE 6-PHOSPHO-BETA GLUCOSIDASE FROM THERMOTOGA MARITIMA AT 2.85 ANSTROM RESOLUTION IN THE MONOCLINIC FORM 1SMJ ; 2.75 ; STRUCTURE OF THE A264E MUTANT OF CYTOCHROME P450 BM3 COMPLEXED WITH PALMITOLEATE 1OUL ; 2.20 ; STRUCTURE OF THE AAA+ PROTEASE DELIVERY PROTEIN SSPB 1Z2R ; 4.20 ; STRUCTURE OF THE ABC TRANSPORTER MSBA IN COMPLEX WITH ADP- VANADATE AND LIPOPOLYSACCHARIDE 1U4D ; 2.10 ; STRUCTURE OF THE ACK1 KINASE DOMAIN BOUND TO DEBROMOHYMENIALDISINE 1QLO ; -1.00 ; STRUCTURE OF THE ACTIVE DOMAIN OF THE HERPES SIMPLEX VIRUS PROTEIN ICP47 IN WATER/SODIUM DODECYL SULFATE SOLUTION DETERMINED BY NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY 1NI2 ; 2.30 ; STRUCTURE OF THE ACTIVE FERM DOMAIN OF EZRIN 1SZV ; -1.00 ; STRUCTURE OF THE ADAPTOR PROTEIN P14 REVEALS A PROFILIN- LIKE FOLD WITH NOVEL FUNCTION 1B04 ; 2.80 ; STRUCTURE OF THE ADENYLATION DOMAIN OF AN NAD+ DEPENDENT LIGASE 1KHZ ; 2.04 ; STRUCTURE OF THE ADPR-ASE IN COMPLEX WITH AMPCPR AND MG 1W5S ; 2.40 ; STRUCTURE OF THE AEROPYRUM PERNIX ORC2 PROTEIN (ADP FORM) 1W5T ; 2.40 ; STRUCTURE OF THE AEROPYRUM PERNIX ORC2 PROTEIN (ADPNP-ADP COMPLEXES) 2BP1 ; 2.40 ; STRUCTURE OF THE AFLATOXIN ALDEHYDE REDUCTASE IN COMPLEX WITH NADPH 1OWT ; -1.00 ; STRUCTURE OF THE ALZHEIMER'S DISEASE AMYLOID PRECURSOR PROTEIN COPPER BINDING DOMAIN 1FP8 ; 2.30 ; STRUCTURE OF THE AMYLOMALTASE FROM THERMUS THERMOPHILUS HB8 IN SPACE GROUP P21212 1J7A ; 1.80 ; STRUCTURE OF THE ANABAENA FERREDOXIN D68K MUTANT 1J7B ; 1.80 ; STRUCTURE OF THE ANABAENA FERREDOXIN MUTANT E94K 1J7C ; 1.80 ; STRUCTURE OF THE ANABAENA FERREDOXIN MUTANT E95K 1Z3U ; 2.25 ; STRUCTURE OF THE ANGIOPOIETIN-2 RECPTOR BINDING DOMAIN AND IDENTIFICATION OF SURFACES INVOLVED IN TIE2 RECOGNITION 1OT8 ; 2.00 ; STRUCTURE OF THE ANKYRIN DOMAIN OF THE DROSOPHILA NOTCH RECEPTOR 1VMP ; -1.00 ; STRUCTURE OF THE ANTI-HIV CHEMOKINE VMIP-II 1H4Y ; 1.61 ; STRUCTURE OF THE ANTI-SIGMA FACTOR ANTAGONIST SPOIIAA IN ITS UNPHOSPHORYLATED FORM 1H4Z ; 2.74 ; STRUCTURE OF THE ANTI-SIGMA FACTOR ANTAGONIST SPOIIAA IN ITS UNPHOSPHORYLATED FORM 1SKK ; -1.00 ; STRUCTURE OF THE ANTIMICROBIAL HEXAPEPTIDE CYC-(KKWWKF) BOUND TO DPC MICELLES 1SKL ; -1.00 ; STRUCTURE OF THE ANTIMICROBIAL HEXAPEPTIDE CYC-(RRNALNALRF) BOUND TO DPC MICELLES 1QVK ; -1.00 ; STRUCTURE OF THE ANTIMICROBIAL HEXAPEPTIDE CYC-(RRWWRF) BOUND TO DPC MICELLES 1QVL ; -1.00 ; STRUCTURE OF THE ANTIMICROBIAL HEXAPEPTIDE CYC-(RRWWRF) BOUND TO SDS MICELLES 1SKI ; -1.00 ; STRUCTURE OF THE ANTIMICROBIAL HEXAPEPTIDE CYC-(RRYYRF) BOUND TO DPC MICELLES 1ZM3 ; 3.07 ; STRUCTURE OF THE APO EEF2-ETA COMPLEX 1BD3 ; 1.93 ; STRUCTURE OF THE APO URACIL PHOSPHORIBOSYLTRANSFERASE, 2 MUTANT C128V 1A6X ; -1.00 ; STRUCTURE OF THE APO-BIOTIN CARBOXYL CARRIER PROTEIN (APO-BCCP87) OF ESCHERICHIA COLI ACETYL-COA CARBOXYLASE, NMR, 49 STRUCTURES 1Z6T ; 2.21 ; STRUCTURE OF THE APOPTOTIC PROTEASE-ACTIVATING FACTOR 1 BOUND TO ADP 1V1F ; 3.00 ; STRUCTURE OF THE ARABIDOPSIS THALIANA SOS3 COMPLEXED WITH CALCIUM(II) AND MANGANESE(II) IONS 1V1G ; 2.70 ; STRUCTURE OF THE ARABIDOPSIS THALIANA SOS3 COMPLEXED WITH CALCIUM(II) ION 1B4A ; 2.50 ; STRUCTURE OF THE ARGININE REPRESSOR FROM BACILLUS STEAROTHERMOPHILUS 1XM9 ; 2.80 ; STRUCTURE OF THE ARMADILLO REPEAT DOMAIN OF PLAKOPHILIN 1 1JWA ; 2.90 ; STRUCTURE OF THE ATP-BOUND MOEB-MOAD PROTEIN COMPLEX 1Z47 ; 1.90 ; STRUCTURE OF THE ATPASE SUBUNIT CYSA OF THE PUTATIVE SULFATE ATP-BINDING CASSETTE (ABC) TRANSPORTER FROM ALICYCLOBACILLUS ACIDOCALDARIUS 1EMU ; 1.90 ; STRUCTURE OF THE AXIN RGS-HOMOLOGOUS DOMAIN IN COMPLEX WITH A SAMP REPEAT FROM APC 1AN4 ; 2.90 ; STRUCTURE OF THE B/HLH OF USF 1R9E ; 2.40 ; STRUCTURE OF THE B12-INDEPENDENT GLYCEROL DEHYDRATASE WITH 1,2-PROPANEDIOL BOUND 1H4X ; 1.16 ; STRUCTURE OF THE BACILLUS CELL FATE DETERMINANT SPOIIAA IN THE PHOSPHORYLATED FORM 1KU0 ; 2.00 ; STRUCTURE OF THE BACILLUS STEAROTHERMOPHILUS L1 LIPASE 1WCV ; 1.60 ; STRUCTURE OF THE BACTERIAL CHROMOSOME SEGREGATION PROTEIN SOJ 2BEJ ; 2.10 ; STRUCTURE OF THE BACTERIAL CHROMOSOME SEGREGATION PROTEIN SOJ 2BEK ; 1.80 ; STRUCTURE OF THE BACTERIAL CHROMOSOME SEGREGATION PROTEIN SOJ 1IJG ; 2.90 ; STRUCTURE OF THE BACTERIOPHAGE PHI29 HEAD-TAIL CONNECTOR PROTEIN 1K1F ; 2.20 ; STRUCTURE OF THE BCR-ABL ONCOPROTEIN OLIGOMERIZATION DOMAIN 1NW7 ; 2.10 ; STRUCTURE OF THE BETA CLASS N6-ADENINE DEOXYRIBONUCLEIC ACID METHYLTRANSFERASE RSRI BOUND TO S-ADENOSYL-L-HOMOCYSTEINE 1NW5 ; 2.05 ; STRUCTURE OF THE BETA CLASS N6-ADENINE DEOXYRIBONUCLEIC ACID METHYLTRANSFERASE RSRI BOUND TO S-ADENOSYLMETHIONINE 1NW6 ; 1.94 ; STRUCTURE OF THE BETA CLASS N6-ADENINE DEOXYRIBONUCLEIC ACID METHYLTRANSFERASE RSRI BOUND TO SINEFUNGIN 1GCE ; 1.80 ; STRUCTURE OF THE BETA-LACTAMASE OF ENTEROBACTER CLOACAE GC1 2C1L ; 1.90 ; STRUCTURE OF THE BFII RESTRICTION ENDONUCLEASE 1TT9 ; 3.42 ; STRUCTURE OF THE BIFUNCTIONAL AND GOLGI ASSOCIATED FORMIMINOTRANSFERASE CYCLODEAMINASE OCTAMER 1OGH ; 1.88 ; STRUCTURE OF THE BIFUNCTIONAL DCTP DEAMINASE-DUTPASE FROM METHANOCALDOCOCCUS JANNASCHII 1W55 ; 2.30 ; STRUCTURE OF THE BIFUNCTIONAL ISPDF FROM CAMPYLOBACTER JEJUNI 1W57 ; 3.09 ; STRUCTURE OF THE BIFUNCTIONAL ISPDF FROM CAMPYLOBACTER JEJUNI CONTAINING ZN 1BDO ; 1.80 ; STRUCTURE OF THE BIOTINYL DOMAIN OF ACETYL-COENZYME A CARBOXYLASE DETERMINED BY MAD PHASING 1U78 ; 2.69 ; STRUCTURE OF THE BIPARTITE DEOXYRIBONUCLEIC ACID-BINDING DOMAIN OF TC3 TRANSPOSASE BOUND TO TRANSPOSON DEOXYRIBONUCLEIC ACID 1XB0 ; 2.20 ; STRUCTURE OF THE BIR DOMAIN OF IAP-LIKE PROTEIN 2 1XFQ ; -1.00 ; STRUCTURE OF THE BLUE SHIFTED INTERMEDIATE STATE OF THE PHOTOACTIVE YELLOW PROTEIN LACKING THE N-TERMINAL PART 1GD6 ; 2.50 ; STRUCTURE OF THE BOMBYX MORI LYSOZYME 1REU ; 2.65 ; STRUCTURE OF THE BONE MORPHOGENETIC PROTEIN 2 MUTANT L51P 1G89 ; -1.00 ; STRUCTURE OF THE BOVINE ANTIMICROBIAL PEPTIDE INDOLICIDIN BOUND TO DODECYLPHOSPHOCHOLINE MICELLES 1G8C ; -1.00 ; STRUCTURE OF THE BOVINE ANTIMICROBIAL PEPTIDE INDOLICIDIN BOUND TO SODIUM DODECYL SULFATE MICELLES 1Y98 ; 2.50 ; STRUCTURE OF THE BRCT REPEATS OF BRCA1 BOUND TO A CTIP PHOSPHOPEPTIDE. 1XAU ; 1.80 ; STRUCTURE OF THE BTLA ECTODOMAIN 2BFW ; 1.80 ; STRUCTURE OF THE C DOMAIN OF GLYCOGEN SYNTHASE FROM PYROCOCCUS ABYSSI 1AUV ; 2.15 ; STRUCTURE OF THE C DOMAIN OF SYNAPSIN IA FROM BOVINE BRAIN 1AUX ; 2.30 ; STRUCTURE OF THE C DOMAIN OF SYNAPSIN IA FROM BOVINE BRAIN WITH CALCIUM ATP-GAMMA-S BOUND 1B7V ; 1.70 ; STRUCTURE OF THE C-553 CYTOCHROME FROM BACILLUS PASTEURII TO 1.7 A RESOLUTION 1IH0 ; -1.00 ; STRUCTURE OF THE C-DOMAIN OF HUMAN CARDIAC TROPONIN C IN COMPLEX WITH CA2+ SENSITIZER EMD 57033 1XU6 ; -1.00 ; STRUCTURE OF THE C-TERMINAL DOMAIN FROM TRYPANOSOMA BRUCEI VARIANT SURFACE GLYCOPROTEIN MITAT1.2 1COK ; -1.00 ; STRUCTURE OF THE C-TERMINAL DOMAIN OF P73 1VYI ; 1.50 ; STRUCTURE OF THE C-TERMINAL DOMAIN OF THE POLYMERASE COFACTOR OF RABIES VIRUS: INSIGHTS IN FUNCTION AND EVOLUTION. 1GO5 ; -1.00 ; STRUCTURE OF THE C-TERMINAL FG-BINDING DOMAIN OF HUMAN TAP 1XX0 ; -1.00 ; STRUCTURE OF THE C-TERMINAL PH DOMAIN OF HUMAN PLECKSTRIN 2BT7 ; 2.35 ; STRUCTURE OF THE C-TERMINAL RECEPTOR-BINDING DOMAIN OF AVIAN REOVIRUS FIBRE SIGMAC, CD CRYSTAL FORM 2BT8 ; 3.00 ; STRUCTURE OF THE C-TERMINAL RECEPTOR-BINDING DOMAIN OF AVIAN REOVIRUS FIBRE SIGMAC, SPACE GROUP P6322. 2BSF ; 2.10 ; STRUCTURE OF THE C-TERMINAL RECEPTOR-BINDING DOMAIN OF AVIAN REOVIRUS FIBRE SIGMAC, ZN CRYSTAL FORM. 1T8C ; -1.00 ; STRUCTURE OF THE C-TYPE LECTIN DOMAIN OF CD23 1T8D ; -1.00 ; STRUCTURE OF THE C-TYPE LECTIN DOMAIN OF CD23 1A2N ; 2.80 ; STRUCTURE OF THE C115A MUTANT OF MURA COMPLEXED WITH THE FLUORINATED ANALOG OF THE REACTION TETRAHEDRAL INTERMEDIATE 1GMI ; 1.70 ; STRUCTURE OF THE C2 DOMAIN FROM NOVEL PROTEIN KINASE C EPSILON 1OQP ; -1.00 ; STRUCTURE OF THE CA2+/C-TERMINAL DOMAIN OF CALTRACTIN IN COMPLEX WITH THE CDC31P-BINDING DOMAIN FROM KAR1P 2CCO ; -1.00 ; STRUCTURE OF THE CALCIUM CHANNEL BLOCKER OMEGA CONOTOXIN GVIA, NMR, 20 STRUCTURES 1RJH ; -1.00 ; STRUCTURE OF THE CALCIUM FREE FORM OF THE C-TYPE LECTIN- LIKE DOMAIN OF TETRANECTIN 1PMZ ; 1.90 ; STRUCTURE OF THE CALCIUM-BINDING POLLEN ALLERGEN CHE A 3 1EL4 ; 1.73 ; STRUCTURE OF THE CALCIUM-REGULATED PHOTOPROTEIN OBELIN DETERMINED BY SULFUR SAS 1E19 ; 1.50 ; STRUCTURE OF THE CARBAMATE KINASE-LIKE CARBAMOYL PHOSPHATE SYNTHETASE FROM THE HYPERTHERMOPHILIC ARCHAEON PYROCOCCUS FURIOSUS BOUND TO ADP 1T3N ; 2.30 ; STRUCTURE OF THE CATALYTIC CORE OF DEOXYRIBONUCLEIC ACID POLYMERASE IOTA IN COMPLEX WITH DEOXYRIBONUCLEIC ACID AND DTTP 1QYU ; 2.00 ; STRUCTURE OF THE CATALYTIC DOMAIN OF 23S RRNA PSEUDOURIDINE SYNTHASE RLUD 1JWQ ; 1.80 ; STRUCTURE OF THE CATALYTIC DOMAIN OF CWLV, N-ACETYLMURAMOYL- L-ALANINE AMIDASE FROM BACILLUS(PAENIBACILLUS) POLYMYXA VAR.COLISTINUS 1LN0 ; 2.00 ; STRUCTURE OF THE CATALYTIC DOMAIN OF HOMING ENDONUCLEASE I- TEVI 1F6W ; 2.30 ; STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN BILE SALT ACTIVATED LIPASE 1NW3 ; 2.50 ; STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN DOT1L, A NON-SET DOMAIN NUCLEOSOMAL HISTONE METHYLTRANSFERASE 3USN ; -1.00 ; STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST STROMELYSIN-1 INHIBITED WITH THE THIADIAZOLE INHIBITOR IPNU-107859, NMR, 1 STRUCTURE 1NB8 ; 2.30 ; STRUCTURE OF THE CATALYTIC DOMAIN OF USP7 (HAUSP) 1PI7 ; -1.00 ; STRUCTURE OF THE CHANNEL-FORMING TRANS-MEMBRANE DOMAIN OF VIRUS PROTEIN "U" (VPU) FROM HIV-1 1PI8 ; -1.00 ; STRUCTURE OF THE CHANNEL-FORMING TRANS-MEMBRANE DOMAIN OF VIRUS PROTEIN "U" (VPU) FROM HIV-1 1PJE ; -1.00 ; STRUCTURE OF THE CHANNEL-FORMING TRANS-MEMBRANE DOMAIN OF VIRUS PROTEIN "U"(VPU) FROM HIV-1 1DXJ ; 1.80 ; STRUCTURE OF THE CHITINASE FROM JACK BEAN 1RYN ; 1.75 ; STRUCTURE OF THE CHLOROPLAST GROUP II INTRON SPLICING FACTOR CRS2 1AP0 ; -1.00 ; STRUCTURE OF THE CHROMATIN BINDING (CHROMO) DOMAIN FROM MOUSE MODIFIER PROTEIN 1, NMR, 26 STRUCTURES 1GUW ; -1.00 ; STRUCTURE OF THE CHROMODOMAIN FROM MOUSE HP1BETA IN COMPLEX WITH THE LYSINE 9-METHYL HISTONE H3 N-TERMINAL PEPTIDE, NMR, 25 STRUCTURES 1ZTU ; 2.50 ; STRUCTURE OF THE CHROMOPHORE BINDING DOMAIN OF BACTERIAL PHYTOCHROME 1K6S ; 2.03 ; STRUCTURE OF THE CLASS D BETA-LACTAMASE OXA-10 IN COMPLEX WITH A PHENYLBORONIC ACID 1K6R ; 2.30 ; STRUCTURE OF THE CLASS D BETA-LACTAMASE OXA-10 IN COMPLEX WITH MOXALACTAM 1GZE ; 2.70 ; STRUCTURE OF THE CLOSTRIDIUM BOTULINUM C3 EXOENZYME (L177C MUTANT) 1GZF ; 1.95 ; STRUCTURE OF THE CLOSTRIDIUM BOTULINUM C3 EXOENZYME (WILD-TYPE) IN COMPLEX WITH NAD 1NH4 ; -1.00 ; STRUCTURE OF THE COAT PROTEIN IN FD FILAMENTOUS BACTERIOPHAGE PARTICLES 1K1E ; 1.67 ; STRUCTURE OF THE COBALT-BOUND FORM OF THE DEOXY-D-MANNOSE- OCTULOSONATE 8-PHOSPHATE PHOSPHATASE (YRBI) FROM HAEMOPHILUS INFLUENZAE (HI1679) 1CCW ; 1.60 ; STRUCTURE OF THE COENZYME B12 DEPENDENT ENZYME GLUTAMATE MUTASE FROM CLOSTRIDIUM COCHLEARIUM 2BE1 ; 2.98 ; STRUCTURE OF THE COMPACT LUMENAL DOMAIN OF YEAST IRE1 1GL1 ; 2.10 ; STRUCTURE OF THE COMPLEX BETWEEN BOVINE ALPHA-CHYMOTRYPSIN AND PMP-C, AN INHIBITOR FROM THE INSECT LOCUSTA MIGRATORIA 1GL0 ; 3.00 ; STRUCTURE OF THE COMPLEX BETWEEN BOVINE ALPHA-CHYMOTRYPSIN AND PMP-D2V, AN INHIBITOR FROM THE INSECT LOCUSTA MIGRATORIA 1UJW ; 2.75 ; STRUCTURE OF THE COMPLEX BETWEEN BTUB AND COLICIN E3 RECEPTOR BINDING DOMAIN 1RJL ; 2.60 ; STRUCTURE OF THE COMPLEX BETWEEN OSPB-CT AND BACTERICIDAL FAB-H6831 1SV3 ; 1.35 ; STRUCTURE OF THE COMPLEX FORMED BETWEEN PHOSPHOLIPASE A2 AND 4-METHOXYBENZOIC ACID AT 1.3A RESOLUTION. 1QGC ; 30.00 ; STRUCTURE OF THE COMPLEX OF AN FAB FRAGMENT OF A NEUTRALIZING ANTIBODY WITH FOOT AND MOUTH DISEASE VIRUS 1MXE ; 1.70 ; STRUCTURE OF THE COMPLEX OF CALMODULIN WITH THE TARGET SEQUENCE OF CAMKI 1UVO ; 1.85 ; STRUCTURE OF THE COMPLEX OF PORCINE PANCREATIC ELASTASE IN COMPLEX WITH CADMIUM REFINED AT 1.85 A RESOLUTION (CRYSTAL A) 1UVP ; 1.85 ; STRUCTURE OF THE COMPLEX OF PORCINE PANCREATIC ELASTASE IN COMPLEX WITH CADMIUM REFINED AT 1.85 A RESOLUTION (CRYSTAL B) 1E91 ; -1.00 ; STRUCTURE OF THE COMPLEX OF THE MAD1-SIN3B INTERACTION DOMAINS 1YHL ; 1.95 ; STRUCTURE OF THE COMPLEX OF TRYPANOSOMA CRUZI FARNESYL DIPHOSPHATE SYNTHASE WITH RISEDRONATE, DMAPP AND MG+2 1YHM ; 2.50 ; STRUCTURE OF THE COMPLEX OF TRYPANOSOMA CRUZI FARNESYL DISPHOSPHATE SYNTHASE WITH ALENDRONATE, ISOPENTENYL DIPHOSPHATE AND MG+2 1TJ9 ; 1.10 ; STRUCTURE OF THE COMPLEXED FORMED BETWEEN GROUP II PHOSPHOLIPASE A2 AND A RATIONALLY DESIGNED TETRA PEPTIDE, VAL-ALA-ARG-SER AT 1.1A RESOLUTION 1UT4 ; 2.50 ; STRUCTURE OF THE CONSERVED DOMAIN OF ANAC, A MEMBER OF THE NAC FAMILY OF TRANSCRIPTION FACTORS 1UT7 ; 1.90 ; STRUCTURE OF THE CONSERVED DOMAIN OF ANAC, A MEMBER OF THE NAC FAMILY OF TRANSCRIPTION FACTORS 1I1Q ; 1.90 ; STRUCTURE OF THE COOPERATIVE ALLOSTERIC ANTHRANILATE SYNTHASE FROM SALMONELLA TYPHIMURIUM 1JWB ; 2.10 ; STRUCTURE OF THE COVALENT ACYL-ADENYLATE FORM OF THE MOEB- MOAD PROTEIN COMPLEX 1LDD ; 2.00 ; STRUCTURE OF THE CUL1-RBX1-SKP1-F BOXSKP2 SCF UBIQUITIN LIGASE COMPLEX 1LDJ ; 3.00 ; STRUCTURE OF THE CUL1-RBX1-SKP1-F BOXSKP2 SCF UBIQUITIN LIGASE COMPLEX 1LDK ; 3.10 ; STRUCTURE OF THE CUL1-RBX1-SKP1-F BOXSKP2 SCF UBIQUITIN LIGASE COMPLEX 1DW1 ; 1.90 ; STRUCTURE OF THE CYANIDE COMPLEX OF SHP, AN OXYGEN BINDING CYTOCHROME C 2AJW ; -1.00 ; STRUCTURE OF THE CYCLIC CONOTOXIN MII-6 1TPY ; 2.20 ; STRUCTURE OF THE CYCLOPROPANE SYNTHASE MMAA2 FROM MYCOBACTERIUM TUBERCULOSIS 1SP7 ; -1.00 ; STRUCTURE OF THE CYS-RICH C-TERMINAL DOMAIN OF HYDRA MINICOLLAGEN 1Q90 ; 3.10 ; STRUCTURE OF THE CYTOCHROME B6F (PLASTOHYDROQUINONE : PLASTOCYANIN OXIDOREDUCTASE) FROM CHLAMYDOMONAS REINHARDTII 1LS9 ; 1.30 ; STRUCTURE OF THE CYTOCHROME C6 FROM THE GREEN ALGA CLADOPHORA GLOMERATA 1EXB ; 2.10 ; STRUCTURE OF THE CYTOPLASMIC BETA SUBUNIT-T1 ASSEMBLY OF VOLTAGE-DEPENDENT K CHANNELS 1TO4 ; 1.55 ; STRUCTURE OF THE CYTOSOLIC CU,ZN SOD FROM S. MANSONI 1TO5 ; 2.20 ; STRUCTURE OF THE CYTOSOLIC CU,ZN SOD FROM S. MANSONI 1RK8 ; 1.90 ; STRUCTURE OF THE CYTOSOLIC PROTEIN PYM BOUND TO THE MAGO- Y14 CORE OF THE EXON JUNCTION COMPLEX 1LK5 ; 1.75 ; STRUCTURE OF THE D-RIBOSE-5-PHOSPHATE ISOMERASE FROM PYROCOCCUS HORIKOSHII 4RSD ; 1.60 ; STRUCTURE OF THE D121A VARIANT OF RIBONUCLEASE A 3RSD ; 1.60 ; STRUCTURE OF THE D121N VARIANT OF RIBONUCLEASE A 1LL6 ; 2.80 ; STRUCTURE OF THE D169N MUTANT OF C. IMMITIS CHITINASE 1 1E0Y ; 2.75 ; STRUCTURE OF THE D170S/T457E DOUBLE MUTANT OF VANILLYL-ALCOHOL OXIDASE 1QWS ; 1.90 ; STRUCTURE OF THE D181N VARIANT OF CATALASE HPII FROM E. COLI 1U5O ; 2.50 ; STRUCTURE OF THE D23A MUTANT OF THE NUCLEAR TRANSPORT CARRIER NTF2 1Z4Q ; 2.05 ; STRUCTURE OF THE D41N VARIANT OF THE HUMAN MITOCHONDRIAL DEOXYRIBONUCLEOTIDASE IN COMPLEX WITH 2',3'-DIDEOXY-2',3- DIDEHYDROTHYMIDINE 5'-MONOPHOSPHATE (D4T-MP) 1Z4P ; 2.00 ; STRUCTURE OF THE D41N VARIANT OF THE HUMAN MITOCHONDRIAL DEOXYRIBONUCLEOTIDASE IN COMPLEX WITH DEOXYRIBOGUANOSINE 5'-MONOPHOSPHATE 1Z4I ; 1.98 ; STRUCTURE OF THE D41N VARIANT OF THE HUMAN MITOCHONDRIAL DEOXYRIBONUCLEOTIDASE IN COMPLEX WITH DEOXYRIBOURIDINE 5'- MONOPHOSPHATE 1Z4K ; 1.75 ; STRUCTURE OF THE D41N VARIANT OF THE HUMAN MITOCHONDRIAL DEOXYRIBONUCLEOTIDASE IN COMPLEX WITH THYMIDINE 3'- MONOPHOSPHATE 1Z4L ; 1.80 ; STRUCTURE OF THE D41N VARIANT OF THE HUMAN MITOCHONDRIAL DEOXYRIBONUCLEOTIDASE IN COMPLEX WITH THYMIDINE 5'- MONOPHOSPHATE 1Z4J ; 1.80 ; STRUCTURE OF THE D41N VARIANT OF THE HUMAN MITOCHONDRIAL DEOXYRIBONUCLEOTIDASE IN COMPLEX WITH URIDINE 2'- MONOPHOSPHATE 1Z4M ; 1.70 ; STRUCTURE OF THE D41N VARIANT OF THE HUMAN MITOCHONDRIAL DEOXYRIBONUCLEOTIDASE IN COMPLEX WITH URIDINE 5'- MONOPHOSPHATE 1IBU ; 3.10 ; STRUCTURE OF THE D53,54N MUTANT OF HISTIDINE DECARBOXYLASE AT 25 C 1IBT ; 2.60 ; STRUCTURE OF THE D53,54N MUTANT OF HISTIDINE DECARBOXYLASE AT-170 C 1IBW ; 3.20 ; STRUCTURE OF THE D53,54N MUTANT OF HISTIDINE DECARBOXYLASE BOUND WITH HISTIDINE METHYL ESTER AT 25 C 1IBV ; 2.50 ; STRUCTURE OF THE D53,54N MUTANT OF HISTIDINE DECARBOXYLASE BOUND WITH HISTIDINE METHYL ESTER AT-170 C 1P5X ; 2.00 ; STRUCTURE OF THE D55N MUTANT OF PHOSPHOLIPASE C FROM BACILLUS CEREUS 1P6D ; 2.00 ; STRUCTURE OF THE D55N MUTANT OF PHOSPHOLIPASE C FROM BACILLUS CEREUS IN COMPLEX WITH (3S)-3,4,DI-N- HEXANOYLOXYBUTYL-1-PHOSPHOCHOLINE 1P6E ; 2.30 ; STRUCTURE OF THE D55N MUTANT OF PHOSPHOLIPASE C FROM BACILLUS CEREUS IN COMPLEX WITH 1,2-DI-N-PENTANOYL-SN- GLYCERO-3-DITHIOPHOSPHOCHOLINE 1MGY ; 2.00 ; STRUCTURE OF THE D85S MUTANT OF BACTERIORHODOPSIN WITH BROMIDE BOUND 1R6A ; 2.60 ; STRUCTURE OF THE DENGUE VIRUS 2'O METHYLTRANSFERASE IN COMPLEX WITH S-ADENOSYL HOMOCYSTEINE AND RIBAVIRIN 5' TRIPHOSPHATE 1J9I ; -1.00 ; STRUCTURE OF THE DEOXYRIBONUCLEIC ACID BINDING DOMAIN OF THE GPNU1 SUBUNIT OF LAMBDA TERMINASE 1T2K ; 3.00 ; STRUCTURE OF THE DEOXYRIBONUCLEIC ACID BINDING DOMAINS OF IRF3, ATF-2 AND JUN BOUND TO DEOXYRIBONUCLEIC ACID 1A02 ; 2.70 ; STRUCTURE OF THE DEOXYRIBONUCLEIC ACID BINDING DOMAINS OF NFAT, FOS AND JUN BOUND TO DEOXYRIBONUCLEIC ACID 1OQY ; -1.00 ; STRUCTURE OF THE DEOXYRIBONUCLEIC ACID REPAIR PROTEIN HHR23A 1D3Y ; 2.00 ; STRUCTURE OF THE DEOXYRIBONUCLEIC ACID TOPOISOMERASE VI A SUBUNIT 1JYF ; 3.00 ; STRUCTURE OF THE DIMERIC LAC REPRESSOR WITH AN 11-RESIDUE C- TERMINAL DELETION. 1JWL ; 4.00 ; STRUCTURE OF THE DIMERIC LAC REPRESSOR/OPERATOR O1/ONPF COMPLEX 1M23 ; -1.00 ; STRUCTURE OF THE DIMERIZED CYTOPLASMIC DOMAIN OF P23 IN SOLUTION 1P23 ; -1.00 ; STRUCTURE OF THE DIMERIZED CYTOPLASMIC DOMAIN OF P23 IN SOLUTION, NMR, 10 STRUCTURES 1DD9 ; 1.60 ; STRUCTURE OF THE DNAG CATALYTIC CORE 1DDE ; 1.70 ; STRUCTURE OF THE DNAG CATALYTIC CORE 1C74 ; 1.90 ; STRUCTURE OF THE DOUBLE MUTANT (K53,56M) OF PHOSPHOLIPASE A2 1NU0 ; 1.60 ; STRUCTURE OF THE DOUBLE MUTANT (L6M; F134M, SEMET FORM) OF YQGF FROM ESCHERICHIA COLI, A HYPOTHETICAL PROTEIN 1QU6 ; -1.00 ; STRUCTURE OF THE DOUBLE-STRANDED RIBONUCLEIC ACID-BINDING DOMAIN OF THE PROTEIN KINASE PKR REVEALS THE MOLECULAR BASIS OF ITS DSRNA- MEDIATED ACTIVATION 1OHG ; 3.45 ; STRUCTURE OF THE DSDNA BACTERIOPHAGE HK97 MATURE EMPTY CAPSID 1GA0 ; 1.60 ; STRUCTURE OF THE E. CLOACAE GC1 BETA-LACTAMASE WITH A CEPHALOSPORIN SULFONE INHIBITOR 1LB2 ; 3.10 ; STRUCTURE OF THE E. COLI ALPHA C-TERMINAL DOMAIN OF RIBONUCLEIC ACID POLYMERASE IN COMPLEX WITH CAP AND DEOXYRIBONUCLEIC ACID 1XS0 ; 1.58 ; STRUCTURE OF THE E. COLI IVY PROTEIN 1PSU ; 2.20 ; STRUCTURE OF THE E. COLI PAAI PROTEIN FROM THE PHYENYLACETIC ACID DEGRADATION OPERON 1ZVT ; 1.70 ; STRUCTURE OF THE E. COLI PARC C-TERMINAL DOMAIN 1ML5 ; 14.00 ; STRUCTURE OF THE E. COLI RIBOSOMAL TERMINATION COMPLEX WITH RELEASE FACTOR 2 1H3D ; 2.70 ; STRUCTURE OF THE E.COLI ATP-PHOSPHORIBOSYLTRANSFERASE 1LL7 ; 2.00 ; STRUCTURE OF THE E171Q MUTANT OF C. IMMITIS CHITINASE 1 1ZM4 ; 2.90 ; STRUCTURE OF THE EEF2-ETA-BTAD COMPLEX 1FSB ; -1.00 ; STRUCTURE OF THE EGF DOMAIN OF P-SELECTIN, NMR, 19 STRUCTURES 1APQ ; -1.00 ; STRUCTURE OF THE EGF-LIKE MODULE OF HUMAN C1R, NMR, 19 STRUCTURES 1UP0 ; 1.75 ; STRUCTURE OF THE ENDOGLUCANASE CEL6 FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH CELLOBIOSE AT 1.75 ANGSTROM 1UP2 ; 1.90 ; STRUCTURE OF THE ENDOGLUCANASE CEL6 FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH GLUCOSE-ISOFAGOMINE AT 1.9 ANGSTROM 1UP3 ; 1.60 ; STRUCTURE OF THE ENDOGLUCANASE CEL6 FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH METHYL-CELLOBIOSYL-4-DEOXY-4-THIO-BETA-D-CELLOBIOSIDE AT 1.6 ANGSTROM 1UOZ ; 1.10 ; STRUCTURE OF THE ENDOGLUCANASE CEL6 FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH THIOCELLOPENTAOSE AT 1.1 ANGSTROM 2C2A ; 1.90 ; STRUCTURE OF THE ENTIRE CYTOPLASMIC PORTION OF A SENSOR HISTIDINE KINASE PROTEIN 1KG0 ; 2.65 ; STRUCTURE OF THE EPSTEIN-BARR VIRUS GP42 PROTEIN BOUND TO THE MHC CLASS II RECEPTOR HLA-DR1 1OTS ; 2.51 ; STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL AND FAB COMPLEX 1OTT ; 3.00 ; STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL E148A MUTANT AND FAB COMPLEX 1OTU ; 3.30 ; STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL E148Q MUTANT AND FAB COMPLEX 2AVU ; 3.00 ; STRUCTURE OF THE ESCHERICHIA COLI FLHDC COMPLEX, A PROKARYOTIC HETEROMERIC REGULATOR OF TRANSCRIPTION 1U5T ; 3.60 ; STRUCTURE OF THE ESCRT-II ENDOSOMAL TRAFFICKING COMPLEX 1J71 ; 1.80 ; STRUCTURE OF THE EXTRACELLULAR ASPARTIC PROTEINASE FROM CANDIDA TROPICALIS YEAST. 1NQL ; 2.80 ; STRUCTURE OF THE EXTRACELLULAR DOMAIN OF HUMAN EPIDERMAL GROWTH FACTOR (EGF) RECEPTOR IN AN INACTIVE (LOW PH) COMPLEX WITH EGF. 1YY9 ; 2.60 ; STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF CETUXIMAB/ERBITUX/IMC-C225 1DN0 ; 2.28 ; STRUCTURE OF THE FAB FRAGMENT FROM A HUMAN IGM COLD AGGLUTININ 1YWJ ; -1.00 ; STRUCTURE OF THE FBP11WW1 DOMAIN 1YWI ; -1.00 ; STRUCTURE OF THE FBP11WW1 DOMAIN COMPLEXED TO THE PEPTIDE APPTPPPLPP 1YWC ; 1.00 ; STRUCTURE OF THE FERROUS CO COMPLEX OF NP4 FROM RHODNIUS PROLIXUS AT PH 7.0 1AY2 ; 2.60 ; STRUCTURE OF THE FIBER-FORMING PROTEIN PILIN AT 2.6 ANGSTROMS RESOLUTION 1DUG ; 1.80 ; STRUCTURE OF THE FIBRINOGEN G CHAIN INTEGRIN BINDING AND FACTOR XIIIA CROSSLINKING SITES OBTAINED THROUGH CARRIER PROTEIN DRIVEN CRYSTALLIZATION 1O0K ; 1.17 ; STRUCTURE OF THE FIRST PARALLEL DEOXYRIBONUCLEIC ACID QUADRUPLEX-DRUG COMPLEX 1QOL ; 3.00 ; STRUCTURE OF THE FMDV LEADER PROTEASE 1ZVU ; 3.00 ; STRUCTURE OF THE FULL-LENGTH E. COLI PARC SUBUNIT 1ZZH ; 2.70 ; STRUCTURE OF THE FULLY OXIDIZED DI-HEME CYTOCHROME C PEROXIDASE FROM R. CAPSULATUS 1CZG ; 2.50 ; STRUCTURE OF THE G62T MUTANT OF SHIGA-LIKE TOXIN I B SUBUNIT 1F5M ; 1.90 ; STRUCTURE OF THE GAF DOMAIN 1ODH ; 2.85 ; STRUCTURE OF THE GCM DOMAIN BOUND TO DEOXYRIBONUCLEIC ACID 1OM9 ; 2.50 ; STRUCTURE OF THE GGA1-APPENDAGE IN COMPLEX WITH THE P56 BINDING PEPTIDE 1ZWT ; -1.00 ; STRUCTURE OF THE GLOBULAR HEAD DOMAIN OF THE BUNDLIN, BFPA, OF THE BUNDLE-FORMING PILUS OF ENTEROPATHOGENIC E.COLI 1RYM ; 1.80 ; STRUCTURE OF THE GROUP II INTRON SPLICING FACTOR CRS2 1XZP ; 2.30 ; STRUCTURE OF THE GTP-BINDING PROTEIN TRME FROM THERMOTOGA MARITIMA 1XZQ ; 2.90 ; STRUCTURE OF THE GTP-BINDING PROTEIN TRME FROM THERMOTOGA MARITIMA COMPLEXED WITH 5-FORMYL-THF 1HLW ; 1.90 ; STRUCTURE OF THE H122A MUTANT OF THE NUCLEOSIDE DIPHOSPHATE KINASE 1F3F ; 1.85 ; STRUCTURE OF THE H122G NUCLEOSIDE DIPHOSPHATE KINASE / D4T- TRIPHOSPHATE.MG COMPLEX 1QLT ; 2.20 ; STRUCTURE OF THE H422A MUTANT OF THE FLAVOENZYME VANILLYL-ALCOHOL OXIDASE 1QLU ; 2.40 ; STRUCTURE OF THE H422A MUTANT VANILLYL-ALCOHOL OXIDASE IN COMPLEX WITH ISOEUGENOL 1E8G ; 2.10 ; STRUCTURE OF THE H61T DOUBLE MUTANT OF VANILLYL-ALCOHOL OXIDASE IN COMPLEX WITH FLUORO-CRESOL 1E8F ; 2.90 ; STRUCTURE OF THE H61T MUTANT OF THE FLAVOENZYME VANILLYL-ALCOHOL OXIDASE IN THE APO FORM 1E8H ; 2.60 ; STRUCTURE OF THE H61T MUTANT OF THE FLAVOENZYME VANILLYL-ALCOHOL OXIDASE IN THE APO FORM COMPLEXED BY ADP 1JXZ ; 1.90 ; STRUCTURE OF THE H90Q MUTANT OF 4-CHLOROBENZOYL-COENZYME A DEHALOGENASE COMPLEXED WITH 4-HYDROXYBENZOYL-COENZYME A (PRODUCT) 1V2I ; 2.20 ; STRUCTURE OF THE HEMAGGLUTININ-NEURAMINIDASE FROM HUMAN PARAINFLUENZA VIRUS TYPE III 1V3B ; 2.00 ; STRUCTURE OF THE HEMAGGLUTININ-NEURAMINIDASE FROM HUMAN PARAINFLUENZA VIRUS TYPE III 1V3C ; 2.30 ; STRUCTURE OF THE HEMAGGLUTININ-NEURAMINIDASE FROM HUMAN PARAINFLUENZA VIRUS TYPE III: COMPLEX WITH NEU5AC 1V3D ; 2.28 ; STRUCTURE OF THE HEMAGGLUTININ-NEURAMINIDASE FROM HUMAN PARAINFLUENZA VIRUS TYPE III: COMPLEX WITH NEU5AC2EN 1V3E ; 1.89 ; STRUCTURE OF THE HEMAGGLUTININ-NEURAMINIDASE FROM HUMAN PARAINFLUENZA VIRUS TYPE III: COMPLEX WITH ZANAMAVIR 1HEI ; 2.10 ; STRUCTURE OF THE HEPATITIS C VIRUS RIBONUCLEIC ACID HELICASE DOMAIN 1M6B ; 2.60 ; STRUCTURE OF THE HER3 (ERBB3) EXTRACELLULAR DOMAIN 1RJ9 ; 1.90 ; STRUCTURE OF THE HETERODIMER OF THE CONSERVED GTPASE DOMAINS OF THE SIGNAL RECOGNITION PARTICLE (FFH) AND ITS RECEPTOR (FTSY) 1XAT ; 3.20 ; STRUCTURE OF THE HEXAPEPTIDE XENOBIOTIC ACETYLTRANSFERASE FROM PSEUDOMONAS AERUGINOSA 1I59 ; 1.80 ; STRUCTURE OF THE HISTIDINE KINASE CHEA ATP-BINDING DOMAIN IN COMPLEX WITH ADPNP AND MAGENSIUM 1I58 ; 1.60 ; STRUCTURE OF THE HISTIDINE KINASE CHEA ATP-BINDING DOMAIN IN COMPLEX WITH ATP ANALOG ADPCP AND MAGNESIUM 1KKS ; -1.00 ; STRUCTURE OF THE HISTONE MRNA HAIRPIN REQUIRED FOR CELL CYCLE REGULATION OF HISTONE GENE EXPRESSION 1A43 ; 2.60 ; STRUCTURE OF THE HIV-1 CAPSID PROTEIN DIMERIZATION DOMAIN AT 2.6A RESOLUTION 1EN1 ; -1.00 ; STRUCTURE OF THE HIV-1 MINUS STRAND PRIMER BINDING SITE 1A1T ; -1.00 ; STRUCTURE OF THE HIV-1 NUCLEOCAPSID PROTEIN BOUND TO THE SL3 PSI-RIBONUCLEIC ACID RECOGNITION ELEMENT, NMR, 25 STRUCTURES 2CRX ; 2.50 ; STRUCTURE OF THE HOLLIDAY JUNCTION INTERMEDIATE IN CRE-LOXP SITE-SPECIFIC RECOMBINATION 1B8I ; 2.40 ; STRUCTURE OF THE HOMEOTIC UBX/EXD/DEOXYRIBONUCLEIC ACID TERNARY COMPLEX 1XWV ; 1.83 ; STRUCTURE OF THE HOUSE DUST MITE ALLERGEN DER F 2: IMPLICATIONS FOR FUNCTION AND MOLECULAR BASIS OF IGE CROSS- REACTIVITY 1N19 ; 1.86 ; STRUCTURE OF THE HSOD A4V MUTANT 1JVR ; -1.00 ; STRUCTURE OF THE HTLV-II MATRIX PROTEIN, NMR, 20 STRUCTURES 1GR3 ; 2.00 ; STRUCTURE OF THE HUMAN COLLAGEN X NC1 TRIMER 1SNT ; 1.75 ; STRUCTURE OF THE HUMAN CYTOSOLIC SIALIDASE NEU2 1VCU ; 2.85 ; STRUCTURE OF THE HUMAN CYTOSOLIC SIALIDASE NEU2 IN COMPLEX WITH THE INHIBITOR DANA 1K8P ; 2.40 ; STRUCTURE OF THE HUMAN G-QUADRUPLEX REVEALS A NOVEL TOPOLOGY 2A7L ; 1.82 ; STRUCTURE OF THE HUMAN HYPOTHETICAL UBIQUITIN-CONJUGATING ENZYME, LOC55284 1F6A ; 3.50 ; STRUCTURE OF THE HUMAN IGE-FC BOUND TO ITS HIGH AFFINITY RECEPTOR FC(EPSILON)RI(ALPHA) 1T9G ; 2.90 ; STRUCTURE OF THE HUMAN MCAD:ETF COMPLEX 2A1T ; 2.80 ; STRUCTURE OF THE HUMAN MCAD:ETF E165BETAA COMPLEX 1P6F ; 2.20 ; STRUCTURE OF THE HUMAN NATURAL CYTOTOXICITY RECEPTOR NKP46 1H2V ; 2.00 ; STRUCTURE OF THE HUMAN NUCLEAR CAP-BINDING-COMPLEX (CBC) 1H2T ; 2.15 ; STRUCTURE OF THE HUMAN NUCLEAR CAP-BINDING-COMPLEX (CBC) IN COMPLEX WITH A CAP ANALOGUE M7GPPPG 1H2U ; 2.40 ; STRUCTURE OF THE HUMAN NUCLEAR CAP-BINDING-COMPLEX (CBC) IN COMPLEX WITH A CAP ANALOGUE M7GPPPG 1CMI ; 2.50 ; STRUCTURE OF THE HUMAN PIN/LC8 DIMER WITH A BOUND PEPTIDE 1W4M ; -1.00 ; STRUCTURE OF THE HUMAN PLECKSTRIN DEP DOMAIN BY MULTIDIMENSIONAL NMR 1L1O ; 2.80 ; STRUCTURE OF THE HUMAN REPLICATION PROTEIN A (RPA) TRIMERIZATION CORE 2A4D ; 1.69 ; STRUCTURE OF THE HUMAN UBIQUITIN-CONJUGATING ENZYME E2 VARIANT 1 (UEV-1) 1WMQ ; 1.60 ; STRUCTURE OF THE HUTP ANTITERMINATION COMPLEX BOUND TO A SINGLE STRANDED REGION OF HUT MRNA 1IHA ; 1.60 ; STRUCTURE OF THE HYBRID RIBONUCLEIC ACID/DEOXYRIBONUCLEIC ACID R-GCUUCGGC-D[BR]U IN PRESENCE OF RH(NH3)6+++ 1IDW ; 1.80 ; STRUCTURE OF THE HYBRID RIBONUCLEIC ACID/DEOXYRIBONUCLEIC ACID R-GCUUCGGC-D[CL]U IN PRESENCE OF RH(NH3)6+++ 1ICG ; 1.53 ; STRUCTURE OF THE HYBRID RIBONUCLEIC ACID/DEOXYRIBONUCLEIC ACID R-GCUUCGGC-D[F]U IN PRESENCE OF IR(NH3)6+++ 1ID9 ; 1.60 ; STRUCTURE OF THE HYBRID RIBONUCLEIC ACID/DEOXYRIBONUCLEIC ACID R-GCUUCGGC-D[F]U IN PRESENCE OF RH(NH3)6+++ 1YEL ; -1.00 ; STRUCTURE OF THE HYPOTHETICAL ARABIDOPSIS THALIANA PROTEIN AT1G16640.1 1ZCH ; 1.85 ; STRUCTURE OF THE HYPOTHETICAL OXIDOREDUCTASE YCND FROM BACILLUS SUBTILIS 1P1M ; 1.50 ; STRUCTURE OF THE HYPOTHETICAL PROTEIN TM0936 FROM THERMOTOGA MARITIMA AT 1.5A BOUND TO NI AND METHIONINE 1NNX ; 1.45 ; STRUCTURE OF THE HYPOTHETICAL PROTEIN YGIW FROM E. COLI. 1BOE ; -1.00 ; STRUCTURE OF THE IGF BINDING DOMAIN OF THE INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-5 (IGFBP-5): IMPLICATIONS FOR IGF AND IGF-I RECEPTOR INTERACTIONS 1DY6 ; 2.10 ; STRUCTURE OF THE IMIPENEM-HYDROLYZING BETA-LACTAMASE SME-1 1YNT ; 3.10 ; STRUCTURE OF THE IMMUNODOMINANT EPITOPE DISPLAYED BY THE SURFACE ANTIGEN 1 (SAG1) OF TOXOPLASMA GONDII COMPLEXED TO A MONOCLONAL ANTIBODY 1O3W ; 1.85 ; STRUCTURE OF THE INHIBITOR FREE TRIPLE MUTANT (K53,56,120M) OF PHOSPHOLIPASE A2 1K3A ; 2.10 ; STRUCTURE OF THE INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR KINASE 1Q7D ; 1.80 ; STRUCTURE OF THE INTEGRIN ALPHA2BETA1 BINDING COLLAGEN PEPTIDE 1T3M ; 1.65 ; STRUCTURE OF THE ISOASPARTYL PEPTIDASE WITH L-ASPARAGINASE ACTIVITY FROM E. COLI 1SVK ; 2.00 ; STRUCTURE OF THE K180P MUTANT OF GI ALPHA SUBUNIT BOUND TO ALF4 AND GDP 1SVS ; 1.50 ; STRUCTURE OF THE K180P MUTANT OF GI ALPHA SUBUNIT BOUND TO GPPNHP. 1STX ; 2.10 ; STRUCTURE OF THE K38A MUTANT OF ECORV BOUND TO COGNATE DEOXYRIBONUCLEIC ACID AND MN2+ 3RSK ; 2.00 ; STRUCTURE OF THE K7A/R10A/K66A VARIANT OF RIBONUCLEASE A 4RSK ; 2.10 ; STRUCTURE OF THE K7A/R10A/K66A VARIANT OF RIBONUCLEASE A COMPLEXED WITH 3'-UMP 1YAE ; 3.11 ; STRUCTURE OF THE KAINATE RECEPTOR SUBUNIT GLUR6 AGONIST BINDING DOMAIN COMPLEXED WITH DOMOIC ACID 2C1T ; 2.60 ; STRUCTURE OF THE KAP60P:NUP2 COMPLEX 1QBK ; 3.00 ; STRUCTURE OF THE KARYOPHERIN BETA2-RAN GPPNHP NUCLEAR TRANSPORT COMPLEX 1M1C ; 3.50 ; STRUCTURE OF THE L-A VIRUS 1MZP ; 2.65 ; STRUCTURE OF THE L1 PROTUBERANCE IN THE RIBOSOME 1AE9 ; 1.90 ; STRUCTURE OF THE LAMBDA INTEGRASE CATALYTIC CORE 1KT0 ; 2.70 ; STRUCTURE OF THE LARGE FKBP-LIKE PROTEIN, FKBP51, INVOLVED IN STEROID RECEPTOR COMPLEXES 1KT1 ; 2.80 ; STRUCTURE OF THE LARGE FKBP-LIKE PROTEIN, FKBP51, INVOLVED IN STEROID RECEPTOR COMPLEXES 1KK0 ; 1.95 ; STRUCTURE OF THE LARGE GAMMA SUBUNIT OF INITIATION FACTOR EIF2 FROM PYROCOCCUS ABYSSI 1KJZ ; 1.85 ; STRUCTURE OF THE LARGE GAMMA SUBUNIT OF INITIATION FACTOR EIF2 FROM PYROCOCCUS ABYSSI-G235D MUTANT 1KK2 ; 2.10 ; STRUCTURE OF THE LARGE GAMMA SUBUNIT OF INITIATION FACTOR EIF2 FROM PYROCOCCUS ABYSSI-G235D MUTANT COMPLEXED WITH GDP-MG2+ 1KK1 ; 1.80 ; STRUCTURE OF THE LARGE GAMMA SUBUNIT OF INITIATION FACTOR EIF2 FROM PYROCOCCUS ABYSSI-G235D MUTANT COMPLEXED WITH GDPNP-MG2+ 1NO7 ; 2.90 ; STRUCTURE OF THE LARGE PROTEASE RESISTANT UPPER DOMAIN OF VP5, THE MAJOR CAPSID PROTEIN OF HERPES SIMPLEX VIRUS-1 1JOT ; 2.20 ; STRUCTURE OF THE LECTIN MPA COMPLEXED WITH T-ANTIGEN DISACCHARIDE 1L1C ; -1.00 ; STRUCTURE OF THE LICT BACTERIAL ANTITERMINATOR PROTEIN IN COMPLEX WITH ITS RIBONUCLEIC ACID TARGET 1XAP ; 2.10 ; STRUCTURE OF THE LIGAND BINDING DOMAIN OF THE RETINOIC ACID RECEPTOR BETA 1WOA ; 2.80 ; STRUCTURE OF THE LOOP6 HINGE MUTANT OF PLASMODIUM FALCIPARUM TRIOSEPHOSPHATE ISOMERASE, W168F, COMPLEXED WITH GLYCEROL-2-PHOSPHATE 1DZE ; 2.50 ; STRUCTURE OF THE M INTERMEDIATE OF BACTERIORHODOPSIN TRAPPED AT 100K 2CSA ; -1.00 ; STRUCTURE OF THE M3 MUSCARINIC ACETYLCHOLINE RECEPTOR BASOLATERAL SORTING SIGNAL 1E9W ; 1.02 ; STRUCTURE OF THE MACROCYCLE THIOSTREPTON SOLVED USING THE ANOMALOUS DISPERSIVE CONTRIBUTION FROM SULFUR 1YKH ; 3.00 ; STRUCTURE OF THE MEDIATOR MED7/MED21 (MED7/SRB7) SUBCOMPLEX 1YKE ; 3.30 ; STRUCTURE OF THE MEDIATOR MED7/MED21 SUBCOMPLEX 1ZP2 ; 3.00 ; STRUCTURE OF THE MEDIATOR SUBUNIT CYCLIN C 1AFJ ; -1.00 ; STRUCTURE OF THE MERCURY-BOUND FORM OF MERP, THE PERIPLASMIC PROTEIN FROM THE BACTERIAL MERCURY DETOXIFICATION SYSTEM, NMR, 20 STRUCTURES 1NI5 ; 2.65 ; STRUCTURE OF THE MESJ PP-ATPASE FROM ESCHERICHIA COLI 1J8D ; 2.30 ; STRUCTURE OF THE METAL-FREE FORM OF THE DEOXY-D-MANNOSE- OCTULOSONATE 8-PHOSPHATE PHOSPHATASE (YRBI) FROM HAEMOPHILUS INFLUENZAE (HI1679) 2C0C ; 1.45 ; STRUCTURE OF THE MGC45594 GENE PRODUCT 1B3J ; 3.00 ; STRUCTURE OF THE MHC CLASS I HOMOLOG MIC-A, A GAMMADELTA T CELL LIGAND 1JE6 ; 2.50 ; STRUCTURE OF THE MHC CLASS I HOMOLOG MICB 1DSV ; -1.00 ; STRUCTURE OF THE MMTV NUCLEOCAPSID PROTEIN (C-TERMINAL ZINC FINGER) 1DSQ ; -1.00 ; STRUCTURE OF THE MMTV NUCLEOCAPSID PROTEIN (ZINC FINGER 1) 1PS5 ; 2.00 ; STRUCTURE OF THE MONOCLINIC C2 FORM OF HEN EGG-WHITE LYSOZYME AT 2.0 ANGSTROMS RESOLUTION 1EV6 ; 1.90 ; STRUCTURE OF THE MONOCLINIC FORM OF THE M-CRESOL/INSULIN R6 HEXAMER 1PWJ ; -1.00 ; STRUCTURE OF THE MONOMERIC 8-KDA DYNEIN LIGHT CHAIN AND MECHANISM OF DOMAIN SWAPPED DIMER ASSEMBLY 1PWK ; -1.00 ; STRUCTURE OF THE MONOMERIC 8-KDA DYNEIN LIGHT CHAIN AND MECHANISM OF DOMAIN SWAPPED DIMER ASSEMBLY 1MSL ; 3.50 ; STRUCTURE OF THE MSCL HOMOLOGUE FROM MYCOBACTERIUM TUBERCULOSIS: A GATED MECHANOSENSITIVE CHANNEL. 1MR2 ; 2.30 ; STRUCTURE OF THE MT-ADPRASE IN COMPLEX WITH 1 MN2+ ION AND AMP-CP (A INHIBITOR), A NUDIX ENZYME 1MK1 ; 2.00 ; STRUCTURE OF THE MT-ADPRASE IN COMPLEX WITH ADPR, A NUDIX ENZYME 1MQE ; 2.00 ; STRUCTURE OF THE MT-ADPRASE IN COMPLEX WITH GADOLIDIUM AND ADP-RIBOSE, A NUDIX ENZYME 1MQW ; 2.30 ; STRUCTURE OF THE MT-ADPRASE IN COMPLEX WITH THREE MN2+ IONS AND AMPCPR, A NUDIX ENZYME 1S7B ; 3.80 ; STRUCTURE OF THE MULTIDRUG RESISTANCE EFFLUX TRANSPORTER EMRE FROM ESCHERICHIA COLI 1E8T ; 2.50 ; STRUCTURE OF THE MULTIFUNCTIONAL PARAMYXOVIRUS HEMAGGLUTININ-NEURAMINIDASE 1E8U ; 2.00 ; STRUCTURE OF THE MULTIFUNCTIONAL PARAMYXOVIRUS HEMAGGLUTININ-NEURAMINIDASE 1E8V ; 2.00 ; STRUCTURE OF THE MULTIFUNCTIONAL PARAMYXOVIRUS HEMAGGLUTININ-NEURAMINIDASE 1CG1 ; 2.50 ; STRUCTURE OF THE MUTANT (K16Q) OF ADENYLOSUCCINATE SYNTHETASE FROM E. COLI COMPLEXED WITH HADACIDIN, GDP, 6- PHOSPHORYL-IMP, AND MG2+ 1CG3 ; 2.50 ; STRUCTURE OF THE MUTANT (R143L) OF ADENYLOSUCCINATE SYNTHETASE FROM E. COLI COMPLEXED WITH HADACIDIN, GDP, 6- PHOSPHORYL-IMP, AND MG2+ 1CG4 ; 2.50 ; STRUCTURE OF THE MUTANT (R303L) OF ADENYLOSUCCINATE SYNTHETASE FROM E. COLI COMPLEXED WITH, GDP, 6-PHOSPHORYL- IMP, AND MG2+ 1JT9 ; 2.06 ; STRUCTURE OF THE MUTANT F174A T FORM OF THE GLUCOSAMINE-6- PHOSPHATE DEAMINASE FROM E.COLI 1QF7 ; 2.20 ; STRUCTURE OF THE MUTANT HIS392GLN OF CATALASE HPII FROM E. COLI 1CF9 ; 1.80 ; STRUCTURE OF THE MUTANT VAL169CYS OF CATALASE HPII FROM ESCHERICHIA COLI 1L6N ; -1.00 ; STRUCTURE OF THE N-TERMINAL 283-RESIDUE FRAGMENT OF THE HIV- 1 GAG POLYPROTEIN 1E32 ; 2.90 ; STRUCTURE OF THE N-TERMINAL DOMAIN AND THE D1 AAA DOMAIN OF MEMBRANE FUSION ATPASE P97 1B47 ; 2.20 ; STRUCTURE OF THE N-TERMINAL DOMAIN OF CBL IN COMPLEX WITH ITS BINDING SITE IN ZAP-70 1V4A ; 2.00 ; STRUCTURE OF THE N-TERMINAL DOMAIN OF ESCHERICHIA COLI GLUTAMINE SYNTHETASE ADENYLYLTRANSFERASE 2A9U ; 2.10 ; STRUCTURE OF THE N-TERMINAL DOMAIN OF HUMAN UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 8 (USP8) 1WLF ; 2.05 ; STRUCTURE OF THE N-TERMINAL DOMAIN OF PEX1 AAA-ATPASE: CHARACTERIZATION OF A PUTATIVE ADAPTOR-BINDING DOMAIN 1S0P ; 1.40 ; STRUCTURE OF THE N-TERMINAL DOMAIN OF THE ADENYLYL CYCLASE- ASSOCIATED PROTEIN (CAP) FROM DICTYOSTELIUM DISCOIDEUM. 1BYW ; 2.60 ; STRUCTURE OF THE N-TERMINAL DOMAIN OF THE HUMAN-ERG POTASSIUM CHANNEL 1GWP ; -1.00 ; STRUCTURE OF THE N-TERMINAL DOMAIN OF THE MATURE HIV-1 CAPSID PROTEIN 1A4H ; 2.50 ; STRUCTURE OF THE N-TERMINAL DOMAIN OF THE YEAST HSP90 CHAPERONE IN COMPLEX WITH GELDANAMYCIN 2D27 ; 2.21 ; STRUCTURE OF THE N-TERMINAL DOMAIN OF XPSE (CRYSTAL FORM I4122) 2D28 ; 2.00 ; STRUCTURE OF THE N-TERMINAL DOMAIN OF XPSE (CRYSTAL FORM P43212) 1J54 ; 1.70 ; STRUCTURE OF THE N-TERMINAL EXONUCLEASE DOMAIN OF THE EPSILON SUBUNIT OF E.COLI DEOXYRIBONUCLEIC ACID POLYMERASE III AT PH 5.8 1J53 ; 1.80 ; STRUCTURE OF THE N-TERMINAL EXONUCLEASE DOMAIN OF THE EPSILON SUBUNIT OF E.COLI DEOXYRIBONUCLEIC ACID POLYMERASE III AT PH 8.5 1SSK ; -1.00 ; STRUCTURE OF THE N-TERMINAL RIBONUCLEIC ACID-BINDING DOMAIN OF THE SARS COV NUCLEOCAPSID PROTEIN 2G3P ; 1.90 ; STRUCTURE OF THE N-TERMINAL TWO DOMAINS OF THE INFECTIVITY PROTEIN G3P OF FILAMENTOUS PHAGE FD 1MKE ; -1.00 ; STRUCTURE OF THE N-WASP EVH1 DOMAIN-WIP COMPLEX 1XGZ ; 2.00 ; STRUCTURE OF THE N298S VARIANT OF HUMAN PANCREATIC ALPHA- AMYLASE 1XH0 ; 2.00 ; STRUCTURE OF THE N298S VARIANT OF HUMAN PANCREATIC ALPHA- AMYLASE COMPLEXED WITH ACARBOSE 1XH1 ; 2.03 ; STRUCTURE OF THE N298S VARIANT OF HUMAN PANCREATIC ALPHA- AMYLASE COMPLEXED WITH CHLORIDE 1XH2 ; 2.20 ; STRUCTURE OF THE N298S VARIANT OF HUMAN PANCREATIC ALPHA- AMYLASE COMPLEXED WITH CHLORIDE AND ACARBOSE 1EDZ ; 2.80 ; STRUCTURE OF THE NAD-DEPENDENT 5,10- METHYLENETETRAHYDROFOLATE DEHYDROGENASE FROM SACCHAROMYCES CEREVISIAE 1JNI ; 1.25 ; STRUCTURE OF THE NAPB SUBUNIT OF THE PERIPLASMIC NITRATE REDUCTASE FROM HAEMOPHILUS INFLUENZAE. 1TLV ; 1.95 ; STRUCTURE OF THE NATIVE AND INACTIVE LICT PRD FROM B. SUBTILIS 1JW9 ; 1.70 ; STRUCTURE OF THE NATIVE MOEB-MOAD PROTEIN COMPLEX 1ML9 ; 1.98 ; STRUCTURE OF THE NEUROSPORA SET DOMAIN PROTEIN DIM-5, A HISTONE LYSINE METHYLTRANSFERASE 1DW2 ; 2.20 ; STRUCTURE OF THE NITRIC OXIDE COMPLEX OF REDUCED SHP, AN OXYGEN BINDING CYTOCHROME C 1NFK ; 2.30 ; STRUCTURE OF THE NUCLEAR FACTOR KAPPA-B (NF-KB) P50 HOMODIMER 1F6T ; 1.92 ; STRUCTURE OF THE NUCLEOSIDE DIPHOSPHATE KINASE/ALPHA- BORANO(RP)-TDP.MG COMPLEX 2AKA ; 1.90 ; STRUCTURE OF THE NUCLEOTIDE-FREE MYOSIN II MOTOR DOMAIN FROM DICTYOSTELIUM DISCOIDEUM FUSED TO THE GTPASE DOMAIN OF DYNAMIN 1 FROM RATTUS NORVEGICUS 1XSA ; -1.00 ; STRUCTURE OF THE NUDIX ENZYME AP4A HYDROLASE FROM HOMO SAPIENS (E63A MUTANT) 1XSC ; -1.00 ; STRUCTURE OF THE NUDIX ENZYME AP4A HYDROLASE FROM HOMO SAPIENS (E63A MUTANT) IN COMPLEX WITH ATP 1XSB ; -1.00 ; STRUCTURE OF THE NUDIX ENZYME AP4A HYDROLASE FROM HOMO SAPIENS (E63A MUTANT) IN COMPLEX WITH ATP. NO ATP RESTRAINTS INCLUDED 2BPT ; 1.99 ; STRUCTURE OF THE NUP1P:KAP95P COMPLEX 1LNZ ; 2.60 ; STRUCTURE OF THE OBG GTP-BINDING PROTEIN 1VAO ; 2.50 ; STRUCTURE OF THE OCTAMERIC FLAVOENZYME VANILLYL-ALCOHOL OXIDASE 1AHV ; 3.10 ; STRUCTURE OF THE OCTAMERIC FLAVOENZYME VANILLYL-ALCOHOL OXIDASE IN COMPLEX WITH 2-NITRO-P-CRESOL 1AHZ ; 3.30 ; STRUCTURE OF THE OCTAMERIC FLAVOENZYME VANILLYL-ALCOHOL OXIDASE IN COMPLEX WITH 4-(1-HEPTENYL)PHENOL 2VAO ; 2.80 ; STRUCTURE OF THE OCTAMERIC FLAVOENZYME VANILLYL-ALCOHOL OXIDASE IN COMPLEX WITH ISOEUGENOL 1AHU ; 2.70 ; STRUCTURE OF THE OCTAMERIC FLAVOENZYME VANILLYL-ALCOHOL OXIDASE IN COMPLEX WITH P-CRESOL 1W1M ; 3.00 ; STRUCTURE OF THE OCTAMERIC FLAVOENZYME VANILLYL-ALCOHOL OXIDASE: GLU502GLY MUTANT 1W1K ; 2.55 ; STRUCTURE OF THE OCTAMERIC FLAVOENZYME VANILLYL-ALCOHOL OXIDASE: ILE238THR MUTANT 1W1L ; 2.70 ; STRUCTURE OF THE OCTAMERIC FLAVOENZYME VANILLYL-ALCOHOL OXIDASE: PHE454TYR MUTANT 1W1J ; 2.70 ; STRUCTURE OF THE OCTAMERIC FLAVOENZYME VANILLYL-ALCOHOL OXIDASE: THE505SER MUTANT 1B4B ; 2.20 ; STRUCTURE OF THE OLIGOMERIZATION DOMAIN OF THE ARGININE REPRESSOR FROM BACILLUS STEAROTHERMOPHILUS 446D ; 3.00 ; STRUCTURE OF THE OLIGONUCLEOTIDE D(CGTATATACG) AS A SITE SPECIFIC COMPLEX WITH NICKEL IONS 1R1M ; 1.90 ; STRUCTURE OF THE OMPA-LIKE DOMAIN OF RMPM FROM NEISSERIA MENINGITIDIS 1Q1V ; -1.00 ; STRUCTURE OF THE ONCOPROTEIN DEK: A PUTATIVE DEOXYRIBONUCLEIC ACID-BINDING DOMAIN RELATED TO THE WINGED HELIX MOTIF 1AH8 ; 2.10 ; STRUCTURE OF THE ORTHORHOMBIC FORM OF THE N-TERMINAL DOMAIN OF THE YEAST HSP90 CHAPERONE 1M6K ; 1.50 ; STRUCTURE OF THE OXA-1 CLASS D BETA-LACTAMASE 1W4V ; 1.80 ; STRUCTURE OF THE OXIDISED FORM OF HUMAN THIOREDOXIN 2 1YQW ; 1.83 ; STRUCTURE OF THE OXIDIZED UNREADY FORM OF NI-FE HYDROGENASE 1OV3 ; 1.80 ; STRUCTURE OF THE P22PHOX-P47PHOX COMPLEX 3RSP ; 1.70 ; STRUCTURE OF THE P93G VARIANT OF RIBONUCLEASE A 1N8S ; 3.04 ; STRUCTURE OF THE PANCREATIC LIPASE-COLIPASE COMPLEX 1PVL ; 2.00 ; STRUCTURE OF THE PANTON-VALENTINE LEUCOCIDIN F COMPONENT FROM STAPHYLOCOCCUS AUREUS 1T5R ; 2.00 ; STRUCTURE OF THE PANTON-VALENTINE LEUCOCIDIN S COMPONENT FROM STAPHYLOCOCCUS AUREUS 1X8S ; 2.50 ; STRUCTURE OF THE PAR-6 PDZ DOMAIN WITH A PALS1 INTERNAL LIGAND 1NP9 ; -1.00 ; STRUCTURE OF THE PARALLEL-STRANDED DEOXYRIBONUCLEIC ACID QUADRUPLEX D(TTAGGGA)4 CONTAINING THE HUMAN TELOMERIC REPEAT 1TS0 ; 1.60 ; STRUCTURE OF THE PB1 INTERMEDIATE FROM TIME-RESOLVED LAUE CRYSTALLOGRAPHY 1TS6 ; 1.60 ; STRUCTURE OF THE PB2 INTERMEDIATE FROM TIME-RESOLVED LAUE CRYSTALLOGRAPHY 1FF3 ; 1.90 ; STRUCTURE OF THE PEPTIDE METHIONINE SULFOXIDE REDUCTASE FROM ESCHERICHIA COLI 1GU6 ; 2.50 ; STRUCTURE OF THE PERIPLASMIC CYTOCHROME C NITRITE REDUCTASE FROM ESCHERICHIA COLI 1P1L ; 2.00 ; STRUCTURE OF THE PERIPLASMIC DIVALENT CATION TOLERANCE PROTEIN CUTA FROM ARCHAEOGLOBUS FULGIDUS 1ESZ ; 2.00 ; STRUCTURE OF THE PERIPLASMIC FERRIC SIDEROPHORE BINDING PROTEIN FHUD COMPLEXED WITH COPROGEN 1PBY ; 1.70 ; STRUCTURE OF THE PHENYLHYDRAZINE ADDUCT OF THE QUINOHEMOPROTEIN AMINE DEHYDROGENASE FROM PARACOCCUS DENITRIFICANS AT 1.7 A RESOLUTION 1B7A ; 2.25 ; STRUCTURE OF THE PHOSPHATIDYLETHANOLAMINE-BINDING PROTEIN FROM BOVINE BRAIN 1RG5 ; 2.50 ; STRUCTURE OF THE PHOTOSYNTHETIC REACTION CENTRE FROM RHODOBACTER SPHAEROIDES CAROTENOIDLESS STRAIN R-26.1 1N4N ; -1.00 ; STRUCTURE OF THE PLANT DEFENSIN PHD1 FROM PETUNIA HYBRIDA 1W1Z ; 2.60 ; STRUCTURE OF THE PLANT LIKE 5-AMINO LAEVULINIC ACID DEHYDRATASE FROM CHLOROBIUM VIBRIOFORME 1L3A ; 2.30 ; STRUCTURE OF THE PLANT TRANSCRIPTIONAL REGULATOR PBF-2 1FB8 ; 2.40 ; STRUCTURE OF THE PLECKSTRIN HOMOLOGY DOMAIN FROM DAPP1/PHISH 1FAO ; 1.80 ; STRUCTURE OF THE PLECKSTRIN HOMOLOGY DOMAIN FROM DAPP1/PHISH IN COMPLEX WITH INOSITOL 1,3,4,5- TETRAKISPHOSPHATE 1FHX ; 2.50 ; STRUCTURE OF THE PLECKSTRIN HOMOLOGY DOMAIN FROM GRP1 IN COMPLEX WITH INOSITOL 1,3,4,5-TETRAKISPHOSPHATE 1FHW ; 1.90 ; STRUCTURE OF THE PLECKSTRIN HOMOLOGY DOMAIN FROM GRP1 IN COMPLEX WITH INOSITOL(1,3,4,5,6)PENTAKISPHOSPHATE 1MAI ; 1.90 ; STRUCTURE OF THE PLECKSTRIN HOMOLOGY DOMAIN FROM PHOSPHOLIPASE C DELTA IN COMPLEX WITH INOSITOL TRISPHOSPHATE 428D ; 1.50 ; STRUCTURE OF THE POTASSIUM FORM OF CGCGAATTCGCG: DEOXYRIBONUCLEIC ACID DEFORMATION BY ELECTROSTATIC COLLAPSE AROUND SMALL CATIONS 2AWG ; 1.60 ; STRUCTURE OF THE PPIASE DOMAIN OF THE HUMAN FK506-BINDING PROTEIN 8 1TS8 ; 1.60 ; STRUCTURE OF THE PR CIS PLANAR INTERMEDIATE FROM TIME- RESOLVED LAUE CRYSTALLOGRAPHY 1TS7 ; 1.60 ; STRUCTURE OF THE PR CIS WOBBLE AND PR E46Q INTERMEDIATES FROM TIME-RESOLVED LAUE CRYSTALLOGRAPHY 1OR8 ; 2.35 ; STRUCTURE OF THE PREDOMINANT PROTEIN ARGININE METHYLTRANSFERASE PRMT1 1ORH ; 2.64 ; STRUCTURE OF THE PREDOMINANT PROTEIN ARGININE METHYLTRANSFERASE PRMT1 1ORI ; 2.50 ; STRUCTURE OF THE PREDOMINANT PROTEIN ARGININE METHYLTRANSFERASE PRMT1 1OHC ; 2.50 ; STRUCTURE OF THE PROLINE DIRECTED PHOSPHATASE CDC14 1UJB ; 2.06 ; STRUCTURE OF THE PROTEIN HISTIDINE PHOSPHATASE SIXA 1UJC ; 1.90 ; STRUCTURE OF THE PROTEIN HISTIDINE PHOSPHATASE SIXA COMPLEXED WITH TUNGSTATE 246D ; 2.20 ; STRUCTURE OF THE PURINE-PYRIMIDINE ALTERNATING RIBONUCLEIC ACID DOUBLE HELIX, R(GUAUAUA)D(C), WITH A 3'-TERMINAL DEOXY RESIDUE 1VPW ; 2.70 ; STRUCTURE OF THE PURR MUTANT, L54M, BOUND TO HYPOXANTHINE AND PURF OPERATOR DEOXYRIBONUCLEIC ACID 1WET ; 2.60 ; STRUCTURE OF THE PURR-GUANINE-PURF OPERATOR COMPLEX 1H6H ; 1.70 ; STRUCTURE OF THE PX DOMAIN FROM P40PHOX BOUND TO PHOSPHATIDYLINOSITOL 3-PHOSPHATE 1N66 ; -1.00 ; STRUCTURE OF THE PYRIMIDINE-RICH INTERNAL LOOP IN THE Y- DOMAIN OF POLIOVIRUS 3'UTR 1SVU ; 2.66 ; STRUCTURE OF THE Q237W MUTANT OF HHAI DEOXYRIBONUCLEIC ACID METHYLTRANSFERASE: AN INSIGHT INTO PROTEIN-PROTEIN INTERACTIONS 1GQ3 ; 2.01 ; STRUCTURE OF THE R105A MUTANT CATALYTIC TRIMER OF ESCHERICHIA COLI ASPARTATE TRANSCARBAMOYLASE AT 2.0-A RESOLUTION 1E96 ; 2.40 ; STRUCTURE OF THE RAC/P67PHOX COMPLEX 1RRP ; 2.96 ; STRUCTURE OF THE RAN-GPPNHP-RANBD1 COMPLEX 1RQK ; 2.70 ; STRUCTURE OF THE REACTION CENTRE FROM RHODOBACTER SPHAEROIDES CAROTENOIDLESS STRAIN R-26.1 RECONSTITUTED WITH 3,4-DIHYDROSPHEROIDENE 1RGN ; 2.80 ; STRUCTURE OF THE REACTION CENTRE FROM RHODOBACTER SPHAEROIDES CAROTENOIDLESS STRAIN R-26.1 RECONSTITUTED WITH SPHEROIDENE 1YRQ ; 2.10 ; STRUCTURE OF THE READY OXIDIZED FORM OF [NIFE]-HYDROGENASE 1REA ; 2.70 ; STRUCTURE OF THE RECA PROTEIN-ADP COMPLEX 1OCY ; 1.50 ; STRUCTURE OF THE RECEPTOR-BINDING DOMAIN OF THE BACTERIOPHAGE T4 SHORT TAIL FIBRE 1MF1 ; 2.70 ; STRUCTURE OF THE RECOMBINANT MOUSE-MUSCLE ADENYLOSUCCINATE SYNTHETASE COMPLEXED WITH AMP 1MF0 ; 2.50 ; STRUCTURE OF THE RECOMBINANT MOUSE-MUSCLE ADENYLOSUCCINATE SYNTHETASE COMPLEXED WITH AMP, GDP, HPO4(2-), AND MG(2+) 1MEZ ; 2.40 ; STRUCTURE OF THE RECOMBINANT MOUSE-MUSCLE ADENYLOSUCCINATE SYNTHETASE COMPLEXED WITH SAMP, GDP, SO4(2-), AND MG(2+) 1OYW ; 1.80 ; STRUCTURE OF THE RECQ CATALYTIC CORE 1OYY ; 2.50 ; STRUCTURE OF THE RECQ CATALYTIC CORE BOUND TO ATP-GAMMA-S 1FT9 ; 2.60 ; STRUCTURE OF THE REDUCED (FEII) CO-SENSING PROTEIN FROM R. RUBRUM 1W89 ; 2.00 ; STRUCTURE OF THE REDUCED FORM OF HUMAN THIOREDOXIN 2 1AFI ; -1.00 ; STRUCTURE OF THE REDUCED FORM OF MERP, THE PERIPLASMIC PROTEIN FROM THE BACTERIAL MERCURY DETOXIFICATION SYSTEM, NMR, 20 STRUCTURES 1SF3 ; 1.05 ; STRUCTURE OF THE REDUCED FORM OF THE P94A MUTANT OF AMICYANIN 1H63 ; 1.62 ; STRUCTURE OF THE REDUCED PENTAERYTHRITOL TETRANITRATE REDUCTASE 2BT2 ; 1.90 ; STRUCTURE OF THE REGULATOR OF G-PROTEIN SIGNALING 16 1ZV4 ; 2.40 ; STRUCTURE OF THE REGULATOR OF G-PROTEIN SIGNALING 17 (RGSZ2) 2AF0 ; 2.30 ; STRUCTURE OF THE REGULATOR OF G-PROTEIN SIGNALING DOMAIN OF RGS2 2ES0 ; 2.10 ; STRUCTURE OF THE REGULATOR OF G-PROTEIN SIGNALING DOMAIN OF RGS6 2A72 ; 2.00 ; STRUCTURE OF THE REGULATOR OF G-PROTEIN SIGNALING DOMAIN OF RGS7 1LXF ; -1.00 ; STRUCTURE OF THE REGULATORY N-DOMAIN OF HUMAN CARDIAC TROPONIN C IN COMPLEX WITH HUMAN CARDIAC TROPONIN-I(147- 163) AND BEPRIDIL 1UAA ; 3.00 ; STRUCTURE OF THE REP HELICASE-SINGLE STRANDED DEOXYRIBONUCLEIC ACID COMPLEX AT 3.0 ANGSTROMS RESOLUTION 1IG9 ; 2.60 ; STRUCTURE OF THE REPLICATING COMPLEX OF A POL ALPHA FAMILY DEOXYRIBONUCLEIC ACID POLYMERASE 1L8R ; 1.65 ; STRUCTURE OF THE RETINAL DETERMINATION PROTEIN DACHSHUND REVEALS A DEOXYRIBONUCLEIC ACID-BINDING MOTIF 1HTJ ; 2.20 ; STRUCTURE OF THE RGS-LIKE DOMAIN FROM PDZ-RHOGEF 1DOA ; 2.60 ; STRUCTURE OF THE RHO FAMILY GTP-BINDING PROTEIN CDC42 IN COMPLEX WITH THE MULTIFUNCTIONAL REGULATOR RHOGDI 1DGW ; 1.70 ; STRUCTURE OF THE RHOMBOHEDRAL CRYSTAL OF CANAVALIN FROM JACK BEAN 1EV3 ; 1.78 ; STRUCTURE OF THE RHOMBOHEDRAL FORM OF THE M-CRESOL/INSULIN R6 HEXAMER 1ZC5 ; -1.00 ; STRUCTURE OF THE RIBONUCLEIC ACID SIGNAL ESSENTIAL FOR TRANSLATIONAL FRAMESHIFTING IN HIV-1 1A8V ; 2.00 ; STRUCTURE OF THE RIBONUCLEIC ACID-BINDING DOMAIN OF THE RHO TRANSCRIPTION TERMINATOR 1J3L ; 2.30 ; STRUCTURE OF THE RIBONUCLEIC ACID-PROCESSING INHIBITOR RRAA FROM THERMUS THERMOPHILIS 1DUL ; 1.80 ; STRUCTURE OF THE RIBONUCLEOPROTEIN CORE OF THE E. COLI SIGNAL RECOGNITION PARTICLE 1SMQ ; 3.10 ; STRUCTURE OF THE RIBONUCLEOTIDE REDUCTASE RNR2 HOMODIMER FROM SACCHAROMYCES CEREVISIAE 1SMS ; 3.10 ; STRUCTURE OF THE RIBONUCLEOTIDE REDUCTASE RNR4 HOMODIMER FROM SACCHAROMYCES CEREVISIAE 1S1H ; 11.70 ; STRUCTURE OF THE RIBOSOMAL 80S-EEF2-SORDARIN COMPLEX FROM YEAST OBTAINED BY DOCKING ATOMIC MODELS FOR RIBONUCLEIC ACID AND PROTEIN COMPONENTS INTO A 11.7 A CRYO-EM MAP. THIS FILE, 1S1H, CONTAINS 40S SUBUNIT. THE 60S RIBOSOMAL SUBUNIT IS IN FILE 1S1I. 1S1I ; 11.70 ; STRUCTURE OF THE RIBOSOMAL 80S-EEF2-SORDARIN COMPLEX FROM YEAST OBTAINED BY DOCKING ATOMIC MODELS FOR RIBONUCLEIC ACID AND PROTEIN COMPONENTS INTO A 11.7 A CRYO-EM MAP. THIS FILE, 1S1I, CONTAINS 60S SUBUNIT. THE 40S RIBOSOMAL SUBUNIT IS IN FILE 1S1H. 1E4P ; -1.00 ; STRUCTURE OF THE RIBOZYME SUBSTRATE HAIRPIN OF NEUROSPORA VS RIBONUCLEIC ACID. A CLOSE LOOK AT THE CLEAVAGE SITE 1YCE ; 2.40 ; STRUCTURE OF THE ROTOR RING OF F-TYPE NA+-ATPASE FROM ILYOBACTER TARTARICUS 1DSZ ; 1.70 ; STRUCTURE OF THE RXR/RAR DEOXYRIBONUCLEIC ACID-BINDING DOMAIN HETERODIMER IN COMPLEX WITH THE RETINOIC ACID RESPONSE ELEMENT DR1 1TV7 ; 2.80 ; STRUCTURE OF THE S-ADENOSYLMETHIONINE DEPENDENT ENZYME MOAA 1JYO ; 1.90 ; STRUCTURE OF THE SALMONELLA VIRULENCE EFFECTOR SPTP IN COMPLEX WITH ITS SECRETION CHAPERONE SICP 1XAK ; 1.80 ; STRUCTURE OF THE SARS-CORONAVIRUS ORF7A ACCESSORY PROTEIN 1NI3 ; 2.80 ; STRUCTURE OF THE SCHIZOSACCHAROMYCES POMBE YCHF GTPASE 1PV0 ; -1.00 ; STRUCTURE OF THE SDA ANTIKINASE 1FF1 ; -1.00 ; STRUCTURE OF THE SECOND EPS15 HOMOLOGY DOMAIN OF HUMAN EPS15 IN COMPLEX WITH PTGSSSTNPFL 1F8H ; -1.00 ; STRUCTURE OF THE SECOND EPS15 HOMOLOGY DOMAIN OF HUMAN EPS15 IN COMPLEX WITH PTGSSSTNPFR 1EH2 ; -1.00 ; STRUCTURE OF THE SECOND EPS15 HOMOLOGY DOMAIN OF HUMAN EPS15, NMR, 20 STRUCTURES 1Q47 ; 2.80 ; STRUCTURE OF THE SEMAPHORIN 3A RECEPTOR-BINDING MODULE 1MVH ; 2.30 ; STRUCTURE OF THE SET DOMAIN HISTONE LYSINE METHYLTRANSFERASE CLR4 1MVX ; 3.00 ; STRUCTURE OF THE SET DOMAIN HISTONE LYSINE METHYLTRANSFERASE CLR4 378D ; 2.40 ; STRUCTURE OF THE SIDE-BY-SIDE BINDING OF DISTAMYCIN TO DEOXYRIBONUCLEIC ACID 1RY1 ; 12.00 ; STRUCTURE OF THE SIGNAL RECOGNITION PARTICLE INTERACTING WITH THE ELONGATION-ARRESTED RIBOSOME 1F2X ; 2.10 ; STRUCTURE OF THE SINGLE-DOMAIN CAMELID ANTIBODY CAB-CA05 1HFV ; 2.80 ; STRUCTURE OF THE SMALL G PROTEIN ARF6 IN COMPLEX WITH GTPGAMMAS 1QL4 ; 1.50 ; STRUCTURE OF THE SOLUBLE DOMAIN OF CYTOCHROME C552 FROM PARACOCCUS DENITRIFICANS IN THE OXIDISED STATE 1QL3 ; 1.40 ; STRUCTURE OF THE SOLUBLE DOMAIN OF CYTOCHROME C552 FROM PARACOCCUS DENITRIFICANS IN THE REDUCED STATE 1CKV ; -1.00 ; STRUCTURE OF THE SOLUBLE METHANE MONOOXYGENASE REGULATORY PROTEIN B 1MNN ; 1.40 ; STRUCTURE OF THE SPORULATION SPECIFIC TRANSCRIPTION FACTOR NDT80 BOUND TO DEOXYRIBONUCLEIC ACID 1YP0 ; 1.50 ; STRUCTURE OF THE STEROIDOGENIC FACTOR-1 LIGAND BINDING DOMAIN BOUND TO PHOSPHOLIPID AND A SHP PEPTIDE MOTIF 1Y08 ; 1.93 ; STRUCTURE OF THE STREPTOCOCCAL ENDOPEPTIDASE IDES, A NOVEL CYSTEINE PROTEINASE WITH STRICT SPECIFICITY FOR IGG 1Z3I ; 3.00 ; STRUCTURE OF THE SWI2/SNF2 CHROMATIN REMODELING DOMAIN OF EUKARYOTIC RAD54 1ZNN ; 2.20 ; STRUCTURE OF THE SYNTHASE SUBUNIT OF PLP SYNTHASE 1BUI ; 2.65 ; STRUCTURE OF THE TERNARY MICROPLASMIN-STAPHYLOKINASE- MICROPLASMIN COMPLEX: A PROTEINASE-COFACTOR-SUBSTRATE COMPLEX IN ACTION. 1AH6 ; 1.80 ; STRUCTURE OF THE TETRAGONAL FORM OF THE N-TERMINAL DOMAIN OF THE YEAST HSP90 CHAPERONE 1Y5Y ; 2.00 ; STRUCTURE OF THE TETRAHYDROMETHANOPTERIN DEPENDENT FORMALDEHYDE-ACTIVATING ENZYME (FAE) FROM METHYLOBACTERIUM EXTORQUENS AM1 1Y60 ; 1.90 ; STRUCTURE OF THE TETRAHYDROMETHANOPTERIN DEPENDENT FORMALDEHYDE-ACTIVATING ENZYME (FAE) FROM METHYLOBACTERIUM EXTORQUENS AM1 WITH BOUND 5,10-METHYLENE TETRAHYDROMETHANOPTERIN 1X8W ; 3.80 ; STRUCTURE OF THE TETRAHYMENA RIBOZYME: BASE TRIPLE SANDWICH AND METAL ION AT THE ACTIVE SITE 1VZJ ; 2.35 ; STRUCTURE OF THE TETRAMERIZATION DOMAIN OF ACETYLCHOLINESTERASE: FOUR-FOLD INTERACTION OF A WWW MOTIF WITH A LEFT-HANDED POLYPROLINE HELIX 1WL7 ; 1.90 ; STRUCTURE OF THE THERMOSTABLE ARABINANASE 1VBL ; 1.91 ; STRUCTURE OF THE THERMOSTABLE PECTATE LYASE PL 47 1J5E ; 3.05 ; STRUCTURE OF THE THERMUS THERMOPHILUS 30S RIBOSOMAL SUBUNIT 1N32 ; 3.00 ; STRUCTURE OF THE THERMUS THERMOPHILUS 30S RIBOSOMAL SUBUNIT BOUND TO CODON AND NEAR-COGNATE TRANSFER RIBONUCLEIC ACID ANTICODON STEM-LOOP MISMATCHED AT THE FIRST CODON POSITION AT THE A SITE WITH PAROMOMYCIN 1N33 ; 3.35 ; STRUCTURE OF THE THERMUS THERMOPHILUS 30S RIBOSOMAL SUBUNIT BOUND TO CODON AND NEAR-COGNATE TRANSFER RIBONUCLEIC ACID ANTICODON STEM-LOOP MISMATCHED AT THE SECOND CODON POSITION AT THE A SITE WITH PAROMOMYCIN 1IBM ; 3.31 ; STRUCTURE OF THE THERMUS THERMOPHILUS 30S RIBOSOMAL SUBUNIT IN COMPLEX WITH A MESSENGER RIBONUCLEIC ACID FRAGMENT AND COGNATE TRANSFER RIBONUCLEIC ACID ANTICODON STEM-LOOP BOUND AT THE A SITE 1IBL ; 3.11 ; STRUCTURE OF THE THERMUS THERMOPHILUS 30S RIBOSOMAL SUBUNIT IN COMPLEX WITH A MESSENGER RIBONUCLEIC ACID FRAGMENT AND COGNATE TRANSFER RIBONUCLEIC ACID ANTICODON STEM-LOOP BOUND AT THE A SITE AND WITH THE ANTIBIOTIC PAROMOMYCIN 1HNZ ; 3.30 ; STRUCTURE OF THE THERMUS THERMOPHILUS 30S RIBOSOMAL SUBUNIT IN COMPLEX WITH HYGROMYCIN B 1HNX ; 3.40 ; STRUCTURE OF THE THERMUS THERMOPHILUS 30S RIBOSOMAL SUBUNIT IN COMPLEX WITH PACTAMYCIN 1HNW ; 3.40 ; STRUCTURE OF THE THERMUS THERMOPHILUS 30S RIBOSOMAL SUBUNIT IN COMPLEX WITH TETRACYCLINE 1IBK ; 3.31 ; STRUCTURE OF THE THERMUS THERMOPHILUS 30S RIBOSOMAL SUBUNIT IN COMPLEX WITH THE ANTIBIOTIC PAROMOMYCIN 1FJG ; 3.00 ; STRUCTURE OF THE THERMUS THERMOPHILUS 30S RIBOSOMAL SUBUNIT IN COMPLEX WITH THE ANTIBIOTICS STREPTOMYCIN, SPECTINOMYCIN, AND PAROMOMYCIN 1N34 ; 3.80 ; STRUCTURE OF THE THERMUS THERMOPHILUS 30S RIBOSOMAL SUBUNIT IN THE PRESENCE OF CODON AND CRYSTALLOGRAPHICALLY DISORDERED NEAR-COGNATE TRANSFER RIBONUCLEIC ACID ANTICODON STEM-LOOP MISMATCHED AT THE FIRST CODON POSITION 1N36 ; 3.65 ; STRUCTURE OF THE THERMUS THERMOPHILUS 30S RIBOSOMAL SUBUNIT IN THE PRESENCE OF CRYSTALLOGRAPHICALLY DISORDERED CODON AND NEAR-COGNATE TRANSFER RIBONUCLEIC ACID ANTICODON STEM-LOOP MISMATCHED AT THE SECOND CODON POSITION 1TYG ; 3.15 ; STRUCTURE OF THE THIAZOLE SYNTHASE/THIS COMPLEX 1C07 ; -1.00 ; STRUCTURE OF THE THIRD EPS15 HOMOLOGY DOMAIN OF HUMAN EPS15 1ZZJ ; 2.30 ; STRUCTURE OF THE THIRD KH DOMAIN OF HNRNP K IN COMPLEX WITH 15-MER SSDNA 1T0Q ; 2.15 ; STRUCTURE OF THE TOLUENE/O-XYLENE MONOOXYGENASE HYDROXYLASE 1T0S ; 2.20 ; STRUCTURE OF THE TOLUENE/O-XYLENE MONOOXYGENASE HYDROXYLASE WITH 4-BROMOPHENOL BOUND 465D ; 1.60 ; STRUCTURE OF THE TOPOISOMERASE II POISON BOUND TO DEOXYRIBONUCLEIC ACID 2EUL ; 2.40 ; STRUCTURE OF THE TRANSCRIPTION FACTOR GFH1. 1UB9 ; 2.05 ; STRUCTURE OF THE TRANSCRIPTIONAL REGULATOR HOMOLOGUE PROTEIN FROM PYROCOCCUS HORIKOSHII OT3 1MP6 ; -1.00 ; STRUCTURE OF THE TRANSMEMBRANE REGION OF THE M2 PROTEIN H+ CHANNEL BY SOLID STATE NMR SPECTROSCOPY 1KC2 ; 2.10 ; STRUCTURE OF THE TRIPLE (LYS(BETA)D3ALA, ASP(BETA)C8ALA, ASPCD2ALA) MUTANT OF THE SRC SH2 DOMAIN BOUND TO THE PQPYEEIPI PEPTIDE 1O2E ; 2.60 ; STRUCTURE OF THE TRIPLE MUTANT (K53,56,120M) + ANISIC ACID COMPLEX OF PHOSPHOLIPASE A2 1GH4 ; 1.90 ; STRUCTURE OF THE TRIPLE MUTANT (K56M, K120M, K121M) OF PHOSPHOLIPASE A2 1GTN ; 2.50 ; STRUCTURE OF THE TRP RIBONUCLEIC ACID-BINDING ATTENUATION PROTEIN (TRAP) BOUND TO AN RIBONUCLEIC ACID MOLECULE CONTAINING 11 GAGCC REPEATS 1KPP ; -1.00 ; STRUCTURE OF THE TSG101 UEV DOMAIN 1KPQ ; -1.00 ; STRUCTURE OF THE TSG101 UEV DOMAIN 1M4Q ; -1.00 ; STRUCTURE OF THE TSG101 UEV DOMAIN IN COMPLEX WITH A HIV-1 PTAP "LATE DOMAIN" PEPTIDE, CNS ENSEMBLE 1M4P ; -1.00 ; STRUCTURE OF THE TSG101 UEV DOMAIN IN COMPLEX WITH A HIV-1 PTAP "LATE DOMAIN" PEPTIDE, DYANA ENSEMBLE 1IAM ; 2.10 ; STRUCTURE OF THE TWO AMINO-TERMINAL DOMAINS OF HUMAN INTERCELLULAR ADHESION MOLECULE-1, ICAM-1 2BM3 ; 1.80 ; STRUCTURE OF THE TYPE II COHESIN FROM CLOSTRIDIUM THERMOCELLUM SDBA 1ZTM ; 3.05 ; STRUCTURE OF THE UNCLEAVED PARAMYXOVIRUS (HPIV3) FUSION PROTEIN 1FOT ; 2.80 ; STRUCTURE OF THE UNLIGANDED CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT FROM SACCHAROMYCES CEREVISIAE 1YQ9 ; 2.35 ; STRUCTURE OF THE UNREADY OXIDIZED FORM OF [NIFE] HYDROGENASE 1JLR ; 2.45 ; STRUCTURE OF THE URACIL PHOSPHORIBOSYLTRANSFERASE GTP COMPLEX 2 MUTANT C128V 1JLS ; 2.50 ; STRUCTURE OF THE URACIL PHOSPHORIBOSYLTRANSFERASE URACIL/CPR 2 MUTANT C128V 1UPF ; 2.30 ; STRUCTURE OF THE URACIL PHOSPHORIBOSYLTRANSFERASE, MUTANT C128V BOUND TO THE DRUG 5-FLUOROURACIL 1UPU ; 2.50 ; STRUCTURE OF THE URACIL PHOSPHORIBOSYLTRANSFERASE, MUTANT C128V, BOUND TO PRODUCT URIDINE-1-MONOPHOSPHATE (UMP) 5LVE ; 2.00 ; STRUCTURE OF THE VARIABLE DOMAIN OF HUMAN IMMUNOGLOBULIN K- 4 LIGHT CHAIN LEN 1LVE ; 1.95 ; STRUCTURE OF THE VARIABLE DOMAIN OF HUMAN IMMUNOGLOBULIN K-4 LIGHT CHAIN LEN 1YG2 ; 2.20 ; STRUCTURE OF THE VIBRIO CHOLERAE VIRULENCE ACTIVATOR APHA 1F0C ; 2.26 ; STRUCTURE OF THE VIRAL SERPIN CRMA 1CZW ; 2.50 ; STRUCTURE OF THE W34A MUTANT OF SHIGA-LIKE TOXIN I B SUBUNIT 1OCB ; 1.75 ; STRUCTURE OF THE WILD-TYPE CELLOBIOHYDROLASE CEL6A FROM HUMICOLAS INSOLENS IN COMPLEX WITH A FLUORESCENT SUBSTRATE 1KK3 ; 1.90 ; STRUCTURE OF THE WILD-TYPE LARGE GAMMA SUBUNIT OF INITIATION FACTOR EIF2 FROM PYROCOCCUS ABYSSI COMPLEXED WITH GDP-MG2+ 1LKY ; 2.30 ; STRUCTURE OF THE WILD-TYPE TEL-SAM POLYMER 1NI0 ; 2.50 ; STRUCTURE OF THE Y94F MUTANT OF THE RESTRICTION ENDONUCLEASE PVUII 1YAG ; 1.90 ; STRUCTURE OF THE YEAST ACTIN-HUMAN GELSOLIN SEGMENT 1 COMPLEX 1EZV ; 2.30 ; STRUCTURE OF THE YEAST CYTOCHROME BC1 COMPLEX CO- CRYSTALLIZED WITH AN ANTIBODY FV-FRAGMENT 1Q17 ; 2.70 ; STRUCTURE OF THE YEAST HST2 PROTEIN DEACETYLASE IN TERNARY COMPLEX WITH 2'-O-ACETYL ADP RIBOSE AND HISTONE PEPTIDE 1Q1A ; 1.50 ; STRUCTURE OF THE YEAST HST2 PROTEIN DEACETYLASE IN TERNARY COMPLEX WITH 2'-O-ACETYL ADP RIBOSE AND HISTONE PEPTIDE 1D0Q ; 1.71 ; STRUCTURE OF THE ZINC-BINDING DOMAIN OF BACILLUS STEAROTHERMOPHILUS DEOXYRIBONUCLEIC ACID PRIMASE 1ZH1 ; 2.50 ; STRUCTURE OF THE ZINC-BINDING DOMAIN OF HCV NS5A 1GZJ ; 1.62 ; STRUCTURE OF THERMOASCUS AURANTIACUS FAMILY 5 ENDOGLUCANASE 1XKO ; 2.48 ; STRUCTURE OF THERMOTOGA MARITIMA CHEX 1TMI ; 1.70 ; STRUCTURE OF THERMOTOGA MARITIMA S63A NON-PROCESSING MUTANT S-ADENOSYLMETHIONINE DECARBOXYLASE 2AUJ ; 2.70 ; STRUCTURE OF THERMUS AQUATICUS RIBONUCLEIC ACID POLYMERASE BETA'-SUBUNIT INSERT 1FNM ; 2.80 ; STRUCTURE OF THERMUS THERMOPHILUS EF-G H573A 1ZYR ; 3.00 ; STRUCTURE OF THERMUS THERMOPHILUS RIBONUCLEIC ACID POLYMERASE HOLOENZYME IN COMPLEX WITH THE ANTIBIOTIC STREPTOLYDIGIN 1NG4 ; 2.30 ; STRUCTURE OF THIO (GLYCINE OXIDASE) FROM BACILLUS SUBTILIS 1E5X ; 2.25 ; STRUCTURE OF THREONINE SYNTHASE FROM ARABIDOPSIS THALIANA 1BTH ; 2.30 ; STRUCTURE OF THROMBIN COMPLEXED WITH BOVINE PANCREATIC TRYPSIN INHIBITOR 1D9I ; 2.30 ; STRUCTURE OF THROMBIN COMPLEXED WITH SELECTIVE NON- ELECTOPHILIC INHIBITORS HAVING CYCLOHEXYL MOIETIES AT P1 1D6W ; 2.00 ; STRUCTURE OF THROMBIN COMPLEXED WITH SELECTIVE NON- ELECTROPHILIC INHIBITORS HAVING CYCLOHEXYL MOIETIES AT P1 2A0Q ; 1.90 ; STRUCTURE OF THROMBIN IN 400 MM POTASSIUM CHLORIDE 1A2C ; 2.10 ; STRUCTURE OF THROMBIN INHIBITED BY AERUGINOSIN298-A FROM A BLUE-GREEN ALGA 1T0B ; 1.70 ; STRUCTURE OF THUA-LIKE PROTEIN FROM BACILLUS STEAROTHERMOPHILUS 2TDM ; 2.60 ; STRUCTURE OF THYMIDYLATE SYNTHASE 1HW4 ; 2.06 ; STRUCTURE OF THYMIDYLATE SYNTHASE SUGGESTS ADVANTAGES OF CHEMOTHERAPY WITH NONCOMPETITIVE INHIBITORS 1TUL ; 2.20 ; STRUCTURE OF TLP20 1CA4 ; 2.20 ; STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 (TRAF2) 1D0A ; 2.00 ; STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 (TRAF2) IN COMPLEX WITH A HUMAN OX40 PEPTIDE 1CZZ ; 2.70 ; STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 IN COMPLEX WITH A 17-RESIDUE CD40 PEPTIDE 1D00 ; 2.00 ; STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 IN COMPLEX WITH A 5-RESIDUE CD40 PEPTIDE 1D01 ; 2.00 ; STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 IN COMPLEX WITH A HUMAN CD30 PEPTIDE 1D0J ; 2.50 ; STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 IN COMPLEX WITH A M4-1BB PEPTIDE 1CA9 ; 2.30 ; STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 IN COMPLEX WITH A PEPTIDE FROM TNF-R2 1A6C ; 3.50 ; STRUCTURE OF TOBACCO RINGSPOT VIRUS 1TQQ ; 2.75 ; STRUCTURE OF TOLC IN COMPLEX WITH HEXAMMINECOBALT 1MU5 ; 2.00 ; STRUCTURE OF TOPOISOMERASE SUBUNIT 1MX0 ; 2.30 ; STRUCTURE OF TOPOISOMERASE SUBUNIT 1BHI ; -1.00 ; STRUCTURE OF TRANSACTIVATION DOMAIN OF CRE-BP1/ATF-2, NMR, 20 STRUCTURES 1ONR ; 1.87 ; STRUCTURE OF TRANSALDOLASE B 2HDC ; -1.00 ; STRUCTURE OF TRANSCRIPTION FACTOR GENESIS/DEOXYRIBONUCLEIC ACID COMPLEX 1F4S ; -1.00 ; STRUCTURE OF TRANSCRIPTIONAL FACTOR ALCR IN COMPLEX WITH A TARGET DEOXYRIBONUCLEIC ACID 1F5E ; -1.00 ; STRUCTURE OF TRANSCRIPTIONAL FACTOR ALCR IN COMPLEX WITH A TARGET DEOXYRIBONUCLEIC ACID 1SMZ ; -1.00 ; STRUCTURE OF TRANSPORTAN IN PHOSPHOLIPID BICELLAR SOLUTION 1RVS ; -1.00 ; STRUCTURE OF TRANSTHYRETIN IN AMYLOID FIBRILS DETERMINED BY SOLID-STATE MAGIC ANGLE SPINNING NMR 1EU8 ; 1.90 ; STRUCTURE OF TREHALOSE MALTOSE BINDING PROTEIN FROM THERMOCOCCUS LITORALIS 2AAR ; 3.50 ; STRUCTURE OF TRIGGER FACTOR BINDING DOMAIN IN BIOLOGICALLY HOMOLOGOUS COMPLEX WITH EUBACTERIAL RIBOSOME. 1G0N ; 2.00 ; STRUCTURE OF TRIHYDROXYNAPHTHALENE REDUCTASE IN COMPLEX WITH NADPH AND 4,5,6,7-TETRACHLORO-PHTHALIDE 1DOH ; 2.10 ; STRUCTURE OF TRIHYDROXYNAPHTHALENE REDUCTASE IN COMPLEX WITH NADPH AND 4-NITRO-INDEN-1-ONE 1YBV ; 2.80 ; STRUCTURE OF TRIHYDROXYNAPHTHALENE REDUCTASE IN COMPLEX WITH NADPH AND AN ACTIVE SITE INHIBITOR 1G0O ; 1.70 ; STRUCTURE OF TRIHYDROXYNAPHTHALENE REDUCTASE IN COMPLEX WITH NADPH AND PYROQUILON 1TIM ; 2.50 ; STRUCTURE OF TRIOSE PHOSPHATE ISOMERASE FROM CHICKEN MUSCLE 1SGV ; 1.90 ; STRUCTURE OF TRNA PSI55 PSEUDOURIDINE SYNTHASE (TRUB) 2A4M ; 2.30 ; STRUCTURE OF TRPRS II BOUND TO ATP 1NO1 ; 2.40 ; STRUCTURE OF TRUNCATED VARIANT OF B.SUBTILIS SPP1 PHAGE G39P HELICASE LOADER/INHIBITOR PROTEIN 1ZI7 ; 2.50 ; STRUCTURE OF TRUNCATED YEAST OXYSTEROL BINDING PROTEIN OSH4 1KV5 ; 1.65 ; STRUCTURE OF TRYPANOSOMA BRUCEI BRUCEI TIM WITH THE SALT- BRIDGE-FORMING RESIDUE ARG191 MUTATED TO SER 1IIH ; 2.20 ; STRUCTURE OF TRYPANOSOMA BRUCEI BRUCEI TRIOSEPHOSPHATE ISOMERASE COMPLEXED WITH 3-PHOSPHOGLYCERATE 1IIG ; 2.60 ; STRUCTURE OF TRYPANOSOMA BRUCEI BRUCEI TRIOSEPHOSPHATE ISOMERASE COMPLEXED WITH 3-PHOSPHONOPROPIONATE 1OEP ; 2.30 ; STRUCTURE OF TRYPANOSOMA BRUCEI ENOLASE REVEALS THE INHIBITORY DIVALENT METAL SITE 1FG4 ; 1.90 ; STRUCTURE OF TRYPAREDOXIN II 1RXP ; 1.70 ; STRUCTURE OF TRYPSIN (ORTHORHOMBIC) WITH 1-(4-TERT- BUTYLCARBAMOYL- PIPERAZINE-1-CARBONYL)-3-(3-GUANIDINO- PROPYL)-4-OXO-AZETIDINE-2-CARBOXYLIC ACID 1WP4 ; 2.00 ; STRUCTURE OF TT368 PROTEIN FROM THERMUS THERMOPHILUS HB8 1X7T ; 1.60 ; STRUCTURE OF TTR R104H: A NON-AMYLOIDOGENIC VARIANT WITH PROTECTIVE CLINICAL EFFECTS 1CKM ; 2.50 ; STRUCTURE OF TWO DIFFERENT CONFORMATIONS OF MRNA CAPPING ENZYME IN COMPLEX WITH GTP 1HJQ ; 2.55 ; STRUCTURE OF TWO FUNGAL BETA-1,4-GALACTANASES: SEARCHING FOR THE BASIS FOR TEMPERATURE AND PH OPTIMUM. 1HJS ; 1.87 ; STRUCTURE OF TWO FUNGAL BETA-1,4-GALACTANASES: SEARCHING FOR THE BASIS FOR TEMPERATURE AND PH OPTIMUM. 1HJU ; 2.15 ; STRUCTURE OF TWO FUNGAL BETA-1,4-GALACTANASES: SEARCHING FOR THE BASIS FOR TEMPERATURE AND PH OPTIMUM. 1M3D ; 2.00 ; STRUCTURE OF TYPE IV COLLAGEN NC1 DOMAINS 1BT0 ; 1.70 ; STRUCTURE OF UBIQUITIN-LIKE PROTEIN, RUB1 1UDA ; 1.80 ; STRUCTURE OF UDP-GALACTOSE-4-EPIMERASE COMPLEXED WITH UDP-4-DEOXY-4-FLUORO-ALPHA-D-GALACTOSE 1UDB ; 1.65 ; STRUCTURE OF UDP-GALACTOSE-4-EPIMERASE COMPLEXED WITH UDP-4-DEOXY-4-FLUORO-ALPHA-D-GLUCOSE 1UDC ; 1.65 ; STRUCTURE OF UDP-GALACTOSE-4-EPIMERASE COMPLEXED WITH UDP-MANNOSE 1UAE ; 1.80 ; STRUCTURE OF UDP-N-ACETYLGLUCOSAMINE ENOLPYRUVYL TRANSFERASE 1W0N ; 0.80 ; STRUCTURE OF UNCOMPLEXED CARBOHYDRATE BINDING DOMAIN CBM36 1UCB ; 2.50 ; STRUCTURE OF UNCOMPLEXED FAB COMPARED TO COMPLEX (1CLY, 1CLZ) 2C36 ; 2.11 ; STRUCTURE OF UNLIGANDED HSV GD REVEALS A MECHANISM FOR RECEPTOR-MEDIATED ACTIVATION OF VIRUS ENTRY 2C3A ; 2.50 ; STRUCTURE OF UNLIGANDED HSV GD REVEALS A MECHANISM FOR RECEPTOR-MEDIATED ACTIVATION OF VIRUS ENTRY 1Y57 ; 1.91 ; STRUCTURE OF UNPHOSPHORYLATED C-SRC IN COMPLEX WITH AN INHIBITOR 1OL6 ; 3.00 ; STRUCTURE OF UNPHOSPHORYLATED D274N MUTANT OF AURORA-A 1DCK ; 2.00 ; STRUCTURE OF UNPHOSPHORYLATED FIXJ-N COMPLEXED WITH MN2+ 1DCM ; 3.00 ; STRUCTURE OF UNPHOSPHORYLATED FIXJ-N WITH AN ATYPICAL CONFORMER (MONOMER A) 1YVL ; 3.00 ; STRUCTURE OF UNPHOSPHORYLATED STAT1 1Y1U ; 3.21 ; STRUCTURE OF UNPHOSPHORYLATED STAT5A 2UP1 ; 2.10 ; STRUCTURE OF UP1-TELOMERIC DEOXYRIBONUCLEIC ACID COMPLEX 1GMU ; 1.50 ; STRUCTURE OF UREE 1GMV ; 2.80 ; STRUCTURE OF UREE 1GMW ; 1.50 ; STRUCTURE OF UREE 1JR2 ; 1.84 ; STRUCTURE OF UROPORPHYRINOGEN III SYNTHASE 2AYO ; 3.50 ; STRUCTURE OF USP14 BOUND TO UBQUITIN ALDEHYDE 2AYN ; 3.20 ; STRUCTURE OF USP14, A PROTEASOME-ASSOCIATED DEUBIQUITINATING ENZYME 2A22 ; 2.20 ; STRUCTURE OF VACUOLAR PROTEIN SORTING 29 FROM CRYPTOSPORIDIUM PARVUM 1VZV ; 3.00 ; STRUCTURE OF VARICELLA-ZOSTER VIRUS PROTEASE 1VLK ; 1.90 ; STRUCTURE OF VIRAL INTERLEUKIN-10 1M5L ; -1.00 ; STRUCTURE OF WILD-TYPE AND MUTANT INTERNAL LOOPS FROM THE SL-1 DOMAIN OF THE HIV-1 PACKAGING SIGNAL 1ZA1 ; 2.20 ; STRUCTURE OF WILD-TYPE E. COLI ASPARTATE TRANSCARBAMOYLASE IN THE PRESENCE OF CTP AT 2.20 A RESOLUTION 1ZA2 ; 2.50 ; STRUCTURE OF WILD-TYPE E. COLI ASPARTATE TRANSCARBAMOYLASE IN THE PRESENCE OF CTP, CARBAMOYL PHOSPHATE AT 2.50 A RESOLUTION 1EY0 ; 1.60 ; STRUCTURE OF WILD-TYPE S. NUCLEASE AT 1.6 A RESOLUTION 1EYD ; 1.70 ; STRUCTURE OF WILD-TYPE S. NUCLEASE AT 1.7 A RESOLUTION 1XTI ; 1.95 ; STRUCTURE OF WILDTYPE HUMAN UAP56 1WSA ; 2.20 ; STRUCTURE OF WOLINELLA SUCCINOGENES L-ASPARAGINASE II 1M1S ; 1.80 ; STRUCTURE OF WR4, A C.ELEGANS MSP FAMILY MEMBER 1ZWK ; 2.60 ; STRUCTURE OF WRBA FROM PSEUDOMONAS AERUGINOSA 1ZWL ; 2.80 ; STRUCTURE OF WRBA FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH FMN 1J8B ; 1.75 ; STRUCTURE OF YBAB FROM HAEMOPHILUS INFLUENZAE (HI0442), A PROTEIN OF UNKNOWN FUNCTION 3CSM ; 3.00 ; STRUCTURE OF YEAST CHORISMATE MUTASE WITH BOUND TRP AND AN ENDOOXABICYCLIC INHIBITOR 1FPW ; -1.00 ; STRUCTURE OF YEAST FREQUENIN 1ZHW ; 1.70 ; STRUCTURE OF YEAST OXYSTEROL BINDING PROTEIN OSH4 IN COMPLEX WITH 20-HYDROXYCHOLESTEROL 1ZHX ; 1.50 ; STRUCTURE OF YEAST OXYSTEROL BINDING PROTEIN OSH4 IN COMPLEX WITH 25-HYDROXYCHOLESTEROL 1ZHT ; 1.90 ; STRUCTURE OF YEAST OXYSTEROL BINDING PROTEIN OSH4 IN COMPLEX WITH 7-HYDROXYCHOLESTEROL 1ZHY ; 1.60 ; STRUCTURE OF YEAST OXYSTEROL BINDING PROTEIN OSH4 IN COMPLEX WITH CHOLESTEROL 1ZHZ ; 1.90 ; STRUCTURE OF YEAST OXYSTEROL BINDING PROTEIN OSH4 IN COMPLEX WITH ERGOSTEROL 1FA0 ; 2.60 ; STRUCTURE OF YEAST POLY(A) POLYMERASE BOUND TO MANGANATE AND 3'-DATP 2JXR ; 2.40 ; STRUCTURE OF YEAST PROTEINASE A 1YPI ; 1.90 ; STRUCTURE OF YEAST TRIOSEPHOSPHATE ISOMERASE AT 1.9 ANGSTROMS RESOLUTION 1YFP ; 2.50 ; STRUCTURE OF YELLOW-EMISSION VARIANT OF GFP 2YFP ; 2.60 ; STRUCTURE OF YELLOW-EMISSION VARIANT OF GFP 1IZM ; 1.95 ; STRUCTURE OF YGFB FROM HAEMOPHILUS INFLUENZAE (HI0817), A CONSERVED HYPOTHETICAL PROTEIN 1ODF ; 2.25 ; STRUCTURE OF YGR205W PROTEIN. 1J85 ; 2.00 ; STRUCTURE OF YIBK FROM HAEMOPHILUS INFLUENZAE (HI0766), A TRUNCATED SEQUENCE HOMOLOG OF TRNA (GUANOSINE-2'-O-) METHYLTRANSFERASE (SPOU) 1MXI ; 1.70 ; STRUCTURE OF YIBK FROM HAEMOPHILUS INFLUENZAE (HI0766): A METHYLTRANSFERASE WITH A COFACTOR BOUND AT A SITE FORMED BY A KNOT 1TO3 ; 2.70 ; STRUCTURE OF YIHT FROM SALMONELLA TYPHIMURIUM 1J7G ; 1.64 ; STRUCTURE OF YIHZ FROM HAEMOPHILUS INFLUENZAE (HI0670), A D- TYR-TRNA(TYR) DEACYLASE 1NMN ; 2.30 ; STRUCTURE OF YQGF FROM ESCHERICHIA COLI, A HYPOTHETICAL PROTEIN 1TVL ; 2.10 ; STRUCTURE OF YTNJ FROM BACILLUS SUBTILIS 1YW1 ; 2.81 ; STRUCTURE OF YTNJ FROM BACILLUS SUBTILIS IN COMPLEX WITH FMN 1XXW ; 2.70 ; STRUCTURE OF ZINC INDUCED HETERODIMER OF TWO CALCIUM FREE ISOFORMS OF PHOSPHOLIPASE A2 FROM NAJA NAJA SAGITTIFERA AT 2.7A RESOLUTION 1H19 ; 2.10 ; STRUCTURE OF [E271Q] LEUKOTRIENE A4 HYDROLASE 1SQM ; 2.30 ; STRUCTURE OF [R563A] LEUKOTRIENE A4 HYDROLASE 1IAV ; 1.80 ; STRUCTURE ON NATIVE (ASN 87) SUBTILISIN FROM BACILLUS LENTUS 1E0U ; 2.80 ; STRUCTURE R271L MUTANT OF E. COLI PYRUVATE KINASE 1TFN ; -1.00 ; STRUCTURE REFINEMENT FOR A 24-NUCLEOTIDE RIBONUCLEIC ACID HAIRPIN, NMR, MINIMIZED AVERAGE STRUCTURE 1VLB ; 1.28 ; STRUCTURE REFINEMENT OF THE ALDEHYDE OXIDOREDUCTASE FROM DESULFOVIBRIO GIGAS AT 1.28 A 1C8Q ; 2.30 ; STRUCTURE SOLUTION AND REFINEMENT OF THE RECOMBINANT HUMAN SALIVARY AMYLASE 1QCH ; -1.00 ; STRUCTURE, DYNAMICS AND HYDRATION OF THE NOGALAMYCIN- D(ATGCAT)2 COMPLEX DETERMINED BY NMR AND MOLECULAR DYNAMICS SIMULATIONS IN SOLUTION 1UYL ; 1.40 ; STRUCTURE-ACTIVITY RELATIONSHIPS IN PURINE-BASED INHIBITOR BINDING TO HSP90 ISOFORMS 1MJH ; 1.70 ; STRUCTURE-BASED ASSIGNMENT OF THE BIOCHEMICAL FUNCTION OF HYPOTHETICAL PROTEIN MJ0577: A TEST CASE OF STRUCTURAL GENOMICS 1BOZ ; 2.10 ; STRUCTURE-BASED DESIGN AND SYNTHESIS OF LIPOPHILIC 2,4- DIAMINO-6-SUBSTITUTED QUINAZOLINES AND THEIR EVALUATION AS INHIBITORS OF DIHYDROFOLATE REDUCTASE AND POTENTIAL ANTITUMOR AGENTS 1FBZ ; 2.40 ; STRUCTURE-BASED DESIGN OF A NOVEL, OSTEOCLAST-SELECTIVE, NONPEPTIDE SRC SH2 INHIBITOR WITH IN VIVO ANTI-RESORPTIVE ACTIVITY 2BR1 ; 2.00 ; STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY 2BRB ; 2.10 ; STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY 2BRG ; 2.10 ; STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY 2BRH ; 2.10 ; STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY 2BRM ; 2.20 ; STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY 2BRN ; 2.80 ; STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY 2BRO ; 2.20 ; STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY 1MF4 ; 1.90 ; STRUCTURE-BASED DESIGN OF POTENT AND SELECTIVE INHIBITORS OF PHOSPHOLIPASE A2: CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN PHOSHOLIPASE A2 FROM NAJA NAJA SAGITTIFERA AND A DESIGNED PEPTIDE INHIBITOR AT 1.9 A RESOLUTION 2BGD ; 2.40 ; STRUCTURE-BASED DESIGN OF PROTEIN TYROSINE PHOSPHATASE-1B INHIBITORS 2BGE ; 1.80 ; STRUCTURE-BASED DESIGN OF PROTEIN TYROSINE PHOSPHATASE-1B INHIBITORS 1VGN ; 2.63 ; STRUCTURE-BASED DESIGN OF THE IRREVERSIBLE INHIBITORS TO METALLO--LACTAMASE (IMP-1) 2BZ5 ; 1.90 ; STRUCTURE-BASED DISCOVERY OF A NEW CLASS OF HSP90 INHIBITORS 1VDH ; 2.00 ; STRUCTURE-BASED FUNCTIONAL IDENTIFICATION OF A NOVEL HEME- BINDING PROTEIN FROM THERMUS THERMOPHILUS HB8 1B78 ; 2.20 ; STRUCTURE-BASED IDENTIFICATION OF THE BIOCHEMICAL FUNCTION OF A HYPOTHETICAL PROTEIN FROM METHANOCOCCUS JANNASCHII:MJ0226 2MJP ; 2.20 ; STRUCTURE-BASED IDENTIFICATION OF THE BIOCHEMICAL FUNCTION OF A HYPOTHETICAL PROTEIN FROM METHANOCOCCUS JANNASCHII:MJ0226 1GK0 ; 2.50 ; STRUCTURE-BASED PREDICTION OF MODIFICATIONS IN GLUTARYLAMIDASE TO ALLOW SINGLE-STEP ENZYMATIC PRODUCTION OF 7-AMINOCEPHALOSPORANIC ACID FROM CEPHALOSPORIN C 1GK1 ; 2.40 ; STRUCTURE-BASED PREDICTION OF MODIFICATIONS IN GLUTARYLAMIDASE TO ALLOW SINGLE-STEP ENZYMATIC PRODUCTION OF 7-AMINOCEPHALOSPORANIC ACID FROM CEPHALOSPORIN C 1SKG ; 1.21 ; STRUCTURE-BASED RATIONAL DRUG DESIGN: CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN PHOSPHOLIPASE A2 AND A PENTAPEPTIDE VAL-ALA-PHE-ARG-SER 1D7L ; 2.20 ; STRUCTURE-FUNCTION CORRELATIONS OF THE REACTION OF REDUCED NICOTINAMIDE ANALOGS WITH P-HYDROXYBENZOATE HYDROXYLASE SUBSTITUTED WITH A SERIES OF 8-SUBSTITUTED FLAVINS 1Z32 ; 1.60 ; STRUCTURE-FUNCTION RELATIONSHIPS IN HUMAN SALIVARY ALPHA- AMYLASE: ROLE OF AROMATIC RESIDUES 1DJ2 ; 2.90 ; STRUCTURES OF ADENYLOSUCCINATE SYNTHETASE FROM TRITICUM AESTIVUM AND ARABIDOPSIS THALIANA 1DJ3 ; 3.00 ; STRUCTURES OF ADENYLOSUCCINATE SYNTHETASE FROM TRITICUM AESTIVUM AND ARABIDOPSIS THALIANA 1L6K ; 2.00 ; STRUCTURES OF APOLIPOPROTEIN A-II AND A LIPID SURROGATE COMPLEX PROVIDE INSIGHTS INTO APOLIPOPROTEIN-LIPID INTERACTIONS 1L6L ; 2.30 ; STRUCTURES OF APOLIPOPROTEIN A-II AND A LIPID SURROGATE COMPLEX PROVIDE INSIGHTS INTO APOLIPOPROTEIN-LIPID INTERACTIONS 3GB1 ; -1.00 ; STRUCTURES OF B1 DOMAIN OF STREPTOCOCCAL PROTEIN G 1FS4 ; 2.38 ; STRUCTURES OF GLYCOGEN PHOSPHORYLASE-INHIBITOR COMPLEXES AND THE IMPLICATIONS FOR STRUCTURE-BASED DRUG DESIGN 1FTQ ; 2.35 ; STRUCTURES OF GLYCOGEN PHOSPHORYLASE-INHIBITOR COMPLEXES AND THE IMPLICATIONS FOR STRUCTURE-BASED DRUG DESIGN 1FTW ; 2.36 ; STRUCTURES OF GLYCOGEN PHOSPHORYLASE-INHIBITOR COMPLEXES AND THE IMPLICATIONS FOR STRUCTURE-BASED DRUG DESIGN 1FTY ; 2.38 ; STRUCTURES OF GLYCOGEN PHOSPHORYLASE-INHIBITOR COMPLEXES AND THE IMPLICATIONS FOR STRUCTURE-BASED DRUG DESIGN 1FU4 ; 2.36 ; STRUCTURES OF GLYCOGEN PHOSPHORYLASE-INHIBITOR COMPLEXES AND THE IMPLICATIONS FOR STRUCTURE-BASED DRUG DESIGN 1FU7 ; 2.36 ; STRUCTURES OF GLYCOGEN PHOSPHORYLASE-INHIBITOR COMPLEXES AND THE IMPLICATIONS FOR STRUCTURE-BASED DRUG DESIGN 1FU8 ; 2.35 ; STRUCTURES OF GLYCOGEN PHOSPHORYLASE-INHIBITOR COMPLEXES AND THE IMPLICATIONS FOR STRUCTURE-BASED DRUG DESIGN 1GGN ; 2.36 ; STRUCTURES OF GLYCOGEN PHOSPHORYLASE-INHIBITOR COMPLEXES AND THE IMPLICATIONS FOR STRUCTURE-BASED DRUG DESIGN 1Q94 ; 2.40 ; STRUCTURES OF HLA-A1101 IN COMPLEX WITH IMMUNODOMINANT NONAMER AND DECAMER HIV-1 EPITOPES CLEARLY REVEAL THE PRESENCE OF A MIDDLE ANCHOR RESIDUE 1QVO ; 2.22 ; STRUCTURES OF HLA-A1101 IN COMPLEX WITH IMMUNODOMINANT NONAMER AND DECAMER HIV-1 EPITOPES CLEARLY REVEAL THE PRESENCE OF A MIDDLE ANCHOR RESIDUE 1H35 ; 2.80 ; STRUCTURES OF HUMAN OXIDOSQUALENE CYCLASE INHIBITORS BOUND TO A HOMOLGOUS ENZYME 1H36 ; 2.80 ; STRUCTURES OF HUMAN OXIDOSQUALENE CYCLASE INHIBITORS BOUND TO A HOMOLGOUS ENZYME 1H37 ; 2.80 ; STRUCTURES OF HUMAN OXIDOSQUALENE CYCLASE INHIBITORS BOUND TO A HOMOLGOUS ENZYME 1H39 ; 2.80 ; STRUCTURES OF HUMAN OXIDOSQUALENE CYCLASE INHIBITORS BOUND TO A HOMOLGOUS ENZYME 1H3A ; 2.85 ; STRUCTURES OF HUMAN OXIDOSQUALENE CYCLASE INHIBITORS BOUND TO A HOMOLGOUS ENZYME 1H3C ; 2.90 ; STRUCTURES OF HUMAN OXIDOSQUALENE CYCLASE INHIBITORS BOUND TO A HOMOLGOUS ENZYME 1O6Q ; 2.80 ; STRUCTURES OF HUMAN OXIDOSQUALENE CYCLASE INHIBITORS BOUND TO A HOMOLGOUS ENZYME 1O6R ; 2.70 ; STRUCTURES OF HUMAN OXIDOSQUALENE CYCLASE INHIBITORS BOUND TO A HOMOLGOUS ENZYME 1O79 ; 2.80 ; STRUCTURES OF HUMAN OXIDOSQUALENE CYCLASE INHIBITORS BOUND TO A HOMOLGOUS ENZYME 1H47 ; 2.00 ; STRUCTURES OF MECP SYNTHASE IN COMPLEX WITH (I) CMP AND (II) CMP AND PRODUCT 1UJ8 ; 1.75 ; STRUCTURES OF ORF3 IN TWO CRYSTAL FORMS, A MEMBER OF ISC MACHINERY OF E. COLI INVOLVED IN THE ASSEMBLY OF IRON- SULFUR CLUSTERS 1BC7 ; 2.01 ; STRUCTURES OF SAP-1 BOUND TO DEOXYRIBONUCLEIC ACID SEQUENCES FROM THE E74 AND C-FOS PROMOTERS PROVIDE INSIGHTS INTO HOW ETS PROTEINS DISCRIMINATE BETWEEN RELATED DEOXYRIBONUCLEIC ACID TARGETS 1BC8 ; 1.93 ; STRUCTURES OF SAP-1 BOUND TO DEOXYRIBONUCLEIC ACID SEQUENCES FROM THE E74 AND C-FOS PROMOTERS PROVIDE INSIGHTS INTO HOW ETS PROTEINS DISCRIMINATE BETWEEN RELATED DEOXYRIBONUCLEIC ACID TARGETS 1GHP ; 1.76 ; STRUCTURES OF THE ACYL-ENZYME COMPLEX OF THE STAPHYLOCOCCUS AUREUS BETA-LACTAMASE MUTANT GLU166ASP:ASN170GLN WITH DEGRADED BENZYLPENICILLIN 1GHM ; 1.86 ; STRUCTURES OF THE ACYL-ENZYME COMPLEX OF THE STAPHYLOCOCCUS AUREUS BETA-LACTAMASE MUTANT GLU166ASP:ASN170GLN WITH DEGRADED CEPHALORIDINE 2BVO ; 1.65 ; STRUCTURES OF THREE HIV-1 HLA-B5703-PEPTIDE COMPLEXES AND IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG-TERM NON-PROGRESSION 2BVP ; 1.35 ; STRUCTURES OF THREE HIV-1 HLA-B5703-PEPTIDE COMPLEXES AND IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG-TERM NON-PROGRESSION 2BVQ ; 2.00 ; STRUCTURES OF THREE HIV-1 HLA-B5703-PEPTIDE COMPLEXES AND IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG-TERM NON-PROGRESSION 1LM5 ; 1.80 ; STRUCTURES OF TWO INTERMEDIATE FILAMENT-BINDING FRAGMENTS OF DESMOPLAKIN REVEAL A UNIQUE REPEAT MOTIF STRUCTURE 1LM7 ; 3.00 ; STRUCTURES OF TWO INTERMEDIATE FILAMENT-BINDING FRAGMENTS OF DESMOPLAKIN REVEAL A UNIQUE REPEAT MOTIF STRUCTURE 1VGA ; 1.80 ; STRUCTURES OF UNLIGATED AND INHIBITOR COMPLEXES OF W168F MUTANT OF TRIOSEPHOSPHATE ISOMERASE FROM PLASMODIUM FALCIPARUM 1WLQ ; 2.80 ; STRUCURE OF GEMININ-CDT1 COMPLEX 1WNT ; 2.30 ; STRUCUTRE OF THE TETRAMERIC FORM OF HUMAN L-XYLULOSE REDUCTASE 1YO8 ; 2.60 ; STRUCUTURE OF THE C-TERMINAL DOMAIN OF HUMAN THROMBOSPONDIN- 2 1YQH ; 1.70 ; STUCTURE OF DOMAIN OF UNKNOWN FUNCTION DUF77 FROM BACILLUS CEREUS 1DPZ ; 2.80 ; STUCTURE OF MODIFIED 3-ISOPROPYLMALATE DEHYDROGENASE AT THE C-TERMINUS, HD711 1GVO ; 1.38 ; STUCTURE OF PENTAERYTHRITOL TETRANIRATE REDUCTASE AND COMPLEXED WITH 2,4 DINITROPHENOL 1GVR ; 1.38 ; STUCTURE OF PENTAERYTHRITOL TETRANIRATE REDUCTASE AND COMPLEXED WITH 2,4,6 TRINITROTOLUENE 1GVQ ; 2.00 ; STUCTURE OF PENTAERYTHRITOL TETRANIRATE REDUCTASE AND COMPLEXED WITH CYCLOHEXANONE 1GVS ; 1.38 ; STUCTURE OF PENTAERYTHRITOL TETRANIRATE REDUCTASE AND COMPLEXED WITH PICRIC ACID 1H50 ; 1.50 ; STUCTURE OF PENTAERYTHRITOL TETRANIRATE REDUCTASE AND COMPLEXES 1H51 ; 1.60 ; STUCTURE OF PENTAERYTHRITOL TETRANIRATE REDUCTASE AND COMPLEXES 1VYR ; 0.90 ; STUCTURE OF PENTAERYTHRITOL TETRANIRATE REDUCTASE COMPLEXED WITH PICRIC ACID 1VYP ; 1.27 ; STUCTURE OF PENTAERYTHRITOL TETRANIRATE REDUCTASE W102F MUTANT AND COMPLEXED WITH PICRIC ACID 1VYS ; 1.80 ; STUCTURE OF PENTAERYTHRITOL TETRANIRATE REDUCTASE W102Y MUTANT AND COMPLEXED WITH PICRIC ACID 5LYM ; 1.80 ; STUDIES OF MONOCLINIC HEN EGG WHITE LYSOZYME. IV. X-RAY REFINEMENT AT 1.8 ANGSTROM RESOLUTION AND A COMPARISON OF THE VARIABLE REGIONS IN THE POLYMORPHIC FORMS 1OO5 ; 2.50 ; STUDIES ON THE NITROREDUCTASE PRODRUG-ACTIVATING SYSTEM. CRYSTAL STRUCTURES OF THE ENZYME ACTIVE FORM AND COMPLEXES WITH THE INHIBITOR DICOUMAROL AND DINITROBENZAMIDE PRODRUGS 1M9W ; -1.00 ; STUDY OF ELECTROSTATIC POTENTIAL SURFACE DISTRIBUTION USING HIGH RESOLUTION SIDE-CHAIN CONFORMATION DETERMINED BY NMR 1DWA ; 2.00 ; STUDY ON RADIATION DAMAGE ON A CRYOCOOLED CRYSTAL. PART 1: STRUCTURE PRIOR TO IRRADIATION 1DWF ; 2.00 ; STUDY ON RADIATION DAMAGE ON A CRYOCOOLED CRYSTAL. PART 2: STRUCTURE AFTER IRRADIATION WITH 9.110E15 PHOTONS/M 1DWH ; 2.00 ; STUDY ON RADIATION DAMAGE ON A CRYOCOOLED CRYSTAL. PART 4: STRUCTURE AFTER IRRADIATION WITH 27.210E15 PHOTONS/ 1DWI ; 2.00 ; STUDY ON RADIATION DAMAGE ON A CRYOCOOLED CRYSTAL. PART 5: STRUCTURE AFTER IRRADIATION WITH 54.010E15 PHOTONS/ 1DWJ ; 2.40 ; STUDY ON RADIATION DAMAGE ON A CRYOCOOLED CRYSTAL. REFINED PART 6: STRUCTURE AFTER A RADIATION DOSE OF 5410E15 PHOTONS 1DWG ; 2.00 ; STUDY ON RADIATION DAMAGE ON A CRYOCOOLED CRYSTAL: PART 3: STRUCTURE AFTER IRRADIATION WITH 18.210E15 PHOTONS/ 1CPU ; 2.00 ; SUBSITE MAPPING OF THE ACTIVE SITE OF HUMAN PANCREATIC ALPHA-AMYLASE USING SUBSTRATES, THE PHARMACOLOGICAL INHIBITOR ACARBOSE, AND AN ACTIVE SITE VARIANT 2CPU ; 2.00 ; SUBSITE MAPPING OF THE ACTIVE SITE OF HUMAN PANCREATIC ALPHA-AMYLASE USING SUBSTRATES, THE PHARMACOLOGICAL INHIBITOR ACARBOSE, AND AN ACTIVE SITE VARIANT 3CPU ; 2.00 ; SUBSITE MAPPING OF THE ACTIVE SITE OF HUMAN PANCREATIC ALPHA-AMYLASE USING SUBSTRATES, THE PHARMACOLOGICAL INHIBITOR ACARBOSE, AND AN ACTIVE SITE VARIANT 1U6Q ; 2.02 ; SUBSTITUTED 2-NAPHTHAMADINE INHIBITORS OF UROKINASE 1OWD ; 2.32 ; SUBSTITUTED 2-NAPHTHAMIDINE INHIBITORS OF UROKINASE 1OWE ; 1.60 ; SUBSTITUTED 2-NAPHTHAMIDINE INHIBITORS OF UROKINASE 1OWH ; 1.61 ; SUBSTITUTED 2-NAPHTHAMIDINE INHIBITORS OF UROKINASE 1OWI ; 2.93 ; SUBSTITUTED 2-NAPHTHAMIDINE INHIBITORS OF UROKINASE 1OWJ ; 3.10 ; SUBSTITUTED 2-NAPHTHAMIDINE INHIBITORS OF UROKINASE 1OWK ; 2.80 ; SUBSTITUTED 2-NAPHTHAMIDINE INHIBITORS OF UROKINASE 1SQA ; 2.00 ; SUBSTITUTED 2-NAPHTHAMIDINE INHIBITORS OF UROKINASE 1SQO ; 1.84 ; SUBSTITUTED 2-NAPHTHAMIDINE INHIBITORS OF UROKINASE 1SQT ; 1.90 ; SUBSTITUTED 2-NAPHTHAMIDINE INHIBITORS OF UROKINASE 276D ; 1.80 ; SUBSTITUTIONS AT C2' OF DAUNOSAMINE IN THE ANTICANCER DAUNORUBICIN ALTER ITS DEOXYRIBONUCLEIC ACID-BINDING SEQUENCE SPECIFICITY 277D ; 1.80 ; SUBSTITUTIONS AT C2' OF DAUNOSAMINE IN THE ANTICANCER DAUNORUBICIN ALTER ITS DEOXYRIBONUCLEIC ACID-BINDING SEQUENCE SPECIFICITY 278D ; 1.80 ; SUBSTITUTIONS AT C2' OF DAUNOSAMINE IN THE ANTICANCER DAUNORUBICIN ALTER ITS DEOXYRIBONUCLEIC ACID-BINDING SEQUENCE SPECIFICITY 288D ; 1.80 ; SUBSTITUTIONS AT C2' OF DAUNOSAMINE IN THE ANTICANCER DAUNORUBICIN ALTER ITS DEOXYRIBONUCLEIC ACID-BINDING SEQUENCE SPECIFICITY 1FHI ; 3.10 ; SUBSTRATE ANALOG (IB2) COMPLEX WITH THE FRAGILE HISTIDINE TRIAD PROTEIN, FHIT 2FHI ; 2.60 ; SUBSTRATE ANALOG (IB2) COMPLEX WITH THE HIS 96 ASN SUBSTITUTION OF THE FRAGILE HISTIDINE TRIAD PROTEIN, FHIT 1AOM ; 1.80 ; SUBSTRATE AND PRODUCT BOUND TO CYTOCHROME CD1 NITRITE REDUCTASE 2D0E ; 2.15 ; SUBSTRATE ASSITED IN OXYGEN ACTIVATION IN CYTOCHROME P450 158A2 1GRB ; 1.85 ; SUBSTRATE BINDING AND CATALYSIS BY GLUTATHIONE REDUCTASE AS DERIVED FROM REFINED ENZYME: SUBSTRATE CRYSTAL STRUCTURES AT 2 ANGSTROMS RESOLUTION 1L7P ; 1.90 ; SUBSTRATE BOUND PHOSPHOSERINE PHOSPHATASE COMPLEX STRUCTURE 1GVY ; 1.70 ; SUBSTRATE DISTORSION BY BETA-MANNANASE FROM PSEUDOMONAS CELLULOSA 1GW1 ; 1.65 ; SUBSTRATE DISTORTION BY BETA-MANNANASE FROM PSEUDOMONAS CELLULOSA 1M80 ; 2.35 ; SUBSTRATE FREE FORM OF ARGININE KINASE 1KJ4 ; 2.90 ; SUBSTRATE SHAPE DETERMINES SPECIFICITY OF RECOGNITION RECOGNITION FOR HIV-1 PROTEASE: ANALYSIS OF CRYSTAL STRUCTURES OF SIX SUBSTRATE COMPLEXES 1KJ7 ; 2.00 ; SUBSTRATE SHAPE DETERMINES SPECIFICITY OF RECOGNITION RECOGNITION FOR HIV-1 PROTEASE: ANALYSIS OF CRYSTAL STRUCTURES OF SIX SUBSTRATE COMPLEXES 1KJF ; 2.00 ; SUBSTRATE SHAPE DETERMINES SPECIFICITY OF RECOGNITION RECOGNITION FOR HIV-1 PROTEASE: ANALYSIS OF CRYSTAL STRUCTURES OF SIX SUBSTRATE COMPLEXES 1KJG ; 2.00 ; SUBSTRATE SHAPE DETERMINES SPECIFICITY OF RECOGNITION RECOGNITION FOR HIV-1 PROTEASE: ANALYSIS OF CRYSTAL STRUCTURES OF SIX SUBSTRATE COMPLEXES 1KJH ; 2.00 ; SUBSTRATE SHAPE DETERMINES SPECIFICITY OF RECOGNITION RECOGNITION FOR HIV-1 PROTEASE: ANALYSIS OF CRYSTAL STRUCTURES OF SIX SUBSTRATE COMPLEXES 1Q5E ; 2.65 ; SUBSTRATE-FREE CYTOCHROME P450EPOK 1YZP ; 1.60 ; SUBSTRATE-FREE MANGANESE PEROXIDASE 1P88 ; -1.00 ; SUBSTRATE-INDUCED STRUCTURAL CHANGES TO THE ISOLATED N- TERMINAL DOMAIN OF 5-ENOLPYRUVYLSHIKIMATE-3-PHOSPHATE SYNTHASE 1P89 ; -1.00 ; SUBSTRATE-INDUCED STRUCTURAL CHANGES TO THE ISOLATED N- TERMINAL DOMAIN OF 5-ENOLPYRUVYLSHIKIMATE-3-PHOSPHATE SYNTHASE 1GNS ; 1.80 ; SUBTILISIN BPN' 1SUA ; 2.10 ; SUBTILISIN BPN' 1SBI ; 2.20 ; SUBTILISIN BPN' 8397 MUTANT (M50F, N76D, G169A, Q206C, N218S) 1YJA ; 1.80 ; SUBTILISIN BPN' 8397+1 (MUTANT WITH MET 50 REPLACED BY PHE, ASN 76 REPLACED BY ASP, GLY 169 REPLACED BY ALA, GLN 206 REPLACED BY CYS, ASN 218 REPLACED BY SER AND LYS 256 REPLACED BY TYR) (M50F, N76D, G169A, Q206C, N218S, AND K256Y) IN 20% DIMETHYLFORMAMIDE 1YJB ; 1.80 ; SUBTILISIN BPN' 8397+1 (MUTANT WITH MET 50 REPLACED BY PHE, ASN 76 REPLACED BY ASP, GLY 169 REPLACED BY ALA, GLN 206 REPLACED BY CYS, ASN 218 REPLACED BY SER AND LYS 256 REPLACED BY TYR) (M50F, N76D, G169A, Q206C, N218S, AND K256Y) IN 35% DIMETHYLFORMAMIDE 1YJC ; 1.80 ; SUBTILISIN BPN' 8397+1 (MUTANT WITH MET 50 REPLACED BY PHE, ASN 76 REPLACED BY ASP, GLY 169 REPLACED BY ALA, GLN 206 REPLACED BY CYS, ASN 218 REPLACED BY SER AND LYS 256 REPLACED BY TYR) (M50F, N76D, G169A, Q206C, N218S, AND K256Y) IN 50% DIMETHYLFORMAMIDE 1SBH ; 1.80 ; SUBTILISIN BPN' 8397+1 MUTANT (M50F, N76D, G169A, Q206C, N218S, K256Y) 1SUP ; 1.60 ; SUBTILISIN BPN' AT 1.6 ANGSTROMS RESOLUTION: ANALYSIS OF DISCRETE DISORDER AND COMPARISON OF CRYSTAL FORMS 1DUI ; 2.00 ; SUBTILISIN BPN' FROM BACILLUS AMYLOLIQUEFACIENS, CRYSTAL GROWTH MUTANT 1SUE ; 1.80 ; SUBTILISIN BPN' FROM BACILLUS AMYLOLIQUEFACIENS, MUTANT 1A2Q ; 1.70 ; SUBTILISIN BPN' MUTANT 7186 1AU9 ; 1.80 ; SUBTILISIN BPN' MUTANT 8324 IN CITRATE 1SPB ; 2.00 ; SUBTILISIN BPN' PROSEGMENT (77 RESIDUES) COMPLEXED WITH A MUTANT SUBTILISIN BPN' (266 RESIDUES). CRYSTAL PH 4.6. CRYSTALLIZATION TEMPERATURE 20 C DIFFRACTION TEMPERATURE -160 C 3VSB ; 2.60 ; SUBTILISIN CARLSBERG D-NAPHTHYL-1-ACETAMIDO BORONIC ACID INHIBITOR COMPLEX 1AVT ; 2.00 ; SUBTILISIN CARLSBERG D-PARA-CHLOROPHENYL-1-ACETAMIDO BORONIC ACID INHIBITOR COMPLEX 1BFU ; 2.20 ; SUBTILISIN CARLSBERG IN 20% DIOXANE 1AV7 ; 2.60 ; SUBTILISIN CARLSBERG L-NAPHTHYL-1-ACETAMIDO BORONIC ACID INHIBITOR COMPLEX 1VSB ; 2.10 ; SUBTILISIN CARLSBERG L-PARA-CHLOROPHENYL-1-ACETAMIDO BORONIC ACID INHIBITOR COMPLEX 1BH6 ; 1.75 ; SUBTILISIN DY IN COMPLEX WITH THE SYNTHETIC INHIBITOR N-BENZYLOXYCARBONYL-ALA-PRO-PHE-CHLOROMETHYL KETONE 1AK9 ; 1.80 ; SUBTILISIN MUTANT 8321 1AQN ; 1.80 ; SUBTILISIN MUTANT 8324 1C3L ; 2.16 ; SUBTILISIN-CARLSBERG COMPLEXED WITH XENON (8 BAR) 1A91 ; -1.00 ; SUBUNIT C OF THE F1FO ATP SYNTHASE OF ESCHERICHIA COLI; NMR, 10 STRUCTURES 1C0V ; -1.00 ; SUBUNIT C OF THE F1FO ATP SYNTHASE OF ESCHERICHIA COLI; NMR, 10 STRUCTURES 2D00 ; 2.20 ; SUBUNIT F OF V-TYPE ATPASE/SYNTHASE 2C35 ; 2.70 ; SUBUNITS RPB4 AND RPB7 OF HUMAN RIBONUCLEIC ACID POLYMERASE II 1VZ5 ; 2.15 ; SUCCINATE COMPLEX OF ATSK 1O9L ; 2.40 ; SUCCINATE:COENZYME-A TRANSFERASE (PIG HEART) 1ZWG ; -1.00 ; SUCCINYL HUMAN PARATHYROID HORMONE 4-37, NMR, 10 STRUCTURES 1OOY ; 1.70 ; SUCCINYL-COA:3-KETOACID COA TRANSFERASE FROM PIG HEART 1M3E ; 2.50 ; SUCCINYL-COA:3-KETOACID COA TRANSFERASE FROM PIG HEART (SELENOMETHIONINE) 1R7A ; 1.77 ; SUCROSE PHOSPHORYLASE FROM BIFIDOBACTERIUM ADOLESCENTIS 1A0S ; 2.40 ; SUCROSE-SPECIFIC PORIN 1A0T ; 2.40 ; SUCROSE-SPECIFIC PORIN, WITH BOUND SUCROSE MOLECULES 1OH2 ; 2.40 ; SUCROSE-SPECIFIC PORIN, WITH BOUND SUCROSE MOLECULES 1BVV ; 1.80 ; SUGAR RING DISTORTION IN THE GLYCOSYL-ENZYME INTERMEDIATE OF A FAMILY G/11 XYLANASE 2BVV ; 1.50 ; SUGAR RING DISTORTION IN THE GLYCOSYL-ENZYME INTERMEDIATE OF A FAMILY G/11 XYLANASE. 1H29 ; 2.51 ; SULFATE RESPIRATION IN DESULFOVIBRIO VULGARIS HILDENBOROUGH: STRUCTURE OF THE 16-HEME CYTOCHROME C HMCA AT 2.5 A RESOLUTION AND A VIEW OF ITS ROLE IN TRANSMEMBRANE ELECTRON TRANSFER 2BLF ; 1.80 ; SULFITE DEHYDROGENASE FROM STARKEYA NOVELLA 2BPB ; 1.90 ; SULFITE DEHYDROGENASE FROM STARKEYA NOVELLA 1SOX ; 1.90 ; SULFITE OXIDASE FROM CHICKEN LIVER 5GEP ; 2.10 ; SULFITE REDUCTASE HEMOPROTEIN CARBON MONOXIDE COMPLEX REDUCED WITH CRII EDTA 4GEP ; 2.00 ; SULFITE REDUCTASE HEMOPROTEIN CYANIDE COMPLEX REDUCED WITH CRII EDTA 7GEP ; 2.40 ; SULFITE REDUCTASE HEMOPROTEIN IN COMPLEX WITH A PARTIALLY OXIDIZED SULFIDE SPECIES 8GEP ; 2.20 ; SULFITE REDUCTASE HEMOPROTEIN NITRATE COMPLEX 6GEP ; 1.80 ; SULFITE REDUCTASE HEMOPROTEIN NITRIC OXIDE COMPLEX REDUCED WITH PROFLAVINE EDTA 3GEO ; 2.10 ; SULFITE REDUCTASE HEMOPROTEIN NITRITE COMPLEX 4AOP ; 1.80 ; SULFITE REDUCTASE HEMOPROTEIN PARTIALLY PHOTOREDUCED WITH PROFLAVINE EDTA, PHOSPHATE PARTIALLY BOUND 3AOP ; 2.10 ; SULFITE REDUCTASE HEMOPROTEIN PHOTOREDUCED WITH PROFLAVINE EDTA, SIROHEME FEII,[4FE-4S] +1, PHOSPHATE BOUND 2GEP ; 1.90 ; SULFITE REDUCTASE HEMOPROTEIN, OXIDIZED, SIROHEME FEIII [4FE-4S] +2,SULFITE COMPLEX 1AOP ; 1.60 ; SULFITE REDUCTASE STRUCTURE AT 1.6 ANGSTROM RESOLUTION 5AOP ; 2.20 ; SULFITE REDUCTASE STRUCTURE REDUCED WITH CRII EDTA, 5-COORDINATE SIROHEME, SIROHEME FEII, [4FE-4S] +1 2AOP ; 1.75 ; SULFITE REDUCTASE: REDUCED WITH CRII EDTA, SIROHEME FEII, [4FE-4S] +1, PHOSPHATE BOUND 1RFM ; 2.50 ; SULFOLACTATE DEHYDROGENASE FROM METHANOCALDOCOCCUS JANNASCHII 1QEZ ; 2.70 ; SULFOLOBUS ACIDOCALDARIUS INORGANIC PYROPHOSPHATASE: AN ARCHAEL PYROPHOSPHATASE. 1W3N ; 2.10 ; SULFOLOBUS SOLFATARICUS 2-KETO-3-DEOXYGLUCONATE (KDG) ALDOLASE COMPLEX WITH D-KDG 1W3T ; 2.10 ; SULFOLOBUS SOLFATARICUS 2-KETO-3-DEOXYGLUCONATE (KDG) ALDOLASE COMPLEX WITH D-KDGAL, D-GLYCERALDEHYDE AND PYRUVATE 1W3I ; 1.70 ; SULFOLOBUS SOLFATARICUS 2-KETO-3-DEOXYGLUCONATE (KDG) ALDOLASE COMPLEX WITH PYRUVATE 2BJD ; 1.27 ; SULFOLOBUS SOLFATARICUS ACYLPHOSPHATASE. TRICLINIC SPACE GROUP 1Z5Z ; 2.00 ; SULFOLOBUS SOLFATARICUS SWI2/SNF2 ATPASE C-TERMINAL DOMAIN 1Z6A ; 3.00 ; SULFOLOBUS SOLFATARICUS SWI2/SNF2 ATPASE CORE DOMAIN 1Z63 ; 3.00 ; SULFOLOBUS SOLFATARICUS SWI2/SNF2 ATPASE CORE IN COMPLEX WITH DSDNA 1XTT ; 1.80 ; SULFOLOBUS SOLFATARICUS URACIL PHOSPHORIBOSYLTRANSFERASE IN COMPLEX WITH URIDINE 5'-MONOPHOSPHATE (UMP) 1XTU ; 2.80 ; SULFOLOBUS SOLFATARICUS URACIL PHOSPHORIBOSYLTRANSFERASE IN COMPLEX WITH URIDINE 5'-MONOPHOSPHATE (UMP) AND CYTIDINE 5'-TRIPHOSPHATE (CTP) 1XTV ; 2.60 ; SULFOLOBUS SOLFATARICUS URACIL PHOSPHORIBOSYLTRANSFERASE WITH URIDINE 5'-MONOPHOSPHATE (UMP) BOUND TO HALF OF THE SUBUNITS 1RHS ; 1.36 ; SULFUR-SUBSTITUTED RHODANESE 1BOH ; 2.30 ; SULFUR-SUBSTITUTED RHODANESE (ORTHORHOMBIC FORM) 1E0C ; 1.80 ; SULFURTRANSFERASE FROM AZOTOBACTER VINELANDII 1H4K ; 2.05 ; SULFURTRANSFERASE FROM AZOTOBACTER VINELANDII IN COMPLEX WITH HYPOPHOSPHITE 1H4M ; 2.10 ; SULFURTRANSFERASE FROM AZOTOBACTER VINELANDII IN COMPLEX WITH PHOSPHATE 1Y8Q ; 2.25 ; SUMO E1 ACTIVATING ENZYME SAE1-SAE2-MG-ATP COMPLEX 1Y8R ; 2.75 ; SUMO E1 ACTIVATING ENZYME SAE1-SAE2-SUMO1-MG-ATP COMPLEX 1OLM ; 1.95 ; SUPERNATANT PROTEIN FACTOR IN COMPLEX WITH RRR-ALPHA-TOCOPHERYLQUINONE: A LINK BETWEEN OXIDIZED VITAMIN E AND CHOLESTEROL BIOSYNTHESIS 1B06 ; 2.20 ; SUPEROXIDE DISMUTASE FROM SULFOLOBUS ACIDOCALDARIUS 1FUN ; 2.85 ; SUPEROXIDE DISMUTASE MUTANT WITH LYS 136 REPLACED BY GLU, CYS 6 REPLACED BY ALA AND CYS 111 REPLACED BY SER (K136E, C6A, C111S) 2A03 ; 2.33 ; SUPEROXIDE DISMUTASE PROTEIN FROM PLASMODIUM BERGHEI 1QDS ; 2.00 ; SUPERSTABLE E65Q MUTANT OF LEISHMANIA MEXICANA TRIOSEPHOSPHATE ISOMERASE (TIM) 1P20 ; 1.34 ; SURPRISING ROLES OF ELECTROSTATIC INTERACTIONS IN DEOXYRIBONUCLEIC ACID- LIGAND COMPLEXES 1E31 ; 2.71 ; SURVIVIN DIMER H. SAPIENS 2TBD ; -1.00 ; SV40 T ANTIGEN DEOXYRIBONUCLEIC ACID-BINDING DOMAIN, NMR, 30 STRUCTURES 1XZW ; 2.50 ; SWEET POTATO PURPLE ACID PHOSPHATASE/PHOSPHATE COMPLEX 1ZFD ; -1.00 ; SWI5 ZINC FINGER DOMAIN 2, NMR, 45 STRUCTURES 1MQT ; 3.30 ; SWINE VESICULAR DISEASE VIRUS COAT PROTEIN 1B7F ; 2.60 ; SXL-LETHAL PROTEIN/RIBONUCLEIC ACID COMPLEX 1CSY ; -1.00 ; SYK TYROSINE KINASE C-TERMINAL SH2 DOMAIN COMPLEXED WITH A PHOSPHOPEPTIDEFROM THE GAMMA CHAIN OF THE HIGH AFFINITY IMMUNOGLOBIN G RECEPTOR, NMR 1CSZ ; -1.00 ; SYK TYROSINE KINASE C-TERMINAL SH2 DOMAIN COMPLEXED WITH A PHOSPHOPEPTIDEFROM THE GAMMA CHAIN OF THE HIGH AFFINITY IMMUNOGLOBIN G RECEPTOR, NMR 1ZYP ; 2.40 ; SYNCHROTRON REDUCED FORM OF THE N-TERMINAL DOMAIN OF SALMONELLA TYPHIMURIUM AHPF 1XFT ; 3.35 ; SYNCHROTRON X-RAY POWDER DIFFRACTION STUDY OF HEXAGONAL TURKEY EGG-WHITE LYSOZYME 1Y6I ; 1.78 ; SYNECHOCYSTIS GUN4 1C8L ; 2.30 ; SYNERGISTIC INHIBITION OF GLYCOGEN PHOSPHORYLASE A BY A POTENTIAL ANTIDIABETIC DRUG AND CAFFEINE 1LVF ; 2.10 ; SYNTAXIN 6 1RVV ; 2.40 ; SYNTHASE/RIBOFLAVIN SYNTHASE COMPLEX OF BACILLUS SUBTILIS 2A4F ; 1.90 ; SYNTHESIS AND ACTIVITY OF N-AXYL AZACYCLIC UREA HIV-1 PROTEASE INHIBITORS WITH HIGH POTENCY AGAINST MULTIPLE DRUG RESISTANT VIRAL STRAINS. 1QFI ; 0.91 ; SYNTHESIS AND STRUCTURE OF PROLINE RING MODIFIED ACTINOMYCINS OF X TYPE 1S9Z ; 2.01 ; SYNTHETIC 17 AMINO ACID LONG PEPTIDE THAT FORMS A NATIVE- LIKE COILED-COIL AT AMBIENT TEMPERATURE AND AGGREGATES INTO AMYLOID-LIKE FIBRILS AT HIGHER TEMPERATURES. 1CS7 ; 3.20 ; SYNTHETIC DEOXYRIBONUCLEIC ACID HAIRPIN WITH STILBENEDIETHER LINKER 6CMH ; -1.00 ; SYNTHETIC LINEAR MODIFIED ENDOTHELIN-1 AGONIST 3CMH ; -1.00 ; SYNTHETIC LINEAR TRUNCATED ENDOTHELIN-1 AGONIST 1BCV ; -1.00 ; SYNTHETIC PEPTIDE CORRESPONDING TO THE MAJOR IMMUNOGEN SITE OF FMD VIRUS, NMR, 10 STRUCTURES 1OGW ; 1.32 ; SYNTHETIC UBIQUITIN WITH FLUORO-LEU AT 50 AND 67 1UBI ; 1.80 ; SYNTHETIC, STRUCTURAL AND BIOLOGICAL STUDIES OF THE UBIQUITIN SYSTEM: CHEMICALLY SYNTHESIZED AND NATIVE UBIQUITIN FOLD INTO IDENTICAL THREE-DIMENSIONAL STRUCTURES. 2HSP ; -1.00 ; Solution Structure of the SH3 Domain of Phospholipase Cgamma 1LAV ; 1.80 ; Stabilization of Escherichia Coli Ribonuclease Hi by Cavity-Filling Mutations within a Hydrophobic Core 1LAW ; 1.80 ; Stabilization of Escherichia Coli Ribonuclease Hi by Cavity-Filling Mutations within a Hydrophobic Core 1SRP ; 2.00 ; Structural Analysis of Serratia Protease 1TYA ; 2.80 ; Structural Analysis of a Series of Mutants of Tyrosyl-tRNA Synthetase: Enhancement of Catalysis by Hydrophobic Interactions 1TYB ; 2.50 ; Structural Analysis of a Series of Mutants of Tyrosyl-tRNA Synthetase: Enhancement of Catalysis by Hydrophobic Interactions 1LE4 ; 2.50 ; Structural Basis for Altered Function in the Common Mutants of Human Apolipoprotein-E 111L ; 1.80 ; Structural Basis of Alpha-Helix Propensity at Two Sites in T4 Lysozyme 216L ; 2.10 ; Structural Basis of Alpha-Helix Propensity at Two Sites in T4 Lysozyme 217L ; 1.70 ; Structural Basis of Alpha-Helix Propensity at Two Sites in T4 Lysozyme 1AZU ; 2.70 ; Structural Features of Azurin at 2.7 Angstroms Resolution 1BNS ; 2.05 ; Structural Studies of Barnase Mutants 2PLT ; 1.50 ; Structure Determination of Plastocyanin from a Crystal Specimen with Hemihedral Twinning Fraction of One-Half 2FBP ; 2.80 ; Structure Refinement of Fructose-1,6-Bisphosphatase and its Fructose 2,6-Bisphosphate Complex at 2.8 Angstroms Resolution 3FBP ; 2.80 ; Structure Refinement of Fructose-1,6-Bisphosphatase and its Fructose 2,6-Bisphosphate Complex at 2.8 Angstroms Resolution 1CRM ; 2.00 ; Structure and Function of Carbonic Anhydrases 2APR ; 1.80 ; Structure and Refinement at 1.8 Angstroms Resolution of the Aspartic Proteinase from Rhizopus Chinensis 2CCY ; 1.67 ; Structure of Ferricytochrome C(Prime) from Rhodospirillum Molischianum at 1.67 Angstroms Resolution 2ILA ; 2.30 ; Structure of Interleukin 1Alpha at 2.7-Angstroms Resolution 1PPN ; 1.60 ; Structure of Monoclinic Papain at 1.60 Angstroms Resolution 1TYD ; 2.50 ; Structure of Tyrosyl-tRNA Synthetase Refined at 2.3 Angstroms Resolution. Interaction of the Enzyme with the Tyrosyl Adenylate Intermediate 2TS1 ; 2.30 ; Structure of Tyrosyl-tRNA Synthetase Refined at 2.3 Angstroms Resolution. Interaction of the Enzyme with the Tyrosyl Adenylate Intermediate 3TS1 ; 2.70 ; Structure of Tyrosyl-tRNA Synthetase Refined at 2.3 Angstroms Resolution. Interaction of the Enzyme with the Tyrosyl Adenylate Intermediate 1BQL ; 2.60 ; Structure of an Anti-Hel Fab Fragment Complexed with Bobwhite Quail Lysozyme 5CSC ; 2.80 ; Structure of an Open Form of Chicken Heart Citrate Synthase at 2.8 Angstroms Resolution 5DNB ; 1.40 ; Structure of the B-DEOXYRIBONUCLEIC ACID Decamer C-C-A-A-C-G-T-T-G-G and Comparison with Isomorphous Decamers C-C-A-A-G-A-T-T-G-G and C-C-A-G-G-C-C-T-G-G 3SGB ; 1.80 ; Structure of the Complex of Streptomyces Griseus Protease B and the Third Domain of the Turkey Ovomucoid Inhibitor at 1.8 Angstroms Resolution 2BSU ; 1.60 ; T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT 2BSV ; 1.60 ; T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT 1L8K ; 2.56 ; T CELL PROTEIN-TYROSINE PHOSPHATASE STRUCTURE 1L0Y ; 2.50 ; T CELL RECEPTOR BETA CHAIN COMPLEXED WITH SUPERANTIGEN SPEA SOAKED WITH ZINC 1H5B ; 1.85 ; T CELL RECEPTOR VALPHA11 (AV11S5) DOMAIN 1XBR ; 2.50 ; T DOMAIN FROM XENOPUS LAEVIS BOUND TO DEOXYRIBONUCLEIC ACID 1VWT ; 1.90 ; T STATE HUMAN HEMOGLOBIN [ALPHA V96W], ALPHA AQUOMET, BETA DEOXY 1JCK ; 3.50 ; T-CELL RECEPTOR BETA CHAIN COMPLEXED WITH SEC3 SUPERANTIGEN 1SBB ; 2.40 ; T-CELL RECEPTOR BETA CHAIN COMPLEXED WITH SUPERANTIGEN SEB 1RDY ; 2.20 ; T-STATE STRUCTURE OF THE ARG 243 TO ALA MUTANT OF PIG KIDNEY FRUCTOSE 1,6-BISPHOSPHATASE EXPRESSED IN E. COLI 1RDZ ; 2.05 ; T-STATE STRUCTURE OF THE ARG 243 TO ALA MUTANT OF PIG KIDNEY FRUCTOSE 1,6-BISPHOSPHATASE EXPRESSED IN E. COLI 1Y09 ; 2.25 ; T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: ALPHAN97A DEOXY LOW-SALT 1Y8W ; 2.90 ; T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: ALPHAR92A OXY (2MM IHP, 20% PEG) (10 TEST SETS) 1YDZ ; 3.30 ; T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: ALPHAY140F OXY (2MM IHP, 20% PEG) (1 TEST SET) 1Y4V ; 1.84 ; T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAC93A DEOXY LOW-SALT (1 TEST SET) 1Y5K ; 2.20 ; T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAD99A DEOXY LOW-SALT (10 TEST SETS) 1Y4Q ; 2.11 ; T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAF42A DEOXY LOW-SALT (1 TEST SET) 1Y4R ; 2.22 ; T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAF45A DEOXY LOW-SALT (1 TEST SET) 1Y5J ; 2.03 ; T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAH97A DEOXY LOW-SALT (1 TEST SET) 1YGF ; 2.70 ; T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAH97A OXY (2MM IHP, 20% PEG) (1 TEST SET) 1Y5F ; 2.14 ; T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAL96A DEOXY LOW-SALT (1 TEST SET) 1Y7G ; 2.10 ; T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAN102A DEOXY LOW-SALT (1 TEST SET) 1Y7Z ; 1.98 ; T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAN108A DEOXY LOW-SALT (1 TEST SET) 1Y7C ; 2.10 ; T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAP100A DEOXY LOW-SALT (1 TEST SET) 1YIH ; 2.00 ; T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAP100A OXY (2.2MM IHP, 20% PEG) (1 TEST SET) 1Y7D ; 1.90 ; T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAP100G DEOXY LOW-SALT (1 TEST SET) 1Y45 ; 2.00 ; T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAP36A DEOXY LOW-SALT (10 TEST SETS) 1YEN ; 2.80 ; T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAP36A OXY (2MM IHP, 20% PEG) (10 TEST SETS) 1Y0T ; 2.14 ; T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAV1M DEOXY LOW-SALT (1 TEST SET) 1Y22 ; 2.16 ; T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAV33A DEOXY LOW-SALT (1 TEST SET) 1YE0 ; 2.50 ; T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAV33A OXY (2MM IHP, 20% PEG) (1 TEST SET) 1Y2Z ; 2.07 ; T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAV34G DEOXY LOW-SALT (1 TEST SET) 1Y4F ; 2.00 ; T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAW37A DEOXY LOW-SALT (10 TEST SETS) 1YEO ; 2.22 ; T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAW37A OXY (10 TEST SETS) 1YGD ; 2.73 ; T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAW37E ALPHA ZINC BETA OXY (10 TEST SETS) 1Y4P ; 1.98 ; T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAW37E DEOXY LOW-SALT (10 TEST SETS) 1YEV ; 2.11 ; T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAW37E OXY (10 TEST SETS) 1Y4G ; 1.91 ; T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAW37G DEOXY LOW-SALT (10 TEST SETS) 1YEU ; 2.12 ; T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAW37G OXY (10 TEST SETS) 1Y4B ; 2.10 ; T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAW37H DEOXY LOW-SALT (10 TEST SETS) 1YG5 ; 2.70 ; T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAW37H OXY (2MM IHP, 20% PEG) (10 TEST SETS) 1Y46 ; 2.22 ; T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAW37Y DEOXY LOW-SALT (10 TEST SETS) 1YEQ ; 2.75 ; T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAW37Y OXY (10 TEST SETS) 1Y83 ; 1.90 ; T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAY145G DEOXY LOW-SALT (1 TEST SET) 1Y31 ; 2.13 ; T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAY35A DEOXY LOW-SALT (1 TEST SET) 1YE1 ; 4.50 ; T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAY35A OXY (2MM IHP, 20% PEG) (1 TEST SET) 1Y35 ; 2.12 ; T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAY35F DEOXY LOW-SALT (1 TEST SET) 1YE2 ; 1.80 ; T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAY35F OXY (2MM IHP, 20% PEG) (1 TEST SET) 1Y85 ; 2.13 ; T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: DESHIS146BETA DEOXY LOW-SALT 1YHR ; 2.60 ; T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: HBA OXY (10.0MM IHP, 20% PEG) (10 TEST SETS) 1YH9 ; 2.20 ; T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: HBA OXY (2MM IHP, 20% PEG) (10 TEST SETS) 1YHE ; 2.10 ; T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: HBA OXY (5.0MM IHP, 20% PEG) (10 TEST SETS) 1XZU ; 2.16 ; T-TO-THIGH QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: ALPHAD94G DEOXY LOW-SALT 1XZ5 ; 2.11 ; T-TO-THIGH QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: ALPHAL91A DEOXY LOW-SALT 1XZV ; 2.11 ; T-TO-THIGH QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: ALPHAP95A DEOXY LOW-SALT 1XZ7 ; 1.90 ; T-TO-THIGH QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: ALPHAR92A DEOXY LOW-SALT 1Y0A ; 2.22 ; T-TO-THIGH QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: ALPHAY140A DEOXY LOW-SALT 1Y0C ; 2.30 ; T-TO-THIGH QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: ALPHAY140F DEOXY LOW-SALT 1Y0W ; 2.14 ; T-TO-THIGH QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAV1M DEOXY LOW-SALT (10 TEST SETS) 1YIE ; 2.40 ; T-TO-THIGH QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAW37A OXY (2.2MM IHP, 13% PEG) (1 TEST SET) 1Y0D ; 2.10 ; T-TO-THIGH QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: DESARG141ALPHA DEOXY LOW-SALT 1XYE ; 2.13 ; T-TO-THIGH TRANSITIONS IN HUMAN HEMOGLOBIN: ALPHA Y42A DEOXY LOW SALT 1XY0 ; 1.99 ; T-TO-THIGH TRANSITIONS IN HUMAN HEMOGLOBIN: ALPHAK40G DEOXY LOW-SALT 1OB5 ; 3.10 ; T. AQUATICUS ELONGATION FACTOR EF-TU COMPLEXED WITH THE ANTIBIOTIC ENACYLOXIN IIA, A GTP ANALOG, AND PHE-TRNA 1LS1 ; 1.10 ; T. AQUATICUS FFH NG DOMAIN AT 1.1A RESOLUTION 1W40 ; 2.03 ; T. CELER L30E K9A VARIANT 1W42 ; 1.80 ; T. CELER L30E R92A VARIANT 1SOW ; 1.90 ; T. GONDII BRADYZOITE-SPECIFIC LDH (LDH2) IN COMPLEX WITH NAD AND OXALATE 1C3C ; 1.80 ; T. MARITIMA ADENYLOSUCCINATE LYASE 1C3U ; 2.30 ; T. MARITIMA ADENYLOSUCCINATE LYASE 1QC7 ; 2.20 ; T. MARITIMA FLIG C-TERMINAL DOMAIN 1TZT ; 1.55 ; T. MARITIMA NUSB, P21 1TZU ; 1.85 ; T. MARITIMA NUSB, P212121 1TZV ; 1.35 ; T. MARITIMA NUSB, P3121, FORM 1 1TZW ; 1.60 ; T. MARITIMA NUSB, P3121, FORM 2 1TZX ; 1.72 ; T. MARITIMA NUSB, P3221 1W41 ; 1.70 ; T.CELER L30E E90A VARIANT 1PZE ; 1.95 ; T.GONDII LDH1 APO FORM 1PZG ; 1.60 ; T.GONDII LDH1 COMPLEXED WITH APAD AND SULFATE AT 1.6 ANGSTROMS 1PZF ; 2.20 ; T.GONDII LDH1 TERNARY COMPLEX WITH APAD+ AND OXALATE 1PZH ; 1.90 ; T.GONDII LDH1 TERNARY COMPLEX WITH NAD AND OXALATE 1X36 ; 2.70 ; T1 CAPSID OF AN AMINO-TERMINAL DELETION MUTANT OF SEMV CP 1VB4 ; 3.30 ; T1 CAPSID STRUCTURE OF SESBANIA MOSAIC VIRUS COAT PROTEIN DELETION MUTANT CP-N(DELTA)36 1VAK ; 3.05 ; T1 CAPSID STRUCTURE OF SESBANIA MOSAIC VIRUS COAT PROTEIN DELETION MUTANT CP-N(DELTA)65 1VB2 ; 3.40 ; T1 CAPSID STRUCTURE OF SESBANIA MOSAIC VIRUS COAT PROTEIN DELETION MUTANT CP-N(DELTA)65-D146N-D149N 1CJ6 ; 1.80 ; T11A MUTANT HUMAN LYSOZYME 1CJ7 ; 1.80 ; T11V MUTANT HUMAN LYSOZYME 1TS2 ; 2.30 ; T128A MUTANT OF TOXIC SHOCK SYNDROME TOXIN-1 FROM S. AUREUS 2BUP ; 1.70 ; T13G MUTANT OF THE ATPASE FRAGMENT OF BOVINE HSC70 1BUP ; 1.70 ; T13S MUTANT OF BOVINE 70 KILODALTON HEAT SHOCK PROTEIN 1A6L ; 2.10 ; T14C MUTANT OF AZOTOBACTER VINELANDII FDI 2GAC ; 2.10 ; T152C MUTANT GLYCOSYLASPARAGINASE FROM FLAVOBACTERIUM MENINGOSEPTICUM 1OSS ; 1.93 ; T190P STREPTOMYCES GRISEUS TRYPSIN IN COMPLEX WITH BENZAMIDINE 1QT3 ; 1.85 ; T26D MUTANT OF T4 LYSOZYME 1QTV ; 2.30 ; T26E APO STRUCTURE OF T4 LYSOZYME 1QT8 ; 1.90 ; T26H MUTANT OF T4 LYSOZYME 1QT4 ; 2.10 ; T26Q MUTANT OF T4 LYSOZYME 1X33 ; 3.60 ; T3 RECOMBINANT CAPSID OF SEMV CP 1TLH ; -1.00 ; T4 ASIA BOUND TO SIGMA70 REGION 4 1NOZ ; 2.20 ; T4 DEOXYRIBONUCLEIC ACID POLYMERASE FRAGMENT (RESIDUES 1-388) AT 110K 1NOY ; 2.20 ; T4 DEOXYRIBONUCLEIC ACID POLYMERASE FRAGMENT (RESIDUES 1-388) AT 298K 1P36 ; 1.45 ; T4 LYOSZYME CORE REPACKING MUTANT I100V/TA 1OV5 ; 2.10 ; T4 LYSOZYME CAVITY MUTANT L99A/M102Q BOUND WITH 2- ALLYLPHENOL 1OV7 ; 2.00 ; T4 LYSOZYME CAVITY MUTANT L99A/M102Q BOUND WITH 2-ALLYL-6- METHYL-PHENOL 1OVH ; 1.95 ; T4 LYSOZYME CAVITY MUTANT L99A/M102Q BOUND WITH 2-CHLORO-6- METHYL-ANILINE 1OWY ; 1.90 ; T4 LYSOZYME CAVITY MUTANT L99A/M102Q BOUND WITH 2-PROPYL- ANILINE 1OVJ ; 2.00 ; T4 LYSOZYME CAVITY MUTANT L99A/M102Q BOUND WITH 3-FLUORO-2- METHYL_ANILINE 1OWZ ; 1.90 ; T4 LYSOZYME CAVITY MUTANT L99A/M102Q BOUND WITH 4- FLUOROPHENETHYL ALCOHOL 1OVK ; 2.10 ; T4 LYSOZYME CAVITY MUTANT L99A/M102Q BOUND WITH N-ALLYL- ANILINE 1P37 ; 1.57 ; T4 LYSOZYME CORE REPACKING BACK-REVERTANT L102M/CORE10 1PQJ ; 1.90 ; T4 LYSOZYME CORE REPACKING MUTANT A111V/CORE10/TA 1PQD ; 1.65 ; T4 LYSOZYME CORE REPACKING MUTANT CORE10/TA 1PQI ; 1.57 ; T4 LYSOZYME CORE REPACKING MUTANT I118L/CORE7/TA 1P2R ; 1.58 ; T4 LYSOZYME CORE REPACKING MUTANT I78V/TA 1PQO ; 1.65 ; T4 LYSOZYME CORE REPACKING MUTANT L118I/TA 1P64 ; 1.62 ; T4 LYSOZYME CORE REPACKING MUTANT L133F/TA 1P46 ; 1.67 ; T4 LYSOZYME CORE REPACKING MUTANT M106I/TA 1P6Y ; 1.54 ; T4 LYSOZYME CORE REPACKING MUTANT M120Y/TA 1P7S ; 1.50 ; T4 LYSOZYME CORE REPACKING MUTANT V103I/TA 1PQM ; 1.52 ; T4 LYSOZYME CORE REPACKING MUTANT V149I/T152V/TA 1P2L ; 1.58 ; T4 LYSOZYME CORE REPACKING MUTANT V87I/TA 1CX7 ; 1.94 ; T4 LYSOZYME METHIONINE CORE MUTANT 1C6P ; 1.90 ; T4 LYSOZYME MUTANT C54T/C97A IN THE PRESENCE OF 8 ATM ARGON 1C6Q ; 1.90 ; T4 LYSOZYME MUTANT C54T/C97A IN THE PRESENCE OF 8 ATM KRYPTON 1C6T ; 2.00 ; T4 LYSOZYME MUTANT C54T/C97A IN THE PRESENCE OF 8 ATM XENON 1C60 ; 2.00 ; T4 LYSOZYME MUTANT C54T/C97A/F153A IN THE PRESENCE OF 8 ATM ARGON 1C61 ; 2.00 ; T4 LYSOZYME MUTANT C54T/C97A/F153A IN THE PRESENCE OF 8 ATM KRYPTON 1C62 ; 2.30 ; T4 LYSOZYME MUTANT C54T/C97A/F153A IN THE PRESENCE OF 8 ATM XENON 1G1V ; 1.90 ; T4 LYSOZYME MUTANT C54T/C97A/I58T 1C63 ; 2.00 ; T4 LYSOZYME MUTANT C54T/C97A/L121A IN THE PRESENCE OF 8 ATM ARGON 1C64 ; 2.00 ; T4 LYSOZYME MUTANT C54T/C97A/L121A IN THE PRESENCE OF 8 ATM KRYPTON 1C65 ; 2.00 ; T4 LYSOZYME MUTANT C54T/C97A/L121A IN THE PRESENCE OF 8 ATM XENON 1C66 ; 2.10 ; T4 LYSOZYME MUTANT C54T/C97A/L121A/L133A IN THE PRESENCE OF 8 ATM ARGON 1C67 ; 2.20 ; T4 LYSOZYME MUTANT C54T/C97A/L121A/L133A IN THE PRESENCE OF 8 ATM KRYPTON 1C68 ; 2.50 ; T4 LYSOZYME MUTANT C54T/C97A/L121A/L133A IN THE PRESENCE OF 8 ATM XENON 1C69 ; 1.80 ; T4 LYSOZYME MUTANT C54T/C97A/L133A IN THE PRESENCE OF 8 ATM ARGON 1C6A ; 2.10 ; T4 LYSOZYME MUTANT C54T/C97A/L133A IN THE PRESENCE OF 8 ATM KRYPTON 1C6B ; 2.20 ; T4 LYSOZYME MUTANT C54T/C97A/L133A IN THE PRESENCE OF 8 ATM XENON 1C6C ; 2.00 ; T4 LYSOZYME MUTANT C54T/C97A/L99A IN THE PRESENCE OF 16 ATM ARGON 1C6D ; 2.00 ; T4 LYSOZYME MUTANT C54T/C97A/L99A IN THE PRESENCE OF 16 ATM KRYPTON 1C6E ; 1.90 ; T4 LYSOZYME MUTANT C54T/C97A/L99A IN THE PRESENCE OF 2 ATM XENON 1C6F ; 2.00 ; T4 LYSOZYME MUTANT C54T/C97A/L99A IN THE PRESENCE OF 32 ATM ARGON 1C6G ; 1.90 ; T4 LYSOZYME MUTANT C54T/C97A/L99A IN THE PRESENCE OF 4 ATM KRYPTON 1C6H ; 1.90 ; T4 LYSOZYME MUTANT C54T/C97A/L99A IN THE PRESENCE OF 4 ATM XENON 1C6I ; 1.90 ; T4 LYSOZYME MUTANT C54T/C97A/L99A IN THE PRESENCE OF 8 ATM ARGON 1C6J ; 1.90 ; T4 LYSOZYME MUTANT C54T/C97A/L99A IN THE PRESENCE OF 8 ATM KRYPTON 1C6K ; 1.90 ; T4 LYSOZYME MUTANT C54T/C97A/L99A IN THE PRESENCE OF 8 ATM XENON 1C6L ; 1.90 ; T4 LYSOZYME MUTANT C54T/C97A/L99A/F153A IN THE PRESENCE OF 8 ATM ARGON 1C6M ; 2.10 ; T4 LYSOZYME MUTANT C54T/C97A/L99A/F153A IN THE PRESENCE OF 8 ATM KRYPTON 1C6N ; 2.20 ; T4 LYSOZYME MUTANT C54T/C97A/L99A/F153A IN THE PRESENCE OF 8 ATM XENON 1I6S ; 1.90 ; T4 LYSOZYME MUTANT C54T/C97A/N101A 1G1W ; 1.80 ; T4 LYSOZYME MUTANT C54T/C97A/Q105M 1CV0 ; 2.12 ; T4 LYSOZYME MUTANT F104M 1CTW ; 2.10 ; T4 LYSOZYME MUTANT I78A 1CU0 ; 2.20 ; T4 LYSOZYME MUTANT I78M 1CVK ; 1.80 ; T4 LYSOZYME MUTANT L118A 1CV4 ; 1.90 ; T4 LYSOZYME MUTANT L118M 1CV3 ; 1.80 ; T4 LYSOZYME MUTANT L121M 1CV5 ; 1.87 ; T4 LYSOZYME MUTANT L133M 1CU2 ; 1.85 ; T4 LYSOZYME MUTANT L84M 1CU6 ; 2.10 ; T4 LYSOZYME MUTANT L91A 1CU5 ; 2.05 ; T4 LYSOZYME MUTANT L91M 2B72 ; 2.10 ; T4 LYSOZYME MUTANT L99A AT 100 MPA 2B73 ; 2.15 ; T4 LYSOZYME MUTANT L99A AT 100 MPA 2B74 ; 2.10 ; T4 LYSOZYME MUTANT L99A AT 100 MPA 2B75 ; 2.10 ; T4 LYSOZYME MUTANT L99A AT 150 MPA 2B6T ; 2.10 ; T4 LYSOZYME MUTANT L99A AT 200 MPA 2B6W ; 2.20 ; T4 LYSOZYME MUTANT L99A AT 200 MPA 2B6X ; 2.11 ; T4 LYSOZYME MUTANT L99A AT 200 MPA 2B6Y ; 2.40 ; T4 LYSOZYME MUTANT L99A AT AMBIENT PRESSURE 2B6Z ; 2.40 ; T4 LYSOZYME MUTANT L99A AT AMBIENT PRESSURE 2B70 ; 2.40 ; T4 LYSOZYME MUTANT L99A AT AMBIENT PRESSURE 1LGU ; 1.90 ; T4 LYSOZYME MUTANT L99A/M102Q 1LGW ; 1.85 ; T4 LYSOZYME MUTANT L99A/M102Q BOUND BY 2-FLUOROANILINE 1LGX ; 1.90 ; T4 LYSOZYME MUTANT L99A/M102Q BOUND BY 3,5-DIFLUOROANILINE 1LI3 ; 1.85 ; T4 LYSOZYME MUTANT L99A/M102Q BOUND BY 3-CHLOROPHENOL 1LI6 ; 2.00 ; T4 LYSOZYME MUTANT L99A/M102Q BOUND BY 5-METHYLPYRROLE 1LI2 ; 2.00 ; T4 LYSOZYME MUTANT L99A/M102Q BOUND BY PHENOL 231L ; 2.50 ; T4 LYSOZYME MUTANT M106K 234L ; 1.90 ; T4 LYSOZYME MUTANT M106L 232L ; 1.73 ; T4 LYSOZYME MUTANT M120K 233L ; 1.90 ; T4 LYSOZYME MUTANT M120L 230L ; 1.90 ; T4 LYSOZYME MUTANT M6L 1CUQ ; 2.05 ; T4 LYSOZYME MUTANT V103M 1CV1 ; 2.10 ; T4 LYSOZYME MUTANT V111M 1CV6 ; 1.90 ; T4 LYSOZYME MUTANT V149M 1CU3 ; 2.12 ; T4 LYSOZYME MUTANT V87M 1B6I ; 1.90 ; T4 LYSOZYME MUTANT WITH CYS 54 REPLACED BY THR, CYS 97 REPLACED BY ALA, THR 21 REPLACED BY CYS AND LYS 124 REPLACED BY CYS (C54T,C97A,T21C,K124C) 1EPY ; 1.85 ; T4 LYSOZYME MUTANT, T21H/C54T/C97A/Q141H/T142H 1CX6 ; 2.01 ; T4 LYSOZYME SUBSTITUTED WITH SELENOMETHIONINE 1JEJ ; 2.50 ; T4 PHAGE APO BGT 1QKJ ; 2.30 ; T4 PHAGE B-GLUCOSYLTRANSFERASE, SUBSTRATE BINDING AND PROPOSED CATALYTIC MECHANISM 1C3J ; 1.88 ; T4 PHAGE BETA-GLUCOSYLTRANSFERASE: SUBSTRATE BINDING AND PROPOSED CATALYTIC MECHANISM 1JIX ; 1.65 ; T4 PHAGE BGT IN COMPLEX WITH CA2+ 1JIU ; 2.50 ; T4 PHAGE BGT IN COMPLEX WITH MG2+ : FORM I 1JIV ; 2.07 ; T4 PHAGE BGT IN COMPLEX WITH MG2+ : FORM II 1JG6 ; 1.90 ; T4 PHAGE BGT IN COMPLEX WITH UDP 1NVK ; 1.80 ; T4 PHAGE BGT IN COMPLEX WITH UDP AND A MN2+ ION AT 1.8 A RESOLUTION 1JG7 ; 1.65 ; T4 PHAGE BGT IN COMPLEX WITH UDP AND MN2+ 1NZD ; 2.00 ; T4 PHAGE BGT-D100A MUTANT IN COMPLEX WITH UDP-GLUCOSE: FORM I 1NZF ; 2.10 ; T4 PHAGE BGT-D100A MUTANT IN COMPLEX WITH UDP-GLUCOSE: FORM II 1RRC ; 2.46 ; T4 POLYNUCLEOTIDE KINASE BOUND TO 5'-GTC-3' SSDNA 1RC8 ; 2.75 ; T4 POLYNUCLEOTIDE KINASE BOUND TO 5'-GTCAC-3' SSDNA 1RPZ ; 2.90 ; T4 POLYNUCLEOTIDE KINASE BOUND TO 5'-TGCAC-3' SSDNA 2C5U ; 2.21 ; T4 RIBONUCLEIC ACID LIGASE (RNL1) CRYSTAL STRUCTURE 1CJ8 ; 1.80 ; T40A MUTANT HUMAN LYSOZYME 1CJ9 ; 1.80 ; T40V MUTANT HUMAN LYSOZYME 1CKC ; 1.80 ; T43A MUTANT HUMAN LYSOZYME 1CKD ; 1.80 ; T43V MUTANT HUMAN LYSOZYME 1GGO ; 2.60 ; T453A MUTANT OF PYRUVATE, PHOSPHATE DIKINASE 1YF3 ; 2.29 ; T4DAM IN COMPLEX WITH ADOHCY AND 13-MER OLIGONUCLEOTIDE MAKING NON- AND SEMI-SPECIFIC (~1/4) CONTACT 1YFJ ; 2.69 ; T4DAM IN COMPLEX WITH ADOHCY AND 15-MER OLIGONUCLEOTIDE SHOWING SEMI-SPECIFIC AND SPECIFIC CONTACT 1YFL ; 3.09 ; T4DAM IN COMPLEX WITH SINEFUNGIN AND 16-MER OLIGONUCLEOTIDE SHOWING SEMI-SPECIFIC AND SPECIFIC CONTACT AND FLIPPED BASE 1EXN ; 2.50 ; T5 5'-EXONUCLEASE 1XO1 ; 2.50 ; T5 5'-EXONUCLEASE MUTANT K83A 1CKF ; 1.80 ; T52A MUTANT HUMAN LYSOZYME 1CKG ; 2.20 ; T52V MUTANT HUMAN LYSOZYME 1MSO ; 1.00 ; T6 HUMAN INSULIN AT 1.0 A RESOLUTION 1TK5 ; 2.20 ; T7 DEOXYRIBONUCLEIC ACID POLYMERASE BINARY COMPLEX WITH 8 OXO GUANOSINE IN THE TEMPLATING STRAND 1SKR ; 2.40 ; T7 DEOXYRIBONUCLEIC ACID POLYMERASE COMPLEXED TO DEOXYRIBONUCLEIC ACID PRIMER/TEMPLATE AND DDATP 1T7P ; 2.20 ; T7 DEOXYRIBONUCLEIC ACID POLYMERASE COMPLEXED TO DEOXYRIBONUCLEIC ACID PRIMER/TEMPLATE,A NUCLEOSIDE TRIPHOSPHATE, AND ITS PROCESSIVITY FACTOR THIOREDOXIN 1ZYQ ; 2.70 ; T7 DEOXYRIBONUCLEIC ACID POLYMERASE IN COMPLEX WITH 8OG AND INCOMING DDATP 1X9W ; 2.30 ; T7 DEOXYRIBONUCLEIC ACID POLYMERASE IN COMPLEX WITH A PRIMER/TEMPLATE DEOXYRIBONUCLEIC ACID CONTAINING A DISORDERED N-2 AMINOFLUORENE ON THE TEMPLATE, CRYSTALLIZED WITH DIDEOXY-ATP AS THE INCOMING NUCLEOTIDE. 1X9S ; 2.70 ; T7 DEOXYRIBONUCLEIC ACID POLYMERASE IN COMPLEX WITH A PRIMER/TEMPLATE DEOXYRIBONUCLEIC ACID CONTAINING A DISORDERED N-2 AMINOFLUORENE ON THE TEMPLATE, CRYSTALLIZED WITH DIDEOXY-CTP AS THE INCOMING NUCLEOTIDE. 1X9M ; 2.10 ; T7 DEOXYRIBONUCLEIC ACID POLYMERASE IN COMPLEX WITH AN N-2- ACETYLAMINOFLUORENE-ADDUCTED DEOXYRIBONUCLEIC ACID 1TK8 ; 2.50 ; T7 DEOXYRIBONUCLEIC ACID POLYMERASE TERNARY COMPLEX WITH 8 OXO GUANOSINE AND DAMP AT THE ELONGATION SITE 1TKD ; 2.49 ; T7 DEOXYRIBONUCLEIC ACID POLYMERASE TERNARY COMPLEX WITH 8 OXO GUANOSINE AND DCMP AT THE ELONGATION SITE 1TK0 ; 2.30 ; T7 DEOXYRIBONUCLEIC ACID POLYMERASE TERNARY COMPLEX WITH 8 OXO GUANOSINE AND DDCTP AT THE INSERTION SITE 1T8E ; 2.54 ; T7 DEOXYRIBONUCLEIC ACID POLYMERASE TERNARY COMPLEX WITH DCTP AT THE INSERTION SITE. 1S76 ; 2.88 ; T7 RIBONUCLEIC ACID POLYMERASE ALPHA BETA METHYLENE ATP ELONGATION COMPLEX 1ARO ; 2.80 ; T7 RIBONUCLEIC ACID POLYMERASE COMPLEXED WITH T7 LYSOZYME 1S77 ; 2.69 ; T7 RNAP PRODUCT PYROPHOSPHATE ELONGATION COMPLEX 2BC3 ; 1.54 ; T7-TAGGED FULL-LENGTH STREPTAVIDIN 1CKH ; 2.00 ; T70V MUTANT HUMAN LYSOZYME 1T2I ; 1.10 ; T76W MUTANT OF RNASE SA FROM STREPTOMYCES AUREOFACIENS 1JC9 ; 2.01 ; TACHYLECTIN 5A FROM TACHYPLEUS TRIDENTATUS (JAPANESE HORSESHOE CRAB) 1TL2 ; 2.00 ; TACHYLECTIN-2 FROM TACHYPLEUS TRIDENTATUS (JAPANESE HORSESHOE CRAB) 1WO1 ; -1.00 ; TACHYPLESIN I IN DODECYLPHOSPHOCHOLINE MICELLES 1MA5 ; -1.00 ; TACHYPLESIN I SOLUTION STRUCTURE IN THE PRESENCE OF 300MM DODECYLPHOSPHOCHOLINE MICELLES 1MA2 ; -1.00 ; TACHYPLESIN I WILD TYPE PEPTIDE NMR STRUCTURE 1CLW ; 2.00 ; TAILSPIKE PROTEIN FROM PHAGE P22, V331A MUTANT 1QA3 ; 2.00 ; TAILSPIKE PROTEIN, MUTANT A334I 1QA2 ; 2.00 ; TAILSPIKE PROTEIN, MUTANT A334V 1QQ1 ; 1.80 ; TAILSPIKE PROTEIN, MUTANT E359G 1QA1 ; 2.00 ; TAILSPIKE PROTEIN, MUTANT V331G 1QRC ; 2.50 ; TAILSPIKE PROTEIN, MUTANT W391A 1FJ5 ; -1.00 ; TAMOXIFEN-DEOXYRIBONUCLEIC ACID ADDUCT 2B2Y ; 2.35 ; TANDEM CHROMODOMAINS OF HUMAN CHD1 2B2W ; 2.40 ; TANDEM CHROMODOMAINS OF HUMAN CHD1 COMPLEXED WITH HISTONE H3 TAIL CONTAINING TRIMETHYLLYSINE 4 2B2U ; 2.95 ; TANDEM CHROMODOMAINS OF HUMAN CHD1 COMPLEXED WITH HISTONE H3 TAIL CONTAINING TRIMETHYLLYSINE 4 AND DIMETHYLARGININE 2 2B2T ; 2.45 ; TANDEM CHROMODOMAINS OF HUMAN CHD1 COMPLEXED WITH HISTONE H3 TAIL CONTAINING TRIMETHYLLYSINE 4 AND PHOSPHOTHREONINE 3 1TAN ; -1.00 ; TANDEM DEOXYRIBONUCLEIC ACID, NMR, MINIMIZED AVERAGE STRUCTURE 1QES ; -1.00 ; TANDEM GU MISMATCHES IN RIBONUCLEIC ACID, NMR, 30 STRUCTURES 1QET ; -1.00 ; TANDEM GU MISMATCHES IN RIBONUCLEIC ACID, NMR, 30 STRUCTURES 1XNI ; 2.80 ; TANDEM TUDOR DOMAIN OF 53BP1 1L0Q ; 2.40 ; TANDEM YVTN BETA-PROPELLER AND PKD DOMAINS FROM AN ARCHAEAL SURFACE LAYER PROTEIN 1KJM ; 2.35 ; TAP-A-ASSOCIATED RAT MHC CLASS I MOLECULE 1KJV ; 1.48 ; TAP-B-ASSOCIATED RAT MHC CLASS I MOLECULE 1BGX ; 2.30 ; TAQ POLYMERASE IN COMPLEX WITH TP7, AN INHIBITORY FAB 1YNN ; 3.30 ; TAQ RIBONUCLEIC ACID POLYMERASE-RIFAMPICIN COMPLEX 1YNJ ; 3.20 ; TAQ RIBONUCLEIC ACID POLYMERASE-SORANGICIN COMPLEX 1KIS ; -1.00 ; TAR - TAR "KISSING" HAIRPIN COMPLEX DERIVED FROM THE HIV GENOME, NMR, 1 STRUCTURE 2A9X ; -1.00 ; TAR RIBONUCLEIC ACID RECOGNITION BY A CYCLIC PEPTIDOMIMETIC OF TAT PROTEIN 289D ; 2.20 ; TARGETING THE MINOR GROOVE OF DEOXYRIBONUCLEIC ACID: CRYSTAL STRUCTURES OF TWO COMPLEXES BETWEEN FURAN DERIVATIVES OF BERENIL AND THE DEOXYRIBONUCLEIC ACID DODECAMER D(CGCGAATTCGCG)2 298D ; 2.20 ; TARGETING THE MINOR GROOVE OF DEOXYRIBONUCLEIC ACID: CRYSTAL STRUCTURES OF TWO COMPLEXES BETWEEN FURAN DERIVATIVES OF BERENIL AND THE DEOXYRIBONUCLEIC ACID DODECAMER D(CGCGAATTCGCG)2 1P44 ; 2.70 ; TARGETING TUBERCULOSIS AND MALARIA THROUGH INHIBITION OF ENOYL REDUCTASE: COMPOUND ACTIVITY AND STRUCTURAL DATA 1P45 ; 2.60 ; TARGETING TUBERCULOSIS AND MALARIA THROUGH INHIBITION OF ENOYL REDUCTASE: COMPOUND ACTIVITY AND STRUCTURAL DATA 1LQA ; 1.60 ; TAS PROTEIN FROM ESCHERICHIA COLI IN COMPLEX WITH NADPH 1D3U ; 2.40 ; TATA-BINDING PROTEIN/TRANSCRIPTION FACTOR (II)B/BRE+TATA- BOX COMPLEX FROM PYROCOCCUS WOESEI 1AIS ; 2.10 ; TATA-BINDING PROTEIN/TRANSCRIPTION FACTOR (II)B/TATA-BOX COMPLEX FROM PYROCOCCUS WOESEI 1GQW ; 3.00 ; TAURINE/ALPHA-KETOGLUTARATE DIOXYGENASE FROM ESCHERICHIA COLI 1GY9 ; 2.50 ; TAURINE/ALPHA-KETOGLUTARATE DIOXYGENASE FROM ESCHERICHIA COLI 1MP9 ; 2.00 ; TBP FROM A MESOTHERMOPHILIC ARCHAEON, SULFOLOBUS ACIDOCALDARIUS 1L0X ; 2.80 ; TCR BETA CHAIN COMPLEXED WITH STREPTOCOCCAL SUPERANTIGEN SPEA 1I9E ; 2.50 ; TCR DOMAIN 1YMM ; 3.50 ; TCR/HLA-DR2B/MBP-PEPTIDE COMPLEX 1AXB ; 2.00 ; TEM-1 BETA-LACTAMASE FROM ESCHERICHIA COLI INHIBITED WITH AN ACYLATION TRANSITION STATE ANALOG 1PZO ; 1.90 ; TEM-1 BETA-LACTAMASE IN COMPLEX WITH A NOVEL, CORE- DISRUPTING, ALLOSTERIC INHIBITOR 1PZP ; 1.45 ; TEM-1 BETA-LACTAMASE IN COMPLEX WITH A NOVEL, CORE- DISRUPTING, ALLOSTERIC INHIBITOR 1ZG4 ; 1.55 ; TEM1 BETA LACTAMASE 1ZG6 ; 2.10 ; TEM1 BETA LACTAMASE MUTANT S70G 1UDD ; 2.15 ; TENA HOMOLOGUE PROTEIN FROM P.HORIKOSHII OT3 1VIW ; 3.00 ; TENEBRIO MOLITOR ALPHA-AMYLASE-INHIBITOR COMPLEX 1WKO ; 1.80 ; TERMINAL FLOWER 1 (TFL1) FROM ARABIDOPSIS THALIANA 1SL0 ; 3.20 ; TERNARY 3' COMPLEX OF T7 DEOXYRIBONUCLEIC ACID POLYMERASE WITH A DEOXYRIBONUCLEIC ACID PRIMER/TEMPLATE CONTAINING A DISORDERED CIS-SYN THYMINE DIMER ON THE TEMPLATE AND AN INCOMING NUCLEOTIDE 1SL2 ; 2.30 ; TERNARY 5' COMPLEX OF T7 DEOXYRIBONUCLEIC ACID POLYMERASE WITH A DEOXYRIBONUCLEIC ACID PRIMER/TEMPLATE CONTAINING A CIS-SYN THYMINE DIMER ON THE TEMPLATE AND AN INCOMING NUCLEOTIDE 1G9H ; 1.80 ; TERNARY COMPLEX BETWEEN PSYCHROPHILIC ALPHA-AMYLASE, COMII (PSEUDO TRI-SACCHARIDE FROM BAYER) AND TRIS (2-AMINO-2- HYDROXYMETHYL-PROPANE-1,3-DIOL) 1O94 ; 2.00 ; TERNARY COMPLEX BETWEEN TRIMETHYLAMINE DEHYDROGENASE AND ELECTRON TRANSFERRING FLAVOPROTEIN 1O95 ; 3.70 ; TERNARY COMPLEX BETWEEN TRIMETHYLAMINE DEHYDROGENASE AND ELECTRON TRANSFERRING FLAVOPROTEIN 1OJ4 ; 2.01 ; TERNARY COMPLEX OF 4-DIPHOSPHOCYTIDYL-2-C-METHYL-D-ERYTHRITOL KINASE 1DY3 ; 2.00 ; TERNARY COMPLEX OF 7,8-DIHYDRO-6-HYDROXYMETHYLPTERINPYROPHOSPHOKINASE FROM ESCHERICHIA COLI WITH ATP AND A SUBSTRATE ANALOGUE. 1TCO ; 2.50 ; TERNARY COMPLEX OF A CALCINEURIN A FRAGMENT, CALCINEURIN B, FKBP12 AND THE IMMUNOSUPPRESSANT DRUG FK506 (TACROLIMUS) 1A71 ; 2.00 ; TERNARY COMPLEX OF AN ACTIVE SITE DOUBLE MUTANT OF HORSE LIVER ALCOHOL DEHYDROGENASE, PHE93>TRP, VAL203>ALA WITH NAD AND TRIFLUOROETHANOL 1JU5 ; -1.00 ; TERNARY COMPLEX OF AN CRK SH2 DOMAIN, CRK-DERIVED PHOPHOPEPTIDE, AND ABL SH3 DOMAIN BY NMR SPECTROSCOPY 1QI1 ; 3.00 ; TERNARY COMPLEX OF AN NADP DEPENDENT ALDEHYDE DEHYDROGENASE 2ALZ ; 2.50 ; TERNARY COMPLEX OF HPOLI WITH DEOXYRIBONUCLEIC ACID AND DCTP 1QFW ; 3.50 ; TERNARY COMPLEX OF HUMAN CHORIONIC GONADOTROPIN WITH FV ANTI ALPHA SUBUNIT AND FV ANTI BETA SUBUNIT 1MA0 ; 2.30 ; TERNARY COMPLEX OF HUMAN GLUTATHIONE-DEPENDENT FORMALDEHYDE DEHYDROGENASE WITH NAD+ AND DODECANOIC ACID 1MC5 ; 2.60 ; TERNARY COMPLEX OF HUMAN GLUTATHIONE-DEPENDENT FORMALDEHYDE DEHYDROGENASE WITH S-(HYDROXYMETHYL)GLUTATHIONE AND NADH 1B3O ; 2.90 ; TERNARY COMPLEX OF HUMAN TYPE-II INOSINE MONOPHOSPHATE DEHYDROGENASE WITH 6-CL-IMP AND SELENAZOLE ADENINE DINUCLEOTIDE 1XKD ; 2.30 ; TERNARY COMPLEX OF ISOCITRATE DEHYDROGENASE FROM THE HYPERTHERMOPHILE AEROPYRUM PERNIX 1N2D ; 2.00 ; TERNARY COMPLEX OF MLC1P BOUND TO IQ2 AND IQ3 OF MYO2P, A CLASS V MYOSIN 13PK ; 2.50 ; TERNARY COMPLEX OF PHOSPHOGLYCERATE KINASE FROM TRYPANOSOMA BRUCEI 1PYT ; 2.35 ; TERNARY COMPLEX OF PROCARBOXYPEPTIDASE A, PROPROTEINASE E, AND CHYMOTRYPSINOGEN C 1QAX ; 2.80 ; TERNARY COMPLEX OF PSEUDOMONAS MEVALONII HMG-COA REDUCTASE WITH HMG-COA AND NAD+ 1QAY ; 2.80 ; TERNARY COMPLEX OF PSEUDOMONAS MEVALONII HMG-COA REDUCTASE WITH MEVALONATE AND NAD+ 1E5Q ; 2.10 ; TERNARY COMPLEX OF SACCHAROPINE REDUCTASE FROM MAGNAPORTHE GRISEA, NADPH AND SACCHAROPINE 1HBX ; 3.15 ; TERNARY COMPLEX OF SAP-1 AND SRF WITH SPECIFIC SRE DEOXYRIBONUCLEIC ACID 1IXY ; 2.50 ; TERNARY COMPLEX OF T4 PHAGE BGT WITH UDP AND A 13 MER DEOXYRIBONUCLEIC ACID DUPLEX 1M5R ; 1.80 ; TERNARY COMPLEX OF T4 PHAGE BGT WITH UDP AND A 13 MER DEOXYRIBONUCLEIC ACID DUPLEX 2AQ4 ; 2.32 ; TERNARY COMPLEX OF THE CATALYTIC CORE OF REV1 WITH DEOXYRIBONUCLEIC ACID AND DCTP. 1O4X ; -1.00 ; TERNARY COMPLEX OF THE DEOXYRIBONUCLEIC ACID BINDING DOMAINS OF THE OCT1 AND SOX2 TRANSCRIPTION FACTORS WITH A 19MER OLIGONUCLEOTIDE FROM THE HOXB1 REGULATORY ELEMENT 1NFB ; 2.90 ; TERNARY COMPLEX OF THE HUMAN TYPE II INOSINE MONOPHOSPHATE DEDHYDROGENASE WITH 6CL-IMP AND NAD 1NF7 ; 2.65 ; TERNARY COMPLEX OF THE HUMAN TYPE II INOSINE MONOPHOSPHATE DEDHYDROGENASE WITH RIBAVIRIN MONOPHOSPHATE AND C2- MYCOPHENOLIC ADENINE DINUCLEOTIDE 2A3Z ; 2.08 ; TERNARY COMPLEX OF THE WH2 DOMAIN OF WASP WITH ACTIN-DNASE I 2A40 ; 1.80 ; TERNARY COMPLEX OF THE WH2 DOMAIN OF WAVE WITH ACTIN-DNASE I 2A41 ; 2.60 ; TERNARY COMPLEX OF THE WH2 DOMAIN OF WIP WITH ACTIN-DNASE I 1CI7 ; 2.60 ; TERNARY COMPLEX OF THYMIDYLATE SYNTHASE FROM PNEUMOCYSTIS CARINII 1D6N ; 2.70 ; TERNARY COMPLEX STRUCTURE OF HUMAN HGPRTASE, PRPP, MG2+, AND THE INHIBITOR HPP REVEALS THE INVOLVEMENT OF THE FLEXIBLE LOOP IN SUBSTRATE BINDING 1OS2 ; 2.15 ; TERNARY ENZYME-PRODUCT-INHIBITOR COMPLEXES OF HUMAN MMP12 6MHT ; 2.05 ; TERNARY STRUCTURE OF HHAI METHYLTRANSFERASE WITH ADOHCY AND DEOXYRIBONUCLEIC ACID CONTAINING 4'-THIO-2'DEOXYCYTIDINE AT THE TARGET 10MH ; 2.55 ; TERNARY STRUCTURE OF HHAI METHYLTRANSFERASE WITH ADOHCY AND HEMIMETHYLATED DEOXYRIBONUCLEIC ACID CONTAINING 5,6-DIHYDRO-5-AZACYTOSINE AT THE TARGET 5MHT ; 2.70 ; TERNARY STRUCTURE OF HHAI METHYLTRANSFERASE WITH HEMIMETHYLATED DEOXYRIBONUCLEIC ACID AND ADOHCY 4MHT ; 2.70 ; TERNARY STRUCTURE OF HHAI METHYLTRANSFERASE WITH NATIVE DEOXYRIBONUCLEIC ACID AND ADOHCY 3MHT ; 2.70 ; TERNARY STRUCTURE OF HHAI METHYLTRANSFERASE WITH UNMODIFIED DEOXYRIBONUCLEIC ACID AND ADOHCY 1Q0T ; 3.10 ; TERNARY STRUCTURE OF T4DAM WITH ADOHCY AND DEOXYRIBONUCLEIC ACID 1TC2 ; 1.81 ; TERNARY SUBSTRATE COMPLEX OF THE HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE FROM TRYPANOSOMA CRUZI 1B9R ; -1.00 ; TERPREDOXIN FROM PSEUDOMONAS SP. 1DV5 ; -1.00 ; TERTIARY STRUCTURE OF APO-D-ALANYL CARRIER PROTEIN 1HQB ; -1.00 ; TERTIARY STRUCTURE OF APO-D-ALANYL CARRIER PROTEIN 1A9V ; -1.00 ; TERTIARY STRUCTURE OF THE MAJOR HOUSE DUST MITE ALLERGEN DER P 2, NMR, 10 STRUCTURES 1BZD ; 1.90 ; TERTIARY STRUCTURES OF THREE AMYLOIDOGENIC TRANSTHYRETIN VARIANTS AND IMPLICATIONS FOR AMYLOID FIBRIL FORMATION 1BZE ; 1.80 ; TERTIARY STRUCTURES OF THREE AMYLOIDOGENIC TRANSTHYRETIN VARIANTS AND IMPLICATIONS FOR AMYLOID FIBRIL FORMATION 1TSH ; 1.70 ; TERTIARY STRUCTURES OF THREE AMYLOIDOGENIC TRANSTHYRETIN VARIANTS AND IMPLICATIONS FOR AMYLOID FIBRIL FORMATION 2TRH ; 1.90 ; TERTIARY STRUCTURES OF THREE AMYLOIDOGENIC TRANSTHYRETIN VARIANTS AND IMPLICATIONS FOR AMYLOID FIBRIL FORMATION 2TRY ; 2.00 ; TERTIARY STRUCTURES OF THREE AMYLOIDOGENIC TRANSTHYRETIN VARIANTS AND IMPLICATIONS FOR AMYLOID FIBRIL FORMATION 1JJ8 ; 2.75 ; TESTING THE WATER-MEDIATED HIN RECOMBINASE DEOXYRIBONUCLEIC ACID RECOGNITION BY SYSTEMATIC MUTATIONS 1JKO ; 2.24 ; TESTING THE WATER-MEDIATED HIN RECOMBINASE DEOXYRIBONUCLEIC ACID RECOGNITION BY SYSTEMATIC MUTATIONS 1JKP ; 2.80 ; TESTING THE WATER-MEDIATED HIN RECOMBINASE DEOXYRIBONUCLEIC ACID RECOGNITION BY SYSTEMATIC MUTATIONS 1JKQ ; 2.86 ; TESTING THE WATER-MEDIATED HIN RECOMBINASE DEOXYRIBONUCLEIC ACID RECOGNITION BY SYSTEMATIC MUTATIONS 1JKR ; 2.28 ; TESTING THE WATER-MEDIATED HIN RECOMBINASE DEOXYRIBONUCLEIC ACID RECOGNITION BY SYSTEMATIC MUTATIONS 1IJW ; 2.40 ; TESTING THE WATER-MEDIATED HIN RECOMBINASE DEOXYRIBONUCLEIC ACID RECOGNITION BY SYSTEMATIC MUTATIONS. 1JJ6 ; 2.30 ; TESTING THE WATER-MEDIATED HIN RECOMBINASE DEOXYRIBONUCLEIC ACID RECOGNITION BY SYSTEMATIC MUTATIONS. 1I9J ; 2.60 ; TESTOSTERONE COMPLEX STRUCTURE OF THE RECOMBINANT MONOCLONAL WILD TYPE ANTI-TESTOSTERONE FAB FRAGMENT 1ORK ; 2.40 ; TET REPRESSOR, CLASS D IN COMPLEX WITH 9-(N,N-DIMETHYLGLYCYLAMIDO)-6-DEMETHYL-6-DEOXY-TETRACYCLINE 1A6I ; 2.40 ; TET REPRESSOR, CLASS D VARIANT 1AF9 ; 2.70 ; TETANUS NEUROTOXIN C FRAGMENT 1A8D ; 1.57 ; TETANUS TOXIN C FRAGMENT 1V7B ; 1.90 ; TETR-FAMILY TRANSCRIPTION FACTOR CGL2612 FROM C.GLUTAMICUM 5FWG ; 2.00 ; TETRA-(5-FLUOROTRYPTOPHANYL)-GLUTATHIONE TRANSFERASE 1BJ0 ; 2.40 ; TETRACYCLINE CHELATED MG2+ -ION INITIATES HELIX UNWINDING FOR TET REPRESSOR INDUCTION 1BJY ; 2.70 ; TETRACYCLINE CHELATED MG2+ -ION INITIATES HELIX UNWINDING FOR TET REPRESSOR INDUCTION 1BJZ ; 2.20 ; TETRACYCLINE CHELATED MG2+ -ION INITIATES HELIX UNWINDING FOR TET REPRESSOR INDUCTION 2TRT ; 2.50 ; TETRACYCLINE REPRESSOR CLASS D 1JKT ; 3.49 ; TETRAGONAL CRYSTAL FORM OF A CATALYTIC DOMAIN OF DEATH- ASSOCIATED PROTEIN KINASE 1IES ; 2.50 ; TETRAGONAL CRYSTAL STRUCTURE OF NATIVE HORSE SPLEEN FERRITIN 1M1D ; 2.20 ; TETRAHYMENA GCN5 WITH BOUND BISUBSTRATE ANALOG INHIBITOR 2PAH ; 3.10 ; TETRAMERIC HUMAN PHENYLALANINE HYDROXYLASE 1FIU ; 1.60 ; TETRAMERIC RESTRICTION ENDONUCLEASE NGOMIV IN COMPLEX WITH CLEAVED DEOXYRIBONUCLEIC ACID 1J2W ; 1.50 ; TETRAMERIC STRUCTURE OF ALDOLASE FROM THERMUS THERMOPHILUS HB8 1Z9W ; 2.50 ; TETRAMERIC STRUCTURE OF APO-7,8-DIHYDRONEOPTERIN ALDOLASE FROM MYCOBACTERIUM TUBERCULOSIS 3KVT ; 2.00 ; TETRAMERIZATION DOMAIN FROM AKV3.1 (SHAW-SUBFAMILY) VOLTAGE-GATED POTASSIUM CHANNEL 1A17 ; 2.45 ; TETRATRICOPEPTIDE REPEATS OF PROTEIN PHOSPHATASE 5 1W0Y ; 2.50 ; TF7A_3771 COMPLEX 1W2K ; 3.00 ; TF7A_4380 COMPLEX 1IWC ; -1.00 ; TFE-INDUDED STRUCTURE OF THE N-TERMINAL DOMAIN OF PIG GASTRIC H/K-ATPASE 1VOL ; 2.70 ; TFIIB (HUMAN CORE DOMAIN)/TBP (A.THALIANA)/TATA ELEMENT TERNARY COMPLEX 1TF3 ; -1.00 ; TFIIIA FINGER 1-3 BOUND TO DEOXYRIBONUCLEIC ACID, NMR, 22 STRUCTURES 1ZF6 ; 1.50 ; TGG DUPLEX A-DEOXYRIBONUCLEIC ACID 2AKG ; -1.00 ; THALLIUM FORM OF THE G-QUADRUPLEX FROM OXYTRICHA NOVA, D(G4T4G4)2 2BLU ; 1.40 ; THAUMATIN AFTER A HIGH DOSE X-RAY "BURN" 2BLR ; 1.40 ; THAUMATIN BEFORE A HIGH DOSE X-RAY "BURN" 1RQW ; 1.05 ; THAUMATIN STRUCTURE AT 1.05 A RESOLUTION 1URH ; 2.80 ; THE "RHODANESE" FOLD AND CATALYTIC MECHANISM OF 3-MERCAPTOPYRUVATE SULFOTRANSFERASES: CRYSTAL STRUCTURE OF SSEA FROM ESCHERICHIA COLI 1GCI ; 0.78 ; THE 0.78 ANGSTROMS STRUCTURE OF A SERINE PROTEASE - BACILLUS LENTUS SUBTILISIN 1MUW ; 0.86 ; THE 0.86 ANGSTROM STRUCTURE OF XYLOSE ISOMERASE 1RTQ ; 0.95 ; THE 0.95 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE AMINOPEPTIDASE FROM AEROMONAS PROTEOLYTICA 1F94 ; 0.97 ; THE 0.97 RESOLUTION STRUCTURE OF BUCANDIN, A NOVEL TOXIN ISOLATED FROM THE MALAYAN KRAIT 1EXR ; 1.00 ; THE 1.0 ANGSTROM CRYSTAL STRUCTURE OF CA+2 BOUND CALMODULIN 1Z53 ; 1.13 ; THE 1.13 ANGSTROM STRUCTURE OF IRON-FREE CYTOCHROME C PEROXIDASE 1AGY ; 1.15 ; THE 1.15 ANGSTROM REFINED STRUCTURE OF FUSARIUM SOLANI PISI CUTINASE 1Z2U ; 1.10 ; THE 1.1A CRYSTALLOGRAPHIC STRUCTURE OF UBIQUITIN- CONJUGATING ENZYME (UBC-2) FROM CAENORHABDITIS ELEGANS: FUNCTIONAL AND EVOLUTIONARY SIGNIFICANCE 1J98 ; 1.20 ; THE 1.2 ANGSTROM STRUCTURE OF BACILLUS SUBTILIS LUXS 1NOT ; 1.20 ; THE 1.2 ANGSTROM STRUCTURE OF G1 ALPHA CONOTOXIN 2KNT ; 1.20 ; THE 1.2 ANGSTROM STRUCTURE OF KUNITZ TYPE DOMAIN C5 1LOK ; 1.20 ; THE 1.20 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE AMINOPEPTIDASE FROM AEROMONAS PROTEOLYTICA COMPLEXED WITH TRIS: A TALE OF BUFFER INHIBITION 1Y6X ; 1.25 ; THE 1.25 A RESOLUTION STRUCTURE OF PHOSPHORIBOSYL-ATP PYROPHOSPHOHYDROLASE FROM MYCOBACTERIUM TUBERCULOSIS 193L ; 1.33 ; THE 1.33 A STRUCTURE OF TETRAGONAL HEN EGG WHITE LYSOZYME 194L ; 1.40 ; THE 1.40 A STRUCTURE OF SPACEHAB-01 HEN EGG WHITE LYSOZYME 1RCQ ; 1.45 ; THE 1.45 A CRYSTAL STRUCTURE OF ALANINE RACEMASE FROM A PATHOGENIC BACTERIUM, PSEUDOMONAS AERUGINOSA, CONTAINS BOTH INTERNAL AND EXTERNAL ALDIMINE FORMS 1JBO ; 1.45 ; THE 1.45A THREE-DIMENSIONAL STRUCTURE OF C-PHYCOCYANIN FROM THE THERMOPHYLIC CYANOBACTERIUM SYNECHOCOCCUS ELONGATUS 1SJ1 ; 1.50 ; THE 1.5 A RESOLUTION CRYSTAL STRUCTURE OF [FE3S4]- FERREDOXIN FROM THE HYPERTHERMOPHILIC ARCHAEON PYROCOCCUS FURIOSUS 1IUQ ; 1.55 ; THE 1.55 A CRYSTAL STRUCTURE OF GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE 2AEX ; 1.58 ; THE 1.58A CRYSTAL STRUCTURE OF HUMAN COPROPORPHYRINOGEN OXIDASE REVEALS THE STRUCTURAL BASIS OF HEREDITARY COPROPORPHYRIA 1L8N ; 1.50 ; THE 1.5A CRYSTAL STRUCTURE OF ALPHA-D-GLUCURONIDASE FROM BACILLUS STEAROTHERMOPHILUS T-1, COMPLEXED WITH 4-O-METHYL- GLUCURONIC ACID AND XYLOTRIOSE 1JXG ; 1.60 ; THE 1.6 A RESOLUTION CRYSTAL STRUCTURE OF A MUTANT POPLAR PLASTOCYANIN BEARING A 21-25 ENGENEERED DISULFIDE BRIDGE 1MY6 ; 1.60 ; THE 1.6 A STRUCTURE OF FE-SUPEROXIDE DISMUTASE FROM THE THERMOPHILIC CYANOBACTERIUM THERMOSYNECHOCOCCUS ELONGATUS : CORRELATION OF EPR AND STRUCTURAL CHARACTERISTICS 1QTX ; 1.65 ; THE 1.65 ANGSTROM STRUCTURE OF CALMODULIN RS20 PEPTIDE COMPLEX 1NS9 ; 1.60 ; THE 1.6A STRUCTURE OF HORSE METHEMOGLOBIN AT PH 7.1 1ECS ; 1.70 ; THE 1.7 A CRYSTAL STRUCTURE OF A BLEOMYCIN RESISTANCE DETERMINANT ENCODED ON THE TRANSPOSON TN5 1K9D ; 1.70 ; THE 1.7 A CRYSTAL STRUCTURE OF ALPHA-D-GLUCURONIDASE, A FAMILY-67 GLYCOSIDE HYDROLASE FROM BACILLUS STEAROTHERMOPHILUS T-1 1IA8 ; 1.70 ; THE 1.7 A CRYSTAL STRUCTURE OF HUMAN CELL CYCLE CHECKPOINT KINASE CHK1 1EWF ; 1.70 ; THE 1.7 ANGSTROM CRYSTAL STRUCTURE OF BPI 1FVK ; 1.70 ; THE 1.7 ANGSTROM STRUCTURE OF WILD TYPE DISULFIDE BOND FORMATION PROTEIN (DSBA) 1H5U ; 1.76 ; THE 1.76 A RESOLUTION CRYSTAL STRUCTURE OF GLYCOGEN PHOSPHORYLASE B COMPLEXED WITH GLUCOSE AND CP320626, A POTENTIAL ANTIDIABETIC DRUG 1EBL ; 1.80 ; THE 1.8 A CRYSTAL STRUCTURE AND ACTIVE SITE ARCHITECTURE OF BETA-KETOACYL-[ACYL CARRIER PROTEIN] SYNTHASE III (FABH) FROM ESCHERICHIA COLI 1HYL ; 1.80 ; THE 1.8 A STRUCTURE OF COLLAGENASE FROM HYPODERMA LINEATUM 1BVX ; 1.80 ; THE 1.8 A STRUCTURE OF GEL GROWN TETRAGONAL HEN EGG WHITE LYSOZYME 1BWH ; 1.80 ; THE 1.8 A STRUCTURE OF GROUND CONTROL GROWN TETRAGONAL HEN EGG WHITE LYSOZYME 1BWI ; 1.80 ; THE 1.8 A STRUCTURE OF MICROBATCH OIL DROP GROWN TETRAGONAL HEN EGG WHITE LYSOZYME 1BWJ ; 1.80 ; THE 1.8 A STRUCTURE OF MICROGRAVITY GROWN TETRAGONAL HEN EGG WHITE LYSOZYME 1AFW ; 1.80 ; THE 1.8 ANGSTROM CRYSTAL STRUCTURE OF THE DIMERIC PEROXISOMAL THIOLASE OF SACCHAROMYCES CEREVISIAE 1YAC ; 1.80 ; THE 1.8 ANGSTROM CRYSTAL STRUCTURE OF THE YCAC GENE PRODUCT FROM ESCHERICHIA COLI REVEALS AN OCTAMERIC HYDROLASE OF UNKNOWN SPECIFICITY 1QS7 ; 1.80 ; THE 1.8 ANGSTROM STRUCTURE OF CALMODULIN RS20 PEPTIDE COMPLEX 1XFC ; 1.90 ; THE 1.9 A CRYSTAL STRUCTURE OF ALANINE RACEMASE FROM MYCOBACTERIUM TUBERCULOSIS CONTAINS A CONSERVED ENTRYWAY INTO THE ACTIVE SITE 1F0K ; 1.90 ; THE 1.9 ANGSTROM CRYSTAL STRUCTURE OF E. COLI MURG 1VRK ; 1.90 ; THE 1.9 ANGSTROM STRUCTURE OF E84K-CALMODULIN RS20 PEPTIDE COMPLEX 1LI1 ; 1.90 ; THE 1.9-A CRYSTAL STRUCTURE OF THE NONCOLLAGENOUS (NC1) DOMAIN OF HUMAN PLACENTA COLLAGEN IV SHOWS STABILIZATION VIA A NOVEL TYPE OF COVALENT MET-LYS CROSS-LINK 1GWI ; 1.92 ; THE 1.92 A STRUCTURE OF STREPTOMYCES COELICOLOR A3(2) CYP154C1: A NEW MONOOXYGENASE THAT FUNCTIONALIZES MACROLIDE RING SYSTEMS 1BFF ; 2.00 ; THE 154 AMINO ACID FORM OF HUMAN BASIC FIBROBLAST GROWTH FACTOR 1XQN ; 2.50 ; THE 15K NEUTRON STRUCTURE OF SACCHARIDE-FREE CONCANAVALIN A 1FM2 ; 2.00 ; THE 2 ANGSTROM CRYSTAL STRUCTURE OF CEPHALOSPORIN ACYLASE 1O8U ; 2.00 ; THE 2 ANGSTROM STRUCTURE OF 6-OXO CAMPHOR HYDROLASE: NEW STRUCTURAL DIVERSITY IN THE CROTONASE SUPERFAMILY 1S4V ; 2.00 ; THE 2.0 A CRYSTAL STRUCTURE OF THE KDEL-TAILED CYSTEINE ENDOPEPTIDASE FUNCTIONING IN PROGRAMMED CELL DEATH OF RICINUS COMMUNIS ENDOSPERM 1MHO ; 2.00 ; THE 2.0 A STRUCTURE OF HOLO S100B FROM BOVINE BRAIN 1S96 ; 2.00 ; THE 2.0 A X-RAY STRUCTURE OF GUANYLATE KINASE FROM E.COLI 1KXG ; 2.00 ; THE 2.0 ANG RESOLUTION STRUCTURE OF BLYS, B LYMPHOCYTE STIMULATOR. 1TE5 ; 2.00 ; THE 2.0 ANGSTROM CRYSTAL STRUCTURE OF PREDICTED GLUTAMINE AMIDOTRANSFERASE FROM PSEUDOMONAS AERUGINOSA PA01 1G5Y ; 2.00 ; THE 2.0 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE RXRALPHA LIGAND BINDING DOMAIN TETRAMER IN THE PRESENCE OF A NON-ACTIVATING RETINOIC ACID ISOMER. 1GV3 ; 2.00 ; THE 2.0 ANGSTROM RESOLUTION STRUCTURE OF THE CATALYTIC PORTION OF A CYANOBACTERIAL MEMBRANE-BOUND MANGANESE SUPEROXIDE DISMUTASE 1UIS ; 2.00 ; THE 2.0 CRYSTAL STRUCTURE OF EQFP611, A FAR-RED FLUORESCENT PROTEIN FROM THE SEA ANEMONE ENTACMAEA QUADRICOLOR 1L5X ; 2.00 ; THE 2.0-ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF A SURVIVAL PROTEIN E (SURE) HOMOLOG FROM PYROBACULUM AEROPHILUM 1FVJ ; 2.06 ; THE 2.06 ANGSTROM STRUCTURE OF THE H32Y MUTANT OF THE DISULFIDE BOND FORMATION PROTEIN (DSBA) 1WZ9 ; 2.10 ; THE 2.1 A STRUCTURE OF A TUMOUR SUPPRESSING SERPIN 1W3W ; 1.99 ; THE 2.1 ANGSTROEM RESOLUTION STRUCTURE OF ANNEXIN A8 1FM9 ; 2.10 ; THE 2.1 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HETERODIMER OF THE HUMAN RXRALPHA AND PPARGAMMA LIGAND BINDING DOMAINS RESPECTIVELY BOUND WITH 9-CIS RETINOIC ACID AND GI262570 AND CO-ACTIVATOR PEPTIDES. 1FM6 ; 2.10 ; THE 2.1 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HETERODIMER OF THE HUMAN RXRALPHA AND PPARGAMMA LIGAND BINDING DOMAINS RESPECTIVELY BOUND WITH 9-CIS RETINOIC ACID AND ROSIGLITAZONE AND CO-ACTIVATOR PEPTIDES. 1CQD ; 2.10 ; THE 2.1 ANGSTROM STRUCTURE OF A CYSTEINE PROTEASE WITH PROLINE SPECIFICITY FROM GINGER RHIZOME, ZINGIBER OFFICINALE 1VRP ; 2.10 ; THE 2.1 STRUCTURE OF T. CALIFORNICA CREATINE KINASE COMPLEXED WITH THE TRANSITION-STATE ANALOGUE COMPLEX, ADP- MG 2+ /NO3-/CREATINE 1PCS ; 2.15 ; THE 2.15 A CRYSTAL STRUCTURE OF A TRIPLE MUTANT PLASTOCYANIN FROM THE CYANOBACTERIUM SYNECHOCYSTIS SP. PCC 6803 1YZW ; 2.10 ; THE 2.1A CRYSTAL STRUCTURE OF THE FAR-RED FLUORESCENT PROTEIN HCRED: INHERENT CONFORMATIONAL FLEXIBILITY OF THE CHROMOPHORE 1NS6 ; 2.05 ; THE 2.1A STRUCTURE OF HORSE (ALPHA HEMICHROME/BETA MET) HEMOGLOBIN AT PH 5.4 1PJP ; 2.20 ; THE 2.2 A CRYSTAL STRUCTURE OF HUMAN CHYMASE IN COMPLEX WITH SUCCINYL-ALA-ALA-PRO-PHE-CHLOROMETHYLKETONE 1R64 ; 2.20 ; THE 2.2 A CRYSTAL STRUCTURE OF KEX2 PROTEASE IN COMPLEX WITH AC-ARG-GLU-LYS-BOROARG PEPTIDYL BORONIC ACID INHIBITOR 1GXW ; 2.18 ; THE 2.2 A RESOLUTION STRUCTURE OF THERMOLYSIN CRYSTALLIZED IN PRESENCE OF POTASSIUM THIOCYANATE 1JVI ; 2.20 ; THE 2.2 ANGSTROM RESOLUTION STRUCTURE OF BACILLUS SUBTILIS LUXS/RIBOSILHOMOCYSTEINE COMPLEX 1K74 ; 2.30 ; THE 2.3 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HETERODIMER OF THE HUMAN PPARGAMMA AND RXRALPHA LIGAND BINDING DOMAINS RESPECTIVELY BOUND WITH GW409544 AND 9-CIS RETINOIC ACID AND CO-ACTIVATOR PEPTIDES. 1JQW ; 2.30 ; THE 2.3 ANGSTROM RESOLUTION STRUCTURE OF BACILLUS SUBTILIS LUXS/HOMOCYSTEINE COMPLEX 1OT5 ; 2.40 ; THE 2.4 ANGSTROM CRYSTAL SRUCTURE OF KEX2 IN COMPLEX WITH A PEPTIDYL-BORONIC ACID INHIBITOR 1W45 ; 2.51 ; THE 2.5 ANGSTROEM STRUCTURE OF THE K16A MUTANT OF ANNEXIN A8, WHICH HAS AN INTACT N-TERMINUS. 1K7L ; 2.50 ; THE 2.5 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HUMAN PPARALPHA LIGAND BINDING DOMAIN BOUND WITH GW409544 AND A CO-ACTIVATOR PEPTIDE. 1G1U ; 2.50 ; THE 2.5 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE RXRALPHA LIGAND BINDING DOMAIN IN TETRAMER IN THE ABSENCE OF LIGAND 2ANT ; 2.60 ; THE 2.6 A STRUCTURE OF ANTITHROMBIN INDICATES A CONFORMATIONAL CHANGE AT THE HEPARIN BINDING SITE 1JGC ; 2.60 ; THE 2.6 A STRUCTURE RESOLUTION OF RHODOBACTER CAPSULATUS BACTERIOFERRITIN WITH METAL-FREE DINUCLEAR SITE AND HEME IRON IN A CRYSTALLOGRAPHIC SPECIAL POSITION 1EQG ; 2.61 ; THE 2.6 ANGSTROM MODEL OF OVINE COX-1 COMPLEXED WITH IBUPROFEN 3LHB ; 2.70 ; THE 2.7 ANGSTROM CRYSTAL STRUCTURE OF DEOXYGENATED HEMOGLOBIN FROM THE SEA LAMPREY (PETROMYZON MARINUS) 1EQH ; 2.70 ; THE 2.7 ANGSTROM MODEL OF OVINE COX-1 COMPLEXED WITH FLURBIPROFEN 1I3S ; 2.70 ; THE 2.7 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF A MUTATED BACULOVIRUS P35 AFTER CASPASE CLEAVAGE 1HT8 ; 2.69 ; THE 2.7 ANGSTROM RESOLUTION MODEL OF OVINE COX-1 COMPLEXED WITH ALCLOFENAC 1HT5 ; 2.75 ; THE 2.75 ANGSTROM RESOLUTION MODEL OF OVINE COX-1 COMPLEXED WITH METHYL ESTER FLURBIPROFEN 1XU8 ; 2.80 ; THE 2.8 A STRUCTURE OF A TUMOUR SUPPRESSING SERPIN 1GFW ; 2.80 ; THE 2.8 ANGSTROM CRYSTAL STRUCTURE OF CASPASE-3 (APOPAIN OR CPP32)IN COMPLEX WITH AN ISATIN SULFONAMIDE INHIBITOR. 1QNO ; 2.00 ; THE 3-D STRUCTURE OF A TRICHODERMA REESEI B-MANNANASE FROM GLYCOSIDE HYDROLASE FAMILY 5 1QNP ; 1.50 ; THE 3-D STRUCTURE OF A TRICHODERMA REESEI B-MANNANASE FROM GLYCOSIDE HYDROLASE FAMILY 5 1QNQ ; 1.65 ; THE 3-D STRUCTURE OF A TRICHODERMA REESEI B-MANNANASE FROM GLYCOSIDE HYDROLASE FAMILY 5 1QNR ; 1.40 ; THE 3-D STRUCTURE OF A TRICHODERMA REESEI B-MANNANASE FROM GLYCOSIDE HYDROLASE FAMILY 5 1QNS ; 1.50 ; THE 3-D STRUCTURE OF A TRICHODERMA REESEI B-MANNANASE FROM GLYCOSIDE HYDROLASE FAMILY 5 1UN7 ; 2.05 ; THE 3-D STRUCTURE OF THE N-ACETYLGLUCOSAMINE-6-PHOSPHATE DEACETYLASE, NAGA, FROM BACILLUS SUBTILIS: A MEMBER OF THE UREASE SUPERFAMILY 1W2V ; 1.55 ; THE 3-DIMENSIONAL STRUCTURE OF A THERMOSTABLE MUTANT OF A XYLANASE (XYN10A) FROM CELLVIBRIO JAPONICUS 1W32 ; 1.20 ; THE 3-DIMENSIONAL STRUCTURE OF A THERMOSTABLE MUTANT OF A XYLANASE (XYN10A) FROM CELLVIBRIO JAPONICUS 1W3H ; 1.50 ; THE 3-DIMENSIONAL STRUCTURE OF A THERMOSTABLE MUTANT OF A XYLANASE (XYN10A) FROM CELLVIBRIO JAPONICUS 1W2P ; 1.45 ; THE 3-DIMENSIONAL STRUCTURE OF A XYLANASE (XYN10A) FROM CELLVIBRIO JAPONICUS 1I3P ; 3.10 ; THE 3.1 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF A MUTATED BACULOVIRUS P35 AFTER CASPASE CLEAVAGE 1Q2Z ; -1.00 ; THE 3D SOLUTION STRUCTURE OF THE C-TERMINAL REGION OF KU86 1HRY ; -1.00 ; THE 3D STRUCTURE OF THE HUMAN SRY-DEOXYRIBONUCLEIC ACID COMPLEX SOLVED BY MULTID-DIMENSIONAL HETERONUCLEAR-EDITED AND -FILTERED NMR 1HRZ ; -1.00 ; THE 3D STRUCTURE OF THE HUMAN SRY-DEOXYRIBONUCLEIC ACID COMPLEX SOLVED BY MULTID-DIMENSIONAL HETERONUCLEAR-EDITED AND -FILTERED NMR 1BHU ; -1.00 ; THE 3D STRUCTURE OF THE STREPTOMYCES METALLOPROTEINASE INHIBITOR, SMPI, ISOLATED FROM STREPTOMYCES NIGRESCENS TK-23, NMR, MINIMIZED AVERAGE STRUCTURE 1Q9I ; 1.60 ; THE A251C:S430C DOUBLE MUTANT OF FLAVOCYTOCHROME C3 FROM SHEWANELLA FRIGIDIMARINA 1AHO ; 0.96 ; THE AB INITIO STRUCTURE DETERMINATION AND REFINEMENT OF A SCORPION PROTEIN TOXIN 1TQY ; 2.00 ; THE ACTINORHODIN KETOSYNTHASE/CHAIN LENGTH FACTOR 1YBA ; 2.24 ; THE ACTIVE FORM OF PHOSPHOGLYCERATE DEHYDROGENASE 1HH8 ; 1.80 ; THE ACTIVE N-TERMINAL REGION OF P67PHOX: STRUCTURE AT 1.8 ANGSTROM RESOLUTION AND BIOCHEMICAL CHARACTERIZATIONS OF THE A128V MUTANT IMPLICATED IN CHRONIC GRANULOMATOUS DISEASE 1QAF ; 2.20 ; THE ACTIVE SITE BASE CONTROLS COFACTOR REACTIVITY IN ESCHERICHIA COLI AMINE OXIDASE : X-RAY CRYSTALLOGRAPHIC STUDIES WITH MUTATIONAL VARIANTS 1QAK ; 2.00 ; THE ACTIVE SITE BASE CONTROLS COFACTOR REACTIVITY IN ESCHERICHIA COLI AMINE OXIDASE : X-RAY CRYSTALLOGRAPHIC STUDIES WITH MUTATIONAL VARIANTS 1QAL ; 2.20 ; THE ACTIVE SITE BASE CONTROLS COFACTOR REACTIVITY IN ESCHERICHIA COLI AMINE OXIDASE : X-RAY CRYSTALLOGRAPHIC STUDIES WITH MUTATIONAL VARIANTS 1DYU ; 2.04 ; THE ACTIVE SITE BASE CONTROLS COFACTOR REACTIVITY IN ESCHERICHIA COLI AMINE OXIDASE: X-RAY CRYSTALLOGRAPHIC STUDIES WITH MUTATIONAL VARIANTS. 1QAE ; 2.05 ; THE ACTIVE SITE OF SERRATIA ENDONUCLEASE CONTAINS A CONSERVED MAGNESIUM-WATER CLUSTER 1O8Q ; 2.60 ; THE ACTIVE SITE OF THE MOLYBDENUM COFACTOR BIOSENTHETIC PROTEIN DOMAIN CNX1G 1O8N ; 2.80 ; THE ACTIVE SITE OF THE MOLYBDENUM COFACTOR BIOSYNTHETIC PROTEIN DOMAIN CNX1G 1O8O ; 2.70 ; THE ACTIVE SITE OF THE MOLYBDENUM COFACTOR BIOSYNTHETIC PROTEIN DOMAIN CNX1G 1OZI ; -1.00 ; THE ALTERNATIVELY SPLICED PDZ2 DOMAIN OF PTP-BL 1AML ; -1.00 ; THE ALZHEIMER`S DISEASE AMYLOID A4 PEPTIDE (RESIDUES 1-40) 1KTH ; 0.95 ; THE ANISOTROPIC REFINEMENT OF KUNITZ TYPE DOMAIN C5 AT 0.95 ANGSTROM 1KY7 ; 2.15 ; THE AP-2 CLATHRIN ADAPTOR ALPHA-APPENDAGE IN COMPLEX WITH AMPHIPHYSIN FXDXF 1RKA ; 2.30 ; THE APO FORM OF E. COLI RIBOKINASE 2CRL ; -1.00 ; THE APO FORM OF HMA DOMAIN OF COPPER CHAPERONE FOR SUPEROXIDE DISMUTASE 1ZLX ; 2.20 ; THE APO STRUCTURE OF HUMAN GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE 2AHD ; 3.00 ; THE APO STRUCTURE OF METHANOCOCCUS JANNASCHII PHOSPHODIESTERASE MJ0936 1Q8Z ; 2.35 ; THE APOENZYME STRUCTURE OF THE YEAST SR PROTEIN KINASE, SKY1P 2BCT ; 2.90 ; THE ARMADILLO REPEAT REGION FROM MURINE BETA-CATENIN 3BCT ; 2.10 ; THE ARMADILLO REPEAT REGION FROM MURINE BETA-CATENIN 1HZZ ; 2.50 ; THE ASYMMETRIC COMPLEX OF THE TWO NUCLEOTIDE-BINDING COMPONENTS (DI, DIII) OF PROTON-TRANSLOCATING TRANSHYDROGENASE 1ZWP ; 1.10 ; THE ATOMIC RESOLUTION CRYSTAL STRUCTURE OF THE PHOSPHOLIPASE A2 (PLA2) COMPLEX WITH NIMESULIDE REVEALS ITS WEAKER BINDING TO PLA2 1QLW ; 1.10 ; THE ATOMIC RESOLUTION STRUCTURE OF A NOVEL BACTERIAL ESTERASE 1LP3 ; 3.00 ; THE ATOMIC STRUCTURE OF ADENO-ASSOCIATED VIRUS (AAV-2), A VECTOR FOR HUMAN GENE THERAPY 1UF2 ; 3.50 ; THE ATOMIC STRUCTURE OF RICE DWARF VIRUS (RDV) 1Q1E ; 2.90 ; THE ATPASE COMPONENT OF E. COLI MALTOSE TRANSPORTER (MALK) IN THE NUCLEOTIDE-FREE FORM 1LEL ; 2.90 ; THE AVIDIN BCAP COMPLEX 355D ; 1.40 ; THE B-DEOXYRIBONUCLEIC ACID DODECAMER AT HIGH RESOLUTION 1F46 ; 1.50 ; THE BACTERIAL CELL-DIVISION PROTEIN ZIPA AND ITS INTERACTION WITH AN FTSZ FRAGMENT REVEALED BY X-RAY CRYSTALLOGRAPHY 1F47 ; 1.95 ; THE BACTERIAL CELL-DIVISION PROTEIN ZIPA AND ITS INTERACTION WITH AN FTSZ FRAGMENT REVEALED BY X-RAY CRYSTALLOGRAPHY 1CJD ; 1.85 ; THE BACTERIOPHAGE PRD1 COAT PROTEIN, P3, IS STRUCTURALLY SIMILAR TO HUMAN ADENOVIRUS HEXON 284D ; 1.10 ; THE BI-LOOP, A NEW GENERAL FOUR-STRANDED DEOXYRIBONUCLEIC ACID MOTIF 1SKN ; 2.50 ; THE BINDING DOMAIN OF SKN-1 IN COMPLEX WITH DEOXYRIBONUCLEIC ACID: A NEW DEOXYRIBONUCLEIC ACID-BINDING MOTIF 1TVK ; 2.89 ; THE BINDING MODE OF EPOTHILONE A ON A,B-TUBULIN BY ELECTRON CRYSTALLOGRAPHY 1FBT ; 2.00 ; THE BISPHOSPHATASE DOMAIN OF THE BIFUNCTIONAL RAT LIVER 6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE 1TIP ; 2.20 ; THE BISPHOSPHATASE DOMAIN OF THE BIFUNCTIONAL RAT LIVER 6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE 1H1K ; 10.00 ; THE BLUETONGUE VIRUS (BTV) CORE BINDS DSRNA 2C3E ; 2.80 ; THE BOVINE MITOCHONDRIAL ADP-ATP CARRIER 1HD9 ; -1.00 ; THE BOWMAN-BIRK INHIBITOR REACTIVE SITE LOOP SEQUENCE REPRESENTS AN INDEPENDENT STRUCTURAL BETA-HAIRPIN MOTIF 1UOY ; 1.50 ; THE BUBBLE PROTEIN FROM PENICILLIUM BREVICOMPACTUM DIERCKX EXUDATE. 1JNK ; 2.30 ; THE C-JUN N-TERMINAL KINASE (JNK3S) COMPLEXED WITH MGAMP-PNP 2BVB ; -1.00 ; THE C-TERMINAL DOMAIN FROM MICRONEMAL PROTEIN 1 (MIC1) FROM TOXOPLASMA GONDII 1DOQ ; -1.00 ; THE C-TERMINAL DOMAIN OF THE RIBONUCLEIC ACID POLYMERASE ALPHA SUBUNIT FROM THERMUS THERMOPHILUS 1TN3 ; 2.00 ; THE C-TYPE LECTIN CARBOHYDRATE RECOGNITION DOMAIN OF HUMAN TETRANECTIN 1I4U ; 1.15 ; THE C1 SUBUNIT OF ALPHA-CRUSTACYANIN 1I5I ; 2.40 ; THE C18S MUTANT OF BOVINE (GAMMA-B)-CRYSTALLIN 1YRK ; 1.70 ; THE C2 DOMAIN OF PKC IS A NEW PHOSPHO-TYROSINE BINDING DOMAIN 3RPB ; -1.00 ; THE C2B-DOMAIN OF RABPHILIN: STRUCTURAL VARIATIONS IN A JANUS-FACED DOMAIN 1P8X ; 2.00 ; THE CALCIUM-ACTIVATED C-TERMINAL HALF OF GELSOLIN 1AVM ; 1.55 ; THE CAMBIALISTIC SUPEROXIDE DISMUTASE (FE-SOD) OF P. SHERMANII COORDINATED BY AZIDE 1HW5 ; 1.82 ; THE CAP/CRP VARIANT T127L/S128A 2PAW ; 2.30 ; THE CATALYTIC FRAGMENT OF POLY(ADP-RIBOSE) POLYMERASE 1PAX ; 2.40 ; THE CATALYTIC FRAGMENT OF POLY(ADP-RIBOSE) POLYMERASE COMPLEXED WITH 3,4-DIHYDRO-5-METHYL-ISOQUINOLINONE 3PAX ; 2.40 ; THE CATALYTIC FRAGMENT OF POLY(ADP-RIBOSE) POLYMERASE COMPLEXED WITH 3-METHOXYBENZAMIDE 2PAX ; 2.40 ; THE CATALYTIC FRAGMENT OF POLY(ADP-RIBOSE) POLYMERASE COMPLEXED WITH 4-AMINO-1,8-NAPHTHALIMIDE 4PAX ; 2.80 ; THE CATALYTIC FRAGMENT OF POLY(ADP-RIBOSE) POLYMERASE COMPLEXED WITH 8-HYDROXY-2-METHYL-3-HYDRO-QUINAZOLIN-4-ONE 1A26 ; 2.25 ; THE CATALYTIC FRAGMENT OF POLY(ADP-RIBOSE) POLYMERASE COMPLEXED WITH CARBA-NAD 1QL6 ; 2.40 ; THE CATALYTIC MECHANISM OF PHOSPHORYLASE KINASE PROBED BY MUTATIONAL STUDIES 1H46 ; 1.52 ; THE CATALYTIC MODULE OF CEL7D FROM PHANEROCHAETE CHRYSOSPORIUM AS A CHIRAL SELECTOR: STRUCTURAL STUDIES OF ITS COMPLEX WITH THE B-BLOCKER (R)-PROPRANOLOL 1Q8T ; 2.00 ; THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE (PKA) IN COMPLEX WITH RHO-KINASE INHIBITOR Y-27632 1Q8W ; 2.20 ; THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE IN COMPLEX WITH RHO-KINASE INHIBITOR FASUDIL (HA-1077) 1Q8U ; 1.90 ; THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE IN COMPLEX WITH RHO-KINASE INHIBITOR H-1152P 1YMG ; 2.24 ; THE CHANNEL ARCHITECTURE OF AQUAPORIN O AT 2.2 ANGSTROM RESOLUTION 1NYJ ; -1.00 ; THE CLOSED STATE STRUCTURE OF M2 PROTEIN H+ CHANNEL BY SOLID STATE NMR SPECTROSCOPY 1PJS ; 2.40 ; THE CO-CRYSTAL STRUCTURE OF CYSG, THE MULTIFUNCTIONAL METHYLTRANSFERASE/DEHYDROGENASE/FERROCHELATASE FOR SIROHEME SYNTHESIS, IN COMPLEX WITH IT NAD COFACTOR 1MKW ; 2.30 ; THE CO-CRYSTAL STRUCTURE OF UNLIGANDED BOVINE ALPHA-THROMBIN AND PRETHROMBIN-2: MOVEMENT OF THE YPPW SEGMENT AND ACTIVE SITE RESIDUES UPON LIGAND BINDING 1MKX ; 2.20 ; THE CO-CRYSTAL STRUCTURE OF UNLIGANDED BOVINE ALPHA-THROMBIN AND PRETHROMBIN-2: MOVEMENT OF THE YPPW SEGMENT AND ACTIVE SITE RESIDUES UPON LIGAND BINDING 1O9M ; 2.40 ; THE COMPLEX OF A NOVEL ANTIBIOTIC WITH THE AMINOACYL SITE OF THE BACTERIAL RIBOSOME REVEALED BY X-RAY CRYSTALLOGRAPHY. 2PCF ; -1.00 ; THE COMPLEX OF CYTOCHROME F AND PLASTOCYANIN DETERMINED WITH PARAMAGNETIC NMR. BASED ON THE STRUCTURES OF CYTOCHROME F AND PLASTOCYANIN, 10 STRUCTURES 1UWJ ; 3.50 ; THE COMPLEX OF MUTANT V599E B-RAF AND BAY439006 1TU2 ; -1.00 ; THE COMPLEX OF NOSTOC CYTOCHROME F AND PLASTOCYANIN DETERMIN WITH PARAMAGNETIC NMR. BASED ON THE STRUCTURES OF CYTOCHROME F AND PLASTOCYANIN, 10 STRUCTURES 1CQF ; 2.20 ; THE COMPLEX OF THE MUTATED SHIGA TOXIN B SUBUNIT AND GB3 TRISACCHARIDE 1UWH ; 2.95 ; THE COMPLEX OF WILD TYPE B-RAF AND BAY439006 1NVS ; 1.80 ; THE COMPLEX STRUCTURE OF CHECKPOINT KINASE CHK1/SB218078 1NVR ; 1.80 ; THE COMPLEX STRUCTURE OF CHECKPOINT KINASE CHK1/STAUROSPORINE 1NVQ ; 2.00 ; THE COMPLEX STRUCTURE OF CHECKPOINT KINASE CHK1/UCN-01 4ERK ; 2.20 ; THE COMPLEX STRUCTURE OF THE MAP KINASE ERK2/OLOMOUCINE 3ERK ; 2.10 ; THE COMPLEX STRUCTURE OF THE MAP KINASE ERK2/SB220025 1A9U ; 2.50 ; THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB203580 1BL6 ; 2.50 ; THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB216995 1BMK ; 2.40 ; THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB218655 1BL7 ; 2.50 ; THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB220025 1WR1 ; -1.00 ; THE COMPLEX STURCTURE OF DSK2P UBA WITH UBIQUITIN 1JNV ; 4.40 ; THE CONFORMATION OF THE EPSILON AND GAMMA SUBUNITS WITHIN THE E. COLI F1 ATPASE 1COO ; -1.00 ; THE COOH-TERMINAL DOMAIN OF RIBONUCLEIC ACID POLYMERASE ALPHA SUBUNIT 1UB7 ; 2.30 ; THE CRYSTAL ANALYSIS OF BETA-KEROACYL-[ACYL CARRIER PROTEIN] SYNTHASE III (FABH)FROM THERMUS THERMOPHILUS. 1KP0 ; 2.70 ; THE CRYSTAL STRUCTURE ANALYSIS OF CREATINE AMIDINOHYDROLASE FROM ACTINOBACILLUS 233D ; 2.40 ; THE CRYSTAL STRUCTURE ANALYSIS OF D(CGCGAASSCGCG)2: A SYNTHETIC DEOXYRIBONUCLEIC ACID DODECAMER DUPLEX CONTAINING FOUR 4'-THIO-2'-DEOXYTHYMIDINE NUCLEOTIDES 1EW6 ; 1.78 ; THE CRYSTAL STRUCTURE AND AMINO ACID SEQUENCE OF DEHALOPEROXIDASE FROM AMPHITRITE ORNATA INDICATE COMMON ANCESTRY WITH GLOBINS 1L1Y ; 2.40 ; THE CRYSTAL STRUCTURE AND CATALYTIC MECHANISM OF CELLOBIOHYDROLASE CELS, THE MAJOR ENZYMATIC COMPONENT OF THE CLOSTRIDIUM THERMOCELLUM CELLULOSOME 1L2A ; 2.50 ; THE CRYSTAL STRUCTURE AND CATALYTIC MECHANISM OF CELLOBIOHYDROLASE CELS, THE MAJOR ENZYMATIC COMPONENT OF THE CLOSTRIDIUM THERMOCELLUM CELLULOSOME 1SIQ ; 2.10 ; THE CRYSTAL STRUCTURE AND MECHANISM OF HUMAN GLUTARYL-COA DEHYDROGENASE 1SIR ; 2.60 ; THE CRYSTAL STRUCTURE AND MECHANISM OF HUMAN GLUTARYL-COA DEHYDROGENASE 1KOH ; 3.80 ; THE CRYSTAL STRUCTURE AND MUTATIONAL ANALYSIS OF A NOVEL RIBONUCLEIC ACID-BINDING DOMAIN FOUND IN THE HUMAN TAP NUCLEAR MRNA EXPORT FACTOR 1KOO ; 3.80 ; THE CRYSTAL STRUCTURE AND MUTATIONAL ANALYSIS OF A NOVEL RIBONUCLEIC ACID-BINDING DOMAIN FOUND IN THE HUMAN TAP NUCLEAR MRNA EXPORT FACTOR 1AM5 ; 2.16 ; THE CRYSTAL STRUCTURE AND PROPOSED AMINO ACID SEQUENCE OF A PEPSIN FROM ATLANTIC COD (GADUS MORHUA) 1PS9 ; 2.20 ; THE CRYSTAL STRUCTURE AND REACTION MECHANISM OF E. COLI 2,4- DIENOYL COA REDUCTASE 1QI7 ; 2.00 ; THE CRYSTAL STRUCTURE AT 2.0 A OF SAPORIN SO6, A RIBOSOME INACTIVATING PROTEIN FROM SAPONARIA OFFICINALIS 1IC1 ; 3.00 ; THE CRYSTAL STRUCTURE FOR THE N-TERMINAL TWO DOMAINS OF ICAM-1 1YZ5 ; 2.80 ; THE CRYSTAL STRUCTURE OF 14-3-3-SIGMA AT 2.8 ANGSTROM RESOLUTION 1Q74 ; 1.70 ; THE CRYSTAL STRUCTURE OF 1D-MYO-INOSITYL 2-ACETAMIDO-2- DEOXY-ALPHA-D-GLUCOPYRANOSIDE DEACETYLASE (MSHB) 1FJH ; 1.68 ; THE CRYSTAL STRUCTURE OF 3-ALPHA-HYDROXYSTEROID DEHYDROGENASE FROM COMAMONAS TESTOSTERONI, A MEMBER OF THE SHORT CHAIN DEHYDROGENASE/REDUCTASE FAMILY 1V53 ; 2.85 ; THE CRYSTAL STRUCTURE OF 3-ISOPROPYLMALATE DEHYDROGENASE FROM BACILLUS COAGULANS 1SYX ; 2.35 ; THE CRYSTAL STRUCTURE OF A BINARY U5 SNRNP COMPLEX 1XHM ; 2.70 ; THE CRYSTAL STRUCTURE OF A BIOLOGICALLY ACTIVE PEPTIDE (SIGK) BOUND TO A G PROTEIN BETA:GAMMA HETERODIMER 1W2Y ; 1.65 ; THE CRYSTAL STRUCTURE OF A COMPLEX OF CAMPYLOBACTER JEJUNI DUTPASE WITH SUBSTRATE ANALOGUE DUPNHP 1C28 ; 2.10 ; THE CRYSTAL STRUCTURE OF A COMPLMENT-1Q FAMILY PROTEIN SUGGESTS AN EVOLUTIONARY LINK TO TUMOR NECROSIS FACTOR 1NR8 ; 1.66 ; THE CRYSTAL STRUCTURE OF A D-LYSINE-BASED CHIRAL PNA-DEOXYRIBONUCLEIC ACID DUPLEX 1I8F ; 1.75 ; THE CRYSTAL STRUCTURE OF A HEPTAMERIC ARCHAEAL SM PROTEIN: IMPLICATIONS FOR THE EUKARYOTIC SNRNP CORE 1WT5 ; 2.10 ; THE CRYSTAL STRUCTURE OF A HUMANIZED ANTIBODY FV 528 1JJI ; 2.20 ; THE CRYSTAL STRUCTURE OF A HYPER-THERMOPHILIC CARBOXYLESTERASE FROM THE ARCHAEON ARCHAEOGLOBUS FULGIDUS 1MG6 ; 1.60 ; THE CRYSTAL STRUCTURE OF A K49 PLA2 FROM THE SNAKE VENOM OF AGKISTRODON ACUTUS 1P9P ; 2.50 ; THE CRYSTAL STRUCTURE OF A M1G37 TRNA METHYLTRANSFERASE, TRMD 1CZ7 ; 2.90 ; THE CRYSTAL STRUCTURE OF A MINUS-END DIRECTED MICROTUBULE MOTOR PROTEIN NCD REVEALS VARIABLE DIMER CONFORMATIONS 1LY8 ; 2.05 ; THE CRYSTAL STRUCTURE OF A MUTANT ENZYME OF COPRINUS CINEREUS PEROXIDASE PROVIDES AN UNDERSTANDING OF ITS INCREASED THERMOSTABILITY AND INSIGHT INTO MODELLING OF PROTEIN STRUCTURES 1XRF ; 1.65 ; THE CRYSTAL STRUCTURE OF A NOVEL, LATENT DIHYDROOROTASE FROM AQUIFEX AEOLICUS AT 1.7 A RESOLUTION 1XRT ; 1.61 ; THE CRYSTAL STRUCTURE OF A NOVEL, LATENT DIHYDROOROTASE FROM AQUIFEX AEOLICUS AT 1.7 A RESOLUTION 352D ; 0.95 ; THE CRYSTAL STRUCTURE OF A PARALLEL-STRANDED PARALLEL-STRANDED GUANINE TETRAPLEX AT 0.95 ANGSTROM RESOLUTION 1YMP ; 2.20 ; THE CRYSTAL STRUCTURE OF A PARTIAL MOUSE NOTCH-1 ANKYRIN DOMAIN: REPEATS 4 THROUGH 7 PRESERVE AN ANKYRIN FOLD 1P28 ; 1.70 ; THE CRYSTAL STRUCTURE OF A PHEROMONE BINDING PROTEIN FROM THE COCKROACH LEUCOPHAEA MADERAE IN COMPLEX WITH A COMPONENT OF THE PHEROMONAL BLEND: 3-HYDROXY-BUTAN-2-ONE. 1ORG ; 1.70 ; THE CRYSTAL STRUCTURE OF A PHEROMONE BINDING PROTEIN FROM THE COCKROACH LEUCOPHAEA MADERAE REVEALS A NEW MECHANISM OF PHEROMONE BINDING 2PHK ; 2.60 ; THE CRYSTAL STRUCTURE OF A PHOSPHORYLASE KINASE PEPTIDE SUBSTRATE COMPLEX: KINASE SUBSTRATE RECOGNITION 1QPS ; 2.50 ; THE CRYSTAL STRUCTURE OF A POST-REACTIVE COGNATE DEOXYRIBONUCLEIC ACID-ECO RI COMPLEX AT 2.50 A IN THE PRESENCE OF MN2+ ION 1U7E ; 2.00 ; THE CRYSTAL STRUCTURE OF A PROTEIN KINASE A COMPLEX 1NEZ ; 2.10 ; THE CRYSTAL STRUCTURE OF A TL/CD8AA COMPLEX AT 2.1A RESOLUTION:IMPLICATIONS FOR MEMORY T CELL GENERATION, CO- RECEPTOR PREFERENCE AND AFFINITY 1R6X ; 1.40 ; THE CRYSTAL STRUCTURE OF A TRUNCATED FORM OF YEAST ATP SULFURYLASE, LACKING THE C-TERMINAL APS KINASE-LIKE DOMAIN, IN COMPLEX WITH SULFATE 1UN6 ; 3.10 ; THE CRYSTAL STRUCTURE OF A ZINC FINGER - RIBONUCLEIC ACID COMPLEX REVEALS TWO MODES OF MOLECULAR RECOGNITION 1U6M ; 2.40 ; THE CRYSTAL STRUCTURE OF ACETYLTRANSFERASE 1DOF ; 2.10 ; THE CRYSTAL STRUCTURE OF ADENYLOSUCCINATE LYASE FROM PYROBACULUM AEROPHILUM: INSIGHTS INTO THERMAL STABILITY AND HUMAN PATHOLOGY 1EQ2 ; 2.00 ; THE CRYSTAL STRUCTURE OF ADP-L-GLYCERO-D-MANNOHEPTOSE 6- EPIMERASE 1YFS ; 2.08 ; THE CRYSTAL STRUCTURE OF ALANYL-TRNA SYNTHETASE IN COMPLEX WITH L-ALANINE 1MQR ; 2.00 ; THE CRYSTAL STRUCTURE OF ALPHA-D-GLUCURONIDASE (E386Q) FROM BACILLUS STEAROTHERMOPHILUS T-6 1MQQ ; 1.65 ; THE CRYSTAL STRUCTURE OF ALPHA-D-GLUCURONIDASE FROM BACILLUS STEAROTHERMOPHILUS T-1 COMPLEXED WITH GLUCURONIC ACID 1MQP ; 1.90 ; THE CRYSTAL STRUCTURE OF ALPHA-D-GLUCURONIDASE FROM BACILLUS STEAROTHERMOPHILUS T-6 4THN ; 2.50 ; THE CRYSTAL STRUCTURE OF ALPHA-THROMBIN-HIRUNORM IV COMPLEX REVEALS A NOVEL SPECIFICITY SITE RECOGNITION MODE. 1K0E ; 2.00 ; THE CRYSTAL STRUCTURE OF AMINODEOXYCHORISMATE SYNTHASE FROM FORMATE GROWN CRYSTALS 1K0G ; 2.05 ; THE CRYSTAL STRUCTURE OF AMINODEOXYCHORISMATE SYNTHASE FROM PHOSPHATE GROWN CRYSTALS 1Y7E ; 3.20 ; THE CRYSTAL STRUCTURE OF AMINOPEPTIDASE I FROM BORRELIA BURGDORFERI B31 1PTW ; 2.30 ; THE CRYSTAL STRUCTURE OF AMP-BOUND PDE4 SUGGESTS A MECHANISM FOR PHOSPHODIESTERASE CATALYSIS 1ZR6 ; 1.55 ; THE CRYSTAL STRUCTURE OF AN ACREMONIUM STRICTUM GLUCOOLIGOSACCHARIDE OXIDASE REVEALS A NOVEL FLAVINYLATION 1HQT ; 2.20 ; THE CRYSTAL STRUCTURE OF AN ALDEHYDE REDUCTASE Y50F MUTANT- NADP COMPLEX AND ITS IMPLICATIONS FOR SUBSTRATE BINDING 1MME ; 3.10 ; THE CRYSTAL STRUCTURE OF AN ALL-RIBONUCLEIC ACID HAMMERHEAD RIBOZYME A PROPOSED MECHANISM FOR RIBONUCLEIC ACID CATALYTIC CLEAVAGE 1PY9 ; 1.80 ; THE CRYSTAL STRUCTURE OF AN AUTOANTIGEN IN MULTIPLE SCLEROSIS 1B0X ; 2.00 ; THE CRYSTAL STRUCTURE OF AN EPH RECEPTOR SAM DOMAIN REVEALS A MECHANISM FOR MODULAR DIMERIZATION. 1PSK ; 2.80 ; THE CRYSTAL STRUCTURE OF AN FAB FRAGMENT THAT BINDS TO THE MELANOMA-ASSOCIATED GD2 GANGLIOSIDE 1HLO ; 2.80 ; THE CRYSTAL STRUCTURE OF AN INTACT HUMAN MAX-DEOXYRIBONUCLEIC ACID COMPLEX: NEW INSIGHTS INTO MECHANISMS OF TRANSCRIPTIONAL CONTROL 1T2Q ; 1.83 ; THE CRYSTAL STRUCTURE OF AN NNA7 FAB THAT RECOGNIZES AN N- TYPE BLOOD GROUP ANTIGEN 333D ; 2.52 ; THE CRYSTAL STRUCTURE OF AN RIBONUCLEIC ACID OLIGOMER INCORPORATING TANDEM ADENOSINE-INOSINE MISMATCHES 1JB8 ; 2.38 ; THE CRYSTAL STRUCTURE OF AN RIBONUCLEIC ACID/DEOXYRIBONUCLEIC ACID HYBRID REVEALS NOVEL INTERMOLECULAR INTERCALATION 1JRI ; 2.80 ; THE CRYSTAL STRUCTURE OF AN SM-LIKE ARCHAEAL PROTEIN WITH TWO HEPTAMERS IN THE ASYMMETRIC UNIT. 1BIT ; 1.83 ; THE CRYSTAL STRUCTURE OF ANIONIC SALMON TRYPSIN IN A SECOND CRYSTAL FORM 1BZX ; 2.10 ; THE CRYSTAL STRUCTURE OF ANIONIC SALMON TRYPSIN IN COMPLEX WITH BOVINE PANCREATIC TRYPSIN INHIBITOR 1QDL ; 2.50 ; THE CRYSTAL STRUCTURE OF ANTHRANILATE SYNTHASE FROM SULFOLOBUS SOLFATARICUS 1J05 ; 1.50 ; THE CRYSTAL STRUCTURE OF ANTI-CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY T84.66 FV FRAGMENT 1XU2 ; 2.35 ; THE CRYSTAL STRUCTURE OF APRIL BOUND TO BCMA 1XU1 ; 1.90 ; THE CRYSTAL STRUCTURE OF APRIL BOUND TO TACI 1IUG ; 2.20 ; THE CRYSTAL STRUCTURE OF ASPARTATE AMINOTRANSFERASE WHICH BELONGS TO SUBGROUP IV FROM THERMUS THERMOPHILUS 1OQC ; 1.80 ; THE CRYSTAL STRUCTURE OF AUGMENTER OF LIVER REGENERATION: A MAMMALIAN FAD DEPENDENT SULFHYDRYL OXIDASE 1V4B ; 1.80 ; THE CRYSTAL STRUCTURE OF AZOR (AZO REDUCTASE) FROM ESCHERICHIA COLI: OXIDIZED FORM 1FEZ ; 3.00 ; THE CRYSTAL STRUCTURE OF BACILLUS CEREUS PHOSPHONOACETALDEHYDE HYDROLASE COMPLEXED WITH TUNGSTATE, A PRODUCT ANALOG 1I6W ; 1.50 ; THE CRYSTAL STRUCTURE OF BACILLUS SUBTILIS LIPASE: A MINIMAL ALPHA/BETA HYDROLASE ENZYME 1GD8 ; 2.30 ; THE CRYSTAL STRUCTURE OF BACTERIA-SPECIFIC L17 RIBOSOMAL PROTEIN. 1V18 ; 2.10 ; THE CRYSTAL STRUCTURE OF BETA-CATENIN ARMADILLO REPEAT COMPLEXED WITH A PHOSPHORYLATED APC 20MER REPEAT. 1OX0 ; 1.30 ; THE CRYSTAL STRUCTURE OF BETA-KETOACYL-[ACYL CARRIER PROTEIN] SYNTHASE II FROM STREPTOCOCCUS PNEUMONIAE 1OXH ; 2.09 ; THE CRYSTAL STRUCTURE OF BETA-KETOACYL-[ACYL CARRIER PROTEIN] SYNTHASE II FROM STREPTOCOCCUS PNEUMONIAE, TRICLINIC FORM 1R30 ; 3.40 ; THE CRYSTAL STRUCTURE OF BIOTIN SYNTHASE, AN S- ADENOSYLMETHIONINE-DEPENDENT RADICAL ENZYME 1TGU ; 2.80 ; THE CRYSTAL STRUCTURE OF BOVINE LIVER CATALASE WITHOUT NADPH 1OJQ ; 1.68 ; THE CRYSTAL STRUCTURE OF C3STAU2 FROM S. AUREUS 1OJZ ; 2.02 ; THE CRYSTAL STRUCTURE OF C3STAU2 FROM S. AUREUS IN WITH NAD 1J55 ; 2.00 ; THE CRYSTAL STRUCTURE OF CA+-BOUND HUMAN S100P DETERMINED AT 2.0A RESOLUTION BY X-RAY 2CT9 ; 2.20 ; THE CRYSTAL STRUCTURE OF CALCINEURIN B HOMOLOGOUS PROEIN 1 (CHP1) 1D0N ; 2.50 ; THE CRYSTAL STRUCTURE OF CALCIUM-FREE EQUINE PLASMA GELSOLIN. 1NX4 ; 2.40 ; THE CRYSTAL STRUCTURE OF CARBAPENEM SYNTHASE (CARC) 1XHN ; 1.95 ; THE CRYSTAL STRUCTURE OF CELLULAR REPRESSOR OF E1A- STIMULATED GENES (CREG) 1VGK ; 2.06 ; THE CRYSTAL STRUCTURE OF CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX, H-2KD AT 2.0 A RESOLUTION 1KHY ; 1.95 ; THE CRYSTAL STRUCTURE OF CLPB N TERMINAL DOMAIN, IMPLICATION TO THE PEPTIDE BINDING FUNCTION OF CLPB 1L4F ; 2.10 ; THE CRYSTAL STRUCTURE OF COBT COMPLEXED WITH 4,5-DIMETHYL-1, 2-PHENYLENEDIAMINE AND NICOTINATE MONONUCLEOTIDE 1L4E ; 2.00 ; THE CRYSTAL STRUCTURE OF COBT COMPLEXED WITH ALPHA-RIBAZOLE- 5'-PHOSPHATE 2A9S ; 1.75 ; THE CRYSTAL STRUCTURE OF COMPETENCE/DAMAGE INDUCIBLE PROTEIN CIHA FROM AGROBACTERIUM TUMEFACIENS 1Z7S ; 3.20 ; THE CRYSTAL STRUCTURE OF COXSACKIEVIRUS A21 1D4M ; 2.90 ; THE CRYSTAL STRUCTURE OF COXSACKIEVIRUS A9 TO 2.9 A RESOLUTION 1R5T ; 2.00 ; THE CRYSTAL STRUCTURE OF CYTIDINE DEAMINASE CDD1, AN ORPHAN C TO U EDITASE FROM YEAST 1UMO ; 2.59 ; THE CRYSTAL STRUCTURE OF CYTOGLOBIN: THE FOURTH GLOBIN TYPE DISCOVERED IN AMN 1OMK ; 1.30 ; THE CRYSTAL STRUCTURE OF D(CACG(5IU)G) 1JTL ; 1.85 ; THE CRYSTAL STRUCTURE OF D(GGCCAATTGG) COMPLEXED WITH DISTAMYCIN 1K2Z ; 2.38 ; THE CRYSTAL STRUCTURE OF D(GGCCAATTGG) COMPLEXED WITH DISTAMYCIN. 5ANA ; 2.25 ; THE CRYSTAL STRUCTURE OF D(GTACGTAC) AT 2.25 ANGSTROMS RESOLUTION. ARE THE A-DEOXYRIBONUCLEIC ACID(APOSTROPHE)S ALWAYS UNWOUND APPROXIMATELY 10 DEGREES AT THE C-G STEPS 2D83 ; 2.10 ; THE CRYSTAL STRUCTURE OF D-AMINO ACID AMIDASE FROM OCHROBACTRUM ANTHROPI SV3 1H76 ; 2.15 ; THE CRYSTAL STRUCTURE OF DIFERRIC PORCINE SERUM TRANSFERRIN 1ZY8 ; 2.59 ; THE CRYSTAL STRUCTURE OF DIHYDROLIPOAMIDE DEHYDROGENASE AND DIHYDROLIPOAMIDE DEHYDROGENASE-BINDING PROTEIN (DIDOMAIN) SUBCOMPLEX OF HUMAN PYRUVATE DEHYDROGENASE COMPLEX. 1UCF ; 1.95 ; THE CRYSTAL STRUCTURE OF DJ-1, A PROTEIN RELATED TO MALE FERTILITY AND PARKINSON'S DISEASE 1DPS ; 1.60 ; THE CRYSTAL STRUCTURE OF DPS, A FERRITIN HOMOLOG THAT BINDS AND PROTECTS DEOXYRIBONUCLEIC ACID 1NLQ ; 1.50 ; THE CRYSTAL STRUCTURE OF DROSOPHILA NLP-CORE PROVIDES INSIGHT INTO PENTAMER FORMATION AND HISTONE BINDING 1KEU ; 2.40 ; THE CRYSTAL STRUCTURE OF DTDP-D-GLUCOSE 4,6-DEHYDRATASE (RMLB) FROM SALMONELLA ENTERICA SEROVAR TYPHIMURIUM WITH DTDP-D-GLUCOSE BOUND 1KEW ; 1.80 ; THE CRYSTAL STRUCTURE OF DTDP-D-GLUCOSE 4,6-DEHYDRATASE (RMLB) FROM SALMONELLA ENTERICA SEROVAR TYPHIMURIUM WITH THYMIDINE DIPHOSPHATE BOUND 1KER ; 2.20 ; THE CRYSTAL STRUCTURE OF DTDP-D-GLUCOSE 4,6-DEHYDRATASE (RMLB) FROM STREPTOCOCCUS SUIS WITH DTDP-D-GLUCOSE BOUND 1KEP ; 1.80 ; THE CRYSTAL STRUCTURE OF DTDP-D-GLUCOSE 4,6-DEHYDRATASE (RMLB) FROM STREPTOCOCCUS SUIS WITH DTDP-XYLOSE BOUND 1KET ; 1.80 ; THE CRYSTAL STRUCTURE OF DTDP-D-GLUCOSE 4,6-DEHYDRATASE (RMLB) FROM STREPTOCOCCUS SUIS WITH THYMIDINE DIPHOSPHATE BOUND 1G1A ; 2.47 ; THE CRYSTAL STRUCTURE OF DTDP-D-GLUCOSE 4,6-DEHYDRATASE (RMLB)FROM SALMONELLA ENTERICA SEROVAR TYPHIMURIUM 1ETV ; 2.00 ; THE CRYSTAL STRUCTURE OF E. COLI FIS MUTANT G72A 1ETW ; 2.00 ; THE CRYSTAL STRUCTURE OF E. COLI FIS MUTANT G72D 1ETK ; 2.10 ; THE CRYSTAL STRUCTURE OF E. COLI FIS MUTANT Q68A 1ETX ; 1.90 ; THE CRYSTAL STRUCTURE OF E. COLI FIS MUTANT Q74A 1ETO ; 1.90 ; THE CRYSTAL STRUCTURE OF E. COLI FIS MUTANT R71L 1ETQ ; 2.80 ; THE CRYSTAL STRUCTURE OF E. COLI FIS MUTANT R71Y 1SQF ; 2.10 ; THE CRYSTAL STRUCTURE OF E. COLI FMU BINARY COMPLEX WITH S- ADENOSYLMETHIONINE AT 2.1 A RESOLUTION 1OH5 ; 2.90 ; THE CRYSTAL STRUCTURE OF E. COLI MUTS BINDING TO DEOXYRIBONUCLEIC ACID WITH A C:A MISMATCH 1OH7 ; 2.50 ; THE CRYSTAL STRUCTURE OF E. COLI MUTS BINDING TO DEOXYRIBONUCLEIC ACID WITH A G:G MISMATCH 1E3M ; 2.20 ; THE CRYSTAL STRUCTURE OF E. COLI MUTS BINDING TO DEOXYRIBONUCLEIC ACID WITH A G:T MISMATCH 1OH6 ; 2.40 ; THE CRYSTAL STRUCTURE OF E. COLI MUTS BINDING TO DEOXYRIBONUCLEIC ACID WITH AN A:A MISMATCH 1OH8 ; 2.90 ; THE CRYSTAL STRUCTURE OF E. COLI MUTS BINDING TO DEOXYRIBONUCLEIC ACID WITH AN UNPAIRED THYMIDINE 1DJ0 ; 1.50 ; THE CRYSTAL STRUCTURE OF E. COLI PSEUDOURIDINE SYNTHASE I AT 1.5 ANGSTROM RESOLUTION 1ETY ; 2.00 ; THE CRYSTAL STRUCTURE OF E. COLI WILD-TYPE FIS 1G2A ; 1.75 ; THE CRYSTAL STRUCTURE OF E.COLI PEPTIDE DEFORMYLASE COMPLEXED WITH ACTINONIN 1O8V ; 1.60 ; THE CRYSTAL STRUCTURE OF ECHINOCOCCUS GRANULOSUS FATTY-ACID-BINDING PROTEIN 1 1G87 ; 1.60 ; THE CRYSTAL STRUCTURE OF ENDOGLUCANASE 9G FROM CLOSTRIDIUM CELLULOLYTICUM 1GA2 ; 1.70 ; THE CRYSTAL STRUCTURE OF ENDOGLUCANASE 9G FROM CLOSTRIDIUM CELLULOLYTICUM COMPLEXED WITH CELLOBIOSE 1W7P ; 3.60 ; THE CRYSTAL STRUCTURE OF ENDOSOMAL COMPLEX ESCRT-II (VPS22/VPS25/VPS36) 2C7B ; 2.30 ; THE CRYSTAL STRUCTURE OF ESTE1, A NEW THERMOPHILIC AND THERMOSTABLE CARBOXYLESTERASE CLONED FROM A METAGENOMIC LIBRARY 1G24 ; 1.70 ; THE CRYSTAL STRUCTURE OF EXOENZYME C3 FROM CLOSTRIDIUM BOTULINUM 1YCP ; 2.50 ; THE CRYSTAL STRUCTURE OF FIBRINOGEN-AA PEPTIDE 1-23 (F8Y) BOUND TO BOVINE THROMBIN EXPLAINS WHY THE MUTATION OF PHE-8 TO TYROSINE STRONGLY INHIBITS NORMAL CLEAVAGE AT ARGININE-16 1QQK ; 3.10 ; THE CRYSTAL STRUCTURE OF FIBROBLAST GROWTH FACTOR 7 (KERATINOCYTE GROWTH FACTOR) 1QQL ; 2.30 ; THE CRYSTAL STRUCTURE OF FIBROBLAST GROWTH FACTOR 7/1 CHIMERA 1F36 ; 2.65 ; THE CRYSTAL STRUCTURE OF FIS MUTANT K36E REVEALS THAT THE TRANSACTIVATION REGION OF THE FIS PROTEIN CONTAINS EXTENDED MOBILE BETA-HAIRPIN ARMS 1EG7 ; 2.50 ; THE CRYSTAL STRUCTURE OF FORMYLTETRAHYDROFOLATE SYNTHETASE FROM MOORELLA THERMOACETICA 1Q8D ; 1.80 ; THE CRYSTAL STRUCTURE OF GDNF FAMILY CO-RECEPTOR ALPHA 1 DOMAIN 3 1KXJ ; 2.80 ; THE CRYSTAL STRUCTURE OF GLUTAMINE AMIDOTRANSFERASE FROM THERMOTOGA MARITIMA 1OBF ; 1.70 ; THE CRYSTAL STRUCTURE OF GLYCERALDEHYDE 3-PHOSPHATE DEHYDROGENASE FROM ALCALIGENES XYLOSOXIDANS AT 1.7 RESOLUTION. 1BII ; 2.40 ; THE CRYSTAL STRUCTURE OF H-2DD MHC CLASS I IN COMPLEX WITH THE HIV-1 DERIVED PEPTIDE P18-110 1SHY ; 3.22 ; THE CRYSTAL STRUCTURE OF HGF BETA-CHAIN IN COMPLEX WITH THE SEMA DOMAIN OF THE MET RECEPTOR. 1NLT ; 2.70 ; THE CRYSTAL STRUCTURE OF HSP40 YDJ1 1X6V ; 1.75 ; THE CRYSTAL STRUCTURE OF HUMAN 3'-PHOSPHOADENOSINE-5'- PHOSPHOSULFATE SYNTHETASE 1 1X9P ; 3.30 ; THE CRYSTAL STRUCTURE OF HUMAN ADENOVIRUS 2 PENTON BASE 1X9T ; 3.50 ; THE CRYSTAL STRUCTURE OF HUMAN ADENOVIRUS 2 PENTON BASE IN COMPLEX WITH AN AD2 N-TERMINAL FIBRE PEPTIDE 1H0C ; 2.50 ; THE CRYSTAL STRUCTURE OF HUMAN ALANINE:GLYOXYLATE AMINOTRANSFERASE 2CY7 ; 1.90 ; THE CRYSTAL STRUCTURE OF HUMAN ATG4B 1CI4 ; 1.90 ; THE CRYSTAL STRUCTURE OF HUMAN BARRIER-TO-AUTOINTEGRATION FACTOR (BAF) 1UQS ; 3.10 ; THE CRYSTAL STRUCTURE OF HUMAN CD1B WITH A BOUND BACTERIAL GLYCOLIPID 1ZT4 ; 3.00 ; THE CRYSTAL STRUCTURE OF HUMAN CD1D WITH AND WITHOUT ALPHA- GALACTOSYLCERAMIDE 1VFQ ; 1.90 ; THE CRYSTAL STRUCTURE OF HUMAN COACTOSIN-LIKE PROTEIN AT 1.9 A RESOLUTION 1XGW ; 1.90 ; THE CRYSTAL STRUCTURE OF HUMAN ENTHOPROTIN N-TERMINAL DOMAIN 1DT9 ; 2.70 ; THE CRYSTAL STRUCTURE OF HUMAN EUKARYOTIC RELEASE FACTOR ERF1-MECHANISM OF STOP CODON RECOGNITION AND PEPTIDYL-TRNA HYDROLYSIS 1ZDU ; 2.50 ; THE CRYSTAL STRUCTURE OF HUMAN LIVER RECEPTOR HOMOLOGUE-1 2F6Q ; 1.95 ; THE CRYSTAL STRUCTURE OF HUMAN PEROXISOMAL DELTA3, DELTA2 ENOYL COA ISOMERASE (PECI) 1NUH ; 2.51 ; THE CRYSTAL STRUCTURE OF HUMAN PHOSPHOGLUCOSE ISOMERASE COMPLEXED WITH 5-PHOSPHOARABINONATE 1FZV ; 2.00 ; THE CRYSTAL STRUCTURE OF HUMAN PLACENTA GROWTH FACTOR-1 (PLGF-1), AN ANGIOGENIC PROTEIN AT 2.0A RESOLUTION 1BY8 ; 2.60 ; THE CRYSTAL STRUCTURE OF HUMAN PROCATHEPSIN K 2F7S ; 2.70 ; THE CRYSTAL STRUCTURE OF HUMAN RAB27B BOUND TO GDP 2ATV ; 1.90 ; THE CRYSTAL STRUCTURE OF HUMAN RERG IN THE GDP BOUND STATE 1ODB ; 2.19 ; THE CRYSTAL STRUCTURE OF HUMAN S100A12 - COPPER COMPLEX 1ZDT ; 2.10 ; THE CRYSTAL STRUCTURE OF HUMAN STEROIDOGENIC FACTOR-1 1O6U ; 2.05 ; THE CRYSTAL STRUCTURE OF HUMAN SUPERNATANT PROTEIN FACTOR 1DJL ; 2.00 ; THE CRYSTAL STRUCTURE OF HUMAN TRANSHYDROGENASE DOMAIN III WITH BOUND NADP 1RGU ; 2.22 ; THE CRYSTAL STRUCTURE OF HUMAN TYROSYL-DEOXYRIBONUCLEIC ACID PHOSPHODIESTERASE COMPLEXED WITH VANADATE, OCTOPAMINE, AND TETRANUCLEOTIDE AGTG 1L1S ; 2.30 ; THE CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN MTH1491 FROM METHANOBACTERIUM THERMOAUTOTROPHICUM 1TT7 ; 2.70 ; THE CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN YHFP, CO- CRYSTALLIZED WITH NAD 1U14 ; 1.68 ; THE CRYSTAL STRUCTURE OF HYPOTHETICAL UPF0244 PROTEIN YJJX AT RESOLUTION 1.68 ANGSTROM 1P53 ; 3.06 ; THE CRYSTAL STRUCTURE OF ICAM-1 D3-D5 FRAGMENT 1ZXQ ; 2.20 ; THE CRYSTAL STRUCTURE OF ICAM-2 1O0V ; 2.60 ; THE CRYSTAL STRUCTURE OF IGE FC REVEALS AN ASYMMETRICALLY BENT CONFORMATION 1PMU ; 2.70 ; THE CRYSTAL STRUCTURE OF JNK3 IN COMPLEX WITH A PHENANTROLINE INHIBITOR 1OZG ; 2.30 ; THE CRYSTAL STRUCTURE OF KLEBSIELLA PNEUMONIAE ACETOLACTATE SYNTHASE WITH ENZYME-BOUND COFACTOR AND WITH AN UNUSUAL INTERMEDIATE 1OZH ; 2.00 ; THE CRYSTAL STRUCTURE OF KLEBSIELLA PNEUMONIAE ACETOLACTATE SYNTHASE WITH ENZYME-BOUND COFACTOR AND WITH AN UNUSUAL INTERMEDIATE. 1OZF ; 2.30 ; THE CRYSTAL STRUCTURE OF KLEBSIELLA PNEUMONIAE ACETOLACTATE SYNTHASE WITH ENZYME-BOUND COFACTORS 1MI5 ; 2.50 ; THE CRYSTAL STRUCTURE OF LC13 TCR IN COMPLEX WITH HLAB8-EBV PEPTIDE COMPLEX 1WZ2 ; 3.21 ; THE CRYSTAL STRUCTURE OF LEUCYL-TRNA SYNTHETASE AND TRNA(LEUCINE) COMPLEX 1ELJ ; 1.85 ; THE CRYSTAL STRUCTURE OF LIGANDED MALTODEXTRIN-BINDING PROTEIN FROM PYROCOCCUS FURIOSUS 1XS5 ; 1.85 ; THE CRYSTAL STRUCTURE OF LIPOPROTEIN TP32 FROM TREPONEMA PALLIDUM 1H91 ; 1.40 ; THE CRYSTAL STRUCTURE OF LOBSTER APOCRUSTACYANIN A1 USING SOFTER X-RAYS. 1OCL ; 2.00 ; THE CRYSTAL STRUCTURE OF MALONAMIDASE E2 COMPLEXED WITH MALONATE FROM BRADYRHIZOBIUM JAPONICUM 1OCM ; 1.90 ; THE CRYSTAL STRUCTURE OF MALONAMIDASE E2 COVALENTLY COMPLEXED WITH PYROPHOSPHATE FROM BRADYRHIZOBIUM JAPONICUM 1OCK ; 1.80 ; THE CRYSTAL STRUCTURE OF MALONAMIDASE E2 FROM BRADYRHIZOBIUM JAPONICUM 1RJN ; 2.30 ; THE CRYSTAL STRUCTURE OF MENB (RV0548C) FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH THE COA PORTION OF NAPHTHOYL COA 1QLM ; 2.00 ; THE CRYSTAL STRUCTURE OF METHENYLTETRAHYDROMETHANOPTERIN CYCLOHYDROLASE FROM THE HYPERTHERMOPHILIC ARCHAEON METHANOPYRUS KANDLERI 1EF9 ; 2.70 ; THE CRYSTAL STRUCTURE OF METHYLMALONYL COA DECARBOXYLASE COMPLEXED WITH 2S-CARBOXYPROPYL COA 2C2P ; 1.75 ; THE CRYSTAL STRUCTURE OF MISMATCH SPECIFIC URACIL-DEOXYRIBONUCLEIC ACID GLYCOSYLASE (MUG) FROM DEINOCOCCUS RADIODURANS 2C2Q ; 1.70 ; THE CRYSTAL STRUCTURE OF MISMATCH SPECIFIC URACIL-DEOXYRIBONUCLEIC ACID GLYCOSYLASE (MUG) FROM DEINOCOCCUS RADIODURANS. INACTIVE MUTANT ASP93ALA. 1DEQ ; 3.50 ; THE CRYSTAL STRUCTURE OF MODIFIED BOVINE FIBRINOGEN (AT ~4 ANGSTROM RESOLUTION) 1UZ5 ; 2.05 ; THE CRYSTAL STRUCTURE OF MOLYBDOPTERIN BIOSYNTHESIS MOEA PROTEIN FROM PYROCOCCUS HORIKOSII 1WC8 ; 1.90 ; THE CRYSTAL STRUCTURE OF MOUSE BET3P 1BQS ; 2.20 ; THE CRYSTAL STRUCTURE OF MUCOSAL ADDRESSIN CELL ADHESION MOLECULE-1 (MADCAM-1) 1Y5R ; 3.00 ; THE CRYSTAL STRUCTURE OF MURINE 11B-HYDROXYSTEROID DEHYDROGENASE COMPLEXED WITH CORTICOSTERONE 1Y5M ; 2.30 ; THE CRYSTAL STRUCTURE OF MURINE 11B-HYDROXYSTEROID DEHYDROGENASE: AN IMPORTANT THERAPEUTIC TARGET FOR DIABETES 1U5Z ; 2.40 ; THE CRYSTAL STRUCTURE OF MURINE APRIL, PH 8.5 1QWJ ; 2.80 ; THE CRYSTAL STRUCTURE OF MURINE CMP-5-N-ACETYLNEURAMINIC ACID SYNTHETASE 1DQT ; 2.00 ; THE CRYSTAL STRUCTURE OF MURINE CTLA4 (CD152) 1R7R ; 3.60 ; THE CRYSTAL STRUCTURE OF MURINE P97/VCP AT 3.6A 1R88 ; 1.71 ; THE CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS MPT51 (FBPC1) 1OGL ; 2.40 ; THE CRYSTAL STRUCTURE OF NATIVE TRYPANOSOMA CRUZI DUTPASE 1Y4Z ; 2.00 ; THE CRYSTAL STRUCTURE OF NITRATE REDUCTASE A, NARGHI, IN COMPLEX WITH THE Q-SITE INHIBITOR PENTACHLOROPHENOL 1N70 ; 1.60 ; THE CRYSTAL STRUCTURE OF NITRITE REDUCTASE MUTANT HIS287ALA FROM RHODOBACTER SPHAEROIDES 2BMO ; 1.20 ; THE CRYSTAL STRUCTURE OF NITROBENZENE DIOXYGENASE 2BMR ; 1.50 ; THE CRYSTAL STRUCTURE OF NITROBENZENE DIOXYGENASE IN COMPLEX WITH 3-NITROTOLUENE 2BMQ ; 1.55 ; THE CRYSTAL STRUCTURE OF NITROBENZENE DIOXYGENASE IN COMPLEX WITH NITROBENZENE 1E9L ; 2.50 ; THE CRYSTAL STRUCTURE OF NOVEL MAMMALIAN LECTIN YM1 SUGGESTS A SACCHARIDE BINDING SITE 1K5J ; 2.30 ; THE CRYSTAL STRUCTURE OF NUCLEOPLASMIN-CORE 1EYV ; 1.60 ; THE CRYSTAL STRUCTURE OF NUSB FROM MYCOBACTERIUM TUBERCULOSIS 1JF0 ; 1.82 ; THE CRYSTAL STRUCTURE OF OBELIN FROM OBELIA GENICULATA AT 1.82 A RESOLUTION 1PJA ; 2.70 ; THE CRYSTAL STRUCTURE OF PALMITOYL PROTEIN THIOESTERASE-2 REVEALS THE BASIS FOR DIVERGENT SUBSTRATE SPECIFICITIES OF THE TWO LYSOSOMAL THIOESTERASES (PPT1 AND PPT2) 1V3Y ; 1.81 ; THE CRYSTAL STRUCTURE OF PEPTIDE DEFORMYLASE FROM THERMUS THERMOPHILUS HB8 1OGQ ; 1.70 ; THE CRYSTAL STRUCTURE OF PGIP (POLYGALACTURONASE INHIBITING PROTEIN), A LEUCINE RICH REPEAT PROTEIN INVOLVED IN PLANT DEFENSE 1I4Z ; 2.10 ; THE CRYSTAL STRUCTURE OF PHASCOLOPSIS GOULDII L98Y METHEMERYTHRIN 1I4Y ; 1.80 ; THE CRYSTAL STRUCTURE OF PHASCOLOPSIS GOULDII WILD TYPE METHEMERYTHRIN 1EIY ; 3.30 ; THE CRYSTAL STRUCTURE OF PHENYLALANYL-TRNA SYNTHETASE FROM THERMUS THERMOPHILUS COMPLEXED WITH COGNATE TRNAPHE 1ZXX ; 1.85 ; THE CRYSTAL STRUCTURE OF PHOSPHOFRUCTOKINASE FROM LACTOBACILLUS DELBRUECKII 2PGI ; 2.30 ; THE CRYSTAL STRUCTURE OF PHOSPHOGLUCOSE ISOMERASE - AN ENZYME WITH AUTOCRINE MOTILITY FACTOR ACTIVITY IN TUMOR CELLS 1GZV ; 3.51 ; THE CRYSTAL STRUCTURE OF PHOSPHOGLUCOSE ISOMERASE FROM PIG MUSCLE COMPLEXED WITH 5-PHOSPHOARABINONATE 1N8T ; 2.50 ; THE CRYSTAL STRUCTURE OF PHOSPHOGLUCOSE ISOMERASE FROM RABBIT MUSCLE 1B0Z ; 2.30 ; THE CRYSTAL STRUCTURE OF PHOSPHOGLUCOSE ISOMERASE-AN ENZYME WITH AUTOCRINE MOTILITY FACTOR ACTIVITY IN TUMOR CELLS 1C7Q ; 2.30 ; THE CRYSTAL STRUCTURE OF PHOSPHOGLUCOSE ISOMERASE/AUTOCRINE MOTILITY FACTOR/NEUROLEUKIN COMPLEXED WITH ITS CARBOHYDRATE PHOSPHATE INHIBITORS AND ITS SUBSTRATE RECOGNITION MECHANISM 1C7R ; 2.50 ; THE CRYSTAL STRUCTURE OF PHOSPHOGLUCOSE ISOMERASE/AUTOCRINE MOTILITY FACTOR/NEUROLEUKIN COMPLEXED WITH ITS CARBOHYDRATE PHOSPHATE INHIBITORS AND ITS SUBSTRATE RECOGNITION MECHANISM 1OD6 ; 1.50 ; THE CRYSTAL STRUCTURE OF PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE FROM THERMUS THERMOPHILUS IN COMPLEX WITH 4'-PHOSPHOPANTETHEINE 1XWM ; 2.50 ; THE CRYSTAL STRUCTURE OF PHOU (PHOSPHATE UPTAKE REGULATOR), STRUCTURAL GENOMICS 1WZ3 ; 1.80 ; THE CRYSTAL STRUCTURE OF PLANT ATG12 1OGP ; 2.60 ; THE CRYSTAL STRUCTURE OF PLANT SULFITE OXIDASE PROVIDES INSIGHT INTO SULFITE OXIDATION IN PLANTS AND ANIMALS 2BMA ; 2.70 ; THE CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM GLUTAMATE DEHYDROGENASE, A PUTATIVE TARGET FOR NOVEL ANTIMALARIAL DRUGS 2ESN ; 2.10 ; THE CRYSTAL STRUCTURE OF PROBABLE TRANSCRIPTIONAL REGULATOR PA0477 FROM PSEUDOMONAS AERUGINOSA 1FAZ ; 1.40 ; THE CRYSTAL STRUCTURE OF PROKARYOTIC PHOSPHOLIPASE A2 1VBJ ; 2.10 ; THE CRYSTAL STRUCTURE OF PROSTAGLANDIN F SYNTHASE FROM TRYPANOSOMA BRUCEI 1BRW ; 2.10 ; THE CRYSTAL STRUCTURE OF PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE IN A CLOSED CONFORMATION 1X7N ; 1.89 ; THE CRYSTAL STRUCTURE OF PYROCOCCUS FURIOSUS PHOSPHOGLUCOSE ISOMERASE WITH BOUND 5-PHOSPHO-D-ARABINONATE AND MANGANESE 1W85 ; 2.00 ; THE CRYSTAL STRUCTURE OF PYRUVATE DEHYDROGENASE E1 BOUND TO THE PERIPHERAL SUBUNIT BINDING DOMAIN OF E2 1W88 ; 2.30 ; THE CRYSTAL STRUCTURE OF PYRUVATE DEHYDROGENASE E1(D180N, E183Q) BOUND TO THE PERIPHERAL SUBUNIT BINDING DOMAIN OF E2 1MT1 ; 2.20 ; THE CRYSTAL STRUCTURE OF PYRUVOYL-DEPENDENT ARGININE DECARBOXYLASE FROM METHANOCOCCUS JANNASCHII 1N13 ; 1.40 ; THE CRYSTAL STRUCTURE OF PYRUVOYL-DEPENDENT ARGININE DECARBOXYLASE FROM METHANOCOCCUS JANNASHII 1KD5 ; 1.58 ; THE CRYSTAL STRUCTURE OF R(GGUCACAGCCC)2 METAL FREE FORM 1KD4 ; 1.85 ; THE CRYSTAL STRUCTURE OF R(GGUCACAGCCC)2, BARIUM FORM 1KD3 ; 1.80 ; THE CRYSTAL STRUCTURE OF R(GGUCACAGCCC)2, THALLIUM FORM 1W3S ; 2.40 ; THE CRYSTAL STRUCTURE OF RECO FROM DEINOCOCCUS RADIODURANS. 1PP4 ; 2.50 ; THE CRYSTAL STRUCTURE OF RHAMNOGALACTURONAN ACETYLESTERASE IN SPACE GROUP P3121 1EU1 ; 1.30 ; THE CRYSTAL STRUCTURE OF RHODOBACTER SPHAEROIDES DIMETHYLSULFOXIDE REDUCTASE REVEALS TWO DISTINCT MOLYBDENUM COORDINATION ENVIRONMENTS. 1JN4 ; 1.80 ; THE CRYSTAL STRUCTURE OF RIBONUCLEASE A IN COMPLEX WITH 2'- DEOXYURIDINE 3'-PYROPHOSPHATE (P'-5') ADENOSINE 1BOL ; 2.00 ; THE CRYSTAL STRUCTURE OF RIBONUCLEASE RH FROM RHIZOPUS NIVEUS AT 2.0 A RESOLUTION 1YRG ; 2.66 ; THE CRYSTAL STRUCTURE OF RNA1P: A NEW FOLD FOR A GTPASE- ACTIVATING PROTEIN 1BXN ; 2.70 ; THE CRYSTAL STRUCTURE OF RUBISCO FROM ALCALIGENES EUTROPHUS TO 2.7 ANGSTROMS. 1LBQ ; 2.40 ; THE CRYSTAL STRUCTURE OF SACCHAROMYCES CEREVISIAE FERROCHELATASE 1OXW ; 2.20 ; THE CRYSTAL STRUCTURE OF SEMET PATATIN 1OI7 ; 1.23 ; THE CRYSTAL STRUCTURE OF SUCCINYL-COA SYNTHETASE ALPHA SUBUNIT FROM THERMUS THERMOPHILUS 1J30 ; 1.70 ; THE CRYSTAL STRUCTURE OF SULERYTHRIN, A RUBRERYTHRIN-LIKE PROTEIN FROM A STRICTLY AEROBIC AND THERMOACIDIPHILIC ARCHAEON 1SKQ ; 1.80 ; THE CRYSTAL STRUCTURE OF SULFOLOBUS SOLFATARICUS ELONGATION FACTOR 1-ALPHA IN COMPLEX WITH MAGNESIUM AND GDP 1OOP ; 3.00 ; THE CRYSTAL STRUCTURE OF SWINE VESICULAR DISEASE VIRUS 1NJO ; 3.70 ; THE CRYSTAL STRUCTURE OF THE 50S LARGE RIBOSOMAL SUBUNIT FROM DEINOCOCCUS RADIODURANS COMPLEXED WITH A SHORT SUBSTRATE ANALOG ACCPUROMYCIN (ACCP) 1NJP ; 3.50 ; THE CRYSTAL STRUCTURE OF THE 50S LARGE RIBOSOMAL SUBUNIT FROM DEINOCOCCUS RADIODURANS COMPLEXED WITH A TRNA ACCEPTOR STEM MIMIC (ASM) 1NJM ; 3.60 ; THE CRYSTAL STRUCTURE OF THE 50S LARGE RIBOSOMAL SUBUNIT FROM DEINOCOCCUS RADIODURANS COMPLEXED WITH A TRNA ACCEPTOR STEM MIMIC (ASM) AND THE ANTIBIOTIC SPARSOMYCIN 1P9X ; 3.40 ; THE CRYSTAL STRUCTURE OF THE 50S LARGE RIBOSOMAL SUBUNIT FROM DEINOCOCCUS RADIODURANS COMPLEXED WITH TELITHROMYCIN KETOLIDE ANTIBIOTIC 1NJN ; 3.70 ; THE CRYSTAL STRUCTURE OF THE 50S LARGE RIBOSOMAL SUBUNIT FROM DEINOCOCCUS RADIODURANS COMPLEXED WITH THE ANTIBIOTIC SPARSOMYCIN 1OND ; 3.40 ; THE CRYSTAL STRUCTURE OF THE 50S LARGE RIBOSOMAL SUBUNIT FROM DEINOCOCCUS RADIODURANS COMPLEXED WITH TROLEANDOMYCIN MACROLIDE ANTIBIOTIC 1G7Y ; 2.50 ; THE CRYSTAL STRUCTURE OF THE 58KD VEGETATIVE LECTIN FROM THE TROPICAL LEGUME DOLICHOS BIFLORUS 1V5D ; 1.50 ; THE CRYSTAL STRUCTURE OF THE ACTIVE FORM CHITOSANASE FROM BACILLUS SP. K17 AT PH6.4 1YQV ; 1.70 ; THE CRYSTAL STRUCTURE OF THE ANTIBODY FAB HYHEL5 COMPLEX WITH LYSOZYME AT 1.7A RESOLUTION 1R6Z ; 2.80 ; THE CRYSTAL STRUCTURE OF THE ARGONAUTE2 PAZ DOMAIN (AS A MBP FUSION) 1W2E ; 2.80 ; THE CRYSTAL STRUCTURE OF THE BACTERIAL CELL DIVISION PROTEIN ZAPA 1Q57 ; 3.45 ; THE CRYSTAL STRUCTURE OF THE BIFUNCTIONAL PRIMASE-HELICASE OF BACTERIOPHAGE T7 1JOL ; 1.96 ; THE CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN FOLINIC ACID (LEUCOVORIN) AND E. COLI DIHYDROFOLATE REDUCTASE 1JOM ; 1.90 ; THE CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN FOLINIC ACID (LEUCOVORIN) AND E. COLI DIHYDROFOLATE REDUCTASE 1FK8 ; 1.95 ; THE CRYSTAL STRUCTURE OF THE BINARY COMPLEX WITH NAD OF 3- ALPHA-HYDROXYSTEROID DEHYDROGENASE FROM COMAMONAS TESTOSTERONI, A MEMBER OF THE SHORT CHAIN DEHYDROGENASE/REDUCTASE FAMILY 1UHN ; 2.10 ; THE CRYSTAL STRUCTURE OF THE CALCIUM BINDING PROTEIN ATCBL2 FROM ARABIDOPSIS THALIANA 1R1Z ; 2.40 ; THE CRYSTAL STRUCTURE OF THE CARBOHYDRATE RECOGNITION DOMAIN OF THE GLYCOPROTEIN SORTING RECEPTOR P58/ERGIC-53 REVEALS A NOVEL METAL BINDING SITE AND CONFORMATIONAL CHANGES ASSOCIATED WITH CALCIUM ION BINDING 1V9K ; 2.00 ; THE CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF PSEUDOURIDINE SYNTHASE RLUC FROM ESCHERICHIA COLI 1YFT ; 2.23 ; THE CRYSTAL STRUCTURE OF THE CATALYTIC FRAGMENT OF ALANYL- TRNA SYNTHETASE IN COMPLEX WTIH GLYCINE 1RIQ ; 2.14 ; THE CRYSTAL STRUCTURE OF THE CATALYTIC FRAGMENT OF THE ALANYL-TRNA SYNTHETASE 1NAB ; 2.15 ; THE CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN A DISACCHARIDE ANTHRACYCLINE AND THE DEOXYRIBONUCLEIC ACID HEXAMER D(CGATCG) REVEALS TWO DIFFERENT BINDING SITES INVOLVING TWO DEOXYRIBONUCLEIC ACID DUPLEXES 1PVN ; 2.00 ; THE CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN IMP DEHYDROGENASE CATALYTIC DOMAIN AND A TRANSITION STATE ANALOGUE MZP 1OQ9 ; 2.40 ; THE CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN STEAROYL ACYL CARRIER PROTEIN DESATURASE FROM RICINUS COMMUNIS (CASTOR BEAN) AND ACETATE. 1OQ4 ; 2.40 ; THE CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN STEAROYL ACYL CARRIER PROTEIN DESATURASE FROM RICINUS COMMUNIS (CASTOR BEAN) AND AZIDE. 1FZZ ; 1.86 ; THE CRYSTAL STRUCTURE OF THE COMPLEX OF NON-PEPTIDIC INHIBITOR ONO-6818 AND PORCINE PANCREATIC ELASTASE. 1GWN ; 2.10 ; THE CRYSTAL STRUCTURE OF THE CORE DOMAIN OF RHOE/RND3 - A CONSTITUTIVELY ACTIVATED SMALL G PROTEIN 1RJR ; 2.10 ; THE CRYSTAL STRUCTURE OF THE D-AMINOACYLASE D366A MUTANT IN COMPLEX WITH 100MM ZNCL2 1RJQ ; 1.80 ; THE CRYSTAL STRUCTURE OF THE D-AMINOACYLASE MUTANT D366A 335D ; 2.40 ; THE CRYSTAL STRUCTURE OF THE DEOXYRIBONUCLEIC ACID DECAMER D(GGCAATTGCG) CONTAINS BOTH MAJOR AND MINOR GROOVE BINDING G.(G.C) TRIPLETS 1DSF ; 2.20 ; THE CRYSTAL STRUCTURE OF THE DISULFIDE-STABILIZED FV FRAGMENT OF ANTICANCER ANTIBODY B1: CONFORMATIONAL INFLUENCE OF AN ENGINEERED DISULFIDE BOND 1SQG ; 1.65 ; THE CRYSTAL STRUCTURE OF THE E. COLI FMU APOENZYME AT 1.65 A RESOLUTION 2ECP ; 2.95 ; THE CRYSTAL STRUCTURE OF THE E. COLI MALTODEXTRIN PHOSPHORYLASE COMPLEX 1G0S ; 1.90 ; THE CRYSTAL STRUCTURE OF THE E.COLI ADP-RIBOSE PYROPHOSPHATASE 1A7G ; 2.40 ; THE CRYSTAL STRUCTURE OF THE E2 DEOXYRIBONUCLEIC ACID-BINDING DOMAIN FROM HUMAN PAPILLOMAVIRUS AT 2.4 ANGSTROMS 1UNF ; 1.97 ; THE CRYSTAL STRUCTURE OF THE EUKARYOTIC FESOD FROM VIGNA UNGUICULATA SUGGESTS A NEW ENZYMATIC MECHANISM 1C5D ; 2.40 ; THE CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A RAT MONOCLONAL ANTIBODY AGAINST THE MAIN IMMUNOGENIC REGION OF THE HUMAN MUSCLE ACETYLCHOLINE RECEPTOR 1OY0 ; 2.80 ; THE CRYSTAL STRUCTURE OF THE FIRST ENZYME OF PANTOTHENATE BIOSYNTHETIC PATHWAY, KETOPANTOATE HYDROXYMETHYLTRANSFERASE FROM MYCOBACTERIUM TUBERCULOSIS SHOWS A DECAMERIC ASSEMBLY AND TERMINAL HELIX-SWAPPING 1QD1 ; 1.70 ; THE CRYSTAL STRUCTURE OF THE FORMIMINOTRANSFERASE DOMAIN OF FORMIMINOTRANSFERASE-CYCLODEAMINASE. 1UW3 ; 2.04 ; THE CRYSTAL STRUCTURE OF THE GLOBULAR DOMAIN OF SHEEP PRION PROTEIN 1BIX ; 2.20 ; THE CRYSTAL STRUCTURE OF THE HUMAN DEOXYRIBONUCLEIC ACID REPAIR ENDONUCLEASE HAP1 SUGGESTS THE RECOGNITION OF EXTRA-HELICAL DEOXYRIBOSE AT DEOXYRIBONUCLEIC ACID ABASIC SITES 1S3X ; 1.84 ; THE CRYSTAL STRUCTURE OF THE HUMAN HSP70 ATPASE DOMAIN 1KDM ; 2.35 ; THE CRYSTAL STRUCTURE OF THE HUMAN SEX HORMONE-BINDING GLOBULIN (TETRAGONAL CRYSTAL FORM) 1UPX ; 1.25 ; THE CRYSTAL STRUCTURE OF THE HYBRID CLUSTER PROTEIN FROM DESULFOVIBRIO DESULFURICANS CONTAINING MOLECULES IN THE OXIDIZED AND REDUCED STATES. 2FBL ; 1.90 ; THE CRYSTAL STRUCTURE OF THE HYPOTHETICAL PROTEIN NE1496 1QCY ; 2.30 ; THE CRYSTAL STRUCTURE OF THE I-DOMAIN OF HUMAN INTEGRIN ALPHA1BETA1 1V5C ; 2.00 ; THE CRYSTAL STRUCTURE OF THE INACTIVE FORM CHITOSANASE FROM BACILLUS SP. K17 AT PH3.7 1OQ7 ; 3.20 ; THE CRYSTAL STRUCTURE OF THE IRON FREE (APO-)FORM OF STEAROYL ACYL CARRIER PROTEIN DESATURASE FROM RICINUS COMMUNIS (CASTOR BEAN). 1NSW ; 1.90 ; THE CRYSTAL STRUCTURE OF THE K18G MUTANT OF THE THIOREDOXIN FROM ALICYCLOBACILLUS ACIDOCALDARIUS 1R8N ; 1.75 ; THE CRYSTAL STRUCTURE OF THE KUNITZ (STI) TYPE INHIBITOR FROM SEEDS OF DELONIX REGIA 1ZUJ ; 2.90 ; THE CRYSTAL STRUCTURE OF THE LACTOCOCCUS LACTIS MG1363 DPSA PROTEIN 1ZS3 ; 2.70 ; THE CRYSTAL STRUCTURE OF THE LACTOCOCCUS LACTIS MG1363 DPSB PROTEIN 1XOV ; 1.80 ; THE CRYSTAL STRUCTURE OF THE LISTERIA MONOCYTOGENES BACTERIOPHAGE PSA ENDOLYSIN PLYPSA 1V8J ; 3.24 ; THE CRYSTAL STRUCTURE OF THE MINIMAL FUNCTIONAL DOMAIN OF THE MICROTUBULE DESTABILIZER KIF2C COMPLEXED WITH MG-ADP 1V8K ; 2.25 ; THE CRYSTAL STRUCTURE OF THE MINIMAL FUNCTIONAL DOMAIN OF THE MICROTUBULE DESTABILIZER KIF2C COMPLEXED WITH MG-AMPPNP 1VDP ; 1.70 ; THE CRYSTAL STRUCTURE OF THE MONOCLINIC FORM OF HEN EGG WHITE LYSOZYME AT 1.7 ANGSTROMS RESOLUTION IN SPACE 1RW3 ; 3.00 ; THE CRYSTAL STRUCTURE OF THE MONOMERIC REVERSE TRANSCRIPTASE FROM MOLONEY MURINE LEUKEMIA VIRUS 1NW2 ; 1.90 ; THE CRYSTAL STRUCTURE OF THE MUTANT R82E OF THIOREDOXIN FROM ALICYCLOBACILLUS ACIDOCALDARIUS 1TJF ; 2.21 ; THE CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF CAP INDICATES VARIABLE OLIGOMERISATION 1XKS ; 2.35 ; THE CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF NUP133 REVEALS A BETA-PROPELLER FOLD COMMON TO SEVERAL NUCLEOPORINS 1Y5L ; 2.50 ; THE CRYSTAL STRUCTURE OF THE NARGHI MUTANT NARI-H66Y 1Y5I ; 1.90 ; THE CRYSTAL STRUCTURE OF THE NARGHI MUTANT NARI-K86A 1Y5N ; 2.50 ; THE CRYSTAL STRUCTURE OF THE NARGHI MUTANT NARI-K86A IN COMPLEX WITH PENTACHLOROPHENOL 1OQB ; 2.80 ; THE CRYSTAL STRUCTURE OF THE ONE-IRON FORM OF THE DI-IRON CENTER IN STEAROYL ACYL CARRIER PROTEIN DESATURASE FROM RICINUS COMMUNIS (CASTOR BEAN). 1VDQ ; 1.50 ; THE CRYSTAL STRUCTURE OF THE ORTHORHOMBIC FORM OF HEN EGG WHITE LYSOZYME AT 1.5 ANGSTROMS RESOLUTION 1VED ; 1.90 ; THE CRYSTAL STRUCTURE OF THE ORTHORHOMBIC FORM OF HEN EGG WHITE LYSOZYME AT 1.9 ANGSTROMS RESOLUTION IN SPACE 1YC9 ; 1.80 ; THE CRYSTAL STRUCTURE OF THE OUTER MEMBRANE PROTEIN VCEC FROM THE BACTERIAL PATHOGEN VIBRIO CHOLERAE AT 1.8 RESOLUTION 1XG6 ; 2.15 ; THE CRYSTAL STRUCTURE OF THE P1 MUTANT (LEU TO ARG)OF A WINGED BEAN CHYMOTRYPSIN INHIBITOR(KUNITZ)SOLVED AT 2.15A RESOLUTION 1WYX ; 1.14 ; THE CRYSTAL STRUCTURE OF THE P130CAS SH3 DOMAIN AT 1.1 A RESOLUTION 1Z1L ; 1.70 ; THE CRYSTAL STRUCTURE OF THE PHOSPHODIESTERASE 2A CATALYTIC DOMAIN 1YUK ; 1.80 ; THE CRYSTAL STRUCTURE OF THE PSI/HYBRID DOMAIN/ I-EGF1 SEGMENT FROM THE HUMAN INTEGRIN BETA2 AT 1.8 RESOLUTION 2B0C ; 2.00 ; THE CRYSTAL STRUCTURE OF THE PUTATIVE PHOSPHATASE FROM ESCHERICHIA COLI 2ERY ; 1.70 ; THE CRYSTAL STRUCTURE OF THE RAS RELATED PROTEIN RRAS2 (RRAS2) IN THE GDP BOUND STATE 1TJD ; 2.50 ; THE CRYSTAL STRUCTURE OF THE REDUCED DISULPHIDE BOND ISOMERASE, DSBC, FROM ESCHERICHIA COLI 2FE5 ; 1.10 ; THE CRYSTAL STRUCTURE OF THE SECOND PDZ DOMAIN OF HUMAN DLG3 1QBZ ; 1.47 ; THE CRYSTAL STRUCTURE OF THE SIV GP41 ECTODOMAIN AT 1.47 A 1UOS ; 2.70 ; THE CRYSTAL STRUCTURE OF THE SNAKE VENOM TOXIN CONVULXIN 1OOW ; 2.00 ; THE CRYSTAL STRUCTURE OF THE SPINACH PLASTOCYANIN DOUBLE MUTANT G8D/L12E GIVES INSIGHT INTO ITS LOW REACTIVITY TOWARDS PHOTOSYSTEM 1 AND CYTOCHROME F 1VDS ; 1.60 ; THE CRYSTAL STRUCTURE OF THE TETRAGONAL FORM OF HEN EGG WHITE LYSOZYME AT 1.6 ANGSTROMS RESOLUTION IN SPACE 1VDT ; 1.70 ; THE CRYSTAL STRUCTURE OF THE TETRAGONAL FORM OF HEN EGG WHITE LYSOZYME AT 1.7 ANGSTROMS RESOLUTION UNDER BASIC CONDITIONS IN SPACE 1EVQ ; 2.60 ; THE CRYSTAL STRUCTURE OF THE THERMOPHILIC CARBOXYLESTERASE EST2 FROM ALICYCLOBACILLUS ACIDOCALDARIUS 1I4W ; 2.60 ; THE CRYSTAL STRUCTURE OF THE TRANSCRIPTION FACTOR SC-MTTFB OFFERS INTRIGUING INSIGHTS INTO MITOCHONDRIAL TRANSCRIPTION 1LJ9 ; 1.60 ; THE CRYSTAL STRUCTURE OF THE TRANSCRIPTIONAL REGULATOR SLYA 2A5L ; 1.70 ; THE CRYSTAL STRUCTURE OF THE TRP REPRESSOR BINDING PROTEIN WRBA FROM PSEUDOMONAS AERUGINOSA 1V6D ; 1.90 ; THE CRYSTAL STRUCTURE OF THE TRYPSIN COMPLEX WITH SYNTHETIC HETEROCHIRAL PEPTIDE 1UXO ; 1.80 ; THE CRYSTAL STRUCTURE OF THE YDEN GENE PRODUCT FROM B. SUBTILIS 1ZA3 ; 3.35 ; THE CRYSTAL STRUCTURE OF THE YSD1 FAB BOUND TO DR5 1XMK ; 0.97 ; THE CRYSTAL STRUCTURE OF THE ZB DOMAIN FROM THE RIBONUCLEIC ACID EDITING ENZYME ADAR1 1JV0 ; 2.00 ; THE CRYSTAL STRUCTURE OF THE ZINC(II) ADDUCT OF THE CAI MICHIGAN 1 VARIANT 1GPZ ; 2.90 ; THE CRYSTAL STRUCTURE OF THE ZYMOGEN CATALYTIC DOMAIN OF COMPLEMENT PROTEASE C1R 1GC9 ; 2.30 ; THE CRYSTAL STRUCTURE OF THERMUS THERMOPHILUS 3- ISOPROPYLMALATE DEHYDROGENASE MUTATED AT 172TH FROM ALA TO GLY 1GC8 ; 2.50 ; THE CRYSTAL STRUCTURE OF THERMUS THERMOPHILUS 3- ISOPROPYLMALATE DEHYDROGENASE MUTATED AT 172TH FROM ALA TO PHE 1PBT ; 1.70 ; THE CRYSTAL STRUCTURE OF TM1154, OXIDOREDUCTASE, SOL/DEVB FAMILY FROM THERMOTOGA MARITIMA 1RJ8 ; 2.23 ; THE CRYSTAL STRUCTURE OF TNF FAMILY MEMBER EDA-A2 1FC3 ; 2.00 ; THE CRYSTAL STRUCTURE OF TRANS-ACTIVATION DOMAIN OF THE SPORULATION RESPONSE REGULATOR, SPO0A 2FBQ ; 1.80 ; THE CRYSTAL STRUCTURE OF TRANSCRIPTIONAL REGULATOR PA3006 2FBH ; 1.80 ; THE CRYSTAL STRUCTURE OF TRANSCRIPTIONAL REGULATOR PA3341 2FBI ; 2.10 ; THE CRYSTAL STRUCTURE OF TRANSCRIPTIONAL REGULATOR PA4135 2A61 ; 1.80 ; THE CRYSTAL STRUCTURE OF TRANSCRIPTIONAL REGULATOR TM0710 FROM THERMOTOGA MARITIMA 1YSQ ; 1.75 ; THE CRYSTAL STRUCTURE OF TRANSCRIPTIONAL REGULATOR YAIJ 1S5X ; 2.40 ; THE CRYSTAL STRUCTURE OF TREMATOMUS BERNACCHII HEMOGLOBIN OXIDIZED BY AIR 1S5Y ; 2.50 ; THE CRYSTAL STRUCTURE OF TREMATOMUS BERNACCHII HEMOGLOBIN OXIDIZED BY FERRICYANIDE 1LA6 ; 2.00 ; THE CRYSTAL STRUCTURE OF TREMATOMUS NEWNESI HEMOGLOBIN IN A PARTIAL HEMICHROME STATE 1WC9 ; 1.60 ; THE CRYSTAL STRUCTURE OF TRUNCATED MOUSE BET3P 1OGK ; 2.85 ; THE CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI DUTPASE IN COMPLEX WITH DUDP 1F7Y ; 2.80 ; THE CRYSTAL STRUCTURE OF TWO UUCG LOOPS HIGHLIGHTS THE ROLE PLAYED BY 2'-HYDROXYL GROUPS IN ITS UNUSUAL STABILITY 1PKD ; 2.30 ; THE CRYSTAL STRUCTURE OF UCN-01 IN COMPLEX WITH PHOSPHO- CDK2/CYCLIN A 1XHB ; 2.50 ; THE CRYSTAL STRUCTURE OF UDP-GALNAC: POLYPEPTIDE ALPHA-N- ACETYLGALACTOSAMINYLTRANSFERASE-T1 2BOO ; 1.80 ; THE CRYSTAL STRUCTURE OF URACIL-DEOXYRIBONUCLEIC ACID N-GLYCOSYLASE (UNG) FROM DEINOCOCCUS RADIODURANS. 1BWO ; 2.10 ; THE CRYSTAL STRUCTURE OF WHEAT NON-SPECIFIC TRANSFER PROTEIN COMPLEXED WITH TWO MOLECULES OF PHOSPHOLIPID AT 2.1 A RESOLUTION 1NZO ; 1.85 ; THE CRYSTAL STRUCTURE OF WILD TYPE PENICILLIN-BINDING PROTEIN 5 FROM E. COLI 1XXL ; 2.10 ; THE CRYSTAL STRUCTURE OF YCGJ PROTEIN FROM BACILLUS SUBITILIS AT 2.1 A RESOLUTION 1GYJ ; 2.10 ; THE CRYSTAL STRUCTURE OF YDCE, A 4-OXALOCROTONATE TAUTOMERASE HOMOLOGUE FROM ESCHERICHIA COLI, CONFIRMS THE STRUCTURAL BASIS FOR OLIGOMER DIVERSITY 1GYX ; 1.35 ; THE CRYSTAL STRUCTURE OF YDCE, A 4-OXALOCROTONATE TAUTOMERASE HOMOLOGUE FROM ESCHERICHIA COLI, CONFIRMS THE STRUCTURAL BASIS FOR OLIGOMER DIVERSITY 1GYY ; 1.35 ; THE CRYSTAL STRUCTURE OF YDCE, A 4-OXALOCROTONATE TAUTOMERASE HOMOLOGUE FROM ESCHERICHIA COLI, CONFIRMS THE STRUCTURAL BASIS FOR OLIGOMER DIVERSITY 1UAQ ; 1.60 ; THE CRYSTAL STRUCTURE OF YEAST CYTOSINE DEAMINASE 1P6O ; 1.14 ; THE CRYSTAL STRUCTURE OF YEAST CYTOSINE DEAMINASE BOUND TO 4(R)-HYDROXYL-3,4-DIHYDROPYRIMIDINE AT 1.14 ANGSTROMS. 1EHZ ; 1.93 ; THE CRYSTAL STRUCTURE OF YEAST PHENYLALANINE TRNA AT 1.93 A RESOLUTION 1T9H ; 1.60 ; THE CRYSTAL STRUCTURE OF YLOQ, A CIRCULARLY PERMUTED GTPASE. 1VF8 ; 1.31 ; THE CRYSTAL STRUCTURE OF YM1 AT 1.31 A RESOLUTION 1DU5 ; 2.50 ; THE CRYSTAL STRUCTURE OF ZEAMATIN. 2A2G ; 2.90 ; THE CRYSTAL STRUCTURES OF A2U-GLOBULIN AND ITS COMPLEX WITH A HYALINE DROPLET INDUCER. 2A2U ; 2.50 ; THE CRYSTAL STRUCTURES OF A2U-GLOBULIN AND ITS COMPLEX WITH A HYALINE DROPLET INDUCER. 1XEI ; 2.10 ; THE CRYSTAL STRUCTURES OF LYSOZYME AT VERY LOW LEVELS OF HYDRATION 1XEJ ; 2.10 ; THE CRYSTAL STRUCTURES OF LYSOZYME AT VERY LOW LEVELS OF HYDRATION 1XEK ; 2.30 ; THE CRYSTAL STRUCTURES OF LYSOZYME AT VERY LOW LEVELS OF HYDRATION 3BTG ; 1.90 ; THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA- TRYPSIN AND TEN P1 VARIANTS OF BPTI 3BTH ; 1.75 ; THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA- TRYPSIN AND TEN P1 VARIANTS OF BPTI 3BTK ; 1.85 ; THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA- TRYPSIN AND TEN P1 VARIANTS OF BPTI 3BTM ; 1.80 ; THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA- TRYPSIN AND TEN P1 VARIANTS OF BPTI 3BTQ ; 1.90 ; THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA- TRYPSIN AND TEN P1 VARIANTS OF BPTI 3BTT ; 1.90 ; THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA- TRYPSIN AND TEN P1 VARIANTS OF BPTI 3BTW ; 2.05 ; THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA- TRYPSIN AND TEN P1 VARIANTS OF BPTI 3BTE ; 1.85 ; THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA- TRYPSIN AND TEN P1 VARIANTS OF BPTI. 3BTF ; 1.80 ; THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA- TRYPSIN AND TEN P1 VARIANTS OF BPTI. 3BTD ; 1.90 ; THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN THE BOVINE BETA-TRYPSIN AND TEN P1 VARIANTS OF BPTI. 1XJX ; 1.70 ; THE CRYSTAL STRUCTURES OF THE DEOXYRIBONUCLEIC ACID BINDING SITES OF THE RUNX1 TRANSCRIPTION FACTOR 1XJY ; 2.00 ; THE CRYSTAL STRUCTURES OF THE DEOXYRIBONUCLEIC ACID BINDING SITES OF THE RUNX1 TRANSCRIPTION FACTOR 1VG9 ; 2.50 ; THE CRYSTAL STRUCTURES OF THE REP-1 PROTEIN IN COMPLEX WITH C-TERMINALLY TRUNCATED RAB7 PROTEIN 1VG0 ; 2.20 ; THE CRYSTAL STRUCTURES OF THE REP-1 PROTEIN IN COMPLEX WITH MONOPRENYLATED RAB7 PROTEIN 1SPP ; 2.40 ; THE CRYSTAL STRUCTURES OF TWO MEMBERS OF THE SPERMADHESIN FAMILY REVEAL THE FOLDING OF THE CUB DOMAIN 1YY6 ; 1.70 ; THE CRYSTAL STRUCURE OF THE N-TERMINAL DOMAIN OF HAUSP/USP7 COMPLEXED WITH AN EBNA1 PEPTIDE 1QC9 ; 3.00 ; THE CRYSTALLOGRAPHIC STRUCTURE OF RESTRICTION ENDONUCLEASE ECO RI AT 3.3 A IN THE ABSENSE OF DEOXYRIBONUCLEIC ACID 2CUA ; 1.60 ; THE CUA DOMAIN OF CYTOCHROME BA3 FROM THERMUS THERMOPHILUS 1QFB ; -1.00 ; THE CYCLIC PEPTIDE CONTRYPHAN-R FROM CONUS RADIATUS 1UZ2 ; 1.95 ; THE CYS121SER MUTANT OF BETA-LACTOGLOBULIN 1EWM ; 2.00 ; THE CYSTEINE PROTEASE CRUZAIN BOUND TO WRR-112 1EWO ; 2.10 ; THE CYSTEINE PROTEASE CRUZAIN BOUND TO WRR-204 1RK5 ; 1.80 ; THE D-AMINOACYLASE MUTANT D366A IN COMPLEX WITH 100MM CUCL2 1XB3 ; 1.50 ; THE D62C/K74C DOUBLE MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN 2COD ; -1.00 ; THE DEPOSITION AND CITATION TITLE IS: SOLUTION STRUCTURE OF THE N-TERMINAL PH DOMAIN OF ARAP2 PROTEIN FROM HUMAN 2CR5 ; -1.00 ; THE DEPOSITION AND CITATION TITLE IS: SOLUTION STRUCTURE OF THE UBX DOMAIN OF D0H8S2298E PROTEIN 436D ; 1.10 ; THE DICKERSON-DREW B-DEOXYRIBONUCLEIC ACID DODECAMER REVISITED-AT ATOMIC RESOLUTION 1LTL ; 3.00 ; THE DODECAMER STRUCTURE OF MCM FROM ARCHAEAL M. THERMOAUTOTROPHICUM 1BJQ ; 2.65 ; THE DOLICHOS BIFLORUS SEED LECTIN IN COMPLEX WITH ADENINE 1L5E ; -1.00 ; THE DOMAIN-SWAPPED DIMER OF CV-N IN SOLUTION 1NBO ; 2.60 ; THE DUAL COENZYME SPECIFICITY OF PHOTOSYNTHETIC GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE INTERPRETED BY THE CRYSTAL STRUCTURE OF A4 ISOFORM COMPLEXED WITH NAD 1WFO ; -1.00 ; THE EIGHTH FN3 DOMAIN OF HUMAN SIDEKICK-2 7CEI ; 2.30 ; THE ENDONUCLEASE DOMAIN OF COLICIN E7 IN COMPLEX WITH ITS INHIBITOR IM7 PROTEIN 1RK6 ; 1.43 ; THE ENZYME IN COMPLEX WITH 50MM CDCL2 1D0L ; 1.97 ; THE ESCHERICHIA COLI LYTIC TRANSGLYCOSYLASE SLT35 IN COMPLEX WITH BULGECIN A 1D0M ; 2.47 ; THE ESCHERICHIA COLI LYTIC TRANSGLYCOSYLASE SLT35 IN COMPLEX WITH BULGECIN A AND (GLCNAC)2 1D0K ; 2.02 ; THE ESCHERICHIA COLI LYTIC TRANSGLYCOSYLASE SLT35 IN COMPLEX WITH TWO MURODIPEPTIDES (GLCNAC-MURNAC-L-ALA-D-GLU) 1Z3H ; 3.10 ; THE EXPORTIN CSE1 IN ITS CARGO-FREE, CYTOPLASMIC STATE 1OCV ; 2.00 ; THE F116W MUTANT STRUCTURE OF KETOSTEROID ISOMERASE FROM COMAMONAS TESTOSTERONI 1NXG ; 2.50 ; THE F383A VARIANT OF TYPE II CITRATE SYNTHASE COMPLEXED WITH NADH 1HW1 ; 1.50 ; THE FADR-DEOXYRIBONUCLEIC ACID COMPLEX: TRANSCRIPTIONAL CONTROL OF FATTY ACID METABOLISM IN ESCHERICHIA COLI 1DWL ; -1.00 ; THE FERREDOXIN-CYTOCHROME COMPLEX USING HETERONUCLEAR NMR AND DOCKING SIMULATION 1GJO ; 2.40 ; THE FGFR2 TYROSINE KINASE DOMAIN 1WFM ; -1.00 ; THE FIRST C2 DOMAIN OF HUMAN SYNAPTOTAGMIN XIII 1F0I ; 1.40 ; THE FIRST CRYSTAL STRUCTURE OF A PHOSPHOLIPASE D 1NOF ; 1.42 ; THE FIRST CRYSTALLOGRAPHIC STRUCTURE OF A XYLANASE FROM GLYCOSYL HYDROLASE FAMILY 5: IMPLICATIONS FOR CATALYSIS 1FF7 ; -1.00 ; THE FIRST EGF-LIKE DOMAIN FROM HUMAN BLOOD COAGULATION FVII (FUCOSYLATED AT SER-60), NMR, 20 STRUCTURES 1FFM ; -1.00 ; THE FIRST EGF-LIKE DOMAIN FROM HUMAN BLOOD COAGULATION FVII (FUCOSYLATED AT SER-60), NMR, MINIMIZED AVERAGE STRUCTURE 1F7E ; -1.00 ; THE FIRST EGF-LIKE DOMAIN FROM HUMAN BLOOD COAGULATION FVII, NMR, 20 STRUCTURES 1F7M ; -1.00 ; THE FIRST EGF-LIKE DOMAIN FROM HUMAN BLOOD COAGULATION FVII, NMR, MINIMIZED AVERAGE STRUCTURE 1KS0 ; -1.00 ; THE FIRST FIBRONECTIN TYPE II MODULE FROM HUMAN MATRIX METALLOPROTEINASE 2 1T4X ; -1.00 ; THE FIRST LEFT-HANDED RIBONUCLEIC ACID STRUCTURE OF (CGCGCG)2, Z-RIBONUCLEIC ACID, NMR, 12 STRUCTURES, DETERMINED IN HIGH SALT 1IU0 ; -1.00 ; THE FIRST PDZ DOMAIN OF PSD-95 1IU2 ; -1.00 ; THE FIRST PDZ DOMAIN OF PSD-95 1DLI ; 2.31 ; THE FIRST STRUCTURE OF UDP-GLUCOSE DEHYDROGENASE (UDPGDH) REVEALS THE CATALYTIC RESIDUES NECESSARY FOR THE TWO-FOLD OXIDATION 1DLJ ; 1.80 ; THE FIRST STRUCTURE OF UDP-GLUCOSE DEHYDROGENASE (UDPGDH) REVEALS THE CATALYTIC RESIDUES NECESSARY FOR THE TWO-FOLD OXIDATION 2C2W ; 2.00 ; THE FLUORINASE FROM STREPTOMYCES CATTLEYA IS ALSO A CHLORINASE. STRUCTURE OF 5'-CHLORO-5'-DEOXYADENOSINE CRYSTALLISED IN THE FLUORINASE. 1E20 ; 2.02 ; THE FMN BINDING PROTEIN ATHAL3 1UJX ; -1.00 ; THE FORKHEAD ASSOCIATED (FHA) DOMAIN LIKE STRUCTURE FROM MOUSE POLYNUCLEOTIDE KINASE 3'-PHOSPHATASE 1WFN ; -1.00 ; THE FOURTH FN3 DOMAIN OF HUMAN SIDEKICK-2 1V4Y ; 1.65 ; THE FUNCTIONAL ROLE OF THE BINUCLEAR METAL CENTER IN D- AMINOACYLASE. ONE-METAL ACTIVATION AND SECOND-METAL ATTENUATION 1V51 ; 1.60 ; THE FUNCTIONAL ROLE OF THE BINUCLEAR METAL CENTER IN D- AMINOACYLASE. ONE-METAL ACTIVATION AND SECOND-METAL ATTENUATION 1F5G ; -1.00 ; THE G7(SYN)-G4(ANTI) STRUCTURE OF R(GCAGGCGUGC)2 1F5H ; -1.00 ; THE G7(SYN)-G4(ANTI) STRUCTURE OF R(GCAGGCGUGC)2 1SAU ; 1.12 ; THE GAMMA SUBUNIT OF THE DISSIMILATORY SULFITE REDUCTASE (DSRC) FROM ARCHAEOGLOBUS FULGIDUS AT 1.1 A RESOLUTION 1NF1 ; 2.50 ; THE GAP RELATED DOMAIN OF NEUROFIBROMIN 1Z0N ; 1.49 ; THE GLYCOGEN-BINDING DOMAIN OF THE AMP-ACTIVATED PROTEIN KINASE 1Z0M ; 1.91 ; THE GLYCOGEN-BINDING DOMAIN OF THE AMP-ACTIVATED PROTEIN KINASE BETA1 SUBUNIT 1KQS ; 3.10 ; THE HALOARCULA MARISMORTUI 50S COMPLEXED WITH A PRETRANSLOCATIONAL INTERMEDIATE IN PROTEIN SYNTHESIS 1FL6 ; 2.80 ; THE HAPTEN COMPLEXED GERMLINE PRECURSOR TO SULFIDE OXIDASE CATALYTIC ANTIBODY 28B4 1DLL ; 1.80 ; THE HC FRAGEMENT OF TETANUS TOXIN COMPLEXED WITH LACTOSE 1FV2 ; 2.50 ; THE HC FRAGMENT OF TETANUS TOXIN COMPLEXED WITH AN ANALOGUE OF ITS GANGLIOSIDE RECEPTOR GT1B 1FV3 ; 2.30 ; THE HC FRAGMENT OF TETANUS TOXIN COMPLEXED WITH AN ANALOGUE OF ITS GANGLIOSIDE RECEPTOR GT1B 1DIW ; 2.00 ; THE HC FRAGMENT OF TETANUS TOXIN COMPLEXED WITH GALACTOSE 1D0H ; 2.10 ; THE HC FRAGMENT OF TETANUS TOXIN COMPLEXED WITH N-ACETYL- GALACTOSAMINE 1DFQ ; 2.60 ; THE HC FRAGMENT OF TETANUS TOXIN COMPLEXED WITH SIALIC ACID 1GW3 ; -1.00 ; THE HELIX-HINGE-HELIX STRUCTURAL MOTIF IN HUMAN APOLIPOPROTEIN A-I DETERMINED BY NMR SPECTROSCOPY, 1 STRUCTURE 1GW4 ; -1.00 ; THE HELIX-HINGE-HELIX STRUCTURAL MOTIF IN HUMAN APOLIPOPROTEIN A-I DETERMINED BY NMR SPECTROSCOPY, 1 STRUCTURE 3PNP ; 1.60 ; THE HIGH RESOLUTION CRYSTAL STRUCTURE OF BOVINE SPLEEN PURINE NUCLEOSIDE PHOSPHORYLASE IN COMPLEX FORMS WITH PHOSPHATE AND 9-DEAZAINOSINE 4PNP ; 1.80 ; THE HIGH RESOLUTION CRYSTAL STRUCTURE OF BOVINE SPLEEN PURINE NUCLEOSIDE PHOSPHORYLASE IN COMPLEX FORMS WITH PHOSPHATE AND 9-DEAZAINOSINE 2HBS ; 2.05 ; THE HIGH RESOLUTION CRYSTAL STRUCTURE OF DEOXYHEMOGLOBIN S 2CTB ; 1.50 ; THE HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CARBOXYPEPTIDASE A AND L-PHENYL LACTATE 2CTC ; 1.40 ; THE HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CARBOXYPEPTIDASE A AND L-PHENYL LACTATE 1FR3 ; 1.50 ; THE HIGH RESOLUTION STRUCTURE OF A MOLYBDATE BINDING PROTEIN FROM SPOROMUSA OVATA 1W6S ; 1.20 ; THE HIGH RESOLUTION STRUCTURE OF METHANOL DEHYDROGENASE FROM METHYLOBACTERIUM EXTORQUENS 1W0D ; 1.65 ; THE HIGH RESOLUTION STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS LEUB (RV2995C) 1E25 ; 1.90 ; THE HIGH RESOLUTION STRUCTURE OF PER-1 CLASS A BETA-LACTAMASE 1UWK ; 1.19 ; THE HIGH RESOLUTION STRUCTURE OF UROCANATE HYDRATASE FROM PSEUDOMONAS PUTIDA IN COMPLEX WITH UROCANATE 1NYW ; 1.60 ; THE HIGH RESOLUTION STRUCTURES OF RMLC FROM STREPTOCCUS SUIS IN COMPLEX WITH DTDP-D-GLUCOSE 1NXM ; 1.30 ; THE HIGH RESOLUTION STRUCTURES OF RMLC FROM STREPTOCOCCUS SUIS 1NZC ; 1.80 ; THE HIGH RESOLUTION STRUCTURES OF RMLC FROM STREPTOCOCCUS SUIS IN COMPLEX WITH DTDP-D-XYLOSE 1ITI ; -1.00 ; THE HIGH RESOLUTION THREE-DIMENSIONAL SOLUTION STRUCTURE OF HUMAN INTERLEUKIN-4 DETERMINED BY MULTI-DIMENSIONAL HETERONUCLEAR MAGNETIC RESONANCE SPECTROSCOPY 244D ; 1.20 ; THE HIGH-RESOLUTION CRYSTAL STRUCTURE OF A PARALLEL-STRANDED GUANINE TETRAPLEX 1N82 ; 1.45 ; THE HIGH-RESOLUTION CRYSTAL STRUCTURE OF IXT6, A THERMOPHILIC, INTRACELLULAR XYLANASE FROM G. STEAROTHERMOPHILUS 1KWC ; 2.10 ; THE HIS145ALA MUTANT OF 2,3-DIHYDROXYBIPHENYL DIOXYGENASE IN COMPLEX WITH 2,3-DIHYDROXYBIPHENYL 1MSN ; 2.00 ; THE HIV PROTEASE (MUTANT Q7K L33I L63I V82F I84V) COMPLEXED WITH KNI-764 (AN INHIBITOR) 1MSM ; 2.00 ; THE HIV PROTEASE (MUTANT Q7K L33I L63I) COMPLEXED WITH KNI- 764 (AN INHIBITOR) 1R7M ; 2.25 ; THE HOMING ENDONUCLEASE I-SCEI BOUND TO ITS DEOXYRIBONUCLEIC ACID RECOGNITION REGION 1NZ4 ; 1.80 ; THE HORSE HEART MYOGLOBIN VARIANT K45E/K63E COMPLEXED WITH CADMIUM 1NZ5 ; 1.70 ; THE HORSE HEART MYOGLOBIN VARIANT K45E/K63E COMPLEXED WITH MANGANESE 1KPR ; 2.80 ; THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E 1KTL ; 3.10 ; THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E 1MHE ; 2.85 ; THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E 2BIL ; 2.55 ; THE HUMAN PROTEIN KINASE PIM1 IN COMPLEX WITH ITS CONSENSUS PEPTIDE PIMTIDE 1Y97 ; 2.50 ; THE HUMAN TREX2 3' EXONUCLEASE STRUCTURE SUGGESTS A MECHANISM FOR EFFICIENT NON-PROCESSIVE DEOXYRIBONUCLEIC ACID CATALYSIS 1OLR ; 1.20 ; THE HUMICOLA GRISEA CEL12A ENZYME STRUCTURE AT 1.2 A RESOLUTION 2AXF ; 1.80 ; THE IMMUNOGENICITY OF A VIRAL CYTOTOXIC T CELL EPITOPE IS CONTROLLED BY ITS MHC-BOUND CONFORMATION 2AXG ; 2.00 ; THE IMMUNOGENICITY OF A VIRAL CYTOTOXIC T CELL EPITOPE IS CONTROLLED BY ITS MHC-BOUND CONFORMATION 1LYC ; 1.57 ; THE IMPACT OF THE PHYSICAL AND CHEMICAL ENVIROMENT ON THE MOLECULAR STRUCTURE OF COPRINUS CINEREUS PEROXIDASE 1LYK ; 2.00 ; THE IMPACT OF THE PHYSICAL AND CHEMICAL ENVIROMENT ON THE MOLECULAR STRUCTURE OF COPRINUS CINEREUS PEROXIDASE 1LY9 ; 2.00 ; THE IMPACT OF THE PHYSICAL AND CHEMICAL ENVIRONMENT ON THE MOLECULAR STRUCTURE OF COPRINUS CINEREUS PEROXIDASE 1GM2 ; -1.00 ; THE INDEPENDENT STRUCTURE OF THE ANTITRYPTIC REACTIVE SITE LOOP OF BOWMAN-BIRK INHIBITOR AND SUNFLOWER TRYPSIN INHIBITOR-1 1RRU ; 2.35 ; THE INFLUENCE OF A CHIRAL AMINO ACID ON THE HELICAL HANDEDNESS OF PNA IN SOLUTION AND IN CRYSTALS 1UWN ; 1.20 ; THE INITIAL EVENTS IN THE PHOTOCYCLE OF PHOTOACTIVE YELLOW PROTEIN: A COMMON MECHANISM ON LIGHT ACTIVATION IN PHOTORECEPTOR PROTEINS 400D ; 1.65 ; THE INTRINSIC STRUCTURE AND STABILITY OF OUT-OF-ALTERNATION BASE PAIRS IN Z-DEOXYRIBONUCLEIC ACID 1QS5 ; 2.50 ; THE INTRODUCTION OF STRAIN AND ITS EFFECTS ON THE STRUCTURE AND STABILITY OF T4 LYSOZYME 1QS9 ; 1.85 ; THE INTRODUCTION OF STRAIN AND ITS EFFECTS ON THE STRUCTURE AND STABILITY OF T4 LYSOZYME 1QSB ; 1.80 ; THE INTRODUCTION OF STRAIN AND ITS EFFECTS ON THE STRUCTURE AND STABILITY OF T4 LYSOZYME 1QTB ; 1.90 ; THE INTRODUCTION OF STRAIN AND ITS EFFECTS ON THE STRUCTURE AND STABILITY OF T4 LYSOZYME 1QTC ; 2.50 ; THE INTRODUCTION OF STRAIN AND ITS EFFECTS ON THE STRUCTURE AND STABILITY OF T4 LYSOZYME 1QTD ; 2.50 ; THE INTRODUCTION OF STRAIN AND ITS EFFECTS ON THE STRUCTURE AND STABILITY OF T4 LYSOZYME 1QTH ; 1.90 ; THE INTRODUCTION OF STRAIN AND ITS EFFECTS ON THE STRUCTURE AND STABILITY OF T4 LYSOZYME 1EKX ; 1.95 ; THE ISOLATED, UNREGULATED CATALYTIC TRIMER OF ASPARTATE TRANSCARBAMOYLASE COMPLEXED WITH BISUBSTRATE ANALOG PALA (N- (PHOSPHONACETYL)-L-ASPARTATE) 1JUB ; 1.40 ; THE K136E MUTANT OF LACTOCOCCUS LACTIS DIHYDROOROTATE DEHYDROGENASE A 1OVD ; 2.25 ; THE K136E MUTANT OF LACTOCOCCUS LACTIS DIHYDROOROTATE DEHYDROGENASE A IN COMPLEX WITH OROTATE 1JQV ; 2.10 ; THE K213E MUTANT OF LACTOCOCCUS LACTIS DIHYDROOROTATE DEHYDROGENASE A 1XB6 ; 1.82 ; THE K24R MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN 1LEI ; 2.70 ; THE KB DEOXYRIBONUCLEIC ACID SEQUENCE FROM THE HLV-LTR FUNCTIONS AS AN ALLOSTERIC REGULATOR OF HIV TRANSCRIPTION 3LCK ; 1.70 ; THE KINASE DOMAIN OF HUMAN LYMPHOCYTE KINASE (LCK), ACTIVATED FORM (AUTO-PHOSPHORYLATED ON TYR394) 1K75 ; 1.75 ; THE L-HISTIDINOL DEHYDROGENASE (HISD) STRUCTURE IMPLICATES DOMAIN SWAPPING AND GENE DUPLICATION. 1V2G ; 2.00 ; THE L109P MUTANT OF E. COLI THIOESTERASE I/PROTEASE I/LYSOPHOSPHOLIPASE L1 (TAP) IN COMPLEXED WITH OCTANOIC ACID 1JB3 ; 1.60 ; THE LAMININ-BINDING DOMAIN OF AGRIN IS STRUCTURALLY RELATED TO N-TIMP-1 1JC7 ; 2.73 ; THE LAMININ-BINDING DOMAIN OF AGRIN IS STRUCTURALLY RELATED TO N-TIMP-1 1NUV ; 1.81 ; THE LEADZYME RIBOZYME BOUND TO MG(H2O)6(II) AND SR(II) AT 1.8 A RESOLUTION 1NUJ ; 1.80 ; THE LEADZYME STRUCTURE BOUND TO MG(H20)6(II) AT 1.8 A RESOLUTION 1N4A ; 2.00 ; THE LIGAND BOUND STRUCTURE OF E.COLI BTUF, THE PERIPLASMIC BINDING PROTEIN FOR VITAMIN B12 1OLZ ; 2.00 ; THE LIGAND-BINDING FACE OF THE SEMAPHORINS REVEALED BY THE HIGH RESOLUTION CRYSTAL STRUCTURE OF SEMA4D 1N4D ; 3.00 ; THE LIGAND-FREE STRUCTURE OF E COLI BTUF, THE PERIPLASMIC BINDING PROTEIN FOR VITAMIN B12 2BFR ; 2.50 ; THE MACRO DOMAIN IS AN ADP-RIBOSE BINDING MODULE 1S2H ; -1.00 ; THE MAD2 SPINDLE CHECKPOINT PROTEIN POSSESSES TWO DISTINCT NATIVELY FOLDED STATES 1KLQ ; -1.00 ; THE MAD2 SPINDLE CHECKPOINT PROTEIN UNDERGOES SIMILAR MAJOR CONFORMATIONAL CHANGES UPON BINDING TO EITHER MAD1 OR CDC20 1VFR ; 1.80 ; THE MAJOR NAD(P)H:FMN OXIDOREDUCTASE FROM VIBRIO FISCHERI 1XQE ; 2.10 ; THE MECHANISM OF AMMONIA TRANSPORT BASED ON THE CRYSTAL STRUCTURE OF AMTB OF E. COLI. 1XQF ; 1.80 ; THE MECHANISM OF AMMONIA TRANSPORT BASED ON THE CRYSTAL STRUCTURE OF AMTB OF E. COLI. 1F2W ; 1.90 ; THE MECHANISM OF CYANAMIDE HYDRATION CATALYZED BY CARBONIC ANHYDRASE II REVEALED BY CRYOGENIC X-RAY DIFFRACTION 1W8R ; 1.93 ; THE MECHANISM OF THE SCHIFF BASE FORMING FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE: STRUCTURAL ANALYSIS OF REACTION INTERMEDIATES 1W8S ; 1.85 ; THE MECHANISM OF THE SCHIFF BASE FORMING FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE: STRUCTURAL ANALYSIS OF REACTION INTERMEDIATES 2BL2 ; 2.10 ; THE MEMBRANE ROTOR OF THE V-TYPE ATPASE FROM ENTEROCOCCUS HIRAE 1GO7 ; 2.10 ; THE METZINCIN'S METHIONINE: PRTC M226C-E189K DOUBLE MUTANT 1GO8 ; 2.00 ; THE METZINCIN'S METHIONINE: PRTC M226L MUTANT 1D2B ; -1.00 ; THE MMP-INHIBITORY, N-TERMINAL DOMAIN OF HUMAN TISSUE INHIBITOR OF METALLOPROTEINASES-1 (N-TIMP-1), SOLUTION NMR, 29 STRUCTURES 2BSG ; 15.00 ; THE MODELED STRUCTURE OF FIBRITIN (GPWAC) OF BACTERIOPHAGE T4 BASED ON CRYO-EM RECONSTRUCTION OF THE EXTENDED TAIL OF BACTERIOPHAGE T4 1XXM ; 1.90 ; THE MODULAR ARCHITECTURE OF PROTEIN-PROTEIN BINDING SITE 1R2A ; -1.00 ; THE MOLECULAR BASIS FOR PROTEIN KINASE A ANCHORING REVEALED BY SOLUTION NMR 1GKA ; 3.23 ; THE MOLECULAR BASIS OF THE COLORATION MECHANISM IN LOBSTER SHELL. BETA-CRUSTACYANIN AT 3.2 A RESOLUTION 1OIP ; 1.95 ; THE MOLECULAR BASIS OF VITAMIN E RETENTION: STRUCTURE OF HUMAN ALPHA-TOCOPHEROL TRANSFER PROTEIN 1OIZ ; 1.88 ; THE MOLECULAR BASIS OF VITAMIN E RETENTION: STRUCTURE OF HUMAN ALPHA-TOCOPHEROL TRANSFER PROTEIN 1Z24 ; 2.60 ; THE MOLECULAR STRUCTURE OF INSECTICYANIN FROM THE TOBACCO HORNWORM MANDUCA SEXTA L. AT 2.6 A RESOLUTION. 2A0Z ; 2.40 ; THE MOLECULAR STRUCTURE OF TOLL-LIKE RECEPTOR 3 LIGAND BINDING DOMAIN 1X8H ; 1.60 ; THE MONO-ZINC CARBAPENEMASE CPHA (N220G MUTANT) SHOWS A ZN(II)- NH2 ARG COORDINATION 1TZ8 ; 1.85 ; THE MONOCLINIC CRYSTAL STRUTURE OF TRANSTHYRETIN IN COMPLEX WITH DIETHYLSTILBESTROL 1VAP ; 1.60 ; THE MONOMERIC ASP49 SECRETORY PHOSPHOLIPASE A2 FROM THE VENOM OF AGKISTRIDON PISCIVORUS PISCIVORUS 3KAR ; 2.30 ; THE MOTOR DOMAIN OF KINESIN-LIKE PROTEIN KAR3, A SACCHAROMYCES CEREVISIAE KINESIN-RELATED PROTEIN 1U0O ; 2.70 ; THE MOUSE VON WILLEBRAND FACTOR A1-BOTROCETIN COMPLEX 2BA4 ; 2.40 ; THE MUTANT A222C OF AGROBACTERIUM RADIOBACTER N-CARBAMOYL-D- AMINO-ACID AMIDOHYDROLASE 2BA5 ; 2.30 ; THE MUTANT A302C OF AGROBACTERIUM RADIOBACTER N-CARBAMOYL-D- AMINO-ACID AMIDOHYDROLASE 2BA6 ; 2.40 ; THE MUTANT A68C-D72C OF DEINOCOCCUS RADIODURANS N-ACYLAMINO ACID RACEMASE 2BA8 ; 2.20 ; THE MUTANT A68C-D72C-NLQ OF DEINOCOCCUS RADIODURANS N- ACYLAMINO ACID RACEMASE 2BA7 ; 2.20 ; THE MUTANT E149C-A182C OF DEINOCOCCUS RADIODURANS N- ACYLAMINO ACID RACEMASE 2BAH ; 2.00 ; THE MUTANT G127C-T313C OF DEINOCOCCUS RADIODURANS N- ACYLAMINO ACID RACEMASE 2BAE ; 2.50 ; THE MUTANT Y218C OF DEINOCOCCUS RADIODURANS N-ACYLAMINO ACID RACEMASE 1E7N ; 2.35 ; THE N-TERMINAL DOMAIN OF BETA-B2-CRYSTALLIN RESEMBLES THE PUTATIVE ANCESTRAL HOMODIMER 1PKV ; 2.60 ; THE N-TERMINAL DOMAIN OF RIBOFLAVIN SYNTHASE IN COMPLEX WITH RIBOFLAVIN 1JRC ; 1.80 ; THE N67A MUTANT OF LACTOCOCCUS LACTIS DIHYDROOROTATE DEHYDROGENASE A 1RNL ; 2.40 ; THE NITRATE/NITRITE RESPONSE REGULATOR PROTEIN NARL FROM NARL 1FP6 ; 2.15 ; THE NITROGENASE FE PROTEIN FROM AZOTOBACTER VINELANDII COMPLEXED WITH MGADP 1YYJ ; -1.00 ; THE NMR SOLUTION STRUCTURE OF A REDESIGNED APOCYTOCHROME B562:RD-APOCYT B562 1IDI ; -1.00 ; THE NMR SOLUTION STRUCTURE OF ALPHA-BUNGAROTOXIN 1IDL ; -1.00 ; THE NMR SOLUTION STRUCTURE OF ALPHA-BUNGAROTOXIN 1F2G ; -1.00 ; THE NMR SOLUTION STRUCTURE OF THE 3FE FERREDOXIN II FROM DESULFOVIBRIO GIGAS, 15 STRUCTURES 1IDG ; -1.00 ; THE NMR SOLUTION STRUCTURE OF THE COMPLEX FORMED BETWEEN ALPHA-BUNGAROTOXIN AND AN 18MER COGNATE PEPTIDE 1IDH ; -1.00 ; THE NMR SOLUTION STRUCTURE OF THE COMPLEX FORMED BETWEEN ALPHA-BUNGAROTOXIN AND AN 18MER COGNATE PEPTIDE 1BW5 ; -1.00 ; THE NMR SOLUTION STRUCTURE OF THE HOMEODOMAIN OF THE RAT INSULIN GENE ENHANCER PROTEIN ISL-1, 50 STRUCTURES 1N8L ; -1.00 ; THE NMR SOLUTION STRUCTURE OF THE TYPE I RAT FATTY ACID SYNTHASE ACP DOMAIN. 1T3V ; -1.00 ; THE NMR SOLUTION STRUCTURE OF TM1816 1SA8 ; -1.00 ; THE NMR STRUCTURE OF A STABLE AND COMPACT ALL-BETA-SHEET VARIANT OF INTESTINAL FATTY ACID-BINDING PROTEIN 1T8V ; -1.00 ; THE NMR STRUCTURE OF D34A I-FABP: IMPLICATIONS FOR THE DETERMINANTS OF LIGAND BINDING STOICHIOMETRY 1DUF ; -1.00 ; THE NMR STRUCTURE OF DEOXYRIBONUCLEIC ACID DODECAMER DETERMINED IN AQUEOUS DILUTE LIQUID CRYSTALLINE PHASE 1GIP ; -1.00 ; THE NMR STRUCTURE OF DEOXYRIBONUCLEIC ACID DODECAMER DETERMINED IN AQUEOUS DILUTE LIQUID CRYSTALLINE PHASE 1PD6 ; -1.00 ; THE NMR STRUCTURE OF DOMAIN C2 OF HUMAN CARDIAC MYOSIN BINDING PROTEIN C 1DZ5 ; -1.00 ; THE NMR STRUCTURE OF THE 38KDA U1A PROTEIN-PIE RIBONUCLEIC ACID COMPLEX REVEALS THE BASIS OF COOPERATIVITY IN REGULATION OF POLYADENYLATION BY HUMAN U1A PROTEIN 1A63 ; -1.00 ; THE NMR STRUCTURE OF THE RIBONUCLEIC ACID BINDING DOMAIN OF E.COLI RHO FACTOR SUGGESTS POSSIBLE RIBONUCLEIC ACID-PROTEIN INTERACTIONS, 10 STRUCTURES 2HFH ; -1.00 ; THE NMR STRUCTURES OF A WINGED HELIX PROTEIN: GENESIS, 20 STRUCTURES 1QDI ; -1.00 ; THE NMR STUDY OF DEOXYRIBONUCLEIC ACID QUADRUPLEX STRUCTURE, (12MER) DEOXYRIBONUCLEIC ACID 1QDK ; -1.00 ; THE NMR STUDY OF DEOXYRIBONUCLEIC ACID QUADRUPLEX STRUCTURE, (12MER) DEOXYRIBONUCLEIC ACID 1QDF ; -1.00 ; THE NMR STUDY OF DEOXYRIBONUCLEIC ACID QUADRUPLEX STRUCTURE, APTAMER (15MER) DEOXYRIBONUCLEIC ACID 1QDH ; -1.00 ; THE NMR STUDY OF DEOXYRIBONUCLEIC ACID QUADRUPLEX STRUCTURE, APTAMER (15MER) DEOXYRIBONUCLEIC ACID 1K8V ; -1.00 ; THE NMR-DERIVED CONFORMATION OF NEUROPEPTIDE F FROM MONIEZIA EXPANSA 1U6C ; -1.00 ; THE NMR-DERIVED SOLUTION STRUCTURE OF THE (2S,3S)-N6-(2,3,4- TRIHYDROXYBUTYL)-2'-DEOXYADENOSYL DEOXYRIBONUCLEIC ACID ADDUCT OF BUTADIENE DIOL EPOXIDE 1UUT ; 2.00 ; THE NUCLEASE DOMAIN OF ADENO-ASSOCIATED VIRUS REP COMPLEXED WITH THE RBE' STEMLOOP OF THE VIRAL INVERTED TERMINAL REPEAT 1E2H ; 1.90 ; THE NUCLEOSIDE BINDING SITE OF HERPES SIMPLEX TYPE 1 THYMIDINE KINASE ANALYZED BY X-RAY CRYSTALLOGRAPHY 1E2I ; 1.90 ; THE NUCLEOSIDE BINDING SITE OF HERPES SIMPLEX TYPE 1 THYMIDINE KINASE ANALYZED BY X-RAY CRYSTALLOGRAPHY 1E2J ; 2.50 ; THE NUCLEOSIDE BINDING SITE OF HERPES SIMPLEX TYPE 1 THYMIDINE KINASE ANALYZED BY X-RAY CRYSTALLOGRAPHY 1OTC ; 2.80 ; THE O. NOVA TELOMERE END BINDING PROTEIN COMPLEXED WITH SINGLE STRAND DEOXYRIBONUCLEIC ACID 1ORF ; 2.40 ; THE OLIGOMERIC STRUCTURE OF HUMAN GRANZYME A REVEALS THE MOLECULAR DETERMINANTS OF SUBSTRATE SPECIFICITY 1TT6 ; 1.80 ; THE ORTHORHOMBIC CRYSTAL STRUCTURE OF TRANSTHYRETIN IN COMPLEX WITH DIETHYLSTILBESTROL 1YIC ; -1.00 ; THE OXIDIZED SACCHAROMYCES CEREVISIAE ISO-1-CYTOCHROME C, NMR, 20 STRUCTURES 1H6R ; 1.50 ; THE OXIDIZED STATE OF A REDOX SENSITIVE VARIANT OF GREEN FLUORESCENT PROTEIN 1ZO3 ; 13.80 ; THE P-SITE AND P/E-SITE TRNA STRUCTURES FITTED TO P/I SITE CODON. 1F42 ; 2.50 ; THE P40 DOMAIN OF HUMAN INTERLEUKIN-12 1JRB ; 1.90 ; THE P56A MUTANT OF LACTOCOCCUS LACTIS DIHYDROOROTATE DEHYDROGENASE A 1ML4 ; 1.80 ; THE PALA-LIGANDED ASPARTATE TRANSCARBAMOYLASE CATALYTIC SUBUNIT FROM PYROCOCCUS ABYSSI 1KA0 ; 1.80 ; THE PAPASE HAL2P COMPLEXED WITH A SODIUM ION AND THE REACTION PRODUCT AMP 1KA1 ; 1.30 ; THE PAPASE HAL2P COMPLEXED WITH CALCIUM AND MAGNESIUM IONS AND REACTION SUBSTRATE: PAP 1K9Y ; 1.90 ; THE PAPASE HAL2P COMPLEXED WITH MAGNESIUM IONS AND REACTION PRODUCTS: AMP AND INORGANIC PHOSPHATE 1K9Z ; 1.50 ; THE PAPASE HAL2P COMPLEXED WITH ZINC IONS 1JGO ; 5.60 ; THE PATH OF MESSENGER RIBONUCLEIC ACID THROUGH THE RIBOSOME. THIS FILE, 1JGO, CONTAINS THE 30S RIBOSOME SUBUNIT, THREE TRNA, AND MRNA MOLECULES. 50S RIBOSOME SUBUNIT IS IN THE FILE 1GIY 1JGP ; 7.00 ; THE PATH OF MESSENGER RIBONUCLEIC ACID THROUGH THE RIBOSOME. THIS FILE, 1JGP, CONTAINS THE 30S RIBOSOME SUBUNIT, THREE TRNA, AND MRNA MOLECULES. 50S RIBOSOME SUBUNIT IS IN THE FILE 1GIY 1JGQ ; 5.00 ; THE PATH OF MESSENGER RIBONUCLEIC ACID THROUGH THE RIBOSOME. THIS FILE, 1JGQ, CONTAINS THE 30S RIBOSOME SUBUNIT, THREE TRNA, AND MRNA MOLECULES. 50S RIBOSOME SUBUNIT IS IN THE FILE 1GIY 1M5Z ; -1.00 ; THE PDZ7 OF GLUTAMATE RECEPTOR INTERACTING PROTEIN BINDS TO ITS TARGET VIA A NOVEL HYDROPHOBIC SURFACE AREA 1RB8 ; 3.50 ; THE PHIX174 DEOXYRIBONUCLEIC ACID BINDING PROTEIN J IN TWO DIFFERENT CAPSID ENVIRONMENTS. 1PFH ; -1.00 ; THE PHOSPHORYLATED FORM OF THE HISTIDINE-CONTAINING PHOSPHOCARRIER PROTEIN HPR 1Q4K ; 2.30 ; THE POLO-BOX DOMAIN OF PLK1 IN COMPLEX WITH A PHOSPHO- PEPTIDE 2BK1 ; 29.00 ; THE PORE STRUCTURE OF PNEUMOLYSIN, OBTAINED BY FITTING THE ALPHA CARBON TRACE OF PERFRINGOLYSIN O INTO A CRYO-EM MAP 2BK2 ; 28.00 ; THE PREPORE STRUCTURE OF PNEUMOLYSIN, OBTAINED BY FITTING THE ALPHA CARBON TRACE OF PERFRINGOLYSIN O INTO A CRYO-EM MAP 1WKM ; 2.30 ; THE PRODUCT BOUND FORM OF THE MN(II)LOADED METHIONINE AMINOPEPTIDASE FROM HYPERTHERMOPHILE PYROCOCCUS FURIOSUS 1X9Y ; 2.50 ; THE PROSTAPHOPAIN B STRUCTURE 1JQX ; 1.70 ; THE R57A MUTANT OF LACTOCOCCUS LACTIS DIHYDROOROTATE DEHYDROGENASE A 117E ; 2.15 ; THE R78K AND D117E ACTIVE SITE VARIANTS OF SACCHAROMYCES CEREVISIAE SOLUBLE INORGANIC PYROPHOSPHATASE: STRUCTURAL STUDIES AND MECHANISTIC IMPLICATIONS 8PRK ; 1.85 ; THE R78K AND D117E ACTIVE SITE VARIANTS OF SACCHAROMYCES CEREVISIAE SOLUBLE INORGANIC PYROPHOSPHATASE: STRUCTURAL STUDIES AND MECHANISTIC IMPLICATIONS 1US8 ; 2.10 ; THE RAD50 SIGNATURE MOTIF: ESSENTIAL TO ATP BINDING AND BIOLOGICAL FUNCTION 1RRB ; -1.00 ; THE RAS-BINDING DOMAIN OF RAF-1 FROM RAT, NMR, 1 STRUCTURE 1NCN ; 2.70 ; THE RECEPTOR-BINDING DOMAIN OF HUMAN B7-2 1N7U ; 2.40 ; THE RECEPTOR-BINDING PROTEIN P2 OF BACTERIOPHAGE PRD1: CRYSTAL FORM I 1N7V ; 2.20 ; THE RECEPTOR-BINDING PROTEIN P2 OF BACTERIOPHAGE PRD1: CRYSTAL FORM III 3PTE ; 1.60 ; THE REFINED CRYSTALLOGRAPHIC STRUCTURE OF A DD-PEPTIDASE PENICILLIN-TARGET ENZYME AT 1.6 A RESOLUTION 1OHF ; 2.80 ; THE REFINED STRUCTURE OF NUDAURELIA CAPENSIS OMEGA VIRUS 2PEC ; 2.20 ; THE REFINED THREE-DIMENSIONAL STRUCTURE OF PECTATE LYASE C FROM ERWINIA CHRYSANTHEMI AT 2.2 ANGSTROMS RESOLUTION: 1KSR ; -1.00 ; THE REPEATING SEGMENTS OF THE F-ACTIN CROSS-LINKING GELATION FACTOR (ABP-120) HAVE AN IMMUNOGLOBULIN FOLD, NMR, 20 STRUCTURES 235L ; 1.90 ; THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE HYDROPHOBIC EFFECT 236L ; 1.90 ; THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE HYDROPHOBIC EFFECT 237L ; 1.70 ; THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE HYDROPHOBIC EFFECT 238L ; 1.80 ; THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE HYDROPHOBIC EFFECT 239L ; 1.80 ; THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE HYDROPHOBIC EFFECT 240L ; 1.75 ; THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE HYDROPHOBIC EFFECT 241L ; 1.70 ; THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE HYDROPHOBIC EFFECT 242L ; 1.80 ; THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE HYDROPHOBIC EFFECT 243L ; 1.75 ; THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE HYDROPHOBIC EFFECT 244L ; 1.70 ; THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE HYDROPHOBIC EFFECT 245L ; 1.80 ; THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE HYDROPHOBIC EFFECT 246L ; 1.80 ; THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE HYDROPHOBIC EFFECT 247L ; 1.75 ; THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE HYDROPHOBIC EFFECT 248L ; 1.90 ; THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE HYDROPHOBIC EFFECT 249L ; 1.90 ; THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE HYDROPHOBIC EFFECT 250L ; 1.80 ; THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE HYDROPHOBIC EFFECT 251L ; 2.60 ; THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE HYDROPHOBIC EFFECT 1Z4H ; -1.00 ; THE RESPONSE REGULATOR TORI BELONGS TO A NEW FAMILY OF ATYPICAL EXCISIONASE 1D8V ; -1.00 ; THE RESTRAINED AND MINIMIZED AVERAGE NMR STRUCTURE OF MAP30. 1Q5Q ; 2.60 ; THE RHODOCOCCUS 20S PROTEASOME 1Q5R ; 3.10 ; THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES 2FOW ; -1.00 ; THE RIBONUCLEIC ACID BINDING DOMAIN OF RIBOSOMAL PROTEIN L11: THREE-DIMENSIONAL STRUCTURE OF THE RIBONUCLEIC ACID-BOUND FORM OF THE PROTEIN, NMR, 26 STRUCTURES 1FOY ; -1.00 ; THE RIBONUCLEIC ACID BINDING DOMAIN OF RIBOSOMAL PROTEIN L11: THREE-DIMENSIONAL STRUCTURE OF THE RIBONUCLEIC ACID-BOUND FORM OF THE PROTEIN, NMR, MINIMIZED AVERAGE STRUCTURE 1I9K ; -1.00 ; THE RIBONUCLEIC ACID I-MOTIF 1SZ9 ; 2.10 ; THE RIBONUCLEIC ACID POLYMERASE II CTD IN MRNA PROCESSING: BETA-TURN RECOGNITION AND BETA-SPIRAL MODEL 1SZA ; 2.20 ; THE RIBONUCLEIC ACID POLYMERASE II CTD IN MRNA PROCESSING: BETA-TURN RECOGNITION AND BETA-SPIRAL MODEL 1WDP ; 1.27 ; THE ROLE OF AN INNER LOOP IN THE CATALYTIC MECHANISM OF SOYBEAN BETA-AMYLASE 1WDQ ; 1.28 ; THE ROLE OF AN INNER LOOP IN THE CATALYTIC MECHANISM OF SOYBEAN BETA-AMYLASE 1WDR ; 1.35 ; THE ROLE OF AN INNER LOOP IN THE CATALYTIC MECHANISM OF SOYBEAN BETA-AMYLASE 1WDS ; 1.64 ; THE ROLE OF AN INNER LOOP IN THE CATALYTIC MECHANISM OF SOYBEAN BETA-AMYLASE 1H6X ; 2.23 ; THE ROLE OF CONSERVED AMONI ACIDS IN THE CLEFT OF THE C-TERMINAL FAMILY 22 CARBOHYDRATE BINDING MODULE OF CLOSTRIDIUM THERMOCELLUM XYN10B IN LIGAND BINDING 1H6Y ; 2.12 ; THE ROLE OF CONSERVED AMONI ACIDS IN THE CLEFT OF THE C-TERMINAL FAMILY 22 CARBOHYDRATE BINDING MODULE OF CLOSTRIDIUM THERMOCELLUM XYN10B IN LIGAND BINDING 311D ; 2.20 ; THE ROLE OF HYDROGEN BONDING IN MINOR-GROOVE DRUG-DEOXYRIBONUCLEIC ACID RECOGNITION. STRUCTURE OF A BIS-AMIDINIUM DERIVATIVE OF HOECHST 33258 COMPLEXED TO THE DODECANUCLEOTIDE D(CGCGAATTCGCG)2 1NGT ; 2.04 ; THE ROLE OF MINOR GROOVE FUNCTIONAL GROUPS IN DEOXYRIBONUCLEIC ACID HYDRATION 1D5D ; 2.25 ; THE ROLE OF PHENYLALANINE 8 IN THE STABILIZATION OF THE S PROTEIN-S PEPTIDE INTERACTION: PACKING AND CAVITIES 1D5E ; 2.25 ; THE ROLE OF PHENYLALANINE 8 IN THE STABILIZATION OF THE S PROTEIN-S PEPTIDE INTERACTION: PACKING AND CAVITIES 1MIK ; 1.76 ; THE ROLE OF WATER MOLECULES IN THE STRUCTURE-BASED DESIGN OF (5-HYDROXYNORVALINE)-2-CYCLOSPORIN: SYNTHESIS, BIOLOGICAL ACTIVITY, AND CRYSTALLOGRAPHIC ANALYSIS WITH CYCLOPHILIN A 1V3H ; 1.60 ; THE ROLES OF GLU186 AND GLU380 IN THE CATALYTIC REACTION OF SOYBEAN BETA-AMYLASE 1V3I ; 1.90 ; THE ROLES OF GLU186 AND GLU380 IN THE CATALYTIC REACTION OF SOYBEAN BETA-AMYLASE 1EAN ; 1.70 ; THE RUNX1 RUNT DOMAIN AT 1.25A RESOLUTION: A STRUCTURAL SWITCH AND SPECIFICALLY BOUND CHLORIDE IONS MODULATE DEOXYRIBONUCLEIC ACID BINDING 1EAO ; 1.40 ; THE RUNX1 RUNT DOMAIN AT 1.25A RESOLUTION: A STRUCTURAL SWITCH AND SPECIFICALLY BOUND CHLORIDE IONS MODULATE DEOXYRIBONUCLEIC ACID BINDING 1EAQ ; 1.25 ; THE RUNX1 RUNT DOMAIN AT 1.25A RESOLUTION: A STRUCTURAL SWITCH AND SPECIFICALLY BOUND CHLORIDE IONS MODULATE DEOXYRIBONUCLEIC ACID BINDING 1N2M ; 1.90 ; THE S53A PROENZYME STRUCTURE OF METHANOCOCCUS JANNASCHII. 1MSV ; 1.75 ; THE S68A S-ADENOSYLMETHIONINE DECARBOXYLASE PROENZYME PROCESSING MUTANT. 1NMK ; 2.10 ; THE SANGLIFEHRIN-CYCLOPHILIN INTERACTION: DEGRADATION WORK, SYNTHETIC MACROCYCLIC ANALOGUES, X-RAY CRYSTAL STRUCTURE AND BINDING DATA 1H1J ; -1.00 ; THE SAP DOMAIN IS A DEOXYRIBONUCLEIC ACID-BINDING DOMAIN CAPABLE OF BINDING S/MAR DEOXYRIBONUCLEIC ACID 1CXW ; -1.00 ; THE SECOND TYPE II MODULE FROM HUMAN MATRIX METALLOPROTEINASE 2 1HQN ; 2.20 ; THE SELENOMETHIONINE DERIVATIVE OF P3, THE MAJOR COAT PROTEIN OF THE LIPID-CONTAINING BACTERIOPHAGE PRD1. 1ION ; 2.30 ; THE SEPTUM SITE-DETERMINING PROTEIN MIND COMPLEXED WITH MG- ADP FROM PYROCOCCUS HORIKOSHII OT3 1EKB ; 2.30 ; THE SERINE PROTEASE DOMAIN OF ENTEROPEPTIDASE BOUND TO INHIBITOR VAL-ASP-ASP-ASP-ASP-LYS-CHLOROMETHANE 1Z23 ; -1.00 ; THE SERINE-RICH DOMAIN FROM CRK-ASSOCIATED SUBSTRATE (P130CAS) 1AOJ ; 2.50 ; THE SH3 DOMAIN OF EPS8 EXISTS AS A NOVEL INTERTWINED DIMER 2FFH ; 3.20 ; THE SIGNAL SEQUENCE BINDING PROTEIN FFH FROM THERMUS AQUATICUS 1UAT ; 1.90 ; THE SIGNIFICANCE OF THE FLEXIBLE LOOP IN THE AZURIN (AZ- ISO2) FROM THE OBLIGATE METHYLOTROPH METHYLOMONAS SP. STRAIN J 3RAP ; 2.20 ; THE SMALL G PROTEIN RAP2 IN A NON CATALYTIC COMPLEX WITH GTP 2RAP ; 2.60 ; THE SMALL G PROTEIN RAP2A IN COMPLEX WITH GTP 1XSW ; -1.00 ; THE SOLID-STATE NMR STRUCTURE OF KALIOTOXIN 1QUT ; 2.44 ; THE SOLUBLE LYTIC TRANSGLYCOSYLASE SLT35 FROM ESCHERICHIA COLI IN COMPLEX WITH N-ACETYLGLUCOSAMINE 1PU3 ; -1.00 ; THE SOLUTION NMR STRUCTURE AND DYNAMICS OF A RECOMBINANT ONCONASE WITH ALTERED N-TERMINAL AND MET23 RESIDUES 1HM1 ; -1.00 ; THE SOLUTION NMR STRUCTURE OF A THERMALLY STABLE FAPY ADDUCT OF AFLATOXIN B1 IN AN OLIGODEOXYNUCLEOTIDE DUPLEX REFINED FROM DISTANCE RESTRAINED MOLECULAR DYNAMICS SIMULATED ANNEALING, MINIMIZED AVERAGE STRUCTURE 1AWO ; -1.00 ; THE SOLUTION NMR STRUCTURE OF ABL SH3 AND ITS RELATIONSHIP TO SH2 IN THE SH(32) CONSTRUCT, 20 STRUCTURES 1AGK ; -1.00 ; THE SOLUTION NMR STRUCTURE OF AN (R)-A-(N6-ADENYL)-STYRENE OXIDE-RAS61 OLIGODEOXYNUCLEOTIDE MODIFIED AT THE SECOND POSITION OF THE CODON 61 REGION, MINIMIZED AVERAGE STRUCTURE 1AGZ ; -1.00 ; THE SOLUTION NMR STRUCTURE OF AN (R)-A-(N6-ADENYL)-STYRENE OXIDE-RAS61 OLIGODEOXYNUCLEOTIDE MODIFIED AT THE THIRD POSITION OF THE CODON 61 REGION, MINIMIZED AVERAGE STRUCTURE 1AGO ; -1.00 ; THE SOLUTION NMR STRUCTURE OF AN (S)-A-(N6-ADENYL)-STYRENE OXIDE-RAS61 OLIGODEOXYNUCLEOTIDE MODIFIED AT THE THIRD POSITION OF THE CODON 61 REGION, MINIMIZED AVERAGE STRUCTURE 1AF1 ; -1.00 ; THE SOLUTION NMR STRUCTURE OF AN R-STYRENE OXIDE ADDUCT AT THE N2 POSITION OF GUANINE OF AN 11 BASE-PAIR OLIGONUCLEOTIDE SEQUENCE CODING FOR AMINO ACIDS 11-13 OF THE PRODUCT OF THE N-RAS PROTOONCOGENE, MINIMIZED AVERAGE STRUCTURE 1AP1 ; -1.00 ; THE SOLUTION NMR STRUCTURE OF AN S-STYRENE OXIDE ADDUCT AT THE N2 POSITION OF GUANINE OF AN 11 BASE-PAIR OLIGONUCLEOTIDE SEQUENCE CODING FOR AMINO ACIDS 11-13 OF THE PRODUCT OF THE N-RAS PROTOONCOGENE, MINIMIZED AVERAGE STRUCTURE 1A2S ; -1.00 ; THE SOLUTION NMR STRUCTURE OF OXIDIZED CYTOCHROME C6 FROM THE GREEN ALGA MONORAPHIDIUM BRAUNII, MINIMIZED AVERAGE STRUCTURE 1AW3 ; -1.00 ; THE SOLUTION NMR STRUCTURE OF OXIDIZED RAT MICROSOMAL CYTOCHROME B5, MINIMIZED AVERAGE STRUCTURE 1BFX ; -1.00 ; THE SOLUTION NMR STRUCTURE OF THE B FORM OF OXIDIZED RAT MICROSOMAL CYTOCHROME B5, MINIMIZED AVERAGE STRUCTURE 1AGU ; -1.00 ; THE SOLUTION NMR STRUCTURE OF THE C10R ADDUCT OF BENZO[A]PYRENE-DIOL-EPOXIDE AT THE N6 POSITION OF ADENINE OF AN 11 BASE-PAIR OLIGONUCLEOTIDE SEQUENCE CODING FOR AMINO ACIDS 60-62 OF THE PRODUCT OF THE N-RAS PROTOONCOGENE, MINIMIZED AVERAGE STRUCTURE 1BT7 ; -1.00 ; THE SOLUTION NMR STRUCTURE OF THE N-TERMINAL PROTEASE DOMAIN OF THE HEPATITIS C VIRUS (HCV) NS3-PROTEIN, FROM BK STRAIN, 20 STRUCTURES 1XV6 ; -1.00 ; THE SOLUTION STRUCTURE OF 2',5'-LINKED 3'-O-(2- METHOXYETHYL)-RIBONUCLEIC ACID HAIRPIN 1QGM ; -1.00 ; THE SOLUTION STRUCTURE OF A 30 RESIDUE AMINO-TERMINAL DOMAIN OF THE CARP GRANULIN-1 PROTEIN. 1FWO ; -1.00 ; THE SOLUTION STRUCTURE OF A 35-RESIDUE FRAGMENT FROM THE GRANULIN/EPITHELIN-LIKE SUBDOMAIN OF RICE ORYZAIN BETA (ROB 382-416 (C398S,C399S,C407S,C413S)) 1I7V ; -1.00 ; THE SOLUTION STRUCTURE OF A BAY REGION 1R-BENZ[A]ANTHRACENE OXIDE ADDUCT AT THE N6 POSITION OF ADENINE OF AN OLIGODEOXYNUCLEOTIDE CONTAINING THE HUMAN N-RAS CODON 61 SEQUENCE 1QBY ; -1.00 ; THE SOLUTION STRUCTURE OF A BAY-REGION 1R-BENZ[A]ANTHRACENE OXIDE ADDUCT AT THE N6 POSITION OF ADENINE OF AN OLIGODEOXYNUCLEOTIDE CONTAINING THE HUMAN N-RAS CODON 61 SEQUENCE 1DL4 ; -1.00 ; THE SOLUTION STRUCTURE OF A BAY-REGION 1S-BENZ[A]ANTHRACENE OXIDE ADDUCT AT THE N6 POSITION OF ADENINE OF AN OLIGODEOXYNUCLEOTIDE CONTAINING THE HUMAN N- RAS CODON 61 SEQUENCE 1BC4 ; -1.00 ; THE SOLUTION STRUCTURE OF A CYTOTOXIC RIBONUCLEASE FROM THE OOCYTES OF RANA CATESBEIANA (BULLFROG), NMR, 15 STRUCTURES 1DSW ; -1.00 ; THE SOLUTION STRUCTURE OF A MONOMERIC, REDUCED FORM OF HUMAN COPPER, ZINC SUPEROXIDE DISMUTASE BEARING THE SAME CHARGE AS THE NATIVE PROTEIN 1DJD ; -1.00 ; THE SOLUTION STRUCTURE OF A NON-BAY REGION 11R- BENZ[A]ANTHRACENE OXIDE ADDUCT AT THE N6 POSITION OF ADENINE OF AN OLIGODEOXYNUCLEOTIDE CONTAINING THE HUMAN N- RAS CODON 61 SEQUENCE 1YYX ; -1.00 ; THE SOLUTION STRUCTURE OF A REDESIGNED APOCYTOCHROME B562 (RD-APOCYT B562) AT 2.8M UREA 1YZA ; -1.00 ; THE SOLUTION STRUCTURE OF A REDESIGNED APOCYTOCHROME B562 (RD-APOCYT B562) WITH THE N-TERMINAL HELIX UNFOLDED 1BM5 ; -1.00 ; THE SOLUTION STRUCTURE OF A SITE-DIRECTED MUTANT (R111M) OF HUMAN CELLULAR RETIONIC ACID BINDING PROTEIN-TYPE II, NMR, 31 STRUCTURES 1U3K ; -1.00 ; THE SOLUTION STRUCTURE OF A SUBSTRATE OF ARCHAEAL PRE-TRNA SPLICING ENDONUCLEASES 1G26 ; -1.00 ; THE SOLUTION STRUCTURE OF A WELL-FOLDED PEPTIDE BASED ON THE 31-RESIDUE AMINO-TERMINAL SUBDOMAIN OF HUMAN GRANULIN A 1KLP ; -1.00 ; THE SOLUTION STRUCTURE OF ACYL CARRIER PROTEIN FROM MYCOBACTERIUM TUBERCULOSIS 1BA4 ; -1.00 ; THE SOLUTION STRUCTURE OF AMYLOID BETA-PEPTIDE (1-40) IN A WATER-MICELLE ENVIRONMENT. IS THE MEMBRANE-SPANNING DOMAIN WHERE WE THINK IT IS? NMR, 10 STRUCTURES 1AGH ; -1.00 ; THE SOLUTION STRUCTURE OF AN 11 BASE-PAIR OLIGONUCLEOTIDE DUPLEX CODING FOR AMINO ACIDS 60-62 OF THE PRODUCT OF THE N-RAS PROTOONCOGENE, NMR, MINIMIZED AVERAGE STRUCTURE 1AG5 ; -1.00 ; THE SOLUTION STRUCTURE OF AN AFLATOXIN B1 EPOXIDE ADDUCT AT THE N7 POSITION OF GUANINE OPPOSITE AN ADENINE IN THE COMPLEMENTARY STRAND OF AN OLIGODEOXYNUCLEOTIDE DUPLEX, NMR, MINIMIZED AVERAGE STRUCTURE 1P9Z ; -1.00 ; THE SOLUTION STRUCTURE OF ANTIFUNGAL PEPTIDE DISTINCT WITH A FIVE-DISULFIDE MOTIF FROM EUCOMMIA ULMOIDES OLIVER 1P8G ; -1.00 ; THE SOLUTION STRUCTURE OF APO COPZ FROM BACILLUS SUBTILIS 1OA5 ; -1.00 ; THE SOLUTION STRUCTURE OF BOVINE PANCREATIC TRYPSIN INHIBITOR AT HIGH PRESSURE 1OA6 ; -1.00 ; THE SOLUTION STRUCTURE OF BOVINE PANCREATIC TRYPSIN INHIBITOR AT HIGH PRESSURE 1HTH ; -1.00 ; THE SOLUTION STRUCTURE OF CYCLIC HUMAN PARATHYROID HORMONE FRAGMENT 1 - 34, NMR, 10 STRUCTURES 1C6S ; -1.00 ; THE SOLUTION STRUCTURE OF CYTOCHROME C6 FROM THE THERMOPHILIC CYANOBACTERIUM SYNECHOCOCCUS ELONGATUS, NMR, 20 STRUCTURES 1U64 ; -1.00 ; THE SOLUTION STRUCTURE OF D(G3T4G4)2 1LVS ; -1.00 ; THE SOLUTION STRUCTURE OF D(G4T4G3)2 1NNV ; -1.00 ; THE SOLUTION STRUCTURE OF HI1450 1PFD ; -1.00 ; THE SOLUTION STRUCTURE OF HIGH PLANT PARSLEY [2FE-2S] FERREDOXIN, NMR, 18 STRUCTURES 1HPY ; -1.00 ; THE SOLUTION STRUCTURE OF HUMAN PARATHYROID HORMONE FRAGMENT 1-34 IN 20% TRIFLUORETHANOL, NMR, 10 STRUCTURES 1BWX ; -1.00 ; THE SOLUTION STRUCTURE OF HUMAN PARATHYROID HORMONE FRAGMENT 1-39, NMR, 10 STRUCTURES 1BZG ; -1.00 ; THE SOLUTION STRUCTURE OF HUMAN PARATHYROID HORMONE-RELATED PROTEIN (1-34) IN NEAR-PHYSIOLOGICAL SOLUTION, NMR, 30 STRUCTURES 2A2V ; -1.00 ; THE SOLUTION STRUCTURE OF JINGZHAOTOXIN-XI 1YOP ; -1.00 ; THE SOLUTION STRUCTURE OF KTI11P 1J0T ; -1.00 ; THE SOLUTION STRUCTURE OF MOLT-INHIBITING HORMONE FROM THE KURUMA PRAWN 1KMG ; -1.00 ; THE SOLUTION STRUCTURE OF MONOMERIC COPPER-FREE SUPEROXIDE DISMUTASE 1AXX ; -1.00 ; THE SOLUTION STRUCTURE OF OXIDIZED RAT MICROSOMAL CYTOCHROME B5, NMR, 19 STRUCTURES 2AXX ; -1.00 ; THE SOLUTION STRUCTURE OF OXIDIZED RAT MICROSOMAL CYTOCHROME B5, NMR, 21 STRUCTURES 1DIP ; -1.00 ; THE SOLUTION STRUCTURE OF PORCINE DELTA-SLEEP-INDUCING PEPTIDE IMMUNOREACTIVE PEPTIDE, NMR, 10 STRUCTURES 1NMJ ; -1.00 ; THE SOLUTION STRUCTURE OF RAT AB-(1-28) AND ITS INTERACTION WITH ZINC: INSIGHTS INTO THE SCARITY OF AMYLOID DEPOSITION IN AGED RAT BRAIN 1L3N ; -1.00 ; THE SOLUTION STRUCTURE OF REDUCED DIMERIC COPPER ZINC SOD: THE STRUCTURAL EFFECTS OF DIMERIZATION 1BA9 ; -1.00 ; THE SOLUTION STRUCTURE OF REDUCED MONOMERIC SUPEROXIDE DISMUTASE, NMR, 36 STRUCTURES 1WIF ; -1.00 ; THE SOLUTION STRUCTURE OF RSGI RUH-020, A PDZ DOMAIN OF HYPOTHETICAL PROTEIN FROM MOUSE 1WIX ; -1.00 ; THE SOLUTION STRUCTURE OF RSGI RUH-026, CONSERVED DOMAIN OF HOOK1 PROTEIN FROM MOUSE 1SGG ; -1.00 ; THE SOLUTION STRUCTURE OF SAM DOMAIN FROM THE RECEPTOR TYROSINE KINASE EPHB2, NMR, 10 STRUCTURES 1FRY ; -1.00 ; THE SOLUTION STRUCTURE OF SHEEP MYELOID ANTIMICROBIAL PEPTIDE, RESIDUES 1-29 (SMAP29) 2COM ; -1.00 ; THE SOLUTION STRUCTURE OF THE 33RD FIBRONECTIN TYPE III DOMAIN OF HUMAN TENASCIN-X 2CUM ; -1.00 ; THE SOLUTION STRUCTURE OF THE 33RD FIBRONECTIN TYPE III DOMAIN OF HUMAN TENASCIN-X 1UYA ; -1.00 ; THE SOLUTION STRUCTURE OF THE A-FORM OF UROGUANYLIN-16 NMR, 10 STRUCTURES 2A00 ; -1.00 ; THE SOLUTION STRUCTURE OF THE AMP-PNP BOUND NUCLEOTIDE BINDING DOMAIN OF KDPB 2A29 ; -1.00 ; THE SOLUTION STRUCTURE OF THE AMP-PNP BOUND NUCLEOTIDE BINDING DOMAIN OF KDPB 1RZW ; -1.00 ; THE SOLUTION STRUCTURE OF THE ARCHAEGLOBUS FULGIDIS PROTEIN AF2095. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET GR4 1UYB ; -1.00 ; THE SOLUTION STRUCTURE OF THE B-FORM OF UROGUANYLIN-16 NMR, 10 STRUCTURES 1G84 ; -1.00 ; THE SOLUTION STRUCTURE OF THE C EPSILON2 DOMAIN FROM IGE 1X53 ; -1.00 ; THE SOLUTION STRUCTURE OF THE C-TERMINAL DOMAIN OF HUMAN ACTIVATOR OF 90 KDA HEAT SHOCK PROTEIN ATPASE HOMOLOG 1 1K42 ; -1.00 ; THE SOLUTION STRUCTURE OF THE CBM4-2 CARBOHYDRATE BINDING MODULE FROM A THERMOSTABLE RHODOTHERMUS MARINUS XYLANASE. 1K45 ; -1.00 ; THE SOLUTION STRUCTURE OF THE CBM4-2 CARBOHYDRATE BINDING MODULE FROM A THERMOSTABLE RHODOTHERMUS MARINUS XYLANASE. 2BUD ; -1.00 ; THE SOLUTION STRUCTURE OF THE CHROMO BARREL DOMAIN FROM THE MALES-ABSENT ON THE FIRST (MOF) PROTEIN 1QK9 ; -1.00 ; THE SOLUTION STRUCTURE OF THE DOMAIN FROM MECP2 THAT BINDS TO METHYLATED DEOXYRIBONUCLEIC ACID 1OIG ; -1.00 ; THE SOLUTION STRUCTURE OF THE DPY MODULE FROM THE DUMPY PROTEIN 1W1N ; -1.00 ; THE SOLUTION STRUCTURE OF THE FATC DOMAIN OF THE PROTEIN KINASE TOR1 FROM YEAST 1X5J ; -1.00 ; THE SOLUTION STRUCTURE OF THE FIFTH FIBRONECTIN TYPE III DOMAIN OF HUMAN NEOGENIN 1UDL ; -1.00 ; THE SOLUTION STRUCTURE OF THE FIFTH SH3 DOMAIN OF INTERSECTIN 2 (KIAA1256) 1X5F ; -1.00 ; THE SOLUTION STRUCTURE OF THE FIRST FIBRONECTIN TYPE III DOMAIN OF HUMAN NEOGENIN 1X5I ; -1.00 ; THE SOLUTION STRUCTURE OF THE FOURTH FIBRONECTIN TYPE III DOMAIN OF HUMAN NEOGENIN 1QQ3 ; -1.00 ; THE SOLUTION STRUCTURE OF THE HEME BINDING VARIANT ARG98CYS OF OXIDIZED ESCHERICHIA COLI CYTOCHROME B562 2AFF ; -1.00 ; THE SOLUTION STRUCTURE OF THE KI67FHA/HNIFK(226-269)3P COMPLEX 1MNX ; -1.00 ; THE SOLUTION STRUCTURE OF THE LOOP E REGION OF THE 5S RRNA FROM SPINACH CHLOROPLASTS. 1I4B ; -1.00 ; THE SOLUTION STRUCTURE OF THE MAJOR FAMILY OF THE MUTANT STEM LOOP C 5'UUA3' TRILOOP OF BROME MOSAIC VIRUS (+) STRAND RIBONUCLEIC ACID 1I4C ; -1.00 ; THE SOLUTION STRUCTURE OF THE MINOR FAMILY OF THE MUTANT STEM LOOP C 5'UUA3' TRILOOP OF BROME MOSAIC VIRUS (+) STRAND RIBONUCLEIC ACID 1JZC ; -1.00 ; THE SOLUTION STRUCTURE OF THE MUTANT 5'AUG3' TRILOOP IN THE RIBONUCLEIC ACID PROMOTER REGION OF THE BROME MOSAIC VIRUS GENOMIC (+)- RIBONUCLEIC ACID 1I46 ; -1.00 ; THE SOLUTION STRUCTURE OF THE MUTANT STEM LOOP C 5'GUA3' TRILOOP OF BROME MOSAIC VIRUS (+) STRAND RIBONUCLEIC ACID 1YFB ; -1.00 ; THE SOLUTION STRUCTURE OF THE N-DOMAIN OF THE TRANSCRIPTION FACTOR ABRB 1YSF ; -1.00 ; THE SOLUTION STRUCTURE OF THE N-DOMAIN OF THE TRANSCRIPTION FACTOR ABRB 1WCO ; -1.00 ; THE SOLUTION STRUCTURE OF THE NISIN-LIPID II COMPLEX 1SVJ ; -1.00 ; THE SOLUTION STRUCTURE OF THE NUCLEOTIDE BINDING DOMAIN OF KDPB 1U7Q ; -1.00 ; THE SOLUTION STRUCTURE OF THE NUCLEOTIDE BINDING DOMAIN OF KDPB 1RHW ; -1.00 ; THE SOLUTION STRUCTURE OF THE PH-INDUCED MONOMER OF DYNEIN LIGHT CHAIN LC8 FROM DROSOPHILA 1SXE ; -1.00 ; THE SOLUTION STRUCTURE OF THE POINTED (PNT) DOMAIN FROM THE TRANSCRITION FACTOR ERG 1X5G ; -1.00 ; THE SOLUTION STRUCTURE OF THE SECOND FIBRONECTIN TYPE III DOMAIN OF HUMAN NEOGENIN 1X5A ; -1.00 ; THE SOLUTION STRUCTURE OF THE SECOND FIBRONECTIN TYPE III DOMAIN OF MOUSE EPHRIN TYPE-A RECEPTOR 1 1ADZ ; -1.00 ; THE SOLUTION STRUCTURE OF THE SECOND KUNITZ DOMAIN OF TISSUE FACTOR PATHWAY INHIBITOR, NMR, 30 STRUCTURES 1X5C ; -1.00 ; THE SOLUTION STRUCTURE OF THE SECOND THIOREDOXIN-LIKE DOMAIN OF HUMAN PROTEIN DISULFIDE-ISOMERASE 1X5D ; -1.00 ; THE SOLUTION STRUCTURE OF THE SECOND THIOREDOXIN-LIKE DOMAIN OF HUMAN PROTEIN DISULFIDE-ISOMERASE A6 1X5K ; -1.00 ; THE SOLUTION STRUCTURE OF THE SIXTH FIBRONECTIN TYPE III DOMAIN OF HUMAN NEOGENIN 1NG7 ; -1.00 ; THE SOLUTION STRUCTURE OF THE SOLUBLE DOMAIN OF POLIOVIRUS 3A PROTEIN 1ESH ; -1.00 ; THE SOLUTION STRUCTURE OF THE STEM LOOP C 5'AUA3' TRILOOP OF BROME MOSAIC VIRUS (+) STRAND RIBONUCLEIC ACID 1LY7 ; -1.00 ; THE SOLUTION STRUCTURE OF THE THE C-TERMINAL DOMAIN OF FRATAXIN, THE PROTEIN RESPONSIBLE FOR FRIEDREICH ATAXIA 1X5E ; -1.00 ; THE SOLUTION STRUCTURE OF THE THIOREDOXIN-LIKE DOMAIN OF HUMAN THIOREDOXIN-RELATED TRANSMEMBRANE PROTEIN 1X5H ; -1.00 ; THE SOLUTION STRUCTURE OF THE THIRD FIBRONECTIN TYPE III DOMAIN OF HUMAN NEOGENIN 1IRH ; -1.00 ; THE SOLUTION STRUCTURE OF THE THIRD KUNITZ DOMAIN OF TISSUE FACTOR PATHWAY INHIBITOR 1X5B ; -1.00 ; THE SOLUTION STRUCTURE OF THE VHS DOMAIN OF HUMAN SIGNAL TRANSDUCING ADAPTOR MOLECULE 2 1B69 ; -1.00 ; THE SOLUTION STRUCTURE OF TN916 INTEGRASE N-TERMINAL DOMAIN/DEOXYRIBONUCLEIC ACID COMPLEX 1TN9 ; -1.00 ; THE SOLUTION STRUCTURE OF TN916 INTEGRASE N-TERMINAL DOMAIN/DEOXYRIBONUCLEIC ACID COMPLEX 2AFP ; -1.00 ; THE SOLUTION STRUCTURE OF TYPE II ANTIFREEZE PROTEIN REVEALS A NEW MEMBER OF THE LECTIN FAMILY 1P9K ; -1.00 ; THE SOLUTION STRUCTURE OF YBCJ FROM E. COLI REVEALS A RECENTLY DISCOVERED ALFAL MOTIF INVOLVED IN RIBONUCLEIC ACID-BINDING 1YHD ; -1.00 ; THE SOLUTION STRUCTURE OF YGGX FROM ESCHERICHIA COLI 1DXN ; -1.00 ; THE SOLUTION STRUCTURE OF [D(CGC)R(AAA)D(TTTGCG)]2: HYBRID JUNCTIONS FLANKED BY DEOXYRIBONUCLEIC ACID DUPLEXES 1L3M ; -1.00 ; THE SOLUTION STRUCTURE OF [D(CGC)R(AMAMAM)D(TTTGCG)]2 1WSO ; -1.00 ; THE SOLUTION STRUCTURES OF HUMAN OREXIN-A 1PXV ; 1.80 ; THE STAPHOSTATIN-STAPHOPAIN COMPLEX: A FORWARD BINDING INHIBITOR IN COMPLEX WITH ITS TARGET CYSTEINE PROTEASE 1OSW ; -1.00 ; THE STEM OF SL1 RIBONUCLEIC ACID IN HIV-1: STRUCTURE AND NUCLEOCAPSID PROTEIN BINDING FOR A 1X3 INTERNAL LOOP 1T7I ; 1.35 ; THE STRUCTURAL AND THERMODYNAMIC BASIS FOR THE BINDING OF TMC114, A NEXT-GENERATION HIV-1 PROTEASE INHIBITOR. 1F30 ; 2.85 ; THE STRUCTURAL BASIS FOR DEOXYRIBONUCLEIC ACID PROTECTION BY E. COLI DPS PROTEIN 1F33 ; 2.60 ; THE STRUCTURAL BASIS FOR DEOXYRIBONUCLEIC ACID PROTECTION BY E. COLI DPS PROTEIN 1UVN ; 3.00 ; THE STRUCTURAL BASIS FOR RIBONUCLEIC ACID SPECIFICITY AND CA2 INHIBITION OF AN RIBONUCLEIC ACID-DEPENDENT RIBONUCLEIC ACID POLYMERASE PHI6P2 CA2+ INHIBITION COMPLEX 1UVK ; 2.45 ; THE STRUCTURAL BASIS FOR RIBONUCLEIC ACID SPECIFICITY AND CA2 INHIBITION OF AN RIBONUCLEIC ACID-DEPENDENT RIBONUCLEIC ACID POLYMERASE PHI6P2 DEAD-END COMPLEX 1UVM ; 2.00 ; THE STRUCTURAL BASIS FOR RIBONUCLEIC ACID SPECIFICITY AND CA2 INHIBITION OF AN RIBONUCLEIC ACID-DEPENDENT RIBONUCLEIC ACID POLYMERASE PHI6P2 WITH 5NT RIBONUCLEIC ACID CONFORMATION A 1UVL ; 2.00 ; THE STRUCTURAL BASIS FOR RIBONUCLEIC ACID SPECIFICITY AND CA2 INHIBITION OF AN RIBONUCLEIC ACID-DEPENDENT RIBONUCLEIC ACID POLYMERASE PHI6P2 WITH 5NT RIBONUCLEIC ACID CONFORMATION B 1UVI ; 2.15 ; THE STRUCTURAL BASIS FOR RIBONUCLEIC ACID SPECIFICITY AND CA2 INHIBITION OF AN RIBONUCLEIC ACID-DEPENDENT RIBONUCLEIC ACID POLYMERASE PHI6P2 WITH 6NT RIBONUCLEIC ACID 1UVJ ; 1.90 ; THE STRUCTURAL BASIS FOR RIBONUCLEIC ACID SPECIFICITY AND CA2 INHIBITION OF AN RIBONUCLEIC ACID-DEPENDENT RIBONUCLEIC ACID POLYMERASE PHI6P2 WITH 7NT RIBONUCLEIC ACID 1YV3 ; 2.00 ; THE STRUCTURAL BASIS OF BLEBBISTATIN INHIBITION AND SPECIFICITY FOR MYOSIN II 1W98 ; 2.15 ; THE STRUCTURAL BASIS OF CDK2 ACTIVATION BY CYCLIN E 1MG9 ; 2.30 ; THE STRUCTURAL BASIS OF CLPS-MEDIATED SWITCH IN CLPA SUBSTRATE RECOGNITION 379D ; 3.10 ; THE STRUCTURAL BASIS OF HAMMERHEAD RIBOZYME SELF-CLEAVAGE 1DL7 ; 2.35 ; THE STRUCTURAL BASIS OF REPERTOIRE SHIFT IN AN IMMUNE RESPONSE TO PHOSPHOCHOLINE 1FZW ; 1.90 ; THE STRUCTURAL BASIS OF THE CATALYTIC MECHANISM AND REGULATION OF GLUCOSE-1-PHOSPHATE THYMIDYLYLTRANSFERASE (RMLA). APO ENZYME. 1G23 ; 2.80 ; THE STRUCTURAL BASIS OF THE CATALYTIC MECHANISM AND REGULATION OF GLUCOSE-1-PHOSPHATE THYMIDYLYLTRANSFERASE (RMLA). GLUCOSE-1-PHOSPHATE COMPLEX. 1G1L ; 1.77 ; THE STRUCTURAL BASIS OF THE CATALYTIC MECHANISM AND REGULATION OF GLUCOSE-1-PHOSPHATE THYMIDYLYLTRANSFERASE (RMLA). TDP-GLUCOSE COMPLEX. 1G3L ; 2.70 ; THE STRUCTURAL BASIS OF THE CATALYTIC MECHANISM AND REGULATION OF GLUCOSE-1-PHOSPHATE THYMIDYLYLTRANSFERASE (RMLA). TDP-L-RHAMNOSE COMPLEX. 1G0R ; 1.87 ; THE STRUCTURAL BASIS OF THE CATALYTIC MECHANISM AND REGULATION OF GLUCOSE-1-PHOSPHATE THYMIDYLYLTRANSFERASE (RMLA). THYMIDINE/GLUCOSE-1-PHOSPHATE COMPLEX. 1FXO ; 1.66 ; THE STRUCTURAL BASIS OF THE CATALYTIC MECHANISM AND REGULATION OF GLUCOSE-1-PHOSPHATE THYMIDYLYLTRANSFERASE (RMLA). TMP COMPLEX. 1G2V ; 2.60 ; THE STRUCTURAL BASIS OF THE CATALYTIC MECHANISM AND REGULATION OF GLUCOSE-1-PHOSPHATE THYMIDYLYLTRANSFERASE (RMLA). TTP COMPLEX. 1UW4 ; 1.95 ; THE STRUCTURAL BASIS OF THE INTERACTION BETWEEN NONSENSE MEDIATED DECAY FACTORS UPF2 AND UPF3 1PZ4 ; 1.35 ; THE STRUCTURAL DETERMINATION OF AN INSECT (MOSQUITO) STEROL CARRIER PROTEIN-2 WITH A LIGAND BOUND C16 FATTY ACID AT 1.35 A RESOLUTION 1DT3 ; 2.60 ; THE STRUCTURAL ORIGINS OF INTERFACIAL ACTIVATION IN THERMOMYCES (HUMICOLA) LANUGINOSA LIPASE 1DT5 ; 2.40 ; THE STRUCTURAL ORIGINS OF INTERFACIAL ACTIVATION IN THERMOMYCES (HUMICOLA) LANUGINOSA LIPASE 1DTE ; 2.35 ; THE STRUCTURAL ORIGINS OF INTERFACIAL ACTIVATION IN THERMOMYCES (HUMICOLA) LANUGINOSA LIPASE 1EIN ; 3.00 ; THE STRUCTURAL ORIGINS OF INTERFACIAL ACTIVATION IN THERMOMYCES (HUMICOLA) LANUGINOSA LIPASE 1DU4 ; 2.50 ; THE STRUCTURAL ORIGINS OF INTERFACIAL ACTIVATION IN THERMOMYCES (HUMICOLA) LANUGINOSA LIPASE OTHER STRUCTURE DETAILS 2BVY ; 2.25 ; THE STRUCTURE AND CHARACTERIZATION OF A MODULAR ENDO-BETA-1,4-MANNANASE FROM CELLULOMONAS FIMI 1P8K ; 2.60 ; THE STRUCTURE AND DEOXYRIBONUCLEIC ACID RECOGNITION OF A BIFUNCTIONAL HOMING ENDONUCLEASE AND GROUP I INTRON SPLICING FACTOR 1J5Q ; 2.55 ; THE STRUCTURE AND EVOLUTION OF THE MAJOR CAPSID PROTEIN OF A LARGE, LIPID-CONTAINING, DEOXYRIBONUCLEIC ACID VIRUS. 1S99 ; 1.65 ; THE STRUCTURE AND FUNCTION OF B. SUBTILIS YKOF GENE PRODUCT: LIGAND FREE PROTEIN 1SBR ; 2.30 ; THE STRUCTURE AND FUNCTION OF B. SUBTILIS YKOF GENE PRODUCT: THE COMPLEX WITH THIAMIN 1XE0 ; 1.70 ; THE STRUCTURE AND FUNCTION OF XENOPUS NO38-CORE, A HISTONE BINDING CHAPERONE IN THE NUCLEOLUS 1XB9 ; 1.90 ; THE STRUCTURE AND FUNCTION OF XENOPUS NO38-CORE, A HISTONE CHAPERONE IN THE NUCLEOLUS 1S2P ; 1.30 ; THE STRUCTURE AND REFINEMENT OF APOCRUSTACYANIN C2 TO 1.3A RESOLUTION AND THE SEARCH FOR DIFFERENCES BETWEEN THIS PROTEIN AND THE HOMOLOGOUS APOPROTEINS A1 AND C1 1S44 ; 1.60 ; THE STRUCTURE AND REFINEMENT OF APOCRUSTACYANIN C2 TO 1.6A RESOLUTION AND THE SEARCH FOR DIFFERENCES BETWEEN THIS PROTEIN AND THE HOMOLOGOUS APOPROTEINS A1 AND C1. 1BDM ; 1.80 ; THE STRUCTURE AT 1.8 ANGSTROMS RESOLUTION OF A SINGLE SITE MUTANT (T189I) OF MALATE DEHYDROGENASE FROM THERMUS FLAVUS WITH INCREASED ENZYMATIC ACTIVITY 1O5W ; 3.20 ; THE STRUCTURE BASIS OF SPECIFIC RECOGNITIONS FOR SUBSTRATES AND INHIBITORS OF RAT MONOAMINE OXIDASE A 1U1Z ; 2.50 ; THE STRUCTURE OF (3R)-HYDROXYACYL-ACP DEHYDRATASE (FABZ) 1H48 ; 2.30 ; THE STRUCTURE OF 2C-METHYL-D-ERYTHRITOL 2,4-CYCLODIPHOSPHATE SYNTHASE IN COMPLEX WITH CMP AND PRODUCT 2B7O ; 2.30 ; THE STRUCTURE OF 3-DEOXY-D-ARABINO-HEPTULOSONATE 7- PHOSPHATE SYNTHASE FROM MYCOBACTERIUM TUBERCULOSIS 1JPP ; 3.10 ; THE STRUCTURE OF A BETA-CATENIN BINDING REPEAT FROM ADENOMATOUS POLYPOSIS COLI (APC) IN COMPLEX WITH BETA- CATENIN 1TTE ; -1.00 ; THE STRUCTURE OF A CLASS II UBIQUITIN-CONJUGATING ENZYME, UBC1. 1NQY ; 2.09 ; THE STRUCTURE OF A COA PYROPHOSPHATASE FROM D. RADIODURANS 1NQZ ; 1.70 ; THE STRUCTURE OF A COA PYROPHOSPHATASE FROM D. RADIODURANS COMPLEXED WITH A MAGNESIUM ION 1KM8 ; 1.90 ; THE STRUCTURE OF A CYTOTOXIC RIBONUCLEASE FROM THE OOCYTE OF RANA CATESBEIANA (BULLFROG) 1KM9 ; 1.96 ; THE STRUCTURE OF A CYTOTOXIC RIBONUCLEASE FROM THE OOCYTE OF RANA CATESBEIANA (BULLFROG) 467D ; 2.16 ; THE STRUCTURE OF A DECAMER FORMING A FOUR-WAY JUNCTION 2C8N ; 2.90 ; THE STRUCTURE OF A FAMILY 51 ARABINOFURANOSIDASE, ARAF51, FROM CLOSTRIDIUM THERMOCELLUM IN COMPLEX WITH 1,3-LINKED ARABINOSIDE OF XYLOBIOSE. 2C7F ; 2.70 ; THE STRUCTURE OF A FAMILY 51 ARABINOFURANOSIDASE, ARAF51, FROM CLOSTRIDIUM THERMOCELLUM IN COMPLEX WITH 1,5-ALPHA-L- ARABINOTRIOSE. 2C3F ; 1.81 ; THE STRUCTURE OF A GROUP A STREPTOCOCCAL PHAGE-ENCODED TAIL-FIBRE SHOWING HYALURONAN LYASE ACTIVITY. 1NRW ; 1.70 ; THE STRUCTURE OF A HALOACID DEHALOGENASE-LIKE HYDROLASE FROM B. SUBTILIS 1Y58 ; -1.00 ; THE STRUCTURE OF A LACTOFERRICINB DERIVATIVE BOUND TO MICELLES 1Y5C ; -1.00 ; THE STRUCTURE OF A LACTOFERRICINB DERIVATIVE BOUND TO MICELLES (LFCINB4-14) 2BVT ; 2.90 ; THE STRUCTURE OF A MODULAR ENDO-BETA-1,4-MANNANASE FROM CELLULOMONAS FIMI EXPLAINS THE PRODUCT SPECIFICITY OF GLYCOSIDE HYDROLASE FAMILY 26 MANNANASES. 2BGG ; 2.20 ; THE STRUCTURE OF A PIWI PROTEIN FROM ARCHAEOGLOBUS FULGIDUS COMPLEXED WITH A 16NT SIRNA DUPLEX. 1W9H ; 1.95 ; THE STRUCTURE OF A PIWI PROTEIN FROM ARCHAEOGLOBUS FULGIDUS. 1RH5 ; 3.20 ; THE STRUCTURE OF A PROTEIN CONDUCTING CHANNEL 1RHZ ; 3.50 ; THE STRUCTURE OF A PROTEIN CONDUCTING CHANNEL 1ZX5 ; 2.30 ; THE STRUCTURE OF A PUTATIVE MANNOSEPHOSPHATE ISOMERASE FROM ARCHAEOGLOBUS FULGIDUS 1U63 ; 3.40 ; THE STRUCTURE OF A RIBOSOMAL PROTEIN L1-MRNA COMPLEX 1S03 ; 2.70 ; THE STRUCTURE OF A RIBOSOMAL PROTEIN S8/SPC OPERON MRNA COMPLEX 1XJR ; 2.70 ; THE STRUCTURE OF A RIGOROUSLY CONSERVED RIBONUCLEIC ACID ELEMENT WITHIN THE SARS VIRUS GENOME 1TKK ; 2.10 ; THE STRUCTURE OF A SUBSTRATE-LIGANDED COMPLEX OF THE L-ALA- D/L-GLU EPIMERASE FROM BACILLUS SUBTILIS 1GWC ; 2.25 ; THE STRUCTURE OF A TAU CLASS GLUTATHIONE S-TRANSFERASE FROM WHEAT, ACTIVE IN HERBICIDE DETOXIFICATION 1W9Y ; 2.10 ; THE STRUCTURE OF ACC OXIDASE 1WA6 ; 2.55 ; THE STRUCTURE OF ACC OXIDASE 1SEK ; 2.10 ; THE STRUCTURE OF ACTIVE SERPIN K FROM MANDUCA SEXTA AND A MODEL FOR SERPIN-PROTEASE COMPLEX FORMATION 1RKB ; 2.00 ; THE STRUCTURE OF ADRENAL GLAND PROTEIN AD-004 1SZN ; 1.54 ; THE STRUCTURE OF ALPHA-GALACTOSIDASE 1T0O ; 1.96 ; THE STRUCTURE OF ALPHA-GALACTOSIDASE FROM TRICHODERMA REESEI COMPLEXED WITH BETA-D-GALACTOSE 1KTB ; 1.90 ; THE STRUCTURE OF ALPHA-N-ACETYLGALACTOSAMINIDASE 1KTC ; 2.40 ; THE STRUCTURE OF ALPHA-N-ACETYLGALACTOSAMINIDASE 1ZQ4 ; 3.20 ; THE STRUCTURE OF AN 8R-LIPOXYGENASE REVEALS THE STRUCTURAL BASIS FOR CALCIUM-REGULATED MEMBRANE BINDING 1U5U ; 2.00 ; THE STRUCTURE OF AN ALLENE OXIDE SYNTHASE REVEALS A NOVEL USE FOR A CATALASE FOLD 1ZA6 ; 2.80 ; THE STRUCTURE OF AN ANTITUMOR CH2-DOMAIN-DELETED HUMANIZED ANTIBODY 1Z31 ; -1.00 ; THE STRUCTURE OF AN ENZYME-ACTIVATING FRAGMENT OF HUMAN TELOMERASE RIBONUCLEIC ACID 1UZC ; -1.00 ; THE STRUCTURE OF AN FF DOMAIN FROM HUMAN HYPA/FBP11 1FAV ; 3.00 ; THE STRUCTURE OF AN HIV-1 SPECIFIC CELL ENTRY INHIBITOR IN COMPLEX WITH THE HIV-1 GP41 TRIMERIC CORE 1A6A ; 2.75 ; THE STRUCTURE OF AN INTERMEDIATE IN CLASS II MHC MATURATION: CLIP BOUND TO HLA-DR3 280D ; 2.40 ; THE STRUCTURE OF AN RIBONUCLEIC ACID DODECAMER SHOWS HOW TANDEM U-U BASE PAIRS INCREASE THE RANGE OF STABLE RIBONUCLEIC ACID STRUCTURES AND THE DIVERSITY OF RECOGNITION SITES 1JOH ; 1.40 ; THE STRUCTURE OF ANTIAMOEBIN I, A MEMBRANE-ACTIVE PEPTIDE 1HL4 ; 1.82 ; THE STRUCTURE OF APO TYPE HUMAN CU, ZN SUPEROXIDE DISMUTASE 1YLE ; 1.70 ; THE STRUCTURE OF ARGININE/ORNITHINE SUCCINYLTRANSFERASE SUBUNIT AI FROM PSEUDOMONAS AERUGINOSA. 1KS4 ; 2.50 ; THE STRUCTURE OF ASPERGILLUS NIGER ENDOGLUCANASE-PALLADIUM COMPLEX 1S58 ; 3.50 ; THE STRUCTURE OF B19 PARVOVIRUS CAPSID 1OGC ; 2.00 ; THE STRUCTURE OF BACILLUS SUBTILIS RBSD COMPLEXED WITH D-RIBOSE 1OGD ; 1.95 ; THE STRUCTURE OF BACILLUS SUBTILIS RBSD COMPLEXED WITH D-RIBOSE 1OGF ; 2.30 ; THE STRUCTURE OF BACILLUS SUBTILIS RBSD COMPLEXED WITH GLYCEROL 1OGE ; 2.05 ; THE STRUCTURE OF BACILLUS SUBTILIS RBSD COMPLEXED WITH RIBOSE 5-PHOSPHATE 1ZP7 ; 2.25 ; THE STRUCTURE OF BACILLUS SUBTILIS RECU HOLLIDAY JUNCTION RESOLVASE AND ITS ROLE IN SUBSTRATE SELECTION AND SEQUENCE SPECIFIC CLEAVAGE. 1NOH ; 2.80 ; THE STRUCTURE OF BACTERIOPHAGE PHI29 SCAFFOLDING PROTEIN GP7 AFTER PROHEAD ASSEMBLY 1O0L ; -1.00 ; THE STRUCTURE OF BCL-W REVEALS A ROLE FOR THE C-TERMINAL RESIDUES IN MODULATING BIOLOGICAL ACTIVITY 1G5X ; 2.45 ; THE STRUCTURE OF BETA-KETOACYL-[ACYL CARRIER PROTEIN] SYNTHASE I 1FJ8 ; 2.27 ; THE STRUCTURE OF BETA-KETOACYL-[ACYL CARRIER PROTEIN] SYNTHASE I IN COMPLEX WITH CERULENIN, IMPLICATIONS FOR DRUG DESIGN 1FJ4 ; 2.35 ; THE STRUCTURE OF BETA-KETOACYL-[ACYL CARRIER PROTEIN] SYNTHASE I IN COMPLEX WITH THIOLACTOMYCIN, IMPLICATIONS FOR DRUG DESIGN 1Q7B ; 2.05 ; THE STRUCTURE OF BETAKETOACYL-[ACP] REDUCTASE FROM E. COLI IN COMPLEX WITH NADP+ 1Q7C ; 2.50 ; THE STRUCTURE OF BETAKETOACYL-[ACP] REDUCTASE Y151F MUTANT IN COMPLEX WITH NADPH FRAGMENT 1KVK ; 2.40 ; THE STRUCTURE OF BINARY COMPLEX BETWEEN A MAMMALIAN MEVALONATE KINASE AND ATP: INSIGHTS INTO THE REACTION MECHANISM AND HUMAN INHERITED DISEASE 1DV2 ; 2.50 ; THE STRUCTURE OF BIOTIN CARBOXYLASE, MUTANT E288K, COMPLEXED WITH ATP 1DAB ; 2.50 ; THE STRUCTURE OF BORDETELLA PERTUSSIS VIRULENCE FACTOR P.69 PERTACTIN 2AKQ ; 3.00 ; THE STRUCTURE OF BOVINE B-LACTOGLOBULIN A IN CRYSTALS GROWN AT VERY LOW IONIC STRENGTH 1NBM ; 3.00 ; THE STRUCTURE OF BOVINE F1-ATPASE COVALENTLY INHIBITED WITH 4-CHLORO-7-NITROBENZOFURAZAN 1GMJ ; 2.20 ; THE STRUCTURE OF BOVINE IF1, THE REGULATORY SUBUNIT OF MITOCHONDRIAL F-ATPASE 1VQ6 ; 2.70 ; THE STRUCTURE OF C-HPMN AND CCA-PHE-CAP-BIO BOUND TO THE LARGE RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI 1CNP ; -1.00 ; THE STRUCTURE OF CALCYCLIN REVEALS A NOVEL HOMODIMERIC FOLD FOR S100 CA2+-BINDING PROTEINS, NMR, 22 STRUCTURES 1W92 ; 1.70 ; THE STRUCTURE OF CARBOMONOXY MURINE NEUROGLOBIN REVEALS A HEME-SLIDING MECHANISM FOR AFFINITY REGULATION 1OPO ; 3.20 ; THE STRUCTURE OF CARNATION MOTTLE VIRUS 1VQN ; 2.40 ; THE STRUCTURE OF CC-HPMN AND CCA-PHE-CAP-BIO BOUND TO THE LARGE RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI 1VQ9 ; 2.40 ; THE STRUCTURE OF CCA-PHE-CAP-BIO AND THE ANTIBIOTIC SPARSOMYCIN BOUND TO THE LARGE RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI 1VQ8 ; 2.20 ; THE STRUCTURE OF CCDA-PHE-CAP-BIO AND THE ANTIBIOTIC SPARSOMYCIN BOUND TO THE LARGE RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI 1VQK ; 2.30 ; THE STRUCTURE OF CCDA-PHE-CAP-BIO BOUND TO THE A SITE OF THE RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI 1VQO ; 2.20 ; THE STRUCTURE OF CCPMN BOUND TO THE LARGE RIBOSOMAL SUBUNIT HALOARCULA MARISMORTUI 1FVV ; 2.80 ; THE STRUCTURE OF CDK2/CYCLIN A IN COMPLEX WITH AN OXINDOLE INHIBITOR 1IUL ; 2.00 ; THE STRUCTURE OF CELL-FREE ID.343 FROM THERMUS THERMOPHILUS 1TYF ; 2.20 ; THE STRUCTURE OF CLPP AT 2.3 ANGSTROM RESOLUTION SUGGESTS A MODEL FOR ATP-DEPENDENT PROTEOLYSIS 1H7E ; 1.83 ; THE STRUCTURE OF CMP:2-KETO-3-DEOXY-MANNO-OCTONIC ACID SYNTHETASE AND OF ITS COMPLEXES WITH SUBSTRATES AND SUBSTRATE ANALOGUES, APO-ENZYME 1H7H ; 2.30 ; THE STRUCTURE OF CMP:2-KETO-3-DEOXY-MANNO-OCTONIC ACID SYNTHETASE AND OF ITS COMPLEXES WITH SUBSTRATES AND SUBSTRATE ANALOGUES, CDP COMPLEX 1H7F ; 2.12 ; THE STRUCTURE OF CMP:2-KETO-3-DEOXY-MANNO-OCTONIC ACID SYNTHETASE AND OF ITS COMPLEXES WITH SUBSTRATES AND SUBSTRATE ANALOGUES, CMP COMPLEX 1H7G ; 2.13 ; THE STRUCTURE OF CMP:2-KETO-3-DEOXY-MANNO-OCTONIC ACID SYNTHETASE AND OF ITS COMPLEXES WITH SUBSTRATES AND SUBSTRATE ANALOGUES, CTP MG2+ COMPLEX 1H7T ; 2.48 ; THE STRUCTURE OF CMP:2-KETO-3-DEOXY-MANNO-OCTONIC ACID SYNTHETASE AND OF ITS COMPLEXES WITH SUBSTRATES AND SUBSTRATE ANALOGUES, HERE COMPLEX WITH CMP-NEUAC, CMP-NEUAC COMPLEX 1GQC ; 2.60 ; THE STRUCTURE OF CMP:2-KETO-3-DEOXY-MANNO-OCTONIC ACID SYNTHETASE COMPLEXED WITH CMP-KDO AT 100K 1GQ9 ; 2.60 ; THE STRUCTURE OF CMP:2-KETO-3-DEOXY-MANNO-OCTONIC ACID SYNTHETASE COMPLEXED WITH CTP AT 100K 1P2A ; 2.50 ; THE STRUCTURE OF CYCLIN DEPENDENT KINASE 2 (CKD2) WITH A TRISUBSTITUTED NAPHTHOSTYRIL INHIBITOR 1JSV ; 1.96 ; THE STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 (CDK2) IN COMPLEX WITH 4-[(6-AMINO-4-PYRIMIDINYL) AMINO]BENZENESULFONAMIDE 1DI8 ; 2.20 ; THE STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 (CDK2) IN COMPLEX WITH 4-[3-HYDROXYANILINO]-6,7-DIMETHOXYQUINAZOLINE 1FVT ; 2.20 ; THE STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 (CDK2) IN COMPLEX WITH AN OXINDOLE INHIBITOR 1CED ; -1.00 ; THE STRUCTURE OF CYTOCHROME C6 FROM MONORAPHIDIUM BRAUNII, NMR, MINIMIZED AVERAGE STRUCTURE 362D ; 1.30 ; THE STRUCTURE OF D(TGCGCA)2 AND A COMPARISON TO OTHER Z-DEOXYRIBONUCLEIC ACID HEXAMERS 1LJX ; 1.64 ; THE STRUCTURE OF D(TPGPCPGPCPA)2 AT 293K: COMPARISON OF THE EFFECT OF SEQUENCE AND TEMPERATURE 1TG8 ; 2.61 ; THE STRUCTURE OF DENGUE VIRUS E GLYCOPROTEIN 1GDJ ; 1.70 ; THE STRUCTURE OF DEOXY-AND OXY-LEGHAEMOGLOBIN FROM LUPIN 1XJW ; 2.71 ; THE STRUCTURE OF E. COLI ASPARTATE TRANSCARBAMOYLASE Q137A MUTANT IN THE R-STATE 1YKI ; 1.70 ; THE STRUCTURE OF E. COLI NITROREDUCTASE BOUND WITH THE ANTIBIOTIC NITROFURAZONE 1YLU ; 2.00 ; THE STRUCTURE OF E. COLI NITROREDUCTASE WITH BOUND ACETATE, CRYSTAL FORM 2 2BNE ; 2.30 ; THE STRUCTURE OF E. COLI UMP KINASE IN COMPLEX WITH UMP 2BNF ; 2.45 ; THE STRUCTURE OF E. COLI UMP KINASE IN COMPLEX WITH UTP 1YLR ; 1.70 ; THE STRUCTURE OF E.COLI NITROREDUCTASE WITH BOUND ACETATE, CRYSTAL FORM 1 2BND ; 2.60 ; THE STRUCTURE OF E.COLI UMP KINASE IN COMPLEX WITH UDP 1R8L ; 2.60 ; THE STRUCTURE OF ENDO-BETA-1,4-GALACTANASE FROM BACILLUS LICHENIFORMIS 1UR0 ; 2.50 ; THE STRUCTURE OF ENDO-BETA-1,4-GALACTANASE FROM BACILLUS LICHENIFORMIS IN COMPLEX WITH TWO OLIGOSACCHARIDE PRODUCTS. 1UR4 ; 2.20 ; THE STRUCTURE OF ENDO-BETA-1,4-GALACTANASE FROM BACILLUS LICHENIFORMIS IN COMPLEX WITH TWO OLIGOSACCHARIDE PRODUCTS. 1KS8 ; 1.40 ; THE STRUCTURE OF ENDOGLUCANASE FROM TERMITE, NASUTITERMES TAKASAGOENSIS, AT PH 2.5. 1KSC ; 1.55 ; THE STRUCTURE OF ENDOGLUCANASE FROM TERMITE, NASUTITERMES TAKASAGOENSIS, AT PH 5.6. 1KSD ; 1.60 ; THE STRUCTURE OF ENDOGLUCANASE FROM TERMITE, NASUTITERMES TAKASAGOENSIS, AT PH 6.5. 1MFG ; 1.25 ; THE STRUCTURE OF ERBIN PDZ DOMAIN BOUND TO THE CARBOXY- TERMINAL TAIL OF THE ERBB2 RECEPTOR 1MFL ; 1.88 ; THE STRUCTURE OF ERBIN PDZ DOMAIN BOUND TO THE CARBOXY- TERMINAL TAIL OF THE ERBB2 RECEPTOR 1TVO ; 2.50 ; THE STRUCTURE OF ERK2 IN COMPLEX WITH A SMALL MOLECULE INHIBITOR 1K6W ; 1.75 ; THE STRUCTURE OF ESCHERICHIA COLI CYTOSINE DEAMINASE 1K70 ; 1.80 ; THE STRUCTURE OF ESCHERICHIA COLI CYTOSINE DEAMINASE BOUND TO 4-HYDROXY-3,4-DIHYDRO-1H-PYRIMIDIN-2-ONE 1ICR ; 1.70 ; THE STRUCTURE OF ESCHERICHIA COLI NITROREDUCTASE COMPLEXED WITH NICOTINIC ACID 1ICU ; 1.80 ; THE STRUCTURE OF ESCHERICHIA COLI NITROREDUCTASE COMPLEXED WITH NICOTINIC ACID 1ICV ; 2.40 ; THE STRUCTURE OF ESCHERICHIA COLI NITROREDUCTASE COMPLEXED WITH NICOTINIC ACID 1UOM ; 2.28 ; THE STRUCTURE OF ESTROGEN RECEPTOR IN COMPLEX WITH A SELECTIVE AND POTENT TETRAHYDROISOCHIOLIN LIGAND. 1FXX ; 2.40 ; THE STRUCTURE OF EXONUCLEASE I SUGGESTS HOW PROCESSIVITY IS ACHIEVED 1T66 ; 2.30 ; THE STRUCTURE OF FAB WITH INTERMEDIATE AFFINITY FOR FLUORESCEIN. 1SZK ; 2.52 ; THE STRUCTURE OF GAMMA-AMINOBUTYRATE AMINOTRANSFERASE MUTANT: E211S 1SZS ; 2.10 ; THE STRUCTURE OF GAMMA-AMINOBUTYRATE AMINOTRANSFERASE MUTANT: I50Q 1SZU ; 2.52 ; THE STRUCTURE OF GAMMA-AMINOBUTYRATE AMINOTRANSFERASE MUTANT: V241A 1W8I ; 2.10 ; THE STRUCTURE OF GENE PRODUCT AF1683 FROM ARCHAEOGLOBUS FULGIDUS. 1ZS7 ; 1.85 ; THE STRUCTURE OF GENE PRODUCT APE0525 FROM AEROPYRUM PERNIX 1YWG ; 2.60 ; THE STRUCTURE OF GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE FROM PLASMODIUM FALCIPARUM 2AMV ; 2.30 ; THE STRUCTURE OF GLYCOGEN PHOSPHORYLASE B WITH AN ALKYL- DIHYDROPYRIDINE-DICARBOXYLIC ACID 1SVD ; 1.80 ; THE STRUCTURE OF HALOTHIOBACILLUS NEAPOLITANUS RUBISCO 2C0K ; 2.60 ; THE STRUCTURE OF HEMOGLOBIN FROM THE BOTFLY GASTEROPHILUS INTESTINALIS 1WTN ; 1.13 ; THE STRUCTURE OF HEW LYSOZYME ORTHORHOMBIC CRYSTAL GROWTH UNDER A HIGH MAGNETIC FIELD 1HH1 ; 2.15 ; THE STRUCTURE OF HJC, A HOLLIDAY JUNCTION RESOLVING ENZYME FROM SULFOLOBUS SOLFATARICUS 1HL5 ; 1.80 ; THE STRUCTURE OF HOLO TYPE HUMAN CU, ZN SUPEROXIDE DISMUTASE 1NA1 ; 3.30 ; THE STRUCTURE OF HRV14 WHEN COMPLEXED WITH PLECONARIL 1NCQ ; 2.50 ; THE STRUCTURE OF HRV14 WHEN COMPLEXED WITH PLECONARIL, AN ANTIVIRAL COMPOUND 1ND3 ; 2.80 ; THE STRUCTURE OF HRV16, WHEN COMPLEXED WITH PLECONARIL, AN ANTIVIRAL COMPOUND 1SOH ; -1.00 ; THE STRUCTURE OF HUMAN APOLIPOPROTEIN C-II IN DODECYL PHOSPHOCHOLINE 1UMK ; 1.75 ; THE STRUCTURE OF HUMAN ERYTHROCYTE NADH-CYTOCHROME B5 REDUCTASE 1ZLY ; 2.07 ; THE STRUCTURE OF HUMAN GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE IN COMPLEX WITH ALPHA,BETA-N- (HYDROXYACETYL)-D-RIBOFURANOSYLAMINE AND 10-FORMYL-5,8, DIDEAZAFOLATE 1JY7 ; 3.20 ; THE STRUCTURE OF HUMAN METHEMOGLOBIN. THE VARIATION OF A THEME 1ZSY ; 1.75 ; THE STRUCTURE OF HUMAN MITOCHONDRIAL 2-ENOYL THIOESTER REDUCTASE (CGI-63) 1OF7 ; 2.40 ; THE STRUCTURE OF HUMAN MITOCHONDRIAL ALDEHYDE DEHYDROGENASE IN COMPLEX WITH THE ANTIDIPSOTROPIC INHIBITOR DAIDZIN 1N0J ; 2.20 ; THE STRUCTURE OF HUMAN MITOCHONDRIAL MN3+ SUPEROXIDE DISMUTASE REVEALS A NOVEL TETRAMERIC INTERFACE OF TWO 4- HELIX BUNDLES 1QAB ; 3.20 ; THE STRUCTURE OF HUMAN RETINOL BINDING PROTEIN WITH ITS CARRIER PROTEIN TRANSTHYRETIN REVEALS INTERACTION WITH THE CARBOXY TERMINUS OF RBP 1U0K ; 1.50 ; THE STRUCTURE OF HYPOTHETICAL PROTEIN PA4716 FROM PSEUDOMONAS AERUGINOSA 1TGE ; 12.50 ; THE STRUCTURE OF IMMATURE DENGUE VIRUS AT 12.5 ANGSTROM 1N6G ; 16.00 ; THE STRUCTURE OF IMMATURE DENGUE-2 PRM PARTICLES 1NA4 ; -1.00 ; THE STRUCTURE OF IMMATURE YELLOW FEVER VIRUS PARTICLE 1PMV ; 2.50 ; THE STRUCTURE OF JNK3 IN COMPLEX WITH A DIHYDROANTHRAPYRAZOLE INHIBITOR 1PMQ ; 2.20 ; THE STRUCTURE OF JNK3 IN COMPLEX WITH AN IMIDAZOLE- PYRIMIDINE INHIBITOR 1SUZ ; 1.80 ; THE STRUCTURE OF K92A ECORV BOUND TO COGNATE DEOXYRIBONUCLEIC ACID AND MG2+ 1PKL ; 2.35 ; THE STRUCTURE OF LEISHMANIA PYRUVATE KINASE 1M3Y ; 2.00 ; THE STRUCTURE OF MAJOR CAPSID PROTEIN OF A LARGE, LIPID CONTAINING, DEOXYRIBONUCLEIC ACID VIRUS 1T5E ; 3.00 ; THE STRUCTURE OF MEXA 2BM4 ; 2.20 ; THE STRUCTURE OF MFPA (RV3361C, C2 CRYSTAL FORM). THE PENTAPEPTIDE REPEAT PROTEIN FROM MYCOBACTERIUM TUBERCULOSIS FOLDS AS A RIGHT-HANDED QUADRILATERAL BETA- HELIX. 2BM6 ; 2.20 ; THE STRUCTURE OF MFPA (RV3361C, C2221 CRYSTAL FORM). THE PENTAPEPTIDE REPEAT PROTEIN FROM MYCOBACTERIUM TUBERCULOSIS FOLDS AS A RIGHT-HANDED QUADRILATERAL BETA- HELIX. 2BM5 ; 2.00 ; THE STRUCTURE OF MFPA (RV3361C, P21 CRYSTAL FORM). THE PENTAPEPTIDE REPEAT PROTEIN FROM MYCOBACTERIUM TUBERCULOSIS FOLDS AS A RIGHT-HANDED QUADRILATERAL BETA- HELIX. 2BM7 ; 2.70 ; THE STRUCTURE OF MFPA (RV3361C, P3221 CRYSTAL FORM). THE PENTAPEPTIDE REPEAT PROTEIN FROM MYCOBACTERIUM TUBERCULOSIS FOLDS AS A RIGHT-HANDED QUADRILATERAL BETA- HELIX. 1Q71 ; -1.00 ; THE STRUCTURE OF MICROCIN J25 IS A THREADED SIDECHAIN-TO- BACKBONE RING STRUCTURE AND NOT A HEAD-TO-TAIL CYCLIZED BACKBONE 426D ; 3.00 ; THE STRUCTURE OF MOST STUDIED DEOXYRIBONUCLEIC ACID FRAGMENT CHANGES UNDER THE INFLUENCE OF IONS: A NEW PACKING OF D(CGCGAATTCGCG) 1N1I ; 2.40 ; THE STRUCTURE OF MSP-1(19) FROM PLASMODIUM KNOWLESI 1YG9 ; 1.30 ; THE STRUCTURE OF MUTANT (N93Q) OF BLA G 2 2C27 ; 1.80 ; THE STRUCTURE OF MYCOTHIOL SYNTHASE IN COMPLEX WITH DES- ACETYLMYCOTHIOL AND COENZYMEA. 1XT0 ; 2.16 ; THE STRUCTURE OF N-TERMINAL SEC7 DOMAIN OF RALF 1OC2 ; 1.50 ; THE STRUCTURE OF NADH IN THE DTDP-D-GLUCOSE DEHYDRATASE (RMLB) ENZYME 1U6I ; 2.20 ; THE STRUCTURE OF NATIVE COENZYME F420-DEPENDENT METHYLENETETRAHYDROMETHANOPTERIN DEHYDROGENASE AT 2.2A RESOLUTION 1U6J ; 2.40 ; THE STRUCTURE OF NATIVE COENZYME F420-DEPENDENT METHYLENETETRAHYDROMETHANOPTERIN DEHYDROGENASE AT 2.4A RESOLUTION 1IUK ; 1.70 ; THE STRUCTURE OF NATIVE ID.343 FROM THERMUS THERMOPHILUS 1QNJ ; 1.10 ; THE STRUCTURE OF NATIVE PORCINE PANCREATIC ELASTASE AT ATOMIC RESOLUTION (1.1 A) 1HXQ ; 1.86 ; THE STRUCTURE OF NUCLEOTIDYLATED GALACTOSE-1-PHOSPHATE URIDYLYLTRANSFERASE FROM ESCHERICHIA COLI AT 1.86 ANGSTROMS RESOLUTION 1OPF ; 3.20 ; THE STRUCTURE OF OMPF PORIN IN A TETRAGONAL CRYSTAL FORM 4BLC ; 2.30 ; THE STRUCTURE OF ORTHORHOMBIC CRYSTALS OF BEEF LIVER CATALASE 1OUY ; 2.50 ; THE STRUCTURE OF P38 ALPHA IN COMPLEX WITH A DIHYDROPYRIDO- PYRIMIDINE INHIBITOR 1OVE ; 2.10 ; THE STRUCTURE OF P38 ALPHA IN COMPLEX WITH A DIHYDROQUINOLINONE 1OUK ; 2.50 ; THE STRUCTURE OF P38 ALPHA IN COMPLEX WITH A PYRIDINYLIMIDAZOLE INHIBITOR 1DI9 ; 2.60 ; THE STRUCTURE OF P38 MITOGEN-ACTIVATED PROTEIN KINASE IN COMPLEX WITH 4-[3-METHYLSULFANYLANILINO]-6,7- DIMETHOXYQUINAZOLINE 1R39 ; 2.30 ; THE STRUCTURE OF P38ALPHA 1R3C ; 2.00 ; THE STRUCTURE OF P38ALPHA C162S MUTANT 1F8V ; 3.00 ; THE STRUCTURE OF PARIACOTO VIRUS REVEALS A DODECAHEDRAL CAGE OF DUPLEX RIBONUCLEIC ACID 2BNK ; 2.90 ; THE STRUCTURE OF PHAGE PHI29 REPLICATION ORGANIZER PROTEIN P16.7 2C5R ; 2.90 ; THE STRUCTURE OF PHAGE PHI29 REPLICATION ORGANIZER PROTEIN P16.7 IN COMPLEX WITH DOUBLE STRANDED DEOXYRIBONUCLEIC ACID 1N7J ; 2.70 ; THE STRUCTURE OF PHENYLETHANOLAMINE N-METHYLTRANSFERASE IN COMPLEX WITH S-ADENOSYLHOMOCYSTEINE AND AN IODINATED INHIBITOR 1N7I ; 2.80 ; THE STRUCTURE OF PHENYLETHANOLAMINE N-METHYLTRANSFERASE IN COMPLEX WITH S-ADENOSYLHOMOCYSTEINE AND THE INHIBITOR LY134046 1LVH ; 2.30 ; THE STRUCTURE OF PHOSPHORYLATED BETA-PHOSPHOGLUCOMUTASE FROM LACTOCCOCUS LACTIS TO 2.3 ANGSTROM RESOLUTION 1BJO ; 2.80 ; THE STRUCTURE OF PHOSPHOSERINE AMINOTRANSFERASE FROM E. COLI IN COMPLEX WITH ALPHA-METHYL-L-GLUTAMATE 1Q6T ; 2.30 ; THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEX WITH COMPOUND 11 1Q6J ; 2.20 ; THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEX WITH COMPOUND 2 1Q6M ; 2.20 ; THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEX WITH COMPOUND 3 1Q6N ; 2.10 ; THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEX WITH COMPOUND 4 1Q6P ; 2.30 ; THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEX WITH COMPOUND 6 1Q6S ; 2.20 ; THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEX WITH COMPOUND 9 1T27 ; 2.20 ; THE STRUCTURE OF PITP COMPLEXED TO PHOSPHATIDYLCHOLINE 1DYR ; 1.86 ; THE STRUCTURE OF PNEUMOCYSTIS CARINII DIHYDROFOLATE REDUCTASE TO 1.9 ANGSTROMS RESOLUTION 1L0Z ; 1.50 ; THE STRUCTURE OF PORCINE PANCREATIC ELASTASE COMPLEXED WITH XENON AND BROMIDE, CRYOPROTECTED WITH DRY PARAFFIN OIL 1L1G ; 1.50 ; THE STRUCTURE OF PORCINE PANCREATIC ELASTASE COMPLEXED WITH XENON AND BROMIDE, CRYOPROTECTED WITH GLYCEROL 1R61 ; 2.50 ; THE STRUCTURE OF PREDICTED METAL-DEPENDENT HYDROLASE FROM BACILLUS STEAROTHERMOPHILUS 1DP5 ; 2.20 ; THE STRUCTURE OF PROTEINASE A COMPLEXED WITH A IA3 MUTANT INHIBITOR 1G0V ; 2.00 ; THE STRUCTURE OF PROTEINASE A COMPLEXED WITH A IA3 MUTANT, MVV 1DPJ ; 1.80 ; THE STRUCTURE OF PROTEINASE A COMPLEXED WITH IA3 PEPTIDE INHIBITOR 1XSZ ; 1.41 ; THE STRUCTURE OF RALF 1ND2 ; 2.50 ; THE STRUCTURE OF RHINOVIRUS 16 1NCR ; 2.70 ; THE STRUCTURE OF RHINOVIRUS 16 WHEN COMPLEXED WITH PLECONARIL, AN ANTIVIRAL COMPOUND 1NBK ; -1.00 ; THE STRUCTURE OF RIBONUCLEIC ACID APTAMER FOR HIV TAT COMPLEXED WITH TWO ARGININAMIDE MOLECULES 1GQM ; 2.70 ; THE STRUCTURE OF S100A12 IN A HEXAMERIC FORM 1FHF ; 2.80 ; THE STRUCTURE OF SOYBEAN PEROXIDASE 1EE2 ; 1.54 ; THE STRUCTURE OF STEROID-ACTIVE ALCOHOL DEHYDROGENASE AT 1.54 A RESOLUTION 1Y7O ; 2.51 ; THE STRUCTURE OF STREPTOCOCCUS PNEUMONIAE A153P CLPP 2A3G ; 2.25 ; THE STRUCTURE OF T6 BOVINE INSULIN 1D6X ; -1.00 ; THE STRUCTURE OF THE ANTIMICROBIAL PEPTIDE TRITRPTICIN BOUND TO MICELLES-A DISTINCT MEMBRANE-BOUND PEPTIDE FOLD 1D61 ; 1.30 ; THE STRUCTURE OF THE B-DEOXYRIBONUCLEIC ACID DECAMER C-C-A-A-C-I-T-T-G-G: MONOCLINIC FORM 1K28 ; 2.90 ; THE STRUCTURE OF THE BACTERIOPHAGE T4 CELL-PUNCTURING DEVICE 1XB1 ; 2.70 ; THE STRUCTURE OF THE BIR DOMAIN OF IAP-LIKE PROTEIN 2 1O7D ; 2.70 ; THE STRUCTURE OF THE BOVINE LYSOSOMAL A-MANNOSIDASE SUGGESTS A NOVEL MECHANISM FOR LOW PH ACTIVATION 1USU ; 2.15 ; THE STRUCTURE OF THE COMPLEX BETWEEN AHA1 AND HSP90 1USV ; 2.70 ; THE STRUCTURE OF THE COMPLEX BETWEEN AHA1 AND HSP90 1MH5 ; 2.10 ; THE STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF THE ESTEROLYTIC ANTIBODY MS6-164 AND A TRANSITION-STATE ANALOG 1H1Y ; 1.87 ; THE STRUCTURE OF THE CYTOSOLIC D-RIBULOSE-5-PHOSPHATE 3-EPIMERASE FROM RICE COMPLEXED WITH SULFATE 1H1Z ; 3.40 ; THE STRUCTURE OF THE CYTOSOLIC D-RIBULOSE-5-PHOSPHATE 3-EPIMERASE FROM RICE COMPLEXED WITH SULFATE AND ZINC 1BQG ; 2.30 ; THE STRUCTURE OF THE D-GLUCARATE DEHYDRATASE PROTEIN FROM PSEUDOMONAS PUTIDA 1LU1 ; 2.60 ; THE STRUCTURE OF THE DOLICHOS BIFLORUS SEED LECTIN IN COMPLEX WITH THE FORSSMAN DISACCHARIDE 2REB ; 2.30 ; THE STRUCTURE OF THE E. COLI RECA PROTEIN MONOMER AND POLYMER 1Y6U ; -1.00 ; THE STRUCTURE OF THE EXCISIONASE (XIS) PROTEIN FROM CONJUGATIVE TRANSPOSON TN916 PROVIDES INSIGHTS INTO THE REGULATION OF HETEROBIVALENT TYROSINE RECOMBINASES 2B0U ; 2.80 ; THE STRUCTURE OF THE FOLLISTATIN:ACTIVIN COMPLEX 1H9U ; 2.70 ; THE STRUCTURE OF THE HUMAN RETINOID-X-RECEPTOR BETA LIGAND BINDING DOMAIN IN COMPLEX WITH THE SPECIFIC SYNTHETIC AGONIST LG100268 1MWW ; 2.08 ; THE STRUCTURE OF THE HYPOTHETICAL PROTEIN HI1388.1 FROM HAEMOPHILUS INFLUENZAE REVEALS A TAUTOMERASE/MIF FOLD 1NSG ; 2.20 ; THE STRUCTURE OF THE IMMUNOPHILIN-IMMUNOSUPPRESSANT FKBP12- RAPAMYCIN COMPLEX INTERACTING WITH HUMAN FRAP 2FAP ; 2.20 ; THE STRUCTURE OF THE IMMUNOPHILIN-IMMUNOSUPPRESSANT FKBP12-(C16)-ETHOXY RAPAMYCIN COMPLEX INTERACTING WITH HUMAN 1FAP ; 2.70 ; THE STRUCTURE OF THE IMMUNOPHILIN-IMMUNOSUPPRESSANT FKBP12-RAPAMYCIN COMPLEX INTERACTING WITH HUMAN FRAP 1ATO ; -1.00 ; THE STRUCTURE OF THE ISOLATED, CENTRAL HAIRPIN OF THE HDV ANTIGENOMIC RIBOZYME, NMR, 10 STRUCTURES 1C4R ; 2.60 ; THE STRUCTURE OF THE LIGAND-BINDING DOMAIN OF NEUREXIN 1BETA: REGULATION OF LNS DOMAIN FUNCTION BY ALTERNATIVE SPLICING 1HFO ; 1.65 ; THE STRUCTURE OF THE MACROPHAGE MIGRATION INHIBITORY FACTOR FROM TRICHINELLA SPIRALIS. 1P38 ; 2.10 ; THE STRUCTURE OF THE MAP KINASE P38 AT 2.1 ANGSTOMS RESOLUTION 1G2U ; 2.10 ; THE STRUCTURE OF THE MUTANT, A172V, OF 3-ISOPROPYLMALATE DEHYDROGENASE FROM THERMUS THERMOPHILUS HB8 : ITS THERMOSTABILITY AND STRUCTURE. 1V5B ; 2.95 ; THE STRUCTURE OF THE MUTANT, S225A AND E251L, OF 3- ISOPROPYLMALATE DEHYDROGENASE FROM BACILLUS COAGULANS 2BNL ; 2.00 ; THE STRUCTURE OF THE N-TERMINAL DOMAIN OF RSBR 1VZO ; 1.80 ; THE STRUCTURE OF THE N-TERMINAL KINASE DOMAIN OF MSK1 REVEALS A NOVEL AUTOINHIBITORY CONFORMATION FOR A DUAL KINASE PROTEIN 1KDK ; 1.70 ; THE STRUCTURE OF THE N-TERMINAL LG DOMAIN OF SHBG IN CRYSTALS SOAKED WITH EDTA 1A04 ; 2.20 ; THE STRUCTURE OF THE NITRATE/NITRITE RESPONSE REGULATOR PROTEIN NARL IN THE MONOCLINIC C2 CRYSTAL FORM 1CEB ; 2.10 ; THE STRUCTURE OF THE NON-COVALENT COMPLEX OF RECOMBINANT KRINGLE 1 DOMAIN OF HUMAN PLASMINOGEN WITH AMCHA (TRANS-4-AMINOMETHYLCYCLOHEXANE-1-CARBOXYLIC ACID) 1CEA ; 2.10 ; THE STRUCTURE OF THE NON-COVALENT COMPLEX OF RECOMBINANT KRINGLE 1 DOMAIN OF HUMAN PLASMINOGEN WITH EACA (EPSILON-AMINOCAPROIC ACID) 1XOC ; 1.55 ; THE STRUCTURE OF THE OLIGOPEPTIDE-BINDING PROTEIN, APPA, FROM BACILLUS SUBTILIS IN COMPLEX WITH A NONAPEPTIDE. 1QO8 ; 2.15 ; THE STRUCTURE OF THE OPEN CONFORMATION OF A FLAVOCYTOCHROME C3 FUMARATE REDUCTASE 1AKI ; 1.50 ; THE STRUCTURE OF THE ORTHORHOMBIC FORM OF HEN EGG-WHITE LYSOZYME AT 1.5 ANGSTROMS RESOLUTION 2BQP ; 1.90 ; THE STRUCTURE OF THE PEA LECTIN-D-GLUCOPYRANOSE COMPLEX 1BQP ; 2.10 ; THE STRUCTURE OF THE PEA LECTIN-D-MANNOPYRANOSE COMPLEX 1QY7 ; 2.00 ; THE STRUCTURE OF THE PII PROTEIN FROM THE CYANOBACTERIA SYNECHOCOCCUS SP. PCC 7942 1Q4O ; 2.20 ; THE STRUCTURE OF THE POLO BOX DOMAIN OF HUMAN PLK1 1E9K ; -1.00 ; THE STRUCTURE OF THE RACK1 INTERACTION SITES LOCATED WITHIN THE UNIQUE N-TERMINAL REGION OF THE CAMP-SPECIFIC PHOSPHODIESTERASE, PDE4D5. 1EVR ; 1.90 ; THE STRUCTURE OF THE RESORCINOL/INSULIN R6 HEXAMER 1QAM ; 2.20 ; THE STRUCTURE OF THE RRNA METHYLTRANSFERASE ERMC': IMPLICATIONS FOR THE REACTION MECHANISM 1QAN ; 2.40 ; THE STRUCTURE OF THE RRNA METHYLTRANSFERASE ERMC': IMPLICATIONS FOR THE REACTION MECHANISM 1QAO ; 2.70 ; THE STRUCTURE OF THE RRNA METHYLTRANSFERASE ERMC': IMPLICATIONS FOR THE REACTION MECHANISM 1QAQ ; 2.80 ; THE STRUCTURE OF THE RRNA METHYLTRANSFERASE ERMC': IMPLICATIONS FOR THE REACTION MECHANISM 2F6F ; 2.00 ; THE STRUCTURE OF THE S295F MUTANT OF HUMAN PTP1B 1Q97 ; 2.30 ; THE STRUCTURE OF THE SACCHAROMYCES CEREVISIAE SR PROTEIN KINASE, SKY1P, WITH BOUND ATP 1PJT ; 2.80 ; THE STRUCTURE OF THE SER128ALA POINT-MUTANT VARIANT OF CYSG, THE MULTIFUNCTIONAL METHYLTRANSFERASE/DEHYDROGENASE/FERROCHELATASE FOR SIROHEME SYNTHESIS 1VQ4 ; 2.70 ; THE STRUCTURE OF THE TRANSITION STATE ANALOGUE "DAA" BOUND TO THE LARGE RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI 1VQM ; 2.30 ; THE STRUCTURE OF THE TRANSITION STATE ANALOGUE "DAN" BOUND TO THE LARGE RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI 1VQ7 ; 2.50 ; THE STRUCTURE OF THE TRANSITION STATE ANALOGUE "DCA" BOUND TO THE LARGE RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI 1VQL ; 2.30 ; THE STRUCTURE OF THE TRANSITION STATE ANALOGUE "DCSN" BOUND TO THE LARGE RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI 1VQ5 ; 2.60 ; THE STRUCTURE OF THE TRANSITION STATE ANALOGUE "RAA" BOUND TO THE LARGE RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI 1VQP ; 2.25 ; THE STRUCTURE OF THE TRANSITION STATE ANALOGUE "RAP" BOUND TO THE LARGE RIBOSOMAL SUBUNIT OF HALOARCULA MARISMORTUI 1AH9 ; -1.00 ; THE STRUCTURE OF THE TRANSLATIONAL INITIATION FACTOR IF1 FROM ESCHERICHIA COLI, NMR, 19 STRUCTURES 1UTD ; 2.10 ; THE STRUCTURE OF THE TRP RAN-BINDING ATTENUATION PROTEIN (TRAP) BOUND TO A 63-NUCLEOTIDE RIBONUCLEIC ACID MOLECULE CONTAINING GAGUUU REPEATS 1GTF ; 1.75 ; THE STRUCTURE OF THE TRP RIBONUCLEIC ACID-BINDING ATTENUATION PROTEIN (TRAP) BOUND TO A 53-NUCLEOTIDE RIBONUCLEIC ACID MOLECULE CONTAINING GAGUU REPEATS 1UTF ; 1.90 ; THE STRUCTURE OF THE TRP RIBONUCLEIC ACID-BINDING ATTENUATION PROTEIN (TRAP) BOUND TO A RIBONUCLEIC ACID MOLECULE CONTAINING UAGAU REPEATS (PART I) 1UTV ; 1.90 ; THE STRUCTURE OF THE TRP RIBONUCLEIC ACID-BINDING ATTENUATION PROTEIN (TRAP) BOUND TO A RIBONUCLEIC ACID MOLECULE CONTAINING UAGAU REPEATS (PART II) 1Q8Y ; 2.05 ; THE STRUCTURE OF THE YEAST SR PROTEIN KINASE, SKY1P, WITH BOUND ADP 1HRU ; 2.00 ; THE STRUCTURE OF THE YRDC GENE PRODUCT FROM E.COLI 1UW2 ; -1.00 ; THE STRUCTURE OF THE ZINC FINGER FROM THE HUMAN SPLICEOSOMAL PROTEIN U1C 1T00 ; 1.51 ; THE STRUCTURE OF THIOREDOXIN FROM S. COELICOLOR 1C5K ; 2.00 ; THE STRUCTURE OF TOLB, AN ESSENTIAL COMPONENT OF THE TOL- DEPENDENT TRANSLOCATION SYSTEM AND ITS INTERACTIONS WITH THE TRANSLOCATION DOMAIN OF COLICIN E9 1LAJ ; 3.40 ; THE STRUCTURE OF TOMATO ASPERMY VIRUS BY X-RAY CRYSTALLOGRAPHY 1S0Y ; 2.30 ; THE STRUCTURE OF TRANS-3-CHLOROACRYLIC ACID DEHALOGENASE, COVALENTLY INACTIVATED BY THE MECHANISM-BASED INHIBITOR 3- BROMOPROPIOLATE AT 2.3 ANGSTROM RESOLUTION 1RLI ; 1.80 ; THE STRUCTURE OF TRP REPRESSOR BINDING PROTEIN FROM BACILLUS SUBTILIS 2AQJ ; 1.80 ; THE STRUCTURE OF TRYPTOPHAN 7-HALOGENASE (PRNA) SUGGESTS A MECHANISM FOR REGIOSELECTIVE CHLORINATION 2ARD ; 2.60 ; THE STRUCTURE OF TRYPTOPHAN 7-HALOGENASE (PRNA) SUGGESTS A MECHANISM FOR REGIOSELECTIVE CHLORINATION 2APG ; 1.90 ; THE STRUCTURE OF TRYPTOPHAN 7-HALOGENASE (PRNA)SUGGESTS A MECHANISM FOR REGIOSELECTIVE CHLORINATION 2AR8 ; 2.20 ; THE STRUCTURE OF TRYPTOPHAN 7-HALOGENASE (PRNA)SUGGESTS A MECHANISM FOR REGIOSELECTIVE CHLORINATION 1IUJ ; 1.60 ; THE STRUCTURE OF TT1380 PROTEIN FROM THERMUS THERMOPHILUS 1QFE ; 2.10 ; THE STRUCTURE OF TYPE I 3-DEHYDROQUINATE DEHYDRATASE FROM SALMONELLA TYPHI 1FFT ; 3.50 ; THE STRUCTURE OF UBIQUINOL OXIDASE FROM ESCHERICHIA COLI 1F6D ; 2.50 ; THE STRUCTURE OF UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE FROM E. COLI. 1JEZ ; 2.20 ; THE STRUCTURE OF XYLOSE REDUCTASE, A DIMERIC ALDO-KETO REDUCTASE FROM CANDIDA TENUIS 1K39 ; 3.29 ; THE STRUCTURE OF YEAST DELTA3-DELTA2-ENOYL-COA ISOMERASE COMPLEXED WITH OCTANOYL-COA 1R6F ; 2.17 ; THE STRUCTURE OF YERSINIA PESTIS V-ANTIGEN, AN ESSENTIAL VIRULENCE FACTOR AND MEDIATOR OF IMMUNITY AGAINST PLAGUE 1V1P ; 2.70 ; THE STRUCTURE SSL FROM STAPHYLOCOCCUS AUREUS FROM AN ORTHORHOMBIC CRYSTAL FORM 2B1E ; 2.00 ; THE STRUCTURES OF EXOCYST SUBUNIT EXO70P AND THE EXO84P C- TERMINAL DOMAINS REVEAL A COMMON MOTIF 1P5W ; 3.30 ; THE STRUCTURES OF HOST RANGE CONTROLLING REGIONS OF THE CAPSIDS OF CANINE AND FELINE PARVOVIRUSES AND MUTANTS 1P5Y ; 3.20 ; THE STRUCTURES OF HOST RANGE CONTROLLING REGIONS OF THE CAPSIDS OF CANINE AND FELINE PARVOVIRUSES AND MUTANTS 1P5E ; 2.22 ; THE STRUCURE OF PHOSPHO-CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR 4,5,6,7-TETRABROMOBENZOTRIAZOLE (TBS) 1DKZ ; 2.00 ; THE SUBSTRATE BINDING DOMAIN OF DNAK IN COMPLEX WITH A SUBSTRATE PEPTIDE, DETERMINED FROM TYPE 1 NATIVE CRYSTALS 1DKX ; 2.00 ; THE SUBSTRATE BINDING DOMAIN OF DNAK IN COMPLEX WITH A SUBSTRATE PEPTIDE, DETERMINED FROM TYPE 1 SELENOMETHIONYL CRYSTALS 1DKY ; 2.80 ; THE SUBSTRATE BINDING DOMAIN OF DNAK IN COMPLEX WITH A SUBSTRATE PEPTIDE, DETERMINED FROM TYPE 2 NATIVE CRYSTALS 1NST ; 2.30 ; THE SULFOTRANSFERASE DOMAIN OF HUMAN HAPARIN SULFATE N-DEACETYLASE/N-SULFOTRANSFERASE 1W3B ; 2.85 ; THE SUPERHELICAL TPR DOMAIN OF O-LINKED GLCNAC TRANSFERASE REVEALS STRUCTURAL SIMILARITIES TO IMPORTIN ALPHA. 1FSA ; 2.30 ; THE T-STATE STRUCTURE OF LYS 42 TO ALA MUTANT OF THE PIG KIDNEY FRUCTOSE 1,6-BISPHOSPHATASE EXPRESSED IN E. COLI 1XXT ; 1.91 ; THE T-TO-T HIGH TRANSITIONS IN HUMAN HEMOGLOBIN: WILD-TYPE DEOXY HB A (LOW SALT, ONE TEST SET) 1MV2 ; -1.00 ; THE TANDEM, FACE-TO-FACE AP PAIRS IN 5'(RGGCAPGCCU)2 1MV1 ; -1.00 ; THE TANDEM, SHEARED PA PAIRS IN 5'(RGGCPAGCCU)2 1MV6 ; -1.00 ; THE TANDEM, SHEARED PP PAIRS IN 5'(RGGCPPGCCU)2 1LLU ; 2.30 ; THE TERNARY COMPLEX OF PSEUDOMONAS AERUGINOSA ALCOHOL DEHYDROGENASE WITH ITS COENZYME AND WEAK SUBSTRATE 1U0N ; 2.95 ; THE TERNARY VON WILLEBRAND FACTOR A1-GLYCOPROTEIN IBALPHA- BOTROCETIN COMPLEX 1WQ6 ; 2.00 ; THE TETRAMER STRUCTURE OF THE NERVY HOMOLGY TWO (NHR2) DOMAIN OF AML1-ETO IS CRITICAL FOR AML1-ETO'S ACTIVITY 1GTL ; 2.80 ; THE THERMOSTABLE SERINE-CARBOXYL TYPE PROTEINASE, KUMAMOLISIN (KSCP) - COMPLEX WITH AC-ILE-PRO-PHE-CHO 1WF6 ; -1.00 ; THE THIRD BRCA1 C-TERMINUS (BRCT) DOMAIN OF SIMILAR TO S.POMBE RAD4+/CUT5+ PRODUCT 1J7M ; -1.00 ; THE THIRD FIBRONECTIN TYPE II MODULE FROM HUMAN MATRIX METALLOPROTEINASE 2 1BFE ; 2.30 ; THE THIRD PDZ DOMAIN FROM THE SYNAPTIC PROTEIN PSD-95 1BE9 ; 1.82 ; THE THIRD PDZ DOMAIN FROM THE SYNAPTIC PROTEIN PSD-95 IN COMPLEX WITH A C-TERMINAL PEPTIDE DERIVED FROM CRIPT. 1C9K ; 2.20 ; THE THREE DIMENSIONAL STRUCTURE OF ADENOSYLCOBINAMIDE KINASE/ ADENOSYLCOBINAMIDE PHOSPHATE GUALYLYLTRANSFERASE (COBU) COMPLEXED WITH GMP: EVIDENCE FOR A SUBSTRATE INDUCED TRANSFERASE ACTIVE SITE 1QZ9 ; 1.85 ; THE THREE DIMENSIONAL STRUCTURE OF KYNURENINASE FROM PSEUDOMONAS FLUORESCENS 1HKF ; 2.20 ; THE THREE DIMENSIONAL STRUCTURE OF NK CELL RECEPTOR NKP44, A TRIGGERING PARTNER IN NATURAL CYTOTOXICITY 1EWS ; -1.00 ; THE THREE-DIMENSIONAL SOLUTION STRUCTURE OF THE RABBIT KIDNEY DEFENSIN, RK-1 1FHS ; -1.00 ; THE THREE-DIMENSIONAL SOLUTION STRUCTURE OF THE SRC HOMOLOGY DOMAIN-2 OF THE GROWTH FACTOR RECEPTOR BOUND PROTEIN-2, NMR, 18 STRUCTURES 1SGL ; 2.20 ; THE THREE-DIMENSIONAL STRUCTURE AND X-RAY SEQUENCE REVEAL THAT TRICHOMAGLIN IS A NOVEL S-LIKE RIBONUCLEASE 1A57 ; -1.00 ; THE THREE-DIMENSIONAL STRUCTURE OF A HELIX-LESS VARIANT OF INTESTINAL FATTY ACID BINDING PROTEIN, NMR, 20 STRUCTURES 2ABD ; -1.00 ; THE THREE-DIMENSIONAL STRUCTURE OF ACYL-COENZYME A BINDING PROTEIN FROM BOVINE LIVER. STRUCTURAL REFINEMENT USING HETERONUCLEAR MULTIDIMENSIONAL NMR SPECTROSCOPY 1LK9 ; 1.53 ; THE THREE-DIMENSIONAL STRUCTURE OF ALLIINASE FROM GARLIC 1ETZ ; 2.60 ; THE THREE-DIMENSIONAL STRUCTURE OF AN ANTI-SWEETENER FAB, NC10.14, SHOWS THE EXTENT OF STRUCTURAL DIVERSITY IN ANTIGEN RECOGNITION BY IMMUNOGLOBULINS 1MOE ; 2.60 ; THE THREE-DIMENSIONAL STRUCTURE OF AN ENGINEERED SCFV T84.66 DIMER OR DIABODY IN VL TO VH LINKAGE. 1LD9 ; 2.40 ; THE THREE-DIMENSIONAL STRUCTURE OF AN H-2LD PEPTIDE COMPLEX EXPLAINS THE UNIQUE INTERACTION OF LD WITH BETA2M AND PEPTIDE 1G5R ; 2.10 ; THE THREE-DIMENSIONAL STRUCTURE OF ATP:CORRINOID ADENOSYLTRANSFERASE FROM SALMONELLA TYPHIMURIUM. APO FORM 1G5T ; 1.80 ; THE THREE-DIMENSIONAL STRUCTURE OF ATP:CORRINOID ADENOSYLTRANSFERASE FROM SALMONELLA TYPHIMURIUM. APO-ATP FORM 1G64 ; 2.10 ; THE THREE-DIMENSIONAL STRUCTURE OF ATP:CORRINOID ADENOSYLTRANSFERASE FROM SALMONELLA TYPHIMURIUM. COBALAMIN/ATP TERNARY COMPLEX 1O4Y ; 1.48 ; THE THREE-DIMENSIONAL STRUCTURE OF BETA-AGARASE A FROM ZOBELLIA GALACTANIVORANS 1O4Z ; 2.30 ; THE THREE-DIMENSIONAL STRUCTURE OF BETA-AGARASE B FROM ZOBELLIA GALACTANIVORANS 1UYP ; 1.90 ; THE THREE-DIMENSIONAL STRUCTURE OF BETA-FRUCTOSIDASE (INVERTASE) FROM THERMOTOGA MARITIMA 1A03 ; -1.00 ; THE THREE-DIMENSIONAL STRUCTURE OF CA2+-BOUND CALCYCLIN: IMPLICATIONS FOR CA2+-SIGNAL TRANSDUCTION BY S100 PROTEINS, NMR, 20 STRUCTURES 1H6J ; 2.32 ; THE THREE-DIMENSIONAL STRUCTURE OF CAPSULE-SPECIFIC CMP:2-KETO-3-DEOXY-MANNO-OCTONIC ACID SYNTHETASE FROM ESCHERICHIA COLI 1NG0 ; 2.70 ; THE THREE-DIMENSIONAL STRUCTURE OF COCKSFOOT MOTTLE VIRUS AT 2.7A RESOLUTION 1E8A ; 1.95 ; THE THREE-DIMENSIONAL STRUCTURE OF HUMAN S100A12 1XVL ; 2.90 ; THE THREE-DIMENSIONAL STRUCTURE OF MNTC FROM SYNECHOCYSTIS 6803 1SHK ; 1.90 ; THE THREE-DIMENSIONAL STRUCTURE OF SHIKIMATE KINASE FROM ERWINIA CHRYSANTHEMI 2SHK ; 2.60 ; THE THREE-DIMENSIONAL STRUCTURE OF SHIKIMATE KINASE FROM ERWINIA CHRYSANTHEMI COMPLEXED WITH ADP 2ASR ; 2.30 ; THE THREE-DIMENSIONAL STRUCTURE OF THE ASPARTATE RECEPTOR FROM ESCHERICHIA COLI 1JJR ; -1.00 ; THE THREE-DIMENSIONAL STRUCTURE OF THE C-TERMINAL DEOXYRIBONUCLEIC ACID BINDING DOMAIN OF HUMAN KU70 1P90 ; 1.80 ; THE THREE-DIMENSIONAL STRUCTURE OF THE CORE DOMAIN OF NAFY FROM AZOTOBACTER VINELANDII DETERMINED AT 1.8 RESOLUTION 2H1P ; 2.40 ; THE THREE-DIMENSIONAL STRUCTURES OF A POLYSACCHARIDE BINDING ANTIBODY TO CRYPTOCOCCUS NEOFORMANS AND ITS COMPLEX WITH A PEPTIDE FROM A PHAGE DISPLAY LIBRARY: IMPLICATIONS FOR THE IDENTIFICATION OF PEPTIDE MIMOTOPES 1TKW ; -1.00 ; THE TRANSIENT COMPLEX OF POPLAR PLASTOCYANIN WITH TURNIP CYTOCHROME F DETERMINED WITH PARAMAGNETIC NMR 1OLQ ; 1.70 ; THE TRICHODERMA REESEI CEL12A P201C MUTANT, STRUCTURE AT 1.7 A RESOLUTION 1V6H ; 1.90 ; THE TRIMERIC STRUCTURE OF DIVALENT CATION TOLERANCE PROTEIN CUTA1 FROM THERMUS THERMOPHILUS HB8 2B59 ; 2.11 ; THE TYPE II COHESIN DOCKERIN COMPLEX 1SK5 ; 0.89 ; THE ULTRA-HIGH RESOLUTION STRUCTURE OF D(CTTTTAAAAG)2: MODULATION OF BENDING BY T-A STEPS AND ITS ROLE IN DEOXYRIBONUCLEIC ACID RECOGNITION 1FL5 ; 2.10 ; THE UNLIGANDED GERMLINE PRECURSOR TO THE SULFIDE OXIDASE CATALYTIC ANTIBODY 28B4. 1QSZ ; -1.00 ; THE VEGF-BINDING DOMAIN OF FLT-1 (MINIMIZED MEAN) 1QSV ; -1.00 ; THE VEGF-BINDING DOMAIN OF FLT-1, 20 NMR STRUCTURES 1VCB ; 2.70 ; THE VHL-ELONGINC-ELONGINB STRUCTURE 1IJB ; 1.80 ; THE VON WILLEBRAND FACTOR MUTANT (I546V) A1 DOMAIN 1IJK ; 2.60 ; THE VON WILLEBRAND FACTOR MUTANT (I546V) A1 DOMAIN- BOTROCETIN COMPLEX 1MTP ; 1.50 ; THE X-RAY CRYSTAL STRUCTURE OF A SERPIN FROM A THERMOPHILIC PROKARYOTE 1O9R ; 1.45 ; THE X-RAY CRYSTAL STRUCTURE OF AGROBACTERIUM TUMEFACIENS DPS, A MEMBER OF THE FAMILY THAT PROTECT DEOXYRIBONUCLEIC ACID WITHOUT BINDING 1K72 ; 1.80 ; THE X-RAY CRYSTAL STRUCTURE OF CEL9G COMPLEXED WITH CELLOTRIOSE 1KFG ; 1.90 ; THE X-RAY CRYSTAL STRUCTURE OF CEL9G FROM CLOSTRIDIUM CELLULOLYTICUM COMPLEXED WITH A THIO-OLIGOSACCHARIDE INHIBITOR 1O9J ; 2.40 ; THE X-RAY CRYSTAL STRUCTURE OF ETA-CRYSTALLIN 1DVO ; 2.00 ; THE X-RAY CRYSTAL STRUCTURE OF FINO, A REPRESSOR OF BACTERIAL CONJUGATION 1Y9E ; 2.80 ; THE X-RAY CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN YHFP FROM BACILLUS SUBTILIS- NATIVE FORM 2BJY ; 2.60 ; THE X-RAY CRYSTAL STRUCTURE OF LISTERIA INNOCUA DPS H31G- H43G MUTANT. 1FI4 ; 2.27 ; THE X-RAY CRYSTAL STRUCTURE OF MEVALONATE 5-DIPHOSPHATE DECARBOXYLASE AT 2.3 ANGSTROM RESOLUTION. 1A0H ; 3.20 ; THE X-RAY CRYSTAL STRUCTURE OF PPACK-MEIZOTHROMBIN DESF1: KRINGLE/THROMBIN AND CARBOHYDRATE/KRINGLE/THROMBIN INTERACTIONS AND LOCATION OF THE LINKER CHAIN 1IU8 ; 1.60 ; THE X-RAY CRYSTAL STRUCTURE OF PYRROLIDONE-CARBOXYLATE PEPTIDASE FROM HYPERTHERMOPHILIC ARCHAEON PYROCOCCUS HORIKOSHII 1HOW ; 2.10 ; THE X-RAY CRYSTAL STRUCTURE OF SKY1P, AN SR PROTEIN KINASE IN YEAST 1IJJ ; 2.85 ; THE X-RAY CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN RABBIT SKELETAL MUSCLE ACTIN AND LATRUNCULIN A AT 2.85 A RESOLUTION 2BK6 ; 2.19 ; THE X-RAY CRYSTAL STRUCTURE OF THE LISTERIA INNOCUA H31G DPS MUTANT. 1H8V ; 1.90 ; THE X-RAY CRYSTAL STRUCTURE OF THE TRICHODERMA REESEI FAMILY 12 ENDOGLUCANASE 3, CEL12A, AT 1.9 A RESOLUTION 1ETB ; 1.70 ; THE X-RAY CRYSTAL STRUCTURE REFINEMENTS OF NORMAL HUMAN TRANSTHYRETIN AND THE AMYLOIDOGENIC VAL 30-->MET VARIANT 1ETA ; 1.70 ; THE X-RAY CRYSTAL STRUCTURE REFINEMENTS OF NORMAL HUMAN TRANSTHYRETIN AND THE AMYLOIDOGENIC VAL 30-->MET VARIANT TO 1.7 ANGSTROMS RESOLUTION 1EKJ ; 1.93 ; THE X-RAY CRYSTALLOGRAPHIC STRUCTURE OF BETA CARBONIC ANHYDRASE FROM THE C3 DICOT PISUM SATIVUM 1M7X ; 2.30 ; THE X-RAY CRYSTALLOGRAPHIC STRUCTURE OF BRANCHING ENZYME 1X7S ; 1.55 ; THE X-RAY CRYSTALLOGRAPHIC STRUCTURE OF THE AMYLOIDOGENIC VARIANT TTR TYR78PHE 1FSX ; 2.10 ; THE X-RAY STRUCTURE DETERMINATION OF BOVINE CARBONMONOXY HB AT 2.1 A RESOLUTION AND ITS RELATIONSHIP TO THE QUATERNARY STRUCTURE OF OTHER HB CRYSTAL FORMS 1CBF ; 2.40 ; THE X-RAY STRUCTURE OF A COBALAMIN BIOSYNTHETIC ENZYME, COBALT PRECORRIN-4 METHYLTRANSFERASE, CBIF 2CBF ; 3.10 ; THE X-RAY STRUCTURE OF A COBALAMIN BIOSYNTHETIC ENZYME, COBALT PRECORRIN-4 METHYLTRANSFERASE, CBIF, FROM BACILLUS MEGATERIUM, WITH THE HIS-TAG CLEAVED OFF 2QWD ; 2.00 ; THE X-RAY STRUCTURE OF A COMPLEX OF 4-AMINO-NEU5AC2EN AND A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE 2QWE ; 2.00 ; THE X-RAY STRUCTURE OF A COMPLEX OF 4-GUANIDINO-NEU5AC2EN AND A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE 2QWG ; 1.80 ; THE X-RAY STRUCTURE OF A COMPLEX OF 5-N-ACETYL-4-AMINO-6- DIETHYLCARBOXAMIDE-4,5-DIHYDRO-2H-PYRAN-2-CARBOXYLIC ACID AND A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE 2QWJ ; 2.00 ; THE X-RAY STRUCTURE OF A COMPLEX OF 5-N-ACETYL-4-AMINO-6- DIETHYLCARBOXAMIDE-4,5-DIHYDRO-2H-PYRAN-2-CARBOXYLIC ACID AND A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE 2QWH ; 1.80 ; THE X-RAY STRUCTURE OF A COMPLEX OF 5-N-ACETYL-5-AMINO-3- (1-ETHYLPROPOXY)-1-CYCLOHEXENE-1-CARBOXYLIC ACID (GS4071) AND A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE 2QWK ; 1.80 ; THE X-RAY STRUCTURE OF A COMPLEX OF 5-N-ACETYL-5-AMINO-3- (1-ETHYLPROPOXY)-1-CYCLOHEXENE-1-CARBOXYLIC ACID (GS4071) AND WILDTYPE TERN N9 INFLUENZA VIRUS NEURAMINIDASE 2QWF ; 1.90 ; THE X-RAY STRUCTURE OF A COMPLEX OF N-ACETYL-4-GUANIDINO-6- METHYL(PROPYL)CARBOXAMIDE-4,5-DIHYDRO-2H-PYRAN-2-CARBOXYLIC ACID AND A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE 2QWI ; 2.00 ; THE X-RAY STRUCTURE OF A COMPLEX OF N-ACETYL-4-GUANIDINO-6- METHYL(PROPYL)CARBOXAMIDE-4,5-DIHYDRO-2H-PYRAN-2-CARBOXYLIC ACID AND WILDTYPE TERN N9 INFLUENZA VIRUS NEURAMINIDASE 2QWC ; 1.60 ; THE X-RAY STRUCTURE OF A COMPLEX OF NEU5AC2EN AND A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE 2QWB ; 2.00 ; THE X-RAY STRUCTURE OF A COMPLEX OF SIALIC ACID AND A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE 1MWE ; 1.70 ; THE X-RAY STRUCTURE OF A COMPLEX OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE COMPLEXED WITH SIALIC ACID AT 4 DEGREES C REVEALING A SECOND SIALIC ACID BINDING SITE 1BJI ; 2.00 ; THE X-RAY STRUCTURE OF A COMPLEX OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE COMPLEXED WITH THE GLAXO 6-CARBOXAMIDE SIALIC ACID ANALOGUE GR217029 2QWA ; 1.70 ; THE X-RAY STRUCTURE OF A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE 1Y9L ; 1.50 ; THE X-RAY STRUCTURE OF AN SECRETION SYSTEM PROTEIN 1EDO ; 2.30 ; THE X-RAY STRUCTURE OF BETA-KETO ACYL CARRIER PROTEIN REDUCTASE FROM BRASSICA NAPUS COMPLEXED WITH NADP+ 2C1H ; 2.60 ; THE X-RAY STRUCTURE OF CHLOROBIUM VIBRIOFORME 5- AMINOLAEVULINIC ACID DEHYDRATASE COMPLEXED WITH A DIACID INHIBITOR 1GVH ; 2.19 ; THE X-RAY STRUCTURE OF FERRIC ESCHERICHIA COLI FLAVOHEMOGLOBIN REVEALS AN UNESPECTED GEOMETRY OF THE DISTAL HEME POCKET 1KI0 ; 1.75 ; THE X-RAY STRUCTURE OF HUMAN ANGIOSTATIN 1F8G ; 2.00 ; THE X-RAY STRUCTURE OF NICOTINAMIDE NUCLEOTIDE TRANSHYDROGENASE FROM RHODOSPIRILLUM RUBRUM COMPLEXED WITH NAD+ 1S6A ; 1.69 ; THE X-RAY STRUCTURE OF THE CYANOBACTERIA SYNECHOCYSTIS HEMOGLOBIN "CYANOGLOBIN" WITH AZIDE LIGAND 1S69 ; 1.68 ; THE X-RAY STRUCTURE OF THE CYANOBACTERIA SYNECHOCYSTIS HEMOGLOBIN "CYANOGLOBIN" WITH CYANIDE LIGAND 1VM9 ; 1.48 ; THE X-RAY STRUCTURE OF THE CYS84ALA CYS85ALA DOUBLE MUTANT OF THE [2FE-2S] FERREDOXIN SUBUNIT OF TOLUENE-4- MONOOXYGENASE FROM PSEUDOMONAS MENDOCINA KR1 2BKC ; 2.30 ; THE X-RAY STRUCTURE OF THE H43G LISTERIA INNOCUA DPS MUTANT 1TUE ; 2.10 ; THE X-RAY STRUCTURE OF THE PAPILLOMAVIRUS HELICASE IN COMPLEX WITH ITS MOLECULAR MATCHMAKER E2 1GJY ; 2.20 ; THE X-RAY STRUCTURE OF THE SORCIN CALCIUM BINDING DOMAIN (SCBD) PROVIDES INSIGHT INTO THE PHOSPHORYLATION AND CALCIUM DEPENDENT PROCESSESS 1QGH ; 2.35 ; THE X-RAY STRUCTURE OF THE UNUSUAL DODECAMERIC FERRITIN FROM LISTERIA INNOCUA, REVEALS A NOVEL INTERSUBUNIT IRON BINDING SITE. 1HQL ; 2.20 ; THE XENOGRAFT ANTIGEN IN COMPLEX WITH THE B4 ISOLECTIN OF GRIFFONIA SIMPLICIFOLIA LECTIN-1 1BP3 ; 2.90 ; THE XRAY STRUCTURE OF A GROWTH HORMONE-PROLACTIN RECEPTOR COMPLEX 2BNJ ; 1.60 ; THE XYLANASE TA FROM THERMOASCUS AURANTIACUS UTILIZES ARABINOSE DECORATIONS OF XYLAN AS SIGNIFICANT SUBSTRATE SPECIFICITY DETERMINANTS. 2DVH ; -1.00 ; THE Y64A MUTANT OF CYTOCHROME C553 FROM DESULFOVIBRIO VULGARIS HILDENBOROUGH, NMR, 39 STRUCTURES 1YVN ; 2.10 ; THE YEAST ACTIN VAL 159 ASN MUTANT COMPLEX WITH HUMAN GELSOLIN SEGMENT 1. 1FL9 ; 2.50 ; THE YJEE PROTEIN 1EHT ; -1.00 ; THEOPHYLLINE-BINDING RIBONUCLEIC ACID IN COMPLEX WITH THEOPHYLLINE, NMR, 10 STRUCTURES 1O15 ; -1.00 ; THEOPHYLLINE-BINDING RIBONUCLEIC ACID IN COMPLEX WITH THEOPHYLLINE, NMR, REGULARIZED MEAN STRUCTURE, REFINEMENT WITH TORSION ANGLE AND BASE-BASE POSITIONAL DATABASE POTENTIALS AND DIPOLAR COUPLINGS 1E07 ; -1.00 ; THEORETICAL MODEL OF HUMAN CARCINOEMBRYONIC ANTIGEN BY HOMOLOGY MODELLING AND CURVE-FITTING TO EXPERIMENTAL SOLUTION SCATTERING DATA 1NCL ; 2.20 ; THERMAL STABILITY OF HEXAMERIC AND TETRAMERIC NUCLEOSIDE, DIPHOSPHATE KINASES 1IZJ ; 2.20 ; THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE 1 MUTANT ENZYME F313A 1IZK ; 2.20 ; THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE 1 MUTANT ENZYME W398V 1UH4 ; 1.80 ; THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE 1/MALTO- TRIDECAOSE COMPLEX 1WZK ; 2.30 ; THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE II (TVA II) MUTATNT D465N 1WZM ; 3.20 ; THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE II (TVA II) MUTATNT R469K 1WZL ; 2.00 ; THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE II (TVA II) MUTATNT R469L 1UH3 ; 2.60 ; THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE/ACARBOSE COMPLEX 1UH2 ; 2.00 ; THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE/MALTO-HEXAOSE COMPLEX 1QYP ; -1.00 ; THERMOCOCCUS CELER RPB9, NMR, 25 STRUCTURES 1PWT ; 1.77 ; THERMODYNAMIC ANALYSIS OF ALPHA-SPECTRIN SH3 AND TWO OF ITS CIRCULAR PERMUTANTS WITH DIFFERENT LOOP LENGTHS: DISCERNING THE REASONS FOR RAPID FOLDING IN PROTEINS 1QY0 ; 1.80 ; THERMODYNAMICS OF BINDING OF 2-METHOXY-3-ISOPROPYLPYRAZINE AND 2-METHOXY-3-ISOBUTYLPYRAZINE TO THE MAJOR URINARY PROTEIN 1QY1 ; 1.70 ; THERMODYNAMICS OF BINDING OF 2-METHOXY-3-ISOPROPYLPYRAZINE AND 2-METHOXY-3-ISOBUTYLPYRAZINE TO THE MAJOR URINARY PROTEIN 1QY2 ; 1.75 ; THERMODYNAMICS OF BINDING OF 2-METHOXY-3-ISOPROPYLPYRAZINE AND 2-METHOXY-3-ISOBUTYLPYRAZINE TO THE MAJOR URINARY PROTEIN 1IN5 ; 2.00 ; THERMOGOTA MARITIMA RUVB A156S MUTANT 3TLI ; 1.95 ; THERMOLYSIN (10% ISOPROPANOL SOAKED CRYSTALS) 8TLI ; 2.20 ; THERMOLYSIN (100% ISOPROPANOL SOAKED CRYSTALS) 1TLI ; 2.05 ; THERMOLYSIN (2% ISOPROPANOL SOAKED CRYSTALS) 4TLI ; 1.95 ; THERMOLYSIN (25% ISOPROPANOL SOAKED CRYSTALS) 2TLI ; 1.95 ; THERMOLYSIN (5% ISOPROPANOL SOAKED CRYSTALS) 1FJW ; 1.90 ; THERMOLYSIN (50 MM PHENOL SOAKED) 1FJ3 ; 2.00 ; THERMOLYSIN (50% ACETONE SOAKED) 1FJT ; 2.20 ; THERMOLYSIN (50% ACETONITRILE SOAKED CRYSTALS) 1FJO ; 2.00 ; THERMOLYSIN (60% ACETONE SOAKED CRYSTALS) 1FJV ; 2.00 ; THERMOLYSIN (60% ACETONITRILE SOAKED CRYSTALS) 5TLI ; 2.10 ; THERMOLYSIN (60% ISOPROPANOL SOAKED CRYSTALS) 6TLI ; 2.10 ; THERMOLYSIN (60% ISOPROPANOL SOAKED CRYSTALS) 1FJQ ; 1.70 ; THERMOLYSIN (70% ACETONE SOAKED CRYSTALS) 1FJU ; 2.00 ; THERMOLYSIN (80% ACETONITRILE SOAKED CRYSTALS) 7TLI ; 1.95 ; THERMOLYSIN (90% ISOPROPANOL SOAKED CRYSTALS) 1TLX ; 2.10 ; THERMOLYSIN (NATIVE) 2TLX ; 1.65 ; THERMOLYSIN (NATIVE) 1KEI ; 1.60 ; THERMOLYSIN (SUBSTRATE-FREE) 1QF1 ; 2.00 ; THERMOLYSIN COMPLEXED WITH (2- SULPHANYLHEPTANOYL)-PHE-ALA. PARAMETERS FOR ZN-BIDENTATION OF MERCAPTOACYLDIPEPTIDES IN METALLOENDOPEPTIDASE 1QF2 ; 2.06 ; THERMOLYSIN COMPLEXED WITH (2-SULPHANYL-3- PHENYLPROPANOYL)-GLY-(5-PHENYLPROLINE). PARAMETERS FOR ZN- MONODENTATION OF MERCAPTOACYLDIPEPTIDES IN METALLOENDOPEPTIDASE 1QF0 ; 2.20 ; THERMOLYSIN COMPLEXED WITH (2-SULPHANYL-3- PHENYLPROPANOYL)-PHE-TYR. PARAMETERS FOR ZN-BIDENTATION OF MERCAPTOACYLDIPEPTIDES IN METALLOENDOPEPTIDASE 1THL ; 1.70 ; THERMOLYSIN COMPLEXED WITH A NOVEL GLUTARAMIDE DERIVATIVE, N-(1-(2(R,S)-CARBOXY-4-PHENYLBUTYL) CYCLOPENTYLCARBONYL)- (S)-TRYPTOPHAN 1KTO ; 1.90 ; THERMOLYSIN COMPLEXED WITH Z-D-ALANINE (BENZYLOXYCARBONYL-D- ALANINE) 1KS7 ; 1.70 ; THERMOLYSIN COMPLEXED WITH Z-D-ASPARTIC ACID (BENZYLOXYCARBONYL-D-ASPARTIC ACID) 1KR6 ; 1.80 ; THERMOLYSIN COMPLEXED WITH Z-D-GLUTAMIC ACID (BENZYLOXYCARBONYL-D-GLUTAMIC ACID) 1KRO ; 1.70 ; THERMOLYSIN COMPLEXED WITH Z-D-THREONINE (BENZYLOXYCARBONYL- D-THREONINE) 1KL6 ; 1.80 ; THERMOLYSIN COMPLEXED WITH Z-L-ALANINE (BENZYLOXYCARBONYL-L- ALANINE) 1KKK ; 1.60 ; THERMOLYSIN COMPLEXED WITH Z-L-ASPARTIC ACID (BENZYLOXYCARBONYL-L-ASPARTIC ACID) 1KJP ; 1.60 ; THERMOLYSIN COMPLEXED WITH Z-L-GLUTAMIC ACID (BENZYLOXYCARBONYL-L-GLUTAMIC ACID) 1KJO ; 1.60 ; THERMOLYSIN COMPLEXED WITH Z-L-THREONINE (BENZYLOXYCARBONYL- L-THREONINE) 1L3F ; 2.30 ; THERMOLYSIN IN THE ABSENCE OF SUBSTRATE HAS AN OPEN CONFORMATION 1OS0 ; 2.10 ; THERMOLYSIN WITH AN ALPHA-AMINO PHOSPHINIC INHIBITOR 1PE7 ; 1.82 ; THERMOLYSIN WITH BICYCLIC INHIBITOR 1PE8 ; 1.80 ; THERMOLYSIN WITH MONOCYCLIC INHIBITOR 1PE5 ; 1.70 ; THERMOLYSIN WITH TRICYCLIC INHIBITOR 1H1A ; 1.75 ; THERMOPHILIC B-1,4-XYLANASE FROM CHAETOMIUM THERMOPHILUM 1M4W ; 2.10 ; THERMOPHILIC B-1,4-XYLANASE FROM NONOMURAEA FLEXUOSA 1IO7 ; 1.50 ; THERMOPHILIC CYTOCHROME P450 (CYP119) FROM SULFOLOBUS SOLFATARICUS: HIGH RESOLUTION STRUCTURAL ORIGIN OF ITS THERMOSTABILITY AND FUNCTIONAL PROPERTIES 1IO8 ; 2.00 ; THERMOPHILIC CYTOCHROME P450 (CYP119) FROM SULFOLOBUS SOLFATARICUS: HIGH RESOLUTION STRUCTURAL ORIGIN OF ITS THERMOSTABILITY AND FUNCTIONAL PROPERTIES 1IO9 ; 2.05 ; THERMOPHILIC CYTOCHROME P450 (CYP119) FROM SULFOLOBUS SOLFATARICUS: HIGH RESOLUTION STRUCTURAL ORIGIN OF ITS THERMOSTABILITY AND FUNCTIONAL PROPERTIES 1F4U ; 2.69 ; THERMOPHILIC P450: CYP119 FROM SULFOLOBUS SOLFACTARICUS 1F4T ; 1.93 ; THERMOPHILIC P450: CYP119 FROM SULFOLOBUS SOLFACTARICUS WITH 4-PHENYLIMIDAZOLE BOUND 1C7I ; 2.00 ; THERMOPHYLIC PNB ESTERASE 1A6E ; 3.20 ; THERMOSOME - MG-ADP-ALF3 COMPLEX 1A6D ; 2.60 ; THERMOSOME FROM T. ACIDOPHILUM 1TGO ; 2.50 ; THERMOSTABLE B TYPE DEOXYRIBONUCLEIC ACID POLYMERASE FROM THERMOCOCCUS GORGONARIUS 1CIU ; 2.30 ; THERMOSTABLE CGTASE FROM THERMOANAEROBACTERIUM THERMOSULFURIGENES EM1 AT PH 8.0. 1N18 ; 2.00 ; THERMOSTABLE MUTANT OF HUMAN SUPEROXIDE DISMUTASE, C6A, C111S 1POO ; 2.10 ; THERMOSTABLE PHYTASE FROM BACILLUS SP 2POO ; 2.05 ; THERMOSTABLE PHYTASE IN FULLY CALCIUM LOADED STATE 1VII ; -1.00 ; THERMOSTABLE SUBDOMAIN FROM CHICKEN VILLIN HEADPIECE, NMR, MINIMIZED AVERAGE STRUCTURE 1BKO ; 2.75 ; THERMOSTABLE THYMIDYLATE SYNTHASE A FROM BACILLUS SUBTILIS 1BKP ; 1.70 ; THERMOSTABLE THYMIDYLATE SYNTHASE A FROM BACILLUS SUBTILIS 1BSF ; 2.20 ; THERMOSTABLE THYMIDYLATE SYNTHASE A FROM BACILLUS SUBTILIS 1BSP ; 2.50 ; THERMOSTABLE THYMIDYLATE SYNTHASE A FROM BACILLUS SUBTILIS 1GOO ; 1.87 ; THERMOSTABLE XYLANASE I FROM THERMOASCUS AURANTIACUS - CRYOCOOLED GLYCEROL COMPLEX 1GOM ; 1.92 ; THERMOSTABLE XYLANASE I FROM THERMOASCUS AURANTIACUS - CRYSTAL FORM I 1GOQ ; 1.80 ; THERMOSTABLE XYLANASE I FROM THERMOASCUS AURANTIACUS - ROOM TEMPERATURE XYLOBIOSE COMPLEX 1GOR ; 1.70 ; THERMOSTABLE XYLANASE I FROM THERMOASCUS AURANTIACUS - XYLOBIOSE COMPLEX AT 100 K 1GOK ; 1.14 ; THERMOSTABLE XYLANASE I FROM THERMOASCUS AURANTIACUS- CRYSTAL FORM II 1B3B ; 3.10 ; THERMOTOGA MARITIMA GLUTAMATE DEHYDROGENASE MUTANT N97D, G376K 2TMG ; 2.90 ; THERMOTOGA MARITIMA GLUTAMATE DEHYDROGENASE MUTANT S128R, T158E, N117R, S160E 1GJW ; 2.10 ; THERMOTOGA MARITIMA MALTOSYLTRANSFERASE COMPLEX WITH MALTOSE 1IN4 ; 1.60 ; THERMOTOGA MARITIMA RUVB HOLLIDAY JUNCTION BRANCH MIGRATION MOTOR 1IN6 ; 1.80 ; THERMOTOGA MARITIMA RUVB K64R MUTANT 1J7K ; 1.80 ; THERMOTOGA MARITIMA RUVB P216G MUTANT 1IN7 ; 1.90 ; THERMOTOGA MARITIMA RUVB R170A 1IN8 ; 1.90 ; THERMOTOGA MARITIMA RUVB T158V 1I6V ; 3.30 ; THERMUS AQUATICUS CORE RIBONUCLEIC ACID POLYMERASE-RIFAMPICIN COMPLEX 1L9U ; 4.00 ; THERMUS AQUATICUS RIBONUCLEIC ACID POLYMERASE HOLOENZYME AT 4 A RESOLUTION 1L9Z ; 6.50 ; THERMUS AQUATICUS RIBONUCLEIC ACID POLYMERASE HOLOENZYME/FORK-JUNCTION PROMOTER DEOXYRIBONUCLEIC ACID COMPLEX AT 6.5 A RESOLUTION 1GVI ; 3.30 ; THERMUS MALTOGENIC AMYLASE IN COMPLEX WITH BETA-CD 1IQ0 ; 2.30 ; THERMUS THERMOPHILUS ARGINYL-TRNA SYNTHETASE 1B5P ; 1.80 ; THERMUS THERMOPHILUS ASPARTATE AMINOTRANSFERASE DOUBLE MUTANT 1 1GCK ; 2.50 ; THERMUS THERMOPHILUS ASPARTATE AMINOTRANSFERASE DOUBLE MUTANT 1 COMPLEXED WITH ASPARTATE 1B5O ; 2.20 ; THERMUS THERMOPHILUS ASPARTATE AMINOTRANSFERASE SINGLE MUTANT 1 5BJ3 ; 2.20 ; THERMUS THERMOPHILUS ASPARTATE AMINOTRANSFERASE TETRA MUTANT 1 5BJ4 ; 2.00 ; THERMUS THERMOPHILUS ASPARTATE AMINOTRANSFERASE TETRA MUTANT 2 1GC4 ; 3.30 ; THERMUS THERMOPHILUS ASPARTATE AMINOTRANSFERASE TETRA MUTANT 2 COMPLEXED WITH ASPARTATE 1GC3 ; 3.30 ; THERMUS THERMOPHILUS ASPARTATE AMINOTRANSFERASE TETRA MUTANT 2 COMPLEXED WITH TRYPTOPHAN 1DT1 ; 1.80 ; THERMUS THERMOPHILUS CYTOCHROME C552 SYNTHESIZED BY ESCHERICHIA COLI 1C52 ; 1.28 ; THERMUS THERMOPHILUS CYTOCHROME-C552: A NEW HIGHLY THERMOSTABLE CYTOCHROME-C STRUCTURE OBTAINED BY MAD PHASING 1SRV ; 1.70 ; THERMUS THERMOPHILUS GROEL (HSP60 CLASS) FRAGMENT (APICAL DOMAIN) COMPRISING RESIDUES 192-336 2BYT ; 3.30 ; THERMUS THERMOPHILUS LEUCYL-TRNA SYNTHETASE COMPLEXED WITH A TRNALEU TRANSCRIPT IN THE POST-EDITING CONFORMATION 2BTE ; 2.90 ; THERMUS THERMOPHILUS LEUCYL-TRNA SYNTHETASE COMPLEXED WITH WITH A TRNALEU TRANSCRIPT IN THE POST-EDITING CONFORMATION AND A POST-TRANSFER EDITING SUBSTRATE ANALOGUE 1G4E ; 1.60 ; THIAMIN PHOSPHATE SYNTHASE 1G4P ; 2.50 ; THIAMIN PHOSPHATE SYNTHASE 1G4S ; 1.70 ; THIAMIN PHOSPHATE SYNTHASE 1G4T ; 1.55 ; THIAMIN PHOSPHATE SYNTHASE 1G67 ; 1.40 ; THIAMIN PHOSPHATE SYNTHASE 1G69 ; 1.50 ; THIAMIN PHOSPHATE SYNTHASE 1G6C ; 1.40 ; THIAMIN PHOSPHATE SYNTHASE 2TPS ; 1.25 ; THIAMIN PHOSPHATE SYNTHASE 2THI ; 2.50 ; THIAMINASE I FROM BACILLUS THIAMINOLYTICUS 3THI ; 2.00 ; THIAMINASE I FROM BACILLUS THIAMINOLYTICUS 4THI ; 2.00 ; THIAMINASE I FROM BACILLUS THIAMINOLYTICUS WITH COVALENTLY BOUND 4-AMINO-2,5-DIMETHYLPYRIMIDINE 1XI3 ; 1.70 ; THIAMINE PHOSPHATE PYROPHOSPHORYLASE FROM PYROCOCCUS FURIOSUS PFU-1255191-001 4VHB ; 1.80 ; THIOCYANATE ADDUCT OF THE BACTERIAL HEMOGLOBIN FROM VITREOSCILLA SP. 1MO2 ; 3.00 ; THIOESTERASE DOMAIN FROM 6-DEOXYERYTHRONOLIDE SYNTHASE (DEBS TE), PH 8.5 1MN6 ; 2.20 ; THIOESTERASE DOMAIN FROM PICROMYCIN POLYKETIDE SYNTHASE, PH 7.6 1MNA ; 1.80 ; THIOESTERASE DOMAIN OF PICROMYCIN POLYKETIDE SYNTHASE (PICS TE), PH 8.0 1MNQ ; 2.20 ; THIOESTERASE DOMAIN OF PICROMYCIN POLYKETIDE SYNTHASE (PICS TE), PH 8.4 1H5V ; 1.10 ; THIOPENTASACCHARIDE COMPLEX OF THE ENDOGLUCANASE CEL5A FROM BACILLUS AGARADHARENS AT 1.1 A RESOLUTION IN THE TETRAGONAL CRYSTAL FORM 1XOA ; -1.00 ; THIOREDOXIN (OXIDIZED DISULFIDE FORM), NMR, 20 STRUCTURES 1XOB ; -1.00 ; THIOREDOXIN (REDUCED DITHIO FORM), NMR, 20 STRUCTURES 1TOF ; -1.00 ; THIOREDOXIN H (OXIDIZED FORM), NMR, 23 STRUCTURES 1QMV ; 1.70 ; THIOREDOXIN PEROXIDASE B FROM RED BLOOD CELLS 1X0R ; 2.00 ; THIOREDOXIN PEROXIDASE FROM AEROPYRUM PERNIX K1 1THX ; 1.70 ; THIOREDOXIN-2 1W8A ; 2.80 ; THIRD LRR DOMAIN OF DROSOPHILA SLIT 1BJ8 ; -1.00 ; THIRD N-TERMINAL DOMAIN OF GP130, NMR, MINIMIZED AVERAGE STRUCTURE 1C3Y ; -1.00 ; THP12-CARRIER PROTEIN FROM YELLOW MEAL WORM 1C3Z ; -1.00 ; THP12-CARRIER PROTEIN FROM YELLOW MEAL WORM 1E9H ; 2.50 ; THR 160 PHOSPHORYLATED CDK2 - HUMAN CYCLIN A3 COMPLEX WITH THE INHIBITOR INDIRUBIN-5-SULPHONATE BOUND 1S54 ; 2.20 ; THR24ALA BACTERIORHODOPSIN 1S51 ; 2.00 ; THR24SER BACTERIORHODOPSIN 1S52 ; 2.30 ; THR24VAL BACTERIORHODOPSIN 1C8W ; 1.80 ; THR45GLY VARIANT OF RIBONUCLEASE A 1S53 ; 2.00 ; THR46SER BACTERIORHODOPSIN 1T2L ; 2.80 ; THREE CRYSTAL STRUCTURES OF HUMAN COACTOSIN-LIKE PROTEIN 1T3X ; 2.00 ; THREE CRYSTAL STRUCTURES OF HUMAN COACTOSIN-LIKE PROTEIN 1T3Y ; 1.15 ; THREE CRYSTAL STRUCTURES OF HUMAN COACTOSIN-LIKE PROTEIN 1NIX ; -1.00 ; THREE DIMENSIONAL SOLUTION STRUCTURE OF HAINANTOXIN-I BY 2D 1H-NMR 1NIY ; -1.00 ; THREE DIMENSIONAL SOLUTION STRUCTURE OF HAINANTOXIN-IV BY 2D 1H-NMR 1I25 ; -1.00 ; THREE DIMENSIONAL SOLUTION STRUCTURE OF HUWENTOXIN-II BY 2D 1H-NMR 1MB6 ; -1.00 ; THREE DIMENSIONAL SOLUTION STRUCTURE OF HUWENTOXIN-IV BY 2D 1H-NMR 1Y29 ; -1.00 ; THREE DIMENSIONAL SOLUTION STRUCTURE OF HUWENTOXIN-X BY 2D 1H-NMR 1X32 ; -1.00 ; THREE DIMENSIONAL SOLUTION STRUCTURE OF THE CHROMO1 DOMAIN OF CPSRP43 1RYV ; -1.00 ; THREE DIMENSIONAL SOLUTION STRUCTURE OF THE K27A MUTANT OF SODIUM CHANNELS INHIBITOR HAINANTOXIN-IV BY 2D 1H-NMR 1RYG ; -1.00 ; THREE DIMENSIONAL SOLUTION STRUCTURE OF THE R29A MUTANT OF SODIUM CHANNELS INHIBITOR HAINANTOXIN-IV BY 2D 1H-NMR 1OWC ; 2.20 ; THREE DIMENSIONAL STRUCTURE ANALYSIS OF THE R109L VARIANT OF THE TYPE II CITRATE SYNTHASE FROM E. COLI 1KB3 ; 2.10 ; THREE DIMENSIONAL STRUCTURE ANALYSIS OF THE R195A VARIANT OF HUMAN PANCREATIC ALPHA AMYLASE 1KGX ; 2.00 ; THREE DIMENSIONAL STRUCTURE ANALYSIS OF THE R195Q VARIANT OF HUMAN PANCREATIC ALPHA AMYLASE 1KGU ; 2.00 ; THREE DIMENSIONAL STRUCTURE ANALYSIS OF THE R337A VARIANT OF HUMAN PANCREATIC ALPHA-AMYLASE 1KGW ; 2.10 ; THREE DIMENSIONAL STRUCTURE ANALYSIS OF THE R337Q VARIANT OF HUMAN PANCREATIC ALPHA-MYLASE 1K3P ; 2.20 ; THREE DIMENSIONAL STRUCTURE ANALYSIS OF THE TYPE II CITRATE SYNTHASE FROM E.COLI 1OWB ; 2.20 ; THREE DIMENSIONAL STRUCTURE ANALYSIS OF THE VARIANT R109L NADH COMPLEX OF TYPE II CITRATE SYNTHASE FROM E. COLI 1QZO ; 2.35 ; THREE DIMENSIONAL STRUCTURE OF A GOAT SIGNALLING PROTEIN SECRETED DURING INVOLUTION 1T3F ; 2.00 ; THREE DIMENSIONAL STRUCTURE OF A HUMANIZED ANTI-IFN-GAMMA FAB (HUZAF) IN P21 21 21 SPACE GROUP 1T04 ; 3.00 ; THREE DIMENSIONAL STRUCTURE OF A HUMANIZED ANTI-IFN-GAMMA FAB IN C2 SPACE GROUP 1W3A ; 2.65 ; THREE DIMENSIONAL STRUCTURE OF A NOVEL PORE-FORMING LECTIN FROM THE MUSHROOM LAETIPORUS SULPHUREUS 1FIZ ; 2.90 ; THREE DIMENSIONAL STRUCTURE OF BETA-ACROSIN FROM BOAR SPERMATOZOA 2C2X ; 2.00 ; THREE DIMENSIONAL STRUCTURE OF BIFUNCTIONAL METHYLENETETRAHYDROFOLATE DEHYDROGENASE-CYCLOHYDROLASE FROM MYCOBACTERIUM TUBERCULOSIS 2C2Y ; 2.30 ; THREE DIMENSIONAL STRUCTURE OF BIFUNCTIONAL METHYLENETETRAHYDROFOLATE DEHYDROGENASE-CYCLOHYDROLASE FROM MYCOBACTERIUM TUBERCULOSIS 1QJZ ; 3.80 ; THREE DIMENSIONAL STRUCTURE OF PHYSALIS MOTTLE VIRUS: IMPLICATIONS FOR THE VIRAL ASSEMBLY 1EVE ; 2.50 ; THREE DIMENSIONAL STRUCTURE OF THE ANTI-ALZHEIMER DRUG, E2020 (ARICEPT), COMPLEXED WITH ITS TARGET ACETYLCHOLINESTERASE 1WR5 ; 1.40 ; THREE DIMENSIONAL STRUCTURE OF THE E41K MUTANT OF TETRAHEME CYTOCHROME C3 FROM DESULFOVIBRIO VULGARIS MIYAZAKI F 1BR0 ; -1.00 ; THREE DIMENSIONAL STRUCTURE OF THE N-TERMINAL DOMAIN OF SYNTAXIN 1A 1OFW ; 1.50 ; THREE DIMENSIONAL STRUCTURE OF THE OXIDIZED FORM OF NINE HEME CYTOCHROME C AT PH 7.5 1OFY ; 2.00 ; THREE DIMENSIONAL STRUCTURE OF THE REDUCED FORM OF NINE-HEME CYTOCHROME C AT PH 7.5 1F06 ; 2.10 ; THREE DIMENSIONAL STRUCTURE OF THE TERNARY COMPLEX OF CORYNEBACTERIUM GLUTAMICUM DIAMINOPIMELATE DEHYDROGENASE NADPH-L-2-AMINO-6-METHYLENE-PIMELATE 1J0P ; 0.91 ; THREE DIMENSIONAL STRUCTURE OF THE Y43L MUTANT OF TETRAHEME CYTOCHROME C3 FROM DESULFOVIBRIO VULGARIS MIYAZAKI F 1Q9M ; 2.30 ; THREE DIMENSIONAL STRUCTURES OF PDE4D IN COMPLEX WITH ROLIPRAMS AND IMPLICATION ON INHIBITOR SELECTIVITY 1UCR ; 1.20 ; THREE-DIMENSIONAL CRYSTAL STRUCTURE OF DISSIMILATORY SULFITE REDUCTASE D (DSRD) 1EPG ; -1.00 ; THREE-DIMENSIONAL NUCLEAR MAGNETIC RESONANCE STRUCTURES OF MOUSE EPIDERMAL GROWTH FACTOR IN ACIDIC AND PHYSIOLOGICAL PH SOLUTIONS 1MTQ ; -1.00 ; THREE-DIMENSIONAL SOLUTION STRUCTURE OF ALPHA-CONOTOXIN GID BY NMR SPECTROSCOPY 1M31 ; -1.00 ; THREE-DIMENSIONAL SOLUTION STRUCTURE OF APO-MTS1 1K2H ; -1.00 ; THREE-DIMENSIONAL SOLUTION STRUCTURE OF APO-S100A1. 1OZO ; -1.00 ; THREE-DIMENSIONAL SOLUTION STRUCTURE OF APO-S100P PROTEIN DETERMINED BY NMR SPECTROSCOPY 1F3K ; -1.00 ; THREE-DIMENSIONAL SOLUTION STRUCTURE OF OMEGA-CONOTOXIN TXVII, AN L-TYPE CALCIUM CHANNEL BLOCKER 1V56 ; -1.00 ; THREE-DIMENSIONAL SOLUTION STRUCTURE OF SPINOXIN, A POTASSIUM CHANNEL BLOCKER 1V4Q ; -1.00 ; THREE-DIMENSIONAL SOLUTION STRUCTURE OF THE ANALOGUE PEPTIDE OF OMEGA-CONOTOXIN MVIIC 1WQB ; -1.00 ; THREE-DIMENSIONAL SOLUTION STRUCUTRE OF APTOTOXIN VII, FROM THE VENOM OF A TRAP-DOOR SPIDER 386D ; 1.80 ; THREE-DIMENSIONAL STRUCTURE AND REACTIVITY OF A PHOTOCHEMICAL CLEAVAGE AGENT BOUND TO DEOXYRIBONUCLEIC ACID 1OG7 ; -1.00 ; THREE-DIMENSIONAL STRUCTURE IN LIPID MICELLES OF THE PEDIOCIN-LIKE ANTIMICROBIAL PEPTIDE SAKACIN P. 1OHN ; -1.00 ; THREE-DIMENSIONAL STRUCTURE IN LIPID MICELLES OF THE PEDIOCIN-LIKE ANTIMICROBIAL PEPTIDE SAKACIN P. 1FU3 ; -1.00 ; THREE-DIMENSIONAL STRUCTURE IN SOLUTION OF THE SODIUM CHANNEL AGONIST/ANTAGONIST DELTA-CONOTOXIN TXVIA 1BVQ ; 2.00 ; THREE-DIMENSIONAL STRUCTURE OF 4-HYDROXYBENZOYL COA THIOESTERASE FROM PSEUDOMONAS SP. STRAIN CBS-3. 1D2Z ; 2.00 ; THREE-DIMENSIONAL STRUCTURE OF A COMPLEX BETWEEN THE DEATH DOMAINS OF PELLE AND TUBE 1AQK ; 1.84 ; THREE-DIMENSIONAL STRUCTURE OF A HUMAN FAB WITH HIGH AFFINITY FOR TETANUS TOXOID 1I3V ; 2.03 ; THREE-DIMENSIONAL STRUCTURE OF A LAMA VHH DOMAIN UNLIGANDED 1I3U ; 1.95 ; THREE-DIMENSIONAL STRUCTURE OF A LLAMA VHH DOMAIN COMPLEXED WITH THE DYE RR1 1SJX ; 2.20 ; THREE-DIMENSIONAL STRUCTURE OF A LLAMA VHH DOMAIN OE7 BINDING THE CELL WALL PROTEIN MALF1 1SJV ; 1.94 ; THREE-DIMENSIONAL STRUCTURE OF A LLAMA VHH DOMAIN SWAPPING 1DQ7 ; 2.20 ; THREE-DIMENSIONAL STRUCTURE OF A NEUROTOXIN FROM RED SCORPION (BUTHUS TAMULUS) AT 2.2A RESOLUTION. 1DPY ; 2.45 ; THREE-DIMENSIONAL STRUCTURE OF A NOVEL PHOSPHOLIPASE A2 FROM INDIAN COMMON KRAIT AT 2.45 A RESOLUTION 1TA0 ; 2.10 ; THREE-DIMENSIONAL STRUCTURE OF A RIBONUCLEIC ACID-POLYMERASE II BINDING PROTEIN WITH ASSOCIATED LIGAND. 1T9Z ; 2.30 ; THREE-DIMENSIONAL STRUCTURE OF A RIBONUCLEIC ACID-POLYMERASE II BINDING PROTEIN. 1P4B ; 2.35 ; THREE-DIMENSIONAL STRUCTURE OF A SINGLE CHAIN FV FRAGMENT COMPLEXED WITH THE PEPTIDE GCN4(7P-14P). 1M2C ; -1.00 ; THREE-DIMENSIONAL STRUCTURE OF ALPHA-CONOTOXIN MII, NMR, 14 STRUCTURES 1JVK ; 1.94 ; THREE-DIMENSIONAL STRUCTURE OF AN IMMUNOGLOBULIN LIGHT CHAIN DIMER ACTING AS A LETHAL AMYLOID PRECURSOR 1H8S ; 2.40 ; THREE-DIMENSIONAL STRUCTURE OF ANTI-AMPICILLIN SINGLE CHAIN FV FRAGMENT COMPLEXED WITH THE HAPTEN. 1H8N ; 1.87 ; THREE-DIMENSIONAL STRUCTURE OF ANTI-AMPICILLIN SINGLE CHAIN FV FRAGMENT FROM PHAGE-DISPLAYED MURINE ANTIBODY LIBRARIES 1H8O ; 2.75 ; THREE-DIMENSIONAL STRUCTURE OF ANTI-AMPICILLIN SINGLE CHAIN FV FRAGMENT. 1CIX ; -1.00 ; THREE-DIMENSIONAL STRUCTURE OF ANTIMICROBIAL PEPTIDE TACHYSTATIN A ISOLATED FROM HORSESHOE CRAB 2A8E ; 2.50 ; THREE-DIMENSIONAL STRUCTURE OF BACILLUS SUBTILIS Q45498 PUTATIVE PROTEIN AT RESOLUTION 2.5A. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET SR204. 1FIW ; 2.10 ; THREE-DIMENSIONAL STRUCTURE OF BETA-ACROSIN FROM RAM SPERMATOZOA 1JHP ; 2.20 ; THREE-DIMENSIONAL STRUCTURE OF COBT IN COMPLEX WITH 5- METHOXYBENZIMIDAZOLE 1JHM ; 2.20 ; THREE-DIMENSIONAL STRUCTURE OF COBT IN COMPLEX WITH 5- METHYLBENZIMIDAZOLE 1JHV ; 2.00 ; THREE-DIMENSIONAL STRUCTURE OF COBT IN COMPLEX WITH P- CRESOL AND NICOTINATE 1JHU ; 2.00 ; THREE-DIMENSIONAL STRUCTURE OF COBT IN COMPLEX WITH P-CRESOL 1JHX ; 2.00 ; THREE-DIMENSIONAL STRUCTURE OF COBT IN COMPLEX WITH PHENOL 1JHY ; 2.00 ; THREE-DIMENSIONAL STRUCTURE OF COBT IN COMPLEX WITH PHENOL AND NICOTINATE 1JHR ; 2.00 ; THREE-DIMENSIONAL STRUCTURE OF COBT IN COMPLEX WITH REACTION PRODUCTS OF 2-HYDROXYPURINE AND NAMN 1JHQ ; 2.00 ; THREE-DIMENSIONAL STRUCTURE OF COBT IN COMPLEX WITH REACTION PRODUCTS OF 5-METHOXYBENZIMIDAZOLE AND NAMN 1JHO ; 2.00 ; THREE-DIMENSIONAL STRUCTURE OF COBT IN COMPLEX WITH THE REACTION PRODUCTS OF 5-METHYLBENZIMIDAZOLE AND NAMN 1CF2 ; 2.10 ; THREE-DIMENSIONAL STRUCTURE OF D-GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE FROM THE HYPERTHERMOPHILIC ARCHAEON METHANOTHERMUS FERVIDUS 1YF2 ; 2.40 ; THREE-DIMENSIONAL STRUCTURE OF DEOXYRIBONUCLEIC ACID SEQUENCE SPECIFICITY (S) SUBUNIT OF A TYPE I RESTRICTION-MODIFICATION ENZYME AND ITS FUNCTIONAL IMPLICATIONS 1SRX ; 2.80 ; THREE-DIMENSIONAL STRUCTURE OF ESCHERICHIA COLI THIOREDOXIN- S2 TO 2.8 ANGSTROMS RESOLUTION 1AL8 ; 2.20 ; THREE-DIMENSIONAL STRUCTURE OF GLYCOLATE OXIDASE WITH BOUND ACTIVE-SITE INHIBITORS 1EFV ; 2.10 ; THREE-DIMENSIONAL STRUCTURE OF HUMAN ELECTRON TRANSFER FLAVOPROTEIN TO 2.1 A RESOLUTION 1BQT ; -1.00 ; THREE-DIMENSIONAL STRUCTURE OF HUMAN INSULIN-LIKE GROWTH FACTOR-I (IGF-I) DETERMINED BY 1H-NMR AND DISTANCE GEOMETRY, 6 STRUCTURES 1RW2 ; -1.00 ; THREE-DIMENSIONAL STRUCTURE OF KU80 CTD 1BOU ; 2.20 ; THREE-DIMENSIONAL STRUCTURE OF LIGAB 1AMO ; 2.60 ; THREE-DIMENSIONAL STRUCTURE OF NADPH-CYTOCHROME P450 REDUCTASE: PROTOTYPE FOR FMN- AND FAD-CONTAINING ENZYMES 1H2R ; 1.40 ; THREE-DIMENSIONAL STRUCTURE OF NI-FE HYDROGENASE FROM DESULFIVIBRIO VULGARIS MIYAZAKI F IN THE REDUCED FORM AT 1.4 A RESOLUTION 1FIY ; 2.80 ; THREE-DIMENSIONAL STRUCTURE OF PHOSPHOENOLPYRUVATE CARBOXYLASE FROM ESCHERICHIA COLI AT 2.8 A RESOLUTION 1NSA ; 2.30 ; THREE-DIMENSIONAL STRUCTURE OF PORCINE PROCARBOXYPEPTIDASE B: A STRUCTURAL BASIS OF ITS INACTIVITY 1BZO ; 2.10 ; THREE-DIMENSIONAL STRUCTURE OF PROKARYOTIC CU,ZN SUPEROXIDE DISMUTASE FROM P.LEIOGNATHI, SOLVED BY X-RAY CRYSTALLOGRAPHY. 1RLA ; 2.10 ; THREE-DIMENSIONAL STRUCTURE OF RAT LIVER ARGINASE, THE BINUCLEAR MANGANESE METALLOENZYME OF THE UREA CYCLE 1B2M ; 2.00 ; THREE-DIMENSIONAL STRUCTURE OF RIBONULCEASE T1 COMPLEXED WITH AN ISOSTERIC PHOSPHONATE ANALOGUE OF GPU: ALTERNATE SUBSTRATE BINDING MODES AND CATALYSIS. 1SAX ; 2.80 ; THREE-DIMENSIONAL STRUCTURE OF S.AUREUS METHICILLIN- RESISTANCE REGULATING TRANSCRIPTIONAL REPRESSOR MECI IN COMPLEX WITH 25-BP DS-DEOXYRIBONUCLEIC ACID 1OKR ; 2.40 ; THREE-DIMENSIONAL STRUCTURE OF S.AUREUS METHICILLIN-RESISTANCE REGULATING TRANSCRIPTIONAL REPRESSOR MECI. 1TDT ; 2.20 ; THREE-DIMENSIONAL STRUCTURE OF TETRAHYDRODIPICOLINATE-N- SUCCINLYTRANSFERASE 1RH8 ; -1.00 ; THREE-DIMENSIONAL STRUCTURE OF THE CALCIUM-FREE PICCOLO C2A- DOMAIN 1UBH ; 1.35 ; THREE-DIMENSIONAL STRUCTURE OF THE CARBON MONOXIDE COMPLEX OF [NIFE]HYDROGENASE FROM DESULUFOVIBRIO VULGARIS MIYAZAKI F 1UBJ ; 1.35 ; THREE-DIMENSIONAL STRUCTURE OF THE CARBON MONOXIDE COMPLEX OF [NIFE]HYDROGENASE FROM DESULUFOVIBRIO VULGARIS MIYAZAKI F 1UBK ; 1.18 ; THREE-DIMENSIONAL STRUCTURE OF THE CARBON MONOXIDE COMPLEX OF [NIFE]HYDROGENASE FROM DESULUFOVIBRIO VULGARIS MIYAZAKI F 1UBL ; 1.20 ; THREE-DIMENSIONAL STRUCTURE OF THE CARBON MONOXIDE COMPLEX OF [NIFE]HYDROGENASE FROM DESULUFOVIBRIO VULGARIS MIYAZAKI F 1UBM ; 1.40 ; THREE-DIMENSIONAL STRUCTURE OF THE CARBON MONOXIDE COMPLEX OF [NIFE]HYDROGENASE FROM DESULUFOVIBRIO VULGARIS MIYAZAKI F 1UBO ; 1.35 ; THREE-DIMENSIONAL STRUCTURE OF THE CARBON MONOXIDE COMPLEX OF [NIFE]HYDROGENASE FROM DESULUFOVIBRIO VULGARIS MIYAZAKI F 1UBR ; 1.34 ; THREE-DIMENSIONAL STRUCTURE OF THE CARBON MONOXIDE COMPLEX OF [NIFE]HYDROGENASE FROM DESULUFOVIBRIO VULGARIS MIYAZAKI F 1UBT ; 1.34 ; THREE-DIMENSIONAL STRUCTURE OF THE CARBON MONOXIDE COMPLEX OF [NIFE]HYDROGENASE FROM DESULUFOVIBRIO VULGARIS MIYAZAKI F 1UBU ; 1.35 ; THREE-DIMENSIONAL STRUCTURE OF THE CARBON MONOXIDE COMPLEX OF [NIFE]HYDROGENASE FROM DESULUFOVIBRIO VULGARIS MIYAZAKI F 1FPT ; 3.00 ; THREE-DIMENSIONAL STRUCTURE OF THE COMPLEX BETWEEN THE FAB FRAGMENT OF AN NEUTRALIZING ANTIBODY FOR TYPE 1 POLIOVIRUS AND ITS VIRAL EPITOPE 1KIL ; 2.30 ; THREE-DIMENSIONAL STRUCTURE OF THE COMPLEXIN/SNARE COMPLEX 1AJB ; 2.50 ; THREE-DIMENSIONAL STRUCTURE OF THE D153G MUTANT OF E. COLI ALKALINE PHOSPHATASE: A MUTANT WITH WEAKER MAGNESIUM 2BW3 ; 2.00 ; THREE-DIMENSIONAL STRUCTURE OF THE HERMES DEOXYRIBONUCLEIC ACID TRANSPOSASE 1L9M ; 2.10 ; THREE-DIMENSIONAL STRUCTURE OF THE HUMAN TRANSGLUTAMINASE 3 ENZYME: BINDING OF CALCIUM IONS CHANGE STRUCTURE FOR ACTIVATION 1L9N ; 2.10 ; THREE-DIMENSIONAL STRUCTURE OF THE HUMAN TRANSGLUTAMINASE 3 ENZYME: BINDING OF CALCIUM IONS CHANGE STRUCTURE FOR ACTIVATION 1LEP ; 3.50 ; THREE-DIMENSIONAL STRUCTURE OF THE IMMUNODOMINANT HEAT-SHOCK PROTEIN CHAPERONIN-10 OF MYCOBACTERIUM LEPRAE 1CEK ; -1.00 ; THREE-DIMENSIONAL STRUCTURE OF THE MEMBRANE-EMBEDDED M2 CHANNEL-LINING SEGMENT FROM THE NICOTINIC ACETYLCHOLINE RECEPTOR BY SOLID-STATE NMR SPECTROSCOPY 1WUH ; 1.24 ; THREE-DIMENSIONAL STRUCTURE OF THE NI-A STATE OF [NIFE]HYDROGENASE FROM DESULUFOVIBRIO VULGARIS MIYAZAKI F 1WUJ ; 1.40 ; THREE-DIMENSIONAL STRUCTURE OF THE NI-B STATE OF [NIFE]HYDROGENASE FROM DESULUFOVIBRIO VULGARIS MIYAZAKI F 1EQ8 ; -1.00 ; THREE-DIMENSIONAL STRUCTURE OF THE PENTAMERIC HELICAL BUNDLE OF THE ACETYLCHOLINE RECEPTOR M2 TRANSMEMBRANE SEGMENT 1EVI ; 2.50 ; THREE-DIMENSIONAL STRUCTURE OF THE PURPLE INTERMEDIATE OF PORCINE KIDNEY D-AMINO ACID OXIDASE 1H0M ; 3.00 ; THREE-DIMENSIONAL STRUCTURE OF THE QUORUM SENSING PROTEIN TRAR BOUND TO ITS AUTOINDUCER AND TO ITS TARGET DEOXYRIBONUCLEIC ACID 1BG1 ; 2.25 ; THREE-DIMENSIONAL STRUCTURE OF THE STAT3B HOMODIMER BOUND TO DEOXYRIBONUCLEIC ACID 1K5W ; -1.00 ; THREE-DIMENSIONAL STRUCTURE OF THE SYNAPTOTAGMIN 1 C2B- DOMAIN: SYNAPTOTAGMIN 1 AS A PHOSPHOLIPID BINDING MACHINE 1DPM ; 2.10 ; THREE-DIMENSIONAL STRUCTURE OF THE ZINC-CONTAINING PHOSPHOTRIESTERASE WITH BOUND SUBSTRATE ANALOG DIETHYL 4-METHYLBENZYLPHOSPHONATE 1EZ2 ; 1.90 ; THREE-DIMENSIONAL STRUCTURE OF THE ZINC-CONTAINING PHOSPHOTRIESTERASE WITH BOUND SUBSTRATE ANALOG DIISOPROPYLMETHYL PHOSPHONATE. 1EYW ; 1.90 ; THREE-DIMENSIONAL STRUCTURE OF THE ZINC-CONTAINING PHOSPHOTRIESTERASE WITH BOUND SUBSTRATE ANALOG TRIETHYLPHOSPHATE 1R9G ; 2.50 ; THREE-DIMENSIONAL STRUCTURE OF YAAE FROM BACILLUS SUBTILIS 1AL7 ; 2.60 ; THREE-DIMENSIONAL STRUCTURES OF GLYCOLATE OXIDASE WITH BOUND ACTIVE-SITE INHIBITORS 1AZH ; -1.00 ; THREE-DIMENSIONAL STRUCTURES OF THREE ENGINEERED CELLULOSE-BINDING DOMAINS OF CELLOBIOHYDROLASE I FROM TRICHODERMA REESEI, NMR, 14 STRUCTURES 1AZJ ; -1.00 ; THREE-DIMENSIONAL STRUCTURES OF THREE ENGINEERED CELLULOSE-BINDING DOMAINS OF CELLOBIOHYDROLASE I FROM TRICHODERMA REESEI, NMR, 18 STRUCTURES 1AZK ; -1.00 ; THREE-DIMENSIONAL STRUCTURES OF THREE ENGINEERED CELLULOSE-BINDING DOMAINS OF CELLOBIOHYDROLASE I FROM TRICHODERMA REESEI, NMR, 19 STRUCTURES 1AZ6 ; -1.00 ; THREE-DIMENSIONAL STRUCTURES OF THREE ENGINEERED CELLULOSE-BINDING DOMAINS OF CELLOBIOHYDROLASE I FROM TRICHODERMA REESEI, NMR, 23 STRUCTURES 1TDJ ; 2.80 ; THREONINE DEAMINASE (BIOSYNTHETIC) FROM E. COLI 1Z71 ; 1.80 ; THROMBIN AND P2 PYRIDINE N-OXIDE INHIBITOR COMPLEX STRUCTURE 1A61 ; 2.20 ; THROMBIN COMPLEXED WITH A BETA-MIMETIC THIAZOLE-CONTAINING INHIBITOR 1UCY ; 2.20 ; THROMBIN COMPLEXED WITH FIBRINOPEPTIDE A ALPHA (RESIDUES 7 - 19). THREE COMPLEXES, ONE WITH EPSILON-THROMBIN AND TWO WITH ALPHA-THROMBIN 1A46 ; 2.12 ; THROMBIN COMPLEXED WITH HIRUGEN AND A BETA-STRAND MIMETIC INHIBITOR 1ZRB ; 1.90 ; THROMBIN IN COMPLEX WITH AN AZAFLUORENYL INHIBITOR 23B 1ZGV ; 2.20 ; THROMBIN IN COMPLEX WITH AN OXAZOLOPYRIDINE INHIBITOR 2 1ZGI ; 2.20 ; THROMBIN IN COMPLEX WITH AN OXAZOLOPYRIDINE INHIBITOR 21 1RIW ; 2.04 ; THROMBIN IN COMPLEX WITH NATURAL PRODUCT INHIBITOR OSCILLARIN 1NT1 ; 2.00 ; THROMBIN IN COMPLEX WITH SELECTIVE MACROCYCLIC INHIBITOR 1NM6 ; 1.80 ; THROMBIN IN COMPLEX WITH SELECTIVE MACROCYCLIC INHIBITOR AT 1.8A 1G30 ; 2.00 ; THROMBIN INHIBITOR COMPLEX 1G32 ; 1.90 ; THROMBIN INHIBITOR COMPLEX 1KTS ; 2.40 ; THROMBIN INHIBITOR COMPLEX 1KTT ; 2.10 ; THROMBIN INHIBITOR COMPLEX 1AY6 ; 1.80 ; THROMBIN INHIBITOR FROM THEONALLA, CYCLOTHEANAMIDE-BASED MACROCYCLIC TRIPEPTIDE MOTIF 1AVG ; 2.60 ; THROMBIN INHIBITOR FROM TRIATOMA PALLIDIPENNIS 1BA8 ; 1.80 ; THROMBIN INHIBITOR WITH A RIGID TRIPEPTIDYL ALDEHYDES 1BB0 ; 2.10 ; THROMBIN INHIBITORS WITH RIGID TRIPEPTIDYL ALDEHYDES 1CA8 ; 2.10 ; THROMBIN INHIBITORS WITH RIGID TRIPEPTIDYL ALDEHYDES 1MUE ; 2.00 ; THROMBIN-HIRUGEN-L405,426 1MU8 ; 2.00 ; THROMBIN-HIRUGEN_L-378,650 1VIT ; 3.20 ; THROMBIN:HIRUDIN 51-65 COMPLEX 3VTK ; 3.00 ; THYMIDINE KINASE FROM HERPES SIMPLEX VIRUS TYPE 1 IN COMPLEX WITH ADP AND 5-IODO-DEOXYURIDINE-MONOPHOSPHATE 2VTK ; 2.80 ; THYMIDINE KINASE FROM HERPES SIMPLEX VIRUS TYPE 1 IN COMPLEX WITH ADP AND DEOXYTHYMIDINE 1VTK ; 2.75 ; THYMIDINE KINASE FROM HERPES SIMPLEX VIRUS TYPE 1 IN COMPLEX WITH ADP AND DEOXYTHYMIDINE-MONOPHOSPHATE 1E2P ; 2.50 ; THYMIDINE KINASE, DHBT 1NJB ; 2.75 ; THYMIDYLATE SYNTHASE 1TSD ; 1.95 ; THYMIDYLATE SYNTHASE COMPLEX WITH 2'-DEOXYURIDINE 5'-MONOPHOSPHATE (DUMP) AND FOLATE ANALOG 1843U89 1TLC ; 2.10 ; THYMIDYLATE SYNTHASE COMPLEXED WITH DGMP AND FOLATE ANALOG 1843U89 1VZA ; 2.50 ; THYMIDYLATE SYNTHASE E60D MUTANT BINARY COMPLEX WITH 2'-DEOXYURIDINE 5'-MONOPHOSPHATE (DUMP) 1RTS ; 3.30 ; THYMIDYLATE SYNTHASE FROM RAT IN TERNARY COMPLEX WITH DUMP AND TOMUDEX 2TSR ; 2.60 ; THYMIDYLATE SYNTHASE FROM RAT IN TERNARY COMPLEX WITH DUMP AND TOMUDEX 1BO8 ; 2.40 ; THYMIDYLATE SYNTHASE R178T MUTANT 1BPJ ; 2.40 ; THYMIDYLATE SYNTHASE R178T, R179T DOUBLE MUTANT 1TSV ; 2.90 ; THYMIDYLATE SYNTHASE R179A MUTANT 1TSW ; 2.55 ; THYMIDYLATE SYNTHASE R179A MUTANT 1TSX ; 2.50 ; THYMIDYLATE SYNTHASE R179E MUTANT 1TSY ; 2.20 ; THYMIDYLATE SYNTHASE R179K MUTANT 1TSZ ; 2.75 ; THYMIDYLATE SYNTHASE R179K MUTANT 1BO7 ; 2.40 ; THYMIDYLATE SYNTHASE R179T MUTANT 1BP0 ; 2.40 ; THYMIDYLATE SYNTHASE R23I MUTANT 1BP6 ; 2.40 ; THYMIDYLATE SYNTHASE R23I, R179T DOUBLE MUTANT 1TLS ; 2.60 ; THYMIDYLATE SYNTHASE TERNARY COMPLEX WITH FDUMP AND METHYLENETETRAHYDROFOLATE 1TSN ; 2.20 ; THYMIDYLATE SYNTHASE TERNARY COMPLEX WITH FDUMP AND METHYLENETETRAHYDROFOLATE 1NJE ; 2.30 ; THYMIDYLATE SYNTHASE WITH 2'-DEOXYCYTIDINE 5'-MONOPHOSPHATE (DCMP) 1NJA ; 2.50 ; THYMIDYLATE SYNTHASE, MUTATION, N229C WITH 2'-DEOXYCYTIDINE 5'-MONOPHOSPHATE (DCMP) 1NJC ; 2.50 ; THYMIDYLATE SYNTHASE, MUTATION, N229D WITH 2'-DEOXYCYTIDINE 5'-MONOPHOSPHATE (DCMP) 1NJD ; 2.50 ; THYMIDYLATE SYNTHASE, MUTATION, N229D WITH 2'-DEOXYURIDINE 5'-MONOPHOSPHATE (DUMP) 1H5R ; 1.90 ; THYMIDYLYLTRANSFERASE COMPLEXED WITH THIMIDINE AND GLUCOSE-1-PHOSPATE 1H5T ; 1.90 ; THYMIDYLYLTRANSFERASE COMPLEXED WITH THYMIDYLYLDIPHOSPHATE-GLUCOSE 1H5S ; 2.30 ; THYMIDYLYLTRANSFERASE COMPLEXED WITH TMP 1IIM ; 2.10 ; THYMIDYLYLTRANSFERASE COMPLEXED WITH TTP 1IIN ; 2.10 ; THYMIDYLYLTRANSFERASE COMPLEXED WITH UDP-GLUCOSE 1NJX ; 1.65 ; THYMINE-GUANINE MISMATCH AT THE POLYMERASE ACTIVE SITE 1NJY ; 2.00 ; THYMINE-THYMINE MISMATCH AT THE POLYMERASE ACTIVE SITE 1HJ0 ; -1.00 ; THYMOSIN BETA9 1NAV ; 2.50 ; THYROID RECEPTOR ALPHA IN COMPLEX WITH AN AGONIST SELECTIVE FOR THYROID RECEPTOR BETA1 1NAX ; 2.70 ; THYROID RECEPTOR BETA1 IN COMPLEX WITH A BETA-SELECTIVE LIGAND 1FTT ; -1.00 ; THYROID TRANSCRIPTION FACTOR 1 HOMEODOMAIN (RATTUS NORVEGICUS) 1XZX ; 2.50 ; THYROXINE-THYROID HORMONE RECEPTOR INTERACTIONS 1Y0X ; 3.10 ; THYROXINE-THYROID HORMONE RECEPTOR INTERACTIONS 1FVR ; 2.20 ; TIE2 KINASE DOMAIN 1GTK ; 1.66 ; TIME-RESOLVED AND STATIC-ENSEMBLE STRUCTURAL CHEMISTRY OF HYDROXYMETHYLBILANE SYNTHASE 1A21 ; 2.35 ; TISSUE FACTOR (TF) FROM RABBIT 1BPV ; -1.00 ; TITIN MODULE A71 FROM HUMAN CARDIAC MUSCLE, NMR, 50 STRUCTURES 1NCT ; -1.00 ; TITIN MODULE M5, N-TERMINALLY EXTENDED, NMR 1NCU ; -1.00 ; TITIN MODULE M5, N-TERMINALLY EXTENDED, NMR 1TIU ; -1.00 ; TITIN, IG REPEAT 27, NMR, 24 STRUCTURES 1TIT ; -1.00 ; TITIN, IG REPEAT 27, NMR, MINIMIZED AVERAGE STRUCTURE 1TYX ; 1.80 ; TITLE OF TAILSPIKE-PROTEIN 1NPI ; 1.16 ; TITYUS SERRULATUS NEUROTOXIN (TS1) AT ATOMIC RESOLUTION 1U6K ; 1.55 ; TLS REFINEMENT OF THE STRUCTURE OF SE-METHIONINE LABELLED COENZYME F420-DEPENDENT METHYLENETETRAHYDROMETHANOPTERIN DEHYDROGENASE (MTD) FROM METHANOPYRUS KANDLERI 1MV4 ; -1.00 ; TM9A251-284: A PEPTIDE MODEL OF THE C-TERMINUS OF A RAT STRIATED ALPHA TROPOMYOSIN 1EI7 ; 2.45 ; TMV COAT PROTEIN REFINED FROM THE 4-LAYER AGGREGATE 1TMZ ; -1.00 ; TMZIP: A CHIMERIC PEPTIDE MODEL OF THE N-TERMINUS OF ALPHA TROPOMYOSIN, NMR, 15 STRUCTURES 1MUR ; 2.50 ; TN5 TRANSPOSASE: 20MER OUTSIDE END 2 MN COMPLEX 1F1Z ; 2.40 ; TNSA, A CATALYTIC COMPONENT OF THE TN7 TRANSPOSITION SYSTEM 1C8N ; 2.25 ; TOBACCO NECROSIS VIRUS 1IYQ ; 2.10 ; TOHO-1 BETA-LACTAMASE IN COMPLEX WITH BENZYLPENICILLIN 1IYO ; 1.80 ; TOHO-1 BETA-LACTAMASE IN COMPLEX WITH CEFOTAXIME 1IYP ; 2.00 ; TOHO-1 BETA-LACTAMASE IN COMPLEX WITH CEPHALOTHIN 1G10 ; -1.00 ; TOLUENE-4-MONOOXYGENASE CATALYTIC EFFECTOR PROTEIN NMR STRUCTURE 1G11 ; -1.00 ; TOLUENE-4-MONOOXYGENASE CATALYTIC EFFECTOR PROTEIN NMR STRUCTURE 1IMH ; 2.86 ; TONEBP/DEOXYRIBONUCLEIC ACID COMPLEX 1BJT ; 2.50 ; TOPOISOMERASE II RESIDUES 409 - 1201 1BGW ; 2.70 ; TOPOISOMERASE RESIDUES 410 - 1202, 1Z5B ; 2.00 ; TOPOISOMERASE VI-B, ADP ALF4- BOUND DIMER FORM 1Z5C ; 2.20 ; TOPOISOMERASE VI-B, ADP PI BOUND DIMER FORM 1Z5A ; 2.20 ; TOPOISOMERASE VI-B, ADP-BOUND DIMER FORM 1Z59 ; 2.10 ; TOPOISOMERASE VI-B, ADP-BOUND MONOMER FORM 1AVQ ; 2.40 ; TOROIDAL STRUCTURE OF LAMBDA EXONUCLEASE DETERMINED AT 2.4 ANGSTROMS 1E3Q ; 2.85 ; TORPEDO CALIFORNICA ACETYLCHOLINESTERASE COMPLEXED WITH BW284C51 1SOM ; 2.20 ; TORPEDO CALIFORNICA ACETYLCHOLINESTERASE INHIBITED BY NERVE AGENT GD (SOMAN). 1TOS ; -1.00 ; TORPEDO CALIFORNICA ACHR RECEPTOR [ALA76] ANALOGUE COMPLEXED WITH THE ANTI-ACETYLCHOLINE MAB6 MONOCLONAL ANTIBODY 1B3A ; 1.60 ; TOTAL CHEMICAL SYNTHESIS AND HIGH-RESOLUTION CRYSTAL STRUCTURE OF THE POTENT ANTI-HIV PROTEIN AOP-RANTES 1SDE ; 1.15 ; TOWARD BETTER ANTIBIOTICS: CRYSTAL STRUCTURE OF D-ALA-D-ALA PEPTIDASE INHIBITED BY A NOVEL BICYCLIC PHOSPHATE INHIBITOR 1SCW ; 1.13 ; TOWARD BETTER ANTIBIOTICS: CRYSTAL STRUCTURE OF R61 DD- PEPTIDASE INHIBITED BY A NOVEL MONOCYCLIC PHOSPHATE INHIBITOR 1G7N ; 1.50 ; TOWARD CHANGING SPECIFICITY: ADIPOCYTE LIPID BINDING PROTEIN MUTANT, APO FORM 1G74 ; 1.70 ; TOWARD CHANGING SPECIFICITY: ADIPOCYTE LIPID BINDING PROTEIN MUTANT, OLEIC ACID BOUND FORM 1OX4 ; 2.50 ; TOWARDS UNDERSTANDING THE MECHANISM OF THE COMPLEX CYCLIZATION REACTION CATALYZED BY IMIDAZOLE GLYCEROPHOSPHATE SYNTHASE 1OX5 ; 2.50 ; TOWARDS UNDERSTANDING THE MECHANISM OF THE COMPLEX CYCLIZATION REACTION CATALYZED BY IMIDAZOLE GLYCEROPHOSPHATE SYNTHASE 1OX6 ; 2.40 ; TOWARDS UNDERSTANDING THE MECHANISM OF THE COMPLEX CYCLIZATION REACTION CATALYZED BY IMIDAZOLE GLYCEROPHOSPHATE SYNTHASE 2QIL ; 2.07 ; TOXIC SHOCK SYNDROME TOXIN-1 AT 2.07 A RESOLUTION 2TSS ; 2.05 ; TOXIC SHOCK SYNDROME TOXIN-1 FROM STAPHYLOCOCCUS AUREUS: ORTHORHOMBICC222(1) CRYSTAL FORM 3TSS ; 1.90 ; TOXIC SHOCK SYNDROME TOXIN-1 TETRAMUTANT, P2(1) CRYSTAL FORM 5TSS ; 2.90 ; TOXIC SHOCK SYNDROME TOXIN-1: ORTHORHOMBIC P222(1) CRYSTAL FORM 4TSS ; 2.75 ; TOXIC SHOCK SYNDROME TOXIN-1: TETRAGONAL P4(1)2(1)2 CRYSTAL FORM 1FGB ; 2.40 ; TOXIN 1SOV ; 1.90 ; TOXOPLASMA GONDII BRADYZOITE-SPECIFIC LDH (LDH2) APO FORM 1FSG ; 1.05 ; TOXOPLASMA GONDII HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE COMPLEXED WITH 9-DEAZAGUANINE, ALPHA-D-5-PHOSPHORIBOSYL-1-PYROPHOSPHATE (PRPP) AND TWO MG2+ IONS 1QK3 ; 1.65 ; TOXOPLASMA GONDII HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE GMP COMPLEX 1QK4 ; 1.90 ; TOXOPLASMA GONDII HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE IMP COMPLEX 1QK5 ; 1.60 ; TOXOPLASMA GONDII HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE WITH XMP, PYROPHOSPHATE AND TWO MG2+ IONS 2F4Z ; 2.11 ; TOXOPLASMA GONDII UBIQUITIN CONJUGATING ENZYME TGTWINSCAN_2721- E2 DOMAIN 1O75 ; 1.95 ; TP47, THE 47-KILODALTON LIPOPROTEIN OF TREPONEMA PALLIDUM 1MA6 ; -1.00 ; TPY4 TACHYPLESIN I TYROSINE MUTANT IN THE PRESENCE OF DODECYLPHOSPHOCHOLINE MICELLES (300 MM) 1NQ0 ; 2.40 ; TR RECEPTOR MUTATIONS CONFERRING HORMONE RESISTANCE AND REDUCED COREPRESSOR RELEASE EXHIBIT DECREASED STABILITY IN THE NTERMINAL LBD 1NQ1 ; 2.90 ; TR RECEPTOR MUTATIONS CONFERRING HORMONE RESISTANCE AND REDUCED COREPRESSOR RELEASE EXHIBIT DECREASED STABILITY IN THE NTERMINAL LBD 1VGE ; 2.00 ; TR1.9 FAB FRAGMENT OF A HUMAN IGG1 KAPPA AUTOANTIBODY 1LB4 ; 2.40 ; TRAF6 APO STRUCTURE 1LB6 ; 1.80 ; TRAF6-CD40 COMPLEX 1LB5 ; 2.40 ; TRAF6-RANK COMPLEX 1BE6 ; 2.15 ; TRANS-CINNAMOYL-SUBTILISIN IN ANHYDROUS ACETONITRILE 1BE8 ; 2.20 ; TRANS-CINNAMOYL-SUBTILISIN IN WATER 1ON9 ; 2.00 ; TRANSCARBOXYLASE 12S CRYSTAL STRUCTURE: HEXAMER ASSEMBLY AND SUBSTRATE BINDING TO A MULTIENZYME CORE (WITH HYDROLYZED METHYLMALONYL-COENZYME A BOUND) 1ON3 ; 1.90 ; TRANSCARBOXYLASE 12S CRYSTAL STRUCTURE: HEXAMER ASSEMBLY AND SUBSTRATE BINDING TO A MULTIENZYME CORE (WITH METHYLMALONYL-COENZYME A AND METHYLMALONIC ACID BOUND) 1WTU ; -1.00 ; TRANSCRIPTION FACTOR 1, NMR, MINIMIZED AVERAGE STRUCTURE 1CI6 ; 2.60 ; TRANSCRIPTION FACTOR ATF4-C/EBP BETA BZIP HETERODIMER 1BOR ; -1.00 ; TRANSCRIPTION FACTOR PML, A PROTO-ONCOPROTEIN, NMR, 1 REPRESENTATIVE STRUCTURE AT PH 7.5, 30 C, IN THE PRESENCE OF ZINC 2CPG ; 1.60 ; TRANSCRIPTIONAL REPRESSOR COPG 1EA4 ; 2.95 ; TRANSCRIPTIONAL REPRESSOR COPG/22BP DSDNA COMPLEX 1B01 ; 2.56 ; TRANSCRIPTIONAL REPRESSOR COPG/DEOXYRIBONUCLEIC ACID COMPLEX 1MF6 ; -1.00 ; TRANSDUCIN GAMMA SUBUNIT, C-TERMINAL DOMAIN 60-71, RHODOPSIN-BOUND STATE: ENSEMBLE OF 15 MODELS DETERMINED BY TRNOE SPECTROSCOPY 1KS6 ; -1.00 ; TRANSFORMING GROWTH FACTOR BETA TYPE II RECEPTOR LIGAND BINDING DOMAIN 1PLO ; -1.00 ; TRANSFORMING GROWTH FACTOR-BETA TYPE II RECEPTOR EXTRACELLULAR DOMAIN 1MIL ; 2.70 ; TRANSFORMING PROTEIN 1U2G ; 2.20 ; TRANSHYDROGENASE (DI.ADPR)2(DIII.NADPH)1 ASYMMETRIC COMPLEX 1U6R ; 1.65 ; TRANSITION STATE ANALOG COMPLEX OF MUSCLE CREATINE KINASE (R134K) MUTANT 1AMN ; 2.80 ; TRANSITION STATE ANALOG: ACETYLCHOLINESTERASE COMPLEXED WITH M-(N,N,N-TRIMETHYLAMMONIO)TRIFLUOROACETOPHENONE 1L7N ; 1.80 ; TRANSITION STATE ANALOGUE OF PHOSPHOSERINE PHOSPHATASE (ALUMINUM FLUORIDE COMPLEX) 1RLT ; 2.20 ; TRANSITION STATE ANALOGUE OF YBIV FROM E. COLI K12 2NGR ; 1.90 ; TRANSITION STATE COMPLEX FOR GTP HYDROLYSIS BY CDC42: COMPARISONS OF THE HIGH RESOLUTION STRUCTURES FOR CDC42 BOUND TO THE ACTIVE AND CATALYTICALLY COMPROMISED FORMS OF THE CDC42-GAP. 1M5O ; 2.20 ; TRANSITION STATE STABILIZATION BY A CATALYTIC RIBONUCLEIC ACID 1M5P ; 2.60 ; TRANSITION STATE STABILIZATION BY A CATALYTIC RIBONUCLEIC ACID 1M5V ; 2.40 ; TRANSITION STATE STABILIZATION BY A CATALYTIC RIBONUCLEIC ACID 1P50 ; 2.80 ; TRANSITION STATE STRUCTURE OF AN ARGININE KINASE MUTANT 1BG0 ; 1.86 ; TRANSITION STATE STRUCTURE OF ARGININE KINASE 1M15 ; 1.20 ; TRANSITION STATE STRUCTURE OF ARGININE KINASE 1GPU ; 1.86 ; TRANSKETOLASE COMPLEX WITH REACTION INTERMEDIATE 1QGD ; 1.90 ; TRANSKETOLASE FROM ESCHERICHIA COLI 1R9J ; 2.22 ; TRANSKETOLASE FROM LEISHMANIA MEXICANA 1TIG ; 2.00 ; TRANSLATION INITIATION FACTOR 3 C-TERMINAL DOMAIN 1TIF ; 1.80 ; TRANSLATION INITIATION FACTOR 3 N-TERMINAL DOMAIN 1AP8 ; -1.00 ; TRANSLATION INITIATION FACTOR EIF4E IN COMPLEX WITH M7GDP, NMR, 20 STRUCTURES 2IFE ; -1.00 ; TRANSLATION INITIATION FACTOR IF3 FROM ESCHERICHIA COLI RIBOSOME BINDING DOMAIN (RESIDUES 84-180) 2EFG ; 2.60 ; TRANSLATIONAL ELONGATION FACTOR G COMPLEXED WITH GDP 1H6Q ; -1.00 ; TRANSLATIONALLY CONTROLLED TUMOR-ASSOCIATED PROTEIN P23FYP FROM SCHIZOSACCHAROMYCES POMBE 1H7Y ; -1.00 ; TRANSLATIONALLY CONTROLLED TUMOR-ASSOCIATED PROTEIN P23FYP FROM SCHIZOSACCHAROMYCES POMBE 1UYN ; 2.60 ; TRANSLOCATOR DOMAIN OF AUTOTRANSPORTER NALP FROM NEISSERIA MENINGITIDIS 1UYO ; 3.20 ; TRANSLOCATOR DOMAIN OF AUTOTRANSPORTER NALP FROM NEISSERIA MENINGITIDIS 2NR1 ; -1.00 ; TRANSMEMBRANE SEGMENT 2 OF NMDA RECEPTOR NR1, NMR, 10 STRUCTURES 1B7E ; 2.90 ; TRANSPOSASE INHIBITOR 1TC3 ; 2.45 ; TRANSPOSASE TC3A1-65 FROM CAENORHABDITIS ELEGANS 2ROY ; 2.20 ; TRANSTHYRETIN (ALSO CALLED PREALBUMIN) COMPLEX WITH 3',5'-DINITRO-N-ACETYL-L-THYRONINE 2ROX ; 2.00 ; TRANSTHYRETIN (ALSO CALLED PREALBUMIN) COMPLEX WITH THYROXINE (T4) 1BZ8 ; 2.00 ; TRANSTHYRETIN (DEL VAL122) 1TFP ; 2.90 ; TRANSTHYRETIN (FORMERLY KNOWN AS PREALBUMIN) 1TTR ; 1.90 ; TRANSTHYRETIN - V/122/I CARDIOMYOPATHIC MUTANT 1TYR ; 1.80 ; TRANSTHYRETIN COMPLEX WITH RETINOIC ACID 1FH2 ; 1.80 ; TRANSTHYRETIN STABILITY AS A KEY FACTOR IN AMYLOIDOGENESIS 1FHN ; 1.75 ; TRANSTHYRETIN STABILITY AS A KEY FACTOR IN AMYLOIDOGENESIS 1F86 ; 1.10 ; TRANSTHYRETIN THR119MET PROTEIN STABILISATION 1U21 ; 1.69 ; TRANSTHYRETIN WITH TETHERED INHIBITOR ON ONE MONOMER. 1Y6W ; 2.40 ; TRAPPED INTERMEDIATE OF CALMODULIN 1BYK ; 2.50 ; TREHALOSE REPRESSOR FROM ESCHERICHIA COLI 1UQT ; 2.00 ; TREHALOSE-6-PHOSPHATE FROM E. COLI BOUND WITH UDP-2-FLUORO GLUCOSE. 1UQU ; 2.00 ; TREHALOSE-6-PHOSPHATE FROM E. COLI BOUND WITH UDP-GLUCOSE. 1GZ5 ; 2.43 ; TREHALOSE-6-PHOSPHATE SYNTHASE. OTSA 1H97 ; 1.17 ; TREMATODE HEMOGLOBIN FROM PARAMPHISTOMUM EPICLITUM 1GWG ; 2.01 ; TRI-IODIDE DERIVATIVE OF APOFERRITIN 1GWD ; 1.77 ; TRI-IODIDE DERIVATIVE OF HEN EGG-WHITE LYSOZYME 1GW9 ; 1.55 ; TRI-IODIDE DERIVATIVE OF XYLOSE ISOMERASE FROM STREPTOMYCES RUBIGINOSUS 1R1N ; 1.74 ; TRI-NUCLEAR OXO-IRON CLUSTERS IN THE FERRIC BINDING PROTEIN FROM N. GONORRHOEAE 1ETH ; 2.80 ; TRIACYLGLYCEROL LIPASE/COLIPASE COMPLEX 1JFA ; 2.50 ; TRICHODIENE SYNTHASE FROM FUSARIUM SPOROTRICHIOIDES 1JFG ; 2.50 ; TRICHODIENE SYNTHASE FROM FUSARIUM SPOROTRICHIOIDES COMPLEXED WITH DIPHOSPHATE 1M24 ; 0.90 ; TRICHOTOXIN_A50E, AN ION CHANNEL-FORMING POLYPEPTIDE 1ZK3 ; 2.20 ; TRICLINIC CRYSTAL STRUCTURE OF THE APO-FORM OF R-SPECIFIC ALCOHOL DEHYDROGENASE (MUTANT G37D) FROM LACTOBACILLUS BREVIS 1MS4 ; 2.21 ; TRICLINIC FORM OF TRYPANOSOMA CRUZI TRANS-SIALIDASE 1MS8 ; 2.00 ; TRICLINIC FORM OF TRYPANOSOMA CRUZI TRANS-SIALIDASE, IN COMPLEX WITH 3-DEOXY-2,3-DEHYDRO-N-ACETYLNEURAMINIC ACID (DANA) 1MS9 ; 1.58 ; TRICLINIC FORM OF TRYPANOSOMA CRUZI TRANS-SIALIDASE, IN COMPLEX WITH LACTOSE 1MS5 ; 2.00 ; TRICLINIC FORM OF TRYPANOSOMA CRUZI TRANS-SIALIDASE, SOAKED WITH N-ACETYLNEURAMINYL-A-2,3-THIO-GALACTOSIDE (NA-S-GAL) 1V7S ; 1.14 ; TRICLINIC HEN LYSOZYME CRYSTALLIZED AT 313K FROM A D2O SOLUTION 1V7T ; 1.13 ; TRICLINIC LYSOZYME WITH LOW SOLVENT CONTENT OBTAINED BY PHASE TRANSITION 1N6E ; 2.60 ; TRICORN PROTEASE IN COMPLEX WITH A TRIDECAPEPTIDE CHLOROMETHYL KETONE DERIVATIVE 1N6D ; 2.80 ; TRICORN PROTEASE IN COMPLEX WITH TETRAPEPTIDE CHLOROMETHYL KETONE DERIVATIVE 1N6F ; 2.70 ; TRICORN PROTEASE IN COMPLEX WITH Z-PHE-DIKETO-ARG-GLU-PHE 1T11 ; 2.50 ; TRIGGER FACTOR 1W26 ; 2.70 ; TRIGGER FACTOR IN COMPLEX WITH THE RIBOSOME FORMS A MOLECULAR CRADLE FOR NASCENT PROTEINS 1W2B ; 3.50 ; TRIGGER FACTOR RIBOSOME BINDING DOMAIN IN COMPLEX WITH 50S 1U27 ; 2.30 ; TRIGLYCINE VARIANT OF THE ARNO PLECKSTRIN HOMOLOGY DOMAIN IN COMPLEX WITH INS(1,3,4,5)P4 1U29 ; 1.80 ; TRIGLYCINE VARIANT OF THE ARNO PLECKSTRIN HOMOLOGY DOMAIN IN COMPLEX WITH INS(1,4,5)P3 1U2B ; 1.80 ; TRIGLYCINE VARIANT OF THE GRP1 PLECKSTRIN HOMOLOGY DOMAIN UNLIGANDED 1DO2 ; 4.00 ; TRIGONAL CRYSTAL FORM OF HEAT SHOCK LOCUS U (HSLU) FROM ESCHERICHIA COLI 1GWA ; 1.85 ; TRIIODIDE DERIVATIVE OF PORCINE PANCREAS ELASTASE 1YVS ; 2.20 ; TRIMERIC DOMAIN SWAPPED BARNASE 1RFO ; -1.00 ; TRIMERIC FOLDON OF THE T4 PHAGEHEAD FIBRITIN 1HIW ; 2.30 ; TRIMERIC HIV-1 MATRIX PROTEIN 1WCR ; -1.00 ; TRIMERIC STRUCTURE OF THE ENZYME IIA FROM ESCHERICHIA COLI PHOSPHOTRANSFERASE SYSTEM SPECIFIC FOR N,N'- DIACETYLCHITOBIOSE 1CE0 ; 2.40 ; TRIMERIZATION SPECIFICITY IN HIV-1 GP41: ANALYSIS WITH A GCN4 LEUCINE ZIPPER MODEL 1TMO ; 2.50 ; TRIMETHYLAMINE N-OXIDE REDUCTASE FROM SHEWANELLA MASSILIA 8TIM ; 2.50 ; TRIOSE PHOSPHATE ISOMERASE 1YDV ; 2.20 ; TRIOSEPHOSPHATE ISOMERASE (TIM) 1BTM ; 2.80 ; TRIOSEPHOSPHATE ISOMERASE (TIM) COMPLEXED WITH 2-PHOSPHOGLYCOLIC ACID 1TPW ; 1.90 ; TRIOSEPHOSPHATE ISOMERASE DRINKS WATER TO KEEP HEALTHY 1SW0 ; 1.71 ; TRIOSEPHOSPHATE ISOMERASE FROM GALLUS GALLUS, LOOP 6 HINGE MUTANT K174L, T175W 1SW7 ; 2.22 ; TRIOSEPHOSPHATE ISOMERASE FROM GALLUS GALLUS, LOOP 6 MUTANT K174N, T175S, A176S 1SW3 ; 2.03 ; TRIOSEPHOSPHATE ISOMERASE FROM GALLUS GALLUS, LOOP 6 MUTANT T175V 1W0M ; 2.50 ; TRIOSEPHOSPHATE ISOMERASE FROM THERMOPROTEUS TENAX 1NEY ; 1.20 ; TRIOSEPHOSPHATE ISOMERASE IN COMPLEX WITH DHAP 1NF0 ; 1.60 ; TRIOSEPHOSPHATE ISOMERASE IN COMPLEX WITH DHAP 1B9B ; 2.85 ; TRIOSEPHOSPHATE ISOMERASE OF THERMOTOGA MARITIMA 1AW2 ; 2.65 ; TRIOSEPHOSPHATE ISOMERASE OF VIBRIO MARINUS 1AW1 ; 2.70 ; TRIOSEPHOSPHATE ISOMERASE OF VIBRIO MARINUS COMPLEXED WITH 2-PHOSPHOGLYCOLATE 1TP0 ; 2.20 ; TRIPLE MUTATION IN INTERLEUKIN 1 BETA CAVITY:REPLACEMENT OF PHENYLALANINES WITH TRYPTOPHAN. 1E40 ; 2.20 ; TRIS/MALTOTRIOSE COMPLEX OF CHIMAERIC AMYLASE FROM B. AMYLOLIQUEFACIENS AND B. LICHENIFORMIS AT 2.2A 1NQB ; 2.00 ; TRIVALENT ANTIBODY FRAGMENT 1V2X ; 1.50 ; TRMH 1FCW ; 17.00 ; TRNA POSITIONS DURING THE ELONGATION CYCLE 1PUD ; 1.85 ; TRNA-GUANINE TRANSGLYCOSYLASE 1WKD ; 2.60 ; TRNA-GUANINE TRANSGLYCOSYLASE 1WKE ; 2.20 ; TRNA-GUANINE TRANSGLYCOSYLASE 1WKF ; 2.20 ; TRNA-GUANINE TRANSGLYCOSYLASE 1Y5V ; 1.58 ; TRNA-GUANINE TRANSGLYCOSYLASE (TGT) IN COMPLEX WITH 6-AMINO- 4-(2-PHENYLETHYL)-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN- 8-ONE 1Y5X ; 2.10 ; TRNA-GUANINE TRANSGLYCOSYLASE (TGT) IN COMPLEX WITH 6-AMINO- 4-[2-(4-METHOXYPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5- G]QUINAZOLIN-8-ONE 1Y5W ; 1.58 ; TRNA-GUANINE TRANSGLYCOSYLASE (TGT) IN COMPLEX WITH 6-AMINO- 4-[2-(4-METHYLPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5- G]QUINAZOLIN-8-ONE 1AE1 ; 2.40 ; TROPINONE REDUCTASE-I COMPLEX WITH NADP 2AE1 ; 2.30 ; TROPINONE REDUCTASE-II 2AE2 ; 1.90 ; TROPINONE REDUCTASE-II COMPLEXED WITH NADP+ AND PSEUDOTROPINE 1IPE ; 2.50 ; TROPINONE REDUCTASE-II COMPLEXED WITH NADPH 1IPF ; 2.50 ; TROPINONE REDUCTASE-II COMPLEXED WITH NADPH AND TROPINONE 1NCX ; 1.80 ; TROPONIN C 1NCZ ; 1.80 ; TROPONIN C 1NCY ; 2.10 ; TROPONIN-C, COMPLEX WITH MANGANESE 1OUT ; 2.30 ; TROUT HEMOGLOBIN I 1JHG ; 1.30 ; TRP REPRESSOR MUTANT V58I 1WAP ; 1.80 ; TRP RIBONUCLEIC ACID-BINDING ATTENUATION PROTEIN IN COMPLEX WITH L-TRYPTOPHAN 1BEU ; 1.90 ; TRP SYNTHASE (D60N-IPP-SER) WITH K+ 1JCM ; 2.10 ; TRPC STABILITY MUTANT CONTAINING AN ENGINEERED DISULPHIDE BRIDGE AND IN COMPLEX WITH A CDRP-RELATED SUBSTRATE 1QF8 ; 1.74 ; TRUNCATED FORM OF CASEIN KINASE II BETA SUBUNIT (2-182) FROM HOMO SAPIENS 1MNE ; 2.70 ; TRUNCATED HEAD OF MYOSIN FROM DICTYOSTELIUM DISCOIDEUM COMPLEXED WITH MG-PYROPHOSPHATE 1MND ; 2.60 ; TRUNCATED HEAD OF MYOSIN FROM DICTYOSTELIUM DISCOIDEUM COMPLEXED WITH MGADP-ALF4 1MMD ; 2.00 ; TRUNCATED HEAD OF MYOSIN FROM DICTYOSTELIUM DISCOIDEUM COMPLEXED WITH MGADP-BEF3 1QNK ; -1.00 ; TRUNCATED HUMAN GROB[5-73], NMR, 20 STRUCTURES 1DZO ; 1.63 ; TRUNCATED PAK PILIN FROM PSEUDOMONAS AERUGINOSA 1JMY ; 2.60 ; TRUNCATED RECOMBINANT HUMAN BILE SALT STIMULATED LIPASE 1GY8 ; 2.00 ; TRYPANOSOMA BRUCEI UDP-GALACTOSE 4' EPIMERASE 1YHK ; 2.10 ; TRYPANOSOMA CRUZI FARNESYL DIPHOSPHATE SYNTHASE 1JVW ; 1.70 ; TRYPANOSOMA CRUZI MACROPHAGE INFECTIVITY POTENTIATOR (TCMIP) 2AH2 ; 1.60 ; TRYPANOSOMA CRUZI TRANS-SIALIDASE IN COMPLEX WITH 2,3- DIFLUOROSIALIC ACID (COVALENT INTERMEDIATE) 1S0J ; 1.65 ; TRYPANOSOMA CRUZI TRANS-SIALIDASE IN COMPLEX WITH MUNANA (MICHAELIS COMPLEX) 1S0I ; 1.60 ; TRYPANOSOMA CRUZI TRANS-SIALIDASE IN COMPLEX WITH SIALYL- LACTOSE (MICHAELIS COMPLEX) 1TCD ; 1.83 ; TRYPANOSOMA CRUZI TRIOSEPHOSPHATE ISOMERASE 1AOG ; 2.30 ; TRYPANOSOMA CRUZI TRYPANOTHIONE REDUCTASE (OXIDIZED FORM) 1MZ5 ; 2.20 ; TRYPANOSOMA RANGELI SIALIDASE 1N1S ; 1.64 ; TRYPANOSOMA RANGELI SIALIDASE 2A75 ; 1.95 ; TRYPANOSOMA RANGELI SIALIDASE IN COMPLEX WITH 2,3- DIFLUOROSIALIC ACID (COVALENT INTERMEDIATE) 2AGS ; 1.70 ; TRYPANOSOMA RANGELI SIALIDASE IN COMPLEX WITH 2-KETO-3- DEOXY-D-GLYCERO-D-GALACTO-2,3-DIFLUORO-NONONIC ACID (2,3- DIFLUORO-KDN) 1N1V ; 2.10 ; TRYPANOSOMA RANGELI SIALIDASE IN COMPLEX WITH DANA 1N1T ; 1.60 ; TRYPANOSOMA RANGELI SIALIDASE IN COMPLEX WITH DANA AT 1.6 A 1N1Y ; 2.80 ; TRYPANOSOMA RANGELI SIALIDASE IN COMPLEX WITH SIALIC ACID 1MZ6 ; 2.90 ; TRYPANOSOMA RANGELI SIALIDASE IN COMPLEX WITH THE INHIBITOR DANA 1O73 ; 2.28 ; TRYPAREDOXIN FROM TRYPANOSOMA BRUCEI 1I5G ; 1.40 ; TRYPAREDOXIN II COMPLEXED WITH GLUTATHIONYLSPERMIDINE 1OC8 ; 1.50 ; TRYPAREDOXIN II FROM C.FASCICULATA SOLVED BY MR 1OC9 ; 2.35 ; TRYPAREDOXIN II FROM C.FASCICULATA SOLVED BY MR 1O6J ; 2.35 ; TRYPAREDOXIN II FROM C.FASCICULATA SOLVED BY SULPHUR PHASING 1O81 ; 1.50 ; TRYPAREDOXIN II FROM C.FASCICULATA SOLVED BY SULPHUR PHASING 1UUL ; 2.80 ; TRYPAREDOXIN PEROXIDASE (TXNPX) FROM TRYPANOSOMA CRUZI IN THE REDUCED STATE 1E2Y ; 3.20 ; TRYPAREDOXIN PEROXIDASE FROM CRITHIDIA FASCICULATA 1QK8 ; 1.40 ; TRYPAREDOXIN-I FROM CRITHIDIA FASCICULATA 2BLW ; 1.20 ; TRYPSIN AFTER A HIGH DOSE X-RAY "BURN" 1PQ7 ; 0.80 ; TRYPSIN AT 0.8 A, PH5 / BORAX 1PQ8 ; 1.00 ; TRYPSIN AT PH 4 AT ATOMIC RESOLUTION 1PQ5 ; 0.85 ; TRYPSIN AT PH 5, 0.85 A 2BLV ; 1.20 ; TRYPSIN BEFORE A HIGH DOSE X-RAY "BURN" 1PPZ ; 1.23 ; TRYPSIN COMPLEXES AT ATOMIC AND ULTRA-HIGH RESOLUTION 1XVO ; 0.84 ; TRYPSIN FROM FUSARIUM OXYSPORUM AT PH 6 1XVM ; 1.10 ; TRYPSIN FROM FUSARIUM OXYSPORUM- ROOM TEMPERATURE TO ATOMIC RESOLUTION 1TIH ; -1.00 ; TRYPSIN INHIBITOR (T1) FROM NICOTIANA ALATA 1G36 ; 1.90 ; TRYPSIN INHIBITOR COMPLEX 1OYQ ; 1.90 ; TRYPSIN INHIBITOR COMPLEX 1Y3U ; 1.80 ; TRYPSIN INHIBITOR COMPLEX 1Y3V ; 1.60 ; TRYPSIN INHIBITOR COMPLEX 1Y3W ; 1.80 ; TRYPSIN INHIBITOR COMPLEX 1Y3X ; 1.70 ; TRYPSIN INHIBITOR COMPLEX 1Y3Y ; 1.75 ; TRYPSIN INHIBITOR COMPLEX 1EB2 ; 2.00 ; TRYPSIN INHIBITOR COMPLEX (BPO) 1AVU ; 2.30 ; TRYPSIN INHIBITOR FROM SOYBEAN (STI) 1V2W ; 1.75 ; TRYPSIN INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN VARIANT X(SSAI)BT.B4 1V2T ; 1.90 ; TRYPSIN INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN VARIANT X(SSFI.GLU)BT.B4 1V2R ; 1.70 ; TRYPSIN INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN VARIANT X(SSRI)BT.B4 1V2Q ; 2.30 ; TRYPSIN INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN VARIANT X(SSWI)BT.B4 1V2P ; 1.92 ; TRYPSIN INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN VARIANT X(SSYI)BT.A4 1V2O ; 1.62 ; TRYPSIN INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN VARIANT X(SSYI)BT.B4 1YYY ; 2.10 ; TRYPSIN INHIBITORS WITH RIGID TRIPEPTIDYL ALDEHYDES 1ZZZ ; 1.90 ; TRYPSIN INHIBITORS WITH RIGID TRIPEPTIDYL ALDEHYDES 1UTJ ; 1.83 ; TRYPSIN SPECIFICITY AS ELUCIDATED BY LIE CALCULATIONS, X-RAY STRUCTURES AND ASSOCIATION CONSTANT MEASUREMENTS 1UTK ; 1.53 ; TRYPSIN SPECIFICITY AS ELUCIDATED BY LIE CALCULATIONS, X-RAY STRUCTURES AND ASSOCIATION CONSTANT MEASUREMENTS 1UTL ; 1.70 ; TRYPSIN SPECIFICITY AS ELUCIDATED BY LIE CALCULATIONS, X-RAY STRUCTURES AND ASSOCIATION CONSTANT MEASUREMENTS 1UTM ; 1.50 ; TRYPSIN SPECIFICITY AS ELUCIDATED BY LIE CALCULATIONS, X-RAY STRUCTURES AND ASSOCIATION CONSTANT MEASUREMENTS 1UTN ; 1.15 ; TRYPSIN SPECIFICITY AS ELUCIDATED BY LIE CALCULATIONS, X-RAY STRUCTURES AND ASSOCIATION CONSTANT MEASUREMENTS 1UTO ; 1.15 ; TRYPSIN SPECIFICITY AS ELUCIDATED BY LIE CALCULATIONS, X-RAY STRUCTURES AND ASSOCIATION CONSTANT MEASUREMENTS 1UTP ; 1.30 ; TRYPSIN SPECIFICITY AS ELUCIDATED BY LIE CALCULATIONS, X-RAY STRUCTURES AND ASSOCIATION CONSTANT MEASUREMENTS 1UTQ ; 1.15 ; TRYPSIN SPECIFICITY AS ELUCIDATED BY LIE CALCULATIONS, X-RAY STRUCTURES AND ASSOCIATION CONSTANT MEASUREMENTS 1AQ7 ; 2.20 ; TRYPSIN WITH INHIBITOR AERUGINOSIN 98-B 1PQA ; 1.23 ; TRYPSIN WITH PMSF AT ATOMIC RESOLUTION 1XUK ; 2.04 ; TRYPSIN-BABIM-SULFATE, PH 5.9 1XUF ; 2.04 ; TRYPSIN-BABIM-ZN+2, PH 8.2 1XUG ; 1.50 ; TRYPSIN-BABIM-ZN+2, PH 8.2 1XUI ; 1.50 ; TRYPSIN-KETO-BABIM, ZN+2-FREE, PH 8.2 1XUH ; 2.37 ; TRYPSIN-KETO-BABIM-CO+2, PH 8.2 1XUJ ; 1.92 ; TRYPSIN-KETO-BABIM-ZN+2, PH 8.2 1TX6 ; 2.20 ; TRYPSIN:BBI COMPLEX 3TGK ; 1.70 ; TRYPSINOGEN MUTANT D194N AND DELETION OF ILE 16-VAL 17 COMPLEXED WITH BOVINE PANCREATIC TRYPSIN INHIBITOR (BPTI) 1BKS ; 2.20 ; TRYPTOPHAN SYNTHASE FROM SALMONELLA TYPHIMURIUM 1TTP ; 2.30 ; TRYPTOPHAN SYNTHASE IN THE PRESENCE OF CESIUM, ROOM TEMPERATURE 1TTQ ; 2.00 ; TRYPTOPHAN SYNTHASE IN THE PRESENCE OF POTASSIUM AT ROOM TEMPERATURE 1UBS ; 1.90 ; TRYPTOPHAN SYNTHASE WITH A MUTATION OF LYS 87 ->THR IN THE B SUBUNIT AND IN THE PRESENCE OF LIGAND L-SERINE 1AX4 ; 2.10 ; TRYPTOPHANASE FROM PROTEUS VULGARIS 1S1Q ; 2.00 ; TSG101(UEV) DOMAIN IN COMPLEX WITH UBIQUITIN 1TLY ; 3.01 ; TSX STRUCTURE 1TLW ; 3.10 ; TSX STRUCTURE COMPLEXED WITH THYMIDINE 1TLZ ; 3.10 ; TSX STRUCTURE COMPLEXED WITH URIDINE 1ZFH ; 2.51 ; TTA DUPLEX B-DEOXYRIBONUCLEIC ACID 1ZFF ; 0.94 ; TTC DUPLEX B-DEOXYRIBONUCLEIC ACID 1TUB ; 3.70 ; TUBULIN ALPHA-BETA DIMER, ELECTRON DIFFRACTION 1Z2B ; 4.10 ; TUBULIN-COLCHICINE-VINBLASTINE: STATHMIN-LIKE DOMAIN COMPLEX 1SA0 ; 3.58 ; TUBULIN-COLCHICINE: STATHMIN-LIKE DOMAIN COMPLEX 1SA1 ; 4.20 ; TUBULIN-PODOPHYLLOTOXIN: STATHMIN-LIKE DOMAIN COMPLEX 1FFX ; 3.95 ; TUBULIN:STATHMIN-LIKE DOMAIN COMPLEX 1KYJ ; -1.00 ; TUMOR ASSOCIATED MUCIN MOTIF FROM CD43 PROTEIN 1A8M ; 2.30 ; TUMOR NECROSIS FACTOR ALPHA, R31D MUTANT 1D9S ; -1.00 ; TUMOR SUPPRESSOR P15(INK4B) STRUCTURE BY COMPARATIVE MODELING AND NMR DATA 1TUP ; 2.20 ; TUMOR SUPPRESSOR P53 COMPLEXED WITH DEOXYRIBONUCLEIC ACID 1H9R ; 1.90 ; TUNGSTATE BOUND COMPLEX DIMOP DOMAIN OF MODE FROM E.COLI 1E3P ; 2.50 ; TUNGSTATE DERIVATIVE OF STREPTOMYCES ANTIBIOTICUS PNPASE/ GPSI ENZYME 1V0R ; 1.70 ; TUNGSTATE-INHIBITED PHOSPHOLIPASE D FROM STREPTOMYCES SP. STRAIN PMF 1H0H ; 1.80 ; TUNGSTEN CONTAINING FORMATE DEHYDROGENASE FROM DESULFOVIBRIO GIGAS 1E18 ; 2.00 ; TUNGSTEN-SUSBSTITUTED DMSO REDUCTASE FROM RHODOBACTER CAPSULATUS 1JEF ; 1.77 ; TURKEY LYSOZYME COMPLEX WITH (GLCNAC)3 1N0A ; -1.00 ; TURN STABILITY IN BETA-HAIRPIN PEPTIDES: 3:5 TYPE I G1 BULGE TURNS 1AUY ; 3.20 ; TURNIP YELLOW MOSAIC VIRUS 1XC0 ; -1.00 ; TWENTY LOWEST ENERGY STRUCTURES OF PA4 BY SOLUTION NMR 3GPD ; 3.50 ; TWINNING IN CRYSTALS OF HUMAN SKELETAL MUSCLE D- GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE 1KEO ; 2.20 ; TWISTS AND TURNS OF THE CD-MPR: LIGAND-BOUND VERSUS LIGAND- FREE RECEPTOR 1WIU ; -1.00 ; TWITCHIN IMMUNOGLOBULIN SUPERFAMILY DOMAIN (IGSF MODULE) (IG 18'), NMR, 30 STRUCTURES 1WIT ; -1.00 ; TWITCHIN IMMUNOGLOBULIN SUPERFAMILY DOMAIN (IGSF MODULE) (IG 18'), NMR, MINIMIZED AVERAGE STRUCTURE 1KOB ; 2.30 ; TWITCHIN KINASE FRAGMENT (APLYSIA), AUTOREGULATED PROTEIN KINASE DOMAIN 1KOA ; 3.30 ; TWITCHIN KINASE FRAGMENT (C.ELEGANS), AUTOREGULATED PROTEIN KINASE AND IMMUNOGLOBULIN DOMAINS 1ZZ2 ; 2.00 ; TWO CLASSES OF P38ALPHA MAP KINASE INHIBITORS HAVING A COMMON DIPHENYLETHER CORE BUT EXHIBITING DIVERGENT BINDING MODES 1H9M ; 1.65 ; TWO CRYSTAL STRUCTURES OF THE CYTOPLASMIC MOLYBDATE-BINDING PROTEIN MODG SUGGEST A NOVEL COOPERATIVE BINDING MECHANISM AND PROVIDE INSIGHTS INTO LIGAND-BINDING SPECIFICITY. PEG-GROWN FORM WITH MOLYBDATE BOUND 1H9J ; 1.80 ; TWO CRYSTAL STRUCTURES OF THE CYTOPLASMIC MOLYBDATE-BINDING PROTEIN MODG SUGGEST A NOVEL COOPERATIVE BINDING MECHANISM AND PROVIDE INSIGHTS INTO LIGAND-BINDING SPECIFICITY. PHOSPHATE-GROWN FORM WITH MOLYBDATE AND PHOSPHATE BOUND 1H9K ; 1.80 ; TWO CRYSTAL STRUCTURES OF THE CYTOPLASMIC MOLYBDATE-BINDING PROTEIN MODG SUGGEST A NOVEL COOPERATIVE BINDING MECHANISM AND PROVIDE INSIGHTS INTO LIGAND-BINDING SPECIFICITY. PHOSPHATE-GROWN FORM WITH TUNGSTATE AND PHOSPHATE BOUND 1QR4 ; 2.55 ; TWO FIBRONECTIN TYPE-III DOMAIN SEGMENT FROM CHICKEN TENASCIN 1IFN ; 4.00 ; TWO FORMS OF PF1 INOVIRUS: X-RAY DIFFRACTION STUDIES ON A STRUCTURAL PHASE TRANSITION AND A CALCULATED LIBRATION 2IFN ; 4.00 ; TWO FORMS OF PF1 INOVIRUS: X-RAY DIFFRACTION STUDIES ON A STRUCTURAL PHASE TRANSITION AND A CALCULATED LIBRATION 2F55 ; 3.30 ; TWO HEPATITIS C VIRUS NS3 HELICASE DOMAINS COMPLEXED WITH THE SAME STRAND OF DEOXYRIBONUCLEIC ACID 1MX7 ; -1.00 ; TWO HOMOLOGOUS RAT CELLULAR RETINOL-BINDING PROTEINS DIFFER IN LOCAL STRUCTURE AND FLEXIBILITY 1MX8 ; -1.00 ; TWO HOMOLOGOUS RAT CELLULAR RETINOL-BINDING PROTEINS DIFFER IN LOCAL STRUCTURE AND FLEXIBILITY 1FOS ; 3.05 ; TWO HUMAN C-FOS:C-JUN:DEOXYRIBONUCLEIC ACID COMPLEXES 1NQ2 ; 2.40 ; TWO RTH MUTANTS WITH IMPAIRED HORMONE BINDING 1NUO ; 3.10 ; TWO RTH MUTANTS WITH IMPAIRED HORMONE BINDING 1NR0 ; 1.70 ; TWO SEVEN-BLADED BETA-PROPELLER DOMAINS REVEALED BY THE STRUCTURE OF A C. ELEGANS HOMOLOGUE OF YEAST ACTIN INTERACTING PROTEIN 1 (AIP1). 1PHK ; 2.20 ; TWO STRUCTURES OF THE CATALYTIC DOMAIN OF PHOSPHORYLASE, KINASE: AN ACTIVE PROTEIN KINASE COMPLEXED WITH NUCLEOTIDE, SUBSTRATE-ANALOGUE AND PRODUCT 1JE8 ; 2.12 ; TWO-COMPONENT RESPONSE REGULATOR NARL/DEOXYRIBONUCLEIC ACID COMPLEX: DEOXYRIBONUCLEIC ACID BENDING FOUND IN A HIGH AFFINITY SITE 1E6K ; 2.00 ; TWO-COMPONENT SIGNAL TRANSDUCTION SYSTEM D12A MUTANT OF CHEY 1E6L ; 1.90 ; TWO-COMPONENT SIGNAL TRANSDUCTION SYSTEM D13A MUTANT OF CHEY 1E6M ; 1.70 ; TWO-COMPONENT SIGNAL TRANSDUCTION SYSTEM D57A MUTANT OF CHEY 1I5R ; 1.60 ; TYPE 1 17-BETA HYDROXYSTEROID DEHYDROGENASE EM1745 COMPLEX 1EQU ; 3.00 ; TYPE 1 17-BETA HYDROXYSTEROID DEHYDROGENASE EQUILIN COMPLEXED WITH NADP+ 1IGR ; 2.60 ; TYPE 1 INSULIN-LIKE GROWTH FACTOR RECEPTOR (DOMAINS 1-3) 1A41 ; 2.30 ; TYPE 1-TOPOISOMERASE CATALYTIC FRAGMENT FROM VACCINIA VIRUS 1CQQ ; 1.85 ; TYPE 2 RHINOVIRUS 3C PROTEASE WITH AG7088 INHIBITOR 1YUG ; -1.00 ; TYPE ALPHA TRANSFORMING GROWTH FACTOR, NMR, 15 MODELS AFTER ECEPP/3 ENERGY MINIMIZATION 1YUF ; -1.00 ; TYPE ALPHA TRANSFORMING GROWTH FACTOR, NMR, 16 MODELS WITHOUT ENERGY MINIMIZATION 1UQR ; 1.70 ; TYPE II 3-DEHYDROQUINATE DEHYDRATASE (DHQASE) FROM ACTINOBACILLUS PLEUROPNEUMONIAE 1GQO ; 2.10 ; TYPE II DEHYDROQUINASE FROM BACILLUS SUBTILIS 1H0R ; 2.10 ; TYPE II DEHYDROQUINASE FROM MYCOBACTERIUM TUBERCULOSIS COMPLEXED WITH 2,3-ANHYDRO-QUINIC ACID 2MSI ; 1.90 ; TYPE III ANTIFREEZE PROTEIN ISOFORM HPLC 12 3MSI ; 1.43 ; TYPE III ANTIFREEZE PROTEIN ISOFORM HPLC 12 4MSI ; 1.60 ; TYPE III ANTIFREEZE PROTEIN ISOFORM HPLC 12 5MSI ; 1.60 ; TYPE III ANTIFREEZE PROTEIN ISOFORM HPLC 12 6MSI ; 1.65 ; TYPE III ANTIFREEZE PROTEIN ISOFORM HPLC 12 7MSI ; 1.70 ; TYPE III ANTIFREEZE PROTEIN ISOFORM HPLC 12 1EKL ; 1.65 ; TYPE III ANTIFREEZE PROTEIN ISOFORM HPLC 12 E35K 2JIA ; 1.60 ; TYPE III ANTIFREEZE PROTEIN ISOFORM HPLC 12 K61I 1B7I ; 1.65 ; TYPE III ANTIFREEZE PROTEIN ISOFORM HPLC 12 K61R 6AME ; 2.10 ; TYPE III ANTIFREEZE PROTEIN ISOFORM HPLC 12 M21A 2AME ; 2.00 ; TYPE III ANTIFREEZE PROTEIN ISOFORM HPLC 12 N14Q 8AME ; 1.90 ; TYPE III ANTIFREEZE PROTEIN ISOFORM HPLC 12 N14SA16H 8MSI ; 2.60 ; TYPE III ANTIFREEZE PROTEIN ISOFORM HPLC 12 N14SQ44T 2MSJ ; 1.90 ; TYPE III ANTIFREEZE PROTEIN ISOFORM HPLC 12 N46S 3AME ; 2.30 ; TYPE III ANTIFREEZE PROTEIN ISOFORM HPLC 12 Q9TQ44T 1B7K ; 2.50 ; TYPE III ANTIFREEZE PROTEIN ISOFORM HPLC 12 R47H 9AME ; 1.80 ; TYPE III ANTIFREEZE PROTEIN ISOFORM HPLC 12 S42G 7AME ; 1.70 ; TYPE III ANTIFREEZE PROTEIN ISOFORM HPLC 12 T15A 2SPG ; 1.75 ; TYPE III ANTIFREEZE PROTEIN ISOFORM HPLC 12 T15S 1MSJ ; 2.30 ; TYPE III ANTIFREEZE PROTEIN ISOFORM HPLC 12 T15V 4AME ; 2.05 ; TYPE III ANTIFREEZE PROTEIN ISOFORM HPLC 12 T18A 9MSI ; 2.60 ; TYPE III ANTIFREEZE PROTEIN ISOFORM HPLC 12 T18N 1JAB ; 1.65 ; TYPE III ANTIFREEZE PROTEIN ISOFORM HPLC 12 T18S 1B7J ; 1.65 ; TYPE III ANTIFREEZE PROTEIN ISOFORM HPLC 12 V20A 1UCS ; 0.62 ; TYPE III ANTIFREEZE PROTEIN RD1 FROM AN ANTARCTIC EEL POUT 1K3E ; 2.80 ; TYPE III SECRETION CHAPERONE CEST 1K3S ; 1.90 ; TYPE III SECRETION CHAPERONE SIGE 1ITB ; 2.50 ; TYPE-1 INTERLEUKIN-1 RECEPTOR COMPLEXED WITH INTERLEUKIN-1 BETA 1A65 ; 2.23 ; TYPE-2 CU-DEPLETED LACCASE FROM COPRINUS CINEREUS 1HFU ; 1.68 ; TYPE-2 CU-DEPLETED LACCASE FROM COPRINUS CINEREUS AT 1.68 A RESOLUTION 1SGY ; 1.80 ; TYR 18 VARIANT OF TURKEY OVOMUCOID INHIBITOR THIRD DOMAIN COMPLEXED WITH STREPTOMYCES GRISEUS PROTEINASE B AT PH 6.5 1UWB ; 3.20 ; TYR 181 CYS HIV-1 RT/8-CL TIBO 1BQN ; 3.30 ; TYR 188 LEU HIV-1 RT/HBY 097 2CSM ; 2.80 ; TYR-BOUND T-STATE OF YEAST CHORISMATE MUTASE 1C72 ; 2.80 ; TYR115, GLN165 AND TRP209 CONTRIBUTE TO THE 1,2-EPOXY-3-(P- NITROPHENOXY)PROPANE CONJUGATING ACTIVITIES OF GLUTATHIONE S-TRANSFERASE CGSTM1-1 1AP5 ; 2.20 ; TYR34->PHE MUTANT OF HUMAN MITOCHONDRIAL MANGANESE SUPEROXIDE DISMUTASE 1AP6 ; 1.90 ; TYR34->PHE MUTANT OF HUMAN MITOCHONDRIAL MANGANESE SUPEROXIDE DISMUTASE 1L7R ; 1.64 ; TYR44PHE MUTANT OF BACTERIAL COCAINE ESTERASE COCE 3TAT ; 3.50 ; TYROSINE AMINOTRANSFERASE FROM E. COLI 1TOH ; 2.30 ; TYROSINE HYDROXYLASE CATALYTIC AND TETRAMERIZATION DOMAINS FROM RAT 2TOH ; 2.30 ; TYROSINE HYDROXYLASE CATALYTIC AND TETRAMERIZATION DOMAINS FROM RAT 1M14 ; 2.60 ; TYROSINE KINASE DOMAIN FROM EPIDERMAL GROWTH FACTOR RECEPTOR 2TPL ; 2.50 ; TYROSINE PHENOL-LYASE FROM CITROBACTER INTERMEDIUS COMPLEX WITH 3-(4'-HYDROXYPHENYL)PROPIONIC ACID, PYRIDOXAL-5'-PHOSPHATE AND CS+ ION 1C7G ; 2.10 ; TYROSINE PHENOL-LYASE FROM ERWINIA HERBICOLA 2SHP ; 2.00 ; TYROSINE PHOSPHATASE SHP-2 1X8X ; 2.00 ; TYROSYL T-RIBONUCLEIC ACID SYNTHETASE FROM E.COLI COMPLEXED WITH TYROSINE 1H3F ; 2.00 ; TYROSYL-TRNA SYNTHETASE FROM THERMUS THERMOPHILUS COMPLEXED WITH TYROSINOL 1H3E ; 2.90 ; TYROSYL-TRNA SYNTHETASE FROM THERMUS THERMOPHILUS COMPLEXED WITH WILD-TYPE TRNATYR(GUA) AND WITH ATP AND TYROSINOL 3SDP ; 2.10 ; The 2.1 Angstroms Resolution Structure of Iron Superoxide Dismutase from Pseudomonas Ovalis 2MAD ; 2.25 ; The Active Site Structure of Methylamine Dehydrogenase: Hydrazines Identify C6 as the Reactive Site of the Tryptophan Derived Quinone Cofactor 2CMD ; 1.87 ; The Crystal Structure of E.Coli Malate Dehydrogenase: A Complex of the Apoenzyme and Citrate at 1.87 Angstroms Resolution 2RVE ; 3.00 ; The Crystal Structure of EcoRV Endonuclease and of its Complexes with Cognate and Non-Cognate DEOXYRIBONUCLEIC ACID Segments 1HDG ; 2.50 ; The Crystal Structure of Holo-Glyceraldehyde-3-Phosphate Dehydrogenase from the Hyperthermophilic Bacterium Thermotoga Maritima at 2.5 Angstroms Resolution 1NTN ; 1.90 ; The Crystal Structure of Neurotoxin-I from Naja Naja Oxiana at 1.9 Angstroms Resolution 7PCY ; 1.80 ; The Crystal Structure of Plastocyanin from a Green Alga, Enteromorpha Prolifera 3TIM ; 2.80 ; The Crystal Structure of the "Open" and the "Closed" Conformation of the Flexible Loop of Trypanosomal Triosephosphate Isomerase 2PTC ; 1.90 ; The Geometry of the Reactive Site and of the Peptide Groups in Trypsin, Trypsinogen and its Complexes with Inhibitors 2TGP ; 1.90 ; The Geometry of the Reactive Site and of the Peptide Groups in Trypsin, Trypsinogen and its Complexes with Inhibitors 3PTB ; 1.70 ; The Geometry of the Reactive Site and of the Peptide Groups in Trypsin, Trypsinogen and its Complexes with Inhibitors 3TPI ; 1.90 ; The Geometry of the Reactive Site and of the Peptide Groups in Trypsin, Trypsinogen and its Complexes with Inhibitors 4PTI ; 1.50 ; The Geometry of the Reactive Site and of the Peptide Groups in Trypsin, Trypsinogen and its Complexes with Inhibitors 1DEG ; 2.90 ; The Linker of Des-Glu84 Calmodulin is Bent as Seen in the Crystal Structure 1ESD ; 2.30 ; The Molecular Mechanism of Enantiorecognition by Esterases 1ESE ; 2.40 ; The Molecular Mechanism of Enantiorecognition by Esterases 4TPI ; 2.20 ; The Refined 2.2-Angstroms (0.22-Nm) X-Ray Crystal Structure of the Ternary Complex Formed by Bovine Trypsinogen, Valine-Valine and the Arg15 Analogue of Bovine Pancreatic Trypsin Inhibitor 2SNV ; 2.80 ; The Refined Structure of Sindbis Virus Core Protein in Comparison with Other Chymotrypsin-Like Serine Proteinase Structures 4HTC ; 2.30 ; The Refined Structure of the Hirudin-Thrombin Complex 4SBV ; 2.80 ; The Refinement of Southern Bean Mosaic Virus in Reciprocal Space 1MBN ; 2.00 ; The Stereochemistry of the Protein Myoglobin 1ASB ; 2.60 ; The Structural Basis for the Reduced Activity of the D223A(D222A) Active Site Mutant of E. Coli Aspartate Aminotransferase 1ASC ; 2.40 ; The Structural Basis for the Reduced Activity of the D223A(D222A) Active Site Mutant of E. Coli Aspartate Aminotransferase 1ASA ; 2.40 ; The Structural Basis for the Reduced Activity of the Y226F(Y225F) Active Site Mutant of E. Coli Aspartate Aminotransferase 1ASF ; 2.80 ; The Structural Basis for the Reduced Activity of the Y226F(Y225F) Active Site Mutant of E. Coli Aspartate Aminotransferase 1ASG ; 2.80 ; The Structural Basis for the Reduced Activity of the Y226F(Y225F) Active Site Mutant of E. Coli Aspartate Aminotransferase 2BP2 ; 3.00 ; The Structure of Bovine Pancreatic Prophospholipase A2 at 3.0 Angstroms Resolution 2CHA ; 2.00 ; The Structure of Crystalline Alpha-Chymotrypsin, V.The Atomic Structure of Tosyl-Alpha-Chymotrypsin at 2 Angstroms Resolution 2NRD ; 2.10 ; The Structure of Cu-Nitrite Reductase from Achromobacter Cycloclastes at Five Ph Values, with Nitrite Bound and with Type II Cu Depleted 2INS ; 2.50 ; The Structure of Des-Phe B1 Bovine Insulin 3HUD ; 3.20 ; The Structure of Human Beta 1 Beta 1 Alcohol Dehydrogenase: Catalytic Effects of Non-Active-Site Substitutions 4GPD ; 2.80 ; The Structure of Lobster Apo-D-Glyceraldehyde-3-Phosphate Dehydrogenase at 3.0 Angstroms Resolution 2PHL ; 2.20 ; The Structure of Phaseolin at 2.2 Angstroms Resolution: Implications for a Common Vicilin(Slash)Legumin Structure and the Genetic Engineering of Seed Storage Proteins 1ASD ; 2.20 ; The Structure of Wild Type E. Coli Aspartate Aminotransferase Reconstituted with N-Meplp 1ASE ; 2.50 ; The Structure of Wild Type E. Coli Aspartate Aminotransferase Reconstituted with Plp-N-Oxide 1D62 ; 2.00 ; The Structure of a /B-DEOXYRIBONUCLEIC ACID Decamer with an I(Slash)A Mismatch and Comparison with the G(Slash)A Mismatch 3HTC ; 2.30 ; The Structure of a Complex of Recombinant Hirudin and Human Alpha-Thrombin 2ER6 ; 2.00 ; The Structure of a Synthetic Pepsin Inhibitor Complexed with Endothiapepsin. 1BCF ; 2.90 ; The Structure of a Unique, Two-Fold Symmetric, Haem-Binding Site 1HSM ; -1.00 ; The Structure of the Hmg Box and its Interaction with DEOXYRIBONUCLEIC ACID 1HSN ; -1.00 ; The Structure of the Hmg Box and its Interaction with DEOXYRIBONUCLEIC ACID 1NHM ; -1.00 ; The Structure of the Hmg Box and its Interaction with DEOXYRIBONUCLEIC ACID 1NHN ; -1.00 ; The Structure of the Hmg Box and its Interaction with DEOXYRIBONUCLEIC ACID 2HMQ ; 1.66 ; The Structures of met and Azidomet Hemerythrin at 1.66 Angstroms Resolution 2HMZ ; 1.66 ; The Structures of met and Azidomet Hemerythrin at 1.66 Angstroms Resolution 1LZH ; 6.00 ; The Structures of the Monoclinic and Orthorhombic Forms of Hen Egg-White Lysozyme at 6 Angstroms Resolution. 2LZH ; 6.00 ; The Structures of the Monoclinic and Orthorhombic Forms of Hen Egg-White Lysozyme at 6 Angstroms Resolution. 2LZ2 ; 2.20 ; The Three Dimensional Structure of Turkey Egg White Lysozyme at 2.2 Angstroms Resolution 1MHU ; -1.00 ; The Three-Dimensional Structure of Human [113Cd7] Metallothionein-2 in Solution Determined by Nuclear Magnetic Resonance Spectroscopy 2AK3 ; 1.85 ; The Three-Dimensional Structure of the Complex between Mitochondrial Matrix Adenylate Kinase and its Substrate AMP at 1.85 Angstroms Resolution 1ISU ; 1.50 ; The Three-Dimensional Structure of the High-Potential Iron-Sulfur Protein Isolated from the Purple Phototrophic Bacterium Rhodocyclus Tenuis Determined and Refined at 1.5 Angstroms Resolution 2PGK ; 3.00 ; The Use of Phase Combination in the Refinement of Phosphoglycerate Kinase at 2.5 Angstroms Resolution 2PTL ; -1.00 ; Three-Dimensional Solution Structure of an Immunoglobulin Light Chain-Binding Domain of Protein L. Comparison with the Igg-Binding Domains of Protein G 1FHB ; -1.00 ; Three-Dimensional Solution Structure of the Cyanide Adduct of a met80Ala Variant of Saccharomyces Cerevisiae Iso-1-Cytochrome C. Identification of Ligand-Residue Interactions in the Distal Heme Cavity 1DIH ; 2.20 ; Three-Dimensional Structure of E. Coli Dihydrodipicolinate Reductase 1CLC ; 1.90 ; Three-Dimensional Structure of Endoglucanase D at 1.9 Angstroms Resolution 2F19 ; 2.80 ; Three-Dimensional Structure of Two Crystal Forms of Fab R19.9, From a Monoclonal Anti-Arsonate Antibody 1L64 ; 1.90 ; Tolerance of T4 Lysozyme to Multiple Xaa (Right Arrow) Ala Substitutions: A Polyalanine Alpha-Helix Containing Ten Consecutive Alanines 1NU4 ; 1.80 ; U1A RIBONUCLEIC ACID BINDING DOMAIN AT 1.8 ANGSTROM RESOLUTION REVEALS A PRE-ORGANIZED C-TERMINAL HELIX 1OIA ; 2.40 ; U1A RNP DOMAIN 1-95 1DRZ ; 2.30 ; U1A SPLICEOSOMAL PROTEIN/HEPATITIS DELTA VIRUS GENOMIC RIBOZYME COMPLEX 1AUD ; -1.00 ; U1A-UTRRNA, NMR, 31 STRUCTURES 1URN ; 1.92 ; U1A/RIBONUCLEIC ACID COMPLEX 1A9N ; 2.38 ; U2 B''/A'/RIBONUCLEIC ACID TERNARY COMPLEX 1QOI ; 2.00 ; U4/U6 SNRNP-SPECIFIC CYCLOPHILIN SNUCYP-20 1NC0 ; -1.00 ; U80G U6 INTRAMOLECULAR STEM-LOOP RIBONUCLEIC ACID FROM SACCHAROMYCES CEREVISIAE 1QCQ ; 2.70 ; UBIQUITIN CONJUGATING ENZYME 2UCZ ; 2.93 ; UBIQUITIN CONJUGATING ENZYME (UBC7) FROM SACCHAROMYCES CEREVISIAE 2AAK ; 2.40 ; UBIQUITIN CONJUGATING ENZYME FROM ARABIDOPSIS THALIANA 1JBB ; 2.00 ; UBIQUITIN CONJUGATING ENZYME, UBC13 1D3Z ; -1.00 ; UBIQUITIN NMR STRUCTURE 1Q5W ; -1.00 ; UBIQUITIN RECOGNITION BY NPL4 ZINC-FINGERS 1YLA ; 2.40 ; UBIQUITIN-CONJUGATING ENZYME E2-25 KDA (HUNTINGTON INTERACTING PROTEIN 2) 1ZDN ; 1.93 ; UBIQUITIN-CONJUGATING ENZYME E2S 1YH2 ; 2.00 ; UBIQUITIN-CONJUGATING ENZYME HSPC150 2BPS ; 2.70 ; UBIQUITIN-LIKE PROTEIN YUKD OF BACILLUS SUBTILIS 2FAZ ; 2.00 ; UBIQUITION LIKE DOMAIN OF HUMAN NUCLEAR ZINC FINGER PROTEIN NP95 1H8C ; -1.00 ; UBX DOMAIN FROM HUMAN FAF1 1EN2 ; 1.40 ; UDA TETRASACCHARIDE COMPLEX. CRYSTAL STRUCTURE OF URTICA DIOICA AGGLUTININ, A SUPERANTIGEN PRESENTED BY MHC MOLECULES OF CLASS I AND CLASS II 1ENM ; 1.90 ; UDA TRISACCHARIDE COMPLEX. CRYSTAL STRUCTURE OF URTICA DIOICA AGGLUTININ, A SUPERANTIGEN PRESENTED BY MHC MOLECULES OF CLASS I AND CLASS II 1EIS ; 1.66 ; UDA UNCOMPLEXED FORM. CRYSTAL STRUCTURE OF URTICA DIOICA AGGLUTININ, A SUPERANTIGEN PRESENTED BY MHC MOLECULES OF CLASS I AND CLASS II 1LXA ; 2.60 ; UDP N-ACETYLGLUCOSAMINE ACYLTRANSFERASE 2BI7 ; 2.00 ; UDP-GALACTOPYRANOSE MUTASE FROM KLEBSIELLA PNEUMONIAE OXIDISED FAD 2BI8 ; 2.35 ; UDP-GALACTOPYRANOSE MUTASE FROM KLEBSIELLA PNEUMONIAE WITH REDUCED FAD 1V0J ; 2.25 ; UDP-GALACTOPYRANOSE MUTASE FROM MYCOBACTERIUM TUBERCULOSIS 1KVQ ; 2.15 ; UDP-GALACTOSE 4-EPIMERASE COMPLEXED WITH UDP-PHENOL 1KVR ; 1.90 ; UDP-GALACTOSE 4-EPIMERASE COMPLEXED WITH UDP-PHENOL 1KVS ; 2.15 ; UDP-GALACTOSE 4-EPIMERASE COMPLEXED WITH UDP-PHENOL 1KVT ; 2.15 ; UDP-GALACTOSE 4-EPIMERASE COMPLEXED WITH UDP-PHENOL 1KVU ; 1.90 ; UDP-GALACTOSE 4-EPIMERASE COMPLEXED WITH UDP-PHENOL 2UDP ; 1.80 ; UDP-GALACTOSE 4-EPIMERASE COMPLEXED WITH UDP-PHENOL 1XEL ; 1.80 ; UDP-GALACTOSE 4-EPIMERASE FROM ESCHERICHIA COLI 1NAI ; 2.00 ; UDP-GALACTOSE 4-EPIMERASE FROM ESCHERICHIA COLI, OXIDIZED 1NAH ; 1.80 ; UDP-GALACTOSE 4-EPIMERASE FROM ESCHERICHIA COLI, REDUCED 1A9Z ; 1.90 ; UDP-GALACTOSE 4-EPIMERASE MUTANT S124A/Y149F COMPLEXED WITH UDP-GALACTOSE 1A9Y ; 1.80 ; UDP-GALACTOSE 4-EPIMERASE MUTANT S124A/Y149F COMPLEXED WITH UDP-GLUCOSE 1QGS ; 2.00 ; UDP-MAGNESIUM COMPLEX OF SPSA FROM BACILLUS SUBTILIS 1QGQ ; 1.50 ; UDP-MANGANESE COMPLEX OF SPSA FROM BACILLUS SUBTILIS 1E0D ; 2.40 ; UDP-N-ACETYLMURAMOYL-L-ALANINE:D-GLUTAMATE LIGASE 1EEH ; 1.90 ; UDP-N-ACETYLMURAMOYL-L-ALANINE:D-GLUTAMATE LIGASE 1UAG ; 1.95 ; UDP-N-ACETYLMURAMOYL-L-ALANINE:D-GLUTAMATE LIGASE 2UAG ; 1.70 ; UDP-N-ACETYLMURAMOYL-L-ALANINE:D-GLUTAMATE LIGASE 3UAG ; 1.77 ; UDP-N-ACETYLMURAMOYL-L-ALANINE:D-GLUTAMATE LIGASE 4UAG ; 1.66 ; UDP-N-ACETYLMURAMOYL-L-ALANINE:D-GLUTAMATE LIGASE 1ZC1 ; -1.00 ; UFD1 EXHIBITS THE AAA-ATPASE FOLD WITH TWO DISTINCT UBIQUITIN INTERACTION SITES 1AFX ; -1.00 ; UGAA EUKARYOTIC RIBOSOMAL RIBONUCLEIC ACID TETRALOOP, NMR, 13 STRUCTURES 1M40 ; 0.85 ; ULTRA HIGH RESOLUTION CRYSTAL STRUCTURE OF TEM-1 1G6X ; 0.86 ; ULTRA HIGH RESOLUTION STRUCTURE OF BOVINE PANCREATIC TRYPSIN INHIBITOR (BPTI) MUTANT WITH ALTERED BINDING LOOP SEQUENCE 1IUA ; 0.80 ; ULTRA-HIGH RESOLUTION STRUCTURE OF HIPIP FROM THERMOCHROMATIUM TEPIDUM 1WUI ; 1.04 ; ULTRA-HIGH RESOLUTION STRUCTURE OF THE NI-A STATE OF [NIFE]HYDROGENASE FROM DESULUFOVIBRIO VULGARIS MIYAZAKI F 1D8G ; 0.74 ; ULTRAHIGH RESOLUTION CRYSTAL STRUCTURE OF B-DEOXYRIBONUCLEIC ACID DECAMER D(CCAGTACTGG) 1R6J ; 0.73 ; ULTRAHIGH RESOLUTION CRYSTAL STRUCTURE OF SYNTENIN PDZ2 1N9B ; 0.90 ; ULTRAHIGH RESOLUTION STRUCTURE OF A CLASS A BETA-LACTAMASE: ON THE MECHANISM AND SPECIFICITY OF THE EXTENDED-SPECTRUM SHV-2 ENZYME 1HG4 ; 2.40 ; ULTRASPIRACLE LIGAND BINDING DOMAIN FROM DROSOPHILA MELANOGASTER 1X9R ; 1.90 ; UMECYANIN FROM HORSE RADDISH- CRYSTAL STRUCTURE OF THE OXIDISED FORM 1X9U ; 1.80 ; UMECYANIN FROM HORSE RADDISH- CRYSTAL STRUCTURE OF THE REDUCED FORM 2BRI ; 3.00 ; UMP KINASE FROM PYROCOCCUS FURIOSUS COMPLEXED WITH ITS SUBSTRATE ANALOG AMPPNP 2BMU ; 2.55 ; UMP KINASE FROM PYROCOCCUS FURIOSUS COMPLEXED WITH ITS SUBSTRATE UMP AND ITS SUBSTRATE ANALOG AMPPNP 2BRX ; 2.40 ; UMP KINASE FROM PYROCOCCUS FURIOSUS WITHOUT LIGANDS 1UKE ; 2.20 ; UMP/CMP KINASE FROM SLIME MOLD 2UKD ; 2.20 ; UMP/CMP KINASE FROM SLIME MOLD COMPLEXED WITH ADP, CMP 3UKD ; 1.90 ; UMP/CMP KINASE FROM SLIME MOLD COMPLEXED WITH ADP, CMP, AND ALF3 4UKD ; 2.00 ; UMP/CMP KINASE FROM SLIME MOLD COMPLEXED WITH ADP, UDP, BERYLLIUM FLUORIDE 1VPN ; 2.00 ; UNASSEMBLED POLYOMAVIRUS VP1 PENTAMER 1UNA ; 2.80 ; UNASSEMBLED VIRUS COAT PROTEIN DIMER, BACTERIOPHAGE RIBONUCLEIC ACID- BINDING DIMER 1PJU ; 2.15 ; UNBOUND FORM OF TOMATO INHIBITOR-II 1O8P ; 2.00 ; UNBOUND STRUCTURE OF CSCBM6-3 FROM CLOSTRIDIUM STERCORARIUM 1ATU ; 2.70 ; UNCLEAVED ALPHA-1-ANTITRYPSIN 1J6Z ; 1.54 ; UNCOMPLEXED ACTIN 1JK6 ; 2.40 ; UNCOMPLEXED DES 1-6 BOVINE NEUROPHYSIN 1AMH ; 2.50 ; UNCOMPLEXED RAT TRYPSIN MUTANT WITH ASP 189 REPLACED WITH SER (D189S) 1R56 ; 2.30 ; UNCOMPLEXED URATE OXIDASE FROM ASPERGILLUS FLAVUS 1YHH ; 1.50 ; UNCYCLIZED PRECURSOR STRUCTURE OF S65A Y66S G67A GFP VARIANT 1YHI ; 1.90 ; UNCYCLIZED PRECURSOR STRUCTURE OF S65A Y66S R96A GFP VARIANT 1YHG ; 2.50 ; UNCYCLIZED PRECURSOR STRUCTURE OF S65G Y66S V68G GFP VARIANT 1SPQ ; 2.16 ; UNDERSTANDING PROTEIN LIDS: STRUCTURAL ANALYSIS OF ACTIVE HINGE MUTANTS IN TRIOSEPHOSPHATE ISOMERASE 1SQ7 ; 2.85 ; UNDERSTANDING PROTEIN LIDS: STRUCTURAL ANALYSIS OF ACTIVE HINGE MUTANTS IN TRIOSEPHOSPHATE ISOMERASE 1SSD ; 2.90 ; UNDERSTANDING PROTEIN LIDS: STRUCTURAL ANALYSIS OF ACTIVE HINGE MUTANTS IN TRIOSEPHOSPHATE ISOMERASE 1SSG ; 2.90 ; UNDERSTANDING PROTEIN LIDS: STRUCTURAL ANALYSIS OF ACTIVE HINGE MUTANTS IN TRIOSEPHOSPHATE ISOMERASE 1SU5 ; 2.70 ; UNDERSTANDING PROTEIN LIDS: STRUCTURAL ANALYSIS OF ACTIVE HINGE MUTANTS IN TRIOSEPHOSPHATE ISOMERASE 1U72 ; 1.90 ; UNDERSTANDING THE ROLE OF LEU22 VARIANTS IN METHOTREXATE RESISTANCE: COMPARISON OF WILD-TYPE AND LEU22ARG VARIANT MOUSE AND HUMAN DIHYDRFOLATE REDUCTASE TERNARY CRYSTAL COMPLEXES WITH METHOTREXATE AND NADPH 1U70 ; 2.50 ; UNDERSTANDING THE ROLE OF LEU22 VARIANTS IN METHOTREXATE RESISTANCE: COMPARISON OF WILD-TYPE AND LEU22ARG VARIANT MOUSE AND HUMAN DIHYDROFOLATE REDUCTASE 1U71 ; 2.20 ; UNDERSTANDING THE ROLE OF LEU22 VARIANTS IN METHOTREXATE RESISTANCE: COMPARISON OF WILD-TYPE AND LEU22ARG VARIANT MOUSE AND HUMAN DIHYDROFOLATE REDUCTASE TERNARY CRYSTAL COMPLEXES WITH METHOTREXATE AND NADPH 1JKX ; 1.60 ; UNEXPECTED FORMATION OF AN EPOXIDE-DERIVED MULTISUBSTRATE ADDUCT INHIBITOR ON THE ACTIVE SITE OF GAR TRANSFORMYLASE 1QAU ; 1.25 ; UNEXPECTED MODES OF PDZ DOMAIN SCAFFOLDING REVEALED BY STRUCTURE OF NNOS- SYNTROPHIN COMPLEX 1QAV ; 1.90 ; UNEXPECTED MODES OF PDZ DOMAIN SCAFFOLDING REVEALED BY STRUCTURE OF NNOS- SYNTROPHIN COMPLEX 1V0S ; 1.75 ; UNINHIBITED FORM OF PHOSPHOLIPASE D FROM STREPTOMYCES SP. STRAIN PMF 5COX ; 3.00 ; UNINHIBITED MOUSE CYCLOOXYGENASE-2 (PROSTAGLANDIN SYNTHASE-2) 1N7K ; 2.00 ; UNIQUE TETRAMERIC STRUCTURE OF DEOXYRIBOSE PHOSPHATE ALDOLASE FROM AEROPYRUM PERNIX 1T3U ; 2.50 ; UNKNOWN CONSERVED BACTERIAL PROTEIN FROM PSEUDOMONAS AERUGINOSA PAO1 1MNU ; 2.50 ; UNLIGANDED BACTERICIDAL ANTIBODY AGAINST NEISSERIA MENINGITIDIS 1DLU ; 2.25 ; UNLIGANDED BIOSYNTHETIC THIOLASE FROM ZOOGLOEA RAMIGERA 1FEC ; 1.70 ; UNLIGANDED CRITHIDIA FASCICULATA TRYPANOTHIONE REDUCTASE AT 1.7 ANGSTROM RESOLUTION 1FEB ; 2.00 ; UNLIGANDED CRITHIDIA FASCICULATA TRYPANOTHIONE REDUCTASE AT 2.0 ANGSTROM RESOLUTION 1FEA ; 2.20 ; UNLIGANDED CRITHIDIA FASCICULATA TRYPANOTHIONE REDUCTASE AT 2.2 ANGSTROM RESOLUTION 1D5I ; 2.00 ; UNLIGANDED GERMLINE PRECURSOR OF AN OXY-COPE CATALYTIC ANTIBODY 1NYL ; 2.60 ; UNLIGANDED GLUTAMINYL-TRNA SYNTHETASE 2AUD ; 2.10 ; UNLIGANDED HINCII 1D5B ; 2.80 ; UNLIGANDED MATURE OXY-COPE CATALYTIC ANTIBODY 1AZ5 ; 2.00 ; UNLIGANDED SIV PROTEASE STRUCTURE IN AN "OPEN" CONFORMATION 1TOE ; 2.00 ; UNLIGANDED STRUCTURE OF HEXAMUTANT + A293D MUTANT OF E. COLI ASPARTATE AMINOTRANSFERASE 1HKH ; 1.73 ; UNLIGATED GAMMA LACTAMASE FROM AN AUREOBACTERIUM SPECIES 1DQ2 ; 2.05 ; UNLOCKED METAL-FREE CONCANAVALIN A 1ON7 ; 2.70 ; UNMETHYLATED FORM OF C-PHYCOCYANIN FROM THEMOSYNECHOCOCCUS VULCANUS AT 2.7A 1JBA ; -1.00 ; UNMYRISTOYLATED GCAP-2 WITH THREE CALCIUM IONS BOUND 1PYQ ; 1.90 ; UNPROCESSED ASPARTATE DECARBOXYLASE MUTANT, WITH ALANINE INSERTED AT POSITION 24 1PT0 ; 2.00 ; UNPROCESSED PYRUVOYL DEPENDENT ASPARTATE DECARBOXYLASE WITH AN ALANINE INSERTION AT POSITION 26 1PT1 ; 1.90 ; UNPROCESSED PYRUVOYL DEPENDENT ASPARTATE DECARBOXYLASE WITH HISTIDINE 11 MUTATED TO ALANINE 1L1V ; -1.00 ; UNUSUAL ACTD/DNA_TA COMPLEX STRUCTURE 1PCL ; 2.20 ; UNUSUAL STRUCTURAL FEATURES IN THE PARALLEL BETA-HELIX IN PECTATE LYASES 1L3K ; 1.10 ; UP1, THE TWO RIBONUCLEIC ACID-RECOGNITION MOTIF DOMAIN OF HNRNP A1 1UP1 ; 1.90 ; UP1, THE TWO RIBONUCLEIC ACID-RECOGNITION MOTIF DOMAIN OF HNRNP A1 1BD4 ; 2.20 ; UPRT-URACIL COMPLEX 1Q3F ; 1.90 ; URACIL DEOXYRIBONUCLEIC ACID GLYCOSYLASE BOUND TO A CATIONIC 1-AZA-2'- DEOXYRIBOSE-CONTIANING DEOXYRIBONUCLEIC ACID 1FLZ ; 2.30 ; URACIL DEOXYRIBONUCLEIC ACID GLYCOSYLASE WITH UAAP 1LAU ; 1.80 ; URACIL-DEOXYRIBONUCLEIC ACID GLYCOSYLASE 1EMJ ; 2.00 ; URACIL-DEOXYRIBONUCLEIC ACID GLYCOSYLASE BOUND TO DEOXYRIBONUCLEIC ACID CONTAINING A 4'-THIO- 2'DEOXYURIDINE ANALOG PRODUCT 1UGI ; 1.55 ; URACIL-DEOXYRIBONUCLEIC ACID GLYCOSYLASE INHIBITOR PROTEIN 1WS2 ; 2.70 ; URATE OXIDASE FROM ASPERGILLUS FLAVUS COMPLEXED WITH 5,6- DIAMINOURACIL 1WRR ; 1.64 ; URATE OXIDASE FROM ASPERGILLUS FLAVUS COMPLEXED WITH 5- AMINO 6-NITRO URACIL 1XXJ ; 2.80 ; URATE OXIDASE FROM ASPERGILLUS FLAVUS COMPLEXED WITH 5- AMINO 6-NITRO URACIL 1XT4 ; 2.01 ; URATE OXIDASE FROM ASPERGILLUS FLAVUS COMPLEXED WITH GUANINE 1XY3 ; 3.20 ; URATE OXIDASE FROM ASPERGILLUS FLAVUS COMPLEXED WITH GUANINE 1R51 ; 1.75 ; URATE OXIDASE FROM ASPERGILLUS FLAVUS COMPLEXED WITH ITS INHIBITOR 8-AZAXANTHIN 1R4S ; 1.80 ; URATE OXIDASE FROM ASPERGILLUS FLAVUS COMPLEXED WITH ITS INHIBITOR 9-METHYL URIC ACID 1R4U ; 1.65 ; URATE OXIDASE FROM ASPERGILLUS FLAVUS COMPLEXED WITH ITS INHIBITOR OXONIC ACID 1WS3 ; 3.20 ; URATE OXIDASE FROM ASPERGILLUS FLAVUS COMPLEXED WITH URACIL 1JZR ; 2.90 ; URE2P IN COMPLEX WITH GLUTATHIONE 1K0B ; 2.50 ; URE2P IN COMPLEX WITH GLUTATHIONE 1K0D ; 2.20 ; URE2P IN COMPLEX WITH GLUTATHIONE 1K0A ; 2.50 ; URE2P IN COMPLEX WITH S-HEXYLGLUTATHIONE 1K0C ; 2.50 ; URE2P IN COMPLEX WITH S-P-NITROBENZYLGLUTATHIONE 1K3F ; 2.50 ; URIDINE PHOSPHORYLASE FROM E. COLI, REFINED IN THE MONOCLINIC CRYSTAL LATTICE 1RYZ ; 2.90 ; URIDINE PHOSPHORYLASE FROM SALMONELLA TYPHIMURIUM. CRYSTAL STRUCTURE AT 2.9 A RESOLUTION 1F92 ; 2.60 ; UROKINASE PLASMINOGEN ACTIVATOR B CHAIN-UKI-1D COMPLEX 1EJN ; 1.80 ; UROKINASE PLASMINOGEN ACTIVATOR B-CHAIN INHIBITOR COMPLEX 1F5L ; 2.10 ; UROKINASE PLASMINOGEN ACTIVATOR B-CHAIN-AMILORIDE COMPLEX 1F5K ; 1.80 ; UROKINASE PLASMINOGEN ACTIVATOR B-CHAIN-BENZAMIDINE COMPLEX 1SC8 ; 2.40 ; UROKINASE PLASMINOGEN ACTIVATOR B-CHAIN-J435 COMPLEX 1VJ9 ; 2.40 ; UROKINASE PLASMINOGEN ACTIVATOR B-CHAIN-JT464 COMPLEX 1VJA ; 2.00 ; UROKINASE PLASMINOGEN ACTIVATOR B-CHAIN-JT464 COMPLEX 1URO ; 1.80 ; UROPORPHYRINOGEN DECARBOXYLASE 1R3Q ; 1.70 ; UROPORPHYRINOGEN DECARBOXYLASE IN COMPLEX WITH COPROPORPHYRINOGEN-I 1R3Y ; 1.75 ; UROPORPHYRINOGEN DECARBOXYLASE IN COMPLEX WITH COPROPORPHYRINOGEN-III 1R3V ; 1.90 ; UROPORPHYRINOGEN DECARBOXYLASE SINGLE MUTANT D86E IN COMPLEX WITH COPROPORPHYRINOGEN-I 1R3S ; 1.65 ; UROPORPHYRINOGEN DECARBOXYLASE SINGLE MUTANT D86G IN COMPLEX WITH COPROPORPHYRINOGEN-I 1R3T ; 1.70 ; UROPORPHYRINOGEN DECARBOXYLASE SINGLE MUTANT D86G IN COMPLEX WITH COPROPORPHYRINOGEN-III 1R3R ; 1.85 ; UROPORPHYRINOGEN DECARBOXYLASE WITH MUTATION D86N 1R3W ; 1.70 ; UROPORPHYRINOGEN DECARBOXYLASE Y164F MUTANT IN COMPLEX WITH COPROPORPHYRINOGEN-III 1SWY ; 1.06 ; USE OF A HALIDE BINDING SITE TO BYPASS THE 1000-ATOM LIMIT TO AB INITIO STRUCTURE DETERMINATION 1SX2 ; 1.06 ; USE OF A HALIDE BINDING SITE TO BYPASS THE 1000-ATOM LIMIT TO STRUCTURE DETERMINATION BY DIRECT METHODS 1SWZ ; 1.06 ; USE OF AN ION-BINDING SITE TO BYPASS THE 1000-ATOM LIMIT TO AB INITIO STRUCTURE DETERMINATION BY DIRECT METHODS 1SX7 ; 1.06 ; USE OF AN ION-BINDING SITE TO BYPASS THE 1000-ATOM LIMIT TO AB INITIO STRUCTURE DETERMINATION BY DIRECT METHODS 1D1U ; 2.30 ; USE OF AN N-TERMINAL FRAGMENT FROM MOLONEY MURINE LEUKEMIA VIRUS REVERSE TRANSCRIPTASE TO FACILITATE CRYSTALLIZATION AND ANALYSIS OF A PSEUDO-16-MER DEOXYRIBONUCLEIC ACID MOLECULE CONTAINING G-A MISPAIRS 1BP4 ; 2.20 ; USE OF PAPAIN AS A MODEL FOR THE STRUCTURE-BASED DESIGN OF CATHEPSIN K INHIBITORS. CRYSTAL STRUCTURES OF TWO PAPAIN INHIBITOR COMPLEXES DEMONSTRATE BINDING TO S'-SUBSITES. 1BQI ; 2.50 ; USE OF PAPAIN AS A MODEL FOR THE STRUCTURE-BASED DESIGN OF CATHEPSIN K INHIBITORS. CRYSTAL STRUCTURES OF TWO PAPAIN INHIBITOR COMPLEXES DEMONSTRATE BINDING TO S'-SUBSITES. 1T8A ; 2.00 ; USE OF SEQUENCE DUPLICATION TO ENGINEER A LIGAND-TRIGGERED LONG-DISTANCE MOLECULAR SWITCH IN T4 LYSOSYME 1T97 ; 2.70 ; USE OF SEQUENCE DUPLICATION TO ENGINEER A LIGAND-TRIGGERED LONG-DISTANCE MOLECULAR SWITCH IN T4 LYSOSYME 1KP6 ; 1.80 ; USTILAGO MAYDIS KILLER TOXIN KP6 ALPHA-SUBUNIT 1RTU ; 1.80 ; USTILAGO SPHAEROGENA RIBONUCLEASE U2 1UTR ; -1.00 ; UTEROGLOBIN-PCB COMPLEX (REDUCED FORM) 1D2M ; 1.90 ; UVRB PROTEIN OF THERMUS THERMOPHILUS HB8; A NUCLEOTIDE EXCISION REPAIR ENZYME 3INK ; 2.50 ; Unraveling the Structure of Interleukin-2: Reply 1NTP ; 1.80 ; Use of the Neutron Diffraction-H(Slash)D Exchange Technique to Determine the Conformational Dynamics of Trypsin 1AVZ ; 3.00 ; V-1 NEF PROTEIN IN COMPLEX WITH WILD TYPE FYN SH3 DOMAIN 1B88 ; 2.50 ; V-ALPHA 2.6 MOUSE T CELL RECEPTOR (TCR) DOMAIN 1ACD ; 2.70 ; V32D/F57H MUTANT OF MURINE ADIPOCYTE LIPID BINDING PROTEIN 1M6M ; 1.80 ; V68N MET MYOGLOBIN 1MNO ; 1.95 ; V68N MYOGLOBIN OXY FORM 1M6C ; 1.90 ; V68N MYOGLOBIN WITH CO 1RID ; 2.10 ; VACCINIA COMPLEMENT PROTEIN IN COMPLEX WITH HEPARIN 1B42 ; 2.20 ; VACCINIA METHYLTRANSFERASE VP39 COMPLEXED WITH M1ADE AND S-ADENOSYLHOMOCYSTEINE 1BKY ; 2.00 ; VACCINIA METHYLTRANSFERASE VP39 COMPLEXED WITH M1CYT AND S-ADENOSYLHOMOCYSTEINE 3MAG ; 1.80 ; VACCINIA METHYLTRANSFERASE VP39 COMPLEXED WITH M3ADE AND S-ADENOSYLHOMOCYSTEINE 3MCT ; 2.00 ; VACCINIA METHYLTRANSFERASE VP39 COMPLEXED WITH M3CYT AND S-ADENOSYLHOMOCYSTEINE 1AV6 ; 2.70 ; VACCINIA METHYLTRANSFERASE VP39 COMPLEXED WITH M7G CAPPED RIBONUCLEIC ACID HEXAMER AND S-ADENOSYLHOMOCYSTEINE 1EAM ; 2.00 ; VACCINIA METHYLTRANSFERASE VP39 MUTANT (EC: 2.7.7.19) 4DCG ; 1.80 ; VACCINIA METHYLTRANSFERASE VP39 MUTANT D182A COMPLEXED WITH M7G AND S-ADENOSYLHOMOCYSTEINE 1EQA ; 2.20 ; VACCINIA METHYLTRANSFERASE VP39 MUTANT E233Q COMPLEXED WITH M7G AND S-ADENOSYLHOMOCYSTEINE 1VP3 ; 1.90 ; VACCINIA VIRUS PROTEIN VP39 IN COMPLEX WITH S-ADENOSYLHOMOCYSTEINE 1VTP ; -1.00 ; VACUOLAR TARGETING PEPTIDE FROM NA-PROPI 1HS7 ; -1.00 ; VAM3P N-TERMINAL DOMAIN SOLUTION STRUCTURE 1YP6 ; 1.80 ; VAN DER WAALS INTERACTIONS DOMINATE HYDROPHOBIC ASSOCIATION IN A PROTEIN BINDING SITE OCCLUDED FROM SOLVENT WATER 1YP7 ; 2.00 ; VAN DER WAALS INTERACTIONS DOMINATE HYDROPHOBIC ASSOCIATION IN A PROTEIN BINDING SITE OCCLUDED FROM SOLVENT WATER 1QHB ; 2.30 ; VANADIUM BROMOPEROXIDASE FROM RED ALGA CORALLINA OFFICINALIS 1AA5 ; 0.89 ; VANCOMYCIN 1TVD ; 1.90 ; VARIABLE DOMAIN OF T CELL RECEPTOR DELTA CHAIN 1F6L ; 2.80 ; VARIABLE LIGHT CHAIN DIMER OF ANTI-FERRITIN ANTIBODY 1AKH ; 2.50 ; VARIANT MATA1 MATALPHA2 DEOXYRIBONUCLEIC ACID TERNARY COMPLEX 1AET ; 2.10 ; VARIATION IN THE STRENGTH OF A CH TO O HYDROGEN BOND IN AN ARTIFICIAL PROTEIN CAVITY (1-METHYLIMIDAZOLE) 1AC4 ; 2.10 ; VARIATION IN THE STRENGTH OF A CH TO O HYDROGEN BOND IN AN ARTIFICIAL PROTEIN CAVITY (2,3,4-TRIMETHYL-1,3-THIAZOLE) 1AEQ ; 2.10 ; VARIATION IN THE STRENGTH OF A CH TO O HYDROGEN BOND IN AN ARTIFICIAL PROTEIN CAVITY (2-ETHYLIMIDAZOLE) 1AC8 ; 2.10 ; VARIATION IN THE STRENGTH OF A CH TO O HYDROGEN BOND IN AN ARTIFICIAL PROTEIN CAVITY (3,4,5-TRIMETHYLTHIAZOLE) 1XQM ; 2.10 ; VARIATIONS ON THE GFP CHROMOPHORE SCAFFOLD: A FRAGMENTED 5- MEMBERED HETEROCYCLE REVEALED IN THE 2.1A CRYSTAL STRUCTURE OF A NON-FLUORESCENT CHROMOPROTEIN 1BJ1 ; 2.40 ; VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH A NEUTRALIZING ANTIBODY 1CZ8 ; 2.40 ; VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH AN AFFINITY MATURED ANTIBODY 1QTY ; 2.70 ; VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH DOMAIN 2 OF THE FLT-1 RECEPTOR 2VPF ; 1.93 ; VASCULAR ENDOTHELIAL GROWTH FACTOR REFINED TO 1.93 ANGSTROMS RESOLUTION 1VSC ; 1.90 ; VCAM-1 1OZ4 ; 4.70 ; VCP/P97 1YQI ; 4.25 ; VCP/P97 COMPLEXED WITH ADP 1Y8E ; 2.20 ; VCP:SURAMIN COMPLEX 1FLT ; 1.70 ; VEGF IN COMPLEX WITH DOMAIN 2 OF THE FLT-1 RECEPTOR 1YWN ; 1.71 ; VEGFR2 IN COMPLEX WITH A NOVEL 4-AMINO-FURO[2,3-D]PYRIMIDINE 1B7L ; 1.80 ; VERIFICATION OF SPMP USING MUTANT HUMAN LYSOZYMES 1B7M ; 2.20 ; VERIFICATION OF SPMP USING MUTANT HUMAN LYSOZYMES 1B7N ; 1.80 ; VERIFICATION OF SPMP USING MUTANT HUMAN LYSOZYMES 1B7O ; 1.80 ; VERIFICATION OF SPMP USING MUTANT HUMAN LYSOZYMES 1B7P ; 2.00 ; VERIFICATION OF SPMP USING MUTANT HUMAN LYSOZYMES 1B7Q ; 2.00 ; VERIFICATION OF SPMP USING MUTANT HUMAN LYSOZYMES 1B7R ; 1.80 ; VERIFICATION OF SPMP USING MUTANT HUMAN LYSOZYMES 1B7S ; 2.00 ; VERIFICATION OF SPMP USING MUTANT HUMAN LYSOZYMES 1YFN ; 1.80 ; VERSATILE MODES OF PEPTIDE RECOGNITION BY THE AAA+ ADAPTOR PROTEIN SSPB- THE CRYSTAL STRUCTURE OF A SSPB-RSEA COMPLEX 1VSR ; 1.80 ; VERY SHORT PATCH REPAIR (VSR) ENDONUCLEASE FROM ESCHERICHIA COLI 1ODG ; 2.80 ; VERY-SHORT-PATCH DEOXYRIBONUCLEIC ACID REPAIR ENDONUCLEASE BOUND TO ITS REACTION PRODUCT SITE 1QNX ; 1.90 ; VES V 5, AN ALLERGEN FROM VESPULA VULGARIS VENOM 1VHP ; -1.00 ; VH-P8, NMR 1UJJ ; 2.60 ; VHS DOMAIN OF HUMAN GGA1 COMPLEXED WITH C-TERMINAL PEPTIDE FROM BACE 1UJK ; 1.90 ; VHS DOMAIN OF HUMAN GGA1 COMPLEXED WITH C-TERMINAL PHOSPHOPEPTIDE FROM BACE 1JWG ; 2.00 ; VHS DOMAIN OF HUMAN GGA1 COMPLEXED WITH CATION-INDEPENDENT M6PR C-TERMINAL PEPTIDE 1ELK ; 1.50 ; VHS DOMAIN OF TOM1 PROTEIN FROM H. SAPIENS 1MT7 ; 1.90 ; VIABILITY OF A DRUG-RESISTANT HIV-1 PROTEASE MUTANT: STRUCTURAL INSIGHTS FOR BETTER ANTIVIRAL THERAPY 1MT8 ; 2.15 ; VIABILITY OF A DRUG-RESISTANT HIV-1 PROTEASE MUTANT: STRUCTURAL INSIGHTS FOR BETTER ANTIVIRAL THERAPY 1MT9 ; 2.00 ; VIABILITY OF A DRUG-RESISTANT HIV-1 PROTEASE MUTANT: STRUCTURAL INSIGHTS FOR BETTER ANTIVIRAL THERAPY 1MTB ; 2.50 ; VIABILITY OF A DRUG-RESISTANT HIV-1 PROTEASE MUTANT: STRUCTURAL INSIGHTS FOR BETTER ANTIVIRAL THERAPY 1N49 ; 2.20 ; VIABILITY OF A DRUG-RESISTANT HIV-1 PROTEASE VARIANT: STRUCTURAL INSIGHTS FOR BETTER ANTI-VIRAL THERAPY 1KIT ; 2.30 ; VIBRIO CHOLERAE NEURAMINIDASE 1W0O ; 1.90 ; VIBRIO CHOLERAE SIALIDASE 1W0P ; 1.60 ; VIBRIO CHOLERAE SIALIDASE WITH ALPHA-2,6-SIALYLLACTOSE 1KO2 ; 2.20 ; VIM-2, A ZN-BETA-LACTAMASE FROM PSEUDOMONAS AERUGINOSA WITH AN OXIDIZED CYS (CYSTEINESULFONIC) 1KO3 ; 1.91 ; VIM-2, A ZN-BETA-LACTAMASE FROM PSEUDOMONAS AERUGINOSA WITH CYS221 REDUCED 1T01 ; 2.06 ; VINCULIN COMPLEXED WITH THE VBS1 HELIX FROM TALIN 1ZVZ ; 1.80 ; VINCULIN HEAD (0-258) IN COMPLEX WITH THE TALIN ROD RESIDUE 820-844 1ZW3 ; 3.30 ; VINCULIN HEAD (0-258) IN COMPLEX WITH THE TALIN ROD RESIDUES 1630-1652 1ZW2 ; 2.10 ; VINCULIN HEAD (0-258) IN COMPLEX WITH THE TALIN ROD RESIDUES 2345-2369 1U6H ; 2.38 ; VINCULIN HEAD (0-258) IN COMPLEX WITH THE TALIN VINCULIN BINDING SITE 2 (849-879) 1XWJ ; 2.60 ; VINCULIN HEAD (1-258) IN COMPLEX WITH THE TALIN VINCULIN BINDING SITE 3 (1945-1969) 1AOK ; 2.00 ; VIPOXIN COMPLEX 1JLT ; 1.40 ; VIPOXIN COMPLEX 1OHR ; 2.10 ; VIRACEPT (R) (NELFINAVIR MESYLATE, AG1343): A POTENT ORALLY BIOAVAILABLE INHIBITOR OF HIV-1 PROTEASE 1TD0 ; 1.95 ; VIRAL CAPSID PROTEIN SHP AT PH 5.5 1MKF ; 2.10 ; VIRAL CHEMOKINE BINDING PROTEIN M3 FROM MURINE GAMMAHERPESVIRUS 68 1ML0 ; 2.80 ; VIRAL CHEMOKINE BINDING PROTEIN M3 FROM MURINE GAMMAHERPESVIRUS68 IN COMPLEX WITH THE P8A VARIANT OF CC- CHEMOKINE MCP-1 1OKH ; 1.75 ; VISCOTOXIN A3 FROM VISCUM ALBUM L. 1JEK ; 1.50 ; VISNA TM CORE STRUCTURE 1NKN ; 2.50 ; VISUALIZING AN UNSTABLE COILED COIL: THE CRYSTAL STRUCTURE OF AN N-TERMINAL SEGMENT OF THE SCALLOP MYOSIN ROD 1NK2 ; -1.00 ; VND/NK-2 HOMEODOMAIN/DEOXYRIBONUCLEIC ACID COMPLEX, NMR, 20 STRUCTURES 1NK3 ; -1.00 ; VND/NK-2 HOMEODOMAIN/DEOXYRIBONUCLEIC ACID COMPLEX, NMR, MINIMIZED AVERAGE STRUCTURE 1VND ; -1.00 ; VND/NK-2 PROTEIN (HOMEODOMAIN), NMR 1VGF ; 2.60 ; VOLVATOXIN A2 (DIAMOND CRYSTAL FORM) 1PP0 ; 1.42 ; VOLVATOXIN A2 IN MONOCLINIC CRYSTAL 1PP6 ; 3.20 ; VVA2 (STRIP CRYSTAL FORM) 1VCY ; 2.60 ; VVA2 ISOFORM 1Q55 ; 30.00 ; W-SHAPED TRANS INTERACTIONS OF CADHERINS MODEL BASED ON FITTING C-CADHERIN (1L3W) TO 3D MAP OF DESMOSOMES OBTAINED BY ELECTRON TOMOGRAPHY 1MP4 ; 2.20 ; W224H VARIANT OF S. ENTERICA RMLA 1PZY ; 2.30 ; W314A-BETA1,4-GALACTOSYLTRANSFERASE-I COMPLEXED WITH ALPHA- LACTALBUMIN IN THE PRESENCE OF N-ACETYLGLUCOSAMINE, UDP AND MANGANESE 1DX9 ; 2.05 ; W57A APOFLAVODOXIN FROM ANABAENA 1OBO ; 1.20 ; W57L FLAVODOXIN FROM ANABAENA 151D ; 1.40 ; WATER RING STRUCTURE AT DEOXYRIBONUCLEIC ACID INTERFACES: HYDRATION AND DYNAMICS OF DEOXYRIBONUCLEIC ACID-ANTHRACYCLINE COMPLEXES. 1X1U ; 2.30 ; WATER-MEDIATE INTERACTION AT APROTEIN-PROTEIN INTERFACE 1X1W ; 2.10 ; WATER-MEDIATE INTERACTION AT APROTEIN-PROTEIN INTERFACE 1X1X ; 2.30 ; WATER-MEDIATE INTERACTION AT APROTEIN-PROTEIN INTERFACE 1X1Y ; 1.90 ; WATER-MEDIATE INTERACTION AT APROTEIN-PROTEIN INTERFACE 1GXR ; 1.65 ; WD40 REGION OF HUMAN GROUCHO/TLE1 1ZTX ; 2.50 ; WEST NILE VIRUS ENVELOPE PROTEIN DIII IN COMPLEX WITH NEUTRALIZING E16 ANTIBODY FAB 1A75 ; 1.90 ; WHITING PARVALBUMIN 1DG1 ; 2.50 ; WHOLE, UNMODIFIED, EF-TU(ELONGATION FACTOR TU). 1TW7 ; 1.30 ; WIDE OPEN 1.3A STRUCTURE OF A MULTI-DRUG RESISTANT HIV-1 PROTEASE REPRESENTS A NOVEL DRUG TARGET 1QK2 ; 2.00 ; WILD TYPE CEL6A WITH A NON-HYDROLYSABLE CELLOTETRAOSE 1MWD ; 1.80 ; WILD TYPE DEOXY MYOGLOBIN 1QKU ; 3.20 ; WILD TYPE ESTROGEN NUCLEAR RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH ESTRADIOL 2GAW ; 2.20 ; WILD TYPE GLYCOSYLASPARAGINASE FROM FLAVOBACTERIUM MENINGOSEPTICUM 1IKW ; 3.00 ; WILD TYPE HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH EFAVIRENZ 1E98 ; 1.90 ; WILD TYPE HUMAN THYMIDYLATE KINASE COMPLEXED WITH AZTMP AND ADP 1MDN ; 1.98 ; WILD TYPE MYOGLOBIN WITH CO 1MWC ; 1.70 ; WILD TYPE MYOGLOBIN WITH CO 1OTB ; 1.10 ; WILD TYPE PHOTOACTIVE YELLOW PROTEIN, P63 AT 295K 1LJL ; 2.01 ; WILD TYPE PI258 S. AUREUS ARSENATE REDUCTASE 1NIK ; 4.10 ; WILD TYPE RIBONUCLEIC ACID POLYMERASE II 1Y4H ; 1.93 ; WILD TYPE STAPHOPAIN-STAPHOSTATIN COMPLEX 1W7S ; 1.85 ; WILD-TYPE AEQUOREA VICTORIA GREEN FLUORESCENT PROTEIN 2AYI ; 3.70 ; WILD-TYPE AMPT FROM THERMUS THERMOPHILUS 1CXI ; 2.20 ; WILD-TYPE CGTASE FROM BACILLUS CIRCULANS STRAIN 251 AT 120 K AND PH 7.55 2AII ; 1.54 ; WILD-TYPE FORMYLGLYCINE GENERATING ENZYME REACTED WITH IODOACETAMIDE 1XZ2 ; 1.90 ; WILD-TYPE HEMOGLOBIN DEOXY NO-SALT 1G39 ; 1.22 ; WILD-TYPE HNF-1ALPHA DIMERIZATION DOMAIN 1D1S ; 2.50 ; WILD-TYPE HUMAN SIGMA (CLASS IV) ALCOHOL DEHYDROGENASE 1ZRS ; 1.50 ; WILD-TYPE LD-CARBOXYPEPTIDASE 1QG0 ; 2.50 ; WILD-TYPE PEA FNR 1NZU ; 2.00 ; WILD-TYPE PENICILLIN-BINDING PROTEIN 5 FROM E. COLI MODIFIED BY BETA-MERCAPTOETHANOL 1J3I ; 2.33 ; WILD-TYPE PLASMODIUM FALCIPARUM DIHYDROFOLATE REDUCTASE- THYMIDYLATE SYNTHASE (PFDHFR-TS) COMPLEXED WITH WR99210, NADPH, AND DUMP 1BYO ; 2.00 ; WILD-TYPE PLASTOCYANIN FROM SILENE 3TGI ; 1.80 ; WILD-TYPE RAT ANIONIC TRYPSIN COMPLEXED WITH BOVINE PANCREATIC TRYPSIN INHIBITOR (BPTI) 1DUK ; 2.13 ; WILD-TYPE RECOMBINANT SPERM WHALE METAQUOMYOGLOBIN 1AY9 ; 3.00 ; WILD-TYPE UMUD' FROM E. COLI 1SSP ; 1.90 ; WILD-TYPE URACIL-DEOXYRIBONUCLEIC ACID GLYCOSYLASE BOUND TO URACIL-CONTAINING DEOXYRIBONUCLEIC ACID 1BDT ; 2.50 ; WILDTYPE ARC-DEOXYRIBONUCLEIC ACID CRYO 1MK5 ; 1.40 ; WILDTYPE CORE-STREPTAVIDIN WITH BIOTIN AT 1.4A. 1M01 ; 2.10 ; WILDTYPE STREPTOMYCES PLICATUS BETA-HEXOSAMINIDASE IN COMPLEX WITH PRODUCT (GLCNAC) 1WKT ; -1.00 ; WILLIOPSIS MRAKII KILLER TOXIN, NMR SOLUTION STRUCTURE 1F9K ; 3.00 ; WINGED BEAN ACIDIC LECTIN COMPLEXED WITH METHYL-ALPHA-D- GALACTOSE 1FAY ; 3.30 ; WINGED BEAN ACIDIC LECTIN COMPLEXED WITH METHYL-ALPHA-D- GALACTOSE (MONOCLINIC FORM) 1WBA ; 1.80 ; WINGED BEAN ALBUMIN 1 1WBL ; 2.50 ; WINGED BEAN LECTIN COMPLEXED WITH METHYL-ALPHA-D-GALACTOSE 1WBF ; 2.30 ; WINGED BEAN LECTIN, SACCHARIDE FREE FORM 1WFB ; 1.50 ; WINTER FLOUNDER ANTIFREEZE PROTEIN ISOFORM HPLC6 AT -180 DEGREES C 1WFA ; 1.70 ; WINTER FLOUNDER ANTIFREEZE PROTEIN ISOFORM HPLC6 AT 4 DEGREES C 1F62 ; -1.00 ; WSTF-PHD 1YFH ; 3.01 ; WT HUMAN O6-ALKYLGUANINE-DEOXYRIBONUCLEIC ACID ALKYLTRANSFERASE BOUND TO DEOXYRIBONUCLEIC ACID CONTAINING AN ALKYLATED CYTOSINE 1IBH ; 2.00 ; X-RAY 3D STRUCTURE OF P.LEIOGNATHI CU,ZN SOD MUTANT M41I 1IBD ; 2.00 ; X-RAY 3D STRUCTURE OF P.LEIOGNATHI CU,ZN SOD MUTANT V29A 1IBF ; 2.20 ; X-RAY 3D STRUCTURE OF P.LEIOGNATHI CU,ZN SOD MUTANT V29G 1IBB ; 2.10 ; X-RAY 3D STRUCTURE OF P.LEIOGNATHI CU,ZN SOD MUTANT W83F 1IB5 ; 2.45 ; X-RAY 3D STRUCTURE OF P.LEIOGNATHI CU,ZN SOD MUTANT W83Y 4CMS ; 2.20 ; X-RAY ANALYSES OF ASPARTIC PROTEINASES IV. STRUCTURE AND REFINEMENT AT 2.2 ANGSTROMS RESOLUTION OF BOVINE CHYMOSIN 1VE8 ; 1.65 ; X-RAY ANALYSES OF OLIGONUCLEOTIDES CONTAINING 5- FORMYLCYTOSINE, SUGGESTING A STRUCTURAL REASON FOR CODON- ANTICODON RECOGNITION OF MITOCHONDRIAL TRNA-MET; PART 1, D(CGCGAATT(F5C)GCG) 1J8G ; 0.61 ; X-RAY ANALYSIS OF A RIBONUCLEIC ACID TETRAPLEX R(UGGGGU)4 AT ULTRA-HIGH RESOLUTION 285D ; 2.50 ; X-RAY AND SOLUTION STUDIES OF DEOXYRIBONUCLEIC ACID OLIGOMERS AND IMPLICATIONS FOR THE STRUCTURAL BASIS OF A-TRACT-DEPENDENT CURVATURE 286D ; 2.50 ; X-RAY AND SOLUTION STUDIES OF DEOXYRIBONUCLEIC ACID OLIGOMERS AND IMPLICATIONS FOR THE STRUCTURAL BASIS OF A-TRACT-DEPENDENT CURVATURE 287D ; 2.20 ; X-RAY AND SOLUTION STUDIES OF DEOXYRIBONUCLEIC ACID OLIGOMERS AND IMPLICATIONS FOR THE STRUCTURAL BASIS OF A-TRACT-DEPENDENT CURVATURE 297D ; 2.50 ; X-RAY AND SOLUTION STUDIES OF DEOXYRIBONUCLEIC ACID OLIGOMERS AND IMPLICATIONS FOR THE STRUCTURAL BASIS OF A-TRACT-DEPENDENT CURVATURE 1QQY ; 1.85 ; X-RAY CRYSTAL STRUCTURE ANALYSIS OF CANINE MILK LYSOZYME (APO-TYPE) 1EL1 ; 1.90 ; X-RAY CRYSTAL STRUCTURE ANALYSIS OF CANINE MILK LYSOZYME (HOLO-TYPE) 1GEB ; 2.03 ; X-RAY CRYSTAL STRUCTURE AND CATALYTIC PROPERTIES OF THR252ILE MUTANT OF CYTOCHROME P450CAM 1EQB ; 2.70 ; X-RAY CRYSTAL STRUCTURE AT 2.7 ANGSTROMS RESOLUTION OF TERNARY COMPLEX BETWEEN THE Y65F MUTANT OF E-COLI SERINE HYDROXYMETHYLTRANSFERASE, GLYCINE AND 5-FORMYL TETRAHYDROFOLATE 1EM1 ; 2.13 ; X-RAY CRYSTAL STRUCTURE FOR HUMAN MANGANESE SUPEROXIDE DISMUTASE, Q143A 1LO8 ; 1.80 ; X-RAY CRYSTAL STRUCTURE OF 4-HYDROXYBENZOYL COA THIOESTERASE COMPLEXED WITH 4-HYDROXYBENZYL COA 1LO9 ; 2.80 ; X-RAY CRYSTAL STRUCTURE OF 4-HYDROXYBENZOYL COA THIOESTERASE MUTANT D17N COMPLEXED WITH 4-HYDROXYBENZOYL COA 1YIW ; 1.39 ; X-RAY CRYSTAL STRUCTURE OF A CHEMICALLY SYNTHESIZED UBIQUITIN 1YJ1 ; 1.30 ; X-RAY CRYSTAL STRUCTURE OF A CHEMICALLY SYNTHESIZED [D- GLN35]UBIQUITIN 1S6B ; 1.60 ; X-RAY CRYSTAL STRUCTURE OF A COMPLEX FORMED BETWEEN TWO HOMOLOGOUS ISOFORMS OF PHOSPHOLIPASE A2 FROM NAJA NAJA SAGITTIFERA: PRINCIPLE OF MOLECULAR ASSOCIATION AND INACTIVATION 1Z3L ; 1.80 ; X-RAY CRYSTAL STRUCTURE OF A MUTANT RIBONUCLEASE S (F8ANB) 1Z3P ; 2.00 ; X-RAY CRYSTAL STRUCTURE OF A MUTANT RIBONUCLEASE S (M13NVA) 1UWW ; 1.40 ; X-RAY CRYSTAL STRUCTURE OF A NON-CRYSTALLINE CELLULOSE SPECIFIC CARBOHYDRATE-BINDING MODULE: CBM28. 1MTO ; 3.20 ; X-RAY CRYSTAL STRUCTURE OF A PHOSPHOFRUCTOKINASE MUTANT FROM BACILLUS STEAROTHERMOPHILUS BOUND WITH FRUTOSE-6- PHOSPHATE 1T9K ; 2.60 ; X-RAY CRYSTAL STRUCTURE OF AIF-2B ALPHA SUBUNIT-RELATED TRANSLATION INITIATION FACTOR [THERMOTOGA MARITIMA] 1TZF ; 2.10 ; X-RAY CRYSTAL STRUCTURE OF ALPHA-D-GLUCOSE-1-PHOSPHATE CYTIDYLYLTRANSFERASE FROM SALMONELLA TYPHI 1SUJ ; 2.38 ; X-RAY CRYSTAL STRUCTURE OF AMBYSTOMA TIGRINUM CONE ARRESTIN 1CLI ; 2.50 ; X-RAY CRYSTAL STRUCTURE OF AMINOIMIDAZOLE RIBONUCLEOTIDE SYNTHETASE (PURM), FROM THE E. COLI PURINE BIOSYNTHETIC PATHWAY, AT 2.5 A RESOLUTION 1KE4 ; 1.72 ; X-RAY CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE FROM E. COLI 1L2S ; 1.94 ; X-RAY CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE FROM E. COLI IN COMPLEX WITH A DOCK-PREDICTED NON-COVALENT INHIBITOR 1KDS ; 2.15 ; X-RAY CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE FROM E. COLI IN COMPLEX WITH THE INHIBITOR 3-NITROPHENYLBORONIC ACID 1KE3 ; 2.15 ; X-RAY CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE FROM E. COLI IN COMPLEX WITH THE INHIBITOR 4,4'-BIPHENYLDIBORONIC ACID 1KE0 ; 2.30 ; X-RAY CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE FROM E. COLI IN COMPLEX WITH THE INHIBITOR 4-(CARBOXYVIN-2-YL) PHENYLBORONIC ACID 1KDW ; 2.28 ; X-RAY CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE FROM E. COLI IN COMPLEX WITH THE INHIBITOR 4-CARBOXYPHENYLBORONIC ACID 1L0E ; 1.90 ; X-RAY CRYSTAL STRUCTURE OF AMPC K67Q MUTANT BETA-LACTAMASE 1L0F ; 1.66 ; X-RAY CRYSTAL STRUCTURE OF AMPC N152H MUTANT BETA-LACTAMASE 1L0D ; 1.53 ; X-RAY CRYSTAL STRUCTURE OF AMPC S64D MUTANT BETA-LACTAMASE 1L0G ; 1.50 ; X-RAY CRYSTAL STRUCTURE OF AMPC S64G MUTANT BETA-LACTAMASE 1KVL ; 1.53 ; X-RAY CRYSTAL STRUCTURE OF AMPC S64G MUTANT BETA-LACTAMASE IN COMPLEX WITH SUBSTRATE AND PRODUCT FORMS OF CEPHALOTHIN 1KVM ; 2.06 ; X-RAY CRYSTAL STRUCTURE OF AMPC WT BETA-LACTAMASE IN COMPLEX WITH COVALENTLY BOUND CEPHALOTHIN 1LL5 ; 1.80 ; X-RAY CRYSTAL STRUCTURE OF AMPC WT BETA-LACTAMASE IN COMPLEX WITH COVALENTLY BOUND IMIPENEM 1Z91 ; 2.50 ; X-RAY CRYSTAL STRUCTURE OF APO-OHRRC15S IN REDUCED FORM: MARR FAMILY PROTEIN 1Y4Y ; 2.00 ; X-RAY CRYSTAL STRUCTURE OF BACILLUS STEAROTHERMOPHILUS HISTIDINE PHOSPHOCARRIER PROTEIN (HPR) 1Y51 ; 1.65 ; X-RAY CRYSTAL STRUCTURE OF BACILLUS STEAROTHERMOPHILUS HISTIDINE PHOSPHOCARRIER PROTEIN (HPR) F29W MUTANT 1Y50 ; 2.00 ; X-RAY CRYSTAL STRUCTURE OF BACILLUS STEAROTHERMOPHILUS HISTIDINE PHOSPHOCARRIER PROTEIN (HPR) F29W MUTANT DOMAIN_SWAPPED DIMER 1YLF ; 2.50 ; X-RAY CRYSTAL STRUCTURE OF BC1842 PROTEIN FROM BACILLUS CEREUS, A MEMBER OF THE RRF2 FAMILY OF PUTATIVE TRANSCRIPTION REGULATORS. 1TXR ; 2.00 ; X-RAY CRYSTAL STRUCTURE OF BESTATIN BOUND TO AAP 1QDQ ; 2.18 ; X-RAY CRYSTAL STRUCTURE OF BOVINE CATHEPSIN B-CA074 COMPLEX 1W6N ; 1.65 ; X-RAY CRYSTAL STRUCTURE OF C2S HUMAN GALECTIN-1 1W6M ; 2.30 ; X-RAY CRYSTAL STRUCTURE OF C2S HUMAN GALECTIN-1 COMPLEXED WITH GALACTOSE 1W6O ; 1.90 ; X-RAY CRYSTAL STRUCTURE OF C2S HUMAN GALECTIN-1 COMPLEXED WITH LACTOSE 1W6P ; 1.80 ; X-RAY CRYSTAL STRUCTURE OF C2S HUMAN GALECTIN-1 COMPLEXED WITH N-ACETYL-LACTOSAMINE 1C3D ; 1.80 ; X-RAY CRYSTAL STRUCTURE OF C3D: A C3 FRAGMENT AND LIGAND FOR COMPLEMENT RECEPTOR 2 1FQR ; 2.00 ; X-RAY CRYSTAL STRUCTURE OF COBALT-BOUND F93I/F95M/W97V CARBONIC ANHYDRASE (CAII) VARIANT 1FSQ ; 2.00 ; X-RAY CRYSTAL STRUCTURE OF COBALT-BOUND F93S/F95L/W97M CARBONIC ANHYDRASE (CAII) VARIANT 1HBJ ; 2.50 ; X-RAY CRYSTAL STRUCTURE OF COMPLEX BETWEEN TORPEDO CALIFORNICA ACHE AND A REVERSIBLE INHIBITOR, 4-AMINO-5-FLUO RO-2-METHYL-3-(3-TRIFLUOROACETYLBENZYLTHIOMETHYL)QUINOLINE 1U61 ; 2.15 ; X-RAY CRYSTAL STRUCTURE OF CONSERVED HYPOTHETICAL PROTEIN FROM BACILLUS CEREUS 1YHF ; 2.00 ; X-RAY CRYSTAL STRUCTURE OF CONSERVED HYPOTHETICAL SPY1581 PROTEIN FROM STREPTOCOCCUS PYOGENES. 1XSV ; 1.70 ; X-RAY CRYSTAL STRUCTURE OF CONSERVED HYPOTHETICAL UPF0122 PROTEIN SAV1236 FROM STAPHYLOCOCCUS AUREUS SUBSP. AUREUS MU50 1FR4 ; 1.60 ; X-RAY CRYSTAL STRUCTURE OF COPPER-BOUND F93I/F95M/W97V CARBONIC ANHYDRASE (CAII) VARIANT 1FSR ; 2.00 ; X-RAY CRYSTAL STRUCTURE OF COPPER-BOUND F93S/F95L/W97M CARBONIC ANHYDRASE (CAII) VARIANT 1M9C ; 2.00 ; X-RAY CRYSTAL STRUCTURE OF CYCLOPHILIN A/HIV-1 CA N- TERMINAL DOMAIN (1-146) M-TYPE COMPLEX. 1M9E ; 1.72 ; X-RAY CRYSTAL STRUCTURE OF CYCLOPHILIN A/HIV-1 CA N- TERMINAL DOMAIN (1-146) M-TYPE H87A COMPLEX. 1M9F ; 1.73 ; X-RAY CRYSTAL STRUCTURE OF CYCLOPHILIN A/HIV-1 CA N- TERMINAL DOMAIN (1-146) M-TYPE H87A,A88M COMPLEX. 1M9X ; 1.70 ; X-RAY CRYSTAL STRUCTURE OF CYCLOPHILIN A/HIV-1 CA N- TERMINAL DOMAIN (1-146) M-TYPE H87A,A88M,G89A COMPLEX. 1M9Y ; 1.90 ; X-RAY CRYSTAL STRUCTURE OF CYCLOPHILIN A/HIV-1 CA N- TERMINAL DOMAIN (1-146) M-TYPE H87A,G89A COMPLEX. 1M9D ; 1.90 ; X-RAY CRYSTAL STRUCTURE OF CYCLOPHILIN A/HIV-1 CA N- TERMINAL DOMAIN (1-146) O-TYPE CHIMERA COMPLEX. 1EUP ; 2.10 ; X-RAY CRYSTAL STRUCTURE OF CYTOCHROME P450ERYF WITH ANDROSTENDIONE BOUND 1S2Z ; 1.75 ; X-RAY CRYSTAL STRUCTURE OF DESULFOVIBRIO VULGARIS RUBRERYTHRIN WITH DISPLACEMENT OF IRON BY ZINC AT THE DIIRON SITE 1S30 ; 2.05 ; X-RAY CRYSTAL STRUCTURE OF DESULFOVIBRIO VULGARIS RUBRERYTHRIN WITH DISPLACEMENT OF IRON BY ZINC AT THE DIIRON SITE 1QYB ; 1.75 ; X-RAY CRYSTAL STRUCTURE OF DESULFOVIBRIO VULGARIS RUBRERYTHRIN WITH ZINC SUBSTITUTED INTO THE [FE(SCYS)4] SITE AND ALTERNATIVE DIIRON SITE STRUCTURES 1P3W ; 2.10 ; X-RAY CRYSTAL STRUCTURE OF E. COLI ISCS 1DYT ; 1.75 ; X-RAY CRYSTAL STRUCTURE OF ECP (RNASE 3) AT 1.75 A 1EIA ; 2.70 ; X-RAY CRYSTAL STRUCTURE OF EQUINE INFECTIOUS ANEMIA VIRUS (EIAV) CAPSID PROTEIN P26 2EIA ; 2.70 ; X-RAY CRYSTAL STRUCTURE OF EQUINE INFECTIOUS ANEMIA VIRUS (EIAV) CAPSID PROTEIN P26 1DLY ; 1.80 ; X-RAY CRYSTAL STRUCTURE OF HEMOGLOBIN FROM THE GREEN UNICELLULAR ALGA CHLAMYDOMONAS EUGAMETOS 2SEB ; 2.50 ; X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH A PEPTIDE FROM HUMAN COLLAGEN II 1D5X ; 2.45 ; X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH DIPEPTIDE MIMETIC AND SEB 1D5M ; 2.00 ; X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH PEPTIDE AND SEB 1D5Z ; 2.00 ; X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH PEPTIDOMIMETIC AND SEB 1H15 ; 3.10 ; X-RAY CRYSTAL STRUCTURE OF HLA-DRA10101/DRB50101 COMPLEXED WITH A PEPTIDE FROM EPSTEIN BARR VIRUS DEOXYRIBONUCLEIC ACID POLYMERASE 1H8I ; 1.75 ; X-RAY CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN WITH A TRIPEPTIDE PHOSPHONATE INHIBITOR. 1KCW ; 3.00 ; X-RAY CRYSTAL STRUCTURE OF HUMAN CERULOPLASMIN AT 3.0 ANGSTROMS 1GZW ; 1.70 ; X-RAY CRYSTAL STRUCTURE OF HUMAN GALECTIN-1 1N45 ; 1.50 ; X-RAY CRYSTAL STRUCTURE OF HUMAN HEME OXYGENASE-1 (HO-1) IN COMPLEX WITH ITS SUBSTRATE HEME 2A1H ; 1.80 ; X-RAY CRYSTAL STRUCTURE OF HUMAN MITOCHONDRIAL BRANCHED CHAIN AMINOTRANSFERASE (BCATM) COMPLEXED WITH GABAPENTIN 2RNF ; 2.40 ; X-RAY CRYSTAL STRUCTURE OF HUMAN RIBONUCLEASE 4 IN COMPLEX WITH D(UP) 1YRC ; 1.40 ; X-RAY CRYSTAL STRUCTURE OF HYDROGENATED CYTOCHROME P450CAM 1T6A ; 2.05 ; X-RAY CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN FROM BACILLUS STEAROTHERMOPHILUS 1U7I ; 1.40 ; X-RAY CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN PA1358 FROM PSEUDOMONAS AERUGINOSA 1YX1 ; 1.80 ; X-RAY CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN PA2260 FROM PSEUDOMONAS AERUGINOSA 1TU1 ; 1.95 ; X-RAY CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN PA94 FROM PSEUDOMONAS AERUGINOSA 1J2F ; 2.30 ; X-RAY CRYSTAL STRUCTURE OF IRF-3 AND ITS FUNCTIONAL IMPLICATIONS 1Y71 ; 1.95 ; X-RAY CRYSTAL STRUCTURE OF KINASE-ASSOCIATED PROTEIN B FROM BACILLUS CEREUS 1P8D ; 2.80 ; X-RAY CRYSTAL STRUCTURE OF LXR LIGAND BINDING DOMAIN WITH 24(S),25-EPOXYCHOLESTEROL 1FQN ; 2.00 ; X-RAY CRYSTAL STRUCTURE OF METAL-FREE F93I/F95M/W97V CARBONIC ANHYDRASE (CAII) VARIANT 1FSN ; 2.00 ; X-RAY CRYSTAL STRUCTURE OF METAL-FREE F93S/F95L/W97M CARBONIC ANHYDRASE (CAII) VARIANT 1XJC ; 2.10 ; X-RAY CRYSTAL STRUCTURE OF MOBB PROTEIN HOMOLOG FROM BACILLUS STEAROTHERMOPHILUS 1M1M ; 2.70 ; X-RAY CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS BETA- KETOACYL-ACYL CARRIER PROTEIN SYNTHASE III (MTFABH) 1XXO ; 1.80 ; X-RAY CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PYRIDOXINE 5'-PHOSPHATE OXIDASE AT 1.8 A RESOLUTION 1Y30 ; 2.20 ; X-RAY CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PYRIDOXINE 5'-PHOSPHATE OXIDASE COMPLEXED WITH FLAVIN MONONUCLEOTIDE AT 2.2 A RESOLUTION 2AQ6 ; 1.70 ; X-RAY CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PYRIDOXINE 5'-PHOSPHATE OXIDASE COMPLEXED WITH PYRIDOXAL 5'-PHOSPHATE AT 1.7 A RESOLUTION 1EPU ; 2.40 ; X-RAY CRYSTAL STRUCTURE OF NEURONAL SEC1 FROM SQUID 1FHH ; 1.50 ; X-RAY CRYSTAL STRUCTURE OF OXIDIZED RUBREDOXIN 1Y1O ; 2.20 ; X-RAY CRYSTAL STRUCTURE OF PENICILLIN-BINDING PROTEIN- RELATED FACTOR A FROM BACILLUS STEAROTHERMOPHILUS 1YRD ; 1.70 ; X-RAY CRYSTAL STRUCTURE OF PERDEUTERATED CYTOCHROME P450CAM 1T9M ; 1.90 ; X-RAY CRYSTAL STRUCTURE OF PHZG FROM PSEUDOMONAS AERUGINOSA 1TY9 ; 1.80 ; X-RAY CRYSTAL STRUCTURE OF PHZG FROM PSEUDOMONAS FLUORESCENS 2BL9 ; 1.90 ; X-RAY CRYSTAL STRUCTURE OF PLASMODIUM VIVAX DIHYDROFOLATE REDUCTASE IN COMPLEX WITH PYRIMETHAMINE AND ITS DERIVATIVE 2BLB ; 3.00 ; X-RAY CRYSTAL STRUCTURE OF PLASMODIUM VIVAX DIHYDROFOLATE REDUCTASE IN COMPLEX WITH PYRIMETHAMINE AND ITS DERIVATIVE 1XHD ; 1.90 ; X-RAY CRYSTAL STRUCTURE OF PUTATIVE ACETYLTRANSFERASE, PRODUCT OF BC4754 GENE [BACILLUS CEREUS] 1XR4 ; 2.37 ; X-RAY CRYSTAL STRUCTURE OF PUTATIVE CITRATE LYASE ALPHA CHAIN/CITRATE-ACP TRANSFERASE [SALMONELLA TYPHIMURIUM] 1SFX ; 1.55 ; X-RAY CRYSTAL STRUCTURE OF PUTATIVE HTH TRANSCRIPTION REGULATOR FROM ARCHAEOGLOBUS FULGIDUS 1Q77 ; 2.70 ; X-RAY CRYSTAL STRUCTURE OF PUTATIVE UNIVERSAL STRESS PROTEIN FROM AQUIFEX AEOLICUS 1W6Q ; 2.10 ; X-RAY CRYSTAL STRUCTURE OF R111H HUMAN GALECTIN-1 1ES9 ; 1.30 ; X-RAY CRYSTAL STRUCTURE OF R22K MUTANT OF THE MAMMALIAN BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASES (PAF-AH) 2AHB ; 2.00 ; X-RAY CRYSTAL STRUCTURE OF R46A,R161A MUTANT OF MYCOBACTERIUM TUBERCULOSIS FABH 1MUQ ; 2.30 ; X-RAY CRYSTAL STRUCTURE OF RATTLESNAKE VENOM COMPLEXED WITH THIODIGALACTOSIDE 1FHM ; 1.50 ; X-RAY CRYSTAL STRUCTURE OF REDUCED RUBREDOXIN 1PVO ; 3.00 ; X-RAY CRYSTAL STRUCTURE OF RHO TRANSCRIPTION TERMINATION FACTOR IN COMPLEX WITH SSRNA SUBSTRATE AND ANPPNP 2A15 ; 1.68 ; X-RAY CRYSTAL STRUCTURE OF RV0760 FROM MYCOBACTERIUM TUBERCULOSIS AT 1.68 ANGSTROM RESOLUTION 1LRZ ; 2.10 ; X-RAY CRYSTAL STRUCTURE OF STAPHYLOCOCCUS AUREUS FEMA 1VPD ; 1.65 ; X-RAY CRYSTAL STRUCTURE OF TARTRONATE SEMIALDEHYDE REDUCTASE [SALMONELLA TYPHIMURIUM LT2] 1RRV ; 2.00 ; X-RAY CRYSTAL STRUCTURE OF TDP-VANCOSAMINYLTRANSFERASE GTFD AS A COMPLEX WITH TDP AND THE NATURAL SUBSTRATE, DESVANCOSAMINYL VANCOMYCIN. 1ERQ ; 1.90 ; X-RAY CRYSTAL STRUCTURE OF TEM-1 BETA LACTAMASE IN COMPLEX WITH A DESIGNED BORONIC ACID INHIBITOR (1R)-1-ACETAMIDO-2- (3-CARBOXY-2-HYDROXYPHENYL)ETHYL BORONIC ACID 1ERM ; 1.70 ; X-RAY CRYSTAL STRUCTURE OF TEM-1 BETA LACTAMASE IN COMPLEX WITH A DESIGNED BORONIC ACID INHIBITOR (1R)-1-ACETAMIDO-2- (3-CARBOXYPHENYL)ETHANE BORONIC ACID 1ERO ; 2.10 ; X-RAY CRYSTAL STRUCTURE OF TEM-1 BETA LACTAMASE IN COMPLEX WITH A DESIGNED BORONIC ACID INHIBITOR (1R)-2- PHENYLACETAMIDO-2-(3-CARBOXYPHENYL)ETHYL BORONIC ACID 1ZXV ; 2.67 ; X-RAY CRYSTAL STRUCTURE OF THE ANTHRAX LETHAL FACTOR BOUND TO A SMALL MOLECULE INHIBITOR, BI-MFM3, 3-{5-[5-(4-CHLORO- PHENYL)-FURAN-2-YLMETHYLENE]-4-OXO-2-THIOXO-THIAZOLIDIN-3- YL}-PROPIONIC ACID. 1UU6 ; 1.40 ; X-RAY CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMICOLA GRISEA CEL12A IN COMPLEX WITH A SOAKED CELLOPENTAOSE 1W2U ; 1.52 ; X-RAY CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMICOLA GRISEA CEL12A IN COMPLEX WITH A SOAKED THIO CELLOTETRAOSE 1UU4 ; 1.49 ; X-RAY CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMICOLA GRISEA CEL12A IN COMPLEX WITH CELLOBIOSE 1UU5 ; 1.70 ; X-RAY CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMICOLA GRISEA CEL12A SOAKED WITH CELLOTETRAOSE 1L4Z ; 2.80 ; X-RAY CRYSTAL STRUCTURE OF THE COMPLEX OF MICROPLASMINOGEN WITH ALPHA DOMAIN OF STREPTOKINASE IN THE PRESENCE CADMIUM IONS 1BU5 ; 1.83 ; X-RAY CRYSTAL STRUCTURE OF THE DESULFOVIBRIO VULGARIS (HILDENBOROUGH) APOFLAVODOXIN-RIBOFLAVIN COMPLEX 1IL0 ; 2.20 ; X-RAY CRYSTAL STRUCTURE OF THE E170Q MUTANT OF HUMAN L-3- HYDROXYACYL-COA DEHYDROGENASE 2F2M ; 3.70 ; X-RAY CRYSTAL STRUCTURE OF THE EMRE MULTIDRUG TRANSPORTER IN COMPLEX WITH TPP 1F3H ; 2.58 ; X-RAY CRYSTAL STRUCTURE OF THE HUMAN ANTI-APOPTOTIC PROTEIN SURVIVIN 1A3K ; 2.10 ; X-RAY CRYSTAL STRUCTURE OF THE HUMAN GALECTIN-3 CARBOHYDRATE RECOGNITION DOMAIN (CRD) AT 2.1 ANGSTROM RESOLUTION 1U7P ; 1.90 ; X-RAY CRYSTAL STRUCTURE OF THE HYPOTHETICAL PHOSPHOTYROSINE PHOSPHATASE MDP-1 OF THE HALOACID DEHALOGENASE SUPERFAMILY 1K3Z ; 2.50 ; X-RAY CRYSTAL STRUCTURE OF THE IKBB/NF-KB P65 HOMODIMER COMPLEX 1P1Z ; 3.26 ; X-RAY CRYSTAL STRUCTURE OF THE LECTIN-LIKE NATURAL KILLER CELL RECEPTOR LY-49C BOUND TO ITS MHC CLASS I LIGAND H-2KB 1LVK ; 1.90 ; X-RAY CRYSTAL STRUCTURE OF THE MG (DOT) 2'(3')-O-(N-METHYLANTHRANILOYL) NUCLEOTIDE BOUND TO DICTYOSTELIUM DISCOIDEUM MYOSIN MOTOR DOMAIN 1CVJ ; 2.60 ; X-RAY CRYSTAL STRUCTURE OF THE POLY(A)-BINDING PROTEIN IN COMPLEX WITH POLYADENYLATE RIBONUCLEIC ACID 1PV4 ; 3.00 ; X-RAY CRYSTAL STRUCTURE OF THE RHO TRANSCRIPTION TERMINATION FACTOR IN COMPLEX WITH SINGLE STRANDED DEOXYRIBONUCLEIC ACID 1IU5 ; 1.50 ; X-RAY CRYSTAL STRUCTURE OF THE RUBREDOXIN MUTANT FROM PYROCOCCUS FURIOSUS 1Q2W ; 1.86 ; X-RAY CRYSTAL STRUCTURE OF THE SARS CORONAVIRUS MAIN PROTEASE 1V8Z ; 2.21 ; X-RAY CRYSTAL STRUCTURE OF THE TRYPTOPHAN SYNTHASE B2 SUBUNIT FROM HYPERTHERMOPHILE, PYROCOCCUS FURIOSUS 1NF2 ; 2.20 ; X-RAY CRYSTAL STRUCTURE OF TM0651 FROM THERMOTOGA MARITIMA 1DLW ; 1.54 ; X-RAY CRYSTAL STRUCTURE OF TRUNCATED HEMOGLOBIN FROM P.CAUDATUM. 1RNF ; 2.10 ; X-RAY CRYSTAL STRUCTURE OF UNLIGANDED HUMAN RIBONUCLEASE 4 2AJ9 ; 2.50 ; X-RAY CRYSTAL STRUCTURE OF W42A,R161A DOUBLE MUTANT OF MYCOBACTERIUM TUBERCULOSIS BETA-KETOACYL-ACP SYNTHASE III 1XI0 ; 2.00 ; X-RAY CRYSTAL STRUCTURE OF WILD-TYPE XEROCOMUS CHRYSENTERON LECTIN XCL 1X99 ; 1.40 ; X-RAY CRYSTAL STRUCTURE OF XEROCOMUS CHRYSENTERON LECTIN XCL AT 1.4 ANGSTROMS RESOLUTION, MUTATED AT Q46M, V54M, L58M 1D8I ; 2.05 ; X-RAY CRYSTAL STRUCTURE OF YEAST RIBONUCLEIC ACID TRIPHOSPHATASE IN COMPLEX WITH A SULFATE ION. 1D8H ; 2.00 ; X-RAY CRYSTAL STRUCTURE OF YEAST RIBONUCLEIC ACID TRIPHOSPHATASE IN COMPLEX WITH SULFATE AND MANGANESE IONS. 1S3J ; 2.25 ; X-RAY CRYSTAL STRUCTURE OF YUSO PROTEIN FROM BACILLUS SUBTILIS 1FQM ; 2.00 ; X-RAY CRYSTAL STRUCTURE OF ZINC-BOUND F93I/F95M/W97V CARBONIC ANHYDRASE (CAII) VARIANT 1FR7 ; 1.50 ; X-RAY CRYSTAL STRUCTURE OF ZINC-BOUND F93S/F95L/W97M CARBONIC ANHYDRASE (CAII) VARIANT 1FQL ; 2.00 ; X-RAY CRYSTAL STRUCTURE OF ZINC-BOUND F95M/W97V CARBONIC ANHYDRASE (CAII) VARIANT 486D ; 7.50 ; X-RAY CRYSTAL STRUCTURES OF 70S RIBOSOME FUNCTIONAL COMPLEXES 1YCH ; 2.80 ; X-RAY CRYSTAL STRUCTURES OF MOORELLA THERMOACETICA FPRA. NOVEL DIIRON SITE STRUCTURE AND MECHANISTIC INSIGHTS INTO A SCAVENGING NITRIC OXIDE REDUCTASE 349D ; 1.90 ; X-RAY CRYSTAL STRUCTURES OF THE DECAMER DGACCGCGGTC: HIGH SALT CONCENTRATION 348D ; 1.70 ; X-RAY CRYSTAL STRUCTURES OF THE DECAMER DGACCGCGGTC: LOW SALT CONCENTRATION 351D ; 1.64 ; X-RAY CRYSTAL STRUCTURES OF THE HEXAMER DCACGCG: CRYSTALS GROWN IN THE PRESENCE OF RUTHENIUM (II) HEXAMMINE CHLORIDE 1IOF ; 2.20 ; X-RAY CRYSTALLINE STRUCTURES OF PYRROLIDONE CARBOXYL PEPTIDASE FROM A HYPERTHERMOPHILE, PYROCOCCUS FURIOSUS, AND ITS CYS-FREE MUTANT 1IOI ; 2.70 ; X-RAY CRYSTALLINE STRUCTURES OF PYRROLIDONE CARBOXYL PEPTIDASE FROM A HYPERTHERMOPHILE, PYROCOCCUS FURIOSUS, AND ITS CYS-FREE MUTANT 1K0Y ; 1.87 ; X-RAY CRYSTALLOGRAPHIC ANALYSES OF SYMMETRICAL ALLOSTERIC EFFECTORS OF HEMOGLOBIN. COMPOUNDS DESIGNED TO LINK PRIMARY AND SECONDARY BINDING SITES 1Q7R ; 1.90 ; X-RAY CRYSTALLOGRAPHIC ANALYSIS OF A PREDICTED AMIDOTRANSFERASE FROM B. STEAROTHERMOPHILUS AT 1.9 A RESOLUTION 1A3I ; 1.97 ; X-RAY CRYSTALLOGRAPHIC DETERMINATION OF A COLLAGEN-LIKE PEPTIDE WITH THE REPEATING SEQUENCE (PRO-PRO-GLY) 1A3J ; 1.60 ; X-RAY CRYSTALLOGRAPHIC DETERMINATION OF A COLLAGEN-LIKE PEPTIDE WITH THE REPEATING SEQUENCE (PRO-PRO-GLY) 1W5R ; 1.45 ; X-RAY CRYSTALLOGRAPHIC STRCUTURE OF A C70Q MYCOBACTERIUM SMEGMATIS N-ARYLAMINE ACETYLTRANSFERASE 1YLZ ; 1.35 ; X-RAY CRYSTALLOGRAPHIC STRUCTURE OF CTX-M-14 BETA-LACTAMASE COMPLEXED WITH CEFTAZIDIME-LIKE BORONIC ACID 1YM1 ; 1.12 ; X-RAY CRYSTALLOGRAPHIC STRUCTURE OF CTX-M-9 BETA-LACTAMASE COMPLEXED WITH A BORONIC ACID INHIBITOR (SM2) 1YLY ; 1.25 ; X-RAY CRYSTALLOGRAPHIC STRUCTURE OF CTX-M-9 BETA-LACTAMASE COMPLEXED WITH CEFTAZIDIME-LIKE BORONIC ACID 1YMS ; 1.60 ; X-RAY CRYSTALLOGRAPHIC STRUCTURE OF CTX-M-9 BETA-LACTAMASE COMPLEXED WITH NAFCININ-LIKE BORONIC ACID INHIBITOR 1YMX ; 1.70 ; X-RAY CRYSTALLOGRAPHIC STRUCTURE OF CTX-M-9 BETA-LACTAMASE COVALENTLY LINKED TO CEFOXITIN 1F38 ; 2.40 ; X-RAY CRYSTALLOGRAPHIC STRUCTURE OF PRECORRIN 8W DECARBOXYLASE, THE PRODUCT OF GENE MT0146 IN THE METHANOBACTERIUM THERMOAUTOTROPHICUM GENOME 1W4T ; 1.95 ; X-RAY CRYSTALLOGRAPHIC STRUCTURE OF PSEUDOMONAS AERUGINOSA ARYLAMINE N-ACETYLTRANSFERASE 1CJR ; 2.30 ; X-RAY CRYSTALLOGRAPHIC STUDIES OF DENATURATION IN RIBONUCLEASE S 1CNG ; 1.90 ; X-RAY CRYSTALLOGRAPHIC STUDIES OF ENGINEERED HYDROGEN BOND NETWORKS IN A PROTEIN-ZINC BINDING SITE 1CNH ; 2.05 ; X-RAY CRYSTALLOGRAPHIC STUDIES OF ENGINEERED HYDROGEN BOND NETWORKS IN A PROTEIN-ZINC BINDING SITE 1CNI ; 1.80 ; X-RAY CRYSTALLOGRAPHIC STUDIES OF ENGINEERED HYDROGEN BOND NETWORKS IN A PROTEIN-ZINC BINDING SITE 1CNJ ; 1.80 ; X-RAY CRYSTALLOGRAPHIC STUDIES OF ENGINEERED HYDROGEN BOND NETWORKS IN A PROTEIN-ZINC BINDING SITE 1CNK ; 2.15 ; X-RAY CRYSTALLOGRAPHIC STUDIES OF ENGINEERED HYDROGEN BOND NETWORKS IN A PROTEIN-ZINC BINDING SITE 1KUV ; 2.00 ; X-RAY CRYSTALLOGRAPHIC STUDIES OF SEROTONIN N- ACETYLTRANSFERASE CATALYSIS AND INHIBITION 1KUX ; 1.80 ; X-RAY CRYSTALLOGRAPHIC STUDIES OF SEROTONIN N- ACETYLTRANSFERASE CATALYSIS AND INHIBITION 1KUY ; 2.40 ; X-RAY CRYSTALLOGRAPHIC STUDIES OF SEROTONIN N- ACETYLTRANSFERASE CATALYSIS AND INHIBITION 1CJQ ; 3.00 ; X-RAY CRYSTALLOGRAPHIC STUDIES OF THE DENATURATION OF THE DENATURATION OF RIBONUCLEASE S. 1AVS ; 1.75 ; X-RAY CRYSTALLOGRAPHIC STUDY OF CALCIUM-SATURATED N-TERMINAL DOMAIN OF TROPONIN C 1ZET ; 2.30 ; X-RAY DATA DO NOT SUPPORT HOOGSTEEN BASE-PAIRING DURING REPLICATION BY HUMAN POLYMERASE IOTA 1H5M ; 1.57 ; X-RAY INDUCED REDUCTION OF HORSERADISH PEROXIDASE C1A COMPOUND III (0-100% DOSE) 1H5D ; 1.60 ; X-RAY INDUCED REDUCTION OF HORSERADISH PEROXIDASE C1A COMPOUND III (0-11% DOSE) 1H5C ; 1.62 ; X-RAY INDUCED REDUCTION OF HORSERADISH PEROXIDASE C1A COMPOUND III (100-200% DOSE) 1H5E ; 1.60 ; X-RAY INDUCED REDUCTION OF HORSERADISH PEROXIDASE C1A COMPOUND III (11-22% DOSE) 1H5F ; 1.60 ; X-RAY INDUCED REDUCTION OF HORSERADISH PEROXIDASE C1A COMPOUND III (22-33% DOSE) 1H5G ; 1.57 ; X-RAY INDUCED REDUCTION OF HORSERADISH PEROXIDASE C1A COMPOUND III (33-44% DOSE) 1H5H ; 1.60 ; X-RAY INDUCED REDUCTION OF HORSERADISH PEROXIDASE C1A COMPOUND III (44-56% DOSE) 1H5I ; 1.60 ; X-RAY INDUCED REDUCTION OF HORSERADISH PEROXIDASE C1A COMPOUND III (56-67% DOSE) 1H5J ; 1.60 ; X-RAY INDUCED REDUCTION OF HORSERADISH PEROXIDASE C1A COMPOUND III (67-78% DOSE) 1H5K ; 1.60 ; X-RAY INDUCED REDUCTION OF HORSERADISH PEROXIDASE C1A COMPOUND III (78-89% DOSE) 1H5L ; 1.60 ; X-RAY INDUCED REDUCTION OF HORSERADISH PEROXIDASE C1A COMPOUND III (89-100% DOSE) 1QNY ; 1.80 ; X-RAY REFINEMENT OF D2O SOAKED CRYSTAL OF CONCANAVALIN A 1QI9 ; 2.05 ; X-RAY SIRAS STRUCTURE DETERMINATION OF A VANADIUM-DEPENDENT HALOPEROXIDASE FROM ASCOPHYLLUM NODOSUM AT 2.0 A RESOLUTION 1WQY ; 2.00 ; X-RAY STRUCTURAL ANALYSIS OF B-DEOXYRIBONUCLEIC ACID DECAMER D(CCATTAATGG)2 CRYSTAL GROWN IN D2O SOLUTION 2BE4 ; 2.10 ; X-RAY STRUCTURE AN EF-HAND PROTEIN FROM DANIO RERIO DR.36843 1AR4 ; 1.90 ; X-RAY STRUCTURE ANALYSIS OF THE CAMBIALISTIC SUPEROXIDE DISMUTASE FROM PROPIONIBACTERIUM SHERMANII ACTIVE WITH FE OR MN 1JRQ ; 2.15 ; X-RAY STRUCTURE ANALYSIS OF THE ROLE OF THE CONSERVED TYROSINE-369 IN ACTIVE SITE OF E. COLI AMINE OXIDASE 1XBF ; 2.00 ; X-RAY STRUCTURE NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET CAR10 FROM C. ACETOBUTYLICUM 1YV7 ; 1.90 ; X-RAY STRUCTURE OF (C87S,DES103-104) ONCONASE 1LO7 ; 1.50 ; X-RAY STRUCTURE OF 4-HYDROXYBENZOYL COA THIOESTERASE COMPLEXED WITH 4-HYDROXYPHENACYL COA 1B4E ; 2.00 ; X-RAY STRUCTURE OF 5-AMINOLEVULINIC ACID DEHYDRATASE COMPLEXED WITH THE INHIBITOR LEVULINIC ACID. 1PGJ ; 2.80 ; X-RAY STRUCTURE OF 6-PHOSPHOGLUCONATE DEHYDROGENASE FROM THE PROTOZOAN PARASITE T. BRUCEI 1YAI ; 1.90 ; X-RAY STRUCTURE OF A BACTERIAL COPPER,ZINC SUPEROXIDE DISMUTASE 1DDZ ; 2.20 ; X-RAY STRUCTURE OF A BETA-CARBONIC ANHYDRASE FROM THE RED ALGA, PORPHYRIDIUM PURPUREUM R-1 1HAU ; 1.90 ; X-RAY STRUCTURE OF A BLUE COPPER NITRITE REDUCTASE AT HIGH PH AND IN COPPER FREE FORM AT 1.9A RESOLUTION 1HAW ; 1.90 ; X-RAY STRUCTURE OF A BLUE COPPER NITRITE REDUCTASE AT HIGH PH AND IN COPPER FREE FORM AT 1.9A RESOLUTION 1QUF ; 2.25 ; X-RAY STRUCTURE OF A COMPLEX NADP+-FERREDOXIN:NADP+ REDUCTASE FROM THE CYANOBACTERIUM ANABAENA PCC 7119 AT 2.25 ANGSTROMS 1JMT ; 2.20 ; X-RAY STRUCTURE OF A CORE U2AF65/U2AF35 HETERODIMER 2BDU ; 2.35 ; X-RAY STRUCTURE OF A CYTOSOLIC 5'-NUCLEOTIDASE III FROM MUS MUSCULUS MM.158936 2BH9 ; 2.50 ; X-RAY STRUCTURE OF A DELETION VARIANT OF HUMAN GLUCOSE 6- PHOSPHATE DEHYDROGENASE COMPLEXED WITH STRUCTURAL AND COENZYME NADP 2A33 ; 1.95 ; X-RAY STRUCTURE OF A LYSINE DECARBOXYLASE-LIKE PROTEIN FROM ARABIDOPSIS THALIANA GENE AT2G37210 1YDH ; 2.15 ; X-RAY STRUCTURE OF A LYSINE DECARBOXYLASE-LIKE PROTEIN FROM ARABIDOPSIS THALIANA GENE AT5G11950 1KU9 ; 2.80 ; X-RAY STRUCTURE OF A METHANOCOCCUS JANNASCHII DEOXYRIBONUCLEIC ACID-BINDING PROTEIN: IMPLICATIONS FOR ANTIBIOTIC RESISTANCE IN STAPHYLOCOCCUS AUREUS 1G4K ; 2.00 ; X-RAY STRUCTURE OF A NOVEL MATRIX METALLOPROTEINASE INHIBITOR COMPLEXED TO STROMELYSIN 2BMM ; 2.48 ; X-RAY STRUCTURE OF A NOVEL THERMOSTABLE HEMOGLOBIN FROM THE ACTINOBACTERIUM THERMOBIFIDA FUSCA 1APA ; 2.30 ; X-RAY STRUCTURE OF A POKEWEED ANTIVIRAL PROTEIN, CODED BY A NEW GENOMIC CLONE, AT 0.23 NM RESOLUTION. A MODEL STRUCTURE PROVIDES A SUITABLE ELECTROSTATIC FIELD FOR SUBSTRATE BINDING. 2ACA ; 2.25 ; X-RAY STRUCTURE OF A PUTATIVE ADENYLATE CYCLASE Q87NV8 FROM VIBRIO PARAHAEMOLYTICUS AT THE 2.25 A RESOLUTION. NORTHEAST STRUCTURAL GENOMICS TARGET VPR19. 1XRI ; 3.30 ; X-RAY STRUCTURE OF A PUTATIVE PHOSPHOPROTEIN PHOSPHATASE FROM ARABIDOPSIS THALIANA GENE AT1G05000 1XCB ; 2.90 ; X-RAY STRUCTURE OF A REX-FAMILY REPRESSOR/NADH COMPLEX FROM THERMUS AQUATICUS 1QM7 ; 2.10 ; X-RAY STRUCTURE OF A THREE-FINGERED CHIMERIC PROTEIN, STABILITY OF A STRUCTURAL SCAFFOLD 1BU2 ; 3.00 ; X-RAY STRUCTURE OF A VIRAL CYCLIN FROM HERPESVIRUS SAIMIRI 1ORQ ; 3.20 ; X-RAY STRUCTURE OF A VOLTAGE-DEPENDENT POTASSIUM CHANNEL IN COMPLEX WITH AN FAB 1WOE ; 1.50 ; X-RAY STRUCTURE OF A Z-DEOXYRIBONUCLEIC ACID HEXAMER D(CGCGCG) 2B8Q ; 2.50 ; X-RAY STRUCTURE OF ACANTHAMOEBA PLOYPHAGA MIMIVIRUS NUCLEOSIDE DIPHOSPHATE KINASE COMPLEXED WITH TDP 1ESW ; 1.90 ; X-RAY STRUCTURE OF ACARBOSE BOUND TO AMYLOMALTASE FROM THERMUS AQUATICUS. IMPLICATIONS FOR THE SYNTHESIS OF LARGE CYCLIC GLUCANS 1I9B ; 2.70 ; X-RAY STRUCTURE OF ACETYLCHOLINE BINDING PROTEIN (ACHBP) 1UX2 ; 2.20 ; X-RAY STRUCTURE OF ACETYLCHOLINE BINDING PROTEIN (ACHBP) 1UV6 ; 2.50 ; X-RAY STRUCTURE OF ACETYLCHOLINE BINDING PROTEIN (ACHBP) IN COMPLEX WITH CARBAMYLCHOLINE 1UW6 ; 2.20 ; X-RAY STRUCTURE OF ACETYLCHOLINE BINDING PROTEIN (ACHBP) IN COMPLEX WITH NICOTINE 1OZ6 ; 2.60 ; X-RAY STRUCTURE OF ACIDIC PHOSPHOLIPASE A2 FROM INDIAN SAW- SCALED VIPER (ECHIS CARINATUS) WITH A POTENT PLATELET AGGREGATION INHIBITORY ACTIVITY 2A3L ; 3.34 ; X-RAY STRUCTURE OF ADENOSINE 5'-MONOPHOSPHATE DEAMINASE FROM ARABIDOPSIS THALIANA IN COMPLEX WITH COFORMYCIN 5'- PHOSPHATE 2DFP ; 2.30 ; X-RAY STRUCTURE OF AGED DI-ISOPROPYL-PHOSPHORO-FLUORIDATE (DFP) BOUND TO ACETYLCHOLINESTERASE 1Y1P ; 1.60 ; X-RAY STRUCTURE OF ALDEHYDE REDUCTASE WITH NADPH 1ZEB ; 1.90 ; X-RAY STRUCTURE OF ALKALINE PHOSPHATASE FROM HUMAN PLACENTA IN COMPLEX WITH 5'-AMP 1ZVC ; 1.79 ; X-RAY STRUCTURE OF ALLENE OXIDE CYCLASE FROM ARABIDOPSIS THALIANA AT3G25760 1Z8K ; 1.71 ; X-RAY STRUCTURE OF ALLENE OXIDE CYCLASE FROM ARABIDOPSIS THALIANA AT3G25770 2AJA ; 2.80 ; X-RAY STRUCTURE OF AN ANKYRIN REPEAT FAMILY PROTEIN Q5ZSV0 FROM LEGIONELLA PNEUMOPHILA. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET LGR21. 1KG8 ; 2.00 ; X-RAY STRUCTURE OF AN EARLY-M INTERMEDIATE OF BACTERIORHODOPSIN 1YCN ; 2.51 ; X-RAY STRUCTURE OF ANNEXIN FROM ARABIDOPSIS THALIANA GENE AT1G35720 2BGK ; 1.60 ; X-RAY STRUCTURE OF APO-SECOISOLARICIRESINOL DEHYDROGENASE 1O82 ; 1.46 ; X-RAY STRUCTURE OF BACTERIOCIN AS-48 AT PH 4.5. SULPHATE BOUND FORM 1AP9 ; 2.35 ; X-RAY STRUCTURE OF BACTERIORHODOPSIN FROM MICROCRYSTALS GROWN IN LIPIDIC CUBIC PHASES 1QHJ ; 1.90 ; X-RAY STRUCTURE OF BACTERIORHODOPSIN GROWN IN LIPIDIC CUBIC PHASES 1MAZ ; 2.20 ; X-RAY STRUCTURE OF BCL-XL, AN INHIBITOR OF PROGRAMMED CELL DEATH 1BIK ; 2.50 ; X-RAY STRUCTURE OF BIKUNIN FROM THE HUMAN INTER-ALPHA-INHIBITOR COMPLEX 2BGL ; 2.80 ; X-RAY STRUCTURE OF BINARY-SECOISOLARICIRESINOL DEHYDROGENASE 1WBE ; 1.36 ; X-RAY STRUCTURE OF BOVINE GLTP 1R5D ; 2.50 ; X-RAY STRUCTURE OF BOVINE SEMINAL RIBONUCLEASE SWAPPING DIMER FROM A NEW CRYSTAL FORM 1LJU ; 1.40 ; X-RAY STRUCTURE OF C15A ARSENATE REDUCTASE FROM PI258 COMPLEXED WITH ARSENITE 1QX2 ; 1.44 ; X-RAY STRUCTURE OF CALCIUM-LOADED CALBINDOMODULIN (A CALBINDIN D9K RE-ENGINEERED TO UNDERGO A CONFORMATIONAL OPENING) AT 1.44 A RESOLUTION 2F6L ; 1.70 ; X-RAY STRUCTURE OF CHORISMATE MUTASE FROM MYCOBACTERIUM TUBERCULOSIS 1XX6 ; 2.00 ; X-RAY STRUCTURE OF CLOSTRIDIUM ACETOBUTYLICUM THYMIDINE KINASE WITH ADP. NORTHEAST STRUCTURAL GENOMICS TARGET CAR26. 2BFU ; 4.00 ; X-RAY STRUCTURE OF CPMV TOP COMPONENT 1YLW ; 1.74 ; X-RAY STRUCTURE OF CTX-M-16 BETA-LACTAMASE 1RTE ; 2.00 ; X-RAY STRUCTURE OF CYANIDE DERIVATIVE OF TRUNCATED HEMOGLOBIN N (TRHBN) FROM MYCOBACTERIUM TUBERCULOSIS 2ATF ; 1.75 ; X-RAY STRUCTURE OF CYSTEINE DIOXYGENASE TYPE I FROM MUS MUSCULUS MM.241056 2EXR ; 1.70 ; X-RAY STRUCTURE OF CYTOKININ OXIDASE/DEHYDROGENASE (CKX) FROM ARABIDOPSIS THALIANA AT5G21482 1T3H ; 2.50 ; X-RAY STRUCTURE OF DEPHOSPHO-COA KINASE FROM E. COLI NORTEAST STRUCTURAL GENOMICS CONSORTIUM TARGET ER57 1KTJ ; 2.15 ; X-RAY STRUCTURE OF DER P 2, THE MAJOR HOUSE DUST MITE ALLERGEN 1NFV ; 1.95 ; X-RAY STRUCTURE OF DESULFOVIBRIO DESULFURICANS BACTERIOFERRITIN: THE DIIRON CENTRE IN DIFFERENT CATALYTIC STATES (AS-ISOLATED STRUCTURE) 1XLU ; 2.20 ; X-RAY STRUCTURE OF DI-ISOPROPYL-PHOSPHORO-FLUORIDATE (DFP) INHIBITED BUTYRYLCHOLINESTERASE AFTER AGING 1FQ8 ; 2.80 ; X-RAY STRUCTURE OF DIFLUOROSTATINE INHIBITOR CP81,198 BOUND TO SACCHAROPEPSIN 1UVH ; 2.80 ; X-RAY STRUCTURE OF DPS FROM MYCOBACTERIUM SMEGMATIS 1SQH ; 2.00 ; X-RAY STRUCTURE OF DROSOPHILA MALONOGASTER PROTEIN Q9VR51 NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET FR87. 1T3B ; 2.50 ; X-RAY STRUCTURE OF DSBC FROM HAEMOPHILUS INFLUENZAE 1OY1 ; 2.95 ; X-RAY STRUCTURE OF ELBB FROM E. COLI. NORTHEAST STRUCTURAL GENOMICS RESEARCH CONSORTIUM (NESG) TARGET ER105 1XQC ; 2.05 ; X-RAY STRUCTURE OF ERALPHA LBD BOUND TO A TETRAHYDROISOQUINOLINE SERM LIGAND AT 2.05A RESOLUTION 1XB7 ; 2.50 ; X-RAY STRUCTURE OF ERRALPHA LBD IN COMPLEX WITH A PGC- 1ALPHA PEPTIDE AT 2.5A RESOLUTION 1DFI ; 2.09 ; X-RAY STRUCTURE OF ESCHERICHIA COLI ENOYL REDUCTASE WITH BOUND NAD 1DFG ; 2.50 ; X-RAY STRUCTURE OF ESCHERICHIA COLI ENOYL REDUCTASE WITH BOUND NAD AND BENZO-DIAZABORINE 1DFH ; 2.20 ; X-RAY STRUCTURE OF ESCHERICHIA COLI ENOYL REDUCTASE WITH BOUND NAD AND THIENO-DIAZABORINE 1DNL ; 1.80 ; X-RAY STRUCTURE OF ESCHERICHIA COLI PYRIDOXINE 5'-PHOSPHATE OXIDASE COMPLEXED WITH FMN AT 1.8 ANGSTROM RESOLUTION 1G76 ; 2.20 ; X-RAY STRUCTURE OF ESCHERICHIA COLI PYRIDOXINE 5'-PHOSPHATE OXIDASE COMPLEXED WITH PYRIDOXAL 5'-PHOSPHATE AT 2.0 A RESOLUTION 1G78 ; 2.20 ; X-RAY STRUCTURE OF ESCHERICHIA COLI PYRIDOXINE 5'-PHOSPHATE OXIDASE COMPLEXED WITH PYRIDOXAL 5'-PHOSPHATE AT 2.0 A RESOLUTION 1G79 ; 2.00 ; X-RAY STRUCTURE OF ESCHERICHIA COLI PYRIDOXINE 5'-PHOSPHATE OXIDASE COMPLEXED WITH PYRIDOXAL 5'-PHOSPHATE AT 2.0 A RESOLUTION 1WV4 ; 2.60 ; X-RAY STRUCTURE OF ESCHERICHIA COLI PYRIDOXINE 5'-PHOSPHATE OXIDASE IN TETRAGONAL CRYSTAL FORM 1G77 ; 2.10 ; X-RAY STRUCTURE OF ESCHERICHIA COLI PYRIDOXINE 5`-PHOSPHATE OXIDASE COMPLEXED WITH PYRIDOXAL 5'-PHOSPHATE AT 2.0 A RESOLUTION 1ZW5 ; 2.30 ; X-RAY STRUCTURE OF FARNESYL DIPHOSPHATE SYNTHASE PROTEIN 2BGV ; 1.90 ; X-RAY STRUCTURE OF FERRIC CYTOCHROME C-550 FROM PARACOCCUS VERSUTUS 1HM6 ; 1.80 ; X-RAY STRUCTURE OF FULL-LENGTH ANNEXIN 1 1L7J ; 1.90 ; X-RAY STRUCTURE OF GALACTOSE MUTAROTASE FROM LACTOCOCCUS LACTIS (APO) 1L7K ; 1.95 ; X-RAY STRUCTURE OF GALACTOSE MUTAROTASE FROM LACTOCOCCUS LACTIS COMPLEXED WITH GALACTOSE 1Z84 ; 1.83 ; X-RAY STRUCTURE OF GALT-LIKE PROTEIN FROM ARABIDOPSIS THALIANA AT5G18200 1ZWJ ; 2.30 ; X-RAY STRUCTURE OF GALT-LIKE PROTEIN FROM ARABIDOPSIS THALIANA AT5G18200 1XMT ; 1.15 ; X-RAY STRUCTURE OF GENE PRODUCT FROM ARABIDOPSIS THALIANA AT1G77540 1XFI ; 1.70 ; X-RAY STRUCTURE OF GENE PRODUCT FROM ARABIDOPSIS THALIANA AT2G17340 1XYG ; 2.19 ; X-RAY STRUCTURE OF GENE PRODUCT FROM ARABIDOPSIS THALIANA AT2G19940 1VM0 ; 1.80 ; X-RAY STRUCTURE OF GENE PRODUCT FROM ARABIDOPSIS THALIANA AT2G34160 1Z90 ; 1.86 ; X-RAY STRUCTURE OF GENE PRODUCT FROM ARABIDOPSIS THALIANA AT3G03250, A PUTATIVE UDP-GLUCOSE PYROPHOSPHORYLASE 2F2G ; 2.10 ; X-RAY STRUCTURE OF GENE PRODUCT FROM ARABIDOPSIS THALIANA AT3G16990 1Y0Z ; 2.40 ; X-RAY STRUCTURE OF GENE PRODUCT FROM ARABIDOPSIS THALIANA AT3G21360 1VK5 ; 1.60 ; X-RAY STRUCTURE OF GENE PRODUCT FROM ARABIDOPSIS THALIANA AT3G22680 1YDW ; 2.49 ; X-RAY STRUCTURE OF GENE PRODUCT FROM ARABIDOPSIS THALIANA AT4G09670 1XQ6 ; 1.80 ; X-RAY STRUCTURE OF GENE PRODUCT FROM ARABIDOPSIS THALIANA AT5G02240 1VK0 ; 2.10 ; X-RAY STRUCTURE OF GENE PRODUCT FROM ARABIDOPSIS THALIANA AT5G06450 1VKP ; 1.53 ; X-RAY STRUCTURE OF GENE PRODUCT FROM ARABIDOPSIS THALIANA AT5G08170, AGMATINE IMINOHYDROLASE 1XY7 ; 1.80 ; X-RAY STRUCTURE OF GENE PRODUCT FROM ARABIDOPSIS THALIANA AT5G48480 1ZTP ; 2.50 ; X-RAY STRUCTURE OF GENE PRODUCT FROM HOMO SAPIENS HS.433573 2AB1 ; 2.59 ; X-RAY STRUCTURE OF GENE PRODUCT FROM HOMO SAPIENS HS.95870 1IHC ; 1.90 ; X-RAY STRUCTURE OF GEPHYRIN N-TERMINAL DOMAIN 1OKT ; 1.90 ; X-RAY STRUCTURE OF GLUTATHIONE S-TRANSFERASE FROM THE MALARIAL PARASITE PLASMODIUM FALCIPARUM 1FQ6 ; 2.70 ; X-RAY STRUCTURE OF GLYCOL INHIBITOR PD-133,450 BOUND TO SACCHAROPEPSIN 1XM8 ; 1.74 ; X-RAY STRUCTURE OF GLYOXALASE II FROM ARABIDOPSIS THALIANA GENE AT2G31350 1TIY ; 2.50 ; X-RAY STRUCTURE OF GUANINE DEAMINASE FROM BACILLUS SUBTILIS NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET SR160 1WTM ; 1.33 ; X-RAY STRUCTURE OF HEW LYSOZYME ORTHORHOMBIC CRYSTAL FORMED IN THE EARTH'S MAGNETIC FIELD 1SAW ; 2.20 ; X-RAY STRUCTURE OF HOMO SAPIENS PROTEIN FLJ36880 1Y7V ; 2.40 ; X-RAY STRUCTURE OF HUMAN ACID-BETA-GLUCOSIDASE COVALENTLY BOUND TO CONDURITOL B EPOXIDE 1IW2 ; 1.90 ; X-RAY STRUCTURE OF HUMAN COMPLEMENT PROTEIN C8GAMMA AT PH7.O 1QYM ; 2.80 ; X-RAY STRUCTURE OF HUMAN GANKYRIN 1QKI ; 3.00 ; X-RAY STRUCTURE OF HUMAN GLUCOSE 6-PHOSPHATE DEHYDROGENASE (VARIANT CANTON R459L) COMPLEXED WITH STRUCTURAL NADP+ 2BHL ; 2.90 ; X-RAY STRUCTURE OF HUMAN GLUCOSE-6-PHOSPHATE DEHYDROGENASE (DELETION VARIANT) COMPLEXED WITH GLUCOSE-6-PHOSPHATE 2A2C ; 1.65 ; X-RAY STRUCTURE OF HUMAN N-ACETYL GALACTOSAMINE KINASE COMPLEXED WITH MG-ADP AND N-ACETYL GALACTOSAMINE 1- PHOSPHATE 2A2D ; 2.20 ; X-RAY STRUCTURE OF HUMAN N-ACETYL GALACTOSAMINE KINASE COMPLEXED WITH MN-AMPPNP AND N-ACETYL GLACTOSAMINE 1UCN ; 2.00 ; X-RAY STRUCTURE OF HUMAN NUCLEOSIDE DIPHOSPHATE KINASE A COMPLEXED WITH ADP AT 2 A RESOLUTION 1QNT ; 1.90 ; X-RAY STRUCTURE OF HUMAN O6ALKYLGUANINE-DEOXYRIBONUCLEIC ACID ALKYLTRANSFERASE 2AMY ; 2.09 ; X-RAY STRUCTURE OF HUMAN PHOSPHOMANNOMUTASE 2 (PMM2) 1TVG ; 1.60 ; X-RAY STRUCTURE OF HUMAN PP25 GENE PRODUCT, HSPC034. NORTHEAST STRUCTURAL GENOMICS TARGET HR1958. 1SU3 ; 2.20 ; X-RAY STRUCTURE OF HUMAN PROMMP-1: NEW INSIGHTS INTO COLLAGENASE ACTION 1Z7X ; 1.95 ; X-RAY STRUCTURE OF HUMAN RIBONUCLEASE INHIBITOR COMPLEXED WITH RIBONUCLEASE I 1AGN ; 3.00 ; X-RAY STRUCTURE OF HUMAN SIGMA ALCOHOL DEHYDROGENASE 1B8Y ; 2.00 ; X-RAY STRUCTURE OF HUMAN STROMELYSIN CATALYTIC DOMAIN COMPLEXED WITH NON-PEPTIDE INHIBITORS: IMPLICATIONS FOR INHIBITOR SELECTIVITY 1CAQ ; 1.80 ; X-RAY STRUCTURE OF HUMAN STROMELYSIN CATALYTIC DOMAIN COMPLEXES WITH NON-PEPTIDE INHIBITORS: IMPLICATION FOR INHIBITOR SELECTIVITY 1CIZ ; 1.64 ; X-RAY STRUCTURE OF HUMAN STROMELYSIN CATALYTIC DOMAIN COMPLEXES WITH NON-PEPTIDE INHIBITORS: IMPLICATION FOR INHIBITOR SELECTIVITY 2BJN ; 1.70 ; X-RAY STRUCTURE OF HUMAN TPC6 1FGJ ; 2.80 ; X-RAY STRUCTURE OF HYDROXYLAMINE OXIDOREDUCTASE 1PG6 ; 1.70 ; X-RAY STRUCTURE OF HYPOTHETICAL PROTEIN SPYM3_0169 FROM STREPTOCOCCUS PYOGENES, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET DR2 2AJ2 ; 3.21 ; X-RAY STRUCTURE OF HYPOTHETICAL PROTEIN VC0467 FROM VIBRIO CHOLERAE: NEW FOLD. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET VCR8. 1XMB ; 2.00 ; X-RAY STRUCTURE OF IAA-AMINOACID HYDROLASE FROM ARABIDOPSIS THALIANA GENE AT5G56660 1FQ7 ; 2.80 ; X-RAY STRUCTURE OF INHIBITOR CP-72,647 BOUND TO SACCHAROPEPSIN 1LW5 ; 2.05 ; X-RAY STRUCTURE OF L-THREONINE ALDOLASE (LOW-SPECIFICITY) IN COMPLEX WITH GLYCINE 1LW4 ; 1.90 ; X-RAY STRUCTURE OF L-THREONINE ALDOLASE (LOW-SPECIFICITY) IN COMPLEX WITH L-ALLO-THREONINE 1IF2 ; 2.00 ; X-RAY STRUCTURE OF LEISHMANIA MEXICANA TRIOSEPHOSPHATE ISOMERASE COMPLEXED WITH IPP 2B6P ; 2.40 ; X-RAY STRUCTURE OF LENS AQUAPORIN-0 (AQP0) (LENS MIP) IN AN OPEN PORE STATE 1XUO ; 1.80 ; X-RAY STRUCTURE OF LFA-1 I-DOMAIN BOUND TO A 1,4-DIAZEPANE- 2,5-DIONE INHIBITOR AT 1.8A RESOLUTION 1XDD ; 2.20 ; X-RAY STRUCTURE OF LFA-1 I-DOMAIN IN COMPLEX WITH LFA703 AT 2.2A RESOLUTION 1XDG ; 2.10 ; X-RAY STRUCTURE OF LFA-1 I-DOMAIN IN COMPLEX WITH LFA878 AT 2.1A RESOLUTION 1YV4 ; 1.51 ; X-RAY STRUCTURE OF M23L ONCONASE AT 100K 1YV6 ; 1.78 ; X-RAY STRUCTURE OF M23L ONCONASE AT 298K 1D2F ; 2.50 ; X-RAY STRUCTURE OF MALY FROM ESCHERICHIA COLI: A PYRIDOXAL- 5'-PHOSPHATE-DEPENDENT ENZYME ACTING AS A MODULATOR IN MAL GENE EXPRESSION 1IK4 ; 2.00 ; X-RAY STRUCTURE OF METHYLGLYOXAL SYNTHASE FROM E. COLI COMPLEXED WITH PHOSPHOGLYCOLOHYDROXAMIC ACID 1Q6W ; 2.81 ; X-RAY STRUCTURE OF MONOAMINE OXIDASE REGULATORY PROTEIN FROM ARCHAEOGLOBUS FULGIUS 135L ; 1.30 ; X-RAY STRUCTURE OF MONOCLINIC TURKEY EGG LYSOZYME AT 1.3 ANGSTROMS RESOLUTION 1LXN ; 2.30 ; X-RAY STRUCTURE OF MTH1187 NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET TT272 1FF4 ; 1.50 ; X-RAY STRUCTURE OF MUSCARINIC TOXIN 2 AT 1.5 ANGSTROM RESOLUTION 1ZZE ; 1.80 ; X-RAY STRUCTURE OF NADPH-DEPENDENT CARBONYL REDUCTASE FROM SPOROBOLOMYCES SALMONICOLOR 1M22 ; 1.40 ; X-RAY STRUCTURE OF NATIVE PEPTIDE AMIDASE FROM STENOTROPHOMONAS MALTOPHILIA AT 1.4 A 1JFB ; 1.00 ; X-RAY STRUCTURE OF NITRIC OXIDE REDUCTASE (CYTOCHROME P450NOR) IN THE FERRIC RESTING STATE AT ATOMIC RESOLUTION 1JFC ; 1.05 ; X-RAY STRUCTURE OF NITRIC OXIDE REDUCTASE (CYTOCHROME P450NOR) IN THE FERROUS CO STATE AT ATOMIC RESOLUTION 1XSR ; 2.80 ; X-RAY STRUCTURE OF NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET SFR7 1TZA ; 2.40 ; X-RAY STRUCTURE OF NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET SOR45 1TO0 ; 2.50 ; X-RAY STRUCTURE OF NORTHEAST STRUCTURAL GENOMICS TARGET PROTEIN SR145 FROM BACILLUS SUBTILIS 1TTZ ; 2.11 ; X-RAY STRUCTURE OF NORTHEAST STRUCTURAL GENOMICS TARGET PROTEIN XCR50 FROM X. CAMPESTRIS 1YDM ; 2.50 ; X-RAY STRUCTURE OF NORTHEAST STRUCTURAL GENOMICS TARGET SR44 2AJL ; 2.50 ; X-RAY STRUCTURE OF NOVEL BIARYL-BASED DIPEPTIDYL PEPTIDASE IV INHIBITOR 1KCX ; 2.12 ; X-RAY STRUCTURE OF NYSGRC TARGET T-45 1SJA ; 2.30 ; X-RAY STRUCTURE OF O-SUCCINYLBENZOATE SYNTHASE COMPLEXED WITH N-ACETYLMETHIONINE 1SJC ; 2.10 ; X-RAY STRUCTURE OF O-SUCCINYLBENZOATE SYNTHASE COMPLEXED WITH N-SUCCINYL METHIONINE 1SJD ; 1.87 ; X-RAY STRUCTURE OF O-SUCCINYLBENZOATE SYNTHASE COMPLEXED WITH N-SUCCINYL PHENYLGLYCINE 1SJB ; 2.20 ; X-RAY STRUCTURE OF O-SUCCINYLBENZOATE SYNTHASE COMPLEXED WITH O-SUCCINYLBENZOIC ACID 1JFV ; 2.00 ; X-RAY STRUCTURE OF OXIDISED C10S, C15A ARSENATE REDUCTASE FROM PI258 1X8M ; 2.60 ; X-RAY STRUCTURE OF PECTIN DEGRADING ENZYME 5-KETO 4- DEOXYURONATE ISOMERASE FROM ESCHERICHIA COLI 1ZY1 ; 3.00 ; X-RAY STRUCTURE OF PEPTIDE DEFORMYLASE FROM ARABIDOPSIS THALIANA (ATPDF1A) IN COMPLEX WITH MET-ALA-SER 1ZXZ ; 2.80 ; X-RAY STRUCTURE OF PEPTIDE DEFORMYLASE FROM ARABIDOPSIS THALIANA (ATPDF1A); CRYSTALS GROWN IN PEG-5000 MME AS PRECIPITANT 1ZY0 ; 2.90 ; X-RAY STRUCTURE OF PEPTIDE DEFORMYLASE FROM ARABIDOPSIS THALIANA (ATPDF1A); CRYSTALS GROWN IN PEG-6000 1W74 ; 2.60 ; X-RAY STRUCTURE OF PEPTIDYL-PROLYL CIS-TRANS ISOMERASE A, PPIA, RV0009, FROM MYCOBACTERIUM TUBERCULOSIS. 1RTW ; 2.35 ; X-RAY STRUCTURE OF PF1337, A TENA HOMOLOGUE FROM PYROCOCCUS FURIOSUS. NORTHEAST STRUCTURAL GENOMICS RESEARCH CONSORTIUM (NESG) TARGET PFR34 1P6B ; 1.90 ; X-RAY STRUCTURE OF PHOSPHOTRIESTERASE, TRIPLE MUTANT H254G/H257W/L303T 2A13 ; 1.32 ; X-RAY STRUCTURE OF PROTEIN FROM ARABIDOPSIS THALIANA AT1G79260 2APJ ; 1.60 ; X-RAY STRUCTURE OF PROTEIN FROM ARABIDOPSIS THALIANA AT4G34215 AT 1.6 ANGSTROM RESOLUTION 1ZXU ; 1.70 ; X-RAY STRUCTURE OF PROTEIN FROM ARABIDOPSIS THALIANA AT5G01750 2A3Q ; 2.32 ; X-RAY STRUCTURE OF PROTEIN FROM MUS MUSCULUS MM.29898 1ZA0 ; 2.00 ; X-RAY STRUCTURE OF PUTATIVE ACYL-ACP DESATURASE DESA2 FROM MYCOBACTERIUM TUBERCULOSIS H37RV 2EWO ; 2.90 ; X-RAY STRUCTURE OF PUTATIVE AGMATINE DEIMINASE Q8DW17, NORTHEAST STRUCTURAL GENOMICS TARGET SMR6. 1YVI ; 2.00 ; X-RAY STRUCTURE OF PUTATIVE HISTIDINE-CONTAINING PHOSPHOTRANSFER PROTEIN FROM RICE, AK104879 1XW8 ; 2.00 ; X-RAY STRUCTURE OF PUTATIVE LACTAM UTILIZATION PROTEIN YBGL. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET ET90. 1XQ1 ; 2.10 ; X-RAY STRUCTURE OF PUTATIVE TROPINONE REDUCATSE FROM ARABIDOPSIS THALIANA GENE AT1G07440 2AFC ; 2.50 ; X-RAY STRUCTURE OF Q8A8B0 HYPOTHETICAL PROTEIN FROM BACTEROIDES THETAIOTAOMICRON . NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET BTR9. 1QYI ; 2.50 ; X-RAY STRUCTURE OF Q8NW41 NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET ZR25. 1JF8 ; 1.12 ; X-RAY STRUCTURE OF REDUCED C10S, C15A ARSENATE REDUCTASE FROM PI258 1YBM ; 2.10 ; X-RAY STRUCTURE OF SELENOMETHIONYL GENE PRODUCT FROM ARABIDOPSIS THALIANA AT5G02240 IN SPACE GROUP P21212 1NPD ; 2.30 ; X-RAY STRUCTURE OF SHIKIMATE DEHYDROGENASE COMPLEXED WITH NAD+ FROM E.COLI (YDIB) NORTHEAST STRUCTURAL GENOMICS RESEARCH CONSORTIUM (NESG) TARGET ER24 1XJ5 ; 2.70 ; X-RAY STRUCTURE OF SPERMIDINE SYNTHASE FROM ARABIDOPSIS THALIANA GENE AT1G23820 2F5I ; 2.30 ; X-RAY STRUCTURE OF SPERMIDINE/SPERMINE N1-ACETYLTRANSFERASE (SAT) FROM HOMO SAPIENS 2BCO ; 2.33 ; X-RAY STRUCTURE OF SUCCINYLGLUTAMATE DESUCCINALASE FROM VIBRIO PARAHAEMOLYTICUS (RIMD 2210633) AT THE RESOLUTION 2.3 A, NORTHEAST STRUCTURAL GENOMICS TARGET VPR14 1MZG ; 2.00 ; X-RAY STRUCTURE OF SUFE FROM E.COLI NORTHEAST STRUCTURAL GENOMICS (NESG) CONSORTIUM TARGET ER30 2BBH ; 1.85 ; X-RAY STRUCTURE OF T.MARITIMA CORA SOLUBLE DOMAIN 2BGM ; 2.00 ; X-RAY STRUCTURE OF TERNARY-SECOISOLARICIRESINOL DEHYDROGENASE 1WV5 ; 2.30 ; X-RAY STRUCTURE OF THE A-DECAMER GCGTATACGC WITH A SINGLE 2'-O-BUTYL THYMINE IN PLACE OF T6, MG-FORM 1WV6 ; 2.55 ; X-RAY STRUCTURE OF THE A-DECAMER GCGTATACGC WITH A SINGLE 2'-O-BUTYL THYMINE IN PLACE OF T6, SR-FORM 1BRR ; 2.90 ; X-RAY STRUCTURE OF THE BACTERIORHODOPSIN TRIMER/LIPID COMPLEX 1EUV ; 1.60 ; X-RAY STRUCTURE OF THE C-TERMINAL ULP1 PROTEASE DOMAIN IN COMPLEX WITH SMT3, THE YEAST ORTHOLOG OF SUMO. 1P5V ; 1.70 ; X-RAY STRUCTURE OF THE CAF1M:CAF1 CHAPERONE:SUBUNIT PREASSEMBLY COMPLEX 1AR5 ; 1.60 ; X-RAY STRUCTURE OF THE CAMBIALISTIC SUPEROXIDE DISMUTASE FROM PROPIONIBACTERIUM SHERMANII ACTIVE WITH FE OR MN 1KD8 ; 1.90 ; X-RAY STRUCTURE OF THE COILED COIL GCN4 ACID BASE HETERODIMER ACID-D12IA16V BASE-D12LA16L 1KDD ; 2.14 ; X-RAY STRUCTURE OF THE COILED COIL GCN4 ACID BASE HETERODIMER ACID-D12LA16I BASE-D12LA16L 1KD9 ; 2.10 ; X-RAY STRUCTURE OF THE COILED COIL GCN4 ACID BASE HETERODIMER ACID-D12LA16L BASE-D12LA16L 1HG1 ; 1.80 ; X-RAY STRUCTURE OF THE COMPLEX BETWEEN ERWINIA CHRYSANTHEMI L-ASPARAGINASE AND D-ASPARTATE 1HFW ; 1.80 ; X-RAY STRUCTURE OF THE COMPLEX BETWEEN ERWINIA CHRYSANTHEMI L-ASPARAGINASE AND L-GLUTAMATE 1HG0 ; 1.90 ; X-RAY STRUCTURE OF THE COMPLEX BETWEEN ERWINIA CHRYSANTHEMI L-ASPARAGINASE AND SUCCINIC ACID 1R5C ; 2.10 ; X-RAY STRUCTURE OF THE COMPLEX OF BOVINE SEMINAL RIBONUCLEASE SWAPPING DIMER WITH D(CPA) 1BHX ; 2.30 ; X-RAY STRUCTURE OF THE COMPLEX OF HUMAN ALPHA THROMBIN WITH THE INHIBITOR SDZ 229-357 1YOX ; 2.30 ; X-RAY STRUCTURE OF THE CONSERVED HYPOTHETICAL PROTEIN PA3696 FROM PSEUDOMONAS AERUGINOSA 1L9J ; 3.25 ; X-RAY STRUCTURE OF THE CYTOCHROME-C(2)-PHOTOSYNTHETIC REACTION CENTER ELECTRON TRANSFER COMPLEX FROM RHODOBACTER SPHAEROIDES IN TYPE I CO-CRYSTALS 1L9B ; 2.40 ; X-RAY STRUCTURE OF THE CYTOCHROME-C(2)-PHOTOSYNTHETIC REACTION CENTER ELECTRON TRANSFER COMPLEX FROM RHODOBACTER SPHAEROIDES IN TYPE II CO-CRYSTALS 1QRI ; 2.60 ; X-RAY STRUCTURE OF THE DEOXYRIBONUCLEIC ACID-ECO RI ENDONUCLEASE COMPLEXES WITH AN E144D MUTATION AT 2.7 A 1QRH ; 2.50 ; X-RAY STRUCTURE OF THE DEOXYRIBONUCLEIC ACID-ECO RI ENDONUCLEASE COMPLEXES WITH AN R145K MUTATION AT 2.7 A 1NF6 ; 2.35 ; X-RAY STRUCTURE OF THE DESULFOVIBRIO DESULFURICANS BACTERIOFERRITIN: THE DIIRON SITE IN DIFFERENT CATALYTIC STATES ("CYCLED" STRUCTURE: REDUCED IN SOLUTION AND ALLOWED TO REOXIDISE BEFORE CRYSTALLISATION) 1NF4 ; 2.05 ; X-RAY STRUCTURE OF THE DESULFOVIBRIO DESULFURICANS BACTERIOFERRITIN: THE DIIRON SITE IN DIFFERENT STATES (REDUCED STRUCTURE) 2B6E ; 1.90 ; X-RAY STRUCTURE OF THE DIFFERENT CRYSTAL FORM OF THE HYPOTHETICAL UPF0152 PROTEIN HI1161: NESG TARGET IR63 1OI2 ; 1.75 ; X-RAY STRUCTURE OF THE DIHYDROXYACETONE KINASE FROM ESCHERICHIA COLI 1OI3 ; 2.00 ; X-RAY STRUCTURE OF THE DIHYDROXYACETONE KINASE FROM ESCHERICHIA COLI 1LOV ; 1.55 ; X-RAY STRUCTURE OF THE E58A MUTANT OF RIBONUCLEASE T1 COMPLEXED WITH 3'-GUANOSINE MONOPHOSPHATE 1EHY ; 2.10 ; X-RAY STRUCTURE OF THE EPOXIDE HYDROLASE FROM AGROBACTERIUM RADIOBACTER AD1 2BGJ ; 2.10 ; X-RAY STRUCTURE OF THE FERREDOXIN-NADP(H) REDUCTASE FROM RHODOBACTER CAPSULATUS AT 2.1 ANGSTROMS 2BGI ; 1.68 ; X-RAY STRUCTURE OF THE FERREDOXIN-NADP(H) REDUCTASE FROM RHODOBACTER CAPSULATUS COMPLEXED WITH THREE MOLECULES OF THE DETERGENT N-HEPTYL-BETA-D-THIOGLUCOSIDE AT 1.7 ANGSTROMS 1QUE ; 1.80 ; X-RAY STRUCTURE OF THE FERREDOXIN:NADP+ REDUCTASE FROM THE CYANOBACTERIUM ANABAENA PCC 7119 AT 1.8 ANGSTROMS 1QUN ; 2.80 ; X-RAY STRUCTURE OF THE FIMC-FIMH CHAPERONE ADHESIN COMPLEX FROM UROPATHOGENIC E.COLI 2BH1 ; 2.40 ; X-RAY STRUCTURE OF THE GENERAL SECRETION PATHWAY COMPLEX OF THE N-TERMINAL DOMAIN OF EPSE AND THE CYTOSOLIC DOMAIN OF EPSL OF VIBRIO CHOLERAE 1M5B ; 1.85 ; X-RAY STRUCTURE OF THE GLUR2 LIGAND BINDING CORE (S1S2J) IN COMPLEX WITH 2-ME-TET-AMPA AT 1.85 A RESOLUTION. 1M5E ; 1.46 ; X-RAY STRUCTURE OF THE GLUR2 LIGAND BINDING CORE (S1S2J) IN COMPLEX WITH ACPA AT 1.46 A RESOLUTION 1M5C ; 1.65 ; X-RAY STRUCTURE OF THE GLUR2 LIGAND BINDING CORE (S1S2J) IN COMPLEX WITH BR-HIBO AT 1.65 A RESOLUTION 1M5F ; 1.95 ; X-RAY STRUCTURE OF THE GLUR2 LIGAND BINDING CORE (S1S2J- Y702F) IN COMPLEX WITH ACPA AT 1.95 A RESOLUTION 1M5D ; 1.73 ; X-RAY STRUCTURE OF THE GLUR2 LIGAND BINDING CORE (S1S2J- Y702F) IN COMPLEX WITH BR-HIBO AT 1.73 A RESOLUTION 1NNK ; 1.85 ; X-RAY STRUCTURE OF THE GLUR2 LIGAND-BINDING CORE (S1S2J) IN COMPLEX WITH (S)-ATPA AT 1.85 A RESOLUTION. CRYSTALLIZATION WITH ZINC IONS. 1NNP ; 1.90 ; X-RAY STRUCTURE OF THE GLUR2 LIGAND-BINDING CORE (S1S2J) IN COMPLEX WITH (S)-ATPA AT 1.9 A RESOLUTION. CRYSTALLIZATION WITHOUT ZINC IONS. 1SYH ; 1.80 ; X-RAY STRUCTURE OF THE GLUR2 LIGAND-BINDING CORE (S1S2J) IN COMPLEX WITH (S)-CPW399 AT 1.85 A RESOLUTION. 1MQD ; 1.46 ; X-RAY STRUCTURE OF THE GLUR2 LIGAND-BINDING CORE (S1S2J) IN COMPLEX WITH (S)-DES-ME-AMPA AT 1.46 A RESOLUTION. CRYSTALLIZATION IN THE PRESENCE OF LITHIUM SULFATE. 1MS7 ; 1.97 ; X-RAY STRUCTURE OF THE GLUR2 LIGAND-BINDING CORE (S1S2J) IN COMPLEX WITH (S)-DES-ME-AMPA AT 1.97 A RESOLUTION, CRYSTALLIZATION IN THE PRESENCE OF ZINC ACETATE 2AIX ; 2.17 ; X-RAY STRUCTURE OF THE GLUR2 LIGAND-BINDING CORE (S1S2J) IN COMPLEX WITH (S)-THIO-ATPA AT 2.2 A RESOLUTION. 1N0T ; 2.10 ; X-RAY STRUCTURE OF THE GLUR2 LIGAND-BINDING CORE (S1S2J) IN COMPLEX WITH THE ANTAGONIST (S)-ATPO AT 2.1 A RESOLUTION. 1S50 ; 1.65 ; X-RAY STRUCTURE OF THE GLUR6 LIGAND BINDING CORE (S1S2A) IN COMPLEX WITH GLUTAMATE AT 1.65 A RESOLUTION 1LOW ; 1.90 ; X-RAY STRUCTURE OF THE H40A MUTANT OF RIBONUCLEASE T1 COMPLEXED WITH 3'-GUANOSINE MONOPHOSPHATE 1LOY ; 1.55 ; X-RAY STRUCTURE OF THE H40A/E58A MUTANT OF RIBONUCLEASE T1 COMPLEXED WITH 3'-GUANOSINE MONOPHOSPHATE 1FLC ; 3.20 ; X-RAY STRUCTURE OF THE HAEMAGGLUTININ-ESTERASE-FUSION GLYCOPROTEIN OF INFLUENZA C VIRUS 1ZO8 ; 1.90 ; X-RAY STRUCTURE OF THE HALOALCOHOL DEHALOGENASE HHEC OF AGROBACTERIUM RADIOBACTER AD1 IN COMPLEX WITH (S)-PARA- NITROSTYRENE OXIDE, WITH A WATER MOLECULE IN THE HALIDE- BINDING SITE 1KO7 ; 1.95 ; X-RAY STRUCTURE OF THE HPR KINASE/PHOSPHATASE FROM STAPHYLOCOCCUS XYLOSUS AT 1.95 A RESOLUTION 1TJT ; 2.19 ; X-RAY STRUCTURE OF THE HUMAN ALPHA-ACTININ ISOFORM 3 AT 2.2A RESOLUTION 1H8D ; 1.40 ; X-RAY STRUCTURE OF THE HUMAN ALPHA-THROMBIN COMPLEX WITH A TRIPEPTIDE PHOSPHONATE INHIBITOR. 1I2T ; 1.04 ; X-RAY STRUCTURE OF THE HUMAN HYPERPLASTIC DISCS PROTEIN: AN ORTHOLOG OF THE C-TERMINAL DOMAIN OF POLY(A)-BINDING PROTEIN 1S9J ; 2.40 ; X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK1) IN A COMPLEX WITH LIGAND AND MGATP 1S9I ; 3.20 ; X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 2 (MEK2)IN A COMPLEX WITH LIGAND AND MGATP 1ZXO ; 3.20 ; X-RAY STRUCTURE OF THE HYPOTHETICAL PROTEIN Q8A1P1 AT THE RESOLUTION 3.2A. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET BTR25. 1ZQ7 ; 2.11 ; X-RAY STRUCTURE OF THE HYPOTHETICAL PROTEIN Q8PZK8 FROM METHANOSARCINA MAZEI AT THE RESOLUTION 2.1A. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET MAR9. 1ZNP ; 2.50 ; X-RAY STRUCTURE OF THE HYPOTHETICAL PROTEIN Q8U9W0 FROM AGROBACTERIUM TUMEFACIENS. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET ATR55. 1ORS ; 1.90 ; X-RAY STRUCTURE OF THE KVAP POTASSIUM CHANNEL VOLTAGE SENSOR IN COMPLEX WITH AN FAB 2BH4 ; 1.55 ; X-RAY STRUCTURE OF THE M100K VARIANT OF FERRIC CYT C-550 FROM PARACOCCUS VERSUTUS DETERMINED AT 100 K. 2BH5 ; 1.95 ; X-RAY STRUCTURE OF THE M100K VARIANT OF FERRIC CYT C-550 FROM PARACOCCUS VERSUTUS DETERMINED AT 295 K. 1G6G ; 1.60 ; X-RAY STRUCTURE OF THE N-TERMINAL FHA DOMAIN FROM S. CEREVISIAE RAD53P IN COMPLEX WITH A PHOSPHOTHREONINE PEPTIDE AT 1.6 A RESOLUTION 1U2H ; 0.96 ; X-RAY STRUCTURE OF THE N-TERMINALLY TRUNCATED HUMAN APEP-1 1L4A ; 2.95 ; X-RAY STRUCTURE OF THE NEURONAL COMPLEXIN/SNARE COMPLEX FROM THE SQUID LOLIGO PEALEI 1EQZ ; 2.50 ; X-RAY STRUCTURE OF THE NUCLEOSOME CORE PARTICLE AT 2.5 A RESOLUTION 1AOI ; 2.80 ; X-RAY STRUCTURE OF THE NUCLEOSOME CORE PARTICLE AT 2.8 A RESOLUTION 1KX3 ; 2.00 ; X-RAY STRUCTURE OF THE NUCLEOSOME CORE PARTICLE, NCP146, AT 2.0 A RESOLUTION 1KX4 ; 2.60 ; X-RAY STRUCTURE OF THE NUCLEOSOME CORE PARTICLE, NCP146B, AT 2.6 A RESOLUTION 1KX5 ; 1.94 ; X-RAY STRUCTURE OF THE NUCLEOSOME CORE PARTICLE, NCP147, AT 1.9 A RESOLUTION 1KV6 ; 2.70 ; X-RAY STRUCTURE OF THE ORPHAN NUCLEAR RECEPTOR ERR3 LIGAND- BINDING DOMAIN IN THE CONSTITUTIVELY ACTIVE CONFORMATION 1K4W ; 1.90 ; X-RAY STRUCTURE OF THE ORPHAN NUCLEAR RECEPTOR ROR BETA LIGAND-BINDING DOMAIN IN THE ACTIVE CONFORMATION 1WYZ ; 2.50 ; X-RAY STRUCTURE OF THE PUTATIVE METHYLTRANSFERASE FROM BACTEROIDES THETAIOTAOMICRON VPI-5482 AT THE RESOLUTION 2.5 A. NORTEAST STRUCTURAL GENOMICS CONSORTIUM TARGET BTR28 1ZKD ; 2.10 ; X-RAY STRUCTURE OF THE PUTATIVE PROTEIN Q6N1P6 FROM RHODOPSEUDOMONAS PALUSTRIS AT THE RESOLUTION 2.1 A , NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET RPR58 1T6M ; 2.11 ; X-RAY STRUCTURE OF THE R70D PI-PLC ENZYME: INSIGHT INTO THE ROLE OF CALCIUM AND SURROUNDING AMINO ACIDS ON ACTIVE SITE GEOMETRY AND CATALYSIS. 1XLY ; 1.95 ; X-RAY STRUCTURE OF THE RIBONUCLEIC ACID-BINDING PROTEIN SHE2P 1UOC ; 2.30 ; X-RAY STRUCTURE OF THE RNASE DOMAIN OF THE YEAST POP2 PROTEIN 1OIV ; 1.98 ; X-RAY STRUCTURE OF THE SMALL G PROTEIN RAB11A IN COMPLEX WITH GDP 1OIX ; 1.70 ; X-RAY STRUCTURE OF THE SMALL G PROTEIN RAB11A IN COMPLEX WITH GDP AND PI 1OIW ; 2.05 ; X-RAY STRUCTURE OF THE SMALL G PROTEIN RAB11A IN COMPLEX WITH GTPGAMMAS 1S2O ; 1.40 ; X-RAY STRUCTURE OF THE SUCROSE-PHOSPHATASE (SPP) FROM SYNECHOCYSTIS SP. PCC6803 AT 1.40 A RESOLUTION 1TJ3 ; 2.80 ; X-RAY STRUCTURE OF THE SUCROSE-PHOSPHATASE (SPP) FROM SYNECHOCYSTIS SP. PCC6803 IN A CLOSED CONFORMATION 1U2S ; 2.50 ; X-RAY STRUCTURE OF THE SUCROSE-PHOSPHATASE (SPP) FROM SYNECHOCYSTIS SP. PCC6803 IN COMPLEX WITH GLUCOSE 1TJ4 ; 2.70 ; X-RAY STRUCTURE OF THE SUCROSE-PHOSPHATASE (SPP) FROM SYNECHOCYSTIS SP. PCC6803 IN COMPLEX WITH SUCROSE 1TJ5 ; 2.20 ; X-RAY STRUCTURE OF THE SUCROSE-PHOSPHATASE (SPP) FROM SYNECHOCYSTIS SP. PCC6803 IN COMPLEX WITH SUCROSE AND PHOSPHATE 1U2T ; 2.90 ; X-RAY STRUCTURE OF THE SUCROSE-PHOSPHATASE (SPP) FROM SYNECHOCYSTIS SP. PCC6803 IN COMPLEX WITH SUCROSE6P 1P5U ; 1.99 ; X-RAY STRUCTURE OF THE TERNARY CAF1M:CAF1:CAF1 CHAPERONE:SUBUNIT:SUBUNIT COMPLEX 1MVK ; 2.50 ; X-RAY STRUCTURE OF THE TETRAMERIC MUTANT OF THE B1 DOMAIN OF STREPTOCOCCAL PROTEIN G 1SYI ; 2.10 ; X-RAY STRUCTURE OF THE Y702F MUTANT OF THE GLUR2 LIGAND- BINDING CORE (S1S2J) IN COMPLEX WITH (S)-CPW399 AT 2.1 A RESOLUTION. 1XHY ; 1.85 ; X-RAY STRUCTURE OF THE Y702F MUTANT OF THE GLUR2 LIGAND- BINDING CORE (S1S2J) IN COMPLEX WITH KAINATE AT 1.85 A RESOLUTION 1XKR ; 1.75 ; X-RAY STRUCTURE OF THERMOTOGA MARITIMA CHEC 2BEI ; 1.84 ; X-RAY STRUCTURE OF THIALYSINE N-ACETYLTRANSFERASE (SSAT2) FROM HOMO SAPIENS 1RCU ; 2.50 ; X-RAY STRUCTURE OF TM1055 NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET VT76 1G7R ; 2.20 ; X-RAY STRUCTURE OF TRANSLATION INITIATION FACTOR IF2/EIF5B 1G7S ; 2.00 ; X-RAY STRUCTURE OF TRANSLATION INITIATION FACTOR IF2/EIF5B COMPLEXED WITH GDP 1G7T ; 2.00 ; X-RAY STRUCTURE OF TRANSLATION INITIATION FACTOR IF2/EIF5B COMPLEXED WITH GDPNP 1UX8 ; 2.15 ; X-RAY STRUCTURE OF TRUNCATED OXYGEN-AVID HAEMOGLOBIN FROM BACILLUS SUBTILIS 1MW7 ; 2.00 ; X-RAY STRUCTURE OF Y162_HELPY NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET PR6 1XQB ; 2.85 ; X-RAY STRUCTURE OF YAEB FROM HAEMOPHILUS INFLUENZAE. NORTHEAST STRUCTURAL GENOMICS RESEARCH CONSORTIUM (NESGC) TARGET IR47. 1SC0 ; 1.70 ; X-RAY STRUCTURE OF YB61_HAEIN NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET IR63 1O0I ; 1.70 ; X-RAY STRUCTURE OF YB61_HAEIN NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET IR63. 1NS5 ; 1.68 ; X-RAY STRUCTURE OF YBEA FROM E.COLI. NORTHEAST STRUCTURAL GENOMICS RESEARCH CONSORTIUM (NESG) TARGET ER45 1LXJ ; 1.80 ; X-RAY STRUCTURE OF YBL001C NORTHEAST STRUCTURAL GENOMICS (NESG) CONSORTIUM TARGET YTYST72 1SDJ ; 2.30 ; X-RAY STRUCTURE OF YDDE_ECOLI NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET ET25. 1SBK ; 2.00 ; X-RAY STRUCTURE OF YDII_ECOLI NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET ER29. 1QGX ; 1.60 ; X-RAY STRUCTURE OF YEAST HAL2P 1OYZ ; 2.10 ; X-RAY STRUCTURE OF YIBA_ECOLI NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET ET31. 1NKV ; 2.90 ; X-RAY STRUCTURE OF YJHP FROM E.COLI NORTHEAST STRUCTURAL GENOMICS RESEARCH CONSORTIUM (NESG) TARGET ER13 1T7H ; 1.13 ; X-RAY STRUCTURE OF [LYS(-2)-ARG(-1)-DES(17-21)]-ENDOTHELIN- 1 PEPTIDE 1NXH ; 2.80 ; X-RAY STRUCTURE: NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET TT87 1URG ; 1.80 ; X-RAY STRUCTURES FROM THE MALTOSE-MALTODEXTRIN BINDING PROTEIN OF THE THERMOACIDOPHILIC BACTERIUM ALICYCLOBACILLUS ACIDOCALDARIUS 1YCG ; 2.80 ; X-RAY STRUCTURES OF MOORELLA THERMOACETICA FPRA. NOVEL DIIRON SITE STRUCTURE AND MECHANISTIC INSIGHTS INTO A SCAVENGING NITRIC OXIDE REDUCTASE 1FVE ; 2.70 ; X-RAY STRUCTURES OF THE ANTIGEN-BINDING DOMAINS FROM THREE VARIANTS OF HUMANIZED ANTI-P185HER2 ANTIBODY 4D5 AND COMPARISON WITH MOLECULAR MODELING 1URS ; 1.45 ; X-RAY STRUCTURES OF THE MALTOSE-MALTODEXTRIN BINDING PROTEIN OF THE THERMOACIDOPHILIC BACTERIUM ALICYCLOBACILLUS ACIDOCALDARIUS 1URD ; 1.53 ; X-RAY STRUCTURES OF THE MALTOSE-MALTODEXTRIN BINDING PROTEIN OF THE THERMOACIDOPHILIC BACTERIUM ALICYCLOBACILLUS ACIDOCALDARIUS PROVIDE INSIGHT INTO ACID STABILITY OF PROTEINS 1MMA ; 2.10 ; X-RAY STRUCTURES OF THE MGADP, MGATPGAMMAS, AND MGAMPPNP COMPLEXES OF THE DICTYOSTELIUM DISCOIDEUM MYOSIN MOTOR DOMAIN 1MMG ; 1.90 ; X-RAY STRUCTURES OF THE MGADP, MGATPGAMMAS, AND MGAMPPNP COMPLEXES OF THE DICTYOSTELIUM DISCOIDEUM MYOSIN MOTOR DOMAIN 1MMN ; 2.10 ; X-RAY STRUCTURES OF THE MGADP, MGATPGAMMAS, AND MGAMPPNP COMPLEXES OF THE DICTYOSTELIUM DISCOIDEUM MYOSIN MOTOR DOMAIN 1YVV ; 2.50 ; X-RAY STRUCTURURE OF P. SYRINGAE Q888A4 OXIDOREDUCTASE AT RESOLUTION 2.5A. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET PSR10. 1XVK ; 1.26 ; X-RAY STRUCUTRE OF AN ECHINOMYCIN-(GCGTACGC)2 COMPLEX 1FQ5 ; 2.40 ; X-RAY STRUTURE OF A CYCLIC STATINE INHIBITOR PD-129,541 BOUND TO YEAST PROTEINASE A 1KRH ; 1.50 ; X-RAY STUCTURE OF BENZOATE DIOXYGENASE REDUCTASE 2AZD ; 2.16 ; X-RAY STUDIES ON MALTODEXTRIN PHOSPHORYLASE (MALP) COMPLEXES: RECOGNITION OF SUBSTRATES AND CATALYTIC MECHANISM OF PHOSPHORYLASE FAMILY 2AV6 ; 2.01 ; X-RAY STUDIES ON MALTODEXTRIN PHOSPHORYLASE COMPLEXES: RECOGNITION OF SUBSTRATES AND CATHALITIC MECHANISM OF PHOSPHORYLASE FAMILY 2AW3 ; 2.20 ; X-RAY STUDIES ON MALTODEXTRIN PHOSPHORYLASE COMPLEXES: RECOGNITION OF SUBSTRATES AND CATHALITIC MECHANISM OF PHOSPHORYLASE FAMILY 2ASV ; 1.95 ; X-RAY STUDIES ON PROTEIN COMPLEXES: ENZYMATIC CATALYSIS IN CRYSTALS OF E. COLI MALTODEXTRIN PHOSPHORYLASE (MALP) 1N5U ; 1.90 ; X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH HEME 1UOR ; 2.80 ; X-RAY STUDY OF RECOMBINANT HUMAN SERUM ALBUMIN. PHASES DETERMINED BY MOLECULAR REPLACEMENT METHOD, USING LOW RESOLUTION STRUCTURE MODEL OF TETRAGONAL FORM OF HUMAN SERUM ALBUMIN 1RSB ; 2.17 ; X-RAY STUDY OF THE DEOXYRIBONUCLEIC ACID OLIGOMER D(ATATAT) IN P65 SPACE GROUP 5PEP ; 2.34 ; X-Ray Analyses of Aspartic Proteases. /II. Three-Dimensional Structure of the Hexagonal Crystal Form of Porcine Pepsin at 2.3 Angstroms Resolution 1PPT ; 1.37 ; X-Ray Analysis (1.4-Angstroms Resolution) of Avian Pancreatic Polypeptide. Small Globular Protein Hormone 4PHV ; 2.10 ; X-Ray Crystal Structure of the HIV Protease Complex with L-700,417, an Inhibitor with Pseudo C2 Symmetry 1PYP ; 3.00 ; X-Ray Diffraction Study of Inorganic Pyrophosphatase from Baker,S Yeast at the 3 Angstroms Resolution (Russian) 1LH1 ; 2.00 ; X-Ray Structural Investigation of Leghemoglobin. Vi. Structure of Acetate- Ferrileghemoglobin at a Resolution of 2.0 Angstroms (Russian) 1LH2 ; 2.00 ; X-Ray Structural Investigation of Leghemoglobin. Vi. Structure of Acetate- Ferrileghemoglobin at a Resolution of 2.0 Angstroms (Russian) 1LH3 ; 2.00 ; X-Ray Structural Investigation of Leghemoglobin. Vi. Structure of Acetate- Ferrileghemoglobin at a Resolution of 2.0 Angstroms (Russian) 1LH5 ; 2.00 ; X-Ray Structural Investigation of Leghemoglobin. Vi. Structure of Acetate- Ferrileghemoglobin at a Resolution of 2.0 Angstroms (Russian) 1LH6 ; 2.00 ; X-Ray Structural Investigation of Leghemoglobin. Vi. Structure of Acetate- Ferrileghemoglobin at a Resolution of 2.0 Angstroms (Russian) 1LH7 ; 2.00 ; X-Ray Structural Investigation of Leghemoglobin. Vi. Structure of Acetate- Ferrileghemoglobin at a Resolution of 2.0 Angstroms (Russian) 2LH1 ; 2.00 ; X-Ray Structural Investigation of Leghemoglobin. Vi. Structure of Acetate- Ferrileghemoglobin at a Resolution of 2.0 Angstroms (Russian) 2LH2 ; 2.00 ; X-Ray Structural Investigation of Leghemoglobin. Vi. Structure of Acetate- Ferrileghemoglobin at a Resolution of 2.0 Angstroms (Russian) 2LH3 ; 2.00 ; X-Ray Structural Investigation of Leghemoglobin. Vi. Structure of Acetate- Ferrileghemoglobin at a Resolution of 2.0 Angstroms (Russian) 2LH5 ; 2.00 ; X-Ray Structural Investigation of Leghemoglobin. Vi. Structure of Acetate- Ferrileghemoglobin at a Resolution of 2.0 Angstroms (Russian) 2LH6 ; 2.00 ; X-Ray Structural Investigation of Leghemoglobin. Vi. Structure of Acetate- Ferrileghemoglobin at a Resolution of 2.0 Angstroms (Russian) 2LH7 ; 2.00 ; X-Ray Structural Investigation of Leghemoglobin. Vi. Structure of Acetate- Ferrileghemoglobin at a Resolution of 2.0 Angstroms (Russian) 1G9J ; 1.90 ; X-TAL STRUCTURE OF THE MUTANT E44Q OF THE CELLULASE CEL48F IN COMPLEX WITH A THIOOLIGOSACCHARIDE 1X11 ; 2.40 ; X11 PTB DOMAIN 1AQC ; 2.30 ; X11 PTB DOMAIN-10MER PEPTIDE COMPLEX 1N5X ; 2.80 ; XANTHINE DEHYDROGENASE FROM BOVINE MILK WITH INHIBITOR TEI- 6720 BOUND 1K8L ; -1.00 ; XBY6: AN ANALOG OF CK14 CONTAINING 6 DITHIOPHOSPHATE GROUPS 1E9V ; 1.72 ; XENON BOUND IN HYDROPHOBIC CHANNEL OF HYBRID CLUSTER PROTEIN FROM DESULFOVIBRIO VULGARIS 1UYU ; 2.00 ; XENON COMPLEX OF WILDTYPE P450CAM FROM PSEUDOMONAS PUTIDA 1VAU ; 1.50 ; XENON DERIVATIVE OF HEN EGG-WHITE LYSOZYME 1L6O ; 2.20 ; XENOPUS DISHEVELLED PDZ DOMAIN 1YCQ ; 2.30 ; XENOPUS LAEVIS MDM2 BOUND TO THE TRANSACTIVATION DOMAIN OF HUMAN P53 1OE4 ; 2.00 ; XENOPUS SMUG1, AN ANTI-MUTATOR URACIL-DEOXYRIBONUCLEIC ACID GLYCOSYLASE 1OE5 ; 2.30 ; XENOPUS SMUG1, AN ANTI-MUTATOR URACIL-DEOXYRIBONUCLEIC ACID GLYCOSYLASE 1OE6 ; 2.65 ; XENOPUS SMUG1, AN ANTI-MUTATOR URACIL-DEOXYRIBONUCLEIC ACID GLYCOSYLASE 1LP9 ; 2.00 ; XENOREACTIVE COMPLEX AHIII 12.2 TCR BOUND TO P1049/HLA-A2.1 1FRE ; -1.00 ; XNF7 BBOX, DEVELOPMENTAL PROTEIN, PH 7.5, 30 C, WITH ZINC, NMR, 1 STRUCTURE 2BHN ; 3.20 ; XPF FROM AEROPYRUM PERNIX 2BGW ; 2.80 ; XPF FROM AEROPYRUM PERNIX, COMPLEX WITH DEOXYRIBONUCLEIC ACID 1NUL ; 1.80 ; XPRTASE FROM E. COLI 1A97 ; 2.60 ; XPRTASE FROM E. COLI COMPLEXED WITH GMP 1A98 ; 2.25 ; XPRTASE FROM E. COLI COMPLEXED WITH GMP 1A95 ; 2.00 ; XPRTASE FROM E. COLI COMPLEXED WITH MG:CPRPP AND GUANINE 1A96 ; 2.00 ; XPRTASE FROM E. COLI WITH BOUND CPRPP AND XANTHINE 1JYU ; 2.75 ; XRAY STRUCTURE OF GRB2 SH2 DOMAIN 1JYQ ; 2.00 ; XRAY STRUCTURE OF GRB2 SH2 DOMAIN COMPLEXED WITH A HIGHLY AFFINE PHOSPHO PEPTIDE 1JYR ; 1.55 ; XRAY STRUCTURE OF GRB2 SH2 DOMAIN COMPLEXED WITH A PHOSPHORYLATED PEPTIDE 1G9G ; 1.90 ; XTAL-STRUCTURE OF THE FREE NATIVE CELLULASE CEL48F 1DYO ; 2.10 ; XYLAN-BINDING DOMAIN FROM CBM 22, FORMALLY X6B DOMAIN 1GNY ; 1.63 ; XYLAN-BINDING MODULE CBM15 1E0V ; 1.70 ; XYLANASE 10A FROM SREPTOMYCES LIVIDANS. CELLOBIOSYL-ENZYME INTERMEDIATE AT 1.7 A 1E0W ; 1.20 ; XYLANASE 10A FROM SREPTOMYCES LIVIDANS. NATIVE STRUCTURE AT 1.2 ANGSTROM RESOLUTION 1E0X ; 1.65 ; XYLANASE 10A FROM SREPTOMYCES LIVIDANS. XYLOBIOSYL-ENZYME INTERMEDIATE AT 1.65 A 1BG4 ; 1.75 ; XYLANASE FROM PENICILLIUM SIMPLICISSIMUM 1B30 ; 2.25 ; XYLANASE FROM PENICILLIUM SIMPLICISSIMUM, COMPLEX WITH 1,2-(4-DEOXY-BETA-L-THREO-HEX-4-ENOPYRANOSYLURONIC ACID)-BETA-1,4-XYLOTRIOSE) 1B3W ; 2.60 ; XYLANASE FROM PENICILLIUM SIMPLICISSIMUM, COMPLEX WITH XYLOBIOSE 1B3Z ; 2.30 ; XYLANASE FROM PENICILLIUM SIMPLICISSIMUM, COMPLEX WITH XYLOPENTAOSE 1B3V ; 2.40 ; XYLANASE FROM PENICILLIUM SIMPLICISSIMUM, COMPLEX WITH XYLOSE 1B3Y ; 2.45 ; XYLANASE FROM PENICILLIUM SIMPLICISSIMUM, COMPLEX WITH XYLOTETRAOSE 1B3X ; 2.20 ; XYLANASE FROM PENICILLIUM SIMPLICISSIMUM, COMPLEX WITH XYLOTRIOSE 1B31 ; 1.75 ; XYLANASE FROM PENICILLIUM SIMPLICISSIMUM, NATIVE WITH PEG200 AS CRYOPROTECTANT 1HIZ ; 2.40 ; XYLANASE T6 (XT6) FROM BACILLUS STEAROTHERMOPHILUS 1V0K ; 1.03 ; XYLANASE XYN10A FROM STREPTOMYCES LIVIDANS IN COMPLEX WITH XYLOBIO-DEOXYNOJIRIMYCIN AT PH 5.8 1V0M ; 1.07 ; XYLANASE XYN10A FROM STREPTOMYCES LIVIDANS IN COMPLEX WITH XYLOBIO-DEOXYNOJIRIMYCIN AT PH 7.5 1V0L ; 0.98 ; XYLANASE XYN10A FROM STREPTOMYCES LIVIDANS IN COMPLEX WITH XYLOBIO-ISOFAGOMINE AT PH 5.8 1V0N ; 1.10 ; XYLANASE XYN10A FROM STREPTOMYCES LIVIDANS IN COMPLEX WITH XYLOBIO-ISOFAGOMINE AT PH 7.5 1OD8 ; 1.05 ; XYLANASE XYN10A FROM STREPTOMYCES LIVIDANS IN COMPLEX WITH XYLOBIO-ISOFAGOMINE LACTAM 1UQZ ; 1.55 ; XYLANASE XYN10B MUTANT (E262S) FROM CELLVIBRIO MIXTUS IN COMPLEX WITH 4-O-METHYL GLUCURONIC ACID 1UR2 ; 1.60 ; XYLANASE XYN10B MUTANT (E262S) FROM CELLVIBRIO MIXTUS IN COMPLEX WITH ARABINOFURANOSE ALPHA 1,3 LINKED TO XYLOTRIOSE 1UR1 ; 1.43 ; XYLANASE XYN10B MUTANT (E262S) FROM CELLVIBRIO MIXTUS IN COMPLEX WITH ARABINOFURANOSE ALPHA-1,3 LINKED TO XYLOBIOSE 1UQY ; 1.72 ; XYLANASE XYN10B MUTANT (E262S) FROM CELLVIBRIO MIXTUS IN COMPLEX WITH XYLOPENTAOSE 1US2 ; 1.85 ; XYLANASE10C (MUTANT E385A) FROM CELLVIBRIO JAPONICUS IN COMPLEX WITH XYLOPENTAOSE 1UMZ ; 1.80 ; XYLOGLUCAN ENDOTRANSGLYCOSYLASE IN COMPLEX WITH THE XYLOGLUCAN NONASACCHARIDE XLLG. 1UN1 ; 2.10 ; XYLOGLUCAN ENDOTRANSGLYCOSYLASE NATIVE STRUCTURE. 1A0D ; 3.00 ; XYLOSE ISOMERASE FROM BACILLUS STEAROTHERMOPHILUS 1A0C ; 2.50 ; XYLOSE ISOMERASE FROM THERMOANAEROBACTERIUM THERMOSULFURIGENES 1A0E ; 2.70 ; XYLOSE ISOMERASE FROM THERMOTOGA NEAPOLITANA 1BXC ; 2.30 ; XYLOSE ISOMERASE FROM THERMUS CALDOPHILUS 1BXB ; 2.20 ; XYLOSE ISOMERASE FROM THERMUS THERMOPHILUS 1S5M ; 0.98 ; XYLOSE ISOMERASE IN SUBSTRATE AND INHIBITOR MICHAELIS STATES: ATOMIC RESOLUTION STUDIES OF A METAL-MEDIATED HYDRIDE SHIFT 1S5N ; 0.95 ; XYLOSE ISOMERASE IN SUBSTRATE AND INHIBITOR MICHAELIS STATES: ATOMIC RESOLUTION STUDIES OF A METAL-MEDIATED HYDRIDE SHIFT 1N48 ; 2.20 ; Y-FAMILY DEOXYRIBONUCLEIC ACID POLYMERASE DPO4 IN COMPLEX WITH DEOXYRIBONUCLEIC ACID CONTAINING ABASIC LESION 1N56 ; 2.40 ; Y-FAMILY DEOXYRIBONUCLEIC ACID POLYMERASE DPO4 IN COMPLEX WITH DEOXYRIBONUCLEIC ACID CONTAINING ABASIC LESION 1R67 ; 1.77 ; Y104A MUTANT OF E.COLI IPP ISOMERASE 1X83 ; 1.80 ; Y104F IPP ISOMERASE REACTED WITH (S)-BROMOHYDRINE OF IPP 1OZM ; 1.95 ; Y106F MUTANT OF Z. MOBILIS TGT 2AV8 ; 2.46 ; Y122F MUTANT OF RIBONUCLEOTIDE REDUCTASE FROM ESCHERICHIA COLI 1FTC ; 2.35 ; Y13C MUTANT OF AZOTOBACTER VINELANDII FDI 1MP5 ; 2.75 ; Y177F VARIANT OF S. ENTERICA RMLA 1YJ4 ; 2.30 ; Y305F TRICHODIENE SYNTHASE 1YYQ ; 2.10 ; Y305F TRICHODIENE SYNTHASE COMPLEXED WITH PYROPHOSPHATE 1YYR ; 2.50 ; Y305F TRICHODIENE SYNTHASE: COMPLEX WITH MG, PYROPHOSPHATE, AND (4R)-7-AZABISABOLENE 1YYS ; 2.75 ; Y305F TRICHODIENE SYNTHASE: COMPLEX WITH MG, PYROPHOSPHATE, AND (4S)-7-AZABISABOLENE 1U0C ; 2.50 ; Y33C MUTATANT OF HOMING ENDONUCLEASE I-CREI 1U0D ; 2.90 ; Y33H MUTATANT OF HOMING ENDONUCLEASE I-CREI 2BER ; 1.80 ; Y370G ACTIVE SITE MUTANT OF THE SIALIDASE FROM MICROMONOSPORA VIRIDIFACIENS IN COMPLEX WITH BETA-NEU5AC (SIALIC ACID). 1Z1Q ; 1.50 ; Y66L VARIANT OF ENHANCED GREEN FLUORESCENT PROTEIN WITH 374- NM ABSORBING CHROMOPHORE 1Z1P ; 2.00 ; Y66L VARIANT OF ENHANCED GREEN FLUORESCENT PROTEIN WITH 412- NM ABSORBING CHROMOPHORE 1T2H ; 1.00 ; Y81W MUTANT OF RNASE SA FROM STREPTOMYCES AUREOFACIENS 1OBV ; 2.10 ; Y94F FLAVODOXIN FROM ANABAENA 1F4P ; 1.30 ; Y98W FLAVODOXIN MUTANT 1.5A (D. VULGARIS) 1IN0 ; 2.14 ; YAJQ PROTEIN (HI1034) 1JMQ ; -1.00 ; YAP65 (L30K MUTANT) WW DOMAIN IN COMPLEX WITH GTPPPPYTVG PEPTIDE 1K9R ; -1.00 ; YAP65 WW DOMAIN COMPLEXED TO ACETYL-PLPPY 1K9Q ; -1.00 ; YAP65 WW DOMAIN COMPLEXED TO N-(N-OCTYL)-GPPPY-NH2 1K5R ; -1.00 ; YAP65 WW DOMAIN S24-AMINO-ETHYLSULFANYL-ACETIC ACID MUTANT 1YTT ; 1.80 ; YB SUBSTITUTED SUBTILISIN FRAGMENT OF MANNOSE BINDING PROTEIN-A (SUB-MBP-A), MAD STRUCTURE AT 110K 1M65 ; 1.57 ; YCDX PROTEIN 1PB0 ; 1.95 ; YCDX PROTEIN IN AUTOINHIBITED STATE 1M68 ; 2.30 ; YCDX PROTEIN, TRINUCLEAR ZINC SITE 1JAL ; 2.40 ; YCHF PROTEIN (HI0393) 1NE8 ; 2.10 ; YDCE PROTEIN FROM BACILLUS SUBTILIS 1OG6 ; 2.80 ; YDHF, AN ALDO-KETO REDUCTASE FROM E.COLI COMPLEXED WITH NADPH 1CK2 ; -1.00 ; YEAST (SACCHAROMYCES CEREVISIAE) RIBOSOMAL PROTEIN L30 1EB3 ; 1.75 ; YEAST 5-AMINOLAEVULINIC ACID DEHYDRATASE 4,7-DIOXOSEBACIC ACID COMPLEX 1W31 ; 1.90 ; YEAST 5-AMINOLAEVULINIC ACID DEHYDRATASE 5-HYDROXYLAEVULINIC ACID COMPLEX 1QNV ; 2.50 ; YEAST 5-AMINOLAEVULINIC ACID DEHYDRATASE LEAD (PB) COMPLEX 1OHL ; 1.60 ; YEAST 5-AMINOLAEVULINIC ACID DEHYDRATASE PUTATIVE CYCLIC REACTION INTERMEDIATE COMPLEX 1PI6 ; 2.50 ; YEAST ACTIN INTERACTING PROTEIN 1 (AIP1), ORTHORHOMBIC CRYSTAL FORM 1PGU ; 2.30 ; YEAST ACTIN INTERACTING PROTEIN 1 (AIP1), SE-MET PROTEIN, MONOCLINIC CRYSTAL FORM 2BKW ; 2.57 ; YEAST ALANINE:GLYOXYLATE AMINOTRANSFERASE YFL030W 1BS2 ; 2.75 ; YEAST ARGINYL-TRNA SYNTHETASE 1WDX ; 2.50 ; YEAST BBC1 SH3 DOMAIN, TRICLINIC CRYSTAL FORM 4CSM ; 2.80 ; YEAST CHORISMATE MUTASE + TYR + ENDOOXABICYCLIC INHIBITOR 5CSM ; 2.00 ; YEAST CHORISMATE MUTASE, T226S MUTANT, COMPLEX WITH TRP 1QPV ; 3.00 ; YEAST COFILIN 1CFY ; 2.30 ; YEAST COFILIN, MONOCLINIC CRYSTAL FORM 1COF ; 2.30 ; YEAST COFILIN, ORTHORHOMBIC CRYSTAL FORM 1TLB ; 2.40 ; YEAST COPROPORPHYRINOGEN OXIDASE 1YSO ; 1.73 ; YEAST CU, ZN SUPEROXIDE DISMUTASE WITH THE REDUCED BRIDGE BROKEN 1KB9 ; 2.30 ; YEAST CYTOCHROME BC1 COMPLEX 1KYO ; 2.97 ; YEAST CYTOCHROME BC1 COMPLEX WITH BOUND SUBSTRATE CYTOCHROME C 1RB7 ; 2.10 ; YEAST CYTOSINE DEAMINASE CRYSTAL FORM P212121 WITH SODIUM ACETATE. 1YSD ; 1.90 ; YEAST CYTOSINE DEAMINASE DOUBLE MUTANT 1YSB ; 1.70 ; YEAST CYTOSINE DEAMINASE TRIPLE MUTANT 1JIH ; 2.25 ; YEAST DEOXYRIBONUCLEIC ACID POLYMERASE ETA 1OIS ; 1.90 ; YEAST DEOXYRIBONUCLEIC ACID TOPOISOMERASE I, N-TERMINAL FRAGMENT 1G7C ; 2.05 ; YEAST EEF1A:EEF1BA IN COMPLEX WITH GDPNP 1ONE ; 1.80 ; YEAST ENOLASE COMPLEXED WITH AN EQUILIBRIUM MIXTURE OF 2'-PHOSPHOGLYCEATE AND PHOSPHOENOLPYRUVATE 1XAQ ; -1.00 ; YEAST FRATAXIN SOLUTION STRUCTURE 1M0T ; 2.30 ; YEAST GLUTATHIONE SYNTHASE 1M0W ; 1.80 ; YEAST GLUTATHIONE SYNTHASE BOUND TO GAMMA-GLUTAMYL-CYSTEINE, AMP-PNP AND 2 MAGNESIUM IONS 1UST ; -1.00 ; YEAST HISTONE H1 GLOBULAR DOMAIN I, HHO1P GI, SOLUTION NMR STRUCTURES 1USS ; -1.00 ; YEAST HISTONE H1 GLOBULAR DOMAIN II, HHO1P GII, SOLUTION NMR STRUCTURES 1FUU ; 2.50 ; YEAST INITIATION FACTOR 4A 1QVA ; 2.50 ; YEAST INITIATION FACTOR 4A N-TERMINAL DOMAIN 1YFG ; 3.00 ; YEAST INITIATOR TRNA 1EE5 ; 2.40 ; YEAST KARYOPHERIN (IMPORTIN) ALPHA IN A COMPLEX WITH A NUCLEOPLASMIN NLS PEPTIDE 1MNM ; 2.25 ; YEAST MATALPHA2/MCM1/DEOXYRIBONUCLEIC ACID TERNARY TRANSCRIPTION COMPLEX CRYSTAL STRUCTURE 1HR6 ; 2.50 ; YEAST MITOCHONDRIAL PROCESSING PEPTIDASE 1HR7 ; 2.55 ; YEAST MITOCHONDRIAL PROCESSING PEPTIDASE BETA-E73Q MUTANT 1HR8 ; 2.70 ; YEAST MITOCHONDRIAL PROCESSING PEPTIDASE BETA-E73Q MUTANT COMPLEXED WITH CYTOCHROME C OXIDASE IV SIGNAL PEPTIDE 1HR9 ; 3.01 ; YEAST MITOCHONDRIAL PROCESSING PEPTIDASE BETA-E73Q MUTANT COMPLEXED WITH MALATE DEHYDROGENASE SIGNAL PEPTIDE 1VA7 ; 2.90 ; YEAST MYO3 SH3 DOMAIN, TRICLINIC CRYSTAL FORM 1TK1 ; 1.90 ; YEAST OXYGEN-DEPENDENT COPROPORPHYRINOGEN OXIDASE 1TKL ; 2.00 ; YEAST OXYGEN-DEPENDENT COPROPORPHYRINOGEN OXIDASE 1QHF ; 1.70 ; YEAST PHOSPHOGLYCERATE MUTASE-3PG COMPLEX STRUCTURE TO 1.7 A 1K0K ; 2.35 ; YEAST PROFILIN, CUBIC CRYSTAL FORM 1A1D ; -1.00 ; YEAST RIBONUCLEIC ACID POLYMERASE SUBUNIT RPB8, NMR, MINIMIZED AVERAGE STRUCTURE, ALPHA CARBONS ONLY 1CN7 ; -1.00 ; YEAST RIBOSOMAL PROTEIN L30 1YTF ; 2.50 ; YEAST TFIIA/TBP/DEOXYRIBONUCLEIC ACID COMPLEX 2TMK ; 2.40 ; YEAST THYMIDYLATE KINASE COMPLEXED WITH 3'-AZIDO-3'-DEOXYTHYMIDINE MONOPHOSPHATE (AZT-MP) 1TMK ; 2.10 ; YEAST THYMIDYLATE KINASE COMPLEXED WITH THYMIDINE MONOPHOSPHATE (DTMP) 1I45 ; 1.80 ; YEAST TRIOSEPHOSPHATE ISOMERASE (MUTANT) 1CLV ; 2.00 ; YELLOW MEAL WORM ALPHA-AMYLASE IN COMPLEX WITH THE AMARANTH ALPHA-AMYLASE INHIBITOR 1PA9 ; 2.00 ; YERSINIA PROTEIN-TYROSINE PHOSPHATASE COMPLEXED WITH PNCS (YOP51,PASTEURELLA X,PTPASE,YOP51DELTA162) (CATALYTIC DOMAIN, RESIDUES 163-468) MUTANT WITH CYS 235 REPLACED BY ARG (C235R) 1YTW ; 2.40 ; YERSINIA PTPASE COMPLEXED WITH TUNGSTATE 1XXV ; 2.50 ; YERSINIA YOPH (RESIDUES 163-468) BINDS PHOSPHONODIFLUOROMETHYL-PHE CONTAINING HEXAPEPTIDE AT TWO SITES 1XXP ; 3.00 ; YERSINIA YOPH (RESIDUES 163-468) C403S BINDS PHOSPHOTYROSYL PEPTIDE AT TWO SITES 1RW1 ; 1.02 ; YFFB (PA3664) PROTEIN 1RXQ ; 1.70 ; YFIT FROM BACILLUS SUBTILIS IS A PROBABLE METAL-DEPENDENT HYDROLASE WITH AN UNUSUAL FOUR-HELIX BUNDLE TOPOLOGY 1NRK ; 2.80 ; YGFZ PROTEIN 1JOP ; 2.60 ; YHCH PROTEIN (HI0227) 1S4C ; 2.20 ; YHCH PROTEIN (HI0227) COPPER COMPLEX 1NIJ ; 2.00 ; YJIA PROTEIN 1E0N ; -1.00 ; YJQ8WW DOMAIN FROM SACCHAROMYCES CEREVISAE 1T0I ; 2.00 ; YLR011WP, A SACCHAROMYCES CEREVISIAE NA(D)PH-DEPENDENT FMN REDUCTASE 1OEE ; 2.10 ; YODA FROM ESCHERICHIA COLI CRYSTALLISED WITH CADMIUM IONS 1OEJ ; 1.81 ; YODA FROM ESCHERICHIA COLI CRYSTALLISED WITH NO ADDED IONS 1OEK ; 2.40 ; YODA FROM ESCHERICHIA COLI CRYSTALLISED WITH ZINC IONS 313D ; 1.68 ; Z-DEOXYRIBONUCLEIC ACID HEXAMER WITH 5' OVERHANGS THAT FORM A REVERSE HOOGSTEEN BASE PAIR 312D ; 1.80 ; Z-DEOXYRIBONUCLEIC ACID HEXAMER WITH 5' OVERHANGS THAT FORM A REVERSE WATSON-CRICK BASE PAIR 314D ; 1.90 ; Z-DEOXYRIBONUCLEIC ACID HEXAMER WITH 5' OVERHANGS THAT FORM A REVERSE WOBBLE BASE PAIR 1NL7 ; 1.90 ; Z. RAMIGERA BIOSYNTHETIC THIOLASE, ACETYLATED ENZYME COMPLEXED WITH COA AT PH 9.5 1M0E ; 2.50 ; ZEBULARINE: A NOVEL DEOXYRIBONUCLEIC ACID METHYLATION INHIBITOR THAT FORMS A COVALENT COMPLEX WITH DEOXYRIBONUCLEIC ACID METHYLTRANSFERASE 1JK2 ; 1.65 ; ZIF268 D20A MUTANT BOUND TO THE GCT DEOXYRIBONUCLEIC ACID SITE 1JK1 ; 1.90 ; ZIF268 D20A MUTANT BOUND TO WT DEOXYRIBONUCLEIC ACID SITE 1AAY ; 1.60 ; ZIF268 ZINC FINGER-DEOXYRIBONUCLEIC ACID COMPLEX 1A1L ; 2.30 ; ZIF268 ZINC FINGER-DEOXYRIBONUCLEIC ACID COMPLEX (GCAC SITE) 1BSK ; 3.00 ; ZINC DEFORMYLASE INHIBITOR COMPLEX FROM E.COLI 1BNL ; 2.90 ; ZINC DEPENDENT DIMERS OBSERVED IN CRYSTALS OF HUMAN ENDOSTATIN 1Y0J ; -1.00 ; ZINC FINGERS AS PROTEIN RECOGNITION MOTIFS: STRUCTURAL BASIS FOR THE GATA-1/FRIEND OF GATA INTERACTION 1G12 ; 1.60 ; ZINC PEPTIDASE FROM GRIFOLA FRONDOSA 1GE5 ; 2.00 ; ZINC PEPTIDASE FROM GRIFOLA FRONDOSA 1GE6 ; 2.20 ; ZINC PEPTIDASE FROM GRIFOLA FRONDOSA 1GE7 ; 2.00 ; ZINC PEPTIDASE FROM GRIFOLA FRONDOSA 1KUH ; 1.60 ; ZINC PROTEASE FROM STREPTOMYCES CAESPITOSUS 1ZE9 ; -1.00 ; ZINC-BINDING DOMAIN OF ALZHEIMER'S DISEASE AMYLOID BETA- PEPTIDE COMPLEXED WITH A ZINC (II) CATION 2BP4 ; -1.00 ; ZINC-BINDING DOMAIN OF ALZHEIMER'S DISEASE AMYLOID BETA- PEPTIDE IN TFE-WATER (80-20) SOLUTION 1ZE7 ; -1.00 ; ZINC-BINDING DOMAIN OF ALZHEIMER'S DISEASE AMYLOID BETA- PEPTIDE IN WATER SOLUTION AT PH 6.5 3ENR ; 2.40 ; ZINC-CALCIUM CONCANAVALIN A AT PH 6.15 1D8E ; 3.00 ; ZINC-DEPLETED FTASE COMPLEXED WITH K-RAS4B PEPTIDE SUBSTRATE AND FPP ANALOG. 1ZKB ; 2.20 ; ZINC-FREE ENGINEERED MALTOSE BINDING PROTEIN 1OEZ ; 2.15 ; ZN HIS46ARG MUTANT OF HUMAN CU, ZN SUPEROXIDE DISMUTASE 1WBQ ; 2.30 ; ZN MG SUBSTITUTED AMINOPEPTIDASE P FROM E. COLI 2BHB ; 2.41 ; ZN SUBSTITUTED E. COLI AMINOPEPTIDASE P 2BH3 ; 2.40 ; ZN SUBSTITUTED E.COLI AMINOPEPTIDASE P IN COMPLEX WITH PRODUCT 1XB8 ; 2.00 ; ZN SUBSTITUTED FORM OF D62C/K74C DOUBLE MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN 1T7Z ; 3.00 ; ZN-ALPHA-2-GLYCOPROTEIN; BACULO-ZAG NO PEG, NO GLYCEROL 1T7V ; 1.95 ; ZN-ALPHA-2-GLYCOPROTEIN; BACULO-ZAG PEG 200 1T7Y ; 2.80 ; ZN-ALPHA-2-GLYCOPROTEIN; BACULO-ZAG PEG 200, NO GLYCEROL 1T80 ; 2.10 ; ZN-ALPHA-2-GLYCOPROTEIN; CHO-ZAG PEG 200 1T7W ; 2.70 ; ZN-ALPHA-2-GLYCOPROTEIN; CHO-ZAG PEG 400 1T7X ; 3.10 ; ZN-ALPHA-2-GLYCOPROTEIN; REFOLDED CHO-ZAG PEG 400 1E67 ; 2.14 ; ZN-AZURIN FROM PSEUDOMONAS AERUGINOSA 1Q7L ; 1.40 ; ZN-BINDING DOMAIN OF THE T347G MUTANT OF HUMAN AMINOACYLASE- I 1HI9 ; 2.40 ; ZN-DEPENDENT D-AMINOPEPTIDASE DPPA FROM BACILLUS SUBTILIS, A SELF-COMPARTMENTALIZING PROTEASE. 1BC2 ; 1.90 ; ZN-DEPENDENT METALLO-BETA-LACTAMASE FROM BACILLUS CEREUS 1W7V ; 2.00 ; ZNMG SUBSTITUTED AMINOPEPTIDASE P FROM E. COLI 1TOT ; -1.00 ; ZZ DOMAIN OF CBP- A NOVEL FOLD FOR A PROTEIN INTERACTION MODULE 1JQ4 ; -1.00 ; [2FE-2S] DOMAIN OF METHANE MONOOXYGENASE REDUCTASE FROM METHYLOCOCCUS CAPSULATUS (BATH) 1E0Z ; -1.00 ; [2FE-2S]-FERREDOXIN FROM HALOBACTERIUM SALINARUM 1E10 ; -1.00 ; [2FE-2S]-FERREDOXIN FROM HALOBACTERIUM SALINARUM 1OCI ; -1.00 ; [3.2.0]BCANA:DEOXYRIBONUCLEIC ACID 1FVN ; -1.00 ; [ALA31, AIB32]-NEUROPEPTIDE Y 1ICY ; -1.00 ; [ALA31,PRO32]-PNPY BOUND TO DPC MICELLES 1BZV ; -1.00 ; [D-ALAB26]-DES(B27-B30)-INSULIN-B26-AMIDE A SUPERPOTENT SINGLE-REPLACEMENT INSULIN ANALOGUE, NMR, MINIMIZED AVERAGE STRUCTURE 1FY3 ; 1.89 ; [G175Q]HBP, A MUTANT OF HUMAN HEPARIN BINDING PROTEIN (CAP37) 1TZ4 ; -1.00 ; [HPP19-23]-PNPY BOUND TO DPC MICELLES 1E3D ; 1.80 ; [NIFE] HYDROGENASE FROM DESULFOVIBRIO DESULFURICANS ATCC 27774 1TZ5 ; -1.00 ; [PNPY19-23]-HPP BOUND TO DPC MICELLES 1P1P ; -1.00 ; [PRO7,13] AA-CONOTOXIN PIVA, NMR, 12 STRUCTURES 1FY1 ; 2.50 ; [R23S,F25E]HBP, A MUTANT OF HUMAN HEPARIN BINDING PROTEIN (CAP37)